,entities,start_tokens,end_tokens,start_chars,end_chars,text,pmid,lf_cytokine_distsv,lf_transcription_factor_distsv,lf_t_lymphocyte_distsv,olabel,orig_index,label,prob_0,prob_1,prob_2
12,CTL immunity,9,11,55,67,"The presence of T-helper cells favors the induction of CTL immunity, whereas the absence of T-helper cells can result in CTL tolerance.",10395322_1,-1,-1,-1,-1,12,-1,0.003906807,8.8702705e-05,0.9960045
15,CTL tolerance,21,23,121,134,"The presence of T-helper cells favors the induction of CTL immunity, whereas the absence of T-helper cells can result in CTL tolerance.",10395322_1,-1,-1,-1,-1,15,-1,0.0012346798,0.0018075026,0.9969578
19,that triggering,3,5,20,35,We demonstrate here that triggering of CD40 in vivo can considerably enhance the efficacy of peptide-based anti-tumor vaccines.,10395322_3,-1,-1,-1,-1,19,-1,3.1473264e-05,0.9999504,1.8135941e-05
21,peptide-based,15,16,93,106,We demonstrate here that triggering of CD40 in vivo can considerably enhance the efficacy of peptide-based anti-tumor vaccines.,10395322_3,0,-1,2,-1,21,-1,0.00029747482,0.9996177,8.4751366e-05
23,tolerogenic peptide,4,6,21,40,The combination of a tolerogenic peptide vaccine containing a minimal essential CTL epitope with an activating antibody against CD40 converts tolerization into strong CTL priming.,10395322_4,-1,-1,-1,-1,23,-1,0.00012853021,0.99983716,3.427543e-05
27,tumor-specific peptide,9,11,58,80,"Moreover, CD40 ligation can provide an already protective tumor-specific peptide vaccine with the capacity to induce therapeutic CTL immunity in tumor-bearing mice.",10395322_5,-1,-1,-1,-1,27,-1,0.0005284378,0.99941003,6.1488536e-05
30,therapeutic CTL immunity,17,20,117,141,"Moreover, CD40 ligation can provide an already protective tumor-specific peptide vaccine with the capacity to induce therapeutic CTL immunity in tumor-bearing mice.",10395322_5,-1,-1,-1,-1,30,-1,0.24902263,0.65111893,0.099858426
33,that the,3,5,24,32,"These findings indicate that the CD40-CD40 ligand pair can act as a 'switch', determining whether naive peripheral CTLs are primed or tolerized, and support the clinical use of CD40-stimulating agents as components of anti-cancer vaccines.",10395322_6,-1,-1,-1,-1,33,-1,4.2500983e-06,0.99999225,3.4827642e-06
41,therapy,14,15,91,98,"The E6 and E7 oncoproteins of human papillomavirus are potentially ideal targets of immune therapy for cervical cancer, because their expression is necessary for cellular transformation.",10419051_1,0,1,-1,-1,41,-1,7.57422e-06,0.9999856,6.8310924e-06
43,cellular transformation,25,27,162,185,"The E6 and E7 oncoproteins of human papillomavirus are potentially ideal targets of immune therapy for cervical cancer, because their expression is necessary for cellular transformation.",10419051_1,-1,-1,-1,-1,43,-1,0.0007796782,0.021562664,0.9776577
44,proteins,5,6,24,32,"Although both E6 and E7 proteins contain numerous predicted cytotoxic T lymphocyte (CTL) epitopes that are capable of binding to human leukocyte antigens, the majority of earlier in vivo tumor rejection studies have focused on E7.",10419051_2,0,1,-1,-1,44,-1,5.351734e-06,0.99998975,4.9310906e-06
52,that gene,3,5,13,22,"We show here that gene gun-mediated skin transfection of plasmid vector encoding the nontransforming, amino-terminal half of E6 resulted in the induction of E6-specific CTL activity and tumor rejection in a murine model.",10419051_3,-1,-1,-1,-1,52,-1,6.4883284e-06,0.9999881,5.468694e-06
70,that transfection,3,5,21,38,Our results indicate that transfection of the mIL-12 gene at the vaccination site may represent an attractive adjuvant for cancer gene immunotherapy.,10419051_6,-1,-1,-1,-1,70,-1,4.5597876e-06,0.99999094,4.512178e-06
75,the transcription factor nuclear factor-kappaB,2,7,14,60,Activation of the transcription factor nuclear factor-kappaB (NFkappaB) is impaired in T cells from patients with renal cell carcinomas (RCCs).,10491412_0,-1,-1,-1,-1,75,-1,1.2242498e-05,0.99997723,1.0526603e-05
83,factor IkappaBalpha,27,29,176,195,"In circulating T cells from a subset of patients with RCCs, the suppression of NFkappaB binding activity is downstream from the stimulus-induced degradation of the cytoplasmic factor IkappaBalpha.",10491412_1,-1,-1,-1,-1,83,-1,1.7066504e-05,0.9999721,1.0787982e-05
87,these cells,26,28,191,202,"Tumor-derived soluble products from cultured RCC explants inhibit NFkappaB activity in T cells from healthy volunteers, despite a normal level of stimulus-induced IkappaBalpha degradation in these cells.",10491412_2,-1,-1,-1,-1,87,-1,1.5879361e-05,9.870568e-06,0.99997425
92,kidney tissue,15,17,96,109,"Indeed, we detected gangliosides in supernatants from RCC explants and not from adjacent normal kidney tissue.",10491412_4,-1,-1,-1,-1,92,-1,0.0023790565,0.90252703,0.09509388
95,the cytokines,30,32,181,194,"Gangliosides prepared from RCC supernatants, as well as the purified bovine gangliosides G(m1) and G(d1a), suppressed NFkappaB binding activity in T cells and reduced expression of the cytokines IL-2 and IFN-gamma.",10491412_5,-1,-1,-1,-1,95,-1,0.706449,0.29043177,0.0031193402
97,Taken together,0,2,0,14,"Taken together, our findings suggest that tumor-derived gangliosides may blunt antitumor immune responses in patients with RCCs.",10491412_6,-1,-1,-1,-1,97,-1,1.13053065e-05,0.99998045,8.205842e-06
98,that tumor-derived,6,8,37,55,"Taken together, our findings suggest that tumor-derived gangliosides may blunt antitumor immune responses in patients with RCCs.",10491412_6,-1,-1,-1,-1,98,-1,2.94532e-05,0.99995685,1.3708667e-05
102,immune responses to the,1,5,16,39,"Vaccine-induced immune responses to the HPV early antigens E6 and E7, which contribute to cell transformation and are thus expressed in these cervical cancers, could potentially eradicate malignant cells.",10772987_1,-1,-1,-1,-1,102,-1,0.8311824,0.16721027,0.0016073163
104,to cell transformation,14,17,87,109,"Vaccine-induced immune responses to the HPV early antigens E6 and E7, which contribute to cell transformation and are thus expressed in these cervical cancers, could potentially eradicate malignant cells.",10772987_1,-1,-1,-1,-1,104,-1,4.7937818e-05,0.00019580791,0.9997563
116,to tumor cell,19,22,111,124,"Data presented here demonstrate that depending on the model either CD4(+) or CD8(+) T cells provide protection to tumor cell challenge, resulting in striking differences in the efficacy of the four vaccines under investigation.",10772987_4,-1,-1,-1,-1,116,-1,0.0049548447,0.73799103,0.25705412
125,function,19,20,108,116,"Thymoma is known to contain CD4+CD8+ T cells, indicating that neoplastic epithelial cells of thymoma have a function as thymic cortical epithelium.",10886240_0,0,1,2,-1,125,-1,0.00021491955,0.9995852,0.00019984048
127,that there,6,8,27,37,"However, it has been shown that there is an impairment of CD4+ T cell development in thymoma and that IFN-gamma-induced HLA-DR expression on cultured thymic epithelial cells (TEC) derived from thymoma is decreased when compared with the normal thymus.",10886240_1,-1,-1,-1,-1,127,-1,4.185783e-06,0.9999913,4.5559686e-06
130,that IFN-gamma-induced,20,22,97,119,"However, it has been shown that there is an impairment of CD4+ T cell development in thymoma and that IFN-gamma-induced HLA-DR expression on cultured thymic epithelial cells (TEC) derived from thymoma is decreased when compared with the normal thymus.",10886240_1,-1,-1,-1,-1,130,-1,0.850834,0.14742315,0.0017428641
136,thymus,42,43,244,250,"However, it has been shown that there is an impairment of CD4+ T cell development in thymoma and that IFN-gamma-induced HLA-DR expression on cultured thymic epithelial cells (TEC) derived from thymoma is decreased when compared with the normal thymus.",10886240_1,-1,1,2,-1,136,-1,1.0537065e-05,0.9999826,6.8687323e-06
138,to play,9,11,45,52,MHC class II transactivator (CIITA) is known to play a critical role in IFN-gamma-induced MHC II expression.,10886240_2,-1,-1,-1,-1,138,-1,9.357091e-06,0.99998486,5.7853013e-06
143,to IFN-gamma,22,24,133,145,"In this study, we attempted to elucidate whether CIITA is responsible for the impaired up-regulation of MHC II molecules in response to IFN-gamma in thymoma TEC.",10886240_3,-1,-1,-1,-1,143,-1,0.99313533,0.0062926337,0.00057203794
144,thymoma TEC,25,27,149,160,"In this study, we attempted to elucidate whether CIITA is responsible for the impaired up-regulation of MHC II molecules in response to IFN-gamma in thymoma TEC.",10886240_3,-1,-1,-1,-1,144,-1,5.2867485e-06,0.99999,4.7215253e-06
146,that the,8,10,83,91,A quantitative reverse transriptase-polymerase chain reaction examination revealed that the induced level of CIITA was significantly lower in thymoma TEC than in normal TEC.,10886240_4,-1,-1,-1,-1,146,-1,4.5763018e-06,0.99999154,3.943499e-06
147,thymoma TEC than,18,21,142,158,A quantitative reverse transriptase-polymerase chain reaction examination revealed that the induced level of CIITA was significantly lower in thymoma TEC than in normal TEC.,10886240_4,-1,-1,-1,-1,147,-1,5.2000587e-06,0.9999894,5.4130255e-06
150,thymoma TEC,12,14,57,68,The induced levels of invariant chain (Ii) and HLA-DR in thymoma TEC were correlated with CIITA expression.,10886240_5,-1,-1,-1,-1,150,-1,7.1077484e-06,0.99998593,6.917295e-06
157,STAT1 to the,10,13,62,74,"A gel mobility shift assay however, revealed translocation of STAT1 to the nucleus in thymoma as well as normal TEC.",10886240_7,-1,-1,-1,-1,157,-1,4.440367e-06,0.99998784,7.754298e-06
161,the thymoma TEC to,6,10,54,72,Intercellular adhesion molecule-1 was up-regulated in the thymoma TEC to a level similar to normal TEC in response to IFN-gamma.,10886240_8,-1,-1,-1,-1,161,-1,4.0176346e-06,0.9999913,4.6646514e-06
164,to IFN-gamma,18,20,115,127,Intercellular adhesion molecule-1 was up-regulated in the thymoma TEC to a level similar to normal TEC in response to IFN-gamma.,10886240_8,-1,-1,-1,-1,164,-1,0.9885224,0.010546909,0.00093071477
167,to IFN-gamma,10,12,73,85,"These results indicate that impaired up-regulation of HLA-DR in response to IFN-gamma results from insufficient induction of CIITA, but not from the signal from IFN-gamma receptor to the nucleus.",10886240_9,-1,-1,-1,-1,167,-1,0.98423994,0.014894532,0.0008655246
169,IFN-gamma receptor to the,25,29,161,186,"These results indicate that impaired up-regulation of HLA-DR in response to IFN-gamma results from insufficient induction of CIITA, but not from the signal from IFN-gamma receptor to the nucleus.",10886240_9,-1,-1,-1,-1,169,-1,0.995363,0.0037432252,0.00089374196
180,the immune response,17,20,112,131,The E6 and E7 oncoproteins are constitutively expressed in these lesions and are therefore putative targets for the immune response against HPV.,10962445_1,-1,-1,-1,-1,180,-1,0.69152886,0.30677527,0.0016959254
181,The relation,0,2,0,12,The relation between HPV 16-specific memory cytotoxic T-cell precursor (mCTLp) activity to both oncoproteins and the natural course of cervical dysplasia was analyzed in 38 patients participating in a nonintervention cohort study of women with CIN and 11 HPV 16-positive cervical carcinoma patients.,10962445_2,-1,-1,-1,-1,181,-1,4.9729915e-06,0.9999902,4.7815674e-06
184,the natural,17,19,113,124,The relation between HPV 16-specific memory cytotoxic T-cell precursor (mCTLp) activity to both oncoproteins and the natural course of cervical dysplasia was analyzed in 38 patients participating in a nonintervention cohort study of women with CIN and 11 HPV 16-positive cervical carcinoma patients.,10962445_2,-1,-1,-1,-1,184,-1,5.5002915e-06,0.99998915,5.3197136e-06
187,the two,31,33,163,170,"In a cross-sectional study at the end of follow-up prior to biopsy, 8 of 20 patients with a persistent HPV 16 infection had specific mCTLp against at least one of the two oncoproteins.",10962445_3,-1,-1,-1,-1,187,-1,1.6332115e-05,0.99997604,7.610213e-06
190,protein,14,15,82,89,"However, 5 of 11 cervical carcinoma patients showed mCTLp activity against the E7 protein only.",10962445_5,0,1,-1,-1,190,-1,4.5969286e-05,0.9999193,3.4721455e-05
204,to interferon alfa,32,35,186,204,"We wanted to study the expression of interferon regulatory factor 4 (IRF4) in various hematologic disorders, especially chronic myeloid leukemia (CML), and its association with response to interferon alfa (IFN-alpha) treatment in CML.MATERIALS AND METHODS: Blood samples from various hematopoietic cell lines, different leukemia patients (70 CML, 29 acute myeloid leukemia [AML], 10 chronic myelomonocytic leukemia [CMMoL], 10 acute lymphoblastic leukemia, and 10 chronic lymphoid leukemia patients), and 33 healthy volunteers were monitored for IRF4 expression by reverse transcriptase polymerase chain reaction.",11013272_1,-1,-1,-1,-1,204,-1,0.89145875,0.10589798,0.0026432502
207,Blood,44,45,257,262,"We wanted to study the expression of interferon regulatory factor 4 (IRF4) in various hematologic disorders, especially chronic myeloid leukemia (CML), and its association with response to interferon alfa (IFN-alpha) treatment in CML.MATERIALS AND METHODS: Blood samples from various hematopoietic cell lines, different leukemia patients (70 CML, 29 acute myeloid leukemia [AML], 10 chronic myelomonocytic leukemia [CMMoL], 10 acute lymphoblastic leukemia, and 10 chronic lymphoid leukemia patients), and 33 healthy volunteers were monitored for IRF4 expression by reverse transcriptase polymerase chain reaction.",11013272_1,0,1,-1,-1,207,-1,0.00024013467,0.9988952,0.00086467696
212,the IRF4,8,10,27,35,"Then, with a focus on CML, the IRF4 level was determined in sorted cell subpopulations from CML patients and healthy volunteers and in in vitro-stimulated CML cells.",11013272_2,-1,-1,-1,-1,212,-1,1.7407754e-05,0.99996614,1.6489836e-05
218,IFN-alpha therapy,12,14,74,91,"Furthermore, IRF4 expression was compared in the CML samples taken before IFN-alpha therapy and in 47 additional CML samples taken during IFN-alpha therapy.",11013272_3,-1,-1,-1,-1,218,-1,0.9993488,0.00033537304,0.0003158113
220,IFN-alpha therapy,22,24,138,155,"Furthermore, IRF4 expression was compared in the CML samples taken before IFN-alpha therapy and in 47 additional CML samples taken during IFN-alpha therapy.",11013272_3,-1,-1,-1,-1,220,-1,0.99943405,0.0002789685,0.00028698903
223,to IFN-alpha,8,10,62,74,IRF4 expression was then correlated with cytogenetic response to IFN-alpha.,11013272_4,-1,-1,-1,-1,223,-1,0.993956,0.0053497697,0.0006941906
228,IFN-alpha therapy,4,6,23,40,"In CML patients during IFN-alpha therapy, a significant increase in IRF4 levels was detected, and this was also observed in sorted T cells from CML patients.",11013272_7,-1,-1,-1,-1,228,-1,0.99930835,0.00041186277,0.0002798324
233,IFN-alpha therapy,4,6,25,42,The increase seen during IFN-alpha therapy was not due to different blood counts.,11013272_8,-1,-1,-1,-1,233,-1,0.99936074,0.00036374765,0.00027555574
235,blood,11,12,68,73,The increase seen during IFN-alpha therapy was not due to different blood counts.,11013272_8,0,1,-1,-1,235,-1,0.009626134,0.14066093,0.8497129
236,to the,2,4,10,16,"In regard to the cytogenetic response with IFN-alpha, a good response was associated with high IRF4 expression.",11013272_9,-1,-1,-1,-1,236,-1,5.0028416e-06,0.99999034,4.6523182e-06
241,to IFN-alpha therapy,22,25,125,145,"CONCLUSION: IRF4 expression is downregulated in T cells of CML patients, and its increase is associated with a good response to IFN-alpha therapy.",11013272_10,-1,-1,-1,-1,241,-1,0.0054524085,0.9943334,0.00021425205
245,to IFN-alpha,17,19,91,103,"These data suggest IRF4 expression as a useful marker to monitor, if not predict, response to IFN-alpha in CML.",11013272_11,-1,-1,-1,-1,245,-1,0.9914163,0.0077580623,0.0008256938
246,immunology,2,3,12,22,Advances in immunology during the past three decades have facilitated our understanding of the biology of specific lymphoid neoplasms including chronic lymphocytic leukemia (CLL).,11042507_0,0,1,2,-1,246,-1,0.98324627,0.013917384,0.0028362896
271,the complex,41,43,213,224,"Here, we include an update on our studies regarding CD154 expression in CLL, a review of the data regarding the consequences of CD40 engagement in CLL B cells, and a discussion of these findings in the context of the complex and potentially opposite outcomes that have been reported for CD40-mediated signals in CLL.",11042507_3,-1,-1,-1,-1,271,-1,6.5704126e-06,0.99998844,4.9802534e-06
274,therapy,3,4,21,28,"The implications for therapy, such as by impedance to CD154-CD40 interaction using antibody to CD154, or by selective inhibitors of NF-kappa B, are considered.",11042507_4,0,1,-1,-1,274,-1,4.48586e-06,0.99999094,4.6289756e-06
276,to CD154,14,16,92,100,"The implications for therapy, such as by impedance to CD154-CD40 interaction using antibody to CD154, or by selective inhibitors of NF-kappa B, are considered.",11042507_4,-1,-1,-1,-1,276,-1,0.014746602,0.2991168,0.6861366
280,transforms cytokine-dependent T lymphocytes,10,14,44,87,Human T cell leukemia virus type 1 (HTLV-1) transforms cytokine-dependent T lymphocytes and causes adult T cell leukemia.,11046040_0,-1,-1,-1,-1,280,-1,0.012140368,0.14402992,0.8438297
283,transcription factors Stat5a,5,8,33,61,"Janus tyrosine kinase (Jak)3 and transcription factors Stat5a and Stat5b are essential for the proliferation of normal T cells and are constitutively hyperactivated in both HTLV-1-transformed human T cell lines and lymphocytes isolated from HTLV-1-infected patients; therefore, a critical role for the Jak3-Stat5 pathway in the progression of this disease has been postulated.",11046040_1,-1,-1,-1,-1,283,-1,1.1706953e-05,0.99997616,1.2147467e-05
293,that tyrphostin,3,5,21,36,We recently reported that tyrphostin AG-490 selectively blocked IL-2 activation of Jak3/Stat5 and growth of murine T cell lines.,11046040_2,-1,-1,-1,-1,293,-1,3.97809e-05,0.9999393,2.0949992e-05
310,DNA binding to the Stat5-responsive,54,59,280,315,"Disruption of constitutive Jak3/Stat5 activation by AG-490 was demonstrated by inhibition of 1) tyrosine phosphorylation of Jak3, Stat5a (Tyr(694)), and Stat5b (Tyr(699)); 2) serine phosphorylation of Stat5a (Ser(726)) as determined by a novel phosphospecific Ab; and 3) Stat5a/b DNA binding to the Stat5-responsive beta-casein promoter.",11046040_5,-1,-1,-1,-1,310,-1,9.790419e-06,0.9999809,9.312347e-06
317,that the,5,7,33,41,"Collectively, these data suggest that the Jak3-Stat5 pathway in HTLV-1-transformed T cells has become functionally redundant for proliferation.",11046040_7,-1,-1,-1,-1,317,-1,3.964128e-06,0.9999925,3.5818343e-06
319,functionally,15,16,102,114,"Collectively, these data suggest that the Jak3-Stat5 pathway in HTLV-1-transformed T cells has become functionally redundant for proliferation.",11046040_7,0,1,2,-1,319,-1,2.7400705e-05,0.99996006,1.2556963e-05
320,this functional,2,4,12,27,Reversal of this functional uncoupling may be required before Jak3/Stat5 inhibitors will be useful in the treatment of this malignancy.,11046040_8,-1,-1,-1,-1,320,-1,8.892901e-05,0.99987876,3.2286807e-05
321,the treatment,15,17,102,115,Reversal of this functional uncoupling may be required before Jak3/Stat5 inhibitors will be useful in the treatment of this malignancy.,11046040_8,-1,-1,-1,-1,321,-1,7.994074e-06,0.99998724,4.7596327e-06
328,cytokines that,7,9,40,54,This phenotype is determined in part by cytokines that influence T cell differentiation.,11086033_1,-1,-1,-1,-1,328,-1,0.97441274,0.024709538,0.00087774784
330,transplantable tumor,1,3,3,23,"In transplantable tumor models such as P1.HTR, tumors grow progressively despite expression of defined tumor Ags.",11086033_2,-1,-1,-1,-1,330,-1,4.362517e-06,0.99999154,4.053876e-06
333,that this,2,4,16,25,"We hypothesized that this failure to reject may be due to poor generation of a type 1 phenotype, through a dominant influence of the type 2-promoting cytokines IL-4 and/or IL-13.",11086033_3,-1,-1,-1,-1,333,-1,6.2677336e-06,0.9999896,4.1466396e-06
339,the type,24,26,129,137,"We hypothesized that this failure to reject may be due to poor generation of a type 1 phenotype, through a dominant influence of the type 2-promoting cytokines IL-4 and/or IL-13.",11086033_3,-1,-1,-1,-1,339,-1,5.0557655e-06,0.99998987,5.081705e-06
349,tumor-specific IFN-gamma,5,7,39,63,Rejection was accompanied by augmented tumor-specific IFN-gamma production and CTL activity.,11086033_6,-1,-1,-1,-1,349,-1,0.9244184,0.07391127,0.0016702862
354,immunity,12,13,99,107,These results suggest that pharmacologic inhibition of Stat6 signaling could potentiate anti-tumor immunity in vivo.,11086033_7,0,-1,2,-1,354,-1,0.99982136,5.172205e-05,0.00012687774
355,cell functions,1,3,9,23,Effector cell functions are regulated by a number of positive signals for the mediation of antitumor immunity.,11129327_0,-1,-1,-1,-1,355,-1,1.9766157e-05,1.0990019e-05,0.99996924
357,immunity,16,17,101,109,Effector cell functions are regulated by a number of positive signals for the mediation of antitumor immunity.,11129327_0,0,-1,2,-1,357,-1,0.9998865,2.8596265e-05,8.4874795e-05
361,the generation,13,15,68,82,"The CD40 and CD40 ligand (CD40L) interaction has been implicated in the generation of effective cell-mediated and humoral immune responses, where cytokines have been shown to play a significant role in the expression of these molecules.",11129327_1,-1,-1,-1,-1,361,-1,7.191947e-06,0.9999864,6.3515818e-06
365,to play,28,30,172,179,"The CD40 and CD40 ligand (CD40L) interaction has been implicated in the generation of effective cell-mediated and humoral immune responses, where cytokines have been shown to play a significant role in the expression of these molecules.",11129327_1,-1,-1,-1,-1,365,-1,6.799866e-06,0.9999881,5.127847e-06
377,to cells,19,21,113,121,"Tumor-transplanted animals showed enhanced expression of CD40L on natural killer (NK) and T cells, when compared to cells from normal animals.",11129327_4,-1,-1,-1,-1,377,-1,0.0012154062,0.047164164,0.9516204
378,tumor cells,4,6,24,35,CD40 expression on AK-5 tumor cells was also induced after s.c. transplantation.,11129327_5,-1,-1,-1,-1,378,-1,0.00021198943,0.0026013998,0.9971866
379,transplantation,12,13,64,79,CD40 expression on AK-5 tumor cells was also induced after s.c. transplantation.,11129327_5,-1,1,2,-1,379,-1,7.458622e-06,0.9999876,4.8820043e-06
385,cytokine release,40,42,266,282,"Administration of anti-(interleukin-12) (anti-IL-12) and anti-(interferon gamma) (anti-IFNgamma) antibodies in tumor-bearing animals showed down-regulation of the expression of CD40L on NK and T cells with simultaneous inhibition of cytotoxic acitivity of NK cells, cytokine release and the production of antitumor antibody.",11129327_6,-1,-1,-1,-1,385,-1,0.9924601,0.0065907747,0.00094921276
393,the immune response,3,6,27,46,"CD40L expression modulated the immune response exerted by NK cells, in part by the activation of nuclear factor kB (NF-kB).",11129327_8,-1,-1,-1,-1,393,-1,0.5656655,0.43286964,0.0014648456
399,CD40L through the,5,8,31,48,"Furthermore, the signaling via CD40L through the use of anti-CD40L antibody promoted the in vitro activation of cytotoxic as well as NF-kappaB binding activity in NK cells from tumor-transplanted animals.",11129327_9,-1,-1,-1,-1,399,-1,0.0053082155,0.041290477,0.95340127
405,that the,3,5,31,39,"These observations demonstrate that the expression of CD40L by the effector cells is regulated by IL-12 and IFNgamma, and could effectively modulate the NK-cell-mediated immune response during the regression of AK-5 tumor.",11129327_10,-1,-1,-1,-1,405,-1,3.6897768e-06,0.9999927,3.6348179e-06
419,that IL-15Ralpha,6,8,31,47,"In this study, we demonstrated that IL-15Ralpha, the IL-15-specific binding receptor, mRNA and protein levels were also elevated in HTLV-I-infected cells.",11160322_1,-1,-1,-1,-1,419,-1,0.0059248847,0.99369556,0.0003795437
420,the IL-15-specific,9,11,49,67,"In this study, we demonstrated that IL-15Ralpha, the IL-15-specific binding receptor, mRNA and protein levels were also elevated in HTLV-I-infected cells.",11160322_1,-1,-1,-1,-1,420,-1,0.18076174,0.81729466,0.0019436298
421,receptor,12,13,76,84,"In this study, we demonstrated that IL-15Ralpha, the IL-15-specific binding receptor, mRNA and protein levels were also elevated in HTLV-I-infected cells.",11160322_1,0,1,2,-1,421,-1,0.0009321233,0.030507367,0.9685606
422,protein,16,17,95,102,"In this study, we demonstrated that IL-15Ralpha, the IL-15-specific binding receptor, mRNA and protein levels were also elevated in HTLV-I-infected cells.",11160322_1,0,1,-1,-1,422,-1,8.025241e-06,0.9999856,6.35254e-06
424,that transient,2,4,10,24,We showed that transient HTLV-I Tax expression lead to increased IL-15Ralpha mRNA levels.,11160322_2,-1,-1,-1,-1,424,-1,4.588026e-06,0.99999154,3.917541e-06
431,that Tax,17,19,102,110,"In addition, by using a reporter construct that bears the human IL-15Ralpha promoter, we demonstrated that Tax expression increased promoter activity by at least 4-fold.",11160322_3,-1,-1,-1,-1,431,-1,6.3645225e-06,0.9999894,4.2729744e-06
432,analysis,9,10,62,70,"Furthermore, using promoter deletion constructs and gel shift analysis, we defined a functional NF-kappaB-binding motif in the human IL-15Ralpha promoter, suggesting that Tax activation of IL-15Ralpha is due, in part, to the induction of NF-kappaB. These data indicate that IL-15Ralpha is transcriptionally regulated by the HTLV-I Tax protein through the action of NF-kappaB. These findings suggest a role for IL-15Ralpha in aberrant T cell proliferation observed in HTLV-I-associated diseases.",11160322_4,0,1,-1,-1,432,-1,7.5408843e-06,0.99998534,7.1557206e-06
433,functional NF-kappaB-binding,14,16,85,113,"Furthermore, using promoter deletion constructs and gel shift analysis, we defined a functional NF-kappaB-binding motif in the human IL-15Ralpha promoter, suggesting that Tax activation of IL-15Ralpha is due, in part, to the induction of NF-kappaB. These data indicate that IL-15Ralpha is transcriptionally regulated by the HTLV-I Tax protein through the action of NF-kappaB. These findings suggest a role for IL-15Ralpha in aberrant T cell proliferation observed in HTLV-I-associated diseases.",11160322_4,-1,-1,-1,-1,433,-1,1.1383923e-05,0.99998,8.604436e-06
436,that Tax,24,26,166,174,"Furthermore, using promoter deletion constructs and gel shift analysis, we defined a functional NF-kappaB-binding motif in the human IL-15Ralpha promoter, suggesting that Tax activation of IL-15Ralpha is due, in part, to the induction of NF-kappaB. These data indicate that IL-15Ralpha is transcriptionally regulated by the HTLV-I Tax protein through the action of NF-kappaB. These findings suggest a role for IL-15Ralpha in aberrant T cell proliferation observed in HTLV-I-associated diseases.",11160322_4,-1,-1,-1,-1,436,-1,5.8061896e-06,0.99998975,4.5003635e-06
438,to the,35,37,218,224,"Furthermore, using promoter deletion constructs and gel shift analysis, we defined a functional NF-kappaB-binding motif in the human IL-15Ralpha promoter, suggesting that Tax activation of IL-15Ralpha is due, in part, to the induction of NF-kappaB. These data indicate that IL-15Ralpha is transcriptionally regulated by the HTLV-I Tax protein through the action of NF-kappaB. These findings suggest a role for IL-15Ralpha in aberrant T cell proliferation observed in HTLV-I-associated diseases.",11160322_4,-1,-1,-1,-1,438,-1,4.394576e-06,0.9999912,4.389454e-06
440,that IL-15Ralpha,43,45,269,285,"Furthermore, using promoter deletion constructs and gel shift analysis, we defined a functional NF-kappaB-binding motif in the human IL-15Ralpha promoter, suggesting that Tax activation of IL-15Ralpha is due, in part, to the induction of NF-kappaB. These data indicate that IL-15Ralpha is transcriptionally regulated by the HTLV-I Tax protein through the action of NF-kappaB. These findings suggest a role for IL-15Ralpha in aberrant T cell proliferation observed in HTLV-I-associated diseases.",11160322_4,-1,-1,-1,-1,440,-1,0.27604958,0.72232616,0.0016242801
443,Tax protein through the,51,55,331,354,"Furthermore, using promoter deletion constructs and gel shift analysis, we defined a functional NF-kappaB-binding motif in the human IL-15Ralpha promoter, suggesting that Tax activation of IL-15Ralpha is due, in part, to the induction of NF-kappaB. These data indicate that IL-15Ralpha is transcriptionally regulated by the HTLV-I Tax protein through the action of NF-kappaB. These findings suggest a role for IL-15Ralpha in aberrant T cell proliferation observed in HTLV-I-associated diseases.",11160322_4,-1,-1,-1,-1,443,-1,3.9588745e-06,0.999992,4.0810423e-06
447,through the,7,9,48,59,"In early CD4(-)CD8(-) pro-thymocytes, signaling through the pre-TCR is crucial for survival and differentiation into CD4(+)CD8(+) cells.",11290785_0,-1,-1,-1,-1,447,-1,4.389307e-06,0.99999106,4.563251e-06
452,to cell,16,18,107,114,"At this more mature stage, interactions between alphabetaTCR and self-Ag/MHC complexes in turn lead either to cell survival and differentiation (positive selection) or to cell death (negative selection).",11290785_1,-1,-1,-1,-1,452,-1,0.0019988567,0.14803481,0.84996635
453,to cell,26,28,168,175,"At this more mature stage, interactions between alphabetaTCR and self-Ag/MHC complexes in turn lead either to cell survival and differentiation (positive selection) or to cell death (negative selection).",11290785_1,-1,-1,-1,-1,453,-1,0.0015258632,0.0942623,0.9042118
455,thymocytes,11,12,83,93,"Intrinsic differences must therefore exist between pre-TCR signals in CD4(-)CD8(-) thymocytes and alphabetaTCR signals in CD4(+)CD8(+) cells, since only the latter can mediate a death signal.",11290785_2,-1,1,2,-1,455,-1,0.0027194212,0.7148191,0.2824615
461,thymoma cell,20,22,116,128,"In this work, we directly compared the capability of pre-TCR and alphabetaTCR to induce apoptosis in a CD4(-)CD8(-) thymoma cell line following receptor cross-linking with mAbs.",11290785_3,-1,-1,-1,-1,461,-1,0.0021752745,0.47249308,0.5253317
462,receptor,24,25,144,152,"In this work, we directly compared the capability of pre-TCR and alphabetaTCR to induce apoptosis in a CD4(-)CD8(-) thymoma cell line following receptor cross-linking with mAbs.",11290785_3,0,1,2,-1,462,-1,0.061550118,0.00023735518,0.9382125
466,thymocytes,21,22,150,160,"Cross-linking of alphabetaTCR triggered high levels of programmed cell death, mimicking the negative selection signal usually induced in CD4(+)CD8(+) thymocytes.",11290785_4,-1,1,2,-1,466,-1,0.0020465339,0.32251385,0.67543966
467,receptor,18,19,118,126,"In contrast, pre-TCR was very inefficient at inducing apoptosis upon cross-linking, despite similar levels of surface receptor expression.",11290785_5,0,1,2,-1,467,-1,0.004647717,0.00016274376,0.99518955
469,TCRzeta,16,17,106,113,"Importantly, inefficient apoptosis induction by the pre-TCR did not result from its weak association with TCRzeta chain, since TCRs containing alpha-pTalpha chimeric chains, binding weakly to TCRzeta, were still able to induce apoptosis.",11290785_6,-1,1,2,-1,469,-1,1.8625731e-05,0.9999541,2.7311946e-05
470,TCRs,20,21,127,131,"Importantly, inefficient apoptosis induction by the pre-TCR did not result from its weak association with TCRzeta chain, since TCRs containing alpha-pTalpha chimeric chains, binding weakly to TCRzeta, were still able to induce apoptosis.",11290785_6,-1,1,2,-1,470,-1,1.2610364e-05,0.99995995,2.7391976e-05
471,to TCRzeta,28,30,189,199,"Importantly, inefficient apoptosis induction by the pre-TCR did not result from its weak association with TCRzeta chain, since TCRs containing alpha-pTalpha chimeric chains, binding weakly to TCRzeta, were still able to induce apoptosis.",11290785_6,-1,-1,-1,-1,471,-1,1.474355e-05,0.9999709,1.4300982e-05
474,the two,16,18,126,133,"Although similar tyrosine phosphorylation and calcium influx were induced after either pre-TCR or alphabetaTCR cross-linking, the two pathways diverged at the level of Fas ligand induction.",11290785_7,-1,-1,-1,-1,474,-1,7.92453e-06,0.99998736,4.6534938e-06
481,that the,7,9,41,49,"Together, these results support the view that the structure of the pre-TCR and alphabetaTCR directly influences their apoptosis-inducing capabilities by activating distinct signaling pathways.",11290785_9,-1,-1,-1,-1,481,-1,3.9057213e-06,0.99999213,3.907003e-06
484,the interferon,3,5,18,32,"Mice deficient in the interferon consensus sequence binding protein (ICSBP) develop a disease resembling chronic myeloid leukemia (CML), which in humans is caused by the BCR/ABL oncoprotein.",11369642_0,-1,-1,-1,-1,484,-1,0.21451062,0.78199047,0.0034989286
491,therapy,11,12,74,81,Interferon-alpha (IFN-alpha) induces ICSBP expression and is an effective therapy for CML.,11369642_1,0,1,-1,-1,491,-1,4.98126e-06,0.9999902,4.813861e-06
494,that ICSBP-modified cells generated,15,19,121,156,This study examined whether enforced expression of ICSBP might antagonize BCR/ABL-induced leukemia; results demonstrated that ICSBP-modified cells generated a protective CD8(+) cytotoxic T-cell response against BCR/ABL-transformed BaF3 cells in a murine leukemia model.,11369642_2,-1,-1,-1,-1,494,-1,2.8757304e-05,0.9999423,2.8937473e-05
495,T-cell,24,25,187,193,This study examined whether enforced expression of ICSBP might antagonize BCR/ABL-induced leukemia; results demonstrated that ICSBP-modified cells generated a protective CD8(+) cytotoxic T-cell response against BCR/ABL-transformed BaF3 cells in a murine leukemia model.,11369642_2,-1,1,2,-1,495,-1,1.8147992e-05,7.140225e-06,0.9999747
498,immune response to,10,13,64,82,ICSBP expression represents a novel means of stimulating a host immune response to BCR/ABL(+) leukemia cells and a potential strategy for immunotherapy of CML.,11369642_3,-1,-1,-1,-1,498,-1,0.9607099,0.03858225,0.0007077776
500,Blood,1,2,1,6,(Blood. 2001;97:3491-3497),11369642_4,0,1,-1,-1,500,-1,0.0021520176,0.9935883,0.004259617
504,to generate,5,7,28,39,We used the Cre-loxP system to generate a T cell-specific deletion of the Pten gene (Pten(flox/-) mice).,11371355_1,-1,-1,-1,-1,504,-1,5.636386e-06,0.99999046,3.9094266e-06
509,thymic cellularity,5,7,33,51,Pten(flox/-) mice show increased thymic cellularity due in part to a defect in thymic negative selection.,11371355_3,-1,-1,-1,-1,509,-1,0.0062778634,0.72771525,0.26600686
518,tolerance to,1,3,11,23,Peripheral tolerance to SEB is also impaired in Pten(flox/-) mice.,11371355_6,-1,-1,-1,-1,518,-1,7.52212e-06,0.9999869,5.6060667e-06
522,TGFbeta,7,8,49,56,"IL-2 responses are susceptible to suppression by TGFbeta, a cytokine widely implicated in suppression of inflammatory responses and secreted by many different tumor cell types.",11418694_0,0,1,-1,-1,522,-1,4.090985e-05,0.9999491,1.0011832e-05
524,tumor cell types,23,26,159,175,"IL-2 responses are susceptible to suppression by TGFbeta, a cytokine widely implicated in suppression of inflammatory responses and secreted by many different tumor cell types.",11418694_0,-1,-1,-1,-1,524,-1,0.00039799488,0.026845243,0.9727568
528,TGFbeta,14,15,108,115,There have been conflicting reports regarding inhibition of IL-2-induced STAT3 and STAT5 phosphorylation by TGFbeta and subsequent suppression of immune responses.,11418694_1,0,1,-1,-1,528,-1,6.9741815e-05,0.9999167,1.3548929e-05
530,TGFbeta-producing,1,2,6,23,Using TGFbeta-producing multiple myeloma tumor cells we demonstrate that tumor-derived TGFbeta can block IL-2-induced proliferation and STAT3 and STAT5 phosphorylation in T cells.,11418694_2,0,1,-1,-1,530,-1,0.00034227342,0.9995229,0.00013479969
531,tumor cells,4,6,41,52,Using TGFbeta-producing multiple myeloma tumor cells we demonstrate that tumor-derived TGFbeta can block IL-2-induced proliferation and STAT3 and STAT5 phosphorylation in T cells.,11418694_2,-1,-1,-1,-1,531,-1,0.00014486823,0.001169009,0.99868613
532,that tumor-derived TGFbeta,8,11,68,94,Using TGFbeta-producing multiple myeloma tumor cells we demonstrate that tumor-derived TGFbeta can block IL-2-induced proliferation and STAT3 and STAT5 phosphorylation in T cells.,11418694_2,-1,-1,-1,-1,532,-1,0.00015754398,0.99982077,2.1667121e-05
539,tumor cells,27,29,170,181,High affinity IL-2R expression was required for the suppression of IL-2 responses as a novel CD25(-) T cell line proliferated and phosphorylated STAT3 when cultured with tumor cells or rTGFbeta1.,11418694_3,-1,-1,-1,-1,539,-1,0.000116634365,0.0013200149,0.99856335
544,T cells to,20,23,110,120,"Activating T cells with IL-15, which does not use the high affinity IL-2R, completely restored the ability of T cells to phosphorylate STAT3 and STAT5 when cultured with tumor cells.",11418694_4,-1,-1,-1,-1,544,-1,0.001613814,0.061907604,0.93647856
547,tumor cells,30,32,170,181,"Activating T cells with IL-15, which does not use the high affinity IL-2R, completely restored the ability of T cells to phosphorylate STAT3 and STAT5 when cultured with tumor cells.",11418694_4,-1,-1,-1,-1,547,-1,0.00016288992,0.0034934515,0.9963437
548,IL-15-treated T cells,0,3,0,21,"IL-15-treated T cells proliferated normally when cocultured with tumor cells or rTGFbeta1, whereas IL-2 responses were consistently inhibited.",11418694_5,-1,-1,-1,-1,548,-1,0.9334366,0.00026336007,0.06629998
549,tumor cells,8,10,65,76,"IL-15-treated T cells proliferated normally when cocultured with tumor cells or rTGFbeta1, whereas IL-2 responses were consistently inhibited.",11418694_5,-1,-1,-1,-1,549,-1,0.00021028073,0.0044845236,0.9953053
552,T cells to,8,11,54,64,"Preincubation with IL-15 also restored the ability of T cells to respond to IL-2 by phosphorylating STAT3 and STAT5, and proliferating normally in the presence of tumor cells.",11418694_6,-1,-1,-1,-1,552,-1,0.0015006042,0.060604613,0.9378947
557,tumor cells,27,29,163,174,"Preincubation with IL-15 also restored the ability of T cells to respond to IL-2 by phosphorylating STAT3 and STAT5, and proliferating normally in the presence of tumor cells.",11418694_6,-1,-1,-1,-1,557,-1,6.18411e-05,0.00021997982,0.9997181
558,T cell function,5,8,34,49,IL-2 pretreatment did not restore T cell function.,11418694_7,-1,-1,-1,-1,558,-1,2.0388154e-05,1.4246153e-05,0.9999653
568,TGFbeta1-producing tumor cells,15,18,81,111,"Thus, activation of T cells by IL-15 renders T cells resistant to suppression by TGFbeta1-producing tumor cells and rTGFbeta1.",11418694_9,-1,-1,-1,-1,568,-1,0.0028419523,0.8302377,0.1669203
580,CD8+ T cell activation,10,15,67,89,"KS initiates in a context of immune dysregulation characterised by CD8+ T cell activation and the production of Th1-type cytokines that induce a generalised activation of endothelial cells leading to adhesion and tissue extravasation of lympho-monocytes, spindle cell formation and angiogenesis.",11423257_1,-1,-1,-1,-1,580,-1,1.4010655e-05,5.8484584e-06,0.9999801
582,Th1-type cytokines that,19,22,112,135,"KS initiates in a context of immune dysregulation characterised by CD8+ T cell activation and the production of Th1-type cytokines that induce a generalised activation of endothelial cells leading to adhesion and tissue extravasation of lympho-monocytes, spindle cell formation and angiogenesis.",11423257_1,-1,-1,-1,-1,582,-1,1.8633671e-05,0.9999664,1.5015845e-05
586,tissue,33,34,213,219,"KS initiates in a context of immune dysregulation characterised by CD8+ T cell activation and the production of Th1-type cytokines that induce a generalised activation of endothelial cells leading to adhesion and tissue extravasation of lympho-monocytes, spindle cell formation and angiogenesis.",11423257_1,-1,1,2,-1,586,-1,1.6770096e-05,0.9999727,1.0483506e-05
595,tissue,9,10,71,77,"Productively-infected circulating cells are recruited into 'activated' tissue sites where HHV8 finds an optimal environment for establishing a persistent, latent infection of KS spindle cells (KSC).",11423257_3,-1,1,2,-1,595,-1,2.8202898e-05,0.9996718,0.00029999748
598,to immune responses that,14,18,94,118,"HHV8 dissemination is favoured by virus escape mechanisms and immune dysregulation, and leads to immune responses that are not effective against the virus but, paradoxically, exacerbates the reactive process.",11423257_4,-1,-1,-1,-1,598,-1,0.00042655977,0.9995284,4.5020228e-05
601,nature that,9,11,54,65,"Although early KS is a reactive process of polyclonal nature that can regress, in time it can progress in to a true sarcoma.",11423257_5,-1,-1,-1,-1,601,-1,1.27268295e-05,0.99996555,2.178038e-05
607,to the,8,10,40,46,"The progression of KS appears to be due to the deregulated expression of oncogenes and oncosuppressor genes, to the long-lasting expression of the HHV8 latency genes and, for AIDS-KS, is promoted by the proliferative and angiogenic effects of the HIV-1 Tat protein.",11423257_6,-1,-1,-1,-1,607,-1,4.2414613e-06,0.9999913,4.4180497e-06
609,to the,18,20,109,115,"The progression of KS appears to be due to the deregulated expression of oncogenes and oncosuppressor genes, to the long-lasting expression of the HHV8 latency genes and, for AIDS-KS, is promoted by the proliferative and angiogenic effects of the HIV-1 Tat protein.",11423257_6,-1,-1,-1,-1,609,-1,5.6463405e-06,0.9999888,5.611416e-06
615,The transcription factor GATA-3,0,4,0,31,The transcription factor GATA-3 is essential for early T cell development and differentiation of naive CD4(+) T cells into Th2 effector cells.,11441076_0,-1,-1,-1,-1,615,-1,6.4904843e-06,0.9999856,7.911996e-06
622,the function,2,4,9,21,"To study the function of GATA-3 during T cell-mediated immune responses in vivo, we investigated CD2-GATA3-transgenic mice in which GATA-3 expression is driven by the CD2 locus control region.",11441076_1,-1,-1,-1,-1,622,-1,5.640809e-06,0.99998903,5.328502e-06
624,T cell-mediated immune responses,7,11,39,71,"To study the function of GATA-3 during T cell-mediated immune responses in vivo, we investigated CD2-GATA3-transgenic mice in which GATA-3 expression is driven by the CD2 locus control region.",11441076_1,-1,-1,-1,-1,624,-1,0.068698004,0.00059141027,0.93071055
633,the IL-1 receptor,13,16,85,102,"In CD2-GATA3-transgenic mice, large fractions of peripheral CD4(+) T cells expressed the IL-1 receptor family member T1/ST2, indicative of advanced Th2 commitment.",11441076_3,-1,-1,-1,-1,633,-1,0.05305612,0.9421213,0.0048225387
640,the Th2 cytokines,10,13,55,72,"Moreover, CD4(+) T cells manifested rapid secretion of the Th2 cytokines IL-4, IL-5, and IL-10, reminiscent of Th2 memory cells.",11441076_5,-1,-1,-1,-1,640,-1,0.07017788,0.9272019,0.0026201773
654,Th2 cytokine,20,22,144,156,"Under Th1 conditions, cellular proliferation of CD2-GATA3-transgenic CD4(+) cells was severely hampered, IFN-gamma production was decreased and Th2 cytokine production was increased.",11441076_7,-1,-1,-1,-1,654,-1,0.24607502,0.74925536,0.004669627
664,functional,2,3,14,24,"The increased functional capacity to secrete Th2 cytokines, along with the increased expression of surface markers for Ag-experienced Th2-committed cells, would argue for a role of GATA-3 in Th2 memory formation.",11441076_10,0,1,2,-1,664,-1,0.07282213,0.40979746,0.5173805
666,Th2 cytokines,6,8,45,58,"The increased functional capacity to secrete Th2 cytokines, along with the increased expression of surface markers for Ag-experienced Th2-committed cells, would argue for a role of GATA-3 in Th2 memory formation.",11441076_10,-1,-1,-1,-1,666,-1,0.3707053,0.6231485,0.006146171
668,Th2-committed cells,19,21,134,153,"The increased functional capacity to secrete Th2 cytokines, along with the increased expression of surface markers for Ag-experienced Th2-committed cells, would argue for a role of GATA-3 in Th2 memory formation.",11441076_10,-1,-1,-1,-1,668,-1,0.0026582757,0.34835437,0.64898735
676,functional,6,7,31,41,"In this study, we investigated functional consequences and molecular events in T cells exposed to low levels of oxidative stress.",11509600_2,0,1,2,-1,676,-1,0.00017915266,0.99974376,7.713921e-05
679,that cytokine,2,4,12,25,"We observed that cytokine production of human PBMC, upon stimulation with an HLA-A*0201-restricted influenza peptide and nonspecific receptor cross-linking, was reduced after exposure to micromolar levels of H2O2.",11509600_3,-1,-1,-1,-1,679,-1,0.5159959,0.4799927,0.0040114042
680,peptide,15,16,109,116,"We observed that cytokine production of human PBMC, upon stimulation with an HLA-A*0201-restricted influenza peptide and nonspecific receptor cross-linking, was reduced after exposure to micromolar levels of H2O2.",11509600_3,0,-1,2,-1,680,-1,0.013061611,0.9848262,0.0021121774
681,receptor,18,19,133,141,"We observed that cytokine production of human PBMC, upon stimulation with an HLA-A*0201-restricted influenza peptide and nonspecific receptor cross-linking, was reduced after exposure to micromolar levels of H2O2.",11509600_3,0,1,2,-1,681,-1,0.0021410424,0.00023996652,0.997619
683,Functional,0,1,0,10,Functional impairment as measured by IFN-gamma release occurred earlier and at lower doses of exogenously added H2O2 than required to induce apoptosis.,11509600_4,0,1,2,-1,683,-1,0.017027024,0.98060983,0.0023631195
684,IFN-gamma release,5,7,37,54,Functional impairment as measured by IFN-gamma release occurred earlier and at lower doses of exogenously added H2O2 than required to induce apoptosis.,11509600_4,-1,-1,-1,-1,684,-1,0.99982196,7.544101e-05,0.000102631864
688,that there,2,4,14,24,This suggests that there is a dose window of oxidative stress leading to T cell unresponsiveness in the absence of apoptosis.,11509600_5,-1,-1,-1,-1,688,-1,5.6276526e-06,0.99999046,3.8935614e-06
689,to T cell,12,15,70,79,This suggests that there is a dose window of oxidative stress leading to T cell unresponsiveness in the absence of apoptosis.,11509600_5,-1,-1,-1,-1,689,-1,0.0020600958,0.17186607,0.8260738
692,Th1 cytokines,3,5,17,30,"The reduction of Th1 cytokines, induced by H2O2, was predominantly observed in memory/effector (CD45RO(+)) T cells and correlated with a block in NF-kappaB activation.",11509600_6,-1,-1,-1,-1,692,-1,0.10392279,0.88973355,0.006343642
696,than IFN-gamma,11,13,69,83,"IL-10 production was more profoundly influenced by low doses of H2O2 than IFN-gamma, TNF-alpha, and IL-2.",11509600_7,-1,-1,-1,-1,696,-1,0.98985636,0.009201687,0.0009420275
697,TNF-alpha,14,15,85,94,"IL-10 production was more profoundly influenced by low doses of H2O2 than IFN-gamma, TNF-alpha, and IL-2.",11509600_7,0,1,-1,-1,697,-1,0.027812263,0.97183776,0.00035004027
700,naive T cells,15,18,106,119,The influence of H2O2 on production of IL-10 was not significantly different between memory/activated and naive T cells.,11509600_8,-1,-1,-1,-1,700,-1,0.0018541162,0.072148025,0.925998
702,that Th1,3,5,27,35,These observations suggest that Th1 and Th2 cytokines are differently regulated under conditions of oxidative stress.,11509600_9,-1,-1,-1,-1,702,-1,5.376665e-06,0.9999863,8.370673e-06
703,Th2 cytokines,6,8,40,53,These observations suggest that Th1 and Th2 cytokines are differently regulated under conditions of oxidative stress.,11509600_9,-1,-1,-1,-1,703,-1,0.40784237,0.58291936,0.009238321
704,Taken together,0,2,0,14,"Taken together, these findings may explain why Ag-experienced, CD45RO(+), T cells found in the tumor milieu are functionally suppressed.",11509600_10,-1,-1,-1,-1,704,-1,1.3228969e-05,0.9999784,8.315882e-06
707,the tumor,17,19,91,100,"Taken together, these findings may explain why Ag-experienced, CD45RO(+), T cells found in the tumor milieu are functionally suppressed.",11509600_10,-1,-1,-1,-1,707,-1,4.907246e-06,0.99999094,4.099704e-06
708,functionally,21,22,112,124,"Taken together, these findings may explain why Ag-experienced, CD45RO(+), T cells found in the tumor milieu are functionally suppressed.",11509600_10,0,1,2,-1,708,-1,4.5182303e-05,0.9999385,1.6276259e-05
712,proteins,4,5,14,22,The E6 and E7 proteins of HPV are constitutively expressed in cervical carcinoma cells making them attractive targets for CTL-based immunotherapy.,11673561_1,0,1,-1,-1,712,-1,1.8956873e-05,0.99997175,9.269855e-06
723,These CTL,0,2,0,9,These CTL were unable to recognize HLA-A*0201(+) HPV16 E6(+) cervical carcinoma cell lines even when the level of endogenous HPV16 E6 in these cells was increased by transfection.,11673561_4,-1,-1,-1,-1,723,-1,0.0013046714,0.057715304,0.94098
727,these cells,24,26,137,148,These CTL were unable to recognize HLA-A*0201(+) HPV16 E6(+) cervical carcinoma cell lines even when the level of endogenous HPV16 E6 in these cells was increased by transfection.,11673561_4,-1,-1,-1,-1,727,-1,3.552157e-05,4.4154895e-05,0.99992037
731,protein,25,26,139,146,"This defect in presentation of HPV16 E6(29-38) correlated with low level expression of HLA class I, proteasome subunits low molecular mass protein 2 and 7, and the transporter proteins TAP1 and TAP2 in the cervical carcinoma cell lines.",11673561_5,0,1,-1,-1,731,-1,7.3699455e-05,0.9998447,8.1661456e-05
732,the transporter proteins TAP1,31,35,160,189,"This defect in presentation of HPV16 E6(29-38) correlated with low level expression of HLA class I, proteasome subunits low molecular mass protein 2 and 7, and the transporter proteins TAP1 and TAP2 in the cervical carcinoma cell lines.",11673561_5,-1,-1,-1,-1,732,-1,6.7183946e-06,0.99998415,9.173512e-06
737,these proteins,5,7,25,39,"The expression of all of these proteins could be up-regulated by IFN-gamma, but this was insufficient for CTL recognition unless the level of HPV16 E6 Ag was also increased by transfection.",11673561_6,-1,-1,-1,-1,737,-1,1.9825098e-05,0.9999714,8.777808e-06
762,factors,6,7,46,53,Tumors produce a variety of immunosuppressive factors which can prevent the proliferation and maturation of a number of normal hemopoietic cell types.,11698483_0,0,1,-1,-1,762,-1,0.99981207,9.899446e-05,8.887484e-05
764,cell types,20,22,139,149,Tumors produce a variety of immunosuppressive factors which can prevent the proliferation and maturation of a number of normal hemopoietic cell types.,11698483_0,-1,-1,-1,-1,764,-1,3.3142413e-05,1.597596e-05,0.9999509
766,T cell function,17,20,97,112,We have investigated whether primary acute myeloid leukemia (AML) cells have an effect on normal T cell function and signaling.,11698483_1,-1,-1,-1,-1,766,-1,1.6822345e-05,1.3534251e-05,0.9999696
767,Tumor cell,0,2,0,10,Tumor cell supernatant (TSN) from AML cells inhibited T cell activation and Th1 cytokine production and also prevented activated T cells from entering the cell cycle.,11698483_2,-1,-1,-1,-1,767,-1,0.0001467418,0.00047517213,0.99937797
771,Th1 cytokine,14,16,76,88,Tumor cell supernatant (TSN) from AML cells inhibited T cell activation and Th1 cytokine production and also prevented activated T cells from entering the cell cycle.,11698483_2,-1,-1,-1,-1,771,-1,0.121589184,0.8720747,0.006336055
773,the cell,25,27,151,159,Tumor cell supernatant (TSN) from AML cells inhibited T cell activation and Th1 cytokine production and also prevented activated T cells from entering the cell cycle.,11698483_2,-1,-1,-1,-1,773,-1,0.0004101723,0.0121503165,0.98743945
776,cell-T cell,8,10,45,56,These effects occurred in the absence of AML cell-T cell contact.,11698483_3,-1,-1,-1,-1,776,-1,1.6275115e-05,6.6765683e-06,0.999977
782,TGF-beta,21,22,128,136,"We have demonstrated that AML TSN contained none of the immunosuppressors described to date, namely gangliosides, nitric oxide, TGF-beta, IL-10, vascular endothelial growth factor, or PGs.",11698483_4,0,1,-1,-1,782,-1,0.00013954195,0.9998317,2.8729426e-05
787,protein,11,12,69,76,"However, the effect was overcome by preincubation with inhibitors of protein secretion and abolished by trypsinization, indicating that the active substance includes one or more proteins.",11698483_6,0,1,-1,-1,787,-1,0.0089925565,0.9904793,0.0005281228
789,that the,19,21,131,139,"However, the effect was overcome by preincubation with inhibitors of protein secretion and abolished by trypsinization, indicating that the active substance includes one or more proteins.",11698483_6,-1,-1,-1,-1,789,-1,6.336964e-06,0.99998915,4.5496677e-06
790,proteins,27,28,178,186,"However, the effect was overcome by preincubation with inhibitors of protein secretion and abolished by trypsinization, indicating that the active substance includes one or more proteins.",11698483_6,0,1,-1,-1,790,-1,0.034079026,0.96426547,0.0016555344
806,the transition,33,35,189,203,"Phosphorylation of pRb by cyclin-dependent kinase 6/4-cyclin D and of p130 did not occur and c-Myc, cyclin D3, and p107 were not induced, consistent with cell cycle inhibition early during the transition from G(0) to G(1).",11698483_10,-1,-1,-1,-1,806,-1,5.215935e-06,0.9999889,5.8174974e-06
808,that TSN generated,3,6,18,36,Our data indicate that TSN generated by AML cells induces T cell immunosuppression and provides a mechanism by which the leukemic clone could evade T cell-mediated killing.,11698483_11,-1,-1,-1,-1,808,-1,6.938957e-06,0.9999883,4.6927917e-06
817,that they,13,15,80,89,"Although MHC class II molecules are frequently detected on MG cells, suggesting that they may be capable of antigen (Ag) presentation to CD4(+) T cells, deficiencies in CD4(+) T-cell activation are associated with these nonimmunogenic tumors.",11746775_1,-1,-1,-1,-1,817,-1,6.573265e-06,0.9999876,5.7765574e-06
841,antigen-presenting cells,31,33,202,226,"IFN-gamma-inducible CIITA expression in MG cells, as well as primary human astrocytes, was directed by two CIITA promoters, pIV, the promoter for IFN-gamma-inducible CIITA expression in nonprofessional antigen-presenting cells (APC), and pIII, the promoter that directs constitutive CIITA expression in B cells.",11746775_4,-1,-1,-1,-1,841,-1,0.7708398,0.00021985185,0.22894034
848,time that,6,8,34,43,"We also demonstrate for the first time that MG cells can process native Ag for presentation to CD4(+) MHC class II-restricted Th1 cells, indicating that MG cells can serve as nonprofessional APC.",11746775_6,-1,-1,-1,-1,848,-1,4.4482767e-06,0.99999094,4.6273512e-06
855,target to,5,7,19,28,"CIITA may be a key target to modulate MHC class II expression, which could augment immunogenicity, Ag presentation, and CD4(+) T-cell activation in MG therapy.",11746775_7,-1,-1,-1,-1,855,-1,4.0335835e-06,0.99999166,4.2607567e-06
857,therapy,28,29,151,158,"CIITA may be a key target to modulate MHC class II expression, which could augment immunogenicity, Ag presentation, and CD4(+) T-cell activation in MG therapy.",11746775_7,0,1,-1,-1,857,-1,5.2682067e-06,0.99998796,6.725414e-06
865,TNF-alpha,20,21,114,123,"The 15-d-PGJ(2) has been shown to both inhibit as well as induce the production of inflammatory mediators such as TNF-alpha, IL-1beta, and cyclooxygenase, mostly occurring via a nuclear receptor called peroxisome proliferator-activated receptor-gamma (PPAR-gamma).",11801678_2,0,1,-1,-1,865,-1,0.14716862,0.8513286,0.0015027989
868,receptor-gamma,36,37,236,250,"The 15-d-PGJ(2) has been shown to both inhibit as well as induce the production of inflammatory mediators such as TNF-alpha, IL-1beta, and cyclooxygenase, mostly occurring via a nuclear receptor called peroxisome proliferator-activated receptor-gamma (PPAR-gamma).",11801678_2,0,1,2,-1,868,-1,0.553769,0.3540817,0.092149325
890,protein,18,19,95,102,"In this study, we report that 15-d-PGJ(2) induced a significant increase in both IL-8 mRNA and protein from activated human T lymphocytes.",11801678_8,0,1,-1,-1,890,-1,1.6663955e-05,0.9999728,1.053669e-05
894,through the nuclear receptor PPAR-gamma,10,15,51,90,"The induction of IL-8 by 15-d-PGJ(2) did not occur through the nuclear receptor PPAR-gamma, as synthetic PPAR-gamma agonists did not mimic the IL-8-inducing effects of 15-d-PGJ(2).",11801678_9,-1,-1,-1,-1,894,-1,3.696768e-05,0.99994445,1.8565821e-05
895,PPAR-gamma agonists,18,20,105,124,"The induction of IL-8 by 15-d-PGJ(2) did not occur through the nuclear receptor PPAR-gamma, as synthetic PPAR-gamma agonists did not mimic the IL-8-inducing effects of 15-d-PGJ(2).",11801678_9,-1,-1,-1,-1,895,-1,0.00018934537,0.9997441,6.658708e-05
896,the IL-8-inducing,23,25,139,156,"The induction of IL-8 by 15-d-PGJ(2) did not occur through the nuclear receptor PPAR-gamma, as synthetic PPAR-gamma agonists did not mimic the IL-8-inducing effects of 15-d-PGJ(2).",11801678_9,-1,-1,-1,-1,896,-1,0.18079588,0.81738156,0.001822591
900,protein,9,10,64,71,"The mechanism of IL-8 induction was through a mitogen-activated protein kinase and NF-kappaB pathway, as inhibitors of both systems abrogated IL-8 protein induction.",11801678_10,0,1,-1,-1,900,-1,0.00019960658,0.999713,8.737157e-05
902,IL-8 protein,21,23,142,154,"The mechanism of IL-8 induction was through a mitogen-activated protein kinase and NF-kappaB pathway, as inhibitors of both systems abrogated IL-8 protein induction.",11801678_10,-1,-1,-1,-1,902,-1,0.99981695,6.895253e-05,0.00011404032
908,the complexity,3,5,20,34,These findings show the complexity with which 15-d-PGJ(2) regulates T cells by possessing both pro- and anti-inflammatory properties depending on the activation state of the cell.,11801678_12,-1,-1,-1,-1,908,-1,8.69464e-06,0.9999825,8.858275e-06
912,the cell,25,27,170,178,These findings show the complexity with which 15-d-PGJ(2) regulates T cells by possessing both pro- and anti-inflammatory properties depending on the activation state of the cell.,11801678_12,-1,-1,-1,-1,912,-1,1.9766456e-05,1.4756818e-05,0.9999654
917,T-cell,6,7,43,49,Mycosis fungoides is a low-grade cutaneous T-cell lymphoma (CTCL) of unknown etiology.,11807001_0,-1,1,2,-1,917,-1,1.3607531e-05,5.294613e-06,0.99998116
919,T(H)1 to T(H)2,12,15,61,75,"In advanced stages of CTCL, a shift in cytokine profile from T(H)1 to T(H)2 is observed, which coincides with eosinophilia, high levels of immunoglobulin E, and increased susceptibility to bacterial infections.",11807001_1,-1,-1,-1,-1,919,-1,0.00013262132,0.9998037,6.364443e-05
921,T(H)2 cytokines,7,9,28,43,"It is, however, unknown why T(H)2 cytokines predominate in advanced CTCL, and the cellular source of these cytokines also remains to be identified.",11807001_2,-1,-1,-1,-1,921,-1,0.12961565,0.866583,0.0038014115
922,the cellular,15,17,78,90,"It is, however, unknown why T(H)2 cytokines predominate in advanced CTCL, and the cellular source of these cytokines also remains to be identified.",11807001_2,-1,-1,-1,-1,922,-1,0.005922156,0.5819035,0.4121743
923,these cytokines,19,21,101,116,"It is, however, unknown why T(H)2 cytokines predominate in advanced CTCL, and the cellular source of these cytokines also remains to be identified.",11807001_2,-1,-1,-1,-1,923,-1,0.8985776,0.09844156,0.002980872
928,tumor cells,12,14,67,78,"In a previous study, constitutive activation of Stat3 was found in tumor cells isolated from affected skin and blood from CTCL patients.",11807001_4,-1,-1,-1,-1,928,-1,0.00014586886,0.00076419476,0.99908996
929,blood,19,20,111,116,"In a previous study, constitutive activation of Stat3 was found in tumor cells isolated from affected skin and blood from CTCL patients.",11807001_4,0,1,-1,-1,929,-1,0.0005544015,0.99734867,0.002096972
931,tumor cell,7,9,28,38,"Here, it is shown that CTCL tumor cell lines, but not nonmalignant cell lines, spontaneously produce interleukin-5 (IL-5), IL-6, and IL-13.",11807001_5,-1,-1,-1,-1,931,-1,7.356138e-05,0.00021551271,0.999711
937,tumor cells,2,4,16,27,"Transfection of tumor cells with dominant-negative Stat3 almost completely blocks IL-5 production and strongly inhibits IL-13 production, whereas IL-6 production is unaffected.",11807001_6,-1,-1,-1,-1,937,-1,0.00016553543,0.003584603,0.99624985
944,cells themselves,8,10,40,56,"Thus, the data show that malignant CTCL cells themselves might contribute to the change in cytokine pattern accompanying progression of CTCL.",11807001_7,-1,-1,-1,-1,944,-1,0.00045480786,0.00079151697,0.99875367
945,to the,12,14,74,80,"Thus, the data show that malignant CTCL cells themselves might contribute to the change in cytokine pattern accompanying progression of CTCL.",11807001_7,-1,-1,-1,-1,945,-1,6.1222186e-06,0.9999883,5.601361e-06
955,the relative,6,8,45,57,"We systematically investigated the impact of the relative maturation levels of dendritic cells (DCs) on their cell surface phenotype, expression of cytokines and chemokines/chemokine receptors (by DNA array and RNase protection analyses), biological activities, and abilities to induce tumor immunity.",11902830_0,-1,-1,-1,-1,955,-1,4.1012854e-06,0.9999913,4.5977004e-06
957,their cell,17,19,104,114,"We systematically investigated the impact of the relative maturation levels of dendritic cells (DCs) on their cell surface phenotype, expression of cytokines and chemokines/chemokine receptors (by DNA array and RNase protection analyses), biological activities, and abilities to induce tumor immunity.",11902830_0,-1,-1,-1,-1,957,-1,5.960215e-05,0.00013063576,0.9998098
959,receptors,27,28,183,192,"We systematically investigated the impact of the relative maturation levels of dendritic cells (DCs) on their cell surface phenotype, expression of cytokines and chemokines/chemokine receptors (by DNA array and RNase protection analyses), biological activities, and abilities to induce tumor immunity.",11902830_0,0,1,2,-1,959,-1,0.3200062,0.00033860374,0.6796552
961,tumor immunity,45,47,286,300,"We systematically investigated the impact of the relative maturation levels of dendritic cells (DCs) on their cell surface phenotype, expression of cytokines and chemokines/chemokine receptors (by DNA array and RNase protection analyses), biological activities, and abilities to induce tumor immunity.",11902830_0,-1,-1,-1,-1,961,-1,0.03153696,0.96782213,0.00064096274
962,their antigen-presenting,7,9,56,80,"Mature DCs expressed significantly heightened levels of their antigen-presenting machinery (e.g., CD54, CD80, CD86) and numerous cytokines and chemokines/chemokine receptors (i.e., Flt-3L, G-CSF, IL-1alpha and -1beta, IL-6, IL-12, CCL-2, -3, -4, -5, -17, and -22, MIP-2, and CCR7) and were significantly better at inducing effector T cell responses in vitro.",11902830_1,-1,-1,-1,-1,962,-1,0.28204486,0.7132651,0.004689964
966,receptors,24,25,164,173,"Mature DCs expressed significantly heightened levels of their antigen-presenting machinery (e.g., CD54, CD80, CD86) and numerous cytokines and chemokines/chemokine receptors (i.e., Flt-3L, G-CSF, IL-1alpha and -1beta, IL-6, IL-12, CCL-2, -3, -4, -5, -17, and -22, MIP-2, and CCR7) and were significantly better at inducing effector T cell responses in vitro.",11902830_1,0,1,2,-1,966,-1,0.011427005,0.00045415506,0.9881188
973,tumor peptide-pulsed,5,7,34,54,"Furthermore, mice vaccinated with tumor peptide-pulsed mature DCs better survived challenge with a weakly immunogenic tumor (8 of 8 survivors) than did mice vaccinated with less mature (3 of 8 survived) or immature (0 of 8 survivors) DCs.",11902830_2,-1,-1,-1,-1,973,-1,0.000364215,0.99959284,4.298256e-05
980,Taken together,0,2,0,14,"Taken together, our data clearly underscore the critical nature of employing DCs of full maturity for DC-based antitumor vaccination strategies.",11902830_4,-1,-1,-1,-1,980,-1,1.0676394e-05,0.9999819,7.445729e-06
990,to the,2,4,12,18,A corollary to the latter is that survival of melanoma in the host is due to the development of anti-apoptotic mechanisms in melanoma cells.,11905805_2,-1,-1,-1,-1,990,-1,8.068721e-06,0.9999864,5.557803e-06
993,to the,15,17,74,80,A corollary to the latter is that survival of melanoma in the host is due to the development of anti-apoptotic mechanisms in melanoma cells.,11905805_2,-1,-1,-1,-1,993,-1,5.425488e-06,0.9999907,3.908637e-06
996,them to,10,12,51,58,What are these mechanisms? And how might we bypass them to improve the treatment of melanoma?,11905805_3,-1,-1,-1,-1,996,-1,3.328185e-05,0.99995685,9.812439e-06
997,the treatment,13,15,67,80,What are these mechanisms? And how might we bypass them to improve the treatment of melanoma?,11905805_3,-1,-1,-1,-1,997,-1,1.8013812e-05,0.9999752,6.7381297e-06
998,receptor,10,11,41,49,"CD30 ligand (CD30L), but not its cognate receptor CD30, is frequently expressed on acute myeloid leukaemia (AML) blasts.",11918534_0,0,1,2,-1,998,-1,0.0009984667,0.0005608214,0.9984407
1005,those cytokines,24,26,165,180,"In the present study, we found that leukaemic blasts presenting surface CD30L displayed a characteristic cytokine-receptor pattern that makes them ideal targets for those cytokines usually produced by Th2-type cell subsets.",11918534_1,-1,-1,-1,-1,1005,-1,0.6716615,0.32366058,0.0046779183
1006,Th2-type cell subsets,29,32,201,222,"In the present study, we found that leukaemic blasts presenting surface CD30L displayed a characteristic cytokine-receptor pattern that makes them ideal targets for those cytokines usually produced by Th2-type cell subsets.",11918534_1,-1,-1,-1,-1,1006,-1,0.002730243,0.33709383,0.6601759
1008,Th2 cytokine receptors,9,12,51,73,"In particular, even though a broad distribution of Th2 cytokine receptors by AML blasts was shown, we demonstrated the almost exclusive expression of interleukin 4 (IL-4) receptor (R), in the absence of its cognate cytokine, by CD30L+ AML.",11918534_2,-1,-1,-1,-1,1008,-1,0.013360624,0.8926995,0.09393992
1011,receptor,30,31,171,179,"In particular, even though a broad distribution of Th2 cytokine receptors by AML blasts was shown, we demonstrated the almost exclusive expression of interleukin 4 (IL-4) receptor (R), in the absence of its cognate cytokine, by CD30L+ AML.",11918534_2,0,1,2,-1,1011,-1,8.3051804e-05,0.0001461651,0.9997708
1018,the Th1-associated,36,38,191,209,"Furthermore, a number of Th2-associated markers, including CD30, IL-4 and GATA-3, were expressed by residual T cells derived from CD30L+ AML but not from CD30L- AML, in which the presence of the Th1-associated marker LAG-3 was documented in some cases.",11918534_3,-1,-1,-1,-1,1018,-1,9.266995e-06,0.99998176,9.005776e-06
1027,T-cell,10,11,67,73,"These results, along with the shift toward IL-4-producing specific T-cell clones observed in CD30L+ AML samples by enzyme-linked Immunospot (ELISpot) assay, were consistent with the hypothesis of a Th2 polarization taking place in T cells from CD30L+ AML.",11918534_5,-1,1,2,-1,1027,-1,1.3687833e-05,9.063256e-06,0.99997723
1030,taking place,34,36,215,227,"These results, along with the shift toward IL-4-producing specific T-cell clones observed in CD30L+ AML samples by enzyme-linked Immunospot (ELISpot) assay, were consistent with the hypothesis of a Th2 polarization taking place in T cells from CD30L+ AML.",11918534_5,-1,-1,-1,-1,1030,-1,9.518809e-06,0.9999826,7.885254e-06
1035,that the,17,19,116,124,The notion that IL-4 was able to enhance in vitro proliferation of CD30L+/IL-4R+ purified leukaemic blasts suggests that the selective interaction of IL-4-producing CD30+ T cells with CD30L+ leukaemic progenitors may have a role in the progression of this particular AML subset.,11918534_6,-1,-1,-1,-1,1035,-1,4.536647e-06,0.9999919,3.6188487e-06
1040,receptors,5,6,34,43,"Activation of apoptosis via death receptors is a tightly regulated event, and the death pathway itself is open to interference on the part of soluble or membrane-bound decoy receptors.",11924906_0,0,1,2,-1,1040,-1,0.0045128153,3.7382055e-05,0.99544984
1045,receptors,29,30,174,183,"Activation of apoptosis via death receptors is a tightly regulated event, and the death pathway itself is open to interference on the part of soluble or membrane-bound decoy receptors.",11924906_0,0,1,2,-1,1045,-1,0.00013645877,4.144769e-05,0.9998221
1049,factor,10,11,64,70,"The aggregation state of the death-inducing ligand is a crucial factor, particularly when these molecules are used as recombinant drugs against tumors.",11924906_1,0,1,-1,-1,1049,-1,0.00016298695,0.999803,3.407528e-05
1055,receptors,16,17,94,103,Whether tumors are sensitive to such ligands is determined by both the net abundance of death receptors versus decoy receptors and the balance between intracellular apoptotic and antiapoptotic mechanisms.,11924906_2,0,1,2,-1,1055,-1,0.0002479581,3.232782e-05,0.9997197
1056,receptors,19,20,117,126,Whether tumors are sensitive to such ligands is determined by both the net abundance of death receptors versus decoy receptors and the balance between intracellular apoptotic and antiapoptotic mechanisms.,11924906_2,0,1,2,-1,1056,-1,8.4890184e-05,3.0446521e-05,0.9998847
1060,tumor cells,7,9,39,50,"This means that in vivo elimination of tumor cells by effector arms such as T lymphocytes, natural killer cells, macrophages, and dendritic cells is dependent on both the function of activated lymphoid cells and the genetic properties of tumor cells.",11924906_3,-1,-1,-1,-1,1060,-1,0.0001198622,0.00094733527,0.9989328
1065,the function,30,32,167,179,"This means that in vivo elimination of tumor cells by effector arms such as T lymphocytes, natural killer cells, macrophages, and dendritic cells is dependent on both the function of activated lymphoid cells and the genetic properties of tumor cells.",11924906_3,-1,-1,-1,-1,1065,-1,3.2617063e-05,0.9999238,4.3582026e-05
1067,the genetic,37,39,212,223,"This means that in vivo elimination of tumor cells by effector arms such as T lymphocytes, natural killer cells, macrophages, and dendritic cells is dependent on both the function of activated lymphoid cells and the genetic properties of tumor cells.",11924906_3,-1,-1,-1,-1,1067,-1,6.7501546e-06,0.9999863,7.0147807e-06
1068,tumor cells,41,43,238,249,"This means that in vivo elimination of tumor cells by effector arms such as T lymphocytes, natural killer cells, macrophages, and dendritic cells is dependent on both the function of activated lymphoid cells and the genetic properties of tumor cells.",11924906_3,-1,-1,-1,-1,1068,-1,3.981779e-05,6.104338e-05,0.99989915
1076,tumor cells,23,25,131,142,"When expressed on cytotoxic T lymphocytes, natural killer cells, monocytes, and dendritic cells, they induce the apoptosis of many tumor cells, whereas their expression on tumor cells induces the apoptosis of killer cells.",11924906_5,-1,-1,-1,-1,1076,-1,9.644026e-05,0.00028694977,0.9996166
1078,tumor cells,30,32,172,183,"When expressed on cytotoxic T lymphocytes, natural killer cells, monocytes, and dendritic cells, they induce the apoptosis of many tumor cells, whereas their expression on tumor cells induces the apoptosis of killer cells.",11924906_5,-1,-1,-1,-1,1078,-1,7.243708e-05,0.00023859653,0.999689
1084,their state,13,15,70,81,"The in vivo result is influenced by the number of infiltrating cells, their state of activation, the cytokine repertoire in the tumor microenvironment, and the ability of the tumor to produce soluble factors inhibiting their cytolytic functions.",11924906_6,-1,-1,-1,-1,1084,-1,9.877566e-06,0.9999707,1.9430105e-05
1085,the cytokine,18,20,97,109,"The in vivo result is influenced by the number of infiltrating cells, their state of activation, the cytokine repertoire in the tumor microenvironment, and the ability of the tumor to produce soluble factors inhibiting their cytolytic functions.",11924906_6,-1,-1,-1,-1,1085,-1,0.5254638,0.4700952,0.0044410145
1086,the tumor,22,24,124,133,"The in vivo result is influenced by the number of infiltrating cells, their state of activation, the cytokine repertoire in the tumor microenvironment, and the ability of the tumor to produce soluble factors inhibiting their cytolytic functions.",11924906_6,-1,-1,-1,-1,1086,-1,4.7793783e-06,0.9999901,5.172167e-06
1088,the tumor to,30,33,171,183,"The in vivo result is influenced by the number of infiltrating cells, their state of activation, the cytokine repertoire in the tumor microenvironment, and the ability of the tumor to produce soluble factors inhibiting their cytolytic functions.",11924906_6,-1,-1,-1,-1,1088,-1,4.3949613e-06,0.99999106,4.556276e-06
1089,factors,35,36,200,207,"The in vivo result is influenced by the number of infiltrating cells, their state of activation, the cytokine repertoire in the tumor microenvironment, and the ability of the tumor to produce soluble factors inhibiting their cytolytic functions.",11924906_6,0,1,-1,-1,1089,-1,0.89420825,0.105390415,0.00040131735
1091,functions,39,40,235,244,"The in vivo result is influenced by the number of infiltrating cells, their state of activation, the cytokine repertoire in the tumor microenvironment, and the ability of the tumor to produce soluble factors inhibiting their cytolytic functions.",11924906_6,0,1,2,-1,1091,-1,0.039682604,0.048082408,0.91223496
1093,TGF-beta,5,6,33,41,"Transforming growth factor beta (TGF-beta), a pleiotropic cytokine that regulates cell growth and differentiation, is secreted by many human tumors and markedly inhibits tumor-specific cellular immunity.",11964281_0,0,1,-1,-1,1093,-1,0.00019686128,0.99977714,2.597401e-05
1094,pleiotropic cytokine that,9,12,46,71,"Transforming growth factor beta (TGF-beta), a pleiotropic cytokine that regulates cell growth and differentiation, is secreted by many human tumors and markedly inhibits tumor-specific cellular immunity.",11964281_0,-1,-1,-1,-1,1094,-1,4.9545117e-05,0.9999231,2.7301645e-05
1097,tumor-specific cellular immunity,27,30,170,202,"Transforming growth factor beta (TGF-beta), a pleiotropic cytokine that regulates cell growth and differentiation, is secreted by many human tumors and markedly inhibits tumor-specific cellular immunity.",11964281_0,-1,-1,-1,-1,1097,-1,0.0079612145,0.8386659,0.15337291
1100,TGF-beta,9,10,62,70,Tumors can avoid the differentiating and apoptotic effects of TGF-beta by expressing a nonfunctional TGF-beta receptor.,11964281_1,0,1,-1,-1,1100,-1,7.930225e-05,0.99990416,1.6581189e-05
1101,TGF-beta receptor,14,16,101,118,Tumors can avoid the differentiating and apoptotic effects of TGF-beta by expressing a nonfunctional TGF-beta receptor.,11964281_1,-1,-1,-1,-1,1101,-1,8.143097e-05,0.9996532,0.0002653205
1104,tumor-specific cytotoxic T lymphocytes,13,17,85,123,We have determined whether this immune evasion strategy can be manipulated to shield tumor-specific cytotoxic T lymphocytes (CTLs) from the inhibitory effects of tumor-derived TGF-beta.,11964281_2,-1,-1,-1,-1,1104,-1,0.0046077715,0.56468546,0.43070677
1107,tumor-derived TGF-beta,25,27,162,184,We have determined whether this immune evasion strategy can be manipulated to shield tumor-specific cytotoxic T lymphocytes (CTLs) from the inhibitory effects of tumor-derived TGF-beta.,11964281_2,-1,-1,-1,-1,1107,-1,4.5836125e-05,0.99994516,9.051666e-06
1108,CTLs that,8,10,55,64,As our model we used Epstein-Barr virus (EBV)-specific CTLs that are infused as treatment for EBV-positive Hodgkin disease but that are vulnerable to the TGF-beta produced by this tumor.,11964281_3,-1,-1,-1,-1,1108,-1,0.002012634,0.009951476,0.98803586
1111,to the TGF-beta,22,25,147,162,As our model we used Epstein-Barr virus (EBV)-specific CTLs that are infused as treatment for EBV-positive Hodgkin disease but that are vulnerable to the TGF-beta produced by this tumor.,11964281_3,-1,-1,-1,-1,1111,-1,0.00027745552,0.9996958,2.6811182e-05
1112,this tumor,27,29,175,185,As our model we used Epstein-Barr virus (EBV)-specific CTLs that are infused as treatment for EBV-positive Hodgkin disease but that are vulnerable to the TGF-beta produced by this tumor.,11964281_3,-1,-1,-1,-1,1112,-1,4.2032057e-06,0.9999908,4.9476816e-06
1116,TGF-beta type,10,12,79,92,CTLs were transduced with a retrovirus vector expressing the dominant-negative TGF-beta type II receptor HATGF-betaRII-Deltacyt.,11964281_4,-1,-1,-1,-1,1116,-1,1.3619026e-05,0.9999739,1.2542139e-05
1117,receptor,13,14,96,104,CTLs were transduced with a retrovirus vector expressing the dominant-negative TGF-beta type II receptor HATGF-betaRII-Deltacyt.,11964281_4,0,1,2,-1,1117,-1,0.0005181468,0.00022946917,0.9992524
1118,protein,5,6,51,58,HATGF-betaRII-Deltacyt- but not green fluorescence protein (eGFP)-transduced CTLs was resistant to the antiproliferative and anticytotoxic effects of exogenous TGF-beta.,11964281_5,0,1,-1,-1,1118,-1,4.3623517e-05,0.9999131,4.3276523e-05
1120,to the,10,12,96,102,HATGF-betaRII-Deltacyt- but not green fluorescence protein (eGFP)-transduced CTLs was resistant to the antiproliferative and anticytotoxic effects of exogenous TGF-beta.,11964281_5,-1,-1,-1,-1,1120,-1,4.441725e-06,0.9999913,4.2717074e-06
1121,TGF-beta,18,19,160,168,HATGF-betaRII-Deltacyt- but not green fluorescence protein (eGFP)-transduced CTLs was resistant to the antiproliferative and anticytotoxic effects of exogenous TGF-beta.,11964281_5,0,1,-1,-1,1121,-1,8.907216e-05,0.9998964,1.4455047e-05
1122,receptor-transduced cells,2,4,14,39,"Additionally, receptor-transduced cells continued to secrete cytokines in response to antigenic stimulation.",11964281_6,-1,-1,-1,-1,1122,-1,0.00014500617,3.3883378e-05,0.9998211
1125,to antigenic,10,12,83,95,"Additionally, receptor-transduced cells continued to secrete cytokines in response to antigenic stimulation.",11964281_6,-1,-1,-1,-1,1125,-1,0.70637685,0.29075372,0.002869399
1126,TGF-beta receptor,0,2,0,17,"TGF-beta receptor ligation results in phosphorylation of Smad2, and this pathway was disrupted in HATGF-betaRII-Deltacyt-transduced CTLs, confirming blockade of the signal transduction pathway.",11964281_7,-1,-1,-1,-1,1126,-1,0.0028847859,0.9944832,0.002631971
1132,TGF-betaRII-Deltacyt,3,4,24,44,"Long-term expression of TGF-betaRII-Deltacyt did not affect CTL function, phenotype, or growth characteristics.",11964281_8,0,1,-1,-1,1132,-1,0.002714038,0.99422014,0.0030658925
1133,CTL function,7,9,60,72,"Long-term expression of TGF-betaRII-Deltacyt did not affect CTL function, phenotype, or growth characteristics.",11964281_8,-1,-1,-1,-1,1133,-1,4.8502705e-05,2.9389887e-05,0.99992204
1134,Tumor-specific CTLs,0,2,0,19,Tumor-specific CTLs expressing HATGF-betaRII-Deltacyt should have a selective functional and survival advantage over unmodified CTLs in the presence of TGF-beta-secreting tumors and may be of value in treatment of these diseases.,11964281_9,-1,-1,-1,-1,1134,-1,0.0045299176,0.7332216,0.26224846
1135,functional,8,9,78,88,Tumor-specific CTLs expressing HATGF-betaRII-Deltacyt should have a selective functional and survival advantage over unmodified CTLs in the presence of TGF-beta-secreting tumors and may be of value in treatment of these diseases.,11964281_9,0,1,2,-1,1135,-1,0.002698446,0.9959692,0.0013323872
1138,TGF-beta-secreting tumors,19,21,152,177,Tumor-specific CTLs expressing HATGF-betaRII-Deltacyt should have a selective functional and survival advantage over unmodified CTLs in the presence of TGF-beta-secreting tumors and may be of value in treatment of these diseases.,11964281_9,-1,-1,-1,-1,1138,-1,1.9170428e-05,0.99996746,1.3416507e-05
1143,nuclear factor of activated T cells,9,15,90,125,The calcium-dependent phosphatase calcineurin and its downstream transcriptional effector nuclear factor of activated T cells (NFAT) are important regulators of inducible gene expression in multiple cell types.,12091710_0,-1,1,2,-1,1143,-1,0.0024213768,0.71359605,0.28398252
1145,cell types,27,29,199,209,The calcium-dependent phosphatase calcineurin and its downstream transcriptional effector nuclear factor of activated T cells (NFAT) are important regulators of inducible gene expression in multiple cell types.,12091710_0,-1,-1,-1,-1,1145,-1,2.2535334e-05,2.13661e-05,0.99995613
1148,the immune response,15,18,105,124,"In T cells, calcineurin-NFAT signaling represents a critical event for mediating cellular activation and the immune response.",12091710_1,-1,-1,-1,-1,1148,-1,0.76956415,0.22807322,0.0023625412
1150,thought to,9,11,67,77,The widely used immunosuppressant agents cyclosporin and FK506 are thought to antagonize the immune response by directly inhibiting calcineurin-NFAT signal transduction in lymphocytes.,12091710_2,-1,-1,-1,-1,1150,-1,1.0663438e-05,0.9999826,6.7520673e-06
1151,the immune response,12,15,89,108,The widely used immunosuppressant agents cyclosporin and FK506 are thought to antagonize the immune response by directly inhibiting calcineurin-NFAT signal transduction in lymphocytes.,12091710_2,-1,-1,-1,-1,1151,-1,0.7110335,0.28657672,0.0023897726
1156,the immune response,12,15,84,103,"To unequivocally establish the importance of calcineurin signaling as a mediator of the immune response, we deleted the gene encoding the predominant calcineurin isoform expressed in lymphocytes, calcineurin A beta (CnA beta).",12091710_3,-1,-1,-1,-1,1156,-1,0.72018754,0.27719888,0.0026135517
1157,the gene,18,20,116,124,"To unequivocally establish the importance of calcineurin signaling as a mediator of the immune response, we deleted the gene encoding the predominant calcineurin isoform expressed in lymphocytes, calcineurin A beta (CnA beta).",12091710_3,-1,-1,-1,-1,1157,-1,5.151432e-06,0.99998987,4.9517316e-06
1169,tumor-cell transplantation,9,11,54,80,"CnA beta(-/-) mice also were permissive to allogeneic tumor-cell transplantation in vivo, similar to cyclosporin-treated wild-type mice.",12091710_6,-1,-1,-1,-1,1169,-1,5.6792807e-05,0.9998715,7.1659786e-05
1182,the retinoic acid receptor,4,8,26,52,Rexinoids binding to both the retinoic acid receptor (RAR) and retinoid X receptor (RXR) families of rexinoid receptors have demonstrated clinical activity in hematologic malignancies and have been shown to mediate genes associated with both growth and differentiation.,12149223_0,-1,-1,-1,-1,1182,-1,0.00047483016,0.9981665,0.0013587119
1183,receptor,14,15,74,82,Rexinoids binding to both the retinoic acid receptor (RAR) and retinoid X receptor (RXR) families of rexinoid receptors have demonstrated clinical activity in hematologic malignancies and have been shown to mediate genes associated with both growth and differentiation.,12149223_0,0,1,2,-1,1183,-1,0.0014591009,0.012061325,0.9864796
1184,receptors,21,22,110,119,Rexinoids binding to both the retinoic acid receptor (RAR) and retinoid X receptor (RXR) families of rexinoid receptors have demonstrated clinical activity in hematologic malignancies and have been shown to mediate genes associated with both growth and differentiation.,12149223_0,0,1,2,-1,1184,-1,0.00014114175,0.0010772339,0.9987816
1187,the treatment,6,8,44,57,"RXR rexinoids have demonstrated efficacy in the treatment of cutaneous T-cell lymphomas, but the mechanism of action is unclear.",12149223_1,-1,-1,-1,-1,1187,-1,7.5295993e-06,0.99998784,4.6351415e-06
1188,T-cell,10,11,71,77,"RXR rexinoids have demonstrated efficacy in the treatment of cutaneous T-cell lymphomas, but the mechanism of action is unclear.",12149223_1,-1,1,2,-1,1188,-1,1.7028573e-05,1.1931178e-05,0.99997103
1189,the mechanism of action,14,18,93,116,"RXR rexinoids have demonstrated efficacy in the treatment of cutaneous T-cell lymphomas, but the mechanism of action is unclear.",12149223_1,-1,-1,-1,-1,1189,-1,1.6158208e-05,0.9999758,8.09539e-06
1194,interleukin-2 receptor,27,29,183,205,We explored the immunomodulatory effects of RAR and RXR rexinoids in human T- and B-cell leukemia cells and demonstrated that RXR rexinoids are capable of up-regulating high-affinity interleukin-2 receptor (IL-2R) expression.,12149223_2,-1,-1,-1,-1,1194,-1,0.99965596,3.72971e-05,0.00030670705
1197,the p55,21,23,117,124,Exposure to 10(-6) to 10(-10) M bexarotene or Panretin for 48 hours was associated with increased expression of both the p55 and p75 subunits of the IL-2R in T-cell leukemias and p75 in B-cell leukemias.,12149223_3,-1,-1,-1,-1,1197,-1,1.441184e-05,0.99997187,1.3773648e-05
1198,p75 subunits,24,26,129,141,Exposure to 10(-6) to 10(-10) M bexarotene or Panretin for 48 hours was associated with increased expression of both the p55 and p75 subunits of the IL-2R in T-cell leukemias and p75 in B-cell leukemias.,12149223_3,-1,-1,-1,-1,1198,-1,1.2007798e-05,0.99996364,2.4346133e-05
1200,T-cell,30,31,158,164,Exposure to 10(-6) to 10(-10) M bexarotene or Panretin for 48 hours was associated with increased expression of both the p55 and p75 subunits of the IL-2R in T-cell leukemias and p75 in B-cell leukemias.,12149223_3,-1,1,2,-1,1200,-1,1.3007247e-05,9.99005e-06,0.999977
1202,the cells to,7,10,58,70,"Furthermore, rexinoid exposure enhanced susceptibility of the cells to denileukin diftitox fusion toxin-targeting and -intoxicating cells expressing high-affinity IL-2R.",12149223_4,-1,-1,-1,-1,1202,-1,0.0018762712,0.6221614,0.37596235
1207,the STAT6 gene,3,6,19,33,Mice deficient for the STAT6 gene (STAT6(-/-) mice) have enhanced immunosurveillance against primary and metastatic tumors.,12421960_0,-1,-1,-1,-1,1207,-1,6.0323014e-06,0.9999877,6.2286563e-06
1212,to the type,13,16,69,80,"Because STAT6 is a downstream effector of the IL-4R, and IL-13 binds to the type 2 IL-4R, IL-13 has been proposed as an inhibitor that blocks differentiation of tumor-specific CD8(+) T cells.",12421960_1,-1,-1,-1,-1,1212,-1,7.5205585e-06,0.9999852,7.2838384e-06
1217,Immunity,0,1,0,8,"Immunity in STAT6(-/-) mice is unusually effective in that 45-80% of STAT6(-/-) mice with established, spontaneous metastatic 4T1 mammary carcinoma, whose primary tumors are surgically excised, survive indefinitely, as compared with <10% of STAT(+/+) (BALB/c) mice.",12421960_2,0,-1,2,-1,1217,-1,0.9994796,0.0002277693,0.00029263677
1220,that immunity,17,19,124,137,"Surprisingly, STAT6(-/-) and BALB/c reciprocal bone marrow chimeras do not have increased immunosurveillance, demonstrating that immunity requires STAT6(-/-) hemopoietic and nonhemopoietic components.",12421960_3,-1,-1,-1,-1,1220,-1,0.054752477,0.94417363,0.0010738488
1222,therefore IL-13,10,12,51,66,"Likewise, CD1(-/-) mice that are NKT deficient and therefore IL-13 deficient also have heightened tumor immunity.",12421960_4,-1,-1,-1,-1,1222,-1,0.79130304,0.20599823,0.00269882
1223,tumor immunity,16,18,98,112,"Likewise, CD1(-/-) mice that are NKT deficient and therefore IL-13 deficient also have heightened tumor immunity.",12421960_4,-1,-1,-1,-1,1223,-1,0.06441782,0.93408495,0.0014971921
1224,that immunity,18,20,108,121,"However, STAT6(-/-) and CD1(-/-) reciprocal bone marrow chimeras do not have increased survival, suggesting that immunity in STAT6(-/-) and CD1(-/-) mice is via noncomplementing mechanisms.",12421960_5,-1,-1,-1,-1,1224,-1,0.028891945,0.96985716,0.0012508876
1227,that IL-13,15,17,93,103,"Metastatic disease is not reduced in BALB/c mice treated with an IL-13 inhibitor, indicating that IL-13 alone is insufficient for negative regulation of 4T1 immunity.",12421960_6,-1,-1,-1,-1,1227,-1,0.94239897,0.056126475,0.0014744861
1229,immunity,25,26,157,165,"Metastatic disease is not reduced in BALB/c mice treated with an IL-13 inhibitor, indicating that IL-13 alone is insufficient for negative regulation of 4T1 immunity.",12421960_6,0,-1,2,-1,1229,-1,0.99196666,0.0007653443,0.0072679906
1233,immunity,26,27,151,159,"Likewise, in vivo depletion of CD4(+)CD25(+) T cells in BALB/c mice does not increase survival, demonstrating that CD4(+)CD25(+) cells do not regulate immunity.",12421960_7,0,-1,2,-1,1233,-1,0.98161846,0.017653426,0.00072810904
1236,that IFN-gamma,10,12,85,99,Cytokine production and tumor challenges into STAT6(-/-)IFN-gamma(-/-) mice indicate that IFN-gamma is essential for immunity.,12421960_8,-1,-1,-1,-1,1236,-1,0.978379,0.020382192,0.0012386896
1237,immunity,15,16,117,125,Cytokine production and tumor challenges into STAT6(-/-)IFN-gamma(-/-) mice indicate that IFN-gamma is essential for immunity.,12421960_8,0,-1,2,-1,1237,-1,0.99985886,5.0559353e-05,9.059509e-05
1245,tumor-derived factors,14,16,84,105,"Using a mammary tumor model syngeneic to BALB/c mice, we have characterized several tumor-derived factors.",12527946_0,-1,-1,-1,-1,1245,-1,0.0002633328,0.9997112,2.5384252e-05
1246,that the,3,5,14,22,"We now report that the DA-3 cell line derived from this tumor, as well as the in vivo tumor itself, express IL-11.",12527946_1,-1,-1,-1,-1,1246,-1,4.165698e-06,0.9999918,4.0946e-06
1248,this tumor,10,12,51,61,"We now report that the DA-3 cell line derived from this tumor, as well as the in vivo tumor itself, express IL-11.",12527946_1,-1,-1,-1,-1,1248,-1,3.9682704e-06,0.9999907,5.276738e-06
1254,the tumor,5,7,27,36,"The expression of IL-11 in the tumor is detectable at the transcriptional and translational levels, as evidenced by RT-PCR and Western blots.",12527946_2,-1,-1,-1,-1,1254,-1,3.6003573e-06,0.99999213,4.2677575e-06
1255,the transcriptional,10,12,54,73,"The expression of IL-11 in the tumor is detectable at the transcriptional and translational levels, as evidenced by RT-PCR and Western blots.",12527946_2,-1,-1,-1,-1,1255,-1,5.082165e-06,0.9999889,6.0109287e-06
1266,the tumor,28,30,162,171,"Interestingly, elevated levels of IL-11 were found in the sera of tumor-bearers, when compared to normal animals and even higher levels of IL-11 were detected in the tumor cystic fluid.",12527946_4,-1,-1,-1,-1,1266,-1,4.317119e-06,0.99999166,4.0330797e-06
1278,the transcription factor,7,10,57,81,"Electromobility shift assays showed decreased binding of the transcription factor C/EBP to the IL-12p40 promoter of LPS-activated macrophages from normal animals, upon pretreatment with IL-11.",12527946_8,-1,-1,-1,-1,1278,-1,5.1058078e-06,0.9999896,5.25116e-06
1279,to the,11,13,88,94,"Electromobility shift assays showed decreased binding of the transcription factor C/EBP to the IL-12p40 promoter of LPS-activated macrophages from normal animals, upon pretreatment with IL-11.",12527946_8,-1,-1,-1,-1,1279,-1,4.291636e-06,0.9999907,4.9948676e-06
1284,that tumor-derived IL-11,3,6,20,44,"Our results suggest that tumor-derived IL-11 may play a role in the depressed IL-12 production by macrophages, leading to the impaired immune functions observed during mammary tumorigenesis.",12527946_10,-1,-1,-1,-1,1284,-1,0.2244482,0.77355224,0.0019995354
1288,to the,19,21,119,125,"Our results suggest that tumor-derived IL-11 may play a role in the depressed IL-12 production by macrophages, leading to the impaired immune functions observed during mammary tumorigenesis.",12527946_10,-1,-1,-1,-1,1288,-1,5.116116e-06,0.99999046,4.4734766e-06
1289,functions,23,24,142,151,"Our results suggest that tumor-derived IL-11 may play a role in the depressed IL-12 production by macrophages, leading to the impaired immune functions observed during mammary tumorigenesis.",12527946_10,0,1,2,-1,1289,-1,0.44830382,0.043712102,0.50798404
1299,the target cells,5,8,24,40,"The effects of IL-16 on the target cells are dependent on the cell type, the presence of co-activators etc.",12528894_2,-1,-1,-1,-1,1299,-1,0.0018013422,0.8071821,0.19101664
1300,the cell type,11,14,58,71,"The effects of IL-16 on the target cells are dependent on the cell type, the presence of co-activators etc.",12528894_2,-1,-1,-1,-1,1300,-1,0.0004985705,0.944466,0.055035483
1303,the regulation function,2,5,14,37,"To understand the regulation function and mechanism of IL-16 on target cells, we used a 130 a.a. recombinant IL-16 to study its effects on the growth of Jurkat T leukemia cells in vitro.",12528894_3,-1,-1,-1,-1,1303,-1,6.441198e-06,0.9999857,7.871266e-06
1305,target cells,10,12,64,76,"To understand the regulation function and mechanism of IL-16 on target cells, we used a 130 a.a. recombinant IL-16 to study its effects on the growth of Jurkat T leukemia cells in vitro.",12528894_3,-1,-1,-1,-1,1305,-1,0.0010199936,0.19724132,0.8017387
1306,IL-16 to,20,22,109,117,"To understand the regulation function and mechanism of IL-16 on target cells, we used a 130 a.a. recombinant IL-16 to study its effects on the growth of Jurkat T leukemia cells in vitro.",12528894_3,-1,-1,-1,-1,1306,-1,0.9987562,0.00074263767,0.0005012575
1310,that the,2,4,9,17,"We found that the rIL-16 stimulated the proliferation of Jurkat cells at low dose (10(-9)M), but inhibited the growth of the cells at higher concentration (10(-5)M).",12528894_4,-1,-1,-1,-1,1310,-1,4.9661853e-06,0.9999901,4.8919483e-06
1314,the cells,23,25,121,130,"We found that the rIL-16 stimulated the proliferation of Jurkat cells at low dose (10(-9)M), but inhibited the growth of the cells at higher concentration (10(-5)M).",12528894_4,-1,-1,-1,-1,1314,-1,4.372578e-05,8.101073e-05,0.9998752
1318,The treatment,0,2,0,13,"The treatment blocked the expression of FasL, but up-regulated the c-myc and Bid expression in the cells.",12528894_6,-1,-1,-1,-1,1318,-1,4.1856197e-06,0.99999154,4.254714e-06
1321,the cells,16,18,95,104,"The treatment blocked the expression of FasL, but up-regulated the c-myc and Bid expression in the cells.",12528894_6,-1,-1,-1,-1,1321,-1,3.4536653e-05,5.543893e-05,0.99991
1325,that the,3,5,22,30,The results suggested that the rIL-16 might be a regulator for the growth or apoptosis of Jurkat cells at a dose-dependent manner.,12528894_8,-1,-1,-1,-1,1325,-1,4.5697743e-06,0.99999094,4.4805493e-06
1333,the generation,7,9,56,70,Currently most attempts at cancer immunotherapy involve the generation of CD8(+) cytotoxic T lymphocytes (CTLs) against tumor-associated antigens.,12566422_0,-1,-1,-1,-1,1333,-1,5.858952e-06,0.99998844,5.656638e-06
1336,tumor-associated antigens,19,21,120,145,Currently most attempts at cancer immunotherapy involve the generation of CD8(+) cytotoxic T lymphocytes (CTLs) against tumor-associated antigens.,12566422_0,-1,-1,-1,-1,1336,-1,0.2847209,0.71234715,0.0029319183
1343,T cells that,6,9,32,44,"Here we demonstrate that CD4(+) T cells that recognize a secreted tumor-specific antigen and exhibit a cytokine secretion profile characteristic of Th2 cells, are capable of clearing established lung and visceral metastases of a CTL-resistant melanoma.",12566422_2,-1,-1,-1,-1,1343,-1,0.00086976844,0.043805834,0.9553244
1344,tumor-specific antigen,12,14,66,88,"Here we demonstrate that CD4(+) T cells that recognize a secreted tumor-specific antigen and exhibit a cytokine secretion profile characteristic of Th2 cells, are capable of clearing established lung and visceral metastases of a CTL-resistant melanoma.",12566422_2,-1,-1,-1,-1,1344,-1,0.57116055,0.42409816,0.004741228
1348,the Th2 cells,5,8,32,45,"Clearance of lung metastases by the Th2 cells was found to be totally dependent on the eosinophil chemokine, eotaxin, and partially dependent on the transcription activator signal transducer and activator of transcription 6 (STAT6), with degranulating eosinophils within the tumors inducing tumor regression.",12566422_3,-1,-1,-1,-1,1348,-1,0.0016850064,0.12807728,0.87023765
1354,the transcription activator signal transducer and activator of transcription 6,25,35,145,223,"Clearance of lung metastases by the Th2 cells was found to be totally dependent on the eosinophil chemokine, eotaxin, and partially dependent on the transcription activator signal transducer and activator of transcription 6 (STAT6), with degranulating eosinophils within the tumors inducing tumor regression.",12566422_3,-1,-1,-1,-1,1354,-1,6.2352287e-06,0.9999838,9.948163e-06
1356,the tumors,43,45,271,281,"Clearance of lung metastases by the Th2 cells was found to be totally dependent on the eosinophil chemokine, eotaxin, and partially dependent on the transcription activator signal transducer and activator of transcription 6 (STAT6), with degranulating eosinophils within the tumors inducing tumor regression.",12566422_3,-1,-1,-1,-1,1356,-1,4.010835e-06,0.99999106,4.910078e-06
1361,the tumors,13,15,78,88,"In contrast, tumor-specific CD4(+) Th1 cells, that recruited macrophages into the tumors, had no effect on tumor growth.",12566422_4,-1,-1,-1,-1,1361,-1,3.975317e-06,0.99999106,4.9690984e-06
1370,Analysis,0,1,0,8,Analysis of truncated S35 constructs and overlapping peptides revealed that the peptide epitope was LGAEAIFRL.,12707369_1,0,1,-1,-1,1370,-1,7.203349e-06,0.99998736,5.424481e-06
1372,peptides,7,8,53,61,Analysis of truncated S35 constructs and overlapping peptides revealed that the peptide epitope was LGAEAIFRL.,12707369_1,0,-1,2,-1,1372,-1,0.0003575736,0.9995264,0.00011603457
1373,that the peptide,9,12,71,87,Analysis of truncated S35 constructs and overlapping peptides revealed that the peptide epitope was LGAEAIFRL.,12707369_1,-1,-1,-1,-1,1373,-1,4.2528667e-05,0.9999335,2.4004648e-05
1375,peptide-pulsed,3,4,15,29,"AT-1 CTL lysed peptide-pulsed CMS8 cells at a nanomolar concentration, and the peptide strongly stimulated IFN-gamma production in AT-1 CTL.",12707369_2,0,-1,2,-1,1375,-1,0.01264139,0.9871524,0.0002062136
1378,the peptide,12,14,75,86,"AT-1 CTL lysed peptide-pulsed CMS8 cells at a nanomolar concentration, and the peptide strongly stimulated IFN-gamma production in AT-1 CTL.",12707369_2,-1,-1,-1,-1,1378,-1,0.000114220136,0.99985135,3.4415152e-05
1381,that the,3,5,28,36,Sequence homology indicated that the S35 was derived from a mouse homologue of human retinoic acid-regulated nuclear matrix-associated protein (ramp).,12707369_3,-1,-1,-1,-1,1381,-1,4.3115833e-06,0.9999913,4.427291e-06
1382,protein,18,19,135,142,Sequence homology indicated that the S35 was derived from a mouse homologue of human retinoic acid-regulated nuclear matrix-associated protein (ramp).,12707369_3,0,1,-1,-1,1382,-1,7.4940126e-06,0.9999845,8.052694e-06
1387,the transcript,7,9,34,48,"The majority of the ramp mRNA was the transcript normally spliced between exons 14 and 15, but a minor population of mRNA with an extended exon 14 was also present in Meth A cells.",12707369_5,-1,-1,-1,-1,1387,-1,5.774793e-06,0.9999883,5.9294343e-06
1394,antigen-presenting cells,13,15,74,98,Our goal was to convert murine RM-9 prostate carcinoma cells in vivo into antigen-presenting cells capable of presenting endogenous tumor antigens and triggering a potent T-helper cell-mediated immune response essential for the generation of a specific antitumor response.,12804139_0,-1,-1,-1,-1,1394,-1,0.65874976,0.00031300233,0.34093726
1395,tumor antigens,19,21,132,146,Our goal was to convert murine RM-9 prostate carcinoma cells in vivo into antigen-presenting cells capable of presenting endogenous tumor antigens and triggering a potent T-helper cell-mediated immune response essential for the generation of a specific antitumor response.,12804139_0,-1,-1,-1,-1,1395,-1,0.67566574,0.32043764,0.003896608
1397,T-helper cell-mediated immune response,25,29,171,209,Our goal was to convert murine RM-9 prostate carcinoma cells in vivo into antigen-presenting cells capable of presenting endogenous tumor antigens and triggering a potent T-helper cell-mediated immune response essential for the generation of a specific antitumor response.,12804139_0,-1,-1,-1,-1,1397,-1,0.11013904,0.006594291,0.88326657
1398,the generation,31,33,224,238,Our goal was to convert murine RM-9 prostate carcinoma cells in vivo into antigen-presenting cells capable of presenting endogenous tumor antigens and triggering a potent T-helper cell-mediated immune response essential for the generation of a specific antitumor response.,12804139_0,-1,-1,-1,-1,1398,-1,5.1734e-06,0.99999,4.8611932e-06
1399,that generating the,2,5,10,29,"We showed that generating the major histocompatibility complex (MHC) class I+/class II+/Ii- phenotype, within an established subcutaneous RM-9 tumor nodule, led to an effective immune response limiting tumor growth.",12804139_1,-1,-1,-1,-1,1399,-1,4.359226e-06,0.9999913,4.397176e-06
1403,immune response limiting tumor,28,32,177,207,"We showed that generating the major histocompatibility complex (MHC) class I+/class II+/Ii- phenotype, within an established subcutaneous RM-9 tumor nodule, led to an effective immune response limiting tumor growth.",12804139_1,-1,-1,-1,-1,1403,-1,0.97861004,0.020555677,0.00083434815
1409,the gene,33,35,191,199,"This phenotype was created by intratumoral injection of plasmid cDNAs coding for interferon gamma, MHC class II transactivator, and an antisense reverse gene construct (RGC) for a segment of the gene for Ii protein (-92,97).",12804139_2,-1,-1,-1,-1,1409,-1,5.1046127e-06,0.99998724,7.6049005e-06
1410,protein,37,38,207,214,"This phenotype was created by intratumoral injection of plasmid cDNAs coding for interferon gamma, MHC class II transactivator, and an antisense reverse gene construct (RGC) for a segment of the gene for Ii protein (-92,97).",12804139_2,0,1,-1,-1,1410,-1,0.00030603155,0.99957496,0.0001189825
1415,the tumor,4,6,29,38,"Nevertheless, irradiation of the tumor nodule on the day preceding initiation of gene therapy yielded 7 of 16 mice that were disease-free in a long-term follow up of 57 days compared to 1 of 7 mice receiving radiotherapy alone.",12804139_4,-1,-1,-1,-1,1415,-1,4.66508e-06,0.99998975,5.558892e-06
1417,gene therapy,13,15,81,93,"Nevertheless, irradiation of the tumor nodule on the day preceding initiation of gene therapy yielded 7 of 16 mice that were disease-free in a long-term follow up of 57 days compared to 1 of 7 mice receiving radiotherapy alone.",12804139_4,-1,-1,-1,-1,1417,-1,6.574361e-06,0.9999865,6.8997547e-06
1420,gene therapy,4,6,32,44,Mice receiving radiotherapy and gene therapy rejected challenge with parental RM-9 cells and demonstrated specific cytotoxic T-cell activity in their splenocytes but not the mouse cured by radiation alone.,12804139_5,-1,-1,-1,-1,1420,-1,5.4668412e-06,0.99998975,4.8067845e-06
1422,T-cell,16,17,125,131,Mice receiving radiotherapy and gene therapy rejected challenge with parental RM-9 cells and demonstrated specific cytotoxic T-cell activity in their splenocytes but not the mouse cured by radiation alone.,12804139_5,-1,1,2,-1,1422,-1,1.3106781e-05,6.642586e-06,0.9999802
1426,that tumor,9,11,67,77,These data were reproduced in additional experiments and confirmed that tumor irradiation prior to gene therapy resulted in complete tumor regression and specific tumor immunity in more than 50% of the mice.,12804139_6,-1,-1,-1,-1,1426,-1,4.985985e-06,0.99999046,4.5777847e-06
1427,to gene therapy,13,16,96,111,These data were reproduced in additional experiments and confirmed that tumor irradiation prior to gene therapy resulted in complete tumor regression and specific tumor immunity in more than 50% of the mice.,12804139_6,-1,-1,-1,-1,1427,-1,5.7106927e-06,0.99998903,5.2530704e-06
1429,tumor immunity,23,25,163,177,These data were reproduced in additional experiments and confirmed that tumor irradiation prior to gene therapy resulted in complete tumor regression and specific tumor immunity in more than 50% of the mice.,12804139_6,-1,-1,-1,-1,1429,-1,0.18253563,0.8142942,0.0031701587
1438,gene therapy,5,7,42,54,"Administering radiation before this novel gene therapy approach, that creates an in situ tumor vaccine, holds promise for the treatment of human prostate carcinoma.",12804139_8,-1,-1,-1,-1,1438,-1,8.260615e-06,0.99998605,5.6287386e-06
1441,the treatment,20,22,122,135,"Administering radiation before this novel gene therapy approach, that creates an in situ tumor vaccine, holds promise for the treatment of human prostate carcinoma.",12804139_8,-1,-1,-1,-1,1441,-1,5.6690897e-06,0.99999,4.317392e-06
1442,T-helper cell immune response,5,9,26,55,A potent antitumor CD4(+) T-helper cell immune response is created by inducing tumor cells in vivo to a MHC class II(+)/Ii(- )phenotype.,12827305_0,-1,-1,-1,-1,1442,-1,0.6484186,0.040822465,0.31075898
1443,tumor cells,13,15,79,90,A potent antitumor CD4(+) T-helper cell immune response is created by inducing tumor cells in vivo to a MHC class II(+)/Ii(- )phenotype.,12827305_0,-1,-1,-1,-1,1443,-1,0.000118516204,0.00062725774,0.99925417
1445,tumor cells,9,11,46,57,MHC class II and Ii molecules were induced in tumor cells in situ following tumor injection of a plasmid containing the gene for the MHC class II transactivator (CIITA).,12827305_1,-1,-1,-1,-1,1445,-1,0.000473365,0.018996803,0.9805298
1448,the gene,20,22,116,124,MHC class II and Ii molecules were induced in tumor cells in situ following tumor injection of a plasmid containing the gene for the MHC class II transactivator (CIITA).,12827305_1,-1,-1,-1,-1,1448,-1,5.433616e-06,0.99998856,6.008033e-06
1451,protein,1,2,3,10,Ii protein was suppressed by the antisense effect of an Ii-reverse gene construct (Ii-RGC) in the same or another co-injected plasmid.,12827305_2,0,1,-1,-1,1451,-1,8.363537e-05,0.99987197,4.4391563e-05
1457,the tumor cells,7,10,39,54,The MHC class II(+)/Ii(- )phenotype of the tumor cells was confirmed by FACS analysis of cells transfected in vitro and by immunostaining of tumor nodules transfected by injections in vivo.,12827305_3,-1,-1,-1,-1,1457,-1,0.0014888464,0.49304268,0.5054685
1458,analysis,14,15,77,85,The MHC class II(+)/Ii(- )phenotype of the tumor cells was confirmed by FACS analysis of cells transfected in vitro and by immunostaining of tumor nodules transfected by injections in vivo.,12827305_3,0,1,-1,-1,1458,-1,8.1683365e-06,0.99998283,8.980655e-06
1459,cells transfected,16,18,89,106,The MHC class II(+)/Ii(- )phenotype of the tumor cells was confirmed by FACS analysis of cells transfected in vitro and by immunostaining of tumor nodules transfected by injections in vivo.,12827305_3,-1,-1,-1,-1,1459,-1,0.0005288354,0.016056845,0.98341435
1472,transcription factor Fos-related antigen 1,12,17,80,122,"Protection against breast cancer was achieved with a DNA vaccine against murine transcription factor Fos-related antigen 1, which is overexpressed in aggressively proliferating D2F2 murine breast carcinoma.",12857959_0,-1,-1,-1,-1,1472,-1,0.0004558835,0.99884415,0.0006999043
1476,Fos-related antigen,23,25,160,179,"tumor and dissemination of pulmonary metastases was markedly suppressed by this oral DNA vaccine, carried by attenuated Salmonella typhimurium, encoding murine Fos-related antigen 1, fused with mutant polyubiquitin, and cotransformed with secretory murine IL-18.",12857959_2,-1,-1,-1,-1,1476,-1,0.07340221,0.92134887,0.0052488614
1478,The life,0,2,0,8,The life span of 60% of vaccinated mice was tripled in the absence of detectable tumor growth after lethal tumor cell challenge.,12857959_3,-1,-1,-1,-1,1478,-1,6.9239663e-06,0.99998665,6.4285136e-06
1482,tumor cell,20,22,107,117,The life span of 60% of vaccinated mice was tripled in the absence of detectable tumor growth after lethal tumor cell challenge.,12857959_3,-1,-1,-1,-1,1482,-1,0.0009881234,0.021070424,0.9779415
1487,target cell,3,5,28,39,"Markedly increased specific target cell lysis was mediated by both MHC class I-restricted CD8+ T cells and natural killer cells isolated from splenocytes of vaccinated mice, including a significant release of proinflammatory cytokines IFN-gamma and IL-2.",12857959_5,-1,-1,-1,-1,1487,-1,0.00036592843,0.0032003394,0.99643373
1492,cytokines IFN-gamma,34,36,225,244,"Markedly increased specific target cell lysis was mediated by both MHC class I-restricted CD8+ T cells and natural killer cells isolated from splenocytes of vaccinated mice, including a significant release of proinflammatory cytokines IFN-gamma and IL-2.",12857959_5,-1,-1,-1,-1,1492,-1,0.9999696,5.0687995e-06,2.5265545e-05
1493,analysis,3,4,26,34,"Importantly, fluorescence analysis of fibroblast growth factor 2 and tumor cell-induced vessel growth in Matrigel plugs demonstrated marked suppression of angiogenesis only in vaccinated animals.",12857959_6,0,1,-1,-1,1493,-1,1.3044117e-05,0.99997807,8.942751e-06
1495,tumor cell-induced,10,12,69,87,"Importantly, fluorescence analysis of fibroblast growth factor 2 and tumor cell-induced vessel growth in Matrigel plugs demonstrated marked suppression of angiogenesis only in vaccinated animals.",12857959_6,-1,-1,-1,-1,1495,-1,0.001771098,0.03799388,0.9602351
1497,Taken together,0,2,0,14,"Taken together, this multifunctional DNA vaccine proved effective in protecting against growth and metastases of breast cancer by combining the action of immune effector cells with suppression of tumor angiogenesis.",12857959_7,-1,-1,-1,-1,1497,-1,9.355078e-06,0.9999833,7.3289066e-06
1507,that the,24,26,132,140,"Many tumor immunologists favor the hypothesis that optimal anti-tumor activity is mediated by type 1 CD4(+) and CD8(+) T cells, and that the production of type 2 CD4(+) T cells may be counterproductive for effective anti-tumor immunity.",14593499_0,-1,-1,-1,-1,1507,-1,5.5766895e-06,0.99999046,3.9180786e-06
1510,immunity,40,41,227,235,"Many tumor immunologists favor the hypothesis that optimal anti-tumor activity is mediated by type 1 CD4(+) and CD8(+) T cells, and that the production of type 2 CD4(+) T cells may be counterproductive for effective anti-tumor immunity.",14593499_0,0,-1,2,-1,1510,-1,0.99950016,0.00024481156,0.00025503006
1515,transcription-6 protein,14,16,85,108,"Since Stat6-deficient or ""knockout"" mice lack the signal transducer and activator of transcription-6 protein and are unable to transmit signals initiated by the type 2 cytokines, IL-4 and IL-13, they have been studied to confirm the T(h)1 vs T(h)2 paradigm.",14593499_1,-1,-1,-1,-1,1515,-1,1.3005291e-05,0.9999726,1.437043e-05
1516,to transmit,19,21,124,135,"Since Stat6-deficient or ""knockout"" mice lack the signal transducer and activator of transcription-6 protein and are unable to transmit signals initiated by the type 2 cytokines, IL-4 and IL-13, they have been studied to confirm the T(h)1 vs T(h)2 paradigm.",14593499_1,-1,-1,-1,-1,1516,-1,6.329537e-06,0.9999895,4.1890257e-06
1517,the type,24,26,157,165,"Since Stat6-deficient or ""knockout"" mice lack the signal transducer and activator of transcription-6 protein and are unable to transmit signals initiated by the type 2 cytokines, IL-4 and IL-13, they have been studied to confirm the T(h)1 vs T(h)2 paradigm.",14593499_1,-1,-1,-1,-1,1517,-1,9.48844e-06,0.9999838,6.761322e-06
1522,the T(h)1,39,41,229,238,"Since Stat6-deficient or ""knockout"" mice lack the signal transducer and activator of transcription-6 protein and are unable to transmit signals initiated by the type 2 cytokines, IL-4 and IL-13, they have been studied to confirm the T(h)1 vs T(h)2 paradigm.",14593499_1,-1,-1,-1,-1,1522,-1,3.88007e-05,0.99990344,5.7732876e-05
1524,transplantable tumor cells that,1,5,6,37,"Using transplantable tumor cells that cause primary solid tumors and metastatic disease, as well as a spontaneous transgenic tumor model, multiple studies have demonstrated that Stat6(-/-) mice are able to reject or delay primary tumor growth, prevent recurrence of primary tumors, and/or reject established, spontaneous metastatic disease.",14593499_2,-1,-1,-1,-1,1524,-1,1.2852605e-05,0.9999722,1.4920208e-05
1526,transgenic tumor,18,20,114,130,"Using transplantable tumor cells that cause primary solid tumors and metastatic disease, as well as a spontaneous transgenic tumor model, multiple studies have demonstrated that Stat6(-/-) mice are able to reject or delay primary tumor growth, prevent recurrence of primary tumors, and/or reject established, spontaneous metastatic disease.",14593499_2,-1,-1,-1,-1,1526,-1,5.368649e-06,0.9999896,4.975133e-06
1531,the Stat6 gene,2,5,12,26,"Deletion of the Stat6 gene, therefore, provides significantly enhanced immunosurveillance.",14593499_3,-1,-1,-1,-1,1531,-1,7.2340545e-06,0.9999858,6.942236e-06
1537,immunity,1,2,8,16,"Because immunity is enhanced in the absence of Stat6 or CD1, it has been hypothesized that these deletions result in the removal of an inhibitor that blocks constitutive immunosurveillance.",14593499_5,0,-1,2,-1,1537,-1,0.99969053,0.0001234574,0.00018601892
1540,that these,16,18,86,96,"Because immunity is enhanced in the absence of Stat6 or CD1, it has been hypothesized that these deletions result in the removal of an inhibitor that blocks constitutive immunosurveillance.",14593499_5,-1,-1,-1,-1,1540,-1,5.8808173e-06,0.99999034,3.8060082e-06
1557,immunity,14,15,106,114,"Although additional studies are clearly needed to clarify the mechanism(s) underlying improved anti-tumor immunity in Stat6(-/-) and CD1(-/-) mice, deletion of these genes results in a potent anti-tumor immunity and may be a basis for an immunotherapy strategy.",14593499_8,0,-1,2,-1,1557,-1,0.9995988,0.00012589728,0.0002752072
1558,these genes,25,27,160,171,"Although additional studies are clearly needed to clarify the mechanism(s) underlying improved anti-tumor immunity in Stat6(-/-) and CD1(-/-) mice, deletion of these genes results in a potent anti-tumor immunity and may be a basis for an immunotherapy strategy.",14593499_8,-1,-1,-1,-1,1558,-1,4.5489783e-06,0.9999902,5.265762e-06
1559,immunity,32,33,203,211,"Although additional studies are clearly needed to clarify the mechanism(s) underlying improved anti-tumor immunity in Stat6(-/-) and CD1(-/-) mice, deletion of these genes results in a potent anti-tumor immunity and may be a basis for an immunotherapy strategy.",14593499_8,0,-1,2,-1,1559,-1,0.9997328,8.6988766e-05,0.00018023924
1560,the two,1,3,7,14,"During the two least decades, the field of tumor immunology has met an expansion of knowledge about the molecular and cellular bases of immune regulation.",14609757_0,-1,-1,-1,-1,1560,-1,1.2610063e-05,0.999979,8.412788e-06
1562,tumor immunology,9,11,43,59,"During the two least decades, the field of tumor immunology has met an expansion of knowledge about the molecular and cellular bases of immune regulation.",14609757_0,-1,-1,-1,-1,1562,-1,0.0021399122,0.997433,0.00042710864
1570,to the,4,6,19,25,This is mainly due to the capacity of tumor cells to escape from immunological detection and to resist to cell mediated cytotoxicity.,14609757_3,-1,-1,-1,-1,1570,-1,3.8443322e-06,0.999992,4.1411486e-06
1571,tumor cells to,8,11,38,52,This is mainly due to the capacity of tumor cells to escape from immunological detection and to resist to cell mediated cytotoxicity.,14609757_3,-1,-1,-1,-1,1571,-1,0.00021497296,0.9910863,0.008698669
1573,to cell,18,20,103,110,This is mainly due to the capacity of tumor cells to escape from immunological detection and to resist to cell mediated cytotoxicity.,14609757_3,-1,-1,-1,-1,1573,-1,0.00011189554,0.00025291432,0.9996352
1575,this tumor,10,12,67,77,We will discuss some mechanisms associated with the acquisition of this tumor resistance and the alteration of T cell function and how cancer profiling through genomics approaches may help to reconceptualize immunotherapy strategies.,14609757_4,-1,-1,-1,-1,1575,-1,4.136485e-06,0.9999906,5.224212e-06
1577,T cell function,17,20,111,126,We will discuss some mechanisms associated with the acquisition of this tumor resistance and the alteration of T cell function and how cancer profiling through genomics approaches may help to reconceptualize immunotherapy strategies.,14609757_4,-1,-1,-1,-1,1577,-1,1.5225454e-05,8.769482e-06,0.9999759
1580,Regulatory T cells play,0,4,0,23,Regulatory T cells play an important role in the maintenance of immunological self-tolerance by suppressing immune responses against autoimmune diseases and cancer.,14738769_0,-1,-1,-1,-1,1580,-1,0.0006679268,0.009244874,0.9900872
1583,the nature,7,9,32,42,"Little is known, however, about the nature of the physiological target antigens for CD4(+) regulatory T (Treg) cells.",14738769_1,-1,-1,-1,-1,1583,-1,5.3956887e-06,0.9999896,4.987075e-06
1585,target antigens,12,14,64,79,"Little is known, however, about the nature of the physiological target antigens for CD4(+) regulatory T (Treg) cells.",14738769_1,-1,-1,-1,-1,1585,-1,0.35888284,0.6376052,0.003511981
1591,protein,8,9,47,54,Here we report the identification of the LAGE1 protein as a ligand for tumor-specific CD4(+) Treg cell clones generated from the tumor-infiltrating lymphocytes (TILs) of cancer patients.,14738769_2,0,1,-1,-1,1591,-1,5.6657386e-06,0.99998903,5.2828073e-06
1595,the tumor-infiltrating lymphocytes,21,24,125,159,Here we report the identification of the LAGE1 protein as a ligand for tumor-specific CD4(+) Treg cell clones generated from the tumor-infiltrating lymphocytes (TILs) of cancer patients.,14738769_2,-1,-1,-1,-1,1595,-1,0.0018411054,0.90644693,0.09171198
1597,functional,2,3,15,25,Phenotypic and functional analyses demonstrated that they were antigen-specific CD4(+) Treg cells expressing CD25 and GITR molecules and possessing suppressive activity on the proliferative response of naive CD4(+) T cells to anti-CD3 antibody stimulation.,14738769_3,0,1,2,-1,1597,-1,0.00035498035,0.9994541,0.00019089153
1598,that they,5,7,48,57,Phenotypic and functional analyses demonstrated that they were antigen-specific CD4(+) Treg cells expressing CD25 and GITR molecules and possessing suppressive activity on the proliferative response of naive CD4(+) T cells to anti-CD3 antibody stimulation.,14738769_3,-1,-1,-1,-1,1598,-1,4.3385958e-06,0.9999901,5.572546e-06
1603,T cells to,30,33,215,225,Phenotypic and functional analyses demonstrated that they were antigen-specific CD4(+) Treg cells expressing CD25 and GITR molecules and possessing suppressive activity on the proliferative response of naive CD4(+) T cells to anti-CD3 antibody stimulation.,14738769_3,-1,-1,-1,-1,1603,-1,0.0020815055,0.031622328,0.96629614
1605,Treg cells to,9,12,74,87,Ligand-specific activation and cell-cell contact were required for TIL102 Treg cells to exert suppressive activity on CD4(+) effector cells.,14738769_4,-1,-1,-1,-1,1605,-1,0.001470349,0.06358593,0.93494374
1608,that the,3,5,23,31,These findings suggest that the presence of tumor-specific CD4(+) Treg cells at tumor sites may have a profound effect on the inhibition of T cell responses against cancer.,14738769_5,-1,-1,-1,-1,1608,-1,4.092257e-06,0.9999925,3.4376362e-06
1615,function,4,5,24,32,Deficient T cell immune function and intracellular signaling in cancer patients may result from effects of tumors or their products on lymphocytes.,14741732_0,0,1,2,-1,1615,-1,0.00027404944,0.0002105617,0.9995154
1621,factors that,14,16,94,106,"Recently, it was demonstrated that several ovarian carcinoma cell lines could produce soluble factors that inhibited T cell proliferation.",14741732_1,-1,-1,-1,-1,1621,-1,0.028147405,0.97158796,0.00026464753
1630,to the,32,34,169,175,"The aim of this study is to assess the effect of supernatants from 3 ovarian carcinoma cell lines (OVCAR3, CAOV3, SKOV3) on signal transduction elements that are linked to the IL-2R and its JAK-STAT pathway.",14741732_2,-1,-1,-1,-1,1630,-1,5.395637e-06,0.9999896,4.9727187e-06
1632,IL-10 gene,14,16,85,95,"A profound inhibition of proliferation, lower level of IFN-gamma and higher level of IL-10 gene expression were observed when CD8+ T cells were co-cultured with supernatants from 3 ovarian carcinoma cell lines.",14741732_3,-1,-1,-1,-1,1632,-1,0.99890435,0.0007430993,0.00035259916
1638,analysis,2,3,13,21,Western blot analysis showed that tumor supernatants suppressed expression of JAK3 and tyrosine phosphorylation of STAT5.,14741732_5,0,1,-1,-1,1638,-1,7.68165e-06,0.99998665,5.68662e-06
1639,that tumor,4,6,29,39,Western blot analysis showed that tumor supernatants suppressed expression of JAK3 and tyrosine phosphorylation of STAT5.,14741732_5,-1,-1,-1,-1,1639,-1,5.6120534e-06,0.99998987,4.560809e-06
1649,T cell proliferation through,9,13,65,93,"These findings suggest that ovarian carcinoma cells may suppress T cell proliferation through inhibition IL-2 dependent signaling pathways, which may be a mechanism of ovarian carcinoma induced immunosuppression.",14741732_8,-1,-1,-1,-1,1649,-1,0.001347762,0.016127145,0.9825251
1654,the cytokine IFN-gamma,17,20,113,135,"The local progression of primary tumors is extrinsically controlled by type 1 immune responses, particularly via the cytokine IFN-gamma, whose secretion is highly dependent on helper T cells.",14744755_0,-1,-1,-1,-1,1654,-1,0.9884212,0.010587517,0.0009912855
1656,The T-box transcription factor T-bet,0,5,0,36,The T-box transcription factor T-bet (Tbx21) plays a critical role in the development of type 1 helper T cells and is essential for the production of IFN-gamma.,14744755_1,-1,-1,-1,-1,1656,-1,5.3579865e-06,0.99998915,5.4753164e-06
1657,Tbx21,6,7,38,43,The T-box transcription factor T-bet (Tbx21) plays a critical role in the development of type 1 helper T cells and is essential for the production of IFN-gamma.,14744755_1,-1,1,2,-1,1657,-1,4.1789368e-05,0.99993134,2.6858273e-05
1664,the T-bet,2,4,6,15,"Here, the T-bet pathway in the autochthonous transgenic adenocarcinoma mouse prostate model is demonstrated to have only a modest effect on the characteristics of primary prostate cancers but rather exerts a significant suppressor function in the development of metastatic disease.",14744755_2,-1,-1,-1,-1,1664,-1,4.682596e-06,0.9999906,4.7940616e-06
1669,function,34,35,231,239,"Here, the T-bet pathway in the autochthonous transgenic adenocarcinoma mouse prostate model is demonstrated to have only a modest effect on the characteristics of primary prostate cancers but rather exerts a significant suppressor function in the development of metastatic disease.",14744755_2,0,1,2,-1,1669,-1,4.7529857e-06,0.9999896,5.6724466e-06
1678,peptides,2,3,22,30,"Overlapping synthetic peptides covering the entire primary sequences of the HPV16 E6, E7 and E4 proteins were used to screen for CD8+ T cell responses using an ELISPOT assay of interferon (IFN)-gamma release.",14751153_2,0,-1,2,-1,1678,-1,4.07216e-05,0.99994123,1.8095641e-05
1681,proteins,16,17,96,104,"Overlapping synthetic peptides covering the entire primary sequences of the HPV16 E6, E7 and E4 proteins were used to screen for CD8+ T cell responses using an ELISPOT assay of interferon (IFN)-gamma release.",14751153_2,0,1,-1,-1,1681,-1,1.1656538e-05,0.9999796,8.744192e-06
1686,to the proteins,3,6,20,35,RESULTS: Reactivity to the proteins was detected in all patients on at least one occasion.,14751153_3,-1,-1,-1,-1,1686,-1,9.030692e-05,0.9998841,2.5553432e-05
1692,the treatment,8,10,58,71,The magnitude and specificities of responses changed over the treatment period.,14751153_5,-1,-1,-1,-1,1692,-1,7.819204e-06,0.99998724,4.8832876e-06
1694,to peptides,6,8,45,56,This was particularly noticeable in response to peptides derived from the E4 protein.,14751153_6,-1,-1,-1,-1,1694,-1,5.7051537e-05,0.999926,1.6938273e-05
1696,protein,12,13,77,84,This was particularly noticeable in response to peptides derived from the E4 protein.,14751153_6,0,1,-1,-1,1696,-1,3.0165942e-05,0.99994874,2.1098078e-05
1715,that interleukin,4,6,29,45,"Although much promising data that interleukin (IL)-12 could be a powerful therapeutic agent against cancer were reported in animal models, its excessive toxicity has become a problem for its clinical application.",14871851_0,-1,-1,-1,-1,1715,-1,0.5191766,0.4729777,0.007845709
1717,toxicity,23,24,153,161,"Although much promising data that interleukin (IL)-12 could be a powerful therapeutic agent against cancer were reported in animal models, its excessive toxicity has become a problem for its clinical application.",14871851_0,0,1,-1,-1,1717,-1,1.3171365e-05,0.9999776,9.291381e-06
1719,that plays,7,9,37,47,"IL-27 is a novel IL-12 family member that plays a role in the early regulation of T helper cell 1 initiation, including induction of T-bet and IL-12 receptor beta 2 expression.",14871851_1,-1,-1,-1,-1,1719,-1,4.641187e-06,0.9999906,4.833579e-06
1724,IL-12 receptor,27,29,143,157,"IL-27 is a novel IL-12 family member that plays a role in the early regulation of T helper cell 1 initiation, including induction of T-bet and IL-12 receptor beta 2 expression.",14871851_1,-1,-1,-1,-1,1724,-1,0.9998555,2.138101e-05,0.00012306856
1733,these cells,33,35,182,193,"C26 cells, which were transduced with the single-chain IL-27 cDNA and became secreting IL-27 (C26-IL-27), exhibited minimal tumor growth in vivo, and all of the mice inoculated with these cells survived healthily with complete tumor remission.",14871851_3,-1,-1,-1,-1,1733,-1,2.2981774e-05,1.8142773e-05,0.9999589
1741,immunity to the,9,12,71,86,Recovered mice from the inoculation showed a tumor-specific protective immunity to the following challenge with parental C26 tumor.,14871851_5,-1,-1,-1,-1,1741,-1,0.029814819,0.9694565,0.0007286945
1755,immunity,15,16,113,121,"These results suggest that IL-27 has potent abilities to induce tumor-specific antitumor activity and protective immunity and that the antitumor activity is mediated mainly through CD8(+) T cells, IFN-gamma, and T-bet but not through STAT4.",14871851_8,0,-1,2,-1,1755,-1,0.9996258,6.827284e-05,0.0003058563
1756,that the,17,19,126,134,"These results suggest that IL-27 has potent abilities to induce tumor-specific antitumor activity and protective immunity and that the antitumor activity is mediated mainly through CD8(+) T cells, IFN-gamma, and T-bet but not through STAT4.",14871851_8,-1,-1,-1,-1,1756,-1,4.309766e-06,0.9999912,4.527904e-06
1761,through STAT4,36,38,226,239,"These results suggest that IL-27 has potent abilities to induce tumor-specific antitumor activity and protective immunity and that the antitumor activity is mediated mainly through CD8(+) T cells, IFN-gamma, and T-bet but not through STAT4.",14871851_8,-1,-1,-1,-1,1761,-1,4.8018983e-06,0.9999893,5.898071e-06
1762,Tumor cells,0,2,0,11,Tumor cells engineered to secrete TNF were used as a model to examine how persistently high local concentrations of TNF suppress tumor growth.,14978132_0,-1,-1,-1,-1,1762,-1,0.00049997884,0.018508205,0.9809919
1764,TNF,5,6,34,37,Tumor cells engineered to secrete TNF were used as a model to examine how persistently high local concentrations of TNF suppress tumor growth.,14978132_0,0,1,-1,-1,1764,-1,0.1615092,0.8364122,0.0020786168
1766,TNF,19,20,116,119,Tumor cells engineered to secrete TNF were used as a model to examine how persistently high local concentrations of TNF suppress tumor growth.,14978132_0,0,1,-1,-1,1766,-1,0.16062875,0.83721775,0.002153466
1768,TNF,0,1,0,3,TNF secretion had no effect on tumor cell proliferation in vitro but caused a very impressive growth arrest in vivo that was dependent on both bone marrow- and non-bone marrow-derived host cells expressing TNFR.,14978132_1,0,1,-1,-1,1768,-1,0.07918738,0.9197634,0.0010492838
1769,tumor cell,6,8,31,41,TNF secretion had no effect on tumor cell proliferation in vitro but caused a very impressive growth arrest in vivo that was dependent on both bone marrow- and non-bone marrow-derived host cells expressing TNFR.,14978132_1,-1,-1,-1,-1,1769,-1,0.0001364194,0.0017947452,0.99806875
1772,TNFR,33,34,206,210,TNF secretion had no effect on tumor cell proliferation in vitro but caused a very impressive growth arrest in vivo that was dependent on both bone marrow- and non-bone marrow-derived host cells expressing TNFR.,14978132_1,0,1,-1,-1,1772,-1,0.00038412528,0.99955493,6.09542e-05
1775,IFN-gamma receptor,12,14,93,111,"Suppression also required an endogenous IFN-gamma pathway consisting minimally of IFN-gamma, IFN-gamma receptor, Stat1, and IFN regulatory factor 1 since mice with targeted disruption of any of the four genes failed to arrest tumor growth.",14978132_2,-1,-1,-1,-1,1775,-1,0.99988663,1.2752005e-05,0.000100645615
1777,IFN regulatory factor,18,21,124,145,"Suppression also required an endogenous IFN-gamma pathway consisting minimally of IFN-gamma, IFN-gamma receptor, Stat1, and IFN regulatory factor 1 since mice with targeted disruption of any of the four genes failed to arrest tumor growth.",14978132_2,-1,-1,-1,-1,1777,-1,0.99305236,0.005850265,0.0010974273
1790,IFN-gamma-inducing cytokines IL-12,6,9,38,72,"Interestingly, mice lacking the major IFN-gamma-inducing cytokines IL-12 and IL-18 or T cells, B cells, and the majority of NK cells that are potential sources of IFN-gamma nevertheless inhibited tumor development.",14978132_4,-1,-1,-1,-1,1790,-1,0.9999747,4.283888e-06,2.1006312e-05
1795,cells that,23,25,127,137,"Interestingly, mice lacking the major IFN-gamma-inducing cytokines IL-12 and IL-18 or T cells, B cells, and the majority of NK cells that are potential sources of IFN-gamma nevertheless inhibited tumor development.",14978132_4,-1,-1,-1,-1,1795,-1,0.0022630356,0.23292005,0.76481694
1804,function,6,7,39,47,These results strongly suggest a novel function for the endogenous IFN-gamma pathway that without measurable IFN-gamma production or activity affects the ability of TNF to suppress tumor development.,14978132_6,0,1,2,-1,1804,-1,6.0928112e-05,0.99990594,3.313062e-05
1810,TNF to,23,25,165,171,These results strongly suggest a novel function for the endogenous IFN-gamma pathway that without measurable IFN-gamma production or activity affects the ability of TNF to suppress tumor development.,14978132_6,-1,-1,-1,-1,1810,-1,1.284794e-05,0.99997914,7.993719e-06
1813,thought to,3,5,17,27,Cancer cells are thought to possess mechanisms for evading the host's immune surveillance system.,15004200_0,-1,-1,-1,-1,1813,-1,8.355745e-06,0.9999838,7.819506e-06
1825,protein,8,9,73,80,Quantitative immunostaining showed correlation between survivin and FasL protein expression in colon cancer tissues (r=0.79).,15004200_5,0,1,-1,-1,1825,-1,1.8801591e-05,0.99996364,1.7599541e-05
1826,tissues,13,14,108,115,Quantitative immunostaining showed correlation between survivin and FasL protein expression in colon cancer tissues (r=0.79).,15004200_5,-1,1,2,-1,1826,-1,0.0005590074,0.22102629,0.7784147
1827,cells transfected,8,10,55,72,FasL expression was up-regulated in LS180 colon cancer cells transfected with the survivin gene.,15004200_6,-1,-1,-1,-1,1827,-1,0.0023661985,0.22856222,0.7690716
1833,cells transfected,9,11,57,74,"In contrast, FasL expression was down-regulated in SW480 cells transfected with a small inhibitory RNA to prevent survivin expression.",15004200_8,-1,-1,-1,-1,1833,-1,0.0018024102,0.22856653,0.7696311
1835,gene transfectants,1,3,9,27,"Survivin gene transfectants showed increased DNA binding of transcription factor specificity protein 1 (Sp1) to the FasL promoter, and up-regulation of Sp1 phosphorylation at serine and threonine residues; the total amount of Sp1 was unchanged.",15004200_9,-1,-1,-1,-1,1835,-1,3.580946e-05,0.99988604,7.809684e-05
1837,transcription factor specificity protein 1,8,13,60,102,"Survivin gene transfectants showed increased DNA binding of transcription factor specificity protein 1 (Sp1) to the FasL promoter, and up-regulation of Sp1 phosphorylation at serine and threonine residues; the total amount of Sp1 was unchanged.",15004200_9,-1,-1,-1,-1,1837,-1,6.488119e-06,0.9999788,1.4734881e-05
1839,to the,16,18,109,115,"Survivin gene transfectants showed increased DNA binding of transcription factor specificity protein 1 (Sp1) to the FasL promoter, and up-regulation of Sp1 phosphorylation at serine and threonine residues; the total amount of Sp1 was unchanged.",15004200_9,-1,-1,-1,-1,1839,-1,4.325779e-06,0.99999,5.732093e-06
1842,the total,32,34,206,215,"Survivin gene transfectants showed increased DNA binding of transcription factor specificity protein 1 (Sp1) to the FasL promoter, and up-regulation of Sp1 phosphorylation at serine and threonine residues; the total amount of Sp1 was unchanged.",15004200_9,-1,-1,-1,-1,1842,-1,4.4173075e-06,0.99999106,4.559736e-06
1853,that T cells,8,11,48,60,"In this article, we provide evidence suggesting that T cells may also play a protective role in liver disease by releasing interleukin-22 (IL-22), a recently identified T cell-derived cytokine whose biological significance is unclear.",15122762_1,-1,-1,-1,-1,1853,-1,0.0020239407,0.20896378,0.78901225
1855,releasing interleukin-22,21,23,113,137,"In this article, we provide evidence suggesting that T cells may also play a protective role in liver disease by releasing interleukin-22 (IL-22), a recently identified T cell-derived cytokine whose biological significance is unclear.",15122762_1,-1,-1,-1,-1,1855,-1,0.9659365,0.032588854,0.0014745974
1856,T cell-derived cytokine,30,33,169,192,"In this article, we provide evidence suggesting that T cells may also play a protective role in liver disease by releasing interleukin-22 (IL-22), a recently identified T cell-derived cytokine whose biological significance is unclear.",15122762_1,-1,-1,-1,-1,1856,-1,0.041908175,0.0005990199,0.9574928
1857,protein,4,5,24,31,IL-22 messenger RNA and protein expression are significantly elevated in T cell-mediated hepatitis induced by concanavalin A (ConA) but are less extensively elevated in the carbon tetrachloride-induced liver injury model.,15122762_2,0,1,-1,-1,1857,-1,1.0971168e-05,0.9999815,7.473799e-06
1865,receptor,22,23,124,132,Activated CD3(+) T cells are likely responsible for the production of IL-22 in the liver after injection of ConA. The IL-22 receptor is normally expressed at high levels by hepatocytes and further induced after ConA injection.,15122762_3,0,1,2,-1,1865,-1,0.006751564,0.55824685,0.43500164
1866,signal transducer and activator of transcription factor 3,7,15,52,109,"IL-22 blockade with a neutralizing antibody reduces signal transducer and activator of transcription factor 3 (STAT3) activation and worsens liver injury in T cell-mediated hepatitis, whereas injection of recombinant IL-22 attenuates such injury.",15122762_4,-1,-1,-1,-1,1866,-1,1.3171768e-05,0.99997854,8.315605e-06
1874,proteins,41,42,209,217,"Stable overexpression of IL-22 in HepG2 cells constitutively activates STAT3 and induces expression of a variety of antiapoptotic (e.g., Bcl-2, Bcl-xL, Mcl-1) and mitogenic (e.g., c-myc, cyclin D1, Rb2, CDK4) proteins.",15122762_6,0,1,-1,-1,1874,-1,1.1958042e-05,0.9999808,7.2935723e-06
1878,the T cell-derived cytokine,3,7,15,42,"In conclusion, the T cell-derived cytokine IL-22 is a survival factor for hepatocytes; this suggests that T cell activation may also prevent and repair liver injury by releasing hepatoprotective cytokine IL-22 in addition to its previously documented central role in hepatocellular injury.",15122762_8,-1,-1,-1,-1,1878,-1,0.46134427,0.5021963,0.036459405
1879,factor,11,12,63,69,"In conclusion, the T cell-derived cytokine IL-22 is a survival factor for hepatocytes; this suggests that T cell activation may also prevent and repair liver injury by releasing hepatoprotective cytokine IL-22 in addition to its previously documented central role in hepatocellular injury.",15122762_8,0,1,-1,-1,1879,-1,0.99971,0.00019861669,9.126932e-05
1881,that T cell activation,17,21,101,123,"In conclusion, the T cell-derived cytokine IL-22 is a survival factor for hepatocytes; this suggests that T cell activation may also prevent and repair liver injury by releasing hepatoprotective cytokine IL-22 in addition to its previously documented central role in hepatocellular injury.",15122762_8,-1,-1,-1,-1,1881,-1,0.0039019927,0.17708237,0.8190156
1891,protein,6,7,33,40,doses of TA-CIN (HPV-16 L2/E6/E7 protein) at four weekly intervals followed by a single dermal scarification of vaccinia HPV-16/18 E6/E7 and were followed up for 12 weeks.,15131030_1,0,1,-1,-1,1891,-1,0.0029255787,0.9965193,0.0005550637
1892,Immunity to,0,2,0,11,"Immunity to HPV-16 was assessed by lymphoproliferation, IFN-gamma enzyme-linked immunospot (ELISPOT), and ELISA.RESULTS: The patient group significantly responded to TA-CIN and not to the control antigen HPV-6 L2/E7 at all postvaccination time points when compared with baseline responses (P < or = 0.05).",15131030_2,-1,-1,-1,-1,1892,-1,0.01332536,0.98602784,0.0006468051
1895,to TA-CIN,23,25,163,172,"Immunity to HPV-16 was assessed by lymphoproliferation, IFN-gamma enzyme-linked immunospot (ELISPOT), and ELISA.RESULTS: The patient group significantly responded to TA-CIN and not to the control antigen HPV-6 L2/E7 at all postvaccination time points when compared with baseline responses (P < or = 0.05).",15131030_2,-1,-1,-1,-1,1895,-1,1.3137385e-05,0.9999751,1.172881e-05
1896,to the,27,29,181,187,"Immunity to HPV-16 was assessed by lymphoproliferation, IFN-gamma enzyme-linked immunospot (ELISPOT), and ELISA.RESULTS: The patient group significantly responded to TA-CIN and not to the control antigen HPV-6 L2/E7 at all postvaccination time points when compared with baseline responses (P < or = 0.05).",15131030_2,-1,-1,-1,-1,1896,-1,6.411145e-06,0.9999877,5.892878e-06
1903,proteins,9,10,59,67,Comparison of stimulation with HPV-16 E6- or E7-GST fusion proteins showed that proliferative responses were biased to HPV-16 E6.,15131030_4,0,1,-1,-1,1903,-1,8.307324e-06,0.99998546,6.1880733e-06
1908,peptides,10,11,63,71,"This bias was also seen by IFN-gamma ELISPOT using overlapping peptides, with HPV-16 E6- or E7-specific T cells being detected in 9 and 2 patients, respectively.",15131030_5,0,-1,2,-1,1908,-1,0.0002955289,0.99960095,0.00010354422
1916,T-cell,18,19,124,130,"Stable disease was recorded in 19 patients, 8 of whom showed a concomitant TA-CIN-specific proliferative and/or E6-specific T-cell response.",15131030_8,-1,1,2,-1,1916,-1,2.0394134e-05,8.128016e-06,0.9999715
1919,T-cell,10,11,41,47,"Of the 4 progressors, 2 failed to make a T-cell response and 2 responded by either proliferation or E6 ELISPOT alone.",15131030_9,-1,1,2,-1,1919,-1,1.778913e-05,7.837216e-06,0.99997437
1924,immunity,28,29,184,192,"CONCLUSIONS: The prime-boost regimen is immunogenic in AGIN patients (humoral and cellular immunity), but there is no simple relationship between induction of systemic HPV-16-specific immunity and clinical outcome.",15131030_10,0,-1,2,-1,1924,-1,0.99003476,0.00014763154,0.009817579
1925,factors that,1,3,6,18,Other factors that may play a role in the eradication of long-term established AGIN lesions need to be determined to identify the patient group that would benefit from immunotherapy with the vaccines used in this study.,15131030_11,-1,-1,-1,-1,1925,-1,3.080411e-05,0.99995863,1.0516976e-05
1936,blood,5,6,36,41,We describe responses of peripheral blood mononuclear cells (PBMC) and T cells from RRP patients and controls to the HPV-11 early proteins E6 and E7.,15138179_1,0,1,-1,-1,1936,-1,0.0013829377,0.9901552,0.00846187
1939,to the,19,21,110,116,We describe responses of peripheral blood mononuclear cells (PBMC) and T cells from RRP patients and controls to the HPV-11 early proteins E6 and E7.,15138179_1,-1,-1,-1,-1,1939,-1,5.2001697e-06,0.99998975,5.0960743e-06
1940,proteins,23,24,130,138,We describe responses of peripheral blood mononuclear cells (PBMC) and T cells from RRP patients and controls to the HPV-11 early proteins E6 and E7.,15138179_1,0,1,-1,-1,1940,-1,9.00056e-06,0.99998415,6.810457e-06
1942,proteins,10,11,48,56,PBMC were exposed in vitro to purified E6 or E7 proteins or transduced with fusion proteins containing the first 11 amino acids of the human immunodeficiency virus type 1 protein tat fused to E6 or E7 (tat-E6/tat-E7).,15138179_2,0,1,-1,-1,1942,-1,1.0405665e-05,0.99997866,1.0936496e-05
1944,proteins,15,16,83,91,PBMC were exposed in vitro to purified E6 or E7 proteins or transduced with fusion proteins containing the first 11 amino acids of the human immunodeficiency virus type 1 protein tat fused to E6 or E7 (tat-E6/tat-E7).,15138179_2,0,1,-1,-1,1944,-1,5.614483e-06,0.9999888,5.601909e-06
1961,IL-10 cytokine-producing cells,37,40,194,224,"T(H)1-like (interleukin-2 [IL-2], gamma interferon [IFN-gamma], IL-12, and IL-18), and T(H)2-like (IL-4 and IL-10) cytokine mRNAs were identified by reverse transcription-PCR, and IFN-gamma and IL-10 cytokine-producing cells were identified by enzyme-linked immunospot assay.",15138179_3,-1,-1,-1,-1,1961,-1,0.98361236,8.505167e-05,0.016302707
1966,IL-10 than,17,19,117,127,These studies show that HPV-11 E6 skews IL-10-IFN-gamma expression by patients with RRP toward greater expression of IL-10 than of IFN-gamma.,15138179_4,-1,-1,-1,-1,1966,-1,0.9992762,0.00041210136,0.00031171992
1969,general cytokine,6,8,24,40,"In addition, there is a general cytokine hyporesponsiveness to E6 that is more prominent for T(H)1-like cytokine expression by patients with severe disease.",15138179_5,-1,-1,-1,-1,1969,-1,0.6575958,0.3387142,0.0036899375
1972,T(H)1-like cytokine,16,18,93,112,"In addition, there is a general cytokine hyporesponsiveness to E6 that is more prominent for T(H)1-like cytokine expression by patients with severe disease.",15138179_5,-1,-1,-1,-1,1972,-1,0.08185981,0.9134818,0.004658434
1973,IL-10 cytokine,3,5,27,41,"Patients showed persistent IL-10 cytokine expression by the nonadherent fraction of PBMC when challenged with E6 and tat-E6, and, in contrast to controls, both T cells and non-T cells from patients expressed IL-10.",15138179_6,-1,-1,-1,-1,1973,-1,0.99997497,3.1857664e-06,2.1791577e-05
1981,to those,11,13,72,80,"However, E7/tat-E7 cytokine responses in patients with RRP were similar to those of the controls.",15138179_7,-1,-1,-1,-1,1981,-1,6.6467383e-06,0.9999871,6.2314452e-06
1988,T-cell,22,23,147,153,"In contrast, E6 inhibited IL-2 and IL-18 mRNA expression that would further contribute to a cytokine microenvironment unfavorable to HPV-specific, T-cell responses that should control persistent HPV infection.",15138179_8,-1,1,2,-1,1988,-1,9.76827e-05,1.8136538e-05,0.9998841
1993,to the,23,25,123,129,"In summary, E6 is the dominant inducer of cytokine expression in RRP, and it induces a skewed expression of IL-10 compared to the expression of IFN-gamma.",15138179_9,-1,-1,-1,-1,1993,-1,4.5778665e-06,0.9999912,4.2454676e-06
2008,protein AML1-eight-twenty-one,37,39,232,261,"In this study, three leukemic cell lines were investigated: Kasumi-1 and SKNO-1 (two acute myeloid leukemia (AML) cell lines carrying the (8;21)-chromosomal translocation, resulting in the expression of the leukemia-specific fusion protein AML1-eight-twenty-one) and REH, an acute lymphoblastic leukemia cell line with the (12;21)-chromosomal translocation and expression of translocation ETS-like leukemia-AML1.",15197237_1,-1,-1,-1,-1,2008,-1,6.6567394e-05,0.9998441,8.932235e-05
2014,proteins,2,3,13,21,"These fusion proteins are implicated in the pathogenesis of the leukemic state by recruiting corepressors and histone deacetylases (HDAC), which interfere with normal cell differentiation.",15197237_2,0,1,-1,-1,2014,-1,5.752423e-06,0.9999895,4.7228114e-06
2022,stimulating factor,19,21,135,153,"In vitro generation of DC was achieved using a cytokine cocktail containing tumor necrosis factor alpha, granulocyte macrophage-colony stimulating factor, c-kit ligand, and soluble CD40 ligand; yet, addition of the HDAC inhibitor (Hdi) trichostatin A enhanced DC differentiation with retention of the fusion transcripts.",15197237_3,-1,-1,-1,-1,2022,-1,0.9998909,1.1924126e-05,9.710684e-05
2031,these cell,4,6,23,33,"Only DC generated from these cell lines after Hdi induced blast-specific cytotoxic T cell responses in HLA-A-matched T cells with a cytotoxicity of 42% in parental Kasumi-1 and 83% in parental REH cells, respectively.",15197237_5,-1,-1,-1,-1,2031,-1,0.00014945278,0.002968251,0.9968823
2036,that the,4,6,27,35,This model system suggests that the Hdi supports the in vitro differentiation of DC from leukemic blasts with AML1-containing fusion proteins.,15197237_6,-1,-1,-1,-1,2036,-1,6.1921683e-06,0.9999889,4.948285e-06
2039,proteins,20,21,133,141,This model system suggests that the Hdi supports the in vitro differentiation of DC from leukemic blasts with AML1-containing fusion proteins.,15197237_6,0,1,-1,-1,2039,-1,6.8899367e-06,0.99998736,5.7324933e-06
2053,These cells,0,2,0,11,"These cells express the Foxp3 transcription factor, display an activated phenotype, and display a polyclonal TCR Vbeta chain repertoire.",15240741_3,-1,-1,-1,-1,2053,-1,1.3674525e-05,9.207437e-06,0.9999771
2054,the Foxp3 transcription factor,3,7,20,50,"These cells express the Foxp3 transcription factor, display an activated phenotype, and display a polyclonal TCR Vbeta chain repertoire.",15240741_3,-1,-1,-1,-1,2054,-1,4.406603e-06,0.99999094,4.597269e-06
2055,TCR,17,18,109,112,"These cells express the Foxp3 transcription factor, display an activated phenotype, and display a polyclonal TCR Vbeta chain repertoire.",15240741_3,-1,1,2,-1,2055,-1,4.4253153e-05,0.9998629,9.2820665e-05
2083,Analysis,0,1,0,8,"Analysis of CD4+ T-helper (Th) immunity against the E2, E6, and E7 antigens of HPV16 in healthy women revealed strong proliferative E2- and E6-specific responses associated with prominent IFN-gamma and interleukin 5 secretion.",15289354_2,0,1,-1,-1,2083,-1,5.9714494e-06,0.99998915,4.8179204e-06
2086,immunity,8,9,31,39,"Analysis of CD4+ T-helper (Th) immunity against the E2, E6, and E7 antigens of HPV16 in healthy women revealed strong proliferative E2- and E6-specific responses associated with prominent IFN-gamma and interleukin 5 secretion.",15289354_2,0,-1,2,-1,2086,-1,0.9933343,0.0006874617,0.005978196
2092,that the naturally,2,5,15,33,This indicates that the naturally arising virus-induced immune response displays a mixed Th1/Th2 cytokine profile.,15289354_3,-1,-1,-1,-1,2092,-1,5.870079e-06,0.99998987,4.231282e-06
2098,peptides,20,21,130,138,"Of all HPV16+ cervical cancer patients, approximately half failed to mount a detectable immune response against the HPV16-derived peptides.",15289354_4,0,-1,2,-1,2098,-1,0.01569127,0.9818523,0.0024564804
2105,that the,2,4,15,23,"This indicates that the HPV16-specific CD4+ T-cell response in cervical cancer patients is either absent or severely impaired, despite a relatively good immune status of the patients, as indicated by intact responses against recall antigens.",15289354_6,-1,-1,-1,-1,2105,-1,4.507812e-06,0.9999918,3.7181592e-06
2106,T-cell,7,8,44,50,"This indicates that the HPV16-specific CD4+ T-cell response in cervical cancer patients is either absent or severely impaired, despite a relatively good immune status of the patients, as indicated by intact responses against recall antigens.",15289354_6,-1,1,2,-1,2106,-1,1.2995183e-05,7.0795836e-06,0.99998
2113,T-cell,8,9,42,48,"It is highly conceivable that proper CD4+ T-cell help is important for launching an effective immune attack against HPV because infection of cervical epithelia by this virus is, at least initially, not accompanied by gross disturbance of this tissue and/or strong proinflammatory stimuli.",15289354_7,-1,1,2,-1,2113,-1,1.0020956e-05,6.4197634e-06,0.99998355
2115,this tissue,40,42,238,249,"It is highly conceivable that proper CD4+ T-cell help is important for launching an effective immune attack against HPV because infection of cervical epithelia by this virus is, at least initially, not accompanied by gross disturbance of this tissue and/or strong proinflammatory stimuli.",15289354_7,-1,-1,-1,-1,2115,-1,0.00016940685,0.9907195,0.00911109
2118,functional,8,9,51,61,"Therefore, our observations concerning the lack of functional HPV16-specific CD4+ T-cell immunity in patients with cervical cancer offer a possible explanation for the development of this disease.",15289354_8,0,1,2,-1,2118,-1,0.00038316482,0.99956006,5.680864e-05
2119,T-cell immunity,12,14,82,97,"Therefore, our observations concerning the lack of functional HPV16-specific CD4+ T-cell immunity in patients with cervical cancer offer a possible explanation for the development of this disease.",15289354_8,-1,-1,-1,-1,2119,-1,9.648022e-05,1.579703e-05,0.9998877
2122,that immune responses,4,7,17,38,"It is well known that immune responses in the intestine remain in a state of controlled inflammation, suggesting that not only active suppression by regulatory T cells plays an important role in the normal intestinal homeostasis, but also its dysregulation leads to the development of inflammatory bowel disease.",15322172_0,-1,-1,-1,-1,2122,-1,0.59351605,0.4041798,0.0023041333
2126,regulatory T cells plays,25,29,149,173,"It is well known that immune responses in the intestine remain in a state of controlled inflammation, suggesting that not only active suppression by regulatory T cells plays an important role in the normal intestinal homeostasis, but also its dysregulation leads to the development of inflammatory bowel disease.",15322172_0,-1,-1,-1,-1,2126,-1,0.0011092897,0.036889337,0.9620014
2128,to the,43,45,263,269,"It is well known that immune responses in the intestine remain in a state of controlled inflammation, suggesting that not only active suppression by regulatory T cells plays an important role in the normal intestinal homeostasis, but also its dysregulation leads to the development of inflammatory bowel disease.",15322172_0,-1,-1,-1,-1,2128,-1,4.3105856e-06,0.99999154,4.18043e-06
2130,that the,6,8,30,38,"In this study, we demonstrate that the CD4(+)CD25(bright) T cells reside in the human intestinal lamina propria (LP) and functionally retain regulatory activities.",15322172_1,-1,-1,-1,-1,2130,-1,3.4421764e-06,0.9999925,4.0962395e-06
2133,functionally,23,24,121,133,"In this study, we demonstrate that the CD4(+)CD25(bright) T cells reside in the human intestinal lamina propria (LP) and functionally retain regulatory activities.",15322172_1,0,1,2,-1,2133,-1,6.077819e-06,0.9999881,5.8328137e-06
2136,TNFR,16,17,114,118,"All human LP CD4(+) T cells regardless of CD25 expression constitutively expressed CTLA-4, glucocorticoid-induced TNFR family-related protein, and Foxp3 and proliferate poorly.",15322172_2,0,1,-1,-1,2136,-1,7.436919e-06,0.9999862,6.3418956e-06
2137,protein,18,19,134,141,"All human LP CD4(+) T cells regardless of CD25 expression constitutively expressed CTLA-4, glucocorticoid-induced TNFR family-related protein, and Foxp3 and proliferate poorly.",15322172_2,0,1,-1,-1,2137,-1,7.1120057e-06,0.9999877,5.1463735e-06
2159,to the,26,28,179,185,These results suggest that CD4(+)CD25(bright) T cells found in the normal and inflamed intestinal mucosa selectively inhibit the host immune response and therefore may contribute to the intestinal immune homeostasis.,15322172_7,-1,-1,-1,-1,2159,-1,4.6794066e-06,0.9999901,5.1855322e-06
2163,tissues,19,20,116,123,BACKGROUND: Regulation of gene expression by signal transducer and activator of transcription 1 (STAT1) within host tissues mediates the antitumor effects of interferon alfa (IFN alpha).,15339971_0,-1,1,2,-1,2163,-1,0.000106946434,0.0008927434,0.9990004
2165,interferon alfa,25,27,158,173,BACKGROUND: Regulation of gene expression by signal transducer and activator of transcription 1 (STAT1) within host tissues mediates the antitumor effects of interferon alfa (IFN alpha).,15339971_0,-1,-1,-1,-1,2165,-1,0.99992466,1.6665059e-05,5.8618058e-05
2169,cell subsets,16,18,117,129,We used a novel flow cytometric assay to examine phosphorylation-mediated activation of STAT1 within immune effector cell subsets following in vitro or in vivo IFN alpha treatments.,15339971_1,-1,-1,-1,-1,2169,-1,1.425139e-05,9.495147e-06,0.99997616
2172,blood,3,4,20,25,METHODS: Peripheral blood mononuclear cells (PBMCs) isolated from healthy donors (n = 17) or melanoma patients (n = 19) were treated in vitro with interferon alfa-2b (IFN alpha-2b) or phosphate-buffered saline (PBS) and subjected to multiparametric flow cytometry to measure the levels of phosphorylated STAT1 (P-STAT1) within immune cell subsets.,15339971_2,0,1,-1,-1,2172,-1,0.0010543289,0.98899734,0.009948357
2175,interferon alfa-2b,31,33,147,165,METHODS: Peripheral blood mononuclear cells (PBMCs) isolated from healthy donors (n = 17) or melanoma patients (n = 19) were treated in vitro with interferon alfa-2b (IFN alpha-2b) or phosphate-buffered saline (PBS) and subjected to multiparametric flow cytometry to measure the levels of phosphorylated STAT1 (P-STAT1) within immune cell subsets.,15339971_2,-1,-1,-1,-1,2175,-1,0.99969375,0.00010182642,0.00020452295
2181,cell subsets,61,63,334,346,METHODS: Peripheral blood mononuclear cells (PBMCs) isolated from healthy donors (n = 17) or melanoma patients (n = 19) were treated in vitro with interferon alfa-2b (IFN alpha-2b) or phosphate-buffered saline (PBS) and subjected to multiparametric flow cytometry to measure the levels of phosphorylated STAT1 (P-STAT1) within immune cell subsets.,15339971_2,-1,-1,-1,-1,2181,-1,1.4259204e-05,7.714848e-06,0.99997795
2183,statistical tests,1,3,4,21,All statistical tests were two-sided.,15339971_4,-1,-1,-1,-1,2183,-1,3.546617e-05,0.9999503,1.4283021e-05
2185,cell subsets,8,10,44,56,RESULTS: P-STAT1 levels in all major immune cell subsets increased within 15 minutes of in vitro IFN alpha-2b treatment of PBMCs; the increase was most pronounced in T lymphocytes and monocytes.,15339971_5,-1,-1,-1,-1,2185,-1,1.735149e-05,9.333686e-06,0.9999733
2192,maximal STAT1,14,16,71,84,"Relatively low doses of IFN alpha-2b (i.e., 10(2)-10(3) IU/mL) induced maximal STAT1 activation in vitro.",15339971_6,-1,-1,-1,-1,2192,-1,8.51287e-06,0.9999826,8.880387e-06
2212,to treatments,28,30,169,182,P-STAT1 levels in the PBMCs of a patient treated sequentially with 5 MU/m2 and 10 MU/m2 IFN alpha-2b (administered by subcutaneous injection) also increased in response to treatments with IFN alpha-2b but did not increase further with the increased dosage of IFN alpha-2b.,15339971_9,-1,-1,-1,-1,2212,-1,6.505098e-06,0.9999887,4.8686566e-06
2222,TGF-beta,2,3,15,23,"Alterations of TGF-beta signaling have been described in colorectal cancer, although the molecular consequences are largely unknown.",15485627_0,0,1,-1,-1,2222,-1,0.00015102584,0.9998273,2.1659558e-05
2225,TGF-beta,5,6,40,48,"By using transgenic mice overexpressing TGF-beta or a dominant-negative TGF-betaRII, we demonstrate that TGF-beta signaling in tumor infiltrating T lymphocytes controls the growth of dysplastic epithelial cells in experimental colorectal cancer, as determined by histology and a novel system for high-resolution chromoendoscopy.",15485627_1,0,1,-1,-1,2225,-1,4.183392e-05,0.99994683,1.13750275e-05
2226,TGF-betaRII,9,10,72,83,"By using transgenic mice overexpressing TGF-beta or a dominant-negative TGF-betaRII, we demonstrate that TGF-beta signaling in tumor infiltrating T lymphocytes controls the growth of dysplastic epithelial cells in experimental colorectal cancer, as determined by histology and a novel system for high-resolution chromoendoscopy.",15485627_1,0,1,-1,-1,2226,-1,0.00052566483,0.998429,0.0010452658
2227,that TGF-beta,13,15,100,113,"By using transgenic mice overexpressing TGF-beta or a dominant-negative TGF-betaRII, we demonstrate that TGF-beta signaling in tumor infiltrating T lymphocytes controls the growth of dysplastic epithelial cells in experimental colorectal cancer, as determined by histology and a novel system for high-resolution chromoendoscopy.",15485627_1,-1,-1,-1,-1,2227,-1,7.188645e-05,0.9999138,1.43042025e-05
2233,TGF-beta,5,6,24,32,"At the molecular level, TGF-beta signaling in T cells regulated STAT-3 activation in tumor cells via IL-6.",15485627_2,0,1,-1,-1,2233,-1,3.4668894e-05,0.9999541,1.1273077e-05
2236,tumor cells,14,16,85,96,"At the molecular level, TGF-beta signaling in T cells regulated STAT-3 activation in tumor cells via IL-6.",15485627_2,-1,-1,-1,-1,2236,-1,5.2805284e-05,0.00015653374,0.9997907
2239,tumor cell-derived,3,5,24,42,IL-6 signaling required tumor cell-derived soluble IL-6R rather than membrane bound IL-6R and suppression of such TGF-beta-dependent IL-6 trans-signaling prevented tumor progression in vivo.,15485627_3,-1,-1,-1,-1,2239,-1,0.0030046827,0.27720618,0.71978915
2243,TGF-beta-dependent IL-6 trans-signaling,16,19,114,153,IL-6 signaling required tumor cell-derived soluble IL-6R rather than membrane bound IL-6R and suppression of such TGF-beta-dependent IL-6 trans-signaling prevented tumor progression in vivo.,15485627_3,-1,-1,-1,-1,2243,-1,0.0002475371,0.999699,5.34736e-05
2245,Taken together,0,2,0,14,"Taken together, our data provide novel insights into TGF-beta signaling in colorectal cancer and suggest novel therapeutic approaches for colorectal cancer based on inhibition of TGF-beta-dependent IL-6 trans-signaling.",15485627_4,-1,-1,-1,-1,2245,-1,1.2531992e-05,0.999977,1.0451158e-05
2246,TGF-beta,9,10,53,61,"Taken together, our data provide novel insights into TGF-beta signaling in colorectal cancer and suggest novel therapeutic approaches for colorectal cancer based on inhibition of TGF-beta-dependent IL-6 trans-signaling.",15485627_4,0,1,-1,-1,2246,-1,2.8144445e-05,0.99996114,1.0689467e-05
2248,TGF-beta-dependent IL-6 trans-signaling,26,29,179,218,"Taken together, our data provide novel insights into TGF-beta signaling in colorectal cancer and suggest novel therapeutic approaches for colorectal cancer based on inhibition of TGF-beta-dependent IL-6 trans-signaling.",15485627_4,-1,-1,-1,-1,2248,-1,0.00027811428,0.9996649,5.69782e-05
2251,receptor,4,5,28,36,The killer cell lectin-like receptor G1 (KLRG1) is expressed in natural killer (NK) cells and effector memory alphabeta T cells.,15498816_0,0,1,2,-1,2251,-1,8.80916e-05,2.3478606e-05,0.9998884
2264,to the,14,16,97,103,Vgamma9/Vdelta2 T cells comprise the majority of peripheral human gammadelta T cells and respond to the microbial metabolite (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate (HMB-PP).,15498816_2,-1,-1,-1,-1,2264,-1,6.7103433e-06,0.99998856,4.7597205e-06
2267,blood,18,19,108,113,"Here, we demonstrate that KLRG1 is expressed in a significant proportion of Vgamma9/Vdelta2 T cells in cord blood and in the majority of peripheral Vgamma9/Vdelta2 T cells from adult donors.",15498816_3,0,1,-1,-1,2267,-1,0.00040945917,0.99876785,0.0008227757
2272,chemokine receptor,29,31,164,182,"KLRG1+ Vgamma9/Vdelta2 T cells displayed an effector memory phenotype, as KLRG1 was expressed mainly in Vgamma9/Vdelta2 T cells lacking CD27, CD45RA, CD62L, and CC chemokine receptor 7 (CCR7).",15498816_4,-1,-1,-1,-1,2272,-1,0.9861476,4.1611926e-05,0.013810856
2282,tumor antigens,5,7,39,53,"BACKGROUND: Although immunization with tumor antigens can eliminate many transplantable tumors in animal models, immune effector mechanisms associated with successful immunotherapy of epithelial cancers remain undefined.",15523090_0,-1,-1,-1,-1,2282,-1,0.5791828,0.41593796,0.004879208
2283,transplantable tumors,10,12,73,94,"BACKGROUND: Although immunization with tumor antigens can eliminate many transplantable tumors in animal models, immune effector mechanisms associated with successful immunotherapy of epithelial cancers remain undefined.",15523090_0,-1,-1,-1,-1,2283,-1,6.257115e-06,0.9999877,6.0064463e-06
2286,tumor antigen,10,12,77,90,"METHODS: Skin from transgenic mice expressing the cervical cancer-associated tumor antigen human papillomavirus type 16 (HPV16) E6 or E7 proteins from a keratin 14 promoter was grafted onto syngeneic, non-transgenic mice.",15523090_1,-1,-1,-1,-1,2286,-1,0.6131137,0.37705895,0.009827352
2288,proteins,22,23,137,145,"METHODS: Skin from transgenic mice expressing the cervical cancer-associated tumor antigen human papillomavirus type 16 (HPV16) E6 or E7 proteins from a keratin 14 promoter was grafted onto syngeneic, non-transgenic mice.",15523090_1,0,1,-1,-1,2288,-1,1.2978577e-05,0.9999782,8.889999e-06
2290,antigen-specific T cells,15,18,99,123,Skin graft rejection was measured after active immunization with HPV16 E7 and adoptive transfer of antigen-specific T cells.,15523090_2,-1,-1,-1,-1,2290,-1,0.7244177,0.00044270238,0.27513966
2294,protein,50,51,359,366,"Cytokine secretion of lymphocytes from mice receiving skin grafts and immunotherapy was detected by enzyme-linked immunosorbent assay, and HPV16 E7-specific memory CD8+ T cells were detected by flow cytometry and ELISPOT.RESULTS: Skin grafts containing HPV16 E6-or E7-expressing keratinocytes were not rejected spontaneously or following immunization with E7 protein and adjuvant.",15523090_3,0,1,-1,-1,2294,-1,0.018361747,0.9806521,0.0009861111
2296,T-cell receptor transgenic,4,7,33,59,Adoptive transfer of E7-specific T-cell receptor transgenic CD8+ T cells combined with immunization resulted in induction of antigen-specific interferon gamma-secreting CD8+ T cells and rejection of HPV16 E7-expressing grafts.,15523090_4,-1,-1,-1,-1,2296,-1,0.0005292735,0.0055517056,0.993919
2298,antigen-specific interferon,18,20,125,152,Adoptive transfer of E7-specific T-cell receptor transgenic CD8+ T cells combined with immunization resulted in induction of antigen-specific interferon gamma-secreting CD8+ T cells and rejection of HPV16 E7-expressing grafts.,15523090_4,-1,-1,-1,-1,2298,-1,0.99996054,7.17285e-06,3.2251253e-05
2305,tumor antigen,13,15,86,99,"CONCLUSIONS: Antigen-specific CD8+ T cells can destroy epithelium expressing HPV16 E7 tumor antigen, but presentation of E7 antigen from skin is insufficient to reactivate memory CD8+ T cells induced by immunotherapy.",15523090_7,-1,-1,-1,-1,2305,-1,0.74040675,0.25483966,0.00475363
2314,function,9,10,46,54,"In this study, we describe the expression and function of CD40, a TNF receptor family member, in cervical carcinomas.",15611226_0,0,1,2,-1,2314,-1,2.4335955e-05,0.9999509,2.481206e-05
2315,TNF receptor,14,16,66,78,"In this study, we describe the expression and function of CD40, a TNF receptor family member, in cervical carcinomas.",15611226_0,-1,-1,-1,-1,2315,-1,0.0002936145,0.9989208,0.0007856468
2321,the NF-kappaB,18,20,116,129,The stimulation of CD40-positive cervical carcinoma cell lines with soluble CD40L (CD154) resulted in activation of the NF-kappaB and MAPK signaling pathways and up-regulation of cell surface markers and intracellular molecules associated with Ag processing and presentation.,15611226_2,-1,-1,-1,-1,2321,-1,8.34987e-06,0.99998415,7.537323e-06
2323,the CD154-induced,2,4,15,32,"Concomitantly, the CD154-induced activation of CD40 in carcinoma cells was found to directly influence susceptibility to CTL-mediated killing.",15611226_3,-1,-1,-1,-1,2323,-1,0.0013885535,0.99410737,0.004504056
2326,to CTL-mediated,16,18,118,133,"Concomitantly, the CD154-induced activation of CD40 in carcinoma cells was found to directly influence susceptibility to CTL-mediated killing.",15611226_3,-1,-1,-1,-1,2326,-1,0.0016612511,0.061243787,0.937095
2332,CD154 treatment,2,4,9,24,"However, CD154 treatment of carcinoma cells expressing proteasome-dependent but TAP-independent Ags from the EBV-encoded BRLF1 and BMLF1 failed to increase tumor cell lysis by specific CTLs.",15611226_5,-1,-1,-1,-1,2332,-1,0.0020772659,0.0081491135,0.9897737
2337,tumor cell,21,23,156,166,"However, CD154 treatment of carcinoma cells expressing proteasome-dependent but TAP-independent Ags from the EBV-encoded BRLF1 and BMLF1 failed to increase tumor cell lysis by specific CTLs.",15611226_5,-1,-1,-1,-1,2337,-1,3.736267e-05,6.271851e-05,0.9999
2339,that chemotherapeutic,4,6,25,46,"Moreover, we demonstrate that chemotherapeutic agents that suppress protein synthesis and reverse the CD40-mediated dissociation of the translational repressor eukaryotic initiation factor 4E-binding protein from the initiation factor eukaryotic initiation factor 4E, such as 5-fluorouracil, etoposide, and quercetin, dramatically increase the susceptibility of cervical carcinoma cells to CD40L-induced apoptosis.",15611226_6,-1,-1,-1,-1,2339,-1,0.79840726,0.1986508,0.0029419742
2341,protein,9,10,68,75,"Moreover, we demonstrate that chemotherapeutic agents that suppress protein synthesis and reverse the CD40-mediated dissociation of the translational repressor eukaryotic initiation factor 4E-binding protein from the initiation factor eukaryotic initiation factor 4E, such as 5-fluorouracil, etoposide, and quercetin, dramatically increase the susceptibility of cervical carcinoma cells to CD40L-induced apoptosis.",15611226_6,0,1,-1,-1,2341,-1,1.571564e-05,0.9999769,7.369313e-06
2343,the translational,17,19,132,149,"Moreover, we demonstrate that chemotherapeutic agents that suppress protein synthesis and reverse the CD40-mediated dissociation of the translational repressor eukaryotic initiation factor 4E-binding protein from the initiation factor eukaryotic initiation factor 4E, such as 5-fluorouracil, etoposide, and quercetin, dramatically increase the susceptibility of cervical carcinoma cells to CD40L-induced apoptosis.",15611226_6,-1,-1,-1,-1,2343,-1,4.8425827e-06,0.99999094,4.2318034e-06
2345,protein,24,25,200,207,"Moreover, we demonstrate that chemotherapeutic agents that suppress protein synthesis and reverse the CD40-mediated dissociation of the translational repressor eukaryotic initiation factor 4E-binding protein from the initiation factor eukaryotic initiation factor 4E, such as 5-fluorouracil, etoposide, and quercetin, dramatically increase the susceptibility of cervical carcinoma cells to CD40L-induced apoptosis.",15611226_6,0,1,-1,-1,2345,-1,6.8027425e-06,0.9999877,5.4649795e-06
2346,the initiation factor,26,29,213,234,"Moreover, we demonstrate that chemotherapeutic agents that suppress protein synthesis and reverse the CD40-mediated dissociation of the translational repressor eukaryotic initiation factor 4E-binding protein from the initiation factor eukaryotic initiation factor 4E, such as 5-fluorouracil, etoposide, and quercetin, dramatically increase the susceptibility of cervical carcinoma cells to CD40L-induced apoptosis.",15611226_6,-1,-1,-1,-1,2346,-1,4.7236954e-06,0.9999907,4.6086197e-06
2349,cells to CD40L-induced,50,53,381,403,"Moreover, we demonstrate that chemotherapeutic agents that suppress protein synthesis and reverse the CD40-mediated dissociation of the translational repressor eukaryotic initiation factor 4E-binding protein from the initiation factor eukaryotic initiation factor 4E, such as 5-fluorouracil, etoposide, and quercetin, dramatically increase the susceptibility of cervical carcinoma cells to CD40L-induced apoptosis.",15611226_6,-1,-1,-1,-1,2349,-1,7.997833e-05,4.8664722e-05,0.9998714
2350,Taken together,0,2,0,14,"Taken together, these observations demonstrate the functional expression of CD40 in epithelial tumors of the cervix and support the clinical exploitation of the CD40 pathway for the treatment of cervical cancer through its multiple effects on tumor cell growth, apoptosis, and immune recognition.",15611226_7,-1,-1,-1,-1,2350,-1,8.9383675e-06,0.99998355,7.482287e-06
2352,the functional,6,8,47,61,"Taken together, these observations demonstrate the functional expression of CD40 in epithelial tumors of the cervix and support the clinical exploitation of the CD40 pathway for the treatment of cervical cancer through its multiple effects on tumor cell growth, apoptosis, and immune recognition.",15611226_7,-1,-1,-1,-1,2352,-1,7.1182267e-06,0.9999876,5.2665064e-06
2357,the treatment,27,29,178,191,"Taken together, these observations demonstrate the functional expression of CD40 in epithelial tumors of the cervix and support the clinical exploitation of the CD40 pathway for the treatment of cervical cancer through its multiple effects on tumor cell growth, apoptosis, and immune recognition.",15611226_7,-1,-1,-1,-1,2357,-1,5.0316075e-06,0.99999034,4.6158625e-06
2359,tumor cell,37,39,243,253,"Taken together, these observations demonstrate the functional expression of CD40 in epithelial tumors of the cervix and support the clinical exploitation of the CD40 pathway for the treatment of cervical cancer through its multiple effects on tumor cell growth, apoptosis, and immune recognition.",15611226_7,-1,-1,-1,-1,2359,-1,0.0001048493,0.0005165432,0.99937856
2363,factor,17,18,103,109,"Since the intrinsically poor immunogenicity of chronic lymphocytic leukemia (CLL) cells might be a key factor in allowing them to avoid immune control mechanisms, the development of methods to enhance CLL cell immunogenicity might lead to improved disease control.",15614042_0,0,1,-1,-1,2363,-1,5.7133417e-05,0.9999287,1.4118442e-05
2364,them to,20,22,122,129,"Since the intrinsically poor immunogenicity of chronic lymphocytic leukemia (CLL) cells might be a key factor in allowing them to avoid immune control mechanisms, the development of methods to enhance CLL cell immunogenicity might lead to improved disease control.",15614042_0,-1,-1,-1,-1,2364,-1,7.777603e-06,0.9999856,6.6437115e-06
2370,cells to,4,6,19,27,The ability of CLL cells to stimulate T cells was increased significantly by the protein kinase C (PKC) agonist phorbol myristic acetate (PMA).,15614042_1,-1,-1,-1,-1,2370,-1,0.004646073,0.33059642,0.6647575
2372,the protein,13,15,77,88,The ability of CLL cells to stimulate T cells was increased significantly by the protein kinase C (PKC) agonist phorbol myristic acetate (PMA).,15614042_1,-1,-1,-1,-1,2372,-1,8.815543e-06,0.9999858,5.3548015e-06
2375,these cells,18,20,95,106,"Antioxidants, such as 2-mercaptoethanol (2-ME), or fetal calf serum could prevent the death of these cells but caused them to enter distinct states of differentiation.",15614042_3,-1,-1,-1,-1,2375,-1,2.6209962e-05,2.7408145e-05,0.99994636
2376,them to,22,24,118,125,"Antioxidants, such as 2-mercaptoethanol (2-ME), or fetal calf serum could prevent the death of these cells but caused them to enter distinct states of differentiation.",15614042_3,-1,-1,-1,-1,2376,-1,6.058075e-06,0.9999826,1.1359997e-05
2380,T-cell,15,16,109,115,"In the presence of 2-ME, PMA-activated CLL cells extended dendritic-like protrusions and exhibited increased T-cell stimulatory capacity.",15614042_4,-1,1,2,-1,2380,-1,2.224417e-05,1.0382214e-05,0.99996734
2385,IL-12 p40,18,20,102,111,"In the presence of serum, PMA-activated CLL cells developed fewer dendrites, made less IL-10 and more IL-12 p40 mRNA transcripts, and showed an increased capacity to induce IFN-gamma production by T cells.",15614042_5,-1,-1,-1,-1,2385,-1,0.9993309,9.529353e-05,0.00057387253
2395,the NF-kappaB,24,26,150,163,The effects of serum on the promotion of type 1 immune responses by phorbol ester-activated CLL cells were dominant and correlated with activation of the NF-kappaB signaling pathway.,15614042_6,-1,-1,-1,-1,2395,-1,1.0327118e-05,0.99998224,7.4231575e-06
2396,agonists,2,3,10,18,"Other PKC agonists, such as Bryostatin-1 and a synthetic Bryostatin analog (Picolog), had similar effects on CLL cells.",15614042_7,0,1,-1,-1,2396,-1,0.87272036,0.118081115,0.009198576
2401,cells that,10,12,65,75,The observation that CLL cells can acquire features of dendritic cells that promote type 1 immunity may find clinical application in immunotherapeutic strategies for this disease.,15614042_8,-1,-1,-1,-1,2401,-1,0.004814286,0.29971018,0.6954756
2403,immunity,15,16,91,99,The observation that CLL cells can acquire features of dendritic cells that promote type 1 immunity may find clinical application in immunotherapeutic strategies for this disease.,15614042_8,0,-1,2,-1,2403,-1,0.9998604,3.4560017e-05,0.000104981205
2408,tumor-specific antigen,25,27,117,139,PURPOSE: The idiotype (Id) of the immunoglobulin on a given B-cell malignancy is a clonal marker that can serve as a tumor-specific antigen.,15623607_0,-1,-1,-1,-1,2408,-1,0.31504557,0.6808204,0.004134057
2409,protein,10,11,61,68,"We developed a novel vaccine formulation by incorporating Id protein with liposomal lymphokine that was more potent than a prototype, carrier-conjugated Id protein vaccine in preclinical studies.",15623607_1,0,1,-1,-1,2409,-1,0.0005113484,0.9993192,0.00016944007
2410,lymphokine that,13,15,84,99,"We developed a novel vaccine formulation by incorporating Id protein with liposomal lymphokine that was more potent than a prototype, carrier-conjugated Id protein vaccine in preclinical studies.",15623607_1,-1,-1,-1,-1,2410,-1,0.99278826,0.005030529,0.002181174
2412,protein,25,26,156,163,"We developed a novel vaccine formulation by incorporating Id protein with liposomal lymphokine that was more potent than a prototype, carrier-conjugated Id protein vaccine in preclinical studies.",15623607_1,0,1,-1,-1,2412,-1,0.00023638173,0.99966896,9.4704264e-05
2428,lymphocyte antigen,17,19,83,101,"Antitumor immune responses were mediated by both CD4+ and CD8+ T cells, were human lymphocyte antigen class I and II associated, and persisted 18 months beyond the completion of vaccination.",15623607_6,-1,-1,-1,-1,2428,-1,0.2262454,0.0008378022,0.7729168
2434,T-cell,26,27,163,169,"CONCLUSIONS: This first clinical report of a liposomal cancer vaccine demonstrates that liposomal delivery is safe, induces sustained tumor-specific CD4+ and CD8+ T-cell responses in lymphoma patients, and may serve as a model for vaccine development against other human cancers and infectious pathogens.",15623607_9,-1,1,2,-1,2434,-1,2.1563206e-05,6.1236974e-06,0.99997234
2452,STAT6-deficient MSCs,3,5,19,39,"Neither BALB/c nor STAT6-deficient MSCs produce inducible NO synthase; however, both produce arginase and reactive oxygen species.",15634881_4,-1,-1,-1,-1,2452,-1,9.769955e-06,0.9999808,9.3976905e-06
2456,Immunity,0,1,0,8,"Immunity in STAT6-deficient mice requires the activation of NO-producing M1 macrophages that are tumoricidal, the reduction in MSC levels to baseline after surgical removal of primary tumor, and the activation of tumor-specific T cells.",15634881_6,0,-1,2,-1,2456,-1,0.9997329,9.6429394e-05,0.00017065798
2466,tumor-specific T cells,33,36,213,235,"Immunity in STAT6-deficient mice requires the activation of NO-producing M1 macrophages that are tumoricidal, the reduction in MSC levels to baseline after surgical removal of primary tumor, and the activation of tumor-specific T cells.",15634881_6,-1,-1,-1,-1,2466,-1,0.0045207823,0.7247638,0.27071536
2468,STAT6 deficiency,8,10,50,66,"These mechanisms occur in STAT6(-/-) mice because STAT6 deficiency prevents signaling through the type 2 IL-4Ralpha, thereby blocking the production of arginase and promoting the synthesis of NO.",15634881_7,-1,-1,-1,-1,2468,-1,7.389556e-06,0.99998486,7.749522e-06
2469,through the type,12,15,86,102,"These mechanisms occur in STAT6(-/-) mice because STAT6 deficiency prevents signaling through the type 2 IL-4Ralpha, thereby blocking the production of arginase and promoting the synthesis of NO.",15634881_7,-1,-1,-1,-1,2469,-1,7.8533785e-06,0.9999852,6.9853863e-06
2478,immunity,5,6,47,55,"Strategies to stimulate CTL-mediated antitumor immunity have included in vitro stimulation and/or genetic engineering of T cells, followed by adoptive transfer into tumor-bearing hosts.",15661898_1,0,-1,2,-1,2478,-1,0.99986756,3.0422576e-05,0.00010199323
2487,Th1 cells to,17,20,74,86,"In this model of B cell lymphoma in SJL/J mice, we used Tim-3(+) T-bet(+) Th1 cells to facilitate the development of tumor-specific CTL.",15661898_2,-1,-1,-1,-1,2487,-1,0.0006015256,0.9168913,0.08250721
2489,tumor-specific CTL,24,26,117,135,"In this model of B cell lymphoma in SJL/J mice, we used Tim-3(+) T-bet(+) Th1 cells to facilitate the development of tumor-specific CTL.",15661898_2,-1,-1,-1,-1,2489,-1,0.0035016679,0.61934507,0.3771533
2490,Tumor-specific Th1 cell,0,3,0,23,Tumor-specific Th1 cell lines were polarized with IL-12 during in vitro stimulation and long term maintenance.,15661898_3,-1,-1,-1,-1,2490,-1,0.0021436557,0.78483266,0.21302369
2497,transplantable cells,18,20,97,117,As few as 5 million Tim-3(+) T-bet(+) Th1 cells enabled recipients to resist growth of malignant transplantable cells.,15661898_4,-1,-1,-1,-1,2497,-1,0.002533671,0.5670429,0.43042344
2502,tumor cells,7,9,44,55,"CFSE(+) Th1 cells colocalized with injected tumor cells in vivo and formed conjugates with the tumor cells within follicles, whereas in nontumor-challenged recipients the CFSE(+) Th1 cells localized only within the T cell zones of the spleen.",15661898_6,-1,-1,-1,-1,2502,-1,9.316858e-05,0.00038239756,0.9995245
2503,the tumor cells,15,18,91,106,"CFSE(+) Th1 cells colocalized with injected tumor cells in vivo and formed conjugates with the tumor cells within follicles, whereas in nontumor-challenged recipients the CFSE(+) Th1 cells localized only within the T cell zones of the spleen.",15661898_6,-1,-1,-1,-1,2503,-1,0.0021772555,0.52269953,0.47512326
2506,the T cell,33,36,211,221,"CFSE(+) Th1 cells colocalized with injected tumor cells in vivo and formed conjugates with the tumor cells within follicles, whereas in nontumor-challenged recipients the CFSE(+) Th1 cells localized only within the T cell zones of the spleen.",15661898_6,-1,-1,-1,-1,2506,-1,0.0016479953,0.14836235,0.84998965
2512,tumor-specific Th1 cells,12,15,82,106,These results provide evidence that adoptive immunotherapy with Tim-3(+) T-bet(+) tumor-specific Th1 cells can be used to induce host cytotoxic responses that inhibit the development and growth of neoplastic cells.,15661898_7,-1,-1,-1,-1,2512,-1,0.0031467231,0.6004897,0.39636362
2520,immunity,19,20,118,126,NKT cells are a regulatory subset of T lymphocytes with immune modulatory effects and an important role in anti-tumor immunity.,15688366_0,0,-1,2,-1,2520,-1,0.9997775,0.000112843416,0.00010962159
2532,NKT cell transplantation,6,9,29,53,Group D mice did not undergo NKT cell transplantation.,15688366_5,-1,-1,-1,-1,2532,-1,0.0012221955,0.7639662,0.2348116
2553,the transcription factor STAT4,2,6,14,44,"Expression of the transcription factor STAT4 was evident in group A, but not in groups B-D. Serum IFNgamma, IL12 and IL4 levels were increased in groups A and E. Adoptive transfer of NKT lymphocytes exposed ex vivo by HCC-derived antigens loaded on dendritic cells and NKT cells from immunized donors led to suppression of HCC in mice.",15688366_12,-1,-1,-1,-1,2553,-1,4.475234e-06,0.99999034,5.1445813e-06
2566,cytokines IFNgamma,31,33,201,219,"NKT-mediated anti-tumor activity was associated increased NKT and CD8+ T lymphocyte numbers, increased expression of STAT4, a marker for IL-12 activity and elevated serum levels of the proinflammatory cytokines IFNgamma and IL12, and of IL4.",15688366_13,-1,-1,-1,-1,2566,-1,0.9999423,8.2353745e-06,4.951027e-05
2569,therapy,13,14,78,85,Ex-vivo modulation of NKT lymphocytes holds promise as a novel mode of immune therapy for HCC.,15688366_14,0,1,-1,-1,2569,-1,4.6483683e-06,0.99998975,5.5921564e-06
2570,Transfecting genes,0,2,0,18,"Transfecting genes into tumors, to upregulate major histocompatibility complex (MHC) class I and class II molecules and inhibit MHC class II associated invariant chain (Ii), induces a potent anti-tumor immune response when preceded by tumor irradiation, in murine RM-9 prostate carcinoma.",15761259_0,-1,-1,-1,-1,2570,-1,4.8154207e-06,0.99999,5.1722063e-06
2576,The transfected genes,0,3,0,21,"The transfected genes are cDNA plasmids for interferon-gamma (pIFN-gamma), MHC class II transactivator (pCIITA), an Ii reverse gene construct (pIi-RGC), and a subtherapeutic dose of adjuvant IL-2 (pIL-2).",15761259_1,-1,-1,-1,-1,2576,-1,3.6160081e-06,0.9999906,5.7637744e-06
2582,tumor-specific cytotoxic T lymphocytes,9,13,72,110,Responding mice rejected challenge with parental tumor and demonstrated tumor-specific cytotoxic T lymphocytes (CTLs).,15761259_2,-1,-1,-1,-1,2582,-1,0.0044257003,0.5009321,0.49464217
2585,the relative,7,9,48,60,"We have extended our investigation to determine the relative roles of each one of the four plasmids pIFN-gamma, pCIITA, pIi-RGC, and pIL-2 in conjunction with radiation for the induction of a curative immune response.",15761259_3,-1,-1,-1,-1,2585,-1,5.5709534e-06,0.99999034,4.077157e-06
2594,tumor cells,22,24,115,126,"An optimal and specific antitumor response is achieved in more than 50% of the mice when, after tumor irradiation, tumor cells are converted in situ to a MHC class I+/class II+/Ii- phenotype with pIFN-gamma, pCIITA, pIi-RGC, and pIL-2.",15761259_5,-1,-1,-1,-1,2594,-1,0.00026358094,0.0053010434,0.9944354
2602,to the gene therapy,3,7,26,45,The radiation contributes to the gene therapy by causing tumor debulking and increasing the permeability of tumors to infiltration of inflammatory cells.,15761259_7,-1,-1,-1,-1,2602,-1,7.4852846e-06,0.99998546,7.0383758e-06
2605,tumors to,16,18,108,117,The radiation contributes to the gene therapy by causing tumor debulking and increasing the permeability of tumors to infiltration of inflammatory cells.,15761259_7,-1,-1,-1,-1,2605,-1,4.5095094e-06,0.9999906,4.9398354e-06
2608,cytokine interferon-gamma,3,5,29,54,"Although the proinflammatory cytokine interferon-gamma (IFN-gamma) has been generally thought to enhance antitumor immune responses and be involved in antitumor mechanisms of many other immunotherapy molecules, it has also been reported that IFN-gamma could promote tumor immune evasion.",15776283_0,-1,-1,-1,-1,2608,-1,0.99997437,3.1712177e-06,2.2447717e-05
2610,generally thought to,10,13,76,96,"Although the proinflammatory cytokine interferon-gamma (IFN-gamma) has been generally thought to enhance antitumor immune responses and be involved in antitumor mechanisms of many other immunotherapy molecules, it has also been reported that IFN-gamma could promote tumor immune evasion.",15776283_0,-1,-1,-1,-1,2610,-1,1.09889925e-05,0.99998164,7.3529495e-06
2612,that IFN-gamma,34,36,237,251,"Although the proinflammatory cytokine interferon-gamma (IFN-gamma) has been generally thought to enhance antitumor immune responses and be involved in antitumor mechanisms of many other immunotherapy molecules, it has also been reported that IFN-gamma could promote tumor immune evasion.",15776283_0,-1,-1,-1,-1,2612,-1,0.9809748,0.01787587,0.0011492718
2629,the tumor,20,22,110,119,"Low level of IFN-gamma upregulates expression of PD-L1, PD-L2, CTLA-4 and Foxp3, which may partly account for the tumor immune evasion promoted by IFN-gamma.",15776283_4,-1,-1,-1,-1,2629,-1,4.64678e-06,0.9999913,4.072078e-06
2637,that regulatory T cells,5,9,37,60,"Experimental tumor models have shown that regulatory T cells, a functionally unique subset of T cells, can suppress effective antitumor immune responses.",15781662_1,-1,-1,-1,-1,2637,-1,0.0015866959,0.077646375,0.9207669
2638,functionally,11,12,64,76,"Experimental tumor models have shown that regulatory T cells, a functionally unique subset of T cells, can suppress effective antitumor immune responses.",15781662_1,0,1,2,-1,2638,-1,0.0005029833,0.99938405,0.000112893824
2650,analysis,18,19,123,131,Regulatory T cells were identified by fluorescence-activated cell sorting using a panel of antibodies and by real-time PCR analysis for Foxp3 expression.,15781662_5,0,1,-1,-1,2650,-1,6.506158e-06,0.99998665,6.8736877e-06
2652,Functional,0,1,0,10,Functional studies were done to analyze their inhibitory role.,15781662_6,0,1,2,-1,2652,-1,0.0006953026,0.9992212,8.35352e-05
2659,blood,15,16,93,98,"Patients with HCC have increased numbers of CD4+CD25+ regulatory T cells in their peripheral blood, which express high levels of HLA-DR, GITR, and low or no CD45RA.",15781662_8,0,1,-1,-1,2659,-1,0.0013832684,0.92640036,0.07221635
2660,These cells,0,2,0,11,"These cells were anergic toward T-cell receptor stimulation and, when cocultured with activated CD4+CD25- cells, potently suppressed their proliferation and cytokine secretion.",15781662_9,-1,-1,-1,-1,2660,-1,2.4576571e-05,2.9693841e-05,0.99994576
2661,toward T-cell receptor,4,7,25,47,"These cells were anergic toward T-cell receptor stimulation and, when cocultured with activated CD4+CD25- cells, potently suppressed their proliferation and cytokine secretion.",15781662_9,-1,-1,-1,-1,2661,-1,0.0016694994,0.06106353,0.937267
2667,tumor-infiltrating lymphocytes,10,12,54,84,There were also high numbers of regulatory T cells in tumor-infiltrating lymphocytes of HCC patients comparable with the increase in their peripheral blood.,15781662_10,-1,-1,-1,-1,2667,-1,0.0024096072,0.8928306,0.104759805
2670,blood,22,23,150,155,There were also high numbers of regulatory T cells in tumor-infiltrating lymphocytes of HCC patients comparable with the increase in their peripheral blood.,15781662_10,0,1,-1,-1,2670,-1,0.00048282265,0.9883957,0.011121467
2671,that the,3,5,17,25,Our data suggest that the increase in frequency of regulatory T cells might play a role in modulation of the immune response against HCC and could be important in design of immunotherapeutic approaches.,15781662_11,-1,-1,-1,-1,2671,-1,4.398911e-06,0.999992,3.6012975e-06
2674,the immune response,19,22,105,124,Our data suggest that the increase in frequency of regulatory T cells might play a role in modulation of the immune response against HCC and could be important in design of immunotherapeutic approaches.,15781662_11,-1,-1,-1,-1,2674,-1,0.66456527,0.3335192,0.0019154907
2675,T cell-mediated immunity that,8,12,53,82,A novel vaccination strategy induced specific CD8(+) T cell-mediated immunity that eradicated spontaneous and experimental pulmonary cancer metastases in syngeneic mice and was also effective in a therapeutic setting of established breast cancer metastases.,15833877_0,-1,-1,-1,-1,2675,-1,0.0015971491,0.012826492,0.98557633
2678,targeting transcription factor Fos-related antigen,4,9,21,71,"This was achieved by targeting transcription factor Fos-related antigen 1(Fra-1), overexpressed by many tumor cells, with an ubiquitinated DNA vaccine against Fra-1, coexpressing secretory IL-18.",15833877_1,-1,-1,-1,-1,2678,-1,0.012791829,0.985471,0.0017372231
2679,tumor cells,15,17,104,115,"This was achieved by targeting transcription factor Fos-related antigen 1(Fra-1), overexpressed by many tumor cells, with an ubiquitinated DNA vaccine against Fra-1, coexpressing secretory IL-18.",15833877_1,-1,-1,-1,-1,2679,-1,0.00054935657,0.029141234,0.9703095
2688,tissues,11,12,79,86,"Specifically, long-lived T memory cells were maintained dormant in nonlymphoid tissues by IL-18 in the absence of tumor antigen.",15833877_3,-1,1,2,-1,2688,-1,0.00016700041,0.9882698,0.011563203
2691,tumor antigen,18,20,114,127,"Specifically, long-lived T memory cells were maintained dormant in nonlymphoid tissues by IL-18 in the absence of tumor antigen.",15833877_3,-1,-1,-1,-1,2691,-1,0.5523011,0.4422966,0.005402307
2692,tumor cell,4,6,22,32,"Importantly, a second tumor cell challenge of these SCID mice restored both, robust tumor-specific cytotoxicity and long-lived T-cell memory, capable of eradicating established pulmonary cancer metastases, suggesting that this vaccine could be effective against tumor recurrence.",15833877_4,-1,-1,-1,-1,2692,-1,0.0022758225,0.17872378,0.8190004
2695,T-cell,19,20,127,133,"Importantly, a second tumor cell challenge of these SCID mice restored both, robust tumor-specific cytotoxicity and long-lived T-cell memory, capable of eradicating established pulmonary cancer metastases, suggesting that this vaccine could be effective against tumor recurrence.",15833877_4,-1,1,2,-1,2695,-1,1.1462013e-05,7.2549005e-06,0.9999813
2696,that this,31,33,217,226,"Importantly, a second tumor cell challenge of these SCID mice restored both, robust tumor-specific cytotoxicity and long-lived T-cell memory, capable of eradicating established pulmonary cancer metastases, suggesting that this vaccine could be effective against tumor recurrence.",15833877_4,-1,-1,-1,-1,2696,-1,5.2499304e-06,0.99999094,3.850801e-06
2699,tumor that,8,10,52,62,The mouse 4T1 mammary carcinoma is a BALB/c-derived tumor that spontaneously metastasizes and induces immune suppression.,15877228_0,-1,-1,-1,-1,2699,-1,4.3213763e-06,0.9999912,4.453686e-06
2704,Transducer Activator,34,36,168,188,"Although >95% of wild type BALB/c mice die from metastatic 4T1 tumor even if the primary mammary tumor is surgically removed, >65% of BALB/c mice with a deleted Signal Transducer Activator of Transcription 6 (STAT6) gene survive post-surgery.",15877228_1,-1,-1,-1,-1,2704,-1,1.13125225e-05,0.9999814,7.3302485e-06
2709,immunity,4,5,39,47,STAT6-deficiency also confers enhanced immunity against spontaneously developing breast cancer since NeuT+/- mice that are STAT6-deficient develop mammary tumors later and survive longer than NeuT+/- mice that are STAT6-competent.,15877228_2,0,-1,2,-1,2709,-1,0.99977404,9.261974e-05,0.00013333008
2719,The generation,21,23,131,145,Rejection of metastastic disease and survival of STAT6-deficient mice after removal of primary tumor involve three mechanisms: (1) The generation of M1 type macrophages that produce nitric oxide and are tumoricidal; (2) A decrease to normal in the elevated levels of myeloid suppressor cells that accumulate during primary tumor growth; and (3) CD8+ tumor-specific T lymphocytes.,15877228_3,-1,-1,-1,-1,2719,-1,4.90437e-06,0.99999034,4.765775e-06
2725,suppressor cells that,48,51,275,296,Rejection of metastastic disease and survival of STAT6-deficient mice after removal of primary tumor involve three mechanisms: (1) The generation of M1 type macrophages that produce nitric oxide and are tumoricidal; (2) A decrease to normal in the elevated levels of myeloid suppressor cells that accumulate during primary tumor growth; and (3) CD8+ tumor-specific T lymphocytes.,15877228_3,-1,-1,-1,-1,2725,-1,0.0034271928,0.0691642,0.9274086
2727,tumor-specific T lymphocytes,63,66,350,378,Rejection of metastastic disease and survival of STAT6-deficient mice after removal of primary tumor involve three mechanisms: (1) The generation of M1 type macrophages that produce nitric oxide and are tumoricidal; (2) A decrease to normal in the elevated levels of myeloid suppressor cells that accumulate during primary tumor growth; and (3) CD8+ tumor-specific T lymphocytes.,15877228_3,-1,-1,-1,-1,2727,-1,0.005208867,0.42396185,0.5708293
2732,the STAT6 transcription factor,17,21,110,140,"STAT6-deficient, but not wild type BALB/c, mice generate nitric oxide producing macrophages because they lack the STAT6 transcription factor which is necessary for signaling through the type 2 IL-4Ralpha complex, and which induces the production of arginase instead of nitric oxide.",15877228_4,-1,-1,-1,-1,2732,-1,5.145001e-06,0.99999,4.9103683e-06
2733,through the type,26,29,174,190,"STAT6-deficient, but not wild type BALB/c, mice generate nitric oxide producing macrophages because they lack the STAT6 transcription factor which is necessary for signaling through the type 2 IL-4Ralpha complex, and which induces the production of arginase instead of nitric oxide.",15877228_4,-1,-1,-1,-1,2733,-1,6.6004727e-06,0.99998784,5.6074086e-06
2738,tumor immunology,3,5,16,32,"This paradox in tumor immunology led us to address two questions: (a) Does an antitumor response, which is intended to destroy the aberrant target population, also at the same time select for aggressive tumor variants (ATV) in vivo? (b) If this process does occur, what is the contribution of the perforin- or Fas-mediated effector mechanism in the immune selection of such ATV? Here, in an experimental mouse lung metastasis model, we showed that ATV generated either naturally in vivo or in vitro by anti-Fas selection resembled each other biologically and genetically as judged by enhanced tumor growth and genome-scale gene expression profiling, respectively.",15899830_1,-1,-1,-1,-1,2738,-1,0.008522691,0.990435,0.0010423092
2759,function,18,19,117,125,"Furthermore, ATV that survived CTL adoptive immunotherapy displayed an even more profound loss of Fas expression and function as well as enhanced malignant proficiency in vivo.",15899830_2,0,1,2,-1,2759,-1,0.00063360715,0.9981895,0.0011768535
2762,IFN-gamma-regulated genes,12,14,78,103,"Lastly, such ATV displayed a diminished responsiveness in their expression of IFN-gamma-regulated genes, including those mechanistically linked to Fas-mediated death (i.e., Fas and caspase-1).",15899830_4,-1,-1,-1,-1,2762,-1,0.99897826,0.0006668749,0.00035487543
2768,IFN-gamma-regulated gene,50,52,252,276,"Overall, we showed that (a) immune selection did occur in vivo and played an important role in the emergence of ATV, (b) ATV bearing a Fas-resistant phenotype was a chief consequence of immune selection, and (c) an overall diminished responsiveness of IFN-gamma-regulated gene expression was characteristic of ATV.",15899830_5,-1,-1,-1,-1,2768,-1,0.99906915,0.0006337948,0.0002970882
2771,IFN-gamma-regulated gene,12,14,64,88,"Thus, in this model, Fas-mediated cytotoxicity, in concert with IFN-gamma-regulated gene expression, mechanistically constituted significant determinants of immune selection of ATV in vivo.",15899830_6,-1,-1,-1,-1,2771,-1,0.99882275,0.0008236128,0.00035366602
2775,therapeutic immunity,11,13,92,112,"We previously demonstrated that IL-4 gene-transfected glioma cell vaccines induce effective therapeutic immunity in preclinical glioma models, and have initiated phase I trials of these vaccines in patients with malignant gliomas.",15905564_0,-1,-1,-1,-1,2775,-1,0.12539274,0.8723017,0.002305555
2787,tumor cells,33,35,200,211,"IL-12/23 p40(-/-) and IFN-gamma(-/-) mice, which were able to reject the initial inoculation of IL-4 expressing tumors, failed to mount a sustained systemic response against parental (nontransfected) tumor cells.",15905564_2,-1,-1,-1,-1,2787,-1,0.00018365396,0.0039258767,0.99589044
2789,IL-12p70-secreting tumor-infiltrating,13,15,90,127,Paracrine production of IL-4 in vaccine sites promoted the accumulation and maturation of IL-12p70-secreting tumor-infiltrating dendritic cells (TIDCs).,15905564_3,-1,-1,-1,-1,2789,-1,0.9972506,0.0019860812,0.000763322
2794,tumor-specific CTL,20,22,121,139,"Adoptive transfer of TIDCs isolated from vaccinated wild-type, but not IL-12/23 p40(-/-), mice were capable of promoting tumor-specific CTL responses in syngeneic recipient animals.",15905564_4,-1,-1,-1,-1,2794,-1,0.006200416,0.77581227,0.21798734
2798,TIDCs to,21,23,132,140,"Interestingly, both STAT4(-/-) and STAT6(-/-) mice failed to reject IL-4-transfected tumors in concert with the reduced capacity of TIDCs to produce IL-12p70 and to promote specific antitumor CTL reactivity.",15905564_5,-1,-1,-1,-1,2798,-1,7.0326705e-06,0.9999852,7.727959e-06
2804,tumor cells,7,9,50,61,"These results suggest that vaccines consisting of tumor cells engineered to produce the type 2 cytokine, IL-4, critically depend on type 1 immunity for their observed therapeutic efficacy.",15905564_6,-1,-1,-1,-1,2804,-1,0.0017027047,0.1271818,0.87111545
2806,the type,12,14,84,92,"These results suggest that vaccines consisting of tumor cells engineered to produce the type 2 cytokine, IL-4, critically depend on type 1 immunity for their observed therapeutic efficacy.",15905564_6,-1,-1,-1,-1,2806,-1,6.752358e-06,0.9999865,6.757821e-06
2809,immunity,24,25,139,147,"These results suggest that vaccines consisting of tumor cells engineered to produce the type 2 cytokine, IL-4, critically depend on type 1 immunity for their observed therapeutic efficacy.",15905564_6,0,-1,2,-1,2809,-1,0.99981886,5.1320105e-05,0.00012985032
2813,that plays,7,9,37,47,IL-27 is a novel IL-12 family member that plays a role in the early regulation of Th1 initiation.,16034109_0,-1,-1,-1,-1,2813,-1,5.0803965e-06,0.99998987,5.090834e-06
2842,the generation,19,21,128,142,"Moreover, IL-27 enhanced proliferation of CD4+ T cell-depleted spleen cells stimulated by allogeneic spleen cells and augmented the generation of CTL.",16034109_5,-1,-1,-1,-1,2842,-1,9.229361e-06,0.9999846,6.1503088e-06
2844,STAT1-deficient naive,1,3,3,24,"In STAT1-deficient naive CD8+ T cells, IL-27-induced proliferation was not reduced, but synergistic IFN-gamma production with IL-12 was diminished with decreased expression of T-bet, IL-12Rbeta2, granzyme B, and perforin.",16034109_6,-1,-1,-1,-1,2844,-1,8.688695e-06,0.9999832,8.124414e-06
2850,T-bet-deficient naive,1,3,3,24,"In T-bet-deficient naive CD8+ T cells, IL-27-induced proliferation was hardly reduced, but synergistic IFN-gamma production with IL-12 was diminished with decreased expression of IL-12Rbeta2, granzyme B, and perforin.",16034109_7,-1,-1,-1,-1,2850,-1,6.5363074e-06,0.9999875,6.0203115e-06
2855,the generation,5,7,31,45,"However, IL-27 still augmented the generation of CTL from T-bet-deficient CD4+ T cell-depleted spleen cells stimulated by allogeneic spleen cells with increased granzyme B expression.",16034109_8,-1,-1,-1,-1,2855,-1,8.0540085e-06,0.9999857,6.239619e-06
2872,to IFN-gamma,36,38,227,239,"PURPOSE: Previously we have reported that RT4, a well differentiated human bladder cancer line, increases the expression of macrophage derived chemokine (MDC) and interferon (IFN)-gamma-inducible protein-10 (IP-10) in response to IFN-gamma and tumor necrosis factor (TNF)-alpha.",16094077_0,-1,-1,-1,-1,2872,-1,0.9925079,0.0067019938,0.0007901707
2881,TNF-alpha,24,25,137,146,"In this study we examined the signal mechanisms for inducting these 2 chemokines in RT4 cells by lipopolysaccharide (LPS), IFN-gamma and TNF-alpha.",16094077_1,0,1,-1,-1,2881,-1,0.10519532,0.8941091,0.00069563685
2883,toll-like receptor,3,5,18,36,The expression of toll-like receptor (TLR)-4 was analyzed by reverse transcriptase-polymerase chain reaction and flow cytometry.,16094077_4,-1,-1,-1,-1,2883,-1,0.0011345671,0.98562,0.013245409
2886,cells to,7,9,32,40,RESULTS: LPS did not induce RT4 cells to produce IP-10 and MDC.,16094077_5,-1,-1,-1,-1,2886,-1,0.0028537933,0.29787976,0.69926643
2887,LPS plus IFN-gamma,2,5,9,27,"However, LPS plus IFN-gamma synergized the productions of the 2 chemokines.",16094077_6,-1,-1,-1,-1,2887,-1,0.95377016,0.040645726,0.005584118
2895,receptor,12,13,72,80,"IFN-gamma up-regulated the expression of TLR-4, which is an LPS binding receptor.",16094077_7,0,1,2,-1,2895,-1,0.0013710962,0.090176545,0.90845233
2900,LPS plus IFN-gamma,14,17,95,113,"Although LPS and IFN-gamma alone marginally activated nuclear factor (NF)-kappaB but not AP-1, LPS plus IFN-gamma augmented NF-kappaB and AP-1.",16094077_8,-1,-1,-1,-1,2900,-1,0.82117724,0.17394221,0.0048805308
2907,to LPS,14,16,89,95,"Extracellular regulated kinase (ERK)1/2, an upstream signal of AP-1, was also responsive to LPS and/or IFN-gamma.",16094077_10,-1,-1,-1,-1,2907,-1,6.28786e-06,0.9999875,6.199007e-06
2909,TNF-alpha,0,1,0,9,"TNF-alpha also activated NF-kappaB, AP-1 and ERK1/2.",16094077_11,0,1,-1,-1,2909,-1,0.0024860217,0.99742246,9.154791e-05
2912,TNF-alpha plus IFN- gamma,2,6,9,34,"However, TNF-alpha plus IFN- gamma was associated with the activation of NF-kappaB but not of AP-1/ERK1/2 for the induction of MDC and IP-10.CONCLUSIONS: IFN-gamma enhances LPS for the induction of MDC and IP-10 through up-regulation of TLR-4, and the signal pathways of NF-kappaB and AP-1/ERK1/2.",16094077_12,-1,-1,-1,-1,2912,-1,0.7367158,0.2602658,0.003018362
2932,that the,7,9,44,52,"Recent observations by us and others showed that the prevalence of Treg is increased in cancer patients, particularly in the tumor environment.",16106066_2,-1,-1,-1,-1,2932,-1,4.5422844e-06,0.999992,3.4678521e-06
2934,the tumor,20,22,121,130,"Recent observations by us and others showed that the prevalence of Treg is increased in cancer patients, particularly in the tumor environment.",16106066_2,-1,-1,-1,-1,2934,-1,4.4039084e-06,0.99999166,3.9078805e-06
2935,that the tumor,9,12,53,67,Our studies in a mouse pancreas cancer model suggest that the tumor actively promotes the accrual of Treg through several mechanisms involving activation of naturally occurring Treg as well as conversion of non-Treg into Treg.,16106066_3,-1,-1,-1,-1,2935,-1,4.269195e-06,0.9999914,4.351791e-06
2937,Treg through,17,19,101,113,Our studies in a mouse pancreas cancer model suggest that the tumor actively promotes the accrual of Treg through several mechanisms involving activation of naturally occurring Treg as well as conversion of non-Treg into Treg.,16106066_3,-1,-1,-1,-1,2937,-1,5.370265e-06,0.99998844,6.1498163e-06
2953,T-cell immunity,14,16,76,91,Our previous work showed that failure is reflected by the absence of type 1 T-cell immunity against HPV16 early antigens E2 and E6 in patients with HPV16+ cervical lesions.,16108057_1,-1,-1,-1,-1,2953,-1,6.282261e-05,1.6220158e-05,0.99992096
2956,peptide-specific type,18,20,105,126,We now show that a majority of both patients with cervical lesions and healthy subjects display HPV16 L1 peptide-specific type 1 T-cell responses with similar magnitude.,16108057_2,-1,-1,-1,-1,2956,-1,0.015980134,0.98320895,0.0008108731
2957,T-cell,21,22,129,135,We now show that a majority of both patients with cervical lesions and healthy subjects display HPV16 L1 peptide-specific type 1 T-cell responses with similar magnitude.,16108057_2,-1,1,2,-1,2957,-1,2.1266935e-05,1.1049517e-05,0.9999677
2958,The T-cell,0,2,0,10,"The T-cell response in patients was directed at a broad range of peptides within L1, suggesting that during persistent or repeated exposure to HPV16 L1, the immune system maximizes its efforts to counter the viral challenge.",16108057_3,-1,-1,-1,-1,2958,-1,0.0033341805,0.24387142,0.75279444
2959,peptides,12,13,65,73,"The T-cell response in patients was directed at a broad range of peptides within L1, suggesting that during persistent or repeated exposure to HPV16 L1, the immune system maximizes its efforts to counter the viral challenge.",16108057_3,0,-1,2,-1,2959,-1,0.95302725,0.03708995,0.009882847
2966,the type,1,3,7,15,"Unlike the type 1 T-cell responses against HPV16 early antigens E2 and E6, type 1 T-cell immunity against L1 does not correlate with health or disease.",16108057_4,-1,-1,-1,-1,2966,-1,4.1014937e-06,0.9999907,5.2204578e-06
2967,T-cell,4,5,18,24,"Unlike the type 1 T-cell responses against HPV16 early antigens E2 and E6, type 1 T-cell immunity against L1 does not correlate with health or disease.",16108057_4,-1,1,2,-1,2967,-1,3.6145448e-05,1.8083303e-05,0.99994576
2970,T-cell immunity,16,18,82,97,"Unlike the type 1 T-cell responses against HPV16 early antigens E2 and E6, type 1 T-cell immunity against L1 does not correlate with health or disease.",16108057_4,-1,-1,-1,-1,2970,-1,0.0004961115,4.4861958e-05,0.99945897
2972,that T-cell,2,4,12,23,"This argues that T-cell responses against early and late HPV16 antigens essentially differ in the manner in which they are induced and regulated, as well as in their impact on the subsequent stages of HPV16-induced cervical disease.",16108057_5,-1,-1,-1,-1,2972,-1,0.0064120595,0.32347214,0.67011577
2990,cells transiently transfected,13,16,82,111,"Formononetin, daidzein and equol also enhanced IL-4 gene promoter activity in EL4 cells transiently transfected with IL-4 gene promoter constructs, but this effect was impaired in EL4 cells transfected with an IL-4 promoter construct deleted of P4 site carrying nuclear factor of activated T cells (NF-AT) and activator protein-1 (AP-1) binding sites.",16108819_5,-1,-1,-1,-1,2990,-1,0.0023098635,0.75775224,0.23993798
2993,cells transfected,29,31,184,201,"Formononetin, daidzein and equol also enhanced IL-4 gene promoter activity in EL4 cells transiently transfected with IL-4 gene promoter constructs, but this effect was impaired in EL4 cells transfected with an IL-4 promoter construct deleted of P4 site carrying nuclear factor of activated T cells (NF-AT) and activator protein-1 (AP-1) binding sites.",16108819_5,-1,-1,-1,-1,2993,-1,0.0026128618,0.30896857,0.6884185
2994,nuclear factor of activated T cells,41,47,262,297,"Formononetin, daidzein and equol also enhanced IL-4 gene promoter activity in EL4 cells transiently transfected with IL-4 gene promoter constructs, but this effect was impaired in EL4 cells transfected with an IL-4 promoter construct deleted of P4 site carrying nuclear factor of activated T cells (NF-AT) and activator protein-1 (AP-1) binding sites.",16108819_5,-1,1,2,-1,2994,-1,0.0030870815,0.63909197,0.35782096
2995,NF-AT,48,49,299,304,"Formononetin, daidzein and equol also enhanced IL-4 gene promoter activity in EL4 cells transiently transfected with IL-4 gene promoter constructs, but this effect was impaired in EL4 cells transfected with an IL-4 promoter construct deleted of P4 site carrying nuclear factor of activated T cells (NF-AT) and activator protein-1 (AP-1) binding sites.",16108819_5,-1,1,2,-1,2995,-1,1.1803942e-05,0.99997365,1.4597289e-05
2998,AP-1 DNA binding,9,12,56,72,"In addition, formononetin, daidzein and equol increased AP-1 DNA binding activities while did not affect NF-AT DNA binding activities.",16108819_6,-1,-1,-1,-1,2998,-1,1.3568863e-05,0.99996686,1.9554953e-05
2999,NF-AT DNA binding,17,20,105,122,"In addition, formononetin, daidzein and equol increased AP-1 DNA binding activities while did not affect NF-AT DNA binding activities.",16108819_6,-1,-1,-1,-1,2999,-1,9.520431e-06,0.9999776,1.2887999e-05
3001,AP-1 DNA binding,7,10,45,61,"The enhancing effects on IL-4 production and AP-1 DNA binding activities were abrogated by specific inhibitors for phosphatidylinositol-3-kinase (PI3K), protein kinase C (PKC) and p38 mitogen-activated protein kinase (MAPK), indicating that formononetin, daidzein and equol might enhance IL-4 production by increased activation of AP-1 through the PI3-K/PKC/p38 MAPK signalling pathway.",16108819_7,-1,-1,-1,-1,3001,-1,8.615205e-06,0.9999825,8.9025e-06
3002,protein,23,24,153,160,"The enhancing effects on IL-4 production and AP-1 DNA binding activities were abrogated by specific inhibitors for phosphatidylinositol-3-kinase (PI3K), protein kinase C (PKC) and p38 mitogen-activated protein kinase (MAPK), indicating that formononetin, daidzein and equol might enhance IL-4 production by increased activation of AP-1 through the PI3-K/PKC/p38 MAPK signalling pathway.",16108819_7,0,1,-1,-1,3002,-1,1.3851007e-05,0.9999783,7.842315e-06
3003,protein,32,33,202,209,"The enhancing effects on IL-4 production and AP-1 DNA binding activities were abrogated by specific inhibitors for phosphatidylinositol-3-kinase (PI3K), protein kinase C (PKC) and p38 mitogen-activated protein kinase (MAPK), indicating that formononetin, daidzein and equol might enhance IL-4 production by increased activation of AP-1 through the PI3-K/PKC/p38 MAPK signalling pathway.",16108819_7,0,1,-1,-1,3003,-1,9.047538e-05,0.9998709,3.863752e-05
3005,AP-1 through the,53,56,331,347,"The enhancing effects on IL-4 production and AP-1 DNA binding activities were abrogated by specific inhibitors for phosphatidylinositol-3-kinase (PI3K), protein kinase C (PKC) and p38 mitogen-activated protein kinase (MAPK), indicating that formononetin, daidzein and equol might enhance IL-4 production by increased activation of AP-1 through the PI3-K/PKC/p38 MAPK signalling pathway.",16108819_7,-1,-1,-1,-1,3005,-1,7.2029566e-06,0.9999863,6.505479e-06
3012,TGF-beta,4,5,33,41,Transforming growth factor-beta (TGF-beta) plays an essential role in regulating the homeostasis of cells in the lymphoid lineage.,16123803_0,0,1,-1,-1,3012,-1,7.297668e-05,0.99991035,1.6693293e-05
3017,TGF-beta,0,1,0,8,"TGF-beta signaling is not required for normal thymopoiesis, but is essential for regulating the expansion, activation, and effector function of the mature CD4+ and CD8+ T cells in the peripheral lymphoid organs and target tissues.",16123803_1,0,1,-1,-1,3017,-1,6.2670435e-05,0.9999248,1.2581078e-05
3020,function,21,22,132,140,"TGF-beta signaling is not required for normal thymopoiesis, but is essential for regulating the expansion, activation, and effector function of the mature CD4+ and CD8+ T cells in the peripheral lymphoid organs and target tissues.",16123803_1,0,1,2,-1,3020,-1,4.8985003e-05,0.9998851,6.595066e-05
3024,target tissues,38,40,215,229,"TGF-beta signaling is not required for normal thymopoiesis, but is essential for regulating the expansion, activation, and effector function of the mature CD4+ and CD8+ T cells in the peripheral lymphoid organs and target tissues.",16123803_1,-1,-1,-1,-1,3024,-1,6.174052e-05,0.9985158,0.0014224838
3026,TGF-beta,15,16,89,97,Recent studies in both mice and humans have elucidated an important and complex role for TGF-beta in regulatory T-cell biology.,16123803_2,0,1,-1,-1,3026,-1,1.7049402e-05,0.9999747,8.205255e-06
3028,TGF-beta,2,3,14,22,"Disruption of TGF-beta signaling in T cells impairs the maintenance of regulatory T cells, results in the expansion of activated effector T cells, and is associated with the production of cytokines that have major effects on cells in their environment.",16123803_3,0,1,-1,-1,3028,-1,5.32203e-05,0.99993277,1.4035373e-05
3035,cytokines that,32,34,188,202,"Disruption of TGF-beta signaling in T cells impairs the maintenance of regulatory T cells, results in the expansion of activated effector T cells, and is associated with the production of cytokines that have major effects on cells in their environment.",16123803_3,-1,-1,-1,-1,3035,-1,0.9480696,0.050362196,0.0015682096
3040,TGF-beta,13,14,99,107,"While autoimmunity and inflammation are the principal phenotypes associated with the abrogation of TGF-beta signaling in T cells in mice, emerging evidence now also directly links Smad-dependent TGF-beta signaling in T cells to the suppression of epithelial neoplasia.",16123803_4,0,1,-1,-1,3040,-1,5.3635795e-05,0.99993324,1.3082015e-05
3042,Smad-dependent TGF-beta,27,29,180,203,"While autoimmunity and inflammation are the principal phenotypes associated with the abrogation of TGF-beta signaling in T cells in mice, emerging evidence now also directly links Smad-dependent TGF-beta signaling in T cells to the suppression of epithelial neoplasia.",16123803_4,-1,-1,-1,-1,3042,-1,6.877821e-05,0.9999138,1.7345696e-05
3043,T cells to the,31,35,217,231,"While autoimmunity and inflammation are the principal phenotypes associated with the abrogation of TGF-beta signaling in T cells in mice, emerging evidence now also directly links Smad-dependent TGF-beta signaling in T cells to the suppression of epithelial neoplasia.",16123803_4,-1,-1,-1,-1,3043,-1,0.0037759482,0.3206182,0.67560583
3044,The TGF-beta receptor-activated Smad3 plays,0,5,0,43,"The TGF-beta receptor-activated Smad3 plays a critical role in mediating many of the inhibitory effects of TGF-beta signaling in T cells, and has now been established as an important suppressor of leukemogenesis.",16123803_5,-1,-1,-1,-1,3044,-1,1.2431169e-05,0.9999769,1.0652511e-05
3046,TGF-beta,16,17,107,115,"The TGF-beta receptor-activated Smad3 plays a critical role in mediating many of the inhibitory effects of TGF-beta signaling in T cells, and has now been established as an important suppressor of leukemogenesis.",16123803_5,0,1,-1,-1,3046,-1,7.021609e-05,0.99991345,1.6312742e-05
3052,TGF-beta,13,14,88,96,These studies are increasing our awareness of the many complex mechanisms through which TGF-beta signaling controls the pathogenesis of cancer.,16123803_6,0,1,-1,-1,3052,-1,9.274787e-05,0.99988806,1.9172216e-05
3055,antigen-presenting cells,4,6,33,57,Dendritic cells are professional antigen-presenting cells associated with efficient antigen processing and presentation to T cells.,16166326_0,-1,-1,-1,-1,3055,-1,0.747818,0.00027437386,0.25190765
3057,to T cells,13,16,120,130,Dendritic cells are professional antigen-presenting cells associated with efficient antigen processing and presentation to T cells.,16166326_0,-1,-1,-1,-1,3057,-1,0.0024948625,0.067983165,0.92952204
3060,tumoricidal functions,12,14,79,100,"However, recent evidence also suggests that dendritic cells may mediate direct tumoricidal functions.",16166326_1,-1,-1,-1,-1,3060,-1,0.0020874967,0.99705315,0.0008593577
3067,function,28,29,172,180,"In this study, we investigated the mechanism by which murine dendritic cells mediate the apoptotic death of murine lymphoma cell lines, and whether dendritic cell effector function could be enhanced by preconditioning tumor cells with the protein phosphatase inhibitor nitric oxide (NO) by altering the balance of proapoptotic/antiapoptotic proteins in the treated cells.",16166326_2,0,1,2,-1,3067,-1,5.513984e-05,4.656748e-05,0.9998982
3068,tumor cells,34,36,218,229,"In this study, we investigated the mechanism by which murine dendritic cells mediate the apoptotic death of murine lymphoma cell lines, and whether dendritic cell effector function could be enhanced by preconditioning tumor cells with the protein phosphatase inhibitor nitric oxide (NO) by altering the balance of proapoptotic/antiapoptotic proteins in the treated cells.",16166326_2,-1,-1,-1,-1,3068,-1,3.8407834e-05,7.924835e-05,0.99988234
3069,the protein,37,39,235,246,"In this study, we investigated the mechanism by which murine dendritic cells mediate the apoptotic death of murine lymphoma cell lines, and whether dendritic cell effector function could be enhanced by preconditioning tumor cells with the protein phosphatase inhibitor nitric oxide (NO) by altering the balance of proapoptotic/antiapoptotic proteins in the treated cells.",16166326_2,-1,-1,-1,-1,3069,-1,1.1614052e-05,0.9999807,7.695896e-06
3071,proteins,52,53,341,349,"In this study, we investigated the mechanism by which murine dendritic cells mediate the apoptotic death of murine lymphoma cell lines, and whether dendritic cell effector function could be enhanced by preconditioning tumor cells with the protein phosphatase inhibitor nitric oxide (NO) by altering the balance of proapoptotic/antiapoptotic proteins in the treated cells.",16166326_2,0,1,-1,-1,3071,-1,9.151383e-06,0.9999856,5.2271857e-06
3072,the treated cells,54,57,353,370,"In this study, we investigated the mechanism by which murine dendritic cells mediate the apoptotic death of murine lymphoma cell lines, and whether dendritic cell effector function could be enhanced by preconditioning tumor cells with the protein phosphatase inhibitor nitric oxide (NO) by altering the balance of proapoptotic/antiapoptotic proteins in the treated cells.",16166326_2,-1,-1,-1,-1,3072,-1,0.002215379,0.43355975,0.5642249
3077,tumor cell,16,18,109,119,"Both immature and spontaneously matured bone marrow-derived dendritic cells (SM-DC) were capable of inducing tumor cell apoptosis, with SM-DCs serving as comparatively better killers.",16166326_4,-1,-1,-1,-1,3077,-1,0.00042717095,0.012090603,0.9874822
3080,tumor cells than,33,36,238,254,"Fas ligand (FasL)-Fas engagement proved important in this activity because elevated expression of membrane-bound FasL was detected on SM-DCs, and dendritic cells derived from FasL-deficient mice were less capable of killing NO-sensitized tumor cells than wild-type dendritic cells.",16166326_5,-1,-1,-1,-1,3080,-1,0.00029585662,0.99698,0.0027241597
3086,cell-mediated tumor,28,30,193,212,"As FasL-deficient dendritic cells were still capable of mediating a residual degree of tumor killing, this suggests that FasL-independent mechanisms of apoptosis are also involved in dendritic cell-mediated tumor killing.",16166326_6,-1,-1,-1,-1,3086,-1,0.0020318902,0.025182284,0.9727858
3087,tumor cells,2,4,19,30,"Because NO-treated tumor cells displayed a preferential loss of survivin protein expression via a proteasome-dependent pathway, enhanced tumor sensitivity to dendritic cell-mediated killing may be associated with the accelerated turnover of this critical antiapoptotic gene product.",16166326_7,-1,-1,-1,-1,3087,-1,0.00030024204,0.011243294,0.9884565
3088,protein,10,11,73,80,"Because NO-treated tumor cells displayed a preferential loss of survivin protein expression via a proteasome-dependent pathway, enhanced tumor sensitivity to dendritic cell-mediated killing may be associated with the accelerated turnover of this critical antiapoptotic gene product.",16166326_7,0,1,-1,-1,3088,-1,1.276057e-05,0.99997914,8.0845075e-06
3095,gene product,35,37,269,281,"Because NO-treated tumor cells displayed a preferential loss of survivin protein expression via a proteasome-dependent pathway, enhanced tumor sensitivity to dendritic cell-mediated killing may be associated with the accelerated turnover of this critical antiapoptotic gene product.",16166326_7,0,1,-1,-1,3095,-1,1.7404129e-05,0.99997056,1.2094837e-05
3096,tumor cells,3,5,24,35,"Importantly, NO-treated tumor cells were also engulfed more readily than control tumor cells and this resulted in enhanced cross-presentation of tumor-associated antigens to specific T cells in vitro.",16166326_8,-1,-1,-1,-1,3096,-1,0.00014305513,0.0021676903,0.99768925
3098,tumor cells,12,14,81,92,"Importantly, NO-treated tumor cells were also engulfed more readily than control tumor cells and this resulted in enhanced cross-presentation of tumor-associated antigens to specific T cells in vitro.",16166326_8,-1,-1,-1,-1,3098,-1,6.076968e-05,0.00021181653,0.9997274
3100,tumor-associated antigens to,21,24,145,173,"Importantly, NO-treated tumor cells were also engulfed more readily than control tumor cells and this resulted in enhanced cross-presentation of tumor-associated antigens to specific T cells in vitro.",16166326_8,-1,-1,-1,-1,3100,-1,5.0801063e-05,0.9999323,1.6894981e-05
3106,that the,3,5,25,33,Our experiments indicate that the accumulation of CD4+CD25+ regulatory T cells (T reg cells) expressing FoxP3 and exhibiting immunosuppressive function originates from the proliferation of naturally occurring CD25+ T cells and requires signaling through transforming growth factor (TGF)-beta receptor II.,16186184_1,-1,-1,-1,-1,3106,-1,3.6487024e-06,0.9999926,3.7112331e-06
3111,function,22,23,143,151,Our experiments indicate that the accumulation of CD4+CD25+ regulatory T cells (T reg cells) expressing FoxP3 and exhibiting immunosuppressive function originates from the proliferation of naturally occurring CD25+ T cells and requires signaling through transforming growth factor (TGF)-beta receptor II.,16186184_1,0,1,2,-1,3111,-1,2.6684584e-05,0.9999474,2.5856776e-05
3115,through transforming growth factor,37,41,246,280,Our experiments indicate that the accumulation of CD4+CD25+ regulatory T cells (T reg cells) expressing FoxP3 and exhibiting immunosuppressive function originates from the proliferation of naturally occurring CD25+ T cells and requires signaling through transforming growth factor (TGF)-beta receptor II.,16186184_1,-1,-1,-1,-1,3115,-1,0.8436951,0.15050423,0.005800658
3116,receptor,42,43,292,300,Our experiments indicate that the accumulation of CD4+CD25+ regulatory T cells (T reg cells) expressing FoxP3 and exhibiting immunosuppressive function originates from the proliferation of naturally occurring CD25+ T cells and requires signaling through transforming growth factor (TGF)-beta receptor II.,16186184_1,0,1,2,-1,3116,-1,0.0006519168,0.00026351327,0.9990845
3126,TGF-beta-dependent,13,14,74,92,This DC subset selectively promotes the proliferation of T reg cells in a TGF-beta-dependent manner in mice and rats.,16186184_3,0,1,-1,-1,3126,-1,4.8446018e-05,0.9999248,2.6746475e-05
3127,Tumor cells,0,2,0,11,Tumor cells are necessary and sufficient to convert DCs into regulatory cells that secrete bioactive TGF-beta and stimulate T reg cell proliferation.,16186184_4,-1,-1,-1,-1,3127,-1,4.7801175e-05,0.00025703263,0.9996952
3129,cells that,11,13,72,82,Tumor cells are necessary and sufficient to convert DCs into regulatory cells that secrete bioactive TGF-beta and stimulate T reg cell proliferation.,16186184_4,-1,-1,-1,-1,3129,-1,0.003023223,0.29448047,0.7024963
3130,TGF-beta,15,16,101,109,Tumor cells are necessary and sufficient to convert DCs into regulatory cells that secrete bioactive TGF-beta and stimulate T reg cell proliferation.,16186184_4,0,1,-1,-1,3130,-1,0.00011558846,0.99986184,2.2523112e-05
3132,cell proliferation,20,22,130,148,Tumor cells are necessary and sufficient to convert DCs into regulatory cells that secrete bioactive TGF-beta and stimulate T reg cell proliferation.,16186184_4,-1,-1,-1,-1,3132,-1,1.3507161e-05,8.185948e-06,0.9999783
3139,immunity,7,8,64,72,"The peripheral tolerance mechanism prevents effective antitumor immunity, even though tumor cells possess recognizable tumor-associated Ags.",16210609_0,0,-1,2,-1,3139,-1,0.99991095,1.8973353e-05,7.010845e-05
3140,though tumor cells,10,13,79,97,"The peripheral tolerance mechanism prevents effective antitumor immunity, even though tumor cells possess recognizable tumor-associated Ags.",16210609_0,-1,-1,-1,-1,3140,-1,0.0037380669,0.24976271,0.7464991
3142,that regulatory T cells,6,10,33,56,"Recently, it has been elucidated that regulatory T cells (Treg) play a critical role in maintaining not only self-tolerance, but also tolerance of tumor cells.",16210609_1,-1,-1,-1,-1,3142,-1,0.0015509953,0.08721046,0.91123855
3146,tumor cells,27,29,147,158,"Recently, it has been elucidated that regulatory T cells (Treg) play a critical role in maintaining not only self-tolerance, but also tolerance of tumor cells.",16210609_1,-1,-1,-1,-1,3146,-1,0.0003047511,0.010492447,0.9892028
3147,the Treg that,3,6,17,30,"However, because the Treg that maintain self-tolerance arise naturally in the thymus and are thought to be anergic in peripheral, it is still unclear where and when Treg for tumor cells are generated.",16210609_2,-1,-1,-1,-1,3147,-1,5.668996e-06,0.9999896,4.67712e-06
3149,the thymus,11,13,74,84,"However, because the Treg that maintain self-tolerance arise naturally in the thymus and are thought to be anergic in peripheral, it is still unclear where and when Treg for tumor cells are generated.",16210609_2,-1,-1,-1,-1,3149,-1,9.12911e-06,0.99998343,7.4342183e-06
3150,thought to,15,17,93,103,"However, because the Treg that maintain self-tolerance arise naturally in the thymus and are thought to be anergic in peripheral, it is still unclear where and when Treg for tumor cells are generated.",16210609_2,-1,-1,-1,-1,3150,-1,8.544737e-06,0.99998546,5.9891236e-06
3152,tumor cells,31,33,174,185,"However, because the Treg that maintain self-tolerance arise naturally in the thymus and are thought to be anergic in peripheral, it is still unclear where and when Treg for tumor cells are generated.",16210609_2,-1,-1,-1,-1,3152,-1,9.899194e-05,0.0005871985,0.99931383
3167,to the,9,11,77,83,The regulatory activity generated in tumor-draining LNs exclusively belonged to the CD4(+) T cell subpopulation that expresses both CD25 and a high level of CD62L.,16210609_4,-1,-1,-1,-1,3167,-1,3.941605e-06,0.9999919,4.1183134e-06
3175,T cell functions,12,15,90,106,"CD62L(high)CD4(+)CD25(+) Treg and CD62L(low)CD4(+)CD25(+) T cells, which possess effector T cell functions, had comparable expression of LFA-1, VLA-4, CTLA-4, lymphocyte activation gene-3, and glucocorticoid-induced TNFR.",16210609_6,-1,-1,-1,-1,3175,-1,1.2682601e-05,7.850668e-06,0.9999795
3179,TNFR,32,33,216,220,"CD62L(high)CD4(+)CD25(+) Treg and CD62L(low)CD4(+)CD25(+) T cells, which possess effector T cell functions, had comparable expression of LFA-1, VLA-4, CTLA-4, lymphocyte activation gene-3, and glucocorticoid-induced TNFR.",16210609_6,0,1,-1,-1,3179,-1,2.5026502e-05,0.999962,1.2955452e-05
3183,The Treg generated,0,3,0,18,The Treg generated in tumor-draining LNs possess the same functional properties as the Treg that arise naturally in the thymus but recognize tumor-associated Ag.,16210609_8,-1,-1,-1,-1,3183,-1,5.2102923e-06,0.99999,4.8244992e-06
3186,functional,9,10,58,68,The Treg generated in tumor-draining LNs possess the same functional properties as the Treg that arise naturally in the thymus but recognize tumor-associated Ag.,16210609_8,0,1,2,-1,3186,-1,0.009271176,0.989205,0.0015237691
3187,the Treg that,12,15,83,96,The Treg generated in tumor-draining LNs possess the same functional properties as the Treg that arise naturally in the thymus but recognize tumor-associated Ag.,16210609_8,-1,-1,-1,-1,3187,-1,4.1942403e-06,0.99999094,4.8313827e-06
3189,the thymus,18,20,116,126,The Treg generated in tumor-draining LNs possess the same functional properties as the Treg that arise naturally in the thymus but recognize tumor-associated Ag.,16210609_8,-1,-1,-1,-1,3189,-1,7.0405954e-06,0.99998605,6.906051e-06
3196,Treg plays,14,16,85,95,Blocking experiments revealed that ligation of CTLA-4 on effector T cells by CD86 on Treg plays a pivotal role in regulating CD4(+) effector T cells.,16210609_10,-1,-1,-1,-1,3196,-1,4.9383552e-06,0.9999895,5.598869e-06
3198,that tumor cells,4,7,28,44,Previous studies have shown that tumor cells predominantly express Th2 type cytokines and transcription factors.,16212886_0,-1,-1,-1,-1,3198,-1,0.0023807043,0.6950024,0.30261692
3199,Th2 type cytokines,9,12,67,85,Previous studies have shown that tumor cells predominantly express Th2 type cytokines and transcription factors.,16212886_0,-1,-1,-1,-1,3199,-1,0.07747365,0.9188798,0.0036465903
3202,Th2-specific transcription factor,4,7,13,46,"GATA-3, as a Th2-specific transcription factor, plays a central role in positive-regulating Th2 development.",16212886_1,-1,-1,-1,-1,3202,-1,7.2274934e-06,0.9999825,1.0246549e-05
3207,tumor cells,7,9,39,50,So whether the expression of GATA-3 in tumor cells has any effect on tumor development is a question of interest.,16212886_2,-1,-1,-1,-1,3207,-1,0.00021636797,0.0034714339,0.9963122
3212,tumor cells through,12,15,63,82,"In the present study, we inhibited the expression of GATA-3 in tumor cells through antisense RNA blockade technique, and observed its effects on tumor in vitro and in vivo.",16212886_3,-1,-1,-1,-1,3212,-1,0.00012294209,0.9984034,0.0014737506
3216,GATA-3 treatment,5,7,34,50,"Our results showed that antisense GATA-3 treatment could inhibit the expression of TNF-alpha and Th2 cytokines in tumor cells, and antisense-induced blockade of GATA-3 could also depress tumor growth in tumor-bearing mice.",16212886_4,-1,-1,-1,-1,3216,-1,6.0122147e-06,0.9999863,7.711713e-06
3218,TNF-alpha,12,13,83,92,"Our results showed that antisense GATA-3 treatment could inhibit the expression of TNF-alpha and Th2 cytokines in tumor cells, and antisense-induced blockade of GATA-3 could also depress tumor growth in tumor-bearing mice.",16212886_4,0,1,-1,-1,3218,-1,0.009549335,0.99008626,0.00036435935
3219,Th2 cytokines,14,16,97,110,"Our results showed that antisense GATA-3 treatment could inhibit the expression of TNF-alpha and Th2 cytokines in tumor cells, and antisense-induced blockade of GATA-3 could also depress tumor growth in tumor-bearing mice.",16212886_4,-1,-1,-1,-1,3219,-1,0.43105635,0.5599402,0.00900339
3220,tumor cells,17,19,114,125,"Our results showed that antisense GATA-3 treatment could inhibit the expression of TNF-alpha and Th2 cytokines in tumor cells, and antisense-induced blockade of GATA-3 could also depress tumor growth in tumor-bearing mice.",16212886_4,-1,-1,-1,-1,3220,-1,0.00071432826,0.025409568,0.97387606
3224,that the,2,4,11,19,We suggest that the ratio of T-bet/GATA-3 can be evaluated as a more important marker of the status of Th1/Th2 type.,16212886_5,-1,-1,-1,-1,3224,-1,4.989358e-06,0.9999913,3.7005127e-06
3225,the status,16,18,89,99,We suggest that the ratio of T-bet/GATA-3 can be evaluated as a more important marker of the status of Th1/Th2 type.,16212886_5,-1,-1,-1,-1,3225,-1,5.2668875e-06,0.99999034,4.3791265e-06
3228,tumor cell,13,15,89,99,And our results might provide some evidence about the molecular regulatory mechanisms in tumor cell development.,16212886_6,-1,-1,-1,-1,3228,-1,0.00013529915,0.0013144803,0.9985501
3234,proteins,4,5,18,26,"The use of fusion proteins, which link cytotoxic molecules to receptor targets, provides one approach to this problem.",16224276_1,0,1,-1,-1,3234,-1,9.839028e-06,0.99998295,7.233972e-06
3235,to receptor targets,10,13,59,78,"The use of fusion proteins, which link cytotoxic molecules to receptor targets, provides one approach to this problem.",16224276_1,-1,-1,-1,-1,3235,-1,9.079578e-05,0.999782,0.00012717003
3236,to this,17,19,102,109,"The use of fusion proteins, which link cytotoxic molecules to receptor targets, provides one approach to this problem.",16224276_1,-1,-1,-1,-1,3236,-1,6.561822e-06,0.99998856,4.9251066e-06
3239,protein,8,9,44,51,"This study examined the ability of a fusion protein of interleukin-2 (IL-2) and diphtheria toxin (Denileukin Diftitox, DAB389IL-2, ONTAK) to eliminate regulatory T lymphocytes based on their expression of high-affinity IL-2 receptors.",16224276_2,0,1,-1,-1,3239,-1,6.8798367e-06,0.9999882,4.9653327e-06
3245,receptors,37,38,224,233,"This study examined the ability of a fusion protein of interleukin-2 (IL-2) and diphtheria toxin (Denileukin Diftitox, DAB389IL-2, ONTAK) to eliminate regulatory T lymphocytes based on their expression of high-affinity IL-2 receptors.",16224276_2,0,1,2,-1,3245,-1,0.0005340487,0.0005515132,0.9989145
3249,the two,20,22,111,118,"Thirteen patients (12 with metastatic melanoma, 1 with metastatic renal cell carcinoma) were treated at one of the two Food and Drug Administration-approved doses of Denileukin Diftitox (seven patients at 9 microg/kg, six patients at 18 microg/kg).",16224276_3,-1,-1,-1,-1,3249,-1,1.9061681e-05,0.99996734,1.3626225e-05
3261,functions,8,9,52,61,JNK1 has divergent roles in regulating the effector functions of CD4+ and CD8+ T cells.,16237070_0,0,1,2,-1,3261,-1,1.0041277e-05,0.9999752,1.4743234e-05
3263,the function,2,4,9,21,"However, the function of JNK1 in tumor immune surveillance is unknown.",16237070_1,-1,-1,-1,-1,3263,-1,1.9302122e-05,0.99997103,9.6113035e-06
3268,to tumor,17,19,94,102,"In this study, we show that similar to IFN-gamma-/- mice, JNK1-/- mice are highly susceptible to tumor development after inoculation of both melanoma cell line B16 and lymphoma cell line EL-4.",16237070_2,-1,-1,-1,-1,3268,-1,4.5515817e-06,0.9999902,5.2015507e-06
3277,IFN-gamma gene transcription,11,14,55,83,JNK1-/- CD8+ T cells have an intrinsic defect in early IFN-gamma gene transcription and production after activation by either anti-CD3/anti-CD28 Abs or dendritic cells loaded with specific Ag in vitro.,16237070_4,-1,-1,-1,-1,3277,-1,0.9969759,0.0023162074,0.00070785056
3284,the transcription,25,27,159,176,"The impaired IFN-gamma production in JNK1-/- CD8+ T cells is associated with reduced expression of both T-bet and Eomesodermin, indicating that JNK1 regulates the transcription program of CD8+ T cells.",16237070_5,-1,-1,-1,-1,3284,-1,4.900244e-06,0.9999908,4.304154e-06
3287,CTL function,13,15,78,90,"Finally, JNK1-/- CD8+ T cells showed reduced perforin expression and impaired CTL function.",16237070_6,-1,-1,-1,-1,3287,-1,2.2679009e-05,1.1707199e-05,0.99996567
3288,Taken together,0,2,0,14,"Taken together, our results demonstrate that JNK1 plays an important role in tumor immune surveillance through regulating the effector functions of CD8+ T cells.",16237070_7,-1,-1,-1,-1,3288,-1,1.03602915e-05,0.99998033,9.274347e-06
3294,functions,20,21,135,144,"Taken together, our results demonstrate that JNK1 plays an important role in tumor immune surveillance through regulating the effector functions of CD8+ T cells.",16237070_7,0,1,2,-1,3294,-1,9.303038e-05,0.99969745,0.00020955803
3297,T-cell growth factor,9,12,48,68,Interleukin-2 (IL-2) is historically known as a T-cell growth factor.,16304057_0,-1,-1,-1,-1,3297,-1,0.6666096,0.000832466,0.33255798
3300,function,14,15,95,103,Accumulating evidence from knockout mice suggests that IL-2 is crucial for the homeostasis and function of CD4+ CD25+ regulatory T cells in vivo.,16304057_1,0,1,2,-1,3300,-1,1.7888578e-05,0.9999635,1.8558778e-05
3305,function,13,14,72,80,"Here, we studied the impact of IL-2 administration on the frequency and function of human CD4+ CD25(hi) T cells in immune intact patients with melanoma or renal cancer.",16304057_3,0,1,2,-1,3305,-1,6.875197e-05,0.9998356,9.561921e-05
3307,that the,2,4,9,17,"We found that the frequency of CD4+ CD25(hi) T cells was significantly increased after IL-2 treatment, and these cells expressed phenotypic markers associated with regulatory T cells.",16304057_4,-1,-1,-1,-1,3307,-1,4.2220768e-06,0.999992,3.7721773e-06
3310,these cells,20,22,107,118,"We found that the frequency of CD4+ CD25(hi) T cells was significantly increased after IL-2 treatment, and these cells expressed phenotypic markers associated with regulatory T cells.",16304057_4,-1,-1,-1,-1,3310,-1,1.4330915e-05,1.2352183e-05,0.9999733
3313,protein,6,7,33,40,"In addition, both transcript and protein levels of Foxp3, a transcription factor exclusively expressed on regulatory T cells, were consistently increased in CD4 T cells following IL-2 treatment.",16304057_5,0,1,-1,-1,3313,-1,7.839822e-06,0.9999864,5.797793e-06
3319,Functional analysis,0,2,0,19,Functional analysis of the increased number of CD4+ CD25(hi) T cells revealed that this population exhibited potent suppressive activity in vitro.,16304057_6,-1,-1,-1,-1,3319,-1,9.383415e-06,0.99998367,6.9843363e-06
3322,that this,14,16,78,87,Functional analysis of the increased number of CD4+ CD25(hi) T cells revealed that this population exhibited potent suppressive activity in vitro.,16304057_6,-1,-1,-1,-1,3322,-1,4.290672e-06,0.9999912,4.5479546e-06
3329,the therapeutic,15,17,110,125,Our findings suggest that selective inhibition of IL-2-mediated enhancement of regulatory T cells may improve the therapeutic effectiveness of IL-2 administration.,16304057_8,-1,-1,-1,-1,3329,-1,5.9736517e-06,0.99998987,4.1304907e-06
3332,peptide,14,15,85,92,Our previous study showed that DNA vaccination with a plasmid vector encoding a core peptide of mucin1 (PDTRP) provided modest protection against challenge with tumor cells that expressed mucin1 protein.,16341143_0,0,-1,2,-1,3332,-1,0.0014195008,0.99786395,0.00071656797
3333,tumor cells that,26,29,161,177,Our previous study showed that DNA vaccination with a plasmid vector encoding a core peptide of mucin1 (PDTRP) provided modest protection against challenge with tumor cells that expressed mucin1 protein.,16341143_0,-1,-1,-1,-1,3333,-1,7.150232e-05,0.99928266,0.000645917
3334,protein,31,32,195,202,Our previous study showed that DNA vaccination with a plasmid vector encoding a core peptide of mucin1 (PDTRP) provided modest protection against challenge with tumor cells that expressed mucin1 protein.,16341143_0,0,1,-1,-1,3334,-1,7.5150725e-05,0.9998834,4.1399508e-05
3342,the GM-CSF,14,16,107,117,The increased protection was directly correlated with a stronger PDTRP-specific immune response induced by the GM-CSF fusion plasmid.,16341143_2,-1,-1,-1,-1,3342,-1,0.96495694,0.032641985,0.0024010926
3344,The plasmid,0,2,0,11,"The plasmid encoding GM-CSF and the target PDTRP antigen induced a greater PDTRP-specific Th proliferation, antibodies, and cytotoxicity.",16341143_3,-1,-1,-1,-1,3344,-1,5.3256417e-06,0.9999889,5.7734856e-06
3346,the target,5,7,32,42,"The plasmid encoding GM-CSF and the target PDTRP antigen induced a greater PDTRP-specific Th proliferation, antibodies, and cytotoxicity.",16341143_3,-1,-1,-1,-1,3346,-1,5.26312e-06,0.99998903,5.6886083e-06
3351,the type,8,10,67,75,"Interestingly, the modified plasmid vaccine predominantly enhanced the type 2 immune responses manifested by an increased IgG1 to IgG2a antibody ratio and a greater induction of GATA-3 and IL-4 mRNA than that of T-bet and IFN-gamma mRNA in spleen cells from vaccinated mice.",16341143_4,-1,-1,-1,-1,3351,-1,5.258796e-06,0.9999893,5.421363e-06
3355,than that,31,33,199,208,"Interestingly, the modified plasmid vaccine predominantly enhanced the type 2 immune responses manifested by an increased IgG1 to IgG2a antibody ratio and a greater induction of GATA-3 and IL-4 mRNA than that of T-bet and IFN-gamma mRNA in spleen cells from vaccinated mice.",16341143_4,-1,-1,-1,-1,3355,-1,7.3047777e-06,0.99998724,5.4405778e-06
3360,that there,11,13,74,84,"In addition, protection against tumor challenge in vaccinated mice showed that there was no significant change in mice survival after in vivo CD8+CTL depletion, indicating that antitumor immunity augmented by plasmid encoding GM-CSF and target PDTRP gene vaccine was dominated by Th2 immune response.",16341143_5,-1,-1,-1,-1,3360,-1,4.9828964e-06,0.9999906,4.462267e-06
3362,immunity,29,30,187,195,"In addition, protection against tumor challenge in vaccinated mice showed that there was no significant change in mice survival after in vivo CD8+CTL depletion, indicating that antitumor immunity augmented by plasmid encoding GM-CSF and target PDTRP gene vaccine was dominated by Th2 immune response.",16341143_5,0,-1,2,-1,3362,-1,0.9998791,3.447208e-05,8.643277e-05
3367,Th2 immune response,43,46,280,299,"In addition, protection against tumor challenge in vaccinated mice showed that there was no significant change in mice survival after in vivo CD8+CTL depletion, indicating that antitumor immunity augmented by plasmid encoding GM-CSF and target PDTRP gene vaccine was dominated by Th2 immune response.",16341143_5,-1,-1,-1,-1,3367,-1,0.46758303,0.52839166,0.004025285
3371,to three,7,9,49,57,This highly effective immune surveillance is due to three interacting mechanisms: (a) the generation of inducible nitric oxide synthase (iNOS)-producing M1 macrophages that are tumoricidal for 4T1 tumor cells; (b) a rapid decrease in myeloid-derived Gr1(+)CD11b(+) suppressor cells that are elevated and down-regulate the CD3zeta chain when primary tumor is present and that suppress T cells by producing arginase; and (c) production of activated lymphocytes.,16357187_1,-1,-1,-1,-1,3371,-1,5.2431747e-06,0.99998975,5.066896e-06
3372,the generation,15,17,86,100,This highly effective immune surveillance is due to three interacting mechanisms: (a) the generation of inducible nitric oxide synthase (iNOS)-producing M1 macrophages that are tumoricidal for 4T1 tumor cells; (b) a rapid decrease in myeloid-derived Gr1(+)CD11b(+) suppressor cells that are elevated and down-regulate the CD3zeta chain when primary tumor is present and that suppress T cells by producing arginase; and (c) production of activated lymphocytes.,16357187_1,-1,-1,-1,-1,3372,-1,5.1221277e-06,0.99998987,4.953706e-06
3375,tumor cells,30,32,197,208,This highly effective immune surveillance is due to three interacting mechanisms: (a) the generation of inducible nitric oxide synthase (iNOS)-producing M1 macrophages that are tumoricidal for 4T1 tumor cells; (b) a rapid decrease in myeloid-derived Gr1(+)CD11b(+) suppressor cells that are elevated and down-regulate the CD3zeta chain when primary tumor is present and that suppress T cells by producing arginase; and (c) production of activated lymphocytes.,16357187_1,-1,-1,-1,-1,3375,-1,7.085803e-05,0.00015202905,0.999777
3376,suppressor cells that,43,46,265,286,This highly effective immune surveillance is due to three interacting mechanisms: (a) the generation of inducible nitric oxide synthase (iNOS)-producing M1 macrophages that are tumoricidal for 4T1 tumor cells; (b) a rapid decrease in myeloid-derived Gr1(+)CD11b(+) suppressor cells that are elevated and down-regulate the CD3zeta chain when primary tumor is present and that suppress T cells by producing arginase; and (c) production of activated lymphocytes.,16357187_1,-1,-1,-1,-1,3376,-1,0.0018381516,0.09266583,0.905496
3387,the generation,20,22,138,152,"Macrophages from wild-type BALB/c mice are polarized by interleukin-13 (IL-13) towards a tumor-promoting M2 phenotype, thereby inhibiting the generation of tumoricidal M1 macrophages.",16357187_2,-1,-1,-1,-1,3387,-1,5.562732e-06,0.99998975,4.694334e-06
3391,IL-13-producting NKT cells,15,18,76,102,"In contrast, CD1(-/-) mice, which are deficient for IL-13 because they lack IL-13-producting NKT cells, generate M1 macrophages that are cytotoxic for 4T1 via the production of nitric oxide.",16357187_3,-1,-1,-1,-1,3391,-1,0.9060047,0.0003665251,0.09362876
3412,gene therapy,12,14,67,79,PURPOSE: The aim of this study was to develop an immunostimulating gene therapy for the treatment of orthotopic bladder carcinoma by transferring the gene for CD40L into the tumor site.,16361570_0,-1,-1,-1,-1,3412,-1,6.883435e-06,0.9999865,6.618435e-06
3413,the treatment,15,17,84,97,PURPOSE: The aim of this study was to develop an immunostimulating gene therapy for the treatment of orthotopic bladder carcinoma by transferring the gene for CD40L into the tumor site.,16361570_0,-1,-1,-1,-1,3413,-1,4.687341e-06,0.99999046,4.8400684e-06
3414,transferring the gene,22,25,133,154,PURPOSE: The aim of this study was to develop an immunostimulating gene therapy for the treatment of orthotopic bladder carcinoma by transferring the gene for CD40L into the tumor site.,16361570_0,-1,-1,-1,-1,3414,-1,4.5089905e-06,0.99999,5.520749e-06
3416,the tumor,28,30,170,179,PURPOSE: The aim of this study was to develop an immunostimulating gene therapy for the treatment of orthotopic bladder carcinoma by transferring the gene for CD40L into the tumor site.,16361570_0,-1,-1,-1,-1,3416,-1,3.630906e-06,0.99999166,4.770624e-06
3421,Th1 type,10,12,83,91,CD40L stimulation of dendritic cells induces interleukin-12 expression that drives Th1 type of immune responses with activation of cytotoxic T cells.,16361570_1,-1,-1,-1,-1,3421,-1,7.1766485e-06,0.99997985,1.2940149e-05
3424,The gene,3,5,21,29,EXPERIMENTAL DESIGN: The gene for murine CD40L was transferred into bladders of tumor-bearing mice using an adenoviral vector construct.,16361570_2,-1,-1,-1,-1,3424,-1,4.9425576e-06,0.9999894,5.6827216e-06
3431,to tumor,15,17,92,100,"Survival of mice as well as transgene expression and immunologic effect, such as resistance to tumor challenge and presence of T regulatory cells, were monitored.",16361570_4,-1,-1,-1,-1,3431,-1,6.9227817e-06,0.9999863,6.7392643e-06
3436,transgene function,4,6,13,31,"As a sign of transgene function, interleukin-12 (IL-12) expression was significantly increased.",16361570_6,-1,-1,-1,-1,3436,-1,1.1867781e-05,0.99997616,1.1952479e-05
3439,gene therapy,1,3,8,20,AdCD40L gene therapy cured 60% of mice with preestablished tumors.,16361570_7,-1,-1,-1,-1,3439,-1,6.972993e-06,0.9999852,7.828143e-06
3443,tumor cells,11,13,77,88,"The cured mice were completely resistant to subcutaneous challenge with MB49 tumor cells, whereas the growth of a syngeneic irrelevant tumor was unaltered.",16361570_8,-1,-1,-1,-1,3443,-1,0.00016006302,0.0013707503,0.9984692
3447,the T,7,9,42,47,"Furthermore, the mRNA expression level of the T regulatory cell transcription factor Foxp3 was evaluated both in tumor biopsies and lymph nodes.",16361570_9,-1,-1,-1,-1,3447,-1,6.1305545e-06,0.99998534,8.570412e-06
3448,cell transcription factor Foxp3,10,14,59,90,"Furthermore, the mRNA expression level of the T regulatory cell transcription factor Foxp3 was evaluated both in tumor biopsies and lymph nodes.",16361570_9,-1,-1,-1,-1,3448,-1,0.0015585722,0.93607134,0.062370062
3451,the tumors,5,7,33,43,There were no differences within the tumors of the different treatment groups.,16361570_10,-1,-1,-1,-1,3451,-1,3.892035e-06,0.9999912,4.8905586e-06
3458,naive T cells,14,17,93,106,"Correspondingly, T cells from AdCD40L-treated mice were not able to inhibit proliferation of naive T cells as opposed to T cells from control-treated, tumor-bearing mice.",16361570_12,-1,-1,-1,-1,3458,-1,0.002052163,0.1112455,0.88670236
3459,to T cells,19,22,118,128,"Correspondingly, T cells from AdCD40L-treated mice were not able to inhibit proliferation of naive T cells as opposed to T cells from control-treated, tumor-bearing mice.",16361570_12,-1,-1,-1,-1,3459,-1,0.0019144748,0.12279538,0.8752901
3461,gene therapy,3,5,21,33,CONCLUSIONS: AdCD40L gene therapy evokes Th1 cytokine responses and counteracts T regulatory cell development and/or function.,16361570_13,-1,-1,-1,-1,3461,-1,5.5047585e-06,0.9999895,5.0042354e-06
3462,Th1 cytokine,6,8,41,53,CONCLUSIONS: AdCD40L gene therapy evokes Th1 cytokine responses and counteracts T regulatory cell development and/or function.,16361570_13,-1,-1,-1,-1,3462,-1,0.1257877,0.8687394,0.00547283
3465,function,16,17,117,125,CONCLUSIONS: AdCD40L gene therapy evokes Th1 cytokine responses and counteracts T regulatory cell development and/or function.,16361570_13,0,1,2,-1,3465,-1,0.0015915561,0.57388085,0.42452762
3469,functions,11,12,67,76,STAT5 belongs to a small family of transcription factors with dual functions.,16375697_0,0,1,2,-1,3469,-1,0.0001428625,0.9997867,7.044433e-05
3475,the plasma,16,18,104,114,"The seven signal transducers and activators of transcription (STAT) act as signaling components between the plasma membrane and the nucleus, and as transcription factors with specific DNA binding ability in the nucleus.",16375697_1,-1,-1,-1,-1,3475,-1,1.5083093e-05,0.99993825,4.6611865e-05
3484,the regulation,13,15,76,90,"It can promote proliferation and inhibit apoptosis, but is also involved in the regulation of differentiation between specific gene expression.",16375697_3,-1,-1,-1,-1,3484,-1,5.0357885e-06,0.99999034,4.602969e-06
3487,to the transformed,4,7,26,44,STAT5 can also contribute to the transformed phenotype.,16375697_4,-1,-1,-1,-1,3487,-1,1.0856301e-05,0.99998116,8.0343725e-06
3490,through receptors,12,14,75,92,"In many leukemias and some solid tumors, STAT5 is constitutively activated through receptors or receptor associated tyrosine kinases and contributes to the survival and the proliferation of malignant cells.",16375697_5,-1,-1,-1,-1,3490,-1,0.00013204546,0.99839634,0.0014716329
3491,receptor,15,16,96,104,"In many leukemias and some solid tumors, STAT5 is constitutively activated through receptors or receptor associated tyrosine kinases and contributes to the survival and the proliferation of malignant cells.",16375697_5,0,1,2,-1,3491,-1,0.007782664,0.5856601,0.40655726
3493,to the,21,23,149,155,"In many leukemias and some solid tumors, STAT5 is constitutively activated through receptors or receptor associated tyrosine kinases and contributes to the survival and the proliferation of malignant cells.",16375697_5,-1,-1,-1,-1,3493,-1,5.768625e-06,0.99998784,6.4409046e-06
3501,these tumor cells,4,7,23,40,Inhibition of STAT5 in these tumor cells results in growth arrest and apoptosis.,16375697_7,-1,-1,-1,-1,3501,-1,0.0018399539,0.4200565,0.57810354
3506,tumor therapy,16,18,114,127,"Targeting of STATs and other downstream mediators of oncogenic tyrosine kinases provides a promising strategy for tumor therapy, which might be refractory to resistance mechanisms incapacitating tyrosine kinase inhibitors.",16375697_8,-1,-1,-1,-1,3506,-1,5.264671e-06,0.99999094,3.7661955e-06
3513,function,27,28,179,187,"The well-studied steps in the activation of STAT5 and its roles in different subcellular compartments suggest original interference strategies, which could be used to inhibit its function.",16375697_9,0,1,2,-1,3513,-1,1.46167e-05,0.9999721,1.3233984e-05
3516,protein-protein,11,12,70,85,The challenge for drug developers will be the exploitation of defined protein-protein or protein-DNA interactions as targets of inhibition.,16375697_10,0,1,-1,-1,3516,-1,9.458273e-05,0.999863,4.236909e-05
3517,protein-DNA,13,14,89,100,The challenge for drug developers will be the exploitation of defined protein-protein or protein-DNA interactions as targets of inhibition.,16375697_10,0,1,-1,-1,3517,-1,5.0047438e-05,0.9999075,4.241759e-05
3523,tumor relapse,18,20,88,101,"Over an observation period of 3 years, 18% of the patients in our collective suffered a tumor relapse with local or distinct metastases after initial R0-resection.",16391798_1,-1,-1,-1,-1,3523,-1,1.2541759e-05,0.999974,1.3410301e-05
3524,that this,3,5,23,32,"Some evidence suggests that this may be due to suppression of anti-tumor responses, a phenomenon that might be attributed to regulatory T cells.",16391798_2,-1,-1,-1,-1,3524,-1,6.4230003e-06,0.9999889,4.6215687e-06
3527,to regulatory T cells,20,24,122,143,"Some evidence suggests that this may be due to suppression of anti-tumor responses, a phenomenon that might be attributed to regulatory T cells.",16391798_2,-1,-1,-1,-1,3527,-1,0.0014379259,0.06862504,0.92993706
3530,the tumor-specific immune response,8,12,40,74,The aim of our study was to investigate the tumor-specific immune response depending on the UICC stage of patients with colorectal cancer.,16391798_3,-1,-1,-1,-1,3530,-1,0.120258026,0.8783661,0.0013758497
3532,The cellular immune responses,0,4,0,29,The cellular immune responses against defined antigens that are overexpressed in most of the patients with colorectal cancer were characterized.,16391798_4,-1,-1,-1,-1,3532,-1,0.7064029,0.2801909,0.013406197
3533,antigens that,6,8,46,59,The cellular immune responses against defined antigens that are overexpressed in most of the patients with colorectal cancer were characterized.,16391798_4,-1,-1,-1,-1,3533,-1,0.9795045,0.019087609,0.0014078973
3536,the tumor,4,6,18,27,"For this purpose, the tumor suppressor gene, p53, was chosen as the tumor-associated antigen that exhibits mutations and overexpression in up to 60% of colorectal carcinoma.",16391798_5,-1,-1,-1,-1,3536,-1,4.185878e-06,0.9999912,4.5908296e-06
3538,the tumor-associated antigen that,14,18,64,97,"For this purpose, the tumor suppressor gene, p53, was chosen as the tumor-associated antigen that exhibits mutations and overexpression in up to 60% of colorectal carcinoma.",16391798_5,-1,-1,-1,-1,3538,-1,4.2590258e-05,0.9999273,3.0076102e-05
3545,that regulatory T cells,6,10,47,70,The predominance of IL-10 production indicated that regulatory T cells directly participate in modulating the anti-tumor immune response.,16391798_7,-1,-1,-1,-1,3545,-1,0.0016521604,0.09868065,0.89966714
3549,the blood,3,5,16,25,IL-10 levels in the blood as well as the expression of regulatory T-cell specific genes at the tumor site correlate with the UICC stage of the disease.,16391798_8,-1,-1,-1,-1,3549,-1,2.7443646e-05,0.9999305,4.2035073e-05
3553,the tumor,16,18,91,100,IL-10 levels in the blood as well as the expression of regulatory T-cell specific genes at the tumor site correlate with the UICC stage of the disease.,16391798_8,-1,-1,-1,-1,3553,-1,5.10068e-06,0.99998903,5.83164e-06
3564,blood,25,26,150,155,"Sezary syndrome (SS) is a leukemic variant of CTCL that presents with erythroderma, lymphadenopathies and presence of malignant T cells in peripheral blood.",16457762_1,0,1,-1,-1,3564,-1,0.0024048672,0.14016068,0.85743445
3572,cells that,8,10,49,59,KIR3DL2 is the first phenotypic marker of Sezary cells that can be used for the diagnostic and follow-up of Sezary syndrome.,16457762_5,-1,-1,-1,-1,3572,-1,0.0041284906,0.28617674,0.70969474
3578,Th2 cytokines,7,9,44,57,CTCL are characterized by a predominance of Th2 cytokines.,16457762_7,-1,-1,-1,-1,3578,-1,0.40223783,0.5912917,0.006470444
3592,tumor cells,5,7,32,43,"Future challenges are to render tumor cells sensitive to apoptosis by inhibiting specific signalling pathways such as the constitutively activated NF-KB pathway, to identify specific surface kinase receptors and to develop specific inhibitors, to develop humanized monoclonal antibodies directed against tumor specific antigens, able to kill tumor cells via complement-dependent and antibody-dependent cytotoxicity, and to stimulate innate immunity.",16457762_10,-1,-1,-1,-1,3592,-1,0.00018040404,0.004899181,0.99492043
3597,receptors,28,29,198,207,"Future challenges are to render tumor cells sensitive to apoptosis by inhibiting specific signalling pathways such as the constitutively activated NF-KB pathway, to identify specific surface kinase receptors and to develop specific inhibitors, to develop humanized monoclonal antibodies directed against tumor specific antigens, able to kill tumor cells via complement-dependent and antibody-dependent cytotoxicity, and to stimulate innate immunity.",16457762_10,0,1,2,-1,3597,-1,3.0531282e-05,2.7438939e-05,0.99994206
3603,tumor cells,49,51,342,353,"Future challenges are to render tumor cells sensitive to apoptosis by inhibiting specific signalling pathways such as the constitutively activated NF-KB pathway, to identify specific surface kinase receptors and to develop specific inhibitors, to develop humanized monoclonal antibodies directed against tumor specific antigens, able to kill tumor cells via complement-dependent and antibody-dependent cytotoxicity, and to stimulate innate immunity.",16457762_10,-1,-1,-1,-1,3603,-1,0.00018003889,0.0013963695,0.9984236
3619,the cells,25,27,172,181,We induced rat peritoneal macrophages with rat breast cancer cell-conditioned medium and analyzed signal transducer and activators of transcription 3 (Stat3) activities of the cells.,16530087_2,-1,-1,-1,-1,3619,-1,3.5435976e-05,3.0810952e-05,0.99993384
3620,Then these cells,0,3,0,16,Then these cells were transfected with Stat3 decoy oligonucleotides (ODNs) and were stimulated by lipopolysaccharide (LPS).,16530087_3,-1,-1,-1,-1,3620,-1,0.0023888368,0.47906354,0.51854753
3626,antigen-presenting function,12,14,91,118,The results demonstrate that induced macrophages displayed a reduction of cytotoxicity and antigen-presenting function in comparison with control but transfection with Stat3 decoy ODNs enhanced cytotoxicity and antigen-presenting function of the macrophages.,16530087_4,-1,-1,-1,-1,3626,-1,0.9950008,0.00021215227,0.0047869817
3629,antigen-presenting function,27,29,211,238,The results demonstrate that induced macrophages displayed a reduction of cytotoxicity and antigen-presenting function in comparison with control but transfection with Stat3 decoy ODNs enhanced cytotoxicity and antigen-presenting function of the macrophages.,16530087_4,-1,-1,-1,-1,3629,-1,0.99737275,0.00018004367,0.0024471849
3642,the cells,14,16,108,117,The data suggest that immunosuppressive activities of TAMs correlate with over-activated Stat3 signaling of the cells and disruption of Stat3 activity of TAMs can enhance rat immune response to breast cancer.,16530087_6,-1,-1,-1,-1,3642,-1,2.7119053e-05,2.0520181e-05,0.9999523
3645,immune response to,26,29,175,193,The data suggest that immunosuppressive activities of TAMs correlate with over-activated Stat3 signaling of the cells and disruption of Stat3 activity of TAMs can enhance rat immune response to breast cancer.,16530087_6,-1,-1,-1,-1,3645,-1,0.97931427,0.019934103,0.0007516335
3660,protein-78,13,14,114,124,"Angiogenin, vascular endothelial growth factor, transforming growth factor-beta, epithelial neutrophil-activating protein-78 and several other proteins involved in immune suppression, angiogenesis and plasma extravasation could be detected in both supernatant and pleural effusion.",16540497_4,0,1,-1,-1,3660,-1,0.32418332,0.04978179,0.6260349
3661,proteins,17,18,143,151,"Angiogenin, vascular endothelial growth factor, transforming growth factor-beta, epithelial neutrophil-activating protein-78 and several other proteins involved in immune suppression, angiogenesis and plasma extravasation could be detected in both supernatant and pleural effusion.",16540497_4,0,1,-1,-1,3661,-1,0.0037017677,0.99595684,0.0003414083
3669,peptide-2,23,24,182,191,"Surrounding stroma and/or infiltrating cells were the most likely source of hepatocyte growth factor, macrophage inflammatory protein (MIP)-1delta, MIP-3alpha, neutrophil-activating peptide-2, and pulmonary and activation-regulated chemokine that can cause leukocyte infiltration and activation.",16540497_5,0,-1,2,-1,3669,-1,0.99982554,5.6560646e-05,0.00011786542
3670,pulmonary and activation-regulated chemokine that,26,31,197,246,"Surrounding stroma and/or infiltrating cells were the most likely source of hepatocyte growth factor, macrophage inflammatory protein (MIP)-1delta, MIP-3alpha, neutrophil-activating peptide-2, and pulmonary and activation-regulated chemokine that can cause leukocyte infiltration and activation.",16540497_5,-1,-1,-1,-1,3670,-1,0.0004554827,0.99945515,8.940723e-05
3672,T-lymphocytes,11,12,44,57,"There was a massive influx of CD4+ and CD8+ T-lymphocytes and macrophages, but not of dendritic cells, in human mesothelioma biopsies.",16540497_6,-1,1,2,-1,3672,-1,1.437841e-05,7.1181003e-06,0.9999784
3675,tissue,7,8,52,58,It was further demonstrated that human mesothelioma tissue contained significant amounts of Foxp3+CD4+CD25+ regulatory T-cells.,16540497_7,-1,1,2,-1,3675,-1,1.3882578e-05,0.9999081,7.8000834e-05
3682,regulatory T-cells that,12,15,85,108,Mesothelioma is infiltrated by immune effector cells but also contains cytokines and regulatory T-cells that suppress an efficient immune response.,16540497_9,-1,-1,-1,-1,3682,-1,0.0007487411,0.019029178,0.98022205
3686,that the,5,7,29,37,It has been shown previously that the suppression of tumor immunosurveillance may be a mechanism by which tumors resist immune detection and elimination.,16585215_0,-1,-1,-1,-1,3686,-1,5.133245e-06,0.9999912,3.7029656e-06
3702,the cells,15,17,73,82,"Further, we examined the role of CD4(+) and/or CD8(+) cells by depleting the cells in vivo and measuring CTL activity in vitro.",16585215_3,-1,-1,-1,-1,3702,-1,4.0347324e-05,4.623237e-05,0.99991345
3706,receptor,8,9,45,53,"We also asked the role of interleukin (IL)-4 receptor alpha (IL-4Ralpha)-signal transducer and activator of transcription 6 (STAT6) signaling, including IL-13, and transforming growth factor beta (TGF-beta) by using gene-disrupted mice or treating mice with cytokine antagonists.",16585215_4,0,1,2,-1,3706,-1,0.009578253,0.03256637,0.95785546
3713,TGF-beta,31,32,197,205,"We also asked the role of interleukin (IL)-4 receptor alpha (IL-4Ralpha)-signal transducer and activator of transcription 6 (STAT6) signaling, including IL-13, and transforming growth factor beta (TGF-beta) by using gene-disrupted mice or treating mice with cytokine antagonists.",16585215_4,0,1,-1,-1,3713,-1,5.590024e-05,0.99993205,1.2018922e-05
3721,that the,3,5,26,34,Further studies suggested that the rejection of tumor in CD1d KO mice was dependent on CD8(+) lymphocytes.,16585215_6,-1,-1,-1,-1,3721,-1,4.8280367e-06,0.99999154,3.639767e-06
3729,TGF-beta,27,28,174,182,"Distinct from other murine tumor models, the negative regulation induced by CD1d-restricted NKT cells was not dependent on IL-4Ralpha-STAT6 signaling, including IL-13, or on TGF-beta.",16585215_7,0,1,-1,-1,3729,-1,2.477168e-05,0.9999682,7.008154e-06
3735,that NKT cells,21,24,149,163,These data suggest that a novel CD1d-restricted NKT cell-mediated mechanism for tumor immunosuppression is active in the K7M2 osteosarcoma model and that NKT cells can regulate immunosurveillance through more than one pathway.,16585215_8,-1,-1,-1,-1,3735,-1,0.0013872564,0.11273551,0.88587725
3740,They play,0,2,0,9,They play a crucial role in cancer progression by inhibiting the effector function of CD4(+) or CD8(+) T lymphocytes.,16612596_1,-1,-1,-1,-1,3740,-1,4.823074e-06,0.9999893,5.896395e-06
3742,function,12,13,74,82,They play a crucial role in cancer progression by inhibiting the effector function of CD4(+) or CD8(+) T lymphocytes.,16612596_1,0,1,2,-1,3742,-1,4.3836466e-05,0.9998895,6.6666915e-05
3744,regulatory T lymphocytes that,3,7,17,46,"However, whether regulatory T lymphocytes that expand during tumor progression can modulate dendritic cell function is unclear.",16612596_2,-1,-1,-1,-1,3744,-1,0.0012459673,0.026761195,0.9719928
3746,cell function,14,16,102,115,"However, whether regulatory T lymphocytes that expand during tumor progression can modulate dendritic cell function is unclear.",16612596_2,-1,-1,-1,-1,3746,-1,2.7868e-05,2.087816e-05,0.99995124
3755,cell function,15,17,120,133,"We present data demonstrating that CD4(+)CD25(+)FoxP3(+) regulatory T cells from tumor-bearing animals impede dendritic cell function by down-regulating the activation of the transcription factor NF-kappaB. The expression of the co-stimulatory molecules CD80, CD86 and CD40, the production of TNF-alpha, IL-12, and CCL5/RANTES by the suppressed DC is strongly down-regulated.",16612596_4,-1,-1,-1,-1,3755,-1,1.7854012e-05,1.3013298e-05,0.9999691
3757,the transcription factor,22,25,171,195,"We present data demonstrating that CD4(+)CD25(+)FoxP3(+) regulatory T cells from tumor-bearing animals impede dendritic cell function by down-regulating the activation of the transcription factor NF-kappaB. The expression of the co-stimulatory molecules CD80, CD86 and CD40, the production of TNF-alpha, IL-12, and CCL5/RANTES by the suppressed DC is strongly down-regulated.",16612596_4,-1,-1,-1,-1,3757,-1,4.35394e-06,0.99999106,4.608362e-06
3762,TNF-alpha,41,42,293,302,"We present data demonstrating that CD4(+)CD25(+)FoxP3(+) regulatory T cells from tumor-bearing animals impede dendritic cell function by down-regulating the activation of the transcription factor NF-kappaB. The expression of the co-stimulatory molecules CD80, CD86 and CD40, the production of TNF-alpha, IL-12, and CCL5/RANTES by the suppressed DC is strongly down-regulated.",16612596_4,0,1,-1,-1,3762,-1,0.065632276,0.9335841,0.0007835761
3766,TGF-beta,4,5,35,43,The suppression mechanism requires TGF-beta and IL-10 and is associated with induction of the Smad signaling pathway and activation of the STAT3 transcription factor.,16612596_5,0,1,-1,-1,3766,-1,7.730903e-05,0.9999068,1.5921216e-05
3768,the Smad,13,15,90,98,The suppression mechanism requires TGF-beta and IL-10 and is associated with induction of the Smad signaling pathway and activation of the STAT3 transcription factor.,16612596_5,-1,-1,-1,-1,3768,-1,1.662347e-05,0.99996936,1.4037066e-05
3769,the STAT3 transcription factor,20,24,135,165,The suppression mechanism requires TGF-beta and IL-10 and is associated with induction of the Smad signaling pathway and activation of the STAT3 transcription factor.,16612596_5,-1,-1,-1,-1,3769,-1,5.0892536e-06,0.99999034,4.611238e-06
3781,Stat1 deficiency,0,2,0,16,"Stat1 deficiency in the host significantly enhances IL-12-mediated tumor regression, resulting in tumor eradication from 60% of SCCVII tumor-bearing mice and significant inhibition of tumor growth when compared with control treatment (P < 0.01).",16618773_2,-1,-1,-1,-1,3781,-1,6.8827153e-06,0.99998677,6.3888424e-06
3783,IL-12-mediated tumor,7,9,52,72,"Stat1 deficiency in the host significantly enhances IL-12-mediated tumor regression, resulting in tumor eradication from 60% of SCCVII tumor-bearing mice and significant inhibition of tumor growth when compared with control treatment (P < 0.01).",16618773_2,-1,-1,-1,-1,3783,-1,0.99884206,0.00072502997,0.00043288746
3789,Stat1-activating cytokine IFN-gamma,6,9,35,70,This effect is independent of both Stat1-activating cytokine IFN-gamma and Stat1-downstream effector molecule FasL because neither neutralization of IFN-gamma nor knocking out of FasL enhances or inhibits IL-12-mediated tumor regression.,16618773_3,-1,-1,-1,-1,3789,-1,0.6899673,0.30597523,0.004057493
3792,IL-12-mediated tumor,27,29,205,225,This effect is independent of both Stat1-activating cytokine IFN-gamma and Stat1-downstream effector molecule FasL because neither neutralization of IFN-gamma nor knocking out of FasL enhances or inhibits IL-12-mediated tumor regression.,16618773_3,-1,-1,-1,-1,3792,-1,0.99897707,0.0006689276,0.00035403908
3794,tumor-specific CTL,6,8,34,52,"IL-12 induces a high intensity of tumor-specific CTL activity in Stat1-deficient mice (P < 0.01), increases the CD8 T-cell density in tumor bearing Stat1-/- mice, and induces a T-cell-dependent tumor regression.",16618773_4,-1,-1,-1,-1,3794,-1,0.0037923858,0.73925763,0.25694993
3797,T-cell,21,22,116,122,"IL-12 induces a high intensity of tumor-specific CTL activity in Stat1-deficient mice (P < 0.01), increases the CD8 T-cell density in tumor bearing Stat1-/- mice, and induces a T-cell-dependent tumor regression.",16618773_4,-1,1,2,-1,3797,-1,1.5158924e-05,8.011078e-06,0.9999769
3799,T-cell-dependent tumor,32,34,177,199,"IL-12 induces a high intensity of tumor-specific CTL activity in Stat1-deficient mice (P < 0.01), increases the CD8 T-cell density in tumor bearing Stat1-/- mice, and induces a T-cell-dependent tumor regression.",16618773_4,-1,-1,-1,-1,3799,-1,0.0010293458,0.012493118,0.9864776
3804,the tumors,12,14,79,89,The increased CTL activity and the high-intensity infiltration of T cells into the tumors in IL-12-treated Stat1-/- mice are likely due to the longer survival than the same cells from wild-type mice.,16618773_5,-1,-1,-1,-1,3804,-1,3.945529e-06,0.9999913,4.794074e-06
3806,to the,21,23,136,142,The increased CTL activity and the high-intensity infiltration of T cells into the tumors in IL-12-treated Stat1-/- mice are likely due to the longer survival than the same cells from wild-type mice.,16618773_5,-1,-1,-1,-1,3806,-1,5.2540604e-06,0.99999046,4.317554e-06
3807,than the,25,27,159,167,The increased CTL activity and the high-intensity infiltration of T cells into the tumors in IL-12-treated Stat1-/- mice are likely due to the longer survival than the same cells from wild-type mice.,16618773_5,-1,-1,-1,-1,3807,-1,4.814079e-06,0.99998987,5.32995e-06
3814,tumor-local IL-12 gene therapy,14,18,81,111,"Together, the data show that inhibition of Stat1 expression in the host enhances tumor-local IL-12 gene therapy for regressing tumors.",16618773_6,-1,-1,-1,-1,3814,-1,0.0004156437,0.99952054,6.387719e-05
3829,This regulation,0,2,0,15,This regulation involved the binding of STAT3 and STAT5 proteins to a highly conserved STAT-binding site located in the first intron of the FOXP3 gene.,16645171_3,-1,-1,-1,-1,3829,-1,4.0435903e-06,0.99999166,4.241471e-06
3832,STAT5 proteins to,8,11,50,67,This regulation involved the binding of STAT3 and STAT5 proteins to a highly conserved STAT-binding site located in the first intron of the FOXP3 gene.,16645171_3,-1,-1,-1,-1,3832,-1,4.9823175e-06,0.99998975,5.2940827e-06
3835,the FOXP3 gene,22,25,136,150,This regulation involved the binding of STAT3 and STAT5 proteins to a highly conserved STAT-binding site located in the first intron of the FOXP3 gene.,16645171_3,-1,-1,-1,-1,3835,-1,5.0107947e-06,0.99998903,6.012449e-06
3838,cell transplantation,26,28,179,199,We also examined the effects of low-dose IL-2 treatment in 12 patients with metastatic cancer and 9 patients with chronic myelogenous leukemia after allogeneic hematopoietic stem cell transplantation.,16645171_4,-1,-1,-1,-1,3838,-1,0.0049148914,0.031010909,0.9640743
3842,blood,20,21,113,118,"Overall, IL-2 treatment resulted in a 1.9 median fold increase in the frequency of CD4+CD25+ cells in peripheral blood as well as a 9.7 median fold increase in FOXP3 expression in CD3+ T cells.",16645171_5,0,1,-1,-1,3842,-1,0.0007350257,0.99795806,0.0013068968
3847,therapy,11,12,62,69,CD56+CD3- natural killer (NK) cells also expanded during IL-2 therapy but did not express FOXP3.,16645171_6,0,1,-1,-1,3847,-1,2.7117196e-05,0.99995923,1.370602e-05
3852,to FOXP3,14,16,103,111,"In vitro treatment of NK cells with 5-aza-2'-deoxycytidine restored the IL-2 signaling pathway leading to FOXP3 expression, suggesting that this gene was constitutively repressed by DNA methylation in these cells.",16645171_7,-1,-1,-1,-1,3852,-1,5.4310176e-06,0.99998987,4.76108e-06
3853,that this gene,19,22,135,149,"In vitro treatment of NK cells with 5-aza-2'-deoxycytidine restored the IL-2 signaling pathway leading to FOXP3 expression, suggesting that this gene was constitutively repressed by DNA methylation in these cells.",16645171_7,-1,-1,-1,-1,3853,-1,4.4412054e-06,0.9999907,4.817307e-06
3854,these cells,29,31,201,212,"In vitro treatment of NK cells with 5-aza-2'-deoxycytidine restored the IL-2 signaling pathway leading to FOXP3 expression, suggesting that this gene was constitutively repressed by DNA methylation in these cells.",16645171_7,-1,-1,-1,-1,3854,-1,1.5935773e-05,1.3127574e-05,0.9999709
3860,tumor cells,15,17,76,87,"Hodgkin lymphoma (HL) is characterized by the presence of a small number of tumor cells in a rich background of inflammatory cells, but the contribution of the abundant nontumor cells to HL pathogenesis is poorly understood.",16740709_0,-1,-1,-1,-1,3860,-1,5.5764292e-05,0.00010777332,0.99983644
3864,cells to,32,34,178,186,"Hodgkin lymphoma (HL) is characterized by the presence of a small number of tumor cells in a rich background of inflammatory cells, but the contribution of the abundant nontumor cells to HL pathogenesis is poorly understood.",16740709_0,-1,-1,-1,-1,3864,-1,0.0034356122,0.1645239,0.8320405
3868,to T-cell receptor,13,16,78,96,We showed that migratory CD4(+) cells induced by HL cells were hyporesponsive to T-cell receptor stimulation and suppressed the activation/proliferation of the effector CD4(+) T cells in an autologous setting.,16740709_1,-1,-1,-1,-1,3868,-1,0.004032729,0.10644368,0.8895236
3876,chemokine receptor,22,24,128,146,We further showed that HL cells in the affected lymph nodes were surrounded by a large number of lymphocytes expressing both CC chemokine receptor 4 (CCR4) and FOXP3.,16740709_2,-1,-1,-1,-1,3876,-1,0.97741246,6.617338e-05,0.022521352
3879,that the,3,5,24,32,These findings indicate that the migratory cells induced by HL cells function as regulatory T (Treg) cells so that these cells create a favorable environment for the tumor cells to escape from host immune system.,16740709_3,-1,-1,-1,-1,3879,-1,3.700052e-06,0.9999927,3.5873834e-06
3881,cells function,10,12,63,77,These findings indicate that the migratory cells induced by HL cells function as regulatory T (Treg) cells so that these cells create a favorable environment for the tumor cells to escape from host immune system.,16740709_3,-1,-1,-1,-1,3881,-1,0.0009271553,0.0058669983,0.9932058
3885,that these cells,20,23,110,126,These findings indicate that the migratory cells induced by HL cells function as regulatory T (Treg) cells so that these cells create a favorable environment for the tumor cells to escape from host immune system.,16740709_3,-1,-1,-1,-1,3885,-1,0.0024560343,0.20565428,0.7918897
3886,the tumor cells to,28,32,162,180,These findings indicate that the migratory cells induced by HL cells function as regulatory T (Treg) cells so that these cells create a favorable environment for the tumor cells to escape from host immune system.,16740709_3,-1,-1,-1,-1,3886,-1,2.0173506e-05,0.99993956,4.0318835e-05
3899,immune response to tumor cells,44,49,237,267,"Recognition of the importance of CCR4(+) Treg cells in the pathogenesis of HL will allow rational design of more effective treatments, such as use of an anti-CCR4 mAb, to overcome the suppressive effect of CCR4(+) Treg cells on the host immune response to tumor cells.",16740709_5,-1,-1,-1,-1,3899,-1,0.88859314,0.0035882553,0.1078186
3909,analysis,2,3,22,30,"Posttherapy molecular analysis of immune activation/suppression markers within the tumor microenvironment demonstrated a dramatic up-regulation of IFN-gamma and a concomitant down-regulation of Forkhead/winged-helix protein 3 (Foxp3), TGFbeta, and IL-10 expression.",16751376_2,0,1,-1,-1,3909,-1,8.715245e-06,0.9999844,6.9380567e-06
3910,the tumor,8,10,79,88,"Posttherapy molecular analysis of immune activation/suppression markers within the tumor microenvironment demonstrated a dramatic up-regulation of IFN-gamma and a concomitant down-regulation of Forkhead/winged-helix protein 3 (Foxp3), TGFbeta, and IL-10 expression.",16751376_2,-1,-1,-1,-1,3910,-1,4.02866e-06,0.99999094,4.997694e-06
3912,protein,23,24,216,223,"Posttherapy molecular analysis of immune activation/suppression markers within the tumor microenvironment demonstrated a dramatic up-regulation of IFN-gamma and a concomitant down-regulation of Forkhead/winged-helix protein 3 (Foxp3), TGFbeta, and IL-10 expression.",16751376_2,0,1,-1,-1,3912,-1,8.781387e-06,0.9999832,8.012956e-06
3914,TGFbeta,29,30,235,242,"Posttherapy molecular analysis of immune activation/suppression markers within the tumor microenvironment demonstrated a dramatic up-regulation of IFN-gamma and a concomitant down-regulation of Forkhead/winged-helix protein 3 (Foxp3), TGFbeta, and IL-10 expression.",16751376_2,0,1,-1,-1,3914,-1,1.6677906e-05,0.9999763,7.080861e-06
3916,Therapy-induced,0,1,0,15,"Therapy-induced reversion of immune suppression was transient since all three markers of suppression recovered rapidly and surpassed pretherapy levels by day 7 after treatment, resulting in tumor resurgence.",16751376_3,0,1,-1,-1,3916,-1,1.2419521e-05,0.99998164,5.946366e-06
3923,analysis,2,3,17,25,"Serial long-term analysis demonstrated that although chronic stimulation enhanced the IFN-gamma response, this was countered by a parallel increase in Foxp3, TGFbeta, and IL-10 expression.",16751376_5,0,1,-1,-1,3923,-1,7.5432763e-06,0.9999869,5.606623e-06
3925,the IFN-gamma,9,11,82,95,"Serial long-term analysis demonstrated that although chronic stimulation enhanced the IFN-gamma response, this was countered by a parallel increase in Foxp3, TGFbeta, and IL-10 expression.",16751376_5,-1,-1,-1,-1,3925,-1,0.98189235,0.016947208,0.0011604388
3928,TGFbeta,23,24,158,165,"Serial long-term analysis demonstrated that although chronic stimulation enhanced the IFN-gamma response, this was countered by a parallel increase in Foxp3, TGFbeta, and IL-10 expression.",16751376_5,0,1,-1,-1,3928,-1,2.765077e-05,0.999964,8.295081e-06
3930,Analysis,0,1,0,8,Analysis of tumor-infiltrating T lymphocyte populations showed that the expression of Foxp3 and IL-10 was associated with CD4(+)CD25(+) T cells.,16751376_6,0,1,-1,-1,3930,-1,7.019236e-06,0.99998796,5.072345e-06
3931,tumor-infiltrating T lymphocyte,2,5,12,43,Analysis of tumor-infiltrating T lymphocyte populations showed that the expression of Foxp3 and IL-10 was associated with CD4(+)CD25(+) T cells.,16751376_6,-1,-1,-1,-1,3931,-1,0.0023017032,0.84819776,0.14950058
3932,that the,7,9,63,71,Analysis of tumor-infiltrating T lymphocyte populations showed that the expression of Foxp3 and IL-10 was associated with CD4(+)CD25(+) T cells.,16751376_6,-1,-1,-1,-1,3932,-1,4.1751646e-06,0.9999919,3.9782444e-06
3938,T suppressor cells,11,14,98,116,Repeated treatment resulted in a progressive increase in tumor-infiltrating CD4(+)CD25(+)Foxp3(+) T suppressor cells establishing their role in long-term neutralization of antitumor activity.,16751376_7,-1,-1,-1,-1,3938,-1,0.00070508523,0.054112684,0.94518214
3940,Analysis,0,1,0,8,"Analysis of tumor-infiltrating CD8(+) T cells demonstrated that although treatment enhanced IFN-gamma production, antitumor cytotoxicity was diminished.",16751376_8,0,1,-1,-1,3940,-1,8.772064e-06,0.9999862,5.0898147e-06
3946,T cells that,4,7,21,33,"Monitoring of CD8(+) T cells that specifically recognized a dominant MHC class I her-2/neu peptide showed a dramatic increase in tetramer-specific CD8(+) T cells after the first treatment; however, continuous therapy resulted in the loss of this population.",16751376_9,-1,-1,-1,-1,3946,-1,0.0017220333,0.056561787,0.9417162
3947,peptide,15,16,91,98,"Monitoring of CD8(+) T cells that specifically recognized a dominant MHC class I her-2/neu peptide showed a dramatic increase in tetramer-specific CD8(+) T cells after the first treatment; however, continuous therapy resulted in the loss of this population.",16751376_9,0,-1,2,-1,3947,-1,1.1679172e-05,0.99998164,6.7334445e-06
3952,therapy,34,35,209,216,"Monitoring of CD8(+) T cells that specifically recognized a dominant MHC class I her-2/neu peptide showed a dramatic increase in tetramer-specific CD8(+) T cells after the first treatment; however, continuous therapy resulted in the loss of this population.",16751376_9,0,1,-1,-1,3952,-1,4.900648e-06,0.9999912,3.9622405e-06
3957,tumor-specific T cells,11,14,81,103,These results demonstrate that both enhanced suppressor activity and deletion of tumor-specific T cells are responsible for the progressive loss of efficacy that is associated with chronic immune therapy.,16751376_10,-1,-1,-1,-1,3957,-1,0.0032283482,0.7410964,0.2556753
3960,therapy,28,29,196,203,These results demonstrate that both enhanced suppressor activity and deletion of tumor-specific T cells are responsible for the progressive loss of efficacy that is associated with chronic immune therapy.,16751376_10,0,1,-1,-1,3960,-1,5.368189e-06,0.99998975,4.829405e-06
3983,FOXP3 protein,25,27,121,134,"Coculture of DCs with autologous T cells leads to an increase in both the number of Treg's, as well as the expression of FOXP3 protein per cell both in healthy donors and myeloma patients.",16763205_3,-1,-1,-1,-1,3983,-1,5.198359e-06,0.9999906,4.1755134e-06
3994,the nature,11,13,54,64,"The efficacy of induction of Treg's by DCs depends on the nature of the DC maturation stimulus, with inflammatory cytokine-treated DCs (Cyt-DCs) being the most effective Treg inducers.",16763205_6,-1,-1,-1,-1,3994,-1,8.987277e-06,0.99998164,9.385446e-06
4000,functional,12,13,73,83,DC-induced Treg's from both healthy donors and patients with myeloma are functional and effectively suppress T-cell responses.,16763205_7,0,1,2,-1,4000,-1,0.00047510385,0.99939156,0.00013332561
4001,T-cell,16,17,109,115,DC-induced Treg's from both healthy donors and patients with myeloma are functional and effectively suppress T-cell responses.,16763205_7,-1,1,2,-1,4001,-1,2.994209e-05,1.1907119e-05,0.99995816
4008,functional FOXP3(high,12,14,61,82,These data reveal a role for DCs in increasing the number of functional FOXP3(high) Treg's in humans.,16763205_9,-1,-1,-1,-1,4008,-1,4.3527496e-05,0.99992406,3.2414795e-05
4010,CTL-associated antigen,0,2,0,22,"CTL-associated antigen 4 (CTLA4) blockade releases inhibitory controls on T cell activation and proliferation, inducing antitumor immunity in both preclinical and early clinical trials.",16778987_0,-1,-1,-1,-1,4010,-1,0.10176691,0.00036124722,0.8978719
4014,immunity,19,20,130,138,"CTL-associated antigen 4 (CTLA4) blockade releases inhibitory controls on T cell activation and proliferation, inducing antitumor immunity in both preclinical and early clinical trials.",16778987_0,0,-1,2,-1,4014,-1,0.9998938,3.2068892e-05,7.415112e-05
4017,GM-CSF-transduced tumor cell,10,13,57,85,We examined the mechanisms of action of anti-CTLA4 and a GM-CSF-transduced tumor cell vaccine (Gvax) and their impact on the balance of effector T cells (Teffs) and Tregs in an in vivo model of B16/BL6 melanoma.,16778987_1,-1,-1,-1,-1,4017,-1,0.96303105,0.00041261112,0.036556404
4030,their function,8,10,55,69,"Anti-CTLA4 did not deplete Tregs or permanently impair their function but acted in a cell-intrinsic manner on both Tregs and Teffs, allowing them to expand, most likely in response to self antigen.",16778987_3,-1,-1,-1,-1,4030,-1,1.4485989e-05,0.9999682,1.739322e-05
4034,them to,23,25,141,148,"Anti-CTLA4 did not deplete Tregs or permanently impair their function but acted in a cell-intrinsic manner on both Tregs and Teffs, allowing them to expand, most likely in response to self antigen.",16778987_3,-1,-1,-1,-1,4034,-1,5.876605e-06,0.9999862,7.925653e-06
4037,the tumor-reactive Teff,3,6,18,41,"While Gvax primed the tumor-reactive Teff compartment, inducing activation, tumor infiltration, and a delay in tumor growth, the combination with CTLA4 blockade induced greater infiltration and a striking change in the intratumor balance of Tregs and Teffs that directly correlated with tumor rejection.",16778987_4,-1,-1,-1,-1,4037,-1,7.656806e-05,0.99987376,4.9672868e-05
4044,Teffs that,40,42,251,261,"While Gvax primed the tumor-reactive Teff compartment, inducing activation, tumor infiltration, and a delay in tumor growth, the combination with CTLA4 blockade induced greater infiltration and a striking change in the intratumor balance of Tregs and Teffs that directly correlated with tumor rejection.",16778987_4,-1,-1,-1,-1,4044,-1,1.3916842e-05,0.99997175,1.4352914e-05
4047,that Tregs,3,5,17,27,"The data suggest that Tregs control both CD4+ and CD8+ T cell activity within the tumor, highlight the importance of the intratumor ratio of effectors to regulators, and demonstrate inversion of the ratio and correlation with tumor rejection during Gvax/anti-CTLA4 immunotherapy.",16778987_5,-1,-1,-1,-1,4047,-1,4.6614364e-06,0.9999914,3.9605866e-06
4049,the tumor,16,18,78,87,"The data suggest that Tregs control both CD4+ and CD8+ T cell activity within the tumor, highlight the importance of the intratumor ratio of effectors to regulators, and demonstrate inversion of the ratio and correlation with tumor rejection during Gvax/anti-CTLA4 immunotherapy.",16778987_5,-1,-1,-1,-1,4049,-1,3.935357e-06,0.9999914,4.7008107e-06
4059,the tumor,17,19,101,110,Studies in cancer patients have suggested that breast tumors recruit regulatory T cells (Tregs) into the tumor microenvironment.,16785502_0,-1,-1,-1,-1,4059,-1,3.8193944e-06,0.99999166,4.4749586e-06
4063,immunity,8,9,51,59,The extent to which local Tregs suppress antitumor immunity in breast cancer is unknown.,16785502_1,0,-1,2,-1,4063,-1,0.999879,2.6820471e-05,9.419492e-05
4069,the tumor,15,17,81,90,"As in human breast cancer, cancers that develop in these mice attract Tregs into the tumor microenvironment to levels of approximately 10-25% of the total CD4+ T cells.",16785502_3,-1,-1,-1,-1,4069,-1,3.779666e-06,0.99999166,4.550694e-06
4071,the total,27,29,145,154,"As in human breast cancer, cancers that develop in these mice attract Tregs into the tumor microenvironment to levels of approximately 10-25% of the total CD4+ T cells.",16785502_3,-1,-1,-1,-1,4071,-1,4.5340626e-06,0.99999034,5.0719073e-06
4078,The treatment,0,2,0,13,The treatment depleted Tregs without concomitant lymphopenia and markedly inhibited tumor growth.,16785502_5,-1,-1,-1,-1,4078,-1,5.0704834e-06,0.9999908,4.1109633e-06
4089,the therapeutic,16,18,109,124,The clinical response was immune-mediated because adoptive transfer of Tregs led to a complete abrogation of the therapeutic effects of immunotoxin treatment.,16785502_7,-1,-1,-1,-1,4089,-1,5.8539777e-06,0.99998975,4.3386685e-06
4092,immunity,9,10,71,79,"Further, Treg down-modulation was accompanied by increased Ag-specific immunity against the neu protein, a self Ag.",16785502_8,0,-1,2,-1,4092,-1,0.9995921,0.00013859484,0.00026930828
4094,protein,13,14,96,103,"Further, Treg down-modulation was accompanied by increased Ag-specific immunity against the neu protein, a self Ag.",16785502_8,0,1,-1,-1,4094,-1,3.055032e-05,0.9999428,2.6686928e-05
4096,that Tregs play,3,6,22,37,"These results suggest that Tregs play a major role in preventing an effective endogenous immune response against breast cancer and that depletion of Tregs, without any additional immunotherapy, may mediate a significant antitumor response.",16785502_9,-1,-1,-1,-1,4096,-1,5.1279267e-06,0.9999902,4.698981e-06
4103,the treatment,19,21,117,130,Here we show that a widely used neutralizing anti-murine IL-2 mAb (S4B6) exhibits unexpected activities that enhance the treatment effects of IL-2 in vivo.,16785526_1,-1,-1,-1,-1,4103,-1,5.6063523e-06,0.9999901,4.2635343e-06
4116,that the,27,29,168,176,"A 5-day treatment with the anti-IL-2 mAb alone gradually increased the CD44(high)CD8+ population, and the increased population was maintained for >300 days, suggesting that the mAb can gradually maintain and potentially enhance the bioactivity of endogenous IL-2 for extended periods.",16785526_4,-1,-1,-1,-1,4116,-1,4.1753087e-06,0.99999213,3.6436381e-06
4120,plus the,8,10,55,63,"Furthermore, combined treatment with the anti-IL-2 mAb plus the IL-2 plasmid markedly enhanced Ag-specific CTL activity in vivo and partially protected mice from tumor metastasis to the lungs, compared with the anti-IL-2 mAb or IL-2 plasmid alone.",16785526_5,-1,-1,-1,-1,4120,-1,6.5145723e-06,0.9999869,6.541124e-06
4124,to the,26,28,179,185,"Furthermore, combined treatment with the anti-IL-2 mAb plus the IL-2 plasmid markedly enhanced Ag-specific CTL activity in vivo and partially protected mice from tumor metastasis to the lungs, compared with the anti-IL-2 mAb or IL-2 plasmid alone.",16785526_5,-1,-1,-1,-1,4124,-1,5.2966006e-06,0.9999865,8.153447e-06
4132,functions,30,31,200,209,These results demonstrated IL-2-enhancing effects of the anti-IL-2 mAb in vivo and suggest that combining a neutralizing anti-IL-2 Ab with IL-2 gene delivery might be used effectively to enhance IL-2 functions in clinical applications.,16785526_6,0,1,2,-1,4132,-1,0.9538363,0.04344739,0.0027163469
4136,the blood,22,24,126,135,We reported earlier that patients with breast or pancreas cancer have an increased prevalence of regulatory T cells (Treg) in the blood and tumor draining lymph nodes (TDLNs) compared with healthy individuals.,16799337_0,-1,-1,-1,-1,4136,-1,2.2336782e-05,0.99994886,2.8803082e-05
4140,tested the,6,8,25,35,"In the current study, we tested the hypothesis that tumor cells promote the prevalence of Treg.",16799337_1,-1,-1,-1,-1,4140,-1,6.0388757e-06,0.99998975,4.2167476e-06
4141,that tumor cells,9,12,47,63,"In the current study, we tested the hypothesis that tumor cells promote the prevalence of Treg.",16799337_1,-1,-1,-1,-1,4141,-1,0.0029661565,0.57311434,0.42391947
4144,The transforming growth factor-beta,0,4,0,35,"The transforming growth factor-beta (TGF-beta) secreting murine pancreas adenocarcinoma, Pan02 cell line was injected into syngeneic C57BL/6 mice and the prevalence of Treg in the TDLNs and tumor spleen was measured weekly.",16799337_2,-1,-1,-1,-1,4144,-1,0.9577893,0.038469378,0.003741352
4145,TGF-beta,5,6,37,45,"The transforming growth factor-beta (TGF-beta) secreting murine pancreas adenocarcinoma, Pan02 cell line was injected into syngeneic C57BL/6 mice and the prevalence of Treg in the TDLNs and tumor spleen was measured weekly.",16799337_2,0,1,-1,-1,4145,-1,0.00021145352,0.999764,2.4496647e-05
4149,the TDLNs,27,29,176,185,"The transforming growth factor-beta (TGF-beta) secreting murine pancreas adenocarcinoma, Pan02 cell line was injected into syngeneic C57BL/6 mice and the prevalence of Treg in the TDLNs and tumor spleen was measured weekly.",16799337_2,-1,-1,-1,-1,4149,-1,6.629646e-06,0.99998534,7.983019e-06
4156,Analysis,0,1,0,8,"Analysis of these CD25+ CD4+ T cells in vitro confirmed expression of the Treg marker, Foxp3.",16799337_4,0,1,-1,-1,4156,-1,6.576049e-06,0.9999876,5.8036085e-06
4159,the Treg,14,16,70,78,"Analysis of these CD25+ CD4+ T cells in vitro confirmed expression of the Treg marker, Foxp3.",16799337_4,-1,-1,-1,-1,4159,-1,5.4083484e-06,0.99998903,5.5869336e-06
4161,their functional,3,5,13,29,"In addition, their functional activity resembled that of Treg, as evidenced by a poor proliferative capacity; suppression of proliferation of CD25- CD4 or CD8T cells and inhibition of interferon-gamma release by CD25- CD4+ T cells.",16799337_5,-1,-1,-1,-1,4161,-1,9.188819e-05,0.9998398,6.831755e-05
4165,interferon-gamma release,32,34,184,208,"In addition, their functional activity resembled that of Treg, as evidenced by a poor proliferative capacity; suppression of proliferation of CD25- CD4 or CD8T cells and inhibition of interferon-gamma release by CD25- CD4+ T cells.",16799337_5,-1,-1,-1,-1,4165,-1,0.99898785,0.00074176723,0.00027038445
4174,TGF-beta-negative,18,19,114,131,"In contrast, Foxp3 was not detected in unreconstituted Pan02-bearing Rag-/- mice, or reconstituted mice bearing a TGF-beta-negative esophageal tumor.",16799337_7,0,1,-1,-1,4174,-1,2.3913182e-05,0.9999629,1.3153661e-05
4179,Foxp3 through,10,12,66,79,These results mimic earlier in vitro studies showing induction of Foxp3 through CD3 plus CD28 stimulation in the presence of TGF-beta.,16799337_9,-1,-1,-1,-1,4179,-1,4.7912426e-06,0.9999908,4.4448584e-06
4180,plus CD28,13,15,84,93,These results mimic earlier in vitro studies showing induction of Foxp3 through CD3 plus CD28 stimulation in the presence of TGF-beta.,16799337_9,-1,-1,-1,-1,4180,-1,0.0019932713,0.009129186,0.9888775
4182,TGF-beta,20,21,125,133,These results mimic earlier in vitro studies showing induction of Foxp3 through CD3 plus CD28 stimulation in the presence of TGF-beta.,16799337_9,0,1,-1,-1,4182,-1,6.4640495e-05,0.9999244,1.0959374e-05
4187,through the,13,15,70,81,"We conclude that Pan02 tumor promotes the prevalence of Treg, in part through the secretion of TGF-beta, which may result in immune evasion.",16799337_10,-1,-1,-1,-1,4187,-1,4.5931515e-06,0.9999914,4.0454947e-06
4188,TGF-beta,17,18,95,103,"We conclude that Pan02 tumor promotes the prevalence of Treg, in part through the secretion of TGF-beta, which may result in immune evasion.",16799337_10,0,1,-1,-1,4188,-1,6.159964e-05,0.9999248,1.3576589e-05
4194,to the,16,18,90,96,"We examined the hypothesis that a failure of the immune system to eradicate tumors is due to the immunosuppressive environment created by the growing tumor, which is influenced by the site of tumor growth.",16818744_0,-1,-1,-1,-1,4194,-1,5.2854075e-06,0.99999,4.716701e-06
4199,that T cell,2,5,16,27,We demonstrated that T cell responses to a bystander Ag in mice were suppressed by a growing CT26 tumor.,16818744_1,-1,-1,-1,-1,4199,-1,0.0035759297,0.2593159,0.7371081
4206,TGF-beta,12,13,66,74,"T cells purified from the growing tumor expressed mRNA for IL-10, TGF-beta, and Foxp3.",16818744_2,0,1,-1,-1,4206,-1,3.784125e-05,0.99994946,1.2654698e-05
4212,the tumor,23,25,146,155,"Intracellular cytokine staining revealed a high frequency of IL-10-secreting macrophages, dendritic cells, and CD4+ and CD8+ T cells infiltrating the tumor.",16818744_3,-1,-1,-1,-1,4212,-1,4.5728802e-06,0.99999034,5.0592507e-06
4213,T cell IFN-gamma,3,6,13,29,"In contrast, T cell IFN-gamma production was weak and CD8+ CTL responses were undetectable in mice with CT26 lung metastases and weak and transient following s.c. injection of CT26 cells, but were enhanced in the presence of anti-IL-10 and anti-TGF-beta.",16818744_4,-1,-1,-1,-1,4213,-1,0.90355253,0.0008064773,0.09564106
4225,the tumor,15,17,76,85,"However, in the lung model, depletion of CD8+ T cells significantly reduced the tumor burden.",16818744_6,-1,-1,-1,-1,4225,-1,4.926797e-06,0.99999034,4.7755343e-06
4232,that tumor,3,5,23,33,These findings suggest that tumor growth facilitates the induction or recruitment of CD4+ regulatory T cells that secrete IL-10 and TGF-beta and suppress effector CD8+ T cell responses.,16818744_8,-1,-1,-1,-1,4232,-1,4.289209e-06,0.99999154,4.1733238e-06
4234,regulatory T cells that,14,18,90,113,These findings suggest that tumor growth facilitates the induction or recruitment of CD4+ regulatory T cells that secrete IL-10 and TGF-beta and suppress effector CD8+ T cell responses.,16818744_8,-1,-1,-1,-1,4234,-1,0.0008376662,0.019997992,0.97916436
4236,TGF-beta,21,22,132,140,These findings suggest that tumor growth facilitates the induction or recruitment of CD4+ regulatory T cells that secrete IL-10 and TGF-beta and suppress effector CD8+ T cell responses.,16818744_8,0,1,-1,-1,4236,-1,2.0606927e-05,0.99997175,7.6037813e-06
4241,TGF-beta,10,11,54,62,"However, CD8+ T regulatory cells expressing IL-10 and TGF-beta are also recruited or activated by the immunosuppressive environment of the lung, where they may suppress the induction of antitumor immunity.",16818744_9,0,1,-1,-1,4241,-1,4.7480775e-05,0.9999411,1.1390171e-05
4246,immunity,32,33,196,204,"However, CD8+ T regulatory cells expressing IL-10 and TGF-beta are also recruited or activated by the immunosuppressive environment of the lung, where they may suppress the induction of antitumor immunity.",16818744_9,0,-1,2,-1,4246,-1,0.9999013,2.597503e-05,7.273971e-05
4247,targeting tumor antigens,4,7,39,63,Cancer immunotherapy utilizes vaccines targeting tumor antigens or tumor endothelium to prevent or regress tumors.,16916758_0,-1,-1,-1,-1,4247,-1,0.23284516,0.7635941,0.0035607782
4253,T cells that,9,12,70,82,Many cancer vaccines are designed to induce antigen-specific effector T cells that migrate to the tumor site.,16916758_1,-1,-1,-1,-1,4253,-1,0.0011030042,0.071947165,0.92694974
4254,to the tumor,13,16,91,103,Many cancer vaccines are designed to induce antigen-specific effector T cells that migrate to the tumor site.,16916758_1,-1,-1,-1,-1,4254,-1,6.159308e-06,0.9999877,6.169096e-06
4257,the tumor,10,12,56,65,"In an optimal situation, the effector T cells penetrate the tumor, release their effector molecules, induce tumor cell death and tumor regression.",16916758_2,-1,-1,-1,-1,4257,-1,4.7306007e-06,0.9999895,5.8045052e-06
4258,release their,13,15,67,80,"In an optimal situation, the effector T cells penetrate the tumor, release their effector molecules, induce tumor cell death and tumor regression.",16916758_2,-1,-1,-1,-1,4258,-1,8.417363e-06,0.9999819,9.727533e-06
4259,tumor cell,19,21,108,118,"In an optimal situation, the effector T cells penetrate the tumor, release their effector molecules, induce tumor cell death and tumor regression.",16916758_2,-1,-1,-1,-1,4259,-1,0.00023634131,0.002221654,0.997542
4261,the tumor,2,4,9,18,"However, the tumor microenvironment is frequently immunosuppressive and contributes to a state of immune ignorance, impacting on the vaccine's ability to break tolerance to tumor antigen/s.",16916758_3,-1,-1,-1,-1,4261,-1,4.7666726e-06,0.9999907,4.4879253e-06
4266,tolerance to tumor,25,28,160,178,"However, the tumor microenvironment is frequently immunosuppressive and contributes to a state of immune ignorance, impacting on the vaccine's ability to break tolerance to tumor antigen/s.",16916758_3,-1,-1,-1,-1,4266,-1,7.1609393e-06,0.9999876,5.185203e-06
4268,the factors,3,5,22,33,This review discusses the factors in the tumor microenvironment that can affect the efficacy of cancer vaccines.,16916758_4,-1,-1,-1,-1,4268,-1,9.729612e-06,0.99998486,5.391897e-06
4269,the tumor,6,8,37,46,This review discusses the factors in the tumor microenvironment that can affect the efficacy of cancer vaccines.,16916758_4,-1,-1,-1,-1,4269,-1,4.8801976e-06,0.99999034,4.7918984e-06
4286,to test,7,9,34,41,The first goal of this article is to test if the injection of autologous dendritic cells infected ex vivo with the Ad-sig-TAA/ecdCD40L can increase the immune response induced against TAA.,16928818_2,-1,-1,-1,-1,4286,-1,7.748284e-06,0.99998724,5.0180734e-06
4290,the immune response,24,27,148,167,The first goal of this article is to test if the injection of autologous dendritic cells infected ex vivo with the Ad-sig-TAA/ecdCD40L can increase the immune response induced against TAA.,16928818_2,-1,-1,-1,-1,4290,-1,0.74852604,0.24952659,0.0019474042
4293,to test the,4,7,19,30,The second goal is to test the effect of adding local chemotherapy in the form of i.t.,16928818_3,-1,-1,-1,-1,4293,-1,5.745076e-06,0.99999034,3.945021e-06
4298,the immune response,7,10,61,80,injection of the AdCDIRESE1A vector-directed chemotherapy on the immune response induced by i.t.,16928818_4,-1,-1,-1,-1,4298,-1,0.74499553,0.25237474,0.0026296554
4301,that the,3,5,17,25,"The results show that the i.t. injection of the AdCDIRESE1A chemotherapy sensitization vector, which encodes the cytosine deaminase chemotherapy sensitization transcription unit, to the i.t. injection of Ad-sig-ecdCD40L vector-infected dendritic cells increased the level of suppression of the growth of the CCL-51 breast cancer cells.",16928818_6,-1,-1,-1,-1,4301,-1,3.8902936e-06,0.9999919,4.228459e-06
4307,to the,25,27,179,185,"The results show that the i.t. injection of the AdCDIRESE1A chemotherapy sensitization vector, which encodes the cytosine deaminase chemotherapy sensitization transcription unit, to the i.t. injection of Ad-sig-ecdCD40L vector-infected dendritic cells increased the level of suppression of the growth of the CCL-51 breast cancer cells.",16928818_6,-1,-1,-1,-1,4307,-1,4.838543e-06,0.99999,5.1494735e-06
4323,to the,7,9,63,69,injection of the AdCDIRESE1A chemotherapy sensitization vector to the i.t.,16928818_11,-1,-1,-1,-1,4323,-1,4.4811277e-06,0.99999034,5.198626e-06
4325,to the,15,17,116,122,administration of dendritic cells infected with a rat HER-2/neu (rH2N)-expressing vector (Ad-sig-rH2N/ecdCD40L) led to the induction of rH2N-specific antitumoral immunity in rH2N transgenic mice (which are anergic to the rH2N antigen).,16928818_12,-1,-1,-1,-1,4325,-1,4.3384775e-06,0.99999154,4.102585e-06
4326,immunity,21,22,162,170,administration of dendritic cells infected with a rat HER-2/neu (rH2N)-expressing vector (Ad-sig-rH2N/ecdCD40L) led to the induction of rH2N-specific antitumoral immunity in rH2N transgenic mice (which are anergic to the rH2N antigen).,16928818_12,0,-1,2,-1,4326,-1,0.9991425,0.00040295866,0.00045453
4328,to the,30,32,214,220,administration of dendritic cells infected with a rat HER-2/neu (rH2N)-expressing vector (Ad-sig-rH2N/ecdCD40L) led to the induction of rH2N-specific antitumoral immunity in rH2N transgenic mice (which are anergic to the rH2N antigen).,16928818_12,-1,-1,-1,-1,4328,-1,5.707461e-06,0.99998844,5.9096647e-06
4337,FOXP3-expressing regulatory T cells,2,6,17,52,"CD4(+)CD25(high) FOXP3-expressing regulatory T cells (Treg) can suppress immune responses to infections and tumors, thereby promoting microbial persistence and tumor progression.",16934529_0,-1,-1,-1,-1,4337,-1,0.0019504798,0.8040242,0.1940253
4339,immune responses to,11,14,73,92,"CD4(+)CD25(high) FOXP3-expressing regulatory T cells (Treg) can suppress immune responses to infections and tumors, thereby promoting microbial persistence and tumor progression.",16934529_0,-1,-1,-1,-1,4339,-1,0.98486507,0.014686578,0.00044841363
4344,function,9,10,49,57,"However, little is known about the phenotype and function of human mucosal Treg.",16934529_1,0,1,2,-1,4344,-1,0.00016109337,0.9997385,0.00010041195
4350,the tumor,9,11,53,62,We found increased numbers of CD4(+)FOXP3(+) Treg in the tumor compared to tumor-free gastric mucosa.,16934529_3,-1,-1,-1,-1,4350,-1,3.690339e-06,0.99999154,4.7355666e-06
4351,to tumor-free,12,14,72,85,We found increased numbers of CD4(+)FOXP3(+) Treg in the tumor compared to tumor-free gastric mucosa.,16934529_3,-1,-1,-1,-1,4351,-1,7.101768e-06,0.99998534,7.531469e-06
4359,that these receptors,18,21,116,136,"Furthermore, gastric Treg expressed increased levels of l-selectin and CCR4, compared to non-Treg cells, suggesting that these receptors contribute to Treg recruitment.",16934529_5,-1,-1,-1,-1,4359,-1,0.0018367177,0.9821342,0.016029056
4360,to Treg,22,24,148,155,"Furthermore, gastric Treg expressed increased levels of l-selectin and CCR4, compared to non-Treg cells, suggesting that these receptors contribute to Treg recruitment.",16934529_5,-1,-1,-1,-1,4360,-1,7.809526e-06,0.9999857,6.4600476e-06
4362,functional antigen-specific Treg,3,6,16,48,"The presence of functional antigen-specific Treg in H. pylori-infected gastric mucosa supports an important role for these cells in suppression of mucosal effector T cell responses, which probably contribute to bacterial persistence and possibly also to gastric tumor progression.",16934529_6,-1,-1,-1,-1,4362,-1,0.053516082,0.9437954,0.0026885828
4363,these cells,16,18,117,128,"The presence of functional antigen-specific Treg in H. pylori-infected gastric mucosa supports an important role for these cells in suppression of mucosal effector T cell responses, which probably contribute to bacterial persistence and possibly also to gastric tumor progression.",16934529_6,-1,-1,-1,-1,4363,-1,1.9489473e-05,1.3700413e-05,0.99996686
4369,receptor-ligand,12,13,91,106,BACKGROUND & OBJECTIVE: Accumulative evidences have indicated the importance of CD40-CD40L receptor-ligand pair in the initiation and regulation of human immune response.,16965650_0,0,1,2,-1,4369,-1,0.40999502,0.00079541025,0.5892096
4399,than that,38,40,283,292,The production of IFN-gamma secreted by the spleen cells from CD40L/OVHM and OVHM cell-inoculated mice co-cultured with 20 Gy-irridiated OVHM cells were measured with enzyme-linked immunosorbent assay (ELISA).RESULTS: Expression of CD40L in OVHM/CD40L cells was significantly higher than that in OVHM cells (P<0.05).,16965650_7,-1,-1,-1,-1,4399,-1,7.1368977e-06,0.99998736,5.443662e-06
4410,the tumor,20,22,142,151,"Although, delayed tumor growth was observed when CD40L-expressing OVHM cells and OVHM cells were injected simultaneously and contralaterally, the tumor growth of OVHM and CD40L/OVHM in BALB/c nude mice was not different.",16965650_10,-1,-1,-1,-1,4410,-1,4.9622977e-06,0.99999094,4.1204585e-06
4416,than those,23,25,147,157,The amounts of IFN-gamma secreted by the co-culture of irradiated OVHM cells with spleen cells from mice injected with CD40L/OVHM were much higher than those from OVHM/parental cell inoculated and naive mice.,16965650_11,-1,-1,-1,-1,4416,-1,6.7374203e-06,0.9999882,5.068976e-06
4424,the generation,9,11,70,84,In vivo immunization of immunocompetent mice with CD40L/OVHM improves the generation of cytotoxic lymphocytes against parent ovarian cancer cells.,16965650_13,-1,-1,-1,-1,4424,-1,7.852786e-06,0.9999869,5.288038e-06
4432,transforming growth factor,14,17,78,104,"These CD8+ T cells selectively express CD103, which is upregulated locally by transforming growth factor (TGF)-beta, and adhere to E-cadherin expressed by mucosal epithelia.",16978200_1,-1,-1,-1,-1,4432,-1,0.977756,0.017930852,0.0043131444
4435,the type,9,11,61,69,Many of these cancers also possess inactivating mutations in the type II TGF-beta receptor and are believed to be insensitive to TGF-beta.,16978200_2,-1,-1,-1,-1,4435,-1,4.7486737e-06,0.99999,5.260365e-06
4436,TGF-beta receptor,12,14,73,90,Many of these cancers also possess inactivating mutations in the type II TGF-beta receptor and are believed to be insensitive to TGF-beta.,16978200_2,-1,-1,-1,-1,4436,-1,6.6229244e-05,0.9996418,0.0002919508
4438,to TGF-beta,20,22,126,137,Many of these cancers also possess inactivating mutations in the type II TGF-beta receptor and are believed to be insensitive to TGF-beta.,16978200_2,-1,-1,-1,-1,4438,-1,2.3507047e-05,0.99996805,8.387845e-06
4441,to TGF-beta,9,11,63,74,The present study aimed to explore whether such refractoriness to TGF-beta is an independently contributing factor to IEL retention.,16978200_3,-1,-1,-1,-1,4441,-1,0.00026071412,0.999705,3.4197405e-05
4442,factor to,15,17,108,117,The present study aimed to explore whether such refractoriness to TGF-beta is an independently contributing factor to IEL retention.,16978200_3,-1,-1,-1,-1,4442,-1,0.00033489685,0.99955755,0.00010755353
4443,deficiency,13,14,72,82,METHODS AND RESULTS: A panel of colorectal cancers enriched for DNA MMR deficiency was examined by immunohistochemistry to explore the expression levels and localization of various components in the TGF-beta signalling pathway.,16978200_4,0,1,-1,-1,4443,-1,0.00018512868,0.99973315,8.171419e-05
4446,the TGF-beta,29,31,195,207,METHODS AND RESULTS: A panel of colorectal cancers enriched for DNA MMR deficiency was examined by immunohistochemistry to explore the expression levels and localization of various components in the TGF-beta signalling pathway.,16978200_4,-1,-1,-1,-1,4446,-1,6.1001487e-05,0.999926,1.3058597e-05
4452,tumour cell,5,7,31,42,"Increases in Smad4 expression, tumour cell proliferation and TGF-beta secretion each emerged as independent predictors of marked lymphocyte infiltration.",16978200_6,-1,-1,-1,-1,4452,-1,5.6269222e-05,0.000120749886,0.99982303
4453,TGF-beta,9,10,61,69,"Increases in Smad4 expression, tumour cell proliferation and TGF-beta secretion each emerged as independent predictors of marked lymphocyte infiltration.",16978200_6,0,1,-1,-1,4453,-1,0.0025302311,0.99736834,0.0001013489
4459,TGF-beta,12,13,89,97,CONCLUSIONS: These results strongly support the hypothesis that refractoriness to normal TGF-beta signalling in colorectal cancers plays a role in the retention of lymphocytes within tumour epithelium.,16978200_7,0,1,-1,-1,4459,-1,0.00020831624,0.999765,2.6675185e-05
4464,the TGF-beta,11,13,76,88,"Since IEL infiltration is an independent predictor of favourable prognosis, the TGF-beta pathway may represent an important therapeutic target.",16978200_8,-1,-1,-1,-1,4464,-1,4.804088e-05,0.9999403,1.1701165e-05
4465,therapeutic target,18,20,124,142,"Since IEL infiltration is an independent predictor of favourable prognosis, the TGF-beta pathway may represent an important therapeutic target.",16978200_8,-1,-1,-1,-1,4465,-1,6.0864e-06,0.9999895,4.433456e-06
4480,therapy,21,22,133,140,We examined the phosphorylation of STAT5 (P-STAT5) in IL-2-stimulated immune cells of normal subjects and in patients receiving IL-2 therapy using a novel flow cytometric assay to characterize the pattern and level of activation within immune subsets.,17020993_2,0,1,-1,-1,4480,-1,2.13259e-05,0.99996793,1.0789398e-05
4484,blood,5,6,39,44,EXPERIMENTAL DESIGN: Normal peripheral blood mononuclear cells (PBMC) were treated in vitro with IL-2 and analyzed for P-STAT5 using an intracellular flow cytometric assay.,17020993_3,0,1,-1,-1,4484,-1,0.0034071535,0.69036764,0.30622524
4488,STAT5-regulated genes,8,10,56,77,PBMC were simultaneously evaluated for the induction of STAT5-regulated genes at the transcript level.,17020993_4,-1,-1,-1,-1,4488,-1,6.353577e-06,0.9999877,5.914667e-06
4489,the transcript,11,13,81,95,PBMC were simultaneously evaluated for the induction of STAT5-regulated genes at the transcript level.,17020993_4,-1,-1,-1,-1,4489,-1,5.8643927e-06,0.9999887,5.5086193e-06
4492,cell subsets,25,27,159,171,PBMC were also obtained from patients immediately before and 1 hour after treatment with high-dose IL-2 and analyzed for the presence of P-STAT5 within immune cell subsets by dual-variable intracellular flow cytometry.,17020993_5,-1,-1,-1,-1,4492,-1,1.5925973e-05,8.37123e-06,0.9999757
4507,The generation,0,2,0,14,The generation of P-STAT5 within immune cell subsets after the therapeutic administration of IL-2 varied significantly between individuals.,17020993_9,-1,-1,-1,-1,4507,-1,4.7677954e-06,0.9999907,4.544449e-06
4508,cell subsets,6,8,40,52,The generation of P-STAT5 within immune cell subsets after the therapeutic administration of IL-2 varied significantly between individuals.,17020993_9,-1,-1,-1,-1,4508,-1,1.7545712e-05,8.4929225e-06,0.999974
4509,the therapeutic,9,11,59,74,The generation of P-STAT5 within immune cell subsets after the therapeutic administration of IL-2 varied significantly between individuals.,17020993_9,-1,-1,-1,-1,4509,-1,5.8461633e-06,0.9999901,4.078175e-06
4520,to therapy,37,39,199,209,"Surprisingly, activated STAT5 persisted within CD4(+) and CD8(+) T lymphocytes, as well as CD56(+) NK cells, for up to 3 weeks post-IL-2 treatment in three patients who exhibited a clinical response to therapy and in a fourth who exhibited a significant inflammatory response after 11 doses of therapy (first cycle).CONCLUSIONS: The flow cytometric assay described herein is a highly efficient and reliable method by which to assess the cellular response to IL-2 within PBMC and specific immune effector subsets, both in vitro and in the clinical setting.",17020993_11,-1,-1,-1,-1,4520,-1,6.3403063e-06,0.99998724,6.3928383e-06
4521,therapy,53,54,294,301,"Surprisingly, activated STAT5 persisted within CD4(+) and CD8(+) T lymphocytes, as well as CD56(+) NK cells, for up to 3 weeks post-IL-2 treatment in three patients who exhibited a clinical response to therapy and in a fourth who exhibited a significant inflammatory response after 11 doses of therapy (first cycle).CONCLUSIONS: The flow cytometric assay described herein is a highly efficient and reliable method by which to assess the cellular response to IL-2 within PBMC and specific immune effector subsets, both in vitro and in the clinical setting.",17020993_11,0,1,-1,-1,4521,-1,5.323029e-06,0.9999894,5.250153e-06
4525,the cellular,75,77,433,445,"Surprisingly, activated STAT5 persisted within CD4(+) and CD8(+) T lymphocytes, as well as CD56(+) NK cells, for up to 3 weeks post-IL-2 treatment in three patients who exhibited a clinical response to therapy and in a fourth who exhibited a significant inflammatory response after 11 doses of therapy (first cycle).CONCLUSIONS: The flow cytometric assay described herein is a highly efficient and reliable method by which to assess the cellular response to IL-2 within PBMC and specific immune effector subsets, both in vitro and in the clinical setting.",17020993_11,-1,-1,-1,-1,4525,-1,0.004517246,0.47684187,0.5186408
4529,to therapeutic,8,10,50,64,Assessment of P-STAT5 in patient PBMC in response to therapeutic IL-2 administration reveals disparate responses between immune cell subsets as well as interpatient variation.,17020993_12,-1,-1,-1,-1,4529,-1,8.303756e-06,0.999987,4.6425075e-06
4530,cell subsets,17,19,128,140,Assessment of P-STAT5 in patient PBMC in response to therapeutic IL-2 administration reveals disparate responses between immune cell subsets as well as interpatient variation.,17020993_12,-1,-1,-1,-1,4530,-1,1.7540782e-05,8.069664e-06,0.99997437
4538,tumor-infiltrating lymphocytes,6,8,47,77,"Alternatively, adoptive transfer of autologous tumor-infiltrating lymphocytes (TIL) can mediate tumor regression in 50% of lymphodepleted patients, but are logistically and technically difficult to generate.",17056585_1,-1,-1,-1,-1,4538,-1,0.0045089773,0.7571932,0.23829782
4542,to generate,28,30,195,206,"Alternatively, adoptive transfer of autologous tumor-infiltrating lymphocytes (TIL) can mediate tumor regression in 50% of lymphodepleted patients, but are logistically and technically difficult to generate.",17056585_1,-1,-1,-1,-1,4542,-1,1.1041844e-05,0.9999827,6.192437e-06
4547,transfer to,16,18,101,112,"In this study, we evaluated the capability of vaccine-induced PBMC to mediate tumor regression after transfer to patients receiving the same chemotherapy-induced lymphodepletion used for TIL transfer therapy.",17056585_2,-1,-1,-1,-1,4547,-1,4.186074e-06,0.9999913,4.530099e-06
4550,TIL transfer therapy,26,29,187,207,"In this study, we evaluated the capability of vaccine-induced PBMC to mediate tumor regression after transfer to patients receiving the same chemotherapy-induced lymphodepletion used for TIL transfer therapy.",17056585_2,-1,-1,-1,-1,4550,-1,7.449566e-06,0.9999858,6.762458e-06
4552,peptide,20,21,130,137,Autologous PBMC from nine gp100-vaccinated patients with metastatic melanoma were stimulated ex vivo with the gp100:209-217(210M) peptide and transferred in combination with high-dose IL-2 and cancer vaccine.,17056585_3,0,-1,2,-1,4552,-1,0.003841784,0.9919641,0.00419408
4555,peptide-reactive,9,10,54,70,"Transferred PBMC contained highly avid, gp100:209-217 peptide-reactive CD8(+) T cells.",17056585_4,0,-1,2,-1,4555,-1,0.022489803,0.977014,0.000496205
4559,peptide-specific,3,4,14,30,gp100:209-217 peptide-specific CD8(+) T cells persisted at high levels in the blood of all patients and demonstrated significant tumor-specific IFN-gamma secretion in vitro.,17056585_6,0,-1,2,-1,4559,-1,0.0022538546,0.99764097,0.00010522004
4561,the blood,13,15,74,83,gp100:209-217 peptide-specific CD8(+) T cells persisted at high levels in the blood of all patients and demonstrated significant tumor-specific IFN-gamma secretion in vitro.,17056585_6,-1,-1,-1,-1,4561,-1,8.2483e-06,0.99998295,8.775215e-06
4562,tumor-specific IFN-gamma,21,23,129,153,gp100:209-217 peptide-specific CD8(+) T cells persisted at high levels in the blood of all patients and demonstrated significant tumor-specific IFN-gamma secretion in vitro.,17056585_6,-1,-1,-1,-1,4562,-1,0.89336395,0.104622416,0.002013698
4566,cell transfer,12,14,87,100,"These studies demonstrate the feasibility and safety of using vaccine-induced PBMC for cell transfer, but suggests that they are not as effective as TIL in adoptive immunotherapy even when transferred into lymphodepleted hosts.",17056585_8,-1,-1,-1,-1,4566,-1,0.00025920584,0.00059231016,0.9991485
4567,that they,17,19,115,124,"These studies demonstrate the feasibility and safety of using vaccine-induced PBMC for cell transfer, but suggests that they are not as effective as TIL in adoptive immunotherapy even when transferred into lymphodepleted hosts.",17056585_8,-1,-1,-1,-1,4567,-1,5.578488e-06,0.9999896,4.8195125e-06
4571,tumor tissue,4,6,28,40,Cell lines established from tumor tissue of cutaneous melanoma biopsies often display constitutive and IFNgamma-inducible expression of MHC class II molecules.,17067677_0,-1,-1,-1,-1,4571,-1,7.77345e-06,0.9999845,7.7224795e-06
4575,transcription factors that,8,11,50,76,"We have analyzed the DNA elements and interacting transcription factors that control the constitutive and IFNgamma-inducible expression of the class II transactivator (CIITA), a co-activator essential for transcription of all MHC class II genes.",17067677_2,-1,-1,-1,-1,4575,-1,4.231899e-06,0.99999166,4.171764e-06
4590,the IFNgamma,17,19,117,129,"Similarly constitutive activation in melanoma of CIITA-PII, CIITA-PIII, and CIITA-PIV does not require components of the IFNgamma signaling pathway.",17067677_5,-1,-1,-1,-1,4590,-1,0.9457592,0.05073525,0.003505502
4592,to the,7,9,48,54,"However, these components are readily recruited to the PURR and CIITA-PIV after exposure of cells to IFNgamma and account for the IFNgamma-induced expression of CIITA.",17067677_6,-1,-1,-1,-1,4592,-1,6.0629095e-06,0.9999887,5.2882037e-06
4593,cells to IFNgamma,15,18,92,109,"However, these components are readily recruited to the PURR and CIITA-PIV after exposure of cells to IFNgamma and account for the IFNgamma-induced expression of CIITA.",17067677_6,-1,-1,-1,-1,4593,-1,0.84198743,0.0017888093,0.1562237
4594,the IFNgamma-induced,21,23,126,146,"However, these components are readily recruited to the PURR and CIITA-PIV after exposure of cells to IFNgamma and account for the IFNgamma-induced expression of CIITA.",17067677_6,-1,-1,-1,-1,4594,-1,0.29934457,0.69908804,0.0015674277
4597,factors,11,12,68,75,"Together, our data reveal the contribution of distinct elements and factors in the constitutive and IFNgamma-inducible expression of CIITA in melanoma cell lines of the skin.",17067677_7,0,1,-1,-1,4597,-1,5.911978e-06,0.9999888,5.3025865e-06
4609,T-cell,22,23,143,149,Naturally arising CD4(+)CD25(+) regulatory T cells (Tregs) have the potential to suppress aberrant immune responses and to regulate peripheral T-cell homeostasis.,17084366_0,-1,1,2,-1,4609,-1,1.0625215e-05,7.1169734e-06,0.99998224
4610,transplantation,6,7,32,47,"In murine models of bone marrow transplantation, Tregs promote donor bone marrow engraftment and decrease the incidence and severity of graft-versus-host-disease without abrogating the beneficial graft-versus-tumor immunologic effect.",17084366_1,-1,1,2,-1,4610,-1,8.7184935e-06,0.9999832,8.083924e-06
4615,that Tregs,7,9,45,55,"These findings, in concert with observations that Tregs in mice and humans share phenotypic and functional characteristics, have led to active investigations into the use of these cells to decrease complications associated with human hematopoietic cell transplantation.",17084366_2,-1,-1,-1,-1,4615,-1,4.78775e-06,0.9999912,4.076041e-06
4616,functional,16,17,96,106,"These findings, in concert with observations that Tregs in mice and humans share phenotypic and functional characteristics, have led to active investigations into the use of these cells to decrease complications associated with human hematopoietic cell transplantation.",17084366_2,0,1,2,-1,4616,-1,0.0017665465,0.9977139,0.0005194995
4619,these cells to,28,31,174,188,"These findings, in concert with observations that Tregs in mice and humans share phenotypic and functional characteristics, have led to active investigations into the use of these cells to decrease complications associated with human hematopoietic cell transplantation.",17084366_2,-1,-1,-1,-1,4619,-1,0.0025245599,0.5496091,0.4478663
4620,cell transplantation,37,39,248,268,"These findings, in concert with observations that Tregs in mice and humans share phenotypic and functional characteristics, have led to active investigations into the use of these cells to decrease complications associated with human hematopoietic cell transplantation.",17084366_2,-1,-1,-1,-1,4620,-1,0.001953769,0.009280566,0.9887656
4624,to the,15,17,91,97,Early human studies suggest that an imbalance of Tregs and effector T cells may contribute to the development of graft-versus-host-disease.,17084366_3,-1,-1,-1,-1,4624,-1,6.0950265e-06,0.9999887,5.1963075e-06
4637,cell transplantation,25,27,164,184,"In this review, we discuss the current knowledge of Treg biology and the potential therapeutic strategies and barriers of Treg immunotherapy in human hematopoietic cell transplantation.",17084366_5,-1,-1,-1,-1,4637,-1,0.0010350507,0.0060137087,0.9929512
4640,the tumor cells,29,32,165,180,"About 50% of cervical cancers are associated with human papillomavirus type 16 (HPV-16), and since the HPV-16 E6 and E7 oncoproteins are constitutively expressed in the tumor cells, they are attractive targets for cytotoxic T lymphocyte (CTL)-mediated immunotherapy.",17096336_0,-1,-1,-1,-1,4640,-1,0.0015640083,0.7456484,0.2527876
4650,T cells transduced,40,43,227,245,"Using reverse immunological methods, we have generated a CTL clone against the HPV-16 E6(49-57) epitope restricted by HLA-A*2402, which is the most common allele in Japan and relatively frequent worldwide, capable of lysing 293T cells transduced with HLA-A*2402 and HPV-16 E6.",17096336_2,-1,-1,-1,-1,4650,-1,0.0021688913,0.09659638,0.9012347
4654,the cells,18,20,107,116,"Although it was unable to recognize the SiHa cervical cancer cell line positive for HPV-16 and HLA-A*2402, the cells became susceptible to lysis when transduced with E6-E7 genes, which was unexpectedly offset by pretreatment with interferon (IFN)-gamma alone.",17096336_3,-1,-1,-1,-1,4654,-1,3.2787073e-05,9.170779e-05,0.99987555
4667,Tetramer analysis,0,2,0,17,Tetramer analysis further revealed that induction of E6(49-57)-specific T cells was possible in 5 of 7 patients with HPV-16-positive high grade cervical intraepithelial neoplasia or cervical cancer by in vitro stimulation with E6(49-57) peptide.,17096336_6,-1,-1,-1,-1,4667,-1,6.8747504e-06,0.9999876,5.534241e-06
4670,peptide,38,39,237,244,Tetramer analysis further revealed that induction of E6(49-57)-specific T cells was possible in 5 of 7 patients with HPV-16-positive high grade cervical intraepithelial neoplasia or cervical cancer by in vitro stimulation with E6(49-57) peptide.,17096336_6,0,-1,2,-1,4670,-1,0.0015355917,0.9977689,0.00069558003
4680,function,9,10,62,70,"AIM: To determine whether beta-glucosylceramide can alter NKT function in opposite directions, colitis was induced by intracolonic installation of trinitrobenzenesulphonic acid, and hepatocellular carcinoma (HCC) was induced by transplantation of Hep3B cells.",17172586_1,0,1,2,-1,4680,-1,9.327944e-05,0.9987803,0.001126454
4682,transplantation,33,34,228,243,"AIM: To determine whether beta-glucosylceramide can alter NKT function in opposite directions, colitis was induced by intracolonic installation of trinitrobenzenesulphonic acid, and hepatocellular carcinoma (HCC) was induced by transplantation of Hep3B cells.",17172586_1,-1,1,2,-1,4682,-1,6.606432e-06,0.99998903,4.365902e-06
4685,analysis,10,11,75,83,"METHODS: The immunological effect of beta-glucosylceramide was assessed by analysis of intrahepatic and intrasplenic lymphocyte populations, serum cytokines and STAT protein expression.",17172586_2,0,1,-1,-1,4685,-1,1.169229e-05,0.9999808,7.447071e-06
4693,the two,11,13,80,87,The beneficial effects were associated with an opposite immunological effect in the two models: the peripheral:intrahepatic CD4:CD8 lymphocyte ratio increased in the colitis model and decreased in the HCC group.,17172586_4,-1,-1,-1,-1,4693,-1,6.2805216e-06,0.9999889,4.8536785e-06
4711,Proteins,0,1,0,8,Proteins encoded by genes of the SSX family are specifically expressed in tumors and are therefore relevant targets for cancer immunotherapy.,17186289_0,0,1,-1,-1,4711,-1,7.531388e-06,0.99998784,4.654064e-06
4715,therefore relevant targets,15,18,89,115,Proteins encoded by genes of the SSX family are specifically expressed in tumors and are therefore relevant targets for cancer immunotherapy.,17186289_0,-1,-1,-1,-1,4715,-1,6.119055e-06,0.99998844,5.500581e-06
4733,peptides,10,11,51,59,After a single in vitro stimulation with a pool of peptides spanning the entire SSX-1 protein we could detect and isolate SSX-1-specific CD4(+) T cells from 5/5 donors analyzed.,17186289_5,0,-1,2,-1,4733,-1,1.798006e-05,0.99996996,1.2053412e-05
4735,protein,15,16,86,93,After a single in vitro stimulation with a pool of peptides spanning the entire SSX-1 protein we could detect and isolate SSX-1-specific CD4(+) T cells from 5/5 donors analyzed.,17186289_5,0,1,-1,-1,4735,-1,2.140981e-05,0.9999695,9.088701e-06
4738,peptides,8,9,78,86,SSX-1-specific polyclonal populations isolated from these cultures recognized peptides located in three distinct regions of the protein containing clusters of sequences with significant predicted binding to frequently expressed MHC class II alleles.,17186289_6,0,-1,2,-1,4738,-1,0.036792487,0.9617475,0.0014599514
4740,the protein,15,17,124,135,SSX-1-specific polyclonal populations isolated from these cultures recognized peptides located in three distinct regions of the protein containing clusters of sequences with significant predicted binding to frequently expressed MHC class II alleles.,17186289_6,-1,-1,-1,-1,4740,-1,8.47398e-06,0.99998426,7.282401e-06
4755,tumor-specific antigen targets,12,15,74,104,The E6 and E7 oncoproteins expressed in ESCC are considered as attractive tumor-specific antigen targets for immunotherapy.,17202676_1,-1,-1,-1,-1,4755,-1,0.00048717082,0.99943477,7.807581e-05
4756,that the,3,5,17,25,We have reported that the HPV16 mE6delta/mE7/TBhsp70delta fusion protein vaccination induced powerful anti-tumor immunity against TC-1 tumor cells in a C57BL/6 mouse model.,17202676_2,-1,-1,-1,-1,4756,-1,4.2462557e-06,0.9999919,3.874077e-06
4757,protein,8,9,65,72,We have reported that the HPV16 mE6delta/mE7/TBhsp70delta fusion protein vaccination induced powerful anti-tumor immunity against TC-1 tumor cells in a C57BL/6 mouse model.,17202676_2,0,1,-1,-1,4757,-1,9.896466e-06,0.9999845,5.555122e-06
4758,immunity,13,14,113,121,We have reported that the HPV16 mE6delta/mE7/TBhsp70delta fusion protein vaccination induced powerful anti-tumor immunity against TC-1 tumor cells in a C57BL/6 mouse model.,17202676_2,0,-1,2,-1,4758,-1,0.9999021,2.7356298e-05,7.049979e-05
4759,TC-1 tumor cells,15,18,130,146,We have reported that the HPV16 mE6delta/mE7/TBhsp70delta fusion protein vaccination induced powerful anti-tumor immunity against TC-1 tumor cells in a C57BL/6 mouse model.,17202676_2,-1,-1,-1,-1,4759,-1,0.0015381417,0.57491595,0.4235459
4763,protein,14,15,81,88,"In the present study, we further evaluate the protective efficacy of this fusion protein vaccine using an HPV E7-expressing human ESCC cell line (EC9706) and a Hu-PBL-SCID mouse model.",17202676_3,0,1,-1,-1,4763,-1,9.544247e-06,0.999985,5.5321316e-06
4767,protein,7,8,50,57,"We demonstrated that immunization with the fusion protein vaccine caused significant inhibition of tumor growth with the delay time to tumor detection (tests vs. controls, 16 d vs. 9 d, p<0.01) and much smaller tumor size (p<0.01) in vivo.",17202676_4,0,1,-1,-1,4767,-1,1.6613318e-05,0.99997544,7.971035e-06
4770,time to tumor,18,21,127,140,"We demonstrated that immunization with the fusion protein vaccine caused significant inhibition of tumor growth with the delay time to tumor detection (tests vs. controls, 16 d vs. 9 d, p<0.01) and much smaller tumor size (p<0.01) in vivo.",17202676_4,-1,-1,-1,-1,4770,-1,6.2780323e-06,0.9999863,7.459942e-06
4775,protein,15,16,57,64,"The inhibitory rate was ca. 69.6%, and 25% of the fusion protein vaccinated-mice remained tumor free by the end of the experiment (42 d).",17202676_5,0,1,-1,-1,4775,-1,1.710354e-05,0.9999732,9.690606e-06
4781,the tumor,14,16,80,89,"Furthermore, the activated lymphocytes (CD8+) were capable of infiltrating into the tumor site, and much more apoptotic cells along with activation of caspase-3 were observed in the tumors from vaccinated-mice.",17202676_6,-1,-1,-1,-1,4781,-1,3.5839403e-06,0.9999919,4.5601405e-06
4783,the tumors,31,33,178,188,"Furthermore, the activated lymphocytes (CD8+) were capable of infiltrating into the tumor site, and much more apoptotic cells along with activation of caspase-3 were observed in the tumors from vaccinated-mice.",17202676_6,-1,-1,-1,-1,4783,-1,3.7611812e-06,0.9999919,4.332575e-06
4785,TNF-alpha,9,10,49,58,"Also, high expression levels of human IFN-gamma, TNF-alpha, granzyme B and perforin were detected in the tumors from vaccinated-mice.",17202676_7,0,1,-1,-1,4785,-1,0.037525333,0.9618492,0.0006254253
4786,the tumors,18,20,101,111,"Also, high expression levels of human IFN-gamma, TNF-alpha, granzyme B and perforin were detected in the tumors from vaccinated-mice.",17202676_7,-1,-1,-1,-1,4786,-1,4.3550913e-06,0.9999912,4.4930366e-06
4788,that the,4,6,24,32,"Therefore, we concluded that the HPV16 mE6delta/mE7/TBhsp70delta fusion protein vaccine is able to stimulate cellular-mediated immune response against E7-containing ESCC cells through CD8+-dependent CTL-induced apoptosis in Hu-PBL-SCID mice.",17202676_8,-1,-1,-1,-1,4788,-1,4.118135e-06,0.99999154,4.3037385e-06
4789,protein,9,10,72,79,"Therefore, we concluded that the HPV16 mE6delta/mE7/TBhsp70delta fusion protein vaccine is able to stimulate cellular-mediated immune response against E7-containing ESCC cells through CD8+-dependent CTL-induced apoptosis in Hu-PBL-SCID mice.",17202676_8,0,1,-1,-1,4789,-1,1.1815017e-05,0.99998164,6.5337263e-06
4791,cellular-mediated immune response,15,18,109,142,"Therefore, we concluded that the HPV16 mE6delta/mE7/TBhsp70delta fusion protein vaccine is able to stimulate cellular-mediated immune response against E7-containing ESCC cells through CD8+-dependent CTL-induced apoptosis in Hu-PBL-SCID mice.",17202676_8,-1,-1,-1,-1,4791,-1,0.20835678,0.00119256,0.7904507
4792,cells through,21,23,170,183,"Therefore, we concluded that the HPV16 mE6delta/mE7/TBhsp70delta fusion protein vaccine is able to stimulate cellular-mediated immune response against E7-containing ESCC cells through CD8+-dependent CTL-induced apoptosis in Hu-PBL-SCID mice.",17202676_8,-1,-1,-1,-1,4792,-1,0.0029583003,0.170665,0.82637674
4798,tolerance to,22,24,144,156,BACKGROUND: A wealth of evidence obtained using mouse models indicates that CD4(+)CD25(+)FOXP3(+) regulatory T cells (Treg) maintain peripheral tolerance to self-antigens and also inhibit anti-tumor immune responses.,17205133_0,-1,-1,-1,-1,4798,-1,8.777124e-06,0.9999831,8.150681e-06
4806,tumor-associated antigen,10,12,44,68,We set out to measure T cell responses to a tumor-associated antigen and examine whether Treg impinge on those anti-tumor immune responses in CRC patients.,17205133_2,-1,-1,-1,-1,4806,-1,0.3201891,0.67509145,0.0047194213
4812,blood,10,11,67,72,An increased frequency of Treg was demonstrated in both peripheral blood and mesenteric lymph nodes of patients with colorectal cancer (CRC) compared with either healthy controls or patients with inflammatory bowel disease (IBD).,17205133_4,0,1,-1,-1,4812,-1,0.0015634665,0.92064804,0.07778851
4814,blood,5,6,34,39,"Depletion of Treg from peripheral blood mononuclear cells (PBMC) of CRC patients unmasked CD4(+) T cell responses, as observed by IFNgamma release, to the tumor associated antigen 5T4, whereas no effect was observed in a healthy age-matched control group.",17205133_5,0,1,-1,-1,4814,-1,0.00026917618,0.99898463,0.00074613385
4817,IFNgamma release,24,26,130,146,"Depletion of Treg from peripheral blood mononuclear cells (PBMC) of CRC patients unmasked CD4(+) T cell responses, as observed by IFNgamma release, to the tumor associated antigen 5T4, whereas no effect was observed in a healthy age-matched control group.",17205133_5,-1,-1,-1,-1,4817,-1,0.99909854,0.00047701356,0.00042452168
4818,to the tumor,27,30,148,160,"Depletion of Treg from peripheral blood mononuclear cells (PBMC) of CRC patients unmasked CD4(+) T cell responses, as observed by IFNgamma release, to the tumor associated antigen 5T4, whereas no effect was observed in a healthy age-matched control group.",17205133_5,-1,-1,-1,-1,4818,-1,1.0280686e-05,0.9999821,7.651975e-06
4821,that Treg,7,9,63,72,"CONCLUSIONS/SIGNIFICANCE: Collectively, these data demonstrate that Treg capable of inhibiting tumor associated antigen-specific immune responses are enriched in patients with CRC.",17205133_6,-1,-1,-1,-1,4821,-1,6.0264447e-06,0.99998903,4.956896e-06
4823,antigen-specific immune responses,14,17,112,145,"CONCLUSIONS/SIGNIFICANCE: Collectively, these data demonstrate that Treg capable of inhibiting tumor associated antigen-specific immune responses are enriched in patients with CRC.",17205133_6,-1,-1,-1,-1,4823,-1,0.99996984,5.540501e-06,2.4629793e-05
4825,Treg to,7,9,51,58,These results support a rationale for manipulating Treg to enhance cancer immunotherapy.,17205133_7,-1,-1,-1,-1,4825,-1,5.046304e-06,0.9999896,5.329227e-06
4827,T-cell,12,13,89,95,Cancer patients often exhibit loss of proper cell-mediated immunity and reduced effector T-cell population in the circulation.,17210719_0,-1,1,2,-1,4827,-1,1.12204425e-05,8.355725e-06,0.99998045
4829,Thymus,0,1,0,6,"Thymus is a major site of T-cell maturation, and tumors induce thymic atrophy to evade cellular immune response.",17210719_1,-1,1,2,-1,4829,-1,1.3313203e-05,0.99997985,6.866749e-06
4830,T-cell,6,7,26,32,"Thymus is a major site of T-cell maturation, and tumors induce thymic atrophy to evade cellular immune response.",17210719_1,-1,1,2,-1,4830,-1,1.1286313e-05,6.544531e-06,0.9999821
4834,cellular immune response,16,19,87,111,"Thymus is a major site of T-cell maturation, and tumors induce thymic atrophy to evade cellular immune response.",17210719_1,-1,-1,-1,-1,4834,-1,0.86771566,0.0003171321,0.1319672
4841,that tumor-induced,14,16,81,99,"In an effort to delineate the mechanisms behind such thymic atrophy, we observed that tumor-induced oxidative stress played a critical role, as it perturbed nuclear factor-kappaB (NF-kappaB) activity.",17210719_3,-1,-1,-1,-1,4841,-1,1.3982089e-05,0.99997807,8.00785e-06
4849,thymic T cells,13,16,123,137,Tumor-induced oxidative stress increased cytosolic IkappaBalpha retention and inhibited NF-kappaB nuclear translocation in thymic T cells.,17210719_4,-1,-1,-1,-1,4849,-1,0.0027643903,0.7076955,0.2895401
4850,These NF-kappaB-perturbed cells,0,3,0,31,These NF-kappaB-perturbed cells became vulnerable to tumor-secreted tumor necrosis factor (TNF)-alpha (TNF-alpha)-mediated apoptosis through the activation of TNF receptor-associated protein death domain-associated Fas-associated protein death domain and caspase-8.,17210719_5,-1,-1,-1,-1,4850,-1,0.0012343555,0.9395454,0.059220284
4851,to tumor-secreted tumor necrosis factor,5,10,50,89,These NF-kappaB-perturbed cells became vulnerable to tumor-secreted tumor necrosis factor (TNF)-alpha (TNF-alpha)-mediated apoptosis through the activation of TNF receptor-associated protein death domain-associated Fas-associated protein death domain and caspase-8.,17210719_5,-1,-1,-1,-1,4851,-1,0.38492274,0.6081896,0.006887709
4852,through the,13,15,133,144,These NF-kappaB-perturbed cells became vulnerable to tumor-secreted tumor necrosis factor (TNF)-alpha (TNF-alpha)-mediated apoptosis through the activation of TNF receptor-associated protein death domain-associated Fas-associated protein death domain and caspase-8.,17210719_5,-1,-1,-1,-1,4852,-1,4.318968e-06,0.99999154,4.1483727e-06
4853,TNF receptor-associated protein,17,20,159,190,These NF-kappaB-perturbed cells became vulnerable to tumor-secreted tumor necrosis factor (TNF)-alpha (TNF-alpha)-mediated apoptosis through the activation of TNF receptor-associated protein death domain-associated Fas-associated protein death domain and caspase-8.,17210719_5,-1,-1,-1,-1,4853,-1,4.156083e-05,0.99992156,3.6911e-05
4854,protein,23,24,230,237,These NF-kappaB-perturbed cells became vulnerable to tumor-secreted tumor necrosis factor (TNF)-alpha (TNF-alpha)-mediated apoptosis through the activation of TNF receptor-associated protein death domain-associated Fas-associated protein death domain and caspase-8.,17210719_5,0,1,-1,-1,4854,-1,1.2059668e-05,0.9999739,1.4097203e-05
4855,TNF-alpha-depleted tumor,2,4,15,39,"Interestingly, TNF-alpha-depleted tumor supernatants, either by antibody neutralization or by TNF-alpha-small interfering RNA transfection of tumor cells, were unable to kill T cell effectively.",17210719_6,-1,-1,-1,-1,4855,-1,1.983052e-05,0.9999683,1.18964235e-05
4856,TNF-alpha-small,12,13,94,109,"Interestingly, TNF-alpha-depleted tumor supernatants, either by antibody neutralization or by TNF-alpha-small interfering RNA transfection of tumor cells, were unable to kill T cell effectively.",17210719_6,0,1,-1,-1,4856,-1,4.174111e-05,0.99993646,2.180477e-05
4858,tumor cells,17,19,142,153,"Interestingly, TNF-alpha-depleted tumor supernatants, either by antibody neutralization or by TNF-alpha-small interfering RNA transfection of tumor cells, were unable to kill T cell effectively.",17210719_6,-1,-1,-1,-1,4858,-1,5.0137543e-05,0.0001851813,0.9997646
4863,the cells,8,10,48,57,"When T cells were overexpressed with NF-kappaB, the cells became resistant to tumor-induced apoptosis.",17210719_7,-1,-1,-1,-1,4863,-1,1.603682e-05,1.5794894e-05,0.99996805
4864,to tumor-induced,12,14,75,91,"When T cells were overexpressed with NF-kappaB, the cells became resistant to tumor-induced apoptosis.",17210719_7,-1,-1,-1,-1,4864,-1,8.200885e-06,0.99998367,8.080251e-06
4868,the cells,16,18,113,122,"In contrast, when degradation-defective IkappaBalpha (IkappaBalpha super-repressor) was introduced into T cells, the cells became more vulnerable, indicating that inhibition of NF-kappaB is the reason behind such tumor/TNF-alpha-mediated apoptosis.",17210719_8,-1,-1,-1,-1,4868,-1,1.9036215e-05,3.0497751e-05,0.9999504
4872,tumor-induced thymic,3,5,23,43,Curcumin could prevent tumor-induced thymic atrophy by restoring the activity of NF-kappaB. Further investigations suggest that neutralization of tumor-induced oxidative stress and restoration of NF-kappaB activity along with the reeducation of the TNF-alpha signaling pathway can be the mechanism behind curcumin-mediated thymic protection.,17210719_9,-1,-1,-1,-1,4872,-1,1.4011852e-05,0.9999788,7.1657805e-06
4878,the TNF-alpha,31,33,245,258,Curcumin could prevent tumor-induced thymic atrophy by restoring the activity of NF-kappaB. Further investigations suggest that neutralization of tumor-induced oxidative stress and restoration of NF-kappaB activity along with the reeducation of the TNF-alpha signaling pathway can be the mechanism behind curcumin-mediated thymic protection.,17210719_9,-1,-1,-1,-1,4878,-1,0.0028490524,0.9970427,0.00010817893
4891,immunity,15,16,101,109,"However, Tregs can also interfere with beneficial immune responses such as anti-tumor and anti-viral immunity in humans and rodents.",17224188_1,0,-1,2,-1,4891,-1,0.99984074,5.2704236e-05,0.00010651777
4894,that they play,10,13,52,66,"Given the overall importance of Tregs, it is likely that they play an important role in diseases of dogs as well.",17224188_2,-1,-1,-1,-1,4894,-1,8.29485e-06,0.9999858,5.9089393e-06
4905,T cells in blood,13,17,76,92,We found that a cross-reactive FoxP3 antibody identified a subset of CD4(+) T cells in blood and lymph nodes of dogs.,17224188_5,-1,-1,-1,-1,4905,-1,0.0015806574,0.0118137365,0.9866056
4909,in blood,17,19,88,96,By flow cytometry the mean percentage of FoxP3(+)CD4(+) T cells in normal dogs was 4.3% in blood and 9.8% in the lymph nodes.,17224188_6,0,1,-1,-1,4909,-1,9.6508295e-05,0.999742,0.00016149448
4912,Treg in blood,13,16,68,81,"In dogs with cancer, there was a significant increase in numbers of Treg in blood (7.5%) and tumor-draining lymph nodes (17.1%) compared to age-matched healthy control dogs.",17224188_7,-1,-1,-1,-1,4912,-1,2.2424343e-05,0.9999378,3.98109e-05
4915,that FoxP3(+)CD4(+,3,5,14,32,We also found that FoxP3(+)CD4(+) T cells in dogs could be significantly expanded in vitro by TCR activation together with addition of TGF-beta and IL-2.,17224188_8,-1,-1,-1,-1,4915,-1,0.00069462956,0.9987972,0.000508157
4917,TCR,17,18,94,97,We also found that FoxP3(+)CD4(+) T cells in dogs could be significantly expanded in vitro by TCR activation together with addition of TGF-beta and IL-2.,17224188_8,-1,1,2,-1,4917,-1,1.6167573e-05,0.9999571,2.6777736e-05
4919,TGF-beta,23,24,135,143,We also found that FoxP3(+)CD4(+) T cells in dogs could be significantly expanded in vitro by TCR activation together with addition of TGF-beta and IL-2.,17224188_8,0,1,-1,-1,4919,-1,1.7519598e-05,0.9999752,7.329504e-06
4920,Treated cells,0,2,0,13,Treated cells also significantly increased expression of TGF-beta and IL-10mRNA.,17224188_9,-1,-1,-1,-1,4920,-1,6.8765105e-05,0.00027455593,0.9996567
4921,TGF-beta,7,8,57,65,Treated cells also significantly increased expression of TGF-beta and IL-10mRNA.,17224188_9,0,1,-1,-1,4921,-1,2.967693e-05,0.9999597,1.0672614e-05
4928,that this,19,21,110,119,We conclude from these studies that a cross-reactive FoxP3 antibody can be used to identify Tregs in dogs and that this reagent may serve as a useful tool for investigating the role of Treg in a variety of diseases of dogs.,17224188_10,-1,-1,-1,-1,4928,-1,4.058419e-06,0.999992,3.941666e-06
4943,transfer to naive,2,5,15,32,"After adoptive transfer to naive recipients, CD11b(+)Gr-1(+) MSCs freshly isolated from spleens of tumor-bearing mice but not naive mice were able to inhibit NK cell cytotoxicity.",17244679_2,-1,-1,-1,-1,4943,-1,5.7693296e-06,0.99998975,4.48236e-06
4949,analysis,4,5,19,27,An in vivo imaging analysis indicates that the removal of tumors resulted in a significant increased ability (P < .05) in NK cell cytotoxicity to eliminate injected YAC-1 cells from the lungs.,17244679_3,0,1,-1,-1,4949,-1,5.0927647e-06,0.9999895,5.347177e-06
4950,that the,6,8,38,46,An in vivo imaging analysis indicates that the removal of tumors resulted in a significant increased ability (P < .05) in NK cell cytotoxicity to eliminate injected YAC-1 cells from the lungs.,17244679_3,-1,-1,-1,-1,4950,-1,4.0771006e-06,0.9999918,4.1168128e-06
4957,analysis,6,7,42,50,Fluorescence-activated cell sorter (FACS) analysis of the composition of lung leukocytes further indicates that the removal of tumors also leads to the reduction of MSCs accumulated in the lung.,17244679_4,0,1,-1,-1,4957,-1,8.431785e-06,0.99998486,6.743177e-06
4959,that the,15,17,107,115,Fluorescence-activated cell sorter (FACS) analysis of the composition of lung leukocytes further indicates that the removal of tumors also leads to the reduction of MSCs accumulated in the lung.,17244679_4,-1,-1,-1,-1,4959,-1,4.911146e-06,0.99999094,4.1427875e-06
4961,to the,22,24,145,151,Fluorescence-activated cell sorter (FACS) analysis of the composition of lung leukocytes further indicates that the removal of tumors also leads to the reduction of MSCs accumulated in the lung.,17244679_4,-1,-1,-1,-1,4961,-1,4.7790822e-06,0.9999912,4.0860627e-06
4965,that MSCs,3,5,19,28,These data suggest that MSCs suppress NK cell cytotoxicity.,17244679_5,-1,-1,-1,-1,4965,-1,1.3442636e-05,0.9999782,8.42321e-06
4971,that MSCs,5,7,39,48,Western blot analyses further suggests that MSCs suppress IL-2-mediated NK cell cytotoxicity by affecting the activity of Stat5.,17244679_8,-1,-1,-1,-1,4971,-1,8.253904e-06,0.9999858,5.976289e-06
4975,T-cell,1,2,6,12,"Adult T-cell leukemia/lymphoma (ATLL) patients are highly immunocompromised, but the underlying mechanism responsible for this state remains obscure.",17278106_0,-1,1,2,-1,4975,-1,1.8575623e-05,1.3649081e-05,0.9999677
4977,this state,17,19,122,132,"Adult T-cell leukemia/lymphoma (ATLL) patients are highly immunocompromised, but the underlying mechanism responsible for this state remains obscure.",17278106_0,-1,-1,-1,-1,4977,-1,7.016101e-06,0.9999876,5.3492886e-06
4978,that FOXP3,3,5,28,38,"Recent studies demonstrated that FOXP3, which is a master control gene of naturally occurring regulatory T (Treg) cells, is expressed in the tumor cells from a subset of patients with ATLL.",17278106_1,-1,-1,-1,-1,4978,-1,4.5261254e-06,0.9999912,4.235717e-06
4984,the tumor cells,25,28,137,152,"Recent studies demonstrated that FOXP3, which is a master control gene of naturally occurring regulatory T (Treg) cells, is expressed in the tumor cells from a subset of patients with ATLL.",17278106_1,-1,-1,-1,-1,4984,-1,0.001655655,0.62583476,0.37250963
4987,these tumors,10,12,49,61,"Since most ATLL cells express both CD4 and CD25, these tumors might originate from CD4(+)CD25(+)FOXP3(+) Treg cells, based on their phenotypic characteristics.",17278106_2,-1,-1,-1,-1,4987,-1,4.4406e-06,0.9999908,4.762429e-06
4991,function,6,7,37,45,"However, whether ATLL cells actually function as Treg cells has not yet been clearly demonstrated.",17278106_3,0,1,2,-1,4991,-1,0.0016920755,0.9973521,0.00095578976
4996,to T-cell receptor-mediated,16,19,85,112,"Here, we show that ATLL cells from a subset of patients are not only hypo-responsive to T-cell receptor-mediated activation, but also suppress the proliferation of autologous CD4(+) non-ATLL cells.",17278106_4,-1,-1,-1,-1,4996,-1,0.005156238,0.24682088,0.74802285
5000,this subset,5,7,29,40,"Furthermore, ATLL cells from this subset of patients secrete only small amounts of IFN-gamma, and suppress IFN-gamma production by autologous CD4(+) non-ATLL cells.",17278106_5,-1,-1,-1,-1,5000,-1,0.0017335429,0.40933746,0.588929
5009,function,14,15,75,83,These are the first data showing that ATLL cells from a subset of patients function as Treg cells in an autologous setting.,17278106_6,0,1,2,-1,5009,-1,0.00020819741,0.99967325,0.00011856544
5025,chemokine release,23,25,147,164,In the present study we investigated the effects of various chemokines on proliferation of acute myelogenous leukemia (AML) cells and constitutive chemokine release by primary AML cells.,17339182_1,-1,-1,-1,-1,5025,-1,0.9926393,0.006431039,0.0009295783
5030,chemokine receptor,13,15,87,105,"We investigated AML cell proliferation (3H-thymidine incorporation, colony formation), chemokine receptor expression, constitutive chemokine release and chemotaxis of normal peripheral blood mononuclear cells.",17339182_3,-1,-1,-1,-1,5030,-1,0.99030054,5.49783e-05,0.009644516
5031,chemokine release,18,20,131,148,"We investigated AML cell proliferation (3H-thymidine incorporation, colony formation), chemokine receptor expression, constitutive chemokine release and chemotaxis of normal peripheral blood mononuclear cells.",17339182_3,-1,-1,-1,-1,5031,-1,0.9972149,0.0020057817,0.00077921944
5033,blood,25,26,185,190,"We investigated AML cell proliferation (3H-thymidine incorporation, colony formation), chemokine receptor expression, constitutive chemokine release and chemotaxis of normal peripheral blood mononuclear cells.",17339182_3,0,1,-1,-1,5033,-1,0.0032109192,0.9923637,0.0044253436
5038,factor-dependent,26,27,167,183,"RESULTS: Exogenous chemokines usually did not have any effect on AML blast proliferation in the absence of hematopoietic growth factors, but when investigating growth factor-dependent (interleukin 3 + granulocyte-macrophage colony-stimulating factor + stem cell factor) proliferation in suspension cultures the following patient subsets were identified: (i) patients whose cells showed chemokine-induced growth enhancement (8 patients); (ii) divergent effects on proliferation (15 patients); and (iii) no effect (most patients).",17339182_4,0,1,-1,-1,5038,-1,0.999895,2.4247654e-05,8.083815e-05
5048,chemokine receptor,7,9,40,58,"These patient subsets did not differ in chemokine receptor expression, but, compared to CD34- AML cells, CD34+ cells showed higher expression of several receptors.",17339182_5,-1,-1,-1,-1,5048,-1,0.99245137,5.401806e-05,0.0074945027
5052,receptors,27,28,153,162,"These patient subsets did not differ in chemokine receptor expression, but, compared to CD34- AML cells, CD34+ cells showed higher expression of several receptors.",17339182_5,0,1,2,-1,5052,-1,0.00035926586,8.875593e-05,0.99955195
5058,chemokine release,5,7,34,51,"Furthermore, a broad constitutive chemokine release profile was detected for most patients, and the following chemokine clusters could be identified: CCL2-4/CXCL1/8, CCL5/CXCL9-11 (possibly also CCL23) and CCL13/17/22/24/CXCL5 (possibly also CXCL6).",17339182_7,-1,-1,-1,-1,5058,-1,0.99819165,0.0012763375,0.00053197803
5062,CXCL6,40,41,242,247,"Furthermore, a broad constitutive chemokine release profile was detected for most patients, and the following chemokine clusters could be identified: CCL2-4/CXCL1/8, CCL5/CXCL9-11 (possibly also CCL23) and CCL13/17/22/24/CXCL5 (possibly also CXCL6).",17339182_7,-1,-1,-1,-1,5062,-1,0.99990284,1.1723188e-05,8.541421e-05
5063,the CCL2,1,3,5,13,Only the CCL2-4/CXCL1/8 cluster showed significant correlations between corresponding mRNA levels and NFkB levels/activation.,17339182_8,-1,-1,-1,-1,5063,-1,0.27913448,0.7178251,0.0030403675
5065,The chemotaxis,0,2,0,14,The chemotaxis of normal immunocompetent cells for patients without constitutive chemokine release was observed to be decreased.,17339182_9,-1,-1,-1,-1,5065,-1,0.8606052,0.1372948,0.002100012
5067,chemokine release,10,12,81,98,The chemotaxis of normal immunocompetent cells for patients without constitutive chemokine release was observed to be decreased.,17339182_9,-1,-1,-1,-1,5067,-1,0.9915531,0.0070946375,0.0013522125
5070,chemokine release,11,13,83,100,INTERPRETATION AND CONCLUSIONS: Differences in chemokine responsiveness as well as chemokine release contribute to patient heterogeneity in AML.,17339182_10,-1,-1,-1,-1,5070,-1,0.9958774,0.0033295816,0.00079303177
5073,to their chemokine,10,13,68,86,Patients with AML can be classified into distinct subsets according to their chemokine responsiveness and chemokine release profile.,17339182_11,-1,-1,-1,-1,5073,-1,0.20254552,0.7929666,0.0044878516
5074,chemokine release,15,17,106,123,Patients with AML can be classified into distinct subsets according to their chemokine responsiveness and chemokine release profile.,17339182_11,-1,-1,-1,-1,5074,-1,0.99799025,0.0014687479,0.00054090604
5079,therapeutic type,23,25,122,138,Regulatory T cells can suppress activated CD4+ and CD8+ T effector cells and may serve as an impediment to spontaneous or therapeutic type 1 antitumor immunity.,17339434_0,-1,-1,-1,-1,5079,-1,5.5594346e-06,0.99999,4.4220997e-06
5080,immunity,27,28,151,159,Regulatory T cells can suppress activated CD4+ and CD8+ T effector cells and may serve as an impediment to spontaneous or therapeutic type 1 antitumor immunity.,17339434_0,0,-1,2,-1,5080,-1,0.9998091,4.151868e-05,0.00014944494
5088,that this cytokine,6,9,23,41,"In this study, we show that this cytokine regimen also results in the profound enhancement of CD4+ tumor-infiltrating lymphocytes (TIL) expressing FoxP3, IL-10, and TGF-beta mRNA, with 50 or 90% of CD4+ TIL coexpressing the CD25 and glucocorticoid-induced TNFR family related molecules, respectively.",17339434_2,-1,-1,-1,-1,5088,-1,0.107411794,0.8901859,0.002402348
5090,tumor-infiltrating lymphocytes,19,21,99,129,"In this study, we show that this cytokine regimen also results in the profound enhancement of CD4+ tumor-infiltrating lymphocytes (TIL) expressing FoxP3, IL-10, and TGF-beta mRNA, with 50 or 90% of CD4+ TIL coexpressing the CD25 and glucocorticoid-induced TNFR family related molecules, respectively.",17339434_2,-1,-1,-1,-1,5090,-1,0.0035246294,0.7807542,0.2157212
5094,TGF-beta,30,31,165,173,"In this study, we show that this cytokine regimen also results in the profound enhancement of CD4+ tumor-infiltrating lymphocytes (TIL) expressing FoxP3, IL-10, and TGF-beta mRNA, with 50 or 90% of CD4+ TIL coexpressing the CD25 and glucocorticoid-induced TNFR family related molecules, respectively.",17339434_2,0,1,-1,-1,5094,-1,0.00035374673,0.9996182,2.8111162e-05
5097,TNFR,47,48,256,260,"In this study, we show that this cytokine regimen also results in the profound enhancement of CD4+ tumor-infiltrating lymphocytes (TIL) expressing FoxP3, IL-10, and TGF-beta mRNA, with 50 or 90% of CD4+ TIL coexpressing the CD25 and glucocorticoid-induced TNFR family related molecules, respectively.",17339434_2,0,1,-1,-1,5097,-1,8.540132e-06,0.9999851,6.317942e-06
5099,Foxp3 protein,3,5,27,40,"Intracellular staining for Foxp3 protein revealed that combined treatment with rFL plus rGM-CSF results in a significant increase in CD4+Foxp3+ T cells in the spleen of both control and tumor-bearing mice, and that nearly half of CD4+ TIL expressed this marker.",17339434_3,-1,-1,-1,-1,5099,-1,4.899884e-06,0.9999907,4.442002e-06
5109,TIL cells,5,7,18,27,"In addition, CD4+ TIL cells were of an activated/memory (ICOS(high)CD62L(low)CD45RB(low)) phenotype and were capable of suppressing allospecific T cell proliferation and IFN-gamma production from (in vivo cross-primed) anti-CMS4 CD8+ T cells in vitro, via a mechanism at least partially dependent on IL-10 and TGF-beta.",17339434_4,-1,-1,-1,-1,5109,-1,8.739179e-06,5.238277e-06,0.99998605
5114,TGF-beta,52,53,310,318,"In addition, CD4+ TIL cells were of an activated/memory (ICOS(high)CD62L(low)CD45RB(low)) phenotype and were capable of suppressing allospecific T cell proliferation and IFN-gamma production from (in vivo cross-primed) anti-CMS4 CD8+ T cells in vitro, via a mechanism at least partially dependent on IL-10 and TGF-beta.",17339434_4,0,1,-1,-1,5114,-1,3.8018516e-05,0.99995196,1.0058171e-05
5118,therapy-induced,21,22,115,130,"Importantly, in vivo depletion of CD4+ T cells resulted in the ability of previously ineffective, rFL plus rGM-CSF therapy-induced CD8+ T cells to now mediate tumor regression.",17339434_5,0,1,-1,-1,5118,-1,0.00010577,0.9998653,2.893864e-05
5119,T cells to,24,27,136,146,"Importantly, in vivo depletion of CD4+ T cells resulted in the ability of previously ineffective, rFL plus rGM-CSF therapy-induced CD8+ T cells to now mediate tumor regression.",17339434_5,-1,-1,-1,-1,5119,-1,0.0012197333,0.03388631,0.964894
5126,to TGF-beta,1,3,8,19,"Similar to TGF-beta, the low MWF (<50kDa) of supernatant derived from SKOV3 could convert part of freshly isolated CD4(+)CD25(-) T cells into CD25(+) population with similar characters as natural CD4(+)CD25(+) regulatory T cells.",17353088_2,-1,-1,-1,-1,5126,-1,3.244236e-05,0.99995947,8.119025e-06
5132,TGF-beta,2,3,11,19,To deplete TGF-beta in the low MWF by neutralizing anti-TGF-beta would eliminate this transformation phenomenon.,17353088_3,0,1,-1,-1,5132,-1,0.0014406273,0.9984951,6.4228356e-05
5134,this transformation,12,14,81,100,To deplete TGF-beta in the low MWF by neutralizing anti-TGF-beta would eliminate this transformation phenomenon.,17353088_3,-1,-1,-1,-1,5134,-1,5.60694e-06,0.99999,4.454335e-06
5136,that TGF-beta,3,5,23,36,"These results indicate that TGF-beta secreted by ovarian carcinoma cells owns vital function in the process of converting peripheral CD4(+)CD25(-) T cells into CD4(+)CD25(+) regulatory T cells, which may provide one immunotherapeutic target for ovarian cancer.",17353088_4,-1,-1,-1,-1,5136,-1,4.189097e-05,0.99994874,9.3589315e-06
5138,function,12,13,84,92,"These results indicate that TGF-beta secreted by ovarian carcinoma cells owns vital function in the process of converting peripheral CD4(+)CD25(-) T cells into CD4(+)CD25(+) regulatory T cells, which may provide one immunotherapeutic target for ovarian cancer.",17353088_4,0,1,2,-1,5138,-1,0.0022693805,0.9850617,0.012668977
5144,protein,11,12,67,74,Sequence variation in the Epstein-Barr virus (EBV) latent membrane protein 1 (LMP1) oncogene structure may affect antigen-presenting cell (APC) function of infected B cells and immune escape by EBV-specific T cells and thus contribute to the development of malignancy.,17372611_0,0,1,-1,-1,5144,-1,5.785085e-05,0.9998373,0.000104900115
5145,antigen-presenting cell,20,22,114,137,Sequence variation in the Epstein-Barr virus (EBV) latent membrane protein 1 (LMP1) oncogene structure may affect antigen-presenting cell (APC) function of infected B cells and immune escape by EBV-specific T cells and thus contribute to the development of malignancy.,17372611_0,-1,-1,-1,-1,5145,-1,0.4667891,0.00025471978,0.5329562
5146,function,25,26,144,152,Sequence variation in the Epstein-Barr virus (EBV) latent membrane protein 1 (LMP1) oncogene structure may affect antigen-presenting cell (APC) function of infected B cells and immune escape by EBV-specific T cells and thus contribute to the development of malignancy.,17372611_0,0,1,2,-1,5146,-1,0.00014337008,0.00039994795,0.9994567
5150,to the,40,42,235,241,Sequence variation in the Epstein-Barr virus (EBV) latent membrane protein 1 (LMP1) oncogene structure may affect antigen-presenting cell (APC) function of infected B cells and immune escape by EBV-specific T cells and thus contribute to the development of malignancy.,17372611_0,-1,-1,-1,-1,5150,-1,4.8351963e-06,0.9999894,5.787529e-06
5153,function through,11,13,62,78,"Normal B cell-associated LMP1 (B-LMP1) upregulates B cell APC function through activation of the necrosis factor (NF)-kappaB subunit, RelB. We examined the ability of B-LMP1 and a nasopharyngeal carcinoma-associated LMP1 (NPC-LMP1) to modulate B cell APC function and T-cell responses.",17372611_1,-1,-1,-1,-1,5153,-1,5.6621728e-05,0.9997614,0.0001819667
5155,factor,17,18,106,112,"Normal B cell-associated LMP1 (B-LMP1) upregulates B cell APC function through activation of the necrosis factor (NF)-kappaB subunit, RelB. We examined the ability of B-LMP1 and a nasopharyngeal carcinoma-associated LMP1 (NPC-LMP1) to modulate B cell APC function and T-cell responses.",17372611_1,0,1,-1,-1,5155,-1,0.9999436,7.6113306e-06,4.8719507e-05
5161,function,41,42,255,263,"Normal B cell-associated LMP1 (B-LMP1) upregulates B cell APC function through activation of the necrosis factor (NF)-kappaB subunit, RelB. We examined the ability of B-LMP1 and a nasopharyngeal carcinoma-associated LMP1 (NPC-LMP1) to modulate B cell APC function and T-cell responses.",17372611_1,0,1,2,-1,5161,-1,0.00073181593,0.09742388,0.9018443
5162,T-cell,43,44,268,274,"Normal B cell-associated LMP1 (B-LMP1) upregulates B cell APC function through activation of the necrosis factor (NF)-kappaB subunit, RelB. We examined the ability of B-LMP1 and a nasopharyngeal carcinoma-associated LMP1 (NPC-LMP1) to modulate B cell APC function and T-cell responses.",17372611_1,-1,1,2,-1,5162,-1,2.7578479e-05,1.0318415e-05,0.9999621
5163,cells transfected,2,4,11,28,B lymphoma cells transfected with NPC-LMP1 stimulated resting T cells in mixed lymphocyte reaction less efficiently than B-LMP1 transfectants.,17372611_2,-1,-1,-1,-1,5163,-1,0.0021899387,0.16105786,0.8367522
5172,regulatory T-cell function,16,19,97,123,"Unexpectedly, antigen presentation to CD4(+) T helper cells was reduced owing to potentiation of regulatory T-cell function by NPC-LMP1 transfectants, which produce increased levels of interleukin-10, rendering CD4(+) T cells hyporesponsive.",17372611_3,-1,-1,-1,-1,5172,-1,1.4879286e-05,1.2760836e-05,0.99997234
5189,the cellular,2,4,9,21,"However, the cellular lineage and mechanism of FOXP3 induction in CD8 T cells remain unclear.",17414320_1,-1,-1,-1,-1,5189,-1,0.0026776695,0.5277537,0.4695686
5192,that interleukin-2,4,6,21,39,"Here, we demonstrate that interleukin-2 (IL-2) induces FOXP3 expression in OKT3-stimulated or antigen-stimulated CD8 T cells, indicating that FOXP3 expression is neither limited to a unique subset of CD8 T cells nor dependent on the mode of T-cell receptor stimulation.",17414320_2,-1,-1,-1,-1,5192,-1,0.9293295,0.06909528,0.0015751631
5196,that FOXP3,21,23,137,147,"Here, we demonstrate that interleukin-2 (IL-2) induces FOXP3 expression in OKT3-stimulated or antigen-stimulated CD8 T cells, indicating that FOXP3 expression is neither limited to a unique subset of CD8 T cells nor dependent on the mode of T-cell receptor stimulation.",17414320_2,-1,-1,-1,-1,5196,-1,5.465503e-06,0.99999,4.530819e-06
5205,function,16,17,102,110,"In the absence of IL-2, antigen stimulation resulted in T-cell activation and acquisition of effector function without induction of FOXP3, indicating that acquisition of effector function is independent of induction of FOXP3 expression in CD8 T cells.",17414320_3,0,1,2,-1,5205,-1,0.0046995953,0.5370019,0.45829847
5208,function,27,28,179,187,"In the absence of IL-2, antigen stimulation resulted in T-cell activation and acquisition of effector function without induction of FOXP3, indicating that acquisition of effector function is independent of induction of FOXP3 expression in CD8 T cells.",17414320_3,0,1,2,-1,5208,-1,0.0008077384,0.9889924,0.010199811
5224,T cells that,11,14,68,80,"These findings indicate that induction of FOXP3 is intrinsic to CD8 T cells that are activated in the presence of IL-2 or IL-15, and in vitro-induced expression of FOXP3 cannot be simply interpreted as an indicator of Treg activity or activation marker.",17414320_5,-1,-1,-1,-1,5224,-1,0.0012518951,0.025175506,0.97357255
5239,the c-MYC protein to this,9,14,46,71,"To study the contribution of EBV genes and of the c-MYC protein to this phenotype, we have generated a conditional B cell system in which the viral proliferation program and expression of c-myc can be regulated independently of each other.",17419945_2,-1,-1,-1,-1,5239,-1,7.368896e-06,0.99998605,6.588946e-06
5245,the cell,9,11,62,70,"In cells proliferating due to exogenous c-myc overexpression, the cell surface phenotype, the pattern of proliferation in single cell suspension, and the immunological characteristics of BL cells could be completely recapitulated.",17419945_3,-1,-1,-1,-1,5245,-1,0.0010015746,0.12813994,0.8708585
5255,the NF-kappaB,14,16,86,99,We provide evidence also for the latter by showing that c-MYC down-regulates genes of the NF-kappaB and interferon pathway in a dose-dependent fashion.,17419945_5,-1,-1,-1,-1,5255,-1,1.7679844e-05,0.99996686,1.5469785e-05
5266,the interferon,4,6,21,35,"c-MYC does not block the interferon pathway completely, it shifts the balance and increases the threshold of interferon induction and action.",17419945_7,-1,-1,-1,-1,5266,-1,0.35596257,0.6410533,0.0029841154
5268,the threshold,15,17,92,105,"c-MYC does not block the interferon pathway completely, it shifts the balance and increases the threshold of interferon induction and action.",17419945_7,-1,-1,-1,-1,5268,-1,1.1342707e-05,0.9999815,7.1297063e-06
5283,tissue,3,4,31,37,Immunofluorescence staining of tissue sections revealed intense IL-13 staining on breast cancer cells.,17438063_2,-1,1,2,-1,5283,-1,1.8165587e-05,0.9999634,1.8374669e-05
5289,that IL-13,16,18,116,126,The expression of phosphorylated signal transducer and activator of transcription 6 in breast cancer cells suggests that IL-13 actually delivers signals to cancer cells.,17438063_3,-1,-1,-1,-1,5289,-1,0.89218056,0.105955824,0.001863674
5316,tumor cells,39,41,242,253,"Fifty milligrams per kilogram body weight dose of CTX was administrated intraperitoneally to mice after B16 melanoma or C26 colon carcinoma tumor models were established, DC vaccine generated from mouse bone marrow and pulsed with B16 or C26 tumor cells lysates were vaccinated 4 days later.",17440723_2,-1,-1,-1,-1,5316,-1,0.00014933119,0.0005597063,0.99929094
5337,the tryptophan,22,24,121,135,"Indoleamine 2, 3-dioxygenase (IDO), a key enzyme that catalyses the initial and rate-limiting step in the degradation of the tryptophan, is simultaneously expressed in murine dendritic cells and macrophages stimulated with interferon-gamma (IFN-gamma).",17466914_0,-1,-1,-1,-1,5337,-1,1.0747751e-05,0.9999819,7.371093e-06
5343,the functional,24,26,137,151,"In the present study, we investigated whether p-Coumaric acid (CA), which is suggested to exhibit antioxidant properties, could suppress the functional expression of IDO in murine bone marrow-derived dendritic cells (BMDCs) stimulated with IFN-gamma.",17466914_1,-1,-1,-1,-1,5343,-1,7.376999e-06,0.99998736,5.309704e-06
5347,protein,10,11,67,74,Treatment with CA reduced intracellular expression of IDO mRNA and protein levels in IFN-gamma-activated murine BMDCs in vitro and in CD11c(+)CD8alpha(+) DCs of tumor-draining lymph node (TDLN) of tumor-bearing mice in vivo.,17466914_2,0,1,-1,-1,5347,-1,6.4793835e-06,0.9999875,5.9794343e-06
5353,the functional,8,10,54,68,"Consequently, we obtained evidence that CA suppresses the functional activity of IDO, which catalyses oxidative catabolism of tryptophan, and significantly recovers the IDO-dependent T cell suppression.",17466914_3,-1,-1,-1,-1,5353,-1,1.2511833e-05,0.9999788,8.7170665e-06
5357,the signal transducer and activator of transcription 1,2,10,14,68,Activation of the signal transducer and activator of transcription 1 (STAT1) is important to be express IDO in IFN-gamma-stimulated murine BMDCs.,17466914_4,-1,-1,-1,-1,5357,-1,5.0207022e-06,0.9999864,8.516817e-06
5364,the signal transducer and activator of transcription 1,14,22,90,144,"To determine whether these inhibitory effects of CA are associated with the alteration of the signal transducer and activator of transcription 1 (STAT1) and IFN-gamma-inducible, dsRNA-activated serine/threonine protein kinase (PKR), BMDCs were pretreated with various concentrations of CA.",17466914_5,-1,-1,-1,-1,5364,-1,4.989938e-06,0.9999856,9.385795e-06
5367,protein,30,31,211,218,"To determine whether these inhibitory effects of CA are associated with the alteration of the signal transducer and activator of transcription 1 (STAT1) and IFN-gamma-inducible, dsRNA-activated serine/threonine protein kinase (PKR), BMDCs were pretreated with various concentrations of CA.",17466914_5,0,1,-1,-1,5367,-1,1.458113e-05,0.9999751,1.0286518e-05
5371,to IFN-gamma,11,13,63,75,We found that CA inhibited the activation of STAT1 in response to IFN-gamma.,17466914_6,-1,-1,-1,-1,5371,-1,0.9955419,0.003914114,0.00054405717
5385,blood lymphocytes,24,26,153,170,"METHODS AND FINDINGS: To gain insights into the molecular mechanisms of immune dysfunction in cancer, gene expression profiles of pure sorted peripheral blood lymphocytes from 12 patients with melanoma were compared to 12 healthy controls.",17488182_2,-1,-1,-1,-1,5385,-1,5.3319458e-05,4.2744374e-05,0.9999039
5393,functional,10,11,73,83,These microarray findings were further confirmed by quantitative PCR and functional responses to IFNs.,17488182_4,0,1,2,-1,5393,-1,0.00058435224,0.9993186,9.709597e-05
5394,to IFNs,12,14,94,101,These microarray findings were further confirmed by quantitative PCR and functional responses to IFNs.,17488182_4,-1,-1,-1,-1,5394,-1,0.95430213,0.042496014,0.003201796
5396,lymphocytes that,4,6,25,41,"The median percentage of lymphocytes that phosphorylate STAT1 in response to interferon-alpha was significantly reduced (Delta = 16.8%; 95% confidence interval, 0.98% to 33.35%) in melanoma patients (n = 9) compared to healthy controls (n = 9) in Phosflow analysis.",17488182_5,-1,-1,-1,-1,5396,-1,0.0032944272,0.19300483,0.8037007
5398,to interferon-alpha,10,12,74,93,"The median percentage of lymphocytes that phosphorylate STAT1 in response to interferon-alpha was significantly reduced (Delta = 16.8%; 95% confidence interval, 0.98% to 33.35%) in melanoma patients (n = 9) compared to healthy controls (n = 9) in Phosflow analysis.",17488182_5,-1,-1,-1,-1,5398,-1,0.98822844,0.010754801,0.0010167875
5401,analysis,51,52,256,264,"The median percentage of lymphocytes that phosphorylate STAT1 in response to interferon-alpha was significantly reduced (Delta = 16.8%; 95% confidence interval, 0.98% to 33.35%) in melanoma patients (n = 9) compared to healthy controls (n = 9) in Phosflow analysis.",17488182_5,0,1,-1,-1,5401,-1,9.872708e-06,0.9999795,1.0611576e-05
5409,IFN-stimulated genes,22,24,122,142,The defect in IFN signaling in the melanoma patient group as a whole was partially overcome at the level of expression of IFN-stimulated genes by prolonged stimulation with the high concentration of IFN-alpha that is achievable only in IFN therapy used in melanoma.,17488182_7,-1,-1,-1,-1,5409,-1,0.9989373,0.0007067497,0.00035592006
5411,IFN-alpha that,32,34,199,213,The defect in IFN signaling in the melanoma patient group as a whole was partially overcome at the level of expression of IFN-stimulated genes by prolonged stimulation with the high concentration of IFN-alpha that is achievable only in IFN therapy used in melanoma.,17488182_7,-1,-1,-1,-1,5411,-1,0.9993332,0.0004219078,0.00024479683
5412,IFN therapy,38,40,236,247,The defect in IFN signaling in the melanoma patient group as a whole was partially overcome at the level of expression of IFN-stimulated genes by prolonged stimulation with the high concentration of IFN-alpha that is achievable only in IFN therapy used in melanoma.,17488182_7,-1,-1,-1,-1,5412,-1,0.99977845,9.877188e-05,0.00012275818
5414,to IFN-alpha,3,5,22,34,The lowest responders to IFN-alpha in the Phosflow assay also showed the lowest gene expression in response to IFN-alpha.,17488182_8,-1,-1,-1,-1,5414,-1,0.98418784,0.0145096015,0.0013025487
5418,to IFN-alpha,17,19,108,120,The lowest responders to IFN-alpha in the Phosflow assay also showed the lowest gene expression in response to IFN-alpha.,17488182_8,-1,-1,-1,-1,5418,-1,0.98691535,0.012065318,0.0010192815
5420,functional,8,9,58,68,"Finally, T cells from low-IFN-response patients exhibited functional abnormalities, including decreased expression of activation markers CD69, CD25, and CD71; TH1 cytokines interleukin-2, IFN-gamma, and tumor necrosis factor alpha, and reduced survival following stimulation with anti-CD3/CD28 antibodies compared to controls.",17488182_9,0,1,2,-1,5420,-1,0.024319932,0.80079824,0.1748819
5421,TH1 cytokines interleukin-2,24,27,159,186,"Finally, T cells from low-IFN-response patients exhibited functional abnormalities, including decreased expression of activation markers CD69, CD25, and CD71; TH1 cytokines interleukin-2, IFN-gamma, and tumor necrosis factor alpha, and reduced survival following stimulation with anti-CD3/CD28 antibodies compared to controls.",17488182_9,-1,-1,-1,-1,5421,-1,0.8639342,0.13147123,0.0045945817
5428,therapies to,7,9,37,49,These findings may be used to design therapies to counteract immune dysfunction in melanoma and to improve cancer immunotherapy.,17488182_11,-1,-1,-1,-1,5428,-1,4.9590913e-06,0.99999106,3.955572e-06
5433,the immune response,2,5,14,33,"To understand the immune response surrounding BCCs, we characterized the genomic, protein, and cellular microenvironment associated with BCC in comparison to normal skin.",17508019_1,-1,-1,-1,-1,5433,-1,0.4851148,0.513458,0.0014271811
5435,protein,13,14,82,89,"To understand the immune response surrounding BCCs, we characterized the genomic, protein, and cellular microenvironment associated with BCC in comparison to normal skin.",17508019_1,0,1,-1,-1,5435,-1,4.699994e-05,0.9999325,2.042368e-05
5442,the tumor,32,34,152,161,"Our results demonstrated the following: (1) CD4+ CD25+ Foxp3+ surround epithelial tumor aggregates; (2) Immature dendritic cells (DCs) were abundant in the tumor microenvironment; (3) BCC showed increased expression of IL-4, IL-10, and CCL22 and increased expression of interferon-associated genes (IFI27, IRF1, IRF7, and G1P2) and IL-12/23, gene indicating a Th2 dominant microenvironment.",17508019_2,-1,-1,-1,-1,5442,-1,3.5623477e-06,0.9999913,5.1094985e-06
5445,interferon-associated genes,54,56,270,297,"Our results demonstrated the following: (1) CD4+ CD25+ Foxp3+ surround epithelial tumor aggregates; (2) Immature dendritic cells (DCs) were abundant in the tumor microenvironment; (3) BCC showed increased expression of IL-4, IL-10, and CCL22 and increased expression of interferon-associated genes (IFI27, IRF1, IRF7, and G1P2) and IL-12/23, gene indicating a Th2 dominant microenvironment.",17508019_2,-1,-1,-1,-1,5445,-1,0.9949532,0.0043664137,0.00068030297
5454,Th2 cytokines,13,15,71,84,"The finding of phenotypic T regs, in conjunction with immature DCs and Th2 cytokines, suggests an attenuated state of immunity to human BCC.",17508019_4,-1,-1,-1,-1,5454,-1,0.23739982,0.75717086,0.0054293373
5456,immunity to,21,23,118,129,"The finding of phenotypic T regs, in conjunction with immature DCs and Th2 cytokines, suggests an attenuated state of immunity to human BCC.",17508019_4,-1,-1,-1,-1,5456,-1,0.124195255,0.87390035,0.0019044224
5463,function,6,7,29,37,"Although dendritic cell (DC) function is impaired in pancreatic cancer patients, the underlying mechanisms are unknown.",17545630_0,0,1,2,-1,5463,-1,0.00068043405,0.0028359706,0.99648356
5467,factors released,5,7,32,48,This study analyzed the soluble factors released by pancreatic cancer cells responsible for inhibiting DC differentiation and activation.,17545630_1,-1,-1,-1,-1,5467,-1,0.022318851,0.9775025,0.00017864286
5474,Th2 cytokines,24,26,132,145,Allostimulation of CD4+ and CD8+ T cells by BxCM-treated mDCs was inefficient and resulted in production of lower levels of Th1 and Th2 cytokines.,17545630_4,-1,-1,-1,-1,5474,-1,0.2752417,0.71945655,0.005301718
5475,Antigen-specific T-cell activation,0,3,0,34,Antigen-specific T-cell activation capability was also reduced in BxCM-treated mDCs.,17545630_5,-1,-1,-1,-1,5475,-1,0.830678,0.00037135425,0.16895075
5491,to the,9,11,38,44,"Furthermore, BxCM, IL-6, or G-CSF led to the activation of signal transducer and activator of transcription 3 (STAT3) in CD14+ monocytes to different degrees.",17545630_10,-1,-1,-1,-1,5491,-1,4.5306665e-06,0.9999907,4.7361723e-06
5501,factors,10,11,53,60,"Therefore, IL-6 and G-CSF in BxCM represent two main factors responsible for suppression of DC differentiation, maturation, and antigen presentation, and this suppression of DC functions may be due to the aberrant activation of STAT3 by BxCM.",17545630_12,0,1,-1,-1,5501,-1,1.1453118e-05,0.9999831,5.427051e-06
5504,functions,29,30,177,186,"Therefore, IL-6 and G-CSF in BxCM represent two main factors responsible for suppression of DC differentiation, maturation, and antigen presentation, and this suppression of DC functions may be due to the aberrant activation of STAT3 by BxCM.",17545630_12,0,1,2,-1,5504,-1,0.00031016598,0.9938777,0.0058121723
5505,to the,33,35,198,204,"Therefore, IL-6 and G-CSF in BxCM represent two main factors responsible for suppression of DC differentiation, maturation, and antigen presentation, and this suppression of DC functions may be due to the aberrant activation of STAT3 by BxCM.",17545630_12,-1,-1,-1,-1,5505,-1,5.178172e-06,0.9999908,4.0117825e-06
5507,T cell function,5,8,40,55,BACKGROUND/AIMS: An efficient cytolytic T cell function is essential for immune mediated rejection of colorectal cancer.,17566017_0,-1,-1,-1,-1,5507,-1,1.3890656e-05,9.341733e-06,0.99997675
5510,the relevance,4,6,18,31,"Here, we assessed the relevance of the T-box transcription factor eomesodermin in colorectal cancer.",17566017_2,-1,-1,-1,-1,5510,-1,7.2699795e-06,0.9999881,4.660883e-06
5511,the T-box transcription factor,7,11,35,65,"Here, we assessed the relevance of the T-box transcription factor eomesodermin in colorectal cancer.",17566017_2,-1,-1,-1,-1,5511,-1,6.829552e-06,0.99998796,5.1663296e-06
5512,tissue,5,6,31,37,"METHODS/ RESULTS: By analysing tissue probes from 88 different colorectal tumours, a significant (p<0.02) inverse correlation between eomesodermin expression in colorectal cancers and the presence of lymph node metastases could be shown, whereas no such correlation was noted for the master transcription factor of regulatory T cells, FoxP3 and CD8 alpha expression.",17566017_3,-1,1,2,-1,5512,-1,2.2228849e-05,0.9999459,3.189223e-05
5525,function,26,27,162,170,"To evaluate whether this effect might be due to effects of eomesodermin on tumour infiltrating CD8 T cells, we subsequently analysed the regulated expression and function of this transcription factor in human T cells.",17566017_4,0,1,2,-1,5525,-1,1.1848723e-05,0.99997795,1.0233437e-05
5526,this transcription factor,28,31,174,199,"To evaluate whether this effect might be due to effects of eomesodermin on tumour infiltrating CD8 T cells, we subsequently analysed the regulated expression and function of this transcription factor in human T cells.",17566017_4,-1,-1,-1,-1,5526,-1,5.0447397e-06,0.99999046,4.480077e-06
5528,this factor,3,5,26,37,"Whereas overexpression of this factor induced perforin but not granzyme expression, siRNA mediated suppression of eomesodermin expression led to significantly reduced IFN-gamma production, perforin levels and cytolytic activity of CD8 T cells.",17566017_5,-1,-1,-1,-1,5528,-1,0.01100571,0.98879284,0.00020145783
5532,TGF-beta,2,3,13,21,"Furthermore, TGF-beta and IL4 could be identified as important inducer of eomesodermin expression.",17566017_6,0,1,-1,-1,5532,-1,7.136581e-05,0.9999138,1.4847813e-05
5539,functions,18,19,125,134,Our findings are consistent with a model in which eomesodermin expression in tumour infiltrating T cells regulates cytolytic functions of CD8 T cells via perforin expression.,17566017_8,0,1,2,-1,5539,-1,0.026533678,0.33419847,0.6392679
5542,the functional,9,11,68,82,These data provide novel insights into control mechanisms governing the functional activity of human CD8 T lymphocytes via T-box transcription factors in cancer.,17566017_9,-1,-1,-1,-1,5542,-1,9.611804e-06,0.9999831,7.327186e-06
5544,T-box transcription factors,18,21,123,150,These data provide novel insights into control mechanisms governing the functional activity of human CD8 T lymphocytes via T-box transcription factors in cancer.,17566017_9,-1,-1,-1,-1,5544,-1,5.842952e-06,0.9999862,7.9926385e-06
5545,The immune response to,2,6,12,34,"BACKGROUND: The immune response to melanoma is rarely curative, suggesting the emergence of immunosuppression.",17574040_0,-1,-1,-1,-1,5545,-1,0.0009871854,0.99893457,7.828548e-05
5547,FOXP3-expressing regulatory T cells,0,4,0,35,FOXP3-expressing regulatory T cells (T(reg) cells) function to suppress immune responses.,17574040_1,-1,-1,-1,-1,5547,-1,0.0018240047,0.8134851,0.18469094
5550,function to,9,11,51,62,FOXP3-expressing regulatory T cells (T(reg) cells) function to suppress immune responses.,17574040_1,-1,-1,-1,-1,5550,-1,2.3056444e-05,0.9999449,3.202517e-05
5557,blood,5,6,33,38,MATERIAL AND METHODS: Peripheral blood mononuclear cells (PBMCs) were isolated and exposed to melanoma-conditioned media (MCM) or control media for 1 week.,17574040_3,0,1,-1,-1,5557,-1,0.0008847041,0.98285747,0.01625785
5571,cells than those,18,21,122,138,"Supernatant cytokines were determined by ELISA.RESULTS: Normal PBMCs exposed to MCM revealed higher proportions of T(reg) cells than those exposed to control media after 6 days (3.4% versus 1.3%, respectively, P < 0.02).",17574040_6,-1,-1,-1,-1,5571,-1,0.0026085237,0.7250265,0.27236497
5579,than those,26,28,146,156,The expression of FOXP3 in T(reg) cells from PBMCs exposed to MCM increased over time by MFI and Western blot but was not significantly different than those exposed to control media.,17574040_7,-1,-1,-1,-1,5579,-1,5.3017807e-06,0.9999893,5.430719e-06
5583,TGF-beta,5,6,23,31,"The level of IL-10 and TGF-beta in supernatants after 6 days growth was higher in MCM than control media, but this did not reach statistical significance.",17574040_8,0,1,-1,-1,5583,-1,0.00012480776,0.9998572,1.8041395e-05
5591,the nature,2,4,11,21,We defined the nature of the cellular immune response in 5 women with human papillomavirus (HPV) 16+cervical carcinoma at a single time point when surgery was performed for treatment.,17589293_0,-1,-1,-1,-1,5591,-1,4.814023e-06,0.9999896,5.5778605e-06
5592,the cellular immune response,5,9,25,53,We defined the nature of the cellular immune response in 5 women with human papillomavirus (HPV) 16+cervical carcinoma at a single time point when surgery was performed for treatment.,17589293_0,-1,-1,-1,-1,5592,-1,0.6550004,0.33699346,0.008006114
5597,T-cell,5,6,30,36,"To monitor the differences in T-cell recognition, 2 approaches of tetramer-guided technology were employed: (i) the in situ localization of major histocompatibility complex class I peptide complexes in the tumor lesions and (ii) the ex vivo sorting of HLA-A*0201-restricted and HPV16 E6-reactive T cells.",17589293_1,-1,1,2,-1,5597,-1,1.4280576e-05,8.319895e-06,0.99997735
5598,tetramer-guided technology,11,13,66,92,"To monitor the differences in T-cell recognition, 2 approaches of tetramer-guided technology were employed: (i) the in situ localization of major histocompatibility complex class I peptide complexes in the tumor lesions and (ii) the ex vivo sorting of HLA-A*0201-restricted and HPV16 E6-reactive T cells.",17589293_1,-1,-1,-1,-1,5598,-1,5.606449e-06,0.9999883,6.0644393e-06
5601,peptide complexes,29,31,181,198,"To monitor the differences in T-cell recognition, 2 approaches of tetramer-guided technology were employed: (i) the in situ localization of major histocompatibility complex class I peptide complexes in the tumor lesions and (ii) the ex vivo sorting of HLA-A*0201-restricted and HPV16 E6-reactive T cells.",17589293_1,-1,-1,-1,-1,5601,-1,4.492315e-05,0.99991775,3.731416e-05
5602,the tumor,32,34,202,211,"To monitor the differences in T-cell recognition, 2 approaches of tetramer-guided technology were employed: (i) the in situ localization of major histocompatibility complex class I peptide complexes in the tumor lesions and (ii) the ex vivo sorting of HLA-A*0201-restricted and HPV16 E6-reactive T cells.",17589293_1,-1,-1,-1,-1,5602,-1,3.5954922e-06,0.99999225,4.137755e-06
5607,blood lymphocytes,8,10,43,60,"CD8 T cells from the periphery (peripheral blood lymphocytes), the tumor (tumor-infiltrating lymphocytes), and T cells harvested from draining lymph nodes (T-LN) were analyzed.",17589293_2,-1,-1,-1,-1,5607,-1,0.00010642325,9.954365e-05,0.99979407
5608,the tumor,12,14,63,72,"CD8 T cells from the periphery (peripheral blood lymphocytes), the tumor (tumor-infiltrating lymphocytes), and T cells harvested from draining lymph nodes (T-LN) were analyzed.",17589293_2,-1,-1,-1,-1,5608,-1,4.3335235e-06,0.9999896,6.0668826e-06
5609,tumor-infiltrating lymphocytes,15,17,74,104,"CD8 T cells from the periphery (peripheral blood lymphocytes), the tumor (tumor-infiltrating lymphocytes), and T cells harvested from draining lymph nodes (T-LN) were analyzed.",17589293_2,-1,-1,-1,-1,5609,-1,0.002574634,0.8497149,0.14771044
5612,tetramer-sorted lymphocytes,2,4,9,36,"HPV16 E6 tetramer-sorted lymphocytes from the different anatomic sites recognized an HLA-A*0201-restricted E6 peptide irrespective of the type of antigen-presenting cells used for stimulation as determined by interferon-gamma production: autologous tumor cells, HLA-A*0201 surrogate antigen-presenting cells pulsed with the nominal peptide, and an HLA-A*0201-matched human dendritic cell line transgenic for HPV16 E6.",17589293_3,-1,-1,-1,-1,5612,-1,0.0044459365,0.42833135,0.5672227
5614,peptide,13,14,110,117,"HPV16 E6 tetramer-sorted lymphocytes from the different anatomic sites recognized an HLA-A*0201-restricted E6 peptide irrespective of the type of antigen-presenting cells used for stimulation as determined by interferon-gamma production: autologous tumor cells, HLA-A*0201 surrogate antigen-presenting cells pulsed with the nominal peptide, and an HLA-A*0201-matched human dendritic cell line transgenic for HPV16 E6.",17589293_3,0,-1,2,-1,5614,-1,0.0075887083,0.99099344,0.0014178257
5615,the type,16,18,134,142,"HPV16 E6 tetramer-sorted lymphocytes from the different anatomic sites recognized an HLA-A*0201-restricted E6 peptide irrespective of the type of antigen-presenting cells used for stimulation as determined by interferon-gamma production: autologous tumor cells, HLA-A*0201 surrogate antigen-presenting cells pulsed with the nominal peptide, and an HLA-A*0201-matched human dendritic cell line transgenic for HPV16 E6.",17589293_3,-1,-1,-1,-1,5615,-1,7.228193e-06,0.9999839,8.920215e-06
5616,antigen-presenting cells,19,21,146,170,"HPV16 E6 tetramer-sorted lymphocytes from the different anatomic sites recognized an HLA-A*0201-restricted E6 peptide irrespective of the type of antigen-presenting cells used for stimulation as determined by interferon-gamma production: autologous tumor cells, HLA-A*0201 surrogate antigen-presenting cells pulsed with the nominal peptide, and an HLA-A*0201-matched human dendritic cell line transgenic for HPV16 E6.",17589293_3,-1,-1,-1,-1,5616,-1,0.64879763,0.00024410193,0.35095826
5618,tumor cells,31,33,249,260,"HPV16 E6 tetramer-sorted lymphocytes from the different anatomic sites recognized an HLA-A*0201-restricted E6 peptide irrespective of the type of antigen-presenting cells used for stimulation as determined by interferon-gamma production: autologous tumor cells, HLA-A*0201 surrogate antigen-presenting cells pulsed with the nominal peptide, and an HLA-A*0201-matched human dendritic cell line transgenic for HPV16 E6.",17589293_3,-1,-1,-1,-1,5618,-1,0.00011814918,0.00033037816,0.99955136
5619,antigen-presenting cells,36,38,283,307,"HPV16 E6 tetramer-sorted lymphocytes from the different anatomic sites recognized an HLA-A*0201-restricted E6 peptide irrespective of the type of antigen-presenting cells used for stimulation as determined by interferon-gamma production: autologous tumor cells, HLA-A*0201 surrogate antigen-presenting cells pulsed with the nominal peptide, and an HLA-A*0201-matched human dendritic cell line transgenic for HPV16 E6.",17589293_3,-1,-1,-1,-1,5619,-1,0.71515435,0.0002355884,0.28461012
5621,peptide,42,43,332,339,"HPV16 E6 tetramer-sorted lymphocytes from the different anatomic sites recognized an HLA-A*0201-restricted E6 peptide irrespective of the type of antigen-presenting cells used for stimulation as determined by interferon-gamma production: autologous tumor cells, HLA-A*0201 surrogate antigen-presenting cells pulsed with the nominal peptide, and an HLA-A*0201-matched human dendritic cell line transgenic for HPV16 E6.",17589293_3,0,-1,2,-1,5621,-1,0.0023406497,0.9971493,0.0005100206
5624,analysis,1,2,8,16,Further analysis showed that the HPV16 E6-reactive CD8 T cells were of high avidity defined by blocking with an anti-CD8-alpha specific monoclonal antibody.,17589293_4,0,1,-1,-1,5624,-1,9.870387e-06,0.9999846,5.4558864e-06
5625,that the,3,5,24,32,Further analysis showed that the HPV16 E6-reactive CD8 T cells were of high avidity defined by blocking with an anti-CD8-alpha specific monoclonal antibody.,17589293_4,-1,-1,-1,-1,5625,-1,5.315072e-06,0.9999907,3.9784827e-06
5630,T-cell,14,15,87,93,"We found that HPV16 E6-reactive T cells reside preferentially within the CD45RA+ CCR7+ T-cell subpopulation of tumor-infiltrating lymphocyte, peripheral blood lymphocyte, and T-LN in cervical cancer patients, suggesting that successful immune surveillance of HPV16+ tumor cells in cervical cancer patients is impaired.",17589293_5,-1,1,2,-1,5630,-1,1.0250193e-05,6.5118525e-06,0.9999832
5631,tumor-infiltrating lymphocyte,17,19,111,140,"We found that HPV16 E6-reactive T cells reside preferentially within the CD45RA+ CCR7+ T-cell subpopulation of tumor-infiltrating lymphocyte, peripheral blood lymphocyte, and T-LN in cervical cancer patients, suggesting that successful immune surveillance of HPV16+ tumor cells in cervical cancer patients is impaired.",17589293_5,-1,-1,-1,-1,5631,-1,0.002312697,0.86880577,0.1288815
5632,blood lymphocyte,21,23,153,169,"We found that HPV16 E6-reactive T cells reside preferentially within the CD45RA+ CCR7+ T-cell subpopulation of tumor-infiltrating lymphocyte, peripheral blood lymphocyte, and T-LN in cervical cancer patients, suggesting that successful immune surveillance of HPV16+ tumor cells in cervical cancer patients is impaired.",17589293_5,-1,-1,-1,-1,5632,-1,4.398273e-05,3.992935e-05,0.9999161
5635,tumor cells,39,41,266,277,"We found that HPV16 E6-reactive T cells reside preferentially within the CD45RA+ CCR7+ T-cell subpopulation of tumor-infiltrating lymphocyte, peripheral blood lymphocyte, and T-LN in cervical cancer patients, suggesting that successful immune surveillance of HPV16+ tumor cells in cervical cancer patients is impaired.",17589293_5,-1,-1,-1,-1,5635,-1,4.748118e-05,6.589111e-05,0.99988663
5637,antigen-reactive T cells,6,9,35,59,"The CD45RA+/CCR7+ phenotype of HPV antigen-reactive T cells may serve as an indicator of dysfunctional T cells, despite effective interferon-gamma production in response to HPV antigens.",17589293_6,-1,-1,-1,-1,5637,-1,0.7217852,0.0005665943,0.27764815
5643,thought to,4,6,31,41,Foxp3 expression was initially thought to be restricted to the CD4(+)CD25(+) regulatory T-cell population.,17615291_0,-1,-1,-1,-1,5643,-1,7.7820905e-06,0.9999863,5.9298854e-06
5644,to the,8,10,56,62,Foxp3 expression was initially thought to be restricted to the CD4(+)CD25(+) regulatory T-cell population.,17615291_0,-1,-1,-1,-1,5644,-1,6.1655687e-06,0.9999889,4.897698e-06
5646,that forkhead,5,7,32,45,"However, recent studies suggest that forkhead box P3 (Foxp3) is expressed in CD4(+)CD25(-) T cells in aged mice.",17615291_1,-1,-1,-1,-1,5646,-1,6.9000366e-06,0.9999883,4.805485e-06
5652,blood,22,23,117,122,"In the present study in B-cell non-Hodgkin lymphoma (NHL), we found that a subset of intratumoral but not peripheral blood CD4(+)CD25(-) T cells, comprising about 15% of intratumoral CD4(+) T cells, express Foxp3 and are capable of suppressing the proliferation of autologous infiltrating CD8(+) T cells.",17615291_2,0,1,-1,-1,5652,-1,3.493413e-05,0.99992335,4.1662017e-05
5663,that the,2,4,9,17,We found that the presence of lymphoma B cells during activation augmented activation-induced Foxp3 expression in CD4(+)CD25(-) T cells.,17615291_4,-1,-1,-1,-1,5663,-1,4.6940886e-06,0.99999094,4.3303735e-06
5669,to the,11,13,70,76,We also found that CD70(+) lymphoma B cells significantly contributed to the activation-induced Foxp3 expression in intratumoral CD4(+)CD25(-) T cells.,17615291_5,-1,-1,-1,-1,5669,-1,4.418501e-06,0.9999913,4.272037e-06
5675,Taken together,0,2,0,14,"Taken together, these studies reveal a novel role for NHL B cells in the development of intratumoral regulatory T cells.",17615291_7,-1,-1,-1,-1,5675,-1,1.0324727e-05,0.9999814,8.299775e-06
5693,tissue,47,48,286,292,"To determine, whether accumulation and activation of intratumoral Tregs help in the progression of breast carcinoma, we have analyzed the intratumoral expression of FOXP3 in invasive breast carcinoma and compared it with its level in ductal carcinoma in situ (DCIS) and adjacent normal tissue with the main aim of using this factor as marker of tumor progression.",17653902_1,-1,1,2,-1,5693,-1,0.0005118496,0.317534,0.6819542
5695,this factor,54,56,320,331,"To determine, whether accumulation and activation of intratumoral Tregs help in the progression of breast carcinoma, we have analyzed the intratumoral expression of FOXP3 in invasive breast carcinoma and compared it with its level in ductal carcinoma in situ (DCIS) and adjacent normal tissue with the main aim of using this factor as marker of tumor progression.",17653902_1,-1,-1,-1,-1,5695,-1,2.9371135e-05,0.99996185,8.800389e-06
5699,transforming growth factor,9,12,61,87,"Intratumoral FOXP3 levels were correlated with the levels of transforming growth factor beta1 (TGF-beta1), vascular endothelial growth factor (VEGF, an invasogenic and angiogenic growth factor) and intratumoral microvessel density (IMD, a prognostic marker for angiogenesis).",17653902_2,-1,-1,-1,-1,5699,-1,0.9867792,0.008938461,0.0042822873
5700,TGF-beta1,14,15,95,104,"Intratumoral FOXP3 levels were correlated with the levels of transforming growth factor beta1 (TGF-beta1), vascular endothelial growth factor (VEGF, an invasogenic and angiogenic growth factor) and intratumoral microvessel density (IMD, a prognostic marker for angiogenesis).",17653902_2,0,1,-1,-1,5700,-1,0.0001424435,0.99966097,0.0001965563
5703,FOXP3 gene,4,6,25,35,"We also analyzed whether FOXP3 gene expression correlated with other clinicopathological variables like age, tumor stage, histological grade and lymph node metastasis.",17653902_3,-1,-1,-1,-1,5703,-1,4.8967217e-06,0.99998987,5.2606706e-06
5705,FOXP3 transcription,4,6,32,51,"Infiltrating cancers had higher FOXP3 transcription (7.43+/-3.44) than did ductal carcinoma in situ (4.27+/-1.97, p<0.05) and normal tissues (3.51+/-1.22, p<0.001).",17653902_4,-1,-1,-1,-1,5705,-1,3.7457633e-06,0.99999166,4.5519832e-06
5707,tissues,22,23,133,140,"Infiltrating cancers had higher FOXP3 transcription (7.43+/-3.44) than did ductal carcinoma in situ (4.27+/-1.97, p<0.05) and normal tissues (3.51+/-1.22, p<0.001).",17653902_4,-1,1,2,-1,5707,-1,0.000118174554,0.9857841,0.01409765
5709,TNM classification,13,15,91,109,Intratumoral FOXP3 expression was significantly higher in patients with stage III disease (TNM classification) compared to patients who had stage II disease (p=0.037).,17653902_5,-1,-1,-1,-1,5709,-1,6.1818275e-05,0.999721,0.00021713745
5712,TGF-beta1,12,13,91,100,"In infiltrating carcinoma, a significant positive correlation between FOXP3 expression and TGF-beta1 expression was noted (p<0.001).",17653902_6,0,1,-1,-1,5712,-1,2.4405268e-05,0.99992347,5.214278e-05
5714,statistically that,20,22,125,143,"Furthermore, a positive correlation between FOXP3 expression with VEGF expression and IMD values was also detected, however, statistically that was non-significant.",17653902_7,-1,-1,-1,-1,5714,-1,5.2549167e-06,0.9999894,5.313514e-06
5721,function,11,12,75,83,Regulation of T cell homeostasis is critical for maintaining normal immune function.,17659375_0,0,1,2,-1,5721,-1,0.026255853,0.96607465,0.007669465
5727,cytokines through their receptors,2,6,15,48,"Signaling from cytokines through their receptors is primarily delivered by two molecular families, namely Janus tyrosine kinases (JAKs) and signal transducers and activators of transcription (STATs).",17659375_3,-1,-1,-1,-1,5727,-1,0.9569594,0.0019480672,0.041092478
5736,made genetically,12,14,74,90,"Invaluable knowledge about JAKs and STATs has arisen from studies of mice made genetically deficient in these molecules, analyses of tumor models, and studies of expression patterns by proteomics/genomics, which all have begun to define the role of JAKs and STATs in survival versus apoptosis.",17659375_4,-1,-1,-1,-1,5736,-1,6.4443975e-06,0.9999883,5.2765245e-06
5750,the lymphocyte life,18,21,107,126,This review seeks to focus on the role of JAK tyrosine kinases and STAT transcription factors in mediating the lymphocyte life cycle and how they might be manipulated for therapeutic applications.,17659375_6,-1,-1,-1,-1,5750,-1,0.0014390901,0.052411012,0.94614995
5761,the T cell,4,7,21,31,The skewed nature of the T cell infiltrate and the lack of an effective host antitumor immune response suggest that RS cells use potent mechanisms to evade immune attack.,17670934_1,-1,-1,-1,-1,5761,-1,0.002143685,0.19041574,0.8074405
5771,protein,20,21,137,144,"In a screen for T cell-inhibitory molecules in cHL, we found that RS cells selectively overexpressed the immunoregulatory glycan-binding protein, galectin-1 (Gal1), through an AP1-dependent enhancer.",17670934_2,0,1,-1,-1,5771,-1,1.0139565e-05,0.9999819,8.009216e-06
5782,Th2 cytokines,13,15,74,87,"In contrast, Gal1 treatment of activated T cells favored the secretion of Th2 cytokines and the expansion of CD4+CD25high FOXP3+ Treg cells.",17670934_4,-1,-1,-1,-1,5782,-1,0.25968218,0.73500824,0.005309512
5792,therapeutic target,6,8,34,52,"Thus, Gal1 represents a potential therapeutic target for restoring immune surveillance in cHL.",17670934_6,-1,-1,-1,-1,5792,-1,4.9915816e-06,0.9999907,4.289426e-06
5798,tumor-infiltrating lymphocytes,6,8,35,65,Tregs with a distinct phenotype in tumor-infiltrating lymphocytes (TIL) contribute to local immune suppression.,17671115_1,-1,-1,-1,-1,5798,-1,0.0025142764,0.82812476,0.16936101
5804,blood,13,14,82,87,EXPERIMENTAL DESIGN: The frequency and phenotype of Treg in TIL and/or peripheral blood mononuclear cells (PBMC) in 15 HNSCC patients and PBMC in 15 normal controls were compared.,17671115_2,0,1,-1,-1,5804,-1,0.0033782132,0.96421546,0.032406345
5808,function,10,11,71,79,Single-cell sorted CD4(+)CD25(high) T cells were tested for regulatory function by coculture with carboxyfluorescein diacetate succinimidyl ester-labeled and activated autologous CD4(+)CD25(-) responder T cells.,17671115_3,0,1,2,-1,5808,-1,0.0008543244,0.9176426,0.08150311
5815,factor-beta1,15,16,113,125,Transwell inserts separating Treg from responders and neutralizing interleukin-10 (IL-10) or transforming growth factor-beta1 (TGF-beta1) antibodies were used to evaluate the mechanisms used by Treg to suppress responder cell proliferation.,17671115_4,0,1,-1,-1,5815,-1,0.9969459,0.00015933548,0.0028946823
5816,TGF-beta1,17,18,127,136,Transwell inserts separating Treg from responders and neutralizing interleukin-10 (IL-10) or transforming growth factor-beta1 (TGF-beta1) antibodies were used to evaluate the mechanisms used by Treg to suppress responder cell proliferation.,17671115_4,0,1,-1,-1,5816,-1,1.7258744e-05,0.99996006,2.2692207e-05
5819,Treg to,28,30,194,201,Transwell inserts separating Treg from responders and neutralizing interleukin-10 (IL-10) or transforming growth factor-beta1 (TGF-beta1) antibodies were used to evaluate the mechanisms used by Treg to suppress responder cell proliferation.,17671115_4,-1,-1,-1,-1,5819,-1,3.4258273e-06,0.99999225,4.264739e-06
5825,relative to,22,24,84,95,"RESULTS: In TIL, CD25(+) cells were enriched in the CD3(+)CD4(+) subset (13 +/- 3%) relative to circulating CD3(+)CD4(+) T cells (3 +/- 0.7%) in HNSCC patients (P < or = 0.01) or normal controls (2 +/- 1.5%; P < or = 0.001).",17671115_5,-1,-1,-1,-1,5825,-1,5.1958586e-06,0.9999901,4.727663e-06
5834,TGF-beta1(+,11,12,41,52,"Tregs in TIL were GITR(+), IL-10(+), and TGF-beta1(+), although circulating Treg up-regulated CD62L and CCR7 but not GITR, IL-10, or TGF-beta1.",17671115_7,0,1,-1,-1,5834,-1,5.484649e-05,0.9999101,3.5064346e-05
5837,TGF-beta1,28,29,133,142,"Tregs in TIL were GITR(+), IL-10(+), and TGF-beta1(+), although circulating Treg up-regulated CD62L and CCR7 but not GITR, IL-10, or TGF-beta1.",17671115_7,0,1,-1,-1,5837,-1,1.1538851e-05,0.9999715,1.6926642e-05
5840,than Treg,13,15,59,68,Treg in TIL mediated stronger suppression (P < or = 0.001) than Treg in PBMC of HNSCC patients.,17671115_8,-1,-1,-1,-1,5840,-1,6.926442e-06,0.99998736,5.7352822e-06
5843,TGF-beta,6,7,39,47,The addition of neutralizing IL-10 and TGF-beta antibodies almost completely abrogated suppression (5 +/- 2.51%).,17671115_9,0,1,-1,-1,5843,-1,7.094675e-05,0.9999125,1.653719e-05
5845,the tumor,19,21,104,113,"Transwell inserts partly prevented suppression (60 +/- 5% versus 95 +/- 5%).CONCLUSIONS: Suppression in the tumor microenvironment is mediated by a unique subset of Treg, which produce IL-10 and TGF-beta1 and do not require cell-to-cell contact between Treg and responder cells for inhibition.",17671115_10,-1,-1,-1,-1,5845,-1,4.2332094e-06,0.9999913,4.455016e-06
5849,TGF-beta1,35,36,195,204,"Transwell inserts partly prevented suppression (60 +/- 5% versus 95 +/- 5%).CONCLUSIONS: Suppression in the tumor microenvironment is mediated by a unique subset of Treg, which produce IL-10 and TGF-beta1 and do not require cell-to-cell contact between Treg and responder cells for inhibition.",17671115_10,0,1,-1,-1,5849,-1,1.4769085e-05,0.9999666,1.8624543e-05
5855,treatment reliably,1,3,5,23,"IL-2 treatment reliably results in 16% to 20% objective clinical response rate in cancer patients, with significant durability of responses in selected patients.",17671219_1,-1,-1,-1,-1,5855,-1,8.200145e-06,0.9999869,4.8560623e-06
5872,that Treg cells,18,21,116,131,"The potency of Treg cell proliferation is negatively determined by the initial prevalence of Treg cells, suggesting that Treg cells are a factor for self-controlling Treg cell proliferation.",17671219_6,-1,-1,-1,-1,5872,-1,0.0019720367,0.12506822,0.87295973
5873,factor,23,24,138,144,"The potency of Treg cell proliferation is negatively determined by the initial prevalence of Treg cells, suggesting that Treg cells are a factor for self-controlling Treg cell proliferation.",17671219_6,0,1,-1,-1,5873,-1,0.00015441657,0.99981827,2.7333039e-05
5879,chemokine receptor,5,7,39,57,"Furthermore, IL-2 treatment stimulates chemokine receptor CXCR4 expression on Treg cells, enables Treg cell migration toward chemokine CXCL12 in the tumor microenvironment, and may enforce Treg cell tumor accumulation.",17671219_8,-1,-1,-1,-1,5879,-1,0.9897412,7.09061e-05,0.0101878885
5882,toward chemokine CXCL12,17,20,118,141,"Furthermore, IL-2 treatment stimulates chemokine receptor CXCR4 expression on Treg cells, enables Treg cell migration toward chemokine CXCL12 in the tumor microenvironment, and may enforce Treg cell tumor accumulation.",17671219_8,-1,-1,-1,-1,5882,-1,0.98149145,0.017433241,0.0010754135
5883,the tumor,21,23,145,154,"Furthermore, IL-2 treatment stimulates chemokine receptor CXCR4 expression on Treg cells, enables Treg cell migration toward chemokine CXCL12 in the tumor microenvironment, and may enforce Treg cell tumor accumulation.",17671219_8,-1,-1,-1,-1,5883,-1,4.6812656e-06,0.9999906,4.7257313e-06
5884,Treg cell tumor,28,31,189,204,"Furthermore, IL-2 treatment stimulates chemokine receptor CXCR4 expression on Treg cells, enables Treg cell migration toward chemokine CXCL12 in the tumor microenvironment, and may enforce Treg cell tumor accumulation.",17671219_8,-1,-1,-1,-1,5884,-1,0.00025186606,0.009489565,0.9902586
5887,functionally,11,12,77,89,Our findings support the concept that administration of IL-2 numerically and functionally affects the Treg cell compartment.,17671219_9,0,1,2,-1,5887,-1,0.00016758234,0.99980444,2.8017925e-05
5888,the Treg cell,13,16,98,111,Our findings support the concept that administration of IL-2 numerically and functionally affects the Treg cell compartment.,17671219_9,-1,-1,-1,-1,5888,-1,0.0016755341,0.15934004,0.8389844
5896,immunity,19,20,91,99,"Dendritic cells (DCs), as specialized APCs, play a key role in the induction of anti-tumor immunity.",17895399_0,0,-1,2,-1,5896,-1,0.9998348,5.2182382e-05,0.0001129581
5898,the targets,13,15,71,82,"They originate from bone marrow (BM) progenitors, which are frequently the targets of chromosomal translocations leading to development of leukemia.",17895399_1,-1,-1,-1,-1,5898,-1,5.5808005e-06,0.9999893,5.1885163e-06
5901,functions,4,5,32,41,Aberrant DC differentiation and functions have been observed and are widely reported in patients with leukemia.,17895399_2,0,1,2,-1,5901,-1,0.0008214809,0.997721,0.0014575038
5906,time that,9,11,44,53,"In this study, we demonstrate for the first time that knockin of the Mll-Een fusion gene can affect myeloid DC differentiation and functions directly, independent of the leukemic disease activities.",17895399_4,-1,-1,-1,-1,5906,-1,3.7236107e-06,0.999992,4.3107393e-06
5907,the Mll-Een,13,15,65,76,"In this study, we demonstrate for the first time that knockin of the Mll-Een fusion gene can affect myeloid DC differentiation and functions directly, independent of the leukemic disease activities.",17895399_4,-1,-1,-1,-1,5907,-1,6.483997e-06,0.99998593,7.629371e-06
5909,functions,23,24,131,140,"In this study, we demonstrate for the first time that knockin of the Mll-Een fusion gene can affect myeloid DC differentiation and functions directly, independent of the leukemic disease activities.",17895399_4,0,1,2,-1,5909,-1,5.119025e-05,0.9997936,0.00015528404
5911,that the Mll-Een-expressing,2,5,10,37,We showed that the Mll-Een-expressing BM cells [enhanced green fluorescent protein+ (EGFP+)] from leukemic and nonleukemic mice had similarly impaired DC differentiation capacities with functional abnormalities.,17895399_5,-1,-1,-1,-1,5911,-1,1.1687658e-05,0.9999784,9.907625e-06
5913,protein+,11,12,75,83,We showed that the Mll-Een-expressing BM cells [enhanced green fluorescent protein+ (EGFP+)] from leukemic and nonleukemic mice had similarly impaired DC differentiation capacities with functional abnormalities.,17895399_5,0,1,-1,-1,5913,-1,0.0001089673,0.9997687,0.0001223156
5914,functional,28,29,186,196,We showed that the Mll-Een-expressing BM cells [enhanced green fluorescent protein+ (EGFP+)] from leukemic and nonleukemic mice had similarly impaired DC differentiation capacities with functional abnormalities.,17895399_5,0,1,2,-1,5914,-1,0.0006648794,0.9990884,0.000246717
5917,functions,17,18,96,105,"In contrast, BM cells without Mll-Een expression (EGFP(-)) showed normal DC differentiation and functions.",17895399_6,0,1,2,-1,5917,-1,0.00016759889,0.9991615,0.0006708925
5920,these cells,22,24,120,131,"A reduction in the frequency of CD11c+ DCs was also observed within the EGFP+ population in spleen and lymph nodes, and these cells were dysfunctional.",17895399_7,-1,-1,-1,-1,5920,-1,2.5833215e-05,1.8175588e-05,0.999956
5921,Taken together,0,2,0,14,"Taken together, our findings suggest that the Mll-Een fusion gene can affect myeloid DC differentiation directly and functions in a cell-autonomous manner, where fully leukemic transformation of the hematopoietic progenitors is not required exclusively.",17895399_8,-1,-1,-1,-1,5921,-1,7.92397e-06,0.99998534,6.688261e-06
5922,that the Mll-Een,6,9,37,53,"Taken together, our findings suggest that the Mll-Een fusion gene can affect myeloid DC differentiation directly and functions in a cell-autonomous manner, where fully leukemic transformation of the hematopoietic progenitors is not required exclusively.",17895399_8,-1,-1,-1,-1,5922,-1,6.2304143e-06,0.9999877,6.0764946e-06
5924,functions,18,19,117,126,"Taken together, our findings suggest that the Mll-Een fusion gene can affect myeloid DC differentiation directly and functions in a cell-autonomous manner, where fully leukemic transformation of the hematopoietic progenitors is not required exclusively.",17895399_8,0,1,2,-1,5924,-1,1.4462311e-05,0.9999697,1.5757729e-05
5932,to the,22,24,156,162,"Therefore, the study provides evidence for a direct causal relationship between leukemic gene fusion and abnormal DC differentiation, possibly contributing to the development of leukemia.",17895399_9,-1,-1,-1,-1,5932,-1,8.223584e-06,0.999985,6.782824e-06
5934,cells types,22,24,136,147,Interleukin-8 (IL-8) is an important mediator in neutrophil-mediated acute inflammation but has also a wide range of actions on various cells types.,17909856_0,-1,-1,-1,-1,5934,-1,4.1613504e-05,6.517246e-05,0.9998932
5943,the IL-8 release,18,21,104,120,The inhibition of the VZV replication with a drug interfering with its DNA replication had no effect on the IL-8 release.,17909856_2,-1,-1,-1,-1,5943,-1,0.0040701022,0.99566334,0.00026653818
5944,the IL-8,1,3,6,14,"Since the IL-8 promoter contains binding sites for NF-kappaB and AP-1, melanoma cells and the T cell line were treated with inhibitors of NF-kappaB, JNK/SAPK or p38/MAPK prior to infection.",17909856_3,-1,-1,-1,-1,5944,-1,0.75148654,0.24552527,0.0029881347
5948,the T cell,15,18,90,100,"Since the IL-8 promoter contains binding sites for NF-kappaB and AP-1, melanoma cells and the T cell line were treated with inhibitors of NF-kappaB, JNK/SAPK or p38/MAPK prior to infection.",17909856_3,-1,-1,-1,-1,5948,-1,0.0010527951,0.09891722,0.90003
5955,the IL-8,13,15,70,78,"In melanoma cells, the JNK/SAPK pathway was shown to be important for the IL-8 secretion during the VZV replication, whereas in the T cell line, not only the JNK/SAPK but also the p38/MAPK pathways were required for IL-8 secretion.",17909856_4,-1,-1,-1,-1,5955,-1,0.9478134,0.050393187,0.0017934907
5957,the T cell,23,26,128,138,"In melanoma cells, the JNK/SAPK pathway was shown to be important for the IL-8 secretion during the VZV replication, whereas in the T cell line, not only the JNK/SAPK but also the p38/MAPK pathways were required for IL-8 secretion.",17909856_4,-1,-1,-1,-1,5957,-1,0.0015032502,0.22280905,0.7756877
5962,the IL-8,3,5,22,30,"The neutralisation of the IL-8 bioactivity had no significant consequence on the VZV replication, suggesting that IL-8 acts neither as a proviral nor as an antiviral cytokine during the VZV replication in vitro.",17909856_5,-1,-1,-1,-1,5962,-1,0.90479463,0.092915855,0.0022895779
5964,that IL-8,16,18,109,118,"The neutralisation of the IL-8 bioactivity had no significant consequence on the VZV replication, suggesting that IL-8 acts neither as a proviral nor as an antiviral cytokine during the VZV replication in vitro.",17909856_5,-1,-1,-1,-1,5964,-1,0.9446754,0.053635247,0.0016893492
5968,tumor-associated antigen,19,21,89,113,"Survivin (SVV), a member of the inhibitors of apoptosis, has been considered as an ideal tumor-associated antigen due to its broad expression pattern in many types of human malignancies.",17931768_0,-1,-1,-1,-1,5968,-1,0.28950274,0.70582443,0.004672831
5975,protein,23,24,130,137,"Here, SVV-specific immune responses were evaluated with dendritic cells (DCs) loaded with a recombinant tatPTD fused SVV (tatSVV) protein both in vitro and in vivo system.",17931768_1,0,1,-1,-1,5975,-1,6.692168e-06,0.9999876,5.7167604e-06
5976,The tatPTD,0,2,0,10,The tatPTD fusion allowed for highly efficient and reproducible protein delivery into the DCs even in the presence of a phagocytosis inhibitor.,17931768_2,-1,-1,-1,-1,5976,-1,1.3217806e-05,0.9999753,1.1400254e-05
5977,protein,9,10,64,71,The tatPTD fusion allowed for highly efficient and reproducible protein delivery into the DCs even in the presence of a phagocytosis inhibitor.,17931768_2,0,1,-1,-1,5977,-1,1.5144158e-05,0.99997795,6.938078e-06
5981,T-cell,5,6,36,42,"The level of SVV-specific cytotoxic T-cell response appeared to be significantly higher for the T-cell line that was primed with the tatSVV-pulsed DCs, as compared to the T-cell line produced with naked (n)-SVV-pulsed DCs in vitro.",17931768_3,-1,1,2,-1,5981,-1,1.0582229e-05,5.963601e-06,0.99998343
5983,the T-cell,13,15,92,102,"The level of SVV-specific cytotoxic T-cell response appeared to be significantly higher for the T-cell line that was primed with the tatSVV-pulsed DCs, as compared to the T-cell line produced with naked (n)-SVV-pulsed DCs in vitro.",17931768_3,-1,-1,-1,-1,5983,-1,0.0016083053,0.12754601,0.87084574
5985,the tatSVV-pulsed,20,22,129,146,"The level of SVV-specific cytotoxic T-cell response appeared to be significantly higher for the T-cell line that was primed with the tatSVV-pulsed DCs, as compared to the T-cell line produced with naked (n)-SVV-pulsed DCs in vitro.",17931768_3,-1,-1,-1,-1,5985,-1,1.584924e-05,0.9999753,8.79757e-06
5986,to the T-cell,26,29,164,177,"The level of SVV-specific cytotoxic T-cell response appeared to be significantly higher for the T-cell line that was primed with the tatSVV-pulsed DCs, as compared to the T-cell line produced with naked (n)-SVV-pulsed DCs in vitro.",17931768_3,-1,-1,-1,-1,5986,-1,0.0024248317,0.36169904,0.63587606
5990,immune response than,11,14,76,96,"Mice that received a xenogeneic tatSVV-pulsed DC vaccine developed a higher immune response than mice vaccinated with the nSVV-pulsed DCs and exhibited prolonged mean survival rate, though mice injected with the DCs alone or the nSVV-pulsed DC also showed anti-tumor effects in the subcutaneous GL26 glioma model.",17931768_4,-1,-1,-1,-1,5990,-1,0.93884486,0.0597917,0.0013634283
6010,blood,14,15,101,106,CIN and cervical cancer patients showed increased CD4(+)/CD25(high) T cell frequencies in peripheral blood and CD4(+) T cell fraction.,17937675_3,0,1,-1,-1,6010,-1,0.00063781097,0.99368143,0.0056807236
6021,IFN-gamma T cell,19,22,108,124,"Moreover, in HPV16(+) cervical cancer patients, in-vitro depletion of CD25(+) T cells resulted in increased IFN-gamma T cell responses against HPV16 E6- and E7 peptides.",17937675_5,-1,-1,-1,-1,6021,-1,0.96364945,0.0001583655,0.036192123
6022,peptides,28,29,160,168,"Moreover, in HPV16(+) cervical cancer patients, in-vitro depletion of CD25(+) T cells resulted in increased IFN-gamma T cell responses against HPV16 E6- and E7 peptides.",17937675_5,0,-1,2,-1,6022,-1,0.0001366856,0.9997979,6.540708e-05
6025,immunity,15,16,100,108,"Thus, increased frequencies of T(regs) in cervical cancer patients may indeed suppress HPV-specific immunity.",17937675_6,0,-1,2,-1,6025,-1,0.99982554,5.4595224e-05,0.00011990504
6026,analysis,1,2,13,21,Longitudinal analysis of CD4(+)/CD25(high) T cell frequencies in patients showed a modest decline 1 year after curative surgery or chemoradiation.,17937675_7,0,1,-1,-1,6026,-1,6.0611833e-06,0.99998915,4.7815984e-06
6032,that T(regs,3,5,20,31,These results imply that T(regs) may suppress the immune control of cervical neoplasia and furthermore that suppression of immunity by T(regs) will be another hurdle to overcome in therapeutic immunization strategies against cervical neoplasia.,17937675_9,-1,-1,-1,-1,6032,-1,6.4839523e-06,0.99998665,6.9087428e-06
6035,immunity,19,20,123,131,These results imply that T(regs) may suppress the immune control of cervical neoplasia and furthermore that suppression of immunity by T(regs) will be another hurdle to overcome in therapeutic immunization strategies against cervical neoplasia.,17937675_9,0,-1,2,-1,6035,-1,0.9997683,0.00010922008,0.00012249696
6040,peptide,3,4,15,22,"A dual altered peptide ligand (APL), composed of the tandemly arranged two single amino acid analogs of two myasthenogenic peptides, p195-212 and p259-271, down-regulated in vitro and in vivo MG-associated T cell responses.",17956982_1,0,-1,2,-1,6040,-1,0.013244222,0.9854264,0.001329377
6041,the tandemly,11,13,49,61,"A dual altered peptide ligand (APL), composed of the tandemly arranged two single amino acid analogs of two myasthenogenic peptides, p195-212 and p259-271, down-regulated in vitro and in vivo MG-associated T cell responses.",17956982_1,-1,-1,-1,-1,6041,-1,5.1724414e-06,0.99998975,5.093353e-06
6044,peptides,22,23,123,131,"A dual altered peptide ligand (APL), composed of the tandemly arranged two single amino acid analogs of two myasthenogenic peptides, p195-212 and p259-271, down-regulated in vitro and in vivo MG-associated T cell responses.",17956982_1,0,-1,2,-1,6044,-1,0.0006996663,0.9991209,0.0001794318
6049,the mechanism of action,15,19,84,107,"In the present study, we investigated the role of CD8(+)CD28(-) regulatory cells in the mechanism of action of the dual APL.",17956982_2,-1,-1,-1,-1,6049,-1,8.95246e-06,0.99998355,7.5383537e-06
6051,that treatment,2,4,16,30,We demonstrated that treatment of mice with the dual APL concomitant with immunization with a myasthenogenic peptide resulted in an increased population of CD8(+)CD28(-) cells that express forkhead box P3 (Foxp3).,17956982_3,-1,-1,-1,-1,6051,-1,4.7487065e-06,0.9999912,4.0167683e-06
6053,peptide,16,17,109,116,We demonstrated that treatment of mice with the dual APL concomitant with immunization with a myasthenogenic peptide resulted in an increased population of CD8(+)CD28(-) cells that express forkhead box P3 (Foxp3).,17956982_3,0,-1,2,-1,6053,-1,0.5232265,0.47215715,0.00461636
6054,cells that,25,27,170,180,We demonstrated that treatment of mice with the dual APL concomitant with immunization with a myasthenogenic peptide resulted in an increased population of CD8(+)CD28(-) cells that express forkhead box P3 (Foxp3).,17956982_3,-1,-1,-1,-1,6054,-1,0.0027254333,0.25392094,0.7433536
6060,the Torpedo,14,16,69,80,"The dual APL inhibited the proliferation of lymph node (LN) cells of the Torpedo acetylcholine receptor-immunized WT C57BL/6 mice, whereas the inhibition was abrogated in CD8(-/-) knockout mice.",17956982_4,-1,-1,-1,-1,6060,-1,7.8488565e-06,0.99998426,7.8888625e-06
6061,receptor-immunized,17,18,95,113,"The dual APL inhibited the proliferation of lymph node (LN) cells of the Torpedo acetylcholine receptor-immunized WT C57BL/6 mice, whereas the inhibition was abrogated in CD8(-/-) knockout mice.",17956982_4,0,1,2,-1,6061,-1,0.07787558,0.84480995,0.077314466
6068,receptor,23,24,134,142,"Moreover, the dual APL did not inhibit the secretion of IFN-gamma by LN cells from CD8(-/-) mice immunized with Torpedo acetylcholine receptor.",17956982_5,0,1,2,-1,6068,-1,0.0008526981,0.048247106,0.95090026
6071,TGF-beta,8,9,42,50,"However, the mRNA expression of IL-10 and TGF-beta by LN cells from CD8(-/-) mice was up-regulated similarly to that of the WT mice.",17956982_6,0,1,-1,-1,6071,-1,3.303346e-05,0.9999559,1.1119004e-05
6073,to that,19,21,109,116,"However, the mRNA expression of IL-10 and TGF-beta by LN cells from CD8(-/-) mice was up-regulated similarly to that of the WT mice.",17956982_6,-1,-1,-1,-1,6073,-1,4.9804135e-06,0.99999,5.043155e-06
6081,to that,18,20,113,120,"Finally, the dual APL-induced CD4(+)CD25(+)Foxp3(+) cells were up-regulated in CD8(-/-) mice to a similar extent to that observed in the WT mice.",17956982_8,-1,-1,-1,-1,6081,-1,6.085929e-06,0.9999883,5.6078557e-06
6085,cells play,8,10,47,57,"Thus, we suggest that CD8(+)CD28(-) regulatory cells play a partial role in the mechanism of action by which the dual APL suppresses experimental autoimmune MG-associated T cell responses.",17956982_9,-1,-1,-1,-1,6085,-1,0.002387074,0.19414526,0.80346775
6086,the mechanism of action,14,18,76,99,"Thus, we suggest that CD8(+)CD28(-) regulatory cells play a partial role in the mechanism of action by which the dual APL suppresses experimental autoimmune MG-associated T cell responses.",17956982_9,-1,-1,-1,-1,6086,-1,7.312392e-06,0.9999857,6.956086e-06
6093,blood,15,16,99,104,"Mast cells are effector cells of IgE-mediated immune responses frequently found at the vicinity of blood vessels, the margins of diverse tumors and at sites of potential infection and inflammation.",17982078_0,0,1,-1,-1,6093,-1,0.23256728,0.28189245,0.48554024
6100,the AP-1 transcription factor,8,12,41,70,"Recent work identified JunB, a member of the AP-1 transcription factor family, as critical regulator of basal and induced expression of inflammatory mediators in fibroblasts and T cells.",17982078_2,-1,-1,-1,-1,6100,-1,5.1725688e-06,0.9999895,5.360227e-06
6115,these cells,1,3,4,15,"But these cells exhibit impaired IgE-mediated degranulation most likely due to diminished expression of SWAP-70, Synaptotagmin-1, and VAMP-8, and due to impaired influx of extracellular calcium.",17982078_5,-1,-1,-1,-1,6115,-1,3.1586365e-05,5.576833e-05,0.9999126
6125,cells to,11,13,69,77,"In line with these findings, the contribution of JunB-deficient mast cells to angiogenesis, as analyzed in an in vitro tube formation assay on matrigel, is severely impaired due to limiting amounts of synthesized and secreted vascular endothelial growth factor.",17982078_7,-1,-1,-1,-1,6125,-1,0.0034431415,0.2595804,0.7369765
6127,to limiting,31,33,178,189,"In line with these findings, the contribution of JunB-deficient mast cells to angiogenesis, as analyzed in an in vitro tube formation assay on matrigel, is severely impaired due to limiting amounts of synthesized and secreted vascular endothelial growth factor.",17982078_7,-1,-1,-1,-1,6127,-1,0.021751573,0.9765302,0.0017182031
6131,cell functions,10,12,53,67,"Thus, JunB is a critical regulator of intrinsic mast cell functions including cross-talk with endothelial cells.",17982078_8,-1,-1,-1,-1,6131,-1,2.4845838e-05,1.8986286e-05,0.99995625
6133,functional status,2,4,12,29,"We examined functional status, activation mechanisms, and biologic role of the mTORC1 signaling pathway in malignant CD4(+) T cells derived from the cutaneous T-cell lymphoma (CTCL).",18025151_0,-1,-1,-1,-1,6133,-1,3.2453674e-05,0.9999373,3.0271389e-05
6137,T-cell,26,27,159,165,"We examined functional status, activation mechanisms, and biologic role of the mTORC1 signaling pathway in malignant CD4(+) T cells derived from the cutaneous T-cell lymphoma (CTCL).",18025151_0,-1,1,2,-1,6137,-1,1.575705e-05,6.1190044e-06,0.9999782
6140,the TORC1,11,13,93,102,"Whereas the spontaneously growing CTCL-derived cell lines displayed persistent activation of the TORC1 as well as the PI3K/Akt and MEK/ERK pathways, the IL-2-dependent cell lines activated the pathways in response to IL-2 and IL-15 but not IL-21.",18025151_1,-1,-1,-1,-1,6140,-1,5.043176e-06,0.99998176,1.3189646e-05
6151,tissues,8,9,48,55,mTORC1 activation was also detected in the CTCL tissues in the lymphoma stage-dependent manner with the highest percentage of positive cells present in the cases with a large cell transformation.,18025151_4,-1,1,2,-1,6151,-1,6.6155306e-05,3.579425e-05,0.9998981
6156,cell transformation,28,30,175,194,mTORC1 activation was also detected in the CTCL tissues in the lymphoma stage-dependent manner with the highest percentage of positive cells present in the cases with a large cell transformation.,18025151_4,-1,-1,-1,-1,6156,-1,6.794168e-05,0.00037834322,0.99955374
6162,through the,7,9,57,68,"Finally, mTORC1 activation was transduced preferentially through the PI3K/Akt pathway.",18025151_7,-1,-1,-1,-1,6162,-1,5.3153044e-06,0.99999046,4.1969074e-06
6169,that the,18,20,136,144,"These findings document the selective gammac-signaling cytokine-mediated activation of the mTORC1 pathway in the CTCL cells and suggest that the pathway represents a therapeutic target in CTCL and, possibly, other T-cell lymphomas.",18025151_8,-1,-1,-1,-1,6169,-1,4.1028793e-06,0.9999918,4.0693085e-06
6170,therapeutic target,23,25,166,184,"These findings document the selective gammac-signaling cytokine-mediated activation of the mTORC1 pathway in the CTCL cells and suggest that the pathway represents a therapeutic target in CTCL and, possibly, other T-cell lymphomas.",18025151_8,-1,-1,-1,-1,6170,-1,4.733109e-06,0.9999913,4.023033e-06
6171,T-cell,32,33,214,220,"These findings document the selective gammac-signaling cytokine-mediated activation of the mTORC1 pathway in the CTCL cells and suggest that the pathway represents a therapeutic target in CTCL and, possibly, other T-cell lymphomas.",18025151_8,-1,1,2,-1,6171,-1,1.3690753e-05,5.702454e-06,0.99998057
6173,function,5,6,30,38,We examined the phenotype and function of CD4+ T cells expressing the semaphorin III receptor neuropilin-1 (Nrp1) in human lymph nodes and peripheral blood.,18028372_0,0,1,2,-1,6173,-1,5.961214e-05,0.99985623,8.410901e-05
6176,receptor,15,16,85,93,We examined the phenotype and function of CD4+ T cells expressing the semaphorin III receptor neuropilin-1 (Nrp1) in human lymph nodes and peripheral blood.,18028372_0,0,1,2,-1,6176,-1,0.012990908,0.56474584,0.42226323
6177,blood,26,27,150,155,We examined the phenotype and function of CD4+ T cells expressing the semaphorin III receptor neuropilin-1 (Nrp1) in human lymph nodes and peripheral blood.,18028372_0,0,1,-1,-1,6177,-1,0.00090403174,0.97887254,0.020223409
6178,T-cell,13,14,67,73,"In lymph nodes, Nrp1 identified a small regulatory CD4+ CD25(high) T-cell subpopulation (Nrp1+ Treg) that expressed higher levels of Forkhead box P3 (Foxp3) message and protein than Nrp1- Treg, and various molecular markers of activated Treg, i.e. CD45RO, human leucocyte antigen (HLA)-DR and glucocorticoid-induced tumour necrosis factor receptor (GITR).",18028372_1,-1,1,2,-1,6178,-1,1.1220173e-05,6.524341e-06,0.99998224
6187,tumour necrosis factor receptor,55,59,316,347,"In lymph nodes, Nrp1 identified a small regulatory CD4+ CD25(high) T-cell subpopulation (Nrp1+ Treg) that expressed higher levels of Forkhead box P3 (Foxp3) message and protein than Nrp1- Treg, and various molecular markers of activated Treg, i.e. CD45RO, human leucocyte antigen (HLA)-DR and glucocorticoid-induced tumour necrosis factor receptor (GITR).",18028372_1,-1,-1,-1,-1,6187,-1,0.9778235,0.007860839,0.014315679
6196,T cells that,15,18,77,89,"Nrp1 was also expressed on a small subpopulation of CD25(int) and CD25- CD4+ T cells that expressed more Foxp3, CD45RO, HLA-DR and GITR than their Nrp1- counterparts.",18028372_4,-1,-1,-1,-1,6196,-1,0.0013731893,0.040057052,0.95856977
6198,than their,27,29,136,146,"Nrp1 was also expressed on a small subpopulation of CD25(int) and CD25- CD4+ T cells that expressed more Foxp3, CD45RO, HLA-DR and GITR than their Nrp1- counterparts.",18028372_4,-1,-1,-1,-1,6198,-1,5.7818843e-06,0.99998915,5.014136e-06
6199,blood,5,6,27,32,"In contrast, in peripheral blood Nrp1 identified a minor CD4+ T-cell subset that did not display the phenotypic features of Treg lacking Foxp3 expression and marginally expressing CD25.",18028372_5,0,1,-1,-1,6199,-1,0.00021657885,0.9994236,0.00035979762
6200,T-cell subset that,12,15,62,80,"In contrast, in peripheral blood Nrp1 identified a minor CD4+ T-cell subset that did not display the phenotypic features of Treg lacking Foxp3 expression and marginally expressing CD25.",18028372_5,-1,-1,-1,-1,6200,-1,0.0009075409,0.009093074,0.98999935
6204,marginally,27,28,158,168,"In contrast, in peripheral blood Nrp1 identified a minor CD4+ T-cell subset that did not display the phenotypic features of Treg lacking Foxp3 expression and marginally expressing CD25.",18028372_5,-1,-1,-1,-1,6204,-1,8.572411e-06,0.9999831,8.302314e-06
6205,the function,2,4,7,19,"Hence, the function of Nrp1+ CD4+ T cells seemingly depends on their anatomical location.",18028372_6,-1,-1,-1,-1,6205,-1,1.3583072e-05,0.9999769,9.5596015e-06
6208,that Treg,7,9,34,43,"In a previous report, we proposed that Treg may curb the anti-tumour T-cell response in cervical cancer.",18028372_7,-1,-1,-1,-1,6208,-1,9.312427e-06,0.9999857,4.9914997e-06
6210,T-cell,13,14,69,75,"In a previous report, we proposed that Treg may curb the anti-tumour T-cell response in cervical cancer.",18028372_7,-1,1,2,-1,6210,-1,2.4074594e-05,1.106203e-05,0.99996483
6211,that Treg,3,5,13,22,"We show here that Treg and Nrp1+ Treg levels dropped in the tumour-draining lymph nodes of patients with cervical cancer following preoperative chemoradiotherapy in a direct relationship with the reduction of tumour mass, suggesting that suppressor cell elimination facilitated the generation of T cells mediating the destruction of the neoplastic cells left behind after cytotoxic therapy.",18028372_8,-1,-1,-1,-1,6211,-1,5.323136e-06,0.9999895,5.156129e-06
6213,the tumour-draining,12,14,56,75,"We show here that Treg and Nrp1+ Treg levels dropped in the tumour-draining lymph nodes of patients with cervical cancer following preoperative chemoradiotherapy in a direct relationship with the reduction of tumour mass, suggesting that suppressor cell elimination facilitated the generation of T cells mediating the destruction of the neoplastic cells left behind after cytotoxic therapy.",18028372_8,-1,-1,-1,-1,6213,-1,3.892267e-05,0.99993205,2.8968045e-05
6218,that suppressor cell,36,39,233,253,"We show here that Treg and Nrp1+ Treg levels dropped in the tumour-draining lymph nodes of patients with cervical cancer following preoperative chemoradiotherapy in a direct relationship with the reduction of tumour mass, suggesting that suppressor cell elimination facilitated the generation of T cells mediating the destruction of the neoplastic cells left behind after cytotoxic therapy.",18028372_8,-1,-1,-1,-1,6218,-1,0.002751762,0.17541425,0.82183397
6219,the generation,41,43,278,292,"We show here that Treg and Nrp1+ Treg levels dropped in the tumour-draining lymph nodes of patients with cervical cancer following preoperative chemoradiotherapy in a direct relationship with the reduction of tumour mass, suggesting that suppressor cell elimination facilitated the generation of T cells mediating the destruction of the neoplastic cells left behind after cytotoxic therapy.",18028372_8,-1,-1,-1,-1,6219,-1,8.110434e-06,0.999987,4.827785e-06
6224,therapy,57,58,382,389,"We show here that Treg and Nrp1+ Treg levels dropped in the tumour-draining lymph nodes of patients with cervical cancer following preoperative chemoradiotherapy in a direct relationship with the reduction of tumour mass, suggesting that suppressor cell elimination facilitated the generation of T cells mediating the destruction of the neoplastic cells left behind after cytotoxic therapy.",18028372_8,0,1,-1,-1,6224,-1,2.3858478e-05,0.9999645,1.1651605e-05
6226,that play,4,6,29,38,Among the several mechanisms that play role in maintaining peripheral self-tolerance is the existence of a unique CD4+CD25+ population of naturally occurring regulatory T (Treg) cells that actively prevent both the activation and the effector function of autoreactive T cells that have escaped different mechanisms of tolerance.,18092144_0,-1,-1,-1,-1,6226,-1,6.0984817e-06,0.9999889,4.969998e-06
6231,cells that,28,30,178,188,Among the several mechanisms that play role in maintaining peripheral self-tolerance is the existence of a unique CD4+CD25+ population of naturally occurring regulatory T (Treg) cells that actively prevent both the activation and the effector function of autoreactive T cells that have escaped different mechanisms of tolerance.,18092144_0,-1,-1,-1,-1,6231,-1,0.0031798955,0.33316055,0.66365945
6234,function,38,39,243,251,Among the several mechanisms that play role in maintaining peripheral self-tolerance is the existence of a unique CD4+CD25+ population of naturally occurring regulatory T (Treg) cells that actively prevent both the activation and the effector function of autoreactive T cells that have escaped different mechanisms of tolerance.,18092144_0,0,1,2,-1,6234,-1,7.678491e-05,0.99974567,0.00017758226
6235,T cells that,41,44,268,280,Among the several mechanisms that play role in maintaining peripheral self-tolerance is the existence of a unique CD4+CD25+ population of naturally occurring regulatory T (Treg) cells that actively prevent both the activation and the effector function of autoreactive T cells that have escaped different mechanisms of tolerance.,18092144_0,-1,-1,-1,-1,6235,-1,0.0010374292,0.018614456,0.98034805
6238,targeting this cell,7,10,39,58,Many studies have shown the benefit of targeting this cell population by restoring self-tolerance.,18092144_1,-1,-1,-1,-1,6238,-1,0.0024637887,0.48825276,0.5092835
6239,Therapies that,0,2,0,14,Therapies that could possibly increase the suppressive ability of T regulatory cells were proven to improve that course of autoimmune diseases.,18092144_2,-1,-1,-1,-1,6239,-1,6.1354367e-06,0.99998975,4.1538674e-06
6249,to the generation,17,20,99,116,Activation and expansion of T helper (Th) cells followed by regulation of activation are essential to the generation of immune responses while limiting concomitant autoreactivity.,18156498_0,-1,-1,-1,-1,6249,-1,2.58083e-05,0.9999629,1.123155e-05
6255,analysis,21,22,145,153,"In order to characterize T cells reactive towards myeloma-derived monoclonal immunoglobulin (mIg), an autologous coculture assay for single-cell analysis of mIg-responding cells was developed.",18156498_1,0,1,-1,-1,6255,-1,0.00025422746,0.97385263,0.02589314
6258,Th cells,11,13,59,67,"When cultured with dendritic cells loaded with mIg, CD4(+) Th cells from patients with progressing multiple myeloma (MM) showed a proliferative MHC class II-dependent response.",18156498_2,-1,-1,-1,-1,6258,-1,9.254267e-06,7.287007e-06,0.99998343
6259,T-cell,2,3,7,13,"CD8(+) T-cell reactivity and Th1 activation were consistently low or absent, and Th2 and regulatory cytokines were expressed.",18156498_3,-1,1,2,-1,6259,-1,1.3419275e-05,9.186617e-06,0.99997735
6266,blood,11,12,58,63,"The presence of such non-Th1 CD4(+) T cells in peripheral blood was independent of treatment status, while the frequencies of responding cells varied between patients and reached the same order of magnitude as those measured for tetanus toxoid-specific Th memory cells.",18156498_4,0,1,-1,-1,6266,-1,0.001396895,0.98010856,0.018494582
6267,treatment status,15,17,83,99,"The presence of such non-Th1 CD4(+) T cells in peripheral blood was independent of treatment status, while the frequencies of responding cells varied between patients and reached the same order of magnitude as those measured for tetanus toxoid-specific Th memory cells.",18156498_4,-1,-1,-1,-1,6267,-1,7.724932e-06,0.9999863,5.9765994e-06
6272,tetanus toxoid-specific Th,38,41,229,255,"The presence of such non-Th1 CD4(+) T cells in peripheral blood was independent of treatment status, while the frequencies of responding cells varied between patients and reached the same order of magnitude as those measured for tetanus toxoid-specific Th memory cells.",18156498_4,-1,-1,-1,-1,6272,-1,7.390147e-05,0.9999032,2.291731e-05
6274,T-cell,4,5,31,37,"Furthermore, investigations of T-cell subpopulations indicated a possible regulatory role on the mIg responsiveness mediated by suppressive CD25(high)FOXP3(+)CD4(+) T cells.",18156498_5,-1,1,2,-1,6274,-1,1.0289201e-05,7.5608223e-06,0.99998224
6284,the therapeutic,4,6,24,39,"Previously, we reported the therapeutic properties of a vaccine prepared by transfer of a cDNA-expression library from breast cancer cells into a highly immunogenic allogeneic fibroblast cell line where genes specifying an array of breast cancer antigens were expressed.",18157008_1,-1,-1,-1,-1,6284,-1,4.7872722e-06,0.99999154,3.7126595e-06
6291,this cell-based,7,9,35,50,"Here, we report the application of this cell-based vaccination strategy for breast cancer metastatic to the brain.",18157008_2,-1,-1,-1,-1,6291,-1,0.0032049639,0.2629209,0.7338741
6292,to the,15,17,101,107,"Here, we report the application of this cell-based vaccination strategy for breast cancer metastatic to the brain.",18157008_2,-1,-1,-1,-1,6292,-1,4.884817e-06,0.9999894,5.7733014e-06
6302,immunity to the,1,4,9,24,"Enhanced immunity to the neoplasm mediated predominantly by CD4+, CD8+, and NK/LAK cells was generated in the spleens of mice injected intracerebrally into the tumor bed with cells from the enriched vaccine, which translated into prolonged survival.",18157008_4,-1,-1,-1,-1,6302,-1,0.029872833,0.9693927,0.0007344378
6306,the tumor,27,29,156,165,"Enhanced immunity to the neoplasm mediated predominantly by CD4+, CD8+, and NK/LAK cells was generated in the spleens of mice injected intracerebrally into the tumor bed with cells from the enriched vaccine, which translated into prolonged survival.",18157008_4,-1,-1,-1,-1,6306,-1,3.848931e-06,0.99999166,4.5473453e-06
6324,the Toll-like receptor-9,9,12,67,91,"Moreover, we compared standard BCG immunotherapy side-by-side with the Toll-like receptor-9 agonist CpG. MB49 tumor-bearing mice were treated with BCG or CpG and survival as well as tumor progression were observed over time.",18157010_4,-1,-1,-1,-1,6324,-1,0.0025758052,0.9938544,0.0035697706
6329,Urine,0,1,0,5,"Urine, blood, and tumors were collected and analyzed.",18157010_5,0,1,-1,-1,6329,-1,0.0005374648,0.9993895,7.299071e-05
6330,blood,2,3,7,12,"Urine, blood, and tumors were collected and analyzed.",18157010_5,0,1,-1,-1,6330,-1,0.00023646068,0.99961567,0.00014780124
6332,tumor-specific immunity,6,8,41,64,Mice were rechallenged and evaluated for tumor-specific immunity.,18157010_6,-1,-1,-1,-1,6332,-1,0.07028698,0.92802536,0.001687638
6336,immunity,21,22,137,145,"In this study, CpGs induced a complete response of large aggressive orthotopic MB49 bladder tumors, resulting in tumor-specific systemic immunity.",18157010_7,0,-1,2,-1,6336,-1,0.9998913,3.617569e-05,7.2545285e-05
6337,that this,4,6,24,33,"Further, data indicated that this potent antitumor effect required T cells.",18157010_8,-1,-1,-1,-1,6337,-1,6.1931696e-06,0.9999894,4.4438093e-06
6352,immunity,10,11,80,88,"Further, immune cell depletion studies demonstrated that CpG-induced protective immunity was CD4+ T-cell dependent.",18157010_12,0,-1,2,-1,6352,-1,0.99964046,0.00014528059,0.00021428571
6353,T-cell,14,15,98,104,"Further, immune cell depletion studies demonstrated that CpG-induced protective immunity was CD4+ T-cell dependent.",18157010_12,-1,1,2,-1,6353,-1,1.3846222e-05,7.318956e-06,0.9999789
6354,Taken together,0,2,0,14,"Taken together, our data suggest that CpGs are superior to BCG for bladder cancer immunotherapy.",18157010_13,-1,-1,-1,-1,6354,-1,1.1951021e-05,0.99997914,8.865928e-06
6364,peptides,23,24,114,122,PURPOSE: The study aims to evaluate the effect of a human papillomavirus type 16 (HPV16) E6 and E7 synthetic long peptides vaccine on the antigen-specific T-cell response in cervical cancer patients.,18172269_0,0,-1,2,-1,6364,-1,0.0035633969,0.99528486,0.0011517743
6365,the antigen-specific T-cell,26,29,134,161,PURPOSE: The study aims to evaluate the effect of a human papillomavirus type 16 (HPV16) E6 and E7 synthetic long peptides vaccine on the antigen-specific T-cell response in cervical cancer patients.,18172269_0,-1,-1,-1,-1,6365,-1,0.045189787,0.42218775,0.5326224
6366,peptides,17,18,123,131,EXPERIMENTAL DESIGN: Patients with resected HPV16-positive cervical cancer were vaccinated with an overlapping set of long peptides comprising the sequences of the HPV16 E6 and E7 oncoproteins emulsified in Montanide ISA-51.,18172269_1,0,-1,2,-1,6366,-1,0.00054061535,0.9993268,0.00013261699
6369,T-cell immune responses,1,4,15,38,"HPV16-specific T-cell immune responses were analyzed by evaluating the magnitude, breadth, type, and polarization by proliferation assays, IFN gamma-ELISPOT, and cytokine production and phenotyped by the T-cell markers CD4, CD8, CD25, and Foxp3.RESULTS: Vaccine-induced T-cell responses against HPV16 E6 and E7 were detected in six of six and five of six patients, respectively.",18172269_2,-1,-1,-1,-1,6369,-1,0.15678263,0.001216613,0.8420007
6374,the T-cell,30,32,200,210,"HPV16-specific T-cell immune responses were analyzed by evaluating the magnitude, breadth, type, and polarization by proliferation assays, IFN gamma-ELISPOT, and cytokine production and phenotyped by the T-cell markers CD4, CD8, CD25, and Foxp3.RESULTS: Vaccine-induced T-cell responses against HPV16 E6 and E7 were detected in six of six and five of six patients, respectively.",18172269_2,-1,-1,-1,-1,6374,-1,0.0025584172,0.16938905,0.8280526
6375,T-cell,43,44,270,276,"HPV16-specific T-cell immune responses were analyzed by evaluating the magnitude, breadth, type, and polarization by proliferation assays, IFN gamma-ELISPOT, and cytokine production and phenotyped by the T-cell markers CD4, CD8, CD25, and Foxp3.RESULTS: Vaccine-induced T-cell responses against HPV16 E6 and E7 were detected in six of six and five of six patients, respectively.",18172269_2,-1,1,2,-1,6375,-1,3.6804755e-05,1.43900825e-05,0.99994874
6383,cytokine IFN,12,14,91,103,The vaccine-induced responses were dominated by effector type CD4(+)CD25(+)Foxp3(-) type 1 cytokine IFN gamma-producing T cells but also included the expansion of T cells with a CD4(+)CD25(+)Foxp3(+) phenotype.,18172269_4,-1,-1,-1,-1,6383,-1,0.9999459,7.872574e-06,4.6204117e-05
6388,peptides,9,10,48,56,"CONCLUSIONS: The HPV16 E6 and E7 synthetic long peptides vaccine is highly immunogenic, in that it increases the number and activity of HPV16-specific CD4(+) and CD8(+) T cells to a broad array of epitopes in all patients.",18172269_5,0,-1,2,-1,6388,-1,0.00014648205,0.99974245,0.000111070774
6391,T cells to,30,33,169,179,"CONCLUSIONS: The HPV16 E6 and E7 synthetic long peptides vaccine is highly immunogenic, in that it increases the number and activity of HPV16-specific CD4(+) and CD8(+) T cells to a broad array of epitopes in all patients.",18172269_5,-1,-1,-1,-1,6391,-1,0.001579496,0.029394057,0.96902645
6393,tumor-specific T cells,8,11,35,57,"The expansion of CD4(+) and CD8(+) tumor-specific T cells, both considered to be important in the antitumor response, indicates the immunotherapeutic potential of this vaccine.",18172269_6,-1,-1,-1,-1,6393,-1,0.0037206358,0.68609893,0.31018037
6401,regulatory T-cell function,18,21,122,148,"Notably, part of the vaccine-induced T cells display a CD4(+)CD25(+)Foxp3(+) phenotype that is frequently associated with regulatory T-cell function, suggesting that strategies to disarm this subset of T cells should be considered as components of immunotherapeutic modalities against HPV-induced cancers.",18172269_7,-1,-1,-1,-1,6401,-1,1.0236687e-05,8.9383e-06,0.9999808
6404,this subset,27,29,187,198,"Notably, part of the vaccine-induced T cells display a CD4(+)CD25(+)Foxp3(+) phenotype that is frequently associated with regulatory T-cell function, suggesting that strategies to disarm this subset of T cells should be considered as components of immunotherapeutic modalities against HPV-induced cancers.",18172269_7,-1,-1,-1,-1,6404,-1,0.0025933757,0.53124845,0.46615815
6410,immunity,23,24,126,134,It has been reported that an increased population of regulatory T cells (Tregs) is one of the reasons for impaired anti-tumor immunity.,18224687_0,0,-1,2,-1,6410,-1,0.99966776,0.0001309085,0.0002012321
6425,the relationship,14,16,96,112,"Furthermore, to elucidate the mechanisms behind Treg accumulation within tumors, they evaluated the relationship between CCL17 or CCL22 expression and the frequency of Foxp3(+) Tregs in gastric cancer.",18224687_3,-1,-1,-1,-1,6425,-1,7.111624e-06,0.99998844,4.4803073e-06
6426,CCL17,17,18,121,126,"Furthermore, to elucidate the mechanisms behind Treg accumulation within tumors, they evaluated the relationship between CCL17 or CCL22 expression and the frequency of Foxp3(+) Tregs in gastric cancer.",18224687_3,0,-1,2,-1,6426,-1,0.9993051,3.759464e-05,0.00065721135
6435,CCL17,19,20,112,117,"Moreover, an in vitro migration assay using Tregs derived from gastric cancers was performed in the presence of CCL17 or CCL22.",18224687_5,0,-1,2,-1,6435,-1,0.9996201,2.7206106e-05,0.0003527085
6441,than that,15,17,78,87,"As a result, the frequency of Foxp3(+) Tregs in TILs was significantly higher than that in normal gastric mucosa (12.4% +/- 7.5% vs. 4.1% +/- 5.3%, p < 0.01).",18224687_6,-1,-1,-1,-1,6441,-1,6.012587e-06,0.9999882,5.8360697e-06
6445,to the,9,11,52,58,"Importantly, the increase in Tregs in TILs occurred to the same extent in early and advanced disease.",18224687_7,-1,-1,-1,-1,6445,-1,6.201337e-06,0.9999883,5.5318233e-06
6447,CCL17(+,5,6,30,37,"Furthermore, the frequency of CCL17(+) or CCL22(+) cells among CD14(+) cells within tumors was significantly higher than that of normal gastric mucosa, and there was a significant correlation between the frequency of CCL17(+) or CCL22(+) cells and Foxp3(+) Tregs in TILs.",18224687_8,0,-1,2,-1,6447,-1,0.9973411,0.00018251075,0.0024763923
6452,than that,20,22,116,125,"Furthermore, the frequency of CCL17(+) or CCL22(+) cells among CD14(+) cells within tumors was significantly higher than that of normal gastric mucosa, and there was a significant correlation between the frequency of CCL17(+) or CCL22(+) cells and Foxp3(+) Tregs in TILs.",18224687_8,-1,-1,-1,-1,6452,-1,6.1814117e-06,0.99998796,5.8156666e-06
6455,CCL17(+,37,38,217,224,"Furthermore, the frequency of CCL17(+) or CCL22(+) cells among CD14(+) cells within tumors was significantly higher than that of normal gastric mucosa, and there was a significant correlation between the frequency of CCL17(+) or CCL22(+) cells and Foxp3(+) Tregs in TILs.",18224687_8,0,-1,2,-1,6455,-1,0.997715,0.00016468247,0.0021202927
6462,that Tregs,9,11,52,62,"In addition, the in vitro migration assay indicated that Tregs were significantly induced to migrate by CCL17 or CCL22.",18224687_9,-1,-1,-1,-1,6462,-1,6.885935e-06,0.9999882,4.9483715e-06
6464,CCL17,17,18,104,109,"In addition, the in vitro migration assay indicated that Tregs were significantly induced to migrate by CCL17 or CCL22.",18224687_9,0,-1,2,-1,6464,-1,0.9995296,3.293572e-05,0.00043755103
6466,CCL17,3,4,15,20,"In conclusion, CCL17 and CCL22 within the tumor are related to the increased population of Foxp3(+) Tregs, with such an observation occurring in early gastric cancer.",18224687_10,0,-1,2,-1,6466,-1,0.9992092,4.6402973e-05,0.0007444058
6468,the tumor,7,9,38,47,"In conclusion, CCL17 and CCL22 within the tumor are related to the increased population of Foxp3(+) Tregs, with such an observation occurring in early gastric cancer.",18224687_10,-1,-1,-1,-1,6468,-1,3.7763343e-06,0.99999094,5.2612127e-06
6469,related to the,10,13,52,66,"In conclusion, CCL17 and CCL22 within the tumor are related to the increased population of Foxp3(+) Tregs, with such an observation occurring in early gastric cancer.",18224687_10,-1,-1,-1,-1,6469,-1,6.883027e-06,0.9999882,4.882887e-06
6475,therapy,8,9,45,52,Here we report the effects of systemic IL-21 therapy on the immune system in two phase 1 trials with this novel cytokine.,18286285_1,0,1,-1,-1,6475,-1,5.696073e-06,0.99998915,5.0951085e-06
6482,two planned treatment,20,23,132,153,EXPERIMENTAL DESIGN: Recombinant IL-21 was administered by intravenous bolus injection at dose levels from 1 to 100 microg/kg using two planned treatment regimens: thrice weekly for 6 weeks (3/week); or once daily for five consecutive days followed by nine dose-free days (5 + 9).,18286285_2,-1,-1,-1,-1,6482,-1,6.765425e-06,0.9999877,5.505762e-06
6485,blood,7,8,52,57,"The following biomarkers were studied in peripheral blood mononuclear cells (PBMC) during treatment: phosphorylation of STAT3, alterations in the composition of leukocyte subsets, ex vivo cytotoxicity, expression of effector molecules in enriched CD8(+) T cells and CD56(+) NK cells by quantitative RT-PCR, and gene array profiling of CD8(+) T cells.",18286285_3,0,1,-1,-1,6485,-1,0.00017785691,0.99942684,0.00039527073
6501,transcriptome analysis,4,6,18,40,"In addition, full transcriptome analysis of CD8(+) T cells displayed changes in several transcripts associated with increased cell cycle progression, cellular motility, and immune activation.",18286285_7,-1,-1,-1,-1,6501,-1,5.6889503e-06,0.9999882,6.1630835e-06
6508,cells to,12,14,74,82,"Finally, cytotoxicity assays showed that IL-21 enhanced the ability of NK cells to kill sensitive targets ex vivo.",18286285_8,-1,-1,-1,-1,6508,-1,0.0034840617,0.30801833,0.6884976
6520,cell function,25,27,167,180,"As CD4+CD25highFoxp3+ naturally occurring T regulatory cells in melanoma patients express ICOS, we investigated the impact of ICOS on naturally occurring T regulatory cell function.",18292519_1,-1,-1,-1,-1,6520,-1,1.3489127e-05,1.2069017e-05,0.9999745
6525,tumor-infiltrating lymphocytes,22,24,116,146,METHODS: Expression of ICOS and T regulatory (Treg) cell markers was determined on CD4+CD25high T cells in PBMC and tumor-infiltrating lymphocytes from melanoma patients (n=10) and PBMC of normal controls (n=10) by multicolor flow cytometry.,18292519_2,-1,-1,-1,-1,6525,-1,0.0021656428,0.8565096,0.14132477
6537,tumor-infiltrating lymphocytes,19,21,116,146,"ICOShigh and ICOS- Treg were also expanded under conditions previously shown to induce Tr1 from RC.RESULTS: Treg in tumor-infiltrating lymphocytes expressed ICOS (mean fluorescence intensity=70+/-10), while Treg in PBMC had low ICOS expression (mean fluorescence intensity=3.5+/-2.5, p<or=0.001).",18292519_6,-1,-1,-1,-1,6537,-1,0.002171406,0.8513602,0.14646836
6541,relative to,19,21,101,112,ICOShigh Treg up-regulated Treg markers (p<or=0.0016) and mediated stronger suppression (p<or=0.001) relative to ICOSlow Treg.,18292519_7,-1,-1,-1,-1,6541,-1,5.9235613e-06,0.9999893,4.7566477e-06
6544,Tr1 cells,3,5,22,31,ICOShigh Treg induced Tr1 cells in nonactivated RC and Th2 cells in preactivated RC.,18292519_8,-1,-1,-1,-1,6544,-1,2.3585335e-05,5.381353e-05,0.99992263
6547,to Tr1 cytokines,3,6,22,38,"ICOShigh Treg exposed to Tr1 cytokines expressed IL-10 and suppressed RC (92+/-12%) in contrast to ICOSlow Treg, which mediated low suppression (21+/-15%; p<or=0.0028).CONCLUSION: ICOShigh Treg can induce diverse immune responses in RC, depending on activation signals and cytokines present.",18292519_9,-1,-1,-1,-1,6547,-1,0.049772818,0.9481141,0.002113137
6561,Treg transit to Tr1,9,13,37,56,"In a ""Tr1"" cytokine milieu, ICOShigh Treg transit to Tr1.",18292519_11,-1,-1,-1,-1,6561,-1,4.350536e-06,0.9999825,1.31387615e-05
6562,T-cell,1,2,6,12,Adult T-cell leukemia/lymphoma is an aggressive lymphoproliferative disorder of CD4+ T lymphocytes associated with human T-cell leukemia virus type 1 (HTLV-I) infection.,18300056_0,-1,1,2,-1,6562,-1,1.3055787e-05,1.0048297e-05,0.9999769
6564,T-cell,16,17,121,127,Adult T-cell leukemia/lymphoma is an aggressive lymphoproliferative disorder of CD4+ T lymphocytes associated with human T-cell leukemia virus type 1 (HTLV-I) infection.,18300056_0,-1,1,2,-1,6564,-1,1.4265967e-05,1.0536987e-05,0.9999752
6572,to the,4,6,25,31,Recent advances have led to the identification of key molecules and cellular pathways involved in HTLV-1 mediated cellular transformation and tumor progression.,18300056_3,-1,-1,-1,-1,6572,-1,4.3021687e-06,0.99999106,4.6069554e-06
6574,cellular transformation,17,19,114,137,Recent advances have led to the identification of key molecules and cellular pathways involved in HTLV-1 mediated cellular transformation and tumor progression.,18300056_3,-1,-1,-1,-1,6574,-1,5.0430215e-05,0.000112341295,0.99983716
6579,targets that,21,23,130,142,"We describe within a few key elements that contribute to neoplastic development of ATL, in addition to interesting molecular drug targets that may lead to more effective therapeutic strategies.",18300056_4,-1,-1,-1,-1,6579,-1,5.1013403e-06,0.99998975,5.112513e-06
6588,therapeutic tumor-infiltrating lymphocytes,36,39,199,241,"The exact role of CD4+CD25(high) regulatory T cells (Treg) in adoptive immunotherapy of melanoma is still to be determined, and an association between an expansion of Treg cells and the expansion of therapeutic tumor-infiltrating lymphocytes (TIL) remains unelucidated.",18312383_0,-1,-1,-1,-1,6588,-1,0.0019741051,0.9118965,0.086129405
6593,functional Treg cells,13,16,63,84,"In this context, the aim of our study was to determine whether functional Treg cells were detectable and amplified among in vitro-expanded TIL from 10 metastatic melanoma lymph nodes (LNs).",18312383_1,-1,-1,-1,-1,6593,-1,0.0009325031,0.0018291875,0.9972383
6599,functionality,24,25,156,169,"In this study, we investigated the expression of forkhead/winged helix transcription factor 3 (Foxp3) in melanoma-invaded LNs and determined proportion and functionality of Treg cells among TIL extracted from these 10 metastatic melanoma LNs at different steps of their in vitro expansion.",18312383_2,0,1,2,-1,6599,-1,1.0995052e-05,0.99997604,1.2980219e-05
6612,functional,3,4,13,23,"In addition, functional assays demonstrated that these CD4+CD25(high) T cells were capable of suppressing autologous CD8+ and CD4+CD25- T cell proliferation.",18312383_4,0,1,2,-1,6612,-1,0.0021646512,0.9970452,0.0007901758
6613,that these,6,8,44,54,"In addition, functional assays demonstrated that these CD4+CD25(high) T cells were capable of suppressing autologous CD8+ and CD4+CD25- T cell proliferation.",18312383_4,-1,-1,-1,-1,6613,-1,4.594272e-06,0.99999106,4.2887773e-06
6616,These cells,0,2,0,11,These cells were indeed Treg cells as they expressed Foxp3.,18312383_5,-1,-1,-1,-1,6616,-1,1.5648555e-05,1.1964878e-05,0.99997246
6627,the therapeutic,3,5,16,31,Here we studied the therapeutic efficacy of IL-21-gene-modified cells (Neuro2a/IL-21) in a syngeneic metastatic neuroblastoma (NB) model.,18324400_1,-1,-1,-1,-1,6627,-1,4.3196605e-06,0.99999166,4.0656228e-06
6650,time to,16,18,107,114,"The administration of two or three doses of Neuro2a/IL-21 cell vaccine further increased the mean survival time to 54 and 75 days, and the cure rate to 27 and 33%, respectively, whereas the use of unmodified Neuro2a or mock-transfected cells had no effect.",18324400_6,-1,-1,-1,-1,6650,-1,5.537503e-06,0.99998844,5.9931526e-06
6655,cell subset,2,4,8,19,In vivo cell subset depletion and a Winn-assay indicated the involvement of CD8 + CTLs.,18324400_7,-1,-1,-1,-1,6655,-1,1.5461363e-05,9.007179e-06,0.99997544
6658,analysis,1,2,20,28,Immunohistochemical analysis indicated a reduction of CD31+ and VEGFR2+ microvessels in late metastases from therapeutically vaccinated mice.,18324400_8,0,1,-1,-1,6658,-1,1.0627308e-05,0.9999819,7.524343e-06
6668,therapy,41,42,261,268,"CONCLUSIONS: Our present data indicate that IL-21-secreting NB cells are effective as therapeutic vaccine in mice bearing metastatic NB, through a specific CTL response involving survivin as antigen, and suggest a potential interest for IL-21 in NB immuno-gene therapy.",18324400_10,0,1,-1,-1,6668,-1,4.859122e-06,0.9999893,5.836354e-06
6690,analysis,19,20,136,144,FoxP3+ expressing cells among CD4+CD25+ population were significantly reduced after resveratrol treatment ex vivo in intracellular FACS analysis.,18328445_4,0,1,-1,-1,6690,-1,6.263324e-06,0.99998486,8.899278e-06
6694,TGF-beta,21,22,150,158,"Single intraperitoneal administration of 4 mg/kg resveratrol suppressed the CD4+CD25+ cell population among CD4+ cells and downregulated secretion of TGF-beta, an immunosuppressive cytokine, measured from the spleens of tumor-bearing mice.",18328445_5,0,1,-1,-1,6694,-1,4.0538533e-05,0.9999502,9.316485e-06
6701,Taken together,0,2,0,14,"Taken together, these results suggest that resveratrol has a suppressive role on CD4+CD25+ cell population and makes peritumoral microenvironment unfavorable to tumor in tumor-bearing mice.",18328445_7,-1,-1,-1,-1,6701,-1,7.975714e-06,0.99998534,6.6954594e-06
6705,to tumor,22,24,158,166,"Taken together, these results suggest that resveratrol has a suppressive role on CD4+CD25+ cell population and makes peritumoral microenvironment unfavorable to tumor in tumor-bearing mice.",18328445_7,-1,-1,-1,-1,6705,-1,4.924503e-06,0.99999,5.0464982e-06
6708,therapy,13,14,95,102,"Thus, resveratrol can be considered as possible adjuvant material for vaccination-based cancer therapy.",18328445_8,0,1,-1,-1,6708,-1,5.6252393e-06,0.9999888,5.5520045e-06
6713,tumor-specific TGF-beta-producing,14,16,82,115,There is limited information on the influence of tumor growth on the expansion of tumor-specific TGF-beta-producing CD4(+) T cells in humans.,18354237_0,-1,-1,-1,-1,6713,-1,0.00017425651,0.9997658,5.9943017e-05
6718,T cells that,15,18,86,98,"In this study, we report the identification and characterization of subsets of CD4(+) T cells that recognize an epitope within the AFP sequence (AFP(46-55)) and develop into TGF-beta-producing CD4(+) T cells.",18354237_2,-1,-1,-1,-1,6718,-1,0.0014291907,0.048021786,0.95054895
6720,TGF-beta-producing,34,35,174,192,"In this study, we report the identification and characterization of subsets of CD4(+) T cells that recognize an epitope within the AFP sequence (AFP(46-55)) and develop into TGF-beta-producing CD4(+) T cells.",18354237_2,0,1,-1,-1,6720,-1,0.0003122529,0.99926597,0.000421731
6722,peptide-specific,2,3,5,21,"In a peptide-specific and dose-dependent manner, AFP(46-55) CD4(+) T cells produce TGF-beta, GM-CSF, and IL-2 but not Th1-, Th2-, Th17-, or Tr1-type cytokines.",18354237_3,0,-1,2,-1,6722,-1,0.00037133304,0.9995409,8.781024e-05
6724,TGF-beta,16,17,83,91,"In a peptide-specific and dose-dependent manner, AFP(46-55) CD4(+) T cells produce TGF-beta, GM-CSF, and IL-2 but not Th1-, Th2-, Th17-, or Tr1-type cytokines.",18354237_3,0,1,-1,-1,6724,-1,1.7450035e-05,0.9999716,1.0876924e-05
6729,Tr1-type cytokines,31,33,140,158,"In a peptide-specific and dose-dependent manner, AFP(46-55) CD4(+) T cells produce TGF-beta, GM-CSF, and IL-2 but not Th1-, Th2-, Th17-, or Tr1-type cytokines.",18354237_3,-1,-1,-1,-1,6729,-1,0.026622564,0.9713454,0.0020320253
6730,These cells,0,2,0,11,These cells express CTLA-4 and glucocorticoid-induced TNR receptor and inhibit T cell proliferation in a contact-dependent manner.,18354237_4,-1,-1,-1,-1,6730,-1,1.1955708e-05,7.810207e-06,0.9999802
6732,TNR receptor,6,8,54,66,These cells express CTLA-4 and glucocorticoid-induced TNR receptor and inhibit T cell proliferation in a contact-dependent manner.,18354237_4,-1,-1,-1,-1,6732,-1,0.0002561397,0.9868646,0.012879189
6735,that the,6,8,23,31,"In this study, we show that the frequency of AFP(46-55) CD4(+) T cells is significantly higher (p = 001) in patients with hepatocellular carcinoma than in healthy donors, suggesting that these cells are expanded in response to tumor Ag.",18354237_5,-1,-1,-1,-1,6735,-1,3.709796e-06,0.9999925,3.8217217e-06
6738,that these cells,37,40,182,198,"In this study, we show that the frequency of AFP(46-55) CD4(+) T cells is significantly higher (p = 001) in patients with hepatocellular carcinoma than in healthy donors, suggesting that these cells are expanded in response to tumor Ag.",18354237_5,-1,-1,-1,-1,6738,-1,0.0025187067,0.2003569,0.7971243
6739,to tumor,44,46,224,232,"In this study, we show that the frequency of AFP(46-55) CD4(+) T cells is significantly higher (p = 001) in patients with hepatocellular carcinoma than in healthy donors, suggesting that these cells are expanded in response to tumor Ag.",18354237_5,-1,-1,-1,-1,6739,-1,6.002457e-06,0.99998903,4.931962e-06
6741,treatments that,5,7,37,52,"In contrast, tumor necrosis-inducing treatments that are shown to improve survival rate can shift the Th1/TGF-beta-producing CD4(+) T cell balance in favor of Th1 responses.",18354237_6,-1,-1,-1,-1,6741,-1,4.7460367e-06,0.9999914,3.841838e-06
6746,that tumor,3,5,21,31,"Our data demonstrate that tumor Ags may contain epitopes which activate the expansion of inducible regulatory T cells, leading to evasion of tumor control.",18354237_7,-1,-1,-1,-1,6746,-1,4.672331e-06,0.9999913,4.0562722e-06
6751,typhimurium to,6,8,48,62,"Vaccines are delivered by attenuated Salmonella typhimurium to secondary lymphoid organs and respectively target vascular endothelial growth factor receptor-2, transcription factor Fos-related antigen-1, anti-apoptosis protein survivin and Legumain, an asparaginyl endopeptidase specifically overexpressed on tumor-associated macrophages (TAMs) in the tumor microenvironment (TME).",18363997_1,-1,-1,-1,-1,6751,-1,1.6508662e-05,0.9999703,1.3162806e-05
6753,growth factor receptor-2,16,19,134,158,"Vaccines are delivered by attenuated Salmonella typhimurium to secondary lymphoid organs and respectively target vascular endothelial growth factor receptor-2, transcription factor Fos-related antigen-1, anti-apoptosis protein survivin and Legumain, an asparaginyl endopeptidase specifically overexpressed on tumor-associated macrophages (TAMs) in the tumor microenvironment (TME).",18363997_1,-1,-1,-1,-1,6753,-1,0.9987447,7.047724e-05,0.0011847471
6754,transcription factor Fos-related antigen-1,20,24,160,202,"Vaccines are delivered by attenuated Salmonella typhimurium to secondary lymphoid organs and respectively target vascular endothelial growth factor receptor-2, transcription factor Fos-related antigen-1, anti-apoptosis protein survivin and Legumain, an asparaginyl endopeptidase specifically overexpressed on tumor-associated macrophages (TAMs) in the tumor microenvironment (TME).",18363997_1,-1,-1,-1,-1,6754,-1,0.008966985,0.9885212,0.0025118247
6755,protein,26,27,219,226,"Vaccines are delivered by attenuated Salmonella typhimurium to secondary lymphoid organs and respectively target vascular endothelial growth factor receptor-2, transcription factor Fos-related antigen-1, anti-apoptosis protein survivin and Legumain, an asparaginyl endopeptidase specifically overexpressed on tumor-associated macrophages (TAMs) in the tumor microenvironment (TME).",18363997_1,0,1,-1,-1,6755,-1,6.741813e-05,0.9998908,4.17203e-05
6758,the tumor,43,45,348,357,"Vaccines are delivered by attenuated Salmonella typhimurium to secondary lymphoid organs and respectively target vascular endothelial growth factor receptor-2, transcription factor Fos-related antigen-1, anti-apoptosis protein survivin and Legumain, an asparaginyl endopeptidase specifically overexpressed on tumor-associated macrophages (TAMs) in the tumor microenvironment (TME).",18363997_1,-1,-1,-1,-1,6758,-1,4.688515e-06,0.9999912,4.1445355e-06
6762,immunity,10,11,75,83,"These vaccines are all capable of inducing potent cell-mediated protective immunity against self-antigens, resulting in marked suppression of tumor growth and dissemination.",18363997_2,0,-1,2,-1,6762,-1,0.9997819,2.9086874e-05,0.00018902199
6765,the tumor,13,15,94,103,"Key mechanisms induced by these DNA vaccines include efficient suppression of angiogenesis in the tumor vasculature and marked activation of cytotoxic T cells, natural killer cells, and antigen-presenting dendritic cells.",18363997_3,-1,-1,-1,-1,6765,-1,4.379059e-06,0.9999902,5.438099e-06
6776,the TME,17,19,106,113,The vaccine targeting Legumain establishes the new paradigm whereby a reduction in the density of TAMs in the TME decreases the release of factors potentiating tumor growth and angiogenesis.,18363997_4,-1,-1,-1,-1,6776,-1,1.06802e-05,0.9999778,1.1485643e-05
6777,the release,20,22,124,135,The vaccine targeting Legumain establishes the new paradigm whereby a reduction in the density of TAMs in the TME decreases the release of factors potentiating tumor growth and angiogenesis.,18363997_4,-1,-1,-1,-1,6777,-1,1.1789617e-05,0.99998295,5.3141284e-06
6778,factors,23,24,139,146,The vaccine targeting Legumain establishes the new paradigm whereby a reduction in the density of TAMs in the TME decreases the release of factors potentiating tumor growth and angiogenesis.,18363997_4,0,1,-1,-1,6778,-1,0.99974674,0.00018557278,6.76527e-05
6782,the TME,6,8,24,31,"This, in turn, remodels the TME and decreases its immunosuppressive milieu and thereby potentiates the DNA vaccine's ability to effectively suppress tumor cell proliferation, vascularization, and metastasis.",18363997_5,-1,-1,-1,-1,6782,-1,1.0235306e-05,0.9999757,1.4036779e-05
6786,tumor cell,24,26,149,159,"This, in turn, remodels the TME and decreases its immunosuppressive milieu and thereby potentiates the DNA vaccine's ability to effectively suppress tumor cell proliferation, vascularization, and metastasis.",18363997_5,-1,-1,-1,-1,6786,-1,0.00025029868,0.0029950058,0.9967547
6790,the treatment,18,20,110,123,It is anticipated that such research efforts will lead to novel DNA-based vaccines that will be effective for the treatment of cancer.,18363997_6,-1,-1,-1,-1,6790,-1,5.6603817e-06,0.99998915,5.1671045e-06
6791,analysis,2,3,14,22,"A comparative analysis of vaccination with irradiated, murine tumor cells engineered to express a large number of immunostimulatory molecules established the superior ability of granulocyte-macrophage colony-stimulating factor (GM-CSF) to evoke potent, specific, and long-lasting anti-tumor immunity.",18364009_0,0,1,-1,-1,6791,-1,6.087045e-06,0.9999887,5.2020782e-06
6792,tumor cells,9,11,62,73,"A comparative analysis of vaccination with irradiated, murine tumor cells engineered to express a large number of immunostimulatory molecules established the superior ability of granulocyte-macrophage colony-stimulating factor (GM-CSF) to evoke potent, specific, and long-lasting anti-tumor immunity.",18364009_0,-1,-1,-1,-1,6792,-1,0.00056029484,0.017449113,0.98199064
6798,immunity,40,41,291,299,"A comparative analysis of vaccination with irradiated, murine tumor cells engineered to express a large number of immunostimulatory molecules established the superior ability of granulocyte-macrophage colony-stimulating factor (GM-CSF) to evoke potent, specific, and long-lasting anti-tumor immunity.",18364009_0,0,-1,2,-1,6798,-1,0.9996834,9.1628455e-05,0.00022505317
6809,immunity,8,9,69,77,More detailed investigations of the mechanisms underlying protective immunity in murine systems together with the characterization of the anti-tumor reactions of patients who achieved durable clinical benefits in response to immunotherapy uncovered several pathways that restrain the efficacy of GM-CSF-secreting tumor cell vaccines.,18364009_3,0,-1,2,-1,6809,-1,0.9996785,0.00010167718,0.00021982031
6816,GM-CSF-secreting tumor cell,39,42,296,323,More detailed investigations of the mechanisms underlying protective immunity in murine systems together with the characterization of the anti-tumor reactions of patients who achieved durable clinical benefits in response to immunotherapy uncovered several pathways that restrain the efficacy of GM-CSF-secreting tumor cell vaccines.,18364009_3,-1,-1,-1,-1,6816,-1,0.9592225,0.0002362985,0.0405412
6818,growth factor protein-8,6,9,41,64,"These include milk fat globule epidermal growth factor protein-8 expansion of forkhead box protein 3+ regulatory T cells, cytotoxic T-lymphocyte antigen-4-mediated negative costimulation, and soluble major histocompatibility complex class I chain-related protein A suppression of NKG2D-dependent innate and adaptive anti-tumor cytotoxicity.",18364009_4,-1,-1,-1,-1,6818,-1,0.9998815,1.7153787e-05,0.00010129768
6820,protein,13,14,91,98,"These include milk fat globule epidermal growth factor protein-8 expansion of forkhead box protein 3+ regulatory T cells, cytotoxic T-lymphocyte antigen-4-mediated negative costimulation, and soluble major histocompatibility complex class I chain-related protein A suppression of NKG2D-dependent innate and adaptive anti-tumor cytotoxicity.",18364009_4,0,1,-1,-1,6820,-1,1.20114255e-05,0.9999738,1.4158399e-05
6822,cytotoxic T-lymphocyte antigen-4-mediated,20,23,122,163,"These include milk fat globule epidermal growth factor protein-8 expansion of forkhead box protein 3+ regulatory T cells, cytotoxic T-lymphocyte antigen-4-mediated negative costimulation, and soluble major histocompatibility complex class I chain-related protein A suppression of NKG2D-dependent innate and adaptive anti-tumor cytotoxicity.",18364009_4,-1,-1,-1,-1,6822,-1,0.012837053,0.00020489268,0.9869581
6824,protein,34,35,255,262,"These include milk fat globule epidermal growth factor protein-8 expansion of forkhead box protein 3+ regulatory T cells, cytotoxic T-lymphocyte antigen-4-mediated negative costimulation, and soluble major histocompatibility complex class I chain-related protein A suppression of NKG2D-dependent innate and adaptive anti-tumor cytotoxicity.",18364009_4,0,1,-1,-1,6824,-1,1.0995646e-05,0.9999795,9.555015e-06
6829,therapies that,17,19,136,150,"Together, these results define key regulatory circuits that attenuate immune-mediated tumor destruction and suggest novel combinatorial therapies that might enhance the clinical activity of GM-CSF-secreting tumor cell vaccines.",18364009_5,-1,-1,-1,-1,6829,-1,4.107323e-06,0.9999919,3.9658535e-06
6831,GM-CSF-secreting tumor cell,25,28,190,217,"Together, these results define key regulatory circuits that attenuate immune-mediated tumor destruction and suggest novel combinatorial therapies that might enhance the clinical activity of GM-CSF-secreting tumor cell vaccines.",18364009_5,-1,-1,-1,-1,6831,-1,0.9554586,0.00029086182,0.044250507
6836,that interleukin,2,4,15,31,We demonstrate that interleukin (IL)-9 has an important role in this process.,18378796_2,-1,-1,-1,-1,6836,-1,0.5211634,0.4729194,0.005917138
6850,that IL-9-mediated,42,44,304,322,"In addition, intestinal IL-9 overexpression predisposes to oral antigen sensitization, which requires mast cells and increased intestinal permeability. These observations demonstrate a central role for IL-9 and mast cells in experimental intestinal permeability in oral antigen sensitization and suggest that IL-9-mediated mast cell responses have an important role in food allergy.",18378796_4,-1,-1,-1,-1,6850,-1,0.48844218,0.50766313,0.0038946825
6853,related to the,9,12,57,71,"One of the major limitations for cancer immunotherapy is related to the frequent existence of an intra-tumoral immunosuppressive environment, to which STAT3 (Signal transducer and activator of transcription-3) activation in tumor and dendritic cells (DCs) are believed to contribute.",18392040_0,-1,-1,-1,-1,6853,-1,6.884241e-06,0.99998724,5.8907062e-06
6863,tested the,5,7,18,28,"In this study, we tested the hypothesis that the combination of CpG (a DC activator) and JSI-124 (a STAT3 inhibitor) may generate synergistic antitumor effects compared to CpG or JSI-124 alone.",18392040_1,-1,-1,-1,-1,6863,-1,6.148492e-06,0.9999896,4.2388983e-06
6864,that the,8,10,40,48,"In this study, we tested the hypothesis that the combination of CpG (a DC activator) and JSI-124 (a STAT3 inhibitor) may generate synergistic antitumor effects compared to CpG or JSI-124 alone.",18392040_1,-1,-1,-1,-1,6864,-1,5.1645275e-06,0.99999106,3.7509585e-06
6872,then tumor-bearing,19,21,106,124,"B16-F10, a mouse melanoma cell line that has constitutively active STAT3, was grafted in C57BL/6 mice and then tumor-bearing mice treated intra-tumorally with (a) phosphate buffered saline, (b) 10 microg CpG, (c) 1 mg kg(-1) JSI-124 or (d) 10 microg CpG+1 mg kg(-1) JSI-124.",18392040_2,-1,-1,-1,-1,6872,-1,4.665351e-06,0.9999896,5.6536087e-06
6885,therapy,7,8,49,56,"Correlating with these findings, the combination therapy resulted in significantly higher intra-tumoral levels of several proinflammatory, TH1-related cytokines (including IL-12, IFN-gamma, TNF-alpha and IL-2), increases in intra-tumoral CD8+ and CD4+ T cells expressing activation/memory markers and NK cells and increases in activated DCs in the tumors and regional lymph nodes (LNs).",18392040_5,0,1,-1,-1,6885,-1,4.0546656e-06,0.99999166,4.2574625e-06
6886,TH1-related cytokines,18,20,139,160,"Correlating with these findings, the combination therapy resulted in significantly higher intra-tumoral levels of several proinflammatory, TH1-related cytokines (including IL-12, IFN-gamma, TNF-alpha and IL-2), increases in intra-tumoral CD8+ and CD4+ T cells expressing activation/memory markers and NK cells and increases in activated DCs in the tumors and regional lymph nodes (LNs).",18392040_5,-1,-1,-1,-1,6886,-1,0.027794488,0.9698734,0.0023321132
6889,TNF-alpha,26,27,190,199,"Correlating with these findings, the combination therapy resulted in significantly higher intra-tumoral levels of several proinflammatory, TH1-related cytokines (including IL-12, IFN-gamma, TNF-alpha and IL-2), increases in intra-tumoral CD8+ and CD4+ T cells expressing activation/memory markers and NK cells and increases in activated DCs in the tumors and regional lymph nodes (LNs).",18392040_5,0,1,-1,-1,6889,-1,0.6188321,0.3793541,0.0018137993
6892,the tumors,53,55,344,354,"Correlating with these findings, the combination therapy resulted in significantly higher intra-tumoral levels of several proinflammatory, TH1-related cytokines (including IL-12, IFN-gamma, TNF-alpha and IL-2), increases in intra-tumoral CD8+ and CD4+ T cells expressing activation/memory markers and NK cells and increases in activated DCs in the tumors and regional lymph nodes (LNs).",18392040_5,-1,-1,-1,-1,6892,-1,3.8997227e-06,0.99999046,5.59374e-06
6894,therapy,4,5,31,38,"Concomitantly, the combination therapy led to a significantly decreased level of immunosuppression, as evidenced by lower intra-tumoral level of VEGF and TGF-beta, and decreased number of CD4+CD25+Foxp3+ regulatory T cells in the regional LNs.",18392040_6,0,1,-1,-1,6894,-1,4.481629e-06,0.9999906,4.9123196e-06
6896,TGF-beta,23,24,154,162,"Concomitantly, the combination therapy led to a significantly decreased level of immunosuppression, as evidenced by lower intra-tumoral level of VEGF and TGF-beta, and decreased number of CD4+CD25+Foxp3+ regulatory T cells in the regional LNs.",18392040_6,0,1,-1,-1,6896,-1,0.00010837473,0.9998746,1.7072165e-05
6904,immunity,14,15,101,109,Oncolytic viruses can exert their antitumor activity via direct oncolysis or activation of antitumor immunity.,18424722_0,0,-1,2,-1,6904,-1,0.9999186,1.6540665e-05,6.483094e-05
6905,the treatment,8,10,64,77,"Although reovirus is currently under clinical investigation for the treatment of localized or disseminated cancer, any potential immune contribution to its efficacy has not been addressed.",18424722_1,-1,-1,-1,-1,6905,-1,6.7483593e-06,0.9999883,4.9090677e-06
6916,cytokines IFN-alpha,11,13,84,103,"Reovirus induced DC maturation and stimulated the production of the proinflammatory cytokines IFN-alpha, TNF-alpha, IL-12p70, and IL-6.",18424722_3,-1,-1,-1,-1,6916,-1,0.99996674,5.1358024e-06,2.8096973e-05
6917,TNF-alpha,14,15,105,114,"Reovirus induced DC maturation and stimulated the production of the proinflammatory cytokines IFN-alpha, TNF-alpha, IL-12p70, and IL-6.",18424722_3,0,1,-1,-1,6917,-1,0.02020046,0.979302,0.0004975469
6925,T cell cytokine,13,16,94,109,"Moreover, short-term coculture of reovirus-activated DC with autologous T cells also enhanced T cell cytokine secretion (IL-2 and IFN-gamma) and induced non-Ag restricted tumor cell killing.",18424722_6,-1,-1,-1,-1,6925,-1,0.20070302,0.0013301665,0.79796684
6927,tumor cell,26,28,171,181,"Moreover, short-term coculture of reovirus-activated DC with autologous T cells also enhanced T cell cytokine secretion (IL-2 and IFN-gamma) and induced non-Ag restricted tumor cell killing.",18424722_6,-1,-1,-1,-1,6927,-1,4.472283e-05,0.00011771339,0.9998375
6930,time that,6,8,37,46,"These data demonstrate for the first time that reovirus directly activates human DC and that reovirus-activated DC stimulate innate killing by not only NK cells, but also T cells, suggesting a novel potential role for T cells in oncolytic virus-induced local tumor cell death.",18424722_7,-1,-1,-1,-1,6930,-1,5.019227e-06,0.9999901,4.8523602e-06
6935,tumor cell,43,45,259,269,"These data demonstrate for the first time that reovirus directly activates human DC and that reovirus-activated DC stimulate innate killing by not only NK cells, but also T cells, suggesting a novel potential role for T cells in oncolytic virus-induced local tumor cell death.",18424722_7,-1,-1,-1,-1,6935,-1,0.00019819498,0.001803397,0.9979984
6949,tissues,14,15,82,89,"However, the identification of Tregs in an ongoing immune response or in inflamed tissues remains elusive.",18424726_1,-1,1,2,-1,6949,-1,0.001029131,0.124554835,0.87441605
6950,that TIRC7,3,5,25,35,"Our experiments indicate that TIRC7, T cell immune response cDNA 7, a novel membrane molecule involved in the regulation of T lymphocyte activation, identifies two Treg subsets (CD25(low)TIRC7(+) and CD25(high)TIRC7(-)) that are characterized by the expression of Foxp3 and a suppressive activity in vitro and in vivo.",18424726_2,-1,-1,-1,-1,6950,-1,3.0887208e-05,0.99991477,5.4354365e-05
6951,T cell immune response,6,10,37,59,"Our experiments indicate that TIRC7, T cell immune response cDNA 7, a novel membrane molecule involved in the regulation of T lymphocyte activation, identifies two Treg subsets (CD25(low)TIRC7(+) and CD25(high)TIRC7(-)) that are characterized by the expression of Foxp3 and a suppressive activity in vitro and in vivo.",18424726_2,-1,-1,-1,-1,6951,-1,0.16056982,0.0009524361,0.8384777
6952,the regulation,19,21,106,120,"Our experiments indicate that TIRC7, T cell immune response cDNA 7, a novel membrane molecule involved in the regulation of T lymphocyte activation, identifies two Treg subsets (CD25(low)TIRC7(+) and CD25(high)TIRC7(-)) that are characterized by the expression of Foxp3 and a suppressive activity in vitro and in vivo.",18424726_2,-1,-1,-1,-1,6952,-1,4.1600892e-06,0.99999106,4.8066117e-06
6954,two Treg subsets,27,30,160,176,"Our experiments indicate that TIRC7, T cell immune response cDNA 7, a novel membrane molecule involved in the regulation of T lymphocyte activation, identifies two Treg subsets (CD25(low)TIRC7(+) and CD25(high)TIRC7(-)) that are characterized by the expression of Foxp3 and a suppressive activity in vitro and in vivo.",18424726_2,-1,-1,-1,-1,6954,-1,0.0020536142,0.6145876,0.38335878
6958,that the,3,5,15,23,"We also showed that the CD25(low)TIRC7(+) subset represents IL-10-secreting Tregs in steady state, which is accumulated intratumorally in a tumor-bearing mice model.",18424726_3,-1,-1,-1,-1,6958,-1,3.8487938e-06,0.99999213,4.046771e-06
6960,IL-10-secreting Tregs,9,11,60,81,"We also showed that the CD25(low)TIRC7(+) subset represents IL-10-secreting Tregs in steady state, which is accumulated intratumorally in a tumor-bearing mice model.",18424726_3,-1,-1,-1,-1,6960,-1,0.9970987,0.0023326236,0.00056878454
6968,these IL-10-secreting cells,2,5,15,42,"Interestingly, these IL-10-secreting cells derived from the CD25(high)TIRC7(-) subset, both in vitro and in vivo, in response to tumoral Ags.",18424726_5,-1,-1,-1,-1,6968,-1,0.058026414,0.20956396,0.7324096
6971,to tumoral,21,23,126,136,"Interestingly, these IL-10-secreting cells derived from the CD25(high)TIRC7(-) subset, both in vitro and in vivo, in response to tumoral Ags.",18424726_5,-1,-1,-1,-1,6971,-1,6.2724025e-06,0.99998844,5.3244457e-06
6975,natural Tregs,13,15,69,82,"Our present results strongly support the notion that, in the pool of natural Tregs, some cells can recognize foreign Ags and that this recognition is an essential step in their expansion and suppressive activity in vivo.",18424726_6,-1,-1,-1,-1,6975,-1,7.3639944e-06,0.9999863,6.3117645e-06
6977,that this,23,25,125,134,"Our present results strongly support the notion that, in the pool of natural Tregs, some cells can recognize foreign Ags and that this recognition is an essential step in their expansion and suppressive activity in vivo.",18424726_6,-1,-1,-1,-1,6977,-1,4.322643e-06,0.9999914,4.235875e-06
6979,life-threatening,4,5,31,47,Colorectal cancer represents a life-threatening complication of inflammatory bowel diseases.,18473765_0,0,-1,2,-1,6979,-1,4.723324e-05,0.99993634,1.6388383e-05
6981,that the,2,4,20,28,Statistics indicate that the risk to develop colorectal cancer is higher in patients affected by ulcerative colitis and to a lesser extent by Crohn's disease and that such a risk is directly proportional to the number of years of active disease.,18473765_1,-1,-1,-1,-1,6981,-1,5.024394e-06,0.9999908,4.1899343e-06
6985,to the,34,36,204,210,Statistics indicate that the risk to develop colorectal cancer is higher in patients affected by ulcerative colitis and to a lesser extent by Crohn's disease and that such a risk is directly proportional to the number of years of active disease.,18473765_1,-1,-1,-1,-1,6985,-1,9.084327e-06,0.99998486,5.999914e-06
6993,that the release,5,8,32,48,"Indeed from the initial concept that the release of free radicals during inflammation might induce the accumulation of genetic mutations thus leading to the onset of dysplastic cells, it is now becoming clear that the large amount of cytokines and growth factors released during inflammation by immune and non immune cells may influence the carcinogenesis process.",18473765_4,-1,-1,-1,-1,6993,-1,8.710644e-06,0.9999856,5.770268e-06
6997,to the,22,24,150,156,"Indeed from the initial concept that the release of free radicals during inflammation might induce the accumulation of genetic mutations thus leading to the onset of dysplastic cells, it is now becoming clear that the large amount of cytokines and growth factors released during inflammation by immune and non immune cells may influence the carcinogenesis process.",18473765_4,-1,-1,-1,-1,6997,-1,4.8715724e-06,0.99999034,4.7941885e-06
6999,that the,34,36,209,217,"Indeed from the initial concept that the release of free radicals during inflammation might induce the accumulation of genetic mutations thus leading to the onset of dysplastic cells, it is now becoming clear that the large amount of cytokines and growth factors released during inflammation by immune and non immune cells may influence the carcinogenesis process.",18473765_4,-1,-1,-1,-1,6999,-1,6.022149e-06,0.9999894,4.561329e-06
7001,factors released,42,44,255,271,"Indeed from the initial concept that the release of free radicals during inflammation might induce the accumulation of genetic mutations thus leading to the onset of dysplastic cells, it is now becoming clear that the large amount of cytokines and growth factors released during inflammation by immune and non immune cells may influence the carcinogenesis process.",18473765_4,-1,-1,-1,-1,7001,-1,0.99701846,0.0025562216,0.00042541983
7011,the nuclear factor kappa B,5,10,28,54,"Moreover, the activation of the nuclear factor kappa B (NF kappa B), a transcription factor activated by several cytokines released during inflammation and responsible for many of their proinflammatory effects, have been shown to promote the growth of the colon tumors in experimental models.",18473765_6,-1,-1,-1,-1,7011,-1,6.5663494e-06,0.99998593,7.4513932e-06
7013,cytokines released,22,24,113,131,"Moreover, the activation of the nuclear factor kappa B (NF kappa B), a transcription factor activated by several cytokines released during inflammation and responsible for many of their proinflammatory effects, have been shown to promote the growth of the colon tumors in experimental models.",18473765_6,-1,-1,-1,-1,7013,-1,0.9993013,0.00048389618,0.0002147485
7026,factors,23,24,160,167,"Activated Stat3 not only upregulates genes crucial for survival, proliferation, angiogenesis, and metastasis but also promotes expression of immune suppressive factors while inhibiting Th1 immunostimulatory molecules.",18479894_2,0,1,-1,-1,7026,-1,2.0528756e-05,0.9999715,8.018893e-06
7029,factors that,10,12,55,67,"By virtue of its ability to promote expression of many factors that activate Stat3 in diverse cells, Stat3 allows malignant and immune cells resonate, forming close partnership for tumor immune evasion, tumor progression, and resistance to therapies.",18479894_3,-1,-1,-1,-1,7029,-1,5.6246636e-06,0.99999034,4.038498e-06
7036,to therapies,39,41,237,249,"By virtue of its ability to promote expression of many factors that activate Stat3 in diverse cells, Stat3 allows malignant and immune cells resonate, forming close partnership for tumor immune evasion, tumor progression, and resistance to therapies.",18479894_3,-1,-1,-1,-1,7036,-1,6.9583166e-06,0.99998677,6.312099e-06
7038,T-cell,11,12,57,63,"Szary syndrome (SzS), the leukemic variant of cutaneous T-cell lymphomas, is incurable.",18480841_0,-1,1,2,-1,7038,-1,1.7949025e-05,9.620615e-06,0.99997234
7042,immunity,12,13,74,82,Dendritic cells (DCs) transfected with tumor mRNA can stimulate antitumor immunity in certain cancer patients.,18480841_1,0,-1,2,-1,7042,-1,0.99991834,1.695521e-05,6.476851e-05
7045,immunity,20,21,117,125,"In this study, we determined whether mRNAs from Szary cells could be used for loading DCs and stimulating antitumor immunity.",18480841_2,0,-1,2,-1,7045,-1,0.9999192,2.3052024e-05,5.7828616e-05
7048,blood,9,10,63,68,Autologous DCs were generated from monocytes of the peripheral blood from 10 patients with SzS. Total RNA was extracted from Szary cells and amplified by T7 in vitro transcription.,18480841_3,0,1,-1,-1,7048,-1,0.0045496696,0.85204846,0.14340183
7057,that IFN-gamma,2,4,9,23,We found that IFN-gamma was required for IL-12p70 production by monocyte-derived DCs from SzS. The oncogenic transcription factor Twist and the tyrosine kinase receptor EphA4 were expressed in total RNA from Szary cells and the paired amplified mRNAs.,18480841_5,-1,-1,-1,-1,7057,-1,0.9817516,0.017119894,0.001128583
7061,the tyrosine,20,22,140,152,We found that IFN-gamma was required for IL-12p70 production by monocyte-derived DCs from SzS. The oncogenic transcription factor Twist and the tyrosine kinase receptor EphA4 were expressed in total RNA from Szary cells and the paired amplified mRNAs.,18480841_5,-1,-1,-1,-1,7061,-1,4.7642066e-06,0.9999902,5.044296e-06
7062,receptor,23,24,160,168,We found that IFN-gamma was required for IL-12p70 production by monocyte-derived DCs from SzS. The oncogenic transcription factor Twist and the tyrosine kinase receptor EphA4 were expressed in total RNA from Szary cells and the paired amplified mRNAs.,18480841_5,0,1,2,-1,7062,-1,5.320569e-05,0.99978787,0.00015893314
7066,IFN-gamma-producing CTLs,4,6,38,62,RNA-transfected DCs induced antitumor IFN-gamma-producing CTLs in 7 of 10 subjects and GrB-producing CTLs in 6 of 9 subjects.,18480841_6,-1,-1,-1,-1,7066,-1,0.9662528,0.00017865501,0.033568513
7075,tumor cells,18,20,105,116,These data support the concept of using tumor mRNA for a vaccine strategy that requires small amounts of tumor cells without need for specific antigens in patients with SzS.,18480841_8,-1,-1,-1,-1,7075,-1,0.00016045426,0.0007971181,0.99904245
7078,immune responses to tumor,4,8,27,52,The induction of effective immune responses to tumor vaccines requires the preferential activation of effector T cells relative to regulatory or suppressive T cells.,18481381_0,-1,-1,-1,-1,7078,-1,0.94811106,0.051005006,0.000883914
7080,T cells relative to,15,19,111,130,The induction of effective immune responses to tumor vaccines requires the preferential activation of effector T cells relative to regulatory or suppressive T cells.,18481381_0,-1,-1,-1,-1,7080,-1,0.0024762687,0.27862638,0.71889734
7084,growth factor receptor,6,9,48,70,"Glial tumors commonly overexpress the epidermal growth factor receptor (EGFR), which can be targeted by monoclonal antibodies.",18481381_1,-1,-1,-1,-1,7084,-1,0.97235775,0.00015344204,0.027488839
7086,that the,3,5,13,21,"Here we show that the coating of glial tumor cells with a clinical grade anti-EGFR antibody, cetuximab, leads to enhanced tumor-specific, interferon-gamma producing CD8+ T cells by dendritic cells (DCs).",18481381_2,-1,-1,-1,-1,7086,-1,4.905188e-06,0.99999106,3.982656e-06
7087,tumor cells,8,10,39,50,"Here we show that the coating of glial tumor cells with a clinical grade anti-EGFR antibody, cetuximab, leads to enhanced tumor-specific, interferon-gamma producing CD8+ T cells by dendritic cells (DCs).",18481381_2,-1,-1,-1,-1,7087,-1,0.00026352212,0.0052101277,0.9945263
7095,cells to,8,10,61,69,"The selective targeting of monoclonal antibody coated glioma cells to activating Fcgamma receptors (FcgammaRs) on DCs, which is achieved with a blocking antibody to the inhibitory form of FcgammaR, leads to the induction of antitumor immunity without the need for an exogenous maturation stimulus.",18481381_3,-1,-1,-1,-1,7095,-1,0.0034652522,0.39178333,0.60475147
7096,receptors,12,13,89,98,"The selective targeting of monoclonal antibody coated glioma cells to activating Fcgamma receptors (FcgammaRs) on DCs, which is achieved with a blocking antibody to the inhibitory form of FcgammaR, leads to the induction of antitumor immunity without the need for an exogenous maturation stimulus.",18481381_3,0,1,2,-1,7096,-1,3.2177955e-05,3.0884978e-05,0.99993694
7097,to the,26,28,162,168,"The selective targeting of monoclonal antibody coated glioma cells to activating Fcgamma receptors (FcgammaRs) on DCs, which is achieved with a blocking antibody to the inhibitory form of FcgammaR, leads to the induction of antitumor immunity without the need for an exogenous maturation stimulus.",18481381_3,-1,-1,-1,-1,7097,-1,5.6104427e-06,0.9999889,5.535462e-06
7098,to the,34,36,204,210,"The selective targeting of monoclonal antibody coated glioma cells to activating Fcgamma receptors (FcgammaRs) on DCs, which is achieved with a blocking antibody to the inhibitory form of FcgammaR, leads to the induction of antitumor immunity without the need for an exogenous maturation stimulus.",18481381_3,-1,-1,-1,-1,7098,-1,5.0879607e-06,0.99999094,4.0191703e-06
7099,immunity,39,40,234,242,"The selective targeting of monoclonal antibody coated glioma cells to activating Fcgamma receptors (FcgammaRs) on DCs, which is achieved with a blocking antibody to the inhibitory form of FcgammaR, leads to the induction of antitumor immunity without the need for an exogenous maturation stimulus.",18481381_3,0,-1,2,-1,7099,-1,0.9998784,3.1256208e-05,9.035371e-05
7105,immunity,21,22,129,137,"Importantly, this approach reduces the concurrent induction of regulatory T cells, which can also be depleted to further enhance immunity.",18481381_4,0,-1,2,-1,7105,-1,0.9997987,9.3595125e-05,0.00010773565
7107,that immunity to,3,6,19,35,"These data suggest that immunity to EGFR expressing tumors, including glioma, can be enhanced through the concerted function of antitumor monoclonal antibodies, activating FcgammaR, and DCs.",18481381_5,-1,-1,-1,-1,7107,-1,3.3445365e-05,0.99995327,1.32565465e-05
7109,through the,16,18,94,105,"These data suggest that immunity to EGFR expressing tumors, including glioma, can be enhanced through the concerted function of antitumor monoclonal antibodies, activating FcgammaR, and DCs.",18481381_5,-1,-1,-1,-1,7109,-1,5.6085196e-06,0.99999046,3.96654e-06
7110,function,19,20,116,124,"These data suggest that immunity to EGFR expressing tumors, including glioma, can be enhanced through the concerted function of antitumor monoclonal antibodies, activating FcgammaR, and DCs.",18481381_5,0,1,2,-1,7110,-1,2.2135926e-05,0.9999635,1.4284764e-05
7114,TNF receptor+,12,14,69,82,"Regulatory T cells (Treg) enriched in FoxP3+, glucocorticoid-induced TNF receptor+, and cytotoxic T-lymphocyte-associated antigen-4+ exert a potential to suppress effector T cells in the periphery.",18512029_0,-1,-1,-1,-1,7114,-1,0.00032711957,0.9984066,0.0012663546
7115,T-lymphocyte-associated antigen-4,17,19,98,131,"Regulatory T cells (Treg) enriched in FoxP3+, glucocorticoid-induced TNF receptor+, and cytotoxic T-lymphocyte-associated antigen-4+ exert a potential to suppress effector T cells in the periphery.",18512029_0,-1,-1,-1,-1,7115,-1,0.011444556,0.00040143947,0.988154
7119,These cells,0,2,0,11,"These cells exist in markedly higher proportions within tumor-infiltrating lymphocytes, peripheral blood lymphocytes, and/or regional lymph node lymphocytes of patients with cancer and their frequencies are suggested to be strongly related to tumor progression and inversely correlated with the efficacy of treatment.",18512029_1,-1,-1,-1,-1,7119,-1,1.6095244e-05,9.988696e-06,0.9999739
7120,tumor-infiltrating lymphocytes,8,10,56,86,"These cells exist in markedly higher proportions within tumor-infiltrating lymphocytes, peripheral blood lymphocytes, and/or regional lymph node lymphocytes of patients with cancer and their frequencies are suggested to be strongly related to tumor progression and inversely correlated with the efficacy of treatment.",18512029_1,-1,-1,-1,-1,7120,-1,0.002363972,0.8550052,0.14263083
7121,blood lymphocytes,12,14,99,116,"These cells exist in markedly higher proportions within tumor-infiltrating lymphocytes, peripheral blood lymphocytes, and/or regional lymph node lymphocytes of patients with cancer and their frequencies are suggested to be strongly related to tumor progression and inversely correlated with the efficacy of treatment.",18512029_1,-1,-1,-1,-1,7121,-1,3.489713e-05,2.48462e-05,0.9999403
7125,related to tumor,32,35,232,248,"These cells exist in markedly higher proportions within tumor-infiltrating lymphocytes, peripheral blood lymphocytes, and/or regional lymph node lymphocytes of patients with cancer and their frequencies are suggested to be strongly related to tumor progression and inversely correlated with the efficacy of treatment.",18512029_1,-1,-1,-1,-1,7125,-1,1.0969152e-05,0.99997985,9.190784e-06
7128,Tumor-specific Treg cells,0,3,0,25,"Tumor-specific Treg cells require ligand-specific activation and cell-to-cell contact to exert their suppressive activity on tumor-specific effector cells (CD8+ cytotoxic T lymphocytes and CD4+ Th cells), which includes decreased cytotoxity, proliferation, and Th1 cytokine secrection.",18512029_2,-1,-1,-1,-1,7128,-1,0.0029061604,0.5713738,0.42571998
7135,Th cells,27,29,194,202,"Tumor-specific Treg cells require ligand-specific activation and cell-to-cell contact to exert their suppressive activity on tumor-specific effector cells (CD8+ cytotoxic T lymphocytes and CD4+ Th cells), which includes decreased cytotoxity, proliferation, and Th1 cytokine secrection.",18512029_2,-1,-1,-1,-1,7135,-1,7.859772e-06,5.7659718e-06,0.9999864
7136,Th1 cytokine,39,41,261,273,"Tumor-specific Treg cells require ligand-specific activation and cell-to-cell contact to exert their suppressive activity on tumor-specific effector cells (CD8+ cytotoxic T lymphocytes and CD4+ Th cells), which includes decreased cytotoxity, proliferation, and Th1 cytokine secrection.",18512029_2,-1,-1,-1,-1,7136,-1,0.11146783,0.8818288,0.006703374
7138,tumor-associated antigens that,11,14,71,101,Depletion or blockade of Treg cells can enhance immune protection from tumor-associated antigens that are expressed as self antigens.,18512029_3,-1,-1,-1,-1,7138,-1,9.274263e-05,0.9998878,1.941864e-05
7154,that tumor-infiltrating,4,6,16,39,"Here, we report that tumor-infiltrating mast cells remodel tumor microenvironment and promote tumor growth.",18524989_1,-1,-1,-1,-1,7154,-1,2.2924916e-05,0.99996424,1.2870582e-05
7160,tumor-derived stem cell factor (SCF,11,17,72,107,Mast cell infiltration and activation in tumors were mainly mediated by tumor-derived stem cell factor (SCF) and its receptor c-Kit on mast cells.,18524989_2,-1,-1,-1,-1,7160,-1,0.891738,0.102095015,0.00616697
7161,receptor,20,21,117,125,Mast cell infiltration and activation in tumors were mainly mediated by tumor-derived stem cell factor (SCF) and its receptor c-Kit on mast cells.,18524989_2,0,1,2,-1,7161,-1,0.008191727,0.009088696,0.98271954
7164,the chemotactic,6,8,46,61,Low concentrations of SCF efficiently induced the chemotactic migration of mast cells.,18524989_3,-1,-1,-1,-1,7164,-1,0.9180159,0.08014301,0.0018410039
7169,factors,14,15,109,116,"Tumor-infiltrating mast cells, activated by higher concentrations of SCF, expressed multiple proinflammatory factors and increased IL-17 expression in tumors.",18524989_4,0,1,-1,-1,7169,-1,0.99397826,0.005851915,0.00016977747
7175,tumor cells,7,9,38,49,The activity of NF-kappaB and AP-1 in tumor cells was intensified in the mast cell-remodeled inflammatory microenvironment.,18524989_5,-1,-1,-1,-1,7175,-1,6.519779e-05,0.00018219516,0.9997526
7190,that the,3,5,25,33,These findings emphasize that the remodeling of the tumor microenvironment can actually be initiated by tumor cell-released SCF and suggest that mast cells are not only a participator but also a critical regulator of inflammation and immunosuppression in the tumor microenvironment.,18524989_7,-1,-1,-1,-1,7190,-1,4.0133705e-06,0.9999926,3.4339666e-06
7191,the tumor,7,9,48,57,These findings emphasize that the remodeling of the tumor microenvironment can actually be initiated by tumor cell-released SCF and suggest that mast cells are not only a participator but also a critical regulator of inflammation and immunosuppression in the tumor microenvironment.,18524989_7,-1,-1,-1,-1,7191,-1,4.1155586e-06,0.9999913,4.5899415e-06
7192,tumor cell-released SCF,15,18,104,127,These findings emphasize that the remodeling of the tumor microenvironment can actually be initiated by tumor cell-released SCF and suggest that mast cells are not only a participator but also a critical regulator of inflammation and immunosuppression in the tumor microenvironment.,18524989_7,-1,-1,-1,-1,7192,-1,0.72286904,0.006742781,0.27038825
7195,the tumor,38,40,255,264,These findings emphasize that the remodeling of the tumor microenvironment can actually be initiated by tumor cell-released SCF and suggest that mast cells are not only a participator but also a critical regulator of inflammation and immunosuppression in the tumor microenvironment.,18524989_7,-1,-1,-1,-1,7195,-1,4.2046604e-06,0.99999166,4.179984e-06
7217,than that,18,20,115,124,"By interferon-gamma secretion assay, the capacity of hybrids to stimulate cytotoxic T-lymphocytes (CTLs) is higher than that of other antigen-loading methods showing stronger tumor antigen-specific CTL cytotoxicity to A673.",18563501_3,-1,-1,-1,-1,7217,-1,9.2075525e-06,0.99998486,5.900622e-06
7219,tumor antigen-specific CTL,26,29,175,201,"By interferon-gamma secretion assay, the capacity of hybrids to stimulate cytotoxic T-lymphocytes (CTLs) is higher than that of other antigen-loading methods showing stronger tumor antigen-specific CTL cytotoxicity to A673.",18563501_3,-1,-1,-1,-1,7219,-1,0.05681983,0.31822053,0.62495965
7222,immune responses to,14,17,89,108,"By in vivo experiment in SCID mice, all dendritic cell-based strategies induced specific immune responses to Ewing's sarcoma after mice-human immune system reconstitution by inoculating human peripheral blood mononuclear cells into the peritoneal cavity of SCID mice.",18563501_4,-1,-1,-1,-1,7222,-1,0.9919115,0.007460383,0.0006281473
7223,blood,29,30,203,208,"By in vivo experiment in SCID mice, all dendritic cell-based strategies induced specific immune responses to Ewing's sarcoma after mice-human immune system reconstitution by inoculating human peripheral blood mononuclear cells into the peritoneal cavity of SCID mice.",18563501_4,0,1,-1,-1,7223,-1,0.007572536,0.97853386,0.0138935195
7236,cell function,9,11,49,62,Down-regulation of CD4+CD25+ regulatory T (Treg) cell function might be beneficial to enhance the immunogenicity of viral and tumor vaccines or to induce breakdown of immunotolerance.,18566377_0,-1,-1,-1,-1,7236,-1,1.842081e-05,1.5416152e-05,0.99996614
7243,that TGF-beta1,16,18,103,117,"Although the mechanism of suppression used by Treg cells remains controversial, it has been postulated that TGF-beta1 mediates their immunosuppressive activity.",18566377_1,-1,-1,-1,-1,7243,-1,3.0370586e-05,0.9999349,3.4726534e-05
7247,peptide that,12,14,51,63,"In this study, we show that P17, a short synthetic peptide that inhibits TGF-beta1 and TGF-beta2 developed in our laboratory, is able to inhibit Treg activity in vitro and in vivo.",18566377_2,-1,-1,-1,-1,7247,-1,2.5351346e-05,0.99995995,1.4679161e-05
7248,TGF-beta1,15,16,73,82,"In this study, we show that P17, a short synthetic peptide that inhibits TGF-beta1 and TGF-beta2 developed in our laboratory, is able to inhibit Treg activity in vitro and in vivo.",18566377_2,0,1,-1,-1,7248,-1,2.4192814e-05,0.9999434,3.2396416e-05
7249,TGF-beta2,17,18,87,96,"In this study, we show that P17, a short synthetic peptide that inhibits TGF-beta1 and TGF-beta2 developed in our laboratory, is able to inhibit Treg activity in vitro and in vivo.",18566377_2,0,1,-1,-1,7249,-1,0.00013138854,0.99984217,2.637477e-05
7254,T cells to,14,17,106,116,"In vitro studies demonstrate that P17 inhibits murine and human Treg-induced unresponsiveness of effector T cells to anti-CD3 stimulation, in an MLR or to a specific Ag.",18566377_3,-1,-1,-1,-1,7254,-1,0.0014621802,0.047717117,0.9508207
7257,peptide,9,10,55,62,"Moreover, administration of P17 to mice immunized with peptide vaccines containing tumor or viral Ags enhanced anti-vaccine immune responses and improved protective immunogenicity against tumor growth or viral infection or replication.",18566377_4,0,-1,2,-1,7257,-1,0.0024046404,0.9972844,0.00031099474
7272,that peptide,3,5,27,39,These findings demonstrate that peptide inhibitors of TGF-beta may be a valuable tool to enhance vaccination efficacy and to break tolerance against pathogens or tumor Ags.,18566377_9,-1,-1,-1,-1,7272,-1,0.00020921636,0.9997327,5.8093578e-05
7273,TGF-beta,7,8,54,62,These findings demonstrate that peptide inhibitors of TGF-beta may be a valuable tool to enhance vaccination efficacy and to break tolerance against pathogens or tumor Ags.,18566377_9,0,1,-1,-1,7273,-1,0.00028823994,0.99968624,2.5489408e-05
7274,tool to,12,14,81,88,These findings demonstrate that peptide inhibitors of TGF-beta may be a valuable tool to enhance vaccination efficacy and to break tolerance against pathogens or tumor Ags.,18566377_9,-1,-1,-1,-1,7274,-1,7.1021277e-06,0.9999883,4.6295195e-06
7285,TGFbeta,28,29,182,189,"Regulatory T cells were enumerated and phenotypically characterized using antibodies to FOXP3.RESULTS: SCCs had higher numbers of CD4 and CD8 cells; infiltrates expressed more CD25, TGFbeta, and IL10 but had significantly lower IL2 compared with cervicitis and CIN III.",18593438_2,0,1,-1,-1,7285,-1,0.00011658097,0.9998659,1.752074e-05
7297,TGFbeta(+,13,14,57,66,The proportion of FOXP3(+) CD25(+); FOXP3(+) CD25(-) and TGFbeta(+) CD25(+) in invasive tumors was 17; 19 and 22 respectively.,18593438_6,0,1,-1,-1,7297,-1,0.00012304577,0.99983525,4.163023e-05
7304,TGFbeta,33,34,186,193,"CONCLUSION: Cervical tumors are marked by the presence of an immunoregulatory environment, and harbor equal proportions of 'inactive' n Tregs; activated n Tregs; and Tregs operating via TGFbeta.",18593438_7,0,1,-1,-1,7304,-1,0.0011238693,0.9988269,4.9186932e-05
7311,T cells to,20,23,99,109,"In this study, we show that ex vivo splenic DCs are capable of inducing conversion of nave CD4(+) T cells to adaptive Foxp3(+)CD4(+) regulatory T cells (aTreg) in the presence of TGF-beta.",18599457_1,-1,-1,-1,-1,7311,-1,0.0016374349,0.04956424,0.94879836
7315,TGF-beta,36,37,180,188,"In this study, we show that ex vivo splenic DCs are capable of inducing conversion of nave CD4(+) T cells to adaptive Foxp3(+)CD4(+) regulatory T cells (aTreg) in the presence of TGF-beta.",18599457_1,0,1,-1,-1,7315,-1,2.8973043e-05,0.9999634,7.60926e-06
7319,to the,4,6,26,32,"This was not attributable to the difference in basal level of costimulation, because deficiency of CD40 or CD80/86 signaling did not diminish the differential induction of Foxp3.",18599457_3,-1,-1,-1,-1,7319,-1,7.3016454e-06,0.99998844,4.2873553e-06
7320,deficiency,14,15,85,95,"This was not attributable to the difference in basal level of costimulation, because deficiency of CD40 or CD80/86 signaling did not diminish the differential induction of Foxp3.",18599457_3,0,1,-1,-1,7320,-1,0.0008424207,0.9990922,6.541941e-05
7326,receptors,19,20,145,154,Further insights into the molecular mechanisms of conversion were gained by analyzing the contribution of several costimulatory and coinhibitory receptors.,18599457_5,0,1,2,-1,7326,-1,0.00015081544,9.137201e-05,0.9997578
7331,TGF-beta,14,15,76,84,Ex vivo PD-L1(-/-) DCs failed to support Foxp3 induction in the presence of TGF-beta.,18599457_7,0,1,-1,-1,7331,-1,5.131569e-05,0.99993885,9.849352e-06
7334,the cellular,5,7,36,48,"Collectively, this study highlights the cellular and molecular parameters that might be exploited to control the de novo generation of aTregs and peripheral tolerance.",18599457_9,-1,-1,-1,-1,7334,-1,0.006486289,0.7362282,0.25728548
7340,The TNF,0,2,0,7,The TNF family member TRAIL is emerging as a promising cytotoxic molecule for antitumor therapy.,18606651_0,-1,-1,-1,-1,7340,-1,0.0017723544,0.9980506,0.00017711353
7342,therapy,14,15,88,95,The TNF family member TRAIL is emerging as a promising cytotoxic molecule for antitumor therapy.,18606651_0,0,1,-1,-1,7342,-1,4.809638e-06,0.9999901,5.0375647e-06
7343,mechanism of action,3,6,13,32,"However, its mechanism of action and the possible modulation of its effect by the microenvironment in follicular lymphomas (FL) remain unknown.",18606651_1,0,1,-1,-1,7343,-1,6.378987e-05,0.99988914,4.7090234e-05
7346,that TRAIL,3,5,13,23,"We show here that TRAIL is cytotoxic only against FL B cells and not against normal B cells, and that DR4 is the main receptor involved in the initiation of the apoptotic cascade.",18606651_2,-1,-1,-1,-1,7346,-1,6.426522e-06,0.9999877,5.807524e-06
7351,receptor,25,26,118,126,"We show here that TRAIL is cytotoxic only against FL B cells and not against normal B cells, and that DR4 is the main receptor involved in the initiation of the apoptotic cascade.",18606651_2,0,1,2,-1,7351,-1,0.00037028492,0.0006518625,0.9989779
7358,protein,6,7,29,36,CD40 induces a rapid RNA and protein up-regulation of c-FLIP and Bcl-x(L).,18606651_4,0,1,-1,-1,7358,-1,9.178151e-06,0.9999833,7.458347e-06
7373,therapy,26,27,153,160,These findings suggest that a cotreatment with TRAIL and an inhibitor of NF-kappaB signaling or a blocking anti-CD40 Ab could be of great interest in FL therapy.,18606651_7,0,1,-1,-1,7373,-1,4.7060107e-06,0.9999888,6.508102e-06
7377,tissue,11,12,71,77,Preferential activation of regulatory T (Treg) cells limits autoimmune tissue damage during chronic immune responses but can also facilitate tumor growth.,18632653_0,-1,1,2,-1,7377,-1,0.011195818,0.880461,0.10834323
7380,that tissue-produced,4,6,14,34,"Here, we show that tissue-produced inflammatory mediators prime maturing dendritic cells (DC) for the differential ability of attracting anti-inflammatory Treg cells.",18632653_1,-1,-1,-1,-1,7380,-1,0.0012923039,0.99857855,0.00012916084
7386,factor,13,14,50,56,"Our data show that prostaglandin E(2) (PGE(2)), a factor overproduced in chronic inflammation and cancer, induces stable Treg-attracting properties in maturing DC, mediated by CCL22.",18632653_2,0,1,-1,-1,7386,-1,0.84575063,0.15357795,0.0006714039
7401,the Th1-attracting chemokines,36,39,224,253,"This PGE(2)-induced overproduction of CCL22 and the resulting attraction of FOXP3(+) Tregs are counteracted by IFN alpha, a mediator of acute inflammation, which also restores the ability of the PGE(2)-exposed DC to secrete the Th1-attracting chemokines: CXCL9, CXCL10, CXCL11, and CCL5.",18632653_4,-1,-1,-1,-1,7401,-1,0.053744286,0.9438461,0.00240956
7414,that the,5,7,26,34,"The current data, showing that the ability of mature DC to interact with Treg cells is predetermined at the stage of DC maturation, pave the way to preferentially target the regulatory versus proinflammatory T cells in autoimmunity and transplantation, as opposed to intracellular infections and cancer.",18632653_6,-1,-1,-1,-1,7414,-1,4.3163677e-06,0.99999213,3.5931062e-06
7420,target the,30,32,163,173,"The current data, showing that the ability of mature DC to interact with Treg cells is predetermined at the stage of DC maturation, pave the way to preferentially target the regulatory versus proinflammatory T cells in autoimmunity and transplantation, as opposed to intracellular infections and cancer.",18632653_6,-1,-1,-1,-1,7420,-1,4.546306e-06,0.999992,3.4660668e-06
7422,transplantation,40,41,236,251,"The current data, showing that the ability of mature DC to interact with Treg cells is predetermined at the stage of DC maturation, pave the way to preferentially target the regulatory versus proinflammatory T cells in autoimmunity and transplantation, as opposed to intracellular infections and cancer.",18632653_6,-1,1,2,-1,7422,-1,6.9355533e-06,0.99998784,5.2388964e-06
7428,the T,27,29,153,158,"In this study, we demonstrate that malignant mature CD4(+) T lymphocytes derived from cutaneous T cell lymphomas (CTCL) variably display some aspects of the T regulatory phenotype.",18684941_0,-1,-1,-1,-1,7428,-1,4.95187e-06,0.99998915,5.890425e-06
7431,TGF-beta,17,18,126,134,"Whereas seven cell lines representing a spectrum of primary cutaneous T cell lymphoproliferative disorders expressed CD25 and TGF-beta, the expression of FOXP3 and, to a lesser degree, IL-10 was restricted to two CTCL cell lines that are dependent on exogenous IL-2.",18684941_1,0,1,-1,-1,7431,-1,2.337901e-05,0.9999671,9.532851e-06
7436,to two,33,35,206,212,"Whereas seven cell lines representing a spectrum of primary cutaneous T cell lymphoproliferative disorders expressed CD25 and TGF-beta, the expression of FOXP3 and, to a lesser degree, IL-10 was restricted to two CTCL cell lines that are dependent on exogenous IL-2.",18684941_1,-1,-1,-1,-1,7436,-1,1.076009e-05,0.99998295,6.259938e-06
7440,through receptors,11,13,45,62,"IL-2, IL-15, and IL-21, all of which signals through receptors containing the common gamma chain, induced expression of IL-10 in the IL-2-dependent cell lines as well as primary leukemic CTCL cells.",18684941_2,-1,-1,-1,-1,7440,-1,0.0026241995,0.9239632,0.073412634
7451,through STAT3,11,13,81,94,"The IL-2-triggered induction of IL-10 and FOXP3 expression occurred by signaling through STAT3 and STAT5, respectively.",18684941_4,-1,-1,-1,-1,7451,-1,8.453391e-06,0.99998534,6.2165295e-06
7453,analysis,1,2,20,28,Immunohistochemical analysis of the CTCL tissues revealed that FOXP3-expressing cells were common among the CD7-negative enlarged atypical and small lymphocytes at the early skin patch and plaque stages.,18684941_5,0,1,-1,-1,7453,-1,8.020013e-06,0.9999863,5.6578615e-06
7455,tissues,5,6,41,48,Immunohistochemical analysis of the CTCL tissues revealed that FOXP3-expressing cells were common among the CD7-negative enlarged atypical and small lymphocytes at the early skin patch and plaque stages.,18684941_5,-1,1,2,-1,7455,-1,0.00019839214,7.926772e-05,0.9997223
7456,that FOXP3-expressing cells,7,10,58,85,Immunohistochemical analysis of the CTCL tissues revealed that FOXP3-expressing cells were common among the CD7-negative enlarged atypical and small lymphocytes at the early skin patch and plaque stages.,18684941_5,-1,-1,-1,-1,7456,-1,0.0020021172,0.9173817,0.08061613
7462,the tumor,6,8,45,54,Their frequency was profoundly diminished at the tumor stage and in the CTCL lymph node lesions with or without large cell transformation.,18684941_6,-1,-1,-1,-1,7462,-1,4.4762237e-06,0.9999902,5.2713444e-06
7464,cell transformation,20,22,118,137,Their frequency was profoundly diminished at the tumor stage and in the CTCL lymph node lesions with or without large cell transformation.,18684941_6,-1,-1,-1,-1,7464,-1,7.732882e-05,0.00037113798,0.9995515
7466,that the T,3,6,23,33,"These results indicate that the T regulatory cell features are induced in CTCL T cells by common gamma chain signaling cytokines such as IL-2 and do not represent a fully predetermined, constitutive phenotype independent of the local environmental stimuli to which these malignant mature CD4(+) T cells become exposed.",18684941_7,-1,-1,-1,-1,7466,-1,4.287112e-06,0.9999908,4.9027312e-06
7474,The FOXP3,2,4,12,21,BACKGROUND: The FOXP3 mRNA expression and the other regulatory T cell-related molecules were investigated and compared with clinicopathological parameters in human primary breast cancer.,18685848_0,-1,-1,-1,-1,7474,-1,5.059186e-06,0.99999,5.0030876e-06
7480,tissues,11,12,68,75,"Total RNA was extracted from frozen normal breast and breast cancer tissues, and the expression of FOXP3, IL-10, TGFbeta1 and CCL22 mRNA was evaluated using quantitative real-time RT-PCR.RESULT: FOXP3, IL-10, TGFbeta1 and CCL22 mRNA expressions were significantly higher in cancer tissue than in normal tissue, not only at pT1, 2, and 3 stages but also at the DCIS stage.",18685848_2,-1,1,2,-1,7480,-1,0.00044140572,0.72871864,0.27083996
7484,TGFbeta1,21,22,113,121,"Total RNA was extracted from frozen normal breast and breast cancer tissues, and the expression of FOXP3, IL-10, TGFbeta1 and CCL22 mRNA was evaluated using quantitative real-time RT-PCR.RESULT: FOXP3, IL-10, TGFbeta1 and CCL22 mRNA expressions were significantly higher in cancer tissue than in normal tissue, not only at pT1, 2, and 3 stages but also at the DCIS stage.",18685848_2,0,1,-1,-1,7484,-1,2.0844964e-05,0.9999441,3.5091227e-05
7488,TGFbeta1,36,37,209,217,"Total RNA was extracted from frozen normal breast and breast cancer tissues, and the expression of FOXP3, IL-10, TGFbeta1 and CCL22 mRNA was evaluated using quantitative real-time RT-PCR.RESULT: FOXP3, IL-10, TGFbeta1 and CCL22 mRNA expressions were significantly higher in cancer tissue than in normal tissue, not only at pT1, 2, and 3 stages but also at the DCIS stage.",18685848_2,0,1,-1,-1,7488,-1,2.2971197e-05,0.99993813,3.8938684e-05
7490,tissue than,46,48,281,292,"Total RNA was extracted from frozen normal breast and breast cancer tissues, and the expression of FOXP3, IL-10, TGFbeta1 and CCL22 mRNA was evaluated using quantitative real-time RT-PCR.RESULT: FOXP3, IL-10, TGFbeta1 and CCL22 mRNA expressions were significantly higher in cancer tissue than in normal tissue, not only at pT1, 2, and 3 stages but also at the DCIS stage.",18685848_2,-1,-1,-1,-1,7490,-1,6.5456115e-05,0.9991609,0.0007736723
7491,tissue,50,51,303,309,"Total RNA was extracted from frozen normal breast and breast cancer tissues, and the expression of FOXP3, IL-10, TGFbeta1 and CCL22 mRNA was evaluated using quantitative real-time RT-PCR.RESULT: FOXP3, IL-10, TGFbeta1 and CCL22 mRNA expressions were significantly higher in cancer tissue than in normal tissue, not only at pT1, 2, and 3 stages but also at the DCIS stage.",18685848_2,-1,1,2,-1,7491,-1,0.00015235816,0.9617922,0.038055453
7497,TGFbeta1,11,12,68,76,"There were positive correlations between FOXP3 and IL-10, FOXP3 and TGFbeta1, as well as FOXP3 and CCL22 mRNA expressions, respectively.",18685848_3,0,1,-1,-1,7497,-1,2.5738707e-05,0.9999292,4.503888e-05
7504,that regulatory T cells,5,9,34,57,"CONCLUSION: These results suggest that regulatory T cells are involved in tumor onset and progression in human primary breast cancer, possibly contributing to poor prognosis of patients with breast cancer.",18685848_5,-1,-1,-1,-1,7504,-1,0.0015263348,0.08087694,0.91759664
7515,To test,2,4,6,13,AIMS: To test if HCV NS3/4A affects innate and adaptive immune responses in vivo.,18689426_3,-1,-1,-1,-1,7515,-1,1.3354096e-05,0.99997973,6.940943e-06
7517,transfected cells,11,13,66,83,"METHODS: NS3 levels were semi-quantified in human liver biopsies, transfected cells, and in transgenic (Tg) mouse livers by western blot.",18689426_4,-1,-1,-1,-1,7517,-1,2.532804e-05,3.52184e-05,0.99993956
7523,transfected cells,20,22,121,138,"The effect of NS3/4A on dsRNA-mediated signalling and on the integrity of IPS-1 was analysed using in vitro translation, transfected cells and Tg mice.",18689426_5,-1,-1,-1,-1,7523,-1,2.7807102e-05,4.2816457e-05,0.9999294
7527,protein,3,4,13,20,RESULTS: NS3 protein levels were in a comparable range (0.1-49 microg/g tissue) in infected human livers and Tg mouse livers.,18689426_7,0,1,-1,-1,7527,-1,1.6090911e-05,0.9999707,1.3223367e-05
7528,tissue,15,16,72,78,RESULTS: NS3 protein levels were in a comparable range (0.1-49 microg/g tissue) in infected human livers and Tg mouse livers.,18689426_7,-1,1,2,-1,7528,-1,9.8852615e-05,0.99886525,0.0010358881
7533,that this,19,21,123,132,"Importantly, these levels of NS3/4A reduced murine innate responses to synthetic dsRNA in vivo, supporting the possibility that this occurs also in infected humans.",18689426_8,-1,-1,-1,-1,7533,-1,6.6602934e-06,0.9999893,4.072291e-06
7543,the innate immunity,38,41,260,279,"Despite this, FLuc- and/or NS3/4A-expressing murine hepatocytes were effectively eliminated by hepatic CTLs, utilising the classical molecules for virus-infected cell lysis, including CD8, IFN gamma, perforin and FasL.CONCLUSIONS: Although HCV NS3/4A inhibits the innate immunity, this does not prevent CTL-mediated clearance of NS3/4A-expressing hepatocytes in vivo.",18689426_10,-1,-1,-1,-1,7543,-1,0.7911168,0.20628434,0.0025989972
7547,proteins,4,5,16,24,"Thus, other HCV proteins are most likely responsible for interfering with the adaptive immunity.",18689426_11,0,1,-1,-1,7547,-1,0.0037217948,0.9953312,0.00094690145
7548,the adaptive immunity,12,15,74,95,"Thus, other HCV proteins are most likely responsible for interfering with the adaptive immunity.",18689426_11,-1,-1,-1,-1,7548,-1,0.29690737,0.70056105,0.0025315993
7549,The status,0,2,0,10,The status of the immune system of patients with B-cell chronic lymphocytic leukemia (B-CLL) is not yet sufficiently characterized.,18695923_0,-1,-1,-1,-1,7549,-1,5.567534e-06,0.9999896,4.805097e-06
7562,the complex,31,33,180,191,"In the current study, we evaluated the expression of FOXP3 in CD4+CD25hi T regulatory lymphocytes (Treg) and their influence on immune response against tumor and viral antigens in the complex system of peripheral blood mononuclear cells.",18695923_2,-1,-1,-1,-1,7562,-1,6.47441e-06,0.9999883,5.182883e-06
7563,blood,36,37,213,218,"In the current study, we evaluated the expression of FOXP3 in CD4+CD25hi T regulatory lymphocytes (Treg) and their influence on immune response against tumor and viral antigens in the complex system of peripheral blood mononuclear cells.",18695923_2,0,1,-1,-1,7563,-1,0.004575007,0.98397267,0.011452293
7571,to the,58,60,281,287,"In 80 B-CLL patients, the frequency of Treg (CD4+CD25hi FOXP3+) cells was significantly higher in B-CLL patients when compared to healthy volunteers (HV) and increased with the progression of the disease (median: 8.24% in stage A, 11.24% in stage B and 12.57% in stage C according to the Binet classification).",18695923_3,-1,-1,-1,-1,7571,-1,4.5010206e-06,0.99999094,4.556953e-06
7572,classification,61,62,294,308,"In 80 B-CLL patients, the frequency of Treg (CD4+CD25hi FOXP3+) cells was significantly higher in B-CLL patients when compared to healthy volunteers (HV) and increased with the progression of the disease (median: 8.24% in stage A, 11.24% in stage B and 12.57% in stage C according to the Binet classification).",18695923_3,0,1,2,-1,7572,-1,1.2181707e-05,0.9999708,1.706352e-05
7577,TNF,26,27,156,159,"The frequency of Treg showed no correlation with prognostic markers such as ZAP-70, CD38 and HLA-G. Notably, Treg frequency correlated with serum levels of TNF (r(2)=0.45, p=0.001).",18695923_4,0,1,-1,-1,7577,-1,0.0025218092,0.9972837,0.00019451058
7578,T-cell immune responses,0,3,0,23,"T-cell immune responses against epitopes derived from the tumor-associated antigens survivin, fibromodulin and RHAMM as well as from the influenza matrix protein were evaluated.",18695923_5,-1,-1,-1,-1,7578,-1,0.014684997,0.00017408555,0.9851409
7579,the tumor-associated antigens,7,10,54,83,"T-cell immune responses against epitopes derived from the tumor-associated antigens survivin, fibromodulin and RHAMM as well as from the influenza matrix protein were evaluated.",18695923_5,-1,-1,-1,-1,7579,-1,0.035685323,0.96272767,0.0015869978
7581,protein,22,23,154,161,"T-cell immune responses against epitopes derived from the tumor-associated antigens survivin, fibromodulin and RHAMM as well as from the influenza matrix protein were evaluated.",18695923_5,0,1,-1,-1,7581,-1,0.001680199,0.99813026,0.00018953397
7582,Functionally,0,1,0,12,"Functionally, higher frequencies of Treg correlated with decreased T-cell responses against viral and tumor antigens.",18695923_6,0,1,2,-1,7582,-1,1.9763882e-05,0.9999696,1.0664082e-05
7584,T-cell,9,10,67,73,"Functionally, higher frequencies of Treg correlated with decreased T-cell responses against viral and tumor antigens.",18695923_6,-1,1,2,-1,7584,-1,2.038602e-05,1.0281654e-05,0.99996936
7585,tumor antigens,14,16,102,116,"Functionally, higher frequencies of Treg correlated with decreased T-cell responses against viral and tumor antigens.",18695923_6,-1,-1,-1,-1,7585,-1,0.6267272,0.36875555,0.004517185
7590,T-cell,11,12,59,65,Szary syndrome (SS) is an aggressive variant of cutaneous T-cell lymphoma.,18769452_0,-1,1,2,-1,7590,-1,1.6429498e-05,1.0773555e-05,0.9999728
7593,the regulatory T cell,4,8,15,36,"Here, we study the regulatory T cell (Treg) function and the expression of FOXP3 in SS.",18769452_2,-1,-1,-1,-1,7593,-1,0.0014124755,0.107886605,0.8907008
7595,function,11,12,44,52,"Here, we study the regulatory T cell (Treg) function and the expression of FOXP3 in SS.",18769452_2,0,1,2,-1,7595,-1,0.0004036099,0.038451776,0.9611445
7600,analysis,2,3,17,25,"Western blotting analysis shows expression of two low molecular splice forms of FOXP3, but not of wild-type (wt) FOXP3.",18769452_4,0,1,-1,-1,7600,-1,6.6838106e-06,0.9999883,5.018615e-06
7607,TGF-beta,7,8,49,57,The malignant T cells produce interleukin-10 and TGF-beta and suppress the growth of non-malignant T cells.,18769452_5,0,1,-1,-1,7607,-1,0.0001674822,0.9998074,2.5154492e-05
7610,The Treg,0,2,0,8,The Treg phenotype and the production of suppressive cytokines are driven by aberrant activation of Jak3 independent of the FOXP3 splice forms.,18769452_6,-1,-1,-1,-1,7610,-1,5.1632787e-06,0.99998856,6.3208504e-06
7613,the FOXP3,18,20,120,129,The Treg phenotype and the production of suppressive cytokines are driven by aberrant activation of Jak3 independent of the FOXP3 splice forms.,18769452_6,-1,-1,-1,-1,7613,-1,5.0376643e-06,0.9999907,4.2116476e-06
7623,that the,5,7,23,31,"In conclusion, we show that the malignant T cells express low molecular splice forms of FOXP3 and function as Tregs.",18769452_8,-1,-1,-1,-1,7623,-1,3.7022428e-06,0.9999924,3.9386387e-06
7626,function,18,19,98,106,"In conclusion, we show that the malignant T cells express low molecular splice forms of FOXP3 and function as Tregs.",18769452_8,0,1,2,-1,7626,-1,3.819359e-05,0.9999324,2.9360355e-05
7628,that FOXP3,5,7,33,43,"Furthermore, we provide evidence that FOXP3 splice forms are functionally different from wt FOXP3 and not involved in the execution of the suppressive function.",18769452_9,-1,-1,-1,-1,7628,-1,6.286448e-06,0.99998784,5.86034e-06
7629,functionally,10,11,61,73,"Furthermore, we provide evidence that FOXP3 splice forms are functionally different from wt FOXP3 and not involved in the execution of the suppressive function.",18769452_9,0,1,2,-1,7629,-1,1.880762e-05,0.9999714,9.749712e-06
7633,function,24,25,151,159,"Furthermore, we provide evidence that FOXP3 splice forms are functionally different from wt FOXP3 and not involved in the execution of the suppressive function.",18769452_9,0,1,2,-1,7633,-1,6.360782e-06,0.9999862,7.4917953e-06
7647,to therapies,28,30,165,177,"We hypothesized that WP1066, a novel STAT3 blockade agent, has marked antitumor activity, even against the melanoma metastasis to brain, a site typically refractory to therapies.",18794085_1,-1,-1,-1,-1,7647,-1,5.4414218e-06,0.99998975,4.792019e-06
7655,these cells,14,16,88,99,WP1066 suppressed the phosphorylation of Janus-activated kinase 2 and STAT3 (Tyr705) in these cells.,18794085_4,-1,-1,-1,-1,7655,-1,3.3360993e-05,6.1662424e-05,0.999905
7675,that this,17,19,116,125,CONCLUSIONS: The antitumor cytotoxic effects of WP1066 and its ability to induce antitumor immune responses suggest that this compound has potential for the effective treatment of melanoma metastatic to brain.,18794085_8,-1,-1,-1,-1,7675,-1,5.2066566e-06,0.99999,4.840629e-06
7683,that blood,2,4,9,19,"We found that blood vessels in SCCs did not express E-selectin, and tumors contained few cutaneous lymphocyte antigen (CLA)(+) T cells, the cell type thought to provide cutaneous immunosurveillance.",18794336_1,-1,-1,-1,-1,7683,-1,0.0002748267,0.99940765,0.00031754107
7685,lymphocyte antigen,17,19,99,117,"We found that blood vessels in SCCs did not express E-selectin, and tumors contained few cutaneous lymphocyte antigen (CLA)(+) T cells, the cell type thought to provide cutaneous immunosurveillance.",18794336_1,-1,-1,-1,-1,7685,-1,0.37709135,0.00073048257,0.62217814
7687,the cell type thought to,24,29,136,160,"We found that blood vessels in SCCs did not express E-selectin, and tumors contained few cutaneous lymphocyte antigen (CLA)(+) T cells, the cell type thought to provide cutaneous immunosurveillance.",18794336_1,-1,-1,-1,-1,7687,-1,6.437109e-05,0.9994837,0.0004519172
7688,Tumors treated,0,2,0,14,"Tumors treated with the Toll-like receptor (TLR)7 agonist imiquimod before excision showed induction of E-selectin on tumor vessels, recruitment of CLA(+) CD8(+) T cells, and histological evidence of tumor regression.",18794336_2,-1,-1,-1,-1,7688,-1,4.210446e-06,0.99999154,4.259062e-06
7689,the Toll-like receptor,3,6,20,42,"Tumors treated with the Toll-like receptor (TLR)7 agonist imiquimod before excision showed induction of E-selectin on tumor vessels, recruitment of CLA(+) CD8(+) T cells, and histological evidence of tumor regression.",18794336_2,-1,-1,-1,-1,7689,-1,0.0009238252,0.9863905,0.012685727
7694,the T cells,4,7,21,32,Approximately 50% of the T cells infiltrating untreated SCCs were FOXP3(+) regulatory T (T reg) cells.,18794336_4,-1,-1,-1,-1,7694,-1,0.0016533982,0.1467641,0.8515825
7702,these cells,12,14,78,89,"Imiquimod-treated tumors contained a decreased percentage of T reg cells, and these cells produced less FOXP3, interleukin (IL)-10, and transforming growth factor (TGF)-beta.",18794336_5,-1,-1,-1,-1,7702,-1,1.9978539e-05,2.3532999e-05,0.9999565
7705,transforming growth factor,22,25,136,162,"Imiquimod-treated tumors contained a decreased percentage of T reg cells, and these cells produced less FOXP3, interleukin (IL)-10, and transforming growth factor (TGF)-beta.",18794336_5,-1,-1,-1,-1,7705,-1,0.9841048,0.012829272,0.0030659214
7712,TGF-beta,24,25,128,136,"Treatment of T reg cells in vitro with imiquimod inhibited their suppressive activity and reduced FOXP3, CD39, CD73, IL-10, and TGF-beta by indirect mechanisms.",18794336_6,0,1,-1,-1,7712,-1,1.841026e-05,0.999974,7.615526e-06
7717,the immune response,8,11,36,55,"In summary, we find that SCCs evade the immune response at least in part by down-regulating vascular E-selectin and recruiting T reg cells.",18794336_8,-1,-1,-1,-1,7717,-1,0.5546051,0.44352084,0.001873974
7720,TLR7 agonists,0,2,0,13,"TLR7 agonists neutralized both of these strategies, supporting their use in SCCs and other tumors with similar immune defects.",18794336_9,-1,-1,-1,-1,7720,-1,0.0053810105,0.9933296,0.0012893836
7728,their functional,16,18,70,86,"Regulatory T (T(reg)) cells are often found in human tumors; however, their functional characteristics have been difficult to evaluate due to low cell numbers and the inability to adequately distinguish between activated and T(reg) cell populations.",18820132_0,-1,-1,-1,-1,7728,-1,0.00020041096,0.99966824,0.00013140477
7738,tumor-infiltrating T cells,13,16,86,112,"Using a novel approach, we examined the intracellular cytokine production capacity of tumor-infiltrating T cells in the single-cell suspensions of enzymatically digested tumors to differentiate T(reg) cells from effector T cells.",18820132_1,-1,-1,-1,-1,7738,-1,0.0018568694,0.8765097,0.12163347
7740,tumors to,23,25,170,179,"Using a novel approach, we examined the intracellular cytokine production capacity of tumor-infiltrating T cells in the single-cell suspensions of enzymatically digested tumors to differentiate T(reg) cells from effector T cells.",18820132_1,-1,-1,-1,-1,7740,-1,3.5231271e-06,0.9999927,3.7043244e-06
7744,to T(reg,1,3,8,16,"Similar to T(reg) cells in the peripheral blood of healthy individuals, tumor-infiltrating FOXP3(+)CD4 T cells, unlike FOXP3(-) T cells, were unable to produce IL-2 and IFN-gamma upon ex vivo stimulation, indicating that FOXP3 expression is a valid biological marker for human T(reg) cells even in the tumor microenvironment.",18820132_2,-1,-1,-1,-1,7744,-1,4.9763266e-06,0.9999883,6.7271676e-06
7747,blood,8,9,42,47,"Similar to T(reg) cells in the peripheral blood of healthy individuals, tumor-infiltrating FOXP3(+)CD4 T cells, unlike FOXP3(-) T cells, were unable to produce IL-2 and IFN-gamma upon ex vivo stimulation, indicating that FOXP3 expression is a valid biological marker for human T(reg) cells even in the tumor microenvironment.",18820132_2,0,1,-1,-1,7747,-1,1.9011057e-05,0.9999602,2.0833117e-05
7748,tumor-infiltrating FOXP3(+)CD4 T cells,13,17,72,110,"Similar to T(reg) cells in the peripheral blood of healthy individuals, tumor-infiltrating FOXP3(+)CD4 T cells, unlike FOXP3(-) T cells, were unable to produce IL-2 and IFN-gamma upon ex vivo stimulation, indicating that FOXP3 expression is a valid biological marker for human T(reg) cells even in the tumor microenvironment.",18820132_2,-1,-1,-1,-1,7748,-1,0.0019461317,0.86631656,0.1317373
7753,that FOXP3,37,39,216,226,"Similar to T(reg) cells in the peripheral blood of healthy individuals, tumor-infiltrating FOXP3(+)CD4 T cells, unlike FOXP3(-) T cells, were unable to produce IL-2 and IFN-gamma upon ex vivo stimulation, indicating that FOXP3 expression is a valid biological marker for human T(reg) cells even in the tumor microenvironment.",18820132_2,-1,-1,-1,-1,7753,-1,5.259473e-06,0.9999901,4.6892483e-06
7756,the tumor,52,54,298,307,"Similar to T(reg) cells in the peripheral blood of healthy individuals, tumor-infiltrating FOXP3(+)CD4 T cells, unlike FOXP3(-) T cells, were unable to produce IL-2 and IFN-gamma upon ex vivo stimulation, indicating that FOXP3 expression is a valid biological marker for human T(reg) cells even in the tumor microenvironment.",18820132_2,-1,-1,-1,-1,7756,-1,4.044151e-06,0.999992,3.910805e-06
7757,FOXP3(+)CD4 T(reg,4,6,27,44,"Accordingly, we enumerated FOXP3(+)CD4 T(reg) cells in intratumoral and peritumoral sections of metastatic melanoma tumors and found a significant increase in proportion of FOXP3(+)CD4 T(reg) cells in the intratumoral compared with peritumoral areas.",18820132_3,-1,-1,-1,-1,7757,-1,2.0807895e-05,0.9999571,2.2102771e-05
7760,FOXP3(+)CD4 T(reg,25,27,173,190,"Accordingly, we enumerated FOXP3(+)CD4 T(reg) cells in intratumoral and peritumoral sections of metastatic melanoma tumors and found a significant increase in proportion of FOXP3(+)CD4 T(reg) cells in the intratumoral compared with peritumoral areas.",18820132_3,-1,-1,-1,-1,7760,-1,2.0864576e-05,0.9999565,2.2677006e-05
7765,tumors than,10,12,56,67,"Moreover, their frequencies were 3- to 5-fold higher in tumors than in peripheral blood from the same patients or healthy donors, respectively.",18820132_4,-1,-1,-1,-1,7765,-1,4.0210557e-06,0.9999918,4.223006e-06
7766,blood,14,15,82,87,"Moreover, their frequencies were 3- to 5-fold higher in tumors than in peripheral blood from the same patients or healthy donors, respectively.",18820132_4,0,1,-1,-1,7766,-1,0.0013361304,0.93242747,0.06623639
7769,that the tumor-infiltrating,3,6,27,54,"These findings demonstrate that the tumor-infiltrating CD4 T(reg) cell population is accurately depicted by FOXP3 expression, they selectively accumulate in tumors, and their frequency in peripheral blood does not properly reflect tumor microenvironment.",18820132_5,-1,-1,-1,-1,7769,-1,1.0081844e-05,0.9999826,7.269358e-06
7776,blood,29,30,199,204,"These findings demonstrate that the tumor-infiltrating CD4 T(reg) cell population is accurately depicted by FOXP3 expression, they selectively accumulate in tumors, and their frequency in peripheral blood does not properly reflect tumor microenvironment.",18820132_5,0,1,-1,-1,7776,-1,0.0022199606,0.960346,0.03743406
7784,functional,4,5,24,34,A better phenotypic and functional characterization of this regulatory T-cell subset could help in identifying modulators of their activity with therapeutic finalities.,18832002_1,0,1,2,-1,7784,-1,0.00052142725,0.9993352,0.00014328801
7785,this regulatory T-cell subset,7,11,55,84,A better phenotypic and functional characterization of this regulatory T-cell subset could help in identifying modulators of their activity with therapeutic finalities.,18832002_1,-1,-1,-1,-1,7785,-1,0.000874994,0.03326662,0.96585846
7786,modulators,15,16,111,121,A better phenotypic and functional characterization of this regulatory T-cell subset could help in identifying modulators of their activity with therapeutic finalities.,18832002_1,-1,-1,-1,-1,7786,-1,0.20286755,0.7937392,0.0033932766
7791,that Foxp3,7,9,37,47,"The results of the present work show that Foxp3, a transcriptional marker of natural CD4+CD25+ Treg, is not expressed by CD8+CD28- Treg, thus indicating different origin and pathways of function for the latter with respect to the former regulatory cell type.",18832002_2,-1,-1,-1,-1,7791,-1,4.6789464e-06,0.99999094,4.3602677e-06
7797,function,33,34,186,194,"The results of the present work show that Foxp3, a transcriptional marker of natural CD4+CD25+ Treg, is not expressed by CD8+CD28- Treg, thus indicating different origin and pathways of function for the latter with respect to the former regulatory cell type.",18832002_2,0,1,2,-1,7797,-1,0.00017040083,0.99975556,7.405317e-05
7799,to the,39,41,223,229,"The results of the present work show that Foxp3, a transcriptional marker of natural CD4+CD25+ Treg, is not expressed by CD8+CD28- Treg, thus indicating different origin and pathways of function for the latter with respect to the former regulatory cell type.",18832002_2,-1,-1,-1,-1,7799,-1,5.0130475e-06,0.99999034,4.6842124e-06
7800,cell type,43,45,248,257,"The results of the present work show that Foxp3, a transcriptional marker of natural CD4+CD25+ Treg, is not expressed by CD8+CD28- Treg, thus indicating different origin and pathways of function for the latter with respect to the former regulatory cell type.",18832002_2,-1,-1,-1,-1,7800,-1,1.8128037e-05,3.2377215e-05,0.99994946
7802,that the,5,7,32,40,"Moreover, the results underline that the glucocorticoid induced TNF receptor is involved in generation processes but not in suppressor function of CD8+CD28- Treg.",18832002_3,-1,-1,-1,-1,7802,-1,3.8685835e-06,0.999992,4.113729e-06
7803,TNF receptor,9,11,64,76,"Moreover, the results underline that the glucocorticoid induced TNF receptor is involved in generation processes but not in suppressor function of CD8+CD28- Treg.",18832002_3,-1,-1,-1,-1,7803,-1,5.9630922e-05,0.9998499,9.0445785e-05
7805,function,20,21,135,143,"Moreover, the results underline that the glucocorticoid induced TNF receptor is involved in generation processes but not in suppressor function of CD8+CD28- Treg.",18832002_3,0,1,2,-1,7805,-1,1.24158705e-05,0.9999709,1.668679e-05
7809,T lymphocytes to Treg,12,16,103,124,"Phenotypic analyses demonstrate that, during their commitment from circulating nonregulatory CD8+CD28- T lymphocytes to Treg (an interleukin-10-dependent process), these cells downmodulate the IL7-receptor, thus differentiating them from long-lived, memory CD8+ T lymphocytes.",18832002_4,-1,-1,-1,-1,7809,-1,0.002458475,0.49999303,0.49754852
7811,these cells,22,24,164,175,"Phenotypic analyses demonstrate that, during their commitment from circulating nonregulatory CD8+CD28- T lymphocytes to Treg (an interleukin-10-dependent process), these cells downmodulate the IL7-receptor, thus differentiating them from long-lived, memory CD8+ T lymphocytes.",18832002_4,-1,-1,-1,-1,7811,-1,1.4807265e-05,1.2692204e-05,0.9999726
7812,the IL7-receptor,25,27,189,205,"Phenotypic analyses demonstrate that, during their commitment from circulating nonregulatory CD8+CD28- T lymphocytes to Treg (an interleukin-10-dependent process), these cells downmodulate the IL7-receptor, thus differentiating them from long-lived, memory CD8+ T lymphocytes.",18832002_4,-1,-1,-1,-1,7812,-1,0.47601295,0.5005137,0.023473406
7818,to the,10,12,62,68,"Interestingly, CD8+CD28- Treg have been found to be resistant to the inhibitory effects of methylprednisolone, one of the most frequently administered corticosteroid drug used in therapy for immunosuppressive purposes.",18832002_5,-1,-1,-1,-1,7818,-1,4.684562e-06,0.9999907,4.558278e-06
7820,therapy,27,28,179,186,"Interestingly, CD8+CD28- Treg have been found to be resistant to the inhibitory effects of methylprednisolone, one of the most frequently administered corticosteroid drug used in therapy for immunosuppressive purposes.",18832002_5,0,1,-1,-1,7820,-1,6.1013575e-06,0.9999883,5.5408996e-06
7832,analysis,8,9,55,63,"The forestomach of mice was dissected for histological analysis, and tunnel test was performed for apoptosis of tumor cells.",18855977_4,0,1,-1,-1,7832,-1,2.0832937e-05,0.99995816,2.102306e-05
7833,tunnel test,11,13,69,80,"The forestomach of mice was dissected for histological analysis, and tunnel test was performed for apoptosis of tumor cells.",18855977_4,-1,-1,-1,-1,7833,-1,1.2035528e-05,0.99997663,1.1294919e-05
7834,tumor cells,18,20,112,123,"The forestomach of mice was dissected for histological analysis, and tunnel test was performed for apoptosis of tumor cells.",18855977_4,-1,-1,-1,-1,7834,-1,0.00082713045,0.033337697,0.9658352
7839,chemokine receptors,17,19,100,119,"CD4(+)CD25(+) Tregs were sorted from different lymphoid tissues and expression of Foxp3, IL-10, and chemokine receptors was analyzed by flow cytometry, semi-quantitative and real-time polymerase chain reaction.",18855977_5,-1,-1,-1,-1,7839,-1,0.86339474,0.00016385523,0.1364414
7850,CCR5 chemokine receptors,24,27,137,161,"These CD4(+)CD25(+) Tregs in regional lymph nodes expressed higher levels of Foxp3 and IL-10, enriched in the CD62L-subset, and CCR1 and CCR5 chemokine receptors.",18855977_8,-1,-1,-1,-1,7850,-1,0.022069426,0.00021461629,0.977716
7855,tumor cells,25,27,151,162,"In mice gavaged with BaP + PC61, the number of tumor nodules and tumor volume decreased significantly with massive infiltrating cells and apoptosis of tumor cells.",18855977_9,-1,-1,-1,-1,7855,-1,0.00018460822,0.0015999869,0.99821544
7861,immunity,17,18,113,121,CONCLUSION: Inducible and activated CD4(+)CD25(+) Tregs in the draining regional lymph nodes suppress host local immunity during tumor growth.,18855977_11,0,-1,2,-1,7861,-1,0.99987817,4.69852e-05,7.490284e-05
7864,immunity to,9,11,56,67,Depletion of CD4(+)CD25(+) Tregs can promote host local immunity to suppress tumor growth.,18855977_12,-1,-1,-1,-1,7864,-1,0.29949299,0.6987624,0.001744546
7873,to the,2,4,12,18,"In contrast to the increasing number of CD4(+) T cells, CD8(+), CD3(-)CD56(+), CD3(+)CD56(+), and gammadeltaT cells were all found to be under-represented in tumor infiltrating lymphocytes.",18941744_2,-1,-1,-1,-1,7873,-1,4.007366e-06,0.9999918,4.168846e-06
7879,the relative,2,4,9,21,"Notably, the relative abundance of CD3(+)CD56(+) cells appeared to be correlated with patient survival.",18941744_3,-1,-1,-1,-1,7879,-1,5.489953e-06,0.99999034,4.1991448e-06
7882,Functional analysis,0,2,0,19,"Functional analysis demonstrated that CD4(+) cells in the tumor tended to produce more IL-10 but less IFN-gamma, whereas CD8(+) cells showed impaired capacity for the production of both IFN-gamma and perforin.",18941744_4,-1,-1,-1,-1,7882,-1,2.2544878e-05,0.99996376,1.3700201e-05
7885,the tumor tended to,8,12,54,73,"Functional analysis demonstrated that CD4(+) cells in the tumor tended to produce more IL-10 but less IFN-gamma, whereas CD8(+) cells showed impaired capacity for the production of both IFN-gamma and perforin.",18941744_4,-1,-1,-1,-1,7885,-1,3.791783e-06,0.9999918,4.379872e-06
7893,the tumor tissue,15,18,90,106,"Consistent with previous reports, we observed a significant increase of Foxp3(+) cells in the tumor tissue.",18941744_5,-1,-1,-1,-1,7893,-1,5.294514e-06,0.9999882,6.5400345e-06
7906,tissues,24,25,146,153,"In support of its role as a negative regulator, CD4(+)CD25(high) cells suppressed the proliferation of CD4(+)CD25(-) cells isolated from the same tissues in an APC dependent manner.",18941744_7,-1,1,2,-1,7906,-1,3.0255156e-05,0.9998491,0.00012059101
7907,the tumor,3,5,15,24,"In conclusion, the tumor microenvironment of hepatocellular carcinoma is featured by the presence of multiple immunosuppressive factors.",18941744_8,-1,-1,-1,-1,7907,-1,4.5204565e-06,0.99999094,4.576552e-06
7909,factors,17,18,128,135,"In conclusion, the tumor microenvironment of hepatocellular carcinoma is featured by the presence of multiple immunosuppressive factors.",18941744_8,0,1,-1,-1,7909,-1,0.99799985,0.0018389045,0.0001611482
7914,the therapeutic use,2,5,9,28,"However, the therapeutic use of cytokines has been hampered by their pleiotropic effects on target-cells.",18947877_1,-1,-1,-1,-1,7914,-1,1.5389289e-05,0.9999789,5.66014e-06
7916,their pleiotropic,11,13,63,80,"However, the therapeutic use of cytokines has been hampered by their pleiotropic effects on target-cells.",18947877_1,-1,-1,-1,-1,7916,-1,4.461959e-05,0.999944,1.1420059e-05
7921,side effects,12,14,68,80,"Thus, cytokines such as IFN-alpha and IL-2 have multiple and severe side effects.",18947877_2,0,1,-1,-1,7921,-1,0.00255505,0.9970624,0.0003825912
7931,that the,2,4,8,16,We show that the combined stimulation of target-cells with IFN-alpha and IL-21 triggers an increased STAT3 activation whereas the activation of other STATs including STAT1/2 is unaffected.,18947877_5,-1,-1,-1,-1,7931,-1,5.557596e-06,0.9999912,3.3134027e-06
7941,T-cell-mediated,24,25,138,153,"In parallel, the combined stimulation with IFN-alpha and IL-21 triggers a selective increase in MHC class I expression and NK- and CD8(+) T-cell-mediated cytotoxicity.",18947877_6,-1,1,2,-1,7941,-1,1.1999988e-05,7.4305817e-06,0.99998057
7946,Taken together,0,2,0,14,"Taken together our data show that the combined use of IFN-alpha and IL-21 boosts STAT3 signaling, cytotoxicity, and anti-tumor efficacy, suggesting that a combinatorial therapeutic use of these cytokines may benefit cancer patients.",18947877_8,-1,-1,-1,-1,7946,-1,9.522272e-06,0.99998295,7.514949e-06
7947,that the,5,7,29,37,"Taken together our data show that the combined use of IFN-alpha and IL-21 boosts STAT3 signaling, cytotoxicity, and anti-tumor efficacy, suggesting that a combinatorial therapeutic use of these cytokines may benefit cancer patients.",18947877_8,-1,-1,-1,-1,7947,-1,5.687495e-06,0.9999907,3.6343286e-06
7951,therapeutic use,27,29,169,184,"Taken together our data show that the combined use of IFN-alpha and IL-21 boosts STAT3 signaling, cytotoxicity, and anti-tumor efficacy, suggesting that a combinatorial therapeutic use of these cytokines may benefit cancer patients.",18947877_8,0,1,-1,-1,7951,-1,1.0592394e-05,0.99998415,5.3196723e-06
7952,these cytokines,30,32,188,203,"Taken together our data show that the combined use of IFN-alpha and IL-21 boosts STAT3 signaling, cytotoxicity, and anti-tumor efficacy, suggesting that a combinatorial therapeutic use of these cytokines may benefit cancer patients.",18947877_8,-1,-1,-1,-1,7952,-1,0.91373646,0.0832474,0.0030162046
7956,tumour-infiltrating lymphocytes,12,14,66,97,"However, a group of cancers are characterized by the abundance of tumour-infiltrating lymphocytes (TILs).",18980207_1,-1,-1,-1,-1,7956,-1,0.0037023954,0.74491614,0.25138143
7974,The T-cell,0,2,0,10,The T-cell zone of the regional lymph nodes of lymphocyte-rich GCs also abounded with CXCR3(+) T cells and CXCL9(+) stromal cells.,18980207_6,-1,-1,-1,-1,7974,-1,0.002016729,0.18324311,0.8147402
7993,tertiary lymphoid tissue,18,21,111,135,"Given similar findings in the regional lymph nodes, the lymphoid stroma of lymphocyte-rich GCs may represent a tertiary lymphoid tissue with predominantly Th1-shifted immune responses.",18980207_11,-1,-1,-1,-1,7993,-1,0.00011990698,9.1721224e-05,0.99978834
7994,Th1-shifted immune responses,23,26,155,183,"Given similar findings in the regional lymph nodes, the lymphoid stroma of lymphocyte-rich GCs may represent a tertiary lymphoid tissue with predominantly Th1-shifted immune responses.",18980207_11,-1,-1,-1,-1,7994,-1,0.046852607,0.95153695,0.0016104665
7995,T-cell,4,5,45,51,"Cutaneous CD4 small/medium-sized pleomorphic T-cell lymphoma (CSTCL) is a cutaneous T-cell lymphoma defined by a predominance of small-to-medium-sized CD4 pleomorphic T cells, with a favorable clinical course.",18987541_0,-1,1,2,-1,7995,-1,1.13389515e-05,6.427676e-06,0.99998224
7996,T-cell,12,13,84,90,"Cutaneous CD4 small/medium-sized pleomorphic T-cell lymphoma (CSTCL) is a cutaneous T-cell lymphoma defined by a predominance of small-to-medium-sized CD4 pleomorphic T cells, with a favorable clinical course.",18987541_0,-1,1,2,-1,7996,-1,1.2098915e-05,7.3316414e-06,0.99998057
8002,TFH cells,12,14,63,72,"Recently, it has been reported that follicular helper T cells (TFH cells) display a distinct gene expression profile, positive for PD-1, CXCL13, and BCL-6.",18987541_2,-1,-1,-1,-1,8002,-1,0.000504752,0.048000533,0.95149475
8007,time the,5,7,24,32,We report for the first time the expression of PD-1 and other TFH cell markers in CSTCLs and discuss its biologic significance.,18987541_3,-1,-1,-1,-1,8007,-1,4.473804e-06,0.9999912,4.388784e-06
8008,TFH cell,12,14,62,70,We report for the first time the expression of PD-1 and other TFH cell markers in CSTCLs and discuss its biologic significance.,18987541_3,-1,-1,-1,-1,8008,-1,0.00030878346,0.004760317,0.9949309
8014,RNA,9,10,76,79,Clonal Ig and T-cell receptor rearrangements and Epstein-Barr virus-encoded RNA expression were also evaluated.,18987541_7,-1,-1,-1,-1,8014,-1,1.3269176e-05,0.9999633,2.3500974e-05
8015,throughout the,8,10,70,84,Histologic examination showed a dense polymorphic lymphoid infiltrate throughout the dermis.,18987541_9,-1,-1,-1,-1,8015,-1,1.4882189e-05,0.99997103,1.410109e-05
8021,T-cell,2,3,11,17,"A dominant T-cell clone was identified in 14 cases, whereas polymerase chain reaction IgH gene rearrangement studies showed that all cases were polyclonal.",18987541_12,-1,1,2,-1,8021,-1,1.2212199e-05,7.0724705e-06,0.9999808
8026,history,20,21,116,123,"None of the patients had lymphadenopathy or showed any evidence of systemic disease, nor did they have any previous history of mycosis fungoides or drug reactions.",18987541_13,0,1,-1,-1,8026,-1,0.00026608774,0.9996455,8.8384375e-05
8033,take place,12,14,75,85,"Moreover, these findings suggest that B-cell stimulation by FTH could also take place in some cutaneous T-cell lymphomas.",18987541_15,-1,-1,-1,-1,8033,-1,2.8648443e-05,0.99995756,1.3832806e-05
8034,T-cell,17,18,104,110,"Moreover, these findings suggest that B-cell stimulation by FTH could also take place in some cutaneous T-cell lymphomas.",18987541_15,-1,1,2,-1,8034,-1,1.8158316e-05,1.2442261e-05,0.9999695
8042,cellular target(s,20,22,160,177,"These drugs exhibit a range of interesting clinical properties, including anti-angiogenic, anti-proliferative, and pro-erythropoietic activities although exact cellular target(s) remain unclear.",19009291_1,-1,-1,-1,-1,8042,-1,0.0053250263,0.4844074,0.5102676
8044,TNF-alpha,8,9,61,70,"Also, anti-inflammatory effects on LPS-stimulated monocytes (TNF-alpha is decreased) and costimulatory effects on anti-CD3 stimulated T cells, (enhanced T cell proliferation and proinflammatory cytokine production) are observed.",19009291_2,0,1,-1,-1,8044,-1,0.04125013,0.958178,0.00057185657
8049,tumour-cell targets,10,12,74,93,These drugs also cause augmentation of NK-cell cytotoxic activity against tumour-cell targets.,19009291_3,-1,-1,-1,-1,8049,-1,2.3996552e-05,0.999948,2.8002207e-05
8054,T-regulatory cell,25,27,195,212,"Having shown that pomalidomide confers T cell-dependent adjuvant-like protection in a preclinical whole tumour-cell vaccine-model, we now show that lenalidomide and pomalidomide strongly inhibit T-regulatory cell proliferation and suppressor-function.",19009291_4,-1,-1,-1,-1,8054,-1,0.0016373275,0.15990674,0.838456
8060,function,3,4,24,32,"Furthermore, suppressor function of pre-treated T regulatory cells against autologous responder-cells is abolished or markedly inhibited without drug related cytotoxicity.",19009291_6,0,1,2,-1,8060,-1,0.00019456769,0.99954504,0.0002603169
8068,cell function,4,6,27,40,Inhibition of T regulatory cell function was not due to changes in TGF-beta or IL-10 production but was associated with decreased T regulatory cell FOXP3 expression.,19009291_8,-1,-1,-1,-1,8068,-1,1.367052e-05,1.3108788e-05,0.9999732
8070,TGF-beta,12,13,67,75,Inhibition of T regulatory cell function was not due to changes in TGF-beta or IL-10 production but was associated with decreased T regulatory cell FOXP3 expression.,19009291_8,0,1,-1,-1,8070,-1,6.7549256e-05,0.9999132,1.9185152e-05
8073,cell FOXP3,23,25,143,153,Inhibition of T regulatory cell function was not due to changes in TGF-beta or IL-10 production but was associated with decreased T regulatory cell FOXP3 expression.,19009291_8,-1,-1,-1,-1,8073,-1,0.001954575,0.8844016,0.11364378
8074,that they,17,19,117,126,"In conclusion, our data provide one explanation for adjuvant properties of lenalidomide and pomalidomide and suggest that they may help overcome an important barrier to tumour-specific immunity in cancer patients.",19009291_9,-1,-1,-1,-1,8074,-1,7.4653376e-06,0.99998736,5.1843017e-06
8075,to tumour-specific immunity,25,28,166,193,"In conclusion, our data provide one explanation for adjuvant properties of lenalidomide and pomalidomide and suggest that they may help overcome an important barrier to tumour-specific immunity in cancer patients.",19009291_9,-1,-1,-1,-1,8075,-1,0.03986008,0.95842606,0.0017138461
8082,to the,30,32,150,156,"The New Zealand Black (NZB) mouse is a murine model for both autoimmune diseases, since high levels of autoantibodies are present, and human CLL, due to the expansion of malignant B-1 cells.",19022624_1,-1,-1,-1,-1,8082,-1,4.983002e-06,0.9999908,4.1602316e-06
8085,the functional,6,8,27,41,"In this study, we examined the functional role of CD4(+)CD25(+) Foxp3(+) Tregs in these different manifestations.",19022624_2,-1,-1,-1,-1,8085,-1,8.215802e-06,0.9999862,5.586636e-06
8089,analysis,2,3,16,24,Flow cytometric analysis showed increased levels of Tregs in NZB mice compared to healthy C57Bl/6 controls.,19022624_3,0,1,-1,-1,8089,-1,1.7549122e-05,0.999969,1.3468626e-05
8111,to the,25,27,147,153,"These results indicate that while high levels of Tregs found in NZB mice might suppress a more severe autoimmune disease, they may also contribute to the development of the B cell malignancy.",19022624_7,-1,-1,-1,-1,8111,-1,4.7783615e-06,0.9999908,4.4185535e-06
8114,antigens to,3,5,27,38,"Lentiviral vectors deliver antigens to dendritic cells (DCs) in vivo, but they do not trigger DC maturation.",19036811_0,-1,-1,-1,-1,8114,-1,0.9949367,0.0041337637,0.0009295616
8130,immune response to,17,20,87,105,"When we coexpressed vFLIP in a lentivector with ovalbumin (Ova), we found an increased immune response to Ova; up to 10 times more Ova-specific CD8(+) T cells secreting gamma interferon were detected in the spleens of vFLIP_Ova-immunized mice than in the spleens of mice immunized with GFP_Ova.",19036811_4,-1,-1,-1,-1,8130,-1,0.7671252,0.23153539,0.0013394117
8139,T-cell,6,7,35,41,"Furthermore, this increased CD8(+) T-cell response correlated with improved tumor-free survival in a tumor therapy model.",19036811_5,-1,1,2,-1,8139,-1,2.0222295e-05,7.891224e-06,0.99997187
8141,tumor therapy,15,17,101,114,"Furthermore, this increased CD8(+) T-cell response correlated with improved tumor-free survival in a tumor therapy model.",19036811_5,-1,-1,-1,-1,8141,-1,4.7768417e-06,0.99999046,4.781126e-06
8145,that NF-kappaB,2,4,18,32,This demonstrates that NF-kappaB activation is sufficient to induce many aspects of DC maturation and that expression of a constitutive NF-kappaB activator can improve the efficacy of a vaccine vector.,19036811_8,-1,-1,-1,-1,8145,-1,1.2442411e-05,0.99998057,7.0068513e-06
8148,NF-kappaB activator,20,22,136,155,This demonstrates that NF-kappaB activation is sufficient to induce many aspects of DC maturation and that expression of a constitutive NF-kappaB activator can improve the efficacy of a vaccine vector.,19036811_8,-1,-1,-1,-1,8148,-1,1.4313373e-05,0.99997866,6.9853136e-06
8151,to chemo-,8,10,38,47,Cancer stem cells (CSC) are resistant to chemo- and radiotherapy.,19048252_0,-1,-1,-1,-1,8151,-1,0.6826358,0.31355485,0.0038094157
8154,receptors,25,26,127,136,"To eliminate cells with phenotypic markers of CSC-like we characterized: (1) expression of CD44, CD24, CD133 and MIC-A/B (NKG2 receptors) in breast (MCF7) and ovarian (SK-OV-3) cells resistant to gemcitabine (GEM), paclitaxel (PTX) and 5-fluorouracil (5-FU) and (2) their elimination by Numb- and Notch-peptide activated CTL.",19048252_1,0,1,2,-1,8154,-1,0.0010173724,0.2298132,0.7691694
8169,tumor cells,14,16,90,101,"Similarly, the number of cells with expressed MIC-A/B increased 4 times in drug-resistant tumor cells compared with drug-sensitive cells.",19048252_3,-1,-1,-1,-1,8169,-1,0.00037325494,0.023078857,0.9765479
8171,MCF7 cells,2,4,9,19,GEM(Res) MCF7 cells had lower levels of the Notch-1-extracellular domain (NECD) and Notch trans-membrane intracellular domain (TMIC) than GEM(Sens) MCF7.,19048252_4,-1,-1,-1,-1,8171,-1,0.8262986,0.00073225785,0.17296915
8178,MCF7 cells,16,18,83,93,"The levels of Numb, and Numb-L-[P]-Ser(265) were similar in GEM(Res) and GEM(Sens) MCF7 cells.",19048252_5,-1,-1,-1,-1,8178,-1,0.80421174,0.0014137451,0.19437444
8182,to TMIC,6,8,44,51,This finding suggests that Notch-1 cleavage to TMIC is inhibited in GEM(Res) MCF7 cells.,19048252_7,-1,-1,-1,-1,8182,-1,2.7912387e-05,0.9999472,2.4903187e-05
8183,MCF7 cells,13,15,77,87,This finding suggests that Notch-1 cleavage to TMIC is inhibited in GEM(Res) MCF7 cells.,19048252_7,-1,-1,-1,-1,8183,-1,0.80165493,0.00078111107,0.19756392
8185,peptides,5,6,38,46,"PBMC activated by natural immunogenic peptides Notch-1 (2112-2120) and Numb-1 (87-95) eliminated NICD(positive), CD24(hi) CD24(lo) MCF7 cells.",19048252_8,0,-1,2,-1,8185,-1,2.5466708e-05,0.99996173,1.2814213e-05
8186,MCF7 cells,27,29,131,141,"PBMC activated by natural immunogenic peptides Notch-1 (2112-2120) and Numb-1 (87-95) eliminated NICD(positive), CD24(hi) CD24(lo) MCF7 cells.",19048252_8,-1,-1,-1,-1,8186,-1,0.9483546,0.00051506807,0.05113039
8187,that the,3,5,13,21,"It is likely that the immunogenic Numb-1 peptide in MCF7 cells originated from Numb, [P]-lated by an unknown kinase, because staurosporine but not wortmannin and MAPK-inhibitors decreased peptide presentation.",19048252_9,-1,-1,-1,-1,8187,-1,6.5432746e-06,0.99998844,4.9796267e-06
8188,peptide,7,8,41,48,"It is likely that the immunogenic Numb-1 peptide in MCF7 cells originated from Numb, [P]-lated by an unknown kinase, because staurosporine but not wortmannin and MAPK-inhibitors decreased peptide presentation.",19048252_9,0,-1,2,-1,8188,-1,0.4821125,0.5108272,0.0070603406
8189,MCF7 cells,9,11,52,62,"It is likely that the immunogenic Numb-1 peptide in MCF7 cells originated from Numb, [P]-lated by an unknown kinase, because staurosporine but not wortmannin and MAPK-inhibitors decreased peptide presentation.",19048252_9,-1,-1,-1,-1,8189,-1,0.5922513,0.0010179989,0.4067307
8190,peptide,29,30,188,195,"It is likely that the immunogenic Numb-1 peptide in MCF7 cells originated from Numb, [P]-lated by an unknown kinase, because staurosporine but not wortmannin and MAPK-inhibitors decreased peptide presentation.",19048252_9,0,-1,2,-1,8190,-1,0.0075544356,0.9921969,0.00024865492
8191,proteins,5,6,32,40,"Numb and Notch are antagonistic proteins which degrade each other to stop and activate cell proliferation, respectively.",19048252_10,0,1,-1,-1,8191,-1,1.4467175e-05,0.99997985,5.621221e-06
8194,Their peptides,0,2,0,14,Their peptides are presented alternatively.,19048252_11,-1,-1,-1,-1,8194,-1,0.0033815033,0.99630475,0.0003137738
8196,proteins,3,4,28,36,Targeting both antagonistic proteins should be useful to prevent metastases in patients whose tumors are resistant to conventional treatments.,19048252_12,0,1,-1,-1,8196,-1,6.7354e-05,0.9999176,1.5005522e-05
8206,T-cell,10,11,53,59,IDO has recently been established as a key enzyme in T-cell suppression-mediated immune tolerance to tumors.,19075017_1,-1,1,2,-1,8206,-1,1.0210335e-05,1.2500506e-05,0.99997723
8207,tolerance to tumors,13,16,88,107,IDO has recently been established as a key enzyme in T-cell suppression-mediated immune tolerance to tumors.,19075017_1,-1,-1,-1,-1,8207,-1,5.7824323e-06,0.9999876,6.582368e-06
8209,to play,3,5,30,37,"STAT1 phosphorylation appears to play an important role in the control of IDO expression by IFNgamma, but the precise regulatory mechanism remains obscure.",19075017_2,-1,-1,-1,-1,8209,-1,8.207682e-06,0.9999864,5.398904e-06
8221,protein,14,15,105,112,"We found that curcumin suppressed STAT1 activation by directly inhibiting Janus-activated kinase 1/2 and protein kinase Cdelta phosphorylation in bone marrow-derived DCs, suppressing the subsequent translocation and binding of STAT1 to the GAS element of the IRF-1 promoter.",19075017_5,0,1,-1,-1,8221,-1,1.1658052e-05,0.99997985,8.471495e-06
8224,STAT1 to the,30,33,227,239,"We found that curcumin suppressed STAT1 activation by directly inhibiting Janus-activated kinase 1/2 and protein kinase Cdelta phosphorylation in bone marrow-derived DCs, suppressing the subsequent translocation and binding of STAT1 to the GAS element of the IRF-1 promoter.",19075017_5,-1,-1,-1,-1,8224,-1,3.5723588e-06,0.9999919,4.5457637e-06
8225,the IRF-1,36,38,255,264,"We found that curcumin suppressed STAT1 activation by directly inhibiting Janus-activated kinase 1/2 and protein kinase Cdelta phosphorylation in bone marrow-derived DCs, suppressing the subsequent translocation and binding of STAT1 to the GAS element of the IRF-1 promoter.",19075017_5,-1,-1,-1,-1,8225,-1,7.040037e-06,0.9999783,1.4618323e-05
8228,T-cell,15,16,123,129,"Coincident with these inhibitory effects on IFNgamma-induced IDO expression, curcumin reversed IDO-mediated suppression of T-cell responses.",19075017_6,-1,1,2,-1,8228,-1,5.5597302e-05,1.6252267e-05,0.99992824
8236,factor-beta-signaling,6,7,50,71,Alterations in genes encoding transforming growth factor-beta-signaling components contribute to colon cancer in humans.,19119184_0,0,1,-1,-1,8236,-1,0.99950767,0.00010873739,0.0003835469
8238,the transforming growth factor-beta,5,9,29,64,"Similarly, mice deficient in the transforming growth factor-beta signaling molecule, Smad3, develop colon cancer, but only after a bacterial trigger occurs, resulting in chronic inflammation.",19119184_1,-1,-1,-1,-1,8238,-1,0.96120554,0.03524112,0.003553362
8242,Smad3-null lymphocytes,3,5,21,43,"To determine whether Smad3-null lymphocytes contribute to increased cancer susceptibility, we crossed Smad3-null mice with mice deficient in both B and T lymphocytes (Rag2(-/-) mice).",19119184_2,-1,-1,-1,-1,8242,-1,0.0018432107,0.87272114,0.12543562
8247,T-regulatory cells,6,8,38,56,"Adoptive transfer of WT CD4(+)CD25(+) T-regulatory cells provided significant protection of Smad3/Rag2-DKO from bacterial-induced typhlocolitis, dysplasia, and tumor development, whereas Smad3(-/-) T-regulatory cells provided no protection.",19119184_4,-1,-1,-1,-1,8247,-1,0.0014047038,0.10433782,0.8942574
8250,T-regulatory cells,26,28,198,216,"Adoptive transfer of WT CD4(+)CD25(+) T-regulatory cells provided significant protection of Smad3/Rag2-DKO from bacterial-induced typhlocolitis, dysplasia, and tumor development, whereas Smad3(-/-) T-regulatory cells provided no protection.",19119184_4,-1,-1,-1,-1,8250,-1,0.0017114738,0.15269697,0.84559155
8252,tissues,14,15,118,125,"Immunohistochemistry, real-time reverse transcriptase-polymerase chain reaction, and Western blot analyses of colonic tissues from Smad3/Rag2-DKO mice 1 week after Helicobacter infection revealed an influx of macrophages, enhanced nuclear factor-kappaB activation, increased Bcl(XL)/Bcl-2 expression, increased c-Myc expression, accentuated epithelial cell proliferation, and up-regulated IFN-gamma, IL-1alpha, TNF-alpha, IL-1beta, and IL-6 transcription levels.",19119184_5,-1,1,2,-1,8252,-1,0.00015606778,0.98311955,0.01672436
8257,TNF-alpha,53,54,411,420,"Immunohistochemistry, real-time reverse transcriptase-polymerase chain reaction, and Western blot analyses of colonic tissues from Smad3/Rag2-DKO mice 1 week after Helicobacter infection revealed an influx of macrophages, enhanced nuclear factor-kappaB activation, increased Bcl(XL)/Bcl-2 expression, increased c-Myc expression, accentuated epithelial cell proliferation, and up-regulated IFN-gamma, IL-1alpha, TNF-alpha, IL-1beta, and IL-6 transcription levels.",19119184_5,0,1,-1,-1,8257,-1,0.017878633,0.98167634,0.00044501337
8259,IL-6 transcription,58,60,436,454,"Immunohistochemistry, real-time reverse transcriptase-polymerase chain reaction, and Western blot analyses of colonic tissues from Smad3/Rag2-DKO mice 1 week after Helicobacter infection revealed an influx of macrophages, enhanced nuclear factor-kappaB activation, increased Bcl(XL)/Bcl-2 expression, increased c-Myc expression, accentuated epithelial cell proliferation, and up-regulated IFN-gamma, IL-1alpha, TNF-alpha, IL-1beta, and IL-6 transcription levels.",19119184_5,-1,-1,-1,-1,8259,-1,0.99883693,0.000698908,0.00046416442
8261,that the,3,5,22,30,"These results suggest that the loss of Smad3 increases susceptibility to colon cancer by at least two mechanisms: deficient T-regulatory cell function, which leads to excessive inflammation after a bacterial trigger; and increased expression of proinflammatory cytokines, enhanced nuclear factor-kappaB activation, and increased expression of both pro-oncogenic and anti-apoptotic proteins that result in increased cell proliferation/survival of epithelial cells in colonic tissues.",19119184_6,-1,-1,-1,-1,8261,-1,4.1673366e-06,0.99999213,3.7142906e-06
8265,T-regulatory cell function,20,23,124,150,"These results suggest that the loss of Smad3 increases susceptibility to colon cancer by at least two mechanisms: deficient T-regulatory cell function, which leads to excessive inflammation after a bacterial trigger; and increased expression of proinflammatory cytokines, enhanced nuclear factor-kappaB activation, and increased expression of both pro-oncogenic and anti-apoptotic proteins that result in increased cell proliferation/survival of epithelial cells in colonic tissues.",19119184_6,-1,-1,-1,-1,8265,-1,0.001007989,0.14745133,0.8515407
8270,proteins that,54,56,381,394,"These results suggest that the loss of Smad3 increases susceptibility to colon cancer by at least two mechanisms: deficient T-regulatory cell function, which leads to excessive inflammation after a bacterial trigger; and increased expression of proinflammatory cytokines, enhanced nuclear factor-kappaB activation, and increased expression of both pro-oncogenic and anti-apoptotic proteins that result in increased cell proliferation/survival of epithelial cells in colonic tissues.",19119184_6,-1,-1,-1,-1,8270,-1,5.360619e-06,0.9999901,4.5056468e-06
8273,tissues,66,67,474,481,"These results suggest that the loss of Smad3 increases susceptibility to colon cancer by at least two mechanisms: deficient T-regulatory cell function, which leads to excessive inflammation after a bacterial trigger; and increased expression of proinflammatory cytokines, enhanced nuclear factor-kappaB activation, and increased expression of both pro-oncogenic and anti-apoptotic proteins that result in increased cell proliferation/survival of epithelial cells in colonic tissues.",19119184_6,-1,1,2,-1,8273,-1,0.0002661971,0.974945,0.024788829
8274,the immune response,9,12,73,92,INTRODUCTION: Periapical chronic lesion formation involves activation of the immune response and alveolar bone resorption around the tooth apex.,19121066_0,-1,-1,-1,-1,8274,-1,0.57289517,0.4249442,0.0021606274
8275,the tooth,17,19,129,138,INTRODUCTION: Periapical chronic lesion formation involves activation of the immune response and alveolar bone resorption around the tooth apex.,19121066_0,-1,-1,-1,-1,8275,-1,9.0132475e-05,0.9998398,7.006176e-05
8281,T-regulatory cell,17,19,62,79,"However, the overall roles of T helper type 1 (Th1), Th2, and T-regulatory cell (Treg) responses and osteoclast regulatory factors in periapical cysts and granulomas have not been fully determined.",19121066_1,-1,-1,-1,-1,8281,-1,0.0015571471,0.29896846,0.69947445
8283,factors,26,27,123,130,"However, the overall roles of T helper type 1 (Th1), Th2, and T-regulatory cell (Treg) responses and osteoclast regulatory factors in periapical cysts and granulomas have not been fully determined.",19121066_1,0,1,-1,-1,8283,-1,4.521879e-06,0.99999094,4.5345105e-06
8290,factors,30,31,176,183,"This study aimed to investigate whether different forms of apical periodontitis, namely cysts and granulomas, show different balances of Th1, Th2 regulators, Treg markers, and factors involved in osteoclast chemotaxis and activation.",19121066_2,0,1,-1,-1,8290,-1,3.6161255e-05,0.99995375,1.0128746e-05
8293,these factors,5,7,28,41,"METHODS: Gene expression of these factors was assessed using quantitative real-time polymerase chain reaction, in samples obtained from healthy gingiva (n = 8), periapical granulomas (n = 20), and cysts (n = 10).RESULTS: Periapical cysts exhibited a greater expression of GATA-3, while a greater expression of T-bet, Foxp3, and interleukin-10 (IL-10) was seen in granulomas.",19121066_3,-1,-1,-1,-1,8293,-1,0.0009811126,0.99896324,5.5611647e-05
8302,factors,2,3,23,30,"Regarding osteoclastic factors, while the expression of SDF-1alpha/CXCL12 and CCR1 was higher in cysts, the expression of RANKL was significantly higher in granulomas.",19121066_5,0,1,-1,-1,8302,-1,0.8249664,0.17423189,0.0008016914
8307,the Th1,16,18,108,115,CONCLUSION: Our results showed a predominance of osteoclast activity in granulomas that was correlated with the Th1 response.,19121066_7,-1,-1,-1,-1,8307,-1,5.7720445e-06,0.9999814,1.2780098e-05
8310,the Th1,12,14,83,90,The concomitant expression of Treg cell markers suggests a possible suppression of the Th1 response in granulomas.,19121066_8,-1,-1,-1,-1,8310,-1,4.8437414e-06,0.99998605,9.110243e-06
8312,the Th2,7,9,28,35,"On the other hand, in cysts the Th2 activity is augmented.",19121066_9,-1,-1,-1,-1,8312,-1,4.539357e-05,0.99994385,1.0727887e-05
8323,that T(Reg,9,11,44,54,"In multiple myeloma (MM), evidence suggests that T(Reg) cells are increased though controversy exists with regards to their function and no relationship to disease stage and treatment has been demonstrated.",19133978_1,-1,-1,-1,-1,8323,-1,5.8664587e-06,0.9999881,6.0507873e-06
8326,to their function,20,23,115,132,"In multiple myeloma (MM), evidence suggests that T(Reg) cells are increased though controversy exists with regards to their function and no relationship to disease stage and treatment has been demonstrated.",19133978_1,-1,-1,-1,-1,8326,-1,8.1611426e-05,0.99985456,6.377794e-05
8327,relationship to,25,27,140,155,"In multiple myeloma (MM), evidence suggests that T(Reg) cells are increased though controversy exists with regards to their function and no relationship to disease stage and treatment has been demonstrated.",19133978_1,-1,-1,-1,-1,8327,-1,1.1462104e-05,0.9999777,1.0825135e-05
8329,functional,8,9,54,64,"Here, we demonstrate significantly elevated levels of functional CD4(+)CD25(+)FoxP3(+) T(Reg) cells in a large cohort of patients with MM as well as monoclonal gammopathy of uncertain significance (MGUS) in comparison to age-matched, healthy controls.",19133978_2,0,1,2,-1,8329,-1,0.0016844909,0.99675,0.0015655368
8336,that these cells,13,16,80,96,"The frequency of Double Negative T(Reg) cells was also evaluated, demonstrating that these cells were reduced in patients with MM.",19133978_3,-1,-1,-1,-1,8336,-1,0.0034057302,0.26112202,0.73547226
8339,blood,11,12,86,91,"Furthermore, a characteristic profile of immunomodulatory cytokines in the peripheral blood and bone marrow of patients with MM and MGUS was demonstrated, compared with healthy controls.",19133978_4,0,1,-1,-1,8339,-1,0.0021916137,0.9577398,0.04006863
8341,to the,5,7,32,38,This data adds further evidence to the understanding of the role of T(Reg) cell subsets in tumour immunology and the fundamentals of the host/tumour immune conflict.,19133978_5,-1,-1,-1,-1,8341,-1,5.3269396e-06,0.9999894,5.2831974e-06
8344,cell subsets,14,16,75,87,This data adds further evidence to the understanding of the role of T(Reg) cell subsets in tumour immunology and the fundamentals of the host/tumour immune conflict.,19133978_5,-1,-1,-1,-1,8344,-1,1.526532e-05,8.904725e-06,0.9999758
8345,tumour immunology,17,19,91,108,This data adds further evidence to the understanding of the role of T(Reg) cell subsets in tumour immunology and the fundamentals of the host/tumour immune conflict.,19133978_5,-1,-1,-1,-1,8345,-1,0.025581764,0.9730483,0.0013698508
8351,to their,13,15,74,82,Regulatory T-cells (Treg) have been the focus of immunologic research due to their role in establishing tolerance for harmless antigens versus allowing immune responses against foes.,19147574_0,-1,-1,-1,-1,8351,-1,5.838194e-06,0.9999888,5.425384e-06
8356,protein,8,9,58,65,"Increased Treg frequencies measured by mRNA expression or protein synthesis of the Treg marker FOXP3 were found in various cancers, indicating that dysregulation of Treg levels contributes to tumor establishment.",19147574_1,0,1,-1,-1,8356,-1,3.8034374e-05,0.99995124,1.0675915e-05
8357,the Treg,11,13,79,87,"Increased Treg frequencies measured by mRNA expression or protein synthesis of the Treg marker FOXP3 were found in various cancers, indicating that dysregulation of Treg levels contributes to tumor establishment.",19147574_1,-1,-1,-1,-1,8357,-1,7.046281e-06,0.9999865,6.3967e-06
8361,to tumor,28,30,189,197,"Increased Treg frequencies measured by mRNA expression or protein synthesis of the Treg marker FOXP3 were found in various cancers, indicating that dysregulation of Treg levels contributes to tumor establishment.",19147574_1,-1,-1,-1,-1,8361,-1,4.9359937e-06,0.99998987,5.254353e-06
8365,transplantation,15,16,93,108,"Furthermore, they constitute a key target of immunomodulatory therapies in cancer as well as transplantation settings.",19147574_2,-1,1,2,-1,8365,-1,9.129553e-06,0.9999844,6.451284e-06
8371,protein,20,21,98,105,"One core obstacle for understanding the role of Treg, thus far, is the inability of FOXP3 mRNA or protein detection methods to differentiate between Treg and activated T cells.",19147574_3,0,1,-1,-1,8371,-1,6.431838e-05,0.9999242,1.1498912e-05
8376,the technical,5,7,37,50,These difficulties are aggravated by the technical demands of sample logistics and processing.,19147574_4,-1,-1,-1,-1,8376,-1,8.694714e-06,0.9999871,4.2025727e-06
8378,the FOXP3,6,8,48,57,"Based on Treg-specific DNA demethylation within the FOXP3 locus, we present a novel method for monitoring Treg in human peripheral blood and solid tissues.",19147574_5,-1,-1,-1,-1,8378,-1,6.5309596e-06,0.9999871,6.3967154e-06
8380,blood,21,22,131,136,"Based on Treg-specific DNA demethylation within the FOXP3 locus, we present a novel method for monitoring Treg in human peripheral blood and solid tissues.",19147574_5,0,1,-1,-1,8380,-1,0.0003904863,0.96855974,0.031049758
8381,tissues,24,25,147,154,"Based on Treg-specific DNA demethylation within the FOXP3 locus, we present a novel method for monitoring Treg in human peripheral blood and solid tissues.",19147574_5,-1,1,2,-1,8381,-1,7.3654286e-05,0.98926467,0.010661701
8382,that Treg,2,4,9,18,We found that Treg numbers are significantly increased in the peripheral blood of patients with interleukin 2-treated melanoma and in formalin-fixed tissue from patients with lung and colon carcinomas.,19147574_6,-1,-1,-1,-1,8382,-1,9.520318e-06,0.9999809,9.566562e-06
8384,blood,11,12,73,78,We found that Treg numbers are significantly increased in the peripheral blood of patients with interleukin 2-treated melanoma and in formalin-fixed tissue from patients with lung and colon carcinomas.,19147574_6,0,1,-1,-1,8384,-1,0.0028437509,0.766052,0.23110425
8386,tissue,21,22,149,155,We found that Treg numbers are significantly increased in the peripheral blood of patients with interleukin 2-treated melanoma and in formalin-fixed tissue from patients with lung and colon carcinomas.,19147574_6,-1,1,2,-1,8386,-1,9.255569e-06,0.99997544,1.5315767e-05
8388,therapy,6,7,43,50,"Conversely, we show that immunosuppressive therapy including therapeutic antibodies leads to a significant reduction of Treg from the peripheral blood of transplantation patients.",19147574_7,0,1,-1,-1,8388,-1,9.147848e-06,0.9999845,6.2899767e-06
8393,blood,20,21,145,150,"Conversely, we show that immunosuppressive therapy including therapeutic antibodies leads to a significant reduction of Treg from the peripheral blood of transplantation patients.",19147574_7,0,1,-1,-1,8393,-1,0.0027332653,0.88956183,0.10770491
8394,transplantation,22,23,154,169,"Conversely, we show that immunosuppressive therapy including therapeutic antibodies leads to a significant reduction of Treg from the peripheral blood of transplantation patients.",19147574_7,-1,1,2,-1,8394,-1,7.570811e-06,0.99998546,7.0146143e-06
8397,blood,11,12,70,75,"In addition, Treg numbers are predictively elevated in the peripheral blood of patients with various solid tumors.",19147574_8,0,1,-1,-1,8397,-1,0.0017423802,0.9001573,0.09810036
8402,protein-based,12,13,81,94,"Although our data generally correspond to data obtained with gene expression and protein-based methods, the results are less fluctuating and more specific to Treg.",19147574_9,0,1,-1,-1,8402,-1,0.00088295364,0.9989207,0.00019639742
8404,to Treg,23,25,155,162,"Although our data generally correspond to data obtained with gene expression and protein-based methods, the results are less fluctuating and more specific to Treg.",19147574_9,-1,-1,-1,-1,8404,-1,9.518709e-06,0.99998355,6.9614603e-06
8407,in blood,7,9,48,56,"The assay presented here measures Treg robustly in blood and solid tissues regardless of conservation levels, promising fast screening of Treg in various clinical settings.",19147574_10,0,1,-1,-1,8407,-1,1.9074032e-05,0.999959,2.1977416e-05
8408,tissues,11,12,67,74,"The assay presented here measures Treg robustly in blood and solid tissues regardless of conservation levels, promising fast screening of Treg in various clinical settings.",19147574_10,-1,1,2,-1,8408,-1,0.00027603155,0.89777714,0.10194684
8419,blood,1,2,11,16,Peripheral blood mononuclear cells (PBMCs) from cancer patients were cultivated in vitro in the presence of a high-affinity chimeric anti-CD25 Ab (basiliximab).,19148493_2,0,1,-1,-1,8419,-1,0.0018063324,0.98963004,0.008563659
8427,analysis,32,33,227,235,"The CD4+CD25high population, interferon-gamma (IFN-gamma) production and FOXP3 expression were analyzed using flow cytometry (FCM), enzyme-linked immunosorbent assay and reverse transcriptase-polymerase chain reaction (RT-PCR) analysis, respectively.",19148493_3,0,1,-1,-1,8427,-1,9.342334e-06,0.99998105,9.618663e-06
8429,the treatment,25,27,146,159,"During in vivo studies, basiliximab was administered intravenously on day 1, followed by AIT using autologous activated lymphocytes on day 8, and the treatment cycle was repeated.",19148493_4,-1,-1,-1,-1,8429,-1,6.0337566e-06,0.99998856,5.378903e-06
8431,analysis,17,18,101,109,"Subjective and objective effects were observed, and patients' PBMCs were subjected to FCM and RT-PCR analysis.",19148493_5,0,1,-1,-1,8431,-1,6.3087505e-06,0.9999864,7.2923335e-06
8432,analysis,2,3,9,17,"In vitro analysis revealed that a low concentration of 0.01 microg/ml basiliximab reduced almost all of CD4+CD25high cells, but less of the CD4+ CD25low cells, and augmented IFN-gamma production of activated PBMCs.",19148493_6,0,1,-1,-1,8432,-1,6.749411e-06,0.9999877,5.5631026e-06
8439,adverse effects,21,23,121,136,"An in vivo study of 9 metastatic cancer patients (7 colorectal and 2 esophageal) demonstrated no subjective or objective adverse effects, even under repeated administration of basiliximab.",19148493_8,0,1,-1,-1,8439,-1,0.0052528437,0.99405825,0.0006889683
8453,that the,4,6,32,40,We investigated the possibility that the mechanism of Treg suppression depends on Fas/FasL-mediated apoptosis of responder cells (RC).,19155494_1,-1,-1,-1,-1,8453,-1,4.5474885e-06,0.99999166,3.8252556e-06
8458,blood,16,17,110,115,CD4(+)CD25(high)Foxp3(+) Treg and autologous CD4(+)CD25(-) and CD8(+)CD25(-) subsets of RC were isolated from blood of 25 cancer patients and 15 normal controls and cocultured in the presence of OKT3 and IL-2 (150 or 1000 IU/ml).,19155494_2,0,1,-1,-1,8458,-1,8.249346e-05,0.99981743,0.00010016105
8463,These Treg,0,2,0,10,"These Treg, when activated via TCR plus IL-2, up-regulated CD95 and CD95L expression (p < 0.001) and suppressed CD8(+) RC proliferation (p < 0.001) by inducing Fas-mediated apoptosis.",19155494_6,-1,-1,-1,-1,8463,-1,5.8002383e-06,0.99998844,5.783016e-06
8464,TCR plus,6,8,31,39,"These Treg, when activated via TCR plus IL-2, up-regulated CD95 and CD95L expression (p < 0.001) and suppressed CD8(+) RC proliferation (p < 0.001) by inducing Fas-mediated apoptosis.",19155494_6,-1,-1,-1,-1,8464,-1,1.0124351e-05,0.9999738,1.6160117e-05
8480,the CTL,9,11,52,59,"OBJECTIVE: To study the mechanism of enhancement of the CTL activity in mice co-expressing of CD80, CD86 and CD137L genes.",19173904_0,-1,-1,-1,-1,8480,-1,0.0025567454,0.12727351,0.8701697
8490,tumor cells,15,17,68,79,"On the 14th, 35th, 56th and 84th day after the first inoculation of tumor cells, TUNEL staining and DNA ladder examination were used to detect apoptosis of splenic T lymphocytes in all groups at each post-inoculation time point.",19173904_3,-1,-1,-1,-1,8490,-1,0.00025416014,0.0043794545,0.99536633
8503,than that,21,23,97,106,"RESULTS: Apoptosis was found in a great number of T lymphocytes in CG on the 14th day, much more than that in group C and E. The number of apoptotic T cells in group C had a significant difference compared with that in the group E from 14th to 84th day (P = 0.003).",19173904_5,-1,-1,-1,-1,8503,-1,9.853483e-06,0.99998045,9.733765e-06
8509,analysis,2,3,11,19,"DNA ladder analysis showed typical positive results in group C and E. The significant apoptosis fragments were found in group C on 21st, 35th and 84th days.",19173904_6,0,1,-1,-1,8509,-1,7.6988e-06,0.99998116,1.1156738e-05
8514,than that,13,15,70,79,"NF-kappaB activity of T cells in groups C and E was remarkably higher than that of groups CG and D, with higher in group D than that of CG (P = 0.002), and with no significant difference between group C and E on 14th day.",19173904_7,-1,-1,-1,-1,8514,-1,7.4985855e-06,0.99998605,6.4544456e-06
8515,than that,26,28,123,132,"NF-kappaB activity of T cells in groups C and E was remarkably higher than that of groups CG and D, with higher in group D than that of CG (P = 0.002), and with no significant difference between group C and E on 14th day.",19173904_7,-1,-1,-1,-1,8515,-1,6.1722208e-06,0.9999877,6.0745133e-06
8517,than that,10,12,57,66,The activity in group E was stable and remarkably higher than that of group C on 56th and 84th days after the first inoculation.,19173904_8,-1,-1,-1,-1,8517,-1,5.812213e-06,0.9999881,6.1188666e-06
8534,this treatment,24,26,177,191,"PURPOSE: The administration of interleukin-2 (IL-2) may increase the frequency of peripherally circulating FOXP3-positive regulatory immune cells, thus potentially compromising this treatment option for patients with metastatic renal cell carcinoma.",19188179_0,-1,-1,-1,-1,8534,-1,5.249253e-06,0.9999906,4.2247493e-06
8537,therapy,4,5,25,32,The impact of IL-2-based therapy on the accumulation of FOXP3-positive immune cells in the tumor microenvironment in metastatic renal cell carcinoma is unknown.,19188179_1,0,1,-1,-1,8537,-1,6.1912765e-06,0.9999889,4.906627e-06
8541,the tumor,13,15,87,96,The impact of IL-2-based therapy on the accumulation of FOXP3-positive immune cells in the tumor microenvironment in metastatic renal cell carcinoma is unknown.,19188179_1,-1,-1,-1,-1,8541,-1,4.4009334e-06,0.99999106,4.4891085e-06
8548,cell subsets,15,17,123,135,Immunohistochemical expression of FOXP3 was estimated by stereological counting technique and correlated with other immune cell subsets and overall survival.,19188179_3,-1,-1,-1,-1,8548,-1,1.9207573e-05,8.662578e-06,0.9999721
8551,The relative,0,2,0,12,"The relative increase in individual patients was median 4.7-fold, range 0.3 to 230.",19188179_5,-1,-1,-1,-1,8551,-1,8.348872e-06,0.9999857,5.9400986e-06
8553,FOXP3-positive cells,0,2,0,20,"FOXP3-positive cells were positively correlated with CD3-positive, CD4-positive, and CD8-positive tumor-infiltrating immune cells at baseline and during treatment (P < 0.05 in all comparisons).",19188179_6,-1,-1,-1,-1,8553,-1,0.0017696762,0.9132146,0.08501566
8559,FOXP3-positive cells,39,41,214,234,"All patients achieving high numbers (>180 cells/mm2) of on-treatment FOXP3-positive intratumoral immune cells were dead within 22 months (n = 11), whereas patients with low numbers (<180 cells/mm2) of on-treatment FOXP3-positive cells (n = 31) had a 5-year survival rate of 19% (hazard ratio, 2.2; confidence interval, 1.03-4.5; P = 0.043).",19188179_7,-1,-1,-1,-1,8559,-1,0.0021004945,0.8851736,0.11272593
8560,FOXP3-positive cells,7,9,59,79,All long-term survivors were characterized by low-baseline FOXP3-positive cells and a modest absolute rise in FOXP3-positive cells.,19188179_8,-1,-1,-1,-1,8560,-1,0.0018211345,0.8711345,0.12704436
8561,FOXP3-positive cells,15,17,110,130,All long-term survivors were characterized by low-baseline FOXP3-positive cells and a modest absolute rise in FOXP3-positive cells.,19188179_8,-1,-1,-1,-1,8561,-1,0.0016903165,0.88476527,0.11354441
8564,FOXP3-positive cells,18,20,154,174,"CONCLUSION: Intratumoral FOXP3-positive regulatory immune cells significantly increased during IL-2-based immunotherapy, and high numbers of on-treatment FOXP3-positive cells were correlated with poor prognosis in patients with metastatic renal cell carcinoma.",19188179_9,-1,-1,-1,-1,8564,-1,0.001900327,0.8829116,0.11518804
8568,to interleukin 6,20,23,112,128,"Suppressor of cytokine signaling 3 (SOCS3) expression in bone marrow cells (BMC) was up-regulated upon exposure to interleukin 6, lipopolysaccharide, or tumor-associated factors.",19190337_0,-1,-1,-1,-1,8568,-1,0.880217,0.117402226,0.0023807155
8569,tumor-associated factors,27,29,153,177,"Suppressor of cytokine signaling 3 (SOCS3) expression in bone marrow cells (BMC) was up-regulated upon exposure to interleukin 6, lipopolysaccharide, or tumor-associated factors.",19190337_0,-1,-1,-1,-1,8569,-1,2.0878942e-05,0.9999716,7.5336793e-06
8574,tissue,8,9,40,46,"Importantly, lung can be as one athymus tissue for the BMCs to differentiate into CD8(+) T cells.",19190337_3,-1,1,2,-1,8574,-1,8.889403e-06,0.9999436,4.7531958e-05
8582,that the,2,4,12,20,"We conclude that the up-regulated SOCS3 in some pathologic conditions, such as tumor and inflammation, might promote BMCs to differentiate into CD8(+) T lymphocytes in lung tissue via up-regulating Notch1 expression.",19190337_5,-1,-1,-1,-1,8582,-1,3.9458923e-06,0.9999918,4.2524634e-06
8586,tissue,29,30,173,179,"We conclude that the up-regulated SOCS3 in some pathologic conditions, such as tumor and inflammation, might promote BMCs to differentiate into CD8(+) T lymphocytes in lung tissue via up-regulating Notch1 expression.",19190337_5,-1,1,2,-1,8586,-1,0.00078695145,0.32342616,0.67578685
8593,to tumor,21,23,162,170,"Established tumors suppress antitumor immune responses and induce tolerance by incompletely characterized mechanisms, and this phenomenon is an important barrier to tumor immunotherapy.",19223534_0,-1,-1,-1,-1,8593,-1,1.2130437e-05,0.99998,7.879482e-06
8594,tumor cells,3,5,24,35,Single vaccination with tumor cells expressing gp96-Ig stimulates robust expansion of tumor-specific CTLs in tumor-nave mice and this expansion is inhibited by established tumors.,19223534_1,-1,-1,-1,-1,8594,-1,0.00081189047,0.016088713,0.98309934
8595,tumor-specific CTLs,11,13,86,105,Single vaccination with tumor cells expressing gp96-Ig stimulates robust expansion of tumor-specific CTLs in tumor-nave mice and this expansion is inhibited by established tumors.,19223534_1,-1,-1,-1,-1,8595,-1,0.0055013667,0.7140826,0.28041604
8604,tumor-specific CTL,10,12,82,100,Comparison of responders to nonresponders revealed an inverse correlation between tumor-specific CTL expansion in the peripheral blood and tumor size.,19223534_4,-1,-1,-1,-1,8604,-1,0.0064220643,0.684754,0.30882385
8606,blood,16,17,129,134,Comparison of responders to nonresponders revealed an inverse correlation between tumor-specific CTL expansion in the peripheral blood and tumor size.,19223534_4,0,1,-1,-1,8606,-1,0.0019092782,0.14790814,0.85018253
8624,immunity,27,28,160,168,"These data show that up-regulation of T-bet, RORgammat, IFNgamma, CCL8, CXCL9, and CXCL10 at the vaccination site are associated with vaccine-induced antitumor immunity.",19223534_7,0,-1,2,-1,8624,-1,0.99989545,2.744219e-05,7.7160475e-05
8628,blood,10,11,68,73,"These data correlate with increased CTL expansion in the peripheral blood of responders, increased infiltration of responder tumors by CD8+ cells and interleukin-17+ cells, and decreased infiltration of responder tumors by CD11b+Gr-1+ cells and FoxP3+ cells.",19223534_8,0,1,-1,-1,8628,-1,0.00016315014,0.99957556,0.00026129663
8639,Taken together,0,2,0,14,"Taken together, our data suggest that established tumors may escape immunosurveillance by preventing clonal expansion of tumor-specific CTL without inducing anergy.",19223534_11,-1,-1,-1,-1,8639,-1,1.1280601e-05,0.99998045,8.23455e-06
8642,tumor-specific CTL,17,19,121,139,"Taken together, our data suggest that established tumors may escape immunosurveillance by preventing clonal expansion of tumor-specific CTL without inducing anergy.",19223534_11,-1,-1,-1,-1,8642,-1,0.0076873302,0.7173397,0.27497295
8654,protein,21,22,125,132,"In our panel of human clones, this stable epigenetic mark correlated better with suppressive activity than did FOXP3 mRNA or protein expression.",19224638_2,0,1,-1,-1,8654,-1,8.453479e-06,0.9999852,6.338577e-06
8658,function,18,19,113,121,"We used expression microarrays to compare Treg and Th clones after activation, which is required for suppressive function.",19224638_3,0,1,2,-1,8658,-1,1.2593343e-05,0.9999769,1.0527883e-05
8659,The transcriptional,0,2,0,19,The transcriptional profile that is specific of activated Treg clones includes a TGF-beta signature.,19224638_4,-1,-1,-1,-1,8659,-1,5.180926e-06,0.9999902,4.5620723e-06
8662,TGF-beta,12,13,81,89,The transcriptional profile that is specific of activated Treg clones includes a TGF-beta signature.,19224638_4,0,1,-1,-1,8662,-1,6.34555e-05,0.99992275,1.3763768e-05
8666,TGF-beta,11,12,62,70,Both activated Treg and Th clones produced the latent form of TGF-beta.,19224638_5,0,1,-1,-1,8666,-1,0.0001657069,0.99981207,2.2207441e-05
8668,the Treg,9,11,64,72,"However, SMAD2 phosphorylation was observed after activation in the Treg but not in the Th clones, indicating that only activated Treg clones produced the bioactive form of TGF-beta.",19224638_6,-1,-1,-1,-1,8668,-1,4.5547768e-06,0.99999,5.5155183e-06
8669,the Th,14,16,84,90,"However, SMAD2 phosphorylation was observed after activation in the Treg but not in the Th clones, indicating that only activated Treg clones produced the bioactive form of TGF-beta.",19224638_6,-1,-1,-1,-1,8669,-1,4.777418e-06,0.9999889,6.2771564e-06
8673,TGF-beta,29,30,173,181,"However, SMAD2 phosphorylation was observed after activation in the Treg but not in the Th clones, indicating that only activated Treg clones produced the bioactive form of TGF-beta.",19224638_6,0,1,-1,-1,8673,-1,5.8055106e-05,0.9999286,1.3323253e-05
8674,TGF-beta,1,2,2,10,"A TGF-beta signature was also displayed by a Th clone ""suppressed"" by a Treg clone.",19224638_7,0,1,-1,-1,8674,-1,0.0002641746,0.99970895,2.6909134e-05
8680,TGF-beta,17,18,96,104,"In conclusion, the hallmark of our panel of activated human Treg clones is to produce bioactive TGF-beta which has autocrine actions on Tregs and can have paracrine actions on other T cells.",19224638_8,0,1,-1,-1,8680,-1,0.0001018314,0.999877,2.1194148e-05
8683,to tumor,6,8,53,61,BACKGROUND: Immunosuppression by gliomas contributes to tumor progression and treatment resistance.,19226468_0,-1,-1,-1,-1,8683,-1,6.3711627e-06,0.99998796,5.696979e-06
8686,tumor cells,16,18,111,122,"It is not known when immunosuppression occurs during tumor development but it likely involves cross-talk among tumor cells, tumor-associated macrophages and microglia (TAMs), and peripheral as well as tumor-infiltrating lymphocytes (TILs).RESULTS: We have performed a kinetic study of this immunomodulation, assessing the dynamics of immune infiltration and function, within the central nervous system (CNS) and peripherally.",19226468_1,-1,-1,-1,-1,8686,-1,9.258444e-05,0.00034753422,0.9995598
8689,tumor-infiltrating lymphocytes,32,34,201,231,"It is not known when immunosuppression occurs during tumor development but it likely involves cross-talk among tumor cells, tumor-associated macrophages and microglia (TAMs), and peripheral as well as tumor-infiltrating lymphocytes (TILs).RESULTS: We have performed a kinetic study of this immunomodulation, assessing the dynamics of immune infiltration and function, within the central nervous system (CNS) and peripherally.",19226468_1,-1,-1,-1,-1,8689,-1,0.0035889542,0.84581476,0.15059628
8692,function,53,54,358,366,"It is not known when immunosuppression occurs during tumor development but it likely involves cross-talk among tumor cells, tumor-associated macrophages and microglia (TAMs), and peripheral as well as tumor-infiltrating lymphocytes (TILs).RESULTS: We have performed a kinetic study of this immunomodulation, assessing the dynamics of immune infiltration and function, within the central nervous system (CNS) and peripherally.",19226468_1,0,1,2,-1,8692,-1,0.00048765904,0.9989919,0.000520405
8706,TNF-alpha,49,50,288,297,"Using multiparameter flow cytometry, splenic T cells were assessed for FoxP3 expression to identify regulatory T cells (Tregs) and production of IFN-gamma and IL-10 after stimulation with PMA/ionomycin; within the CNS, CD4+ TILs were quantified, and TAMs were quantified and assessed for TNF-alpha and IL-10 production after stimulation with LPS.",19226468_4,0,1,-1,-1,8706,-1,0.007210431,0.99257964,0.00020991077
8716,throughout the,19,21,99,113,"The percentage of FoxP3+ regulatory T cells (Tregs) increased by day 26, with elevated frequencies throughout the duration of the study.",19226468_6,-1,-1,-1,-1,8716,-1,1.0575246e-05,0.9999814,8.050396e-06
8729,TNF-alpha,28,29,145,154,"At the final time points examined (tumor morbidity or 40 dpi), there was an increase in the frequency of TAMs with decreased capacity to secrete TNF-alpha.",19226468_8,0,1,-1,-1,8729,-1,0.0058657066,0.99396485,0.00016947849
8738,Functional,0,1,0,10,"Functional impairment of TAMs occurs relatively late in the course of GBM tumor growth, potentially providing a window of opportunity for therapeutic strategies directed towards preventing their functional impairment.",19226468_11,0,1,2,-1,8738,-1,0.019493496,0.97908634,0.0014201291
8745,their functional,27,29,189,205,"Functional impairment of TAMs occurs relatively late in the course of GBM tumor growth, potentially providing a window of opportunity for therapeutic strategies directed towards preventing their functional impairment.",19226468_11,-1,-1,-1,-1,8745,-1,9.225615e-05,0.9998623,4.5357243e-05
8748,adaptive immune responses,13,16,64,89,"Dendritic cells (DCs) have a central role in the development of adaptive immune responses, including antitumor immunity.",19234174_0,-1,-1,-1,-1,8748,-1,0.9999007,3.968763e-05,5.9644983e-05
8749,immunity,19,20,111,119,"Dendritic cells (DCs) have a central role in the development of adaptive immune responses, including antitumor immunity.",19234174_0,0,-1,2,-1,8749,-1,0.9999033,2.6998636e-05,6.958927e-05
8750,Factors,0,1,0,7,Factors present in the tumor milieu can alter the maturation of DCs and inhibit their capacity to activate T cells.,19234174_1,0,1,-1,-1,8750,-1,0.00013024911,0.9998573,1.2405408e-05
8751,the tumor,3,5,19,28,Factors present in the tumor milieu can alter the maturation of DCs and inhibit their capacity to activate T cells.,19234174_1,-1,-1,-1,-1,8751,-1,5.394139e-06,0.99999046,4.0971454e-06
8757,analysis,3,4,22,30,"Using gene expression analysis, we found that human DCs increased the expression of TGF-beta1 transcripts following culture with human lung carcinoma cells (LCCs).",19234174_2,0,1,-1,-1,8757,-1,1.047844e-05,0.99997866,1.08938175e-05
8760,TGF-beta1 transcripts,14,16,84,105,"Using gene expression analysis, we found that human DCs increased the expression of TGF-beta1 transcripts following culture with human lung carcinoma cells (LCCs).",19234174_2,-1,-1,-1,-1,8760,-1,9.594187e-06,0.99998045,1.0008327e-05
8763,TGF-beta1 protein,6,8,40,57,These DCs produced increased amounts of TGF-beta1 protein compared with DCs not exposed to tumor cells.,19234174_3,-1,-1,-1,-1,8763,-1,1.924181e-05,0.9999677,1.3086769e-05
8764,to tumor cells,13,16,88,102,These DCs produced increased amounts of TGF-beta1 protein compared with DCs not exposed to tumor cells.,19234174_3,-1,-1,-1,-1,8764,-1,0.0019287879,0.73135716,0.26671404
8767,TNF-alpha,10,11,66,75,"Furthermore, LCCs decreased CD86 expression and the production of TNF-alpha and IL-12 p70 by mature DCs.",19234174_5,0,1,-1,-1,8767,-1,0.00054486096,0.9993874,6.772777e-05
8770,TGF-beta1,10,11,62,71,"Moreover, LCCs also converted mature DCs into cells producing TGF-beta1.",19234174_6,0,1,-1,-1,8770,-1,3.5473135e-05,0.99989855,6.596948e-05
8771,These TGF-beta1-producing,0,2,0,25,These TGF-beta1-producing DCs were poor at eliciting the activation of naive CD4(+) T cells and sustaining their proliferation and differentiation into Th1 (IFN-gamma(+)) effectors.,19234174_7,-1,-1,-1,-1,8771,-1,8.9254034e-05,0.9998572,5.3495733e-05
8778,TGF-beta1-producing,2,3,9,28,"Instead, TGF-beta1-producing DCs demonstrated an increased ability to generate CD4(+)CD25(+)Foxp3(+) regulatory T cells that suppress the proliferation of T lymphocytes.",19234174_8,0,1,-1,-1,8778,-1,0.00011289907,0.9998061,8.0993006e-05
8779,to generate,8,10,67,78,"Instead, TGF-beta1-producing DCs demonstrated an increased ability to generate CD4(+)CD25(+)Foxp3(+) regulatory T cells that suppress the proliferation of T lymphocytes.",19234174_8,-1,-1,-1,-1,8779,-1,7.1968734e-06,0.99998736,5.4256093e-06
8780,regulatory T cells that,12,16,101,124,"Instead, TGF-beta1-producing DCs demonstrated an increased ability to generate CD4(+)CD25(+)Foxp3(+) regulatory T cells that suppress the proliferation of T lymphocytes.",19234174_8,-1,-1,-1,-1,8780,-1,0.00095173414,0.02562608,0.9734221
8784,the function,8,10,50,62,These results identify a novel mechanism by which the function of human DCs is altered by tumor cells and contributes to the evasion of the immune response.,19234174_9,-1,-1,-1,-1,8784,-1,1.2481635e-05,0.99997234,1.5187172e-05
8785,tumor cells,16,18,90,101,These results identify a novel mechanism by which the function of human DCs is altered by tumor cells and contributes to the evasion of the immune response.,19234174_9,-1,-1,-1,-1,8785,-1,0.00011515016,0.0010853776,0.99879944
8786,to the,20,22,118,124,These results identify a novel mechanism by which the function of human DCs is altered by tumor cells and contributes to the evasion of the immune response.,19234174_9,-1,-1,-1,-1,8786,-1,4.7713984e-06,0.9999908,4.386418e-06
8787,the immune response,24,27,136,155,These results identify a novel mechanism by which the function of human DCs is altered by tumor cells and contributes to the evasion of the immune response.,19234174_9,-1,-1,-1,-1,8787,-1,0.7127539,0.2849942,0.0022518667
8789,the tumor,18,20,103,112,"Epithelial ovarian cancer (EOC) is a highly inflammatory malignancy, characterized by the presence, at the tumor site, of regulatory T cells (Treg) that suppress antitumor immunity.",19238008_0,-1,-1,-1,-1,8789,-1,4.6926307e-06,0.9999893,6.077206e-06
8793,immunity,32,33,172,180,"Epithelial ovarian cancer (EOC) is a highly inflammatory malignancy, characterized by the presence, at the tumor site, of regulatory T cells (Treg) that suppress antitumor immunity.",19238008_0,0,-1,2,-1,8793,-1,0.999866,4.2801825e-05,9.123891e-05
8796,cytokine interleukin,13,15,70,90,"Recently, a new lineage of CD4+ T cells producing the proinflammatory cytokine interleukin (IL)-17 [T helper (TH) 17] has been identified as a major player in some autoimmune diseases.",19238008_1,-1,-1,-1,-1,8796,-1,0.99995375,6.4666583e-06,3.9760725e-05
8801,TH17 cells,3,5,12,22,"The role of TH17 cells in cancer, however, and their relationship with coexisting Treg populations, whose differentiation is partially controlled by the same mediators (ie, transforming growth factor-beta), are yet unclear.",19238008_2,-1,-1,-1,-1,8801,-1,0.0005356174,0.041004196,0.95846015
8802,their relationship,11,13,47,65,"The role of TH17 cells in cancer, however, and their relationship with coexisting Treg populations, whose differentiation is partially controlled by the same mediators (ie, transforming growth factor-beta), are yet unclear.",19238008_2,-1,-1,-1,-1,8802,-1,8.959597e-06,0.999984,7.0303154e-06
8811,TH17 cells,21,23,153,163,"Here, we show that EOC-associated/infiltrating lymphocytes derived by culturing tumor samples in the presence of IL-2 contain significant frequencies of TH17 cells, coproducing interferon-gamma (IFN)-gamma and tumor necrosis factor (TNF)-alpha, which represent, in some cases, up to 40% of total CD4+ T cells.",19238008_3,-1,-1,-1,-1,8811,-1,0.00020738544,0.010021684,0.9897709
8817,TH17 cells,0,2,0,10,"TH17 cells were also detected ex vivo, but at lower proportions than in cultured tumor-infiltrating lymphocytes/tumor-associated lymphocytes, and were confined to the CD4+CD25- fraction.",19238008_4,-1,-1,-1,-1,8817,-1,5.2401312e-05,0.00016504797,0.9997825
8821,to the,22,24,160,166,"TH17 cells were also detected ex vivo, but at lower proportions than in cultured tumor-infiltrating lymphocytes/tumor-associated lymphocytes, and were confined to the CD4+CD25- fraction.",19238008_4,-1,-1,-1,-1,8821,-1,4.7390026e-06,0.9999912,4.0777595e-06
8822,analysis,2,3,12,20,"Remarkably, analysis of EOC-associated conventional CD4CD25 T cell and Treg populations isolated ex vivo from tumor samples by cell sorting and cultured with tumor-associated CD3- cells in the presence of IL-2 revealed that EOC Treg stimulated under these conditions were rapidly converted into TH17 cells, down-regulated FOXP3 expression, and lost their suppressive capacity.",19238008_5,0,1,-1,-1,8822,-1,5.1710067e-06,0.9999907,4.157248e-06
8833,TH17 cells,44,46,295,305,"Remarkably, analysis of EOC-associated conventional CD4CD25 T cell and Treg populations isolated ex vivo from tumor samples by cell sorting and cultured with tumor-associated CD3- cells in the presence of IL-2 revealed that EOC Treg stimulated under these conditions were rapidly converted into TH17 cells, down-regulated FOXP3 expression, and lost their suppressive capacity.",19238008_5,-1,-1,-1,-1,8833,-1,0.00021468854,0.0061572776,0.99362814
8838,TH17 cells,6,8,29,39,"Thus, although the impact of TH17 cells on the evolution of EOC remains to be established, our data suggest that local IL-2 treatment in ovarian cancer may result in the conversion of tumor-associated Treg into TH17 cells, relieve Treg-mediated suppression, and contribute to enhance antitumor immunity.",19238008_6,-1,-1,-1,-1,8838,-1,0.00021168112,0.005552169,0.9942362
8844,tumor-associated Treg,34,36,184,205,"Thus, although the impact of TH17 cells on the evolution of EOC remains to be established, our data suggest that local IL-2 treatment in ovarian cancer may result in the conversion of tumor-associated Treg into TH17 cells, relieve Treg-mediated suppression, and contribute to enhance antitumor immunity.",19238008_6,-1,-1,-1,-1,8844,-1,6.3727625e-06,0.9999882,5.4807865e-06
8845,TH17 cells,37,39,211,221,"Thus, although the impact of TH17 cells on the evolution of EOC remains to be established, our data suggest that local IL-2 treatment in ovarian cancer may result in the conversion of tumor-associated Treg into TH17 cells, relieve Treg-mediated suppression, and contribute to enhance antitumor immunity.",19238008_6,-1,-1,-1,-1,8845,-1,0.0003484385,0.011900504,0.987751
8846,relieve Treg-mediated,40,42,223,244,"Thus, although the impact of TH17 cells on the evolution of EOC remains to be established, our data suggest that local IL-2 treatment in ovarian cancer may result in the conversion of tumor-associated Treg into TH17 cells, relieve Treg-mediated suppression, and contribute to enhance antitumor immunity.",19238008_6,-1,-1,-1,-1,8846,-1,3.7391026e-05,0.9999224,4.026677e-05
8848,immunity,49,50,294,302,"Thus, although the impact of TH17 cells on the evolution of EOC remains to be established, our data suggest that local IL-2 treatment in ovarian cancer may result in the conversion of tumor-associated Treg into TH17 cells, relieve Treg-mediated suppression, and contribute to enhance antitumor immunity.",19238008_6,0,-1,2,-1,8848,-1,0.99991775,2.4904379e-05,5.7284193e-05
8852,the treatment,16,18,123,136,Immune-cell-based approaches using cytotoxic and dendritic cells are under constant scrutiny to design novel therapies for the treatment of tumors.,19240181_0,-1,-1,-1,-1,8852,-1,5.5524197e-06,0.9999901,4.3340096e-06
8856,economical,10,11,59,69,These strategies are hampered by the lack of efficient and economical large-scale production methods for effector cells.,19240181_1,0,1,-1,-1,8856,-1,1.6333532e-05,0.99997604,7.5675484e-06
8860,termed tumor killer T cells,21,26,111,138,"Here we describe the propagation of large amounts of a unique population of CD4(+) cytotoxic T cells, which we termed tumor killer T cells (TKTC), because of their potent and broad antitumor cell activity.",19240181_2,-1,-1,-1,-1,8860,-1,0.0036332952,0.1891722,0.80719453
8866,blood,8,9,54,59,"With this cultivation strategy, TKTCs from peripheral blood mononuclear cells are generated within a short period of time using a pulse with a stimulating cell line followed by continuous growth in serum-free medium supplemented with a mixture of interleukin-2 and cyclosporin A. Expression and functional profiling did not allow a classification of TKTCs to any thus far defined subtype of T cells.",19240181_3,0,1,-1,-1,8866,-1,0.0002031089,0.9992229,0.0005740005
8872,functional,45,46,295,305,"With this cultivation strategy, TKTCs from peripheral blood mononuclear cells are generated within a short period of time using a pulse with a stimulating cell line followed by continuous growth in serum-free medium supplemented with a mixture of interleukin-2 and cyclosporin A. Expression and functional profiling did not allow a classification of TKTCs to any thus far defined subtype of T cells.",19240181_3,0,1,2,-1,8872,-1,0.00024898959,0.9996587,9.231322e-05
8873,classification,51,52,332,346,"With this cultivation strategy, TKTCs from peripheral blood mononuclear cells are generated within a short period of time using a pulse with a stimulating cell line followed by continuous growth in serum-free medium supplemented with a mixture of interleukin-2 and cyclosporin A. Expression and functional profiling did not allow a classification of TKTCs to any thus far defined subtype of T cells.",19240181_3,0,1,2,-1,8873,-1,6.506558e-05,0.99991214,2.2831433e-05
8874,TKTCs to,53,55,350,358,"With this cultivation strategy, TKTCs from peripheral blood mononuclear cells are generated within a short period of time using a pulse with a stimulating cell line followed by continuous growth in serum-free medium supplemented with a mixture of interleukin-2 and cyclosporin A. Expression and functional profiling did not allow a classification of TKTCs to any thus far defined subtype of T cells.",19240181_3,-1,-1,-1,-1,8874,-1,5.5290748e-06,0.99998915,5.307066e-06
8877,that TKTCs,3,5,24,34,Cytotoxic assays showed that TKTCs kill a panel of tumor targets of diverse tissue origin while leaving normal cells unaffected.,19240181_4,-1,-1,-1,-1,8877,-1,1.1742398e-05,0.99998,8.256634e-06
8878,tumor targets,9,11,51,64,Cytotoxic assays showed that TKTCs kill a panel of tumor targets of diverse tissue origin while leaving normal cells unaffected.,19240181_4,-1,-1,-1,-1,8878,-1,5.9756944e-06,0.9999894,4.596359e-06
8879,tissue,13,14,76,82,Cytotoxic assays showed that TKTCs kill a panel of tumor targets of diverse tissue origin while leaving normal cells unaffected.,19240181_4,-1,1,2,-1,8879,-1,6.199207e-05,0.9997607,0.00017729944
8881,that TKTC,3,5,30,39,"Blocking experiments revealed that TKTC killing was, to a significant extent, mediated by tumor necrosis factor-related apoptosis-inducing ligand and was independent of MHC restriction.",19240181_5,-1,-1,-1,-1,8881,-1,7.800903e-06,0.9999852,6.9691373e-06
8884,factor-related,17,18,105,119,"Blocking experiments revealed that TKTC killing was, to a significant extent, mediated by tumor necrosis factor-related apoptosis-inducing ligand and was independent of MHC restriction.",19240181_5,0,1,-1,-1,8884,-1,0.9999081,1.4288305e-05,7.755755e-05
8886,that TKTCs,3,5,22,32,These results suggest that TKTCs have a high potential as a novel tool in the adoptive immunotherapy of cancer.,19240181_6,-1,-1,-1,-1,8886,-1,1.1479493e-05,0.99997723,1.13474625e-05
8889,analysis,1,2,20,28,"Immunohistochemical analysis of FOXP3 in primary breast tumors showed that a high number of tumor-infiltrating regulatory T cells (Ti-Treg) within lymphoid infiltrates surrounding the tumor was predictive of relapse and death, in contrast to those present within the tumor bed.",19244125_0,0,1,-1,-1,8889,-1,6.3708712e-06,0.9999889,4.7544463e-06
8893,tumor-infiltrating regulatory T cells,14,18,92,129,"Immunohistochemical analysis of FOXP3 in primary breast tumors showed that a high number of tumor-infiltrating regulatory T cells (Ti-Treg) within lymphoid infiltrates surrounding the tumor was predictive of relapse and death, in contrast to those present within the tumor bed.",19244125_0,-1,-1,-1,-1,8893,-1,0.002898802,0.590262,0.4068392
8895,the tumor,25,27,180,189,"Immunohistochemical analysis of FOXP3 in primary breast tumors showed that a high number of tumor-infiltrating regulatory T cells (Ti-Treg) within lymphoid infiltrates surrounding the tumor was predictive of relapse and death, in contrast to those present within the tumor bed.",19244125_0,-1,-1,-1,-1,8895,-1,3.5240682e-06,0.9999918,4.651943e-06
8897,to those,36,38,239,247,"Immunohistochemical analysis of FOXP3 in primary breast tumors showed that a high number of tumor-infiltrating regulatory T cells (Ti-Treg) within lymphoid infiltrates surrounding the tumor was predictive of relapse and death, in contrast to those present within the tumor bed.",19244125_0,-1,-1,-1,-1,8897,-1,4.5275347e-06,0.9999907,4.7623785e-06
8898,the tumor,40,42,263,272,"Immunohistochemical analysis of FOXP3 in primary breast tumors showed that a high number of tumor-infiltrating regulatory T cells (Ti-Treg) within lymphoid infiltrates surrounding the tumor was predictive of relapse and death, in contrast to those present within the tumor bed.",19244125_0,-1,-1,-1,-1,8898,-1,3.2003286e-06,0.99999225,4.501619e-06
8899,analysis,2,3,8,16,"Ex vivo analysis showed that these tumor-infiltrating FOXP3(+) T cells are typical Treg based on their CD4(+)CD25(high)CD127(low)FOXP3(+) phenotype, their anergic state on in vitro stimulation, and their suppressive functions.",19244125_1,0,1,-1,-1,8899,-1,4.8614083e-06,0.99999034,4.739021e-06
8900,that these tumor-infiltrating FOXP3(+,4,8,24,61,"Ex vivo analysis showed that these tumor-infiltrating FOXP3(+) T cells are typical Treg based on their CD4(+)CD25(high)CD127(low)FOXP3(+) phenotype, their anergic state on in vitro stimulation, and their suppressive functions.",19244125_1,-1,-1,-1,-1,8900,-1,3.793263e-05,0.9999362,2.5886833e-05
8902,typical Treg,12,14,75,87,"Ex vivo analysis showed that these tumor-infiltrating FOXP3(+) T cells are typical Treg based on their CD4(+)CD25(high)CD127(low)FOXP3(+) phenotype, their anergic state on in vitro stimulation, and their suppressive functions.",19244125_1,-1,-1,-1,-1,8902,-1,7.997808e-06,0.999984,7.9354095e-06
8907,functions,32,33,216,225,"Ex vivo analysis showed that these tumor-infiltrating FOXP3(+) T cells are typical Treg based on their CD4(+)CD25(high)CD127(low)FOXP3(+) phenotype, their anergic state on in vitro stimulation, and their suppressive functions.",19244125_1,0,1,2,-1,8907,-1,2.621504e-05,0.9999436,3.0217125e-05
8908,These Ti-Treg,0,2,0,13,"These Ti-Treg could be selectively recruited through CCR4 as illustrated by (a) selective blood Treg CCR4 expression and migration to CCR4 ligands, (b) CCR4 down-regulation on Ti-Treg, and (c) correlation between Ti-Treg in lymphoid infiltrates and intratumoral CCL22 expression.",19244125_2,-1,-1,-1,-1,8908,-1,6.3113e-06,0.9999889,4.7296057e-06
8910,blood Treg,15,17,90,100,"These Ti-Treg could be selectively recruited through CCR4 as illustrated by (a) selective blood Treg CCR4 expression and migration to CCR4 ligands, (b) CCR4 down-regulation on Ti-Treg, and (c) correlation between Ti-Treg in lymphoid infiltrates and intratumoral CCL22 expression.",19244125_2,-1,-1,-1,-1,8910,-1,0.00015044218,0.9997794,7.014925e-05
8919,tumor-associated antigens,28,30,184,209,"Importantly, in contrast to other T cells, Ti-Treg are selectively activated locally and proliferate in situ, showing T-cell receptor engagement and suggesting specific recognition of tumor-associated antigens (TAA).",19244125_3,-1,-1,-1,-1,8919,-1,0.15256211,0.8446181,0.0028198876
8921,that Ti-Treg,10,12,63,75,"Immunohistochemical stainings for ICOS, Ki67, and DC-LAMP show that Ti-Treg were close to mature DC-LAMP(+) dendritic cells (DC) in lymphoid infiltrates but not in tumor bed and were activated and proliferating.",19244125_4,-1,-1,-1,-1,8921,-1,6.2958406e-06,0.99998844,5.2648534e-06
8928,that Treg,5,7,31,40,"Altogether, these results show that Treg are selectively recruited within lymphoid infiltrates and activated by mature DC likely through TAA presentation, resulting in the prevention of effector T-cell activation, immune escape, and ultimately tumor progression.",19244125_6,-1,-1,-1,-1,8928,-1,6.6938064e-06,0.9999883,4.9423634e-06
8929,through TAA,19,21,129,140,"Altogether, these results show that Treg are selectively recruited within lymphoid infiltrates and activated by mature DC likely through TAA presentation, resulting in the prevention of effector T-cell activation, immune escape, and ultimately tumor progression.",19244125_6,-1,-1,-1,-1,8929,-1,1.519668e-05,0.99996495,1.987616e-05
8934,Treg physiology,6,8,30,45,"This study sheds new light on Treg physiology and validates CCR4/CCL22 and ICOS as therapeutic targets in breast tumors, which represent a major health problem.",19244125_7,-1,-1,-1,-1,8934,-1,7.384893e-06,0.99998116,1.1481618e-05
8935,therapeutic targets,14,16,83,102,"This study sheds new light on Treg physiology and validates CCR4/CCL22 and ICOS as therapeutic targets in breast tumors, which represent a major health problem.",19244125_7,-1,-1,-1,-1,8935,-1,4.427186e-06,0.9999914,4.110926e-06
8939,transcription factor Foxp3,8,11,60,86,Regulatory T cells (Tregs) expressing forkhead/winged-helix transcription factor Foxp3 represent a distinct lineage of lymphocytes which play a central role in protecting the host from autoimmune diseases.,19254475_0,-1,-1,-1,-1,8939,-1,5.0715494e-06,0.99999034,4.5521724e-06
8945,immunity,10,11,55,63,"However, Tregs also pose a major problem to anti-tumor immunity.",19254475_1,0,-1,2,-1,8945,-1,0.99969566,9.2101895e-05,0.00021222998
8951,function,6,7,53,61,How tumor development subverts normal self-tolerance function of Tregs thereby thwarts host anti-tumor immunity remains elusive.,19254475_3,0,1,2,-1,8951,-1,4.0856245e-05,0.9999311,2.8069939e-05
8952,Tregs thereby thwarts,8,11,65,86,How tumor development subverts normal self-tolerance function of Tregs thereby thwarts host anti-tumor immunity remains elusive.,19254475_3,-1,-1,-1,-1,8952,-1,9.438653e-06,0.99998426,6.3508774e-06
8953,immunity,13,14,103,111,How tumor development subverts normal self-tolerance function of Tregs thereby thwarts host anti-tumor immunity remains elusive.,19254475_3,0,-1,2,-1,8953,-1,0.99991286,2.3136186e-05,6.399929e-05
8964,to the,39,41,256,262,This review will discuss our current knowledge in understanding the dynamics and plasticity of Foxp3+ Treg activation and induction in tumor bearing hosts and their interaction with various antigen presenting cells (APCs) in tumor microenvironment leading to the establishment of active local and systemic immune suppression.,19254475_4,-1,-1,-1,-1,8964,-1,3.945005e-06,0.9999919,4.1871504e-06
8965,toll-like receptor,1,3,9,27,"Although toll-like receptor (TLR) agonists, such as CpG, are used as immunotherapeutic agents in clinical trials for cancer and infectious diseases, their effects are limited and the underlying mechanism(s) that restrains CpG efficacy remains obscure.",19258507_0,-1,-1,-1,-1,8965,-1,0.002444694,0.9346453,0.06291
8967,agonists,6,7,34,42,"Although toll-like receptor (TLR) agonists, such as CpG, are used as immunotherapeutic agents in clinical trials for cancer and infectious diseases, their effects are limited and the underlying mechanism(s) that restrains CpG efficacy remains obscure.",19258507_0,0,1,-1,-1,8967,-1,0.81002,0.05193755,0.1380424
8972,that signal transducer and activator of transcription 3,4,12,14,69,"Here, we show that signal transducer and activator of transcription 3 (Stat3) plays a key role in down-modulating immunostimulatory effects of CpG. In the absence of interleukin-6 (IL-6) and IL-10 induction, CpG directly activates Stat3 within minutes through TLR9.",19258507_1,-1,-1,-1,-1,8972,-1,5.380716e-06,0.9999889,5.7035027e-06
8980,through TLR9,43,45,252,264,"Here, we show that signal transducer and activator of transcription 3 (Stat3) plays a key role in down-modulating immunostimulatory effects of CpG. In the absence of interleukin-6 (IL-6) and IL-10 induction, CpG directly activates Stat3 within minutes through TLR9.",19258507_1,-1,-1,-1,-1,8980,-1,1.1079325e-05,0.99997735,1.1581672e-05
8999,tumor antigen-specific T cells,52,56,318,348,"Innate immune responses induced by CpG in mice with a Stat3-ablated hematopoietic system cause potent antitumor effects, leading to eradication of large (>1 cm) B16 melanoma tumors within 72 h. Moreover, ablating Stat3 in myeloid cells increases CpG-induced dendritic cell maturation, T-cell activation, generation of tumor antigen-specific T cells, and long-lasting antitumor immunity.",19258507_3,-1,-1,-1,-1,8999,-1,0.061076544,0.26824266,0.67068076
9000,immunity,60,61,377,385,"Innate immune responses induced by CpG in mice with a Stat3-ablated hematopoietic system cause potent antitumor effects, leading to eradication of large (>1 cm) B16 melanoma tumors within 72 h. Moreover, ablating Stat3 in myeloid cells increases CpG-induced dendritic cell maturation, T-cell activation, generation of tumor antigen-specific T cells, and long-lasting antitumor immunity.",19258507_3,0,-1,2,-1,9000,-1,0.99981433,6.3387175e-05,0.00012230742
9003,factors,13,14,88,95,A critical role of Stat3 in mediating immunosuppression by certain cytokines and growth factors in the tumor microenvironment has been recently documented.,19258507_4,0,1,-1,-1,9003,-1,0.9999374,1.1028211e-05,5.15369e-05
9004,the tumor,15,17,99,108,A critical role of Stat3 in mediating immunosuppression by certain cytokines and growth factors in the tumor microenvironment has been recently documented.,19258507_4,-1,-1,-1,-1,9004,-1,6.1360397e-06,0.9999889,4.9252867e-06
9006,TLR agonists,9,11,57,69,"By demonstrating direct and rapid activation of Stat3 by TLR agonists, we identify a second level of Stat3-mediated immunosuppression.",19258507_5,-1,-1,-1,-1,9006,-1,0.0016723789,0.9979334,0.00039423848
9008,that targeting Stat3,4,7,28,48,Our results further suggest that targeting Stat3 can drastically improve CpG-based immunotherapeutic approaches.,19258507_6,-1,-1,-1,-1,9008,-1,6.5460936e-06,0.9999882,5.206057e-06
9009,T cell therapy,3,6,21,35,BACKGROUND: Adoptive T cell therapy involving the use of ex vivo generated antigen-specific cytotoxic T lymphocytes provides a promising approach to immunotherapy.,19270751_0,-1,-1,-1,-1,9009,-1,0.0016172995,0.030084822,0.96829796
9011,generated antigen-specific cytotoxic T lymphocytes,12,17,65,115,BACKGROUND: Adoptive T cell therapy involving the use of ex vivo generated antigen-specific cytotoxic T lymphocytes provides a promising approach to immunotherapy.,19270751_0,-1,-1,-1,-1,9011,-1,0.04231976,0.14781345,0.80986685
9014,transferred T cells,10,13,78,97,It has become increasingly apparent that anti-tumor efficacy using adoptively transferred T cells is linked to their duration of in vivo persistence and can only be achieved when combined with some form of pre-infusion patient conditioning regimen.,19270751_1,-1,-1,-1,-1,9014,-1,0.0015012592,0.08012268,0.91837597
9015,to their,15,17,108,116,It has become increasingly apparent that anti-tumor efficacy using adoptively transferred T cells is linked to their duration of in vivo persistence and can only be achieved when combined with some form of pre-infusion patient conditioning regimen.,19270751_1,-1,-1,-1,-1,9015,-1,8.621355e-06,0.9999838,7.5914104e-06
9020,transferred T cells,18,21,117,136,We have established a unique clinical model that allows for evaluation of a given conditioning regimen on adoptively transferred T cells in humans.,19270751_3,-1,-1,-1,-1,9020,-1,0.0023172023,0.112612285,0.8850705
9028,tumor-reactive antigen-specific CTL,7,10,44,79,"Patients received two infusions of a single tumor-reactive antigen-specific CTL clone expanded to 10(10)/m(2); the first infusion was given without fludarabine conditioning, and the second CTL infusion was given after a course of fludarabine (25 mg/m(2)/dayx5 days).",19270751_6,-1,-1,-1,-1,9028,-1,0.055941038,0.47475526,0.46930373
9036,to ten,5,7,41,47,Nineteen CTL infusions were administered to ten patients.,19270751_8,-1,-1,-1,-1,9036,-1,1.2086642e-05,0.99998116,6.761511e-06
9044,transferred CTL,13,15,72,87,Fludarabine led to a 2.9 fold improvement in the in vivo persistence of transferred CTL clones from a median of 4.5 days (range 0-38+) to 13.0 days (range 2-63+) (p<0.05).,19270751_12,-1,-1,-1,-1,9044,-1,0.0011249199,0.044387423,0.95448774
9048,cytokines IL-7,8,10,71,85,Fludarabine lymphodepletion increased plasma levels of the homeostatic cytokines IL-7 and IL-15.,19270751_13,-1,-1,-1,-1,9048,-1,0.9999579,6.72357e-06,3.537514e-05
9050,the relative,5,7,41,53,"Surprisingly, fludarabine also increased the relative percentage of CD4+ T cells expressing the regulatory protein Foxp3.CONCLUSIONS/SIGNIFICANCE: Lymphodepletion with fludarabine enhances transferred T cell persistence but suggest that additional improvements to optimize T cell survival and address regulatory T cells are critical in providing anti-tumor efficacy.",19270751_14,-1,-1,-1,-1,9050,-1,6.4067403e-06,0.99998903,4.5121437e-06
9052,the regulatory protein,14,17,92,114,"Surprisingly, fludarabine also increased the relative percentage of CD4+ T cells expressing the regulatory protein Foxp3.CONCLUSIONS/SIGNIFICANCE: Lymphodepletion with fludarabine enhances transferred T cell persistence but suggest that additional improvements to optimize T cell survival and address regulatory T cells are critical in providing anti-tumor efficacy.",19270751_14,-1,-1,-1,-1,9052,-1,1.0150899e-05,0.9999764,1.340665e-05
9053,transferred T cell,23,26,189,207,"Surprisingly, fludarabine also increased the relative percentage of CD4+ T cells expressing the regulatory protein Foxp3.CONCLUSIONS/SIGNIFICANCE: Lymphodepletion with fludarabine enhances transferred T cell persistence but suggest that additional improvements to optimize T cell survival and address regulatory T cells are critical in providing anti-tumor efficacy.",19270751_14,-1,-1,-1,-1,9053,-1,0.0019835087,0.11080993,0.88720655
9067,T-cell,20,21,118,124,They are traditionally viewed as the immunologic centerpiece that is able to prime CD4(+) helper and CD8(+) cytotoxic T-cell effector populations.,19275918_1,-1,1,2,-1,9067,-1,1.1128682e-05,7.020217e-06,0.9999819
9068,the functional plasticity,5,8,41,66,"However, accumulated evidence highlights the functional plasticity of DC, which are shown to also be able to display a tolerogenic function eliciting the differentiation of T suppressor (Ts) and regulatory (Treg) cells.",19275918_2,-1,-1,-1,-1,9068,-1,8.984611e-06,0.99998534,5.723665e-06
9071,tolerogenic function,21,23,119,139,"However, accumulated evidence highlights the functional plasticity of DC, which are shown to also be able to display a tolerogenic function eliciting the differentiation of T suppressor (Ts) and regulatory (Treg) cells.",19275918_2,-1,-1,-1,-1,9071,-1,1.37176985e-05,0.9999727,1.3541317e-05
9077,This tolerogenic state,0,3,0,22,This tolerogenic state of DC is characterized by low costimulatory potential and high expression of inhibitory receptors.,19275918_3,-1,-1,-1,-1,9077,-1,8.391387e-06,0.999985,6.6138437e-06
9078,receptors,16,17,111,120,This tolerogenic state of DC is characterized by low costimulatory potential and high expression of inhibitory receptors.,19275918_3,0,1,2,-1,9078,-1,3.1131505e-05,2.6604455e-05,0.9999423
9093,to trigger,15,17,91,101,"In contrast, ILT3-knockdown DC have robust cytokine and chemokine production, and are able to trigger stronger T-cell responses to viral antigens or alloantigens.",19275918_6,-1,-1,-1,-1,9093,-1,6.9847365e-06,0.99998856,4.4081053e-06
9094,T-cell,18,19,111,117,"In contrast, ILT3-knockdown DC have robust cytokine and chemokine production, and are able to trigger stronger T-cell responses to viral antigens or alloantigens.",19275918_6,-1,1,2,-1,9094,-1,3.8634615e-05,1.4989034e-05,0.99994636
9097,the functional,3,5,31,45,"Understanding and manipulating the functional immunogenic/tolerogenic dichotomy of DC has important clinical applications for achieving tolerance in organ transplantation, stemming autoimmune diseases or, conversely, generating efficient immunogenic vaccines for immunotherapy in cancer and chronic viral diseases.",19275918_7,-1,-1,-1,-1,9097,-1,4.6936933e-05,0.99993277,2.030634e-05
9099,transplantation,18,19,155,170,"Understanding and manipulating the functional immunogenic/tolerogenic dichotomy of DC has important clinical applications for achieving tolerance in organ transplantation, stemming autoimmune diseases or, conversely, generating efficient immunogenic vaccines for immunotherapy in cancer and chronic viral diseases.",19275918_7,-1,1,2,-1,9099,-1,1.4088197e-05,0.9999728,1.3103759e-05
9101,to the,2,4,12,18,"In addition to the direct targeting effects on HER2-positive cells, trastuzumab may have a therapeutic role modulating the activity of the cellular immune system in patients with breast cancer.",19277040_0,-1,-1,-1,-1,9101,-1,4.42047e-06,0.9999914,4.2035167e-06
9107,the cellular,21,23,135,147,"In addition to the direct targeting effects on HER2-positive cells, trastuzumab may have a therapeutic role modulating the activity of the cellular immune system in patients with breast cancer.",19277040_0,-1,-1,-1,-1,9107,-1,0.0041881357,0.25942123,0.7363907
9117,trastuzumab therapy,33,35,139,158,"To investigate this further, the balance of T-regulatory (T(reg)), Th17, natural killer (NK) and NK T (NKT) cells before, during and after trastuzumab therapy was investigated.",19277040_1,-1,-1,-1,-1,9117,-1,1.4738711e-05,0.9999745,1.0815544e-05
9120,Th17 cells,8,10,52,62,"Sequential frequencies of circulating T(reg) cells, Th17 cells, NK and NKT cells were measured in peripheral blood of breast cancer patients and normal controls throughout therapy.",19277040_2,-1,-1,-1,-1,9120,-1,0.0003028833,0.013627423,0.9860697
9122,blood,19,20,109,114,"Sequential frequencies of circulating T(reg) cells, Th17 cells, NK and NKT cells were measured in peripheral blood of breast cancer patients and normal controls throughout therapy.",19277040_2,0,1,-1,-1,9122,-1,7.230525e-05,0.9998424,8.5323816e-05
9123,throughout therapy,27,29,161,179,"Sequential frequencies of circulating T(reg) cells, Th17 cells, NK and NKT cells were measured in peripheral blood of breast cancer patients and normal controls throughout therapy.",19277040_2,-1,-1,-1,-1,9123,-1,6.1999044e-06,0.9999882,5.6240883e-06
9125,blood,12,13,89,94,"Individuals with breast cancer had significantly higher T(reg) frequencies of peripheral blood compared with healthy controls (9.2 or 8.6 vs 6%; P<0.05), and no significant differences in T(reg) frequencies were observed between HER2-positive and HER2-negative individuals.",19277040_3,0,1,-1,-1,9125,-1,0.0006822011,0.023843022,0.9754748
9128,Th17 cells,3,5,14,24,The number of Th17 cells was lowest in HER2-positive patients compared with both healthy controls and HER2-negative patients (0.31 vs 0.75% or 0.84%; P=0.01).,19277040_4,-1,-1,-1,-1,9128,-1,0.00054281723,0.013549585,0.98590755
9139,that T(reg,5,7,33,43,This study supports earlier data that T(reg) cells are present at higher frequencies in breast cancer patients compared with healthy individuals.,19277040_6,-1,-1,-1,-1,9139,-1,6.2495046e-06,0.9999876,6.136284e-06
9144,Th17 cells,18,20,118,128,"For the first time, we show that HER2-positive individuals with breast carcinomas have reduced numbers of circulating Th17 cells, which appear, in turn to have an inverse relationship with T(reg) frequency in MBC.",19277040_7,-1,-1,-1,-1,9144,-1,0.00035534252,0.012125769,0.98751885
9145,turn to,25,27,147,154,"For the first time, we show that HER2-positive individuals with breast carcinomas have reduced numbers of circulating Th17 cells, which appear, in turn to have an inverse relationship with T(reg) frequency in MBC.",19277040_7,-1,-1,-1,-1,9145,-1,4.060285e-06,0.99999106,4.8606234e-06
9149,the T(reg,5,7,25,34,"The change in balance of the T(reg) : Th17 ratio appears to characterise the cancer state, and furthermore, is disrupted by trastuzumab therapy.",19277040_8,-1,-1,-1,-1,9149,-1,6.8793324e-06,0.99998355,9.519644e-06
9154,trastuzumab therapy,24,26,124,143,"The change in balance of the T(reg) : Th17 ratio appears to characterise the cancer state, and furthermore, is disrupted by trastuzumab therapy.",19277040_8,-1,-1,-1,-1,9154,-1,1.2440262e-05,0.9999776,9.911604e-06
9157,Th subset,7,9,47,56,The recent discovery of IL-17-producing CD4(+) Th subset significantly revised the Th1/Th2 dichotomy model proposed by Mosmann and Coffman almost two decades ago.,19283720_0,-1,-1,-1,-1,9157,-1,0.00018520879,0.007376598,0.99243826
9160,Th17 cells,0,2,0,10,Th17 cells are involved in the pathogenesis of many human autoimmune diseases.,19283720_1,-1,-1,-1,-1,9160,-1,0.00018786457,0.0018090277,0.99800307
9162,Th17 cells,0,2,0,10,"Th17 cells, their developmental pathways and their effector functions, therefore, provide novel therapeutic targets.",19283720_2,-1,-1,-1,-1,9162,-1,6.550662e-05,0.00040501446,0.9995295
9165,functions,9,10,60,69,"Th17 cells, their developmental pathways and their effector functions, therefore, provide novel therapeutic targets.",19283720_2,0,1,2,-1,9165,-1,0.000101456,0.99969804,0.00020054198
9167,therapeutic targets,15,17,96,115,"Th17 cells, their developmental pathways and their effector functions, therefore, provide novel therapeutic targets.",19283720_2,-1,-1,-1,-1,9167,-1,5.220127e-06,0.99999034,4.4839235e-06
9169,protein,4,5,27,34,The inhibitor of apoptosis protein survivin is highly expressed in neuroblastoma (NB) and survivin-specific T cells were identified in Stage 4 patients.,19291796_0,0,1,-1,-1,9169,-1,1.8536653e-05,0.99997234,9.12604e-06
9173,peptides,17,18,115,123,"Therefore, we generated a novel survivin minigene DNA vaccine (pUS-high) encoding exclusively for survivin-derived peptides with superior MHC class I (H2-K(k)) binding affinities and tested its efficacy to suppress tumor growth and metastases in a syngeneic NB mouse model.",19291796_1,0,-1,2,-1,9173,-1,0.0050311047,0.9936957,0.0012731632
9183,target cell,16,18,102,113,"This response was as effective as a survivin full-length vaccine and was associated with an increased target cell lysis, increased presence of CD8(+) T-cells at the primary tumor site and enhanced production of proinflammatory cytokines by systemic CD8(+) T cells.",19291796_5,-1,-1,-1,-1,9183,-1,8.085953e-05,0.00022892497,0.9996902
9184,T-cells,25,26,150,157,"This response was as effective as a survivin full-length vaccine and was associated with an increased target cell lysis, increased presence of CD8(+) T-cells at the primary tumor site and enhanced production of proinflammatory cytokines by systemic CD8(+) T cells.",19291796_5,-1,1,2,-1,9184,-1,1.1819686e-05,7.277239e-06,0.9999809
9189,T-cells,10,11,48,55,"Furthermore, depletion of CD8(+) but not CD4(+) T-cells completely abrogated the pUS-high mediated primary tumor growth suppression, demonstrating a CD8(+) T-cell mediated effect.",19291796_6,-1,1,2,-1,9189,-1,1.3010335e-05,7.1579475e-06,0.99997985
9192,T-cell,25,26,156,162,"Furthermore, depletion of CD8(+) but not CD4(+) T-cells completely abrogated the pUS-high mediated primary tumor growth suppression, demonstrating a CD8(+) T-cell mediated effect.",19291796_6,-1,1,2,-1,9192,-1,1.2872575e-05,6.3874454e-06,0.9999807
9200,T-cell,4,5,25,31,"Rare cases of peripheral T-cell lymphomas with follicular growth pattern (PTCL-F) have been recently reported, and their association with t(5;9)(q33;q22) involving ITK and SYK has been suggested.",19295409_0,-1,1,2,-1,9200,-1,1.3914276e-05,1.0815201e-05,0.9999752
9212,cells that,5,7,41,51,"Neoplastic cells were medium-sized clear cells that were CD4+ (24/27, 89%), CD10+ (21/29, 72%), BCL-6+ (14/19, 74%), and expressed programed death-1 (27/27, 100%), CXCL13 (23/27, 85%), and ICOS (11/11, 100%), markers of follicular helper T cells (TFH).",19295409_3,-1,-1,-1,-1,9212,-1,0.0023215753,0.23214681,0.7655316
9219,T-cell,12,13,110,116,Three patients with sequential biopsies disclosed clinical and histopathologic features of angioimmunoblastic T-cell lymphoma at initial presentation.,19295409_6,-1,1,2,-1,9219,-1,1.4295263e-05,8.428859e-06,0.99997723
9220,that this,3,5,17,26,"Our results show that this rare form of PTCL-F (1) has an immunophenotype indicative of derivation from TFH cells, (2) is associated with t(5;9) in a proportion of cases, and (3) shows some overlapping features with angioimmunoblastic T-cell lymphoma, raising the question of a possible relationship.",19295409_7,-1,-1,-1,-1,9220,-1,3.8276144e-06,0.999992,4.1644557e-06
9221,TFH cells,19,21,104,113,"Our results show that this rare form of PTCL-F (1) has an immunophenotype indicative of derivation from TFH cells, (2) is associated with t(5;9) in a proportion of cases, and (3) shows some overlapping features with angioimmunoblastic T-cell lymphoma, raising the question of a possible relationship.",19295409_7,-1,-1,-1,-1,9221,-1,0.0015659207,0.17639636,0.8220377
9222,T-cell,46,47,235,241,"Our results show that this rare form of PTCL-F (1) has an immunophenotype indicative of derivation from TFH cells, (2) is associated with t(5;9) in a proportion of cases, and (3) shows some overlapping features with angioimmunoblastic T-cell lymphoma, raising the question of a possible relationship.",19295409_7,-1,1,2,-1,9222,-1,1.5968455e-05,8.061985e-06,0.9999759
9229,tolerance to tumor-associated antigens,18,22,81,119,CD4+25+Foxp3+ regulatory T cells (Treg) play a critical role in the induction of tolerance to tumor-associated antigens and suppression of antitumor immunity.,19307989_0,-1,-1,-1,-1,9229,-1,0.086138204,0.91171604,0.002145755
9230,immunity,26,27,149,157,CD4+25+Foxp3+ regulatory T cells (Treg) play a critical role in the induction of tolerance to tumor-associated antigens and suppression of antitumor immunity.,19307989_0,0,-1,2,-1,9230,-1,0.999913,2.9881434e-05,5.7118086e-05
9232,that Treg,3,5,23,32,We reported previously that Treg are significantly elevated in the peripheral blood of patients with pancreas cancer and that in a murine pancreas cancer model induction of Treg seems to be transforming growth factor (TGF)-beta dependent.,19307989_2,-1,-1,-1,-1,9232,-1,6.7526184e-06,0.99998796,5.2663927e-06
9234,blood,11,12,78,83,We reported previously that Treg are significantly elevated in the peripheral blood of patients with pancreas cancer and that in a murine pancreas cancer model induction of Treg seems to be transforming growth factor (TGF)-beta dependent.,19307989_2,0,1,-1,-1,9234,-1,0.0009287793,0.98110116,0.017970128
9238,transforming growth factor,31,34,190,216,We reported previously that Treg are significantly elevated in the peripheral blood of patients with pancreas cancer and that in a murine pancreas cancer model induction of Treg seems to be transforming growth factor (TGF)-beta dependent.,19307989_2,-1,-1,-1,-1,9238,-1,0.97726953,0.019128315,0.0036021334
9239,that Treg,5,7,36,45,Here we provide additional evidence that Treg are increased locally within the tumor microenvironment by a mechanism that seems dependent on TGF-beta receptor expression and the presence of tumor derived TGF-beta.,19307989_3,-1,-1,-1,-1,9239,-1,9.028895e-06,0.999985,5.971054e-06
9240,the tumor,11,13,75,84,Here we provide additional evidence that Treg are increased locally within the tumor microenvironment by a mechanism that seems dependent on TGF-beta receptor expression and the presence of tumor derived TGF-beta.,19307989_3,-1,-1,-1,-1,9240,-1,4.0187247e-06,0.99999166,4.274028e-06
9242,TGF-beta receptor,21,23,141,158,Here we provide additional evidence that Treg are increased locally within the tumor microenvironment by a mechanism that seems dependent on TGF-beta receptor expression and the presence of tumor derived TGF-beta.,19307989_3,-1,-1,-1,-1,9242,-1,4.189849e-05,0.99988794,7.0138536e-05
9245,TGF-beta,30,31,204,212,Here we provide additional evidence that Treg are increased locally within the tumor microenvironment by a mechanism that seems dependent on TGF-beta receptor expression and the presence of tumor derived TGF-beta.,19307989_3,0,1,-1,-1,9245,-1,4.260577e-05,0.99994624,1.11084455e-05
9248,TGF-beta,11,12,67,75,The murine pancreas cancer cell line Pan02 produces high levels of TGF-beta both in vitro and in vivo.,19307989_4,0,1,-1,-1,9248,-1,4.6540918e-05,0.9999409,1.2586587e-05
9255,TGF-beta,17,18,113,121,Immunohistochemical staining of Foxp3 in explanted tumors shows an identifiable population of Treg in the Pan02 (TGF-beta positive) tumors but not Eso2 (TGF-beta negative).,19307989_6,0,1,-1,-1,9255,-1,0.00016512496,0.99981207,2.288399e-05
9257,TGF-beta,25,26,153,161,Immunohistochemical staining of Foxp3 in explanted tumors shows an identifiable population of Treg in the Pan02 (TGF-beta positive) tumors but not Eso2 (TGF-beta negative).,19307989_6,0,1,-1,-1,9257,-1,0.00012697125,0.99985325,1.974043e-05
9268,TGF-beta receptor,16,18,89,106,"If Rag-/- mice are instead reconstituted with naive CD4+25- T cells expressing a mutated TGF-beta receptor, induction of Foxp3+ Treg in Pan02 bearing mice is blocked.",19307989_9,-1,-1,-1,-1,9268,-1,5.743728e-05,0.9997837,0.00015892112
9273,TGF-beta,9,10,61,69,"Collectively, these observations further support the role of TGF-beta in the induction of Treg in pancreas adenocarcinoma.",19307989_10,0,1,-1,-1,9273,-1,7.119693e-05,0.9999137,1.5083025e-05
9287,naringenin treatment,12,14,71,91,We used bleomycin to induce pulmonary fibrosis in mice with or without naringenin treatment and measured the immune-associated lymphocytes and their secreted cytokines using flow cytometry and ELISA from lung tissue.,19318568_3,-1,-1,-1,-1,9287,-1,2.0740137e-05,0.9999627,1.6550468e-05
9292,tissue,30,31,209,215,We used bleomycin to induce pulmonary fibrosis in mice with or without naringenin treatment and measured the immune-associated lymphocytes and their secreted cytokines using flow cytometry and ELISA from lung tissue.,19318568_3,-1,1,2,-1,9292,-1,0.00015782757,0.9910697,0.008772467
9293,to test the,14,17,102,113,Both passive and spontaneous metastatic models in bleomycin-treated C57BL/6 and BALB/c mice were used to test the hypothesis that mice with pulmonary fibrosis could have an increased risk of lung cancer and associated cancer progression.,19318568_4,-1,-1,-1,-1,9293,-1,4.70414e-06,0.9999918,3.5587127e-06
9297,life,21,22,126,130,"Here, we show that mice with lung fibrosis challenged using tumors show an increased incidence of lung metastasis and shorter life spans compared with the mice without lung fibrosis.",19318568_5,0,-1,2,-1,9297,-1,0.00020053811,0.9997025,9.697602e-05
9301,factor-beta1,13,14,89,101,A fibrotic environment in the lung results in increased abundance of transforming growth factor-beta1 and CD4(+)CD25(+)Foxp3(+) regulatory T cells and a decreased proportion of activated effector T cells.,19318568_6,0,1,-1,-1,9301,-1,0.9957931,0.00039479331,0.0038120626
9311,factor-beta1,23,24,201,213,Naringenin significantly reduces lung metastases in mice with pulmonary fibrosis and increases their survival by improving the immunosuppressive environment through down-regulating transforming growth factor-beta1 and reducing regulatory T cells.,19318568_8,0,1,-1,-1,9311,-1,0.9949935,0.00041752186,0.004588969
9315,the treatment,8,10,50,63,Naringenin could be an ideal therapeutic agent in the treatment of both cancer and fibrosis.,19318568_9,-1,-1,-1,-1,9315,-1,5.6328195e-06,0.99998975,4.562636e-06
9317,factor,3,4,41,47,The Ca(2+)-regulated calcineurin/nuclear factor of activated T cells (NFAT) cascade controls alternative pathways of T-cell activation and peripheral tolerance.,19318584_0,0,1,-1,-1,9317,-1,8.35158e-06,0.99998486,6.8468976e-06
9324,tumors than,16,18,105,116,"In a murine model of bronchoalveolar adenocarcinoma, mice lacking NFATc2 developed more and larger solid tumors than wild-type littermates.",19318584_2,-1,-1,-1,-1,9324,-1,4.7405842e-06,0.9999901,5.1660254e-06
9327,the tumors,9,11,54,64,"The extent of central tumor necrosis was decreased in the tumors in NFATc2((-/-)) mice, and this finding was associated with reduced tumor necrosis factor-alpha and interleukin-2 (IL-2) production by CD8(+) T cells.",19318584_3,-1,-1,-1,-1,9327,-1,3.6443034e-06,0.99999166,4.6918276e-06
9337,tumor necrosis factor receptor,27,31,196,226,"Adoptive transfer of CD8(+) T cells of NFATc2((-/-)) mice induced transforming growth factor-beta(1) in the airways of recipient mice, thus supporting CD4(+)CD25(+)Foxp-3(+)glucocorticoid-induced tumor necrosis factor receptor (GITR)(+) regulatory T (T(reg)) cell survival.",19318584_4,-1,-1,-1,-1,9337,-1,0.9953955,0.0026389242,0.0019655607
9352,the treatment,19,21,106,119,"Agonistic signaling through GITR, in the absence of NFATc2, thus emerges as a novel possible strategy for the treatment of human bronchial adenocarcinoma in the absence of NFATc2 by enhancing IL-2Ralpha(+) effector and IL-7Ralpha(+) memory-expressing T cells.",19318584_6,-1,-1,-1,-1,9352,-1,4.1612393e-06,0.9999918,4.041e-06
9360,the tumor,9,11,45,54,This study demonstrates that CD8+ T cells in the tumor microenvironment display reduced functionality and hyporesponsiveness.,19319531_0,-1,-1,-1,-1,9360,-1,4.2385345e-06,0.99999154,4.1845783e-06
9361,functionality,14,15,88,101,This study demonstrates that CD8+ T cells in the tumor microenvironment display reduced functionality and hyporesponsiveness.,19319531_0,0,1,2,-1,9361,-1,3.9129314e-05,0.99992657,3.4320652e-05
9362,to the tumor-infiltrating,3,6,30,55,"TGF-beta contributed markedly to the tumor-infiltrating CD8+ T cells' (TILs) reduced functionality, which could be reversed using a small molecule TGF-beta inhibitor.",19319531_1,-1,-1,-1,-1,9362,-1,8.830306e-06,0.9999844,6.7339192e-06
9365,functionality,15,16,85,98,"TGF-beta contributed markedly to the tumor-infiltrating CD8+ T cells' (TILs) reduced functionality, which could be reversed using a small molecule TGF-beta inhibitor.",19319531_1,0,1,2,-1,9365,-1,0.00011667856,0.99973077,0.00015255183
9366,TGF-beta,25,26,147,155,"TGF-beta contributed markedly to the tumor-infiltrating CD8+ T cells' (TILs) reduced functionality, which could be reversed using a small molecule TGF-beta inhibitor.",19319531_1,0,1,-1,-1,9366,-1,5.2278843e-05,0.9999355,1.21832745e-05
9372,TGF-beta,31,32,141,149,"Upon T-cell receptor (TCR) activation, the activation of ITK and ERK kinases were reduced in CD8+ TILs, as compared to splenic CD8+ T cells: TGF-beta inhibitor could reverse this phenomenon.",19319531_2,0,1,-1,-1,9372,-1,0.00010716337,0.9998752,1.7618842e-05
9376,time the,6,8,38,46,"This study demonstrates for the first time the association of the Spred-1 gene, an inhibitor of the Ras/MAPK pathway, with CD8+ TILs and TGF-beta activity.",19319531_3,-1,-1,-1,-1,9376,-1,4.3084065e-06,0.9999913,4.4017825e-06
9381,TGF-beta,26,27,137,145,"This study demonstrates for the first time the association of the Spred-1 gene, an inhibitor of the Ras/MAPK pathway, with CD8+ TILs and TGF-beta activity.",19319531_3,0,1,-1,-1,9381,-1,2.1309852e-05,0.9999695,9.19168e-06
9383,TGF-beta,8,9,41,49,Spred-1 was upregulated in CD8+ TILs and TGF-beta enhanced the expression of Spred-1 in effector/memory CD8+ T cells and not in rested/memory CD8+ T cells.,19319531_4,0,1,-1,-1,9383,-1,5.3357206e-05,0.99993265,1.3967407e-05
9390,that TGF-beta,10,12,60,73,"Based on these findings, this study supports the hypothesis that TGF-beta mediates an inhibitory mechanism on CD8+ TILs involving TCR-signaling blockade and the upregulation of Spred-1, thus implicating Spred-1 as a potential new target for future anti-tumor immune studies.",19319531_5,-1,-1,-1,-1,9390,-1,8.561963e-05,0.99989974,1.4662412e-05
9392,TCR-signaling,21,22,130,143,"Based on these findings, this study supports the hypothesis that TGF-beta mediates an inhibitory mechanism on CD8+ TILs involving TCR-signaling blockade and the upregulation of Spred-1, thus implicating Spred-1 as a potential new target for future anti-tumor immune studies.",19319531_5,-1,1,2,-1,9392,-1,1.9528525e-05,0.99995923,2.123755e-05
9404,the relative,2,4,9,21,"However, the relative contribution of tumor location to the glioma-mediated immunosuppression, as well as the immune mechanisms involved in the failure of glioma rejection are not fully defined.",19337997_2,-1,-1,-1,-1,9404,-1,7.44598e-06,0.99998784,4.772626e-06
9406,to the,8,10,53,59,"However, the relative contribution of tumor location to the glioma-mediated immunosuppression, as well as the immune mechanisms involved in the failure of glioma rejection are not fully defined.",19337997_2,-1,-1,-1,-1,9406,-1,5.986138e-06,0.99998844,5.568138e-06
9414,antigen-dependent T-cell proliferation,18,21,131,169,"In contrast to DC infiltrating subcutaneously grown GL261 gliomas, tumor-infiltrating DC from intracranial gliomas do not activate antigen-dependent T-cell proliferation in vitro.",19337997_5,-1,-1,-1,-1,9414,-1,0.40088546,0.00053022144,0.5985843
9417,TGF-beta1,20,21,131,140,"In addition, brain-localized GL261 gliomas are characterized by significantly higher numbers of Foxp3(+) Treg and higher levels of TGF-beta1 mRNA and protein expression when compared with GL261 gliomas in the skin.",19337997_6,0,1,-1,-1,9417,-1,1.7932924e-05,0.99995315,2.8875538e-05
9418,protein,23,24,150,157,"In addition, brain-localized GL261 gliomas are characterized by significantly higher numbers of Foxp3(+) Treg and higher levels of TGF-beta1 mRNA and protein expression when compared with GL261 gliomas in the skin.",19337997_6,0,1,-1,-1,9418,-1,6.6849693e-06,0.9999871,6.2085123e-06
9423,to TGF-beta,17,19,70,81,"Our data show that gliomas in the CNS, but not in the skin, give rise to TGF-beta production and accumulation of both Treg and functionally impaired DC.",19337997_7,-1,-1,-1,-1,9423,-1,0.0007603313,0.9991912,4.8492497e-05
9425,functionally,26,27,127,139,"Our data show that gliomas in the CNS, but not in the skin, give rise to TGF-beta production and accumulation of both Treg and functionally impaired DC.",19337997_7,0,1,2,-1,9425,-1,2.0935353e-05,0.9999689,1.014693e-05
9427,the tumor,3,5,10,19,"Thus, not the tumor itself, but its location dictates the efficiency of the anti-tumor immune response.",19337997_8,-1,-1,-1,-1,9427,-1,4.5936918e-06,0.9999888,6.6066063e-06
9432,tumor-associated antigens,16,18,126,151,"Previous reports have suggested that autoimmune sequelae may be an unavoidable consequence of successful immunization against tumor-associated antigens, which are typically non-mutated self-antigens.",19338001_0,-1,-1,-1,-1,9432,-1,0.23978014,0.75701493,0.003204975
9435,T-cell-mediated,10,11,52,67,"Using a melanoma model, we demonstrated that CD4(+) T-cell-mediated anti-tumor immunity and autoimmunity could be separated by modulating the STAT4/STAT6 signaling axis.",19338001_1,-1,1,2,-1,9435,-1,1.3250862e-05,9.409747e-06,0.99997735
9436,immunity,12,13,79,87,"Using a melanoma model, we demonstrated that CD4(+) T-cell-mediated anti-tumor immunity and autoimmunity could be separated by modulating the STAT4/STAT6 signaling axis.",19338001_1,0,-1,2,-1,9436,-1,0.99981123,5.2021504e-05,0.0001368596
9439,immunity,16,17,118,126,"Our results have revealed an unexpected dichotomy in the effector phase following cancer vaccination where anti-tumor immunity is mediated via a STAT6 and IL-4-dependent pathway, whereas autoimmune pathology is mediated via STAT4 through a mechanism that relies partially on IFN-gamma.",19338001_2,0,-1,2,-1,9439,-1,0.99960953,4.3744272e-05,0.00034674816
9442,STAT4 through,32,34,224,237,"Our results have revealed an unexpected dichotomy in the effector phase following cancer vaccination where anti-tumor immunity is mediated via a STAT6 and IL-4-dependent pathway, whereas autoimmune pathology is mediated via STAT4 through a mechanism that relies partially on IFN-gamma.",19338001_2,-1,-1,-1,-1,9442,-1,5.220705e-06,0.9999894,5.3740214e-06
9443,that relies,36,38,250,261,"Our results have revealed an unexpected dichotomy in the effector phase following cancer vaccination where anti-tumor immunity is mediated via a STAT6 and IL-4-dependent pathway, whereas autoimmune pathology is mediated via STAT4 through a mechanism that relies partially on IFN-gamma.",19338001_2,-1,-1,-1,-1,9443,-1,9.714087e-06,0.9999844,5.956615e-06
9447,tissue,13,14,100,106,Our results offer a possibility to elicit specific anti-tumor responses without triggering unwanted tissue autoimmune diseases.,19338001_3,-1,1,2,-1,9447,-1,0.00031228695,0.99925584,0.00043191254
9456,factor-1-null,6,7,46,59,METHODS: We established interferon regulatory factor-1-null (irf-1(-/-)) mice with inducible and persistent expression of HCV structural proteins (irf-1/CN2 mice).,19362089_2,0,1,-1,-1,9456,-1,1.2000934e-05,0.9999764,1.1573413e-05
9457,proteins,20,21,137,145,METHODS: We established interferon regulatory factor-1-null (irf-1(-/-)) mice with inducible and persistent expression of HCV structural proteins (irf-1/CN2 mice).,19362089_2,0,1,-1,-1,9457,-1,6.273295e-06,0.9999877,6.014936e-06
9461,Proteins,0,1,0,8,Proteins associated with these processes were also assessed.,19362089_5,0,1,-1,-1,9461,-1,0.0017168232,0.9981862,9.6946445e-05
9474,protein,9,10,44,51,IL-2 and IL-10 were induced by the HCV core protein in splenocytes.,19362089_9,0,1,-1,-1,9474,-1,2.052172e-05,0.99996424,1.5238349e-05
9484,that target the,29,32,184,199,"This mouse model, in which HCV expression and disruption of IFN signaling synergize to promote lymphoproliferation, will be an important tool for the development of therapeutic agents that target the lymphoproliferative pathway.",19362089_11,-1,-1,-1,-1,9484,-1,4.153403e-06,0.9999924,3.46181e-06
9494,functions,5,6,21,30,"We now show that IDO functions as a molecular switch in TDLNs, maintaining Tregs in their normal suppressive phenotype when IDO was active, but allowing inflammation-induced conversion of Tregs to a polyfunctional T-helper phenotype similar to proinflammatory T-helper-17 (TH17) cells when IDO was blocked.",19366986_1,0,1,2,-1,9494,-1,1.4140172e-05,0.9999751,1.0821669e-05
9498,Tregs to,30,32,188,196,"We now show that IDO functions as a molecular switch in TDLNs, maintaining Tregs in their normal suppressive phenotype when IDO was active, but allowing inflammation-induced conversion of Tregs to a polyfunctional T-helper phenotype similar to proinflammatory T-helper-17 (TH17) cells when IDO was blocked.",19366986_1,-1,-1,-1,-1,9498,-1,3.953936e-06,0.999992,4.0069544e-06
9504,Tregs to the TH17-like,5,9,24,46,"In vitro, conversion of Tregs to the TH17-like phenotype was driven by antigen-activated effector T cells and required interleukin-6 (IL-6) produced by activated pDCs.",19366986_2,-1,-1,-1,-1,9504,-1,6.335046e-06,0.999984,9.680864e-06
9514,Tregs to the TH17,34,38,193,210,"In vivo, using a model of established B16 melanoma, the combination of an IDO-inhibitor drug plus antitumor vaccine caused up-regulation of IL-6 in pDCs and in situ conversion of a majority of Tregs to the TH17 phenotype, with marked enhancement of CD8+ T-cell activation and antitumor efficacy.",19366986_4,-1,-1,-1,-1,9514,-1,8.484587e-06,0.99998295,8.550154e-06
9523,tumor cell,8,10,67,77,"Methylglyoxal profoundly stimulates host's immune response against tumor cell by producing reactive oxygen intermediates (ROI's) and reactive nitrogen intermediates (RNI's) [Bhattacharyya, N., Pal, A., Patra, S., Haldar, A.K., Roy, S., Ray, M., 2008.",19375802_0,-1,-1,-1,-1,9523,-1,0.0005502437,0.018547721,0.98090196
9525,tumor cells,8,10,67,78,Activation of macrophages and lymphocytes by methylglyoxal against tumor cells in the host.,19375802_1,-1,-1,-1,-1,9525,-1,0.0012085169,0.06563098,0.9331605
9534,through the,10,12,42,53,"Production of TLR 4 and TLR 9, which acts through the same signaling pathway, were also upregulated.",19375802_6,-1,-1,-1,-1,9534,-1,7.604426e-06,0.9999869,5.565656e-06
9536,the IL-6,6,8,46,54,"Hence, concluded that methylglyoxal augmented the IL-6 and IL-1 beta, expression of TLR 4 and TLR 9 and produced MAPKs, important regulators of ROIs and RNIs.",19375802_7,-1,-1,-1,-1,9536,-1,0.91774976,0.079949185,0.0023010555
9550,thought that FOXP3,2,5,6,24,It is thought that FOXP3 is not a specific marker to determine regulatory T cells (Treg) in humans.,19383912_1,-1,-1,-1,-1,9550,-1,8.186643e-06,0.9999851,6.698919e-06
9554,the functional,4,6,18,32,"Here, we examined the functional phenotype and cytokine profile of the in vitro induced FOXP3(+) T cells, primary FOXP3(+) and FOXP3(-) T cells in patients with ulcerative colitis and tumors including colon carcinoma, melanoma, hepatic carcinoma, ovarian carcinoma, pancreatic cancer, and renal cell carcinoma.",19383912_2,-1,-1,-1,-1,9554,-1,1.6130083e-05,0.99996936,1.45442145e-05
9565,T cells in blood,11,15,71,87,"We observed similar levels of suppressive capacity of primary FOXP3(+) T cells in blood, tumors, and colitic tissues.",19383912_3,-1,-1,-1,-1,9565,-1,0.0014225567,0.027409147,0.97116816
9567,tissues,20,21,109,116,"We observed similar levels of suppressive capacity of primary FOXP3(+) T cells in blood, tumors, and colitic tissues.",19383912_3,-1,1,2,-1,9567,-1,2.0555153e-05,0.9996848,0.00029467142
9583,functionally,26,27,154,166,"Although the in vitro activated T cells expressed FOXP3, these induced FOXP3(+) T cells expressed high levels of multiple effector cytokines and were not functionally suppressive.",19383912_5,0,1,2,-1,9583,-1,4.1617357e-05,0.9999418,1.6558379e-05
9586,that FOXP3,5,7,28,38,The data reinforce the fact that FOXP3 remains an accurate marker to define primary Tregs in patients with cancer and autoimmune disease.,19383912_6,-1,-1,-1,-1,9586,-1,6.768831e-06,0.99998844,4.787422e-06
9589,that the,2,4,11,19,We suggest that the combination of FOXP3 and cytokine profile is useful for further functionally distinguishing primary Tregs from activated conventional T cells.,19383912_7,-1,-1,-1,-1,9589,-1,5.324806e-06,0.9999913,3.4266834e-06
9592,functionally,14,15,84,96,We suggest that the combination of FOXP3 and cytokine profile is useful for further functionally distinguishing primary Tregs from activated conventional T cells.,19383912_7,0,1,2,-1,9592,-1,0.00016407226,0.99981946,1.6507287e-05
9598,transcriptional activator,16,18,98,123,"In the present study, we investigated the possibility to use irradiated, non-replicating class II transcriptional activator (CIITA)-transfected tumor TS/A cells as a cell-based vaccine.",19395374_0,-1,-1,-1,-1,9598,-1,6.532394e-06,0.9999875,5.951001e-06
9608,Immunity generated,0,2,0,18,"Immunity generated in the TS/A-CIITA-vaccinated mice correlated with an efficient priming of CD4(+) T cells and consequent triggering and maintenance of CD8(+) CTL effectors, as assessed by adoptive transfer assays.",19395374_3,-1,-1,-1,-1,9608,-1,0.79030555,0.20838198,0.0013124949
9614,the two cell-based,6,9,56,74,"Important qualitative differences were observed between the two cell-based vaccines, as TS/A-CIITA-vaccinated mice developed a CTL response containing a large proportion of anti-gp70 AH1 epitope-specific cells, completely absent in TS/A-vaccinated mice, and a mixed T(h)1/T(h)2 type of response as opposed to a T(h)2 type of response in TS/A-vaccinated mice.",19395374_4,-1,-1,-1,-1,9614,-1,0.0047020023,0.72161996,0.273678
9620,T(h)2 type,45,47,311,321,"Important qualitative differences were observed between the two cell-based vaccines, as TS/A-CIITA-vaccinated mice developed a CTL response containing a large proportion of anti-gp70 AH1 epitope-specific cells, completely absent in TS/A-vaccinated mice, and a mixed T(h)1/T(h)2 type of response as opposed to a T(h)2 type of response in TS/A-vaccinated mice.",19395374_4,-1,-1,-1,-1,9620,-1,2.0279802e-05,0.99996006,1.9596824e-05
9631,tumor cells,10,12,75,86,"These results let to envisage the use of CIITA-transfected non-replicating tumor cells as a vaccination strategy for prevention and, possibly, adjuvant immunotherapy in human settings.",19395374_6,-1,-1,-1,-1,9631,-1,0.00015931945,0.00094140414,0.9988992
9632,peptide,10,11,75,82,Melanoma patients were injected with various vaccines containing a MAGE-A3 peptide presented by HLA-DP4.,19435913_0,0,-1,2,-1,9632,-1,0.33691853,0.64754725,0.015534244
9634,the blood,7,9,48,57,"Anti-MAGE-A3.DP4 T cells were not detectable in the blood before vaccination, but their frequencies after vaccination ranged from 2 x 10(-6) to 2 x 10(-3) among the CD4(+) blood T lymphocytes of the patients.",19435913_1,-1,-1,-1,-1,9634,-1,2.486619e-05,0.99994063,3.4450735e-05
9638,blood T lymphocytes,32,35,172,191,"Anti-MAGE-A3.DP4 T cells were not detectable in the blood before vaccination, but their frequencies after vaccination ranged from 2 x 10(-6) to 2 x 10(-3) among the CD4(+) blood T lymphocytes of the patients.",19435913_1,-1,-1,-1,-1,9638,-1,0.00031634702,0.00042789712,0.9992557
9641,blood T lymphocytes that,3,7,11,35,The CD4(+) blood T lymphocytes that stained ex vivo with HLA-DP4 tetramers folded with the MAGE-A3 peptide were selected by flow cytometry and amplified under clonal conditions.,19435913_2,-1,-1,-1,-1,9641,-1,0.0025054102,0.8911749,0.10631966
9644,peptide,17,18,99,106,The CD4(+) blood T lymphocytes that stained ex vivo with HLA-DP4 tetramers folded with the MAGE-A3 peptide were selected by flow cytometry and amplified under clonal conditions.,19435913_2,0,-1,2,-1,9644,-1,0.00037218153,0.9995003,0.00012747328
9646,T-cell,7,8,23,29,About 5% of the CD4(+) T-cell clones that recognized the MAGE-A3.DP4 antigen had a CD25(+) phenotype in the resting state.,19435913_3,-1,1,2,-1,9646,-1,9.4930665e-06,5.6030835e-06,0.99998486
9655,T-cell,14,15,82,88,These CD25(+) clones had a high capacity to suppress the proliferation of another T-cell clone after peptide stimulation in vitro.,19435913_4,-1,1,2,-1,9655,-1,1.37059105e-05,6.278567e-06,0.99998
9656,peptide,17,18,101,108,These CD25(+) clones had a high capacity to suppress the proliferation of another T-cell clone after peptide stimulation in vitro.,19435913_4,0,-1,2,-1,9656,-1,0.99855894,0.0009777496,0.00046324925
9664,cytokines IFN-gamma,9,11,65,84,"They produced active transforming growth factor-beta but none of cytokines IFN-gamma, interleukin-2 (IL-2), IL-4, IL-5, and IL-10.",19435913_6,-1,-1,-1,-1,9664,-1,0.9999646,4.9562645e-06,3.0431998e-05
9668,cells that,8,10,49,59,"Most of the CD25(-) clonal populations contained cells that expressed FOXP3 in the resting state, but FOXP3 demethylation was not observed.",19435913_8,-1,-1,-1,-1,9668,-1,0.0013282695,0.07633927,0.92233247
9674,T cells that,9,12,60,72,We conclude that MAGE-A3.DP4 vaccination can produce CD4(+) T cells that may exert regulatory T-cell function in vivo.,19435913_9,-1,-1,-1,-1,9674,-1,0.0013368358,0.04732744,0.95133567
9675,regulatory T-cell function,14,17,83,109,We conclude that MAGE-A3.DP4 vaccination can produce CD4(+) T cells that may exert regulatory T-cell function in vivo.,19435913_9,-1,-1,-1,-1,9675,-1,2.2415923e-05,2.4293602e-05,0.99995327
9687,immunity,13,14,91,99,"Costimulatory molecules play critical roles in modulating innate, adaptive, and regulatory immunity and have potential to serve as effective immunomodulatory components of therapeutic vaccines.",19435920_2,0,-1,2,-1,9687,-1,0.9996118,9.274532e-05,0.0002954831
9691,tested the function,5,8,18,37,"In this study, we tested the function of a novel soluble form of 4-1BB ligand (4-1BBL) costimulatory molecule in modulating innate, adaptive, and regulatory immunity and assessed its therapeutic efficacy in the HPV-16 E7-expressing TC-1 cervical cancer and survivin-expressing 3LL lung carcinoma mouse models.",19435920_3,-1,-1,-1,-1,9691,-1,5.5890055e-06,0.9999888,5.6162826e-06
9692,immunity,33,34,157,165,"In this study, we tested the function of a novel soluble form of 4-1BB ligand (4-1BBL) costimulatory molecule in modulating innate, adaptive, and regulatory immunity and assessed its therapeutic efficacy in the HPV-16 E7-expressing TC-1 cervical cancer and survivin-expressing 3LL lung carcinoma mouse models.",19435920_3,0,-1,2,-1,9692,-1,0.9994301,6.7769884e-05,0.0005020147
9699,T-cell,16,17,96,102,"Vaccination with 4-1BBL activated dendritic cells and enhanced antigen uptake, generated CD8(+) T-cell effector/memory responses, and endowed T effector cells refractory to suppression by CD4(+)CD25(+)FoxP3(+) T regulatory cells.",19435920_4,-1,1,2,-1,9699,-1,1.2335547e-05,7.0871342e-06,0.9999807
9705,peptide,10,11,51,58,"Immunization with 4-1BBL in combination with an E7 peptide or survivin protein resulted in eradication of TC-1 and 3LL tumors, respectively.",19435920_5,0,-1,2,-1,9705,-1,0.025658026,0.9397241,0.03461791
9706,protein,13,14,71,78,"Immunization with 4-1BBL in combination with an E7 peptide or survivin protein resulted in eradication of TC-1 and 3LL tumors, respectively.",19435920_5,0,1,-1,-1,9706,-1,0.000105690364,0.99983597,5.833927e-05
9709,than TLR agonists LPS,6,10,26,47,"4-1BBL was more effective than TLR agonists LPS, MPL, and CpG and an agonistic 4-1BB antibody as a component of E7 peptide-based therapeutic vaccine for the generation of immune responses and eradication of TC-1 established tumors in the absence of detectable toxicity.",19435920_6,-1,-1,-1,-1,9709,-1,1.5294818e-05,0.9999628,2.1924472e-05
9710,peptide-based therapeutic,27,29,115,140,"4-1BBL was more effective than TLR agonists LPS, MPL, and CpG and an agonistic 4-1BB antibody as a component of E7 peptide-based therapeutic vaccine for the generation of immune responses and eradication of TC-1 established tumors in the absence of detectable toxicity.",19435920_6,-1,-1,-1,-1,9710,-1,0.00016727007,0.99968445,0.00014831296
9711,the generation,31,33,153,167,"4-1BBL was more effective than TLR agonists LPS, MPL, and CpG and an agonistic 4-1BB antibody as a component of E7 peptide-based therapeutic vaccine for the generation of immune responses and eradication of TC-1 established tumors in the absence of detectable toxicity.",19435920_6,-1,-1,-1,-1,9711,-1,5.523737e-06,0.9999894,5.0510694e-06
9716,toxicity,47,48,260,268,"4-1BBL was more effective than TLR agonists LPS, MPL, and CpG and an agonistic 4-1BB antibody as a component of E7 peptide-based therapeutic vaccine for the generation of immune responses and eradication of TC-1 established tumors in the absence of detectable toxicity.",19435920_6,0,1,-1,-1,9716,-1,7.79982e-06,0.9999856,6.615917e-06
9719,T-cell,17,18,138,144,Therapeutic efficacy was associated with reversal of tumor-mediated nonresponsiveness/anergy as well as establishment of long-term CD8(+) T-cell memory.,19435920_7,-1,1,2,-1,9719,-1,1.3650266e-05,7.1597788e-06,0.99997914
9721,toxicity,8,9,69,77,Potent pleiotropic immunomodulatory activities combined with lack of toxicity highlight the potential of 4-1BBL molecule as an effective component of therapeutic cancer vaccines.,19435920_8,0,1,-1,-1,9721,-1,9.004448e-06,0.999984,7.021377e-06
9727,tolerance that,13,15,79,93,Regulatory T cells (Tregs) play an important role in maintaining immunological tolerance that is one of the main obstacles to overcome for improving antitumor immunity.,19455675_0,-1,-1,-1,-1,9727,-1,7.811902e-06,0.9999856,6.6618313e-06
9730,immunity,26,27,159,167,Regulatory T cells (Tregs) play an important role in maintaining immunological tolerance that is one of the main obstacles to overcome for improving antitumor immunity.,19455675_0,0,-1,2,-1,9730,-1,0.9998845,3.7807702e-05,7.771187e-05
9731,the Treg,2,4,10,18,"Recently, the Treg has been shown to constitutively express OX40 (CD134), which is a member of the TNF-receptor family that is transiently expressed on effector T cells after TCR triggering, and through which the signal enhances effector T-cell proliferation and memory T-cell development.",19455675_1,-1,-1,-1,-1,9731,-1,4.382882e-06,0.99999106,4.5911097e-06
9733,the TNF-receptor,20,22,95,111,"Recently, the Treg has been shown to constitutively express OX40 (CD134), which is a member of the TNF-receptor family that is transiently expressed on effector T cells after TCR triggering, and through which the signal enhances effector T-cell proliferation and memory T-cell development.",19455675_1,-1,-1,-1,-1,9733,-1,9.785092e-05,0.99972695,0.00017516829
9737,TCR triggering,32,34,175,189,"Recently, the Treg has been shown to constitutively express OX40 (CD134), which is a member of the TNF-receptor family that is transiently expressed on effector T cells after TCR triggering, and through which the signal enhances effector T-cell proliferation and memory T-cell development.",19455675_1,-1,-1,-1,-1,9737,-1,9.2670125e-06,0.9999759,1.4843311e-05
9743,to Tregs,11,13,62,70,"However, little is known about the role of OX40 costimulation to Tregs in tumor immunology.",19455675_2,-1,-1,-1,-1,9743,-1,2.6896996e-05,0.9999559,1.71584e-05
9744,tumor immunology,14,16,74,90,"However, little is known about the role of OX40 costimulation to Tregs in tumor immunology.",19455675_2,-1,-1,-1,-1,9744,-1,0.008637625,0.99051416,0.0008482386
9746,the function,7,9,43,55,Here we show that OX40 signaling modulates the function of naturally occurring Tregs in vitro and in vivo.,19455675_3,-1,-1,-1,-1,9746,-1,1.3185163e-05,0.9999784,8.3680925e-06
9754,TCR triggering,13,15,73,87,"Tregs suppressed the proliferation of nave CD4(+) CD25(-) T cells after TCR triggering, in contrast, OX40 costimulated Tregs that reduced Foxp3 expression reversed the suppressive function.",19455675_5,-1,-1,-1,-1,9754,-1,1.3927262e-05,0.9999707,1.5359985e-05
9755,Tregs that,21,23,120,130,"Tregs suppressed the proliferation of nave CD4(+) CD25(-) T cells after TCR triggering, in contrast, OX40 costimulated Tregs that reduced Foxp3 expression reversed the suppressive function.",19455675_5,-1,-1,-1,-1,9755,-1,3.9263077e-06,0.9999924,3.7019638e-06
9758,function,29,30,181,189,"Tregs suppressed the proliferation of nave CD4(+) CD25(-) T cells after TCR triggering, in contrast, OX40 costimulated Tregs that reduced Foxp3 expression reversed the suppressive function.",19455675_5,0,1,2,-1,9758,-1,6.9667863e-06,0.9999864,6.5703994e-06
9761,TCR-stimulated,8,9,50,64,"In addition, Tregs inhibited the proliferation of TCR-stimulated (primed) CD4(+) T cells and nave CD8(+) T cells after TCR-mediated activation, however, Tregs with OX40 costimulation lost their suppressive function.",19455675_6,-1,1,2,-1,9761,-1,4.6395344e-05,0.99992096,3.2692147e-05
9764,TCR-mediated,23,24,120,132,"In addition, Tregs inhibited the proliferation of TCR-stimulated (primed) CD4(+) T cells and nave CD8(+) T cells after TCR-mediated activation, however, Tregs with OX40 costimulation lost their suppressive function.",19455675_6,-1,1,2,-1,9764,-1,1.9256739e-05,0.99993265,4.8113143e-05
9767,function,35,36,207,215,"In addition, Tregs inhibited the proliferation of TCR-stimulated (primed) CD4(+) T cells and nave CD8(+) T cells after TCR-mediated activation, however, Tregs with OX40 costimulation lost their suppressive function.",19455675_6,0,1,2,-1,9767,-1,1.6295764e-05,0.99996984,1.3874092e-05
9770,the cytokine,8,10,63,75,"Interestingly, Tregs minimally suppressed the proliferation or the cytokine secretion of Ag-specific CD8(+) T cells after Ag-restimulation.",19455675_7,-1,-1,-1,-1,9770,-1,0.4922525,0.5045717,0.0031758042
9773,function to the,4,7,31,46,"Furthermore, Tregs suppressive function to the antitumor effect was reversed by OX40 costimulation in vivo.",19455675_8,-1,-1,-1,-1,9773,-1,2.7644339e-05,0.99994695,2.5386458e-05
9776,T-cell function,10,12,60,75,"Our data indicate that, in addition to controlling effector T-cell function, OX40 costimulation directly controls Treg-mediated suppression in tumor immunity.",19455675_9,-1,-1,-1,-1,9776,-1,1.6541679e-05,1.31443785e-05,0.9999703
9778,tumor immunity,20,22,143,157,"Our data indicate that, in addition to controlling effector T-cell function, OX40 costimulation directly controls Treg-mediated suppression in tumor immunity.",19455675_9,-1,-1,-1,-1,9778,-1,0.031208972,0.9679607,0.0008303353
9782,the thymus,11,13,67,77,"Adaptive Foxp3(+)CD4(+) regulatory T (iTreg) cells develop outside the thymus under subimmunogenic antigen presentation, during chronic inflammation, and during normal homeostasis of the gut.",19464985_0,-1,-1,-1,-1,9782,-1,1.1364384e-05,0.9999796,8.96814e-06
9789,to the,27,29,159,165,"iTreg cells are essential in mucosal immune tolerance and in the control of severe chronic allergic inflammation, and most likely are one of the main barriers to the eradication of tumors.",19464985_1,-1,-1,-1,-1,9789,-1,7.464609e-06,0.999987,5.4814386e-06
9791,The Foxp3(+,0,2,0,11,"The Foxp3(+) iTreg cell repertoire is drawn from naive conventional CD4(+) T cells, whereas natural Treg (nTreg) cells are selected by high-avidity interactions in the thymus.",19464985_2,-1,-1,-1,-1,9791,-1,4.0018367e-05,0.9999305,2.9437091e-05
9795,natural Treg,17,19,92,104,"The Foxp3(+) iTreg cell repertoire is drawn from naive conventional CD4(+) T cells, whereas natural Treg (nTreg) cells are selected by high-avidity interactions in the thymus.",19464985_2,-1,-1,-1,-1,9795,-1,5.7063894e-06,0.9999895,4.8063894e-06
9797,the thymus,29,31,164,174,"The Foxp3(+) iTreg cell repertoire is drawn from naive conventional CD4(+) T cells, whereas natural Treg (nTreg) cells are selected by high-avidity interactions in the thymus.",19464985_2,-1,-1,-1,-1,9797,-1,7.637359e-06,0.99998724,5.1167726e-06
9807,immune responses to,22,25,129,148,"We speculate that iTreg cell development is driven by the need to maintain a noninflammatory environment in the gut, to suppress immune responses to environmental and food allergens, and to decrease chronic inflammation, whereas nTreg cells prevent autoimmunity and raise the activation threshold for all immune responses.",19464985_4,-1,-1,-1,-1,9807,-1,0.98835677,0.011226839,0.00041638222
9816,T-cell,12,13,74,80,"Although T central memory cells have been described as the most effective T-cell subtype against tumor growth, little is known about the requirements needed for their optimal ex vivo generation.",19501956_0,-1,1,2,-1,9816,-1,9.917902e-06,6.7567426e-06,0.9999833
9827,Antigen-specific T-cell,0,2,0,23,Antigen-specific T-cell lines were generated by ex vivo stimulation with Class-I and Class-II melanoma peptide pulsed dendritic cells in the presence of either IL-2 or IL-15 plus IL-21.,19501956_2,-1,-1,-1,-1,9827,-1,0.5752638,0.0005549635,0.42418122
9829,peptide,14,15,103,110,Antigen-specific T-cell lines were generated by ex vivo stimulation with Class-I and Class-II melanoma peptide pulsed dendritic cells in the presence of either IL-2 or IL-15 plus IL-21.,19501956_2,0,-1,2,-1,9829,-1,0.99951077,0.00022045267,0.00026879806
9832,IL-15 plus,25,27,168,178,Antigen-specific T-cell lines were generated by ex vivo stimulation with Class-I and Class-II melanoma peptide pulsed dendritic cells in the presence of either IL-2 or IL-15 plus IL-21.,19501956_2,-1,-1,-1,-1,9832,-1,0.9998282,4.0705545e-05,0.00013098674
9846,to interleukin,19,21,112,126,"PURPOSE: To assess the extent of signal transducer and activator of transcription (STAT) activation in response to interleukin 2 (IL-2) in melanoma patients' T cells, along with clinical stage of tumor progression.",19509154_0,-1,-1,-1,-1,9846,-1,0.71542245,0.27923995,0.0053375266
9850,blood,7,8,51,56,"EXPERIMENTAL DESIGN: T lymphocytes from peripheral blood of healthy donors and of American Joint Committee on Cancer stage I to IV melanoma patients, as well as from metastatic lymph nodes of patients, were evaluated for responsiveness to IL-2.",19509154_1,0,1,-1,-1,9850,-1,0.0021709707,0.026353674,0.97147536
9867,blood,22,23,143,148,"By phospho-specific flow cytometry, defective STAT1 and STAT5 activation in response to IL-2 was found mainly in T lymphocytes from peripheral blood and/or tumor site of American Joint Committee on Cancer stage III and IV patients, compared with stage I and II patients and to donors, and in melanoma antigen-specific T cells isolated from metastatic lymph nodes.",19509154_6,0,1,-1,-1,9867,-1,0.0012822166,0.04697553,0.9517423
9870,antigen-specific T cells,52,55,301,325,"By phospho-specific flow cytometry, defective STAT1 and STAT5 activation in response to IL-2 was found mainly in T lymphocytes from peripheral blood and/or tumor site of American Joint Committee on Cancer stage III and IV patients, compared with stage I and II patients and to donors, and in melanoma antigen-specific T cells isolated from metastatic lymph nodes.",19509154_6,-1,-1,-1,-1,9870,-1,0.70234597,0.00038156522,0.29727253
9878,to transforming growth factor,19,23,137,166,Serum from advanced melanoma patients inhibited IL-2-dependent STAT activation in donors' T cells and a neutralizing monoclonal antibody to transforming growth factor beta1 counteracted such inhibition.,19509154_8,-1,-1,-1,-1,9878,-1,0.9070649,0.08562035,0.007314747
9884,T(H)17 cells,18,20,118,130,"Using biopsy specimens from patients with B-cell non-Hodgkin's lymphoma, we observed a significantly low frequency of T(H)17 cells, including several samples with no detectable amount of interleukin (IL)-17-producing cells present in the tumor microenvironment.",19509224_0,-1,-1,-1,-1,9884,-1,0.003031728,0.6256781,0.37129018
9887,the tumor,34,36,234,243,"Using biopsy specimens from patients with B-cell non-Hodgkin's lymphoma, we observed a significantly low frequency of T(H)17 cells, including several samples with no detectable amount of interleukin (IL)-17-producing cells present in the tumor microenvironment.",19509224_0,-1,-1,-1,-1,9887,-1,4.108255e-06,0.99999166,4.225559e-06
9909,tested the,30,32,158,168,"Because a subset of lymphoma B cells express IL-2 and given that IL-2 signaling is critically important in the development of regulatory T (T(reg)) cells, we tested the role of IL-2 signaling in T(H)17 cell development.",19509224_3,-1,-1,-1,-1,9909,-1,6.6144526e-06,0.9999893,4.065125e-06
9910,T(H)17 cell,37,39,195,206,"Because a subset of lymphoma B cells express IL-2 and given that IL-2 signaling is critically important in the development of regulatory T (T(reg)) cells, we tested the role of IL-2 signaling in T(H)17 cell development.",19509224_3,-1,-1,-1,-1,9910,-1,0.0027878666,0.49362198,0.5035901
9911,that treatment,2,4,9,23,We found that treatment with anti-IL-2 antibody to interrupt IL-2 signaling significantly inhibited Foxp3 expression in CD4(+) T cells.,19509224_4,-1,-1,-1,-1,9911,-1,5.2655396e-06,0.9999908,3.954134e-06
9917,IL-17-producing cells,20,22,142,163,"In contrast, interruption of IL-2 signaling up-regulated IL-17 expression in CD4(+) T cells and restored lymphoma-mediated down-regulation of IL-17-producing cells.",19509224_5,-1,-1,-1,-1,9917,-1,0.9426182,0.00020995906,0.057171956
9922,IL-17-producing cells,18,20,96,117,"Furthermore, the reversal of T(reg) cell activity by LPS or CpG-A resulted in an enhancement of IL-17-producing cells.",19509224_6,-1,-1,-1,-1,9922,-1,0.9618459,0.00013970424,0.03801444
9923,Taken together,0,2,0,14,"Taken together, our study indicated that lymphoma B cells play an important role in skewing the balance between T(reg) and T(H)17 cells resulting in the establishment of a profoundly inhibitory tumor microenvironment.",19509224_7,-1,-1,-1,-1,9923,-1,7.4063805e-06,0.9999856,7.032834e-06
9925,cells play,9,11,52,62,"Taken together, our study indicated that lymphoma B cells play an important role in skewing the balance between T(reg) and T(H)17 cells resulting in the establishment of a profoundly inhibitory tumor microenvironment.",19509224_7,-1,-1,-1,-1,9925,-1,0.0022199054,0.1613209,0.83645916
9928,T(H)17 cells,22,24,123,135,"Taken together, our study indicated that lymphoma B cells play an important role in skewing the balance between T(reg) and T(H)17 cells resulting in the establishment of a profoundly inhibitory tumor microenvironment.",19509224_7,-1,-1,-1,-1,9928,-1,0.0030250454,0.6570983,0.33987668
9936,analysis,21,22,160,168,Regulatory T-cells were identified by fluorescence-activated cell sorting by using a panel of antibodies and by reverse transcriptase polymerase chain reaction analysis for FOXP3 expression.,19538059_1,0,1,-1,-1,9936,-1,8.767291e-06,0.99998367,7.588326e-06
9938,Functional,0,1,0,10,Functional studies were done to analyze their inhibitory role.,19538059_2,0,1,2,-1,9938,-1,0.0006953026,0.9992212,8.35352e-05
9946,blood,16,17,100,105,"Patients with NSCLC have increased numbers of CD4(+)CD25(high) FOXP3(+) T(regs) in their peripheral blood and pleura effusion (PE), which express high levels of CTLA-4, GITR.",19538059_4,0,1,-1,-1,9946,-1,0.0007731094,0.96734667,0.03188015
9949,These cells,0,2,0,11,"These cells were anergic toward T-cell receptor stimulation and, when cocultured with activated CD4(+)CD25(-) cells, potently suppressed their proliferation and cytokine secretion.",19538059_5,-1,-1,-1,-1,9949,-1,2.4014613e-05,3.0095662e-05,0.999946
9950,toward T-cell receptor,4,7,25,47,"These cells were anergic toward T-cell receptor stimulation and, when cocultured with activated CD4(+)CD25(-) cells, potently suppressed their proliferation and cytokine secretion.",19538059_5,-1,-1,-1,-1,9950,-1,0.0015855827,0.060389597,0.93802476
9958,blood,20,21,127,132,"Our data suggest that in NSCLC patients, there is an increase of CD4(+)CD25(high)FOXP3(+) regulatory T-cells in the peripheral blood and tumor microenvironment.",19538059_6,0,1,-1,-1,9958,-1,0.0009737963,0.9586192,0.040407084
9960,These T-cells,0,2,0,13,"These T-cells might prevent effective antitumor immune responses, and the increase in frequency of CD4(+)CD25(high)FOXP3(+) Tregs might play a role in the modulation of the immune response against NSCLC and could be important in the design of immunotherapeutic approaches.",19538059_7,-1,-1,-1,-1,9960,-1,0.0015799997,0.11618552,0.88223445
9966,the immune response,26,29,169,188,"These T-cells might prevent effective antitumor immune responses, and the increase in frequency of CD4(+)CD25(high)FOXP3(+) Tregs might play a role in the modulation of the immune response against NSCLC and could be important in the design of immunotherapeutic approaches.",19538059_7,-1,-1,-1,-1,9966,-1,0.6326387,0.3655213,0.0018400021
9973,related to,7,9,31,41,"In many cases, this process is related to an inappropriate T cell response to environmental allergens, and other T cell-dependent pathways may also be involved (such as Th17).",19538496_1,-1,-1,-1,-1,9973,-1,6.438291e-06,0.9999882,5.340621e-06
9980,T cells that,7,10,31,43,Regulatory T cells (Tregs) are T cells that suppress potentially harmful immune responses.,19538496_2,-1,-1,-1,-1,9980,-1,0.0015711538,0.060659267,0.9377696
9987,IL-10-producing Tregs,11,13,58,79,"Two major subsets of Treg are CD25(hi), Foxp3(+)Tregs and IL-10-producing Tregs. There is evidence that the numbers or function of both subsets may be deficient in patients with atopic allergic disease.",19538496_3,-1,-1,-1,-1,9987,-1,0.9972494,0.002111025,0.0006396395
9989,that the,17,19,99,107,"Two major subsets of Treg are CD25(hi), Foxp3(+)Tregs and IL-10-producing Tregs. There is evidence that the numbers or function of both subsets may be deficient in patients with atopic allergic disease.",19538496_3,-1,-1,-1,-1,9989,-1,4.8030784e-06,0.99999094,4.25534e-06
9990,function,21,22,119,127,"Two major subsets of Treg are CD25(hi), Foxp3(+)Tregs and IL-10-producing Tregs. There is evidence that the numbers or function of both subsets may be deficient in patients with atopic allergic disease.",19538496_3,0,1,2,-1,9990,-1,0.00023108638,0.99956983,0.00019912458
9995,Treg-suppressive function,19,21,114,139,Recent work has extended these findings into the airway in asthma where Foxp3 expression was reduced and CD25(hi) Treg-suppressive function was deficient.,19538496_4,-1,-1,-1,-1,9995,-1,1.4325933e-05,0.99997365,1.2071298e-05
9999,function,27,28,187,195,"In animal models of allergic airways disease, Tregs can suppress established airway inflammation and airway hyperresponsiveness, and protocols to enhance the development, recruitment and function of Tregs have been described.",19538496_5,0,1,2,-1,9999,-1,4.0137158e-05,0.99992085,3.897587e-05
10005,Treg function,22,24,142,155,"Together with studies of patients and in vitro studies of human T cells, these investigations are defining potential interventions to enhance Treg function in the airway in asthma.",19538496_6,-1,-1,-1,-1,10005,-1,1.3853517e-05,0.99997354,1.2602732e-05
10011,IL-10 Treg function,25,28,179,198,"Existing therapies including corticosteroids and allergen immunotherapy act on Tregs, in part to increase IL-10 production, while vitamin D3 and long-acting beta-agonists enhance IL-10 Treg function.",19538496_7,-1,-1,-1,-1,10011,-1,0.9966876,0.0015465209,0.0017659953
10012,Treg function,6,8,42,55,"Other possibilities may be enhancement of Treg function via histamine or prostanoid receptors, or by blocking pro-inflammatory pathways that prevent suppression by Tregs (activation of Toll-like receptors, or production of cytokines such as IL-6 and TNF-alpha).",19538496_8,-1,-1,-1,-1,10012,-1,9.002213e-06,0.9999752,1.5778778e-05
10013,receptors,12,13,84,93,"Other possibilities may be enhancement of Treg function via histamine or prostanoid receptors, or by blocking pro-inflammatory pathways that prevent suppression by Tregs (activation of Toll-like receptors, or production of cytokines such as IL-6 and TNF-alpha).",19538496_8,0,1,2,-1,10013,-1,9.6748576e-05,0.00012834399,0.9997749
10016,Toll-like receptors,27,29,185,204,"Other possibilities may be enhancement of Treg function via histamine or prostanoid receptors, or by blocking pro-inflammatory pathways that prevent suppression by Tregs (activation of Toll-like receptors, or production of cytokines such as IL-6 and TNF-alpha).",19538496_8,-1,-1,-1,-1,10016,-1,0.0024420584,0.77528495,0.22227302
10019,TNF-alpha,38,39,250,259,"Other possibilities may be enhancement of Treg function via histamine or prostanoid receptors, or by blocking pro-inflammatory pathways that prevent suppression by Tregs (activation of Toll-like receptors, or production of cytokines such as IL-6 and TNF-alpha).",19538496_8,0,1,-1,-1,10019,-1,0.7467771,0.25183102,0.0013918959
10028,TCRalphabeta play,7,9,38,55,Regulatory T cells (Tregs) expressing TCRalphabeta play a critical role in the maintenance of the immune system homeostasis.,19539651_0,-1,-1,-1,-1,10028,-1,9.978337e-06,0.9999825,7.5545313e-06
10032,the cell,2,4,14,22,Tregs express the cell surface markers CD4 and CD25 as well as the transcription factor Foxp3.,19539651_1,-1,-1,-1,-1,10032,-1,0.0038630066,0.44752115,0.5486158
10033,the transcription factor Foxp3,12,16,63,93,Tregs express the cell surface markers CD4 and CD25 as well as the transcription factor Foxp3.,19539651_1,-1,-1,-1,-1,10033,-1,5.390423e-06,0.99998987,4.6834416e-06
10038,TGF-beta,17,18,116,124,Foxp3(+)CD4(+)CD25(+)TCRalphabeta(+) Tregs can be generated from mouse and human CD4(+)CD25(-) T cells in vitro via TGF-beta induction.,19539651_2,0,1,-1,-1,10038,-1,4.3128006e-05,0.9999459,1.1047252e-05
10041,function,11,12,80,88,"As growing evidences suggest that gammadelta T cells also have immunoregulatory function, we have attempted to identify and characterize Foxp3(+) cells in mouse and human gammadelta T cells.",19539651_3,0,1,2,-1,10041,-1,2.4422867e-05,0.9999548,2.0787222e-05
10050,TGF-beta,11,12,82,90,"When mouse splenocytes were stimulated with anti-TCRgammadelta in the presence of TGF-beta, a population of Foxp3(+) gammadelta T cells appeared, in most of which expressed CD25 as well.",19539651_5,0,1,-1,-1,10050,-1,6.215298e-05,0.9999231,1.4738585e-05
10054,TGF-beta,8,9,42,50,"Compared with CD25(-) gammadelta T cells, TGF-beta induced CD25(+) gammadelta T cells not only expressed Foxp3, but also had increased TGF-beta and GITR expression.",19539651_6,0,1,-1,-1,10054,-1,6.921278e-05,0.99991333,1.7478464e-05
10057,TGF-beta,24,25,135,143,"Compared with CD25(-) gammadelta T cells, TGF-beta induced CD25(+) gammadelta T cells not only expressed Foxp3, but also had increased TGF-beta and GITR expression.",19539651_6,0,1,-1,-1,10057,-1,5.8370264e-05,0.9999275,1.4132302e-05
10058,the TGF-beta,2,4,13,25,"Furthermore, the TGF-beta induced gammadelta T cells mediated a potent immunosuppressive effect on anti-CD3 stimulated T cell activation and proliferation.",19539651_7,-1,-1,-1,-1,10058,-1,0.0002703533,0.9997009,2.879399e-05
10061,blood,10,11,59,64,"In contrast, although a small fraction of human peripheral blood and tumor infiltrating gammadelta T cells expressed Foxp3, similar culture condition with anti-TCRgammadelta plus TGF-beta failed to generate functional human Foxp3(+) gammadelta T cells.",19539651_8,0,1,-1,-1,10061,-1,0.00023351249,0.9971204,0.0026461529
10065,plus TGF-beta,25,27,174,187,"In contrast, although a small fraction of human peripheral blood and tumor infiltrating gammadelta T cells expressed Foxp3, similar culture condition with anti-TCRgammadelta plus TGF-beta failed to generate functional human Foxp3(+) gammadelta T cells.",19539651_8,-1,-1,-1,-1,10065,-1,0.0001657051,0.99981457,1.9726265e-05
10066,to generate functional,28,31,195,217,"In contrast, although a small fraction of human peripheral blood and tumor infiltrating gammadelta T cells expressed Foxp3, similar culture condition with anti-TCRgammadelta plus TGF-beta failed to generate functional human Foxp3(+) gammadelta T cells.",19539651_8,-1,-1,-1,-1,10066,-1,1.1774298e-05,0.9999826,5.643678e-06
10072,function,16,17,99,107,"In conclusion, our results suggest that mouse splenic Foxp3(+) gammadelta T cells with suppressive function can be induced by TCR and TGF-beta costimulation, whereas functional human Foxp3(+) gammadelta T cells in peripheral blood could not be generated under the same condition.",19539651_9,0,1,2,-1,10072,-1,5.1510568e-05,0.99989545,5.29891e-05
10073,TCR,21,22,126,129,"In conclusion, our results suggest that mouse splenic Foxp3(+) gammadelta T cells with suppressive function can be induced by TCR and TGF-beta costimulation, whereas functional human Foxp3(+) gammadelta T cells in peripheral blood could not be generated under the same condition.",19539651_9,-1,1,2,-1,10073,-1,1.1831241e-05,0.99997294,1.52530065e-05
10074,TGF-beta,23,24,134,142,"In conclusion, our results suggest that mouse splenic Foxp3(+) gammadelta T cells with suppressive function can be induced by TCR and TGF-beta costimulation, whereas functional human Foxp3(+) gammadelta T cells in peripheral blood could not be generated under the same condition.",19539651_9,0,1,-1,-1,10074,-1,0.00029706612,0.9996754,2.7613805e-05
10075,functional,27,28,166,176,"In conclusion, our results suggest that mouse splenic Foxp3(+) gammadelta T cells with suppressive function can be induced by TCR and TGF-beta costimulation, whereas functional human Foxp3(+) gammadelta T cells in peripheral blood could not be generated under the same condition.",19539651_9,0,1,2,-1,10075,-1,5.429537e-05,0.9999285,1.7266331e-05
10078,blood,36,37,225,230,"In conclusion, our results suggest that mouse splenic Foxp3(+) gammadelta T cells with suppressive function can be induced by TCR and TGF-beta costimulation, whereas functional human Foxp3(+) gammadelta T cells in peripheral blood could not be generated under the same condition.",19539651_9,0,1,-1,-1,10078,-1,0.017556712,0.79844695,0.18399641
10084,the generated immune response,4,8,37,66,"Immune tolerance consistently blunts the generated immune response, and the largely solitary focus on CD8+ T cell immunity has proven ineffective in the absence of CD4+ T cell help.",19561540_1,-1,-1,-1,-1,10084,-1,0.21227154,0.7861465,0.0015819671
10086,CD8+ T cell immunity,15,20,102,122,"Immune tolerance consistently blunts the generated immune response, and the largely solitary focus on CD8+ T cell immunity has proven ineffective in the absence of CD4+ T cell help.",19561540_1,-1,-1,-1,-1,10086,-1,0.00011458375,1.141483e-05,0.999874
10090,these twin-tier,2,4,11,26,"To address these twin-tier deficiencies, we developed a translational model of melanoma immunotherapy focused on the exploitation of high-avidity CD4+ T cells that become generated in germline antigen-deficient mice.",19561540_2,-1,-1,-1,-1,10090,-1,1.0241179e-05,0.9999809,8.845894e-06
10093,T cells that,22,25,151,163,"To address these twin-tier deficiencies, we developed a translational model of melanoma immunotherapy focused on the exploitation of high-avidity CD4+ T cells that become generated in germline antigen-deficient mice.",19561540_2,-1,-1,-1,-1,10093,-1,0.0016570948,0.053710666,0.9446323
10096,tyrosinase-related protein-1,5,7,31,59,We had previously identified a tyrosinase-related protein-1 specific HLA-DRB1*0401-restricted epitope.,19561540_3,-1,-1,-1,-1,10096,-1,2.8938624e-05,0.99987054,0.000100517565
10098,tyrosinase-related protein-1,9,11,57,85,"Using this epitope in conjunction with a newly described tyrosinase-related protein-1 germline-knockout, we demonstrate that endogenous tyrosinase-related protein-1 expression alters the functionality of the autoreactive T cell repertoire.",19561540_4,-1,-1,-1,-1,10098,-1,9.573436e-06,0.9999677,2.2695953e-05
10100,tyrosinase-related protein-1,17,19,136,164,"Using this epitope in conjunction with a newly described tyrosinase-related protein-1 germline-knockout, we demonstrate that endogenous tyrosinase-related protein-1 expression alters the functionality of the autoreactive T cell repertoire.",19561540_4,-1,-1,-1,-1,10100,-1,9.916434e-06,0.99996686,2.3277644e-05
10101,the functionality,21,23,183,200,"Using this epitope in conjunction with a newly described tyrosinase-related protein-1 germline-knockout, we demonstrate that endogenous tyrosinase-related protein-1 expression alters the functionality of the autoreactive T cell repertoire.",19561540_4,-1,-1,-1,-1,10101,-1,8.385765e-06,0.9999851,6.462545e-06
10108,triggers the,25,27,168,180,"More importantly, we show, by using major histocompatibility complex-mismatched combinations, that CD4+ T cells derived from the self-antigen deficient host indirectly triggers the eradication of established B16 lung metastases.",19561540_5,-1,-1,-1,-1,10108,-1,5.3481403e-06,0.99999034,4.3634222e-06
10109,that the treatment,2,5,15,33,We demonstrate that the treatment effect is mediated entirely by endogenous CD8+ T cells and is not affected by the depletion of host regulatory T cells.,19561540_6,-1,-1,-1,-1,10109,-1,5.0845124e-06,0.99999106,3.882792e-06
10117,through the,19,21,137,148,These findings suggest that high-avidity CD4+ T cells can overcome endogenous conditions and mediate their antitumor effects exclusively through the elicitation of CD8+ T cell immunity.,19561540_7,-1,-1,-1,-1,10117,-1,8.221179e-06,0.9999871,4.6597897e-06
10118,CD8+ T cell immunity,23,28,164,184,These findings suggest that high-avidity CD4+ T cells can overcome endogenous conditions and mediate their antitumor effects exclusively through the elicitation of CD8+ T cell immunity.,19561540_7,-1,-1,-1,-1,10118,-1,0.00012916705,1.0299709e-05,0.9998605
10119,the Th17 subset,1,4,9,24,"Although the Th17 subset and its signature cytokine, interleukin (IL)-17A (IL-17), are implicated in certain autoimmune diseases, their role in cancer remains to be further explored.",19564351_0,-1,-1,-1,-1,10119,-1,0.0013337476,0.8335268,0.16513947
10128,to tumor,18,20,92,100,"IL-17 has been shown to be elevated in several types of cancer, but how it might contribute to tumor growth is still unclear.",19564351_1,-1,-1,-1,-1,10128,-1,1.1662699e-05,0.9999807,7.6183806e-06
10135,analysis,4,5,30,38,Adoptive transfer studies and analysis of the tumor microenvironment suggest that CD4(+) T cells are the predominant source of IL-17.,19564351_3,0,1,-1,-1,10135,-1,6.925636e-06,0.99998736,5.673499e-06
10136,the tumor,6,8,42,51,Adoptive transfer studies and analysis of the tumor microenvironment suggest that CD4(+) T cells are the predominant source of IL-17.,19564351_3,-1,-1,-1,-1,10136,-1,4.497237e-06,0.99999106,4.4598564e-06
10143,tumor cells,10,12,64,75,"Enhancement of tumor growth by IL-17 involves direct effects on tumor cells and tumor-associated stromal cells, which bear IL-17 receptors.",19564351_4,-1,-1,-1,-1,10143,-1,0.0001758451,0.0022298875,0.9975942
10146,IL-17 receptors,19,21,123,138,"Enhancement of tumor growth by IL-17 involves direct effects on tumor cells and tumor-associated stromal cells, which bear IL-17 receptors.",19564351_4,-1,-1,-1,-1,10146,-1,0.9980268,8.5463165e-05,0.0018877307
10153,The Th17,0,2,0,8,"The Th17 response can thus promote tumor growth, in part via an IL-6-Stat3 pathway.",19564351_6,-1,-1,-1,-1,10153,-1,3.6672125e-05,0.9999368,2.6447895e-05
10161,chemokine receptors,6,8,27,46,"In particular, the role of chemokine receptors in metastasis remains controversial.",19567680_2,-1,-1,-1,-1,10161,-1,0.89742833,0.0001139552,0.10245772
10163,the tumor cells that,26,30,125,145,"Here, using a highly metastatic breast cancer (4T1) model, we show that lung metastasis is a feature of only a proportion of the tumor cells that express CCR4.",19567680_3,-1,-1,-1,-1,10163,-1,1.7561542e-05,0.99993646,4.596657e-05
10168,These chemokines,0,2,0,16,These chemokines acting through CCR4 attract both tumor and immune cells.,19567680_5,-1,-1,-1,-1,10168,-1,0.68098164,0.3147194,0.0042989743
10174,tumor cells,12,14,79,90,"However, CCR4-mediated chemotaxis was not sufficient to produce metastasis, as tumor cells in the lung were efficiently eliminated by natural killer (NK) cells.",19567680_6,-1,-1,-1,-1,10174,-1,0.00016962648,0.0014733772,0.998357
10181,protein,19,20,122,129,"Lung metastasis required CCR4(+) regulatory T cells (Treg), which directly killed NK cells using beta-galactoside-binding protein.",19567680_7,0,1,-1,-1,10181,-1,1.1472328e-05,0.99998045,8.061636e-06
10188,tumor cell,22,24,138,148,"Thus, strategies that abrogate any part of this process should improve the outcome through activation of effector cells and prevention of tumor cell migration.",19567680_8,-1,-1,-1,-1,10188,-1,0.00016957127,0.000994758,0.99883574
10190,cells through,8,10,46,59,We confirm this prediction by killing CCR4(+) cells through delivery of TARC-fused toxins or depleting Tregs and preventing lung metastasis.,19567680_9,-1,-1,-1,-1,10190,-1,0.0044688997,0.4095773,0.5859538
10191,TARC-fused toxins,12,14,72,89,We confirm this prediction by killing CCR4(+) cells through delivery of TARC-fused toxins or depleting Tregs and preventing lung metastasis.,19567680_9,-1,-1,-1,-1,10191,-1,1.945851e-05,0.99997056,1.0010195e-05
10197,protein,2,3,7,14,"The E7 protein is found predominantly in the nucleus and, to a lesser extent, in the cytoplasm in cervical cancer cell lines.",19574175_2,0,1,-1,-1,10197,-1,3.7638885e-05,0.9999385,2.389076e-05
10203,functionally,7,8,28,40,HPV E7 has been shown to be functionally associated with the tumor suppressor interferon regulatory factor (IRF)-1 in cervical carcinogenesis.,19574175_3,0,1,2,-1,10203,-1,1.1122138e-05,0.9999831,5.847539e-06
10204,the tumor,10,12,57,66,HPV E7 has been shown to be functionally associated with the tumor suppressor interferon regulatory factor (IRF)-1 in cervical carcinogenesis.,19574175_3,-1,-1,-1,-1,10204,-1,4.9632235e-06,0.9999906,4.4869576e-06
10211,function,20,21,112,120,"MATERIALS AND METHODS: In this study, new gene ontology technology was used to predict changes in the molecular function and biologic processes caused by the interaction between IRF-1 and HPV E7.RESULTS: The molecular function and biologic processes of IRF-1 and the combined IRF-1 and HPV E7 (IRF-1-E7) were derived using the GoFigure server.",19574175_4,0,1,2,-1,10211,-1,0.00046664276,0.9988644,0.00066893577
10215,function,36,37,218,226,"MATERIALS AND METHODS: In this study, new gene ontology technology was used to predict changes in the molecular function and biologic processes caused by the interaction between IRF-1 and HPV E7.RESULTS: The molecular function and biologic processes of IRF-1 and the combined IRF-1 and HPV E7 (IRF-1-E7) were derived using the GoFigure server.",19574175_4,0,1,2,-1,10215,-1,0.0005939443,0.99869967,0.00070635177
10223,functions,5,6,40,49,The combined IRF-1-E7 demonstrated more functions and biologic processes compared with IRF-1 alone.,19574175_5,0,1,2,-1,10223,-1,0.00681141,0.97456384,0.018624756
10235,tumor cells,17,19,101,112,Invariant NKT (iNKT) cells recognize lipid antigens presented by CD1d and respond rapidly by killing tumor cells and release cytokines that activate and regulate adaptive immune responses.,19585513_0,-1,-1,-1,-1,10235,-1,0.000724707,0.011503386,0.98777187
10236,release cytokines that,20,23,117,139,Invariant NKT (iNKT) cells recognize lipid antigens presented by CD1d and respond rapidly by killing tumor cells and release cytokines that activate and regulate adaptive immune responses.,19585513_0,-1,-1,-1,-1,10236,-1,8.159181e-05,0.99989176,2.6612497e-05
10242,to their,26,28,153,161,"They are essential for tumor rejection in various mouse models, but clinical trials in humans involving iNKT cells have been less successful, partly due to their rarity in humans compared with mice.",19585513_1,-1,-1,-1,-1,10242,-1,6.5632144e-06,0.9999871,6.3598786e-06
10243,functional,6,7,36,46,"Here we describe an accumulation of functional iNKT cells in human omentum, a migratory organ with healing properties.",19585513_2,0,1,2,-1,10243,-1,0.0013631973,0.9983424,0.00029435346
10245,Analysis,0,1,0,8,"Analysis of 39 omental samples revealed that T cells are the predominant lymphoid cell type and of these, 10% expressed the invariant Valpha24Jalpha18 TCR chain, found on iNKT cells, higher than in any other human organ tested to date.",19585513_3,0,1,-1,-1,10245,-1,5.9852555e-06,0.99998784,6.203794e-06
10246,that T cells,6,9,40,52,"Analysis of 39 omental samples revealed that T cells are the predominant lymphoid cell type and of these, 10% expressed the invariant Valpha24Jalpha18 TCR chain, found on iNKT cells, higher than in any other human organ tested to date.",19585513_3,-1,-1,-1,-1,10246,-1,0.0015367611,0.12000144,0.8784618
10248,cell type,13,15,82,91,"Analysis of 39 omental samples revealed that T cells are the predominant lymphoid cell type and of these, 10% expressed the invariant Valpha24Jalpha18 TCR chain, found on iNKT cells, higher than in any other human organ tested to date.",19585513_3,-1,-1,-1,-1,10248,-1,4.613632e-05,0.00016407507,0.9997898
10251,TCR,25,26,151,154,"Analysis of 39 omental samples revealed that T cells are the predominant lymphoid cell type and of these, 10% expressed the invariant Valpha24Jalpha18 TCR chain, found on iNKT cells, higher than in any other human organ tested to date.",19585513_3,-1,1,2,-1,10251,-1,0.00015363174,0.9992225,0.0006238057
10254,tested to,40,42,220,229,"Analysis of 39 omental samples revealed that T cells are the predominant lymphoid cell type and of these, 10% expressed the invariant Valpha24Jalpha18 TCR chain, found on iNKT cells, higher than in any other human organ tested to date.",19585513_3,-1,-1,-1,-1,10254,-1,5.045201e-06,0.99998844,6.462179e-06
10256,in blood,14,16,74,82,"About 15% of omental hematopoietic cells expressed CD1d, compared with 1% in blood (p<0.001).",19585513_4,0,1,-1,-1,10256,-1,5.970179e-05,0.9998369,0.00010340147
10259,released IFN-gamma,9,11,55,73,Enriched omental iNKT cells killed CD1d(+) targets and released IFN-gamma and IL-4 upon activation.,19585513_5,-1,-1,-1,-1,10259,-1,0.9895633,0.0093671465,0.001069547
10263,tumor immunity,13,15,73,87,These data suggest a novel role for the omentum in immune regulation and tumor immunity and identify it as a potential source of iNKT cells for therapeutic use.,19585513_7,-1,-1,-1,-1,10263,-1,0.009254198,0.990328,0.0004177488
10265,therapeutic use,26,28,144,159,These data suggest a novel role for the omentum in immune regulation and tumor immunity and identify it as a potential source of iNKT cells for therapeutic use.,19585513_7,0,1,-1,-1,10265,-1,4.9949726e-06,0.9999907,4.328472e-06
10266,tumor-associated antigens,12,14,54,79,"In mice, injection of messenger RNA (mRNA) coding for tumor-associated antigens can induce antitumor immune responses and therefore offers a broadly applicable immunotherapy approach.",19609242_0,-1,-1,-1,-1,10266,-1,0.3457364,0.6500233,0.0042402428
10270,to the,11,13,57,63,In 10 patients keyhole limpet hemocyanin (KLH) was added to the vaccine.,19609242_2,-1,-1,-1,-1,10270,-1,1.4358814e-05,0.99997747,8.114116e-06
10272,toxicity,2,3,15,23,Endpoints were toxicity and immune responses.,19609242_4,0,1,-1,-1,10272,-1,4.682207e-05,0.999925,2.8211925e-05
10275,treatment the,1,3,7,20,"During treatment the frequency of Foxp3+/CD4+ regulatory T cells was significantly decreased upon mRNA vaccination in peripheral blood of the patients in the KLH arm, whereas myeloid suppressor cells (CD11b+HLA-DR lo monocytes) were reduced in the patients not receiving KLH.",19609242_6,-1,-1,-1,-1,10275,-1,3.8547164e-06,0.9999925,3.5977225e-06
10277,blood,18,19,129,134,"During treatment the frequency of Foxp3+/CD4+ regulatory T cells was significantly decreased upon mRNA vaccination in peripheral blood of the patients in the KLH arm, whereas myeloid suppressor cells (CD11b+HLA-DR lo monocytes) were reduced in the patients not receiving KLH.",19609242_6,0,1,-1,-1,10277,-1,0.0001029015,0.9997917,0.00010545351
10285,the treatment,4,6,29,42,"The significant influence of the treatment on the frequency of immunosuppressive cells, the increase of vaccine-directed T cells upon treatment in a subset of patients together with the demonstration of a complete clinical response encourage further clinical investigation of the protamine-mRNA vaccine.",19609242_10,-1,-1,-1,-1,10285,-1,4.4186895e-06,0.9999912,4.4509857e-06
10301,blood,18,19,107,112,OBJECTIVE: To investigate the expression of transcription factors (TF) T-bet and GATA-3 mRNA in peripheral blood mononuclear cells and its correlation with immune status in esophageal cancer patients.,19615257_0,0,1,-1,-1,10301,-1,0.00321916,0.9694216,0.027359208
10305,to the,10,12,63,69,"METHODS: Sixty patients were divided into two groups according to the clinical data: group A consisting of stage I and II, group B including stage III and IV.",19615257_1,-1,-1,-1,-1,10305,-1,5.02081e-06,0.9999888,6.175796e-06
10306,The gene,0,2,0,8,The gene expression of T-bet and GATA-3 in 60 esophageal cancer patients and 30 healthy controls was detected by reverse transcription-polymerase chain reaction (RT-PCR).,19615257_2,-1,-1,-1,-1,10306,-1,3.9750025e-06,0.99999106,4.9114415e-06
10313,than that,49,51,258,267,"The expression of IFN-gamma and IL-4 was measured by enzyme linked immunosorbent assay (ELISA).RESULTS: Expression of T-bet mRNA in esophageal cancer patients (stage I and II: 0.27 +/- 0.05 ng/L, stage III and IV: 0.12 +/- 0.02 ng/L) was significantly lower than that in the healthy controls (1.35 +/- 0.14 ng/L), but the expression of GATA-3 mRNA in esophageal cancer patients (stage I and II: 0.45 +/- 0.06, stage III and IV: 0.55 +/- 0.03) was significantly higher than that in the healthy controls (0.09 +/- 0.10).",19615257_3,-1,-1,-1,-1,10313,-1,7.367347e-06,0.9999856,7.000127e-06
10317,than that,97,99,468,477,"The expression of IFN-gamma and IL-4 was measured by enzyme linked immunosorbent assay (ELISA).RESULTS: Expression of T-bet mRNA in esophageal cancer patients (stage I and II: 0.27 +/- 0.05 ng/L, stage III and IV: 0.12 +/- 0.02 ng/L) was significantly lower than that in the healthy controls (1.35 +/- 0.14 ng/L), but the expression of GATA-3 mRNA in esophageal cancer patients (stage I and II: 0.45 +/- 0.06, stage III and IV: 0.55 +/- 0.03) was significantly higher than that in the healthy controls (0.09 +/- 0.10).",19615257_3,-1,-1,-1,-1,10317,-1,7.5000917e-06,0.9999857,6.7972883e-06
10319,The plasma,0,2,0,10,"The plasma level of Th1 cytokine IFN-gamma in the patients [stage I and II: (12.12 +/- 1.48) ng/L, stage III and IV: (8.44 +/- 0.90) ng/L] was significantly lower than that in the healthy controls, while the level of Th2 cytokine IL-4 in the patients [stage I and II: (18.64 +/- 0.77) ng/L, stage III and IV: (25.28 +/- 2.02) ng/L] was significantly higher than that in the healthy controls.",19615257_4,-1,-1,-1,-1,10319,-1,5.0824815e-06,0.9999882,6.7184155e-06
10320,Th1 cytokine IFN-gamma,4,7,20,42,"The plasma level of Th1 cytokine IFN-gamma in the patients [stage I and II: (12.12 +/- 1.48) ng/L, stage III and IV: (8.44 +/- 0.90) ng/L] was significantly lower than that in the healthy controls, while the level of Th2 cytokine IL-4 in the patients [stage I and II: (18.64 +/- 0.77) ng/L, stage III and IV: (25.28 +/- 2.02) ng/L] was significantly higher than that in the healthy controls.",19615257_4,-1,-1,-1,-1,10320,-1,0.93266684,0.062400784,0.0049323887
10322,than that,40,42,163,172,"The plasma level of Th1 cytokine IFN-gamma in the patients [stage I and II: (12.12 +/- 1.48) ng/L, stage III and IV: (8.44 +/- 0.90) ng/L] was significantly lower than that in the healthy controls, while the level of Th2 cytokine IL-4 in the patients [stage I and II: (18.64 +/- 0.77) ng/L, stage III and IV: (25.28 +/- 2.02) ng/L] was significantly higher than that in the healthy controls.",19615257_4,-1,-1,-1,-1,10322,-1,6.7349583e-06,0.9999862,7.0507026e-06
10325,Th2 cytokine,51,53,217,229,"The plasma level of Th1 cytokine IFN-gamma in the patients [stage I and II: (12.12 +/- 1.48) ng/L, stage III and IV: (8.44 +/- 0.90) ng/L] was significantly lower than that in the healthy controls, while the level of Th2 cytokine IL-4 in the patients [stage I and II: (18.64 +/- 0.77) ng/L, stage III and IV: (25.28 +/- 2.02) ng/L] was significantly higher than that in the healthy controls.",19615257_4,-1,-1,-1,-1,10325,-1,0.27104786,0.7192841,0.009668061
10327,than that,87,89,357,366,"The plasma level of Th1 cytokine IFN-gamma in the patients [stage I and II: (12.12 +/- 1.48) ng/L, stage III and IV: (8.44 +/- 0.90) ng/L] was significantly lower than that in the healthy controls, while the level of Th2 cytokine IL-4 in the patients [stage I and II: (18.64 +/- 0.77) ng/L, stage III and IV: (25.28 +/- 2.02) ng/L] was significantly higher than that in the healthy controls.",19615257_4,-1,-1,-1,-1,10327,-1,6.6049743e-06,0.99998677,6.6064804e-06
10332,the plasma,13,15,63,73,"However, neither in the expression of T-bet and GATA-3, nor in the plasma level of IFN-gamma and IL-4, showed a significant difference between group A and B.CONCLUSION: In the peripheral blood of esophageal cancer patients, the expression of T-bet decreased, while GATA-3 increased, Th1/Th2 balance is broken, and the Th2 is dominant.",19615257_5,-1,-1,-1,-1,10332,-1,5.8903092e-06,0.9999875,6.6735697e-06
10335,blood,34,35,187,192,"However, neither in the expression of T-bet and GATA-3, nor in the plasma level of IFN-gamma and IL-4, showed a significant difference between group A and B.CONCLUSION: In the peripheral blood of esophageal cancer patients, the expression of T-bet decreased, while GATA-3 increased, Th1/Th2 balance is broken, and the Th2 is dominant.",19615257_5,0,1,-1,-1,10335,-1,0.00035054845,0.9896562,0.0099932095
10339,the Th2,56,58,314,321,"However, neither in the expression of T-bet and GATA-3, nor in the plasma level of IFN-gamma and IL-4, showed a significant difference between group A and B.CONCLUSION: In the peripheral blood of esophageal cancer patients, the expression of T-bet decreased, while GATA-3 increased, Th1/Th2 balance is broken, and the Th2 is dominant.",19615257_5,-1,-1,-1,-1,10339,-1,1.2270963e-05,0.9999814,6.3206126e-06
10341,GATA-3 play,2,4,10,21,T-bet and GATA-3 play a part role in the regulation of Th1/Th2 balance.,19615257_6,-1,-1,-1,-1,10341,-1,7.711479e-06,0.99998176,1.0484841e-05
10342,the regulation,8,10,37,51,T-bet and GATA-3 play a part role in the regulation of Th1/Th2 balance.,19615257_6,-1,-1,-1,-1,10342,-1,4.4126914e-06,0.9999907,4.877687e-06
10343,tumor antigens,11,13,57,71,"Since human papillomavirus (HPV) E6 and E7 are promising tumor antigens, we engineered E6 and E7 antigens to generate an optimal HPV DNA vaccine by codon optimization (Co), fusion of E6 and E7, addition of a tissue plasminogen activator (tpa) signal sequence, addition of CD40 ligand (CD40L) or Fms-like tyrosine kinase-3 ligand (Flt3L).",19651174_0,-1,-1,-1,-1,10343,-1,0.43775427,0.5579217,0.004324063
10344,antigens to generate,19,22,97,117,"Since human papillomavirus (HPV) E6 and E7 are promising tumor antigens, we engineered E6 and E7 antigens to generate an optimal HPV DNA vaccine by codon optimization (Co), fusion of E6 and E7, addition of a tissue plasminogen activator (tpa) signal sequence, addition of CD40 ligand (CD40L) or Fms-like tyrosine kinase-3 ligand (Flt3L).",19651174_0,-1,-1,-1,-1,10344,-1,0.661407,0.3348805,0.0037124734
10345,tissue plasminogen activator,43,46,208,236,"Since human papillomavirus (HPV) E6 and E7 are promising tumor antigens, we engineered E6 and E7 antigens to generate an optimal HPV DNA vaccine by codon optimization (Co), fusion of E6 and E7, addition of a tissue plasminogen activator (tpa) signal sequence, addition of CD40 ligand (CD40L) or Fms-like tyrosine kinase-3 ligand (Flt3L).",19651174_0,-1,-1,-1,-1,10345,-1,0.95633596,0.04226959,0.0013945086
10358,immunity,39,40,201,209,"When E6(Co) and E7(Co) were fused (E67(Co)), CD8(+) T cell responses specific for E6 or E7 antigen decreased, but the preventive antitumor effect rather improved, demonstrating the importance of broad immunity.",19651174_2,0,-1,2,-1,10358,-1,0.9997073,8.703559e-05,0.00020575452
10361,than that,22,24,146,155,"Interestingly, Flt3L-fused HPV DNA vaccine exhibited stronger E6- and E7-specific CD8(+) T cell responses as well as therapeutic antitumor effect than that of CD40L linked HPV DNA vaccine.",19651174_3,-1,-1,-1,-1,10361,-1,6.111301e-06,0.9999888,5.1472184e-06
10369,than those,44,46,226,236,"Finally, the optimal construct, tFE67(Co), was generated by including tpa signal sequence, Flt3L, fusion of E6 and E7, and codon optimization, which induces 23 and 25 times stronger E6- and E7-specific CD8(+) T cell responses than those of initial E67 fusion construct.",19651174_4,-1,-1,-1,-1,10369,-1,1.0628645e-05,0.9999827,6.6147813e-06
10376,that tFE67(Co,15,17,91,104,"Thus, our results provide valuable insight on effective HPV DNA vaccine design and suggest that tFE67(Co) delivered with electroporation may be a promising therapeutic HPV DNA vaccine against cervical cancer.",19651174_6,-1,-1,-1,-1,10376,-1,6.604032e-05,0.9999093,2.471265e-05
10380,the target,15,17,92,102,"Carcinoembryonic antigen (CEA) is over-expressed on various human cancer cells and has been the target of immunotherapies using dendritic cells (DCs) pulsed with CEA-specific RNA or peptides, or transduced by CEA-expressing adenovirus or vaccinia virus.",19659778_0,-1,-1,-1,-1,10380,-1,5.5838523e-06,0.9999894,4.998911e-06
10382,peptides,30,31,182,190,"Carcinoembryonic antigen (CEA) is over-expressed on various human cancer cells and has been the target of immunotherapies using dendritic cells (DCs) pulsed with CEA-specific RNA or peptides, or transduced by CEA-expressing adenovirus or vaccinia virus.",19659778_0,0,-1,2,-1,10382,-1,0.6510276,0.34032395,0.008648435
10384,protein antigens,7,9,49,65,"Because activated DCs do not phagocytose soluble protein antigens efficiently and pure immature DCs are not obtained easily ex vivo, an efficacious whole CEA protein-loaded DC vaccine has not been reported.",19659778_1,-1,-1,-1,-1,10384,-1,0.99945134,0.00030428232,0.00024441446
10385,protein-loaded,25,26,158,172,"Because activated DCs do not phagocytose soluble protein antigens efficiently and pure immature DCs are not obtained easily ex vivo, an efficacious whole CEA protein-loaded DC vaccine has not been reported.",19659778_1,0,1,-1,-1,10385,-1,0.00036639077,0.99953985,9.375624e-05
10387,the antigen,2,4,11,22,"To improve the antigen delivery into DCs, we utilized CEA conjugated to a protein-transduction domain, human immunodeficiency virus transactivating Tat.",19659778_2,-1,-1,-1,-1,10387,-1,0.38177985,0.61155856,0.0066616256
10389,protein-transduction,14,15,74,94,"To improve the antigen delivery into DCs, we utilized CEA conjugated to a protein-transduction domain, human immunodeficiency virus transactivating Tat.",19659778_2,0,1,-1,-1,10389,-1,9.913907e-06,0.99998105,9.069888e-06
10390,transactivating Tat,20,22,132,151,"To improve the antigen delivery into DCs, we utilized CEA conjugated to a protein-transduction domain, human immunodeficiency virus transactivating Tat.",19659778_2,-1,-1,-1,-1,10390,-1,7.878017e-06,0.9999846,7.5160515e-06
10391,the truncated,4,6,25,38,"Furthermore, we purified the truncated non-glycosylated CEA from Escherichia coli to overcome the safety concerns and immunosuppressive functions associated with the native CEA protein.",19659778_3,-1,-1,-1,-1,10391,-1,5.2000128e-06,0.9999901,4.7376284e-06
10394,functions,18,19,136,145,"Furthermore, we purified the truncated non-glycosylated CEA from Escherichia coli to overcome the safety concerns and immunosuppressive functions associated with the native CEA protein.",19659778_3,0,1,2,-1,10394,-1,0.0018266786,0.9973827,0.00079057715
10395,the native,21,23,162,172,"Furthermore, we purified the truncated non-glycosylated CEA from Escherichia coli to overcome the safety concerns and immunosuppressive functions associated with the native CEA protein.",19659778_3,-1,-1,-1,-1,10395,-1,6.2416398e-06,0.99998915,4.5895426e-06
10396,protein,24,25,177,184,"Furthermore, we purified the truncated non-glycosylated CEA from Escherichia coli to overcome the safety concerns and immunosuppressive functions associated with the native CEA protein.",19659778_3,0,1,-1,-1,10396,-1,3.6162513e-05,0.99991524,4.8642083e-05
10398,analysis,8,9,66,74,"Using confocal microscopy and fluorescence activating cell sorter analysis, we demonstrated that the Tat-CEA protein entered the cytoplasm of DCs efficiently within 10 min of co-culture, compared with the negligible amount of CEA into DCs 30 min later.",19659778_4,0,1,-1,-1,10398,-1,9.910701e-06,0.9999789,1.1206832e-05
10399,that the Tat-CEA protein,12,16,92,116,"Using confocal microscopy and fluorescence activating cell sorter analysis, we demonstrated that the Tat-CEA protein entered the cytoplasm of DCs efficiently within 10 min of co-culture, compared with the negligible amount of CEA into DCs 30 min later.",19659778_4,-1,-1,-1,-1,10399,-1,1.2174622e-05,0.9999746,1.3221503e-05
10412,interleukin-4 than those,23,26,139,163,T helper type 1 responses were more prominent in the DC (Tat-CEA) immunized mice whose splenocytes secreted more interferon-gamma and less interleukin-4 than those from DC (CEA) immunized mice.,19659778_6,-1,-1,-1,-1,10412,-1,0.9930757,0.0060663656,0.0008579036
10425,proteins,9,10,47,55,"The genome of Epstein-Barr virus (EBV) encodes proteins essential for malignant transformation, for example, latent membrane protein 1(LMP1).",19664329_0,0,1,-1,-1,10425,-1,4.1947485e-05,0.999938,2.0055637e-05
10427,protein,20,21,125,132,"The genome of Epstein-Barr virus (EBV) encodes proteins essential for malignant transformation, for example, latent membrane protein 1(LMP1).",19664329_0,0,1,-1,-1,10427,-1,0.00012719205,0.9996338,0.00023900376
10428,proteins to,5,7,42,53,"Whereas, LMP1 up-regulates anti-apoptotic proteins to support viral replication, it also potentiates apoptosis, suggesting that a viral protein contributes to the survival of the virus, and it also elicit host defense leading to the destruction of the infected cells.",19664329_1,-1,-1,-1,-1,10428,-1,1.2791855e-05,0.9999778,9.354849e-06
10430,protein,20,21,136,143,"Whereas, LMP1 up-regulates anti-apoptotic proteins to support viral replication, it also potentiates apoptosis, suggesting that a viral protein contributes to the survival of the virus, and it also elicit host defense leading to the destruction of the infected cells.",19664329_1,0,1,-1,-1,10430,-1,8.837728e-05,0.99988556,2.6028256e-05
10431,to the,22,24,156,162,"Whereas, LMP1 up-regulates anti-apoptotic proteins to support viral replication, it also potentiates apoptosis, suggesting that a viral protein contributes to the survival of the virus, and it also elicit host defense leading to the destruction of the infected cells.",19664329_1,-1,-1,-1,-1,10431,-1,8.154742e-06,0.99998605,5.848705e-06
10433,to the,36,38,226,232,"Whereas, LMP1 up-regulates anti-apoptotic proteins to support viral replication, it also potentiates apoptosis, suggesting that a viral protein contributes to the survival of the virus, and it also elicit host defense leading to the destruction of the infected cells.",19664329_1,-1,-1,-1,-1,10433,-1,6.176166e-06,0.9999896,4.2356087e-06
10437,immunity,2,3,14,22,"The antitumor immunity is exerted by infiltrated CD8+ T cells elaborating cytotoxic effectors, like Fas ligand (FasL, CD95L or CD178).",19664329_2,0,-1,2,-1,10437,-1,0.9996439,9.109242e-05,0.00026500042
10448,cytokine-targeting therapy,18,20,134,160,"Recent reports suggest that mutations affecting the Fas-mediated apoptotic pathway reduce individuals' susceptibility to cancers, but cytokine-targeting therapy which precisely regulates the Fas level on tumor cells could still contribute to enhancement of antitumor immunity in cancer patients.",19664329_5,-1,-1,-1,-1,10448,-1,0.973545,0.025199752,0.0012552394
10450,tumor cells,27,29,204,215,"Recent reports suggest that mutations affecting the Fas-mediated apoptotic pathway reduce individuals' susceptibility to cancers, but cytokine-targeting therapy which precisely regulates the Fas level on tumor cells could still contribute to enhancement of antitumor immunity in cancer patients.",19664329_5,-1,-1,-1,-1,10450,-1,0.00019003189,0.0015149746,0.998295
10452,immunity,36,37,267,275,"Recent reports suggest that mutations affecting the Fas-mediated apoptotic pathway reduce individuals' susceptibility to cancers, but cytokine-targeting therapy which precisely regulates the Fas level on tumor cells could still contribute to enhancement of antitumor immunity in cancer patients.",19664329_5,0,-1,2,-1,10452,-1,0.9999449,1.1364802e-05,4.371953e-05
10453,Regulatory T cells play,0,4,0,23,Regulatory T cells play an important role in tumor escape from host antitumor immunity.,19673890_0,-1,-1,-1,-1,10453,-1,0.00075554656,0.008332254,0.9909122
10455,immunity,13,14,78,86,Regulatory T cells play an important role in tumor escape from host antitumor immunity.,19673890_0,0,-1,2,-1,10455,-1,0.9999223,2.0489217e-05,5.7187888e-05
10457,the tumor,12,14,82,91,"Increased frequencies of CD4(+)CD25(+) regulatory T cells have been documented in the tumor sites, malignant effusions, and peripheral blood of patients with ovarian carcinoma.",19673890_1,-1,-1,-1,-1,10457,-1,4.254019e-06,0.99999034,5.444041e-06
10458,blood,21,22,135,140,"Increased frequencies of CD4(+)CD25(+) regulatory T cells have been documented in the tumor sites, malignant effusions, and peripheral blood of patients with ovarian carcinoma.",19673890_1,0,1,-1,-1,10458,-1,0.00019687343,0.99829143,0.0015116332
10463,These cells,0,2,0,11,"These cells did not express FOXP3 by single-cell analysis, and few cells expressed FOXP3 when they were activated with anti-CD3/CD28 dual signal.",19673890_4,-1,-1,-1,-1,10463,-1,2.0869924e-05,1.529994e-05,0.9999639
10465,analysis,8,9,49,57,"These cells did not express FOXP3 by single-cell analysis, and few cells expressed FOXP3 when they were activated with anti-CD3/CD28 dual signal.",19673890_4,0,1,-1,-1,10465,-1,0.00087115937,0.25024906,0.74887973
10477,TGF-beta,12,13,99,107,"Neutralization assays revealed that neutralizing antibody against transforming growth factor beta (TGF-beta), interleukin-10, and interleukin-4 did not abrogate elevated FOXP3 expression induced by carcinoma cell culture supernatant, whereas neutralizing leukemia inhibitory factor (LIF) partially abrogated FOXP3 expression, but LIF alone could not increase FOXP3 expression in activated nave T cells.",19673890_6,0,1,-1,-1,10477,-1,0.00085077656,0.99907887,7.03644e-05
10484,LIF,46,47,330,333,"Neutralization assays revealed that neutralizing antibody against transforming growth factor beta (TGF-beta), interleukin-10, and interleukin-4 did not abrogate elevated FOXP3 expression induced by carcinoma cell culture supernatant, whereas neutralizing leukemia inhibitory factor (LIF) partially abrogated FOXP3 expression, but LIF alone could not increase FOXP3 expression in activated nave T cells.",19673890_6,0,-1,2,-1,10484,-1,4.2075088e-05,0.9999473,1.0607753e-05
10486,nave T cells,55,58,389,402,"Neutralization assays revealed that neutralizing antibody against transforming growth factor beta (TGF-beta), interleukin-10, and interleukin-4 did not abrogate elevated FOXP3 expression induced by carcinoma cell culture supernatant, whereas neutralizing leukemia inhibitory factor (LIF) partially abrogated FOXP3 expression, but LIF alone could not increase FOXP3 expression in activated nave T cells.",19673890_6,-1,-1,-1,-1,10486,-1,0.0022116033,0.076525524,0.92126286
10487,that these cells,9,12,56,72,"Further, an in vitro coculture suppression assay showed that these cells could suppress the proliferation of autologous CD4(+)CD25(-)CD45RA(-) T cells.",19673890_7,-1,-1,-1,-1,10487,-1,0.0026284521,0.2713023,0.72606915
10508,immunity,10,11,52,60,The aim of this study was to enhance the anti-tumor immunity of gp96 vaccine through naloxone administration.,19706340_1,0,-1,2,-1,10508,-1,0.9996339,0.00011576916,0.00025031692
10509,through naloxone,14,16,77,93,The aim of this study was to enhance the anti-tumor immunity of gp96 vaccine through naloxone administration.,19706340_1,-1,-1,-1,-1,10509,-1,5.6006123e-05,0.9999294,1.4557996e-05
10512,the tumor,12,14,73,82,"Therefore, we used BALB/c mouse model of fibrosarcoma tumor and analyzed the tumor size, splenocyte proliferation, spleen and tumor-infiltrated lymphocytes.",19706340_2,-1,-1,-1,-1,10512,-1,4.6389364e-06,0.99999,5.391328e-06
10513,tumor-infiltrated lymphocytes,21,23,126,155,"Therefore, we used BALB/c mouse model of fibrosarcoma tumor and analyzed the tumor size, splenocyte proliferation, spleen and tumor-infiltrated lymphocytes.",19706340_2,-1,-1,-1,-1,10513,-1,0.00317267,0.8450568,0.15177058
10527,the tumors,9,11,45,55,The results indicated that on days 27 and 32 the tumors in the gp96+Nal group grew significantly slower.,19706340_5,-1,-1,-1,-1,10527,-1,3.818912e-06,0.9999913,4.9387127e-06
10535,that naloxone,3,5,24,37,Our results demonstrate that naloxone is an effective immunoadjuvant in cancer immunotherapy.,19706340_8,-1,-1,-1,-1,10535,-1,0.00032772415,0.9996309,4.1322324e-05
10539,to play,23,25,127,134,"The negative signal provided by interactions of programmed death-1 (PD-1) and its ligands, B7-H1 and B7-DC, has been suggested to play an important role in tumor evasion from host immunity.",19724910_0,-1,-1,-1,-1,10539,-1,5.7412526e-06,0.9999893,4.947584e-06
10541,immunity,33,34,180,188,"The negative signal provided by interactions of programmed death-1 (PD-1) and its ligands, B7-H1 and B7-DC, has been suggested to play an important role in tumor evasion from host immunity.",19724910_0,0,-1,2,-1,10541,-1,0.99990964,2.711231e-05,6.3327236e-05
10562,the tumors,2,4,19,29,Cells infiltrating the tumors were characterized by immunohistochemistry.,19724910_7,-1,-1,-1,-1,10562,-1,5.355464e-06,0.9999893,5.368043e-06
10579,the tumor,18,20,115,124,"B7-DC blockade decreased the levels of IL-10 and FoxP3, suggesting that regulatory systems are mainly inhibited at the tumor site.",19724910_12,-1,-1,-1,-1,10579,-1,4.097501e-06,0.9999913,4.558407e-06
10588,the tumor,23,25,188,197,"Collectively, blocking of B7-H1 or B7-DC efficiently induced regression of pre-established pancreatic cancers by up-regulating IFN-gamma production and down-regulating IL-10 production at the tumor site.",19724910_14,-1,-1,-1,-1,10588,-1,3.962135e-06,0.9999913,4.717292e-06
10596,immunity,8,9,51,59,It augments initiation of T helper type 1-mediated immunity by enhancing the proliferation and cytokine production of T cells.,19740343_1,0,-1,2,-1,10596,-1,0.9815668,0.0006381009,0.017795196
10602,cells transduced,1,3,6,22,"COS-7 cells transduced with the mouse (m) p28 gene secreted a monomeric mp28 protein; however, those transduced with the mEBI3 gene did not detect a mEBI3 protein in the culture supernatants.",19740343_3,-1,-1,-1,-1,10602,-1,0.003779272,0.3283664,0.6678543
10605,protein,15,16,77,84,"COS-7 cells transduced with the mouse (m) p28 gene secreted a monomeric mp28 protein; however, those transduced with the mEBI3 gene did not detect a mEBI3 protein in the culture supernatants.",19740343_3,0,1,-1,-1,10605,-1,0.00025988027,0.99959916,0.00014097319
10606,those transduced,19,21,95,111,"COS-7 cells transduced with the mouse (m) p28 gene secreted a monomeric mp28 protein; however, those transduced with the mEBI3 gene did not detect a mEBI3 protein in the culture supernatants.",19740343_3,-1,-1,-1,-1,10606,-1,4.907136e-06,0.9999895,5.601817e-06
10609,protein,30,31,155,162,"COS-7 cells transduced with the mouse (m) p28 gene secreted a monomeric mp28 protein; however, those transduced with the mEBI3 gene did not detect a mEBI3 protein in the culture supernatants.",19740343_3,0,1,-1,-1,10609,-1,1.8514418e-05,0.9999709,1.0518669e-05
10630,the functions,11,13,62,75,"Furthermore, production of both mp28 and mp40, which inhibits the functions of IL-12 and IL-23, prolonged the graft survival longer than the grafts expressing either mp28 or mp40.",19740343_9,-1,-1,-1,-1,10630,-1,2.034822e-05,0.9999559,2.3792632e-05
10633,than the,23,25,132,140,"Furthermore, production of both mp28 and mp40, which inhibits the functions of IL-12 and IL-23, prolonged the graft survival longer than the grafts expressing either mp28 or mp40.",19740343_9,-1,-1,-1,-1,10633,-1,6.273958e-06,0.99998856,5.229196e-06
10636,cellular immune responses,11,14,67,92,We propose that p28 can be a regulatory subunit for IL-27-mediated cellular immune responses and a possible therapeutic agent to suppress unfavourable immune responses.,19740343_10,-1,-1,-1,-1,10636,-1,0.6174454,0.000668442,0.38188612
10642,T-cell,8,9,41,47,"Based on their role for the induction of T-cell responses, dendritic cells (DCs) are popular candidates in cancer vaccine development.",19758325_0,-1,1,2,-1,10642,-1,2.825322e-05,9.754595e-06,0.999962
10646,Toll-like receptor-3,17,19,113,133,We established a novel single-step intracellular delivery of peptide/poly(I:C) complexes for antigen loading and Toll-like receptor-3 (TLR3)-mediated maturation of human DCs using a cell-penetrating peptide (tat(49-57): RKKRRQRRR) as delivery vector.,19758325_1,-1,-1,-1,-1,10646,-1,0.00034469692,0.99749833,0.0021569463
10647,cell-penetrating peptide,26,28,182,206,We established a novel single-step intracellular delivery of peptide/poly(I:C) complexes for antigen loading and Toll-like receptor-3 (TLR3)-mediated maturation of human DCs using a cell-penetrating peptide (tat(49-57): RKKRRQRRR) as delivery vector.,19758325_1,-1,-1,-1,-1,10647,-1,0.009935857,0.031042391,0.9590218
10649,Towards this,0,2,0,12,"Towards this end, a cationic tat-sequence was fused with an antigenic, major histocompatibility complex (MHC) class I-binding melanoma epitope (Melan-A/Mart-1 sequence: ELAGIGILTV) and then mixed with negatively charged poly(I:C) dsRNA to form peptide/nucleic acid complexes.",19758325_2,-1,-1,-1,-1,10649,-1,5.375822e-06,0.99998784,6.8343725e-06
10664,to peptide-loaded,23,25,173,190,"When peptide/poly(I:C) complex-loaded DCs were used for autologous T cell stimulation, epitope-specific interferon-gamma secretion was quantitatively superior in comparison to peptide-loaded DCs matured by a cytokine cocktail, as detected by enzyme-linked immunospot assays.",19758325_6,-1,-1,-1,-1,10664,-1,1.18133885e-05,0.9999782,1.0044612e-05
10668,antigenic peptides,5,7,28,46,"Thus, complexes of cationic antigenic peptides and poly(I:C) might be of great utility for a TLR3-mediated DC maturation and intracellular peptide targeting in a single step.",19758325_7,-1,-1,-1,-1,10668,-1,0.9956073,0.0003546561,0.004038045
10670,peptide targeting,24,26,139,156,"Thus, complexes of cationic antigenic peptides and poly(I:C) might be of great utility for a TLR3-mediated DC maturation and intracellular peptide targeting in a single step.",19758325_7,-1,-1,-1,-1,10670,-1,0.0025195258,0.99690056,0.0005799227
10671,antigen-specific T cells,7,10,54,78,Resulting DCs induce a strong expansion/activation of antigen-specific T cells in the context of an IL-12p70 secretion.,19758325_8,-1,-1,-1,-1,10671,-1,0.6968495,0.00050272694,0.30264768
10679,peptide-stimulated,10,11,67,85,"Here, we assessed the immunotherapeutic effects of autologous MUC1 peptide-stimulated CD4(+) effector cells following adoptive transfer in patients with ovarian cancer.",19762283_1,0,-1,2,-1,10679,-1,0.95123094,0.045082286,0.0036867573
10682,peptide,2,3,11,18,"Using MUC1 peptide and IL-2 for ex vivo CD4(+)/Th1 effector cell generation, we show that three monthly treatment cycles of peripheral blood T cell restimulation and intraperitoneal re-infusion selectively modulated endogenous T cell-mediated immune responses that correlated with diminished serum CA125 tumor marker levels and enhanced patient survival.",19762283_2,0,-1,2,-1,10682,-1,0.6563386,0.30117017,0.042491257
10683,cell generation,10,12,60,75,"Using MUC1 peptide and IL-2 for ex vivo CD4(+)/Th1 effector cell generation, we show that three monthly treatment cycles of peripheral blood T cell restimulation and intraperitoneal re-infusion selectively modulated endogenous T cell-mediated immune responses that correlated with diminished serum CA125 tumor marker levels and enhanced patient survival.",19762283_2,-1,-1,-1,-1,10683,-1,0.00015282565,0.0016050953,0.99824214
10684,that three,15,17,85,95,"Using MUC1 peptide and IL-2 for ex vivo CD4(+)/Th1 effector cell generation, we show that three monthly treatment cycles of peripheral blood T cell restimulation and intraperitoneal re-infusion selectively modulated endogenous T cell-mediated immune responses that correlated with diminished serum CA125 tumor marker levels and enhanced patient survival.",19762283_2,-1,-1,-1,-1,10684,-1,7.893972e-06,0.9999871,5.0262825e-06
10686,blood T cell,22,25,135,147,"Using MUC1 peptide and IL-2 for ex vivo CD4(+)/Th1 effector cell generation, we show that three monthly treatment cycles of peripheral blood T cell restimulation and intraperitoneal re-infusion selectively modulated endogenous T cell-mediated immune responses that correlated with diminished serum CA125 tumor marker levels and enhanced patient survival.",19762283_2,-1,-1,-1,-1,10686,-1,7.957473e-05,8.793374e-05,0.9998324
10687,T cell-mediated immune responses that,32,37,227,264,"Using MUC1 peptide and IL-2 for ex vivo CD4(+)/Th1 effector cell generation, we show that three monthly treatment cycles of peripheral blood T cell restimulation and intraperitoneal re-infusion selectively modulated endogenous T cell-mediated immune responses that correlated with diminished serum CA125 tumor marker levels and enhanced patient survival.",19762283_2,-1,-1,-1,-1,10687,-1,0.005059622,0.023821333,0.97111905
10690,therapy,11,12,81,88,"Although PBL from all patients showed elevated MUC1 cytolytic activity following therapy, such responses did not correlate with therapeutic efficacy.",19762283_4,0,1,-1,-1,10690,-1,7.137732e-06,0.99998796,4.903685e-06
10693,to that,22,24,128,135,Long-term survivors showed elevated levels of systemic memory (CD45RO) and nave (CD45RA) CD3/CD4/CD25(+) T cells when compared to that of pre-treatment levels and similarly treated short-term survivors.,19762283_5,-1,-1,-1,-1,10693,-1,4.9640785e-06,0.9999902,4.8560787e-06
10697,CTLA-4 that,8,10,54,65,Such cells co-expressed different levels of Foxp3 and CTLA-4 that resulted in progressively lower systemic Foxp3/CTLA-4 memory T cell ratios that further correlated with disease-free survival.,19762283_6,-1,-1,-1,-1,10697,-1,0.001770376,0.0052195974,0.99301004
10702,the CCR5,12,14,82,90,"Lastly, these patients showed elevated levels of MUC1-specific T cells expressing the CCR5 and CCR1 chemokine receptors and the chemokine CCL4 associated with Th1 cell differentiation/memory.",19762283_7,-1,-1,-1,-1,10702,-1,0.0022168057,0.9083054,0.08947777
10703,chemokine receptors,16,18,100,119,"Lastly, these patients showed elevated levels of MUC1-specific T cells expressing the CCR5 and CCR1 chemokine receptors and the chemokine CCL4 associated with Th1 cell differentiation/memory.",19762283_7,-1,-1,-1,-1,10703,-1,0.9798799,0.00013488506,0.01998512
10704,the chemokine CCL4,19,22,124,142,"Lastly, these patients showed elevated levels of MUC1-specific T cells expressing the CCR5 and CCR1 chemokine receptors and the chemokine CCL4 associated with Th1 cell differentiation/memory.",19762283_7,-1,-1,-1,-1,10704,-1,0.5224364,0.46873757,0.008826027
10710,tumor immunity,32,34,236,250,"We suggest that effective immunotherapy with autologous MUC1-stimulated CD4(+) effector cells induces differential levels of systemic ""Ag-experienced"" and ""Ag-inexperienced"" CD4/CD25(+) TReg cell subpopulations that influence long-term tumor immunity in ovarian cancer patients.",19762283_8,-1,-1,-1,-1,10710,-1,0.03897936,0.9600623,0.0009583192
10713,the general,2,4,9,20,"However, the general effector mechanism is not fully settled.",19773201_1,-1,-1,-1,-1,10713,-1,1.46831935e-05,0.99997723,8.094799e-06
10716,the relative,13,15,81,93,Twenty-four patients with CTCL and 14 patients with GVHD were included to assess the relative numbers of regulatory T cells (Treg) and any change in the serum cytokine profile during 6 months of ECP therapy.,19773201_2,-1,-1,-1,-1,10716,-1,7.785487e-06,0.9999857,6.462771e-06
10721,therapy,36,37,199,206,Twenty-four patients with CTCL and 14 patients with GVHD were included to assess the relative numbers of regulatory T cells (Treg) and any change in the serum cytokine profile during 6 months of ECP therapy.,19773201_2,0,1,-1,-1,10721,-1,5.6055414e-06,0.9999876,6.850084e-06
10722,The relative,0,2,0,12,The relative amount of Treg cells was twice as high in CTCL compared to GVHD and healthy controls.,19773201_3,-1,-1,-1,-1,10722,-1,6.147276e-06,0.9999893,4.6120863e-06
10726,TGF-beta,0,1,0,8,TGF-beta was on average three times higher in GVHD than in CTCL.,19773201_4,0,1,-1,-1,10726,-1,0.00030522828,0.9996743,2.0442372e-05
10727,three times,4,6,24,35,TGF-beta was on average three times higher in GVHD than in CTCL.,19773201_4,-1,-1,-1,-1,10727,-1,3.9362407e-05,0.99994457,1.6033737e-05
10729,TGF-beta,10,11,60,68,Both patient groups had a small but significant increase in TGF-beta after treatment.,19773201_5,0,1,-1,-1,10729,-1,0.00019358487,0.9997794,2.7068372e-05
10731,Treg function,5,7,36,49,Our results indicate a strengthened Treg function as a result of ECP.,19773201_6,-1,-1,-1,-1,10731,-1,4.0372826e-05,0.9998796,8.002141e-05
10732,TGF-beta,1,2,9,17,"Elevated TGF-beta may indicate high Treg activation in GVHD, whereas an increased number of Treg cells in CTCL could be interpreted as a response that is involved in down-regulating the lymphoma cells.",19773201_7,0,1,-1,-1,10732,-1,4.4952463e-05,0.9999455,9.582458e-06
10738,T cell function plays,2,6,17,38,"Although altered T cell function plays a part in immunosenescence, the mechanisms remain uncertain.",19805226_0,-1,-1,-1,-1,10738,-1,0.0017486162,0.03352596,0.96472543
10742,to T cell receptor,24,28,138,156,Here we identify a bona fide age-dependent PD-1(+) memory phenotype (MP) CD4(+) T cell subpopulation that hardly proliferates in response to T cell receptor (TCR) stimulation and produces abundant osteopontin at the cost of typical T cell lymphokines.,19805226_1,-1,-1,-1,-1,10742,-1,0.0042893966,0.1431322,0.85257834
10743,TCR,29,30,158,161,Here we identify a bona fide age-dependent PD-1(+) memory phenotype (MP) CD4(+) T cell subpopulation that hardly proliferates in response to T cell receptor (TCR) stimulation and produces abundant osteopontin at the cost of typical T cell lymphokines.,19805226_1,-1,1,2,-1,10743,-1,2.2605289e-05,0.99994373,3.371125e-05
10746,typical T cell lymphokines,40,44,224,250,Here we identify a bona fide age-dependent PD-1(+) memory phenotype (MP) CD4(+) T cell subpopulation that hardly proliferates in response to T cell receptor (TCR) stimulation and produces abundant osteopontin at the cost of typical T cell lymphokines.,19805226_1,-1,-1,-1,-1,10746,-1,0.9122926,0.07311125,0.014596159
10747,These T cells,0,3,0,13,"These T cells demonstrate impaired repopulation in Rag2(-/-) mice, but a homeostatic proliferation in gamma-ray-irradiated mice.",19805226_2,-1,-1,-1,-1,10747,-1,0.0013279708,0.07970885,0.91896325
10748,These T cells,0,3,0,13,"These T cells also reveal a unique molecular signature, including a strong expression of C/EBPalpha normally expressed in myeloid-lineage cells, with diminished c-Myc and cyclin D1.",19805226_3,-1,-1,-1,-1,10748,-1,0.00069445185,0.028371759,0.9709338
10753,the TCR-mediated,10,12,58,74,Transduction of Cebpa in regular CD4(+) T cells inhibited the TCR-mediated proliferation with c-Myc and cyclin D1 repression and caused a striking activation of Spp1 encoding osteopontin along with concomitant repression of T cell lymphokine genes.,19805226_4,-1,-1,-1,-1,10753,-1,1.1857616e-05,0.99996436,2.381642e-05
10755,T cell lymphokine genes,33,37,224,247,Transduction of Cebpa in regular CD4(+) T cells inhibited the TCR-mediated proliferation with c-Myc and cyclin D1 repression and caused a striking activation of Spp1 encoding osteopontin along with concomitant repression of T cell lymphokine genes.,19805226_4,-1,-1,-1,-1,10755,-1,0.1333826,0.014160753,0.8524566
10756,these T cells,1,4,9,22,"Although these T cells gradually increase in number with age and become predominant at the senescent stage in normal mice, the generation is robustly accelerated during leukemia.",19805226_5,-1,-1,-1,-1,10756,-1,0.0009864689,0.032981247,0.96603227
10758,the generation,21,23,123,137,"Although these T cells gradually increase in number with age and become predominant at the senescent stage in normal mice, the generation is robustly accelerated during leukemia.",19805226_5,-1,-1,-1,-1,10758,-1,5.1105794e-06,0.9999901,4.8030556e-06
10765,to the,14,16,99,105,The results suggest that global T cell immunodepression in senescence and leukemia is attributable to the increase in PD-1(+) MP CD4(+) T cells expressing C/EBPalpha.,19805226_7,-1,-1,-1,-1,10765,-1,4.890623e-06,0.99999094,4.170759e-06
10767,Though TGF-beta,0,2,0,15,"Though TGF-beta inhibition enhances antitumor immunity mediated by CD8(+) T cells in several tumor models, it is not always sufficient for rejection of tumors.",19830696_0,-1,-1,-1,-1,10767,-1,0.00029177792,0.9996731,3.512524e-05
10768,immunity,5,6,46,54,"Though TGF-beta inhibition enhances antitumor immunity mediated by CD8(+) T cells in several tumor models, it is not always sufficient for rejection of tumors.",19830696_0,0,-1,2,-1,10768,-1,0.999821,4.4766897e-05,0.00013420792
10773,to maximize the,4,7,15,30,"In this study, to maximize the antitumor effect of TGF-beta blockade, we tested the effect of anti-TGF-beta combined with an irradiated tumor vaccine in a subcutaneous CT26 colon carcinoma tumor model.",19830696_1,-1,-1,-1,-1,10773,-1,5.409126e-06,0.99998987,4.743025e-06
10774,TGF-beta,10,11,51,59,"In this study, to maximize the antitumor effect of TGF-beta blockade, we tested the effect of anti-TGF-beta combined with an irradiated tumor vaccine in a subcutaneous CT26 colon carcinoma tumor model.",19830696_1,0,1,-1,-1,10774,-1,0.00076217146,0.999173,6.480206e-05
10775,tested the,14,16,73,83,"In this study, to maximize the antitumor effect of TGF-beta blockade, we tested the effect of anti-TGF-beta combined with an irradiated tumor vaccine in a subcutaneous CT26 colon carcinoma tumor model.",19830696_1,-1,-1,-1,-1,10775,-1,5.333319e-06,0.99999046,4.1460426e-06
10779,tumor cell,2,4,15,25,"The irradiated tumor cell vaccine alone in prophylactic setting significantly delayed tumor growth, whereas anti-TGF-beta antibodies alone did not show any antitumor effect.",19830696_2,-1,-1,-1,-1,10779,-1,0.003913042,0.0949794,0.9011076
10786,T-cell,2,3,7,13,"CD8(+) T-cell depletion completely abrogated the vaccine efficacy, and so protection required CD8(+) T cells.",19830696_4,-1,1,2,-1,10786,-1,1.3576232e-05,7.774917e-06,0.99997866
10791,to the,8,10,44,50,"Depletion of CD25(+) T regulatory cells led to the almost complete rejection of tumors without the vaccine, whereas anti-TGF-beta did not change the number of CD25(+) T regulatory cells in unvaccinated and vaccinated mice.",19830696_5,-1,-1,-1,-1,10791,-1,6.0480274e-06,0.9999896,4.272699e-06
10797,Though the,0,2,0,10,"Though the abrogation of CD1d-restricted NKT cells, which have been reported to induce TGF-beta production by MDSC through an IL-13-IL-4R-STAT6 pathway, partially enhanced antitumor immunity regardless of vaccination, abrogation of the NKT cell-IL-13-IL-4R-STAT-6 immunoregulatory pathway did not enhance vaccine efficacy.",19830696_6,-1,-1,-1,-1,10797,-1,6.5109025e-06,0.99998796,5.5675464e-06
10800,TGF-beta,14,15,87,95,"Though the abrogation of CD1d-restricted NKT cells, which have been reported to induce TGF-beta production by MDSC through an IL-13-IL-4R-STAT6 pathway, partially enhanced antitumor immunity regardless of vaccination, abrogation of the NKT cell-IL-13-IL-4R-STAT-6 immunoregulatory pathway did not enhance vaccine efficacy.",19830696_6,0,1,-1,-1,10800,-1,8.335907e-05,0.9999007,1.5960144e-05
10803,immunity,26,27,182,190,"Though the abrogation of CD1d-restricted NKT cells, which have been reported to induce TGF-beta production by MDSC through an IL-13-IL-4R-STAT6 pathway, partially enhanced antitumor immunity regardless of vaccination, abrogation of the NKT cell-IL-13-IL-4R-STAT-6 immunoregulatory pathway did not enhance vaccine efficacy.",19830696_6,0,-1,2,-1,10803,-1,0.9998442,5.522227e-05,0.000100609
10806,Taken together,0,2,0,14,"Taken together, these data indicated that anti-TGF-beta enhances efficacy of a prophylactic vaccine in normal individuals despite their not having the elevated TGF-beta levels found in patients with cancer and that the effect is not dependent on TGF-beta solely from CD4(+)CD25(+) T regulatory cells or the NKT cell-IL-13-IL-4R-STAT-6 immunoregulatory pathway.",19830696_7,-1,-1,-1,-1,10806,-1,5.777042e-06,0.99998856,5.623414e-06
10811,TGF-beta,23,24,160,168,"Taken together, these data indicated that anti-TGF-beta enhances efficacy of a prophylactic vaccine in normal individuals despite their not having the elevated TGF-beta levels found in patients with cancer and that the effect is not dependent on TGF-beta solely from CD4(+)CD25(+) T regulatory cells or the NKT cell-IL-13-IL-4R-STAT-6 immunoregulatory pathway.",19830696_7,0,1,-1,-1,10811,-1,1.1662629e-05,0.99998224,6.13025e-06
10812,that the,31,33,210,218,"Taken together, these data indicated that anti-TGF-beta enhances efficacy of a prophylactic vaccine in normal individuals despite their not having the elevated TGF-beta levels found in patients with cancer and that the effect is not dependent on TGF-beta solely from CD4(+)CD25(+) T regulatory cells or the NKT cell-IL-13-IL-4R-STAT-6 immunoregulatory pathway.",19830696_7,-1,-1,-1,-1,10812,-1,3.8638755e-06,0.999992,4.1383378e-06
10813,TGF-beta,38,39,246,254,"Taken together, these data indicated that anti-TGF-beta enhances efficacy of a prophylactic vaccine in normal individuals despite their not having the elevated TGF-beta levels found in patients with cancer and that the effect is not dependent on TGF-beta solely from CD4(+)CD25(+) T regulatory cells or the NKT cell-IL-13-IL-4R-STAT-6 immunoregulatory pathway.",19830696_7,0,1,-1,-1,10813,-1,1.2496853e-05,0.9999815,5.9257754e-06
10822,to tumor,17,19,110,118,CD4(+)CD25(+)Foxp3(+) regulatory T cells (Treg) known to mediate self-tolerance were also shown to contribute to tumor progression.,19841169_0,-1,-1,-1,-1,10822,-1,5.509078e-06,0.99998903,5.4098286e-06
10823,transplantation,3,4,18,33,"In mouse melanoma transplantation models, Treg depletion resulted in the stimulation of antitumor immune responses and tumor eradication.",19841169_1,-1,1,2,-1,10823,-1,5.2763244e-06,0.99998856,6.167637e-06
10830,to the,6,8,34,40,"To study Treg in conditions close to the clinical situation, we used a ret transgenic mouse spontaneous melanoma model, which, in contrast to transplantation models, resembles human melanoma regarding clinical development.",19841169_2,-1,-1,-1,-1,10830,-1,5.5174373e-06,0.9999889,5.5999753e-06
10832,to transplantation,25,27,139,157,"To study Treg in conditions close to the clinical situation, we used a ret transgenic mouse spontaneous melanoma model, which, in contrast to transplantation models, resembles human melanoma regarding clinical development.",19841169_2,-1,-1,-1,-1,10832,-1,5.516324e-06,0.9999893,5.25661e-06
10847,function,2,3,22,30,The immunosuppressive function of Treg from transgenic tumor-bearing mice was similar to that from transgenic tumor-free mice or nontransgenic littermates.,19841169_5,0,1,2,-1,10847,-1,0.00029005934,0.9995659,0.00014398292
10849,transgenic tumor-bearing,6,8,44,68,The immunosuppressive function of Treg from transgenic tumor-bearing mice was similar to that from transgenic tumor-free mice or nontransgenic littermates.,19841169_5,-1,-1,-1,-1,10849,-1,8.350721e-06,0.9999813,1.0398868e-05
10850,to that,11,13,86,93,The immunosuppressive function of Treg from transgenic tumor-bearing mice was similar to that from transgenic tumor-free mice or nontransgenic littermates.,19841169_5,-1,-1,-1,-1,10850,-1,4.639275e-06,0.9999906,4.814702e-06
10851,transgenic tumor-free,14,16,99,120,The immunosuppressive function of Treg from transgenic tumor-bearing mice was similar to that from transgenic tumor-free mice or nontransgenic littermates.,19841169_5,-1,-1,-1,-1,10851,-1,1.2857646e-05,0.9999733,1.3865383e-05
10855,the treatment,2,4,13,26,"Furthermore, the treatment of mice with macroscopical tumors also failed to inhibit tumor progression, which correlated with the inability to deplete intratumoral Treg.",19841169_7,-1,-1,-1,-1,10855,-1,4.5909883e-06,0.9999914,3.991216e-06
10867,tumor-promoting functions,21,23,145,170,"We suggest that in the autochthonous melanoma genesis, other immunosuppressive cells could play an important role and replace immunosuppressive, tumor-promoting functions of Treg.",19841169_8,-1,-1,-1,-1,10867,-1,1.1471413e-05,0.9999789,9.67369e-06
10872,the tumor,13,15,97,106,"Therefore, effective melanoma immunotherapy should include the inhibition of Treg migration into the tumor combined with neutralization of other immunosuppressive cells and factors in the tumor microenvironment.",19841169_9,-1,-1,-1,-1,10872,-1,4.462948e-06,0.9999896,5.863291e-06
10874,factors,23,24,173,180,"Therefore, effective melanoma immunotherapy should include the inhibition of Treg migration into the tumor combined with neutralization of other immunosuppressive cells and factors in the tumor microenvironment.",19841169_9,0,1,-1,-1,10874,-1,0.0001369919,0.9998466,1.6408007e-05
10875,the tumor,25,27,184,193,"Therefore, effective melanoma immunotherapy should include the inhibition of Treg migration into the tumor combined with neutralization of other immunosuppressive cells and factors in the tumor microenvironment.",19841169_9,-1,-1,-1,-1,10875,-1,5.0255594e-06,0.9999901,4.9006844e-06
10879,blood lymphocyte,3,5,17,33,"Ten patients had blood lymphocyte proliferative T cell responses directed against E6/2 (14-34) and/or E6/4 (45-68) peptides, which were identified in the present study as immunodominant among HPV-16 E6 and E7 large peptides.",19843089_1,-1,-1,-1,-1,10879,-1,1.8416857e-05,1.2793583e-05,0.9999689
10881,peptides,24,25,115,123,"Ten patients had blood lymphocyte proliferative T cell responses directed against E6/2 (14-34) and/or E6/4 (45-68) peptides, which were identified in the present study as immunodominant among HPV-16 E6 and E7 large peptides.",19843089_1,0,-1,2,-1,10881,-1,2.1702974e-05,0.9999548,2.3447943e-05
10883,peptides,41,42,215,223,"Ten patients had blood lymphocyte proliferative T cell responses directed against E6/2 (14-34) and/or E6/4 (45-68) peptides, which were identified in the present study as immunodominant among HPV-16 E6 and E7 large peptides.",19843089_1,0,-1,2,-1,10883,-1,3.4716508e-05,0.9999161,4.920147e-05
10890,peptides,33,34,165,173,"Twelve months later, proliferative T cell responses remained detectable in only six women and the immunodominant antigens remained the E6/2 (14-34) and E6/4 (45-68) peptides.",19843089_3,0,-1,2,-1,10890,-1,3.61126e-05,0.9999397,2.4210818e-05
10892,peptides,5,6,30,38,The latter large fragments of peptides contained many epitopes able to bind to at least seven human leucocyte antigen (HLA) class I molecules and were strong binders to seven HLA-DR class II molecules.,19843089_4,0,-1,2,-1,10892,-1,0.0009431018,0.9985876,0.00046931647
10912,the Treg,21,23,142,150,"Although therapeutic strategies have been proposed to deplete Tregs in patients with breast cancer and other malignancies, dynamic changes in the Treg compartment as a function of stage and treatment of breast cancer remain poorly understood.",19855964_1,-1,-1,-1,-1,10912,-1,6.2989607e-06,0.999987,6.733905e-06
10913,function,26,27,168,176,"Although therapeutic strategies have been proposed to deplete Tregs in patients with breast cancer and other malignancies, dynamic changes in the Treg compartment as a function of stage and treatment of breast cancer remain poorly understood.",19855964_1,0,1,2,-1,10913,-1,4.460687e-05,0.9999211,3.425618e-05
10915,blood,5,6,30,35,"Here, we evaluated peripheral blood CD4(+) T cells and FoxP3(+) CD4(+) T cells from 45 patients with early or late stage breast cancer and compared percentages, absolute counts, and Treg function to those from healthy volunteers (HV) of comparable age.",19855964_2,0,1,-1,-1,10915,-1,0.00013242109,0.9996146,0.0002529149
10919,Treg function to those,35,39,182,204,"Here, we evaluated peripheral blood CD4(+) T cells and FoxP3(+) CD4(+) T cells from 45 patients with early or late stage breast cancer and compared percentages, absolute counts, and Treg function to those from healthy volunteers (HV) of comparable age.",19855964_2,-1,-1,-1,-1,10919,-1,1.2306545e-05,0.99997103,1.6637343e-05
10926,Functionally,0,1,0,12,"Functionally, FoxP3(+) CD4(+) T cells from all donor groups similarly expressed CTLA-4 and failed to secrete IFN-gamma in response to stimulation.",19855964_5,0,1,2,-1,10926,-1,8.809835e-06,0.9999857,5.499978e-06
10941,treatment status,49,51,311,327,"Thus, although Tregs comprise an increased percentage of circulating CD4(+) T cells in patients with metastatic breast cancer and patients in remission after completing the adjuvant chemotherapy, the systemic Treg pool, as measured by absolute counts, appears relatively constant regardless of disease stage or treatment status.",19855964_6,-1,-1,-1,-1,10941,-1,8.633474e-06,0.9999856,5.8118717e-06
10950,to play,12,14,53,60,CD25+ FOXP3+CD4+ T cells (Treg) have been considered to play an important role in immune tolerance against several tumor antigens.,19902430_0,-1,-1,-1,-1,10950,-1,5.946228e-06,0.9999881,6.0187253e-06
10952,tumor antigens,22,24,115,129,CD25+ FOXP3+CD4+ T cells (Treg) have been considered to play an important role in immune tolerance against several tumor antigens.,19902430_0,-1,-1,-1,-1,10952,-1,0.5508767,0.44553363,0.0035897305
10959,time that,7,9,30,39,"Here, we showed for the first time that vascular endothelial growth factor receptor 2 (VEGFR2) is selectively expressed by FOXP3high but not FOXP3low Treg.",19902430_2,-1,-1,-1,-1,10959,-1,4.254506e-06,0.9999913,4.436475e-06
10960,growth factor receptor,11,14,61,83,"Here, we showed for the first time that vascular endothelial growth factor receptor 2 (VEGFR2) is selectively expressed by FOXP3high but not FOXP3low Treg.",19902430_2,-1,-1,-1,-1,10960,-1,0.99304813,5.570813e-05,0.006896141
10962,FOXP3low Treg,25,27,141,154,"Here, we showed for the first time that vascular endothelial growth factor receptor 2 (VEGFR2) is selectively expressed by FOXP3high but not FOXP3low Treg.",19902430_2,-1,-1,-1,-1,10962,-1,8.16782e-06,0.99998546,6.327152e-06
10964,tissues,7,8,35,42,Such VEGFR2+ Treg exist in several tissues including PBMC and malignant effusion-derived lymphocytes.,19902430_3,-1,1,2,-1,10964,-1,6.2374485e-05,0.99686325,0.0030743973
10968,function,15,16,89,97,"In conclusion, VEGFR2 may be a novel target for controlling Treg with highly suppressive function.",19902430_4,0,1,2,-1,10968,-1,1.0732016e-05,0.9999796,9.683315e-06
10973,T-suppressor cells,23,25,143,161,Tumor-resident CD8(+) T cells display a quiescent effector/memory phenotype that is maintained in part by infiltrating CD4(+) CD25(+) Foxp3(+) T-suppressor cells.,19923444_0,-1,-1,-1,-1,10973,-1,0.0010919197,0.068780385,0.93012774
10975,function to tumor-associated,11,14,67,95,"Intratumoral delivery of IL-12, in contrast, can restore cytotoxic function to tumor-associated CD8(+) T cells and induce the apoptotic death of T-suppressor cells.",19923444_1,-1,-1,-1,-1,10975,-1,0.0002136047,0.9993309,0.00045558007
10978,T-suppressor cells,24,26,145,163,"Intratumoral delivery of IL-12, in contrast, can restore cytotoxic function to tumor-associated CD8(+) T cells and induce the apoptotic death of T-suppressor cells.",19923444_1,-1,-1,-1,-1,10978,-1,0.00035705764,0.019421194,0.9802217
10981,IL-12 treatment,9,11,47,62,Depletion of CD8(+) T cells from tumors before IL-12 treatment resulted in the abrogation of treatment-mediated T-suppressor cell apoptosis revealing a link between CD8(+) T cell activation and T-suppressor elimination.,19923444_2,-1,-1,-1,-1,10981,-1,0.99951553,0.00024674227,0.000237728
10983,treatment-mediated T-suppressor cell,16,19,93,129,Depletion of CD8(+) T cells from tumors before IL-12 treatment resulted in the abrogation of treatment-mediated T-suppressor cell apoptosis revealing a link between CD8(+) T cell activation and T-suppressor elimination.,19923444_2,-1,-1,-1,-1,10983,-1,0.0022637958,0.88431823,0.11341801
10988,T-suppressor cell,6,8,36,53,"Furthermore, IL-12 failed to induce T-suppressor cell loss in IFN-gamma- or FasL-deficient mice demonstrating a requirement for IFN-gamma and FasL in this process.",19923444_3,-1,-1,-1,-1,10988,-1,0.0007060835,0.09425155,0.9050423
10993,T cells to,6,9,38,48,Adoptive transfer of wild-type CD8(+) T cells to FasL-knockout mice restored posttherapy T-suppressor cell elimination from tumors establishing that expression of FasL on CD8(+) T cells was sufficient to promote T-suppressor cell death.,19923444_4,-1,-1,-1,-1,10993,-1,0.0020285917,0.072952695,0.9250188
10994,T-suppressor cell,13,15,89,106,Adoptive transfer of wild-type CD8(+) T cells to FasL-knockout mice restored posttherapy T-suppressor cell elimination from tumors establishing that expression of FasL on CD8(+) T cells was sufficient to promote T-suppressor cell death.,19923444_4,-1,-1,-1,-1,10994,-1,0.002117303,0.306066,0.6918167
10999,T-suppressor cell,32,34,212,229,Adoptive transfer of wild-type CD8(+) T cells to FasL-knockout mice restored posttherapy T-suppressor cell elimination from tumors establishing that expression of FasL on CD8(+) T cells was sufficient to promote T-suppressor cell death.,19923444_4,-1,-1,-1,-1,10999,-1,0.0018624885,0.2807289,0.71740854
11007,T-suppressor cell,9,11,54,71,Adoptive transfer of wild-type CD8(+) T cells induced T-suppressor cell death in IFN-gamma-knockout mice confirming that autocrine IFN-gamma was sufficient for CD8(+) T cell FasL expression.,19923444_6,-1,-1,-1,-1,11007,-1,0.00059961836,0.04793531,0.9514651
11037,their Treg cell,8,11,56,71,Patients treated with both IFN-alpha and IL-2 increased their Treg cell levels during the first 2 weeks after initiation of treatment.,19929575_3,-1,-1,-1,-1,11037,-1,0.001451903,0.109435074,0.8891131
11042,treatment than,30,32,152,166,"Patients who derived complete response (CR), partial response (PR), or stable disease (SD) from IFN-alpha monotherapy had lower Treg cell levels before treatment than did patients whose disease progressed.",19929575_4,-1,-1,-1,-1,11042,-1,5.0574436e-06,0.99998987,5.1320044e-06
11049,T-cell,2,3,15,21,"Involvement of T-cell responses has been suggested, but pancreatitis-specific T cells have not been described.",19931255_1,-1,1,2,-1,11049,-1,1.7390115e-05,7.92165e-06,0.9999747
11051,T-cell,4,5,26,32,"METHODS: We characterized T-cell responses against pancreatitis, pancreatic carcinoma-associated antigens, and tetanus toxoid in the bone marrow, blood, and/or pancreatitis lesions of patients with pancreatitis, pancreatic cancer, and healthy individuals.",19931255_2,-1,1,2,-1,11051,-1,2.1947802e-05,1.117142e-05,0.99996686
11053,tetanus toxoid,14,16,111,125,"METHODS: We characterized T-cell responses against pancreatitis, pancreatic carcinoma-associated antigens, and tetanus toxoid in the bone marrow, blood, and/or pancreatitis lesions of patients with pancreatitis, pancreatic cancer, and healthy individuals.",19931255_2,-1,-1,-1,-1,11053,-1,0.0049160644,0.99488384,0.0002000763
11055,blood,21,22,146,151,"METHODS: We characterized T-cell responses against pancreatitis, pancreatic carcinoma-associated antigens, and tetanus toxoid in the bone marrow, blood, and/or pancreatitis lesions of patients with pancreatitis, pancreatic cancer, and healthy individuals.",19931255_2,0,1,-1,-1,11055,-1,0.000259318,0.99908245,0.0006582063
11057,functionally,3,4,13,25,"T cells were functionally characterized by antigen-dependent secretion of interferon (IFN)-gamma, interleukin (Il)-4, and IL-10, which indicate type 1, type 2, or regulatory T-cell responses, respectively.",19931255_3,0,1,2,-1,11057,-1,3.8956554e-05,0.99993825,2.2776921e-05
11074,T cell-derived cytokines,0,3,0,24,T cell-derived cytokines in tissue lesions were quantified by enzyme-linked immunosorbent assay.,19931255_6,-1,-1,-1,-1,11074,-1,0.05976962,0.000724369,0.93950593
11075,tissue,4,5,28,34,T cell-derived cytokines in tissue lesions were quantified by enzyme-linked immunosorbent assay.,19931255_6,-1,1,2,-1,11075,-1,2.0593076e-05,0.9999478,3.1649262e-05
11078,T-cell,16,17,115,121,"RESULTS: Chronic pancreatitis patients showed similar to pancreatic cancer patients and healthy individuals type 1 T-cell responses against tetanus toxoid; however, they exhibited strong IL-10-based T-cell responses against pancreatitis-associated but not pancreatic carcinoma-associated antigens.",19931255_7,-1,1,2,-1,11078,-1,2.336607e-05,8.127542e-06,0.9999685
11079,tetanus toxoid,19,21,140,154,"RESULTS: Chronic pancreatitis patients showed similar to pancreatic cancer patients and healthy individuals type 1 T-cell responses against tetanus toxoid; however, they exhibited strong IL-10-based T-cell responses against pancreatitis-associated but not pancreatic carcinoma-associated antigens.",19931255_7,-1,-1,-1,-1,11079,-1,0.006063871,0.9937482,0.00018795472
11081,IL-10-based T-cell,27,29,187,205,"RESULTS: Chronic pancreatitis patients showed similar to pancreatic cancer patients and healthy individuals type 1 T-cell responses against tetanus toxoid; however, they exhibited strong IL-10-based T-cell responses against pancreatitis-associated but not pancreatic carcinoma-associated antigens.",19931255_7,-1,-1,-1,-1,11081,-1,0.945729,0.0001893314,0.054081645
11090,the blood,16,18,127,136,"Pancreatitis-specific IL-10 responses were mediated by IL-10(+)IFN-gamma(-)FoxP3(+) regulatory T cells, which were expanded in the blood, bone marrow, and pancreatitis lesions and possessed the potential to suppress the proliferation of autologous conventional T cells in an antigen-specific manner.",19931255_9,-1,-1,-1,-1,11090,-1,2.2548438e-05,0.99994814,2.9357794e-05
11101,tumor cell,10,12,90,100,Mitigation of regulatory T cell-mediated immunosuppression and elicitation of immunogenic tumor cell death are crucial events for optimal anti-tumor immune activity in vivo.,19940990_0,-1,-1,-1,-1,11101,-1,0.0007776999,0.024001872,0.9752204
11107,these two,32,34,176,185,"This study was designed to investigate the potential synergistic activity of the combined use of cyclophosphamide (CP) and doxorubicin (DR), both of which are known to resolve these two issues.",19940990_1,-1,-1,-1,-1,11107,-1,1.8220933e-05,0.99997294,8.8046e-06
11111,the tumor,36,38,220,229,BALB/c mice were inoculated subcutaneously with CT-26 carcinoma cells in the bilateral flank and treated with an intraperitoneal injection of a low dose of CP followed by an intratumoral injection of DR into one side of the tumor.,19940990_2,-1,-1,-1,-1,11111,-1,4.1033522e-06,0.9999907,5.214606e-06
11115,the tumor,17,19,92,101,"We found that, in addition to a significant suppression of growth on the DR-treated side of the tumor, combination therapy suppressed the growth of DR-untreated remote tumors in both tumor-specific and T cell-dependent manners.",19940990_3,-1,-1,-1,-1,11115,-1,3.9282104e-06,0.9999896,6.50005e-06
11116,therapy,21,22,115,122,"We found that, in addition to a significant suppression of growth on the DR-treated side of the tumor, combination therapy suppressed the growth of DR-untreated remote tumors in both tumor-specific and T cell-dependent manners.",19940990_3,0,1,-1,-1,11116,-1,4.23086e-06,0.9999913,4.4983276e-06
11122,therapy,1,2,12,19,Combination therapy increased the frequency of interferon (IFN)-gamma-producing T lymphocytes specific to a CT-26-associated class I-binding tumor peptide in the tumor-draining lymph nodes.,19940990_5,0,1,-1,-1,11122,-1,4.472975e-06,0.9999908,4.6697005e-06
11127,tumor peptide,16,18,141,154,Combination therapy increased the frequency of interferon (IFN)-gamma-producing T lymphocytes specific to a CT-26-associated class I-binding tumor peptide in the tumor-draining lymph nodes.,19940990_5,-1,-1,-1,-1,11127,-1,3.485312e-05,0.99994874,1.6447944e-05
11128,the tumor-draining,19,21,158,176,Combination therapy increased the frequency of interferon (IFN)-gamma-producing T lymphocytes specific to a CT-26-associated class I-binding tumor peptide in the tumor-draining lymph nodes.,19940990_5,-1,-1,-1,-1,11128,-1,3.0336983e-05,0.9999503,1.9366753e-05
11129,analysis,2,3,14,22,"Real-time PCR analysis revealed that combination therapy led to an increase in IFN-gamma and tumor necrosis factor-alpha mRNA expression; however, levels of Foxp3 and transforming growth factor-beta within the remote tumor tissues were decreased.",19940990_6,0,1,-1,-1,11129,-1,5.493835e-06,0.9999877,6.7795636e-06
11131,therapy,6,7,49,56,"Real-time PCR analysis revealed that combination therapy led to an increase in IFN-gamma and tumor necrosis factor-alpha mRNA expression; however, levels of Foxp3 and transforming growth factor-beta within the remote tumor tissues were decreased.",19940990_6,0,1,-1,-1,11131,-1,4.868876e-06,0.99998987,5.295154e-06
11138,tumor tissues,32,34,217,230,"Real-time PCR analysis revealed that combination therapy led to an increase in IFN-gamma and tumor necrosis factor-alpha mRNA expression; however, levels of Foxp3 and transforming growth factor-beta within the remote tumor tissues were decreased.",19940990_6,-1,-1,-1,-1,11138,-1,1.8213304e-05,0.99981743,0.0001644178
11149,immunity,23,24,127,135,It has been reported that an increased population of regulatory T cells (T-regs) is one of the reasons for impaired anti-tumor immunity.,20002703_0,0,-1,2,-1,11149,-1,0.9996884,0.00012196671,0.00018968055
11153,tumor-infiltrating lymphocytes,9,11,52,82,We investigated the frequency of Foxp3(+) T-regs in tumor-infiltrating lymphocytes (TILs) and peripheral blood lymphocytes (PBLs) of patients with esophageal squamous cell carcinoma (ESCC).,20002703_1,-1,-1,-1,-1,11153,-1,0.0026559767,0.7622088,0.23513523
11155,blood lymphocytes,16,18,105,122,We investigated the frequency of Foxp3(+) T-regs in tumor-infiltrating lymphocytes (TILs) and peripheral blood lymphocytes (PBLs) of patients with esophageal squamous cell carcinoma (ESCC).,20002703_1,-1,-1,-1,-1,11155,-1,2.6381944e-05,1.8678364e-05,0.99995494
11161,the relationship,16,18,105,121,"Furthermore, in order to elucidate the mechanisms behind T-regs accumulation within tumors, we evaluated the relationship between CCL17 or CCL22 expression and the frequency of Foxp3(+) T-regs.",20002703_2,-1,-1,-1,-1,11161,-1,6.9537987e-06,0.9999887,4.332478e-06
11162,CCL17,19,20,130,135,"Furthermore, in order to elucidate the mechanisms behind T-regs accumulation within tumors, we evaluated the relationship between CCL17 or CCL22 expression and the frequency of Foxp3(+) T-regs.",20002703_2,0,-1,2,-1,11162,-1,0.99970067,2.4129942e-05,0.0002752974
11170,CCL17(+,3,4,17,24,The frequency of CCL17(+) or CCL22(+) cells among CD14(+) cells in tumors was also evaluated by flow cytometry.,20002703_4,0,-1,2,-1,11170,-1,0.9983907,0.00012226915,0.0014871707
11177,CCL17,18,19,102,107,"Moreover, an in vitro migration assay using T-regs derived from ESCC was performed in the presence of CCL17 or CCL22.",20002703_5,0,-1,2,-1,11177,-1,0.9997485,2.2378956e-05,0.00022906347
11183,than that,11,13,66,75,"The frequency of Foxp3(+) T-regs in TILs was significantly higher than that in the normal esophageal mucosa (24.6 +/- 10.0 vs 7.1 +/- 5.9%, P < 0.01).",20002703_6,-1,-1,-1,-1,11183,-1,6.2241297e-06,0.9999875,6.2722343e-06
11188,than that,14,16,83,92,"The frequency of Foxp3(+) T-regs in PBLs of ESCC patients was significantly higher than that in normal healthy donors (7.0 +/- 4.2 vs 2.5 +/- 1.0%, P < 0.01).",20002703_7,-1,-1,-1,-1,11188,-1,6.822215e-06,0.9999869,6.2437452e-06
11190,CCL17(+,5,6,30,37,"Furthermore, the frequency of CCL17(+) or CCL22(+) cells among CD14(+) cells within tumors was significantly higher than that of normal esophageal mucosa, and there was a significant correlation between the frequency of CCL17(+) or CCL22(+) cells and Foxp3(+) T-regs in TILs.",20002703_8,0,-1,2,-1,11190,-1,0.99763656,0.00016874215,0.0021947313
11195,than that,20,22,116,125,"Furthermore, the frequency of CCL17(+) or CCL22(+) cells among CD14(+) cells within tumors was significantly higher than that of normal esophageal mucosa, and there was a significant correlation between the frequency of CCL17(+) or CCL22(+) cells and Foxp3(+) T-regs in TILs.",20002703_8,-1,-1,-1,-1,11195,-1,5.992249e-06,0.9999883,5.6746085e-06
11198,CCL17(+,37,38,220,227,"Furthermore, the frequency of CCL17(+) or CCL22(+) cells among CD14(+) cells within tumors was significantly higher than that of normal esophageal mucosa, and there was a significant correlation between the frequency of CCL17(+) or CCL22(+) cells and Foxp3(+) T-regs in TILs.",20002703_8,0,-1,2,-1,11198,-1,0.9979996,0.00015099798,0.0018493646
11205,that T-regs,9,11,52,63,"In addition, the in vitro migration assay indicated that T-regs were significantly induced to migrate by CCL17 or CCL22.",20002703_9,-1,-1,-1,-1,11205,-1,8.533908e-06,0.9999808,1.0678745e-05
11207,CCL17,17,18,105,110,"In addition, the in vitro migration assay indicated that T-regs were significantly induced to migrate by CCL17 or CCL22.",20002703_9,0,-1,2,-1,11207,-1,0.9997044,2.614693e-05,0.00026943974
11209,CCL17,3,4,15,20,"In conclusion, CCL17 and CCL22 within the tumor are related to the increased population of Foxp3(+) T-regs in ESCC.",20002703_10,0,-1,2,-1,11209,-1,0.9991585,5.0556086e-05,0.0007909868
11211,the tumor,7,9,38,47,"In conclusion, CCL17 and CCL22 within the tumor are related to the increased population of Foxp3(+) T-regs in ESCC.",20002703_10,-1,-1,-1,-1,11211,-1,3.913643e-06,0.9999907,5.384786e-06
11212,related to the,10,13,52,66,"In conclusion, CCL17 and CCL22 within the tumor are related to the increased population of Foxp3(+) T-regs in ESCC.",20002703_10,-1,-1,-1,-1,11212,-1,6.7116384e-06,0.99998796,5.302876e-06
11219,that regulatory T cells,3,7,18,41,Our hypothesis is that regulatory T cells (Tregs) are important to obstruct antitumor immune responses in patients with OSCC.,20012605_2,-1,-1,-1,-1,11219,-1,0.0015948806,0.07334352,0.9250615
11226,blood,17,18,91,96,"In the present study, we investigated the frequency, phenotype, and activity of Tregs from blood and lesions of patients with OSCC.",20012605_3,0,1,-1,-1,11226,-1,0.00063198654,0.99787843,0.0014895514
11231,these cells,2,4,6,17,"Also, these cells express surface Treg markers, such as GITR, CD45RO, CD69, LAP, CTLA-4, CCR4, and IL-10.",20012605_5,-1,-1,-1,-1,11231,-1,1.441648e-05,1.1294159e-05,0.99997425
11241,these cells,20,22,115,126,"Interestingly, approximately 25% of CD4(+)CD25(-) T cells of PBMC from patients also expressed FoxP3 and, although these cells weakly suppress allogeneic T cells proliferative response, they inhibited IFN-gamma and induced IL-10 and TGF-beta secretion in these co-cultures.",20012605_7,-1,-1,-1,-1,11241,-1,1.6629141e-05,1.24294365e-05,0.99997103
11246,TGF-beta,37,38,233,241,"Interestingly, approximately 25% of CD4(+)CD25(-) T cells of PBMC from patients also expressed FoxP3 and, although these cells weakly suppress allogeneic T cells proliferative response, they inhibited IFN-gamma and induced IL-10 and TGF-beta secretion in these co-cultures.",20012605_7,0,1,-1,-1,11246,-1,0.00015928154,0.99982125,1.949141e-05
11249,that Treg cells,5,8,20,35,"Thus, our data show that Treg cells are present in OSCC lesions and PBMC, and these cells appear to suppress immune responses both systemically and in the tumor microenvironment.",20012605_8,-1,-1,-1,-1,11249,-1,0.0016634946,0.11605555,0.882281
11250,these cells,17,19,78,89,"Thus, our data show that Treg cells are present in OSCC lesions and PBMC, and these cells appear to suppress immune responses both systemically and in the tumor microenvironment.",20012605_8,-1,-1,-1,-1,11250,-1,1.6976668e-05,1.6830441e-05,0.99996626
11253,the tumor,28,30,151,160,"Thus, our data show that Treg cells are present in OSCC lesions and PBMC, and these cells appear to suppress immune responses both systemically and in the tumor microenvironment.",20012605_8,-1,-1,-1,-1,11253,-1,3.8686608e-06,0.9999919,4.1984827e-06
11263,the functional,1,3,11,25,"Dissecting the functional subtypes of T cells with multicolor fluorescent microscopy revealed substantial populations of cytotoxic T cells, helper T cells and FoxP3(+) regulatory T cells.",20013807_2,-1,-1,-1,-1,11263,-1,3.579621e-05,0.9999461,1.8103307e-05
11274,Analysis,0,1,0,8,"Analysis of the macrophage population also showed a dominance of anti-inflammatory cells, as the M2 type scavenger receptor CD163 was abundantly present.",20013807_4,0,1,-1,-1,11274,-1,9.198966e-06,0.9999846,6.1207484e-06
11278,type scavenger receptor,16,19,100,123,"Analysis of the macrophage population also showed a dominance of anti-inflammatory cells, as the M2 type scavenger receptor CD163 was abundantly present.",20013807_4,-1,-1,-1,-1,11278,-1,0.005600946,0.9772888,0.017110331
11287,the tyrosine,7,9,44,56,"Most metastatic GISTs had been treated with the tyrosine kinase inhibitors imatinib and sunitinib, but the high macrophage infiltrate was not related to this treatment.",20013807_7,-1,-1,-1,-1,11287,-1,6.131999e-06,0.9999881,5.7302454e-06
11289,related to this treatment,22,26,142,167,"Most metastatic GISTs had been treated with the tyrosine kinase inhibitors imatinib and sunitinib, but the high macrophage infiltrate was not related to this treatment.",20013807_7,-1,-1,-1,-1,11289,-1,1.3853217e-05,0.99997663,9.505889e-06
11291,that treatment,16,18,115,129,"However, imatinib and sunitinib did induce secretion of anti-inflammatory IL-10 in macrophage cultures, indicating that treatment with these inhibitors might contribute to an immune suppressive microenvironment in GIST.",20013807_8,-1,-1,-1,-1,11291,-1,5.9916392e-06,0.9999895,4.5382376e-06
11304,the therapeutic,12,14,68,83,"Here, we studied whether the removal of Treg cells could potentiate the therapeutic efficacy of Neuro2a/IL-21 vaccine.",20039320_2,-1,-1,-1,-1,11304,-1,6.4815613e-06,0.99998975,3.7944303e-06
11306,targets Treg cells,7,10,43,61,"The administration of anti-CD25 mAb, which targets Treg cells, slightly potentiated the effect of vaccine IT (50% cure rate), but anti-CD4 mAb had a more potent effect leading to 80% cure rate.",20039320_3,-1,-1,-1,-1,11306,-1,0.0014884836,0.09784185,0.9006697
11313,immunity to,9,11,65,76,"In mice receiving vaccine+anti-CD4 mAb, which developed systemic immunity to NB, CD4+ T cells counts completely recovered in 90 days.",20039320_5,-1,-1,-1,-1,11313,-1,0.014552825,0.98490995,0.0005372153
11318,these cells,19,21,100,111,"Depletion of CD8+ T cells abrogated the effect of the combined IT, indicating a predominant role of these cells in driving the immune response.",20039320_6,-1,-1,-1,-1,11318,-1,1.3493576e-05,8.391131e-06,0.9999782
11319,the immune response,23,26,123,142,"Depletion of CD8+ T cells abrogated the effect of the combined IT, indicating a predominant role of these cells in driving the immune response.",20039320_6,-1,-1,-1,-1,11319,-1,0.50531334,0.49299872,0.0016879097
11325,therapy,5,6,33,40,"Moreover, mice receiving vaccine therapy alone or vaccine+anti-CD4 mAb showed increased IFN-gamma serum levels and IFN-gamma-producing CD8+ T cells were found in spleen cells.",20039320_9,0,1,-1,-1,11325,-1,7.025901e-06,0.99998724,5.6794747e-06
11331,their precursors,13,15,85,101,"In conclusion, anti-CD4 mAb potentiated IL-21-based IT by removing Treg cells and/or their precursors and other potentially immune-suppressive CD4+ cell subsets, thus allowing the development of an IL-21-driven CD8+ T cell response, which mediates NB rejection.",20039320_10,-1,-1,-1,-1,11331,-1,0.003067739,0.3588994,0.6380329
11332,cell subsets,21,23,148,160,"In conclusion, anti-CD4 mAb potentiated IL-21-based IT by removing Treg cells and/or their precursors and other potentially immune-suppressive CD4+ cell subsets, thus allowing the development of an IL-21-driven CD8+ T cell response, which mediates NB rejection.",20039320_10,-1,-1,-1,-1,11332,-1,1.4079114e-05,8.58493e-06,0.99997735
11345,tumor-infiltrating lymphocytes,8,10,22,52,"CD8+, CD4+ and Foxp3+ tumor-infiltrating lymphocytes, tryptase and chymase mast cells (MCs), CD34, number of microvessels and vascular endothelial growth factor were determined by immunohistochemistry.",20053697_2,-1,-1,-1,-1,11345,-1,0.002840282,0.79182106,0.20533858
11355,the interleukin,13,15,73,88,"Tryptase MCs, CD8+ and Foxp3+ lymphocytes had significantly increased in the interleukin 2 (IL-2) treated group.",20053697_6,-1,-1,-1,-1,11355,-1,0.42679113,0.56715006,0.006058766
11365,the tumoral,22,24,129,140,This study indicates that immunotherapy leads to an increase in cytotoxic CD8+ lymphocytes and tryptase MCs and to a decrease of the tumoral neoangiogenesis.,20053697_8,-1,-1,-1,-1,11365,-1,5.43341e-06,0.9999888,5.7999637e-06
11375,cytokine interleukin,14,16,81,101,We and others have shown direct cytotoxic effect of the novel common gamma chain cytokine interleukin (IL)-21 on primary B cells from CLL patients.,20081380_2,-1,-1,-1,-1,11375,-1,0.99994504,7.311927e-06,4.7657886e-05
11389,receptor,7,8,44,52,We demonstrate here the expression of IL-21 receptor in CD4(+)CD25(High) regulatory cells from CLL patients.,20081380_4,0,1,2,-1,11389,-1,0.035224073,0.13142736,0.8333485
11398,blood,31,32,187,192,"In contrast to IL-2, the IL-21 cytokine failed to mediate expansion of regulatory T cells or induced expression of Foxp3 in CD4(+)CD25(Intermediate) or CD4(+)CD25(Dim/-) T cells in whole blood derived from CLL patients.",20081380_5,0,1,-1,-1,11398,-1,0.0055684526,0.9629924,0.03143906
11399,to their,4,6,27,35,"Interestingly, in contrast to their differential effects on expansion of the CD4(+)CD25(+)Foxp3(+)T cells, IL-2 and IL-21 exhibited a redundant role in Treg mediated suppression of NK cell mediated antibody dependent cytotoxicity function.",20081380_6,-1,-1,-1,-1,11399,-1,4.539763e-06,0.9999908,4.6845357e-06
11401,CD4(+)CD25(+)Foxp3(+)T cells,12,14,77,105,"Interestingly, in contrast to their differential effects on expansion of the CD4(+)CD25(+)Foxp3(+)T cells, IL-2 and IL-21 exhibited a redundant role in Treg mediated suppression of NK cell mediated antibody dependent cytotoxicity function.",20081380_6,-1,-1,-1,-1,11401,-1,7.786326e-05,4.0810715e-05,0.9998814
11404,function,33,34,230,238,"Interestingly, in contrast to their differential effects on expansion of the CD4(+)CD25(+)Foxp3(+)T cells, IL-2 and IL-21 exhibited a redundant role in Treg mediated suppression of NK cell mediated antibody dependent cytotoxicity function.",20081380_6,0,1,2,-1,11404,-1,0.00021344305,0.0003897101,0.9993968
11406,related toxicities,3,5,19,37,"Given the infusion related toxicities and pro-survival effect of IL-2 in CLL, these studies provide a rationale to explore IL-21 as an alternate gamma chain cytokine in CLL therapy.",20081380_7,-1,-1,-1,-1,11406,-1,4.302826e-05,0.9999335,2.3466793e-05
11410,therapy,29,30,173,180,"Given the infusion related toxicities and pro-survival effect of IL-2 in CLL, these studies provide a rationale to explore IL-21 as an alternate gamma chain cytokine in CLL therapy.",20081380_7,0,1,-1,-1,11410,-1,5.4436964e-06,0.9999881,6.462811e-06
11413,the interleukin-1 receptor,7,10,46,72,We report that melanoma cell lines expressing the interleukin-1 receptor exhibit 4- to 10-fold lower levels of mRNA of microphthalmia-associated transcription factor (MITF-M) when treated with interleukin-1beta.,20099279_0,-1,-1,-1,-1,11413,-1,0.509547,0.43552747,0.05492553
11444,IL-1 cytokines,14,16,90,104,We estimate that approximately 13% of melanoma cell lines are MITF-M-negative and secrete IL-1 cytokines.,20099279_5,-1,-1,-1,-1,11444,-1,0.9999602,3.7941518e-06,3.6045178e-05
11446,that the,3,5,23,31,These results indicate that the repression of melanocyte-differentiation genes by IL-1 produced by stromal cells or by tumor cells themselves may represent an additional mechanism of melanoma immune escape.,20099279_6,-1,-1,-1,-1,11446,-1,4.621129e-06,0.9999919,3.4976479e-06
11450,tumor cells themselves,17,20,119,141,These results indicate that the repression of melanocyte-differentiation genes by IL-1 produced by stromal cells or by tumor cells themselves may represent an additional mechanism of melanoma immune escape.,20099279_6,-1,-1,-1,-1,11450,-1,0.0021247282,0.30555028,0.69232506
11451,The functional,0,2,0,14,The functional development of tumor-specific CD4(+) T cells has a critical impact on the outcome of antitumor immune responses.,20118405_0,-1,-1,-1,-1,11451,-1,2.8415237e-05,0.9999589,1.2728553e-05
11459,immunity,5,6,32,40,"To mount an effective antitumor immunity, it is desirable to elicit activated type 1 T helper cells.",20118405_2,0,-1,2,-1,11459,-1,0.9998877,2.791243e-05,8.436069e-05
11463,that type,4,6,16,25,"Here, we report that type 1 T helper cell-like effector cells that arose in tumor-bearing hosts progressively expressed programmed death 1 during tumor growth.",20118405_3,-1,-1,-1,-1,11463,-1,4.3983746e-06,0.99999106,4.5643737e-06
11466,cells that,11,13,56,66,"Here, we report that type 1 T helper cell-like effector cells that arose in tumor-bearing hosts progressively expressed programmed death 1 during tumor growth.",20118405_3,-1,-1,-1,-1,11466,-1,0.0039094426,0.33832046,0.65777004
11471,interleukin-7 receptor,17,19,125,147,"The programmed death 1(hi) effector cells displayed a dysfunctional phenotype, characterized by selective down-regulation of interleukin-7 receptor, heightened apoptosis, and poor antitumor efficacy.",20118405_4,-1,-1,-1,-1,11471,-1,0.99991417,9.38118e-06,7.636382e-05
11472,This tumor-driven,0,2,0,17,This tumor-driven aberrant T-cell response could be prevented by a single dose of the widely used chemotherapy agent cyclophosphamide.,20118405_5,-1,-1,-1,-1,11472,-1,1.0207685e-05,0.99998367,6.1091027e-06
11473,T-cell,3,4,27,33,This tumor-driven aberrant T-cell response could be prevented by a single dose of the widely used chemotherapy agent cyclophosphamide.,20118405_5,-1,1,2,-1,11473,-1,1.8217142e-05,9.0085805e-06,0.9999727
11476,that chemotherapy,2,4,8,25,"We show that chemotherapy conditioned the host environment, creating a transient window for optimal effector differentiation for adoptively transferred CD4(+) T cells.",20118405_6,-1,-1,-1,-1,11476,-1,0.34793213,0.6488634,0.003204552
11483,to type,16,18,120,127,"This robust effector differentiation, which was antigen-driven and mechanistically dependent on an intact host response to type I interferon, gave rise to activated polyfunctional T helper cells with high interleukin-7 receptor, rapid clonal expansion, and potent antitumor activity against established B-cell lymphomas.",20118405_7,-1,-1,-1,-1,11483,-1,1.17762775e-05,0.99997807,1.0186427e-05
11487,interleukin-7 receptor,31,33,205,227,"This robust effector differentiation, which was antigen-driven and mechanistically dependent on an intact host response to type I interferon, gave rise to activated polyfunctional T helper cells with high interleukin-7 receptor, rapid clonal expansion, and potent antitumor activity against established B-cell lymphomas.",20118405_7,-1,-1,-1,-1,11487,-1,0.9978235,4.302362e-05,0.0021334994
11491,to the,14,16,108,114,We hypothesize that prevention of tumor-induced effector cell dysfunction is a major mechanism contributing to the efficacy of combined chemoimmunotherapy.,20118405_8,-1,-1,-1,-1,11491,-1,7.679643e-06,0.99998665,5.653473e-06
11497,TCR,23,24,142,145,"In a basic study of immunotolerance, injection of an endogenous superantigen, i.e. the minor lymphocyte stimulatory (Mls)-1(a), into specific TCR Vbeta8.1-Tg mice enabled generation of anergic CD25(-) iTreg, the immunosuppressive function of which was maintained by IL-10 production via p38-MAPK activation.",20127675_1,-1,1,2,-1,11497,-1,1.2426334e-05,0.9999713,1.632573e-05
11500,function,36,37,230,238,"In a basic study of immunotolerance, injection of an endogenous superantigen, i.e. the minor lymphocyte stimulatory (Mls)-1(a), into specific TCR Vbeta8.1-Tg mice enabled generation of anergic CD25(-) iTreg, the immunosuppressive function of which was maintained by IL-10 production via p38-MAPK activation.",20127675_1,0,1,2,-1,11500,-1,0.00036788025,0.99947315,0.00015895313
11507,Peptide,0,1,0,7,Peptide OVA(323-339) iv.-injection into its specific TCR-Tg (OT-II) mice also induced adaptive tolerance by iTreg.,20127675_3,0,-1,2,-1,11507,-1,0.012804053,0.98632103,0.0008749356
11508,TCR-Tg,9,10,53,59,Peptide OVA(323-339) iv.-injection into its specific TCR-Tg (OT-II) mice also induced adaptive tolerance by iTreg.,20127675_3,-1,1,2,-1,11508,-1,1.3281259e-05,0.9999732,1.3493676e-05
11510,Peptide,0,1,0,7,"Peptide immunotherapy with p38-inhibitor after CD25(+) Treg-depletion was performed in an OVA-expressing lymphoma E.G7-bearing tolerant model established by adoptive transfer of OT-II CD25(-) iTreg, which resulted in suppression of tumor growth.",20127675_4,0,-1,2,-1,11510,-1,0.0005499794,0.9993895,6.0469953e-05
11516,immunity,4,5,25,33,"Similarly, the antitumor immunity induced by peptide immunotherapy in colon carcinoma CT26-bearing mice, in which the number of IL-10-secreting iTreg is increased, was augmented by treatment with p38-inhibitor after CD25(+) Treg-depletion and resulted in inhibition of tumor progression.",20127675_5,0,-1,2,-1,11516,-1,0.9998307,3.388671e-05,0.00013536766
11517,peptide,7,8,45,52,"Similarly, the antitumor immunity induced by peptide immunotherapy in colon carcinoma CT26-bearing mice, in which the number of IL-10-secreting iTreg is increased, was augmented by treatment with p38-inhibitor after CD25(+) Treg-depletion and resulted in inhibition of tumor progression.",20127675_5,0,-1,2,-1,11517,-1,0.3418858,0.6506332,0.0074810116
11527,to the,13,15,99,105,These results suggest that simultaneous inhibition of two distinct Treg-functions may be important to the success of cancer immunotherapy.,20127675_6,-1,-1,-1,-1,11527,-1,1.3790803e-05,0.9999777,8.50774e-06
11528,Tehranolide named,0,2,0,17,Tehranolide named as new type of a sesquiterpene lactone with an endoperoxide group which purified from Artemisia diffusa and having similar structure to Artemisinin.,20138670_0,-1,-1,-1,-1,11528,-1,2.239465e-05,0.99995935,1.8285755e-05
11537,the tumor,11,13,72,81,"In the present research we emphasized on the direct correlation between the tumor sizes, immune response; including cytokin network, T regulatory cells and Tehranolide intraperitoneally injected Tehranolide.",20138670_2,-1,-1,-1,-1,11537,-1,4.746751e-06,0.9999893,6.015203e-06
11548,the immune responses,21,24,120,140,"First we evaluated the effects of Tehranolide on cell growth inhibition (in vitro) by MTT assay and second investigated the immune responses, these include measuring tumor growth in the female Balb/c mice transplanted with spontaneous mouse mammary tumor and treated with Tehranolide, splenocyte proliferation detected by using the BrdU kit, measurement of cytokine profile by ELISA and analysis of T-lymphocytes subpopulation in spleen by Flow cytometry.",20138670_4,-1,-1,-1,-1,11548,-1,0.452173,0.5453935,0.0024335056
11558,analysis,62,63,387,395,"First we evaluated the effects of Tehranolide on cell growth inhibition (in vitro) by MTT assay and second investigated the immune responses, these include measuring tumor growth in the female Balb/c mice transplanted with spontaneous mouse mammary tumor and treated with Tehranolide, splenocyte proliferation detected by using the BrdU kit, measurement of cytokine profile by ELISA and analysis of T-lymphocytes subpopulation in spleen by Flow cytometry.",20138670_4,0,1,-1,-1,11558,-1,6.6989187e-06,0.9999869,6.4571723e-06
11559,T-lymphocytes,64,65,399,412,"First we evaluated the effects of Tehranolide on cell growth inhibition (in vitro) by MTT assay and second investigated the immune responses, these include measuring tumor growth in the female Balb/c mice transplanted with spontaneous mouse mammary tumor and treated with Tehranolide, splenocyte proliferation detected by using the BrdU kit, measurement of cytokine profile by ELISA and analysis of T-lymphocytes subpopulation in spleen by Flow cytometry.",20138670_4,-1,1,2,-1,11559,-1,1.5338672e-05,9.213253e-06,0.99997544
11560,the tumor,10,12,54,63,"Our results showed a significant (p<0.05) decrease in the tumor volume and the level of IL-4 in the animals treated with Tehranolide, compared to untreated group.",20138670_5,-1,-1,-1,-1,11560,-1,4.5135725e-06,0.99998915,6.305628e-06
11566,the lymphocytes,10,12,48,63,"In addition, a significant (p<0.05) increase in the lymphocytes proliferation and the level of IFN-gamma in the animals treated with Tehranolide in comparison with control group.",20138670_6,-1,-1,-1,-1,11566,-1,5.9845763e-05,0.00042281477,0.9995173
11572,the regulatory T cells,4,8,25,47,"Furthermore, we regulate the regulatory T cells in order to improve the outcome of cancer immunotherapy.",20138670_7,-1,-1,-1,-1,11572,-1,0.0015160015,0.09232768,0.9061563
11577,that Tehranolide,9,11,73,89,The measurement of splenic CD4(+)CD25(+)Foxp3(+) T lymphocytes indicated that Tehranolide significantly (p<0.05) decreased the number of these lymphocytes.,20138670_8,-1,-1,-1,-1,11577,-1,1.405195e-05,0.99997437,1.1553682e-05
11579,these lymphocytes,19,21,137,154,The measurement of splenic CD4(+)CD25(+)Foxp3(+) T lymphocytes indicated that Tehranolide significantly (p<0.05) decreased the number of these lymphocytes.,20138670_8,-1,-1,-1,-1,11579,-1,1.9216895e-05,1.3757605e-05,0.9999671
11581,that the,3,5,20,28,These findings show that the use of Tehranolide molecule represents a novel strategy with major suggestions for cancer therapy approaches.,20138670_9,-1,-1,-1,-1,11581,-1,4.038201e-06,0.99999225,3.7252385e-06
11583,therapy,18,19,119,126,These findings show that the use of Tehranolide molecule represents a novel strategy with major suggestions for cancer therapy approaches.,20138670_9,0,1,-1,-1,11583,-1,5.80429e-06,0.9999877,6.4430055e-06
11584,to treat,4,6,35,43,"Antiestrogens are universally used to treat estrogen receptor--positive breast cancer, but relapses occur commonly due to the development of drug resistance.",20145137_0,-1,-1,-1,-1,11584,-1,8.160675e-06,0.99998665,5.1457055e-06
11585,receptor,7,8,53,61,"Antiestrogens are universally used to treat estrogen receptor--positive breast cancer, but relapses occur commonly due to the development of drug resistance.",20145137_0,0,1,2,-1,11585,-1,0.02325508,0.5473005,0.42944443
11587,to the,18,20,119,125,"Antiestrogens are universally used to treat estrogen receptor--positive breast cancer, but relapses occur commonly due to the development of drug resistance.",20145137_0,-1,-1,-1,-1,11587,-1,5.590486e-06,0.99999046,3.971105e-06
11591,TGFbeta,11,12,71,78,"The ability of antiestrogen to induce transforming growth factor beta (TGFbeta) in breast cancer cells may be relevant to the emergence of resistance, not only at the level of cell autonomous effects of TGFbeta on cancer progression but also at the level of its effects on the host immune system.",20145137_1,0,1,-1,-1,11591,-1,0.0011254634,0.9988134,6.121546e-05
11593,relevant to the,19,22,110,125,"The ability of antiestrogen to induce transforming growth factor beta (TGFbeta) in breast cancer cells may be relevant to the emergence of resistance, not only at the level of cell autonomous effects of TGFbeta on cancer progression but also at the level of its effects on the host immune system.",20145137_1,-1,-1,-1,-1,11593,-1,6.429777e-06,0.9999876,5.965201e-06
11596,TGFbeta,36,37,203,210,"The ability of antiestrogen to induce transforming growth factor beta (TGFbeta) in breast cancer cells may be relevant to the emergence of resistance, not only at the level of cell autonomous effects of TGFbeta on cancer progression but also at the level of its effects on the host immune system.",20145137_1,0,1,-1,-1,11596,-1,0.0004785051,0.9994808,4.068224e-05
11602,TGFbeta,9,10,70,77,"To evaluate the potential role of tumor-derived, antiestrogen-induced TGFbeta as an immune suppressor, we established in vitro mixed lymphocyte tumor reactions (MLTR) using MCF-7 cells and peripheral blood mononuclear cells (PBMC), as well as tumor tissue and autologous tumor infiltrating lymphocytes (TIL) obtained from primary breast cancer biopsies.",20145137_2,0,1,-1,-1,11602,-1,0.00011191926,0.9998691,1.899345e-05
11603,lymphocyte tumor,20,22,133,149,"To evaluate the potential role of tumor-derived, antiestrogen-induced TGFbeta as an immune suppressor, we established in vitro mixed lymphocyte tumor reactions (MLTR) using MCF-7 cells and peripheral blood mononuclear cells (PBMC), as well as tumor tissue and autologous tumor infiltrating lymphocytes (TIL) obtained from primary breast cancer biopsies.",20145137_2,-1,-1,-1,-1,11603,-1,0.0027591877,0.1783596,0.8188813
11604,MCF-7 cells,27,29,173,184,"To evaluate the potential role of tumor-derived, antiestrogen-induced TGFbeta as an immune suppressor, we established in vitro mixed lymphocyte tumor reactions (MLTR) using MCF-7 cells and peripheral blood mononuclear cells (PBMC), as well as tumor tissue and autologous tumor infiltrating lymphocytes (TIL) obtained from primary breast cancer biopsies.",20145137_2,-1,-1,-1,-1,11604,-1,0.8990323,0.0011097158,0.09985802
11605,blood,31,32,200,205,"To evaluate the potential role of tumor-derived, antiestrogen-induced TGFbeta as an immune suppressor, we established in vitro mixed lymphocyte tumor reactions (MLTR) using MCF-7 cells and peripheral blood mononuclear cells (PBMC), as well as tumor tissue and autologous tumor infiltrating lymphocytes (TIL) obtained from primary breast cancer biopsies.",20145137_2,0,1,-1,-1,11605,-1,0.0039269747,0.98164773,0.014425227
11607,tumor tissue,41,43,243,255,"To evaluate the potential role of tumor-derived, antiestrogen-induced TGFbeta as an immune suppressor, we established in vitro mixed lymphocyte tumor reactions (MLTR) using MCF-7 cells and peripheral blood mononuclear cells (PBMC), as well as tumor tissue and autologous tumor infiltrating lymphocytes (TIL) obtained from primary breast cancer biopsies.",20145137_2,-1,-1,-1,-1,11607,-1,6.8244067e-06,0.9999838,9.386039e-06
11611,MCF-7 cells,5,7,41,52,"In allogeneic MLTR, antiestrogen-treated MCF-7 cells caused downregulation of the effector molecules granzyme B, perforin, and Fas ligand in CD8(+) T cells, and suppressed the generation of cytotoxic effector cells in a TGFbeta-dependent manner.",20145137_3,-1,-1,-1,-1,11611,-1,0.768808,0.0020086612,0.22918329
11614,the generation,29,31,172,186,"In allogeneic MLTR, antiestrogen-treated MCF-7 cells caused downregulation of the effector molecules granzyme B, perforin, and Fas ligand in CD8(+) T cells, and suppressed the generation of cytotoxic effector cells in a TGFbeta-dependent manner.",20145137_3,-1,-1,-1,-1,11614,-1,5.9581707e-06,0.9999889,5.144074e-06
11616,TGFbeta-dependent,37,38,220,237,"In allogeneic MLTR, antiestrogen-treated MCF-7 cells caused downregulation of the effector molecules granzyme B, perforin, and Fas ligand in CD8(+) T cells, and suppressed the generation of cytotoxic effector cells in a TGFbeta-dependent manner.",20145137_3,0,1,-1,-1,11616,-1,4.6716155e-05,0.9999311,2.2209322e-05
11625,tumor cells,20,22,132,143,"In autologous MLTR, antiestrogen treatment gave rise to enhanced Foxp3 expression of TIL/PBMC and decreased the number of apoptotic tumor cells.",20145137_5,-1,-1,-1,-1,11625,-1,0.00029574052,0.0039677513,0.9957366
11627,TGFbeta,8,9,45,52,These effects were reversed by addition of a TGFbeta neutralizing antibody.,20145137_6,0,1,-1,-1,11627,-1,0.0009373888,0.9990097,5.2845262e-05
11629,the tumor,9,11,75,84,"Our findings offer evidence that antiestrogen induces immunosuppression in the tumor microenvironment, through a TGFbeta-dependent mechanism that may contribute to the development of antiestrogen resistance in breast cancer.",20145137_7,-1,-1,-1,-1,11629,-1,4.426268e-06,0.99999094,4.5810148e-06
11631,TGFbeta-dependent,15,16,113,130,"Our findings offer evidence that antiestrogen induces immunosuppression in the tumor microenvironment, through a TGFbeta-dependent mechanism that may contribute to the development of antiestrogen resistance in breast cancer.",20145137_7,0,1,-1,-1,11631,-1,5.8500595e-05,0.9999157,2.5784915e-05
11633,to the,20,22,161,167,"Our findings offer evidence that antiestrogen induces immunosuppression in the tumor microenvironment, through a TGFbeta-dependent mechanism that may contribute to the development of antiestrogen resistance in breast cancer.",20145137_7,-1,-1,-1,-1,11633,-1,5.19567e-06,0.99999,4.8172305e-06
11635,T-cell,4,5,33,39,We generated an adenovirus-based T-cell vaccine (Ad-p14) that reliably elicits T-cell responses to human papillomavirus (HPV) oncogenes of the 2 most common high-risk HPV serotypes.,20145549_0,-1,1,2,-1,11635,-1,2.8398783e-05,1.5887885e-05,0.9999558
11636,that reliably,9,11,57,70,We generated an adenovirus-based T-cell vaccine (Ad-p14) that reliably elicits T-cell responses to human papillomavirus (HPV) oncogenes of the 2 most common high-risk HPV serotypes.,20145549_0,-1,-1,-1,-1,11636,-1,6.4026094e-06,0.9999888,4.7669996e-06
11637,T-cell,12,13,79,85,We generated an adenovirus-based T-cell vaccine (Ad-p14) that reliably elicits T-cell responses to human papillomavirus (HPV) oncogenes of the 2 most common high-risk HPV serotypes.,20145549_0,-1,1,2,-1,11637,-1,1.8642577e-05,8.347771e-06,0.99997306
11647,the relevant T-cell,13,16,87,106,"Although ensuring maximal biologic safety, the construct includes approximately 70% of the relevant T-cell epitopes.",20145549_2,-1,-1,-1,-1,11647,-1,0.003012408,0.5832276,0.41376004
11657,the therapeutic,3,5,19,34,"To further improve the therapeutic effect, vaccination was combined with systemic application of imiquimod, anti-CD4, alpha-interferon, or anti-GITR.",20145549_5,-1,-1,-1,-1,11657,-1,4.9368614e-06,0.9999912,3.9180777e-06
11658,the therapeutic,4,6,42,57,"Although adding alpha-interferon improved the therapeutic potential of Ad-p14 by 40%, the combination with anti-GITR resulted in complete and permanent eradication of all TC1 tumors.",20145549_6,-1,-1,-1,-1,11658,-1,5.227476e-06,0.99999046,4.3104865e-06
11660,TC1 tumors,25,27,171,181,"Although adding alpha-interferon improved the therapeutic potential of Ad-p14 by 40%, the combination with anti-GITR resulted in complete and permanent eradication of all TC1 tumors.",20145549_6,-1,-1,-1,-1,11660,-1,7.3467218e-06,0.9999764,1.6276192e-05
11663,immune response modifiers,14,17,88,113,"Ad-p14 has clinical potential for treating HPV-induced lesions, and the added effect of immune response modifiers stresses the importance of combined protocols for immunotherapy of malignant tumors.",20145549_7,-1,-1,-1,-1,11663,-1,0.99974245,7.843716e-05,0.00017910884
11681,the analysis,6,8,25,37,The aim of this study is the analysis of tumor immune escape mechanisms in a colorectal liver metastases mouse model at different points in time during tumor growth.,20205946_2,-1,-1,-1,-1,11681,-1,4.980871e-06,0.9999902,4.8229404e-06
11683,in time,23,25,137,144,The aim of this study is the analysis of tumor immune escape mechanisms in a colorectal liver metastases mouse model at different points in time during tumor growth.,20205946_2,-1,-1,-1,-1,11683,-1,1.914279e-05,0.9999609,1.9941013e-05
11689,in time,15,17,104,111,Metastatic tumor growth in the liver was examined by standard histological procedures at defined points in time during metastatic growth.,20205946_4,-1,-1,-1,-1,11689,-1,3.9715793e-05,0.999933,2.721932e-05
11690,tissue,1,2,6,12,"Liver tissue with metastases was additionally analyzed for cytokines, T cell markers and Fas/Fas-L expression using immunohistochemistry, immunofluorescence and RT-PCR.",20205946_5,-1,1,2,-1,11690,-1,0.00024456973,0.99766845,0.0020869907
11693,analysis,4,5,30,38,Comparisons were performed by analysis of variance or paired and unpaired t test when appropriate.,20205946_6,0,1,-1,-1,11693,-1,3.3572815e-05,0.9999486,1.7826782e-05
11694,t test,11,13,74,80,Comparisons were performed by analysis of variance or paired and unpaired t test when appropriate.,20205946_6,-1,-1,-1,-1,11694,-1,1.8266412e-05,0.9999682,1.3606057e-05
11701,tissue,23,24,141,147,T cells of regulatory phenotype (CD4+CD25+Foxp3+) which might play a role in protumoral immune response were found to infiltrate peritumoral tissue increasingly during carcinogenesis.,20205946_8,-1,1,2,-1,11701,-1,1.4951211e-05,0.99990416,8.088871e-05
11702,cytokines IL-10,2,4,14,29,"Expression of cytokines IL-10, TGF-beta and TNF-alpha were increased during tumor growth whereas IFN-gamma showed a decrease of the expression from day 10 on following an initial increase.",20205946_9,-1,-1,-1,-1,11702,-1,0.99997044,4.135132e-06,2.5403693e-05
11703,TGF-beta,5,6,31,39,"Expression of cytokines IL-10, TGF-beta and TNF-alpha were increased during tumor growth whereas IFN-gamma showed a decrease of the expression from day 10 on following an initial increase.",20205946_9,0,1,-1,-1,11703,-1,8.405095e-05,0.9998982,1.7695867e-05
11704,TNF-alpha,7,8,44,53,"Expression of cytokines IL-10, TGF-beta and TNF-alpha were increased during tumor growth whereas IFN-gamma showed a decrease of the expression from day 10 on following an initial increase.",20205946_9,0,1,-1,-1,11704,-1,0.01164298,0.9880483,0.00030870043
11708,tumor cell,14,16,87,97,"Moreover, liver metastases of murine colon carcinoma show an up-regulation of FAS-L on tumor cell surface with a decreased expression of FAS from day 10 on.",20205946_10,-1,-1,-1,-1,11708,-1,0.0006648985,0.014824386,0.9845108
11714,Thymic function,0,2,0,15,"Thymic function decreases in line with tumor progression in patients with cancer, resulting in immunodeficiency and a poor prognosis.",20229083_0,-1,-1,-1,-1,11714,-1,4.670914e-05,0.9999163,3.697584e-05
11718,thymic function,9,11,46,61,"In the present study, we attempted to restore thymic function by BALB/c (H-2(d)) syngeneic (Syn), or B6 (H-2(b)) allogeneic (Allo) bone marrow transplantation (BMT) using intra-bone marrow-bone marrow transplantation (IBM-BMT) plus Syn-, Allo- or C3H (H-2(k)) 3rd-party fetal thymus transplantation (TT).",20229083_1,-1,-1,-1,-1,11718,-1,1.1366091e-05,0.9999753,1.3336499e-05
11719,transplantation,34,35,143,158,"In the present study, we attempted to restore thymic function by BALB/c (H-2(d)) syngeneic (Syn), or B6 (H-2(b)) allogeneic (Allo) bone marrow transplantation (BMT) using intra-bone marrow-bone marrow transplantation (IBM-BMT) plus Syn-, Allo- or C3H (H-2(k)) 3rd-party fetal thymus transplantation (TT).",20229083_1,-1,1,2,-1,11719,-1,8.426919e-06,0.99998355,7.987978e-06
11720,transplantation,42,43,201,216,"In the present study, we attempted to restore thymic function by BALB/c (H-2(d)) syngeneic (Syn), or B6 (H-2(b)) allogeneic (Allo) bone marrow transplantation (BMT) using intra-bone marrow-bone marrow transplantation (IBM-BMT) plus Syn-, Allo- or C3H (H-2(k)) 3rd-party fetal thymus transplantation (TT).",20229083_1,-1,1,2,-1,11720,-1,1.013342e-05,0.9999802,9.645376e-06
11722,thymus transplantation,58,60,276,298,"In the present study, we attempted to restore thymic function by BALB/c (H-2(d)) syngeneic (Syn), or B6 (H-2(b)) allogeneic (Allo) bone marrow transplantation (BMT) using intra-bone marrow-bone marrow transplantation (IBM-BMT) plus Syn-, Allo- or C3H (H-2(k)) 3rd-party fetal thymus transplantation (TT).",20229083_1,-1,-1,-1,-1,11722,-1,2.579437e-05,0.99995995,1.4297279e-05
11749,T cell function,17,20,97,112,"Furthermore, there was a positive correlation between survival days and the number of T cells or T cell function, while there was a negative correlation between survival days and lung metastasis, the number of Gr-1(+)/CD11b(+) cells, or the percentage of FoxP3(+) cells.",20229083_6,-1,-1,-1,-1,11749,-1,1.4555501e-05,9.046296e-06,0.9999764
11761,T cell function,29,32,161,176,"These results suggest that BMT + TT, particularly Allo-BMT + Allo-TT or 3rd-party TT, is most effective in prolonging survival as a result of the restoration of T cell function in hosts with advanced tumors.",20229083_7,-1,-1,-1,-1,11761,-1,1.9358962e-05,9.390773e-06,0.9999713
11765,tumor-specific T-cell,7,9,38,59,The diversity and extent of the local tumor-specific T-cell response in a given individual is largely unknown.,20233872_0,-1,-1,-1,-1,11765,-1,0.0050558615,0.70208156,0.29286253
11767,T-cell,9,10,49,55,"We have performed an in-depth study of the local T-cell repertoire in a selected group of patients with cervical cancer, by systematic analyses of the proportion, breadth, and polarization of human papillomavirus (HPV) E6/E7-specific T cells within the total population of tumor-infiltrating lymphocytes (TIL) and tumor-draining lymph node cells (TDLNC).",20233872_1,-1,1,2,-1,11767,-1,1.04297615e-05,6.808454e-06,0.99998283
11770,the total,42,44,249,258,"We have performed an in-depth study of the local T-cell repertoire in a selected group of patients with cervical cancer, by systematic analyses of the proportion, breadth, and polarization of human papillomavirus (HPV) E6/E7-specific T cells within the total population of tumor-infiltrating lymphocytes (TIL) and tumor-draining lymph node cells (TDLNC).",20233872_1,-1,-1,-1,-1,11770,-1,4.0033715e-06,0.999992,3.9874444e-06
11771,tumor-infiltrating lymphocytes,46,48,273,303,"We have performed an in-depth study of the local T-cell repertoire in a selected group of patients with cervical cancer, by systematic analyses of the proportion, breadth, and polarization of human papillomavirus (HPV) E6/E7-specific T cells within the total population of tumor-infiltrating lymphocytes (TIL) and tumor-draining lymph node cells (TDLNC).",20233872_1,-1,-1,-1,-1,11771,-1,0.0024783243,0.8543467,0.14317495
11777,peptides,12,13,68,76,"Isolated T cells were stimulated with sets of overlapping E6 and E7 peptides and analyzed by multiparameter flow cytometry with respect to activation, cytokine production, and T-cell receptor Vbeta usage.",20233872_2,0,-1,2,-1,11777,-1,0.0030476812,0.9962555,0.0006968266
11781,T-cell,6,7,27,33,HPV-specific CD4+ and CD8+ T-cell responses were detected in TIL and TDLNC and their relative contribution varied between <1% and 66% of all T cells.,20233872_3,-1,1,2,-1,11781,-1,9.973106e-06,5.3843323e-06,0.9999846
11784,their relative,15,17,79,93,HPV-specific CD4+ and CD8+ T-cell responses were detected in TIL and TDLNC and their relative contribution varied between <1% and 66% of all T cells.,20233872_3,-1,-1,-1,-1,11784,-1,6.1027426e-06,0.9999893,4.656792e-06
11789,peptide-epitope,28,29,184,199,"In general, these HPV-specific responses were surprisingly broad, aimed at multiple E6 and E7 epitopes and involved multiple dominant and subdominant T-cell receptor Vbetas per single peptide-epitope.",20233872_4,0,-1,2,-1,11789,-1,0.0014532505,0.9980876,0.00045914212
11790,IFNgamma-producing T cells,6,9,27,53,"In most patients, only few IFNgamma-producing T cells were found and the amount of IFNgamma produced was low, suggesting that these are poised T cells, rendered functionally inactive within the tumor environment.",20233872_5,-1,-1,-1,-1,11790,-1,0.84902143,0.00034588703,0.15063271
11793,that these,21,23,121,131,"In most patients, only few IFNgamma-producing T cells were found and the amount of IFNgamma produced was low, suggesting that these are poised T cells, rendered functionally inactive within the tumor environment.",20233872_5,-1,-1,-1,-1,11793,-1,5.2826845e-06,0.9999896,5.145564e-06
11795,functionally,29,30,161,173,"In most patients, only few IFNgamma-producing T cells were found and the amount of IFNgamma produced was low, suggesting that these are poised T cells, rendered functionally inactive within the tumor environment.",20233872_5,0,1,2,-1,11795,-1,4.106135e-05,0.9999424,1.6546881e-05
11796,the tumor,32,34,190,199,"In most patients, only few IFNgamma-producing T cells were found and the amount of IFNgamma produced was low, suggesting that these are poised T cells, rendered functionally inactive within the tumor environment.",20233872_5,-1,-1,-1,-1,11796,-1,3.9633433e-06,0.999992,4.0654463e-06
11797,the TIL,4,6,28,35,"Importantly, stimulation of the TIL and TDLNC with cognate antigen in the presence of commonly used Toll-like receptor ligands significantly enhanced the effector T-cell function.",20233872_6,-1,-1,-1,-1,11797,-1,4.95866e-06,0.99999,5.0190347e-06
11801,Toll-like receptor ligands,17,20,100,126,"Importantly, stimulation of the TIL and TDLNC with cognate antigen in the presence of commonly used Toll-like receptor ligands significantly enhanced the effector T-cell function.",20233872_6,-1,-1,-1,-1,11801,-1,0.7283575,0.22989646,0.04174603
11803,T-cell function,24,26,163,178,"Importantly, stimulation of the TIL and TDLNC with cognate antigen in the presence of commonly used Toll-like receptor ligands significantly enhanced the effector T-cell function.",20233872_6,-1,-1,-1,-1,11803,-1,1.3776538e-05,9.59394e-06,0.99997663
11805,immunity,13,14,80,88,"In conclusion, our study suggests that within a given patient with HPV-specific immunity many different tumor-specific CD4+ and CD8+ T cells are locally present and poised for action.",20233872_7,0,-1,2,-1,11805,-1,0.9990491,0.00039768673,0.0005531437
11809,T-cell,4,5,25,31,This vast existing local T-cell population is awaiting proper stimulation and can be exploited for the immunotherapy of cancer.,20233872_8,-1,1,2,-1,11809,-1,1.3244814e-05,1.1109642e-05,0.9999757
11812,to tumor,11,13,86,94,Immune dysfunction is well documented during tumor progression and likely contributes to tumor immune evasion.,20305684_0,-1,-1,-1,-1,11812,-1,8.036727e-06,0.9999863,5.7174398e-06
11815,antigen-specific tumor,11,13,54,76,CD8(+) cytotoxic T lymphocytes (CTLs) are involved in antigen-specific tumor destruction and CD4(+) T cells are essential for helping this CD8(+) T cell-dependent tumor eradication.,20305684_1,-1,-1,-1,-1,11815,-1,0.9930056,0.0058487677,0.0011456377
11818,T cell-dependent tumor,26,29,146,168,CD8(+) cytotoxic T lymphocytes (CTLs) are involved in antigen-specific tumor destruction and CD4(+) T cells are essential for helping this CD8(+) T cell-dependent tumor eradication.,20305684_1,-1,-1,-1,-1,11818,-1,0.00097210513,0.011195604,0.9878323
11821,T-cell function to,5,8,32,50,Tumors often target and inhibit T-cell function to escape from immune surveillance.,20305684_2,-1,-1,-1,-1,11821,-1,0.0014062005,0.033799056,0.9647947
11824,towards type,12,14,68,80,"This dysfunction includes loss of effector and memory T cells, bias towards type 2 cytokines and expansion of T regulatory (Treg) cells.",20305684_3,-1,-1,-1,-1,11824,-1,1.5261407e-05,0.9999732,1.1559356e-05
11831,this plant-derived,18,20,128,146,Curcumin has previously been shown to have antitumor activity and some research has addressed the immunoprotective potential of this plant-derived polyphenol in tumor-bearing hosts.,20305684_4,-1,-1,-1,-1,11831,-1,1.1360375e-05,0.99998057,8.022285e-06
11836,T cell-based immune responses,14,18,88,117,Here we examined the role of curcumin in the prevention of tumor-induced dysfunction of T cell-based immune responses.,20305684_5,-1,-1,-1,-1,11836,-1,0.08238117,0.0010270706,0.9165917
11837,T-cell,9,10,52,58,"We observed severe loss of both effector and memory T-cell populations, downregulation of type 1 and upregulation of type 2 immune responses and decreased proliferation of effector T cells in the presence of tumors.",20305684_6,-1,1,2,-1,11837,-1,8.216302e-06,6.6648086e-06,0.9999851
11850,the type,29,31,143,151,"Curcumin, in turn, prevented this loss of T cells, expanded central memory T cell (T(CM))/effector memory T cell (T(EM)) populations, reversed the type 2 immune bias and attenuated the tumor-induced inhibition of T-cell proliferation in tumor-bearing hosts.",20305684_7,-1,-1,-1,-1,11850,-1,4.4654225e-06,0.9999908,4.755403e-06
11851,the tumor-induced,36,38,181,198,"Curcumin, in turn, prevented this loss of T cells, expanded central memory T cell (T(CM))/effector memory T cell (T(EM)) populations, reversed the type 2 immune bias and attenuated the tumor-induced inhibition of T-cell proliferation in tumor-bearing hosts.",20305684_7,-1,-1,-1,-1,11851,-1,5.6567246e-06,0.9999894,4.9366786e-06
11854,that tumor,3,5,31,41,Further investigation revealed that tumor burden upregulated Treg cell populations and stimulated the production of the immunosuppressive cytokines transforming growth factor (TGF)-beta and IL-10 in these cells.,20305684_8,-1,-1,-1,-1,11854,-1,4.996992e-06,0.9999907,4.278918e-06
11858,cytokines transforming growth factor,17,21,138,174,Further investigation revealed that tumor burden upregulated Treg cell populations and stimulated the production of the immunosuppressive cytokines transforming growth factor (TGF)-beta and IL-10 in these cells.,20305684_8,-1,-1,-1,-1,11858,-1,0.99986005,2.0270425e-05,0.00011967692
11860,these cells,25,27,199,210,Further investigation revealed that tumor burden upregulated Treg cell populations and stimulated the production of the immunosuppressive cytokines transforming growth factor (TGF)-beta and IL-10 in these cells.,20305684_8,-1,-1,-1,-1,11860,-1,1.7474162e-05,1.4096481e-05,0.9999684
11864,TGF-beta,16,17,104,112,"Curcumin, however, inhibited the suppressive activity of Treg cells by downregulating the production of TGF-beta and IL-10 in these cells.",20305684_9,0,1,-1,-1,11864,-1,5.128495e-05,0.99993193,1.6781894e-05
11866,these cells,20,22,126,137,"Curcumin, however, inhibited the suppressive activity of Treg cells by downregulating the production of TGF-beta and IL-10 in these cells.",20305684_9,-1,-1,-1,-1,11866,-1,1.3681965e-05,9.829858e-06,0.9999765
11869,T cells to,10,13,70,80,"More importantly, curcumin treatment enhanced the ability of effector T cells to kill cancer cells.",20305684_10,-1,-1,-1,-1,11869,-1,0.0014927016,0.05965746,0.9388499
11871,that the,5,7,34,42,"Overall, our observations suggest that the unique properties of curcumin may be exploited for successful attenuation of tumor-induced suppression of cell-mediated immune responses.",20305684_11,-1,-1,-1,-1,11871,-1,4.9193095e-06,0.99999154,3.4978968e-06
11873,cell-mediated immune responses,21,24,149,179,"Overall, our observations suggest that the unique properties of curcumin may be exploited for successful attenuation of tumor-induced suppression of cell-mediated immune responses.",20305684_11,-1,-1,-1,-1,11873,-1,0.19576848,0.0009544665,0.8032771
11890,the cellular,22,24,123,135,"Herein, using prophylactic depletion of FoxP3(+) Tregs with either anti-CD4, anti-CD25, or anti-FR4 mAbs, we have compared the cellular and effector requirements for elimination of the renal carcinoma RENCA and prevention of methylcholanthrene-induced fibrosarcoma.",20332236_3,-1,-1,-1,-1,11890,-1,0.004301401,0.6264306,0.36926806
11892,these two,2,4,18,27,"Collectively from these two models, it was clear that CD8(+) T cells and natural killer cells played an important role downstream of Treg depletion.",20332236_4,-1,-1,-1,-1,11892,-1,7.063513e-06,0.9999876,5.387887e-06
11896,cells played,17,19,88,100,"Collectively from these two models, it was clear that CD8(+) T cells and natural killer cells played an important role downstream of Treg depletion.",20332236_4,-1,-1,-1,-1,11896,-1,0.0034757985,0.24639365,0.75013053
11900,T cells to,10,13,65,75,"However, whereas all three mAbs quantitatively depleted FoxP3(+) T cells to a similar extent, subtle differences in the downstream mechanisms of tumor control existed for all three approaches.",20332236_5,-1,-1,-1,-1,11900,-1,0.0025894712,0.09041777,0.90699273
11905,lymphocyte subset,6,8,34,51,"In general, neutralization of any lymphocyte subset or effector mechanism was insufficient to alter tumor suppression initiated by Treg depletion, and in some settings, the neutralization of multiple effector mechanisms failed to prevent tumor rejection.",20332236_6,-1,-1,-1,-1,11905,-1,1.8181605e-05,8.606157e-06,0.9999732
11913,that Tregs,3,5,21,31,These studies reveal that Tregs control multiple redundant elements of the immune effector response capable of inhibiting tumor initiation and underscore the importance of effectively targeting these cells in any cancer immunotherapy.,20332236_7,-1,-1,-1,-1,11913,-1,5.25697e-06,0.99999094,3.8473213e-06
11917,targeting these cells,25,28,184,205,These studies reveal that Tregs control multiple redundant elements of the immune effector response capable of inhibiting tumor initiation and underscore the importance of effectively targeting these cells in any cancer immunotherapy.,20332236_7,-1,-1,-1,-1,11917,-1,0.0028362116,0.3484225,0.6487413
11918,protein,1,2,5,12,CagA protein is the most assessed effecter molecule of Helicobacter pylori.,20363211_0,0,1,-1,-1,11918,-1,0.001359274,0.9973578,0.0012829583
11921,protein,8,9,40,47,"In this report, we demonstrate how CagA protein regulates the functions of dendritic cells (DC) against H. pylori infection.",20363211_1,0,1,-1,-1,11921,-1,5.093467e-06,0.9999901,4.7980297e-06
11922,the functions,10,12,58,71,"In this report, we demonstrate how CagA protein regulates the functions of dendritic cells (DC) against H. pylori infection.",20363211_1,-1,-1,-1,-1,11922,-1,1.4508172e-05,0.99996674,1.8799228e-05
11925,protein,7,8,32,39,"In addition, we found that CagA protein was tyrosine-phosphorylated in DC.",20363211_2,0,1,-1,-1,11925,-1,1.0496136e-05,0.99997807,1.13787255e-05
11929,to those,12,14,74,82,The responses to cagA-positive H. pylori in DC were reduced in comparison to those induced by cagA-negative H. pylori.,20363211_3,-1,-1,-1,-1,11929,-1,5.5391642e-06,0.99998987,4.6213704e-06
11933,T cells toward Th1 type cells,18,24,123,152,CagA-overexpressing DC also exhibited a decline in the responses against LPS stimulation and the differentiation of CD4(+) T cells toward Th1 type cells compared to wild type DC.,20363211_4,-1,-1,-1,-1,11933,-1,3.2448923e-05,5.171101e-05,0.99991584
11945,protein,5,6,29,36,These data suggest that CagA protein negatively regulates the functions of DC via CagA phosphorylation and that cagA-positive H. pylori strains suppress host immune responses resulting in their chronic colonization of the stomach.,20363211_6,0,1,-1,-1,11945,-1,1.30981525e-05,0.9999683,1.8595876e-05
11946,the functions,8,10,58,71,These data suggest that CagA protein negatively regulates the functions of DC via CagA phosphorylation and that cagA-positive H. pylori strains suppress host immune responses resulting in their chronic colonization of the stomach.,20363211_6,-1,-1,-1,-1,11946,-1,9.151418e-06,0.9999789,1.1999499e-05
11952,tumor antigens,3,5,31,45,"Tumor-derived exosomes express tumor antigens, leading to their promising utility as tumor vaccines, but they also can suppress T-cell signaling molecules and reduce cytotoxic effects.",20372811_0,-1,-1,-1,-1,11952,-1,0.44177637,0.5538945,0.0043291296
11953,to their,7,9,55,63,"Tumor-derived exosomes express tumor antigens, leading to their promising utility as tumor vaccines, but they also can suppress T-cell signaling molecules and reduce cytotoxic effects.",20372811_0,-1,-1,-1,-1,11953,-1,4.804201e-06,0.9999901,5.075932e-06
11956,T-cell,20,21,128,134,"Tumor-derived exosomes express tumor antigens, leading to their promising utility as tumor vaccines, but they also can suppress T-cell signaling molecules and reduce cytotoxic effects.",20372811_0,-1,1,2,-1,11956,-1,3.2816424e-05,1.05111885e-05,0.9999567
11963,T-cells,17,18,131,138,"EXO/IL-12 was identified by transmission electron microscopy and Western blotting, which induced proliferation and cytotoxicity of T-cells and were analyzed by CFSE-based flow cytometry.",20372811_3,-1,1,2,-1,11963,-1,3.63125e-05,1.7924958e-05,0.99994576
11968,T lymphocytes than,22,25,138,156,"Our results showed that EXO/IL-12 was much more efficient in induction of the proliferation, release of IFN-gamma and cytotoxic effect of T lymphocytes than conventional exosomes in vitro.",20372811_5,-1,-1,-1,-1,11968,-1,0.0023674646,0.057840474,0.93979204
11971,T-cells,14,15,88,95,"Exosomes inhibited the expression of JAK3 and phosphorylation of STAT5 in high doses in T-cells, but not JAK2, while EXO/IL-12 had much less attenuated reduction of the expression of p-STAT5.",20372811_6,-1,1,2,-1,11971,-1,1.7873514e-05,1.1471143e-05,0.9999707
11985,immunity,3,4,23,31,"Antitumor activity and immunity feedback to GOLFIG were strictly correlated with the best outcome observed in patients with autoimmunity signs, increase of central memory T cells, and decrease of regulatory T cells (Treg) in the peripheral blood.",20386463_1,0,-1,2,-1,11985,-1,0.99931085,0.00012583246,0.0005633808
11992,blood,40,41,240,245,"Antitumor activity and immunity feedback to GOLFIG were strictly correlated with the best outcome observed in patients with autoimmunity signs, increase of central memory T cells, and decrease of regulatory T cells (Treg) in the peripheral blood.",20386463_1,0,1,-1,-1,11992,-1,0.00031459884,0.9978351,0.0018502875
11994,the Treg tumor,7,10,53,67,We thus investigated a potential correlation between the Treg tumor infiltration at diagnosis and the clinical outcome in a current randomized phase 3 trial aimed to compare the GOLFIG regimen with the standard FOLFOX chemotherapy (GOLFIG-2).,20386463_2,-1,-1,-1,-1,11994,-1,3.813201e-06,0.9999901,6.1116475e-06
12007,Treg tumor,0,2,0,10,"Treg tumor infiltration scores were correlated with overall survival, treatment-relative survival, and progression-free survival (PFS).",20386463_4,-1,-1,-1,-1,12007,-1,4.5298852e-06,0.99998987,5.6464164e-06
12009,Treg tumor,1,3,7,17,"Higher Treg tumor infiltration scores were associated with a better prognosis in the whole series (Treg high score vs. low score: overall survival=mean 43.2 mo vs. 28.6 mo, P=0.0005) and a better outcome after treatment (Treg high score vs. low score: PFS=mean 15.8 mo vs. 8.8 mo, P=0.0009; treatment-relative survival=mean 23.1 mo vs. 18.2 mo, P=0.004).",20386463_5,-1,-1,-1,-1,12009,-1,4.3364885e-06,0.9999888,6.8839954e-06
12017,T-lymphocyte tumor,8,10,41,59,Our results suggest that a higher FoxP3+ T-lymphocyte tumor infiltration score is a favorable prognostic factor in colon cancer patients undergoing chemo or chemoimmunotherapy.,20386463_7,-1,-1,-1,-1,12017,-1,0.0011556133,0.04772411,0.9511203
12018,factor,16,17,105,111,Our results suggest that a higher FoxP3+ T-lymphocyte tumor infiltration score is a favorable prognostic factor in colon cancer patients undergoing chemo or chemoimmunotherapy.,20386463_7,0,1,-1,-1,12018,-1,0.5167623,0.47956586,0.0036718338
12035,blood,40,41,252,257,"In this study, we analyzed the impact of administration of dendritic cell (DC) vaccination in combination with low-dose interleukin (IL)-2 in patients with metastatic renal cell carcinoma on the frequency of CD4+CD25highFoxp3+ Treg cells in peripheral blood.",20386464_1,0,1,-1,-1,12035,-1,0.0061887577,0.36223522,0.631576
12036,that the treatment,2,5,9,27,We found that the treatment increased the frequency of Treg cells more than 7-fold compared with pretreatment levels (P<0.0001).,20386464_2,-1,-1,-1,-1,12036,-1,5.0096332e-06,0.99999094,3.997408e-06
12044,functional,1,2,2,12,A functional assay showed that isolated Treg cells were capable of inhibiting proliferation of responder cells.,20386464_4,0,1,2,-1,12044,-1,0.013680532,0.98534125,0.0009782598
12061,that the,5,7,30,38,"Further, the results indicate that the IL-2-induced effect on Treg cells is reversible and declines shortly after termination of IL-2 treatment.",20386464_7,-1,-1,-1,-1,12061,-1,4.6243767e-06,0.99999166,3.7728416e-06
12069,therapy to,22,24,152,162,Our data suggest that approaches combining DC-mediated immunotherapy and depletion of Treg cells may be necessary to enhance the ability of vaccination therapy to elicit effective antitumor responses in cancer patients.,20386464_8,-1,-1,-1,-1,12069,-1,5.789904e-06,0.99999046,3.70726e-06
12081,cell function,28,30,198,211,"Because of their role in mitosis chemotherapeutic agents targeting microtubules are widely used, and this study determined the outcome of disturbing tubulin cytoskeleton dynamics on human dendritic cell function.",20386470_1,-1,-1,-1,-1,12081,-1,2.1985314e-05,1.3584419e-05,0.9999645
12084,the generation,10,12,43,57,Dendritic cells (DCs) play a major role in the generation of the adaptive immune response owing to their capacity for antigen presentation leading to T lymphocyte activation and differentiation and there is compelling evidence for their contribution to the antitumoral immune response.,20386470_2,-1,-1,-1,-1,12084,-1,5.6691647e-06,0.9999889,5.43985e-06
12087,to their,18,20,96,104,Dendritic cells (DCs) play a major role in the generation of the adaptive immune response owing to their capacity for antigen presentation leading to T lymphocyte activation and differentiation and there is compelling evidence for their contribution to the antitumoral immune response.,20386470_2,-1,-1,-1,-1,12087,-1,6.842458e-06,0.9999857,7.4036984e-06
12089,to T lymphocyte activation,25,29,147,173,Dendritic cells (DCs) play a major role in the generation of the adaptive immune response owing to their capacity for antigen presentation leading to T lymphocyte activation and differentiation and there is compelling evidence for their contribution to the antitumoral immune response.,20386470_2,-1,-1,-1,-1,12089,-1,0.0022882111,0.1529205,0.8447913
12092,to the,39,41,250,256,Dendritic cells (DCs) play a major role in the generation of the adaptive immune response owing to their capacity for antigen presentation leading to T lymphocyte activation and differentiation and there is compelling evidence for their contribution to the antitumoral immune response.,20386470_2,-1,-1,-1,-1,12092,-1,5.0521166e-06,0.9999907,4.301375e-06
12095,that target the tubulin,2,6,11,34,"Two agents that target the tubulin cytoskeleton were used, taxol and colchicine, and a brief pretreatment with either increased antigen presentation by DCs independently of significant phenotypic change, cell death, or cytokine production.",20386470_3,-1,-1,-1,-1,12095,-1,5.7661914e-06,0.9999893,4.9088476e-06
12104,the cytokine,4,6,32,44,We therefore determined whether the cytokine secretion profile in response to lipopolysaccharide (LPS) was modified.,20386470_5,-1,-1,-1,-1,12104,-1,0.6069836,0.38891685,0.0040995
12110,TNFalpha,9,10,48,56,"LPS stimulation of DCs induced IL-10, IL-12p70, TNFalpha and IL-1beta secretion, and taxol pretreatment modified this response by down-regulating IL-1beta secretion whereas colchicine induced a proinflammatory cytokine profile with reduced IL-10 and increased IL-12p70 and TNFalpha secretion.",20386470_6,0,1,-1,-1,12110,-1,3.3098917e-05,0.99994993,1.6937047e-05
12118,TNFalpha,38,39,273,281,"LPS stimulation of DCs induced IL-10, IL-12p70, TNFalpha and IL-1beta secretion, and taxol pretreatment modified this response by down-regulating IL-1beta secretion whereas colchicine induced a proinflammatory cytokine profile with reduced IL-10 and increased IL-12p70 and TNFalpha secretion.",20386470_6,0,1,-1,-1,12118,-1,3.653614e-05,0.99994695,1.6507882e-05
12119,Taken together,0,2,0,14,"Taken together, these data reveal new immunomodulatory strategies of microtubule disrupting agents in dendritic cells, that of modifying the cytokine response to LPS and that of increasing T lymphocyte activation without induction of inflammatory cytokine secretion by dendritic cells.",20386470_7,-1,-1,-1,-1,12119,-1,8.851301e-06,0.99998343,7.687173e-06
12123,the cytokine,20,22,137,149,"Taken together, these data reveal new immunomodulatory strategies of microtubule disrupting agents in dendritic cells, that of modifying the cytokine response to LPS and that of increasing T lymphocyte activation without induction of inflammatory cytokine secretion by dendritic cells.",20386470_7,-1,-1,-1,-1,12123,-1,0.6090671,0.38583097,0.005101918
12124,to LPS,23,25,159,165,"Taken together, these data reveal new immunomodulatory strategies of microtubule disrupting agents in dendritic cells, that of modifying the cytokine response to LPS and that of increasing T lymphocyte activation without induction of inflammatory cytokine secretion by dendritic cells.",20386470_7,-1,-1,-1,-1,12124,-1,7.706395e-06,0.999985,7.343114e-06
12130,immunity factors,8,10,44,60,AIM: We analysed local cellular and humoral immunity factors in the anal mucosa in an attempt to explain how HIV infection increases the risk of anal cancer in HPV-infected patients.,20394639_0,-1,-1,-1,-1,12130,-1,0.9629175,0.03323096,0.0038515595
12140,Tissue,0,1,0,6,"Tissue CD1a(+), CD3(+), CD4(+), CD8(+) cells and mRNAs of selected cytokines and chemokines were quantified and compared in patients with or without AIN3 or cancer using morphometric or immunohistochemistry analysis and qRT-PCR.RESULTS: Sixty-six individuals (22 patients and 44 controls) were included.",20394639_3,-1,1,2,-1,12140,-1,7.539631e-06,0.99998033,1.214286e-05
12144,analysis,36,37,207,215,"Tissue CD1a(+), CD3(+), CD4(+), CD8(+) cells and mRNAs of selected cytokines and chemokines were quantified and compared in patients with or without AIN3 or cancer using morphometric or immunohistochemistry analysis and qRT-PCR.RESULTS: Sixty-six individuals (22 patients and 44 controls) were included.",20394639_3,0,1,-1,-1,12144,-1,9.310798e-06,0.99998045,1.027818e-05
12150,tissues,12,13,76,83,IL-8 and IL23 levels were significantly higher in cancer than in non-cancer tissues regardless of HIV status (P = 0.02).,20394639_6,-1,1,2,-1,12150,-1,3.665244e-05,0.9984378,0.001525554
12158,to the,38,40,234,240,FoxP3 expression was significantly higher in HIV-infected cases than in controls with AIN3/cancer (P < 0.04).CONCLUSION: Depletion of CD1a(+) and CD3(+) cells and overexpression of FoxP3 in the anal mucosa appear likely to contribute to the risk of HPV-related anal cancer in HIV-infected patients.,20394639_7,-1,-1,-1,-1,12158,-1,5.45073e-06,0.99999,4.5770885e-06
12164,Therapeutic subunit,0,2,0,19,Therapeutic subunit vaccines based on tumor-associated antigens (TAA) represent an attractive approach for the treatment of cancer.,20406989_0,-1,-1,-1,-1,12164,-1,1.3307374e-05,0.9999777,8.958856e-06
12165,tumor-associated antigens,5,7,38,63,Therapeutic subunit vaccines based on tumor-associated antigens (TAA) represent an attractive approach for the treatment of cancer.,20406989_0,-1,-1,-1,-1,12165,-1,0.10991673,0.8862981,0.0037850975
12167,the treatment,15,17,107,120,Therapeutic subunit vaccines based on tumor-associated antigens (TAA) represent an attractive approach for the treatment of cancer.,20406989_0,-1,-1,-1,-1,12167,-1,5.255068e-06,0.9999896,5.1322777e-06
12170,the tumor necrosis factor,3,7,21,46,"We recently proposed the tumor necrosis factor family costimulatory ligands as potential adjuvants for therapeutic vaccines and, hence, generated a soluble form of 4-1BBL chimeric with streptavidin (SA-4-1BBL) that has pleiotropic effects on cells of innate, adaptive, and regulatory immunity.",20406989_2,-1,-1,-1,-1,12170,-1,0.7432131,0.25156984,0.0052170083
12176,immunity,49,50,284,292,"We recently proposed the tumor necrosis factor family costimulatory ligands as potential adjuvants for therapeutic vaccines and, hence, generated a soluble form of 4-1BBL chimeric with streptavidin (SA-4-1BBL) that has pleiotropic effects on cells of innate, adaptive, and regulatory immunity.",20406989_2,0,-1,2,-1,12176,-1,0.99892396,9.081784e-05,0.0009851914
12185,receptor,39,40,216,224,We herein tested whether these effects can translate into effective cancer immunotherapy when SA-4-1BBL was also used as a vehicle to deliver TAAs in vivo to dendritic cells (DCs) constitutively expressing the 4-1BB receptor.,20406989_3,0,1,2,-1,12185,-1,0.0006691431,0.0009735999,0.99835724
12186,receptor,8,9,39,47,"SA-4-1BBL was internalized by DCs upon receptor binding and immunization with biotinylated antigens conjugated to SA-4-1BBL resulted in increased antigen uptake and cross-presentation by DCs, leading to the generation of effective T-cell immune responses.",20406989_4,0,1,2,-1,12186,-1,0.001194635,0.0010791274,0.99772626
12190,to the generation,31,34,200,217,"SA-4-1BBL was internalized by DCs upon receptor binding and immunization with biotinylated antigens conjugated to SA-4-1BBL resulted in increased antigen uptake and cross-presentation by DCs, leading to the generation of effective T-cell immune responses.",20406989_4,-1,-1,-1,-1,12190,-1,5.380237e-06,0.9999895,5.1541824e-06
12191,T-cell immune responses,36,39,231,254,"SA-4-1BBL was internalized by DCs upon receptor binding and immunization with biotinylated antigens conjugated to SA-4-1BBL resulted in increased antigen uptake and cross-presentation by DCs, leading to the generation of effective T-cell immune responses.",20406989_4,-1,-1,-1,-1,12191,-1,0.22738187,0.0009752339,0.77164286
12198,T-cell,15,16,87,93,Therapeutic efficacy of the vaccines was associated with increased CD4(+) T and CD8(+) T-cell effector and memory responses and higher intratumoral CD8(+) T effector/CD4(+)CD25(+)Foxp3(+) T regulatory cell ratio.,20406989_6,-1,1,2,-1,12198,-1,1.4529291e-05,8.99036e-06,0.9999765
12204,functions,5,6,32,41,"Thus, potent pleiotropic immune functions of SA-4-1BBL combined with its ability to serve as a vehicle to increase the delivery of antigens to DCs in vivo endow this molecule with the potential to serve as an effective immunomodulatory component of therapeutic vaccines against cancer and chronic infections.",20406989_7,0,1,2,-1,12204,-1,0.004129888,0.9871912,0.008678902
12208,antigens to,24,26,131,142,"Thus, potent pleiotropic immune functions of SA-4-1BBL combined with its ability to serve as a vehicle to increase the delivery of antigens to DCs in vivo endow this molecule with the potential to serve as an effective immunomodulatory component of therapeutic vaccines against cancer and chronic infections.",20406989_7,-1,-1,-1,-1,12208,-1,0.97090036,0.027522815,0.0015768023
12226,tissues,14,15,80,87,Foxp3(+) regulatory T cells (Tregs) suppress immune responses in the peripheral tissues and play a role in the immunosuppression of cancer tissues.,20422211_2,-1,1,2,-1,12226,-1,0.00027424286,0.05621169,0.94351405
12229,tissues,24,25,139,146,Foxp3(+) regulatory T cells (Tregs) suppress immune responses in the peripheral tissues and play a role in the immunosuppression of cancer tissues.,20422211_2,-1,1,2,-1,12229,-1,0.00016805892,0.032731064,0.9671009
12250,T-helper type,5,7,32,45,This suggests the occurrence of T-helper type 1 (Th1)-shifted immune responses in Ly-rich GCs.,20422211_6,-1,-1,-1,-1,12250,-1,5.4641127e-06,0.9999826,1.18819335e-05
12261,the tissue,11,13,56,66,"Since Tregs are known to express CCR4, we also examined the tissue distribution of cells expressing its ligand CCL22.",20422211_9,-1,-1,-1,-1,12261,-1,6.1507335e-06,0.9999889,4.9010437e-06
12282,the tumor,38,40,216,225,"Like the normal components of this lymphoid structure, FL cells interact with various immune cells, such as the follicular helper T cells, suppressor regulatory T cells, dendritic cells, and histiocytes, that define the tumor microenvironment.",20425464_1,-1,-1,-1,-1,12282,-1,5.1908637e-06,0.9999896,5.1583575e-06
12284,that the nature,5,8,35,50,Gene expression studies have shown that the nature of the tumor microenvironment predicts survival in patients with FL and may influence the response to immunotherapy and risk of transformation.,20425464_2,-1,-1,-1,-1,12284,-1,6.031241e-06,0.99998736,6.576424e-06
12285,the tumor,9,11,54,63,Gene expression studies have shown that the nature of the tumor microenvironment predicts survival in patients with FL and may influence the response to immunotherapy and risk of transformation.,20425464_2,-1,-1,-1,-1,12285,-1,4.954506e-06,0.9999893,5.7737743e-06
12290,tumor cell,8,10,50,60,"The immune system may either promote or constrain tumor cell development, depending on the relative distribution and activation status of various cell subpopulations.",20425464_3,-1,-1,-1,-1,12290,-1,6.2872205e-05,0.00017770345,0.9997594
12291,the relative,14,16,87,99,"The immune system may either promote or constrain tumor cell development, depending on the relative distribution and activation status of various cell subpopulations.",20425464_3,-1,-1,-1,-1,12291,-1,7.0805145e-06,0.9999865,6.437764e-06
12297,that the,12,14,80,88,The prognostic value of germline genetic variants of some immune genes suggests that the host genetic background may also influence the biology of FL.,20425464_4,-1,-1,-1,-1,12297,-1,7.470505e-06,0.99998796,4.6129076e-06
12302,tools that,13,15,83,93,Some efforts have been carried out to validate those findings and provide clinical tools that may be used at the time of diagnosis.,20425464_5,-1,-1,-1,-1,12302,-1,2.0595497e-05,0.99996996,9.439858e-06
12303,the time,19,21,109,117,Some efforts have been carried out to validate those findings and provide clinical tools that may be used at the time of diagnosis.,20425464_5,-1,-1,-1,-1,12303,-1,6.7674187e-06,0.9999876,5.6763743e-06
12313,to Th1,15,17,91,97,RNA expression profile of SCC patients was analyzed for 8 different sets of genes relating to Th1 versus Th2 response using Gene Set Enrichment Analysis.,20463594_3,-1,-1,-1,-1,12313,-1,6.327209e-06,0.99998116,1.2466317e-05
12316,Analysis,24,25,144,152,RNA expression profile of SCC patients was analyzed for 8 different sets of genes relating to Th1 versus Th2 response using Gene Set Enrichment Analysis.,20463594_3,0,1,-1,-1,12316,-1,1.1141432e-05,0.9999788,1.0031063e-05
12321,TGF-beta,30,31,155,163,"SCC from immunocompetent patients and OTRs were analyzed by real-time polymerase chain reactions for CD4, CD8, TBET, GATA-3, FOXP3, RORC, IFN-gamma, IL-4, TGF-beta, IL-10, and IL-17A mRNA expression.",20463594_4,0,1,-1,-1,12321,-1,4.9034083e-05,0.99993575,1.5168175e-05
12326,Th2 gene,13,15,77,85,SCC in immunocompetent patients and OTRs was associated with a mixed Th1 and Th2 gene expression signature.,20463594_7,-1,-1,-1,-1,12326,-1,8.7354365e-06,0.99997914,1.2163025e-05
12335,TGF-beta,8,9,48,56,"Regulatory T cells, characterized by FOX-P3 and TGF-beta mRNA level, were decreased in OTRs.",20463594_12,0,1,-1,-1,12335,-1,8.755971e-05,0.99989474,1.7726175e-05
12339,that the,18,20,117,125,Our findings support the hypothesis that nontumor-bearing skin adjacent to SCC in OTRs is not necessarily normal and that the local microenvironment may contribute to a field effect contributing to higher recurrence rates and more aggressive behavior observed in these patients.,20463594_13,-1,-1,-1,-1,12339,-1,4.6954224e-06,0.9999908,4.5155266e-06
12343,mediators that,15,17,100,114,INTRODUCTION: Cysts and granulomas are chronic periapical lesions mediated by a set of inflammatory mediators that develop to contain a periapical infection.,20478453_0,-1,-1,-1,-1,12343,-1,0.98155296,0.016702224,0.0017447607
12346,the nature,3,5,20,30,"This study analyzed the nature of the inflammatory infiltrate, presence of mast cells, and in situ expression of cytokines (interleukin [IL]-17 and transforming growth factor [TGF]-beta), chemokines (macrophage inflammatory protein [MIP]-1beta and monocyte chemotactic protein [MCP]-1), and nuclear transcription factor (FoxP3) in human periapical granulomas and cysts compared with a control group.",20478453_1,-1,-1,-1,-1,12346,-1,3.528133e-06,0.99999154,4.9801074e-06
12351,transforming growth factor,25,28,148,174,"This study analyzed the nature of the inflammatory infiltrate, presence of mast cells, and in situ expression of cytokines (interleukin [IL]-17 and transforming growth factor [TGF]-beta), chemokines (macrophage inflammatory protein [MIP]-1beta and monocyte chemotactic protein [MCP]-1), and nuclear transcription factor (FoxP3) in human periapical granulomas and cysts compared with a control group.",20478453_1,-1,-1,-1,-1,12351,-1,0.98053086,0.015879888,0.0035893477
12354,chemotactic protein,39,41,257,276,"This study analyzed the nature of the inflammatory infiltrate, presence of mast cells, and in situ expression of cytokines (interleukin [IL]-17 and transforming growth factor [TGF]-beta), chemokines (macrophage inflammatory protein [MIP]-1beta and monocyte chemotactic protein [MCP]-1), and nuclear transcription factor (FoxP3) in human periapical granulomas and cysts compared with a control group.",20478453_1,-1,-1,-1,-1,12354,-1,0.9999584,4.170941e-06,3.7394693e-05
12357,The type,0,2,0,8,"The type of inflammatory infiltrate was evaluated by hematoxylin-eosin staining, and the presence of mast cells was analyzed by toluidine blue staining.",20478453_3,-1,-1,-1,-1,12357,-1,5.0542308e-06,0.9999895,5.3952454e-06
12374,TGF-beta,14,15,67,75,A significant difference in the expression of IL-17 (P = .001) and TGF-beta (P = .003) was observed between cysts and granulomas and the control group.,20478453_8,0,1,-1,-1,12374,-1,1.9841043e-05,0.99997234,7.820863e-06
12391,to the,1,3,9,15,"Contrary to the common notion that MDSC are a heterogeneous population of exclusively immature cells, we find the coexpression of markers associated with mature phenotype.",20484028_3,-1,-1,-1,-1,12391,-1,5.736684e-06,0.9999896,4.633585e-06
12396,time the,5,7,22,30,"We show for the first time the overexpression of CD80, CD83, and DC-Sign in human MDSC.",20484028_4,-1,-1,-1,-1,12396,-1,4.635542e-06,0.99999046,4.8467705e-06
12400,function,23,24,136,144,"Further, increased levels of signal transducer and activator of transcription 3 (Stat3), an important regulator in MDSC development and function, were noted in MM-MDSC.",20484028_5,0,1,2,-1,12400,-1,0.00010992521,0.99972814,0.00016187187
12413,T-cell,19,20,139,145,Several observations suggest a redox imbalance in MDSC and indicate an important role of Stat3-dependent oxidative stress in MDSC-mediated T-cell suppression.,20484028_9,-1,1,2,-1,12413,-1,1.1039562e-05,9.7995935e-06,0.99997914
12419,that statins,6,8,44,56,"In particular, compelling evidence suggests that statins have a wide range of immunomodulatory properties.",20491794_1,-1,-1,-1,-1,12419,-1,7.694954e-05,0.9999112,1.1815717e-05
12428,transforming growth factor,15,18,109,135,"Tumour immune tolerance involves the production of immunosuppressive molecules, such as interleukin (IL)-10, transforming growth factor (TGF)-beta and indoleamine-2,3-dioxygenase (IDO) by tumours, which induce a regulatory T cell (T(reg)) response.",20491794_3,-1,-1,-1,-1,12428,-1,0.9874977,0.00911477,0.003387625
12436,TGF-beta,16,17,85,93,"In this study, we investigated the effect of simvastatin on the production of IL-10, TGF-beta and IDO production and the proliferation of T(regs) using several cancer cell lines, and Lewis lung cancer (3LL) cells-inoculated mouse tumour model.",20491794_4,0,1,-1,-1,12436,-1,3.393921e-05,0.9999529,1.3184588e-05
12448,TGF-beta,9,10,55,63,"The production of the immune regulatory markers IL-10, TGF-beta in 3LL and NCI-H292 cells increased after treatment with simvastatin.",20491794_6,0,1,-1,-1,12448,-1,4.361927e-05,0.99994266,1.3661489e-05
12462,to these,3,5,10,18,"Thus, due to these opposing actions, simvastatin had no net effect on tumour growth.",20491794_10,-1,-1,-1,-1,12462,-1,8.666969e-06,0.99998677,4.5674897e-06
12474,the FoxP3(+,9,11,42,53,"In adult T cell leukemia/lymphoma (ATLL), the FoxP3(+) population was distinct from the leukemic T cell clones.",20525891_2,-1,-1,-1,-1,12474,-1,8.6403656e-05,0.9998579,5.5636407e-05
12482,that the plasma,6,9,25,40,"In this study, we report that the plasma concentration of the chemokine CCL22 is abnormally high in HTLV-1-infected subjects and that the concentration is strongly correlated with the frequency of FoxP3(+) cells, which express the CCL22 receptor CCR4.",20525891_4,-1,-1,-1,-1,12482,-1,6.8971667e-06,0.9999871,6.010649e-06
12483,the chemokine CCL22,11,14,58,77,"In this study, we report that the plasma concentration of the chemokine CCL22 is abnormally high in HTLV-1-infected subjects and that the concentration is strongly correlated with the frequency of FoxP3(+) cells, which express the CCL22 receptor CCR4.",20525891_4,-1,-1,-1,-1,12483,-1,0.9611619,0.037092537,0.0017454458
12484,that the,21,23,129,137,"In this study, we report that the plasma concentration of the chemokine CCL22 is abnormally high in HTLV-1-infected subjects and that the concentration is strongly correlated with the frequency of FoxP3(+) cells, which express the CCL22 receptor CCR4.",20525891_4,-1,-1,-1,-1,12484,-1,3.7276343e-06,0.9999924,3.944021e-06
12488,the CCL22 receptor,37,40,227,245,"In this study, we report that the plasma concentration of the chemokine CCL22 is abnormally high in HTLV-1-infected subjects and that the concentration is strongly correlated with the frequency of FoxP3(+) cells, which express the CCL22 receptor CCR4.",20525891_4,-1,-1,-1,-1,12488,-1,0.10911214,0.87583065,0.015057245
12489,that CCL22,4,6,17,27,"Further, we show that CCL22 is produced by cells that express the HTLV-1 transactivator protein Tax, and that the increased CCL22 enhances the migration and survival of FoxP3(+) cells in vitro.",20525891_5,-1,-1,-1,-1,12489,-1,0.8525696,0.14459096,0.002839425
12490,cells that,9,11,43,53,"Further, we show that CCL22 is produced by cells that express the HTLV-1 transactivator protein Tax, and that the increased CCL22 enhances the migration and survival of FoxP3(+) cells in vitro.",20525891_5,-1,-1,-1,-1,12490,-1,0.0034449815,0.23238575,0.7641692
12492,transactivator protein Tax,14,17,73,99,"Further, we show that CCL22 is produced by cells that express the HTLV-1 transactivator protein Tax, and that the increased CCL22 enhances the migration and survival of FoxP3(+) cells in vitro.",20525891_5,-1,-1,-1,-1,12492,-1,4.825969e-06,0.99999034,4.8102356e-06
12493,that the,19,21,105,113,"Further, we show that CCL22 is produced by cells that express the HTLV-1 transactivator protein Tax, and that the increased CCL22 enhances the migration and survival of FoxP3(+) cells in vitro.",20525891_5,-1,-1,-1,-1,12493,-1,4.7859785e-06,0.99999106,4.1456256e-06
12498,that FoxP3(+,4,6,17,29,"Finally, we show that FoxP3(+) cells inhibit the proliferation of ex vivo, autologous leukemic clones from patients with ATLL.",20525891_6,-1,-1,-1,-1,12498,-1,0.0001424052,0.999803,5.4618682e-05
12506,these FoxP3(+,18,20,112,125,"We conclude that HTLV-1-induced CCL22 causes the high frequency of FoxP3(+) cells observed in HTLV-1 infection; these FoxP3(+) cells may both retard the progression of ATLL and HTLV-1-associated inflammatory diseases and contribute to the immune suppression seen in HTLV-1 infection, especially in ATLL.",20525891_7,-1,-1,-1,-1,12506,-1,5.4433956e-05,0.9999113,3.4221623e-05
12509,to the,35,37,232,238,"We conclude that HTLV-1-induced CCL22 causes the high frequency of FoxP3(+) cells observed in HTLV-1 infection; these FoxP3(+) cells may both retard the progression of ATLL and HTLV-1-associated inflammatory diseases and contribute to the immune suppression seen in HTLV-1 infection, especially in ATLL.",20525891_7,-1,-1,-1,-1,12509,-1,4.55235e-06,0.9999912,4.3016976e-06
12511,T cells played,5,8,43,57,We previously demonstrated that gammadelta T cells played an important role in tumor immune surveillance by providing an early source of IFN-gamma.,20525896_0,-1,-1,-1,-1,12511,-1,0.0020330083,0.05001094,0.94795614
12525,tumor immunity,23,25,145,159,Vgamma1 and Vgamma4 gammadelta T cells are the principal subsets of peripheral lymphoid gammadelta T cells and they might play distinct roles in tumor immunity.,20525896_2,-1,-1,-1,-1,12525,-1,0.011229404,0.98836154,0.0004090792
12530,that these,3,5,14,24,We also found that these effects were exerted by the activated (CD44(high)) portion of Vgamma4 gammadelta T cells.,20525896_4,-1,-1,-1,-1,12530,-1,5.047457e-06,0.99999106,3.836806e-06
12533,that IFN-gamma,3,5,22,36,We further determined that IFN-gamma and perforin are critical elements in the Vgamma4-mediated antitumor immune response.,20525896_5,-1,-1,-1,-1,12533,-1,0.9780682,0.020534089,0.0013977182
12540,to the,33,35,213,219,"Indeed, CD44(high) Vgamma4 gammadelta T cells produced significantly more IFN-gamma and perforin on activation, and showed greater cytolytic activity than did CD44(high) Vgamma1 gammadelta T cells, apparently due to the high level of eomesodermin (Eomes) in these activated Vgamma4 gammadelta T cells.",20525896_6,-1,-1,-1,-1,12540,-1,6.2628064e-06,0.99998903,4.6552414e-06
12548,function,27,28,181,189,"Consistently, transfection of dominant-negative Eomes in Vgamma4 gammadelta T cells diminished the level of IFN-gamma secretion, indicating a critical role of Eomes in the effector function of these gammadelta T cells.",20525896_7,0,1,2,-1,12548,-1,7.1250804e-05,0.99982977,9.8941855e-05
12552,functions,5,6,33,42,"Our results thus reveal distinct functions of Vgamma4 and Vgamma1 gammadelta T cells in antitumor immune response, and identify a protective role of activated Vgamma4 gammadelta T cells, with possible implications for tumor immune therapy.",20525896_8,0,1,2,-1,12552,-1,2.6888794e-05,0.99995315,1.9977633e-05
12557,therapy,36,37,231,238,"Our results thus reveal distinct functions of Vgamma4 and Vgamma1 gammadelta T cells in antitumor immune response, and identify a protective role of activated Vgamma4 gammadelta T cells, with possible implications for tumor immune therapy.",20525896_8,0,1,-1,-1,12557,-1,6.4570067e-06,0.99998796,5.5849146e-06
12558,proteins,1,2,11,19,"Heat-shock proteins have biochemical and immunological roles in chaperoning/signaling and activation of innate and adaptive immune responses, respectively.",20544406_0,0,1,-1,-1,12558,-1,0.00029122547,0.99965477,5.4032545e-05
12561,the immune response,3,6,16,35,"Their effect on the immune response is due to a phenomenon known as cross-priming of antigen, in which exogenous antigens are presented via MHC class I by antigen presenting cells.",20544406_1,-1,-1,-1,-1,12561,-1,0.4179623,0.5801679,0.0018698628
12571,the immune response,2,5,12,31,"Analyses of the immune response, 2weeks after the last immunization revealed decreased CD4+ CD25+ Foxp3+ naturally occurring regulatory T cells (Tregs) at the tumor site and increased IFN-/IL-4 level.",20544406_4,-1,-1,-1,-1,12571,-1,0.5703598,0.4274462,0.0021939643
12577,the tumor,30,32,156,165,"Analyses of the immune response, 2weeks after the last immunization revealed decreased CD4+ CD25+ Foxp3+ naturally occurring regulatory T cells (Tregs) at the tumor site and increased IFN-/IL-4 level.",20544406_4,-1,-1,-1,-1,12577,-1,4.4608587e-06,0.9999907,4.8659554e-06
12582,that tumor-associated,4,6,24,45,Many studies have shown that tumor-associated macrophages (TAMs) contribute to tumor development and poor prognosis in various cancers.,20545696_0,-1,-1,-1,-1,12582,-1,1.8769802e-05,0.9999708,1.0488706e-05
12584,to tumor,11,13,76,84,Many studies have shown that tumor-associated macrophages (TAMs) contribute to tumor development and poor prognosis in various cancers.,20545696_0,-1,-1,-1,-1,12584,-1,5.87123e-06,0.9999876,6.558625e-06
12589,tissue,15,16,81,87,CD68 (+) and CD163 (+) macrophage infiltration was analyzed in paraffin-embedded tissue samples from 39 patients.,20545696_2,-1,1,2,-1,12589,-1,1.5656995e-05,0.99994624,3.8090086e-05
12601,tumor cell,21,23,88,98,"In an in vitro study using ICC cell lines (HuCCT1, RBE, and MEC) and human macrophages, tumor cell supernatant (TCS) from cell lines induced an activation of signal transducers and activators of transcription-3 (Stat3) and macrophage polarization toward the M2 phenotype.",20545696_9,-1,-1,-1,-1,12601,-1,8.912223e-05,0.00019147045,0.9997193
12608,toward the,46,48,247,257,"In an in vitro study using ICC cell lines (HuCCT1, RBE, and MEC) and human macrophages, tumor cell supernatant (TCS) from cell lines induced an activation of signal transducers and activators of transcription-3 (Stat3) and macrophage polarization toward the M2 phenotype.",20545696_9,-1,-1,-1,-1,12608,-1,1.1631463e-05,0.99997663,1.17621075e-05
12609,Tumor cell,0,2,0,10,"Tumor cell supernatant (TCS) from HuCCT1 most strongly induced Stat3 activation and production of cytokines and other bioactive molecules such as interleukin (IL)-10, vascular endothelial growth factor (VEGF)-A, transforming growth factor (TGF)-beta, and matrix metalloproteinase (MMP)-2.",20545696_10,-1,-1,-1,-1,12609,-1,0.00022619078,0.003990774,0.9957831
12615,transforming growth factor,32,35,212,238,"Tumor cell supernatant (TCS) from HuCCT1 most strongly induced Stat3 activation and production of cytokines and other bioactive molecules such as interleukin (IL)-10, vascular endothelial growth factor (VEGF)-A, transforming growth factor (TGF)-beta, and matrix metalloproteinase (MMP)-2.",20545696_10,-1,-1,-1,-1,12615,-1,0.9923632,0.005419633,0.0022171522
12620,that TAMs,18,20,137,146,"Down-regulation of Stat3 by siRNA significantly suppressed the production of IL-10 and VEGF-A. These results provide suggestive evidence that TAMs contribute to cancer progression via Stat3 activation, and CD163 is useful for evaluating M2 TAMs and predicting the clinical prognosis of ICC patients.",20545696_11,-1,-1,-1,-1,12620,-1,6.359005e-06,0.9999871,6.558259e-06
12627,peptides,34,35,225,233,One half of a group of 20 patients with human papillomavirus type 16 (HPV16)-induced vulvar intraepithelial neoplasia grade 3 displayed a complete regression (CR) after therapeutic vaccination with HPV16 E6/E7 synthetic long peptides.,20547850_0,0,-1,2,-1,12627,-1,0.0042258766,0.9950435,0.00073056377
12633,immunity,22,23,144,152,"To investigate immune correlates of treatment failure, patients were grouped according to median lesion size at study entry, and HPV16-specific immunity was analyzed at different time points by complementary immunological assays.",20547850_2,0,-1,2,-1,12633,-1,0.9997886,4.6000554e-05,0.00016546788
12639,in cytokine,10,12,69,80,"Characteristically, this response was accompanied by a distinct peak in cytokine levels after the first vaccination.",20547850_4,-1,-1,-1,-1,12639,-1,0.6584725,0.3365136,0.005013968
12644,immunity to,5,7,25,36,"No disparity in T memory immunity to control antigens was found, indicating that the differences in HPV-specific immunity did not reflect general immune failure.",20547850_6,-1,-1,-1,-1,12644,-1,0.0726192,0.9244674,0.0029133398
12646,that the,13,15,76,84,"No disparity in T memory immunity to control antigens was found, indicating that the differences in HPV-specific immunity did not reflect general immune failure.",20547850_6,-1,-1,-1,-1,12646,-1,4.8433885e-06,0.9999914,3.7529849e-06
12647,immunity,18,19,113,121,"No disparity in T memory immunity to control antigens was found, indicating that the differences in HPV-specific immunity did not reflect general immune failure.",20547850_6,0,-1,2,-1,12647,-1,0.9987942,0.0001850402,0.001020713
12652,T cells to,9,12,66,76,"Notably, a high ratio of HPV16-specific vaccine-prompted effector T cells to HPV16-specific CD4(+)CD25(+)Foxp3(+) T cells was predictive of clinical success.",20547850_8,-1,-1,-1,-1,12652,-1,0.0011829681,0.04311664,0.95570046
12656,immunity,10,11,63,71,Foxp3(+) T cells have been associated previously with impaired immunity in malignancies.,20547850_9,0,-1,2,-1,12656,-1,0.9995658,0.0002108269,0.00022344595
12657,that the,3,5,20,28,Here we demonstrate that the vaccine-prompted level of this population is associated with early treatment failure.,20547850_10,-1,-1,-1,-1,12657,-1,4.5499673e-06,0.99999213,3.369724e-06
12660,Th17 cells,1,3,9,19,"Although Th17 cells reportedly play critical roles in the development of autoimmunity and allergic reactions, information on Th17 cells in cancer-bearing hosts is still limited.",20550524_0,-1,-1,-1,-1,12660,-1,0.00022539507,0.0045186817,0.9952559
12663,Th17 cells,18,20,125,135,"Although Th17 cells reportedly play critical roles in the development of autoimmunity and allergic reactions, information on Th17 cells in cancer-bearing hosts is still limited.",20550524_0,-1,-1,-1,-1,12663,-1,0.00021410115,0.0041570747,0.99562883
12666,Th17 cells,10,12,58,68,"In the present study, we investigated the distribution of Th17 cells in relation to regulatory T cells (Treg) in the tumor-infiltrating lymphocytes (TILs), regional lymph node lymphocytes, and peripheral blood lymphocytes of gastric cancer patients.",20550524_1,-1,-1,-1,-1,12666,-1,0.00015115266,0.0037274978,0.99612135
12667,relation to regulatory T cells,13,18,72,102,"In the present study, we investigated the distribution of Th17 cells in relation to regulatory T cells (Treg) in the tumor-infiltrating lymphocytes (TILs), regional lymph node lymphocytes, and peripheral blood lymphocytes of gastric cancer patients.",20550524_1,-1,-1,-1,-1,12667,-1,0.00184522,0.1561501,0.84200466
12669,the tumor-infiltrating lymphocytes,22,25,113,147,"In the present study, we investigated the distribution of Th17 cells in relation to regulatory T cells (Treg) in the tumor-infiltrating lymphocytes (TILs), regional lymph node lymphocytes, and peripheral blood lymphocytes of gastric cancer patients.",20550524_1,-1,-1,-1,-1,12669,-1,0.0016081205,0.89904743,0.099344455
12672,blood lymphocytes,36,38,204,221,"In the present study, we investigated the distribution of Th17 cells in relation to regulatory T cells (Treg) in the tumor-infiltrating lymphocytes (TILs), regional lymph node lymphocytes, and peripheral blood lymphocytes of gastric cancer patients.",20550524_1,-1,-1,-1,-1,12672,-1,5.094538e-05,2.964561e-05,0.9999194
12675,Th17 cells,6,8,46,56,"Interleukin (IL)-17-producing CD4(+) cells as Th17 cells and CD4(+)CD25(+)FoxP3(+) cells as Treg were evaluated by flow cytometry and expressed as a percentage of the total CD4(+) cells, in addition to performing a Th1/Th2 balance assay.",20550524_2,-1,-1,-1,-1,12675,-1,0.00041813726,0.026544388,0.9730374
12678,the total,25,27,163,172,"Interleukin (IL)-17-producing CD4(+) cells as Th17 cells and CD4(+)CD25(+)FoxP3(+) cells as Treg were evaluated by flow cytometry and expressed as a percentage of the total CD4(+) cells, in addition to performing a Th1/Th2 balance assay.",20550524_2,-1,-1,-1,-1,12678,-1,5.019088e-06,0.99998903,5.8962364e-06
12685,Th17 cells,16,18,68,78,"In TILs from patients with early disease (n = 27), the frequency of Th17 cells was significantly higher than that in the normal gastric mucosa (23.7  8.9 vs 4.5  3.1%).",20550524_4,-1,-1,-1,-1,12685,-1,0.00012935394,0.0013535261,0.9985171
12686,than that,21,23,104,113,"In TILs from patients with early disease (n = 27), the frequency of Th17 cells was significantly higher than that in the normal gastric mucosa (23.7  8.9 vs 4.5  3.1%).",20550524_4,-1,-1,-1,-1,12686,-1,5.5144387e-06,0.9999888,5.7253765e-06
12690,Th17 cells,16,18,71,81,"In TILs from patients with advanced disease (n = 28), the frequency of Th17 cells was also significantly higher, but lower compared to early disease, than that in the normal gastric mucosa (15.1  6.2 vs 4.0  2.0%).",20550524_5,-1,-1,-1,-1,12690,-1,0.00012779569,0.0014459151,0.9984263
12692,than that,30,32,150,159,"In TILs from patients with advanced disease (n = 28), the frequency of Th17 cells was also significantly higher, but lower compared to early disease, than that in the normal gastric mucosa (15.1  6.2 vs 4.0  2.0%).",20550524_5,-1,-1,-1,-1,12692,-1,5.4710167e-06,0.9999894,5.185158e-06
12695,Th17 cell-distribution,3,5,21,43,This observation for Th17 cell-distribution was also confirmed by immunohistochemistry.,20550524_6,-1,-1,-1,-1,12695,-1,0.0014511943,0.7522335,0.24631526
12700,Th17 cells,6,8,35,45,"In conclusion, the accumulation of Th17 cells as well as Treg in the tumor microenvironment of gastric cancer occurred in early disease and then the infiltration of Th17 cells gradually decreased according to the disease progression, in contrast to increased Treg.",20550524_8,-1,-1,-1,-1,12700,-1,0.00011013613,0.0013842665,0.9985057
12702,the tumor,13,15,65,74,"In conclusion, the accumulation of Th17 cells as well as Treg in the tumor microenvironment of gastric cancer occurred in early disease and then the infiltration of Th17 cells gradually decreased according to the disease progression, in contrast to increased Treg.",20550524_8,-1,-1,-1,-1,12702,-1,3.9604492e-06,0.99999106,4.992983e-06
12703,then the,24,26,140,148,"In conclusion, the accumulation of Th17 cells as well as Treg in the tumor microenvironment of gastric cancer occurred in early disease and then the infiltration of Th17 cells gradually decreased according to the disease progression, in contrast to increased Treg.",20550524_8,-1,-1,-1,-1,12703,-1,3.621812e-06,0.99999213,4.2106653e-06
12704,Th17 cells,28,30,165,175,"In conclusion, the accumulation of Th17 cells as well as Treg in the tumor microenvironment of gastric cancer occurred in early disease and then the infiltration of Th17 cells gradually decreased according to the disease progression, in contrast to increased Treg.",20550524_8,-1,-1,-1,-1,12704,-1,0.000111763264,0.0012060825,0.9986821
12705,to the,33,35,206,212,"In conclusion, the accumulation of Th17 cells as well as Treg in the tumor microenvironment of gastric cancer occurred in early disease and then the infiltration of Th17 cells gradually decreased according to the disease progression, in contrast to increased Treg.",20550524_8,-1,-1,-1,-1,12705,-1,4.311834e-06,0.9999902,5.514483e-06
12734,tumor cells,28,30,181,192,"To address these questions, wild-type or IFN-gamma-deficient OVA-specific CD8(+) T cells were activated in RAG-2(-/-) gamma c(-/-) recipients with control or IL-4-expressing OVA(+) tumor cells, and then transferred to secondary recipients for tumor challenge.",20562261_4,-1,-1,-1,-1,12734,-1,6.7469446e-05,0.00012301713,0.99980956
12735,then transferred to,32,35,198,217,"To address these questions, wild-type or IFN-gamma-deficient OVA-specific CD8(+) T cells were activated in RAG-2(-/-) gamma c(-/-) recipients with control or IL-4-expressing OVA(+) tumor cells, and then transferred to secondary recipients for tumor challenge.",20562261_4,-1,-1,-1,-1,12735,-1,4.7734684e-06,0.9999907,4.5595175e-06
12741,the transcription factor GATA-3,10,14,66,97,Tumor-derived IL-4 induced the expression of type 2 cytokines and the transcription factor GATA-3 by responding CD8 T cells while reducing their CD8 coreceptor expression and ability to eliminate a secondary tumor challenge.,20562261_5,-1,-1,-1,-1,12741,-1,9.654719e-06,0.99997854,1.1814394e-05
12762,functional,9,10,57,67,These findings may explain the anomalies in the reported functional phenotype of type 2 polarized CD8 T cells.,20562261_8,0,1,2,-1,12762,-1,0.00018975885,0.99973196,7.823545e-05
12767,immunity,18,19,120,128,OBJECTIVES: Costimulatory signals are essential for T-cell activation and hence play a very important role in antitumor immunity.,20563597_0,0,-1,2,-1,12767,-1,0.9998159,6.8798094e-05,0.0001153442
12769,to tumor necrosis factor (TNF,7,13,28,57,B7 and 4-1BBL which belongs to tumor necrosis factor (TNF) family provide costimulatory interaction for T-cell activation and function.,20563597_1,-1,-1,-1,-1,12769,-1,0.23114105,0.7668593,0.0019996155
12771,function,22,23,126,134,B7 and 4-1BBL which belongs to tumor necrosis factor (TNF) family provide costimulatory interaction for T-cell activation and function.,20563597_1,0,1,2,-1,12771,-1,0.0015732632,0.029900603,0.96852624
12776,tumor immunity,15,17,74,88,"This study investigated the role of B7 and 4-1BBL in the amplification of tumor immunity by transduction of the B7-1, B7-2 and 4-1BBL into mouse hepatocellular carcinoma cell line H22.METHODS: The tumorigenicity of H22 variants expressing either B7-1, B7-2 (H22/B7-1/B7-2) or 4-1BBL was compared with an H22 variant expressing B7-1, B7-2 and 4-1BBL (H22/B7-1/B7-2/4-1BBL).",20563597_2,-1,-1,-1,-1,12776,-1,0.00871801,0.99070144,0.00058049994
12778,the B7-1,20,24,108,116,"This study investigated the role of B7 and 4-1BBL in the amplification of tumor immunity by transduction of the B7-1, B7-2 and 4-1BBL into mouse hepatocellular carcinoma cell line H22.METHODS: The tumorigenicity of H22 variants expressing either B7-1, B7-2 (H22/B7-1/B7-2) or 4-1BBL was compared with an H22 variant expressing B7-1, B7-2 and 4-1BBL (H22/B7-1/B7-2/4-1BBL).",20563597_2,-1,-1,-1,-1,12778,-1,0.001611283,0.7094929,0.2888958
12781,The tumorigenicity,40,42,193,211,"This study investigated the role of B7 and 4-1BBL in the amplification of tumor immunity by transduction of the B7-1, B7-2 and 4-1BBL into mouse hepatocellular carcinoma cell line H22.METHODS: The tumorigenicity of H22 variants expressing either B7-1, B7-2 (H22/B7-1/B7-2) or 4-1BBL was compared with an H22 variant expressing B7-1, B7-2 and 4-1BBL (H22/B7-1/B7-2/4-1BBL).",20563597_2,-1,-1,-1,-1,12781,-1,6.4414307e-06,0.9999875,6.028539e-06
12795,cells that,14,16,66,76,"RESULTS: Syngeneic BALB/c mice injected with H22/B7-1/B7-2/4-1BBL cells that expressed elevated levels of B7-1, B7-2 and 4-1BBL showed a tumor development frequency of 50% compared with 100% in mice injected with the H22 parental line, H22/neo, H22/B7-1/B7-2 and H22/4-1BBL.",20563597_5,-1,-1,-1,-1,12795,-1,0.0026340573,0.30473298,0.6926329
12800,tumor cells,4,6,25,36,"Mice inoculated with H22 tumor cells expressing B7-1, B7-2 and 4-1BBL developed a strong cytotoxic T lymphocyte response and long-term immunity against wild-type tumor, suggesting a synergistic effect between the B7 and 4-1BBL costimulatory pathways.",20563597_6,-1,-1,-1,-1,12800,-1,0.00034261544,0.005349817,0.9943076
12804,immunity,27,28,135,143,"Mice inoculated with H22 tumor cells expressing B7-1, B7-2 and 4-1BBL developed a strong cytotoxic T lymphocyte response and long-term immunity against wild-type tumor, suggesting a synergistic effect between the B7 and 4-1BBL costimulatory pathways.",20563597_6,0,-1,2,-1,12804,-1,0.9993117,0.00043425217,0.0002541558
12806,the B7,37,39,209,215,"Mice inoculated with H22 tumor cells expressing B7-1, B7-2 and 4-1BBL developed a strong cytotoxic T lymphocyte response and long-term immunity against wild-type tumor, suggesting a synergistic effect between the B7 and 4-1BBL costimulatory pathways.",20563597_6,-1,-1,-1,-1,12806,-1,0.0029120203,0.39016843,0.6069195
12812,T-cell-mediated,25,26,156,171,Results showed that H22/B7-1/B7-2/4-1BBL tumor vaccines probably protect the infiltrating lymphocytes from apoptosis and induce NF-B activation to improve T-cell-mediated antitumor response.,20563597_7,-1,1,2,-1,12812,-1,1.189306e-05,6.87076e-06,0.99998116
12817,gene transfer,22,24,86,99,"CONCLUSIONS: In this study, the antitumor consequences of using B7-1, B7-2 and 4-1BBL gene transfer have demonstrated the therapeutic potential of gene therapy approach for hepatocellular carcinoma.",20563597_8,-1,-1,-1,-1,12817,-1,7.730071e-06,0.9999838,8.465116e-06
12818,the therapeutic,26,28,118,133,"CONCLUSIONS: In this study, the antitumor consequences of using B7-1, B7-2 and 4-1BBL gene transfer have demonstrated the therapeutic potential of gene therapy approach for hepatocellular carcinoma.",20563597_8,-1,-1,-1,-1,12818,-1,4.5081633e-06,0.99999154,3.924777e-06
12819,gene therapy,30,32,147,159,"CONCLUSIONS: In this study, the antitumor consequences of using B7-1, B7-2 and 4-1BBL gene transfer have demonstrated the therapeutic potential of gene therapy approach for hepatocellular carcinoma.",20563597_8,-1,-1,-1,-1,12819,-1,6.1458777e-06,0.9999877,6.1343358e-06
12821,T-cell,8,9,69,75,Reports focusing on the immunological microenvironment of peripheral T-cell lymphomas (PTCL) are rare.,20595635_0,-1,1,2,-1,12821,-1,1.9270274e-05,1.108109e-05,0.9999696
12826,T-cells to the,16,19,101,115,Here we studied the reciprocal contribution of regulatory (Treg) and interleukin-17-producing (Th17) T-cells to the composition of the lymphoma-associated microenvironment of angioimmunoblastic T-cell lymphoma (AITL) and PTCL not otherwise specified on tissue microarrays from 30 PTCLs not otherwise specified and 37 AITLs.,20595635_1,-1,-1,-1,-1,12826,-1,0.0029315876,0.2585575,0.73851097
12828,T-cell,26,27,194,200,Here we studied the reciprocal contribution of regulatory (Treg) and interleukin-17-producing (Th17) T-cells to the composition of the lymphoma-associated microenvironment of angioimmunoblastic T-cell lymphoma (AITL) and PTCL not otherwise specified on tissue microarrays from 30 PTCLs not otherwise specified and 37 AITLs.,20595635_1,-1,1,2,-1,12828,-1,1.7174672e-05,8.006373e-06,0.99997485
12829,tissue,37,38,253,259,Here we studied the reciprocal contribution of regulatory (Treg) and interleukin-17-producing (Th17) T-cells to the composition of the lymphoma-associated microenvironment of angioimmunoblastic T-cell lymphoma (AITL) and PTCL not otherwise specified on tissue microarrays from 30 PTCLs not otherwise specified and 37 AITLs.,20595635_1,-1,1,2,-1,12829,-1,1.2246832e-05,0.9999746,1.3129989e-05
12830,that Th17,2,4,9,18,"We found that Th17 but not Treg cells were differently represented in the two lymphomas and correlated with the amount of mast cells (MCs) and granulocytes, which preferentially occurred in the cellular milieu of AITL cases.",20595635_2,-1,-1,-1,-1,12830,-1,1.2519264e-05,0.99997747,9.99584e-06
12832,the two,12,14,70,77,"We found that Th17 but not Treg cells were differently represented in the two lymphomas and correlated with the amount of mast cells (MCs) and granulocytes, which preferentially occurred in the cellular milieu of AITL cases.",20595635_2,-1,-1,-1,-1,12832,-1,8.6341415e-06,0.99998474,6.636297e-06
12835,the cellular,33,35,190,202,"We found that Th17 but not Treg cells were differently represented in the two lymphomas and correlated with the amount of mast cells (MCs) and granulocytes, which preferentially occurred in the cellular milieu of AITL cases.",20595635_2,-1,-1,-1,-1,12835,-1,0.00392928,0.21929203,0.7767787
12839,to the,10,12,76,82,"We observed that MCs directly synthesized interleukin-6 and thus contribute to the establishment of a pro-inflammatory, Th17 permissive environment in AITL.",20595635_3,-1,-1,-1,-1,12839,-1,4.6854598e-06,0.9999906,4.7303624e-06
12841,that the,3,5,24,32,We further hypothesized that the AITL clone itself could be responsible for the preferential accumulation of MCs at sites of infiltration through the synthesis of CXCL-13 and its interaction with the CXCR3 and CXCR5 receptors expressed on MCs.,20595635_4,-1,-1,-1,-1,12841,-1,4.2563142e-06,0.9999919,3.8587673e-06
12843,through the,21,23,138,149,We further hypothesized that the AITL clone itself could be responsible for the preferential accumulation of MCs at sites of infiltration through the synthesis of CXCL-13 and its interaction with the CXCR3 and CXCR5 receptors expressed on MCs.,20595635_4,-1,-1,-1,-1,12843,-1,4.696733e-06,0.9999914,3.8430985e-06
12845,receptors,34,35,216,225,We further hypothesized that the AITL clone itself could be responsible for the preferential accumulation of MCs at sites of infiltration through the synthesis of CXCL-13 and its interaction with the CXCR3 and CXCR5 receptors expressed on MCs.,20595635_4,0,1,2,-1,12845,-1,0.0006448463,0.021784961,0.9775702
12851,toward the,18,20,103,113,"On these bases, we conclude that MCs have a role in molding the immunological microenvironment of AITL toward the maintenance of pro-inflammatory conditions prone to Th17 generation and autoimmunity.",20595635_6,-1,-1,-1,-1,12851,-1,5.994812e-06,0.9999887,5.3226595e-06
12852,to Th17 generation,25,28,163,181,"On these bases, we conclude that MCs have a role in molding the immunological microenvironment of AITL toward the maintenance of pro-inflammatory conditions prone to Th17 generation and autoimmunity.",20595635_6,-1,-1,-1,-1,12852,-1,7.3228857e-06,0.99998355,9.186963e-06
12864,CTLA-4-blocking therapy,11,13,54,77,"Here, we used this model to investigate the effect of CTLA-4-blocking therapy on the kinetics of T(reg) frequency and function.",20600326_3,-1,-1,-1,-1,12864,-1,0.0022275005,0.00667363,0.99109894
12867,function,21,22,118,126,"Here, we used this model to investigate the effect of CTLA-4-blocking therapy on the kinetics of T(reg) frequency and function.",20600326_3,0,1,2,-1,12867,-1,0.00119502,0.99238825,0.0064168056
12868,CTLA-4-blocking treatment,4,6,25,50,"As previously published, CTLA-4-blocking treatment, initiated on day 20 after bone marrow transplantation, led to overt autoimmunity by day 35.",20600326_4,-1,-1,-1,-1,12868,-1,0.0030317754,0.006436062,0.99053216
12869,transplantation,14,15,90,105,"As previously published, CTLA-4-blocking treatment, initiated on day 20 after bone marrow transplantation, led to overt autoimmunity by day 35.",20600326_4,-1,1,2,-1,12869,-1,3.838764e-05,0.99994767,1.3939565e-05
12874,The T(reg,0,2,0,9,The T(reg) expansion occurred selectively in the recipient-derived CD4+ T-cell compartment.,20600326_6,-1,-1,-1,-1,12874,-1,5.952082e-06,0.99998784,6.193732e-06
12876,T-cell,11,12,72,78,The T(reg) expansion occurred selectively in the recipient-derived CD4+ T-cell compartment.,20600326_6,-1,1,2,-1,12876,-1,1.1737832e-05,6.2830904e-06,0.999982
12884,relative to,21,23,135,146,Purified CD4(+)CD25(high)FR4(high) T(reg) from 'day 35' treated chimeras showed increased IL-10 and IFN-gamma mRNA-expression (RT-PCR) relative to control chimeras.,20600326_8,-1,-1,-1,-1,12884,-1,5.861219e-06,0.99998903,5.0994977e-06
12887,transplantation,10,11,83,98,"In this model of CTLA-4-blockade-induced autoimmunity after allogeneic bone marrow transplantation, anti-CTLA-4-mAb gives rise to a progressive expansion - without a prior transient reduction - of T(reg) cells.",20600326_9,-1,1,2,-1,12887,-1,2.249686e-05,0.99996686,1.0588373e-05
12893,function,14,15,74,82,"T(reg) of autoimmune animals do not show a defect in in vitro suppressive function but show an in vivo activated cytokine profile, suggesting that the expansion occurs as a compensatory phenomenon to control autoimmunity.",20600326_10,0,1,2,-1,12893,-1,1.1143204e-05,0.9999728,1.5986261e-05
12895,that the,25,27,142,150,"T(reg) of autoimmune animals do not show a defect in in vitro suppressive function but show an in vivo activated cytokine profile, suggesting that the expansion occurs as a compensatory phenomenon to control autoimmunity.",20600326_10,-1,-1,-1,-1,12895,-1,4.2570405e-06,0.9999918,3.937322e-06
12898,tumor antigen genes to,3,7,21,43,Targeted delivery of tumor antigen genes to dendritic cells (DCs) using adenoviral (Ad) vectors holds great potential for cancer immunotherapy.,20664356_0,-1,-1,-1,-1,12898,-1,5.141454e-05,0.9999263,2.22028e-05
12904,T-cell,27,28,185,191,"We previously showed that CD40 targeting of Ad vectors enhanced specific transduction of DC in human skin, while simultaneously ensuring their stable maturation and superior allogeneic T-cell stimulatory capacity.",20664356_1,-1,1,2,-1,12904,-1,5.09523e-05,1.3043122e-05,0.9999361
12913,T-effector cells,38,40,258,274,"In this study, we evaluated whether CD40-targeted Ad encoding the full-length melanoma antigen recognized by T cells-1 (CD40-Ad-MART-1) could be used to efficiently and selectively transduce conventional and plasmacytoid DC to prime melanoma-specific CD8(+) T-effector cells in human melanoma-draining sentinel lymph nodes (SLNs).",20664356_2,-1,-1,-1,-1,12913,-1,0.0011834694,0.14096119,0.8578553
12915,protein,10,11,60,67,"CD40 targeting of Ad was achieved using a bispecific fusion protein, binding and neutralizing the Ad fiber knob through soluble coxsackie and adenovirus receptor while retargeting the virus to hCD40 through the tumor necrosis factor-like domain of mCD40L.",20664356_3,0,1,-1,-1,12915,-1,6.192181e-06,0.9999881,5.768148e-06
12918,receptor,24,25,153,161,"CD40 targeting of Ad was achieved using a bispecific fusion protein, binding and neutralizing the Ad fiber knob through soluble coxsackie and adenovirus receptor while retargeting the virus to hCD40 through the tumor necrosis factor-like domain of mCD40L.",20664356_3,0,1,2,-1,12918,-1,0.00052319624,0.00020857742,0.99926823
12921,through the tumor,31,34,199,216,"CD40 targeting of Ad was achieved using a bispecific fusion protein, binding and neutralizing the Ad fiber knob through soluble coxsackie and adenovirus receptor while retargeting the virus to hCD40 through the tumor necrosis factor-like domain of mCD40L.",20664356_3,-1,-1,-1,-1,12921,-1,1.9346222e-05,0.9999682,1.2500298e-05
12922,factor-like,35,36,226,237,"CD40 targeting of Ad was achieved using a bispecific fusion protein, binding and neutralizing the Ad fiber knob through soluble coxsackie and adenovirus receptor while retargeting the virus to hCD40 through the tumor necrosis factor-like domain of mCD40L.",20664356_3,0,1,-1,-1,12922,-1,0.9998381,2.9882505e-05,0.0001319897
12927,functional,7,8,51,61,"Moreover, CD40-Ad-MART-1 enhanced the expansion of functional MART-1-specific CD8(+) T cells from SLN with concomitant decreases in CD4:CD8 T-cell ratios and CD4(+)CD25(hi)FoxP3(+) regulatory T-cell rates.",20664356_5,0,1,2,-1,12927,-1,6.259559e-05,0.99990463,3.278934e-05
12929,T-cell,20,21,140,146,"Moreover, CD40-Ad-MART-1 enhanced the expansion of functional MART-1-specific CD8(+) T cells from SLN with concomitant decreases in CD4:CD8 T-cell ratios and CD4(+)CD25(hi)FoxP3(+) regulatory T-cell rates.",20664356_5,-1,1,2,-1,12929,-1,1.5709942e-05,7.578018e-06,0.99997663
12931,that transduction,3,5,28,45,Additional studies revealed that transduction and activation of monocyte-derived DCs with CD40-Ad-MART-1 significantly enhanced their priming efficiency of functional CD8(+) effector T cells with high avidity.,20664356_6,-1,-1,-1,-1,12931,-1,5.795467e-06,0.9999895,4.647605e-06
12933,functional,18,19,156,166,Additional studies revealed that transduction and activation of monocyte-derived DCs with CD40-Ad-MART-1 significantly enhanced their priming efficiency of functional CD8(+) effector T cells with high avidity.,20664356_6,0,1,2,-1,12933,-1,0.00018123645,0.9997439,7.485457e-05
12943,therapy,23,24,146,153,"Unfortunately, the need for multiple administrations of antigens often limits the use of one of the most effective vaccine approaches, immunogene therapy using viral vectors, because neutralizing antibodies are rapidly produced.",20683443_1,0,1,-1,-1,12943,-1,6.8648105e-06,0.9999875,5.643329e-06
12945,therapy,6,7,44,51,"We hypothesized that after viral immunogene therapy ""primed"" an initial strong antitumor immune response, subsequent ""boosts"" could be provided by sequential courses of chemotherapy.",20683443_2,0,1,-1,-1,12945,-1,9.32604e-06,0.99998343,7.221975e-06
12949,therapy,4,5,39,46,Three adenoviral (Ad)-based immunogene therapy regimens were administered to animals with large malignant mesothelioma and lung cancer tumors followed by three weekly administrations of a drug regimen commonly used to treat these tumors (Cisplatin/Gemcitabine).,20683443_3,0,1,-1,-1,12949,-1,8.301304e-06,0.99998343,8.285019e-06
12953,to treat these tumors,29,33,215,236,Three adenoviral (Ad)-based immunogene therapy regimens were administered to animals with large malignant mesothelioma and lung cancer tumors followed by three weekly administrations of a drug regimen commonly used to treat these tumors (Cisplatin/Gemcitabine).,20683443_3,-1,-1,-1,-1,12953,-1,4.675519e-06,0.99999046,4.898098e-06
12954,therapy,1,2,11,18,"Immunogene therapy followed by chemotherapy resulted in markedly increased antitumor efficacy associated with increased numbers of antigen-specific, activated CD8(+) T-cells systemically and within the tumors.",20683443_4,0,1,-1,-1,12954,-1,8.114352e-06,0.9999856,6.289731e-06
12957,T-cells,21,22,166,173,"Immunogene therapy followed by chemotherapy resulted in markedly increased antitumor efficacy associated with increased numbers of antigen-specific, activated CD8(+) T-cells systemically and within the tumors.",20683443_4,-1,1,2,-1,12957,-1,1.3711928e-05,7.977195e-06,0.9999783
12958,the tumors,25,27,198,208,"Immunogene therapy followed by chemotherapy resulted in markedly increased antitumor efficacy associated with increased numbers of antigen-specific, activated CD8(+) T-cells systemically and within the tumors.",20683443_4,-1,-1,-1,-1,12958,-1,3.793786e-06,0.99999154,4.7153317e-06
12961,T-regulatory cells,20,22,120,138,"Possible mechanisms included: (i) decreases in immunosuppressive cells such as myeloid-derived suppressor cells (MDSC), T-regulatory cells (T-regs), and B-cells, (ii) stimulation of memory cells by intratumoral antigen release leading to efficient cross-priming, (iii) alteration of the tumor microenvironment with production of ""danger signals"" and immunostimulatory cytokines, and (iv) augmented trafficking of T-cells into the tumors.",20683443_5,-1,-1,-1,-1,12961,-1,0.0018800016,0.27287808,0.72524196
12964,antigen release,38,40,211,226,"Possible mechanisms included: (i) decreases in immunosuppressive cells such as myeloid-derived suppressor cells (MDSC), T-regulatory cells (T-regs), and B-cells, (ii) stimulation of memory cells by intratumoral antigen release leading to efficient cross-priming, (iii) alteration of the tumor microenvironment with production of ""danger signals"" and immunostimulatory cytokines, and (iv) augmented trafficking of T-cells into the tumors.",20683443_5,-1,-1,-1,-1,12964,-1,0.99852115,0.0010218739,0.00045695205
12966,the tumor,50,52,283,292,"Possible mechanisms included: (i) decreases in immunosuppressive cells such as myeloid-derived suppressor cells (MDSC), T-regulatory cells (T-regs), and B-cells, (ii) stimulation of memory cells by intratumoral antigen release leading to efficient cross-priming, (iii) alteration of the tumor microenvironment with production of ""danger signals"" and immunostimulatory cytokines, and (iv) augmented trafficking of T-cells into the tumors.",20683443_5,-1,-1,-1,-1,12966,-1,4.2148554e-06,0.9999912,4.60766e-06
12969,T-cells,71,72,413,420,"Possible mechanisms included: (i) decreases in immunosuppressive cells such as myeloid-derived suppressor cells (MDSC), T-regulatory cells (T-regs), and B-cells, (ii) stimulation of memory cells by intratumoral antigen release leading to efficient cross-priming, (iii) alteration of the tumor microenvironment with production of ""danger signals"" and immunostimulatory cytokines, and (iv) augmented trafficking of T-cells into the tumors.",20683443_5,-1,1,2,-1,12969,-1,1.1301951e-05,5.641706e-06,0.9999831
12970,the tumors,73,75,426,436,"Possible mechanisms included: (i) decreases in immunosuppressive cells such as myeloid-derived suppressor cells (MDSC), T-regulatory cells (T-regs), and B-cells, (ii) stimulation of memory cells by intratumoral antigen release leading to efficient cross-priming, (iii) alteration of the tumor microenvironment with production of ""danger signals"" and immunostimulatory cytokines, and (iv) augmented trafficking of T-cells into the tumors.",20683443_5,-1,-1,-1,-1,12970,-1,3.9089823e-06,0.9999913,4.776577e-06
12976,therapy,20,21,117,124,This approach is currently being tested in a clinical trial and could be applied to other trials of viral immunogene therapy.,20683443_6,0,1,-1,-1,12976,-1,1.1384699e-05,0.99997854,1.0122208e-05
12981,protein,19,20,101,108,"Given that local cell-mediated immunity (CMI) against the human papillomavirus type 16 E6 (HPV16 E6) protein is important for eradication of HPV16 E6-expressing cancer cells in the cervical mucosa, the HPV16 E6 protein may be a target for the mucosal immunotherapy of cervical cancer.",20706715_0,0,1,-1,-1,12981,-1,3.3937897e-05,0.9999515,1.4582816e-05
12985,protein,37,38,211,218,"Given that local cell-mediated immunity (CMI) against the human papillomavirus type 16 E6 (HPV16 E6) protein is important for eradication of HPV16 E6-expressing cancer cells in the cervical mucosa, the HPV16 E6 protein may be a target for the mucosal immunotherapy of cervical cancer.",20706715_0,0,1,-1,-1,12985,-1,3.385809e-05,0.9999509,1.5283627e-05
12995,to the,1,3,9,15,"Compared to the L. casei-PgsA-treated mice, significantly higher levels of serum IgG and mucosal IgA were observed in L. casei-PgsA-E6-immunized mice; these differences were significantly enhanced after boost.",20706715_3,-1,-1,-1,-1,12995,-1,4.223331e-06,0.99999154,4.1809362e-06
12999,IFN-gamma-secreting cells,21,23,123,148,"Consistent with this, systemic and local CMI were significantly increased after the boost, as shown by increased counts of IFN-gamma-secreting cells in splenocytes, mesenteric lymph nodes (MLN), and vaginal samples.",20706715_4,-1,-1,-1,-1,12999,-1,0.9753736,0.000121324,0.024505155
13000,the TC-1 tumor,3,6,16,30,"Furthermore, in the TC-1 tumor model, animals receiving the orally administered L. casei-PgsA-E6 showed reduced tumor size and increased survival rate versus mice receiving control (L. casei-PgsA) immunization.",20706715_5,-1,-1,-1,-1,13000,-1,4.3996333e-06,0.9999893,6.3382336e-06
13006,that the,5,7,37,45,"Collectively, these results indicate that the oral administration of lactobacilli bearing the surface-displayed E6 protein induces T cell-mediated cellular immunity and antitumor effects in mice.",20706715_7,-1,-1,-1,-1,13006,-1,4.872497e-06,0.9999914,3.6740482e-06
13008,protein,15,16,115,122,"Collectively, these results indicate that the oral administration of lactobacilli bearing the surface-displayed E6 protein induces T cell-mediated cellular immunity and antitumor effects in mice.",20706715_7,0,1,-1,-1,13008,-1,6.2141866e-05,0.9999063,3.154721e-05
13009,T cell-mediated cellular immunity,17,21,131,164,"Collectively, these results indicate that the oral administration of lactobacilli bearing the surface-displayed E6 protein induces T cell-mediated cellular immunity and antitumor effects in mice.",20706715_7,-1,-1,-1,-1,13009,-1,1.6276328e-05,6.426344e-06,0.99997723
13013,therapy,14,15,87,94,BACKGROUND: High-dose interferon-alpha 2b (IFN-alpha 2b) is the only approved systemic therapy in the United States for the adjuvant treatment of melanoma.,20712892_0,0,1,-1,-1,13013,-1,6.619287e-06,0.9999875,5.930051e-06
13021,mechanism of action,8,11,56,75,"The study objective was to explore the immunomodulatory mechanism of action for IFN-alpha 2b by measuring serum regulatory T cell (Treg), serum transforming growth factor-beta (TGF-beta), interleukin (IL)-10, and autoantibody levels in patients with melanoma treated with the induction phase of the high-dose IFN-alpha 2b regimen.",20712892_1,0,1,-1,-1,13021,-1,9.900462e-05,0.9998393,6.1718616e-05
13026,TGF-beta,29,30,177,185,"The study objective was to explore the immunomodulatory mechanism of action for IFN-alpha 2b by measuring serum regulatory T cell (Treg), serum transforming growth factor-beta (TGF-beta), interleukin (IL)-10, and autoantibody levels in patients with melanoma treated with the induction phase of the high-dose IFN-alpha 2b regimen.",20712892_1,0,1,-1,-1,13026,-1,0.00017750016,0.99979156,3.0938263e-05
13037,TGF-beta,16,17,94,102,"Serum Treg levels were measured as whole lymphocytes in CD4+ cells using flow cytometry while TGF-beta, IL-10, and autoantibody levels were measured using enzyme-linked immunosorbent assays.",20712892_3,0,1,-1,-1,13037,-1,0.00011672907,0.9998603,2.2986454e-05
13054,TGF-beta,9,10,54,62,"No significant effects were observed on the levels of TGF-beta, IL-10, and autoantibodies in patients with melanoma treated with IFN-alpha 2b.",20712892_8,0,1,-1,-1,13054,-1,5.7281904e-05,0.9999255,1.7269163e-05
13059,Treg that,13,15,83,92,CONCLUSIONS: Patients with melanoma in this study showed increased basal levels of Treg that may be relevant to their disease and its progression.,20712892_9,-1,-1,-1,-1,13059,-1,4.9595965e-06,0.9999881,7.018239e-06
13060,relevant to their,17,20,100,117,CONCLUSIONS: Patients with melanoma in this study showed increased basal levels of Treg that may be relevant to their disease and its progression.,20712892_9,-1,-1,-1,-1,13060,-1,1.8491464e-05,0.99996626,1.52042085e-05
13075,T-cell,4,5,17,23,"Among the CD4(+) T-cell population in the skin, at least one-fifth express Foxp3.",20722759_1,-1,1,2,-1,13075,-1,1.2568213e-05,8.267628e-06,0.99997926
13079,to antigenic,6,8,34,46,"As the skin is constantly exposed to antigenic challenge and is a common site of vaccination, understanding the role of these skin-resident Treg cells is important.",20722759_2,-1,-1,-1,-1,13079,-1,0.223337,0.77458584,0.0020771981
13086,the types,18,20,97,106,"Although the suppressive effect of Treg cells on T cells is well documented, less is known about the types of innate immune cells influenced by Treg cells and whether the Treg cells suppress acute innate immune responses in vivo.",20722759_3,-1,-1,-1,-1,13086,-1,7.943271e-06,0.9999825,9.564397e-06
13089,the Treg cells,30,33,167,181,"Although the suppressive effect of Treg cells on T cells is well documented, less is known about the types of innate immune cells influenced by Treg cells and whether the Treg cells suppress acute innate immune responses in vivo.",20722759_3,-1,-1,-1,-1,13089,-1,0.0012716524,0.07708187,0.9216465
13094,that Treg cells,2,5,15,30,We demonstrate that Treg cells limit this response by inhibiting neutrophil accumulation and survival within hours of tumour cell inoculation.,20722759_5,-1,-1,-1,-1,13094,-1,0.0023910548,0.15885493,0.83875394
13096,tumour cell,17,19,118,129,We demonstrate that Treg cells limit this response by inhibiting neutrophil accumulation and survival within hours of tumour cell inoculation.,20722759_5,-1,-1,-1,-1,13096,-1,7.5894255e-05,0.00013166158,0.9997924
13099,chemoattractants CXCL1,12,14,78,100,"This effect, which was associated with decreased expression of the neutrophil chemoattractants CXCL1 and CXCL2, promoted survival of the inoculated tumour cells.",20722759_6,-1,-1,-1,-1,13099,-1,0.9999279,9.732362e-06,6.2379586e-05
13102,tumour cells,22,24,148,160,"This effect, which was associated with decreased expression of the neutrophil chemoattractants CXCL1 and CXCL2, promoted survival of the inoculated tumour cells.",20722759_6,-1,-1,-1,-1,13102,-1,0.00024860786,0.002304688,0.99744666
13104,that Treg cells,5,8,26,41,"Overall, these data imply that Treg cells in the skin are rapidly mobilized and that this activity serves to limit the amplification of inflammatory responses at this site.",20722759_7,-1,-1,-1,-1,13104,-1,0.001821997,0.12849829,0.86967975
13106,that this,15,17,80,89,"Overall, these data imply that Treg cells in the skin are rapidly mobilized and that this activity serves to limit the amplification of inflammatory responses at this site.",20722759_7,-1,-1,-1,-1,13106,-1,5.558596e-06,0.99998987,4.576503e-06
13112,cellular targets,37,39,253,269,"BACKGROUND: Anti-CD20 monoclonal antibody treatment has not only increased survival and cure rates in many non-Hodgkin lymphomas, but also has prompted an explosion in the development of novel antibodies and biologically active substances with specific cellular targets in the field of malignancies treatment.",20815894_0,-1,-1,-1,-1,13112,-1,0.0007141675,0.0071915495,0.9920942
13117,the gene-modified T cells,8,12,50,75,"Since the robust immune responses are elicited by the gene-modified T cells, gene based T cell therapy may also provide a powerful tool for cancer immunotherapy.",20815894_1,-1,-1,-1,-1,13117,-1,0.0022072808,0.8400664,0.15772635
13119,T cell therapy,15,18,88,102,"Since the robust immune responses are elicited by the gene-modified T cells, gene based T cell therapy may also provide a powerful tool for cancer immunotherapy.",20815894_1,-1,-1,-1,-1,13119,-1,0.0006964773,0.015402539,0.98390096
13122,T cell receptor that,14,18,79,99,"METHODS: In this study, we developed a vector construction encoding a chimeric T cell receptor that recognizes the CD20 antigen and delivers co-stimulatory signals to achieve T cell activation.",20815894_2,-1,-1,-1,-1,13122,-1,0.0012335634,0.02290301,0.97586346
13129,blood-derived T cells,10,13,74,95,One non-Hodgkin lymphoma cell line Raji cells co-cultured with peripheral blood-derived T cells were stably transfected with anti-CD20scFvFc/CD28/CD3zeta gene or anti-CD20scFvFc gene.,20815894_3,-1,-1,-1,-1,13129,-1,0.0010405114,0.0028503314,0.99610907
13146,blood-derived T cells,13,16,94,115,"Activity of AP-1 was analyzed by EMSA.RESULTS: Following efficient transduction of peripheral blood-derived T cells with anti-CD20scFvFc/CD28/CD3zeta gene, an obvious cell lysis of Raji cells was observed in co-culture.",20815894_8,-1,-1,-1,-1,13146,-1,0.00092624,0.006090312,0.99298346
13150,T cells transduced,0,3,0,18,T cells transduced anti-CD20scFvFc/CD28/CD3zeta gene had superior secretion of IFN-gamma and IL-2 compared to T cells transduced anti-CD20scFvFc gene.,20815894_9,-1,-1,-1,-1,13150,-1,0.001025683,0.02176264,0.9772117
13153,to T cells transduced,13,17,107,128,T cells transduced anti-CD20scFvFc/CD28/CD3zeta gene had superior secretion of IFN-gamma and IL-2 compared to T cells transduced anti-CD20scFvFc gene.,20815894_9,-1,-1,-1,-1,13153,-1,5.3033862e-05,0.99975747,0.00018947036
13159,T cells transduced,4,7,26,44,"CONCLUSION: So adoptively T cells transduced anti-CD20scFvFc/CD28/CD3zeta gene mediates enhanced anti-tumor activities against CD20 positive tumor cells, suggesting a potential of gene-based immunotherapy for non-Hodgkin lymphoma.",20815894_11,-1,-1,-1,-1,13159,-1,0.0017492066,0.06588845,0.93236226
13161,tumor cells,16,18,141,152,"CONCLUSION: So adoptively T cells transduced anti-CD20scFvFc/CD28/CD3zeta gene mediates enhanced anti-tumor activities against CD20 positive tumor cells, suggesting a potential of gene-based immunotherapy for non-Hodgkin lymphoma.",20815894_11,-1,-1,-1,-1,13161,-1,4.489333e-05,0.00012133737,0.9998337
13163,function,4,5,28,36,OBJECTIVE: Defective immune function is an important cause of tumor development.,20822377_0,0,1,2,-1,13163,-1,0.14920372,0.8156245,0.035171747
13167,function,17,18,105,113,Accumulation of myeloid-derived suppressor cell (MDSC) associated with inhibition of dendritic cell (DC) function is one of the major immunological abnormalities in cancer.,20822377_1,0,1,2,-1,13167,-1,0.00014908296,0.00047177466,0.99937916
13175,blood,11,12,61,66,"Then we detected the frequency of MDSC in spleen, peripheral blood (PB), lymph node (LN) and tumor tissue of HCC mice and its potential mechanisms.",20822377_4,0,1,-1,-1,13175,-1,0.004467995,0.63038707,0.36514494
13176,tumor tissue,22,24,93,105,"Then we detected the frequency of MDSC in spleen, peripheral blood (PB), lymph node (LN) and tumor tissue of HCC mice and its potential mechanisms.",20822377_4,-1,-1,-1,-1,13176,-1,8.055894e-06,0.9999708,2.117607e-05
13178,function,14,15,82,90,We also evaluated IL-10 production of MDSC and mechanism by which MDSC inhibit DC function.,20822377_5,0,1,2,-1,13178,-1,0.0005095325,0.9960198,0.0034707428
13179,Toll-like receptor,2,4,9,27,"RESULTS: Toll-like receptor (TLR)-ligand (LPS, CpG, poly(I:C))-induced IL-12 production of DC was decreased in HCC mice compared with control.",20822377_6,-1,-1,-1,-1,13179,-1,0.0014844056,0.96554685,0.032968745
13182,The T cell,0,3,0,10,The T cell stimulatory activity of DC was lower in HCC mice than in controls.,20822377_7,-1,-1,-1,-1,13182,-1,0.0054752245,0.27511305,0.7194117
13187,the IL-10,24,26,115,124,"Meanwhile, an increase in the frequency of MDSC in tumor development was detected in spleen, PB, LN and tumor, and the IL-10 levels were higher in HCC mice derived MDSC than in control.",20822377_8,-1,-1,-1,-1,13187,-1,0.88692147,0.11090832,0.0021702198
13190,TLR-ligand-induced IL-12,5,7,32,56,"Furthermore, the MDSC inhibited TLR-ligand-induced IL-12 production of DC by IL-10 production and suppressed T cell stimulatory activity of DC.",20822377_9,-1,-1,-1,-1,13190,-1,0.44237506,0.5542115,0.003413437
13193,that the,4,6,25,33,"Finally, we demonstrated that the increase in the frequency of MDSC was mediated by MyD88-NF-kB pathway.",20822377_10,-1,-1,-1,-1,13193,-1,4.3898845e-06,0.999992,3.624925e-06
13198,antigen-specific cytotoxic T lymphocytes,3,7,21,61,Adoptive transfer of antigen-specific cytotoxic T lymphocytes has shown promise for the therapy of cancer.,20842106_0,-1,-1,-1,-1,13198,-1,0.51100266,0.00040226468,0.48859504
13199,the therapy,11,13,84,95,Adoptive transfer of antigen-specific cytotoxic T lymphocytes has shown promise for the therapy of cancer.,20842106_0,-1,-1,-1,-1,13199,-1,4.589399e-06,0.99999034,5.058971e-06
13200,tumor-specific T cells,2,5,9,31,"However, tumor-specific T cells are susceptible to diverse inhibitory signals from the tumor microenvironment.",20842106_1,-1,-1,-1,-1,13200,-1,0.0027346003,0.78031874,0.21694668
13202,the tumor,12,14,83,92,"However, tumor-specific T cells are susceptible to diverse inhibitory signals from the tumor microenvironment.",20842106_1,-1,-1,-1,-1,13202,-1,5.5439946e-06,0.99998987,4.6072355e-06
13206,function,12,13,71,79,"The Akt/protein kinase B plays a central role in T-cell proliferation, function, and survival and we hypothesized that expression of constitutively active Akt (caAkt) in T cells could provide resistance to many of these tumor-associated inhibitory mechanisms.",20842106_2,0,1,2,-1,13206,-1,0.0012011689,0.055920422,0.94287837
13210,these tumor-associated,37,39,214,236,"The Akt/protein kinase B plays a central role in T-cell proliferation, function, and survival and we hypothesized that expression of constitutively active Akt (caAkt) in T cells could provide resistance to many of these tumor-associated inhibitory mechanisms.",20842106_2,-1,-1,-1,-1,13210,-1,7.81721e-06,0.9999857,6.51541e-06
13221,to T cells,6,9,52,62,"These characteristics provided a survival advantage to T cells cocultured with tumor cells in vitro; CD3/28-stimulated T cells expressing a chimeric antigen receptor (CAR) specific for disialoganglioside (GD2) that redirected their activity to the immunosuppressive, GD2-expressing neuroblastoma cell line, LAN-1, resisted tumor-induced apoptosis when co-expressing transgenic caAkt.",20842106_5,-1,-1,-1,-1,13221,-1,0.0017644127,0.12252581,0.8757097
13222,tumor cells,11,13,79,90,"These characteristics provided a survival advantage to T cells cocultured with tumor cells in vitro; CD3/28-stimulated T cells expressing a chimeric antigen receptor (CAR) specific for disialoganglioside (GD2) that redirected their activity to the immunosuppressive, GD2-expressing neuroblastoma cell line, LAN-1, resisted tumor-induced apoptosis when co-expressing transgenic caAkt.",20842106_5,-1,-1,-1,-1,13222,-1,0.000104643404,0.001059979,0.9988354
13227,to the,37,39,241,247,"These characteristics provided a survival advantage to T cells cocultured with tumor cells in vitro; CD3/28-stimulated T cells expressing a chimeric antigen receptor (CAR) specific for disialoganglioside (GD2) that redirected their activity to the immunosuppressive, GD2-expressing neuroblastoma cell line, LAN-1, resisted tumor-induced apoptosis when co-expressing transgenic caAkt.",20842106_5,-1,-1,-1,-1,13227,-1,4.69011e-06,0.9999908,4.4304525e-06
13236,transferred T lymphocytes,24,27,170,195,"In conclusion, caAkt-transduced T cells showed resistance to several evasion strategies employed by tumors and may therefore enhance the antitumor activity of adoptively transferred T lymphocytes.",20842106_6,-1,-1,-1,-1,13236,-1,0.0016419177,0.08502992,0.9133282
13240,the tumor,2,4,13,22,We evaluated the tumor response and in vivo expansion of allogeneic NK cells in recurrent ovarian and breast cancer.,20849361_1,-1,-1,-1,-1,13240,-1,4.820901e-06,0.9999906,4.6162904e-06
13252,blood,29,30,163,168,"Subcutaneous IL-2 (10 MU) was given three times/week  6 doses after NK cell infusion to promote expansion, defined as detection of 100 donor-derived NK cells/L blood 14 days after infusion, based on molecular chimerism and flow cytometry.",20849361_4,0,1,-1,-1,13252,-1,0.05121622,0.7854708,0.16331297
13259,T-regulatory cells,0,2,0,18,T-regulatory cells (Treg) were elevated at day +14 compared with pre-chemotherapy (P = 0.03).,20849361_9,-1,-1,-1,-1,13259,-1,0.002727265,0.2940578,0.703215
13277,the tumor,9,11,52,61,"In addition, the ratio of various subpopulations in the tumor microenvironment is highly dependent on the nature of the host's immune response.",20857491_1,-1,-1,-1,-1,13277,-1,4.4587646e-06,0.99999034,5.200213e-06
13278,the nature,16,18,102,112,"In addition, the ratio of various subpopulations in the tumor microenvironment is highly dependent on the nature of the host's immune response.",20857491_1,-1,-1,-1,-1,13278,-1,6.723004e-06,0.9999862,7.109716e-06
13283,the tumor that,10,13,57,71,"Here, we characterize Foxp3-expressing CD8(+) T cells in the tumor that demonstrate effector function and accumulate in the context of an effective anti-tumor response.",20857491_2,-1,-1,-1,-1,13283,-1,3.5511505e-06,0.99999225,4.256827e-06
13284,function,15,16,93,101,"Here, we characterize Foxp3-expressing CD8(+) T cells in the tumor that demonstrate effector function and accumulate in the context of an effective anti-tumor response.",20857491_2,0,1,2,-1,13284,-1,0.00013463975,0.9994267,0.00043869676
13295,tumor antigen-specific,3,5,20,42,Foxp3 expression in tumor antigen-specific CD8 T cells is restricted to the tumor microenvironment and influenced by cues in the tumor.,20857491_4,-1,-1,-1,-1,13295,-1,0.6818922,0.31623015,0.0018776712
13297,to the tumor,10,13,69,81,Foxp3 expression in tumor antigen-specific CD8 T cells is restricted to the tumor microenvironment and influenced by cues in the tumor.,20857491_4,-1,-1,-1,-1,13297,-1,5.799486e-06,0.99998844,5.7259044e-06
13298,the tumor,19,21,125,134,Foxp3 expression in tumor antigen-specific CD8 T cells is restricted to the tumor microenvironment and influenced by cues in the tumor.,20857491_4,-1,-1,-1,-1,13298,-1,4.8422335e-06,0.99999046,4.7283143e-06
13309,tolerance to,24,26,124,136,"Adoptive transfer studies, using RNEU((420-429)) -specific effector T cells into neu-N mice (a model that results in immune tolerance to neu), confirm that CD8(+) Foxp3(+) T cells are present in tumors only if there is an existing pool of tumor-rejecting effector T cells.",20857491_6,-1,-1,-1,-1,13309,-1,4.8249103e-06,0.99999034,4.8014817e-06
13320,tumor-rejecting antigen-specific T cells,9,13,42,82,CD8(+) Foxp3(+) TILs mark the presence of tumor-rejecting antigen-specific T cells and their accumulation serves as a marker for an effective T cell response.,20857491_7,-1,-1,-1,-1,13320,-1,0.022751573,0.7568836,0.22036481
13328,the antigen-induced,23,25,131,150,"Such early effectors, if present, should be characterized by a specific phenotype, distinct from that expressed at later stages of the antigen-induced differentiation program, by short-lived effector cells, memory precursors, and terminal effectors.",20861189_1,-1,-1,-1,-1,13328,-1,0.6899093,0.30762017,0.002470569
13333,tissues,6,7,30,37,"Here, we show that neoplastic tissues from primary and metastatic lesions of melanoma patients contain a subset of CD8(+) T cells expressing FOXP3.",20861189_2,-1,1,2,-1,13333,-1,0.00035382115,0.9477459,0.051900283
13344,blood,15,16,105,110,Their frequency was significantly higher in TILN compared with tumor-free lymph nodes or with peripheral blood and in primary tumors compared with TILN.,20861189_4,0,1,-1,-1,13344,-1,0.001878318,0.013598539,0.9845232
13354,factor-1,24,25,121,130,"CD8(+) FOXP3(+) T cells did not express markers of regulatory [CTLA-4, CCL4, interleukin-10 (IL-10), transforming growth factor-1], exhausted (PD-1), or senescent (CD57) CD8(+) T lymphocytes.",20861189_5,0,1,-1,-1,13354,-1,0.9948689,0.0005180102,0.004613114
13356,this subset,2,4,9,20,"Instead, this subset showed an antigen-experienced ""EM1"" phenotype (CCR7(-) CD45RA(-) CD28(+) CD27(+)) and exhibited a CD127(-), KLRG1(-), HLA-DR(+), CD38(+), T-bet(+), perforin(+) ""early effector"" profile predicted by current models.",20861189_6,-1,-1,-1,-1,13356,-1,0.0013861087,0.27606195,0.72255194
13364,analysis,27,28,152,160,"CD8(+) FOXP3(+) T cells produced IFN- on short in vitro activation, recognized autologous tumor by CD107a mobilization, and expressed Ki-67 on ex vivo analysis.",20861189_7,0,1,-1,-1,13364,-1,5.6572576e-06,0.99998736,7.0061906e-06
13366,tumor plus,4,6,26,36,"In response to autologous tumor plus IL-2/IL-15, the CD8(+) FOXP3(+) T cells proliferated promptly and showed competence for differentiation (downregulation of CD27 and upregulation of T-bet).",20861189_8,-1,-1,-1,-1,13366,-1,2.8720455e-05,0.9999571,1.4226282e-05
13372,immunity,9,10,63,71,These results suggest development of early phases of antitumor immunity even in advanced melanoma.,20861189_9,0,-1,2,-1,13372,-1,0.9999151,1.6594724e-05,6.8335015e-05
13377,immunity,19,20,95,103,"Moreover, the CD8(+) FOXP3(+) ""early effector"" subset may be an invaluable tool for monitoring immunity at tumor site.",20861189_10,0,-1,2,-1,13377,-1,0.999193,0.0004975002,0.00030950853
13380,the function,6,8,32,44,"In cancer, the phenotype and/or the function of T cells may differ according to their distribution through immune-associated tissues, namely immune compartments.",20883319_0,-1,-1,-1,-1,13380,-1,4.1085746e-05,0.99990976,4.9172868e-05
13382,to their,14,16,77,85,"In cancer, the phenotype and/or the function of T cells may differ according to their distribution through immune-associated tissues, namely immune compartments.",20883319_0,-1,-1,-1,-1,13382,-1,5.8033843e-06,0.99998903,5.182175e-06
13384,tissues,19,20,125,132,"In cancer, the phenotype and/or the function of T cells may differ according to their distribution through immune-associated tissues, namely immune compartments.",20883319_0,-1,1,2,-1,13384,-1,0.00018903357,0.006161793,0.9936492
13390,the T cell subsets,24,28,147,165,"Here, in N-methyl-N-nitrosourea (MNU)-induced mammary carcinomas of rat as a relevant model for human breast tumors, the impact of tumor burden on the T cell subsets populating the tumor microenvironment, the tumor-adjacent and -opposite mammary lymph nodes, and the spleen was assessed.",20883319_1,-1,-1,-1,-1,13390,-1,0.0017741848,0.06698191,0.9312439
13391,the tumor,29,31,177,186,"Here, in N-methyl-N-nitrosourea (MNU)-induced mammary carcinomas of rat as a relevant model for human breast tumors, the impact of tumor burden on the T cell subsets populating the tumor microenvironment, the tumor-adjacent and -opposite mammary lymph nodes, and the spleen was assessed.",20883319_1,-1,-1,-1,-1,13391,-1,4.581334e-06,0.9999901,5.2574164e-06
13392,the tumor-adjacent,33,35,205,223,"Here, in N-methyl-N-nitrosourea (MNU)-induced mammary carcinomas of rat as a relevant model for human breast tumors, the impact of tumor burden on the T cell subsets populating the tumor microenvironment, the tumor-adjacent and -opposite mammary lymph nodes, and the spleen was assessed.",20883319_1,-1,-1,-1,-1,13392,-1,2.485216e-05,0.99995506,2.0068795e-05
13394,the tumors,1,3,3,13,"In the tumors, ratio of CD8(+) cytotoxic and CD4(+) helper T cells were not significantly different than other immune compartments.",20883319_2,-1,-1,-1,-1,13394,-1,3.6958024e-06,0.9999918,4.5398624e-06
13398,these cells,7,9,27,38,"On the other hand, most of these cells were further identified with CD4(+) CD25(hi) or CD4(+) Foxp3(+) , CD8(+) Foxp3(+) regulatory phenotype.",20883319_3,-1,-1,-1,-1,13398,-1,2.3798537e-05,3.3371958e-05,0.9999428
13405,tissue,13,14,85,91,The selective presence of Tregs in the mammary tumors but not in neighboring-mammary tissue was also confirmed by the expression of Treg-associated genes.,20883319_4,-1,1,2,-1,13405,-1,0.0003440298,0.14763008,0.85202587
13407,Treg-associated genes,21,23,132,153,The selective presence of Tregs in the mammary tumors but not in neighboring-mammary tissue was also confirmed by the expression of Treg-associated genes.,20883319_4,-1,-1,-1,-1,13407,-1,5.151392e-06,0.9999896,5.184076e-06
13411,the tumors,13,15,84,94,The percentage of CD161(+) NKT cells was also significantly increased especially in the tumors and mammary lymph nodes.,20883319_5,-1,-1,-1,-1,13411,-1,3.846545e-06,0.9999914,4.7870712e-06
13414,to the,10,12,57,63,"In the lymph nodes of tumor-bearing animals, in contrast to the spleen, total amount of CD8(+) cells and CD4(+) cells were increased but both of these compartments harbored high numbers of CD4(+) CD25(hi) Treg cells.",20883319_6,-1,-1,-1,-1,13414,-1,3.9258157e-06,0.99999106,5.0606973e-06
13426,the T cells,23,26,149,160,"TGF- was determined as the major suppressive cytokine secreted by the immune cells of tumor-bearing animals, in addition, proliferation capacity of the T cells was diminished.",20883319_7,-1,-1,-1,-1,13426,-1,0.0017315861,0.09986356,0.8984049
13428,T cell subsets through the,6,11,40,66,"Hence, the differential distribution of T cell subsets through the spleen, the mammary lymph nodes and the tumor mass in MNU-induced mammary tumor-bearing animals may contribute to a tumor-associated immunosuppression.",20883319_8,-1,-1,-1,-1,13428,-1,0.0020896331,0.09434502,0.9035653
13430,the tumor,18,20,103,112,"Hence, the differential distribution of T cell subsets through the spleen, the mammary lymph nodes and the tumor mass in MNU-induced mammary tumor-bearing animals may contribute to a tumor-associated immunosuppression.",20883319_8,-1,-1,-1,-1,13430,-1,4.1044264e-06,0.9999901,5.730421e-06
13439,immune response gene,3,6,17,37,"Indeed, specific immune response gene signatures, obtained from whole biopsy samples, have been associated with patient survival.",20944673_1,-1,-1,-1,-1,13439,-1,0.9689132,0.030035947,0.0010507993
13446,functional,13,14,93,103,We identified 677 non-redundant genes defining the FL interface and involving 26 FL-specific functional networks.,20944673_3,0,1,2,-1,13446,-1,0.000138767,0.9998103,5.1025094e-05
13454,through transcriptomic,23,25,128,150,"In addition, FL microenvironment was characterized by a strong enrichment in follicular helper T cells (T(FH)), as demonstrated through transcriptomic and flow cytometry analyses.",20944673_5,-1,-1,-1,-1,13454,-1,8.51723e-06,0.9999852,6.23494e-06
13462,tonsil-derived T(FH,16,18,94,113,"Moreover, purified FL-derived T(FH), expressed IL4 at very high levels compared with purified tonsil-derived T(FH) or non-T(FH) microenvironment.",20944673_7,-1,-1,-1,-1,13462,-1,0.00017358524,0.99942446,0.0004020055
13463,that tumor-infiltrating T(FH,5,8,35,63,"Altogether, our study demonstrated that tumor-infiltrating T(FH) specifically express functional IL-4 in FL, creating an IL-4-dependent T(FH)-B cell axis.",20944673_8,-1,-1,-1,-1,13463,-1,2.2251115e-05,0.999961,1.6722423e-05
13464,functional,11,12,86,96,"Altogether, our study demonstrated that tumor-infiltrating T(FH) specifically express functional IL-4 in FL, creating an IL-4-dependent T(FH)-B cell axis.",20944673_8,0,1,2,-1,13464,-1,0.0015250371,0.9983333,0.00014172622
13465,T(FH)-B cell,19,21,136,148,"Altogether, our study demonstrated that tumor-infiltrating T(FH) specifically express functional IL-4 in FL, creating an IL-4-dependent T(FH)-B cell axis.",20944673_8,-1,-1,-1,-1,13465,-1,0.0021144927,0.80654824,0.19133733
13468,therapeutic target,12,14,76,94,This cross talk could sustain FL pathogenesis and represent a new potential therapeutic target.,20944673_9,-1,-1,-1,-1,13468,-1,5.886273e-06,0.9999896,4.445803e-06
13477,tissue,3,4,23,29,Surgically removed CRC tissue was collected from 12 patients with CRC.,20952660_2,-1,1,2,-1,13477,-1,8.073741e-05,0.99892694,0.000992252
13483,tissue,6,7,37,43,Chemokine CXCL11 was examined in CRC tissue by Western blotting.,20952660_4,-1,1,2,-1,13483,-1,2.0951746e-05,0.9996512,0.00032780424
13484,Treg chemotaxis,0,2,0,15,Treg chemotaxis was examined in a transwell system.,20952660_5,-1,-1,-1,-1,13484,-1,0.44881535,0.54778093,0.003403704
13493,tissue that,9,11,51,62,"Abundant Foxp3+IL-17+ T cells were detected in CRC tissue that expresses high levels of TGF-, CXCR3, CCR6, and RORt.",20952660_7,-1,-1,-1,-1,13493,-1,6.0885704e-06,0.99997795,1.5938424e-05
13497,tissue-derived,8,9,43,57,"High levels of CXCL11 were detected in CRC tissue-derived CD68+ cells, which had a strong chemotactic effect on Foxp3+ Tregs.",20952660_8,-1,1,2,-1,13497,-1,1.4005968e-05,0.99996686,1.9190133e-05
13509,the cells to,26,29,149,161,Hypoxia induced the expression of IL-17 in Foxp3+ Tregs; Foxp3+IL-17+ T cells were capable of inducing CRC-associated cell markers in BMMo and drove the cells to be cancer-initiating cells.,20952660_9,-1,-1,-1,-1,13509,-1,0.0012016501,0.15626444,0.8425339
13516,tissue-derived Foxp3+IL-17,1,3,4,30,CRC tissue-derived Foxp3+IL-17+ cells have the capacity to induce cancer-initiating cells.,20952660_11,-1,-1,-1,-1,13516,-1,0.014314475,0.98502874,0.00065682136
13521,to chemotherapy,17,19,93,108,"Survivin is overexpressed by 70-80% of pancreatic cancers, and is associated with resistance to chemotherapy and a poor prognosis.",20960189_0,-1,-1,-1,-1,13521,-1,0.7204176,0.27431285,0.005269509
13525,the tumor-suppressive,8,10,71,92,Recent reports have demonstrated that gemcitabine treatment attenuates the tumor-suppressive environment by eliminating CD11b(+)/Gr-1(+) myeloid-derived suppressor cells (MDSCs).,20960189_2,-1,-1,-1,-1,13525,-1,1.6376673e-05,0.999974,9.629425e-06
13530,tested this,5,7,18,29,"In this study, we tested this hypothesis using modified vaccinia Ankara (MVA) expressing full-length murine survivin.",20960189_4,-1,-1,-1,-1,13530,-1,6.817153e-06,0.99998856,4.5725533e-06
13541,immune response to,4,7,33,51,"To analyze the survivin-specific immune response to MVA-survivin immunization, we utilized a peptide library of 15mers with 11 residues overlapping from full-length murine survivin.",20960189_9,-1,-1,-1,-1,13541,-1,0.95383143,0.045304485,0.00086407043
13542,peptide,13,14,93,100,"To analyze the survivin-specific immune response to MVA-survivin immunization, we utilized a peptide library of 15mers with 11 residues overlapping from full-length murine survivin.",20960189_9,0,-1,2,-1,13542,-1,0.00064115843,0.9992016,0.000157223
13545,peptide,18,19,143,150,Splenocytes from mice immunized with MVA-survivin produced intracellular -interferon in response to in vitro stimulation with the overlapping peptide library.,20960189_10,0,-1,2,-1,13545,-1,0.00644062,0.99274397,0.0008154567
13546,T cells that,4,7,35,47,Increased survivin-specific CD8(+) T cells that specifically recognized the Pan02 tumor line were seen in mice treated with MVA-survivin and gemcitabine.,20960189_11,-1,-1,-1,-1,13546,-1,0.0017447905,0.043597806,0.9546574
13556,function,1,2,17,25,Immunomodulatory function of bone marrow derived mesenchymal stem cells in cancer has recently been investigated.,20970781_0,0,1,2,-1,13556,-1,0.011474049,0.98752904,0.000996869
13561,tissue,15,16,84,90,But the resident mesenchymal stem cells as whole in cancer and in the breast cancer tissue have not been studied well.,20970781_1,-1,1,2,-1,13561,-1,3.6963134e-05,0.99920756,0.0007554936
13564,tissues to,19,21,103,113,"In the present work we isolated adipose derived stem cells (ASCs) from breast cancer and normal breast tissues to investigate the expressions of IL-4, IL-10 and transforming growth factor (TGF)-1 in ASCs and to see if ASCs isolated from patients can modulate the regulatory molecules on peripheral blood lymphocytes.",20970781_2,-1,-1,-1,-1,13564,-1,0.000100458834,0.9987765,0.0011230102
13567,transforming growth factor,29,32,161,187,"In the present work we isolated adipose derived stem cells (ASCs) from breast cancer and normal breast tissues to investigate the expressions of IL-4, IL-10 and transforming growth factor (TGF)-1 in ASCs and to see if ASCs isolated from patients can modulate the regulatory molecules on peripheral blood lymphocytes.",20970781_2,-1,-1,-1,-1,13567,-1,0.9851702,0.011978028,0.002851807
13570,blood lymphocytes,50,52,299,316,"In the present work we isolated adipose derived stem cells (ASCs) from breast cancer and normal breast tissues to investigate the expressions of IL-4, IL-10 and transforming growth factor (TGF)-1 in ASCs and to see if ASCs isolated from patients can modulate the regulatory molecules on peripheral blood lymphocytes.",20970781_2,-1,-1,-1,-1,13570,-1,6.581969e-05,5.4391247e-05,0.99987984
13571,that IL-10,3,5,19,29,Our results showed that IL-10 and TGF-1 have significantly higher mRNA expressions in ASCs isolated from breast cancer patients than those from normal individuals (P value <0.05).,20970781_3,-1,-1,-1,-1,13571,-1,0.92313874,0.07481787,0.002043395
13573,than those,19,21,129,139,Our results showed that IL-10 and TGF-1 have significantly higher mRNA expressions in ASCs isolated from breast cancer patients than those from normal individuals (P value <0.05).,20970781_3,-1,-1,-1,-1,13573,-1,5.2394403e-06,0.9999887,6.134067e-06
13589,tissue,10,11,69,75,These data collectively conclude that resident ASCs in breast cancer tissue may have crucial roles in breast tumor growth and progression by inducing regulatory molecules and promoting anti-inflammatory reaction within the tumor microenvironment.,20970781_7,-1,1,2,-1,13589,-1,0.000191027,0.005293511,0.9945155
13591,the tumor,30,32,219,228,These data collectively conclude that resident ASCs in breast cancer tissue may have crucial roles in breast tumor growth and progression by inducing regulatory molecules and promoting anti-inflammatory reaction within the tumor microenvironment.,20970781_7,-1,-1,-1,-1,13591,-1,4.1038634e-06,0.9999913,4.600332e-06
13594,tumor cells,18,20,115,126,Further investigation is required to see if the immune suppression induced by ASCs is an independent property from tumor cells or ASCs gain their immunosuppressive potential from malignant cells.,20970781_8,-1,-1,-1,-1,13594,-1,0.00016912853,0.0010878609,0.998743
13597,tumor-associated antigen,4,6,20,44,"HBx is an oncogenic tumor-associated antigen and is dominantly expressed in hepatitis and hepatoma tissues, the induction of active cellular responses against HBx should be a promising approach for the treatment of hepatitis B virus-related hepatocellular carcinoma.",21042781_0,-1,-1,-1,-1,13597,-1,0.15343605,0.84217846,0.0043854783
13598,tissues,14,15,99,106,"HBx is an oncogenic tumor-associated antigen and is dominantly expressed in hepatitis and hepatoma tissues, the induction of active cellular responses against HBx should be a promising approach for the treatment of hepatitis B virus-related hepatocellular carcinoma.",21042781_0,-1,1,2,-1,13598,-1,9.9142955e-05,0.003048089,0.9968528
13601,the treatment,30,32,198,211,"HBx is an oncogenic tumor-associated antigen and is dominantly expressed in hepatitis and hepatoma tissues, the induction of active cellular responses against HBx should be a promising approach for the treatment of hepatitis B virus-related hepatocellular carcinoma.",21042781_0,-1,-1,-1,-1,13601,-1,4.8090706e-06,0.9999913,3.9517613e-06
13603,to test,5,7,31,38,The present study was designed to test whether a replication-defective adenovirus vaccine expressing HBx antigen could be effectively used in the immunotherapy of hepatocellular carcinoma.,21042781_1,-1,-1,-1,-1,13603,-1,5.8341475e-06,0.99998975,4.427508e-06
13614,immunity,14,15,99,107,We found that immunotherapy with Ad-HBx was effective at both protective and therapeutic antitumor immunity in the hepatoma models in immune-competent mice.,21042781_3,0,-1,2,-1,13614,-1,0.99983,3.3220993e-05,0.000136693
13622,the CTL,7,9,39,46,"In addition, the induction efficacy of the CTL response is dramatically enhanced by immunotherapy.",21042781_5,-1,-1,-1,-1,13622,-1,0.0072221905,0.1869931,0.8057847
13623,Cytokine analysis,0,2,0,17,Cytokine analysis confirmed that the antitumor efficacy of Ad-HBx may mostly result from cellular immunity.,21042781_6,-1,-1,-1,-1,13623,-1,0.99287957,0.006253174,0.0008672425
13624,that the,3,5,28,36,Cytokine analysis confirmed that the antitumor efficacy of Ad-HBx may mostly result from cellular immunity.,21042781_6,-1,-1,-1,-1,13624,-1,5.146283e-06,0.9999912,3.6450247e-06
13626,antigen to the treatment,13,17,80,104,Our findings may prove useful in development of adenovirus vaccine based on HBx antigen to the treatment of HBV-associated hepatocellular carcinoma.,21042781_7,-1,-1,-1,-1,13626,-1,0.5809413,0.414384,0.0046745944
13627,Analysis,0,1,0,8,"Analysis of cytokine and chemokine production by tumor cell lines including five lung cancers, a malignant mesothelioma, and a malignant melanoma recently established in our laboratory showed rather high production of IL-8 in all tumors and IL-6 in one lung cancer, the malignant mesothelioma, and the malignant melanoma.",21048114_0,0,1,-1,-1,13627,-1,6.0799707e-06,0.9999883,5.5673145e-06
13630,tumor cell,7,9,49,59,"Analysis of cytokine and chemokine production by tumor cell lines including five lung cancers, a malignant mesothelioma, and a malignant melanoma recently established in our laboratory showed rather high production of IL-8 in all tumors and IL-6 in one lung cancer, the malignant mesothelioma, and the malignant melanoma.",21048114_0,-1,-1,-1,-1,13630,-1,0.00051332475,0.020187022,0.9792996
13637,to these tumor cells,6,10,39,59,We investigated the migration of PBMCs to these tumor cells using Transwell plates and showed enrichment of Foxp3(+) CD4 regulatory T cells (Tregs) in migrated T cells to both IL-6- and IL-8-producing tumors.,21048114_1,-1,-1,-1,-1,13637,-1,0.0018257468,0.7555295,0.2426447
13638,Transwell plates,11,13,66,82,We investigated the migration of PBMCs to these tumor cells using Transwell plates and showed enrichment of Foxp3(+) CD4 regulatory T cells (Tregs) in migrated T cells to both IL-6- and IL-8-producing tumors.,21048114_1,-1,-1,-1,-1,13638,-1,1.4088936e-05,0.99997187,1.4070849e-05
13642,T cells to,28,31,160,170,We investigated the migration of PBMCs to these tumor cells using Transwell plates and showed enrichment of Foxp3(+) CD4 regulatory T cells (Tregs) in migrated T cells to both IL-6- and IL-8-producing tumors.,21048114_1,-1,-1,-1,-1,13642,-1,0.0017001319,0.041127,0.9571728
13644,IL-8-producing tumors,34,36,186,207,We investigated the migration of PBMCs to these tumor cells using Transwell plates and showed enrichment of Foxp3(+) CD4 regulatory T cells (Tregs) in migrated T cells to both IL-6- and IL-8-producing tumors.,21048114_1,-1,-1,-1,-1,13644,-1,0.99857056,0.0010058011,0.00042368678
13651,the tumors,5,7,31,41,Frequent production of IL-8 by the tumors and Treg migration to those tumors through induction of IL-8R expression by IL-6 is one of the mechanisms for tumor escape.,21048114_3,-1,-1,-1,-1,13651,-1,3.8739095e-06,0.9999906,5.5309756e-06
13653,to those tumors through,10,14,61,84,Frequent production of IL-8 by the tumors and Treg migration to those tumors through induction of IL-8R expression by IL-6 is one of the mechanisms for tumor escape.,21048114_3,-1,-1,-1,-1,13653,-1,6.953188e-06,0.99998474,8.357738e-06
13658,Cytotoxic T Lymphocyte Antigen,0,4,0,30,Cytotoxic T Lymphocyte Antigen 4 (CTLA4) blockade has shown antitumor activity against common cancers.,21056008_0,-1,-1,-1,-1,13658,-1,0.025553163,0.0001174059,0.9743294
13665,that tremelimumab,3,5,17,34,"Our results show that tremelimumab enhanced the proliferative response of T effector cells (Teff) upon TCR stimulation, and abrogated Treg suppressive ability.",21056008_3,-1,-1,-1,-1,13665,-1,2.0421588e-05,0.99996173,1.7826575e-05
13670,TCR,17,18,103,106,"Our results show that tremelimumab enhanced the proliferative response of T effector cells (Teff) upon TCR stimulation, and abrogated Treg suppressive ability.",21056008_3,-1,1,2,-1,13670,-1,1.7406759e-05,0.99996424,1.8330702e-05
13678,tumor antigens,30,32,180,194,"In the presence of tremelimumab, frequencies of IL-2-secreting CD4(+) T cells and IFN--secreting CD4(+) and CD8(+) T cells were increased in response to polyclonal activation and tumor antigens.",21056008_4,-1,-1,-1,-1,13678,-1,0.59033364,0.40504688,0.004619478
13689,Taken together,0,2,0,14,"Taken together, this data indicates that tremelimumab induces immune responses mainly by direct activation of Teff rather than by affecting Tregs.",21056008_6,-1,-1,-1,-1,13689,-1,8.390585e-06,0.9999838,7.880971e-06
13691,that tremelimumab,6,8,36,53,"Taken together, this data indicates that tremelimumab induces immune responses mainly by direct activation of Teff rather than by affecting Tregs.",21056008_6,-1,-1,-1,-1,13691,-1,4.7831516e-05,0.99991477,3.7364833e-05
13700,the thymus-derived TH17 lymphocyte subset,3,8,28,69,Molecular studies implicate the thymus-derived TH17 lymphocyte subset in a remarkable immunotherapeutic regression.,21061759_1,-1,-1,-1,-1,13700,-1,0.0040399423,0.7740739,0.22188611
13703,tissue,9,10,65,71,The authors performed RT-PCR of total RNA from paraffin-embedded tissue before and after treatment with DPCP.,21061759_2,-1,1,2,-1,13703,-1,1.33055055e-05,0.99995077,3.592202e-05
13707,treatment there,15,17,89,104,"Before treatment with DPCP, the authors found elevated expression of IL 17C/D/E/F; after treatment there was no detectable expression.",21061759_3,-1,-1,-1,-1,13707,-1,4.3850637e-06,0.9999919,3.7521922e-06
13714,the time,5,7,32,40,Conclusions are limited to only the time samples were obtained.,21061759_6,-1,-1,-1,-1,13714,-1,1.0124575e-05,0.9999825,7.4555965e-06
13716,the immunomodulatory agent,9,12,72,98,Remarkable regression of an in-transit metastatic melanoma treated with the immunomodulatory agent DPCP showed gain and loss of gene expression of the TH17 pathway.,21061759_7,-1,-1,-1,-1,13716,-1,0.5531299,0.44336668,0.0035034127
13718,the TH17,21,23,147,155,Remarkable regression of an in-transit metastatic melanoma treated with the immunomodulatory agent DPCP showed gain and loss of gene expression of the TH17 pathway.,21061759_7,-1,-1,-1,-1,13718,-1,2.4479601e-05,0.99995947,1.6062184e-05
13721,to TH7,9,11,46,52,Further study of this pathway from NK to NK-T to TH7 and TH1 cells both with and without accessory or dendritic cells will improve understanding of contact sensitizers as topical immunomodulators.,21061759_8,-1,-1,-1,-1,13721,-1,1.0761396e-05,0.9999651,2.4117158e-05
13724,topical immunomodulators,29,31,171,195,Further study of this pathway from NK to NK-T to TH7 and TH1 cells both with and without accessory or dendritic cells will improve understanding of contact sensitizers as topical immunomodulators.,21061759_8,-1,-1,-1,-1,13724,-1,0.71176165,0.28632566,0.0019126958
13727,immunity,8,9,70,78,Therapeutic strategies combining the induction of effective antitumor immunity with the inhibition of the mechanisms of tumor-induced immunosuppression represent a key objective in cancer immunotherapy.,21123824_0,0,-1,2,-1,13727,-1,0.99982077,2.3060484e-05,0.0001562409
13741,function,34,35,234,242,"Herein we demonstrate that effector/memory CD4(+) T helper-1 (Th-1) lymphocytes, in addition to polarizing type-1 antitumor immune responses, impair tumor-induced CD4(+)CD25(+)FoxP3(+) regulatory T lymphocyte (Treg) immunosuppressive function in vitro and in vivo.",21123824_1,0,1,2,-1,13741,-1,0.0076946532,0.81541646,0.17688893
13743,the generation,4,6,24,38,Th-1 cells also inhibit the generation of FoxP3(+) Tregs from naive CD4(+)CD25(-)FoxP3(-) T cells by an interferon--dependent mechanism.,21123824_2,-1,-1,-1,-1,13743,-1,5.0729905e-06,0.9999902,4.6841933e-06
13749,Th-1 lymphocytes,13,15,59,75,"In addition, in an aggressive mouse leukemia model (12B1), Th-1 lymphocytes act synergistically with a chaperone-rich cell lysate (CRCL) vaccine, leading to improved survival and long-lasting protection against leukemia.",21123824_3,-1,-1,-1,-1,13749,-1,9.99641e-05,0.0019982848,0.9979018
13753,tumor-specific antigens,8,10,39,62,The combination of CRCL as a source of tumor-specific antigens and Th-1 lymphocytes as an adjuvant has the potential to stimulate efficient specific antitumor immunity while restraining Treg-induced suppression.,21123824_4,-1,-1,-1,-1,13753,-1,0.57600874,0.41933993,0.004651241
13754,Th-1 lymphocytes,11,13,67,83,The combination of CRCL as a source of tumor-specific antigens and Th-1 lymphocytes as an adjuvant has the potential to stimulate efficient specific antitumor immunity while restraining Treg-induced suppression.,21123824_4,-1,-1,-1,-1,13754,-1,4.27064e-05,0.00024408528,0.99971324
13757,immunity,24,25,159,167,The combination of CRCL as a source of tumor-specific antigens and Th-1 lymphocytes as an adjuvant has the potential to stimulate efficient specific antitumor immunity while restraining Treg-induced suppression.,21123824_4,0,-1,2,-1,13757,-1,0.99989855,1.7730368e-05,8.368091e-05
13760,immunity,9,10,50,58,Renal cell carcinoma (RCC) can inhibit protective immunity by induction of immunosuppressive cells that produce inhibitory cytokines such as interleukin (IL)-10 and transforming growth factor (TGF)-.,21150720_0,0,-1,2,-1,13760,-1,0.99983907,4.6466244e-05,0.000114430906
13761,cells that,14,16,93,103,Renal cell carcinoma (RCC) can inhibit protective immunity by induction of immunosuppressive cells that produce inhibitory cytokines such as interleukin (IL)-10 and transforming growth factor (TGF)-.,21150720_0,-1,-1,-1,-1,13761,-1,0.002938227,0.23450783,0.762554
13764,transforming growth factor,24,27,165,191,Renal cell carcinoma (RCC) can inhibit protective immunity by induction of immunosuppressive cells that produce inhibitory cytokines such as interleukin (IL)-10 and transforming growth factor (TGF)-.,21150720_0,-1,-1,-1,-1,13764,-1,0.9813586,0.015506636,0.003134777
13770,blood,15,16,106,111,"Therefore, we asked for the prognostic influence of cells with immunosuppressive properties in peripheral blood (pB) in a cohort of metastatic clear cell renal cell carcinoma (mRCC) patients uniformly receiving sorafenib treatment.",21150720_2,0,1,-1,-1,13770,-1,0.0028935324,0.45223466,0.54487175
13778,cell subsets,19,21,115,127,"IL-10 and TGF- mRNA levels, regulatory T-cell (Treg) counts, and frequencies of IL-10/TGF- producing mononuclear cell subsets were determined in pB from 46 patients with mRCC before receiving sorafenib treatment.",21150720_3,-1,-1,-1,-1,13778,-1,1.3936125e-05,7.7868835e-06,0.9999783
13781,factors,7,8,68,75,Relationship between established clinical and laboratory prognostic factors and outcome were examined by univariate and multivariate Cox regression analysis.,21150720_4,0,1,-1,-1,13781,-1,0.99512523,0.003910424,0.0009643538
13782,analysis,18,19,148,156,Relationship between established clinical and laboratory prognostic factors and outcome were examined by univariate and multivariate Cox regression analysis.,21150720_4,0,1,-1,-1,13782,-1,1.68042e-05,0.9999671,1.612005e-05
13788,analysis,3,4,18,26,"In a multivariate analysis low ECOG score and-surprisingly-high TGF-1 mRNA levels were independently associated with favorable progression-free survival (P=0.005 and P=0.003, respectively) and overall survival (P=0.001 and P=0.039, respectively).",21150720_7,0,1,-1,-1,13788,-1,9.930208e-06,0.9999826,7.474242e-06
13790,blood,12,13,84,89,"In conclusion, mRCC is associated with an immunosuppressive phenotype in peripheral blood.",21150720_8,0,1,-1,-1,13790,-1,0.0016900527,0.95803267,0.04027729
13793,functions,14,15,101,110,The positive prognostic influence of high TGF-1 mRNA expression levels may reflect immune promoting functions of TGF- in combined activity with inflammatory cytokines.,21150720_9,0,1,2,-1,13793,-1,0.0013239345,0.9978046,0.0008714359
13798,thought to,9,11,40,50,"PURPOSE: Regulatory T cells (Tregs) are thought to inhibit antitumor immune responses, and their depletion could therefore have a synergistic effect with therapeutic cancer vaccines.",21177412_0,-1,-1,-1,-1,13798,-1,6.8211098e-06,0.999987,6.18288e-06
13805,blood Treg,8,10,51,61,We investigated the impact of three medications on blood Treg frequency in vaccinated cancer patients.,21177412_1,-1,-1,-1,-1,13805,-1,3.7972102e-05,0.99994063,2.1436017e-05
13811,the transcription factor FOXP3,20,24,112,142,"EXPERIMENTAL DESIGN: To date, the most specific marker for human Tregs is demethylation in the DNA that encodes the transcription factor FOXP3.",21177412_2,-1,-1,-1,-1,13811,-1,5.7713396e-06,0.99998903,5.1411166e-06
13817,blood,20,21,122,127,"Thus, we used a FOXP3 methylation-specific quantitative PCR assay (MS-qPCR) to measure Treg frequencies in the peripheral blood mononuclear cells (PBMCs) of melanoma patients.",21177412_3,0,1,-1,-1,13817,-1,0.0026050883,0.83716404,0.16023085
13821,trials that,6,8,44,55,"The patients participated in three clinical trials that combined tumor vaccines with potential Treg-depleting agents: low-dose cyclophosphamide, anti-CD25 monoclonal antibody daclizumab, and the IL-2/diphtheria toxin fusion protein denileukin diftitox.",21177412_4,-1,-1,-1,-1,13821,-1,5.066594e-06,0.9999902,4.6876526e-06
13826,protein,29,30,224,231,"The patients participated in three clinical trials that combined tumor vaccines with potential Treg-depleting agents: low-dose cyclophosphamide, anti-CD25 monoclonal antibody daclizumab, and the IL-2/diphtheria toxin fusion protein denileukin diftitox.",21177412_4,0,1,-1,-1,13826,-1,4.0133247e-05,0.9999484,1.14847235e-05
13828,blood Treg,8,10,39,49,"RESULTS: In the nine control patients, blood Treg frequencies varied over time; there was a 46% reduction in one patient.",21177412_5,-1,-1,-1,-1,13828,-1,3.4375935e-05,0.99994135,2.4218989e-05
13833,in Tregs,9,11,49,57,"In treated patients, a more than 2-fold decrease in Tregs was observed in one out of 11 patients receiving cyclophosphamide and in four out of 13 receiving daclizumab, but there was no such Treg decrease in any of the six patients who received denileukin diftitox.",21177412_6,-1,-1,-1,-1,13833,-1,6.75082e-06,0.99998665,6.653337e-06
13838,in blood Tregs,10,13,51,65,"As a positive control, a more than 2-fold increase in blood Tregs was detected in four out of nine patients who were treated with interleukin-2.CONCLUSIONS: We used a MS-qPCR method that detects Tregs but not other activated T lymphocytes; however, none of the Treg-depleting strategies that we tested led, in the majority of patients, to a conservative 50% reduction in blood Tregs.",21177412_7,-1,-1,-1,-1,13838,-1,1.163673e-05,0.9999783,1.0047113e-05
13843,the Treg-depleting,46,48,257,275,"As a positive control, a more than 2-fold increase in blood Tregs was detected in four out of nine patients who were treated with interleukin-2.CONCLUSIONS: We used a MS-qPCR method that detects Tregs but not other activated T lymphocytes; however, none of the Treg-depleting strategies that we tested led, in the majority of patients, to a conservative 50% reduction in blood Tregs.",21177412_7,-1,-1,-1,-1,13843,-1,7.457425e-05,0.9998858,3.961224e-05
13848,in blood Tregs,66,69,368,382,"As a positive control, a more than 2-fold increase in blood Tregs was detected in four out of nine patients who were treated with interleukin-2.CONCLUSIONS: We used a MS-qPCR method that detects Tregs but not other activated T lymphocytes; however, none of the Treg-depleting strategies that we tested led, in the majority of patients, to a conservative 50% reduction in blood Tregs.",21177412_7,-1,-1,-1,-1,13848,-1,1.4427085e-05,0.9999753,1.0195729e-05
13854,to tumour,26,28,143,152,"BACKGROUND: 'FOXP3+ regulatory T cells' (Tregs) are reported to be increased in tumour-bearing hosts including patients with melanoma, leading to tumour immune suppression.",21198537_0,-1,-1,-1,-1,13854,-1,4.7193685e-06,0.9999908,4.5103316e-06
13856,that the,9,11,52,60,"However, this idea is challenged by recent evidence that the 'FOXP3+ Treg' fraction in fact contains activated 'nonregulatory' T cells.",21198537_1,-1,-1,-1,-1,13856,-1,5.0325975e-06,0.99999154,3.4644954e-06
13863,functionally,10,11,42,54,"Also, FOXP3+ T cells are reported to have functionally and kinetically distinct subsets.",21198537_2,0,1,2,-1,13863,-1,6.567142e-05,0.99990857,2.5806503e-05
13870,three subsets,9,11,45,58,"METHODS: FOXP3+ T cells were classified into three subsets, namely CD45RO+FOXP3(low) nonregulatory T cells, CD45RO+FOXP3(high) effector Tregs, and CD45RO-FOXP3(low) nave Tregs, according to their expression levels of FOXP3 and CD45RO.",21198537_4,-1,-1,-1,-1,13870,-1,0.0011593212,0.03409305,0.9647476
13875,to their,31,33,188,196,"METHODS: FOXP3+ T cells were classified into three subsets, namely CD45RO+FOXP3(low) nonregulatory T cells, CD45RO+FOXP3(high) effector Tregs, and CD45RO-FOXP3(low) nave Tregs, according to their expression levels of FOXP3 and CD45RO.",21198537_4,-1,-1,-1,-1,13875,-1,5.1943207e-06,0.99998975,5.104182e-06
13879,these FOXP3,6,8,42,53,The percentage and cytokine production of these FOXP3+ T-cell subsets were assessed by flow cytometry.,21198537_5,-1,-1,-1,-1,13879,-1,1.18867865e-05,0.99997807,1.002223e-05
13890,interferon-+ cells,48,50,280,299,"Moreover, we found three unexpected perturbations in FOXP3+ T-cell subsets: (i) patients with melanoma showed higher frequencies of FOXP3(low) nonregulatory T cells, which decreased and normalized after tumour removal; (ii) FOXP3(low) nave Tregs containing higher frequencies of interferon-+ cells increased with tumour progression; and (iii) CD45RO+FOXP3(high) effector Tregs were pronouncedly infiltrated around tumour tissues.",21198537_7,-1,-1,-1,-1,13890,-1,0.9497757,0.0002908853,0.04993343
13893,tumour tissues,67,69,416,430,"Moreover, we found three unexpected perturbations in FOXP3+ T-cell subsets: (i) patients with melanoma showed higher frequencies of FOXP3(low) nonregulatory T cells, which decreased and normalized after tumour removal; (ii) FOXP3(low) nave Tregs containing higher frequencies of interferon-+ cells increased with tumour progression; and (iii) CD45RO+FOXP3(high) effector Tregs were pronouncedly infiltrated around tumour tissues.",21198537_7,-1,-1,-1,-1,13893,-1,8.873357e-06,0.99998033,1.075721e-05
13900,that the,13,15,88,96,"The degree of perturbation is associated with tumour burden and progression, suggesting that the perturbation reflects fundamental pathophysiological processes in patients with melanoma.",21198537_9,-1,-1,-1,-1,13900,-1,4.3764603e-06,0.99999166,3.911236e-06
13902,analysis,2,3,14,22,The presented analysis provides a practical approach to investigate the immunological environment of cancer patients.,21198537_10,0,1,-1,-1,13902,-1,6.8297427e-06,0.99998724,5.943332e-06
13921,LPS to trigger the toll-like receptor,10,16,50,87,"As PTX has been reported to mimic the activity of LPS to trigger the toll-like receptor 4 (TLR4) signalling pathway in macrophages, we investigated the possible role of TLR4 in the effect of PTX.",21223350_3,-1,-1,-1,-1,13921,-1,0.0013467191,0.9793467,0.019306613
13928,than that,10,12,59,68,"However, although TLR4 expression on Treg cells was higher than that on Teff cells, the expression level remained unaltered in both Treg and Teff cells after PTX treatment.",21223350_4,-1,-1,-1,-1,13928,-1,1.1420382e-05,0.99998176,6.7727697e-06
13929,Teff cells,13,15,72,82,"However, although TLR4 expression on Treg cells was higher than that on Teff cells, the expression level remained unaltered in both Treg and Teff cells after PTX treatment.",21223350_4,-1,-1,-1,-1,13929,-1,0.00033075214,0.016169598,0.98349965
13932,Teff cells,25,27,141,151,"However, although TLR4 expression on Treg cells was higher than that on Teff cells, the expression level remained unaltered in both Treg and Teff cells after PTX treatment.",21223350_4,-1,-1,-1,-1,13932,-1,0.00033926155,0.017513558,0.98214716
13935,Teff cells,8,10,53,63,"Surface molecules and activation markers in Treg and Teff cells did not change, either.",21223350_5,-1,-1,-1,-1,13935,-1,0.0005089004,0.027829532,0.97166157
13936,that the,3,5,21,29,Further study showed that the effect of PTX on TLR4-/- mice deficient in TLR4 signalling was similar to that on C57BL/6 mice both in vivo and in vitro.,21223350_6,-1,-1,-1,-1,13936,-1,3.9665965e-06,0.9999924,3.6956744e-06
13938,to that,17,19,101,108,Further study showed that the effect of PTX on TLR4-/- mice deficient in TLR4 signalling was similar to that on C57BL/6 mice both in vivo and in vitro.,21223350_6,-1,-1,-1,-1,13938,-1,5.0808585e-06,0.9999902,4.7146245e-06
13940,that the,3,5,20,28,These data indicate that the selective impairment of Treg cells by PTX is independent of TLR4.,21223350_7,-1,-1,-1,-1,13940,-1,4.945473e-06,0.99999166,3.4339732e-06
13943,to release Th2-dominated,6,9,39,63,It is very important for immunotherapy to release Th2-dominated and Treg-dominated immunological conditions in patients with malignant diseases.,21224532_0,-1,-1,-1,-1,13943,-1,1.546596e-05,0.9999703,1.4270592e-05
13947,blood,15,16,106,111,"In the present study, we assessed the population of CD4+IL-10+T-cells and CD4+Foxp3+T-cells in peripheral blood in patients with colorectal cancer using a flow cytometric analysis, and we investigated whether Th2-dominated and Treg-dominated condition could be modulated by PSK.",21224532_1,0,1,-1,-1,13947,-1,0.00091925065,0.98885137,0.010229396
13948,analysis,25,26,171,179,"In the present study, we assessed the population of CD4+IL-10+T-cells and CD4+Foxp3+T-cells in peripheral blood in patients with colorectal cancer using a flow cytometric analysis, and we investigated whether Th2-dominated and Treg-dominated condition could be modulated by PSK.",21224532_1,0,1,-1,-1,13948,-1,1.2737184e-05,0.99997294,1.4365558e-05
13951,blood,1,2,11,16,Peripheral blood samples were collected preoperatively from 40 patients with colorectal cancer before and after oral administration of PSK (3 g/day  1 week).,21224532_2,0,1,-1,-1,13951,-1,0.0037600943,0.9499527,0.04628715
13958,release Th2-dominated,6,8,37,58,These results suggest that PSK could release Th2-dominated and Treg-dominated immunological condition in patients with colorectal cancer.,21224532_5,-1,-1,-1,-1,13958,-1,1.9830775e-05,0.9999583,2.1925878e-05
13963,the nuclear factor,2,5,11,29,Members of the nuclear factor of activated T cell (NFAT) family of transcription factors were originally described in T lymphocytes but later shown to be expressed in several immune and non-immune cell types.,21225259_0,-1,-1,-1,-1,13963,-1,4.8530346e-06,0.9999907,4.4895646e-06
13968,cell types,33,35,197,207,Members of the nuclear factor of activated T cell (NFAT) family of transcription factors were originally described in T lymphocytes but later shown to be expressed in several immune and non-immune cell types.,21225259_0,-1,-1,-1,-1,13968,-1,1.8731393e-05,1.5115755e-05,0.99996614
13970,cellular transformation,4,6,27,50,"NFAT proteins can modulate cellular transformation intrinsically, and NFAT-deficient (NFAT1-/-) mice are indeed more susceptible to transformation than wild-type counterparts.",21225259_1,-1,-1,-1,-1,13970,-1,0.0026496665,0.08258783,0.9147625
13971,to transformation than,18,21,129,151,"NFAT proteins can modulate cellular transformation intrinsically, and NFAT-deficient (NFAT1-/-) mice are indeed more susceptible to transformation than wild-type counterparts.",21225259_1,-1,-1,-1,-1,13971,-1,5.23926e-06,0.9999896,5.1761026e-06
13973,to tumor,8,10,58,66,"However, the contribution of an NFAT1-/- microenvironment to tumor progression has not been studied.",21225259_2,-1,-1,-1,-1,13973,-1,5.4987904e-06,0.99998903,5.505213e-06
13988,the cytokine,23,25,159,171,A massive mononuclear perivascular infiltrate and reduced expression of TGF- in the absence of NFAT1 suggested a role for tumor-infiltrating immune cells and the cytokine milieu.,21225259_6,-1,-1,-1,-1,13988,-1,0.4520518,0.5444916,0.0034566578
13991,this cytokine,16,18,109,122,"However, these processes are independent of an IL-4-induced regulatory tumor microenvironment, since lack of this cytokine does not alter the phenotype in NFAT1-/- animals.",21225259_7,-1,-1,-1,-1,13991,-1,0.82030797,0.17503433,0.00465767
13995,cells to tumor,13,16,101,115,Bone marrow chimera experiments meant to differentiate the contributions of stromal and infiltrating cells to tumor progression demonstrated that NFAT1-induced susceptibility to pulmonary tumor growth depends on NFAT1-expressing parenchyma rather than on bone marrow-derived cells.,21225259_8,-1,-1,-1,-1,13995,-1,0.003639376,0.66705614,0.32930446
14006,Th2 cytokine,24,26,168,180,"These results suggest an important role for NFAT1 in radio-resistant tumor-associated parenchyma, which is independent of the anti-tumor immune response and Th1 versus Th2 cytokine milieu established by the cancer cells, but able to promote site-specific tumor growth.",21225259_9,-1,-1,-1,-1,14006,-1,0.20832373,0.7873305,0.00434578
14014,function,10,11,65,73,Tumor growth occurs by the imbalance between cells with effector function and cells with suppressor/regulatory functions.,21238620_0,0,1,2,-1,14014,-1,0.0029794562,0.4273318,0.56968874
14016,functions,15,16,111,120,Tumor growth occurs by the imbalance between cells with effector function and cells with suppressor/regulatory functions.,21238620_0,0,1,2,-1,14016,-1,2.7162632e-05,0.99979085,0.00018198836
14019,the chemical,6,8,45,57,To investigate this scenario we administered the chemical carcinogen Urethane in BALB/c mice and followed these animals during 120 days to observe lung tumor development.,21238620_1,-1,-1,-1,-1,14019,-1,0.15296066,0.8441001,0.0029392573
14025,blood,18,19,99,104,"In another set of experiments the same protocol was performed with the harvest of spleen, lung and blood at 20 and 30 days after Urethane injection.",21238620_2,0,1,-1,-1,14025,-1,0.0038682108,0.9885324,0.0075993673
14035,the time,10,12,60,68,Urethane led to lung nodules development after 120 days and the time point evaluation showed that splenocytes stimulated ex vivo expressed higher levels of IFN- 20 days after the chemical injection.,21238620_5,-1,-1,-1,-1,14035,-1,6.5512563e-06,0.9999869,6.5413797e-06
14038,the chemical,28,30,176,188,Urethane led to lung nodules development after 120 days and the time point evaluation showed that splenocytes stimulated ex vivo expressed higher levels of IFN- 20 days after the chemical injection.,21238620_5,-1,-1,-1,-1,14038,-1,0.106233366,0.8905758,0.0031907728
14052,IFN--producing cells,15,17,83,104,In periphery there was an increase at the effector immune response (as depicted by IFN--producing cells) and in tumor development site there was an increase at the suppressor cell (CD11b+Gr-1+) phenotype.,21238620_10,-1,-1,-1,-1,14052,-1,0.9689441,0.00012907965,0.030926857
14055,the suppressor cell,28,31,161,180,In periphery there was an increase at the effector immune response (as depicted by IFN--producing cells) and in tumor development site there was an increase at the suppressor cell (CD11b+Gr-1+) phenotype.,21238620_10,-1,-1,-1,-1,14055,-1,0.0018464477,0.21472374,0.78342986
14058,therapy,6,7,51,58,Suppressor/regulatory cells are targets for cancer therapy.,21238620_11,0,1,-1,-1,14058,-1,4.672671e-06,0.9999907,4.566985e-06
14060,gene therapy,2,4,25,37,"Targeted cancer-specific gene therapy is a promising strategy for treating metastatic lung cancer, which is a leading cause of lung cancer-related deaths.",21282355_0,-1,-1,-1,-1,14060,-1,8.203881e-06,0.9999838,8.065769e-06
14062,gene therapy,6,8,43,55,"Previously, we developed a cancer-targeted gene therapy expression system with high tumor specificity and strong activity that selectively induced lung cancer cell killing without affecting normal cells in immunocompromised mice.",21282355_1,-1,-1,-1,-1,14062,-1,5.499142e-06,0.99999,4.559349e-06
14068,gene therapy,6,8,36,48,"Here, we found this cancer-targeted gene therapy, SV-BikDD, composed of the survivin promoter in the VP16-GAL4-WPRE integrated systemic amplifier system to drive the apoptotic gene BikDD, not only caused cytotoxic effects in cancer cells but also elicited a cancer-specific cytotoxic T lymphocyte response to synergistically increase the therapeutic effect and further develop an effective systemic antitumoral immunity against rechallenges of tumorigenic dose of parental tumor cells inoculated at distant sites in immunocompetent mice.",21282355_2,-1,-1,-1,-1,14068,-1,4.7861004e-06,0.99998987,5.3120475e-06
14077,the therapeutic,50,52,334,349,"Here, we found this cancer-targeted gene therapy, SV-BikDD, composed of the survivin promoter in the VP16-GAL4-WPRE integrated systemic amplifier system to drive the apoptotic gene BikDD, not only caused cytotoxic effects in cancer cells but also elicited a cancer-specific cytotoxic T lymphocyte response to synergistically increase the therapeutic effect and further develop an effective systemic antitumoral immunity against rechallenges of tumorigenic dose of parental tumor cells inoculated at distant sites in immunocompetent mice.",21282355_2,-1,-1,-1,-1,14077,-1,4.3931823e-06,0.99999154,4.057805e-06
14078,immunity,60,61,411,419,"Here, we found this cancer-targeted gene therapy, SV-BikDD, composed of the survivin promoter in the VP16-GAL4-WPRE integrated systemic amplifier system to drive the apoptotic gene BikDD, not only caused cytotoxic effects in cancer cells but also elicited a cancer-specific cytotoxic T lymphocyte response to synergistically increase the therapeutic effect and further develop an effective systemic antitumoral immunity against rechallenges of tumorigenic dose of parental tumor cells inoculated at distant sites in immunocompetent mice.",21282355_2,0,-1,2,-1,14078,-1,0.99942327,5.3273496e-05,0.0005234665
14080,tumor cells,68,70,473,484,"Here, we found this cancer-targeted gene therapy, SV-BikDD, composed of the survivin promoter in the VP16-GAL4-WPRE integrated systemic amplifier system to drive the apoptotic gene BikDD, not only caused cytotoxic effects in cancer cells but also elicited a cancer-specific cytotoxic T lymphocyte response to synergistically increase the therapeutic effect and further develop an effective systemic antitumoral immunity against rechallenges of tumorigenic dose of parental tumor cells inoculated at distant sites in immunocompetent mice.",21282355_2,-1,-1,-1,-1,14080,-1,0.00013641926,0.00084855483,0.9990151
14082,gene therapy,5,7,34,46,"In addition, this cancer-targeted gene therapy does not elicit an immune response against normal tissues, but CMV-BikDD treatment does.",21282355_3,-1,-1,-1,-1,14082,-1,6.0030357e-06,0.9999882,5.7758716e-06
14084,tissues,15,16,97,104,"In addition, this cancer-targeted gene therapy does not elicit an immune response against normal tissues, but CMV-BikDD treatment does.",21282355_3,-1,1,2,-1,14084,-1,0.0005471316,0.79633075,0.20312208
14086,The therapeutic,0,2,0,15,The therapeutic vector could also induce proinflammatory cytokines to activate innate immunity and provide some benefits in antitumor gene therapy.,21282355_4,-1,-1,-1,-1,14086,-1,4.4343274e-06,0.99999154,4.03732e-06
14087,cytokines to,7,9,57,69,The therapeutic vector could also induce proinflammatory cytokines to activate innate immunity and provide some benefits in antitumor gene therapy.,21282355_4,-1,-1,-1,-1,14087,-1,0.9611025,0.03741907,0.0014784469
14089,gene therapy,18,20,134,146,The therapeutic vector could also induce proinflammatory cytokines to activate innate immunity and provide some benefits in antitumor gene therapy.,21282355_4,-1,-1,-1,-1,14089,-1,5.443238e-06,0.99998975,4.862128e-06
14095,gene therapy,27,29,185,197,"Thus, this study provides a promising strategy with benefit of antitumoral immune response worthy of further development in clinical trials for treating lung cancer via cancer-targeted gene therapy.",21282355_5,-1,-1,-1,-1,14095,-1,4.6666955e-06,0.99998987,5.468589e-06
14106,to tumour,19,21,135,144,"Most cancers are accompanied by leukocyte infiltration which, contrary to an anticipated immuno-protective role, could be contributing to tumour development and cancer progression.",21291541_1,-1,-1,-1,-1,14106,-1,1.9182437e-05,0.9999653,1.5501304e-05
14112,these cells play,34,37,222,238,"Epstein-Barr virus (EBV) associated cancers, including nasopharyngeal carcinoma and Hodgkin's Disease, show a considerable leukocyte infiltration which surrounds the neoplastic cells, raising the questions as to what role these cells play in either restricting or supporting the tumour and what draws the cells into the tumour.",21291541_2,-1,-1,-1,-1,14112,-1,0.0024978684,0.2638753,0.7336268
14113,the tumour,42,44,275,285,"Epstein-Barr virus (EBV) associated cancers, including nasopharyngeal carcinoma and Hodgkin's Disease, show a considerable leukocyte infiltration which surrounds the neoplastic cells, raising the questions as to what role these cells play in either restricting or supporting the tumour and what draws the cells into the tumour.",21291541_2,-1,-1,-1,-1,14113,-1,4.6770947e-06,0.9999889,6.43441e-06
14114,the cells,47,49,301,310,"Epstein-Barr virus (EBV) associated cancers, including nasopharyngeal carcinoma and Hodgkin's Disease, show a considerable leukocyte infiltration which surrounds the neoplastic cells, raising the questions as to what role these cells play in either restricting or supporting the tumour and what draws the cells into the tumour.",21291541_2,-1,-1,-1,-1,14114,-1,2.7866276e-05,2.1642361e-05,0.9999504
14115,the tumour,50,52,316,326,"Epstein-Barr virus (EBV) associated cancers, including nasopharyngeal carcinoma and Hodgkin's Disease, show a considerable leukocyte infiltration which surrounds the neoplastic cells, raising the questions as to what role these cells play in either restricting or supporting the tumour and what draws the cells into the tumour.",21291541_2,-1,-1,-1,-1,14115,-1,5.0799313e-06,0.99998796,7.0082388e-06
14121,protein,27,28,173,180,"In order to begin to address this we have studied a transgenic model of multistage carcinogenesis with epithelial expression of the EBV primary oncoprotein, latent membrane protein 1 (LMP1).",21291541_3,0,1,-1,-1,14121,-1,0.00015996708,0.9987503,0.0010896994
14124,The pathology,2,4,9,22,"RESULTS: The pathology advances with time leading to erosive dermatitis which is inflamed with a mixed infiltrate involving activated CD8+ T-cells, CD4+ T-cells including CD4+/CD25+/FoxP3+ Treg cells, mast cells and neutrophils.",21291541_5,-1,-1,-1,-1,14124,-1,0.0005787421,0.98372287,0.015698452
14127,T-cells,22,23,139,146,"RESULTS: The pathology advances with time leading to erosive dermatitis which is inflamed with a mixed infiltrate involving activated CD8+ T-cells, CD4+ T-cells including CD4+/CD25+/FoxP3+ Treg cells, mast cells and neutrophils.",21291541_5,-1,1,2,-1,14127,-1,1.1788693e-05,6.4245164e-06,0.99998176
14128,T-cells,26,27,153,160,"RESULTS: The pathology advances with time leading to erosive dermatitis which is inflamed with a mixed infiltrate involving activated CD8+ T-cells, CD4+ T-cells including CD4+/CD25+/FoxP3+ Treg cells, mast cells and neutrophils.",21291541_5,-1,1,2,-1,14128,-1,1.10699075e-05,5.599784e-06,0.9999833
14131,the pathology,12,14,76,89,Also significant dermal deposition of immunoglobulin-G (IgG) is observed as the pathology advances.,21291541_6,-1,-1,-1,-1,14131,-1,0.00047152358,0.98980904,0.009719463
14134,factor,9,10,50,56,"Along with NF-kappaB activation, STAT3, a central factor in inflammation regulation, is activated in the transgenic tissue.",21291541_7,0,1,-1,-1,14134,-1,7.597632e-06,0.99998665,5.751178e-06
14136,the transgenic tissue,17,20,101,122,"Along with NF-kappaB activation, STAT3, a central factor in inflammation regulation, is activated in the transgenic tissue.",21291541_7,-1,-1,-1,-1,14136,-1,7.2413595e-06,0.9999784,1.4374215e-05
14137,factors,2,3,21,28,"Several inflammatory factors are subsequently upregulated, notably CD30 and its ligand CD153, also leukocyte trafficking factors including CXCL10, CXCL13, L-selectin and TGF1, and inflammatory cytokines including IL-1, IL-3 and the murine IL-8 analogues CXCL1, CXCL2 and CXCL5-6, amongst others.",21291541_8,0,1,-1,-1,14137,-1,0.98134,0.018361079,0.00029893816
14138,trafficking factors,16,18,109,128,"Several inflammatory factors are subsequently upregulated, notably CD30 and its ligand CD153, also leukocyte trafficking factors including CXCL10, CXCL13, L-selectin and TGF1, and inflammatory cytokines including IL-1, IL-3 and the murine IL-8 analogues CXCL1, CXCL2 and CXCL5-6, amongst others.",21291541_8,-1,-1,-1,-1,14138,-1,0.022593455,0.94634527,0.031061256
14154,the pathology to,25,28,166,182,"The crucial role of mature T- and/or B-lymphocytes in the advancing pathology is demonstrated by their elimination, which precludes mast cell infiltration and limits the pathology to an early, benign stage.",21291541_9,-1,-1,-1,-1,14154,-1,3.644622e-05,0.99989927,6.432223e-05
14155,to the,5,7,27,33,"CONCLUSIONS: LMP1 can lead to the activation of several key factors mediating proliferation, angiogenesis and inflammation in vivo.",21291541_10,-1,-1,-1,-1,14155,-1,8.772521e-06,0.99998593,5.3164763e-06
14156,factors,11,12,60,67,"CONCLUSIONS: LMP1 can lead to the activation of several key factors mediating proliferation, angiogenesis and inflammation in vivo.",21291541_10,0,1,-1,-1,14156,-1,0.00023196048,0.99973553,3.247341e-05
14159,to the,15,17,110,116,"With the initiation of an inflammatory programme, leukocyte recruitment follows which then itself contributes to the progressing pathology in these transgenic mice, with a pivotal role for B-and/or T-cells in the process.",21291541_11,-1,-1,-1,-1,14159,-1,5.7760312e-06,0.9999881,6.1853875e-06
14161,these transgenic,20,22,142,158,"With the initiation of an inflammatory programme, leukocyte recruitment follows which then itself contributes to the progressing pathology in these transgenic mice, with a pivotal role for B-and/or T-cells in the process.",21291541_11,-1,-1,-1,-1,14161,-1,4.152193e-06,0.99999094,4.923202e-06
14162,T-cells,30,31,198,205,"With the initiation of an inflammatory programme, leukocyte recruitment follows which then itself contributes to the progressing pathology in these transgenic mice, with a pivotal role for B-and/or T-cells in the process.",21291541_11,-1,1,2,-1,14162,-1,1.1050756e-05,9.115149e-06,0.99997985
14183,tissue,4,5,27,33,The surgically removed Eca tissue was collected.,21314287_4,-1,1,2,-1,14183,-1,8.636071e-05,0.99805707,0.0018565682
14185,tissue,4,5,24,30,Cells isolated from Eca tissue were analyzed by flow cytometry.,21314287_5,-1,1,2,-1,14185,-1,3.1593303e-05,0.9995696,0.00039881424
14188,tissue-derived,9,10,34,48,The results showed that 2-10% Eca tissue-derived CD4(+) T cells expressed Foxp3; only 0.2-0.8% non-ca tissue-derived CD4(+) T cells expressed Foxp3.,21314287_6,-1,1,2,-1,14188,-1,1.7671473e-05,0.9999521,3.0222625e-05
14191,tissue-derived,23,24,102,116,The results showed that 2-10% Eca tissue-derived CD4(+) T cells expressed Foxp3; only 0.2-0.8% non-ca tissue-derived CD4(+) T cells expressed Foxp3.,21314287_6,-1,1,2,-1,14191,-1,1.8040068e-05,0.9999497,3.22879e-05
14194,analysis,1,2,8,16,Further analysis showed that 3-15% Eca-isolated CD4(+) T cells were also IL-17 positive whereas only 0.4-1.5% non-ca tissue-isolated CD4(+) T cells were IL-17 positive.,21314287_7,0,1,-1,-1,14194,-1,7.382839e-06,0.99998724,5.410175e-06
14198,tissue-isolated,24,25,117,132,Further analysis showed that 3-15% Eca-isolated CD4(+) T cells were also IL-17 positive whereas only 0.4-1.5% non-ca tissue-isolated CD4(+) T cells were IL-17 positive.,21314287_7,-1,1,2,-1,14198,-1,5.4236116e-05,0.99984646,9.9279045e-05
14206,tissue that,23,25,97,108,We also found that about 4.8-11.2% Foxp3(+) IL-17(+) T cells in isolated CD4(+) T cells from Eca tissue that were significantly less than in non-ca tissue derived CD4(+) T cells.,21314287_8,-1,-1,-1,-1,14206,-1,5.9530776e-06,0.99998057,1.3515734e-05
14208,tissue,31,32,148,154,We also found that about 4.8-11.2% Foxp3(+) IL-17(+) T cells in isolated CD4(+) T cells from Eca tissue that were significantly less than in non-ca tissue derived CD4(+) T cells.,21314287_8,-1,1,2,-1,14208,-1,5.937937e-06,0.9999795,1.4589109e-05
14224,T cells that,21,24,120,132,Coculturing CD68+ cells and Foxp3+ T cells under hypoxic environment resulted in abundant expression of IL-17 in Foxp3+ T cells that could be blocked by pretreatment with either anti-IL-17 or anti-transforming growth factor beta antibodies.,21314287_11,-1,-1,-1,-1,14224,-1,0.0031246478,0.06806159,0.9288138
14226,that IL-17+Foxp3,2,4,12,28,We conclude that IL-17+Foxp3+ T cells may contribute to the development of Eca.,21314287_12,-1,-1,-1,-1,14226,-1,0.00052663794,0.9994,7.329904e-05
14228,to the,9,11,53,59,We conclude that IL-17+Foxp3+ T cells may contribute to the development of Eca.,21314287_12,-1,-1,-1,-1,14228,-1,6.6154576e-06,0.9999877,5.710538e-06
14230,that IL-10,5,7,30,40,"Our previous works have shown that IL-10 and IFN co-regulate indoleamine-2,3-dioxygenase (IDO)-expressing immunosuppressive dendritic cells (DCs) in melanoma SLNs.",21327637_1,-1,-1,-1,-1,14230,-1,0.9290815,0.06925556,0.0016630084
14236,the relationship,8,10,37,53,The goal of this study is to examine the relationship between melanoma SLN tumor burden and the degree of SLN immune dysfunction as a model to study tumor-induced immune dysfunction.,21327637_2,-1,-1,-1,-1,14236,-1,6.1654277e-06,0.9999889,4.9543246e-06
14255,Foxp3-expressing T-regs,34,36,195,218,"By using quantitative real-time PCR, gene expressions of cytokines (IL-4, IL-10, IFN, TGF, GM-CSF) and the surrogates of immunosuppressive regulatory and effector cells (IDO-expressing DCs and Foxp3-expressing T-regs, respectively) were measured and correlated against the SLN tumor burden (MART1) and against each other.",21327637_6,-1,-1,-1,-1,14255,-1,5.5324526e-06,0.99998856,5.9219647e-06
14260,Statistical test,0,2,0,16,Statistical test used Student's t-test and stepwise multivariate regression analysis.,21327637_8,-1,-1,-1,-1,14260,-1,2.2035301e-05,0.99996877,9.163814e-06
14262,analysis,10,11,76,84,Statistical test used Student's t-test and stepwise multivariate regression analysis.,21327637_8,0,1,-1,-1,14262,-1,1.9913094e-05,0.9999635,1.6504346e-05
14264,this analysis,18,20,98,111,Statistical significance was determined at P<0.05.RESULTS: SLNs of 74 patients were analyzed in this analysis.,21327637_9,-1,-1,-1,-1,14264,-1,5.512846e-06,0.9999862,8.281448e-06
14271,analysis,6,7,42,50,"Among the various cytokines, multivariate analysis showed that only IFN gene expression correlated independently with MART1 gene expression (P<0.0001, r=0.91).",21327637_12,0,1,-1,-1,14271,-1,1.44342275e-05,0.99997723,8.320814e-06
14273,IFN gene,10,12,68,77,"Among the various cytokines, multivariate analysis showed that only IFN gene expression correlated independently with MART1 gene expression (P<0.0001, r=0.91).",21327637_12,-1,-1,-1,-1,14273,-1,0.9985359,0.0007595913,0.0007045696
14275,that IFN,4,6,35,44,"Similar multivariate analyses show that IFN (P<0.0001, r=0.78), IL-10 (P=0.0037, r=0.60), and TGF (P<0.0001, r=0.95) gene expressions correlated independently with IDO gene expression.",21327637_13,-1,-1,-1,-1,14275,-1,0.9327389,0.0645668,0.0026943055
14283,Foxp3 gene,34,36,108,118,"IFN (P<0.0001, r=0.87) and GM-CSF (P=0.042, r=0.76) gene expressions correlated independently with Foxp3 gene expression.",21327637_14,-1,-1,-1,-1,14283,-1,4.0720633e-06,0.99999154,4.367104e-06
14290,theory that,6,8,33,44,"Our data are consistent with our theory that melanoma induces expressions of specific cytokines, which in turn, stimulate immune suppressors within the SLN.",21327637_17,-1,-1,-1,-1,14290,-1,4.4899357e-06,0.9999913,4.2039733e-06
14295,that IL-10,7,9,46,56,This study also supports our previous finding that IL-10 and IFN co-regulate IDO within the SLN.,21327637_18,-1,-1,-1,-1,14295,-1,0.91111374,0.08709011,0.0017961778
14300,cytokine that,8,10,30,43,"In our data, IFN is the sole cytokine that correlates with the SLN tumor burden and seems to play a central role in tumor-induced immunological changes in the SLN immune microenvironment.",21327637_19,-1,-1,-1,-1,14300,-1,0.9799564,0.018774325,0.0012691945
14303,to play,18,20,91,98,"In our data, IFN is the sole cytokine that correlates with the SLN tumor burden and seems to play a central role in tumor-induced immunological changes in the SLN immune microenvironment.",21327637_19,-1,-1,-1,-1,14303,-1,5.9631793e-06,0.99998903,5.0515687e-06
14313,therapy,36,37,208,215,"RESULTS: Here we characterise the effects of conditioned media from reovirus-infected, dying human melanoma cells (reoTCM), in the absence of live virus, to address the immune bystander potential of reovirus therapy.",21338484_1,0,1,-1,-1,14313,-1,5.6188737e-06,0.9999895,4.8596935e-06
14320,the type,19,21,109,117,"In addition to RANTES, IL-8, MIP-1 and MIP-1, reovirus-infected melanoma cells secreted eotaxin, IP-10 and the type 1 interferon IFN-.",21338484_2,-1,-1,-1,-1,14320,-1,1.0708116e-05,0.9999809,8.323543e-06
14321,interferon IFN-,22,24,120,136,"In addition to RANTES, IL-8, MIP-1 and MIP-1, reovirus-infected melanoma cells secreted eotaxin, IP-10 and the type 1 interferon IFN-.",21338484_2,-1,-1,-1,-1,14321,-1,0.9999676,6.36445e-06,2.6141744e-05
14325,that IL-8,14,16,90,99,"To address the mechanisms responsible for the inflammatory composition of reoTCM, we show that IL-8 and IFN- secretion by reovirus-infected melanoma cells was associated with activation of NF-B and decreased by pre-treatment with small molecule inhibitors of NF-B and PKR; specific siRNA-mediated knockdown further confirmed a role for PKR.",21338484_3,-1,-1,-1,-1,14325,-1,0.92712086,0.071054965,0.0018241368
14336,tumour targets,16,18,111,125,"Following culture in reoTCM, NK cells upregulated CD69 expression and acquired greater lytic potential against tumour targets.",21338484_5,-1,-1,-1,-1,14336,-1,6.6580624e-06,0.9999881,5.211366e-06
14338,immunity,15,16,108,116,"Furthermore, melanoma cell-loaded DC cultured in reoTCM were more effective at priming adaptive anti-tumour immunity.",21338484_6,0,-1,2,-1,14338,-1,0.9999137,2.0947777e-05,6.5292494e-05
14340,that the,5,7,36,44,"CONCLUSIONS: These data demonstrate that the PKR- and NF-B-dependent induction of pro-inflammatory molecules that accompanies reovirus-mediated killing can recruit and activate innate and adaptive effector cells, thus potentially altering the tumour microenvironment to support bystander immune-mediated therapy as well as direct viral oncolysis.",21338484_7,-1,-1,-1,-1,14340,-1,4.2374877e-06,0.9999924,3.4429506e-06
14344,the tumour,31,33,240,250,"CONCLUSIONS: These data demonstrate that the PKR- and NF-B-dependent induction of pro-inflammatory molecules that accompanies reovirus-mediated killing can recruit and activate innate and adaptive effector cells, thus potentially altering the tumour microenvironment to support bystander immune-mediated therapy as well as direct viral oncolysis.",21338484_7,-1,-1,-1,-1,14344,-1,5.6742006e-06,0.99998987,4.4735507e-06
14346,therapy,38,39,305,312,"CONCLUSIONS: These data demonstrate that the PKR- and NF-B-dependent induction of pro-inflammatory molecules that accompanies reovirus-mediated killing can recruit and activate innate and adaptive effector cells, thus potentially altering the tumour microenvironment to support bystander immune-mediated therapy as well as direct viral oncolysis.",21338484_7,0,1,-1,-1,14346,-1,7.4698814e-06,0.9999864,6.1587953e-06
14357,tissue,5,6,24,30,Colorectal cancer (CRC) tissue was collected from surgically removed cancer tissue of 22 patients with CRC.,21352252_2,-1,1,2,-1,14357,-1,9.636734e-05,0.9963253,0.0035782927
14358,tissue,12,13,76,82,Colorectal cancer (CRC) tissue was collected from surgically removed cancer tissue of 22 patients with CRC.,21352252_2,-1,1,2,-1,14358,-1,8.9980495e-05,0.9940434,0.0058666714
14362,tissue,8,9,36,42,Foxp3(+) IL-17(+) T cells in cancer tissue were examined by flow cytometry.,21352252_3,-1,1,2,-1,14362,-1,3.2115917e-05,0.99979144,0.00017641569
14378,tissue,17,18,80,86,The results showed that a number of Foxp3(+) IL-17(+) T cells were found in CRC tissue (22.8  2.6 cells/mm(2) tissue) that was significantly more than in non-cancer colonic mucosa (5.6  1.04 cells/mm(2) tissue).,21352252_6,-1,1,2,-1,14378,-1,1.4655576e-05,0.99974245,0.00024290994
14379,tissue,24,25,111,117,The results showed that a number of Foxp3(+) IL-17(+) T cells were found in CRC tissue (22.8  2.6 cells/mm(2) tissue) that was significantly more than in non-cancer colonic mucosa (5.6  1.04 cells/mm(2) tissue).,21352252_6,-1,1,2,-1,14379,-1,7.7896046e-05,0.99427444,0.0056477077
14382,tissue,41,42,205,211,The results showed that a number of Foxp3(+) IL-17(+) T cells were found in CRC tissue (22.8  2.6 cells/mm(2) tissue) that was significantly more than in non-cancer colonic mucosa (5.6  1.04 cells/mm(2) tissue).,21352252_6,-1,1,2,-1,14382,-1,8.240084e-05,0.9936388,0.0062787863
14383,The Foxp3(+,0,2,0,11,"The Foxp3(+) IL-17(+) cells also CD4(+), CCR6(+), transforming growth factor (TGF)-beta(+) and IL-6(+) .",21352252_7,-1,-1,-1,-1,14383,-1,2.3191731e-05,0.9999542,2.2537291e-05
14387,transforming growth factor,13,16,50,76,"The Foxp3(+) IL-17(+) cells also CD4(+), CCR6(+), transforming growth factor (TGF)-beta(+) and IL-6(+) .",21352252_7,-1,-1,-1,-1,14387,-1,0.98598635,0.011270792,0.0027428619
14391,to tumour protein,9,12,56,73,The CD8(+) T cells proliferated markedly after exposure to tumour protein in culture that was suppressed in the presence of CRC-derived Foxp3(+) IL-17(+) T cells; the suppression was attenuated by pretreatment with anti-IL-17 antibody.,21352252_8,-1,-1,-1,-1,14391,-1,7.1528125e-06,0.999987,5.8187684e-06
14406,This subset,0,2,0,11,This subset of T cells may be a novel therapeutic target in the treatment of CRC.,21352252_10,-1,-1,-1,-1,14406,-1,0.003544144,0.4787578,0.5176981
14408,therapeutic target,9,11,38,56,This subset of T cells may be a novel therapeutic target in the treatment of CRC.,21352252_10,-1,-1,-1,-1,14408,-1,5.1372695e-06,0.9999901,4.7279964e-06
14409,the treatment,12,14,60,73,This subset of T cells may be a novel therapeutic target in the treatment of CRC.,21352252_10,-1,-1,-1,-1,14409,-1,4.738648e-06,0.9999907,4.559378e-06
14417,T (Th17,2,5,15,22,IL-17(+)CD4(+) T (Th17) cells mediate inflammation of autoimmune diseases.,21357259_1,-1,-1,-1,-1,14417,-1,3.3433174e-05,0.99994624,2.0317868e-05
14421,blood,13,14,85,90,A small population of IL-17(+)Foxp3(+)CD4(+) T cells has been observed in peripheral blood in healthy human beings.,21357259_2,0,1,-1,-1,14421,-1,8.076999e-05,0.9997695,0.0001496855
14445,T cells functionally,2,5,23,43,IL-17(+)Foxp3(+)CD4(+) T cells functionally suppressed T cell activation and stimulated inflammatory cytokine production in the colitic tissues.,21357259_8,-1,-1,-1,-1,14445,-1,0.002288316,0.02003533,0.9776764
14449,tissues,17,18,136,143,IL-17(+)Foxp3(+)CD4(+) T cells functionally suppressed T cell activation and stimulated inflammatory cytokine production in the colitic tissues.,21357259_8,-1,1,2,-1,14449,-1,3.0514271e-05,0.9997806,0.00018891343
14450,that IL-17(+)Foxp3(+,3,5,18,38,"Our data indicate that IL-17(+)Foxp3(+) cells may be ""inflammatory"" Treg cells in the pathological microenvironments.",21357259_9,-1,-1,-1,-1,14450,-1,0.011250628,0.98816645,0.0005829423
14454,These cells,0,2,0,11,"These cells may contribute to the pathogenesis of ulcerative colitis through inducing inflammatory cytokines and inhibiting local T cell immunity, and in turn may mechanistically link human chronic inflammation to tumor development.",21357259_10,-1,-1,-1,-1,14454,-1,1.9122243e-05,1.5275942e-05,0.99996567
14455,to the,4,6,27,33,"These cells may contribute to the pathogenesis of ulcerative colitis through inducing inflammatory cytokines and inhibiting local T cell immunity, and in turn may mechanistically link human chronic inflammation to tumor development.",21357259_10,-1,-1,-1,-1,14455,-1,6.0257503e-06,0.9999883,5.614036e-06
14458,T cell immunity,17,20,130,145,"These cells may contribute to the pathogenesis of ulcerative colitis through inducing inflammatory cytokines and inhibiting local T cell immunity, and in turn may mechanistically link human chronic inflammation to tumor development.",21357259_10,-1,-1,-1,-1,14458,-1,0.00010460478,1.5514044e-05,0.99987984
14460,to tumor,30,32,211,219,"These cells may contribute to the pathogenesis of ulcerative colitis through inducing inflammatory cytokines and inhibiting local T cell immunity, and in turn may mechanistically link human chronic inflammation to tumor development.",21357259_10,-1,-1,-1,-1,14460,-1,6.067407e-06,0.9999883,5.5599126e-06
14465,complex Treg cell,18,21,114,131,"Our data therefore challenge commonly held beliefs of the anti-inflammatory role of Treg cells and suggest a more complex Treg cell biology, at least in the context of human chronic inflammation and associated carcinoma.",21357259_11,-1,-1,-1,-1,14465,-1,0.0012654376,0.04385036,0.9548842
14470,receptor,3,4,18,26,"Expression of its receptor, TIE2, defines a highly proangiogenic subpopulation of myeloid cells in circulation and tumors called TIE2-expressing monocytes/macrophages (TEMs).",21368233_1,0,1,2,-1,14470,-1,0.009049781,0.0013429617,0.9896073
14491,CCL17,32,33,190,195,"Previously, we demonstrated that ANGPT2 augments the expression of various proangiogenic genes, the potent immunosuppressive cytokine, IL-10, and a chemokine for regulatory T cells (Tregs), CCL17 by TEMs in vitro.",21368233_3,0,-1,2,-1,14491,-1,0.99984,1.662181e-05,0.00014342096
14493,that TEMs,3,5,12,21,"We now show that TEMs also express higher levels of IL-10 than TIE2(-) macrophages in tumors and that ANGPT2-stimulated release of IL-10 by TEMs suppresses T cell proliferation, increases the ratio of CD4(+) T cells to CD8(+) T cells, and promotes the expansion of CD4(+)CD25(high)FOXP3(+) Tregs.",21368233_4,-1,-1,-1,-1,14493,-1,4.5953834e-06,0.9999908,4.5679876e-06
14494,IL-10 than TIE2(-,10,13,52,69,"We now show that TEMs also express higher levels of IL-10 than TIE2(-) macrophages in tumors and that ANGPT2-stimulated release of IL-10 by TEMs suppresses T cell proliferation, increases the ratio of CD4(+) T cells to CD8(+) T cells, and promotes the expansion of CD4(+)CD25(high)FOXP3(+) Tregs.",21368233_4,-1,-1,-1,-1,14494,-1,0.9980293,0.0014694493,0.0005012939
14502,T cells to,36,39,208,218,"We now show that TEMs also express higher levels of IL-10 than TIE2(-) macrophages in tumors and that ANGPT2-stimulated release of IL-10 by TEMs suppresses T cell proliferation, increases the ratio of CD4(+) T cells to CD8(+) T cells, and promotes the expansion of CD4(+)CD25(high)FOXP3(+) Tregs.",21368233_4,-1,-1,-1,-1,14502,-1,0.0010744542,0.015713798,0.9832117
14510,tumor TEMs,28,30,176,186,"Furthermore, syngeneic murine tumors expressing high levels of ANGPT2 contained not only high numbers of TEMs but also increased numbers of Tregs, whereas genetic depletion of tumor TEMs resulted in a marked reduction in the frequency of Tregs in tumors.",21368233_5,-1,-1,-1,-1,14510,-1,6.4850815e-06,0.99998724,6.2948848e-06
14514,Taken together,0,2,0,14,"Taken together, our data suggest that ANGPT2-stimulated TEMs represent a novel, potent immunosuppressive force in tumors.",21368233_6,-1,-1,-1,-1,14514,-1,1.0418162e-05,0.99998105,8.52397e-06
14525,antigen-presenting cells,14,16,94,118,"Colonic CD90+ mesenchymal myofibroblasts and fibroblasts (CMFs) are abundant, nonprofessional antigen-presenting cells in the normal human colonic mucosa that suppress proliferation of activated CD4+ effector T cells.",21376048_1,-1,-1,-1,-1,14525,-1,0.86187077,0.00022081505,0.13790846
14533,tissues,26,27,154,161,"METHODS: Allogeneic cocultures of CD4+ T cells and CMFs, derived from normal mucosa of patients undergoing colectomy for colon cancer or inflamed colonic tissues from patients with ulcerative colitis or Crohn's disease, were used to assess activation of the Treg cells.",21376048_3,-1,1,2,-1,14533,-1,0.0010899476,0.9159677,0.08294234
14535,the Treg cells,43,46,254,268,"METHODS: Allogeneic cocultures of CD4+ T cells and CMFs, derived from normal mucosa of patients undergoing colectomy for colon cancer or inflamed colonic tissues from patients with ulcerative colitis or Crohn's disease, were used to assess activation of the Treg cells.",21376048_3,-1,-1,-1,-1,14535,-1,0.0016354868,0.0813641,0.9170004
14545,factor-,47,48,247,255,"RESULTS: Coculture of normal CMF with resting or nave CD4+ T cells led to development of cells with a Treg phenotype; it also induced proliferation of a CD25+ CD127- FoxP3+ T cells, which expressed CTLA-4, interleukin-10, and transforming growth factor- and had suppressive activities.",21376048_4,0,1,-1,-1,14545,-1,0.99993706,6.2891027e-06,5.6678462e-05
14548,interleukin-2 to,10,12,63,79,"In contrast to dendritic cells, normal CMFs required exogenous interleukin-2 to induce proliferation of naturally occurring Treg cells.",21376048_5,-1,-1,-1,-1,14548,-1,0.99874616,0.00095137605,0.0003024674
14555,to transiently generate,18,21,124,147,CMFs from patients with inflammatory bowel diseases had reduced capacity to induce active Treg cells and increased capacity to transiently generate CD4+CD25+/- CD127+ T cells that express low levels of FoxP3.CONCLUSIONS: CMFs suppress the immune response in normal colon tissue and might therefore help maintain colonic mucosal tolerance.,21376048_7,-1,-1,-1,-1,14555,-1,5.514109e-06,0.99999,4.53676e-06
14556,T cells that,24,27,167,179,CMFs from patients with inflammatory bowel diseases had reduced capacity to induce active Treg cells and increased capacity to transiently generate CD4+CD25+/- CD127+ T cells that express low levels of FoxP3.CONCLUSIONS: CMFs suppress the immune response in normal colon tissue and might therefore help maintain colonic mucosal tolerance.,21376048_7,-1,-1,-1,-1,14556,-1,0.0008546965,0.02228798,0.97685724
14557,the immune response,35,38,235,254,CMFs from patients with inflammatory bowel diseases had reduced capacity to induce active Treg cells and increased capacity to transiently generate CD4+CD25+/- CD127+ T cells that express low levels of FoxP3.CONCLUSIONS: CMFs suppress the immune response in normal colon tissue and might therefore help maintain colonic mucosal tolerance.,21376048_7,-1,-1,-1,-1,14557,-1,0.53727055,0.46122015,0.001509261
14558,tissue,41,42,271,277,CMFs from patients with inflammatory bowel diseases had reduced capacity to induce active Treg cells and increased capacity to transiently generate CD4+CD25+/- CD127+ T cells that express low levels of FoxP3.CONCLUSIONS: CMFs suppress the immune response in normal colon tissue and might therefore help maintain colonic mucosal tolerance.,21376048_7,-1,1,2,-1,14558,-1,0.0008393597,0.57436216,0.4247985
14570,the plasticity,11,13,79,93,"Mounting data implicates chromatin regulation, namely promoter methylation, in the plasticity of nave human T cells.",21377729_2,-1,-1,-1,-1,14570,-1,1.1479501e-05,0.99998176,6.7430146e-06
14571,nave,14,15,97,102,"Mounting data implicates chromatin regulation, namely promoter methylation, in the plasticity of nave human T cells.",21377729_2,-1,-1,-1,-1,14571,-1,8.2691395e-06,0.9999856,6.1229844e-06
14573,that this plasticity,5,8,35,55,Recent in vitro evidence indicates that this plasticity may be phenotypically altered by using methylation inhibitors which are approved for clinical use in certain types of cancer.,21377729_3,-1,-1,-1,-1,14573,-1,1.0863973e-05,0.9999819,7.2205307e-06
14592,Th2 cells to,8,11,53,65,"Our data indicates that 5A2 treatment can depolarize Th2 cells to effectively secrete interferon gamma, signal via T-bet, and achieve demethylation of critical Th1 specific promoters.",21377729_6,-1,-1,-1,-1,14592,-1,0.0009849984,0.14904371,0.8499713
14603,proteins,5,6,47,55,Cytoplasmic delivery and cross-presentation of proteins and peptides is necessary for processing and presentation of antigens for the generation of cytotoxic T cells.,21383765_0,0,1,-1,-1,14603,-1,0.0047528455,0.9951514,9.570861e-05
14604,peptides,7,8,60,68,Cytoplasmic delivery and cross-presentation of proteins and peptides is necessary for processing and presentation of antigens for the generation of cytotoxic T cells.,21383765_0,0,-1,2,-1,14604,-1,0.9612119,0.035608854,0.0031791877
14606,the generation,17,19,130,144,Cytoplasmic delivery and cross-presentation of proteins and peptides is necessary for processing and presentation of antigens for the generation of cytotoxic T cells.,21383765_0,-1,-1,-1,-1,14606,-1,7.911453e-06,0.99998665,5.4755956e-06
14610,peptide,10,11,53,60,"We previously described the use of the 16 amino acid peptide penetratin from the Drosophila Antennapedia homeodomain (penetratin, Antp) to transport cytotoxic T lymphocyte epitopes derived from ovalbumin (OVA) or the Mucin-1 tumor-associated antigen into cells.",21383765_1,0,-1,2,-1,14610,-1,8.334313e-05,0.99985826,5.839111e-05
14612,to transport cytotoxic T lymphocyte,22,27,136,171,"We previously described the use of the 16 amino acid peptide penetratin from the Drosophila Antennapedia homeodomain (penetratin, Antp) to transport cytotoxic T lymphocyte epitopes derived from ovalbumin (OVA) or the Mucin-1 tumor-associated antigen into cells.",21383765_1,-1,-1,-1,-1,14612,-1,0.0033075248,0.316753,0.6799395
14614,tumor-associated antigen,37,39,225,249,"We previously described the use of the 16 amino acid peptide penetratin from the Drosophila Antennapedia homeodomain (penetratin, Antp) to transport cytotoxic T lymphocyte epitopes derived from ovalbumin (OVA) or the Mucin-1 tumor-associated antigen into cells.",21383765_1,-1,-1,-1,-1,14614,-1,0.6012561,0.3923781,0.0063658734
14618,protein,10,11,63,70,We have now shown that penetratin covalently conjugated to OVA protein and linked in tandem to CD4(+) and/or CD8(+) T-cell epitopes from OVA-stimulated T cells in vitro (B3Z T-cell hybridoma and OT-I and OT-II T cells).,21383765_2,0,1,-1,-1,14618,-1,1.8252958e-05,0.99997234,9.367581e-06
14619,tandem to,14,16,85,94,We have now shown that penetratin covalently conjugated to OVA protein and linked in tandem to CD4(+) and/or CD8(+) T-cell epitopes from OVA-stimulated T cells in vitro (B3Z T-cell hybridoma and OT-I and OT-II T cells).,21383765_2,-1,-1,-1,-1,14619,-1,4.3763243e-06,0.99999106,4.5841966e-06
14620,T-cell,21,22,116,122,We have now shown that penetratin covalently conjugated to OVA protein and linked in tandem to CD4(+) and/or CD8(+) T-cell epitopes from OVA-stimulated T cells in vitro (B3Z T-cell hybridoma and OT-I and OT-II T cells).,21383765_2,-1,1,2,-1,14620,-1,9.92231e-06,5.8719893e-06,0.99998426
14622,T-cell,31,32,174,180,We have now shown that penetratin covalently conjugated to OVA protein and linked in tandem to CD4(+) and/or CD8(+) T-cell epitopes from OVA-stimulated T cells in vitro (B3Z T-cell hybridoma and OT-I and OT-II T cells).,21383765_2,-1,1,2,-1,14622,-1,1.2576583e-05,6.196391e-06,0.99998116
14627,peptide,11,12,73,80,The induction of these responses was directly mediated by the penetratin peptide as linking a nonspecific 16-mer peptide to OVA or mixing did not induce CD8(+) or CD4(+) T-cell responses in vitro.,21383765_3,0,-1,2,-1,14627,-1,0.00051490386,0.99931264,0.00017245622
14628,peptide to,17,19,113,123,The induction of these responses was directly mediated by the penetratin peptide as linking a nonspecific 16-mer peptide to OVA or mixing did not induce CD8(+) or CD4(+) T-cell responses in vitro.,21383765_3,-1,-1,-1,-1,14628,-1,0.0002578741,0.99963915,0.00010295755
14629,T-cell,30,31,170,176,The induction of these responses was directly mediated by the penetratin peptide as linking a nonspecific 16-mer peptide to OVA or mixing did not induce CD8(+) or CD4(+) T-cell responses in vitro.,21383765_3,-1,1,2,-1,14629,-1,1.9088802e-05,7.059699e-06,0.9999739
14634,T-cell-dependent,8,9,42,58,Tumor protection was mediated by a CD8(+) T-cell-dependent mechanism and did not require CD4(+) help to protect mice 7 days after a boost immunization.,21383765_5,-1,1,2,-1,14634,-1,1.5961441e-05,1.1438807e-05,0.9999726
14637,antigen-specific IFN--secreting,16,18,88,120,"Alternatively, 40 days after a boost immunization, the presence of CD4(+) help enhanced antigen-specific IFN--secreting CD8(+) T cells and tumor protection in mice challenged with B16.OVA.",21383765_6,-1,-1,-1,-1,14637,-1,0.9998485,4.1425865e-05,0.0001100532
14642,tumor therapy,16,18,99,112,"In addition, immunization with AntpOVA significantly delayed growth of B16.OVA tumors in mice in a tumor therapy model.",21383765_8,-1,-1,-1,-1,14642,-1,4.462686e-06,0.99999106,4.4397166e-06
14650,the tumor,36,38,215,224,"Although polyclonal regulatory T cells (Tregs) that once expressed Foxp3 (ex-Tregs) derived from Foxp3(+) Tregs have been described in homeostatic and autoimmune settings, little is known regarding the influence of the tumor environment on ex-Treg development.",21389255_0,-1,-1,-1,-1,14650,-1,5.6181157e-06,0.99999,4.3889545e-06
14658,transfer to,3,5,14,25,"On the second transfer to a Rag2(-/-) B6 male environment, these ex-Tregs expanded strongly, whereas Tregs that maintained expression of Foxp3 expression did not.",21389255_2,-1,-1,-1,-1,14658,-1,3.8036762e-06,0.99999166,4.525351e-06
14660,Tregs that,18,20,101,111,"On the second transfer to a Rag2(-/-) B6 male environment, these ex-Tregs expanded strongly, whereas Tregs that maintained expression of Foxp3 expression did not.",21389255_2,-1,-1,-1,-1,14660,-1,3.5838334e-06,0.9999925,3.8915573e-06
14662,analysis,5,6,41,49,Both FACS and quantitative real-time-PCR analysis revealed that ex-Tregs upregulated genes characteristic of a Th1 effector-memory phenotype including IFN- and downregulated a panel of Treg-specific genes.,21389255_3,0,1,-1,-1,14662,-1,5.8427995e-06,0.9999887,5.4390816e-06
14667,Treg-specific genes,24,26,186,205,Both FACS and quantitative real-time-PCR analysis revealed that ex-Tregs upregulated genes characteristic of a Th1 effector-memory phenotype including IFN- and downregulated a panel of Treg-specific genes.,21389255_3,-1,-1,-1,-1,14667,-1,5.5304913e-06,0.99998784,6.686441e-06
14669,transferred to,6,8,51,65,"Peripheral HY-specific green Tregs were adoptively transferred to Rag2(-/-) B6 male mice, to dissect the factors regulating ex-Treg differentiation.",21389255_4,-1,-1,-1,-1,14669,-1,4.118074e-06,0.9999919,4.0189434e-06
14671,the factors,16,18,101,112,"Peripheral HY-specific green Tregs were adoptively transferred to Rag2(-/-) B6 male mice, to dissect the factors regulating ex-Treg differentiation.",21389255_4,-1,-1,-1,-1,14671,-1,4.578535e-06,0.9999913,4.1050885e-06
14678,the plasticity,7,9,46,60,"Collectively, our study not only demonstrates the plasticity of Ag-specific Tregs in the context of the tumor environment, but also defines key molecular and cellular events that modulate ex-Treg differentiation.",21389255_7,-1,-1,-1,-1,14678,-1,7.4116674e-06,0.9999877,4.850105e-06
14681,the tumor,16,18,100,109,"Collectively, our study not only demonstrates the plasticity of Ag-specific Tregs in the context of the tumor environment, but also defines key molecular and cellular events that modulate ex-Treg differentiation.",21389255_7,-1,-1,-1,-1,14681,-1,4.128103e-06,0.9999914,4.4457174e-06
14684,functions,5,6,41,50,"Several studies have shown physiological functions of interleukin (IL)-32, a novel cytokine.",21423208_0,0,1,2,-1,14684,-1,4.9569047e-05,0.9999052,4.5144447e-05
14690,that IL-32,6,8,25,36,"In this study, we showed that IL-32 inhibited tumor growth in IL-32-overexpressing transgenic mice inoculated with melanoma as well as colon tumor growth in xenograft nude mice inoculated with IL-32-transfected colon cancer cells (SW620).",21423208_2,-1,-1,-1,-1,14690,-1,0.005552051,0.527562,0.46688592
14692,IL-32-overexpressing transgenic,12,14,63,95,"In this study, we showed that IL-32 inhibited tumor growth in IL-32-overexpressing transgenic mice inoculated with melanoma as well as colon tumor growth in xenograft nude mice inoculated with IL-32-transfected colon cancer cells (SW620).",21423208_2,-1,-1,-1,-1,14692,-1,0.003476721,0.027133511,0.9693897
14705,tumor-promoting genes,8,10,56,77,"The expression of antiapoptotic, cell proliferation and tumor-promoting genes (bcl-2, X-chromosome inhibitor of apoptosis protein (IAP), cellular IAP and cellular FADD-like IL-1-converting enzyme-inhibitory protein, cyclin D), cyclin-dependent kinase 4, cycolooxygenase-2 and inducible nitric oxide synthase was decreased, whereas the expression of apoptotic target genes (caspase-3 and -9, bax) increased.",21423208_4,-1,-1,-1,-1,14705,-1,5.113072e-06,0.99998844,6.4970864e-06
14706,protein,17,18,122,129,"The expression of antiapoptotic, cell proliferation and tumor-promoting genes (bcl-2, X-chromosome inhibitor of apoptosis protein (IAP), cellular IAP and cellular FADD-like IL-1-converting enzyme-inhibitory protein, cyclin D), cyclin-dependent kinase 4, cycolooxygenase-2 and inducible nitric oxide synthase was decreased, whereas the expression of apoptotic target genes (caspase-3 and -9, bax) increased.",21423208_4,0,1,-1,-1,14706,-1,3.0712097e-05,0.9999304,3.8856953e-05
14710,protein,29,30,208,215,"The expression of antiapoptotic, cell proliferation and tumor-promoting genes (bcl-2, X-chromosome inhibitor of apoptosis protein (IAP), cellular IAP and cellular FADD-like IL-1-converting enzyme-inhibitory protein, cyclin D), cyclin-dependent kinase 4, cycolooxygenase-2 and inducible nitric oxide synthase was decreased, whereas the expression of apoptotic target genes (caspase-3 and -9, bax) increased.",21423208_4,0,1,-1,-1,14710,-1,0.00011058663,0.99982685,6.255658e-05
14712,target genes,53,55,360,372,"The expression of antiapoptotic, cell proliferation and tumor-promoting genes (bcl-2, X-chromosome inhibitor of apoptosis protein (IAP), cellular IAP and cellular FADD-like IL-1-converting enzyme-inhibitory protein, cyclin D), cyclin-dependent kinase 4, cycolooxygenase-2 and inducible nitric oxide synthase was decreased, whereas the expression of apoptotic target genes (caspase-3 and -9, bax) increased.",21423208_4,-1,-1,-1,-1,14712,-1,4.2013394e-06,0.9999901,5.6752624e-06
14714,blood,5,6,21,26,"In tumor, spleen and blood, the number of cytotoxic CD8(+) T cells and CD57(+) natural killer cells and the levels of IL-10 increased, but that of tumor necrosis factor- (TNF-), IL-1 and IL-6 decreased.",21423208_5,0,1,-1,-1,14714,-1,7.28365e-05,0.9998586,6.851308e-05
14723,factor-,33,34,162,170,"In tumor, spleen and blood, the number of cytotoxic CD8(+) T cells and CD57(+) natural killer cells and the levels of IL-10 increased, but that of tumor necrosis factor- (TNF-), IL-1 and IL-6 decreased.",21423208_5,0,1,-1,-1,14723,-1,0.99995816,4.8114252e-06,3.703852e-05
14724,TNF-,35,36,172,177,"In tumor, spleen and blood, the number of cytotoxic CD8(+) T cells and CD57(+) natural killer cells and the levels of IL-10 increased, but that of tumor necrosis factor- (TNF-), IL-1 and IL-6 decreased.",21423208_5,0,1,-1,-1,14724,-1,0.0008399669,0.9990891,7.09693e-05
14735,the IL-32-induced,29,31,172,190,"In addition, when IL-32 was knocked down by small interfering RNA (siRNA) or neutralized with an anti-IL-32 antibody, IL-32-induced colon cancer cell growth inhibition, the IL-32-induced decrease of TNF-, IL-1 and IL-6 production, and the increase of IL-10 production were abolished.",21423208_7,-1,-1,-1,-1,14735,-1,0.0018281613,0.9388852,0.059286665
14736,TNF-,33,34,203,208,"In addition, when IL-32 was knocked down by small interfering RNA (siRNA) or neutralized with an anti-IL-32 antibody, IL-32-induced colon cancer cell growth inhibition, the IL-32-induced decrease of TNF-, IL-1 and IL-6 production, and the increase of IL-10 production were abolished.",21423208_7,0,1,-1,-1,14736,-1,0.003820848,0.9958846,0.00029453918
14749,the functional tolerance,5,8,24,48,One such setting may be the functional tolerance displayed by tumor-bearing hosts toward tumor-associated antigens.,21517755_1,-1,-1,-1,-1,14749,-1,1.20309105e-05,0.99998116,6.7765386e-06
14751,toward tumor-associated antigens,12,15,82,114,One such setting may be the functional tolerance displayed by tumor-bearing hosts toward tumor-associated antigens.,21517755_1,-1,-1,-1,-1,14751,-1,0.09453474,0.90288043,0.0025848525
14754,to tumor-induced,10,12,57,73,Foxp3(+) Tregs are now recognized as a major contributor to tumor-induced immune suppression and functional tolerance.,21517755_2,-1,-1,-1,-1,14754,-1,1.1366716e-05,0.9999807,7.983903e-06
14755,functional tolerance,15,17,97,117,Foxp3(+) Tregs are now recognized as a major contributor to tumor-induced immune suppression and functional tolerance.,21517755_2,-1,-1,-1,-1,14755,-1,6.676972e-05,0.99990547,2.7751756e-05
14763,T cells toward,16,19,92,106,The first is the ability of IDO-expressing DCs to drive the differentiation of naive CD4(+) T cells toward a Foxp3+ (inducible Treg) phenotype.,21517755_4,-1,-1,-1,-1,14763,-1,0.0016152133,0.041356448,0.9570283
14770,target cells,21,23,138,150,"The second link is the ability of IDO-expressing DCs to directly activate mature, pre-existing Tregs for markedly enhanced suppression of target cells.",21517755_5,-1,-1,-1,-1,14770,-1,0.0009290294,0.12205366,0.87701726
14771,the third,1,3,4,13,"And the third link is the ability of IDO to prevent the inflammation-induced conversion (""reprogramming"") of Tregs into pro-inflammatory T-helper-like cells in vivo.",21517755_6,-1,-1,-1,-1,14771,-1,9.0375925e-06,0.99998355,7.44729e-06
14776,T-helper-like cells,23,25,137,156,"And the third link is the ability of IDO to prevent the inflammation-induced conversion (""reprogramming"") of Tregs into pro-inflammatory T-helper-like cells in vivo.",21517755_6,-1,-1,-1,-1,14776,-1,0.00011872077,0.0005131832,0.999368
14777,Taken together,0,2,0,14,"Taken together, these findings suggest that IDO may represent an important regulatory checkpoint influencing Treg activity: both by stabilizing and augmenting the suppressive phenotype, and by preventing Treg reprogramming into non-suppressive helper-like cells.",21517755_7,-1,-1,-1,-1,14777,-1,9.197824e-06,0.99998343,7.418255e-06
14787,to T,11,13,67,71,We hypothesised that immune suppression in this subtype may be due to T regulatory cells (Treg) recruitment driven by hypoxia-induced up-regulation of CXCR4 in Treg.,21521526_1,-1,-1,-1,-1,14787,-1,7.038937e-06,0.99998605,6.8717245e-06
14793,tissue,11,12,73,79,METHODS: Immunoperoxidase staining for FOXP3 and CXCL12 was performed on tissue microarrays from 491 breast cancers.,21521526_2,-1,1,2,-1,14793,-1,2.4356788e-05,0.99994445,3.116523e-05
14799,tumour CXCL12,7,9,48,61,"RESULTS: High Treg infiltration correlated with tumour CXCL12 positivity (OR 1.89, 95% CI 1.22 to 2.94, P = 0.004) and basal phenotype (OR 3.14, 95% CI 1.08 to 9.17, P = 0.004) in univariate and multivariate analyses.",21521526_4,-1,-1,-1,-1,14799,-1,0.931903,0.06584768,0.0022492835
14805,analysis,50,51,253,261,"CXCL12 positivity correlated with improved survival (P = 0.005), whereas high Treg correlated with shorter survival for all breast cancers (P = 0.001), luminal cancers (P < 0.001) and basal-like cancers (P = 0.040) that were confirmed in a multivariate analysis (OR 1.61, 95% CI 1.02 to 2.53, P = 0.042).",21521526_5,0,1,-1,-1,14805,-1,1.0505943e-05,0.99998105,8.436868e-06
14808,therapy,5,6,33,40,"In patients treated with hormone therapy, high Treg were associated with a shorter survival in a multivariate analysis (OR 1.78, 95% CI 1.01 to 3.15, P = 0.040).",21521526_6,0,1,-1,-1,14808,-1,5.499797e-05,0.99991405,3.0943054e-05
14810,analysis,18,19,110,118,"In patients treated with hormone therapy, high Treg were associated with a shorter survival in a multivariate analysis (OR 1.78, 95% CI 1.01 to 3.15, P = 0.040).",21521526_6,0,1,-1,-1,14810,-1,1.2757979e-05,0.9999753,1.1952321e-05
14839,factor-1,14,15,86,95,METHODS: The frequencies of CD4(+)Foxp3(+) Tregs and the level of transforming growth factor-1 (TGF-1) were analyzed from 56 patients with gastric cancer by flow cytometry and enzyme-linked immunosorbent assay respectively.,21528082_1,0,1,-1,-1,14839,-1,0.984855,0.0008534051,0.014291519
14841,Foxp3 gene,0,2,0,10,Foxp3 gene expression was analyzed by real-time polymerase chain reaction.,21528082_2,-1,-1,-1,-1,14841,-1,4.5004826e-06,0.9999896,5.857724e-06
14855,to the,5,7,44,50,Neutralizing anti-TGF-1 antibody was added to the co-culture system for neutralization experiments.,21528082_7,-1,-1,-1,-1,14855,-1,5.9136846e-06,0.9999894,4.667067e-06
14858,than that,20,22,106,115,RESULTS: The level of serum TGF-1 in gastric cancer patients (15.1  5.5 ng/mL) was significantly higher than that of the gender- and age-matched healthy controls (10.3  3.4 ng/mL) (P < 0.05).,21528082_8,-1,-1,-1,-1,14858,-1,6.696002e-06,0.99998724,6.051047e-06
14869,that the,12,14,65,73,"Moreover, using the purified CD4(+)CD25(-) T cells, we confirmed that the increased Tregs were mainly induced from the conversation of CD4(+)CD25(-) naive T cells, and induced Tregs were functional and able to suppress the proliferation of effector T cells.",21528082_11,-1,-1,-1,-1,14869,-1,4.415255e-06,0.99999166,3.9722386e-06
14872,naive T cells,25,28,149,162,"Moreover, using the purified CD4(+)CD25(-) T cells, we confirmed that the increased Tregs were mainly induced from the conversation of CD4(+)CD25(-) naive T cells, and induced Tregs were functional and able to suppress the proliferation of effector T cells.",21528082_11,-1,-1,-1,-1,14872,-1,0.0012729006,0.046645135,0.95208204
14874,functional,33,34,187,197,"Moreover, using the purified CD4(+)CD25(-) T cells, we confirmed that the increased Tregs were mainly induced from the conversation of CD4(+)CD25(-) naive T cells, and induced Tregs were functional and able to suppress the proliferation of effector T cells.",21528082_11,0,1,2,-1,14874,-1,6.7091576e-05,0.99990296,2.9953548e-05
14892,the tumor,20,22,128,137,"CONCLUSION: Gastric cancer cell can induce Tregs development via producing TGF-1, by which the existence of cross-talk between the tumor and immune cells might regulate anti-tumor immune responses.",21528082_14,-1,-1,-1,-1,14892,-1,4.1804205e-06,0.9999902,5.5800556e-06
14895,The forkhead transcription factor Foxp3,0,5,0,39,The forkhead transcription factor Foxp3 is the only definitive marker of CD4(+)CD25(+) regulatory T cells (Tregs) and has been identified as a key regulator in the development and function of Tregs.,21547596_0,-1,-1,-1,-1,14895,-1,4.597946e-06,0.9999914,3.9327874e-06
14900,function,31,32,180,188,The forkhead transcription factor Foxp3 is the only definitive marker of CD4(+)CD25(+) regulatory T cells (Tregs) and has been identified as a key regulator in the development and function of Tregs.,21547596_0,0,1,2,-1,14900,-1,1.2445462e-05,0.9999758,1.1709684e-05
14906,tumor-infiltrating Tregs,10,12,53,77,"In this study, we validated Foxp3 expression in both tumor-infiltrating Tregs and melanoma cells by performing immunohistochemical analysis of human melanoma tissue sections.",21547596_2,-1,-1,-1,-1,14906,-1,9.645839e-06,0.99998057,9.749709e-06
14908,analysis,18,19,131,139,"In this study, we validated Foxp3 expression in both tumor-infiltrating Tregs and melanoma cells by performing immunohistochemical analysis of human melanoma tissue sections.",21547596_2,0,1,-1,-1,14908,-1,1.2251861e-05,0.99997985,7.9336805e-06
14909,tissue,22,23,158,164,"In this study, we validated Foxp3 expression in both tumor-infiltrating Tregs and melanoma cells by performing immunohistochemical analysis of human melanoma tissue sections.",21547596_2,-1,1,2,-1,14909,-1,3.5493176e-05,0.99987984,8.462287e-05
14912,analysis,17,18,112,120,"Further, we assessed Foxp3 expression in melanoma cell lines by performing flow cytometry, confocal microscopic analysis, reverse transcription-polymerase chain reaction (RT-PCR), and Western blotting.",21547596_3,0,1,-1,-1,14912,-1,4.0377116e-05,0.99986005,9.953997e-05
14917,transforming growth factor,20,23,125,151,"Inhibition of Foxp3 expression in melanoma cells using small interfering RNA (siRNA) resulted in downregulation of B7-H1 and transforming growth factor (TGF)- expression; in contrast, Foxp3 overexpression resulted in the upregulation of the expression of these proteins.",21547596_4,-1,-1,-1,-1,14917,-1,0.9755662,0.020155719,0.0042781094
14921,these proteins,39,41,256,270,"Inhibition of Foxp3 expression in melanoma cells using small interfering RNA (siRNA) resulted in downregulation of B7-H1 and transforming growth factor (TGF)- expression; in contrast, Foxp3 overexpression resulted in the upregulation of the expression of these proteins.",21547596_4,-1,-1,-1,-1,14921,-1,7.4714394e-06,0.9999862,6.3404445e-06
14937,Foxp3-dependent Treg-like,8,10,56,81,These findings indicated that melanoma cells could have Foxp3-dependent Treg-like suppressive effects on T cells and suggested that the mimicking of Treg function by melanoma cells may represent a possible mechanism of tumor resistance to immune destruction in the melanoma tumor microenvironment.,21547596_8,-1,-1,-1,-1,14937,-1,7.010523e-06,0.9999857,7.259584e-06
14939,that the,17,19,127,135,These findings indicated that melanoma cells could have Foxp3-dependent Treg-like suppressive effects on T cells and suggested that the mimicking of Treg function by melanoma cells may represent a possible mechanism of tumor resistance to immune destruction in the melanoma tumor microenvironment.,21547596_8,-1,-1,-1,-1,14939,-1,4.397363e-06,0.999992,3.5361045e-06
14940,Treg function,21,23,149,162,These findings indicated that melanoma cells could have Foxp3-dependent Treg-like suppressive effects on T cells and suggested that the mimicking of Treg function by melanoma cells may represent a possible mechanism of tumor resistance to immune destruction in the melanoma tumor microenvironment.,21547596_8,-1,-1,-1,-1,14940,-1,8.6480795e-06,0.99997926,1.2141343e-05
14953,tumor-infiltrating Tregs,30,32,162,186,"However, this evidence is supported by in vitro or mouse model studies with no data from in vivo or human studies to support its role in enriching peripheral and tumor-infiltrating Tregs.",21570917_1,-1,-1,-1,-1,14953,-1,9.82474e-06,0.99998224,7.886236e-06
14958,blood,3,4,23,28,We analyzed peripheral blood samples from untreated renal cell carcinoma (RCC) patients and following interleukin (IL)-2 treatment for the expression of FoxP3 and Helios.,21570917_3,0,1,-1,-1,14958,-1,0.0017987671,0.95669335,0.041507877
14968,natural Tregs,11,13,74,87,"Interestingly, IL-2 administration results in expansion of FoxP3+ Helios+ natural Tregs (nTregs) significantly more than FoxP3+ Helios- iTregs.",21570917_5,-1,-1,-1,-1,14968,-1,9.062067e-06,0.9999796,1.1310689e-05
14969,than FoxP3,18,20,116,126,"Interestingly, IL-2 administration results in expansion of FoxP3+ Helios+ natural Tregs (nTregs) significantly more than FoxP3+ Helios- iTregs.",21570917_5,-1,-1,-1,-1,14969,-1,6.7966184e-06,0.9999863,6.8687514e-06
14970,that the,3,5,15,23,"Our work shows that the increased FoxP3+ Treg subpopulation in RCC patients co-express Helios, indicating that they could be derived from natural but not induced Tregs.",21570917_6,-1,-1,-1,-1,14970,-1,4.022921e-06,0.99999213,3.8063636e-06
14973,that they,17,19,106,115,"Our work shows that the increased FoxP3+ Treg subpopulation in RCC patients co-express Helios, indicating that they could be derived from natural but not induced Tregs.",21570917_6,-1,-1,-1,-1,14973,-1,5.9460303e-06,0.99998915,4.9384385e-06
14979,the autoimmune regulator,29,32,208,232,Much has been learnt about the mechanisms of thymic self-tolerance induction from work on both the rare autosomal recessive disease autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED) and the autoimmune regulator (AIRE) protein mutated in this disease.,21574164_0,-1,-1,-1,-1,14979,-1,1.791032e-05,0.99996805,1.4017704e-05
14981,protein,35,36,240,247,Much has been learnt about the mechanisms of thymic self-tolerance induction from work on both the rare autosomal recessive disease autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED) and the autoimmune regulator (AIRE) protein mutated in this disease.,21574164_0,0,1,-1,-1,14981,-1,8.790922e-06,0.99998415,7.0673836e-06
14984,tissue-specific antigens,11,13,73,97,"Normally, AIRE drives low-level expression of huge numbers of peripheral tissue-specific antigens (TSAgs) in medullary thymic epithelial cells (mTECs), leading to the deletion of TSAg-reactive thymocytes maturing nearby.",21574164_1,-1,-1,-1,-1,14984,-1,0.9259211,0.063853495,0.010225404
14988,to the,26,28,160,166,"Normally, AIRE drives low-level expression of huge numbers of peripheral tissue-specific antigens (TSAgs) in medullary thymic epithelial cells (mTECs), leading to the deletion of TSAg-reactive thymocytes maturing nearby.",21574164_1,-1,-1,-1,-1,14988,-1,4.111202e-06,0.99999166,4.174255e-06
14989,TSAg-reactive thymocytes,30,32,179,203,"Normally, AIRE drives low-level expression of huge numbers of peripheral tissue-specific antigens (TSAgs) in medullary thymic epithelial cells (mTECs), leading to the deletion of TSAg-reactive thymocytes maturing nearby.",21574164_1,-1,-1,-1,-1,14989,-1,0.002556414,0.8649879,0.1324556
14991,Th17-related cells,10,12,75,93,The very recently discovered neutralizing autoantibodies (autoAbs) against Th17-related cells and cytokines in two autoimmunity-related syndromes associated with AIRE-mutant thymi or AIRE-deficient thymomas help to explain the chronic mucocutaneous candidiasis (CMC) seen in both syndromes.,21574164_2,-1,-1,-1,-1,14991,-1,0.0019610457,0.6662054,0.33183357
14994,AIRE-mutant thymi,20,22,162,179,The very recently discovered neutralizing autoantibodies (autoAbs) against Th17-related cells and cytokines in two autoimmunity-related syndromes associated with AIRE-mutant thymi or AIRE-deficient thymomas help to explain the chronic mucocutaneous candidiasis (CMC) seen in both syndromes.,21574164_2,-1,-1,-1,-1,14994,-1,5.131818e-05,0.99982435,0.00012440475
14995,AIRE-deficient thymomas,23,25,183,206,The very recently discovered neutralizing autoantibodies (autoAbs) against Th17-related cells and cytokines in two autoimmunity-related syndromes associated with AIRE-mutant thymi or AIRE-deficient thymomas help to explain the chronic mucocutaneous candidiasis (CMC) seen in both syndromes.,21574164_2,-1,-1,-1,-1,14995,-1,1.7215774e-05,0.9999639,1.8929155e-05
15001,AIRE deficiency,16,18,114,129,"The surprising parallels between these syndromes also demand new hypotheses and research into the consequences of AIRE deficiency and the ensuing autoimmunizing pathways, and suggest more appropriate treatment regimens as discussed in this review.",21574164_3,-1,-1,-1,-1,15001,-1,0.0035469483,0.9923955,0.0040575196
15007,immunity through,6,8,45,61,Interferon-alpha (IFN-) promotes anti-tumor immunity through its actions on immune cells.,21604071_0,-1,-1,-1,-1,15007,-1,0.29243016,0.7054221,0.002147779
15012,blood,18,19,140,145,We hypothesized that elevated percentages of myeloid-derived suppressor cells (MDSC) and increased pro-inflammatory cytokines in peripheral blood would be associated with impaired response to IFN- in patients with gastrointestinal (GI) malignancies.,21604071_1,0,1,-1,-1,15012,-1,0.00530777,0.9904874,0.0042048646
15013,to IFN-,25,27,189,197,We hypothesized that elevated percentages of myeloid-derived suppressor cells (MDSC) and increased pro-inflammatory cytokines in peripheral blood would be associated with impaired response to IFN- in patients with gastrointestinal (GI) malignancies.,21604071_1,-1,-1,-1,-1,15013,-1,0.9568465,0.041902654,0.001250822
15016,plasma IL-6,5,7,43,54,"This study evaluated relationships between plasma IL-6, IL-10, circulating MDSC subsets, and IFN--induced signal transduction in 40 patients with GI malignancies.",21604071_2,-1,-1,-1,-1,15016,-1,0.9746105,0.023867097,0.0015225087
15021,Plasma IL-6,0,2,0,11,Plasma IL-6 and IL-10 were significantly higher in patients versus normal donors.,21604071_3,-1,-1,-1,-1,15021,-1,0.94824624,0.049855456,0.0018982221
15024,Plasma IL-6,0,2,0,11,Plasma IL-6 was correlated with CD33(+)HLADR(-)CD15(+) MDSC (P = 0.008) and IL-10 with CD33(+)HLADR(-)CD15(-) MDSC (P = 0.002).,21604071_5,-1,-1,-1,-1,15024,-1,0.94710815,0.051291108,0.0016007053
15028,IFN--induced STAT1,18,20,98,117,"The percentage of CD15(+) and CD15(-) but not CD14(+) MDSC subsets were inversely correlated with IFN--induced STAT1 phosphorylation in CD4(+) T cells, while co-culture with in vitro generated MDSC led to reduced IFN- responsiveness in both PBMC and the CD4(+) subset of T cells from normal donors.",21604071_6,-1,-1,-1,-1,15028,-1,0.9950513,0.0041059866,0.00084262865
15051,blood,18,19,99,104,The aim of the study was to observe the variation of CD4(+)CD25(+) regulatory T cells in periphery blood and tumor microenvironment of non-small cell lung cancer (NSCLC) patients and the effects of CpG ODN.,21611754_0,0,1,-1,-1,15051,-1,0.00026726286,0.99790883,0.0018239454
15057,Foxp3 gene,9,11,52,62,"The proportion of CD4(+)CD25(+) regulatory T cells, Foxp3 gene expression, levels of tumor growth factor- (TGF-) and immunoreactive fibronectin- (IFN-) in the periphery blood of 30 NSCLC patients and 30 healthy volunteers were compared.",21611754_1,-1,-1,-1,-1,15057,-1,3.7695725e-06,0.99999166,4.5925617e-06
15059,factor-,17,18,98,106,"The proportion of CD4(+)CD25(+) regulatory T cells, Foxp3 gene expression, levels of tumor growth factor- (TGF-) and immunoreactive fibronectin- (IFN-) in the periphery blood of 30 NSCLC patients and 30 healthy volunteers were compared.",21611754_1,0,1,-1,-1,15059,-1,0.9999479,5.9264585e-06,4.6111418e-05
15063,blood,30,31,173,178,"The proportion of CD4(+)CD25(+) regulatory T cells, Foxp3 gene expression, levels of tumor growth factor- (TGF-) and immunoreactive fibronectin- (IFN-) in the periphery blood of 30 NSCLC patients and 30 healthy volunteers were compared.",21611754_1,0,1,-1,-1,15063,-1,0.00030953417,0.99611783,0.0035726973
15066,Foxp3 gene,0,2,0,10,Foxp3 gene expression in the tumor microenvironment of NSCLC patients was also observed.,21611754_3,-1,-1,-1,-1,15066,-1,4.8498846e-06,0.9999908,4.320357e-06
15067,the tumor,4,6,25,34,Foxp3 gene expression in the tumor microenvironment of NSCLC patients was also observed.,21611754_3,-1,-1,-1,-1,15067,-1,4.924531e-06,0.99999094,4.1591366e-06
15073,blood,18,19,114,119,"The results showed CD4(+)CD25(+) regulatory T cell proportion, Foxp3 expression and TGF- levels in the periphery blood of NSCLC patients were higher than those of healthy volunteers (p<0.05), and these indicators of patients were significantly decreased after CpG ODN 2006 treatment (p<0.05).",21611754_4,0,1,-1,-1,15073,-1,0.00073180656,0.9770303,0.022237873
15074,than those,24,26,150,160,"The results showed CD4(+)CD25(+) regulatory T cell proportion, Foxp3 expression and TGF- levels in the periphery blood of NSCLC patients were higher than those of healthy volunteers (p<0.05), and these indicators of patients were significantly decreased after CpG ODN 2006 treatment (p<0.05).",21611754_4,-1,-1,-1,-1,15074,-1,6.1868172e-06,0.99998844,5.349339e-06
15079,than that,9,11,58,67,Foxp3 expression in the metastatic lymph nodes was higher than that in the non-metastatic ones of NSCLC patients (p=0.000).,21611754_5,-1,-1,-1,-1,15079,-1,1.0076512e-05,0.9999838,6.0961015e-06
15084,blood,19,20,118,123,"In conclusion, a rise in the proportion of CD4(+)CD25(+)Foxp3(+) regulatory T cells was demonstrated in the periphery blood and tumor microenvironments of NSCLC patients.",21611754_6,0,1,-1,-1,15084,-1,6.1265426e-05,0.9998252,0.00011359817
15090,blood,17,18,117,122,CpG ODN 2006 downregulated the CD4(+)CD25(+)Foxp3(+) regulatory T cells proportion and TGF- levels in the periphery blood of these patients.,21611754_7,0,1,-1,-1,15090,-1,0.00016948975,0.99875736,0.0010731223
15096,that the,4,6,15,23,"Here, we found that the E6 oncogene from HPV16, but not HPV18, suppressed MHC I expression.",21621523_1,-1,-1,-1,-1,15096,-1,3.753135e-06,0.99999225,4.010618e-06
15103,to cytotoxic T lymphocytes,8,12,64,90,"The expression of HPV16E6 strongly enhanced cellular resistance to cytotoxic T lymphocytes (CTLs)-mediated lytic activity, and knockdown of HPV16E6 by antisense had the opposite effect.",21621523_3,-1,-1,-1,-1,15103,-1,0.0008176981,0.021411097,0.97777116
15105,The regulation,0,2,0,14,"The regulation of HPV16E6-mediated MHC I suppression might be through the regulation of lymphotoxin (LT) and its receptor, LTR. In addition, cells from the spleen and liver of LT- or LTR-deficient mice showed increased MHC I expression.",21621523_4,-1,-1,-1,-1,15105,-1,4.173776e-06,0.9999912,4.6403848e-06
15106,through the regulation,9,12,62,84,"The regulation of HPV16E6-mediated MHC I suppression might be through the regulation of lymphotoxin (LT) and its receptor, LTR. In addition, cells from the spleen and liver of LT- or LTR-deficient mice showed increased MHC I expression.",21621523_4,-1,-1,-1,-1,15106,-1,7.1360396e-06,0.99998534,7.585842e-06
15107,receptor,19,20,113,121,"The regulation of HPV16E6-mediated MHC I suppression might be through the regulation of lymphotoxin (LT) and its receptor, LTR. In addition, cells from the spleen and liver of LT- or LTR-deficient mice showed increased MHC I expression.",21621523_4,0,1,2,-1,15107,-1,0.009030128,0.16258657,0.8283833
15111,that the,5,7,36,44,"Overall, these results demonstrated that the E6 oncogene of HPV16 might play an important role in cell transformation and cancer development through LT-mediated MHC I downregulation in humans.",21621523_5,-1,-1,-1,-1,15111,-1,3.6585066e-06,0.9999924,3.9262477e-06
15113,cell transformation,17,19,98,117,"Overall, these results demonstrated that the E6 oncogene of HPV16 might play an important role in cell transformation and cancer development through LT-mediated MHC I downregulation in humans.",21621523_5,-1,-1,-1,-1,15113,-1,6.0225444e-05,0.0001961222,0.99974364
15116,therapy,6,7,41,48,Recombinant human interleukin-2 (rhIL-2) therapy is approved for treating patients with advanced melanoma yet significant responses are observed in only 10-15% of patients.,21638127_0,0,1,-1,-1,15116,-1,4.8637175e-06,0.99999046,4.6255445e-06
15133,cell subset,20,22,119,130,"In tumor-free mice and subcutaneous tumor-bearing mouse models, CD8 Foxp3+ T cells were a rare but naturally occurring cell subset.",21638127_3,-1,-1,-1,-1,15133,-1,1.4178701e-05,8.5879e-06,0.99997723
15158,Functionally,0,1,0,12,Functionally polarized helper T cells (Th cells) play crucial roles in the induction of tumor immunity.,21646476_0,0,1,2,-1,15158,-1,2.9965024e-05,0.9999579,1.206731e-05
15160,Th cells,6,8,39,47,Functionally polarized helper T cells (Th cells) play crucial roles in the induction of tumor immunity.,21646476_0,-1,-1,-1,-1,15160,-1,2.4682015e-05,7.0426126e-05,0.9999049
15163,tumor immunity,16,18,88,102,Functionally polarized helper T cells (Th cells) play crucial roles in the induction of tumor immunity.,21646476_0,-1,-1,-1,-1,15163,-1,0.031592194,0.9674973,0.00091055094
15166,IFN-producing Th1 cells that,8,12,59,87,"There is considerable knowledge about the contributions of IFN-producing Th1 cells that supports the role of cytotoxic cluster of differentiation (CD8) T cells and natural killer (NK) cells, but much less is known about how IL-4-producing Th2 cells contribute to tumor immunity.",21646476_1,-1,-1,-1,-1,15166,-1,0.99280494,0.004741306,0.002453819
15172,to tumor immunity,44,47,260,277,"There is considerable knowledge about the contributions of IFN-producing Th1 cells that supports the role of cytotoxic cluster of differentiation (CD8) T cells and natural killer (NK) cells, but much less is known about how IL-4-producing Th2 cells contribute to tumor immunity.",21646476_1,-1,-1,-1,-1,15172,-1,0.0048967944,0.99473554,0.00036761136
15174,the cellular,6,8,31,43,"In this study, we investigated the cellular and molecular mechanisms employed by memory Th2 cells in sustaining tumor immunity by using a mouse model system wherein ovalbumin (OVA) is used as a specific tumor antigen.",21646476_2,-1,-1,-1,-1,15174,-1,0.0028659105,0.52078086,0.47635326
15176,tumor immunity,18,20,112,126,"In this study, we investigated the cellular and molecular mechanisms employed by memory Th2 cells in sustaining tumor immunity by using a mouse model system wherein ovalbumin (OVA) is used as a specific tumor antigen.",21646476_2,-1,-1,-1,-1,15176,-1,0.09624727,0.9017666,0.0019861865
15177,tumor antigen,36,38,203,216,"In this study, we investigated the cellular and molecular mechanisms employed by memory Th2 cells in sustaining tumor immunity by using a mouse model system wherein ovalbumin (OVA) is used as a specific tumor antigen.",21646476_2,-1,-1,-1,-1,15177,-1,0.80659044,0.18954699,0.0038625335
15181,tumor cells,20,22,145,156,"In this model, we found that OVA-specific memory Th2 cells exerted potent and long-lasting antitumor effects against NK-sensitive OVA-expressing tumor cells, wherein antitumor effects were mediated by NK cells.",21646476_3,-1,-1,-1,-1,15181,-1,5.6388457e-05,0.0002220889,0.99972147
15195,immunity through,11,13,68,84,"Our findings show that memory Th2 cells can induce potent antitumor immunity through IL-4-induced activation of NK cells, suggesting potential applications in cellular therapy for cancer patients.",21646476_6,-1,-1,-1,-1,15195,-1,0.7682541,0.22888127,0.002864586
15197,cellular therapy,23,25,159,175,"Our findings show that memory Th2 cells can induce potent antitumor immunity through IL-4-induced activation of NK cells, suggesting potential applications in cellular therapy for cancer patients.",21646476_6,-1,-1,-1,-1,15197,-1,0.0011351237,0.034920383,0.96394455
15206,blood,28,29,142,147,"BACKGROUND: The purpose of this study was to investigate the presence of CD4(+) CD25(+) FOXP3(+) regulatory T (Treg) cells both in peripheral blood and local tumors in patients with nasal inverted papilloma (NIP).METHODS: By using flow cytometry, the frequencies of CD4(+) CD25(+) FOXP3(+) Treg cells in both peripheral blood and tissues from 18 patients with NIP and 8 control subjects were determined.",21674673_0,0,1,-1,-1,15206,-1,0.0009844418,0.9773591,0.021656472
15212,blood,59,60,320,325,"BACKGROUND: The purpose of this study was to investigate the presence of CD4(+) CD25(+) FOXP3(+) regulatory T (Treg) cells both in peripheral blood and local tumors in patients with nasal inverted papilloma (NIP).METHODS: By using flow cytometry, the frequencies of CD4(+) CD25(+) FOXP3(+) Treg cells in both peripheral blood and tissues from 18 patients with NIP and 8 control subjects were determined.",21674673_0,0,1,-1,-1,15212,-1,0.00085581455,0.9764658,0.022678312
15213,tissues,61,62,330,337,"BACKGROUND: The purpose of this study was to investigate the presence of CD4(+) CD25(+) FOXP3(+) regulatory T (Treg) cells both in peripheral blood and local tumors in patients with nasal inverted papilloma (NIP).METHODS: By using flow cytometry, the frequencies of CD4(+) CD25(+) FOXP3(+) Treg cells in both peripheral blood and tissues from 18 patients with NIP and 8 control subjects were determined.",21674673_0,-1,1,2,-1,15213,-1,1.3901663e-05,0.9998971,8.900904e-05
15215,CCL17 proteins,2,4,10,24,CCL22 and CCL17 proteins in NIP tumors were analyzed by using enzyme-linked immunosorbent assay.,21674673_1,-1,-1,-1,-1,15215,-1,0.9947619,0.001530537,0.0037075304
15222,analysis,27,28,159,167,The suppressive capacity of Treg cells was estimated by WST-8 and enzyme-linked immunosorbent assay (ELISA; interferon-gamma [IFN-] and interleukin-4 [IL-4]) analysis.,21674673_2,0,1,-1,-1,15222,-1,9.653566e-06,0.99998116,9.12411e-06
15225,tumor tissues,17,19,93,106,RESULTS: Patients with NIP showed increased CD4(+) CD25(+) FOXP3(+) Treg cell frequencies in tumor tissues and CD4(+) T cell fraction rather than in peripheral blood.,21674673_3,-1,-1,-1,-1,15225,-1,6.8799263e-06,0.9999764,1.678152e-05
15228,blood,29,30,160,165,RESULTS: Patients with NIP showed increased CD4(+) CD25(+) FOXP3(+) Treg cell frequencies in tumor tissues and CD4(+) T cell fraction rather than in peripheral blood.,21674673_3,0,1,-1,-1,15228,-1,0.0010077615,0.9812422,0.017750097
15242,immune response thus,6,9,40,60,Regulatory T cells can affect antiviral immune response thus influencing the outcome of the disease.,21684822_1,-1,-1,-1,-1,15242,-1,0.959701,0.039423533,0.00087559485
15246,functional,6,7,30,40,AIM: To determine numeric and functional distribution of regulatory T cells expressing CD4+CD25hiFoxp3+ (T-regs) during the different stages of hepatitis C virus-related liver disease.,21684822_2,0,1,2,-1,15246,-1,0.000114013535,0.9998443,4.1695093e-05
15252,Target cell,0,2,0,11,Target cell proliferation and interferon-gamma production were evaluated in 37 HCV patients.,21684822_5,-1,-1,-1,-1,15252,-1,0.00011783208,0.00029283168,0.9995894
15269,tissue,13,14,85,91,This study aimed to investigate whether Treg are accumulated in human gastric cancer tissue and the mechanism of Treg induction by gastric cancer cells.,21695703_1,-1,1,2,-1,15269,-1,0.0002829713,0.25114754,0.7485695
15273,Tissue,2,3,9,15,METHODS: Tissue infiltrated leukocytes from gastric adenocarcinomas were subjected to flow cytometry and immunohistochemistry.,21695703_2,-1,1,2,-1,15273,-1,2.3670098e-05,0.9999366,3.9694765e-05
15275,function,4,5,23,31,"Percentage, phenotype, function, and clinical relevance of Treg were analyzed.",21695703_3,0,1,2,-1,15275,-1,0.00044144146,0.99936765,0.00019094237
15285,tissues,14,15,70,77,RESULTS: The percentages of CD4(+) Foxp3(+) T cells in gastric cancer tissues were significantly higher than those from adjacent non-tumor gastric tissues (P<0.05).,21695703_5,-1,1,2,-1,15285,-1,0.00023458473,0.9457774,0.05398803
15286,than those,18,20,104,114,RESULTS: The percentages of CD4(+) Foxp3(+) T cells in gastric cancer tissues were significantly higher than those from adjacent non-tumor gastric tissues (P<0.05).,21695703_5,-1,-1,-1,-1,15286,-1,5.06028e-06,0.9999896,5.3075496e-06
15287,tissues,24,25,147,154,RESULTS: The percentages of CD4(+) Foxp3(+) T cells in gastric cancer tissues were significantly higher than those from adjacent non-tumor gastric tissues (P<0.05).,21695703_5,-1,1,2,-1,15287,-1,4.5479846e-05,0.996398,0.003556538
15290,that the,10,12,74,82,The results of classical Treg phenotype and proliferation assay supported that the elevated CD4(+) Foxp3(+) T cells represents a suppressive Treg population.,21695703_6,-1,-1,-1,-1,15290,-1,3.827272e-06,0.99999225,3.8742596e-06
15301,functional Treg,5,7,30,45,CONCLUSION: The proportion of functional Treg is elevated in human gastric cancer and related to poor prognosis.,21695703_9,-1,-1,-1,-1,15301,-1,0.00011612077,0.99983776,4.6083263e-05
15302,related to,14,16,86,96,CONCLUSION: The proportion of functional Treg is elevated in human gastric cancer and related to poor prognosis.,21695703_9,-1,-1,-1,-1,15302,-1,6.7477786e-06,0.9999871,6.164029e-06
15304,naive T cells to Treg,7,12,45,66,"Gastric cancer cells directly convert CD4(+) naive T cells to Treg by TGF-1, suggesting a possible mechanism through which tumor cells evade the immune system.",21695703_10,-1,-1,-1,-1,15304,-1,7.300984e-05,0.9998068,0.00012018522
15307,tumor cells,21,23,124,135,"Gastric cancer cells directly convert CD4(+) naive T cells to Treg by TGF-1, suggesting a possible mechanism through which tumor cells evade the immune system.",21695703_10,-1,-1,-1,-1,15307,-1,3.95564e-05,8.729335e-05,0.99987316
15310,the immunomodulatory agent IFN-2,18,22,134,167,Recent reports have described complete or major molecular remission in patients with polycythemia vera after long-term treatment with the immunomodulatory agent IFN-2.,21708889_0,-1,-1,-1,-1,15310,-1,0.8616099,0.1372512,0.0011390166
15313,that the,7,9,42,50,"Accordingly, there are reasons to believe that the immune system is a key player in eradicating the JAK2 mutated clone in these patients.",21708889_1,-1,-1,-1,-1,15313,-1,5.017809e-06,0.9999908,4.158557e-06
15318,regulatory T cells play,2,6,9,32,"Foxp3(+) regulatory T cells play a pivotal role in maintaining immune homeostasis and, importantly, preventing immune reactivity to self-antigens; however, their suppressive activity can compromise an effective antitumor immune response, and high frequencies of regulatory T cells in peripheral blood have been reported in both hematologic and solid cancers.",21708889_2,-1,-1,-1,-1,15318,-1,0.00069397606,0.013163298,0.9861428
15323,blood,45,46,295,300,"Foxp3(+) regulatory T cells play a pivotal role in maintaining immune homeostasis and, importantly, preventing immune reactivity to self-antigens; however, their suppressive activity can compromise an effective antitumor immune response, and high frequencies of regulatory T cells in peripheral blood have been reported in both hematologic and solid cancers.",21708889_2,0,1,-1,-1,15323,-1,0.000739219,0.9829989,0.016261835
15325,function,9,10,44,52,"We have analyzed the number, phenotype, and function of circulating CD4(+)CD25(+)Foxp3(+) T cells in patients with chronic myeloproliferative neoplasms.",21708889_3,0,1,2,-1,15325,-1,9.297403e-05,0.9998087,9.828906e-05
15327,this subset,8,10,45,56,"Surprisingly, we found a marked expansion of this subset of lymphocytes in patients treated with IFN-2 (13.0%; 95% confidence interval [CI] 10.8% to 15.2%) compared with healthy donors (6.1%; 95% CI 4.9% to 7.2%), patients with untreated chronic myeloproliferative neoplasms (6.9%; 95% CI 5.8% to 7.4%), or patients treated with hydroxyurea (5.8%; 95% CI 4.3% to 7.4%; P < .0001).",21708889_4,-1,-1,-1,-1,15327,-1,0.002180593,0.3347369,0.6630824
15339,Th2 immune responses,13,16,89,109,"We previously showed that exposure to UV radiation after immunization suppresses Th1 and Th2 immune responses, leading to impaired Ab and allo-immune responses, but the impact of UV radiation after immunization on anti-tumor immune responses mediated by tumor-specific CD8(+) T cell responses remains less clear.",21710495_0,-1,-1,-1,-1,15339,-1,0.25457016,0.74172527,0.0037045842
15346,functional,6,7,38,48,"Furthermore, the exact phenotypic and functional characteristics of regulatory T cell population responsible for the UV-induced immunosuppression still remain elusive.",21710495_1,0,1,2,-1,15346,-1,0.0044557685,0.9943468,0.0011973683
15366,tumor cells,32,34,183,194,"This suppression was mediated by interleukin (IL)-10 released from CD4(+) CD25(+) T cells, by which impaired the induction of cytotoxic T lymphocytes (CTL) able to kill Ag-expressing tumor cells.",21710495_3,-1,-1,-1,-1,15366,-1,0.00017139022,0.0024569968,0.99737155
15370,Tr1-type regulatory T cell,28,32,155,181,"In addition, we generated a panel of T cell clones from UV-irradiated and non-irradiated mice, and all of the clones derived from UV-irradiated mice had a Tr1-type regulatory T cell phenotype with expression of IL-10 and c-Maf, but not Foxp3.",21710495_4,-1,-1,-1,-1,15370,-1,0.0013263117,0.59015954,0.40851417
15373,These Tr1-type regulatory T cell,0,5,0,32,These Tr1-type regulatory T cell clones suppressed tumor rejection in vivo as well as Th cell activation in vitro in an IL-10 dependent manner.,21710495_5,-1,-1,-1,-1,15373,-1,0.0018449678,0.74123037,0.25692466
15375,Th cell,14,16,86,93,These Tr1-type regulatory T cell clones suppressed tumor rejection in vivo as well as Th cell activation in vitro in an IL-10 dependent manner.,21710495_5,-1,-1,-1,-1,15375,-1,9.311777e-06,5.2891905e-06,0.99998546
15382,Tr1 cells that,32,35,212,226,"Given that suppression of Ag-specific CTL responses can be induced in Ag-sensitized mice by UV irradiation, our results may imply that exposure to UV radiation during premalignant stage induces tumor-Ag specific Tr1 cells that mediate tumor-Ag specific immune suppression resulting in the promotion of tumor progression.",21710495_6,-1,-1,-1,-1,15382,-1,0.0011149709,0.614811,0.38407397
15398,these Th17 cells,5,8,21,37,"However, the role of these Th17 cells in the pathogenesis of gastric cancer is less clear.",21710691_2,-1,-1,-1,-1,15398,-1,0.0023908666,0.21809793,0.7795112
15405,these tumours,5,7,24,37,"At the molecular level, these tumours demonstrate hyper-activation of the latent transcription factor signal transducer and activator of transcription (STAT)3 via the IL-6 cytokine family member, IL-11.",21710691_4,-1,-1,-1,-1,15405,-1,4.4124263e-06,0.99998975,5.8286146e-06
15407,transcription factor signal transducer and activator of transcription,12,20,81,150,"At the molecular level, these tumours demonstrate hyper-activation of the latent transcription factor signal transducer and activator of transcription (STAT)3 via the IL-6 cytokine family member, IL-11.",21710691_4,-1,-1,-1,-1,15407,-1,5.9943172e-06,0.9999863,7.765691e-06
15408,the IL-6 cytokine,22,25,163,180,"At the molecular level, these tumours demonstrate hyper-activation of the latent transcription factor signal transducer and activator of transcription (STAT)3 via the IL-6 cytokine family member, IL-11.",21710691_4,-1,-1,-1,-1,15408,-1,0.96218675,0.035436645,0.0023766737
15410,the generation,5,7,20,34,"In gp130(F/F) mice, the generation of Th17 cells, as well as the gastric expression of IL-17a and other Th17-related factors (Rort, IL-23), were augmented compared to wild-type gp130(+/+) mice.",21710691_5,-1,-1,-1,-1,15410,-1,4.984091e-06,0.99998903,6.001295e-06
15411,Th17 cells,8,10,38,48,"In gp130(F/F) mice, the generation of Th17 cells, as well as the gastric expression of IL-17a and other Th17-related factors (Rort, IL-23), were augmented compared to wild-type gp130(+/+) mice.",21710691_5,-1,-1,-1,-1,15411,-1,3.9319562e-05,0.00028775382,0.9996729
15414,Th17-related factors,21,23,104,124,"In gp130(F/F) mice, the generation of Th17 cells, as well as the gastric expression of IL-17a and other Th17-related factors (Rort, IL-23), were augmented compared to wild-type gp130(+/+) mice.",21710691_5,-1,-1,-1,-1,15414,-1,6.72774e-06,0.9999838,9.447609e-06
15419,Th17 generation,13,15,74,89,"Consistent with a role for IL-6 and STAT3 in regulating IL-17A, increased Th17 generation and gastric expression of Th17-related factors in gp130(F/F) mice were reduced to wild-type levels in gp130(F/F) :Stat3(-/+) mice displaying normalized STAT3 activity, and also in gp130(F/F) :IL-6(-/-) mice.",21710691_6,-1,-1,-1,-1,15419,-1,6.148624e-06,0.9999815,1.2386199e-05
15420,Th17-related factors,19,21,116,136,"Consistent with a role for IL-6 and STAT3 in regulating IL-17A, increased Th17 generation and gastric expression of Th17-related factors in gp130(F/F) mice were reduced to wild-type levels in gp130(F/F) :Stat3(-/+) mice displaying normalized STAT3 activity, and also in gp130(F/F) :IL-6(-/-) mice.",21710691_6,-1,-1,-1,-1,15420,-1,5.1247794e-06,0.9999887,6.247634e-06
15430,Th17-related factors,9,11,60,80,"Collectively, our data suggest that increased expression of Th17-related factors does not correlate with the molecular pathogenesis of gastric tumourigenesis.",21710691_9,-1,-1,-1,-1,15430,-1,2.7481192e-05,0.9999578,1.4712891e-05
15440,receptors,15,16,110,119,Their development and maturation involve a complex variety of interactions with nonlymphoid cell products and receptors.,21740230_1,0,1,2,-1,15440,-1,6.884723e-05,2.1231035e-05,0.9999099
15443,tumor cells,17,19,118,129,"Highly specialized to defend against bacterial and viral infections, T cells also mediate immune surveillance against tumor cells and react to foreign tissues.",21740230_2,-1,-1,-1,-1,15443,-1,0.00011364492,0.0010386813,0.9988477
15445,tissues,23,24,151,158,"Highly specialized to defend against bacterial and viral infections, T cells also mediate immune surveillance against tumor cells and react to foreign tissues.",21740230_2,-1,1,2,-1,15445,-1,0.0012041839,0.98790133,0.010894444
15449,the thymus,21,23,125,135,"T cell progenitors originate in the bone marrow and, through a series of defined and coordinated developmental stages, enter the thymus, differentiate, undergo selection, and eventually mature into functional T cells.",21740230_3,-1,-1,-1,-1,15449,-1,9.32855e-06,0.99998164,9.050012e-06
15450,functional T cells,33,36,198,216,"T cell progenitors originate in the bone marrow and, through a series of defined and coordinated developmental stages, enter the thymus, differentiate, undergo selection, and eventually mature into functional T cells.",21740230_3,-1,-1,-1,-1,15450,-1,0.0007231753,0.0031969748,0.99607986
15454,complex transcriptional,9,11,50,73,"The steps in this process are regulated through a complex transcriptional network, specific receptor-ligand pair interactions, and sensitization to trophic factors, which mediate the homing, proliferation, survival, and differentiation of developing T cells.",21740230_4,-1,-1,-1,-1,15454,-1,4.600906e-06,0.9999901,5.240807e-06
15455,receptor-ligand,14,15,92,107,"The steps in this process are regulated through a complex transcriptional network, specific receptor-ligand pair interactions, and sensitization to trophic factors, which mediate the homing, proliferation, survival, and differentiation of developing T cells.",21740230_4,0,1,2,-1,15455,-1,0.6958219,0.0022549757,0.30192322
15456,to trophic factors,20,23,145,163,"The steps in this process are regulated through a complex transcriptional network, specific receptor-ligand pair interactions, and sensitization to trophic factors, which mediate the homing, proliferation, survival, and differentiation of developing T cells.",21740230_4,-1,-1,-1,-1,15456,-1,2.101165e-05,0.9999695,9.503681e-06
15465,antigen-specific T cells,9,12,54,78,"PURPOSE: To predict the potential antitumor effect of antigen-specific T cells in melanoma patients, we investigated T-cell effector function in relation to tumor-escape mechanisms.",21750202_0,-1,-1,-1,-1,15465,-1,0.67610395,0.0003899204,0.32350615
15466,T-cell,18,19,117,123,"PURPOSE: To predict the potential antitumor effect of antigen-specific T cells in melanoma patients, we investigated T-cell effector function in relation to tumor-escape mechanisms.",21750202_0,-1,1,2,-1,15466,-1,9.703151e-06,6.1399446e-06,0.99998415
15467,function,20,21,133,141,"PURPOSE: To predict the potential antitumor effect of antigen-specific T cells in melanoma patients, we investigated T-cell effector function in relation to tumor-escape mechanisms.",21750202_0,0,1,2,-1,15467,-1,9.897597e-05,0.000110803856,0.99979025
15468,relation to tumor-escape,22,25,145,169,"PURPOSE: To predict the potential antitumor effect of antigen-specific T cells in melanoma patients, we investigated T-cell effector function in relation to tumor-escape mechanisms.",21750202_0,-1,-1,-1,-1,15468,-1,1.1817617e-05,0.9999784,9.747448e-06
15471,blood,17,18,94,99,"EXPERIMENTAL DESIGN: CD8(+) T cells isolated from tumor, adjacent normal skin, and peripheral blood of 17 HLA-A2(+) patients with advanced-stage melanoma were analyzed for their antigen specificity and effector function against melanocyte differentiation antigens MART-1, gp100, and tyrosinase by using HLA-A2/peptide tetramers and functional assays.",21750202_1,0,1,-1,-1,15471,-1,0.0004440782,0.9960939,0.0034620205
15472,their antigen,29,31,172,185,"EXPERIMENTAL DESIGN: CD8(+) T cells isolated from tumor, adjacent normal skin, and peripheral blood of 17 HLA-A2(+) patients with advanced-stage melanoma were analyzed for their antigen specificity and effector function against melanocyte differentiation antigens MART-1, gp100, and tyrosinase by using HLA-A2/peptide tetramers and functional assays.",21750202_1,-1,-1,-1,-1,15472,-1,0.36033297,0.63233626,0.00733077
15473,function,34,35,211,219,"EXPERIMENTAL DESIGN: CD8(+) T cells isolated from tumor, adjacent normal skin, and peripheral blood of 17 HLA-A2(+) patients with advanced-stage melanoma were analyzed for their antigen specificity and effector function against melanocyte differentiation antigens MART-1, gp100, and tyrosinase by using HLA-A2/peptide tetramers and functional assays.",21750202_1,0,1,2,-1,15473,-1,0.0027407333,0.9200488,0.07721055
15477,functional,50,51,332,342,"EXPERIMENTAL DESIGN: CD8(+) T cells isolated from tumor, adjacent normal skin, and peripheral blood of 17 HLA-A2(+) patients with advanced-stage melanoma were analyzed for their antigen specificity and effector function against melanocyte differentiation antigens MART-1, gp100, and tyrosinase by using HLA-A2/peptide tetramers and functional assays.",21750202_1,0,1,2,-1,15477,-1,0.00082964246,0.9988701,0.0003002049
15482,tumor cell,24,26,153,163,"In addition, the presence of tumor-escape mechanisms PD-L1/PD-1 pathway, FoxP3 and loss of HLA or melanocyte differentiation antigens, both required for tumor cell recognition and killing, were studied.",21750202_2,-1,-1,-1,-1,15482,-1,8.72069e-05,0.00027996118,0.99963284
15486,tissues,16,17,101,108,RESULTS: Higher percentages of melanocyte antigen-specific CD8(+) T cells were found in the melanoma tissues as compared with adjacent normal skin and peripheral blood.,21750202_3,-1,1,2,-1,15486,-1,0.00024678078,0.974147,0.025606208
15487,blood,25,26,162,167,RESULTS: Higher percentages of melanocyte antigen-specific CD8(+) T cells were found in the melanoma tissues as compared with adjacent normal skin and peripheral blood.,21750202_3,0,1,-1,-1,15487,-1,0.00019259348,0.99718,0.002627377
15488,Functional analysis,0,2,0,19,"Functional analysis revealed 2 important findings: (i) in 5 of 17 patients, we found cytokine production after specific peptide stimulation by tumor-infiltrating lymphocytes (TIL), not by autologous peripheral blood lymphocytes (PBL); (ii) CD8(+) T cells from 7 of 17 patients did not produce cytokines after specific stimulation, which corresponded with significant loss of tumor HLA-A2 expression.",21750202_4,-1,-1,-1,-1,15488,-1,9.875371e-06,0.9999831,7.1006075e-06
15490,peptide,22,23,120,127,"Functional analysis revealed 2 important findings: (i) in 5 of 17 patients, we found cytokine production after specific peptide stimulation by tumor-infiltrating lymphocytes (TIL), not by autologous peripheral blood lymphocytes (PBL); (ii) CD8(+) T cells from 7 of 17 patients did not produce cytokines after specific stimulation, which corresponded with significant loss of tumor HLA-A2 expression.",21750202_4,0,-1,2,-1,15490,-1,0.99947494,0.00015657999,0.00036847027
15491,tumor-infiltrating lymphocytes,25,27,143,173,"Functional analysis revealed 2 important findings: (i) in 5 of 17 patients, we found cytokine production after specific peptide stimulation by tumor-infiltrating lymphocytes (TIL), not by autologous peripheral blood lymphocytes (PBL); (ii) CD8(+) T cells from 7 of 17 patients did not produce cytokines after specific stimulation, which corresponded with significant loss of tumor HLA-A2 expression.",21750202_4,-1,-1,-1,-1,15491,-1,0.0022189454,0.86867774,0.12910335
15493,blood lymphocytes,35,37,210,227,"Functional analysis revealed 2 important findings: (i) in 5 of 17 patients, we found cytokine production after specific peptide stimulation by tumor-infiltrating lymphocytes (TIL), not by autologous peripheral blood lymphocytes (PBL); (ii) CD8(+) T cells from 7 of 17 patients did not produce cytokines after specific stimulation, which corresponded with significant loss of tumor HLA-A2 expression.",21750202_4,-1,-1,-1,-1,15493,-1,5.110258e-05,3.2652046e-05,0.9999162
15499,to T-cell function,9,12,64,82,The presence of other tumor-escape mechanisms did not correlate to T-cell function.,21750202_5,-1,-1,-1,-1,15499,-1,0.0019229741,0.064080335,0.9339967
15500,that functional T-cell,5,8,27,49,"CONCLUSIONS: Our data show that functional T-cell responses could be missed when only PBL and not TIL are evaluated, emphasizing the importance of TIL analysis for immunomonitoring.",21750202_6,-1,-1,-1,-1,15500,-1,0.0147422,0.48646027,0.4987975
15504,TIL analysis,25,27,147,159,"CONCLUSIONS: Our data show that functional T-cell responses could be missed when only PBL and not TIL are evaluated, emphasizing the importance of TIL analysis for immunomonitoring.",21750202_6,-1,-1,-1,-1,15504,-1,8.821527e-06,0.99998534,5.867136e-06
15507,T-cell functionality,11,13,58,78,"Furthermore, loss of tumor HLA-A2 may explain the lack of T-cell functionality.",21750202_7,-1,-1,-1,-1,15507,-1,2.2266844e-05,1.5835052e-05,0.99996185
15518,peptides together,38,40,242,259,EXPERIMENTAL DESIGN: HLA-A2.1(+) melanoma patients scheduled for regional lymph node dissection were vaccinated four times biweekly via intradermal or intranodal injection with 12  10 to 17  10 mature DCs loaded with tyrosinase and gp100 peptides together with keyhole limpet hemocyanin (KLH).,21771874_2,-1,-1,-1,-1,15518,-1,0.0006243262,0.9991211,0.00025450267
15520,T-cell,3,4,20,26,KLH-specific B- and T-cell responses were monitored in blood.,21771874_4,-1,1,2,-1,15520,-1,1.6921018e-05,1.20439445e-05,0.99997103
15521,in blood,7,9,52,60,KLH-specific B- and T-cell responses were monitored in blood.,21771874_4,0,1,-1,-1,15521,-1,4.464905e-05,0.9999201,3.522793e-05
15522,tyrosinase-specific T-cell,2,4,11,37,"gp100- and tyrosinase-specific T-cell responses were monitored in blood by tetramer analysis and in biopsies from delayed-type hypersensitivity (DTH) skin tests by tetramer and functional analyses with (51)Cr release assays or IFN release, following coculture with peptide-pulsed T2 cells or gp100- or tyrosinase-expressing tumor cells.",21771874_5,-1,-1,-1,-1,15522,-1,0.0024639985,0.7914161,0.2061199
15523,in blood,7,9,63,71,"gp100- and tyrosinase-specific T-cell responses were monitored in blood by tetramer analysis and in biopsies from delayed-type hypersensitivity (DTH) skin tests by tetramer and functional analyses with (51)Cr release assays or IFN release, following coculture with peptide-pulsed T2 cells or gp100- or tyrosinase-expressing tumor cells.",21771874_5,0,1,-1,-1,15523,-1,2.0531374e-05,0.9999559,2.363158e-05
15524,tetramer analysis,10,12,75,92,"gp100- and tyrosinase-specific T-cell responses were monitored in blood by tetramer analysis and in biopsies from delayed-type hypersensitivity (DTH) skin tests by tetramer and functional analyses with (51)Cr release assays or IFN release, following coculture with peptide-pulsed T2 cells or gp100- or tyrosinase-expressing tumor cells.",21771874_5,-1,-1,-1,-1,15524,-1,8.405135e-06,0.99998164,9.894814e-06
15527,functional,26,27,177,187,"gp100- and tyrosinase-specific T-cell responses were monitored in blood by tetramer analysis and in biopsies from delayed-type hypersensitivity (DTH) skin tests by tetramer and functional analyses with (51)Cr release assays or IFN release, following coculture with peptide-pulsed T2 cells or gp100- or tyrosinase-expressing tumor cells.",21771874_5,0,1,2,-1,15527,-1,0.00028257613,0.99961156,0.000105870284
15529,IFN release,33,35,227,239,"gp100- and tyrosinase-specific T-cell responses were monitored in blood by tetramer analysis and in biopsies from delayed-type hypersensitivity (DTH) skin tests by tetramer and functional analyses with (51)Cr release assays or IFN release, following coculture with peptide-pulsed T2 cells or gp100- or tyrosinase-expressing tumor cells.",21771874_5,-1,-1,-1,-1,15529,-1,0.9994704,0.00026084643,0.00026879465
15530,peptide-pulsed T2 cells,39,42,266,289,"gp100- and tyrosinase-specific T-cell responses were monitored in blood by tetramer analysis and in biopsies from delayed-type hypersensitivity (DTH) skin tests by tetramer and functional analyses with (51)Cr release assays or IFN release, following coculture with peptide-pulsed T2 cells or gp100- or tyrosinase-expressing tumor cells.",21771874_5,-1,-1,-1,-1,15530,-1,0.04392637,0.10380879,0.8522649
15531,tyrosinase-expressing tumor cells,45,48,303,336,"gp100- and tyrosinase-specific T-cell responses were monitored in blood by tetramer analysis and in biopsies from delayed-type hypersensitivity (DTH) skin tests by tetramer and functional analyses with (51)Cr release assays or IFN release, following coculture with peptide-pulsed T2 cells or gp100- or tyrosinase-expressing tumor cells.",21771874_5,-1,-1,-1,-1,15531,-1,0.0020920802,0.8298227,0.16808523
15532,functional tumor antigen-specific T cells,9,14,42,83,"RESULTS: In 19 of 43 vaccinated patients, functional tumor antigen-specific T cells could be detected.",21771874_6,-1,-1,-1,-1,15532,-1,0.03810382,0.06969064,0.8922056
15535,functional tumor antigen-specific T cells,6,11,53,94,Intradermal vaccinations proved superior in inducing functional tumor antigen-specific T cells.,21771874_8,-1,-1,-1,-1,15535,-1,0.04719095,0.1744643,0.7783448
15536,the antigen-specific T-cell,7,10,49,76,Coadministration of IL-2 did not further augment the antigen-specific T-cell response but did result in higher regulatory T-cell frequencies.,21771874_9,-1,-1,-1,-1,15536,-1,0.052934173,0.39881214,0.5482537
15538,T-cell,8,9,67,73,CONCLUSION: Intradermal vaccination resulted in superior antitumor T-cell induction when compared with intranodal vaccination.,21771874_10,-1,1,2,-1,15538,-1,1.7980376e-05,1.2645215e-05,0.99996936
15540,T-cell,3,4,19,25,Spontaneous CD4(+) T-cell responses to the tumor-specific antigen NY-ESO-1 (ESO) are frequently found in patients with epithelial ovarian cancer (EOC).,21829534_0,-1,1,2,-1,15540,-1,1.7813052e-05,9.673906e-06,0.9999726
15541,to the tumor-specific antigen,5,9,36,65,Spontaneous CD4(+) T-cell responses to the tumor-specific antigen NY-ESO-1 (ESO) are frequently found in patients with epithelial ovarian cancer (EOC).,21829534_0,-1,-1,-1,-1,15541,-1,0.1889845,0.8076719,0.0033436434
15543,Treg type,7,9,42,51,"If these responses are of effector or/and Treg type, however, has remained unclear.",21829534_1,-1,-1,-1,-1,15543,-1,6.8906097e-06,0.99998486,8.192179e-06
15544,functional,5,6,19,29,"Here, we have used functional approaches together with recently developed MHC class II/ESO tetramers to assess the frequency, phenotype and function of ESO-specific cells in circulating lymphocytes from EOC patients.",21829534_2,0,1,2,-1,15544,-1,0.0010531964,0.99875903,0.00018782713
15546,tetramers to,14,16,91,103,"Here, we have used functional approaches together with recently developed MHC class II/ESO tetramers to assess the frequency, phenotype and function of ESO-specific cells in circulating lymphocytes from EOC patients.",21829534_2,-1,-1,-1,-1,15546,-1,6.840705e-06,0.9999869,6.308501e-06
15548,function,22,23,140,148,"Here, we have used functional approaches together with recently developed MHC class II/ESO tetramers to assess the frequency, phenotype and function of ESO-specific cells in circulating lymphocytes from EOC patients.",21829534_2,0,1,2,-1,15548,-1,9.4990406e-05,0.99982196,8.307189e-05
15553,immune responses to the antigen,14,19,87,118,We found that circulating ESO-specific CD4(+) T cells in EOC patients with spontaneous immune responses to the antigen are prevalently T(H)1 type cells secreting IFN- but no IL-17 or IL-10 and are not suppressive.,21829534_3,-1,-1,-1,-1,15553,-1,0.9997501,9.8541015e-05,0.0001513956
15554,T(H)1 type cells,21,24,135,151,We found that circulating ESO-specific CD4(+) T cells in EOC patients with spontaneous immune responses to the antigen are prevalently T(H)1 type cells secreting IFN- but no IL-17 or IL-10 and are not suppressive.,21829534_3,-1,-1,-1,-1,15554,-1,0.0017228604,0.41349792,0.58477926
15567,T-cell,5,6,25,31,"Thus, spontaneous CD4(+) T-cell responses to ESO in cancer patients are prevalently of T(H)1 type and not Treg.",21829534_6,-1,1,2,-1,15567,-1,1.7584192e-05,8.2405395e-06,0.99997413
15569,T(H)1 type,15,17,87,97,"Thus, spontaneous CD4(+) T-cell responses to ESO in cancer patients are prevalently of T(H)1 type and not Treg.",21829534_6,-1,-1,-1,-1,15569,-1,2.1445832e-05,0.99994636,3.224228e-05
15571,Their relatively,0,2,0,16,"Their relatively low frequency and advanced differentiation stage, however, may limit their efficacy, that may be boosted by immunogenic ESO vaccines.",21829534_7,-1,-1,-1,-1,15571,-1,8.847502e-06,0.99998426,6.9354355e-06
15585,The cytokine,0,2,0,12,"The cytokine milieu was analyzed by quantitative reverse transcriptase-polymerase chain reaction (RT-PCR).RESULTS: Oral squamous cell carcinoma expresses high levels of IL-1, IL-6, and transforming growth factor (TGF)-.",21837700_2,-1,-1,-1,-1,15585,-1,0.4337328,0.56159806,0.0046691024
15590,transforming growth factor,26,29,186,212,"The cytokine milieu was analyzed by quantitative reverse transcriptase-polymerase chain reaction (RT-PCR).RESULTS: Oral squamous cell carcinoma expresses high levels of IL-1, IL-6, and transforming growth factor (TGF)-.",21837700_2,-1,-1,-1,-1,15590,-1,0.9779765,0.018881036,0.0031425746
15595,tumor-infiltrating lymphocytes,15,17,90,120,"A unique subset of FOXP3(+) IL-17-producing CD4(+) T cells was consistently identified in tumor-infiltrating lymphocytes from advanced stages of cancer, but not in the circulation, at a frequency of 0.5% to 5.5 % of total CD4(+) T and positively correlated with the frequency of IL-17(+)FOXP3(-) T cells.",21837700_3,-1,-1,-1,-1,15595,-1,0.0014652044,0.9199948,0.07854004
15603,The IL-17(+)FOXP3(+,0,2,0,19,The IL-17(+)FOXP3(+) T cells express CCR6 and suppress the proliferation of autologous CD4(+) CD25(-) responder T-cells in vitro.,21837700_4,-1,-1,-1,-1,15603,-1,0.002328506,0.9973158,0.00035561403
15607,T-cells,18,19,112,119,The IL-17(+)FOXP3(+) T cells express CCR6 and suppress the proliferation of autologous CD4(+) CD25(-) responder T-cells in vitro.,21837700_4,-1,1,2,-1,15607,-1,1.2350574e-05,9.2091705e-06,0.9999784
15609,IL-17-producing FOXP3(+,5,7,31,54,CONCLUSIONS: The prevalence of IL-17-producing FOXP3(+) CD4(+) tumor infiltrating lymphocytes is increased in oral squamous cell carcinoma.,21837700_5,-1,-1,-1,-1,15609,-1,0.9988869,0.0004615367,0.0006515331
15616,tumor-specific immune responses,12,15,75,106,BACKGROUND: The presence of Tregs in tumors is associated with compromised tumor-specific immune responses and has a clear negative impact on survival of cancer patients.,21843083_0,-1,-1,-1,-1,15616,-1,0.32686648,0.67096347,0.0021700573
15628,the tumor,13,15,93,102,NLGP-mediated downregulation of CCR4 along with its ligand CCL22 restricts Treg migration at the tumor site.,21843083_5,-1,-1,-1,-1,15628,-1,4.5932584e-06,0.9999908,4.5730394e-06
15629,to Tregs,4,6,22,30,"NLGP is not apoptotic to Tregs but significantly downregulates the expression of Foxp3, CTLA4 and GITR.",21843083_6,-1,-1,-1,-1,15629,-1,6.6068847e-06,0.999987,6.4333976e-06
15633,the functional,3,5,17,31,"It also reverses the functional impairment of T-effector cells by Tregs, in terms of IFN- secretion, cellular proliferation and tumor cell cytotoxicity.",21843083_7,-1,-1,-1,-1,15633,-1,5.5014014e-05,0.99990535,3.9615657e-05
15634,T-effector cells,7,9,46,62,"It also reverses the functional impairment of T-effector cells by Tregs, in terms of IFN- secretion, cellular proliferation and tumor cell cytotoxicity.",21843083_7,-1,-1,-1,-1,15634,-1,0.00043460616,0.036127955,0.9634374
15639,tumor cell,21,23,129,139,"It also reverses the functional impairment of T-effector cells by Tregs, in terms of IFN- secretion, cellular proliferation and tumor cell cytotoxicity.",21843083_7,-1,-1,-1,-1,15639,-1,4.248745e-05,0.00014879202,0.99980885
15646,Treg function,11,13,73,86,"Interaction between Foxp3, p-NFATc3 and p-Smad2/3, needed for successful Treg function, is also inhibited by NLGP.CONCLUSION: All of these coordinated events might result in inhibition of Treg associated-tumor growth and therefore increased survivability of mice having NLGP treatment before or/and after tumor inoculation.",21843083_9,-1,-1,-1,-1,15646,-1,1.2423237e-05,0.99997187,1.5654441e-05
15655,T-cell,12,13,59,65,"Thus, the possibility of NLGP being an excellent tool as a T-cell anergy breaker by abrogating the suppressor functions of Tregs in cancer needs to be explored further in the clinic.",21843083_10,-1,1,2,-1,15655,-1,1.440764e-05,8.621207e-06,0.999977
15657,functions,19,20,110,119,"Thus, the possibility of NLGP being an excellent tool as a T-cell anergy breaker by abrogating the suppressor functions of Tregs in cancer needs to be explored further in the clinic.",21843083_10,0,1,2,-1,15657,-1,9.374905e-06,0.9999814,9.173505e-06
15664,functions,18,19,116,125,Signal transducer and activator of transcription 3 (Stat3) is a potent transcription factor with diverse biological functions.,21864492_0,0,1,2,-1,15664,-1,0.0001867853,0.99970776,0.00010537691
15671,blood,22,23,137,142,"In the present study, the population of CD11b(+)Gr-1(+) myeloid-derived suppressor cells (MDSCs) was significantly increased in lung and blood of doxycycline-treated bitransgenic mice, but CD4(+) and CD8(+) T cells were decreased.",21864492_2,0,1,-1,-1,15671,-1,0.00011377027,0.9997645,0.000121697136
15674,cytokines IL-1,14,16,121,136,"In bronchioalveolar lavage fluid and plasma of doxycycline-treated bitransgenic mice, concentrations of MDSC-stimulating cytokines IL-1, IL-6, IL-10, IL-13, INF-, TNF-, and GM-CSF were significantly increased, which stimulated alveolar monocytes/macrophages to CD11b(+)Gr-1(+) cell conversion in vitro.",21864492_3,-1,-1,-1,-1,15674,-1,0.9999566,7.0621018e-06,3.6374728e-05
15678,TNF-,25,26,165,170,"In bronchioalveolar lavage fluid and plasma of doxycycline-treated bitransgenic mice, concentrations of MDSC-stimulating cytokines IL-1, IL-6, IL-10, IL-13, INF-, TNF-, and GM-CSF were significantly increased, which stimulated alveolar monocytes/macrophages to CD11b(+)Gr-1(+) cell conversion in vitro.",21864492_3,0,1,-1,-1,15678,-1,0.01675392,0.98269606,0.0005500685
15684,blood,22,23,159,164,"Phosphorylation of proto-oncogenic intracellular signaling molecules Stat3, Erk1/2, and P38 was significantly increased in CD11b(+)Gr-1(+) cells from lung and blood of doxycycline-treated bitransgenic mice.",21864492_4,0,1,-1,-1,15684,-1,0.0002238237,0.9996699,0.000106257314
15686,function,13,14,110,118,CD11b(+)Gr-1(+) cells from lung of doxycycline-treated bitransgenic mice strongly inhibited proliferation and function of wild-type CD4(+) T cells in vitro.,21864492_5,0,1,2,-1,15686,-1,4.373357e-05,0.99984634,0.00010987522
15701,the TGF-,10,12,64,73,"Here, we employed two conditional mutagenesis systems to delete the TGF- signaling pathway component Smad4 in T cells and observed the spontaneous development of massive polyps within the gastroduodenal regions of mice.",21881210_1,-1,-1,-1,-1,15701,-1,1.599352e-05,0.9999757,8.283099e-06
15712,TNF-,18,19,105,110,"The epithelial lesions contained increased levels of transcripts encoding IL-11, IL-6, TGF-, IL-1, and TNF-, and lamina propria cells isolated from lesions contained abundant IL-17A+CD4+ T cells.",21881210_2,0,1,-1,-1,15712,-1,6.157683e-05,0.99991214,2.6326403e-05
15716,that Smad4 deficiency,4,7,22,43,"Furthermore, we found that Smad4 deficiency attenuated TGF--mediated in vitro polarization of FoxP3+CD4+ T cells, but not IL-17A+CD4+ T cells, suggesting that the epithelial lesions may have arisen as a consequence of unchecked Th17 cell activity.",21881210_3,-1,-1,-1,-1,15716,-1,1.201927e-05,0.9999801,7.915651e-06
15722,that the,26,28,155,163,"Furthermore, we found that Smad4 deficiency attenuated TGF--mediated in vitro polarization of FoxP3+CD4+ T cells, but not IL-17A+CD4+ T cells, suggesting that the epithelial lesions may have arisen as a consequence of unchecked Th17 cell activity.",21881210_3,-1,-1,-1,-1,15722,-1,5.9146173e-06,0.99998975,4.3501987e-06
15723,Th17 cell,38,40,229,238,"Furthermore, we found that Smad4 deficiency attenuated TGF--mediated in vitro polarization of FoxP3+CD4+ T cells, but not IL-17A+CD4+ T cells, suggesting that the epithelial lesions may have arisen as a consequence of unchecked Th17 cell activity.",21881210_3,-1,-1,-1,-1,15723,-1,0.0012663051,0.12514895,0.87358475
15736,Th17 cell,11,13,55,64,"Thus, our data indicate that a chronic increase in gut Th17 cell activity can be associated with the development of premalignant lesions of the gastroduodenal region.",21881210_6,-1,-1,-1,-1,15736,-1,0.0005537927,0.034359746,0.9650864
15744,tumor immunity regulation,20,23,86,111,"It has been known that regulatory T (Treg) cells and mast cells (MCs) are involved in tumor immunity regulation, but the exact roles and mechanisms of Treg cells and MCs in B-cell non-Hodgkin's lymphoma (NHL) are incompletely defined.",21898141_0,-1,-1,-1,-1,15744,-1,2.2543742e-05,0.9999658,1.16224655e-05
15748,that the,7,9,31,39,"In the present study, we found that the number of Foxp3(+) Treg cells and CD117(+) MCs increased in B-cell NHL patients.",21898141_1,-1,-1,-1,-1,15748,-1,4.0855616e-06,0.99999154,4.4109615e-06
15763,that Treg cell,5,8,35,49,"Collectively, our results indicate that Treg cell and MCs are involved in immunosuppression in B-cell NHL, and IL-9 is a key mediator of Treg cells and MCs in that process.",21898141_5,-1,-1,-1,-1,15763,-1,0.0014177936,0.11984476,0.8787374
15775,T cell immunity,18,21,108,123,"Identification of molecular adjuvants to in vivo ""modulate "" DC to coordinately render improved Th1 and CD8 T cell immunity, and attenuated deleterious Treg effects, is a critical challenge.",21934655_1,-1,-1,-1,-1,15775,-1,6.2691644e-05,8.995561e-06,0.99992836
15778,genetic targeting,7,9,29,46,"Here, we report that in vivo genetic targeting of the active transcription factor XBP1s to DC (XBP1s/DC) potentiated vaccine-induced prophylactic and therapeutic antitumor immunity in multiple tumor models.",21934655_2,-1,-1,-1,-1,15778,-1,4.489061e-06,0.99999106,4.426661e-06
15780,transcription factor XBP1s to,12,16,61,90,"Here, we report that in vivo genetic targeting of the active transcription factor XBP1s to DC (XBP1s/DC) potentiated vaccine-induced prophylactic and therapeutic antitumor immunity in multiple tumor models.",21934655_2,-1,-1,-1,-1,15780,-1,7.779935e-06,0.999982,1.0269397e-05
15782,immunity,26,27,172,180,"Here, we report that in vivo genetic targeting of the active transcription factor XBP1s to DC (XBP1s/DC) potentiated vaccine-induced prophylactic and therapeutic antitumor immunity in multiple tumor models.",21934655_2,0,-1,2,-1,15782,-1,0.99989605,2.2166309e-05,8.178973e-05
15793,tumor-associated Treg,22,24,133,154,The novel targeted vaccine induced durable Th1 and CD8 T cell responses to poorly immunogenic self/tumor antigen (Ag) and attenuated tumor-associated Treg suppressive function.,21934655_4,-1,-1,-1,-1,15793,-1,5.8299506e-06,0.99998915,5.023446e-06
15794,function,25,26,167,175,The novel targeted vaccine induced durable Th1 and CD8 T cell responses to poorly immunogenic self/tumor antigen (Ag) and attenuated tumor-associated Treg suppressive function.,21934655_4,0,1,2,-1,15794,-1,1.0474935e-05,0.9999722,1.7290717e-05
15803,functional,2,3,18,28,XBP1s/DC elevated functional DEC205(+)CD8(+)DC in the draining lymph nodes (DLN).,21934655_6,0,1,2,-1,15803,-1,9.0312744e-05,0.9998665,4.3160875e-05
15810,to tumor,21,23,129,137,"The data suggest a novel role for XBP1s in modulating DC to potentiate tumor vaccine efficacy via overcoming two major obstacles to tumor vaccines (i.e., T cell hyporesponsiveness against poorly immunologic self/tumor Ag and tumor-associated Treg-mediated suppression) and improving DEC205(+)CD8(+)DC.",21934655_7,-1,-1,-1,-1,15810,-1,7.881815e-06,0.9999862,5.9846575e-06
15812,tumor-associated Treg-mediated,36,38,225,255,"The data suggest a novel role for XBP1s in modulating DC to potentiate tumor vaccine efficacy via overcoming two major obstacles to tumor vaccines (i.e., T cell hyporesponsiveness against poorly immunologic self/tumor Ag and tumor-associated Treg-mediated suppression) and improving DEC205(+)CD8(+)DC.",21934655_7,-1,-1,-1,-1,15812,-1,3.919474e-05,0.99992454,3.623628e-05
15815,tumor tissue,12,14,63,75,BACKGROUND: Regulatory T cells (Tregs) are highly prevalent in tumor tissue and can suppress effective anti-tumor immune responses.,21935436_0,-1,-1,-1,-1,15815,-1,5.9892163e-06,0.9999856,8.451676e-06
15819,tumor-infiltrating Tregs,7,9,37,61,"However, the source of the increased tumor-infiltrating Tregs and their contribution to cancer progression remain poorly understood.",21935436_1,-1,-1,-1,-1,15819,-1,1.1008415e-05,0.99997854,1.0404375e-05
15826,that FoxP3(+,3,5,19,31,"Our results showed that FoxP3(+) Tregs highly aggregated and were in an activated phenotype (CD69(+)HLA-DR(high)) in the tumor site, where they can suppress the proliferation and INF- secretion of CD4(+)CD25(-) T cells.",21935436_3,-1,-1,-1,-1,15826,-1,2.2577668e-05,0.999959,1.8415321e-05
15828,the tumor,20,22,117,126,"Our results showed that FoxP3(+) Tregs highly aggregated and were in an activated phenotype (CD69(+)HLA-DR(high)) in the tumor site, where they can suppress the proliferation and INF- secretion of CD4(+)CD25(-) T cells.",21935436_3,-1,-1,-1,-1,15828,-1,3.6577721e-06,0.9999918,4.576512e-06
15832,These tumor-infiltrating Tregs,0,3,0,30,"These tumor-infiltrating Tregs could be selectively recruited though CCR6-CCL20 axis as illustrated by (a) high expression of CCR6 on circulating Tregs and their selective migration to CCR6 ligand CCL20, and (b) correlation of distribution and expression between tumor-infiltrating Tregs and intratumoral CCL20.",21935436_4,-1,-1,-1,-1,15832,-1,7.694517e-06,0.9999856,6.7185642e-06
15837,to CCR6,27,29,182,189,"These tumor-infiltrating Tregs could be selectively recruited though CCR6-CCL20 axis as illustrated by (a) high expression of CCR6 on circulating Tregs and their selective migration to CCR6 ligand CCL20, and (b) correlation of distribution and expression between tumor-infiltrating Tregs and intratumoral CCL20.",21935436_4,-1,-1,-1,-1,15837,-1,0.0048396713,0.7581007,0.23705961
15838,tumor-infiltrating Tregs,42,44,263,287,"These tumor-infiltrating Tregs could be selectively recruited though CCR6-CCL20 axis as illustrated by (a) high expression of CCR6 on circulating Tregs and their selective migration to CCR6 ligand CCL20, and (b) correlation of distribution and expression between tumor-infiltrating Tregs and intratumoral CCL20.",21935436_4,-1,-1,-1,-1,15838,-1,8.366007e-06,0.9999846,6.9633397e-06
15839,that the,5,7,22,30,"In addition, we found that the number of tumor-infiltrating Tregs was associated with cirrhosis background (P=0.011) and tumor differentiation (P=0.003), and was an independent prognostic factor for overall survival (HR=2.408, P=0.013) and disease-free survival (HR=2.204, P=0.041).",21935436_5,-1,-1,-1,-1,15839,-1,4.4883336e-06,0.99999106,4.439911e-06
15840,tumor-infiltrating Tregs,9,11,41,65,"In addition, we found that the number of tumor-infiltrating Tregs was associated with cirrhosis background (P=0.011) and tumor differentiation (P=0.003), and was an independent prognostic factor for overall survival (HR=2.408, P=0.013) and disease-free survival (HR=2.204, P=0.041).",21935436_5,-1,-1,-1,-1,15840,-1,1.3322555e-05,0.99997354,1.3175973e-05
15842,factor,39,40,192,198,"In addition, we found that the number of tumor-infiltrating Tregs was associated with cirrhosis background (P=0.011) and tumor differentiation (P=0.003), and was an independent prognostic factor for overall survival (HR=2.408, P=0.013) and disease-free survival (HR=2.204, P=0.041).",21935436_5,0,1,-1,-1,15842,-1,0.0004417867,0.99951696,4.1310323e-05
15844,tumor-infiltrating Tregs,2,4,14,38,The increased tumor-infiltrating Tregs predicted poorer prognosis in HCC patients.,21935436_6,-1,-1,-1,-1,15844,-1,1.3878441e-05,0.9999771,9.012865e-06
15853,therapeutic target,11,13,70,88,"Thus, blocking CCL20-CCR6 axis-mediated Treg migration may be a novel therapeutic target for HCC.",21935436_8,-1,-1,-1,-1,15853,-1,5.720687e-06,0.9999895,4.7729895e-06
15855,transcription factor peroxisome proliferator-activated receptor,2,7,21,84,"The ligand-activated transcription factor peroxisome proliferator-activated receptor (PPAR)- is highly expressed in colonic epithelial cells; however, the role of PPAR ligands, such as fatty acids, in mucosal inflammation and malignant transformation has not been clarified.",21940900_0,-1,-1,-1,-1,15855,-1,0.00064921443,0.99901533,0.00033539912
15859,that the,3,5,25,33,Recent evidence suggests that the anti-inflammatory/chemoprotective properties of fish oil (FO)-derived n-3 polyunsaturated fatty acids (PUFAs) may be partly mediated by PPAR.,21940900_1,-1,-1,-1,-1,15859,-1,5.147175e-06,0.99999094,3.924176e-06
15878,T cell activation status,7,11,46,70,Dietary FO independently modulated MLN CD4(+) T cell activation status by decreasing CD44 expression.,21940900_9,-1,-1,-1,-1,15878,-1,0.00061499164,0.004006419,0.9953786
15887,Protein,0,1,0,7,Protein vaccines may be a useful strategy for cancer immunotherapy because recombinant tumor antigen proteins can be produced on a large scale at relatively low cost and have been shown to be safe for clinical application.,21945963_0,0,1,-1,-1,15887,-1,0.00014345387,0.99983203,2.4532426e-05
15888,tumor antigen proteins,12,15,87,109,Protein vaccines may be a useful strategy for cancer immunotherapy because recombinant tumor antigen proteins can be produced on a large scale at relatively low cost and have been shown to be safe for clinical application.,21945963_0,-1,-1,-1,-1,15888,-1,0.018124068,0.9811835,0.00069242803
15891,protein,2,3,9,16,"However, protein vaccines have historically exhibited poor immunogenicity; thus, an improved strategy is needed for successful induction of immune responses.",21945963_1,0,1,-1,-1,15891,-1,0.04313361,0.9561847,0.000681739
15894,TAT peptide,0,2,0,11,TAT peptide is a protein transduction domain composed of an 11-amino acid peptide (TAT(47-57): YGRKKRRQRRR).,21945963_2,-1,-1,-1,-1,15894,-1,1.4913558e-05,0.9999671,1.799262e-05
15896,peptide,12,13,74,81,TAT peptide is a protein transduction domain composed of an 11-amino acid peptide (TAT(47-57): YGRKKRRQRRR).,21945963_2,0,-1,2,-1,15896,-1,0.00014531484,0.999736,0.00011869157
15899,this peptide,4,6,23,35,The positive charge of this peptide allows protein antigen fused with it to improve cell penetration.,21945963_3,-1,-1,-1,-1,15899,-1,0.00012335733,0.99981314,6.356538e-05
15900,protein antigen,7,9,43,58,The positive charge of this peptide allows protein antigen fused with it to improve cell penetration.,21945963_3,-1,-1,-1,-1,15900,-1,0.9797594,0.01699041,0.0032502294
15905,TAT peptide,19,21,113,124,Poly(I:C) is a synthetic double-stranded RNA that is negatively charged and favors interaction with the cationic TAT peptide.,21945963_4,-1,-1,-1,-1,15905,-1,1.5399231e-05,0.9999684,1.6141134e-05
15912,protein,12,13,73,80,"Therefore, we demonstrated that vaccine with a mixture of TAT-CEA fusion protein and poly(I:C) can induce anti-tumor immunity in a murine colorectal tumor model.",21945963_6,0,1,-1,-1,15912,-1,1.371488e-05,0.9999752,1.10793235e-05
15913,immunity,21,22,117,125,"Therefore, we demonstrated that vaccine with a mixture of TAT-CEA fusion protein and poly(I:C) can induce anti-tumor immunity in a murine colorectal tumor model.",21945963_6,0,-1,2,-1,15913,-1,0.9998863,3.459316e-05,7.920288e-05
15916,protein,10,11,66,73,Splenocytes from mice vaccinated with a mixture of TAT-CEA fusion protein and poly(I:C) effectively induced CEA-specific IFN--producing T cells and showed cytotoxic activity specific for MC-38-cea2 tumor cells expressing CEA.,21945963_7,0,1,-1,-1,15916,-1,6.6623534e-06,0.9999876,5.7017005e-06
15917,IFN--producing T cells,19,22,121,144,Splenocytes from mice vaccinated with a mixture of TAT-CEA fusion protein and poly(I:C) effectively induced CEA-specific IFN--producing T cells and showed cytotoxic activity specific for MC-38-cea2 tumor cells expressing CEA.,21945963_7,-1,-1,-1,-1,15917,-1,0.95237786,0.00017965243,0.04744254
15918,tumor cells,29,31,199,210,Splenocytes from mice vaccinated with a mixture of TAT-CEA fusion protein and poly(I:C) effectively induced CEA-specific IFN--producing T cells and showed cytotoxic activity specific for MC-38-cea2 tumor cells expressing CEA.,21945963_7,-1,-1,-1,-1,15918,-1,4.993701e-05,0.00010751877,0.9998425
15920,protein,7,8,41,48,Vaccine with a mixture of TAT-CEA fusion protein and poly(I:C) delayed tumor growth in MC-38-cea-2 tumor-bearing mice.,21945963_8,0,1,-1,-1,15920,-1,1.5029668e-05,0.99997485,1.0078652e-05
15930,immunity,33,34,187,195,"Depletion of CD8(+) T cells and NK cells reversed the inhibition of tumor growth in an MC-38-cea2-bearing mice, indicating that CD8(+) T cells and NK cells are responsible for anti-tumor immunity by vaccine with a mixture of TAT-CEA fusion protein and poly(I:C).",21945963_9,0,-1,2,-1,15930,-1,0.9997272,0.000109292276,0.00016353397
15932,protein,42,43,240,247,"Depletion of CD8(+) T cells and NK cells reversed the inhibition of tumor growth in an MC-38-cea2-bearing mice, indicating that CD8(+) T cells and NK cells are responsible for anti-tumor immunity by vaccine with a mixture of TAT-CEA fusion protein and poly(I:C).",21945963_9,0,1,-1,-1,15932,-1,1.1539641e-05,0.99998176,6.6952625e-06
15933,Taken together,0,2,0,14,"Taken together, these results suggest that poly(I:C) could be used as a potent adjuvant to induce the anti-tumor immunity of a TAT-CEA fusion protein vaccine in a murine colorectal tumor model.",21945963_10,-1,-1,-1,-1,15933,-1,7.62202e-06,0.9999852,7.119887e-06
15938,immunity,22,23,113,121,"Taken together, these results suggest that poly(I:C) could be used as a potent adjuvant to induce the anti-tumor immunity of a TAT-CEA fusion protein vaccine in a murine colorectal tumor model.",21945963_10,0,-1,2,-1,15938,-1,0.99981445,5.6940382e-05,0.00012858358
15940,protein,27,28,142,149,"Taken together, these results suggest that poly(I:C) could be used as a potent adjuvant to induce the anti-tumor immunity of a TAT-CEA fusion protein vaccine in a murine colorectal tumor model.",21945963_10,0,1,-1,-1,15940,-1,1.5901007e-05,0.9999746,9.52113e-06
15956,the tumor,5,7,22,31,"In the lymph nodes of the tumor microenvironment and spleen, the proportion of Treg cells was significantly higher in the tumor-bearing mice.",21963624_4,-1,-1,-1,-1,15956,-1,4.289164e-06,0.9999906,5.178932e-06
15959,the tumor-bearing,20,22,118,135,"In the lymph nodes of the tumor microenvironment and spleen, the proportion of Treg cells was significantly higher in the tumor-bearing mice.",21963624_4,-1,-1,-1,-1,15959,-1,4.455911e-06,0.9999901,5.4015804e-06
15973,the tumor,26,28,151,160,"In conclusion, GP reduced the proportion of Treg cells and Foxp3 lowered expression in Treg cells, and up-regulated Th1/Th2 cytokine ratio in serum in the tumor bearing mice, which might partially cause the inhibition of tumor growth.",21963624_7,-1,-1,-1,-1,15973,-1,4.461389e-06,0.99999034,5.2283726e-06
15979,the T-cell antigen,3,6,16,34,"However, during the T-cell antigen response, the physiologic function of endogenous miR-17-92 and the roles of the individual miRNAs remain elusive.",21972292_1,-1,-1,-1,-1,15979,-1,0.5507249,0.41308582,0.036189232
15981,function,10,11,61,69,"However, during the T-cell antigen response, the physiologic function of endogenous miR-17-92 and the roles of the individual miRNAs remain elusive.",21972292_1,0,1,2,-1,15981,-1,1.7438535e-05,0.9999685,1.3988571e-05
15985,functionally,6,7,25,37,"In the present study, we functionally dissected the miR-17-92 cluster and revealed that miR-17 and miR-19b are the key players controlling Th1 responses through multiple coordinated biologic processes.",21972292_2,0,1,2,-1,15985,-1,1.52938e-05,0.9999782,6.46292e-06
15998,the functionally,12,14,72,88,"Mechanistically, we identified Pten (phosphatase and tensin homolog) as the functionally important target of miR-19b, whereas the function of miR-17 is mediated by TGFRII and the novel target CREB1.",21972292_4,-1,-1,-1,-1,15998,-1,1.6511825e-05,0.999974,9.4823945e-06
16000,the function,20,22,126,138,"Mechanistically, we identified Pten (phosphatase and tensin homolog) as the functionally important target of miR-19b, whereas the function of miR-17 is mediated by TGFRII and the novel target CREB1.",21972292_4,-1,-1,-1,-1,16000,-1,6.223072e-06,0.9999882,5.519171e-06
16003,target CREB1,31,33,186,198,"Mechanistically, we identified Pten (phosphatase and tensin homolog) as the functionally important target of miR-19b, whereas the function of miR-17 is mediated by TGFRII and the novel target CREB1.",21972292_4,-1,-1,-1,-1,16003,-1,6.8791633e-06,0.99997795,1.5195864e-05
16004,the Th1 cell-inducible regulatory T cell,6,12,37,77,"Because of its vigorous control over the Th1 cell-inducible regulatory T cell balance, the loss of miR-17-92 in CD4 T cells results in tumor evasion.",21972292_5,-1,-1,-1,-1,16004,-1,0.0013812864,0.12578243,0.8728363
16011,T cell-based tumor therapy,15,19,90,116,Our results suggest that miR-19b and miR-17 could be harnessed to enhance the efficacy of T cell-based tumor therapy.,21972292_6,-1,-1,-1,-1,16011,-1,0.0018327137,0.05992215,0.9382452
16014,T-box transcription factor 21 gene,16,21,98,132,Large granular lymphocyte (LGL) leukemia is a chronic lymphoproliferative disease in which T-bet [T-box transcription factor 21 gene (tbx21)] overexpression may play a pathogenic role.,21983879_0,-1,-1,-1,-1,16014,-1,4.620352e-06,0.99998784,7.520435e-06
16015,tbx21,22,23,134,139,Large granular lymphocyte (LGL) leukemia is a chronic lymphoproliferative disease in which T-bet [T-box transcription factor 21 gene (tbx21)] overexpression may play a pathogenic role.,21983879_0,-1,1,2,-1,16015,-1,2.0279474e-05,0.99996305,1.6678783e-05
16019,T-cells,7,8,60,67,T-bet orchestrates the differentiation of mature peripheral T-cells into interferon- (IFN-) and tumor necrosis factor- producing CD4+ T-helper type I (Th1) and CD8+ T cytotoxic cells that are necessary for antiviral responses.,21983879_1,-1,1,2,-1,16019,-1,1.376498e-05,9.782359e-06,0.9999765
16023,factor-,16,17,113,121,T-bet orchestrates the differentiation of mature peripheral T-cells into interferon- (IFN-) and tumor necrosis factor- producing CD4+ T-helper type I (Th1) and CD8+ T cytotoxic cells that are necessary for antiviral responses.,21983879_1,0,1,-1,-1,16023,-1,0.9999603,4.865102e-06,3.4850902e-05
16024,T-helper type,20,22,137,150,T-bet orchestrates the differentiation of mature peripheral T-cells into interferon- (IFN-) and tumor necrosis factor- producing CD4+ T-helper type I (Th1) and CD8+ T cytotoxic cells that are necessary for antiviral responses.,21983879_1,-1,-1,-1,-1,16024,-1,1.796451e-05,0.9998524,0.00012953767
16027,cells that,31,33,180,190,T-bet orchestrates the differentiation of mature peripheral T-cells into interferon- (IFN-) and tumor necrosis factor- producing CD4+ T-helper type I (Th1) and CD8+ T cytotoxic cells that are necessary for antiviral responses.,21983879_1,-1,-1,-1,-1,16027,-1,0.0027464957,0.20534003,0.79191345
16029,antigen-presenting cells,5,7,26,50,"When IL-12 is produced by antigen-presenting cells, T-bet expression is induced, causing direct stimulation of ifng gene transcription while simultaneously acting as a transcriptional repressor of the IL4 gene, which then leads to Th1 dominance and T-helper type 2 differentiation blockade.",21983879_2,-1,-1,-1,-1,16029,-1,0.7514223,0.00025890104,0.24831878
16031,ifng gene transcription,17,20,111,134,"When IL-12 is produced by antigen-presenting cells, T-bet expression is induced, causing direct stimulation of ifng gene transcription while simultaneously acting as a transcriptional repressor of the IL4 gene, which then leads to Th1 dominance and T-helper type 2 differentiation blockade.",21983879_2,-1,-1,-1,-1,16031,-1,0.98193604,0.016073223,0.001990798
16036,to Th1,35,37,228,234,"When IL-12 is produced by antigen-presenting cells, T-bet expression is induced, causing direct stimulation of ifng gene transcription while simultaneously acting as a transcriptional repressor of the IL4 gene, which then leads to Th1 dominance and T-helper type 2 differentiation blockade.",21983879_2,-1,-1,-1,-1,16036,-1,3.5756016e-06,0.9999894,7.01596e-06
16037,T-helper type,39,41,249,262,"When IL-12 is produced by antigen-presenting cells, T-bet expression is induced, causing direct stimulation of ifng gene transcription while simultaneously acting as a transcriptional repressor of the IL4 gene, which then leads to Th1 dominance and T-helper type 2 differentiation blockade.",21983879_2,-1,-1,-1,-1,16037,-1,2.0492054e-05,0.9999063,7.3150164e-05
16040,the ifng,11,13,70,78,"Additionally, T-bet has been shown to regulate histone acetylation of the ifng promoter and enhancer to loosen condensed DNA, creating greater accessibility for other transcription factor binding, which further amplifies IFN production.",21983879_3,-1,-1,-1,-1,16040,-1,0.6938245,0.29907614,0.007099283
16044,that treatment,2,4,9,23,We found that treatment with a farnesyltransferase inhibitor tipifarnib reduced Th1 cytokines in LGL leukemia patient T-cells and blocked T-bet protein expression and IL-12 responsiveness in T-cells from healthy donors.,21983879_4,-1,-1,-1,-1,16044,-1,5.7476036e-06,0.9999896,4.5722795e-06
16046,Th1 cytokines,10,12,80,93,We found that treatment with a farnesyltransferase inhibitor tipifarnib reduced Th1 cytokines in LGL leukemia patient T-cells and blocked T-bet protein expression and IL-12 responsiveness in T-cells from healthy donors.,21983879_4,-1,-1,-1,-1,16046,-1,0.14170502,0.8484618,0.009833177
16047,T-cells,16,17,118,125,We found that treatment with a farnesyltransferase inhibitor tipifarnib reduced Th1 cytokines in LGL leukemia patient T-cells and blocked T-bet protein expression and IL-12 responsiveness in T-cells from healthy donors.,21983879_4,-1,1,2,-1,16047,-1,2.2595503e-05,1.7459153e-05,0.99995995
16048,T-bet protein,19,21,138,151,We found that treatment with a farnesyltransferase inhibitor tipifarnib reduced Th1 cytokines in LGL leukemia patient T-cells and blocked T-bet protein expression and IL-12 responsiveness in T-cells from healthy donors.,21983879_4,-1,-1,-1,-1,16048,-1,4.6102177e-06,0.9999894,5.9589347e-06
16050,T-cells,26,27,191,198,We found that treatment with a farnesyltransferase inhibitor tipifarnib reduced Th1 cytokines in LGL leukemia patient T-cells and blocked T-bet protein expression and IL-12 responsiveness in T-cells from healthy donors.,21983879_4,-1,1,2,-1,16050,-1,4.1887615e-05,1.3165448e-05,0.99994504
16052,the ifng gene,12,15,79,92,"The mechanism of suppression was based on modulation of histone acetylation of the ifng gene, which culminated in Th1 blockade.",21983879_5,-1,-1,-1,-1,16052,-1,0.0013781083,0.99828464,0.00033719974
16054,Tumour cells,0,2,0,12,Tumour cells often express deregulated profiles of chemokine receptors that regulate cancer cell migration and proliferation.,21984373_0,-1,-1,-1,-1,16054,-1,5.3793938e-05,9.012347e-05,0.9998561
16055,chemokine receptors that,7,10,51,75,Tumour cells often express deregulated profiles of chemokine receptors that regulate cancer cell migration and proliferation.,21984373_0,-1,-1,-1,-1,16055,-1,0.9608171,0.01862054,0.020562334
16059,to the,15,17,86,92,"Notch1 pathway activation is seen in T cell acute lymphoblastic leukaemia (T-ALL) due to the high frequency of Notch1 mutations affecting approximately 60% of patients, causing ligand-independent signalling and/or prolonging Notch1 half-life.",21984373_1,-1,-1,-1,-1,16059,-1,5.750116e-06,0.99998987,4.3748255e-06
16062,function,13,14,82,90,"We have investigated the possible regulative role of Notch1 on the expression and function of chemokine receptors CCR5, CCR9 and CXCR4 that play a role in determining blast malignant properties and localization of extramedullary infiltrations in leukaemia.",21984373_2,0,1,2,-1,16062,-1,1.2116989e-05,0.999974,1.390943e-05
16063,chemokine receptors CCR5,15,18,94,118,"We have investigated the possible regulative role of Notch1 on the expression and function of chemokine receptors CCR5, CCR9 and CXCR4 that play a role in determining blast malignant properties and localization of extramedullary infiltrations in leukaemia.",21984373_2,-1,-1,-1,-1,16063,-1,0.176326,0.0006574009,0.8230166
16064,that play,22,24,135,144,"We have investigated the possible regulative role of Notch1 on the expression and function of chemokine receptors CCR5, CCR9 and CXCR4 that play a role in determining blast malignant properties and localization of extramedullary infiltrations in leukaemia.",21984373_2,-1,-1,-1,-1,16064,-1,5.105028e-06,0.9999895,5.392519e-06
16069,function,19,20,129,137,We inhibited the pathway through -Secretase inhibitor and Notch1 RNA interference and analysed the effect on the expression and function of chemokine receptors.,21984373_3,0,1,2,-1,16069,-1,7.927181e-05,0.9998579,6.2750565e-05
16070,chemokine receptors,21,23,141,160,We inhibited the pathway through -Secretase inhibitor and Notch1 RNA interference and analysed the effect on the expression and function of chemokine receptors.,21984373_3,-1,-1,-1,-1,16070,-1,0.97911364,5.1794286e-05,0.020834517
16072,the transcription,8,10,69,86,"Our results indicate that -Secretase inhibitor negatively regulates the transcription level of the CC chemokine receptors 5 and 9 in T-ALL cell lines and patients' primary leukaemia cells, leaving CXCR4 expression unaltered.",21984373_4,-1,-1,-1,-1,16072,-1,7.727163e-06,0.999987,5.271407e-06
16074,chemokine receptors,14,16,103,122,"Our results indicate that -Secretase inhibitor negatively regulates the transcription level of the CC chemokine receptors 5 and 9 in T-ALL cell lines and patients' primary leukaemia cells, leaving CXCR4 expression unaltered.",21984373_4,-1,-1,-1,-1,16074,-1,0.98750025,6.0538663e-05,0.012439268
16075,T-ALL cell,20,22,134,144,"Our results indicate that -Secretase inhibitor negatively regulates the transcription level of the CC chemokine receptors 5 and 9 in T-ALL cell lines and patients' primary leukaemia cells, leaving CXCR4 expression unaltered.",21984373_4,-1,-1,-1,-1,16075,-1,0.0010141941,0.13509464,0.8638912
16080,through CCL25,4,6,27,40,"Furthermore, engaging CCR9 through CCL25 administration rescues proliferation inhibition associated with abrogation of Notch activity.",21984373_6,-1,-1,-1,-1,16080,-1,0.40021634,0.59599113,0.0037925288
16082,that the,7,9,50,58,"Finally, through RNA interference we demonstrated that the oncogenic isoform in T-ALL, Notch1, plays a role in controlling CCR5 and CCR9 expression and functions.",21984373_7,-1,-1,-1,-1,16082,-1,3.6938527e-06,0.9999924,3.9153592e-06
16086,functions,26,27,152,161,"Finally, through RNA interference we demonstrated that the oncogenic isoform in T-ALL, Notch1, plays a role in controlling CCR5 and CCR9 expression and functions.",21984373_7,0,1,2,-1,16086,-1,5.5210105e-05,0.99969923,0.00024558717
16089,chemokine receptors,10,12,59,78,"These findings suggest that Notch1, acting in concert with chemokine receptors pathways, may provide leukaemia cells with proliferative advantage and specific chemotactic abilities, therefore influencing tumour cell progression and localization.",21984373_8,-1,-1,-1,-1,16089,-1,0.9881257,4.234243e-05,0.011832063
16093,tumour cell,28,30,204,215,"These findings suggest that Notch1, acting in concert with chemokine receptors pathways, may provide leukaemia cells with proliferative advantage and specific chemotactic abilities, therefore influencing tumour cell progression and localization.",21984373_8,-1,-1,-1,-1,16093,-1,3.1310534e-05,3.3135173e-05,0.9999355
16095,tissues,14,15,83,90,"Chronic inflammation is a major driving force in the development of cancer in many tissues, but the array of factors involved in this neoplastic transformation are not well understood.",21987656_0,-1,1,2,-1,16095,-1,0.00017223584,0.0014998321,0.9983279
16097,factors,20,21,109,116,"Chronic inflammation is a major driving force in the development of cancer in many tissues, but the array of factors involved in this neoplastic transformation are not well understood.",21987656_0,0,1,-1,-1,16097,-1,5.9819005e-05,0.99993014,9.987325e-06
16102,this cytokine,17,19,98,111,"We have investigated the role of interleukin (IL)-21 in colitis-associated colon cancer (CAC), as this cytokine is overexpressed in the gut mucosa of patients with ulcerative colitis (UC), a chronic inflammatory disease associated with colon cancer.",21987656_1,-1,-1,-1,-1,16102,-1,0.7864127,0.20898569,0.0046016425
16128,the tumor,2,4,14,23,"Expression of the tumor suppressor, promyelocytic leukemia (PML) protein, is reduced or abolished in gastric carcinomas, in association with an increased level of lymphatic invasion, development of higher pTNM staging, and unfavorable prognosis.",22022583_1,-1,-1,-1,-1,16128,-1,4.9445875e-06,0.99999,5.050442e-06
16129,protein,11,12,65,72,"Expression of the tumor suppressor, promyelocytic leukemia (PML) protein, is reduced or abolished in gastric carcinomas, in association with an increased level of lymphatic invasion, development of higher pTNM staging, and unfavorable prognosis.",22022583_1,0,1,-1,-1,16129,-1,7.521678e-05,0.9998914,3.333179e-05
16130,the relationship,4,6,24,40,"Herein, we investigated the relationship between the extent of tumor-infiltrating lymphocytes and the status of PML protein expression in advanced gastric carcinoma.",22022583_2,-1,-1,-1,-1,16130,-1,5.8937035e-06,0.9999895,4.568469e-06
16132,tumor-infiltrating lymphocytes,10,12,63,93,"Herein, we investigated the relationship between the extent of tumor-infiltrating lymphocytes and the status of PML protein expression in advanced gastric carcinoma.",22022583_2,-1,-1,-1,-1,16132,-1,0.0027616087,0.7117479,0.28549048
16133,the status,13,15,98,108,"Herein, we investigated the relationship between the extent of tumor-infiltrating lymphocytes and the status of PML protein expression in advanced gastric carcinoma.",22022583_2,-1,-1,-1,-1,16133,-1,4.452259e-06,0.9999912,4.32973e-06
16134,protein,17,18,116,123,"Herein, we investigated the relationship between the extent of tumor-infiltrating lymphocytes and the status of PML protein expression in advanced gastric carcinoma.",22022583_2,0,1,-1,-1,16134,-1,9.273129e-05,0.99983025,7.698096e-05
16135,T-cells,6,7,43,50,"We observed higher numbers of infiltrating T-cells in gastric carcinoma tissues in which PML expression was reduced or abolished, compared to tissues positive for PML.",22022583_3,-1,1,2,-1,16135,-1,2.2333956e-05,1.7033333e-05,0.99996066
16136,tissues,10,11,72,79,"We observed higher numbers of infiltrating T-cells in gastric carcinoma tissues in which PML expression was reduced or abolished, compared to tissues positive for PML.",22022583_3,-1,1,2,-1,16136,-1,0.00011990356,0.9807098,0.019170301
16137,to tissues,21,23,139,149,"We observed higher numbers of infiltrating T-cells in gastric carcinoma tissues in which PML expression was reduced or abolished, compared to tissues positive for PML.",22022583_3,-1,-1,-1,-1,16137,-1,1.03659095e-05,0.9999654,2.425748e-05
16139,T-cell,3,4,14,20,The extent of T-cell migration toward culture supernatants obtained from interferon-gamma (IFN--stimulated gastric carcinoma cell lines was additionally affected by expression of PML in vitro.,22022583_4,-1,1,2,-1,16139,-1,1.385111e-05,8.928393e-06,0.99997723
16144,Interferon-gamma-inducible protein,0,2,0,34,Interferon-gamma-inducible protein 10 (IP-10/CXCL10) expression was increased in gastric carcinoma tissues displaying reduced PML levels.,22022583_5,-1,-1,-1,-1,16144,-1,0.9983096,0.001428052,0.00026224507
16145,tissues,12,13,99,106,Interferon-gamma-inducible protein 10 (IP-10/CXCL10) expression was increased in gastric carcinoma tissues displaying reduced PML levels.,22022583_5,-1,1,2,-1,16145,-1,0.0002273292,0.88957125,0.110201456
16147,protein,13,14,82,89,"Moreover, both Pml knockout and knockdown cells displayed enhanced IP-10 mRNA and protein expression in the presence of IFN-.",22022583_6,0,1,-1,-1,16147,-1,6.4063215e-06,0.9999876,5.9947943e-06
16155,to the,14,16,107,113,"PML knockdown increased IFN--mediated Signal Transducer and Activator of Transcription-1 (STAT-1) binding to the IP-10 promoter, resulting in elevated transcription of the IP-10 gene.",22022583_7,-1,-1,-1,-1,16155,-1,4.0986265e-06,0.9999913,4.586183e-06
16159,protein,4,5,19,26,"Conversely, PML IV protein expression suppressed IP-10 promoter activation.",22022583_8,0,1,-1,-1,16159,-1,2.273277e-05,0.9999634,1.3888113e-05
16162,protein,11,12,52,59,"Based on these results, we propose that loss of PML protein expression in gastric cancer cells contributes to increased IP-10 transcription via enhancement of STAT-1 activity, which, in turn, promotes lymphocyte trafficking within tumor regions.",22022583_9,0,1,-1,-1,16162,-1,1.783089e-05,0.9999577,2.4545525e-05
16168,lymphocyte trafficking,34,36,201,223,"Based on these results, we propose that loss of PML protein expression in gastric cancer cells contributes to increased IP-10 transcription via enhancement of STAT-1 activity, which, in turn, promotes lymphocyte trafficking within tumor regions.",22022583_9,-1,-1,-1,-1,16168,-1,4.989212e-05,3.420788e-05,0.99991584
16176,cellular immune responses,27,30,136,161,"Regulatory T cells (T(reg)) are CD4(+) T lymphocytes with constitutive expression of CD25 and FOXP3, as well as the ability to modulate cellular immune responses.",22041284_0,-1,-1,-1,-1,16176,-1,0.7675524,0.0008757963,0.23157182
16179,function,8,9,47,55,"In this study, the phenotypic characteristics, function and feasibility of enrichment and expansion of canine T(reg) were examined.",22041284_1,0,1,2,-1,16179,-1,0.0002396125,0.999577,0.00018345467
16181,blood,2,3,18,23,"Canine peripheral blood mononuclear cells were isolated and enriched by labelling of CD25, and expansion of T(reg) was achieved by adding interleukin (IL)-2 for 1 week.",22041284_2,0,1,-1,-1,16181,-1,0.0011108394,0.9958968,0.0029923068
16185,functional,2,3,15,25,Phenotypic and functional analyses of T(reg) were performed prior to and after expansion.,22041284_3,0,1,2,-1,16185,-1,0.00035133772,0.9995741,7.449536e-05
16194,factors,13,14,76,83,Expansion of canine T(reg) was possible by adding IL-2 without other growth factors.,22041284_6,0,1,-1,-1,16194,-1,0.9999485,9.52882e-06,4.2008774e-05
16207,to T(reg,17,19,101,109,"Enrichment and expansion of canine T(reg) is feasible, and canine T(reg) had similar characteristics to T(reg) from other species.",22041284_10,-1,-1,-1,-1,16207,-1,7.517325e-06,0.9999825,1.0050337e-05
16217,therapeutic targets,34,36,251,270,"Many transformed lymphoma cells show immune-phenotypes resembling the corresponding normal lymphocytes; thus, they provide a guide for proper diagnosis and present promising routes to improve their pathophysiologic understanding and to identify novel therapeutic targets.",22042699_0,-1,-1,-1,-1,16217,-1,4.7064796e-06,0.9999912,4.1635626e-06
16242,to the,36,38,246,252,"Interestingly, miR-135b suppressed T-helper (Th) 2 master regulators STAT6 and GATA3, and miR-135b blockade attenuated IL-17 production and paracrine inflammatory response by ALCL cells, indicating that miR-135b-mediated Th2 suppression may lead to the skewing to ALCL immunophenotype overlapping with Th17 cells.",22042699_6,-1,-1,-1,-1,16242,-1,4.629459e-06,0.9999914,3.954838e-06
16244,Th17 cells,44,46,302,312,"Interestingly, miR-135b suppressed T-helper (Th) 2 master regulators STAT6 and GATA3, and miR-135b blockade attenuated IL-17 production and paracrine inflammatory response by ALCL cells, indicating that miR-135b-mediated Th2 suppression may lead to the skewing to ALCL immunophenotype overlapping with Th17 cells.",22042699_6,-1,-1,-1,-1,16244,-1,0.00019559404,0.0019798374,0.99782467
16248,therapeutic target,24,26,157,175,"Furthermore, antisense-based miR-135b inhibition reduced tumor angiogenesis and growth in vivo, demonstrating significance of this ""Th17 mimic"" pathway as a therapeutic target.",22042699_7,-1,-1,-1,-1,16248,-1,5.235913e-06,0.99999046,4.2878996e-06
16250,to tumorigenesis through,10,13,95,119,These results collectively illuminated unique contribution of oncogenic kinase-linked microRNA to tumorigenesis through modulation of tumor immune-phenotype and microenvironment.,22042699_8,-1,-1,-1,-1,16250,-1,5.647882e-06,0.99998903,5.3327517e-06
16253,tissues,15,16,86,93,"Dickkopf-1 (DKK1), broadly expressed in myeloma cells but highly restricted in normal tissues, together with its functional roles as an osteoblast formation inhibitor, may be an ideal target for immunotherapy in myeloma.",22049519_0,-1,1,2,-1,16253,-1,0.000625724,0.76973736,0.22963686
16255,functional,20,21,113,123,"Dickkopf-1 (DKK1), broadly expressed in myeloma cells but highly restricted in normal tissues, together with its functional roles as an osteoblast formation inhibitor, may be an ideal target for immunotherapy in myeloma.",22049519_0,0,1,2,-1,16255,-1,2.720167e-05,0.9999585,1.4265076e-05
16265,immunity that,20,22,106,119,The goal of this study was to examine whether DKK1 can be used as a tumor vaccine to elicit DKK1-specific immunity that can control myeloma growth or even eradicate established myeloma in vivo.,22049519_2,-1,-1,-1,-1,16265,-1,0.7543554,0.24335888,0.0022857669
16274,the therapeutic,20,22,117,132,"Furthermore, the addition of CpG as an adjuvant, or injection of B7H1-blocking or OX40-agonist Abs, further enhanced the therapeutic effects of the vaccine.",22049519_4,-1,-1,-1,-1,16274,-1,5.8386186e-06,0.99999,4.1414405e-06
16288,function,10,11,56,64,BACKGROUND: CD8+ effector cells often have an antitumor function in patients with cancer.,22051182_0,0,1,2,-1,16288,-1,0.0008317962,0.99817264,0.0009955558
16290,Tcregs,8,9,40,46,"However, CD8+Foxp3+ regulatory T cells (Tcregs) and interleukin (IL)-17-producing CD8+ T cells (Tc17 cells) also derive from the CD8+ T cell lineage.",22051182_1,-1,1,2,-1,16290,-1,7.5835637e-06,0.9999777,1.4749725e-05
16293,Tc17 cells,18,20,96,106,"However, CD8+Foxp3+ regulatory T cells (Tcregs) and interleukin (IL)-17-producing CD8+ T cells (Tc17 cells) also derive from the CD8+ T cell lineage.",22051182_1,-1,-1,-1,-1,16293,-1,0.00042362127,0.021532912,0.97804356
16294,the CD8+ T cell,24,29,125,140,"However, CD8+Foxp3+ regulatory T cells (Tcregs) and interleukin (IL)-17-producing CD8+ T cells (Tc17 cells) also derive from the CD8+ T cell lineage.",22051182_1,-1,-1,-1,-1,16294,-1,0.0020490286,0.07792708,0.92002386
16301,Tcregs,19,20,105,111,"In the present study, we aimed to investigate the distribution, characterization, and generation of CD8+ Tcregs and Tc17 cells in NPC patients.",22051182_3,-1,1,2,-1,16301,-1,1.640217e-05,0.9999275,5.6064637e-05
16302,Tc17 cells,21,23,116,126,"In the present study, we aimed to investigate the distribution, characterization, and generation of CD8+ Tcregs and Tc17 cells in NPC patients.",22051182_3,-1,-1,-1,-1,16302,-1,3.7832673e-05,9.2435796e-05,0.9998697
16303,blood,3,4,20,25,"METHODS: Peripheral blood and tumor biopsy tissues from 21 newly diagnosed patients with nasopharyngeal carcinoma (NPC) were collected, along with peripheral blood from 21 healthy donors.",22051182_4,0,1,-1,-1,16303,-1,0.0066195303,0.29893416,0.6944463
16305,tissues,7,8,43,50,"METHODS: Peripheral blood and tumor biopsy tissues from 21 newly diagnosed patients with nasopharyngeal carcinoma (NPC) were collected, along with peripheral blood from 21 healthy donors.",22051182_4,-1,1,2,-1,16305,-1,0.00030190803,0.9723964,0.027301637
16307,blood,25,26,158,163,"METHODS: Peripheral blood and tumor biopsy tissues from 21 newly diagnosed patients with nasopharyngeal carcinoma (NPC) were collected, along with peripheral blood from 21 healthy donors.",22051182_4,0,1,-1,-1,16307,-1,0.0026881276,0.8360587,0.16125318
16309,Tcregs,4,5,34,40,"The biological characteristics of Tcregs and Tc17 cells from blood and tumor tissues were examined by intracellular staining, tetramer staining and fluorescence-activated cell sorting (FACS) analysis.",22051182_5,-1,1,2,-1,16309,-1,8.712282e-06,0.9999734,1.7848113e-05
16310,Tc17 cells,6,8,45,55,"The biological characteristics of Tcregs and Tc17 cells from blood and tumor tissues were examined by intracellular staining, tetramer staining and fluorescence-activated cell sorting (FACS) analysis.",22051182_5,-1,-1,-1,-1,16310,-1,3.101719e-05,6.440213e-05,0.99990463
16311,blood,9,10,61,66,"The biological characteristics of Tcregs and Tc17 cells from blood and tumor tissues were examined by intracellular staining, tetramer staining and fluorescence-activated cell sorting (FACS) analysis.",22051182_5,0,1,-1,-1,16311,-1,0.00016137684,0.999132,0.0007067175
16312,tumor tissues,11,13,71,84,"The biological characteristics of Tcregs and Tc17 cells from blood and tumor tissues were examined by intracellular staining, tetramer staining and fluorescence-activated cell sorting (FACS) analysis.",22051182_5,-1,-1,-1,-1,16312,-1,7.841028e-06,0.9999714,2.07278e-05
16315,analysis,28,29,191,199,"The biological characteristics of Tcregs and Tc17 cells from blood and tumor tissues were examined by intracellular staining, tetramer staining and fluorescence-activated cell sorting (FACS) analysis.",22051182_5,0,1,-1,-1,16315,-1,7.452233e-06,0.99998236,1.0148045e-05
16317,function,2,3,16,24,The suppressive function of Tcregs was investigated using a proliferation assay that involved co-culture of sorted CD8+CD25+ T cells with nave CD4+ T cells in vitro.,22051182_6,0,1,2,-1,16317,-1,1.318092e-05,0.9999751,1.17347745e-05
16318,Tcregs,4,5,28,34,The suppressive function of Tcregs was investigated using a proliferation assay that involved co-culture of sorted CD8+CD25+ T cells with nave CD4+ T cells in vitro.,22051182_6,-1,1,2,-1,16318,-1,8.526203e-06,0.9999788,1.2648819e-05
16322,Tcregs,8,9,48,54,RESULTS: We observed an increased prevalence of Tcregs and Tc17 cells among tumor-infiltrating lymphocytes (TILs) and different distribution among peripheral blood mononuclear cells (PBMCs) in NPC patients.,22051182_7,-1,1,2,-1,16322,-1,6.1233964e-06,0.99998415,9.672708e-06
16323,Tc17 cells,10,12,59,69,RESULTS: We observed an increased prevalence of Tcregs and Tc17 cells among tumor-infiltrating lymphocytes (TILs) and different distribution among peripheral blood mononuclear cells (PBMCs) in NPC patients.,22051182_7,-1,-1,-1,-1,16323,-1,8.0709186e-05,0.000558511,0.99936086
16324,tumor-infiltrating lymphocytes,13,15,76,106,RESULTS: We observed an increased prevalence of Tcregs and Tc17 cells among tumor-infiltrating lymphocytes (TILs) and different distribution among peripheral blood mononuclear cells (PBMCs) in NPC patients.,22051182_7,-1,-1,-1,-1,16324,-1,0.0037784898,0.73179716,0.26442432
16326,blood,23,24,158,163,RESULTS: We observed an increased prevalence of Tcregs and Tc17 cells among tumor-infiltrating lymphocytes (TILs) and different distribution among peripheral blood mononuclear cells (PBMCs) in NPC patients.,22051182_7,0,1,-1,-1,16326,-1,0.0014650472,0.9903094,0.008225494
16329,that the Tcregs,3,6,25,40,"Cytokine profiles showed that the Tcregs expressed a high level of IL-10 and low level of transforming growth factor , whereas Tc17 cells expressed a high level of tumor necrosis factor .",22051182_8,-1,-1,-1,-1,16329,-1,6.3679163e-06,0.9999856,8.07298e-06
16331,transforming growth factor,16,19,90,116,"Cytokine profiles showed that the Tcregs expressed a high level of IL-10 and low level of transforming growth factor , whereas Tc17 cells expressed a high level of tumor necrosis factor .",22051182_8,-1,-1,-1,-1,16331,-1,0.9820172,0.014048514,0.003934185
16332,Tc17 cells,22,24,128,138,"Cytokine profiles showed that the Tcregs expressed a high level of IL-10 and low level of transforming growth factor , whereas Tc17 cells expressed a high level of tumor necrosis factor .",22051182_8,-1,-1,-1,-1,16332,-1,9.310264e-05,0.0010212213,0.9988857
16337,the Tcregs,15,17,80,90,"Interestingly, both subsets expressed a high level of interferon  in TILs, and the Tcregs suppressed nave CD4+ T cell proliferation by a cell contact-dependent mechanism in vitro.",22051182_9,-1,-1,-1,-1,16337,-1,6.6500565e-06,0.9999846,8.694559e-06
16341,protein,11,12,78,85,"Moreover, we demonstrated the existence of Epstein-Barr virus latent membrane protein (LMP) 1 and LMP2 antigen-specific Tcregs in NPC.CONCLUSIONS: Our data provide new insights into the composition and function of CD8+ T-cell subsets in NPC, which may have an important influence on NPC immunotherapy.",22051182_10,0,1,-1,-1,16341,-1,2.9661709e-05,0.99993885,3.1500254e-05
16342,antigen-specific Tcregs,18,20,103,126,"Moreover, we demonstrated the existence of Epstein-Barr virus latent membrane protein (LMP) 1 and LMP2 antigen-specific Tcregs in NPC.CONCLUSIONS: Our data provide new insights into the composition and function of CD8+ T-cell subsets in NPC, which may have an important influence on NPC immunotherapy.",22051182_10,-1,-1,-1,-1,16342,-1,0.9732072,0.024433753,0.0023590277
16344,function,32,33,202,210,"Moreover, we demonstrated the existence of Epstein-Barr virus latent membrane protein (LMP) 1 and LMP2 antigen-specific Tcregs in NPC.CONCLUSIONS: Our data provide new insights into the composition and function of CD8+ T-cell subsets in NPC, which may have an important influence on NPC immunotherapy.",22051182_10,0,1,2,-1,16344,-1,0.00024924084,0.9988863,0.0008644974
16346,tumor-induced T(reg,6,8,36,55,A number of studies have implicated tumor-induced T(reg) cell activity in the sub-optimal response to therapeutic vaccines.,22057676_0,-1,-1,-1,-1,16346,-1,5.86485e-06,0.99998856,5.580063e-06
16349,to therapeutic,15,17,99,113,A number of studies have implicated tumor-induced T(reg) cell activity in the sub-optimal response to therapeutic vaccines.,22057676_0,-1,-1,-1,-1,16349,-1,1.1376201e-05,0.9999832,5.4231296e-06
16350,targeting T(reg,4,6,39,54,Development of neo-adjuvant strategies targeting T(reg) cells is therefore imperative.,22057676_1,-1,-1,-1,-1,16350,-1,7.850014e-06,0.999985,7.2250928e-06
16357,TGF-1-induced T(reg,22,24,118,138,"We report here, for the first time, that Scutellaria ocmulgee leaf extract (SocL) and flavonoid wogonin could inhibit TGF-1-induced T(reg) activity in malignant gliomas.",22057676_3,-1,-1,-1,-1,16357,-1,6.8938293e-06,0.99998665,6.428691e-06
16364,blood TGF-1,30,32,188,200,"F344 rats, subcutaneously transplanted with F98 gliomas, were treated with SocL. There was a significant inhibition of intra-tumoral TGF-1 and T(reg) cell frequency as well as peripheral blood TGF-1 levels in SocL-treated animals compared to the controls.",22057676_4,-1,-1,-1,-1,16364,-1,4.3029817e-05,0.99986947,8.748239e-05
16365,to the,37,39,241,247,"F344 rats, subcutaneously transplanted with F98 gliomas, were treated with SocL. There was a significant inhibition of intra-tumoral TGF-1 and T(reg) cell frequency as well as peripheral blood TGF-1 levels in SocL-treated animals compared to the controls.",22057676_4,-1,-1,-1,-1,16365,-1,4.9229434e-06,0.99998987,5.249319e-06
16366,TGF-1-mediated T(reg,8,10,56,77,"SocL extract and wogonin also inhibited glioma-induced, TGF-1-mediated T(reg) activity in vitro.",22057676_5,-1,-1,-1,-1,16366,-1,9.588594e-06,0.9999801,1.0312698e-05
16375,the T cells,37,40,214,225,"We also observed an inhibition of Smad-3, GSK-3 and ERK1/2 signaling by SocL and wogonin in T(reg) cells, while phosphorylation of P38 MAPK was considerably enhanced, indicating that SocL or wogonin could inhibit the T cells' response to TGF-1 via modulation of both Smad and non-Smad signaling pathways.",22057676_7,-1,-1,-1,-1,16375,-1,0.0015237735,0.16976634,0.82870996
16376,to TGF-1,42,44,236,245,"We also observed an inhibition of Smad-3, GSK-3 and ERK1/2 signaling by SocL and wogonin in T(reg) cells, while phosphorylation of P38 MAPK was considerably enhanced, indicating that SocL or wogonin could inhibit the T cells' response to TGF-1 via modulation of both Smad and non-Smad signaling pathways.",22057676_7,-1,-1,-1,-1,16376,-1,1.3887015e-05,0.9999653,2.080372e-05
16383,to TGF-1,28,30,186,195,"Overall, this study suggests that Scutellaria can potentially reverse tumor-mediated immune suppression via inhibition of TGF-1 secretion as well as via inhibition of T cells' response to TGF-1.",22057676_8,-1,-1,-1,-1,16383,-1,1.1355434e-05,0.9999739,1.4764982e-05
16401,plus granulocyte-macrophage colony stimulating factor,26,31,129,182,"In 1 study (Mel38), patients received 1 injection with an adjuvant mixture alone, composed of incomplete Freund's adjuvant (IFA) plus granulocyte-macrophage colony stimulating factor (GM-CSF).",22130163_5,-1,-1,-1,-1,16401,-1,0.9989792,0.00034024942,0.0006805286
16403,peptide antigens plus IFA,11,15,73,98,"In a second study, patients received multiple vaccinations with melanoma peptide antigens plus IFA.",22130163_6,-1,-1,-1,-1,16403,-1,0.9724262,0.0021281436,0.02544573
16404,"cells, T cells",12,16,94,108,"Single injections with adjuvant alone induced dermal inflammatory infiltrates consisting of B cells, T cells, mature DCs, and vessels resembling high endothelial venules (HEVs).",22130163_7,-1,-1,-1,-1,16404,-1,2.3216307e-05,1.824103e-05,0.9999585
16405,These cellular,0,2,0,14,These cellular aggregates usually lacked organization and were transient.,22130163_8,-1,-1,-1,-1,16405,-1,0.0064812237,0.56292886,0.4305899
16407,peptides,7,8,49,57,"In contrast, multiple repeated vaccinations with peptides in adjuvant induced more organized and persistent lymphoid aggregates containing separate B and T cell areas, mature DCs, HEV-like vessels, and lymphoid chemokines.",22130163_9,0,-1,2,-1,16407,-1,0.0010303889,0.99858487,0.00038473934
16413,FoxP3CD4 lymphocytes,15,17,86,106,"Within these structures, there are proliferating CD4and CD8 T lymphocytes, as well as FoxP3CD4 lymphocytes, suggesting a complex interplay of lymphoid expansion and regulation within the dermal immunization microenvironment.",22130163_10,-1,-1,-1,-1,16413,-1,0.00286831,0.5984004,0.39873123
16417,the physiology,3,5,17,31,Further study of the physiology of the vaccine site microenvironment promises to identify opportunities for enhancing cancer vaccine efficacy by modulating immune activation and regulation at the site of vaccination.,22130163_11,-1,-1,-1,-1,16417,-1,7.1011855e-06,0.99998724,5.60939e-06
16423,The cytokine interleukin-17A,0,3,0,28,"The cytokine interleukin-17A supports tumour vascularization and growth, however, its role in lung cancer is unknown.",22186896_1,-1,-1,-1,-1,16423,-1,0.94226116,0.055260606,0.0024782328
16426,interleukin-17A that,16,18,80,100,"Here we show, in the lungs of patients with lung adenocarcinoma, an increase in interleukin-17A that is inversely correlated with the expression of T-bet and correlated with the T regulatory cell transcription factor Foxp3.",22186896_2,-1,-1,-1,-1,16426,-1,0.99856013,0.000979638,0.00046025563
16429,the T,29,31,174,179,"Here we show, in the lungs of patients with lung adenocarcinoma, an increase in interleukin-17A that is inversely correlated with the expression of T-bet and correlated with the T regulatory cell transcription factor Foxp3.",22186896_2,-1,-1,-1,-1,16429,-1,4.934372e-06,0.99999034,4.7653116e-06
16430,cell transcription factor Foxp3,32,36,191,222,"Here we show, in the lungs of patients with lung adenocarcinoma, an increase in interleukin-17A that is inversely correlated with the expression of T-bet and correlated with the T regulatory cell transcription factor Foxp3.",22186896_2,-1,-1,-1,-1,16430,-1,0.0012913577,0.9415574,0.057151206
16442,the tumour,16,18,146,156,This is associated with the local upregulation of interleukin-23 and induction of interleukin-17A/interleukin-17R-expressing T cells infiltrating the tumour.,22186896_5,-1,-1,-1,-1,16442,-1,5.7652687e-06,0.99998844,5.8318597e-06
16447,therapy,7,8,63,70,These results suggest that local anti-interleukin-17A antibody therapy could be considered for the treatment of lung tumours.,22186896_7,0,1,-1,-1,16447,-1,7.12933e-06,0.9999869,5.9667277e-06
16448,the treatment,12,14,95,108,These results suggest that local anti-interleukin-17A antibody therapy could be considered for the treatment of lung tumours.,22186896_7,-1,-1,-1,-1,16448,-1,6.880226e-06,0.99998844,4.7288545e-06
16453,the transcription factor Tbet,21,25,111,140,We have recently shown that intratumor (i.t.) injection of syngenic dendritic cells (DC) engineered to express the transcription factor Tbet (TBX21) promotes protective type-1 T cell-mediated immunity via a mechanism that is largely interleukin (IL)-12p70-independent.,22215017_0,-1,-1,-1,-1,16453,-1,4.0915606e-06,0.99999106,4.9072655e-06
16454,TBX21,26,27,142,147,We have recently shown that intratumor (i.t.) injection of syngenic dendritic cells (DC) engineered to express the transcription factor Tbet (TBX21) promotes protective type-1 T cell-mediated immunity via a mechanism that is largely interleukin (IL)-12p70-independent.,22215017_0,-1,1,2,-1,16454,-1,1.6989197e-05,0.99996877,1.4256178e-05
16455,type-1 T cell-mediated immunity,30,34,169,200,We have recently shown that intratumor (i.t.) injection of syngenic dendritic cells (DC) engineered to express the transcription factor Tbet (TBX21) promotes protective type-1 T cell-mediated immunity via a mechanism that is largely interleukin (IL)-12p70-independent.,22215017_0,-1,-1,-1,-1,16455,-1,0.011515993,0.56182736,0.4266567
16459,type-1 immunity,7,9,39,54,"Since IL-12 is a classical promoter of type-1 immunity, the current study was undertaken to determine whether gene therapy using combined Tbet and IL-12 complementary DNA (cDNA) would yield improved antitumor efficacy based on the complementary/synergistic action of these biologic modifiers.",22215017_1,-1,-1,-1,-1,16459,-1,0.0060877255,0.99276006,0.0011521654
16462,gene therapy,18,20,110,122,"Since IL-12 is a classical promoter of type-1 immunity, the current study was undertaken to determine whether gene therapy using combined Tbet and IL-12 complementary DNA (cDNA) would yield improved antitumor efficacy based on the complementary/synergistic action of these biologic modifiers.",22215017_1,-1,-1,-1,-1,16462,-1,9.15303e-06,0.99998426,6.6357934e-06
16474,the tumor,48,50,285,294,"Mice bearing established subcutaneous (s.c.) tumors injected with DC concomitantly expressing ectopic Tbet and IL12 (i.e., DC.Tbet/IL12) displayed superior (i) rates of tumor rejection and extended overall survival, (ii) cross-priming of Tc1 reactive against antigens expressed within the tumor microenvironment, and (iii) infiltration of CD8(+) T cells into treated tumors in association with elevated locoregional production of CXCR3 ligand chemokines.",22215017_2,-1,-1,-1,-1,16474,-1,5.0683975e-06,0.9999895,5.4005163e-06
16476,treated tumors,63,65,359,373,"Mice bearing established subcutaneous (s.c.) tumors injected with DC concomitantly expressing ectopic Tbet and IL12 (i.e., DC.Tbet/IL12) displayed superior (i) rates of tumor rejection and extended overall survival, (ii) cross-priming of Tc1 reactive against antigens expressed within the tumor microenvironment, and (iii) infiltration of CD8(+) T cells into treated tumors in association with elevated locoregional production of CXCR3 ligand chemokines.",22215017_2,-1,-1,-1,-1,16476,-1,3.7194397e-06,0.9999918,4.518154e-06
16481,tumor antigen-derived peptides,5,8,38,68,"Furthermore, DC.Tbet/IL12 pulsed with tumor antigen-derived peptides and injected as a therapy distal to the tumor site prevented tumor growth and activated robust antigen-specific Tc1 responses.",22215017_5,-1,-1,-1,-1,16481,-1,0.07331647,0.92367685,0.0030067032
16482,therapy,12,13,87,94,"Furthermore, DC.Tbet/IL12 pulsed with tumor antigen-derived peptides and injected as a therapy distal to the tumor site prevented tumor growth and activated robust antigen-specific Tc1 responses.",22215017_5,0,1,-1,-1,16482,-1,5.096796e-06,0.9999893,5.627361e-06
16483,to the tumor,14,17,102,114,"Furthermore, DC.Tbet/IL12 pulsed with tumor antigen-derived peptides and injected as a therapy distal to the tumor site prevented tumor growth and activated robust antigen-specific Tc1 responses.",22215017_5,-1,-1,-1,-1,16483,-1,5.338292e-06,0.9999877,6.950609e-06
16485,antigen-specific Tc1,24,26,164,184,"Furthermore, DC.Tbet/IL12 pulsed with tumor antigen-derived peptides and injected as a therapy distal to the tumor site prevented tumor growth and activated robust antigen-specific Tc1 responses.",22215017_5,-1,-1,-1,-1,16485,-1,0.9827639,0.008068102,0.009168092
16487,the translation,3,5,19,34,These data support the translation use of combined Tbet and IL-12p70 gene therapy in the cancer setting.,22215017_6,-1,-1,-1,-1,16487,-1,6.9322296e-06,0.99998915,3.933506e-06
16489,IL-12p70 gene therapy,10,13,60,81,These data support the translation use of combined Tbet and IL-12p70 gene therapy in the cancer setting.,22215017_6,-1,-1,-1,-1,16489,-1,0.99737585,0.0018569152,0.0007672716
16492,plasma cells,17,19,119,131,"BACKGROUND: Multiple myeloma (MM) is an immunoproliferative disease characterised by the uncontrolled proliferation of plasma cells, which is accompanied by defects in the immune system.",22223085_0,-1,-1,-1,-1,16492,-1,2.0149999e-05,9.459996e-06,0.99997044
16507,therapy,5,6,31,38,"Subsequently, the influence of therapy on those components of immune system was assessed.",22223085_2,0,1,-1,-1,16507,-1,6.9848234e-06,0.9999876,5.3537697e-06
16516,therapy,41,42,263,270,"We found that patients with higher percentages of Treg live shorter (median overall survival 21 months vs not-reached, P=0.013).CONCLUSION: This study identifies several abnormalities of immune system in MM, which only partly could be normalised after successful therapy.",22223085_5,0,1,-1,-1,16516,-1,5.99788e-06,0.99998915,4.793584e-06
16528,T-cell growth factor,11,14,49,69,"Initially, interleukin 2 (IL-2) has been used as T-cell growth factor in clinical vaccination trials.",22276195_1,-1,-1,-1,-1,16528,-1,0.6598898,0.0007970117,0.3393131
16530,function,18,19,92,100,"In murine models, however, a role of IL-2 in development, differentiation, homeostasis, and function of T(reg) cells was established.",22276195_2,0,1,2,-1,16530,-1,4.783079e-05,0.9998938,5.84026e-05
16534,T(reg)-cell,7,8,42,53,"In IL-2 treated cancer patients a further T(reg)-cell expansion was described, yet, the mechanism of expansion is still elusive.",22276195_3,-1,1,2,-1,16534,-1,0.0010889957,0.88610965,0.112801306
16536,that functional T(reg,3,6,15,36,Here we report that functional T(reg) cells of a nave phenotype--as determined by CCR7 and CD45RA expression--are significantly expanded in colorectal cancer patients.,22276195_4,-1,-1,-1,-1,16536,-1,7.2275284e-06,0.99998534,7.4007726e-06
16539,peptide,15,16,83,90,Treatment of 15 UICC stage IV colorectal cancer patients with IL-2 in a phase I/II peptide vaccination trial further enlarges the already increased nave T(reg)-cell pool.,22276195_5,0,-1,2,-1,16539,-1,0.9470487,0.050918944,0.0020324271
16542,T(reg)-cell,24,25,154,165,Treatment of 15 UICC stage IV colorectal cancer patients with IL-2 in a phase I/II peptide vaccination trial further enlarges the already increased nave T(reg)-cell pool.,22276195_5,-1,1,2,-1,16542,-1,0.0013289631,0.6354765,0.3631945
16546,thymic generation,15,17,101,118,Higher frequencies of T-cell receptor excision circles in nave T(reg) cells indicate IL-2 dependent thymic generation of nave T(reg) cells as a mechanism leading to increased frequencies of T(reg) cells post IL-2 treatment in cancer patients.,22276195_6,-1,-1,-1,-1,16546,-1,6.645637e-06,0.9999883,5.086996e-06
16547,nave T(reg,18,20,122,133,Higher frequencies of T-cell receptor excision circles in nave T(reg) cells indicate IL-2 dependent thymic generation of nave T(reg) cells as a mechanism leading to increased frequencies of T(reg) cells post IL-2 treatment in cancer patients.,22276195_6,-1,-1,-1,-1,16547,-1,5.581435e-06,0.9999875,6.959044e-06
16558,complex regulation,6,8,30,48,These results point to a more complex regulation of T(reg) cells in context of IL-2 administration.,22276195_8,-1,-1,-1,-1,16558,-1,1.1389716e-05,0.9999784,1.0238458e-05
16562,therapy,8,9,56,63,Future strategies therefore might aim at combining IL-2 therapy with novel strategies to circumvent expansion and differentiation of nave T(reg) cells.,22276195_9,0,1,-1,-1,16562,-1,8.311679e-06,0.99998605,5.6809686e-06
16566,factors,3,4,30,37,BACKGROUND: Immunosuppressive factors such as regulatory T cells (Tregs) limit the efficacy of immunotherapies.,22303460_0,0,1,-1,-1,16566,-1,7.874633e-05,0.9999093,1.1909866e-05
16571,the Tregs-targeting,4,6,18,37,"Herein, we report the Tregs-targeting and immune-promoting effect of a class I specific HDAC inhibitor, entinostat, in combination with either IL-2 in a murine renal cell carcinoma (RENCA) model or a survivin-based vaccine therapy (SurVaxM) in a castration resistant prostate cancer (CR Myc-CaP) model.",22303460_2,-1,-1,-1,-1,16571,-1,4.341105e-06,0.99999046,5.1580228e-06
16573,therapy,38,39,223,230,"Herein, we report the Tregs-targeting and immune-promoting effect of a class I specific HDAC inhibitor, entinostat, in combination with either IL-2 in a murine renal cell carcinoma (RENCA) model or a survivin-based vaccine therapy (SurVaxM) in a castration resistant prostate cancer (CR Myc-CaP) model.",22303460_2,0,1,-1,-1,16573,-1,4.974991e-06,0.99998975,5.2382065e-06
16575,Myc-CaP tumors,7,9,33,47,"METHODS AND RESULTS: RENCA or CR Myc-CaP tumors were implanted orthotopically or subcutaneously, respectively.",22303460_3,-1,-1,-1,-1,16575,-1,1.5895212e-05,0.9999677,1.6427484e-05
16579,the blood,2,4,9,18,Tregs in the blood were assessed by FACS analysis.,22303460_5,-1,-1,-1,-1,16579,-1,4.9193684e-05,0.9998828,6.7922774e-05
16580,analysis,8,9,41,49,Tregs in the blood were assessed by FACS analysis.,22303460_5,0,1,-1,-1,16580,-1,1.0318301e-05,0.9999807,9.015941e-06
16582,analysis,7,8,44,52,Real time quantitative PCR and Western blot analysis of isolated T cell subpopulations from spleen were performed to determine Foxp3 gene and protein expression.,22303460_6,0,1,-1,-1,16582,-1,6.932787e-06,0.99998665,6.3963225e-06
16585,Foxp3 gene,19,21,127,137,Real time quantitative PCR and Western blot analysis of isolated T cell subpopulations from spleen were performed to determine Foxp3 gene and protein expression.,22303460_6,-1,-1,-1,-1,16585,-1,3.972629e-06,0.9999908,5.1642755e-06
16586,protein,22,23,142,149,Real time quantitative PCR and Western blot analysis of isolated T cell subpopulations from spleen were performed to determine Foxp3 gene and protein expression.,22303460_6,0,1,-1,-1,16586,-1,5.7299644e-06,0.9999887,5.6392523e-06
16588,function,2,3,16,24,The suppressive function of Tregs was tested by T cell proliferation assay.,22303460_7,0,1,2,-1,16588,-1,0.00020249578,0.9996928,0.0001047649
16599,function,9,10,91,99,Entinostat down-regulated Foxp3 expression transcriptionally and blocked Tregs suppressive function without affecting T effector cells (Teffs).,22303460_9,0,1,2,-1,16599,-1,1.2428884e-05,0.9999752,1.2368109e-05
16606,that STAT3,26,28,172,182,"In vitro low dose entinostat (0.5 M) induced STAT3 acetylation and a specific inhibitor of STAT3 partially rescued entinostat-induced down-regulation of Foxp3, suggesting that STAT3 signaling is involved in Foxp3 down-regulation by entinostat.",22303460_10,-1,-1,-1,-1,16606,-1,8.806217e-06,0.9999858,5.3505955e-06
16613,The cytokine,0,2,0,12,The cytokine and chemokine micromilieu of papillomas is T(H)2-like with a marked absence of IFN- expression.,22322668_1,-1,-1,-1,-1,16613,-1,0.50961083,0.48555568,0.004833462
16626,function,2,3,17,25,Their suppressor function was measured by inhibition of peripheral blood mononuclear cell (PBMC) proliferation.,22322668_4,0,1,2,-1,16626,-1,0.00085470744,0.9985013,0.00064395205
16627,blood,9,10,67,72,Their suppressor function was measured by inhibition of peripheral blood mononuclear cell (PBMC) proliferation.,22322668_4,0,1,-1,-1,16627,-1,0.0042616613,0.9718417,0.023896646
16629,these T cells,11,14,55,68,"Expression of PD-1, CD69, and Helios was identified on these T cells.",22322668_5,-1,-1,-1,-1,16629,-1,0.00021047126,0.00421788,0.9955716
16630,CCL17,4,5,14,19,"PD-L1, PD-L2, CCL17, and CCL22 mRNA was also identified in papillomas by quantitative PCR.RESULTS: Functional Tregs were markedly enriched in papillomas and strongly inhibited anti-CD3 and anti-CD28 antibody activated PBMC proliferation.",22322668_6,0,-1,2,-1,16630,-1,0.9991748,5.3892338e-05,0.0007714183
16632,Functional Tregs,18,20,99,115,"PD-L1, PD-L2, CCL17, and CCL22 mRNA was also identified in papillomas by quantitative PCR.RESULTS: Functional Tregs were markedly enriched in papillomas and strongly inhibited anti-CD3 and anti-CD28 antibody activated PBMC proliferation.",22322668_6,-1,-1,-1,-1,16632,-1,1.1685305e-05,0.99997926,9.028818e-06
16633,The natural Treg,0,3,0,16,"The natural Treg marker Helios was reduced on Tregs from papillomas, indicating that the majority of Tregs in papillomas are adaptive.",22322668_7,-1,-1,-1,-1,16633,-1,5.9254694e-06,0.99998903,5.0773115e-06
16635,that the,13,15,80,88,"The natural Treg marker Helios was reduced on Tregs from papillomas, indicating that the majority of Tregs in papillomas are adaptive.",22322668_7,-1,-1,-1,-1,16635,-1,5.25506e-06,0.99999,4.726761e-06
16642,that they,22,24,178,187,"The majority of the papilloma-derived CD4(+) T cells expressed the CD4(+)CD25(-)CD127(low/-)Foxp3(-)PD1(+)CD69(+) phenotype and failed to suppress PBMC proliferation, suggesting that they are chronically activated and exhausted.",22322668_8,-1,-1,-1,-1,16642,-1,5.4642665e-06,0.99998784,6.6450316e-06
16643,The Treg-attracting chemokine CCL22,0,4,0,35,The Treg-attracting chemokine CCL22 was equally expressed by all laryngeal tissues examined.,22322668_9,-1,-1,-1,-1,16643,-1,0.25857666,0.73890954,0.002513784
16644,tissues,10,11,75,82,The Treg-attracting chemokine CCL22 was equally expressed by all laryngeal tissues examined.,22322668_9,-1,1,2,-1,16644,-1,0.000375243,0.02494224,0.9746825
16645,CCL17,2,3,9,14,"However, CCL17 was robustly expressed by papillomas compared with unaffected laryngeal tissues from RRP patients and individuals without RRP.",22322668_10,0,-1,2,-1,16645,-1,0.99909997,4.9510232e-05,0.0008505499
16646,tissues,12,13,87,94,"However, CCL17 was robustly expressed by papillomas compared with unaffected laryngeal tissues from RRP patients and individuals without RRP.",22322668_10,-1,1,2,-1,16646,-1,0.00016436011,0.97611123,0.023724416
16647,tissues,9,10,65,72,PD-L1 was elevated in papillomas compared with control laryngeal tissues.,22322668_11,-1,1,2,-1,16647,-1,0.0003970698,0.35937953,0.6402234
16649,functional Tregs,10,12,56,72,"CONCLUSIONS: Papilloma CD4(+) T cells are enriched with functional Tregs, and the adaptive Helios(-) Treg fraction was increased within the T(H)2-like papilloma micromilieu.",22322668_12,-1,-1,-1,-1,16649,-1,4.1720206e-05,0.9999324,2.5842659e-05
16652,the T(H)2-like,23,25,136,150,"CONCLUSIONS: Papilloma CD4(+) T cells are enriched with functional Tregs, and the adaptive Helios(-) Treg fraction was increased within the T(H)2-like papilloma micromilieu.",22322668_12,-1,-1,-1,-1,16652,-1,4.308326e-05,0.99991584,4.1073265e-05
16653,T-cells,2,3,34,41,CD4(+)CD25(-)CD127(low/-)Foxp3(-) T-cells failed to suppress PBMC proliferation and may be exhausted.,22322668_13,-1,1,2,-1,16653,-1,1.5640539e-05,1.0255947e-05,0.99997413
16659,therapy,6,7,33,40,"A major concern in targeted drug therapy is that the inhibition of receptors and signaling molecules in tumor cells may also affect similar components in the tumor microenvironment or in the immune system, with undefined consequences for inhibition of tumor growth.",22323550_0,0,1,-1,-1,16659,-1,6.0148104e-06,0.9999888,5.211474e-06
16660,that the,8,10,44,52,"A major concern in targeted drug therapy is that the inhibition of receptors and signaling molecules in tumor cells may also affect similar components in the tumor microenvironment or in the immune system, with undefined consequences for inhibition of tumor growth.",22323550_0,-1,-1,-1,-1,16660,-1,5.197944e-06,0.9999908,4.0361742e-06
16661,receptors,12,13,67,76,"A major concern in targeted drug therapy is that the inhibition of receptors and signaling molecules in tumor cells may also affect similar components in the tumor microenvironment or in the immune system, with undefined consequences for inhibition of tumor growth.",22323550_0,0,1,2,-1,16661,-1,0.0010313496,0.0015602923,0.99740833
16662,tumor cells,17,19,104,115,"A major concern in targeted drug therapy is that the inhibition of receptors and signaling molecules in tumor cells may also affect similar components in the tumor microenvironment or in the immune system, with undefined consequences for inhibition of tumor growth.",22323550_0,-1,-1,-1,-1,16662,-1,0.000120312616,0.0007697478,0.9991099
16663,the tumor,25,27,154,163,"A major concern in targeted drug therapy is that the inhibition of receptors and signaling molecules in tumor cells may also affect similar components in the tumor microenvironment or in the immune system, with undefined consequences for inhibition of tumor growth.",22323550_0,-1,-1,-1,-1,16663,-1,4.662229e-06,0.9999907,4.605074e-06
16673,relative to tumor-bearing,15,18,121,146,"First, FTS exhibited antitumor activity in intracranial immune-competent tumor-bearing mice and increased their survival relative to tumor-bearing immune-compromised mice.",22323550_3,-1,-1,-1,-1,16673,-1,7.055327e-06,0.9999858,7.1507166e-06
16677,the tumor,24,26,123,132,"Second, FTS induced an increase in regulatory T cells in mouse splenocytes, in which Foxp3+ T cells did not interfere with the tumor growth inhibitory effects of FTS.",22323550_4,-1,-1,-1,-1,16677,-1,4.596358e-06,0.9999912,4.17456e-06
16679,T-cell,9,10,54,60,"Third, FTS induced an increase in antitumor cytotoxic T-cell reactivity in glioma cells by downregulating their own expression of Foxp3.",22323550_5,-1,1,2,-1,16679,-1,1.279113e-05,8.971747e-06,0.9999783
16686,the tumor,10,12,82,91,This downregulation induced a TGF--associated mechanism in glioma cells altering the tumor microenvironment and causing reduced resistance of the tumor to the immune system.,22323550_6,-1,-1,-1,-1,16686,-1,4.9228884e-06,0.9999901,4.9526393e-06
16687,the tumor to the,18,22,143,159,This downregulation induced a TGF--associated mechanism in glioma cells altering the tumor microenvironment and causing reduced resistance of the tumor to the immune system.,22323550_6,-1,-1,-1,-1,16687,-1,3.959884e-06,0.9999914,4.5656907e-06
16694,protein,7,8,44,51,"Galectin-1 (Gal-1), a -galactoside-binding protein, can alter fate and effector function of Th cells; however, little is known about how Gal-1 induces Th cell differentiation.",22345665_0,0,1,-1,-1,16694,-1,1.1011918e-05,0.9999801,8.9073965e-06
16695,function,14,15,81,89,"Galectin-1 (Gal-1), a -galactoside-binding protein, can alter fate and effector function of Th cells; however, little is known about how Gal-1 induces Th cell differentiation.",22345665_0,0,1,2,-1,16695,-1,5.626029e-05,0.999877,6.676241e-05
16696,Th cells,16,18,93,101,"Galectin-1 (Gal-1), a -galactoside-binding protein, can alter fate and effector function of Th cells; however, little is known about how Gal-1 induces Th cell differentiation.",22345665_0,-1,-1,-1,-1,16696,-1,7.6191554e-06,6.289878e-06,0.99998605
16697,Th cell,28,30,152,159,"Galectin-1 (Gal-1), a -galactoside-binding protein, can alter fate and effector function of Th cells; however, little is known about how Gal-1 induces Th cell differentiation.",22345665_0,-1,-1,-1,-1,16697,-1,7.738121e-06,6.1564674e-06,0.99998605
16700,Th cells,11,13,61,69,"In this article, we show that both uncommitted and polarized Th cells bound by Gal-1 expressed an immunoregulatory signature defined by IL-10.",22345665_1,-1,-1,-1,-1,16700,-1,8.148189e-06,7.668018e-06,0.99998426
16703,to cell,8,10,58,65,"IL-10 synthesis was stimulated by direct Gal-1 engagement to cell surface glycoproteins, principally CD45, on activated Th cells and enhanced by IL-21 expression through the c-Maf/aryl hydrocarbon receptor pathway, independent of APCs.",22345665_2,-1,-1,-1,-1,16703,-1,0.0043271678,0.42384046,0.57183236
16704,Th cells,18,20,120,128,"IL-10 synthesis was stimulated by direct Gal-1 engagement to cell surface glycoproteins, principally CD45, on activated Th cells and enhanced by IL-21 expression through the c-Maf/aryl hydrocarbon receptor pathway, independent of APCs.",22345665_2,-1,-1,-1,-1,16704,-1,9.673472e-06,8.379224e-06,0.999982
16705,through the,25,27,162,173,"IL-10 synthesis was stimulated by direct Gal-1 engagement to cell surface glycoproteins, principally CD45, on activated Th cells and enhanced by IL-21 expression through the c-Maf/aryl hydrocarbon receptor pathway, independent of APCs.",22345665_2,-1,-1,-1,-1,16705,-1,5.9869712e-06,0.9999893,4.7145572e-06
16706,receptor,29,30,197,205,"IL-10 synthesis was stimulated by direct Gal-1 engagement to cell surface glycoproteins, principally CD45, on activated Th cells and enhanced by IL-21 expression through the c-Maf/aryl hydrocarbon receptor pathway, independent of APCs.",22345665_2,0,1,2,-1,16706,-1,0.23596759,0.30896544,0.45506686
16713,functions,7,8,44,53,"Collectively, these findings show how Gal-1 functions as a major glycome determinant regulating Th cell development, inflammation, and tumor immunity.",22345665_4,0,1,2,-1,16713,-1,2.7322001e-05,0.9999484,2.4351473e-05
16714,Th cell,14,16,96,103,"Collectively, these findings show how Gal-1 functions as a major glycome determinant regulating Th cell development, inflammation, and tumor immunity.",22345665_4,-1,-1,-1,-1,16714,-1,8.921417e-06,7.724143e-06,0.9999833
16715,tumor immunity,21,23,135,149,"Collectively, these findings show how Gal-1 functions as a major glycome determinant regulating Th cell development, inflammation, and tumor immunity.",22345665_4,-1,-1,-1,-1,16715,-1,0.09673619,0.9017662,0.0014976183
16721,immunity,32,33,192,200,"CD4(+)CD25(hi)Foxp3(+) regulatory T cells (T(regs)) are critical mediators of self-tolerance, which is crucial for the prevention of autoimmune disease, but T(regs) can also inhibit antitumor immunity.",22375050_0,0,-1,2,-1,16721,-1,0.99985254,4.630757e-05,0.000101122656
16727,these cells to,22,25,109,123,"T(regs) inhibit the proliferation of CD4(+)CD25(-) conventional T cells (T(cons)), as well as the ability of these cells to produce effector cytokines; however, the molecular mechanism of suppression remains unclear.",22375050_1,-1,-1,-1,-1,16727,-1,0.0018518844,0.076633826,0.9215143
16732,the release,10,12,54,65,"Here, we showed that human T(regs) rapidly suppressed the release of calcium ions (Ca(2+)) from intracellular stores in response to T cell receptor (TCR) activation in T(cons).",22375050_2,-1,-1,-1,-1,16732,-1,1.0223062e-05,0.9999813,8.4545745e-06
16733,to T cell receptor,25,29,129,147,"Here, we showed that human T(regs) rapidly suppressed the release of calcium ions (Ca(2+)) from intracellular stores in response to T cell receptor (TCR) activation in T(cons).",22375050_2,-1,-1,-1,-1,16733,-1,0.001967406,0.20192386,0.79610866
16734,TCR,30,31,149,152,"Here, we showed that human T(regs) rapidly suppressed the release of calcium ions (Ca(2+)) from intracellular stores in response to T cell receptor (TCR) activation in T(cons).",22375050_2,-1,1,2,-1,16734,-1,2.4365392e-05,0.9998617,0.00011394562
16738,the transcription factor nuclear factor of activated T cells,18,27,110,170,"The inhibition of Ca(2+) signaling resulted in decreased dephosphorylation, and thus decreased activation, of the transcription factor nuclear factor of activated T cells 1 (NFAT1) and reduced the activation of nuclear factor B (NF-B).",22375050_3,-1,-1,-1,-1,16738,-1,0.0014400762,0.9008995,0.09766038
16742,TCR-proximal,11,12,59,71,"In contrast, Ca(2+)-independent events in T(cons), such as TCR-proximal signaling and activation of the transcription factor activator protein 1 (AP-1), were not affected during coculture with T(regs).",22375050_4,-1,1,2,-1,16742,-1,1.3134605e-05,0.99995124,3.5565783e-05
16743,the transcription factor activator protein 1 (AP-1,16,24,100,150,"In contrast, Ca(2+)-independent events in T(cons), such as TCR-proximal signaling and activation of the transcription factor activator protein 1 (AP-1), were not affected during coculture with T(regs).",22375050_4,-1,-1,-1,-1,16743,-1,6.4851756e-06,0.9999827,1.0849352e-05
16746,the generation,15,17,92,106,"Despite suppressing intracellular Ca(2+) mobilization, coculture with T(regs) did not block the generation of inositol 1,4,5-trisphosphate in TCR-stimulated T(cons).",22375050_5,-1,-1,-1,-1,16746,-1,7.7633385e-06,0.99998665,5.558101e-06
16747,TCR-stimulated T(cons,21,23,142,163,"Despite suppressing intracellular Ca(2+) mobilization, coculture with T(regs) did not block the generation of inositol 1,4,5-trisphosphate in TCR-stimulated T(cons).",22375050_5,-1,-1,-1,-1,16747,-1,4.7104913e-05,0.9999167,3.6263653e-05
16748,The T(reg)-induced,0,2,0,18,The T(reg)-induced suppression of the activity of NFAT and NF-B and of the expression of the gene encoding the cytokine interleukin-2 was reversed in T(cons) by increasing the concentration of intracellular Ca(2+).,22375050_6,-1,-1,-1,-1,16748,-1,8.699119e-06,0.9999825,8.779262e-06
16751,the gene,15,17,90,98,The T(reg)-induced suppression of the activity of NFAT and NF-B and of the expression of the gene encoding the cytokine interleukin-2 was reversed in T(cons) by increasing the concentration of intracellular Ca(2+).,22375050_6,-1,-1,-1,-1,16751,-1,5.1034867e-06,0.9999889,5.9450936e-06
16752,the cytokine interleukin-2,18,21,108,134,The T(reg)-induced suppression of the activity of NFAT and NF-B and of the expression of the gene encoding the cytokine interleukin-2 was reversed in T(cons) by increasing the concentration of intracellular Ca(2+).,22375050_6,-1,-1,-1,-1,16752,-1,0.9866043,0.012591818,0.0008039212
16758,function,6,7,39,47,This increased understanding of T(reg) function may be exploited to generate possible therapies for the treatment of autoimmune diseases and cancer.,22375050_8,0,1,2,-1,16758,-1,2.1830572e-05,0.99994135,3.6815472e-05
16759,to generate,10,12,65,76,This increased understanding of T(reg) function may be exploited to generate possible therapies for the treatment of autoimmune diseases and cancer.,22375050_8,-1,-1,-1,-1,16759,-1,7.3241467e-06,0.99998784,4.84661e-06
16761,the treatment,15,17,100,113,This increased understanding of T(reg) function may be exploited to generate possible therapies for the treatment of autoimmune diseases and cancer.,22375050_8,-1,-1,-1,-1,16761,-1,5.9861095e-06,0.9999894,4.603062e-06
16763,the IL-1,8,10,36,44,"Interleukin-33 (IL-33), a member of the IL-1 family of cytokines, binds to its plasma membrane receptor, heterodimeric complex consisted of membrane-bound ST2L and IL-1R accessory protein, inducing NFkB and MAPK activation.",22392053_0,-1,-1,-1,-1,16763,-1,0.84374124,0.15198222,0.004276558
16767,receptor,19,20,95,103,"Interleukin-33 (IL-33), a member of the IL-1 family of cytokines, binds to its plasma membrane receptor, heterodimeric complex consisted of membrane-bound ST2L and IL-1R accessory protein, inducing NFkB and MAPK activation.",22392053_0,0,1,2,-1,16767,-1,0.0006327634,0.988189,0.0111781815
16770,protein,30,31,180,187,"Interleukin-33 (IL-33), a member of the IL-1 family of cytokines, binds to its plasma membrane receptor, heterodimeric complex consisted of membrane-bound ST2L and IL-1R accessory protein, inducing NFkB and MAPK activation.",22392053_0,0,1,-1,-1,16770,-1,1.903178e-05,0.99996734,1.3616079e-05
16777,Th2 lymphocytes,8,10,43,58,"ST2L is expressed on several immune cells: Th2 lymphocytes, NK, NKT and mast cells and on cells of myeloid lineage: monocytes, dendritic cells and granulocytes.",22392053_2,-1,-1,-1,-1,16777,-1,0.00014469647,0.0018270089,0.99802834
16782,Th2 immune responses,7,10,40,60,IL-33/ST2 axis can promote both Th1 and Th2 immune responses depending on the type of activated cell and microenvironment and cytokine network in damaged tissue.,22392053_3,-1,-1,-1,-1,16782,-1,0.319434,0.67632306,0.0042429683
16783,the type,12,14,74,82,IL-33/ST2 axis can promote both Th1 and Th2 immune responses depending on the type of activated cell and microenvironment and cytokine network in damaged tissue.,22392053_3,-1,-1,-1,-1,16783,-1,6.9489993e-06,0.999985,8.114517e-06
16786,tissue,24,25,154,160,IL-33/ST2 axis can promote both Th1 and Th2 immune responses depending on the type of activated cell and microenvironment and cytokine network in damaged tissue.,22392053_3,-1,1,2,-1,16786,-1,0.00024709493,0.99659604,0.003156909
16795,receptor,40,41,263,271,"We found that ST2 deletion enhance the development of T cell-mediated autoimmune disorders, EAE and diabetes mellitus type I. Disease development was accompanied by dominantly Th1/Th17 immune response but also higher IL-33 production, which suggest that IL-33 in receptor independent manner could promote the development of inflammatory autoreactive T cells.",22392053_5,0,1,2,-1,16795,-1,0.07303754,0.008169046,0.9187933
16803,these cells,14,16,85,96,"Deletion of IL-33/ST2 axis enhances cytotoxicity of NK cells, production of IFN- in these cells and systemic production of IFN-, IL-17 and TNF-, which leads to attenuated tumor growth.",22392053_9,-1,-1,-1,-1,16803,-1,2.0294776e-05,1.4941811e-05,0.99996483
16806,TNF-,24,25,141,146,"Deletion of IL-33/ST2 axis enhances cytotoxicity of NK cells, production of IFN- in these cells and systemic production of IFN-, IL-17 and TNF-, which leads to attenuated tumor growth.",22392053_9,0,1,-1,-1,16806,-1,0.004046896,0.99578094,0.00017219437
16816,therapeutic targets,27,29,175,194,"In conclusion, we observed that IL-33 has attenuated anti-inflammatory effects in T cell-mediated responses and that both IL-33 and ST2 could be further explored as potential therapeutic targets in treatment of immune-mediated diseases.",22392053_11,-1,-1,-1,-1,16816,-1,5.512575e-06,0.99999034,4.097442e-06
16822,the related peptide,2,5,11,30,"Therefore, the related peptide epitopes derived from Pokemon is essential for the development of specific immunotherapy of malignant tumors.",22405859_1,-1,-1,-1,-1,16822,-1,0.00038286595,0.9994165,0.00020071487
16830,peptide-binding,24,25,166,181,"In this study, we predicted and identified HLA-A(*)0201-restricted cytotoxic T lymphocyte (CTL) epitopes derived from Pokemon with computer-based epitope prediction, peptide-binding assay and testing of the induced CTLs toward different kinds of carcinoma cells.",22405859_2,0,-1,2,-1,16830,-1,0.00029169078,0.9996092,9.913893e-05
16833,CTLs toward,31,33,215,226,"In this study, we predicted and identified HLA-A(*)0201-restricted cytotoxic T lymphocyte (CTL) epitopes derived from Pokemon with computer-based epitope prediction, peptide-binding assay and testing of the induced CTLs toward different kinds of carcinoma cells.",22405859_2,-1,-1,-1,-1,16833,-1,0.0021033303,0.006797612,0.99109906
16837,peptides,7,8,51,59,"The results demonstrated that effectors induced by peptides of Pokemon containing residues 32-40, 61-69, 87-95, and 319-327 could specifically secrete IFN- and lyse tumor cell lines of Pokemon-positive and HLA-A2-matched.",22405859_3,0,-1,2,-1,16837,-1,1.2457407e-05,0.9999739,1.3617883e-05
16840,tumor cell,34,36,166,176,"The results demonstrated that effectors induced by peptides of Pokemon containing residues 32-40, 61-69, 87-95, and 319-327 could specifically secrete IFN- and lyse tumor cell lines of Pokemon-positive and HLA-A2-matched.",22405859_3,-1,-1,-1,-1,16840,-1,0.0016457639,0.20691791,0.79143625
16843,that Pokemon32,3,5,20,34,"The results suggest that Pokemon32, Pokemon61, Pokemon87, and Pokemon319 peptides are novel HLA-A(*)0201-restricted restricted CTL epitopes, and could be utilized in the cancer immunotherapy against a broad spectrum of tumors.",22405859_4,-1,-1,-1,-1,16843,-1,6.4184445e-05,0.99984336,9.239713e-05
16846,Pokemon319 peptides,11,13,62,81,"The results suggest that Pokemon32, Pokemon61, Pokemon87, and Pokemon319 peptides are novel HLA-A(*)0201-restricted restricted CTL epitopes, and could be utilized in the cancer immunotherapy against a broad spectrum of tumors.",22405859_4,-1,-1,-1,-1,16846,-1,4.3179603e-05,0.9999074,4.940675e-05
16854,natural Tregs,6,8,32,45,"Increment of CD25(high+) FOXP3+ natural Tregs has been reported in patients with hepatocellular carcinoma (HCC); however, the involvement of other type of Tregs remain elusive.",22419479_1,-1,-1,-1,-1,16854,-1,7.227811e-06,0.99998724,5.5494074e-06
16859,FOXP3- Tregs,5,7,28,40,We aimed to clarify whether FOXP3- Tregs are increased and functionally suppressive or not in patients with HCC.,22419479_2,-1,-1,-1,-1,16859,-1,5.162695e-06,0.9999908,3.9721062e-06
16860,functionally,10,11,59,71,We aimed to clarify whether FOXP3- Tregs are increased and functionally suppressive or not in patients with HCC.,22419479_2,0,1,2,-1,16860,-1,5.7547455e-05,0.9999243,1.8138511e-05
16861,Treg subsets,1,3,9,21,"Distinct Treg subsets were phenotypically identified by the expression of CD4, CD25, CD127 and forkhead/winged helix transcription factor (FOXP3).",22419479_4,-1,-1,-1,-1,16861,-1,0.00018835155,0.010529855,0.9892818
16865,Their gene,0,2,0,10,"Their gene profiles, frequency and suppressor functions against T cell proliferation were compared among the subjects.",22419479_5,-1,-1,-1,-1,16865,-1,5.2944642e-06,0.9999894,5.361234e-06
16866,functions,7,8,46,55,"Their gene profiles, frequency and suppressor functions against T cell proliferation were compared among the subjects.",22419479_5,0,1,2,-1,16866,-1,0.00014097868,0.99972874,0.00013032157
16877,two types,2,4,14,23,We determined two types of CD4+ CD127- T cells with comparable regulatory ability; one is CD25(high+) cells expressing FOXP3 (CD25(high+) FOXP3+ Tregs) and the other is CD25- cells without FOXP3- expression (CD25- FOXP3- cells).,22419479_7,-1,-1,-1,-1,16877,-1,5.9775075e-06,0.99998665,7.372893e-06
16886,FOXP3- cells,40,42,214,226,We determined two types of CD4+ CD127- T cells with comparable regulatory ability; one is CD25(high+) cells expressing FOXP3 (CD25(high+) FOXP3+ Tregs) and the other is CD25- cells without FOXP3- expression (CD25- FOXP3- cells).,22419479_7,-1,-1,-1,-1,16886,-1,0.0016237481,0.8745688,0.12380738
16888,FOXP3- Tregs,7,9,50,62,"The peripheral or intrahepatic frequency of CD25- FOXP3- Tregs in HCC patients is higher than those in other groups, of which significance is more than CD25(high+) FOXP3+ cells.",22419479_8,-1,-1,-1,-1,16888,-1,5.525531e-06,0.9999889,5.512557e-06
16889,than those,14,16,89,99,"The peripheral or intrahepatic frequency of CD25- FOXP3- Tregs in HCC patients is higher than those in other groups, of which significance is more than CD25(high+) FOXP3+ cells.",22419479_8,-1,-1,-1,-1,16889,-1,5.5408386e-06,0.9999888,5.613921e-06
16893,FOXP3- Tregs,4,6,21,33,"Of importance, CD25- FOXP3- Tregs, but not CD25(high+) FOXP3+ cells, dynamically change in patients accompanied by the ablation or the recurrence of HCC.",22419479_9,-1,-1,-1,-1,16893,-1,4.6469254e-06,0.9999902,5.096198e-06
16898,FOXP3- T cells,1,4,6,20,"CD25- FOXP3- T cells with CD127- IL-10+ phenoype are inducible in vitro from naive CD4(+) T cells, in which programmed cell death 1 ligand 1, immunoglobulin-like transcript 4 and human leukocyte antigen G are involved.. In conclusion, CD25- FOXP3- Tregs with suppressive capacity are increased in patients with HCC, suggesting their distinct roles from CD25+ FOXP3+ Tregs.",22419479_10,-1,-1,-1,-1,16898,-1,0.0017717006,0.79919666,0.19903167
16905,FOXP3- Tregs,44,46,241,253,"CD25- FOXP3- T cells with CD127- IL-10+ phenoype are inducible in vitro from naive CD4(+) T cells, in which programmed cell death 1 ligand 1, immunoglobulin-like transcript 4 and human leukocyte antigen G are involved.. In conclusion, CD25- FOXP3- Tregs with suppressive capacity are increased in patients with HCC, suggesting their distinct roles from CD25+ FOXP3+ Tregs.",22419479_10,-1,-1,-1,-1,16905,-1,5.2851497e-06,0.9999889,5.770458e-06
16909,The cytokine IL-12,0,3,0,18,The cytokine IL-12 induces IFN- production by T and NK cells.,22426209_0,-1,-1,-1,-1,16909,-1,0.9708409,0.027721478,0.001437588
16914,immunity,8,9,51,59,"In preclinical models, it contributes to antitumor immunity.",22426209_1,0,-1,2,-1,16914,-1,0.999894,2.6978874e-05,7.905965e-05
16916,trial testing,5,7,24,37,"Moreover, in a clinical trial testing a combination of IL-12 and rituximab in patients with follicular B cell non-Hodgkin lymphoma (FL), those treated with IL-12 showed a lower response rate, suggesting that IL-12 actually plays a detrimental role.",22426209_3,-1,-1,-1,-1,16916,-1,5.3643016e-06,0.9999902,4.397351e-06
16919,those treated,25,27,137,150,"Moreover, in a clinical trial testing a combination of IL-12 and rituximab in patients with follicular B cell non-Hodgkin lymphoma (FL), those treated with IL-12 showed a lower response rate, suggesting that IL-12 actually plays a detrimental role.",22426209_3,-1,-1,-1,-1,16919,-1,5.444398e-06,0.99998915,5.4541315e-06
16921,that IL-12,36,38,203,213,"Moreover, in a clinical trial testing a combination of IL-12 and rituximab in patients with follicular B cell non-Hodgkin lymphoma (FL), those treated with IL-12 showed a lower response rate, suggesting that IL-12 actually plays a detrimental role.",22426209_3,-1,-1,-1,-1,16921,-1,0.9188421,0.07933731,0.0018206585
16924,IL-12 treatment,8,10,45,60,"Here, we investigated whether the failure of IL-12 treatment for FL was due to T cell exhaustion, a condition characterized by reduced T cell differentiation, proliferation, and function, which has been observed in chronic viral infection.",22426209_4,-1,-1,-1,-1,16924,-1,0.9992151,0.00046600332,0.0003188359
16925,to T cell,14,17,76,85,"Here, we investigated whether the failure of IL-12 treatment for FL was due to T cell exhaustion, a condition characterized by reduced T cell differentiation, proliferation, and function, which has been observed in chronic viral infection.",22426209_4,-1,-1,-1,-1,16925,-1,0.0019976508,0.14131807,0.85668427
16927,function,31,32,178,186,"Here, we investigated whether the failure of IL-12 treatment for FL was due to T cell exhaustion, a condition characterized by reduced T cell differentiation, proliferation, and function, which has been observed in chronic viral infection.",22426209_4,0,1,2,-1,16927,-1,0.0022349844,0.9410822,0.056682885
16929,to IL-12,5,7,32,40,We found that extended exposure to IL-12 induced T cell exhaustion and contributed to the poor prognosis in FL patients.,22426209_5,-1,-1,-1,-1,16929,-1,0.9670778,0.031766675,0.0011554636
16931,to the,13,15,83,89,We found that extended exposure to IL-12 induced T cell exhaustion and contributed to the poor prognosis in FL patients.,22426209_5,-1,-1,-1,-1,16931,-1,6.561731e-06,0.9999881,5.3042118e-06
16932,T cells to IL-12,8,12,50,66,"Long-term exposure of freshly isolated human CD4+ T cells to IL-12 in vitro caused T cell dysfunction and induced expression of TIM-3, a T cell immunoglobulin and mucin domain protein with a known role in T cell exhaustion, via an IFN--independent mechanism.",22426209_6,-1,-1,-1,-1,16932,-1,0.70968556,0.0032035825,0.28711087
16942,T cell function,10,13,55,70,TIM-3 was required for the negative effect of IL-12 on T cell function.,22426209_7,-1,-1,-1,-1,16942,-1,2.3880575e-05,1.20739005e-05,0.9999641
16944,T cells that,9,12,61,73,"Importantly, TIM-3 also was highly expressed on intratumoral T cells that displayed marked functional impairment.",22426209_8,-1,-1,-1,-1,16944,-1,0.0019174634,0.07444226,0.92364025
16945,functional,14,15,91,101,"Importantly, TIM-3 also was highly expressed on intratumoral T cells that displayed marked functional impairment.",22426209_8,0,1,2,-1,16945,-1,0.08096743,0.90649706,0.012535514
16951,IL-15 plays,0,2,0,11,IL-15 plays many important roles within the immune system.,22447977_0,-1,-1,-1,-1,16951,-1,0.99926096,0.00041617485,0.00032281893
16959,to IL-15R,20,22,135,145,"IL-15 signals in lymphocytes via trans presentation, where accessory cells such as macrophages and dendritic cells present IL-15 bound to IL-15R in trans to NK cells and CD8(+) memory T cells expressing IL-15/IL-2R and common  chain ((c)).",22447977_1,-1,-1,-1,-1,16959,-1,0.031302758,0.9676471,0.001050145
16960,trans to,23,25,149,157,"IL-15 signals in lymphocytes via trans presentation, where accessory cells such as macrophages and dendritic cells present IL-15 bound to IL-15R in trans to NK cells and CD8(+) memory T cells expressing IL-15/IL-2R and common  chain ((c)).",22447977_1,-1,-1,-1,-1,16960,-1,5.113245e-06,0.99998987,5.0536833e-06
16963,that the,4,6,22,30,"Previously, we showed that the prophylactic delivery of IL-15 to Rag2(-/-)(c)(-/-) mice (mature T, B, and NK cell negative) afforded protection against a lethal HSV-2 challenge and metastasis of B16/F10 melanoma cells.",22447977_2,-1,-1,-1,-1,16963,-1,5.053026e-06,0.9999914,3.5867154e-06
16964,IL-15 to,9,11,56,64,"Previously, we showed that the prophylactic delivery of IL-15 to Rag2(-/-)(c)(-/-) mice (mature T, B, and NK cell negative) afforded protection against a lethal HSV-2 challenge and metastasis of B16/F10 melanoma cells.",22447977_2,-1,-1,-1,-1,16964,-1,0.9988913,0.000709682,0.0003990319
16971,IL-15 to,20,22,117,125,"In this study, we demonstrated that in vivo delivery of an adenoviral construct optimized for the secretion of human IL-15 to Rag2(-/-)(c)(-/-) mice resulted in significant increases in spleen size and cell number, leading us to hypothesize that IL-15 signals differently in myeloid immune cells compared with lymphocytes, for which IL-15/IL-2R and (c) expression are essential.",22447977_3,-1,-1,-1,-1,16971,-1,0.99913555,0.0005339715,0.00033049905
16974,that IL-15,40,42,242,252,"In this study, we demonstrated that in vivo delivery of an adenoviral construct optimized for the secretion of human IL-15 to Rag2(-/-)(c)(-/-) mice resulted in significant increases in spleen size and cell number, leading us to hypothesize that IL-15 signals differently in myeloid immune cells compared with lymphocytes, for which IL-15/IL-2R and (c) expression are essential.",22447977_3,-1,-1,-1,-1,16974,-1,0.92791945,0.07024936,0.0018311293
16982,to IL-15,28,30,172,180,"Furthermore, treatment with IL-15 induced RANTES production by Rag2(-/-)(c)(-/-) bone marrow cells, but the presence of (c) did not increase bone marrow cell sensitivity to IL-15.",22447977_4,-1,-1,-1,-1,16982,-1,0.95601434,0.042344127,0.0016415747
16983,This IL-15-mediated,0,2,0,19,"This IL-15-mediated RANTES production by Rag2(-/-)(c)(-/-) bone marrow cells occurred independently of the IL-15/IL-2R and Jak/STAT pathways and instead required IL-15R signaling as well as activation of JNK and NF-B. Importantly, we also showed that the trans presentation of IL-15 by IL-15R boosts IL-15-mediated IFN- production by NK cells but reduces IL-15-mediated RANTES production by Rag2(-/-)(c)(-/-) myeloid bone marrow cells.",22447977_5,-1,-1,-1,-1,16983,-1,0.20176029,0.7960797,0.0021600225
16987,that the trans,36,39,250,264,"This IL-15-mediated RANTES production by Rag2(-/-)(c)(-/-) bone marrow cells occurred independently of the IL-15/IL-2R and Jak/STAT pathways and instead required IL-15R signaling as well as activation of JNK and NF-B. Importantly, we also showed that the trans presentation of IL-15 by IL-15R boosts IL-15-mediated IFN- production by NK cells but reduces IL-15-mediated RANTES production by Rag2(-/-)(c)(-/-) myeloid bone marrow cells.",22447977_5,-1,-1,-1,-1,16987,-1,5.319101e-06,0.99999034,4.353866e-06
16990,IL-15-mediated IFN-,45,47,305,325,"This IL-15-mediated RANTES production by Rag2(-/-)(c)(-/-) bone marrow cells occurred independently of the IL-15/IL-2R and Jak/STAT pathways and instead required IL-15R signaling as well as activation of JNK and NF-B. Importantly, we also showed that the trans presentation of IL-15 by IL-15R boosts IL-15-mediated IFN- production by NK cells but reduces IL-15-mediated RANTES production by Rag2(-/-)(c)(-/-) myeloid bone marrow cells.",22447977_5,-1,-1,-1,-1,16990,-1,0.99997437,3.574e-06,2.2047509e-05
16994,that IL-15,4,6,22,32,Our data clearly show that IL-15 signaling in NK cells is different from that of myeloid immune cells.,22447977_6,-1,-1,-1,-1,16994,-1,0.86595917,0.13167204,0.0023688402
17001,targeted immune responses,13,16,87,112,Additional insights into IL-15 biology may lead to novel therapies aimed at bolstering targeted immune responses against cancer and infectious disease.,22447977_7,-1,-1,-1,-1,17001,-1,0.7741519,0.22381134,0.0020367932
17009,receptor,1,2,6,14,"IL-22 receptor (IL-22R) expression is limited to epithelial cells of the digestive organs, respiratory tract and skin.",22471280_1,0,1,2,-1,17009,-1,0.097645804,0.2163089,0.6860453
17019,blood,12,13,76,81,"Interestingly, there is an increase in Th17 frequency within the peripheral blood and tumour microenvironment of advanced cancer patients.",22471280_3,0,1,-1,-1,17019,-1,0.001674229,0.15625043,0.84207535
17023,functions,12,13,78,87,"Subsequently, IL-17 has been shown to display both pro-tumour and anti-tumour functions.",22471280_4,0,1,2,-1,17023,-1,5.563183e-05,0.99989676,4.7627917e-05
17025,the IL-17 receptor,6,9,40,58,"Because many tumours lack expression of the IL-17 receptor, the effects of IL-17 on tumour growth are generated by cells that surround the tumour cells.",22471280_5,-1,-1,-1,-1,17025,-1,0.020875022,0.9754195,0.003705443
17030,cells that,20,22,115,125,"Because many tumours lack expression of the IL-17 receptor, the effects of IL-17 on tumour growth are generated by cells that surround the tumour cells.",22471280_5,-1,-1,-1,-1,17030,-1,0.002963849,0.083796166,0.9132399
17031,the tumour cells,23,26,135,151,"Because many tumours lack expression of the IL-17 receptor, the effects of IL-17 on tumour growth are generated by cells that surround the tumour cells.",22471280_5,-1,-1,-1,-1,17031,-1,0.0020209,0.6797006,0.31827846
17033,tumour tissues,11,13,55,69,"Like IL-17, high levels of IL-22 have been detected in tumour tissues and the peripheral blood of cancer patients; however, the direct effect of IL-22 on tumour cells has remained largely unknown.",22471280_6,-1,-1,-1,-1,17033,-1,9.0584705e-05,0.99631786,0.0035915277
17035,blood,16,17,89,94,"Like IL-17, high levels of IL-22 have been detected in tumour tissues and the peripheral blood of cancer patients; however, the direct effect of IL-22 on tumour cells has remained largely unknown.",22471280_6,0,1,-1,-1,17035,-1,0.0034314005,0.7670844,0.22948425
17037,tumour cells,29,31,154,166,"Like IL-17, high levels of IL-22 have been detected in tumour tissues and the peripheral blood of cancer patients; however, the direct effect of IL-22 on tumour cells has remained largely unknown.",22471280_6,-1,-1,-1,-1,17037,-1,7.233652e-05,0.00020408172,0.9997236
17042,factor,21,22,125,131,"In this report, we show that IL-22 stimulated production of vascular endothelial growth factor (VEGF) and the anti-apoptotic factor Bcl-X(L) in IL-22R-positive HPAFII human pancreatic cancer cells.",22471280_7,0,1,-1,-1,17042,-1,0.15317042,0.8463039,0.0005256902
17050,through the,16,18,105,116,We show further that IL-22 activation of HPAFII cells diminished T cell production of interferon (IFN)- through the action of IL-10.,22471280_9,-1,-1,-1,-1,17050,-1,6.5861523e-06,0.9999893,4.184353e-06
17053,time that,7,9,34,43,"Strikingly, we show for the first time that IL-22 can fully protect cancer cells from natural killer (NK) cell-mediated cytotoxicity by stimulating tumour production of IL-10 and transforming growth factor (TGF)-1.",22471280_10,-1,-1,-1,-1,17053,-1,4.6751215e-06,0.99999046,4.8076404e-06
17059,transforming growth factor,30,33,179,205,"Strikingly, we show for the first time that IL-22 can fully protect cancer cells from natural killer (NK) cell-mediated cytotoxicity by stimulating tumour production of IL-10 and transforming growth factor (TGF)-1.",22471280_10,-1,-1,-1,-1,17059,-1,0.9791531,0.017529216,0.003317781
17064,than function,16,18,91,104,Our data support the idea that IL-22 may act to promote the pathogenesis of cancers rather than function in anti-tumour immunity.,22471280_11,-1,-1,-1,-1,17064,-1,2.1422022e-05,0.9999589,1.9653642e-05
17065,immunity,20,21,120,128,Our data support the idea that IL-22 may act to promote the pathogenesis of cancers rather than function in anti-tumour immunity.,22471280_11,0,-1,2,-1,17065,-1,0.9998915,3.1761716e-05,7.6729724e-05
17070,the tumor,26,28,154,163,"The development of multiple myeloma (MM) involves a series of genetic alterations and changes in the bone marrow microenvironment, favoring the growth of the tumor and failure of local immune control.",22489248_0,-1,-1,-1,-1,17070,-1,4.269101e-06,0.9999902,5.529845e-06
17071,functional,2,3,17,27,Quantitative and functional alterations in CD4(+) and CD8(+) T cells have been described in MM.,22489248_1,0,1,2,-1,17071,-1,0.0014966265,0.997614,0.00088940444
17080,immunity,24,25,138,146,The balance between T regulatory cells (Treg) and T helper (Th) 17 cells represents one essential prerequisite for maintaining anti-tumor immunity in MM.,22489248_2,0,-1,2,-1,17080,-1,0.9991406,0.0004222294,0.0004371256
17081,Tregs play,0,2,0,10,Tregs play an important role in the preservation of self-tolerance and modulation of overall immune responses against infections and tumor cells.,22489248_3,-1,-1,-1,-1,17081,-1,3.846467e-06,0.999992,4.171034e-06
17084,tumor cells,19,21,133,144,Tregs play an important role in the preservation of self-tolerance and modulation of overall immune responses against infections and tumor cells.,22489248_3,-1,-1,-1,-1,17084,-1,0.00023873901,0.0029340012,0.9968272
17088,targeting them,13,15,83,97,"In MM patients, Tregs seem to contribute to myeloma-related immune dysfunction and targeting them could, therefore, help to restore and enhance vital immune responses.",22489248_4,-1,-1,-1,-1,17088,-1,4.592471e-06,0.99999106,4.297084e-06
17092,Th17 cells,0,2,0,10,Th17 cells protect against fungal and parasitic infections and participate in inflammatory reactions and autoimmunity.,22489248_5,-1,-1,-1,-1,17092,-1,0.00018399152,0.0019181737,0.99789774
17098,Th17 cells,23,25,123,133,"The interplay of TGF- and IL-6, expressed at high levels in the bone marrow of myeloma patients, may affect generation of Th17 cells both directly or via other pro-inflammatory cytokines and thereby modulate antitumor immune responses.",22489248_6,-1,-1,-1,-1,17098,-1,0.00040729635,0.022063684,0.97752905
17102,analysis,2,3,11,19,A detailed analysis of the balance between Tregs and Th17 cells seems necessary in order to design more effective and less toxic modes of immunotherapy myeloma which still is an uncurable malignancy.,22489248_7,0,1,-1,-1,17102,-1,6.7200635e-06,0.9999875,5.855478e-06
17105,Th17 cells,9,11,53,63,A detailed analysis of the balance between Tregs and Th17 cells seems necessary in order to design more effective and less toxic modes of immunotherapy myeloma which still is an uncurable malignancy.,22489248_7,-1,-1,-1,-1,17105,-1,0.00032572597,0.010651267,0.989023
17115,tumor cells,14,16,95,106,Our previous studies indicate that hMSH2 is ectopically expressed on the surface of epithelial tumor cells and recognized by both T cell receptor  (TCR) and natural killer group 2 member D (NKG2D) on V2 T cells.,22493490_1,-1,-1,-1,-1,17115,-1,5.241085e-05,0.00015657229,0.99979097
17124,protein,7,8,51,58,"Under oxidative stress, both p38 mitogen-activated protein kinase (MAPK) and c-Jun N-terminal kinase (JNK) pathways have been confirmed to mediate the ectopic expression of hMSH2 through the apoptosis-signaling kinase 1 (ASK1) upstream and activating transcription factor 3 (ATF3) downstream of both pathways.",22493490_4,0,1,-1,-1,17124,-1,8.560134e-05,0.99985874,5.561179e-05
17127,through the,30,32,179,190,"Under oxidative stress, both p38 mitogen-activated protein kinase (MAPK) and c-Jun N-terminal kinase (JNK) pathways have been confirmed to mediate the ectopic expression of hMSH2 through the apoptosis-signaling kinase 1 (ASK1) upstream and activating transcription factor 3 (ATF3) downstream of both pathways.",22493490_4,-1,-1,-1,-1,17127,-1,5.064755e-06,0.9999906,4.3328414e-06
17129,cell-derived interleukin,4,6,26,50,"Moreover, renal carcinoma cell-derived interleukin (IL)-18 in oxidative stress was a prominent stimulator for ectopically induced expression of hMSH2, which was promoted by interferon (IFN)- as well.",22493490_5,-1,-1,-1,-1,17129,-1,0.08075738,0.0012859554,0.91795665
17135,tumor cells,12,14,74,85,Our results not only establish a mechanism of ectopic hMSH2 expression in tumor cells but also find a biological linkage between ectopic expression of hMSH2 and activation of  T cells in stressful conditions.,22493490_7,-1,-1,-1,-1,17135,-1,0.00017425873,0.004608491,0.9952172
17137,T cells play,2,5,11,23,"Because  T cells play an important role in the early stage of innate anti-tumor response,  T cell activation triggered by ectopically expressed hMSH2 may be an important event in immunosurveillance for carcinogenesis.",22493490_8,-1,-1,-1,-1,17137,-1,0.0011380864,0.034098417,0.9647635
17139,T cell activation triggered,18,22,95,122,"Because  T cells play an important role in the early stage of innate anti-tumor response,  T cell activation triggered by ectopically expressed hMSH2 may be an important event in immunosurveillance for carcinogenesis.",22493490_8,-1,-1,-1,-1,17139,-1,0.0016306709,0.02434696,0.9740224
17142,the TNFR,9,11,54,62,"The provision of T cell co-stimulation via members of the TNFR super-family, including OX40 (CD134) and 4-1BB (CD137), provides critical signals that promote T cell survival and differentiation.",22496812_0,-1,-1,-1,-1,17142,-1,7.2226458e-06,0.99998665,6.1724445e-06
17147,immunity,13,14,94,102,"Recent studies have demonstrated that ligation of OX40 can augment T cell-mediated anti-tumor immunity in pre-clinical models and more importantly, OX40 agonists are under clinical development for cancer immunotherapy.",22496812_1,0,-1,2,-1,17147,-1,0.99966085,7.21883e-05,0.00026697843
17148,agonists,22,23,153,161,"Recent studies have demonstrated that ligation of OX40 can augment T cell-mediated anti-tumor immunity in pre-clinical models and more importantly, OX40 agonists are under clinical development for cancer immunotherapy.",22496812_1,0,1,-1,-1,17148,-1,0.92986643,0.0024827637,0.06765073
17149,therapeutic target,7,9,36,54,"OX40 is of particular interest as a therapeutic target as it is not expressed on nave T cells but rather, is transiently up-regulated following TCR stimulation.",22496812_2,-1,-1,-1,-1,17149,-1,5.4967304e-06,0.9999901,4.4111234e-06
17152,TCR,25,26,145,148,"OX40 is of particular interest as a therapeutic target as it is not expressed on nave T cells but rather, is transiently up-regulated following TCR stimulation.",22496812_2,-1,1,2,-1,17152,-1,1.2324946e-05,0.9999716,1.6048061e-05
17153,TCR,1,2,9,12,"Although TCR engagement is necessary for inducing OX40 expression, the downstream signals that regulate OX40 itself remain unclear.",22496812_3,-1,1,2,-1,17153,-1,2.988764e-05,0.9999194,5.064132e-05
17159,TCR,13,14,74,77,"In this study, we demonstrate that OX40 expression is regulated through a TCR and common gamma chain cytokine-dependent signaling cascade that requires JAK3-mediated activation of the downstream transcription factors STAT3 and STAT5.",22496812_4,-1,1,2,-1,17159,-1,3.576164e-05,0.9996829,0.000281388
17163,transcription factors STAT3,28,31,195,222,"In this study, we demonstrate that OX40 expression is regulated through a TCR and common gamma chain cytokine-dependent signaling cascade that requires JAK3-mediated activation of the downstream transcription factors STAT3 and STAT5.",22496812_4,-1,-1,-1,-1,17163,-1,5.6340127e-06,0.9999889,5.393133e-06
17167,tumor types,16,18,118,129,"Furthermore, combined treatment with an agonist anti-OX40 mAb and IL-2 augmented tumor immunotherapy against multiple tumor types.",22496812_5,-1,-1,-1,-1,17167,-1,7.724737e-06,0.9999839,8.426295e-06
17168,therapy,1,2,5,12,"Dual therapy was also able to restore the function of anergic tumor-reactive CD8 T cells in mice with long-term well-established (>5 wks) tumors, leading to increased survival of the tumor-bearing hosts.",22496812_6,0,1,-1,-1,17168,-1,4.7339695e-06,0.99999094,4.281523e-06
17170,the function,7,9,38,50,"Dual therapy was also able to restore the function of anergic tumor-reactive CD8 T cells in mice with long-term well-established (>5 wks) tumors, leading to increased survival of the tumor-bearing hosts.",22496812_6,-1,-1,-1,-1,17170,-1,1.0089967e-05,0.99997914,1.0815378e-05
17175,the tumor-bearing,32,34,179,196,"Dual therapy was also able to restore the function of anergic tumor-reactive CD8 T cells in mice with long-term well-established (>5 wks) tumors, leading to increased survival of the tumor-bearing hosts.",22496812_6,-1,-1,-1,-1,17175,-1,5.425978e-06,0.9999895,5.1133698e-06
17179,cytokine signaling to,11,14,66,87,"Together, these data reveal the ability of TCR/common gamma chain cytokine signaling to regulate OX40 expression and demonstrate a novel means of augmenting cancer immunotherapy by providing dual anti-OX40/common gamma chain cytokine-directed therapy.",22496812_7,-1,-1,-1,-1,17179,-1,0.9290274,0.06842432,0.0025483596
17180,cytokine-directed therapy,32,34,225,250,"Together, these data reveal the ability of TCR/common gamma chain cytokine signaling to regulate OX40 expression and demonstrate a novel means of augmenting cancer immunotherapy by providing dual anti-OX40/common gamma chain cytokine-directed therapy.",22496812_7,-1,-1,-1,-1,17180,-1,0.9937012,0.005549012,0.00074974133
17182,T-cell immunity,15,17,102,117,Human CD34(+) progenitor-derived Langerhans-type dendritic cells (LCs) are more potent stimulators of T-cell immunity against tumor and viral antigens in vitro than are monocyte-derived DCs (moDCs).,22510877_0,-1,-1,-1,-1,17182,-1,0.00022732305,2.755365e-05,0.9997452
17189,protein,9,10,56,63,"LCs synthesize the highest amounts of IL-15R- mRNA and protein, which binds IL-15 for presentation to responder lymphocytes, thereby signaling the phosphorylation of signal transducer and activator of transcription 5 (pSTAT5).",22510877_2,0,1,-1,-1,17189,-1,1.2542746e-05,0.99997735,1.0159362e-05
17198,antigenic peptides,15,17,96,114,"LCs electroporated with Wilms tumor 1 (WT1) mRNA achieve sufficiently sustained presentation of antigenic peptides, which together with IL-15R-/IL-15, break tolerance against WT1 by stimulating robust autologous, WT1-specific cytolytic T-lymphocytes (CTLs).",22510877_3,-1,-1,-1,-1,17198,-1,0.9995258,0.0001257332,0.0003485435
17203,T-lymphocytes,34,35,237,250,"LCs electroporated with Wilms tumor 1 (WT1) mRNA achieve sufficiently sustained presentation of antigenic peptides, which together with IL-15R-/IL-15, break tolerance against WT1 by stimulating robust autologous, WT1-specific cytolytic T-lymphocytes (CTLs).",22510877_3,-1,1,2,-1,17203,-1,1.5389829e-05,1.090286e-05,0.9999738
17205,These CTLs,0,2,0,10,"These CTLs develop from healthy persons after only 7 days' stimulation without exogenous cytokines and lyse MHC-restricted tumor targets, which include primary WT1(+) leukemic blasts.",22510877_4,-1,-1,-1,-1,17205,-1,0.001852262,0.07969738,0.9184503
17207,tumor targets,18,20,123,136,"These CTLs develop from healthy persons after only 7 days' stimulation without exogenous cytokines and lyse MHC-restricted tumor targets, which include primary WT1(+) leukemic blasts.",22510877_4,-1,-1,-1,-1,17207,-1,4.568913e-06,0.9999913,4.1324665e-06
17214,T-cell activation than,10,13,70,92,"LCs therefore provide a more potent costimulatory cytokine milieu for T-cell activation than do moDCs, thus accounting for their superior stimulation of MHC-restricted Ag-specific CTLs without need for exogenous cytokines.",22510877_6,-1,-1,-1,-1,17214,-1,0.0020490931,0.013803049,0.9841479
17226,the therapeutic,2,4,15,30,"To investigate the therapeutic efficacy of lipoteichoic acid of Bifidobacterium (BLTA) in combination with 5-fluorouracil (5-FU) treatment on the mice bearing inoculated hepatoma-22 (H(22)) cells and the effects of BLTA on immunological regulation of organism, and explore its mechanisms.",22522606_0,-1,-1,-1,-1,17226,-1,3.8149255e-06,0.99999213,4.102623e-06
17234,The tumor,0,2,0,9,The tumor size were observed and measured regularly.,22522606_2,-1,-1,-1,-1,17234,-1,5.0636863e-06,0.99999034,4.6343353e-06
17249,proteins,5,6,30,38,Expression change of mRNA and proteins of Foxp3 and TIM-3 were detected by Real-Time-PCR and Western blot in tumor-bearing mice tumor tissue.,22522606_7,0,1,-1,-1,17249,-1,6.589051e-06,0.9999877,5.700032e-06
17253,tumor tissue,20,22,128,140,Expression change of mRNA and proteins of Foxp3 and TIM-3 were detected by Real-Time-PCR and Western blot in tumor-bearing mice tumor tissue.,22522606_7,-1,-1,-1,-1,17253,-1,5.678725e-06,0.9999839,1.0384465e-05
17264,proteins,19,20,121,129,"Spleen cells of tumor-bearing mice had high CD4(+)CD25(+)regulatory T cell (CD4(+)CD25(+)T(reg)) ratio and high mRNA and proteins expression of Foxp3 and TIM-3, but in the BLTA and 5-FU group, CD4(+)CD25(+)T(reg) ratio degraded, with down regulation mRNA and proteins expression of Foxp3 and TIM-3.",22522606_10,0,1,-1,-1,17264,-1,5.888209e-06,0.99998665,7.4218665e-06
17269,proteins,44,45,259,267,"Spleen cells of tumor-bearing mice had high CD4(+)CD25(+)regulatory T cell (CD4(+)CD25(+)T(reg)) ratio and high mRNA and proteins expression of Foxp3 and TIM-3, but in the BLTA and 5-FU group, CD4(+)CD25(+)T(reg) ratio degraded, with down regulation mRNA and proteins expression of Foxp3 and TIM-3.",22522606_10,0,1,-1,-1,17269,-1,6.337094e-06,0.99998593,7.7777395e-06
17299,immunity,8,9,48,56,"As CD4(+) T lymphocytes coordinate and regulate immunity, a better understanding of interactions between SCLC tumour cells and CD4(+) T cells may lead to effective molecular immunotherapy.",22532287_4,0,-1,2,-1,17299,-1,0.9886197,0.010559385,0.0008210061
17300,SCLC tumour cells,16,19,105,122,"As CD4(+) T lymphocytes coordinate and regulate immunity, a better understanding of interactions between SCLC tumour cells and CD4(+) T cells may lead to effective molecular immunotherapy.",22532287_4,-1,-1,-1,-1,17300,-1,0.0020657761,0.29608744,0.7018467
17304,SCLC tumour cell,9,12,32,48,"We show that some, but not all, SCLC tumour cell lines secrete molecules that induce IL-10 secretion by and de novo differentiation of functional CD4(+)CD25(+)FOXP3(+)CD127(lo)Helios(-) regulatory T (Treg) cells in healthy blood lymphocytes.",22532287_5,-1,-1,-1,-1,17304,-1,0.0016178318,0.34342518,0.654957
17307,functional,25,26,135,145,"We show that some, but not all, SCLC tumour cell lines secrete molecules that induce IL-10 secretion by and de novo differentiation of functional CD4(+)CD25(+)FOXP3(+)CD127(lo)Helios(-) regulatory T (Treg) cells in healthy blood lymphocytes.",22532287_5,0,1,2,-1,17307,-1,0.00015495777,0.99968636,0.00015875645
17311,blood lymphocytes,36,38,223,240,"We show that some, but not all, SCLC tumour cell lines secrete molecules that induce IL-10 secretion by and de novo differentiation of functional CD4(+)CD25(+)FOXP3(+)CD127(lo)Helios(-) regulatory T (Treg) cells in healthy blood lymphocytes.",22532287_5,-1,-1,-1,-1,17311,-1,5.0407336e-05,4.4470155e-05,0.9999051
17314,SCLC tumour,7,9,31,42,"FOXP3(+) T cells were found in SCLC tumour biopsies, and patients with higher ratios of FOXP3(+) cells in tumour infiltrates have a worse survival rate.",22532287_6,-1,-1,-1,-1,17314,-1,8.240777e-06,0.99997926,1.2508714e-05
17319,SCLC tumour cells,4,7,25,42,"The inhibitory effect of SCLC tumour cells was not affected by blocking IL-10 receptor or TGF- signalling but was partially reversed by blocking IL-15, which is reported to be involved in human Treg cells induction.",22532287_7,-1,-1,-1,-1,17319,-1,0.0023801934,0.15784141,0.83977836
17320,IL-10 receptor,12,14,72,86,"The inhibitory effect of SCLC tumour cells was not affected by blocking IL-10 receptor or TGF- signalling but was partially reversed by blocking IL-15, which is reported to be involved in human Treg cells induction.",22532287_7,-1,-1,-1,-1,17320,-1,0.9994641,4.6916586e-05,0.0004889242
17326,SCLC cells that,4,7,22,37,IL-15 was secreted by SCLC cells that inhibited CD4(+) T-cell proliferation and was present in SCLC biopsy tumour cells.,22532287_8,-1,-1,-1,-1,17326,-1,4.5314187e-05,0.99982435,0.00013041172
17329,tumour cells,18,20,107,119,IL-15 was secreted by SCLC cells that inhibited CD4(+) T-cell proliferation and was present in SCLC biopsy tumour cells.,22532287_8,-1,-1,-1,-1,17329,-1,9.876982e-05,0.00052783795,0.9993734
17331,that SCLC tumour cells,4,8,33,55,These novel findings demonstrate that SCLC tumour cells can induce CD4(+) T-cell-mediated immunosuppression.,22532287_9,-1,-1,-1,-1,17331,-1,0.0022506218,0.8858574,0.11189196
17332,T-cell-mediated,12,13,74,89,These novel findings demonstrate that SCLC tumour cells can induce CD4(+) T-cell-mediated immunosuppression.,22532287_9,-1,1,2,-1,17332,-1,1.2577272e-05,7.577311e-06,0.99997973
17334,SCLC tumour cells,7,10,42,59,This gives a potential mechanism by which SCLC tumour cells may downregulate local and systemic immune responses and contribute to poor patient survival.,22532287_10,-1,-1,-1,-1,17334,-1,0.0024375175,0.53201836,0.46554416
17337,that IL-15,3,5,17,27,Our data suggest that IL-15 and Treg cells are potential new therapeutic targets to improve immune response and patient survival in SCLC.,22532287_11,-1,-1,-1,-1,17337,-1,0.86917347,0.1283974,0.002429094
17339,therapeutic targets to,11,14,61,83,Our data suggest that IL-15 and Treg cells are potential new therapeutic targets to improve immune response and patient survival in SCLC.,22532287_11,-1,-1,-1,-1,17339,-1,3.8834005e-06,0.9999924,3.6872111e-06
17353,the factors that,7,10,34,50,"In the present study, we explored the factors that influence CD4(+) Treg reconstitution in patients receiving adoptive immunotherapy following conditioning regimens designed to enhance T-cell function and evaluated potential associations between CD4(+) Treg levels and clinical responses to therapy.",22555974_1,-1,-1,-1,-1,17353,-1,5.884109e-06,0.9999901,4.0008144e-06
17356,T-cell function,26,28,185,200,"In the present study, we explored the factors that influence CD4(+) Treg reconstitution in patients receiving adoptive immunotherapy following conditioning regimens designed to enhance T-cell function and evaluated potential associations between CD4(+) Treg levels and clinical responses to therapy.",22555974_1,-1,-1,-1,-1,17356,-1,1.8001085e-05,9.718769e-06,0.9999722
17358,to therapy,40,42,288,298,"In the present study, we explored the factors that influence CD4(+) Treg reconstitution in patients receiving adoptive immunotherapy following conditioning regimens designed to enhance T-cell function and evaluated potential associations between CD4(+) Treg levels and clinical responses to therapy.",22555974_1,-1,-1,-1,-1,17358,-1,9.691945e-06,0.99998355,6.742769e-06
17359,The analysis,0,2,0,12,The analysis of 4 trials employing nonmyeloablative chemotherapy with or without total body irradiation (TBI) before adoptive T-cell transfer revealed that the percentage and number of reconstituting CD4(+)FoxP3(+) Tregs observed in the peripheral blood was higher in nonresponders than in responders.,22555974_2,-1,-1,-1,-1,17359,-1,4.8802503e-06,0.9999907,4.365743e-06
17364,T-cell transfer,19,21,126,141,The analysis of 4 trials employing nonmyeloablative chemotherapy with or without total body irradiation (TBI) before adoptive T-cell transfer revealed that the percentage and number of reconstituting CD4(+)FoxP3(+) Tregs observed in the peripheral blood was higher in nonresponders than in responders.,22555974_2,-1,-1,-1,-1,17364,-1,8.20684e-05,0.00017477646,0.99974304
17365,that the,22,24,151,159,The analysis of 4 trials employing nonmyeloablative chemotherapy with or without total body irradiation (TBI) before adoptive T-cell transfer revealed that the percentage and number of reconstituting CD4(+)FoxP3(+) Tregs observed in the peripheral blood was higher in nonresponders than in responders.,22555974_2,-1,-1,-1,-1,17365,-1,4.259274e-06,0.9999918,3.9650363e-06
17368,blood,36,37,248,253,The analysis of 4 trials employing nonmyeloablative chemotherapy with or without total body irradiation (TBI) before adoptive T-cell transfer revealed that the percentage and number of reconstituting CD4(+)FoxP3(+) Tregs observed in the peripheral blood was higher in nonresponders than in responders.,22555974_2,0,1,-1,-1,17368,-1,0.0020523677,0.3452756,0.652672
17374,the TBI,22,24,114,121,"The addition of TBI resulted in a further depletion of CD4(+) Tregs, and the degree of depletion was dependent on the TBI dose.",22555974_3,-1,-1,-1,-1,17374,-1,5.30041e-05,0.99991715,2.9805367e-05
17381,therapy,16,17,105,112,"These observations provide strong evidence that endogenous CD4(+) Tregs have a negative impact on cancer therapy, and suggest that strategies reducing Treg levels may provide clinical benefit to cancer patients.",22555974_5,0,1,-1,-1,17381,-1,5.00855e-06,0.9999893,5.7453053e-06
17395,that the,4,6,16,24,"Here, we showed that the expression of perforin, CD95L, and promyelocytic leukemia zinc finger, a transcription factor required for maintenance of iNKT cell functions, was reduced or suppressed in CML patients at diagnosis, as compared with healthy individuals.",22585600_2,-1,-1,-1,-1,17395,-1,3.93999e-06,0.99999213,3.9334873e-06
17398,cell functions,26,28,152,166,"Here, we showed that the expression of perforin, CD95L, and promyelocytic leukemia zinc finger, a transcription factor required for maintenance of iNKT cell functions, was reduced or suppressed in CML patients at diagnosis, as compared with healthy individuals.",22585600_2,-1,-1,-1,-1,17398,-1,2.3017341e-05,1.8611783e-05,0.9999584
17400,blood,4,5,26,31,The proliferation rate of blood iNKT cells in response to their cognate ligand was likewise diminished.,22585600_3,0,1,-1,-1,17400,-1,0.00038450936,0.9993185,0.0002970459
17402,to their,9,11,55,63,The proliferation rate of blood iNKT cells in response to their cognate ligand was likewise diminished.,22585600_3,-1,-1,-1,-1,17402,-1,1.5587992e-05,0.99997723,7.1760414e-06
17403,These functional,0,2,0,16,These functional deficiencies were corrected in patients having achieved complete cytogenetic remission following TK inhibitor or IFN- therapy.,22585600_4,-1,-1,-1,-1,17403,-1,0.0002373683,0.9996892,7.3424584e-05
17405,IFN- therapy,16,18,130,143,These functional deficiencies were corrected in patients having achieved complete cytogenetic remission following TK inhibitor or IFN- therapy.,22585600_4,-1,-1,-1,-1,17405,-1,0.9994487,0.00030998065,0.00024126425
17409,that their,4,6,18,28,"Instead, we found that their anergic status originated from both intrinsic and APC-dependent dysfunctions.",22585600_6,-1,-1,-1,-1,17409,-1,5.389899e-06,0.99998987,4.730242e-06
17412,functional,10,11,63,73,Our data demonstrate that chronic phase CML is associated with functional deficiencies of iNKT cells that are restored upon remission.,22585600_7,0,1,2,-1,17412,-1,0.010923674,0.98735285,0.0017234787
17413,cells that,14,16,95,105,Our data demonstrate that chronic phase CML is associated with functional deficiencies of iNKT cells that are restored upon remission.,22585600_7,-1,-1,-1,-1,17413,-1,0.0026780884,0.34906036,0.64826155
17419,receptor,5,6,31,39,Surface expression of the IL-2 receptor -chain (CD25) has been used to discriminate between CD4(+) CD25(HI) FOXP3(+) regulatory T (Treg) cells and CD4(+) CD25(NEG) FOXP3(-) non-Treg cells.,22585674_0,0,1,2,-1,17419,-1,0.17974073,0.34514117,0.47511804
17428,that the,5,7,28,36,"However, this study reports that the majority of resting human memory CD4(+) FOXP3(-) T cells expresses intermediate levels of CD25 and that CD25 expression can be used to delineate a functionally distinct memory subpopulation.",22585674_1,-1,-1,-1,-1,17428,-1,3.989687e-06,0.99999154,4.439795e-06
17433,functionally,33,34,184,196,"However, this study reports that the majority of resting human memory CD4(+) FOXP3(-) T cells expresses intermediate levels of CD25 and that CD25 expression can be used to delineate a functionally distinct memory subpopulation.",22585674_1,0,1,2,-1,17433,-1,3.9453746e-05,0.999944,1.6548769e-05
17435,T-cell,4,5,21,27,The CD25(NEG) memory T-cell population contains the vast majority of late differentiated cells that respond to antigens associated with chronic immune responses and are increased in patients with systemic lupus erythematosus (SLE).,22585674_2,-1,1,2,-1,17435,-1,9.050668e-06,7.2342464e-06,0.99998367
17437,cells that,13,15,89,99,The CD25(NEG) memory T-cell population contains the vast majority of late differentiated cells that respond to antigens associated with chronic immune responses and are increased in patients with systemic lupus erythematosus (SLE).,22585674_2,-1,-1,-1,-1,17437,-1,0.002055861,0.237642,0.7603021
17438,to antigens,16,18,108,119,The CD25(NEG) memory T-cell population contains the vast majority of late differentiated cells that respond to antigens associated with chronic immune responses and are increased in patients with systemic lupus erythematosus (SLE).,22585674_2,-1,-1,-1,-1,17438,-1,0.9364372,0.061141063,0.0024217914
17442,to antigens,10,12,50,61,"In contrast, the CD25(INT) memory T cells respond to antigens associated with recall responses, produce a greater array of cytokines, and are less dependent on costimulation for effector responses due to their expression of CD25.",22585674_3,-1,-1,-1,-1,17442,-1,0.84598297,0.14988886,0.0041281474
17444,to their,34,36,201,209,"In contrast, the CD25(INT) memory T cells respond to antigens associated with recall responses, produce a greater array of cytokines, and are less dependent on costimulation for effector responses due to their expression of CD25.",22585674_3,-1,-1,-1,-1,17444,-1,5.7428524e-06,0.99998856,5.65822e-06
17445,to the,3,5,17,23,"Lastly, compared to the CD25(NEG) and Treg-cell populations, the CD25(INT) memory population is lost to a greater degree from the blood of cancer patients treated with IL-2.",22585674_4,-1,-1,-1,-1,17445,-1,4.226492e-06,0.99999106,4.6924692e-06
17446,Treg-cell,8,9,38,47,"Lastly, compared to the CD25(NEG) and Treg-cell populations, the CD25(INT) memory population is lost to a greater degree from the blood of cancer patients treated with IL-2.",22585674_4,-1,1,2,-1,17446,-1,1.3085907e-05,1.5466418e-05,0.9999714
17449,the blood,23,25,126,135,"Lastly, compared to the CD25(NEG) and Treg-cell populations, the CD25(INT) memory population is lost to a greater degree from the blood of cancer patients treated with IL-2.",22585674_4,-1,-1,-1,-1,17449,-1,3.3668264e-05,0.9999027,6.361504e-05
17457,functionally,33,34,170,182,"Collectively, these results show that in humans, a large proportion of CD4(+) memory T cells express intermediate levels of CD25, and this CD25(INT) FOXP3(-) subset is a functionally distinct memory population that is uniquely affected by IL-2.",22585674_5,0,1,2,-1,17457,-1,3.202542e-05,0.99995446,1.3520423e-05
17467,T(eff)-attracting chemokines,12,14,76,104,Colorectal tumors with reduced accumulation of T(eff) express low levels of T(eff)-attracting chemokines such as CXCL10/IP10 and CCL5/RANTES.,22593190_1,-1,-1,-1,-1,17467,-1,0.07308168,0.92220455,0.0047137504
17471,T(eff)-attracting chemokines,13,15,80,108,"In this study, we investigated the feasibility of enhancing tumor production of T(eff)-attracting chemokines as a cancer therapeutic strategy using a tissue explant culture system to analyze chemokine induction in intact tumor tissues.",22593190_2,-1,-1,-1,-1,17471,-1,0.075257786,0.9189016,0.0058406126
17473,tissue,22,23,150,156,"In this study, we investigated the feasibility of enhancing tumor production of T(eff)-attracting chemokines as a cancer therapeutic strategy using a tissue explant culture system to analyze chemokine induction in intact tumor tissues.",22593190_2,-1,1,2,-1,17473,-1,8.474272e-06,0.9999796,1.1948679e-05
17476,tumor tissues,32,34,221,234,"In this study, we investigated the feasibility of enhancing tumor production of T(eff)-attracting chemokines as a cancer therapeutic strategy using a tissue explant culture system to analyze chemokine induction in intact tumor tissues.",22593190_2,-1,-1,-1,-1,17476,-1,1.7551363e-05,0.99993074,5.1737527e-05
17478,to IFN,10,12,72,79,"In different tumor explants, we observed highly heterogeneous responses to IFN or poly-I:C (a TLR3 ligand) when they were applied individually.",22593190_3,-1,-1,-1,-1,17478,-1,0.96141803,0.03700159,0.0015803202
17487,this triple,1,3,9,20,"Applying this triple combination also uniformly suppressed the production of CCL22/MDC, a chemokine associated with infiltration of T regulatory cells (T(reg)).",22593190_6,-1,-1,-1,-1,17487,-1,6.560606e-06,0.9999882,5.237539e-06
17493,The T(eff)-enhancing,0,2,0,20,"The T(eff)-enhancing effects of this treatment occurred selectively in tumor tissues, as compared with tissues derived from tumor margins.",22593190_7,-1,-1,-1,-1,17493,-1,0.00013740995,0.9997923,7.02877e-05
17494,this treatment,4,6,32,46,"The T(eff)-enhancing effects of this treatment occurred selectively in tumor tissues, as compared with tissues derived from tumor margins.",22593190_7,-1,-1,-1,-1,17494,-1,5.1362376e-06,0.99999046,4.458884e-06
17495,tumor tissues,9,11,71,84,"The T(eff)-enhancing effects of this treatment occurred selectively in tumor tissues, as compared with tissues derived from tumor margins.",22593190_7,-1,-1,-1,-1,17495,-1,1.13824735e-05,0.9999107,7.7948156e-05
17496,tissues,15,16,103,110,"The T(eff)-enhancing effects of this treatment occurred selectively in tumor tissues, as compared with tissues derived from tumor margins.",22593190_7,-1,1,2,-1,17496,-1,1.9584706e-05,0.9996592,0.00032119805
17501,tumor-associated cells,8,10,52,74,"These effects relied on the increased propensity of tumor-associated cells (mostly fibroblasts and infiltrating inflammatory cells) to hyperactivate NF-B and produce T(eff)-attracting chemokines in response to treatment, resulting in an enhanced ability of the treated tumors to attract T(eff) cells and reduced ability to attract T(reg) cells.",22593190_8,-1,-1,-1,-1,17501,-1,0.002811425,0.74988276,0.24730581
17504,T(eff)-attracting chemokines,23,25,167,195,"These effects relied on the increased propensity of tumor-associated cells (mostly fibroblasts and infiltrating inflammatory cells) to hyperactivate NF-B and produce T(eff)-attracting chemokines in response to treatment, resulting in an enhanced ability of the treated tumors to attract T(eff) cells and reduced ability to attract T(reg) cells.",22593190_8,-1,-1,-1,-1,17504,-1,0.04426799,0.95300955,0.0027225418
17505,to treatment,27,29,208,220,"These effects relied on the increased propensity of tumor-associated cells (mostly fibroblasts and infiltrating inflammatory cells) to hyperactivate NF-B and produce T(eff)-attracting chemokines in response to treatment, resulting in an enhanced ability of the treated tumors to attract T(eff) cells and reduced ability to attract T(reg) cells.",22593190_8,-1,-1,-1,-1,17505,-1,5.08965e-06,0.9999901,4.7755057e-06
17506,the treated tumors to,36,40,258,279,"These effects relied on the increased propensity of tumor-associated cells (mostly fibroblasts and infiltrating inflammatory cells) to hyperactivate NF-B and produce T(eff)-attracting chemokines in response to treatment, resulting in an enhanced ability of the treated tumors to attract T(eff) cells and reduced ability to attract T(reg) cells.",22593190_8,-1,-1,-1,-1,17506,-1,3.460332e-06,0.9999926,3.964219e-06
17514,the tumor,12,14,86,95,"Together, our findings suggest the feasibility of exploiting NF-B hyperactivation in the tumor microenvironment to selectively enhance T(eff) entry into colon tumors.",22593190_9,-1,-1,-1,-1,17514,-1,4.499104e-06,0.9999912,4.314561e-06
17520,pleiotropic cytokine,6,8,26,46,"Interleukin-6 (IL-6) is a pleiotropic cytokine involved in the regulation of the cross talk between haematopoietic/immune cells and stromal cells, including the onset and resolution of inflammation, responses to infection, tissue remodelling and cancer.",22652781_0,-1,-1,-1,-1,17520,-1,0.13476601,0.860856,0.0043779644
17521,the regulation,10,12,59,73,"Interleukin-6 (IL-6) is a pleiotropic cytokine involved in the regulation of the cross talk between haematopoietic/immune cells and stromal cells, including the onset and resolution of inflammation, responses to infection, tissue remodelling and cancer.",22652781_0,-1,-1,-1,-1,17521,-1,4.898552e-06,0.99998975,5.3118033e-06
17528,tissue,35,36,223,229,"Interleukin-6 (IL-6) is a pleiotropic cytokine involved in the regulation of the cross talk between haematopoietic/immune cells and stromal cells, including the onset and resolution of inflammation, responses to infection, tissue remodelling and cancer.",22652781_0,-1,1,2,-1,17528,-1,0.0012561042,0.99087924,0.007864639
17532,receptor,12,13,83,91,"IL-6 can interact with both membrane-bound and soluble forms of its ligand-binding receptor, the IL-6Ralpha, triggering signalling via dimerization of gp130, the signalling subunit of the IL-6 receptor complex.",22652781_2,0,1,2,-1,17532,-1,0.0019990092,0.8692046,0.12879643
17533,the IL-6Ralpha,14,16,93,107,"IL-6 can interact with both membrane-bound and soluble forms of its ligand-binding receptor, the IL-6Ralpha, triggering signalling via dimerization of gp130, the signalling subunit of the IL-6 receptor complex.",22652781_2,-1,-1,-1,-1,17533,-1,0.022185119,0.9770701,0.0007447976
17537,the IL-6 receptor complex,28,32,184,209,"IL-6 can interact with both membrane-bound and soluble forms of its ligand-binding receptor, the IL-6Ralpha, triggering signalling via dimerization of gp130, the signalling subunit of the IL-6 receptor complex.",22652781_2,-1,-1,-1,-1,17537,-1,0.0007880422,0.9990687,0.0001433304
17539,to the,2,4,11,17,This leads to the activation of the JAK/STAT pathway and mainly culminates in the activation of the STAT3 transcription factor.,22652781_3,-1,-1,-1,-1,17539,-1,5.546404e-06,0.9999895,4.9250543e-06
17542,the STAT3 transcription factor,16,20,96,126,This leads to the activation of the JAK/STAT pathway and mainly culminates in the activation of the STAT3 transcription factor.,22652781_3,-1,-1,-1,-1,17542,-1,5.9458807e-06,0.9999888,5.289788e-06
17546,function,14,15,88,96,"Both IL-6 and STAT3 have recently emerged as main regulators of the differentiation and function of Th17 cells, via a positive feedback loop enhancing expression and/or activation of IL-6 itself, IL-17 and STAT3.",22652781_4,0,1,2,-1,17546,-1,9.502453e-05,0.99967384,0.00023110182
17547,Th17 cells,16,18,100,110,"Both IL-6 and STAT3 have recently emerged as main regulators of the differentiation and function of Th17 cells, via a positive feedback loop enhancing expression and/or activation of IL-6 itself, IL-17 and STAT3.",22652781_4,-1,-1,-1,-1,17547,-1,0.000105259,0.0020194766,0.9978752
17554,therapeutic targets,26,28,187,206,"Dysregulated IL-6 production and signalling are associated with chronic inflammatory diseases, auto-immunity and cancer, and are the object of intense translational research as promising therapeutic targets.",22652781_5,-1,-1,-1,-1,17554,-1,4.698883e-06,0.9999913,4.0376544e-06
17557,that TGF-beta,3,5,13,26,"Here we show that TGF-beta regulates proliferation, migration, and tumorigenicity of mesenchymal GBM cancer stem cells (CSCs) in vivo and in vitro.",22676416_2,-1,-1,-1,-1,17557,-1,0.00013129241,0.9998485,2.0148156e-05
17560,TGF-beta,7,8,41,49,"In contrast, proneural GBM CSCs resisted TGF-beta due to TGFR2 deficiency.",22676416_3,0,1,-1,-1,17560,-1,0.0005408395,0.9994209,3.8313887e-05
17561,to TGFR2 deficiency,9,12,54,73,"In contrast, proneural GBM CSCs resisted TGF-beta due to TGFR2 deficiency.",22676416_3,-1,-1,-1,-1,17561,-1,3.480359e-05,0.99995136,1.3869058e-05
17563,functional,2,3,5,15,"On a functional level, proneural CSC lines caused a significantly stronger TGF-beta-dependent suppression of NKG2D expression on CD8(+) T and NK cells in vitro providing a mechanistic explanation for the reduced immune infiltration of proneural GBMs.",22676416_5,0,1,2,-1,17563,-1,0.001111396,0.9986052,0.00028338327
17564,TGF-beta-dependent,12,13,75,93,"On a functional level, proneural CSC lines caused a significantly stronger TGF-beta-dependent suppression of NKG2D expression on CD8(+) T and NK cells in vitro providing a mechanistic explanation for the reduced immune infiltration of proneural GBMs.",22676416_5,0,1,-1,-1,17564,-1,2.5270672e-05,0.9999598,1.4950332e-05
17570,TGF-beta-dependently,7,8,36,56,"Thus, the molecular subtype of CSCs TGF-beta-dependently contributes to the degree of immune infiltration.",22676416_6,0,1,-1,-1,17570,-1,2.1247364e-05,0.9999672,1.1579147e-05
17571,to the,9,11,69,75,"Thus, the molecular subtype of CSCs TGF-beta-dependently contributes to the degree of immune infiltration.",22676416_6,-1,-1,-1,-1,17571,-1,6.069586e-06,0.9999888,5.1356706e-06
17585,analysis,10,11,61,69,"At 6 months following the first vaccination, flow cytometric analysis demonstrated a significant increase in the frequency of CD4+ICOS(hi) T cells from 52% pre-vaccination to 234% (p<0.001), with a concomitant decrease in the frequency of CD4+FoxP3+ T cells (regulatory T cells [Treg]) from 196 to 105% (p<0.05).",22678162_5,0,1,-1,-1,17585,-1,1.3147876e-05,0.9999732,1.3665397e-05
17594,analysis,1,2,8,16,ELISpot analysis of CD4+ICOS(hi) sorted T cells demonstrated that following vaccination the cytokines produced by Mam-A-specific T cells switched from IL-10 (7821 spm pre-vaccination to 3214 spm 5months post-vaccine p<0.001) to IFN- (126 spm pre-vaccination to 12431 spm 5months post-vaccine p<0.001).,22678162_6,0,1,-1,-1,17594,-1,6.322875e-06,0.9999883,5.3894946e-06
17597,the cytokines,12,14,88,101,ELISpot analysis of CD4+ICOS(hi) sorted T cells demonstrated that following vaccination the cytokines produced by Mam-A-specific T cells switched from IL-10 (7821 spm pre-vaccination to 3214 spm 5months post-vaccine p<0.001) to IFN- (126 spm pre-vaccination to 12431 spm 5months post-vaccine p<0.001).,22678162_6,-1,-1,-1,-1,17597,-1,0.513008,0.4829366,0.0040554088
17601,to IFN-,47,49,234,242,ELISpot analysis of CD4+ICOS(hi) sorted T cells demonstrated that following vaccination the cytokines produced by Mam-A-specific T cells switched from IL-10 (7821 spm pre-vaccination to 3214 spm 5months post-vaccine p<0.001) to IFN- (126 spm pre-vaccination to 12431 spm 5months post-vaccine p<0.001).,22678162_6,-1,-1,-1,-1,17601,-1,0.9800796,0.018551506,0.001368995
17604,T cells to,5,8,26,36,The ratio of CD4+ICOS(hi) T cells to CD4+FoxP3+ T cells increased from 0.370.12 before vaccination to 2.30.72 (p=0.021) following vaccination.,22678162_7,-1,-1,-1,-1,17604,-1,0.0012023549,0.029016702,0.9697809
17610,protein,18,19,119,126,"Further, these activated CD4+ICOS(hi) T cells induced preferential lysis of human breast cancer cells expressing Mam-A protein.",22678162_8,0,1,-1,-1,17610,-1,1.0984711e-05,0.99998295,6.068127e-06
17616,immunity,12,13,92,100,These encouraging results strongly suggest that Mam-A cDNA vaccination can induce antitumor immunity in breast cancer patients.,22678162_10,0,-1,2,-1,17616,-1,0.9999224,1.4190463e-05,6.341145e-05
17617,therapy,9,10,70,77,Intrinsic immunosuppression is a major obstacle for successful cancer therapy.,22678911_0,0,1,-1,-1,17617,-1,5.490881e-06,0.9999896,4.8206753e-06
17622,immunity,7,8,60,68,"A microenvironmental component that might prevent antitumor immunity is the presence of dying tumor cells, which are abundant following conventional cancer ablation methods such as chemo- or radiotherapy.",22678911_2,0,-1,2,-1,17622,-1,0.99983346,5.93559e-05,0.00010719866
17624,tumor cells,13,15,94,105,"A microenvironmental component that might prevent antitumor immunity is the presence of dying tumor cells, which are abundant following conventional cancer ablation methods such as chemo- or radiotherapy.",22678911_2,-1,-1,-1,-1,17624,-1,0.0001955904,0.0021229873,0.9976814
17626,factors to the tumor,7,11,49,69,"Shedding of apoptotic debris and/or secretion of factors to the tumor bed or draining lymph nodes thus might have a profound impact on professional phagocytes, such as DCs, and subsequent priming of lymphocytes.",22678911_3,-1,-1,-1,-1,17626,-1,0.11240398,0.88591594,0.0016800887
17634,tumor cells,12,14,93,104,"Priming with apoptotic debris prevented DCs from establishing cytotoxicity toward live human tumor cells by inducing a Treg-cell population, defined by coexpression of CD39 and CD69.",22678911_5,-1,-1,-1,-1,17634,-1,0.00048520905,0.022468949,0.97704583
17635,Treg-cell,17,18,119,128,"Priming with apoptotic debris prevented DCs from establishing cytotoxicity toward live human tumor cells by inducing a Treg-cell population, defined by coexpression of CD39 and CD69.",22678911_5,-1,1,2,-1,17635,-1,6.62529e-05,0.0003543831,0.99957937
17638,the release,8,10,63,74,"Immunosuppression via Treg cells was transferable and required the release of sphingosine-1-phosphate (S1P) from apoptotic cells, acting via S1P receptor 4 on DCs to induce IL-27 secretion.",22678911_6,-1,-1,-1,-1,17638,-1,6.8764016e-06,0.9999875,5.585135e-06
17640,receptor,22,23,145,153,"Immunosuppression via Treg cells was transferable and required the release of sphingosine-1-phosphate (S1P) from apoptotic cells, acting via S1P receptor 4 on DCs to induce IL-27 secretion.",22678911_6,0,1,2,-1,17640,-1,0.00011521989,0.00015544979,0.99972934
17644,them to,11,13,62,69,"We propose that CD69 expression on CD39(+) Treg cells enables them to interact with CD73-expressing CD8(+) T cells to generate adenosine, thereby suppressing cytotoxicity.",22678911_7,-1,-1,-1,-1,17644,-1,5.6166314e-06,0.999987,7.351208e-06
17645,T cells to generate,18,22,107,126,"We propose that CD69 expression on CD39(+) Treg cells enables them to interact with CD73-expressing CD8(+) T cells to generate adenosine, thereby suppressing cytotoxicity.",22678911_7,-1,-1,-1,-1,17645,-1,0.0043200115,0.16659096,0.82908905
17649,tumor cells,8,10,50,61,These findings aid the understanding of how dying tumor cells limit antitumor immunity.,22678911_8,-1,-1,-1,-1,17649,-1,0.00024189119,0.0016054902,0.99815255
17650,immunity,12,13,78,86,These findings aid the understanding of how dying tumor cells limit antitumor immunity.,22678911_8,0,-1,2,-1,17650,-1,0.9999101,2.4432165e-05,6.5495886e-05
17652,to Th1,8,10,63,69,"Autocrine IFN- signaling is important for CD4 differentiation to Th1 effector cells, but it has been unclear whether it contributes to CD8 T cell differentiation.",22706089_0,-1,-1,-1,-1,17652,-1,1.4671204e-05,0.99992514,6.015434e-05
17657,that naive,5,7,22,32,"We show in this paper that naive murine CD8 T cells rapidly and transiently produce low levels of IFN- upon stimulation with Ag and B7-1, with production peaking at 8 h and declining by 24 h. The autocrine IFN- signals for upregulation of expression of T-bet and granzyme B and induces weak cytolytic activity and effector IFN- production.",22706089_1,-1,-1,-1,-1,17657,-1,4.963633e-06,0.99999106,4.0160976e-06
17667,IFN- to,4,6,32,40,"IFN- acts synergistically with IFN- to support development of strong effector functions, whereas IL-12 induces high T-bet expression and strong function in the absence of IFN- signaling.",22706089_2,-1,-1,-1,-1,17667,-1,0.9992047,0.0005276485,0.00026768522
17668,functions,11,12,80,89,"IFN- acts synergistically with IFN- to support development of strong effector functions, whereas IL-12 induces high T-bet expression and strong function in the absence of IFN- signaling.",22706089_2,0,1,2,-1,17668,-1,0.0002101345,0.99913377,0.00065608014
17671,function,21,22,146,154,"IFN- acts synergistically with IFN- to support development of strong effector functions, whereas IL-12 induces high T-bet expression and strong function in the absence of IFN- signaling.",22706089_2,0,1,2,-1,17671,-1,2.0298232e-05,0.99996054,1.917876e-05
17678,factor,18,19,96,102,"Thus, IFN- is not only an important CD8 T cell effector cytokine, it is an autocrine/paracrine factor whose contributions to differentiation vary depending on whether the response is supported by IL-12 or type I IFN.",22706089_3,0,1,-1,-1,17678,-1,6.405908e-05,0.9999273,8.704539e-06
17687,protein,10,11,64,71,Our previous studies have demonstrated that hepatitis B virus X protein (HBx) was able to inhibit the growth of HCC cells via inducing apoptosis and inhibiting tumor angiogenesis.,22710287_1,0,1,-1,-1,17687,-1,0.0008103729,0.9989774,0.00021228469
17700,IL-12 named,36,38,264,275,"In this study, to further investigate the regulatory effect of IL-12 on HBx-mediated intervention of hepatoma microenvironment especially on intervention of neovessels and immune microenvironment, we constructed the recombinant adenovirus expressing HBx and mouse IL-12 named Ad-HBx-mIL-12.",22710287_3,-1,-1,-1,-1,17700,-1,0.9992681,0.00051459396,0.00021727248
17708,blood,37,38,218,223,"Moreover, treatment with Ad-HBx-mIL-12 not only induced a massive accumulation of immune cells (CD8(+) T leukocytes, macrophages and dendritic cells) in tumors in situ, also apparently reduced the number of angiogenic blood vessels within tumor tissues.",22710287_5,0,1,-1,-1,17708,-1,0.69949716,0.2602431,0.040259797
17709,tumor tissues,40,42,239,252,"Moreover, treatment with Ad-HBx-mIL-12 not only induced a massive accumulation of immune cells (CD8(+) T leukocytes, macrophages and dendritic cells) in tumors in situ, also apparently reduced the number of angiogenic blood vessels within tumor tissues.",22710287_5,-1,-1,-1,-1,17709,-1,1.0304994e-05,0.9999652,2.4505807e-05
17714,the tumor,22,24,131,140,"These results suggest that HBx-mIL-12 can not only induce cell cycle arrest and apoptosis in HCC cells, but also effectively shift the tumor microenvironment from pro-oncogenic to antitumor through recruitment of immune cells and inhibiting stromal cell growth, such as vascular endothelial cells.",22710287_6,-1,-1,-1,-1,17714,-1,3.8674616e-06,0.9999918,4.3471014e-06
17724,these cells,11,13,66,77,"However, the distribution, phenotypic features, and regulation of these cells in gastric cancer remain unknown.",22729557_1,-1,-1,-1,-1,17724,-1,1.8295104e-05,1.5715677e-05,0.999966
17728,blood,12,13,70,75,"METHODS: The levels of CD8(+)Foxp3(+) T lymphocytes in the peripheral blood, tumor-draining lymph nodes, non-tumor tissues, and tumor tissues of patients with gastric cancer were detected by flow cytometry.",22729557_2,0,1,-1,-1,17728,-1,0.0064821984,0.53618914,0.45732868
17730,tissues,19,20,115,122,"METHODS: The levels of CD8(+)Foxp3(+) T lymphocytes in the peripheral blood, tumor-draining lymph nodes, non-tumor tissues, and tumor tissues of patients with gastric cancer were detected by flow cytometry.",22729557_2,-1,1,2,-1,17730,-1,6.6409964e-05,0.99504733,0.004886273
17731,tumor tissues,22,24,128,141,"METHODS: The levels of CD8(+)Foxp3(+) T lymphocytes in the peripheral blood, tumor-draining lymph nodes, non-tumor tissues, and tumor tissues of patients with gastric cancer were detected by flow cytometry.",22729557_2,-1,-1,-1,-1,17731,-1,1.1954274e-05,0.99992514,6.288239e-05
17735,function,2,3,16,24,The suppressive function of CD8(+)Foxp3(+) T lymphocytes was analyzed by their effect on CD4(+) T-cell proliferation and IFN- production.,22729557_4,0,1,2,-1,17735,-1,1.2730064e-05,0.99997365,1.3669757e-05
17746,tumor tissues,10,12,58,71,"RESULTS: The frequency of CD8(+)Foxp3(+) T lymphocytes in tumor tissues was significantly higher than that in non-tumor tissues, and similar results were also observed in tumor-draining lymph nodes compared with peripheral blood.",22729557_6,-1,-1,-1,-1,17746,-1,1.42872605e-05,0.99992454,6.118568e-05
17747,than that,15,17,97,106,"RESULTS: The frequency of CD8(+)Foxp3(+) T lymphocytes in tumor tissues was significantly higher than that in non-tumor tissues, and similar results were also observed in tumor-draining lymph nodes compared with peripheral blood.",22729557_6,-1,-1,-1,-1,17747,-1,6.6873217e-06,0.99998796,5.3966573e-06
17748,tissues,19,20,120,127,"RESULTS: The frequency of CD8(+)Foxp3(+) T lymphocytes in tumor tissues was significantly higher than that in non-tumor tissues, and similar results were also observed in tumor-draining lymph nodes compared with peripheral blood.",22729557_6,-1,1,2,-1,17748,-1,2.2903136e-05,0.9995622,0.0004149155
17750,blood,34,35,223,228,"RESULTS: The frequency of CD8(+)Foxp3(+) T lymphocytes in tumor tissues was significantly higher than that in non-tumor tissues, and similar results were also observed in tumor-draining lymph nodes compared with peripheral blood.",22729557_6,0,1,-1,-1,17750,-1,0.008860542,0.2560772,0.7350623
17756,tumor tissues,14,16,95,108,"TGF-1 levels were positively correlated with the frequency of CD8(+)Foxp3(+) T lymphocytes in tumor tissues, and in vitro TGF-1 could induce the generation of CD8(+)Foxp3(+) T lymphocytes in a dose-dependent manner.",22729557_8,-1,-1,-1,-1,17756,-1,4.846212e-06,0.9999877,7.403784e-06
17758,the generation,23,25,143,157,"TGF-1 levels were positively correlated with the frequency of CD8(+)Foxp3(+) T lymphocytes in tumor tissues, and in vitro TGF-1 could induce the generation of CD8(+)Foxp3(+) T lymphocytes in a dose-dependent manner.",22729557_8,-1,-1,-1,-1,17758,-1,5.899613e-06,0.9999894,4.698668e-06
17772,T-cell functions,23,25,155,171,"CONCLUSIONS: Our data have shown that increased intratumoral CD8(+)Foxp3(+) T lymphocytes are associated with tumor stage and potentially influence CD4(+) T-cell functions, which may provide insights for developing novel immunotherapy protocols against gastric cancer.",22729557_11,-1,-1,-1,-1,17772,-1,1.3761892e-05,7.1989216e-06,0.99997914
17773,functional cell,2,4,15,30,Phenotypic and functional cell properties are usually analyzed at the level of defined cell populations but not single cells.,22735807_0,-1,-1,-1,-1,17773,-1,4.8387727e-05,2.4419816e-05,0.99992716
17778,functional,10,11,67,77,"Yet, large differences between individual cells may have important functional consequences.",22735807_1,0,1,2,-1,17778,-1,0.013233582,0.98527527,0.0014912005
17779,that T-cell-mediated immunity,3,6,13,42,"It is likely that T-cell-mediated immunity depends on the polyfunctionality of individual T cells, rather than the sum of functions of responding T-cell subpopulations.",22735807_2,-1,-1,-1,-1,17779,-1,0.029431775,0.3762894,0.5942789
17782,than the,16,18,106,114,"It is likely that T-cell-mediated immunity depends on the polyfunctionality of individual T cells, rather than the sum of functions of responding T-cell subpopulations.",22735807_2,-1,-1,-1,-1,17782,-1,5.766676e-06,0.9999894,4.7938183e-06
17783,functions,20,21,122,131,"It is likely that T-cell-mediated immunity depends on the polyfunctionality of individual T cells, rather than the sum of functions of responding T-cell subpopulations.",22735807_2,0,1,2,-1,17783,-1,0.0017840938,0.99763227,0.00058361626
17784,T-cell,23,24,146,152,"It is likely that T-cell-mediated immunity depends on the polyfunctionality of individual T cells, rather than the sum of functions of responding T-cell subpopulations.",22735807_2,-1,1,2,-1,17784,-1,1.01702735e-05,8.212999e-06,0.99998164
17787,tumor-specific T cells,19,22,147,169,"We performed highly sensitive single-cell gene expression profiling, allowing the direct ex vivo characterization of individual virus-specific and tumor-specific T cells from healthy donors and melanoma patients.",22735807_3,-1,-1,-1,-1,17787,-1,0.0030570964,0.7386616,0.25828132
17789,the natural tumor peptide,7,11,47,72,We have previously shown that vaccination with the natural tumor peptide Melan-A-induced T cells with superior effector functions as compared with vaccination with the analog peptide optimized for enhanced HLA-A*0201 binding.,22735807_4,-1,-1,-1,-1,17789,-1,8.522696e-06,0.99998605,5.3864865e-06
17791,functions,17,18,120,129,We have previously shown that vaccination with the natural tumor peptide Melan-A-induced T cells with superior effector functions as compared with vaccination with the analog peptide optimized for enhanced HLA-A*0201 binding.,22735807_4,0,1,2,-1,17791,-1,0.00050710817,0.00020696208,0.999286
17793,peptide,25,26,175,182,We have previously shown that vaccination with the natural tumor peptide Melan-A-induced T cells with superior effector functions as compared with vaccination with the analog peptide optimized for enhanced HLA-A*0201 binding.,22735807_4,0,-1,2,-1,17793,-1,2.3143048e-05,0.99996424,1.2629735e-05
17794,that natural peptide,3,6,14,34,"Here we found that natural peptide vaccination induced tumor-reactive CD8 T cells with frequent coexpression of both memory/homing-associated genes (CD27, IL7R, EOMES, CXCR3, and CCR5) and effector-related genes (IFNG, KLRD1, PRF1, and GZMB), comparable with protective Epstein-Barr virus-specific and cytomegalovirus-specific T cells.",22735807_5,-1,-1,-1,-1,17794,-1,0.00091603183,0.9989706,0.00011329733
17805,peptide,16,17,135,142,"In contrast, memory/homing-associated and effector-associated genes were less frequently coexpressed after vaccination with the analog peptide.",22735807_6,0,-1,2,-1,17805,-1,0.5492735,0.43885955,0.011867017
17813,functional gene,2,4,11,26,Such broad functional gene expression signatures within antigen-specific T cells may be critical for mounting efficient responses to pathogens or tumors.,22735807_8,-1,-1,-1,-1,17813,-1,4.1943e-05,0.99994636,1.1742484e-05
17814,antigen-specific T cells,7,10,56,80,Such broad functional gene expression signatures within antigen-specific T cells may be critical for mounting efficient responses to pathogens or tumors.,22735807_8,-1,-1,-1,-1,17814,-1,0.7117782,0.00056863565,0.28765318
17819,the functional,20,22,141,155,"In summary, direct ex vivo high-resolution molecular characterization of individual T cells provides key insights into the processes shaping the functional properties of tumor-specific and virus-specific T cells.",22735807_9,-1,-1,-1,-1,17819,-1,1.5799307e-05,0.9999747,9.4148645e-06
17824,toll-like receptor,7,9,45,63,AIM: To investigated the interaction between toll-like receptor 4 (TLR4)-activated hepatoma cells and macrophages in the induction of tumor-immune suppression mediated by CD4+CD25(high) family of transcription factor P3 (FOXP3) regulatory T cells (Tregs).METHODS: The proportion of FOXP3+ Tregs was identified in peripheral blood and tumor tissues of 60 hepatocellular carcinoma (HCC) patients.,22736917_0,-1,-1,-1,-1,17824,-1,0.000574415,0.9885351,0.010890481
17834,blood,48,49,324,329,AIM: To investigated the interaction between toll-like receptor 4 (TLR4)-activated hepatoma cells and macrophages in the induction of tumor-immune suppression mediated by CD4+CD25(high) family of transcription factor P3 (FOXP3) regulatory T cells (Tregs).METHODS: The proportion of FOXP3+ Tregs was identified in peripheral blood and tumor tissues of 60 hepatocellular carcinoma (HCC) patients.,22736917_0,0,1,-1,-1,17834,-1,0.00030364297,0.9983506,0.0013457921
17835,tumor tissues,50,52,334,347,AIM: To investigated the interaction between toll-like receptor 4 (TLR4)-activated hepatoma cells and macrophages in the induction of tumor-immune suppression mediated by CD4+CD25(high) family of transcription factor P3 (FOXP3) regulatory T cells (Tregs).METHODS: The proportion of FOXP3+ Tregs was identified in peripheral blood and tumor tissues of 60 hepatocellular carcinoma (HCC) patients.,22736917_0,-1,-1,-1,-1,17835,-1,7.572227e-06,0.999977,1.5417994e-05
17837,tumor tissues,5,7,32,45,TLR4 expression was examined in tumor tissues and cell lines.,22736917_1,-1,-1,-1,-1,17837,-1,6.523568e-06,0.9999802,1.3303322e-05
17842,blood,10,11,64,69,The correlation was examined between FOXP3+ Tregs in peripheral blood and TLR4 expression of HCC tissues.,22736917_2,0,1,-1,-1,17842,-1,0.0039201765,0.39815664,0.5979232
17844,tissues,16,17,97,104,The correlation was examined between FOXP3+ Tregs in peripheral blood and TLR4 expression of HCC tissues.,22736917_2,-1,1,2,-1,17844,-1,0.00082717225,0.0004323704,0.9987404
17850,cytokines tumor,26,28,171,186,"Following activation of TLR4 in H22 murine hepatoma cells pre-incubated with lipopolysaccharide (LPS) and co-cultured with macrophage cell line RAW246.7, the synthesis of cytokines tumor necrosis factor-, CCL22, and interleukin (IL)-10 by the two cell lines was detected and analyzed.",22736917_3,-1,-1,-1,-1,17850,-1,0.9984865,0.0010107309,0.0005028259
17851,factor-,29,30,196,204,"Following activation of TLR4 in H22 murine hepatoma cells pre-incubated with lipopolysaccharide (LPS) and co-cultured with macrophage cell line RAW246.7, the synthesis of cytokines tumor necrosis factor-, CCL22, and interleukin (IL)-10 by the two cell lines was detected and analyzed.",22736917_3,0,1,-1,-1,17851,-1,0.99995303,5.5918554e-06,4.1337844e-05
17854,the two cell,37,40,240,252,"Following activation of TLR4 in H22 murine hepatoma cells pre-incubated with lipopolysaccharide (LPS) and co-cultured with macrophage cell line RAW246.7, the synthesis of cytokines tumor necrosis factor-, CCL22, and interleukin (IL)-10 by the two cell lines was detected and analyzed.",22736917_3,-1,-1,-1,-1,17854,-1,0.004391088,0.5576513,0.43795764
17862,tissues,33,34,192,199,"RESULTS: FOXP3+ Tregs were enriched in tumor sites, and circulating FOXP3+ Tregs were increased in HCC patients in correlation with multiple tumor foci and up-regulated TLR4 expression in HCC tissues.",22736917_4,-1,1,2,-1,17862,-1,0.0005289948,0.045017898,0.9544531
17863,analysis,1,2,18,26,Semi-quantitative analysis indicated that TLR4 was over-expressed in HCC compared with the matched normal tissues.,22736917_5,0,1,-1,-1,17863,-1,6.160085e-06,0.9999889,4.8939255e-06
17864,that TLR4,3,5,37,46,Semi-quantitative analysis indicated that TLR4 was over-expressed in HCC compared with the matched normal tissues.,22736917_5,-1,-1,-1,-1,17864,-1,8.284417e-06,0.99998033,1.1391758e-05
17866,tissues,14,15,106,113,Semi-quantitative analysis indicated that TLR4 was over-expressed in HCC compared with the matched normal tissues.,22736917_5,-1,1,2,-1,17866,-1,0.00031899277,0.72342724,0.27625376
17868,that the,4,6,39,47,Cell cultivation experiments indicated that the mRNAs of IL-10 and CCL22 were significantly up-regulated in the RAW246.7 cell line when co-cultured with LPS pre-incubated H22 cells.,22736917_6,-1,-1,-1,-1,17868,-1,3.8823755e-06,0.99999166,4.466891e-06
17878,Tregs to the tumor,14,18,86,104,"CONCLUSION: In hepatoma cell lines, TLR4 may indirectly facilitate the recruitment of Tregs to the tumor site and promote intrahepatic metastasis through its interaction with macrophages.",22736917_7,-1,-1,-1,-1,17878,-1,4.015594e-06,0.9999906,5.3763856e-06
17882,function,7,8,57,65,NFAT transcription factors control T-cell activation and function.,22738913_0,0,1,2,-1,17882,-1,0.0028919044,0.011407861,0.98570025
17883,the transcription factor NFATc2,2,6,14,45,"Specifically, the transcription factor NFATc2 affects the regulation of cell differentiation and growth and plays a critical role in the development of colonic inflammation.",22738913_1,-1,-1,-1,-1,17883,-1,0.00017942113,0.9997888,3.1735104e-05
17884,the regulation,7,9,54,68,"Specifically, the transcription factor NFATc2 affects the regulation of cell differentiation and growth and plays a critical role in the development of colonic inflammation.",22738913_1,-1,-1,-1,-1,17884,-1,5.7809725e-06,0.99998784,6.324874e-06
17890,NFATc2 to the,16,19,114,127,"Here, we used an experimental model of colitis-associated colorectal carcinoma to investigate the contribution of NFATc2 to the promotion of colonic tumors.",22738913_2,-1,-1,-1,-1,17890,-1,6.0884027e-05,0.9999012,3.7956957e-05
17900,cytokines interleukin,30,32,223,244,"This observed decrease in colonic tumor progression was associated with reduced endoscopic inflammation, increased apoptosis of lamina propria T lymphocytes, and significantly reduced levels of the critical proinflammatory cytokines interleukin (IL)-21 and IL-6.",22738913_4,-1,-1,-1,-1,17900,-1,0.99994314,8.174176e-06,4.85897e-05
17907,Taken together,0,2,0,14,"Taken together, our findings highlight a pivotal role for NFATc2 in the establishment of inflammation-associated colorectal tumors mediated by control of IL-6 expression.",22738913_6,-1,-1,-1,-1,17907,-1,1.38313135e-05,0.99997556,1.0641755e-05
17918,tumor cells,3,5,20,31,"Stat3 inhibition in tumor cells induces the expression of chemokines and proinflammatory cytokines, so we proposed to apply Stat3-inhibited breast cancer cells as a source of immunogens to induce an antitumor immune response.",22753933_1,-1,-1,-1,-1,17918,-1,0.00060948334,0.038910836,0.96047974
17935,cells transfected,5,7,45,62,Prophylactic administration of breast cancer cells transfected with Stat3Y705F (Stat3Y705F-breast cancer cells) inhibited primary tumor growth compared with administration of empty vector-transfected cells in both models.,22753933_4,-1,-1,-1,-1,17935,-1,0.0025540246,0.20308076,0.7943652
17944,that the,7,9,37,45,In vivo assays of C4HD tumors showed that the antitumor immune response involves the participation of CD4(+) T cells and cytotoxic NK cells.,22753933_6,-1,-1,-1,-1,17944,-1,4.5291454e-06,0.9999914,4.071415e-06
17952,tumor cell,11,13,94,104,"Therapeutic immunization with Stat3Y705F-breast cancer cells inhibited tumor growth, promoted tumor cell differentiation, and decreased metastasis.",22753933_7,-1,-1,-1,-1,17952,-1,7.791181e-05,0.00034026147,0.99958175
17956,to their,15,17,109,117,"Furthermore, inhibition of Stat3 activation in breast cancer cells induced cellular senescence, contributing to their immunogenic phenotype.",22753933_8,-1,-1,-1,-1,17956,-1,1.0219403e-05,0.99998,9.815297e-06
17961,that Stat3,5,7,31,41,"Moreover, our findings showing that Stat3 inactivation results in induction of a cellular senescence program disclose a potential mechanism for immunotherapy research.",22753933_10,-1,-1,-1,-1,17961,-1,6.179729e-06,0.99998844,5.417833e-06
17965,immunity,6,7,42,50,Interleukin-12 (IL12) enhances anti-tumor immunity when delivered to the tumor microenvironment.,22777646_0,0,-1,2,-1,17965,-1,0.9998815,3.8059152e-05,8.042568e-05
17966,to the tumor,9,12,66,78,Interleukin-12 (IL12) enhances anti-tumor immunity when delivered to the tumor microenvironment.,22777646_0,-1,-1,-1,-1,17966,-1,6.0762595e-06,0.99998903,4.9379996e-06
17971,tumors to,8,10,47,56,The identity of these local mechanisms used by tumors to suppress immunosurveillance represents a key knowledge gap for improving tumor immunotherapy.,22777646_2,-1,-1,-1,-1,17971,-1,4.4180183e-06,0.9999918,3.7565885e-06
17973,immunity,9,10,60,68,"From a systems perspective, local suppression of anti-tumor immunity is a closed-loop system - where system response is determined by an unknown combination of external inputs and local cellular cross-talk.",22777646_3,0,-1,2,-1,17973,-1,0.99720484,0.00081704295,0.0019780954
17983,to IL12,28,30,167,174,"Following an induction period, the B16 melanoma cell model, a transplantable model for spontaneous malignant melanoma, inhibited the response of a T helper cell model to IL12.",22777646_5,-1,-1,-1,-1,17983,-1,0.91943616,0.07885532,0.0017085077
17988,protein-1,3,4,38,47,Tumor-derived Wnt-inducible signaling protein-1 (WISP-1) was identified to exert paracrine action on immune cells by inhibiting their response to IL12.,22777646_7,0,1,-1,-1,17988,-1,1.7192757e-05,0.99994016,4.2670694e-05
17992,to IL12,20,22,143,150,Tumor-derived Wnt-inducible signaling protein-1 (WISP-1) was identified to exert paracrine action on immune cells by inhibiting their response to IL12.,22777646_7,-1,-1,-1,-1,17992,-1,0.9633043,0.035576496,0.0011192351
17995,the tumor,20,22,125,134,"Moreover, WISP-1 was expressed in vivo following intradermal challenge with B16F10 cells and was inferred to be expressed at the tumor periphery.",22777646_8,-1,-1,-1,-1,17995,-1,4.0912937e-06,0.99999166,4.283388e-06
17999,immunity through,18,20,131,147,"Collectively, the data suggest that (1) biochemical cues associated with epithelial-to-mesenchymal transition can shape anti-tumor immunity through paracrine action and (2) remnants of the immunoselective pressure associated with evolution in cancer include both sculpting of tumor antigens and expression of proteins that proactively shape anti-tumor immunity.",22777646_9,-1,-1,-1,-1,17999,-1,0.39656308,0.60067624,0.0027606755
18001,tumor antigens,40,42,276,290,"Collectively, the data suggest that (1) biochemical cues associated with epithelial-to-mesenchymal transition can shape anti-tumor immunity through paracrine action and (2) remnants of the immunoselective pressure associated with evolution in cancer include both sculpting of tumor antigens and expression of proteins that proactively shape anti-tumor immunity.",22777646_9,-1,-1,-1,-1,18001,-1,0.6848604,0.3111203,0.004019281
18002,proteins that,45,47,309,322,"Collectively, the data suggest that (1) biochemical cues associated with epithelial-to-mesenchymal transition can shape anti-tumor immunity through paracrine action and (2) remnants of the immunoselective pressure associated with evolution in cancer include both sculpting of tumor antigens and expression of proteins that proactively shape anti-tumor immunity.",22777646_9,-1,-1,-1,-1,18002,-1,3.6713926e-05,0.99995065,1.2688622e-05
18003,immunity,50,51,352,360,"Collectively, the data suggest that (1) biochemical cues associated with epithelial-to-mesenchymal transition can shape anti-tumor immunity through paracrine action and (2) remnants of the immunoselective pressure associated with evolution in cancer include both sculpting of tumor antigens and expression of proteins that proactively shape anti-tumor immunity.",22777646_9,0,-1,2,-1,18003,-1,0.99985015,4.5804813e-05,0.00010399681
18005,T-cell,3,4,17,23,"Antitumor type I T-cell responses involving IFN- production are critical to control cancer, but the efficacy of this response is limited by a variety of immunosuppressive mechanisms that promote tumoral immune escape.",22798340_0,-1,1,2,-1,18005,-1,0.0019194889,0.043849234,0.95423126
18017,T cells that,20,23,111,123,"One critical mechanism involves the accumulation of FOXP3(+) T regulatory cells (Treg), a class of suppressive T cells that prevent excessive tissue destruction caused by unchecked immune responses.",22798340_1,-1,-1,-1,-1,18017,-1,0.0015532234,0.052977253,0.9454695
18018,tissue,25,26,142,148,"One critical mechanism involves the accumulation of FOXP3(+) T regulatory cells (Treg), a class of suppressive T cells that prevent excessive tissue destruction caused by unchecked immune responses.",22798340_1,-1,1,2,-1,18018,-1,0.00010753753,0.999691,0.00020150027
18020,that FOXP3(+,4,6,29,41,Recent studies have revealed that FOXP3(+) Treg include distinct subsets specifically controlling over the corresponding effector subset.,22798340_2,-1,-1,-1,-1,18020,-1,7.2001014e-05,0.9998908,3.722888e-05
18029,T-cell,19,20,98,104,"In particular, CXCR3(+) Treg have been described as a subset specialized in the control of type I T-cell responses in vivo.",22798340_3,-1,1,2,-1,18029,-1,2.6663252e-05,2.0681207e-05,0.9999527
18043,that they,8,10,47,56,"In addition, they coexpress Helios, suggesting that they originate from natural Treg.",22798340_6,-1,-1,-1,-1,18043,-1,5.7602347e-06,0.9999894,4.868947e-06
18044,natural Treg,12,14,72,84,"In addition, they coexpress Helios, suggesting that they originate from natural Treg.",22798340_6,-1,-1,-1,-1,18044,-1,8.352978e-06,0.9999863,5.336248e-06
18045,that the,4,6,17,25,"Finally, we show that the proportion of CXCR3(+) Treg at tumor sites is directly correlated with that of CXCR3(+) T effectors, consistent with expression of CXCR3 ligands.",22798340_7,-1,-1,-1,-1,18045,-1,3.833687e-06,0.99999225,3.9621464e-06
18052,that natural,7,9,43,55,"Together, our findings support the concept that natural CXCR3(+) T-bet(+) Treg selectively accumulate in ovarian tumors to control type I T-cell responses, resulting in the collateral limitation of efficient antitumor immunity.",22798340_8,-1,-1,-1,-1,18052,-1,8.096798e-06,0.9999876,4.3058976e-06
18055,tumors to,18,20,113,122,"Together, our findings support the concept that natural CXCR3(+) T-bet(+) Treg selectively accumulate in ovarian tumors to control type I T-cell responses, resulting in the collateral limitation of efficient antitumor immunity.",22798340_8,-1,-1,-1,-1,18055,-1,3.9378233e-06,0.99999225,3.8619864e-06
18057,T-cell,23,24,138,144,"Together, our findings support the concept that natural CXCR3(+) T-bet(+) Treg selectively accumulate in ovarian tumors to control type I T-cell responses, resulting in the collateral limitation of efficient antitumor immunity.",22798340_8,-1,1,2,-1,18057,-1,2.853167e-05,1.3665344e-05,0.9999578
18059,immunity,34,35,218,226,"Together, our findings support the concept that natural CXCR3(+) T-bet(+) Treg selectively accumulate in ovarian tumors to control type I T-cell responses, resulting in the collateral limitation of efficient antitumor immunity.",22798340_8,0,-1,2,-1,18059,-1,0.9998801,2.9602968e-05,9.0407986e-05
18061,T-cell transfer,6,8,36,51,We examined the effects of adoptive T-cell transfer (ACT) on the population of regulatory T cells (Tregs) in a mouse colorectal cancer transplant model.,22812187_0,-1,-1,-1,-1,18061,-1,0.00056345155,0.010654382,0.9887822
18068,blood,20,21,116,121,"In an in vivo study, Treg populations in Balb/c mice colon26 transplant model after ACT were analyzed in peripheral blood, local lymph node, and tumor.",22812187_1,0,1,-1,-1,18068,-1,0.0029864158,0.964253,0.032760587
18071,TGF-beta to,13,15,67,78,In an in vitro study CD4+ cells were cultured in medium containing TGF-beta to induce Tregs.,22812187_2,-1,-1,-1,-1,18071,-1,1.1772117e-05,0.99998045,7.8370385e-06
18074,this Treg,7,9,31,40,LAK cells were added or not in this Treg induction system.,22812187_3,-1,-1,-1,-1,18074,-1,8.153984e-06,0.9999856,6.2944955e-06
18099,Th17 cells,9,11,57,67,BACKGROUND: Recent studies suggest a potential impact of Th17 cells on tumor.,22820395_0,-1,-1,-1,-1,18099,-1,0.00021192347,0.0039076568,0.9958805
18103,Th17 cells,10,12,58,68,"In the present study, we investigated the distribution of Th17 cells in relation to Foxp3-expressing T cells in the tumor-infiltrating lymphocytes (TILs) from patients with uterine cervical cancer (UCC), cervical tissues from patients with cervical intraepithelial neoplasia (CIN) and healthy cervical tissues.",22820395_1,-1,-1,-1,-1,18103,-1,0.00012764249,0.0025905105,0.9972818
18104,relation to Foxp3-expressing T cells,13,18,72,108,"In the present study, we investigated the distribution of Th17 cells in relation to Foxp3-expressing T cells in the tumor-infiltrating lymphocytes (TILs) from patients with uterine cervical cancer (UCC), cervical tissues from patients with cervical intraepithelial neoplasia (CIN) and healthy cervical tissues.",22820395_1,-1,-1,-1,-1,18104,-1,0.0014196269,0.9017569,0.09682351
18105,the tumor-infiltrating lymphocytes,19,22,112,146,"In the present study, we investigated the distribution of Th17 cells in relation to Foxp3-expressing T cells in the tumor-infiltrating lymphocytes (TILs) from patients with uterine cervical cancer (UCC), cervical tissues from patients with cervical intraepithelial neoplasia (CIN) and healthy cervical tissues.",22820395_1,-1,-1,-1,-1,18105,-1,0.001362985,0.90441924,0.09421771
18107,tissues,36,37,213,220,"In the present study, we investigated the distribution of Th17 cells in relation to Foxp3-expressing T cells in the tumor-infiltrating lymphocytes (TILs) from patients with uterine cervical cancer (UCC), cervical tissues from patients with cervical intraepithelial neoplasia (CIN) and healthy cervical tissues.",22820395_1,-1,1,2,-1,18107,-1,0.00078013324,0.11563996,0.8835799
18108,tissues,49,50,302,309,"In the present study, we investigated the distribution of Th17 cells in relation to Foxp3-expressing T cells in the tumor-infiltrating lymphocytes (TILs) from patients with uterine cervical cancer (UCC), cervical tissues from patients with cervical intraepithelial neoplasia (CIN) and healthy cervical tissues.",22820395_1,-1,1,2,-1,18108,-1,0.00028159714,0.015302203,0.9844162
18109,Th17 cells,2,4,9,19,METHODS: Th17 cells and Foxp3-expressing T cells were evaluated by immunohistochemical staining.,22820395_2,-1,-1,-1,-1,18109,-1,0.00023875957,0.0057796445,0.99398154
18110,Foxp3-expressing T cells,5,8,24,48,METHODS: Th17 cells and Foxp3-expressing T cells were evaluated by immunohistochemical staining.,22820395_2,-1,-1,-1,-1,18110,-1,0.0017969114,0.8752204,0.12298268
18118,Th17 cells,16,18,85,95,"RESULTS: Compared with controls, patients with UCC or CIN had a higher proportion of Th17 cells and Foxp3-expressing T cells, when the ratio of Th17/Foxp3-expressing T cells in TILs was decreased in individual cases, it was more markedly decreased in TILs than normal cervical tissues.",22820395_5,-1,-1,-1,-1,18118,-1,2.934657e-05,0.00012354177,0.99984705
18119,Foxp3-expressing T cells,19,22,100,124,"RESULTS: Compared with controls, patients with UCC or CIN had a higher proportion of Th17 cells and Foxp3-expressing T cells, when the ratio of Th17/Foxp3-expressing T cells in TILs was decreased in individual cases, it was more markedly decreased in TILs than normal cervical tissues.",22820395_5,-1,-1,-1,-1,18119,-1,0.0014403291,0.89687115,0.10168848
18123,TILs than,44,46,251,260,"RESULTS: Compared with controls, patients with UCC or CIN had a higher proportion of Th17 cells and Foxp3-expressing T cells, when the ratio of Th17/Foxp3-expressing T cells in TILs was decreased in individual cases, it was more markedly decreased in TILs than normal cervical tissues.",22820395_5,-1,-1,-1,-1,18123,-1,4.1412272e-06,0.9999919,3.9307192e-06
18124,tissues,48,49,277,284,"RESULTS: Compared with controls, patients with UCC or CIN had a higher proportion of Th17 cells and Foxp3-expressing T cells, when the ratio of Th17/Foxp3-expressing T cells in TILs was decreased in individual cases, it was more markedly decreased in TILs than normal cervical tissues.",22820395_5,-1,1,2,-1,18124,-1,0.00039625008,0.01675733,0.98284644
18125,the cytokine(IL-6,2,4,11,28,"Meanwhile, the cytokine(IL-6, TGF- and IL-10) concentrations were significantly higher in UCC patients than those in healthy controls.",22820395_6,-1,-1,-1,-1,18125,-1,0.9456609,0.05247186,0.0018672959
18128,than those,16,18,104,114,"Meanwhile, the cytokine(IL-6, TGF- and IL-10) concentrations were significantly higher in UCC patients than those in healthy controls.",22820395_6,-1,-1,-1,-1,18128,-1,6.448718e-06,0.9999871,6.4258015e-06
18130,Th17 cells,6,8,42,52,"Interestingly, the levels of intratumoral Th17 cells were positively correlated with MVD in tumors.",22820395_7,-1,-1,-1,-1,18130,-1,8.6130036e-05,0.0008021499,0.9991117
18136,Th17 cells,20,22,130,140,CONCLUSIONS: The imbalance of Th17/Foxp3-expressing T cells may play critical roles in the development and progression of UCC and Th17 cells may promote tumor progression by fostering angiogenesis.,22820395_8,-1,-1,-1,-1,18136,-1,0.00029972044,0.012361571,0.9873388
18139,the transcriptomes,2,4,13,31,"By comparing the transcriptomes of primary and metastatic tumor cells in a mouse model of spontaneous bone metastasis, we found that a substantial number of genes suppressed in bone metastases are targets of the interferon regulatory factor Irf7.",22820642_1,-1,-1,-1,-1,18139,-1,5.9214763e-06,0.99998903,5.0028966e-06
18140,tumor cells,8,10,58,69,"By comparing the transcriptomes of primary and metastatic tumor cells in a mouse model of spontaneous bone metastasis, we found that a substantial number of genes suppressed in bone metastases are targets of the interferon regulatory factor Irf7.",22820642_1,-1,-1,-1,-1,18140,-1,0.0002858468,0.0046262555,0.9950879
18144,the interferon regulatory factor Irf7,34,39,208,245,"By comparing the transcriptomes of primary and metastatic tumor cells in a mouse model of spontaneous bone metastasis, we found that a substantial number of genes suppressed in bone metastases are targets of the interferon regulatory factor Irf7.",22820642_1,-1,-1,-1,-1,18144,-1,6.0433395e-05,0.99990606,3.3453674e-05
18146,tumor cells,4,6,23,34,Restoration of Irf7 in tumor cells or administration of interferon led to reduced bone metastases and prolonged survival time.,22820642_2,-1,-1,-1,-1,18146,-1,0.00064936944,0.026821865,0.97252876
18150,the interferon,4,6,21,35,"In mice deficient in the interferon (IFN) receptor or in natural killer (NK) and CD8(+) T cell responses, metastasis was accelerated, indicating that Irf7-driven suppression of metastasis was reliant on IFN signaling to host immune cells.",22820642_3,-1,-1,-1,-1,18150,-1,0.3534401,0.6416371,0.004922774
18152,receptor,9,10,42,50,"In mice deficient in the interferon (IFN) receptor or in natural killer (NK) and CD8(+) T cell responses, metastasis was accelerated, indicating that Irf7-driven suppression of metastasis was reliant on IFN signaling to host immune cells.",22820642_3,0,1,2,-1,18152,-1,0.00024059578,0.00040818166,0.9993512
18155,that Irf7-driven,29,31,145,161,"In mice deficient in the interferon (IFN) receptor or in natural killer (NK) and CD8(+) T cell responses, metastasis was accelerated, indicating that Irf7-driven suppression of metastasis was reliant on IFN signaling to host immune cells.",22820642_3,-1,-1,-1,-1,18155,-1,1.1496201e-05,0.9999802,8.31159e-06
18163,Irf7-regulated genes,17,19,103,123,We confirmed the clinical relevance of these findings in over 800 patients in which high expression of Irf7-regulated genes in primary tumors was associated with prolonged bone metastasis-free survival.,22820642_4,-1,-1,-1,-1,18163,-1,1.1063316e-05,0.99997795,1.0995472e-05
18165,This gene,0,2,0,9,This gene signature may identify patients that could benefit from IFN-based therapies.,22820642_5,-1,-1,-1,-1,18165,-1,6.77058e-06,0.9999864,6.8372447e-06
18167,IFN-based therapies,10,12,66,85,This gene signature may identify patients that could benefit from IFN-based therapies.,22820642_5,-1,-1,-1,-1,18167,-1,0.99870133,0.0008716744,0.00042698366
18177,cell transplantation,4,6,33,53,In allogeneic hematopoietic stem cell transplantation (allo-HSCT) therapy-related toxicity and alloreactivity increase inflammatory cytokines that might favor an MDSC accumulation.,22828446_2,-1,-1,-1,-1,18177,-1,0.0062405714,0.072345346,0.9214141
18178,therapy-related toxicity,9,11,66,90,In allogeneic hematopoietic stem cell transplantation (allo-HSCT) therapy-related toxicity and alloreactivity increase inflammatory cytokines that might favor an MDSC accumulation.,22828446_2,-1,-1,-1,-1,18178,-1,2.217977e-05,0.9999653,1.2465809e-05
18179,cytokines that,15,17,132,146,In allogeneic hematopoietic stem cell transplantation (allo-HSCT) therapy-related toxicity and alloreactivity increase inflammatory cytokines that might favor an MDSC accumulation.,22828446_2,-1,-1,-1,-1,18179,-1,0.9853813,0.013390414,0.001228357
18183,These cells,0,2,0,11,These cells represent one of the few well-described human MDSC subsets under physiological and pathological conditions.,22828446_4,-1,-1,-1,-1,18183,-1,2.0752186e-05,2.0391173e-05,0.9999589
18189,cells they,4,6,26,36,"Compared to healthy donor cells they were pSTAT1(low) (phosphorylated signal transducer and activator of transcription) and indoleamine 2,3-dioxygenase (IDO)(high).",22828446_6,-1,-1,-1,-1,18189,-1,0.003445029,0.46661618,0.52993876
18199,T-cell-suppressive,5,6,25,43,"Overall, we identified a T-cell-suppressive monocytic population that expands after allo-HSCT.",22828446_9,-1,1,2,-1,18199,-1,0.0013766512,0.0035150787,0.9951082
18205,these cells,12,14,75,86,It will be of great interest to prospectively investigate the influence of these cells on the graft-versus-tumor and -host reaction.,22828446_11,-1,-1,-1,-1,18205,-1,3.2953565e-05,3.3415574e-05,0.9999337
18214,T-cell,8,9,40,46,"In addition, there is an association of T-cell large granular lymphocytic leukemia with rheumatoid arthritis.",22830400_2,-1,1,2,-1,18214,-1,1.179463e-05,7.335783e-06,0.9999808
18217,antigen-driven immune response,9,12,46,76,It is believed that LGL leukemia begins as an antigen-driven immune response with subsequent constitutive activation of cytotoxic T lymphocytes or natural killer cells through PDGF and IL-15 contributing to their survival.,22830400_3,-1,-1,-1,-1,18217,-1,0.99996257,7.776697e-06,2.9737812e-05
18220,cells through,23,25,162,175,It is believed that LGL leukemia begins as an antigen-driven immune response with subsequent constitutive activation of cytotoxic T lymphocytes or natural killer cells through PDGF and IL-15 contributing to their survival.,22830400_3,-1,-1,-1,-1,18220,-1,0.004306593,0.26925617,0.7264372
18222,to their,29,31,204,212,It is believed that LGL leukemia begins as an antigen-driven immune response with subsequent constitutive activation of cytotoxic T lymphocytes or natural killer cells through PDGF and IL-15 contributing to their survival.,22830400_3,-1,-1,-1,-1,18222,-1,1.3148069e-05,0.99997354,1.330893e-05
18228,therapy,5,6,24,31,"However, no standard of therapy has been established, as large prospective trials have not been conducted.",22830400_6,0,1,-1,-1,18228,-1,5.5391324e-06,0.9999888,5.6443373e-06
18230,to treatment,7,9,42,54,"In addition, some patients are refractory to treatment.",22830400_7,-1,-1,-1,-1,18230,-1,7.1241693e-06,0.9999876,5.25968e-06
18232,therapy,5,6,23,30,The lack of a curative therapy for LGL leukemia means that new treatment options are needed.,22830400_8,0,1,-1,-1,18232,-1,1.022611e-05,0.99998283,6.900525e-06
18236,therapeutic treatment,13,15,91,112,Insight into the various dysregulated signaling pathways in LGL leukemia may provide novel therapeutic treatment modalities.,22830400_9,-1,-1,-1,-1,18236,-1,6.486478e-06,0.9999889,4.5995666e-06
18238,cytokine TGF-1,5,7,40,55,Elevated levels of the immunoregulatory cytokine TGF-1 in cancer and HIV infection have been linked to the suppression of protective immune responses.,22859956_0,-1,-1,-1,-1,18238,-1,0.47492355,0.51225716,0.012819317
18239,to the,15,17,101,107,Elevated levels of the immunoregulatory cytokine TGF-1 in cancer and HIV infection have been linked to the suppression of protective immune responses.,22859956_0,-1,-1,-1,-1,18239,-1,5.359518e-06,0.9999907,3.8870476e-06
18241,The transcriptional regulation,0,3,0,30,The transcriptional regulation of TGF-1 is complex and still not completely understood.,22859956_1,-1,-1,-1,-1,18241,-1,5.4137727e-06,0.9999901,4.475741e-06
18245,time that the transcription factor GLI2,6,12,29,68,We report here for the first time that the transcription factor GLI2 regulates the expression of TGF-1 in human CD4(+) T cells.,22859956_2,-1,-1,-1,-1,18245,-1,2.6695792e-05,0.99996114,1.2139073e-05
18255,the GLI2 activator,14,17,78,96,"At least two of these sites within the human TGF-1 promoter are regulated by the GLI2 activator as knockdown of GLI2 in regulatory CD4(+)CD25(hi) T cells, high producers of TGF-1, significantly decreased TGF-1 transcription.",22859956_4,-1,-1,-1,-1,18255,-1,7.3023853e-06,0.9999858,6.874535e-06
18259,TGF-1 transcription,35,37,206,226,"At least two of these sites within the human TGF-1 promoter are regulated by the GLI2 activator as knockdown of GLI2 in regulatory CD4(+)CD25(hi) T cells, high producers of TGF-1, significantly decreased TGF-1 transcription.",22859956_4,-1,-1,-1,-1,18259,-1,6.1766614e-06,0.9999869,6.921895e-06
18260,nave,2,3,14,19,"Additionally, nave CD4(+) T cells, low producers of TGF-1, increased their basal level of TGF-1 mRNA following lentiviral infection with GLI2.",22859956_5,-1,-1,-1,-1,18260,-1,6.3763564e-06,0.9999893,4.334134e-06
18265,The transcriptional regulation,0,3,0,30,The transcriptional regulation of TGF-1 by GLI2 is a new extension to Sonic Hedgehog (SHH) and TGF-1 cross-regulation and may provide insight into the detrimental elevation of TGF-1 leading to pathogenesis in cancer and HIV infection.,22859956_6,-1,-1,-1,-1,18265,-1,4.1920316e-06,0.99999154,4.317897e-06
18273,Tregs play,2,4,10,20,MDSCs and Tregs play an essential role in the immunosuppressive networks that contribute to tumor-immune evasion.,22891289_0,-1,-1,-1,-1,18273,-1,4.377342e-06,0.99999094,4.6730156e-06
18276,to tumor-immune,13,15,89,104,MDSCs and Tregs play an essential role in the immunosuppressive networks that contribute to tumor-immune evasion.,22891289_0,-1,-1,-1,-1,18276,-1,0.0020772885,0.9976902,0.0002324879
18280,function,9,10,60,68,The mechanisms by which tumors promote the expansion and/or function of these suppressive cells and the cross-talk between MDSC and Treg remain incompletely defined.,22891289_1,0,1,2,-1,18280,-1,0.00018401432,0.9996809,0.00013510093
18286,to Treg,8,10,57,64,Previous reports have suggested that MDSC may contribute to Treg induction in cancer.,22891289_2,-1,-1,-1,-1,18286,-1,1.4188624e-05,0.9999778,7.9271e-06
18287,that tumor-induced,5,7,28,46,"Herein, we provide evidence that tumor-induced gr-MDSCs, endowed with the potential of suppressing conventional T Lc, surprisingly impair TGF-1-mediated generation of CD4(+)CD25(+)FoxP3(+) iTregs.",22891289_3,-1,-1,-1,-1,18287,-1,6.926695e-06,0.9999877,5.3395443e-06
18290,TGF-1-mediated generation,21,23,138,164,"Herein, we provide evidence that tumor-induced gr-MDSCs, endowed with the potential of suppressing conventional T Lc, surprisingly impair TGF-1-mediated generation of CD4(+)CD25(+)FoxP3(+) iTregs.",22891289_3,-1,-1,-1,-1,18290,-1,7.4403247e-06,0.9999862,6.440409e-06
18313,the cytokine,32,34,210,222,"We tested how mcd-exosomes influence CD4+ T cell proliferation induced by bone marrow derived dendritic cells; we quantified NF-B activation in mature macrophages stimulated with mcd-exosomes, and we compared the cytokine profile of LPS-stimulated, IL-4 induced, and mcd-exosome treated macrophages.",22898052_1,-1,-1,-1,-1,18313,-1,0.47512984,0.5217605,0.0031095797
18320,the treated,17,19,114,125,"We observed that mcd-exosomes helped the maturation of dendritic cells, enhancing T cell proliferation induced by the treated dendritic cells.",22898052_2,-1,-1,-1,-1,18320,-1,5.6678027e-06,0.9999889,5.4736447e-06
18323,The cytokine,0,2,0,12,"The cytokine and chemokine profile of macrophages treated with tumor cell derived exosomes showed marked differences from those induced by either LPS or IL-4, and it suggested that exosomes may play a role in the tumor progression and metastasis formation through supporting tumor immune escape mechanisms.",22898052_4,-1,-1,-1,-1,18323,-1,0.41030833,0.5853296,0.0043620197
18326,tumor cell,9,11,63,73,"The cytokine and chemokine profile of macrophages treated with tumor cell derived exosomes showed marked differences from those induced by either LPS or IL-4, and it suggested that exosomes may play a role in the tumor progression and metastasis formation through supporting tumor immune escape mechanisms.",22898052_4,-1,-1,-1,-1,18326,-1,0.00031232653,0.0032648349,0.9964228
18331,the tumor,35,37,209,218,"The cytokine and chemokine profile of macrophages treated with tumor cell derived exosomes showed marked differences from those induced by either LPS or IL-4, and it suggested that exosomes may play a role in the tumor progression and metastasis formation through supporting tumor immune escape mechanisms.",22898052_4,-1,-1,-1,-1,18331,-1,4.07082e-06,0.9999913,4.6435102e-06
18336,therapy,18,19,129,136,"INTRODUCTION: In this study we describe a patient with a prolonged myasthenic crisis refractory to conventional immunomodulatory therapy who was treated with GM-CSF (granulocyte macrophage colony-stimulating factor, sargramostim).METHODS: T-regulatory cell (Treg) suppressive function and Foxp3 expression were evaluated before and after treatment with GM-CSF.RESULTS: Treatment with GM-CSF was associated with clinical improvement, expansion in the circulating numbers of Foxp3(+) cells, increase in Foxp3 expression levels in Tregs, early improvement in Treg suppressive capacity for AChR--induced T-cell proliferation, and subsequent enhancement in Treg suppression of polyclonal T-cell proliferation.",22907239_0,0,1,-1,-1,18336,-1,1.5056096e-05,0.99997306,1.1853673e-05
18340,T-regulatory cell,32,34,239,256,"INTRODUCTION: In this study we describe a patient with a prolonged myasthenic crisis refractory to conventional immunomodulatory therapy who was treated with GM-CSF (granulocyte macrophage colony-stimulating factor, sargramostim).METHODS: T-regulatory cell (Treg) suppressive function and Foxp3 expression were evaluated before and after treatment with GM-CSF.RESULTS: Treatment with GM-CSF was associated with clinical improvement, expansion in the circulating numbers of Foxp3(+) cells, increase in Foxp3 expression levels in Tregs, early improvement in Treg suppressive capacity for AChR--induced T-cell proliferation, and subsequent enhancement in Treg suppression of polyclonal T-cell proliferation.",22907239_0,-1,-1,-1,-1,18340,-1,0.0008408025,0.044289134,0.95487
18342,function,38,39,276,284,"INTRODUCTION: In this study we describe a patient with a prolonged myasthenic crisis refractory to conventional immunomodulatory therapy who was treated with GM-CSF (granulocyte macrophage colony-stimulating factor, sargramostim).METHODS: T-regulatory cell (Treg) suppressive function and Foxp3 expression were evaluated before and after treatment with GM-CSF.RESULTS: Treatment with GM-CSF was associated with clinical improvement, expansion in the circulating numbers of Foxp3(+) cells, increase in Foxp3 expression levels in Tregs, early improvement in Treg suppressive capacity for AChR--induced T-cell proliferation, and subsequent enhancement in Treg suppression of polyclonal T-cell proliferation.",22907239_0,0,1,2,-1,18342,-1,4.9746508e-05,0.99986076,8.945196e-05
18365,the type,24,26,143,151,BACKGROUND: Several studies have documented modulation of Th17 and T regulatory (Treg) cells in various human malignancies which may vary with the type and extent of the disease.,22956260_0,-1,-1,-1,-1,18365,-1,6.1141927e-06,0.999985,8.865541e-06
18370,these two T cell subsets,24,29,146,170,"However, such data in patients with oral cancer is scarce and hence the current study was designed to elaborate the immunological balance between these two T cell subsets in oral cancer.",22956260_1,-1,-1,-1,-1,18370,-1,0.00274654,0.14497921,0.85227424
18373,blood,13,14,74,79,METHODS AND RESULTS: We analyzed various T cell subsets in the peripheral blood of 45 oral squamous cell carcinoma (OSCC) patients and 40 healthy volunteers.,22956260_2,0,1,-1,-1,18373,-1,0.00057479605,0.98829937,0.0111258095
18380,relation to,43,45,226,237,"We found that, compared with the healthy controls, patients had a significantly (p < 0.0001) higher proportion of both Th17 (CD4(+)IL17A(+)) and Treg (CD4(+)CD25(+)FOXP3(+)) cells, which further showed a reciprocal balance in relation to clinico-pathological parameters in patients.",22956260_3,-1,-1,-1,-1,18380,-1,5.950494e-06,0.9999881,6.00149e-06
18382,these cells,9,11,48,59,"We also detected a circulating CD8(+) subset of these cells in both patients and healthy controls, although the difference between the two groups was statistically insignificant.",22956260_4,-1,-1,-1,-1,18382,-1,2.0382817e-05,1.4893496e-05,0.9999647
18384,the two,22,24,131,138,"We also detected a circulating CD8(+) subset of these cells in both patients and healthy controls, although the difference between the two groups was statistically insignificant.",22956260_4,-1,-1,-1,-1,18384,-1,8.014348e-06,0.99998724,4.7680696e-06
18386,Th17 cells,3,5,22,32,"Higher frequencies of Th17 cells were found in patients with early stages and without lymph node involvement, while an increased prevalence of Tregs was associated with higher clinical stages and lymph node involvement.",22956260_5,-1,-1,-1,-1,18386,-1,0.0006550504,0.023021493,0.9763234
18388,Th17 cells,2,4,10,20,"Moreover, Th17 cells were quantitatively and positively correlated to CD4(+)T and CD8(+)T cells and inversely correlated with Tregs.",22956260_6,-1,-1,-1,-1,18388,-1,0.00024606058,0.006813874,0.99294007
18393,CD4(+)T,8,9,53,60,"Contrarily, Tregs showed a negative association with CD4(+)T and CD8(+)T cells.",22956260_7,-1,-1,-1,-1,18393,-1,0.0024585081,0.012908009,0.9846335
18394,CD8(+)T cells,10,12,65,78,"Contrarily, Tregs showed a negative association with CD4(+)T and CD8(+)T cells.",22956260_7,-1,-1,-1,-1,18394,-1,4.0015377e-05,1.2670937e-05,0.9999473
18399,factor,12,13,74,80,Such counter regulation of Th17 and Tregs may be a significant prognostic factor in oral cancer patients.,22956260_9,0,1,-1,-1,18399,-1,0.00920982,0.99047756,0.00031258186
18401,histologically,11,12,85,99,"Using xMAP technology and RT-PCR, we investigated cytokine/chemokine profiles during histologically defined phases of disease: (i) no/mild, (ii) moderate, (iii) severe colitis without dysplasia/cancer and (iv) severe colitis with dysplasia/cancer, compared with age-matched wild-type (WT) littermates.",22962436_1,-1,-1,-1,-1,18401,-1,0.0017631925,0.99799013,0.00024669248
18403,thymus,15,16,104,110,"The histology correlated with progressive increases in colon weight/cm and spleen weight, and decreased thymus weight, all more advanced in mice with dysplasia/cancer.",22962436_3,-1,1,2,-1,18403,-1,7.7839206e-05,0.9998652,5.6980483e-05
18407,TNF-,8,9,30,35,"IL-1, IL-6, IL-12p40, IL-17, TNF-, CCL2 and CXCL1 protein levels in colons, but not small intestines increased with colitis progression and were significantly increased in mice with moderate and severe colitis compared with WT mice, irrespective of the absence/presence of dysplasia/cancer.",22962436_4,0,1,-1,-1,18407,-1,0.00023790998,0.9996798,8.227675e-05
18409,CXCL1 protein,12,14,46,59,"IL-1, IL-6, IL-12p40, IL-17, TNF-, CCL2 and CXCL1 protein levels in colons, but not small intestines increased with colitis progression and were significantly increased in mice with moderate and severe colitis compared with WT mice, irrespective of the absence/presence of dysplasia/cancer.",22962436_4,-1,-1,-1,-1,18409,-1,0.98363036,0.011964428,0.004405234
18411,IL-17 transcription,1,3,8,27,"Colonic IL-17 transcription increased 40- to 70-fold in all stages of colitis, whereas IFN- mRNA was gradually up-regulated 12- to 55-fold with colitis progression, and further to 62-fold in mice with dysplasia/cancer.",22962436_6,-1,-1,-1,-1,18411,-1,0.9986754,0.00084971555,0.0004748829
18420,FoxP3 transcription,0,2,0,19,"FoxP3 transcription was significantly enhanced (3.5-fold) in mice with moderate and severe colitis, but not in mice with dysplasia/cancer, compared with WT mice.",22962436_8,-1,-1,-1,-1,18420,-1,4.0165023e-06,0.9999918,4.2538345e-06
18421,analysis,2,3,27,35,"Constrained correspondence analysis demonstrated an association between increased protein levels of TNF-, CCL2, IL-1, IL-6 and CXCL1 and dysplasia/cancer.",22962436_9,0,1,-1,-1,18421,-1,2.1420066e-05,0.9999639,1.466345e-05
18422,protein,8,9,82,89,"Constrained correspondence analysis demonstrated an association between increased protein levels of TNF-, CCL2, IL-1, IL-6 and CXCL1 and dysplasia/cancer.",22962436_9,0,1,-1,-1,18422,-1,2.6749321e-05,0.99996066,1.2549283e-05
18423,TNF-,11,12,100,105,"Constrained correspondence analysis demonstrated an association between increased protein levels of TNF-, CCL2, IL-1, IL-6 and CXCL1 and dysplasia/cancer.",22962436_9,0,1,-1,-1,18423,-1,8.9235335e-05,0.9998652,4.552543e-05
18428,T(h)1 cytokine transcription,15,18,98,126,"In conclusion, colonic responses are dominated by a mixed T(h)1/T(h)17 phenotype, with increasing T(h)1 cytokine transcription with progression of colitis in Gi2(-/-) mice.",22962436_10,-1,-1,-1,-1,18428,-1,4.103495e-05,0.9999219,3.700406e-05
18429,immunity,1,2,11,19,Anti-tumor immunity is thought to play a significant role in chemotherapeutic response of breast tumors.,22986814_0,0,-1,2,-1,18429,-1,0.9997787,5.2106498e-05,0.00016923128
18430,thought to play,3,6,23,38,Anti-tumor immunity is thought to play a significant role in chemotherapeutic response of breast tumors.,22986814_0,-1,-1,-1,-1,18430,-1,9.244251e-06,0.99998295,7.777123e-06
18438,IL17F+ helper T cells,23,27,120,141,"In the present study, we investigated whether tumor infiltrating FOXP3+ regulatory T cells, CD8+ cytotoxic T cells, and IL17F+ helper T cells were associated with a pathological complete response (pCR) to neoadjuvant chemotherapy (NAC).",22986814_1,-1,-1,-1,-1,18438,-1,0.7773984,0.00048780776,0.22211377
18450,IL17F+ T cells,10,13,47,61,"Intratumoral infiltration of FOXP3+, CD8+, and IL17F+ T cells was observed in 62.2, 80.0, and 62.2% of tumors, respectively.",22986814_4,-1,-1,-1,-1,18450,-1,0.8541483,0.00036408138,0.14548759
18457,analysis,1,2,13,21,Multivariate analysis indicated that only FOXP3 infiltrates (P=0.014) and the conventional predictive factor Ki67 (P=0.031) were statistically significant and independent predictors of pCR.,22986814_6,0,1,-1,-1,18457,-1,8.870395e-06,0.999985,6.1819424e-06
18461,factor,18,19,104,110,Multivariate analysis indicated that only FOXP3 infiltrates (P=0.014) and the conventional predictive factor Ki67 (P=0.031) were statistically significant and independent predictors of pCR.,22986814_6,0,1,-1,-1,18461,-1,0.00021403721,0.9997484,3.750465e-05
18468,to NAC,19,21,108,114,"FOXP3 infiltrate, in combination with Ki67, could thus be used as a clinically useful predictor of response to NAC.",22986814_8,-1,-1,-1,-1,18468,-1,1.2102456e-05,0.9999765,1.1367101e-05
18472,immunity,16,17,118,126,"The possible indirect mechanism through which chemotherapy exerts its anti-tumor activity, i.e., enhancing anti-tumor immunity by inhibiting FOXP3, was also suggested.",22986814_9,0,-1,2,-1,18472,-1,0.9998399,3.724886e-05,0.00012279792
18474,The AP1 transcription factor,0,4,0,28,The AP1 transcription factor Batf3 is required for homeostatic development of CD8(+) classical dendritic cells that prime CD8 T-cell responses against intracellular pathogens.,22992524_0,-1,-1,-1,-1,18474,-1,5.6781514e-06,0.99998975,4.552309e-06
18475,cells that,15,17,106,116,The AP1 transcription factor Batf3 is required for homeostatic development of CD8(+) classical dendritic cells that prime CD8 T-cell responses against intracellular pathogens.,22992524_0,-1,-1,-1,-1,18475,-1,0.0060316343,0.3383406,0.6556278
18476,T-cell,19,20,127,133,The AP1 transcription factor Batf3 is required for homeostatic development of CD8(+) classical dendritic cells that prime CD8 T-cell responses against intracellular pathogens.,22992524_0,-1,1,2,-1,18476,-1,3.5583213e-05,8.730517e-06,0.99995565
18478,the cytokines interleukin,25,28,178,203,"Here we identify an alternative, Batf3-independent pathway in mice for CD8(+) dendritic cell development operating during infection with intracellular pathogens and mediated by the cytokines interleukin (IL)-12 and interferon-.",22992524_1,-1,-1,-1,-1,18478,-1,0.9245522,0.07217235,0.003275436
18481,the related AP1 factors,11,15,83,106,"This alternative pathway results from molecular compensation for Batf3 provided by the related AP1 factors Batf, which also functions in T and B cells, and Batf2 induced by cytokines in response to infection.",22992524_2,-1,-1,-1,-1,18481,-1,7.2693692e-06,0.9999871,5.5474807e-06
18482,functions,19,20,124,133,"This alternative pathway results from molecular compensation for Batf3 provided by the related AP1 factors Batf, which also functions in T and B cells, and Batf2 induced by cytokines in response to infection.",22992524_2,0,1,2,-1,18482,-1,7.962627e-05,0.9998809,3.944238e-05
18490,factors,3,4,24,31,Compensation among BATF factors is based on the shared capacity of their leucine zipper domains to interact with non-AP1 factors such as IRF4 and IRF8 to mediate cooperative gene activation.,22992524_4,0,1,-1,-1,18490,-1,9.863405e-06,0.99998367,6.4132714e-06
18494,factors,19,20,121,128,Compensation among BATF factors is based on the shared capacity of their leucine zipper domains to interact with non-AP1 factors such as IRF4 and IRF8 to mediate cooperative gene activation.,22992524_4,0,1,-1,-1,18494,-1,5.6948447e-06,0.99999,4.335117e-06
18496,IRF8 to,24,26,146,153,Compensation among BATF factors is based on the shared capacity of their leucine zipper domains to interact with non-AP1 factors such as IRF4 and IRF8 to mediate cooperative gene activation.,22992524_4,-1,-1,-1,-1,18496,-1,1.0457721e-05,0.99998116,8.417469e-06
18500,immune responses to,16,19,113,132,"Conceivably, manipulating this alternative pathway of dendritic cell development could be of value in augmenting immune responses to vaccines.",22992524_5,-1,-1,-1,-1,18500,-1,0.99856514,0.0012376809,0.00019719484
18501,gene therapy,1,3,16,28,Immune-mediated gene therapy using adenovirus expressing Flt3 ligand and thymidine kinase followed by ganciclovir administration (Flt3/TK) effectively elicits tumor regression in preclinical glioma models.,22996231_0,-1,-1,-1,-1,18501,-1,1.0068627e-05,0.99998295,6.9383836e-06
18507,the therapeutic,6,8,35,50,"Specifically, we aimed to optimize the therapeutic efficacy of Flt3L/TK treatment in the RG2 model by overexpressing the following genes within the brain tumor microenvironment: 1) a TK mutant with enhanced cytotoxicity (SR39 mutant TK), 2) Flt3L-IgG fusion protein that has a longer half-life, 3) CD40L to stimulate DC maturation, 4) T helper cell type 1 polarizing dendritic cell cytokines interleukin-12 or C-X-C motif ligand 10 chemokine (CXCL)-10, 5) C-C motif ligand 2 chemokine (CCL2) or C-C motif ligand 3 chemokine (CCL3) to enhance dendritic cell recruitment into the tumor microenvironment, 6) T helper cell type 1 cytokines interferon- or interleukin-2 to enhance effector T-cell functions, and 7) IB or p65RHD (nuclear factor kappa-B [NF-B] inhibitors) to suppress the function of Foxp3+ Tregs and enhanced effector T-cell functions.",22996231_2,-1,-1,-1,-1,18507,-1,3.935214e-06,0.99999225,3.8273342e-06
18517,CD40L to,54,56,298,306,"Specifically, we aimed to optimize the therapeutic efficacy of Flt3L/TK treatment in the RG2 model by overexpressing the following genes within the brain tumor microenvironment: 1) a TK mutant with enhanced cytotoxicity (SR39 mutant TK), 2) Flt3L-IgG fusion protein that has a longer half-life, 3) CD40L to stimulate DC maturation, 4) T helper cell type 1 polarizing dendritic cell cytokines interleukin-12 or C-X-C motif ligand 10 chemokine (CXCL)-10, 5) C-C motif ligand 2 chemokine (CCL2) or C-C motif ligand 3 chemokine (CCL3) to enhance dendritic cell recruitment into the tumor microenvironment, 6) T helper cell type 1 cytokines interferon- or interleukin-2 to enhance effector T-cell functions, and 7) IB or p65RHD (nuclear factor kappa-B [NF-B] inhibitors) to suppress the function of Foxp3+ Tregs and enhanced effector T-cell functions.",22996231_2,-1,-1,-1,-1,18517,-1,0.0010621762,0.0021746664,0.9967631
18518,T helper cell type,62,66,335,353,"Specifically, we aimed to optimize the therapeutic efficacy of Flt3L/TK treatment in the RG2 model by overexpressing the following genes within the brain tumor microenvironment: 1) a TK mutant with enhanced cytotoxicity (SR39 mutant TK), 2) Flt3L-IgG fusion protein that has a longer half-life, 3) CD40L to stimulate DC maturation, 4) T helper cell type 1 polarizing dendritic cell cytokines interleukin-12 or C-X-C motif ligand 10 chemokine (CXCL)-10, 5) C-C motif ligand 2 chemokine (CCL2) or C-C motif ligand 3 chemokine (CCL3) to enhance dendritic cell recruitment into the tumor microenvironment, 6) T helper cell type 1 cytokines interferon- or interleukin-2 to enhance effector T-cell functions, and 7) IB or p65RHD (nuclear factor kappa-B [NF-B] inhibitors) to suppress the function of Foxp3+ Tregs and enhanced effector T-cell functions.",22996231_2,-1,-1,-1,-1,18518,-1,0.00010749554,0.001877521,0.9980149
18519,cell cytokines interleukin-12,69,72,377,406,"Specifically, we aimed to optimize the therapeutic efficacy of Flt3L/TK treatment in the RG2 model by overexpressing the following genes within the brain tumor microenvironment: 1) a TK mutant with enhanced cytotoxicity (SR39 mutant TK), 2) Flt3L-IgG fusion protein that has a longer half-life, 3) CD40L to stimulate DC maturation, 4) T helper cell type 1 polarizing dendritic cell cytokines interleukin-12 or C-X-C motif ligand 10 chemokine (CXCL)-10, 5) C-C motif ligand 2 chemokine (CCL2) or C-C motif ligand 3 chemokine (CCL3) to enhance dendritic cell recruitment into the tumor microenvironment, 6) T helper cell type 1 cytokines interferon- or interleukin-2 to enhance effector T-cell functions, and 7) IB or p65RHD (nuclear factor kappa-B [NF-B] inhibitors) to suppress the function of Foxp3+ Tregs and enhanced effector T-cell functions.",22996231_2,-1,-1,-1,-1,18519,-1,0.96970874,0.00047190132,0.0298194
18527,the tumor,105,107,574,583,"Specifically, we aimed to optimize the therapeutic efficacy of Flt3L/TK treatment in the RG2 model by overexpressing the following genes within the brain tumor microenvironment: 1) a TK mutant with enhanced cytotoxicity (SR39 mutant TK), 2) Flt3L-IgG fusion protein that has a longer half-life, 3) CD40L to stimulate DC maturation, 4) T helper cell type 1 polarizing dendritic cell cytokines interleukin-12 or C-X-C motif ligand 10 chemokine (CXCL)-10, 5) C-C motif ligand 2 chemokine (CCL2) or C-C motif ligand 3 chemokine (CCL3) to enhance dendritic cell recruitment into the tumor microenvironment, 6) T helper cell type 1 cytokines interferon- or interleukin-2 to enhance effector T-cell functions, and 7) IB or p65RHD (nuclear factor kappa-B [NF-B] inhibitors) to suppress the function of Foxp3+ Tregs and enhanced effector T-cell functions.",22996231_2,-1,-1,-1,-1,18527,-1,4.6016717e-06,0.9999906,4.7664535e-06
18528,T helper cell type,111,115,605,623,"Specifically, we aimed to optimize the therapeutic efficacy of Flt3L/TK treatment in the RG2 model by overexpressing the following genes within the brain tumor microenvironment: 1) a TK mutant with enhanced cytotoxicity (SR39 mutant TK), 2) Flt3L-IgG fusion protein that has a longer half-life, 3) CD40L to stimulate DC maturation, 4) T helper cell type 1 polarizing dendritic cell cytokines interleukin-12 or C-X-C motif ligand 10 chemokine (CXCL)-10, 5) C-C motif ligand 2 chemokine (CCL2) or C-C motif ligand 3 chemokine (CCL3) to enhance dendritic cell recruitment into the tumor microenvironment, 6) T helper cell type 1 cytokines interferon- or interleukin-2 to enhance effector T-cell functions, and 7) IB or p65RHD (nuclear factor kappa-B [NF-B] inhibitors) to suppress the function of Foxp3+ Tregs and enhanced effector T-cell functions.",22996231_2,-1,-1,-1,-1,18528,-1,0.00017632861,0.007284312,0.99253935
18529,cytokines interferon-,116,118,626,648,"Specifically, we aimed to optimize the therapeutic efficacy of Flt3L/TK treatment in the RG2 model by overexpressing the following genes within the brain tumor microenvironment: 1) a TK mutant with enhanced cytotoxicity (SR39 mutant TK), 2) Flt3L-IgG fusion protein that has a longer half-life, 3) CD40L to stimulate DC maturation, 4) T helper cell type 1 polarizing dendritic cell cytokines interleukin-12 or C-X-C motif ligand 10 chemokine (CXCL)-10, 5) C-C motif ligand 2 chemokine (CCL2) or C-C motif ligand 3 chemokine (CCL3) to enhance dendritic cell recruitment into the tumor microenvironment, 6) T helper cell type 1 cytokines interferon- or interleukin-2 to enhance effector T-cell functions, and 7) IB or p65RHD (nuclear factor kappa-B [NF-B] inhibitors) to suppress the function of Foxp3+ Tregs and enhanced effector T-cell functions.",22996231_2,-1,-1,-1,-1,18529,-1,0.9999697,3.879885e-06,2.6383039e-05
18530,interleukin-2 to,119,121,652,668,"Specifically, we aimed to optimize the therapeutic efficacy of Flt3L/TK treatment in the RG2 model by overexpressing the following genes within the brain tumor microenvironment: 1) a TK mutant with enhanced cytotoxicity (SR39 mutant TK), 2) Flt3L-IgG fusion protein that has a longer half-life, 3) CD40L to stimulate DC maturation, 4) T helper cell type 1 polarizing dendritic cell cytokines interleukin-12 or C-X-C motif ligand 10 chemokine (CXCL)-10, 5) C-C motif ligand 2 chemokine (CCL2) or C-C motif ligand 3 chemokine (CCL3) to enhance dendritic cell recruitment into the tumor microenvironment, 6) T helper cell type 1 cytokines interferon- or interleukin-2 to enhance effector T-cell functions, and 7) IB or p65RHD (nuclear factor kappa-B [NF-B] inhibitors) to suppress the function of Foxp3+ Tregs and enhanced effector T-cell functions.",22996231_2,-1,-1,-1,-1,18530,-1,0.99838936,0.0011788731,0.0004318264
18531,T-cell functions,123,125,686,702,"Specifically, we aimed to optimize the therapeutic efficacy of Flt3L/TK treatment in the RG2 model by overexpressing the following genes within the brain tumor microenvironment: 1) a TK mutant with enhanced cytotoxicity (SR39 mutant TK), 2) Flt3L-IgG fusion protein that has a longer half-life, 3) CD40L to stimulate DC maturation, 4) T helper cell type 1 polarizing dendritic cell cytokines interleukin-12 or C-X-C motif ligand 10 chemokine (CXCL)-10, 5) C-C motif ligand 2 chemokine (CCL2) or C-C motif ligand 3 chemokine (CCL3) to enhance dendritic cell recruitment into the tumor microenvironment, 6) T helper cell type 1 cytokines interferon- or interleukin-2 to enhance effector T-cell functions, and 7) IB or p65RHD (nuclear factor kappa-B [NF-B] inhibitors) to suppress the function of Foxp3+ Tregs and enhanced effector T-cell functions.",22996231_2,-1,-1,-1,-1,18531,-1,1.994202e-05,1.2670697e-05,0.99996746
18534,the function,143,145,782,794,"Specifically, we aimed to optimize the therapeutic efficacy of Flt3L/TK treatment in the RG2 model by overexpressing the following genes within the brain tumor microenvironment: 1) a TK mutant with enhanced cytotoxicity (SR39 mutant TK), 2) Flt3L-IgG fusion protein that has a longer half-life, 3) CD40L to stimulate DC maturation, 4) T helper cell type 1 polarizing dendritic cell cytokines interleukin-12 or C-X-C motif ligand 10 chemokine (CXCL)-10, 5) C-C motif ligand 2 chemokine (CCL2) or C-C motif ligand 3 chemokine (CCL3) to enhance dendritic cell recruitment into the tumor microenvironment, 6) T helper cell type 1 cytokines interferon- or interleukin-2 to enhance effector T-cell functions, and 7) IB or p65RHD (nuclear factor kappa-B [NF-B] inhibitors) to suppress the function of Foxp3+ Tregs and enhanced effector T-cell functions.",22996231_2,-1,-1,-1,-1,18534,-1,7.4989052e-06,0.9999839,8.5349275e-06
18537,T-cell functions,152,154,833,849,"Specifically, we aimed to optimize the therapeutic efficacy of Flt3L/TK treatment in the RG2 model by overexpressing the following genes within the brain tumor microenvironment: 1) a TK mutant with enhanced cytotoxicity (SR39 mutant TK), 2) Flt3L-IgG fusion protein that has a longer half-life, 3) CD40L to stimulate DC maturation, 4) T helper cell type 1 polarizing dendritic cell cytokines interleukin-12 or C-X-C motif ligand 10 chemokine (CXCL)-10, 5) C-C motif ligand 2 chemokine (CCL2) or C-C motif ligand 3 chemokine (CCL3) to enhance dendritic cell recruitment into the tumor microenvironment, 6) T helper cell type 1 cytokines interferon- or interleukin-2 to enhance effector T-cell functions, and 7) IB or p65RHD (nuclear factor kappa-B [NF-B] inhibitors) to suppress the function of Foxp3+ Tregs and enhanced effector T-cell functions.",22996231_2,-1,-1,-1,-1,18537,-1,1.762184e-05,1.1426686e-05,0.9999709
18538,immunity,1,2,11,19,Anti-tumor immunity and tumor specific effector T-cell functions were assessed by cytotoxic T lymphocyte assay and intracellular IFN- staining.,22996231_3,0,-1,2,-1,18538,-1,0.9996197,0.00012398645,0.00025636036
18540,T-cell functions,6,8,48,64,Anti-tumor immunity and tumor specific effector T-cell functions were assessed by cytotoxic T lymphocyte assay and intracellular IFN- staining.,22996231_3,-1,-1,-1,-1,18540,-1,1.0568301e-05,8.848962e-06,0.99998057
18546,the nuclear factor kappa-B,13,17,87,113,"Our data showed that overexpression of interferon- or interleukin-2, or inhibition of the nuclear factor kappa-B within the tumor microenvironment, enhanced cytotoxic T lymphocyte-mediated immune responses and successfully extended the median survival of rats bearing intracranial RG2 when combined with Flt3L/TK.",22996231_4,-1,-1,-1,-1,18546,-1,2.5826144e-05,0.99993885,3.53011e-05
18547,the tumor,18,20,121,130,"Our data showed that overexpression of interferon- or interleukin-2, or inhibition of the nuclear factor kappa-B within the tumor microenvironment, enhanced cytotoxic T lymphocyte-mediated immune responses and successfully extended the median survival of rats bearing intracranial RG2 when combined with Flt3L/TK.",22996231_4,-1,-1,-1,-1,18547,-1,4.145405e-06,0.9999912,4.6654554e-06
18548,T lymphocyte-mediated immune responses,24,28,168,206,"Our data showed that overexpression of interferon- or interleukin-2, or inhibition of the nuclear factor kappa-B within the tumor microenvironment, enhanced cytotoxic T lymphocyte-mediated immune responses and successfully extended the median survival of rats bearing intracranial RG2 when combined with Flt3L/TK.",22996231_4,-1,-1,-1,-1,18548,-1,0.034251712,0.0006223882,0.9651259
18552,T-cell functions,6,8,44,60,These findings indicate that enhancement of T-cell functions constitutes a critical therapeutic target to overcome immune evasion and enhance therapeutic efficacy for brain cancer.,22996231_5,-1,-1,-1,-1,18552,-1,1.9664874e-05,1.0709598e-05,0.9999696
18553,therapeutic target to,11,14,84,105,These findings indicate that enhancement of T-cell functions constitutes a critical therapeutic target to overcome immune evasion and enhance therapeutic efficacy for brain cancer.,22996231_5,-1,-1,-1,-1,18553,-1,6.2084177e-06,0.99998903,4.761866e-06
18555,targets to,7,9,38,48,"In addition, our study provides novel targets to be used in combination with immune-therapeutic strategies for glioblastoma, which are currently being tested in the clinic.",22996231_6,-1,-1,-1,-1,18555,-1,4.1293474e-06,0.99999154,4.3584746e-06
18558,cell functions,7,9,46,60,Baseline levels of innate and adaptive immune cell functions were studied in patients with pancreatic cancer.,22996369_0,-1,-1,-1,-1,18558,-1,3.9177157e-05,1.8587783e-05,0.9999422
18560,therapy then,13,15,71,83,The effects of pemetrexed were measured at 7 and 14 days after initial therapy then 14 days after combination therapy with gemcitabine.,22996369_1,-1,-1,-1,-1,18560,-1,6.1013657e-06,0.9999887,5.1640277e-06
18561,therapy,19,20,110,117,The effects of pemetrexed were measured at 7 and 14 days after initial therapy then 14 days after combination therapy with gemcitabine.,22996369_1,0,1,-1,-1,18561,-1,9.481723e-06,0.99998236,8.171285e-06
18568,cells that,12,14,81,91,Pemetrexed increased intracellular accumulation of interferon gamma (IFN) in NK cells that correlated negatively with survival.,22996369_5,-1,-1,-1,-1,18568,-1,0.0031138747,0.43058023,0.56630594
18570,cells to,6,8,52,60,Addition of gemcitabine decreased IFN-producing NK cells to baseline.,22996369_6,-1,-1,-1,-1,18570,-1,0.0031971843,0.35130298,0.6454999
18572,therapy,19,20,117,124,Memory (CD45RO*) T cells enumerated at baseline correlated negatively with survival but were decreased by pemetrexed therapy.,22996369_7,0,1,-1,-1,18572,-1,6.5416116e-06,0.9999889,4.554915e-06
18575,tumor tissue,12,14,75,87,"Memory T cells were increased in subjects with greater B7-H3 expression in tumor tissue, whereas OX40*-activated total T cells and helper T-cell subset were decreased.",22996369_8,-1,-1,-1,-1,18575,-1,6.22057e-06,0.9999875,6.3517036e-06
18576,total T cells,19,22,113,126,"Memory T cells were increased in subjects with greater B7-H3 expression in tumor tissue, whereas OX40*-activated total T cells and helper T-cell subset were decreased.",22996369_8,-1,-1,-1,-1,18576,-1,0.00057866774,0.01235428,0.98706704
18577,helper T-cell subset,23,26,131,151,"Memory T cells were increased in subjects with greater B7-H3 expression in tumor tissue, whereas OX40*-activated total T cells and helper T-cell subset were decreased.",22996369_8,-1,-1,-1,-1,18577,-1,6.735135e-05,8.1963735e-05,0.99985063
18580,immunity,5,6,30,38,"In conclusion, innate NK-cell immunity and FoxP3*, CD8* T cells seemed beneficial to pancreatic cancer patients.",22996369_10,0,-1,2,-1,18580,-1,0.08026371,0.00019903299,0.91953725
18587,immunity,12,13,85,93,Higher levels of B7-H3 expression in pancreatic tumors were detrimental to effective immunity.,22996369_11,0,-1,2,-1,18587,-1,0.9998115,8.801152e-05,0.000100560435
18588,therapy,2,3,20,27,"Although pemetrexed therapy increased activation of a subset of NK cells to produce IFN, addition of gemcitabine abated those responses, decreasing IFN-producing NK cells, whereas NK cells producing interleukin-2 without IFN at this timepoint positively correlated with survival.",22996369_12,0,1,-1,-1,18588,-1,6.733042e-06,0.99998856,4.6619743e-06
18590,cells to,10,12,67,75,"Although pemetrexed therapy increased activation of a subset of NK cells to produce IFN, addition of gemcitabine abated those responses, decreasing IFN-producing NK cells, whereas NK cells producing interleukin-2 without IFN at this timepoint positively correlated with survival.",22996369_12,-1,-1,-1,-1,18590,-1,0.002846864,0.3050345,0.69211864
18598,this timepoint,35,37,231,245,"Although pemetrexed therapy increased activation of a subset of NK cells to produce IFN, addition of gemcitabine abated those responses, decreasing IFN-producing NK cells, whereas NK cells producing interleukin-2 without IFN at this timepoint positively correlated with survival.",22996369_12,-1,-1,-1,-1,18598,-1,1.7193177e-05,0.9999722,1.0606682e-05
18600,adaptive immunity thus,3,6,20,42,Innate immunity and adaptive immunity thus are important in defense against pancreatic cancer.,22996369_13,-1,-1,-1,-1,18600,-1,0.9843311,0.014646131,0.0010228753
18612,the tumor,8,10,60,69,"Tregs can prevent anti-tumor-specific T cells from clearing the tumor, making Tregs a significant barrier for effective immunotherapy.",23000301_1,-1,-1,-1,-1,18612,-1,4.4693747e-06,0.9999906,4.965131e-06
18617,blood,13,14,71,76,An increase in the number of Tregs has been detected in the peripheral blood and tumor infiltrating lymphocytes of patients with hepatocellular carcinoma.,23000301_2,0,1,-1,-1,18617,-1,0.0010720458,0.9364816,0.062446337
18621,antigen-presenting cells that play,6,10,26,60,Dendritic cells (DCs) are antigen-presenting cells that play a pivotal role in the initiation of immune responses.,23000301_3,-1,-1,-1,-1,18621,-1,0.97613835,0.017453708,0.006407972
18632,immunity,28,29,186,194,The evidence for their ability to act as natural adjuvant in the stimulation of specific anti-tumor cytotoxic T lymphocytes and in the induction of protective and therapeutic anti-tumor immunity is now overwhelming.,23000301_4,0,-1,2,-1,18632,-1,0.99975175,6.0157563e-05,0.00018806188
18638,the tumor,21,23,123,132,The aim of our study was to investigate the variation of Tregs in hepatocellular carcinoma mice and how Tregs derived from the tumor mice affect DCs' function.,23000301_5,-1,-1,-1,-1,18638,-1,4.674395e-06,0.99999034,5.01684e-06
18639,function,27,28,150,158,The aim of our study was to investigate the variation of Tregs in hepatocellular carcinoma mice and how Tregs derived from the tumor mice affect DCs' function.,23000301_5,0,1,2,-1,18639,-1,9.1905895e-05,0.9997054,0.00020275013
18640,that Tregs,2,4,9,19,We found that Tregs derived from the tumor mice down-regulated the expression of costimulatory molecules CD80/CD86 on DCs and inhibited the production of TNF- and IL-12 from DCs.,23000301_6,-1,-1,-1,-1,18640,-1,5.1405195e-06,0.9999902,4.586213e-06
18641,the tumor,6,8,33,42,We found that Tregs derived from the tumor mice down-regulated the expression of costimulatory molecules CD80/CD86 on DCs and inhibited the production of TNF- and IL-12 from DCs.,23000301_6,-1,-1,-1,-1,18641,-1,3.7807904e-06,0.99999154,4.6472596e-06
18644,TNF-,23,24,154,159,We found that Tregs derived from the tumor mice down-regulated the expression of costimulatory molecules CD80/CD86 on DCs and inhibited the production of TNF- and IL-12 from DCs.,23000301_6,0,1,-1,-1,18644,-1,4.5547888e-05,0.99993205,2.2359254e-05
18647,function,2,3,16,24,"The suppressive function of Tregs was mediated by cell-to-cell contact, CTLA-4 expression and IL-10 secretion.",23000301_7,0,1,2,-1,18647,-1,2.4425317e-05,0.9999521,2.3500039e-05
18656,to the tumor,21,24,148,160,"In conclusion, these mechanisms acting in hepatocellular carcinoma may be necessary to better understand the immunosuppression of Tregs and helpful to the tumor immunotherapy.",23000301_8,-1,-1,-1,-1,18656,-1,5.67063e-06,0.9999889,5.3863946e-06
18678,The tumor-bearing,0,2,0,17,"The tumor-bearing mice had longer survival times and slower tumor growth rates following treatment with CY, but its effects were temporary.",23000689_4,-1,-1,-1,-1,18678,-1,5.319827e-06,0.99998844,6.2225813e-06
18701,therapy,33,34,214,221,"The changes in intracellular cAMP concentrations correlated with the upregulation of effector T cells and the downregulation of Tregs, indicating the close association of cAMP analogs and low-dose CY in the immune therapy of B-cell lymphoma.",23000689_7,0,1,-1,-1,18701,-1,6.9721304e-06,0.9999864,6.657734e-06
18715,tumor cell,22,24,138,148,"CSC-enriched spheroid culture-derived cells (SDC) exhibited higher expression of ALDH, ICAM1 and of stem/progenitor cell markers on all 3 tumor cell lines investigated and lower MHC class I on the cervical cancer cell line as compared to their monolayer-derived cells (MDC).RESULTS: The expression of ICAM1 and MHCI was upregulated by IFN- treatment.",23001491_2,-1,-1,-1,-1,18715,-1,0.00013912388,0.001531958,0.99832886
18718,to their,39,41,235,243,"CSC-enriched spheroid culture-derived cells (SDC) exhibited higher expression of ALDH, ICAM1 and of stem/progenitor cell markers on all 3 tumor cell lines investigated and lower MHC class I on the cervical cancer cell line as compared to their monolayer-derived cells (MDC).RESULTS: The expression of ICAM1 and MHCI was upregulated by IFN- treatment.",23001491_2,-1,-1,-1,-1,18718,-1,5.3910235e-06,0.9999887,5.9454264e-06
18722,IFN- treatment,54,56,335,350,"CSC-enriched spheroid culture-derived cells (SDC) exhibited higher expression of ALDH, ICAM1 and of stem/progenitor cell markers on all 3 tumor cell lines investigated and lower MHC class I on the cervical cancer cell line as compared to their monolayer-derived cells (MDC).RESULTS: The expression of ICAM1 and MHCI was upregulated by IFN- treatment.",23001491_2,-1,-1,-1,-1,18722,-1,0.99971026,0.00014808826,0.00014159358
18727,the subset,2,4,9,19,"Finally, the subset of ALDH(high) expressing SDC presented more sensitivity toward CD8(+) CTL killing than the ALDH(low) SDC.CONCLUSIONS: Tumor therapy resistance has been attributed to cancer stem cells (CSC).",23001491_5,-1,-1,-1,-1,18727,-1,0.0022837555,0.5026827,0.49503356
18730,than the,17,19,102,110,"Finally, the subset of ALDH(high) expressing SDC presented more sensitivity toward CD8(+) CTL killing than the ALDH(low) SDC.CONCLUSIONS: Tumor therapy resistance has been attributed to cancer stem cells (CSC).",23001491_5,-1,-1,-1,-1,18730,-1,6.0778793e-06,0.99998856,5.3122326e-06
18731,Tumor therapy,23,25,138,151,"Finally, the subset of ALDH(high) expressing SDC presented more sensitivity toward CD8(+) CTL killing than the ALDH(low) SDC.CONCLUSIONS: Tumor therapy resistance has been attributed to cancer stem cells (CSC).",23001491_5,-1,-1,-1,-1,18731,-1,5.7414913e-06,0.99998987,4.4391268e-06
18734,to CTL-mediated,7,9,39,54,We show in vitro susceptibility of CSC to CTL-mediated lysis.,23001491_6,-1,-1,-1,-1,18734,-1,0.0024020462,0.08736859,0.9102293
18741,immune response to treat,3,7,24,48,Harnessing the adaptive immune response to treat malignancy is now a clinical reality.,23008334_0,-1,-1,-1,-1,18741,-1,0.8635033,0.13492917,0.0015675724
18742,to treat,4,6,28,36,"Several strategies are used to treat melanoma; however, very few result in a complete response.",23008334_1,-1,-1,-1,-1,18742,-1,6.9234397e-06,0.9999869,6.2417744e-06
18745,immunity,11,12,64,72,CD4(+) T cells are important and potent mediators of anti-tumor immunity and adoptive transfer of specific CD4(+) T cells can promote tumor regression in mice and patients.,23008334_2,0,-1,2,-1,18745,-1,0.9998895,3.284418e-05,7.7654026e-05
18750,immunity,18,19,113,121,"OX40, a costimulatory molecule expressed primarily on activated CD4(+) T cells, promotes and enhances anti-tumor immunity with limited success on large tumors in mice.",23008334_3,0,-1,2,-1,18750,-1,0.9997818,9.278658e-05,0.00012534822
18762,Th2 cytokines,47,49,304,317,"We show that OX40 engagement, in the context of chemotherapy-induced lymphopenia, induces a novel CD4(+) T cell population characterized by the expression of the master regulator eomesodermin that leads to both terminal differentiation and central memory phenotype, with concomitant secretion of Th1 and Th2 cytokines.",23008334_4,-1,-1,-1,-1,18762,-1,0.27160665,0.7229108,0.005482473
18768,the therapy,3,5,15,26,The potency of the therapy extends to support a bystander killing effect of antigen loss variants.,23008334_6,-1,-1,-1,-1,18768,-1,6.924758e-06,0.99998844,4.6320065e-06
18771,that these,3,5,17,27,Our results show that these uniquely programmed effector CD4(+) T cells have a distinctive phenotype with increased tumoricidal capability and support the use of immune modulation in reprogramming the phenotype of CD4(+) T cells.,23008334_7,-1,-1,-1,-1,18771,-1,3.597401e-06,0.9999927,3.705826e-06
18777,The receptor tyrosine,0,3,0,21,"The receptor tyrosine kinase inhibitor, sunitinib, is astonishingly effective in its capacity to reduce MDSCs in peripheral tissues such as blood (human) and spleen (mouse), restoring responsiveness of bystander T lymphocytes to TcR stimulation.",23017141_0,-1,-1,-1,-1,18777,-1,1.1777686e-05,0.9999765,1.1757093e-05
18779,tissues,19,20,124,131,"The receptor tyrosine kinase inhibitor, sunitinib, is astonishingly effective in its capacity to reduce MDSCs in peripheral tissues such as blood (human) and spleen (mouse), restoring responsiveness of bystander T lymphocytes to TcR stimulation.",23017141_0,-1,1,2,-1,18779,-1,6.652297e-05,0.9972652,0.0026682205
18780,blood,22,23,140,145,"The receptor tyrosine kinase inhibitor, sunitinib, is astonishingly effective in its capacity to reduce MDSCs in peripheral tissues such as blood (human) and spleen (mouse), restoring responsiveness of bystander T lymphocytes to TcR stimulation.",23017141_0,0,1,-1,-1,18780,-1,4.7170874e-05,0.99985874,9.405746e-05
18781,T lymphocytes to TcR,36,40,212,232,"The receptor tyrosine kinase inhibitor, sunitinib, is astonishingly effective in its capacity to reduce MDSCs in peripheral tissues such as blood (human) and spleen (mouse), restoring responsiveness of bystander T lymphocytes to TcR stimulation.",23017141_0,-1,-1,-1,-1,18781,-1,0.0039480217,0.20976031,0.7862916
18792,that GM-CSF,16,18,93,104,"The presence or absence of GM-CSF is likely the major determinant in each compartment, given that GM-CSF's capacity to preempt STAT3-dependent with dominant STAT5-dependent hematopoietic programming confers sunitinib resistance and redirects differentiation from the n-MDSC lineage to the more versatile monocytoid (m-MDSC) lineage.",23017141_4,-1,-1,-1,-1,18792,-1,0.97549224,0.021829285,0.0026784828
18797,to the,38,40,282,288,"The presence or absence of GM-CSF is likely the major determinant in each compartment, given that GM-CSF's capacity to preempt STAT3-dependent with dominant STAT5-dependent hematopoietic programming confers sunitinib resistance and redirects differentiation from the n-MDSC lineage to the more versatile monocytoid (m-MDSC) lineage.",23017141_4,-1,-1,-1,-1,18797,-1,5.7632437e-06,0.99998903,5.162887e-06
18809,to T cell-secreted IFN-,26,30,179,203,"Ironically, m-MDSCs manifesting resistance to sunitinib also have the greatest potential to differentiate into tumoricidal accessory cells, by virtue of their capacity to respond to T cell-secreted IFN- or to TLR agonists with nitric oxide and peroxynitrate production.",23017141_6,-1,-1,-1,-1,18809,-1,0.8938445,0.095900476,0.010255036
18810,to TLR agonists,31,34,207,222,"Ironically, m-MDSCs manifesting resistance to sunitinib also have the greatest potential to differentiate into tumoricidal accessory cells, by virtue of their capacity to respond to T cell-secreted IFN- or to TLR agonists with nitric oxide and peroxynitrate production.",23017141_6,-1,-1,-1,-1,18810,-1,0.00032377875,0.99961084,6.534995e-05
18811,cells play,1,3,10,20,Dendritic cells play a central role in keeping the balance between immunity and immune tolerance.,23049782_0,-1,-1,-1,-1,18811,-1,0.002518967,0.052437272,0.94504386
18813,immunity,11,12,67,75,Dendritic cells play a central role in keeping the balance between immunity and immune tolerance.,23049782_0,0,-1,2,-1,18813,-1,0.99783164,0.0017138893,0.00045452235
18815,factor,2,3,6,12,"A key factor in this equilibrium is the lifespan of DC, as its reduction restrains antigen availability leading to termination of immune responses.",23049782_1,0,1,-1,-1,18815,-1,1.006976e-05,0.99998295,6.977687e-06
18817,the lifespan,7,9,36,48,"A key factor in this equilibrium is the lifespan of DC, as its reduction restrains antigen availability leading to termination of immune responses.",23049782_1,-1,-1,-1,-1,18817,-1,1.0795988e-05,0.99998236,6.9005214e-06
18819,to termination,19,21,112,126,"A key factor in this equilibrium is the lifespan of DC, as its reduction restrains antigen availability leading to termination of immune responses.",23049782_1,-1,-1,-1,-1,18819,-1,1.0865033e-05,0.9999802,8.978235e-06
18822,lifespan,8,9,44,52,"Lack of p50 in murine DC promoted increased lifespan, enhanced level of maturation associated with increased expression of the proinflammatory cytokines IL-1, IL-18 and IFN-, enhanced capacity of activating and expanding CD4(+) and CD8(+) T cells in vivo and decreased ability to induce differentiation of FoxP3(+) regulatory T cells.",23049782_3,0,-1,2,-1,18822,-1,7.670457e-06,0.99998677,5.545728e-06
18824,cytokines IL-1,21,23,143,157,"Lack of p50 in murine DC promoted increased lifespan, enhanced level of maturation associated with increased expression of the proinflammatory cytokines IL-1, IL-18 and IFN-, enhanced capacity of activating and expanding CD4(+) and CD8(+) T cells in vivo and decreased ability to induce differentiation of FoxP3(+) regulatory T cells.",23049782_3,-1,-1,-1,-1,18824,-1,0.9999548,7.580889e-06,3.757021e-05
18831,antigen-pulsed LPS-treated,8,10,56,82,"In agreement, vaccination of melanoma-bearing mice with antigen-pulsed LPS-treated p50(-/-) BM-DC boosted antitumor immunity and inhibition of tumor growth.",23049782_4,-1,-1,-1,-1,18831,-1,0.95613194,0.041462872,0.0024051885
18832,immunity,15,16,116,124,"In agreement, vaccination of melanoma-bearing mice with antigen-pulsed LPS-treated p50(-/-) BM-DC boosted antitumor immunity and inhibition of tumor growth.",23049782_4,0,-1,2,-1,18832,-1,0.99985206,3.905102e-05,0.00010882912
18837,tuning the,23,25,154,164,"We propose that nuclear accumulation of the p50 NF-B subunit in DC, as occurring during lipopolysaccharide-driven maturation, is a homeostatic mechanism tuning the balance between uncontrolled activation of adaptive immunity and immune tolerance.",23049782_5,-1,-1,-1,-1,18837,-1,8.10026e-06,0.99998593,5.9473555e-06
18841,cytokine that plays,5,8,42,61,Interleukin (IL)-17 is a pro-inflammatory cytokine that plays critical roles in host defense against extracellular bacteria and fungi and also in the pathogenesis of autoimmune diseases.,23052209_0,-1,-1,-1,-1,18841,-1,0.87686133,0.120024845,0.0031138172
18843,TCR+ T,3,5,11,19,"While CD4+ TCR+ T helper (Th) 17 cells are the best-described cellular source of IL-17, many innate-like T cells are in fact potent producers of IL-17.",23052209_1,-1,-1,-1,-1,18843,-1,2.9635945e-05,0.9999205,4.9856677e-05
18853,the IL-17,8,10,59,68,"Given the increasing interest in therapeutic modulation of the IL-17 axis, it is crucial to better understand the cellular origins of IL-17 in various infection and diseases settings.",23052209_2,-1,-1,-1,-1,18853,-1,0.64149183,0.3559278,0.0025803042
18855,the cellular,18,20,110,122,"Given the increasing interest in therapeutic modulation of the IL-17 axis, it is crucial to better understand the cellular origins of IL-17 in various infection and diseases settings.",23052209_2,-1,-1,-1,-1,18855,-1,0.005071192,0.5767862,0.4181426
18858,IL-17-producing T cells,5,8,32,55,"While the diverse population of IL-17-producing T cells share many common characteristics, notable differences also exist.",23052209_3,-1,-1,-1,-1,18858,-1,0.91512954,0.00023218435,0.084638305
18861,IL-17-producing T cell types,9,13,48,76,"In this review, we discuss the heterogeneity of IL-17-producing T cell types focusing on their development, regulation, and function.",23052209_4,-1,-1,-1,-1,18861,-1,0.89183843,0.00046610908,0.1076955
18864,function,21,22,124,132,"In this review, we discuss the heterogeneity of IL-17-producing T cell types focusing on their development, regulation, and function.",23052209_4,0,1,2,-1,18864,-1,1.5999103e-05,0.999967,1.7028762e-05
18865,T-cell,0,1,0,6,"T-cell immunodeficiency is a common feature in patients with chronic myeloid leukemia (CML), and deficiency in CD3 levels was detected in T cells from these patients, which may represent a characteristic that is related to a lower T cell activation.",23057733_0,-1,1,2,-1,18865,-1,2.1689713e-05,8.079317e-06,0.9999702
18866,deficiency,17,18,97,107,"T-cell immunodeficiency is a common feature in patients with chronic myeloid leukemia (CML), and deficiency in CD3 levels was detected in T cells from these patients, which may represent a characteristic that is related to a lower T cell activation.",23057733_0,0,1,-1,-1,18866,-1,9.217506e-05,0.99988127,2.6579804e-05
18870,related to,37,39,212,222,"T-cell immunodeficiency is a common feature in patients with chronic myeloid leukemia (CML), and deficiency in CD3 levels was detected in T cells from these patients, which may represent a characteristic that is related to a lower T cell activation.",23057733_0,-1,-1,-1,-1,18870,-1,5.1366096e-06,0.99999034,4.461717e-06
18877,TCR,19,20,110,113,"In this study, we explored the possibility that forced TCR gene expression may upreg-u-late T cell receptor (TCR) signaling activation and reverse interleukin-2 (IL-2) production in T cells from patients with CML.",23057733_1,-1,1,2,-1,18877,-1,2.4124607e-05,0.9998266,0.00014929287
18883,cells that,13,15,88,98,"Phosphorylated TCR, phosphorylated NF-B, and the IL-2 level in TCR-transfected CD3+T cells that were activated with anti-CD3 and anti-CD28 antibodies were measured by Western blot and enzyme-linked immunosorbent assay (ELISA).",23057733_3,-1,-1,-1,-1,18883,-1,0.0023269225,0.25905958,0.7386135
18889,gene transfection,40,42,269,286,"After CD3 and CD28 antibody stimulation, a significantly higher phosphorylated TCR chain level was demonstrated, and an increased IL-2 production in TCR-upregulated T cells was associated with the increased expression of the phosphorylated NF-B. In conclusion, TCR gene transfection could restore TCR chain deficiency and enhance IL-2 production in T cells from patients with CML.",23057733_5,-1,-1,-1,-1,18889,-1,4.4992835e-06,0.99998915,6.368874e-06
18890,deficiency,46,47,312,322,"After CD3 and CD28 antibody stimulation, a significantly higher phosphorylated TCR chain level was demonstrated, and an increased IL-2 production in TCR-upregulated T cells was associated with the increased expression of the phosphorylated NF-B. In conclusion, TCR gene transfection could restore TCR chain deficiency and enhance IL-2 production in T cells from patients with CML.",23057733_5,0,1,-1,-1,18890,-1,0.00036240075,0.9992545,0.0003830857
18898,tumor antigens to Cytotoxic T Lymphocytes,48,54,289,330,"Neuroblastoma (NB), the most common solid extracranial cancer of childhood, displays a remarkable low expression of Major Histocompatibility Complex class I (MHC-I) and Antigen Processing Machinery (APM) molecules, including Endoplasmic Reticulum (ER) Aminopeptidases, and poorly presents tumor antigens to Cytotoxic T Lymphocytes (CTL).",23071666_0,-1,-1,-1,-1,18898,-1,0.012777677,0.32639715,0.66082513
18900,that this,4,6,25,34,We have previously shown that this is due to low expression of the transcription factor NF-kB p65.,23071666_1,-1,-1,-1,-1,18900,-1,5.6328277e-06,0.99999034,4.0208242e-06
18902,the transcription factor NF-kB,12,16,63,93,We have previously shown that this is due to low expression of the transcription factor NF-kB p65.,23071666_1,-1,-1,-1,-1,18902,-1,1.6127357e-05,0.9999758,8.092905e-06
18905,the Interferon Regulatory Factor 1,12,17,50,84,"Herein, we show that not only NF-kB p65, but also the Interferon Regulatory Factor 1 (IRF1) and certain APM components are low in a subset of NB cell lines with aggressive features.",23071666_2,-1,-1,-1,-1,18905,-1,1.3547144e-05,0.99996996,1.6479791e-05
18918,the three,4,6,24,33,"Absence and presence of the three molecules neatly segregated between high-grade and low-grade NB, respectively.",23071666_5,-1,-1,-1,-1,18918,-1,1.4466571e-05,0.9999753,1.0244746e-05
18923,to those,24,26,157,165,"Finally, APM reconstitution by double IRF1/p65 transfection rendered a NB cell line susceptible to killing by anti MAGE-A3 CTLs, lytic efficiency comparable to those seen upon IFN- treatment.",23071666_6,-1,-1,-1,-1,18923,-1,5.8024707e-06,0.9999889,5.2857495e-06
18924,IFN- treatment,28,30,176,191,"Finally, APM reconstitution by double IRF1/p65 transfection rendered a NB cell line susceptible to killing by anti MAGE-A3 CTLs, lytic efficiency comparable to those seen upon IFN- treatment.",23071666_6,-1,-1,-1,-1,18924,-1,0.99973506,0.000119214084,0.00014576787
18935,therapy,26,27,183,190,These findings provide molecular insight into defective MHC-I expression in NB cells and provide the rational for T cell-based immunotherapy in NB variants refractory to conventional therapy.,23071666_8,0,1,-1,-1,18935,-1,4.8969646e-06,0.9999908,4.242915e-06
18936,The natural,0,2,0,11,"The natural killer T (NKT) cell ligand, alpha-galactosylceramide (-GalCer), represents a potential adjuvant to boost immunotherapeutic vaccination strategies against poorly immunogenic cancers.",23090488_0,-1,-1,-1,-1,18936,-1,1.8122373e-05,0.9999726,9.316258e-06
18943,the therapeutic,8,10,42,57,The objective of this study was to assess the therapeutic potential of an -GalCer-loaded tumor-cell vaccine against solid tumors in mice and to enhance the effectiveness of this approach by removing immune suppression associated with the activity of Foxp3(+) regulatory T cells (Tregs).,23090488_1,-1,-1,-1,-1,18943,-1,4.943924e-06,0.9999912,3.890324e-06
18955,tumor cells,15,17,95,106,"In the B16F10 melanoma model, we show that single vaccination with irradiated, -GalCer-loaded tumor cells resulted in suppression of established subcutaneous (s.c.) B16F10 tumor growth, which was mediated by NKT cell-dependent IFN- production and enhanced in the absence of IL-17A. Selective depletion of Foxp3(+) Tregs in transgenic DEpletion of REGulatory T cells (DEREG) mice led to significant inhibition of B16F10 tumor growth and enhanced survival of mice receiving vaccination.",23090488_2,-1,-1,-1,-1,18955,-1,0.00040470832,0.008788632,0.99080676
18957,cell-dependent IFN-,36,38,213,233,"In the B16F10 melanoma model, we show that single vaccination with irradiated, -GalCer-loaded tumor cells resulted in suppression of established subcutaneous (s.c.) B16F10 tumor growth, which was mediated by NKT cell-dependent IFN- production and enhanced in the absence of IL-17A. Selective depletion of Foxp3(+) Tregs in transgenic DEpletion of REGulatory T cells (DEREG) mice led to significant inhibition of B16F10 tumor growth and enhanced survival of mice receiving vaccination.",23090488_2,-1,-1,-1,-1,18957,-1,0.6578567,0.0018679327,0.3402753
18969,immunity,16,17,91,99,Short-term elimination of Foxp3(+) Tregs (<7 days) was sufficient to boost vaccine-induced immunity.,23090488_3,0,-1,2,-1,18969,-1,0.99979335,7.819892e-05,0.00012852384
18970,therapy,5,6,45,52,"Enhanced antitumor activity with combination therapy was associated with an increase in systemic NK cell and effector CD8(+) T-cell activation and IFN- production, as well as infiltration of effector CD8(+) T cells into the tumor.",23090488_4,0,1,-1,-1,18970,-1,5.57556e-06,0.99998915,5.2934943e-06
18975,the tumor,36,38,221,230,"Enhanced antitumor activity with combination therapy was associated with an increase in systemic NK cell and effector CD8(+) T-cell activation and IFN- production, as well as infiltration of effector CD8(+) T cells into the tumor.",23090488_4,-1,-1,-1,-1,18975,-1,4.3092386e-06,0.9999908,4.8695306e-06
18977,that transient,5,7,36,50,"Overall, these findings demonstrate that transient depletion of Foxp3(+) Tregs constitutes a highly effective strategy to improve the therapeutic efficacy of anticancer vaccination with NKT cell adjuvants.",23090488_5,-1,-1,-1,-1,18977,-1,5.037205e-06,0.9999912,3.7697578e-06
18981,the therapeutic,19,21,130,145,"Overall, these findings demonstrate that transient depletion of Foxp3(+) Tregs constitutes a highly effective strategy to improve the therapeutic efficacy of anticancer vaccination with NKT cell adjuvants.",23090488_5,-1,-1,-1,-1,18981,-1,4.764221e-06,0.9999913,3.897395e-06
18983,protein,1,2,14,21,Water-soluble protein signals (pheromones) of the ciliate Euplotes have been supposed to be functional precursors of growth factors and cytokines that regulate cell-cell interaction in multi-cellular eukaryotes.,23103669_0,0,1,-1,-1,18983,-1,0.008729267,0.9911679,0.00010276197
18986,functional precursors,15,17,92,113,Water-soluble protein signals (pheromones) of the ciliate Euplotes have been supposed to be functional precursors of growth factors and cytokines that regulate cell-cell interaction in multi-cellular eukaryotes.,23103669_0,-1,-1,-1,-1,18986,-1,0.016416231,0.43811992,0.54546386
18987,factors,19,20,124,131,Water-soluble protein signals (pheromones) of the ciliate Euplotes have been supposed to be functional precursors of growth factors and cytokines that regulate cell-cell interaction in multi-cellular eukaryotes.,23103669_0,0,1,-1,-1,18987,-1,0.9999329,1.3231055e-05,5.3842825e-05
18988,cytokines that,21,23,136,150,Water-soluble protein signals (pheromones) of the ciliate Euplotes have been supposed to be functional precursors of growth factors and cytokines that regulate cell-cell interaction in multi-cellular eukaryotes.,23103669_0,-1,-1,-1,-1,18988,-1,0.9699047,0.028597398,0.0014978937
18991,that native,4,6,28,39,"This work provides evidence that native preparations of the Euplotes raikovi pheromone Er-1 (a helical protein of 40 amino acids) specifically increases viability, DNA synthesis, proliferation, and the production of interferon-, tumor necrosis factor-, interleukin (IL)-1, IL-2, and IL-13 in human Jurkat T-cells.",23103669_1,-1,-1,-1,-1,18991,-1,4.9512364e-06,0.99999,5.030598e-06
18993,helical protein,15,17,95,110,"This work provides evidence that native preparations of the Euplotes raikovi pheromone Er-1 (a helical protein of 40 amino acids) specifically increases viability, DNA synthesis, proliferation, and the production of interferon-, tumor necrosis factor-, interleukin (IL)-1, IL-2, and IL-13 in human Jurkat T-cells.",23103669_1,-1,-1,-1,-1,18993,-1,3.1700205e-05,0.99988234,8.599752e-05
18997,factor-,39,40,245,253,"This work provides evidence that native preparations of the Euplotes raikovi pheromone Er-1 (a helical protein of 40 amino acids) specifically increases viability, DNA synthesis, proliferation, and the production of interferon-, tumor necrosis factor-, interleukin (IL)-1, IL-2, and IL-13 in human Jurkat T-cells.",23103669_1,0,1,-1,-1,18997,-1,0.9999602,4.64812e-06,3.5209523e-05
19000,Jurkat T-cells,50,52,301,315,"This work provides evidence that native preparations of the Euplotes raikovi pheromone Er-1 (a helical protein of 40 amino acids) specifically increases viability, DNA synthesis, proliferation, and the production of interferon-, tumor necrosis factor-, interleukin (IL)-1, IL-2, and IL-13 in human Jurkat T-cells.",23103669_1,-1,-1,-1,-1,19000,-1,8.2147926e-05,5.6006982e-05,0.99986184
19004,receptor,16,17,83,91,"Also, Er-1 significantly decreases the mRNA levels of the  and  subunits of IL-2 receptor (IL-2R), while the mRNA levels of the  subunit appeared to be not affected.",23103669_2,0,1,2,-1,19004,-1,0.5260927,0.10443245,0.36947483
19009,T-cell treatments,1,3,7,24,"Jurkat T-cell treatments with Er-1 induced the down-regulation of the IL-2R subunit by a reversible and time-dependent endocytosis, and increased the levels of phosphorylation of the extracellular signal-regulated kinases (ERK).",23103669_3,-1,-1,-1,-1,19009,-1,0.0013574646,0.15041311,0.8482294
19016,The cell-type,0,2,0,13,"The cell-type specificity of these effects was supported by the finding that Er-1, although unable to directly influence the growth of human glioma U-373 cells, induced Jurkat cells to synthesize and release factors that, in turn, inhibited the U-373 cell proliferation.",23103669_4,-1,-1,-1,-1,19016,-1,0.0014324576,0.8389309,0.1596366
19023,Jurkat cells to,28,31,169,184,"The cell-type specificity of these effects was supported by the finding that Er-1, although unable to directly influence the growth of human glioma U-373 cells, induced Jurkat cells to synthesize and release factors that, in turn, inhibited the U-373 cell proliferation.",23103669_4,-1,-1,-1,-1,19023,-1,0.004628273,0.03543423,0.9599375
19024,release factors that,33,36,200,220,"The cell-type specificity of these effects was supported by the finding that Er-1, although unable to directly influence the growth of human glioma U-373 cells, induced Jurkat cells to synthesize and release factors that, in turn, inhibited the U-373 cell proliferation.",23103669_4,-1,-1,-1,-1,19024,-1,3.203528e-05,0.9999591,8.817049e-06
19031,T-cell,13,14,82,88,"Overall, these findings imply that Er-1 coupling to IL-2R and ERK immuno-enhances T-cell activity, and that this effect likely translates to an inhibition of glioma cell growth.",23103669_5,-1,1,2,-1,19031,-1,1.584634e-05,1.14537315e-05,0.9999727
19032,that this,17,19,103,112,"Overall, these findings imply that Er-1 coupling to IL-2R and ERK immuno-enhances T-cell activity, and that this effect likely translates to an inhibition of glioma cell growth.",23103669_5,-1,-1,-1,-1,19032,-1,4.2758297e-06,0.99999166,4.0306422e-06
19033,translates to,21,23,127,140,"Overall, these findings imply that Er-1 coupling to IL-2R and ERK immuno-enhances T-cell activity, and that this effect likely translates to an inhibition of glioma cell growth.",23103669_5,-1,-1,-1,-1,19033,-1,7.2345083e-06,0.9999864,6.352345e-06
19035,function,8,9,57,65,"Previous studies have reported alterations in numbers or function of regulatory T (Treg) cells in myasthenia gravis (MG) patients, but published results have been inconsistent, likely due to the isolation of heterogenous ""Treg"" populations.",23110942_0,0,1,2,-1,19035,-1,4.1910218e-05,0.9999113,4.6783087e-05
19039,to the,33,35,188,194,"Previous studies have reported alterations in numbers or function of regulatory T (Treg) cells in myasthenia gravis (MG) patients, but published results have been inconsistent, likely due to the isolation of heterogenous ""Treg"" populations.",23110942_0,-1,-1,-1,-1,19039,-1,5.563967e-06,0.9999906,3.8971284e-06
19045,that there,27,29,142,152,"In this study, we used surface CD4, CD25(high), and CD127(low/-) expression to isolate a relatively pure population of Tregs, and established that there was no alteration in the relative numbers of Tregs within the peripheral T cell pool in MG patients.",23110942_1,-1,-1,-1,-1,19045,-1,4.336243e-06,0.9999913,4.356508e-06
19046,the relative,33,35,174,186,"In this study, we used surface CD4, CD25(high), and CD127(low/-) expression to isolate a relatively pure population of Tregs, and established that there was no alteration in the relative numbers of Tregs within the peripheral T cell pool in MG patients.",23110942_1,-1,-1,-1,-1,19046,-1,5.4630104e-06,0.99998975,4.7568224e-06
19050,that Treg-mediated,8,10,53,71,"In vitro proliferation assays, however, demonstrated that Treg-mediated suppression of responder T (Tresp) cells was impaired in MG patients and was associated with a reduced expression of FOXP3 in isolated Tregs.",23110942_2,-1,-1,-1,-1,19050,-1,1.4507239e-05,0.999974,1.14917675e-05
19056,Tresp cells,6,8,50,61,"Suppression of both polyclonal and AChR-activated Tresp cells from MG patients could be restored using Tregs isolated from healthy controls, indicating that the defect in immune regulation in MG is primarily localized to isolated Treg cells, and revealing a potential novel therapeutic target.",23110942_3,-1,-1,-1,-1,19056,-1,4.008007e-05,0.000119678785,0.99984026
19058,that the,22,24,152,160,"Suppression of both polyclonal and AChR-activated Tresp cells from MG patients could be restored using Tregs isolated from healthy controls, indicating that the defect in immune regulation in MG is primarily localized to isolated Treg cells, and revealing a potential novel therapeutic target.",23110942_3,-1,-1,-1,-1,19058,-1,3.7575733e-06,0.9999925,3.7117495e-06
19062,therapeutic target,43,45,274,292,"Suppression of both polyclonal and AChR-activated Tresp cells from MG patients could be restored using Tregs isolated from healthy controls, indicating that the defect in immune regulation in MG is primarily localized to isolated Treg cells, and revealing a potential novel therapeutic target.",23110942_3,-1,-1,-1,-1,19062,-1,4.670554e-06,0.9999914,3.910907e-06
19067,blood lymphocytes,19,21,127,144,PURPOSE: To evaluate CD4(+)CD25(+)FOXP3(+) T regulatory cells (T(REG)) and associated immune-regulatory pathways in peripheral blood lymphocytes (PBL) of metastatic renal cell carcinoma (mRCC) patients and healthy volunteers.,23118856_0,-1,-1,-1,-1,19067,-1,2.7836582e-05,2.4449213e-05,0.99994767
19071,analysis,19,20,142,150,"We subsequently investigated the effects of immunotherapy on circulating T(REG) combining an extensive phenotype examination, DNA methylation analysis and global transcriptome analysis.",23118856_1,0,1,-1,-1,19071,-1,1.562896e-05,0.99996877,1.5588945e-05
19072,transcriptome analysis,22,24,162,184,"We subsequently investigated the effects of immunotherapy on circulating T(REG) combining an extensive phenotype examination, DNA methylation analysis and global transcriptome analysis.",23118856_1,-1,-1,-1,-1,19072,-1,8.228167e-06,0.9999852,6.5896693e-06
19074,analysis,15,16,88,96,DESIGN: Eighteen patients with mRCC and twelve volunteers (controls) were available for analysis.,23118856_2,0,1,-1,-1,19074,-1,8.785691e-06,0.9999839,7.2574935e-06
19078,the FOXP3,11,13,66,75,T(REG) were also quantified by analyzing the epigenetic status of the FOXP3 locus using methylation specific PCR.,23118856_5,-1,-1,-1,-1,19078,-1,7.1475115e-06,0.9999857,7.206511e-06
19084,the gene,20,22,103,111,"As a third approach, RNA of the PBL was hybridized to Affymetrix GeneChip Human Gene 1.0 ST Arrays and the gene signatures were explored using pathway analysis.",23118856_6,-1,-1,-1,-1,19084,-1,5.2299138e-06,0.99998844,6.3846264e-06
19085,analysis,27,28,151,159,"As a third approach, RNA of the PBL was hybridized to Affymetrix GeneChip Human Gene 1.0 ST Arrays and the gene signatures were explored using pathway analysis.",23118856_6,0,1,-1,-1,19085,-1,9.9666295e-06,0.9999815,8.518782e-06
19089,the two,13,15,73,80,A significant increase in T(REG) was detected in all mRCC patients after the two cycles of immunotherapy.,23118856_8,-1,-1,-1,-1,19089,-1,8.840412e-06,0.99998665,4.5685433e-06
19097,Analysis,3,4,20,28,"Gene Set Enrichment Analysis (GSEA) of the microarray data showed significant enrichment of FOXP3 target genes, CTLA-4 and TGF- associated pathways in the patient cohort.",23118856_11,0,1,-1,-1,19097,-1,4.3768574e-05,0.99991214,4.403431e-05
19099,FOXP3 target genes,15,18,92,110,"Gene Set Enrichment Analysis (GSEA) of the microarray data showed significant enrichment of FOXP3 target genes, CTLA-4 and TGF- associated pathways in the patient cohort.",23118856_11,-1,-1,-1,-1,19099,-1,4.641953e-06,0.9999896,5.730167e-06
19103,blood,7,8,48,53,CONCLUSION: Immune monitoring of the peripheral blood and tumor tissue is important for a wide range of diseases and treatment strategies.,23118856_12,0,1,-1,-1,19103,-1,0.0005194141,0.9856969,0.013783641
19104,tumor tissue,9,11,58,70,CONCLUSION: Immune monitoring of the peripheral blood and tumor tissue is important for a wide range of diseases and treatment strategies.,23118856_12,-1,-1,-1,-1,19104,-1,1.593575e-05,0.999897,8.708664e-05
19113,that CCL2,4,6,21,30,"Here, we demonstrate that CCL2 is a critical determinant for both tumor metastasis and immunosuppression induced by Snail(+) tumor cells.",23143679_2,-1,-1,-1,-1,19113,-1,0.3966211,0.6008061,0.0025727162
19115,tumor cells,20,22,125,136,"Here, we demonstrate that CCL2 is a critical determinant for both tumor metastasis and immunosuppression induced by Snail(+) tumor cells.",23143679_2,-1,-1,-1,-1,19115,-1,0.00011717034,0.00047962568,0.99940324
19117,tumor cells,7,9,51,62,CCL2 is significantly upregulated in various human tumor cells accompanied by Snail expression induced by snail transduction or TGF treatment.,23143679_3,-1,-1,-1,-1,19117,-1,0.00027140806,0.0048687994,0.99485993
19119,TGF treatment,18,20,128,142,CCL2 is significantly upregulated in various human tumor cells accompanied by Snail expression induced by snail transduction or TGF treatment.,23143679_3,-1,-1,-1,-1,19119,-1,8.092139e-06,0.9999862,5.7516086e-06
19121,tumor-derived CCL2,3,5,13,31,The Snail(+) tumor-derived CCL2 amplifies EMT events in other cells including Snail(-) tumor cells and epithelial cells within tumor microenvironment.,23143679_4,-1,-1,-1,-1,19121,-1,0.076737404,0.922102,0.0011606594
19123,tumor cells,14,16,87,98,The Snail(+) tumor-derived CCL2 amplifies EMT events in other cells including Snail(-) tumor cells and epithelial cells within tumor microenvironment.,23143679_4,-1,-1,-1,-1,19123,-1,0.000115889714,0.00045574727,0.99942833
19128,tumor cells,12,14,60,71,CCL2 secondarily induces Lipocalin 2 (LCN2) in the Snail(+) tumor cells in an autocrine manner.,23143679_5,-1,-1,-1,-1,19128,-1,0.00010890283,0.0005538916,0.99933726
19135,tumor-specific CTL,15,17,118,136,"The CCL2/LCN2-induced DCreg cells subsequently induce immunosuppressive CD4(+)FOXP3(+) Treg cells, and finally impair tumor-specific CTL induction.",23143679_7,-1,-1,-1,-1,19135,-1,0.0031861234,0.67761225,0.3192016
19142,that CCL2,3,5,22,31,These results suggest that CCL2 is more than a chemoattractant factor that is the significant effector molecule responsible for immune evasion of Snail(+) tumor cells.,23143679_9,-1,-1,-1,-1,19142,-1,0.5618883,0.4353586,0.0027531097
19144,chemoattractant factor that,9,12,47,74,These results suggest that CCL2 is more than a chemoattractant factor that is the significant effector molecule responsible for immune evasion of Snail(+) tumor cells.,23143679_9,-1,-1,-1,-1,19144,-1,0.9935602,0.0052675293,0.0011722634
19146,tumor cells,24,26,155,166,These results suggest that CCL2 is more than a chemoattractant factor that is the significant effector molecule responsible for immune evasion of Snail(+) tumor cells.,23143679_9,-1,-1,-1,-1,19146,-1,7.1208975e-05,0.00020066298,0.999728
19149,treatment to,7,9,39,51,CCL2 would be an attractive target for treatment to eliminate cancer cells via amelioration of tumor metastasis and immunosuppression.,23143679_10,-1,-1,-1,-1,19149,-1,3.790944e-06,0.9999927,3.5299477e-06
19157,to their,19,21,137,145,Subunit vaccines containing universal tumor associated antigens (TAAs) present an attractive treatment modality for cancer primarily due to their safety and potential to generate long-term immunological responses that can safeguard against recurrences.,23144888_0,-1,-1,-1,-1,19157,-1,5.9393947e-06,0.9999883,5.7448724e-06
19158,to generate,24,26,167,178,Subunit vaccines containing universal tumor associated antigens (TAAs) present an attractive treatment modality for cancer primarily due to their safety and potential to generate long-term immunological responses that can safeguard against recurrences.,23144888_0,-1,-1,-1,-1,19158,-1,7.305332e-06,0.9999877,4.935649e-06
19160,TAA-based subunit,2,4,9,26,"However, TAA-based subunit vaccines require potent adjuvants for therapeutic efficacy.",23144888_1,-1,-1,-1,-1,19160,-1,0.00017160813,0.9996221,0.00020628553
19169,the therapeutic,9,11,44,59,The present study was designed to i) assess the therapeutic efficacy of a prime-boost vaccination and ii) investigate the mechanistic basis of vaccine efficacy.,23144888_3,-1,-1,-1,-1,19169,-1,5.469125e-06,0.9999906,3.9079177e-06
19183,Taken together,0,2,0,14,"Taken together, these results shed light on the mechanistic basis of the SA-4-1BBL/SVN subunit vaccine formulation in a lung carcinoma model and demonstrate the robust therapeutic efficacy of the prime-boost immunization strategy with important clinical implications.",23144888_8,-1,-1,-1,-1,19183,-1,7.460108e-06,0.9999857,6.858137e-06
19191,plasma cell,9,11,39,50,BACKGROUND: Multiple myeloma (MM) is a plasma cell malignancy frequently associated with impaired immune cell numbers and functions.,23152910_0,-1,-1,-1,-1,19191,-1,2.8519928e-05,1.808889e-05,0.9999534
19193,functions,20,21,122,131,BACKGROUND: Multiple myeloma (MM) is a plasma cell malignancy frequently associated with impaired immune cell numbers and functions.,23152910_0,0,1,2,-1,19193,-1,0.00026142527,0.0002086997,0.99952984
19198,T cell functions,18,21,96,112,"In MM, several studies have previously shown that CD4 regulatory T (Treg) cells hamper effector T cell functions and enhance immune dysfunction.",23152910_1,-1,-1,-1,-1,19198,-1,1.155919e-05,8.631284e-06,0.99997985
19202,functionally,11,12,49,61,"In this study, we aimed to prove the presence of functionally suppressive Treg cells expressing CD8 phenotype (CD8 Treg cells) in MM.",23152910_2,0,1,2,-1,19202,-1,2.0355179e-05,0.99996793,1.1666879e-05
19205,To the,0,2,0,6,"To the best of our knowledge, this has not been reported previously in MM.METHODS: We analyzed CD8 Treg cells and their transcription factor FoxP3 from 64 newly diagnosed MM patients using flow cytometry and real time-polymerase chain reaction (RT-PCR).",23152910_3,-1,-1,-1,-1,19205,-1,8.853424e-06,0.999984,7.1522727e-06
19208,their transcription factor FoxP3,22,26,114,146,"To the best of our knowledge, this has not been reported previously in MM.METHODS: We analyzed CD8 Treg cells and their transcription factor FoxP3 from 64 newly diagnosed MM patients using flow cytometry and real time-polymerase chain reaction (RT-PCR).",23152910_3,-1,-1,-1,-1,19208,-1,5.749527e-06,0.99998856,5.7386924e-06
19213,functionally,12,13,60,72,CD8 Treg cells from 5 MM patients and 5 healthy donors were functionally evaluated using proliferation assays.,23152910_5,0,1,2,-1,19213,-1,0.00048506758,0.9994636,5.1286308e-05
19215,their transcription factor FoxP3,19,23,97,129,"RESULTS: CD8 Treg cells (CD8+CD25hi+) were significantly elevated in MM patients (P<0.0001), and their transcription factor FoxP3 expression was also higher in MM (P<0.0001) compared to healthy donors which was evidenced by flow cytometry and RT-PCR analyses.",23152910_6,-1,-1,-1,-1,19215,-1,5.1837737e-06,0.99999034,4.5230413e-06
19218,total lymphocyte,6,8,42,58,CD8 Treg cells negatively correlated with total lymphocyte count (P=0.016).,23152910_7,-1,-1,-1,-1,19218,-1,0.00014231188,0.00036499268,0.99949276
19219,Functional,0,1,0,10,Functional studies revealed that CD8 Treg cells isolated from MM patients and healthy donors inhibited proliferation of CD4 T cells in a concentration dependent manner.,23152910_8,0,1,2,-1,19219,-1,5.853536e-05,0.99991095,3.0471661e-05
19235,functionally,11,12,69,81,CONCLUSIONS: These findings show the presence of increased number of functionally suppressive CD8 Treg cells in MM patients.,23152910_12,0,1,2,-1,19235,-1,7.487536e-05,0.99990225,2.2870827e-05
19237,that these,2,4,11,21,We believe that these suppressive CD8 Treg cells might enhance immune impairment and disease progression in MM.,23152910_13,-1,-1,-1,-1,19237,-1,5.3955696e-06,0.99999046,4.179684e-06
19248,that tumor,26,28,165,175,"Whereas enhanced Th17 response and related molecules such as interleukin (IL)-17, IL-21, IL-22, IL-23 and STAT3 accompanied tumor induction and progression, finding that tumor growth/stage was negatively correlated with increased infiltration of Th17 cells in the tumor mass has prompted elucidation of various antitumor mechanisms elicited by Th17 and their related molecules.",23159638_1,-1,-1,-1,-1,19248,-1,3.997891e-06,0.99999154,4.4371277e-06
19249,Th17 cells,36,38,246,256,"Whereas enhanced Th17 response and related molecules such as interleukin (IL)-17, IL-21, IL-22, IL-23 and STAT3 accompanied tumor induction and progression, finding that tumor growth/stage was negatively correlated with increased infiltration of Th17 cells in the tumor mass has prompted elucidation of various antitumor mechanisms elicited by Th17 and their related molecules.",23159638_1,-1,-1,-1,-1,19249,-1,3.8175505e-05,9.104187e-05,0.9998708
19250,the tumor,39,41,260,269,"Whereas enhanced Th17 response and related molecules such as interleukin (IL)-17, IL-21, IL-22, IL-23 and STAT3 accompanied tumor induction and progression, finding that tumor growth/stage was negatively correlated with increased infiltration of Th17 cells in the tumor mass has prompted elucidation of various antitumor mechanisms elicited by Th17 and their related molecules.",23159638_1,-1,-1,-1,-1,19250,-1,3.7044151e-06,0.99999154,4.7436256e-06
19252,their related,53,55,353,366,"Whereas enhanced Th17 response and related molecules such as interleukin (IL)-17, IL-21, IL-22, IL-23 and STAT3 accompanied tumor induction and progression, finding that tumor growth/stage was negatively correlated with increased infiltration of Th17 cells in the tumor mass has prompted elucidation of various antitumor mechanisms elicited by Th17 and their related molecules.",23159638_1,-1,-1,-1,-1,19252,-1,1.8698785e-05,0.99996614,1.51112445e-05
19255,factors,24,25,149,156,"The pro-tumor efficacy of Th17 response included promotion of neutrophilia and induction of angiogenic (e.g. VEGF, MMP2 and MMP9) and anti-apoptotic factors (e.g. Bcl-XL), as well as expansion and activation of myeloid-derived suppressor cells, which facilitate generation of tumor-specific regulatory T cells.",23159638_2,0,1,-1,-1,19255,-1,1.7085778e-05,0.99997735,5.515911e-06
19258,tumor-specific regulatory T cells,45,49,276,309,"The pro-tumor efficacy of Th17 response included promotion of neutrophilia and induction of angiogenic (e.g. VEGF, MMP2 and MMP9) and anti-apoptotic factors (e.g. Bcl-XL), as well as expansion and activation of myeloid-derived suppressor cells, which facilitate generation of tumor-specific regulatory T cells.",23159638_2,-1,-1,-1,-1,19258,-1,0.0031380944,0.5404397,0.45642215
19262,Th17 cells to,20,23,145,158,"Other tumor immunogenic settings revealed anti-tumor pathways including induction of cytotoxic activity, expression of MHC antigens, the ability Th17 cells to reside within the tumor, and to convert into IFN- producers.",23159638_3,-1,-1,-1,-1,19262,-1,0.00035064248,0.93747133,0.062177997
19263,the tumor,25,27,173,182,"Other tumor immunogenic settings revealed anti-tumor pathways including induction of cytotoxic activity, expression of MHC antigens, the ability Th17 cells to reside within the tumor, and to convert into IFN- producers.",23159638_3,-1,-1,-1,-1,19263,-1,3.590952e-06,0.9999914,5.0133012e-06
19266,Th17 cell related,2,5,9,26,"Notably, Th17 cell related molecules exert indirect pro- or anti-tumor effects via inducing viral persistence or mediating protective mechanisms against bacterial and viral infection.",23159638_4,-1,-1,-1,-1,19266,-1,0.0017599615,0.42633286,0.57190716
19268,Th17 cells,11,13,78,88,"Herein, the recent literature revealing such immunoediting events mediated by Th17 cells and their associated molecules as delivered by various experimental regimens and observed in cancer patient are revised, with a focus on some proposed anti-cancer therapies.",23159638_5,-1,-1,-1,-1,19268,-1,0.00011226902,0.0018908314,0.99799687
19277,analysis,26,27,153,161,"In a previous study, we screened Y Box protein 1 (YB-1) as a potential neuroblastoma-associated antigen from sera of AGN2a-immunized mice by serological analysis of recombinant cDNA expression libraries technique.",23169344_2,0,1,-1,-1,19277,-1,1.0270044e-05,0.99998295,6.761272e-06
19290,T-cell,7,8,42,48,"It was demonstrated that anti-YB-1 CD8(+) T-cell responses could be induced by AGN2a immunization, and the strongest CD8(+) T-cell responses against AGN2a were induced by YB-1-immunized mice in the context of Treg depletion compared with YB-1 only immunization group and control group.",23169344_5,-1,1,2,-1,19290,-1,1.64976e-05,9.188754e-06,0.99997437
19292,T-cell,21,22,124,130,"It was demonstrated that anti-YB-1 CD8(+) T-cell responses could be induced by AGN2a immunization, and the strongest CD8(+) T-cell responses against AGN2a were induced by YB-1-immunized mice in the context of Treg depletion compared with YB-1 only immunization group and control group.",23169344_5,-1,1,2,-1,19292,-1,1.7695542e-05,9.060324e-06,0.9999733
19302,than that,30,32,170,179,"Importantly, the survival rate of mice treated with YB-1 immunization combined with Treg depletion was 80% when challenged by 1  10(4) AGN2a cells, significantly higher than that of mice immunized with YB-1 alone (P < 0.01).",23169344_6,-1,-1,-1,-1,19302,-1,5.8470237e-06,0.9999894,4.726803e-06
19304,T-cell,2,3,13,19,"Furthermore, T-cell adoptive therapy showed that the neuroblastoma growth was inhibited when T cells or splenic cells from YB-1-immunized mice with Treg depletion were transferred to AGN2a bearing mice.",23169344_7,-1,1,2,-1,19304,-1,1.3166463e-05,5.854357e-06,0.99998105
19305,therapy,4,5,29,36,"Furthermore, T-cell adoptive therapy showed that the neuroblastoma growth was inhibited when T cells or splenic cells from YB-1-immunized mice with Treg depletion were transferred to AGN2a bearing mice.",23169344_7,0,1,-1,-1,19305,-1,4.4603375e-06,0.99998915,6.3714742e-06
19306,that the,6,8,44,52,"Furthermore, T-cell adoptive therapy showed that the neuroblastoma growth was inhibited when T cells or splenic cells from YB-1-immunized mice with Treg depletion were transferred to AGN2a bearing mice.",23169344_7,-1,-1,-1,-1,19306,-1,4.1969834e-06,0.9999914,4.358915e-06
19311,transferred to,25,27,168,182,"Furthermore, T-cell adoptive therapy showed that the neuroblastoma growth was inhibited when T cells or splenic cells from YB-1-immunized mice with Treg depletion were transferred to AGN2a bearing mice.",23169344_7,-1,-1,-1,-1,19311,-1,4.035616e-06,0.9999918,4.205896e-06
19317,that YB-1,3,5,24,33,These results indicated that YB-1 immunization combined with Treg depletion could induce specific T-cell responses against neuroblastoma and could be a potential strategy for the prevention and treatment of neuroblastoma in the early stage.,23169344_9,-1,-1,-1,-1,19317,-1,1.189704e-05,0.9999609,2.7249482e-05
19319,T-cell,13,14,98,104,These results indicated that YB-1 immunization combined with Treg depletion could induce specific T-cell responses against neuroblastoma and could be a potential strategy for the prevention and treatment of neuroblastoma in the early stage.,23169344_9,-1,1,2,-1,19319,-1,2.7669197e-05,1.1578807e-05,0.9999608
19331,that Treg cells play,7,11,40,60,"This work will discuss the central role that Treg cells play in the development of uterine cancer, which makes these cells a key missing component in current cancer immunotherapy.",23178746_3,-1,-1,-1,-1,19331,-1,9.9354846e-05,0.9997075,0.00019308402
19333,these cells,20,22,111,122,"This work will discuss the central role that Treg cells play in the development of uterine cancer, which makes these cells a key missing component in current cancer immunotherapy.",23178746_3,-1,-1,-1,-1,19333,-1,1.9592193e-05,8.69828e-06,0.99997175
19337,factor,24,25,152,158,"CD200, as an immunosuppressive molecule, is overexpressed in some hematological malignancies and it has also been shown to be an independent prognostic factor in AML.",23179394_1,0,1,-1,-1,19337,-1,0.010553644,0.9892019,0.00024445413
19343,T-reg cytokine,11,13,64,78,We also assessed the effect of CD200-CD200R blockade on Th1 and T-reg cytokine production and T cell proliferation in autologous AML- and monocyte-DC mixed lymphocyte reactions (MLRs).,23179394_3,-1,-1,-1,-1,19343,-1,0.029256111,0.96867037,0.0020735678
19367,immune response through,11,14,74,97,These data present a significant role for CD200 in suppressing anti-tumor immune response through stimulation of regulatory mechanisms in AML patients and suggest that CD200 may have a prognostic value in this malignancy and its blockade may be used as a target for AML immunotherapy.,23179394_10,-1,-1,-1,-1,19367,-1,0.9594819,0.03975384,0.0007642885
19377,therapies targeted,3,5,24,42,"Development of specific therapies targeted at CSCs holds hope for the improvement of survival and quality of life of cancer patients, especially for sufferers of metastatic disease.",23180012_1,-1,-1,-1,-1,19377,-1,4.347506e-06,0.9999913,4.3423347e-06
19379,life,17,18,109,113,"Development of specific therapies targeted at CSCs holds hope for the improvement of survival and quality of life of cancer patients, especially for sufferers of metastatic disease.",23180012_1,0,-1,2,-1,19379,-1,0.0022478593,0.99734515,0.00040697085
19390,function,9,10,70,78,We examined their biological characteristics as well as immunological function and further detected the possible molecular mechanism involved in the leukemia genesis.,23180012_3,0,1,2,-1,19390,-1,0.00093684637,0.99784815,0.0012149741
19396,function,21,22,157,165,"RESULTS: We showed that CML patient-derived Flk1(+)CD31(-)CD34(-) MSCs had normal morphology, phenotype and karyotype but appeared impaired immunomodulatory function.",23180012_4,0,1,2,-1,19396,-1,0.2678845,0.7237703,0.008345232
19402,functions,6,7,57,66,"CML patient-derived MSCs have dampening immunomodulatory functions, suggesting that the dysregulation of hematopoiesis and immune response might originate from MSCs rather than HSCs.",23180012_6,0,1,2,-1,19402,-1,0.006965344,0.9896107,0.003423981
19403,that the,9,11,79,87,"CML patient-derived MSCs have dampening immunomodulatory functions, suggesting that the dysregulation of hematopoiesis and immune response might originate from MSCs rather than HSCs.",23180012_6,-1,-1,-1,-1,19403,-1,4.524471e-06,0.9999918,3.6728377e-06
19411,state to,31,33,210,218,"These Ph(+) putative CML hemangioblast upregulated TGF-1 and resultantly activated matrix metalloproteinase-9 (MMP-9) to enhance s-KitL and s-ICAM-1 secretion, which activated c-kit(+) HSCs from the quiescent state to proliferative state.",23180012_7,-1,-1,-1,-1,19411,-1,6.310675e-06,0.99998534,8.37532e-06
19414,MSCs that,4,6,35,44,CONCLUSIONS: Flk1(+)CD31(-)CD34(-) MSCs that express BCR/ABL leukemia oncogene are CSCs of CML and they play a critical role in the progression of CML through PI3K/Akt/NF-B/MMP-9/s-ICAM-1/s-KitL signaling pathway beyond HSCs.,23180012_9,-1,-1,-1,-1,19414,-1,1.9160489e-05,0.99994767,3.3144075e-05
19415,they play,15,17,99,108,CONCLUSIONS: Flk1(+)CD31(-)CD34(-) MSCs that express BCR/ABL leukemia oncogene are CSCs of CML and they play a critical role in the progression of CML through PI3K/Akt/NF-B/MMP-9/s-ICAM-1/s-KitL signaling pathway beyond HSCs.,23180012_9,-1,-1,-1,-1,19415,-1,4.9255523e-06,0.99998856,6.5589566e-06
19424,two cell types that,19,23,113,132,CD4(+)CD25(+)Foxp3(+) T regulatory cells (Tregs) and CD1d-restricted invariant natural killer T (iNKT) cells are two cell types that are known to regulate immune reactions.,23182710_0,-1,-1,-1,-1,19424,-1,0.00010572329,0.99947816,0.00041611728
19432,to their,15,17,104,112,"Therefore, the modulatory effects of the specific anti-CD25 antibodies can also be partially attributed to their interactions with the effector cells.",23182710_3,-1,-1,-1,-1,19432,-1,8.308609e-06,0.9999857,5.9467015e-06
19436,functions,4,5,19,28,"Here, the effector functions of iNKT cells were analysed in combination with anti-CD25 mAb PC61.",23182710_4,0,1,2,-1,19436,-1,0.04938603,0.70601153,0.24460247
19442,cells take place,11,14,73,89,"In order to determine whether mutual interactions between Tregs and iNKT cells take place, we compared IFN production after -GalCer administration in anti-CD25-treated and ""depletion of regulatory T cell"" (DEREG) mice.",23182710_6,-1,-1,-1,-1,19442,-1,0.0046087797,0.43911248,0.55627877
19448,that the,22,24,123,131,"Since no profound effects on IFN induction were observed in DEREG mice, deficient in FoxP3(+) Tregs, our results indicate that the anti-CD25 antibody acts directly on CD25(+) effector cells.",23182710_7,-1,-1,-1,-1,19448,-1,4.2748848e-06,0.9999919,3.88441e-06
19451,TC-1 tumour,12,14,95,106,"In vivo experiments demonstrated that although both -GalCer and PC61 administration inhibited TC-1 tumour growth in mice, no additive/synergic effects were observed when these substances were used in combination therapy.",23182710_8,-1,-1,-1,-1,19451,-1,9.26468e-06,0.9999759,1.4767785e-05
19453,therapy,30,31,213,220,"In vivo experiments demonstrated that although both -GalCer and PC61 administration inhibited TC-1 tumour growth in mice, no additive/synergic effects were observed when these substances were used in combination therapy.",23182710_8,0,1,-1,-1,19453,-1,5.581149e-06,0.9999896,4.8467296e-06
19456,tumor cells,2,4,16,27,Conditioning of tumor cells with chemotherapeutic drug has been shown to enhance the anti-tumor effects of cancer vaccines and adoptive cell therapy.,23185240_1,-1,-1,-1,-1,19456,-1,0.0006555953,0.0056251124,0.99371934
19460,cell therapy,20,22,136,148,Conditioning of tumor cells with chemotherapeutic drug has been shown to enhance the anti-tumor effects of cancer vaccines and adoptive cell therapy.,23185240_1,-1,-1,-1,-1,19460,-1,0.0010048711,0.044112578,0.95488256
19469,tumor cells,5,7,30,41,"We found that pretreatment of tumor cells with AT-101 enhanced susceptibility of L3.6pl and MiaPaCa-2 tumor cells to ATC and aATC-mediated cytotoxicity, which was in part mediated via enhanced release of cytolytic granule GrzB from ATC and aATC.",23185240_4,-1,-1,-1,-1,19469,-1,0.0004585754,0.021898212,0.9776432
19470,tumor cells to,15,18,102,116,"We found that pretreatment of tumor cells with AT-101 enhanced susceptibility of L3.6pl and MiaPaCa-2 tumor cells to ATC and aATC-mediated cytotoxicity, which was in part mediated via enhanced release of cytolytic granule GrzB from ATC and aATC.",23185240_4,-1,-1,-1,-1,19470,-1,0.00017640114,0.9951934,0.004630143
19481,proteins,41,42,294,302,"Priming (conditioning) of PC cells with AT-101 can significantly enhance the anti-tumor activity of EGFRBi armed ATC through increased IFN- induced activation of pS(727)-Stat1 and inhibition of pY(705)-Stat3 phosphorylation, and resulting in increased ratio of pro-apoptotic to anti-apoptotic proteins.",23185240_6,0,1,-1,-1,19481,-1,1.728622e-05,0.9999696,1.3089977e-05
19484,tumoral lymphocytic,16,18,97,116,"PURPOSE: Breast carcinomas, including basal and hereditary cases, often present with a prominent tumoral lymphocytic infiltrate.",23213058_0,-1,-1,-1,-1,19484,-1,0.005457391,0.45714524,0.5373974
19487,these cells,7,9,43,54,Chemokines could play a role in attracting these cells and contribute to tumor progression.,23213058_1,-1,-1,-1,-1,19487,-1,5.5953427e-05,4.046627e-05,0.9999037
19488,to tumor,11,13,70,78,Chemokines could play a role in attracting these cells and contribute to tumor progression.,23213058_1,-1,-1,-1,-1,19488,-1,7.2196535e-06,0.9999863,6.5181234e-06
19491,the relationship,8,10,56,72,We explored tumoral expression of CXCL10 and determined the relationship between CXCL10 and lymphocytic infiltrate in a cohort of breast cancers.,23213058_2,-1,-1,-1,-1,19491,-1,1.1569235e-05,0.9999815,6.892308e-06
19494,tissue,4,5,27,33,"EXPERIMENTAL DESIGN: Using tissue microarrays of 364 breast tumors, we evaluated expression of CXCL10 and its receptor, CXCR3, in relation to histopathologic features, biomarkers, and lymphocyte markers.",23213058_3,-1,1,2,-1,19494,-1,1.0677839e-05,0.999977,1.2376661e-05
19497,receptor,18,19,110,118,"EXPERIMENTAL DESIGN: Using tissue microarrays of 364 breast tumors, we evaluated expression of CXCL10 and its receptor, CXCR3, in relation to histopathologic features, biomarkers, and lymphocyte markers.",23213058_3,0,1,2,-1,19497,-1,0.0019283482,0.9861508,0.011920795
19498,relation to,23,25,130,141,"EXPERIMENTAL DESIGN: Using tissue microarrays of 364 breast tumors, we evaluated expression of CXCL10 and its receptor, CXCR3, in relation to histopathologic features, biomarkers, and lymphocyte markers.",23213058_3,-1,-1,-1,-1,19498,-1,6.906584e-06,0.9999869,6.2073273e-06
19503,T-lymphocyte,15,16,89,101,"In addition, we overexpressed CXCL10 and CXCR3 in MCF7 breast cancer cells and monitored T-lymphocyte migration and invasion.",23213058_4,-1,1,2,-1,19503,-1,1.583878e-05,1.2816657e-05,0.9999713
19507,the lymphocytic,3,5,28,43,Further characterization of the lymphocytic infiltrate revealed an association with CXCL10 expression for peritumoral CD4+ and CD8+ lymphocytes.,23213058_6,-1,-1,-1,-1,19507,-1,0.007096743,0.3131647,0.6797386
19514,T-BET+ T(H)1 cells,15,18,70,88,"CD8+ intratumoral lymphocytes, FOXP3+ regulatory T cells (Tregs), and T-BET+ T(H)1 cells were associated with BRCA1 and basal tumors.",23213058_7,-1,-1,-1,-1,19514,-1,0.0016836124,0.8787954,0.11952102
19516,MCF7 cells,3,5,23,33,Conditioned media from MCF7 cells overexpressing both CXCL10 and CXCR3 increased T-lymphocyte migration and invasion.,23213058_8,-1,-1,-1,-1,19516,-1,0.77648306,0.0009846009,0.22253235
19518,T-lymphocyte,11,12,81,93,Conditioned media from MCF7 cells overexpressing both CXCL10 and CXCR3 increased T-lymphocyte migration and invasion.,23213058_8,-1,1,2,-1,19518,-1,1.4687721e-05,9.806617e-06,0.99997556
19519,that CXCL10,5,7,34,45,"CONCLUSIONS: Our findings suggest that CXCL10 may act in a paracrine manner, affecting the tumor microenvironment, and in an autocrine manner, acting on the tumor cells themselves and may play a role in tumor invasiveness and progression.",23213058_9,-1,-1,-1,-1,19519,-1,0.9313107,0.06661164,0.0020776961
19520,the tumor,15,17,87,96,"CONCLUSIONS: Our findings suggest that CXCL10 may act in a paracrine manner, affecting the tumor microenvironment, and in an autocrine manner, acting on the tumor cells themselves and may play a role in tumor invasiveness and progression.",23213058_9,-1,-1,-1,-1,19520,-1,4.94093e-06,0.99999,5.106725e-06
19521,the tumor cells themselves,27,31,153,179,"CONCLUSIONS: Our findings suggest that CXCL10 may act in a paracrine manner, affecting the tumor microenvironment, and in an autocrine manner, acting on the tumor cells themselves and may play a role in tumor invasiveness and progression.",23213058_9,-1,-1,-1,-1,19521,-1,0.000103656166,0.99826163,0.0016346674
19524,The CXCL10-CXCR3,0,2,0,16,"The CXCL10-CXCR3 axis can serve as a potential target in BRCA1 and basal breast cancers, which present with a prominent lymphocytic infiltrate and a poor prognosis.",23213058_10,-1,-1,-1,-1,19524,-1,0.06342258,0.9340051,0.0025722927
19529,transcription factors T-bet,10,13,90,117,"Besides controlling tumor-sensitive proliferative and angiogenic effects, mTOR influences transcription factors T-bet and Eomesodermin (Eomes) in CD8 cytotoxic T cells (Tc), which are key in rejecting tumors, and allografts.",23222894_1,-1,-1,-1,-1,19529,-1,5.6835374e-06,0.99998796,6.3467296e-06
19536,transplant immunity,11,13,48,67,"METHODS: To study the role of mTOR in tumor and transplant immunity in an antigen-specific way, we used T-cell receptor transgenic B6.OTI recipients, B6.OVA.TG donors, and OVA-B16F10 melanoma cells.",23222894_2,-1,-1,-1,-1,19536,-1,0.050344154,0.9480018,0.0016540501
19538,T-cell receptor transgenic,20,23,104,130,"METHODS: To study the role of mTOR in tumor and transplant immunity in an antigen-specific way, we used T-cell receptor transgenic B6.OTI recipients, B6.OVA.TG donors, and OVA-B16F10 melanoma cells.",23222894_2,-1,-1,-1,-1,19538,-1,0.0005213389,0.008090785,0.9913879
19545,function,11,12,64,72,RESULTS: The role of mTOR in regulating the differentiation and function of alloreactive Tc cells in vitro was explored by stimulating OTI-Tc cells with ovalbumin-transgenic antigen-presenting cells in the presence of rapamycin or tacrolimus.,23222894_4,0,1,2,-1,19545,-1,6.294908e-05,0.9998273,0.000109711655
19546,Tc cells,14,16,89,97,RESULTS: The role of mTOR in regulating the differentiation and function of alloreactive Tc cells in vitro was explored by stimulating OTI-Tc cells with ovalbumin-transgenic antigen-presenting cells in the presence of rapamycin or tacrolimus.,23222894_4,-1,-1,-1,-1,19546,-1,9.509641e-06,7.2650923e-06,0.9999832
19548,antigen-presenting cells,26,28,174,198,RESULTS: The role of mTOR in regulating the differentiation and function of alloreactive Tc cells in vitro was explored by stimulating OTI-Tc cells with ovalbumin-transgenic antigen-presenting cells in the presence of rapamycin or tacrolimus.,23222894_4,-1,-1,-1,-1,19548,-1,0.4861869,0.00026253884,0.51355064
19552,Tc cells to,15,18,103,114,"Rapamycin, but not tacrolimus, induced a pro-antitumor phenotypic shift from CD62LCD44 effector memory Tc cells to CD62LCD44 central memory Tc cells, which featured up-regulated levels of T-bet and Eomes and preserved levels of interferon- and perforin.",23222894_5,-1,-1,-1,-1,19552,-1,0.0009515287,0.051078014,0.9479705
19553,Tc cells,21,23,140,148,"Rapamycin, but not tacrolimus, induced a pro-antitumor phenotypic shift from CD62LCD44 effector memory Tc cells to CD62LCD44 central memory Tc cells, which featured up-regulated levels of T-bet and Eomes and preserved levels of interferon- and perforin.",23222894_5,-1,-1,-1,-1,19553,-1,8.5252605e-06,6.9276966e-06,0.9999845
19562,analysis,35,36,257,265,"For future investigations, an in vivo model was established whereby DsRedOTI-Tc cells adoptively transferred into B6 mice bearing either a ovalbumin-transgenic mouse skin transplant or OVA-B16F10 tumor could be traced by fluorescence-activated cell sorting analysis as effector or memory Tc cells in transplant and tumor tissues.",23222894_6,0,1,-1,-1,19562,-1,1.1899694e-05,0.999979,9.133659e-06
19563,Tc cells,40,42,288,296,"For future investigations, an in vivo model was established whereby DsRedOTI-Tc cells adoptively transferred into B6 mice bearing either a ovalbumin-transgenic mouse skin transplant or OVA-B16F10 tumor could be traced by fluorescence-activated cell sorting analysis as effector or memory Tc cells in transplant and tumor tissues.",23222894_6,-1,-1,-1,-1,19563,-1,1.0460932e-05,6.7252195e-06,0.99998283
19565,tumor tissues,45,47,315,328,"For future investigations, an in vivo model was established whereby DsRedOTI-Tc cells adoptively transferred into B6 mice bearing either a ovalbumin-transgenic mouse skin transplant or OVA-B16F10 tumor could be traced by fluorescence-activated cell sorting analysis as effector or memory Tc cells in transplant and tumor tissues.",23222894_6,-1,-1,-1,-1,19565,-1,6.586144e-06,0.9999833,1.0081746e-05
19566,Tc cells,12,14,76,84,"CONCLUSION: mTOR, but not calcineurin, inhibition spares antitumoral memory Tc cells by distinctively regulating T-bet and Eomes.",23222894_7,-1,-1,-1,-1,19566,-1,8.21085e-06,5.7701886e-06,0.99998605
19570,tumor transplant,8,10,38,54,"This finding is now testable in a new tumor transplant model, which incorporates DsRedOTI-Tc cell tracing, opening the way to study the differential effects of immunosuppressants in posttransplantation malignancy.",23222894_8,-1,-1,-1,-1,19570,-1,4.7241388e-06,0.9999912,4.120169e-06
19571,cell tracing,15,17,93,105,"This finding is now testable in a new tumor transplant model, which incorporates DsRedOTI-Tc cell tracing, opening the way to study the differential effects of immunosuppressants in posttransplantation malignancy.",23222894_8,-1,-1,-1,-1,19571,-1,0.00020985979,0.00031317575,0.9994771
19575,plasma cell,9,11,39,50,BACKGROUND: Multiple myeloma (MM) is a plasma cell malignancy with a multifaceted immune dysfunction.,23232072_0,-1,-1,-1,-1,19575,-1,3.092667e-05,2.0143956e-05,0.999949
19582,the release,6,8,53,64,IDO1-driven tryptophan breakdown was correlated with the release of hepatocyte growth factor (HGF) and with the frequency of Treg cells and NY-ESO-1-specific CD8(+) T cells.,23232072_4,-1,-1,-1,-1,19582,-1,8.960467e-06,0.9999839,7.1584955e-06
19603,receptor,6,7,39,47,"Mechanistically, the antagonism of MET receptor for HGF with SU11274, a MET inhibitor, prevented HGF-induced AKT phosphorylation in MM cells and translated into reduced IDO protein levels and functional activity.",23232072_9,0,1,2,-1,19603,-1,0.02172793,0.3835974,0.59467465
19608,protein,28,29,173,180,"Mechanistically, the antagonism of MET receptor for HGF with SU11274, a MET inhibitor, prevented HGF-induced AKT phosphorylation in MM cells and translated into reduced IDO protein levels and functional activity.",23232072_9,0,1,-1,-1,19608,-1,6.8977247e-06,0.9999813,1.1866019e-05
19609,functional,31,32,192,202,"Mechanistically, the antagonism of MET receptor for HGF with SU11274, a MET inhibitor, prevented HGF-induced AKT phosphorylation in MM cells and translated into reduced IDO protein levels and functional activity.",23232072_9,0,1,2,-1,19609,-1,0.00019153937,0.99965,0.00015847929
19620,T-regulatory cells,11,13,59,77,The aim of current study is to evaluate the frequencies of T-regulatory cells (Treg) on the basis of distinct phenotypes in the differential diagnosis between malignant and tuberculous pleural effusion.,23252864_1,-1,-1,-1,-1,19620,-1,0.0017847475,0.21048106,0.78773415
19624,tuberculous pleural,29,31,173,192,The aim of current study is to evaluate the frequencies of T-regulatory cells (Treg) on the basis of distinct phenotypes in the differential diagnosis between malignant and tuberculous pleural effusion.,23252864_1,-1,-1,-1,-1,19624,-1,1.7599867e-05,0.99996865,1.3772934e-05
19627,IFN- ,7,9,43,49,"In addition, to evaluate Interferon-gamma (IFN- ) and interleukin-16 (IL-16) levels and their correlation to Treg cells in malignant and tuberculous pleural effusions.",23252864_2,-1,-1,-1,-1,19627,-1,0.99997497,2.9355404e-06,2.208275e-05
19631,to Treg cells,19,22,107,120,"In addition, to evaluate Interferon-gamma (IFN- ) and interleukin-16 (IL-16) levels and their correlation to Treg cells in malignant and tuberculous pleural effusions.",23252864_2,-1,-1,-1,-1,19631,-1,0.0012687879,0.0870668,0.9116644
19632,tuberculous pleural,25,27,138,157,"In addition, to evaluate Interferon-gamma (IFN- ) and interleukin-16 (IL-16) levels and their correlation to Treg cells in malignant and tuberculous pleural effusions.",23252864_2,-1,-1,-1,-1,19632,-1,1.6799535e-05,0.99996793,1.5222675e-05
19637,blood,4,5,29,34,"Pleural fluid and peripheral blood were assessed for frequencies of T regs, IL-16, and IFN-.",23252864_4,0,1,-1,-1,19637,-1,0.0014575439,0.03562612,0.9629163
19647,blood,24,25,165,170,"Pleural effusions from both tuberculous and malignant groups represented significantly higher levels (more in TB) for the following cell populations than peripheral blood: total lymphocytes, CD3+lymphocyte, CD4+CD25+lymphocyte and Treg (CD4+ CD25+FoxP3+).",23252864_5,0,1,-1,-1,19647,-1,0.0018071689,0.6516218,0.346571
19648,total lymphocytes,26,28,172,189,"Pleural effusions from both tuberculous and malignant groups represented significantly higher levels (more in TB) for the following cell populations than peripheral blood: total lymphocytes, CD3+lymphocyte, CD4+CD25+lymphocyte and Treg (CD4+ CD25+FoxP3+).",23252864_5,-1,-1,-1,-1,19648,-1,7.810685e-05,0.00043869915,0.9994831
19653,than that,11,13,73,82,Levels of IL-16 and IFN- in tuberculous group were significantly higher than that in malignant group.,23252864_6,-1,-1,-1,-1,19653,-1,7.981776e-06,0.99998605,5.940276e-06
19662,the function,12,14,64,76,Forkhead box P3 (FOXP3) is a transcription factor necessary for the function of regulatory T cells (T(reg) cells).,23252899_0,-1,-1,-1,-1,19662,-1,8.409509e-06,0.99998116,1.0446876e-05
19677,function,34,35,181,189,"Here, we discuss the role of T(reg) cells in the pathogenesis of myasthenia gravis (MG) and review evidence indicating that a significant defect in T(reg) cell in vitro suppressive function exists in MG patients, without an alteration in circulating frequency.",23252899_2,0,1,2,-1,19677,-1,3.2111104e-05,0.99993515,3.2731918e-05
19678,This functional,0,2,0,15,"This functional defect is associated with a reduced expression of key functional molecules, such as FOXP3 on isolated T(reg) cells, and appears to be more pronounced in immunosuppression-naive MG patients.",23252899_3,-1,-1,-1,-1,19678,-1,1.744327e-05,0.9999701,1.2503851e-05
19679,functional,11,12,70,80,"This functional defect is associated with a reduced expression of key functional molecules, such as FOXP3 on isolated T(reg) cells, and appears to be more pronounced in immunosuppression-naive MG patients.",23252899_3,0,1,2,-1,19679,-1,0.033102248,0.9622774,0.0046203304
19684,factor,6,7,69,75,In vitro administration of granulocyte macrophage-colony-stimulating factor (GM-CSF) enhanced the suppressive function of T(reg) cells and upregulated FOXP3 expression.,23252899_4,0,1,-1,-1,19684,-1,0.99993014,7.298199e-06,6.252773e-05
19687,function,13,14,110,118,In vitro administration of granulocyte macrophage-colony-stimulating factor (GM-CSF) enhanced the suppressive function of T(reg) cells and upregulated FOXP3 expression.,23252899_4,0,1,2,-1,19687,-1,2.3706207e-05,0.9999541,2.2201173e-05
19692,relevant T(reg,5,7,37,51,These findings indicate a clinically relevant T(reg) cell-intrinsic defect in immune regulation in MG that may reveal a novel therapeutic target.,23252899_5,-1,-1,-1,-1,19692,-1,6.2088925e-06,0.99998724,6.552321e-06
19696,therapeutic target,20,22,126,144,These findings indicate a clinically relevant T(reg) cell-intrinsic defect in immune regulation in MG that may reveal a novel therapeutic target.,23252899_5,-1,-1,-1,-1,19696,-1,4.6886494e-06,0.99999106,4.224183e-06
19697,The transcription factor interferon,0,4,0,35,The transcription factor interferon regulatory factor-8 (IRF-8) is crucial for myeloid cell development and immune response and also acts as a tumor suppressor gene.,23308054_0,-1,-1,-1,-1,19697,-1,0.0064658667,0.9931444,0.00038972142
19698,factor-8,5,6,47,55,The transcription factor interferon regulatory factor-8 (IRF-8) is crucial for myeloid cell development and immune response and also acts as a tumor suppressor gene.,23308054_0,0,1,-1,-1,19698,-1,0.00012514993,0.9998103,6.455265e-05
19710,cells transplanted,2,4,17,35,"B16-F10 melanoma cells transplanted into IRF-8-deficient (IRF-8(-/-)) mice grow more rapidly, leading to higher numbers of lung metastasis, with respect to control animals.",23308054_2,-1,-1,-1,-1,19710,-1,0.0043595918,0.22834156,0.7672988
19718,receptor,20,21,152,160,"These events correlated with reduced dendritic cell and T cell infiltration, accumulation of myeloid-derived suppressor cells and a chemokine/chemokine receptor expression profile within the tumor microenvironment supporting tumor growth, angiogenesis, and metastasis.",23308054_3,0,1,2,-1,19718,-1,0.99954766,2.8166714e-05,0.00042418123
19719,the tumor,24,26,187,196,"These events correlated with reduced dendritic cell and T cell infiltration, accumulation of myeloid-derived suppressor cells and a chemokine/chemokine receptor expression profile within the tumor microenvironment supporting tumor growth, angiogenesis, and metastasis.",23308054_3,-1,-1,-1,-1,19719,-1,4.4391054e-06,0.9999908,4.7947024e-06
19727,chemokine receptor,23,25,192,210,Injection of the demethylating agent 5-aza-2'-deoxycytidine into melanoma-bearing IRF-8(-/-) animals induced intratumoral IRF-8 expression and resulted in the re-establishment of a chemokine/ chemokine receptor pattern favoring leukocyte infiltration and melanoma growth arrest.,23308054_5,-1,-1,-1,-1,19727,-1,0.9992524,2.1226586e-05,0.0007264327
19734,factors,12,13,77,84,"Lastly, IRF-8 expression in melanoma cells was directly modulated by soluble factors, among which interleukin-27 (IL-27), released by immune cells from tumor-bearing mice.",23308054_7,0,1,-1,-1,19734,-1,5.4945507e-05,0.9999372,7.863869e-06
19745,function,24,25,140,148,"Collectively, these results underscore a key role of IRF-8 in the cross talk between melanoma and immune cells, thus revealing its critical function within the tumor microenvironment in regulating melanoma progression and invasiveness.",23308054_8,0,1,2,-1,19745,-1,8.032231e-06,0.9999845,7.4446693e-06
19746,the tumor,26,28,156,165,"Collectively, these results underscore a key role of IRF-8 in the cross talk between melanoma and immune cells, thus revealing its critical function within the tumor microenvironment in regulating melanoma progression and invasiveness.",23308054_8,-1,-1,-1,-1,19746,-1,4.4912476e-06,0.9999907,4.790607e-06
19749,blood,15,16,81,86,A higher frequency of regulatory T cells (Tregs) has been observed in peripheral blood mononuclear cells (PBMC) of patients with different types of solid tumors and hematological malignancies as compared to healthy donors.,23319273_0,0,1,-1,-1,19749,-1,0.00037925705,0.9984469,0.0011738393
19756,function,15,16,89,97,"In prostate cancer patients, Tregs in PBMC have been shown to have increased suppressive function.",23319273_1,0,1,2,-1,19756,-1,1.7718006e-05,0.99996316,1.9118293e-05
19759,tumor cells to,7,10,53,67,Tumor-induced biological changes in Tregs may enable tumor cells to escape immunosurveillance.,23319273_2,-1,-1,-1,-1,19759,-1,0.00011979116,0.99884355,0.0010366053
19765,blood,25,26,176,181,"We performed genome-wide expression analyses comparing the expression levels of more than 38,500 genes in Tregs with similar suppressive activity, isolated from the peripheral blood of healthy donors and patients with metastatic castration-resistant prostate cancer (mCRPC).",23319273_3,0,1,-1,-1,19765,-1,0.0003088853,0.9980039,0.001687268
19772,function,26,27,178,186,"The differentially expressed genes in mCRPC Tregs are involved in cell cycle processes, cellular growth and proliferation, immune responses, hematological system development and function and the interleukin-2 (IL-2) and transforming growth factor- (TGF-) pathways.",23319273_4,0,1,2,-1,19772,-1,0.00014670334,0.99811816,0.0017352119
19773,the interleukin-2,28,30,191,208,"The differentially expressed genes in mCRPC Tregs are involved in cell cycle processes, cellular growth and proliferation, immune responses, hematological system development and function and the interleukin-2 (IL-2) and transforming growth factor- (TGF-) pathways.",23319273_4,-1,-1,-1,-1,19773,-1,0.9415482,0.056683693,0.0017681173
19775,factor-,36,37,240,248,"The differentially expressed genes in mCRPC Tregs are involved in cell cycle processes, cellular growth and proliferation, immune responses, hematological system development and function and the interleukin-2 (IL-2) and transforming growth factor- (TGF-) pathways.",23319273_4,0,1,-1,-1,19775,-1,0.99994993,5.5104074e-06,4.4556455e-05
19777,that the,2,4,17,25,"Studies revealed that the levels of expression of genes responsible for T-cell proliferation (C-FOS, C-JUN and DUSP1) and cellular migration (RGS1) were greater in Tregs from mCRPC patients as compared to values observed in healthy donors.",23319273_5,-1,-1,-1,-1,19777,-1,3.7863642e-06,0.99999225,3.9243755e-06
19784,these Tregs,12,14,78,89,Increased RGS1 expression in Tregs from mCRPC patients suggests a decrease in these Tregs' migratory ability.,23319273_6,-1,-1,-1,-1,19784,-1,6.0721422e-06,0.99998355,1.0414315e-05
19788,blood,17,18,88,93,"In addition, the higher frequency of CD4(+) CD25(high) CD127(-) Tregs in the peripheral blood of mCRPC patients may be the result of an increase in Treg proliferation capacity.",23319273_7,0,1,-1,-1,19788,-1,0.00081858557,0.9873552,0.01182627
19791,that the,3,5,21,29,Results also suggest that the alterations observed in gene expression profiles of Tregs in mCRPC patients may be part of the mechanism of tumor escape from host immune surveillance.,23319273_8,-1,-1,-1,-1,19791,-1,3.986092e-06,0.9999924,3.611397e-06
19796,protein,1,2,9,16,Survivin protein is an attractive candidate for cancer immunotherapy since it is abundantly expressed in most common human cancers and mostly absent in normal adult tissues.,23335100_0,0,1,-1,-1,19796,-1,7.36472e-05,0.999908,1.8382956e-05
19798,tissues,25,26,165,172,Survivin protein is an attractive candidate for cancer immunotherapy since it is abundantly expressed in most common human cancers and mostly absent in normal adult tissues.,23335100_0,-1,1,2,-1,19798,-1,0.00012118532,0.9713428,0.028536042
19801,the therapeutic,6,8,28,43,"In this study, we evaluated the therapeutic efficacy of a novel survivin-based vaccine by subcutaneous or intraperitoneum injection of BALB/c mice with murine fiber-induced MM tumor cells followed by vaccination with recombinant Fowlpox virus replicons encoding survivin.",23335100_2,-1,-1,-1,-1,19801,-1,4.5089932e-06,0.99999166,3.814909e-06
19802,tumor cells,26,28,176,187,"In this study, we evaluated the therapeutic efficacy of a novel survivin-based vaccine by subcutaneous or intraperitoneum injection of BALB/c mice with murine fiber-induced MM tumor cells followed by vaccination with recombinant Fowlpox virus replicons encoding survivin.",23335100_2,-1,-1,-1,-1,19802,-1,0.00012724035,0.0003074022,0.9995653
19808,T-cell,13,14,92,98,"Flow cytometry and immunofluorescence analyses of tumors from vaccinated mice showed CD8(+) T-cell infiltration, and real-time PCR demonstrated increased mRNA and protein levels of immunostimulatory cytokines.",23335100_4,-1,1,2,-1,19808,-1,1.3885103e-05,9.621518e-06,0.9999765
19809,protein,23,24,163,170,"Flow cytometry and immunofluorescence analyses of tumors from vaccinated mice showed CD8(+) T-cell infiltration, and real-time PCR demonstrated increased mRNA and protein levels of immunostimulatory cytokines.",23335100_4,0,1,-1,-1,19809,-1,1.3656348e-05,0.99997926,7.0567476e-06
19811,peptide-pulsed,3,4,21,35,"Analyses of survivin peptide-pulsed spleen and lymph node cells from vaccinated mice using ELISPOT and intracellular cytokine staining confirmed antigen-specific, interferon--producing CD8(+) T-cell responses.",23335100_5,0,-1,2,-1,19811,-1,0.9829343,0.015890697,0.0011749729
19816,T-cell,24,25,193,199,"Analyses of survivin peptide-pulsed spleen and lymph node cells from vaccinated mice using ELISPOT and intracellular cytokine staining confirmed antigen-specific, interferon--producing CD8(+) T-cell responses.",23335100_5,-1,1,2,-1,19816,-1,2.3133909e-05,7.937551e-06,0.9999689
19821,T-cell,11,12,95,101,Our results demonstrate that vaccination with recombinant Fowlpox expressing survivin improves T-cell responses against aggressive MM tumors and may form the basis for promising clinical applications.,23335100_8,-1,1,2,-1,19821,-1,2.948323e-05,1.11807585e-05,0.99995935
19824,that the,4,6,21,29,"It has been reported that the imbalance of T helper IL-17-producing cells (Th17 cells)/regulatory T cells (Tregs) was closely associated with advanced tumor growth and poor prognosis in lung cancer, but little is known about whether this imbalance is existed in the peripheral blood of patients with non-small cell lung cancer (NSCLC).",23335103_0,-1,-1,-1,-1,19824,-1,4.4103404e-06,0.9999919,3.7396462e-06
19826,IL-17-producing cells,10,12,52,73,"It has been reported that the imbalance of T helper IL-17-producing cells (Th17 cells)/regulatory T cells (Tregs) was closely associated with advanced tumor growth and poor prognosis in lung cancer, but little is known about whether this imbalance is existed in the peripheral blood of patients with non-small cell lung cancer (NSCLC).",23335103_0,-1,-1,-1,-1,19826,-1,0.94643337,0.00016010339,0.05340657
19833,blood,47,48,277,282,"It has been reported that the imbalance of T helper IL-17-producing cells (Th17 cells)/regulatory T cells (Tregs) was closely associated with advanced tumor growth and poor prognosis in lung cancer, but little is known about whether this imbalance is existed in the peripheral blood of patients with non-small cell lung cancer (NSCLC).",23335103_0,0,1,-1,-1,19833,-1,0.0004524313,0.99563944,0.0039081452
19837,Th17 cells,7,9,33,43,"Here, the percentage of Treg and Th17 cells, and the expression of transcription factors RORt and FoxP3 were studied by flow cytometry, real-time PCR, and Western blotting, respectively.",23335103_1,-1,-1,-1,-1,19837,-1,2.4628474e-05,0.00010566741,0.9998696
19847,that there,3,5,19,29,"The results showed that there was an increase in the percentage of Tregs, the mRNA and protein expression of FoxP3, the level of Treg-related cytokines in patients with NSCLC while compared to that in healthy patients.",23335103_3,-1,-1,-1,-1,19847,-1,3.5173287e-06,0.9999925,4.018433e-06
19851,protein,17,18,87,94,"The results showed that there was an increase in the percentage of Tregs, the mRNA and protein expression of FoxP3, the level of Treg-related cytokines in patients with NSCLC while compared to that in healthy patients.",23335103_3,0,1,-1,-1,19851,-1,6.853814e-06,0.99998736,5.786579e-06
19854,Treg-related cytokines,25,27,129,151,"The results showed that there was an increase in the percentage of Tregs, the mRNA and protein expression of FoxP3, the level of Treg-related cytokines in patients with NSCLC while compared to that in healthy patients.",23335103_3,-1,-1,-1,-1,19854,-1,0.03643057,0.96140814,0.0021613238
19855,to that,33,35,190,197,"The results showed that there was an increase in the percentage of Tregs, the mRNA and protein expression of FoxP3, the level of Treg-related cytokines in patients with NSCLC while compared to that in healthy patients.",23335103_3,-1,-1,-1,-1,19855,-1,4.6917103e-06,0.99999046,4.804313e-06
19857,Th17 cells,5,7,28,38,"Moreover, the percentage of Th17 cells, RORt mRNA, and protein expression were decreased in peripheral blood of NSCLC patients.",23335103_4,-1,-1,-1,-1,19857,-1,0.00013196177,0.0033453435,0.99652267
19858,protein,12,13,56,63,"Moreover, the percentage of Th17 cells, RORt mRNA, and protein expression were decreased in peripheral blood of NSCLC patients.",23335103_4,0,1,-1,-1,19858,-1,7.3695933e-06,0.9999863,6.314185e-06
19859,blood,18,19,104,109,"Moreover, the percentage of Th17 cells, RORt mRNA, and protein expression were decreased in peripheral blood of NSCLC patients.",23335103_4,0,1,-1,-1,19859,-1,0.00016742089,0.99960345,0.00022910014
19861,that the,3,5,21,29,"Our results indicate that the Th17/Treg balance is abnormal in peripheral blood, which may be important in the development of NSCLC.",23335103_6,-1,-1,-1,-1,19861,-1,4.2185425e-06,0.9999919,3.934338e-06
19862,blood,11,12,74,79,"Our results indicate that the Th17/Treg balance is abnormal in peripheral blood, which may be important in the development of NSCLC.",23335103_6,0,1,-1,-1,19862,-1,0.0020549812,0.50511014,0.49283487
19878,the TGF-1 gene,4,7,31,46,"The interference efficiency of the TGF-1 gene was tested by real-time PCR and ELISA; the expression of Foxp3, IFN- and CD83 in CD4(+), CD8(+) or dendritic cells was examined via flow cytometry; and the tumorigenic ability of the cancer cells was investigated in the animal experiments.",23361571_3,-1,-1,-1,-1,19878,-1,4.7959725e-06,0.9999895,5.6693625e-06
19884,the tumorigenic,39,41,200,215,"The interference efficiency of the TGF-1 gene was tested by real-time PCR and ELISA; the expression of Foxp3, IFN- and CD83 in CD4(+), CD8(+) or dendritic cells was examined via flow cytometry; and the tumorigenic ability of the cancer cells was investigated in the animal experiments.",23361571_3,-1,-1,-1,-1,19884,-1,7.412386e-06,0.9999864,6.2184513e-06
19902,Foxp3 gene,15,17,98,108,"The supernatant from Hepa1-6 cells and recombinant TGF-1 significantly induced the expression of Foxp3 gene in vitro, while that from sh TGF-1 Hepa1-6 cells restored it.",23361571_6,-1,-1,-1,-1,19902,-1,3.6956e-06,0.99999225,4.038998e-06
19911,that the,4,6,33,41,The animal experiments indicated that the knockdown TGF-1 gene impaired the tumorigenic ability of Hepa1-6 cells.,23361571_8,-1,-1,-1,-1,19911,-1,3.8501926e-06,0.99999225,3.873373e-06
19912,TGF-1 gene,7,9,52,63,The animal experiments indicated that the knockdown TGF-1 gene impaired the tumorigenic ability of Hepa1-6 cells.,23361571_8,-1,-1,-1,-1,19912,-1,5.35035e-06,0.9999876,7.1001045e-06
19913,the tumorigenic,10,12,73,88,The animal experiments indicated that the knockdown TGF-1 gene impaired the tumorigenic ability of Hepa1-6 cells.,23361571_8,-1,-1,-1,-1,19913,-1,1.0059957e-05,0.99998367,6.251715e-06
19917,therapeutic target,13,15,68,86,"CONCLUSION: TGF-1, expressed in cancer cells, might be a potential therapeutic target for cancer treatment.",23361571_9,-1,-1,-1,-1,19917,-1,5.9021518e-06,0.9999895,4.619179e-06
19919,The generation,0,2,0,14,The generation of effector CD8(+) T cells with lytic capacity is crucial for tumor control.,23380742_0,-1,-1,-1,-1,19919,-1,5.9698687e-06,0.9999887,5.3948497e-06
19927,that the,4,6,16,24,"Here, we report that the Notch pathway has an important role in both these processes in human CD8(+) T cells.",23380742_2,-1,-1,-1,-1,19927,-1,4.6113573e-06,0.9999914,3.9867123e-06
19934,tumor antigen-specific,20,22,108,130,The role for Notch signaling in CD8(+) T cell priming was determined using an ex-vivo model system in which tumor antigen-specific primary CD8(+) T cell responses were measured.,23380742_4,-1,-1,-1,-1,19934,-1,0.6276276,0.37050998,0.0018624715
19940,factor--,32,33,229,238,"Inhibition of Notch using -secretase inhibitors or soluble Delta-like4-Fc during activation reduced expansion of antigen-specific CD8(+) T cells, which was mirrored by decreased frequencies of interferon (IFN)-, tumor necrosis factor--, and granzymeB-producing CD8(+) T cells.",23380742_5,0,1,-1,-1,19940,-1,0.99991524,1.5974705e-05,6.879851e-05
19943,functionally,11,12,64,76,"Moreover, T cells primed when Notch signaling was prevented are functionally low-avidity T cells.",23380742_6,0,1,2,-1,19943,-1,0.0004801988,0.9994216,9.826009e-05
19945,T cell function,8,11,60,75,"In addition, Notch partially regulates established effector T cell function.",23380742_7,-1,-1,-1,-1,19945,-1,1.5420635e-05,1.0975728e-05,0.99997365
19946,IFN release,6,8,49,61,Activation-induced Notch signaling is needed for IFN release but not for cytolytic activity.,23380742_8,-1,-1,-1,-1,19946,-1,0.99960595,0.00016243503,0.00023161144
19950,T cell functions,17,20,107,123,These data indicate that Notch signaling controls human CD8(+) T cell priming and also influences effector T cell functions.,23380742_9,-1,-1,-1,-1,19950,-1,1.3893861e-05,9.4428215e-06,0.99997663
19956,immunity,21,22,161,169,We evaluated the effectiveness of rhamnogalacturonan II (RG-II)-stimulated bone marrow-derived dendritic cells (BMDCs) vaccination on the induction of antitumor immunity in a mouse lymphoma model using EG7-lymphoma cells expressing ovalbumin (OVA).,23392255_0,0,-1,2,-1,19956,-1,0.99985766,3.7433743e-05,0.00010493488
19962,factor-,9,10,57,65,"RG-II induced interleukin (IL)-12, IL-1, tumor necrosis factor- (TNF-) and interferon- (IFN-) production during dendritic cell (DC) maturation.",23392255_2,0,1,-1,-1,19962,-1,0.99995875,4.3822847e-06,3.6794143e-05
19963,TNF-,11,12,67,72,"RG-II induced interleukin (IL)-12, IL-1, tumor necrosis factor- (TNF-) and interferon- (IFN-) production during dendritic cell (DC) maturation.",23392255_2,0,1,-1,-1,19963,-1,0.005721677,0.9939959,0.0002823503
19970,Toll-like receptors,7,9,39,58,"Using BMDCs from the mice deficient in Toll-like receptors (TLRs), we revealed that RG-II activity is dependent on TLR4.",23392255_4,-1,-1,-1,-1,19970,-1,0.001235331,0.8860789,0.11268581
19977,immune response through the TLR4,8,13,58,90,These results suggested that RG-II expedites the DC-based immune response through the TLR4 signaling pathway.,23392255_6,-1,-1,-1,-1,19977,-1,0.493381,0.5020073,0.0046116947
19980,T-cell-mediated,4,5,20,35,"The extent to which T-cell-mediated immune surveillance is impaired in human cancer remains a question of major importance, given its potential impact on the development of generalized treatments of advanced disease where the highest degree of heterogeneity exists.",23423978_0,-1,1,2,-1,19980,-1,1.3529646e-05,1.0080619e-05,0.9999764
19982,generalized treatments,27,29,173,195,"The extent to which T-cell-mediated immune surveillance is impaired in human cancer remains a question of major importance, given its potential impact on the development of generalized treatments of advanced disease where the highest degree of heterogeneity exists.",23423978_0,-1,-1,-1,-1,19982,-1,8.665107e-06,0.9999846,6.7113724e-06
19985,analysis,7,8,33,41,"Here, we report the first global analysis of immune dysfunction in patients with advanced hepatocellular carcinoma (HCC).",23423978_1,0,1,-1,-1,19985,-1,6.8693457e-06,0.99998796,5.2269493e-06
19987,analysis,5,6,58,66,"Using multi-parameter fluorescence-activated cell sorting analysis, we quantified the cumulative frequency of regulatory T cells (Treg), exhausted CD4(+) helper T cells, and myeloid-derived suppressor cells (MDSC) to gain concurrent views on the overall level of immune dysfunction in these inoperable patients.",23423978_2,0,1,-1,-1,19987,-1,8.783522e-06,0.9999832,8.081712e-06
20000,T-cell-mediated,2,3,13,28,"In dampening T-cell-mediated antitumor immunity, we hypothesized that these processes may facilitate HCC progression and thwart the efficacy of immunotherapeutic interventions.",23423978_4,-1,1,2,-1,20000,-1,2.3519471e-05,1.9957746e-05,0.9999566
20001,immunity,4,5,39,47,"In dampening T-cell-mediated antitumor immunity, we hypothesized that these processes may facilitate HCC progression and thwart the efficacy of immunotherapeutic interventions.",23423978_4,0,-1,2,-1,20001,-1,0.999874,3.0345143e-05,9.56185e-05
20002,that these,8,10,65,75,"In dampening T-cell-mediated antitumor immunity, we hypothesized that these processes may facilitate HCC progression and thwart the efficacy of immunotherapeutic interventions.",23423978_4,-1,-1,-1,-1,20002,-1,5.0431613e-06,0.9999913,3.6926408e-06
20003,thwart the,16,18,121,131,"In dampening T-cell-mediated antitumor immunity, we hypothesized that these processes may facilitate HCC progression and thwart the efficacy of immunotherapeutic interventions.",23423978_4,-1,-1,-1,-1,20003,-1,9.2745695e-06,0.99998426,6.460087e-06
20004,testing this,1,3,3,15,"In testing this hypothesis, we showed that combined regimens to deplete Tregs, MDSC, and PD-1(+) T cells in patients with advanced HCC restored production of granzyme B by CD8(+) T cells, reaching levels observed in normal controls and also modestly increased the number of IFN- producing CD4(+) T cells.",23423978_5,-1,-1,-1,-1,20004,-1,4.8909315e-06,0.9999912,3.934992e-06
20015,T-cell function,7,9,53,68,These clinical findings encourage efforts to restore T-cell function in patients with advanced stage disease by highlighting combined approaches to deplete endogenous suppressor cell populations that can also expand effector T-cell populations.,23423978_6,-1,-1,-1,-1,20015,-1,2.4513103e-05,1.7692637e-05,0.9999578
20019,T-cell,30,31,225,231,These clinical findings encourage efforts to restore T-cell function in patients with advanced stage disease by highlighting combined approaches to deplete endogenous suppressor cell populations that can also expand effector T-cell populations.,23423978_6,-1,1,2,-1,20019,-1,1.2720706e-05,8.015927e-06,0.99997926
20020,T cells play,1,4,6,18,Donor T cells play pivotal roles in graft-versus-host disease (GVHD) and graft-versus-leukemia (GVL) effects following bone marrow transplantation (BMT).,23430112_0,-1,-1,-1,-1,20020,-1,0.0016298438,0.063671716,0.9346985
20021,transplantation,21,22,131,146,Donor T cells play pivotal roles in graft-versus-host disease (GVHD) and graft-versus-leukemia (GVL) effects following bone marrow transplantation (BMT).,23430112_0,-1,1,2,-1,20021,-1,1.0138624e-05,0.9999815,8.349083e-06
20025,state to,27,29,147,155,"DNAX accessory molecule 1 (DNAM-1) is a costimulatory and adhesion molecule, expressed mainly by natural killer cells and CD8(+) T cells at steady state to promote adhesion to ligand-expressing targets and enhance cytolysis.",23430112_1,-1,-1,-1,-1,20025,-1,4.684187e-06,0.9999907,4.630347e-06
20041,function,9,10,61,69,The absence of DNAM-1 promoted the expansion and suppressive function of Treg after BMT.,23430112_6,0,1,2,-1,20041,-1,3.7626814e-05,0.99993145,3.093144e-05
20051,IL-10-driven Th2 immune responses,6,10,40,73,IgG4 subclass antibodies are present in IL-10-driven Th2 immune responses in some inflammatory conditions.,23454746_1,-1,-1,-1,-1,20051,-1,0.99993646,1.6687329e-05,4.6800913e-05
20055,functional,15,16,105,115,"Since Th2-biased inflammation is a hallmark of tumor microenvironments, we investigated the presence and functional implications of IgG4 in malignant melanoma.",23454746_2,0,1,2,-1,20055,-1,0.0005842155,0.9993197,9.616927e-05
20063,blood,10,11,56,61,"When compared with B cells from patient lymph nodes and blood, tumor-associated B cells were polarized to produce IgG4.",23454746_4,0,1,-1,-1,20063,-1,9.691451e-05,0.9997776,0.00012551385
20068,tumor cells,9,11,46,57,"Secreted B cells increased VEGF and IgG4, and tumor cells enhanced IL-10 secretion in cocultures.",23454746_5,-1,-1,-1,-1,20068,-1,4.2393633e-05,0.000118138836,0.9998394
20070,tumor antigen-specific,5,7,27,49,"Unlike IgG1, an engineered tumor antigen-specific IgG4 was ineffective in triggering effector cell-mediated tumor killing in vitro.",23454746_6,-1,-1,-1,-1,20070,-1,0.5677477,0.42970833,0.0025439456
20072,cell-mediated tumor,13,15,94,113,"Unlike IgG1, an engineered tumor antigen-specific IgG4 was ineffective in triggering effector cell-mediated tumor killing in vitro.",23454746_6,-1,-1,-1,-1,20072,-1,0.001934719,0.044552635,0.9535126
20074,tumoricidal functions,6,8,62,83,Antigen-specific and nonspecific IgG4 inhibited IgG1-mediated tumoricidal functions.,23454746_7,-1,-1,-1,-1,20074,-1,0.0006902264,0.9986688,0.0006409923
20080,tumor-induced Th2-biased,7,9,45,69,"These findings suggest that IgG4 promoted by tumor-induced Th2-biased inflammation may restrict effector cell functions against tumors, providing a previously unexplored aspect of tumor-induced immune escape and a basis for biomarker development and patient-specific therapeutic approaches.",23454746_11,-1,-1,-1,-1,20080,-1,4.9237646e-05,0.99992347,2.7275082e-05
20081,cell functions,13,15,105,119,"These findings suggest that IgG4 promoted by tumor-induced Th2-biased inflammation may restrict effector cell functions against tumors, providing a previously unexplored aspect of tumor-induced immune escape and a basis for biomarker development and patient-specific therapeutic approaches.",23454746_11,-1,-1,-1,-1,20081,-1,2.3842133e-05,1.4335672e-05,0.99996185
20086,regulation that,7,9,46,61,"IL-33 is a multifunctional cytokine in immune regulation that activates Th1 cells, Th2 cells, CD8(+) T cells and NK cells.",23499895_0,-1,-1,-1,-1,20086,-1,6.4626875e-06,0.99998605,7.5151447e-06
20091,that transgenic,3,5,17,32,Our study showed that transgenic expression of IL-33 attenuated tumor metastasis in the B16 melanoma and Lewis lung carcinoma (LLC) metastatic models.,23499895_1,-1,-1,-1,-1,20091,-1,4.7540134e-06,0.99999034,4.9461837e-06
20098,the tumor tissues,16,19,92,109,The percentages and cytotoxicity of CD8(+) T cells and NK cells and their infiltration into the tumor tissues were significantly increased by the transgenic expression of IL-33 in tumor-bearing mice.,23499895_2,-1,-1,-1,-1,20098,-1,5.7631214e-06,0.999984,1.0246214e-05
20099,the transgenic,23,25,142,156,The percentages and cytotoxicity of CD8(+) T cells and NK cells and their infiltration into the tumor tissues were significantly increased by the transgenic expression of IL-33 in tumor-bearing mice.,23499895_2,-1,-1,-1,-1,20099,-1,4.5157262e-06,0.9999912,4.3501677e-06
20110,the two cell subsets,22,26,128,148,"Furthermore, IL-33 stimulated the activation of NF-B and increased CD69 expression, which is a marker of the activated form of the two cell subsets, in CD8(+) T cells and NK cells.",23499895_5,-1,-1,-1,-1,20110,-1,0.0016051538,0.08921276,0.90918213
20120,These cells,0,2,0,11,"These cells provide prosurvival signals to tumors; however, little is known regarding their interactions with immune cells within the tumor microenvironment.",23514705_1,-1,-1,-1,-1,20120,-1,4.101363e-05,3.0218924e-05,0.9999287
20121,to tumors,5,7,40,49,"These cells provide prosurvival signals to tumors; however, little is known regarding their interactions with immune cells within the tumor microenvironment.",23514705_1,-1,-1,-1,-1,20121,-1,7.462758e-06,0.99998605,6.456822e-06
20124,the tumor,20,22,130,139,"These cells provide prosurvival signals to tumors; however, little is known regarding their interactions with immune cells within the tumor microenvironment.",23514705_1,-1,-1,-1,-1,20124,-1,4.5435545e-06,0.9999912,4.2950855e-06
20125,that factors,2,4,16,28,"We hypothesized that factors produced by human PSC could enhance myeloid-derived suppressor cell (MDSC) differentiation and function, which promotes an immunosuppressive microenvironment.",23514705_2,-1,-1,-1,-1,20125,-1,3.0413566e-05,0.9999634,6.1869337e-06
20127,function,18,19,124,132,"We hypothesized that factors produced by human PSC could enhance myeloid-derived suppressor cell (MDSC) differentiation and function, which promotes an immunosuppressive microenvironment.",23514705_2,0,1,2,-1,20127,-1,0.003033329,0.10452849,0.89243823
20130,protein,33,34,183,190,"Primary PSC cell lines (n = 7) were generated from human specimens and phenotypically confirmed via expression of vimentin, -smooth muscle actin (-SMA), and glial fibrillary acidic protein (GFAP).",23514705_3,0,1,-1,-1,20130,-1,0.49123695,0.5020506,0.0067124753
20131,analysis,1,2,8,16,"Luminex analysis indicated that PSC but not human fetal primary pancreatic fibroblast cells (HPF; negative controls) produced MDSC-promoting cytokines [interleukin (IL-6), VEGF, macrophage colony-stimulating factor (M-CSF) ] and chemokines (SDF-1, MCP-1).",23514705_4,0,1,-1,-1,20131,-1,9.677917e-06,0.9999827,7.582032e-06
20141,blood,3,4,22,27,"Culture of peripheral blood mononuclear cells [peripheral blood mononuclear cell (PBMC), n = 3 donors] with PSC supernatants or IL-6/granulocyte macrophage colony-stimulating factor (GM-CSF; positive control) for 7 days promoted PBMC differentiation into an MDSC (CD11b+CD33+) phenotype and a subpopulation of polymorphonuclear CD11b+CD33+CD15+ cells.",23514705_5,0,1,-1,-1,20141,-1,0.0007694486,0.9972644,0.0019662054
20143,blood,8,9,58,63,"Culture of peripheral blood mononuclear cells [peripheral blood mononuclear cell (PBMC), n = 3 donors] with PSC supernatants or IL-6/granulocyte macrophage colony-stimulating factor (GM-CSF; positive control) for 7 days promoted PBMC differentiation into an MDSC (CD11b+CD33+) phenotype and a subpopulation of polymorphonuclear CD11b+CD33+CD15+ cells.",23514705_5,0,1,-1,-1,20143,-1,0.0033671781,0.9460445,0.050588276
20149,cells functionally,4,6,26,44,The resulting CD11b+CD33+ cells functionally suppressed autologous T-lymphocyte proliferation.,23514705_6,-1,-1,-1,-1,20149,-1,0.009284303,0.24891931,0.7417964
20151,to STAT3,8,10,50,58,Culture of normal PBMCs with PSC supernatants led to STAT3 but not STAT1 or STAT5 phosphorylation.,23514705_8,-1,-1,-1,-1,20151,-1,7.978841e-06,0.99998534,6.721209e-06
20163,that STAT3,19,21,114,124,These results identify a novel role for PSC in driving immune escape in pancreatic cancer and extend the evidence that STAT3 acts as a driver of stromal immunosuppression to enhance its interest as a therapeutic target.,23514705_11,-1,-1,-1,-1,20163,-1,6.0754023e-06,0.99998915,4.778025e-06
20165,therapeutic target,34,36,200,218,These results identify a novel role for PSC in driving immune escape in pancreatic cancer and extend the evidence that STAT3 acts as a driver of stromal immunosuppression to enhance its interest as a therapeutic target.,23514705_11,-1,-1,-1,-1,20165,-1,5.0406643e-06,0.99999094,4.0733894e-06
20167,T cells that,12,15,66,78,4-1BB agonist antibody treatment induces a population of KLRG1(+) T cells that infiltrate melanoma tumors.,23547098_0,-1,-1,-1,-1,20167,-1,0.0010432906,0.037160177,0.9617966
20170,function,5,6,31,39,"We investigated the origin and function of these cells, as well as their place within established T cell paradigms.",23547098_1,0,1,2,-1,20170,-1,0.00013902226,0.99970067,0.00016037632
20171,these cells,7,9,43,54,"We investigated the origin and function of these cells, as well as their place within established T cell paradigms.",23547098_1,-1,-1,-1,-1,20171,-1,1.8225743e-05,2.3381304e-05,0.9999584
20172,their place,13,15,67,78,"We investigated the origin and function of these cells, as well as their place within established T cell paradigms.",23547098_1,-1,-1,-1,-1,20172,-1,6.696472e-06,0.999984,9.2568935e-06
20174,that these T cells,2,6,8,26,"We find that these T cells, particularly the CD4 lineage, represent a novel phenotype characterized by enhanced, multipotent cytotoxicity.",23547098_2,-1,-1,-1,-1,20174,-1,0.002417586,0.49514407,0.5024383
20176,this T cell,5,8,36,47,"Distinct from described polarities, this T cell phenotype is driven by the T-box transcription factor Eomesodermin.",23547098_3,-1,-1,-1,-1,20176,-1,0.0014529905,0.13893746,0.85960954
20177,the T-box transcription factor,12,16,71,101,"Distinct from described polarities, this T cell phenotype is driven by the T-box transcription factor Eomesodermin.",23547098_3,-1,-1,-1,-1,20177,-1,6.635165e-06,0.9999877,5.5994833e-06
20180,antigen-presenting cells,13,15,67,91,"Formation of this phenotype requires 4-1BB signaling on both T and antigen-presenting cells and the resulting production of the cytokines IL-27, IL-15, and IL-10.",23547098_4,-1,-1,-1,-1,20180,-1,0.6453225,0.00030477642,0.35437274
20182,the cytokines,20,22,124,137,"Formation of this phenotype requires 4-1BB signaling on both T and antigen-presenting cells and the resulting production of the cytokines IL-27, IL-15, and IL-10.",23547098_4,-1,-1,-1,-1,20182,-1,0.586014,0.4099066,0.004079461
20189,these cells,33,35,193,204,"Furthermore, we find CD4(+) T cells bearing the signature features of this phenotype in the livers of mice infected with both bacterial and viral intracellular pathogens, suggesting a role for these cells in infectious immunity.",23547098_5,-1,-1,-1,-1,20189,-1,1.1307499e-05,7.895879e-06,0.9999808
20190,immunity,37,38,219,227,"Furthermore, we find CD4(+) T cells bearing the signature features of this phenotype in the livers of mice infected with both bacterial and viral intracellular pathogens, suggesting a role for these cells in infectious immunity.",23547098_5,0,-1,2,-1,20190,-1,0.99988186,2.914443e-05,8.8928784e-05
20191,These T cells,0,3,0,13,"These T cells constitute a novel phenotype that resolves multiple questions associated with 4-1BB activation, including how 4-1BB enhances tumor-specific cytotoxicity and how 4-1BB can promote tumor immunity while repressing autoimmunity.",23547098_6,-1,-1,-1,-1,20191,-1,0.0005385384,0.02464581,0.9748157
20194,tumor immunity,33,35,193,207,"These T cells constitute a novel phenotype that resolves multiple questions associated with 4-1BB activation, including how 4-1BB enhances tumor-specific cytotoxicity and how 4-1BB can promote tumor immunity while repressing autoimmunity.",23547098_6,-1,-1,-1,-1,20194,-1,0.110609256,0.88806397,0.0013267362
20195,cells plays,6,8,55,66,An imbalance of immunosuppressive and immunomodulatory cells plays an important role in inhibiting the anti-tumour immune response in a tumour-bearing host.,23572151_0,-1,-1,-1,-1,20195,-1,0.003812036,0.15393603,0.84225196
20199,"cells, regulatory T cells",2,7,11,36,"Among such cells, regulatory T cells (Tregs), together with immunosuppressive macrophages, such as CD163+ M2 macrophages, play roles in maintaining the tumour microenvironment.",23572151_1,-1,-1,-1,-1,20199,-1,2.5270163e-05,1.8870154e-05,0.9999559
20203,the tumour,27,29,148,158,"Among such cells, regulatory T cells (Tregs), together with immunosuppressive macrophages, such as CD163+ M2 macrophages, play roles in maintaining the tumour microenvironment.",23572151_1,-1,-1,-1,-1,20203,-1,4.4940393e-06,0.9999912,4.2682213e-06
20227,Tregs cells,10,12,45,56,We also examined the presence of CD3+ Foxp3+ Tregs cells in lesional skin from 10 patients with KA and 18 patients with SCC.,23572151_4,-1,-1,-1,-1,20227,-1,2.8401204e-05,4.9775077e-05,0.9999218
20234,tumour cells,8,10,41,53,"In addition, the expression of pSTAT1 on tumour cells was observed only in KA.",23572151_8,-1,-1,-1,-1,20234,-1,8.9300665e-05,0.00037427945,0.9995365
20236,that the,3,5,23,31,These findings suggest that the induction of immunosuppressive and immunomodulatory cells differs between KA and SCC.,23572151_9,-1,-1,-1,-1,20236,-1,5.3667327e-06,0.9999913,3.3918782e-06
20238,the function,5,7,28,40,"MicroRNAs (miRNAs) regulate the function of several immune cells, but their role in promoting CD8(+) Tcell immunity remains unknown.",23601686_0,-1,-1,-1,-1,20238,-1,9.935707e-06,0.9999802,9.8116125e-06
20241,Tcell immunity,19,23,101,116,"MicroRNAs (miRNAs) regulate the function of several immune cells, but their role in promoting CD8(+) Tcell immunity remains unknown.",23601686_0,-1,-1,-1,-1,20241,-1,8.3333034e-05,1.4503236e-05,0.9999021
20250,deficiency,1,2,10,20,miRNA-155 deficiency resulted in accumulation of suppressor of cytokine signaling-1 (SOCS-1) causing defective cytokine signaling through STAT5.,23601686_4,0,1,-1,-1,20250,-1,1.21496905e-05,0.99998,7.863898e-06
20252,cytokine signaling through STAT5,15,19,111,143,miRNA-155 deficiency resulted in accumulation of suppressor of cytokine signaling-1 (SOCS-1) causing defective cytokine signaling through STAT5.,23601686_4,-1,-1,-1,-1,20252,-1,0.7093987,0.28678477,0.003816628
20255,deficiency,15,16,88,98,"Consistently, enforced expression of SOCS-1 in CD8(+) Tcells phenocopied the miRNA-155 deficiency, whereas SOCS-1 silencing augmented tumor destruction.",23601686_5,0,1,-1,-1,20255,-1,5.5574623e-05,0.99993026,1.4172939e-05
20259,Tcells that,15,19,93,105,These findings identify miRNA-155 and its target SOCS-1 as key regulators of effector CD8(+) Tcells that can be modulated to potentiate immunotherapies for infectious diseases and cancer.,23601686_6,-1,-1,-1,-1,20259,-1,0.0019395238,0.055723317,0.9423373
20263,gene transfected,15,17,82,98,AIM: To study anti-tumor effects of exosomes from class II transactivator (CIITA) gene transfected CT26 cells.,23621273_0,-1,-1,-1,-1,20263,-1,8.434919e-06,0.9999827,8.908073e-06
20274,protein,17,18,91,98,RESULTS: Exosomes from CT26-CIITA cells were found to contain a high level of MHC class II protein.,23621273_3,0,1,-1,-1,20274,-1,2.4173156e-05,0.999966,9.79202e-06
20286,TNF-,14,15,94,99,"In addition, compared to exosomes from CT26 cells, CT26-CIITA-derived exosomes induced higher TNF- and IL-12 mRNA levels.",23621273_6,0,1,-1,-1,20286,-1,0.00066717644,0.99923515,9.767098e-05
20299,receptor,8,9,54,62,Immune signatures in breast tumors differ by estrogen receptor (ER) status.,23624818_0,0,1,2,-1,20299,-1,0.0007932346,0.9971976,0.0020090742
20304,cytokines that,16,18,101,115,The purpose of this study was to assess associations between ER phenotypes and circulating levels of cytokines that co-ordinate cell-mediated [T-helper type 1 (Th1)] and humoral [T-helper type 2 (Th2)] immunity.,23624818_1,-1,-1,-1,-1,20304,-1,0.95799875,0.040456116,0.001545152
20306,T-helper type,21,23,143,156,The purpose of this study was to assess associations between ER phenotypes and circulating levels of cytokines that co-ordinate cell-mediated [T-helper type 1 (Th1)] and humoral [T-helper type 2 (Th2)] immunity.,23624818_1,-1,-1,-1,-1,20306,-1,1.1631455e-05,0.999954,3.4400076e-05
20308,T-helper type,31,33,179,192,The purpose of this study was to assess associations between ER phenotypes and circulating levels of cytokines that co-ordinate cell-mediated [T-helper type 1 (Th1)] and humoral [T-helper type 2 (Th2)] immunity.,23624818_1,-1,-1,-1,-1,20308,-1,1.0619749e-05,0.9999666,2.2702834e-05
20310,immunity,38,39,202,210,The purpose of this study was to assess associations between ER phenotypes and circulating levels of cytokines that co-ordinate cell-mediated [T-helper type 1 (Th1)] and humoral [T-helper type 2 (Th2)] immunity.,23624818_1,0,-1,2,-1,20310,-1,0.8068958,0.0019536777,0.19115047
20316,Th1 to Th2 cytokines,2,6,10,30,Ratios of Th1 to Th2 cytokines were also evaluated.,23624818_3,-1,-1,-1,-1,20316,-1,0.060553666,0.93513656,0.004309719
20318,Th-2 cytokine,6,8,32,45,"Levels of interleukin (IL)-5, a Th-2 cytokine, were higher in ER(-) than in ER(+) tumors.",23624818_4,-1,-1,-1,-1,20318,-1,0.13292708,0.8602653,0.006807614
20326,Th1 cytokines,1,3,9,22,"Elevated Th1 cytokines were also detected in women with ER(-) and TNBCs, with women in the highest tertile of interferon 2 (OR = 2.39, 95 % CI 1.31-4.35) or tumor necrosis factor- (OR = 2.27, 95 % CI 1.21-4.26) being twice as likely to have TNBC versus LumA cancer.",23624818_6,-1,-1,-1,-1,20326,-1,0.11287986,0.8824039,0.004716249
20332,factor-,38,39,173,181,"Elevated Th1 cytokines were also detected in women with ER(-) and TNBCs, with women in the highest tertile of interferon 2 (OR = 2.39, 95 % CI 1.31-4.35) or tumor necrosis factor- (OR = 2.27, 95 % CI 1.21-4.26) being twice as likely to have TNBC versus LumA cancer.",23624818_6,0,1,-1,-1,20332,-1,0.9999552,4.9498317e-06,3.9841674e-05
20338,Th1 cytokines to,12,15,69,85,"When cytokine ratios were examined, women with the highest ratios of Th1 cytokines to IL-5 levels were least likely to have ER(-) or TNBCs compared to ER(+) or LumA cancers, respectively.",23624818_7,-1,-1,-1,-1,20338,-1,9.683802e-05,0.99978334,0.00011986637
20345,TNBC than,18,20,96,105,"The strongest associations were in premenopausal women, who were up to 80 % less likely to have TNBC than LumA cancers (IL-12p40/IL-5, OR = 0.19, 95 % CI 0.07-0.56).",23624818_8,-1,-1,-1,-1,20345,-1,1.06373245e-05,0.99997306,1.6290689e-05
20348,function,5,6,36,44,"These findings indicate that immune function is associated with ER(-) and TNBC and may be most relevant among younger women, who are likely to be diagnosed with these aggressive phenotypes.",23624818_9,0,1,2,-1,20348,-1,0.051738825,0.93488145,0.013379704
20362,to tumor,22,24,150,158,"In tumors rendered immunogenic by model antigen expression or following administration of antitumor vaccines, we found that high NF-B activity leads to tumor rejection and/or growth suppression in mice.",23635779_2,-1,-1,-1,-1,20362,-1,5.0850795e-06,0.99999,4.880159e-06
20364,T cell chemokines,15,18,100,117,"Using a global RNA expression microarray, we demonstrated that NF-B enhanced expression of several T cell chemokines, including Ccl2, and decreased CCL2 expression was associated with enhanced tumor growth in a mouse lung cancer model.",23635779_3,-1,-1,-1,-1,20364,-1,0.34031585,0.00076669693,0.65891737
20369,function,3,4,21,29,"To investigate NF-B function in human lung tumors, we identified a gene expression signature in human lung adenocarcinoma cell lines that was associated with NF-B activity level.",23635779_4,0,1,2,-1,20369,-1,1.4418102e-05,0.9999714,1.4200392e-05
20383,gene transcripts,10,12,50,66,"miRNAs (miR) have been shown to modulate critical gene transcripts involved in tumorigenesis, but their role in tumor-mediated immunosuppression is largely unknown.",23636127_0,-1,-1,-1,-1,20383,-1,7.49268e-06,0.999985,7.509577e-06
20389,tissue,10,11,55,61,"On the basis of miRNA gene expression in gliomas using tissue microarrays, in situ hybridization, and molecular modeling, miR-124 was identified as a lead candidate for modulating STAT3 signaling, a key pathway mediating immunosuppression in the tumor microenvironment.",23636127_1,-1,1,2,-1,20389,-1,1.2678419e-05,0.99997294,1.4353287e-05
20391,the tumor,39,41,242,251,"On the basis of miRNA gene expression in gliomas using tissue microarrays, in situ hybridization, and molecular modeling, miR-124 was identified as a lead candidate for modulating STAT3 signaling, a key pathway mediating immunosuppression in the tumor microenvironment.",23636127_1,-1,-1,-1,-1,20391,-1,4.817545e-06,0.99999034,4.7911262e-06
20395,the STAT3,12,14,62,71,"Upon upregulating miR-124 in glioma cancer stem cells (gCSC), the STAT3 pathway was inhibited, and miR-124 reversed gCSC-mediated immunosuppression of T-cell proliferation and induction of forkhead box P3 (Foxp3)(+) regulatory T cells (Treg).",23636127_3,-1,-1,-1,-1,20395,-1,5.9237805e-06,0.9999881,5.9611493e-06
20404,TNF-,23,24,168,173,"Treatment of T cells from immunosuppressed glioblastoma patients with miR-124 induced marked effector response including upregulation of interleukin (IL)-2, IFN-, and TNF-.",23636127_4,0,1,-1,-1,20404,-1,7.286487e-05,0.99990475,2.2342509e-05
20405,T-cell transfers,8,10,72,88,Both systemic administration of miR-124 or adoptive miR-124-transfected T-cell transfers exerted potent anti-glioma therapeutic effects in clonotypic and genetically engineered murine models of glioblastoma and enhanced effector responses in the local tumor microenvironment.,23636127_5,-1,-1,-1,-1,20405,-1,0.00018588876,0.0030358043,0.9967784
20410,These therapeutic,0,2,0,17,"These therapeutic effects were ablated in both CD4(+)- and CD8(+)-depleted mice and nude mouse systems, indicating that the therapeutic effect of miR-124 depends on the presence of a T-cell-mediated antitumor immune response.",23636127_6,-1,-1,-1,-1,20410,-1,4.067302e-06,0.99999166,4.232597e-06
20411,that the therapeutic,17,20,115,135,"These therapeutic effects were ablated in both CD4(+)- and CD8(+)-depleted mice and nude mouse systems, indicating that the therapeutic effect of miR-124 depends on the presence of a T-cell-mediated antitumor immune response.",23636127_6,-1,-1,-1,-1,20411,-1,4.3586233e-06,0.9999913,4.301604e-06
20413,T-cell-mediated,29,30,183,198,"These therapeutic effects were ablated in both CD4(+)- and CD8(+)-depleted mice and nude mouse systems, indicating that the therapeutic effect of miR-124 depends on the presence of a T-cell-mediated antitumor immune response.",23636127_6,-1,1,2,-1,20413,-1,1.2989526e-05,8.614053e-06,0.9999784
20420,immune responses to,9,12,63,82,The immune system has evolved regulatory mechanisms to control immune responses to self-antigens.,23657628_0,-1,-1,-1,-1,20420,-1,0.9711562,0.028226538,0.000617319
20423,cells play,5,7,20,30,"Regulatory T (Treg) cells play a pivotal role in maintaining immune tolerance, but tumour growth is associated with local immunosuppression, which can subvert effector immune responses.",23657628_1,-1,-1,-1,-1,20423,-1,0.002921698,0.17899683,0.81808156
20437,receptor,8,9,53,61,This study addresses the hypothesis that blocking RA receptor alpha (RAR) may enhance the efficacy of a tumour vaccine by inhibiting the induction of Treg cells.,23657628_4,0,1,2,-1,20437,-1,0.00014280542,0.0023096947,0.99754745
20446,that this,19,21,118,127,We found that RA significantly enhanced TGF--induced expression of Foxp3 on nave and committed T cells in vitro and that this was blocked by an antagonist of RAR (RARi).,23657628_5,-1,-1,-1,-1,20446,-1,5.0597446e-06,0.9999907,4.208347e-06
20452,tumour cells,23,25,135,147,"In addition, RARi significantly suppressed TGF- and IL-10 and enhanced IL-12 production by dendritic cells (DC) in response to killed tumour cells or TLR agonists.",23657628_6,-1,-1,-1,-1,20452,-1,0.0002718651,0.0012150233,0.99851304
20453,TLR agonists,26,28,151,163,"In addition, RARi significantly suppressed TGF- and IL-10 and enhanced IL-12 production by dendritic cells (DC) in response to killed tumour cells or TLR agonists.",23657628_6,-1,-1,-1,-1,20453,-1,0.003432227,0.9961725,0.0003952487
20459,tumour-infiltrating FoxP3(+,9,11,68,95,This protective effect was associated with significant reduction in tumour-infiltrating FoxP3(+) and IL-10(+) Treg cells and a corresponding increase in tumour-infiltrating CD4(+) and CD8(+) T cells that secreted IFN-.,23657628_8,-1,-1,-1,-1,20459,-1,5.8576436e-05,0.9998933,4.8153986e-05
20463,T cells that,28,31,191,203,This protective effect was associated with significant reduction in tumour-infiltrating FoxP3(+) and IL-10(+) Treg cells and a corresponding increase in tumour-infiltrating CD4(+) and CD8(+) T cells that secreted IFN-.,23657628_8,-1,-1,-1,-1,20463,-1,0.0007747072,0.011314422,0.98791087
20493,receptor,7,8,40,48,TSCC showed more diffuse Ki67 and IL-22 receptor (IL-22R) expression by IHC.,23667456_7,0,1,2,-1,20493,-1,0.056632362,0.59233105,0.35103658
20494,cytotoxic T cell function,1,5,11,36,Diminished cytotoxic T cell function in TSCC due to decreased CD8/T-reg ratio may permit tumor progression.,23667456_9,-1,-1,-1,-1,20494,-1,3.4409433e-05,9.55479e-06,0.999956
20500,targeted therapy,7,9,41,57,IL-22 may be an attractive candidate for targeted therapy of SCC without endangering allograft survival.,23667456_11,-1,-1,-1,-1,20500,-1,6.7380165e-06,0.9999889,4.357391e-06
20511,factor-1,8,9,42,51,"In our study, Tregs and hypoxia inducible factor-1 were found to be positively correlated with each other and were increased with the tumor progression.",23723999_3,0,1,-1,-1,20511,-1,0.055619724,0.94278896,0.0015913486
20513,the tumor,22,24,131,140,"In our study, Tregs and hypoxia inducible factor-1 were found to be positively correlated with each other and were increased with the tumor progression.",23723999_3,-1,-1,-1,-1,20513,-1,3.971366e-06,0.9999913,4.765984e-06
20522,therapeutic target,10,12,56,74,These findings confirmed the crucial role of Tregs as a therapeutic target in gastric cancer therapy and provided helpful thoughts for the design of immunotherapy for gastric cancer in the future.,23723999_5,-1,-1,-1,-1,20522,-1,6.315394e-06,0.99998796,5.7324582e-06
20523,therapy,15,16,93,100,These findings confirmed the crucial role of Tregs as a therapeutic target in gastric cancer therapy and provided helpful thoughts for the design of immunotherapy for gastric cancer in the future.,23723999_5,0,1,-1,-1,20523,-1,4.37402e-06,0.9999908,4.7983162e-06
20535,blood,20,21,117,122,"For example, a high number of CD4+CD25++Foxp3+ regulatory T-cells (Foxp3+Tregs) have been observed in the peripheral blood and tumor microenvironment of cancer patients.",23725550_1,0,1,-1,-1,20535,-1,0.00034863525,0.99452484,0.0051264884
20539,temozolomide to,19,21,105,120,"On the basis of this, we conducted a study on DC-based vaccination in advanced melanoma, adding low-dose temozolomide to obtain lymphodepletion.",23725550_2,-1,-1,-1,-1,20539,-1,3.5978435e-05,0.9999522,1.1832123e-05
20549,Foxp3+Treg cells,3,5,33,49,Temozolomide reduced circulating Foxp3+Treg cells in all patients.,23725550_7,-1,-1,-1,-1,20549,-1,0.0030771585,0.699893,0.29702988
20555,Foxp3+Treg cell,4,6,27,42,"Conversely, IL-2 increased Foxp3+Treg cell count by 75.4%.",23725550_9,-1,-1,-1,-1,20555,-1,0.002594883,0.70614815,0.291257
20557,this cytokine,5,7,22,35,"Of note the effect of this cytokine, albeit not statistically significant, on the DCR subgroup led to a further 33.8% reduction in Foxp3+Treg cells.",23725550_10,-1,-1,-1,-1,20557,-1,0.8064989,0.18954884,0.0039522406
20561,Foxp3+Treg cells,25,27,131,147,"Of note the effect of this cytokine, albeit not statistically significant, on the DCR subgroup led to a further 33.8% reduction in Foxp3+Treg cells.",23725550_10,-1,-1,-1,-1,20561,-1,0.0017800467,0.7357796,0.26244044
20562,that the,5,7,33,41,"CONCLUSIONS: Our results suggest that the combined immunological therapy, at least as far as the DCR subgroup is concerned, effectively reduced the number of Foxp3+Treg cells, which exerted a blunting effect on the growth-stimulating effect of IL-2.",23725550_11,-1,-1,-1,-1,20562,-1,4.974609e-06,0.9999912,3.8147396e-06
20563,therapy,9,10,65,72,"CONCLUSIONS: Our results suggest that the combined immunological therapy, at least as far as the DCR subgroup is concerned, effectively reduced the number of Foxp3+Treg cells, which exerted a blunting effect on the growth-stimulating effect of IL-2.",23725550_11,0,1,-1,-1,20563,-1,5.6854255e-06,0.9999883,5.9500867e-06
20566,Foxp3+Treg cells,27,29,158,174,"CONCLUSIONS: Our results suggest that the combined immunological therapy, at least as far as the DCR subgroup is concerned, effectively reduced the number of Foxp3+Treg cells, which exerted a blunting effect on the growth-stimulating effect of IL-2.",23725550_11,-1,-1,-1,-1,20566,-1,0.0022228279,0.72436124,0.27341595
20574,tissue,18,19,114,120,"Study animals were analysed for gastric and adipose pathology, inflammatory markers in serum, stomach and adipose tissue, and immune responses in blood, spleen, stomach and adipose tissue.",23729675_2,-1,1,2,-1,20574,-1,6.8575624e-05,0.0001827414,0.99974877
20575,immune responses in blood,21,25,126,151,"Study animals were analysed for gastric and adipose pathology, inflammatory markers in serum, stomach and adipose tissue, and immune responses in blood, spleen, stomach and adipose tissue.",23729675_2,-1,-1,-1,-1,20575,-1,0.9860596,0.012690231,0.0012502408
20576,tissue,31,32,181,187,"Study animals were analysed for gastric and adipose pathology, inflammatory markers in serum, stomach and adipose tissue, and immune responses in blood, spleen, stomach and adipose tissue.",23729675_2,-1,1,2,-1,20576,-1,7.623472e-05,0.00045424385,0.9994696
20577,cells in blood,6,9,55,69,Obesity increased bone marrow-derived immature myeloid cells in blood and gastric tissue of H felis-infected mice.,23729675_4,-1,-1,-1,-1,20577,-1,0.005804124,0.07162555,0.9225703
20578,tissue,11,12,82,88,Obesity increased bone marrow-derived immature myeloid cells in blood and gastric tissue of H felis-infected mice.,23729675_4,-1,1,2,-1,20578,-1,2.2759374e-05,0.999858,0.00011915805
20585,tissue,25,26,169,175,"Obesity also led to elevations in CD4 T cells, IL-17A, granulocyte macrophage colony-stimulating factor, phosphorylated STAT3 and prosurvival gene expression in gastric tissue of H felis-infected mice.",23729675_5,-1,1,2,-1,20585,-1,2.3194623e-05,0.9997938,0.000183039
20586,tissue,4,5,23,29,"Conversely, in adipose tissue of obese mice, H felis infection increased macrophage accumulation and expression of IL-6, C-C motif ligand 7 (CCL7) and leptin.",23729675_6,-1,1,2,-1,20586,-1,0.0011483898,0.67758983,0.32126173
20594,factors,12,13,117,124,"Interestingly, gastric inflammation augmented obesity-induced adipose inflammation and production of adipose-derived factors in obese, but not lean, mice.",23729675_9,0,1,-1,-1,20594,-1,0.24577235,0.7535185,0.00070917356
20596,through cytokine-mediated,9,11,85,110,"Our findings suggest that obesity accelerates Helicobacter-associated gastric cancer through cytokine-mediated cross-talk between inflamed gastric and adipose tissues, augmenting immune responses at both tissue sites, and thereby contributing to a protumorigenic gastric microenvironment.",23729675_10,-1,-1,-1,-1,20596,-1,0.6491798,0.3482203,0.0025998624
20597,tissues,17,18,159,166,"Our findings suggest that obesity accelerates Helicobacter-associated gastric cancer through cytokine-mediated cross-talk between inflamed gastric and adipose tissues, augmenting immune responses at both tissue sites, and thereby contributing to a protumorigenic gastric microenvironment.",23729675_10,-1,1,2,-1,20597,-1,0.00015486144,0.003070977,0.99677414
20599,tissue,24,25,204,210,"Our findings suggest that obesity accelerates Helicobacter-associated gastric cancer through cytokine-mediated cross-talk between inflamed gastric and adipose tissues, augmenting immune responses at both tissue sites, and thereby contributing to a protumorigenic gastric microenvironment.",23729675_10,-1,1,2,-1,20599,-1,0.000280515,0.0046243416,0.99509513
20604,cytokine that,9,11,50,63,"AIMS: Interleukin-17 (IL-17) is a proinflammatory cytokine that is most prominently produced by T-helper type 17 (Th17) cells, a distinct CD4+ T-helper cell subset.",23738752_0,-1,-1,-1,-1,20604,-1,0.97873724,0.020047178,0.0012156338
20605,T-helper type,16,18,96,109,"AIMS: Interleukin-17 (IL-17) is a proinflammatory cytokine that is most prominently produced by T-helper type 17 (Th17) cells, a distinct CD4+ T-helper cell subset.",23738752_0,-1,-1,-1,-1,20605,-1,2.0433996e-05,0.9999205,5.9116057e-05
20608,T-helper cell subset,28,31,143,163,"AIMS: Interleukin-17 (IL-17) is a proinflammatory cytokine that is most prominently produced by T-helper type 17 (Th17) cells, a distinct CD4+ T-helper cell subset.",23738752_0,-1,-1,-1,-1,20608,-1,0.00013797532,0.001983034,0.997879
20613,IL-17-producing cells,11,13,54,75,The aim of this study was to investigate the level of IL-17-producing cells in the breast cancer tumour microenvironment and its prognostic role.,23738752_1,-1,-1,-1,-1,20613,-1,0.9438159,0.00012491834,0.05605929
20620,IL-17-producing cells,6,8,35,56,"We found that increased numbers of IL-17-producing cells were correlated with high histological grade, negative ER/PR status, and triple-negative molecular subtypes segregated by immunoprofiles.",23738752_3,-1,-1,-1,-1,20620,-1,0.95363075,0.00011642771,0.046252847
20625,nodal status,12,14,57,69,"However, they did not correlate with stage, tumour size, nodal status, HER2 status, or histological type.",23738752_4,-1,-1,-1,-1,20625,-1,0.9897474,0.0017052905,0.008547308
20629,IL-17-producing cells,7,9,43,64,Patients with tumours with high numbers of IL-17-producing cells had shorter disease-free survival (DFS) than patients with tumours with low numbers of IL-17-producing cells (P < 0.01).,23738752_5,-1,-1,-1,-1,20629,-1,0.9558012,0.0001250746,0.04407369
20632,IL-17-producing cells,24,26,152,173,Patients with tumours with high numbers of IL-17-producing cells had shorter disease-free survival (DFS) than patients with tumours with low numbers of IL-17-producing cells (P < 0.01).,23738752_5,-1,-1,-1,-1,20632,-1,0.9629113,0.000119660595,0.036969118
20633,analysis,2,3,16,24,"In multivariate analysis, high IL-17 level [hazard ratio (HR) 2.24; 95% CI 1.06-4.75], advanced T stage (HR 2.73; 95% CI 1.30-5.73), positive HER2 status (HR 4.88; 95% CI 1.47-16.18) and triple-negative subtype (HR 7.46; 95% CI 1.38-40.36) were significant prognostic factors for DFS.CONCLUSIONS: Our results indicate that a high level of IL-17-producing cells in the breast cancer tumour microenvironment is a poor prognostic factor.",23738752_6,0,1,-1,-1,20633,-1,1.0717503e-05,0.9999807,8.550591e-06
20638,factors,69,70,268,275,"In multivariate analysis, high IL-17 level [hazard ratio (HR) 2.24; 95% CI 1.06-4.75], advanced T stage (HR 2.73; 95% CI 1.30-5.73), positive HER2 status (HR 4.88; 95% CI 1.47-16.18) and triple-negative subtype (HR 7.46; 95% CI 1.38-40.36) were significant prognostic factors for DFS.CONCLUSIONS: Our results indicate that a high level of IL-17-producing cells in the breast cancer tumour microenvironment is a poor prognostic factor.",23738752_6,0,1,-1,-1,20638,-1,0.05177551,0.9474677,0.0007567729
20640,IL-17-producing cells,81,83,339,360,"In multivariate analysis, high IL-17 level [hazard ratio (HR) 2.24; 95% CI 1.06-4.75], advanced T stage (HR 2.73; 95% CI 1.30-5.73), positive HER2 status (HR 4.88; 95% CI 1.47-16.18) and triple-negative subtype (HR 7.46; 95% CI 1.38-40.36) were significant prognostic factors for DFS.CONCLUSIONS: Our results indicate that a high level of IL-17-producing cells in the breast cancer tumour microenvironment is a poor prognostic factor.",23738752_6,-1,-1,-1,-1,20640,-1,0.9396358,0.00011986944,0.060244296
20643,factor,93,94,427,433,"In multivariate analysis, high IL-17 level [hazard ratio (HR) 2.24; 95% CI 1.06-4.75], advanced T stage (HR 2.73; 95% CI 1.30-5.73), positive HER2 status (HR 4.88; 95% CI 1.47-16.18) and triple-negative subtype (HR 7.46; 95% CI 1.38-40.36) were significant prognostic factors for DFS.CONCLUSIONS: Our results indicate that a high level of IL-17-producing cells in the breast cancer tumour microenvironment is a poor prognostic factor.",23738752_6,0,1,-1,-1,20643,-1,0.014058317,0.9855552,0.00038653516
20648,to the,14,16,82,88,"While the mechanism is not well understood, BM-MSCs have been shown to contribute to the immunosuppressive response found in a number of diseases.",23777268_1,-1,-1,-1,-1,20648,-1,7.5893017e-06,0.9999864,6.0236594e-06
20652,to the,10,12,69,75,"At day 28 post-transplantation, BM-MSCs migrated from the subserosal to the mucosal layer of the stomach.",23777268_3,-1,-1,-1,-1,20652,-1,5.097556e-06,0.9999887,6.2606186e-06
20659,functions,19,20,133,142,The grafted BM-MSCs significantly stimulated systemic and local interleukin-10 (IL-10)-secreting T cell and regulatory T cell (Treg) functions.,23777268_4,0,1,2,-1,20659,-1,4.1966905e-05,0.00012090139,0.99983716
20664,cytokines IL-10,3,5,21,36,"Moreover, inhibitory cytokines IL-10 and transforming growth factor-1 increased in the gastric tissue, while there was a decrease in inflammatory interferon- (IFN-).",23777268_6,-1,-1,-1,-1,20664,-1,0.9999627,5.7064212e-06,3.1637876e-05
20666,factor-1,8,9,61,70,"Moreover, inhibitory cytokines IL-10 and transforming growth factor-1 increased in the gastric tissue, while there was a decrease in inflammatory interferon- (IFN-).",23777268_6,0,1,-1,-1,20666,-1,0.98910844,0.0006982278,0.010193267
20668,tissue,13,14,96,102,"Moreover, inhibitory cytokines IL-10 and transforming growth factor-1 increased in the gastric tissue, while there was a decrease in inflammatory interferon- (IFN-).",23777268_6,-1,1,2,-1,20668,-1,0.00031920493,0.8095503,0.19013049
20674,the immune responses,15,18,90,110,A coculture system in the presence or absence of BM-MSCs was also established to evaluate the immune responses in vitro.,23777268_8,-1,-1,-1,-1,20674,-1,0.729514,0.26845032,0.002035634
20675,IL-10-secreting T cells,3,6,15,38,"An increase in IL-10-secreting T cells and Tregs, associated with increased expression of Gata-3 and FoxP3, generation of IL-10 in the supernatant, and proliferation of gastric epithelial cells (GECs) was observed.",23777268_9,-1,-1,-1,-1,20675,-1,0.9131978,0.00030281977,0.08649925
20684,that transplantation,3,5,27,47,These findings demonstrate that transplantation of BM-MSCs into a chronic H. pylori-infected mouse model results in the generation of an immunosuppressive environment.,23777268_10,-1,-1,-1,-1,20684,-1,4.941698e-06,0.99999094,4.1045387e-06
20685,the generation,16,18,116,130,These findings demonstrate that transplantation of BM-MSCs into a chronic H. pylori-infected mouse model results in the generation of an immunosuppressive environment.,23777268_10,-1,-1,-1,-1,20685,-1,4.9164623e-06,0.9999906,4.5121596e-06
20690,Chemokine receptors CCR6,0,3,0,24,Chemokine receptors CCR6 and CCR7 have been reported to play important roles in T cell migration and organ-specific metastasis of various tumors.,23835793_0,-1,-1,-1,-1,20690,-1,0.3454644,0.00082149555,0.65371406
20691,to play,8,10,53,60,Chemokine receptors CCR6 and CCR7 have been reported to play important roles in T cell migration and organ-specific metastasis of various tumors.,23835793_0,-1,-1,-1,-1,20691,-1,5.8095484e-06,0.99998915,5.0416984e-06
20703,the CCR6,18,20,84,92,"The expression of CCR6, CCR7 and their ligands mRNA (CCL20, CCL19/CCL21) as well as the CCR6 and CCR7 proteins were detected by real-time RT-PCR and immunohistochemistry (IHC), respectively.",23835793_2,-1,-1,-1,-1,20703,-1,0.0015528661,0.88340825,0.11503883
20704,proteins,22,23,102,110,"The expression of CCR6, CCR7 and their ligands mRNA (CCL20, CCL19/CCL21) as well as the CCR6 and CCR7 proteins were detected by real-time RT-PCR and immunohistochemistry (IHC), respectively.",23835793_2,0,1,-1,-1,20704,-1,6.1723936e-06,0.999987,6.8609784e-06
20709,blood,19,20,114,119,Flow cytometry was used to investigate the percentage of CD4+CD25+Foxp3+ regulatory T cells (Tregs) in peripheral blood mononuclear cells (PBMCs).,23835793_3,0,1,-1,-1,20709,-1,0.00022644582,0.9993704,0.00040312106
20716,transforming growth factor,20,23,112,138,"Furthermore, a number of cytokines, including interleukin (IL)-2, IL-4, IL-10, IL-12p70, interferon (IFN)- and transforming growth factor (TGF)-1 were detected by ELISA.",23835793_4,-1,-1,-1,-1,20716,-1,0.98660165,0.010782256,0.0026161843
20718,that CCR6,3,5,19,28,"The results showed that CCR6 and CCR7 were expressed in tumors in situ, metastatic LNs and CD4+CD25+Foxp3+ Tregs.",23835793_5,-1,-1,-1,-1,20718,-1,0.002040123,0.80548596,0.19247392
20721,that the,3,5,20,28,"It was hypothesized that the expression profile of CCR6, CCR7 and the proliferation of CD4+CD25+Foxp3+ Tregs affected the process of LN metastasis in LSCC patients.",23835793_6,-1,-1,-1,-1,20721,-1,4.0243717e-06,0.99999213,3.843688e-06
20728,the Foxp3,6,8,39,48,"Therefore, the increased percentage of the Foxp3+ Tregs and the upregulation of Foxp3 expression on CCR6+ Tregs in LSCC patients may have accounted for the downregulation of antitumor immunity in these patients, which could be valuable for assessment of prognosis in LSCC treatment.",23835793_7,-1,-1,-1,-1,20728,-1,6.96124e-06,0.9999863,6.6889556e-06
20735,immunity,31,32,184,192,"Therefore, the increased percentage of the Foxp3+ Tregs and the upregulation of Foxp3 expression on CCR6+ Tregs in LSCC patients may have accounted for the downregulation of antitumor immunity in these patients, which could be valuable for assessment of prognosis in LSCC treatment.",23835793_7,0,-1,2,-1,20735,-1,0.9999145,1.9500072e-05,6.5863416e-05
20743,tolerance to,20,22,126,138,"Here, we further studied the immunogenicity of chimeric murine MSLN-virus-like particles (mMSLN-VLPs), their ability to break tolerance to mMSLN, a self-antigen, and deciphered the mechanism of immune responses elicited by mMSLN-VLP immunization using a pancreatic cancer (PC) mouse model.",23874581_1,-1,-1,-1,-1,20743,-1,5.5902224e-06,0.99998903,5.3416393e-06
20748,the tolerance to,21,24,119,135,"In addition to what we have found with xenogeneic human MSLN-VLP (hMSLN-VLP), mMSLN-VLP immunization was able to break the tolerance to intrinsic MSLN and mount mMSLN-specific, cytotoxic CD8(+) T cells which led to a significant reduction in tumor volume and prolonged survival in an orthotopic PC mouse model.",23874581_2,-1,-1,-1,-1,20748,-1,4.4541607e-06,0.99999106,4.541345e-06
20754,tumor tissues,17,19,103,116,"Furthermore, CD4(+)foxp3(+) regulatory T cells (Tregs) were progressively decreased in both spleen and tumor tissues following mMSLN-VLP immunization and this was at least partly due to elevated levels of IL-6 production from activated plasmocytoid dendritic cell (pDC)-like cells following mMSLN-VLP immunization.",23874581_3,-1,-1,-1,-1,20754,-1,6.2457375e-06,0.99998355,1.0179258e-05
20764,Treg subset,12,14,88,99,"Moreover, mMSLN-VLP treatment mainly reduced the frequency of the CD4(+)foxp3(+)ICOS(-) Treg subset.",23874581_4,-1,-1,-1,-1,20764,-1,0.0010618366,0.6222136,0.3767245
20780,to target,12,14,68,77,"However, combination therapies will likely need to be used in order to target residual CD4(+)foxp3(+)ICOS(+) Treg cells.",23874581_7,-1,-1,-1,-1,20780,-1,6.024755e-06,0.99999,4.0222376e-06
20807,T-cell,10,11,52,58,"Together, these effects result in an altered CD8(+) T-cell adhesiveness to the extracellular matrix and selectins, sensitivity to FasL-mediated apoptosis, and cytotoxicity.",23878002_6,-1,1,2,-1,20807,-1,1.1858081e-05,7.6529695e-06,0.99998057
20808,to the,12,14,72,78,"Together, these effects result in an altered CD8(+) T-cell adhesiveness to the extracellular matrix and selectins, sensitivity to FasL-mediated apoptosis, and cytotoxicity.",23878002_6,-1,-1,-1,-1,20808,-1,2.9090956e-05,0.999946,2.491349e-05
20811,cell types,3,5,24,34,INTRODUCTION: Different cell types and cytokines have been identified as contributors to the formation of periapical lesions.,23880265_0,-1,-1,-1,-1,20811,-1,3.0344092e-05,2.3354123e-05,0.99994624
20813,to the,12,14,86,92,INTRODUCTION: Different cell types and cytokines have been identified as contributors to the formation of periapical lesions.,23880265_0,-1,-1,-1,-1,20813,-1,9.568186e-06,0.99998283,7.6102283e-06
20819,transforming growth factor,15,18,95,121,"In this perspective, this study aimed to evaluate the immunoexpression of interleukin (IL)-17, transforming growth factor (TGF)-1, and the forkhead box P3 (FoxP3) in periapical lesions, correlating them with the type of lesion, the intensity of the inflammatory infiltrate, and the thickness of the cystic epithelial lining.",23880265_1,-1,-1,-1,-1,20819,-1,0.98373705,0.012827713,0.003435258
20820,the forkhead,21,23,136,148,"In this perspective, this study aimed to evaluate the immunoexpression of interleukin (IL)-17, transforming growth factor (TGF)-1, and the forkhead box P3 (FoxP3) in periapical lesions, correlating them with the type of lesion, the intensity of the inflammatory infiltrate, and the thickness of the cystic epithelial lining.",23880265_1,-1,-1,-1,-1,20820,-1,6.3367443e-06,0.99998796,5.7373313e-06
20823,the type,35,37,209,217,"In this perspective, this study aimed to evaluate the immunoexpression of interleukin (IL)-17, transforming growth factor (TGF)-1, and the forkhead box P3 (FoxP3) in periapical lesions, correlating them with the type of lesion, the intensity of the inflammatory infiltrate, and the thickness of the cystic epithelial lining.",23880265_1,-1,-1,-1,-1,20823,-1,6.555099e-06,0.9999839,9.500845e-06
20826,the thickness,48,50,279,292,"In this perspective, this study aimed to evaluate the immunoexpression of interleukin (IL)-17, transforming growth factor (TGF)-1, and the forkhead box P3 (FoxP3) in periapical lesions, correlating them with the type of lesion, the intensity of the inflammatory infiltrate, and the thickness of the cystic epithelial lining.",23880265_1,-1,-1,-1,-1,20826,-1,7.389837e-06,0.99998474,7.876274e-06
20830,analysis,28,29,148,156,"METHODS: Twenty periapical granulomas (PGs), 20 radicular cysts (RCs), and 20 residual radicular cysts (RRCs) were submitted to immunohistochemical analysis using anti-IL-17, anti-TGF-1, and anti-FoxP3 antibodies.",23880265_2,0,1,-1,-1,20830,-1,8.601701e-06,0.99998355,7.815986e-06
20887,to the,21,23,109,115,"As a result, the ratio of antigen-specific CD8+ T cells and MDSCs in tumors increased up to 85-fold compared to the control.",23922012_8,-1,-1,-1,-1,20887,-1,4.568792e-06,0.9999906,4.899874e-06
20905,to this,21,23,156,163,Ovarian cancer is a prevalent gynecological malignancy with potent immune-suppression capabilities; regulatory T cells (Tregs) are significant contributors to this immune-suppression.,23948613_0,-1,-1,-1,-1,20905,-1,6.957272e-06,0.9999864,6.632714e-06
20906,TNF,9,10,55,58,"As ovarian cancer patients present with high levels of TNF and Tregs expressing TNFR2 are associated with maximal suppressive capacity, we investigated TNFR2+ Tregs within these patients.",23948613_1,0,1,-1,-1,20906,-1,0.0087730475,0.990888,0.00033892936
20908,TNFR2,13,14,80,85,"As ovarian cancer patients present with high levels of TNF and Tregs expressing TNFR2 are associated with maximal suppressive capacity, we investigated TNFR2+ Tregs within these patients.",23948613_1,0,1,-1,-1,20908,-1,0.0002509977,0.99971765,3.1344043e-05
20910,TNFR2,23,24,152,157,"As ovarian cancer patients present with high levels of TNF and Tregs expressing TNFR2 are associated with maximal suppressive capacity, we investigated TNFR2+ Tregs within these patients.",23948613_1,0,1,-1,-1,20910,-1,0.00039430085,0.99956685,3.8849797e-05
20913,TNFR2,2,3,8,13,"Indeed, TNFR2+ Tregs from tumor-associated ascites were the most potent suppressor T cell fraction.",23948613_2,0,1,-1,-1,20913,-1,0.00014696117,0.9998274,2.5650497e-05
20917,suppressor T cell,12,15,72,89,"Indeed, TNFR2+ Tregs from tumor-associated ascites were the most potent suppressor T cell fraction.",23948613_2,-1,-1,-1,-1,20917,-1,5.924696e-05,0.0002658538,0.9996749
20921,blood TNFR2,12,14,85,96,They were abundantly present within the ascites and more suppressive than peripheral blood TNFR2+ Tregs in patients.,23948613_3,-1,-1,-1,-1,20921,-1,0.0041033397,0.9953679,0.0005288045
20926,TNFR2,6,7,39,44,"Additionally, CD73 expression level on TNFR2+ Tregs was inversely correlated with IFN- production by effector T cells.",23948613_5,0,1,-1,-1,20926,-1,3.175587e-05,0.9999584,9.825528e-06
20930,This Treg,0,2,0,9,This Treg fraction can be selectively recruited into the ascites from the peripheral blood of patients.,23948613_6,-1,-1,-1,-1,20930,-1,8.81179e-06,0.9999852,5.9971476e-06
20933,blood,13,14,85,90,This Treg fraction can be selectively recruited into the ascites from the peripheral blood of patients.,23948613_6,0,1,-1,-1,20933,-1,0.0019266206,0.9429389,0.055134464
20934,Targeting TNFR2,0,2,0,15,Targeting TNFR2+ Tregs may offer new approaches to enhance the poor survival rates of ovarian cancer.,23948613_7,-1,-1,-1,-1,20934,-1,0.0001485892,0.9998305,2.090321e-05
20938,the T-cell,2,4,13,23,Signals from the T-cell recognition of antigen program effector functions are necessary to clear infections and tumors.,23963642_0,-1,-1,-1,-1,20938,-1,0.0043741744,0.34684682,0.64877903
20940,functions,9,10,64,73,Signals from the T-cell recognition of antigen program effector functions are necessary to clear infections and tumors.,23963642_0,0,1,2,-1,20940,-1,0.00019177642,0.0005080239,0.9993001
20946,functions,9,10,46,55,"In T lymphocytes, JNK1 and JNK2 have distinct functions depending on their maturation state and cell-type.",23963642_2,0,1,2,-1,20946,-1,0.00042306702,0.9992723,0.00030470657
20953,function,10,11,74,82,"However, the mechanisms that regulate their isoform-specific activity and function are still unclear.",23963642_3,0,1,2,-1,20953,-1,3.2053216e-05,0.99994373,2.4207407e-05
20955,protein,12,13,59,66,"Here, we identify plenty of SH3 (POSH) and JNK-interacting protein 1 (JIP-1) as a multiprotein scaffold network for TCR-mediated JNK1 activation in CD8(+) T cells.",23963642_4,0,1,-1,-1,20955,-1,1.1759146e-05,0.9999776,1.0633751e-05
20956,TCR-mediated,23,24,116,128,"Here, we identify plenty of SH3 (POSH) and JNK-interacting protein 1 (JIP-1) as a multiprotein scaffold network for TCR-mediated JNK1 activation in CD8(+) T cells.",23963642_4,-1,1,2,-1,20956,-1,9.270281e-06,0.999972,1.8784238e-05
20962,the transcription factors,23,26,136,161,"Disruption of the POSH/JIP-1 complex led to profound defects in the activation of JNK1, as well as deficient activation or induction of the transcription factors c-Jun, T-bet, and Eomesodermin.",23963642_5,-1,-1,-1,-1,20962,-1,4.1954218e-06,0.9999912,4.682532e-06
20974,TCR-dependent,12,13,77,90,"Collectively, these data identify a mechanism for the specific regulation of TCR-dependent JNK1 activation and function that is key for CD8(+) T-cell responses.",23963642_7,-1,1,2,-1,20974,-1,1.230866e-05,0.9999664,2.132896e-05
20975,function that,16,18,111,124,"Collectively, these data identify a mechanism for the specific regulation of TCR-dependent JNK1 activation and function that is key for CD8(+) T-cell responses.",23963642_7,-1,-1,-1,-1,20975,-1,1.7908817e-05,0.99996316,1.896528e-05
20976,T-cell,23,24,143,149,"Collectively, these data identify a mechanism for the specific regulation of TCR-dependent JNK1 activation and function that is key for CD8(+) T-cell responses.",23963642_7,-1,1,2,-1,20976,-1,1.6887998e-05,8.34714e-06,0.9999747
20977,Regulatory T cells play,0,4,0,23,Regulatory T cells play a key role in suppressing tumor immunity.,23975869_0,-1,-1,-1,-1,20977,-1,0.0008160873,0.009358696,0.9898253
20978,tumor immunity,9,11,50,64,Regulatory T cells play a key role in suppressing tumor immunity.,23975869_0,-1,-1,-1,-1,20978,-1,0.028644187,0.97071135,0.0006444565
20989,factor-,21,22,116,124,"Here, we investigated the effect of triptolide on regulatory T cells and on the level of IL-10, transforming growth factor-, and vascular endothelial growth factor in tumor-bearing mice.",23975869_2,0,1,-1,-1,20989,-1,0.9999217,7.2185335e-06,7.104883e-05
20993,three treatment,22,24,126,141,"Fifty male C57BL/6 mice were randomly grouped as follows: normal control group, model group with B16-F10 cells implanted, and three treatment groups with cyclophosphamide, triptolide-high dose, triptolide-low dose.",23975869_3,-1,-1,-1,-1,20993,-1,7.618641e-06,0.99998343,8.94832e-06
20999,analysis,18,19,109,117,The proportion of regulatory T cells in the spleen and axillary lymph nodes was evaluated by flow cytometric analysis.,23975869_4,0,1,-1,-1,20999,-1,4.134259e-05,0.99991906,3.9576895e-05
21000,cytokines IL-10,2,4,14,29,"Production of cytokines IL-10, transforming growth factor-, and vascular endothelial growth factor in serum was measured using enzyme-labeled immunosorbent assay kits.",23975869_5,-1,-1,-1,-1,21000,-1,0.9999629,5.346617e-06,3.166106e-05
21002,factor-,7,8,51,59,"Production of cytokines IL-10, transforming growth factor-, and vascular endothelial growth factor in serum was measured using enzyme-labeled immunosorbent assay kits.",23975869_5,0,1,-1,-1,21002,-1,0.9999095,8.238026e-06,8.22274e-05
21008,factor-,11,12,57,65,"The mRNA levels of Foxp3, IL-10, and transforming growth factor- in the spleen and vascular endothelial growth factor in tumor tissue were detected by real-time PCR.",23975869_6,0,1,-1,-1,21008,-1,0.999925,6.744143e-06,6.814748e-05
21011,tumor tissue,21,23,122,134,"The mRNA levels of Foxp3, IL-10, and transforming growth factor- in the spleen and vascular endothelial growth factor in tumor tissue were detected by real-time PCR.",23975869_6,-1,-1,-1,-1,21011,-1,1.3107658e-05,0.99995935,2.758156e-05
21013,that triptolide,3,5,19,34,The results showed that triptolide significantly decreased the proportion of regulatory T cells and lowered the Foxp3 level in the spleen and axillary lymph nodes of tumor-bearing mice.,23975869_7,-1,-1,-1,-1,21013,-1,2.1770948e-05,0.99996626,1.1905274e-05
21016,the Foxp3,15,17,108,117,The results showed that triptolide significantly decreased the proportion of regulatory T cells and lowered the Foxp3 level in the spleen and axillary lymph nodes of tumor-bearing mice.,23975869_7,-1,-1,-1,-1,21016,-1,5.7966404e-06,0.99998975,4.4755516e-06
21021,factor-,6,7,44,52,"Production of IL-10 and transforming growth factor- in peripheral blood, and the mRNA level of IL-10 and transforming growth factor- in the spleen were also decreased.",23975869_8,0,1,-1,-1,21021,-1,0.99987245,1.4591165e-05,0.00011301139
21022,blood,9,10,67,72,"Production of IL-10 and transforming growth factor- in peripheral blood, and the mRNA level of IL-10 and transforming growth factor- in the spleen were also decreased.",23975869_8,0,1,-1,-1,21022,-1,0.00094225514,0.97268176,0.026375946
21026,factor-,20,21,126,134,"Production of IL-10 and transforming growth factor- in peripheral blood, and the mRNA level of IL-10 and transforming growth factor- in the spleen were also decreased.",23975869_8,0,1,-1,-1,21026,-1,0.9998803,1.4218408e-05,0.000105486404
21031,that triptolide,6,8,38,53,"In conclusion, our study demonstrated that triptolide might inhibit tumor growth by inhibiting regulatory T cells and some cytokines such as IL-10 and transforming growth factor-, as well as production of vascular endothelial growth factor.",23975869_10,-1,-1,-1,-1,21031,-1,1.0599391e-05,0.99998176,7.636443e-06
21037,factor-,26,27,171,179,"In conclusion, our study demonstrated that triptolide might inhibit tumor growth by inhibiting regulatory T cells and some cytokines such as IL-10 and transforming growth factor-, as well as production of vascular endothelial growth factor.",23975869_10,0,1,-1,-1,21037,-1,0.9999324,6.3496946e-06,6.124934e-05
21045,those tumors,25,27,131,143,"Although evidence for an active immune response, including infiltration with CD8(+) T cells, can be found in a subset of patients, those tumors are nonetheless not immunologically rejected.",23986400_1,-1,-1,-1,-1,21045,-1,3.9564998e-06,0.9999908,5.2788278e-06
21048,the subset,10,12,42,52,"In the current report, we show that it is the subset of T cell-inflamed tumors that showed high expression of three defined immunosuppressive mechanisms: indoleamine-2,3-dioxygenase (IDO), PD-L1/B7-H1, and FoxP3(+) regulatory T cells (T(regs)), suggesting that these inhibitory pathways might serve as negative feedback mechanisms that followed, rather than preceded, CD8(+) T cell infiltration.",23986400_2,-1,-1,-1,-1,21048,-1,0.0016938542,0.30097744,0.69732875
21049,T cell-inflamed tumors that,13,17,56,83,"In the current report, we show that it is the subset of T cell-inflamed tumors that showed high expression of three defined immunosuppressive mechanisms: indoleamine-2,3-dioxygenase (IDO), PD-L1/B7-H1, and FoxP3(+) regulatory T cells (T(regs)), suggesting that these inhibitory pathways might serve as negative feedback mechanisms that followed, rather than preceded, CD8(+) T cell infiltration.",23986400_2,-1,-1,-1,-1,21049,-1,0.0041249576,0.109085456,0.8867897
21054,that these,45,47,256,266,"In the current report, we show that it is the subset of T cell-inflamed tumors that showed high expression of three defined immunosuppressive mechanisms: indoleamine-2,3-dioxygenase (IDO), PD-L1/B7-H1, and FoxP3(+) regulatory T cells (T(regs)), suggesting that these inhibitory pathways might serve as negative feedback mechanisms that followed, rather than preceded, CD8(+) T cell infiltration.",23986400_2,-1,-1,-1,-1,21054,-1,4.5984466e-06,0.99999154,3.862514e-06
21060,the tumor,22,24,122,131,"Mechanistic studies in mice revealed that up-regulated expression of IDO and PD-L1, as well as recruitment of T(regs), in the tumor microenvironment depended on the presence of CD8(+) T cells.",23986400_3,-1,-1,-1,-1,21060,-1,4.0312952e-06,0.99999154,4.41972e-06
21067,that these,3,5,18,28,"Our results argue that these major immunosuppressive pathways are intrinsically driven by the immune system rather than being orchestrated by cancer cells, and imply that cancer immunotherapy approaches targeting negative regulatory immune checkpoints might be preferentially beneficial for patients with a preexisting T cell-inflamed tumor microenvironment.",23986400_5,-1,-1,-1,-1,21067,-1,4.556306e-06,0.9999919,3.5280266e-06
21073,T cell-inflamed tumor,43,46,319,340,"Our results argue that these major immunosuppressive pathways are intrinsically driven by the immune system rather than being orchestrated by cancer cells, and imply that cancer immunotherapy approaches targeting negative regulatory immune checkpoints might be preferentially beneficial for patients with a preexisting T cell-inflamed tumor microenvironment.",23986400_5,-1,-1,-1,-1,21073,-1,0.006199622,0.032230593,0.9615698
21074,Tumour-infiltrating lymphocytes,0,2,0,31,Tumour-infiltrating lymphocytes (TILs) have been found to play crucial roles in a series of cancers.,24007242_0,-1,-1,-1,-1,21074,-1,0.005460657,0.67248285,0.3220565
21076,to play,8,10,55,62,Tumour-infiltrating lymphocytes (TILs) have been found to play crucial roles in a series of cancers.,24007242_0,-1,-1,-1,-1,21076,-1,5.0253734e-06,0.9999894,5.6272925e-06
21078,these cells,5,7,23,34,"However, the impact of these cells on gallbladder carcinoma (GBC) remains poorly understood.",24007242_1,-1,-1,-1,-1,21078,-1,2.931119e-05,3.5757457e-05,0.9999349
21084,these cells,33,35,171,182,"In this study, we examined infiltrating FoxP3+, IL-17+, CD4+ and CD8+ cells by immunohistochemistry in specimens of 104 patients with GBC and evaluated the association of these cells with clinicopathological features and prognosis.",24007242_2,-1,-1,-1,-1,21084,-1,1.7687355e-05,9.2465925e-06,0.99997306
21100,IL-17-producing cells,33,35,147,168,"The group with high FoxP3+ cells showed poor overall survival (OS, P < 0.001) and disease-free survival (DFS, P < 0.001), and high infiltration of IL-17-producing cells was also a predictor of poor OS (P = 0.024).",24007242_6,-1,-1,-1,-1,21100,-1,0.96960056,9.038532e-05,0.030309005
21101,analysis,1,2,13,21,Multivariate analysis revealed that the presence of intratumoral FoxP3+ cells was an independent prognostic indicator for poor DFS (P < 0.01).,24007242_7,0,1,-1,-1,21101,-1,1.13607775e-05,0.9999826,5.993335e-06
21102,that the,3,5,31,39,Multivariate analysis revealed that the presence of intratumoral FoxP3+ cells was an independent prognostic indicator for poor DFS (P < 0.01).,24007242_7,-1,-1,-1,-1,21102,-1,5.5282226e-06,0.99999046,4.0655796e-06
21106,that FoxP3,6,8,36,46,"In summary, these findings indicate that FoxP3+ and IL-17+ cells cooperatively facilitate pathogenesis and progression of GBC and show prognostic significance for OS or DFS.",24007242_8,-1,-1,-1,-1,21106,-1,7.151427e-06,0.9999869,6.008928e-06
21109,that tumor-evoked,3,5,23,40,We reported previously that tumor-evoked regulatory B cells (tBregs) play an essential role in breast cancer lung metastasis by inducing TGF--dependent conversion of metastasis-promoting Foxp3(+) regulatory T cells (Tregs).,24043896_0,-1,-1,-1,-1,21109,-1,8.2896995e-06,0.9999865,5.129296e-06
21125,the generation,12,14,72,86,"The mechanism of this process is that RSV inactivates Stat3, preventing the generation and function of tBregs, including expression of TGF-.",24043896_2,-1,-1,-1,-1,21125,-1,6.4858746e-06,0.9999875,6.067564e-06
21126,function,15,16,91,99,"The mechanism of this process is that RSV inactivates Stat3, preventing the generation and function of tBregs, including expression of TGF-.",24043896_2,0,1,2,-1,21126,-1,0.00011179748,0.9998104,7.7793076e-05
21138,to play,13,15,77,84,"Since their identification in 2005, T helper (TH)17 cells have been proposed to play important roles in several human diseases, including various autoimmune conditions, inflammations, allergy, and tumors.",24044962_0,-1,-1,-1,-1,21138,-1,5.694434e-06,0.99998844,5.8166124e-06
21147,to Th17,41,43,222,229,"Focusing on human studies, we review the current understanding of molecular interactions (IL-1, IL-6, IL-23, IL-21 and TGF-), the signaling pathway (STAT3RORt) and the migration (induced by CCR6/CCL20) that contribute to Th17 differentiation and function in tumor microenvironment.",24044962_1,-1,-1,-1,-1,21147,-1,2.2145654e-05,0.99995565,2.2187785e-05
21148,function,45,46,250,258,"Focusing on human studies, we review the current understanding of molecular interactions (IL-1, IL-6, IL-23, IL-21 and TGF-), the signaling pathway (STAT3RORt) and the migration (induced by CCR6/CCL20) that contribute to Th17 differentiation and function in tumor microenvironment.",24044962_1,0,1,2,-1,21148,-1,4.857622e-05,0.9998822,6.9164096e-05
21150,to the,11,13,70,76,"Furthermore, we also make a synthesis of contradictory conclusions as to the roles that these cells are playing in the process of tumourigenesis in order to provide guidance of Th17-targeted therapy in tumors.",24044962_2,-1,-1,-1,-1,21150,-1,6.1760516e-06,0.9999882,5.651541e-06
21151,that these cells,14,17,83,99,"Furthermore, we also make a synthesis of contradictory conclusions as to the roles that these cells are playing in the process of tumourigenesis in order to provide guidance of Th17-targeted therapy in tumors.",24044962_2,-1,-1,-1,-1,21151,-1,0.0028866346,0.30186385,0.6952495
21156,Th17-targeted therapy,30,32,177,198,"Furthermore, we also make a synthesis of contradictory conclusions as to the roles that these cells are playing in the process of tumourigenesis in order to provide guidance of Th17-targeted therapy in tumors.",24044962_2,-1,-1,-1,-1,21156,-1,7.4287336e-06,0.9999845,8.071131e-06
21160,that the thymus,1,4,12,27,"Considering that the thymus is the site of most T-cell development, this phenomenon may be related to thymic involution.",24051497_1,-1,-1,-1,-1,21160,-1,1.1245109e-05,0.999982,6.786679e-06
21164,related to thymic,16,19,91,108,"Considering that the thymus is the site of most T-cell development, this phenomenon may be related to thymic involution.",24051497_1,-1,-1,-1,-1,21164,-1,2.4598485e-05,0.9999672,8.196732e-06
21172,The thymuses,2,4,9,21,RESULTS: The thymuses of tumor-bearing mice showed less cellularity than those of healthy mice.,24051497_4,-1,-1,-1,-1,21172,-1,1.3673299e-05,0.9999752,1.1070588e-05
21174,cellularity than those,9,12,56,78,RESULTS: The thymuses of tumor-bearing mice showed less cellularity than those of healthy mice.,24051497_4,-1,-1,-1,-1,21174,-1,0.009137093,0.20879047,0.7820724
21181,three factors,7,9,22,35,"Foxn1, KGF, and IL-7, three factors known to be involved in thymic development, were also downregulated in the thymuses of tumor bearers.",24051497_6,-1,-1,-1,-1,21181,-1,2.7923372e-05,0.99996114,1.0947095e-05
21184,the thymuses,21,23,107,119,"Foxn1, KGF, and IL-7, three factors known to be involved in thymic development, were also downregulated in the thymuses of tumor bearers.",24051497_6,-1,-1,-1,-1,21184,-1,7.915811e-06,0.9999851,6.9633834e-06
21187,the thymic,9,11,54,64,"When these mice were intravenously injected with KGF, the thymic microenvironment, thymopoiesis, and T-cell differentiation all returned to near normal status.",24051497_7,-1,-1,-1,-1,21187,-1,6.8769286e-06,0.99998784,5.23026e-06
21196,the thymic,16,18,113,123,CONCLUSIONS: The decreases in thymopoiesis and impaired T-cell differentiation may be attributable to changes in the thymic microenvironment.,24051497_8,-1,-1,-1,-1,21196,-1,7.728546e-06,0.9999876,4.7017616e-06
21197,the function,1,3,10,22,"Improving the function of TEC, rather than T-cell progenitors, should be the focus of therapy.",24051497_9,-1,-1,-1,-1,21197,-1,3.3408876e-05,0.9999317,3.4836114e-05
21199,than T-cell,7,9,38,49,"Improving the function of TEC, rather than T-cell progenitors, should be the focus of therapy.",24051497_9,-1,-1,-1,-1,21199,-1,0.0013536552,0.08980321,0.90884316
21201,therapy,16,17,86,93,"Improving the function of TEC, rather than T-cell progenitors, should be the focus of therapy.",24051497_9,0,1,-1,-1,21201,-1,4.8906318e-06,0.9999908,4.2391216e-06
21205,the functional,16,18,101,115,"Although elevated CD4Foxp3 regulatory T cell (Treg) frequencies within tumors are well documented, the functional and phenotypic characteristics of CD4Foxp3 and CD4Foxp3 T cell subsets from matched blood, healthy colon, and colorectal cancer require in-depth investigation.",24064667_0,-1,-1,-1,-1,21205,-1,5.5496548e-05,0.9999206,2.3919789e-05
21207,blood,30,31,204,209,"Although elevated CD4Foxp3 regulatory T cell (Treg) frequencies within tumors are well documented, the functional and phenotypic characteristics of CD4Foxp3 and CD4Foxp3 T cell subsets from matched blood, healthy colon, and colorectal cancer require in-depth investigation.",24064667_0,0,1,-1,-1,21207,-1,0.00027269757,0.9990681,0.0006592981
21208,that the,3,5,24,32,Flow cytometry revealed that the majority of intratumoral CD4Foxp3 T cells (Tregs) were Helios and expressed higher levels of cytotoxic T-lymphocyte antigen 4 (CTLA-4) and CD39 than Tregs from colon and blood.,24064667_1,-1,-1,-1,-1,21208,-1,4.153484e-06,0.9999908,4.9769565e-06
21211,cytotoxic T-lymphocyte antigen,21,24,129,159,Flow cytometry revealed that the majority of intratumoral CD4Foxp3 T cells (Tregs) were Helios and expressed higher levels of cytotoxic T-lymphocyte antigen 4 (CTLA-4) and CD39 than Tregs from colon and blood.,24064667_1,-1,-1,-1,-1,21211,-1,0.036738932,0.00026006682,0.9630011
21213,than Tregs,30,32,180,190,Flow cytometry revealed that the majority of intratumoral CD4Foxp3 T cells (Tregs) were Helios and expressed higher levels of cytotoxic T-lymphocyte antigen 4 (CTLA-4) and CD39 than Tregs from colon and blood.,24064667_1,-1,-1,-1,-1,21213,-1,5.8530195e-06,0.9999882,5.9448794e-06
21214,blood,35,36,206,211,Flow cytometry revealed that the majority of intratumoral CD4Foxp3 T cells (Tregs) were Helios and expressed higher levels of cytotoxic T-lymphocyte antigen 4 (CTLA-4) and CD39 than Tregs from colon and blood.,24064667_1,0,1,-1,-1,21214,-1,6.2263956e-05,0.9998492,8.857082e-05
21216,functions,14,15,95,104,"Moreover, 30% of intratumoral CD4Foxp3 T cells expressed markers associated with regulatory functions, including latency-associated peptide (LAP), lymphocyte activation gene-3 (LAG-3), and CD25.",24064667_2,0,1,2,-1,21216,-1,2.7180307e-05,0.99982435,0.00014845513
21217,peptide,18,19,135,142,"Moreover, 30% of intratumoral CD4Foxp3 T cells expressed markers associated with regulatory functions, including latency-associated peptide (LAP), lymphocyte activation gene-3 (LAG-3), and CD25.",24064667_2,0,-1,2,-1,21217,-1,0.0001791627,0.999694,0.0001268196
21225,factor-,13,14,88,96,"This unique population of cells produced interleukin-10 (IL-10) and transforming growth factor- (TGF-), and was 50-fold more suppressive than Foxp3 Tregs.",24064667_3,0,1,-1,-1,21225,-1,0.9999217,7.643038e-06,7.0655304e-05
21235,factor,17,18,103,109,It has been reported that dense intratumoral infiltration of Foxp3 (+)Tregs (Tregs) was an independent factor for poor prognosis of breast cancer (BC) patients.,24124553_0,0,1,-1,-1,21235,-1,0.00018635238,0.9997887,2.499655e-05
21236,the cytokines,2,4,9,22,"However, the cytokines activating the Treg infiltration are not known.",24124553_1,-1,-1,-1,-1,21236,-1,0.6912109,0.30575025,0.0030387493
21237,the Treg,5,7,34,42,"However, the cytokines activating the Treg infiltration are not known.",24124553_1,-1,-1,-1,-1,21237,-1,8.302166e-06,0.99998534,6.335677e-06
21249,that tumor,3,5,18,28,"It was identified that tumor secretion of CCL22 was positively correlated with the intratumoral Treg infiltration (P<0.0001), but its association with lymphoid aggregates surrounding the tumor was not proven to be significant (P=0.056).",24124553_4,-1,-1,-1,-1,21249,-1,4.6934424e-06,0.9999906,4.6766786e-06
21253,the tumor,27,29,183,192,"It was identified that tumor secretion of CCL22 was positively correlated with the intratumoral Treg infiltration (P<0.0001), but its association with lymphoid aggregates surrounding the tumor was not proven to be significant (P=0.056).",24124553_4,-1,-1,-1,-1,21253,-1,4.1192607e-06,0.9999912,4.642545e-06
21257,the tumor,10,12,59,68,"Moreover, CCL22 expression was found to be associated with the tumor histological features known to be related with unfavorable prognosis of patients, including high histological grade (P<0.0001), negative ER (P<0.0001), negative PR (P=0.001), and HER2 amplification (P=0.028).",24124553_5,-1,-1,-1,-1,21257,-1,4.0432155e-06,0.9999906,5.3845592e-06
21262,CCL22 tumor,6,8,42,53,"Similar to intratumoral Treg infiltrates, CCL22 tumor secretion correlated with the prognosis of the molecular subtypes of breast carcinoma (P<0.0001).",24124553_6,-1,-1,-1,-1,21262,-1,0.99140376,0.002581677,0.00601467
21265,analysis,1,2,11,19,"Univariate analysis revealed CCL22 to be an independent prognostic factor for overall survival (OS, P<0.0001) and progression-free survival (PFS, P<0.0001) of BC patients that were confirmed by multivariate analysis (P=0.011 and P=0.010 respectively).",24124553_7,0,1,-1,-1,21265,-1,9.681619e-06,0.9999838,6.4761407e-06
21266,CCL22 to,3,5,29,37,"Univariate analysis revealed CCL22 to be an independent prognostic factor for overall survival (OS, P<0.0001) and progression-free survival (PFS, P<0.0001) of BC patients that were confirmed by multivariate analysis (P=0.011 and P=0.010 respectively).",24124553_7,-1,-1,-1,-1,21266,-1,0.99388784,0.0024308187,0.0036813184
21267,factor,9,10,67,73,"Univariate analysis revealed CCL22 to be an independent prognostic factor for overall survival (OS, P<0.0001) and progression-free survival (PFS, P<0.0001) of BC patients that were confirmed by multivariate analysis (P=0.011 and P=0.010 respectively).",24124553_7,0,1,-1,-1,21267,-1,0.33374605,0.6641285,0.0021255421
21269,analysis,34,35,207,215,"Univariate analysis revealed CCL22 to be an independent prognostic factor for overall survival (OS, P<0.0001) and progression-free survival (PFS, P<0.0001) of BC patients that were confirmed by multivariate analysis (P=0.011 and P=0.010 respectively).",24124553_7,0,1,-1,-1,21269,-1,8.502488e-06,0.99998486,6.6727634e-06
21272,the tumor,14,16,99,108,"In contrast, although TGF-1 expression was positively correlated with both Tregs infiltrates into the tumor bed and lymphoid aggregates surrounding the tumor (P=0.023; P=0.046, respectively), its expression was not significantly associated with the molecular subtypes of breast carcinoma and the prognosis of the patients.",24124553_8,-1,-1,-1,-1,21272,-1,3.5600165e-06,0.99999094,5.4491034e-06
21273,the tumor,21,23,149,158,"In contrast, although TGF-1 expression was positively correlated with both Tregs infiltrates into the tumor bed and lymphoid aggregates surrounding the tumor (P=0.023; P=0.046, respectively), its expression was not significantly associated with the molecular subtypes of breast carcinoma and the prognosis of the patients.",24124553_8,-1,-1,-1,-1,21273,-1,3.864384e-06,0.99999106,5.025751e-06
21288,the proto-oncogene c-MYC,2,5,19,43,Over-expression of the proto-oncogene c-MYC is frequently observed in a variety of tumors and is a hallmark of Burkitts lymphoma.,24130880_0,-1,-1,-1,-1,21288,-1,1.5857546e-05,0.9999709,1.32141295e-05
21295,therapy,17,18,105,112,"The fact that many tumors are oncogene-addicted to c-MYC, renders c-MYC a powerful target for anti-tumor therapy.",24130880_1,0,1,-1,-1,21295,-1,4.304041e-06,0.9999912,4.4881886e-06
21297,peptides,15,16,109,117,"Using a xenogenic vaccination strategy by immunizing C57BL/6 mice with human c-MYC protein or non-homologous peptides, we show that the human c-MYC protein, despite its high homology between mouse and man, contains several immunogenic epitopes presented in the context of murine H2(b) haplotype.",24130880_2,0,-1,2,-1,21297,-1,2.4601555e-05,0.9999604,1.4938141e-05
21298,that the,19,21,127,135,"Using a xenogenic vaccination strategy by immunizing C57BL/6 mice with human c-MYC protein or non-homologous peptides, we show that the human c-MYC protein, despite its high homology between mouse and man, contains several immunogenic epitopes presented in the context of murine H2(b) haplotype.",24130880_2,-1,-1,-1,-1,21298,-1,5.2603073e-06,0.99999046,4.2225693e-06
21301,T-cell,7,8,46,52,"We identified an MHC class II-restricted CD4 T-cell epitope and therein an MHC class I-restricted CD8 T-cell epitope (SSPQGSPEPL) that, after prime/boost immunization, protected up to 25% of mice against a lethal lymphoma challenge.",24130880_3,-1,1,2,-1,21301,-1,1.11637855e-05,8.499798e-06,0.99998033
21303,T-cell,16,17,104,110,"We identified an MHC class II-restricted CD4 T-cell epitope and therein an MHC class I-restricted CD8 T-cell epitope (SSPQGSPEPL) that, after prime/boost immunization, protected up to 25% of mice against a lethal lymphoma challenge.",24130880_3,-1,1,2,-1,21303,-1,1.1561379e-05,7.994835e-06,0.99998045
21308,blood,10,11,90,95,Lymphoma-rejecting animals contained MHC multimer-binding CD8 cell within the peripheral blood and displayed in vivo cytolytic activity with specificity for SSPQGSPEPL.,24130880_4,0,1,-1,-1,21308,-1,0.001219271,0.88727385,0.11150685
21309,Taken together these,0,3,0,20,Taken together these data suggest that oncogenic c-MYC can be targeted with specific T-cells.,24130880_5,-1,-1,-1,-1,21309,-1,9.522432e-06,0.99998367,6.817218e-06
21312,T-cells,13,14,85,92,Taken together these data suggest that oncogenic c-MYC can be targeted with specific T-cells.,24130880_5,-1,1,2,-1,21312,-1,1.526354e-05,1.2923175e-05,0.99997187
21314,cell transplantation,21,23,141,161,Cytomegalovirus (CMV) reactivation may lead to CMV disease associated with high morbidity and mortality in patients after hematopoietic stem cell transplantation (HSCT); the identification of clinically relevant markers may aid in the identification of patients at increased risk for developing CMV-associated complications.,24140122_0,-1,-1,-1,-1,21314,-1,0.008508951,0.07141983,0.92007124
21326,blood,42,43,217,222,"We evaluated the phosphorylation of signal transducer and activator of transcription 5 (STAT5) in CD4(+) T cells, CD8(+) T cells, and TCR T cells in response to stimulation with IL-7 or IL-2 after HSCT by analyzing blood samples taken monthly 1 to 6 months after HSCT.",24140122_1,0,1,-1,-1,21326,-1,9.6569354e-05,0.99986136,4.199647e-05
21329,the time,9,11,60,68,Patients were monitored weekly with a quantitative PCR from the time of engraftment for CMV viral load in whole blood until at least day 100 after HSCT.,24140122_2,-1,-1,-1,-1,21329,-1,1.0742078e-05,0.9999784,1.0808317e-05
21330,blood,19,20,112,117,Patients were monitored weekly with a quantitative PCR from the time of engraftment for CMV viral load in whole blood until at least day 100 after HSCT.,24140122_2,0,1,-1,-1,21330,-1,0.01060849,0.6991579,0.29023367
21333,to IL-7,15,17,106,113,We identified a correlation between clinical outcome regarding CMV replication and the ability to respond to IL-7 and IL-2 defined by STAT5 phosphorylation (pSTAT5).,24140122_3,-1,-1,-1,-1,21333,-1,0.9421261,0.056235757,0.0016381801
21339,than those,27,29,165,175,Patients with recurrent or prolonged CMV replications had significantly lower pSTAT5 upon stimulation of T cells with either IL-7 or IL-2 at time points 1 through 3 than those without CMV replication (P < .05).,24140122_4,-1,-1,-1,-1,21339,-1,5.2864616e-06,0.99998915,5.5940523e-06
21344,to IL-7,5,7,35,42,"We conclude that reduced responses to IL-7, reflected by pSTAT5, may represent a clinically relevant functional biomarker for individuals at increased risk for CMV reactivation; our data may also aid in designing better strategies to improve anti-CMV immune responses without increasing the risk of developing graft-versus-host disease.",24140122_6,-1,-1,-1,-1,21344,-1,0.94492453,0.053278044,0.0017974086
21345,relevant functional,16,18,92,111,"We conclude that reduced responses to IL-7, reflected by pSTAT5, may represent a clinically relevant functional biomarker for individuals at increased risk for CMV reactivation; our data may also aid in designing better strategies to improve anti-CMV immune responses without increasing the risk of developing graft-versus-host disease.",24140122_6,-1,-1,-1,-1,21345,-1,0.00014102893,0.99982554,3.3483826e-05
21352,blood,11,12,74,79,Cytokine-induced killer (CIK) cells are usually generated from peripheral blood mononuclear cells with the stimulation of IL-2 in vitro.,24145357_0,0,1,-1,-1,21352,-1,0.00048374585,0.9987012,0.00081500073
21361,IL-15-CIK cells,23,25,159,174,"Unlike the conventional IL-2-stimulated CIK cells (IL-2-CIK cells), we investigated the characteristics and potential mechanism of IL-15-stimulated CIK cells (IL-15-CIK cells) in this study.",24145357_1,-1,-1,-1,-1,21361,-1,0.9380819,0.00019056188,0.061727483
21366,IL-15-CIK cells,14,16,93,108,"Compared with IL-2-CIK cells, the percentage of CD3CD56 cells was significantly increased in IL-15-CIK cells, but the expression of regulatory T (Treg) cells and IL-35 was significantly decreased in IL-15-CIK cells.",24145357_2,-1,-1,-1,-1,21366,-1,0.937188,0.0002359947,0.06257598
21371,IL-15-CIK cells,33,35,199,214,"Compared with IL-2-CIK cells, the percentage of CD3CD56 cells was significantly increased in IL-15-CIK cells, but the expression of regulatory T (Treg) cells and IL-35 was significantly decreased in IL-15-CIK cells.",24145357_2,-1,-1,-1,-1,21371,-1,0.9386546,0.00023768998,0.061107766
21374,IL-15-CIK cells,13,15,82,97,"Meanwhile, the in vitro cytotoxicity against human myeloid leukemia cells K562 of IL-15-CIK cells was significantly augmented compared with IL-2-CIK cells.",24145357_3,-1,-1,-1,-1,21374,-1,0.92337966,0.00019113501,0.07642922
21377,that IL-15,3,5,19,29,These data suggest that IL-15 may improve the cytotoxicity of CIK cells against leukemia cells by upregulating CD3CD56 cells and downregulating Treg cells and IL-35.,24145357_4,-1,-1,-1,-1,21377,-1,0.8099461,0.18772858,0.0023252452
21392,therapy,9,10,52,59,"This study aimed to determine the effect of radical therapy on HPV-specific T cells and other immune parameters in 20 OPC patients, as a prelude to future immunotherapy studies.",24146146_1,0,1,-1,-1,21392,-1,5.5913606e-06,0.99998856,5.819088e-06
21395,tissue,8,9,44,50,HPV DNA could be detected in 9/12 available tissue samples (8/9 HPV(+) samples were also p16(+)).,24146146_2,-1,1,2,-1,21395,-1,8.768901e-06,0.9999776,1.3658721e-05
21397,peptides,9,10,54,62,"HPV-specific T cell responses against HPV16 E6 and E7 peptides were detected by enzyme-linked immunoSPOT in 10/13 and 8/13 evaluable patients, respectively, but did not appear to correlate with HPV status.",24146146_3,0,-1,2,-1,21397,-1,0.0006858752,0.9989876,0.00032652522
21405,therapy,26,27,163,170,"These reductions in T cell response could not be explained by a concurrent decrease in memory T cells whose absolute numbers were relatively unaffected by radical therapy (27,975 vs. 25,661/10(5) PBMC) despite a significant decrease in overall lymphocyte counts (1.74 vs. 0.69  10(9)/L).",24146146_5,0,1,-1,-1,21405,-1,6.2936474e-06,0.99998903,4.7268372e-06
21412,to the,6,8,52,58,"This suggests that immunosuppression may contribute to the reduction in HPV-specific T cell responses post-treatment, although study of larger patient cohorts will be required to test whether this affects clinical outcome.",24146146_7,-1,-1,-1,-1,21412,-1,6.760053e-06,0.9999887,4.616612e-06
21414,to test,25,27,176,183,"This suggests that immunosuppression may contribute to the reduction in HPV-specific T cell responses post-treatment, although study of larger patient cohorts will be required to test whether this affects clinical outcome.",24146146_7,-1,-1,-1,-1,21414,-1,7.682466e-06,0.99998796,4.395174e-06
21419,T cell immunity,17,20,134,149,Overall these findings suggest that HPV-targeted immunotherapy in post-therapy OPC patients will require multiple strategies to boost T cell immunity and to overcome the influence of immunosuppressive cells.,24146146_8,-1,-1,-1,-1,21419,-1,7.7799355e-05,1.125037e-05,0.99991095
21423,The thymus,0,2,0,10,The thymus is a central lymphoid organ critical for the development and maintenance of an effective peripheral T-cell repertoire.,24198066_0,-1,-1,-1,-1,21423,-1,1.6969703e-05,0.99997175,1.1318499e-05
21425,T-cell,17,18,111,117,The thymus is a central lymphoid organ critical for the development and maintenance of an effective peripheral T-cell repertoire.,24198066_0,-1,1,2,-1,21425,-1,1.7068542e-05,8.658591e-06,0.99997425
21428,function,16,17,103,111,"Most important, it provides a specialized environment for the selection of rearranged clones that will function appropriately in the adaptive immune response.",24198066_1,0,1,2,-1,21428,-1,0.00026977822,0.99958855,0.0001416855
21435,related to the,8,11,36,50,"Here, we review some of our results related to the studies of the cell-mediated immunity in a mammary tumor model; more specifically, those related to the tumor-induced impaired T-cell development and thymic involution.",24198066_3,-1,-1,-1,-1,21435,-1,5.124782e-06,0.99998915,5.750589e-06
21436,the cell-mediated immunity,13,16,62,88,"Here, we review some of our results related to the studies of the cell-mediated immunity in a mammary tumor model; more specifically, those related to the tumor-induced impaired T-cell development and thymic involution.",24198066_3,-1,-1,-1,-1,21436,-1,0.0013082579,0.00063229416,0.99805945
21438,those related to the tumor-induced,25,30,134,168,"Here, we review some of our results related to the studies of the cell-mediated immunity in a mammary tumor model; more specifically, those related to the tumor-induced impaired T-cell development and thymic involution.",24198066_3,-1,-1,-1,-1,21438,-1,6.0123753e-06,0.99998724,6.717051e-06
21443,the tumor-induced thymic,11,14,79,103,"Collectively, the understanding of the mechanisms and pathways associated with the tumor-induced thymic involution is essential for the development of innovative and safe therapies to fight against the immune suppression caused by the tumor development.",24198066_4,-1,-1,-1,-1,21443,-1,8.136972e-06,0.9999856,6.340949e-06
21445,therapies to,24,26,171,183,"Collectively, the understanding of the mechanisms and pathways associated with the tumor-induced thymic involution is essential for the development of innovative and safe therapies to fight against the immune suppression caused by the tumor development.",24198066_4,-1,-1,-1,-1,21445,-1,3.5691603e-06,0.9999926,3.852769e-06
21447,the tumor,33,35,231,240,"Collectively, the understanding of the mechanisms and pathways associated with the tumor-induced thymic involution is essential for the development of innovative and safe therapies to fight against the immune suppression caused by the tumor development.",24198066_4,-1,-1,-1,-1,21447,-1,4.164607e-06,0.9999912,4.6074883e-06
21449,nave,4,5,35,40,"Upon antigen-specific stimulation, nave CD4 T cells have the potential to differentiate into various T helper (Th) cell subsets.",24215739_0,-1,-1,-1,-1,21449,-1,6.068303e-06,0.99998903,4.893235e-06
21455,cell subsets,20,22,117,129,"Upon antigen-specific stimulation, nave CD4 T cells have the potential to differentiate into various T helper (Th) cell subsets.",24215739_0,-1,-1,-1,-1,21455,-1,1.4467127e-05,9.955294e-06,0.99997556
21456,Th cell,3,5,18,25,Earlier models of Th cell differentiation focused on IFN--producing Th1 cells and IL-4-secreting Th2 cells.,24215739_1,-1,-1,-1,-1,21456,-1,9.557256e-06,9.048723e-06,0.9999814
21457,IFN--producing Th1 cells,8,11,53,78,Earlier models of Th cell differentiation focused on IFN--producing Th1 cells and IL-4-secreting Th2 cells.,24215739_1,-1,-1,-1,-1,21457,-1,0.91359675,0.00030151522,0.08610163
21460,Th cell subsets,5,8,33,48,The discovery of additional CD4 Th cell subsets has extended our understanding of Th cell differentiation beyond this dichotomy.,24215739_2,-1,-1,-1,-1,21460,-1,1.6632699e-05,2.064319e-05,0.9999627
21461,Th cell,13,15,83,90,The discovery of additional CD4 Th cell subsets has extended our understanding of Th cell differentiation beyond this dichotomy.,24215739_2,-1,-1,-1,-1,21461,-1,8.827548e-06,7.431116e-06,0.9999838
21465,Th9 cell subset,6,9,38,53,"Among these is the recently described Th9 cell subset, which preferentially produces interleukin (IL)-9.",24215739_3,-1,-1,-1,-1,21465,-1,4.602604e-05,0.00034390477,0.9996101
21468,Th9 cell,8,10,43,51,"Here, we review the latest developments in Th9 cell development and differentiation, focusing on contributing environmental signals, and discuss potential physiological and pathophysiological functions of these cells.",24215739_4,-1,-1,-1,-1,21468,-1,1.6965108e-05,3.6059762e-05,0.99994695
21469,functions,26,27,192,201,"Here, we review the latest developments in Th9 cell development and differentiation, focusing on contributing environmental signals, and discuss potential physiological and pathophysiological functions of these cells.",24215739_4,0,1,2,-1,21469,-1,0.00043655536,0.99924856,0.00031483063
21470,these cells,28,30,205,216,"Here, we review the latest developments in Th9 cell development and differentiation, focusing on contributing environmental signals, and discuss potential physiological and pathophysiological functions of these cells.",24215739_4,-1,-1,-1,-1,21470,-1,1.2594783e-05,1.3424785e-05,0.9999739
21473,Th9 cells,10,12,72,81,"We describe the challenges inherent to unambiguously defining roles for Th9 cells using the available experimental animal models, and suggest new experimental models to address these concerns.",24215739_5,-1,-1,-1,-1,21473,-1,0.00011074705,0.0016840182,0.9982052
21487,that Nanog,3,5,16,26,We further show that Nanog was selectively induced in hypoxic areas of B16-F10 tumors.,24227785_3,-1,-1,-1,-1,21487,-1,1.2915708e-05,0.99998045,6.583871e-06
21490,tyrosinase-related protein-2 peptide-based,13,16,98,140,"Stable short hairpin RNA-mediated depletion of Nanog, combined with melanocyte differentiation Ag tyrosinase-related protein-2 peptide-based vaccination, resulted in complete inhibition of B16-F10 tumor growth.",24227785_4,-1,-1,-1,-1,21490,-1,0.00019703971,0.9996979,0.00010503964
21492,Nanog targeting,0,2,0,15,Nanog targeting significantly reduced immunosuppressive cells (regulatory T cells and macrophages) and increased CD8(+) T effector cells in tumor bed in part by modulating TGF-1 production.,24227785_5,-1,-1,-1,-1,21492,-1,4.6906703e-06,0.99999094,4.4219264e-06
21501,the TGF-1,10,12,71,81,"Additionally, Nanog regulated TGF-1 under hypoxia by directly binding the TGF-1 proximal promoter.",24227785_6,-1,-1,-1,-1,21501,-1,1.3945823e-05,0.9999578,2.8311173e-05
21502,functional,7,8,41,51,"Collectively, our data establish a novel functional link between hypoxia-induced Nanog and TGF-1 regulation and point to a major role of Nanog in hypoxia-driven immunosuppression.",24227785_7,0,1,2,-1,21502,-1,0.0005181283,0.9994098,7.2079165e-05
21504,TGF-1 regulation,13,15,91,108,"Collectively, our data establish a novel functional link between hypoxia-induced Nanog and TGF-1 regulation and point to a major role of Nanog in hypoxia-driven immunosuppression.",24227785_7,-1,-1,-1,-1,21504,-1,6.7223286e-06,0.999985,8.325133e-06
21507,Tumor-infiltrating lymphocytes,0,2,0,30,Tumor-infiltrating lymphocytes (TILs) have been reported as a prognostic factor in various cancers and are a promising target for immunotherapy.,24243586_0,-1,-1,-1,-1,21507,-1,0.004912498,0.7136333,0.28145424
21509,factor,11,12,73,79,Tumor-infiltrating lymphocytes (TILs) have been reported as a prognostic factor in various cancers and are a promising target for immunotherapy.,24243586_0,0,1,-1,-1,21509,-1,0.033056386,0.96636057,0.0005830312
21525,The total,0,2,0,9,The total number of primary TILs (CD4 plus CD8) and CD8(+) primary TILs of stage 3 patients with distant metastases was positively correlated with their overall survival.,24243586_6,-1,-1,-1,-1,21525,-1,4.55299e-06,0.9999906,4.8351562e-06
21532,analysis,15,16,93,101,"To evaluate whether CD8(+) effector T cells are activated or differentiated, flow cytometric analysis of peripheral blood mononuclear cells (PBMC) was performed.",24243586_7,0,1,-1,-1,21532,-1,1.7827826e-05,0.9999652,1.7031234e-05
21533,blood,18,19,116,121,"To evaluate whether CD8(+) effector T cells are activated or differentiated, flow cytometric analysis of peripheral blood mononuclear cells (PBMC) was performed.",24243586_7,0,1,-1,-1,21533,-1,0.0010509687,0.99765354,0.0012955447
21541,immunity,5,6,38,46,These results suggest that anti-tumor immunity is clinically relevant in angiosarcoma.,24243586_9,0,-1,2,-1,21541,-1,0.9998016,4.9365353e-05,0.00014904358
21546,therapy,20,21,138,145,Development of agents that specifically kill cancer cells and simultaneously elicit antitumor immune response is a step forward in cancer therapy.,24270218_0,0,1,-1,-1,21546,-1,4.81842e-06,0.99998987,5.3577046e-06
21549,the immune response,17,20,116,135,Immunostimulation can result in eliminating of the cancer cells; immunotherapy is a promising approach in balancing the immune response by Treg.,24270218_1,-1,-1,-1,-1,21549,-1,0.7785699,0.21916103,0.0022690466
21553,to the,13,15,91,97,"In the present study, we investigated whether the administration of salvigenin contributes to the augmentation of antitumor immunity and the regression of tumor tissues in a mouse model of breast cancer.",24270218_2,-1,-1,-1,-1,21553,-1,5.4727816e-06,0.9999895,5.0412436e-06
21554,immunity,18,19,124,132,"In the present study, we investigated whether the administration of salvigenin contributes to the augmentation of antitumor immunity and the regression of tumor tissues in a mouse model of breast cancer.",24270218_2,0,-1,2,-1,21554,-1,0.9998599,2.388262e-05,0.00011617252
21556,tumor tissues,23,25,155,168,"In the present study, we investigated whether the administration of salvigenin contributes to the augmentation of antitumor immunity and the regression of tumor tissues in a mouse model of breast cancer.",24270218_2,-1,-1,-1,-1,21556,-1,4.8900605e-05,0.99870706,0.0012439936
21558,the tumor,11,13,68,77,"Salvigenin was purified from Tanacetum canescens, and its effect on the tumor volume was investigated.",24270218_3,-1,-1,-1,-1,21558,-1,4.412439e-06,0.9999907,4.9265545e-06
21569,the IFN-,15,17,90,99,Our results demonstrated that a significant decrease in the level of IL-4 and increase in the IFN- in the animals treated with salvigenin and significant decreased in the level of splenic CD4+CD25+Foxp3+ T regulatory cells.,24270218_5,-1,-1,-1,-1,21569,-1,0.952213,0.04571759,0.0020694577
21576,that interferon,3,5,17,32,We have reported that interferon (IFN)- can attack cancer cells by multiple antitumor mechanisms including the induction of direct cancer cell death and the enhancement of an immune response in several pancreatic cancer models.,24289533_0,-1,-1,-1,-1,21576,-1,0.44664702,0.5492888,0.0040641343
21582,the tumors,6,8,47,57,"However, an immunotolerant microenvironment in the tumors is often responsible for the failure of the cancer immunotherapy.",24289533_1,-1,-1,-1,-1,21582,-1,4.650301e-06,0.9999906,4.774984e-06
21589,immunity,19,20,110,118,Here we examined whether the suppression of regulatory T cells (Tregs) within tumors can enhance an antitumor immunity induced by an intratumoral IFN- gene transfer.,24289533_2,0,-1,2,-1,21589,-1,0.9999231,1.6711203e-05,6.021856e-05
21590,IFN- gene transfer,24,27,146,165,Here we examined whether the suppression of regulatory T cells (Tregs) within tumors can enhance an antitumor immunity induced by an intratumoral IFN- gene transfer.,24289533_2,-1,-1,-1,-1,21590,-1,0.9969567,0.002540899,0.00050240615
21592,TNF receptor,12,14,99,111,"First we showed that an intraperitoneal administration of an agonistic anti-glucocorticoid induced TNF receptor (GITR) monoclonal antibody (mAb), which is reported to suppress the function of Tregs, significantly inhibited subcutaneous tumor growth in a murine pancreatic cancer model.",24289533_3,-1,-1,-1,-1,21592,-1,0.00045181232,0.9980003,0.0015478092
21594,the function,28,30,176,188,"First we showed that an intraperitoneal administration of an agonistic anti-glucocorticoid induced TNF receptor (GITR) monoclonal antibody (mAb), which is reported to suppress the function of Tregs, significantly inhibited subcutaneous tumor growth in a murine pancreatic cancer model.",24289533_3,-1,-1,-1,-1,21594,-1,7.161426e-06,0.99998605,6.7987753e-06
21600,the IFN--adenovirus,11,13,71,91,The anti-GITR mAb was then combined with the intratumoral injection of the IFN--adenovirus vector.,24289533_4,-1,-1,-1,-1,21600,-1,0.288634,0.70943683,0.0019292078
21601,The treatment,0,2,0,13,The treatment with the antibody synergistically augmented the antitumor effect of IFN- gene therapy not only in the vector-injected tumors but also in the vector-uninjected tumors.,24289533_5,-1,-1,-1,-1,21601,-1,4.9504506e-06,0.9999906,4.526425e-06
21604,IFN- gene therapy,11,14,82,100,The treatment with the antibody synergistically augmented the antitumor effect of IFN- gene therapy not only in the vector-injected tumors but also in the vector-uninjected tumors.,24289533_5,-1,-1,-1,-1,21604,-1,0.9974732,0.0019594387,0.0005672776
21609,that the,2,4,22,30,"Immunostaining showed that the anti-GITR mAb decreased Foxp3(+) cells infiltrating in the tumors, while the intratumoral IFN- gene transfer increased CD4(+) and CD8(+) T cells in the tumors.",24289533_6,-1,-1,-1,-1,21609,-1,4.0433124e-06,0.99999166,4.297738e-06
21612,the tumors,12,14,86,96,"Immunostaining showed that the anti-GITR mAb decreased Foxp3(+) cells infiltrating in the tumors, while the intratumoral IFN- gene transfer increased CD4(+) and CD8(+) T cells in the tumors.",24289533_6,-1,-1,-1,-1,21612,-1,3.4900238e-06,0.99999166,4.82958e-06
21614,IFN- gene transfer,18,21,121,140,"Immunostaining showed that the anti-GITR mAb decreased Foxp3(+) cells infiltrating in the tumors, while the intratumoral IFN- gene transfer increased CD4(+) and CD8(+) T cells in the tumors.",24289533_6,-1,-1,-1,-1,21614,-1,0.99602157,0.003381732,0.0005967307
21616,the tumors,30,32,180,190,"Immunostaining showed that the anti-GITR mAb decreased Foxp3(+) cells infiltrating in the tumors, while the intratumoral IFN- gene transfer increased CD4(+) and CD8(+) T cells in the tumors.",24289533_6,-1,-1,-1,-1,21616,-1,3.4901311e-06,0.9999919,4.643956e-06
21619,therapy,4,5,27,34,"Therefore, the combination therapy strongly inclined the immune balance of the tumor microenvironment in an antitumor direction, leading to a marked systemic antitumor effect.",24289533_7,0,1,-1,-1,21619,-1,4.1569406e-06,0.9999912,4.723621e-06
21621,the tumor,11,13,75,84,"Therefore, the combination therapy strongly inclined the immune balance of the tumor microenvironment in an antitumor direction, leading to a marked systemic antitumor effect.",24289533_7,-1,-1,-1,-1,21621,-1,4.5271904e-06,0.99998987,5.6027534e-06
21623,The CCR5,0,2,0,8,"The CCR5 expression on Tregs was downregulated in the antibody-treated mice, which may explain the decrease of tumor-infiltrating Tregs.",24289533_8,-1,-1,-1,-1,21623,-1,0.002456703,0.9472884,0.05025491
21627,tumor-infiltrating Tregs,18,20,111,135,"The CCR5 expression on Tregs was downregulated in the antibody-treated mice, which may explain the decrease of tumor-infiltrating Tregs.",24289533_8,-1,-1,-1,-1,21627,-1,1.0801248e-05,0.99998224,6.9690896e-06
21630,the tumor immunity,8,11,52,70,The combination of Treg-suppression by GITR mAb and the tumor immunity induction by IFN- gene therapy could be a promising therapeutic strategy for pancreatic cancer.,24289533_9,-1,-1,-1,-1,21630,-1,0.018068066,0.9810766,0.00085535285
21631,IFN- gene therapy,13,16,84,102,The combination of Treg-suppression by GITR mAb and the tumor immunity induction by IFN- gene therapy could be a promising therapeutic strategy for pancreatic cancer.,24289533_9,-1,-1,-1,-1,21631,-1,0.99725866,0.002231924,0.0005094026
21634,functional,2,3,14,24,Generation of functional dendritic cells (DCs) with boosted immunity after the withdrawal of initial activation/maturation conditions remains a significant challenge.,24296809_0,0,1,2,-1,21634,-1,0.26510075,0.70411384,0.030785443
21636,immunity,10,11,60,68,Generation of functional dendritic cells (DCs) with boosted immunity after the withdrawal of initial activation/maturation conditions remains a significant challenge.,24296809_0,0,-1,2,-1,21636,-1,0.9997782,5.6579065e-05,0.0001652435
21642,the function,23,25,136,148,"In this study, we investigated the impact of a newly developed maturation cocktail consisting of OK-432 and interferon-gamma (IFN-) on the function of human monocyte-derived DCs (MoDCs).",24296809_1,-1,-1,-1,-1,21642,-1,1.1501963e-05,0.99997675,1.1730216e-05
21644,plus IFN-,4,6,21,31,"We found that OK-432 plus IFN- stimulation could induce significantly stronger expression of surface molecules, production of cytokines, as well as migration of DCs compared with OK-432 stimulation alone.",24296809_2,-1,-1,-1,-1,21644,-1,0.9947351,0.0045163343,0.0007486078
21646,plus IFN--induced,7,9,42,60,"Most importantly, DCs matured with OK-432 plus IFN--induced maintained secretion of interleukin-12 (IL-12)p70 in secondary culture after stimulus withdrawal.",24296809_3,-1,-1,-1,-1,21646,-1,0.9792964,0.01971018,0.0009934471
21648,Functionally,0,1,0,12,"Functionally, OK-432 plus IFN--conditioned DCs induce remarkable Th1 and Tc1 responses more effectively than OK-432 alone, even more than the use of -type-1 cytokine cocktail.",24296809_4,0,1,2,-1,21648,-1,8.252492e-06,0.9999856,6.173232e-06
21649,plus IFN--conditioned,3,5,21,43,"Functionally, OK-432 plus IFN--conditioned DCs induce remarkable Th1 and Tc1 responses more effectively than OK-432 alone, even more than the use of -type-1 cytokine cocktail.",24296809_4,-1,-1,-1,-1,21649,-1,0.97955865,0.018549385,0.0018919418
21653,than the,20,22,134,142,"Functionally, OK-432 plus IFN--conditioned DCs induce remarkable Th1 and Tc1 responses more effectively than OK-432 alone, even more than the use of -type-1 cytokine cocktail.",24296809_4,-1,-1,-1,-1,21653,-1,6.62624e-06,0.9999883,5.0290646e-06
21655,plus IFN-,8,10,37,47,"As a result, DCs matured with OK-432 plus IFN- can prime stronger cytotoxic lymphocyte (CTL) and natural killer (NK) cell response against tumor cells in vitro.",24296809_5,-1,-1,-1,-1,21655,-1,0.99351877,0.0055505,0.0009306581
21656,cytotoxic lymphocyte,13,15,67,87,"As a result, DCs matured with OK-432 plus IFN- can prime stronger cytotoxic lymphocyte (CTL) and natural killer (NK) cell response against tumor cells in vitro.",24296809_5,-1,-1,-1,-1,21656,-1,1.4231379e-05,4.2418933e-06,0.9999815
21660,tumor cells,27,29,140,151,"As a result, DCs matured with OK-432 plus IFN- can prime stronger cytotoxic lymphocyte (CTL) and natural killer (NK) cell response against tumor cells in vitro.",24296809_5,-1,-1,-1,-1,21660,-1,0.0003719793,0.009896698,0.98973125
21661,blood,1,2,11,16,Peripheral blood mononuclear cells activated by DCs matured with OK-432 plus IFN- also showed greater tumor growth inhibition in vivo in null mice.,24296809_6,0,1,-1,-1,21661,-1,0.020914666,0.9529555,0.026129782
21663,plus IFN-,10,12,72,82,Peripheral blood mononuclear cells activated by DCs matured with OK-432 plus IFN- also showed greater tumor growth inhibition in vivo in null mice.,24296809_6,-1,-1,-1,-1,21663,-1,0.995462,0.0037286042,0.0008093862
21665,analysis,2,3,22,30,Molecular mechanistic analysis showed that DC maturation using IFN- in concert with OK-432 involves the activation of p38 and nuclear factor-kappa B (NF-B) pathways.,24296809_7,0,1,-1,-1,21665,-1,9.707981e-06,0.9999821,8.137618e-06
21669,factor-kappa,20,21,135,147,Molecular mechanistic analysis showed that DC maturation using IFN- in concert with OK-432 involves the activation of p38 and nuclear factor-kappa B (NF-B) pathways.,24296809_7,0,1,-1,-1,21669,-1,2.036659e-05,0.9999695,1.0114533e-05
21671,to generate,6,8,37,48,This study provided a novel strategy to generate more potent immune segments in DC vaccine.,24296809_8,-1,-1,-1,-1,21671,-1,7.7382865e-06,0.99998736,4.91445e-06
21673,tumor-infiltrating interleukin,11,13,69,99,"BACKGROUND AND AIM: Recent studies have shown that imbalance between tumor-infiltrating interleukin (IL)-17(+) T cells and regulatory T cells (Tregs) is an important regulator of progression in various cancers, but little is known regarding this imbalance in hepatocellular carcinoma (HCC).",24303990_0,-1,-1,-1,-1,21673,-1,0.10837805,0.8889114,0.0027105585
21688,tissue,13,14,55,61,"The expressions of IL-17, FoxP3, CD4, and CD8 in liver tissue were measured by immunochemistry for the evaluation of liver-infiltrating lymphocytes.",24303990_3,-1,1,2,-1,21688,-1,0.00023858712,0.98154193,0.018219464
21703,tumor-infiltrating FoxP3(+,11,13,66,92,"In surgical specimens of less differentiated HCC, the quantity of tumor-infiltrating FoxP3(+) Tregs was significantly lower and IL-17(+) T cells and CD8(+) T cells were significantly higher.",24303990_5,-1,-1,-1,-1,21703,-1,7.253098e-05,0.9998791,4.828252e-05
21725,lymphoid tissue chemokine,3,6,22,47,BACKGROUND: Secondary lymphoid tissue chemokine (SLC) is a key CC chemokine for chemotaxis of immune cells and has been an attractive candidate for anti-tumor treatments.,24304581_0,-1,-1,-1,-1,21725,-1,0.14659229,0.00058318255,0.8528245
21732,to tumors,9,11,49,58,"However, among the immune cells recruited by SLC to tumors, the CD25+ Foxp3+ regulatory T cells (Tregs) compromise the anti-tumor effects.",24304581_1,-1,-1,-1,-1,21732,-1,4.341445e-06,0.9999906,5.0770964e-06
21740,therapy,8,9,43,50,"In this study, we proposed the combination therapy of intratumoral co-administration of SLC and anti-CD25 monoclonal antibodies (mAbs).",24304581_2,0,1,-1,-1,21740,-1,4.710358e-06,0.99999094,4.3302825e-06
21741,that the,2,4,16,24,We hypothesized that the intratumoral injections of SLC and depletion of Tregs would have stronger inhibition effects on the progression of hepatocellular carcinoma (HCC) in mice.,24304581_3,-1,-1,-1,-1,21741,-1,4.3860464e-06,0.9999919,3.7262034e-06
21754,the tumors,18,20,81,91,"The percentages of Tregs, effector CD8+ T cells and CD4+ T cells were checked in the tumors, lymph nodes, spleen and liver at regular intervals.",24304581_5,-1,-1,-1,-1,21754,-1,4.2130278e-06,0.99999034,5.4080715e-06
21761,the tumor,7,9,46,55,The final anti-tumor effects were measured by the tumor volume and weight as well as the intratumoral activity of MMP2 and MMP9.,24304581_7,-1,-1,-1,-1,21761,-1,4.7653048e-06,0.99998987,5.422752e-06
21767,therapy,7,8,48,55,"RESULTS: Our experiments showed the combination therapy significantly decreased the frequency of Tregs, and increased CD8+ T cells and CD4+ T cells at tumor sites.",24304581_9,0,1,-1,-1,21767,-1,4.0992327e-06,0.9999913,4.6005557e-06
21783,therapy,33,34,176,183,"Unexpectedly, we observed a significantly decreased percentage of Tregs, and increased CD8+ T cells and CD4+ T cells in the lymph nodes, spleen and liver after the combination therapy.",24304581_11,0,1,-1,-1,21783,-1,4.880778e-06,0.99999,5.0900962e-06
21786,therapy,13,14,83,90,The growth and invasiveness of HCC was also maximally inhibited in the combination therapy compared with the SLC alone.,24304581_12,0,1,-1,-1,21786,-1,4.7281046e-06,0.9999901,5.214951e-06
21791,therapy,20,21,124,131,"Furthermore, we confirmed SLC induced the maturation of DCs via NF-B p65 and this maturation would benefit the combination therapy.",24304581_13,0,1,-1,-1,21791,-1,4.5868446e-06,0.9999906,4.808095e-06
21811,TNF-,2,3,7,12,"Foxp3, TNF- and TGF- mRNA expressions were assessed in tumor and lung tissues of LLC mice.",24325354_4,0,1,-1,-1,21811,-1,8.492675e-05,0.99988997,2.5142082e-05
21814,tissues,13,14,72,79,"Foxp3, TNF- and TGF- mRNA expressions were assessed in tumor and lung tissues of LLC mice.",24325354_4,-1,1,2,-1,21814,-1,6.902858e-05,0.99516135,0.0047695953
21818,tumor cell,23,25,129,139,"In addition, IL-10, IFN- and IL-4 levels were determined in sera and also in splenocyte culture supernatants at the presence of tumor cell lysate (10g/ml) and Con A (3g/ml) after 72h. Results showed the cytotoxic effects of umbelliprenin on LLC cells (IC=51.65.4M) while no adverse effect was seen at this concentration on normal splenocytes.",24325354_5,-1,-1,-1,-1,21818,-1,8.441798e-05,0.00019393588,0.9997217
21822,TNF-,0,1,0,5,TNF- mRNA expression in both lung and tumor tissues was increased.,24325354_6,0,1,-1,-1,21822,-1,0.00012602132,0.99984527,2.8694056e-05
21823,tumor tissues,7,9,39,52,TNF- mRNA expression in both lung and tumor tissues was increased.,24325354_6,-1,-1,-1,-1,21823,-1,9.497853e-06,0.9999387,5.1730494e-05
21826,tumor tissues,9,11,55,68,"However, Foxp3 and TGF- expressions were decreased in tumor tissues.",24325354_7,-1,-1,-1,-1,21826,-1,5.442655e-06,0.9999856,8.956048e-06
21830,to the,13,15,87,93,Serum level of IFN- was elevated in the umbelliprenin treated cancerous mice compared to the control group while IL-10 and IL-4 secretions were reduced.,24325354_8,-1,-1,-1,-1,21830,-1,5.0353747e-06,0.9999901,4.8735037e-06
21847,tolerance to,20,22,125,137,Regulatory T (Treg) cells act to suppress activation of the immune system and thereby maintain immunological homeostasis and tolerance to self-antigens.,24354800_0,-1,-1,-1,-1,21847,-1,6.4561277e-06,0.99998724,6.304672e-06
21861,factor-,25,26,153,161,"These diagnosed patients demonstrated a lower number of CD4(+) CD25(+) cells co-expressing a higher level of FoxP3, interleukin-10, transforming growth factor- and CD152/CTLA-4 than the normal population.",24354800_4,0,1,-1,-1,21861,-1,0.9999304,6.837239e-06,6.278863e-05
21862,than the,28,30,179,187,"These diagnosed patients demonstrated a lower number of CD4(+) CD25(+) cells co-expressing a higher level of FoxP3, interleukin-10, transforming growth factor- and CD152/CTLA-4 than the normal population.",24354800_4,-1,-1,-1,-1,21862,-1,6.555732e-06,0.99998796,5.452404e-06
21866,cells than,20,22,103,113,Treg cells from patients showed a higher suppressive capability on CD4(+) CD25(-) responder T (Tresp) cells than normal.,24354800_5,-1,-1,-1,-1,21866,-1,0.0027041344,0.16633804,0.8309577
21876,that Treg cells,11,14,63,78,"A co-culture study at these definite ex vivo ratios, indicated that Treg cells from B-ALL patients exhibited higher immunosuppression than Treg cells from normal healthy individuals.",24354800_8,-1,-1,-1,-1,21876,-1,0.0018408298,0.09342303,0.9047361
21877,than Treg cells,20,23,134,149,"A co-culture study at these definite ex vivo ratios, indicated that Treg cells from B-ALL patients exhibited higher immunosuppression than Treg cells from normal healthy individuals.",24354800_8,-1,-1,-1,-1,21877,-1,0.0017393789,0.08032559,0.91793513
21885,Taken together,0,2,0,14,"Taken together, our study indicated that the CD4(+) CD25(+) FoxP3(+) Treg cells played an important role in immunosuppression, resulting in a positive disease-correlation in these patients.",24354800_10,-1,-1,-1,-1,21885,-1,7.1373647e-06,0.99998605,6.862929e-06
21886,that the,6,8,36,44,"Taken together, our study indicated that the CD4(+) CD25(+) FoxP3(+) Treg cells played an important role in immunosuppression, resulting in a positive disease-correlation in these patients.",24354800_10,-1,-1,-1,-1,21886,-1,3.6630688e-06,0.99999213,4.1623166e-06
21888,Treg cells played,16,19,71,88,"Taken together, our study indicated that the CD4(+) CD25(+) FoxP3(+) Treg cells played an important role in immunosuppression, resulting in a positive disease-correlation in these patients.",24354800_10,-1,-1,-1,-1,21888,-1,0.0012525863,0.057933293,0.9408142
21890,To the,0,2,0,6,"To the best of our knowledge, this is the first detailed report on the frequency, regulation and functionality of Treg cells in B-ALL.",24354800_11,-1,-1,-1,-1,21890,-1,7.3372476e-06,0.9999858,6.886372e-06
21895,functionality,19,20,97,110,"To the best of our knowledge, this is the first detailed report on the frequency, regulation and functionality of Treg cells in B-ALL.",24354800_11,0,1,2,-1,21895,-1,2.2732635e-05,0.9999547,2.2562332e-05
21899,factor,12,13,60,66,"We document human T lymphotropic virus type 1 (HTLV-1) bZIP factor (HBZ)-specific CD4 T cell responses in an adult T cell leukemia/lymphoma (ATL) patient after allogeneic hematopoietic stem cell transplantation (HCT) and identified a novel HLA-DRB1*15:01-restricted HBZ-derived naturally presented minimum epitope sequence, RRRAEKKAADVA (HBZ114-125).",24363428_0,0,1,-1,-1,21899,-1,0.20629764,0.7921146,0.001587682
21902,cell transplantation,32,34,190,210,"We document human T lymphotropic virus type 1 (HTLV-1) bZIP factor (HBZ)-specific CD4 T cell responses in an adult T cell leukemia/lymphoma (ATL) patient after allogeneic hematopoietic stem cell transplantation (HCT) and identified a novel HLA-DRB1*15:01-restricted HBZ-derived naturally presented minimum epitope sequence, RRRAEKKAADVA (HBZ114-125).",24363428_0,-1,-1,-1,-1,21902,-1,0.0064562466,0.076877214,0.91666657
21904,This peptide,0,2,0,12,"This peptide was also presented on HLA-DRB1*15:02, recognized by CD4 T cells.",24363428_1,-1,-1,-1,-1,21904,-1,2.7861948e-05,0.99996006,1.2106597e-05
21914,life,14,15,89,93,We surmise that HTLV-1 transmission from mothers to infants through breast milk in early life induces tolerance to HBZ and results in insufficient HBZ-specific T cell responses in HTLV-1 asymptomatic carriers or ATL patients.,24363428_4,0,-1,2,-1,21914,-1,2.2233899e-05,0.99995756,2.015266e-05
21915,tolerance to,16,18,102,114,We surmise that HTLV-1 transmission from mothers to infants through breast milk in early life induces tolerance to HBZ and results in insufficient HBZ-specific T cell responses in HTLV-1 asymptomatic carriers or ATL patients.,24363428_4,-1,-1,-1,-1,21915,-1,8.883539e-06,0.9999845,6.63069e-06
21919,protein,17,18,112,119,"In contrast, after allogeneic HCT, the reconstituted immune system from donor-derived cells can recognize virus protein HBZ as foreign, and HBZ-specific immune responses are provoked that contribute to the graft-versus-HTLV-1 effect.",24363428_5,0,1,-1,-1,21919,-1,0.16314843,0.8312486,0.0056029866
21922,to the,30,32,199,205,"In contrast, after allogeneic HCT, the reconstituted immune system from donor-derived cells can recognize virus protein HBZ as foreign, and HBZ-specific immune responses are provoked that contribute to the graft-versus-HTLV-1 effect.",24363428_5,-1,-1,-1,-1,21922,-1,5.240818e-06,0.99999034,4.4192425e-06
21923,that TNFR2,4,6,21,31,"It has been reported that TNFR2 is involved in regulatory T cell induction and myeloid-derived suppressor cell (MDSC) accumulation, two kinds of immunosuppressive cells contributing to tumor immune evasion.",24379122_0,-1,-1,-1,-1,21923,-1,1.3926118e-05,0.9999801,5.996019e-06
21928,to tumor,28,30,182,190,"It has been reported that TNFR2 is involved in regulatory T cell induction and myeloid-derived suppressor cell (MDSC) accumulation, two kinds of immunosuppressive cells contributing to tumor immune evasion.",24379122_0,-1,-1,-1,-1,21928,-1,6.2196336e-06,0.9999877,6.0314846e-06
21929,transmembrane TNF-,1,3,8,27,"Because transmembrane TNF- (tmTNF-) is the primary ligand for TNFR2, we hypothesized that tmTNF- is mainly responsible for the activation of MDSCs.",24379122_1,-1,-1,-1,-1,21929,-1,4.2202595e-05,0.9999387,1.9021149e-05
21932,TNFR2,11,12,64,69,"Because transmembrane TNF- (tmTNF-) is the primary ligand for TNFR2, we hypothesized that tmTNF- is mainly responsible for the activation of MDSCs.",24379122_1,0,1,-1,-1,21932,-1,0.0002360084,0.9997124,5.1534003e-05
21933,that tmTNF-,15,17,87,99,"Because transmembrane TNF- (tmTNF-) is the primary ligand for TNFR2, we hypothesized that tmTNF- is mainly responsible for the activation of MDSCs.",24379122_1,-1,-1,-1,-1,21933,-1,2.2697106e-05,0.9999641,1.3230799e-05
21935,that tmTNF-,4,6,17,29,"Indeed, we found that tmTNF-, rather than secretory TNF- (sTNF-), activated MDSCs with enhanced suppressive activities, including upregulating arginase-1 and inducible NO synthase transcription, promoting secretion of NO, reactive oxygen species, IL-10, and TGF-, and enhancing inhibition of lymphocyte proliferation.",24379122_2,-1,-1,-1,-1,21935,-1,1.825645e-05,0.9999691,1.2560609e-05
21937,TNF-,10,11,53,58,"Indeed, we found that tmTNF-, rather than secretory TNF- (sTNF-), activated MDSCs with enhanced suppressive activities, including upregulating arginase-1 and inducible NO synthase transcription, promoting secretion of NO, reactive oxygen species, IL-10, and TGF-, and enhancing inhibition of lymphocyte proliferation.",24379122_2,0,1,-1,-1,21937,-1,4.0910913e-05,0.99993503,2.401199e-05
21944,TNFR2,7,8,39,44,"This effect of tmTNF- was mediated by TNFR2, as TNFR2 deficiency significantly impaired tmTNF--induced release of IL-10 and NO and inhibition of T cell proliferation by MDSC supernatant.",24379122_3,0,1,-1,-1,21944,-1,2.13759e-05,0.99996936,9.249081e-06
21945,TNFR2 deficiency,10,12,49,65,"This effect of tmTNF- was mediated by TNFR2, as TNFR2 deficiency significantly impaired tmTNF--induced release of IL-10 and NO and inhibition of T cell proliferation by MDSC supernatant.",24379122_3,-1,-1,-1,-1,21945,-1,1.631909e-05,0.9999727,1.1015881e-05
21946,tmTNF--induced release,14,16,89,112,"This effect of tmTNF- was mediated by TNFR2, as TNFR2 deficiency significantly impaired tmTNF--induced release of IL-10 and NO and inhibition of T cell proliferation by MDSC supernatant.",24379122_3,-1,-1,-1,-1,21946,-1,1.3819297e-05,0.9999771,9.110509e-06
21957,the tumor,35,37,235,244,"Consistently, our in vivo study showed that ectopic expression of uncleavable tmTNF- mutant by 4T1 cells significantly promoted tumor progression and angiogenesis, accompanied with more accumulation of MDSCs and regulatory T cells in the tumor site, increased production of NO, IL-10, and TGF-, as well as poor lymphocyte infiltration.",24379122_5,-1,-1,-1,-1,21957,-1,3.8751314e-06,0.9999913,4.8622655e-06
21961,cells that,10,12,57,67,"In contrast, enforced expression of sTNF- mutant by 4T1 cells that only released sTNF- without expression of surface tmTNF- markedly reduced MDSC accumulation and induced more lymphocyte infiltration instead, showing obvious tumor regression.",24379122_6,-1,-1,-1,-1,21961,-1,0.0036437584,0.29407164,0.7022846
21966,that tmTNF-,3,5,17,29,Our data suggest that tmTNF- acts as a potent activator of MDSCs via TNFR2 and reveals another novel immunosuppressive effect of this membrane molecule that promotes tumor immune escape.,24379122_7,-1,-1,-1,-1,21966,-1,5.522268e-05,0.9999261,1.8630184e-05
21968,TNFR2,13,14,70,75,Our data suggest that tmTNF- acts as a potent activator of MDSCs via TNFR2 and reveals another novel immunosuppressive effect of this membrane molecule that promotes tumor immune escape.,24379122_7,0,1,-1,-1,21968,-1,5.7498142e-05,0.9999263,1.618355e-05
21979,factors,24,25,98,105,"OBJECTIVES: T helper 17 (Th17), T cytotoxic 17 (Tc17) and regulatory T (Treg) cells are important factors in the pathogenesis of inflammatory and autoimmune diseases.",24388919_0,0,1,-1,-1,21979,-1,1.150485e-05,0.9999807,7.791686e-06
21982,these cells,7,9,45,56,"However, information concerning the roles of these cells in antitumor immunity or endometrial tumorigenesis remains limited.",24388919_1,-1,-1,-1,-1,21982,-1,2.598798e-05,2.534968e-05,0.9999486
21983,immunity,11,12,70,78,"However, information concerning the roles of these cells in antitumor immunity or endometrial tumorigenesis remains limited.",24388919_1,0,-1,2,-1,21983,-1,0.9998957,3.020784e-05,7.417403e-05
21998,blood,14,15,87,92,"METHODS: We assessed the expression of interleukin (IL)-17 and Foxp3 in the peripheral blood of endometrial carcinoma patients and healthy controls by flow cytometry to determine the relative numbers of Th17, Tc17 and Treg cells.",24388919_3,0,1,-1,-1,21998,-1,0.0030716332,0.79733145,0.1995969
22000,the relative,27,29,179,191,"METHODS: We assessed the expression of interleukin (IL)-17 and Foxp3 in the peripheral blood of endometrial carcinoma patients and healthy controls by flow cytometry to determine the relative numbers of Th17, Tc17 and Treg cells.",24388919_3,-1,-1,-1,-1,22000,-1,6.4237684e-06,0.9999883,5.2874907e-06
22004,Th17 cells,0,2,0,10,Th17 cells and Tc17 cells were counted as percentages of the total number of CD3(+) T cells; Treg cells were counted as a percentage of the total number of CD4(+) T cells.,24388919_4,-1,-1,-1,-1,22004,-1,4.4317458e-05,0.00018174178,0.9997739
22005,Tc17 cells,3,5,15,25,Th17 cells and Tc17 cells were counted as percentages of the total number of CD3(+) T cells; Treg cells were counted as a percentage of the total number of CD4(+) T cells.,24388919_4,-1,-1,-1,-1,22005,-1,0.00010043931,0.0019492399,0.9979504
22006,the total,10,12,57,66,Th17 cells and Tc17 cells were counted as percentages of the total number of CD3(+) T cells; Treg cells were counted as a percentage of the total number of CD4(+) T cells.,24388919_4,-1,-1,-1,-1,22006,-1,5.8632368e-06,0.9999881,6.115279e-06
22009,the total,27,29,136,145,Th17 cells and Tc17 cells were counted as percentages of the total number of CD3(+) T cells; Treg cells were counted as a percentage of the total number of CD4(+) T cells.,24388919_4,-1,-1,-1,-1,22009,-1,5.585711e-06,0.99998844,6.021328e-06
22012,Tc17 cells,5,7,27,37,We also evaluated Th17 and Tc17 cells in tumor tissue by immunohistochemical staining.,24388919_5,-1,-1,-1,-1,22012,-1,0.00013674775,0.0010103538,0.99885297
22013,tumor tissue,8,10,41,53,We also evaluated Th17 and Tc17 cells in tumor tissue by immunohistochemical staining.,24388919_5,-1,-1,-1,-1,22013,-1,7.286553e-06,0.9999839,8.813744e-06
22016,these three cell types,7,11,38,60,"IL-17 and IL-10, dominant products of these three cell types, were detected by using enzyme-linked immunosorbent assays.",24388919_6,-1,-1,-1,-1,22016,-1,0.0012765107,0.8815731,0.11715039
22027,the IL-17,8,10,48,57,"However, there was no significant difference on the IL-17 levels in the serum.",24388919_9,-1,-1,-1,-1,22027,-1,0.74014646,0.25667283,0.00318069
22029,tumor tissues,5,7,48,61,"Additionally, immunohistochemistry performed on tumor tissues indicated that the amounts of Th17 and Tc17 increased in the cancer patients.",24388919_10,-1,-1,-1,-1,22029,-1,1.8382158e-05,0.99987686,0.00010474961
22030,that the,8,10,72,80,"Additionally, immunohistochemistry performed on tumor tissues indicated that the amounts of Th17 and Tc17 increased in the cancer patients.",24388919_10,-1,-1,-1,-1,22030,-1,4.540011e-06,0.99999106,4.422378e-06
22039,these cells,4,6,25,36,Restoring the balance of these cells may help with the research and development of immunotherapies for endometrial carcinoma.,24388919_12,-1,-1,-1,-1,22039,-1,3.789279e-05,4.0030398e-05,0.99992204
22042,the relationship,4,6,22,38,"OBJECTIVE: To explore the relationship between the presence of HPV-16 DNA and the expression Treg surface marker Foxp3(+), peripheral blood levels of Th17/Treg cell-associated cytokines and explore their roles and significance in cervical cancer progression.",24401583_0,-1,-1,-1,-1,22042,-1,5.559097e-06,0.99999034,4.1272947e-06
22047,blood,22,23,134,139,"OBJECTIVE: To explore the relationship between the presence of HPV-16 DNA and the expression Treg surface marker Foxp3(+), peripheral blood levels of Th17/Treg cell-associated cytokines and explore their roles and significance in cervical cancer progression.",24401583_0,0,1,-1,-1,22047,-1,0.003358879,0.7370152,0.2596259
22048,cell-associated cytokines,26,28,160,185,"OBJECTIVE: To explore the relationship between the presence of HPV-16 DNA and the expression Treg surface marker Foxp3(+), peripheral blood levels of Th17/Treg cell-associated cytokines and explore their roles and significance in cervical cancer progression.",24401583_0,-1,-1,-1,-1,22048,-1,0.15030104,0.00093638967,0.8487626
22063,cell-associated cytokines,4,6,32,57,"The concentrations of Th17/Treg cell-associated cytokines were detected by enzyme-linked immunosorbent assay (ELISA).RESULTS: Under the same status of HPV16 DNA in vivo, the levels of Foxp3(+), transforming growth factor- (TGF-) and interleukin-10 (IL-10) were significantly higher than those of the control group (P < 0.01) while the levels of interleukin-17 (IL-17) and interleukin-21 (IL-21)were significantly lower than those of the control group (P < 0.05) .",24401583_5,-1,-1,-1,-1,22063,-1,0.12803027,0.00122407,0.87074566
22069,factor-,32,33,214,222,"The concentrations of Th17/Treg cell-associated cytokines were detected by enzyme-linked immunosorbent assay (ELISA).RESULTS: Under the same status of HPV16 DNA in vivo, the levels of Foxp3(+), transforming growth factor- (TGF-) and interleukin-10 (IL-10) were significantly higher than those of the control group (P < 0.01) while the levels of interleukin-17 (IL-17) and interleukin-21 (IL-21)were significantly lower than those of the control group (P < 0.05) .",24401583_5,0,1,-1,-1,22069,-1,0.9999486,5.547357e-06,4.5808534e-05
22073,than those,44,46,284,294,"The concentrations of Th17/Treg cell-associated cytokines were detected by enzyme-linked immunosorbent assay (ELISA).RESULTS: Under the same status of HPV16 DNA in vivo, the levels of Foxp3(+), transforming growth factor- (TGF-) and interleukin-10 (IL-10) were significantly higher than those of the control group (P < 0.01) while the levels of interleukin-17 (IL-17) and interleukin-21 (IL-21)were significantly lower than those of the control group (P < 0.05) .",24401583_5,-1,-1,-1,-1,22073,-1,6.0944285e-06,0.99998784,6.0865004e-06
22079,than those,68,70,421,431,"The concentrations of Th17/Treg cell-associated cytokines were detected by enzyme-linked immunosorbent assay (ELISA).RESULTS: Under the same status of HPV16 DNA in vivo, the levels of Foxp3(+), transforming growth factor- (TGF-) and interleukin-10 (IL-10) were significantly higher than those of the control group (P < 0.01) while the levels of interleukin-17 (IL-17) and interleukin-21 (IL-21)were significantly lower than those of the control group (P < 0.05) .",24401583_5,-1,-1,-1,-1,22079,-1,5.832232e-06,0.99998844,5.712732e-06
22092,Treg cytokines,47,49,259,273,"In the different status of HPV16 type DNA, the expression of Foxp3(+) was closely correlated with Federation International of Gynecology and Obstetrics (FIGO) stage, histological grade and lymphnode metastasis (P < 0.05) except for age (P > 0.05).CONCLUSION: Treg cytokines, HPV16 integration rate and severity of cervical lesions are positively correlated while Th17 cytokines show opposite effects.",24401583_7,-1,-1,-1,-1,22092,-1,0.16498293,0.83008265,0.004934351
22093,Th17 cytokines,62,64,363,377,"In the different status of HPV16 type DNA, the expression of Foxp3(+) was closely correlated with Federation International of Gynecology and Obstetrics (FIGO) stage, histological grade and lymphnode metastasis (P < 0.05) except for age (P > 0.05).CONCLUSION: Treg cytokines, HPV16 integration rate and severity of cervical lesions are positively correlated while Th17 cytokines show opposite effects.",24401583_7,-1,-1,-1,-1,22093,-1,0.23544468,0.7589742,0.0055811238
22094,cell-associated cytokines,1,3,10,35,Th17/Treg cell-associated cytokines may play an important role in the occurrence and development of cervical cancer.,24401583_8,-1,-1,-1,-1,22094,-1,0.17524004,0.0011494892,0.8236104
22097,the thymus,11,13,57,67,Myasthenia gravis (MG) is an autoimmune disease in which the thymus frequently presents follicular hyperplasia and signs of inflammation and T cells display a defect in suppressive regulation.,24405842_0,-1,-1,-1,-1,22097,-1,1.658549e-05,0.99996614,1.721941e-05
22101,function,10,11,65,73,Defects in a suppressive assay can indicate either the defective function of Treg cells or the resistance of Tconv cells to suppression by Treg cells.,24405842_1,0,1,2,-1,22101,-1,0.00012687268,0.99962974,0.00024338084
22104,Tconv cells to,18,21,109,123,Defects in a suppressive assay can indicate either the defective function of Treg cells or the resistance of Tconv cells to suppression by Treg cells.,24405842_1,-1,-1,-1,-1,22104,-1,4.545464e-05,0.9997795,0.00017504222
22113,thymic Treg cells,7,10,59,76,We first performed cross-experiment studies using purified thymic Treg cells and Tconv cells from controls (CTRL) and MG patients.,24405842_3,-1,-1,-1,-1,22113,-1,0.0034061647,0.43873295,0.5578609
22114,Tconv cells,11,13,81,92,We first performed cross-experiment studies using purified thymic Treg cells and Tconv cells from controls (CTRL) and MG patients.,24405842_3,-1,-1,-1,-1,22114,-1,0.0007756057,0.05018086,0.9490435
22119,time that,20,22,122,131,"We confirmed that MG Treg cells were defective in suppressing CTRL Tconv proliferation, and we demonstrated for the first time that MG Tconv cells were resistant to Treg cell suppression.",24405842_4,-1,-1,-1,-1,22119,-1,4.653358e-06,0.9999907,4.589291e-06
22120,Tconv cells,23,25,135,146,"We confirmed that MG Treg cells were defective in suppressing CTRL Tconv proliferation, and we demonstrated for the first time that MG Tconv cells were resistant to Treg cell suppression.",24405842_4,-1,-1,-1,-1,22120,-1,0.0015567156,0.2962433,0.7022
22121,to Treg cell,27,30,162,174,"We confirmed that MG Treg cells were defective in suppressing CTRL Tconv proliferation, and we demonstrated for the first time that MG Tconv cells were resistant to Treg cell suppression.",24405842_4,-1,-1,-1,-1,22121,-1,0.0012331669,0.08081498,0.9179519
22123,Tconv cells triggered,4,7,21,42,The activation of MG Tconv cells triggered a lower upregulation of FoxP3 and a higher upregulation of CD4 and CD25 than CTRL cells.,24405842_5,-1,-1,-1,-1,22123,-1,3.276414e-05,0.9999119,5.533081e-05
22128,the factors that,2,5,15,31,"To investigate the factors that could explain these differences, we analyzed the transcriptomes of purified thymic Treg and Tconv cells from MG patients in comparison to CTRL cells.",24405842_6,-1,-1,-1,-1,22128,-1,1.4775271e-05,0.99998,5.2989103e-06
22130,the transcriptomes,12,14,77,95,"To investigate the factors that could explain these differences, we analyzed the transcriptomes of purified thymic Treg and Tconv cells from MG patients in comparison to CTRL cells.",24405842_6,-1,-1,-1,-1,22130,-1,7.880198e-06,0.9999877,4.338867e-06
22131,thymic Treg,16,18,108,119,"To investigate the factors that could explain these differences, we analyzed the transcriptomes of purified thymic Treg and Tconv cells from MG patients in comparison to CTRL cells.",24405842_6,-1,-1,-1,-1,22131,-1,7.976722e-06,0.99998677,5.2436785e-06
22132,Tconv cells,19,21,124,135,"To investigate the factors that could explain these differences, we analyzed the transcriptomes of purified thymic Treg and Tconv cells from MG patients in comparison to CTRL cells.",24405842_6,-1,-1,-1,-1,22132,-1,0.002475282,0.36923152,0.62829316
22136,this analysis,6,8,33,46,"Many of the pathways revealed by this analysis are involved in other autoimmune diseases, and T cells from MG patients exhibit a Th1/Th17/Tfh signature.",24405842_7,-1,-1,-1,-1,22136,-1,6.176108e-06,0.99998784,5.966113e-06
22138,IL-17-related genes,3,5,15,34,"An increase in IL-17-related genes was only observed in Treg cells, while increases in IFN-, IL-21, and TNF- were observed in both Treg and Tconv cells.",24405842_8,-1,-1,-1,-1,22138,-1,0.9981877,0.0013380813,0.00047418047
22141,TNF-,20,21,105,110,"An increase in IL-17-related genes was only observed in Treg cells, while increases in IFN-, IL-21, and TNF- were observed in both Treg and Tconv cells.",24405842_8,0,1,-1,-1,22141,-1,0.00048286628,0.99946135,5.575847e-05
22143,Tconv cells,27,29,142,153,"An increase in IL-17-related genes was only observed in Treg cells, while increases in IFN-, IL-21, and TNF- were observed in both Treg and Tconv cells.",24405842_8,-1,-1,-1,-1,22143,-1,0.0012694871,0.22469275,0.7740378
22146,TNF-,6,7,25,30,"In addition, the role of TNF- in the defect in Tconv cells from MG patients was further confirmed by functional studies.",24405842_10,0,1,-1,-1,22146,-1,8.479242e-05,0.9998901,2.5091473e-05
22148,Tconv cells,11,13,48,59,"In addition, the role of TNF- in the defect in Tconv cells from MG patients was further confirmed by functional studies.",24405842_10,-1,-1,-1,-1,22148,-1,0.0007535111,0.042617638,0.9566289
22149,functional,20,21,102,112,"In addition, the role of TNF- in the defect in Tconv cells from MG patients was further confirmed by functional studies.",24405842_10,0,1,2,-1,22149,-1,0.00022820741,0.9997274,4.430078e-05
22150,that the,5,7,33,41,"Altogether, our results indicate that the immunoregulatory defects observed in MG patients are caused by both Treg cell and Tconv cell impairment and involve several pro-inflammatory cytokines, with TNF- playing a key role in this process.",24405842_11,-1,-1,-1,-1,22150,-1,4.020325e-06,0.99999225,3.692792e-06
22152,Tconv cell,20,22,124,134,"Altogether, our results indicate that the immunoregulatory defects observed in MG patients are caused by both Treg cell and Tconv cell impairment and involve several pro-inflammatory cytokines, with TNF- playing a key role in this process.",24405842_11,-1,-1,-1,-1,22152,-1,0.0015907446,0.25473082,0.7436785
22154,TNF- playing,30,32,199,212,"Altogether, our results indicate that the immunoregulatory defects observed in MG patients are caused by both Treg cell and Tconv cell impairment and involve several pro-inflammatory cytokines, with TNF- playing a key role in this process.",24405842_11,-1,-1,-1,-1,22154,-1,1.809805e-05,0.9999733,8.648316e-06
22157,the thymus,5,7,36,46,The chronic inflammation present in the thymus of MG patients could provide an explanation for the escape of thymic T cells from regulation in the MG thymus.,24405842_12,-1,-1,-1,-1,22157,-1,8.53051e-06,0.999984,7.468973e-06
22159,thymic T cells,18,21,109,123,The chronic inflammation present in the thymus of MG patients could provide an explanation for the escape of thymic T cells from regulation in the MG thymus.,24405842_12,-1,-1,-1,-1,22159,-1,0.0036027848,0.586397,0.4100002
22162,thymus,26,27,150,156,The chronic inflammation present in the thymus of MG patients could provide an explanation for the escape of thymic T cells from regulation in the MG thymus.,24405842_12,-1,1,2,-1,22162,-1,1.1225158e-05,0.9999782,1.0576433e-05
22167,Th1 immune response,11,14,80,99,"Activated STAT3 promotes survival and proliferation of cancer cells, suppresses Th1 immune response, and induces dysfunction of immune cells.",24407159_1,-1,-1,-1,-1,22167,-1,0.2751903,0.72062147,0.00418826
22171,function,27,28,170,178,We investigated whether pretreating myeloma cells with a phosphor (p)-STAT3 inhibitor (JSI-124) and/or bortezomib before loading into dendritic cells (DCs) can affect DC function.,24407159_2,0,1,2,-1,22171,-1,0.00012347399,0.9997037,0.0001727646
22175,protein,15,16,103,110,The combination treatment with JSI-124 and bortezomib resulted in the highest expression of heat shock protein (HSP) 90 and the lowest expression of p-STAT3 in dying myeloma cells.,24407159_3,0,1,-1,-1,22175,-1,0.000371594,0.99955636,7.2045885e-05
22178,cells treated,5,7,30,43,DCs loaded with dying myeloma cells treated by JSI-124 and bortezomib produced the least amount of p-STAT3 compared to other treatments.,24407159_4,-1,-1,-1,-1,22178,-1,0.004700748,0.24613357,0.7491656
22195,function through the,15,18,95,115,"The data suggest that pretreatment of myeloma cells with JSI-124 and bortezomib can recover DC function through the up-regulation of HSP90 and the down-regulation of p-STAT3 and inhibitory cytokines, and that these DCs can potently generate myeloma-specific CTLs.",24407159_7,-1,-1,-1,-1,22195,-1,2.0700125e-05,0.9999523,2.6952108e-05
22198,that these,31,33,204,214,"The data suggest that pretreatment of myeloma cells with JSI-124 and bortezomib can recover DC function through the up-regulation of HSP90 and the down-regulation of p-STAT3 and inhibitory cytokines, and that these DCs can potently generate myeloma-specific CTLs.",24407159_7,-1,-1,-1,-1,22198,-1,4.763895e-06,0.99999154,3.7428988e-06
22207,The treatment,0,2,0,13,"The treatment delayed tumor growth, but unexpectedly increased the proportion of Tregs in tumor.",24416401_2,-1,-1,-1,-1,22207,-1,5.9961408e-06,0.99999,4.041301e-06
22220,term tumor-free,5,7,34,49,"This combination resulted in long term tumor-free survival of up to 80% of mice, and the tumor-free mice were more resistant to re-challenge with tumor.",24416401_5,-1,-1,-1,-1,22220,-1,1.0828029e-05,0.99997807,1.1084914e-05
22222,the tumor-free,17,19,85,99,"This combination resulted in long term tumor-free survival of up to 80% of mice, and the tumor-free mice were more resistant to re-challenge with tumor.",24416401_5,-1,-1,-1,-1,22222,-1,1.190668e-05,0.99997747,1.0643865e-05
22230,This treatment,0,2,0,14,"This treatment markedly inhibited tumor growth, and was accompanied by massive infiltration of IFN-producing T cells.",24416401_7,-1,-1,-1,-1,22230,-1,4.591198e-06,0.9999913,4.056419e-06
22232,IFN-producing T cells,14,17,95,117,"This treatment markedly inhibited tumor growth, and was accompanied by massive infiltration of IFN-producing T cells.",24416401_7,-1,-1,-1,-1,22232,-1,0.9265551,0.00023770305,0.07320727
22240,therapy,15,16,93,100,"In a spontaneous 4T1 lung metastasis model with resection of primary tumor, this combination therapy markedly increased the survival of mice, indicating it was effective in reducing lethal metastasis burden.",24416401_9,0,1,-1,-1,22240,-1,4.6761515e-06,0.99999046,4.9153464e-06
22242,Taken together,0,2,0,14,"Taken together, our data show that anti-TGF antibody and cyclophosphamide represents an effective chemoimmunotherapeutic combination.",24416401_10,-1,-1,-1,-1,22242,-1,1.274525e-05,0.99997663,1.0570134e-05
22252,TNF-,9,10,42,47,"Bcl11b(-/-) CD4(+) T cells, with elevated TNF- levels, but not the Bcl11b(-/-) CD8(+) T cells, were required for the reduced tumor burden, as were NK1.1(+) cells, found in increased numbers in Bcl11b(F/F)/CD4-Cre mice.",24446520_1,0,1,-1,-1,22252,-1,0.00011670874,0.9998559,2.7368811e-05
22274,TNF-,26,27,156,161,"Finally, the reduced tumor burden, increased numbers of NK cells in the lung, and increased hematopoiesis in Bcl11b(F/F)/CD4-Cre mice were all dependent on TNF-.",24446520_5,0,1,-1,-1,22274,-1,6.902613e-05,0.999913,1.7992055e-05
22275,TNF- treatment,2,4,10,25,"Moreover, TNF- treatment of wild-type mice also reduced the tumor burden and increased hematopoiesis and the numbers and activity of NK cells in the lung.",24446520_6,-1,-1,-1,-1,22275,-1,1.2804403e-05,0.99997985,7.3490105e-06
22276,the tumor,9,11,57,66,"Moreover, TNF- treatment of wild-type mice also reduced the tumor burden and increased hematopoiesis and the numbers and activity of NK cells in the lung.",24446520_6,-1,-1,-1,-1,22276,-1,4.7099456e-06,0.9999901,5.1654733e-06
22281,TNF-,4,5,24,29,"In vitro treatment with TNF- of lineage-negative hematopoietic progenitors increased NK and myeloid differentiation, further supporting a role of TNF- in promoting hematopoiesis.",24446520_7,0,1,-1,-1,22281,-1,3.8264647e-05,0.9999448,1.6898995e-05
22282,TNF-,20,21,147,152,"In vitro treatment with TNF- of lineage-negative hematopoietic progenitors increased NK and myeloid differentiation, further supporting a role of TNF- in promoting hematopoiesis.",24446520_7,0,1,-1,-1,22282,-1,3.108786e-05,0.9999536,1.5307285e-05
22284,TNF-,7,8,38,43,"These studies reveal a novel role for TNF- in the antitumor immune response, specifically in stimulating hematopoiesis and increasing the numbers and activity of NK cells.",24446520_8,0,1,-1,-1,22284,-1,2.6103775e-05,0.9999608,1.3162103e-05
22297,Th17 cells,25,27,171,181,"IL-6 regulates T cell differentiation, activation and resistance against apoptosis and thereby controls the balance between pro-inflammatory T cell subsets such as Th1 or Th17 cells and immunosuppressive regulatory T cells.",24447345_1,-1,-1,-1,-1,22297,-1,0.00041772216,0.022769663,0.9768126
22302,tumor cell,6,8,32,42,"In fact, IL-6 directly promotes tumor cell proliferation and survival through STAT3 activation.",24447345_3,-1,-1,-1,-1,22302,-1,8.7194945e-05,0.00048273907,0.99943
22303,through STAT3,11,13,70,83,"In fact, IL-6 directly promotes tumor cell proliferation and survival through STAT3 activation.",24447345_3,-1,-1,-1,-1,22303,-1,1.2363535e-05,0.9999801,7.497847e-06
22309,therapeutics targeting IL-6,5,8,29,56,"During recent years, several therapeutics targeting IL-6 dependent pathways have been developed.",24447345_5,-1,-1,-1,-1,22309,-1,0.35406852,0.6420495,0.0038819276
22311,targeting this,13,15,94,108,"Although clinical data about anti-IL-6 treatment in intestinal diseases are currently scarce, targeting this pathway might be a promising strategy in IBD and CRC.",24447345_6,-1,-1,-1,-1,22311,-1,3.9977535e-06,0.9999925,3.563038e-06
22312,that the,3,5,12,20,"It is known that the intake of omega-3 fatty acids, such as eicosapentaenoic (EPA) and docosahexaenoic acid (DHA), is beneficial for preventing and/or treating allergic diseases.",24460246_0,-1,-1,-1,-1,22312,-1,4.9001746e-06,0.99999094,4.2173397e-06
22315,Th2-skewed immunity,10,12,75,94,The pathogenesis of allergic diseases is associated with overactivation of Th2-skewed immunity.,24460246_1,-1,-1,-1,-1,22315,-1,0.0055093965,0.9938055,0.0006850391
22317,Th2 cytokines,5,7,36,49,"Basophils generate large amounts of Th2 cytokines such as interleukin (IL)-4 and IL-13, which are critically involved in allergic inflammation.",24460246_2,-1,-1,-1,-1,22317,-1,0.30675536,0.6845532,0.00869141
22320,Th2 cytokine,7,9,39,51,We investigated how EPA and DHA affect Th2 cytokine expression in phorbol 12-myristate 13-acetate- and ionomycin (PI)-activated RBL-2H3 basophilic leukemia cells.,24460246_3,-1,-1,-1,-1,22320,-1,0.19943799,0.79552865,0.0050333673
22324,their transcription,15,17,80,99,EPA and DHA induced a dramatic decrease in the production of IL-4 and IL-13 and their transcription in a dose-dependent manner.,24460246_4,-1,-1,-1,-1,22324,-1,6.270396e-06,0.9999871,6.658031e-06
22328,Analysis,0,1,0,8,Analysis of certain transcription factors revealed that nuclear expression of c-Fos and the mRNA expression were suppressed by EPA and DHA.,24460246_6,0,1,-1,-1,22328,-1,6.255298e-06,0.99998915,4.581356e-06
22335,nuclear factor of activated T cells,11,17,86,121,"Furthermore, they significantly inhibited the nuclear expression and translocation of nuclear factor of activated T cells (NF-AT)1.",24460246_7,-1,1,2,-1,22335,-1,0.0024930518,0.57718456,0.42032242
22338,proteins,15,16,83,91,"In contrast, the expression levels of nuclear factor kappa-B (NF-B), GATA-binding proteins (GATAs), and CCAAT/enhancer binding protein alpha (C/EBP) were not significantly affected by EPA and DHA.",24460246_8,0,1,-1,-1,22338,-1,7.5352964e-06,0.99998224,1.0232426e-05
22340,protein,17,18,130,137,"Phosphorylation of extracellular signal-related kinase was inhibited by EPA and DHA, and phosphorylation of p38 mitogen-activated protein kinase was decreased by DHA, but not by EPA.",24460246_9,0,1,-1,-1,22340,-1,0.00043093014,0.99946576,0.000103284154
22341,Taken together,0,2,0,14,"Taken together, our data suggest that EPA and DHA may suppress Th2-skewed allergic immune responses by inhibiting the expression of basophilic IL-4 and IL-13.",24460246_10,-1,-1,-1,-1,22341,-1,1.06330735e-05,0.9999796,9.769692e-06
22348,tumor-infiltrating T lymphocytes,9,12,60,92,"The interaction of integrin E(CD103)7, often expressed on tumor-infiltrating T lymphocytes, with its cognate ligand, the epithelial cell marker E-cadherin on tumor cells, plays a major role in antitumor CTL responses.",24477908_0,-1,-1,-1,-1,22348,-1,0.0029007774,0.7785898,0.21850942
22351,tumor cells,24,26,160,171,"The interaction of integrin E(CD103)7, often expressed on tumor-infiltrating T lymphocytes, with its cognate ligand, the epithelial cell marker E-cadherin on tumor cells, plays a major role in antitumor CTL responses.",24477908_0,-1,-1,-1,-1,22351,-1,5.2203257e-05,0.00015931975,0.99978846
22355,TCR,8,9,37,40,"CD103 is induced on CD8 T cells upon TCR engagement and exposure to TGF-1, abundant within the tumor microenvironment.",24477908_1,-1,1,2,-1,22355,-1,2.0969392e-05,0.99995124,2.7757738e-05
22356,to TGF-1,12,14,65,74,"CD103 is induced on CD8 T cells upon TCR engagement and exposure to TGF-1, abundant within the tumor microenvironment.",24477908_1,-1,-1,-1,-1,22356,-1,1.1463515e-05,0.9999739,1.4687248e-05
22357,the tumor,17,19,92,101,"CD103 is induced on CD8 T cells upon TCR engagement and exposure to TGF-1, abundant within the tumor microenvironment.",24477908_1,-1,-1,-1,-1,22357,-1,4.2997835e-06,0.9999914,4.2645484e-06
22358,the transcriptional,2,4,9,28,"However, the transcriptional mechanisms underlying the cooperative role of these two signaling pathways in inducing CD103 expression in CD8 T lymphocytes remain unknown.",24477908_2,-1,-1,-1,-1,22358,-1,7.781759e-06,0.9999876,4.619976e-06
22360,these two,10,12,75,84,"However, the transcriptional mechanisms underlying the cooperative role of these two signaling pathways in inducing CD103 expression in CD8 T lymphocytes remain unknown.",24477908_2,-1,-1,-1,-1,22360,-1,1.3709534e-05,0.9999801,6.2468835e-06
22365,that the transcription factors,23,27,127,157,"Using a human CTL system model based on a CD8(+)/CD103(-) T cell clone specific of a lung tumor-associated Ag, we demonstrated that the transcription factors Smad2/3 and NFAT-1 are two critical regulators of this process.",24477908_3,-1,-1,-1,-1,22365,-1,4.71204e-06,0.9999912,4.14062e-06
22366,NFAT-1,29,30,170,176,"Using a human CTL system model based on a CD8(+)/CD103(-) T cell clone specific of a lung tumor-associated Ag, we demonstrated that the transcription factors Smad2/3 and NFAT-1 are two critical regulators of this process.",24477908_3,-1,1,2,-1,22366,-1,1.50958895e-05,0.99992514,5.9790076e-05
22371,these transcriptional,21,23,120,141,"We also identified promoter and enhancer elements of the human ITGAE gene, encoding CD103, involved in its induction by these transcriptional regulators.",24477908_4,-1,-1,-1,-1,22371,-1,4.665114e-06,0.99999046,4.892645e-06
22373,TCR-engaged,14,15,87,98,"Overall, our results explain how TGF-1 can participate in CD103 expression on locally TCR-engaged Ag-specific CD8 T cells, thus contributing to antitumor CTL responses and cancer cell destruction.",24477908_5,-1,1,2,-1,22373,-1,2.4051129e-05,0.99994814,2.7775448e-05
22394,IL-17A+ T cells,6,9,40,55,"The frequency of intratumoral Tregs and IL-17A+ T cells, and the levels of FoxP3 and IL-17 mRNA were analyzed.",24487033_2,-1,-1,-1,-1,22394,-1,0.8787647,0.00028891012,0.120946325
22403,tumor tissues,9,11,52,65,The activities of matrix metalloproteases (MMPs) in tumor tissues were analyzed.,24487033_4,-1,-1,-1,-1,22403,-1,6.6679263e-06,0.99997973,1.3577023e-05
22405,blood,6,7,32,37,"Meanwhile, Tregs from patient's blood was co-cultured with human CRC cells in the presence of IL-17.",24487033_5,0,1,-1,-1,22405,-1,0.0007118976,0.9827032,0.01658491
22409,protein,1,2,5,12,MMPs protein and mRNA levels were determined after 48 or 24h incubation.,24487033_6,0,1,-1,-1,22409,-1,7.155811e-05,0.99988496,4.343946e-05
22410,that Tregs,2,4,9,19,We found that Tregs and IL-17A+T cells were accumulated in CRC.,24487033_7,-1,-1,-1,-1,22410,-1,4.754913e-06,0.9999907,4.5796155e-06
22411,IL-17A+T cells,5,7,24,38,We found that Tregs and IL-17A+T cells were accumulated in CRC.,24487033_7,-1,-1,-1,-1,22411,-1,0.9183442,0.00023625178,0.08141953
22413,Tregs/IL-17A+T cells,3,5,13,33,The ratio of Tregs/IL-17A+T cells was decreased in CRC tissues.,24487033_8,-1,-1,-1,-1,22413,-1,0.018094677,0.65356046,0.32834482
22414,tissues,9,10,55,62,The ratio of Tregs/IL-17A+T cells was decreased in CRC tissues.,24487033_8,-1,1,2,-1,22414,-1,2.7293228e-05,0.998701,0.0012716544
22416,IL-17A+T cells,5,7,33,47,More intratumoral Tregs and less IL-17A+T cells were associated with suppressed MMPs activities and decreased metastases score.,24487033_9,-1,-1,-1,-1,22416,-1,0.8801122,0.00026997004,0.11961785
22417,that Tregs,6,8,40,50,"In addition, vitro studies demonstrated that Tregs suppressed MMPs expression in the presence of IL-17.",24487033_10,-1,-1,-1,-1,22417,-1,6.3557277e-06,0.9999894,4.2745155e-06
22429,functions,13,14,86,95,Cytotoxicity and IFN- production by human  T cells underlie their potent antitumor functions.,24489097_0,0,1,2,-1,22429,-1,0.00026154504,0.9990765,0.0006619157
22433,the thymus to,9,12,55,68,"Given the recent disclosure of a major contribution of the thymus to murine  T cell functional differentiation, in this study we have analyzed a series of human pediatric thymuses.",24489097_2,-1,-1,-1,-1,22433,-1,5.3788935e-06,0.99998784,6.792935e-06
22434,T cell functional,14,17,79,96,"Given the recent disclosure of a major contribution of the thymus to murine  T cell functional differentiation, in this study we have analyzed a series of human pediatric thymuses.",24489097_2,-1,-1,-1,-1,22434,-1,6.057366e-05,3.4278575e-05,0.9999051
22436,thymuses,30,31,173,181,"Given the recent disclosure of a major contribution of the thymus to murine  T cell functional differentiation, in this study we have analyzed a series of human pediatric thymuses.",24489097_2,-1,1,2,-1,22436,-1,1.4971343e-05,0.99997187,1.3185479e-05
22438,thymocytes,6,7,34,44,We found that ex vivo-isolated  thymocytes produced negligible IFN- and lacked cytolytic activity against leukemia cells.,24489097_3,-1,1,2,-1,22438,-1,0.0016598729,0.20519309,0.79314715
22444,TCR,2,3,14,17,"Unexpectedly, TCR activation was dispensable for these stages of functional differentiation.",24489097_5,-1,1,2,-1,22444,-1,3.6473248e-05,0.99991965,4.3889497e-05
22446,functional,10,11,65,75,"Unexpectedly, TCR activation was dispensable for these stages of functional differentiation.",24489097_5,0,1,2,-1,22446,-1,0.0025538323,0.9967597,0.00068641885
22448,the transcription factors T-bet,14,18,91,122,"The effects of IL-2/IL-15 depended on MAPK/ERK signaling and induced de novo expression of the transcription factors T-bet and eomesodermin, as well as the cytolytic enzyme perforin, required for the cytotoxic type 1 program.",24489097_6,-1,-1,-1,-1,22448,-1,6.0401535e-06,0.9999877,6.2014988e-06
22461,functions,28,29,142,151,"Although the role of Notch in CD4(+) and CD8(+)  T cells is well documented, there are no reports on how Notch signaling regulates effector functions of  T cells.",24489102_1,0,1,2,-1,22461,-1,7.919621e-05,0.999762,0.00015877813
22465,blood,10,11,50,55, T cells are a minor fraction in the peripheral blood but are known to play a major role in defense against pathogens and tumors.,24489102_2,0,1,-1,-1,22465,-1,0.00019983071,0.99827886,0.0015212668
22466,to play,14,16,70,77, T cells are a minor fraction in the peripheral blood but are known to play a major role in defense against pathogens and tumors.,24489102_2,-1,-1,-1,-1,22466,-1,5.641092e-06,0.9999896,4.691635e-06
22469,that Notch receptors,6,9,23,43,"In this study, we show that Notch receptors (mRNA and protein) are expressed in peripheral  T cells.",24489102_3,-1,-1,-1,-1,22469,-1,6.937661e-05,0.9996971,0.00023354594
22470,protein,12,13,54,61,"In this study, we show that Notch receptors (mRNA and protein) are expressed in peripheral  T cells.",24489102_3,0,1,-1,-1,22470,-1,8.384877e-06,0.99998426,7.406965e-06
22487,functions,24,25,137,146,"Our study describes for the first time, to our knowledge, the role of Notch as an additional signal contributing to Ag-specific effector functions of  T cells.",24489102_7,0,1,2,-1,22487,-1,0.004142933,0.8861602,0.10969684
22493,tissues,16,17,75,82,"In this article, we report that cutaneous T cell lymphoma (CTCL) cells and tissues ubiquitously express the immunosuppressive cell surface protein CD80 (B7-1).",24523507_0,-1,1,2,-1,22493,-1,0.00019408287,0.9822322,0.01757371
22496,protein CD80,23,25,139,151,"In this article, we report that cutaneous T cell lymphoma (CTCL) cells and tissues ubiquitously express the immunosuppressive cell surface protein CD80 (B7-1).",24523507_0,-1,-1,-1,-1,22496,-1,0.0021216974,0.09708778,0.90079063
22501,the STAT5,15,17,89,98,"CD80 expression in CTCL cells is strictly dependent on the expression of both members of the STAT5 family, STAT5a and STAT5b, as well as their joint ability to transcriptionally activate the CD80 gene.",24523507_1,-1,-1,-1,-1,22501,-1,5.987906e-06,0.99998903,4.919818e-06
22505,to transcriptionally,29,31,157,177,"CD80 expression in CTCL cells is strictly dependent on the expression of both members of the STAT5 family, STAT5a and STAT5b, as well as their joint ability to transcriptionally activate the CD80 gene.",24523507_1,-1,-1,-1,-1,22505,-1,4.912726e-06,0.9999913,3.8379853e-06
22506,the CD80 gene,32,35,187,200,"CD80 expression in CTCL cells is strictly dependent on the expression of both members of the STAT5 family, STAT5a and STAT5b, as well as their joint ability to transcriptionally activate the CD80 gene.",24523507_1,-1,-1,-1,-1,22506,-1,5.663888e-05,0.9998468,9.6535354e-05
22509,the cytokine,10,12,60,72,"In IL-2-dependent CTCL cells, CD80 expression is induced by the cytokine in a Jak1/3- and STAT5a/b-dependent manner, whereas in the CTCL cells with constitutive STAT5 activation, CD80 expression is also STAT5a/b dependent but is independent of Jak activity.",24523507_2,-1,-1,-1,-1,22509,-1,0.6718688,0.32507646,0.003054766
22517,the cell-inhibitory receptor,20,23,128,156,"Although depletion of CD80 expression does not affect the proliferation rate and viability of CTCL cells, induced expression of the cell-inhibitory receptor of CD80, CD152 (CTLA-4), impairs growth of the cells.",24523507_3,-1,-1,-1,-1,22517,-1,0.0015319738,0.0751897,0.92327833
22520,the cells,34,36,200,209,"Although depletion of CD80 expression does not affect the proliferation rate and viability of CTCL cells, induced expression of the cell-inhibitory receptor of CD80, CD152 (CTLA-4), impairs growth of the cells.",24523507_3,-1,-1,-1,-1,22520,-1,7.707519e-05,0.00019306698,0.9997298
22529,that the CD80-CD152,13,16,74,93,These data identify a new mechanism of immune evasion in CTCL and suggest that the CD80-CD152 axis may become a therapeutic target in this type of lymphoma.,24523507_5,-1,-1,-1,-1,22529,-1,0.015646558,0.98109347,0.0032600386
22530,therapeutic target,20,22,112,130,These data identify a new mechanism of immune evasion in CTCL and suggest that the CD80-CD152 axis may become a therapeutic target in this type of lymphoma.,24523507_5,-1,-1,-1,-1,22530,-1,5.017545e-06,0.9999907,4.2213182e-06
22531,this type,23,25,134,143,These data identify a new mechanism of immune evasion in CTCL and suggest that the CD80-CD152 axis may become a therapeutic target in this type of lymphoma.,24523507_5,-1,-1,-1,-1,22531,-1,4.2786896e-06,0.99998975,5.9836348e-06
22533,Tc17 cells,5,7,29,39,"BACKGROUND: The existence of Tc17 cells was recently shown in several types of infectious and autoimmune diseases, but their distribution and functions in uterine cervical cancer (UCC) have not been fully elucidated.",24523865_0,-1,-1,-1,-1,22533,-1,0.00041137583,0.011273689,0.98831487
22536,functions,23,24,142,151,"BACKGROUND: The existence of Tc17 cells was recently shown in several types of infectious and autoimmune diseases, but their distribution and functions in uterine cervical cancer (UCC) have not been fully elucidated.",24523865_0,0,1,2,-1,22536,-1,1.4131088e-05,0.99997044,1.5427218e-05
22538,Tc17 cells,5,7,26,36,"METHODS: The frequency of Tc17 cells in peripheral blood samples obtained from UCC patients, cervical intraepithelial neoplasia (CIN) patients and healthy controls was determined by flow cytometry.",24523865_1,-1,-1,-1,-1,22538,-1,0.00018491989,0.0017597848,0.99805534
22539,blood,9,10,51,56,"METHODS: The frequency of Tc17 cells in peripheral blood samples obtained from UCC patients, cervical intraepithelial neoplasia (CIN) patients and healthy controls was determined by flow cytometry.",24523865_1,0,1,-1,-1,22539,-1,0.0011132131,0.98580605,0.013080779
22541,Tc17 cells,5,7,27,37,"Besides, the prevalence of Tc17 cells and their relationships to Th17 cells and Foxp3-expressing T cells as well as microvessels in tissue samples of the patients were assessed by immunohistochemistry staining.",24523865_2,-1,-1,-1,-1,22541,-1,0.00012474756,0.0028136303,0.99706155
22542,their relationships to Th17 cells,8,13,42,75,"Besides, the prevalence of Tc17 cells and their relationships to Th17 cells and Foxp3-expressing T cells as well as microvessels in tissue samples of the patients were assessed by immunohistochemistry staining.",24523865_2,-1,-1,-1,-1,22542,-1,0.002178387,0.7290906,0.26873106
22543,Foxp3-expressing T cells,14,17,80,104,"Besides, the prevalence of Tc17 cells and their relationships to Th17 cells and Foxp3-expressing T cells as well as microvessels in tissue samples of the patients were assessed by immunohistochemistry staining.",24523865_2,-1,-1,-1,-1,22543,-1,0.001784182,0.8712173,0.12699851
22544,tissue,22,23,132,138,"Besides, the prevalence of Tc17 cells and their relationships to Th17 cells and Foxp3-expressing T cells as well as microvessels in tissue samples of the patients were assessed by immunohistochemistry staining.",24523865_2,-1,1,2,-1,22544,-1,6.6569883e-06,0.999985,8.307969e-06
22547,Tc17 cells,16,18,83,93,"RESULTS: Compared to controls, patients with UCC or CIN had a higher proportion of Tc17 cells in both peripheral blood and cervical tissues, but the level of Tc17 cells in UCC tissues was significantly higher than that in CIN tissues.",24523865_3,-1,-1,-1,-1,22547,-1,2.6456168e-05,4.1618296e-05,0.99993193
22548,blood,21,22,113,118,"RESULTS: Compared to controls, patients with UCC or CIN had a higher proportion of Tc17 cells in both peripheral blood and cervical tissues, but the level of Tc17 cells in UCC tissues was significantly higher than that in CIN tissues.",24523865_3,0,1,-1,-1,22548,-1,0.0016694127,0.9582194,0.040111173
22549,tissues,24,25,132,139,"RESULTS: Compared to controls, patients with UCC or CIN had a higher proportion of Tc17 cells in both peripheral blood and cervical tissues, but the level of Tc17 cells in UCC tissues was significantly higher than that in CIN tissues.",24523865_3,-1,1,2,-1,22549,-1,0.00025968076,0.91281897,0.08692141
22551,Tc17 cells,30,32,158,168,"RESULTS: Compared to controls, patients with UCC or CIN had a higher proportion of Tc17 cells in both peripheral blood and cervical tissues, but the level of Tc17 cells in UCC tissues was significantly higher than that in CIN tissues.",24523865_3,-1,-1,-1,-1,22551,-1,5.2195686e-05,0.00017176835,0.99977607
22552,tissues,34,35,176,183,"RESULTS: Compared to controls, patients with UCC or CIN had a higher proportion of Tc17 cells in both peripheral blood and cervical tissues, but the level of Tc17 cells in UCC tissues was significantly higher than that in CIN tissues.",24523865_3,-1,1,2,-1,22552,-1,0.0003807659,0.8144233,0.18519595
22553,than that,38,40,209,218,"RESULTS: Compared to controls, patients with UCC or CIN had a higher proportion of Tc17 cells in both peripheral blood and cervical tissues, but the level of Tc17 cells in UCC tissues was significantly higher than that in CIN tissues.",24523865_3,-1,-1,-1,-1,22553,-1,5.837524e-06,0.9999894,4.7683575e-06
22554,tissues,42,43,226,233,"RESULTS: Compared to controls, patients with UCC or CIN had a higher proportion of Tc17 cells in both peripheral blood and cervical tissues, but the level of Tc17 cells in UCC tissues was significantly higher than that in CIN tissues.",24523865_3,-1,1,2,-1,22554,-1,4.695008e-05,0.99603796,0.0039150734
22557,the status,13,15,73,83,"Besides, the increased level of Tc17 in UCC patients was associated with the status of pelvic lymph node metastases and increased microvessel density.",24523865_4,-1,-1,-1,-1,22557,-1,6.6597486e-06,0.9999875,5.8557794e-06
22558,Tc17 cells,7,9,58,68,"Finally, significant correlations of infiltration between Tc17 cells and Th17 cells or Foxp3-expressing T cells were observed in UCC and CIN tissues.",24523865_5,-1,-1,-1,-1,22558,-1,0.00020323567,0.0063223517,0.9934744
22559,Th17 cells,10,12,73,83,"Finally, significant correlations of infiltration between Tc17 cells and Th17 cells or Foxp3-expressing T cells were observed in UCC and CIN tissues.",24523865_5,-1,-1,-1,-1,22559,-1,0.00014362262,0.002832686,0.99702376
22560,Foxp3-expressing T cells,13,16,87,111,"Finally, significant correlations of infiltration between Tc17 cells and Th17 cells or Foxp3-expressing T cells were observed in UCC and CIN tissues.",24523865_5,-1,-1,-1,-1,22560,-1,0.0018012726,0.8715945,0.12660426
22561,tissues,22,23,141,148,"Finally, significant correlations of infiltration between Tc17 cells and Th17 cells or Foxp3-expressing T cells were observed in UCC and CIN tissues.",24523865_5,-1,1,2,-1,22561,-1,1.8053976e-05,0.9996885,0.000293468
22563,that Tc17 cell,5,8,34,48,CONCLUSIONS: This study indicates that Tc17 cell infiltration in cervical cancers is associated with cancer progression accompanied by increased infiltrations of Th17 cells and regulatory T cells as well as promoted tumor vasculogenesis.,24523865_6,-1,-1,-1,-1,22563,-1,0.0032643375,0.42403576,0.5726999
22564,Th17 cells,22,24,162,172,CONCLUSIONS: This study indicates that Tc17 cell infiltration in cervical cancers is associated with cancer progression accompanied by increased infiltrations of Th17 cells and regulatory T cells as well as promoted tumor vasculogenesis.,24523865_6,-1,-1,-1,-1,22564,-1,0.00046734462,0.018118305,0.98141426
22579,to the,3,5,25,31,Our hypothesis according to the common dogma is that there is no HPV16 specific immune response in offspring of the CIN mother as she/he has not started the sexual life yet.,24524328_3,-1,-1,-1,-1,22579,-1,4.744293e-06,0.9999902,4.9770338e-06
22580,that there,8,10,48,58,Our hypothesis according to the common dogma is that there is no HPV16 specific immune response in offspring of the CIN mother as she/he has not started the sexual life yet.,24524328_3,-1,-1,-1,-1,22580,-1,6.340043e-06,0.9999876,6.068838e-06
22584,life,29,30,164,168,Our hypothesis according to the common dogma is that there is no HPV16 specific immune response in offspring of the CIN mother as she/he has not started the sexual life yet.,24524328_3,0,-1,2,-1,22584,-1,2.2323717e-05,0.9999435,3.4209086e-05
22585,peptides,9,10,39,47,"METHODS: We used overlapping 30-35 mer peptides covering the entire HPV16 E2, E6 and E7 protein sequences.",24524328_4,0,-1,2,-1,22585,-1,0.00024446016,0.99967825,7.731459e-05
22587,protein,19,20,88,95,"METHODS: We used overlapping 30-35 mer peptides covering the entire HPV16 E2, E6 and E7 protein sequences.",24524328_4,0,1,-1,-1,22587,-1,6.247757e-05,0.9999087,2.8788552e-05
22590,Foxp3+CD25+,10,17,85,99,"Assays for lymphocyte proliferation capacity, cytokine production and HPV16-specific Foxp3+CD25+CD4+ regulatory T-cells were performed.",24524328_5,-1,-1,-1,-1,22590,-1,0.0007702079,0.998437,0.0007927509
22591,CD4,18,19,100,103,"Assays for lymphocyte proliferation capacity, cytokine production and HPV16-specific Foxp3+CD25+CD4+ regulatory T-cells were performed.",24524328_5,-1,-1,-1,-1,22591,-1,0.00068327785,0.0002179493,0.9990988
22593,T-cell,4,5,38,44,RESULTS: HPV16-specific proliferative T-cell responses were broader in children than in their mothers.,24524328_6,-1,1,2,-1,22593,-1,3.2566364e-05,1.323203e-05,0.9999542
22596,peptide,9,10,50,57,Nine of 10 children had responses against both E2 peptide pools compared to only 4 of the 10 mothers.,24524328_7,0,-1,2,-1,22596,-1,0.55685514,0.15291491,0.29022998
22601,The cytokine,0,2,0,12,"The cytokine levels of IL-2 (p=0.023) and IL-5 (p=0.028) induced by all peptide pools, were also higher among children than their mothers.",24524328_9,-1,-1,-1,-1,22601,-1,0.5268253,0.46900773,0.004166923
22602,peptide,24,25,76,83,"The cytokine levels of IL-2 (p=0.023) and IL-5 (p=0.028) induced by all peptide pools, were also higher among children than their mothers.",24524328_9,0,-1,2,-1,22602,-1,0.0010527393,0.99652404,0.0024231935
22603,than their,32,34,123,133,"The cytokine levels of IL-2 (p=0.023) and IL-5 (p=0.028) induced by all peptide pools, were also higher among children than their mothers.",24524328_9,-1,-1,-1,-1,22603,-1,9.5403775e-06,0.9999809,9.590714e-06
22607,TNF-,20,21,94,99,The children of the mothers with incident CIN3 had significantly higher IFN- (p=0.032) and TNF- (p=0.008) levels than other children.,24524328_10,0,1,-1,-1,22607,-1,0.00051685504,0.999423,6.015373e-05
22612,immunity,15,16,87,95,CONCLUSIONS: Our study is the first to show that also children could have HPV-specific immunity.,24524328_11,0,-1,2,-1,22612,-1,0.9991309,0.00017174364,0.00069737836
22614,that the,3,5,20,28,These data indicate that the children have circulating HPV16-specific memory T-cells which might have been induced by previous HPV16 exposure or ongoing HPV 16 infection.,24524328_12,-1,-1,-1,-1,22614,-1,4.8844913e-06,0.9999914,3.74998e-06
22615,T-cells,10,11,77,84,These data indicate that the children have circulating HPV16-specific memory T-cells which might have been induced by previous HPV16 exposure or ongoing HPV 16 infection.,24524328_12,-1,1,2,-1,22615,-1,1.3846371e-05,1.3563636e-05,0.9999726
22618,the generation,15,17,116,130,Development of effective immune therapies for cancer patients requires better understanding of hurdles that prevent the generation of effective antitumor immune responses.,24532578_0,-1,-1,-1,-1,22618,-1,6.613048e-06,0.99998856,4.8615107e-06
22620,immunity,10,11,80,88,Administration of -galactosylceramide (-GalCer) in animals enhances antitumor immunity via activation of the invariant NKT (iNKT) cells.,24532578_1,0,-1,2,-1,22620,-1,0.99981946,5.4491124e-05,0.00012614358
22630,that the tuberous sclerosis,5,9,24,51,"We report in this study that the tuberous sclerosis 1 (TSC1), a negative regulator of mTOR signaling, plays a crucial role in iNKT cell anergy.",24532578_4,-1,-1,-1,-1,22630,-1,7.2365688e-06,0.99998415,8.663046e-06
22634,Deficiency,0,1,0,10,"Deficiency of TSC1 in iNKT cells results in resistance to -GalCer-induced anergy, manifested by increased expansion of and cytokine production by iNKT cells in response to secondary Ag stimulation.",24532578_5,0,1,-1,-1,22634,-1,8.767248e-06,0.99998534,5.84043e-06
22644,immunity,8,9,63,71,"Moreover, TSC1-deficient iNKT cells display enhanced antitumor immunity in a melanoma lung metastasis model.",24532578_7,0,-1,2,-1,22644,-1,0.9999291,1.7005186e-05,5.3935124e-05
22646,therapy,12,13,78,85,Our data suggest targeting TSC1/2 as a strategy for boosting antitumor immune therapy.,24532578_8,0,1,-1,-1,22646,-1,7.635149e-06,0.99998677,5.6359136e-06
22653,their receptor,37,39,234,248,"Hepatocyte growth factor, produced by stromal and follicular dendritic cells, and present at high concentrations in the sera of patients with chronic lymphocytic leukemia, prolongs the survival of leukemic B cells by interacting with their receptor, c-MET.",24561793_0,-1,-1,-1,-1,22653,-1,0.00090668944,0.99165606,0.0074373027
22657,to the,23,25,151,157,"It is, however, unknown whether hepatocyte growth factor influences microenvironmental cells, such as nurse-like cells, which deliver survival signals to the leukemic clone.",24561793_1,-1,-1,-1,-1,22657,-1,6.4653045e-06,0.99998856,4.979832e-06
22668,hepatocyte growth factor treatment,14,18,109,143,"Indoleamine 2,3-dioxygenase, an enzyme modulating T-cell proliferation and induced on normal monocytes after hepatocyte growth factor treatment, was detected together with interleukin-10 on nurse-like cells, and on freshly-prepared patients' monocytes.",24561793_5,-1,-1,-1,-1,22668,-1,0.99912995,0.00031957583,0.00055049756
22691,T-cell,24,25,161,167,Hepatocyte growth factor may thus have a dual pathophysiological role: directly through enhancement of survival of the leukemic clone and indirectly by favoring T-cell immunosuppression.,24561793_9,-1,1,2,-1,22691,-1,1.945473e-05,6.9321745e-06,0.99997365
22694,T-cell,13,14,75,81,Transforming growth factor beta (TGF-) has an important role in mediating T-cell suppression in B-cell non-Hodgkin lymphoma (NHL).,24569779_0,-1,1,2,-1,22694,-1,1.3146934e-05,8.124541e-06,0.9999788
22702,Tm cells,16,18,87,95,"As reported here, we show that exhaustion is a major mechanism by which TGF- inhibits Tm cells, and TGF- mediated exhaustion is associated with upregulation of CD70.",24569779_2,-1,-1,-1,-1,22702,-1,8.038853e-06,7.3425795e-06,0.9999846
22704,that TGF-,2,4,9,19,We found that TGF- upregulates CD70 expression on effector Tm cells while it preferentially induces Foxp3 expression in naive T cells.,24569779_3,-1,-1,-1,-1,22704,-1,2.0162282e-05,0.9999715,8.337113e-06
22705,Tm cells,9,11,60,68,We found that TGF- upregulates CD70 expression on effector Tm cells while it preferentially induces Foxp3 expression in naive T cells.,24569779_3,-1,-1,-1,-1,22705,-1,9.459765e-06,9.250056e-06,0.9999813
22707,naive T cells,18,21,121,134,We found that TGF- upregulates CD70 expression on effector Tm cells while it preferentially induces Foxp3 expression in naive T cells.,24569779_3,-1,-1,-1,-1,22707,-1,0.0016949567,0.12022792,0.87807715
22712,Tm cells,10,12,63,71,CD70+ T cells account for TGF--induced exhaustion of effector Tm cells.,24569779_5,-1,-1,-1,-1,22712,-1,1.2703037e-05,1.1308685e-05,0.9999759
22714,Tm cells,8,10,63,71,Both TGF--induced and preexisting intratumoral CD70+ effector Tm cells from B-cell NHL have an exhausted phenotype and express higher levels of PD-1 and TIM-3 compared with CD70- T cells.,24569779_6,-1,-1,-1,-1,22714,-1,8.759128e-06,8.3154355e-06,0.99998295
22719,these cells,11,13,90,101,"Signaling transduction, proliferation and cytokine production are profoundly decreased in these cells, and they are highly susceptible to apoptosis.",24569779_7,-1,-1,-1,-1,22719,-1,2.6721289e-05,5.030988e-05,0.999923
22726,Tm cell,5,7,47,54,These findings confirm TGF--mediated effector Tm cell exhaustion as an important mechanism of immune suppression in B-cell NHL.,24569779_9,-1,-1,-1,-1,22726,-1,1.5362277e-05,1.5444039e-05,0.9999691
22732,relevant to the,1,4,11,26,"Biomarkers relevant to the antitumor effects of IL-2 that may be altered by sorafenib including the percentages of natural T-regulatory cells (Tregs), myeloid-derived suppressor cells (MDSC), and STAT5 phosphorylation (pSTAT5) in T cells were evaluated.",24598448_1,-1,-1,-1,-1,22732,-1,6.5625427e-06,0.9999877,5.712227e-06
22735,natural T-regulatory cells,18,21,115,141,"Biomarkers relevant to the antitumor effects of IL-2 that may be altered by sorafenib including the percentages of natural T-regulatory cells (Tregs), myeloid-derived suppressor cells (MDSC), and STAT5 phosphorylation (pSTAT5) in T cells were evaluated.",24598448_1,-1,-1,-1,-1,22735,-1,0.0031918446,0.54817057,0.44863757
22740,that the,2,4,16,24,We hypothesized that the proposed treatment schedule is feasible and safe and may lead to enhanced tumor response.,24598448_2,-1,-1,-1,-1,22740,-1,4.6173095e-06,0.9999919,3.4954203e-06
22749,blood,16,17,82,87,"The percentage of Tregs, MDSC, and pSTAT5 in T cells were evaluated in peripheral blood by flow cytometry.",24598448_6,0,1,-1,-1,22749,-1,0.00813608,0.87317944,0.118684426
22752,toxicity,9,10,59,67,Twelve of the 18 patients were evaluable for dose-limiting toxicity.,24598448_7,0,1,-1,-1,22752,-1,6.5467364e-05,0.9999161,1.8426266e-05
22753,toxicity,2,3,17,25,No dose-limiting toxicity was observed.,24598448_8,0,1,-1,-1,22753,-1,0.0006557581,0.99926597,7.8301964e-05
22754,The treatment-related toxicity,0,3,0,30,The treatment-related toxicity was predictable and did not seem to be additive with this schedule of administration.,24598448_9,-1,-1,-1,-1,22754,-1,1.7510434e-05,0.9999707,1.1782426e-05
22762,T-cell,20,21,109,115,HD IL-2 followed by sorafenib was safe and feasible in patients with MM and RCC and did not adversely affect T-cell signaling through STAT5 in response to IL-2.,24598448_12,-1,1,2,-1,22762,-1,2.6710866e-05,1.03484e-05,0.9999629
22763,through STAT5,22,24,126,139,HD IL-2 followed by sorafenib was safe and feasible in patients with MM and RCC and did not adversely affect T-cell signaling through STAT5 in response to IL-2.,24598448_12,-1,-1,-1,-1,22763,-1,6.372215e-06,0.9999871,6.495064e-06
22767,tissues,15,16,104,111,"Kras(G12D/+);Trp53(R172H/+);Pdx-1-Cre (KPC) mice, which express an activated form of Kras in pancreatic tissues, develop pancreatic intraepithelial neoplasms (PanIN) that progress to pancreatic ductal adenocarcinoma (PDA).",24607504_1,-1,1,2,-1,22767,-1,0.000382846,0.015506854,0.98411036
22772,T-cell immunity,30,32,198,213,We used these mice to study immune suppression in PDA.METHODS: We immunized KPC and Kras(G12D/+);Pdx-1-Cre mice with attenuated intracellular Listeria monocytogenes (which induces CD4(+) and CD8(+) T-cell immunity) engineered to express Kras(G12D) (LM-Kras).,24607504_2,-1,-1,-1,-1,22772,-1,0.00015791123,2.7439055e-05,0.9998147
22780,tissues,8,9,52,59,"Survival times were measured; pancreatic and spleen tissues were collected and analyzed by histologic, flow cytometry, andimmunohistochemical analyses.",24607504_4,-1,1,2,-1,22780,-1,0.0027587393,0.2692996,0.7279417
22782,T-cell,7,8,39,45,"RESULTS: Interferon -mediated, CD8(+) T-cell responses were observed in KPC and Kras(G12D/+);Pdx-1-Cre mice given LM-Kras, but not in unvaccinated mice.",24607504_5,-1,1,2,-1,22782,-1,2.3649616e-05,1.4797588e-05,0.9999616
22793,T cells that,25,28,148,160,"The combination of LM-Kras and Treg cell depletion reduced numbers of Foxp3(+)CD4(+) T cells in pancreatic lymph nodes, increased numbers of CD4(+) T cells that secrete interleukin 17 and interferon , and caused CD11b(+)Gr1(+) cells in the pancreas to acquire an immunostimulatory phenotype.",24607504_8,-1,-1,-1,-1,22793,-1,0.0012650988,0.024921505,0.9738134
22812,tumor cell,27,29,167,177,"In this study, we have analyzed the in vitro immunomodulatory potential of a non-toxic neem leaf glycoprotein (NLGP) in reprogramming Stage III supraglottic laryngeal tumor cell lysate (SLTCL) induced M2 TAMs to their classical anti-tumor shape (M1).",24607970_1,-1,-1,-1,-1,22812,-1,0.00072774396,0.020491235,0.9787811
22813,TAMs to their,35,38,204,217,"In this study, we have analyzed the in vitro immunomodulatory potential of a non-toxic neem leaf glycoprotein (NLGP) in reprogramming Stage III supraglottic laryngeal tumor cell lysate (SLTCL) induced M2 TAMs to their classical anti-tumor shape (M1).",24607970_1,-1,-1,-1,-1,22813,-1,5.2613836e-06,0.99998724,7.5359953e-06
22821,functions,25,26,172,181,"Data generated from this study support that NLGP is effective in preventing the SLTCL induced generation (CD68(+)CD206(+)IL-10(high) to CD68(+)CD206(-)IL-10(low) TAMs) and functions (NO(low) to NO(high), MHC-I(low) to MHC-I(high), CD80(low) to CD80(high)) of pro-tumorous M2 macrophages, which in turn associated with sustained anti-tumor effector functions by promoting cytotoxic T cell activities and suppressing regulatory T cells.",24607970_2,0,1,2,-1,22821,-1,0.0008654195,0.99399227,0.0051423474
22825,to CD80(high,41,43,241,253,"Data generated from this study support that NLGP is effective in preventing the SLTCL induced generation (CD68(+)CD206(+)IL-10(high) to CD68(+)CD206(-)IL-10(low) TAMs) and functions (NO(low) to NO(high), MHC-I(low) to MHC-I(high), CD80(low) to CD80(high)) of pro-tumorous M2 macrophages, which in turn associated with sustained anti-tumor effector functions by promoting cytotoxic T cell activities and suppressing regulatory T cells.",24607970_2,-1,-1,-1,-1,22825,-1,0.0028499987,0.9766987,0.02045129
22827,functions,58,59,348,357,"Data generated from this study support that NLGP is effective in preventing the SLTCL induced generation (CD68(+)CD206(+)IL-10(high) to CD68(+)CD206(-)IL-10(low) TAMs) and functions (NO(low) to NO(high), MHC-I(low) to MHC-I(high), CD80(low) to CD80(high)) of pro-tumorous M2 macrophages, which in turn associated with sustained anti-tumor effector functions by promoting cytotoxic T cell activities and suppressing regulatory T cells.",24607970_2,0,1,2,-1,22827,-1,0.0014344028,0.03021154,0.96835405
22832,targeted STAT3,17,19,111,125,"Furthermore, our data also suggest that NLGP prevents M2 skewness of TAMs by downregulating phosphorylation of targeted STAT3.",24607970_3,-1,-1,-1,-1,22832,-1,6.822285e-06,0.99998856,4.5679944e-06
22835,Tumor-associated lymphocytes,0,2,0,28,Tumor-associated lymphocytes as well as background lymphocytic thyroiditis are frequently mentioned in pathology reports of patients who have undergone surgery for thyroid cancer.,24623740_1,-1,-1,-1,-1,22835,-1,0.003363743,0.73620933,0.2604269
22836,lymphocytic thyroiditis,6,8,51,74,Tumor-associated lymphocytes as well as background lymphocytic thyroiditis are frequently mentioned in pathology reports of patients who have undergone surgery for thyroid cancer.,24623740_1,-1,-1,-1,-1,22836,-1,0.0022185175,0.00029311323,0.9974884
22839,The nature,0,2,0,10,The nature of this lymphocytic reaction is not well understood.,24623740_2,-1,-1,-1,-1,22839,-1,1.0926625e-05,0.9999796,9.491631e-06
22840,this lymphocytic,3,5,14,30,The nature of this lymphocytic reaction is not well understood.,24623740_2,-1,-1,-1,-1,22840,-1,0.012116605,0.17629133,0.8115921
22845,the lymphocytic,2,4,17,32,We characterized the lymphocytic infiltration that accompanies thyroid cancer and compared it with that present in thyroid autoimmunity.,24623740_4,-1,-1,-1,-1,22845,-1,0.007772747,0.26460892,0.72761834
22859,cell type,16,18,85,94,"Although FOXP3(+) regulatory T cells were also present, DN T cells were the dominant cell type, associated with thyroid cancer.",24623740_6,-1,-1,-1,-1,22859,-1,3.636571e-05,0.00013952053,0.9998241
22867,that the,13,15,84,92,"CD25 expression on DN T cells remained unchanged after stimulation, which indicates that the increase in the absolute number of DN T cells in thyroid autoimmunity was at the expense of inactivation of single-positive T cells.",24623740_8,-1,-1,-1,-1,22867,-1,4.262054e-06,0.999992,3.7181921e-06
22878,tumor immunity,16,18,82,96,"We concluded that in the setting of thyroid cancer, DN T cells appear to suppress tumor immunity.",24623740_9,-1,-1,-1,-1,22878,-1,0.026669104,0.9726849,0.00064601505
22885,that thyroid,5,7,34,46,"Together, these findings indicate that thyroid cancer-associated DN T cells might regulate proliferation and effector function of T cells and thereby contribute to tumor tolerance and active avoidance of tumor immunity.",24623740_11,-1,-1,-1,-1,22885,-1,5.191448e-06,0.9999896,5.1625652e-06
22887,function,16,17,118,126,"Together, these findings indicate that thyroid cancer-associated DN T cells might regulate proliferation and effector function of T cells and thereby contribute to tumor tolerance and active avoidance of tumor immunity.",24623740_11,0,1,2,-1,22887,-1,0.008968694,0.93175656,0.059274744
22890,to tumor tolerance,23,26,161,179,"Together, these findings indicate that thyroid cancer-associated DN T cells might regulate proliferation and effector function of T cells and thereby contribute to tumor tolerance and active avoidance of tumor immunity.",24623740_11,-1,-1,-1,-1,22890,-1,5.6083627e-06,0.99998915,5.287964e-06
22891,tumor immunity,30,32,204,218,"Together, these findings indicate that thyroid cancer-associated DN T cells might regulate proliferation and effector function of T cells and thereby contribute to tumor tolerance and active avoidance of tumor immunity.",24623740_11,-1,-1,-1,-1,22891,-1,0.065723635,0.9330508,0.0012255437
22898,tumor-related Treg subsets,2,5,16,42,The complicated tumor-related Treg subsets and their functional mechanisms are not fully addressed yet.,24668348_1,-1,-1,-1,-1,22898,-1,0.001463837,0.93685967,0.06167647
22899,their functional,6,8,47,63,The complicated tumor-related Treg subsets and their functional mechanisms are not fully addressed yet.,24668348_1,-1,-1,-1,-1,22899,-1,6.4502645e-05,0.9999021,3.341758e-05
22900,Treg subset,7,9,54,65,"We have previously identified a novel CD4CD69Foxp3 Treg subset in tumor-bearing mice, which suppresses CD4 T cell response via membrane-bound transforming growth factor beta 1 (mTGF-1) and then promotes tumor progression.",24668348_2,-1,-1,-1,-1,22900,-1,0.0012088914,0.7217826,0.27700856
22909,T cells that,20,23,149,161,"In hepatocellular carcinoma patients, here, we identified tumor-infiltrating human CD4CD69 Tregs which represent ~67.2 % of tumor-infiltrating CD4 T cells that is significantly higher than conventional CD4CD25Foxp3 Tregs.",24668348_3,-1,-1,-1,-1,22909,-1,0.0017724007,0.052114252,0.94611335
22922,tumor tissue,9,11,56,68,"Furthermore, the percentage of these CD4CD69 Tregs in tumor tissue was significantly correlated with tumor progression, which is more pronounced at the late stage of cancer patients.",24668348_6,-1,-1,-1,-1,22922,-1,1.2516447e-05,0.9999536,3.386089e-05
22928,these Tregs,22,24,155,166,"Thus, we have identified a tumor-induced new population of human CD4CD69 Tregs in cancer patients with phenotype of CD25Foxp3mTGF-1CTLA-4PD-1, and these Tregs can suppress antitumor immune response via mTGF-1.",24668348_7,-1,-1,-1,-1,22928,-1,4.9289956e-06,0.9999902,4.793251e-06
22931,Treg subsets,8,10,42,54,"Our results not only enrich the family of Treg subsets, providing new mechanistic insight to tumor-induced immune suppression in human, but also suggest a potential target for cancer immunotherapy.",24668348_8,-1,-1,-1,-1,22931,-1,0.00024463917,0.008545545,0.99120986
22932,to tumor-induced,15,17,90,106,"Our results not only enrich the family of Treg subsets, providing new mechanistic insight to tumor-induced immune suppression in human, but also suggest a potential target for cancer immunotherapy.",24668348_8,-1,-1,-1,-1,22932,-1,1.39762715e-05,0.99997675,9.263185e-06
22935,These Treg cells,0,3,0,16,These Treg cells inhibit T cell response via membrane-bound TGF-.,24668348_10,-1,-1,-1,-1,22935,-1,0.0013421858,0.06788076,0.9307771
22939,these cells,3,5,18,29,The percentage of these cells was significantly correlated with tumor progression.,24668348_11,-1,-1,-1,-1,22939,-1,3.428883e-05,2.0704078e-05,0.9999449
22942,these cells,3,5,18,29,The percentage of these cells was higher than conventional CD4CD25Foxp3 Tregs.,24668348_12,-1,-1,-1,-1,22942,-1,2.7622891e-05,1.7699635e-05,0.9999547
22945,These Treg cells,0,3,0,16,"These Treg cells not only exist in tumor-bearing mice, but also in cancer patients.",24668348_13,-1,-1,-1,-1,22945,-1,0.0015297986,0.0761246,0.92234564
22950,the tumor,12,14,89,98,Increasing evidence suggests that communication between tumor and immune cells can alter the tumor microenvironment in ways that promote tumor development.,24676671_0,-1,-1,-1,-1,22950,-1,4.373254e-06,0.9999912,4.3979594e-06
22956,the immune response,8,11,46,65,"The purpose of this study was to characterize the immune response elicited by TLR-9-activated OSCC cells, to identify the cytokines involved in the signaling pathway and to elucidate the molecular mechanism of this pathway in OSCC cells.",24676671_1,-1,-1,-1,-1,22956,-1,0.57260233,0.42533043,0.0020672495
22960,the cytokines,19,21,118,131,"The purpose of this study was to characterize the immune response elicited by TLR-9-activated OSCC cells, to identify the cytokines involved in the signaling pathway and to elucidate the molecular mechanism of this pathway in OSCC cells.",24676671_1,-1,-1,-1,-1,22960,-1,0.44776914,0.54830086,0.003930041
22967,T-cell immune responses,11,14,58,81,"MTS, flow cytometry and ELISA assay were used to evaluate T-cell immune responses, cancer cell proliferation and pro-inflammatory cytokine secretion, respectively.",24676671_2,-1,-1,-1,-1,22967,-1,0.08837625,0.0010077753,0.910616
22970,analysis,2,3,13,21,"Western blot analysis, EMSA and ChIP assay were employed to detect the activity of the NF-B and AP-1 signaling pathways.",24676671_3,0,1,-1,-1,22970,-1,6.505225e-06,0.9999863,7.2536363e-06
22975,T-cells,6,7,36,43,A marked response was observed when T-cells were co-cultured with supernatants from CpG-ODN-treated OSCC cells.,24676671_4,-1,1,2,-1,22975,-1,1.5897996e-05,8.245931e-06,0.9999759
22981,T-cell,23,24,128,134,This response was characterized by increased CD4+ and CD8+ T-cell proliferation and an increase in IFN- production by the CD4+ T-cell population.,24676671_5,-1,1,2,-1,22981,-1,9.962178e-06,7.870224e-06,0.9999821
22986,to the IL-6,22,25,127,138,Treatment of OSCC cells with CpG-ODN resulted in an increase in IL-6 secretion as well as an increase in AP-1 binding activity to the IL-6 promoter.,24676671_6,-1,-1,-1,-1,22986,-1,0.37052917,0.62594676,0.003524033
22989,T-cell immune response,12,15,89,111,"Moreover, blockage of the TLR-9/AP-1 pathway significantly decreased IL-6 expression and T-cell immune response.",24676671_7,-1,-1,-1,-1,22989,-1,0.29300234,0.0010188033,0.7059788
22990,the TLR-9,4,6,15,24,"In human OSCC, the TLR-9 pathway, when stimulated by CpG-ODNs, promotes a T-cell immune response mediated by AP-1-activated IL-6 secretion.",24676671_8,-1,-1,-1,-1,22990,-1,5.38549e-05,0.9999025,4.3701253e-05
22991,T-cell immune response,15,18,74,96,"In human OSCC, the TLR-9 pathway, when stimulated by CpG-ODNs, promotes a T-cell immune response mediated by AP-1-activated IL-6 secretion.",24676671_8,-1,-1,-1,-1,22991,-1,0.27425396,0.00083183486,0.72491413
22992,AP-1-activated IL-6,20,22,109,128,"In human OSCC, the TLR-9 pathway, when stimulated by CpG-ODNs, promotes a T-cell immune response mediated by AP-1-activated IL-6 secretion.",24676671_8,-1,-1,-1,-1,22992,-1,0.30794913,0.6890342,0.0030166765
22996,tumor cell,16,18,108,118,"Although the complete molecular mechanism has yet to be understood, these findings provide evidence linking tumor cell activities to immune system responses.",24676671_9,-1,-1,-1,-1,22996,-1,4.4341574e-05,0.00014216041,0.9998135
22999,therapeutic targets,8,10,54,73,"In addition, the TLR-9/AP-1/IL-6 pathway provides new therapeutic targets for the prevention and treatment of OSCC.",24676671_10,-1,-1,-1,-1,22999,-1,5.1502366e-06,0.99999034,4.466681e-06
23005,to treat,32,34,208,216,"ETHNOPHARMACOLOGICAL RELEVANCE: The larvae of Musca domestica (Diptera: Muscidae) have been used traditionally for malnutritional stagnation, decubital necrosis, osteomyelitis, ecthyma and lip scald and also to treat coma and gastric cancer in the traditional Chinese medicine.",24690776_0,-1,-1,-1,-1,23005,-1,4.8464362e-06,0.9999901,5.052971e-06
23006,the traditional,39,41,244,259,"ETHNOPHARMACOLOGICAL RELEVANCE: The larvae of Musca domestica (Diptera: Muscidae) have been used traditionally for malnutritional stagnation, decubital necrosis, osteomyelitis, ecthyma and lip scald and also to treat coma and gastric cancer in the traditional Chinese medicine.",24690776_0,-1,-1,-1,-1,23006,-1,5.023451e-06,0.9999901,4.8897423e-06
23007,relation to the traditional,12,16,77,104,Its in vitro antitumor activity and immunomodulatory effect in nave mice in relation to the traditional uses were also reported.,24690776_1,-1,-1,-1,-1,23007,-1,9.730957e-06,0.99998283,7.4682516e-06
23010,mechanism of action,12,15,61,80,"However, the in vivo antitumor effect of this insect and its mechanism of action have not yet been well studied.",24690776_2,0,1,-1,-1,23010,-1,0.000104995444,0.9998349,6.010751e-05
23015,the peptide,14,16,81,92,The objectives of this study were to evaluate the in vivo antitumor potential of the peptide fraction from Musca domestica larvae (MDPF) and to elucidate its immunological mechanisms.,24690776_3,-1,-1,-1,-1,23015,-1,6.822249e-05,0.9998913,4.048866e-05
23039,Th1 transcription factors T-bet,17,21,114,145,MDPF also significantly promoted the production of IFN- and up-regulated the mRNA expression levels of IFN- and Th1 transcription factors T-bet and STAT-4 in splenocytes from the S180-bearing mice.,24690776_7,-1,-1,-1,-1,23039,-1,4.764193e-06,0.99998736,7.832146e-06
23042,Th2 cytokine IL-10,2,5,9,27,"However, Th2 cytokine IL-10 and transcription factors GATA-3 and STAT-6 were not significantly changed both at transcriptional and protein levels following MDPF treatment.",24690776_8,-1,-1,-1,-1,23042,-1,0.9029923,0.09337478,0.0036328642
23043,transcription factors GATA-3,6,9,32,60,"However, Th2 cytokine IL-10 and transcription factors GATA-3 and STAT-6 were not significantly changed both at transcriptional and protein levels following MDPF treatment.",24690776_8,-1,-1,-1,-1,23043,-1,1.1078015e-05,0.99997246,1.6439082e-05
23046,protein,19,20,131,138,"However, Th2 cytokine IL-10 and transcription factors GATA-3 and STAT-6 were not significantly changed both at transcriptional and protein levels following MDPF treatment.",24690776_8,0,1,-1,-1,23046,-1,7.923697e-06,0.99998534,6.7681126e-06
23049,transplantable tumor,8,10,54,74,CONCLUSIONS: MDPF significantly inhibit the growth of transplantable tumor in mice and its in vivo antitumor activity might be achieved by switching-on of Th1-based protective cell-mediated immunity.,24690776_9,-1,-1,-1,-1,23049,-1,5.1216557e-06,0.9999902,4.6262535e-06
23053,peptide,7,8,37,44,"Here, we sought to determine whether peptide vaccines designed harbor both class I as well as class II restricted antigenic motifs could concurrently induce CD4 and CD8 T cell activation against autologous tumor antigens.",24690990_0,0,-1,2,-1,23053,-1,0.00014351525,0.99983346,2.2948823e-05
23056,tumor antigens,33,35,206,220,"Here, we sought to determine whether peptide vaccines designed harbor both class I as well as class II restricted antigenic motifs could concurrently induce CD4 and CD8 T cell activation against autologous tumor antigens.",24690990_0,-1,-1,-1,-1,23056,-1,0.5351707,0.46164644,0.0031828484
23057,tissues to,10,12,70,80,"Based on our prior genome-wide interrogation of human prostate cancer tissues to identify genes over-expressed in cancer and absent in the periphery, we targeted SIM2 as a prototype autologous tumor antigen for these studies.",24690990_1,-1,-1,-1,-1,23057,-1,0.0005061202,0.9835788,0.01591509
23062,tumor antigen,30,32,193,206,"Based on our prior genome-wide interrogation of human prostate cancer tissues to identify genes over-expressed in cancer and absent in the periphery, we targeted SIM2 as a prototype autologous tumor antigen for these studies.",24690990_1,-1,-1,-1,-1,23062,-1,0.81167567,0.18226437,0.0060599525
23065,that the,6,8,41,49,"Using humanized transgenic mice we found that the 9aa HLA-A*0201 epitope, SIM2(237-245), was effective at inducing an antigen specific response against SIM2-expressing prostate cancer cell line, PC3.",24690990_2,-1,-1,-1,-1,23065,-1,4.172079e-06,0.9999918,4.0851496e-06
23068,peptide,4,5,34,41,"Immunization with a multi-epitope peptide harboring both MHC-I and MHC-II restricted epitopes induced an IFN- response in CD8 T cells to the HLA-A*0201-restricted SIM2(237-245) epitope, and an IL-2 response by CD4 T cells to the SIM2(240-254) epitope.",24690990_3,0,-1,2,-1,23068,-1,9.509329e-05,0.9998572,4.7736805e-05
23070,T cells to the,18,22,127,141,"Immunization with a multi-epitope peptide harboring both MHC-I and MHC-II restricted epitopes induced an IFN- response in CD8 T cells to the HLA-A*0201-restricted SIM2(237-245) epitope, and an IL-2 response by CD4 T cells to the SIM2(240-254) epitope.",24690990_3,-1,-1,-1,-1,23070,-1,0.0027854417,0.23592508,0.7612894
23071,T cells to the,35,39,215,229,"Immunization with a multi-epitope peptide harboring both MHC-I and MHC-II restricted epitopes induced an IFN- response in CD8 T cells to the HLA-A*0201-restricted SIM2(237-245) epitope, and an IL-2 response by CD4 T cells to the SIM2(240-254) epitope.",24690990_3,-1,-1,-1,-1,23071,-1,0.002843437,0.21540403,0.7817525
23072,This peptide,0,2,0,12,This peptide was also effective at inducing CD8+ T-cells that responded specifically to SIM2-expressing tumor cells.,24690990_4,-1,-1,-1,-1,23072,-1,2.184628e-05,0.9999682,9.972534e-06
23073,T-cells that,9,11,49,61,This peptide was also effective at inducing CD8+ T-cells that responded specifically to SIM2-expressing tumor cells.,24690990_4,-1,-1,-1,-1,23073,-1,0.0011375606,0.030370727,0.9684917
23075,tumor cells,15,17,104,115,This peptide was also effective at inducing CD8+ T-cells that responded specifically to SIM2-expressing tumor cells.,24690990_4,-1,-1,-1,-1,23075,-1,0.00022601883,0.0062460257,0.99352795
23079,peptide,12,13,69,76,"Collectively, the data presented in this study suggest that a single peptide containing multiple SIM2 epitopes can be used to induce both a CD4 and CD8 T cell response, providing a peptide-based vaccine formulation for potential use in immunotherapy of various cancers.",24690990_5,0,-1,2,-1,23079,-1,0.00020778622,0.99971133,8.083957e-05
23082,peptide-based,33,34,181,194,"Collectively, the data presented in this study suggest that a single peptide containing multiple SIM2 epitopes can be used to induce both a CD4 and CD8 T cell response, providing a peptide-based vaccine formulation for potential use in immunotherapy of various cancers.",24690990_5,0,-1,2,-1,23082,-1,0.00049758574,0.9993438,0.00015858735
23085,antigen-presenting cells,9,11,39,63,"Dendritic cells (DCs), the most potent antigen-presenting cells have been extensively applied in clinical trials for evaluation of antitumor immunity.",24690994_0,-1,-1,-1,-1,23085,-1,0.6983725,0.00025852708,0.30136898
23087,immunity,22,23,141,149,"Dendritic cells (DCs), the most potent antigen-presenting cells have been extensively applied in clinical trials for evaluation of antitumor immunity.",24690994_0,0,-1,2,-1,23087,-1,0.9998105,5.9357026e-05,0.00013013525
23095,generated IL-6 transgene-engineered,17,20,93,128,"In this study, we constructed a recombinant adenoviral vector (AdVIL-6) expressing IL-6, and generated IL-6 transgene-engineered DC vaccine (DCOVA/IL-6) by transfection of murine bone marrow-derived ovalbumin (OVA)-pulsed DCs (DCOVA) with AdVIL-6.",24690994_2,-1,-1,-1,-1,23095,-1,0.0017773628,0.9980781,0.00014451145
23100,immunity,12,13,92,100,We then assessed DCOVA/IL-6-stimulated cytotoxic T-lymphocyte (CTL) responses and antitumor immunity in OVA-specific animal tumor model.,24690994_3,0,-1,2,-1,23100,-1,0.99988496,3.6637226e-05,7.843442e-05
23103,transgene-encoded IL-6,13,15,98,120,"We demonstrate that DCOVA/IL-6 vaccine up-regulates expression of DC maturation markers, secretes transgene-encoded IL-6, and more efficiently stimulates OVA-specific CTL responses and therapeutic immunity against OVA-expressing B16 melanoma BL6-10OVA in vivo than the control DCOVA/Null vaccine.",24690994_4,-1,-1,-1,-1,23103,-1,0.41637138,0.5806757,0.0029529147
23105,therapeutic immunity,24,26,185,205,"We demonstrate that DCOVA/IL-6 vaccine up-regulates expression of DC maturation markers, secretes transgene-encoded IL-6, and more efficiently stimulates OVA-specific CTL responses and therapeutic immunity against OVA-expressing B16 melanoma BL6-10OVA in vivo than the control DCOVA/Null vaccine.",24690994_4,-1,-1,-1,-1,23105,-1,0.045966502,0.9531521,0.00088137144
23106,than the,35,37,260,268,"We demonstrate that DCOVA/IL-6 vaccine up-regulates expression of DC maturation markers, secretes transgene-encoded IL-6, and more efficiently stimulates OVA-specific CTL responses and therapeutic immunity against OVA-expressing B16 melanoma BL6-10OVA in vivo than the control DCOVA/Null vaccine.",24690994_4,-1,-1,-1,-1,23106,-1,5.7202756e-06,0.99999,4.294191e-06
23112,that IL-6,5,7,28,37,"In addition, we demonstrate that IL-6 down-regulates Foxp3-expression of CD4+25+Foxp3+ Tr-cells in vitro.",24690994_6,-1,-1,-1,-1,23112,-1,0.8491624,0.1483094,0.0025282048
23115,Taken together,0,2,0,14,"Taken together, our results demonstrate that AdV-mediated IL-6 transgene-engineered DC vaccine stimulates potent CTL responses and antitumor immunity by counteracting CD4+25+ Tr immunosuppression via IL-6-induced Foxp3 down-regulation.",24690994_7,-1,-1,-1,-1,23115,-1,1.0516955e-05,0.9999796,9.815668e-06
23117,IL-6 transgene-engineered,8,10,58,83,"Taken together, our results demonstrate that AdV-mediated IL-6 transgene-engineered DC vaccine stimulates potent CTL responses and antitumor immunity by counteracting CD4+25+ Tr immunosuppression via IL-6-induced Foxp3 down-regulation.",24690994_7,-1,-1,-1,-1,23117,-1,0.9972373,0.0019744516,0.0007881441
23119,immunity,18,19,141,149,"Taken together, our results demonstrate that AdV-mediated IL-6 transgene-engineered DC vaccine stimulates potent CTL responses and antitumor immunity by counteracting CD4+25+ Tr immunosuppression via IL-6-induced Foxp3 down-regulation.",24690994_7,0,-1,2,-1,23119,-1,0.9998913,3.388359e-05,7.4848984e-05
23121,IL-6-induced Foxp3,28,30,200,218,"Taken together, our results demonstrate that AdV-mediated IL-6 transgene-engineered DC vaccine stimulates potent CTL responses and antitumor immunity by counteracting CD4+25+ Tr immunosuppression via IL-6-induced Foxp3 down-regulation.",24690994_7,-1,-1,-1,-1,23121,-1,0.99456185,0.004742276,0.00069588446
23125,functions,20,21,134,143,"Epstein-Barr virus (EBV) infection has been observed in tumor-infiltrated macrophages, but its infection effects on macrophage immune functions are poorly understood.",24696473_0,0,1,2,-1,23125,-1,0.8627857,0.0022667146,0.13494754
23127,the tumor,8,10,41,50,"Here, we showed that some macrophages in the tumor stroma of nasopharyngeal carcinoma (NPC) tissue expressed the immunosuppressive protein indoleamine 2,3-dioxygenase (IDO) more strongly than did tumor cells.",24696473_1,-1,-1,-1,-1,23127,-1,3.7587672e-06,0.99999166,4.6382806e-06
23129,tissue,17,18,92,98,"Here, we showed that some macrophages in the tumor stroma of nasopharyngeal carcinoma (NPC) tissue expressed the immunosuppressive protein indoleamine 2,3-dioxygenase (IDO) more strongly than did tumor cells.",24696473_1,-1,1,2,-1,23129,-1,3.074134e-05,0.99849415,0.001475141
23131,protein,21,22,131,138,"Here, we showed that some macrophages in the tumor stroma of nasopharyngeal carcinoma (NPC) tissue expressed the immunosuppressive protein indoleamine 2,3-dioxygenase (IDO) more strongly than did tumor cells.",24696473_1,0,1,-1,-1,23131,-1,2.8924542e-05,0.99996257,8.468481e-06
23133,tumor cells,31,33,196,207,"Here, we showed that some macrophages in the tumor stroma of nasopharyngeal carcinoma (NPC) tissue expressed the immunosuppressive protein indoleamine 2,3-dioxygenase (IDO) more strongly than did tumor cells.",24696473_1,-1,-1,-1,-1,23133,-1,0.00014790866,0.0012580404,0.9985941
23134,protein,5,6,28,35,"EBV infection induced mRNA, protein, and enzymatic activity of IDO in human monocyte-derived macrophages (MDMs).",24696473_2,0,1,-1,-1,23134,-1,2.0450507e-05,0.9999653,1.4217244e-05
23137,TNF-,10,11,67,72,"Infection increased the production of tumor necrosis factor alpha (TNF-) and interleukin-6 (IL-6), whereas the neutralizing antibodies against TNF- and IL-6 inhibited IDO induction.",24696473_3,0,1,-1,-1,23137,-1,0.00017493476,0.9997547,7.036541e-05
23141,TNF-,23,24,144,149,"Infection increased the production of tumor necrosis factor alpha (TNF-) and interleukin-6 (IL-6), whereas the neutralizing antibodies against TNF- and IL-6 inhibited IDO induction.",24696473_3,0,1,-1,-1,23141,-1,0.00018294122,0.99974877,6.829302e-05
23144,protein,6,7,51,58,"EBV infection also activated the mitogen-activated protein kinase (MAPK) p38 and NF-B, and the inhibition of these two pathways with SB202190 and SN50 almost abrogated TNF- and IL-6 production and inhibited IDO production.",24696473_4,0,1,-1,-1,23144,-1,6.325442e-05,0.9999101,2.6607506e-05
23146,these two,19,21,110,119,"EBV infection also activated the mitogen-activated protein kinase (MAPK) p38 and NF-B, and the inhibition of these two pathways with SB202190 and SN50 almost abrogated TNF- and IL-6 production and inhibited IDO production.",24696473_4,-1,-1,-1,-1,23146,-1,8.782622e-06,0.99998546,5.8189644e-06
23147,TNF-,28,29,169,174,"EBV infection also activated the mitogen-activated protein kinase (MAPK) p38 and NF-B, and the inhibition of these two pathways with SB202190 and SN50 almost abrogated TNF- and IL-6 production and inhibited IDO production.",24696473_4,0,1,-1,-1,23147,-1,0.000799924,0.9991178,8.2223436e-05
23157,function,48,49,277,285,"Moreover, the activation of IDO in response to EBV infection of MDMs suppressed the proliferation of T cells and impaired the cytotoxic activity of CD8(+) T cells, whereas the inhibition of IDO activity with 1-methyl-l-tryptophan (1-MT) did not affect T cell proliferation and function.",24696473_5,0,1,2,-1,23157,-1,0.00012031822,0.00018186508,0.9996978
23161,TNF--dependent,15,16,103,118,"These findings indicate that EBV-induced IDO expression in MDMs is substantially mediated by IL-6- and TNF--dependent mechanisms via the p38/MAPK and NF-B pathways, suggesting that a possible role of EBV-mediated IDO expression in tumor stroma of NPC may be to create a microenvironment of suppressed T cell immune responses.",24696473_6,0,1,-1,-1,23161,-1,0.00016537753,0.9997974,3.719091e-05
23166,T cell immune responses,46,50,303,326,"These findings indicate that EBV-induced IDO expression in MDMs is substantially mediated by IL-6- and TNF--dependent mechanisms via the p38/MAPK and NF-B pathways, suggesting that a possible role of EBV-mediated IDO expression in tumor stroma of NPC may be to create a microenvironment of suppressed T cell immune responses.",24696473_6,-1,-1,-1,-1,23166,-1,0.2992992,0.0009258463,0.69977486
23171,tumor cells,22,24,120,131,IMPORTANCE: CD8(+) cytotoxic T lymphocytes (CTLs) play an important role in the control of viral infections and destroy tumor cells.,24696473_7,-1,-1,-1,-1,23171,-1,0.0004828361,0.017501548,0.9820157
23172,the tryptophan-catabolizing,2,4,14,41,"Activation of the tryptophan-catabolizing enzyme indoleamine 2,3-dioxygenase (IDO) in cancer tissues facilitates immune escape by the impairment of CTL functions.",24696473_8,-1,-1,-1,-1,23172,-1,0.00020693727,0.99975806,3.4998848e-05
23173,tissues,12,13,93,100,"Activation of the tryptophan-catabolizing enzyme indoleamine 2,3-dioxygenase (IDO) in cancer tissues facilitates immune escape by the impairment of CTL functions.",24696473_8,-1,1,2,-1,23173,-1,0.0007642738,0.60730374,0.39193192
23175,CTL functions,20,22,148,161,"Activation of the tryptophan-catabolizing enzyme indoleamine 2,3-dioxygenase (IDO) in cancer tissues facilitates immune escape by the impairment of CTL functions.",24696473_8,-1,-1,-1,-1,23175,-1,2.3103597e-05,7.725906e-06,0.9999691
23176,the tumor,8,10,51,60,"IDO expression was observed in some macrophages of the tumor stroma of nasopharyngeal carcinoma (NPC) tissue, and IDO could be induced in Epstein-Barr virus (EBV)-infected human monocyte-derived macrophages (MDMs).",24696473_9,-1,-1,-1,-1,23176,-1,3.8922485e-06,0.9999908,5.268553e-06
23178,tissue,17,18,102,108,"IDO expression was observed in some macrophages of the tumor stroma of nasopharyngeal carcinoma (NPC) tissue, and IDO could be induced in Epstein-Barr virus (EBV)-infected human monocyte-derived macrophages (MDMs).",24696473_9,-1,1,2,-1,23178,-1,0.00018522904,0.9276468,0.07216794
23183,TNF--dependent,13,14,83,98,"Instead, EBV-induced IDO expression in MDMs is substantially mediated by IL-6- and TNF--dependent mechanisms via the p38/MAPK and NF-B pathways, which suppressed the proliferation of T cells and impaired the cytotoxic activity of CD8(+) T cells.",24696473_11,0,1,-1,-1,23183,-1,0.00023025778,0.99972457,4.5117486e-05
23198,The zinc-finger protein,0,3,0,23,"The zinc-finger protein A20, a negative regulator of the nuclear factor (NF)-B pathway, was found to play a crucial role in controlling the maturation and function of human monocyte-derived DCs.",24713261_1,-1,-1,-1,-1,23198,-1,8.14999e-06,0.9999839,7.9383e-06
23199,the nuclear factor,9,12,53,71,"The zinc-finger protein A20, a negative regulator of the nuclear factor (NF)-B pathway, was found to play a crucial role in controlling the maturation and function of human monocyte-derived DCs.",24713261_1,-1,-1,-1,-1,23199,-1,4.489888e-06,0.9999902,5.2861947e-06
23200,to play,17,19,99,106,"The zinc-finger protein A20, a negative regulator of the nuclear factor (NF)-B pathway, was found to play a crucial role in controlling the maturation and function of human monocyte-derived DCs.",24713261_1,-1,-1,-1,-1,23200,-1,4.5073384e-06,0.9999906,4.9277946e-06
23202,function,27,28,156,164,"The zinc-finger protein A20, a negative regulator of the nuclear factor (NF)-B pathway, was found to play a crucial role in controlling the maturation and function of human monocyte-derived DCs.",24713261_1,0,1,2,-1,23202,-1,2.8076924e-05,0.99992335,4.8536218e-05
23213,receptor-interacting protein,2,4,14,42,"Additionally, receptor-interacting protein (RIP) and the NF-Bp65 pathway were elevated in AML-DCs when A20 was reduced.",24713261_6,-1,-1,-1,-1,23213,-1,0.00033004856,0.9991934,0.00047656437
23217,through the,30,32,211,222,"Hence, this study identified A20 as a negative regulator for controlling AML-DC maturation and immunostimulatory potency, as A20 down-regulation resulted in AML-DCs with enhanced autologous CTLs immune capacity through the NF-B pathway.",24713261_7,-1,-1,-1,-1,23217,-1,4.9992623e-06,0.99999094,4.077051e-06
23227,function,8,9,47,55,"However, cytokine production may saturate as a function of antigen input, or be dominated by the precursor frequency of antigen-specific T cells.",24719192_2,0,1,2,-1,23227,-1,0.00038547922,0.9994562,0.00015827731
23229,the precursor,17,19,93,106,"However, cytokine production may saturate as a function of antigen input, or be dominated by the precursor frequency of antigen-specific T cells.",24719192_2,-1,-1,-1,-1,23229,-1,0.0037485245,0.71314937,0.28310204
23230,antigen-specific T cells,21,24,120,144,"However, cytokine production may saturate as a function of antigen input, or be dominated by the precursor frequency of antigen-specific T cells.",24719192_2,-1,-1,-1,-1,23230,-1,0.7165846,0.0004989642,0.28291646
23231,that T cells,4,7,23,35,"Surprisingly, we found that T cells scale their collective output of IL-2 to total antigen input over a large dynamic range, independently of population size.",24719192_3,-1,-1,-1,-1,23231,-1,0.0024464394,0.18290614,0.8146474
23233,to total antigen,13,16,74,90,"Surprisingly, we found that T cells scale their collective output of IL-2 to total antigen input over a large dynamic range, independently of population size.",24719192_3,-1,-1,-1,-1,23233,-1,0.20208916,0.79310125,0.0048095784
23235,that this,9,11,77,86,"Through experimental quantitation and computational modeling, we demonstrate that this scaling is enforced by an inhibitory cross-talk between antigen and IL-2 signaling, and a nonlinear acceleration of IL-2 secretion per cell.",24719192_4,-1,-1,-1,-1,23235,-1,4.8985216e-06,0.99999106,3.99206e-06
23245,immunity,20,21,111,119,"Newly identified nuocytes or group 2 innate lymphoid cells (ILC2s) play an important role in Th2 cell mediated immunity such as protective immune responses to helminth parasites, allergic asthma, and chronic rhinosinusitis.",24741632_0,0,-1,2,-1,23245,-1,0.934305,0.00034156293,0.06535342
23246,immune responses to,24,27,139,158,"Newly identified nuocytes or group 2 innate lymphoid cells (ILC2s) play an important role in Th2 cell mediated immunity such as protective immune responses to helminth parasites, allergic asthma, and chronic rhinosinusitis.",24741632_0,-1,-1,-1,-1,23246,-1,0.9973149,0.0024163383,0.00026885493
23249,that there,4,6,25,35,Our previous study found that there was a predominant Th2 phenotype in patients with gastric cancer.,24741632_2,-1,-1,-1,-1,23249,-1,4.6369714e-06,0.99999154,3.8839416e-06
23253,related genes,6,8,25,38,"In this study, the ILC2s related genes or molecules in PBMC from patients with gastric cancer were measured, and the potential correlation between them was analyzed.",24741632_3,-1,-1,-1,-1,23253,-1,4.4139597e-05,0.9999057,5.008698e-05
23262,related factors,54,56,275,290,"The expression levels of ROR, GATA3, T1/ST2, IL-17RB, CRTH2, IL-33, IL-5, and IL-4 mRNA were significantly increased in patients, but no significant changes were found in ICOS, CD45, and IL-13 expression, and there was a positive correlation between ROR or IL-13 and other related factors, such as ICOS and CD45.",24741632_4,-1,-1,-1,-1,23262,-1,6.52546e-05,0.99991107,2.3703786e-05
23266,that there,3,5,24,34,These results suggested that there are polarized ILC2s in gastric cancer patients which might contribute to immunosuppressive microenvironment and closely related to the upregulation of MDSCs and M2 macrophages.,24741632_7,-1,-1,-1,-1,23266,-1,4.4059825e-06,0.9999913,4.310375e-06
23268,related to the,20,23,155,169,These results suggested that there are polarized ILC2s in gastric cancer patients which might contribute to immunosuppressive microenvironment and closely related to the upregulation of MDSCs and M2 macrophages.,24741632_7,-1,-1,-1,-1,23268,-1,7.0532624e-06,0.9999877,5.2635546e-06
23271,through their,13,15,74,87,Foxp3(+) Tregs have been known as a major regulator of immune homeostasis through their immunosuppressive function.,24744433_0,-1,-1,-1,-1,23271,-1,5.6059857e-06,0.9999896,4.785045e-06
23272,function,16,17,106,114,Foxp3(+) Tregs have been known as a major regulator of immune homeostasis through their immunosuppressive function.,24744433_0,0,1,2,-1,23272,-1,2.578855e-05,0.9999527,2.152346e-05
23274,T cell subset that,6,10,25,43,Th17 lineage is a CD4(+) T cell subset that exerts its function by secreting proinflammatory cytokines and protecting host against microbial infections.,24744433_1,-1,-1,-1,-1,23274,-1,0.0010660501,0.020979565,0.9779544
23275,function,12,13,55,63,Th17 lineage is a CD4(+) T cell subset that exerts its function by secreting proinflammatory cytokines and protecting host against microbial infections.,24744433_1,0,1,2,-1,23275,-1,3.9852213e-05,0.99990976,5.0348717e-05
23280,Th17 cells plays,8,11,45,61,The altered ratio between Foxp3(+) Tregs and Th17 cells plays an important role in the pathogenesis of immune-related diseases.,24744433_2,-1,-1,-1,-1,23280,-1,0.0004474394,0.91356325,0.085989356
23282,that Tregs,7,9,48,58,"Recent mice and human studies have demonstrated that Tregs can be reprogrammed into a novel population, IL-17(+)Foxp3(+) T cells, phenotypically and functionally resembling Th17 cells under the complicated cytokine stimulation.",24744433_3,-1,-1,-1,-1,23282,-1,4.9778255e-06,0.99999094,4.063713e-06
23285,functionally,24,25,149,161,"Recent mice and human studies have demonstrated that Tregs can be reprogrammed into a novel population, IL-17(+)Foxp3(+) T cells, phenotypically and functionally resembling Th17 cells under the complicated cytokine stimulation.",24744433_3,0,1,2,-1,23285,-1,4.0600764e-05,0.99993825,2.1134187e-05
23286,Th17 cells,26,28,173,183,"Recent mice and human studies have demonstrated that Tregs can be reprogrammed into a novel population, IL-17(+)Foxp3(+) T cells, phenotypically and functionally resembling Th17 cells under the complicated cytokine stimulation.",24744433_3,-1,-1,-1,-1,23286,-1,0.00036557642,0.011199742,0.98843455
23292,therapy targeting Tregs,13,16,82,105,The identification of IL-17(+)Foxp3(+) T cells may provide a new understanding of therapy targeting Tregs and Th17 cells in autoimmune diseases and cancer.,24744433_4,-1,-1,-1,-1,23292,-1,4.2751008e-06,0.9999919,3.8419394e-06
23293,Th17 cells,17,19,110,120,The identification of IL-17(+)Foxp3(+) T cells may provide a new understanding of therapy targeting Tregs and Th17 cells in autoimmune diseases and cancer.,24744433_4,-1,-1,-1,-1,23293,-1,0.00058457704,0.041936938,0.9574784
23295,the pleiotropic functions,16,19,103,128,"Here, we highlight significant data regarding the phenotype profile, origination, differentiation, and the pleiotropic functions of IL-17(+)Foxp3(+) T cells and the reciprocal relationships of these cells to Tregs and Th17 cells.",24744433_5,-1,-1,-1,-1,23295,-1,1.4221316e-05,0.9999732,1.2559535e-05
23300,these cells to Tregs,29,33,193,213,"Here, we highlight significant data regarding the phenotype profile, origination, differentiation, and the pleiotropic functions of IL-17(+)Foxp3(+) T cells and the reciprocal relationships of these cells to Tregs and Th17 cells.",24744433_5,-1,-1,-1,-1,23300,-1,0.0034084958,0.7108734,0.28571802
23301,Th17 cells,34,36,218,228,"Here, we highlight significant data regarding the phenotype profile, origination, differentiation, and the pleiotropic functions of IL-17(+)Foxp3(+) T cells and the reciprocal relationships of these cells to Tregs and Th17 cells.",24744433_5,-1,-1,-1,-1,23301,-1,0.00015475912,0.003766785,0.99607855
23306,therapy,16,17,103,110,"Furthermore, the role of IL-17(+)Foxp3(+) T cells in tumorigenesis and clinical implications in cancer therapy are discussed in this review.",24744433_6,0,1,-1,-1,23306,-1,5.0547596e-06,0.9999901,4.8937213e-06
23311,to the generation,15,18,104,121,Thymic central tolerance is a critical process that prevents autoimmunity but also presents a challenge to the generation of anti-tumor immune responses.,24752296_0,-1,-1,-1,-1,23311,-1,1.141145e-05,0.9999813,7.284949e-06
23316,tissue-specific antigens,17,19,112,136,Medullary thymic epithelial cells (mTECs) eliminate self-reactive T cells by displaying a diverse repertoire of tissue-specific antigens (TSAs) that are also shared by tumors.,24752296_1,-1,-1,-1,-1,23316,-1,0.6196219,0.37470827,0.005669825
23321,the generation,10,12,77,91,"Therefore, while protecting against autoimmunity, mTECs simultaneously limit the generation of tumor-specific effector T cells by expressing tumor self-antigens.",24752296_2,-1,-1,-1,-1,23321,-1,7.722315e-06,0.9999869,5.333585e-06
23330,therapies to,2,4,6,18,"Thus, therapies to deplete Aire-expressing mTECs represent an attractive strategy to increase the pool of tumor-specific effector T cells.",24752296_4,-1,-1,-1,-1,23330,-1,4.129063e-06,0.9999924,3.4960724e-06
23336,the TNF,4,6,27,34,Recent work has implicated the TNF family members RANK and RANK-Ligand (RANKL) in the development of Aire-expressing mTECs.,24752296_5,-1,-1,-1,-1,23336,-1,0.0026610133,0.99714226,0.0001966877
23343,the thymus to,16,19,100,113,We show that in vivo RANKL blockade selectively and transiently depletes Aire and TSA expression in the thymus to create a window of defective negative selection.,24752296_6,-1,-1,-1,-1,23343,-1,6.4788833e-06,0.9999876,5.8934056e-06
23348,these tumor-specific,19,21,130,150,"Furthermore, we demonstrate that RANKL blockade can rescue melanoma-specific T cells from thymic deletion and that persistence of these tumor-specific effector T cells promoted increased host survival in response to tumor challenge.",24752296_7,-1,-1,-1,-1,23348,-1,1.3934118e-05,0.9999784,7.619061e-06
23350,to tumor,30,32,213,221,"Furthermore, we demonstrate that RANKL blockade can rescue melanoma-specific T cells from thymic deletion and that persistence of these tumor-specific effector T cells promoted increased host survival in response to tumor challenge.",24752296_7,-1,-1,-1,-1,23350,-1,5.775153e-06,0.9999896,4.605065e-06
23353,tolerance through,6,8,47,64,These results indicate that modulating central tolerance through RANKL can alter thymic output and potentially provide therapeutic benefit by enhancing anti-tumor immunity.,24752296_8,-1,-1,-1,-1,23353,-1,6.1369656e-06,0.99998903,4.832926e-06
23356,immunity,21,22,163,171,These results indicate that modulating central tolerance through RANKL can alter thymic output and potentially provide therapeutic benefit by enhancing anti-tumor immunity.,24752296_8,0,-1,2,-1,23356,-1,0.99987173,4.5617737e-05,8.260588e-05
23366,MCF7 cells,6,8,29,39,"Using a mouse tumor model of MCF7 cells, we showed that CPT strongly inhibited MCF7 cell growth in vivo with polarization of immune reactions toward Th1-type responses, stimulation of naive CD4+ T cell proliferation, and also increased IFN- and perforin production of CD4+ T cells in response to tumor-activated splenocytes.",24761844_2,-1,-1,-1,-1,23366,-1,0.45554674,0.001404525,0.5430488
23368,MCF7 cell,15,17,79,88,"Using a mouse tumor model of MCF7 cells, we showed that CPT strongly inhibited MCF7 cell growth in vivo with polarization of immune reactions toward Th1-type responses, stimulation of naive CD4+ T cell proliferation, and also increased IFN- and perforin production of CD4+ T cells in response to tumor-activated splenocytes.",24761844_2,-1,-1,-1,-1,23368,-1,0.44545573,0.0017507424,0.5527936
23369,toward Th1-type,25,27,142,157,"Using a mouse tumor model of MCF7 cells, we showed that CPT strongly inhibited MCF7 cell growth in vivo with polarization of immune reactions toward Th1-type responses, stimulation of naive CD4+ T cell proliferation, and also increased IFN- and perforin production of CD4+ T cells in response to tumor-activated splenocytes.",24761844_2,-1,-1,-1,-1,23369,-1,6.5217064e-06,0.9999856,7.958317e-06
23370,naive CD4+ T cell,31,36,184,201,"Using a mouse tumor model of MCF7 cells, we showed that CPT strongly inhibited MCF7 cell growth in vivo with polarization of immune reactions toward Th1-type responses, stimulation of naive CD4+ T cell proliferation, and also increased IFN- and perforin production of CD4+ T cells in response to tumor-activated splenocytes.",24761844_2,-1,-1,-1,-1,23370,-1,0.003984972,0.108517766,0.88749725
23373,to tumor-activated,52,54,294,312,"Using a mouse tumor model of MCF7 cells, we showed that CPT strongly inhibited MCF7 cell growth in vivo with polarization of immune reactions toward Th1-type responses, stimulation of naive CD4+ T cell proliferation, and also increased IFN- and perforin production of CD4+ T cells in response to tumor-activated splenocytes.",24761844_2,-1,-1,-1,-1,23373,-1,0.0007715396,0.99910045,0.00012804952
23374,that the,4,6,27,35,"Furthermore, data revealed that the cytotoxic activity of CD4+ T cells induced by CPT was markedly abrogated by concanamycin A(CMA), a perforin inhibitor, but not IFN- Ab.",24761844_3,-1,-1,-1,-1,23374,-1,5.1600387e-06,0.9999912,3.6980218e-06
23388,T cells to,17,20,106,116,"Thus, our results suggested that CPT mainly inhibited breast tumor growth through inducing cytotoxic CD4+ T cells to secrete perforin.",24761844_5,-1,-1,-1,-1,23388,-1,0.00077138277,0.013542633,0.9856859
23394,tumor therapy,11,13,69,82,"These findings suggest a novel potential therapeutic role for CPT in tumor therapy, and demonstrate that CPT performs its antitumor functions through cytotoxic CD4+ T cells.",24761844_7,-1,-1,-1,-1,23394,-1,4.1711114e-06,0.99999154,4.3473615e-06
23396,functions through,21,23,132,149,"These findings suggest a novel potential therapeutic role for CPT in tumor therapy, and demonstrate that CPT performs its antitumor functions through cytotoxic CD4+ T cells.",24761844_7,-1,-1,-1,-1,23396,-1,7.6874e-05,0.9998684,5.470149e-05
23400,factors,18,19,89,96,"AIMS: Dysfunction of the host immune system in cancer patients can be due to a number of factors, including lymphocyte apoptosis.",24761872_0,0,1,-1,-1,23400,-1,0.00024683014,0.9997255,2.7683964e-05
23402,that Foxp3+T,3,5,23,35,Several studies showed that Foxp3+T cells take part in inducing this process by expressing FasL in tumor patients.,24761872_1,-1,-1,-1,-1,23402,-1,0.0007826898,0.99249685,0.006720432
23403,Foxp3+T cells take,4,7,28,46,Several studies showed that Foxp3+T cells take part in inducing this process by expressing FasL in tumor patients.,24761872_1,-1,-1,-1,-1,23403,-1,6.65037e-05,0.9997986,0.00013491031
23406,the relationship,2,4,9,25,"However, the relationship between apoptosis, CD8+T cells and Foxp3+T cells in HCC patients is still unclear.",24761872_2,-1,-1,-1,-1,23406,-1,8.977311e-06,0.99998605,5.008529e-06
23408,Foxp3+T cells,10,12,61,74,"However, the relationship between apoptosis, CD8+T cells and Foxp3+T cells in HCC patients is still unclear.",24761872_2,-1,-1,-1,-1,23408,-1,0.0022670287,0.7507834,0.24694958
23413,Foxp3+T cells,19,21,136,149,The present study was designed to investigate the correlation between apoptosis levels and Fas/FasL expression in CD8+T lymphocytes and Foxp3+T cells in patients with HCC.METHODS: CD8+T cells and CD3+Foxp3+T cells were tested from peripheral blood of HCC patients and normal controls and subjected to multicolor flow cytometry.,24761872_3,-1,-1,-1,-1,23413,-1,0.0023741752,0.7850939,0.21253191
23417,blood,35,36,242,247,The present study was designed to investigate the correlation between apoptosis levels and Fas/FasL expression in CD8+T lymphocytes and Foxp3+T cells in patients with HCC.METHODS: CD8+T cells and CD3+Foxp3+T cells were tested from peripheral blood of HCC patients and normal controls and subjected to multicolor flow cytometry.,24761872_3,0,1,-1,-1,23417,-1,0.0017024549,0.9944349,0.0038626657
23421,receptor,13,14,64,72,The expression of an apoptosis marker (annexin V) and the death receptor Fas in CD8+T cells and FasL in CD3+Foxp3+T cells were evaluated.,24761872_4,0,1,2,-1,23421,-1,0.00787897,0.00028874632,0.99183226
23425,The relationship,0,2,0,16,"The relationship between apoptosis and Fas expression, as well as FasL expression in CD3+Foxp3+T cells was then evaluated.",24761872_6,-1,-1,-1,-1,23425,-1,6.8240124e-06,0.9999881,5.0518433e-06
23436,CD3+Foxp3+T cells,6,8,46,63,Serum TGF-1 levels correlated inversely with CD3+Foxp3+T cells.,24761872_8,-1,-1,-1,-1,23436,-1,8.489964e-05,3.8192054e-05,0.999877
23445,to the,9,11,50,56,BACKGROUND: T regulatory cells (Tregs) contribute to the progression of head and neck squamous cell carcinoma (HNSCC) by suppressing antitumor immunity.,24761979_0,-1,-1,-1,-1,23445,-1,4.1729986e-06,0.9999908,4.968349e-06
23447,immunity,25,26,143,151,BACKGROUND: T regulatory cells (Tregs) contribute to the progression of head and neck squamous cell carcinoma (HNSCC) by suppressing antitumor immunity.,24761979_0,0,-1,2,-1,23447,-1,0.99987686,3.9833765e-05,8.3294064e-05
23448,the functional,6,8,35,49,"However, little is known regarding the functional heterogeneity of Tregs in HNSCC patients.",24761979_1,-1,-1,-1,-1,23448,-1,5.587621e-05,0.99993026,1.3876559e-05
23451,three Treg subsets,10,13,59,77,"METHODS: Using multicolor flow cytometry, the frequency of three Treg subsets, separated on the basis of CD45RA and Foxp3, from the peripheral circulation of newly-presenting HNSCC patients (19 oral cavity squamous cell carcinoma, 20 hypopharyngeal squamous cell carcinoma, 18 nasopharyngeal squamous cell carcinoma, 19 oropharyngeal squamous cell carcinoma, and 36 laryngeal squamous cell carcinoma) were assessed with regard to 31 healthy donors and clinicopathological features.",24761979_2,-1,-1,-1,-1,23451,-1,0.0022183901,0.4140077,0.583774
23462,the functional,2,4,10,24,"Moreover, the functional capacity of each Treg subsets was evaluated based on CD45RA and CD25 expression.",24761979_3,-1,-1,-1,-1,23462,-1,0.00075548264,0.99870574,0.0005387834
23463,Treg subsets,7,9,42,54,"Moreover, the functional capacity of each Treg subsets was evaluated based on CD45RA and CD25 expression.",24761979_3,-1,-1,-1,-1,23463,-1,0.000502172,0.038772203,0.96072555
23472,three subsets,4,6,28,41,"Further dividing Tregs into three subsets based on Foxp3 and CD45RA expression revealed that the frequency of CD45RA-Foxp3high Tregs and CD45RA-Foxp3lowCD4+ T cells in patients with HNSCC developing from different subsites was higher than in healthy donors (P <0.0001, P <0.0001), whereas the frequency of CD45RA+Foxp3low Tregs was lower than in healthy donors (P <0.0001).",24761979_6,-1,-1,-1,-1,23472,-1,0.0019465378,0.1217375,0.876316
23474,that the,13,15,88,96,"Further dividing Tregs into three subsets based on Foxp3 and CD45RA expression revealed that the frequency of CD45RA-Foxp3high Tregs and CD45RA-Foxp3lowCD4+ T cells in patients with HNSCC developing from different subsites was higher than in healthy donors (P <0.0001, P <0.0001), whereas the frequency of CD45RA+Foxp3low Tregs was lower than in healthy donors (P <0.0001).",24761979_6,-1,-1,-1,-1,23474,-1,4.3821833e-06,0.9999919,3.6774575e-06
23481,Functionally,0,1,0,12,Functionally study revealed that CD45RA-CD25+++ Tregs significantly inhibit the proliferation of CD4+CD25- T cells (P <0.001) and secrete lower levels of cytokines (P <0.01) compared with CD45RA-CD25++CD4+ T cells.,24761979_7,0,1,2,-1,23481,-1,1.1870879e-05,0.9999807,7.461074e-06
23491,nodal status,19,21,108,120,"Importantly, the frequency of CD45RA-Foxp3high Tregs positively correlate with tumor stage (P <0.0001) and nodal status (P <0.0001).CONCLUSIONS: CD45RA-Foxp3high Tregs increase in the peripheral circulation of HNSCC patients, and correlate with tumor stage and nodal status; suggesting a role in tumor progression which may be manipulated by future immunotherapy.",24761979_8,-1,-1,-1,-1,23491,-1,0.97462875,0.014398791,0.010972455
23495,nodal status,44,46,263,275,"Importantly, the frequency of CD45RA-Foxp3high Tregs positively correlate with tumor stage (P <0.0001) and nodal status (P <0.0001).CONCLUSIONS: CD45RA-Foxp3high Tregs increase in the peripheral circulation of HNSCC patients, and correlate with tumor stage and nodal status; suggesting a role in tumor progression which may be manipulated by future immunotherapy.",24761979_8,-1,-1,-1,-1,23495,-1,0.988172,0.0047458312,0.0070821876
23497,The transcription factor T-bet,0,4,0,30,The transcription factor T-bet controls the Th1 genetic program in T cells for effective antitumor responses.,24778280_0,-1,-1,-1,-1,23497,-1,5.7470684e-06,0.9999889,5.379459e-06
23498,the Th1 genetic,5,8,40,55,The transcription factor T-bet controls the Th1 genetic program in T cells for effective antitumor responses.,24778280_0,-1,-1,-1,-1,23498,-1,4.536234e-06,0.99999034,5.0822014e-06
23500,factors that,15,17,103,115,"Anti-CTLA-4 immunotherapy elicits dramatic antitumor responses in mice and in human patients; however, factors that regulate T-bet expression during an antitumor response mediated by anti-CTLA-4 remain to be elucidated.",24778280_1,-1,-1,-1,-1,23500,-1,4.3888926e-06,0.99999213,3.4528541e-06
23505,that treatment,6,8,28,42,We were the first to report that treatment with anti-CTLA-4 led to an increase in the frequency of T cells expressing inducible costimulator (ICOS).,24778280_2,-1,-1,-1,-1,23505,-1,5.1319407e-06,0.9999908,4.0219957e-06
23513,the Th1 cytokine IFN-,24,28,124,146,"In both treated patients and mice, our data revealed that CD4(+)ICOS(hi) T cells can act as effector T cells, which produce the Th1 cytokine IFN-.",24778280_3,-1,-1,-1,-1,23513,-1,0.7229944,0.2726339,0.004371716
23514,analysis that,7,9,40,53,We also showed in a small retrospective analysis that an increased frequency of CD4(+)ICOS(hi) T cells correlated with better clinical outcome and the absence of ICOS or its ligand (ICOSL) in mouse models led to impaired tumor rejection.,24778280_4,-1,-1,-1,-1,23514,-1,4.3177224e-06,0.9999912,4.4955655e-06
23533,therapy,19,20,129,136,We found that ICOS-mediated PI3K signaling is required for T-bet expression during an antitumor response elicited by anti-CTLA-4 therapy.,24778280_9,0,1,-1,-1,23533,-1,4.7186845e-06,0.9999908,4.4819762e-06
23534,the regulation,6,8,34,48,Our data provide new insight into the regulation of T-bet expression and suggest that ICOS can be targeted to improve Th1 antitumor responses.,24778280_10,-1,-1,-1,-1,23534,-1,4.2421593e-06,0.9999919,3.8089988e-06
23537,targeted to,17,19,98,109,Our data provide new insight into the regulation of T-bet expression and suggest that ICOS can be targeted to improve Th1 antitumor responses.,24778280_10,-1,-1,-1,-1,23537,-1,4.3219948e-06,0.99999225,3.483475e-06
23541,the TCR,8,10,42,49,"Naive CD4(+) T cells require signals from the TCR and CD28 to produce IL-2, expand, and differentiate.",24778448_0,-1,-1,-1,-1,23541,-1,2.1479778e-05,0.99994004,3.843284e-05
23542,CD28 to,11,13,54,61,"Naive CD4(+) T cells require signals from the TCR and CD28 to produce IL-2, expand, and differentiate.",24778448_0,-1,-1,-1,-1,23542,-1,0.0029917052,0.026562652,0.9704456
23548,cell types to,26,29,150,163,"However, these same signals are not sufficient to induce autocrine IL-2 production by naive CD8(+) T cells, which require cytokines provided by other cell types to drive their differentiation.",24778448_1,-1,-1,-1,-1,23548,-1,0.005579677,0.11307438,0.8813459
23568,IFN--producing CTLs,24,26,160,180,"Naive murine CD8 T cells haplo-insufficient for Ikzf1 failed to upregulate Ikaros, produced autocrine IL-2, and differentiated in an IL-2-dependent manner into IFN--producing CTLs in response to TCR/CD28 stimulation alone.",24778448_5,-1,-1,-1,-1,23568,-1,0.9612036,0.00019623908,0.03860017
23574,cells to,31,33,203,211,"Furthermore, Ikzf1 haplo-insufficient CD8(+) T cells were more effective at controlling Listeria infection and B16 melanoma growth in vivo, and they could provide help to neighboring, non-IL-2-producing cells to differentiate into IFN--producing effectors.",24778448_6,-1,-1,-1,-1,23574,-1,0.0029227708,0.25809693,0.7389803
23577,that naive,10,12,67,77,"Therefore, by repressing autocrine IL-2 production, Ikaros ensures that naive CD8(+) T cells remain dependent on licensing by APCs and CD4(+) T cells, and it may therefore act as a cell-intrinsic safeguard against inappropriate CTL differentiation and immunopathology.",24778448_7,-1,-1,-1,-1,23577,-1,6.2310446e-06,0.9999896,4.1627186e-06
23583,the tumor,6,8,39,48,We describe a new mechanism regulating the tumor endothelial barrier and T cell infiltration into tumors.,24793239_0,-1,-1,-1,-1,23583,-1,4.434705e-06,0.9999908,4.769847e-06
23589,these tumors,1,3,3,15,"In these tumors, FasL expression was associated with scarce CD8(+) infiltration and a predominance of FoxP3(+) T regulatory (Treg) cells.",24793239_2,-1,-1,-1,-1,23589,-1,3.670331e-06,0.9999919,4.4161147e-06
23612,T cells that,20,23,123,135,Pharmacologic inhibition of VEGF and PGE2 produced a marked increase in the influx of tumor-rejecting CD8(+) over FoxP3(+) T cells that was dependent on attenuation of FasL expression and led to CD8-dependent tumor growth suppression.,24793239_5,-1,-1,-1,-1,23612,-1,0.002031253,0.048547175,0.9494216
23623,the tumor,14,16,67,76,"High number of regulatory T cells (Tregs), both circulating and at the tumor site, often indicates a poor prognosis in CRC patient's possibly impairing natural killer (NK) cell function.",24797894_0,-1,-1,-1,-1,23623,-1,4.17409e-06,0.99999106,4.8162665e-06
23625,cell function,34,36,172,185,"High number of regulatory T cells (Tregs), both circulating and at the tumor site, often indicates a poor prognosis in CRC patient's possibly impairing natural killer (NK) cell function.",24797894_0,-1,-1,-1,-1,23625,-1,2.0012412e-05,1.5444995e-05,0.9999645
23635,transferred Tregs,35,37,201,218,"To determine the role of Tregs in CRC development and their effects on NK cells, we created novel transgenic Rag-Apc mice that lack T cells and develop spontaneous intestinal tumors, and we adoptively transferred Tregs or transiently depleted NK cells during initial stages of tumorigenesis.",24797894_1,-1,-1,-1,-1,23635,-1,4.516873e-06,0.9999914,4.041442e-06
23646,Treg transfer,2,4,13,26,"Importantly, Treg transfer increased small intestinal polyp formation up to 65% (P<0.0005) and increased colon tumors multiplicities by 84% (P<0.0001) with a significant decrease in NK cells as compared to control mice.",24797894_3,-1,-1,-1,-1,23646,-1,4.0435216e-06,0.9999918,4.1327917e-06
23654,Treg transfer,0,2,0,13,"Treg transfer or NK cell transient depletion markedly increased interleukin (IL)-22 systemically and the inflammatory signaling molecules P2X7R, and STAT3 in the tumors; and impaired production of the tumor suppressor interferon (IFN)- systemically.",24797894_5,-1,-1,-1,-1,23654,-1,4.063608e-06,0.9999918,4.1642484e-06
23655,cell transient,4,6,20,34,"Treg transfer or NK cell transient depletion markedly increased interleukin (IL)-22 systemically and the inflammatory signaling molecules P2X7R, and STAT3 in the tumors; and impaired production of the tumor suppressor interferon (IFN)- systemically.",24797894_5,-1,-1,-1,-1,23655,-1,0.001117761,0.06531357,0.93356866
23659,the tumors,22,24,158,168,"Treg transfer or NK cell transient depletion markedly increased interleukin (IL)-22 systemically and the inflammatory signaling molecules P2X7R, and STAT3 in the tumors; and impaired production of the tumor suppressor interferon (IFN)- systemically.",24797894_5,-1,-1,-1,-1,23659,-1,3.6850824e-06,0.9999918,4.4854783e-06
23660,the tumor,29,31,197,206,"Treg transfer or NK cell transient depletion markedly increased interleukin (IL)-22 systemically and the inflammatory signaling molecules P2X7R, and STAT3 in the tumors; and impaired production of the tumor suppressor interferon (IFN)- systemically.",24797894_5,-1,-1,-1,-1,23660,-1,4.87201e-06,0.9999906,4.5119614e-06
23663,the tumor,20,22,105,114,"Notably, IL-22 binding protein (IL-22 BP) was associated with NKs and a significant decrease was seen at the tumor site in mice adoptively transferred with Tregs or depleted of NK cells.",24797894_6,-1,-1,-1,-1,23663,-1,3.749151e-06,0.99999166,4.6292216e-06
23685,tissue,13,14,84,90,"In this study, single cells were isolated from surgically removed high-grade glioma tissue and examined by flow cytometry.",24813240_4,-1,1,2,-1,23685,-1,1.24237395e-05,0.9999579,2.9612305e-05
23694,tissue,13,14,80,86,The results showed that abundant IL-17(+) Tregs were found in high-grade glioma tissue.,24813240_6,-1,1,2,-1,23694,-1,6.094137e-05,0.9979808,0.0019583679
23696,transforming growth factor,5,8,32,58,"The immune suppressor molecule, transforming growth factor (TGF)-beta, was detected in the IL-17(+) Tregs.",24813240_7,-1,-1,-1,-1,23696,-1,0.9860393,0.010852785,0.0031079194
23697,the IL-17(+,13,15,87,98,"The immune suppressor molecule, transforming growth factor (TGF)-beta, was detected in the IL-17(+) Tregs.",24813240_7,-1,-1,-1,-1,23697,-1,0.5231826,0.4730983,0.0037190877
23701,the IL-17(+,12,14,69,80,"The proliferation of CD8(+) T cells was suppressed by culturing with the IL-17(+) Tregs, which was partially abrogated by neutralizing antibodies of either TGF-beta or IL-17 and completely abrogated by neutralizing antibodies against both TGF-beta and IL-17.",24813240_8,-1,-1,-1,-1,23701,-1,0.5065055,0.49037755,0.0031169283
23703,TGF-beta,26,27,156,164,"The proliferation of CD8(+) T cells was suppressed by culturing with the IL-17(+) Tregs, which was partially abrogated by neutralizing antibodies of either TGF-beta or IL-17 and completely abrogated by neutralizing antibodies against both TGF-beta and IL-17.",24813240_8,0,1,-1,-1,23703,-1,4.4070515e-05,0.9999397,1.6249678e-05
23705,TGF-beta,37,38,239,247,"The proliferation of CD8(+) T cells was suppressed by culturing with the IL-17(+) Tregs, which was partially abrogated by neutralizing antibodies of either TGF-beta or IL-17 and completely abrogated by neutralizing antibodies against both TGF-beta and IL-17.",24813240_8,0,1,-1,-1,23705,-1,5.7297842e-05,0.9999242,1.8541277e-05
23710,tissue,11,12,61,67,"In conclusion, IL-17(+) Tregs exist in the high-grade glioma tissue; this subset of T cells can suppress CD8(+) T cell activities via releasing TGF-beta and IL-17.",24813240_9,-1,1,2,-1,23710,-1,7.3275164e-06,0.99997675,1.593234e-05
23711,this subset,13,15,69,80,"In conclusion, IL-17(+) Tregs exist in the high-grade glioma tissue; this subset of T cells can suppress CD8(+) T cell activities via releasing TGF-beta and IL-17.",24813240_9,-1,-1,-1,-1,23711,-1,0.0021666114,0.39102146,0.60681194
23714,releasing TGF-beta,26,28,134,152,"In conclusion, IL-17(+) Tregs exist in the high-grade glioma tissue; this subset of T cells can suppress CD8(+) T cell activities via releasing TGF-beta and IL-17.",24813240_9,-1,-1,-1,-1,23714,-1,1.593899e-05,0.9999753,8.710846e-06
23718,cells to,12,14,76,84,"CD8(+) T cells must detect foreign antigens and differentiate into effector cells to eliminate infections. But, when self-antigen is recognized instead, mechanisms of peripheral tolerance prevent acquisition of effector function to avoid autoimmunity.",24823810_0,-1,-1,-1,-1,23718,-1,0.003678552,0.4609462,0.5353753
23720,function to,33,35,220,231,"CD8(+) T cells must detect foreign antigens and differentiate into effector cells to eliminate infections. But, when self-antigen is recognized instead, mechanisms of peripheral tolerance prevent acquisition of effector function to avoid autoimmunity.",24823810_0,-1,-1,-1,-1,23720,-1,0.0003356101,0.9929779,0.0066865026
23722,the tissue,11,13,82,92,"These distinct responses are influenced by inflammatory and regulatory clues from the tissue environment, but the mechanism(s) by which naive T cells interpret these signals to generate the appropriate immune response are unclear.",24823810_1,-1,-1,-1,-1,23722,-1,1.814498e-05,0.9999604,2.1484313e-05
23724,naive T cells,21,24,136,149,"These distinct responses are influenced by inflammatory and regulatory clues from the tissue environment, but the mechanism(s) by which naive T cells interpret these signals to generate the appropriate immune response are unclear.",24823810_1,-1,-1,-1,-1,23724,-1,0.002128953,0.08775707,0.910114
23726,to generate the,27,30,174,189,"These distinct responses are influenced by inflammatory and regulatory clues from the tissue environment, but the mechanism(s) by which naive T cells interpret these signals to generate the appropriate immune response are unclear.",24823810_1,-1,-1,-1,-1,23726,-1,7.447893e-06,0.9999882,4.3110317e-06
23730,these cell-fate,7,9,49,64,"The identification of the molecules operative in these cell-fate decisions is crucial for developing new treatment options for patients with cancer or autoimmunity, where manipulation of T cell activity is desired to alter the course of disease.",24823810_2,-1,-1,-1,-1,23730,-1,0.0016884824,0.14525782,0.8530536
23740,the T-box transcription factors T-bet,28,33,153,190,"With the use of an in vivo murine model to examine CD8(+) T cell responses to healthy self-tissue, we correlated self-tolerance with a failure to induce the T-box transcription factors T-bet and Eomes.",24823810_3,-1,-1,-1,-1,23740,-1,6.4148126e-06,0.99998736,6.2121976e-06
23746,these functional,8,10,40,56,"In the context of a Listeria infection, these functional responses relied on elevated T-bet expression, independent of Eomes.",24823810_5,-1,-1,-1,-1,23746,-1,5.559128e-05,0.9999249,1.9514302e-05
23750,T-bet to,17,19,107,115,"Alternatively, infection with LCMV induced higher Eomes expression, which was sufficient in the absence of T-bet to promote effector cytokine production.",24823810_6,-1,-1,-1,-1,23750,-1,5.2102614e-06,0.9999907,4.054205e-06
23752,place T-box transcription factors,2,6,12,45,"Our results place T-box transcription factors at a molecular crossroads between CD8(+) T cell anergy and effector function upon recognition of peripheral self-antigen, and suggest that inflammation during T cell priming directs these distinct cellular responses.",24823810_7,-1,-1,-1,-1,23752,-1,4.5064153e-06,0.99999094,4.609983e-06
23754,function,18,19,114,122,"Our results place T-box transcription factors at a molecular crossroads between CD8(+) T cell anergy and effector function upon recognition of peripheral self-antigen, and suggest that inflammation during T cell priming directs these distinct cellular responses.",24823810_7,0,1,2,-1,23754,-1,0.006227695,0.8360587,0.15771365
23761,cells that,16,18,95,105,The biology of follicular lymphoma (FL) is largely dictated by the immune-effector and stromal cells that comprise its tumor microenvironment.,24836297_0,-1,-1,-1,-1,23761,-1,0.0026930075,0.10934728,0.8879597
23763,T-cell,1,2,16,22,"FL-infiltrating T-cell populations that are thought to be fundamental to FL biology are follicular helper T-cells (TFH), follicular regulatory T-cells (TFR), a recently described population that regulates TFH activity, and regulatory T-cells (Treg).",24836297_1,-1,1,2,-1,23763,-1,1.3933647e-05,1.47283645e-05,0.9999713
23765,thought to,5,7,44,54,"FL-infiltrating T-cell populations that are thought to be fundamental to FL biology are follicular helper T-cells (TFH), follicular regulatory T-cells (TFR), a recently described population that regulates TFH activity, and regulatory T-cells (Treg).",24836297_1,-1,-1,-1,-1,23765,-1,4.8518277e-06,0.99998903,6.1450824e-06
23775,These T-cell,0,2,0,12,These T-cell populations have dynamic interactions with mesenchymal stromal cells (MSCs) in the tumor microenvironment.,24836297_2,-1,-1,-1,-1,23775,-1,0.0014671446,0.09555152,0.90298134
23778,the tumor,14,16,92,101,These T-cell populations have dynamic interactions with mesenchymal stromal cells (MSCs) in the tumor microenvironment.,24836297_2,-1,-1,-1,-1,23778,-1,4.17158e-06,0.9999913,4.5460038e-06
23784,TFR cells,19,21,111,120,"Whereas MSCs have been shown to support FL B-cell and Treg viability, their effects on FL-infiltrating TFH and TFR cells have not been described.",24836297_3,-1,-1,-1,-1,23784,-1,0.0017265825,0.36785182,0.6304216
23785,that MSCs,3,5,15,24,"Herein we show that MSCs support the viability of FL-infiltrating TFH and TFR, as well as Tregs, in part through an IL-6-dependent mechanism.",24836297_4,-1,-1,-1,-1,23785,-1,6.136348e-06,0.9999876,6.308692e-06
23792,that MSCs,3,5,23,32,"We further demonstrate that MSCs mediate TFH to TFR conversion by inducing the expression of FoxP3 in TFH cells, demonstrating for the first time that human TFR can be derived from TFH cells.",24836297_5,-1,-1,-1,-1,23792,-1,7.7483755e-06,0.99998665,5.5839537e-06
23793,TFH to TFR,6,9,41,51,"We further demonstrate that MSCs mediate TFH to TFR conversion by inducing the expression of FoxP3 in TFH cells, demonstrating for the first time that human TFR can be derived from TFH cells.",24836297_5,-1,-1,-1,-1,23793,-1,8.335455e-06,0.9999826,9.126255e-06
23796,TFH cells,17,19,102,111,"We further demonstrate that MSCs mediate TFH to TFR conversion by inducing the expression of FoxP3 in TFH cells, demonstrating for the first time that human TFR can be derived from TFH cells.",24836297_5,-1,-1,-1,-1,23796,-1,7.1071976e-05,0.00092164346,0.9990073
23798,time that,24,26,141,150,"We further demonstrate that MSCs mediate TFH to TFR conversion by inducing the expression of FoxP3 in TFH cells, demonstrating for the first time that human TFR can be derived from TFH cells.",24836297_5,-1,-1,-1,-1,23798,-1,5.590175e-06,0.9999901,4.320568e-06
23800,TFH cells,32,34,181,190,"We further demonstrate that MSCs mediate TFH to TFR conversion by inducing the expression of FoxP3 in TFH cells, demonstrating for the first time that human TFR can be derived from TFH cells.",24836297_5,-1,-1,-1,-1,23800,-1,0.00016977837,0.005751808,0.9940784
23801,that the,1,3,6,14,"Given that the balance of TFH and TFR populations likely dictate, in part, the biology of this disease, our data support the potential for targeting MSCs as a therapeutic strategy.",24836297_6,-1,-1,-1,-1,23801,-1,4.614156e-06,0.99999154,3.839557e-06
23807,targeting MSCs,27,29,139,153,"Given that the balance of TFH and TFR populations likely dictate, in part, the biology of this disease, our data support the potential for targeting MSCs as a therapeutic strategy.",24836297_6,-1,-1,-1,-1,23807,-1,6.0297953e-06,0.99998796,6.0463567e-06
23809,to therapy,3,5,25,35,"Despite initial response to therapy, most acute myeloid leukemia (AML) patients relapse.",24855276_0,-1,-1,-1,-1,23809,-1,1.7198521e-05,0.999974,8.761147e-06
23817,tumor cells,14,16,89,100,"In vitro cellular engineering may require increasing the ""stemness"" or immunogenicity of tumor cells and activating or restoring cancer-impaired immune-effector and antigen-presenting cells.",24855276_2,-1,-1,-1,-1,23817,-1,0.00024215059,0.0035482044,0.9962096
23818,antigen-presenting cells,23,25,165,189,"In vitro cellular engineering may require increasing the ""stemness"" or immunogenicity of tumor cells and activating or restoring cancer-impaired immune-effector and antigen-presenting cells.",24855276_2,-1,-1,-1,-1,23818,-1,0.67590123,0.0002542831,0.3238445
23819,the cells,3,5,30,39,"Leukapheresis samples provide the cells needed to engineer therapies: LPCs to be targeted, normal hematopoietic stem cells to be spared, and cancer-impaired immune cells to be repaired and activated.",24855276_3,-1,-1,-1,-1,23819,-1,0.0013442567,0.070755795,0.92789996
23824,cells to,18,20,117,125,"Leukapheresis samples provide the cells needed to engineer therapies: LPCs to be targeted, normal hematopoietic stem cells to be spared, and cancer-impaired immune cells to be repaired and activated.",24855276_3,-1,-1,-1,-1,23824,-1,0.002674912,0.118738644,0.8785864
23825,cells to,26,28,164,172,"Leukapheresis samples provide the cells needed to engineer therapies: LPCs to be targeted, normal hematopoietic stem cells to be spared, and cancer-impaired immune cells to be repaired and activated.",24855276_3,-1,-1,-1,-1,23825,-1,0.0025871792,0.10601791,0.8913949
23834,cells generally,3,5,12,27,CD34(+) AML cells generally displayed more colony-forming and aldehyde dehydrogenase activity than CD34(-) AML cells.,24855276_5,-1,-1,-1,-1,23834,-1,0.0028999797,0.17904548,0.81805456
23841,factor- receptor,28,30,152,169,"Along with exposure to bone marrow stromal cells and low (1%-5%) oxygen, culture with RepSox (a reprogramming tool and inhibitor of transforming growth factor- receptor 1) consistently slowed decline of CD34(+) AML and myelodysplastic syndrome (MDS) cells.",24855276_6,-1,-1,-1,-1,23841,-1,0.98904306,0.00042117786,0.010535841
23849,receptor that,16,18,92,105,"RepSox also accelerated loss of T cell immunoglobulin mucin-3 (Tim-3), an immune checkpoint receptor that impairs antitumor immunity, from the surface of AML and MDS cells.",24855276_8,-1,-1,-1,-1,23849,-1,0.006614164,0.8790492,0.11433671
23850,immunity,20,21,124,132,"RepSox also accelerated loss of T cell immunoglobulin mucin-3 (Tim-3), an immune checkpoint receptor that impairs antitumor immunity, from the surface of AML and MDS cells.",24855276_8,0,-1,2,-1,23850,-1,0.99982435,6.930667e-05,0.00010649175
23855,factor-,12,13,89,97,"Our results suggest RepSox may reduce Tim-3 expression by inhibiting transforming growth factor- signaling and slow decay of CD34(+) AML cells by increasing CXCL12 and MYC, two factors that inhibit AML cell differentiation.",24855276_9,0,1,-1,-1,23855,-1,0.9998951,1.0757985e-05,9.413061e-05
23859,two factors that,28,31,174,190,"Our results suggest RepSox may reduce Tim-3 expression by inhibiting transforming growth factor- signaling and slow decay of CD34(+) AML cells by increasing CXCL12 and MYC, two factors that inhibit AML cell differentiation.",24855276_9,-1,-1,-1,-1,23859,-1,1.0609762e-05,0.9999831,6.328814e-06
23865,T-cell,4,5,24,30,"An increasing number of T-cell epitopes derived from various tumor-associated antigens have been reported, and they proved to play significant roles for tumor rejection both in vivo and in vitro.",24861249_0,-1,1,2,-1,23865,-1,1.9323868e-05,1.37539055e-05,0.999967
23866,tumor-associated antigens,9,11,61,86,"An increasing number of T-cell epitopes derived from various tumor-associated antigens have been reported, and they proved to play significant roles for tumor rejection both in vivo and in vitro.",24861249_0,-1,-1,-1,-1,23866,-1,0.29269695,0.7024106,0.004892489
23868,to play,18,20,123,130,"An increasing number of T-cell epitopes derived from various tumor-associated antigens have been reported, and they proved to play significant roles for tumor rejection both in vivo and in vitro.",24861249_0,-1,-1,-1,-1,23868,-1,4.680458e-06,0.9999906,4.753843e-06
23872,protein,16,17,85,92,"Over 85% of Ewing's sarcoma family of tumors (ESFTs) express tumor-specific chimeric protein EWS/FLI-1, making it an attractive target for therapeutic cytotoxic T-lymphocyte responses.",24861249_1,0,1,-1,-1,23872,-1,6.473052e-06,0.99998736,6.1262253e-06
23874,therapeutic cytotoxic T-lymphocyte,25,28,139,173,"Over 85% of Ewing's sarcoma family of tumors (ESFTs) express tumor-specific chimeric protein EWS/FLI-1, making it an attractive target for therapeutic cytotoxic T-lymphocyte responses.",24861249_1,-1,-1,-1,-1,23874,-1,0.0025569508,0.09709762,0.9003455
23875,peptide,6,7,28,35,"Here, we identified a novel peptide epitope derived from the EWS/FLI-1 protein and demonstrated that effectors induced by the peptide could specifically secrete IFN- and lyse the tumor cell line of EWS/FLI-1-positive and HLA-matched cells.",24861249_2,0,-1,2,-1,23875,-1,7.159913e-05,0.9998934,3.4920296e-05
23877,protein,12,13,71,78,"Here, we identified a novel peptide epitope derived from the EWS/FLI-1 protein and demonstrated that effectors induced by the peptide could specifically secrete IFN- and lyse the tumor cell line of EWS/FLI-1-positive and HLA-matched cells.",24861249_2,0,1,-1,-1,23877,-1,1.3109333e-05,0.9999757,1.1161476e-05
23879,the peptide,19,21,122,133,"Here, we identified a novel peptide epitope derived from the EWS/FLI-1 protein and demonstrated that effectors induced by the peptide could specifically secrete IFN- and lyse the tumor cell line of EWS/FLI-1-positive and HLA-matched cells.",24861249_2,-1,-1,-1,-1,23879,-1,1.25874385e-05,0.99997807,9.39244e-06
23881,the tumor cell,27,30,176,190,"Here, we identified a novel peptide epitope derived from the EWS/FLI-1 protein and demonstrated that effectors induced by the peptide could specifically secrete IFN- and lyse the tumor cell line of EWS/FLI-1-positive and HLA-matched cells.",24861249_2,-1,-1,-1,-1,23881,-1,0.001790403,0.77803093,0.2201787
23894,peptide,12,13,68,75,"Therefore, these data provide evidence for the use of the EWS/FLI-l peptide epitope in T cell-based immunotherapeutic concepts against Ewing's sarcoma cell in vitro and in vivo.",24861249_4,0,-1,2,-1,23894,-1,0.0017980702,0.9964803,0.0017216279
23897,Toll-like receptor,5,7,24,42,PURPOSE: Imiquimod is a Toll-like receptor 7 agonist used topically to treat external genital warts and basal cell carcinoma.,24893628_0,-1,-1,-1,-1,23897,-1,0.005083046,0.8200688,0.17484824
23898,topically to treat,10,13,58,76,PURPOSE: Imiquimod is a Toll-like receptor 7 agonist used topically to treat external genital warts and basal cell carcinoma.,24893628_0,-1,-1,-1,-1,23898,-1,1.3233627e-05,0.99998045,6.268447e-06
23912,the IFN receptor,22,25,130,147,"Recruitment was not dependent upon the specificity of the activated CD8(+) T cells, but was significantly reduced in mice lacking the IFN receptor.",24893628_3,-1,-1,-1,-1,23912,-1,0.036256425,0.95608515,0.007658381
23916,to IFN receptor,21,24,144,160,"Intravaginal imiquimod deposition induced upregulation of CXCL9 and CXCL10 mRNA expression in the genital tract, which are produced in response to IFN receptor signaling and attract cells expressing their ligand, CXCR3.",24893628_4,-1,-1,-1,-1,23916,-1,0.40937388,0.55295694,0.03766919
23919,The T cells,0,3,0,11,"The T cells attracted by imiquimod to the cervicovaginal tract expressed CXCR3 as well as CD49a, an integrin involved in homing and retention of CD8(+) T cells at mucosal sites.",24893628_5,-1,-1,-1,-1,23919,-1,0.0013228153,0.092708886,0.9059683
23920,to the,6,8,35,41,"The T cells attracted by imiquimod to the cervicovaginal tract expressed CXCR3 as well as CD49a, an integrin involved in homing and retention of CD8(+) T cells at mucosal sites.",24893628_5,-1,-1,-1,-1,23920,-1,4.8625648e-06,0.99998987,5.2887044e-06
23925,T cells to the,19,23,155,169,Our results indicate that intramuscular CRT/E7 vaccination in conjunction with intravaginal imiquimod deposition recruits antigen-specific CXCR3(+) CD8(+) T cells to the genital tract.,24893628_6,-1,-1,-1,-1,23925,-1,0.0025890665,0.23286238,0.7645486
23932,the tumor,8,10,64,73,Our findings support accumulating evidence that manipulation of the tumor microenvironment can enhance the therapeutic efficacy of strategies that induce tumor-specific T cells.,24893628_9,-1,-1,-1,-1,23932,-1,4.826699e-06,0.99999094,4.289517e-06
23933,the therapeutic,13,15,103,118,Our findings support accumulating evidence that manipulation of the tumor microenvironment can enhance the therapeutic efficacy of strategies that induce tumor-specific T cells.,24893628_9,-1,-1,-1,-1,23933,-1,5.865112e-06,0.9999902,3.895759e-06
23935,tumor-specific T cells,20,23,154,176,Our findings support accumulating evidence that manipulation of the tumor microenvironment can enhance the therapeutic efficacy of strategies that induce tumor-specific T cells.,24893628_9,-1,-1,-1,-1,23935,-1,0.002734187,0.79664785,0.20061797
23942,IFN-activated STAT2,3,5,16,35,Yet evidence of IFN-activated STAT2 as having tumor suppressor function in vivo and participation in antitumor immunity is lacking.,24895110_1,-1,-1,-1,-1,23942,-1,0.99937373,0.00044009593,0.00018620736
23944,function,9,10,63,71,Yet evidence of IFN-activated STAT2 as having tumor suppressor function in vivo and participation in antitumor immunity is lacking.,24895110_1,0,1,2,-1,23944,-1,1.914411e-05,0.9999604,2.0405132e-05
23945,immunity,16,17,111,119,Yet evidence of IFN-activated STAT2 as having tumor suppressor function in vivo and participation in antitumor immunity is lacking.,24895110_1,0,-1,2,-1,23945,-1,0.99990344,2.0744725e-05,7.5831565e-05
23946,tumor transplantation,6,8,28,49,Here we show in a syngeneic tumor transplantation model that STAT2 reduces tumor growth.,24895110_2,-1,-1,-1,-1,23946,-1,4.8673587e-06,0.99999106,4.128235e-06
23947,that STAT2,9,11,56,66,Here we show in a syngeneic tumor transplantation model that STAT2 reduces tumor growth.,24895110_2,-1,-1,-1,-1,23947,-1,3.269846e-05,0.99995947,7.885192e-06
23952,IFN- treatment,0,2,0,15,IFN- treatment of Stat2(-/-) mice did not cause tumor regression.,24895110_4,-1,-1,-1,-1,23952,-1,0.9993498,0.0003931544,0.00025710536
23955,analysis,2,3,16,24,Gene expression analysis revealed a small subset of immunomodulatory genes to be downregulated in tumors established in Stat2(-/-) mice.,24895110_5,0,1,-1,-1,23955,-1,1.0476001e-05,0.9999814,8.063427e-06
23957,genes to,9,11,69,77,Gene expression analysis revealed a small subset of immunomodulatory genes to be downregulated in tumors established in Stat2(-/-) mice.,24895110_5,-1,-1,-1,-1,23957,-1,9.2821965e-06,0.99998236,8.361433e-06
23959,tumor antigen,4,6,23,36,"Additionally, we found tumor antigen cross-presentation by Stat2(-/-) dendritic cells to T cells to be impaired.",24895110_6,-1,-1,-1,-1,23959,-1,0.46597207,0.529277,0.0047508925
23960,cells to T cells to,11,16,80,99,"Additionally, we found tumor antigen cross-presentation by Stat2(-/-) dendritic cells to T cells to be impaired.",24895110_6,-1,-1,-1,-1,23960,-1,0.0028657252,0.14198837,0.8551459
23962,tumor antigen,3,5,21,34,Adoptive transfer of tumor antigen specific CD8(+) T cells primed by Stat2(-/-) dendritic cells into tumor-bearing Stat2(-/-) mice did not induce tumor regression with IFN- intervention.,24895110_7,-1,-1,-1,-1,23962,-1,0.47913814,0.5151591,0.005702834
23972,IFN--treated tumor-bearing,22,24,103,130,We observed that an increase in the number of CD4(+) and CD8(+) T cells in the draining lymph nodes of IFN--treated tumor-bearing WT mice was absent in IFN- treated Stat2(-/-) mice.,24895110_8,-1,-1,-1,-1,23972,-1,0.9911272,0.007900282,0.0009725346
23974,IFN- treated,29,31,153,166,We observed that an increase in the number of CD4(+) and CD8(+) T cells in the draining lymph nodes of IFN--treated tumor-bearing WT mice was absent in IFN- treated Stat2(-/-) mice.,24895110_8,-1,-1,-1,-1,23974,-1,0.99947923,0.00033946574,0.00018135652
23976,STAT2 function,9,11,59,73,Thus our study provides evidence for further evaluation of STAT2 function in cancer patients receiving type I IFN based immunotherapy.,24895110_9,-1,-1,-1,-1,23976,-1,1.3635191e-05,0.99996996,1.6403366e-05
23979,the therapeutic,6,8,41,56,BACKGROUND: Recent reports have revealed the therapeutic potential of cell-mediated immunity in neoplasms such as cutaneous squamous cell carcinoma (SCC).OBJECTIVES: To define the antigenic coexpression of regulatory T cells (Tregs) and plasmacytoid dendritic cells (pDCs) and assess the CD8(+) /Foxp3(+) CD25(+) cell ratio at peritumoral and intratumoral levels in order to investigate a correlation with the aggressiveness of SCC tumours.,24910265_0,-1,-1,-1,-1,23979,-1,4.174934e-06,0.999992,3.7879236e-06
23983,the antigenic,24,26,176,189,BACKGROUND: Recent reports have revealed the therapeutic potential of cell-mediated immunity in neoplasms such as cutaneous squamous cell carcinoma (SCC).OBJECTIVES: To define the antigenic coexpression of regulatory T cells (Tregs) and plasmacytoid dendritic cells (pDCs) and assess the CD8(+) /Foxp3(+) CD25(+) cell ratio at peritumoral and intratumoral levels in order to investigate a correlation with the aggressiveness of SCC tumours.,24910265_0,-1,-1,-1,-1,23983,-1,0.1150285,0.8821159,0.002855591
24004,transforming growth factor,22,25,114,140,"We determined the profiles of Tregs and CD123(+) cells; immunostained for CD4, CD8, CD123, interleukin (IL)-1 and transforming growth factor (TGF)-1; and unequivocally double stained for Foxp3CD25.RESULTS: Peritumorally, CD4, CD8 and Foxp3 expression showed no difference between the two groups.",24910265_2,-1,-1,-1,-1,24004,-1,0.9855598,0.011613164,0.0028269875
24006,the two,46,48,281,288,"We determined the profiles of Tregs and CD123(+) cells; immunostained for CD4, CD8, CD123, interleukin (IL)-1 and transforming growth factor (TGF)-1; and unequivocally double stained for Foxp3CD25.RESULTS: Peritumorally, CD4, CD8 and Foxp3 expression showed no difference between the two groups.",24910265_2,-1,-1,-1,-1,24006,-1,5.7202424e-06,0.99999,4.3350715e-06
24010,The Foxp3(+,0,2,0,11,"The Foxp3(+) CD25(+) /Foxp3(+) ratio was higher in G2-G3 cases (P=00005), confirming the trend in this group of activated T lymphocytes towards total Treg Foxp3(+) cells, while the CD8(+) /Foxp3(+) CD25(+) ratio was higher in G1 (P=00005).",24910265_4,-1,-1,-1,-1,24010,-1,5.001763e-05,0.99991536,3.4602974e-05
24011,the trend,22,24,88,97,"The Foxp3(+) CD25(+) /Foxp3(+) ratio was higher in G2-G3 cases (P=00005), confirming the trend in this group of activated T lymphocytes towards total Treg Foxp3(+) cells, while the CD8(+) /Foxp3(+) CD25(+) ratio was higher in G1 (P=00005).",24910265_4,-1,-1,-1,-1,24011,-1,5.212737e-06,0.9999908,3.9859115e-06
24013,T lymphocytes towards total Treg Foxp3(+,29,35,125,165,"The Foxp3(+) CD25(+) /Foxp3(+) ratio was higher in G2-G3 cases (P=00005), confirming the trend in this group of activated T lymphocytes towards total Treg Foxp3(+) cells, while the CD8(+) /Foxp3(+) CD25(+) ratio was higher in G1 (P=00005).",24910265_4,-1,-1,-1,-1,24013,-1,0.01166051,0.2445451,0.7437944
24025,to that,10,12,47,54,The CD8(+) /Foxp3(+) CD25(+) ratio was similar to that observed in peritumoral infiltration.,24910265_7,-1,-1,-1,-1,24025,-1,6.1712612e-06,0.99998856,5.296814e-06
24030,T-cell,32,33,166,172,"CONCLUSIONS: Our data suggest that intratumoral recruitment of Tregs, high expression of TGF-1 and IL-10, almost negative CD123+, and a low CD8(+) /Foxp3(+) CD25(+) T-cell ratio may contribute to the aggressiveness of cutaneous SCC, as already evidenced for other solid tumours.",24910265_8,-1,1,2,-1,24030,-1,1.4074353e-05,6.32977e-06,0.9999796
24031,to the,36,38,194,200,"CONCLUSIONS: Our data suggest that intratumoral recruitment of Tregs, high expression of TGF-1 and IL-10, almost negative CD123+, and a low CD8(+) /Foxp3(+) CD25(+) T-cell ratio may contribute to the aggressiveness of cutaneous SCC, as already evidenced for other solid tumours.",24910265_8,-1,-1,-1,-1,24031,-1,6.941065e-06,0.99998784,5.2125924e-06
24033,T-cell,3,4,24,30,Patients with cutaneous T-cell lymphoma (CTCL) are frequently colonized with Staphylococcus aureus (SA).,24957145_0,-1,1,2,-1,24033,-1,2.2655082e-05,9.676017e-06,0.9999677
24040,to Stat3-mediated interleukin-10,26,29,159,191,"Here, we show that SA isolates from involved skin express staphylococcal enterotoxins (SEs) that induce crosstalk between malignant and benign T cells leading to Stat3-mediated interleukin-10 (IL-10) production by the malignant T cells.",24957145_2,-1,-1,-1,-1,24040,-1,0.26124668,0.73591757,0.0028357918
24052,T cells to,25,28,169,179,"Instead, SEs triggered a cascade of events involving cell-cell and asymmetric cytokine interactions between malignant and benign T cells, which stimulated the malignant T cells to express high levels of IL-10.",24957145_4,-1,-1,-1,-1,24052,-1,0.0013752084,0.05366289,0.94496185
24057,the immune dysregulation,16,19,101,125,Much evidence supports that malignant activation of the Stat3/IL-10 axis plays a key role in driving the immune dysregulation and severe immunodeficiency that characteristically develops in CTCL patients.,24957145_5,-1,-1,-1,-1,24057,-1,1.7711493e-05,0.99996734,1.4995195e-05
24083,T-cell,4,5,16,22,The CD4 and CD8 T-cell role was analyzed in vitro and in vivo.,24987872_4,-1,1,2,-1,24083,-1,1.1270111e-05,5.782642e-06,0.99998283
24094,the tumor,18,20,115,124,In vitro assays and immunohistochemical analyses revealed the recruitment of T effector cells and CD8 T cells into the tumor area.,24987872_7,-1,-1,-1,-1,24094,-1,3.880622e-06,0.9999919,4.2571546e-06
24100,therapy,1,2,13,20,Photodynamic therapy (PDT) by selective photosensitization of cancer cells and subsequent laser application results in local tumor necrosis.,25005268_0,0,1,-1,-1,24100,-1,9.881056e-06,0.9999826,7.485891e-06
24104,function,8,9,38,46,"However, the effects of PDT on immune function, which may depend on the type of immune response, are controversial.",25005268_1,0,1,2,-1,24104,-1,0.22794335,0.5813897,0.1906669
24105,the type,14,16,68,76,"However, the effects of PDT on immune function, which may depend on the type of immune response, are controversial.",25005268_1,-1,-1,-1,-1,24105,-1,1.0404605e-05,0.9999826,7.010782e-06
24109,function,16,17,92,100,We investigated the immunological changes induced by PDT and the effect of PDT on level and function of regulatory T cells (Treg) in patients with invasive esophageal squamous cell carcinoma (ESCC).,25005268_2,0,1,2,-1,24109,-1,3.3958768e-05,0.99991393,5.2057963e-05
24113,blood,4,5,22,27,We analyzed patient's blood samples before and after PDT.,25005268_3,0,1,-1,-1,24113,-1,0.00065269653,0.99400085,0.0053464463
24114,Blood,0,1,0,5,"Blood CD4+CD25+CD127-FoxP3+ Treg levels were quantified by FACS, and Treg function was evaluated by coculture proliferation assays with T effector (Teff) cells.",25005268_4,0,1,-1,-1,24114,-1,2.9404537e-05,0.99994934,2.1273889e-05
24116,Treg function,11,13,69,82,"Blood CD4+CD25+CD127-FoxP3+ Treg levels were quantified by FACS, and Treg function was evaluated by coculture proliferation assays with T effector (Teff) cells.",25005268_4,-1,-1,-1,-1,24116,-1,8.702536e-06,0.9999784,1.2931668e-05
24125,Treg function,5,7,21,34,The effect of PDT on Treg function at Day 7 was accompanied by slight but statistically significant increases in peripheral neutrophil granulocytes (p = 0.035) and monocytes (p = 0.013) and a statistically significant increase (approximately 18-fold) in serum IL-6 levels (p = 0.008).,25005268_6,-1,-1,-1,-1,24125,-1,2.0831045e-05,0.99989974,7.9403304e-05
24129,Treg function,5,7,29,42,"In conclusion, PDT abolished Treg function, possibly due to increased IL-6 levels in treated ESCC patients.",25005268_7,-1,-1,-1,-1,24129,-1,1.6576754e-05,0.9999485,3.4971577e-05
24136,functions to,11,13,59,71,STAT3 is highly activated in a wide variety of cancers and functions to promote tumor survival.,25015826_0,-1,-1,-1,-1,24136,-1,8.8683e-06,0.99998343,7.645332e-06
24140,this treatment,20,22,130,144,"We previously reported that blocking STAT3 activation inhibited human hepatocellular carcinoma (HCC) growth in vitro, but whether this treatment also triggered antitumor immune responses in vivo remained unknown.",25015826_1,-1,-1,-1,-1,24140,-1,7.4973564e-06,0.9999881,4.376336e-06
24145,the STAT3,8,10,38,47,"In this study, we found that blocking the STAT3 pathway in HCC cells dramatically inhibited murine HCC growth in vivo and prolonged survival of tumor-bearing mice.",25015826_2,-1,-1,-1,-1,24145,-1,7.778491e-06,0.9999862,6.002978e-06
24154,function,11,12,67,75,"In T cell-deficient nude mice, a unique NK cell-mediated antitumor function against STAT3-blocked HCC was suggested.",25015826_4,0,1,2,-1,24154,-1,0.000373166,0.9960204,0.003606433
24163,TGF- cytokines,9,11,64,79,"Furthermore, regulatory T cells and immunosuppressive IL-10 and TGF- cytokines were reduced in mice bearing STAT3-blocked HCC cells, suggesting that these factors may be involved in HCC-induced NK cell suppression.",25015826_6,-1,-1,-1,-1,24163,-1,0.039468613,0.95903814,0.0014932551
24166,that these factors,21,24,145,163,"Furthermore, regulatory T cells and immunosuppressive IL-10 and TGF- cytokines were reduced in mice bearing STAT3-blocked HCC cells, suggesting that these factors may be involved in HCC-induced NK cell suppression.",25015826_6,-1,-1,-1,-1,24166,-1,6.5744775e-06,0.9999889,4.5658358e-06
24173,The transcription factor,0,3,0,24,The transcription factor NF-B is central to inflammatory signaling and activation of innate and adaptive immune responses.,25024217_0,-1,-1,-1,-1,24173,-1,5.5756605e-06,0.99999,4.442473e-06
24178,the tnfaip3 gene,22,25,151,167,"Activation of the NF-B pathway is tightly controlled by several negative feedback mechanisms, including A20, an ubiquitin-modifying enzyme encoded by the tnfaip3 gene.",25024217_1,-1,-1,-1,-1,24178,-1,1.1160975e-05,0.99997747,1.1357199e-05
24185,T-cell functions,28,30,158,174,"As we observed high expression of A20 transcripts in dysfunctional CD8 T cells in an autochthonous melanoma, we analyzed the role of A20 in regulation of CD8 T-cell functions, using mice in which A20 was selectively deleted in mature conventional T cells.",25024217_3,-1,-1,-1,-1,24185,-1,1.407605e-05,8.79507e-06,0.9999771
24191,to antigen,7,9,50,60,"A20-deleted CD8 T cells had increased sensitivity to antigen stimulation with production of large amounts of IL-2 and IFN, correlated with sustained nuclear expression of NF-B components reticuloendotheliosis oncogene c-Rel and p65.",25024217_5,-1,-1,-1,-1,24191,-1,0.7350773,0.25848517,0.006437472
24205,TNF,11,12,79,83,Tumor-infiltrating A20-deleted CD8 T cells had enhanced production of IFN and TNF and reduced expression of the inhibitory receptor programmed cell death 1.,25024217_8,0,1,-1,-1,24205,-1,0.00010182597,0.9998704,2.7714259e-05
24207,receptor,18,19,125,133,Tumor-infiltrating A20-deleted CD8 T cells had enhanced production of IFN and TNF and reduced expression of the inhibitory receptor programmed cell death 1.,25024217_8,0,1,2,-1,24207,-1,4.200337e-05,3.8215952e-05,0.9999198
24212,targeted to,27,29,141,152,"As manipulation of A20 expression in CD8 T cells did not result in pathologic manifestations in the mice, we propose it as a candidate to be targeted to increase antitumor efficiency of adoptive T-cell immunotherapy.",25024217_9,-1,-1,-1,-1,24212,-1,4.0220643e-06,0.9999926,3.3974964e-06
24213,T-cell,34,35,195,201,"As manipulation of A20 expression in CD8 T cells did not result in pathologic manifestations in the mice, we propose it as a candidate to be targeted to increase antitumor efficiency of adoptive T-cell immunotherapy.",25024217_9,-1,1,2,-1,24213,-1,1.2403236e-05,7.720714e-06,0.99997985
24215,immune responses through,6,9,34,58,"Cancer cells may escape from host immune responses through active suppression of the immune response, but the detailed mechanisms in colorectal cancer remain to be elucidated.",25034363_0,-1,-1,-1,-1,24215,-1,0.974458,0.024879687,0.0006624045
24216,the immune response,12,15,81,100,"Cancer cells may escape from host immune responses through active suppression of the immune response, but the detailed mechanisms in colorectal cancer remain to be elucidated.",25034363_0,-1,-1,-1,-1,24216,-1,0.743116,0.2544808,0.0024031608
24222,tissues,11,12,66,73,"In this study, 108 colorectal tumor samples and their peritumoral tissues were collected for immunohistochemistry of infiltrating lymphocytes.",25034363_1,-1,1,2,-1,24222,-1,3.0092615e-05,0.99945015,0.0005197907
24225,Tregs cells,2,4,8,19,"Th1 and Tregs cells were determined by the positiveexpression of T-bet and FOXP3 proteins, respectively.",25034363_2,-1,-1,-1,-1,24225,-1,9.027967e-05,0.0019019339,0.99800783
24228,FOXP3 proteins,14,16,76,90,"Th1 and Tregs cells were determined by the positiveexpression of T-bet and FOXP3 proteins, respectively.",25034363_2,-1,-1,-1,-1,24228,-1,4.5004276e-06,0.9999908,4.6650184e-06
24229,The Tr1 cells,0,3,0,13,The Tr1 cells were identified by CD49b and LAG-3 protein expression.,25034363_3,-1,-1,-1,-1,24229,-1,0.00164366,0.20901331,0.78934294
24231,IL-17-positive cells,0,2,0,20,IL-17-positive cells were identified by IL-17 expression.,25034363_4,-1,-1,-1,-1,24231,-1,0.96279925,0.00016749435,0.037033305
24233,that the,2,4,15,23,"Results showed that the percentage of T-bet-positive cells was significantly decreased, while the percentages of IL-17-, FOXP3-, CD49b-, and LAG-3-positive cells were significantly increased in tumor tissues compared to that in peritumoral tissues.",25034363_5,-1,-1,-1,-1,24233,-1,3.7664547e-06,0.999992,4.2541683e-06
24234,T-bet-positive cells,6,8,38,58,"Results showed that the percentage of T-bet-positive cells was significantly decreased, while the percentages of IL-17-, FOXP3-, CD49b-, and LAG-3-positive cells were significantly increased in tumor tissues compared to that in peritumoral tissues.",25034363_5,-1,-1,-1,-1,24234,-1,0.0014609905,0.8385943,0.15994467
24239,tumor tissues,29,31,194,207,"Results showed that the percentage of T-bet-positive cells was significantly decreased, while the percentages of IL-17-, FOXP3-, CD49b-, and LAG-3-positive cells were significantly increased in tumor tissues compared to that in peritumoral tissues.",25034363_5,-1,-1,-1,-1,24239,-1,5.6336507e-06,0.9999838,1.0535087e-05
24240,to that,32,34,217,224,"Results showed that the percentage of T-bet-positive cells was significantly decreased, while the percentages of IL-17-, FOXP3-, CD49b-, and LAG-3-positive cells were significantly increased in tumor tissues compared to that in peritumoral tissues.",25034363_5,-1,-1,-1,-1,24240,-1,5.056727e-06,0.9999901,4.892219e-06
24241,tissues,36,37,240,247,"Results showed that the percentage of T-bet-positive cells was significantly decreased, while the percentages of IL-17-, FOXP3-, CD49b-, and LAG-3-positive cells were significantly increased in tumor tissues compared to that in peritumoral tissues.",25034363_5,-1,1,2,-1,24241,-1,1.0795486e-05,0.99991775,7.147425e-05
24245,cells to T-bet-positive cells,11,15,55,84,"The ratio of IL-17-, FOXP3-, CD49b-, and LAG3-positive cells to T-bet-positive cells was significantly higher in tumor tissues than in peritumoral tissues.",25034363_6,-1,-1,-1,-1,24245,-1,0.00012757172,0.00025996479,0.9996124
24246,tumor tissues than,19,22,113,131,"The ratio of IL-17-, FOXP3-, CD49b-, and LAG3-positive cells to T-bet-positive cells was significantly higher in tumor tissues than in peritumoral tissues.",25034363_6,-1,-1,-1,-1,24246,-1,4.4172084e-06,0.9999896,5.9186e-06
24247,tissues,24,25,147,154,"The ratio of IL-17-, FOXP3-, CD49b-, and LAG3-positive cells to T-bet-positive cells was significantly higher in tumor tissues than in peritumoral tissues.",25034363_6,-1,1,2,-1,24247,-1,6.723041e-06,0.9999746,1.8721319e-05
24249,IL-17-positive cells,4,6,31,51,"The percentage of infiltrating IL-17-positive cells in tumor tissues was negatively associated with lymph metastasis, invasion, and TNM stage.",25034363_7,-1,-1,-1,-1,24249,-1,0.96488446,0.0001101821,0.035005383
24250,tumor tissues,7,9,55,68,"The percentage of infiltrating IL-17-positive cells in tumor tissues was negatively associated with lymph metastasis, invasion, and TNM stage.",25034363_7,-1,-1,-1,-1,24250,-1,7.8206875e-05,0.9992592,0.0006625533
24257,Tr1 cells,6,8,36,45,The percentage of positive Th17 and Tr1 cells is a marker for poor prognosis in patients with CRC.,25034363_9,-1,-1,-1,-1,24257,-1,1.6056183e-05,2.5142732e-05,0.99995875
24261,IL-17-positive cells,22,24,134,154,"In conclusion, decreased composition of regulative Th1 cells and increased composition of FOXP(+) Tregs-, CD49b(+)/LAG-3(+) Tr1-, and IL-17-positive cells in tumor tissues may be associated with the progression of colorectal cancer.",25034363_10,-1,-1,-1,-1,24261,-1,0.9597253,0.00012759102,0.040147096
24262,tumor tissues,25,27,158,171,"In conclusion, decreased composition of regulative Th1 cells and increased composition of FOXP(+) Tregs-, CD49b(+)/LAG-3(+) Tr1-, and IL-17-positive cells in tumor tissues may be associated with the progression of colorectal cancer.",25034363_10,-1,-1,-1,-1,24262,-1,7.892717e-06,0.9999778,1.4225668e-05
24266,Tr1-positive cells,6,8,34,52,The high percentage of IL-17- and Tr1-positive cells in tumor tissues is a predictive marker for poor prognosis of colorectal cancer.,25034363_11,-1,-1,-1,-1,24266,-1,0.0032617196,0.5859528,0.41078544
24267,tumor tissues,9,11,56,69,The high percentage of IL-17- and Tr1-positive cells in tumor tissues is a predictive marker for poor prognosis of colorectal cancer.,25034363_11,-1,-1,-1,-1,24267,-1,3.0415029e-05,0.9997807,0.00018882447
24269,protein osteopontin,2,4,18,37,"The matricellular protein osteopontin (OPN, Spp-1) is widely associated with cancer aggressiveness when produced by tumor cells, but its impact is uncertain when produced by leukocytes in the context of the tumor stroma.",25035397_0,-1,-1,-1,-1,24269,-1,0.9947515,0.0041211233,0.0011273713
24270,tumor cells,18,20,116,127,"The matricellular protein osteopontin (OPN, Spp-1) is widely associated with cancer aggressiveness when produced by tumor cells, but its impact is uncertain when produced by leukocytes in the context of the tumor stroma.",25035397_0,-1,-1,-1,-1,24270,-1,0.00028972322,0.00217825,0.997532
24272,the tumor,34,36,203,212,"The matricellular protein osteopontin (OPN, Spp-1) is widely associated with cancer aggressiveness when produced by tumor cells, but its impact is uncertain when produced by leukocytes in the context of the tumor stroma.",25035397_0,-1,-1,-1,-1,24272,-1,5.480463e-06,0.9999902,4.344517e-06
24274,tumor cells,13,15,67,78,"In a broad study using Spp1(-/-) mice along with gene silencing in tumor cells, we obtained evidence of distinct and common activities of OPN when produced by tumor or host cells in a spontaneously metastatic model of breast cancer.",25035397_1,-1,-1,-1,-1,24274,-1,0.00025588463,0.0042644627,0.9954797
24278,tumor cells,16,18,108,119,"Different cellular localization of OPN is associated with its distinct activities, being mainly secreted in tumor cells while intracellular in myeloid cells.",25035397_2,-1,-1,-1,-1,24278,-1,8.3782405e-05,0.00017608544,0.9997402
24280,tumor cells,3,5,16,27,"OPN produced by tumor cells supported their survival in the blood stream, whereas both tumor- and host-derived OPN, particularly from myeloid cells, rendered the metastatic site more immunosuppressive.",25035397_3,-1,-1,-1,-1,24280,-1,0.00015164973,0.0005781027,0.99927026
24282,the blood,9,11,56,65,"OPN produced by tumor cells supported their survival in the blood stream, whereas both tumor- and host-derived OPN, particularly from myeloid cells, rendered the metastatic site more immunosuppressive.",25035397_3,-1,-1,-1,-1,24282,-1,5.8016918e-05,0.99989235,4.9629798e-05
24295,than their,11,13,65,75,"Notably, monocytic MDSCs in Spp1(-/-) mice were less suppressive than their wild-type counterparts due to lower expression of arginase-1, IL6, and phospho-Stat3.",25035397_7,-1,-1,-1,-1,24295,-1,6.1201176e-06,0.99998844,5.496753e-06
24302,functions,6,7,36,45,"Overall, our results unveiled novel functions for OPN in shaping local immunosuppression in the lung metastatic niche.",25035397_10,0,1,2,-1,24302,-1,0.00016519526,0.9997789,5.592031e-05
24304,TEL-AML the,2,4,12,23,BACKGROUND: TEL-AML the most common genetic alteration in childhood precursor B acute lymphoblastic leukemia (BCP-ALL) is associated with a favorable prognosis.,25062112_0,-1,-1,-1,-1,24304,-1,9.181681e-06,0.99997973,1.1055394e-05
24308,factor receptor,13,15,85,100,PATIENTS AND METHOD: We studied the expression of nerve growth factor/tumor necrosis factor receptor (NGFR/TNFR)/ligand family members on 108 primary BCP-ALL samples by flow cytometry and compared both their baseline expression and CD40-induced modulation on TEL-AML positive and negative leukemia samples.,25062112_1,-1,-1,-1,-1,24308,-1,0.9978836,3.825138e-05,0.0020780987
24311,that TEL-AML,5,7,34,46,"RESULTS: Our findings demonstrate that TEL-AML positive patients exhibit a significantly higher percentage of CD40, CD27 and p75NTR positive blasts at diagnosis.",25062112_2,-1,-1,-1,-1,24311,-1,6.791502e-05,0.99981934,0.00011279057
24314,to the,4,6,27,33,This might well contribute to the improved relapse-free survival of these patients assessed in Kaplan Meier analysis as CD27 and p75NTR directly mediate apoptotic signals.,25062112_3,-1,-1,-1,-1,24314,-1,7.3166743e-06,0.9999875,5.192942e-06
24317,analysis,16,17,108,116,This might well contribute to the improved relapse-free survival of these patients assessed in Kaplan Meier analysis as CD27 and p75NTR directly mediate apoptotic signals.,25062112_3,0,1,-1,-1,24317,-1,1.8998762e-05,0.9999647,1.6340451e-05
24336,factors,61,62,408,415,CONCLUSION: These data provide novel insights in immunological control mechanisms preserved in this leukemia subtype and suggest that not only treatment with chemicals such as HDAC inhibitors but also retained in vivo response to CD40 ligation contributes to improved immune surveillance in these patients which may add to a superior relapse-free survival observed particularly in the presence of other risk factors.,25062112_5,0,1,-1,-1,24336,-1,0.8411433,0.15528227,0.0035743765
24343,function,7,8,36,44,"Here, we analyzed the phenotype and function of dendritic cells (DCs), and the frequency of IL-10-producing regulatory B cells (Breg) and Foxp3(+) regulatory T cells (Treg) in different stages of N-nitrosodiethylamine (DEN)-induced rat HCC in order to understand their roles in this disease.",25066760_2,0,1,2,-1,24343,-1,2.9963456e-05,0.99992275,4.7296107e-05
24359,that the,3,5,14,22,We also found that the frequency of IL-10-producing Breg and CD4(+)CD25(+)Foxp3(+) Treg in HCC rats was obviously increased during all of these three stages.,25066760_4,-1,-1,-1,-1,24359,-1,4.131578e-06,0.9999918,4.049472e-06
24362,these three,22,24,138,149,We also found that the frequency of IL-10-producing Breg and CD4(+)CD25(+)Foxp3(+) Treg in HCC rats was obviously increased during all of these three stages.,25066760_4,-1,-1,-1,-1,24362,-1,1.2085854e-05,0.9999752,1.27487565e-05
24367,that the,3,5,20,28,Our results suggest that the dysfunction of DCs and the increase of IL-10-producing Breg and Foxp3(+) Treg might play important roles in HCC progression.,25066760_7,-1,-1,-1,-1,24367,-1,3.6820422e-06,0.9999924,3.9049105e-06
24378,peptide,37,38,246,253,"Here, for the first time, we developed a novel combination adjuvant alum-polysaccharide-HH2 (APH) with potent immunomodulating activities, consisting of alum, polysaccharide of Escherichia coli and the synthetic cationic innate defense regulator peptide HH2.METHODS: The adjuvant effects of APH were examined using NY-ESO-1 protein-based vaccines in prophylactic and therapeutic models.",25070035_2,0,-1,2,-1,24378,-1,0.0003493715,0.999584,6.658118e-05
24380,protein-based,49,50,324,337,"Here, for the first time, we developed a novel combination adjuvant alum-polysaccharide-HH2 (APH) with potent immunomodulating activities, consisting of alum, polysaccharide of Escherichia coli and the synthetic cationic innate defense regulator peptide HH2.METHODS: The adjuvant effects of APH were examined using NY-ESO-1 protein-based vaccines in prophylactic and therapeutic models.",25070035_2,0,1,-1,-1,24380,-1,0.0044320785,0.99499387,0.00057406106
24384,therapy,17,18,124,131,We further determined the immunogenicity and anti-tumor effect of NY-ESO-1-APH (NAPH) vaccine using adoptive cellular/serum therapy in C57/B6 and nude mice.,25070035_3,0,1,-1,-1,24384,-1,4.0490245e-06,0.99999,6.009279e-06
24392,TNF-,21,22,147,152,"RESULTS: The APH complex significantly promoted antigen uptake, maturation and cross-presentation of dendritic cells and enhanced the secretion of TNF-, MCP-1 and IFN- by human peripheral blood mononuclear cells compared with individual components.",25070035_5,0,1,-1,-1,24392,-1,0.0013714236,0.9985055,0.00012313362
24395,blood,29,30,190,195,"RESULTS: The APH complex significantly promoted antigen uptake, maturation and cross-presentation of dendritic cells and enhanced the secretion of TNF-, MCP-1 and IFN- by human peripheral blood mononuclear cells compared with individual components.",25070035_5,0,1,-1,-1,24395,-1,0.008287258,0.9804576,0.011255155
24401,therapy,5,6,36,43,"In addition, passive serum/cellular therapy potently inhibited tumor growth of NY-ESO-1-B16.",25070035_7,0,1,-1,-1,24401,-1,4.886079e-06,0.9999893,5.8248943e-06
24411,cellular immune responses to,18,22,118,146,"Therefore, NAPH vaccination effectively stimulated innate immunity, and boosted both arms of the adaptive humoral and cellular immune responses to suppress tumorigenesis and growth of melanoma.",25070035_9,-1,-1,-1,-1,24411,-1,0.067131184,0.060918808,0.87195
24429,T-cell,22,23,130,136,"Cytokine-matured DCs are regularly used, but to induce memory-type CTLs, they require additional activation stimuli, such as CD4+ T-cell help or TLR activation.",25100611_1,-1,1,2,-1,24429,-1,2.3705063e-05,1.0350879e-05,0.9999659
24454,the tumorigenicity,3,5,30,48,"Embelin substantially reduced the tumorigenicity of pancreatic cancer cells in vivo, which was associated with reduced inflammatory cells and immune suppressive cells, IL-17A(+) Th17, GM-CSF(+) Th, MDSCs and Treg, through inhibition of IL-6 secretion.",25128650_3,-1,-1,-1,-1,24454,-1,5.9349813e-06,0.9999889,5.2076293e-06
24465,IL-6-induced STAT3,4,6,27,45,"Moreover, embelin decrease IL-6-induced STAT3 phosphorylation.",25128650_4,-1,-1,-1,-1,24465,-1,0.99728656,0.002124116,0.00058933714
24479,the regulatory T cells,20,24,139,161,"After co-culturing with IDO expressing or control vector-transfected 2LL-EGFP cells, T cell apoptosis was determined and the proportion of the regulatory T cells (Tregs) and CD8+ T cell subset was measured.",25138378_4,-1,-1,-1,-1,24479,-1,0.0011449092,0.07011781,0.9287373
24481,CD8+ T cell subset,28,33,174,192,"After co-culturing with IDO expressing or control vector-transfected 2LL-EGFP cells, T cell apoptosis was determined and the proportion of the regulatory T cells (Tregs) and CD8+ T cell subset was measured.",25138378_4,-1,-1,-1,-1,24481,-1,1.6466465e-05,5.233423e-06,0.9999783
24482,The total cellular protein,0,4,0,26,The total cellular protein samples of 2 LL-EGFP-IDO cells were isolated for detecting JAK-STAT1 signalling pathway.,25138378_5,-1,-1,-1,-1,24482,-1,4.072907e-05,0.9998882,7.105072e-05
24502,analysis,13,14,79,87,"Increased expression of IDO, p-JAK1 and p-STAT1 were confirmed by Western blot analysis.",25138378_10,0,1,-1,-1,24502,-1,7.896838e-06,0.9999858,6.319224e-06
24519,therapeutic tool to,7,10,50,69,"Therefore, targeting angiogenesis is an important therapeutic tool to reduce MM progression.",25142285_1,-1,-1,-1,-1,24519,-1,5.5996256e-06,0.9999902,4.1352687e-06
24539,to this,25,27,161,168,"Moreover, we observed a reduction in proliferation, migration and network formation and an induction of apoptosis upon exposure of murine endothelial cell lines to this conditioned medium.",25142285_6,-1,-1,-1,-1,24539,-1,6.6370317e-06,0.9999877,5.6403446e-06
24540,that the,3,5,24,32,"We furthermore observed that the JAK-STAT signaling pathway was highly activated in endothelial cells in response to stimulated iNKT cells, indicating the possible role of IFN- in the anti-angiogenic process.",25142285_7,-1,-1,-1,-1,24540,-1,4.1596018e-06,0.99999213,3.6813358e-06
24549,cells to target,11,14,74,89,"In conclusion, these results highlight the possibility of recruiting iNKT cells to target MM and angiogenesis.",25142285_8,-1,-1,-1,-1,24549,-1,0.0033564577,0.81018025,0.18646333
24552,their therapeutic,15,17,114,131,This gives a rationale for combining immunotherapy with conventional anti-tumour treatments in view of increasing their therapeutic potential.,25142285_9,-1,-1,-1,-1,24552,-1,9.46006e-06,0.99998474,5.7403668e-06
24565,urine,52,53,324,329,"Although several studies assessing the potential prognostic value of InfBMs in cancer have been published in the past decades, they have had no impact on the management of patients with urothelial bladder carcinoma (UBC).OBJECTIVE: To review and summarise the scientific literature on the prognostic value of tumour, serum, urine, and germline DNA InfBMs on UBC.EVIDENCE ACQUISITION: A systematic review of the literature was performed searching the Medline and Embase databases for original articles published between January 1975 and November 2013.",25151017_2,0,1,-1,-1,24565,-1,0.0009863917,0.9988269,0.0001866218
24570,analysis,10,11,61,69,The main inclusion criterion was the provision of a survival analysis (Kaplan-Meier and/or Cox) according to the Reporting Recommendations for Tumor Marker Prognostic Studies guidelines for the assessment of prognostic markers.,25151017_3,0,1,-1,-1,24570,-1,4.577683e-05,0.99991715,3.7007907e-05
24571,to the,17,19,106,112,The main inclusion criterion was the provision of a survival analysis (Kaplan-Meier and/or Cox) according to the Reporting Recommendations for Tumor Marker Prognostic Studies guidelines for the assessment of prognostic markers.,25151017_3,-1,-1,-1,-1,24571,-1,8.179008e-06,0.9999857,6.068433e-06
24578,missing relevant,6,8,39,55,Main limitations of these studies were missing relevant information about design or analysis and heterogeneous methodology used.,25151017_7,-1,-1,-1,-1,24578,-1,0.10042955,0.8974074,0.0021630402
24579,analysis,12,13,84,92,Main limitations of these studies were missing relevant information about design or analysis and heterogeneous methodology used.,25151017_7,0,1,-1,-1,24579,-1,5.34698e-05,0.99991584,3.0654945e-05
24581,tumour cells,6,8,47,59,"Inflammatory cells, costimulatory molecules in tumour cells, and serum cytokines showed prognostic significance, mainly in univariable analyses.",25151017_8,-1,-1,-1,-1,24581,-1,0.000101460166,0.00014415187,0.99975437
24583,protein,2,3,16,23,High C-reactive protein values were consistently reported as an independent prognostic factor for mortality in invasive UBC.CONCLUSIONS: There is a dearth of studies on InfBMs in UBC compared with other tumour types.,25151017_9,0,1,-1,-1,24583,-1,0.9995888,7.328541e-05,0.00033789538
24584,factor,11,12,87,93,High C-reactive protein values were consistently reported as an independent prognostic factor for mortality in invasive UBC.CONCLUSIONS: There is a dearth of studies on InfBMs in UBC compared with other tumour types.,25151017_9,0,1,-1,-1,24584,-1,0.80557615,0.1929368,0.0014870726
24586,tumour types,31,33,203,215,High C-reactive protein values were consistently reported as an independent prognostic factor for mortality in invasive UBC.CONCLUSIONS: There is a dearth of studies on InfBMs in UBC compared with other tumour types.,25151017_9,-1,-1,-1,-1,24586,-1,6.562481e-06,0.9999821,1.12888965e-05
24590,the translational,8,10,57,74,"Currently, methodological drawbacks of the studies limit the translational potential of results.",25151017_11,-1,-1,-1,-1,24590,-1,8.3710875e-06,0.9999871,4.4880503e-06
24611,the tumor,9,11,49,58,"In murine tumor systems, HMGB1 was ubiquitous in the tumor microenvironment, activating the NF-B signal transduction pathway in MDSCs and regulating their quantity and quality.",25164013_6,-1,-1,-1,-1,24611,-1,4.4120848e-06,0.9999906,4.9760347e-06
24618,to their,16,18,102,110,"We found that HMGB1 promotes the development of MDSCs from bone marrow progenitor cells, contributing to their ability to suppress antigen-driven activation of CD4(+) and CD8(+) T cells.",25164013_7,-1,-1,-1,-1,24618,-1,7.059417e-06,0.9999864,6.552453e-06
24625,the T-cell,26,28,181,191,"Furthermore, HMGB1 increased MDSC-mediated production of IL-10, enhanced crosstalk between MDSCs and macrophages, and facilitated the ability of MDSCs to downregulate expression of the T-cell homing receptor L-selectin.",25164013_8,-1,-1,-1,-1,24625,-1,0.0029850835,0.32564646,0.6713685
24626,receptor,29,30,199,207,"Furthermore, HMGB1 increased MDSC-mediated production of IL-10, enhanced crosstalk between MDSCs and macrophages, and facilitated the ability of MDSCs to downregulate expression of the T-cell homing receptor L-selectin.",25164013_8,0,1,2,-1,24626,-1,0.008761876,0.0017402427,0.9894979
24631,tissues,12,13,86,93,The increased number of CD4(+)CD25(+)Treg cells in tumor local and peripheral splenic tissues is related to the low immune function as well as to tumor recurrence and metastasis.,25168696_0,-1,1,2,-1,24631,-1,0.00030526993,0.021115722,0.978579
24632,related to the,14,17,97,111,The increased number of CD4(+)CD25(+)Treg cells in tumor local and peripheral splenic tissues is related to the low immune function as well as to tumor recurrence and metastasis.,25168696_0,-1,-1,-1,-1,24632,-1,5.7846682e-06,0.99998796,6.3101015e-06
24633,function,19,20,123,131,The increased number of CD4(+)CD25(+)Treg cells in tumor local and peripheral splenic tissues is related to the low immune function as well as to tumor recurrence and metastasis.,25168696_0,0,1,2,-1,24633,-1,0.014719032,0.9577423,0.02753866
24634,to tumor,23,25,143,151,The increased number of CD4(+)CD25(+)Treg cells in tumor local and peripheral splenic tissues is related to the low immune function as well as to tumor recurrence and metastasis.,25168696_0,-1,-1,-1,-1,24634,-1,3.7538562e-06,0.9999908,5.370458e-06
24637,functions,20,21,131,140,Our pre-clinical studies showed that low-dose radiation (LDR) of the spleen in liver cancer patients significantly improves immune functions.,25168696_1,0,1,2,-1,24637,-1,0.70486486,0.15597682,0.1391583
24647,the blood,21,23,148,157,"Using the diethylnitrosamine (DEN)-induced rat liver tumor model and in vitro cell experiments, the percentage of CD4(+)CD25(+)Treg/CD4(+) cells in the blood and the expressions of Foxp3(+), IL-10, TGF-, and cytotoxic T lymphocyte-associated antigen-4(CTLA-4) in spleen and liver tumors significantly decreased after LDR of the spleen in rats with liver cancer.",25168696_4,-1,-1,-1,-1,24647,-1,5.3529915e-05,0.9998217,0.00012478394
24652,T lymphocyte-associated antigen-4(CTLA-4,36,39,219,259,"Using the diethylnitrosamine (DEN)-induced rat liver tumor model and in vitro cell experiments, the percentage of CD4(+)CD25(+)Treg/CD4(+) cells in the blood and the expressions of Foxp3(+), IL-10, TGF-, and cytotoxic T lymphocyte-associated antigen-4(CTLA-4) in spleen and liver tumors significantly decreased after LDR of the spleen in rats with liver cancer.",25168696_4,-1,-1,-1,-1,24652,-1,0.0003913284,6.0211965e-05,0.9995485
24655,The tumors,0,2,0,10,"The tumors became smaller than those in the non-radiated group, with both showing a parallel relation.",25168696_5,-1,-1,-1,-1,24655,-1,3.5061244e-06,0.999992,4.4530016e-06
24656,than those,4,6,26,36,"The tumors became smaller than those in the non-radiated group, with both showing a parallel relation.",25168696_5,-1,-1,-1,-1,24656,-1,5.664309e-06,0.9999875,6.806668e-06
24667,function,17,18,125,133,"This process also changed CTLA-4 molecule expression on the surfaces of CD4(+)CD25(+)Treg cells and reduced their inhibitory function against CD4(+)CD25(-)T cell proliferation, and the suppression function of CD4(+)CD25(+)Treg cells was further weakened with the introduction of the CTLA-4 inhibitor.",25168696_8,0,1,2,-1,24667,-1,2.5727095e-05,0.99993765,3.666866e-05
24670,function,26,27,197,205,"This process also changed CTLA-4 molecule expression on the surfaces of CD4(+)CD25(+)Treg cells and reduced their inhibitory function against CD4(+)CD25(-)T cell proliferation, and the suppression function of CD4(+)CD25(+)Treg cells was further weakened with the introduction of the CTLA-4 inhibitor.",25168696_8,0,1,2,-1,24670,-1,1.4353282e-05,0.9999726,1.3086222e-05
24673,the CTLA-4,37,39,279,289,"This process also changed CTLA-4 molecule expression on the surfaces of CD4(+)CD25(+)Treg cells and reduced their inhibitory function against CD4(+)CD25(-)T cell proliferation, and the suppression function of CD4(+)CD25(+)Treg cells was further weakened with the introduction of the CTLA-4 inhibitor.",25168696_8,-1,-1,-1,-1,24673,-1,0.0033853764,0.37049127,0.62612337
24674,that the,2,4,21,29,Findings demonstrate that the reduction of CTLA-4 expression on the CD4(+)CD25(+)Treg cell surface and the further inhibition of cell function may be considered as important regulators of LDR-induced immunomodulatory effects.,25168696_9,-1,-1,-1,-1,24674,-1,4.0663153e-06,0.99999213,3.8445273e-06
24679,cell function,18,20,129,142,Findings demonstrate that the reduction of CTLA-4 expression on the CD4(+)CD25(+)Treg cell surface and the further inhibition of cell function may be considered as important regulators of LDR-induced immunomodulatory effects.,25168696_9,-1,-1,-1,-1,24679,-1,1.7474445e-05,1.2093602e-05,0.99997044
24695,to that,18,20,116,123,"Herein, we characterize the postpartum murine mammary gland and find an orchestrated influx of immune cells similar to that which occurs during wound healing.",25187059_3,-1,-1,-1,-1,24695,-1,1.1013584e-05,0.99998164,7.309671e-06
24699,the transient,15,17,89,102,"Further, the normal involuting gland may be in an immunosuppressed state as discerned by the transient presence of Foxp3(+) regulatory T cells and IL-10(+) macrophages with T cell suppressive function.",25187059_4,-1,-1,-1,-1,24699,-1,5.0588524e-06,0.9999908,4.0951077e-06
24704,function,32,33,192,200,"Further, the normal involuting gland may be in an immunosuppressed state as discerned by the transient presence of Foxp3(+) regulatory T cells and IL-10(+) macrophages with T cell suppressive function.",25187059_4,0,1,2,-1,24704,-1,0.002996633,0.93576455,0.061238766
24720,cytokine IL-10,9,11,80,94,"Targeting involution with a neutralizing antibody against the immunosuppressive cytokine IL-10 reduces tumor growth in involution group mice but not in nulliparous mice, implicating the involution microenvironment as the primary target of IL-10 treatment.",25187059_7,-1,-1,-1,-1,24720,-1,0.99996734,4.6999626e-06,2.8061027e-05
24726,Relevance to,0,2,0,12,"Relevance to women is implicated, as we find postlactational human breast tissue has transient high IL-10(+) and Foxp3(+) immune cell infiltrate.",25187059_8,-1,-1,-1,-1,24726,-1,6.61175e-06,0.99998593,7.4598893e-06
24727,tissue,12,13,74,80,"Relevance to women is implicated, as we find postlactational human breast tissue has transient high IL-10(+) and Foxp3(+) immune cell infiltrate.",25187059_8,-1,1,2,-1,24727,-1,0.00043010898,0.82510865,0.17446123
24749,Then the,0,2,0,8,Then the vaccine was injected into C57BL/6J mice and the effect was examined.,25198660_3,-1,-1,-1,-1,24749,-1,4.897689e-06,0.99999094,4.214517e-06
24751,that the,3,5,16,24,"Our study found that the vaccine could promote the proliferation of antigen-specific T cells, enhance the killing activity of cytotoxic T lymphocytes (CTLs), promote Th1-type cell-mediated secretion of cytokines IFN- and IL-2 while inhibiting Th2-type cell-mediated secretion of IL-4, and inhibit the secretion of TGF-.",25198660_4,-1,-1,-1,-1,24751,-1,5.1106445e-06,0.99999046,4.4684366e-06
24753,antigen-specific T cells,11,14,68,92,"Our study found that the vaccine could promote the proliferation of antigen-specific T cells, enhance the killing activity of cytotoxic T lymphocytes (CTLs), promote Th1-type cell-mediated secretion of cytokines IFN- and IL-2 while inhibiting Th2-type cell-mediated secretion of IL-4, and inhibit the secretion of TGF-.",25198660_4,-1,-1,-1,-1,24753,-1,0.60306907,0.00047773318,0.39645323
24757,Th1-type cell-mediated,28,30,166,188,"Our study found that the vaccine could promote the proliferation of antigen-specific T cells, enhance the killing activity of cytotoxic T lymphocytes (CTLs), promote Th1-type cell-mediated secretion of cytokines IFN- and IL-2 while inhibiting Th2-type cell-mediated secretion of IL-4, and inhibit the secretion of TGF-.",25198660_4,-1,-1,-1,-1,24757,-1,0.0007744084,0.19410717,0.8051184
24758,cytokines IFN-,32,34,202,217,"Our study found that the vaccine could promote the proliferation of antigen-specific T cells, enhance the killing activity of cytotoxic T lymphocytes (CTLs), promote Th1-type cell-mediated secretion of cytokines IFN- and IL-2 while inhibiting Th2-type cell-mediated secretion of IL-4, and inhibit the secretion of TGF-.",25198660_4,-1,-1,-1,-1,24758,-1,0.99997187,4.171316e-06,2.3998773e-05
24759,Th2-type cell-mediated,38,40,244,266,"Our study found that the vaccine could promote the proliferation of antigen-specific T cells, enhance the killing activity of cytotoxic T lymphocytes (CTLs), promote Th1-type cell-mediated secretion of cytokines IFN- and IL-2 while inhibiting Th2-type cell-mediated secretion of IL-4, and inhibit the secretion of TGF-.",25198660_4,-1,-1,-1,-1,24759,-1,0.00084498856,0.21105133,0.7881037
24766,therapy,22,23,152,159,"Generally, the epigenetically modified vaccine could enhance the body's antitumor immune response, providing feasibility research on cancer vaccine for therapy of pancreatic cancer.",25198660_5,0,1,-1,-1,24766,-1,5.247325e-06,0.9999895,5.211036e-06
24769,therapy,9,10,69,76,The long-lasting clinical response by lymphoma patients to anti-CD20 therapy has been attributed to the induction of an anti-tumor adaptive immunity.,25231744_0,0,1,-1,-1,24769,-1,6.0912153e-06,0.99998784,6.057206e-06
24770,to the,13,15,97,103,The long-lasting clinical response by lymphoma patients to anti-CD20 therapy has been attributed to the induction of an anti-tumor adaptive immunity.,25231744_0,-1,-1,-1,-1,24770,-1,5.729627e-06,0.99998987,4.376669e-06
24776,tumor immunity,4,6,17,31,"Here, we compare tumor immunity in tumor-bearing animals that did or did not receive anti-CD20 treatment.",25231744_2,-1,-1,-1,-1,24776,-1,0.010497857,0.9889721,0.00053000136
24790,therapy,3,4,22,29,"Strikingly, anti-CD20 therapy reversed the initial expansion of Tregs, and was accompanied by a marked increase in the number of Th1 cells, with no detectable change in Th2 and Th17 cell numbers.",25231744_4,0,1,-1,-1,24790,-1,4.457487e-06,0.9999908,4.751187e-06
24796,Th17 cell,32,34,177,186,"Strikingly, anti-CD20 therapy reversed the initial expansion of Tregs, and was accompanied by a marked increase in the number of Th1 cells, with no detectable change in Th2 and Th17 cell numbers.",25231744_4,-1,-1,-1,-1,24796,-1,0.00030763508,0.008606207,0.9910862
24805,the transfer,15,17,78,90,"Also, CD4(+) effector memory T cells were evidenced in surviving animals, and the transfer of CD4(+) T cells induced long-term protection.",25231744_6,-1,-1,-1,-1,24805,-1,4.8590764e-06,0.9999913,3.802449e-06
24808,therapy,3,4,16,23,"Thus, anti-CD20 therapy promotes strong anti-tumor adaptive immunity, opposes Treg expansion and inhibits tumor cells from maintaining an immunosuppressive environment.",25231744_7,0,1,-1,-1,24808,-1,4.693987e-06,0.9999912,4.1438e-06
24811,tumor cells,15,17,106,117,"Thus, anti-CD20 therapy promotes strong anti-tumor adaptive immunity, opposes Treg expansion and inhibits tumor cells from maintaining an immunosuppressive environment.",25231744_7,-1,-1,-1,-1,24811,-1,0.00015857967,0.0010547457,0.9987866
24813,T cells that,9,12,73,85,"CD1d-restricted NKT cells represent a unique lineage of immunoregulatory T cells that are divided into two groups, type I and type II, based on their TCR usage. Because there are no specific tools to identify type II NKT cells, little is known about their developmental requirements and functional regulation.",25236978_0,-1,-1,-1,-1,24813,-1,0.0014308626,0.057479557,0.9410896
24817,their TCR,26,28,144,153,"CD1d-restricted NKT cells represent a unique lineage of immunoregulatory T cells that are divided into two groups, type I and type II, based on their TCR usage. Because there are no specific tools to identify type II NKT cells, little is known about their developmental requirements and functional regulation.",25236978_0,-1,-1,-1,-1,24817,-1,1.1237233e-05,0.9999776,1.1176207e-05
24819,tools to,35,37,191,199,"CD1d-restricted NKT cells represent a unique lineage of immunoregulatory T cells that are divided into two groups, type I and type II, based on their TCR usage. Because there are no specific tools to identify type II NKT cells, little is known about their developmental requirements and functional regulation.",25236978_0,-1,-1,-1,-1,24819,-1,5.1375155e-06,0.9999912,3.7024467e-06
24823,functional regulation,51,53,287,308,"CD1d-restricted NKT cells represent a unique lineage of immunoregulatory T cells that are divided into two groups, type I and type II, based on their TCR usage. Because there are no specific tools to identify type II NKT cells, little is known about their developmental requirements and functional regulation.",25236978_0,-1,-1,-1,-1,24823,-1,7.784908e-06,0.99998593,6.252314e-06
24826,protein,13,14,91,98,"In our previous study, we showed that signaling lymphocytic activation molecule associated protein (SAP) is essential for the development of type II NKT cells.",25236978_1,0,1,-1,-1,24826,-1,1.1661912e-05,0.99997807,1.0313119e-05
24831,TCR transgenic,7,9,31,45,"Here, using a type II NKT-cell TCR transgenic mouse model, we demonstrated that CD1d-expressing hematopoietic cells, but not thymic epithelial cells, meditate efficient selection of type II NKT cells.",25236978_2,-1,-1,-1,-1,24831,-1,7.3134606e-06,0.9999821,1.0553403e-05
24840,protein,17,18,110,117,"Furthermore, we showed that SAP regulates type II NKT-cell development by controlling early growth response 2 protein and promyelocytic leukemia zinc finger expression.",25236978_3,0,1,-1,-1,24840,-1,8.5652726e-05,0.99987805,3.6302044e-05
24842,transgenic T cells,2,5,19,37,SAP-deficient 24 transgenic T cells (24 T cells) exhibited an immature phenotype with reduced Th2 cytokine-producing capacity and diminished cytotoxicity to CD1d-expressing lymphoma cells.,25236978_4,-1,-1,-1,-1,24842,-1,0.00062878337,0.055455502,0.94391567
24844,Th2 cytokine-producing,16,18,98,120,SAP-deficient 24 transgenic T cells (24 T cells) exhibited an immature phenotype with reduced Th2 cytokine-producing capacity and diminished cytotoxicity to CD1d-expressing lymphoma cells.,25236978_4,-1,-1,-1,-1,24844,-1,0.20670359,0.7891634,0.004132998
24849,IFN regulatory factor,13,16,87,108,The impaired IL-4 production by SAP-deficient 24 T cells was associated with reduced IFN regulatory factor 4 and GATA-3 induction following TCR stimulation.,25236978_5,-1,-1,-1,-1,24849,-1,0.99629587,0.0029216916,0.0007824813
24851,TCR,21,22,142,145,The impaired IL-4 production by SAP-deficient 24 T cells was associated with reduced IFN regulatory factor 4 and GATA-3 induction following TCR stimulation.,25236978_5,-1,1,2,-1,24851,-1,1.2216764e-05,0.99997497,1.2760493e-05
24856,these T cells,3,6,22,35,Aberrant responses of these T cells may contribute to the immune dysregulation observed in X-linked lymphoproliferative disease caused by mutations in SAP.,25236978_7,-1,-1,-1,-1,24856,-1,0.0010780308,0.060041368,0.9388806
24857,to the immune dysregulation,8,12,51,78,Aberrant responses of these T cells may contribute to the immune dysregulation observed in X-linked lymphoproliferative disease caused by mutations in SAP.,25236978_7,-1,-1,-1,-1,24857,-1,1.7366994e-05,0.9999689,1.3695646e-05
24864,relevant TH-1-polarized immune responses,22,26,155,195,"To further elucidate why an allogeneic gene-modified [interleukin-7 (IL-7)/CD80-cotransfected] renal cell cancer (RCC) vaccine failed to induce clinically relevant TH-1-polarized immune responses, peripheral blood mononuclear cells from enrolled study patients were analyzed by gene expression profiling (GEP) both prior and after vaccination.",25242680_1,-1,-1,-1,-1,24864,-1,0.0859861,0.9119673,0.0020465967
24865,blood,28,29,208,213,"To further elucidate why an allogeneic gene-modified [interleukin-7 (IL-7)/CD80-cotransfected] renal cell cancer (RCC) vaccine failed to induce clinically relevant TH-1-polarized immune responses, peripheral blood mononuclear cells from enrolled study patients were analyzed by gene expression profiling (GEP) both prior and after vaccination.",25242680_1,0,1,-1,-1,24865,-1,0.0001765109,0.9995358,0.0002877393
24870,factors,23,24,189,196,"At baseline before vaccination, a profound downregulation of gene signatures associated with antigen presentation, immune response/T cells, cytokines/chemokines and signaling/transcription factors was observed in RCC patients as compared to healthy controls.",25242680_2,0,1,-1,-1,24870,-1,4.7596873e-06,0.9999901,5.106536e-06
24875,that the,6,8,40,48,"Most interestingly, our results suggest that the nuclear factor-kappa B signaling pathway might be involved in the impairment of immunological responsiveness and the observed TH-2 deviation.",25242680_4,-1,-1,-1,-1,24875,-1,4.6449813e-06,0.9999914,3.899488e-06
24876,factor-kappa,9,10,57,69,"Most interestingly, our results suggest that the nuclear factor-kappa B signaling pathway might be involved in the impairment of immunological responsiveness and the observed TH-2 deviation.",25242680_4,0,1,-1,-1,24876,-1,5.341785e-05,0.9999299,1.6617187e-05
24887,the cellular,9,11,50,62,"During the past decade, a better understanding of the cellular and molecular mechanisms underlying tumor immunity has provided the appropriate framework for the development of therapeutic strategies for cancer immunotherapy.",25253145_0,-1,-1,-1,-1,24887,-1,0.0059947628,0.5665863,0.42741892
24888,tumor immunity,15,17,99,113,"During the past decade, a better understanding of the cellular and molecular mechanisms underlying tumor immunity has provided the appropriate framework for the development of therapeutic strategies for cancer immunotherapy.",25253145_0,-1,-1,-1,-1,24888,-1,0.012333904,0.98703706,0.0006289819
24892,this complex,1,3,6,18,"Under this complex scenario, galectins have emerged as promising molecular targets for cancer therapy responsible of creating immunosuppressive microenvironments at sites of tumor growth and metastasis.",25253145_1,-1,-1,-1,-1,24892,-1,7.4250274e-06,0.9999871,5.4580173e-06
24894,therapy,14,15,94,101,"Under this complex scenario, galectins have emerged as promising molecular targets for cancer therapy responsible of creating immunosuppressive microenvironments at sites of tumor growth and metastasis.",25253145_1,0,1,-1,-1,24894,-1,4.441409e-06,0.9999908,4.787566e-06
24898,to thwart the,13,16,74,87,"Galectins, expressed in tumor, stromal, and endothelial cells, contribute to thwart the development of immune responses by favoring the expansion of T regulatory cells and contributing to their immunosuppressive activity, driving the differentiation of tolerogenic dendritic cells, limiting T cell viability, and maintaining T cell anergy.",25253145_2,-1,-1,-1,-1,24898,-1,8.1779235e-06,0.9999857,6.088792e-06
24903,to their,30,32,185,193,"Galectins, expressed in tumor, stromal, and endothelial cells, contribute to thwart the development of immune responses by favoring the expansion of T regulatory cells and contributing to their immunosuppressive activity, driving the differentiation of tolerogenic dendritic cells, limiting T cell viability, and maintaining T cell anergy.",25253145_2,-1,-1,-1,-1,24903,-1,6.3512875e-06,0.9999877,5.9382246e-06
24907,limiting T cell,43,46,282,297,"Galectins, expressed in tumor, stromal, and endothelial cells, contribute to thwart the development of immune responses by favoring the expansion of T regulatory cells and contributing to their immunosuppressive activity, driving the differentiation of tolerogenic dendritic cells, limiting T cell viability, and maintaining T cell anergy.",25253145_2,-1,-1,-1,-1,24907,-1,0.005637154,0.00046264197,0.9939002
24921,The tumor-promoting,0,2,0,19,The tumor-promoting effect of inflammation is now widely recognized and understood.,25258409_1,-1,-1,-1,-1,24921,-1,1.380226e-05,0.99998033,5.8217593e-06
24922,that treatment,4,6,29,43,"Recent studies have revealed that treatment with nicotine ameliorates colitis in humans and experimental murine models, whereas the effect of nicotine on colitis-associated colonic tumorigenesis remains unclear.",25258409_2,-1,-1,-1,-1,24922,-1,6.0654497e-06,0.99998987,4.100438e-06
24933,receptor,9,10,67,75,Nicotine and a selective agonist of the 7-nicotinic acetylcholine receptor (7-nAChR) reduced the severity of DSS-induced acute colonic inflammation.,25258409_5,0,1,2,-1,24933,-1,0.0013413326,0.15729499,0.84136367
24936,the IL-6,22,24,142,150,"In addition, the suppressive effect of nicotine on acute colitis was attenuated by an antagonist of 7-nAChR. Furthermore, nicotine inhibited the IL-6 production of CD4 T cells in the DSS-induced inflamed colonic mucosa.",25258409_6,-1,-1,-1,-1,24936,-1,0.85443807,0.14331834,0.0022436148
24943,TNF-,6,7,45,50,Nicotine markedly inhibited the elevation of TNF- and IL-6 mRNA as well as phosphorylated signal transducer and activator of transcription (Stat) 3 expression in the colons of the tumor model mice.,25258409_8,0,1,-1,-1,24943,-1,0.00026945645,0.9996644,6.610264e-05
24948,the tumor,29,31,177,186,Nicotine markedly inhibited the elevation of TNF- and IL-6 mRNA as well as phosphorylated signal transducer and activator of transcription (Stat) 3 expression in the colons of the tumor model mice.,25258409_8,-1,-1,-1,-1,24948,-1,3.718747e-06,0.9999914,4.8885827e-06
24957,TNF-,40,41,290,295,"These results demonstrate that nicotine suppresses acute colitis and colitis-associated tumorigenesis, and this effect may be associated with the activation of 7-nAChR. Furthermore, it is presumed that nicotine downregulates the expression of inflammatory mediators such as IL-6/Stat3 and TNF-, thereby reducing the colonic tumorigenesis associated with chronic colitis.",25258409_9,0,1,-1,-1,24957,-1,0.0112545295,0.98848456,0.00026092865
24964,the cytokines they release,2,6,13,39,"Depending on the cytokines they release and the immune responses they mediate, CD4(+) T cells are classically divided into two major cell populations: Th1 and Th2 cells.",25261206_1,-1,-1,-1,-1,24964,-1,0.00010723619,0.99985635,3.6424466e-05
24965,the immune responses they,7,11,44,69,"Depending on the cytokines they release and the immune responses they mediate, CD4(+) T cells are classically divided into two major cell populations: Th1 and Th2 cells.",25261206_1,-1,-1,-1,-1,24965,-1,0.00024359788,0.99969625,6.0179296e-05
24972,T-helper cell subsets,11,14,80,101,"However, recent studies challenged this Th1/Th2 paradigm by discovering several T-helper cell subsets with specific differentiation program and functions, including Th17 cells, Treg cells, andTfh cells.",25261206_2,-1,-1,-1,-1,24972,-1,2.7895723e-05,4.6913574e-05,0.99992514
24973,functions,19,20,144,153,"However, recent studies challenged this Th1/Th2 paradigm by discovering several T-helper cell subsets with specific differentiation program and functions, including Th17 cells, Treg cells, andTfh cells.",25261206_2,0,1,2,-1,24973,-1,0.00016989434,0.99905473,0.00077539566
24974,"Th17 cells, Treg cells",22,27,165,187,"However, recent studies challenged this Th1/Th2 paradigm by discovering several T-helper cell subsets with specific differentiation program and functions, including Th17 cells, Treg cells, andTfh cells.",25261206_2,-1,-1,-1,-1,24974,-1,0.000118183765,0.0018793921,0.99800247
24975,Tfh cells,30,32,193,202,"However, recent studies challenged this Th1/Th2 paradigm by discovering several T-helper cell subsets with specific differentiation program and functions, including Th17 cells, Treg cells, andTfh cells.",25261206_2,-1,-1,-1,-1,24975,-1,0.0006234747,0.05016908,0.94920737
24978,the Th17,13,15,81,89,"In this chapter, we summarize the current understanding and recent progresses on the Th17 lineage differentiation and its effector impacts on variety of inflammatory responses or disease pathogenesis.",25261206_3,-1,-1,-1,-1,24978,-1,4.2060507e-05,0.9999212,3.676256e-05
24984,tolerance to tumor antigens,18,22,96,123,"Dendritic cells (DC) that interact with T cells represent a crucial site for the development of tolerance to tumor antigens, but there remains incomplete knowledge about how DC-tolerizing signals evolve during tumorigenesis.",25261236_1,-1,-1,-1,-1,24984,-1,0.10672719,0.8905389,0.0027339365
24990,receptors,24,25,144,153,"In this study, we show that DCs isolated from patients with metastatic or locally advanced breast cancer express high levels of the adiponectin receptors AdipoR1 and AdipoR2, which are sufficient to blunt antitumor immunity.",25261236_2,0,1,2,-1,24990,-1,0.0009077948,0.98700607,0.012086086
24992,immunity,35,36,215,223,"In this study, we show that DCs isolated from patients with metastatic or locally advanced breast cancer express high levels of the adiponectin receptors AdipoR1 and AdipoR2, which are sufficient to blunt antitumor immunity.",25261236_2,0,-1,2,-1,24992,-1,0.99988973,2.8032744e-05,8.2277315e-05
24993,receptor,13,14,109,117,Mechanistic investigations of ligand-receptor interactions on DCs revealed novel signaling pathways for each receptor.,25261236_3,0,1,2,-1,24993,-1,0.0038565,0.0018221888,0.99432135
25003,antigen-specific T-cell,20,22,128,151,"Stimulation of these pathways was sufficient to block activation of NF-B in DC, thereby attenuating their ability to stimulate antigen-specific T-cell responses.",25261236_5,-1,-1,-1,-1,25003,-1,0.8622229,0.00045700782,0.13732015
25007,therapy,24,25,160,167,"Furthermore, by defining a critical role for adiponectin signaling in this process, our work suggests new and broadly applicable strategies for immunometabolic therapy in patients with cancer.",25261236_7,0,1,-1,-1,25007,-1,6.478485e-06,0.9999881,5.481105e-06
25008,peptide,1,2,19,26,Latency-associated peptide (LAP) - expressing regulatory T cells (Tregs) are important for immunological self-tolerance and immune homeostasis.,25268580_0,0,-1,2,-1,25008,-1,0.57648623,0.41547516,0.008038624
25018,blood,14,15,101,106,"The phenotypes, cytokine-release patterns, and suppressive ability of Tregs isolated from peripheral blood and tumor tissues were analyzed.",25268580_2,0,1,-1,-1,25018,-1,0.0007679176,0.98617584,0.013056288
25019,tumor tissues,16,18,111,124,"The phenotypes, cytokine-release patterns, and suppressive ability of Tregs isolated from peripheral blood and tumor tissues were analyzed.",25268580_2,-1,-1,-1,-1,25019,-1,1.135509e-05,0.99993587,5.2762003e-05
25020,that the,2,4,9,17,We found that the population of LAP-positive CD4Foxp3 Tregs significantly increased in peripheral blood and cancer tissues of CRC patients as compared to that in the peripheral blood and tissues of healthy subjects.,25268580_3,-1,-1,-1,-1,25020,-1,3.5080002e-06,0.9999927,3.7538275e-06
25022,blood,13,14,100,105,We found that the population of LAP-positive CD4Foxp3 Tregs significantly increased in peripheral blood and cancer tissues of CRC patients as compared to that in the peripheral blood and tissues of healthy subjects.,25268580_3,0,1,-1,-1,25022,-1,0.00038957447,0.98845214,0.0111582335
25023,tissues,16,17,117,124,We found that the population of LAP-positive CD4Foxp3 Tregs significantly increased in peripheral blood and cancer tissues of CRC patients as compared to that in the peripheral blood and tissues of healthy subjects.,25268580_3,-1,1,2,-1,25023,-1,0.0004191337,0.39341465,0.60616624
25024,to that,22,24,153,160,We found that the population of LAP-positive CD4Foxp3 Tregs significantly increased in peripheral blood and cancer tissues of CRC patients as compared to that in the peripheral blood and tissues of healthy subjects.,25268580_3,-1,-1,-1,-1,25024,-1,4.284542e-06,0.99999094,4.7337485e-06
25026,blood,27,28,179,184,We found that the population of LAP-positive CD4Foxp3 Tregs significantly increased in peripheral blood and cancer tissues of CRC patients as compared to that in the peripheral blood and tissues of healthy subjects.,25268580_3,0,1,-1,-1,25026,-1,0.00016057737,0.9962968,0.0035425522
25027,tissues,29,30,189,196,We found that the population of LAP-positive CD4Foxp3 Tregs significantly increased in peripheral blood and cancer tissues of CRC patients as compared to that in the peripheral blood and tissues of healthy subjects.,25268580_3,-1,1,2,-1,25027,-1,4.3992583e-05,0.9954222,0.004533764
25030,tumor necrosis factor receptor,10,14,65,95,"However, LAP Tregs expressed more effector molecules, including tumor necrosis factor receptor II, granzyme B, perforin, Ki67, and CCR5, than their LAP negative counterparts.",25268580_5,-1,-1,-1,-1,25030,-1,0.98447555,0.003963437,0.011561043
25032,than their,26,28,138,148,"However, LAP Tregs expressed more effector molecules, including tumor necrosis factor receptor II, granzyme B, perforin, Ki67, and CCR5, than their LAP negative counterparts.",25268580_5,-1,-1,-1,-1,25032,-1,7.68483e-06,0.9999846,7.701146e-06
25036,factor--mediated,14,15,89,106,"The in vitro immunosuppressive activity of LAP Tregs, exerted via a transforming growth factor--mediated mechanism, was more potent than that of LAP Tregs.",25268580_6,0,1,-1,-1,25036,-1,0.9965809,0.00028626993,0.0031328555
25037,than that,20,22,134,143,"The in vitro immunosuppressive activity of LAP Tregs, exerted via a transforming growth factor--mediated mechanism, was more potent than that of LAP Tregs.",25268580_6,-1,-1,-1,-1,25037,-1,7.456931e-06,0.999987,5.5442965e-06
25041,blood,10,11,66,71,"Furthermore, the enrichment of LAP Treg population in peripheral blood mononuclear cells (PBMCs) of CRC patients correlated with cancer metastases.",25268580_7,0,1,-1,-1,25041,-1,0.0016685377,0.98745894,0.010872531
25049,immune response to,17,20,108,126,The increased frequency of LAP Tregs in PBMCs of CRC patients suggests their potential role in controlling immune response to cancer and presents LAP as a marker of tumor-specific Tregs in CRC patients.,25268580_9,-1,-1,-1,-1,25049,-1,0.98078144,0.01852582,0.00069273106
25050,tumor-specific Tregs,28,30,166,186,The increased frequency of LAP Tregs in PBMCs of CRC patients suggests their potential role in controlling immune response to cancer and presents LAP as a marker of tumor-specific Tregs in CRC patients.,25268580_9,-1,-1,-1,-1,25050,-1,7.471701e-06,0.99998677,5.778332e-06
25052,tumor-suppressor gene,9,11,49,70,"Runt-related transcription factor 3 (Runx3) is a tumor-suppressor gene and plays an important role in immune regulation, whose reduced expression may play an important role in the development and progression of gastric carcinoma.",25270738_0,-1,-1,-1,-1,25052,-1,5.271454e-06,0.9999882,6.5394174e-06
25063,the relationship,25,27,145,161,The aim of this study was to investigate the role of Runx3 on the levels of transcription factors in patients with gastric carcinoma and analyze the relationship between the expression of Runx3 and Th1-type cytokines in peripheral blood mononuclear cells (PBMCs).,25270738_1,-1,-1,-1,-1,25063,-1,4.495724e-06,0.9999913,4.1623007e-06
25065,Th1-type cytokines,33,35,198,216,The aim of this study was to investigate the role of Runx3 on the levels of transcription factors in patients with gastric carcinoma and analyze the relationship between the expression of Runx3 and Th1-type cytokines in peripheral blood mononuclear cells (PBMCs).,25270738_1,-1,-1,-1,-1,25065,-1,0.026843993,0.9708882,0.0022678457
25066,blood,37,38,231,236,The aim of this study was to investigate the role of Runx3 on the levels of transcription factors in patients with gastric carcinoma and analyze the relationship between the expression of Runx3 and Th1-type cytokines in peripheral blood mononuclear cells (PBMCs).,25270738_1,0,1,-1,-1,25066,-1,0.024657095,0.73503655,0.24030638
25068,that the,3,5,19,27,"Our results showed that the expression levels of Runx3, T-bet, and IFN- in patients with gastric carcinoma were obviously lower than those in control groups, and there was a positive correlation between the expression of Runx3 and T-bet or IFN- in patients (p<0.01).",25270738_2,-1,-1,-1,-1,25068,-1,3.8046248e-06,0.99999213,4.0665946e-06
25071,than those,22,24,129,139,"Our results showed that the expression levels of Runx3, T-bet, and IFN- in patients with gastric carcinoma were obviously lower than those in control groups, and there was a positive correlation between the expression of Runx3 and T-bet or IFN- in patients (p<0.01).",25270738_2,-1,-1,-1,-1,25071,-1,5.9881927e-06,0.9999883,5.7058055e-06
25087,that the,38,40,242,250,"In order to further confirm this result, the Runx3 gene was constructed into pIRES2-eGFP and the recombined plasmid was transfected into SGC-7901 cells with liposome in vitro, the results obtained from the reverse transcription PCR indicated that the mRNA of Runx3, T-bet, or IFN- was significantly upregulated individually in Runx3 gene-transfected SGC-7901 cells.",25270738_3,-1,-1,-1,-1,25087,-1,4.089336e-06,0.9999918,4.1899143e-06
25092,that the,2,4,13,21,It suggested that the Runx3 and Th1-associated factors including T-bet and IFN- synchronization declines in gastric carcinoma may contribute to the development of cancer.,25270738_4,-1,-1,-1,-1,25092,-1,3.747429e-06,0.9999919,4.3637997e-06
25093,Th1-associated factors,6,8,32,54,It suggested that the Runx3 and Th1-associated factors including T-bet and IFN- synchronization declines in gastric carcinoma may contribute to the development of cancer.,25270738_4,-1,-1,-1,-1,25093,-1,5.11113e-06,0.9999882,6.666323e-06
25096,to the,19,21,142,148,It suggested that the Runx3 and Th1-associated factors including T-bet and IFN- synchronization declines in gastric carcinoma may contribute to the development of cancer.,25270738_4,-1,-1,-1,-1,25096,-1,4.9763944e-06,0.9999895,5.495763e-06
25097,immunity,7,8,59,67,Eosinophil granulocytes have been implicated in anticancer immunity but recent data indicate that eosinophils can also promote cancer.,25275020_0,0,-1,2,-1,25097,-1,0.9996829,0.00011950632,0.0001976156
25104,T-cells,16,17,137,144,"Importantly, 72% of patients with positive staining for phospho-signal-transducer-and-activator-of-transcription (pY-STAT3) in malignant T-cells also stained positively for eosinophils, whereas this was only observed in 28% of pY-STAT3-negative patients (p<0.01).",25275020_3,-1,1,2,-1,25104,-1,2.0712514e-05,1.2166474e-05,0.9999671
25106,T-cells,3,4,19,26,"Notably, malignant T-cells expressed eosinophilic activation and trafficking factors: High-mobility group BOX-1 protein (HMGB1) and interleukin 5 (IL5).",25275020_4,-1,1,2,-1,25106,-1,1.475307e-05,1.1732036e-05,0.99997354
25107,trafficking factors,8,10,65,84,"Notably, malignant T-cells expressed eosinophilic activation and trafficking factors: High-mobility group BOX-1 protein (HMGB1) and interleukin 5 (IL5).",25275020_4,-1,-1,-1,-1,25107,-1,1.2522252e-05,0.9999739,1.3526076e-05
25108,protein,14,15,112,119,"Notably, malignant T-cells expressed eosinophilic activation and trafficking factors: High-mobility group BOX-1 protein (HMGB1) and interleukin 5 (IL5).",25275020_4,0,1,-1,-1,25108,-1,1.2095307e-05,0.999977,1.08805e-05
25113,T-cells,8,9,49,56,"In conclusion, these data suggest that malignant T-cells orchestrate accumulation and activation of eosinophils supporting the notion of STAT3 being a putative target for therapy.",25275020_6,-1,1,2,-1,25113,-1,1.3107766e-05,7.784075e-06,0.99997914
25117,therapy,25,26,171,178,"In conclusion, these data suggest that malignant T-cells orchestrate accumulation and activation of eosinophils supporting the notion of STAT3 being a putative target for therapy.",25275020_6,0,1,-1,-1,25117,-1,5.1230227e-06,0.99999106,3.76704e-06
25121,tumour cells,12,14,98,110,"Tumour progression is associated with immune-suppressive conditions that facilitate the escape of tumour cells from the regimen of immune cells, subsequently paralysing the host defence mechanisms.",25284464_0,-1,-1,-1,-1,25121,-1,7.421702e-05,9.998037e-05,0.9998258
25129,the tumour,20,22,88,98,"Induction of CD4(+) CD25(+) FoxP3(+) T regulatory (Treg) cells has been implicated in the tumour immune escape mechanism, although the novel anti-cancer treatment strategies targeting Treg cells remain unknown.",25284464_1,-1,-1,-1,-1,25129,-1,4.875539e-06,0.9999908,4.308203e-06
25132,targeting Treg cells,32,35,176,196,"Induction of CD4(+) CD25(+) FoxP3(+) T regulatory (Treg) cells has been implicated in the tumour immune escape mechanism, although the novel anti-cancer treatment strategies targeting Treg cells remain unknown.",25284464_1,-1,-1,-1,-1,25132,-1,0.0019671156,0.1381623,0.85987055
25139,to the,24,26,140,146,"The focus of this study is to define the interaction between tumour and immune system, i.e. how immune tolerance starts and gradually leads to the induction of adaptive Treg cells in the tumour microenvironment.",25284464_2,-1,-1,-1,-1,25139,-1,4.2094666e-06,0.99999154,4.205454e-06
25141,the tumour,32,34,183,193,"The focus of this study is to define the interaction between tumour and immune system, i.e. how immune tolerance starts and gradually leads to the induction of adaptive Treg cells in the tumour microenvironment.",25284464_2,-1,-1,-1,-1,25141,-1,4.758894e-06,0.99999034,4.902659e-06
25142,protein,5,6,54,61,Our study identified hyperactivated mitogen-activated protein kinase kinase (MEK)/extracellular signal-regulated kinase (ERK) -signalling as a potential target for reversing Treg cell augmentation in breast cancer patients.,25284464_3,0,1,-1,-1,25142,-1,0.0001283423,0.99981886,5.2877724e-05
25146,factor-,13,14,107,115,"In more mechanistic detail, pharmacological inhibitors of MEK/ERK signalling inhibited transforming growth factor- (TGF-) production in tumour cells that essentially blocked TGF--SMAD3/SMAD4-mediated induction of CD25/interleukin-2 receptor  on CD4(+) T-cell surface.",25284464_4,0,1,-1,-1,25146,-1,0.9999312,6.3596804e-06,6.2486426e-05
25148,tumour cells that,19,22,138,155,"In more mechanistic detail, pharmacological inhibitors of MEK/ERK signalling inhibited transforming growth factor- (TGF-) production in tumour cells that essentially blocked TGF--SMAD3/SMAD4-mediated induction of CD25/interleukin-2 receptor  on CD4(+) T-cell surface.",25284464_4,-1,-1,-1,-1,25148,-1,8.37958e-05,0.998307,0.0016092078
25149,receptor,28,29,235,243,"In more mechanistic detail, pharmacological inhibitors of MEK/ERK signalling inhibited transforming growth factor- (TGF-) production in tumour cells that essentially blocked TGF--SMAD3/SMAD4-mediated induction of CD25/interleukin-2 receptor  on CD4(+) T-cell surface.",25284464_4,0,1,2,-1,25149,-1,0.37650087,0.0023262084,0.6211729
25150,T-cell,33,34,256,262,"In more mechanistic detail, pharmacological inhibitors of MEK/ERK signalling inhibited transforming growth factor- (TGF-) production in tumour cells that essentially blocked TGF--SMAD3/SMAD4-mediated induction of CD25/interleukin-2 receptor  on CD4(+) T-cell surface.",25284464_4,-1,1,2,-1,25150,-1,1.893313e-05,1.046711e-05,0.99997056
25152,those cells,8,10,54,65,"As a result high-affinity binding of interleukin-2 on those cells was prohibited, causing lack of Janus kinase 1 (JAK1)/JAK3-mediated signal transducer and activator of transcription 3 (STAT3)/STAT5 activation required for FoxP3 expression.",25284464_5,-1,-1,-1,-1,25152,-1,3.0484125e-05,1.7706843e-05,0.9999517
25157,the nano-curcumin made,23,26,140,162,"Finally, for a more radical approach towards a safe MEK inhibitor, we validate the potential of multi-kinase inhibitor curcumin, especially the nano-curcumin made out of pure curcumin with greater bioavailability; in repealing tumour-shed TGF--induced Treg cell augmentation.",25284464_6,-1,-1,-1,-1,25157,-1,9.785142e-06,0.9999825,7.780554e-06
25158,tumour-shed TGF--induced Treg cell,36,40,227,262,"Finally, for a more radical approach towards a safe MEK inhibitor, we validate the potential of multi-kinase inhibitor curcumin, especially the nano-curcumin made out of pure curcumin with greater bioavailability; in repealing tumour-shed TGF--induced Treg cell augmentation.",25284464_6,-1,-1,-1,-1,25158,-1,0.0022383512,0.9323281,0.06543354
25160,T-cell,15,16,91,97,"Recent studies on acute myelogenous leukemia (AML) patients have revealed the existence of T-cell immunodeficiencies, characterized by peripheral T lymphocytes that are unable to interact with blasts, reduced thymic emigrants and oligoclonal restricted repertoires.",25382729_0,-1,1,2,-1,25160,-1,1.0460942e-05,5.6798185e-06,0.9999838
25161,T lymphocytes that,21,24,146,164,"Recent studies on acute myelogenous leukemia (AML) patients have revealed the existence of T-cell immunodeficiencies, characterized by peripheral T lymphocytes that are unable to interact with blasts, reduced thymic emigrants and oligoclonal restricted repertoires.",25382729_0,-1,-1,-1,-1,25161,-1,0.0005697196,0.014245238,0.985185
25165,that there,3,5,27,37,"These observations suggest that there is a profound thymic dysregulation, which is difficult to study in AML patients.",25382729_1,-1,-1,-1,-1,25165,-1,4.6389973e-06,0.99999166,3.7257832e-06
25170,thymus,15,16,95,101,"Using the C1498 AML mouse model, we demonstrated that leukemia development was associated with thymus atrophy, which was defined by abnormal organ weight and reduced cellularity.",25382729_2,-1,1,2,-1,25170,-1,0.0005203967,0.99862635,0.0008532881
25172,T-cell,15,16,73,79,"In addition, we observed a dramatic loss of peripheral CD4(+) and CD8(+) T-cell numbers with increased frequencies of CD4(+) FoxP3(+) regulatory and activated/memory Tcells.",25382729_3,-1,1,2,-1,25172,-1,1.2266962e-05,7.3549245e-06,0.99998033
25176,to this,4,6,37,44,"Investigating the mechanisms leading to this atrophy, we observed a significant accumulation of the monocyte chemoattractant protein 1 (MCP-1/CCL2) in thymi of leukemic mice.",25382729_4,-1,-1,-1,-1,25176,-1,6.0015323e-06,0.9999876,6.384804e-06
25177,the monocyte chemoattractant protein 1,14,19,96,134,"Investigating the mechanisms leading to this atrophy, we observed a significant accumulation of the monocyte chemoattractant protein 1 (MCP-1/CCL2) in thymi of leukemic mice.",25382729_4,-1,-1,-1,-1,25177,-1,0.003299137,0.9954464,0.0012544758
25181,T-cell,17,18,122,128,"Treatment of AML-bearing animals with a blocking anti-CCL2 antibody revealed a lower tumor burden, augmented antileukemic T-cell responses, and improved survival rate compared to nontreated mice.",25382729_5,-1,1,2,-1,25181,-1,4.712132e-05,1.613973e-05,0.9999368
25186,that the CCL2 protein,4,8,20,41,"Altogether, we show that the CCL2 protein participates in thymic atrophy in AML mice, and this could have important implications for future immunotherapeutic strategies.",25382729_7,-1,-1,-1,-1,25186,-1,0.00026448703,0.999655,8.0520564e-05
25189,immune responses to,1,4,9,28,"Adaptive immune responses to Ags released by dying cells play a critical role in the development of autoimmunity, allograft rejection, and spontaneous as well as therapy-induced tumor rejection.",25385820_0,-1,-1,-1,-1,25189,-1,0.9917321,0.0077430694,0.0005247371
25191,cells play,8,10,51,61,"Adaptive immune responses to Ags released by dying cells play a critical role in the development of autoimmunity, allograft rejection, and spontaneous as well as therapy-induced tumor rejection.",25385820_0,-1,-1,-1,-1,25191,-1,0.0039969175,0.22343338,0.77256966
25193,therapy-induced tumor,27,29,162,183,"Adaptive immune responses to Ags released by dying cells play a critical role in the development of autoimmunity, allograft rejection, and spontaneous as well as therapy-induced tumor rejection.",25385820_0,-1,-1,-1,-1,25193,-1,6.9412886e-06,0.99998856,4.4702356e-06
25199,immune response to cell-associated,23,27,142,176,"Although cell death in these situations is considered sterile, various reports have implicated type I IFNs as drivers of the ensuing adaptive immune response to cell-associated Ags.",25385820_1,-1,-1,-1,-1,25199,-1,0.91332966,0.0028165914,0.08385374
25202,this type,6,8,38,47,"However, the mechanisms that underpin this type I IFN production are poorly defined.",25385820_2,-1,-1,-1,-1,25202,-1,1.9727488e-05,0.9999689,1.1361368e-05
25208,cells to,22,24,123,131,"In this article, we show that dendritic cells (DCs) can uptake and sense nuclear DNA-associated entities released by dying cells to induce type I IFN.",25385820_3,-1,-1,-1,-1,25208,-1,0.003786262,0.3283305,0.6678833
25213,function,13,14,70,78,"Remarkably, this molecular pathway requires STING, but not TLR or NLR function, and results in the activation of IRF3 in a TBK1-dependent manner.",25385820_4,0,1,2,-1,25213,-1,4.838576e-05,0.999856,9.5608295e-05
25218,function,7,8,33,41,DCs are shown to depend on STING function in vivo to efficiently prime IFN-dependent CD8(+) T cell responses to tumor Ags.,25385820_5,0,1,2,-1,25218,-1,2.8078714e-05,0.99994326,2.8658962e-05
25222,to tumor,19,21,109,117,DCs are shown to depend on STING function in vivo to efficiently prime IFN-dependent CD8(+) T cell responses to tumor Ags.,25385820_5,-1,-1,-1,-1,25222,-1,7.630416e-06,0.9999856,6.7375568e-06
25223,the generation,9,11,51,65,"Furthermore, loss of STING activity in DCs impairs the generation of follicular Th cells and plasma cells, as well as anti-nuclear Abs, in an inducible model of systemic lupus erythematosus.",25385820_6,-1,-1,-1,-1,25223,-1,5.9901317e-06,0.9999887,5.2932596e-06
25224,Th cells,13,15,80,88,"Furthermore, loss of STING activity in DCs impairs the generation of follicular Th cells and plasma cells, as well as anti-nuclear Abs, in an inducible model of systemic lupus erythematosus.",25385820_6,-1,-1,-1,-1,25224,-1,1.0059917e-05,8.426419e-06,0.9999815
25225,plasma cells,16,18,93,105,"Furthermore, loss of STING activity in DCs impairs the generation of follicular Th cells and plasma cells, as well as anti-nuclear Abs, in an inducible model of systemic lupus erythematosus.",25385820_6,-1,-1,-1,-1,25225,-1,1.2673563e-05,7.4456584e-06,0.99998
25227,that the,3,5,23,31,"These findings suggest that the STING pathway could be manipulated to enable the rational design of immunotherapies that enhance or diminish antitumor and autoimmune responses, respectively.",25385820_7,-1,-1,-1,-1,25227,-1,4.381866e-06,0.999992,3.590143e-06
25235,These cells,0,2,0,11,"These cells constitutively or inducibly express a number of receptors of the TNFR and TLR families, whose signals are transduced by TNFR-associated factor (TRAF) molecules.",25422508_1,-1,-1,-1,-1,25235,-1,1.9193432e-05,2.2348802e-05,0.9999585
25236,receptors,9,10,60,69,"These cells constitutively or inducibly express a number of receptors of the TNFR and TLR families, whose signals are transduced by TNFR-associated factor (TRAF) molecules.",25422508_1,0,1,2,-1,25236,-1,6.951047e-05,9.117767e-05,0.9998393
25237,the TNFR,11,13,73,81,"These cells constitutively or inducibly express a number of receptors of the TNFR and TLR families, whose signals are transduced by TNFR-associated factor (TRAF) molecules.",25422508_1,-1,-1,-1,-1,25237,-1,1.3164455e-05,0.9999764,1.0419098e-05
25240,TNFR-associated factor,22,24,132,154,"These cells constitutively or inducibly express a number of receptors of the TNFR and TLR families, whose signals are transduced by TNFR-associated factor (TRAF) molecules.",25422508_1,-1,-1,-1,-1,25240,-1,7.2808702e-06,0.99998677,5.9903086e-06
25242,that TRAF3,4,6,24,34,"In vitro studies showed that TRAF3 is required for TLR-induced type I IFN production, but the in vivo function of TRAF3 in myeloid cells remains unknown.",25422508_2,-1,-1,-1,-1,25242,-1,1.2067307e-05,0.99998057,7.353797e-06
25243,TLR-induced type,9,11,51,67,"In vitro studies showed that TRAF3 is required for TLR-induced type I IFN production, but the in vivo function of TRAF3 in myeloid cells remains unknown.",25422508_2,-1,-1,-1,-1,25243,-1,7.419526e-06,0.999985,7.567782e-06
25246,function,19,20,102,110,"In vitro studies showed that TRAF3 is required for TLR-induced type I IFN production, but the in vivo function of TRAF3 in myeloid cells remains unknown.",25422508_2,0,1,2,-1,25246,-1,1.0075861e-05,0.9999839,5.970501e-06
25250,the generation,6,8,27,41,"In this article, we report the generation and characterization of myeloid cell-specific TRAF3-deficient (M-TRAF3(-/-)) mice, which allowed us to gain insights into the in vivo functions of TRAF3 in myeloid cells.",25422508_3,-1,-1,-1,-1,25250,-1,4.7287986e-06,0.9999908,4.4972703e-06
25251,cell-specific TRAF3-deficient,12,14,74,103,"In this article, we report the generation and characterization of myeloid cell-specific TRAF3-deficient (M-TRAF3(-/-)) mice, which allowed us to gain insights into the in vivo functions of TRAF3 in myeloid cells.",25422508_3,-1,-1,-1,-1,25251,-1,0.012612328,0.10502187,0.88236576
25254,functions,30,31,176,185,"In this article, we report the generation and characterization of myeloid cell-specific TRAF3-deficient (M-TRAF3(-/-)) mice, which allowed us to gain insights into the in vivo functions of TRAF3 in myeloid cells.",25422508_3,0,1,2,-1,25254,-1,9.701354e-06,0.99998116,9.096091e-06
25257,that TRAF3,2,4,9,19,"We found that TRAF3 ablation did not affect the maturation or homeostasis of myeloid cells in young adult mice, even though TRAF3-deficient macrophages and neutrophils exhibited constitutive NF-B2 activation.",25422508_4,-1,-1,-1,-1,25257,-1,9.959235e-06,0.9999833,6.692611e-06
25260,though TRAF3-deficient,21,23,117,139,"We found that TRAF3 ablation did not affect the maturation or homeostasis of myeloid cells in young adult mice, even though TRAF3-deficient macrophages and neutrophils exhibited constitutive NF-B2 activation.",25422508_4,-1,-1,-1,-1,25260,-1,0.00012225186,0.9998368,4.0901083e-05
25269,Taken together,0,2,0,14,"Taken together, our findings indicate that TRAF3 expressed in myeloid cells regulates immune responses in myeloid cells and acts to inhibit inflammation and tumor development in mice.",25422508_8,-1,-1,-1,-1,25269,-1,9.666802e-06,0.9999819,8.413758e-06
25270,that TRAF3,6,8,38,48,"Taken together, our findings indicate that TRAF3 expressed in myeloid cells regulates immune responses in myeloid cells and acts to inhibit inflammation and tumor development in mice.",25422508_8,-1,-1,-1,-1,25270,-1,7.3124293e-06,0.999987,5.731742e-06
25284,the Tregs,4,6,28,37,"The entire re-evaluation of the Tregs was supported due to the increasingly influential and state of the art immunological techniques, as cell sorting and also the expanding understanding of the immune system and its functions which aided in attaining a greater insight into the mechanisms of regulation and suppression.",25427312_1,-1,-1,-1,-1,25284,-1,4.901647e-06,0.99999,5.1152692e-06
25285,to the,9,11,56,62,"The entire re-evaluation of the Tregs was supported due to the increasingly influential and state of the art immunological techniques, as cell sorting and also the expanding understanding of the immune system and its functions which aided in attaining a greater insight into the mechanisms of regulation and suppression.",25427312_1,-1,-1,-1,-1,25285,-1,5.429324e-06,0.99998987,4.699324e-06
25292,functions,35,36,217,226,"The entire re-evaluation of the Tregs was supported due to the increasingly influential and state of the art immunological techniques, as cell sorting and also the expanding understanding of the immune system and its functions which aided in attaining a greater insight into the mechanisms of regulation and suppression.",25427312_1,0,1,2,-1,25292,-1,0.006058803,0.96875787,0.025183287
25295,that Tregs,5,7,44,54,"Many researchers nowadays have demonstrated that Tregs may well have therapeutic possibilities for the treatment of autoimmune diseases if it was a possibility to isolate and infuse these Tregs into patients, preferably without any harmful side effects.",25427312_2,-1,-1,-1,-1,25295,-1,7.1958552e-06,0.99998796,4.8196925e-06
25297,the treatment,13,15,99,112,"Many researchers nowadays have demonstrated that Tregs may well have therapeutic possibilities for the treatment of autoimmune diseases if it was a possibility to isolate and infuse these Tregs into patients, preferably without any harmful side effects.",25427312_2,-1,-1,-1,-1,25297,-1,7.8309995e-06,0.99998677,5.349616e-06
25299,these Tregs,27,29,182,193,"Many researchers nowadays have demonstrated that Tregs may well have therapeutic possibilities for the treatment of autoimmune diseases if it was a possibility to isolate and infuse these Tregs into patients, preferably without any harmful side effects.",25427312_2,-1,-1,-1,-1,25299,-1,8.043945e-06,0.9999865,5.433823e-06
25300,side effects,36,38,240,252,"Many researchers nowadays have demonstrated that Tregs may well have therapeutic possibilities for the treatment of autoimmune diseases if it was a possibility to isolate and infuse these Tregs into patients, preferably without any harmful side effects.",25427312_2,0,1,-1,-1,25300,-1,0.00040635295,0.9995129,8.0706224e-05
25303,their generation,8,10,42,58,"Therefore, modulation of Tregs as well as their generation is being researched since they were proposed as therapeutic interventions in several disease sceneries, nonetheless, sometimes with disastrous consequences.",25427312_3,-1,-1,-1,-1,25303,-1,7.5709827e-06,0.9999844,7.99367e-06
25312,the topic,12,14,81,90,"This literature study gives an overview of the current accessible information on the topic of the characterization, the generation, regulation and functions of the Inducible Treg populations and their subsets in the human immune system.",25427312_5,-1,-1,-1,-1,25312,-1,4.8077272e-06,0.99999034,4.8077823e-06
25314,the generation,18,20,116,130,"This literature study gives an overview of the current accessible information on the topic of the characterization, the generation, regulation and functions of the Inducible Treg populations and their subsets in the human immune system.",25427312_5,-1,-1,-1,-1,25314,-1,4.5832967e-06,0.9999893,6.1106048e-06
25316,functions,23,24,147,156,"This literature study gives an overview of the current accessible information on the topic of the characterization, the generation, regulation and functions of the Inducible Treg populations and their subsets in the human immune system.",25427312_5,0,1,2,-1,25316,-1,1.8884119e-05,0.9999565,2.4621033e-05
25319,their subsets,30,32,195,208,"This literature study gives an overview of the current accessible information on the topic of the characterization, the generation, regulation and functions of the Inducible Treg populations and their subsets in the human immune system.",25427312_5,-1,-1,-1,-1,25319,-1,0.0009864293,0.06206023,0.93695325
25326,those lymphocytes,20,22,136,153,OBJECTIVE: To investigate B7-H4 expression and its correlation with the number of infiltrating T lymphocytes and cytokine production by those lymphocytes in human cervical cancer and to determine the effect of recombinant B7-H4 on the active peripheral blood T cells of the patients in vitro.,25446402_0,-1,-1,-1,-1,25326,-1,1.2640182e-05,8.793313e-06,0.99997854
25331,blood T cells,38,41,253,266,OBJECTIVE: To investigate B7-H4 expression and its correlation with the number of infiltrating T lymphocytes and cytokine production by those lymphocytes in human cervical cancer and to determine the effect of recombinant B7-H4 on the active peripheral blood T cells of the patients in vitro.,25446402_0,-1,-1,-1,-1,25331,-1,0.00038561787,0.0014077008,0.9982066
25341,blood T lymphocytes,3,6,21,40,"After the peripheral blood T lymphocytes of patients were co-cultured with B7-H4, proliferation, apoptosis, and cell subtypes were analyzed using flow cytometry.",25446402_3,-1,-1,-1,-1,25341,-1,0.0009564016,0.00476468,0.9942789
25350,their IFN-,7,9,51,62,"The number of infiltrating CD8(+)T lymphocytes and their IFN- production in positive B7-H4 expression cervical cancers was significantly lower than in negative B7-H4 cases (P<0.01, P<0.05), but there was no significant difference between cases positive and negative for B7-H4 with respect to infiltrating FOXP3(+)T and CD4(+)T cells or TGF-1 production.",25446402_5,-1,-1,-1,-1,25350,-1,0.9586468,0.03936151,0.0019916666
25379,the T cells,8,11,48,59,B7-H4 had no significant effect on apoptosis of the T cells.,25446402_10,-1,-1,-1,-1,25379,-1,0.0012978531,0.113941506,0.8847607
25392,B7-H4 plays,0,2,0,11,B7-H4 plays an important role in depressing the anti-tumor immunity of CD8(+)T cell in microenvironments of cervical cancer.,25446402_13,-1,-1,-1,-1,25392,-1,0.0006791939,0.0057758903,0.99354494
25394,immunity,9,10,59,67,B7-H4 plays an important role in depressing the anti-tumor immunity of CD8(+)T cell in microenvironments of cervical cancer.,25446402_13,0,-1,2,-1,25394,-1,0.9863325,0.012671488,0.000996055
25399,receptor,8,9,35,43,"CD25, the alpha subunit of the IL2 receptor, is a canonical marker of regulatory T cells (Treg) and hence has been implicated in immune suppression in cancer.",25480168_0,0,1,2,-1,25399,-1,0.42949528,0.3269043,0.24360049
25403,tissues,17,18,100,107,"However, CD25 is also required for optimal expansion and activity of effector T cells in peripheral tissues.",25480168_1,-1,1,2,-1,25403,-1,0.00062400015,0.83610415,0.16327187
25412,tumor-infiltrating lymphocytes,14,16,90,120,"To investigate this possibility, we used multiparameter flow cytometry and IHC to analyze tumor-infiltrating lymphocytes (TIL) in primary high-grade serous carcinomas, the most common and fatal subtype of ovarian cancer.",25480168_3,-1,-1,-1,-1,25412,-1,0.0033523773,0.7927191,0.2039285
25420,T cells that,13,16,85,97,"In addition to conventional CD25FoxP3 Tregs, we identified a subset of CD25FoxP3 T cells that comprised up to 13% of CD4 TIL.",25480168_5,-1,-1,-1,-1,25420,-1,0.0016164958,0.06367821,0.9347053
25428,TIL subsets,2,4,11,22,"Among CD4 TIL subsets, CD25FoxP3 cells expressed the highest levels of PD-1.",25480168_7,-1,-1,-1,-1,25428,-1,0.00041413624,0.011346864,0.98823905
25433,T-helper cytokines,12,14,68,86,"Moreover, after in vitro stimulation, they failed to produce common T-helper cytokines (IFN, TNF, IL2, IL4, IL10, or IL17A), suggesting that they were functionally exhausted.",25480168_8,-1,-1,-1,-1,25433,-1,0.45417055,0.45927078,0.086558685
25435,TNF,17,18,94,98,"Moreover, after in vitro stimulation, they failed to produce common T-helper cytokines (IFN, TNF, IL2, IL4, IL10, or IL17A), suggesting that they were functionally exhausted.",25480168_8,0,1,-1,-1,25435,-1,0.0013735447,0.9984664,0.0001601102
25438,that they,30,32,138,147,"Moreover, after in vitro stimulation, they failed to produce common T-helper cytokines (IFN, TNF, IL2, IL4, IL10, or IL17A), suggesting that they were functionally exhausted.",25480168_8,-1,-1,-1,-1,25438,-1,6.2982213e-06,0.99998784,5.9087256e-06
25439,functionally,33,34,153,165,"Moreover, after in vitro stimulation, they failed to produce common T-helper cytokines (IFN, TNF, IL2, IL4, IL10, or IL17A), suggesting that they were functionally exhausted.",25480168_8,0,1,2,-1,25439,-1,9.125493e-05,0.99987185,3.684027e-05
25447,TIL that,8,10,45,53,"Thus, CD25 identifies a subset of CD4FoxP3 TIL that, despite being exhausted at diagnosis, have a strong, positive association with patient survival and warrant consideration as effector T cells for immunotherapy.",25480168_10,-1,-1,-1,-1,25447,-1,5.6190847e-06,0.9999888,5.564509e-06
25449,The antigenic,0,2,0,13,The antigenic variability of tumor cells leading to dynamic changes in cancer epitope landscape along with escape from immune surveillance by down-regulating tumor antigen expression/presentation and immune tolerance are major obstacles for the design of effective vaccines.,25483665_0,-1,-1,-1,-1,25449,-1,0.10612728,0.89048225,0.0033905234
25450,tumor cells,4,6,29,40,The antigenic variability of tumor cells leading to dynamic changes in cancer epitope landscape along with escape from immune surveillance by down-regulating tumor antigen expression/presentation and immune tolerance are major obstacles for the design of effective vaccines.,25483665_0,-1,-1,-1,-1,25450,-1,0.00022027687,0.0021416477,0.9976381
25452,tumor antigen,22,24,158,171,The antigenic variability of tumor cells leading to dynamic changes in cancer epitope landscape along with escape from immune surveillance by down-regulating tumor antigen expression/presentation and immune tolerance are major obstacles for the design of effective vaccines.,25483665_0,-1,-1,-1,-1,25452,-1,0.42596272,0.56847036,0.00556691
25456,targeting antigenically,18,20,124,147,We have developed a novel concept for immunogen construction based on introduction of massive mutations within the epitopes targeting antigenically variable pathogens and diseases.,25483665_1,-1,-1,-1,-1,25456,-1,0.09920021,0.89894813,0.0018517249
25457,that these,4,6,22,32,"Previously, we showed that these immunogens carrying large combinatorial libraries of mutated epitope variants, termed as variable epitope libraries (VELs), induce potent, broad and long lasting CD8+IFN-+ T-cell response as well as HIV-neutralizing antibodies.",25483665_2,-1,-1,-1,-1,25457,-1,4.9838227e-06,0.99999154,3.4921009e-06
25459,T-cell,33,34,206,212,"Previously, we showed that these immunogens carrying large combinatorial libraries of mutated epitope variants, termed as variable epitope libraries (VELs), induce potent, broad and long lasting CD8+IFN-+ T-cell response as well as HIV-neutralizing antibodies.",25483665_2,-1,1,2,-1,25459,-1,3.8776896e-05,1.1550886e-05,0.9999497
25468,peptide,20,21,137,144,"The constructed VELs had complexities of 10,500 and 8,000 individual members, generated as combinatorial M13 phage display and synthetic peptide libraries, respectively, with structural composition GWXPXDXPI, where X is any of 20 natural amino acids.",25483665_4,0,-1,2,-1,25468,-1,0.00069459534,0.9991948,0.00011066449
25475,IFN-+ T-cell,9,11,64,77,"Vaccinated mice developed epitope-specific spleen cell and CD8+ IFN-+ T-cell responses that recognize more than 50% of the panel of 87 mutated epitope variants, as demonstrated in T-cell proliferation assays and FACS analysis.",25483665_6,-1,-1,-1,-1,25475,-1,0.92320406,0.00024075832,0.076555155
25480,analysis,35,36,218,226,"Vaccinated mice developed epitope-specific spleen cell and CD8+ IFN-+ T-cell responses that recognize more than 50% of the panel of 87 mutated epitope variants, as demonstrated in T-cell proliferation assays and FACS analysis.",25483665_6,0,1,-1,-1,25480,-1,6.839451e-06,0.99998486,8.291924e-06
25486,functionality,4,5,27,40,Acquisition of an impaired functionality by plasmacytoid dendritic cells (pDCs) contributing to cancer progression has been documented in different types of cancers.,25492101_0,0,1,2,-1,25486,-1,0.0002663423,0.99951744,0.0002161815
25497,functionality,29,30,179,192,"In the present study, we postulate that molecules secreted by (pre)neoplastic epithelial cells of the genital tract (cervix/vulva) might attract pDCs but also modify their proper functionality, allowing these cells to initiate a tolerogenic response interfering with antitumor immunity.",25492101_1,0,1,2,-1,25497,-1,4.7587626e-05,0.9998524,0.00010002958
25498,these cells to,32,35,203,217,"In the present study, we postulate that molecules secreted by (pre)neoplastic epithelial cells of the genital tract (cervix/vulva) might attract pDCs but also modify their proper functionality, allowing these cells to initiate a tolerogenic response interfering with antitumor immunity.",25492101_1,-1,-1,-1,-1,25498,-1,0.002335681,0.21973187,0.7779325
25500,immunity,42,43,277,285,"In the present study, we postulate that molecules secreted by (pre)neoplastic epithelial cells of the genital tract (cervix/vulva) might attract pDCs but also modify their proper functionality, allowing these cells to initiate a tolerogenic response interfering with antitumor immunity.",25492101_1,0,-1,2,-1,25500,-1,0.9999038,2.6412617e-05,6.969569e-05
25503,through the,12,14,98,109,"We demonstrated that pDCs are recruited during the cervical metaplasia-dysplasia-cancer sequence, through the action of their chemoattractant, chemerin.",25492101_2,-1,-1,-1,-1,25503,-1,5.8146143e-06,0.9999901,4.0385735e-06
25504,their chemoattractant,16,18,120,141,"We demonstrated that pDCs are recruited during the cervical metaplasia-dysplasia-cancer sequence, through the action of their chemoattractant, chemerin.",25492101_2,-1,-1,-1,-1,25504,-1,0.19398262,0.8031075,0.002909872
25511,function,10,11,86,94,We also demonstrated that cervical/vulvar neoplastic keratinocytes inhibit the proper function of pDCs by decreasing their IFN secretion in response to CpG oligonucleotides.,25492101_4,0,1,2,-1,25511,-1,4.613851e-05,0.99991727,3.6585618e-05
25512,their IFN,15,17,117,127,We also demonstrated that cervical/vulvar neoplastic keratinocytes inhibit the proper function of pDCs by decreasing their IFN secretion in response to CpG oligonucleotides.,25492101_4,-1,-1,-1,-1,25512,-1,0.912196,0.08590701,0.0018969967
25524,factor,6,7,33,39,We identified HMGB1 as a soluble factor produced by neoplastic keratinocytes from the genital tract involved in pDCs functional alteration.,25492101_7,0,1,-1,-1,25524,-1,0.90022826,0.09950965,0.0002620147
25527,functional,18,19,117,127,We identified HMGB1 as a soluble factor produced by neoplastic keratinocytes from the genital tract involved in pDCs functional alteration.,25492101_7,0,1,2,-1,25527,-1,0.00028824678,0.999483,0.00022868464
25531,these cells to,16,19,111,125,"Indeed, this molecule inhibited pDC maturation, decreased IFN secretion following TLR9 stimulation and forced these cells to become tolerogenic.",25492101_8,-1,-1,-1,-1,25531,-1,0.0016451249,0.4808419,0.517513
25533,that the,3,5,22,30,Our findings indicate that the use of inhibitory molecules notably directed against HMGB1 in cervical/vulvar (pre)neoplastic lesions might prevent alterations of pDCs functionality and represent an attractive therapeutic strategy to overcome immune tolerance in cancers.,25492101_10,-1,-1,-1,-1,25533,-1,4.1213793e-06,0.99999213,3.721545e-06
25534,functionality,22,23,167,180,Our findings indicate that the use of inhibitory molecules notably directed against HMGB1 in cervical/vulvar (pre)neoplastic lesions might prevent alterations of pDCs functionality and represent an attractive therapeutic strategy to overcome immune tolerance in cancers.,25492101_10,0,1,2,-1,25534,-1,7.952981e-06,0.9999777,1.4369585e-05
25546,protein-coding,5,6,26,40,RESULTS: We identified 12 protein-coding candidate variants that segregated in the 3 affected cousins from whom we had samples.,25492914_4,0,1,-1,-1,25546,-1,2.5801215e-05,0.9999573,1.6885562e-05
25562,that STAT4,5,7,30,40,"CONCLUSIONS: Our data suggest that STAT4 is a potential cKS-predisposition gene, but further functional and genetic validation is needed.",25492914_10,-1,-1,-1,-1,25562,-1,6.610144e-06,0.9999871,6.2244007e-06
25564,functional,15,16,93,103,"CONCLUSIONS: Our data suggest that STAT4 is a potential cKS-predisposition gene, but further functional and genetic validation is needed.",25492914_10,0,1,2,-1,25564,-1,6.510932e-05,0.99990904,2.5872705e-05
25575,Th cells that,8,11,62,75,We have recently demonstrated that patients have CLL-specific Th cells that support CLL proliferation.,25505279_2,-1,-1,-1,-1,25575,-1,0.0013327769,0.13445057,0.8642167
25579,Th cells,11,13,53,61,"In this article, we show that CLL cells attract such Th cells, thereby establishing an Ag-dependent collaboration.",25505279_3,-1,-1,-1,-1,25579,-1,1.0338745e-05,7.5315024e-06,0.9999821
25583,Th cells,28,30,163,171,"Blocking experiments performed in vitro as wells as in vivo, using a xenograft model, revealed that secretion of IFN- was a major mechanism by which CLL-specific Th cells increased CD38 on CLL cells.",25505279_4,-1,-1,-1,-1,25583,-1,6.66649e-06,5.8556843e-06,0.9999875
25586,the transcription factor T-bet,3,7,18,48,"The expression of the transcription factor T-bet in peripheral blood CLL cells significantly correlated with CD38 expression, and transient transfection of CLL cells with T-bet resulted in T-bet(hi)CD38(hi) cells.",25505279_5,-1,-1,-1,-1,25586,-1,5.1099605e-06,0.9999893,5.5772994e-06
25587,blood,9,10,63,68,"The expression of the transcription factor T-bet in peripheral blood CLL cells significantly correlated with CD38 expression, and transient transfection of CLL cells with T-bet resulted in T-bet(hi)CD38(hi) cells.",25505279_5,0,1,-1,-1,25587,-1,0.0004932357,0.99855775,0.0009489685
25589,transient transfection,19,21,130,152,"The expression of the transcription factor T-bet in peripheral blood CLL cells significantly correlated with CD38 expression, and transient transfection of CLL cells with T-bet resulted in T-bet(hi)CD38(hi) cells.",25505279_5,-1,-1,-1,-1,25589,-1,4.1186813e-06,0.99999166,4.2561874e-06
25594,that T-bet,6,8,60,70,"Finally, chromatin immunoprecipitation experiments revealed that T-bet can bind to regulatory regions of the CD38 gene.",25505279_6,-1,-1,-1,-1,25594,-1,6.2283557e-06,0.9999881,5.6329013e-06
25601,Th cells,8,10,55,63,"These data suggest that CLL cells attract CLL-specific Th cells and initiate a positive feedback loop with upregulation of T-bet, CD38, and type 1 chemokines allowing further recruitment of Th cells and increased type 1 cytokine secretion.",25505279_7,-1,-1,-1,-1,25601,-1,7.448009e-06,6.953373e-06,0.9999857
25605,Th cells,31,33,190,198,"These data suggest that CLL cells attract CLL-specific Th cells and initiate a positive feedback loop with upregulation of T-bet, CD38, and type 1 chemokines allowing further recruitment of Th cells and increased type 1 cytokine secretion.",25505279_7,-1,-1,-1,-1,25605,-1,8.509223e-06,6.429552e-06,0.9999851
25612,that targeting the,25,28,181,199,This insight provides a cellular and molecular mechanism that links the inflammatory signature observed in CLL pathogenesis with CD38 expression and aggressive disease and suggests that targeting the IFN-/IFN-R/JAK/STAT/T-bet/CD38 pathway could play a role in the therapy of CLL.,25505279_8,-1,-1,-1,-1,25612,-1,3.89711e-06,0.9999926,3.5070661e-06
25614,the therapy,35,37,262,273,This insight provides a cellular and molecular mechanism that links the inflammatory signature observed in CLL pathogenesis with CD38 expression and aggressive disease and suggests that targeting the IFN-/IFN-R/JAK/STAT/T-bet/CD38 pathway could play a role in the therapy of CLL.,25505279_8,-1,-1,-1,-1,25614,-1,4.7875933e-06,0.9999908,4.441295e-06
25628,tissue,5,6,19,25,"In this study, NPC tissue was collected from patients with NPC.",25544502_4,-1,1,2,-1,25628,-1,1.9678022e-05,0.99981874,0.000161642
25631,proteins,6,7,36,44,Western blotting was used to assess proteins of interleukin 10 and nuclear factor I-A (NFI-A).,25544502_6,0,1,-1,-1,25631,-1,1.1742068e-05,0.9999814,6.8221125e-06
25639,tissue,14,15,72,78,"The results showed that NPC cell line C666-1 and surgically removed NPC tissue expressed miR-21, which was upregulated by the presence of the Toll-like receptor 3 ligand, Poly I: C. Exposure to miR-21 increased the expression of NFI-A and interleukin (IL)-10 in naive B cells.",25544502_8,-1,1,2,-1,25639,-1,2.3900826e-05,0.99935573,0.00062034954
25641,the Toll-like receptor,25,28,138,160,"The results showed that NPC cell line C666-1 and surgically removed NPC tissue expressed miR-21, which was upregulated by the presence of the Toll-like receptor 3 ligand, Poly I: C. Exposure to miR-21 increased the expression of NFI-A and interleukin (IL)-10 in naive B cells.",25544502_8,-1,-1,-1,-1,25641,-1,0.00030590972,0.9979068,0.0017872604
25651,tissue,12,13,59,65,High frequency of IL-10(+) B cells was detected in the NPC tissue.,25544502_9,-1,1,2,-1,25651,-1,5.366226e-06,0.9999827,1.1937314e-05
25659,T-cell,19,20,106,112,We conclude that NPC-derived miR-21 induces IL-10(+) B cells; the latter is capable of suppressing CD8(+) T-cell activities.,25544502_11,-1,1,2,-1,25659,-1,1.36460685e-05,8.716217e-06,0.9999777
25661,the treatment,7,9,36,49,miR-21 may be a potential target in the treatment of NPC.,25544502_12,-1,-1,-1,-1,25661,-1,5.156951e-06,0.99999046,4.3687487e-06
25668,tumor cells,27,29,151,162,"However, the regulatory mechanism(s) for p53 expression in B lymphoma cells, and the possible role of p53 in the development of the radioresistance in tumor cells are largely unknown.",25544504_1,-1,-1,-1,-1,25668,-1,0.00012047876,0.0016829385,0.99819666
25693,The IL-17(+)Foxp3(+,0,2,0,19,The IL-17(+)Foxp3(+) T cells suppressed p53 expression in k1106 cells.,25544504_9,-1,-1,-1,-1,25693,-1,0.0037287457,0.9958677,0.0004035224
25701,protein,20,21,122,129,"Collectively, irradiated k1106 cells induce the expression of IL-17 in Tregs, which interferes with the expression of p53 protein in k1106 cells and thereby represses irradiation-triggered apoptosis in k1106 cells.",25544504_10,0,1,-1,-1,25701,-1,6.03536e-06,0.9999882,5.714671e-06
25707,transferred T cells,13,16,101,120,"Lymphodepleting regimens are used before adoptive immunotherapy to augment the antitumor efficacy of transferred T cells by removing endogenous homeostatic ""cytokine sinks."" These conditioning modalities, however, are often associated with severe toxicities.",25548153_0,-1,-1,-1,-1,25707,-1,0.0008901214,0.033069585,0.9660403
25713,T cells to,11,14,67,77,We found that microRNA-155 (miR-155) enabled tumor-specific CD8(+) T cells to mediate profound antitumor responses in lymphoreplete hosts that were not potentiated by immune-ablation.,25548153_1,-1,-1,-1,-1,25713,-1,0.0014791156,0.03876472,0.9597562
25715,T-cell,2,3,17,23,"miR-155 enhanced T-cell responsiveness to limited amounts of homeostatic c cytokines, resulting in delayed cellular contraction and sustained cytokine production.",25548153_2,-1,1,2,-1,25715,-1,1.30786e-05,7.5222074e-06,0.9999794
25723,protein,15,16,108,115,"miR-155 restrained the expression of the inositol 5-phosphatase Ship1, an inhibitor of the serine-threonine protein kinase Akt, and multiple negative regulators of signal transducer and activator of transcription 5 (Stat5), including suppressor of cytokine signaling 1 (Socs1) and the protein tyrosine phosphatase Ptpn2.",25548153_3,0,1,-1,-1,25723,-1,9.341845e-06,0.99998295,7.683204e-06
25727,the protein tyrosine phosphatase,45,49,281,313,"miR-155 restrained the expression of the inositol 5-phosphatase Ship1, an inhibitor of the serine-threonine protein kinase Akt, and multiple negative regulators of signal transducer and activator of transcription 5 (Stat5), including suppressor of cytokine signaling 1 (Socs1) and the protein tyrosine phosphatase Ptpn2.",25548153_3,-1,-1,-1,-1,25727,-1,8.551045e-06,0.999985,6.411219e-06
25730,functions,20,21,167,176,"Expression of constitutively active Stat5a recapitulated the survival advantages conferred by miR-155, whereas constitutive Akt activation promoted sustained effector functions.",25548153_4,0,1,2,-1,25730,-1,1.3560687e-05,0.9999745,1.1897325e-05
25732,tumor-specific T cells,8,11,55,77,"Our results indicate that overexpression of miR-155 in tumor-specific T cells can be used to increase the effectiveness of adoptive immunotherapies in a cell-intrinsic manner without the need for life-threatening, lymphodepleting maneuvers.",25548153_5,-1,-1,-1,-1,25732,-1,0.0023510884,0.82057846,0.17707038
25737,life-threatening,29,30,196,212,"Our results indicate that overexpression of miR-155 in tumor-specific T cells can be used to increase the effectiveness of adoptive immunotherapies in a cell-intrinsic manner without the need for life-threatening, lymphodepleting maneuvers.",25548153_5,0,-1,2,-1,25737,-1,3.8984177e-05,0.9999471,1.39984795e-05
25740,the regulation,11,13,34,48,"However, the effect of 14-3-3 in the regulation of interactions between tumor cells and the immune system has not been previously reported.",25556369_1,-1,-1,-1,-1,25740,-1,4.4742974e-06,0.9999908,4.6518585e-06
25741,tumor cells,16,18,73,84,"However, the effect of 14-3-3 in the regulation of interactions between tumor cells and the immune system has not been previously reported.",25556369_1,-1,-1,-1,-1,25741,-1,6.189527e-05,0.00025131836,0.99968684
25748,tissues,12,13,61,68,"In oral squamous cell carcinoma (OSCC) cell lines and cancer tissues, we found that 14-3-3 is overexpressed.",25556369_3,-1,1,2,-1,25748,-1,0.0004795835,0.5330917,0.46642873
25760,tumor-specific T cells,23,26,141,163,"Furthermore, supernatants from 14-3-3 knockdown OSCC cells dramatically altered the response of peritoneal macrophages, dendritic cells and tumor-specific T cells.",25556369_6,-1,-1,-1,-1,25760,-1,0.0027915477,0.75941575,0.23779275
25763,relieved the,17,19,84,96,"Interestingly, Stat3 was found to directly interact with 14-3-3 and its disruption relieved the inhibition induced by 14-3-3 in tumor inflammation.",25556369_7,-1,-1,-1,-1,25763,-1,2.5975856e-05,0.9999646,9.462793e-06
25765,Taken together,0,2,0,14,"Taken together, our studies provide evidence that 14-3-3 may regulate tumor inflammation and immune response through Stat3 signaling in OSCC.",25556369_8,-1,-1,-1,-1,25765,-1,1.2493893e-05,0.99997735,1.0144945e-05
25768,immune response through Stat3,18,22,94,123,"Taken together, our studies provide evidence that 14-3-3 may regulate tumor inflammation and immune response through Stat3 signaling in OSCC.",25556369_8,-1,-1,-1,-1,25768,-1,0.7629821,0.23533309,0.0016848136
25772,antigenic peptides to cytotoxic T lymphocytes,16,22,95,140,Human leukocyte antigen class I antigens (HLA-I) is essential in immune response by presenting antigenic peptides to cytotoxic T lymphocytes.,25618241_0,-1,-1,-1,-1,25772,-1,0.16831365,0.00092827197,0.8307581
25775,factors,7,8,38,45,"In addition, elevated level of growth factors like TGF- or EGF in microenvironment is related to the prostate cancer deterioration.",25618241_2,0,1,-1,-1,25775,-1,0.9999442,9.640881e-06,4.6163343e-05
25777,related to the,15,18,87,101,"In addition, elevated level of growth factors like TGF- or EGF in microenvironment is related to the prostate cancer deterioration.",25618241_2,-1,-1,-1,-1,25777,-1,8.029731e-06,0.9999852,6.77393e-06
25780,the regulation,11,13,55,69,"Thus, we wondered whether TGF- or EGF was involved in the regulation of HLA-I during the development of prostate cancer cells.",25618241_3,-1,-1,-1,-1,25780,-1,5.524202e-06,0.9999896,4.9044133e-06
25784,that TGF-,6,8,31,41,"In this study, we demonstrated that TGF- and EGF both downregulated the expression of HLA-I, thereby attenuated the cytotoxic T cell mediated lysis of prostate cancer cells.",25618241_4,-1,-1,-1,-1,25784,-1,1.0101769e-05,0.99998283,7.0272367e-06
25787,the cytotoxic T cell,19,23,113,133,"In this study, we demonstrated that TGF- and EGF both downregulated the expression of HLA-I, thereby attenuated the cytotoxic T cell mediated lysis of prostate cancer cells.",25618241_4,-1,-1,-1,-1,25787,-1,0.0019423673,0.11937292,0.8786847
25789,that TGF-,4,6,18,28,"Next, we revealed that TGF- and EGF induced downregulation of HLA-I is associated with classical epithelial-mesenchymal transition (EMT) morphological changes and expression profiles.",25618241_5,-1,-1,-1,-1,25789,-1,1.7442379e-05,0.9999733,9.3167e-06
25793,the plausible target,8,11,40,60,"At last, we discussed that NF-B/p65 is the plausible target for Snail to induce HLA-I downregulation.",25618241_7,-1,-1,-1,-1,25793,-1,8.541074e-06,0.9999856,5.8900223e-06
25795,Taken together,0,2,0,14,"Taken together, this is the first evidence to reveal that both TGF- and EGF can induce HLA-I downregulation which is then proven to be associated with EMT in prostate cancer cells.",25618241_8,-1,-1,-1,-1,25795,-1,8.025657e-06,0.999985,7.050284e-06
25805,factors,8,9,59,66,These discoveries provide a deeper understanding of growth factors induced immune escape and introduce potential therapeutic targets for prostate cancers.,25618241_9,0,1,-1,-1,25805,-1,0.9999254,1.8664938e-05,5.585766e-05
25806,therapeutic targets,15,17,113,132,These discoveries provide a deeper understanding of growth factors induced immune escape and introduce potential therapeutic targets for prostate cancers.,25618241_9,-1,-1,-1,-1,25806,-1,5.625899e-06,0.9999896,4.7562958e-06
25808,T-cell tolerance,21,23,116,132,"Recent studies have demonstrated that -catenin in DCs serves as a key mediator in promoting both CD4(+) and CD8(+) T-cell tolerance, although how -catenin exerts its functions remains incompletely understood.",25730849_0,-1,-1,-1,-1,25808,-1,0.00012619645,0.00053171953,0.99934214
25809,functions,29,30,168,177,"Recent studies have demonstrated that -catenin in DCs serves as a key mediator in promoting both CD4(+) and CD8(+) T-cell tolerance, although how -catenin exerts its functions remains incompletely understood.",25730849_0,0,1,2,-1,25809,-1,7.3562944e-05,0.99989235,3.4047338e-05
25814,T-cell immunity,33,35,221,236,"Here we report that activation of -catenin in DCs inhibits cross-priming of CD8(+) T cells by up-regulating mTOR-dependent IL-10, suggesting blocking -catenin/mTOR/IL-10 signaling as a viable approach to augment CD8(+) T-cell immunity.",25730849_1,-1,-1,-1,-1,25814,-1,6.0807073e-05,1.4276041e-05,0.9999249
25820,T-cell immunity,13,15,89,104,"Further studies revealed that DC--catenin(-/-) mice were deficient in generating CD8(+) T-cell immunity despite normal clonal expansion, likely due to impaired IL-10 production by -catenin(-/-) DCs.",25730849_3,-1,-1,-1,-1,25820,-1,0.000135211,2.8569175e-05,0.9998362
25828,T-cell,32,33,176,182,"Deletion of -catenin in DCs or blocking IL-10 after clonal expansion similarly led to reduced CD8(+) T cells, suggesting that -catenin in DCs plays a positive role in CD8(+) T-cell maintenance postclonal expansion through IL-10.",25730849_4,-1,1,2,-1,25828,-1,1.2688429e-05,7.10848e-06,0.9999802
25829,through IL-10,36,38,216,229,"Deletion of -catenin in DCs or blocking IL-10 after clonal expansion similarly led to reduced CD8(+) T cells, suggesting that -catenin in DCs plays a positive role in CD8(+) T-cell maintenance postclonal expansion through IL-10.",25730849_4,-1,-1,-1,-1,25829,-1,0.9849519,0.014372752,0.00067538145
25834,functions,4,5,29,38,"Despite -catenin's opposite functions in regulating CD8(+) T-cell responses, selectively blocking -catenin with a pharmacological inhibitor during priming phase augmented DC vaccine-induced CD8(+) T-cell immunity and improved antitumor efficacy, suggesting manipulating -catenin signaling as a feasible therapeutic strategy to improve DC vaccine efficacy.",25730849_6,0,1,2,-1,25834,-1,1.1123518e-05,0.9999765,1.2336024e-05
25835,T-cell,9,10,60,66,"Despite -catenin's opposite functions in regulating CD8(+) T-cell responses, selectively blocking -catenin with a pharmacological inhibitor during priming phase augmented DC vaccine-induced CD8(+) T-cell immunity and improved antitumor efficacy, suggesting manipulating -catenin signaling as a feasible therapeutic strategy to improve DC vaccine efficacy.",25730849_6,-1,1,2,-1,25835,-1,2.6160233e-05,1.0756316e-05,0.99996316
25836,T-cell immunity,27,29,199,214,"Despite -catenin's opposite functions in regulating CD8(+) T-cell responses, selectively blocking -catenin with a pharmacological inhibitor during priming phase augmented DC vaccine-induced CD8(+) T-cell immunity and improved antitumor efficacy, suggesting manipulating -catenin signaling as a feasible therapeutic strategy to improve DC vaccine efficacy.",25730849_6,-1,-1,-1,-1,25836,-1,0.00022617044,2.2224722e-05,0.9997516
25843,T-cell,16,17,105,111,The poor efficacy of the in vivo anti-tumor immune response has been partially attributed to ineffective T-cell responses mounted against the tumor.,25745993_0,-1,1,2,-1,25843,-1,3.731559e-05,8.631539e-06,0.9999541
25844,the tumor,20,22,138,147,The poor efficacy of the in vivo anti-tumor immune response has been partially attributed to ineffective T-cell responses mounted against the tumor.,25745993_0,-1,-1,-1,-1,25844,-1,5.7494626e-06,0.9999896,4.662842e-06
25849,immunity,20,21,131,139,Fas-FasL-dependent activation-induced cell death (AICD) of T cells is believed to be a major contributor to compromised anti-tumor immunity.,25745993_1,0,-1,2,-1,25849,-1,0.99935347,0.00043700027,0.00020957006
25852,therapy,16,17,106,113,"The molecular mechanisms of AICD are well-investigated, yet the possibility of regulating AICD for cancer therapy remains to be explored.",25745993_2,0,1,-1,-1,25852,-1,5.3071717e-06,0.99998903,5.6595554e-06
25857,the tumor,22,24,115,124,"In this study, we show that histone deacetylase inhibitors (HDACIs) can inhibit apoptosis of CD4(+) T cells within the tumor, thereby enhancing anti-tumor immune responses and suppressing melanoma growth.",25745993_3,-1,-1,-1,-1,25857,-1,3.7172283e-06,0.9999912,5.0781746e-06
25868,that the,4,6,22,30,"Importantly, we found that the co-administration of HDACIs and anti-CTLA4 could further enhance the infiltration of CD4(+) T cells and achieve a synergistic therapeutic effect on tumor.",25745993_6,-1,-1,-1,-1,25868,-1,4.7457283e-06,0.9999913,3.9023225e-06
25874,that the,5,7,34,42,"Therefore, our study demonstrates that the modulation of AICD of tumor-infiltrating CD4(+) T cells using HDACIs can enhance anti-tumor immune responses, uncovering a novel mechanism underlying the anti-tumor effect of HDACIs.",25745993_7,-1,-1,-1,-1,25874,-1,4.170128e-06,0.99999225,3.5520143e-06
25887,the tumor-infiltrating T cells,23,27,157,187,"To study whether the infiltration of T cell subpopulations was correlated with cervical adenocarcinoma patient survival, similar to squamous cell carcinoma, the tumor-infiltrating T cells, Tregs, Th17 cells and IL-17(+) cell frequencies were analyzed in a cohort of cervical adenocarcinoma patients (n=67).",25795131_2,-1,-1,-1,-1,25887,-1,0.0017035144,0.8753547,0.12294183
25889,Th17 cells,30,32,196,206,"To study whether the infiltration of T cell subpopulations was correlated with cervical adenocarcinoma patient survival, similar to squamous cell carcinoma, the tumor-infiltrating T cells, Tregs, Th17 cells and IL-17(+) cell frequencies were analyzed in a cohort of cervical adenocarcinoma patients (n=67).",25795131_2,-1,-1,-1,-1,25889,-1,0.00016515012,0.0050722556,0.9947626
25892,total cell,4,6,29,39,"Intraepithelial, stromal and total cell frequencies were scored using triple immunofluorescence.",25795131_3,-1,-1,-1,-1,25892,-1,4.7240133e-05,8.977761e-05,0.999863
25895,the tumor,7,9,38,47,"The majority of Tregs were present in the tumor stroma, while other T cells and IL-17(+) cells infiltrated the tumor epithelium three times more frequently.",25795131_4,-1,-1,-1,-1,25895,-1,3.5162834e-06,0.9999919,4.596283e-06
25899,the tumor,20,22,107,116,"The majority of Tregs were present in the tumor stroma, while other T cells and IL-17(+) cells infiltrated the tumor epithelium three times more frequently.",25795131_4,-1,-1,-1,-1,25899,-1,3.4765405e-06,0.9999918,4.790274e-06
25900,three times,23,25,128,139,"The majority of Tregs were present in the tumor stroma, while other T cells and IL-17(+) cells infiltrated the tumor epithelium three times more frequently.",25795131_4,-1,-1,-1,-1,25900,-1,1.679392e-05,0.99997115,1.1994738e-05
25903,the tumor,1,3,7,16,"Within the tumor epithelium, a high T cell frequency was significantly correlated with improved disease-free survival (p=0.034).",25795131_6,-1,-1,-1,-1,25903,-1,3.85879e-06,0.9999912,5.021492e-06
25909,Th17 cells,7,9,36,46,A low number of Tregs combined with Th17 cells present were also correlated with poor survival (p=0.018).,25795131_8,-1,-1,-1,-1,25909,-1,0.00011666206,0.0010943542,0.998789
25915,that Tregs,3,5,22,32,"These results suggest that Tregs and IL-17(+) cells represent a beneficial immune response, whereas Th17 cells might represent a poor response in cervical adenocarcinoma.",25795131_10,-1,-1,-1,-1,25915,-1,5.1984043e-06,0.99998975,5.10353e-06
25919,Th17 cells,16,18,100,110,"These results suggest that Tregs and IL-17(+) cells represent a beneficial immune response, whereas Th17 cells might represent a poor response in cervical adenocarcinoma.",25795131_10,-1,-1,-1,-1,25919,-1,0.00030894644,0.010176089,0.98951495
25923,that the,12,14,86,94,"This contrasts with the correlations described in squamous cell carcinoma, suggesting that the local immune response in cervical adenocarcinoma contributes differently to tumor growth than in squamous cell carcinoma.",25795131_11,-1,-1,-1,-1,25923,-1,4.8868615e-06,0.9999912,3.982679e-06
25925,to tumor,22,24,168,176,"This contrasts with the correlations described in squamous cell carcinoma, suggesting that the local immune response in cervical adenocarcinoma contributes differently to tumor growth than in squamous cell carcinoma.",25795131_11,-1,-1,-1,-1,25925,-1,7.3400547e-06,0.999985,7.6723245e-06
25929,that the transforming growth factor beta,4,10,31,71,There is accumulating evidence that the transforming growth factor beta (TGF-) and nuclear factor kappa-B (NFB) pathways are tightly connected and play a key role in malignant transformation in cancer.,25832000_0,-1,-1,-1,-1,25929,-1,0.7738803,0.21729268,0.008827028
25941,functions,9,10,61,70,"There is a plethora of studies examining the pro-tumorigenic functions of carcinoembryonic antigen (CEA), but its receptor CEAR is far less studied.",25832000_2,0,1,2,-1,25941,-1,1.3471377e-05,0.9999691,1.7397035e-05
25943,receptor,19,20,114,122,"There is a plethora of studies examining the pro-tumorigenic functions of carcinoembryonic antigen (CEA), but its receptor CEAR is far less studied.",25832000_2,0,1,2,-1,25943,-1,0.002059977,0.8151829,0.18275706
25945,that TGF-,9,11,44,54,"So far, there is a single connecting report that TGF- also may signal through CEAR.",25832000_3,-1,-1,-1,-1,25945,-1,2.1389975e-05,0.9999677,1.0881093e-05
25948,tissues,4,5,29,36,"The crosstalk between cancer tissues is further complicated by the expression of CEAR and TGF- receptors in stromal cells, and implications of TGF- in epithelial-mesenchymal transition.",25832000_4,-1,1,2,-1,25948,-1,0.00018672955,0.003103089,0.99671006
25950,TGF- receptors,14,16,90,105,"The crosstalk between cancer tissues is further complicated by the expression of CEAR and TGF- receptors in stromal cells, and implications of TGF- in epithelial-mesenchymal transition.",25832000_4,-1,-1,-1,-1,25950,-1,6.47774e-05,0.99956745,0.0003677855
25954,tumor-infiltrating Tregs,2,4,13,37,"Furthermore, tumor-infiltrating Tregs and Bregs may directly instruct cancer cells by secreting TGF- binding to their CEAR.",25832000_5,-1,-1,-1,-1,25954,-1,6.3227253e-06,0.9999876,6.1337564e-06
25957,to their,15,17,110,118,"Furthermore, tumor-infiltrating Tregs and Bregs may directly instruct cancer cells by secreting TGF- binding to their CEAR.",25832000_5,-1,-1,-1,-1,25957,-1,6.245543e-06,0.99998677,6.982873e-06
25962,TGF--R types,6,8,16,29,"CEAR, TGF-1-3, TGF--R types I-III and NFB class I and II molecules have an outstanding human-canine sequence identity, and only a canine CEA homolog has not yet been identified.",25832000_7,-1,-1,-1,-1,25962,-1,7.812417e-06,0.9999819,1.0311301e-05
25973,that regulatory T cells,2,6,16,39,We hypothesized that regulatory T cells (Treg) may exert a functional and clinical impact on antitumor immunity in cetuximab-treated individuals.,25832655_1,-1,-1,-1,-1,25973,-1,0.0015736693,0.07766725,0.9207591
25975,functional,12,13,59,69,We hypothesized that regulatory T cells (Treg) may exert a functional and clinical impact on antitumor immunity in cetuximab-treated individuals.,25832655_1,0,1,2,-1,25975,-1,0.004797547,0.9937152,0.001487204
25976,immunity,18,19,103,111,We hypothesized that regulatory T cells (Treg) may exert a functional and clinical impact on antitumor immunity in cetuximab-treated individuals.,25832655_1,0,-1,2,-1,25976,-1,0.9998764,3.1862102e-05,9.173884e-05
25990,These Treg,0,2,0,10,These Treg suppressed cetuximab-mediated antibody-dependent cellular cytotoxicity (ADCC) and their presence correlated with poor clinical outcome in two prospective clinical trial cohorts.,25832655_4,-1,-1,-1,-1,25990,-1,6.9996013e-06,0.99998677,6.2317877e-06
25999,T-cell receptor triggering,22,25,129,155,"Cetuximab expanded CTLA-4(+)FOXP3(+) Treg in vitro, in part, by inducing dendritic cell maturation, in combination with TGF and T-cell receptor triggering.",25832655_5,-1,-1,-1,-1,25999,-1,9.616072e-05,2.6533122e-05,0.9998772
26003,targeted CTLA-4(+,6,8,30,47,"In ex vivo assays, ipilimumab targeted CTLA-4(+) Treg and restored cytolytic functions of NK cells mediating ADCC.",25832655_7,-1,-1,-1,-1,26003,-1,0.009558188,0.95187914,0.03856264
26005,functions,13,14,77,86,"In ex vivo assays, ipilimumab targeted CTLA-4(+) Treg and restored cytolytic functions of NK cells mediating ADCC.",25832655_7,0,1,2,-1,26005,-1,0.0057500503,0.73755646,0.25669348
26007,Taken together,0,2,0,14,"Taken together, our results argue that differences in Treg-mediated suppression contribute to the clinical response to cetuximab treatment, suggesting its improvement by adding ipilimumab or other strategies of Treg ablation to promote antitumor immunity.",25832655_8,-1,-1,-1,-1,26007,-1,1.0467383e-05,0.9999814,8.133773e-06
26010,to the,12,14,91,97,"Taken together, our results argue that differences in Treg-mediated suppression contribute to the clinical response to cetuximab treatment, suggesting its improvement by adding ipilimumab or other strategies of Treg ablation to promote antitumor immunity.",25832655_8,-1,-1,-1,-1,26010,-1,6.4211686e-06,0.99998784,5.7534066e-06
26015,immunity,35,36,246,254,"Taken together, our results argue that differences in Treg-mediated suppression contribute to the clinical response to cetuximab treatment, suggesting its improvement by adding ipilimumab or other strategies of Treg ablation to promote antitumor immunity.",25832655_8,0,-1,2,-1,26015,-1,0.99988115,3.3053428e-05,8.58419e-05
26016,function,3,4,18,26,Decline in immune function and inflammation concomitantly develop with ageing.,25850032_0,0,1,2,-1,26016,-1,0.72607684,0.05561109,0.21831203
26032,IL-6 deficiency,25,27,159,174,The impaired antitumour effect of CD4(+) T cells with their defective Th1 differentiation in an aged environment is restored by interleukin (IL)-6 blockade or IL-6 deficiency.,25850032_2,-1,-1,-1,-1,26032,-1,0.9998159,4.4571178e-05,0.00013957368
26035,T cells to,10,13,59,69,"IL-6 blockade also restores the impaired ability of CD4(+) T cells to promote CD8(+) T-cell-dependent tumour elimination in aged mice, which requires IFN-.",25850032_3,-1,-1,-1,-1,26035,-1,0.001563512,0.045144465,0.9532921
26036,T-cell-dependent tumour,16,18,85,108,"IL-6 blockade also restores the impaired ability of CD4(+) T cells to promote CD8(+) T-cell-dependent tumour elimination in aged mice, which requires IFN-.",25850032_3,-1,-1,-1,-1,26036,-1,0.0017946224,0.019431002,0.97877437
26042,to IL-10,3,5,22,30,"IL-6 also contributes to IL-10 production from CD4(+) T cells in aged mice, causing attenuated responses of CD8(+) T cells.",25850032_5,-1,-1,-1,-1,26042,-1,0.94225,0.056550194,0.0011996948
26046,that IL-6,3,5,23,32,These findings suggest that IL-6 serves as an extrinsic factor counteracting CD4(+) T-cell-mediated immunity against tumour in old age.,25850032_6,-1,-1,-1,-1,26046,-1,0.8954786,0.10209741,0.0024240105
26047,factor,9,10,56,62,These findings suggest that IL-6 serves as an extrinsic factor counteracting CD4(+) T-cell-mediated immunity against tumour in old age.,25850032_6,0,1,-1,-1,26047,-1,0.0003619301,0.9995895,4.85708e-05
26048,T-cell-mediated immunity,13,15,84,108,These findings suggest that IL-6 serves as an extrinsic factor counteracting CD4(+) T-cell-mediated immunity against tumour in old age.,25850032_6,-1,-1,-1,-1,26048,-1,0.0005936979,5.5372853e-05,0.99935085
26052,Th22 cells,7,9,38,48,"AIM: To investigate the expression of Th22 cells and related cytokines in colorectal cancer (CRC) tissues, and the probably mechanism.",25892871_0,-1,-1,-1,-1,26052,-1,0.00025595925,0.003977654,0.9957664
26053,related cytokines,10,12,53,70,"AIM: To investigate the expression of Th22 cells and related cytokines in colorectal cancer (CRC) tissues, and the probably mechanism.",25892871_0,-1,-1,-1,-1,26053,-1,0.84332174,0.1524975,0.0041808467
26054,tissues,18,19,98,105,"AIM: To investigate the expression of Th22 cells and related cytokines in colorectal cancer (CRC) tissues, and the probably mechanism.",25892871_0,-1,1,2,-1,26054,-1,0.00017164437,0.015414426,0.98441386
26057,tissues,6,7,33,40,"METHODS: CRC tumor and paratumor tissues were collected to detect the expression levels of Th22 cells and of related cytokines by immunohistochemistry, flow cytometry and real-time quantitative polymerase chain reaction (RT-qPCR).",25892871_1,-1,1,2,-1,26057,-1,2.905851e-05,0.9996761,0.00029483103
26060,Th22 cells,15,17,91,101,"METHODS: CRC tumor and paratumor tissues were collected to detect the expression levels of Th22 cells and of related cytokines by immunohistochemistry, flow cytometry and real-time quantitative polymerase chain reaction (RT-qPCR).",25892871_1,-1,-1,-1,-1,26060,-1,8.7233406e-05,0.0004060163,0.9995067
26061,related cytokines,19,21,109,126,"METHODS: CRC tumor and paratumor tissues were collected to detect the expression levels of Th22 cells and of related cytokines by immunohistochemistry, flow cytometry and real-time quantitative polymerase chain reaction (RT-qPCR).",25892871_1,-1,-1,-1,-1,26061,-1,0.9023496,0.09350603,0.0041443915
26070,cells to,19,21,119,127,IL-22 alone or with a STAT3 inhibitor was injected into a BALB/c nude mouse model with subcutaneously transplanted RKO cells to study the effects of IL-22 on colon cancer growth.,25892871_3,-1,-1,-1,-1,26070,-1,0.0035702027,0.31788978,0.67854005
26073,Th22 cells,5,7,27,37,"RESULTS: The percentage of Th22 cells in the CD4(+) T subset was significantly higher in tumor tissues compared with that in paratumor tissues (1.47%  0.083% vs 1.23%  0.077%, P < 0.05) as determined by flow cytometry.",25892871_4,-1,-1,-1,-1,26073,-1,0.0012046429,0.040343523,0.9584519
26075,T subset,11,13,52,60,"RESULTS: The percentage of Th22 cells in the CD4(+) T subset was significantly higher in tumor tissues compared with that in paratumor tissues (1.47%  0.083% vs 1.23%  0.077%, P < 0.05) as determined by flow cytometry.",25892871_4,-1,-1,-1,-1,26075,-1,0.00022984532,0.009279257,0.9904909
26076,tumor tissues,17,19,89,102,"RESULTS: The percentage of Th22 cells in the CD4(+) T subset was significantly higher in tumor tissues compared with that in paratumor tissues (1.47%  0.083% vs 1.23%  0.077%, P < 0.05) as determined by flow cytometry.",25892871_4,-1,-1,-1,-1,26076,-1,5.9265317e-06,0.9999832,1.0837765e-05
26078,tissues,24,25,135,142,"RESULTS: The percentage of Th22 cells in the CD4(+) T subset was significantly higher in tumor tissues compared with that in paratumor tissues (1.47%  0.083% vs 1.23%  0.077%, P < 0.05) as determined by flow cytometry.",25892871_4,-1,1,2,-1,26078,-1,6.9194593e-06,0.9999716,2.1392385e-05
26079,analysis,1,2,8,16,"RT-qPCR analysis revealed that the mRNA expression levels of IL-22, aryl hydrocarbon receptor, CCL20 and CCL22 were significantly higher in tumor tissues compared with those in paratumor tissues.",25892871_5,0,1,-1,-1,26079,-1,6.285022e-06,0.9999871,6.5680356e-06
26080,that the,3,5,26,34,"RT-qPCR analysis revealed that the mRNA expression levels of IL-22, aryl hydrocarbon receptor, CCL20 and CCL22 were significantly higher in tumor tissues compared with those in paratumor tissues.",25892871_5,-1,-1,-1,-1,26080,-1,3.9016327e-06,0.9999919,4.1746034e-06
26083,tumor tissues,22,24,140,153,"RT-qPCR analysis revealed that the mRNA expression levels of IL-22, aryl hydrocarbon receptor, CCL20 and CCL22 were significantly higher in tumor tissues compared with those in paratumor tissues.",25892871_5,-1,-1,-1,-1,26083,-1,7.5568823e-06,0.99996364,2.8768342e-05
26085,tissues,29,30,187,194,"RT-qPCR analysis revealed that the mRNA expression levels of IL-22, aryl hydrocarbon receptor, CCL20 and CCL22 were significantly higher in tumor tissues compared with those in paratumor tissues.",25892871_5,-1,1,2,-1,26085,-1,1.3908705e-05,0.9998104,0.0001757557
26087,tumor tissues,9,11,55,68,"CCL27 mRNA also displayed a higher expression level in tumor tissues compared with that in paratumor tissues; however, these levels were not significantly different (2.58  0.93 vs 2.30  0.78, P > 0.05).",25892871_6,-1,-1,-1,-1,26087,-1,1.3932558e-05,0.9998902,9.584647e-05
26089,tissues,16,17,101,108,"CCL27 mRNA also displayed a higher expression level in tumor tissues compared with that in paratumor tissues; however, these levels were not significantly different (2.58  0.93 vs 2.30  0.78, P > 0.05).",25892871_6,-1,1,2,-1,26089,-1,6.0253922e-05,0.9952192,0.0047206073
26097,Th22 cells that,2,5,12,27,CONCLUSION: Th22 cells that accumulate in CRC may be associated with the chemotactic effect of the tumor microenvironment.,25892871_9,-1,-1,-1,-1,26097,-1,0.0001070505,0.9990527,0.0008403012
26098,the chemotactic,12,14,69,84,CONCLUSION: Th22 cells that accumulate in CRC may be associated with the chemotactic effect of the tumor microenvironment.,25892871_9,-1,-1,-1,-1,26098,-1,0.9058478,0.09180328,0.002348899
26099,the tumor,16,18,95,104,CONCLUSION: Th22 cells that accumulate in CRC may be associated with the chemotactic effect of the tumor microenvironment.,25892871_9,-1,-1,-1,-1,26099,-1,5.8720952e-06,0.99998903,5.0447516e-06
26104,that plays,5,7,37,47,PDAC builds a tumor microenvironment that plays critical roles in tumor progression and metastasis.,25952647_1,-1,-1,-1,-1,26104,-1,6.9630332e-06,0.99998724,5.7702177e-06
26106,the relationship,2,4,9,25,"However, the relationship between chemotherapy and modulation of PDAC-induced tumor microenvironment remains poorly understood.",25952647_2,-1,-1,-1,-1,26106,-1,1.3955311e-05,0.9999808,5.2566206e-06
26119,tumor tissues,12,14,80,93,"GM-CSF production was significantly enhanced in various PDAC cell lines or PDAC tumor tissues from patients after treatment with chemotherapy, which induced the differentiation of monocytes into myeloid-derived suppressor cells (MDSC).",25952647_5,-1,-1,-1,-1,26119,-1,6.531724e-05,0.99766123,0.0022734778
26135,that the targeting,18,21,128,146,"Together, these results describe a role of GM-CSF in the modification of chemotherapy-treated PDAC microenvironment and suggest that the targeting of GM-CSF may benefit PDAC patients' refractory to current anticancer regimens by defeating MDSC-mediated immune escape.",25952647_8,-1,-1,-1,-1,26135,-1,4.5739876e-06,0.9999913,4.167667e-06
26139,This deficiency,0,2,0,15,This deficiency is in part due to an incomplete understanding of how to best invoke dendritic cells (DC) that are crucial for the induction of tumor-specific CD8(+) T cells capable of mediating durable protective immunity.,25972487_1,-1,-1,-1,-1,26139,-1,2.6572112e-05,0.9999628,1.0669777e-05
26147,immunity,37,38,213,221,This deficiency is in part due to an incomplete understanding of how to best invoke dendritic cells (DC) that are crucial for the induction of tumor-specific CD8(+) T cells capable of mediating durable protective immunity.,25972487_1,0,-1,2,-1,26147,-1,0.99982303,5.824456e-05,0.000118652664
26149,the transcription factor,7,10,39,63,"In this regard, elevated expression of the transcription factor X box-binding protein 1 (XBP1) in DC appears to play a decisive role in promoting the ability of DC to cross-present Ags to CD8(+) T cells in the therapeutic setting.",25972487_2,-1,-1,-1,-1,26149,-1,4.176946e-06,0.9999913,4.571319e-06
26150,protein,12,13,78,85,"In this regard, elevated expression of the transcription factor X box-binding protein 1 (XBP1) in DC appears to play a decisive role in promoting the ability of DC to cross-present Ags to CD8(+) T cells in the therapeutic setting.",25972487_2,0,1,-1,-1,26150,-1,5.7243305e-06,0.9999882,6.050084e-06
26152,to play,20,22,109,116,"In this regard, elevated expression of the transcription factor X box-binding protein 1 (XBP1) in DC appears to play a decisive role in promoting the ability of DC to cross-present Ags to CD8(+) T cells in the therapeutic setting.",25972487_2,-1,-1,-1,-1,26152,-1,4.563685e-06,0.9999907,4.763932e-06
26157,the therapeutic,40,42,206,221,"In this regard, elevated expression of the transcription factor X box-binding protein 1 (XBP1) in DC appears to play a decisive role in promoting the ability of DC to cross-present Ags to CD8(+) T cells in the therapeutic setting.",25972487_2,-1,-1,-1,-1,26157,-1,4.2034826e-06,0.9999919,3.92653e-06
26173,blood-,9,10,53,59,"Similarly, human XBP1 improved the capacity of human blood- and skin-derived DC to activate human T cells.",25972487_6,0,1,-1,-1,26173,-1,6.180798e-05,0.99987674,6.146371e-05
26179,immunity,30,31,210,218,"These data support an important intrinsic role for XBP1 in DC for effective cross-priming and orchestration of Batf3(+) DC-pDC interactions, thereby enabling effective vaccine induction of protective antitumor immunity.",25972487_7,0,-1,2,-1,26179,-1,0.99993014,1.5913223e-05,5.3981286e-05
26186,this tolerogenic,3,5,26,42,The mechanisms underlying this tolerogenic phenomenon remain poorly understood.,25984582_1,-1,-1,-1,-1,26186,-1,0.000157679,0.9998191,2.3213734e-05
26202,T-cells,32,33,183,190,"Among various immune cells in colon, dendritic cells (DCs) are unique not only in their accessibility to luminal contents but also in their ability to induce tolerogenic phenotype in T-cells.",25984582_3,-1,1,2,-1,26202,-1,1.6287871e-05,7.0353476e-06,0.99997663
26207,naive T-cells,28,30,177,190,"We found that DCs exposed to butyrate express the immunosuppressive enzymes indoleamine 2,3-dioxygenase 1 (IDO1) and aldehyde dehydrogenase 1A2 (Aldh1A2), promote conversion of naive T-cells into immunosuppressive forkhead box P3(+) (FoxP3(+)) Tregs (regulatory T-cells) and suppress conversion of naive T-cells into pro-inflammatory interferon (IFN)--producing cells.",25984582_4,-1,-1,-1,-1,26207,-1,0.0018320682,0.11526523,0.88290274
26212,naive T-cells,49,51,298,311,"We found that DCs exposed to butyrate express the immunosuppressive enzymes indoleamine 2,3-dioxygenase 1 (IDO1) and aldehyde dehydrogenase 1A2 (Aldh1A2), promote conversion of naive T-cells into immunosuppressive forkhead box P3(+) (FoxP3(+)) Tregs (regulatory T-cells) and suppress conversion of naive T-cells into pro-inflammatory interferon (IFN)--producing cells.",25984582_4,-1,-1,-1,-1,26212,-1,0.0015560625,0.089451075,0.9089929
26215,generate Tregs,11,13,58,72,Slc5a8-null DCs do not induce IDO1 and Aldh1A2 and do not generate Tregs or suppress IFN--producing T-cells in response to butyrate.,25984582_5,-1,-1,-1,-1,26215,-1,6.3554357e-06,0.9999893,4.344012e-06
26216,IFN--producing T-cells,15,17,85,108,Slc5a8-null DCs do not induce IDO1 and Aldh1A2 and do not generate Tregs or suppress IFN--producing T-cells in response to butyrate.,25984582_5,-1,-1,-1,-1,26216,-1,0.9608474,0.00021200044,0.038940605
26218,IFN--producing T-cells,17,19,85,108,We also provide invivo evidence for an obligatory role for Slc5a8in suppression of IFN--producing T-cells.,25984582_6,-1,-1,-1,-1,26218,-1,0.9601522,0.00024814034,0.039599665
26222,the transporter to,7,10,45,63,This agrees with the high-affinity nature of the transporter to mediate butyrate entry into cells.,25984582_8,-1,-1,-1,-1,26222,-1,5.241334e-06,0.9999887,6.1427017e-06
26226,that this transporter,21,24,136,157,We conclude that Slc5a8 is an obligatory link between dietary fibre and mucosal immune system via the bacterial metabolite butyrate and that this transporter is a conditional tumour suppressor in colon linked to dietary fibre content.,25984582_9,-1,-1,-1,-1,26226,-1,7.6056153e-06,0.99998593,6.5062463e-06
26236,peptides,7,8,31,39,"METHODS: Overlapping 30-35 mer peptides covering the entire HPV16 E2-, E6- and E7 protein sequences were used for defining the lymphocyte proliferation capacity, cytokine production (IL-2, IL-5, IL-10, IL-17A, IFN- and TNF-) and numbers of HPV16 -specific CD4+ CD25+ Foxp3+ regulatory T-cells in 10 women who developed CIN, and in 22 control women who tested constantly HPV-negative during the follow-up.",25990808_2,0,-1,2,-1,26236,-1,4.5218545e-05,0.99992967,2.5084857e-05
26238,protein,17,18,82,89,"METHODS: Overlapping 30-35 mer peptides covering the entire HPV16 E2-, E6- and E7 protein sequences were used for defining the lymphocyte proliferation capacity, cytokine production (IL-2, IL-5, IL-10, IL-17A, IFN- and TNF-) and numbers of HPV16 -specific CD4+ CD25+ Foxp3+ regulatory T-cells in 10 women who developed CIN, and in 22 control women who tested constantly HPV-negative during the follow-up.",25990808_2,0,1,-1,-1,26238,-1,2.1886486e-05,0.9999653,1.2855055e-05
26239,the lymphocyte,23,25,123,137,"METHODS: Overlapping 30-35 mer peptides covering the entire HPV16 E2-, E6- and E7 protein sequences were used for defining the lymphocyte proliferation capacity, cytokine production (IL-2, IL-5, IL-10, IL-17A, IFN- and TNF-) and numbers of HPV16 -specific CD4+ CD25+ Foxp3+ regulatory T-cells in 10 women who developed CIN, and in 22 control women who tested constantly HPV-negative during the follow-up.",25990808_2,-1,-1,-1,-1,26239,-1,0.002688817,0.362061,0.6352502
26244,TNF-,41,42,220,225,"METHODS: Overlapping 30-35 mer peptides covering the entire HPV16 E2-, E6- and E7 protein sequences were used for defining the lymphocyte proliferation capacity, cytokine production (IL-2, IL-5, IL-10, IL-17A, IFN- and TNF-) and numbers of HPV16 -specific CD4+ CD25+ Foxp3+ regulatory T-cells in 10 women who developed CIN, and in 22 control women who tested constantly HPV-negative during the follow-up.",25990808_2,0,1,-1,-1,26244,-1,0.0642816,0.9350703,0.00064811355
26249,related to the,3,6,21,35,"HPV-specific CMI was related to the demographic data including sexual behavior, smoking and alcohol consumption.",25990808_3,-1,-1,-1,-1,26249,-1,1.2076226e-05,0.9999794,8.581263e-06
26251,T-cell,10,11,55,61,"RESULTS: Women with CIN and their controls had similar T-cell mediated immunity against HPV16 E2, E6 and E7 peptide pools.",25990808_4,-1,1,2,-1,26251,-1,1.1968128e-05,8.047292e-06,0.99998
26252,immunity,12,13,71,79,"RESULTS: Women with CIN and their controls had similar T-cell mediated immunity against HPV16 E2, E6 and E7 peptide pools.",25990808_4,0,-1,2,-1,26252,-1,0.08815341,0.00045461775,0.91139203
26253,peptide,20,21,108,115,"RESULTS: Women with CIN and their controls had similar T-cell mediated immunity against HPV16 E2, E6 and E7 peptide pools.",25990808_4,0,-1,2,-1,26253,-1,0.04688534,0.94799364,0.0051209866
26254,T-cell,5,6,32,38,"However, nearly fourfold higher T-cell reactivity against common antigens was found in the CIN women than in the healthy donors (p=0.001).",25990808_5,-1,1,2,-1,26254,-1,1.723952e-05,1.1817403e-05,0.9999709
26263,the T-cell,6,8,36,46,"Smoking and use of alcohol affected the T-cell response to common antigens but not to HPV peptides (p=0.032 and 0.045, respectively).CONCLUSION: While both the CIN women and controls exhibited an HPV16-specific CMI, IL-17A might be of importance in HPV induced pathology.",25990808_7,-1,-1,-1,-1,26263,-1,0.003259358,0.22144955,0.77529114
26267,peptides,16,17,90,98,"Smoking and use of alcohol affected the T-cell response to common antigens but not to HPV peptides (p=0.032 and 0.045, respectively).CONCLUSION: While both the CIN women and controls exhibited an HPV16-specific CMI, IL-17A might be of importance in HPV induced pathology.",25990808_7,0,-1,2,-1,26267,-1,0.9858271,0.008865939,0.0053070146
26275,that the,5,7,30,38,It has recently been reported that the CD40-CD40 ligand (CD40L) interaction is important in Th17 development.,25992978_0,-1,-1,-1,-1,26275,-1,4.569958e-06,0.9999912,4.201612e-06
26283,Th17 cells,22,24,146,156,"In addition, transforming growth factor-beta (TGF-) promotes tumorigenesis as an immunosuppressive cytokine and is crucial in the development of Th17 cells.",25992978_1,-1,-1,-1,-1,26283,-1,0.0006311906,0.048621133,0.9507477
26287,function,16,17,98,106,This study investigated the role of CD40 in breast cancer cells and its role in immunosuppressive function and tumor progression.,25992978_2,0,1,2,-1,26287,-1,0.0006520243,0.99881953,0.00052847626
26299,cells through the,27,30,194,211,"Direct CD40-CD40L interaction between MDA-MB231 cells and activated T cells also increased TGF- production and induced the production of IL-17, which accelerated the proliferation of MDA-MB231 cells through the activation of STAT3.",25992978_4,-1,-1,-1,-1,26299,-1,0.0034036634,0.8092456,0.18735075
26301,Taken together,0,2,0,14,"Taken together, the direct CD40-CD40L interaction of breast tumor cells and activated T cells increases TGF- production and the differentiation of Th17 cells, which promotes the proliferation of breast cancer cells.",25992978_5,-1,-1,-1,-1,26301,-1,7.829349e-06,0.99998486,7.2813777e-06
26303,tumor cells,9,11,60,71,"Taken together, the direct CD40-CD40L interaction of breast tumor cells and activated T cells increases TGF- production and the differentiation of Th17 cells, which promotes the proliferation of breast cancer cells.",25992978_5,-1,-1,-1,-1,26303,-1,7.1225564e-05,0.00019668072,0.9997321
26307,Th17 cells,22,24,148,158,"Taken together, the direct CD40-CD40L interaction of breast tumor cells and activated T cells increases TGF- production and the differentiation of Th17 cells, which promotes the proliferation of breast cancer cells.",25992978_5,-1,-1,-1,-1,26307,-1,0.00019639509,0.0068538683,0.9929497
26321,their related cytokines,19,22,86,109,"In the present study, we mainly investigated the role of Th22, Th17, and Th1 cell and their related cytokines (IL-22, IL-17, and IFN-r) in the pathophysiology of CML.",26000313_1,-1,-1,-1,-1,26321,-1,0.31715196,0.6777119,0.0051361048
26325,blood,7,8,32,37,"Bone marrow (BM) and peripheral blood (PB) were extracted from newly diagnosed (ND), chronic phase- (CP-) CML patients, and controls.",26000313_2,0,1,-1,-1,26325,-1,0.0023922094,0.2530373,0.74457043
26326,Th subsets,0,2,0,10,Th subsets were examined by flow cytometry.,26000313_3,-1,-1,-1,-1,26326,-1,0.0005208948,0.02583517,0.9736439
26342,Th17 cells,12,14,82,92,"In addition, there existed a significantly positive relationship between Th22 and Th17 cells in PB or BM.",26000313_7,-1,-1,-1,-1,26342,-1,8.198969e-05,0.0005516675,0.99936634
26344,Th cells,7,9,56,64,"A significantly negative relationship was found between Th cells (Th22, Th17, or Th1) and BCR-ABL (%) IS or the number of PB white blood cells.",26000313_8,-1,-1,-1,-1,26344,-1,9.22115e-06,8.288853e-06,0.9999825
26349,blood cells,29,31,131,142,"A significantly negative relationship was found between Th cells (Th22, Th17, or Th1) and BCR-ABL (%) IS or the number of PB white blood cells.",26000313_8,-1,-1,-1,-1,26349,-1,2.1728587e-05,1.1370387e-05,0.999967
26351,that Th22,4,6,31,40,"All these results demonstrated that Th22, Th17, and Th1 cells might be important therapeutic targets in CML and could facilitate a better outcome for tumor immunotherapy.",26000313_9,-1,-1,-1,-1,26351,-1,0.0012405467,0.99865806,0.00010132775
26354,therapeutic targets,15,17,81,100,"All these results demonstrated that Th22, Th17, and Th1 cells might be important therapeutic targets in CML and could facilitate a better outcome for tumor immunotherapy.",26000313_9,-1,-1,-1,-1,26354,-1,6.0780694e-06,0.9999893,4.610934e-06
26358,T-cell,13,14,76,82,One of the obstacles for cancer immunotherapy is the inefficiency of CD8(+) T-cell recruitment to tumors.,26025380_0,-1,1,2,-1,26358,-1,1.3502548e-05,6.4330834e-06,0.9999801
26359,to tumors,15,17,95,104,One of the obstacles for cancer immunotherapy is the inefficiency of CD8(+) T-cell recruitment to tumors.,26025380_0,-1,-1,-1,-1,26359,-1,7.639447e-06,0.999984,8.295238e-06
26362,T-cell,8,9,40,46,"STAT3 has been shown to suppress CD8(+) T-cell antitumor functions in various cancer models, in part by restricting accumulation of CD8(+) T cells.",26025380_1,-1,1,2,-1,26362,-1,1.0094581e-05,6.509134e-06,0.9999833
26363,functions,10,11,57,66,"STAT3 has been shown to suppress CD8(+) T-cell antitumor functions in various cancer models, in part by restricting accumulation of CD8(+) T cells.",26025380_1,0,1,2,-1,26363,-1,0.0005689135,0.004347893,0.9950832
26371,that STAT3,4,6,14,24,"Here, we show that STAT3 signaling in CD8(+) T cells inhibits chemokine CXCL10 production by tumor-associated myeloid cells by reducing IFN expression by T cells.",26025380_3,-1,-1,-1,-1,26371,-1,6.680975e-06,0.9999883,5.0305466e-06
26381,the receptor,14,16,82,94,"We further demonstrate that ablating STAT3 in T cells allows expression of CXCR3, the receptor of CXCL10, on CD8(+) T cells, resulting in efficient accumulation of CD8(+) T cells at tumor sites.",26025380_4,-1,-1,-1,-1,26381,-1,0.00030093666,0.99897087,0.0007281594
26397,T cells through,20,23,120,135,"Together, our study reveals a negative regulation by STAT3 signaling in T cells on cross-talk between myeloid cells and T cells through IFN/CXCR3/CXCL10, which is important for CD8(+) T cells homing to tumors.",26025380_6,-1,-1,-1,-1,26397,-1,0.0025801663,0.0489448,0.948475
26399,to tumors,34,36,200,209,"Together, our study reveals a negative regulation by STAT3 signaling in T cells on cross-talk between myeloid cells and T cells through IFN/CXCR3/CXCL10, which is important for CD8(+) T cells homing to tumors.",26025380_6,-1,-1,-1,-1,26399,-1,5.1390907e-06,0.9999888,6.087046e-06
26402,T-cell,12,13,86,92,Our results thus provide new insights applicable to cancer immunotherapy and adoptive T-cell strategies.,26025380_7,-1,1,2,-1,26402,-1,1.529406e-05,8.746955e-06,0.99997604
26404,tumor cells,5,7,27,38,"In order to understand how tumor cells can escape immune surveillance mechanisms and thus develop antitumor therapies, it is critically important to investigate the mechanisms by which the immune system interacts with the tumor microenvironment.",26047948_0,-1,-1,-1,-1,26404,-1,0.0005863178,0.025795767,0.9736179
26410,the tumor,33,35,218,227,"In order to understand how tumor cells can escape immune surveillance mechanisms and thus develop antitumor therapies, it is critically important to investigate the mechanisms by which the immune system interacts with the tumor microenvironment.",26047948_0,-1,-1,-1,-1,26410,-1,4.8614916e-06,0.99999046,4.6311943e-06
26411,that chemokine receptor,7,10,31,54,"In our current study, we found that chemokine receptor 5 (CCR5) neutralization resulted in reduced melanoma tumor size, decreased percentage of CD11b+ Gr-1(+) myeloid-derived suppressor cells (MDSCs), and increased proportion of cluster of differentiation (CD)3+ T cells in tumor tissues.",26047948_1,-1,-1,-1,-1,26411,-1,0.18078516,0.7548148,0.06440002
26416,tumor tissues,47,49,274,287,"In our current study, we found that chemokine receptor 5 (CCR5) neutralization resulted in reduced melanoma tumor size, decreased percentage of CD11b+ Gr-1(+) myeloid-derived suppressor cells (MDSCs), and increased proportion of cluster of differentiation (CD)3+ T cells in tumor tissues.",26047948_1,-1,-1,-1,-1,26416,-1,7.853933e-06,0.99997854,1.3598181e-05
26433,cells transfected,37,39,211,228,"CCR5 blockade also induces suppressor of cytokine signaling 3 (SOCS3) upregulations, and anti-CCR5 antibody fails to suppress expression of phospho-Stat3 (p-Stat3), matrix metallopeptidase 9 (MMP9), and IL-6 in cells transfected with SOCS3 short-interfering RNA (SiRNA).",26047948_5,-1,-1,-1,-1,26433,-1,0.0026394718,0.2551113,0.7422492
26435,that CCR5,4,6,23,32,All these data suggest that CCR5 blockade suppresses melanoma development through inhibition of IL-6-Stat3 pathway via upregulation of SOCS3.,26047948_6,-1,-1,-1,-1,26435,-1,0.004184588,0.8612797,0.13453564
26441,translation to,11,13,58,72,The paucity of regulatory T cells (Tregs) limits clinical translation to control aberrant immune reactions including graft-versus-host disease (GVHD).,26063163_0,-1,-1,-1,-1,26441,-1,4.096872e-06,0.9999924,3.5871292e-06
26442,that the,3,5,22,30,Recent studies showed that the agonistic antibody to DR3 (DR3) expanded CD4(+)FoxP3(+) Tregs in vivo.,26063163_1,-1,-1,-1,-1,26442,-1,4.5298366e-06,0.99999154,3.907552e-06
26446,transplantation,21,22,130,145,We investigated whether treating donor mice with a single dose of DR3 could alleviate acute GVHD in a MHC-mismatched bone marrow transplantation model.,26063163_2,-1,1,2,-1,26446,-1,8.839924e-06,0.99998295,8.249464e-06
26447,functional Tregs,5,7,40,56,DR3 induced selective proliferation of functional Tregs. CD4(+) T cells isolated from DR3-treated mice contained higher numbers of Tregs and were less proliferative to allogeneic stimuli.,26063163_3,-1,-1,-1,-1,26447,-1,1.9440944e-05,0.99996483,1.5678685e-05
26451,that Tregs,5,7,31,41,"In vivo GVHD studies confirmed that Tregs from DR3-treated donors expanded robustly and higher frequencies of Tregs within donor CD4(+) T cells were maintained, resulting in improved survival.",26063163_4,-1,-1,-1,-1,26451,-1,5.3589883e-06,0.9999901,4.5589663e-06
26458,TNF,11,12,60,64,"Serum levels of proinflammatory cytokines (IFN, IL-1, and TNF) and infiltration of donor T cells into GVHD target tissues (gastrointestinal tract and liver) were decreased.",26063163_6,0,1,-1,-1,26458,-1,0.00012324553,0.9998332,4.3492426e-05
26460,target tissues,21,23,110,124,"Serum levels of proinflammatory cytokines (IFN, IL-1, and TNF) and infiltration of donor T cells into GVHD target tissues (gastrointestinal tract and liver) were decreased.",26063163_6,-1,-1,-1,-1,26460,-1,4.8591413e-05,0.99851173,0.0014396701
26466,Treg-based therapies,9,11,64,84,This novel strategy will facilitate the clinical application of Treg-based therapies.,26063163_9,-1,-1,-1,-1,26466,-1,6.4076403e-06,0.9999864,7.1741024e-06
26472,tumor antigen,9,11,48,61,This lack of success is conceivably due to poor tumor antigen presentation combined with immuno-suppressive mechanisms exploited by the tumor itself.,26079374_1,-1,-1,-1,-1,26472,-1,0.47168002,0.52284783,0.0054721436
26473,the tumor,18,20,132,141,This lack of success is conceivably due to poor tumor antigen presentation combined with immuno-suppressive mechanisms exploited by the tumor itself.,26079374_1,-1,-1,-1,-1,26473,-1,5.8857086e-06,0.99998915,4.98325e-06
26475,tumor cells,15,17,91,102,Knock down of Inhibitor of differentiation protein 2 (Id2-kd) in mouse neuroblastoma whole tumor cells rendered these cells immunogenic.,26079374_2,-1,-1,-1,-1,26475,-1,0.00039491343,0.017567812,0.9820373
26476,these cells,18,20,112,123,Knock down of Inhibitor of differentiation protein 2 (Id2-kd) in mouse neuroblastoma whole tumor cells rendered these cells immunogenic.,26079374_2,-1,-1,-1,-1,26476,-1,5.6887526e-05,0.00017326989,0.99976987
26480,immunity,23,24,133,141,Id2-kd neuroblastoma (Neuro2a) cells (Id2-kd N2a) failed to grow in most immune competent mice and these mice subsequently developed immunity against further wild-type Neuro2a tumor cell challenge.,26079374_3,0,-1,2,-1,26480,-1,0.99956244,0.0002479198,0.00018955991
26481,tumor cell,28,30,176,186,Id2-kd neuroblastoma (Neuro2a) cells (Id2-kd N2a) failed to grow in most immune competent mice and these mice subsequently developed immunity against further wild-type Neuro2a tumor cell challenge.,26079374_3,-1,-1,-1,-1,26481,-1,6.4672495e-05,0.00022065057,0.9997147
26485,these cells,14,16,107,118,"Id2-kd N2a cells grew aggressively in immune-compromised hosts, thereby establishing the immunogenicity of these cells.",26079374_4,-1,-1,-1,-1,26485,-1,2.3987905e-05,1.7494212e-05,0.9999585
26494,immunity,17,18,111,119,"Mechanistically, immune cell depletion studies demonstrated that while CD8+ T cells are critical for antitumor immunity, CD4+ T cells are also required to induce a sustained long-lasting helper effect.",26079374_6,0,-1,2,-1,26494,-1,0.9994599,0.0002950553,0.0002450348
26497,T-cells,7,8,30,37,An increase in number of CD8+ T-cells and enhanced production of interferon gamma (IFN) was observed in tumor antigen stimulated splenocytes of vaccinated mice.,26079374_7,-1,1,2,-1,26497,-1,1.6251397e-05,9.89856e-06,0.9999739
26500,tumor antigen,20,22,105,118,An increase in number of CD8+ T-cells and enhanced production of interferon gamma (IFN) was observed in tumor antigen stimulated splenocytes of vaccinated mice.,26079374_7,-1,-1,-1,-1,26500,-1,0.48067337,0.5147203,0.0046062754
26501,T-cells,10,11,53,60,"More importantly, a massive influx of cytotoxic CD8+ T-cells infiltrated the shrinking tumor following combined immunotherapy.",26079374_8,-1,1,2,-1,26501,-1,1.5273883e-05,8.852256e-06,0.9999759
26502,the shrinking tumor,12,15,73,92,"More importantly, a massive influx of cytotoxic CD8+ T-cells infiltrated the shrinking tumor following combined immunotherapy.",26079374_8,-1,-1,-1,-1,26502,-1,1.08002205e-05,0.99997663,1.251152e-05
26506,tumor cell immunity,9,12,56,75,"These findings show that down regulation of Id2 induced tumor cell immunity and in combination with checkpoint blockade produced a novel, potent, T-cell mediated tumor vaccine strategy.",26079374_9,-1,-1,-1,-1,26506,-1,0.00030781698,0.00016614715,0.99952614
26507,T-cell,24,25,146,152,"These findings show that down regulation of Id2 induced tumor cell immunity and in combination with checkpoint blockade produced a novel, potent, T-cell mediated tumor vaccine strategy.",26079374_9,-1,1,2,-1,26507,-1,1.041522e-05,6.8764543e-06,0.9999827
26510,the tumor,9,11,57,66,IL-12 promotes a rapid reversal of immune suppression in the tumor microenvironment.,26085681_0,-1,-1,-1,-1,26510,-1,4.8723123e-06,0.9999907,4.4778653e-06
26513,to regulatory T cell,10,14,59,79,"However, the adjuvant activity of IL-12 is short-lived due to regulatory T cell (Treg) reinfiltration.",26085681_1,-1,-1,-1,-1,26513,-1,0.0013834557,0.06952075,0.9290958
26515,analysis,1,2,13,21,Quantitative analysis of Treg kinetics in IL-12-treated tumors and tumor-draining lymph nodes revealed a transient loss followed by a rapid 4-fold expansion of tumor Treg between days 3 and 10.,26085681_2,0,1,-1,-1,26515,-1,6.2607783e-06,0.9999894,4.3224773e-06
26517,IL-12-treated tumors,6,8,42,62,Quantitative analysis of Treg kinetics in IL-12-treated tumors and tumor-draining lymph nodes revealed a transient loss followed by a rapid 4-fold expansion of tumor Treg between days 3 and 10.,26085681_2,-1,-1,-1,-1,26517,-1,0.99773645,0.0016779064,0.0005856539
26520,tumor Treg,23,25,160,170,Quantitative analysis of Treg kinetics in IL-12-treated tumors and tumor-draining lymph nodes revealed a transient loss followed by a rapid 4-fold expansion of tumor Treg between days 3 and 10.,26085681_2,-1,-1,-1,-1,26520,-1,7.0315064e-06,0.9999875,5.51542e-06
26521,Subset-specific analysis,0,2,0,24,"Subset-specific analysis demonstrated that the posttreatment rebound was driven by the CD4(+)CD25(+)Foxp3(+) neuropilin-1(low) peripheral Treg (pTreg), resulting in a 3-5-fold increase in the pTreg to CD4(+)CD25(+)Foxp3(+) neuropilin-1(high) thymic Treg ratio by day 10.",26085681_3,-1,-1,-1,-1,26521,-1,0.002441619,0.037263505,0.9602948
26522,that the,3,5,38,46,"Subset-specific analysis demonstrated that the posttreatment rebound was driven by the CD4(+)CD25(+)Foxp3(+) neuropilin-1(low) peripheral Treg (pTreg), resulting in a 3-5-fold increase in the pTreg to CD4(+)CD25(+)Foxp3(+) neuropilin-1(high) thymic Treg ratio by day 10.",26085681_3,-1,-1,-1,-1,26522,-1,4.124704e-06,0.9999918,4.112653e-06
26527,thymic Treg,36,38,242,253,"Subset-specific analysis demonstrated that the posttreatment rebound was driven by the CD4(+)CD25(+)Foxp3(+) neuropilin-1(low) peripheral Treg (pTreg), resulting in a 3-5-fold increase in the pTreg to CD4(+)CD25(+)Foxp3(+) neuropilin-1(high) thymic Treg ratio by day 10.",26085681_3,-1,-1,-1,-1,26527,-1,9.802465e-06,0.9999821,8.066371e-06
26532,TNFR,20,21,146,150,"The expanding pTreg displayed hypermethylation of the CpG islands in Treg-specific demethylated region, CTLA-4 exon 2, and glucocorticoid-induced TNFR exon 5, were phenotypically unstable, and exhibited diminished suppressive function consistent with an uncommitted in vitro-induced Treg-like phenotype.",26085681_4,0,1,-1,-1,26532,-1,1.1127609e-05,0.99997985,8.9867635e-06
26533,function,32,33,226,234,"The expanding pTreg displayed hypermethylation of the CpG islands in Treg-specific demethylated region, CTLA-4 exon 2, and glucocorticoid-induced TNFR exon 5, were phenotypically unstable, and exhibited diminished suppressive function consistent with an uncommitted in vitro-induced Treg-like phenotype.",26085681_4,0,1,2,-1,26533,-1,1.6969056e-05,0.999966,1.6996883e-05
26538,thymic Treg,21,23,149,160,"In vitro culture of posttherapy Treg populations under Th1-promoting conditions resulted in higher levels of IFN- production by pTreg compared with thymic Treg, confirming their transitional state.",26085681_5,-1,-1,-1,-1,26538,-1,4.512983e-06,0.99999,5.4532884e-06
26539,their transitional state,25,28,173,197,"In vitro culture of posttherapy Treg populations under Th1-promoting conditions resulted in higher levels of IFN- production by pTreg compared with thymic Treg, confirming their transitional state.",26085681_5,-1,-1,-1,-1,26539,-1,4.3759765e-06,0.9999907,4.9282175e-06
26546,T-cell,0,1,0,6,"T-cell exhaustion was originally identified during chronic infection in mice, and was subsequently observed in humans with cancer.",26086965_0,-1,1,2,-1,26546,-1,2.0010531e-05,1.035072e-05,0.9999696
26549,the tumor,5,7,25,34,"The exhausted T cells in the tumor microenvironment show overexpressed inhibitory receptors, decreased effector cytokine production and cytolytic activity, leading to the failure of cancer elimination.",26086965_1,-1,-1,-1,-1,26549,-1,4.0385403e-06,0.9999913,4.6059336e-06
26550,receptors,11,12,82,91,"The exhausted T cells in the tumor microenvironment show overexpressed inhibitory receptors, decreased effector cytokine production and cytolytic activity, leading to the failure of cancer elimination.",26086965_1,0,1,2,-1,26550,-1,2.890037e-05,2.0629634e-05,0.9999505
26552,to the,22,24,164,170,"The exhausted T cells in the tumor microenvironment show overexpressed inhibitory receptors, decreased effector cytokine production and cytolytic activity, leading to the failure of cancer elimination.",26086965_1,-1,-1,-1,-1,26552,-1,4.9099726e-06,0.99999046,4.629084e-06
26569,toxicity,13,14,73,81,Mutyh-/- mice were more sensitive than wild-type (WT) animals to AOM/DSS toxicity and accumulated DNA 8-oxoG in their gastrointestinal tract.,26109431_3,0,1,-1,-1,26569,-1,8.671324e-06,0.99997985,1.1428172e-05
26577,cytokines GM-CSF,12,14,87,103,"The colon of untreated Mutyh-/- mice expressed higher basal levels of pro-inflammatory cytokines GM-CSF and IFN, and treatment with AOM/DSS induced an early decrease in circulating CD4+ and CD8+ T lymphocytes and an increase in myeloid-derived suppressor cells (MDSCs).",26109431_6,-1,-1,-1,-1,26577,-1,0.99994004,8.284099e-06,5.1764808e-05
26585,TGF--latency-associated peptide,24,26,141,173,"Adenomas from Mutyh-/- mice had a greater infiltrate of Foxp3+ T regulatory cells, granulocytes, macrophages, MDSCs and strong expression of TGF--latency-associated peptide and IL6.",26109431_7,-1,-1,-1,-1,26585,-1,2.9475646e-05,0.999948,2.2470815e-05
26588,that the,2,4,11,19,We propose that the AOM/DSS initiation/promotion protocol in Mutyh-/- mice provides a good model for MAP.,26109431_9,-1,-1,-1,-1,26588,-1,4.3958275e-06,0.9999918,3.842968e-06
26589,cell transplantation,13,15,104,124,"Acute graft-versus-host disease (aGVHD) remains a major complication following allogeneic hematopoietic cell transplantation, limiting the success of this therapy.",26153763_0,-1,-1,-1,-1,26589,-1,0.0016541146,0.0021038472,0.99624205
26590,limiting the,16,18,126,138,"Acute graft-versus-host disease (aGVHD) remains a major complication following allogeneic hematopoietic cell transplantation, limiting the success of this therapy.",26153763_0,-1,-1,-1,-1,26590,-1,0.115276694,0.8828621,0.0018612378
26591,this therapy,20,22,150,162,"Acute graft-versus-host disease (aGVHD) remains a major complication following allogeneic hematopoietic cell transplantation, limiting the success of this therapy.",26153763_0,-1,-1,-1,-1,26591,-1,9.3714825e-06,0.99998534,5.2539535e-06
26592,that interleukin-22,3,5,23,42,"We previously reported that interleukin-22 (IL-22) participates to aGVHD development, but the underlying mechanisms of its contribution remain poorly understood.",26153763_1,-1,-1,-1,-1,26592,-1,0.9201626,0.0782447,0.0015927779
26598,function,11,12,61,69,"In this study, we analyzed the mechanism of the pathological function of IL-22 in intestinal aGVHD.",26153763_2,0,1,2,-1,26598,-1,0.0005344591,0.99923325,0.0002322808
26602,signal transducer and activator of transcription factor-1,14,21,100,157,Ex-vivo colon culture experiments indicated that IL-22 was able to induce Th1-like inflammation via signal transducer and activator of transcription factor-1 (STAT1) and CXCL10 induction in the presence of type I interferon (IFN).,26153763_3,-1,-1,-1,-1,26602,-1,1.1261933e-05,0.9999702,1.8575298e-05
26614,IFN receptor,27,29,135,147,"To evaluate a potential synergy between IL-22 and type I IFN in aGVHD, we transplanted recipient mice, either wild-type (WT) or type I IFN receptor deficient (IFNAR(-/-)), with bone marrow cells and WT or IL-22 deficient (IL-22(-/-)) T cells.",26153763_4,-1,-1,-1,-1,26614,-1,0.99843615,4.2231874e-05,0.0015216327
26624,tissues,20,21,171,178,"Finally, immunohistochemistry staining of STAT1 performed on gastrointestinal biopsies of 20 transplanted patients showed exacerbated STAT1 activation in gastrointestinal tissues of patients with aGVHD as compared with those without aGVHD.",26153763_6,-1,1,2,-1,26624,-1,0.00047535796,0.8552638,0.14426087
26638,to tumor,9,11,61,69,"However, the detailed mechanisms by which S100A8 contributes to tumor progression have not been elucidated.",26165843_2,-1,-1,-1,-1,26638,-1,8.357266e-06,0.9999845,7.1154905e-06
26643,peptide,9,10,28,35,"We found that S100A8 (2-89) peptide stimulated cell migration in a manner dependent on TLR4, MD-2 and MyD88.",26165843_4,0,-1,2,-1,26643,-1,0.0021861936,0.99727315,0.0005406506
26647,peptide,7,8,18,25,The S100A8 (2-89) peptide also activated p38 and NF-B in TLR4-dependent manner.,26165843_5,0,-1,2,-1,26647,-1,0.0003750145,0.9994591,0.00016588981
26649,The peptide,0,2,0,11,"The peptide induced the upregulation of both IL-6 and Ccl2 in peritoneal macrophages obtained from wild-type mice, but not TLR4-deficient mice.",26165843_6,-1,-1,-1,-1,26649,-1,0.00022158568,0.9997218,5.657053e-05
26660,the TLR4,3,5,20,28,"To further evaluate the TLR4 dependency on tumor microenvironment, Lewis lung carcinoma-bearing mice were treated with Eritoran, an antagonist of TLR4/MD-2 complex.",26165843_8,-1,-1,-1,-1,26660,-1,8.116165e-06,0.9999745,1.7357092e-05
26667,the treatment,16,18,112,125,We found that both tumor volume and pulmonary recruitment of myeloid-derived suppressor cells were reduced with the treatment of Eritoran for five consecutive days.,26165843_9,-1,-1,-1,-1,26667,-1,5.6272556e-06,0.99999046,3.954823e-06
26671,T-cells,14,15,98,105,"Eritoran reduced the development of tumor vasculature, and increased tumor-infiltration of CD8(+) T-cells.",26165843_10,-1,1,2,-1,26671,-1,1.5668667e-05,1.0099659e-05,0.99997425
26672,Taken together,0,2,0,14,"Taken together, S100A8 appears to play a crucial role in the activation of the TLR4/MD-2 pathway and the promotion of a tumor growth-enhancing immune microenvironment.",26165843_11,-1,-1,-1,-1,26672,-1,8.084749e-06,0.9999844,7.549785e-06
26673,to play,5,7,31,38,"Taken together, S100A8 appears to play a crucial role in the activation of the TLR4/MD-2 pathway and the promotion of a tumor growth-enhancing immune microenvironment.",26165843_11,-1,-1,-1,-1,26673,-1,5.3890485e-06,0.99998856,6.0790267e-06
26684,immune responses to,11,14,66,85,Recent studies show that CD8(+) Treg cells might impede effective immune responses to established tumors.,26166762_1,-1,-1,-1,-1,26684,-1,0.9555381,0.043768536,0.0006934003
26691,tumor-infiltrating lymphocytes,3,5,28,58,The immunohistochemistry of tumor-infiltrating lymphocytes revealed a significant correlation between the intratumoral CD8(+) T cells and the forkhead box p3 (Foxp3)(+) cells in the intraepithelial and stromal areas of advanced OC tissues.,26166762_4,-1,-1,-1,-1,26691,-1,0.0022167135,0.8713202,0.1264631
26694,the forkhead,17,19,138,150,The immunohistochemistry of tumor-infiltrating lymphocytes revealed a significant correlation between the intratumoral CD8(+) T cells and the forkhead box p3 (Foxp3)(+) cells in the intraepithelial and stromal areas of advanced OC tissues.,26166762_4,-1,-1,-1,-1,26694,-1,5.8320916e-06,0.99998915,4.9969226e-06
26697,tissues,33,34,231,238,The immunohistochemistry of tumor-infiltrating lymphocytes revealed a significant correlation between the intratumoral CD8(+) T cells and the forkhead box p3 (Foxp3)(+) cells in the intraepithelial and stromal areas of advanced OC tissues.,26166762_4,-1,1,2,-1,26697,-1,0.00019078968,0.011193928,0.9886153
26702,blood,15,16,81,86,We examined the expression of Treg markers in CD8(+) T cells from the peripheral blood and fresh tumor tissues of OC patients using flow cytometry.,26166762_5,0,1,-1,-1,26702,-1,0.0029275247,0.9180999,0.07897257
26703,tumor tissues,18,20,97,110,We examined the expression of Treg markers in CD8(+) T cells from the peripheral blood and fresh tumor tissues of OC patients using flow cytometry.,26166762_5,-1,-1,-1,-1,26703,-1,1.1009881e-05,0.99997056,1.8429186e-05
26705,Treg cell subsets,9,12,48,65,"Our results indicated an increase in the CD8(+) Treg cell subsets of OC patients compared with those in patients with benign ovarian tumors and healthy controls, including an increased expression of CD25, cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), and Foxp3 and decreased CD28 expression.",26166762_6,-1,-1,-1,-1,26705,-1,1.0037175e-05,7.634388e-06,0.99998236
26708,T-lymphocyte-associated protein,36,38,215,246,"Our results indicated an increase in the CD8(+) Treg cell subsets of OC patients compared with those in patients with benign ovarian tumors and healthy controls, including an increased expression of CD25, cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), and Foxp3 and decreased CD28 expression.",26166762_6,-1,-1,-1,-1,26708,-1,0.0004559479,0.0008426209,0.99870133
26713,the tumor,3,5,23,32,"To demonstrate whether the tumor microenvironment could convert CD8(+) effector T cells into suppressor cells, we used an in vitro transwell culturing system.",26166762_7,-1,-1,-1,-1,26713,-1,4.620496e-06,0.9999913,4.112259e-06
26727,through TGF-1,21,23,127,141,"In addition, the in vitro-induced CD8(+) Treg cells inhibited nave CD4(+) T-cell proliferation, which was partially mediated through TGF-1 and IFN-.",26166762_9,-1,-1,-1,-1,26727,-1,1.0289449e-05,0.999972,1.7723487e-05
26732,that tumors,25,27,124,135,"Our study suggests that CD8(+) Treg cells were increased in OC patients and could be induced in vitro, which may be the way that tumors limit antitumor immunity and evade immune surveillance.",26166762_10,-1,-1,-1,-1,26732,-1,4.7707363e-06,0.99999034,4.8705874e-06
26733,immunity,29,30,152,160,"Our study suggests that CD8(+) Treg cells were increased in OC patients and could be induced in vitro, which may be the way that tumors limit antitumor immunity and evade immune surveillance.",26166762_10,0,-1,2,-1,26733,-1,0.9998079,8.853136e-05,0.00010361267
26745,Foxp3-positive Tregs,0,2,0,20,Foxp3-positive Tregs in the duodenal mucosa were examined by immunohistochemistry and immunofluorescence.,26173451_3,-1,-1,-1,-1,26745,-1,6.3656134e-06,0.9999882,5.4458e-06
26760,Foxp3-positive cells,10,12,62,82,"Some large cell intestinal lymphoma cases had high numbers of Foxp3-positive cells, but the increase was not statistically significant.",26173451_7,-1,-1,-1,-1,26760,-1,0.0018934305,0.88063663,0.11746995
26769,than that,20,22,119,128,"In small cell intestinal lymphoma cases, the overall survival of dogs with a high Treg density was significantly worse than that of dogs with a normal Treg density.",26173451_9,-1,-1,-1,-1,26769,-1,7.621682e-06,0.99998665,5.7231264e-06
26774,Foxp3-positive Tregs,10,12,53,73,"These results suggest that a change in the number of Foxp3-positive Tregs contributes to the pathogenesis of canine IBD and intestinal lymphoma by disrupting mucosal tolerance and suppressing antitumor immunity, respectively.",26173451_10,-1,-1,-1,-1,26774,-1,5.180604e-06,0.99998915,5.6346053e-06
26775,to the,13,15,86,92,"These results suggest that a change in the number of Foxp3-positive Tregs contributes to the pathogenesis of canine IBD and intestinal lymphoma by disrupting mucosal tolerance and suppressing antitumor immunity, respectively.",26173451_10,-1,-1,-1,-1,26775,-1,4.379313e-06,0.99999094,4.6898294e-06
26777,immunity,29,30,202,210,"These results suggest that a change in the number of Foxp3-positive Tregs contributes to the pathogenesis of canine IBD and intestinal lymphoma by disrupting mucosal tolerance and suppressing antitumor immunity, respectively.",26173451_10,0,-1,2,-1,26777,-1,0.9999163,1.8820398e-05,6.488033e-05
26781,the IL-12,9,11,47,56,Interleukin-12 (IL-12) was the first member of the IL-12 family of cytokines to be identified and has therefore become its eponym.,26182974_0,-1,-1,-1,-1,26781,-1,0.91295457,0.084962636,0.0020828384
26782,cytokines to,13,15,67,79,Interleukin-12 (IL-12) was the first member of the IL-12 family of cytokines to be identified and has therefore become its eponym.,26182974_0,-1,-1,-1,-1,26782,-1,0.97516155,0.022888824,0.0019495792
26784,protein,4,5,22,29,"It is a heterodimeric protein of two subunits (p35, p40) secreted by phagocytic cells in response to pathogens and mainly acts through STAT4 to induce IFN- production in T and NK cells.",26182974_1,0,1,-1,-1,26784,-1,5.1670727e-06,0.9999907,4.18697e-06
26785,two subunits,6,8,33,45,"It is a heterodimeric protein of two subunits (p35, p40) secreted by phagocytic cells in response to pathogens and mainly acts through STAT4 to induce IFN- production in T and NK cells.",26182974_1,-1,-1,-1,-1,26785,-1,7.973496e-06,0.99998474,7.343498e-06
26789,through STAT4 to,24,27,127,143,"It is a heterodimeric protein of two subunits (p35, p40) secreted by phagocytic cells in response to pathogens and mainly acts through STAT4 to induce IFN- production in T and NK cells.",26182974_1,-1,-1,-1,-1,26789,-1,4.2208653e-06,0.9999912,4.551421e-06
26795,functions,5,6,39,48,IFN- in turn mediates proinflammatory functions and activates T-bet.,26182974_2,0,1,2,-1,26795,-1,0.00074520236,0.9985952,0.0006595582
26802,to TH1,9,11,64,70,"Following its identification and the finding of its association to TH1 commitment, great hopes were placed in IL-12 to become a target for therapeutic applications in multiple settings of autoimmunity and cancer.",26182974_4,-1,-1,-1,-1,26802,-1,3.6412212e-06,0.99998856,7.829818e-06
26804,IL-12 to,18,20,110,118,"Following its identification and the finding of its association to TH1 commitment, great hopes were placed in IL-12 to become a target for therapeutic applications in multiple settings of autoimmunity and cancer.",26182974_4,-1,-1,-1,-1,26804,-1,0.9987766,0.00072773953,0.0004956239
26809,the related,5,7,25,36,"Though, the discovery of the related members of the IL-12 family and several rather disappointing attempts to translate experimental results into clinical practice, have relativized these hopes.",26182974_5,-1,-1,-1,-1,26809,-1,8.076969e-06,0.9999856,6.312994e-06
26810,the IL-12,9,11,48,57,"Though, the discovery of the related members of the IL-12 family and several rather disappointing attempts to translate experimental results into clinical practice, have relativized these hopes.",26182974_5,-1,-1,-1,-1,26810,-1,0.8137607,0.18370615,0.0025331941
26811,to translate,17,19,107,119,"Though, the discovery of the related members of the IL-12 family and several rather disappointing attempts to translate experimental results into clinical practice, have relativized these hopes.",26182974_5,-1,-1,-1,-1,26811,-1,8.883898e-06,0.99998593,5.2266696e-06
26812,relativized these,26,28,170,187,"Though, the discovery of the related members of the IL-12 family and several rather disappointing attempts to translate experimental results into clinical practice, have relativized these hopes.",26182974_5,-1,-1,-1,-1,26812,-1,1.0015342e-05,0.9999839,6.0777293e-06
26817,the cytokine,12,14,65,77,"In this review, we will first briefly depict the biochemistry of the cytokine, its receptor and the related signal transduction, before summarizing the regulation of IL-12 production and its biological functions.",26182974_7,-1,-1,-1,-1,26817,-1,0.71117014,0.28284752,0.005982385
26818,receptor,16,17,83,91,"In this review, we will first briefly depict the biochemistry of the cytokine, its receptor and the related signal transduction, before summarizing the regulation of IL-12 production and its biological functions.",26182974_7,0,1,2,-1,26818,-1,0.0980313,0.13561323,0.76635545
26819,the related,18,20,96,107,"In this review, we will first briefly depict the biochemistry of the cytokine, its receptor and the related signal transduction, before summarizing the regulation of IL-12 production and its biological functions.",26182974_7,-1,-1,-1,-1,26819,-1,6.50629e-06,0.9999869,6.638628e-06
26821,the regulation,25,27,148,162,"In this review, we will first briefly depict the biochemistry of the cytokine, its receptor and the related signal transduction, before summarizing the regulation of IL-12 production and its biological functions.",26182974_7,-1,-1,-1,-1,26821,-1,5.2992036e-06,0.9999895,5.2197747e-06
26823,functions,33,34,202,211,"In this review, we will first briefly depict the biochemistry of the cytokine, its receptor and the related signal transduction, before summarizing the regulation of IL-12 production and its biological functions.",26182974_7,0,1,2,-1,26823,-1,0.0001662837,0.99965715,0.00017657493
26831,functions,9,10,73,82,STAT3 is an oncogenic transcription factor with potent immunosuppressive functions.,26208907_0,0,1,2,-1,26831,-1,0.0003514826,0.9995029,0.00014566054
26835,the tumor,15,17,99,108,We found that pharmacologic inhibition of STAT3 or its selective knockout in cancer cells improved the tumor growth-inhibitory efficacy of anthracycline-based chemotherapies.,26208907_1,-1,-1,-1,-1,26835,-1,4.846431e-06,0.99999094,4.2117367e-06
26854,these therapy-relevant,1,3,6,28,"Among these therapy-relevant stress pathways, Stat3(-/-) cancer cells manifested one significant improvement, namely an increase in the expression of multiple type-1 interferon-responsive genes, including that of the chemokines Cxcl9 and Cxcl10.",26208907_5,-1,-1,-1,-1,26854,-1,5.5279256e-06,0.99998915,5.3112685e-06
26858,type-1 interferon-responsive genes,23,26,159,193,"Among these therapy-relevant stress pathways, Stat3(-/-) cancer cells manifested one significant improvement, namely an increase in the expression of multiple type-1 interferon-responsive genes, including that of the chemokines Cxcl9 and Cxcl10.",26208907_5,-1,-1,-1,-1,26858,-1,9.048573e-05,0.9998795,3.002042e-05
26860,the chemokines,30,32,213,227,"Among these therapy-relevant stress pathways, Stat3(-/-) cancer cells manifested one significant improvement, namely an increase in the expression of multiple type-1 interferon-responsive genes, including that of the chemokines Cxcl9 and Cxcl10.",26208907_5,-1,-1,-1,-1,26860,-1,0.84594834,0.15133063,0.0027211057
26863,type-1 interferon,2,4,14,31,This enhanced type-1 interferon response could be suppressed by reintroducing wild-type Stat3 (but not a transactivation-deficient mutant Stat3(Y705F)) into the tumor cells.,26208907_6,-1,-1,-1,-1,26863,-1,0.09338374,0.90382534,0.0027909412
26866,Stat3(Y705F,18,19,138,149,This enhanced type-1 interferon response could be suppressed by reintroducing wild-type Stat3 (but not a transactivation-deficient mutant Stat3(Y705F)) into the tumor cells.,26208907_6,-1,-1,-1,-1,26866,-1,0.002038583,0.99760145,0.00036000318
26867,the tumor cells,22,25,157,172,This enhanced type-1 interferon response could be suppressed by reintroducing wild-type Stat3 (but not a transactivation-deficient mutant Stat3(Y705F)) into the tumor cells.,26208907_6,-1,-1,-1,-1,26867,-1,0.001535322,0.81851524,0.17994943
26873,type-1 interferon receptor,7,10,42,68,"Finally, the neutralization of the common type-1 interferon receptor or that of the chemokine receptor CXCR3 (which binds CXCL9 and CXCL10) abolished the difference in the chemotherapeutic response between Stat3(-/-) and control tumors.",26208907_8,-1,-1,-1,-1,26873,-1,0.012383194,0.96647996,0.021136865
26875,the chemokine receptor,13,16,80,102,"Finally, the neutralization of the common type-1 interferon receptor or that of the chemokine receptor CXCR3 (which binds CXCL9 and CXCL10) abolished the difference in the chemotherapeutic response between Stat3(-/-) and control tumors.",26208907_8,-1,-1,-1,-1,26875,-1,0.051545907,0.9154521,0.033001978
26878,the chemotherapeutic,28,30,168,188,"Finally, the neutralization of the common type-1 interferon receptor or that of the chemokine receptor CXCR3 (which binds CXCL9 and CXCL10) abolished the difference in the chemotherapeutic response between Stat3(-/-) and control tumors.",26208907_8,-1,-1,-1,-1,26878,-1,0.9069427,0.09058313,0.0024741099
26881,that STAT3,5,7,34,44,"Altogether, these results suggest that STAT3 inhibitors may improve the outcome of chemotherapy by enhancing the type-1 interferon response of cancer cells.",26208907_9,-1,-1,-1,-1,26881,-1,9.198844e-06,0.99998367,7.146774e-06
26884,the type-1 interferon,16,19,109,130,"Altogether, these results suggest that STAT3 inhibitors may improve the outcome of chemotherapy by enhancing the type-1 interferon response of cancer cells.",26208907_9,-1,-1,-1,-1,26884,-1,0.067592055,0.9306509,0.0017570428
26886,The tumor-promoting chemokine,0,3,0,29,"The tumor-promoting chemokine CCL5 has been implicated in malignant transformation of breast epithelial cells, with studies to date focusing mainly on basal-type breast cancers.",26249173_0,-1,-1,-1,-1,26886,-1,0.04005654,0.95818686,0.001756639
26901,chemokine receptor,11,13,81,99,"Mechanistic investigations revealed that CCL5 activates CCR3, a highly expressed chemokine receptor on CD4 T cells, and also boosts Gfi1 expression to promote the differentiation of Th2 cells, which enhance the prometastatic activity of tumor-associated myeloid cells.",26249173_3,-1,-1,-1,-1,26901,-1,0.98494935,8.928877e-05,0.014961436
26910,toward this,3,5,25,36,"Clinically, polarization toward this immunosuppressive Th2 phenotype was also evident in patients with advanced luminal breast cancer.",26249173_4,-1,-1,-1,-1,26910,-1,6.8466084e-06,0.9999875,5.6741437e-06
26927,Th subsets,0,2,0,10,Th subsets were examined by flow cytometry.,26255628_2,-1,-1,-1,-1,26927,-1,0.0005208948,0.02583517,0.9736439
26932,that the,4,6,15,23,"Here, we found that the frequency of Th22 cells was significantly elevated in peripheral blood (PB) and bone marrow (BM) of newly-diagnosed MM patients, and recovered in complete remission patients after chemotherapy.",26255628_5,-1,-1,-1,-1,26932,-1,3.9555766e-06,0.99999213,3.867031e-06
26933,Th22 cells,8,10,37,47,"Here, we found that the frequency of Th22 cells was significantly elevated in peripheral blood (PB) and bone marrow (BM) of newly-diagnosed MM patients, and recovered in complete remission patients after chemotherapy.",26255628_5,-1,-1,-1,-1,26933,-1,0.00020009714,0.0014028536,0.99839705
26934,blood,15,16,89,94,"Here, we found that the frequency of Th22 cells was significantly elevated in peripheral blood (PB) and bone marrow (BM) of newly-diagnosed MM patients, and recovered in complete remission patients after chemotherapy.",26255628_5,0,1,-1,-1,26934,-1,0.003080155,0.35652396,0.64039594
26937,Th17 cells,2,4,16,26,The circulating Th17 cells accompanied by IL-17A levels were also up-regulated in MM patients and decreased after remission.,26255628_6,-1,-1,-1,-1,26937,-1,0.00027546284,0.0063610706,0.9933635
26939,that there,3,5,14,24,We also found that there was a significantly positive correlation between Th22 and Th17 cells in MM patients.,26255628_7,-1,-1,-1,-1,26939,-1,5.0736326e-06,0.9999908,4.086424e-06
26941,Th17 cells,13,15,83,93,We also found that there was a significantly positive correlation between Th22 and Th17 cells in MM patients.,26255628_7,-1,-1,-1,-1,26941,-1,6.759636e-05,0.00026723024,0.99966526
26944,Th17 cells,7,9,38,48,"Moreover, the frequencies of Th22 and Th17 cells were higher in stage III than in stage I+II of MM.",26255628_8,-1,-1,-1,-1,26944,-1,2.2780365e-05,4.029225e-05,0.99993694
26946,that Th22,3,5,22,31,Our data demonstrated that Th22 and Th17 cells might be important therapeutic targets in multiple myeloma and could facilitate the effect of antitumor immunotherapy.,26255628_9,-1,-1,-1,-1,26946,-1,0.0033903427,0.9964302,0.00017949774
26947,Th17 cells,6,8,36,46,Our data demonstrated that Th22 and Th17 cells might be important therapeutic targets in multiple myeloma and could facilitate the effect of antitumor immunotherapy.,26255628_9,-1,-1,-1,-1,26947,-1,0.0002329489,0.0029307937,0.9968363
26948,therapeutic targets,11,13,66,85,Our data demonstrated that Th22 and Th17 cells might be important therapeutic targets in multiple myeloma and could facilitate the effect of antitumor immunotherapy.,26255628_9,-1,-1,-1,-1,26948,-1,7.3746774e-06,0.99998736,5.223289e-06
26968,tumor tissue,11,13,62,74,"Subsequently, there was a significant decrease in the size of tumor tissue and the numbers of heteromorphic tumor cells.",26270121_6,-1,-1,-1,-1,26968,-1,7.6226647e-06,0.9999726,1.9792782e-05
26970,tumor cells,18,20,108,119,"Subsequently, there was a significant decrease in the size of tumor tissue and the numbers of heteromorphic tumor cells.",26270121_6,-1,-1,-1,-1,26970,-1,8.3522544e-05,0.00030337006,0.9996131
26971,The tumor,0,2,0,9,The tumor metastasis in the lung and liver of the Ad-mIL-28B group also decreased.,26270121_7,-1,-1,-1,-1,26971,-1,3.9749275e-06,0.9999913,4.753406e-06
26982,to the,13,15,113,119,BACKGROUND AIMS: Epstein-Barr virus (EBV)-associated post-transplant lymphoproliferative disorders (PTLD) belong to the most dreaded complications of immunosuppression.,26276009_0,-1,-1,-1,-1,26982,-1,4.672935e-06,0.99998987,5.445482e-06
26984,T-cell transfer,4,6,29,44,"The efficacy of EBV-specific T-cell transfer for PTLD has been previously shown, yet the optimal choice of EBV-derived antigens inducing polyclonal CD4(+) and CD8(+) T cells that cover a wide range of human leukocyte antigen types and efficiently control PTLD remains unclear.",26276009_1,-1,-1,-1,-1,26984,-1,9.3534174e-05,0.00026987557,0.99963653
26987,T cells that,27,30,166,178,"The efficacy of EBV-specific T-cell transfer for PTLD has been previously shown, yet the optimal choice of EBV-derived antigens inducing polyclonal CD4(+) and CD8(+) T cells that cover a wide range of human leukocyte antigen types and efficiently control PTLD remains unclear.",26276009_1,-1,-1,-1,-1,26987,-1,0.0014847589,0.027613666,0.97090155
26988,antigen types,37,39,217,230,"The efficacy of EBV-specific T-cell transfer for PTLD has been previously shown, yet the optimal choice of EBV-derived antigens inducing polyclonal CD4(+) and CD8(+) T cells that cover a wide range of human leukocyte antigen types and efficiently control PTLD remains unclear.",26276009_1,-1,-1,-1,-1,26988,-1,0.9997379,6.572869e-05,0.00019631868
26989,T-cell,6,7,23,29,"METHODS: A pool of 125 T-cell epitopes from seven latent and nine lytic EBV-derived proteins (EBVmix) and peptide pools of EBNA1, EBNA3c, LMP2a and BZLF1 were used to determine T-cell frequencies and to isolate T cells through the use of the interferon (IFN)- cytokine capture system.",26276009_2,-1,1,2,-1,26989,-1,2.3528613e-05,1.8500414e-05,0.99995804
26990,proteins,15,16,84,92,"METHODS: A pool of 125 T-cell epitopes from seven latent and nine lytic EBV-derived proteins (EBVmix) and peptide pools of EBNA1, EBNA3c, LMP2a and BZLF1 were used to determine T-cell frequencies and to isolate T cells through the use of the interferon (IFN)- cytokine capture system.",26276009_2,0,1,-1,-1,26990,-1,1.0517353e-05,0.9999813,8.175377e-06
26991,peptide,20,21,106,113,"METHODS: A pool of 125 T-cell epitopes from seven latent and nine lytic EBV-derived proteins (EBVmix) and peptide pools of EBNA1, EBNA3c, LMP2a and BZLF1 were used to determine T-cell frequencies and to isolate T cells through the use of the interferon (IFN)- cytokine capture system.",26276009_2,0,-1,2,-1,26991,-1,4.4696197e-05,0.999938,1.7273545e-05
26993,T-cell,34,35,177,183,"METHODS: A pool of 125 T-cell epitopes from seven latent and nine lytic EBV-derived proteins (EBVmix) and peptide pools of EBNA1, EBNA3c, LMP2a and BZLF1 were used to determine T-cell frequencies and to isolate T cells through the use of the interferon (IFN)- cytokine capture system.",26276009_2,-1,1,2,-1,26993,-1,1.0804428e-05,7.330951e-06,0.9999819
26995,T cells through the,39,43,211,230,"METHODS: A pool of 125 T-cell epitopes from seven latent and nine lytic EBV-derived proteins (EBVmix) and peptide pools of EBNA1, EBNA3c, LMP2a and BZLF1 were used to determine T-cell frequencies and to isolate T cells through the use of the interferon (IFN)- cytokine capture system.",26276009_2,-1,-1,-1,-1,26995,-1,0.003541465,0.28972077,0.70673776
26996,the interferon,45,47,238,252,"METHODS: A pool of 125 T-cell epitopes from seven latent and nine lytic EBV-derived proteins (EBVmix) and peptide pools of EBNA1, EBNA3c, LMP2a and BZLF1 were used to determine T-cell frequencies and to isolate T cells through the use of the interferon (IFN)- cytokine capture system.",26276009_2,-1,-1,-1,-1,26996,-1,0.48651966,0.5091753,0.0043050116
26999,functionality,6,7,39,52,We further evaluated the phenotype and functionality of the generated T-cell lines in vitro.,26276009_3,0,1,2,-1,26999,-1,5.468042e-05,0.99990654,3.8736154e-05
27000,the generated T-cell,8,11,56,76,We further evaluated the phenotype and functionality of the generated T-cell lines in vitro.,26276009_3,-1,-1,-1,-1,27000,-1,0.00292091,0.42531562,0.57176346
27001,T-cell,6,7,45,51,RESULTS: EBVmix induced significantly higher T-cell frequencies and allowed selecting more CD4(+)IFN-(+) and CD8(+)IFN-(+) cells than single peptide pools.,26276009_4,-1,1,2,-1,27001,-1,9.963476e-06,7.329741e-06,0.9999827
27002,cells than,17,19,125,135,RESULTS: EBVmix induced significantly higher T-cell frequencies and allowed selecting more CD4(+)IFN-(+) and CD8(+)IFN-(+) cells than single peptide pools.,26276009_4,-1,-1,-1,-1,27002,-1,0.004422659,0.22100581,0.77457154
27003,peptide,20,21,143,150,RESULTS: EBVmix induced significantly higher T-cell frequencies and allowed selecting more CD4(+)IFN-(+) and CD8(+)IFN-(+) cells than single peptide pools.,26276009_4,0,-1,2,-1,27003,-1,2.326512e-05,0.9999665,1.0181453e-05
27012,proteins,21,22,137,145,This control was mainly mediated by EBV-specific CD8(+) cells with an oligoclonal epitope signature covering both latent and lytic viral proteins.,26276009_7,0,1,-1,-1,27012,-1,3.4225217e-05,0.99995625,9.581675e-06
27015,T-cell,6,7,38,44,"CONCLUSIONS: EBVmix induces a broader T-cell response, probably because of its coverage of latent and lytic EBV-derived proteins that may be important to control EBV-transformed B cells and might offer an improvement of T-cell therapies.",26276009_9,-1,1,2,-1,27015,-1,1.2851101e-05,7.927738e-06,0.99997914
27016,proteins that,19,21,120,133,"CONCLUSIONS: EBVmix induces a broader T-cell response, probably because of its coverage of latent and lytic EBV-derived proteins that may be important to control EBV-transformed B cells and might offer an improvement of T-cell therapies.",26276009_9,-1,-1,-1,-1,27016,-1,8.081304e-06,0.9999871,4.759478e-06
27019,T-cell therapies,35,37,220,236,"CONCLUSIONS: EBVmix induces a broader T-cell response, probably because of its coverage of latent and lytic EBV-derived proteins that may be important to control EBV-transformed B cells and might offer an improvement of T-cell therapies.",26276009_9,-1,-1,-1,-1,27019,-1,0.00042684408,0.0061189467,0.9934542
27021,tumor necrosis factor receptor,5,9,46,76,"T cell stimulation via glucocorticoid-induced tumor necrosis factor receptor (TNFR)-related protein (GITR) elicits antitumor activity in various tumor models; however, the underlying mechanism of action remains unclear.",26280119_0,-1,-1,-1,-1,27021,-1,0.9378661,0.03793183,0.024202125
27022,protein,10,11,92,99,"T cell stimulation via glucocorticoid-induced tumor necrosis factor receptor (TNFR)-related protein (GITR) elicits antitumor activity in various tumor models; however, the underlying mechanism of action remains unclear.",26280119_0,0,1,-1,-1,27022,-1,1.1271424e-05,0.99998105,7.678941e-06
27025,mechanism of action,26,29,183,202,"T cell stimulation via glucocorticoid-induced tumor necrosis factor receptor (TNFR)-related protein (GITR) elicits antitumor activity in various tumor models; however, the underlying mechanism of action remains unclear.",26280119_0,0,1,-1,-1,27025,-1,2.2278617e-05,0.9999621,1.562966e-05
27027,immunity generated,11,13,71,89,Here we demonstrate a crucial role for interleukin (IL)-9 in antitumor immunity generated by the GITR agonistic antibody DTA-1.,26280119_1,-1,-1,-1,-1,27027,-1,0.92040074,0.07854893,0.0010503224
27029,receptor,1,2,5,13,"IL-4 receptor knockout (Il4ra(-/-)) mice, which have reduced expression of IL-9, were resistant to tumor growth inhibition by DTA-1.",26280119_2,0,1,2,-1,27029,-1,0.13982584,0.30461165,0.5555625
27031,to tumor,18,20,96,104,"IL-4 receptor knockout (Il4ra(-/-)) mice, which have reduced expression of IL-9, were resistant to tumor growth inhibition by DTA-1.",26280119_2,-1,-1,-1,-1,27031,-1,4.0727846e-06,0.9999912,4.7138465e-06
27035,tumor-specific cytotoxic T lymphocyte,6,10,43,80,"In particular, DTA-1-induced IL-9 promoted tumor-specific cytotoxic T lymphocyte (CTL) responses by enhancing the function of dendritic cells in vivo.",26280119_4,-1,-1,-1,-1,27035,-1,0.00491667,0.54900074,0.4460826
27037,the function,16,18,110,122,"In particular, DTA-1-induced IL-9 promoted tumor-specific cytotoxic T lymphocyte (CTL) responses by enhancing the function of dendritic cells in vivo.",26280119_4,-1,-1,-1,-1,27037,-1,2.5704814e-05,0.999941,3.3254986e-05
27044,TNFR-associated factor,18,20,108,130,"Furthermore, GITR signaling enhanced the differentiation of IL-9-producing CD4(+) T-helper (TH9) cells in a TNFR-associated factor 6 (TRAF6)- and NF-B-dependent manner and inhibited the generation of induced regulatory T cells in vitro.",26280119_5,-1,-1,-1,-1,27044,-1,6.265751e-06,0.99998796,5.7524308e-06
27045,the generation,27,29,183,197,"Furthermore, GITR signaling enhanced the differentiation of IL-9-producing CD4(+) T-helper (TH9) cells in a TNFR-associated factor 6 (TRAF6)- and NF-B-dependent manner and inhibited the generation of induced regulatory T cells in vitro.",26280119_5,-1,-1,-1,-1,27045,-1,5.2204146e-06,0.99999,4.7561703e-06
27048,immunity,8,9,69,77,Our findings demonstrate that GITR co-stimulation mediates antitumor immunity by promoting TH9 cell differentiation and enhancing CTL responses and thus provide a mechanism of action for GITR agonist-mediated cancer immunotherapies.,26280119_6,0,-1,2,-1,27048,-1,0.9997856,7.134618e-05,0.00014307462
27049,TH9 cell,11,13,91,99,Our findings demonstrate that GITR co-stimulation mediates antitumor immunity by promoting TH9 cell differentiation and enhancing CTL responses and thus provide a mechanism of action for GITR agonist-mediated cancer immunotherapies.,26280119_6,-1,-1,-1,-1,27049,-1,1.389621e-05,2.3467588e-05,0.99996257
27052,mechanism of action,22,25,163,182,Our findings demonstrate that GITR co-stimulation mediates antitumor immunity by promoting TH9 cell differentiation and enhancing CTL responses and thus provide a mechanism of action for GITR agonist-mediated cancer immunotherapies.,26280119_6,0,1,-1,-1,27052,-1,7.0623435e-05,0.999892,3.7325586e-05
27055,cells play,8,10,33,43,"Follicular helper CD4(+) T (TFH) cells play a fundamental role in humoral immunity deriving from their ability to provide help for germinal center (GC) formation, B cell differentiation into plasma cells and memory cells, and antibody production in secondary lymphoid tissues.",26300592_0,-1,-1,-1,-1,27055,-1,0.002942009,0.28782216,0.70923585
27056,immunity,15,16,74,82,"Follicular helper CD4(+) T (TFH) cells play a fundamental role in humoral immunity deriving from their ability to provide help for germinal center (GC) formation, B cell differentiation into plasma cells and memory cells, and antibody production in secondary lymphoid tissues.",26300592_0,0,-1,2,-1,27056,-1,0.9996877,9.844056e-05,0.00021396052
27060,plasma cells,35,37,191,203,"Follicular helper CD4(+) T (TFH) cells play a fundamental role in humoral immunity deriving from their ability to provide help for germinal center (GC) formation, B cell differentiation into plasma cells and memory cells, and antibody production in secondary lymphoid tissues.",26300592_0,-1,-1,-1,-1,27060,-1,2.1552642e-05,1.3535102e-05,0.99996483
27063,TFH cells,0,2,0,9,"TFH cells can be identified by a combination of markers, including the chemokine receptor CXCR5, costimulatory molecules ICOS and PD-1, transcription repressor Bcl-6, and cytokine IL-21.",26300592_1,-1,-1,-1,-1,27063,-1,0.0002136023,0.009622074,0.9901642
27064,the chemokine receptor,12,15,67,89,"TFH cells can be identified by a combination of markers, including the chemokine receptor CXCR5, costimulatory molecules ICOS and PD-1, transcription repressor Bcl-6, and cytokine IL-21.",26300592_1,-1,-1,-1,-1,27064,-1,0.06232979,0.8780478,0.059622366
27071,blood,23,24,141,146,"It is difficult and impossible to get access to secondary lymphoid tissues in humans, so studies are usually performed with human peripheral blood samples as circulating counterparts of tissue TFH cells.",26300592_2,0,1,-1,-1,27071,-1,0.00056635373,0.99815816,0.0012754832
27072,tissue TFH cells,29,32,186,202,"It is difficult and impossible to get access to secondary lymphoid tissues in humans, so studies are usually performed with human peripheral blood samples as circulating counterparts of tissue TFH cells.",26300592_2,-1,-1,-1,-1,27072,-1,0.0018693552,0.16417165,0.83395904
27073,TFH cell generation,3,6,13,32,"A balance of TFH cell generation and function is critical for protective antibody response, whereas overactivation of TFH cells or overexpression of TFH-associated molecules may result in autoimmune diseases.",26300592_3,-1,-1,-1,-1,27073,-1,0.00015167896,0.987638,0.012210371
27074,function,7,8,37,45,"A balance of TFH cell generation and function is critical for protective antibody response, whereas overactivation of TFH cells or overexpression of TFH-associated molecules may result in autoimmune diseases.",26300592_3,0,1,2,-1,27074,-1,0.001391551,0.04357317,0.9550352
27075,TFH cells,18,20,118,127,"A balance of TFH cell generation and function is critical for protective antibody response, whereas overactivation of TFH cells or overexpression of TFH-associated molecules may result in autoimmune diseases.",26300592_3,-1,-1,-1,-1,27075,-1,7.1972965e-05,0.0007890855,0.99913895
27077,that TFH cells,4,7,25,39,"Emerging data have shown that TFH cells and TFH-associated molecules may be involved in the pathogenesis of neuroautoimmune diseases including multiple sclerosis (MS), neuromyelitis optica (NMO)/neuromyelitis optica spectrum disorders (NMOSD), and myasthenia gravis (MG).",26300592_4,-1,-1,-1,-1,27077,-1,0.0026102918,0.46402356,0.5333661
27083,TFH cells,6,8,39,48,"This review summarizes the features of TFH cells, including their development, function, and roles as well as TFH-associated molecules in neuroautoimmune diseases and their animal models.",26300592_5,-1,-1,-1,-1,27083,-1,0.00025553867,0.014245778,0.98549867
27085,function,13,14,79,87,"This review summarizes the features of TFH cells, including their development, function, and roles as well as TFH-associated molecules in neuroautoimmune diseases and their animal models.",26300592_5,0,1,2,-1,27085,-1,4.778865e-05,0.99986887,8.329872e-05
27089,the cytokine,2,4,9,21,"However, the cytokine background associated with these disorders and whether it differs between ocular adnexal MZLs with (IgG4-associated MZL) and without (IgG4-negative MZL) numerous IgG4(+) plasma cells are unknown.",26311608_1,-1,-1,-1,-1,27089,-1,0.4358138,0.56076324,0.0034229506
27091,plasma cells,31,33,192,204,"However, the cytokine background associated with these disorders and whether it differs between ocular adnexal MZLs with (IgG4-associated MZL) and without (IgG4-negative MZL) numerous IgG4(+) plasma cells are unknown.",26311608_1,-1,-1,-1,-1,27091,-1,1.3091954e-05,9.364262e-06,0.99997747
27098,analysis,33,34,205,213,"In this study, we identified the mRNA expression pattern of Th2 and regulatory T-cell (Treg) cytokines in IgG4-RD and in IgG4-associated MZL and IgG4-negative MZL using real-time polymerase chain reaction analysis.",26311608_2,0,1,-1,-1,27098,-1,8.5923775e-06,0.9999844,6.9666594e-06
27100,transforming growth factor,18,21,149,175,"Ocular IgG4-RD and IgG4-associated MZL exhibited significantly higher expression ratios of interleukin (IL)-4/-actin, IL-10/-actin, IL-13/-actin, transforming growth factor (TGF) 1/-actin, and FOXP3/-actin than did IgG4-negative MZL (p<0.05).",26311608_3,-1,-1,-1,-1,27100,-1,0.9860751,0.011308388,0.002616569
27123,blood,9,10,57,62,"CD4(+)CD25(-) T cells were separated from the peripheral blood mononuclear cells of MG patients and HCs, and the CD4(+)CD25(+) Tregs were separated from HCs by Magnetic cell sorting (MACS).",26347149_4,0,1,-1,-1,27123,-1,0.00073161616,0.99649364,0.0027747112
27134,The FoxP3,0,2,0,9,The FoxP3 expression of the induced CD4(+)CD25(+) T cells in MG patients was detected by real-time PCR at mRNA level.,26347149_7,-1,-1,-1,-1,27134,-1,4.587808e-06,0.9999908,4.649823e-06
27139,T cells to,12,15,81,91,The induced CD4(+)CD25(+) T cells were co-cultured with autologous CD4(+)CD25(-) T cells to estimate the suppressive ability of the induced CD4(+)CD25(+) T cells to CD4(+)CD25(-) T cells.,26347149_8,-1,-1,-1,-1,27139,-1,0.002088485,0.06395314,0.9339584
27142,T cells to,24,27,154,164,The induced CD4(+)CD25(+) T cells were co-cultured with autologous CD4(+)CD25(-) T cells to estimate the suppressive ability of the induced CD4(+)CD25(+) T cells to CD4(+)CD25(-) T cells.,26347149_8,-1,-1,-1,-1,27142,-1,0.0014765413,0.032935087,0.9655883
27164,function,27,28,141,149,"The proportion and FoxP3 expression of the induced CD4(+)CD25(+) T cells are the highest at the level of 40ng/ml IFN-, and the suppressive function of the CD4(+)CD25(+) T cells induced by 40ng/ml IFN- is the strongest in MG patients.",26347149_12,0,1,2,-1,27164,-1,7.80942e-06,0.9999844,7.840202e-06
27175,targeted therapy,10,12,59,75,It will also provide the scientific basis for the clinical targeted therapy of MG.,26347149_14,-1,-1,-1,-1,27175,-1,5.490515e-06,0.99998975,4.7434405e-06
27186,to the,42,44,240,246,"On one hand, the surveillance role of the immune system plays an important role in endogenous tumor prevention, but on the other hand, in some special circumstances such as in chronic inflammation, the immune system can actually contribute to the formation and progression of tumors.",26364615_1,-1,-1,-1,-1,27186,-1,5.769315e-06,0.99998915,5.09945e-06
27192,targeting the,23,25,163,176,"In the present manuscript, we explore known and potential various types of cancer prevention strategies and focus on nonvaccine-based cancer preventive strategies targeting the immune system at the early stages of tumorigenesis.",26364615_3,-1,-1,-1,-1,27192,-1,4.2972656e-06,0.9999913,4.3774935e-06
27200,blood,11,12,68,73,We detected an increase in Bregs producing IL-10 both in peripheral blood mononuclear cells (PBMCs) and in gastric tumors.,26378021_2,0,1,-1,-1,27200,-1,0.017433586,0.80726826,0.17529811
27203,analysis,3,4,26,34,Multicolor flow cytometry analysis revealed that a subset of CD19+CD24hiCD38hi B cells produces IL-10.,26378021_3,0,1,-1,-1,27203,-1,1.1876084e-05,0.99997747,1.0653675e-05
27208,Functional,0,1,0,10,Functional studies indicated that increased Bregs do not inhibit the proliferation of CD3+T cells or CD4+ helper T cells (Th cells).,26378021_4,0,1,2,-1,27208,-1,0.00024161571,0.99962926,0.0001290681
27213,Th cells,21,23,122,130,Functional studies indicated that increased Bregs do not inhibit the proliferation of CD3+T cells or CD4+ helper T cells (Th cells).,26378021_4,-1,-1,-1,-1,27213,-1,1.3064341e-05,1.6873139e-05,0.99996996
27216,TNF-,10,11,54,59,"However, Bregs do suppress the secretion of IFN- and TNF- by CD4+Th cells.",26378021_5,0,1,-1,-1,27216,-1,0.0013493194,0.9985569,9.3752606e-05
27222,T cells to,8,11,72,82,Neutralization experiments showed that Bregs convert CD4+CD25- effector T cells to CD4+FoxP3+Tregs via TGF-1.,26378021_7,-1,-1,-1,-1,27222,-1,0.001083219,0.04319949,0.9557173
27227,T cells cytokines,17,20,124,141,"Collectively, these findings demonstrate that increased Bregs play a immunosuppressive role in gastric cancer by inhibiting T cells cytokines as well as conversion to Tregs.",26378021_8,-1,-1,-1,-1,27227,-1,0.15927689,0.0008249512,0.83989817
27228,to Tregs,24,26,164,172,"Collectively, these findings demonstrate that increased Bregs play a immunosuppressive role in gastric cancer by inhibiting T cells cytokines as well as conversion to Tregs.",26378021_8,-1,-1,-1,-1,27228,-1,4.614668e-06,0.99999094,4.4952167e-06
27232,receptor,10,11,78,86,We have previously shown that a specific promyelocytic leukemia-retinoic acid receptor alpha (PML-RARA) DNA vaccine combined with all-trans retinoic acid (ATRA) increases the number of long term survivors with enhanced immune responses in a mouse model of acute promyelocytic leukemia (APL).,26378812_0,0,1,2,-1,27232,-1,0.00064355857,0.00047455388,0.9988819
27239,therapeutic plasmid,12,14,79,98,PVAX14 is comprised of novel immunogenic DNA sequences inserted into the pVAX1 therapeutic plasmid.,26378812_2,-1,-1,-1,-1,27239,-1,4.267088e-06,0.9999908,4.9529262e-06
27241,to that,12,14,82,89,APL mice treated with pVAX14 combined with ATRA had increased survival comparable to that obtained with a specific PML-RARA vaccine.,26378812_3,-1,-1,-1,-1,27241,-1,6.285761e-06,0.9999883,5.40639e-06
27247,T-cells,17,18,110,117,"In both preclinical models, pVAX14 vaccine significantly increased interferon gamma (IFN) production, memory T-cells (memT), reduced the number of colony forming units (CFU) and increased expression of the adapter molecule signalling to NF-B, MyD88.",26378812_6,-1,1,2,-1,27247,-1,1.8234814e-05,1.1205359e-05,0.99997056
27257,the nuclear receptor,18,21,79,99,"Nuclear receptor subfamily 2, group F, member 6 (NR2F6) is an orphan member of the nuclear receptor superfamily.",26387951_0,-1,-1,-1,-1,27257,-1,8.7728495e-06,0.99998045,1.0776402e-05
27258,that genetic,4,6,14,26,"Here, we show that genetic ablation of Nr2f6 significantly improves survival in the murine transgenic TRAMP prostate cancer model.",26387951_1,-1,-1,-1,-1,27258,-1,5.36612e-06,0.9999896,4.9812143e-06
27260,transgenic TRAMP,15,17,91,107,"Here, we show that genetic ablation of Nr2f6 significantly improves survival in the murine transgenic TRAMP prostate cancer model.",26387951_1,-1,-1,-1,-1,27260,-1,1.0640377e-05,0.99997675,1.2558645e-05
27267,the tumor,26,28,144,153,This is paralleled by increased frequencies of both CD4(+) and CD8(+) T cells and higher expression levels of interleukin 2 and interferon  at the tumor site.,26387951_3,-1,-1,-1,-1,27267,-1,4.0940163e-06,0.9999912,4.753274e-06
27271,the interleukin,21,23,118,133,"Mechanistically, CD4(+) and CD8(+) T cell-intrinsic NR2F6 acts as a direct repressor of the NFAT/AP-1 complex on both the interleukin 2 and the interferon  cytokine promoters, attenuating their transcriptional thresholds.",26387951_4,-1,-1,-1,-1,27271,-1,0.42289755,0.57175606,0.005346352
27272,the interferon,25,27,140,154,"Mechanistically, CD4(+) and CD8(+) T cell-intrinsic NR2F6 acts as a direct repressor of the NFAT/AP-1 complex on both the interleukin 2 and the interferon  cytokine promoters, attenuating their transcriptional thresholds.",26387951_4,-1,-1,-1,-1,27272,-1,0.44603983,0.5497051,0.0042550974
27274,their transcriptional thresholds,32,35,189,221,"Mechanistically, CD4(+) and CD8(+) T cell-intrinsic NR2F6 acts as a direct repressor of the NFAT/AP-1 complex on both the interleukin 2 and the interferon  cytokine promoters, attenuating their transcriptional thresholds.",26387951_4,-1,-1,-1,-1,27274,-1,6.601462e-06,0.99998796,5.4434104e-06
27283,immunity,20,21,129,137,"Altogether, this defines NR2F6 as an intracellular immune checkpoint in effector T cells, governing the amplitude of anti-cancer immunity.",26387951_6,0,-1,2,-1,27283,-1,0.9996433,0.00014142273,0.0002152461
27285,TNFR,2,3,27,31,"The glucocorticoid-induced TNFR family-related protein (GITR, TNFRSF18, CD357) is expressed on effector and regulatory T (Treg) cells.",26423152_0,0,1,-1,-1,27285,-1,2.0068945e-05,0.9999672,1.2740209e-05
27286,protein,4,5,47,54,"The glucocorticoid-induced TNFR family-related protein (GITR, TNFRSF18, CD357) is expressed on effector and regulatory T (Treg) cells.",26423152_0,0,1,-1,-1,27286,-1,6.2205095e-06,0.9999893,4.5213023e-06
27287,TNFRSF18,8,9,62,70,"The glucocorticoid-induced TNFR family-related protein (GITR, TNFRSF18, CD357) is expressed on effector and regulatory T (Treg) cells.",26423152_0,0,1,-1,-1,27287,-1,0.0067075095,0.9929397,0.00035271136
27294,cell-mediated immune responses,13,16,85,115,Previous studies demonstrated that GITR triggering by anti-GITR mAb enhanced T and B cell-mediated immune responses.,26423152_1,-1,-1,-1,-1,27294,-1,0.13744889,0.0012135119,0.86133766
27301,the true,12,14,67,75,"Because the activities of mAbs are controlled by their Fc regions, the true effect of GITR signaling needs to be determined by examining its interaction with authentic ligand.",26423152_3,-1,-1,-1,-1,27301,-1,6.7247693e-06,0.9999894,3.9054876e-06
27310,The pGITRL,0,2,0,10,The pGITRL was more effective than anti-GITR mAb in enhancing the proliferation of effector and regulatory cells in vitro and in vivo.,26423152_5,-1,-1,-1,-1,27310,-1,0.68981767,0.30332235,0.006859969
27317,analysis,1,2,9,17,Detailed analysis revealed that pGITRL induced extensive proliferation of Foxp3(+)CD4(+) Treg cells and led to the accumulation of activated Treg cells in tumor tissue and draining lymph nodes.,26423152_7,0,1,-1,-1,27317,-1,6.238044e-06,0.9999889,4.874274e-06
27318,that pGITRL,3,5,27,38,Detailed analysis revealed that pGITRL induced extensive proliferation of Foxp3(+)CD4(+) Treg cells and led to the accumulation of activated Treg cells in tumor tissue and draining lymph nodes.,26423152_7,-1,-1,-1,-1,27318,-1,0.5554619,0.43708906,0.007449087
27321,to the,15,17,108,114,Detailed analysis revealed that pGITRL induced extensive proliferation of Foxp3(+)CD4(+) Treg cells and led to the accumulation of activated Treg cells in tumor tissue and draining lymph nodes.,26423152_7,-1,-1,-1,-1,27321,-1,4.1309086e-06,0.9999919,3.983529e-06
27323,tumor tissue,23,25,155,167,Detailed analysis revealed that pGITRL induced extensive proliferation of Foxp3(+)CD4(+) Treg cells and led to the accumulation of activated Treg cells in tumor tissue and draining lymph nodes.,26423152_7,-1,-1,-1,-1,27323,-1,8.527417e-06,0.9999733,1.8128178e-05
27330,tumor tissue,33,35,212,224,"Because GITR signaling could not neutralize the suppressive activity of activated Treg cells, pGITRL seems to lose its adjuvant effect when sufficient activated Treg cells have accumulated in the lymph nodes and tumor tissue.",26423152_8,-1,-1,-1,-1,27330,-1,8.90225e-06,0.99997246,1.8614372e-05
27337,through Treg cells,16,19,109,127,These results suggest that GITR signaling has stimulatory effects on effector T cells and inhibitory effects through Treg cells.,26423152_10,-1,-1,-1,-1,27337,-1,0.0011554464,0.053847805,0.9449967
27341,the tumor-infiltrating T cell,13,17,69,98,Foxp3(+) regulatory T cells (Tregs) are often highly enriched within the tumor-infiltrating T cell pool.,26433463_0,-1,-1,-1,-1,27341,-1,0.0016295915,0.9105712,0.087799236
27342,that the,9,11,77,85,Using a well-characterised model of carcinogen-induced fibrosarcomas we show that the enriched tumor-infiltrating Treg population comprises largely of CXCR3(+) T-bet(+) 'TH1-like' Tregs which are thymus-derived Helios(+) cells.,26433463_1,-1,-1,-1,-1,27342,-1,3.692142e-06,0.9999926,3.6633082e-06
27343,tumor-infiltrating Treg,12,14,95,118,Using a well-characterised model of carcinogen-induced fibrosarcomas we show that the enriched tumor-infiltrating Treg population comprises largely of CXCR3(+) T-bet(+) 'TH1-like' Tregs which are thymus-derived Helios(+) cells.,26433463_1,-1,-1,-1,-1,27343,-1,5.7280613e-06,0.9999883,5.990615e-06
27347,thymus-derived,28,29,196,210,Using a well-characterised model of carcinogen-induced fibrosarcomas we show that the enriched tumor-infiltrating Treg population comprises largely of CXCR3(+) T-bet(+) 'TH1-like' Tregs which are thymus-derived Helios(+) cells.,26433463_1,-1,1,2,-1,27347,-1,9.431173e-05,0.9998795,2.6216285e-05
27350,that the,13,15,79,87,"Whilst IL-2 maintains homeostatic ratios of Tregs in lymphoid organs, we found that the perturbation in Treg frequencies in tumors is IL-2 independent.",26433463_2,-1,-1,-1,-1,27350,-1,4.819355e-06,0.9999913,3.8655494e-06
27353,that the TH1,4,7,18,30,"Moreover, we show that the TH1 phenotype of tumor-infiltrating Tregs is dispensable for their ability to influence tumor progression.",26433463_3,-1,-1,-1,-1,27353,-1,5.9329523e-06,0.9999845,9.505319e-06
27354,tumor-infiltrating Tregs,9,11,44,68,"Moreover, we show that the TH1 phenotype of tumor-infiltrating Tregs is dispensable for their ability to influence tumor progression.",26433463_3,-1,-1,-1,-1,27354,-1,1.522204e-05,0.99997485,9.88723e-06
27364,than Tconvs,31,33,182,193,"We did however find that unlike Tconvs, the majority of intra-tumoral Tregs express the activation markers CD69, CD25, ICOS, CD103 and CTLA4 and are significantly more proliferative than Tconvs.",26433463_4,-1,-1,-1,-1,27364,-1,6.81952e-06,0.9999857,7.430223e-06
27367,than their,12,14,64,74,"Moreover, we have found that CD69(+) Tregs are more suppressive than their CD69- counterparts.",26433463_5,-1,-1,-1,-1,27367,-1,6.7305173e-06,0.99998736,5.899027e-06
27370,the tumor,10,12,66,75,"Collectively, these data indicate superior activation of Tregs in the tumor microenvironment, promoting their suppressive ability and selective proliferation at this site.",26433463_6,-1,-1,-1,-1,27370,-1,4.0908367e-06,0.99999154,4.4209596e-06
27376,natural T cells,20,23,120,135,The liver resident lymphoid population is featured by the presence of a large number of CD3(+)CD56(+) cells referred as natural T cells.,26437631_0,-1,-1,-1,-1,27376,-1,0.0009900184,0.017466148,0.9815438
27377,the natural T cells,9,13,50,69,"In human hepatocellular carcinoma (HCC) patients, the natural T cells were found to be sharply decreased in tumor (5.8713.553%) versus non-tumor (14.026.151%) tissues.",26437631_1,-1,-1,-1,-1,27377,-1,0.0019872491,0.5189008,0.47911194
27380,tissues,39,40,165,172,"In human hepatocellular carcinoma (HCC) patients, the natural T cells were found to be sharply decreased in tumor (5.8713.553%) versus non-tumor (14.026.151%) tissues.",26437631_1,-1,1,2,-1,27380,-1,9.151455e-06,0.99994385,4.6979545e-05
27381,the natural T cells,7,11,45,64,"More intriguingly, a substantial fraction of the natural T cells (22.7618.61%) assumed FOXP3 expression.",26437631_2,-1,-1,-1,-1,27381,-1,0.002002777,0.48734358,0.5106536
27383,These FOXP3-expressing,0,2,0,22,"These FOXP3-expressing CD3(+)CD56(+) cells lost the expression of IFN- and perforin, which are critical for the effector function of natural T cells.",26437631_3,-1,-1,-1,-1,27383,-1,1.0530246e-05,0.99997807,1.1380656e-05
27388,function,19,20,122,130,"These FOXP3-expressing CD3(+)CD56(+) cells lost the expression of IFN- and perforin, which are critical for the effector function of natural T cells.",26437631_3,0,1,2,-1,27388,-1,0.00012457093,0.9995372,0.00033817935
27389,natural T cells,21,24,134,149,"These FOXP3-expressing CD3(+)CD56(+) cells lost the expression of IFN- and perforin, which are critical for the effector function of natural T cells.",26437631_3,-1,-1,-1,-1,27389,-1,0.00091872725,0.02560346,0.9734778
27392,CTLA-4 typically,12,14,64,80,"On the other hand, they acquired surface expression of CD25 and CTLA-4 typically found in regulatory T (Treg) cells.",26437631_4,-1,-1,-1,-1,27392,-1,0.002009586,0.0041029896,0.9938875
27398,naive T cells,15,18,114,127,"Consistent with the phenotypic conversion, they imposed an inhibitory effect on anti-CD3-induced proliferation of naive T cells.",26437631_5,-1,-1,-1,-1,27398,-1,0.0025567655,0.16918156,0.8282617
27399,that transforming growth factor,3,7,29,60,Further studies demonstrated that transforming growth factor 1 (TGF-1) could effectively induce FOXP3 expression in CD3(+)CD56(+) cells and the cells were thus endowed with a potent immunosuppressive capacity.,26437631_6,-1,-1,-1,-1,27399,-1,0.71883756,0.27234,0.008822433
27403,the cells,21,23,142,151,Further studies demonstrated that transforming growth factor 1 (TGF-1) could effectively induce FOXP3 expression in CD3(+)CD56(+) cells and the cells were thus endowed with a potent immunosuppressive capacity.,26437631_6,-1,-1,-1,-1,27403,-1,1.7923858e-05,2.0633519e-05,0.9999615
27405,analysis,3,4,22,30,"Finally, Kaplan-Meier analysis revealed that the relative abundance of FOXP3-expressing CD3(+)CD56(+) cells in tumor tissues was significantly correlated with the survival of HCC patients.",26437631_7,0,1,-1,-1,27405,-1,8.9177e-06,0.99998415,6.9221073e-06
27406,that the relative,5,8,40,57,"Finally, Kaplan-Meier analysis revealed that the relative abundance of FOXP3-expressing CD3(+)CD56(+) cells in tumor tissues was significantly correlated with the survival of HCC patients.",26437631_7,-1,-1,-1,-1,27406,-1,5.4195393e-06,0.99999046,4.173713e-06
27409,tumor tissues,15,17,111,124,"Finally, Kaplan-Meier analysis revealed that the relative abundance of FOXP3-expressing CD3(+)CD56(+) cells in tumor tissues was significantly correlated with the survival of HCC patients.",26437631_7,-1,-1,-1,-1,27409,-1,6.5867457e-06,0.9999821,1.12505695e-05
27414,tissues,19,20,114,121,"In conclusion, the present study identified a new type of regulatory immune cells whose emergence in liver cancer tissues may contribute to tumor progression.",26437631_8,-1,1,2,-1,27414,-1,0.0002520529,0.014977356,0.9847706
27415,to tumor,22,24,137,145,"In conclusion, the present study identified a new type of regulatory immune cells whose emergence in liver cancer tissues may contribute to tumor progression.",26437631_8,-1,-1,-1,-1,27415,-1,5.6375457e-06,0.9999883,6.0466355e-06
27422,immunity,14,15,96,104,The present study was aimed at analysing how expression of endogenous galectin-3 regulates host immunity and lung metastasis in B16F10 murine melanoma model.,26442663_3,0,-1,2,-1,27422,-1,0.9998216,6.98428e-05,0.0001085827
27426,tumor targets,30,32,167,180,"Transgenic Gal-3(+/-) (hemizygous) and Gal-3(-/-) (null) mice exhibited decreased levels of Natural Killer (NK) cells and lower NK mediated cytotoxicity against YAC-1 tumor targets, compared to Gal-3(+/+) (wild-type) mice.",26442663_4,-1,-1,-1,-1,27426,-1,4.680686e-06,0.9999907,4.6555597e-06
27428,T cell proliferation than,12,16,76,101,"On stimulation, Gal-3(+/-) and Gal-3(-/-) mice splenocytes showed increased T cell proliferation than Gal-3(+/+) mice.",26442663_5,-1,-1,-1,-1,27428,-1,0.0010268142,0.01711437,0.9818588
27431,to T cells,18,21,101,111,Intracellular calcium flux was found to be lower in activated T cells of Gal-3(-/-) mice as compared to T cells from Gal-3(+/+) and Gal-3(+/-) mice.,26442663_6,-1,-1,-1,-1,27431,-1,0.0016628158,0.14927952,0.84905773
27434,Th17 cytokine,10,12,39,52,"In Gal-3(-/-) mice, serum Th1, Th2 and Th17 cytokine levels were found to be lowest, exhibiting dysregulation of pro-inflammatory and anti-inflammatory cytokines balance.",26442663_7,-1,-1,-1,-1,27434,-1,0.26253724,0.7298579,0.00760484
27439,IFN- Receptor,10,12,59,73,Marked decrease in serum IFN- levels and splenic IFN-R1 (IFN- Receptor 1) expressing T and NK cell percentages were observed in Gal-3(-/-) mice.,26442663_8,-1,-1,-1,-1,27439,-1,0.9995338,3.8908795e-05,0.00042728023
27442,IFN- treatment,2,4,15,30,"On recombinant IFN- treatment of splenocytes in vitro, Suppressor of Cytokine Signaling (SOCS) 1 and SOCS3 protein expression was higher in Gal-3(-/-) mice compared to that in Gal-3(+/+) and Gal-3(+/-) mice; suggesting possible attenuation of Signal Transducer and Activator of Transcription (STAT) 1 mediated IFN- signaling in Gal-3(-/-) mice.",26442663_9,-1,-1,-1,-1,27442,-1,0.99971205,0.0001431344,0.00014475825
27444,protein,19,20,108,115,"On recombinant IFN- treatment of splenocytes in vitro, Suppressor of Cytokine Signaling (SOCS) 1 and SOCS3 protein expression was higher in Gal-3(-/-) mice compared to that in Gal-3(+/+) and Gal-3(+/-) mice; suggesting possible attenuation of Signal Transducer and Activator of Transcription (STAT) 1 mediated IFN- signaling in Gal-3(-/-) mice.",26442663_9,0,1,-1,-1,27444,-1,5.565903e-06,0.9999894,5.0251433e-06
27445,to that,28,30,166,173,"On recombinant IFN- treatment of splenocytes in vitro, Suppressor of Cytokine Signaling (SOCS) 1 and SOCS3 protein expression was higher in Gal-3(-/-) mice compared to that in Gal-3(+/+) and Gal-3(+/-) mice; suggesting possible attenuation of Signal Transducer and Activator of Transcription (STAT) 1 mediated IFN- signaling in Gal-3(-/-) mice.",26442663_9,-1,-1,-1,-1,27445,-1,5.129016e-06,0.9999901,4.729223e-06
27450,cells to,5,7,31,39,"The ability of B16F10 melanoma cells to form metastatic colonies in the lungs of Gal-3(+/+) and Gal-3(-/-) mice remained comparable, whereas it was found to be reduced in Gal-3(+/-) mice.",26442663_10,-1,-1,-1,-1,27450,-1,0.003742178,0.23693448,0.75932336
27458,Th17 cytokine,39,41,250,263,"Our data indicates that complete absence of endogenous host galectin-3 facilitates lung metastasis of B16F10 cells in mice, which may be contributed by dysregulated immune responses resulting from decreased NK cytotoxicity, disturbed serum Th1, Th2, Th17 cytokine milieu, reduced serum IFN- levels and attenuation of splenic STAT1 mediated IFN- signalling in Gal-3(-/-) mice.",26442663_11,-1,-1,-1,-1,27458,-1,0.18455103,0.8118403,0.0036086678
27466,functions,14,15,78,87,"Regulatory T cells (Treg cells) are known to exert certain immune suppression functions, in addition to immune mediating effects.",26464657_1,0,1,2,-1,27466,-1,7.2089184e-05,0.9997776,0.00015028074
27473,the functional,4,6,34,48,This study therefore investigated the functional role and related mechanism of Treg cells in BCL.,26464657_3,-1,-1,-1,-1,27473,-1,9.077755e-06,0.9999832,7.733045e-06
27478,blood,1,2,11,16,Peripheral blood mononuclear cells (PBMCs) were separated and analyzed for the ratio of CD4+/CD25+ Treg cells.,26464657_6,0,1,-1,-1,27478,-1,0.0016309473,0.9955226,0.0028464196
27484,transforming growth factor,7,10,37,63,"The mRNA expression levels of Foxp3, transforming growth factor (TGF)-1 and interleukin (IL)-10 genes were quantified by real-time PCR, while their serum levels were determined by enzyme-linked immunosorbent assay (ELISA).",26464657_7,-1,-1,-1,-1,27484,-1,0.98258495,0.013469395,0.0039456156
27493,to protein,11,13,52,62,"mRNA levels of Foxp3, TGF-1 and IL-10, in addition to protein levels of TGF-1 and IL-10 were potentiated in lymphoma patients but decreased in CR patients (P<0.05 in all cases).",26464657_10,-1,-1,-1,-1,27493,-1,1.15281955e-05,0.99998045,8.058685e-06
27497,functions,7,8,47,56,"CD4+/CD25+ Treg cells exert immune suppressing functions in BCL via regulating cytokines, thereby facilitating the pathogenesis and progression of lymphoma.",26464657_11,0,1,2,-1,27497,-1,2.170371e-05,0.9999287,4.9604398e-05
27510,factor-,15,16,81,89,"MFE stimulated the production of cytokines, nitric oxide (NO) and tumor necrosis factor- (TNF-) and tumoricidal properties of macrophages.",26473845_4,0,1,-1,-1,27510,-1,0.999938,5.8905175e-06,5.616123e-05
27511,TNF-,17,18,91,96,"MFE stimulated the production of cytokines, nitric oxide (NO) and tumor necrosis factor- (TNF-) and tumoricidal properties of macrophages.",26473845_4,0,1,-1,-1,27511,-1,0.013745409,0.9858708,0.00038373866
27513,through the,3,5,26,37,MFE activated macrophages through the mitogen-activated protein kinase (MAPKinase) and nuclear factor-B (NF-B) signaling pathways downstream from toll-like receptor (TLR) 4.,26473845_5,-1,-1,-1,-1,27513,-1,6.8993313e-06,0.9999871,5.9663307e-06
27514,protein,6,7,56,63,MFE activated macrophages through the mitogen-activated protein kinase (MAPKinase) and nuclear factor-B (NF-B) signaling pathways downstream from toll-like receptor (TLR) 4.,26473845_5,0,1,-1,-1,27514,-1,0.00032658674,0.99956185,0.00011161184
27515,toll-like receptor,21,23,148,166,MFE activated macrophages through the mitogen-activated protein kinase (MAPKinase) and nuclear factor-B (NF-B) signaling pathways downstream from toll-like receptor (TLR) 4.,26473845_5,-1,-1,-1,-1,27515,-1,0.0014214228,0.95660263,0.04197602
27533,T-cell,3,4,21,27,PURPOSE: Inefficient T-cell reconstitution from x-ray-induced immune damage reduces antitumor response.,26475064_0,-1,1,2,-1,27533,-1,2.2570768e-05,1.896472e-05,0.9999585
27536,T-cell,5,6,29,35,To understand the profile of T-cell reconstitution after irradiation will overcome the barrier of antitumor immunity.,26475064_1,-1,1,2,-1,27536,-1,1.4689478e-05,7.475041e-06,0.9999778
27538,immunity,15,16,108,116,To understand the profile of T-cell reconstitution after irradiation will overcome the barrier of antitumor immunity.,26475064_1,0,-1,2,-1,27538,-1,0.9999006,2.6918837e-05,7.2466646e-05
27545,T-cell,23,24,147,153,This study aimed to identify the recovery profile of T-cell subsets following x-ray irradiation and to highlight the role of cinnamon on efficient T-cell restoration postexposure in the antitumor response.,26475064_2,-1,1,2,-1,27545,-1,1.1748663e-05,6.9919693e-06,0.99998116
27567,than that,11,13,59,68,RESULTS: Reconstitution of CD4(+) T cells was delayed more than that of CD8(+) T cells in T-cell restoration after SLTBI.,26475064_6,-1,-1,-1,-1,27567,-1,1.0590343e-05,0.9999813,8.094399e-06
27569,T-cell,19,20,90,96,RESULTS: Reconstitution of CD4(+) T cells was delayed more than that of CD8(+) T cells in T-cell restoration after SLTBI.,26475064_6,-1,1,2,-1,27569,-1,1.2232736e-05,6.9787498e-06,0.9999807
27573,Tc1 cells,7,9,33,42,"The production of IFN by Th1 or Tc1 cells was sharply decreased and was accompanied by reduced T-bet mRNA, even when total T-cell numbers had recovered; the frequencies of Th17 and Treg cells and their specific transcription factors (RORt and Foxp3, respectively) were obviously increased.",26475064_7,-1,-1,-1,-1,27573,-1,1.1280693e-05,1.4427124e-05,0.99997425
27575,total T-cell,22,24,118,130,"The production of IFN by Th1 or Tc1 cells was sharply decreased and was accompanied by reduced T-bet mRNA, even when total T-cell numbers had recovered; the frequencies of Th17 and Treg cells and their specific transcription factors (RORt and Foxp3, respectively) were obviously increased.",26475064_7,-1,-1,-1,-1,27575,-1,0.0009914286,0.06558326,0.93342525
27582,T-cell,2,3,32,38,Irradiation-induced inefficient T-cell reconstitution impaired the antitumor capacities in the lung melanoma model.,26475064_8,-1,1,2,-1,27582,-1,1.6853099e-05,9.590022e-06,0.99997365
27585,the generation,7,9,58,72,Pretreatment with cinnamon in irradiated mice accelerated the generation of Th1 and reduced the differentiation of Treg cells by activating T-bet and limiting transcriptions of Foxp3.,26475064_9,-1,-1,-1,-1,27585,-1,5.8916157e-06,0.99998903,5.0898775e-06
27590,limiting transcriptions,22,24,150,173,Pretreatment with cinnamon in irradiated mice accelerated the generation of Th1 and reduced the differentiation of Treg cells by activating T-bet and limiting transcriptions of Foxp3.,26475064_9,-1,-1,-1,-1,27590,-1,0.09004964,0.9072454,0.0027049757
27593,T-cell,8,9,66,72,Improvement resulting from cinnamon pretreatment on the efficient T-cell recovery profile from SLTBI promoted antitumor immunity in the lung melanoma model.,26475064_10,-1,1,2,-1,27593,-1,1.1621795e-05,7.887147e-06,0.99998057
27594,immunity,15,16,120,128,Improvement resulting from cinnamon pretreatment on the efficient T-cell recovery profile from SLTBI promoted antitumor immunity in the lung melanoma model.,26475064_10,0,-1,2,-1,27594,-1,0.9998981,2.0822805e-05,8.101105e-05
27596,T-cell,2,3,13,19,CONCLUSIONS: T-cell reconstitution from SLTBI was characterized by impaired Th1 and elevated Th17 and Treg cells.,26475064_11,-1,1,2,-1,27596,-1,1.13063215e-05,6.1533406e-06,0.9999825
27607,T-cell,6,7,34,40,The role of cinnamon in efficient T-cell reconstitution from SLTBI is effective in antitumor immunity.,26475064_13,-1,1,2,-1,27607,-1,1.2930922e-05,7.238801e-06,0.99997985
27608,immunity,14,15,93,101,The role of cinnamon in efficient T-cell reconstitution from SLTBI is effective in antitumor immunity.,26475064_13,0,-1,2,-1,27608,-1,0.9998933,2.5652456e-05,8.100572e-05
27613,function,14,15,83,91,T cell abnormalities are a common feature of CLL and contribute to impaired immune function in these patients.,26478573_1,0,1,2,-1,27613,-1,0.16140017,0.81947994,0.019119946
27618,IL-17A-producing Th17 cells,10,13,76,103,Previous work from our laboratory documented elevated circulating levels of IL-17A-producing Th17 cells in CLL patients as compared to healthy age-matched control subjects.,26478573_3,-1,-1,-1,-1,27618,-1,0.8692672,0.000281732,0.13045102
27622,that Th17 cells,3,6,23,38,"Recent studies suggest that Th17 cells are heterogeneous, expressing different profiles of cytokines, and that different subsets of Th17s mediate different biological functions.",26478573_5,-1,-1,-1,-1,27622,-1,0.0028718975,0.4783041,0.51882404
27627,functions,24,25,167,176,"Recent studies suggest that Th17 cells are heterogeneous, expressing different profiles of cytokines, and that different subsets of Th17s mediate different biological functions.",26478573_5,0,1,2,-1,27627,-1,0.00034853927,0.9993149,0.00033661872
27631,blood,21,22,128,133,"In the present study, we found significantly higher levels of IL-17F-expressing CD4(+) T cells in CLL versus healthy peripheral blood mononuclear cells following in vitro stimulation in the presence of Th17-promoting cytokines.",26478573_6,0,1,-1,-1,27631,-1,0.00044640532,0.99855405,0.0009995744
27634,Th17-promoting cytokines,32,34,202,226,"In the present study, we found significantly higher levels of IL-17F-expressing CD4(+) T cells in CLL versus healthy peripheral blood mononuclear cells following in vitro stimulation in the presence of Th17-promoting cytokines.",26478573_6,-1,-1,-1,-1,27634,-1,0.061600227,0.9359868,0.0024129245
27636,IL-17F-expressing Th17 cells,5,8,36,64,"Furthermore, the differentiation of IL-17F-expressing Th17 cells was significantly enhanced when purified CD4(+) T cells from CLL patients were cultured in the presence of autologous CLL B cells.",26478573_7,-1,-1,-1,-1,27636,-1,0.9167827,0.0003685658,0.08284886
27640,that IL-17F triggers,6,9,47,67,"Lastly, single-cell network profiling revealed that IL-17F triggers NFB phosphorylation in T and B cells from patients with CLL, but not age-matched healthy controls.",26478573_8,-1,-1,-1,-1,27640,-1,0.0026229317,0.9972127,0.0001643848
27643,Taken together,0,2,0,14,"Taken together, our data suggest that the phenotype of Th17 cells in CLL patients is distinct from healthy individuals, expressing higher levels of IL-17F, and that B and T cells from CLL patients are particularly responsive to IL-17F, as compared to healthy age-matched control individuals.",26478573_9,-1,-1,-1,-1,27643,-1,8.353247e-06,0.99998426,7.3819583e-06
27644,that the,6,8,33,41,"Taken together, our data suggest that the phenotype of Th17 cells in CLL patients is distinct from healthy individuals, expressing higher levels of IL-17F, and that B and T cells from CLL patients are particularly responsive to IL-17F, as compared to healthy age-matched control individuals.",26478573_9,-1,-1,-1,-1,27644,-1,3.8148687e-06,0.9999925,3.7382079e-06
27645,Th17 cells,10,12,55,65,"Taken together, our data suggest that the phenotype of Th17 cells in CLL patients is distinct from healthy individuals, expressing higher levels of IL-17F, and that B and T cells from CLL patients are particularly responsive to IL-17F, as compared to healthy age-matched control individuals.",26478573_9,-1,-1,-1,-1,27645,-1,0.0001336027,0.0037148087,0.9961516
27649,to IL-17F,39,41,225,234,"Taken together, our data suggest that the phenotype of Th17 cells in CLL patients is distinct from healthy individuals, expressing higher levels of IL-17F, and that B and T cells from CLL patients are particularly responsive to IL-17F, as compared to healthy age-matched control individuals.",26478573_9,-1,-1,-1,-1,27649,-1,0.976849,0.021408068,0.001742936
27656,IL12RB2 gene,8,10,53,65,We asked whether specific polymorphisms of the human IL12RB2 gene may confer susceptibility to LAC.,26547104_1,-1,-1,-1,-1,27656,-1,0.99510914,0.0036446436,0.0012462154
27660,to the,13,15,85,91,We studied IL12RB2 single nucleotide polymorphisms (SNPs) spanning from the promoter to the first untranslated exon of the gene.,26547104_2,-1,-1,-1,-1,27660,-1,5.2771156e-06,0.9999887,6.0984394e-06
27661,the gene,19,21,119,127,We studied IL12RB2 single nucleotide polymorphisms (SNPs) spanning from the promoter to the first untranslated exon of the gene.,26547104_2,-1,-1,-1,-1,27661,-1,5.1668535e-06,0.99998736,7.4849845e-06
27672,to the,11,13,83,89,"In conclusion, genetically determined low signaling activity of IL-12R predisposes to the development of LAC.",26547104_7,-1,-1,-1,-1,27672,-1,6.0938323e-06,0.99998915,4.704119e-06
27677,T-cell trafficking to the tumor,6,11,44,75,"However, the mechanisms underlying effector T-cell trafficking to the tumor microenvironment remain poorly understood in patients with colon cancer.",26567139_1,-1,-1,-1,-1,27677,-1,0.0030569031,0.3693937,0.6275494
27680,the regulation,15,17,80,94,"The polycomb repressive complex 2 (PRC2) is involved in cancer progression, but the regulation of tumor immunity by epigenetic mechanisms has yet to be investigated.",26567139_2,-1,-1,-1,-1,27680,-1,4.830969e-06,0.9999902,4.8983775e-06
27681,tumor immunity,18,20,98,112,"The polycomb repressive complex 2 (PRC2) is involved in cancer progression, but the regulation of tumor immunity by epigenetic mechanisms has yet to be investigated.",26567139_2,-1,-1,-1,-1,27681,-1,0.094292,0.90419096,0.0015170946
27684,the relationship,6,8,27,43,"In this study, we examined the relationship between the repressive PRC2 machinery and effector T-cell trafficking.",26567139_3,-1,-1,-1,-1,27684,-1,6.1905403e-06,0.99998915,4.609342e-06
27686,T-cell trafficking,15,17,95,113,"In this study, we examined the relationship between the repressive PRC2 machinery and effector T-cell trafficking.",26567139_3,-1,-1,-1,-1,27686,-1,1.9378444e-05,2.383196e-05,0.9999567
27690,Th1-type chemokines,23,25,160,179,"We found that PRC2 components and demethylase JMJD3-mediated histone H3 lysine 27 trimethylation (H3K27me3) repress the expression and subsequent production of Th1-type chemokines CXCL9 and CXCL10, mediators of effector T-cell trafficking.",26567139_4,-1,-1,-1,-1,27690,-1,0.03219266,0.9653527,0.0024546105
27693,T-cell trafficking,32,34,220,238,"We found that PRC2 components and demethylase JMJD3-mediated histone H3 lysine 27 trimethylation (H3K27me3) repress the expression and subsequent production of Th1-type chemokines CXCL9 and CXCL10, mediators of effector T-cell trafficking.",26567139_4,-1,-1,-1,-1,27693,-1,2.475892e-05,1.492669e-05,0.9999603
27696,Th1-type chemokines,28,30,138,157,"Moreover, the expression levels of PRC2 components, including EZH2, SUZ12, and EED, were inversely associated with those of CD4, CD8, and Th1-type chemokines in human colon cancer tissue, and this expression pattern was significantly associated with patient survival.",26567139_5,-1,-1,-1,-1,27696,-1,0.028297642,0.968982,0.0027203984
27697,tissue,34,35,180,186,"Moreover, the expression levels of PRC2 components, including EZH2, SUZ12, and EED, were inversely associated with those of CD4, CD8, and Th1-type chemokines in human colon cancer tissue, and this expression pattern was significantly associated with patient survival.",26567139_5,-1,1,2,-1,27697,-1,0.00033825933,0.9584052,0.041256554
27705,T-cell-mediated immunity,20,22,157,181,"Therefore, targeting epigenetic programs may have significant implications for improving the efficacy of current cancer immunotherapies relying on effective T-cell-mediated immunity at the tumor site.",26567139_7,-1,-1,-1,-1,27705,-1,7.456579e-05,1.480039e-05,0.9999106
27706,the tumor,23,25,185,194,"Therefore, targeting epigenetic programs may have significant implications for improving the efficacy of current cancer immunotherapies relying on effective T-cell-mediated immunity at the tumor site.",26567139_7,-1,-1,-1,-1,27706,-1,4.2031666e-06,0.9999912,4.6338396e-06
27714,immunity,15,16,84,92,"Because regulatory T cells (Tregs) are regarded as a critical hurdle in anti-tumour immunity, we assessed the distribution of Tregs in 45 cases of EBVaGC and 45 cases of EBV-negative gastric carcinoma (EBVnGC) with matched clinicopathological parameters by immunohistochemistry.",26673957_2,0,-1,2,-1,27714,-1,0.9995796,0.000124269,0.00029616788
27717,that Tregs,2,4,10,20,"We showed that Tregs were significantly increased in EBVaGC compared to EBVnGC (15.9211.45/HPF vs. 8.456.16/HPF, p=0.001).",26673957_3,-1,-1,-1,-1,27717,-1,5.8925034e-06,0.99998903,5.0800477e-06
27722,blood,2,3,16,21,"When peripheral blood mononuclear cells (PBMCs) were co-cultured with EBV (+) gastric carcinoma cell lines, the Treg frequency increased, and they underwent phenotypic and functional changes.",26673957_5,0,1,-1,-1,27722,-1,0.004985733,0.9788383,0.016175933
27725,the Treg,20,22,108,116,"When peripheral blood mononuclear cells (PBMCs) were co-cultured with EBV (+) gastric carcinoma cell lines, the Treg frequency increased, and they underwent phenotypic and functional changes.",26673957_5,-1,-1,-1,-1,27725,-1,5.084341e-06,0.99998975,5.1383654e-06
27727,functional,30,31,172,182,"When peripheral blood mononuclear cells (PBMCs) were co-cultured with EBV (+) gastric carcinoma cell lines, the Treg frequency increased, and they underwent phenotypic and functional changes.",26673957_5,0,1,2,-1,27727,-1,0.0001082423,0.9998184,7.3363866e-05
27733,the Treg,18,20,115,123,"The enhanced recruitment by CCL22 produced by EBVaGC cells, the decreased emigration due to CCR7 downregulation on the Treg surface, the higher proliferation rate, and the lower apoptosis rate of Tregs at tumour sites may promote the accumulation of Tregs in EBVaGC.",26673957_6,-1,-1,-1,-1,27733,-1,7.0406713e-06,0.99998534,7.670732e-06
27741,therapeutic targets,15,17,112,131,Histone/protein deacetylases (HDACs) are frequently upregulated in human malignancies and have therefore become therapeutic targets in cancer therapy.,26704363_0,-1,-1,-1,-1,27741,-1,4.9828345e-06,0.9999906,4.444082e-06
27742,therapy,19,20,142,149,Histone/protein deacetylases (HDACs) are frequently upregulated in human malignancies and have therefore become therapeutic targets in cancer therapy.,26704363_0,0,1,-1,-1,27742,-1,4.3094697e-06,0.99999106,4.686745e-06
27744,tumor cells to,21,24,127,141,"However, inhibiting certain HDAC isoforms can have protolerogenic effects on the immune system, which could make it easier for tumor cells to evade the host immune system.",26704363_1,-1,-1,-1,-1,27744,-1,0.00014799341,0.99841857,0.0014334626
27749,therapy,19,20,119,126,"Therefore, a better understanding of how each HDAC isoform affects immune biology is needed to develop targeted cancer therapy.",26704363_2,0,1,-1,-1,27749,-1,4.547766e-06,0.9999907,4.749479e-06
27751,their T-regulatory,17,19,106,124,"While HDAC5(-/-) mice replicate at expected Mendelian ratios and do not develop overt autoimmune disease, their T-regulatory (Treg) cells show reduced suppressive function in vitro and in vivo.",26704363_4,-1,-1,-1,-1,27751,-1,5.575532e-05,0.99982065,0.0001235788
27754,function,26,27,163,171,"While HDAC5(-/-) mice replicate at expected Mendelian ratios and do not develop overt autoimmune disease, their T-regulatory (Treg) cells show reduced suppressive function in vitro and in vivo.",26704363_4,0,1,2,-1,27754,-1,6.856525e-06,0.9999852,7.9672e-06
27755,T-cells,4,5,17,24,"Likewise, CD4(+) T-cells lacking HDAC5 convert poorly to Tregs under appropriately polarizing conditions.",26704363_5,-1,1,2,-1,27755,-1,1.5659874e-05,1.0679351e-05,0.99997365
27756,to Tregs,9,11,54,62,"Likewise, CD4(+) T-cells lacking HDAC5 convert poorly to Tregs under appropriately polarizing conditions.",26704363_5,-1,-1,-1,-1,27756,-1,7.14904e-06,0.99998784,5.054859e-06
27757,To test,0,2,0,7,"To test if this attenuated Treg formation and suppressive function translated into improved anticancer immunity, we inoculated HDAC5(-/-) mice and littermate controls with a lung adenocarcinoma cell line.",26704363_6,-1,-1,-1,-1,27757,-1,8.944094e-06,0.99998593,5.075432e-06
27760,function translated,9,11,58,77,"To test if this attenuated Treg formation and suppressive function translated into improved anticancer immunity, we inoculated HDAC5(-/-) mice and littermate controls with a lung adenocarcinoma cell line.",26704363_6,-1,-1,-1,-1,27760,-1,1.1034748e-05,0.9999807,8.294286e-06
27761,immunity,14,15,103,111,"To test if this attenuated Treg formation and suppressive function translated into improved anticancer immunity, we inoculated HDAC5(-/-) mice and littermate controls with a lung adenocarcinoma cell line.",26704363_6,0,-1,2,-1,27761,-1,0.9998068,6.282628e-05,0.00013034677
27764,immunity,11,12,62,70,"Cumulatively, lack of HDAC5 did not lead to better anticancer immunity.",26704363_7,0,-1,2,-1,27764,-1,0.9997905,5.4587847e-05,0.00015490816
27766,T cells missing,5,8,21,36,"We found that CD8(+) T cells missing HDAC5 had a reduced ability to produce the cytokine, IFN-, in vitro and in vivo, which may offset the benefit of weakened Treg function and formation.",26704363_8,-1,-1,-1,-1,27766,-1,0.00064908894,0.00014771575,0.99920326
27768,the cytokine,15,17,76,88,"We found that CD8(+) T cells missing HDAC5 had a reduced ability to produce the cytokine, IFN-, in vitro and in vivo, which may offset the benefit of weakened Treg function and formation.",26704363_8,-1,-1,-1,-1,27768,-1,0.73878306,0.2574243,0.0037926987
27771,Treg function,33,35,160,173,"We found that CD8(+) T cells missing HDAC5 had a reduced ability to produce the cytokine, IFN-, in vitro and in vivo, which may offset the benefit of weakened Treg function and formation.",26704363_8,-1,-1,-1,-1,27771,-1,1.866896e-05,0.9999567,2.4621602e-05
27772,Taken together,0,2,0,14,"Taken together, targeting HDAC5 weakens suppressive function and de-novo induction of Tregs, but also reduces the ability of CD8(+) T cells to produce IFN-.",26704363_9,-1,-1,-1,-1,27772,-1,8.231236e-06,0.9999852,6.529994e-06
27774,function,7,8,52,60,"Taken together, targeting HDAC5 weakens suppressive function and de-novo induction of Tregs, but also reduces the ability of CD8(+) T cells to produce IFN-.",26704363_9,0,1,2,-1,27774,-1,1.061143e-05,0.99997914,1.0208222e-05
27777,T cells to,22,25,132,142,"Taken together, targeting HDAC5 weakens suppressive function and de-novo induction of Tregs, but also reduces the ability of CD8(+) T cells to produce IFN-.",26704363_9,-1,-1,-1,-1,27777,-1,0.0019999114,0.04215717,0.955843
27794,tissues,28,29,163,170,"MATERIALS AND METHODS: FoxP3+ Tregs in human colorectal adenomas were evaluated with immunohistochemistry (IHC) and real-time PCR, and compared to CRCs and normal tissues.",26724144_2,-1,1,2,-1,27794,-1,2.0650843e-05,0.99940574,0.00057362637
27797,cytokine interleukin,8,10,50,70,"In addition, the change of Treg immunosuppressive cytokine interleukin (IL)-10 was examined with IHC and real-time PCR.RESULTS: increased FoxP3+Tregs were observed in the adenomatous stroma/epithelium and the density in colorectal adenomas, which was similar to that in the CRCs, significantly increased as compared to normal tissues.",26724144_3,-1,-1,-1,-1,27797,-1,0.9999471,6.6113353e-06,4.633713e-05
27801,to that,37,39,259,266,"In addition, the change of Treg immunosuppressive cytokine interleukin (IL)-10 was examined with IHC and real-time PCR.RESULTS: increased FoxP3+Tregs were observed in the adenomatous stroma/epithelium and the density in colorectal adenomas, which was similar to that in the CRCs, significantly increased as compared to normal tissues.",26724144_3,-1,-1,-1,-1,27801,-1,5.207053e-06,0.99998987,4.983938e-06
27804,tissues,49,50,326,333,"In addition, the change of Treg immunosuppressive cytokine interleukin (IL)-10 was examined with IHC and real-time PCR.RESULTS: increased FoxP3+Tregs were observed in the adenomatous stroma/epithelium and the density in colorectal adenomas, which was similar to that in the CRCs, significantly increased as compared to normal tissues.",26724144_3,-1,1,2,-1,27804,-1,0.00013230044,0.9626082,0.03725951
27814,that IL-10,12,14,95,105,Double IHCs with CD4/CD25 and IL-10/FoxP3 antibodies confirmed above observations and revealed that IL-10 was at least partially released from increased Tregs.,26724144_6,-1,-1,-1,-1,27814,-1,0.93551433,0.062886104,0.0015995867
27817,that the,5,7,45,53,"Quantitative real-time PCR results confirmed that the expression levels of FoxP3 and IL-10 mRNAs in the adenomas were increased, which equivalent to that in the CRCs.",26724144_7,-1,-1,-1,-1,27817,-1,3.6995605e-06,0.9999924,3.9153365e-06
27821,to that,22,24,146,153,"Quantitative real-time PCR results confirmed that the expression levels of FoxP3 and IL-10 mRNAs in the adenomas were increased, which equivalent to that in the CRCs.",26724144_7,-1,-1,-1,-1,27821,-1,6.7759206e-06,0.9999881,5.1700213e-06
27825,the tumor,8,10,44,53,"CONCLUSION: accumulation of FoxP3+ Tregs in the tumor microenvironment is an early event along the adenoma-carcinoma sequence, and might play a role in the regulation of host immune response to the initiation of CRC.",26724144_8,-1,-1,-1,-1,27825,-1,4.301457e-06,0.9999906,5.0787626e-06
27828,the regulation,26,28,152,166,"CONCLUSION: accumulation of FoxP3+ Tregs in the tumor microenvironment is an early event along the adenoma-carcinoma sequence, and might play a role in the regulation of host immune response to the initiation of CRC.",26724144_8,-1,-1,-1,-1,27828,-1,4.7446833e-06,0.99999046,4.821121e-06
27829,immune response to the,30,34,175,197,"CONCLUSION: accumulation of FoxP3+ Tregs in the tumor microenvironment is an early event along the adenoma-carcinoma sequence, and might play a role in the regulation of host immune response to the initiation of CRC.",26724144_8,-1,-1,-1,-1,27829,-1,0.7582477,0.24002957,0.0017227707
27833,tumor cells to,19,22,142,156,"Indoleamine 2,3-dioxygenase (IDO), a tryptophan-catabolizing intracellular enzyme of the L-kynurenine pathway, causes preneoplastic cells and tumor cells to escape the immune system by inducing immune tolerance; this mechanism might be associated with the development and progression of human malignancies.",26727596_0,-1,-1,-1,-1,27833,-1,0.0006494814,0.93778753,0.06156293
27840,diethylnitrosamine,12,13,57,75,"In the present study, we investigated the role of IDO in diethylnitrosamine (DEN)-induced hepatocarcinogenesis by using IDO-knockout (KO) mice.",26727596_1,-1,-1,-1,-1,27840,-1,0.00031279927,0.99960655,8.065723e-05
27848,tissue,9,10,70,76,HCC overexpressed IDO and L-kynurenine compared to surrounding normal tissue in the DEN-treated IDO-WT mice.,26727596_4,-1,1,2,-1,27848,-1,5.6455352e-05,0.99655664,0.0033868996
27858,protein,6,7,33,40,"The expression levels of the IDO protein, of L-kynurenine, and of IFN-, COX-2, TNF-, and Foxp3 mRNA were also significantly increased in the DEN-induced hepatic tumors that developed in the IDO-WT mice.",26727596_6,0,1,-1,-1,27858,-1,6.950371e-06,0.9999839,9.165762e-06
27860,TNF-,17,18,80,85,"The expression levels of the IDO protein, of L-kynurenine, and of IFN-, COX-2, TNF-, and Foxp3 mRNA were also significantly increased in the DEN-induced hepatic tumors that developed in the IDO-WT mice.",26727596_6,0,1,-1,-1,27860,-1,9.222262e-05,0.999884,2.3772236e-05
27863,tumors that,30,32,163,174,"The expression levels of the IDO protein, of L-kynurenine, and of IFN-, COX-2, TNF-, and Foxp3 mRNA were also significantly increased in the DEN-induced hepatic tumors that developed in the IDO-WT mice.",26727596_6,-1,-1,-1,-1,27863,-1,3.8599483e-06,0.9999918,4.33936e-06
27880,immunity,7,8,46,54,"As melanoma progression is controlled by host immunity, here we present a novel approach interrogating immunoregulatory pathways using the genome-wide maps of expression quantitative trait loci (eQTL) to reveal biologically relevant germline variants modulating cutaneous melanoma outcomes.",26733611_1,0,-1,2,-1,27880,-1,0.9997209,0.0001268967,0.00015214524
27893,that their,4,6,21,31,"Furthermore, we show that their combined effect on melanoma OS is substantially enhanced reaching the level of clinical applicability (HR, 1.92; 95% CI, 1.43-2.60; P = 2.38e-5).CONCLUSIONS: Our unique approach of interrogating lymphocyte-specific eQTLs reveals novel and biologically relevant immunomodulatory eQTL predictors of cutaneous melanoma prognosis that are independent of current histopathologic markers.",26733611_6,-1,-1,-1,-1,27893,-1,6.022839e-06,0.9999895,4.4534827e-06
27906,through regulation,13,15,94,112,Nuclear Factor (NF)-B is positioned to provide the interface between COPD and carcinogenesis through regulation of chronic inflammation in the lungs.,26756215_0,-1,-1,-1,-1,27906,-1,6.8837103e-06,0.9999883,4.768857e-06
27908,tetracycline-inducible transgenic,2,4,8,41,"Using a tetracycline-inducible transgenic mouse model that conditionally expresses activated IB kinase  (IKK) in airway epithelium (IKTA), we found that sustained NF-B signaling results in chronic inflammation and emphysema by 4 months.",26756215_1,-1,-1,-1,-1,27908,-1,6.433063e-06,0.99998844,5.1254824e-06
27934,through generation,14,16,93,111,These studies indicate that sustained activation of NF-B pathway links COPD and lung cancer through generation and maintenance of a pro-tumorigenic inflammatory environment consisting of alternatively activated macrophages and regulatory T cells.,26756215_7,-1,-1,-1,-1,27934,-1,7.5552307e-06,0.9999864,6.073995e-06
27955,cell transplantation,44,46,177,197,"CD4(+)CD25(+)Tregs or CD4(+)CD25(+)CD127(lo)Tregs expanded ex vivo with rapamycin could be used to suppress regrowth of residual lymphoma after autologous hematopoietic cell transplantation (HCT), and to counteract both graft-versus-host disease and lymphoma re-growth after allogeneic HCT in select patients with lymphoma susceptible to the regulation by Tregs.",26758248_5,-1,-1,-1,-1,27955,-1,0.0030176253,0.008018403,0.98896396
27957,to the regulation,68,71,343,360,"CD4(+)CD25(+)Tregs or CD4(+)CD25(+)CD127(lo)Tregs expanded ex vivo with rapamycin could be used to suppress regrowth of residual lymphoma after autologous hematopoietic cell transplantation (HCT), and to counteract both graft-versus-host disease and lymphoma re-growth after allogeneic HCT in select patients with lymphoma susceptible to the regulation by Tregs.",26758248_5,-1,-1,-1,-1,27957,-1,4.6307537e-06,0.9999907,4.7201693e-06
27978,blood,17,18,130,135,Human leukocyte antigen (HLA)-DR and CD86 expression was significantly reduced in CD11b(+)CD11c(+) cells obtained from peripheral blood mononuclear cells (PBMCs) of healthy donors by IL-6 treatment and was STAT3 dependent.,26759006_4,0,1,-1,-1,27978,-1,0.0011959741,0.99718374,0.0016202081
27980,IL-6 treatment,27,29,183,197,Human leukocyte antigen (HLA)-DR and CD86 expression was significantly reduced in CD11b(+)CD11c(+) cells obtained from peripheral blood mononuclear cells (PBMCs) of healthy donors by IL-6 treatment and was STAT3 dependent.,26759006_4,-1,-1,-1,-1,27980,-1,0.99955255,0.0002337655,0.00021367287
27994,tumor tissues,9,11,61,74,There was a relationship between HLA-DR expression levels in tumor tissues and the size of CD4(+) T and CD8(+) T cell compartments.,26759006_8,-1,-1,-1,-1,27994,-1,5.461315e-06,0.9999826,1.1961496e-05
27998,that IL-6,3,5,22,31,"Our findings indicate that IL-6 causes a dysfunction in human DCs that activates cancer antigen-specific Th cells, suggesting that blocking the IL-6/STAT3 signaling pathway might be a promising strategy to improve cancer immunotherapy.",26759006_9,-1,-1,-1,-1,27998,-1,0.8832475,0.11381171,0.0029408091
28000,antigen-specific Th cells,14,17,88,113,"Our findings indicate that IL-6 causes a dysfunction in human DCs that activates cancer antigen-specific Th cells, suggesting that blocking the IL-6/STAT3 signaling pathway might be a promising strategy to improve cancer immunotherapy.",26759006_9,-1,-1,-1,-1,28000,-1,0.6922992,0.00047508202,0.3072257
28013,T-cell-mediated tumor cell,15,18,101,127,"Tregs promote tumor growth by modulating the antitumor immune response, mainly through inhibition of T-cell-mediated tumor cell killing: this has been suggested to be dependent on IL-10 and/or TGF-.",26782287_1,-1,-1,-1,-1,28013,-1,1.4500753e-05,1.04448e-05,0.99997497
28021,tumor tissue,12,14,70,82,"In stomach cancer, the mechanisms behind the accumulation of Tregs in tumor tissue has not been fully elucidated, and neither has Treg gene expression in situ.",26782287_2,-1,-1,-1,-1,28021,-1,1.3532003e-05,0.9999342,5.231643e-05
28022,Treg gene,23,25,130,139,"In stomach cancer, the mechanisms behind the accumulation of Tregs in tumor tissue has not been fully elucidated, and neither has Treg gene expression in situ.",26782287_2,-1,-1,-1,-1,28022,-1,4.017807e-06,0.9999902,5.723354e-06
28023,tissue,5,6,31,37,"MATERIALS AND METHODS: Stomach tissue from gastric cancer patients undergoing gastric resection was analyzed using flow cytometry and cell sorting, followed by RT-PCR.RESULTS: We observed that stomach CD4+ FOXP3+ T cells proliferated to a higher degree than CD4+ FOXP3- T cells, which may contribute to Treg accumulation in the mucosa.",26782287_3,-1,1,2,-1,28023,-1,1.49709795e-05,0.99995613,2.8892566e-05
28030,FOXP3- T cells,44,47,263,277,"MATERIALS AND METHODS: Stomach tissue from gastric cancer patients undergoing gastric resection was analyzed using flow cytometry and cell sorting, followed by RT-PCR.RESULTS: We observed that stomach CD4+ FOXP3+ T cells proliferated to a higher degree than CD4+ FOXP3- T cells, which may contribute to Treg accumulation in the mucosa.",26782287_3,-1,-1,-1,-1,28030,-1,0.002483355,0.7831394,0.21437721
28031,to Treg,51,53,300,307,"MATERIALS AND METHODS: Stomach tissue from gastric cancer patients undergoing gastric resection was analyzed using flow cytometry and cell sorting, followed by RT-PCR.RESULTS: We observed that stomach CD4+ FOXP3+ T cells proliferated to a higher degree than CD4+ FOXP3- T cells, which may contribute to Treg accumulation in the mucosa.",26782287_3,-1,-1,-1,-1,28031,-1,6.8818667e-06,0.9999875,5.667016e-06
28036,the FOXP3 gene,20,23,142,156,"By analyzing DNA methylation, we demonstrated that both proliferating and nonproliferating FOXP3+ T cells exhibited complete demethylation of the FOXP3 gene, indicating a stable FOXP3 expression in both cell populations.",26782287_4,-1,-1,-1,-1,28036,-1,4.6833093e-06,0.9999902,5.0784315e-06
28039,analysis,2,3,13,21,"Furthermore, analysis of T-cell populations isolated directly from the tumor and tumor-free mucosa demonstrated that CD4+ CD25high T cells have a higher IL-10/IFN- gene expression ratio but express lower levels of TGF- than CD4+ CD25low/- T cells.",26782287_5,0,1,-1,-1,28039,-1,5.6176264e-06,0.9999896,4.7390045e-06
28040,T-cell,4,5,25,31,"Furthermore, analysis of T-cell populations isolated directly from the tumor and tumor-free mucosa demonstrated that CD4+ CD25high T cells have a higher IL-10/IFN- gene expression ratio but express lower levels of TGF- than CD4+ CD25low/- T cells.",26782287_5,-1,1,2,-1,28040,-1,1.0186297e-05,6.4840488e-06,0.99998343
28041,the tumor,9,11,67,76,"Furthermore, analysis of T-cell populations isolated directly from the tumor and tumor-free mucosa demonstrated that CD4+ CD25high T cells have a higher IL-10/IFN- gene expression ratio but express lower levels of TGF- than CD4+ CD25low/- T cells.",26782287_5,-1,-1,-1,-1,28041,-1,3.7320137e-06,0.99999166,4.6585224e-06
28046,TGF- than,33,35,215,225,"Furthermore, analysis of T-cell populations isolated directly from the tumor and tumor-free mucosa demonstrated that CD4+ CD25high T cells have a higher IL-10/IFN- gene expression ratio but express lower levels of TGF- than CD4+ CD25low/- T cells.",26782287_5,-1,-1,-1,-1,28046,-1,6.7722135e-06,0.99998736,5.884665e-06
28059,the tumor,4,6,21,30,"The immune status of the tumor microenvironment influences tumor progression, and hepatocellular carcinoma (HCC) with an immunosuppressive signature often is associated with a poor prognosis.",26786094_0,-1,-1,-1,-1,28059,-1,4.803321e-06,0.99999,5.2051423e-06
28064,tumor cell,18,20,107,117,This study examined the impact of a bone marrow-derived dendritic cell (DC) vaccine loaded with autologous tumor cell lysate on tumor progression and the tumor microenvironment using an orthotopic murine HCC model.,26786094_1,-1,-1,-1,-1,28064,-1,0.0067608133,0.27617472,0.7170644
28066,the tumor,25,27,150,159,This study examined the impact of a bone marrow-derived dendritic cell (DC) vaccine loaded with autologous tumor cell lysate on tumor progression and the tumor microenvironment using an orthotopic murine HCC model.,26786094_1,-1,-1,-1,-1,28066,-1,4.096124e-06,0.99999106,4.8241222e-06
28072,tumor-infiltrating lymphocytes,19,21,93,123,"The impact of DC vaccine loaded with Hepa1-6 cell lysate on tumor progression, survival, and tumor-infiltrating lymphocytes and cytokines was examined.",26786094_3,-1,-1,-1,-1,28072,-1,0.0036178804,0.869257,0.12712514
28077,generated through,18,20,102,119,Treating mice with DC vaccine loaded with Hepa1-6 cell lysate inhibited the progression of murine HCC generated through orthotopic implantation of Hepa1-6 cells and resulted in a 90% survival rate by day 60 compared with a survival rate lower than 5% for untreated mice.,26786094_4,-1,-1,-1,-1,28077,-1,1.0805957e-05,0.9999832,6.0396424e-06
28082,the tumor,11,13,88,97,This anti-tumor response was associated with inhibition of STAT3 phosphorylation within the tumor.,26786094_5,-1,-1,-1,-1,28082,-1,4.0702676e-06,0.99999094,5.0403946e-06
28086,the tumor,12,14,76,85,The DC vaccine reduced accumulation of Foxp3+CD4+ regulatory T cells within the tumor microenvironment and prevented TGF- production from the tumor tissue.,26786094_6,-1,-1,-1,-1,28086,-1,4.12719e-06,0.99999166,4.18404e-06
28088,the tumor tissue,20,23,139,155,The DC vaccine reduced accumulation of Foxp3+CD4+ regulatory T cells within the tumor microenvironment and prevented TGF- production from the tumor tissue.,26786094_6,-1,-1,-1,-1,28088,-1,4.9712326e-06,0.9999893,5.7607444e-06
28089,Tumor cell,0,2,0,10,Tumor cell lysate-loaded DC vaccine prevented HCC progression in a clinically relevant orthotopic murine HCC model.,26786094_7,-1,-1,-1,-1,28089,-1,0.0019755908,0.08919798,0.9088264
28095,the tumor,15,17,85,94,The effect of DC vaccine on the accumulation of Foxp3+CD4+ regulatory T cells within the tumor microenvironment and on the production of TGF- suggests that tumor regression by DC vaccination may be associated with an altered immunosuppressive tumor microenvironment.,26786094_8,-1,-1,-1,-1,28095,-1,4.133729e-06,0.99999154,4.337497e-06
28098,that tumor,25,27,152,162,The effect of DC vaccine on the accumulation of Foxp3+CD4+ regulatory T cells within the tumor microenvironment and on the production of TGF- suggests that tumor regression by DC vaccination may be associated with an altered immunosuppressive tumor microenvironment.,26786094_8,-1,-1,-1,-1,28098,-1,4.455523e-06,0.99999166,3.931202e-06
28107,the tumor,3,5,23,32,"The latter inactivates the tumor suppressor protein retinoblastoma (Rb), which leads to the overexpression of p16(INK4) protein, providing unique Ags for therapeutic HPV-specific cancer vaccination.",26851223_2,-1,-1,-1,-1,28107,-1,4.3760006e-06,0.99999154,4.0956265e-06
28108,protein,6,7,44,51,"The latter inactivates the tumor suppressor protein retinoblastoma (Rb), which leads to the overexpression of p16(INK4) protein, providing unique Ags for therapeutic HPV-specific cancer vaccination.",26851223_2,0,1,-1,-1,28108,-1,5.4399493e-06,0.99999,4.568955e-06
28109,to the,14,16,85,91,"The latter inactivates the tumor suppressor protein retinoblastoma (Rb), which leads to the overexpression of p16(INK4) protein, providing unique Ags for therapeutic HPV-specific cancer vaccination.",26851223_2,-1,-1,-1,-1,28109,-1,4.5396237e-06,0.99999154,3.907023e-06
28110,protein,20,21,120,127,"The latter inactivates the tumor suppressor protein retinoblastoma (Rb), which leads to the overexpression of p16(INK4) protein, providing unique Ags for therapeutic HPV-specific cancer vaccination.",26851223_2,0,1,-1,-1,28110,-1,7.790367e-06,0.99998677,5.458125e-06
28113,protein,9,10,65,72,We developed potential adenoviral vaccines that express a fusion protein of HPV-16 E6 and E7 (Ad.,26851223_3,0,1,-1,-1,28113,-1,1.4468205e-05,0.99997854,6.934946e-06
28132,immunity,6,7,46,54,"E6E7.p16 with Ad.PD1 could improve antitumor immunity against HPV-related tumors and that p16 may enhance the immunogenicity of DC, through cyclin-dependent pathways, Th1 cytokine secretion, and by adding a nonviral Ag highly overexpressed in HPV-induced cancers.",26851223_15,0,-1,2,-1,28132,-1,0.99982375,5.510871e-05,0.000121177036
28137,Th1 cytokine,24,26,168,180,"E6E7.p16 with Ad.PD1 could improve antitumor immunity against HPV-related tumors and that p16 may enhance the immunogenicity of DC, through cyclin-dependent pathways, Th1 cytokine secretion, and by adding a nonviral Ag highly overexpressed in HPV-induced cancers.",26851223_15,-1,-1,-1,-1,28137,-1,0.12893341,0.86565846,0.005408168
28143,tissue,6,7,43,49,"MATERIALS AND METHODS: Surgically obtained tissue and blood samples of 100 Dupuytren patients were processed by immunohistochemistry, flow cytometry, as well as immunoscope analysis.",26852784_2,-1,1,2,-1,28143,-1,8.800476e-06,0.9999765,1.473541e-05
28144,blood,8,9,54,59,"MATERIALS AND METHODS: Surgically obtained tissue and blood samples of 100 Dupuytren patients were processed by immunohistochemistry, flow cytometry, as well as immunoscope analysis.",26852784_2,0,1,-1,-1,28144,-1,0.00024421816,0.99954885,0.00020696323
28145,analysis,26,27,173,181,"MATERIALS AND METHODS: Surgically obtained tissue and blood samples of 100 Dupuytren patients were processed by immunohistochemistry, flow cytometry, as well as immunoscope analysis.",26852784_2,0,1,-1,-1,28145,-1,1.2214407e-05,0.9999757,1.2105678e-05
28146,tissue,3,4,35,41,Macroscopically normal aponeurotic tissue served as control.,26852784_3,-1,1,2,-1,28146,-1,0.00020412363,0.97609144,0.023704384
28148,protein,29,30,130,137,"RESULTS: Locally, microvascular alterations and massive infiltration by mononuclear cells (CD3+, CD4>CD8, CD45RO>CD45RA, S100 protein, CD56, CD68, scarce CD19 and mast cells) forming perivascular clusters were found in DD tissue.",26852784_4,0,1,-1,-1,28148,-1,0.00033679564,0.9993955,0.0002676582
28150,tissue,48,49,226,232,"RESULTS: Locally, microvascular alterations and massive infiltration by mononuclear cells (CD3+, CD4>CD8, CD45RO>CD45RA, S100 protein, CD56, CD68, scarce CD19 and mast cells) forming perivascular clusters were found in DD tissue.",26852784_4,-1,1,2,-1,28150,-1,0.00047580813,0.65218085,0.34734333
28152,tissue-derived T-cells,4,6,35,57,Cytokine profiling of fibromatosis tissue-derived T-cells showed a Th1/TH17-weighted immune response.,26852784_5,-1,-1,-1,-1,28152,-1,0.0025587596,0.30574116,0.69170016
28154,analysis,1,2,12,20,Immunoscope analysis revealed a restricted T-cell receptor / repertoire pointing to an (auto)antigen-driven process.,26852784_6,0,1,-1,-1,28154,-1,7.9283745e-06,0.9999869,5.150405e-06
28161,the theory that the,27,31,194,213,"CONCLUSION: The striking accumulation of immune cells, expression of leukocyte adhesion molecules, as well as pro-inflammatory and pro-fibrotic cytokines near markedly narrowed vessels supports the theory that the abnormal proliferation of fibroblasts and production of extracellular matrix proteins in DD seems to be related to immune-mediated microvascular damage.",26852784_7,-1,-1,-1,-1,28161,-1,4.0849472e-06,0.9999919,4.045377e-06
28162,proteins,40,41,291,299,"CONCLUSION: The striking accumulation of immune cells, expression of leukocyte adhesion molecules, as well as pro-inflammatory and pro-fibrotic cytokines near markedly narrowed vessels supports the theory that the abnormal proliferation of fibroblasts and production of extracellular matrix proteins in DD seems to be related to immune-mediated microvascular damage.",26852784_7,0,1,-1,-1,28162,-1,0.99908185,0.00046376686,0.00045438364
28164,related to,46,48,318,328,"CONCLUSION: The striking accumulation of immune cells, expression of leukocyte adhesion molecules, as well as pro-inflammatory and pro-fibrotic cytokines near markedly narrowed vessels supports the theory that the abnormal proliferation of fibroblasts and production of extracellular matrix proteins in DD seems to be related to immune-mediated microvascular damage.",26852784_7,-1,-1,-1,-1,28164,-1,9.533636e-06,0.99998355,6.9013854e-06
28167,T-cells,7,8,60,67,The restricted T-cell receptor repertoire of intra-lesional T-cells points to an antigen-driven process.,26852784_8,-1,1,2,-1,28167,-1,1.7823511e-05,1.09117655e-05,0.99997115
28170,T-cells,0,1,0,7,T-cells seem to play an important role in the development of Dupuytren's disease.,26852784_9,-1,1,2,-1,28170,-1,1.4131876e-05,8.338848e-06,0.99997747
28171,to play,2,4,13,20,T-cells seem to play an important role in the development of Dupuytren's disease.,26852784_9,-1,-1,-1,-1,28171,-1,9.339657e-06,0.9999814,9.243601e-06
28181,to tumor,15,17,102,110,"However, we describe here a different, cell-extrinsic mechanism through which mutant KRAS contributes to tumor development.",26880715_2,-1,-1,-1,-1,28181,-1,8.415752e-06,0.9999832,8.434103e-06
28182,Tumor cells,0,2,0,11,"Tumor cells carrying mutated KRAS induced highly suppressive T cells, and silencing KRAS reversed this effect.",26880715_3,-1,-1,-1,-1,28182,-1,8.242468e-05,0.00033628065,0.9995813
28186,tumor cells,8,10,62,73,Overexpression of the mutant KRAS(G12V)gene in wild-type KRAS tumor cells led to regulatory T-cell (Treg) induction.,26880715_4,-1,-1,-1,-1,28186,-1,5.4314627e-05,0.00020710302,0.9997385
28187,to regulatory T-cell,11,14,78,98,Overexpression of the mutant KRAS(G12V)gene in wild-type KRAS tumor cells led to regulatory T-cell (Treg) induction.,26880715_4,-1,-1,-1,-1,28187,-1,0.0015126418,0.11151716,0.8869702
28193,factor-1,14,15,91,100,We also demonstrate that mutant KRAS induces the secretion of IL10 and transforming growth factor-1 (both required for Treg induction) by tumor cells through the activation of the MEK-ERK-AP1 pathway.,26880715_5,0,1,-1,-1,28193,-1,0.98513377,0.00094823126,0.013918001
28195,tumor cells through the,23,27,139,162,We also demonstrate that mutant KRAS induces the secretion of IL10 and transforming growth factor-1 (both required for Treg induction) by tumor cells through the activation of the MEK-ERK-AP1 pathway.,26880715_5,-1,-1,-1,-1,28195,-1,9.227828e-05,0.99911267,0.0007950991
28202,This cell-extrinsic,0,2,0,19,This cell-extrinsic mechanism allows tumor cells harboring a mutant KRAS oncogene to escape immune recognition.,26880715_7,-1,-1,-1,-1,28202,-1,0.0010780027,0.0141441235,0.9847778
28203,tumor cells,4,6,37,48,This cell-extrinsic mechanism allows tumor cells harboring a mutant KRAS oncogene to escape immune recognition.,26880715_7,-1,-1,-1,-1,28203,-1,0.00058183767,0.02993566,0.9694826
28209,function,18,19,118,126,"Thus, an oncogene can promote tumor progression independent of its transforming activity by increasing the number and function of Tregs.",26880715_8,0,1,2,-1,28209,-1,0.00041615547,0.9993754,0.00020848442
28217,functional,14,15,96,106,Regulatory T cells (Tregs) comprise numerous heterogeneous subsets with distinct phenotypic and functional features.,26885615_0,0,1,2,-1,28217,-1,0.0003723265,0.999491,0.00013669435
28221,Treg subsets,14,16,92,104,"Identifying Treg markers is critical to investigate the role and clinical impact of various Treg subsets in pathological settings, and also for developing more effective immunotherapies.",26885615_1,-1,-1,-1,-1,28221,-1,0.0002237716,0.010170608,0.98960567
28227,blood,10,11,63,68,In this study we report similar observations in the peripheral blood of patients with pancreatic cancer (PC) and liver metastases from colorectal cancer (LICRC).,26885615_3,0,1,-1,-1,28227,-1,0.001370964,0.9540239,0.044605184
28234,that FoxP3-LAP+ Tregs,9,12,60,81,"However, defining Tregs based on GARP/LAP expression showed that FoxP3-LAP+ Tregs in non-activated and activated settings, and FoxP3+Helios+GARP+LAP+ activated Tregs were significantly increased in both groups of patients, compared with controls.",26885615_5,-1,-1,-1,-1,28234,-1,8.034404e-06,0.9999852,6.760326e-06
28241,Treg subsets,17,19,114,126,This work implies that a combination of Treg-specific markers could be used to more accurately determine expanded Treg subsets and to understand their contribution in cancer settings.,26885615_6,-1,-1,-1,-1,28241,-1,0.0004627202,0.06333621,0.9362011
28244,T cells made IL-10,5,9,31,49,"Additionally, GARP-/+LAP+ CD4+ T cells made IL-10, and not IFN-, and levels of IL-10-secreting CD4+ T cells were elevated in LICRC patients, especially with higher tumor staging.",26885615_7,-1,-1,-1,-1,28244,-1,0.72313,0.00219584,0.27467415
28249,Taken together,0,2,0,14,"Taken together, our results indicate that investigations of Treg levels in different cancers should consider diverse Treg-related markers such as GARP, LAP, Helios, and others and not only FoxP3 as a sole Treg-specific marker.",26885615_8,-1,-1,-1,-1,28249,-1,9.693723e-06,0.999982,8.314998e-06
28258,the immune response,3,6,12,31,The role of the immune response in this phenomenon is yet unclear.,26899388_1,-1,-1,-1,-1,28258,-1,0.8764771,0.12193522,0.0015876936
28272,tumor-infiltrating T cells,9,12,50,76,"Furthermore, the production of IFN- and IL-17 by tumor-infiltrating T cells was analyzed.",26899388_3,-1,-1,-1,-1,28272,-1,0.002113217,0.8926825,0.10520429
28274,tumor-infiltrating T cells,3,6,14,40,The number of tumor-infiltrating T cells and Tregs was higher in HPV-positive than HPV-negative OPSCC (p < 0.0001).,26899388_4,-1,-1,-1,-1,28274,-1,0.0026416602,0.8194865,0.17787185
28280,trend toward,10,12,57,69,"Although a high number of intra-tumoral T cells showed a trend toward improved survival of all OPSCC patients, their prognostic effect in patients with a low number of intra-tumoral IL-17(+) non-T cells was significant with regard to disease-specific (p = 0.033) and disease-free survival (p = 0.012).",26899388_6,-1,-1,-1,-1,28280,-1,9.014121e-06,0.99998486,6.128109e-06
28289,related to,12,14,64,74,"This suggests that a high frequency of IL-17(+) non-T cells was related to a poor immune response, which was further supported by the observation that a high number of T cells was correlated with improved disease-free survival in the HPV-positive OPSCC (p = 0.008).",26899388_7,-1,-1,-1,-1,28289,-1,1.213453e-05,0.99998057,7.3432498e-06
28295,Th17 cell,7,9,33,42,"In addition, we detected a minor Th17 cell population.",26899388_8,-1,-1,-1,-1,28295,-1,0.00035143204,0.015933583,0.983715
28297,IL-17 than those,11,14,78,94,"However, T cells obtained from HPV-positive OPSCC produced significantly more IL-17 than those from HPV-negative tumors (p = 0.006).",26899388_9,-1,-1,-1,-1,28297,-1,0.99528694,0.0037546747,0.0009583276
28301,tumor-infiltrating T cells,13,16,87,113,"The improved prognosis of HPV-positive OPSCC is thus correlated with higher numbers of tumor-infiltrating T cells, more active Th17 cells and lower numbers of IL-17(+) non-T cells.",26899388_10,-1,-1,-1,-1,28301,-1,0.0027519611,0.7956627,0.20158535
28302,Th17 cells,19,21,127,137,"The improved prognosis of HPV-positive OPSCC is thus correlated with higher numbers of tumor-infiltrating T cells, more active Th17 cells and lower numbers of IL-17(+) non-T cells.",26899388_10,-1,-1,-1,-1,28302,-1,0.00048460695,0.029913113,0.9696023
28305,tumor-reactive T cells,3,6,24,46,Acquired dysfunction of tumor-reactive T cells is one mechanism by which tumors can evade the immune system.,26903482_0,-1,-1,-1,-1,28305,-1,0.005964718,0.6646526,0.32938266
28310,therapy,13,14,103,110,Identifying and correcting pathways that contribute to such dysfunction should enable novel anticancer therapy design.,26903482_1,0,1,-1,-1,28310,-1,6.494383e-06,0.9999881,5.4186066e-06
28314,to tumor,10,12,69,77,Impaired T cell-intrinsic NF-B may create a vicious cycle conducive to tumor progression and further T cell dysfunction.,26903482_3,-1,-1,-1,-1,28314,-1,6.084513e-06,0.99998844,5.4800457e-06
28326,functional tumor-specific,9,11,72,97,T cell-restricted constitutively active IKK augmented the frequency of functional tumor-specific CD8(+) T cells and improved tumor control.,26903482_6,-1,-1,-1,-1,28326,-1,5.712949e-05,0.99991715,2.5663225e-05
28343,transplantation,12,13,56,71,"In this study, a LC mouse model was created by adoptive transplantation with LC cells.",26910585_2,-1,1,2,-1,28343,-1,4.9155324e-06,0.9999902,4.9175396e-06
28345,The tumor-bearing,0,2,0,17,The tumor-bearing mice were vaccinated with LC cell extracts plus adjuvant TNBS or adoptive transplantation with specific CD8(+) CD196(+) T cells.,26910585_3,-1,-1,-1,-1,28345,-1,6.9041766e-06,0.99998546,7.687401e-06
28349,transplantation,14,15,92,107,The tumor-bearing mice were vaccinated with LC cell extracts plus adjuvant TNBS or adoptive transplantation with specific CD8(+) CD196(+) T cells.,26910585_3,-1,1,2,-1,28349,-1,4.739997e-06,0.99999034,4.928996e-06
28352,that the,3,5,19,27,The results showed that the vaccination with LC extracts (LCE)/TNBS markedly inhibited the LC growth and induced CD8(+) CD196(+) T cells in LC tissue and the spleen.,26910585_4,-1,-1,-1,-1,28352,-1,4.9084006e-06,0.9999907,4.3937357e-06
28355,tissue,25,26,143,149,The results showed that the vaccination with LC extracts (LCE)/TNBS markedly inhibited the LC growth and induced CD8(+) CD196(+) T cells in LC tissue and the spleen.,26910585_4,-1,1,2,-1,28355,-1,0.00041653053,0.18374032,0.8158431
28361,to TNBS,1,3,9,16,Exposure to TNBS induced RAW264.7 cells to produce macrophage inflammatory protein-3; the latter activated signal transducer and activator of transcription 3 and further induced perforin expression in the CD8(+) CD196(+) T cells.,26910585_6,-1,-1,-1,-1,28361,-1,2.3808185e-05,0.9999628,1.3426556e-05
28362,cells to,5,7,34,42,Exposure to TNBS induced RAW264.7 cells to produce macrophage inflammatory protein-3; the latter activated signal transducer and activator of transcription 3 and further induced perforin expression in the CD8(+) CD196(+) T cells.,26910585_6,-1,-1,-1,-1,28362,-1,0.0025348223,0.25067908,0.74678606
28363,protein-3,10,11,75,85,Exposure to TNBS induced RAW264.7 cells to produce macrophage inflammatory protein-3; the latter activated signal transducer and activator of transcription 3 and further induced perforin expression in the CD8(+) CD196(+) T cells.,26910585_6,0,1,-1,-1,28363,-1,0.9099989,0.08619706,0.003804074
28381,blood,13,14,70,75,Our study found a higher percentage of CD4(+) Tregs in the peripheral blood of NSCLC compared with healthy donors.,27000869_3,0,1,-1,-1,28381,-1,0.0033917266,0.51458484,0.48202345
28382,the Foxp3,9,11,62,71,NSCLC patients showed demethylation of eight CpG sites within the Foxp3 promoter with methylation ratios negatively correlated with CD4(+)CD25(+)Foxp3(+) T levels.,27000869_4,-1,-1,-1,-1,28382,-1,5.990133e-06,0.99998796,6.0976095e-06
28389,tumor cells,5,7,24,35,"To verify the effect of tumor cells on the phenotype and function of CD4(+) Tregs, we established a coculture system using NSCLC cell line and healthy CD4(+) T cells and showed that SPC-A1 induced IL-10 and TGF-1 secretion by affecting the function of CD4(+) Tregs.",27000869_6,-1,-1,-1,-1,28389,-1,4.2291143e-05,0.00021077463,0.99974686
28391,function,11,12,57,65,"To verify the effect of tumor cells on the phenotype and function of CD4(+) Tregs, we established a coculture system using NSCLC cell line and healthy CD4(+) T cells and showed that SPC-A1 induced IL-10 and TGF-1 secretion by affecting the function of CD4(+) Tregs.",27000869_6,0,1,2,-1,28391,-1,5.0306477e-05,0.9998696,8.006886e-05
28398,the function,43,45,237,249,"To verify the effect of tumor cells on the phenotype and function of CD4(+) Tregs, we established a coculture system using NSCLC cell line and healthy CD4(+) T cells and showed that SPC-A1 induced IL-10 and TGF-1 secretion by affecting the function of CD4(+) Tregs.",27000869_6,-1,-1,-1,-1,28398,-1,1.3346053e-05,0.9999695,1.7151238e-05
28403,the Foxp3,6,8,36,45,"Furthermore, eight CpG sites within the Foxp3 promoter also appeared to have undergone demethylation.",27000869_8,-1,-1,-1,-1,28403,-1,5.5526693e-06,0.9999893,5.1636566e-06
28415,to tumor,19,21,153,161,Our study provides one possible mechanism describing Foxp3 promoter demethylation changes by which NSCLC down-regulates immune responses and contributes to tumor progression.,27000869_11,-1,-1,-1,-1,28415,-1,5.732851e-06,0.9999888,5.446089e-06
28418,tumor cells,3,5,25,36,"Radiation modulates both tumor cells and immune cells in the tumor microenvironment to exert its anti-tumor activity; however, the molecular connection between tumor cells and immune cells that mediates radiation-exerted tumor suppression activity in the tumor microenvironment is largely unknown.",27014915_0,-1,-1,-1,-1,28418,-1,0.00019665652,0.0015727069,0.99823064
28420,the tumor,9,11,57,66,"Radiation modulates both tumor cells and immune cells in the tumor microenvironment to exert its anti-tumor activity; however, the molecular connection between tumor cells and immune cells that mediates radiation-exerted tumor suppression activity in the tumor microenvironment is largely unknown.",27014915_0,-1,-1,-1,-1,28420,-1,4.7997564e-06,0.99999046,4.741875e-06
28423,tumor cells,24,26,160,171,"Radiation modulates both tumor cells and immune cells in the tumor microenvironment to exert its anti-tumor activity; however, the molecular connection between tumor cells and immune cells that mediates radiation-exerted tumor suppression activity in the tumor microenvironment is largely unknown.",27014915_0,-1,-1,-1,-1,28423,-1,0.00010705038,0.0004631289,0.99942976
28424,cells that,28,30,183,193,"Radiation modulates both tumor cells and immune cells in the tumor microenvironment to exert its anti-tumor activity; however, the molecular connection between tumor cells and immune cells that mediates radiation-exerted tumor suppression activity in the tumor microenvironment is largely unknown.",27014915_0,-1,-1,-1,-1,28424,-1,0.0045995275,0.16531914,0.8300813
28426,the tumor,36,38,251,260,"Radiation modulates both tumor cells and immune cells in the tumor microenvironment to exert its anti-tumor activity; however, the molecular connection between tumor cells and immune cells that mediates radiation-exerted tumor suppression activity in the tumor microenvironment is largely unknown.",27014915_0,-1,-1,-1,-1,28426,-1,4.7427125e-06,0.9999908,4.4188487e-06
28430,tissue,18,19,112,118,We report here that radiation induces rapid activation of the p65/p50 and p50/p50 NF-B complexes in human soft tissue sarcoma (STS) cells.,27014915_1,-1,1,2,-1,28430,-1,1.863226e-05,0.9999231,5.8204638e-05
28432,to the TNF,5,8,45,56,Radiation-activated p65/p50 and p50/p50 bind to the TNF promoter to activate its transcription in STS cells.,27014915_2,-1,-1,-1,-1,28432,-1,1.6687261e-05,0.99997056,1.2734044e-05
28436,TNF,1,2,18,22,Radiation-induced TNF induces tumor cell death in an autocrine manner.,27014915_3,0,1,-1,-1,28436,-1,0.0009774785,0.99894434,7.82425e-05
28437,tumor cell,3,5,31,41,Radiation-induced TNF induces tumor cell death in an autocrine manner.,27014915_3,-1,-1,-1,-1,28437,-1,0.00043324914,0.011049075,0.98851764
28439,tumor cell,14,16,85,95,A sublethal dose of Smac mimetic BV6 induces cIAP1 and cIAP2 degradation to increase tumor cell sensitivity to radiation-induced cell death in vitro and to enhance radiation-mediated suppression of STS xenografts in vivo.,27014915_4,-1,-1,-1,-1,28439,-1,0.00011803777,0.0008435868,0.99903846
28444,TNF-induced,18,19,114,126,"Inhibition of caspases, RIP1, or RIP3 blocks radiation/TNF-induced cell death, whereas inhibition of RIP1 blocks TNF-induced caspase activation, suggesting that caspases and RIP1 act sequentially to mediate the non-compensatory cell death pathways.",27014915_5,0,1,-1,-1,28444,-1,0.0001635451,0.9998048,3.1665986e-05
28452,the T cell chemokines CCL2,18,23,106,132,"Furthermore, we determined in a syngeneic sarcoma mouse model that radiation up-regulates IRF3, IFN, and the T cell chemokines CCL2 and CCL5 in the tumor microenvironment, which are associated with activation and increased infiltration of Th1/Tc1 T cells in the tumor microenvironment.",27014915_6,-1,-1,-1,-1,28452,-1,0.6413119,0.35136488,0.0073232497
28453,the tumor,26,28,145,154,"Furthermore, we determined in a syngeneic sarcoma mouse model that radiation up-regulates IRF3, IFN, and the T cell chemokines CCL2 and CCL5 in the tumor microenvironment, which are associated with activation and increased infiltration of Th1/Tc1 T cells in the tumor microenvironment.",27014915_6,-1,-1,-1,-1,28453,-1,4.060013e-06,0.9999908,5.1217908e-06
28455,the tumor,43,45,259,268,"Furthermore, we determined in a syngeneic sarcoma mouse model that radiation up-regulates IRF3, IFN, and the T cell chemokines CCL2 and CCL5 in the tumor microenvironment, which are associated with activation and increased infiltration of Th1/Tc1 T cells in the tumor microenvironment.",27014915_6,-1,-1,-1,-1,28455,-1,4.0323202e-06,0.99999106,4.936084e-06
28456,tumor-infiltrating T cells,2,5,10,36,"Moreover, tumor-infiltrating T cells are in their active form since both the perforin and FasL pathways are activated in irradiated tumor tissues.",27014915_7,-1,-1,-1,-1,28456,-1,0.002600951,0.8146602,0.18273886
28459,tumor tissues,21,23,132,145,"Moreover, tumor-infiltrating T cells are in their active form since both the perforin and FasL pathways are activated in irradiated tumor tissues.",27014915_7,-1,-1,-1,-1,28459,-1,1.0166921e-05,0.9999734,1.6397917e-05
28462,functions,4,5,35,44,"Therefore, radiation-induced NF-B functions as a molecular link between tumor cells and immune cells in the tumor microenvironment for radiation-mediated tumor suppression.",27014915_9,0,1,2,-1,28462,-1,3.6359404e-05,0.9999329,3.0781994e-05
28463,tumor cells,10,12,73,84,"Therefore, radiation-induced NF-B functions as a molecular link between tumor cells and immune cells in the tumor microenvironment for radiation-mediated tumor suppression.",27014915_9,-1,-1,-1,-1,28463,-1,0.00011727573,0.0006942446,0.9991885
28465,the tumor,16,18,105,114,"Therefore, radiation-induced NF-B functions as a molecular link between tumor cells and immune cells in the tumor microenvironment for radiation-mediated tumor suppression.",27014915_9,-1,-1,-1,-1,28465,-1,4.5875e-06,0.99999034,5.124803e-06
28468,tumor immunity,3,5,25,39,"Recent studies implicate tumor immunity in the development of various tumors, including malignant mesothelioma.",27042963_1,-1,-1,-1,-1,28468,-1,0.0859486,0.91257596,0.0014754926
28472,T-cell,7,8,34,40,"In order to establish an in vitro T-cell model to clarify the effects of long-term exposure of asbestos on tumor immunity, in this study, human T-cell line MT-2 cells were cultured with asbestos for longer than 8 months and the resultant cells (MT-2Rst) were assessed for the expression of forkhead transcription factor FoxO1.",27042963_2,-1,1,2,-1,28472,-1,1.0844848e-05,7.917336e-06,0.9999813
28475,tumor immunity,19,21,107,121,"In order to establish an in vitro T-cell model to clarify the effects of long-term exposure of asbestos on tumor immunity, in this study, human T-cell line MT-2 cells were cultured with asbestos for longer than 8 months and the resultant cells (MT-2Rst) were assessed for the expression of forkhead transcription factor FoxO1.",27042963_2,-1,-1,-1,-1,28475,-1,0.0073528592,0.99219793,0.00044919318
28477,T-cell,27,28,144,150,"In order to establish an in vitro T-cell model to clarify the effects of long-term exposure of asbestos on tumor immunity, in this study, human T-cell line MT-2 cells were cultured with asbestos for longer than 8 months and the resultant cells (MT-2Rst) were assessed for the expression of forkhead transcription factor FoxO1.",27042963_2,-1,1,2,-1,28477,-1,9.435648e-06,7.0502665e-06,0.99998355
28483,forkhead transcription factor,53,56,290,319,"In order to establish an in vitro T-cell model to clarify the effects of long-term exposure of asbestos on tumor immunity, in this study, human T-cell line MT-2 cells were cultured with asbestos for longer than 8 months and the resultant cells (MT-2Rst) were assessed for the expression of forkhead transcription factor FoxO1.",27042963_2,-1,-1,-1,-1,28483,-1,6.8253967e-06,0.9999877,5.412376e-06
28485,analysis,2,3,16,24,Gene expression analysis revealed that the amount of FoxO1 mRNA decreased after long-term exposure of the MT-2 cells to asbestos.,27042963_3,0,1,-1,-1,28485,-1,9.777707e-06,0.9999815,8.713907e-06
28486,that the,4,6,34,42,Gene expression analysis revealed that the amount of FoxO1 mRNA decreased after long-term exposure of the MT-2 cells to asbestos.,27042963_3,-1,-1,-1,-1,28486,-1,4.265957e-06,0.9999918,3.9947668e-06
28488,cells to,17,19,111,119,Gene expression analysis revealed that the amount of FoxO1 mRNA decreased after long-term exposure of the MT-2 cells to asbestos.,27042963_3,-1,-1,-1,-1,28488,-1,0.0052955477,0.28044304,0.7142615
28490,target genes,10,12,64,76,"In accordance with this reduction in FoxO1, pro-apoptotic Foxo1 target genes Puma, Fas ligand and Bim were also seen to be down-regulated in MT-2Rst cells.",27042963_4,-1,-1,-1,-1,28490,-1,5.016619e-06,0.9999901,4.8884554e-06
28505,therapy,6,7,56,63,Successful immunogenic apoptosis in experimental cancer therapy depends on the induction of strong host anti-tumor responses.,27050509_0,0,1,-1,-1,28505,-1,4.8294046e-06,0.9999906,4.6374175e-06
28507,that tumors,1,3,6,17,"Given that tumors are often resistant to apoptosis, it is important to identify alternative molecular mechanisms that elicit immunogenic cell death.",27050509_1,-1,-1,-1,-1,28507,-1,5.250694e-06,0.99999034,4.3912128e-06
28514,cells release,5,7,34,47,"We report that necroptotic cancer cells release damage-associated molecular patterns and promote maturation of dendritic cells, the cross-priming of cytotoxic Tcells, and the production of IFN- in response to tumor antigen stimulation.",27050509_3,-1,-1,-1,-1,28514,-1,0.0033412164,0.1893011,0.8073577
28520,to tumor antigen,32,35,208,224,"We report that necroptotic cancer cells release damage-associated molecular patterns and promote maturation of dendritic cells, the cross-priming of cytotoxic Tcells, and the production of IFN- in response to tumor antigen stimulation.",27050509_3,-1,-1,-1,-1,28520,-1,0.24486703,0.75129765,0.00383529
28526,therapy,21,22,129,136,Our study broadens the current concept of immunogenic cell death and opens doors for the development of new strategies in cancer therapy.,27050509_5,0,1,-1,-1,28526,-1,4.8998095e-06,0.9999908,4.3320993e-06
28531,functionally,14,15,83,95,There are many molecules that define regulatory T cells (Tregs) phenotypically and functionally.,27095576_0,0,1,2,-1,28531,-1,4.962092e-05,0.9999318,1.8605966e-05
28532,transmembrane protein,9,11,51,72,Glycoprotein A repetitions predominant (GARP) is a transmembrane protein containing leucine rich repeats.,27095576_1,-1,-1,-1,-1,28532,-1,1.7887849e-05,0.9999676,1.452542e-05
28539,Tregs that,9,11,44,54,"Besides, GARP is a cell surface molecule of Tregs that maintains their regulatory function and homeosatsis.",27095576_4,-1,-1,-1,-1,28539,-1,3.619249e-06,0.9999908,5.572901e-06
28541,function,14,15,82,90,"Besides, GARP is a cell surface molecule of Tregs that maintains their regulatory function and homeosatsis.",27095576_4,0,1,2,-1,28541,-1,1.5921523e-05,0.99996233,2.1751272e-05
28544,transforming growth factor,12,15,69,95,GARP has also been proved to promote the activation and secretion of transforming growth factor  (TGF-).,27095576_5,-1,-1,-1,-1,28544,-1,0.9714534,0.023279253,0.0052673286
28547,T cells that,2,5,7,19,CD4(+) T cells that express the forkhead box P3 (FOXP3) transcription factor function as regulatory T (Treg) cells and hinder effective immune responses against cancer cells.,27111280_0,-1,-1,-1,-1,28547,-1,0.0012594715,0.044760168,0.9539804
28548,the forkhead,6,8,28,40,CD4(+) T cells that express the forkhead box P3 (FOXP3) transcription factor function as regulatory T (Treg) cells and hinder effective immune responses against cancer cells.,27111280_0,-1,-1,-1,-1,28548,-1,6.2829554e-06,0.9999882,5.5083174e-06
28550,transcription factor function,13,16,56,85,CD4(+) T cells that express the forkhead box P3 (FOXP3) transcription factor function as regulatory T (Treg) cells and hinder effective immune responses against cancer cells.,27111280_0,-1,-1,-1,-1,28550,-1,7.129874e-06,0.9999851,7.753442e-06
28566,two types,21,23,125,134,"Here we show that CRCs, which are commonly infiltrated by suppression-competent FOXP3(hi) Treg cells, can be classified into two types by the degree of additional infiltration of FOXP3(lo) nonsuppressive T cells.",27111280_3,-1,-1,-1,-1,28566,-1,8.195325e-06,0.9999827,9.113819e-06
28573,the naive T cell,14,18,82,98,"The latter, which are distinguished from FOXP3(+) Treg cells by non-expression of the naive T cell marker CD45RA and instability of FOXP3, secreted inflammatory cytokines.",27111280_4,-1,-1,-1,-1,28573,-1,0.0026772341,0.66116214,0.33616063
28578,than those,15,17,99,109,"Indeed, CRCs with abundant infiltration of FOXP3(lo) T cells showed significantly better prognosis than those with predominantly FOXP3(hi) Treg cell infiltration.",27111280_5,-1,-1,-1,-1,28578,-1,4.983109e-06,0.9999894,5.6501954e-06
28584,transforming growth factor,16,19,109,135,"Development of such inflammatory FOXP3(lo) non-Treg cells may depend on secretion of interleukin (IL)-12 and transforming growth factor (TGF)- by tissues and their presence was correlated with tumor invasion by intestinal bacteria, especially Fusobacterium nucleatum.",27111280_6,-1,-1,-1,-1,28584,-1,0.97732955,0.019021094,0.0036493535
28585,tissues,21,22,147,154,"Development of such inflammatory FOXP3(lo) non-Treg cells may depend on secretion of interleukin (IL)-12 and transforming growth factor (TGF)- by tissues and their presence was correlated with tumor invasion by intestinal bacteria, especially Fusobacterium nucleatum.",27111280_6,-1,1,2,-1,28585,-1,3.927509e-05,0.9996723,0.00028841986
28589,functionally,2,3,6,18,"Thus, functionally distinct subpopulations of tumor-infiltrating FOXP3(+) T cells contribute in opposing ways to determining CRC prognosis.",27111280_7,0,1,2,-1,28589,-1,7.0432834e-05,0.99991226,1.7252785e-05
28590,tumor-infiltrating FOXP3(+,6,8,46,72,"Thus, functionally distinct subpopulations of tumor-infiltrating FOXP3(+) T cells contribute in opposing ways to determining CRC prognosis.",27111280_7,-1,-1,-1,-1,28590,-1,8.8931876e-05,0.9998766,3.4421864e-05
28595,tumor tissues,7,9,39,52,"Depletion of FOXP3(hi) Treg cells from tumor tissues, which would augment antitumor immunity, could thus be used as an effective treatment strategy for CRCs and other cancers, whereas strategies that locally increase the population of FOXP3(lo) non-Treg cells could be used to suppress or prevent tumor formation.",27111280_8,-1,-1,-1,-1,28595,-1,1.6924409e-05,0.9999254,5.7699624e-05
28596,immunity,14,15,84,92,"Depletion of FOXP3(hi) Treg cells from tumor tissues, which would augment antitumor immunity, could thus be used as an effective treatment strategy for CRCs and other cancers, whereas strategies that locally increase the population of FOXP3(lo) non-Treg cells could be used to suppress or prevent tumor formation.",27111280_8,0,-1,2,-1,28596,-1,0.99982846,3.6680605e-05,0.00013475578
28610,to tumour,7,9,39,48,"Regulatory T cells (T-regs) contribute to tumour immune escape, but their role in basal cell carcinoma (BCC) is not understood.",27117439_1,-1,-1,-1,-1,28610,-1,6.536457e-06,0.9999875,5.9838153e-06
28616,analysis,15,16,102,110,"The fraction of T-regs among T cells was analysed by immunohistochemistry followed by automated image analysis in facial BCC, peritumoural skin and normal, buttock skin.",27117439_2,0,1,-1,-1,28616,-1,1.0213331e-05,0.9999788,1.1025628e-05
28627,Transforming growth factor,0,3,0,26,"Transforming growth factor (TGF)- and T-reg chemokine expression was increased in BCC and peritumoural skin, but not in buttock skin, with expression levels correlating with Foxp3.",27117439_7,-1,-1,-1,-1,28627,-1,0.97391576,0.021436336,0.004647914
28628,T-reg chemokine,5,7,39,54,"Transforming growth factor (TGF)- and T-reg chemokine expression was increased in BCC and peritumoural skin, but not in buttock skin, with expression levels correlating with Foxp3.",27117439_7,-1,-1,-1,-1,28628,-1,0.03650398,0.96088505,0.0026109498
28649,T-cell proliferation to,57,60,344,367,"METHODS: The expression and activation of NF-B, Akt and IDO1 by MyD88(+) EOC SKOV3 cells was determined using western blot; the TLR4/MD-2 complex on SKOV3 cells and the phenotype of T lymphocytes were determined using flow cytometry; IDO activity was evaluated by measuring L-kynurenine; Immunesuppressive cytokines were detected using ELISA; T-cell proliferation to mitogen stimulation was assessed by MTT assay; the cytotoxicity of lymphocytes and NK cells was measured using LDH-cytotoxicity assay.",27118139_3,-1,-1,-1,-1,28649,-1,0.0013543717,0.0025892232,0.99605644
28667,therapy,12,13,79,86,"BACKGROUND: Chronic lymphocytic leukemia (CLL) remains incurable with standard therapy, and is characterized by excessive expansion of monoclonal abnormal mature B cells and more regulatory immune properties of T cell compartment.",27118475_0,0,1,-1,-1,28667,-1,4.7656863e-06,0.99998987,5.352985e-06
28672,function,8,9,52,60,"Thus, developing novel strategies to enhance immune function merits further investigation as a possible therapy for CLL.METHODS: We generated a fusion cytokine (fusokine) arising from the combination of human GM-CSF and IL-4 (named GIFT4).",27118475_1,0,1,2,-1,28672,-1,0.1407915,0.7902473,0.06896121
28673,therapy,15,16,104,111,"Thus, developing novel strategies to enhance immune function merits further investigation as a possible therapy for CLL.METHODS: We generated a fusion cytokine (fusokine) arising from the combination of human GM-CSF and IL-4 (named GIFT4).",27118475_1,0,1,-1,-1,28673,-1,5.5857467e-06,0.99998915,5.2402675e-06
28687,function,17,18,101,109,"The phenotype and secretome of GIFT4-treated CLL cells (GIFT4-CLL cells), and the immune stimulatory function of GIFT4-CLL cells on autologous T cells were analyzed by flow cytometry and luminex assay.",27118475_4,0,1,2,-1,28687,-1,0.002840349,0.996161,0.0009985989
28697,relative to,11,13,66,77,"GIFT4-CLL cells secreted IL-1, IL-6, ICAM-1 and substantial IL-2 relative to unstimulated CLL cells.",27118475_6,-1,-1,-1,-1,28697,-1,3.4277156e-05,0.999944,2.17416e-05
28708,that these,18,20,120,130,"GIFT4-CLL cells directly propelled the expansion of autologous IFN--producing CD314(+) cytotoxic T cells in vitro, and that these could lyse autologous CLL cells.",27118475_8,-1,-1,-1,-1,28708,-1,6.8976015e-06,0.9999863,6.857644e-06
28710,protein,5,6,37,44,"Furthermore, administration of GIFT4 protein promoted the expansion of human T cells in NOD-scid IL2R(null) immune deficient mice adoptively pre-transferred with peripheral blood mononuclear cells from subjects with CLL.CONCLUSION: GIFT4 has potent capability to converts primary CLL cells into APC-like immune helper cells that initiate a T cell driven anti-CLL immune response.",27118475_9,0,1,-1,-1,28710,-1,5.929496e-06,0.9999893,4.7526396e-06
28713,blood,24,25,174,179,"Furthermore, administration of GIFT4 protein promoted the expansion of human T cells in NOD-scid IL2R(null) immune deficient mice adoptively pre-transferred with peripheral blood mononuclear cells from subjects with CLL.CONCLUSION: GIFT4 has potent capability to converts primary CLL cells into APC-like immune helper cells that initiate a T cell driven anti-CLL immune response.",27118475_9,0,1,-1,-1,28713,-1,0.00024804685,0.9994855,0.00026648928
28717,helper cells that,44,47,312,329,"Furthermore, administration of GIFT4 protein promoted the expansion of human T cells in NOD-scid IL2R(null) immune deficient mice adoptively pre-transferred with peripheral blood mononuclear cells from subjects with CLL.CONCLUSION: GIFT4 has potent capability to converts primary CLL cells into APC-like immune helper cells that initiate a T cell driven anti-CLL immune response.",27118475_9,-1,-1,-1,-1,28717,-1,0.001793425,0.050934877,0.9472717
28721,T-helper-cell,4,5,28,41,We propose that deregulated T-helper-cell (Th) signaling underlies evolving Th17 cytokine expression seen during progression of cutaneous T-cell lymphoma (CTCL).,27144517_0,-1,1,2,-1,28721,-1,0.00017720259,0.0037204996,0.99610233
28723,Th17 cytokine,11,13,76,89,We propose that deregulated T-helper-cell (Th) signaling underlies evolving Th17 cytokine expression seen during progression of cutaneous T-cell lymphoma (CTCL).,27144517_0,-1,-1,-1,-1,28723,-1,0.19865803,0.796067,0.0052749505
28724,T-cell,19,20,138,144,We propose that deregulated T-helper-cell (Th) signaling underlies evolving Th17 cytokine expression seen during progression of cutaneous T-cell lymphoma (CTCL).,27144517_0,-1,1,2,-1,28724,-1,1.7404462e-05,6.1495543e-06,0.9999764
28729,Th17 related cytokines,16,19,118,140,"Though isogenic, indolent and aggressive-stage cell lines had diverged phenotypically, the latter expressing multiple Th17 related cytokines, the former a narrower profile.",27144517_3,-1,-1,-1,-1,28729,-1,0.07088904,0.92582643,0.0032845456
28733,Th17 cytokine,8,10,54,67,"Importantly, indolent stage cells remained poised for Th17 cytokine expression, readily inducible by treatment with IL-2 - a cytokine which mitigates Th17 differentiation in mice.",27144517_4,-1,-1,-1,-1,28733,-1,0.17221874,0.8227906,0.0049906624
28744,cells to,9,11,58,66,"Like IL-2 treatment, SOCS1 knockdown drove indolent stage cells to mimic key aggressive stage properties, notably IL17F upregulation.",27144517_7,-1,-1,-1,-1,28744,-1,0.002787202,0.38929373,0.6079191
28751,therapeutic target,25,27,182,200,"Collectively, our results show how JAK/STAT pathway mutations contribute to disease progression in CTCL cells by potentiating inflammatory cytokine signaling, widening the potential therapeutic target range for this intractable entity.",27144517_9,-1,-1,-1,-1,28751,-1,5.772033e-06,0.99999,4.1901308e-06
28756,testing their,19,21,134,147,MAC-1/2A cells also provide a candidate human Th17 laboratory model for identifying potentally actionable CTCL markers or targets and testing their druggability in vitro.,27144517_10,-1,-1,-1,-1,28756,-1,5.053977e-06,0.9999907,4.2325973e-06
28764,these tumours,21,23,144,157,"Within the lesions, all of the early papillomavirus genes are expressed and promote the excessive replication of fibroblasts which characterise these tumours.",27160146_1,-1,-1,-1,-1,28764,-1,4.9926516e-06,0.9999875,7.5769076e-06
28765,the natural,10,12,68,79,"Equine sarcoids differ from BPV induced fibro-papillomas of cattle (the natural host of BPV), in that they do not produce high amounts of virus particles, do not usually regress spontaneously and do not sero-convert to BPV; features which suggest that affected horses lack an effective anti-viral immune response to BPV.",27160146_2,-1,-1,-1,-1,28765,-1,6.209681e-06,0.99998844,5.352222e-06
28766,that they,18,20,97,106,"Equine sarcoids differ from BPV induced fibro-papillomas of cattle (the natural host of BPV), in that they do not produce high amounts of virus particles, do not usually regress spontaneously and do not sero-convert to BPV; features which suggest that affected horses lack an effective anti-viral immune response to BPV.",27160146_2,-1,-1,-1,-1,28766,-1,4.7919143e-06,0.9999889,6.3359776e-06
28769,immune response to,51,54,297,315,"Equine sarcoids differ from BPV induced fibro-papillomas of cattle (the natural host of BPV), in that they do not produce high amounts of virus particles, do not usually regress spontaneously and do not sero-convert to BPV; features which suggest that affected horses lack an effective anti-viral immune response to BPV.",27160146_2,-1,-1,-1,-1,28769,-1,0.96496546,0.034122683,0.0009118556
28770,T-cells,14,15,65,72,"Equine sarcoids contain large numbers of CD4+CD8+dual positive T-cells which uniformly express FOXP3, the key transcription factor of regulatory T-cells, and FOXP3 is also expressed within the BPV infected fibroblasts.",27160146_3,-1,1,2,-1,28770,-1,1.1629573e-05,7.263864e-06,0.99998105
28781,cytokine TGF,15,17,100,113,"Compared to healthy skin, sarcoids showed increased mRNA transcription for FOXP3 and the regulatory cytokine TGF.",27160146_4,-1,-1,-1,-1,28781,-1,0.9930091,0.0063676336,0.0006232695
28785,function,12,13,65,73,"Transcription of IL17, which has been shown to have a regulatory function in human papillomavirus-associated tumours, was also elevated in equine sarcoids compared to spleen.",27160146_5,0,1,2,-1,28785,-1,1.0401787e-05,0.9999778,1.17503605e-05
28790,T cell cytokines,10,13,57,73,"In contrast, the levels of mRNA transcripts for effector T cell cytokines IL2, IL4 and interferon-gamma (IFN) were not elevated in sarcoids compared to healthy skin or spleen.",27160146_6,-1,-1,-1,-1,28790,-1,0.18897876,0.0015198333,0.80950135
28800,that the,2,4,11,19,We suggest that the regulatory cytokine micro-environment within sarcoids enables the persistence of the lesions by preventing an effective anti-viral immune response.,27160146_8,-1,-1,-1,-1,28800,-1,3.8117512e-06,0.99999225,3.951626e-06
28807,that Th17 cells,4,7,21,36,It has been reported that Th17 cells as a newly identified subset of CD4(+) T cells are involved in the pathogenesis of several hematological disorders.,27176825_1,-1,-1,-1,-1,28807,-1,0.0031547241,0.5825264,0.41431886
28812,Th17 cells,5,7,21,31,"However, the role of Th17 cells in the pathophysiology of B-ALL is still unclear.",27176825_2,-1,-1,-1,-1,28812,-1,0.0004695109,0.019422159,0.9801083
28817,blood,15,16,88,93,METHODS: The frequencies of T cells were determined by flow cytometry in the peripheral blood and bone marrow of 44 newly diagnosed B-ALL patients and 25 age-matched healthy donors.,27176825_3,0,1,-1,-1,28817,-1,0.0026657144,0.7613318,0.2360025
28818,The cell,0,2,0,8,"The cell viability and apoptosis were determined by CCK-8 assay and Annexin V staining, respectively.",27176825_4,-1,-1,-1,-1,28818,-1,0.00042008166,0.0055328263,0.99404705
28822,Th17 cells,11,13,73,83,RESULTS: We assessed and observed a significantly increased frequency of Th17 cells and a drastically decreased frequency of Th1 cells in peripheral blood mononuclear cells and bone marrow mononuclear cells from newly diagnosed B-ALL patients compared with healthy donors.,27176825_6,-1,-1,-1,-1,28822,-1,0.00015839038,0.0028349627,0.9970066
28824,blood,23,24,149,154,RESULTS: We assessed and observed a significantly increased frequency of Th17 cells and a drastically decreased frequency of Th1 cells in peripheral blood mononuclear cells and bone marrow mononuclear cells from newly diagnosed B-ALL patients compared with healthy donors.,27176825_6,0,1,-1,-1,28824,-1,0.002317342,0.99640036,0.0012822433
28827,Th17-related cytokines,5,7,33,55,"Furthermore, increased levels of Th17-related cytokines including IL-17, IL-21, IL-23, IL-1, and IL-6 were presented in between blood and marrow in B-ALL patients.",27176825_7,-1,-1,-1,-1,28827,-1,0.051669274,0.94500095,0.0033297339
28831,blood,22,23,129,134,"Furthermore, increased levels of Th17-related cytokines including IL-17, IL-21, IL-23, IL-1, and IL-6 were presented in between blood and marrow in B-ALL patients.",27176825_7,0,1,-1,-1,28831,-1,0.00071413774,0.99696016,0.0023256885
28833,two Th17-secreted cytokines,5,8,23,50,"Both IL-17A and IL-21, two Th17-secreted cytokines, induced the proliferation of B-ALL cell line Nalm-6 and patient B-ALL cells isolated from B-ALL patients, herein either cytokine led to the phosphorylation of Akt and Stat3.",27176825_8,-1,-1,-1,-1,28833,-1,0.25897706,0.73559195,0.005430987
28839,to the,30,32,185,191,"Both IL-17A and IL-21, two Th17-secreted cytokines, induced the proliferation of B-ALL cell line Nalm-6 and patient B-ALL cells isolated from B-ALL patients, herein either cytokine led to the phosphorylation of Akt and Stat3.",27176825_8,-1,-1,-1,-1,28839,-1,4.223951e-06,0.9999914,4.308756e-06
28847,Th17 cells,7,9,48,58,CONCLUSIONS: Our findings suggest that elevated Th17 cells secrete IL-17A by which promotes the proliferation and resistance to daunorubicin in B-ALL cells through activation of Akt signaling.,27176825_10,-1,-1,-1,-1,28847,-1,0.00010761084,0.0016946782,0.99819773
28851,cells through,22,24,150,163,CONCLUSIONS: Our findings suggest that elevated Th17 cells secrete IL-17A by which promotes the proliferation and resistance to daunorubicin in B-ALL cells through activation of Akt signaling.,27176825_10,-1,-1,-1,-1,28851,-1,0.0037934054,0.40595198,0.59025466
28852,Th17 cells,0,2,0,10,Th17 cells may represent a novel target to improve B-ALL immunotherapy.,27176825_11,-1,-1,-1,-1,28852,-1,0.00022307714,0.0029187275,0.99685824
28853,target to,6,8,33,42,Th17 cells may represent a novel target to improve B-ALL immunotherapy.,27176825_11,-1,-1,-1,-1,28853,-1,4.054064e-06,0.99999213,3.7901214e-06
28858,functions,10,11,46,55,FoxP3+ regulatory T (Treg) cells have diverse functions in the suppression of antitumor immunity.,27177223_0,0,1,2,-1,28858,-1,6.4175794e-05,0.99986887,6.694989e-05
28860,immunity,16,17,88,96,FoxP3+ regulatory T (Treg) cells have diverse functions in the suppression of antitumor immunity.,27177223_0,0,-1,2,-1,28860,-1,0.9998598,4.6078036e-05,9.407694e-05
28861,that FoxP3hiCD45RA-CD4,2,4,8,30,"We show that FoxP3hiCD45RA-CD4+ Treg cells [activated Treg (aTreg) cells] are the predominant cell population among tumor-infiltrating FoxP3+ T cells, and that high aTreg cell-infiltrating content is associated with reduced survival in patients with head and neck squamous cell carcinoma (HNSCC).",27177223_1,-1,-1,-1,-1,28861,-1,0.0006878901,0.99198407,0.0073280707
28867,tumor-infiltrating FoxP3,21,23,116,140,"We show that FoxP3hiCD45RA-CD4+ Treg cells [activated Treg (aTreg) cells] are the predominant cell population among tumor-infiltrating FoxP3+ T cells, and that high aTreg cell-infiltrating content is associated with reduced survival in patients with head and neck squamous cell carcinoma (HNSCC).",27177223_1,-1,-1,-1,-1,28867,-1,6.0305933e-06,0.9999887,5.3054086e-06
28874,tumor-associated antigen,10,12,65,89,In vitro studies have demonstrated that aTreg cells can suppress tumor-associated antigen (TAA) effector T cell immune responses in HNSCC.,27177223_2,-1,-1,-1,-1,28874,-1,0.15541746,0.8401772,0.004405361
28876,T cell immune responses,16,20,105,128,In vitro studies have demonstrated that aTreg cells can suppress tumor-associated antigen (TAA) effector T cell immune responses in HNSCC.,27177223_2,-1,-1,-1,-1,28876,-1,0.18821365,0.00088997936,0.81089634
28877,chemokine receptor,3,5,14,32,"Moreover, C-C chemokine receptor 4 (CCR4) was specifically expressed by aTreg cells in the peripheral blood of HNSCC patients.",27177223_3,-1,-1,-1,-1,28877,-1,0.9946621,3.379168e-05,0.0053040674
28880,blood,18,19,102,107,"Moreover, C-C chemokine receptor 4 (CCR4) was specifically expressed by aTreg cells in the peripheral blood of HNSCC patients.",27177223_3,0,1,-1,-1,28880,-1,0.00025719972,0.9991646,0.0005782061
28882,that monocyte chemoattractant protein-1,10,14,61,100,"Using a RayBiotech human chemokine antibody array, we showed that monocyte chemoattractant protein-1 (MCP-1), an endogenous CCR4-binding ligand, was specifically upregulated in the HNSCC microenvironment compared to the other four CCR4-binding ligands.",27177223_4,-1,-1,-1,-1,28882,-1,0.027095137,0.9660288,0.0068760626
28885,to the,31,33,213,219,"Using a RayBiotech human chemokine antibody array, we showed that monocyte chemoattractant protein-1 (MCP-1), an endogenous CCR4-binding ligand, was specifically upregulated in the HNSCC microenvironment compared to the other four CCR4-binding ligands.",27177223_4,-1,-1,-1,-1,28885,-1,5.892384e-06,0.99998975,4.367146e-06
28887,immunity,12,13,102,110,"Blocking MCP-1/CCR4 signaling-induced aTreg cell recruitment using a CCR4 antagonist evoked antitumor immunity in mice, and lead to inhibition of tumor growth and prolonged survival.",27177223_5,0,-1,2,-1,28887,-1,0.99988675,3.3857435e-05,7.9368816e-05
28891,cell trafficking,4,6,26,42,"Therefore, blocking aTreg cell trafficking in tumors using CCR4-binding agents may be an effective immunotherapy for HNSCC.",27177223_6,-1,-1,-1,-1,28891,-1,4.5927205e-05,0.00023265042,0.99972147
28893,The tumor,0,2,0,9,"The tumor microenvironment impacts tumor progression and individual cells, including CD4(+) T cells, which have been detected in bladder cancer tissues.",27196763_0,-1,-1,-1,-1,28893,-1,4.4603075e-06,0.99999106,4.5125444e-06
28897,tissues,23,24,144,151,"The tumor microenvironment impacts tumor progression and individual cells, including CD4(+) T cells, which have been detected in bladder cancer tissues.",27196763_0,-1,1,2,-1,28897,-1,2.7239414e-05,0.9995876,0.00038511647
28899,these T cells,5,8,30,43,"The detailed mechanism of how these T cells were recruited to the bladder cancer tumor and their impact on bladder cancer progression, however, remains unclear.",27196763_1,-1,-1,-1,-1,28899,-1,0.0012787399,0.059905194,0.9388161
28900,to the,10,12,59,65,"The detailed mechanism of how these T cells were recruited to the bladder cancer tumor and their impact on bladder cancer progression, however, remains unclear.",27196763_1,-1,-1,-1,-1,28900,-1,5.9208173e-06,0.9999875,6.643217e-06
28905,T cells than,25,28,146,158,"Using a human clinical bladder cancer sample survey and in vitro coculture system, we found that bladder cancer has a greater capacity to recruit T cells than surrounding normal bladder tissues.",27196763_2,-1,-1,-1,-1,28905,-1,0.0017469068,0.052694123,0.945559
28906,tissues,31,32,186,193,"Using a human clinical bladder cancer sample survey and in vitro coculture system, we found that bladder cancer has a greater capacity to recruit T cells than surrounding normal bladder tissues.",27196763_2,-1,1,2,-1,28906,-1,7.937653e-05,0.99218506,0.0077356417
28911,function through,8,10,62,78,"Mechanism dissection revealed that infiltrating T cells might function through secreting the cytokine IL1, which increases the recruitment of T cells to bladder cancer and enhances the bladder cancer androgen receptor (AR) signaling that results in increased bladder cancer cell invasion via upregulation of hypoxia-inducible factor-1 (HIF1)/VEGFa expression.",27196763_4,-1,-1,-1,-1,28911,-1,0.00022867494,0.9995521,0.00021917859
28912,the cytokine IL1,11,14,89,105,"Mechanism dissection revealed that infiltrating T cells might function through secreting the cytokine IL1, which increases the recruitment of T cells to bladder cancer and enhances the bladder cancer androgen receptor (AR) signaling that results in increased bladder cancer cell invasion via upregulation of hypoxia-inducible factor-1 (HIF1)/VEGFa expression.",27196763_4,-1,-1,-1,-1,28912,-1,0.7821889,0.21159784,0.006213251
28914,T cells to,20,23,142,152,"Mechanism dissection revealed that infiltrating T cells might function through secreting the cytokine IL1, which increases the recruitment of T cells to bladder cancer and enhances the bladder cancer androgen receptor (AR) signaling that results in increased bladder cancer cell invasion via upregulation of hypoxia-inducible factor-1 (HIF1)/VEGFa expression.",27196763_4,-1,-1,-1,-1,28914,-1,0.0011793199,0.028936883,0.96988374
28916,receptor,31,32,209,217,"Mechanism dissection revealed that infiltrating T cells might function through secreting the cytokine IL1, which increases the recruitment of T cells to bladder cancer and enhances the bladder cancer androgen receptor (AR) signaling that results in increased bladder cancer cell invasion via upregulation of hypoxia-inducible factor-1 (HIF1)/VEGFa expression.",27196763_4,0,1,2,-1,28916,-1,0.00014361119,0.9984744,0.0013820117
28919,factor-1,48,49,326,335,"Mechanism dissection revealed that infiltrating T cells might function through secreting the cytokine IL1, which increases the recruitment of T cells to bladder cancer and enhances the bladder cancer androgen receptor (AR) signaling that results in increased bladder cancer cell invasion via upregulation of hypoxia-inducible factor-1 (HIF1)/VEGFa expression.",27196763_4,0,1,-1,-1,28919,-1,0.0014157434,0.9983687,0.0002156258
28924,T24 cells,10,12,60,69,"Finally, in vivo mouse models of xenografted bladder cancer T24 cells with CD4(+) T cells confirmed in vitro coculture studies and concluded that infiltrating CD4(+) T cells can promote bladder cancer metastasis via modulation of the IL1ARHIF1VEGFa signaling.",27196763_6,-1,-1,-1,-1,28924,-1,0.0001684887,0.0045451066,0.9952864
28930,to target this,6,9,45,59,Future clinical trials using small molecules to target this newly identified signaling pathway may facilitate the development of new therapeutic approaches to better suppress bladder cancer metastasis.,27196763_7,-1,-1,-1,-1,28930,-1,5.0410013e-06,0.9999912,3.8062583e-06
28941,cytokine IL-15,6,8,58,72,"Among immunotherapeutic strategies, the immunostimulatory cytokine IL-15 could represent a serious candidate for the reactivation of antitumor immunity.",27217584_1,-1,-1,-1,-1,28941,-1,0.99995613,6.32804e-06,3.755597e-05
28943,immunity,18,19,143,151,"Among immunotherapeutic strategies, the immunostimulatory cytokine IL-15 could represent a serious candidate for the reactivation of antitumor immunity.",27217584_1,0,-1,2,-1,28943,-1,0.99983144,3.8483755e-05,0.0001300076
28949,the IL-15,10,12,51,60,"In this work, we studied the antitumor activity of the IL-15 superagonist receptor-linker-IL-15 (RLI), designed to bypass the need of endogenous IL-15R.",27217584_3,-1,-1,-1,-1,28949,-1,0.85328144,0.1437195,0.0029991097
28950,receptor-linker-IL-15,13,14,74,95,"In this work, we studied the antitumor activity of the IL-15 superagonist receptor-linker-IL-15 (RLI), designed to bypass the need of endogenous IL-15R.",27217584_3,0,1,2,-1,28950,-1,0.9878705,0.0067075286,0.0054218946
28955,to the,7,9,46,52,RLI consists of human IL-15 covalently linked to the human IL-15R sushi(+) domain.,27217584_4,-1,-1,-1,-1,28955,-1,6.1790884e-06,0.9999887,5.178038e-06
28973,function,16,17,89,97,RLI could induce a greater accumulation of memory CD8(+) T cells and a stronger effector function in comparison with IL-15.,27217584_8,0,1,2,-1,28973,-1,0.0131774675,0.13896793,0.8478546
28975,tumor-infiltrated lymphocytes,4,6,23,52,"Ex vivo stimulation of tumor-infiltrated lymphocytes from 16 patients with renal cell carcinoma demonstrated 56% of a strong tumor-infiltrated lymphocyte reactivation with the combination anti-PD-1/RLI compared with 43 and 6% with RLI or anti-PD-1, respectively.",27217584_9,-1,-1,-1,-1,28975,-1,0.0023762516,0.8705315,0.12709227
28977,tumor-infiltrated lymphocyte,19,21,125,153,"Ex vivo stimulation of tumor-infiltrated lymphocytes from 16 patients with renal cell carcinoma demonstrated 56% of a strong tumor-infiltrated lymphocyte reactivation with the combination anti-PD-1/RLI compared with 43 and 6% with RLI or anti-PD-1, respectively.",27217584_9,-1,-1,-1,-1,28977,-1,0.0024634223,0.80951655,0.18802
28980,that the,6,8,40,48,"Altogether, this work provides evidence that the sushi-IL-15R/IL-15 fusion protein RLI enhances antitumor activity of anti-PD-1 treatment and is a promising approach to stimulate host immunity.",27217584_10,-1,-1,-1,-1,28980,-1,3.913013e-06,0.9999919,4.194016e-06
28981,protein,10,11,76,83,"Altogether, this work provides evidence that the sushi-IL-15R/IL-15 fusion protein RLI enhances antitumor activity of anti-PD-1 treatment and is a promising approach to stimulate host immunity.",27217584_10,0,1,-1,-1,28981,-1,2.526332e-05,0.99995494,1.9748313e-05
28984,immunity,26,27,185,193,"Altogether, this work provides evidence that the sushi-IL-15R/IL-15 fusion protein RLI enhances antitumor activity of anti-PD-1 treatment and is a promising approach to stimulate host immunity.",27217584_10,0,-1,2,-1,28984,-1,0.99989176,3.7075497e-05,7.110934e-05
28985,T-cell,1,2,6,12,Adult T-cell leukemia/lymphoma (ATL) develops in human T-cell leukemia virus type 1 (HTLV-1) carriers.,27223899_0,-1,1,2,-1,28985,-1,1.4192107e-05,1.2380797e-05,0.9999734
28986,T-cell,9,10,55,61,Adult T-cell leukemia/lymphoma (ATL) develops in human T-cell leukemia virus type 1 (HTLV-1) carriers.,27223899_0,-1,1,2,-1,28986,-1,1.4409281e-05,1.2024373e-05,0.99997354
28997,T cells that,22,25,117,129,"Here, we present a new mouse model of acute type ATL that can be generated rapidly by transplanting invitro-induced T cells that have been retrovirally transduced with HBZ and two cooperative genes, BCLxL and AKT, into mice.",27223899_3,-1,-1,-1,-1,28997,-1,0.0017301304,0.046796005,0.95147383
29001,these T cells to,6,10,45,61,"Co-transduction of HBZ and BCLxL/AKT allowed these T cells to grow invitro in the absence of cytokines (Flt3-ligand and interleukin-7), which did not occur with any two-gene combination.",27223899_4,-1,-1,-1,-1,29001,-1,9.852026e-05,0.99902296,0.00087853294
29006,transplanted T cells,1,4,9,29,"Although transplanted T cells were a mixture of cells transduced with different combinations of the genes, tumors that developed in mice were composed of HBZ/BCLxL/AKT triply transduced T cells, showing the synergistic effect of the three genes.",27223899_5,-1,-1,-1,-1,29006,-1,0.001857274,0.17629296,0.82184976
29007,cells transduced,8,10,48,64,"Although transplanted T cells were a mixture of cells transduced with different combinations of the genes, tumors that developed in mice were composed of HBZ/BCLxL/AKT triply transduced T cells, showing the synergistic effect of the three genes.",27223899_5,-1,-1,-1,-1,29007,-1,0.004132565,0.27343002,0.7224375
29008,the genes,14,16,96,105,"Although transplanted T cells were a mixture of cells transduced with different combinations of the genes, tumors that developed in mice were composed of HBZ/BCLxL/AKT triply transduced T cells, showing the synergistic effect of the three genes.",27223899_5,-1,-1,-1,-1,29008,-1,5.7929315e-06,0.9999877,6.449885e-06
29009,tumors that,17,19,107,118,"Although transplanted T cells were a mixture of cells transduced with different combinations of the genes, tumors that developed in mice were composed of HBZ/BCLxL/AKT triply transduced T cells, showing the synergistic effect of the three genes.",27223899_5,-1,-1,-1,-1,29009,-1,3.9254383e-06,0.99999225,3.822625e-06
29010,triply transduced T cells,26,30,168,193,"Although transplanted T cells were a mixture of cells transduced with different combinations of the genes, tumors that developed in mice were composed of HBZ/BCLxL/AKT triply transduced T cells, showing the synergistic effect of the three genes.",27223899_5,-1,-1,-1,-1,29010,-1,0.0024139294,0.6959855,0.3016006
29012,the three genes,36,39,229,244,"Although transplanted T cells were a mixture of cells transduced with different combinations of the genes, tumors that developed in mice were composed of HBZ/BCLxL/AKT triply transduced T cells, showing the synergistic effect of the three genes.",27223899_5,-1,-1,-1,-1,29012,-1,7.048945e-06,0.99998677,6.1323185e-06
29016,tool to,5,7,31,38,"Our model provides a versatile tool to examine the roles of these hits, in collaboration with HBZ, in the development of acute ATL.",27223899_7,-1,-1,-1,-1,29016,-1,5.561843e-06,0.9999901,4.358219e-06
29024,T cells that,13,16,68,80,Invariant natural killer T (iNKT) cells are a subset of innate-like T cells that act as important mediators of immune responses.,27226296_0,-1,-1,-1,-1,29024,-1,0.0014180052,0.0499026,0.9486793
29036,that basic helix-loop-helix transcription factor,4,9,16,64,"Here, we report that basic helix-loop-helix transcription factor family, member e40 (Bhlhe40), is an important regulator for IFN- production in iNKT cells.",27226296_3,-1,-1,-1,-1,29036,-1,7.128189e-06,0.99998426,8.624624e-06
29051,T-box transcription factor Tbx21,14,18,98,130,Bhlhe40 alone shows no significant effects on Ifng promoter activities but contributes to enhance T-box transcription factor Tbx21 (T-bet)-mediated Ifng promoter activation.,27226296_6,-1,1,2,-1,29051,-1,1.2117081e-05,0.9999778,1.0062346e-05
29053,analysis,2,3,30,38,"Chromatin immunoprecipitation analysis revealed that Bhlhe40 accumulates in the T-box region of the Ifng locus and contributes to histone H3-lysine 9 acetylation of the Ifng locus, which is impaired without T-bet conditions.",27226296_7,0,1,-1,-1,29053,-1,1.0227949e-05,0.9999833,6.4752917e-06
29055,the T-box,8,10,76,85,"Chromatin immunoprecipitation analysis revealed that Bhlhe40 accumulates in the T-box region of the Ifng locus and contributes to histone H3-lysine 9 acetylation of the Ifng locus, which is impaired without T-bet conditions.",27226296_7,-1,-1,-1,-1,29055,-1,1.07395335e-05,0.99997807,1.1163217e-05
29056,the Ifng,12,14,96,104,"Chromatin immunoprecipitation analysis revealed that Bhlhe40 accumulates in the T-box region of the Ifng locus and contributes to histone H3-lysine 9 acetylation of the Ifng locus, which is impaired without T-bet conditions.",27226296_7,-1,-1,-1,-1,29056,-1,0.7037653,0.29002967,0.0062050433
29058,the Ifng,23,25,165,173,"Chromatin immunoprecipitation analysis revealed that Bhlhe40 accumulates in the T-box region of the Ifng locus and contributes to histone H3-lysine 9 acetylation of the Ifng locus, which is impaired without T-bet conditions.",27226296_7,-1,-1,-1,-1,29058,-1,0.6953608,0.29836628,0.0062729735
29065,T cells play,1,4,3,15, T cells play a critical role in early anti-tumor immunity and perform cytotoxicity via NKG2D for recognition and multiple cytotoxic factors for tumor killing.,27256566_0,-1,-1,-1,-1,29065,-1,0.00079902605,0.021022834,0.9781782
29066,immunity,10,11,52,60, T cells play a critical role in early anti-tumor immunity and perform cytotoxicity via NKG2D for recognition and multiple cytotoxic factors for tumor killing.,27256566_0,0,-1,2,-1,29066,-1,0.9994899,0.00011087722,0.00039915534
29067,factors,21,22,135,142, T cells play a critical role in early anti-tumor immunity and perform cytotoxicity via NKG2D for recognition and multiple cytotoxic factors for tumor killing.,27256566_0,0,1,-1,-1,29067,-1,0.0046531097,0.9951762,0.00017062621
29069,metabolism,8,9,64,74,"Recent studies have demonstrated pivotal roles of mTOR-mediated metabolism in the maturation, differentiation, and effector function of diverse immune cells, including DCs, NK cells, CD4+ T cell subsets, and CD8+ T cells, but the role of mTOR signaling in  T cells is barely known.",27256566_1,0,1,2,-1,29069,-1,1.814233e-05,0.9999678,1.3999291e-05
29071,function,17,18,124,132,"Recent studies have demonstrated pivotal roles of mTOR-mediated metabolism in the maturation, differentiation, and effector function of diverse immune cells, including DCs, NK cells, CD4+ T cell subsets, and CD8+ T cells, but the role of mTOR signaling in  T cells is barely known.",27256566_1,0,1,2,-1,29071,-1,0.0014525309,0.98537076,0.0131767355
29074,CD4+ T cell subsets,29,34,183,202,"Recent studies have demonstrated pivotal roles of mTOR-mediated metabolism in the maturation, differentiation, and effector function of diverse immune cells, including DCs, NK cells, CD4+ T cell subsets, and CD8+ T cells, but the role of mTOR signaling in  T cells is barely known.",27256566_1,-1,-1,-1,-1,29074,-1,1.639697e-05,4.965152e-06,0.99997854
29082,tumor cell,25,27,169,179,"Here, we showed that suppressing mTOR signaling in in vitro-expanded V4  T cells via the mechanistic inhibitor rapamycin enhanced their cytotoxicity against multiple tumor cell lines, and these cells performed better tumor-suppressing effects upon adoptive therapy.",27256566_2,-1,-1,-1,-1,29082,-1,0.0007698538,0.04609961,0.9531305
29083,these cells,30,32,191,202,"Here, we showed that suppressing mTOR signaling in in vitro-expanded V4  T cells via the mechanistic inhibitor rapamycin enhanced their cytotoxicity against multiple tumor cell lines, and these cells performed better tumor-suppressing effects upon adoptive therapy.",27256566_2,-1,-1,-1,-1,29083,-1,1.7089134e-05,1.4230152e-05,0.99996877
29085,therapy,38,39,260,267,"Here, we showed that suppressing mTOR signaling in in vitro-expanded V4  T cells via the mechanistic inhibitor rapamycin enhanced their cytotoxicity against multiple tumor cell lines, and these cells performed better tumor-suppressing effects upon adoptive therapy.",27256566_2,0,1,-1,-1,29085,-1,4.065211e-06,0.99999154,4.400499e-06
29087,TNF-,14,15,101,106,Further investigation revealed that elevated cytotoxicity was a result of up-regulation of NKG2D and TNF-.,27256566_3,0,1,-1,-1,29087,-1,0.00036282404,0.9995896,4.754763e-05
29093,TNF-,18,19,122,127,The inhibition of STAT5 pathways via siRNA interference or a specific inhibitor eliminated the up-regulation of NKG2D and TNF- in rapamycin-treated V4  T cells.,27256566_5,0,1,-1,-1,29093,-1,2.8060249e-05,0.9999597,1.2220365e-05
29097,function,13,14,86,94,These results uncovered an important role of mTOR signaling in the cytotoxic effector function of  T cells and provided a potential strategy to improve  T cell-based cancer immunotherapy.,27256566_6,0,1,2,-1,29097,-1,0.0044357707,0.16083443,0.8347298
29103,Toll-like receptor-myeloid differentiation factor,5,9,29,78,The activation of TLR-MyD88 (Toll-like receptor-myeloid differentiation factor 88) signaling within T cells functions as a potent costimulatory signal that boosts antitumor and antiviral responses.,27267778_0,-1,-1,-1,-1,29103,-1,0.8399015,0.13969238,0.020406038
29104,T cells functions,13,16,100,117,The activation of TLR-MyD88 (Toll-like receptor-myeloid differentiation factor 88) signaling within T cells functions as a potent costimulatory signal that boosts antitumor and antiviral responses.,27267778_0,-1,-1,-1,-1,29104,-1,0.0015250555,0.017657723,0.9808172
29108,gene analysis,3,5,23,36,"We compared microarray gene analysis data between TLR1-TLR2-stimulated and unstimulated T-cell receptor transgenic ""pmel"" and MyD88(-/-) pmel CD8(+) T cells and identified changes in the expression of several TNF family members.",27267778_2,-1,-1,-1,-1,29108,-1,8.974756e-06,0.99998367,7.412246e-06
29110,T-cell receptor transgenic,10,13,88,114,"We compared microarray gene analysis data between TLR1-TLR2-stimulated and unstimulated T-cell receptor transgenic ""pmel"" and MyD88(-/-) pmel CD8(+) T cells and identified changes in the expression of several TNF family members.",27267778_2,-1,-1,-1,-1,29110,-1,0.0013798884,0.02444595,0.9741742
29113,TNF,32,33,209,212,"We compared microarray gene analysis data between TLR1-TLR2-stimulated and unstimulated T-cell receptor transgenic ""pmel"" and MyD88(-/-) pmel CD8(+) T cells and identified changes in the expression of several TNF family members.",27267778_2,0,1,-1,-1,29113,-1,0.0022987665,0.9975793,0.000122030855
29119,T cells to TLR1-TLR2,25,29,121,141,"A link between 4-1BB and TLR1-TLR2 signaling in CD8(+) T cells was highlighted by the suboptimal responses of 4-1BB(-/-) T cells to TLR1-TLR2 agonist, but their normal response to CD28 or OX40 costimulation.",27267778_4,-1,-1,-1,-1,29119,-1,0.010043885,0.73653543,0.25342077
29121,to CD28,35,37,177,184,"A link between 4-1BB and TLR1-TLR2 signaling in CD8(+) T cells was highlighted by the suboptimal responses of 4-1BB(-/-) T cells to TLR1-TLR2 agonist, but their normal response to CD28 or OX40 costimulation.",27267778_4,-1,-1,-1,-1,29121,-1,0.015214317,0.63456863,0.35021707
29123,the TLR1-TLR2,13,15,84,97,Blocking 4-1BB signaling with antibodies also hindered the costimulatory effects of the TLR1-TLR2 agonist.,27267778_5,-1,-1,-1,-1,29123,-1,7.2026334e-05,0.99990475,2.3272181e-05
29126,TLR1-TLR2-stimulated cells,9,11,44,70,"The elevated levels of 4-1BB transcripts in TLR1-TLR2-stimulated cells were not due to increased mRNA stability nor increased histone activation, but instead were associated with increased binding of p65 and c-Jun to two distinct 4-1BB promoter sites.",27267778_6,-1,-1,-1,-1,29126,-1,0.0009731954,0.9348153,0.06421148
29128,to two,34,36,214,220,"The elevated levels of 4-1BB transcripts in TLR1-TLR2-stimulated cells were not due to increased mRNA stability nor increased histone activation, but instead were associated with increased binding of p65 and c-Jun to two distinct 4-1BB promoter sites.",27267778_6,-1,-1,-1,-1,29128,-1,5.8346545e-06,0.99998987,4.285661e-06
29134,that the,3,5,21,29,These studies reveal that the costimulatory effects of TLR1-TLR2 signaling in CD8(+) T cells are in part mediated by 4-1BB and are important for mounting an effective antitumor immune response.,27267778_8,-1,-1,-1,-1,29134,-1,3.933008e-06,0.99999225,3.834594e-06
29140,T-cell,9,10,45,51,"BACKGROUND: Regulatory T-cells (Tregs) are a T-cell subpopulation with suppressive capacities, which are specifically attracted by C-C motif chemokine 22 (CCL22).",27272839_0,-1,1,2,-1,29140,-1,9.978044e-06,9.184327e-06,0.9999808
29149,the Treg-specific transcription factor forkhead,16,21,107,154,MATERIALS AND METHODS: Eighty paraffin-embedded human breast cancer samples were stained for CCL22 and for the Treg-specific transcription factor forkhead box P3 (FOXP3).,27272839_3,-1,-1,-1,-1,29149,-1,6.3658144e-06,0.9999883,5.3000263e-06
29156,the tertiary,7,9,34,46,"Moreover, Treg infiltrated 93% of the tertiary lymphoid structures.",27272839_6,-1,-1,-1,-1,29156,-1,6.716106e-05,0.9997794,0.00015344347
29160,the tertiary,10,12,76,88,CCL22 expression positively correlated with FOXP3(+) cell infiltration into the tertiary lymphoid structures.,27272839_7,-1,-1,-1,-1,29160,-1,4.2457254e-05,0.9998808,7.672056e-05
29161,that CCL22,5,7,36,46,CONCLUSION: Our results demonstrate that CCL22 expression correlates with infiltration by FOXP3(+) cells.,27272839_8,-1,-1,-1,-1,29161,-1,0.87859684,0.11888373,0.002519439
29165,nodal status,8,10,65,77,"Interestingly, Treg presence negatively correlated with positive nodal status.",27272839_9,-1,-1,-1,-1,29165,-1,0.98437345,0.004744274,0.010882188
29166,to their,2,4,12,20,"In addition to their unfavorable role as mediators of evasion from antitumor immune response, Tregs might also have a beneficial role by reducing inflammation thereby limiting early tumor growth and spreading.",27272839_10,-1,-1,-1,-1,29166,-1,6.1072465e-06,0.9999888,5.056985e-06
29170,thereby limiting,25,27,159,175,"In addition to their unfavorable role as mediators of evasion from antitumor immune response, Tregs might also have a beneficial role by reducing inflammation thereby limiting early tumor growth and spreading.",27272839_10,-1,-1,-1,-1,29170,-1,0.01820255,0.9810414,0.00075614726
29172,Gfi1 plays,0,2,0,10,Gfi1 plays an important role in the development and maintenance of many hematopoietic linage cells.,27284976_0,-1,-1,-1,-1,29172,-1,0.0001654755,0.9997527,8.186064e-05
29181,cell subsets,14,16,84,96,We herein demonstrate a critical role of Gfi1 in regulating the development of iNKT cell subsets.,27284976_2,-1,-1,-1,-1,29181,-1,1.2860515e-05,1.002591e-05,0.9999771
29182,the thymus,1,3,3,13,"In the thymus of T cell-specific Gfi1-deficient mice, iNKT cells normally developed up to stage 2, while the number of stage 3 NK1.1pos iNKT cells was significantly reduced.",27284976_3,-1,-1,-1,-1,29182,-1,7.0848064e-06,0.9999869,6.013629e-06
29183,T cell-specific Gfi1-deficient,4,7,17,47,"In the thymus of T cell-specific Gfi1-deficient mice, iNKT cells normally developed up to stage 2, while the number of stage 3 NK1.1pos iNKT cells was significantly reduced.",27284976_3,-1,-1,-1,-1,29183,-1,0.004439035,0.025866332,0.9696946
29190,T cell-specific Gfi1-deficient,13,16,84,114,"Furthermore, CD4pos iNKT cells were selectively reduced in the peripheral organs of T cell-specific Gfi1-deficient mice.",27284976_4,-1,-1,-1,-1,29190,-1,0.0038180943,0.0120048225,0.9841771
29192,IFN-and Th2 cytokines,4,7,37,59,"The -GalCer-dependent production of IFN-and Th2 cytokines, but not IL-17A, was severely reduced in T cell-specific Gfi1-deficient mice.",27284976_5,-1,-1,-1,-1,29192,-1,0.99987423,2.2975204e-05,0.00010276446
29194,T cell-specific Gfi1-deficient,16,19,101,131,"The -GalCer-dependent production of IFN-and Th2 cytokines, but not IL-17A, was severely reduced in T cell-specific Gfi1-deficient mice.",27284976_5,-1,-1,-1,-1,29194,-1,0.0017571388,0.020378755,0.9778641
29201,function,13,14,88,96,These findings demonstrate the important role of Gfi1 in regulating the development and function of NKT1- and NKT2-type iNKT cell subsets.,27284976_7,0,1,2,-1,29201,-1,1.7092565e-05,0.9999635,1.9328907e-05
29202,cell subsets,19,21,125,137,These findings demonstrate the important role of Gfi1 in regulating the development and function of NKT1- and NKT2-type iNKT cell subsets.,27284976_7,-1,-1,-1,-1,29202,-1,1.2438106e-05,8.782637e-06,0.9999788
29210,plasma IL18,3,5,16,27,"RESULTS: Higher plasma IL18 was associated with longer overall survival (OS), but higher IL18 in pancreatic cancer tissues was associated with shorter OS and increased invasion and metastasis.",27297583_3,-1,-1,-1,-1,29210,-1,0.9418217,0.05565142,0.0025269617
29212,tissues,21,22,115,122,"RESULTS: Higher plasma IL18 was associated with longer overall survival (OS), but higher IL18 in pancreatic cancer tissues was associated with shorter OS and increased invasion and metastasis.",27297583_3,-1,1,2,-1,29212,-1,0.0007495971,0.021358352,0.9778921
29215,transplanted tumors,13,15,89,108,Recombinant IL18 alone had no antitumor effect in the syngeneic mice with orthotopically transplanted tumors and promoted tumors in immunocompromised mice; it also facilitated immune responses in vitro and in vivo by augmenting the activity of cytotoxic T cells and NK cells in peripheral blood and lymph nodes.,27297583_4,-1,-1,-1,-1,29215,-1,4.549917e-06,0.99999046,4.9492132e-06
29221,blood,45,46,289,294,Recombinant IL18 alone had no antitumor effect in the syngeneic mice with orthotopically transplanted tumors and promoted tumors in immunocompromised mice; it also facilitated immune responses in vitro and in vivo by augmenting the activity of cytotoxic T cells and NK cells in peripheral blood and lymph nodes.,27297583_4,0,1,-1,-1,29221,-1,0.005412035,0.8771333,0.11745463
29225,through the,19,21,104,115,"However, IL18 promoted the proliferation and invasion of pancreatic cancer cells, in vitro and in vivo, through the NF-B pathway.",27297583_5,-1,-1,-1,-1,29225,-1,4.970765e-06,0.9999907,4.3102823e-06
29234,functions,8,9,67,76,CONCLUSIONS: IL18 has both cancer-promoting and cancer-suppressing functions.,27297583_7,0,1,2,-1,29234,-1,1.9051868e-05,0.99996173,1.9217836e-05
29246,functionality,28,29,175,188,"Despite of the potential implications for cancer immunotherapy, conventional approaches using in vitro expanded CD8(+) T cells have suboptimal outcomes, mostly due to loss of functionality from cellular exhaustion.",27306834_0,0,1,2,-1,29246,-1,7.5587974e-05,0.99986076,6.363701e-05
29250,functional,6,7,45,55,"We therefore investigated the phenotypic and functional differences among in vitro activated CD8(+) T cells of three different sources, namely nave (NTeff), memory (MTeff) and tumor-infiltrating lymphocytes (TILeff) from human and mice, to better understand mechanisms behind potent effector functions and potential for overcoming current limitations.",27306834_1,0,1,2,-1,29250,-1,0.0019669125,0.9975707,0.00046234217
29254,tumor-infiltrating lymphocytes,32,34,177,207,"We therefore investigated the phenotypic and functional differences among in vitro activated CD8(+) T cells of three different sources, namely nave (NTeff), memory (MTeff) and tumor-infiltrating lymphocytes (TILeff) from human and mice, to better understand mechanisms behind potent effector functions and potential for overcoming current limitations.",27306834_1,-1,-1,-1,-1,29254,-1,0.0025331303,0.9108714,0.08659553
29257,functions,49,50,293,302,"We therefore investigated the phenotypic and functional differences among in vitro activated CD8(+) T cells of three different sources, namely nave (NTeff), memory (MTeff) and tumor-infiltrating lymphocytes (TILeff) from human and mice, to better understand mechanisms behind potent effector functions and potential for overcoming current limitations.",27306834_1,0,1,2,-1,29257,-1,0.0077943243,0.95821106,0.033994593
29262,than those,28,30,186,196,"In line with the greater proliferation activity and longer telomere lengths of NTeff populations, cells of nave origin exhibited significantly less amounts of T cell exhaustion markers than those of MTeff and TILeff, and moreover, acquired distinct expression patterns of memory-promoting transcription factors, T-bet and Eomes, induced in a rapid and sustainable manner.",27306834_2,-1,-1,-1,-1,29262,-1,6.6535194e-06,0.99998736,5.979046e-06
29271,to tumor-induced,24,26,163,179,"NTeff cells appeared to have lower expression of Foxp1 and were refractory to apoptosis upon TGF- conditioning, implying better survival potential and resistance to tumor-induced immune suppression.",27306834_3,-1,-1,-1,-1,29271,-1,6.580375e-06,0.99998724,6.143923e-06
29273,to tumor-specific CTLs,7,10,33,55,"Of CD8(+) T cell pools activated to tumor-specific CTLs, nave cell generated effectors possessed the most potent cytotoxic activity, validating implications for use in rational design of adoptive immunotherapy.",27306834_4,-1,-1,-1,-1,29273,-1,0.0032935364,0.77140456,0.22530195
29274,cell generated,12,14,63,77,"Of CD8(+) T cell pools activated to tumor-specific CTLs, nave cell generated effectors possessed the most potent cytotoxic activity, validating implications for use in rational design of adoptive immunotherapy.",27306834_4,-1,-1,-1,-1,29274,-1,0.0008686286,0.0030323223,0.996099
29278,functional subsets,14,16,88,106,Distinct metabolic programs support the differentiation of CD4(+) Tcells into separate functional subsets.,27317260_0,-1,-1,-1,-1,29278,-1,0.0006720622,0.0018710905,0.99745685
29286,Th9 cell,8,10,61,69,We found that histone deacetylase SIRT1 negatively regulated Th9 cell differentiation.,27317260_2,-1,-1,-1,-1,29286,-1,4.723131e-05,0.00031179746,0.99964106
29287,deficiency,1,2,2,12,"A deficiency of SIRT1 induced by either conditional deletion in mouse CD4(+) Tcells or the use of small interfering RNA (siRNA) in mouse or human Tcells increased IL-9 production, whereas ectopic SIRT1 expression inhibited it.",27317260_3,0,1,-1,-1,29287,-1,2.595201e-05,0.9999597,1.4316979e-05
29292,Th9 cell,4,6,25,33,"Notably, SIRT1 inhibited Th9 cell differentiation that regulated anti-tumor immunity and allergic pulmonary inflammation.",27317260_4,-1,-1,-1,-1,29292,-1,1.5708376e-05,2.323989e-05,0.999961
29294,immunity,10,11,76,84,"Notably, SIRT1 inhibited Th9 cell differentiation that regulated anti-tumor immunity and allergic pulmonary inflammation.",27317260_4,0,-1,2,-1,29294,-1,0.99967,0.00010969408,0.00022030619
29295,through the,2,4,22,33,Glycolytic activation through the mTOR-hypoxia-inducible factor-1 (HIF1) was required for the differentiation of Th9 cells that conferred protection against tumors and is involved in allergic airway inflammation.,27317260_5,-1,-1,-1,-1,29295,-1,4.3854957e-06,0.9999913,4.263458e-06
29296,factor-1,5,6,57,66,Glycolytic activation through the mTOR-hypoxia-inducible factor-1 (HIF1) was required for the differentiation of Th9 cells that conferred protection against tumors and is involved in allergic airway inflammation.,27317260_5,0,1,-1,-1,29296,-1,8.029595e-05,0.99987984,3.98981e-05
29299,Th9 cells that,15,18,115,129,Glycolytic activation through the mTOR-hypoxia-inducible factor-1 (HIF1) was required for the differentiation of Th9 cells that conferred protection against tumors and is involved in allergic airway inflammation.,27317260_5,-1,-1,-1,-1,29299,-1,0.00025890867,0.9762799,0.023461204
29302,Th9 cell,13,15,111,119,"Our results define the essential features of SIRT1-mTOR-HIF1 signaling-coupled glycolytic pathway in inducing Th9 cell differentiation, with implications for metabolic reprogramming as an immunotherapeutic approach.",27317260_6,-1,-1,-1,-1,29302,-1,1.9797486e-05,4.456321e-05,0.9999356
29304,antigen-specific T cells,10,13,69,93,MHC-multimers are reagents used for the detection and enumeration of antigen-specific T cells (ASTs).,27327144_0,-1,-1,-1,-1,29304,-1,0.67925245,0.00049093977,0.32025662
29308,TCR,11,12,64,67,These reagents exploit the mechanism by which T cell receptors (TCR) on cytotoxic CD8 T cells recognize specific antigens in the context of a major histocompatibility complex (MHC) molecule during antigen presentation.,27327144_1,-1,1,2,-1,29308,-1,1.8891971e-05,0.99992406,5.7033747e-05
29315,peptide,12,13,94,101,MHC-multimers are fluorescently-labeled dextran polymers that carry MHC Class I molecules and peptide sequences that can be modified to represent specific cognate sequences of the antigen of interest with dextramers having a 10-fold multiplicity of the MHC/peptide combination within a single multimer.,27327144_2,0,-1,2,-1,29315,-1,0.00028386735,0.99963975,7.635175e-05
29318,the antigen,24,26,176,187,MHC-multimers are fluorescently-labeled dextran polymers that carry MHC Class I molecules and peptide sequences that can be modified to represent specific cognate sequences of the antigen of interest with dextramers having a 10-fold multiplicity of the MHC/peptide combination within a single multimer.,27327144_2,-1,-1,-1,-1,29318,-1,0.8099602,0.18536024,0.004679516
29323,to the TCR,9,12,77,87,"Since the binding of antigen-specific dextramers mimics antigen presentation to the TCR, the present study sought to determine whether this TCR engagement on the AST was sufficient to elicit a functional T cell response.",27327144_3,-1,-1,-1,-1,29323,-1,1.9110112e-05,0.99995863,2.2287357e-05
29326,this TCR,20,22,135,143,"Since the binding of antigen-specific dextramers mimics antigen presentation to the TCR, the present study sought to determine whether this TCR engagement on the AST was sufficient to elicit a functional T cell response.",27327144_3,-1,-1,-1,-1,29326,-1,1.3987575e-05,0.999966,1.9948877e-05
29329,functional T cell,31,34,193,210,"Since the binding of antigen-specific dextramers mimics antigen presentation to the TCR, the present study sought to determine whether this TCR engagement on the AST was sufficient to elicit a functional T cell response.",27327144_3,-1,-1,-1,-1,29329,-1,0.00598855,0.023088293,0.9709231
29334,blood,21,22,134,139,The effect of binding of CMV specific dextramers on the activation of the NFAT signal transduction cascade was assessed in peripheral blood from bone marrow transplant recipients previously determined to be positive for CMV-ASTs (CASTs).,27327144_4,0,1,-1,-1,29334,-1,0.003022634,0.9738019,0.02317544
29343,functional,7,8,50,60,The NFAT1 activation correlated with a downstream functional response in the form of interferon gamma production.,27327144_7,0,1,2,-1,29343,-1,0.0005488683,0.99935,0.000101139034
29348,blood,23,24,168,173,"Sample preparation, temperature, and duration of dextramer exposure were important parameters affecting the dextramer-induced NFAT activation with 2h exposure in whole blood at room temperature being the optimal of the conditions tested.",27327144_8,0,1,-1,-1,29348,-1,0.0015708187,0.984248,0.014181127
29353,to the,8,10,68,74,Intra- and inter-individual heterogeneity was observed with regards to the NFAT activation in the CASTs.,27327144_9,-1,-1,-1,-1,29353,-1,5.7047173e-06,0.9999893,5.0304457e-06
29367,that the,19,21,123,131,"Thus, the data demonstrate that binding of antigen-specific dextramers to ASTs specifically results in activation of NFAT, that the NFAT activation correlates with a downstream functional response and that the response can be heterogeneous.",27327144_12,-1,-1,-1,-1,29367,-1,4.8798543e-06,0.9999906,4.5250913e-06
29368,functional,27,28,177,187,"Thus, the data demonstrate that binding of antigen-specific dextramers to ASTs specifically results in activation of NFAT, that the NFAT activation correlates with a downstream functional response and that the response can be heterogeneous.",27327144_12,0,1,2,-1,29368,-1,0.00027638444,0.9996599,6.3698535e-05
29369,that the,30,32,201,209,"Thus, the data demonstrate that binding of antigen-specific dextramers to ASTs specifically results in activation of NFAT, that the NFAT activation correlates with a downstream functional response and that the response can be heterogeneous.",27327144_12,-1,-1,-1,-1,29369,-1,5.50476e-06,0.9999907,3.761898e-06
29370,This functional,0,2,0,15,This functional parameter may provide insight to the issue whether enumeration alone of ASTs is a sufficient parameter to assess an individual's immune status against a specific antigen.,27327144_13,-1,-1,-1,-1,29370,-1,0.00011127862,0.99986386,2.4826515e-05
29371,to the,6,8,46,52,This functional parameter may provide insight to the issue whether enumeration alone of ASTs is a sufficient parameter to assess an individual's immune status against a specific antigen.,27327144_13,-1,-1,-1,-1,29371,-1,7.433226e-06,0.99998724,5.3309327e-06
29387,The forkhead,0,2,0,12,The forkhead lineage-transcription factor (FoxP3) was considered for many years to be a highly specific intracellular regulatory marker of CD4+CD25+ T regulatory cells.,27339600_3,-1,-1,-1,-1,29387,-1,6.492721e-06,0.9999887,4.880724e-06
29388,factor,3,4,35,41,The forkhead lineage-transcription factor (FoxP3) was considered for many years to be a highly specific intracellular regulatory marker of CD4+CD25+ T regulatory cells.,27339600_3,0,1,-1,-1,29388,-1,6.3358807e-06,0.9999889,4.783052e-06
29407,that FoxP3,8,10,37,47,"In addition, most studies' report on that FoxP3 expression in all abovementioned cells is related to their status of activation since nave (non-activated cells) were found poorly FoxP3 expressing.",27339600_7,-1,-1,-1,-1,29407,-1,5.711748e-06,0.99998975,4.5011784e-06
29409,related to their status,16,20,90,113,"In addition, most studies' report on that FoxP3 expression in all abovementioned cells is related to their status of activation since nave (non-activated cells) were found poorly FoxP3 expressing.",27339600_7,-1,-1,-1,-1,29409,-1,1.6702947e-05,0.9999697,1.3544556e-05
29410,nave,23,24,134,139,"In addition, most studies' report on that FoxP3 expression in all abovementioned cells is related to their status of activation since nave (non-activated cells) were found poorly FoxP3 expressing.",27339600_7,-1,-1,-1,-1,29410,-1,9.153603e-06,0.99998593,4.932887e-06
29424,immunity,17,18,100,108,"BACKGROUND: Regulatory T cells (Tregs), particularly the CD4(+)CD25(+)Foxp3(+) Tregs, down regulate immunity and promote tumor cell growth by directly suppressing CD8(+) and CD4(+) T cells.",27389040_0,0,-1,2,-1,29424,-1,0.97153383,0.026942074,0.001524046
29425,tumor cell,20,22,121,131,"BACKGROUND: Regulatory T cells (Tregs), particularly the CD4(+)CD25(+)Foxp3(+) Tregs, down regulate immunity and promote tumor cell growth by directly suppressing CD8(+) and CD4(+) T cells.",27389040_0,-1,-1,-1,-1,29425,-1,2.6831965e-05,4.90802e-05,0.99992406
29429,generating interleukin-10,7,9,47,72,"Alternatively they can promote tumor growth by generating interleukin-10 (IL-10) and transforming growth factor  (TGF) in situ, which help tumor cells to evade the immune system.",27389040_1,-1,-1,-1,-1,29429,-1,0.9768003,0.022099657,0.0011000411
29431,transforming growth factor,13,16,85,111,"Alternatively they can promote tumor growth by generating interleukin-10 (IL-10) and transforming growth factor  (TGF) in situ, which help tumor cells to evade the immune system.",27389040_1,-1,-1,-1,-1,29431,-1,0.9625931,0.032389946,0.0050170086
29433,tumor cells to,25,28,141,155,"Alternatively they can promote tumor growth by generating interleukin-10 (IL-10) and transforming growth factor  (TGF) in situ, which help tumor cells to evade the immune system.",27389040_1,-1,-1,-1,-1,29433,-1,0.00016706878,0.9970921,0.0027408425
29441,the Tregs,6,8,37,46,"Flow cytometry was used to determine the Tregs levels in the spleen and peripheral blood, and immunohistochemistry was performed to determine the expression levels of TGF and IL-10 in the tumor microenvironment.",27389040_4,-1,-1,-1,-1,29441,-1,5.4456564e-06,0.9999894,5.1331767e-06
29443,blood,14,15,83,88,"Flow cytometry was used to determine the Tregs levels in the spleen and peripheral blood, and immunohistochemistry was performed to determine the expression levels of TGF and IL-10 in the tumor microenvironment.",27389040_4,0,1,-1,-1,29443,-1,0.0032681583,0.311909,0.6848228
29448,the tumor,30,32,185,194,"Flow cytometry was used to determine the Tregs levels in the spleen and peripheral blood, and immunohistochemistry was performed to determine the expression levels of TGF and IL-10 in the tumor microenvironment.",27389040_4,-1,-1,-1,-1,29448,-1,3.9974184e-06,0.99999154,4.515874e-06
29457,that the,5,7,34,42,The flow cytometry results showed that the ratios of CD4(+)CD25(+)Foxp3(+) Tregs to lymphocytes and CD4(+) cells in the spleen and in peripheral blood were significantly decreased after treatment with IFN (P<0.05).,27389040_6,-1,-1,-1,-1,29457,-1,4.1117733e-06,0.9999914,4.4359767e-06
29458,Tregs to lymphocytes,11,14,75,95,The flow cytometry results showed that the ratios of CD4(+)CD25(+)Foxp3(+) Tregs to lymphocytes and CD4(+) cells in the spleen and in peripheral blood were significantly decreased after treatment with IFN (P<0.05).,27389040_6,-1,-1,-1,-1,29458,-1,0.001353878,0.8873358,0.111310296
29461,blood,24,25,145,150,The flow cytometry results showed that the ratios of CD4(+)CD25(+)Foxp3(+) Tregs to lymphocytes and CD4(+) cells in the spleen and in peripheral blood were significantly decreased after treatment with IFN (P<0.05).,27389040_6,0,1,-1,-1,29461,-1,0.0004412748,0.99877685,0.0007818788
29466,the tumor,6,8,32,41,"Expression of TGF and IL-10 in the tumor microenvironment in the CT and RT groups was higher compared with the control group (P<0.01), while the expression of TGF and IL-10 in the INF group was not significantly different (P>0.05).CONCLUSIONS: The results show that INF-2b inhibits cancer cell immune evasion by decreasing the levels of CD4(+)CD25(+)Foxp3(+) Tregs and suppressing the expression of TGF and IL-10 in the tumor microenvironment.",27389040_7,-1,-1,-1,-1,29466,-1,4.3939885e-06,0.9999901,5.5449163e-06
29481,the tumor,79,81,425,434,"Expression of TGF and IL-10 in the tumor microenvironment in the CT and RT groups was higher compared with the control group (P<0.01), while the expression of TGF and IL-10 in the INF group was not significantly different (P>0.05).CONCLUSIONS: The results show that INF-2b inhibits cancer cell immune evasion by decreasing the levels of CD4(+)CD25(+)Foxp3(+) Tregs and suppressing the expression of TGF and IL-10 in the tumor microenvironment.",27389040_7,-1,-1,-1,-1,29481,-1,4.4826265e-06,0.9999901,5.3608132e-06
29486,that T cell,23,26,121,132,"In the last 15 years, it has become apparent that ovarian cancer is recognized by the immune system, taking into account that T cell infiltration can be associated with increased overall survival.",27420920_0,-1,-1,-1,-1,29486,-1,0.00302053,0.19386797,0.8031115
29491,that the,26,28,163,171,Several studies indicate that a correct combination of cluster of differentiation 8 and cluster of differentiation 4 T cells is key to fight tumor progression and that the presence of regulatory T cells (Tregs) infiltrating ovarian solid tumors (or present in ascites) is deleterious.,27420920_1,-1,-1,-1,-1,29491,-1,5.0166573e-06,0.99999106,3.962614e-06
29497,tumor necrosis factor receptor,7,11,71,101,"Several markers that characterize Tregs include glucocorticoid-induced tumor necrosis factor receptor, cytotoxic T lymphocyte antigen-4, and forkhead box protein 3 (Foxp3).",27420920_2,-1,-1,-1,-1,29497,-1,0.92931587,0.027455047,0.043229062
29498,cytotoxic T lymphocyte antigen-4,12,16,103,135,"Several markers that characterize Tregs include glucocorticoid-induced tumor necrosis factor receptor, cytotoxic T lymphocyte antigen-4, and forkhead box protein 3 (Foxp3).",27420920_2,-1,-1,-1,-1,29498,-1,0.0060847043,8.434661e-05,0.9938309
29500,protein,20,21,154,161,"Several markers that characterize Tregs include glucocorticoid-induced tumor necrosis factor receptor, cytotoxic T lymphocyte antigen-4, and forkhead box protein 3 (Foxp3).",27420920_2,0,1,-1,-1,29500,-1,6.6384214e-06,0.99998534,8.029802e-06
29502,that Tregs,3,5,19,29,Research has shown that Tregs can infiltrate cancerous tissue and contribute to tumor growth by secreting immunosuppressive cytokines such as transforming growth factor beta and interleukin (IL)-10.,27420920_3,-1,-1,-1,-1,29502,-1,5.744038e-06,0.9999889,5.290071e-06
29503,tissue,8,9,55,61,Research has shown that Tregs can infiltrate cancerous tissue and contribute to tumor growth by secreting immunosuppressive cytokines such as transforming growth factor beta and interleukin (IL)-10.,27420920_3,-1,1,2,-1,29503,-1,0.0006435379,0.25956413,0.7397924
29504,to tumor,11,13,77,85,Research has shown that Tregs can infiltrate cancerous tissue and contribute to tumor growth by secreting immunosuppressive cytokines such as transforming growth factor beta and interleukin (IL)-10.,27420920_3,-1,-1,-1,-1,29504,-1,5.069483e-06,0.99998903,5.929608e-06
29508,these cells,2,4,13,24,"Importantly, these cells might hamper the efficacy of immunotherapeutic approaches, thus strategies involving depletion or regulation of this population have been proposed and tested in experimental models.",27420920_4,-1,-1,-1,-1,29508,-1,2.7298565e-05,2.3095416e-05,0.9999496
29515,the relevance,7,9,36,49,"In this Minireview, we will discuss the relevance of Tregs in ovarian cancer and the experimental approaches destined to impair their immunosuppressive effects.",27420920_5,-1,-1,-1,-1,29515,-1,5.5523005e-06,0.9999896,4.836752e-06
29524,Th9 cells,9,11,58,67,"However, whether dectin-1 directs DCs to prime antitumour Th9 cells remains unclear.",27492902_1,-1,-1,-1,-1,29524,-1,2.9703548e-05,6.578454e-05,0.9999045
29526,agonists,9,10,45,53,"Here, we show that DCs activated by dectin-1 agonists potently promote naive CD4(+) T cells to differentiate into Th9 cells.",27492902_2,0,1,-1,-1,29526,-1,0.9989114,0.00071731565,0.00037125064
29528,T cells to,15,18,84,94,"Here, we show that DCs activated by dectin-1 agonists potently promote naive CD4(+) T cells to differentiate into Th9 cells.",27492902_2,-1,-1,-1,-1,29528,-1,0.0015250469,0.057964697,0.94051033
29529,Th9 cells,20,22,114,123,"Here, we show that DCs activated by dectin-1 agonists potently promote naive CD4(+) T cells to differentiate into Th9 cells.",27492902_2,-1,-1,-1,-1,29529,-1,0.00033373915,0.020192355,0.979474
29530,their Th9-polarizing,7,9,51,71,Abrogation of dectin-1 in DCs completely abolishes their Th9-polarizing capability in response to dectin-1 agonist curdlan.,27492902_3,-1,-1,-1,-1,29530,-1,5.2869756e-05,0.9998913,5.5805707e-05
29532,TNFSF15,7,8,49,56,"Notably, dectin-1 stimulation of DCs upregulates TNFSF15 and OX40L, which are essential for dectin-1-activated DC-induced Th9 cell priming.",27492902_4,0,1,-1,-1,29532,-1,0.0014520643,0.9983619,0.00018601332
29534,Th9 cell,17,19,122,130,"Notably, dectin-1 stimulation of DCs upregulates TNFSF15 and OX40L, which are essential for dectin-1-activated DC-induced Th9 cell priming.",27492902_4,-1,-1,-1,-1,29534,-1,1.3837184e-05,1.5488635e-05,0.9999707
29537,TNFSF15,21,22,139,146,"Mechanistically, dectin-1 activates Syk, Raf1 and NF-B signalling pathways, resulting in increased p50 and RelB nuclear translocation and TNFSF15 and OX40L expression.",27492902_5,0,1,-1,-1,29537,-1,0.0003933906,0.9995254,8.1186e-05
29541,Th9 cells,16,18,128,137,"Furthermore, immunization of tumour-bearing mice with dectin-1-activated DCs induces potent antitumour response that depends on Th9 cells and IL-9 induced by dectin-1-activated DCs in vivo.",27492902_6,-1,-1,-1,-1,29541,-1,2.0900725e-05,5.584402e-05,0.99992335
29543,Th9 cells,10,12,69,78,Our results identify dectin-1-activated DCs as a powerful inducer of Th9 cells and antitumour immunity and may have important clinical implications.,27492902_7,-1,-1,-1,-1,29543,-1,1.2287298e-05,1.7907792e-05,0.99996984
29544,immunity,14,15,94,102,Our results identify dectin-1-activated DCs as a powerful inducer of Th9 cells and antitumour immunity and may have important clinical implications.,27492902_7,0,-1,2,-1,29544,-1,0.9998241,5.070767e-05,0.00012527597
29551,the Treg,9,11,78,86,"Recent studies have revealed considerable heterogeneity and plasticity within the Treg compartment, depending on the immunological context, which may result in Tregs losing their suppressive function in inflammatory environments.",27497235_1,-1,-1,-1,-1,29551,-1,4.652535e-06,0.9999894,5.909135e-06
29555,function,27,28,191,199,"Recent studies have revealed considerable heterogeneity and plasticity within the Treg compartment, depending on the immunological context, which may result in Tregs losing their suppressive function in inflammatory environments.",27497235_1,0,1,2,-1,29555,-1,2.8536282e-05,0.99994206,2.9404155e-05
29558,immunity,20,21,161,169,We review how dysfunctional Tregs contribute to disease pathogenesis in inflammatory conditions and how inappropriate regulatory responses may hamper protective immunity in the context of infection and cancer.,27497235_2,0,-1,2,-1,29558,-1,0.9999038,2.284148e-05,7.326231e-05
29561,targeted therapeutically to,7,10,35,62,"We also discuss how Tregs might be targeted therapeutically to re-establish a proper balance between regulatory and effector responses in autoimmunity, infections, and cancer.",27497235_3,-1,-1,-1,-1,29561,-1,4.164867e-06,0.9999925,3.3782458e-06
29563,Th9 cells,2,4,9,18,Th17 and Th9 cells have been demonstrated to possess immune regulatory functions in malignant pleural effusion (MPE).,27535421_0,-1,-1,-1,-1,29563,-1,0.000224631,0.0063843504,0.99339104
29565,functions,11,12,71,80,Th17 and Th9 cells have been demonstrated to possess immune regulatory functions in malignant pleural effusion (MPE).,27535421_0,0,1,2,-1,29565,-1,7.277018e-05,0.99923515,0.000692072
29568,function,8,9,54,62,"However, whether IL-17 can affect differentiation and function of Th9 cells in MPE remains unknown.",27535421_1,0,1,2,-1,29568,-1,6.348987e-05,0.9998375,9.898245e-05
29569,Th9 cells,10,12,66,75,"However, whether IL-17 can affect differentiation and function of Th9 cells in MPE remains unknown.",27535421_1,-1,-1,-1,-1,29569,-1,1.6767386e-05,3.955798e-05,0.9999436
29576,Th9 cells,19,21,104,113,"The objective of the present study was to explore the impact of IL-17 on the in vivo differentiation of Th9 cells in relation to Th2 cells in a murine model of MPE, and to explore whether IL-17 inhibits MPE formation via IL-9dependent mechanism.",27535421_2,-1,-1,-1,-1,29576,-1,2.9550796e-05,0.00010810665,0.9998623
29577,relation to Th2 cells,22,26,117,138,"The objective of the present study was to explore the impact of IL-17 on the in vivo differentiation of Th9 cells in relation to Th2 cells in a murine model of MPE, and to explore whether IL-17 inhibits MPE formation via IL-9dependent mechanism.",27535421_2,-1,-1,-1,-1,29577,-1,0.0024276813,0.22420408,0.77336824
29580,that Th9,3,5,13,21,It was found that Th9 and Th2 cells were decreased in MPE from IL-17 -/- mice as compared with wild type mice.,27535421_3,-1,-1,-1,-1,29580,-1,1.2778051e-05,0.99997294,1.4336706e-05
29584,IL-17 deficiency,0,2,0,16,"IL-17 deficiency inhibited Th9 and Th2 cell differentiation via suppressing transcription factors IRF4 and GATA-3, respectively.",27535421_4,-1,-1,-1,-1,29584,-1,0.9999094,2.5293579e-05,6.5265136e-05
29587,transcription factors IRF4,10,13,76,102,"IL-17 deficiency inhibited Th9 and Th2 cell differentiation via suppressing transcription factors IRF4 and GATA-3, respectively.",27535421_4,-1,-1,-1,-1,29587,-1,1.2443218e-05,0.9999691,1.841289e-05
29589,IL-17 deficiency,0,2,0,16,"IL-17 deficiency enhanced MPE formation by promoting angiogenesis and proliferation of pleural tumors, and thus accelerated the death of mice bearing MPE.",27535421_5,-1,-1,-1,-1,29589,-1,0.999884,2.8658304e-05,8.737184e-05
29590,pleural tumors,11,13,87,101,"IL-17 deficiency enhanced MPE formation by promoting angiogenesis and proliferation of pleural tumors, and thus accelerated the death of mice bearing MPE.",27535421_5,-1,-1,-1,-1,29590,-1,1.4021986e-05,0.9999732,1.2793724e-05
29599,that IL-17,7,9,47,57,Our data provide the first definitive evidence that IL-17 promotes the differentiation of Th9 and Th2 cells in MPE.,27535421_7,-1,-1,-1,-1,29599,-1,0.766253,0.23127164,0.0024754356
29603,that IL-17,4,6,30,40,Our findings also demonstrate that IL-17 inhibits the formation of MPE and improves the survival of mice bearing MPE via an IL-9-dependent mechanism.,27535421_8,-1,-1,-1,-1,29603,-1,0.82441765,0.1733896,0.0021927922
29612,tumor cells,2,4,16,27,HPV 16-positive tumor cells exclusively carry the HPV 16 oncogenes E6 and E7.,27548034_2,-1,-1,-1,-1,29612,-1,0.00028463986,0.008745983,0.9909695
29629,blood,4,5,28,33,The frequency of peripheral blood mononuclear cells secreting IFN- and perforin was significantly (P<0.05) increased in HPV-vaccinated versus nonvaccinated volunteers.,27548034_7,0,1,-1,-1,29629,-1,0.006116311,0.980272,0.013611662
29643,Function,0,1,0,8,Function of dendritic cells (DCs) is impaired by some cancer cells.,27556503_0,0,1,2,-1,29643,-1,0.0010232,0.99862504,0.00035174802
29648,function,14,15,66,74,"However, the effect of bladder cancer cell (BCC) on phenotype and function of DCs remains unclear.",27556503_1,0,1,2,-1,29648,-1,0.00024128161,0.99958163,0.00017710023
29650,blood,7,8,40,45,"In this study, healthy human peripheral blood mononuclear cells (PBMCs) derived DCs were co-cultured with BCC pumc-91 and adriamycin-resistant pumc-91/ADM.",27556503_2,0,1,-1,-1,29650,-1,0.0008060956,0.98527366,0.013920236
29656,T cell-derived cytokine,11,14,81,104,"Furthermore, co-cultured DCs showed impaired allogeneic T cell proliferation and T cell-derived cytokine secretion.",27556503_5,-1,-1,-1,-1,29656,-1,0.05402913,0.0007855794,0.94518524
29658,Taken together,0,2,0,14,"Taken together, these results suggest BCC may inhibit maturation and function of DCs involving of Jak2/STAT3 pathway, and there may be different mechanisms by which adriamycin-resistant BCC restrains DC function in antitumor immune response.",27556503_8,-1,-1,-1,-1,29658,-1,9.908402e-06,0.9999815,8.567242e-06
29660,function,11,12,69,77,"Taken together, these results suggest BCC may inhibit maturation and function of DCs involving of Jak2/STAT3 pathway, and there may be different mechanisms by which adriamycin-resistant BCC restrains DC function in antitumor immune response.",27556503_8,0,1,2,-1,29660,-1,9.205244e-05,0.99980325,0.00010468307
29662,function,31,32,203,211,"Taken together, these results suggest BCC may inhibit maturation and function of DCs involving of Jak2/STAT3 pathway, and there may be different mechanisms by which adriamycin-resistant BCC restrains DC function in antitumor immune response.",27556503_8,0,1,2,-1,29662,-1,3.0422178e-05,0.99992037,4.918737e-05
29665,receptor,3,4,24,32,Killer cell lectin-like receptor subfamily G member 1 (KLRG1) has been found on human memory T lymphocytes.,27557510_0,0,1,2,-1,29665,-1,0.0001625018,4.7716203e-05,0.9997899
29678,to the,6,8,45,51,Our results indicated KLRG1 might contribute to the impaired antitumor immunity of memory T cells in tumor microenvironment.,27557510_6,-1,-1,-1,-1,29678,-1,6.7302926e-06,0.9999883,4.92885e-06
29679,immunity,10,11,71,79,Our results indicated KLRG1 might contribute to the impaired antitumor immunity of memory T cells in tumor microenvironment.,27557510_6,0,-1,2,-1,29679,-1,0.9999062,3.2603766e-05,6.1142746e-05
29696,the cell subset,7,10,30,45,Regulatory T (Treg) cells and the cell subset secreting IL-17 (Th17) in peripheral blood were detected with flow cytometry.,27584054_1,-1,-1,-1,-1,29696,-1,1.2322181e-05,9.662083e-06,0.99997807
29699,blood,17,18,83,88,Regulatory T (Treg) cells and the cell subset secreting IL-17 (Th17) in peripheral blood were detected with flow cytometry.,27584054_1,0,1,-1,-1,29699,-1,0.0025968063,0.9792453,0.018157884
29704,Th17 cell,26,28,157,166,"Serum levels of IL-10 and IL-17 were determined with ELISA, and expression of Foxp3 and RORt was assessed with quantitative real-time PCR.RESULTS: Treg and Th17 cell proportions in peripheral blood in the CLL patients were significantly higher than control.",27584054_2,-1,-1,-1,-1,29704,-1,9.8513134e-05,0.0010727774,0.9988287
29705,blood,31,32,193,198,"Serum levels of IL-10 and IL-17 were determined with ELISA, and expression of Foxp3 and RORt was assessed with quantitative real-time PCR.RESULTS: Treg and Th17 cell proportions in peripheral blood in the CLL patients were significantly higher than control.",27584054_2,0,1,-1,-1,29705,-1,0.0017061533,0.7198048,0.27848902
29718,Th17 cells,13,15,86,96,"Compared with the non-remission group, Treg cells were significantly decreased, while Th17 cells were significantly increased, resulting in decreased Treg/Th17 ratio, in the remission group.",27584054_6,-1,-1,-1,-1,29718,-1,1.4359792e-05,1.7414832e-05,0.9999683
29725,analysis,1,2,12,20,"Correlation analysis showed that, Treg and Th17 cell counts were significantly associated with CD38 and ZAP-70 expression in the CLL patients.",27584054_8,0,1,-1,-1,29725,-1,7.393489e-06,0.99998486,7.761089e-06
29728,Th17 cell,7,9,43,52,"Correlation analysis showed that, Treg and Th17 cell counts were significantly associated with CD38 and ZAP-70 expression in the CLL patients.",27584054_8,-1,-1,-1,-1,29728,-1,0.000257309,0.0014452275,0.9982975
29732,factors,12,13,86,93,"Moreover, the IL-10/IL-17 ratio was also significantly associated with CLL prognostic factors.",27584054_9,0,1,-1,-1,29732,-1,0.99136955,0.0074359835,0.0011944463
29740,the cells,7,9,35,44,"However, how MDSCs are induced and the cells from which they arise remains unknown.",27593937_2,-1,-1,-1,-1,29740,-1,6.3647574e-05,0.00011183938,0.9998246
29742,that tumor-derived cytokines,4,7,35,63,"Although studies have demonstrated that tumor-derived cytokines promote MDSC accumulation and activation, little is known regarding the role of the tumor stroma in MDSC accumulation and activation.",27593937_3,-1,-1,-1,-1,29742,-1,0.11390477,0.88403124,0.0020640309
29744,the tumor,20,22,144,153,"Although studies have demonstrated that tumor-derived cytokines promote MDSC accumulation and activation, little is known regarding the role of the tumor stroma in MDSC accumulation and activation.",27593937_3,-1,-1,-1,-1,29744,-1,4.9352448e-06,0.9999907,4.4115045e-06
29749,cell-derived factor,10,12,71,90,Tumor-associated fibroblasts (TAFs) attracted monocytes by the stromal cell-derived factor (SDF)-1a/CXCR4 pathway and induced their differentiation into MDSCs through interleukin (IL)-6-mediated STAT3 activation.,27593937_5,-1,-1,-1,-1,29749,-1,0.6549773,0.001685575,0.34333712
29751,through interleukin,20,22,159,178,Tumor-associated fibroblasts (TAFs) attracted monocytes by the stromal cell-derived factor (SDF)-1a/CXCR4 pathway and induced their differentiation into MDSCs through interleukin (IL)-6-mediated STAT3 activation.,27593937_5,-1,-1,-1,-1,29751,-1,0.599141,0.39517063,0.0056883604
29758,function,14,15,100,108,TAF-treated monocytes (T-MDSCs) then impaired T-cell proliferation and altered the phenotype and/or function of T-cells in an STAT3-dependent manner.,27593937_6,0,1,2,-1,29758,-1,0.00019261599,0.9995036,0.00030373572
29759,T-cells,16,17,112,119,TAF-treated monocytes (T-MDSCs) then impaired T-cell proliferation and altered the phenotype and/or function of T-cells in an STAT3-dependent manner.,27593937_6,-1,1,2,-1,29759,-1,1.24680455e-05,6.8595277e-06,0.99998057
29763,functionally,10,11,70,82,"CD11b+ myeloid cells, which resembled T-MDSCs both phenotypically and functionally, were primarily in the peritumoral stroma and a positive association with TAFs in vivo.",27593937_7,0,1,2,-1,29763,-1,0.0002511235,0.99968004,6.879164e-05
29771,that TAF-derived cytokines,9,12,44,70,"Together, our results are the first to show that TAF-derived cytokines, such as IL-6 and SDF-1a, can induce MDSC generation and activation and then impair human anti-tumor immune responses, which create favorable conditions for HCC progression.",27593937_10,-1,-1,-1,-1,29771,-1,0.05240956,0.9458555,0.0017349806
29787,cells that,8,10,54,64,Myeloid-derived suppressor cells (MDSCs) are immature cells that do not differentiate into mature myeloid cells.,27601624_0,-1,-1,-1,-1,29787,-1,0.0040950673,0.2660508,0.72985417
29790,function,17,18,135,143,Two major populations of PMN-MDSCs (Ly6GhighLy6ClowGr1highCD11b+) and MO-MDSCs (Ly6G-Ly6ChighGr-1intCD11b+) have an immune suppressive function.,27601624_1,0,1,2,-1,29790,-1,3.505711e-05,0.999925,3.9958584e-05
29801,that IRF4,6,8,24,33,"In this study, we found that IRF4 expression was remarkably suppressed during the development of MDSCs in the tumor microenvironment.",27601624_4,-1,-1,-1,-1,29801,-1,1.1073169e-05,0.9999794,9.572899e-06
29803,the tumor,18,20,106,115,"In this study, we found that IRF4 expression was remarkably suppressed during the development of MDSCs in the tumor microenvironment.",27601624_4,-1,-1,-1,-1,29803,-1,4.2812467e-06,0.9999913,4.4315952e-06
29805,protein,4,5,18,25,"Both the mRNA and protein levels of IRF4 in MDSCs were gradually reduced, depending on the development of tumors in the 4T1 model.",27601624_5,0,1,-1,-1,29805,-1,8.087869e-06,0.9999857,6.1888068e-06
29819,the total,10,12,64,73,"In contrast, IRF4 overexpression in bone marrow cells inhibited the total numbers of MDSCs, especially PMN-MDSCs.",27601624_8,-1,-1,-1,-1,29819,-1,5.577281e-06,0.99998975,4.7247495e-06
29826,that IRF4,4,6,22,31,"Finally, we confirmed that IRF4 expression in MDSCs can modulate their activity to inhibit T cell proliferation through IL-10 production and ROS generation, and myeloid-specific deletion of IRF4 leads to the increase of MDSC differentiation.",27601624_10,-1,-1,-1,-1,29826,-1,8.413307e-06,0.9999825,9.11213e-06
29829,T cell proliferation through IL-10,15,20,91,125,"Finally, we confirmed that IRF4 expression in MDSCs can modulate their activity to inhibit T cell proliferation through IL-10 production and ROS generation, and myeloid-specific deletion of IRF4 leads to the increase of MDSC differentiation.",27601624_10,-1,-1,-1,-1,29829,-1,0.5524001,0.0023548848,0.44524503
29832,to the,31,33,201,207,"Finally, we confirmed that IRF4 expression in MDSCs can modulate their activity to inhibit T cell proliferation through IL-10 production and ROS generation, and myeloid-specific deletion of IRF4 leads to the increase of MDSC differentiation.",27601624_10,-1,-1,-1,-1,29832,-1,4.380593e-06,0.9999914,4.2023744e-06
29833,that IRF4,4,6,30,39,"Our present findings indicate that IRF4 reduction induced by tumor formation can increase the number of MDSCs, and increases in the IRF4 expression in MDSCs may infringe on the immune-suppressive function of MDSCs.",27601624_11,-1,-1,-1,-1,29833,-1,1.3601572e-05,0.9999752,1.1184764e-05
29836,the IRF4,21,23,128,136,"Our present findings indicate that IRF4 reduction induced by tumor formation can increase the number of MDSCs, and increases in the IRF4 expression in MDSCs may infringe on the immune-suppressive function of MDSCs.",27601624_11,-1,-1,-1,-1,29836,-1,1.0445057e-05,0.99998057,9.013421e-06
29838,function,31,32,196,204,"Our present findings indicate that IRF4 reduction induced by tumor formation can increase the number of MDSCs, and increases in the IRF4 expression in MDSCs may infringe on the immune-suppressive function of MDSCs.",27601624_11,0,1,2,-1,29838,-1,2.845731e-05,0.9999527,1.8873963e-05
29841,transplantation,27,28,178,193,"The immunogenic tumor dormancy has been demonstrated in animal models of cancer, which can explain clinical observations such as an increased incidence of cancer following organ transplantation.",27603507_0,-1,1,2,-1,29841,-1,1.7639397e-05,0.99997306,9.319097e-06
29846,related to the,8,11,40,54,"Here, we provide a review of literature related to the contribution of Tregs in tumor dormancy or recurrence.",27603507_2,-1,-1,-1,-1,29846,-1,5.31202e-06,0.99999046,4.246537e-06
29855,factors,12,13,70,77,This could be due to a disparity among patients in harboring multiple factors associated with tumor immunoediting and immune evasion mechanisms.,27603507_4,0,1,-1,-1,29855,-1,6.7165936e-05,0.9999167,1.6106407e-05
29857,The nature,0,2,0,10,The nature of gut intraepithelial lymphocytes (IELs) lacking antigen receptors remains controversial.,27612641_0,-1,-1,-1,-1,29857,-1,6.564807e-06,0.9999856,7.850761e-06
29862,to TF,32,34,193,198,"Herein we showed that, in humans and in mice, innate intestinal IELs expressing intracellular CD3 (iCD3(+)) differentiate along an Id2 transcription factor (TF)-independentpathway in response to TF NOTCH1, interleukin-15 (IL-15), and Granzyme B signals.",27612641_1,-1,-1,-1,-1,29862,-1,6.1260225e-06,0.9999896,4.290334e-06
29867,peptide,16,17,106,113,"In NOTCH1-activated human hematopoietic precursors, IL-15 induced Granzyme B, which cleaved NOTCH1 into a peptide lacking transcriptional activity.",27612641_2,0,-1,2,-1,29867,-1,0.00010750371,0.99984837,4.410572e-05
29869,target genes,5,7,20,32,"As a result, NOTCH1 target genes indispensable for Tcell differentiation were silenced and precursors were reprogrammed into innate cells with Tcell marks including intracellular CD3 and Tcell rearrangements.",27612641_3,-1,-1,-1,-1,29869,-1,4.967096e-06,0.99999034,4.7320486e-06
29878,to IL-15,32,34,220,228,"In the intraepithelial lymphoma complicating celiac disease, iCD3(+) innate IELs acquired gain-of-function mutations in Janus kinase 1 or Signal transducer and activator of transcription 3, which enhanced their response to IL-15.",27612641_4,-1,-1,-1,-1,29878,-1,0.97085446,0.027992403,0.0011530529
29879,Tcell-like,4,7,29,40,"Overall we characterized gut Tcell-like innate IELs, deciphered their pathway of differentiation and showed their malignant transformation in celiac disease.",27612641_5,-1,-1,-1,-1,29879,-1,3.8801518e-05,2.2331235e-05,0.99993885
29902,factor-,15,16,79,87,"The expression of Forkhead box P3 (Foxp3), interleukin 10, transforming growth factor-, chemokine CC motif ligands 17, 20, and CC chemokine receptor 4 was determined using real-time quantitative polymerase chain reaction.",27614428_2,0,1,-1,-1,29902,-1,0.9999316,6.6196994e-06,6.1766e-05
29904,chemokine receptor,27,29,131,149,"The expression of Forkhead box P3 (Foxp3), interleukin 10, transforming growth factor-, chemokine CC motif ligands 17, 20, and CC chemokine receptor 4 was determined using real-time quantitative polymerase chain reaction.",27614428_2,-1,-1,-1,-1,29904,-1,0.98165864,7.500655e-05,0.018266281
29920,the total,14,16,81,90,COX-2 inhibitor did not prevent the progression of tongue SCC and did not reduce the total amount of Tregs.,27614428_7,-1,-1,-1,-1,29920,-1,5.912779e-06,0.9999889,5.173079e-06
29922,Tregs function,0,2,0,14,"Tregs function at the early stage of the development of tongue SCC, and it may be effective to suppress Tregs at the early stage of tumor progression for the treatment and/or prevention of tongue SCC.",27614428_8,-1,-1,-1,-1,29922,-1,6.8203276e-06,0.9999839,9.254827e-06
29930,the treatment,29,31,154,167,"Tregs function at the early stage of the development of tongue SCC, and it may be effective to suppress Tregs at the early stage of tumor progression for the treatment and/or prevention of tongue SCC.",27614428_8,-1,-1,-1,-1,29930,-1,5.2209966e-06,0.99998903,5.7274096e-06
29932,enzymes that,9,11,45,57,"Histone deacetylases (HDACs) are a family of enzymes that influence expression of genes implicated in tumor initiation, progression, and anti-tumor responses.",27614429_0,-1,-1,-1,-1,29932,-1,0.0002102473,0.99966717,0.00012263593
29935,to their,2,4,12,20,"In addition to their canonical role in deacetylation of histones, HDACs regulate many non-canonical targets, such as Signal Transducer and Activator of Transcription 3 (STAT3).",27614429_1,-1,-1,-1,-1,29935,-1,5.056212e-06,0.99999034,4.574821e-06
29939,that tumors,2,4,15,26,"We hypothesize that tumors use epigenetic mechanisms to dysregulate CD1d-mediated antigen presentation, thereby impairing the ability of natural killer T (NKT) cells to recognize and destroy malignant cells.",27614429_2,-1,-1,-1,-1,29939,-1,4.5887423e-06,0.9999913,4.0587915e-06
29946,cells to,24,26,160,168,"We hypothesize that tumors use epigenetic mechanisms to dysregulate CD1d-mediated antigen presentation, thereby impairing the ability of natural killer T (NKT) cells to recognize and destroy malignant cells.",27614429_2,-1,-1,-1,-1,29946,-1,0.003441257,0.37305427,0.62350446
29949,tumor cells,7,9,46,57,"In this study, we pre-treated CD1d-expressing tumor cells with HDAC inhibitors (HDACi) and assessed CD1d-dependent NKT cell responses to mantle cell lymphoma (MCL).",27614429_3,-1,-1,-1,-1,29949,-1,0.00022973168,0.010455259,0.98931503
29962,to the,7,9,43,49,"Mechanistically, we found that HDAC2 binds to the CD1D promoter.",27614429_7,-1,-1,-1,-1,29962,-1,5.22463e-06,0.99999046,4.3087357e-06
29963,tumor cells,4,6,22,33,Knockdown of HDAC2 in tumor cells resulted in a significant increase in CD1d-mediated antigen presentation.,27614429_8,-1,-1,-1,-1,29963,-1,0.0004984351,0.05369917,0.9458024
29975,Taken together,0,2,0,14,"Taken together, our studies demonstrate the efficacy of HDACi in restoring anti-tumor responses to MCL through both cell-intrinsic and cell-extrinsic mechanisms and strongly implicate a role for HDACi in enhancing immune responses to cancer.",27614429_11,-1,-1,-1,-1,29975,-1,7.1907925e-06,0.99998605,6.7620795e-06
29981,immune responses to,31,34,214,233,"Taken together, our studies demonstrate the efficacy of HDACi in restoring anti-tumor responses to MCL through both cell-intrinsic and cell-extrinsic mechanisms and strongly implicate a role for HDACi in enhancing immune responses to cancer.",27614429_11,-1,-1,-1,-1,29981,-1,0.97227716,0.027010048,0.0007127904
29985,this subset,5,7,23,34,"In our previous study, this subset was detected in tumor-draining lymph nodes (TDLNs) of patients with breast cancer.",27619682_1,-1,-1,-1,-1,29985,-1,0.0018023576,0.37045696,0.6277407
29988,their function,5,7,25,39,"As little is known about their function in TDLNs of cancer patients, in this study, their frequency as well as their ability to produce interleukin (IL)-2, IL-10, or interferon (IFN)- were investigated in TDLNs of colorectal cancer (CRC) patients.",27619682_2,-1,-1,-1,-1,29988,-1,6.830469e-06,0.99998677,6.4420096e-06
30013,IFN--producing cells than,11,14,74,100,"Moreover, CD4+CD25-FoxP3+ cells contained higher percentages of IL-2- and IFN--producing cells than CD4+CD25+FoxP3+ subpopulation.",27619682_7,-1,-1,-1,-1,30013,-1,0.99888104,0.0005540415,0.00056485966
30014,two subsets,7,9,36,47,"But, no difference was seen between two subsets in terms of IL-10 production.",27619682_8,-1,-1,-1,-1,30014,-1,0.0050051156,0.40647686,0.588518
30021,TSLP,4,5,30,34,Thymic stromal lymphopoietin (TSLP) activates dendritic cells to induce Th2-mediated inflammation.,27634769_0,0,1,-1,-1,30021,-1,0.00034538255,0.9994344,0.0002202045
30022,cells to,8,10,56,64,Thymic stromal lymphopoietin (TSLP) activates dendritic cells to induce Th2-mediated inflammation.,27634769_0,-1,-1,-1,-1,30022,-1,0.00421933,0.41267937,0.58310133
30024,protein,5,6,35,42,"Periostin, an extracellular matrix protein produced by fibroblasts, induces chronic inflammation by stimulating TSLP production.",27634769_1,0,1,-1,-1,30024,-1,0.9679482,0.02931513,0.0027366932
30025,TSLP,15,16,112,116,"Periostin, an extracellular matrix protein produced by fibroblasts, induces chronic inflammation by stimulating TSLP production.",27634769_1,0,1,-1,-1,30025,-1,6.230197e-05,0.99988556,5.212161e-05
30026,Th2-type immune responses,6,9,38,63,"Recently, a reinforcing cycle linking Th2-type immune responses with periostin-induced keratinocyte activation has been proposed in atopic dermatitis pathogenesis.",27634769_2,-1,-1,-1,-1,30026,-1,0.14536253,0.852214,0.0024235016
30029,TSLP,9,10,43,47,"In this study, we investigated the role of TSLP and periostin in the development of cutaneous T-cell lymphoma (CTCL), where Th2 cytokines and chemokines are also dominant.",27634769_3,0,1,-1,-1,30029,-1,1.8689221e-05,0.99995244,2.8899927e-05
30031,T-cell,17,18,94,100,"In this study, we investigated the role of TSLP and periostin in the development of cutaneous T-cell lymphoma (CTCL), where Th2 cytokines and chemokines are also dominant.",27634769_3,-1,1,2,-1,30031,-1,2.04877e-05,7.2515973e-06,0.9999722
30032,Th2 cytokines,24,26,124,137,"In this study, we investigated the role of TSLP and periostin in the development of cutaneous T-cell lymphoma (CTCL), where Th2 cytokines and chemokines are also dominant.",27634769_3,-1,-1,-1,-1,30032,-1,0.23486647,0.7602083,0.004925306
30034,TSLP,0,1,0,4,"TSLP and periostin mRNA expression levels were elevated in CTCL lesional skin, both of which correlated with IL4 expression levels.",27634769_4,0,1,-1,-1,30034,-1,2.6180558e-05,0.9999311,4.2713265e-05
30036,than those,27,29,166,176,"In vitro and ex vivo, IL4 or IL13 stimulated periostin expression by dermal fibroblasts, and fibroblasts from CTCL lesional skin expressed higher levels of periostin than those from control skin.",27634769_5,-1,-1,-1,-1,30036,-1,6.820391e-06,0.9999865,6.6032153e-06
30037,than those,10,12,71,81,Serum periostin levels of CTCL patients were also significantly higher than those of healthy individuals.,27634769_6,-1,-1,-1,-1,30037,-1,1.008769e-05,0.9999832,6.761034e-06
30039,blood,10,11,46,51,"Hut78 and MJ, CTCL cell lines, and peripheral blood mononuclear cells from leukemic CTCL patients expressed the TSLP receptor.",27634769_7,0,1,-1,-1,30039,-1,0.0021241743,0.9879077,0.00996815
30041,the TSLP receptor,18,21,108,125,"Hut78 and MJ, CTCL cell lines, and peripheral blood mononuclear cells from leukemic CTCL patients expressed the TSLP receptor.",27634769_7,-1,-1,-1,-1,30041,-1,0.00019025581,0.99768674,0.0021229428
30042,TSLP,0,1,0,4,TSLP induced production of IL4 and IL13 by Hut78 and MJ cells through the activation of STAT5.,27634769_8,0,1,-1,-1,30042,-1,5.361602e-05,0.99988484,6.1533356e-05
30044,cells through the,11,14,56,73,TSLP induced production of IL4 and IL13 by Hut78 and MJ cells through the activation of STAT5.,27634769_8,-1,-1,-1,-1,30044,-1,0.0024038607,0.8182009,0.17939523
30046,TSLP,2,3,10,14,"Moreover, TSLP induced proliferation of CTCL cells both in vitro and in vivo These data suggest that periostin-mediated TSLP production by keratinocytes directly stimulates CTCL tumor cell growth in addition to inducing a Th2-dominant tumor environment in CTCL.",27634769_9,0,1,-1,-1,30046,-1,7.131554e-05,0.99985003,7.863e-05
30050,TSLP,19,20,120,124,"Moreover, TSLP induced proliferation of CTCL cells both in vitro and in vivo These data suggest that periostin-mediated TSLP production by keratinocytes directly stimulates CTCL tumor cell growth in addition to inducing a Th2-dominant tumor environment in CTCL.",27634769_9,0,1,-1,-1,30050,-1,8.195528e-05,0.9998448,7.323103e-05
30051,tumor cell,26,28,178,188,"Moreover, TSLP induced proliferation of CTCL cells both in vitro and in vivo These data suggest that periostin-mediated TSLP production by keratinocytes directly stimulates CTCL tumor cell growth in addition to inducing a Th2-dominant tumor environment in CTCL.",27634769_9,-1,-1,-1,-1,30051,-1,3.3783563e-05,2.1674e-05,0.99994457
30053,Th2-dominant tumor,34,36,222,240,"Moreover, TSLP induced proliferation of CTCL cells both in vitro and in vivo These data suggest that periostin-mediated TSLP production by keratinocytes directly stimulates CTCL tumor cell growth in addition to inducing a Th2-dominant tumor environment in CTCL.",27634769_9,-1,-1,-1,-1,30053,-1,7.750621e-06,0.9999856,6.7244036e-06
30066,function,13,14,69,77,"Here, we examined the frequency, phenotype, induction mechanism, and function of Tr1 cells in GBM patients.",27644153_2,0,1,2,-1,30066,-1,5.2241387e-05,0.9998958,5.1982555e-05
30067,Tr1 cells,15,17,81,90,"Here, we examined the frequency, phenotype, induction mechanism, and function of Tr1 cells in GBM patients.",27644153_2,-1,-1,-1,-1,30067,-1,1.1014699e-05,1.2992617e-05,0.99997604
30069,Tr1 cells,12,14,87,96,"Compared to healthy controls, GBM patients presented significantly higher frequency of Tr1 cells in peripheral blood.",27644153_3,-1,-1,-1,-1,30069,-1,2.4196703e-05,4.8951973e-05,0.9999268
30070,blood,16,17,111,116,"Compared to healthy controls, GBM patients presented significantly higher frequency of Tr1 cells in peripheral blood.",27644153_3,0,1,-1,-1,30070,-1,0.0022948652,0.1352075,0.8624976
30071,The Tr1,0,2,0,7,The Tr1 frequency was further elevated in the tumor.,27644153_4,-1,-1,-1,-1,30071,-1,5.6607723e-06,0.9999838,1.0569625e-05
30072,the tumor,7,9,42,51,The Tr1 frequency was further elevated in the tumor.,27644153_4,-1,-1,-1,-1,30072,-1,4.561589e-06,0.99999106,4.3879504e-06
30073,the Tr1 cells,5,8,30,43,"By surface marker expression, the Tr1 cells were enriched in the antigen-experienced effector/memory cell compartment.",27644153_5,-1,-1,-1,-1,30073,-1,0.0018562168,0.3025143,0.6956294
30074,the antigen-experienced,11,13,61,84,"By surface marker expression, the Tr1 cells were enriched in the antigen-experienced effector/memory cell compartment.",27644153_5,-1,-1,-1,-1,30074,-1,0.69489056,0.30276224,0.002347227
30076,Tr1 cells,3,5,14,23,A minority of Tr1 cells presented IL-10+TGF-+ double expression.,27644153_6,-1,-1,-1,-1,30076,-1,7.707423e-05,0.0006925887,0.9992304
30081,TGF--expressing cells,11,13,77,99,"Interestingly, naive CD4+CD45RA+ T cells could differentiate into IL-10- and TGF--expressing cells, if incubated with tumor-associated macrophages (TAMs) or with macrophages conditioned with primary glioma cells, suggesting that tumor cells and TAMs had a role in inducing Tr1 cells in GBM patients.",27644153_7,-1,-1,-1,-1,30081,-1,0.0028189607,0.89155716,0.10562386
30085,that tumor cells,32,35,225,241,"Interestingly, naive CD4+CD45RA+ T cells could differentiate into IL-10- and TGF--expressing cells, if incubated with tumor-associated macrophages (TAMs) or with macrophages conditioned with primary glioma cells, suggesting that tumor cells and TAMs had a role in inducing Tr1 cells in GBM patients.",27644153_7,-1,-1,-1,-1,30085,-1,0.0037869331,0.32895315,0.66725993
30087,Tr1 cells,42,44,274,283,"Interestingly, naive CD4+CD45RA+ T cells could differentiate into IL-10- and TGF--expressing cells, if incubated with tumor-associated macrophages (TAMs) or with macrophages conditioned with primary glioma cells, suggesting that tumor cells and TAMs had a role in inducing Tr1 cells in GBM patients.",27644153_7,-1,-1,-1,-1,30087,-1,9.525544e-05,0.0011772952,0.9987275
30088,Tr1 cells,2,4,13,22,"Coculture of Tr1 cells with proinflammatory CD4+ T cells resulted in TGF--dependent reduction of interferon gamma (IFN-) and IL-10-dependent reduction of tumor necrosis factor alpha (TNF-), while coculture of Tr1 cells with CD8+ T cells resulted in lower tumor-specific cytotoxicity.",27644153_8,-1,-1,-1,-1,30088,-1,5.5008277e-05,0.00039085894,0.9995541
30095,TNF-,29,30,185,190,"Coculture of Tr1 cells with proinflammatory CD4+ T cells resulted in TGF--dependent reduction of interferon gamma (IFN-) and IL-10-dependent reduction of tumor necrosis factor alpha (TNF-), while coculture of Tr1 cells with CD8+ T cells resulted in lower tumor-specific cytotoxicity.",27644153_8,0,1,-1,-1,30095,-1,0.15495922,0.84409386,0.0009469404
30096,Tr1 cells,35,37,212,221,"Coculture of Tr1 cells with proinflammatory CD4+ T cells resulted in TGF--dependent reduction of interferon gamma (IFN-) and IL-10-dependent reduction of tumor necrosis factor alpha (TNF-), while coculture of Tr1 cells with CD8+ T cells resulted in lower tumor-specific cytotoxicity.",27644153_8,-1,-1,-1,-1,30096,-1,3.3724664e-05,0.000120564946,0.9998456
30101,Tr1 cells,8,10,56,65,"Together, these results demonstrated an upregulation of Tr1 cells in GBM with anti-inflammatory functions.",27644153_9,-1,-1,-1,-1,30101,-1,1.3901729e-05,2.029495e-05,0.9999658
30102,functions,14,15,96,105,"Together, these results demonstrated an upregulation of Tr1 cells in GBM with anti-inflammatory functions.",27644153_9,0,1,2,-1,30102,-1,0.023356987,0.91920847,0.05743457
30110,treatment targets,17,19,126,143,"Thus, immunosuppression-related signaling, especially that involving immune checkpoint and inflammation, has emerged as novel treatment targets for PAC.",27672267_2,-1,-1,-1,-1,30110,-1,6.3029124e-06,0.99998856,5.103028e-06
30118,interleukin-12 subunit,11,13,68,90,"IL-35 is a novel heterodimeric and inhibitory cytokine, composed of interleukin-12 subunit alpha (P35) and Epstein-Barr virus -induced gene 3 (EBI3).",27682874_0,-1,-1,-1,-1,30118,-1,0.9995436,0.0002069428,0.00024939582
30121,cell types,11,13,53,63,"IL-35 has been reported to be produced by a range of cell types, especially regulatory T cells, and to exert immunosuppressive effects via the STATx signaling pathway.",27682874_1,-1,-1,-1,-1,30121,-1,2.9518138e-05,4.2843258e-05,0.99992764
30124,the STATx,25,27,139,148,"IL-35 has been reported to be produced by a range of cell types, especially regulatory T cells, and to exert immunosuppressive effects via the STATx signaling pathway.",27682874_1,-1,-1,-1,-1,30124,-1,5.408002e-06,0.99998987,4.7216963e-06
30130,tissues,15,16,86,93,IL-35 mainly expressed in CD4+ T cells in human colorectal cancer tumors and adjacent tissues.,27682874_3,-1,1,2,-1,30130,-1,3.758423e-05,0.99938667,0.00057573256
30131,tumor-adjacent tissues,4,6,30,52,Increased IL-35 expression in tumor-adjacent tissues was significantly associated with tumor metastasis.,27682874_4,-1,-1,-1,-1,30131,-1,1.6212196e-05,0.9999621,2.174971e-05
30142,that Tregs,2,4,12,22,We observed that Tregs obtained from colorectal cancer patients were capable of inducing more IL-35 production.,27682874_8,-1,-1,-1,-1,30142,-1,6.3600914e-06,0.99998915,4.495333e-06
30143,than that,9,11,65,74,"In addition, EBI3 promoter-driven luciferase activity was higher than that of the mock plasmid after IL-35stimulation.",27682874_9,-1,-1,-1,-1,30143,-1,8.279457e-06,0.9999851,6.5854715e-06
30147,that the,5,7,26,34,"Thus, our study indicates that the high level of IL-35 in colorectal cancer promotes the production of IL-35 via STAT1 and STAT3, which suppresses T cell proliferation and may participate in tumor immunotolerance.",27682874_10,-1,-1,-1,-1,30147,-1,4.303849e-06,0.99999154,4.1063936e-06
30153,receptor that,8,10,44,57,Programmed death-1 (PD-1) is a coinhibitory receptor that downregulates the activity of tumor-infiltrating lymphocytes (TIL) in cancer and of virus-specific T cells in chronic infection.,27683557_0,-1,-1,-1,-1,30153,-1,0.0044778525,0.7153807,0.28014144
30155,tumor-infiltrating lymphocytes,14,16,88,118,Programmed death-1 (PD-1) is a coinhibitory receptor that downregulates the activity of tumor-infiltrating lymphocytes (TIL) in cancer and of virus-specific T cells in chronic infection.,27683557_0,-1,-1,-1,-1,30155,-1,0.0023527155,0.85697746,0.14066985
30160,that TGF1,2,4,15,25,"We demonstrate that TGF1 enhances antigen-induced PD-1 expression through SMAD3-dependent, SMAD2-independent transcriptional activation in T cells in vitro and in TILs in vivo The PD-1hi subset seen in CD8+ TILs is absent in Smad3-deficient tumor-specific CD8+ TILs, resulting in enhanced cytokine production by TILs and in draining lymph nodes and antitumor activity.",27683557_2,-1,-1,-1,-1,30160,-1,1.0298866e-05,0.999977,1.275109e-05
30162,through SMAD3-dependent,8,10,67,90,"We demonstrate that TGF1 enhances antigen-induced PD-1 expression through SMAD3-dependent, SMAD2-independent transcriptional activation in T cells in vitro and in TILs in vivo The PD-1hi subset seen in CD8+ TILs is absent in Smad3-deficient tumor-specific CD8+ TILs, resulting in enhanced cytokine production by TILs and in draining lymph nodes and antitumor activity.",27683557_2,-1,-1,-1,-1,30162,-1,3.6195954e-05,0.99993825,2.5495394e-05
30163,SMAD2-independent transcriptional,11,13,92,125,"We demonstrate that TGF1 enhances antigen-induced PD-1 expression through SMAD3-dependent, SMAD2-independent transcriptional activation in T cells in vitro and in TILs in vivo The PD-1hi subset seen in CD8+ TILs is absent in Smad3-deficient tumor-specific CD8+ TILs, resulting in enhanced cytokine production by TILs and in draining lymph nodes and antitumor activity.",27683557_2,-1,-1,-1,-1,30163,-1,1.002847e-05,0.9999825,7.466618e-06
30170,Smad3-deficient tumor-specific,35,37,226,256,"We demonstrate that TGF1 enhances antigen-induced PD-1 expression through SMAD3-dependent, SMAD2-independent transcriptional activation in T cells in vitro and in TILs in vivo The PD-1hi subset seen in CD8+ TILs is absent in Smad3-deficient tumor-specific CD8+ TILs, resulting in enhanced cytokine production by TILs and in draining lymph nodes and antitumor activity.",27683557_2,-1,-1,-1,-1,30170,-1,2.4631943e-05,0.99996376,1.161504e-05
30174,to TGF1,2,4,12,20,"In addition to TGF1's previously known effects on T-cell function, our findings suggest that TGF1 mediates T-cell suppression via PD-1 upregulation in the tumor microenvironment (TME).",27683557_3,-1,-1,-1,-1,30174,-1,1.0337679e-05,0.9999715,1.8164537e-05
30175,T-cell function,9,11,51,66,"In addition to TGF1's previously known effects on T-cell function, our findings suggest that TGF1 mediates T-cell suppression via PD-1 upregulation in the tumor microenvironment (TME).",27683557_3,-1,-1,-1,-1,30175,-1,2.183501e-05,2.2430972e-05,0.9999558
30176,that TGF1,15,17,89,99,"In addition to TGF1's previously known effects on T-cell function, our findings suggest that TGF1 mediates T-cell suppression via PD-1 upregulation in the tumor microenvironment (TME).",27683557_3,-1,-1,-1,-1,30176,-1,1.137793e-05,0.99996924,1.9331084e-05
30177,T-cell,18,19,109,115,"In addition to TGF1's previously known effects on T-cell function, our findings suggest that TGF1 mediates T-cell suppression via PD-1 upregulation in the tumor microenvironment (TME).",27683557_3,-1,1,2,-1,30177,-1,1.0853212e-05,8.309131e-06,0.9999808
30178,the tumor,24,26,153,162,"In addition to TGF1's previously known effects on T-cell function, our findings suggest that TGF1 mediates T-cell suppression via PD-1 upregulation in the tumor microenvironment (TME).",27683557_3,-1,-1,-1,-1,30178,-1,4.4617987e-06,0.99999154,4.043231e-06
30182,TGF-producing cells that,8,11,66,91,They highlight bidirectional cross-talk between effector TILs and TGF-producing cells that upregulates multiple components of the PD-1 signaling pathway to inhibit antitumor immunity.,27683557_4,-1,-1,-1,-1,30182,-1,2.6456686e-05,0.99993634,3.724421e-05
30185,immunity,22,23,175,183,They highlight bidirectional cross-talk between effector TILs and TGF-producing cells that upregulates multiple components of the PD-1 signaling pathway to inhibit antitumor immunity.,27683557_4,0,-1,2,-1,30185,-1,0.99983585,5.534159e-05,0.00010882944
30187,receptor,6,7,45,53,"SIGNIFICANCE: Engagement of the coinhibitory receptor PD-1 or its ligand, PD-L1, dramatically inhibits the antitumor function of TILs within the TME.",27683557_5,0,1,2,-1,30187,-1,0.001377245,0.01770532,0.98091745
30189,function,18,19,117,125,"SIGNIFICANCE: Engagement of the coinhibitory receptor PD-1 or its ligand, PD-L1, dramatically inhibits the antitumor function of TILs within the TME.",27683557_5,0,1,2,-1,30189,-1,3.1480187e-05,0.999931,3.7578026e-05
30191,the TME,22,24,141,148,"SIGNIFICANCE: Engagement of the coinhibitory receptor PD-1 or its ligand, PD-L1, dramatically inhibits the antitumor function of TILs within the TME.",27683557_5,-1,-1,-1,-1,30191,-1,4.9357955e-06,0.99998975,5.3030567e-06
30192,function,6,7,49,57,Our findings represent a novel immunosuppressive function of TGF and demonstrate that TGF1 allows tumors to evade host immune responses in part through enhanced SMAD3-mediated PD-1 expression on TILs.,27683557_6,0,1,2,-1,30192,-1,2.4483514e-05,0.9999583,1.7271639e-05
30194,that TGF1,11,13,82,92,Our findings represent a novel immunosuppressive function of TGF and demonstrate that TGF1 allows tumors to evade host immune responses in part through enhanced SMAD3-mediated PD-1 expression on TILs.,27683557_6,-1,-1,-1,-1,30194,-1,1.6164919e-05,0.9999485,3.532774e-05
30195,tumors to,14,16,100,109,Our findings represent a novel immunosuppressive function of TGF and demonstrate that TGF1 allows tumors to evade host immune responses in part through enhanced SMAD3-mediated PD-1 expression on TILs.,27683557_6,-1,-1,-1,-1,30195,-1,3.661734e-06,0.99999285,3.5240482e-06
30216,Tr1 cells,10,12,53,62,"In this study, we investigated the potential role of Tr1 cells in DLBCL.",27704876_4,-1,-1,-1,-1,30216,-1,1.5373582e-05,2.5635896e-05,0.999959
30218,to that,4,6,23,30,"We found that compared to that in healthy controls, the frequency of Tr1 cells was significantly increased in DLBCL patients, even during complete remission.",27704876_5,-1,-1,-1,-1,30218,-1,5.331564e-06,0.9999893,5.432387e-06
30220,Tr1 cells,13,15,69,78,"We found that compared to that in healthy controls, the frequency of Tr1 cells was significantly increased in DLBCL patients, even during complete remission.",27704876_5,-1,-1,-1,-1,30220,-1,2.716791e-05,8.021714e-05,0.9998926
30221,that these Tr1 cells,3,7,21,41,Further study showed that these Tr1 cells were enriched in the CD25low/-Foxp3-CD49b+LAG-3+ fraction and could be developed in vitro from naive CD45RA+ CD4+ T cells.,27704876_6,-1,-1,-1,-1,30221,-1,0.002225187,0.5401762,0.45759857
30229,Tr1 cells,14,16,87,96,"To examine the effect of Tr1 upregulation, we cocultured the enriched in vitro-induced Tr1 cells (iTr1) with autologous primary DLBCL cells and CD3+ T cells and found that iTr1 cells both enhanced the survival of CD20+ DLBCL tumor cells and suppressed the antitumor response of CD3+ T cells through the production of IL-10.",27704876_7,-1,-1,-1,-1,30229,-1,2.2604156e-05,6.0922128e-05,0.99991643
30235,tumor cells,42,44,225,236,"To examine the effect of Tr1 upregulation, we cocultured the enriched in vitro-induced Tr1 cells (iTr1) with autologous primary DLBCL cells and CD3+ T cells and found that iTr1 cells both enhanced the survival of CD20+ DLBCL tumor cells and suppressed the antitumor response of CD3+ T cells through the production of IL-10.",27704876_7,-1,-1,-1,-1,30235,-1,0.00018912385,0.00093163515,0.99887925
30237,T cells through the,52,56,283,302,"To examine the effect of Tr1 upregulation, we cocultured the enriched in vitro-induced Tr1 cells (iTr1) with autologous primary DLBCL cells and CD3+ T cells and found that iTr1 cells both enhanced the survival of CD20+ DLBCL tumor cells and suppressed the antitumor response of CD3+ T cells through the production of IL-10.",27704876_7,-1,-1,-1,-1,30237,-1,0.0036039609,0.31643426,0.67996174
30240,Tr1 cells,7,9,47,56,"Furthermore, the frequency of CD4+Foxp3-IL-10+ Tr1 cells in DLBCL patients during complete remission is directly associated with the risk of relapse.",27704876_8,-1,-1,-1,-1,30240,-1,4.074317e-05,5.0143688e-05,0.99990904
30245,that Tr1 cells,5,8,34,48,"Together, these results suggested that Tr1 cells contributed to tumor cell maintenance and may serve as a prognostic marker and therapeutic target.",27704876_9,-1,-1,-1,-1,30245,-1,0.0019776402,0.2916706,0.7063518
30246,to tumor cell,9,12,61,74,"Together, these results suggested that Tr1 cells contributed to tumor cell maintenance and may serve as a prognostic marker and therapeutic target.",27704876_9,-1,-1,-1,-1,30246,-1,0.0018898767,0.15925878,0.83885133
30247,therapeutic target,21,23,128,146,"Together, these results suggested that Tr1 cells contributed to tumor cell maintenance and may serve as a prognostic marker and therapeutic target.",27704876_9,-1,-1,-1,-1,30247,-1,5.437863e-06,0.99998975,4.754954e-06
30254,this immune response,9,12,43,63,"In this study, we address the mechanism of this immune response and its possible clinical significance.",27707838_3,-1,-1,-1,-1,30254,-1,0.71132797,0.28641433,0.0022577052
30260,chemokine release,17,19,100,117,"Isogenic cell lines, which represent DDRD-positive and -negative, were used to study the effects of chemokine release on peripheral blood mononuclear cell (PBMC) migration and the mechanism of immune signaling activation.",27707838_5,-1,-1,-1,-1,30260,-1,0.99700314,0.0023773164,0.00061963475
30261,blood,21,22,132,137,"Isogenic cell lines, which represent DDRD-positive and -negative, were used to study the effects of chemokine release on peripheral blood mononuclear cell (PBMC) migration and the mechanism of immune signaling activation.",27707838_5,0,1,-1,-1,30261,-1,0.0023761499,0.9921429,0.0054809577
30267,protein,15,16,101,108,"Finally, we studied the association between the DDRD subtype and expression of the immune-checkpoint protein PD-L1 as detected by IHC.",27707838_6,0,1,-1,-1,30267,-1,1.6360143e-05,0.9999684,1.5245536e-05
30268,statistical tests,1,3,4,21,All statistical tests were two-sided.,27707838_7,-1,-1,-1,-1,30268,-1,3.546617e-05,0.9999503,1.4283021e-05
30276,the chemokines CXCL10,32,35,163,184,RESULTS: We found that DDRD breast tumors were associated with CD4+ and CD8+ lymphocytic infiltration (Fisher's exact test P < .001) and that DDRD cells expressed the chemokines CXCL10 and CCL5 3.5- to 11.9-fold more than DNA damage response-proficient cells (P < .01).,27707838_8,-1,-1,-1,-1,30276,-1,0.9595731,0.03886343,0.0015634652
30280,cells statistically,4,6,29,48,"Conditioned medium from DDRD cells statistically significantly attracted PBMCs when compared with medium from DNA damage response-proficient cells (P < .05), and this was dependent on CXCL10 and CCL5.",27707838_9,-1,-1,-1,-1,30280,-1,0.003510538,0.3885836,0.6079058
30292,T-cell-mediated,14,15,95,110,Activation of this pathway and associated PD-L1 expression may explain the paradoxical lack of T-cell-mediated cytotoxicity observed in DDRD tumors.,27707838_14,-1,1,2,-1,30292,-1,1.4570035e-05,8.545407e-06,0.9999769
30300,to therapy,15,17,124,134,"Tumor-associated neutrophils are increasingly recognized for their ability to promote tumor progression, mediate resistance to therapy, and regulate immunosuppression.",27737879_0,-1,-1,-1,-1,30300,-1,8.678265e-06,0.99998367,7.665944e-06
30301,that the chemokine receptor,7,11,46,73,"Evidence from various murine models has shown that the chemokine receptor CXCR2 attracts neutrophil into tumors and, therefore, represents a tractable therapeutic target.",27737879_1,-1,-1,-1,-1,30301,-1,0.013774969,0.98198664,0.004238421
30304,tractable therapeutic target,22,25,141,169,"Evidence from various murine models has shown that the chemokine receptor CXCR2 attracts neutrophil into tumors and, therefore, represents a tractable therapeutic target.",27737879_1,-1,-1,-1,-1,30304,-1,5.1468733e-06,0.9999895,5.389476e-06
30312,that tumor,11,13,60,70,"Using a genetically engineered mouse model of PDA, we found that tumor and stromal cells differentially expressed CXCR2 ligands, with Cxcl5 high in tumor and Cxcl2 high in stroma.",27737879_4,-1,-1,-1,-1,30312,-1,4.5714355e-06,0.9999901,5.3423587e-06
30322,functional T cells,8,11,45,63,"In the absence of neutrophils, activated and functional T cells infiltrated pancreatic tumors otherwise devoid of effector T cells.",27737879_7,-1,-1,-1,-1,30322,-1,0.00017958626,0.00017018573,0.99965024
30328,targeting this,18,20,128,142,"Thus, the CXCR2-ligand axis helps establish an immunosuppressive microenvironment in PDA, highlighting the potential utility of targeting this axis as a novel therapy for this deadly disease.",27737879_8,-1,-1,-1,-1,30328,-1,3.859807e-06,0.9999924,3.7291952e-06
30329,therapy,24,25,159,166,"Thus, the CXCR2-ligand axis helps establish an immunosuppressive microenvironment in PDA, highlighting the potential utility of targeting this axis as a novel therapy for this deadly disease.",27737879_8,0,1,-1,-1,30329,-1,4.8917773e-06,0.99999046,4.6885657e-06
30331,Th17 cells,0,2,0,10,"Th17 cells represent a distinct subset of CD4 effector T cells with potent pathogenic qualities, capable of directly mediating tumor cell destruction.",27741090_0,-1,-1,-1,-1,30331,-1,0.0002884798,0.0063518533,0.99335974
30334,tumor cell,20,22,127,137,"Th17 cells represent a distinct subset of CD4 effector T cells with potent pathogenic qualities, capable of directly mediating tumor cell destruction.",27741090_0,-1,-1,-1,-1,30334,-1,0.0001457389,0.000989815,0.9988644
30341,the Th17,10,12,51,59,We investigated the effect of in vivo IL-2 on both the Th17 and FoxP3CD4 T-cell compartments in a human model of cancer.,27741090_2,-1,-1,-1,-1,30341,-1,1.415497e-05,0.9999691,1.6755666e-05
30342,FoxP3CD4 T-cell,13,15,64,79,We investigated the effect of in vivo IL-2 on both the Th17 and FoxP3CD4 T-cell compartments in a human model of cancer.,27741090_2,-1,-1,-1,-1,30342,-1,0.0026930107,0.6889211,0.3083859
30344,blood,22,23,115,120,"High-dose IL-2 (HDIL-2) was administered at a dose of 720,000 IU/kg to patients with melanoma (n=7) and peripheral blood was collected at baseline and at 24, 48, 72, and 96 hours posttreatment.",27741090_3,0,1,-1,-1,30344,-1,0.0037654485,0.50705177,0.48918277
30345,blood,1,2,11,16,Peripheral blood mononuclear cells (PBMCs) were isolated and subjected to intracellular cytokine and extracellular receptor staining for flow cytometry.,27741090_4,0,1,-1,-1,30345,-1,0.0022436765,0.9905524,0.007203951
30349,receptor,16,17,115,123,Peripheral blood mononuclear cells (PBMCs) were isolated and subjected to intracellular cytokine and extracellular receptor staining for flow cytometry.,27741090_4,0,1,2,-1,30349,-1,0.00080644625,6.4295746e-05,0.99912924
30351,Th17 cells,11,13,73,83,We report that HDIL-2 increased both frequencies and absolute numbers of Th17 cells on day 4 of treatment.,27741090_5,-1,-1,-1,-1,30351,-1,5.9355636e-05,0.0003261004,0.9996145
30360,the Th17-cell,28,30,185,198,"The administration of HDIL-2 to patients with melanoma increased IL-6 production by peripheral immune cells, a cytokine vital in the downregulation of FoxP3 expression and expansion of the Th17-cell population.",27741090_6,-1,-1,-1,-1,30360,-1,0.0023656532,0.70604277,0.29159158
30361,that FoxP3CD4 T cells,4,8,29,50,"Furthermore, we demonstrated that FoxP3CD4 T cells express IL-17 in patients with melanoma undergoing HDIL-2 therapy.",27741090_7,-1,-1,-1,-1,30361,-1,0.0026827666,0.78660655,0.21071072
30363,therapy,16,17,109,116,"Furthermore, we demonstrated that FoxP3CD4 T cells express IL-17 in patients with melanoma undergoing HDIL-2 therapy.",27741090_7,0,1,-1,-1,30363,-1,6.300929e-06,0.99998856,5.099058e-06
30364,Taken together,0,2,0,14,"Taken together, our findings indicate that HDIL-2 combined with the conditions of malignancy create an immune environment supportive of Th17 differentiation and that expansion of this compartment may occur through the transdifferentiation of IL-17-secreting FoxP3CD4 T cells.",27741090_8,-1,-1,-1,-1,30364,-1,8.549636e-06,0.9999844,7.043337e-06
30370,through the transdifferentiation,30,33,206,238,"Taken together, our findings indicate that HDIL-2 combined with the conditions of malignancy create an immune environment supportive of Th17 differentiation and that expansion of this compartment may occur through the transdifferentiation of IL-17-secreting FoxP3CD4 T cells.",27741090_8,-1,-1,-1,-1,30370,-1,2.2643475e-05,0.9999664,1.097925e-05
30371,IL-17-secreting FoxP3CD4 T cells,34,38,242,274,"Taken together, our findings indicate that HDIL-2 combined with the conditions of malignancy create an immune environment supportive of Th17 differentiation and that expansion of this compartment may occur through the transdifferentiation of IL-17-secreting FoxP3CD4 T cells.",27741090_8,-1,-1,-1,-1,30371,-1,0.8744897,0.00078952155,0.12472076
30377,tissues,17,18,103,110,"Forty-eight cases of colorectal carcinomas, 22 cases of colon polyps and 21 cases of normal colorectal tissues were collected.",27752897_1,-1,1,2,-1,30377,-1,0.00029868676,0.00617422,0.99352705
30384,these three,14,16,76,87,"The correlation among Foxp3, IL-10 and Stat3, and the clinical relevance of these three indexes were analyzed.",27752897_2,-1,-1,-1,-1,30384,-1,2.8613551e-05,0.99995494,1.6407956e-05
30386,that the,3,5,19,27,"The results showed that the levels of Foxp3 expressed in infiltrating CD4+CD25+Foxp3+Tregs, and IL-10 and Stat3 in CRC tissues were all significantly higher than those in polypus tissues and normal colon tissues (P< 0.01).",27752897_3,-1,-1,-1,-1,30386,-1,3.6039864e-06,0.9999925,3.9366637e-06
30390,tissues,19,20,119,126,"The results showed that the levels of Foxp3 expressed in infiltrating CD4+CD25+Foxp3+Tregs, and IL-10 and Stat3 in CRC tissues were all significantly higher than those in polypus tissues and normal colon tissues (P< 0.01).",27752897_3,-1,1,2,-1,30390,-1,0.00019964755,0.028092071,0.9717082
30391,than those,24,26,157,167,"The results showed that the levels of Foxp3 expressed in infiltrating CD4+CD25+Foxp3+Tregs, and IL-10 and Stat3 in CRC tissues were all significantly higher than those in polypus tissues and normal colon tissues (P< 0.01).",27752897_3,-1,-1,-1,-1,30391,-1,6.057865e-06,0.9999889,5.073313e-06
30392,tissues,28,29,179,186,"The results showed that the levels of Foxp3 expressed in infiltrating CD4+CD25+Foxp3+Tregs, and IL-10 and Stat3 in CRC tissues were all significantly higher than those in polypus tissues and normal colon tissues (P< 0.01).",27752897_3,-1,1,2,-1,30392,-1,0.00035881516,0.5095774,0.49006376
30393,tissues,32,33,204,211,"The results showed that the levels of Foxp3 expressed in infiltrating CD4+CD25+Foxp3+Tregs, and IL-10 and Stat3 in CRC tissues were all significantly higher than those in polypus tissues and normal colon tissues (P< 0.01).",27752897_3,-1,1,2,-1,30393,-1,0.0003310212,0.121335424,0.8783336
30394,analysis,2,3,20,28,"Pearson correlation analysis indicated that the expression level of Foxp3 was positively correlated with Stat3 at mRNA level (r=0.526, P=0.036), and was positively correlated with IL-10 at protein level (r=0.314, P=0.030).",27752897_4,0,1,-1,-1,30394,-1,1.2506195e-05,0.9999764,1.1058235e-05
30395,that the,4,6,39,47,"Pearson correlation analysis indicated that the expression level of Foxp3 was positively correlated with Stat3 at mRNA level (r=0.526, P=0.036), and was positively correlated with IL-10 at protein level (r=0.314, P=0.030).",27752897_4,-1,-1,-1,-1,30395,-1,4.2751512e-06,0.9999913,4.480773e-06
30399,protein,31,32,189,196,"Pearson correlation analysis indicated that the expression level of Foxp3 was positively correlated with Stat3 at mRNA level (r=0.526, P=0.036), and was positively correlated with IL-10 at protein level (r=0.314, P=0.030).",27752897_4,0,1,-1,-1,30399,-1,0.000124427,0.99983144,4.411671e-05
30400,The Foxp3,0,2,0,9,"The Foxp3 expressed in CD4+CD25+Foxp3+Tregs was correlated with the histological grade, lymph node metastasis and TNM stage of CRC (P<0.05 for all).",27752897_5,-1,-1,-1,-1,30400,-1,5.507704e-06,0.9999894,5.0612484e-06
30403,The IL-10,0,2,0,9,The IL-10 expression was correlated with the histological grade and TNM stage (both P<0.05).,27752897_6,-1,-1,-1,-1,30403,-1,0.92590195,0.07210309,0.0019949733
30406,The Stat3,0,2,0,9,The Stat3 expression was correlated with the lymph node metastasis and TNM stage (both P<0.05).,27752897_7,-1,-1,-1,-1,30406,-1,8.114498e-06,0.9999856,6.3282505e-06
30410,CD4+CD25+Foxp3+Tregs,4,5,22,42,It was concluded that CD4+CD25+Foxp3+Tregs can inhibit tumor immunity in combination with some other related inhibitory cytokines and that Foxp3 expression in CD4+CD25+Foxp3+Tregs correlates with CRC progression.,27752897_8,-1,-1,-1,-1,30410,-1,0.009530929,0.16082391,0.8296451
30411,tumor immunity,7,9,55,69,It was concluded that CD4+CD25+Foxp3+Tregs can inhibit tumor immunity in combination with some other related inhibitory cytokines and that Foxp3 expression in CD4+CD25+Foxp3+Tregs correlates with CRC progression.,27752897_8,-1,-1,-1,-1,30411,-1,0.05107773,0.9473731,0.0015491989
30414,that Foxp3,18,20,134,144,It was concluded that CD4+CD25+Foxp3+Tregs can inhibit tumor immunity in combination with some other related inhibitory cytokines and that Foxp3 expression in CD4+CD25+Foxp3+Tregs correlates with CRC progression.,27752897_8,-1,-1,-1,-1,30414,-1,5.1989023e-06,0.9999901,4.7038366e-06
30415,CD4+CD25+Foxp3+Tregs,22,23,159,179,It was concluded that CD4+CD25+Foxp3+Tregs can inhibit tumor immunity in combination with some other related inhibitory cytokines and that Foxp3 expression in CD4+CD25+Foxp3+Tregs correlates with CRC progression.,27752897_8,-1,-1,-1,-1,30415,-1,0.0106399385,0.1814494,0.8079107
30418,the tumor,11,13,61,70,Regulatory T cells (Tregs) have an immunosuppressive role in the tumor microenvironment.,27756099_0,-1,-1,-1,-1,30418,-1,4.717137e-06,0.9999908,4.436058e-06
30420,functions,11,12,61,70,"Since effector Tregs (eTregs), which have highly suppressive functions, are located in a subpopulation of Foxp3+ CD4+ Tregs, the TCR-inducible costimulatory receptor (ICOS) was applied as a marker of eTregs that infiltrated gastric cancer tissue and the induction pathway of ICOS+ Foxp3+ cells was analyzed by flow cytometry and immunohistochemistry.",27756099_1,0,1,2,-1,30420,-1,8.806488e-06,0.9999765,1.4624154e-05
30423,the TCR-inducible,25,27,125,142,"Since effector Tregs (eTregs), which have highly suppressive functions, are located in a subpopulation of Foxp3+ CD4+ Tregs, the TCR-inducible costimulatory receptor (ICOS) was applied as a marker of eTregs that infiltrated gastric cancer tissue and the induction pathway of ICOS+ Foxp3+ cells was analyzed by flow cytometry and immunohistochemistry.",27756099_1,-1,-1,-1,-1,30423,-1,6.4188926e-06,0.9999871,6.5141517e-06
30424,receptor,28,29,157,165,"Since effector Tregs (eTregs), which have highly suppressive functions, are located in a subpopulation of Foxp3+ CD4+ Tregs, the TCR-inducible costimulatory receptor (ICOS) was applied as a marker of eTregs that infiltrated gastric cancer tissue and the induction pathway of ICOS+ Foxp3+ cells was analyzed by flow cytometry and immunohistochemistry.",27756099_1,0,1,2,-1,30424,-1,0.0028795286,0.00013427819,0.9969862
30426,tissue,43,44,239,245,"Since effector Tregs (eTregs), which have highly suppressive functions, are located in a subpopulation of Foxp3+ CD4+ Tregs, the TCR-inducible costimulatory receptor (ICOS) was applied as a marker of eTregs that infiltrated gastric cancer tissue and the induction pathway of ICOS+ Foxp3+ cells was analyzed by flow cytometry and immunohistochemistry.",27756099_1,-1,1,2,-1,30426,-1,0.00018321337,0.9838725,0.015944282
30430,tumor-infiltrating lymphocytes,1,3,3,33,"In tumor-infiltrating lymphocytes (TILs), ICOS+ Foxp3+ CD4+ T cells were abundantly observed in the late stages of gastric cancer.",27756099_2,-1,-1,-1,-1,30430,-1,0.00238534,0.8902164,0.107398234
30440,TNF,15,16,71,74,"ICOS+ CD4+ TILs exhibited the ability to produce IL-10, but not IFN-, TNF, or IL-17 and also to suppress the proliferation of CFSE-labeled responder CD8+ T cells.",27756099_3,0,1,-1,-1,30440,-1,0.0008913596,0.9990226,8.601614e-05
30446,protein,4,5,26,33,"With the agonistic ICOS-L protein (rICOS-L Ig), ICOS+ Foxp3+ cells were efficiently induced from naive CD4+ T cells under a stimulation with TGF- and CD3/CD28 mAbs.",27756099_4,0,1,-1,-1,30446,-1,1.1724548e-05,0.99997973,8.536691e-06
30453,antigenic peptide,12,14,69,86,"Furthermore, when A*0201 PBMCs were cultured with the CMV or Melan-A antigenic peptide and rICOS-L Ig, the induction of CMV or Melan-A tetramer-binding CD8+ T cells, respectively, was inhibited.",27756099_5,-1,-1,-1,-1,30453,-1,0.9994417,0.00012537994,0.0004330119
30460,related to plasmacytoid,10,13,51,74,The expression of ICOS in Foxp3+ cells was closely related to plasmacytoid dendritic cells (pDCs) and their expression of ICOS-L and TLR9 as well as Helicobacter pylori infection.,27756099_6,-1,-1,-1,-1,30460,-1,5.136e-05,0.99992263,2.594471e-05
30466,Treg-targeting therapeutic,15,17,93,119,"Collectively, our results demonstrate the potential of ICOS as a promising target for direct Treg-targeting therapeutic agents for gastric cancer, and that of eradicating therapy for H. pylori as an indirect immune therapy for gastric cancer.",27756099_7,-1,-1,-1,-1,30466,-1,4.2867055e-06,0.99999046,5.2487917e-06
30468,therapy,26,27,171,178,"Collectively, our results demonstrate the potential of ICOS as a promising target for direct Treg-targeting therapeutic agents for gastric cancer, and that of eradicating therapy for H. pylori as an indirect immune therapy for gastric cancer.",27756099_7,0,1,-1,-1,30468,-1,4.7165204e-06,0.99998987,5.398037e-06
30469,therapy,34,35,215,222,"Collectively, our results demonstrate the potential of ICOS as a promising target for direct Treg-targeting therapeutic agents for gastric cancer, and that of eradicating therapy for H. pylori as an indirect immune therapy for gastric cancer.",27756099_7,0,1,-1,-1,30469,-1,6.749375e-06,0.99998534,7.891873e-06
30470,the functions,10,12,62,75,An imperative demand is present for a better understanding of the functions and regulations of the immune system and how they affect HCC pathogenesis.,27797409_1,-1,-1,-1,-1,30470,-1,9.078995e-06,0.9999815,9.438564e-06
30476,termed Th9 cells,13,16,66,82,"Recently, a group of interleukin 9 (IL-9)-producing CD4+ T cells, termed Th9 cells, has been described in mice and humans with both tumour-inhibiting as well as tumour-promoting effects.",27797409_2,-1,-1,-1,-1,30476,-1,0.0013994928,0.08173148,0.91686904
30480,Th9 cells,4,6,22,31,The specific roles of Th9 cells in human HCC are not entirely understood.,27797409_3,-1,-1,-1,-1,30480,-1,0.00011421619,0.0010734369,0.99881244
30482,functions,7,8,38,47,"Here, we examined the frequencies and functions of IL-9-producing Th9 cells in HCC patients.",27797409_4,0,1,2,-1,30482,-1,5.491248e-05,0.99988246,6.2594554e-05
30483,IL-9-producing Th9 cells,9,12,51,75,"Here, we examined the frequencies and functions of IL-9-producing Th9 cells in HCC patients.",27797409_4,-1,-1,-1,-1,30483,-1,0.87779707,0.0003145368,0.12188834
30484,that the,2,4,9,17,We found that the frequencies of circulating IL-9-producing Th9 cells were significantly higher in HCC patients compared to in healthy individuals.,27797409_5,-1,-1,-1,-1,30484,-1,4.1533785e-06,0.99999213,3.7162285e-06
30485,IL-9-producing Th9 cells,7,10,45,69,We found that the frequencies of circulating IL-9-producing Th9 cells were significantly higher in HCC patients compared to in healthy individuals.,27797409_5,-1,-1,-1,-1,30485,-1,0.89258724,0.0003111391,0.107101634
30488,IL-9-producing Th9 cells,7,10,36,60,"In HCC patients, the frequencies of IL-9-producing Th9 cells were significantly higher in peritumour and tumour tissues than in unaffected liver tissues.",27797409_6,-1,-1,-1,-1,30488,-1,0.8749744,0.00028334762,0.124742195
30489,tumour tissues than,16,19,105,124,"In HCC patients, the frequencies of IL-9-producing Th9 cells were significantly higher in peritumour and tumour tissues than in unaffected liver tissues.",27797409_6,-1,-1,-1,-1,30489,-1,8.352167e-06,0.9999769,1.4832741e-05
30490,tissues,22,23,145,152,"In HCC patients, the frequencies of IL-9-producing Th9 cells were significantly higher in peritumour and tumour tissues than in unaffected liver tissues.",27797409_6,-1,1,2,-1,30490,-1,0.0002866689,0.8251665,0.17454682
30491,tumour-infiltrating Th9,6,8,40,63,"Interestingly, HCC patients with higher tumour-infiltrating Th9 frequency had significantly shorter disease-free survival period after resection.",27797409_7,-1,-1,-1,-1,30491,-1,8.204789e-05,0.9998497,6.8244706e-05
30498,tumour cells,17,19,115,127,"We found that incubation of primary HCC cells with autologous Th9 significantly elevated the CCL20 production from tumour cells, which could be partially inhibited by suppressing STAT3.",27797409_10,-1,-1,-1,-1,30498,-1,0.00026584638,0.0017818735,0.9979522
30503,Th9 cells,9,11,58,67,"Together, this study suggested a tumour-promoting role of Th9 cells in HCC.",27797409_11,-1,-1,-1,-1,30503,-1,3.3400873e-05,9.0450834e-05,0.99987614
30504,therapy,20,21,147,154,OBJECTIVE: Limited efficacy of immune checkpoint inhibitors in pancreatic ductal adenocarcinoma (PDAC) has prompted investigation into combination therapy.,27797936_0,0,1,-1,-1,30504,-1,5.019092e-06,0.99998987,5.130326e-06
30505,that interleukin 6,2,5,16,34,We hypothesised that interleukin 6 (IL-6) blockade would modulate immunological features of PDAC and enhance the efficacy of anti-programmed death-1-ligand 1 (PD-L1) checkpoint inhibitor therapy.,27797936_1,-1,-1,-1,-1,30505,-1,0.8094782,0.18709227,0.0034295472
30508,therapy,28,29,187,194,We hypothesised that interleukin 6 (IL-6) blockade would modulate immunological features of PDAC and enhance the efficacy of anti-programmed death-1-ligand 1 (PD-L1) checkpoint inhibitor therapy.,27797936_1,0,1,-1,-1,30508,-1,4.4775948e-06,0.9999913,4.1830294e-06
30513,targeting IL-6,13,15,78,92,"In vivo efficacy and mechanistic studies were conducted with antibodies (Abs) targeting IL-6, PD-L1, CD4 or CD8 in subcutaneous or orthotopic models using Panc02, MT5 or KPC-luc cell lines; and the aggressive, genetically engineered PDAC model (KrasLSL-G12D, Trp53LSL-R270H, Pdx1-cre, Brca2F/F (KPC-Brca2 mice)).",27797936_3,-1,-1,-1,-1,30513,-1,0.8307752,0.1656782,0.0035465357
30517,analysis,13,14,101,109,Systemic and local changes in immunophenotype were measured by flow cytometry or immunohistochemical analysis.,27797936_4,0,1,-1,-1,30517,-1,1.6616279e-05,0.9999697,1.3634993e-05
30527,This treatment,0,2,0,14,This treatment combination also elicited significant antitumour activity in mice bearing orthotopic KPC-luc tumours and limited tumour progression in KPC-Brca2 mice (p<0.001).,27797936_8,-1,-1,-1,-1,30527,-1,5.4209227e-06,0.9999901,4.5000643e-06
30530,analysis,1,2,13,21,Histological analysis revealed increased T-cell infiltration and reduced -smooth muscle actin cells in tumours from multiple models.,27797936_9,0,1,-1,-1,30530,-1,1.2712363e-05,0.9999794,7.892398e-06
30531,T-cell,4,5,41,47,Histological analysis revealed increased T-cell infiltration and reduced -smooth muscle actin cells in tumours from multiple models.,27797936_9,-1,1,2,-1,30531,-1,1.4319914e-05,1.07590095e-05,0.99997497
30536,that targeted,22,24,168,181,"Finally, IL-6 and PD-L1 blockade increased overall survival in KPC-Brca2 mice compared with isotype controls (p=0.0012).CONCLUSIONS: These preclinical results indicate that targeted inhibition of IL-6 may enhance the efficacy of anti-PD-L1 in PDAC.",27797936_10,-1,-1,-1,-1,30536,-1,5.1708735e-06,0.9999907,4.171808e-06
30541,thought to,9,11,61,71,"Natural polyphenolic compounds of grapes and their seeds are thought to be therapeutic adjuvants in a variety of diseases, including cancer prevention.",27833081_0,-1,-1,-1,-1,30541,-1,5.608897e-06,0.9999881,6.358429e-06
30546,the regulation,14,16,84,98,This study was carried out to investigate the effect of grape phenolic compounds on the regulation of cancer-mediated immune suppression.,27833081_1,-1,-1,-1,-1,30546,-1,3.955873e-06,0.9999918,4.3190344e-06
30551,function,25,26,155,163,"Laricitrin exhibits the greatest potential to ameliorate the suppressive effects of lung cancer on dendritic cells' (DCs') differentiation, maturation and function.",27833081_2,0,1,2,-1,30551,-1,0.0010238815,0.9909242,0.008052013
30557,T cells towards,23,26,114,129,Human lung cancer A549 and CL1-5 cells change the phenotype of DCs that express to high levels of IL-10 and prime T cells towards an immune suppression type-2 response (Th2).,27833081_3,-1,-1,-1,-1,30557,-1,0.0010273692,0.0273197,0.9716529
30565,Th2 to Th1,18,21,120,130,"Laricitrin decreases expression of IL-10 in cancer-conditioned DCs, and subsequently switches CD4+ T cell response from Th2 to Th1 in vitro and in vivo.",27833081_5,-1,-1,-1,-1,30565,-1,6.8911663e-06,0.9999808,1.234919e-05
30572,protein,1,2,17,24,Follistatin-like protein 1 (FSTL1) is a newly characterized protein that can regulate the immune response in various ways.,27859422_0,0,1,-1,-1,30572,-1,2.6485275e-05,0.99994814,2.532891e-05
30574,the immune response,14,17,86,105,Follistatin-like protein 1 (FSTL1) is a newly characterized protein that can regulate the immune response in various ways.,27859422_0,-1,-1,-1,-1,30574,-1,0.68299264,0.3148254,0.0021819118
30589,protein nuclear factor,11,14,66,88,"In the experimental groups, the expression of the critical immune protein nuclear factor (NF)-b was upregulated, whereas Jun N-terminal kinase (JNK) was downregulated.",27859422_5,-1,-1,-1,-1,30589,-1,7.842097e-06,0.9999857,6.4500005e-06
30594,the antigen,14,16,90,101,"Our findings demonstrate that FSTL1 plays a critical role in immune regulation, enhancing the antigen presentation ability of DCs by up-regulating NF-b expression and down-regulating JNK expression.",27859422_6,-1,-1,-1,-1,30594,-1,0.45004636,0.54440624,0.0055473456
30598,immunity,17,18,110,118,"Based on our hypothesis in which continuous exposure to asbestos of immune cells cause reduction of antitumor immunity, the decrease of natural killer cell killing activity with reduction of NKp46 activating receptor expression, inhibition of cytotoxic Tcell clonal expansion, reduced CXCR3 chemokine receptor expression and production of interferon- production in CD4+ Tcells were reported using cell line models, freshly isolated peripheral blood immune cells from health donors as well as asbestos exposed patients such as pleural plaque and mesothelioma.",27878235_1,0,-1,2,-1,30598,-1,0.99948645,0.00017615293,0.00033743653
30602,receptor,32,33,208,216,"Based on our hypothesis in which continuous exposure to asbestos of immune cells cause reduction of antitumor immunity, the decrease of natural killer cell killing activity with reduction of NKp46 activating receptor expression, inhibition of cytotoxic Tcell clonal expansion, reduced CXCR3 chemokine receptor expression and production of interferon- production in CD4+ Tcells were reported using cell line models, freshly isolated peripheral blood immune cells from health donors as well as asbestos exposed patients such as pleural plaque and mesothelioma.",27878235_1,0,1,2,-1,30602,-1,3.9186856e-05,3.807176e-05,0.99992275
30604,chemokine receptor,46,48,292,310,"Based on our hypothesis in which continuous exposure to asbestos of immune cells cause reduction of antitumor immunity, the decrease of natural killer cell killing activity with reduction of NKp46 activating receptor expression, inhibition of cytotoxic Tcell clonal expansion, reduced CXCR3 chemokine receptor expression and production of interferon- production in CD4+ Tcells were reported using cell line models, freshly isolated peripheral blood immune cells from health donors as well as asbestos exposed patients such as pleural plaque and mesothelioma.",27878235_1,-1,-1,-1,-1,30604,-1,0.99091715,5.9996095e-05,0.009022859
30608,blood,70,71,446,451,"Based on our hypothesis in which continuous exposure to asbestos of immune cells cause reduction of antitumor immunity, the decrease of natural killer cell killing activity with reduction of NKp46 activating receptor expression, inhibition of cytotoxic Tcell clonal expansion, reduced CXCR3 chemokine receptor expression and production of interferon- production in CD4+ Tcells were reported using cell line models, freshly isolated peripheral blood immune cells from health donors as well as asbestos exposed patients such as pleural plaque and mesothelioma.",27878235_1,0,1,-1,-1,30608,-1,0.001200269,0.9965243,0.0022754371
30610,pleural plaque,84,86,529,543,"Based on our hypothesis in which continuous exposure to asbestos of immune cells cause reduction of antitumor immunity, the decrease of natural killer cell killing activity with reduction of NKp46 activating receptor expression, inhibition of cytotoxic Tcell clonal expansion, reduced CXCR3 chemokine receptor expression and production of interferon- production in CD4+ Tcells were reported using cell line models, freshly isolated peripheral blood immune cells from health donors as well as asbestos exposed patients such as pleural plaque and mesothelioma.",27878235_1,-1,-1,-1,-1,30610,-1,7.5217875e-05,0.9998735,5.125971e-05
30611,to these,2,4,12,20,"In addition to these findings, regulatory Tcells (Treg) showed enhanced function through cell-cell contact and increased secretion of typical soluble factors, interleukin (IL)-10 and transforming growth factor (TGF)-, in a cell line model using the MT-2 human polyclonal Tcells and its sublines exposed continuously to asbestos fibers.",27878235_2,-1,-1,-1,-1,30611,-1,3.7479072e-06,0.9999918,4.460068e-06
30614,function through cell-cell,15,18,73,99,"In addition to these findings, regulatory Tcells (Treg) showed enhanced function through cell-cell contact and increased secretion of typical soluble factors, interleukin (IL)-10 and transforming growth factor (TGF)-, in a cell line model using the MT-2 human polyclonal Tcells and its sublines exposed continuously to asbestos fibers.",27878235_2,-1,-1,-1,-1,30614,-1,0.00042705686,0.0057229917,0.99384993
30616,factors,25,26,151,158,"In addition to these findings, regulatory Tcells (Treg) showed enhanced function through cell-cell contact and increased secretion of typical soluble factors, interleukin (IL)-10 and transforming growth factor (TGF)-, in a cell line model using the MT-2 human polyclonal Tcells and its sublines exposed continuously to asbestos fibers.",27878235_2,0,1,-1,-1,30616,-1,0.998599,0.0013216744,7.930523e-05
30618,transforming growth factor,30,33,184,210,"In addition to these findings, regulatory Tcells (Treg) showed enhanced function through cell-cell contact and increased secretion of typical soluble factors, interleukin (IL)-10 and transforming growth factor (TGF)-, in a cell line model using the MT-2 human polyclonal Tcells and its sublines exposed continuously to asbestos fibers.",27878235_2,-1,-1,-1,-1,30618,-1,0.97887087,0.017717794,0.003411273
30626,the cell,22,24,158,166,"Since these sublines showed a remarkable reduction of FoxO1 transcription factor, which regulates various cell cycle regulators in asbestos-exposed sublines, the cell cycle progression in these sublines was examined and compared with that of the original MT-2 cells.",27878235_3,-1,-1,-1,-1,30626,-1,0.004504436,0.6115762,0.38391933
30636,immunity,6,7,45,53,The overall findings indicate that antitumor immunity in asbestos-exposed individuals may be reduced in Treg through changes in the function and volume of Treg.,27878235_6,0,-1,2,-1,30636,-1,0.99981314,4.31582e-05,0.00014374492
30637,Treg through,14,16,104,116,The overall findings indicate that antitumor immunity in asbestos-exposed individuals may be reduced in Treg through changes in the function and volume of Treg.,27878235_6,-1,-1,-1,-1,30637,-1,5.1952625e-06,0.9999888,5.9564027e-06
30638,the function,18,20,128,140,The overall findings indicate that antitumor immunity in asbestos-exposed individuals may be reduced in Treg through changes in the function and volume of Treg.,27878235_6,-1,-1,-1,-1,30638,-1,3.4570377e-05,0.9999342,3.119533e-05
30643,tumor immunity,11,13,57,71,BACKGROUND: CD4+CD25+ regulatory T (Treg) cells suppress tumor immunity by inhibiting immune cells.,27887569_0,-1,-1,-1,-1,30643,-1,0.013750864,0.9857487,0.0005004975
30648,receptor activator,14,16,87,105,"Zoledronic acid (ZA), a nitrogen-containing bisphosphonate, inhibits the expression of receptor activator of nuclear factor kappa-B ligand (RANKL) on osteoblasts to inhibit osteoclastogenesis.",27887569_2,-1,-1,-1,-1,30648,-1,0.00015060099,0.99964714,0.00020223066
30652,Treg-cell,15,16,101,110,"In a mouse model of bisphosphonate-related osteonecrosis of the jaw, administration of ZA suppressed Treg-cell activity and activated inflammatory Th17 cells.",27887569_3,-1,1,2,-1,30652,-1,5.6789322e-05,0.000159853,0.99978346
30653,Th17 cells,20,22,147,157,"In a mouse model of bisphosphonate-related osteonecrosis of the jaw, administration of ZA suppressed Treg-cell activity and activated inflammatory Th17 cells.",27887569_3,-1,-1,-1,-1,30653,-1,0.00045086077,0.012877349,0.98667186
30661,Treg cells treated,24,27,166,184,This study investigated the immune modulation of Treg cells by ZA.METHODS: Flow cytometry was used to analyze the phenotypic and immunosuppressive characteristics of Treg cells treated with ZA.,27887569_5,-1,-1,-1,-1,30661,-1,0.0011196153,0.052797142,0.94608325
30674,functions,4,5,44,53,"Chemotactic migration and immunosuppressive functions were also significantly attenuated in Treg cells pretreated with ZA, and these effects were dose-dependent.",27887569_10,0,1,2,-1,30674,-1,0.41921216,0.26496568,0.31582212
30684,function,21,22,148,156,"CONCLUSIONS: Our findings demonstrated that ZA acted as an immune modulator by significantly inhibiting the expansion, migration, immunosuppressive function and pro-metastatic ability of Treg cells.",27887569_12,0,1,2,-1,30684,-1,0.0014207063,0.9980235,0.0005558384
30687,therapy,12,13,74,81,Immunomodulation of Treg cells by ZA represents a new strategy for cancer therapy.,27887569_13,0,1,-1,-1,30687,-1,5.008619e-06,0.9999896,5.3992712e-06
30688,to the,12,14,85,91,Cigarette smoking is associated with numerous diseases and poses a serious challenge to the current healthcare system worldwide.,27902485_0,-1,-1,-1,-1,30688,-1,6.5855297e-06,0.99998724,6.1874234e-06
30691,immunity,13,14,85,93,Smoking impacts both innate and adaptive immunity and plays dual roles in regulating immunity by either exacerbation of pathogenic immune responses or attenuation of defensive immunity.,27902485_1,0,-1,2,-1,30691,-1,0.99973327,9.5910604e-05,0.00017081697
30693,immunity,25,26,176,184,Smoking impacts both innate and adaptive immunity and plays dual roles in regulating immunity by either exacerbation of pathogenic immune responses or attenuation of defensive immunity.,27902485_1,0,-1,2,-1,30693,-1,0.99983835,6.4733315e-05,9.685055e-05
30705,immunity,14,15,97,105,"Although previous reviews have described the effects of smoking on various diseases and regional immunity associated with specific diseases, a comprehensive and updated review is rarely seen to demonstrate impacts of smoking on general immunity and, especially on major components of immune cells.",27902485_4,0,-1,2,-1,30705,-1,0.9912128,0.0010557107,0.0077315783
30707,general immunity,34,36,228,244,"Although previous reviews have described the effects of smoking on various diseases and regional immunity associated with specific diseases, a comprehensive and updated review is rarely seen to demonstrate impacts of smoking on general immunity and, especially on major components of immune cells.",27902485_4,-1,-1,-1,-1,30707,-1,0.10912177,0.8834713,0.0074068606
30722,the the,4,6,22,29,OBJECTIVE: To observe the the potential benefit of sunitinib in combination with cyclooxygenase-2(COX-2) inhibitor in renal cell carcinoma therapy.,27926489_0,-1,-1,-1,-1,30722,-1,4.645771e-06,0.99999154,3.7726973e-06
30724,therapy,20,21,139,146,OBJECTIVE: To observe the the potential benefit of sunitinib in combination with cyclooxygenase-2(COX-2) inhibitor in renal cell carcinoma therapy.,27926489_0,0,1,-1,-1,30724,-1,4.2847255e-06,0.9999908,4.9505934e-06
30737,blood,16,17,90,95,The myeloid-derived suppressor cells (MDSCs) and regulatory T cells (Tregs) in peripheral blood and spleen were determined by flow cytometry.,27926489_5,0,1,-1,-1,30737,-1,0.00090994796,0.99456763,0.0045224368
30739,protein,2,3,10,17,The MDSCs protein was extracted for STAT3 analysis by western blot.,27926489_6,0,1,-1,-1,30739,-1,1.3222674e-05,0.9999764,1.0409403e-05
30740,STAT3 analysis,6,8,36,50,The MDSCs protein was extracted for STAT3 analysis by western blot.,27926489_6,-1,-1,-1,-1,30740,-1,6.7859073e-06,0.9999865,6.6344232e-06
30746,than those,12,14,82,92,Combination of sunitinib and celecoxib in vivo could effectively reduce the MDSCs than those in control group.,27926489_9,-1,-1,-1,-1,30746,-1,6.3610914e-06,0.9999871,6.5711683e-06
30752,therapy,3,4,24,31,CONCLUSION: Combination therapy with sunitinib and celecoxib intensified the curative effects to renal cell carcinoma by suppressing immune regulatory cells.,27926489_11,0,1,-1,-1,30752,-1,7.6015563e-06,0.9999871,5.260275e-06
30763,deficiency,1,2,5,15,SHP2 deficiency in T cells aggravated colitis with increased level of pro-inflammatory cytokines including IFN- and IL-17A.,27935860_3,0,1,-1,-1,30763,-1,1.7543653e-05,0.999972,1.05112185e-05
30769,tumors than,11,13,66,77,"In contrast, the SHP2CD4-/- mice developed much fewer and smaller tumors than wild type mice with higher level of IFN- and enhanced cytotoxicity of CD8+ T cells in the tumor and peritumoral areas.",27935860_4,-1,-1,-1,-1,30769,-1,4.2323254e-06,0.99999034,5.4295338e-06
30773,the tumor,30,32,165,174,"In contrast, the SHP2CD4-/- mice developed much fewer and smaller tumors than wild type mice with higher level of IFN- and enhanced cytotoxicity of CD8+ T cells in the tumor and peritumoral areas.",27935860_4,-1,-1,-1,-1,30773,-1,4.1303724e-06,0.9999908,5.0083863e-06
30781,IFN- receptor,3,5,24,38,"IFN- neutralization or IFN- receptor knockout but not IL-17A neutralization, abrogated the anti-tumor effect of SHP2 knockout with lowered levels of perforin 1, FasL and granzyme B. Finally, the expression of granzyme B was negatively correlated with the malignancy of colon cancer in human patients.",27935860_6,-1,-1,-1,-1,30781,-1,0.9996038,3.002534e-05,0.0003662331
30787,to treat,9,11,53,61,"In conclusion, these findings suggest a new strategy to treat colitis-associated cancer via targeting SHP2.",27935860_7,-1,-1,-1,-1,30787,-1,4.816606e-06,0.9999901,5.0866997e-06
30791,receptor-negative,16,17,87,104,The expression of IL-17A and programmed death ligand 1 (PDL1) is increased in estrogen receptor-negative breast cancer.,27935862_0,0,1,2,-1,30791,-1,0.00144691,0.99660766,0.0019454071
30793,tumor cell,2,4,16,26,IL-17A promotes tumor cell survival and invasiveness and inhibits the antitumor immune response.,27935862_1,-1,-1,-1,-1,30793,-1,0.0009025425,0.06943483,0.92966264
30797,protein,5,6,31,38,The PDL1-PD1 (programmed death protein 1) signaling pathway promotes escape from immune surveillance in tumor cells.,27935862_2,0,1,-1,-1,30797,-1,0.12676121,0.8074208,0.06581802
30798,tumor cells,16,18,104,115,The PDL1-PD1 (programmed death protein 1) signaling pathway promotes escape from immune surveillance in tumor cells.,27935862_2,-1,-1,-1,-1,30798,-1,0.00060486974,0.03482717,0.964568
30801,the relationship,17,19,103,119,"The pro-tumor properties of IL-17A and PDL1 in various cancers have been previously examined; however, the relationship and roles of IL-17A and PDL1 in ER-negative breast cancer have not been evaluated.",27935862_3,-1,-1,-1,-1,30801,-1,6.162787e-06,0.9999877,6.1556034e-06
30805,tumor cells,10,12,66,77,"Therefore, we assessed whether IL-17A promotes PDL1 expression in tumor cells and whether targeting of IL-17A could inhibit ER-negative breast cancer progression in a murine model.",27935862_4,-1,-1,-1,-1,30805,-1,0.00055705995,0.04872372,0.9507193
30808,that IL-17A,3,5,19,30,Our study revealed that IL-17A promoted PDL1 expression in human and mouse cells.,27935862_5,-1,-1,-1,-1,30808,-1,0.89260215,0.10471261,0.0026852456
30813,the tumor,13,15,77,86,"In the murine cancer model, targeting of IL-17A inhibited PDL1 expression in the tumor microenvironment, decreased the percentage of Treg cells in tumor-infiltrating lymphocytes, and promoted CD4+ and CD8+ T cells to secrete interferon gamma.",27935862_6,-1,-1,-1,-1,30813,-1,3.988397e-06,0.9999906,5.4412703e-06
30816,tumor-infiltrating lymphocytes,24,26,147,177,"In the murine cancer model, targeting of IL-17A inhibited PDL1 expression in the tumor microenvironment, decreased the percentage of Treg cells in tumor-infiltrating lymphocytes, and promoted CD4+ and CD8+ T cells to secrete interferon gamma.",27935862_6,-1,-1,-1,-1,30816,-1,0.0016515232,0.8781189,0.120229594
30817,T cells to,34,37,206,216,"In the murine cancer model, targeting of IL-17A inhibited PDL1 expression in the tumor microenvironment, decreased the percentage of Treg cells in tumor-infiltrating lymphocytes, and promoted CD4+ and CD8+ T cells to secrete interferon gamma.",27935862_6,-1,-1,-1,-1,30817,-1,0.0013055438,0.036141627,0.9625528
30826,targeting relies,4,6,32,48,Clinical efficacy of PD-1/PD-L1 targeting relies upon the reactivation of tumor-specific but functionally impaired PD-1+ T cells present before therapy.,27979840_0,-1,-1,-1,-1,30826,-1,6.4464125e-06,0.9999881,5.4420143e-06
30829,functionally,12,13,93,105,Clinical efficacy of PD-1/PD-L1 targeting relies upon the reactivation of tumor-specific but functionally impaired PD-1+ T cells present before therapy.,27979840_0,0,1,2,-1,30829,-1,0.00012176468,0.9998511,2.715378e-05
30831,therapy,20,21,144,151,Clinical efficacy of PD-1/PD-L1 targeting relies upon the reactivation of tumor-specific but functionally impaired PD-1+ T cells present before therapy.,27979840_0,0,1,-1,-1,30831,-1,4.6193995e-06,0.9999914,3.9615084e-06
30835,T cells that,11,14,70,82,"Thus, analyzing early-stage primary tumors may reveal the presence of T cells that are not yet functionally impaired.",27979840_1,-1,-1,-1,-1,30835,-1,0.0014358223,0.044494413,0.9540698
30836,functionally,17,18,95,107,"Thus, analyzing early-stage primary tumors may reveal the presence of T cells that are not yet functionally impaired.",27979840_1,0,1,2,-1,30836,-1,0.0041558673,0.99552995,0.00031418202
30841,Tumor-infiltrating lymphocytes,0,2,0,30,"Tumor-infiltrating lymphocytes coexpressed PD-1 with the inhibitory receptors TIM-3, CTLA-4, LAG-3, and TIGIT, but also displayed a recently activated, nonexhausted phenotype.",27979840_3,-1,-1,-1,-1,30841,-1,0.002693331,0.8856168,0.111689925
30843,receptors TIM-3,7,9,68,83,"Tumor-infiltrating lymphocytes coexpressed PD-1 with the inhibitory receptors TIM-3, CTLA-4, LAG-3, and TIGIT, but also displayed a recently activated, nonexhausted phenotype.",27979840_3,-1,-1,-1,-1,30843,-1,0.0044114087,0.7038387,0.29174986
30849,functional,15,16,86,96,"We also identified a subset of CD8+PD-1+FOXP3+ T lymphocytes at the earliest phase of functional differentiation after priming, termed ""early effector cells"" (EEC), which also exhibited an activated nonexhausted phenotype, but was less differentiated and associated with coexpression of multiple inhibitory receptors.",27979840_4,0,1,2,-1,30849,-1,0.00049137924,0.9991386,0.00037004755
30852,receptors,49,50,307,316,"We also identified a subset of CD8+PD-1+FOXP3+ T lymphocytes at the earliest phase of functional differentiation after priming, termed ""early effector cells"" (EEC), which also exhibited an activated nonexhausted phenotype, but was less differentiated and associated with coexpression of multiple inhibitory receptors.",27979840_4,0,1,2,-1,30852,-1,9.8237986e-05,4.8303205e-05,0.9998535
30857,receptor,7,8,48,56,"The identification of EECs marked by inhibitory receptor expression at tumor sites will enable investigations of early stages of adaptive antitumor immunity, as well as support the rationale for administering immunotherapy in early-stage non-small cell lung cancer.",27979840_6,0,1,2,-1,30857,-1,0.00011411727,5.355939e-05,0.9998324
30859,immunity,21,22,148,156,"The identification of EECs marked by inhibitory receptor expression at tumor sites will enable investigations of early stages of adaptive antitumor immunity, as well as support the rationale for administering immunotherapy in early-stage non-small cell lung cancer.",27979840_6,0,-1,2,-1,30859,-1,0.9999049,1.8955243e-05,7.617741e-05
30862,Forkheadbox protein,0,2,0,19,"Forkheadbox protein 3 (FOXP3), initially identified as a key transcription factor for regulatory T cells (Treg cells), was also expressed in many tumors including pancreatic ductal adenocarcinoma (PDAC).",27991933_0,-1,-1,-1,-1,30862,-1,7.659333e-06,0.9999858,6.5642007e-06
30869,tissues,8,9,36,43,"In this study, we utilized 120 PDAC tissues after radical resection to detect cancer-FOXP3 and Treg cells by immunohistochemistry and evaluated clinical and pathological features of these patients.",27991933_2,-1,1,2,-1,30869,-1,0.0011230535,0.55949336,0.43938357
30874,tumor tissues,9,11,71,84,Cancer-FOXP3 was positively correlated with Treg cells accumulation in tumor tissues derived from PDAC patients.,27991933_3,-1,-1,-1,-1,30874,-1,8.813617e-06,0.99997413,1.7013626e-05
30877,the tumor,4,6,40,49,Overexpression of cancer-FOXP3 promoted the tumor growth in immunocompetent syngeneic mice but not in immunocompromised or Treg cell-depleted mice.,27991933_5,-1,-1,-1,-1,30877,-1,4.5593015e-06,0.99999106,4.396705e-06
30882,blood to the tumor,17,21,122,140,"Furthermore, CCL5 was directly trans-activated by cancer-FOXP3 and promoted the recruitment of Treg cells from peripheral blood to the tumor site in vitro and in vivo.",27991933_6,-1,-1,-1,-1,30882,-1,0.00026530257,0.99806076,0.0016739679
30885,that Treg cells,9,12,57,72,"This finding has been further reinforced by the evidence that Treg cells recruitment by cancer-FOXP3 was impaired by neutralization of CCL5, thereby inhibiting the growth of PDAC.",27991933_7,-1,-1,-1,-1,30885,-1,0.001893714,0.13834815,0.8597581
30898,the immune response,20,23,117,136,Foxp3+ T regulatory cells (Tregs) play critical roles in immune homeostasis primarily by suppressing many aspects of the immune response.,28001437_0,-1,-1,-1,-1,30898,-1,0.7054146,0.29275134,0.0018340455
30900,their cell,5,7,31,41,Tregs uniquely express GARP on their cell surface and GARP functions as a delivery system for latent TGF-.,28001437_1,-1,-1,-1,-1,30900,-1,0.0001638127,0.00070514256,0.99913114
30901,functions,10,11,59,68,Tregs uniquely express GARP on their cell surface and GARP functions as a delivery system for latent TGF-.,28001437_1,0,1,2,-1,30901,-1,1.4341471e-05,0.9999714,1.4293938e-05
30903,Treg-derived TGF-,1,3,3,21,"As Treg-derived TGF- may mediate the suppressive functions of Tregs, GARP may represent a target to inhibit Treg suppression in cancer or augment suppression in autoimmunity.",28001437_2,-1,-1,-1,-1,30903,-1,1.1816518e-05,0.999979,9.138643e-06
30905,functions,7,8,50,59,"As Treg-derived TGF- may mediate the suppressive functions of Tregs, GARP may represent a target to inhibit Treg suppression in cancer or augment suppression in autoimmunity.",28001437_2,0,1,2,-1,30905,-1,3.2719072e-05,0.9999347,3.264063e-05
30907,target to,15,17,91,100,"As Treg-derived TGF- may mediate the suppressive functions of Tregs, GARP may represent a target to inhibit Treg suppression in cancer or augment suppression in autoimmunity.",28001437_2,-1,-1,-1,-1,30907,-1,3.7213163e-06,0.9999926,3.7055675e-06
30911,Treg-derived TGF-,13,15,57,75,"Areas covered: This article will focus on 1) the role of Treg-derived TGF- in the suppressive activity of Treg, 2) the cellular and molecular regulation of expression of GARP on mouse and human Tregs, 3) the role of integrins in the activation of latent-TGF-/GARP complex, 4) an overview of our present understanding of the function of the latent-TGF-/GARP complex.",28001437_3,-1,-1,-1,-1,30911,-1,1.5267045e-05,0.9999716,1.3063117e-05
30914,the cellular,24,26,116,128,"Areas covered: This article will focus on 1) the role of Treg-derived TGF- in the suppressive activity of Treg, 2) the cellular and molecular regulation of expression of GARP on mouse and human Tregs, 3) the role of integrins in the activation of latent-TGF-/GARP complex, 4) an overview of our present understanding of the function of the latent-TGF-/GARP complex.",28001437_3,-1,-1,-1,-1,30914,-1,0.0033343537,0.89447916,0.10218653
30920,the function,61,63,322,334,"Areas covered: This article will focus on 1) the role of Treg-derived TGF- in the suppressive activity of Treg, 2) the cellular and molecular regulation of expression of GARP on mouse and human Tregs, 3) the role of integrins in the activation of latent-TGF-/GARP complex, 4) an overview of our present understanding of the function of the latent-TGF-/GARP complex.",28001437_3,-1,-1,-1,-1,30920,-1,6.058033e-06,0.9999889,5.081937e-06
30924,targeting the,8,10,48,61,Expert opinion: Two approaches are outlined for targeting the L-TGF-1/GARP complex for therapeutic purposes.,28001437_4,-1,-1,-1,-1,30924,-1,3.8097642e-06,0.9999925,3.7375555e-06
30927,Tregs play,0,2,0,10,Tregs play a major role in suppressive effector T cell responses to tumors and TGF-1 may be a major contributor to this process.,28001437_5,-1,-1,-1,-1,30927,-1,4.318582e-06,0.9999918,3.9331226e-06
30929,to tumors,11,13,65,74,Tregs play a major role in suppressive effector T cell responses to tumors and TGF-1 may be a major contributor to this process.,28001437_5,-1,-1,-1,-1,30929,-1,6.5214344e-06,0.99998593,7.5539233e-06
30931,to this,20,22,113,120,Tregs play a major role in suppressive effector T cell responses to tumors and TGF-1 may be a major contributor to this process.,28001437_5,-1,-1,-1,-1,30931,-1,7.274372e-06,0.9999875,5.265301e-06
30936,to tumor,16,18,95,103,One approach is to specifically block the production of active TGF-1 from Tregs as an adjunct to tumor immunotherapy.,28001437_6,-1,-1,-1,-1,30936,-1,7.760912e-06,0.99998677,5.4891166e-06
30942,Th1-type immunity,0,2,0,17,"Th1-type immunity is considered to be required for efficient response to BCG in bladder cancer, although Th2 predisposition of BCG responders has recently been reported.",28005163_0,-1,-1,-1,-1,30942,-1,0.00434318,0.99475855,0.0008982413
30948,the relationship,5,7,24,40,The aim was to evaluate the relationship of Th1 and Th2 components in 23 patients undergoing BCG treatment.,28005163_1,-1,-1,-1,-1,30948,-1,5.7764614e-06,0.99998915,5.0373583e-06
30952,blood,1,2,11,16,"Peripheral blood, serum and urine samples were prospectively collected at baseline, during and after BCG.",28005163_2,0,1,-1,-1,30952,-1,0.0027109992,0.9776184,0.019670673
30953,urine,5,6,28,33,"Peripheral blood, serum and urine samples were prospectively collected at baseline, during and after BCG.",28005163_2,0,1,-1,-1,30953,-1,0.0006872621,0.9991708,0.00014194107
30958,TNF-R75,19,20,100,107,"Th1 (neopterin, tryptophan, kynurenine, kynurenine-to-tryptophan ratio (KTR), IL-12, IFN-, soluble TNF-R75 and IL-2R) and Th2 (IL-4, IL-10) biomarkers as well as CD4 expression in T helper (Th), effector and regulatory T cells were determined.",28005163_3,0,1,-1,-1,30958,-1,0.001764,0.99797076,0.00026516814
30964,cell subsets,2,4,13,25,"Local immune cell subsets were measured on formalin-fixed, paraffin-embedded cancer tissue by immunohistochemistry to examine expression of transcription factors that control Th1 (T-bet) and Th2-type (GATA3) immunity.",28005163_4,-1,-1,-1,-1,30964,-1,1.7987553e-05,8.388668e-06,0.99997365
30965,tissue,11,12,84,90,"Local immune cell subsets were measured on formalin-fixed, paraffin-embedded cancer tissue by immunohistochemistry to examine expression of transcription factors that control Th1 (T-bet) and Th2-type (GATA3) immunity.",28005163_4,-1,1,2,-1,30965,-1,5.2039533e-05,0.9989491,0.0009989123
30967,transcription factors that,18,21,140,166,"Local immune cell subsets were measured on formalin-fixed, paraffin-embedded cancer tissue by immunohistochemistry to examine expression of transcription factors that control Th1 (T-bet) and Th2-type (GATA3) immunity.",28005163_4,-1,-1,-1,-1,30967,-1,4.2686497e-06,0.9999914,4.2983893e-06
30972,immunity,31,32,208,216,"Local immune cell subsets were measured on formalin-fixed, paraffin-embedded cancer tissue by immunohistochemistry to examine expression of transcription factors that control Th1 (T-bet) and Th2-type (GATA3) immunity.",28005163_4,0,-1,2,-1,30972,-1,0.9248297,0.071964495,0.0032057937
30976,therapy,62,63,194,201,"BCG responders showed significantly higher levels of urinary (p=0.003) and serum neopterin (p=0.012), kynurenine (p=0.015), KTR (p=0.005), IFN- (p=0.005) and IL-12 (p=0.003) during therapy, whereas levels of IL-10 decreased significantly (p<0.001) compared to non-responders.",28005163_6,0,1,-1,-1,30976,-1,5.056838e-06,0.9999902,4.7258286e-06
30981,the Th cell,9,12,56,67,"We observed a significant increase in CD4 expression in the Th cell population (p<0.05), with only a modest tendency toward higher frequency in responders compared to non-responders (p=0.303).",28005163_8,-1,-1,-1,-1,30981,-1,0.0014960116,0.19691037,0.8015936
30982,tendency toward,25,27,110,125,"We observed a significant increase in CD4 expression in the Th cell population (p<0.05), with only a modest tendency toward higher frequency in responders compared to non-responders (p=0.303).",28005163_8,-1,-1,-1,-1,30982,-1,6.3397083e-06,0.9999883,5.3005724e-06
30985,Th2-promoting factors,0,2,0,21,Th2-promoting factors such as GATA3 may trigger Th1-type immune responses and thus contribute to the BCG success.,28005163_10,-1,-1,-1,-1,30985,-1,8.543632e-06,0.9999838,7.7093555e-06
30987,trigger Th1-type immune responses,6,10,40,73,Th2-promoting factors such as GATA3 may trigger Th1-type immune responses and thus contribute to the BCG success.,28005163_10,-1,-1,-1,-1,30987,-1,0.07653979,0.9218427,0.0016175432
30989,to the,13,15,94,100,Th2-promoting factors such as GATA3 may trigger Th1-type immune responses and thus contribute to the BCG success.,28005163_10,-1,-1,-1,-1,30989,-1,6.196146e-06,0.9999883,5.5456044e-06
30992,tumor immunity,10,12,52,66,"The role of IL-33, particularly in tumor growth and tumor immunity, remains ill-defined.",28011934_0,-1,-1,-1,-1,30992,-1,0.075009376,0.92336696,0.0016236246
31003,therapy,19,20,94,101,"Notably, in addition to a direct action on CD8+ T cell expansion and IFN- production, rIL-33 therapy activated myeloid dendritic cells (mDCs) in tumor-bearing mice, restored antitumor T cell activity, and increased Ag cross-presentation within the tumor microenvironment.",28011934_3,0,1,-1,-1,31003,-1,4.4818144e-06,0.99999094,4.607729e-06
31007,the tumor,42,44,245,254,"Notably, in addition to a direct action on CD8+ T cell expansion and IFN- production, rIL-33 therapy activated myeloid dendritic cells (mDCs) in tumor-bearing mice, restored antitumor T cell activity, and increased Ag cross-presentation within the tumor microenvironment.",28011934_3,-1,-1,-1,-1,31007,-1,4.5455554e-06,0.99999094,4.524424e-06
31008,therapy,3,4,25,32,"Furthermore, combination therapy consisting of rIL-33 and agonistic anti-CD40 Abs demonstrated synergistic antitumor activity.",28011934_4,0,1,-1,-1,31008,-1,5.6015756e-06,0.9999894,4.978872e-06
31011,that the,4,6,27,35,"Importantly, we identified that the IL-33 receptor ST2, MyD88, and STAT1 cooperate to induce costimulatory molecule expression on mDCs in response to rIL-33.",28011934_6,-1,-1,-1,-1,31011,-1,3.942463e-06,0.999992,4.0719333e-06
31012,receptor,7,8,42,50,"Importantly, we identified that the IL-33 receptor ST2, MyD88, and STAT1 cooperate to induce costimulatory molecule expression on mDCs in response to rIL-33.",28011934_6,0,1,2,-1,31012,-1,0.030017613,0.11742683,0.8525556
31021,to treat,40,42,252,260,"Thus, our study revealed a novel IL-33-ST2-MyD88-STAT1 axis that restores mDC activation and maturation in established cancer and, thereby, the magnitude of antitumor immune responses, suggesting a potential use of rIL-33 as a new immunotherapy option to treat established cancer.",28011934_7,-1,-1,-1,-1,31021,-1,5.5663563e-06,0.9999888,5.670337e-06
31026,TCR gene,8,10,54,62,METHODS: Immunophenotyping of circulating T cells and TCR gene restriction analysis using Biomed-2 protocol.,28018996_2,-1,-1,-1,-1,31026,-1,8.779806e-06,0.9999701,2.117426e-05
31027,analysis,11,12,75,83,METHODS: Immunophenotyping of circulating T cells and TCR gene restriction analysis using Biomed-2 protocol.,28018996_2,0,1,-1,-1,31027,-1,1.4001954e-05,0.99997306,1.2952506e-05
31031,blood,18,19,130,135,NF-B staining and mRNA quantification of inflammatory genes in HK-2 epithelial renal cells exposed to supernatants of peripheral blood mononuclear cells with clonal T-cell population.,28018996_3,0,1,-1,-1,31031,-1,0.0009116861,0.9982961,0.0007922589
31033,T-cell,23,24,166,172,NF-B staining and mRNA quantification of inflammatory genes in HK-2 epithelial renal cells exposed to supernatants of peripheral blood mononuclear cells with clonal T-cell population.,28018996_3,-1,1,2,-1,31033,-1,9.661684e-06,6.0059797e-06,0.9999844
31034,T-cell,10,11,53,59,"RESULTS: Here, we could identify a persistent clonal T-cell population, only characterized by in-depth immunophenotyping of circulating lymphocytes and using multiplex PCR analysis of TCR gene rearrangements, in two patients with polymorphic inflammatory renal fibrosis of unknown origin.",28018996_4,-1,1,2,-1,31034,-1,9.118692e-06,5.82712e-06,0.9999851
31036,analysis,25,26,172,180,"RESULTS: Here, we could identify a persistent clonal T-cell population, only characterized by in-depth immunophenotyping of circulating lymphocytes and using multiplex PCR analysis of TCR gene rearrangements, in two patients with polymorphic inflammatory renal fibrosis of unknown origin.",28018996_4,0,1,-1,-1,31036,-1,7.2176967e-06,0.99998593,6.8163686e-06
31037,TCR gene,27,29,184,192,"RESULTS: Here, we could identify a persistent clonal T-cell population, only characterized by in-depth immunophenotyping of circulating lymphocytes and using multiplex PCR analysis of TCR gene rearrangements, in two patients with polymorphic inflammatory renal fibrosis of unknown origin.",28018996_4,-1,-1,-1,-1,31037,-1,1.1277604e-05,0.9999646,2.4096433e-05
31040,blood,11,12,65,70,"Using an in vitro approach, we could demonstrate that peripheral blood mononuclear cells including the clonal population can trigger a phenotype switch of epithelial renal cells from a quiescent state to a pro-inflammatory state characterized by NF-B nuclear translocation and overexpression of inflammatory cytokine or chemokine.",28018996_5,0,1,-1,-1,31040,-1,0.000847601,0.997378,0.0017744331
31045,state to,30,32,195,203,"Using an in vitro approach, we could demonstrate that peripheral blood mononuclear cells including the clonal population can trigger a phenotype switch of epithelial renal cells from a quiescent state to a pro-inflammatory state characterized by NF-B nuclear translocation and overexpression of inflammatory cytokine or chemokine.",28018996_5,-1,-1,-1,-1,31045,-1,4.2479446e-06,0.99998796,7.790353e-06
31052,T-cell,8,9,60,66,"CONCLUSION: These preliminary data suggest that circulating T-cell clones may directly activate epithelial renal cells or promote a T-/B-cell population with autoimmune reactive properties against kidney cells, which, in the absence of overt renal lymphoma infiltration, lead to the subsequent inflammatory renal fibrotic phenotype.",28018996_6,-1,1,2,-1,31052,-1,9.801236e-06,5.6390195e-06,0.9999846
31054,kidney cells,26,28,197,209,"CONCLUSION: These preliminary data suggest that circulating T-cell clones may directly activate epithelial renal cells or promote a T-/B-cell population with autoimmune reactive properties against kidney cells, which, in the absence of overt renal lymphoma infiltration, lead to the subsequent inflammatory renal fibrotic phenotype.",28018996_6,-1,-1,-1,-1,31054,-1,5.8020993e-05,2.1297881e-05,0.9999206
31056,to the,41,43,276,282,"CONCLUSION: These preliminary data suggest that circulating T-cell clones may directly activate epithelial renal cells or promote a T-/B-cell population with autoimmune reactive properties against kidney cells, which, in the absence of overt renal lymphoma infiltration, lead to the subsequent inflammatory renal fibrotic phenotype.",28018996_6,-1,-1,-1,-1,31056,-1,4.6174255e-06,0.9999913,4.0699083e-06
31062,T-cell,5,6,35,41,"We explored approaches to overcome T-cell suppression in murine breast and kidney adenocarcinomas, and lung fibrosarcoma expressing immunogenic antigens.",28052005_1,-1,1,2,-1,31062,-1,1.1528774e-05,1.1283555e-05,0.9999771
31065,that treatment,2,4,12,26,"We observed that treatment with a reversible proteasome inhibitor bortezomib (1 mg/kg body weight) in tumor-bearing mice significantly enhanced the expression of lymphocyte-stimulatory cytokines IL-2, IL-12, and IL-15.",28052005_2,-1,-1,-1,-1,31065,-1,4.5773904e-06,0.99999106,4.3658606e-06
31068,lymphocyte-stimulatory cytokines,24,26,162,194,"We observed that treatment with a reversible proteasome inhibitor bortezomib (1 mg/kg body weight) in tumor-bearing mice significantly enhanced the expression of lymphocyte-stimulatory cytokines IL-2, IL-12, and IL-15.",28052005_2,-1,-1,-1,-1,31068,-1,0.6846766,0.00089537806,0.31442803
31073,IL-15 cytokines,4,6,28,43,Neutralization of IL-12 and IL-15 cytokines with a regimen of blocking antibodies pre- and post-adoptive transfer of low-avidity HA518-526-specific CD8+T-cells following intravenous injection of 4T1HA cells increased the number of pulmonary tumor nodules.,28052005_4,-1,-1,-1,-1,31073,-1,0.9999707,3.422922e-06,2.5809926e-05
31079,the tumor,6,8,47,56,This neutralization effect was counteracted by the tumor metastasis-suppressing action of bortezomib treatments.,28052005_5,-1,-1,-1,-1,31079,-1,6.255138e-06,0.9999894,4.350566e-06
31089,IL-15 receptors,13,15,65,80,"We also noted a trend of increased expression of IL-2, IL-12 and IL-15 receptors as well as increased phosphorylation of STAT5 in tumor-infiltrating CD8+T-cells following bortezomib treatment.",28052005_7,-1,-1,-1,-1,31089,-1,0.99784756,8.012021e-05,0.0020722696
31093,protein,9,10,98,105,"Furthermore, bortezomib-treated CD8+T-cells showed increased phosphorylation of mitogen-activated protein kinase p38, and Akt, which was abrogated by phosphatidylinositide 3-kinase (PI3K) inhibitor.",28052005_8,0,1,-1,-1,31093,-1,0.00017232727,0.9997756,5.208835e-05
31095,the therapeutic,3,5,19,34,"These data support the therapeutic potential of bortezomib in conjunction with other immunotherapies to augment the strength of convergent signals from CD8+T-cell signaling molecules including TCR, cytokine receptors and downstream PI3K/Akt/STAT5 pathways to sustain CD8+T-cell effector function in the tumor microenvironment.",28052005_9,-1,-1,-1,-1,31095,-1,4.3578357e-06,0.9999919,3.7291543e-06
31098,TCR,25,26,193,196,"These data support the therapeutic potential of bortezomib in conjunction with other immunotherapies to augment the strength of convergent signals from CD8+T-cell signaling molecules including TCR, cytokine receptors and downstream PI3K/Akt/STAT5 pathways to sustain CD8+T-cell effector function in the tumor microenvironment.",28052005_9,-1,1,2,-1,31098,-1,2.706056e-05,0.9998826,9.036726e-05
31099,cytokine receptors,27,29,198,216,"These data support the therapeutic potential of bortezomib in conjunction with other immunotherapies to augment the strength of convergent signals from CD8+T-cell signaling molecules including TCR, cytokine receptors and downstream PI3K/Akt/STAT5 pathways to sustain CD8+T-cell effector function in the tumor microenvironment.",28052005_9,-1,-1,-1,-1,31099,-1,0.99953175,1.5442554e-05,0.0004528065
31101,function,37,38,287,295,"These data support the therapeutic potential of bortezomib in conjunction with other immunotherapies to augment the strength of convergent signals from CD8+T-cell signaling molecules including TCR, cytokine receptors and downstream PI3K/Akt/STAT5 pathways to sustain CD8+T-cell effector function in the tumor microenvironment.",28052005_9,0,1,2,-1,31101,-1,0.00010576694,0.000102652826,0.9997917
31102,the tumor,39,41,299,308,"These data support the therapeutic potential of bortezomib in conjunction with other immunotherapies to augment the strength of convergent signals from CD8+T-cell signaling molecules including TCR, cytokine receptors and downstream PI3K/Akt/STAT5 pathways to sustain CD8+T-cell effector function in the tumor microenvironment.",28052005_9,-1,-1,-1,-1,31102,-1,4.6011396e-06,0.9999914,4.024323e-06
31103,T cells that,2,5,5,17,CD8+ T cells that express retinoic acid-related orphan receptor (ROR)t (TC17 cells) have been shown to promote procarcinogenic inflammation and contribute to a tolerogenic microenvironment in tumors.,28053236_0,-1,-1,-1,-1,31103,-1,0.001453619,0.045876633,0.9526697
31104,receptor,9,10,55,63,CD8+ T cells that express retinoic acid-related orphan receptor (ROR)t (TC17 cells) have been shown to promote procarcinogenic inflammation and contribute to a tolerogenic microenvironment in tumors.,28053236_0,0,1,2,-1,31104,-1,0.0015080426,0.9250748,0.073417194
31105,TC17 cells,12,14,73,83,CD8+ T cells that express retinoic acid-related orphan receptor (ROR)t (TC17 cells) have been shown to promote procarcinogenic inflammation and contribute to a tolerogenic microenvironment in tumors.,28053236_0,-1,-1,-1,-1,31105,-1,0.0010965394,0.06805572,0.9308477
31111,functional,5,6,36,46,We investigated their phenotype and functional properties in relationship to the pathogenesis of human distal bile duct cancer (DBDC).,28053236_1,0,1,2,-1,31111,-1,0.00038553888,0.99939835,0.00021615966
31112,relationship to the,8,11,61,80,We investigated their phenotype and functional properties in relationship to the pathogenesis of human distal bile duct cancer (DBDC).,28053236_1,-1,-1,-1,-1,31112,-1,7.58205e-06,0.999984,8.416601e-06
31117,TC17 cells,19,21,105,115,DBDC patients had an elevated level of type 17 immune responses and the frequency of CD8+RORt+ T cells (TC17 cells) was increased in peripheral blood.,28053236_2,-1,-1,-1,-1,31117,-1,0.00093753095,0.06087091,0.93819153
31118,blood,26,27,145,150,DBDC patients had an elevated level of type 17 immune responses and the frequency of CD8+RORt+ T cells (TC17 cells) was increased in peripheral blood.,28053236_2,0,1,-1,-1,31118,-1,8.271954e-05,0.99982005,9.729368e-05
31124,TH17 cells,20,22,120,130,The CD8+RORt+ T cells represented a highly activated subset and produced IL-17A in equal amount as CD4+RORt+ T cells (TH17 cells).,28053236_3,-1,-1,-1,-1,31124,-1,0.0007873699,0.06820474,0.931008
31132,plasticity toward,23,25,146,163,"Most CD8+RORt+ T cells coexpressed T-bet, a lineage transcription factor for TH1 and TC1 development, suggesting that CD8+RORt+ T cells undergo plasticity toward a TC17/1-like phenotype with coproduction of IL-17A and INF-.",28053236_4,-1,-1,-1,-1,31132,-1,5.50262e-06,0.9999871,7.375801e-06
31137,TCR,16,17,84,87,"In comparison with CD8+RORt- T cells, the CD8+RORt+ T cells had a higher level of TCR signaling and were terminally differentiated and exhausted.",28053236_5,-1,1,2,-1,31137,-1,1.2428804e-05,0.9999678,1.9727935e-05
31139,These cells,0,2,0,11,These cells also had impaired ability to re-express perforin after degranulation and reduced cytotoxic immune function.,28053236_6,-1,-1,-1,-1,31139,-1,2.4531635e-05,1.9148523e-05,0.99995625
31141,function,15,16,110,118,These cells also had impaired ability to re-express perforin after degranulation and reduced cytotoxic immune function.,28053236_6,0,1,2,-1,31141,-1,0.059363015,0.0046345294,0.9360025
31145,protein,14,15,79,86,A subset of CD8+RORt+ T cells expressing a low level of programmed cell death protein 1 and a high level of OX40 were associated with reduced patient survival.,28053236_7,0,1,-1,-1,31145,-1,0.00029629437,0.99944013,0.0002635812
31147,functionally,9,10,58,70,"In conclusion, CD8+RORt+ T cells are proinflammatory and functionally impaired and may contribute to the pathogenesis of DBDC.",28053236_8,0,1,2,-1,31147,-1,0.0009352247,0.9989134,0.00015143257
31148,to the,14,16,99,105,"In conclusion, CD8+RORt+ T cells are proinflammatory and functionally impaired and may contribute to the pathogenesis of DBDC.",28053236_8,-1,-1,-1,-1,31148,-1,6.5199933e-06,0.9999871,6.3841794e-06
31160,targets that,1,3,5,17,Drug targets that are in use to interfere with inflammation in cancer are discussed.,28067176_4,-1,-1,-1,-1,31160,-1,5.6370272e-06,0.99998975,4.6575315e-06
31162,tumor-induced tolerance,4,6,34,57,CONCLUSION: Inflammation mediates tumor-induced tolerance.,28067176_5,-1,-1,-1,-1,31162,-1,2.1666143e-05,0.99997103,7.338371e-06
31167,peptide,5,6,27,34,"MENK, an endogenous opioid peptide has been reported to have many immunological and antitumor activities.",28088065_0,0,-1,2,-1,31167,-1,0.9991602,8.431121e-05,0.00075546285
31179,TLR4 through,36,38,235,247,"We found bone marrow derived dendritic cells (BMDCs) in 36 female C57BL/6 mice treated with MENK enhanced expression of key surface molecules, increased production of critical cytokines reduced endocytosis of FITC-dextran, upregulated TLR4 through MyD88/NF-B signaling pathway and mounted higher antitumor activity.",28088065_4,-1,-1,-1,-1,31179,-1,9.195481e-06,0.99997854,1.2232523e-05
31185,receptors,3,4,24,33,"Surprisingly, mu-opioid receptors were the main participants of this kind of activation, not delta-opioid receptors nor kappa-opioid receptors, and these interactions could be partly blocked by Naltrexone (a kind of opioid antagonist).",28088065_6,0,1,2,-1,31185,-1,4.02825e-05,7.495377e-05,0.9998847
31188,receptors,16,17,106,115,"Surprisingly, mu-opioid receptors were the main participants of this kind of activation, not delta-opioid receptors nor kappa-opioid receptors, and these interactions could be partly blocked by Naltrexone (a kind of opioid antagonist).",28088065_6,0,1,2,-1,31188,-1,4.1984356e-05,0.00011894643,0.99983907
31189,receptors,19,20,133,142,"Surprisingly, mu-opioid receptors were the main participants of this kind of activation, not delta-opioid receptors nor kappa-opioid receptors, and these interactions could be partly blocked by Naltrexone (a kind of opioid antagonist).",28088065_6,0,1,2,-1,31189,-1,4.2410666e-05,9.803232e-05,0.9998596
31201,receptor,15,16,97,105,"Thus, it is concluded that MENK could exert antitumor effect through precisely regulating opioid receptor mediated functions of DCs.",28088065_8,0,1,2,-1,31201,-1,0.026122589,0.2927516,0.6811259
31202,functions,17,18,115,124,"Thus, it is concluded that MENK could exert antitumor effect through precisely regulating opioid receptor mediated functions of DCs.",28088065_8,0,1,2,-1,31202,-1,0.0024316101,0.96268034,0.034888007
31205,The c-Rel transcription factor,0,4,0,30,"The c-Rel transcription factor is a unique member of the nuclear factor (NF)-B family that has a role in curtailing the proliferation, differentiation, cytokine production, and overall activity of B- and T-cells.",28090796_0,-1,-1,-1,-1,31205,-1,5.4833235e-06,0.9999894,5.0853764e-06
31206,the nuclear factor,9,12,53,71,"The c-Rel transcription factor is a unique member of the nuclear factor (NF)-B family that has a role in curtailing the proliferation, differentiation, cytokine production, and overall activity of B- and T-cells.",28090796_0,-1,-1,-1,-1,31206,-1,4.915482e-06,0.99999034,4.7916287e-06
31210,T-cells,34,35,205,212,"The c-Rel transcription factor is a unique member of the nuclear factor (NF)-B family that has a role in curtailing the proliferation, differentiation, cytokine production, and overall activity of B- and T-cells.",28090796_0,-1,1,2,-1,31210,-1,1.4073651e-05,1.7160191e-05,0.99996877
31218,the relationship,3,5,21,37,"To better understand the relationship between c-Rel expression and effects on B- and T-cell expansion, the current study evaluated c-Rel expression in cord blood mononuclear cells.",28090796_2,-1,-1,-1,-1,31218,-1,7.2337725e-06,0.9999887,4.0532536e-06
31220,T-cell,13,14,85,91,"To better understand the relationship between c-Rel expression and effects on B- and T-cell expansion, the current study evaluated c-Rel expression in cord blood mononuclear cells.",28090796_2,-1,1,2,-1,31220,-1,1.176136e-05,9.268745e-06,0.9999789
31223,blood,24,25,156,161,"To better understand the relationship between c-Rel expression and effects on B- and T-cell expansion, the current study evaluated c-Rel expression in cord blood mononuclear cells.",28090796_2,0,1,-1,-1,31223,-1,0.00017537439,0.99973553,8.907168e-05
31226,blood,7,8,44,49,"This particular source was selected as cord blood is an important source of cells used for transplantation and immunotherapy, primarily in treating leukemias.",28090796_3,0,1,-1,-1,31226,-1,0.011240071,0.79136217,0.19739775
31228,transplantation,16,17,91,106,"This particular source was selected as cord blood is an important source of cells used for transplantation and immunotherapy, primarily in treating leukemias.",28090796_3,-1,1,2,-1,31228,-1,7.263782e-06,0.99998593,6.791614e-06
31238,blood,52,53,277,282,"As stem cell factor (SCF) and FLT3 are important agents for hematopoietic stem cell expansion, and cytokines like interleukin (IL)-2, -7, and -15 are essential for T- and B- (and also NK) cell development and proliferation, the current study evaluated c-Rel expression in cord blood mononuclear cells and CD34+cells, as well as effects on B-, T-, and NK cells associated with alterations in c-Rel expression, using flow cytometry and PCR.",28090796_4,0,1,-1,-1,31238,-1,0.00014539225,0.99978215,7.246449e-05
31253,blood-derived,10,11,62,75,"Further, inhibition of c-Rel expression by siRNA reduced cord blood-derived B-, T-, and NK cell differentiation and expansion.",28090796_6,0,1,-1,-1,31253,-1,0.0009091974,0.9961958,0.002895029
31259,blood,9,10,59,64,"These results indicated that with cells isolated from cord blood, c-Rel has an important role in B-, T-, and NK cell differentiation and, further, that agents (select cytokines/growth factors) that could impact on its expression might not only affect immune cell profiles in a host but could potentially also limit apoptotic activities in (non-)immune cells in that host.",28090796_7,0,1,-1,-1,31259,-1,0.00018649953,0.99958056,0.000232906
31264,factors,34,35,184,191,"These results indicated that with cells isolated from cord blood, c-Rel has an important role in B-, T-, and NK cell differentiation and, further, that agents (select cytokines/growth factors) that could impact on its expression might not only affect immune cell profiles in a host but could potentially also limit apoptotic activities in (non-)immune cells in that host.",28090796_7,0,1,-1,-1,31264,-1,0.99994254,1.0233562e-05,4.7244164e-05
31270,blood,12,13,67,72,"In the context of cancer (immuno)therapy, in particular, when cord blood is used an important source in stem cell transplantation in leukemia patients, such down-regulating changes in c-Rel levels could be counter-productive.",28090796_8,0,1,-1,-1,31270,-1,0.01385581,0.036860347,0.9492838
31271,cell transplantation,20,22,109,129,"In the context of cancer (immuno)therapy, in particular, when cord blood is used an important source in stem cell transplantation in leukemia patients, such down-regulating changes in c-Rel levels could be counter-productive.",28090796_8,-1,-1,-1,-1,31271,-1,0.0030422607,0.025536763,0.971421
31280,antigen-specific targeting,9,11,57,83,We previously showed that polyclonal T cells can acquire antigen-specific targeting activity through arming with exosomal peptide-MHC (pMHC).,28096300_1,-1,-1,-1,-1,31280,-1,0.995097,0.0039716093,0.000931477
31282,peptide-MHC,16,17,122,133,We previously showed that polyclonal T cells can acquire antigen-specific targeting activity through arming with exosomal peptide-MHC (pMHC).,28096300_1,0,-1,2,-1,31282,-1,0.0044888505,0.9948726,0.0006384632
31289,immunity,36,37,212,220,"In this study, we assessed the suppressive effect of CD8+25+ Tregs or CD8+25+ Tregs armed with ovalbumin (OVA)-specific exosomes on other immune cells and OVA-specific dendritic cell (DCOVA)-stimulated antitumor immunity.",28096300_2,0,-1,2,-1,31289,-1,0.9998611,3.9050854e-05,9.9787765e-05
31303,through the,8,10,52,63,"Tregs also anergize DCs by preventing DC maturation through the down-regulation of Iab, CD80, CD86, and inflammatory cytokines, leading to defects in T cell stimulation.",28096300_5,-1,-1,-1,-1,31303,-1,5.254742e-06,0.9999906,4.1619605e-06
31309,CTLs through,8,10,32,44,"Moreover, CD8+25+ Tregs inhibit CTLs through inducing CTL death via perforin-mediated apoptosis and through reducing effector CTL cytotoxic activity via down-regulating CTL perforin-production and degranulation.",28096300_6,-1,-1,-1,-1,31309,-1,0.0028847987,0.014729693,0.9823856
31317,immunity,22,23,123,131,"In addition, we show that CD8+25+ Tregs suppress DCOVA-stimulated CTL responses in priming and effector phases and inhibit immunity against OVA-expressing CCLOVA lung cancer.",28096300_7,0,-1,2,-1,31317,-1,0.99958104,0.00025685038,0.00016203754
31324,Taken together,0,2,0,14,"Taken together, our investigation reveals that assigning antigen specificity to nonspecific polyclonal CD8+25+ Tregs for enhanced immune suppression can be achieved through exosomal pMHC arming.",28096300_9,-1,-1,-1,-1,31324,-1,9.460995e-06,0.9999825,8.015648e-06
31335,therapy,6,7,33,40,"In mouse models of PD-1 blockade therapy, we found that tumor-reactive cytotoxic T lymphocytes (CTLs) in draining lymph nodes (DLNs) carry increased mitochondrial mass and more reactive oxygen species (ROS).",28096382_1,0,1,-1,-1,31335,-1,4.3810674e-06,0.99999094,4.681661e-06
31336,that tumor-reactive cytotoxic T lymphocytes,10,15,51,94,"In mouse models of PD-1 blockade therapy, we found that tumor-reactive cytotoxic T lymphocytes (CTLs) in draining lymph nodes (DLNs) carry increased mitochondrial mass and more reactive oxygen species (ROS).",28096382_1,-1,-1,-1,-1,31336,-1,0.0040783845,0.5102176,0.48570403
31341,the tumoricidal,14,16,99,114,We show that ROS generation by ROS precursors or indirectly by mitochondrial uncouplers synergized the tumoricidal activity of PD-1 blockade by expansion of effector/memory CTLs in DLNs and within the tumor.,28096382_2,-1,-1,-1,-1,31341,-1,9.225557e-05,0.9998827,2.4981717e-05
31343,the tumor,29,31,197,206,We show that ROS generation by ROS precursors or indirectly by mitochondrial uncouplers synergized the tumoricidal activity of PD-1 blockade by expansion of effector/memory CTLs in DLNs and within the tumor.,28096382_2,-1,-1,-1,-1,31343,-1,4.049517e-06,0.9999914,4.5255915e-06
31344,These CTLs,0,2,0,10,These CTLs carry not only the activation of mechanistic target of rapamycin (mTOR) and AMP-activated protein kinase (AMPK) but also an increment of their downstream transcription factors such as PPAR-gamma coactivator 1 (PGC-1) and T-bet.,28096382_3,-1,-1,-1,-1,31344,-1,0.002011913,0.08948268,0.9085054
31347,protein,17,18,101,108,These CTLs carry not only the activation of mechanistic target of rapamycin (mTOR) and AMP-activated protein kinase (AMPK) but also an increment of their downstream transcription factors such as PPAR-gamma coactivator 1 (PGC-1) and T-bet.,28096382_3,0,1,-1,-1,31347,-1,3.6480196e-05,0.9999347,2.8784138e-05
31350,PPAR-gamma coactivator,33,35,195,217,These CTLs carry not only the activation of mechanistic target of rapamycin (mTOR) and AMP-activated protein kinase (AMPK) but also an increment of their downstream transcription factors such as PPAR-gamma coactivator 1 (PGC-1) and T-bet.,28096382_3,-1,-1,-1,-1,31350,-1,5.454264e-05,0.99991465,3.085276e-05
31354,therapy,16,17,90,97,"Furthermore, direct activators of mTOR, AMPK, or PGC-1 also synergized the PD-1 blockade therapy whereas none of above-mentioned chemicals alone had any effects on tumor growth.",28096382_4,0,1,-1,-1,31354,-1,4.262261e-06,0.99999094,4.8447578e-06
31362,functions,8,9,48,57,AIM: To investigate the abundance and potential functions of LAP+CD4+ T cells in colorectal cancer (CRC).METHODS: Proportions of LAP+CD4+ T cells were examined in peripheral blood and tumor/paratumor tissues of CRC patients and healthy controls using flow cytometry.,28210081_0,0,1,2,-1,31362,-1,5.2566204e-05,0.99989915,4.8234655e-05
31365,blood,29,30,174,179,AIM: To investigate the abundance and potential functions of LAP+CD4+ T cells in colorectal cancer (CRC).METHODS: Proportions of LAP+CD4+ T cells were examined in peripheral blood and tumor/paratumor tissues of CRC patients and healthy controls using flow cytometry.,28210081_0,0,1,-1,-1,31365,-1,0.0009205105,0.9936832,0.005396341
31366,tissues,32,33,200,207,AIM: To investigate the abundance and potential functions of LAP+CD4+ T cells in colorectal cancer (CRC).METHODS: Proportions of LAP+CD4+ T cells were examined in peripheral blood and tumor/paratumor tissues of CRC patients and healthy controls using flow cytometry.,28210081_0,-1,1,2,-1,31366,-1,9.539418e-06,0.9999682,2.2308901e-05
31368,T-lymphocyte-associated protein,11,13,73,104,"Expression of phenotypic markers such as forkhead box (Fox)p3, cytotoxic T-lymphocyte-associated protein (CTLA)-4, chemokine CC receptor (CCR)4 and CCR5 was measured using flow cytometry.",28210081_1,-1,-1,-1,-1,31368,-1,7.87429e-05,0.00017177753,0.9997495
31370,receptor,17,18,128,136,"Expression of phenotypic markers such as forkhead box (Fox)p3, cytotoxic T-lymphocyte-associated protein (CTLA)-4, chemokine CC receptor (CCR)4 and CCR5 was measured using flow cytometry.",28210081_1,0,1,2,-1,31370,-1,0.036712773,0.00019975854,0.96308744
31376,cytokines interleukin,11,13,83,104,Real-time quantitative polymerase chain reaction was used to measure expression of cytokines interleukin (IL)-10 and transforming growth factor (TGF)-.,28210081_3,-1,-1,-1,-1,31376,-1,0.9999374,7.4694726e-06,5.509559e-05
31377,transforming growth factor,15,18,117,143,Real-time quantitative polymerase chain reaction was used to measure expression of cytokines interleukin (IL)-10 and transforming growth factor (TGF)-.,28210081_3,-1,-1,-1,-1,31377,-1,0.97666264,0.0197421,0.003595232
31380,blood,14,15,83,88,"RESULTS: The proportion of LAP+CD4+ T cells was significantly higher in peripheral blood from patients (9.44%  3.18%) than healthy controls (1.49%  1.00%, P < 0.001).",28210081_4,0,1,-1,-1,31380,-1,0.00018727512,0.99889404,0.0009186612
31384,tumor tissues,14,16,79,92,"Among patients, the proportion of LAP+CD4+ T cells was significantly higher in tumor tissues (11.76%  3.74%) compared with paratumor tissues (3.87%  1.64%, P < 0.001).",28210081_5,-1,-1,-1,-1,31384,-1,7.1558134e-06,0.9999745,1.8401895e-05
31385,tissues,26,27,134,141,"Among patients, the proportion of LAP+CD4+ T cells was significantly higher in tumor tissues (11.76%  3.74%) compared with paratumor tissues (3.87%  1.64%, P < 0.001).",28210081_5,-1,1,2,-1,31385,-1,1.0887041e-05,0.99990094,8.815884e-05
31406,the tumor,8,10,44,53,CONCLUSION: LAP+CD4+ T cells accumulated in the tumor microenvironment of CRC patients and were involved in immune evasion mediated by IL-10 and TGF-.,28210081_10,-1,-1,-1,-1,31406,-1,4.00343e-06,0.99999154,4.4196777e-06
31410,immunity,6,7,38,46,IL-21 is known to promote anti-tumour immunity due to its ability to promote T cell responses and counteract Treg-mediated suppression.,28239749_0,0,-1,2,-1,31410,-1,0.99976355,7.793157e-05,0.00015856184
31421,natural Treg,18,20,110,122,"However, whether this represents inhibition of FOXP3 induction in nave CD4 T cells or curtailed expansion of natural Treg remains unclear.",28239749_2,-1,-1,-1,-1,31421,-1,2.065104e-05,0.999972,7.310723e-06
31424,factors,13,14,98,105,"Moreover, whether this effect is maintained in an environment of tumour-derived immunosuppressive factors is not known.",28239749_3,0,1,-1,-1,31424,-1,0.9996369,0.0002719853,9.114061e-05
31430,that FOXP3,29,31,133,143,"Here, we show that in the context of a number of cancers, nave CD45RA+ CD4 T cells are induced to express high levels of FOXP3, and that FOXP3 expression correlates with inhibition of T cell proliferation.",28239749_4,-1,-1,-1,-1,31430,-1,5.633957e-06,0.9999895,4.9026266e-06
31438,that Treg,2,4,12,21,We conclude that Treg induction in nave T cells is a common phenomenon amongst a number of different cancers and that the ability of IL-21 to counteract this effect is further evidence of its promise in cancer therapy.,28239749_6,-1,-1,-1,-1,31438,-1,7.862968e-06,0.99998665,5.4435745e-06
31440,that the,20,22,114,122,We conclude that Treg induction in nave T cells is a common phenomenon amongst a number of different cancers and that the ability of IL-21 to counteract this effect is further evidence of its promise in cancer therapy.,28239749_6,-1,-1,-1,-1,31440,-1,4.617985e-06,0.9999913,4.049022e-06
31443,therapy,37,38,211,218,We conclude that Treg induction in nave T cells is a common phenomenon amongst a number of different cancers and that the ability of IL-21 to counteract this effect is further evidence of its promise in cancer therapy.,28239749_6,0,1,-1,-1,31443,-1,4.863736e-06,0.99999046,4.6624364e-06
31445,to treat,10,12,77,85,Immunotherapy is being increasingly recognized as a key therapeutic modality to treat cancer and represents one of the most exciting treatments for the disease.,28258697_0,-1,-1,-1,-1,31445,-1,5.912383e-06,0.9999887,5.3937283e-06
31450,therapies targeting the,11,14,86,109,"Fighting cancer with immunotherapy has revolutionized treatment for some patients and therapies targeting the immune checkpoint molecules such as CTLA-4 and PD-1 have achieved durable responses in melanoma, renal cancer, Hodgkin's diseases and lung cancer.",28258697_1,-1,-1,-1,-1,31450,-1,3.227379e-06,0.99999297,3.7852913e-06
31453,these treatments,6,8,29,45,"However, the success rate of these treatments has been low and a large number of cancers, including colorectal cancer remain largely refractory to CTLA-4 and PD-1 blockade.",28258697_2,-1,-1,-1,-1,31453,-1,5.0671097e-06,0.99999,4.895536e-06
31454,to CTLA-4,24,26,144,153,"However, the success rate of these treatments has been low and a large number of cancers, including colorectal cancer remain largely refractory to CTLA-4 and PD-1 blockade.",28258697_2,-1,-1,-1,-1,31454,-1,0.002416501,0.21099944,0.7865841
31457,receptors that,8,10,58,72,This has provided impetus to identify other co-inhibitory receptors that could be exploited to enhance response rates of current immunotherapeutic agents and achieve responses to the cancers that are refectory to immunotherapy.,28258697_3,-1,-1,-1,-1,31457,-1,0.0032976875,0.75989413,0.2368082
31459,to the,24,26,176,182,This has provided impetus to identify other co-inhibitory receptors that could be exploited to enhance response rates of current immunotherapeutic agents and achieve responses to the cancers that are refectory to immunotherapy.,28258697_3,-1,-1,-1,-1,31459,-1,5.8801866e-06,0.999987,7.0606934e-06
31463,receptor that,4,6,25,38,"Tim-3 is a co-inhibitory receptor that is expressed on IFN-g-producing T cells, FoxP3+ Treg cells and innate immune cells (macrophages and dendritic cells) where it has been shown to suppress their responses upon interaction with their ligand(s).",28258697_4,-1,-1,-1,-1,31463,-1,0.0017078612,0.8984974,0.099794745
31464,IFN-g-producing T cells,9,12,55,78,"Tim-3 is a co-inhibitory receptor that is expressed on IFN-g-producing T cells, FoxP3+ Treg cells and innate immune cells (macrophages and dendritic cells) where it has been shown to suppress their responses upon interaction with their ligand(s).",28258697_4,-1,-1,-1,-1,31464,-1,0.9468031,0.00019072086,0.05300622
31475,immunity,29,30,188,196,"Tim-3 has gained prominence as a potential candidate for cancer immunotherapy, where it has been shown that in vivo blockade of Tim-3 with other check-point inhibitors enhances anti-tumor immunity and suppresses tumor growth in several preclinical tumor models.",28258697_5,0,-1,2,-1,31475,-1,0.9997702,6.768552e-05,0.00016214364
31484,cell types,19,21,114,124,"This review discusses the recent findings on Tim-3, the role it plays in regulating immune responses in different cell types and the rationale for targeting Tim-3 for effective cancer immunotherapy.",28258697_6,-1,-1,-1,-1,31484,-1,3.1682768e-05,1.8108873e-05,0.9999502
31486,targeting Tim-3,25,27,147,162,"This review discusses the recent findings on Tim-3, the role it plays in regulating immune responses in different cell types and the rationale for targeting Tim-3 for effective cancer immunotherapy.",28258697_6,-1,-1,-1,-1,31486,-1,6.18042e-06,0.9999876,6.241321e-06
31490,to tumor-infiltrating lymphocytes,11,14,69,102,Triple-negative breast cancer (TNBC) cells are modulated in reaction to tumor-infiltrating lymphocytes.,28264810_0,-1,-1,-1,-1,31490,-1,0.0023800582,0.870358,0.12726198
31492,to this,5,7,34,41,"However, their specific responses to this immune pressure are unknown.",28264810_1,-1,-1,-1,-1,31492,-1,2.0631403e-05,0.9999695,9.886243e-06
31497,the TNBC cell,17,20,99,112,"In order to address this question, we first used mRNA sequencing to compare the immunophenotype of the TNBC cell line MDA-MB-231 and the luminal breast cancer cell line MCF7 after both were cocultured with activated human T cells.",28264810_2,-1,-1,-1,-1,31497,-1,0.0024906471,0.7281935,0.26931584
31502,the cytokine-induced,3,5,24,44,"Despite similarities in the cytokine-induced immune signatures of the two cell lines, MDA-MD-231 cells were able to transcribe more IDO1 than MCF7 cells.",28264810_3,-1,-1,-1,-1,31502,-1,0.37673396,0.6216477,0.0016183223
31503,the two cell,8,11,66,78,"Despite similarities in the cytokine-induced immune signatures of the two cell lines, MDA-MD-231 cells were able to transcribe more IDO1 than MCF7 cells.",28264810_3,-1,-1,-1,-1,31503,-1,0.0029579513,0.75513846,0.24190356
31505,to transcribe,17,19,113,126,"Despite similarities in the cytokine-induced immune signatures of the two cell lines, MDA-MD-231 cells were able to transcribe more IDO1 than MCF7 cells.",28264810_3,-1,-1,-1,-1,31505,-1,6.5410673e-06,0.9999887,4.807994e-06
31506,than MCF7 cells,21,24,137,152,"Despite similarities in the cytokine-induced immune signatures of the two cell lines, MDA-MD-231 cells were able to transcribe more IDO1 than MCF7 cells.",28264810_3,-1,-1,-1,-1,31506,-1,0.05995953,0.23122765,0.7088128
31507,The two cell,0,3,0,12,The two cell lines had similar upstream JAK/STAT1 signaling and IDO1 mRNA stability.,28264810_4,-1,-1,-1,-1,31507,-1,0.0020342208,0.8539311,0.14403467
31510,protein,14,15,74,81,"However, using a series of breast cancer cell lines, IFN stimulated IDO1 protein expression and enzymatic activity only in ER-, not ER+, cell lines.",28264810_5,0,1,-1,-1,31510,-1,1.1411465e-05,0.9999769,1.1751044e-05
31514,MCF7 cells,10,12,82,92,"Treatment with 5-aza-deoxycytidine reversed the suppression of IDO1 expression in MCF7 cells, suggesting that DNA methylation was potentially involved in IDO1 induction.",28264810_6,-1,-1,-1,-1,31514,-1,0.6511052,0.0008490161,0.34804574
31516,this trend,2,4,13,23,We confirmed this trend of IDO1 methylation by bisulfite pyrosequencing breast cancer cell lines and an independent cohort of primary breast tumors.,28264810_8,-1,-1,-1,-1,31516,-1,7.961382e-06,0.99998724,4.7917056e-06
31519,Taken together,0,2,0,14,"Taken together, these findings suggest that IDO1 promoter methylation regulates anti-immune responses in breast cancer subtypes and could be used as a predictive biomarker for IDO1 inhibitor-based immunotherapy.",28264810_9,-1,-1,-1,-1,31519,-1,1.15022285e-05,0.9999789,9.596925e-06
31526,to this,1,3,4,11,"Due to this controversial function, we aimed to explore whether an insufficient anti-tumour response during colitis-associated colon cancer could be ascribed to a hypoxic microenvironment.",28278498_2,-1,-1,-1,-1,31526,-1,6.2645727e-06,0.9999887,5.052612e-06
31527,function,4,5,26,34,"Due to this controversial function, we aimed to explore whether an insufficient anti-tumour response during colitis-associated colon cancer could be ascribed to a hypoxic microenvironment.",28278498_2,0,1,2,-1,31527,-1,4.4913715e-05,0.9999205,3.4560806e-05
31530,T cell immunity,16,19,94,109,"METHODS: Colitis-associated colon cancer was induced in wildtype mice, and hypoxia as well as T cell immunity were analysed in the colonic tumour tissues.",28278498_3,-1,-1,-1,-1,31530,-1,0.00015450662,1.652925e-05,0.99982893
31532,tumour tissues,24,26,139,153,"METHODS: Colitis-associated colon cancer was induced in wildtype mice, and hypoxia as well as T cell immunity were analysed in the colonic tumour tissues.",28278498_3,-1,-1,-1,-1,31532,-1,2.8400867e-05,0.9996935,0.00027806257
31536,function,25,26,153,161,"In addition, CD4+ effector T cells and regulatory T cells were cultured under normoxic and hypoxic conditions and examined regarding their phenotype and function.",28278498_4,0,1,2,-1,31536,-1,0.00020351599,0.9991986,0.00059784733
31541,that T cell,8,11,52,63,"Complementary ex vivo and in vitro studies revealed that T cell stimulation under hypoxic conditions inhibited the differentiation, proliferation and IFN- production of TH1 cells and enhanced the suppressive capacity of regulatory T cells.",28278498_6,-1,-1,-1,-1,31541,-1,0.003641744,0.17681183,0.8195464
31549,CD4+ T cell functions,13,18,71,92,"Moreover, we identified an active role for HIF-1 in the modulation of CD4+ T cell functions under hypoxic conditions.",28278498_7,-1,-1,-1,-1,31549,-1,2.1687747e-05,7.1592162e-06,0.99997115
31551,function,9,10,59,67,CONCLUSION: Our data indicate that oxygen availability can function as a local modulator of CD4+ T cell responses and thus influences tumour immune surveillance in inflammation-associated colon cancer.,28278498_8,0,1,2,-1,31551,-1,5.5975186e-05,0.9999138,3.0173347e-05
31560,that Th17 cells,3,6,13,28,Here we show that Th17 cells are a source of tumour-induced Foxp3+ cells.,28290453_1,-1,-1,-1,-1,31560,-1,0.0036800096,0.5154541,0.4808659
31561,tumour-induced Foxp3,10,12,45,65,Here we show that Th17 cells are a source of tumour-induced Foxp3+ cells.,28290453_1,-1,-1,-1,-1,31561,-1,1.741231e-05,0.9999722,1.0411892e-05
31563,to natural,2,4,12,22,"In addition to natural (n)Treg and induced (i)Treg cells that develop from naive precursors, suppressive IL-17A+Foxp3+ and ex-Th17 Foxp3+ cells are converted from IL-17A+Foxp3neg cells in tumour-bearing mice.",28290453_2,-1,-1,-1,-1,31563,-1,6.1652418e-06,0.9999893,4.621641e-06
31564,cells that,8,10,51,61,"In addition to natural (n)Treg and induced (i)Treg cells that develop from naive precursors, suppressive IL-17A+Foxp3+ and ex-Th17 Foxp3+ cells are converted from IL-17A+Foxp3neg cells in tumour-bearing mice.",28290453_2,-1,-1,-1,-1,31564,-1,0.0031597614,0.31528267,0.6815576
31565,naive precursors,12,14,75,91,"In addition to natural (n)Treg and induced (i)Treg cells that develop from naive precursors, suppressive IL-17A+Foxp3+ and ex-Th17 Foxp3+ cells are converted from IL-17A+Foxp3neg cells in tumour-bearing mice.",28290453_2,-1,-1,-1,-1,31565,-1,0.0025032184,0.41659376,0.58090305
31569,IL-17A+Foxp3neg cells,26,28,163,184,"In addition to natural (n)Treg and induced (i)Treg cells that develop from naive precursors, suppressive IL-17A+Foxp3+ and ex-Th17 Foxp3+ cells are converted from IL-17A+Foxp3neg cells in tumour-bearing mice.",28290453_2,-1,-1,-1,-1,31569,-1,0.9315888,0.0005046116,0.06790656
31571,Foxp3-expressing IL-17A+,3,5,25,49,"Metabolic phenotyping of Foxp3-expressing IL-17A+, ex-Th17 and iTreg cells demonstrates the dissociation between the metabolic fitness and the suppressive function of Foxp3-expressing Treg cell subsets.",28290453_3,-1,-1,-1,-1,31571,-1,0.013120949,0.9859176,0.00096141046
31576,function,20,21,155,163,"Metabolic phenotyping of Foxp3-expressing IL-17A+, ex-Th17 and iTreg cells demonstrates the dissociation between the metabolic fitness and the suppressive function of Foxp3-expressing Treg cell subsets.",28290453_3,0,1,2,-1,31576,-1,6.765115e-06,0.9999876,5.6838007e-06
31577,Foxp3-expressing Treg cell subsets,22,26,167,201,"Metabolic phenotyping of Foxp3-expressing IL-17A+, ex-Th17 and iTreg cells demonstrates the dissociation between the metabolic fitness and the suppressive function of Foxp3-expressing Treg cell subsets.",28290453_3,-1,-1,-1,-1,31577,-1,0.0023081372,0.7457996,0.25189227
31578,Foxp3-expressing subsets,2,4,13,37,"Although all Foxp3-expressing subsets are immunosuppressive, glycolysis is a prominent metabolic pathway exerted only by IL-17A+Foxp3+ cells.",28290453_4,-1,-1,-1,-1,31578,-1,0.0010118763,0.96891946,0.030068683
31581,Transcriptome analysis,0,2,0,22,"Transcriptome analysis and flow cytometry of IL-17A+Foxp3+ cells indicate that Folr4, GARP, Itgb8, Pglyrp1, Il1rl1, Itgae, TIGIT and ICOS are Th17-to-Treg cell transdifferentiation-associated markers.",28290453_5,-1,-1,-1,-1,31581,-1,5.882501e-06,0.9999876,6.4687397e-06
31587,Th17-to-Treg cell transdifferentiation-associated,27,30,142,191,"Transcriptome analysis and flow cytometry of IL-17A+Foxp3+ cells indicate that Folr4, GARP, Itgb8, Pglyrp1, Il1rl1, Itgae, TIGIT and ICOS are Th17-to-Treg cell transdifferentiation-associated markers.",28290453_5,-1,-1,-1,-1,31587,-1,0.00015838449,0.99969244,0.00014916553
31588,Tumour-associated Th17-to-Treg cell,0,3,0,35,Tumour-associated Th17-to-Treg cell conversion identified here provides insights for targeting the dynamism of Th17-Treg cells in cancer immunotherapy.,28290453_6,-1,-1,-1,-1,31588,-1,0.0016518262,0.8970488,0.10129937
31589,targeting the,9,11,85,98,Tumour-associated Th17-to-Treg cell conversion identified here provides insights for targeting the dynamism of Th17-Treg cells in cancer immunotherapy.,28290453_6,-1,-1,-1,-1,31589,-1,3.915689e-06,0.9999927,3.3124443e-06
31590,Th17-Treg cells,13,15,111,126,Tumour-associated Th17-to-Treg cell conversion identified here provides insights for targeting the dynamism of Th17-Treg cells in cancer immunotherapy.,28290453_6,-1,-1,-1,-1,31590,-1,0.0019397974,0.4477369,0.55032337
31605,tumor cells,4,6,23,34,"Moreover, grafted D2F2 tumor cells grew faster and intratumoral Foxp3+ cell accumulation was observed in these mice compared to sham-treated controls.",28332605_4,-1,-1,-1,-1,31605,-1,0.00069772557,0.013763307,0.98553896
31613,receptor,12,13,87,95,Results from reporter cell lines suggested that acrolein acts via the aryl-hydrocarbon receptor which could be inhibited by resveratrol and 3'-methoxy-4'-nitroflavone Acrolein- stimulation of human PBMCs increased Foxp3+ expression by T cells which could be antagonized by resveratrol.,28332605_5,0,1,2,-1,31613,-1,0.0025845026,0.74174714,0.25566834
31627,the regulation,5,7,33,47,"Besides the established roles in the regulation of inflammation and autoimmune disease, studies have shown that iNKT cells have important roles in tumor surveillance and the control of tumor metastasis.",28401935_1,-1,-1,-1,-1,31627,-1,4.5793868e-06,0.99999034,5.026356e-06
31633,that the,3,5,14,22,"Here we found that the absence of iNKT cells markedly decreased the total number of intestinal polyps in APCMin/+ mice, a model for colorectal cancer.",28401935_2,-1,-1,-1,-1,31633,-1,4.5310426e-06,0.99999166,3.822535e-06
31635,the total,11,13,64,73,"Here we found that the absence of iNKT cells markedly decreased the total number of intestinal polyps in APCMin/+ mice, a model for colorectal cancer.",28401935_2,-1,-1,-1,-1,31635,-1,4.9900095e-06,0.99999046,4.5772085e-06
31638,IL-17-producing cells,9,11,63,84,"Polyp iNKT cells were enriched for interleukin-10 (IL-10)- and IL-17-producing cells, showed a distinct phenotype being CD4+, NK1.1- CD44int, and PD-1lo, and they were negative for the NKT cell transcription factor promyelocytic leukemia zinc-finger.",28401935_3,-1,-1,-1,-1,31638,-1,0.9588793,0.00015071339,0.040970013
31640,the NKT cell transcription factor,31,36,181,214,"Polyp iNKT cells were enriched for interleukin-10 (IL-10)- and IL-17-producing cells, showed a distinct phenotype being CD4+, NK1.1- CD44int, and PD-1lo, and they were negative for the NKT cell transcription factor promyelocytic leukemia zinc-finger.",28401935_3,-1,-1,-1,-1,31640,-1,4.43845e-05,0.9998826,7.300849e-05
31646,FoxP3 protein,23,25,127,140,"The absence of iNKT cells was associated with a reduced frequency of regulatory T (Tregs) cells and lower expression levels of FoxP3 protein and transcript uniquely in the polyps, and a switch to an inflammatory macrophage phenotype.",28401935_4,-1,-1,-1,-1,31646,-1,4.063142e-06,0.99999166,4.2271513e-06
31656,this tissue,42,44,226,237,"Moreover, in iNKT cell-deficient APCMin/+ mice, expression of T-helper (TH) 1-associated genes, such as IFN- and Nos2, was increased in polyps, concomitantly with elevated frequencies of conventional CD4+ and CD8+ T cells in this tissue.",28401935_5,-1,-1,-1,-1,31656,-1,1.1281572e-05,0.99995303,3.562767e-05
31661,TH1 immunity,23,25,165,177,The results suggest that a population of regulatory iNKT cells locally promote intestinal polyp formation by enhancing Treg cells and immunosuppression of antitumor TH1 immunity.,28401935_6,-1,-1,-1,-1,31661,-1,0.006730229,0.9920866,0.0011831807
31665,to the,12,14,70,76,Memory cytotoxic T lymphocytes (CTLs) are able to provide protections to the host against repeated insults from intracellular pathogens.,28405920_0,-1,-1,-1,-1,31665,-1,1.0624869e-05,0.99998116,8.230929e-06
31667,functions,11,12,64,73,"However, it has not been completely understood how the effector functions of memory CTLs are induced upon antigen challenge, which is directly related to the efficacy of their protection.",28405920_1,0,1,2,-1,31667,-1,0.0107653085,0.7429866,0.24624805
31670,related to the,24,27,143,157,"However, it has not been completely understood how the effector functions of memory CTLs are induced upon antigen challenge, which is directly related to the efficacy of their protection.",28405920_1,-1,-1,-1,-1,31670,-1,1.0004816e-05,0.9999844,5.612515e-06
31679,function,21,22,114,122,"Third signal cytokines, such as IL-12 and type I interferon, have been suggested to be involved in the protective function of memory CTLs, but direct evidence is warranted.",28405920_2,0,1,2,-1,31679,-1,0.00075587665,0.99883837,0.00040572177
31686,functions,16,17,83,92,"In this report, we found that memory CTLs need to be reactivated to exert effector functions.",28405920_3,0,1,2,-1,31686,-1,0.0014923236,0.9883879,0.010119831
31695,to antigen,12,14,78,88,This reactivation of memory CTLs requires cytokines such as IL-12 in addition to antigen but was less dependent upon costimulation and IL-2 compared to naive CTLs.,28405920_5,-1,-1,-1,-1,31695,-1,0.9154671,0.08125175,0.003281133
31696,to naive CTLs,23,26,149,162,This reactivation of memory CTLs requires cytokines such as IL-12 in addition to antigen but was less dependent upon costimulation and IL-2 compared to naive CTLs.,28405920_5,-1,-1,-1,-1,31696,-1,0.0044808504,0.4213333,0.5741859
31698,than their naive,9,12,61,77,"Memory CTLs responded more quickly and with greater strength than their naive counterparts upon stimulation, which is associated with higher upregulation of important transcription factors such as T-bet and phosphorylated STAT4.",28405920_6,-1,-1,-1,-1,31698,-1,8.219522e-06,0.9999839,7.884076e-06
31703,than naive CTLs,8,11,50,65,"In addition, memory CTLs underwent less expansion than naive CTLs upon pathogen challenge.",28405920_7,-1,-1,-1,-1,31703,-1,0.005006543,0.27973402,0.71525943
31704,functions,4,5,24,33,"In conclusion, effector functions of established memory CTLs may be affected by certain cytokines such as IL-12 and type I IFN.",28405920_8,0,1,2,-1,31704,-1,0.0074201464,0.08233924,0.9102406
31713,to the,11,13,64,70,"Thus, a pathogen's ability to induce cytokines could contribute to the efficacy of protection of an established memory CTL population.",28405920_9,-1,-1,-1,-1,31713,-1,5.478571e-06,0.9999901,4.426328e-06
31718,that the,4,6,26,34,"Recent studies have shown that the CXCR5+CD8+ T cells present more potent proinflammatory function than CXCR5-CD8+ T cells in chronic virus infections and in follicular lymphoma, but the role of CXCR5+CD8+ T cells in colorectal cancer is yet unclear.",28412245_1,-1,-1,-1,-1,31718,-1,4.7375515e-06,0.99999106,4.1631693e-06
31720,function than,14,16,90,103,"Recent studies have shown that the CXCR5+CD8+ T cells present more potent proinflammatory function than CXCR5-CD8+ T cells in chronic virus infections and in follicular lymphoma, but the role of CXCR5+CD8+ T cells in colorectal cancer is yet unclear.",28412245_1,-1,-1,-1,-1,31720,-1,0.00017166829,0.9997131,0.000115176714
31727,blood,16,17,84,89,"In this study, we demonstrated that CXCR5+CD8+ T cells were very rare in peripheral blood mononuclear cells from healthy and colorectal cancer individuals, but were significantly enriched in resected tumors and tumor-associated lymph nodes.",28412245_2,0,1,-1,-1,31727,-1,0.0009831174,0.9973093,0.0017075517
31739,CD8+ T cell subset,32,37,195,213,"Compared to CXCR5-CD8+ T cells, the CXCR5+CD8+ T cells demonstrated significantly higher Bcl-6 expression and lower Blimp1 expression, suggesting that CXCR5+CD8+ T cells might represent a memory CD8+ T cell subset.",28412245_3,-1,-1,-1,-1,31739,-1,2.8013796e-05,6.932704e-06,0.9999651
31745,TNF,14,15,82,86,"Under ex vivo condition, the CXCR5+CD8+ T cells demonstrated lower degranulation, TNF expression and IFN expression than CXCR5-CD8+ T cells.",28412245_5,0,1,-1,-1,31745,-1,4.2903637e-05,0.9999398,1.7279228e-05
31750,TNF,11,12,66,70,"However, after PMA + ionomycin stimulation, the degranulation and TNF expression by CXCR5+CD8+ T cells were significantly elevated to a level comparable with CXCR5-CD8+ T cells, whereas the IFN expression by PMA + ionomycin-stimulated CXCR5+CD8+ T cells were significantly higher than that by CXCR5-CD8+ T cells.",28412245_6,0,1,-1,-1,31750,-1,2.1883054e-05,0.99996495,1.31170345e-05
31754,the IFN,32,34,187,195,"However, after PMA + ionomycin stimulation, the degranulation and TNF expression by CXCR5+CD8+ T cells were significantly elevated to a level comparable with CXCR5-CD8+ T cells, whereas the IFN expression by PMA + ionomycin-stimulated CXCR5+CD8+ T cells were significantly higher than that by CXCR5-CD8+ T cells.",28412245_6,-1,-1,-1,-1,31754,-1,0.89820284,0.09816922,0.0036279769
31756,than that,46,48,282,291,"However, after PMA + ionomycin stimulation, the degranulation and TNF expression by CXCR5+CD8+ T cells were significantly elevated to a level comparable with CXCR5-CD8+ T cells, whereas the IFN expression by PMA + ionomycin-stimulated CXCR5+CD8+ T cells were significantly higher than that by CXCR5-CD8+ T cells.",28412245_6,-1,-1,-1,-1,31756,-1,7.332253e-06,0.9999877,4.9916716e-06
31758,TCR-stimulation,2,3,20,35,"Following long-term TCR-stimulation, CXCR5+CD8+ T cells demonstrated significantly more potent proliferation capacity and higher IFN expression than CXCR5-CD8+ T cells.",28412245_7,-1,1,2,-1,31758,-1,4.737321e-05,0.9999286,2.4057956e-05
31763,TCR-stimulated,0,1,0,14,TCR-stimulated CXCR5+CD8+ T cells also showed a gradual downregulation in CXCR5 expression.,28412245_8,-1,1,2,-1,31763,-1,5.7131332e-05,0.9999151,2.7768729e-05
31765,that TCR-stimulated,3,5,17,36,We further found that TCR-stimulated CXCR5+CD8+ T cells demonstrated higher granzyme B production and induced more specific lysis of autologous tumor cells than CXCR5-CD8+ T cells.,28412245_9,-1,-1,-1,-1,31765,-1,3.234366e-05,0.99995303,1.4638057e-05
31767,tumor cells than,21,24,144,160,We further found that TCR-stimulated CXCR5+CD8+ T cells demonstrated higher granzyme B production and induced more specific lysis of autologous tumor cells than CXCR5-CD8+ T cells.,28412245_9,-1,-1,-1,-1,31767,-1,9.629746e-05,0.9995291,0.000374592
31773,CD8+ T cell subset,13,18,81,99,"Together, these data demonstrate that CXCR5+CD8+ T cells represent a significant CD8+ T cell subset in colorectal tumors and have the potential to contribute to antitumor immunity, but their specific roles require further studies in vivo.",28412245_10,-1,-1,-1,-1,31773,-1,2.3775332e-05,5.870446e-06,0.99997044
31778,immunity,29,30,171,179,"Together, these data demonstrate that CXCR5+CD8+ T cells represent a significant CD8+ T cell subset in colorectal tumors and have the potential to contribute to antitumor immunity, but their specific roles require further studies in vivo.",28412245_10,0,-1,2,-1,31778,-1,0.99982053,6.546535e-05,0.0001140776
31782,growth factor receptor,7,10,41,63,The mutant Type III variant of epidermal growth factor receptor (EGFRvIII) is present in approximately one-third of glioblastoma (GBM) patients.,28412740_0,-1,-1,-1,-1,31782,-1,0.9918595,5.829306e-05,0.008082253
31783,tissues,6,7,28,35,"It is never found in normal tissues; therefore, it represents a candidate target for GBM immunotherapy.",28412740_1,-1,1,2,-1,31783,-1,0.0003785383,0.8072554,0.19236605
31787,peptide,3,4,11,18,"PEPvIII, a peptide sequence from EGFRvIII, was designed to represent a target of glioma and is presented by MHC I/II complexes.",28412740_2,0,-1,2,-1,31787,-1,0.00078492495,0.99895144,0.0002635973
31794,T cells to,16,19,72,82,Dendritic cells (DCs) have great potential to sensitize CD4+ T and CD8+ T cells to precisely target and eradicate GBM.,28412740_3,-1,-1,-1,-1,31794,-1,0.0012805016,0.032235518,0.96648407
31796,that PEPvIII,4,6,14,26,"Here, we show that PEPvIII could be loaded by DCs and presented to T lymphocytes, especially PEPvIII-specific CTLs, to precisely kill U87-EGFRvIII cells.",28412740_4,-1,-1,-1,-1,31796,-1,0.0043512937,0.98356795,0.01208082
31797,to T lymphocytes,13,16,64,80,"Here, we show that PEPvIII could be loaded by DCs and presented to T lymphocytes, especially PEPvIII-specific CTLs, to precisely kill U87-EGFRvIII cells.",28412740_4,-1,-1,-1,-1,31797,-1,0.0017816599,0.07087627,0.927342
31798,PEPvIII-specific CTLs,18,20,93,114,"Here, we show that PEPvIII could be loaded by DCs and presented to T lymphocytes, especially PEPvIII-specific CTLs, to precisely kill U87-EGFRvIII cells.",28412740_4,-1,-1,-1,-1,31798,-1,0.0020931016,0.03683003,0.9610769
31806,the tumour,21,23,139,149,"In addition to inhibiting proliferation and inducing the apoptosis of U87-EGFRvIII cells, miR-326 also reduced the expression of TGF-1 in the tumour environment, resulting in improved efficacy of T cell activation and killing via suppressing the SMO/Gli2 axis, which at least partially reversed the immunosuppressive environment.",28412740_5,-1,-1,-1,-1,31806,-1,5.1204383e-06,0.99999,4.8731827e-06
31815,immunity,15,16,106,114,"This finding suggested that a DC-based vaccine combined with miR-326 may induce more powerful anti-tumour immunity against GBM cells that express a relevant antigen, which provides a promising approach for GBM immunotherapy.",28412740_7,0,-1,2,-1,31815,-1,0.99987936,3.1614127e-05,8.899558e-05
31816,cells that,18,20,127,137,"This finding suggested that a DC-based vaccine combined with miR-326 may induce more powerful anti-tumour immunity against GBM cells that express a relevant antigen, which provides a promising approach for GBM immunotherapy.",28412740_7,-1,-1,-1,-1,31816,-1,0.002840822,0.2161877,0.78097147
31817,relevant antigen,22,24,148,164,"This finding suggested that a DC-based vaccine combined with miR-326 may induce more powerful anti-tumour immunity against GBM cells that express a relevant antigen, which provides a promising approach for GBM immunotherapy.",28412740_7,-1,-1,-1,-1,31817,-1,0.8154286,0.17729948,0.0072718603
31822,cells that play,5,8,40,55,Neutrophils are important innate immune cells that play key roles in tumor development.,28432279_1,-1,-1,-1,-1,31822,-1,0.00816064,0.56676006,0.42507932
31832,function,15,16,120,128,The sustained expression of IL-35 could promote chronic inflammation to augment the proangiogenic and immunosuppressive function of neutrophils.,28432279_4,0,1,2,-1,31832,-1,0.0012591443,0.99788636,0.00085452246
31834,cytokines IL-1,6,8,56,71,IL-35 stimulated macrophages to secrete proinflammatory cytokines IL-1 and IL-6.,28432279_5,-1,-1,-1,-1,31834,-1,0.9999429,8.952797e-06,4.811125e-05
31837,T cells to,3,6,20,30,"IL-1 stimulated  T cells to produce IL-17, which in turn increased the production of G-CSF.",28432279_6,-1,-1,-1,-1,31837,-1,0.002455722,0.07632828,0.921216
31849,function,30,31,190,198,"By increasing the expression of G-CSF and IL-6, IL-35 could up-regulate the expression of MMP-9 and Bv8, and down-regulate TRAIL expression in neutrophils, thus augmenting the proangiogenic function of neutrophils.",28432279_7,0,1,2,-1,31849,-1,0.0004246011,0.99880576,0.00076959457
31858,functioning,10,11,65,76,Our findings suggest that IL-35 can promote tumor progression by functioning as an up-stream cytokine to promote cancer-associated inflammation and control neutrophil polarization.,28432279_9,0,1,2,-1,31858,-1,1.3605724e-05,0.9999752,1.1132438e-05
31859,cytokine to,14,16,93,104,Our findings suggest that IL-35 can promote tumor progression by functioning as an up-stream cytokine to promote cancer-associated inflammation and control neutrophil polarization.,28432279_9,-1,-1,-1,-1,31859,-1,0.95703197,0.041135862,0.0018321929
31861,tumor therapy,12,14,77,90,Targeting IL-35 might be an important approach for designing new strategy of tumor therapy.,28432279_10,-1,-1,-1,-1,31861,-1,4.7614144e-06,0.9999906,4.6343757e-06
31870,Treg cells that,12,15,85,100,"Tumours, including intestinal malignancies, often present with local accumulation of Treg cells that can prevent tumour clearance, but how tumour progression leads to Treg cell accumulation is incompletely understood.",28437001_1,-1,-1,-1,-1,31870,-1,0.0014716779,0.11344749,0.8850809
31873,to Treg cell,25,28,164,176,"Tumours, including intestinal malignancies, often present with local accumulation of Treg cells that can prevent tumour clearance, but how tumour progression leads to Treg cell accumulation is incompletely understood.",28437001_1,-1,-1,-1,-1,31873,-1,0.0017653616,0.12817688,0.8700577
31884,Treg subset,42,44,270,281,"Here using genetically modified mouse models we show that ablation of E-cadherin, a process associated with epithelial to mesenchymal transition and tumour progression, promotes the accumulation of intestinal Treg cells by the specific accumulation of the KLRG1+ GATA3+ Treg subset.",28437001_2,-1,-1,-1,-1,31884,-1,0.00010021224,0.002165754,0.99773395
31894,cytokine that,18,20,126,139,"Both E-cadherin ablation and increased -catenin signals resulted in epithelial cells with higher levels of interleukin-33, a cytokine that preferentially expands KLRG1+ GATA3+ Treg cells.",28437001_4,-1,-1,-1,-1,31894,-1,0.9952159,0.0042505404,0.00053353346
31901,to the,14,16,97,103,"Accordingly, Treg cell accumulation in intestinal tumours from APCmin/+ mice was exclusively due to the increase in KLRG1+ GATA3+ Treg cells.",28437001_6,-1,-1,-1,-1,31901,-1,4.443911e-06,0.9999913,4.2359193e-06
31906,Treg cell subsets,12,15,76,93,"Our data identify a novel axis through which epithelial cells control local Treg cell subsets, which may be activated during intestinal tumorigenesis.",28437001_7,-1,-1,-1,-1,31906,-1,1.2331608e-05,1.0777577e-05,0.999977
31915,to the,4,6,28,34,"M2 cell products contribute to the growth-promoting attributes of the tumor microenvironment (TME) and bias immunity toward type 2, away from the type 1 mechanisms with antitumor properties.",28461570_1,-1,-1,-1,-1,31915,-1,6.6456637e-06,0.9999876,5.80056e-06
31916,the tumor,9,11,66,75,"M2 cell products contribute to the growth-promoting attributes of the tumor microenvironment (TME) and bias immunity toward type 2, away from the type 1 mechanisms with antitumor properties.",28461570_1,-1,-1,-1,-1,31916,-1,4.543066e-06,0.9999906,4.8420407e-06
31918,immunity toward type,17,20,108,128,"M2 cell products contribute to the growth-promoting attributes of the tumor microenvironment (TME) and bias immunity toward type 2, away from the type 1 mechanisms with antitumor properties.",28461570_1,-1,-1,-1,-1,31918,-1,0.013905159,0.9855774,0.000517446
31919,the type,24,26,142,150,"M2 cell products contribute to the growth-promoting attributes of the tumor microenvironment (TME) and bias immunity toward type 2, away from the type 1 mechanisms with antitumor properties.",28461570_1,-1,-1,-1,-1,31919,-1,5.2704954e-06,0.9999894,5.391711e-06
31922,immunity,4,5,16,24,"To drive type 1 immunity in CNS tissues, we infected GL261 tumor-bearing mice with attenuated rabies virus (RABV).",28461570_2,0,-1,2,-1,31922,-1,0.99967146,0.00013119921,0.00019736266
31923,tissues,7,8,32,39,"To drive type 1 immunity in CNS tissues, we infected GL261 tumor-bearing mice with attenuated rabies virus (RABV).",28461570_2,-1,1,2,-1,31923,-1,0.0005703433,0.5090616,0.4903681
31927,tissues trans-axonally,6,8,40,62,"These neurotropic viruses spread to CNS tissues trans-axonally, where they induce a strong type 1 immune response that involves Th1, CD8, and B cell entry across the blood-brain barrier and virus clearance in the absence of overt sequelae.",28461570_3,-1,-1,-1,-1,31927,-1,0.00029273218,0.9864747,0.013232567
31930,immune response that,16,19,98,118,"These neurotropic viruses spread to CNS tissues trans-axonally, where they induce a strong type 1 immune response that involves Th1, CD8, and B cell entry across the blood-brain barrier and virus clearance in the absence of overt sequelae.",28461570_3,-1,-1,-1,-1,31930,-1,0.9704808,0.0285977,0.00092143135
31933,the blood-brain,29,31,162,177,"These neurotropic viruses spread to CNS tissues trans-axonally, where they induce a strong type 1 immune response that involves Th1, CD8, and B cell entry across the blood-brain barrier and virus clearance in the absence of overt sequelae.",28461570_3,-1,-1,-1,-1,31933,-1,3.928014e-05,0.99992955,3.1126772e-05
31938,to the tumor,6,9,36,48,"Despite the failure of virus spread to the tumor, infection resulted in significantly enhanced tumor necrosis, extensive CD4 T cell accumulation, and high levels of the proinflammatory factors IFN-, TNF-, and inducible NO synthase in the TME merely 4 d postinfection, before significant virus spread or the appearance of RABV-specific immune mechanisms in CNS tissues.",28461570_5,-1,-1,-1,-1,31938,-1,6.375909e-06,0.9999869,6.757469e-06
31942,factors IFN-,30,32,185,198,"Despite the failure of virus spread to the tumor, infection resulted in significantly enhanced tumor necrosis, extensive CD4 T cell accumulation, and high levels of the proinflammatory factors IFN-, TNF-, and inducible NO synthase in the TME merely 4 d postinfection, before significant virus spread or the appearance of RABV-specific immune mechanisms in CNS tissues.",28461570_5,-1,-1,-1,-1,31942,-1,0.99993265,2.4594914e-05,4.2782267e-05
31943,TNF-,33,34,200,205,"Despite the failure of virus spread to the tumor, infection resulted in significantly enhanced tumor necrosis, extensive CD4 T cell accumulation, and high levels of the proinflammatory factors IFN-, TNF-, and inducible NO synthase in the TME merely 4 d postinfection, before significant virus spread or the appearance of RABV-specific immune mechanisms in CNS tissues.",28461570_5,0,1,-1,-1,31943,-1,0.0069523626,0.99284923,0.00019834828
31944,the TME,40,42,236,243,"Despite the failure of virus spread to the tumor, infection resulted in significantly enhanced tumor necrosis, extensive CD4 T cell accumulation, and high levels of the proinflammatory factors IFN-, TNF-, and inducible NO synthase in the TME merely 4 d postinfection, before significant virus spread or the appearance of RABV-specific immune mechanisms in CNS tissues.",28461570_5,-1,-1,-1,-1,31944,-1,5.5216587e-06,0.9999888,5.6582426e-06
31946,tissues,60,61,362,369,"Despite the failure of virus spread to the tumor, infection resulted in significantly enhanced tumor necrosis, extensive CD4 T cell accumulation, and high levels of the proinflammatory factors IFN-, TNF-, and inducible NO synthase in the TME merely 4 d postinfection, before significant virus spread or the appearance of RABV-specific immune mechanisms in CNS tissues.",28461570_5,-1,1,2,-1,31946,-1,0.00023976118,0.012080771,0.9876795
31949,functionally,8,9,57,69,"Although the majority of infiltrating CD4 cells appeared functionally inactive, the proinflammatory changes in the TME later resulted in the loss of accumulating M2 and increased M1 TAMs.",28461570_6,0,1,2,-1,31949,-1,0.00026504375,0.9996339,0.00010106921
31951,the TME,15,17,111,118,"Although the majority of infiltrating CD4 cells appeared functionally inactive, the proinflammatory changes in the TME later resulted in the loss of accumulating M2 and increased M1 TAMs.",28461570_6,-1,-1,-1,-1,31951,-1,6.9539155e-06,0.9999864,6.633701e-06
31954,the Th1 transcription factor T-bet,3,8,18,52,"Mice deficient in the Th1 transcription factor T-bet did not gain any survival advantage from RABV infection, exhibiting only limited tumor necrosis and no change in TME cytokines or TAM phenotype and highlighting the importance of type 1 mechanisms in this process.",28461570_7,-1,-1,-1,-1,31954,-1,4.5135416e-06,0.99998987,5.5598157e-06
31956,TME cytokines,27,29,166,179,"Mice deficient in the Th1 transcription factor T-bet did not gain any survival advantage from RABV infection, exhibiting only limited tumor necrosis and no change in TME cytokines or TAM phenotype and highlighting the importance of type 1 mechanisms in this process.",28461570_7,-1,-1,-1,-1,31956,-1,0.15580197,0.84081703,0.003380989
31971,the Tregs,7,9,34,43,"Here, we explored how OA affected the Tregs in lung cancer environment and the involved underlying mechanism.",28472762_3,-1,-1,-1,-1,31971,-1,4.684765e-06,0.9999901,5.1918164e-06
31974,the generation,6,8,29,43,It is found that OA reversed the generation of Tregs induced by H460 lung cancer cells co-culture.,28472762_4,-1,-1,-1,-1,31974,-1,5.6977774e-06,0.99998975,4.575691e-06
31979,tumor-infiltrating lymphocytes,15,17,89,119,"Furthermore, in vivo, OA reduced tumor formation rate and attenuated Foxp3 expression in tumor-infiltrating lymphocytes.",28472762_5,-1,-1,-1,-1,31979,-1,0.0026038506,0.8314617,0.16593446
31980,that transforming,3,5,14,31,We also found that transforming growth factor-1 (TGF-1) neutralizing antibody reversed the enhancement of Treg number and expression of p-Smad3'p-p38'p-JNK'p-ERK1/2 in the co-culture model.,28472762_6,-1,-1,-1,-1,31980,-1,6.6007756e-06,0.999987,6.3382736e-06
31981,factor-1,6,7,39,48,We also found that transforming growth factor-1 (TGF-1) neutralizing antibody reversed the enhancement of Treg number and expression of p-Smad3'p-p38'p-JNK'p-ERK1/2 in the co-culture model.,28472762_6,0,1,-1,-1,31981,-1,0.97928864,0.0014181046,0.019293228
31991,the T cells,10,13,58,69,OA also inhibited Treg activity by a direct inhibition of the T cells' response to TGF-1.,28472762_8,-1,-1,-1,-1,31991,-1,0.0010004026,0.077198595,0.921801
31992,to TGF-1,15,17,80,89,OA also inhibited Treg activity by a direct inhibition of the T cells' response to TGF-1.,28472762_8,-1,-1,-1,-1,31992,-1,1.8741726e-05,0.9999541,2.7120395e-05
31994,the generation,9,11,55,69,"In conclusion, our study demonstrated that OA inhibits the generation of Tregs in lung cancer environment by inhibiting the T cells' response to TGF-1 and decreasing the secretion of TGF-1 in lung cancer cells via NF-B signaling.",28472762_9,-1,-1,-1,-1,31994,-1,5.0944177e-06,0.99998987,5.0047524e-06
31996,the T cells,19,22,120,131,"In conclusion, our study demonstrated that OA inhibits the generation of Tregs in lung cancer environment by inhibiting the T cells' response to TGF-1 and decreasing the secretion of TGF-1 in lung cancer cells via NF-B signaling.",28472762_9,-1,-1,-1,-1,31996,-1,0.0009936243,0.075923584,0.92308277
31997,to TGF-1,24,26,142,151,"In conclusion, our study demonstrated that OA inhibits the generation of Tregs in lung cancer environment by inhibiting the T cells' response to TGF-1 and decreasing the secretion of TGF-1 in lung cancer cells via NF-B signaling.",28472762_9,-1,-1,-1,-1,31997,-1,1.0649547e-05,0.9999714,1.799628e-05
32019,blood,8,9,49,54,"The frequencies of ILC2s and MDSCs in peripheral blood mononuclear cells were determined, and the mRNA expression levels of ILC2s or Th2related transcription factors and cytokines, and MDSCsrelated products were assessed.",28487978_4,0,1,-1,-1,32019,-1,0.0032638072,0.95269156,0.04404466
32025,that the,3,5,25,33,"The results demonstrated that the frequencies of the circulatory ILC2s and MDSCs were enhanced in lung cancer patients, as were ILC2related transcription factors and cytokines in peripheral blood.",28487978_5,-1,-1,-1,-1,32025,-1,3.978462e-06,0.99999225,3.8162652e-06
32029,blood,28,29,191,196,"The results demonstrated that the frequencies of the circulatory ILC2s and MDSCs were enhanced in lung cancer patients, as were ILC2related transcription factors and cytokines in peripheral blood.",28487978_5,0,1,-1,-1,32029,-1,0.0037163268,0.8691828,0.12710086
32046,function,7,8,36,44,Increased CD8+ T cell frequency and function is associated with better prognosis in cancer patients.,28488547_1,0,1,2,-1,32046,-1,0.0058057257,0.8278865,0.16630772
32050,immunity,14,15,89,97,Interleukin 10 is a cytokine with controversial roles in CD8+ T cell-mediated anti-tumor immunity.,28488547_2,0,-1,2,-1,32050,-1,0.999642,9.443502e-05,0.00026362386
32052,the interleukin 10,3,6,22,40,We therefore examined the interleukin 10 expression and consumption in CD8+ T cells harvested from the peripheral blood and resected tumors of gastric cancer patients of stages II-IV.,28488547_3,-1,-1,-1,-1,32052,-1,0.8042189,0.19363269,0.002148384
32055,blood,18,19,114,119,We therefore examined the interleukin 10 expression and consumption in CD8+ T cells harvested from the peripheral blood and resected tumors of gastric cancer patients of stages II-IV.,28488547_3,0,1,-1,-1,32055,-1,0.0026650548,0.27129474,0.72604024
32057,that the,2,4,9,17,We found that the gastric cancer patients presented significantly elevated frequencies of interleukin 10-expressing cells in both CD4+ and CD8+ T cells compared to healthy controls.,28488547_4,-1,-1,-1,-1,32057,-1,4.022545e-06,0.999992,3.915828e-06
32062,the interleukin,3,5,21,36,"But distinctive from the interleukin 10-expressing CD4+ T cells, which increased in frequency in advanced cancer, the interleukin 10-expressing CD8+ T cells did not increase with cancer stage in the peripheral blood and actually decreased with cancer stage in resected tumor.",28488547_5,-1,-1,-1,-1,32062,-1,0.37165666,0.62332195,0.0050214403
32064,the interleukin,19,21,114,129,"But distinctive from the interleukin 10-expressing CD4+ T cells, which increased in frequency in advanced cancer, the interleukin 10-expressing CD8+ T cells did not increase with cancer stage in the peripheral blood and actually decreased with cancer stage in resected tumor.",28488547_5,-1,-1,-1,-1,32064,-1,0.40120035,0.5937408,0.0050588367
32067,blood,35,36,210,215,"But distinctive from the interleukin 10-expressing CD4+ T cells, which increased in frequency in advanced cancer, the interleukin 10-expressing CD8+ T cells did not increase with cancer stage in the peripheral blood and actually decreased with cancer stage in resected tumor.",28488547_5,0,1,-1,-1,32067,-1,0.0005444494,0.99587053,0.0035849817
32070,interleukin 10 receptor,3,6,19,42,Interleukin 10 and interleukin 10 receptor expression was also enriched in interferon gamma-expressing activated CD8+ T cells.,28488547_6,-1,-1,-1,-1,32070,-1,0.9996246,3.7351816e-05,0.0003380588
32073,to interleukin,1,3,9,23,"Compared to interleukin 10-nonexpressing CD8+ T cells, interleukin 10 receptor-expressing CD8+ T cells secreted significantly elevated interferon gamma levels.",28488547_7,-1,-1,-1,-1,32073,-1,0.42201602,0.57281095,0.005173045
32075,interleukin 10 receptor-expressing,9,12,55,89,"Compared to interleukin 10-nonexpressing CD8+ T cells, interleukin 10 receptor-expressing CD8+ T cells secreted significantly elevated interferon gamma levels.",28488547_7,-1,-1,-1,-1,32075,-1,0.99841404,0.00022027001,0.0013656146
32082,interleukin 10 receptor,26,29,160,183,"Treatment of anti-CD3/CD28-stimulated, purified CD8+ T cells with interleukin 10 alone could significantly enhance CD8+ T cell survival, an effect dependent on interleukin 10 receptor expression.",28488547_8,-1,-1,-1,-1,32082,-1,0.9995073,5.206653e-05,0.00044062387
32086,Analysis,0,1,0,8,Analysis of downstream signal transducer and activator of transcription molecules showed that interleukin 10 treatment significantly increased the phosphorylation of signal transducer and activator of transcription 3 and signal transducer and activator of transcription 1 to lesser extent.,28488547_10,0,1,-1,-1,32086,-1,6.545893e-06,0.9999881,5.3682766e-06
32088,that interleukin 10 treatment,11,15,89,118,Analysis of downstream signal transducer and activator of transcription molecules showed that interleukin 10 treatment significantly increased the phosphorylation of signal transducer and activator of transcription 3 and signal transducer and activator of transcription 1 to lesser extent.,28488547_10,-1,-1,-1,-1,32088,-1,0.0012131325,0.99869066,9.623934e-05
32091,signal transducer and activator of transcription 1 to,28,36,221,274,Analysis of downstream signal transducer and activator of transcription molecules showed that interleukin 10 treatment significantly increased the phosphorylation of signal transducer and activator of transcription 3 and signal transducer and activator of transcription 1 to lesser extent.,28488547_10,-1,-1,-1,-1,32091,-1,1.3835482e-05,0.9999726,1.3598178e-05
32094,that interleukin 10,5,8,36,55,"Together, these results demonstrate that interleukin 10 possessed stimulatory roles in activated CD8+ T cells from gastric cancer patients.",28488547_11,-1,-1,-1,-1,32094,-1,0.79589564,0.20238367,0.0017207362
32101,peptide,23,24,124,131,"Here, we describe a novel combination of aluminum salts (alum), CpG oligodeoxynucleotide (CpG) and innate defense regulator peptide HH2 for improving anti-tumor immune responses.",28515346_2,0,-1,2,-1,32101,-1,0.019411787,0.9792473,0.0013409483
32107,TNF-,10,11,68,73,"The CpG-HH2 complex significantly enhanced the production of IFN-, TNF- and IL-1, promoted the uptake of antigen and strengthened the activation of p38, Erk1/2 and NF-B in vitro, compared to CpG or HH2 alone.",28515346_3,0,1,-1,-1,32107,-1,0.0006310852,0.9992192,0.00014975856
32113,antigen plus,3,5,27,39,Immunization with NY-ESO-1 antigen plus alum-CpG-HH2 combinatorial adjuvant effectively inhibited tumor growth and reduced tumor burden in prophylactic and therapeutic tumor models and even in passive serum or cellular therapy.,28515346_4,-1,-1,-1,-1,32113,-1,0.9911827,0.0065360055,0.0022812989
32116,therapeutic tumor,19,21,156,173,Immunization with NY-ESO-1 antigen plus alum-CpG-HH2 combinatorial adjuvant effectively inhibited tumor growth and reduced tumor burden in prophylactic and therapeutic tumor models and even in passive serum or cellular therapy.,28515346_4,-1,-1,-1,-1,32116,-1,3.9881565e-06,0.9999913,4.720159e-06
32117,cellular therapy,28,30,210,226,Immunization with NY-ESO-1 antigen plus alum-CpG-HH2 combinatorial adjuvant effectively inhibited tumor growth and reduced tumor burden in prophylactic and therapeutic tumor models and even in passive serum or cellular therapy.,28515346_4,-1,-1,-1,-1,32117,-1,0.00032465725,0.0027158135,0.99695957
32136,therapy,14,15,101,108,The identification of mechanisms leading to local immune dysregulation is critical to improve cancer therapy.,28533483_1,0,1,-1,-1,32136,-1,6.3470175e-06,0.99998856,5.098883e-06
32137,that Interleukin-1 receptor,3,6,20,47,"We here demonstrate that Interleukin-1 receptor 8 (IL-1R8 - previously known as SIGIRR/TIR8), a negative regulator of Toll-Like and Interleukin-1 Receptor family signaling, is up-regulated during breast epithelial cell transformation and in primary breast tumors.",28533483_2,-1,-1,-1,-1,32137,-1,0.643556,0.32979676,0.02664728
32138,IL-1R8 -,8,10,51,59,"We here demonstrate that Interleukin-1 receptor 8 (IL-1R8 - previously known as SIGIRR/TIR8), a negative regulator of Toll-Like and Interleukin-1 Receptor family signaling, is up-regulated during breast epithelial cell transformation and in primary breast tumors.",28533483_2,-1,-1,-1,-1,32138,-1,0.9990522,0.00013604612,0.00081173616
32140,Interleukin-1 Receptor,22,24,132,154,"We here demonstrate that Interleukin-1 receptor 8 (IL-1R8 - previously known as SIGIRR/TIR8), a negative regulator of Toll-Like and Interleukin-1 Receptor family signaling, is up-regulated during breast epithelial cell transformation and in primary breast tumors.",28533483_2,-1,-1,-1,-1,32140,-1,0.9998789,1.0300213e-05,0.000110801324
32141,cell transformation,32,34,214,233,"We here demonstrate that Interleukin-1 receptor 8 (IL-1R8 - previously known as SIGIRR/TIR8), a negative regulator of Toll-Like and Interleukin-1 Receptor family signaling, is up-regulated during breast epithelial cell transformation and in primary breast tumors.",28533483_2,-1,-1,-1,-1,32141,-1,5.059156e-05,0.00020150328,0.99974793
32154,analysis,4,5,31,39,"Finally, immune-gene signature analysis in clinical specimens revealed that high IL-1R8 expression is associated with impaired innate immune sensing and T-cell exclusion from the tumor microenvironment.",28533483_5,0,1,-1,-1,32154,-1,9.35981e-06,0.9999826,8.033088e-06
32157,T-cell,21,22,153,159,"Finally, immune-gene signature analysis in clinical specimens revealed that high IL-1R8 expression is associated with impaired innate immune sensing and T-cell exclusion from the tumor microenvironment.",28533483_5,-1,1,2,-1,32157,-1,1.5386384e-05,9.551246e-06,0.9999751
32158,the tumor,24,26,175,184,"Finally, immune-gene signature analysis in clinical specimens revealed that high IL-1R8 expression is associated with impaired innate immune sensing and T-cell exclusion from the tumor microenvironment.",28533483_5,-1,-1,-1,-1,32158,-1,4.8032866e-06,0.99999046,4.7301273e-06
32162,immunity,16,17,116,124,Our results indicate that high IL-1R8 expression acts as a novel immunomodulatory mechanism leading to dysregulated immunity with important implications for breast cancer immunotherapy.,28533483_6,0,-1,2,-1,32162,-1,0.999871,3.859672e-05,9.029567e-05
32163,therapy,1,2,12,19,Anti-CTL4-A therapy is associated with development of colitis.,28548891_0,0,1,-1,-1,32163,-1,5.625282e-06,0.99998975,4.636967e-06
32165,T-cells,15,16,123,130,Endoscopic characteristics resembled inflammatory bowel disease and histology revealed predominance of plasmacytes or CD4+ T-cells.,28548891_3,-1,1,2,-1,32165,-1,1.4542034e-05,7.71606e-06,0.9999777
32177,T-cell,18,19,134,140,Histone acetylation and the families of enzymes responsible for controlling these epigenetic marks have been implicated in regulating T-cell maturation and phenotype.,28550044_0,-1,1,2,-1,32177,-1,9.912622e-06,6.2523195e-06,0.9999839
32178,T-cell,17,18,98,104,"Here, we demonstrate a previously undefined role of histone deacetylase 11 (HDAC11) in regulating T-cell effector functions.",28550044_1,-1,1,2,-1,32178,-1,1.18233565e-05,8.5611155e-06,0.9999796
32179,functions,19,20,114,123,"Here, we demonstrate a previously undefined role of histone deacetylase 11 (HDAC11) in regulating T-cell effector functions.",28550044_1,0,1,2,-1,32179,-1,0.00024824863,0.000700342,0.9990515
32182,relative to naive,15,18,98,115,"Using EGFP-HDAC11 transgenic reporter mice, we found that HDAC11 expression was lower in effector relative to naive and central memory T-cell populations, and activation of resting T cells resulted in its decreased expression.",28550044_2,-1,-1,-1,-1,32182,-1,7.093237e-06,0.9999869,6.0465577e-06
32183,T-cell,21,22,135,141,"Using EGFP-HDAC11 transgenic reporter mice, we found that HDAC11 expression was lower in effector relative to naive and central memory T-cell populations, and activation of resting T cells resulted in its decreased expression.",28550044_2,-1,1,2,-1,32183,-1,1.0827169e-05,7.522504e-06,0.99998164
32185,that T cells,9,12,53,65,"Experiments using HDAC11 knockout (KO) mice revealed that T cells from these mice displayed enhanced proliferation, proinflammatory cytokine production, and effector molecule expression.",28550044_3,-1,-1,-1,-1,32185,-1,0.0018647161,0.18679236,0.8113429
32189,TBX21,15,16,83,88,"In addition, HDAC11KO T cells had increased expression of Eomesodermin (Eomes) and TBX21 (Tbet), transcription factors previously shown to regulate inflammatory cytokine and effector molecule production.",28550044_4,-1,1,2,-1,32189,-1,2.8957134e-05,0.999954,1.7048756e-05
32194,these genes,10,12,73,84,"Conversely, overexpression of HDAC11 resulted in decreased expression of these genes.",28550044_5,-1,-1,-1,-1,32194,-1,7.509448e-06,0.999985,7.454307e-06
32197,Tbet gene,11,13,77,86,"Chromatin immunoprecipitation showed the presence of HDAC11 at the Eomes and Tbet gene promoters in resting T cells, where it rapidly disassociated following T-cell activation.",28550044_6,-1,-1,-1,-1,32197,-1,4.456117e-06,0.9999895,6.0544785e-06
32201,to tolerance,8,10,42,54,"In vivo, HDAC11KO T cells were refractory to tolerance induction.",28550044_7,-1,-1,-1,-1,32201,-1,1.7139864e-05,0.99997556,7.322157e-06
32209,Taken together,0,2,0,14,"Taken together, these data demonstrate a previously unknown role of HDAC11 as a negative epigenetic regulator of T-cell effector phenotype and function.",28550044_10,-1,-1,-1,-1,32209,-1,1.4951931e-05,0.9999752,9.887694e-06
32211,T-cell,18,19,113,119,"Taken together, these data demonstrate a previously unknown role of HDAC11 as a negative epigenetic regulator of T-cell effector phenotype and function.",28550044_10,-1,1,2,-1,32211,-1,1.0064987e-05,7.249578e-06,0.9999827
32212,function,22,23,143,151,"Taken together, these data demonstrate a previously unknown role of HDAC11 as a negative epigenetic regulator of T-cell effector phenotype and function.",28550044_10,0,1,2,-1,32212,-1,0.00012717057,0.9981504,0.0017223866
32216,immunity,18,19,116,124,Inflammation plays a critical role in the initiation of colorectal cancer but is also required to mediate antitumor immunity in established tumors.,28558303_0,0,-1,2,-1,32216,-1,0.9999274,1.788742e-05,5.4734985e-05
32219,the cellular,3,5,23,35,"Therefore, identifying the cellular and molecular components in colorectal tumors is necessary for the understanding of tumor progression and the development of novel treatment strategies.",28558303_1,-1,-1,-1,-1,32219,-1,0.0053629265,0.6575719,0.33706522
32233,plasmablast subset,2,4,18,36,This CD19loCD27hi plasmablast subset presented high interleukin 10 (IL-10) expression but not transforming growth factor- (TGF-) secretion.,28558303_3,-1,-1,-1,-1,32233,-1,0.0015709563,0.8138019,0.18462719
32237,factor-,16,17,114,122,This CD19loCD27hi plasmablast subset presented high interleukin 10 (IL-10) expression but not transforming growth factor- (TGF-) secretion.,28558303_3,0,1,-1,-1,32237,-1,0.99993515,6.418461e-06,5.8424346e-05
32239,the tumor-infiltrating IL-10,2,5,16,44,"Phenotypically, the tumor-infiltrating IL-10+ CD19loCD27hi plasmablasts presented lower CD24, CD38, and IgA, and higher Tim-1 and IgG expression compared to the IL-10- CD19loCD27hi plasmablasts.",28558303_4,-1,-1,-1,-1,32239,-1,0.119541444,0.87880754,0.0016510823
32242,to the IL-10-,24,27,154,167,"Phenotypically, the tumor-infiltrating IL-10+ CD19loCD27hi plasmablasts presented lower CD24, CD38, and IgA, and higher Tim-1 and IgG expression compared to the IL-10- CD19loCD27hi plasmablasts.",28558303_4,-1,-1,-1,-1,32242,-1,0.17451231,0.8234203,0.0020674276
32244,The tumor-infiltrating IL-10,0,3,0,28,The tumor-infiltrating IL-10+ CD19loCD27hi plasmablasts were found to be gut-homing due to their higher expression of 47 while peripheral blood B cells did not show the same characteristic.,28558303_5,-1,-1,-1,-1,32244,-1,0.08468882,0.9140155,0.0012957797
32247,to their,12,14,88,96,The tumor-infiltrating IL-10+ CD19loCD27hi plasmablasts were found to be gut-homing due to their higher expression of 47 while peripheral blood B cells did not show the same characteristic.,28558303_5,-1,-1,-1,-1,32247,-1,5.4958664e-06,0.9999893,5.2319683e-06
32248,blood,20,21,140,145,The tumor-infiltrating IL-10+ CD19loCD27hi plasmablasts were found to be gut-homing due to their higher expression of 47 while peripheral blood B cells did not show the same characteristic.,28558303_5,0,1,-1,-1,32248,-1,0.00013874989,0.9996278,0.00023345985
32256,factor-,21,22,151,159,"When cocultured with autologous T cells, CD19loCD27hi plasmablasts demonstrated potent activity in suppressing interferon- (IFN-) and tumor necrosis factor- (TNF-) expression but did not promote Foxp3 expression.",28558303_6,0,1,-1,-1,32256,-1,0.99995387,4.8699912e-06,4.122037e-05
32257,TNF-,23,24,161,166,"When cocultured with autologous T cells, CD19loCD27hi plasmablasts demonstrated potent activity in suppressing interferon- (IFN-) and tumor necrosis factor- (TNF-) expression but did not promote Foxp3 expression.",28558303_6,0,1,-1,-1,32257,-1,0.006459208,0.9933831,0.00015769317
32262,tumor-infiltrating lymphocytes,18,20,115,145,"Overall, this study demonstrate that in colorectal cancer, CD19loCD27hi plasmablasts make up a large percentage in tumor-infiltrating lymphocytes and possess potent immunoregulatory functions, and thus could be utilized in future therapeutic strategies.",28558303_7,-1,-1,-1,-1,32262,-1,0.0016461149,0.91879666,0.07955722
32263,functions,24,25,182,191,"Overall, this study demonstrate that in colorectal cancer, CD19loCD27hi plasmablasts make up a large percentage in tumor-infiltrating lymphocytes and possess potent immunoregulatory functions, and thus could be utilized in future therapeutic strategies.",28558303_7,0,1,2,-1,32263,-1,3.6721303e-05,0.9999132,5.0105988e-05
32269,cytokines to,12,14,76,88,Immune cells constantly survey the host for pathogens or tumors and secrete cytokines to alert surrounding cells of these threats.,28575659_0,-1,-1,-1,-1,32269,-1,0.94765514,0.050848786,0.0014960171
32271,these threats,18,20,116,129,Immune cells constantly survey the host for pathogens or tumors and secrete cytokines to alert surrounding cells of these threats.,28575659_0,-1,-1,-1,-1,32271,-1,3.641983e-05,0.99994934,1.4223513e-05
32276,cytokine-responsive cells translate,8,11,51,86,"Given these divergent timescales, we addressed how cytokine-responsive cells translate brief cytokine exposure into phenotypic changes that persist over long timescales.",28575659_2,-1,-1,-1,-1,32276,-1,0.99127954,0.006821777,0.0018986047
32281,to transient,5,7,35,47,We studied melanoma cell responses to transient exposure to the cytokine interferon  (IFN) by combining a systems-scale analysis of gene expression dynamics with computational modeling and experiments.,28575659_3,-1,-1,-1,-1,32281,-1,8.530696e-06,0.9999858,5.6591966e-06
32282,to the cytokine interferon,8,12,57,83,We studied melanoma cell responses to transient exposure to the cytokine interferon  (IFN) by combining a systems-scale analysis of gene expression dynamics with computational modeling and experiments.,28575659_3,-1,-1,-1,-1,32282,-1,0.6759601,0.31853497,0.0055048903
32284,analysis,20,21,122,130,We studied melanoma cell responses to transient exposure to the cytokine interferon  (IFN) by combining a systems-scale analysis of gene expression dynamics with computational modeling and experiments.,28575659_3,0,1,-1,-1,32284,-1,7.2586113e-06,0.9999862,6.5401277e-06
32286,that IFN,2,4,14,23,We discovered that IFN is captured by phosphatidylserine (PS) on the surface of viable cells both invitro and invivo then slowly released to drive long-term transcription of cytokine-response genes.,28575659_4,-1,-1,-1,-1,32286,-1,0.95648557,0.041177064,0.0023373412
32290,released to,27,29,132,143,We discovered that IFN is captured by phosphatidylserine (PS) on the surface of viable cells both invitro and invivo then slowly released to drive long-term transcription of cytokine-response genes.,28575659_4,-1,-1,-1,-1,32290,-1,5.7872217e-06,0.9999896,4.607569e-06
32292,cytokine-response genes,33,35,177,200,We discovered that IFN is captured by phosphatidylserine (PS) on the surface of viable cells both invitro and invivo then slowly released to drive long-term transcription of cytokine-response genes.,28575659_4,-1,-1,-1,-1,32292,-1,0.9960525,0.0034759731,0.00047156517
32294,function,5,6,40,48,This mechanism introduces an additional function for PS in dynamically regulating inflammation across diverse cancer and primary cell types and has potential to usher in new immunotherapies targeting PS and inflammatory pathways.,28575659_5,0,1,2,-1,32294,-1,7.399585e-05,0.99988806,3.7915506e-05
32295,cell types,17,19,129,139,This mechanism introduces an additional function for PS in dynamically regulating inflammation across diverse cancer and primary cell types and has potential to usher in new immunotherapies targeting PS and inflammatory pathways.,28575659_5,-1,-1,-1,-1,32295,-1,2.5353545e-05,2.1316926e-05,0.99995327
32300,receptor,3,4,18,26,The adenosine A2A receptor (A2AR) could protect cancerous tissues from immune clearance via inhibiting T cells response.,28592285_1,0,1,2,-1,32300,-1,0.00068140606,0.010483299,0.9888353
32301,tissues,10,11,58,65,The adenosine A2A receptor (A2AR) could protect cancerous tissues from immune clearance via inhibiting T cells response.,28592285_1,-1,1,2,-1,32301,-1,0.00016112746,0.0039657867,0.99587315
32309,tissues,36,37,217,224,"Here, we sought to explore the expression and immunotherapeutic value of A2AR blockade in HNSCC.METHODS: The expression of A2AR was evaluated by immunostaining in 43 normal mucosae, 48 dysplasia and 165 primary HNSCC tissues.",28592285_3,-1,1,2,-1,32309,-1,0.000141569,0.0035546937,0.9963037
32312,tissue,5,6,33,39,"RESULTS: Immunostaining of HNSCC tissue samples revealed that increased expression of A2AR on tumor infiltrating immune cells correlated with advanced pathological grade, larger tumor size and positive lymph node status.",28592285_5,-1,1,2,-1,32312,-1,2.1074127e-05,0.9998828,9.6065116e-05
32318,tissues,11,12,72,79,Elevated A2AR expression was also detected in recurrent HNSCC and HNSCC tissues with induction chemotherapy.,28592285_6,-1,1,2,-1,32318,-1,0.0005711201,0.33776042,0.66166836
32328,the tumor,7,9,53,62,Pharmacological blockade of A2AR by SCH58261 delayed the tumor growth in the HNSCC mouse model.,28592285_9,-1,-1,-1,-1,32328,-1,5.771651e-06,0.9999896,4.5492834e-06
32337,therapy,17,18,123,130,CONCLUSIONS: These results offer a preclinical proof for the administration of A2AR inhibitor on prophylactic experimental therapy of HNSCC and suggest that A2AR blockade can be a potential novel strategy for HNSCC immunotherapy.,28592285_11,0,1,-1,-1,32337,-1,4.711411e-06,0.9999902,5.0813187e-06
32343,that the,2,4,8,16,"We show that the DNA exonuclease Trex1 is induced by radiation doses above 12-18 Gy in different cancer cells, and attenuates their immunogenicity by degrading DNA that accumulates in the cytosol upon radiation.",28598415_2,-1,-1,-1,-1,32343,-1,3.9351917e-06,0.9999924,3.720673e-06
32357,T cells that,9,12,45,57,This effect is essential for priming of CD8+ T cells that mediate systemic tumour rejection (abscopal effect) in the context of immune checkpoint blockade.,28598415_5,-1,-1,-1,-1,32357,-1,0.0015777976,0.035301123,0.9631212
32362,immunity,10,11,69,77,"Thus, Trex1 is an upstream regulator of radiation-driven anti-tumour immunity.",28598415_6,0,-1,2,-1,32362,-1,0.99982256,5.4428085e-05,0.00012302506
32379,cells that,18,20,100,110,"Therefore, we hypothesized that OSCC may favor the recruitment and retention of regulatory T (Treg) cells that express the CCL20 receptor, CCR6.",28600287_2,-1,-1,-1,-1,32379,-1,0.0016097239,0.18388543,0.8145048
32381,receptor,23,24,129,137,"Therefore, we hypothesized that OSCC may favor the recruitment and retention of regulatory T (Treg) cells that express the CCL20 receptor, CCR6.",28600287_2,0,1,2,-1,32381,-1,0.011708635,0.6225934,0.36569798
32383,blood Treg cells,8,11,38,54,"Interestingly, most (60%) peripheral blood Treg cells express CCR6, and CCR6+ Treg cells exhibit an activated effector/memory phenotype.",28600287_3,-1,-1,-1,-1,32383,-1,0.000319849,0.0013273212,0.99835277
32387,CCR6- Treg cells,12,15,45,61,"In contrast, a significant portion (>30%) of CCR6- Treg cells were found to be CD45RA+ naive Treg cells.",28600287_4,-1,-1,-1,-1,32387,-1,4.7177928e-05,1.2284443e-05,0.9999405
32389,naive Treg cells,20,23,87,103,"In contrast, a significant portion (>30%) of CCR6- Treg cells were found to be CD45RA+ naive Treg cells.",28600287_4,-1,-1,-1,-1,32389,-1,0.0015870293,0.096302904,0.90211
32390,to CCR6- naive,1,4,9,23,"Compared to CCR6- naive or memory Treg cells, CCR6+ Treg cells exhibit stronger suppressive activity and display higher FOXP3 expression along with lower methylation at the Treg-specific demethylated region of the FOXP3 gene.",28600287_5,-1,-1,-1,-1,32390,-1,0.00012286656,0.9995691,0.00030797085
32395,the Treg-specific,27,29,169,186,"Compared to CCR6- naive or memory Treg cells, CCR6+ Treg cells exhibit stronger suppressive activity and display higher FOXP3 expression along with lower methylation at the Treg-specific demethylated region of the FOXP3 gene.",28600287_5,-1,-1,-1,-1,32395,-1,1.0029002e-05,0.9999831,6.9008292e-06
32396,the FOXP3 gene,32,35,210,224,"Compared to CCR6- naive or memory Treg cells, CCR6+ Treg cells exhibit stronger suppressive activity and display higher FOXP3 expression along with lower methylation at the Treg-specific demethylated region of the FOXP3 gene.",28600287_5,-1,-1,-1,-1,32396,-1,4.796942e-06,0.99999046,4.7381727e-06
32401,tumor-infiltrating lymphocytes,16,18,85,115,This predominance of CCR6+ Treg cells was also found in the draining lymph nodes and tumor-infiltrating lymphocytes of OSCC patients with early or late clinical staging.,28600287_6,-1,-1,-1,-1,32401,-1,0.003406843,0.8756864,0.120906755
32404,tumor-infiltrating lymphocytes,8,10,41,71,"Moreover, CCR6+ Treg cells isolated from tumor-infiltrating lymphocytes or draining lymph nodes maintained similar phenotypic and suppressive characteristics ex vivo as did their counterparts isolated from peripheral blood.",28600287_7,-1,-1,-1,-1,32404,-1,0.0031010853,0.83313847,0.16376042
32406,blood,29,30,217,222,"Moreover, CCR6+ Treg cells isolated from tumor-infiltrating lymphocytes or draining lymph nodes maintained similar phenotypic and suppressive characteristics ex vivo as did their counterparts isolated from peripheral blood.",28600287_7,0,1,-1,-1,32406,-1,0.00014468664,0.9995425,0.0003128956
32408,that CCR6,3,5,22,31,These results suggest that CCR6 marks activated effector or memory Treg phenotypes with superior suppressive activity in humans.,28600287_8,-1,-1,-1,-1,32408,-1,0.0020080667,0.95529646,0.042695455
32411,therapy,10,11,89,96,Tumor migration/metastasis and immunosuppression are major obstacles in effective cancer therapy.,28612394_0,0,1,-1,-1,32411,-1,5.1156107e-06,0.99999,4.925508e-06
32415,therapy,12,13,78,85,"Incidentally, these 2 hurdles usually coexist inside tumors, therefore making therapy significantly more complicated, as both oncogenic mechanisms must be addressed for successful therapeutic intervention.",28612394_1,0,1,-1,-1,32415,-1,5.5283845e-06,0.9999902,4.210392e-06
32417,that the tumor,4,7,29,43,"Our recent report highlights that the tumor expression of a TNF family member, CD70, is correlated with poor survival for primary gliomas.",28612394_2,-1,-1,-1,-1,32417,-1,4.8205534e-06,0.99999094,4.2749093e-06
32418,TNF,10,11,60,63,"Our recent report highlights that the tumor expression of a TNF family member, CD70, is correlated with poor survival for primary gliomas.",28612394_2,0,1,-1,-1,32418,-1,0.0008522257,0.99906844,7.937044e-05
32421,tumor cells,15,17,89,100,"In this study, we investigated how CD70 expression by GBM affects the characteristics of tumor cells and the tumor microenvironment.",28612394_3,-1,-1,-1,-1,32421,-1,4.4810615e-05,0.0001403568,0.9998148
32422,the tumor,18,20,105,114,"In this study, we investigated how CD70 expression by GBM affects the characteristics of tumor cells and the tumor microenvironment.",28612394_3,-1,-1,-1,-1,32422,-1,4.590775e-06,0.9999907,4.7015474e-06
32423,that the,2,4,9,17,"We found that the ablation of CD70 in primary GBM decreased CD44 and SOX2 gene expression, and inhibited tumor migration, growth and the ability to attract monocyte-derived M2 macrophages in vitro.",28612394_4,-1,-1,-1,-1,32423,-1,4.267385e-06,0.99999166,4.1047574e-06
32424,SOX2 gene,13,15,69,78,"We found that the ablation of CD70 in primary GBM decreased CD44 and SOX2 gene expression, and inhibited tumor migration, growth and the ability to attract monocyte-derived M2 macrophages in vitro.",28612394_4,-1,-1,-1,-1,32424,-1,6.066574e-06,0.9999864,7.5160283e-06
32428,the tumor,1,3,3,12,"In the tumor microenvironment, CD70 was associated with immune cell infiltrates, such as T cells; myeloid-derived suppressor cells; and monocytes/macrophages based on the RNA-sequencing profile.",28612394_5,-1,-1,-1,-1,32428,-1,3.9758006e-06,0.99999154,4.5037327e-06
32434,than T cells,8,11,46,58,The CD163+ macrophages were far more abundant than T cells were.,28612394_6,-1,-1,-1,-1,32434,-1,0.0025459928,0.090005755,0.9074482
32436,their tumor,21,23,132,143,"This overwhelming level of macrophages was identified only in GBM and not in low-grade gliomas and normal brain specimens, implying their tumor association.",28612394_7,-1,-1,-1,-1,32436,-1,5.0587073e-06,0.99998987,5.0485487e-06
32437,tumor cells,5,7,26,37,"CD70 was detected only on tumor cells, not on macrophages, and was highly correlated with CD163 gene expression in primary GBM.",28612394_8,-1,-1,-1,-1,32437,-1,0.00022733888,0.0021541365,0.9976185
32448,to target this,3,6,20,34,Our current efforts to target this molecule using chimeric antigen receptor T cells hold great potential for treating patients with GBM.,28612394_11,-1,-1,-1,-1,32448,-1,3.840714e-06,0.9999924,3.831962e-06
32449,antigen receptor T cells,9,13,59,83,Our current efforts to target this molecule using chimeric antigen receptor T cells hold great potential for treating patients with GBM.,28612394_11,-1,-1,-1,-1,32449,-1,8.0128535e-05,7.0120445e-06,0.99991286
32454,cell therapy,21,23,128,140,Systemic high dose interleukin-2 (IL-2) postconditioning has long been utilized in boosting the efficacy of T cells in adoptive cell therapy (ACT) of solid tumors.,28614908_0,-1,-1,-1,-1,32454,-1,0.0012296416,0.068215035,0.9305553
32457,toxicity,4,5,32,40,The resulting severe off-target toxicity of these regimens renders local production at the tumor an attractive concept with possible safety gains.,28614908_1,0,1,-1,-1,32457,-1,1.2542542e-05,0.9999802,7.2851494e-06
32459,the tumor,12,14,87,96,The resulting severe off-target toxicity of these regimens renders local production at the tumor an attractive concept with possible safety gains.,28614908_1,-1,-1,-1,-1,32459,-1,4.900535e-06,0.99998903,6.02787e-06
32461,tumor-infiltrating lymphocyte therapy,14,17,113,150,We evaluated the efficacy and safety of intratumorally administered IL-2-coding adenoviruses in combination with tumor-infiltrating lymphocyte therapy in syngeneic Syrian hamsters bearing HapT1 pancreatic tumors and with T cell receptor transgenic ACT in B16.OVA melanoma bearing C57BL/6 mice.,28614908_2,-1,-1,-1,-1,32461,-1,2.2648152e-05,0.99994886,2.8447705e-05
32463,T cell receptor transgenic,27,31,221,247,We evaluated the efficacy and safety of intratumorally administered IL-2-coding adenoviruses in combination with tumor-infiltrating lymphocyte therapy in syngeneic Syrian hamsters bearing HapT1 pancreatic tumors and with T cell receptor transgenic ACT in B16.OVA melanoma bearing C57BL/6 mice.,28614908_2,-1,-1,-1,-1,32463,-1,0.0004208551,0.0056374404,0.99394166
32467,the cell therapy,25,28,155,171,"In both models, local production of IL-2 successfully replaced the need for systemic recombinant IL-2 (rIL-2) administration and increased the efficacy of the cell therapy.",28614908_4,-1,-1,-1,-1,32467,-1,0.00029784613,0.02885636,0.9708457
32472,the tumor,34,36,185,194,"Furthermore, vectored delivery of IL-2 significantly enhanced the infiltration of CD8+ T cells, M1-like macrophages, and B-cells while systemic rIL-2 increased CD25+FoxP3+ T cells at the tumor.",28614908_5,-1,-1,-1,-1,32472,-1,4.417405e-06,0.9999902,5.354958e-06
32473,analysis,7,8,54,62,"In contrast with vectored delivery, histopathological analysis of systemic rIL-2-treated animals revealed significant changes in lungs, livers, hearts, spleens, and kidneys.",28614908_6,0,1,-1,-1,32473,-1,6.9060693e-06,0.99998677,6.371982e-06
32479,Therapies targeting,0,2,0,19,Therapies targeting immune checkpoints are effective in tumors with a high mutation burden that express multiple neo-antigens.,28620836_0,-1,-1,-1,-1,32479,-1,4.562174e-06,0.99999154,3.8697444e-06
32486,antigenic targets,21,23,120,137,"However, glial tumors including those seen in children carry fewer mutations and there is an unmet need to identify new antigenic targets of anti-tumor immunity.",28620836_1,-1,-1,-1,-1,32486,-1,0.96959096,0.028084526,0.0023244852
32487,immunity,25,26,152,160,"However, glial tumors including those seen in children carry fewer mutations and there is an unmet need to identify new antigenic targets of anti-tumor immunity.",28620836_1,0,-1,2,-1,32487,-1,0.99985695,3.2049273e-05,0.00011095475
32489,cell antigen,5,7,26,38,SOX2 is an embryonal stem cell antigen implicated in the biology of glioma initiating cells.,28620836_2,-1,-1,-1,-1,32489,-1,0.13429043,0.00030767042,0.865402
32501,tissue,9,10,65,71,We examined the expression of SOX2 on archived paraffin-embedded tissue from pediatric glial tumors.,28620836_4,-1,1,2,-1,32501,-1,1.5647183e-05,0.99995637,2.799347e-05
32504,T-cell immunity to SOX2,3,7,16,39,The presence of T-cell immunity to SOX2 was examined in both blood and tumor-infiltrating T-cells in children and young adults with glioma.,28620836_5,-1,-1,-1,-1,32504,-1,0.03594407,0.20473213,0.7593238
32505,blood,11,12,61,66,The presence of T-cell immunity to SOX2 was examined in both blood and tumor-infiltrating T-cells in children and young adults with glioma.,28620836_5,0,1,-1,-1,32505,-1,0.00029645066,0.99911994,0.0005835868
32506,tumor-infiltrating T-cells,13,15,71,97,The presence of T-cell immunity to SOX2 was examined in both blood and tumor-infiltrating T-cells in children and young adults with glioma.,28620836_5,-1,-1,-1,-1,32506,-1,0.002579859,0.7731717,0.2242484
32507,The nature,0,2,0,10,The nature of tumor-infiltrating immune cells was analyzed with a 37-marker panel using single-cell mass cytometry.,28620836_6,-1,-1,-1,-1,32507,-1,4.241377e-06,0.9999906,5.179564e-06
32511,tumor cells,4,6,21,32,SOX2 is expressed by tumor cells but not surrounding normal tissue in pediatric gliomas of all grades.,28620836_7,-1,-1,-1,-1,32511,-1,0.00059550896,0.029823774,0.96958077
32512,tissue,10,11,60,66,SOX2 is expressed by tumor cells but not surrounding normal tissue in pediatric gliomas of all grades.,28620836_7,-1,1,2,-1,32512,-1,0.00020521098,0.9937827,0.0060121445
32513,T-cells,0,1,0,7,T-cells against this antigen can be detected in blood and tumor tissue in glioma patients.,28620836_8,-1,1,2,-1,32513,-1,1.482719e-05,9.752189e-06,0.99997544
32514,this antigen,2,4,16,28,T-cells against this antigen can be detected in blood and tumor tissue in glioma patients.,28620836_8,-1,-1,-1,-1,32514,-1,0.7404988,0.2530766,0.006424641
32515,in blood,7,9,45,53,T-cells against this antigen can be detected in blood and tumor tissue in glioma patients.,28620836_8,0,1,-1,-1,32515,-1,2.4327112e-05,0.9999516,2.40408e-05
32516,tumor tissue,10,12,58,70,T-cells against this antigen can be detected in blood and tumor tissue in glioma patients.,28620836_8,-1,-1,-1,-1,32516,-1,5.419213e-06,0.99998736,7.1746426e-06
32518,T-cells,6,7,38,45,"Glial tumors are enriched for CD8/CD4 T-cells with tissue resident memory (TRM; CD45RO+, CD69+, CCR7-) phenotype, which co-express multiple inhibitory checkpoints including PD-1, PD-L1 and TIGIT.",28620836_9,-1,1,2,-1,32518,-1,1.0310388e-05,6.694244e-06,0.9999831
32519,tissue,8,9,51,57,"Glial tumors are enriched for CD8/CD4 T-cells with tissue resident memory (TRM; CD45RO+, CD69+, CCR7-) phenotype, which co-express multiple inhibitory checkpoints including PD-1, PD-L1 and TIGIT.",28620836_9,-1,1,2,-1,32519,-1,2.8582706e-05,0.9997662,0.00020519913
32526,tumor cells,14,16,100,111,"Our data demonstrate immunogenicity of SOX2, which is specifically overexpressed on pediatric glial tumor cells.",28620836_11,-1,-1,-1,-1,32526,-1,5.827988e-05,0.00026967292,0.99967206
32527,tumor immunity,1,3,11,25,Harnessing tumor immunity in glioma will likely require the combined targeting of multiple inhibitory checkpoints.,28620836_12,-1,-1,-1,-1,32527,-1,0.076905474,0.9215702,0.0015243998
32534,protein,21,22,133,140,BACKGROUND: T cell immunoglobulin and immunoreceptor tyrosine-based inhibitory motif (ITIM) domain (TIGIT) and programmed cell death protein 1 (PD-1) are important inhibitory receptors that associate with T cell exhaustion in acute myeloid leukemia (AML).,28629373_0,0,1,-1,-1,32534,-1,0.0013251659,0.99179333,0.0068815015
32535,receptors that,29,31,175,189,BACKGROUND: T cell immunoglobulin and immunoreceptor tyrosine-based inhibitory motif (ITIM) domain (TIGIT) and programmed cell death protein 1 (PD-1) are important inhibitory receptors that associate with T cell exhaustion in acute myeloid leukemia (AML).,28629373_0,-1,-1,-1,-1,32535,-1,0.0032499454,0.49553466,0.5012154
32543,transcription factor B lymphocyte-induced maturation protein 1,7,14,42,104,"Specifically, we investigated the role of transcription factor B lymphocyte-induced maturation protein 1 (Blimp-1) in T cell response and transcriptional regulation of TIGIT and PD-1 in AML.METHODS: Peripheral blood samples collected from patients with AML were used in this study.",28629373_2,-1,-1,-1,-1,32543,-1,6.579868e-05,0.9994654,0.0004688268
32548,blood,32,33,210,215,"Specifically, we investigated the role of transcription factor B lymphocyte-induced maturation protein 1 (Blimp-1) in T cell response and transcriptional regulation of TIGIT and PD-1 in AML.METHODS: Peripheral blood samples collected from patients with AML were used in this study.",28629373_2,0,1,-1,-1,32548,-1,0.002056094,0.9868917,0.011052252
32554,functional,2,3,15,25,Phenotypic and functional studies of Blimp-1-expressing T cells were performed using flow cytometry-based assays.,28629373_5,0,1,2,-1,32554,-1,0.00062849146,0.9992125,0.00015899885
32555,Blimp-1-expressing T cells,5,8,37,63,Phenotypic and functional studies of Blimp-1-expressing T cells were performed using flow cytometry-based assays.,28629373_5,-1,-1,-1,-1,32555,-1,0.0021047983,0.8244887,0.1734065
32563,the TIGIT,15,17,88,97,"Using siRNA to silence Blimp-1, we further elucidated the regulatory role of Blimp-1 in the TIGIT and PD-1 expression and T cell immune response.",28629373_7,-1,-1,-1,-1,32563,-1,6.5092004e-06,0.999984,9.412286e-06
32564,T cell immune response,21,25,122,144,"Using siRNA to silence Blimp-1, we further elucidated the regulatory role of Blimp-1 in the TIGIT and PD-1 expression and T cell immune response.",28629373_7,-1,-1,-1,-1,32564,-1,0.08688266,0.00044949976,0.9126679
32569,receptors,11,12,76,85,"Consistent with exhaustion, Blimp-1+ T cells upregulate multiple inhibitory receptors including PD-1 and TIGIT.",28629373_9,0,1,2,-1,32569,-1,6.904758e-05,6.117365e-05,0.9998698
32572,functionally,5,6,22,34,"In addition, they are functionally impaired manifested by low cytokine production and decreased cytotoxicity capacity.",28629373_10,0,1,2,-1,32572,-1,0.00033979895,0.9995962,6.405968e-05
32574,the functional,2,4,13,27,"Importantly, the functional defect is reversed by inhibition of Blimp-1 via siRNA knockdown.",28629373_11,-1,-1,-1,-1,32574,-1,3.8461432e-05,0.99994075,2.0819405e-05
32577,to the,4,6,27,33,"Furthermore, Blimp-1 binds to the promoters of PD-1 and TIGIT and positively regulates their expression.",28629373_12,-1,-1,-1,-1,32577,-1,4.3736736e-06,0.9999908,4.8199686e-06
32583,targeting Blimp-1,20,22,111,128,"CONCLUSIONS: Our study demonstrates an important inhibitory effect of Blimp-1 on T cell response in AML; thus, targeting Blimp-1 and its regulated molecules to improve the immune response may provide effective leukemia therapeutics.",28629373_13,-1,-1,-1,-1,32583,-1,5.420489e-06,0.9999844,1.0221319e-05
32585,the immune response,28,31,168,187,"CONCLUSIONS: Our study demonstrates an important inhibitory effect of Blimp-1 on T cell response in AML; thus, targeting Blimp-1 and its regulated molecules to improve the immune response may provide effective leukemia therapeutics.",28629373_13,-1,-1,-1,-1,32585,-1,0.5591869,0.43896627,0.001846829
32588,FOXP3-dependent regulatory T cell function,4,9,31,73,"Although strategies that block FOXP3-dependent regulatory T cell function (CTLA4 blockade) and the inhibitory receptor PD1 have shown great promise in promoting antitumor immune responses in humans, their widespread implementation for cancer immunotherapy has been hampered by significant off-target autoimmune side effects that can be lethal.",28646041_0,-1,-1,-1,-1,32588,-1,0.0018554089,0.821541,0.17660362
32591,receptor,16,17,110,118,"Although strategies that block FOXP3-dependent regulatory T cell function (CTLA4 blockade) and the inhibitory receptor PD1 have shown great promise in promoting antitumor immune responses in humans, their widespread implementation for cancer immunotherapy has been hampered by significant off-target autoimmune side effects that can be lethal.",28646041_0,0,1,2,-1,32591,-1,0.0003362465,0.00065762654,0.9990062
32594,side effects that,43,46,311,328,"Although strategies that block FOXP3-dependent regulatory T cell function (CTLA4 blockade) and the inhibitory receptor PD1 have shown great promise in promoting antitumor immune responses in humans, their widespread implementation for cancer immunotherapy has been hampered by significant off-target autoimmune side effects that can be lethal.",28646041_0,-1,-1,-1,-1,32594,-1,0.0019136956,0.9978446,0.00024171626
32599,these side effects,27,30,168,186,"Our work has shown that absence of OX40 and CD30 costimulatory signals prevents CD4 T cell-driven autoimmunity in Foxp3-deficient mice, suggesting a novel way to block these side effects.",28646041_1,-1,-1,-1,-1,32599,-1,5.8275746e-05,0.99991286,2.8903936e-05
32609,side effects,3,5,27,39,"By dissociating autoimmune side effects from anticancer immune responses, this potentially shifts this antitumor approach to patients with far less advanced disease.",28646041_4,0,1,-1,-1,32609,-1,0.3438771,0.64824617,0.007876724
32616,tissue,7,8,53,59,Increased IL-4 expression in human colorectal cancer tissue and growth of colon cancer cell lines implied that IL-4-induced Stat6-mediated tumorigenic signaling likely contributes to intestinal tumor progression in ApcMin/+ mice.,28654863_1,-1,1,2,-1,32616,-1,0.00029603275,0.9632929,0.03641108
32619,Stat6-mediated tumorigenic,18,20,124,150,Increased IL-4 expression in human colorectal cancer tissue and growth of colon cancer cell lines implied that IL-4-induced Stat6-mediated tumorigenic signaling likely contributes to intestinal tumor progression in ApcMin/+ mice.,28654863_1,-1,-1,-1,-1,32619,-1,8.077747e-06,0.99998474,7.140378e-06
32633,factor-BB,15,16,127,136,"We found that IL-4-induced Stat6-mediated proliferation of intestinal epithelial cells is augmented by platelet-derived growth factor-BB, a tumor-promoting growth factor.",28654863_5,0,1,-1,-1,32633,-1,0.99886274,0.00018998279,0.0009472503
32634,tumor-promoting growth factor,18,21,140,169,"We found that IL-4-induced Stat6-mediated proliferation of intestinal epithelial cells is augmented by platelet-derived growth factor-BB, a tumor-promoting growth factor.",28654863_5,-1,-1,-1,-1,32634,-1,0.65685,0.338345,0.0048050755
32643,that Stat6,11,13,77,87,"Furthermore, proliferation of polyp epithelial cells was reduced, indicating that Stat6 in part controlled polyp formation.",28654863_8,-1,-1,-1,-1,32643,-1,8.040885e-06,0.9999819,1.0077397e-05
32647,T-cell,20,21,123,129,"Stat6 also promoted expansion of MDSCs in the spleen and lamina propria of ApcMin/+ mice, implying regulation of antitumor T-cell response.",28654863_9,-1,1,2,-1,32647,-1,3.6161473e-05,1.3617042e-05,0.9999503
32651,tumor cells,12,14,72,83,"In addition, a strong CD8-mediated cytotoxic response led to killing of tumor cells in Stat6-deficient ApcMin/+ mice.",28654863_11,-1,-1,-1,-1,32651,-1,0.00049393054,0.0069998153,0.9925062
32655,that Stat6,5,7,31,41,"Therefore, these findings show that Stat6 has an oncogenic role in intestinal tumorigenesis by promoting polyp cell proliferation and immunosuppressive mediators, and preventing an active cytotoxic process.",28654863_12,-1,-1,-1,-1,32655,-1,4.4744684e-06,0.99999,5.503654e-06
32663,the tumor,16,18,103,112,"BACKGROUND/AIM: Tumor-associated macrophages (TAMs), together with splenic CD11b+ cells, help maintain the tumor microenvironment.",28668835_0,-1,-1,-1,-1,32663,-1,4.51741e-06,0.9999912,4.3030395e-06
32669,the tumor,9,11,44,53,"In order to elucidate the effects of IQM on the tumor microenvironment, we investigated the immunomodulatory effect of IQM during melanoma growth by using the B16F10 melanoma model.",28668835_2,-1,-1,-1,-1,32669,-1,4.322484e-06,0.99999094,4.7478816e-06
32674,the tumor,12,14,75,84,"MATERIALS AND METHODS: To elucidate the immunomodulatory effects of IQM on the tumor microenvironment, we isolated CD11b+ TAMs and splenic CD11b+ cells and evaluated the immunomodulatory effects of IQM, using the B16F10 melanoma model.",28668835_3,-1,-1,-1,-1,32674,-1,4.71909e-06,0.99999094,4.3975515e-06
32682,the tumor,21,23,114,123,"RESULTS: IQM suppressed B16F10 melanoma growth in parallel with reduction of Foxp3+ regulatory T cells (Tregs) at the tumor site, caused by the down-regulation of CCL22 production by tumor-derived and splenic CD11b+ cells.",28668835_4,-1,-1,-1,-1,32682,-1,4.2688594e-06,0.99999094,4.743916e-06
32699,the tumor,16,18,131,140,"Furthermore, intratumoral administration of anti-CCL22 antibody inhibited B16F10 melanoma growth by decreasing Treg recruitment at the tumor site.",28668835_8,-1,-1,-1,-1,32699,-1,4.190947e-06,0.99999034,5.4511165e-06
32702,through tumor-associated,16,18,102,126,CONCLUSION: Our results suggest a possible mechanism for the antitumor immune response induced by IQM through tumor-associated macrophages.,28668835_9,-1,-1,-1,-1,32702,-1,2.7059474e-05,0.9999598,1.3079106e-05
32703,functions,1,2,18,27,"Immunosuppressive functions of glucocorticoids (GC) can be mediated via various mechanisms, including the modulation of dendritic cells (DC).",28675711_0,0,1,2,-1,32703,-1,0.0007340125,0.9988951,0.0003708495
32709,transgenic TCR,22,24,137,151,"Our study investigates the effects of tolerogenic GC-treated DCs on NK and T cell anti-tumor responses in OT-1/Rag-/- mice, expressing a transgenic TCR in CD8+ T cells.",28675711_1,-1,-1,-1,-1,32709,-1,8.6719365e-06,0.9999809,1.0343377e-05
32712,to the,8,10,51,57,"The effects caused by GC-treated DCs were compared to the responses to immunogenic, CpG-activated DCs.",28675711_2,-1,-1,-1,-1,32712,-1,5.1191723e-06,0.9999907,4.214902e-06
32718,the tumor cells,17,20,97,112,"The effects of DCs on anti-tumor immune responses were analyzed using the EG7 tumor model, where the tumor cells express the peptide epitope recognized by OT-1 T cells.",28675711_3,-1,-1,-1,-1,32718,-1,0.0019588356,0.6221419,0.37589923
32719,the peptide,21,23,121,132,"The effects of DCs on anti-tumor immune responses were analyzed using the EG7 tumor model, where the tumor cells express the peptide epitope recognized by OT-1 T cells.",28675711_3,-1,-1,-1,-1,32719,-1,0.0001929196,0.9997491,5.790503e-05
32722,peptide-treated,7,8,43,58,We observed that immunization with CpG and peptide-treated DCs protected against tumor growth by activation of NK cell response.,28675711_4,0,-1,2,-1,32722,-1,0.0025184678,0.99727577,0.00020577523
32728,the peptide,3,5,13,24,"In contrast, the peptide and GC-treated DCs in OT-1 mice increased the numbers of immature Mac-1+CD27- NK cells as well as Foxp3+ and IL-10 secreting CD8+OT-1 cells with suppressive properties.",28675711_6,-1,-1,-1,-1,32728,-1,9.613347e-06,0.99998236,8.042032e-06
32734,that the generation,2,5,12,31,We conclude that the generation of tolerogenic DCs is one of many immunosuppressive mechanisms that can be induced by GC.,28675711_7,-1,-1,-1,-1,32734,-1,5.987948e-06,0.9999893,4.774782e-06
32737,that tolerogenic,3,5,23,39,Our study demonstrated that tolerogenic DCs modify anti-tumor immune response by suppressing NK cell activity and stimulating the formation of IL-10-secreting CD8+ Tregs.,28675711_8,-1,-1,-1,-1,32737,-1,1.2200664e-05,0.9999819,5.8919163e-06
32744,their natural,12,14,77,90,Cytokines are potent immune modulating agents but are not ideal medicines in their natural form due to their short half-life and pleiotropic systemic effects.,28678791_0,-1,-1,-1,-1,32744,-1,8.549716e-06,0.9999851,6.3497505e-06
32745,to their,16,18,100,108,Cytokines are potent immune modulating agents but are not ideal medicines in their natural form due to their short half-life and pleiotropic systemic effects.,28678791_0,-1,-1,-1,-1,32745,-1,9.259788e-06,0.9999839,6.834724e-06
32749,protein,11,12,73,80,NKTR-214 is a clinical-stage biologic that comprises interleukin-2 (IL2) protein bound by multiple releasable polyethylene glycol (PEG) chains.,28678791_1,0,1,-1,-1,32749,-1,0.011732278,0.98684293,0.0014247698
32756,protein,18,19,104,111,"When administered in vivo, the PEG chains slowly release, creating a cascade of increasingly active IL2 protein conjugates bound by fewer PEG chains.",28678791_3,0,1,-1,-1,32756,-1,0.98299533,0.015840339,0.0011643376
32759,protein,1,2,9,16,Free-IL2 protein is undetectable in vivo as it is eliminated faster than formed.,28678791_5,0,1,-1,-1,32759,-1,0.0010346697,0.9988595,0.00010577078
32767,receptor complex,24,26,122,138,"The PEG chains on NKTR-214 are located at the region of IL2 that contacts the alpha () subunit of the heterotrimeric IL2 receptor complex, IL2R, reducing its ability to bind and activate the heterotrimer.",28678791_6,-1,-1,-1,-1,32767,-1,0.022751737,0.97504723,0.0022010864
32779,the receptor complex,22,25,122,142,"Therefore, without the use of mutations, PEGylation reduces the affinity for IL2R to a greater extent than for IL2R, the receptor complex predominant on CD8 T cells.",28678791_8,-1,-1,-1,-1,32779,-1,1.1090995e-05,0.99997425,1.4651328e-05
32784,the tumor,13,15,74,83,NKTR-214 treatment in vivo favors activation of CD8 T cells over Tregs in the tumor microenvironment to provide anti-tumor efficacy in multiple syngeneic models.,28678791_9,-1,-1,-1,-1,32784,-1,4.8865563e-06,0.9999907,4.3572077e-06
32787,pharmacology,18,19,112,124,Mechanistic modeling based on in vitro and in vivo kinetic data provides insight into the mechanism of NKTR-214 pharmacology.,28678791_10,0,1,-1,-1,32787,-1,0.0002231925,0.999683,9.380053e-05
32790,protein,5,6,38,45,The model reveals that conjugated-IL2 protein derived from NKTR-214 occupy IL-2R to a greater extent compared to free-IL2 protein.,28678791_11,0,1,-1,-1,32790,-1,0.0011192417,0.9986664,0.00021434679
32793,protein,18,19,124,131,The model reveals that conjugated-IL2 protein derived from NKTR-214 occupy IL-2R to a greater extent compared to free-IL2 protein.,28678791_11,0,1,-1,-1,32793,-1,0.0017820541,0.99801385,0.00020405295
32797,mechanism of action,28,31,201,220,The model accurately describes the sustained in vivo signaling observed after a single dose of NKTR-214 and explains how the properties of NKTR-214 impart a unique kinetically-controlled immunological mechanism of action.,28678791_12,0,1,-1,-1,32797,-1,0.0001002028,0.99981934,8.043601e-05
32799,proteins that,15,17,96,109,Reed-Sternberg (RS) cells of classical Hodgkin lymphoma (cHL) express multiple immunoregulatory proteins that shape the cHL microenvironment and allow tumor cells to evade immune surveillance.,28698206_0,-1,-1,-1,-1,32799,-1,7.959831e-06,0.99998605,5.9305175e-06
32801,tumor cells to,23,26,151,165,Reed-Sternberg (RS) cells of classical Hodgkin lymphoma (cHL) express multiple immunoregulatory proteins that shape the cHL microenvironment and allow tumor cells to evade immune surveillance.,28698206_0,-1,-1,-1,-1,32801,-1,0.0005923347,0.9446423,0.054765396
32802,proteins,4,5,39,47,"Expression of certain immunoregulatory proteins is modulated by prosurvival transcription factors, such as NFB and STATs.",28698206_1,0,1,-1,-1,32802,-1,9.998899e-05,0.9998709,2.9068944e-05
32805,these factors,1,3,8,21,"Because these factors also induce expression of the oncogenic PIM1/2/3 serine/threonine kinases, and as PIMs modulate transcriptional activity of NFB and STATs, we hypothesized that these kinases support RS cell survival and foster their immune privilege.",28698206_2,-1,-1,-1,-1,32805,-1,7.818731e-06,0.99998784,4.2883585e-06
32809,that these,26,28,178,188,"Because these factors also induce expression of the oncogenic PIM1/2/3 serine/threonine kinases, and as PIMs modulate transcriptional activity of NFB and STATs, we hypothesized that these kinases support RS cell survival and foster their immune privilege.",28698206_2,-1,-1,-1,-1,32809,-1,5.711143e-06,0.9999906,3.6545111e-06
32811,foster their,34,36,226,238,"Because these factors also induce expression of the oncogenic PIM1/2/3 serine/threonine kinases, and as PIMs modulate transcriptional activity of NFB and STATs, we hypothesized that these kinases support RS cell survival and foster their immune privilege.",28698206_2,-1,-1,-1,-1,32811,-1,2.1884074e-05,0.99996674,1.13936885e-05
32826,than T cells,17,20,127,139,"In coculture experiments, T cells incubated with SEL24-B489-treated RS cells exhibited higher expression of activation markers than T cells coincubated with control RS cells.",28698206_9,-1,-1,-1,-1,32826,-1,0.0014256041,0.08037209,0.9182023
32828,Taken together,0,2,0,14,"Taken together, our data indicate that PIM kinases in cHL exhibit pleiotropic effects, orchestrating tumor immune escape and supporting RS cell survival.",28698206_10,-1,-1,-1,-1,32828,-1,1.2338119e-05,0.9999784,9.1840075e-06
32835,these cells,14,16,96,107,Inhibition of PIM kinases decreases RS cell viability and disrupts signaling circuits that link these cells with their niches.,28698206_11,-1,-1,-1,-1,32835,-1,1.5108345e-05,9.283957e-06,0.99997556
32838,therapeutic targets,6,8,32,51,"Thus, PIM kinases are promising therapeutic targets in cHL.",28698206_12,-1,-1,-1,-1,32838,-1,5.2188493e-06,0.9999906,4.165737e-06
32842,functions,11,12,56,65,Regulatory T cells (Tregs) have been proposed to dampen functions of anti-neoplastic immune cells and thus promote cancer progression.,28721449_0,0,1,2,-1,32842,-1,2.137264e-05,0.99995804,2.0578542e-05
32846,Mission Trial,8,10,24,37,"In a phase IV trial (Re:Mission Trial, NCT01347996, http://www.clinicaltrials.gov ) 84 patients (age 18-79) with acute myeloid leukemia (AML) in first complete remission (CR) received ten consecutive 3-week cycles of immunotherapy with histamine dihydrochloride (HDC) and low-dose interleukin-2 (IL-2) to prevent relapse of leukemia in the post-consolidation phase.",28721449_1,-1,-1,-1,-1,32846,-1,6.809219e-06,0.99998367,9.4686975e-06
32854,function,8,9,43,51,"This study aimed at defining the features, function and dynamics of Foxp3+CD25highCD4+ Tregs during immunotherapy and to determine the potential impact of Tregs on relapse risk and survival.",28721449_2,0,1,2,-1,32854,-1,4.4318e-05,0.99990535,5.027077e-05
32862,blood,10,11,63,68,We observed a pronounced increase in Treg counts in peripheral blood during initial cycles of HDC/IL-2.,28721449_3,0,1,-1,-1,32862,-1,0.0021392468,0.18416399,0.81369674
32865,thymic-derived natural Tregs,4,7,33,61,"The accumulating Tregs resembled thymic-derived natural Tregs (nTregs), showed augmented expression of CTLA-4 and suppressed the cell cycle proliferation of conventional T cells ex vivo.",28721449_4,-1,-1,-1,-1,32865,-1,4.796154e-06,0.9999901,5.042698e-06
32867,the cell,18,20,125,133,"The accumulating Tregs resembled thymic-derived natural Tregs (nTregs), showed augmented expression of CTLA-4 and suppressed the cell cycle proliferation of conventional T cells ex vivo.",28721449_4,-1,-1,-1,-1,32867,-1,0.002566164,0.2718347,0.7255991
32879,Treg telomere,16,18,101,114,Exploratory analyses implied that a reduced expansion of Tregs in later treatment cycles and a short Treg telomere length were significantly associated with a favorable clinical outcome.,28721449_7,-1,-1,-1,-1,32879,-1,1.3680645e-05,0.9999716,1.4658851e-05
32881,Tregs that,13,15,99,109,Our results suggest that immunotherapy with HDC/IL-2 in AML entails induction of immunosuppressive Tregs that may be targeted for improved anti-leukemic efficiency.,28721449_8,-1,-1,-1,-1,32881,-1,5.41125e-06,0.9999895,5.109036e-06
32883,The regulatory T cells,0,4,0,22,The regulatory T cells (Treg) play an important role in the tumor tolerance.,28731226_0,-1,-1,-1,-1,32883,-1,0.0016070395,0.08713258,0.91126037
32886,the tumor tolerance,12,15,56,75,The regulatory T cells (Treg) play an important role in the tumor tolerance.,28731226_0,-1,-1,-1,-1,32886,-1,5.370536e-06,0.99998915,5.518149e-06
32889,the Treg,4,6,24,32,The methods to regulate the Treg population in cancer-bearing hosts are limited currently.,28731226_1,-1,-1,-1,-1,32889,-1,6.4878336e-06,0.9999881,5.4321736e-06
32904,the Tregs,6,8,42,51,The mechanism by which curcumin regulated the Tregs was observed by cell culture approaches.,28731226_6,-1,-1,-1,-1,32904,-1,6.8007967e-06,0.9999876,5.636886e-06
32907,that the,3,5,19,27,"The results showed that the frequency of peripheral Treg was markedly higher in LC patients than that in healthy subjects, which was suppressed after treating with curcumin for 2 weeks.",28731226_7,-1,-1,-1,-1,32907,-1,4.0551895e-06,0.99999213,3.846203e-06
32909,than that,15,17,92,101,"The results showed that the frequency of peripheral Treg was markedly higher in LC patients than that in healthy subjects, which was suppressed after treating with curcumin for 2 weeks.",28731226_7,-1,-1,-1,-1,32909,-1,7.949487e-06,0.99998546,6.5771137e-06
32914,therapy,12,13,74,81,The peripheral Th1 cells were increased in LC patients after the curcumin therapy.,28731226_8,0,1,-1,-1,32914,-1,6.6065863e-06,0.9999876,5.840571e-06
32919,Tregs to Th1 cells,14,18,92,110,The data of the in vitro experiments showed that curcumin converted the LC patient-isolated Tregs to Th1 cells via repressing the gene transcription of forkhead protein-3 and increasing the expression of interferon-.,28731226_9,-1,-1,-1,-1,32919,-1,0.001119418,0.45280394,0.54607666
32920,the gene transcription,20,23,126,148,The data of the in vitro experiments showed that curcumin converted the LC patient-isolated Tregs to Th1 cells via repressing the gene transcription of forkhead protein-3 and increasing the expression of interferon-.,28731226_9,-1,-1,-1,-1,32920,-1,4.2544616e-06,0.99999034,5.4360307e-06
32921,forkhead protein-3,24,26,152,170,The data of the in vitro experiments showed that curcumin converted the LC patient-isolated Tregs to Th1 cells via repressing the gene transcription of forkhead protein-3 and increasing the expression of interferon-.,28731226_9,-1,-1,-1,-1,32921,-1,1.5244088e-05,0.9999659,1.8907833e-05
32924,Tregs to Th1 cells,8,12,56,74,"In conclusion, curcumin can convert LC patient-isolated Tregs to Th1 cells.",28731226_10,-1,-1,-1,-1,32924,-1,0.0014112627,0.4206753,0.57791346
32928,immunity,9,10,60,68,The results suggest that curcumin may improve the antitumor immunity by regulating the tumor specific immune tolerance.,28731226_11,0,-1,2,-1,32928,-1,0.99987507,3.3176202e-05,9.173855e-05
32929,the tumor,12,14,83,92,The results suggest that curcumin may improve the antitumor immunity by regulating the tumor specific immune tolerance.,28731226_11,-1,-1,-1,-1,32929,-1,4.432971e-06,0.9999907,4.8513502e-06
32931,T-cell therapy,3,5,18,32,Purpose: Adoptive T-cell therapy using autologous tumor-infiltrating lymphocytes (TIL) has shown an overall clinical response rate 40%-50% in metastatic melanoma patients.,28754817_0,-1,-1,-1,-1,32931,-1,0.0013747098,0.03746266,0.96116257
32932,tumor-infiltrating lymphocytes,7,9,50,80,Purpose: Adoptive T-cell therapy using autologous tumor-infiltrating lymphocytes (TIL) has shown an overall clinical response rate 40%-50% in metastatic melanoma patients.,28754817_0,-1,-1,-1,-1,32932,-1,0.0038989899,0.8027102,0.19339082
32938,function,2,3,16,24,The suppressive function of the ITIM and ITSM motifs of BTLA is well described.,28754817_2,0,1,2,-1,32938,-1,2.1106523e-05,0.9999627,1.6200676e-05
32941,the functional,6,8,29,43,"Here, we sought to determine the functional characteristics of the CD8+BTLA+TIL subset and define the contribution of the Grb2 motif of BTLA in T-cell costimulation.",28754817_3,-1,-1,-1,-1,32941,-1,2.0991287e-05,0.99996495,1.4001574e-05
32946,T-cell,24,25,144,150,"Here, we sought to determine the functional characteristics of the CD8+BTLA+TIL subset and define the contribution of the Grb2 motif of BTLA in T-cell costimulation.",28754817_3,-1,1,2,-1,32946,-1,4.00182e-05,1.1773949e-05,0.99994814
32947,the functional,5,7,35,49,Experimental Design: We determined the functional role and downstream signal of BTLA in both human CD8+ TILs and mouse CD8+ T cells.,28754817_4,-1,-1,-1,-1,32947,-1,9.440811e-06,0.9999831,7.4348886e-06
32950,Functional,0,1,0,10,"Functional assays were used including single-cell analysis, reverse-phase protein array (RPPA), antigen-specific vaccination models with adoptively transferred TCR-transgenic T cells as well as patient-derived xenograft (PDX) model using immunodeficient NOD-scid IL2Rgammanull (NSG) tumor-bearing mice treated with autologous TILs.",28754817_5,0,1,2,-1,32950,-1,9.628974e-05,0.99981505,8.866118e-05
32951,analysis,6,7,50,58,"Functional assays were used including single-cell analysis, reverse-phase protein array (RPPA), antigen-specific vaccination models with adoptively transferred TCR-transgenic T cells as well as patient-derived xenograft (PDX) model using immunodeficient NOD-scid IL2Rgammanull (NSG) tumor-bearing mice treated with autologous TILs.",28754817_5,0,1,-1,-1,32951,-1,6.542116e-05,0.9982256,0.0017089103
32952,protein,9,10,74,81,"Functional assays were used including single-cell analysis, reverse-phase protein array (RPPA), antigen-specific vaccination models with adoptively transferred TCR-transgenic T cells as well as patient-derived xenograft (PDX) model using immunodeficient NOD-scid IL2Rgammanull (NSG) tumor-bearing mice treated with autologous TILs.",28754817_5,0,1,-1,-1,32952,-1,1.7158503e-05,0.9999658,1.7087828e-05
32954,transferred TCR-transgenic T cells,20,24,148,182,"Functional assays were used including single-cell analysis, reverse-phase protein array (RPPA), antigen-specific vaccination models with adoptively transferred TCR-transgenic T cells as well as patient-derived xenograft (PDX) model using immunodeficient NOD-scid IL2Rgammanull (NSG) tumor-bearing mice treated with autologous TILs.",28754817_5,-1,-1,-1,-1,32954,-1,0.0015282773,0.85682905,0.14164272
32966,tumor target,12,14,79,91,"However, CD8+BTLA+ TILs displayed improved survival following the killing of a tumor target and heightened ""serial killing"" capacity.",28754817_7,-1,-1,-1,-1,32966,-1,5.329755e-06,0.9999895,5.2112987e-06
32967,function,11,12,69,77,"Using mutants of BTLA signaling motifs, we uncovered a costimulatory function mediated by Grb2 through enhancing the secretion of IL-2 and the activation of Src after TCR stimulation.",28754817_8,0,1,2,-1,32967,-1,0.000112172565,0.9998267,6.110564e-05
32971,TCR,27,28,167,170,"Using mutants of BTLA signaling motifs, we uncovered a costimulatory function mediated by Grb2 through enhancing the secretion of IL-2 and the activation of Src after TCR stimulation.",28754817_8,-1,1,2,-1,32971,-1,3.1718606e-05,0.9998791,8.9194386e-05
32978,functional,41,42,239,249,"Conclusions: Our data portrays BTLA as a molecule with the singular ability to provide both costimulatory and coinhibitory signals to activated CD8+ T cells, resulting in extended survival, improved tumor control, and the development of a functional recall response.",28754817_9,0,1,2,-1,32978,-1,0.0028239298,0.9969921,0.00018393678
32981,to treat this,3,6,25,38,"More therapeutic options to treat this disease are needed, for the current standard of care is ineffective.",28775207_1,-1,-1,-1,-1,32981,-1,4.9877376e-06,0.9999908,4.1919366e-06
33005,analysis,1,2,6,14,"Human analysis of human datasets from The Cancer Genome Atlas and tissue microarrays correlated with observations from our mouse model experiments, especially in patients with grade 1, stage II disease.",28775207_6,0,1,-1,-1,33005,-1,5.973683e-06,0.99998844,5.632291e-06
33007,tissue,11,12,66,72,"Human analysis of human datasets from The Cancer Genome Atlas and tissue microarrays correlated with observations from our mouse model experiments, especially in patients with grade 1, stage II disease.",28775207_6,-1,1,2,-1,33007,-1,1.4785004e-05,0.9999691,1.6133157e-05
33010,to tumor,10,12,63,71,"We propose that in aggressive PDAC, elevated G-CSF contributes to tumor progression through promoting increases in infiltration of neutrophil-like cells with high immunosuppressive activity.",28775207_7,-1,-1,-1,-1,33010,-1,6.1950545e-06,0.99998856,5.259715e-06
33016,the release,16,18,114,125,"Glutamine-synthetase (GS), the glutamine-synthesizing enzyme from glutamate, controls important events, including the release of inflammatory mediators, mammalian target of rapamycin (mTOR) activation, and autophagy.",28813676_0,-1,-1,-1,-1,33016,-1,8.759936e-06,0.9999845,6.7618494e-06
33020,toward the,10,12,77,87,"We report that pharmacologic inhibition of GS skews M2-polarized macrophages toward the M1-like phenotype, characterized by reduced intracellular glutamine and increased succinate with enhanced glucose flux through glycolysis, which could be partly related to HIF1 activation.",28813676_2,-1,-1,-1,-1,33020,-1,6.209037e-06,0.9999876,6.1481396e-06
33022,related to HIF1,34,37,249,265,"We report that pharmacologic inhibition of GS skews M2-polarized macrophages toward the M1-like phenotype, characterized by reduced intracellular glutamine and increased succinate with enhanced glucose flux through glycolysis, which could be partly related to HIF1 activation.",28813676_2,-1,-1,-1,-1,33022,-1,2.762714e-05,0.9999597,1.2683438e-05
33028,to foster,35,37,210,219,"As a result of these metabolic changes and HIF1 accumulation, GS-inhibited macrophages display an increased capacity to induce Tcell recruitment, reduced Tcell suppressive potential, and an impaired ability to foster endothelial cell branching or cancer cell motility.",28813676_3,-1,-1,-1,-1,33028,-1,9.049147e-06,0.99998534,5.6395397e-06
33037,function,15,16,104,112,"These data identify GS activity as mediator of the proangiogenic, immunosuppressive, and pro-metastatic function of M2-like macrophages and highlight the possibility of targeting this enzyme in the treatment of cancer metastasis.",28813676_5,0,1,2,-1,33037,-1,0.00011862687,0.9997601,0.00012122457
33039,targeting this,24,26,169,183,"These data identify GS activity as mediator of the proangiogenic, immunosuppressive, and pro-metastatic function of M2-like macrophages and highlight the possibility of targeting this enzyme in the treatment of cancer metastasis.",28813676_5,-1,-1,-1,-1,33039,-1,3.567333e-06,0.9999926,3.8512994e-06
33040,the treatment,28,30,194,207,"These data identify GS activity as mediator of the proangiogenic, immunosuppressive, and pro-metastatic function of M2-like macrophages and highlight the possibility of targeting this enzyme in the treatment of cancer metastasis.",28813676_5,-1,-1,-1,-1,33040,-1,4.4011613e-06,0.9999913,4.289167e-06
33046,the Tregs,5,7,30,39,"However, different subsets of the Tregs and their relevance to GC are unknown.",28817117_1,-1,-1,-1,-1,33046,-1,4.914442e-06,0.9999895,5.5602586e-06
33047,their relevance to,8,11,44,62,"However, different subsets of the Tregs and their relevance to GC are unknown.",28817117_1,-1,-1,-1,-1,33047,-1,6.1278806e-06,0.9999887,5.1388547e-06
33051,Treg subset,19,21,114,125,"Here, we found that patients with GC showed a significantly higher Tregs infiltration in tumors, and CD45RA-CCR7- Treg subset constituted most tumor-infiltrating Tregs.",28817117_2,-1,-1,-1,-1,33051,-1,0.0014524569,0.44366208,0.55488545
33052,tumor-infiltrating Tregs,23,25,143,167,"Here, we found that patients with GC showed a significantly higher Tregs infiltration in tumors, and CD45RA-CCR7- Treg subset constituted most tumor-infiltrating Tregs.",28817117_2,-1,-1,-1,-1,33052,-1,7.3291203e-06,0.9999858,6.861382e-06
33054,Treg subset,2,4,32,43,Tumor-infiltrating CD45RA-CCR7- Treg subset with an effector/memory phenotype accumulated in tumors and expressed low level of HLA-DR.,28817117_3,-1,-1,-1,-1,33054,-1,0.0012633821,0.22929919,0.7694374
33056,tumor-derived TNF-,1,3,8,27,Gastric tumor-derived TNF- induced CD45RA-CCR7- Treg subset with similar phenotype to their status in tumors and inhibited their HLA-DR expression via activating STAT3 phosphorylation.,28817117_4,-1,-1,-1,-1,33056,-1,0.00015106502,0.99980253,4.639919e-05
33057,Treg subset,5,7,49,60,Gastric tumor-derived TNF- induced CD45RA-CCR7- Treg subset with similar phenotype to their status in tumors and inhibited their HLA-DR expression via activating STAT3 phosphorylation.,28817117_4,-1,-1,-1,-1,33057,-1,0.0008599043,0.086555995,0.9125842
33058,to their status,10,13,84,99,Gastric tumor-derived TNF- induced CD45RA-CCR7- Treg subset with similar phenotype to their status in tumors and inhibited their HLA-DR expression via activating STAT3 phosphorylation.,28817117_4,-1,-1,-1,-1,33058,-1,5.0359063e-06,0.9999888,6.184112e-06
33062,These tumor-associated,0,2,0,22,"These tumor-associated CD45RA-CCR7- Treg subset exerted superior immunosuppressive properties to effectively suppress CD8+ T cells' anti-tumor function including CD8+ T-cell IFN- and granzyme B (GrB) production as well as CD8+ T-cell proliferation in vitro, and also contributed to the growth and progression of human gastric tumors in vivo, via IL-10 secretion and cell-cell contact mechanisms.",28817117_5,-1,-1,-1,-1,33062,-1,7.308661e-06,0.99998367,9.0357225e-06
33063,Treg subset,3,5,36,47,"These tumor-associated CD45RA-CCR7- Treg subset exerted superior immunosuppressive properties to effectively suppress CD8+ T cells' anti-tumor function including CD8+ T-cell IFN- and granzyme B (GrB) production as well as CD8+ T-cell proliferation in vitro, and also contributed to the growth and progression of human gastric tumors in vivo, via IL-10 secretion and cell-cell contact mechanisms.",28817117_5,-1,-1,-1,-1,33063,-1,0.0013154122,0.5431566,0.45552793
33066,function,18,19,143,151,"These tumor-associated CD45RA-CCR7- Treg subset exerted superior immunosuppressive properties to effectively suppress CD8+ T cells' anti-tumor function including CD8+ T-cell IFN- and granzyme B (GrB) production as well as CD8+ T-cell proliferation in vitro, and also contributed to the growth and progression of human gastric tumors in vivo, via IL-10 secretion and cell-cell contact mechanisms.",28817117_5,0,1,2,-1,33066,-1,0.00043434554,0.9882261,0.011339494
33067,T-cell IFN-,22,24,167,179,"These tumor-associated CD45RA-CCR7- Treg subset exerted superior immunosuppressive properties to effectively suppress CD8+ T cells' anti-tumor function including CD8+ T-cell IFN- and granzyme B (GrB) production as well as CD8+ T-cell proliferation in vitro, and also contributed to the growth and progression of human gastric tumors in vivo, via IL-10 secretion and cell-cell contact mechanisms.",28817117_5,-1,-1,-1,-1,33067,-1,0.69415516,0.001225215,0.30461964
33069,to the,44,46,280,286,"These tumor-associated CD45RA-CCR7- Treg subset exerted superior immunosuppressive properties to effectively suppress CD8+ T cells' anti-tumor function including CD8+ T-cell IFN- and granzyme B (GrB) production as well as CD8+ T-cell proliferation in vitro, and also contributed to the growth and progression of human gastric tumors in vivo, via IL-10 secretion and cell-cell contact mechanisms.",28817117_5,-1,-1,-1,-1,33069,-1,4.1862463e-06,0.99999046,5.388237e-06
33074,Treg subset,5,7,52,63,"Moreover, increased tumor-infiltrating CD45RA-CCR7- Treg subset as well as higher intratumoral CD45RA-CCR7- Treg/CD8+ T-cell ratio was associated with advanced disease progression and reduced GC patient survival.",28817117_6,-1,-1,-1,-1,33074,-1,0.0014344315,0.40613264,0.5924329
33075,T-cell,15,16,118,124,"Moreover, increased tumor-infiltrating CD45RA-CCR7- Treg subset as well as higher intratumoral CD45RA-CCR7- Treg/CD8+ T-cell ratio was associated with advanced disease progression and reduced GC patient survival.",28817117_6,-1,1,2,-1,33075,-1,1.3355227e-05,6.2084946e-06,0.99998045
33078,Treg subset,10,12,89,100,This study therefore identifies a novel immunosuppressive pathway involving CD45RA-CCR7- Treg subset development within the GC microenvironment.,28817117_7,-1,-1,-1,-1,33078,-1,0.0008498876,0.047622845,0.95152724
33084,to treat this,15,18,88,101,"Efforts to inhibit this pathway may therefore prove a valuable strategy to prevent, and to treat this immune suppressive of GC.",28817117_8,-1,-1,-1,-1,33084,-1,4.4977182e-06,0.9999912,4.278145e-06
33090,immune responses through,26,29,128,152,"B cells give rise to polarized subsets, including B effector 1 (Be1) cells and regulatory B cells, which can promote or inhibit immune responses through expression of IFN- and IL-10, respectively.",28848066_0,-1,-1,-1,-1,33090,-1,0.97682273,0.022570971,0.0006061905
33095,these cells,18,20,117,128,"Such subsets likely explain why B cell depletion can either ameliorate or exacerbate inflammatory diseases; however, these cells remain poorly understood because of the absence of specific markers.",28848066_1,-1,-1,-1,-1,33095,-1,3.32162e-05,2.9238648e-05,0.99993753
33101,that TIM-4,3,5,12,22,We now show that TIM-4 is expressed by a subset of B cells distinct from those expressing TIM-1.,28848066_3,-1,-1,-1,-1,33101,-1,1.0343608e-05,0.9999784,1.1175886e-05
33131,T cells-effects that,27,30,154,174,"Moreover, TIM-4+ B cells promoted proinflammatory Th differentiation in vivo, increasing IFN- while decreasing IL-4, IL-10, and Foxp3 expression by CD4+ T cells-effects that are opposite from those of TIM-1+ B cells.",28848066_9,-1,-1,-1,-1,33131,-1,0.0040093223,0.369002,0.6269886
33150,cells that,12,14,74,84,"Thus, TIM-4+ B cells are enriched for IFN--producing proinflammatory Be1 cells that enhance immune responsiveness and can be specifically targeted with anti-TIM-4.",28848066_12,-1,-1,-1,-1,33150,-1,0.0045185443,0.32503566,0.6704458
33158,tumor cells,28,30,164,175,"Natural killer (NK) cells are large granular lymphocytes of the innate immune system and play a pivotal role against virus-infected cells, microbial pathogens, and tumor cells.",28891726_0,-1,-1,-1,-1,33158,-1,0.00019440369,0.00301849,0.9967871
33162,cells play,12,14,61,71,"NK cells secrete several cytokine,s but IFN- secreted by NK cells play a vital role in the activation of the innate and adaptive immune systems.",28891726_1,-1,-1,-1,-1,33162,-1,0.0027541653,0.20500894,0.79223686
33166,functional,8,9,42,52,"But during any infection or tumor burden, functional activity of NK cells is downregulated significantly by nTreg cells.",28891726_2,0,1,2,-1,33166,-1,0.00055302854,0.99925274,0.00019416794
33184,cell functional,2,4,7,22,The NK cell functional activity was govern by high level of IFN- measurement during tumor progression.,28891726_6,-1,-1,-1,-1,33184,-1,2.7410588e-05,2.1898564e-05,0.99995065
33187,The FoxP3,0,2,0,9,The FoxP3+ CD25+ CD4+ T regulatory cell population was found to be continuously increased with high-level expression of FoxP3 during DL growth.,28891726_7,-1,-1,-1,-1,33187,-1,5.3074305e-06,0.9999901,4.6150603e-06
33196,the FoxP3 transcription factor,19,23,97,127,The rapid increase in the number of Treg cells during DL progression may be due to high level of the FoxP3 transcription factor.,28891726_8,-1,-1,-1,-1,33196,-1,5.1991206e-06,0.9999902,4.5210136e-06
33197,The tumor,0,2,0,9,The tumor microenvironment of DL cell progression has highly deleterious effect on NK cells after massive growth of tumor burden in BALB/c mice.,28891726_9,-1,-1,-1,-1,33197,-1,5.0454846e-06,0.9999902,4.768625e-06
33211,factors,7,8,58,65,Emerging evidence suggests a role for micro-environmental factors such as CD25+ cells modulating response to PD-1 inhibition.,28940183_1,0,1,-1,-1,33211,-1,2.2314469e-05,0.9999708,6.906538e-06
33224,Treg function,6,8,36,49,There was no difference in systemic Treg function or numbers between ApcMin/+ and wild-type mice.,28940183_4,-1,-1,-1,-1,33224,-1,2.6614409e-05,0.99993205,4.1295447e-05
33229,Tslp,28,29,166,170,"However, increased numbers of small intestinal CD25+ Tregs were observed with increased Cox-2 activity in the absence of any difference in the expression of Tgf- or Tslp between ApcMin/+ and wild-type mice.",28940183_5,0,1,-1,-1,33229,-1,2.7916009e-05,0.99994445,2.7611652e-05
33230,therapy,2,3,16,23,"Cox-2 inhibitor therapy (Celecoxib) reversed the increase in ApcMin/+ intestinal CD25+ Treg numbers, without decreasing numbers of CD25+ systemic Tregs .",28940183_6,0,1,-1,-1,33230,-1,5.2713244e-06,0.99999034,4.3888053e-06
33234,Forkhead box protein,0,3,0,20,Forkhead box protein 3 (FoxP3+ ) and Cox-2+ cells were co-localized to the interstitium of adenomas of Apcmin/+ mice.,28940183_7,-1,-1,-1,-1,33234,-1,9.063836e-06,0.999984,6.9383645e-06
33237,to the,14,16,68,74,Forkhead box protein 3 (FoxP3+ ) and Cox-2+ cells were co-localized to the interstitium of adenomas of Apcmin/+ mice.,28940183_7,-1,-1,-1,-1,33237,-1,5.146345e-06,0.99998975,5.1093443e-06
33242,the relevance,10,12,68,81,"For therapeutic potential, further studies are required to evaluate the relevance of these findings to human cancer as well as the functional significance of CD25+ intestinal Tregs in cancer.",28940183_9,-1,-1,-1,-1,33242,-1,7.000335e-06,0.9999876,5.373668e-06
33245,the functional,21,23,127,141,"For therapeutic potential, further studies are required to evaluate the relevance of these findings to human cancer as well as the functional significance of CD25+ intestinal Tregs in cancer.",28940183_9,-1,-1,-1,-1,33245,-1,2.389768e-05,0.9999659,1.0204213e-05
33249,to rely,13,15,92,99,"The antitumor effectiveness of cyclophosphamide (CTX) and other chemotherapeutics was shown to rely not only on direct cytotoxicity but also on immunogenic tumor cell death and systemic immunomodulatory mechanisms, including regulatory T cell (Treg) depletion, Th1 cell polarization, type I interferon (IFN) and proinflammatory cytokine production.",28975621_0,-1,-1,-1,-1,33249,-1,7.859277e-06,0.99998534,6.808724e-06
33250,tumor cell,24,26,156,166,"The antitumor effectiveness of cyclophosphamide (CTX) and other chemotherapeutics was shown to rely not only on direct cytotoxicity but also on immunogenic tumor cell death and systemic immunomodulatory mechanisms, including regulatory T cell (Treg) depletion, Th1 cell polarization, type I interferon (IFN) and proinflammatory cytokine production.",28975621_0,-1,-1,-1,-1,33250,-1,8.306815e-05,0.0005653128,0.9993517
33258,IFN regulatory factor,0,3,0,21,"IFN regulatory factor (IRF)-1 is a transcriptional regulator of IFNs and IFN-inducible genes, involved in the control of Th1 and Treg differentiation and in sterile inflammation.",28975621_1,-1,-1,-1,-1,33258,-1,0.9826089,0.015816657,0.0015744504
33261,IFN-inducible genes,11,13,73,92,"IFN regulatory factor (IRF)-1 is a transcriptional regulator of IFNs and IFN-inducible genes, involved in the control of Th1 and Treg differentiation and in sterile inflammation.",28975621_1,-1,-1,-1,-1,33261,-1,0.99861264,0.0009211115,0.00046613265
33272,time that IRF-1,6,9,31,46,This study shows for the first time that IRF-1 is important for the antitumor efficacy of CTX in mice.,28975621_3,-1,-1,-1,-1,33272,-1,9.934613e-06,0.99996936,2.064429e-05
33275,that Irf1 gene,8,11,59,73,"Moreover, experiments in tumor-bearing C57BL/6 mice showed that Irf1 gene expression in the spleen was transiently increased following CTX administration and correlated with the induction of Th1 cell expansion and of Il12p40 gene expression, which is the main Th1-driving cytokine.",28975621_4,-1,-1,-1,-1,33275,-1,4.44755e-06,0.9999896,5.8841397e-06
33282,Th1-driving cytokine,40,42,260,280,"Moreover, experiments in tumor-bearing C57BL/6 mice showed that Irf1 gene expression in the spleen was transiently increased following CTX administration and correlated with the induction of Th1 cell expansion and of Il12p40 gene expression, which is the main Th1-driving cytokine.",28975621_4,-1,-1,-1,-1,33282,-1,0.04119726,0.9517008,0.007101935
33288,that the gene,3,6,27,40,"Further experiments showed that the gene and/or protein expression of caspase-1, iNOS, IL-1, IL-6 and CXCL10 and the levels of nitric oxide were modulated following CTX in an IRF-1-direct- or -indirect-dependent manner, and highlighted the importance of caspase-1 in driving the sterile inflammatory response to CTX.",28975621_7,-1,-1,-1,-1,33288,-1,4.5964234e-06,0.9999901,5.35556e-06
33289,protein,7,8,48,55,"Further experiments showed that the gene and/or protein expression of caspase-1, iNOS, IL-1, IL-6 and CXCL10 and the levels of nitric oxide were modulated following CTX in an IRF-1-direct- or -indirect-dependent manner, and highlighted the importance of caspase-1 in driving the sterile inflammatory response to CTX.",28975621_7,0,1,-1,-1,33289,-1,9.997806e-06,0.9999825,7.473343e-06
33300,the regulation,14,16,79,93,"Our data identify IRF-1 as important for the antitumor efficacy of CTX and for the regulation of many immunomodulatory activities of CTX, such as Th1 polarization, Treg depletion and inflammation.",28975621_8,-1,-1,-1,-1,33300,-1,4.220549e-06,0.99999154,4.203702e-06
33303,Antigen-independent tonic,0,2,0,25,"Antigen-independent tonic signaling by chimeric antigen receptors (CARs) can increase differentiation and exhaustion of Tcells, limiting their potency.",28978471_0,-1,-1,-1,-1,33303,-1,0.9971071,0.0022265434,0.0006664102
33306,limiting their,20,22,129,143,"Antigen-independent tonic signaling by chimeric antigen receptors (CARs) can increase differentiation and exhaustion of Tcells, limiting their potency.",28978471_0,-1,-1,-1,-1,33306,-1,0.22167808,0.77417743,0.0041444954
33307,Tcells to,9,13,53,63,"Incorporating 4-1BB costimulation in CARs may enable Tcells to resist this functional exhaustion; however, the potential ramifications of tonic 4-1BB signaling in CAR Tcells remain unclear.",28978471_1,-1,-1,-1,-1,33307,-1,0.001180821,0.042910766,0.9559084
33308,this functional,14,16,71,86,"Incorporating 4-1BB costimulation in CARs may enable Tcells to resist this functional exhaustion; however, the potential ramifications of tonic 4-1BB signaling in CAR Tcells remain unclear.",28978471_1,-1,-1,-1,-1,33308,-1,0.00014581977,0.9997608,9.343444e-05
33312,that tonic,4,6,15,25,"Here, we found that tonic CAR-derived 4-1BB signaling can produce toxicity in Tcells via continuous TRAF2-dependent activation of the nuclear factor B (NF-B) pathway and augmented FAS-dependent cell death.",28978471_2,-1,-1,-1,-1,33312,-1,6.105806e-06,0.9999894,4.5376137e-06
33313,toxicity,13,14,66,74,"Here, we found that tonic CAR-derived 4-1BB signaling can produce toxicity in Tcells via continuous TRAF2-dependent activation of the nuclear factor B (NF-B) pathway and augmented FAS-dependent cell death.",28978471_2,0,1,-1,-1,33313,-1,3.070986e-05,0.99994993,1.9343177e-05
33316,the nuclear factor,23,26,131,149,"Here, we found that tonic CAR-derived 4-1BB signaling can produce toxicity in Tcells via continuous TRAF2-dependent activation of the nuclear factor B (NF-B) pathway and augmented FAS-dependent cell death.",28978471_2,-1,-1,-1,-1,33316,-1,4.948967e-06,0.9999902,4.884029e-06
33325,function,21,22,157,165,Attenuating CAR expression by substitution with a self-inactivating lentiviral vector minimized tonic signaling and improved Tcell expansion and anti-tumor function.,28978471_4,0,1,2,-1,33325,-1,5.8297926e-05,0.9998642,7.74221e-05
33338,Tcell receptor-triggered,5,9,26,51,"We found that APC ensures Tcell receptor-triggered activation through Nuclear Factor of Activated Tcells (NFAT), since APC is necessary for NFAT's nuclear localization in a microtubule-dependent fashion and for NFAT-driven transcription leading to cytokine gene expression.",28978472_2,-1,-1,-1,-1,33338,-1,0.0002822615,0.00010167257,0.999616
33339,through Nuclear Factor,10,13,63,85,"We found that APC ensures Tcell receptor-triggered activation through Nuclear Factor of Activated Tcells (NFAT), since APC is necessary for NFAT's nuclear localization in a microtubule-dependent fashion and for NFAT-driven transcription leading to cytokine gene expression.",28978472_2,-1,-1,-1,-1,33339,-1,6.453908e-06,0.99998856,5.036856e-06
33342,to cytokine gene,40,43,247,263,"We found that APC ensures Tcell receptor-triggered activation through Nuclear Factor of Activated Tcells (NFAT), since APC is necessary for NFAT's nuclear localization in a microtubule-dependent fashion and for NFAT-driven transcription leading to cytokine gene expression.",28978472_2,-1,-1,-1,-1,33342,-1,0.0017104547,0.99816775,0.00012180024
33343,deficiency,4,5,22,32,"Ultimately, mouse Apc deficiency reduces the presence of NFAT in the nucleus of intestinal regulatory Tcells (Tregs) and impairs Treg differentiation and the acquisition of a suppressive phenotype, which is characterized by the production of the anti-inflammatory cytokine IL-10.",28978472_4,0,1,-1,-1,33343,-1,6.1504415e-06,0.99998724,6.646803e-06
33352,cytokine IL-10,43,45,265,279,"Ultimately, mouse Apc deficiency reduces the presence of NFAT in the nucleus of intestinal regulatory Tcells (Tregs) and impairs Treg differentiation and the acquisition of a suppressive phenotype, which is characterized by the production of the anti-inflammatory cytokine IL-10.",28978472_4,-1,-1,-1,-1,33352,-1,0.99996567,5.3069416e-06,2.8948944e-05
33367,Tr1 cells,10,12,55,64,"Thus, this study aimed to investigate whether Treg and Tr1 cells participate in immunological status against cancer.",28982868_1,-1,-1,-1,-1,33367,-1,2.9878924e-05,0.00010488233,0.9998652
33369,blood,5,6,33,38,"PATIENTS AND METHODS: Peripheral blood was withdrawn from patients (n=78), and healthy volunteers as controls (n=23).",28982868_2,0,1,-1,-1,33369,-1,0.0026382904,0.92242455,0.07493716
33371,blood,2,3,15,20,"The peripheral blood mononuclear cells were subjected to FACScan analysis after labeling with anti-CD4, -CD25, - Foxp3, -CD49b and -LAG3 antibodies.",28982868_3,0,1,-1,-1,33371,-1,0.004242813,0.983459,0.012298226
33374,analysis,9,10,65,73,"The peripheral blood mononuclear cells were subjected to FACScan analysis after labeling with anti-CD4, -CD25, - Foxp3, -CD49b and -LAG3 antibodies.",28982868_3,0,1,-1,-1,33374,-1,7.2875987e-06,0.9999844,8.337928e-06
33377,factors,6,7,50,57,Patients' clinical course and clinicopathological factors were compared.,28982868_5,0,1,-1,-1,33377,-1,0.2159407,0.78246,0.0015993617
33388,the tumor,9,11,46,55,Ligation of programmed cell death-1 (PD-1) in the tumor microenvironment is known to inhibit effective adaptive antitumor immunity.,28993412_0,-1,-1,-1,-1,33388,-1,5.6478957e-06,0.9999895,4.8477555e-06
33390,immunity,19,20,122,130,Ligation of programmed cell death-1 (PD-1) in the tumor microenvironment is known to inhibit effective adaptive antitumor immunity.,28993412_0,0,-1,2,-1,33390,-1,0.99988055,3.0474717e-05,8.896514e-05
33391,tumor types,15,17,94,105,"Blockade of PD-1 in humans has resulted in impressive, durable regression responses in select tumor types.",28993412_1,-1,-1,-1,-1,33391,-1,8.2907645e-06,0.99997663,1.5127133e-05
33394,the functions,11,13,62,75,PD-1 was recently shown to be expressed on and thereby impair the functions of tumor-infiltrating murine and human myeloid dendritic cells (TIDC) in ovarian cancer.,28993412_3,-1,-1,-1,-1,33394,-1,1.2009466e-05,0.9999758,1.2244429e-05
33399,the regulation,7,9,37,51,"In the present work, we characterize the regulation of PD-1 expression and the effects of PD-1 blockade on TIDC.",28993412_4,-1,-1,-1,-1,33399,-1,4.2035604e-06,0.9999913,4.4795465e-06
33413,these two,13,15,93,102,"While PD-1 blockade or IL10 neutralization as monotherapies were inefficient, combination of these two led to improved survival and delayed tumor growth; this was accompanied by augmented antitumor T- and B-cell responses and decreased infiltration of immunosuppressive MDSC.",28993412_8,-1,-1,-1,-1,33413,-1,2.1256401e-05,0.99996805,1.0696537e-05
33418,Taken together,0,2,0,14,"Taken together, our findings implicate compensatory release of IL10 as one of the adaptive resistance mechanisms that undermine the efficacy of anti-PD-1 (or anti-PD-L1) monotherapies and prompt further studies aimed at identifying such resistance mechanisms.",28993412_9,-1,-1,-1,-1,33418,-1,7.939656e-06,0.99998593,6.1355768e-06
33429,the cytokine interleukin-9 (IL-9,17,22,85,117,"Tumor-specific CD4+ T helper 9 (TH9) cells, so-called because of their production of the cytokine interleukin-9 (IL-9), are a powerful effector T cell subset for cancer immunotherapy.",29018172_0,-1,-1,-1,-1,33429,-1,0.9816912,0.017305905,0.001002874
33435,TH9 cells,17,19,103,112,We found that pretreatment of nave CD4+ T cells with IL-7 further enhanced their differentiation into TH9 cells and augmented their antitumor activity.,29018172_1,-1,-1,-1,-1,33435,-1,0.0002126041,0.0064373193,0.9933501
33440,the STAT5,12,14,90,99,IL-7 markedly increased the abundance of the histone acetyltransferase p300 by activating the STAT5 and PI3K-AKT-mTOR signaling pathways and promoting the acetylation of histones at the Il9 promoter.,29018172_2,-1,-1,-1,-1,33440,-1,6.421578e-06,0.99998677,6.784479e-06
33442,the Il9,25,27,182,189,IL-7 markedly increased the abundance of the histone acetyltransferase p300 by activating the STAT5 and PI3K-AKT-mTOR signaling pathways and promoting the acetylation of histones at the Il9 promoter.,29018172_2,-1,-1,-1,-1,33442,-1,0.5139875,0.48238534,0.003627199
33443,the transcriptional,4,6,13,32,"As a result, the transcriptional regulator Foxo1 was dephosphorylated and translocated to the nucleus, bound to the Il9 promoter, and induced the production of IL-9 protein.",29018172_3,-1,-1,-1,-1,33443,-1,3.807105e-06,0.9999914,4.8228867e-06
33444,translocated to the,11,14,74,93,"As a result, the transcriptional regulator Foxo1 was dephosphorylated and translocated to the nucleus, bound to the Il9 promoter, and induced the production of IL-9 protein.",29018172_3,-1,-1,-1,-1,33444,-1,4.2738243e-06,0.99998975,5.9313084e-06
33445,to the Il9,17,20,109,119,"As a result, the transcriptional regulator Foxo1 was dephosphorylated and translocated to the nucleus, bound to the Il9 promoter, and induced the production of IL-9 protein.",29018172_3,-1,-1,-1,-1,33445,-1,0.09913001,0.89897376,0.0018962066
33447,IL-9 protein,27,29,160,172,"As a result, the transcriptional regulator Foxo1 was dephosphorylated and translocated to the nucleus, bound to the Il9 promoter, and induced the production of IL-9 protein.",29018172_3,-1,-1,-1,-1,33447,-1,0.99986684,4.8526395e-05,8.464518e-05
33449,to the Il9,7,10,32,42,"In contrast, Foxp1, which bound to the Il9 promoter in nave CD4+ T cells and inhibited Il9 expression, was outcompeted for binding to the Il9 promoter by Foxo1 and translocated to the cytoplasm.",29018172_4,-1,-1,-1,-1,33449,-1,0.06586024,0.932694,0.0014456976
33452,to the Il9,26,29,132,142,"In contrast, Foxp1, which bound to the Il9 promoter in nave CD4+ T cells and inhibited Il9 expression, was outcompeted for binding to the Il9 promoter by Foxo1 and translocated to the cytoplasm.",29018172_4,-1,-1,-1,-1,33452,-1,0.059144408,0.9396481,0.0012075012
33453,translocated to the,33,36,165,184,"In contrast, Foxp1, which bound to the Il9 promoter in nave CD4+ T cells and inhibited Il9 expression, was outcompeted for binding to the Il9 promoter by Foxo1 and translocated to the cytoplasm.",29018172_4,-1,-1,-1,-1,33453,-1,4.1215308e-06,0.9999908,5.039053e-06
33454,deficiency,8,9,45,55,"Furthermore, forced expression of Foxo1 or a deficiency in Foxp1 in CD4+ T cells markedly increased the production of IL-9, whereas a deficiency in Foxo1 inhibited the ability of IL-7 to enhance the differentiation and antitumor activity of TH9 cells.",29018172_5,0,1,-1,-1,33454,-1,3.703584e-05,0.999944,1.9032754e-05
33459,deficiency,25,26,134,144,"Furthermore, forced expression of Foxo1 or a deficiency in Foxp1 in CD4+ T cells markedly increased the production of IL-9, whereas a deficiency in Foxo1 inhibited the ability of IL-7 to enhance the differentiation and antitumor activity of TH9 cells.",29018172_5,0,1,-1,-1,33459,-1,5.561683e-05,0.99992466,1.9747018e-05
33461,IL-7 to,32,34,179,186,"Furthermore, forced expression of Foxo1 or a deficiency in Foxp1 in CD4+ T cells markedly increased the production of IL-9, whereas a deficiency in Foxo1 inhibited the ability of IL-7 to enhance the differentiation and antitumor activity of TH9 cells.",29018172_5,-1,-1,-1,-1,33461,-1,0.99896574,0.0007393788,0.00029480507
33463,TH9 cells,41,43,241,250,"Furthermore, forced expression of Foxo1 or a deficiency in Foxp1 in CD4+ T cells markedly increased the production of IL-9, whereas a deficiency in Foxo1 inhibited the ability of IL-7 to enhance the differentiation and antitumor activity of TH9 cells.",29018172_5,-1,-1,-1,-1,33463,-1,3.9010552e-05,0.00015302029,0.999808
33467,TH9 cell,19,21,100,108,"Thus, we identified the roles of Foxo1 as a positive regulator and Foxp1 as a negative regulator of TH9 cell differentiation and antitumor activity, which may provide potential targets for cancer immunotherapy.",29018172_6,-1,-1,-1,-1,33467,-1,3.9513907e-05,0.00012068639,0.99983966
33469,IFN--producing cytotoxic T lymphocytes,0,4,0,39,IFN--producing cytotoxic T lymphocytes are essential for host defense against viral infection and cancer.,29021521_0,-1,-1,-1,-1,33469,-1,0.90968513,0.00028565538,0.09002916
33470,that the,3,5,13,21,"Here we show that the RNA-binding tristetraprolin, encoded by Zfp36, is needed for CD8+ T-cell production of IFN- in vivo.",29021521_1,-1,-1,-1,-1,33470,-1,4.4047656e-06,0.99999166,3.90528e-06
33472,T-cell,17,18,88,94,"Here we show that the RNA-binding tristetraprolin, encoded by Zfp36, is needed for CD8+ T-cell production of IFN- in vivo.",29021521_1,-1,1,2,-1,33472,-1,2.0058755e-05,9.382066e-06,0.99997056
33478,T-cells,17,18,105,112,"When activated in vitro, however, IFN- production by naive wild type and tristetraprolin-deficient CD8+ T-cells is comparable.",29021521_2,-1,1,2,-1,33478,-1,1.9720723e-05,1.1032759e-05,0.99996924
33482,receptor,5,6,31,39,"Importantly, deletion of IL-27 receptor WSX-1 in tristetraprolin-deficient mice (WSX-1/tristetraprolin double knockout) leads to a reduction in cytotoxic T lymphocyte numbers.",29021521_5,0,1,2,-1,33482,-1,0.15940373,0.08052832,0.760068
33490,tumor cytotoxic T lymphocytes,33,37,222,251,"Moreover, tumor growth is accelerated, not only in tristetraprolin-deficient mice after cytotoxic T lymphocyte depletion, but also in WSX-1/tristetraprolin double knockout mice, with substantial reduction in the number of tumor cytotoxic T lymphocytes.",29021521_6,-1,-1,-1,-1,33490,-1,0.0023637756,0.11077344,0.88686275
33492,cytotoxic T lymphocyte function,10,14,67,98,"This study describes a regulatory pathway for IL-27 expression and cytotoxic T lymphocyte function mediated by tristetraprolin, contributing to regulation of antitumour immunity.",29021521_7,-1,-1,-1,-1,33492,-1,1.6056047e-05,7.850476e-06,0.99997604
33494,to regulation,19,21,141,154,"This study describes a regulatory pathway for IL-27 expression and cytotoxic T lymphocyte function mediated by tristetraprolin, contributing to regulation of antitumour immunity.",29021521_7,-1,-1,-1,-1,33494,-1,6.980708e-06,0.99998665,6.336833e-06
33495,immunity,23,24,169,177,"This study describes a regulatory pathway for IL-27 expression and cytotoxic T lymphocyte function mediated by tristetraprolin, contributing to regulation of antitumour immunity.",29021521_7,0,-1,2,-1,33495,-1,0.9997378,0.0001144394,0.00014779223
33496,cytokines that,7,9,28,42,IL-27 is one of a number of cytokines that can induce antitumour CD8+ T cell responses.,29021521_8,-1,-1,-1,-1,33496,-1,0.9793357,0.019647796,0.0010164835
33499,that TTP,4,6,22,30,"Here the authors show that TTP, encoded by Zfp36, degrades p28 to inhibit IL-27 production by macrophages and is thereby a negative regulator of the antitumour response.",29021521_9,-1,-1,-1,-1,33499,-1,8.75143e-06,0.999984,7.2470166e-06
33521,these cells,26,28,162,173,"Allogeneic immune cells, particularly T cells in donor grafts, recognize and eliminate leukemic cells via graft-versus-leukemia (GVL) reactivity, and transfer of these cells is often used for high-risk hematological malignancies, including acute myeloid leukemia.",29038366_0,-1,-1,-1,-1,33521,-1,2.7509324e-05,1.581087e-05,0.9999566
33522,these cells,2,4,15,26,"Unfortunately, these cells also attack host normal tissues through the often fatal graft-versus-host disease (GVHD).",29038366_1,-1,-1,-1,-1,33522,-1,5.628795e-05,0.000109412766,0.9998343
33523,tissues through the,8,11,51,70,"Unfortunately, these cells also attack host normal tissues through the often fatal graft-versus-host disease (GVHD).",29038366_1,-1,-1,-1,-1,33523,-1,0.0007728467,0.9932406,0.00598658
33529,T9IL-33 cells,24,26,132,145,"Here, we show that, in mice and humans, a population of interleukin-9 (IL-9)-producing T cells activated via the ST2-IL-33 pathway (T9IL-33 cells) increases GVL while decreasing GVHD through two opposing mechanisms: protection from fatal immunity by amphiregulin expression and augmentation of antileukemic activity compared with T9, T1, and unmanipulated T cells through CD8 expression.",29038366_3,-1,-1,-1,-1,33529,-1,0.00203957,0.16012429,0.83783615
33530,through two,32,34,183,194,"Here, we show that, in mice and humans, a population of interleukin-9 (IL-9)-producing T cells activated via the ST2-IL-33 pathway (T9IL-33 cells) increases GVL while decreasing GVHD through two opposing mechanisms: protection from fatal immunity by amphiregulin expression and augmentation of antileukemic activity compared with T9, T1, and unmanipulated T cells through CD8 expression.",29038366_3,-1,-1,-1,-1,33530,-1,6.473069e-06,0.99998903,4.463813e-06
33531,immunity,40,41,238,246,"Here, we show that, in mice and humans, a population of interleukin-9 (IL-9)-producing T cells activated via the ST2-IL-33 pathway (T9IL-33 cells) increases GVL while decreasing GVHD through two opposing mechanisms: protection from fatal immunity by amphiregulin expression and augmentation of antileukemic activity compared with T9, T1, and unmanipulated T cells through CD8 expression.",29038366_3,0,-1,2,-1,33531,-1,0.99691075,0.0016078401,0.0014815098
33534,T cells through,57,60,356,371,"Here, we show that, in mice and humans, a population of interleukin-9 (IL-9)-producing T cells activated via the ST2-IL-33 pathway (T9IL-33 cells) increases GVL while decreasing GVHD through two opposing mechanisms: protection from fatal immunity by amphiregulin expression and augmentation of antileukemic activity compared with T9, T1, and unmanipulated T cells through CD8 expression.",29038366_3,-1,-1,-1,-1,33534,-1,0.0013567584,0.019292668,0.9793506
33537,T9IL-33 cells,6,8,38,51,"Thus, adoptive transfer of allogeneic T9IL-33 cells offers an attractive approach for separating GVL activity from GVHD.",29038366_4,-1,-1,-1,-1,33537,-1,0.002685304,0.2682716,0.7290431
33548,the tumor,6,8,43,52,We found that fucoidan treatment decreased the tumor incidence and mean tumor weight and prolonged the tumor latency.,29043842_3,-1,-1,-1,-1,33548,-1,4.4696535e-06,0.99999,5.499415e-06
33550,the tumor,15,17,99,108,We found that fucoidan treatment decreased the tumor incidence and mean tumor weight and prolonged the tumor latency.,29043842_3,-1,-1,-1,-1,33550,-1,4.333014e-06,0.99999034,5.2642013e-06
33551,that the,4,6,34,42,Flow cytometric analyses revealed that the number of blood natural killer cells was higher after fucoidan treatment and that the proportions of CD4 and CD8 T cells were also increased.,29043842_4,-1,-1,-1,-1,33551,-1,4.700496e-06,0.9999912,4.0618925e-06
33552,blood natural,8,10,53,66,Flow cytometric analyses revealed that the number of blood natural killer cells was higher after fucoidan treatment and that the proportions of CD4 and CD8 T cells were also increased.,29043842_4,-1,-1,-1,-1,33552,-1,0.00019488897,0.9997223,8.281028e-05
33555,that the,18,20,120,128,Flow cytometric analyses revealed that the number of blood natural killer cells was higher after fucoidan treatment and that the proportions of CD4 and CD8 T cells were also increased.,29043842_4,-1,-1,-1,-1,33555,-1,4.8235197e-06,0.99999106,4.14414e-06
33562,to those,21,23,128,136,"The serum levels of interleukin (IL)-6, IL-12p40, and interferon (IFN)- were higher in the rats treated with fucoidan compared to those of model rats.",29043842_5,-1,-1,-1,-1,33562,-1,5.273911e-06,0.9999888,5.901197e-06
33566,the blood,13,15,62,71,"Moreover, the percentage of CD3+ Foxp3+ regulatory T cells in the blood and the levels of IL-10 and transforming growth factor  in the serum were lower in the rats treated with fucoidan.",29043842_6,-1,-1,-1,-1,33566,-1,1.7149989e-05,0.9999528,3.0051897e-05
33569,transforming growth factor,21,24,100,126,"Moreover, the percentage of CD3+ Foxp3+ regulatory T cells in the blood and the levels of IL-10 and transforming growth factor  in the serum were lower in the rats treated with fucoidan.",29043842_6,-1,-1,-1,-1,33569,-1,0.971873,0.023918575,0.004208505
33577,tumor tissues,20,22,113,126,"Furthermore, fucoidan treatment decreased the expression of Foxp3 and programmed cell death 1 ligand 1 (PDL1) in tumor tissues.",29043842_7,-1,-1,-1,-1,33577,-1,9.009837e-06,0.99996257,2.8398084e-05
33579,tumor tissues,10,12,60,73,The levels of p-phosphatidyl inositol kinase 3 and p-AKT in tumor tissues were also lower than those of model rats.,29043842_8,-1,-1,-1,-1,33579,-1,1.1868608e-05,0.99990475,8.332332e-05
33580,than those,15,17,90,100,The levels of p-phosphatidyl inositol kinase 3 and p-AKT in tumor tissues were also lower than those of model rats.,29043842_8,-1,-1,-1,-1,33580,-1,6.8172535e-06,0.999987,6.1631467e-06
33587,through the,13,15,104,115,This study provides experimental evidence toward elucidating the immune enhancement induced by fucoidan through the programmed cell death 1/PDL1 signaling pathway.,29043842_10,-1,-1,-1,-1,33587,-1,4.949513e-06,0.99999094,4.1377657e-06
33597,the tumor,17,19,97,106,The clinical significance of regulatory T cells (Treg) and tumor-associated macrophages (TAM) in the tumor microenvironment of human bladder cancer remains unclear.,29048388_0,-1,-1,-1,-1,33597,-1,4.2225415e-06,0.99999154,4.1960516e-06
33601,their relevance to,8,11,36,54,The aim of this study is to explore their relevance to oncological features in non-muscle invasive bladder cancer (NMIBC).,29048388_1,-1,-1,-1,-1,33601,-1,4.3959194e-06,0.9999907,4.852387e-06
33602,analysis,4,5,35,43,"We carried out immunohistochemical analysis of forkhead box P3 (FOXP3, Treg maker), CD204 (TAM marker), and interleukin-6 (IL6) using surgical specimens obtained from 154 NMIBC patients.",29048388_2,0,1,-1,-1,33602,-1,7.88346e-06,0.99998593,6.1784585e-06
33609,The Treg,0,2,0,8,The Treg and TAM counts surrounding the cancer lesion and IL6-positive cancer cell counts were evaluated against clinicopathological variables.,29048388_3,-1,-1,-1,-1,33609,-1,4.433369e-06,0.99998903,6.5368786e-06
33615,the Treg,6,8,29,37,We focused on the ability of the Treg and TAM counts around the cancer lesion to predict outcomes after adjuvant intravesical Bacille Calmette-Gurin (BCG) treatment.,29048388_4,-1,-1,-1,-1,33615,-1,4.341871e-06,0.9999894,6.2720014e-06
33627,analysis,2,3,7,15,"In our analysis of 71 patients treated with BCG, high counts of Treg and TAM were associated with shorter recurrence-free survival, and the former was an independent predictor of recurrence.",29048388_7,0,1,-1,-1,33627,-1,6.187516e-06,0.999987,6.785205e-06
33635,the tumor,12,14,70,79,Poor response to intravesical BCG was associated with Treg and TAM in the tumor microenvironment.,29048388_8,-1,-1,-1,-1,33635,-1,4.546232e-06,0.99999094,4.4925637e-06
33641,peptides,8,9,55,63,"Here, we identify and characterize immunogenic HLA-A24 peptides derived from these antigens for potential vaccination therapy of HLA-A24+ patients with MM.",29089645_1,0,-1,2,-1,33641,-1,0.050979577,0.937307,0.011713467
33642,these antigens,11,13,77,91,"Here, we identify and characterize immunogenic HLA-A24 peptides derived from these antigens for potential vaccination therapy of HLA-A24+ patients with MM.",29089645_1,-1,-1,-1,-1,33642,-1,0.5036385,0.49107972,0.0052818274
33643,therapy,16,17,118,125,"Here, we identify and characterize immunogenic HLA-A24 peptides derived from these antigens for potential vaccination therapy of HLA-A24+ patients with MM.",29089645_1,0,1,-1,-1,33643,-1,6.3086695e-06,0.99998796,5.673465e-06
33647,peptides,67,68,206,214,"The identified immunogenic HLA-A24-specific XBP1 unspliced (UN)185-193 (I S P W I L A V L), XBP1 spliced (SP)223-231 (V Y P E G P S S L), CD138265-273 (I F A V C L V G F) and CS1240-248 (L F V L G L F L W) peptides induced antigen-specific CTL with anti-MM activity in an HLA-A24 restricted manner.",29089645_2,0,-1,2,-1,33647,-1,7.411862e-05,0.999879,4.6823487e-05
33648,antigen-specific CTL,69,71,223,243,"The identified immunogenic HLA-A24-specific XBP1 unspliced (UN)185-193 (I S P W I L A V L), XBP1 spliced (SP)223-231 (V Y P E G P S S L), CD138265-273 (I F A V C L V G F) and CS1240-248 (L F V L G L F L W) peptides induced antigen-specific CTL with anti-MM activity in an HLA-A24 restricted manner.",29089645_2,-1,-1,-1,-1,33648,-1,0.7409096,0.00042601363,0.25866446
33650,peptides,8,9,52,60,"Furthermore, a cocktail containing the four HLA-A24 peptides evoked MM-specific CTL with distinct phenotypic profiles (CD28, CD40L, 41BB, CD38, CD69) and anti-tumor activities, evidenced by perforin upregulation, CD107a degranulation (cytotoxicity) and Th1-type cytokines (IFN-/IL-2/TNF-) production in response to HLA-A24+ MM cells.",29089645_3,0,-1,2,-1,33650,-1,0.0001037236,0.99972683,0.00016946136
33654,Th1-type cytokines,42,44,253,271,"Furthermore, a cocktail containing the four HLA-A24 peptides evoked MM-specific CTL with distinct phenotypic profiles (CD28, CD40L, 41BB, CD38, CD69) and anti-tumor activities, evidenced by perforin upregulation, CD107a degranulation (cytotoxicity) and Th1-type cytokines (IFN-/IL-2/TNF-) production in response to HLA-A24+ MM cells.",29089645_3,-1,-1,-1,-1,33654,-1,0.030001508,0.9679735,0.002025036
33667,therapy to,9,11,67,77,These results provide the framework for a multipeptide vaccination therapy to induce tumor-specific CTL in HLA-A24-positive patients with myeloma and other cancers expressing these antigens.,29089645_5,-1,-1,-1,-1,33667,-1,3.534173e-06,0.99999297,3.546885e-06
33668,tumor-specific CTL,12,14,85,103,These results provide the framework for a multipeptide vaccination therapy to induce tumor-specific CTL in HLA-A24-positive patients with myeloma and other cancers expressing these antigens.,29089645_5,-1,-1,-1,-1,33668,-1,0.0058664717,0.7201406,0.27399296
33669,these antigens,23,25,175,189,These results provide the framework for a multipeptide vaccination therapy to induce tumor-specific CTL in HLA-A24-positive patients with myeloma and other cancers expressing these antigens.,29089645_5,-1,-1,-1,-1,33669,-1,0.7999064,0.1948947,0.0051989285
33678,tumour cells,5,7,30,42,METHODS: Exosomes released by tumour cells infected with IRF-1-expressing adenovirus (IRF-1-Exo) or treated with interferon- (IFN-Exo) were isolated via ultracentrifugation.,29112686_2,-1,-1,-1,-1,33678,-1,0.0008403542,0.05268893,0.94647074
33684,The IRF-1 target proteins IL-15R,0,5,0,33,The IRF-1 target proteins IL-15R and MHC class I (MHC-I) were analysed by western blot.,29112686_3,-1,-1,-1,-1,33684,-1,0.00029473333,0.9996118,9.345526e-05
33690,tumour cells,7,9,59,71,Splenocytes from tumour-bearing mice were co-cultured with tumour cells.,29112686_6,-1,-1,-1,-1,33690,-1,0.00032895885,0.003538252,0.99613285
33691,The IFN-positive,0,2,0,17,The IFN-positive and granzyme B-positive CD8+ splenocyte cells were quantified by flow cytometry.,29112686_7,-1,-1,-1,-1,33691,-1,0.21975102,0.7766506,0.0035984071
33693,The IRF-1-Exo,2,4,9,22,RESULTS: The IRF-1-Exo or IFN-Exo displayed increased IL-15R and MHC-I expression.,29112686_8,-1,-1,-1,-1,33693,-1,1.5875814e-05,0.9999683,1.5818126e-05
33708,The IRF-1,2,4,13,22,CONCLUSIONS: The IRF-1 priming of TEXs enhances antitumour immune response.,29112686_13,-1,-1,-1,-1,33708,-1,2.3467579e-05,0.9999393,3.714847e-05
33713,tumor-specific T-cell,24,26,144,165,"BACKGROUND: Whole-cell tumor vaccines have shown much promise; however, only limited success has been achieved for the goal of eliciting robust tumor-specific T-cell responses.",29115974_0,-1,-1,-1,-1,33713,-1,0.004673761,0.8017376,0.19358866
33715,the STAT3,19,21,90,99,"METHODS: Hepatocellular carcinoma (HCC) cells, H22 and Hepa1-6, were modified by blocking the STAT3 signaling pathway with a STAT3 decoy oligodeoxynucleotide, and the immunogenicity and possibility of using these cell lysates as a vaccine were evaluated.",29115974_1,-1,-1,-1,-1,33715,-1,7.1274685e-06,0.9999871,5.7247776e-06
33718,these cell,36,38,207,217,"METHODS: Hepatocellular carcinoma (HCC) cells, H22 and Hepa1-6, were modified by blocking the STAT3 signaling pathway with a STAT3 decoy oligodeoxynucleotide, and the immunogenicity and possibility of using these cell lysates as a vaccine were evaluated.",29115974_1,-1,-1,-1,-1,33718,-1,4.7739017e-05,2.9736739e-05,0.99992263
33733,the tumor tissues,33,36,177,194,"In addition, STAT3-blocked whole HCC cell lysates stimulated the activation of T cells and natural killer (NK) cells, and enhanced the infiltration of cytotoxic CD8+ T cells in the tumor tissues.",29115974_3,-1,-1,-1,-1,33733,-1,5.597771e-06,0.9999862,8.220371e-06
33736,the generation,16,18,82,96,"In addition, the maturation of dendritic cells (DCs) was enhanced, which promoted the generation of immunological memory against HCC.",29115974_4,-1,-1,-1,-1,33736,-1,7.1448903e-06,0.999987,5.797852e-06
33743,the generation,7,9,55,69,"Additionally, immunization with this vaccine decreased the generation of Tregs and the production of TGF- and IL-10.",29115974_6,-1,-1,-1,-1,33743,-1,8.148792e-06,0.9999858,6.0947477e-06
33757,generated STAT3-blocked,4,6,23,46,CONCLUSIONS: The newly generated STAT3-blocked whole-cell HCC vaccine has potential for cancer cell vaccination.,29115974_8,-1,-1,-1,-1,33757,-1,0.00034237583,0.9994479,0.00020974824
33759,tissue,5,6,37,43,Macrophages are exquisite sensors of tissue homeostasis that can rapidly switch between pro- and anti-inflammatory or regulatory modes to respond to perturbations in their microenvironment.,29150563_0,-1,1,2,-1,33759,-1,1.814826e-05,0.99996376,1.8080835e-05
33764,This functional plasticity,0,3,0,26,This functional plasticity involves a precise orchestration of gene expression patterns whose transcriptional regulators have not been fully characterized.,29150563_1,-1,-1,-1,-1,33764,-1,3.280799e-05,0.99995255,1.4625979e-05
33767,the transcription factor,4,7,29,53,"We had previously identified the transcription factor NFAT5 as an activator of TLR-induced responses, and in this study we explore its contribution to macrophage functions in different polarization settings.",29150563_2,-1,-1,-1,-1,33767,-1,4.5861575e-06,0.9999914,3.952858e-06
33772,functions,25,26,162,171,"We had previously identified the transcription factor NFAT5 as an activator of TLR-induced responses, and in this study we explore its contribution to macrophage functions in different polarization settings.",29150563_2,0,1,2,-1,33772,-1,0.012416241,0.010144326,0.9774394
33774,functions,13,14,90,99,"We found that both in classically and alternatively polarized macrophages, NFAT5 enhanced functions associated with a proinflammatory profile such as bactericidal capacity and the ability to promote Th1 polarization over Th2 responses.",29150563_3,0,1,2,-1,33774,-1,0.0009836148,0.9978787,0.0011377339
33780,the Th1-stimulatory cytokine IL-12,6,10,34,68,"In this regard, NFAT5 upregulated the Th1-stimulatory cytokine IL-12 in classically activated macrophages, whereas in alternatively polarized ones it enhanced the expression of the pro-Th1 mediators Fizz-1 and arginase 1, indicating that it could promote proinflammatory readiness by regulating independent genes in differently polarized macrophages.",29150563_4,-1,-1,-1,-1,33780,-1,0.6934162,0.30326754,0.0033163242
33791,the tumor,45,47,284,293,"Finally, adoptive transfer assays in vivo revealed a reduced antitumor capacity in NFAT5-deficient macrophages against syngeneic Lewis lung carcinoma and ID8 ovarian carcinoma cells, a defect that in the ID8 model was associated with a reduced accumulation of effector CD8 T cells at the tumor site.",29150563_5,-1,-1,-1,-1,33791,-1,4.5910174e-06,0.9999901,5.2472633e-06
33792,analysis,3,4,21,29,"Altogether, detailed analysis of the effect of NFAT5 in pro- and anti-inflammatory macrophages uncovered its ability to regulate distinct genes under both polarization modes and revealed its predominant role in promoting proinflammatory macrophage functions.",29150563_6,0,1,-1,-1,33792,-1,6.0901857e-06,0.9999895,4.3979985e-06
33796,functions,34,35,248,257,"Altogether, detailed analysis of the effect of NFAT5 in pro- and anti-inflammatory macrophages uncovered its ability to regulate distinct genes under both polarization modes and revealed its predominant role in promoting proinflammatory macrophage functions.",29150563_6,0,1,2,-1,33796,-1,0.0014053133,0.00034435512,0.9982503
33799,Toll-like receptor,9,11,62,80,Metabolic shifts in mitochondrial dynamics may be involved in Toll-like receptor agonist-mediated inflammatory responses and immune cell polarization.,29180626_1,-1,-1,-1,-1,33799,-1,0.021924652,0.89812404,0.07995134
33803,immunity,12,13,89,97,"However, whether the mitochondrial morphology in myeloid immune cells affects anti-tumor immunity is unclear.",29180626_2,0,-1,2,-1,33803,-1,0.99984443,5.610159e-05,9.9457946e-05
33805,protein,10,11,57,64,"Here we show that FAM73b, a mitochondrial outer membrane protein, has a pivotal function in Toll-like receptor-regulated mitochondrial morphology switching from fusion to fission.",29180626_3,0,1,-1,-1,33805,-1,3.452164e-05,0.99989676,6.876083e-05
33806,function,15,16,80,88,"Here we show that FAM73b, a mitochondrial outer membrane protein, has a pivotal function in Toll-like receptor-regulated mitochondrial morphology switching from fusion to fission.",29180626_3,0,1,2,-1,33806,-1,2.8921053e-05,0.99994504,2.5975845e-05
33807,Toll-like receptor-regulated,17,19,92,120,"Here we show that FAM73b, a mitochondrial outer membrane protein, has a pivotal function in Toll-like receptor-regulated mitochondrial morphology switching from fusion to fission.",29180626_3,-1,-1,-1,-1,33807,-1,0.00021214921,0.9994019,0.00038590553
33814,immunity,13,14,98,106,"In tumor-associated macrophages, this switch results in T-cell activation and enhances anti-tumor immunity.",29180626_5,0,-1,2,-1,33814,-1,0.99986875,4.6921305e-05,8.432588e-05
33815,that the,3,5,13,21,We also show that the mitochondrial morphology affects Parkin expression and its recruitment to mitochondria.,29180626_6,-1,-1,-1,-1,33815,-1,4.7662465e-06,0.99999106,4.2180523e-06
33828,CD4+ T cell subsets,16,21,88,107,"CD8+ T lymphocytes mediate potent immune responses against tumor, but the role of human CD4+ T cell subsets in cancer immunotherapy remains ill-defined.",29213079_0,-1,-1,-1,-1,33828,-1,2.1797005e-05,5.0239933e-06,0.9999732
33830,three T,7,9,40,47,"Herein, we exhibit that CD26 identifies three T helper subsets with distinct immunological properties in both healthy individuals and cancer patients.",29213079_1,-1,-1,-1,-1,33830,-1,4.127945e-05,0.9998956,6.307856e-05
33839,cell transfer,14,16,96,109,"Paradoxically, CD26high T cells persist in and regress multiple solid tumors following adoptive cell transfer.",29213079_3,-1,-1,-1,-1,33839,-1,0.0011470738,0.021455938,0.97739697
33840,analysis,1,2,8,16,"Further analysis revealed that CD26high cells have a rich chemokine receptor profile (including CCR2 and CCR5), profound cytotoxicity (Granzyme B and CD107A), resistance to apoptosis (c-KIT and Bcl2), and enhanced stemness (-catenin and Lef1).",29213079_4,0,1,-1,-1,33840,-1,6.2108884e-06,0.9999882,5.600741e-06
33843,chemokine receptor,9,11,58,76,"Further analysis revealed that CD26high cells have a rich chemokine receptor profile (including CCR2 and CCR5), profound cytotoxicity (Granzyme B and CD107A), resistance to apoptosis (c-KIT and Bcl2), and enhanced stemness (-catenin and Lef1).",29213079_4,-1,-1,-1,-1,33843,-1,0.9920196,5.5105258e-05,0.007925246
33849,to traffic to,10,13,66,79,"These properties license CD26high T cells with a natural capacity to traffic to, regress and survive in solid tumors.",29213079_5,-1,-1,-1,-1,33849,-1,6.40967e-06,0.9999845,9.103377e-06
33852,CD4+ T cell subsets,5,10,38,57,"Collectively, these findings identify CD4+ T cell subsets with properties critical for improving cancer immunotherapy.",29213079_6,-1,-1,-1,-1,33852,-1,2.4667832e-05,6.25017e-06,0.9999691
33854,functions,8,9,50,59,Interferon regulatory factors (IRF) have critical functions in lymphoid development and in immune response regulation.,29233972_0,0,1,2,-1,33854,-1,1.3862586e-05,0.99997187,1.4228582e-05
33855,immune response regulation,14,17,91,117,Interferon regulatory factors (IRF) have critical functions in lymphoid development and in immune response regulation.,29233972_0,-1,-1,-1,-1,33855,-1,0.79690266,0.20148511,0.0016122295
33856,the function,5,7,37,49,"Although many studies have described the function of IRF4 in CD4+ T cells, few have focused on the IRF4 homologue, IRF8.",29233972_1,-1,-1,-1,-1,33856,-1,6.750475e-06,0.9999881,5.126835e-06
33859,the IRF4,19,21,95,103,"Although many studies have described the function of IRF4 in CD4+ T cells, few have focused on the IRF4 homologue, IRF8.",29233972_1,-1,-1,-1,-1,33859,-1,8.713771e-06,0.9999831,8.217556e-06
33861,that IRF8,4,6,14,23,"Here, we show that IRF8 is required for Th9 differentiation in vitro and in vivo.",29233972_2,-1,-1,-1,-1,33861,-1,8.423732e-05,0.9998851,3.071566e-05
33863,IRF8 functions through,0,3,0,22,"IRF8 functions through a transcription factor complex consisting of IRF8, IRF4, PU.1 and BATF, which binds to DNA and boosts Il9 transcription.",29233972_3,-1,-1,-1,-1,33863,-1,1.1251196e-05,0.99997866,1.0034947e-05
33864,transcription factor complex,4,7,25,53,"IRF8 functions through a transcription factor complex consisting of IRF8, IRF4, PU.1 and BATF, which binds to DNA and boosts Il9 transcription.",29233972_3,-1,-1,-1,-1,33864,-1,5.865388e-06,0.9999887,5.458812e-06
33868,Il9 transcription,23,25,125,142,"IRF8 functions through a transcription factor complex consisting of IRF8, IRF4, PU.1 and BATF, which binds to DNA and boosts Il9 transcription.",29233972_3,-1,-1,-1,-1,33868,-1,0.9965694,0.0027107433,0.0007198177
33869,IRF8 deficiency,3,5,13,28,"By contrast, IRF8 deficiency promotes the expression of other genes such as Il4, as IRF8 dimerises with the transcriptional repressor ETV6 and inhibits Il4 expression.",29233972_4,-1,-1,-1,-1,33869,-1,2.3652712e-05,0.9999609,1.5435753e-05
33873,the transcriptional,19,21,104,123,"By contrast, IRF8 deficiency promotes the expression of other genes such as Il4, as IRF8 dimerises with the transcriptional repressor ETV6 and inhibits Il4 expression.",29233972_4,-1,-1,-1,-1,33873,-1,4.3373757e-06,0.9999912,4.465296e-06
33876,Th9 cells,11,13,58,67,"In vivo, IRF8 is essential for the anti-tumour effects of Th9 cells in mouse melanoma models.",29233972_5,-1,-1,-1,-1,33876,-1,1.1774853e-05,1.4840076e-05,0.9999734
33877,that IRF8 complexes,3,6,17,36,"Our results show that IRF8 complexes boost the Th9 program and repress Il4 expression to modulate Th9 cell differentiation, thereby implicating IRF8 as a potential therapeutic target to affect Th9 responses in cancer therapy.",29233972_6,-1,-1,-1,-1,33877,-1,7.938336e-06,0.99998474,7.2615294e-06
33878,the Th9,7,9,43,50,"Our results show that IRF8 complexes boost the Th9 program and repress Il4 expression to modulate Th9 cell differentiation, thereby implicating IRF8 as a potential therapeutic target to affect Th9 responses in cancer therapy.",29233972_6,-1,-1,-1,-1,33878,-1,2.0282188e-05,0.9999577,2.207283e-05
33880,Th9 cell,16,18,98,106,"Our results show that IRF8 complexes boost the Th9 program and repress Il4 expression to modulate Th9 cell differentiation, thereby implicating IRF8 as a potential therapeutic target to affect Th9 responses in cancer therapy.",29233972_6,-1,-1,-1,-1,33880,-1,4.7846977e-05,0.00019107624,0.99976116
33883,therapeutic target to,26,29,164,185,"Our results show that IRF8 complexes boost the Th9 program and repress Il4 expression to modulate Th9 cell differentiation, thereby implicating IRF8 as a potential therapeutic target to affect Th9 responses in cancer therapy.",29233972_6,-1,-1,-1,-1,33883,-1,3.536627e-06,0.99999285,3.6468734e-06
33885,therapy,34,35,217,224,"Our results show that IRF8 complexes boost the Th9 program and repress Il4 expression to modulate Th9 cell differentiation, thereby implicating IRF8 as a potential therapeutic target to affect Th9 responses in cancer therapy.",29233972_6,0,1,-1,-1,33885,-1,4.3501086e-06,0.99999094,4.7292906e-06
33887,the IL-17,8,10,47,56,"BACKGROUND: Interleukin (IL)-25 is a member of the IL-17 family, which can promote and augment T-helper (Th) type 2 responses.",29238954_0,-1,-1,-1,-1,33887,-1,0.8516459,0.14550045,0.0028536657
33892,receptor,7,8,40,48,"The expression of IL-25 and its cognate receptor, IL-25 receptor (IL-25R), is upregulated and correlated with disease activity in Th2-associated diseases.",29238954_1,0,1,2,-1,33892,-1,0.00088452315,0.9815812,0.01753425
33893,receptor,10,11,56,64,"The expression of IL-25 and its cognate receptor, IL-25 receptor (IL-25R), is upregulated and correlated with disease activity in Th2-associated diseases.",29238954_1,0,1,2,-1,33893,-1,0.019081717,0.07960137,0.9013168
33897,function,7,8,42,50,OBJECTIVES: To examine the expression and function of IL-25 in cutaneous T-cell lymphoma (CTCL).METHODS: Expression and location of IL-25 in lesional skin was investigated with immunohistochemistry.,29238954_2,0,1,2,-1,33897,-1,4.7156325e-05,0.99989736,5.5473934e-05
33898,T-cell,12,13,73,79,OBJECTIVES: To examine the expression and function of IL-25 in cutaneous T-cell lymphoma (CTCL).METHODS: Expression and location of IL-25 in lesional skin was investigated with immunohistochemistry.,29238954_2,-1,1,2,-1,33898,-1,1.6224729e-05,7.2672474e-06,0.9999765
33902,tumour cells,6,8,30,42,The direct effect of IL-25 on tumour cells was also examined using CTCL cell lines and peripheral blood mononuclear cells in patients with Szary syndrome.,29238954_5,-1,-1,-1,-1,33902,-1,0.00014447197,0.00068167533,0.9991738
33904,blood,17,18,98,103,The direct effect of IL-25 on tumour cells was also examined using CTCL cell lines and peripheral blood mononuclear cells in patients with Szary syndrome.,29238954_5,0,1,-1,-1,33904,-1,0.0049165837,0.9812516,0.013831855
33906,Th2 cytokines,0,2,0,13,"Th2 cytokines, IL-4 and IL-13, and periostin induced IL-25 expression by normal human epidermal keratinocytes.",29238954_7,-1,-1,-1,-1,33906,-1,0.23062916,0.76139206,0.007978795
33912,blood,1,2,11,16,"Peripheral blood mononuclear cells from one patient with Szary syndrome expressed IL-25R and showed increase of IL-13 production by IL-25.CONCLUSIONS: Th2 cytokines highly expressed in CTCL lesional skin induce IL-25 production by epidermal keratinocytes, which may, in turn, lead to formation of a Th2-dominant microenvironment through the direct induction of IL-13 by tumour cells.",29238954_11,0,1,-1,-1,33912,-1,0.0021545745,0.99047405,0.00737134
33915,Th2 cytokines,21,23,152,165,"Peripheral blood mononuclear cells from one patient with Szary syndrome expressed IL-25R and showed increase of IL-13 production by IL-25.CONCLUSIONS: Th2 cytokines highly expressed in CTCL lesional skin induce IL-25 production by epidermal keratinocytes, which may, in turn, lead to formation of a Th2-dominant microenvironment through the direct induction of IL-13 by tumour cells.",29238954_11,-1,-1,-1,-1,33915,-1,0.20707586,0.7859242,0.006999953
33919,through the,49,51,330,341,"Peripheral blood mononuclear cells from one patient with Szary syndrome expressed IL-25R and showed increase of IL-13 production by IL-25.CONCLUSIONS: Th2 cytokines highly expressed in CTCL lesional skin induce IL-25 production by epidermal keratinocytes, which may, in turn, lead to formation of a Th2-dominant microenvironment through the direct induction of IL-13 by tumour cells.",29238954_11,-1,-1,-1,-1,33919,-1,4.9177006e-06,0.99999154,3.5813152e-06
33921,tumour cells,56,58,371,383,"Peripheral blood mononuclear cells from one patient with Szary syndrome expressed IL-25R and showed increase of IL-13 production by IL-25.CONCLUSIONS: Th2 cytokines highly expressed in CTCL lesional skin induce IL-25 production by epidermal keratinocytes, which may, in turn, lead to formation of a Th2-dominant microenvironment through the direct induction of IL-13 by tumour cells.",29238954_11,-1,-1,-1,-1,33921,-1,0.00015079825,0.0015066997,0.9983425
33922,therapy,1,2,9,16,Adoptive therapy with chimeric antigen receptor (CAR)-redirected Tcells has achieved remarkable efficacy in the treatment of hematopoietic malignancies.,29241547_0,0,1,-1,-1,33922,-1,4.829886e-06,0.9999901,5.041025e-06
33925,the treatment,15,17,109,122,Adoptive therapy with chimeric antigen receptor (CAR)-redirected Tcells has achieved remarkable efficacy in the treatment of hematopoietic malignancies.,29241547_0,-1,-1,-1,-1,33925,-1,5.3649223e-06,0.9999895,5.109782e-06
33929,that IL-18,3,5,31,41,Systematic screening indicates that IL-18 polarizes CAR Tcells toward T-bethigh FoxO1low effectors with an acute inflammatory response.,29241547_3,-1,-1,-1,-1,33929,-1,0.90928847,0.08861037,0.002101117
33930,Tcells toward T-bethigh,7,12,56,80,Systematic screening indicates that IL-18 polarizes CAR Tcells toward T-bethigh FoxO1low effectors with an acute inflammatory response.,29241547_3,-1,-1,-1,-1,33930,-1,0.0043773446,0.49845317,0.49716952
33932,IL-18 release,7,9,38,51,CAR Tcells engineered with inducible IL-18 release exhibited superior activity against large pancreatic and lung tumors that were refractory to CAR Tcells without cytokines.,29241547_4,-1,-1,-1,-1,33932,-1,0.9990465,0.0005969833,0.00035647873
33933,tumors that,17,19,114,125,CAR Tcells engineered with inducible IL-18 release exhibited superior activity against large pancreatic and lung tumors that were refractory to CAR Tcells without cytokines.,29241547_4,-1,-1,-1,-1,33933,-1,3.6220672e-06,0.999992,4.3787327e-06
33938,Tcell treatment,2,6,10,26,IL-18 CAR Tcell treatment was accompanied by an overall change in the immune cell landscape associated with the tumor.,29241547_5,-1,-1,-1,-1,33938,-1,0.0027620643,0.16704573,0.83019227
33941,the tumor,19,21,109,118,IL-18 CAR Tcell treatment was accompanied by an overall change in the immune cell landscape associated with the tumor.,29241547_5,-1,-1,-1,-1,33941,-1,3.7732464e-06,0.9999912,5.0649223e-06
33948,antigen gene,7,9,43,55,"We found a HLA class II histocompatibility antigen gene, DQ alpha 1 chain (HLA-DQA1), that was expressed more than 9-fold higher in high-load hepatitis C virus (HCV) livers than low-load HCV livers using transcriptomics of chronic HCV-infected livers.",29248968_0,-1,-1,-1,-1,33948,-1,0.9353504,0.047685627,0.016963938
33967,the lymphocytic,19,21,110,125,HLA-DQA1-positive cells in the liver sinusoid were positive for CD68 (macrophages or Kupffer cells); those in the lymphocytic infiltrates were positive for CD20 (B cells) or CD3 (T cells).,29248968_4,-1,-1,-1,-1,33967,-1,0.005025892,0.32077342,0.67420065
33970,antigen-presenting cell,3,5,15,38,mRNA levels of antigen-presenting cell (APC) markers such as CD68 and CD11c were significantly upregulated in the HCV-high group and were correlated with HLA-DQA mRNA levels.,29248968_5,-1,-1,-1,-1,33970,-1,0.66313326,0.00024935402,0.33661735
34015,Taken together,0,2,0,14,"Taken together, our data suggest that constitutive Eomes expression enhances CD8 T-cell proliferation and survival, in part through the enhancement of interleukin-2 responsiveness through CD25 induction.",29271784_5,-1,-1,-1,-1,34015,-1,1.06897305e-05,0.99998,9.28692e-06
34018,through the,19,21,124,135,"Taken together, our data suggest that constitutive Eomes expression enhances CD8 T-cell proliferation and survival, in part through the enhancement of interleukin-2 responsiveness through CD25 induction.",29271784_5,-1,-1,-1,-1,34018,-1,6.3807574e-06,0.9999888,4.7807807e-06
34021,The receptors,2,4,12,25,"BACKGROUND: The receptors of Notch family play an important role in controlling the development, differentiation, and function of multiple cell types.",29301578_0,-1,-1,-1,-1,34021,-1,5.789294e-05,0.9997092,0.00023288486
34022,Notch family play,5,8,29,46,"BACKGROUND: The receptors of Notch family play an important role in controlling the development, differentiation, and function of multiple cell types.",29301578_0,-1,-1,-1,-1,34022,-1,1.2118509e-05,0.9999765,1.1325085e-05
34024,function,19,20,118,126,"BACKGROUND: The receptors of Notch family play an important role in controlling the development, differentiation, and function of multiple cell types.",29301578_0,0,1,2,-1,34024,-1,0.00015889722,0.9995523,0.00028872403
34025,cell types,22,24,139,149,"BACKGROUND: The receptors of Notch family play an important role in controlling the development, differentiation, and function of multiple cell types.",29301578_0,-1,-1,-1,-1,34025,-1,2.6205522e-05,1.9479046e-05,0.99995434
34035,shRNA to generate,17,20,108,125,METHODS: Melanoma cell line B16 cells were transfected by lentivirus containing mouse Notch1 gene or Notch1 shRNA to generate B16 cell line that highly or lowly expressed Notch1.,29301578_2,-1,-1,-1,-1,34035,-1,1.011131e-05,0.9999808,9.107407e-06
34063,IFN- release,20,22,124,137,Notch1 expression in B16 melanoma cells inhibited the infiltration of CD8+ cytotoxic T lymphocytes and NK cells and reduced IFN- release in tumor tissue.,29301578_8,-1,-1,-1,-1,34063,-1,0.9995314,0.00025856905,0.00021008606
34064,tumor tissue,23,25,141,153,Notch1 expression in B16 melanoma cells inhibited the infiltration of CD8+ cytotoxic T lymphocytes and NK cells and reduced IFN- release in tumor tissue.,29301578_8,-1,-1,-1,-1,34064,-1,5.514842e-06,0.99998856,5.965372e-06
34072,to the,20,22,146,152,"The percentage of CD4+CD25+FoxP3+ Tregs and Gr1+CD11b+MDSCs were significantly increased in tumor microenvironment, and all these were attributed to the upregulation of TGF-1.CONCLUSION: These findings suggested that Notch1 signaling in B16 melanoma cells might inhibit antitumor immunity by upregulation of TGF-1.",29301578_10,-1,-1,-1,-1,34072,-1,4.458728e-06,0.9999918,3.8040903e-06
34076,immunity,39,40,281,289,"The percentage of CD4+CD25+FoxP3+ Tregs and Gr1+CD11b+MDSCs were significantly increased in tumor microenvironment, and all these were attributed to the upregulation of TGF-1.CONCLUSION: These findings suggested that Notch1 signaling in B16 melanoma cells might inhibit antitumor immunity by upregulation of TGF-1.",29301578_10,0,-1,2,-1,34076,-1,0.999912,2.4778843e-05,6.315327e-05
34082,lifelong,29,30,168,176,"The B-lymphotropic Epstein-Barr virus (EBV), pandemic in humans, is rapidly controlled on initial infection by T cell surveillance; thereafter, the virus establishes a lifelong latent infection in the host.",29311309_0,0,-1,2,-1,34082,-1,1.0487093e-05,0.999982,7.5372136e-06
34088,to treating,3,5,17,28,A major approach to treating EBV-associated lymphomas is adoptive transfer of autologous or allogeneic T cells that are stimulated/expanded on EBV-transformed B cells.,29311309_3,-1,-1,-1,-1,34088,-1,4.7425897e-06,0.9999906,4.645075e-06
34090,T cells that,14,17,103,115,A major approach to treating EBV-associated lymphomas is adoptive transfer of autologous or allogeneic T cells that are stimulated/expanded on EBV-transformed B cells.,29311309_3,-1,-1,-1,-1,34090,-1,0.00177648,0.036326967,0.9618965
34108,immunity,13,14,74,82,The mouse model offers a unique tool for uncovering basic features of EBV immunity.,29311309_7,0,-1,2,-1,34108,-1,0.9987348,0.00041322343,0.00085202075
34118,immunity,6,7,41,49,"These findings provide insights into EBV immunity, demonstrating that LMP1 signaling alone is sufficient to induce a prominent cytotoxic CD4 response, and suggest strategies for immunotherapy in EBV-related and other cancers.",29311309_10,0,-1,2,-1,34118,-1,0.99660987,0.0017405957,0.0016494802
34139,tissue-resident T cells,1,4,6,29,"Liver tissue-resident T cells were investigated using immunostaining, western blotting, and real-time PCR.RESULTS: OV+NDMA-induced CCA tissues showed significantly higher numbers of inflammatory cells, especially eosinophils, bile duct proliferation and IL-17+ cell infiltration compared to normal livers.",29331794_5,-1,-1,-1,-1,34139,-1,0.0013353389,0.030782644,0.9678821
34140,tissues,18,19,135,142,"Liver tissue-resident T cells were investigated using immunostaining, western blotting, and real-time PCR.RESULTS: OV+NDMA-induced CCA tissues showed significantly higher numbers of inflammatory cells, especially eosinophils, bile duct proliferation and IL-17+ cell infiltration compared to normal livers.",29331794_5,-1,1,2,-1,34140,-1,0.00053325074,0.68343866,0.3160281
34151,the Foxp3,12,14,62,71,Accumulation of CD4+ and IL-17+ cells and intense staining of the Foxp3+ marker were consistent with their protein levels.,29331794_7,-1,-1,-1,-1,34151,-1,9.309228e-06,0.9999825,8.176353e-06
34152,their protein,19,21,101,114,Accumulation of CD4+ and IL-17+ cells and intense staining of the Foxp3+ marker were consistent with their protein levels.,29331794_7,-1,-1,-1,-1,34152,-1,8.734451e-06,0.9999846,6.5928016e-06
34157,their transcription,16,18,84,103,"Infiltration of IL-17+ inflammatory cells and Foxp3+ cells, as well as increases in their transcription expression levels, were significantly lower in the melatonin-treated group.",29331794_8,-1,-1,-1,-1,34157,-1,4.466567e-06,0.9999906,4.920051e-06
34160,TNF-,9,10,50,55,"In contrast, increased CD4+ cell infiltration and TNF- expression were also observed through melatonin treatment.",29331794_9,0,1,-1,-1,34160,-1,4.1901432e-05,0.9999391,1.9068922e-05
34163,Th17 cells,11,13,85,95,"CONCLUSION: Melatonin exerts an immunomodulatory effect, suppressing eosinophils and Th17 cells and expression of Foxp3, but enhancing CD4+ cells and TNF-.",29331794_10,-1,-1,-1,-1,34163,-1,0.0001534963,0.0032420196,0.99660444
34166,TNF-,24,25,150,155,"CONCLUSION: Melatonin exerts an immunomodulatory effect, suppressing eosinophils and Th17 cells and expression of Foxp3, but enhancing CD4+ cells and TNF-.",29331794_10,0,1,-1,-1,34166,-1,8.45252e-05,0.99989414,2.137627e-05
34174,related to,4,6,20,30,High serum CA125 is related to metabolic tumor burden and poor prognosis.,29337110_2,-1,-1,-1,-1,34174,-1,1.3269258e-05,0.9999789,7.880976e-06
34177,Treg subset,2,4,16,27,The circulating Treg subset is another independent prognostic factor for pancreatic cancer.,29337110_3,-1,-1,-1,-1,34177,-1,0.0008445277,0.15748727,0.8416682
34178,factor,8,9,62,68,The circulating Treg subset is another independent prognostic factor for pancreatic cancer.,29337110_3,0,1,-1,-1,34178,-1,0.8138742,0.18445395,0.0016719069
34179,that the,4,6,31,39,Our unpublished data indicated that the circulating Treg proportion might be related to the serum CA125 level.,29337110_4,-1,-1,-1,-1,34179,-1,5.2185574e-06,0.99999094,3.7900152e-06
34181,related to the,11,14,77,91,Our unpublished data indicated that the circulating Treg proportion might be related to the serum CA125 level.,29337110_4,-1,-1,-1,-1,34181,-1,2.3466775e-05,0.9999671,9.45688e-06
34185,tissues,15,16,100,107,"However, the potential relationship and underlying mechanism of MUC16 and Treg in pancreatic cancer tissues remain unclear.",29337110_5,-1,1,2,-1,34185,-1,0.0001586965,0.0048155594,0.9950257
34188,tissues,9,10,47,54,"In this study, we found that pancreatic cancer tissues were positive for both MUC16 C terminal (MUC16c) and Foxp3 expression and that their expression was correlated.",29337110_6,-1,1,2,-1,34188,-1,0.00046346692,0.042416703,0.9571198
34191,that their,24,26,129,139,"In this study, we found that pancreatic cancer tissues were positive for both MUC16 C terminal (MUC16c) and Foxp3 expression and that their expression was correlated.",29337110_6,-1,-1,-1,-1,34191,-1,4.5636207e-06,0.99999106,4.387758e-06
34196,the regulation,6,8,40,54,The PI3K/AKT pathway may participate in the regulation of IL-6 expression and secretion.,29337110_8,-1,-1,-1,-1,34196,-1,5.6817967e-06,0.9999888,5.469636e-06
34201,the cells,10,12,51,60,"By treating CD4+ T cells with IL-6 or co-culturing the cells with pancreatic cancer cells, tumor-derived IL-6 was identified to promote Foxp3 expression and Treg differentiation, which was significantly inhibited by the JAK2 inhibitor AG-490.",29337110_9,-1,-1,-1,-1,34201,-1,8.652062e-05,0.00020586117,0.99970764
34203,tumor-derived IL-6,17,19,91,109,"By treating CD4+ T cells with IL-6 or co-culturing the cells with pancreatic cancer cells, tumor-derived IL-6 was identified to promote Foxp3 expression and Treg differentiation, which was significantly inhibited by the JAK2 inhibitor AG-490.",29337110_9,-1,-1,-1,-1,34203,-1,0.5070874,0.48959544,0.0033171112
34208,that the relationship,6,9,31,52,"In sum, our study demonstrated that the relationship between the MUC16c level and Foxp3 expression in the local tumor environment was consistent with that of the serum CA125 level and circulating Treg proportion in the systemic environment.",29337110_10,-1,-1,-1,-1,34208,-1,5.764326e-06,0.99998987,4.3880123e-06
34218,tumor-associated Treg,5,7,37,58,MUC16c promoted Foxp3 expression and tumor-associated Treg enrichment in tumor tissues through tumor-secreted IL-6 activation of the JAK2/STAT3 pathway.,29337110_11,-1,-1,-1,-1,34218,-1,4.9216637e-06,0.9999902,4.838946e-06
34219,tumor tissues through tumor-secreted IL-6,9,14,73,114,MUC16c promoted Foxp3 expression and tumor-associated Treg enrichment in tumor tissues through tumor-secreted IL-6 activation of the JAK2/STAT3 pathway.,29337110_11,-1,-1,-1,-1,34219,-1,0.17954405,0.81769985,0.0027560587
34222,therapy,10,11,75,82,These findings may provide deeper insight into potential pancreatic cancer therapy approaches.,29337110_12,0,1,-1,-1,34222,-1,7.1991203e-06,0.99998665,6.187007e-06
34223,The function,2,4,17,29,"BACKGROUND/AIMS: The function of regulatory T cells (Treg) and helper T cells 17 (Th17) related indexes, such as interleukin (IL)-6, IL-17, transforming growth factor (TGF)-1, and forkhead box protein 3(FoxP3) in gastric adenocarcinoma tissues remains undefined.",29391307_0,-1,-1,-1,-1,34223,-1,9.052745e-06,0.99998033,1.0651958e-05
34231,transforming growth factor,29,32,140,166,"BACKGROUND/AIMS: The function of regulatory T cells (Treg) and helper T cells 17 (Th17) related indexes, such as interleukin (IL)-6, IL-17, transforming growth factor (TGF)-1, and forkhead box protein 3(FoxP3) in gastric adenocarcinoma tissues remains undefined.",29391307_0,-1,-1,-1,-1,34231,-1,0.9836104,0.013609189,0.0027805269
34233,protein,37,38,194,201,"BACKGROUND/AIMS: The function of regulatory T cells (Treg) and helper T cells 17 (Th17) related indexes, such as interleukin (IL)-6, IL-17, transforming growth factor (TGF)-1, and forkhead box protein 3(FoxP3) in gastric adenocarcinoma tissues remains undefined.",29391307_0,0,1,-1,-1,34233,-1,1.0537527e-05,0.9999788,1.0669947e-05
34234,tissues,43,44,237,244,"BACKGROUND/AIMS: The function of regulatory T cells (Treg) and helper T cells 17 (Th17) related indexes, such as interleukin (IL)-6, IL-17, transforming growth factor (TGF)-1, and forkhead box protein 3(FoxP3) in gastric adenocarcinoma tissues remains undefined.",29391307_0,-1,1,2,-1,34234,-1,0.0004798453,0.08498217,0.914538
34235,the relevance,4,6,29,42,We investigated and analyzed the relevance of the proteins with the clinicopathological characteristics and the interactions among them in gastric cancer.,29391307_1,-1,-1,-1,-1,34235,-1,5.5339015e-06,0.99998915,5.3111366e-06
34236,the proteins,7,9,46,58,We investigated and analyzed the relevance of the proteins with the clinicopathological characteristics and the interactions among them in gastric cancer.,29391307_1,-1,-1,-1,-1,34236,-1,2.3628056e-05,0.99996424,1.2123886e-05
34241,transcription- polymerase,10,12,69,94,"Immunohistochemistry (IHC) as well as quantitative real-time reverse transcription- polymerase chain reaction (RT-PCR) was used to determine the expression levels of IL-6, TGF-1, IL-17, and FoxP3 in the prepared tissues.",29391307_3,-1,-1,-1,-1,34241,-1,1.0474903e-05,0.99997866,1.0831e-05
34249,tissues,36,37,213,220,"Immunohistochemistry (IHC) as well as quantitative real-time reverse transcription- polymerase chain reaction (RT-PCR) was used to determine the expression levels of IL-6, TGF-1, IL-17, and FoxP3 in the prepared tissues.",29391307_3,-1,1,2,-1,34249,-1,0.0002063117,0.98686594,0.012927715
34250,Statistical analysis,0,2,0,20,Statistical analysis included ANOVA and chi-square test.,29391307_4,-1,-1,-1,-1,34250,-1,2.0083611e-05,0.99996924,1.0632628e-05
34257,tissues,19,20,103,110,"RESULTS: The expression levels of IL-6, IL-17, FoxP3, and TGF-1 had significantly increased in cancer tissues compared to controls.",29391307_5,-1,1,2,-1,34257,-1,0.00013414718,0.9844013,0.015464526
34264,tissues,23,24,126,133,"Clinical staging of gastric cancer were correlated with the rise of IL-6, IL-17, FoxP3, and TGF-1 levels expressed in cancer tissues.",29391307_6,-1,1,2,-1,34264,-1,0.00013848036,0.9842981,0.015563403
34268,related to that,9,12,55,70,"The expression level of TGF-1 and IL-6 was positively related to that of IL-17 and FoxP3, similar to FoxP3 and IL-17 in gastric cancer tissues.",29391307_7,-1,-1,-1,-1,34268,-1,3.2903663e-05,0.9999509,1.6219019e-05
34271,to FoxP3,18,20,99,107,"The expression level of TGF-1 and IL-6 was positively related to that of IL-17 and FoxP3, similar to FoxP3 and IL-17 in gastric cancer tissues.",29391307_7,-1,-1,-1,-1,34271,-1,5.031944e-06,0.9999895,5.469964e-06
34273,tissues,25,26,136,143,"The expression level of TGF-1 and IL-6 was positively related to that of IL-17 and FoxP3, similar to FoxP3 and IL-17 in gastric cancer tissues.",29391307_7,-1,1,2,-1,34273,-1,0.000731264,0.27567786,0.72359085
34282,the transcription factor forkhead,8,12,44,77,Regulatory T cells (Tregs) characterized by the transcription factor forkhead box P3 (FoxP3) are crucial for maintaining immune tolerance and preventing autoimmunity.,29455107_0,-1,-1,-1,-1,34282,-1,7.0391684e-06,0.9999875,5.45777e-06
34286,function,5,6,24,32,"However, FoxP3 does not function alone and Helios is considered a potential candidate for defining Treg subsets.",29455107_1,0,1,2,-1,34286,-1,7.759116e-05,0.9998921,3.0227617e-05
34287,Treg subsets,16,18,99,111,"However, FoxP3 does not function alone and Helios is considered a potential candidate for defining Treg subsets.",29455107_1,-1,-1,-1,-1,34287,-1,0.00032977588,0.01901696,0.9806533
34290,function,9,10,50,58,"In this study, we investigated the expression and function of Helios for identifying Tregs in childhood precursor B-cell acute lymphoblastic leukemia (pre-B ALL).",29455107_2,0,1,2,-1,34290,-1,3.31678e-05,0.99994314,2.3736644e-05
34299,function,34,35,198,206,"Our results demonstrated that patients with pre-B ALL had a higher percentage of Helios+ FoxP3+ CD4+ Tregs. And there was a positive correlation between the expression of Helios and the suppressive function of Tregs, the risk gradation of ALL.",29455107_3,0,1,2,-1,34299,-1,1.4885915e-05,0.9999734,1.1687277e-05
34304,functional Tregs,14,16,75,91,Helios in combination with CD4 and FoxP3 may be an effective way to detect functional Tregs in pre-B ALL by promoting the secretion of transforming growth factor (TGF)-1.,29455107_4,-1,-1,-1,-1,34304,-1,2.2904707e-05,0.9999635,1.3616275e-05
34306,transforming growth factor,24,27,135,161,Helios in combination with CD4 and FoxP3 may be an effective way to detect functional Tregs in pre-B ALL by promoting the secretion of transforming growth factor (TGF)-1.,29455107_4,-1,-1,-1,-1,34306,-1,0.9779018,0.018455498,0.0036426804
34311,nalm-6 cells,9,11,56,68,We also found Helios+ Tregs decreased apoptosis rate of nalm-6 cells by up-regulating the expression of anti-apoptosis protein Bcl-2.,29455107_6,-1,-1,-1,-1,34311,-1,0.0005251333,0.016205339,0.9832696
34313,protein,17,18,119,126,We also found Helios+ Tregs decreased apoptosis rate of nalm-6 cells by up-regulating the expression of anti-apoptosis protein Bcl-2.,29455107_6,0,1,-1,-1,34313,-1,6.2500417e-06,0.9999877,6.0128655e-06
34317,that the,18,20,110,118,"In summary, these data strongly imply the physiological importance of Helios expression in Tregs, and suggest that the manipulation of Helios may serve as a novel strategy for cancer immunotherapy.",29455107_7,-1,-1,-1,-1,34317,-1,4.4840676e-06,0.999992,3.4864256e-06
34319,cytokine released,8,10,41,58,Interleukin 33 (IL33) is an inflammatory cytokine released during necrotic cell death.,29463593_0,-1,-1,-1,-1,34319,-1,0.99890995,0.0008365385,0.0002535625
34323,receptor,14,15,81,89,The epithelium and stroma of the intestine express large amounts of IL33 and its receptor St2.,29463593_1,0,1,2,-1,34323,-1,0.006035031,0.5918185,0.40214643
34332,to tumorigenesis,18,20,107,123,"Here, we utilized a mouse model of sporadic colon cancer to investigate the contribution of IL33 signaling to tumorigenesis in the absence of preexisting inflammation.",29463593_4,-1,-1,-1,-1,34332,-1,6.4395394e-06,0.9999876,5.9786707e-06
34334,that genetic,2,4,16,28,We demonstrated that genetic ablation of St2 enhanced colon tumor development.,29463593_5,-1,-1,-1,-1,34334,-1,8.683337e-06,0.9999862,5.113363e-06
34343,target genes,23,25,161,173,We detected St2 expression within the radioresistant mesenchymal cell compartment of the colon whose stimulation with IL33 induced expression of bona fide NF-B target genes.,29463593_8,-1,-1,-1,-1,34343,-1,4.548029e-06,0.9999914,4.054084e-06
34345,deficiency,6,7,40,50,"Mechanistically, we discovered that St2 deficiency within the nonhematopoietic compartment coincided with increased abundance of regulatory T cells and suppression of an IFN gene expression signature, whereas IL33 administration triggered IFN expression by tumor allograft-infiltrating T cells.",29463593_9,0,1,-1,-1,34345,-1,4.4020508e-05,0.9999373,1.8734263e-05
34348,IFN gene,23,25,170,179,"Mechanistically, we discovered that St2 deficiency within the nonhematopoietic compartment coincided with increased abundance of regulatory T cells and suppression of an IFN gene expression signature, whereas IL33 administration triggered IFN expression by tumor allograft-infiltrating T cells.",29463593_9,-1,-1,-1,-1,34348,-1,0.99852943,0.000988101,0.0004824784
34349,triggered IFN,31,33,230,244,"Mechanistically, we discovered that St2 deficiency within the nonhematopoietic compartment coincided with increased abundance of regulatory T cells and suppression of an IFN gene expression signature, whereas IL33 administration triggered IFN expression by tumor allograft-infiltrating T cells.",29463593_9,-1,-1,-1,-1,34349,-1,0.9590407,0.039575316,0.0013839856
34353,this IFN gene,3,6,16,30,"The decrease of this IFN gene expression signature was associated with more aggressive disease in human colon cancer patients, suggesting that lack of IL33 signaling impaired the generation of a potent IFN-mediated antitumor immune response.",29463593_10,-1,-1,-1,-1,34353,-1,0.0007648869,0.99908173,0.00015334824
34355,the generation,27,29,176,190,"The decrease of this IFN gene expression signature was associated with more aggressive disease in human colon cancer patients, suggesting that lack of IL33 signaling impaired the generation of a potent IFN-mediated antitumor immune response.",29463593_10,-1,-1,-1,-1,34355,-1,6.408445e-06,0.99998903,4.5994175e-06
34359,functions,7,8,40,49,"Collectively, our data reveal that IL33 functions as a tumor suppressor in sporadic colon cancer.",29463593_11,0,1,2,-1,34359,-1,6.623165e-05,0.9998994,3.4393182e-05
34364,cytotoxic T-lymphocyte antigen-4,17,20,109,141,"A majority of cancers fail to respond to immunotherapy with antibodies targeting immune checkpoints, such as cytotoxic T-lymphocyte antigen-4 (CTLA-4) or programmed death-1 (PD-1)/PD-1 ligand (PD-L1).",29467463_0,-1,-1,-1,-1,34364,-1,0.04212884,0.00036450577,0.9575067
34367,factor-,5,6,47,55,"Cancers frequently express transforming growth factor- (TGF), which drives immune dysfunction in the tumor microenvironment by inducing regulatory T cells (Tregs) and inhibiting CD8+ and TH1 cells.",29467463_1,0,1,-1,-1,34367,-1,0.9998826,1.2449097e-05,0.00010503561
34369,the tumor,15,17,99,108,"Cancers frequently express transforming growth factor- (TGF), which drives immune dysfunction in the tumor microenvironment by inducing regulatory T cells (Tregs) and inhibiting CD8+ and TH1 cells.",29467463_1,-1,-1,-1,-1,34369,-1,4.1344883e-06,0.9999912,4.649989e-06
34374,this therapeutic,2,4,11,27,"To address this therapeutic challenge, we invent bifunctional antibody-ligand traps (Y-traps) comprising an antibody targeting CTLA-4 or PD-L1 fused to a TGF receptor II ectodomain sequence that simultaneously disables autocrine/paracrine TGF in the target cell microenvironment (a-CTLA4-TGFRIIecd and a-PDL1-TGFRIIecd).",29467463_2,-1,-1,-1,-1,34374,-1,4.365184e-06,0.9999914,4.219679e-06
34375,traps,10,11,78,83,"To address this therapeutic challenge, we invent bifunctional antibody-ligand traps (Y-traps) comprising an antibody targeting CTLA-4 or PD-L1 fused to a TGF receptor II ectodomain sequence that simultaneously disables autocrine/paracrine TGF in the target cell microenvironment (a-CTLA4-TGFRIIecd and a-PDL1-TGFRIIecd).",29467463_2,-1,1,2,-1,34375,-1,7.5631024e-06,0.99998534,7.090216e-06
34376,targeting CTLA-4,17,19,117,133,"To address this therapeutic challenge, we invent bifunctional antibody-ligand traps (Y-traps) comprising an antibody targeting CTLA-4 or PD-L1 fused to a TGF receptor II ectodomain sequence that simultaneously disables autocrine/paracrine TGF in the target cell microenvironment (a-CTLA4-TGFRIIecd and a-PDL1-TGFRIIecd).",29467463_2,-1,-1,-1,-1,34376,-1,0.0038174957,0.285853,0.7103295
34378,TGF receptor,24,26,154,167,"To address this therapeutic challenge, we invent bifunctional antibody-ligand traps (Y-traps) comprising an antibody targeting CTLA-4 or PD-L1 fused to a TGF receptor II ectodomain sequence that simultaneously disables autocrine/paracrine TGF in the target cell microenvironment (a-CTLA4-TGFRIIecd and a-PDL1-TGFRIIecd).",29467463_2,-1,-1,-1,-1,34378,-1,0.00061498844,0.9982634,0.0011215864
34381,the target cell,35,38,248,263,"To address this therapeutic challenge, we invent bifunctional antibody-ligand traps (Y-traps) comprising an antibody targeting CTLA-4 or PD-L1 fused to a TGF receptor II ectodomain sequence that simultaneously disables autocrine/paracrine TGF in the target cell microenvironment (a-CTLA4-TGFRIIecd and a-PDL1-TGFRIIecd).",29467463_2,-1,-1,-1,-1,34381,-1,0.0020580578,0.78447175,0.21347019
34382,tumor-infiltrating Tregs,6,8,49,73,a-CTLA4-TGFRIIecd is more effective in reducing tumor-infiltrating Tregs and inhibiting tumor progression compared with CTLA-4 antibody (Ipilimumab).,29467463_3,-1,-1,-1,-1,34382,-1,1.30792705e-05,0.99997437,1.2511896e-05
34392,IFN- plays,0,2,0,11,"IFN- plays a crucial role in anti-tumor responses and also induces expression of PD-L1, a well-established inhibitor of anti-tumor immune function.",29516506_0,-1,-1,-1,-1,34392,-1,0.9992225,0.00045325214,0.00032421554
34393,function,21,22,139,147,"IFN- plays a crucial role in anti-tumor responses and also induces expression of PD-L1, a well-established inhibitor of anti-tumor immune function.",29516506_0,0,1,2,-1,34393,-1,0.00018269329,0.9997019,0.00011535075
34394,the function,5,7,48,60,Understanding how molecular signaling regulates the function of IFN- might improve its anti-tumor efficacy.,29516506_1,-1,-1,-1,-1,34394,-1,1.775755e-05,0.9999722,1.0037705e-05
34396,that the tumor,4,7,14,28,"Here, we show that the tumor expression of IFN- expression alone has no significant prognostic value in patients with locally advanced lung adenocarcinoma.",29516506_2,-1,-1,-1,-1,34396,-1,4.547078e-06,0.99999106,4.352852e-06
34401,to those,15,17,100,108,"Surprisingly, patients with tumors expressing both IFN- and PD-L1 have the best prognosis compared to those with tumors expressing IFN- or PD-L1 alone.",29516506_3,-1,-1,-1,-1,34401,-1,4.4478265e-06,0.9999908,4.7705475e-06
34404,Transcriptome analysis,0,2,0,22,Transcriptome analysis demonstrated that tumor tissues expressing IFN- display gene expression associated with suppressed cell cycle progression and expansion.,29516506_4,-1,-1,-1,-1,34404,-1,6.1066567e-06,0.99998856,5.2924056e-06
34405,that tumor tissues,3,6,36,54,Transcriptome analysis demonstrated that tumor tissues expressing IFN- display gene expression associated with suppressed cell cycle progression and expansion.,29516506_4,-1,-1,-1,-1,34405,-1,1.3929575e-05,0.99995553,3.0577907e-05
34413,functions,6,7,34,43,The current concept is that PD-L1 functions as a shield protecting tumor cells from cytolytic T cell (CTL)-mediated anti-tumor progression.,29516506_6,0,1,2,-1,34413,-1,1.581435e-05,0.99996316,2.0984404e-05
34414,tumor cells,11,13,67,78,The current concept is that PD-L1 functions as a shield protecting tumor cells from cytolytic T cell (CTL)-mediated anti-tumor progression.,29516506_6,-1,-1,-1,-1,34414,-1,0.00023017194,0.0038734209,0.99589646
34420,tumors to the,21,24,122,135,"However, our data indicate that PD-L1 expression in the presence of IFN- might serve as biomarker for the sensitivity of tumors to the inhibitory effect of IFN-.",29516506_7,-1,-1,-1,-1,34420,-1,3.5600985e-06,0.99999297,3.5205485e-06
34422,analysis,1,2,12,20,Mechanistic analysis revealed that in lung adenocarcinoma cells IFN--induced activation of JAK2-STAT1 and PI3K-AKT pathways.,29516506_8,0,1,-1,-1,34422,-1,7.5482917e-06,0.9999869,5.5309874e-06
34424,cells IFN--induced,7,9,58,77,Mechanistic analysis revealed that in lung adenocarcinoma cells IFN--induced activation of JAK2-STAT1 and PI3K-AKT pathways.,29516506_8,-1,-1,-1,-1,34424,-1,0.9439056,0.0012127808,0.054881632
34431,maximize the IFN--mediated,22,25,142,169,"Inhibition of PI3K downregulated PD-L1 expression and enhanced the anti-proliferative effect of IFN-, suggesting that blockade of PI3K might maximize the IFN--mediated anti-tumor effect.",29516506_10,-1,-1,-1,-1,34431,-1,0.91517955,0.083163366,0.0016570764
34432,to IFN-,13,15,97,105,Our findings provide evidence for crosstalk between JAK2-STAT1 and PI3K-AKT pathways in response to IFN- in lung adenocarcinoma and have implications for the design of combinatorial targeted therapy and immunotherapy for the treatment of lung adenocarcinoma.,29516506_11,-1,-1,-1,-1,34432,-1,0.9953933,0.003961191,0.00064550486
34434,targeted therapy,26,28,183,199,Our findings provide evidence for crosstalk between JAK2-STAT1 and PI3K-AKT pathways in response to IFN- in lung adenocarcinoma and have implications for the design of combinatorial targeted therapy and immunotherapy for the treatment of lung adenocarcinoma.,29516506_11,-1,-1,-1,-1,34434,-1,5.9865015e-06,0.9999881,5.9277254e-06
34435,the treatment,31,33,222,235,Our findings provide evidence for crosstalk between JAK2-STAT1 and PI3K-AKT pathways in response to IFN- in lung adenocarcinoma and have implications for the design of combinatorial targeted therapy and immunotherapy for the treatment of lung adenocarcinoma.,29516506_11,-1,-1,-1,-1,34435,-1,5.181806e-06,0.99999034,4.5094994e-06
34437,protein,2,3,24,31,The prolactin-inducible protein (PIP) is considered a valuable biomarker that is associated with both benign and malignant pathological conditions of the mammary gland.,29536339_0,0,1,-1,-1,34437,-1,1.1430356e-05,0.9999821,6.4496207e-06
34441,The function,0,2,0,12,"The function of PIP in breast tumorigenesis remains unknown; however, evidence from our laboratory and others suggest that it regulates host immunity.",29536339_1,-1,-1,-1,-1,34441,-1,7.634602e-06,0.99998665,5.7203983e-06
34444,immunity,23,24,141,149,"The function of PIP in breast tumorigenesis remains unknown; however, evidence from our laboratory and others suggest that it regulates host immunity.",29536339_1,0,-1,2,-1,34444,-1,0.99988973,4.2956675e-05,6.7365225e-05
34461,protein,8,9,72,79,This was associated with decreased phosphorylation of mitogen-activated protein kinase (MAPK) and signal transducer of activation of transcription (STAT) proteins in macrophages from PIP-/- mice.,29536339_5,0,1,-1,-1,34461,-1,0.000121370285,0.9998141,6.4562635e-05
34465,proteins,23,24,154,162,This was associated with decreased phosphorylation of mitogen-activated protein kinase (MAPK) and signal transducer of activation of transcription (STAT) proteins in macrophages from PIP-/- mice.,29536339_5,0,1,-1,-1,34465,-1,7.677176e-06,0.9999857,6.586003e-06
34468,proteins,15,16,82,90,"Interestingly, the expression of suppressors of cytokine signaling (SOCS) 1 and 3 proteins, known to suppress IFN- and LPS signaling, was higher in PIP-/- macrophages compared to those from WT mice.",29536339_6,0,1,-1,-1,34468,-1,7.0637366e-06,0.9999869,6.105138e-06
34472,to those,31,33,177,185,"Interestingly, the expression of suppressors of cytokine signaling (SOCS) 1 and 3 proteins, known to suppress IFN- and LPS signaling, was higher in PIP-/- macrophages compared to those from WT mice.",29536339_6,-1,-1,-1,-1,34472,-1,4.826014e-06,0.9999902,4.953623e-06
34473,that deficiency,5,7,31,46,"Collectively, our studies show that deficiency of PIP significantly affects intracellular signaling events leading to decreased pro-inflammatory cytokine production, and further confirms a role for PIP as an important immunoregulatory protein.",29536339_7,-1,-1,-1,-1,34473,-1,7.862934e-06,0.999987,5.0993126e-06
34476,protein,32,33,235,242,"Collectively, our studies show that deficiency of PIP significantly affects intracellular signaling events leading to decreased pro-inflammatory cytokine production, and further confirms a role for PIP as an important immunoregulatory protein.",29536339_7,0,1,-1,-1,34476,-1,7.163167e-06,0.9999869,5.9151243e-06
34483,that the,4,6,21,29,"Here, we demonstrate that the pro-inflammatory cytokine interleukin (IL)-18 is critically involved in these hallmarks in multiple myeloma (MM).",29551594_1,-1,-1,-1,-1,34483,-1,5.3858016e-06,0.99999046,4.1830494e-06
34484,cytokine interleukin,7,9,47,67,"Here, we demonstrate that the pro-inflammatory cytokine interleukin (IL)-18 is critically involved in these hallmarks in multiple myeloma (MM).",29551594_1,-1,-1,-1,-1,34484,-1,0.99994564,7.314219e-06,4.7080055e-05
34487,Tcell-dependent,15,18,88,104,Mice deficient for IL-18 were remarkably protected from VkMYC MM progression in a CD8+ Tcell-dependent manner.,29551594_2,-1,-1,-1,-1,34487,-1,1.88943e-05,1.0089152e-05,0.9999709
34493,transcriptome analysis,2,4,9,31,A global transcriptome analysis of the immune microenvironment in 73 MM patients strongly supported the negative impact of IL-18-driven MDSCs on Tcell responses.,29551594_4,-1,-1,-1,-1,34493,-1,7.645793e-06,0.9999856,6.80086e-06
34498,plasma IL-18,7,9,39,51,"Strikingly, high levels of bone marrow plasma IL-18 were associated with poor overall survival in MM patients.",29551594_5,-1,-1,-1,-1,34498,-1,0.99830365,0.0011073183,0.0005889643
34499,that IL-18,6,8,47,57,"Furthermore, our preclinical studies suggested that IL-18 could be a potential therapeutic target in MM.",29551594_6,-1,-1,-1,-1,34499,-1,0.8192111,0.17847183,0.0023170153
34500,therapeutic target,12,14,79,97,"Furthermore, our preclinical studies suggested that IL-18 could be a potential therapeutic target in MM.",29551594_6,-1,-1,-1,-1,34500,-1,6.518512e-06,0.9999887,4.768786e-06
34506,tumor immunity,15,17,113,127,"One mechanism is tumor-induced myelopoiesis, whereby the expansion of immunosuppressive myeloid cells can impair tumor immunity.",29593283_1,-1,-1,-1,-1,34506,-1,0.07160956,0.9274339,0.0009566005
34513,immunity,20,21,96,104,"The cDC subset, cDC1, which includes human CD141+ DCs and mouse CD103+ DCs, supports anti-tumor immunity by stimulating CD8+ T-cell responses.",29593283_3,0,-1,2,-1,34513,-1,0.9998393,6.685916e-05,9.381672e-05
34514,T-cell,25,26,125,131,"The cDC subset, cDC1, which includes human CD141+ DCs and mouse CD103+ DCs, supports anti-tumor immunity by stimulating CD8+ T-cell responses.",29593283_3,-1,1,2,-1,34514,-1,1.7732755e-05,6.2359354e-06,0.99997604
34519,factor,4,5,56,62,"Mechanistically, tumor-produced granulocyte-stimulating factor downregulates interferon regulatory factor-8 in cDC progenitors, and thus results in reduced cDC1 development.",29593283_6,0,1,-1,-1,34519,-1,0.9999294,1.0512044e-05,6.008631e-05
34521,factor-8,8,9,99,107,"Mechanistically, tumor-produced granulocyte-stimulating factor downregulates interferon regulatory factor-8 in cDC progenitors, and thus results in reduced cDC1 development.",29593283_6,0,1,-1,-1,34521,-1,0.0025022854,0.997168,0.0003297718
34524,T-cell,9,10,68,74,Tumor-induced reductions in cDC1 development impair anti-tumor CD8+ T-cell responses and correlate with poor patient outcomes.,29593283_7,-1,1,2,-1,34524,-1,1.4973763e-05,5.9507975e-06,0.999979
34527,tissue generally,2,4,16,32,"Although cancer tissue generally shows limited immune responses, some cancers abound with lymphocytes, which generally show favorable prognosis.",29594353_0,-1,-1,-1,-1,34527,-1,0.00011491954,0.99903846,0.0008466491
34534,tissue,15,16,91,97,"These cancers, despite their rarity, are important in analyzing immune responses in cancer tissue.",29594353_1,-1,1,2,-1,34534,-1,0.0008396842,0.8762312,0.1229291
34535,Transforming growth factor,0,3,0,26,"Transforming growth factor 1 (TFG1) is a multifunctional cytokine, generally having an immunosuppressive function.",29594353_2,-1,-1,-1,-1,34535,-1,0.9755299,0.01994941,0.004520634
34539,function,16,17,107,115,"Transforming growth factor 1 (TFG1) is a multifunctional cytokine, generally having an immunosuppressive function.",29594353_2,0,1,2,-1,34539,-1,0.00048941403,0.9991997,0.00031087312
34545,peptide,4,5,54,61,"Immunohistochemistry revealed that latency-associated peptide (LAP) of TGF1 was localized in mainly immune cells in all cases, which was more abundant than in control GCs.",29594353_4,0,-1,2,-1,34545,-1,1.3237864e-05,0.9999753,1.1438228e-05
34561,than those,10,12,68,78,Mature dendritic cells in Ly-rich GCs expressed LAP more frequently than those in the secondary lymphoid organs.,29594353_9,-1,-1,-1,-1,34561,-1,6.267091e-06,0.99998724,6.486207e-06
34565,to Treg cells,12,15,76,89,"Our data revealed abundant expression of TGF1 in immune cells with contact to Treg cells in lymphoid stroma, which is consistent with the notion that TGF1 is one of the immunosuppressive factors in cancer stroma.",29594353_10,-1,-1,-1,-1,34565,-1,0.0019323078,0.058494832,0.9395729
34567,that TGF1,25,27,146,156,"Our data revealed abundant expression of TGF1 in immune cells with contact to Treg cells in lymphoid stroma, which is consistent with the notion that TGF1 is one of the immunosuppressive factors in cancer stroma.",29594353_10,-1,-1,-1,-1,34567,-1,1.1898861e-05,0.9999653,2.2831799e-05
34569,factors,32,33,189,196,"Our data revealed abundant expression of TGF1 in immune cells with contact to Treg cells in lymphoid stroma, which is consistent with the notion that TGF1 is one of the immunosuppressive factors in cancer stroma.",29594353_10,0,1,-1,-1,34569,-1,0.0070492486,0.99287134,7.9436286e-05
34573,The type,0,2,0,8,The type 1 regulatory T (Tr1) cells have recently emerged as a critical participant in maintaining self-tolerance.,29625086_2,-1,-1,-1,-1,34573,-1,3.7474615e-06,0.99999106,5.1910197e-06
34578,Tr1 cells,6,8,27,36,"In this study, we examined Tr1 cells in H. pylori infection and gastric cancer development.",29625086_3,-1,-1,-1,-1,34578,-1,3.4274683e-05,0.00013875992,0.99982697
34581,blood,14,15,95,100,"While H. pylori-uninfected (uninfected) subjects presented low Tr1 frequency in the peripheral blood, H. pylori-infected asymptomatic (infected) individuals and H. pylori-infected gastric cancer (cancer) individuals both presented elevated Tr1 frequency.",29625086_4,0,1,-1,-1,34581,-1,0.0024531307,0.8255018,0.17204507
34583,the Tr1 cells,1,4,9,22,"Although the Tr1 cells from infected asymptomatic subjects were functionally more potent than those from uninfected healthy subjects, the Tr1 cells in cancer individuals demonstrated several functional impairments, such as reduced interleukin 10 (IL-10) expression, lower secretion of cytolytic factors including granzyme B and perforin, and lower capacity to suppress CD4+CD25- T cell and CD8+ T cell proliferation.",29625086_5,-1,-1,-1,-1,34583,-1,0.0017741863,0.30425134,0.6939745
34584,functionally,9,10,64,76,"Although the Tr1 cells from infected asymptomatic subjects were functionally more potent than those from uninfected healthy subjects, the Tr1 cells in cancer individuals demonstrated several functional impairments, such as reduced interleukin 10 (IL-10) expression, lower secretion of cytolytic factors including granzyme B and perforin, and lower capacity to suppress CD4+CD25- T cell and CD8+ T cell proliferation.",29625086_5,0,1,2,-1,34584,-1,2.1499181e-05,0.9999684,1.0036288e-05
34585,than those,12,14,89,99,"Although the Tr1 cells from infected asymptomatic subjects were functionally more potent than those from uninfected healthy subjects, the Tr1 cells in cancer individuals demonstrated several functional impairments, such as reduced interleukin 10 (IL-10) expression, lower secretion of cytolytic factors including granzyme B and perforin, and lower capacity to suppress CD4+CD25- T cell and CD8+ T cell proliferation.",29625086_5,-1,-1,-1,-1,34585,-1,6.6781463e-06,0.9999863,7.050703e-06
34586,the Tr1 cells,19,22,134,147,"Although the Tr1 cells from infected asymptomatic subjects were functionally more potent than those from uninfected healthy subjects, the Tr1 cells in cancer individuals demonstrated several functional impairments, such as reduced interleukin 10 (IL-10) expression, lower secretion of cytolytic factors including granzyme B and perforin, and lower capacity to suppress CD4+CD25- T cell and CD8+ T cell proliferation.",29625086_5,-1,-1,-1,-1,34586,-1,0.0015001151,0.22904201,0.7694579
34587,functional,27,28,191,201,"Although the Tr1 cells from infected asymptomatic subjects were functionally more potent than those from uninfected healthy subjects, the Tr1 cells in cancer individuals demonstrated several functional impairments, such as reduced interleukin 10 (IL-10) expression, lower secretion of cytolytic factors including granzyme B and perforin, and lower capacity to suppress CD4+CD25- T cell and CD8+ T cell proliferation.",29625086_5,0,1,2,-1,34587,-1,0.00017249957,0.99975544,7.210403e-05
34590,factors,44,45,295,302,"Although the Tr1 cells from infected asymptomatic subjects were functionally more potent than those from uninfected healthy subjects, the Tr1 cells in cancer individuals demonstrated several functional impairments, such as reduced interleukin 10 (IL-10) expression, lower secretion of cytolytic factors including granzyme B and perforin, and lower capacity to suppress CD4+CD25- T cell and CD8+ T cell proliferation.",29625086_5,0,1,-1,-1,34590,-1,0.999941,1.6159296e-05,4.2810665e-05
34595,function,6,7,31,39,"In addition, the frequency and function of Tr1 cells were positively correlated with the disease-free survival of the gastric cancer patients.",29625086_6,0,1,2,-1,34595,-1,0.00010927462,0.999785,0.000105740124
34596,Tr1 cells,8,10,43,52,"In addition, the frequency and function of Tr1 cells were positively correlated with the disease-free survival of the gastric cancer patients.",29625086_6,-1,-1,-1,-1,34596,-1,1.3037761e-05,1.8490695e-05,0.9999685
34600,that Tr1 cells,3,6,22,36,These results suggest that Tr1 cells might be involved in the regulating immune responses in H. pylori infection and gastric cancer development.,29625086_7,-1,-1,-1,-1,34600,-1,0.0017540044,0.2893218,0.70892423
34604,that Tr1 cells,2,5,9,23,The fact that Tr1 cells could suppress inflammation and produce cytotoxic molecules at the same time has made them attractive potential candidates for future immunotherapies.,29625086_8,-1,-1,-1,-1,34604,-1,0.0023490156,0.31401446,0.6836365
34607,made them,17,19,105,114,The fact that Tr1 cells could suppress inflammation and produce cytotoxic molecules at the same time has made them attractive potential candidates for future immunotherapies.,29625086_8,-1,-1,-1,-1,34607,-1,1.1046244e-05,0.9999796,9.339105e-06
34612,the tumor-immune,19,21,148,164,"Increasing evidence indicates that Wnt/-catenin signaling, one of the best-characterized cancer drivers, promotes cancer progression by regulating the tumor-immune cycle in most of the nodes, including dendritic cells, T cells, and tumor cells.",29678298_1,-1,-1,-1,-1,34612,-1,0.0013565879,0.9984125,0.00023085339
34616,tumor cells,36,38,233,244,"Increasing evidence indicates that Wnt/-catenin signaling, one of the best-characterized cancer drivers, promotes cancer progression by regulating the tumor-immune cycle in most of the nodes, including dendritic cells, T cells, and tumor cells.",29678298_1,-1,-1,-1,-1,34616,-1,2.219054e-05,2.5847303e-05,0.99995196
34622,that targeting,2,4,11,25,"We propose that targeting Wnt/-catenin signaling would potentially improve clinical outcomes of cancer patients by overcoming the primary, adaptive, and acquired resistance to immunotherapy.",29678298_3,-1,-1,-1,-1,34622,-1,5.145517e-06,0.99999106,3.8533326e-06
34627,tumor cells termed,22,25,132,150,"BACKGROUND: It has been proposed that cancer establishment, maintenance, and recurrence may be attributed to a unique population of tumor cells termed cancer-initiating cells (CICs) that may include characteristics of putative cancer stem cell-like cells.",29699516_0,-1,-1,-1,-1,34627,-1,0.00011024755,0.9989222,0.00096761016
34630,cell-like cells,38,40,239,254,"BACKGROUND: It has been proposed that cancer establishment, maintenance, and recurrence may be attributed to a unique population of tumor cells termed cancer-initiating cells (CICs) that may include characteristics of putative cancer stem cell-like cells.",29699516_0,-1,-1,-1,-1,34630,-1,1.7984426e-05,6.7577057e-06,0.9999752
34633,tumor cells,18,20,103,114,Studies in lung cancer have shown that such cells can be enriched and propagated in vitro by culturing tumor cells in serum-free suspension as tumorspheres.,29699516_1,-1,-1,-1,-1,34633,-1,0.00031635712,0.00576225,0.9939214
34653,TC-1 cells,3,5,9,19,"In vivo, TC-1 cells enriched for CICs were resistant to human papillomavirus 16 E6/E7 peptide vaccine-mediated killing.",29699516_7,-1,-1,-1,-1,34653,-1,0.00023038575,0.009477429,0.99029213
34655,peptide,15,16,86,93,"In vivo, TC-1 cells enriched for CICs were resistant to human papillomavirus 16 E6/E7 peptide vaccine-mediated killing.",29699516_7,0,-1,2,-1,34655,-1,0.083291866,0.9158455,0.00086269714
34664,TC-1 cells,17,19,112,122,"Furthermore, cultured cytotoxic T lymphocytes (CTLs) from vaccinated mice demonstrated reduced capacity to lyse TC-1 cells enriched for CICs compared to non-enriched TC-1 cells.",29699516_9,-1,-1,-1,-1,34664,-1,0.00029335267,0.009034283,0.9906723
34666,TC-1 cells,25,27,166,176,"Furthermore, cultured cytotoxic T lymphocytes (CTLs) from vaccinated mice demonstrated reduced capacity to lyse TC-1 cells enriched for CICs compared to non-enriched TC-1 cells.",29699516_9,-1,-1,-1,-1,34666,-1,0.00019718711,0.004102948,0.9956999
34669,TC-1 cells,10,12,67,77,"Following treatment with IFN-, both CIC enriched and non-enriched TC-1 cells expressed similar levels of MHC-I, and the increased MHC-I expression on CICs resulted in greater CTL-mediated tumor lysis and improved tumor-free survival in mice.",29699516_10,-1,-1,-1,-1,34669,-1,2.3169454e-05,4.1530973e-05,0.9999354
34671,CTL-mediated tumor,28,30,176,194,"Following treatment with IFN-, both CIC enriched and non-enriched TC-1 cells expressed similar levels of MHC-I, and the increased MHC-I expression on CICs resulted in greater CTL-mediated tumor lysis and improved tumor-free survival in mice.",29699516_10,-1,-1,-1,-1,34671,-1,0.0009986219,0.0053093475,0.99369204
34674,that the,5,7,35,43,"CONCLUSIONS: These results suggest that the attenuated expression of MHC-I molecules by CICs represents a potential strategy of CICs to escape immune recognition, and that the development of successful immunotherapy strategies targeting CICs may decrease their resistance to T cell-mediated immune detection by enhancing CIC MHC-I expression.",29699516_11,-1,-1,-1,-1,34674,-1,4.264275e-06,0.99999225,3.4894067e-06
34676,that the,26,28,167,175,"CONCLUSIONS: These results suggest that the attenuated expression of MHC-I molecules by CICs represents a potential strategy of CICs to escape immune recognition, and that the development of successful immunotherapy strategies targeting CICs may decrease their resistance to T cell-mediated immune detection by enhancing CIC MHC-I expression.",29699516_11,-1,-1,-1,-1,34676,-1,4.3918726e-06,0.9999919,3.7361099e-06
34679,to T cell-mediated,39,42,272,290,"CONCLUSIONS: These results suggest that the attenuated expression of MHC-I molecules by CICs represents a potential strategy of CICs to escape immune recognition, and that the development of successful immunotherapy strategies targeting CICs may decrease their resistance to T cell-mediated immune detection by enhancing CIC MHC-I expression.",29699516_11,-1,-1,-1,-1,34679,-1,0.0018316963,0.10166096,0.8965074
34684,receptors,16,17,90,99,"Tyrosine kinase inhibitors (TKIs) target angiogenesis by affecting, for example, the VEGF receptors in tumors and have improved outcomes for patients with metastatic renal cell carcinoma (mRCC).",29700053_0,0,1,2,-1,34684,-1,0.00090442685,0.0052442993,0.9938512
34697,the TKI,9,11,48,55,"In this study, we investigated the influence of the TKI pazopanib on dendritic cell (DC) performance and immune priming.",29700053_3,-1,-1,-1,-1,34697,-1,1.2980042e-05,0.99996805,1.8955174e-05
34708,T-cell,11,12,69,75,In treated patients pazopanib appeared to enhance a circulating CD4+ T-cell population that expresses CD137 (4-1BB).,29700053_8,-1,1,2,-1,34708,-1,1.157177e-05,6.1853807e-06,0.99998224
34728,Treg-like cells,21,23,101,116,"At an early stage of tumor development, we have identified a subset of FOXP3- CD8+ CD25+ KIR+ CD127- Treg-like cells, which are IFN+ .",29768737_2,-1,-1,-1,-1,34728,-1,0.0014093214,0.27273965,0.725851
34732,the IFN+,15,17,87,96,"However, this early-induced CD8+ CD25+ CD127- T-cell subset is certainly distinct from the IFN+ CD8+ T-effector cells.",29768737_3,-1,-1,-1,-1,34732,-1,0.5374866,0.45882013,0.0036933355
34733,T-effector cells,19,21,102,118,"However, this early-induced CD8+ CD25+ CD127- T-cell subset is certainly distinct from the IFN+ CD8+ T-effector cells.",29768737_3,-1,-1,-1,-1,34733,-1,0.00054837513,0.04282435,0.95662725
34738,TFH cells,24,26,136,145,"These CD8+ CD25+ CD127- T cells express other FOXP3- CD8+ Treg cell signature markers, and can selectively suppress autoreactive HLA-E+ TFH cells as well as tumor-induced CD4+ Treg cells.",29768737_4,-1,-1,-1,-1,34738,-1,0.0011513901,0.094429694,0.90441895
34741,to FOXP3,2,4,12,20,"In contrast to FOXP3+ CD8+ Tregs, this subset does not inhibit effector T-cell proliferation or their functions as they are HLA-E- .",29768737_5,-1,-1,-1,-1,34741,-1,5.829042e-06,0.9999888,5.429965e-06
34743,this subset,9,11,34,45,"In contrast to FOXP3+ CD8+ Tregs, this subset does not inhibit effector T-cell proliferation or their functions as they are HLA-E- .",29768737_5,-1,-1,-1,-1,34743,-1,0.0017249763,0.33539182,0.6628832
34745,their functions,18,20,96,111,"In contrast to FOXP3+ CD8+ Tregs, this subset does not inhibit effector T-cell proliferation or their functions as they are HLA-E- .",29768737_5,-1,-1,-1,-1,34745,-1,2.618745e-05,0.99993205,4.1723535e-05
34749,Treg-like subset,6,8,37,53,Adoptive transfer of this early-CD8+ Treg-like subset restrained tumor growth and inhibited CD4+ Treg generation that impedes the immune surveillance and impairs cancer immunotherapy.,29768737_6,-1,-1,-1,-1,34749,-1,0.0014061972,0.8095634,0.18903038
34751,Treg generation that,15,18,97,117,Adoptive transfer of this early-CD8+ Treg-like subset restrained tumor growth and inhibited CD4+ Treg generation that impedes the immune surveillance and impairs cancer immunotherapy.,29768737_6,-1,-1,-1,-1,34751,-1,4.7418325e-06,0.9999883,6.8954973e-06
34756,the tumor-microenvironment,14,16,70,96,"At the late stage of tumor development, when CD4+ Treg cells dominate the tumor-microenvironment, CD4+ Tregs mediate the clonal deletion of these tumor-suppressive FOXP3- IFN+ CD8+ CD25+ CD127- T cells and ensure tumor immune evasion.",29768737_7,-1,-1,-1,-1,34756,-1,0.00011726883,0.999796,8.681996e-05
34759,these tumor-suppressive FOXP3- IFN+,25,29,140,176,"At the late stage of tumor development, when CD4+ Treg cells dominate the tumor-microenvironment, CD4+ Tregs mediate the clonal deletion of these tumor-suppressive FOXP3- IFN+ CD8+ CD25+ CD127- T cells and ensure tumor immune evasion.",29768737_7,-1,-1,-1,-1,34759,-1,0.0053921966,0.99414945,0.00045842567
34763,the tumor,9,11,47,56,"Our findings suggest that at an early stage of the tumor, this tumor-induced IFN-producing FOXP3- CD8+ CD25+ CD127- T-cell subset can potentiate immune surveillance by targeting HLA-E-restricted CD4+ Treg cells while leaving the effector T-cell population unaffected.",29768737_8,-1,-1,-1,-1,34763,-1,3.8915236e-06,0.9999914,4.733408e-06
34764,this tumor-induced IFN-producing FOXP3-,12,16,58,98,"Our findings suggest that at an early stage of the tumor, this tumor-induced IFN-producing FOXP3- CD8+ CD25+ CD127- T-cell subset can potentiate immune surveillance by targeting HLA-E-restricted CD4+ Treg cells while leaving the effector T-cell population unaffected.",29768737_8,-1,-1,-1,-1,34764,-1,9.0860405e-05,0.9998803,2.8761886e-05
34769,T-cell,38,39,239,245,"Our findings suggest that at an early stage of the tumor, this tumor-induced IFN-producing FOXP3- CD8+ CD25+ CD127- T-cell subset can potentiate immune surveillance by targeting HLA-E-restricted CD4+ Treg cells while leaving the effector T-cell population unaffected.",29768737_8,-1,1,2,-1,34769,-1,9.524963e-06,7.047664e-06,0.99998343
34777,the regulation,9,11,37,51,AIMS: To evaluate the roles of PE in the regulation of anti-tumor effects and the cellular immune response in the tumor microenvironment.,29783020_1,-1,-1,-1,-1,34777,-1,3.854456e-06,0.99999166,4.524531e-06
34778,the cellular immune response,15,19,78,106,AIMS: To evaluate the roles of PE in the regulation of anti-tumor effects and the cellular immune response in the tumor microenvironment.,29783020_1,-1,-1,-1,-1,34778,-1,0.8283737,0.1451202,0.026506178
34779,the tumor,20,22,110,119,AIMS: To evaluate the roles of PE in the regulation of anti-tumor effects and the cellular immune response in the tumor microenvironment.,29783020_1,-1,-1,-1,-1,34779,-1,4.3023565e-06,0.9999908,4.93357e-06
34785,the cell,23,25,147,155,RESULTS: Our study demonstrated that PE in vitro could significantly increase the percentage of apoptosis and necrosis in HPV+TC-1 cells and block the cell cycle phase.,29783020_3,-1,-1,-1,-1,34785,-1,0.0030441687,0.4608502,0.53610563
34793,factors,2,3,8,15,"The key factors in the canonical Wnt signaling pathway in the experimental group (PE+mDC+naive CD4+T cells) were challenged, and the levels of beta-catenin, C-myc, cyclin D1 and PPAR1 were significantly enhanced at the 5th day.",29783020_5,0,1,-1,-1,34793,-1,5.1298184e-06,0.9999901,4.7351355e-06
34801,the subset,3,5,15,25,"In particular, the subset proportion of Th1 cells (characterized by IFN production and the transcription factor Tbet) increased significantly, and both Th2 cells (characterized by IL-4 production and the transcription factor GATA3) and Th17 cells (characterized by IL-17 production and the transcription factor RoRt) decreased profoundly.",29783020_6,-1,-1,-1,-1,34801,-1,0.0017311395,0.51296866,0.48530018
34804,the transcription factor Tbet,15,19,88,117,"In particular, the subset proportion of Th1 cells (characterized by IFN production and the transcription factor Tbet) increased significantly, and both Th2 cells (characterized by IL-4 production and the transcription factor GATA3) and Th17 cells (characterized by IL-17 production and the transcription factor RoRt) decreased profoundly.",29783020_6,-1,-1,-1,-1,34804,-1,4.594299e-06,0.9999893,6.1789215e-06
34806,the transcription factor GATA3,33,37,201,231,"In particular, the subset proportion of Th1 cells (characterized by IFN production and the transcription factor Tbet) increased significantly, and both Th2 cells (characterized by IL-4 production and the transcription factor GATA3) and Th17 cells (characterized by IL-17 production and the transcription factor RoRt) decreased profoundly.",29783020_6,-1,-1,-1,-1,34806,-1,6.059105e-06,0.99998665,7.3043348e-06
34807,Th17 cells,39,41,237,247,"In particular, the subset proportion of Th1 cells (characterized by IFN production and the transcription factor Tbet) increased significantly, and both Th2 cells (characterized by IL-4 production and the transcription factor GATA3) and Th17 cells (characterized by IL-17 production and the transcription factor RoRt) decreased profoundly.",29783020_6,-1,-1,-1,-1,34807,-1,2.0356143e-05,8.7328495e-05,0.99989223
34809,the transcription factor,47,50,287,311,"In particular, the subset proportion of Th1 cells (characterized by IFN production and the transcription factor Tbet) increased significantly, and both Th2 cells (characterized by IL-4 production and the transcription factor GATA3) and Th17 cells (characterized by IL-17 production and the transcription factor RoRt) decreased profoundly.",29783020_6,-1,-1,-1,-1,34809,-1,4.2915703e-06,0.9999908,4.9085133e-06
34829,analysis,26,27,141,149,HCC cell lines HCCLM3 and Hepa1-6 were used to evaluate the efficacy of FM targeting NF-B and STAT3 signaling with western blot and qRT-PCR analysis.,29784005_5,0,1,-1,-1,34829,-1,4.744503e-06,0.99998856,6.6619405e-06
34831,blood,7,8,52,57,CD8+NKG2D+ cells were derived from human peripheral blood and were used for evaluation of immune cells-mediated inflammation and oncolysis on HCCLM3 cells.,29784005_6,0,1,-1,-1,34831,-1,0.00020800658,0.99911994,0.0006720064
34843,TNF-,19,20,115,120,RESULTS: FM significantly inhibited the activation of NF-B and STAT3 signaling in HCC cells induced by cytokines (TNF- or IL-6) and in co-culture system with CD8+NKG2D+ cells.,29784005_11,0,1,-1,-1,34843,-1,0.00053954846,0.99939644,6.402178e-05
34846,cells to,5,7,31,39,"Furthermore, FM sensitized HCC cells to CD8+NKG2D+ cells-mediated oncolysis.",29784005_12,-1,-1,-1,-1,34846,-1,0.002825967,0.22694615,0.77022785
34851,life,27,28,164,168,"In HCC-bearing mice, FM at a non-toxic dose failed to reduce tumor growth in immune compromised mice, whereas it significantly inhibited tumor growth and prolonged life span in immune competent mice.",29784005_13,0,-1,2,-1,34851,-1,1.9906292e-05,0.9999634,1.6682765e-05
34853,IFN--producing cells,4,6,20,41,"While the number of IFN--producing cells within TME was increased in mice treated with FM, the infiltration of CD8+ T cells and NK cells was not increased.",29784005_14,-1,-1,-1,-1,34853,-1,0.9713903,0.0001208902,0.02848879
34865,time that,28,30,158,167,"Finally, we identified that depletion of CD8+ T cells rather than NK cells abrogated the antitumor activity of FM.CONCLUSIONS: Our results show for the first time that CD8+ T cells mediate the antitumor activity of FM at a non-toxic dose.",29784005_15,-1,-1,-1,-1,34865,-1,4.7164335e-06,0.9999906,4.689559e-06
34869,to this,5,7,30,37,"This may provide new insights to this ancient mysterious prescription in cancer therapy, which offers a novel and practical therapeutic strategy and the possibilities of combined immunotherapy for HCC as well as other inflammation-related cancers in clinic.",29784005_16,-1,-1,-1,-1,34869,-1,4.9550326e-06,0.99998975,5.2782634e-06
34870,therapy,12,13,80,87,"This may provide new insights to this ancient mysterious prescription in cancer therapy, which offers a novel and practical therapeutic strategy and the possibilities of combined immunotherapy for HCC as well as other inflammation-related cancers in clinic.",29784005_16,0,1,-1,-1,34870,-1,4.837592e-06,0.99998975,5.3816084e-06
34880,the relationship,9,11,50,66,"Thus, we investigated the prevalence of Tregs and the relationship between them and TGF- and IL-10 concentrations and measured expression of FOXP3, CTLA-4, CD28, and GITR genes, as well as protein expression of selected genes in benign effusions and MPEs.",29785404_2,-1,-1,-1,-1,34880,-1,6.2838153e-06,0.9999887,4.998174e-06
34888,protein,35,36,190,197,"Thus, we investigated the prevalence of Tregs and the relationship between them and TGF- and IL-10 concentrations and measured expression of FOXP3, CTLA-4, CD28, and GITR genes, as well as protein expression of selected genes in benign effusions and MPEs.",29785404_2,0,1,-1,-1,34888,-1,8.20107e-06,0.99998724,4.577338e-06
34908,the genes,5,7,32,41,Relative mRNA expression of all the genes was higher in CD4+CD25+ compared to CD4+CD25- cells.,29785404_7,-1,-1,-1,-1,34908,-1,6.2380227e-06,0.99998736,6.3461994e-06
34915,CD28 genes,16,18,77,87,"In CD4+CD25+ cells from MPEs, relative mRNA expression of FOXP3, CTLA-4, and CD28 genes was significantly higher than in benign effusions; however, the level of CD4+CD25+CTLA-4+ cells in analyzed groups showed no significant differences.",29785404_8,-1,-1,-1,-1,34915,-1,0.002887272,0.021861574,0.97525114
34920,cell subset,10,12,60,71,We found numerous genes correlations in an entire CD4+CD25+ cell subset and CD4+CD25+ cells from MPEs.,29785404_9,-1,-1,-1,-1,34920,-1,1.4089748e-05,8.912739e-06,0.999977
34927,factors,8,9,75,82,Understanding of relations between cellular and cytokine immunosuppressive factors in tumor microenvironment may determine success of anticancer response.,29785404_11,0,1,-1,-1,34927,-1,0.043052368,0.9567691,0.00017852259
34937,blood,11,12,63,68,The number of Tregs is increased in tumor sites and peripheral blood of breast cancer patients.,29797233_1,0,1,-1,-1,34937,-1,0.0024924562,0.7236151,0.2738924
34939,functional,7,8,43,53,"However, the data regarding phenotypic and functional heterogeneity of Treg subpopulations in breast cancer are limited.",29797233_2,0,1,2,-1,34939,-1,0.0011256356,0.99877554,9.8806995e-05
34944,Tregs that,12,14,79,89,"The present study aimed to investigate the number and suppressive potential of Tregs that possess natural nave-(N nTregs), effector/memory-like (EM nTregs), and Tr1-like phenotypes in breast cancer patients and healthy women.",29797233_3,-1,-1,-1,-1,34944,-1,3.5490564e-06,0.99999166,4.7580565e-06
34948,Tr1 subsets,13,15,98,109,"Numbers of CD4+CD25+FoxP3+CD45RA+ N nTregs, CD4+CD25+FoxP3+CD45RA- EM nTregs, and CD4+IL-4-IL-10+ Tr1 subsets and the expression of CTLA-4, CD39, GITR, LAP, and IL-35 by these Treg subsets were measured in freshly obtained peripheral blood by flow cytometry.",29797233_5,-1,-1,-1,-1,34948,-1,0.0014795988,0.4294534,0.56906694
34951,these Treg subsets,30,33,170,188,"Numbers of CD4+CD25+FoxP3+CD45RA+ N nTregs, CD4+CD25+FoxP3+CD45RA- EM nTregs, and CD4+IL-4-IL-10+ Tr1 subsets and the expression of CTLA-4, CD39, GITR, LAP, and IL-35 by these Treg subsets were measured in freshly obtained peripheral blood by flow cytometry.",29797233_5,-1,-1,-1,-1,34951,-1,0.0020505942,0.8161268,0.18182254
34952,blood,39,40,234,239,"Numbers of CD4+CD25+FoxP3+CD45RA+ N nTregs, CD4+CD25+FoxP3+CD45RA- EM nTregs, and CD4+IL-4-IL-10+ Tr1 subsets and the expression of CTLA-4, CD39, GITR, LAP, and IL-35 by these Treg subsets were measured in freshly obtained peripheral blood by flow cytometry.",29797233_5,0,1,-1,-1,34952,-1,0.004358358,0.055901106,0.93974054
34953,that the,6,8,32,40,"RESULTS: Herein, we demonstrate that the percentages of N nTregs, EM nTregs, CD25+ and FoxP3+ Tr1 cells are elevated in the peripheral blood of breast cancer patients, but do not correlate with cancer stages.",29797233_6,-1,-1,-1,-1,34953,-1,3.909351e-06,0.99999213,3.9905644e-06
34955,Tr1 cells,21,23,94,103,"RESULTS: Herein, we demonstrate that the percentages of N nTregs, EM nTregs, CD25+ and FoxP3+ Tr1 cells are elevated in the peripheral blood of breast cancer patients, but do not correlate with cancer stages.",29797233_6,-1,-1,-1,-1,34955,-1,0.00063254667,0.031648546,0.96771896
34957,blood,28,29,135,140,"RESULTS: Herein, we demonstrate that the percentages of N nTregs, EM nTregs, CD25+ and FoxP3+ Tr1 cells are elevated in the peripheral blood of breast cancer patients, but do not correlate with cancer stages.",29797233_6,0,1,-1,-1,34957,-1,0.00031292916,0.9984682,0.0012187833
34959,Tr1 cells,7,9,37,46,"Nevertheless, the frequency of CD25+ Tr1 cells was associated with nodal involvement, while the number of EM nTregs correlated with clinical outcome.",29797233_7,-1,-1,-1,-1,34959,-1,2.6451431e-05,4.513856e-05,0.99992836
34964,Treg subsets,9,11,51,63,"The expression of CTLA-4 and IL-35 by all assessed Treg subsets was increased throughout all tumor stages (I-III).CONCLUSIONS: Collectively, the current study shows phenotypic alterations in suppressive receptors of Treg subsets, suggesting that breast cancer patients have increased activity of N nTregs, EM nTregs and Tr1 cells; and EM nTregs and CD25+ Tr1 cells represent prospective markers for assessing disease prognosis.",29797233_8,-1,-1,-1,-1,34964,-1,0.00062760507,0.06663731,0.9327352
34968,receptors,29,30,203,212,"The expression of CTLA-4 and IL-35 by all assessed Treg subsets was increased throughout all tumor stages (I-III).CONCLUSIONS: Collectively, the current study shows phenotypic alterations in suppressive receptors of Treg subsets, suggesting that breast cancer patients have increased activity of N nTregs, EM nTregs and Tr1 cells; and EM nTregs and CD25+ Tr1 cells represent prospective markers for assessing disease prognosis.",29797233_8,0,1,2,-1,34968,-1,0.0011031597,0.7886567,0.2102401
34969,Treg subsets,31,33,216,228,"The expression of CTLA-4 and IL-35 by all assessed Treg subsets was increased throughout all tumor stages (I-III).CONCLUSIONS: Collectively, the current study shows phenotypic alterations in suppressive receptors of Treg subsets, suggesting that breast cancer patients have increased activity of N nTregs, EM nTregs and Tr1 cells; and EM nTregs and CD25+ Tr1 cells represent prospective markers for assessing disease prognosis.",29797233_8,-1,-1,-1,-1,34969,-1,0.00069415267,0.0896154,0.9096905
34971,Tr1 cells,49,51,320,329,"The expression of CTLA-4 and IL-35 by all assessed Treg subsets was increased throughout all tumor stages (I-III).CONCLUSIONS: Collectively, the current study shows phenotypic alterations in suppressive receptors of Treg subsets, suggesting that breast cancer patients have increased activity of N nTregs, EM nTregs and Tr1 cells; and EM nTregs and CD25+ Tr1 cells represent prospective markers for assessing disease prognosis.",29797233_8,-1,-1,-1,-1,34971,-1,1.8290775e-05,2.5432935e-05,0.99995637
34972,Tr1 cells,58,60,355,364,"The expression of CTLA-4 and IL-35 by all assessed Treg subsets was increased throughout all tumor stages (I-III).CONCLUSIONS: Collectively, the current study shows phenotypic alterations in suppressive receptors of Treg subsets, suggesting that breast cancer patients have increased activity of N nTregs, EM nTregs and Tr1 cells; and EM nTregs and CD25+ Tr1 cells represent prospective markers for assessing disease prognosis.",29797233_8,-1,-1,-1,-1,34972,-1,8.1666774e-05,0.00064529263,0.999273
34981,Toll-like receptor-3,10,12,71,91,"Immune adjuvants, including double-stranded (ds)RNAs, which signal via Toll-like receptor-3 (TLR3) and helicase (RIG-I/MDA5) pathways, all induce intratumoral production of CTL-attractants, but also Treg attractants and suppressive factors, raising the question of whether induction of these opposing groups of immune mediators can be separated.",29853604_1,-1,-1,-1,-1,34981,-1,0.00058099686,0.99731857,0.0021004311
34985,factors,35,36,232,239,"Immune adjuvants, including double-stranded (ds)RNAs, which signal via Toll-like receptor-3 (TLR3) and helicase (RIG-I/MDA5) pathways, all induce intratumoral production of CTL-attractants, but also Treg attractants and suppressive factors, raising the question of whether induction of these opposing groups of immune mediators can be separated.",29853604_1,0,1,-1,-1,34985,-1,1.0629588e-05,0.99998283,6.5382474e-06
34992,that the,14,16,74,82,"Here, we use human tumor explant cultures and cell culture models to show that the (ds) RNA Sendai Virus (SeV), poly-I:C, and rintatolimod (poly-I:C12U) all activate the TLR3 pathway involving TRAF3 and IRF3, and induce IFN, ISG-60, and CXCL10 to promote CTL chemotaxis to ex vivo-treated tumors.",29853604_2,-1,-1,-1,-1,34992,-1,3.9888655e-06,0.99999166,4.36835e-06
34993,the TLR3,39,41,166,174,"Here, we use human tumor explant cultures and cell culture models to show that the (ds) RNA Sendai Virus (SeV), poly-I:C, and rintatolimod (poly-I:C12U) all activate the TLR3 pathway involving TRAF3 and IRF3, and induce IFN, ISG-60, and CXCL10 to promote CTL chemotaxis to ex vivo-treated tumors.",29853604_2,-1,-1,-1,-1,34993,-1,6.9451285e-06,0.9999856,7.478022e-06
34997,CXCL10 to,54,56,238,247,"Here, we use human tumor explant cultures and cell culture models to show that the (ds) RNA Sendai Virus (SeV), poly-I:C, and rintatolimod (poly-I:C12U) all activate the TLR3 pathway involving TRAF3 and IRF3, and induce IFN, ISG-60, and CXCL10 to promote CTL chemotaxis to ex vivo-treated tumors.",29853604_2,-1,-1,-1,-1,34997,-1,0.9933948,0.0052331206,0.0013721187
34998,CTL chemotaxis to,57,60,256,273,"Here, we use human tumor explant cultures and cell culture models to show that the (ds) RNA Sendai Virus (SeV), poly-I:C, and rintatolimod (poly-I:C12U) all activate the TLR3 pathway involving TRAF3 and IRF3, and induce IFN, ISG-60, and CXCL10 to promote CTL chemotaxis to ex vivo-treated tumors.",29853604_2,-1,-1,-1,-1,34998,-1,0.036938284,0.023192737,0.939869
35002,TNF-dependent,24,25,125,139,"However, in contrast with SeV and poly I:C, rintatolimod did not activate the MAVS/helicase pathway, thus avoiding NFB- and TNF-dependent induction of COX2, COX2/PGE2-dependent induction of IDO, IL10, CCL22, and CXCL12, and eliminating Treg attraction.",29853604_3,0,1,-1,-1,35002,-1,1.8958117e-05,0.9999678,1.3242828e-05
35018,type-1 immunity,35,37,250,265,Our data identify the helicase/NFB/TNF/COX2 axis as the key suppressive pathway of dsRNA signaling in human TME and suggest that selective targeting of TLR3 or elimination of NFB/TNF/COX2-driven suppression may allow for selective enhancement of type-1 immunity.,29853604_5,-1,-1,-1,-1,35018,-1,0.006401624,0.99268097,0.00091734057
35022,factors,19,20,145,152,Significance: This study characterizes two different poly-I:C-induced signaling pathways in their induction of immunostimulatory and suppressive factors and suggests improved ways to reprogram the TME to enhance the antitumor efficacy of immunotherapies.,29853604_6,0,1,-1,-1,35022,-1,2.0986728e-05,0.9999709,8.12736e-06
35024,the TME to,26,29,193,203,Significance: This study characterizes two different poly-I:C-induced signaling pathways in their induction of immunostimulatory and suppressive factors and suggests improved ways to reprogram the TME to enhance the antitumor efficacy of immunotherapies.,29853604_6,-1,-1,-1,-1,35024,-1,4.6858636e-06,0.99999,5.3121294e-06
35031,cellular therapy,29,31,159,175,"Memory stem T (TSCM) cells, a new subset of memory T cells with self-renewal and multipotent capacities, are considered as a promising candidates for adoptive cellular therapy.",29864078_0,-1,-1,-1,-1,35031,-1,0.002263967,0.09007757,0.9076584
35033,TSCM cells,7,9,37,47,"However, the low proportion of human TSCM cells in total CD8 T cells limits their utility.",29864078_1,-1,-1,-1,-1,35033,-1,0.001614329,0.13014214,0.8682436
35038,TSCM cells,8,10,35,45,"Here, we aimed to induce human CD8 TSCM cells by stimulating naive precursors with interleukin-21 (IL-21).",29864078_2,-1,-1,-1,-1,35038,-1,0.00040505125,0.016541677,0.98305327
35039,naive precursors,12,14,61,77,"Here, we aimed to induce human CD8 TSCM cells by stimulating naive precursors with interleukin-21 (IL-21).",29864078_2,-1,-1,-1,-1,35039,-1,0.008525016,0.39046985,0.6010051
35042,the generation,5,7,29,43,"We found that IL-21 promoted the generation of TSCM cells, described as CD45RACD45ROCD62LCCR7CD122CD95 cells, with a higher efficiency than that observed with other common -chain cytokines.",29864078_3,-1,-1,-1,-1,35042,-1,6.951146e-06,0.9999877,5.377129e-06
35043,TSCM cells,8,10,47,57,"We found that IL-21 promoted the generation of TSCM cells, described as CD45RACD45ROCD62LCCR7CD122CD95 cells, with a higher efficiency than that observed with other common -chain cytokines.",29864078_3,-1,-1,-1,-1,35043,-1,0.0010398123,0.08133552,0.91762465
35045,than that,20,22,135,144,"We found that IL-21 promoted the generation of TSCM cells, described as CD45RACD45ROCD62LCCR7CD122CD95 cells, with a higher efficiency than that observed with other common -chain cytokines.",29864078_3,-1,-1,-1,-1,35045,-1,6.619313e-06,0.99998856,4.7683943e-06
35048,these lymphocytes,10,12,58,75,"Upon adoptive transfer into an A375 melanoma mouse model, these lymphocytes mediated much stronger antitumor responses.",29864078_4,-1,-1,-1,-1,35048,-1,9.5692456e-05,0.00021849977,0.9996859
35049,analysis,2,3,20,28,"Further mechanistic analysis revealed that IL-21 activated the Janus kinase signal transducer and activator of transcription 3 pathway by upregulating signal transducer and activator of transcription 3 phosphorylation and consequently promoting the expression of T-bet and suppressor of cytokine signaling 1, but decreasing the expression of eomesodermin and GATA binding protein 3.",29864078_5,0,1,-1,-1,35049,-1,6.5711465e-06,0.99998856,4.9129935e-06
35059,the generation,6,8,41,55,Our findings provide novel insights into the generation of human CD8 TSCM cells and reveal a novel potential clinical application of IL-21.,29864078_6,-1,-1,-1,-1,35059,-1,4.496551e-06,0.99999106,4.475681e-06
35060,TSCM cells,11,13,69,79,Our findings provide novel insights into the generation of human CD8 TSCM cells and reveal a novel potential clinical application of IL-21.,29864078_6,-1,-1,-1,-1,35060,-1,0.00043891688,0.020756908,0.9788042
35066,the chemotherapy,26,28,177,193,"Hypoxia is reported to participate in tumor progression, promote drug resistance, and immune escape within tumor microenvironment, and thus impair therapeutic effects including the chemotherapy and advanced immunotherapy.",29882235_0,-1,-1,-1,-1,35066,-1,0.49744812,0.49604455,0.00650732
35070,functionalities,8,9,60,75,"Based on the properties including good biodegradability and functionalities, the pH-sensitive zeolitic imidazolate framework 8 embedded with catalase and doxorubicin constructs the core and serves as an oxygen generator and drug reservoir.",29882235_2,0,1,2,-1,35070,-1,7.2554326e-06,0.999984,8.663433e-06
35076,tumor targeting,9,11,59,74,Murine melanoma cell membrane coating on the core provides tumor targeting ability and elicits an immune response due to abundance of antigens.,29882235_3,-1,-1,-1,-1,35076,-1,5.5683427e-06,0.99998987,4.563276e-06
35080,that this,3,5,19,28,"It is demonstrated that this biomimetic core-shell nanoplatform with oxygen generation can be partial to accumulate in tumor and downregulate the expression of hypoxia-inducible factor 1, which can further enhance the therapeutic effects of chemotherapy and reduce the expression of programmed death ligand 1 (PD-L1).",29882235_4,-1,-1,-1,-1,35080,-1,3.822864e-06,0.9999919,4.2318356e-06
35087,the therapeutic,31,33,215,230,"It is demonstrated that this biomimetic core-shell nanoplatform with oxygen generation can be partial to accumulate in tumor and downregulate the expression of hypoxia-inducible factor 1, which can further enhance the therapeutic effects of chemotherapy and reduce the expression of programmed death ligand 1 (PD-L1).",29882235_4,-1,-1,-1,-1,35087,-1,5.731688e-06,0.99999,4.2705124e-06
35090,therapy,5,6,42,49,"Combined with immune checkpoints blockade therapy by programmed death 1 (PD-1) antibody, the dual inhibition of the PD-1/PD-L1 axis elicits significant immune response and presents a robust effect in lengthening tumor recurrent time and inhibiting tumor metastasis.",29882235_5,0,1,-1,-1,35090,-1,5.275395e-06,0.99998975,4.9764003e-06
35103,tumor tissues,18,20,98,111,"Regulatory Tcells (Tregs) are critical for maintaining immune homeostasis, but their presence in tumor tissues impairs anti-tumor immunity and portends poor prognoses in cancer patients.",29898397_0,-1,-1,-1,-1,35103,-1,3.4489305e-05,0.9996549,0.00031059238
35104,immunity,22,23,131,139,"Regulatory Tcells (Tregs) are critical for maintaining immune homeostasis, but their presence in tumor tissues impairs anti-tumor immunity and portends poor prognoses in cancer patients.",29898397_0,0,-1,2,-1,35104,-1,0.9997646,0.00010014583,0.00013527315
35107,the function,11,13,64,76,"Here, we reveal a mechanism to selectively target and reprogram the function of tumor-infiltrating Tregs (TI-Tregs) by exploiting their dependency on the histone H3K27 methyltransferase enhancer of zeste homolog 2 (EZH2) in tumors.",29898397_1,-1,-1,-1,-1,35107,-1,8.773257e-06,0.9999839,7.270227e-06
35108,tumor-infiltrating Tregs,14,16,80,104,"Here, we reveal a mechanism to selectively target and reprogram the function of tumor-infiltrating Tregs (TI-Tregs) by exploiting their dependency on the histone H3K27 methyltransferase enhancer of zeste homolog 2 (EZH2) in tumors.",29898397_1,-1,-1,-1,-1,35108,-1,7.812239e-06,0.99998486,7.353583e-06
35116,functions,17,18,121,130,"Disruption of EZH2 activity in Tregs, either pharmacologically or genetically, drove the acquisition of pro-inflammatory functions in TI-Tregs,remodeling the tumor microenvironment and enhancing the recruitment and function of CD8+ and CD4+ effector Tcells that eliminate tumors.",29898397_2,0,1,2,-1,35116,-1,0.00081617245,0.9984693,0.00071447744
35118,the tumor,23,25,155,164,"Disruption of EZH2 activity in Tregs, either pharmacologically or genetically, drove the acquisition of pro-inflammatory functions in TI-Tregs,remodeling the tumor microenvironment and enhancing the recruitment and function of CD8+ and CD4+ effector Tcells that eliminate tumors.",29898397_2,-1,-1,-1,-1,35118,-1,4.342061e-06,0.9999912,4.436221e-06
35120,function,31,32,216,224,"Disruption of EZH2 activity in Tregs, either pharmacologically or genetically, drove the acquisition of pro-inflammatory functions in TI-Tregs,remodeling the tumor microenvironment and enhancing the recruitment and function of CD8+ and CD4+ effector Tcells that eliminate tumors.",29898397_2,0,1,2,-1,35120,-1,3.7725993e-05,0.9999088,5.3511918e-05
35121,Tcells that,39,43,251,263,"Disruption of EZH2 activity in Tregs, either pharmacologically or genetically, drove the acquisition of pro-inflammatory functions in TI-Tregs,remodeling the tumor microenvironment and enhancing the recruitment and function of CD8+ and CD4+ effector Tcells that eliminate tumors.",29898397_2,-1,-1,-1,-1,35121,-1,0.0010632708,0.031536516,0.96740025
35123,function,4,5,26,34,"Moreover, abolishing EZH2 function in Tregs was mechanistically distinct from, more potent than, and less toxic than a generalized Treg depletion approach.",29898397_3,0,1,2,-1,35123,-1,9.522199e-06,0.99998105,9.386111e-06
35126,toxic than,18,20,106,116,"Moreover, abolishing EZH2 function in Tregs was mechanistically distinct from, more potent than, and less toxic than a generalized Treg depletion approach.",29898397_3,-1,-1,-1,-1,35126,-1,1.3667146e-05,0.9999752,1.118711e-05
35127,generalized Treg,21,23,119,135,"Moreover, abolishing EZH2 function in Tregs was mechanistically distinct from, more potent than, and less toxic than a generalized Treg depletion approach.",29898397_3,-1,-1,-1,-1,35127,-1,1.1764599e-05,0.9999796,8.647216e-06
35129,to target Tregs,5,8,30,45,This study reveals a strategy to target Tregs in cancer that mitigates autoimmunity by reprogramming their function in tumors to enhance anti-cancer immunity.,29898397_4,-1,-1,-1,-1,35129,-1,5.250928e-06,0.99999106,3.7251843e-06
35131,their function,15,17,101,115,This study reveals a strategy to target Tregs in cancer that mitigates autoimmunity by reprogramming their function in tumors to enhance anti-cancer immunity.,29898397_4,-1,-1,-1,-1,35131,-1,1.8999855e-05,0.99996305,1.793105e-05
35132,tumors to,18,20,119,128,This study reveals a strategy to target Tregs in cancer that mitigates autoimmunity by reprogramming their function in tumors to enhance anti-cancer immunity.,29898397_4,-1,-1,-1,-1,35132,-1,3.8747676e-06,0.9999927,3.416817e-06
35133,immunity,22,23,149,157,This study reveals a strategy to target Tregs in cancer that mitigates autoimmunity by reprogramming their function in tumors to enhance anti-cancer immunity.,29898397_4,0,-1,2,-1,35133,-1,0.9998228,6.607479e-05,0.00011119511
35135,receptors,4,5,32,41,"The expression of co-inhibitory receptors, such as CTLA-4 and PD-1, on effector T cells is a key mechanism for ensuring immune homeostasis.",29899446_0,0,1,2,-1,35135,-1,2.5538668e-05,1.8781262e-05,0.99995565
35138,receptors,4,5,41,50,"Dysregulated expression of co-inhibitory receptors on CD4+ T cells promotes autoimmunity, whereas sustained overexpression on CD8+ T cells promotes T cell dysfunction or exhaustion, leading to impaired ability to clear chronic viral infections and diseases such as cancer1,2.",29899446_1,0,1,2,-1,35138,-1,8.828236e-05,7.644779e-05,0.99983525
35144,protein,5,6,20,27,"Here, using RNA and protein expression profiling at single-cell resolution in mouse cells, we identify a module of co-inhibitory receptors that includes not only several known co-inhibitory receptors (PD-1, TIM-3, LAG-3 and TIGIT) but also many new surface receptors.",29899446_2,0,1,-1,-1,35144,-1,1.0419948e-05,0.9999826,6.948665e-06
35146,receptors that,21,23,129,143,"Here, using RNA and protein expression profiling at single-cell resolution in mouse cells, we identify a module of co-inhibitory receptors that includes not only several known co-inhibitory receptors (PD-1, TIM-3, LAG-3 and TIGIT) but also many new surface receptors.",29899446_2,-1,-1,-1,-1,35146,-1,0.0032996212,0.7843401,0.21236034
35147,receptors,29,30,190,199,"Here, using RNA and protein expression profiling at single-cell resolution in mouse cells, we identify a module of co-inhibitory receptors that includes not only several known co-inhibitory receptors (PD-1, TIM-3, LAG-3 and TIGIT) but also many new surface receptors.",29899446_2,0,1,2,-1,35147,-1,7.283757e-05,8.810716e-05,0.99983907
35150,receptors,44,45,257,266,"Here, using RNA and protein expression profiling at single-cell resolution in mouse cells, we identify a module of co-inhibitory receptors that includes not only several known co-inhibitory receptors (PD-1, TIM-3, LAG-3 and TIGIT) but also many new surface receptors.",29899446_2,0,1,2,-1,35150,-1,6.5835e-05,7.626514e-05,0.9998579
35151,functionally,1,2,3,15,"We functionally validated two new co-inhibitory receptors, activated protein C receptor (PROCR) and podoplanin (PDPN).",29899446_3,0,1,2,-1,35151,-1,1.3547513e-05,0.9999801,6.4097508e-06
35153,receptors,6,7,48,57,"We functionally validated two new co-inhibitory receptors, activated protein C receptor (PROCR) and podoplanin (PDPN).",29899446_3,0,1,2,-1,35153,-1,9.1960756e-05,0.00053265085,0.9993754
35154,protein,9,10,69,76,"We functionally validated two new co-inhibitory receptors, activated protein C receptor (PROCR) and podoplanin (PDPN).",29899446_3,0,1,-1,-1,35154,-1,2.2769033e-05,0.99995434,2.2920667e-05
35155,receptor,11,12,79,87,"We functionally validated two new co-inhibitory receptors, activated protein C receptor (PROCR) and podoplanin (PDPN).",29899446_3,0,1,2,-1,35155,-1,0.00017456937,0.0009803611,0.9988451
35157,receptors,4,5,28,37,The module of co-inhibitory receptors is co-expressed in both CD4+ and CD8+ T cells and is part of a larger co-inhibitory gene program that is shared by non-responsive T cells in several physiological contexts and is driven by the immunoregulatory cytokine IL-27.,29899446_4,0,1,2,-1,35157,-1,4.6685138e-05,5.5058183e-05,0.9998982
35164,analysis,1,2,14,22,"Computational analysis identified the transcription factors PRDM1 and c-MAF as cooperative regulators of the co-inhibitory module, and this was validated experimentally.",29899446_5,0,1,-1,-1,35164,-1,8.213008e-06,0.99998665,5.1521724e-06
35165,the transcription factors PRDM1,3,7,34,65,"Computational analysis identified the transcription factors PRDM1 and c-MAF as cooperative regulators of the co-inhibitory module, and this was validated experimentally.",29899446_5,-1,-1,-1,-1,35165,-1,2.181398e-05,0.9999268,5.1414318e-05
35170,receptors,8,9,68,77,This molecular circuit underlies the co-expression of co-inhibitory receptors in T cells and identifies regulators of T cell function with the potential to control autoimmunity and tumour immunity.,29899446_6,0,1,2,-1,35170,-1,3.8855487e-05,3.8934533e-05,0.99992216
35172,T cell function,16,19,118,133,This molecular circuit underlies the co-expression of co-inhibitory receptors in T cells and identifies regulators of T cell function with the potential to control autoimmunity and tumour immunity.,29899446_6,-1,-1,-1,-1,35172,-1,1.2610976e-05,7.52854e-06,0.99997985
35175,tumour immunity,26,28,181,196,This molecular circuit underlies the co-expression of co-inhibitory receptors in T cells and identifies regulators of T cell function with the potential to control autoimmunity and tumour immunity.,29899446_6,-1,-1,-1,-1,35175,-1,0.055440426,0.94343036,0.0011292454
35186,the gene,46,48,262,270,METHODS: Pancreata of C57BL/6 or Rag1-/- mice were given pancreatic injections of a combination of KrasG12D/+; Trp53 R172H/+; Pdx-1cre (KPC) pancreatic cancer cells and pancreatic stellate cells (PSCs) extracted from C57BL/6 (control) or mice with disruption of the gene encoding the NFB p50 subunit (Nfkb1 or p50-/- mice).,29909021_2,-1,-1,-1,-1,35186,-1,4.409889e-06,0.99999046,5.1460092e-06
35198,T-cell,0,1,0,6,T-cell migration toward cancer cells was measured using the Boyden chamber assay.,29909021_7,-1,1,2,-1,35198,-1,2.2721513e-05,9.256462e-06,0.99996793
35204,tumors than,20,22,108,119,RESULTS: C57BL/6 mice coinjected with KPC cells (or LLC or B16-F10 cells) and p50-/- PSCs developed smaller tumors than mice given injections of the cancer cells along with control PSCs.,29909021_8,-1,-1,-1,-1,35204,-1,3.8534845e-06,0.9999914,4.730073e-06
35207,Tumors that,0,2,0,11,"Tumors that formed when KPC cells were injected along with p50-/- PSCs had increased infiltration by activated cytotoxic T cells along with decreased levels of CXCL12, compared with tumors grown from KPC cells injected along with control PSCs.",29909021_9,-1,-1,-1,-1,35207,-1,3.6025074e-06,0.99999213,4.2747147e-06
35217,The CXCL12,0,2,0,10,The CXCL12 inhibitor slowed tumor growth and increased tumor infiltration by cytotoxic T cells.,29909021_11,-1,-1,-1,-1,35217,-1,0.87708515,0.12045108,0.002463775
35221,T-cell,9,10,43,49,Invitro expression of p50 by PSCs reduced T-cell migration toward and killing of cancer cells.,29909021_12,-1,1,2,-1,35221,-1,1.2335795e-05,7.908865e-06,0.99997985
35225,CXCL12 than,13,15,81,92,"When cultured with cancer cells, control PSCs expressed 10-fold higher levels of CXCL12 than p50-/- PSCs.",29909021_13,-1,-1,-1,-1,35225,-1,0.99547935,0.0034781895,0.0010424015
35226,The CXCL12,0,2,0,10,The CXCL12 inhibitor increased migration of T cells toward KPC cells in culture.,29909021_14,-1,-1,-1,-1,35226,-1,0.8742541,0.12329603,0.0024499123
35227,T cells toward,6,9,44,58,The CXCL12 inhibitor increased migration of T cells toward KPC cells in culture.,29909021_14,-1,-1,-1,-1,35227,-1,0.0023433072,0.027363189,0.97029346
35234,the tumor,34,36,193,202,"CONCLUSIONS: In studies of mice and cell lines, we found that NFB activity in PSCs promotes tumor growth by increasing expression of CXCL12, which prevents cytotoxic Tcells from infiltrating the tumor and killing cancer cells.",29909021_15,-1,-1,-1,-1,35234,-1,4.9774117e-06,0.99998987,5.140395e-06
35238,tumor cells,6,8,41,52,Strategies to block CXCL12 in pancreatic tumor cells might increase antitumor immunity.,29909021_16,-1,-1,-1,-1,35238,-1,0.00025390874,0.0017752417,0.9979709
35239,immunity,11,12,78,86,Strategies to block CXCL12 in pancreatic tumor cells might increase antitumor immunity.,29909021_16,0,-1,2,-1,35239,-1,0.9999244,1.8587649e-05,5.698038e-05
35245,T-cell,22,23,116,122,"In this study, the inhibitory effect of Brucea javanica (BJ) on cell growth and inflammation was confirmed in human T-cell acute lymphocytic leukemia (T-ALL) cells, and its efficacy as an antileukemic agent was verified.",29966986_1,-1,1,2,-1,35245,-1,1.155356e-05,7.491521e-06,0.9999809
35250,T-ALL Jurkat cells through,10,14,74,100,"Our results showed that BJ extract induced caspase-dependent apoptosis of T-ALL Jurkat cells through inhibition of the CK2-mediated signaling pathway, while exerting no significant cytotoxicity in normal peripheral blood mononuclear cells.",29966986_2,-1,-1,-1,-1,35250,-1,8.076554e-05,0.99966395,0.00025531254
35252,blood,29,30,215,220,"Our results showed that BJ extract induced caspase-dependent apoptosis of T-ALL Jurkat cells through inhibition of the CK2-mediated signaling pathway, while exerting no significant cytotoxicity in normal peripheral blood mononuclear cells.",29966986_2,0,1,-1,-1,35252,-1,0.001631999,0.9923476,0.006020362
35256,the interleukin,13,15,78,93,"Moreover, BJ extract suppressed the NF-B signaling pathway, thus, inhibiting the interleukin (IL)-2 expression induced by phorbol 12-myristate 13-acetate (PMA) and phytohemagglutinin (PHA).",29966986_3,-1,-1,-1,-1,35256,-1,0.54061174,0.45344293,0.0059453025
35259,T-ALL cell,16,18,108,118,"Notably, combined treatment with BJ extract plus CX-4945 or imatinib exerted enhanced inhibitory effects on T-ALL cell growth and IL-2 production.",29966986_4,-1,-1,-1,-1,35259,-1,0.00066811184,0.045103382,0.9542286
35263,T-ALL treatment,16,18,92,107,"Overall, these results suggest that BJ extract can be a potent therapeutic herbal agent for T-ALL treatment and prevention of IL-2 mediated inflammatory immune responses.",29966986_5,-1,-1,-1,-1,35263,-1,1.0241737e-05,0.99996865,2.107043e-05
35268,the Th17-related transcription factor,9,13,46,83,"FoxP3+ regulatory T cells (Treg) coexpressing the Th17-related transcription factor RORt accumulate in the lamina propria of IBD patients, where they are thought to represent an intermediate stage of development toward a Th17 proinflammatory phenotype.",29991500_1,-1,-1,-1,-1,35268,-1,5.777909e-06,0.9999889,5.2525393e-06
35271,thought to,26,28,155,165,"FoxP3+ regulatory T cells (Treg) coexpressing the Th17-related transcription factor RORt accumulate in the lamina propria of IBD patients, where they are thought to represent an intermediate stage of development toward a Th17 proinflammatory phenotype.",29991500_1,-1,-1,-1,-1,35271,-1,5.5786936e-06,0.9999883,6.0668863e-06
35275,these cells,5,7,21,32,"However, the role of these cells in CAC is unknown.",29991500_2,-1,-1,-1,-1,35275,-1,2.1595255e-05,1.7298542e-05,0.99996114
35278,function,16,17,97,105,"RORt+FoxP3+ cells were investigated in human samples of CAC, and their phenotypic stability and function were investigated in an azoxymethane/dextran sulfate sodium model of CAC using Treg fate-mapping reporter and Treg-specific RORt conditional knockout mice.",29991500_3,0,1,2,-1,35278,-1,1.3895466e-05,0.9999691,1.7012439e-05
35284,The functional,0,2,0,14,The functional role of CTLA-4 expressed by Tregs and FoxO3 in dendritic cells (DC) was studied in vitro and in vivo by siRNA-silencing experiments.,29991500_5,-1,-1,-1,-1,35284,-1,1.2177781e-05,0.99998045,7.4048603e-06
35288,tumor-infiltrating Tregs,8,10,66,90,RORt expression identified a phenotypically stable population of tumor-infiltrating Tregs in humans and mice.,29991500_6,-1,-1,-1,-1,35288,-1,1.0486567e-05,0.9999814,8.154828e-06
35294,cytokine that triggers STAT3-dependent,7,11,44,82,"Tumor-infiltrating DCs produced less IL6, a cytokine that triggers STAT3-dependent proliferative signals in neoplastic cells.",29991500_8,-1,-1,-1,-1,35294,-1,0.67927635,0.31467092,0.00605273
35300,the transcription factor,15,18,111,135,"RORt-deficient Tregs isolated from tumors overexpressed CTLA-4 and induced DCs to have elevated expression of the transcription factor FoxO3, thus reducing IL6 expression.",29991500_9,-1,-1,-1,-1,35300,-1,5.2764635e-06,0.9999901,4.612328e-06
35303,the tumors,12,14,72,82,"Finally, in vivo silencing of FoxO3 obtained by siRNA microinjection in the tumors of RORt-deficient mice restored IL6 expression and tumor growth.",29991500_10,-1,-1,-1,-1,35303,-1,4.248809e-06,0.99999034,5.367721e-06
35308,tumor-infiltrating Tregs,7,9,47,71,These data demonstrate that RORt expressed by tumor-infiltrating Tregs sustains tumor growth by leaving IL6 expression in DCs unchecked.,29991500_11,-1,-1,-1,-1,35308,-1,8.126161e-06,0.9999856,6.3154994e-06
35312,cell function,9,11,61,74,Mucosa-associated lymphoid tissue 1 (Malt1) regulates immune cell function by mediating the activation of nuclear factor B (NF-B) signaling through both its adaptor and proteolytic function.,30025160_0,-1,-1,-1,-1,35312,-1,2.1656882e-05,1.2283982e-05,0.999966
35316,function,29,30,183,191,Mucosa-associated lymphoid tissue 1 (Malt1) regulates immune cell function by mediating the activation of nuclear factor B (NF-B) signaling through both its adaptor and proteolytic function.,30025160_0,0,1,2,-1,35316,-1,7.963686e-06,0.9999838,8.21789e-06
35320,the functional,3,5,11,25,"Until now, the functional distinction between Malt1 self-cleavage and its general protease function in regulating NF-B signaling and immune activation remained unclear.",30025160_2,-1,-1,-1,-1,35320,-1,2.1070979e-05,0.99996996,9.026013e-06
35322,function,13,14,91,99,"Until now, the functional distinction between Malt1 self-cleavage and its general protease function in regulating NF-B signaling and immune activation remained unclear.",30025160_2,0,1,2,-1,35322,-1,1.7905035e-05,0.9999684,1.3644185e-05
35324,target genes,20,22,118,130,"Here we demonstrate, using a new mouse model, the importance of Malt1 self-cleavage in regulating expression of NF-B target genes and subsequent Tcell activation.",30025160_3,-1,-1,-1,-1,35324,-1,4.3637174e-06,0.9999912,4.4385865e-06
35326,that Treg,5,7,36,45,"Significantly, we further establish that Treg homeostasis is critically linked to Malt1 function via a Treg intrinsic and extrinsic mechanism.",30025160_4,-1,-1,-1,-1,35326,-1,8.380185e-06,0.9999862,5.4204465e-06
35328,function,13,14,88,96,"Significantly, we further establish that Treg homeostasis is critically linked to Malt1 function via a Treg intrinsic and extrinsic mechanism.",30025160_4,0,1,2,-1,35328,-1,0.00016598585,0.99942756,0.00040644108
35330,TCR-mediated,0,1,0,12,"TCR-mediated Malt1 proteolytic activity and self-cleavage was found to drive Il2 expression in conventional CD4+ Tcells, thereby regulating Il2 availability for Treg homeostasis.",30025160_5,-1,1,2,-1,35330,-1,1.1118216e-05,0.9999709,1.8026367e-05
35340,time that,6,8,38,47,These results establish for the first time that inhibition of MALT1 proteolytic activity could be a viable therapeutic strategy to augment anti-tumor immunity.,30025160_7,-1,-1,-1,-1,35340,-1,4.0223977e-06,0.99999166,4.2653874e-06
35343,immunity,22,23,150,158,These results establish for the first time that inhibition of MALT1 proteolytic activity could be a viable therapeutic strategy to augment anti-tumor immunity.,30025160_7,0,-1,2,-1,35343,-1,0.9998301,4.7761652e-05,0.00012201368
35346,tumor cell,13,15,82,92,We have previously shown that Notch1 plays a critical role in modulating melanoma tumor cell growth and survival.,30036609_0,-1,-1,-1,-1,35346,-1,0.00027614838,0.0042395643,0.99548435
35354,functional,17,18,108,118,"Notch1 inhibition reduces immune suppressive cells (i.e. MDSCs and Tregs) while allowing the recruitment of functional CD8(+) T cells, leading to a decrease in the Tregs/CD8(+) ratio, a key parameter in assessing positive responses to immune-checkpoint inhibitors.",30036609_2,0,1,2,-1,35354,-1,7.686704e-05,0.9998857,3.741648e-05
35369,the transcription,2,4,16,33,"Notch1 controls the transcription of IL8 and IL6; and the secretion of CCL5 likely by inhibiting the expression of SNAP23, a member of the SNAREs family of proteins involved in cell exocytosis.",30036609_6,-1,-1,-1,-1,35369,-1,5.1370384e-06,0.99998987,4.970676e-06
35375,proteins,29,30,156,164,"Notch1 controls the transcription of IL8 and IL6; and the secretion of CCL5 likely by inhibiting the expression of SNAP23, a member of the SNAREs family of proteins involved in cell exocytosis.",30036609_6,0,1,-1,-1,35375,-1,7.596918e-06,0.9999862,6.1840724e-06
35381,therapy,21,22,149,156,"Hence, targeting Notch1 would affect both melanoma intrinsic growth/survival properties, and provide an immune-responsive TME, thus improving immune therapy efficacy.",30036609_8,0,1,-1,-1,35381,-1,6.7142887e-06,0.99998796,5.322316e-06
35383,tissue,20,21,145,151,"M1 macrophages are involved in inflammation by producing proinflammatory cytokines, whereas M2 macrophages are associated with wound healing and tissue regeneration by producing anti-inflammatory cytokines.",30047999_0,-1,1,2,-1,35383,-1,6.8585505e-05,0.99988234,4.9109847e-05
35395,tumour tissues,9,11,50,64,"Meanwhile, the M1 cell frequencies were higher in tumour tissues and inflamed colons of KO mice than of littermate controls.",30047999_4,-1,-1,-1,-1,35395,-1,2.5317613e-05,0.99979097,0.00018378062
35407,deficiency,4,5,34,44,Results indicated that miR-15a/16 deficiency in the macrophages directs M1 polarization for tumour suppression and proinflammation.,30047999_8,0,1,-1,-1,35407,-1,6.434264e-05,0.99991786,1.7841727e-05
35413,deficiency,16,17,108,118,"Thus, miR-15a/16 deletion in macrophages holds a distinct biological significance from that of the microRNA deficiency in tumour cells.",30047999_9,0,1,-1,-1,35413,-1,3.8333008e-05,0.99994254,1.9152352e-05
35414,tumour cells,18,20,122,134,"Thus, miR-15a/16 deletion in macrophages holds a distinct biological significance from that of the microRNA deficiency in tumour cells.",30047999_9,-1,-1,-1,-1,35414,-1,0.00012140024,0.00040605434,0.99947256
35419,T cell-mediated immunity,16,19,96,120,Dendritic cells (DCs) are the most potent professional antigen presenting cells and inducers of T cell-mediated immunity.,30068989_0,-1,-1,-1,-1,35419,-1,0.00010512659,1.621265e-05,0.99987864
35420,analysis,3,4,22,30,A previous microarray analysis revealed expression of mDC-specific genes and identified Rsad2 (radical S-adenosyl methionine domain containing 2) as a candidate specific marker for DC maturation.,30068989_2,0,1,-1,-1,35420,-1,7.0445694e-06,0.9999876,5.393635e-06
35423,cells to,5,7,43,51,C57BL/6 mice received intravenously B16F10 cells to establish a pulmonary metastasis model.,30068989_4,-1,-1,-1,-1,35423,-1,0.006694737,0.20232248,0.7909828
35427,The cytotoxic T lymphocyte,0,4,0,26,The cytotoxic T lymphocyte (CTL) population was examined from splenocytes of DC-vaccinated mice by flow cytometry.,30068989_6,-1,-1,-1,-1,35427,-1,0.0026414052,0.09180059,0.90555793
35430,function,11,12,64,72,Rsad2 was induced at high levels in LPS-stimulated mDCs and mDC function was markedly attenuated under conditions of Rsad2 knockdown.,30068989_7,0,1,2,-1,35430,-1,0.0001547699,0.99968815,0.00015704997
35431,the IRF7-mediated,9,11,53,70,"Moreover, Rsad2 was necessary for mDC maturation via the IRF7-mediated signaling pathway.",30068989_8,-1,-1,-1,-1,35431,-1,4.3120373e-05,0.99990904,4.783033e-05
35434,the CTL,2,4,8,15,Data on the CTL population further supported the results as above.,30068989_10,-1,-1,-1,-1,35434,-1,0.0028272155,0.14357571,0.85359704
35436,Taken together,0,2,0,14,"Taken together, Rsad2 was an obvious and specific marker necessary for DC maturation and these findings will be clearly helpful for further understanding of DC biology.",30068989_11,-1,-1,-1,-1,35436,-1,1.0391005e-05,0.9999821,7.533226e-06
35438,factors,1,2,14,21,Environmental factors and chronic inflammation are correlated with the disease risk.,30075815_1,0,1,-1,-1,35438,-1,0.00572616,0.9940749,0.00019893813
35447,the tumour,10,12,59,69,"The anti-tumour immune responses, known to be initiated in the tumour and draining lymph nodes, may play a major role in future treatment strategies.",30075815_3,-1,-1,-1,-1,35447,-1,4.964788e-06,0.99998903,6.0149778e-06
35463,the transcription factor Foxp3,35,39,174,204,"Activated CD4+ T cells differentiate into four main separate lineages: Th1, Th2, Th17 and Treg, and they are recognized by their effector molecules IFN-, IL-13, IL-17A, and the transcription factor Foxp3, respectively.",30075815_5,-1,-1,-1,-1,35463,-1,4.6453547e-06,0.9999907,4.707465e-06
35468,blood,14,15,84,89,"Here, we investigate the lineage commitment specifically in tumour, lymph nodes and blood and relate them to the disease stage and response to neoadjuvant chemotherapy.",30075815_7,0,1,-1,-1,35468,-1,0.0044631124,0.78223586,0.21330108
35469,them to the,17,20,101,112,"Here, we investigate the lineage commitment specifically in tumour, lymph nodes and blood and relate them to the disease stage and response to neoadjuvant chemotherapy.",30075815_7,-1,-1,-1,-1,35469,-1,4.858103e-06,0.9999893,5.86674e-06
35472,Blood,2,3,9,14,"RESULTS: Blood, tumour and regional lymph nodes were obtained from patients at time of transurethral resection of the bladder and at radical cystectomy.",30075815_8,0,1,-1,-1,35472,-1,0.0020950013,0.99214727,0.0057577356
35481,blood,22,23,157,162,"Tumour-infiltrating CD4+ lymphocytes were significantly hypomethylated in all four investigated lineage loci compared to CD4+ lymphocytes in lymph nodes and blood (lymph nodes vs tumour-infiltrating lymphocytes: IFNG -4229bp p<0.0001, IL13 -11bp p<0.05, IL17A -122bp p<0.01 and FOXP3 -77bp p>0.05).",30075815_9,0,1,-1,-1,35481,-1,0.0021650135,0.9935707,0.0042643175
35482,tumour-infiltrating lymphocytes,27,29,179,210,"Tumour-infiltrating CD4+ lymphocytes were significantly hypomethylated in all four investigated lineage loci compared to CD4+ lymphocytes in lymph nodes and blood (lymph nodes vs tumour-infiltrating lymphocytes: IFNG -4229bp p<0.0001, IL13 -11bp p<0.05, IL17A -122bp p<0.01 and FOXP3 -77bp p>0.05).",30075815_9,-1,-1,-1,-1,35482,-1,0.0026861432,0.79221135,0.20510252
35488,the IFNG -4229,11,14,99,113,More advanced post-cystectomy tumour stages correlated significantly with increased methylation at the IFNG -4229bp locus.,30075815_11,-1,-1,-1,-1,35488,-1,0.035429835,0.9611293,0.003440853
35498,blood,15,16,93,98,"Neoadjuvant chemotherapy seemed to result in a relocation of Th1-committed CD4+ T cells from blood, presumably to the tumour, indicated by shifts in the methylation patterns, whereas no such shifts were seen for lineages corresponding to IL13, IL17A and FOXP3.CONCLUSION: Increased lineage commitment in CD4+ T cells, as determined by demethylation in predictive CpG sites, is associated with lower post-cystectomy tumour stage, complete response to neoadjuvant chemotherapy and overall better outcome, suggesting epigenetic profiling of CD4+ T cell lineages as a useful readout for clinical staging.",30075815_13,0,1,-1,-1,35498,-1,0.01867408,0.77511764,0.20620832
35499,to the tumour,18,21,111,124,"Neoadjuvant chemotherapy seemed to result in a relocation of Th1-committed CD4+ T cells from blood, presumably to the tumour, indicated by shifts in the methylation patterns, whereas no such shifts were seen for lineages corresponding to IL13, IL17A and FOXP3.CONCLUSION: Increased lineage commitment in CD4+ T cells, as determined by demethylation in predictive CpG sites, is associated with lower post-cystectomy tumour stage, complete response to neoadjuvant chemotherapy and overall better outcome, suggesting epigenetic profiling of CD4+ T cell lineages as a useful readout for clinical staging.",30075815_13,-1,-1,-1,-1,35499,-1,8.192925e-06,0.9999833,8.488321e-06
35501,to IL13,39,41,235,242,"Neoadjuvant chemotherapy seemed to result in a relocation of Th1-committed CD4+ T cells from blood, presumably to the tumour, indicated by shifts in the methylation patterns, whereas no such shifts were seen for lineages corresponding to IL13, IL17A and FOXP3.CONCLUSION: Increased lineage commitment in CD4+ T cells, as determined by demethylation in predictive CpG sites, is associated with lower post-cystectomy tumour stage, complete response to neoadjuvant chemotherapy and overall better outcome, suggesting epigenetic profiling of CD4+ T cell lineages as a useful readout for clinical staging.",30075815_13,-1,-1,-1,-1,35501,-1,0.8228184,0.174665,0.0025166797
35510,to the,3,5,23,29,Controversy remains as to the role of Notch signaling pathway in CD8+ T cells regulation in tumorigenesis.,30086535_1,-1,-1,-1,-1,35510,-1,6.533359e-06,0.9999883,5.1268207e-06
35511,T cells regulation,13,16,70,88,Controversy remains as to the role of Notch signaling pathway in CD8+ T cells regulation in tumorigenesis.,30086535_1,-1,-1,-1,-1,35511,-1,0.0010360995,0.032717787,0.9662461
35523,bloods,25,26,160,166,"Forty-eight lung adenocarcinoma patients and twenty healthy individuals were enrolled in the current study, and CD8+ T cells were purified from both peripheral bloods and bronchoalveolar lavage fluids.",30086535_3,0,1,-1,-1,35523,-1,0.00047324898,0.9958365,0.0036902323
35532,growth factor receptor,29,32,178,200,"Notch2 mRNA expression was elevated in both peripheral and lung-resident CD8+ T cells in lung adenocarcinoma patients, however, did not correlated with tumor stages or epidermal growth factor receptor mutation.",30086535_7,-1,-1,-1,-1,35532,-1,0.9953551,0.00011861225,0.0045262054
35544,therapy,10,11,55,62,"In this study, we investigated the impact of nivolumab therapy on peripheral blood regulatory T cells (Treg) and its relation to patient outcomes.",30131384_1,0,1,-1,-1,35544,-1,5.9245667e-06,0.99998915,4.942641e-06
35545,blood regulatory T cells,13,17,77,101,"In this study, we investigated the impact of nivolumab therapy on peripheral blood regulatory T cells (Treg) and its relation to patient outcomes.",30131384_1,-1,-1,-1,-1,35545,-1,0.00048406224,0.0034375142,0.99607843
35547,relation to,22,24,117,128,"In this study, we investigated the impact of nivolumab therapy on peripheral blood regulatory T cells (Treg) and its relation to patient outcomes.",30131384_1,-1,-1,-1,-1,35547,-1,6.7265346e-06,0.99998677,6.496307e-06
35548,blood Tregs,4,6,32,43,EXPERIMENTAL DESIGN: Peripheral blood Tregs and conventional CD4+ T cells from patients with resected high-risk melanoma treated with adjuvant nivolumab were assessed for gene expression changes by RNA-seq.,30131384_2,-1,-1,-1,-1,35548,-1,0.0002936449,0.99845743,0.0012488951
35553,function,1,2,12,20,Suppressive function of Tregs was assessed in allogeneic mixed lymphocyte reactions.,30131384_4,0,1,2,-1,35553,-1,0.0013194298,0.99836296,0.0003176648
35564,Treg-suppressive function,14,16,88,113,"In vitro blockade of PD-1 increased Treg percentages and pSTAT3 expression, and reduced Treg-suppressive function.",30131384_7,-1,-1,-1,-1,35564,-1,1.0371843e-05,0.99997973,9.855073e-06
35565,to IL10,4,6,23,30,"PD-1 blockade also led to IL10 production by T cells, resulting in higher Treg proliferation.",30131384_8,-1,-1,-1,-1,35565,-1,0.78535837,0.21238312,0.002258521
35572,function,14,15,90,98,"The addition of a STAT3 inhibitor ameliorated the increase in Tregs, enhanced suppressive function, and decreased T-cell IL10 production in vitro.",30131384_9,0,1,2,-1,35572,-1,2.035461e-05,0.9999505,2.9125258e-05
35573,T-cell IL10,18,20,114,125,"The addition of a STAT3 inhibitor ameliorated the increase in Tregs, enhanced suppressive function, and decreased T-cell IL10 production in vitro.",30131384_9,-1,-1,-1,-1,35573,-1,0.8366065,0.0017134441,0.16168007
35576,function,12,13,85,93,"CONCLUSIONS: These results demonstrate that induction of pSTAT3, reduced suppressive function, and a paradoxical increase in Treg proliferation are novel correlates of patient benefit from PD-1 blockade.",30131384_10,0,1,2,-1,35576,-1,1.979067e-05,0.99994993,3.0287018e-05
35578,the relationship,2,4,16,32,"We investigated the relationship between Neutrophil-to-lymphocyte ratio (NLR) and the quantities of neutrophil elastase, CD3, Foxp3, and CD204 in tumor-infiltrating cells and circulating cytokines (IL-2, -6, -8, 17a, and TGF-) in muscle-invasive bladder cancer.",30199269_0,-1,-1,-1,-1,35578,-1,5.4946336e-06,0.99999,4.538006e-06
35581,tumor-infiltrating cells,24,26,146,170,"We investigated the relationship between Neutrophil-to-lymphocyte ratio (NLR) and the quantities of neutrophil elastase, CD3, Foxp3, and CD204 in tumor-infiltrating cells and circulating cytokines (IL-2, -6, -8, 17a, and TGF-) in muscle-invasive bladder cancer.",30199269_0,-1,-1,-1,-1,35581,-1,0.0022733219,0.7906483,0.20707844
35586,in blood,10,12,63,71,IL-6 and IL-8 levels showed a significant correlation with NLR in blood and Foxp3+ cells around the tumor.,30199269_1,0,1,-1,-1,35586,-1,2.8997254e-05,0.9998765,9.450475e-05
35589,the tumor,17,19,96,105,IL-6 and IL-8 levels showed a significant correlation with NLR in blood and Foxp3+ cells around the tumor.,30199269_1,-1,-1,-1,-1,35589,-1,4.0149002e-06,0.9999914,4.5657252e-06
35590,blood cells,4,6,31,42,"After co-culture of peripheral blood cells with bladder cancer cell lines, the induction of regulatory T cell (Treg) was higher in T24 whose IL-6 and IL-8 levels were higher.",30199269_2,-1,-1,-1,-1,35590,-1,1.834724e-05,1.093201e-05,0.9999707
35607,the genetic,13,15,71,82,"To investigate the role of the NLRP3 inflammasome in MM, we determined the genetic polymorphisms and expression of NLRP3 inflammasome-related genes (IL-1, IL-18, CARD8, and NF-B) in MM patients, and explored their clinical relevance.",30211233_1,-1,-1,-1,-1,35607,-1,4.9383107e-06,0.99998903,6.035146e-06
35613,the relationship,4,6,29,45,"Furthermore, we investigated the relationship of the NLRP3 inflammasome with Th cells in MM.",30211233_2,-1,-1,-1,-1,35613,-1,7.3957026e-06,0.99998665,5.9169515e-06
35615,Th cells,11,13,77,85,"Furthermore, we investigated the relationship of the NLRP3 inflammasome with Th cells in MM.",30211233_2,-1,-1,-1,-1,35615,-1,7.717191e-06,7.2432717e-06,0.999985
35616,that the,3,5,17,25,Our study showed that the CARD8-C10X (rs2043211) AT genotype contributed to the susceptibility of MM.,30211233_3,-1,-1,-1,-1,35616,-1,4.7791973e-06,0.99999034,4.8292973e-06
35617,to the,12,14,73,79,Our study showed that the CARD8-C10X (rs2043211) AT genotype contributed to the susceptibility of MM.,30211233_3,-1,-1,-1,-1,35617,-1,7.3649353e-06,0.9999863,6.3641746e-06
35620,the three,4,6,17,26,The WBC count in the three CARD8 genotypes showed an increasing trend (AA<AT<TT).,30211233_5,-1,-1,-1,-1,35620,-1,1.1551263e-05,0.99998045,8.028009e-06
35629,that the,4,6,22,30,"Furthermore, we found that the genotype of CARD8-C10X (rs2043211) or NF-B-94 ins/del ATTG was closely related to the frequency of Th1.",30211233_8,-1,-1,-1,-1,35629,-1,4.0927025e-06,0.99999166,4.2674706e-06
35630,related to the,18,21,103,117,"Furthermore, we found that the genotype of CARD8-C10X (rs2043211) or NF-B-94 ins/del ATTG was closely related to the frequency of Th1.",30211233_8,-1,-1,-1,-1,35630,-1,6.5937306e-06,0.99998724,6.156111e-06
35633,the genetic,2,4,11,22,"Therefore, the genetic polymorphisms of the NLRP3 inflammasome associated with Th cells might be involved in the pathogenesis of multiple myeloma.",30211233_9,-1,-1,-1,-1,35633,-1,5.4116595e-06,0.9999888,5.7472535e-06
35635,Th cells,11,13,79,87,"Therefore, the genetic polymorphisms of the NLRP3 inflammasome associated with Th cells might be involved in the pathogenesis of multiple myeloma.",30211233_9,-1,-1,-1,-1,35635,-1,8.475019e-06,5.9127087e-06,0.9999856
35637,receptor-directed,10,11,57,74,PURPOSE: Clinical responses with programmed death (PD-1) receptor-directed antibodies occur in about 20% of patients with advanced head and neck squamous cell cancer (HNSCCa).,30242022_0,0,1,2,-1,35637,-1,0.008909523,0.004975612,0.98611486
35640,proteins,7,8,37,45,"Viral neoantigens, such as the E6/E7 proteins of HPV16/18, are attractive targets for therapeutic immunization and offer an immune activation strategy that may be complementary to PD-1 inhibition.",30242022_1,0,1,-1,-1,35640,-1,3.529406e-05,0.99993694,2.7821397e-05
35652,antigen-specific T-cell,7,9,50,73,"Eighteen of 21 evaluable patients showed elevated antigen-specific T-cell activity by IFN ELISpot, and persistent cellular responses surpassing 100 spot-forming units (SFUs)/106 peripheral blood mononuclear cells (PBMCs) were noted out to 1 year.",30242022_4,-1,-1,-1,-1,35652,-1,0.5558585,0.00058815343,0.4435534
35655,blood,24,25,190,195,"Eighteen of 21 evaluable patients showed elevated antigen-specific T-cell activity by IFN ELISpot, and persistent cellular responses surpassing 100 spot-forming units (SFUs)/106 peripheral blood mononuclear cells (PBMCs) were noted out to 1 year.",30242022_4,0,1,-1,-1,35655,-1,0.002678257,0.9883894,0.008932314
35663,therapy,10,11,72,79,One patient developed metastatic disease and was treated with anti-PD-1 therapy with a rapid and durable complete response.,30242022_7,0,1,-1,-1,35663,-1,4.5558645e-06,0.99999034,5.0977933e-06
35664,T cells that,10,13,73,85,Flow-cytometric analyses revealed induction of HPV16-specific PD-1+ CD8+ T cells that were not found prior to MEDI0547 (0% vs. 1.8%).CONCLUSIONS: These data demonstrate that MEDI0457 can generate durable HPV16/18 antigen-specific peripheral and tumor immune responses.,30242022_8,-1,-1,-1,-1,35664,-1,0.0021540418,0.05038574,0.9474603
35670,tumor immune responses,37,40,245,267,Flow-cytometric analyses revealed induction of HPV16-specific PD-1+ CD8+ T cells that were not found prior to MEDI0547 (0% vs. 1.8%).CONCLUSIONS: These data demonstrate that MEDI0457 can generate durable HPV16/18 antigen-specific peripheral and tumor immune responses.,30242022_8,-1,-1,-1,-1,35670,-1,0.7715805,0.22570297,0.002716532
35681,the T helper cells type,4,9,26,49,OBJECTIVE: To investigate the T helper cells type 1 (Th1) /Th2/Th17/Treg paradigms in peripheral blood of infertile PCOS compared with normal fertile women.,30246693_2,-1,-1,-1,-1,35681,-1,4.0721232e-05,0.99977106,0.00018821281
35683,blood,17,18,97,102,OBJECTIVE: To investigate the T helper cells type 1 (Th1) /Th2/Th17/Treg paradigms in peripheral blood of infertile PCOS compared with normal fertile women.,30246693_2,0,1,-1,-1,35683,-1,0.0008239225,0.9857588,0.01341735
35684,blood,3,4,20,25,METHODS: Peripheral blood mononuclear cells (PBMCs) were isolated at the late follicular phase from 10 PCOS and 10 fertile women.,30246693_3,0,1,-1,-1,35684,-1,0.0026113852,0.9797091,0.017679596
35695,cells subsets,40,42,223,236,"PBMCs were stimulated with PMA and ionomycin in the presence of Berefeldin A as Golgi stop agent to detect intracellular cytokine production (IFN-, IL-17, and IL-4) from CD3+CD4+T cells population indicating T helper (Th) cells subsets by flowcytometry.",30246693_4,-1,-1,-1,-1,35695,-1,1.3591727e-05,1.14292825e-05,0.99997497
35699,that the,8,10,34,42,"RESULTS: In this study, we report that the frequency of Th1 cells was increased compared to Th2 cells in infertile PCOS when considering Th1/Th2 ratio (P=0.05).",30246693_6,-1,-1,-1,-1,35699,-1,4.0180057e-06,0.99999213,3.798223e-06
35701,to Th2 cells,17,20,89,101,"RESULTS: In this study, we report that the frequency of Th1 cells was increased compared to Th2 cells in infertile PCOS when considering Th1/Th2 ratio (P=0.05).",30246693_6,-1,-1,-1,-1,35701,-1,0.0014948011,0.11885589,0.8796493
35702,Analysis,0,1,0,8,Analysis of Th17/Th2 ratio showed a significant difference with a bias toward Th17 dominancy in PCOS (P=0.02).,30246693_7,0,1,-1,-1,35702,-1,8.408283e-06,0.99998605,5.4967295e-06
35703,toward Th17,11,13,71,82,Analysis of Th17/Th2 ratio showed a significant difference with a bias toward Th17 dominancy in PCOS (P=0.02).,30246693_7,-1,-1,-1,-1,35703,-1,4.2904256e-05,0.99993896,1.8081437e-05
35706,than that,14,16,94,103,"The proportion of CD4+CD25+Foxp3+ regulatory T cells was significantly lower in PCOS patients than that of healthy fertile women (P=0.02).CONCLUSION: In summary, Th1 and Th17 bias and reduction of Treg and Th2 cells as regulators of immune responses might be involved in the pathogenesis of PCOS.",30246693_8,-1,-1,-1,-1,35706,-1,6.3240327e-06,0.9999883,5.3980693e-06
35714,immune response to,7,10,43,61,"These results are suggestive of an altered immune response to inflammatory status in PCOS patients, likely causing some complications such as infertility in these patients.",30246693_9,-1,-1,-1,-1,35714,-1,0.89447266,0.104139835,0.0013874595
35744,that the IL-10,3,6,17,31,We further found that the IL-10 expression level and the STAT3 activation level were significantly higher in MYD88 L265P mutant lymphomas than in MYD88 WT lymphomas.,30253331_5,-1,-1,-1,-1,35744,-1,0.6617542,0.33532023,0.0029255922
35745,the STAT3,9,11,53,62,We further found that the IL-10 expression level and the STAT3 activation level were significantly higher in MYD88 L265P mutant lymphomas than in MYD88 WT lymphomas.,30253331_5,-1,-1,-1,-1,35745,-1,6.345234e-06,0.9999869,6.7272285e-06
35769,factor,39,40,232,238,"In this study, we demonstrated that breast cancer cells (BCCs) also expressed and secreted IL-35 and higher level of IL-35 in BCCs was closely associated with poor prognosis of patients and was an independent unfavorable prognostic factor for breast cancer.",30321288_3,0,1,-1,-1,35769,-1,0.003548569,0.9962782,0.00017324222
35774,Tconv cells,18,20,132,143,Subsequent study revealed that BCC-derived IL-35 inhibited conventional T (Tconv) cell proliferation and further induced suppressed Tconv cells into IL-35-producing induced regulatory T (iTr35) cells.,30321288_4,-1,-1,-1,-1,35774,-1,0.0015318929,0.52954286,0.46892524
35778,cytokine IL-10,9,11,68,82,"Furthermore, BCC-derived IL-35 promoted the secretion of inhibitory cytokine IL-10 and obviously decreased the secretion of Th1-type cytokine IFN- and Th17-type cytokine IL-17 in Tconv cells.",30321288_5,-1,-1,-1,-1,35778,-1,0.99996734,5.2587407e-06,2.7406237e-05
35780,Th1-type cytokine IFN-,17,20,124,147,"Furthermore, BCC-derived IL-35 promoted the secretion of inhibitory cytokine IL-10 and obviously decreased the secretion of Th1-type cytokine IFN- and Th17-type cytokine IL-17 in Tconv cells.",30321288_5,-1,-1,-1,-1,35780,-1,0.6521645,0.34040114,0.0074343625
35781,Th17-type cytokine IL-17,21,24,152,176,"Furthermore, BCC-derived IL-35 promoted the secretion of inhibitory cytokine IL-10 and obviously decreased the secretion of Th1-type cytokine IFN- and Th17-type cytokine IL-17 in Tconv cells.",30321288_5,-1,-1,-1,-1,35781,-1,0.42670476,0.56749415,0.0058010924
35782,Tconv cells,25,27,180,191,"Furthermore, BCC-derived IL-35 promoted the secretion of inhibitory cytokine IL-10 and obviously decreased the secretion of Th1-type cytokine IFN- and Th17-type cytokine IL-17 in Tconv cells.",30321288_5,-1,-1,-1,-1,35782,-1,0.0012705282,0.2741747,0.7245548
35784,receptor,6,7,40,48,"Meanwhile, the expression of inhibitory receptor CD73 was also elevated on the surface of Tconv cells following the BCCs' supernatant treatment.",30321288_6,0,1,2,-1,35784,-1,8.36904e-05,3.885201e-05,0.99987745
35786,Tconv cells,15,17,90,101,"Meanwhile, the expression of inhibitory receptor CD73 was also elevated on the surface of Tconv cells following the BCCs' supernatant treatment.",30321288_6,-1,-1,-1,-1,35786,-1,0.0004406853,0.024831519,0.9747277
35789,Tconv cells,5,7,45,56,"Mechanistically, BCC-derived IL-35 exhausted Tconv cells and induced iTr35 by activating transcription factor STAT1/STAT3.",30321288_7,-1,-1,-1,-1,35789,-1,0.00084480166,0.09498343,0.90417176
35791,functions,5,6,28,37,"Hence, our results indicate functions of BCC-derived IL-35 in promoting tumor progression through proliferation inhibition of tumor-infiltrating Tconv cells and induction of iTr35 cells in tumor microenvironment.",30321288_8,0,1,2,-1,35791,-1,1.8739018e-05,0.9999641,1.7176075e-05
35794,tumor-infiltrating Tconv cells,17,20,126,156,"Hence, our results indicate functions of BCC-derived IL-35 in promoting tumor progression through proliferation inhibition of tumor-infiltrating Tconv cells and induction of iTr35 cells in tumor microenvironment.",30321288_8,-1,-1,-1,-1,35794,-1,0.0013950295,0.93760496,0.061000045
35799,therapeutic target,11,13,66,84,This study highlights that IL-35 produced by BCCs are a potential therapeutic target for breast cancer.,30321288_9,-1,-1,-1,-1,35799,-1,6.544313e-06,0.9999889,4.589817e-06
35803,to the,12,14,81,87,Regulatory T cells (Tregs) mediate immunosuppressive signals that can contribute to the progression of head and neck squamous cell carcinoma (HNSCC).,30357458_0,-1,-1,-1,-1,35803,-1,6.368502e-06,0.99998796,5.6894155e-06
35806,factor that,14,16,65,76,"Interleukin-33 (IL-33) is defined as an 'alarmin', an endogenous factor that is expressed during tissue and cell damage, which has been shown to promote Treg proliferation in non-lymphoid organs.",30357458_1,-1,-1,-1,-1,35806,-1,1.7722532e-05,0.99997616,6.0917077e-06
35807,tissue,19,20,97,103,"Interleukin-33 (IL-33) is defined as an 'alarmin', an endogenous factor that is expressed during tissue and cell damage, which has been shown to promote Treg proliferation in non-lymphoid organs.",30357458_1,-1,1,2,-1,35807,-1,8.507542e-05,0.9995277,0.0003872842
35819,functional analysis,24,26,134,153,"In this study, we examined IL-33+ and Foxp3+ cells by immunohistochemistry in 68 laryngeal squamous cell cancer patients, followed by functional analysis of IL-33 in Tregs.",30357458_3,-1,-1,-1,-1,35819,-1,4.53542e-05,0.99993443,2.0159612e-05
35822,function,5,6,29,37,"In addition, the suppressive function of Tregs was assessed by cell proliferation assays.",30357458_4,0,1,2,-1,35822,-1,5.911984e-05,0.99990153,3.9331968e-05
35829,receptor,6,7,28,36,ST2 is regarded as the only receptor of IL-33.,30357458_6,0,1,2,-1,35829,-1,0.006566479,0.83739495,0.1560386
35834,Functional,0,1,0,10,Functional investigation demonstrated that IL-33 increased the proportion of Foxp3+GATA3+ Tregs and improved the suppressive functions of Tregs by inducing IL-10 and TGF-1 as well as decreasing the proliferation of responder T cells.,30357458_8,0,1,2,-1,35834,-1,5.912772e-05,0.99992037,2.0515652e-05
35840,functions,16,17,125,134,Functional investigation demonstrated that IL-33 increased the proportion of Foxp3+GATA3+ Tregs and improved the suppressive functions of Tregs by inducing IL-10 and TGF-1 as well as decreasing the proliferation of responder T cells.,30357458_8,0,1,2,-1,35840,-1,3.1605774e-05,0.999928,4.036958e-05
35848,the Treg,8,10,53,61,Our data demonstrate that stromal IL-33 both expands the Treg population and enhances their functions in the tumor microenvironment.,30357458_10,-1,-1,-1,-1,35848,-1,9.443983e-06,0.9999795,1.1014632e-05
35849,their functions,13,15,86,101,Our data demonstrate that stromal IL-33 both expands the Treg population and enhances their functions in the tumor microenvironment.,30357458_10,-1,-1,-1,-1,35849,-1,4.725033e-05,0.9999119,4.0850202e-05
35850,the tumor,16,18,105,114,Our data demonstrate that stromal IL-33 both expands the Treg population and enhances their functions in the tumor microenvironment.,30357458_10,-1,-1,-1,-1,35850,-1,4.9338605e-06,0.9999906,4.4374706e-06
35855,to the,14,16,86,92,BACKGROUND: The prognosis of pancreatic ductal adenocarcinoma (PDAC) remains poor due to the difficulty of disease diagnosis and therapy.,30359281_0,-1,-1,-1,-1,35855,-1,5.705432e-06,0.9999896,4.628563e-06
35856,therapy,21,22,129,136,BACKGROUND: The prognosis of pancreatic ductal adenocarcinoma (PDAC) remains poor due to the difficulty of disease diagnosis and therapy.,30359281_0,0,1,-1,-1,35856,-1,5.8501023e-06,0.99998844,5.74809e-06
35863,tumor tissues,22,24,106,119,"In this study, we aim to analyze the expression of CD8 and FoxP3 on T lymphocytes and TGF- expressionin tumor tissues, andthen analyze the possible clinical significance of these finding in order to find a novel effective immunotherapy target in PDAC using a murine model.",30359281_2,-1,-1,-1,-1,35863,-1,7.845745e-06,0.9999788,1.34276925e-05
35869,tissue,3,4,11,17,METHODS: A tissue microarray using patient PDAC samples was stained and analyzed for associations with clinicopathological characteristics.,30359281_3,-1,1,2,-1,35869,-1,2.4770809e-05,0.999933,4.2193504e-05
35874,tumor tissues,13,15,63,76,"RESULTS: The infiltrating FoxP3+ regulatory T cells (Tregs) in tumor tissues were associated with survival, while CD8+ tumor infiltrating lymphocytes (TILs) were not.",30359281_5,-1,-1,-1,-1,35874,-1,1.4924689e-05,0.99991965,6.541455e-05
35884,factor,8,9,54,60,IIR was further verified as an independent prognostic factor according to multivariate analysis as well as TGF- expression.,30359281_7,0,1,-1,-1,35884,-1,0.031543374,0.96777904,0.00067758927
35886,analysis,12,13,87,95,IIR was further verified as an independent prognostic factor according to multivariate analysis as well as TGF- expression.,30359281_7,0,1,-1,-1,35886,-1,1.5645535e-05,0.99997497,9.334289e-06
35894,therapy,2,3,17,24,This combination therapy significantly depleted periphery and intra-tumor FoxP3+ Tregs while increasing intra-tumor CD8+ TILs levels compared to controls or anti-TGF- monotherapy (p<0.05).,30359281_10,0,1,-1,-1,35894,-1,4.315948e-06,0.9999912,4.4850176e-06
35916,cell transplantation,15,17,108,128,Graft-versus host disease (GVHD) remains the most significant complication of allogeneic hematopoietic stem cell transplantation (allo-HSCT).,30445020_0,-1,-1,-1,-1,35916,-1,0.0059199925,0.022009464,0.97207063
35921,CD11c+CD80,3,4,14,24,We found that CD11c+CD80+ dendritic cells (DCs) were up-regulated but did not enhance GVHD.,30445020_3,-1,-1,-1,-1,35921,-1,0.0020492992,6.5942186e-05,0.9978848
35925,T cells that,9,12,46,58,Regulatory T cells (Tregs) and central memory T cells that express high levels of CD62L and CD44 had an expansion after Notch inhibition.,30445020_4,-1,-1,-1,-1,35925,-1,0.00087566936,0.023563135,0.9755611
35927,Factor-,3,4,23,31,"Reduced Tumor Necrosis Factor- and increased Interferon- production were found, which might be ascribed to the expansion of Tregs and central memory T cells, and result in increased sensitivity of tumor cells to cytotoxic T lymphocyte activity.",30445020_5,0,1,-1,-1,35927,-1,0.99994767,6.135155e-06,4.630438e-05
35929,to the,15,17,106,112,"Reduced Tumor Necrosis Factor- and increased Interferon- production were found, which might be ascribed to the expansion of Tregs and central memory T cells, and result in increased sensitivity of tumor cells to cytotoxic T lymphocyte activity.",30445020_5,-1,-1,-1,-1,35929,-1,5.3180493e-06,0.99999,4.6509103e-06
35932,tumor cells to cytotoxic T lymphocyte,32,38,199,236,"Reduced Tumor Necrosis Factor- and increased Interferon- production were found, which might be ascribed to the expansion of Tregs and central memory T cells, and result in increased sensitivity of tumor cells to cytotoxic T lymphocyte activity.",30445020_5,-1,-1,-1,-1,35932,-1,4.2177868e-05,6.527567e-05,0.9998925
35933,Receptor-Fas,1,2,4,16,Fas Receptor-Fas Ligand interaction plays a critical role in GVL instead of aGVHD.,30445020_6,0,1,2,-1,35933,-1,0.033552196,0.94538486,0.021062978
35955,bloods,8,9,43,49,"CD4+ T cells were purified from peripheral bloods and bronchoalveolar lavage fluids (BALF), and were stimulated with -secretase inhibitor (GSI).",30473538_4,0,1,-1,-1,35955,-1,0.00021985176,0.9989504,0.00082975463
35956,to Notch receptors,2,5,19,37,mRNA corresponding to Notch receptors and transcriptional factors were measured by real-time PCR.,30473538_5,-1,-1,-1,-1,35956,-1,0.00039899265,0.9990393,0.00056177605
35957,transcriptional factors,6,8,42,65,mRNA corresponding to Notch receptors and transcriptional factors were measured by real-time PCR.,30473538_5,-1,-1,-1,-1,35957,-1,6.1177157e-06,0.9999888,5.091537e-06
35964,bloods,14,15,91,97,Notch1 mRNA expression was significantly elevated in CD4+ T cells purified from peripheral bloods and tumor site BALF in lung adenocarcinoma patients.,30473538_8,0,1,-1,-1,35964,-1,0.0009271061,0.99396896,0.0051039737
35984,to the tumor,10,13,78,90,Prevention of intratumoral Treg accumulation by inhibition of their migration to the tumor microenvironment is a promising therapeutic strategy.,30572845_1,-1,-1,-1,-1,35984,-1,8.906431e-06,0.99998236,8.6886375e-06
35990,the two,11,13,50,57,The aim of this study was to identify the role of the two major Treg-attracting chemokines CCL1 and CCL22 in human breast cancer.,30572845_2,-1,-1,-1,-1,35990,-1,5.974348e-06,0.99998915,4.911947e-06
35991,Treg-attracting chemokines CCL1,14,17,64,95,The aim of this study was to identify the role of the two major Treg-attracting chemokines CCL1 and CCL22 in human breast cancer.,30572845_2,-1,-1,-1,-1,35991,-1,0.0042454335,0.9834706,0.012283989
35993,tissue,5,6,33,39,METHODS: One hundred ninety-nine tissue samples of patients with invasive breast cancer were stained for CCL1 and CCL22 by immunohistochemistry.,30572845_3,-1,1,2,-1,35993,-1,4.3242893e-05,0.99972516,0.00023159359
35999,the transcription factor FoxP3,14,18,95,125,"Chemokine expression and tumor infiltration by regulatory T cells, determined by expression of the transcription factor FoxP3, were quantified and their correlation to clinical features was statistically analyzed.",30572845_4,-1,-1,-1,-1,35999,-1,5.6778895e-06,0.9999894,4.888228e-06
36005,tissues,12,13,66,73,RESULTS: Both CCL1 and CCL22 were expressed in most breast cancer tissues.,30572845_5,-1,1,2,-1,36005,-1,0.0004400808,0.1590921,0.8404679
36008,tissue,13,14,93,99,CCL1 was significantly over-expressed in invasive breast cancer as compared to normal breast tissue.,30572845_6,-1,1,2,-1,36008,-1,5.062085e-05,0.9964174,0.0035319964
36012,tumor-infiltrating FoxP3,15,17,86,110,"CCL1, but surprisingly not CCL22, showed a significant correlation with the number of tumor-infiltrating FoxP3+ Treg (p<0.001).",30572845_7,-1,-1,-1,-1,36012,-1,1.1609101e-05,0.99997973,8.65986e-06
36016,related to,8,10,56,66,High numbers of intratumoral CCL1 expressing cells were related to high grade tumors (G4) and a positive estrogen receptor (ER) status whereas high CCL22 expression was generally seen in lower grade tumors.,30572845_8,-1,-1,-1,-1,36016,-1,8.915583e-06,0.9999833,7.831958e-06
36018,receptor,20,21,114,122,High numbers of intratumoral CCL1 expressing cells were related to high grade tumors (G4) and a positive estrogen receptor (ER) status whereas high CCL22 expression was generally seen in lower grade tumors.,30572845_8,0,1,2,-1,36018,-1,0.00041438403,0.9982742,0.0013114266
36028,this trend,29,31,152,162,"The median survival of 88 patients with high intratumoral CCL1 expression was 37months compared to 50months for the 87 patients with low CCL1 levels, this trend was however not statistically significant.",30572845_9,-1,-1,-1,-1,36028,-1,6.734427e-06,0.9999883,4.937417e-06
36039,therapeutic target,10,12,52,70,"Thus, CCL1 may serve as prognostic marker and novel therapeutic target in breast cancer.",30572845_12,-1,-1,-1,-1,36039,-1,5.9930644e-06,0.9999889,5.065978e-06
36040,protein,4,5,39,46,"High mobility group nucleosome-binding protein 1 (HMGN1 or N1) is a Th1-polarizing alarmin, but alone is insufficient to induce antitumor immunity.",30619338_0,0,1,-1,-1,36040,-1,2.0769477e-05,0.9999602,1.8985926e-05
36043,immunity,23,24,138,146,"High mobility group nucleosome-binding protein 1 (HMGN1 or N1) is a Th1-polarizing alarmin, but alone is insufficient to induce antitumor immunity.",30619338_0,0,-1,2,-1,36043,-1,0.99989176,3.1091688e-05,7.7062534e-05
36047,immunity,26,27,164,172,"We previously showed that combination of N1 and R848, a synthetic TLR7/8 agonist, synergistically activates dendritic cells (DCs) and induces therapeutic antitumor immunity, however, it remained unclear how N1 and R848 synergistically activate DCs.",30619338_1,0,-1,2,-1,36047,-1,0.99969304,7.7467026e-05,0.0002295395
36053,TNF-,47,48,262,267,"Here, we show that co-stimulation with N1 and R848 of human monocyte-derived DCs (MoDCs) markedly upregulated DC's surface expression of CD80, CD83, CD86, and HLA-DR, as well as synergistic production of pro-inflammatory cytokines including IL-12p70, IL-1, and TNF-.",30619338_2,0,1,-1,-1,36053,-1,0.00043326797,0.9995073,5.942001e-05
36068,analysis,1,2,8,16,"RNA-seq analysis in human MoDCs revealed that N1 plus R848 synergistically upregulated the expression of genes predominantly involved in DC maturation pathway, particularly genes critical for the polarization of Th1 immune responses (e.g., IL12A, IL12B, and IFNB1, etc.).",30619338_6,0,1,-1,-1,36068,-1,6.598515e-06,0.9999877,5.6758718e-06
36075,Th1 immune responses,30,33,212,232,"RNA-seq analysis in human MoDCs revealed that N1 plus R848 synergistically upregulated the expression of genes predominantly involved in DC maturation pathway, particularly genes critical for the polarization of Th1 immune responses (e.g., IL12A, IL12B, and IFNB1, etc.).",30619338_6,-1,-1,-1,-1,36075,-1,0.32070112,0.670497,0.0088018235
36082,transcriptional factors,38,40,214,237,"Overall, our findings show that (1) N1 synergizes with R848 in activating human and mouse DCs and (2) the synergistic effect based on various intracellular signaling events culminated in the activation of multiple transcriptional factors.",30619338_7,-1,-1,-1,-1,36082,-1,7.3410956e-06,0.9999876,5.0139706e-06
36088,Interleukin-32,0,1,0,14,Interleukin-32 (IL-32) was originally identified in natural killer (NK) cells activated by IL-2 in 1992.,30638183_0,0,-1,2,-1,36088,-1,0.051150862,0.00027022336,0.94857883
36094,cell transcript,6,8,22,37,"Thus, it was named NK cell transcript 4 (NK4) because of its unknown function at that time.",30638183_1,-1,-1,-1,-1,36094,-1,0.0010657207,0.074049525,0.9248848
36095,function,16,17,69,77,"Thus, it was named NK cell transcript 4 (NK4) because of its unknown function at that time.",30638183_1,0,1,2,-1,36095,-1,1.9840605e-05,0.9999627,1.7471295e-05
36096,that time,18,20,81,90,"Thus, it was named NK cell transcript 4 (NK4) because of its unknown function at that time.",30638183_1,-1,-1,-1,-1,36096,-1,8.192451e-06,0.9999809,1.08837485e-05
36097,The function,0,2,0,12,The function of IL-32 has been elucidated over the last decade.,30638183_2,-1,-1,-1,-1,36097,-1,1.0992239e-05,0.99998045,8.542666e-06
36104,those cytokines,23,25,156,171,IL-32 is primarily considered to be a booster of inflammatory reactions because it is induced by proinflammatory cytokines and stimulates the production of those cytokines and vice versa.,30638183_3,-1,-1,-1,-1,36104,-1,0.9347833,0.062080845,0.0031358562
36112,IL-32 fosters the tumor,2,6,14,37,"Collectively, IL-32 fosters the tumor progression by nuclear factor-B (NF-B)-mediated cytokines and metalloproteinase production, as well as stimulation of differentiation into immunosuppressive cell types in some cancer types.",30638183_6,-1,-1,-1,-1,36112,-1,0.022838525,0.35880128,0.6183602
36114,cell types,24,26,197,207,"Collectively, IL-32 fosters the tumor progression by nuclear factor-B (NF-B)-mediated cytokines and metalloproteinase production, as well as stimulation of differentiation into immunosuppressive cell types in some cancer types.",30638183_6,-1,-1,-1,-1,36114,-1,2.1589312e-05,1.7705785e-05,0.99996066
36117,tumor cell,8,10,35,45,"However, it is also able to induce tumor cell apoptosis and enhance NK and cytotoxic T cell sensitivity in other cancer types.",30638183_7,-1,-1,-1,-1,36117,-1,6.307657e-05,0.0002997303,0.99963725
36121,the function,7,9,32,44,"In this review, we will address the function of each IL-32 isoform in different cancer types studied to date, and suggest further strategies to comprehensively elucidate the roles of IL-32 in a contextdependent manner. [BMB Reports 2019; 52(3): 165-174].",30638183_8,-1,-1,-1,-1,36121,-1,5.9584313e-06,0.99998784,6.252487e-06
36130,protein,10,11,60,67,"The IRE1/XBP1s signaling pathway is an arm of the unfolded protein response (UPR) that safeguards the fidelity of the cellular proteome during endoplasmic reticulum (ER) stress, and that has also emerged as a key regulator of dendritic cell (DC) homeostasis.",30687308_0,0,1,-1,-1,36130,-1,7.19694e-05,0.99990165,2.6335292e-05
36133,the cellular,20,22,115,127,"The IRE1/XBP1s signaling pathway is an arm of the unfolded protein response (UPR) that safeguards the fidelity of the cellular proteome during endoplasmic reticulum (ER) stress, and that has also emerged as a key regulator of dendritic cell (DC) homeostasis.",30687308_0,-1,-1,-1,-1,36133,-1,0.0015387912,0.8647986,0.13366255
36137,the regulation,9,11,42,56,"However, in the context of DC activation, the regulation of the IRE1/XBP1s axis is not fully understood.",30687308_1,-1,-1,-1,-1,36137,-1,5.2320806e-06,0.9999907,4.1111944e-06
36140,that cell,6,8,24,33,"In this work, we report that cell lysates generated from melanoma cell lines markedly induce XBP1s and certain members of the UPR such as the chaperone BiP in bone marrow derived DCs (BMDCs).",30687308_2,-1,-1,-1,-1,36140,-1,0.0010797622,0.042995654,0.9559247
36155,tumor antigens,24,26,158,172,"Altogether, this work provides evidence indicating that ex-vivo activation of the IRE1/XBP1 pathway in BMDCs enhances CD8+ T cell specific responses against tumor antigens.",30687308_4,-1,-1,-1,-1,36155,-1,0.49269336,0.50344706,0.0038595342
36158,T subset,7,9,31,39,V9V2 T cells are the main  T subset in the peripheral blood and lymphoid organs.,30708194_0,-1,-1,-1,-1,36158,-1,0.00018365205,0.0065939752,0.99322236
36160,blood,12,13,58,63,V9V2 T cells are the main  T subset in the peripheral blood and lymphoid organs.,30708194_0,0,1,-1,-1,36160,-1,0.00040303217,0.99697554,0.0026214377
36164,functions,20,21,125,134,Previous studies have shown that V9V2 T cells could expand in the presence of phosphoantigens and IL-2 and exert antitumor functions.,30708194_1,0,1,2,-1,36164,-1,7.0211e-05,0.9998229,0.000106844294
36170,T cells to,11,14,64,74,"In this study, we examined the proliferative response of V9V2 T cells to IL-21, a cytokine previously shown to promote NK cell and CD8 T cell cytotoxicity.",30708194_3,-1,-1,-1,-1,36170,-1,0.0018591124,0.044674583,0.9534664
36192,the STAT,6,8,47,55,Blocking Tim-3 increased the proliferation and the STAT phosphorylation in V9V2 T cells in response to IL-21.,30708194_10,-1,-1,-1,-1,36192,-1,5.0419203e-06,0.99999034,4.6420755e-06
36203,lifespan,17,18,115,123,"Despite having favorable prognosis, patients with differentiated thyroid carcinoma (DTC) still suffer from reduced lifespan due to recurrences, metastasis, and dedifferentiation.",30711567_0,0,-1,2,-1,36203,-1,4.201145e-05,0.9999435,1.451809e-05
36206,to the,8,10,40,46,"Regulatory B (Breg) cells are essential to the maintenance of peripheral tolerance, but upregulated Breg response may impede the clearance of pathogens and tumor cells.",30711567_1,-1,-1,-1,-1,36206,-1,6.11166e-06,0.9999893,4.625592e-06
36209,tumor cells,26,28,156,167,"Regulatory B (Breg) cells are essential to the maintenance of peripheral tolerance, but upregulated Breg response may impede the clearance of pathogens and tumor cells.",30711567_1,-1,-1,-1,-1,36209,-1,0.00035034798,0.009479774,0.9901698
36227,IL-10 than the,11,14,68,82,"Moreover, each IL-10-producing B cell in DTC patients produced more IL-10 than the counterparts in healthy controls.",30711567_5,-1,-1,-1,-1,36227,-1,0.9957723,0.0035121972,0.00071549497
36228,This IL-10,0,2,0,10,This IL-10+ subset was enriched in the CD27+ fraction.,30711567_6,-1,-1,-1,-1,36228,-1,0.87270546,0.12534054,0.0019539546
36252,the two,24,26,153,160,"Unstimulated CD27+ B cells presented low STAT3 and Erk phosphorylation in both healthy controls and DTC patients, with no significant difference between the two groups.",30711567_12,-1,-1,-1,-1,36252,-1,6.6865828e-06,0.9999881,5.277203e-06
36255,cell-mediated IL-10,7,9,36,55,"Overall, this study suggests that B cell-mediated IL-10 production can exert complex effects toward autologous T cells.",30711567_13,-1,-1,-1,-1,36255,-1,0.6334143,0.002514808,0.3640709
36260,Th9 cells,2,4,15,24,Tumor specific Th9 cells are potential effector cells for adoptive therapy of human cancers.,30717817_0,-1,-1,-1,-1,36260,-1,0.00021849276,0.0039583873,0.995823
36262,therapy,10,11,67,74,Tumor specific Th9 cells are potential effector cells for adoptive therapy of human cancers.,30717817_0,0,1,-1,-1,36262,-1,4.92582e-06,0.9999895,5.515747e-06
36263,TNF,0,1,0,3,"TNF family members OX40L, TL1A and GITRL have been shown to promote the induction of Th9 cells and antitumor immunity.",30717817_1,0,1,-1,-1,36263,-1,0.0002786901,0.9996847,3.6657355e-05
36268,Th9 cells,16,18,85,94,"TNF family members OX40L, TL1A and GITRL have been shown to promote the induction of Th9 cells and antitumor immunity.",30717817_1,-1,-1,-1,-1,36268,-1,2.2048973e-05,4.3982895e-05,0.99993396
36269,immunity,20,21,109,117,"TNF family members OX40L, TL1A and GITRL have been shown to promote the induction of Th9 cells and antitumor immunity.",30717817_1,0,-1,2,-1,36269,-1,0.9998635,4.1887997e-05,9.4652074e-05
36271,TNF-,5,6,21,26,"However, the role of TNF-, the prototype of the TNF superfamily cytokines, in Th9 cell differentiation and their antitumor efficacy is not defined.",30717817_2,0,1,-1,-1,36271,-1,5.8579146e-05,0.9999176,2.3826826e-05
36273,the TNF superfamily cytokines,10,14,45,74,"However, the role of TNF-, the prototype of the TNF superfamily cytokines, in Th9 cell differentiation and their antitumor efficacy is not defined.",30717817_2,-1,-1,-1,-1,36273,-1,0.06550518,0.93238413,0.0021106957
36274,Th9 cell,16,18,79,87,"However, the role of TNF-, the prototype of the TNF superfamily cytokines, in Th9 cell differentiation and their antitumor efficacy is not defined.",30717817_2,-1,-1,-1,-1,36274,-1,0.0002456665,0.007951431,0.9918029
36276,that TNF-,4,6,16,26,"Here, we showed that TNF- potently promoted nave CD4+ T cells to differentiate into Th9 cells in vitro.",30717817_3,-1,-1,-1,-1,36276,-1,4.4832406e-05,0.9999386,1.6602411e-05
36277,T cells to,11,14,56,66,"Here, we showed that TNF- potently promoted nave CD4+ T cells to differentiate into Th9 cells in vitro.",30717817_3,-1,-1,-1,-1,36277,-1,0.000988198,0.0297054,0.96930635
36278,Th9 cells,16,18,86,95,"Here, we showed that TNF- potently promoted nave CD4+ T cells to differentiate into Th9 cells in vitro.",30717817_3,-1,-1,-1,-1,36278,-1,0.00015591702,0.003251369,0.9965927
36280,TNF-,5,6,29,34,"Furthermore, the addition of TNF- during Th9 cell differentiation increased T cell survival and proliferation.",30717817_4,0,1,-1,-1,36280,-1,0.00013782414,0.9998266,3.5608147e-05
36281,Th9 cell,7,9,42,50,"Furthermore, the addition of TNF- during Th9 cell differentiation increased T cell survival and proliferation.",30717817_4,-1,-1,-1,-1,36281,-1,5.220356e-05,0.00029836447,0.9996494
36285,TNF--treated Th9 cells,7,10,43,66,"More importantly, the adoptive transfer of TNF--treated Th9 cells induced more potent antitumor effects than regular Th9 cells in mouse tumor model.",30717817_5,-1,-1,-1,-1,36285,-1,0.003172604,0.8663237,0.13050373
36287,Th9 cells,17,19,118,127,"More importantly, the adoptive transfer of TNF--treated Th9 cells induced more potent antitumor effects than regular Th9 cells in mouse tumor model.",30717817_5,-1,-1,-1,-1,36287,-1,1.7196231e-05,4.0836934e-05,0.99994195
36289,TNF-,0,1,0,5,"TNF- signals via two cell surface receptors, TNFR1 and TNFR2.",30717817_6,0,1,-1,-1,36289,-1,0.002353773,0.9975298,0.000116451214
36290,two cell,3,5,18,26,"TNF- signals via two cell surface receptors, TNFR1 and TNFR2.",30717817_6,-1,-1,-1,-1,36290,-1,0.0069836695,0.18686588,0.80615044
36291,receptors,6,7,35,44,"TNF- signals via two cell surface receptors, TNFR1 and TNFR2.",30717817_6,0,1,2,-1,36291,-1,6.13122e-05,2.5603375e-05,0.9999131
36292,TNFR1,8,9,46,51,"TNF- signals via two cell surface receptors, TNFR1 and TNFR2.",30717817_6,0,1,-1,-1,36292,-1,1.6453061e-05,0.9999603,2.32084e-05
36293,TNFR2,10,11,56,61,"TNF- signals via two cell surface receptors, TNFR1 and TNFR2.",30717817_6,0,1,-1,-1,36293,-1,7.1008675e-05,0.9999114,1.7595517e-05
36294,that TNF-,3,5,29,39,Mechanistic studies revealed that TNF- drove Th9 cell differentiation through TNFR2 but not TNFR1.,30717817_7,-1,-1,-1,-1,36294,-1,0.00010234306,0.9998746,2.3094542e-05
36295,Th9 cell,6,8,46,54,Mechanistic studies revealed that TNF- drove Th9 cell differentiation through TNFR2 but not TNFR1.,30717817_7,-1,-1,-1,-1,36295,-1,2.8759054e-05,6.829144e-05,0.99990296
36296,through TNFR2,9,11,71,84,Mechanistic studies revealed that TNF- drove Th9 cell differentiation through TNFR2 but not TNFR1.,30717817_7,-1,-1,-1,-1,36296,-1,7.4487776e-05,0.99991,1.5538766e-05
36297,TNFR1,13,14,93,98,Mechanistic studies revealed that TNF- drove Th9 cell differentiation through TNFR2 but not TNFR1.,30717817_7,0,1,-1,-1,36297,-1,1.1011524e-05,0.9999739,1.5095273e-05
36299,TNF-,8,9,45,50,"In addition, under Th9 polarizing condition, TNF- activated STAT5 and NF-B pathways in T cells in a TNFR2-dependent manner.",30717817_8,0,1,-1,-1,36299,-1,7.200959e-05,0.99990106,2.6937441e-05
36302,TNFR2-dependent,19,20,102,117,"In addition, under Th9 polarizing condition, TNF- activated STAT5 and NF-B pathways in T cells in a TNFR2-dependent manner.",30717817_8,0,1,-1,-1,36302,-1,1.4752631e-05,0.99997437,1.0876767e-05
36305,TNF--induced Th9 cell,11,14,77,99,Inhibition of STAT5 and NF-B pathways by their specific inhibitors impaired TNF--induced Th9 cell differentiation.,30717817_9,-1,-1,-1,-1,36305,-1,0.005687863,0.89271945,0.10159269
36306,TNF-,3,4,23,28,Our results identified TNF- as a new powerful inducer of Th9 cells and clarified the molecular mechanisms underlying TNF--induced Th9 cell differentiation.,30717817_10,0,1,-1,-1,36306,-1,9.083859e-05,0.99988425,2.4884028e-05
36307,Th9 cells,10,12,58,67,Our results identified TNF- as a new powerful inducer of Th9 cells and clarified the molecular mechanisms underlying TNF--induced Th9 cell differentiation.,30717817_10,-1,-1,-1,-1,36307,-1,2.6304087e-05,8.649456e-05,0.9998871
36309,TNF--induced Th9 cell,18,21,118,140,Our results identified TNF- as a new powerful inducer of Th9 cells and clarified the molecular mechanisms underlying TNF--induced Th9 cell differentiation.,30717817_10,-1,-1,-1,-1,36309,-1,0.0026067914,0.90920043,0.088192716
36317,tumor types,48,50,299,310,"However, resistance to PARP inhibitors may preexist or evolve during treatment in many cancer types and may be overcome by combining PARP inhibitors with other therapies, such as immune checkpoint inhibitors, which confer durable responses and are rapidly becoming the standard of care for multiple tumor types.",30755715_1,-1,-1,-1,-1,36317,-1,9.552366e-06,0.999977,1.3434225e-05
36319,the therapeutic,3,5,24,39,"This study investigated the therapeutic potential of combining niraparib, a highly selective PARP1/2 inhibitor, with anti-PD-1 immune checkpoint inhibitors in preclinical tumor models.",30755715_2,-1,-1,-1,-1,36319,-1,4.058388e-06,0.9999919,4.084188e-06
36324,the type,10,12,72,80,Our results indicate that niraparib treatment increases the activity of the type I (alpha) and type II (gamma) interferon pathways and enhances the infiltration of CD8+ cells and CD4+ cells in tumors.,30755715_3,-1,-1,-1,-1,36324,-1,4.9781033e-06,0.9999896,5.4421116e-06
36336,tumor cell,18,20,127,137,"Interestingly, mice with tumors cured by niraparib monotherapy completely rejected tumor growth upon rechallenge with the same tumor cell line, suggesting the potential establishment of immune memory in animals treated with niraparib monotherapy.",30755715_5,-1,-1,-1,-1,36336,-1,0.00048008366,0.012036182,0.98748374
36339,Taken together,0,2,0,14,"Taken together, our findings uncovered immunomodulatory effects of niraparib that may sensitize tumors to immune checkpoint blockade therapies.",30755715_6,-1,-1,-1,-1,36339,-1,1.1194845e-05,0.99998057,8.18823e-06
36341,tumors to,13,15,96,105,"Taken together, our findings uncovered immunomodulatory effects of niraparib that may sensitize tumors to immune checkpoint blockade therapies.",30755715_6,-1,-1,-1,-1,36341,-1,4.7208378e-06,0.9999912,4.1387216e-06
36347,T-helper cells that,13,16,53,72,IL-9-producing CD4+ (Th9) cells are a subset of CD4+ T-helper cells that are endowed with powerful antitumor capacity.,30914642_0,-1,-1,-1,-1,36347,-1,0.00021884762,0.9955264,0.0042547057
36350,Th9 cell-priming,11,13,63,79,Both IL-4 and TGF- have been reported to be indispensable for Th9 cell-priming and differentiation.,30914642_1,-1,-1,-1,-1,36350,-1,3.3371056e-05,3.18051e-05,0.9999348
36351,that Th9 cell,7,10,27,40,"Here we show, by contrast, that Th9 cell development can occur in the absence of TGF- signaling.",30914642_2,-1,-1,-1,-1,36351,-1,0.0022350335,0.19646658,0.8012983
36358,IL-9-producing T cells,15,18,89,111,"When TGF- was replaced by IL-1, the combination of IL-1 and IL-4 efficiently promoted IL-9-producing T cells (Th9IL-4+IL-1).",30914642_3,-1,-1,-1,-1,36358,-1,0.9271512,0.00029462608,0.07255421
36361,IL-1 cells,2,4,9,20,"Th9IL-4+ IL-1 cells are phenotypically distinct T cells compared to classic Th9 cells (Th9IL-4+TGF-) and other Th cells, and are enriched for IL-1 and NF-B gene signatures.",30914642_4,-1,-1,-1,-1,36361,-1,0.81338286,0.00025625355,0.18636085
36364,Th9 cells,12,14,77,86,"Th9IL-4+ IL-1 cells are phenotypically distinct T cells compared to classic Th9 cells (Th9IL-4+TGF-) and other Th cells, and are enriched for IL-1 and NF-B gene signatures.",30914642_4,-1,-1,-1,-1,36364,-1,9.310396e-05,0.0020657957,0.997841
36366,Th cells,19,21,113,121,"Th9IL-4+ IL-1 cells are phenotypically distinct T cells compared to classic Th9 cells (Th9IL-4+TGF-) and other Th cells, and are enriched for IL-1 and NF-B gene signatures.",30914642_4,-1,-1,-1,-1,36366,-1,8.306826e-06,5.9366157e-06,0.9999857
36371,Th9IL-4+IL-1 cells,10,12,71,90,Inhibition of NF-B but not TGF--signaling negates IL-9 production by Th9IL-4+IL-1 cells.,30914642_5,-1,-1,-1,-1,36371,-1,0.016331699,0.5214547,0.4622136
36372,Th9IL-4+TGF- cells,6,8,40,59,"Furthermore, when compared with classic Th9IL-4+TGF- cells, Th9IL-4+IL-1 cells are less exhausted, exhibit cytotoxic T effector gene signature and tumor killing function, and exert a superior antitumor response in a mouse melanoma model.",30914642_6,-1,-1,-1,-1,36372,-1,0.0014262061,0.88634497,0.112228885
36373,Th9IL-4+IL-1 cells,9,11,61,80,"Furthermore, when compared with classic Th9IL-4+TGF- cells, Th9IL-4+IL-1 cells are less exhausted, exhibit cytotoxic T effector gene signature and tumor killing function, and exert a superior antitumor response in a mouse melanoma model.",30914642_6,-1,-1,-1,-1,36373,-1,0.008766367,0.6530059,0.33822775
36377,function,24,25,163,171,"Furthermore, when compared with classic Th9IL-4+TGF- cells, Th9IL-4+IL-1 cells are less exhausted, exhibit cytotoxic T effector gene signature and tumor killing function, and exert a superior antitumor response in a mouse melanoma model.",30914642_6,0,1,2,-1,36377,-1,0.00035017528,0.9988513,0.0007985473
36379,Th9 cell,8,10,52,60,Our study thus describes an alternative pathway for Th9 cell differentiation and provides a potential avenue for antitumor therapies.,30914642_7,-1,-1,-1,-1,36379,-1,1.3059045e-05,1.4203092e-05,0.9999727
36399,Th17 cells,36,38,181,191,"The aim of this study was to investigate the frequency of circulating CD4+CD25-Foxp3+ Treg cells and their role in NSCLC. Methods: The frequencies of Treg, T helper (Th)1, Th2, and Th17 cells in peripheral blood were separately measured in 36 NSCLC patients and 20 healthy controls (HCs) using flow cytometry.",30925076_2,-1,-1,-1,-1,36399,-1,0.00011839984,0.0011989683,0.99868256
36400,blood,40,41,206,211,"The aim of this study was to investigate the frequency of circulating CD4+CD25-Foxp3+ Treg cells and their role in NSCLC. Methods: The frequencies of Treg, T helper (Th)1, Th2, and Th17 cells in peripheral blood were separately measured in 36 NSCLC patients and 20 healthy controls (HCs) using flow cytometry.",30925076_2,0,1,-1,-1,36400,-1,0.0035943263,0.8980056,0.098400064
36417,the tumor,12,14,68,77,The drivers and the specification of CD4+ T cell differentiation in the tumor microenvironment and their contributions to tumor immunity or tolerance are incompletely understood.,30926808_0,-1,-1,-1,-1,36417,-1,5.5097366e-06,0.9999902,4.245155e-06
36419,to tumor immunity,18,21,119,136,The drivers and the specification of CD4+ T cell differentiation in the tumor microenvironment and their contributions to tumor immunity or tolerance are incompletely understood.,30926808_0,-1,-1,-1,-1,36419,-1,0.0108756665,0.9885923,0.00053201546
36427,FoxP3neg tumor-promoting IL-10+IL-17+IFN+,16,19,91,133,"Specifically, CD11b+CD103- DC predominate in PDA, express high IL-23 and TGF-, and induce FoxP3neg tumor-promoting IL-10+IL-17+IFN+regulatory CD4+ T cells.",30926808_2,-1,-1,-1,-1,36427,-1,0.030637678,0.96860325,0.000758998
36434,receptor,18,19,112,120,The balance between this distinctive TH program and canonical FoxP3+TREGS is unaffected by pattern recognition receptor ligation and is modulated by DC expression of retinoic acid.,30926808_3,0,1,2,-1,36434,-1,0.031127457,0.00057758874,0.9682949
36435,This TH-signature,0,2,0,17,This TH-signature is mimicked in human PDA where it is associated with immune-tolerance and diminished patient survival.,30926808_4,-1,-1,-1,-1,36435,-1,1.11681375e-05,0.9999801,8.70602e-06
36437,CD4+ T cell tolerance,7,12,46,67,Our data suggest that CD11b+CD103- DC promote CD4+ T cell tolerance in PDA which may underscore its resistance to immunotherapy.,30926808_5,-1,-1,-1,-1,36437,-1,0.00011006354,8.674007e-05,0.99980325
36445,the tumor,32,34,215,224,"Here, we examined the association of programmed cell death ligand 1 (PD-L1) expression with epithelial-mesenchymal transition (EMT)-associated markers in pancreatic ductal adenocarcinoma (PDA) within the context of the tumor microenvironment.",30927618_1,-1,-1,-1,-1,36445,-1,4.113757e-06,0.9999912,4.7406074e-06
36451,them to,17,19,135,142,"RESULTS: Immunohistochemistry revealed a significant correlation between vimentin and PD-L1 expression, whereas double staining showed them to be simultaneously expressed by PDA cells.",30927618_4,-1,-1,-1,-1,36451,-1,5.6209033e-06,0.99998915,5.2294386e-06
36457,tumor cells,1,3,4,15,"PDA tumor cells promoted PD-L1 expression and EMT under the presence of IFN-, which was inhibited by the signal transducer and activator of transcription (STAT)1 small interfering RNA.CONCLUSIONS: Strong correlations were observed between PD-L1 expression, EMT, and the immunosuppressive tumor microenvironment.",30927618_6,-1,-1,-1,-1,36457,-1,0.00010056109,0.0006906129,0.99920887
36460,the signal transducer and activator of transcription,18,25,102,154,"PDA tumor cells promoted PD-L1 expression and EMT under the presence of IFN-, which was inhibited by the signal transducer and activator of transcription (STAT)1 small interfering RNA.CONCLUSIONS: Strong correlations were observed between PD-L1 expression, EMT, and the immunosuppressive tumor microenvironment.",30927618_6,-1,-1,-1,-1,36460,-1,6.8289796e-06,0.9999862,6.950261e-06
36463,Targeting STAT1,0,2,0,15,Targeting STAT1 combined with PD-1/PD-L1 immunotherapy may improve outcomes for patients with PDA.,30927618_7,-1,-1,-1,-1,36463,-1,5.0252406e-06,0.99998486,1.0109664e-05
36471,tissues,12,13,73,80,Tregs are decisive not only in the protection against destruction of own tissues by autoimmune immunocompetent cells but also in the immunological answer to developing cancers.,30944830_1,-1,1,2,-1,36471,-1,0.00019363272,0.001044594,0.9987618
36481,blood,7,8,57,62,The percentage of regulatory T-lymphocytes in peripheral blood and bone marrow was elevated compared to those in healthy individuals and correlated with progressive disease.,30944830_4,0,1,-1,-1,36481,-1,0.004249941,0.65350413,0.34224588
36482,to those,14,16,101,109,The percentage of regulatory T-lymphocytes in peripheral blood and bone marrow was elevated compared to those in healthy individuals and correlated with progressive disease.,30944830_4,-1,-1,-1,-1,36482,-1,5.9964314e-06,0.99998796,5.985382e-06
36483,Regulatory T-cells taken,0,3,0,24,"Regulatory T-cells taken from children diagnosed with leukemia showed a higher suppressive capability, which was confirmed by detecting elevated levels of secreted IL-10 and TGF-beta.",30944830_5,-1,-1,-1,-1,36483,-1,0.0006673551,0.007444082,0.9918886
36485,TGF-beta,25,26,174,182,"Regulatory T-cells taken from children diagnosed with leukemia showed a higher suppressive capability, which was confirmed by detecting elevated levels of secreted IL-10 and TGF-beta.",30944830_5,0,1,-1,-1,36485,-1,1.4521493e-05,0.9999794,6.151743e-06
36490,targeted therapies,10,12,48,66,"Presumably, Treg cells could be a vital part of targeted therapies.",30944830_7,-1,-1,-1,-1,36490,-1,5.962134e-06,0.99998915,4.837114e-06
36498,blood,18,19,107,112,"This proposition results from the fact that in some studies, higher percentage of Treg cells in peripheral blood was demonstrated.",30944830_9,0,1,-1,-1,36498,-1,0.004341264,0.33831,0.6573487
36501,them to the,12,15,77,88,"However, observations confirming these facts are scarce; thus, extrapolating them to the population of children with hematological malignancies needs to be verified in additional studies.",30944830_10,-1,-1,-1,-1,36501,-1,7.5446633e-06,0.9999876,4.8373367e-06
36509,two subsets,17,19,107,118,"We comprehensively characterized myeloid cells in tumor draining lymph nodes (tdLN) of mice and identified two subsets of conventional type-2 dendritic cells (cDC2) that traffic from tumor to tdLN and present tumor-derived antigens to CD4+ Tconv, but then fail to support antitumor CD4+ Tconv differentiation.",30955881_1,-1,-1,-1,-1,36509,-1,0.004881097,0.16274264,0.83237624
36512,that traffic,27,29,165,177,"We comprehensively characterized myeloid cells in tumor draining lymph nodes (tdLN) of mice and identified two subsets of conventional type-2 dendritic cells (cDC2) that traffic from tumor to tdLN and present tumor-derived antigens to CD4+ Tconv, but then fail to support antitumor CD4+ Tconv differentiation.",30955881_1,-1,-1,-1,-1,36512,-1,8.364819e-06,0.9999838,7.884398e-06
36513,tumor to tdLN,30,33,183,196,"We comprehensively characterized myeloid cells in tumor draining lymph nodes (tdLN) of mice and identified two subsets of conventional type-2 dendritic cells (cDC2) that traffic from tumor to tdLN and present tumor-derived antigens to CD4+ Tconv, but then fail to support antitumor CD4+ Tconv differentiation.",30955881_1,-1,-1,-1,-1,36513,-1,6.8733775e-06,0.9999844,8.699742e-06
36514,tumor-derived antigens to,35,38,209,234,"We comprehensively characterized myeloid cells in tumor draining lymph nodes (tdLN) of mice and identified two subsets of conventional type-2 dendritic cells (cDC2) that traffic from tumor to tdLN and present tumor-derived antigens to CD4+ Tconv, but then fail to support antitumor CD4+ Tconv differentiation.",30955881_1,-1,-1,-1,-1,36514,-1,0.00015764605,0.99981517,2.7194188e-05
36525,relative to Treg,15,18,88,104,"Analogous cDC2 populations were identified in patients, and as in mice, their abundance relative to Treg predicts protective ICOS+ PD-1lo CD4+ Tconv phenotypes and survival.",30955881_3,-1,-1,-1,-1,36525,-1,6.5172326e-06,0.99998796,5.498501e-06
36530,therapy,27,28,160,167,"Further, in melanoma patients with lowTreg abundance, intratumoral cDC2 density alonecorrelates with abundant CD4+ Tconv and with responsiveness to anti-PD-1 therapy.",30955881_4,0,1,-1,-1,36530,-1,5.001492e-06,0.99999046,4.5848583e-06
36537,the cytokine,6,8,42,54,BACKGROUND: The immunosuppressive role of the cytokine IL-35 in patients with non-small cell lung cancer (NSCLC) is poorly understood.,30956278_0,-1,-1,-1,-1,36537,-1,0.6635604,0.33229098,0.00414865
36548,analysis,3,4,27,35,"Immunohistochemistry, FACS analysis, real-time PCR, as well as western blot from samples of the control (CTR), peri-tumoural (PT) and the tumoural (TU) region of the lung derived from patients with NSCLC and 10 controls were performed.",30956278_3,0,1,-1,-1,36548,-1,7.400541e-06,0.9999826,1.0055007e-05
36550,the tumoural,27,29,134,146,"Immunohistochemistry, FACS analysis, real-time PCR, as well as western blot from samples of the control (CTR), peri-tumoural (PT) and the tumoural (TU) region of the lung derived from patients with NSCLC and 10 controls were performed.",30956278_3,-1,-1,-1,-1,36550,-1,6.14787e-06,0.99998474,9.067136e-06
36553,the TU,10,12,51,57,RESULTS: Here we found elevated levels of IL-35 in the TU region as well as postoperative serum from patients with lung adenocarcinoma.,30956278_4,-1,-1,-1,-1,36553,-1,5.7929024e-06,0.9999875,6.668143e-06
36555,TNFA,20,21,128,132,"Consistently, we found an increased expression of IL-35+Foxp-3+ cells, which associated with ARG1 mRNA expression and decreased TNFA in the TU region of the lung of patients with NSCLC as compared to their CTR region.",30956278_5,0,1,-1,-1,36555,-1,1.4567683e-05,0.9999776,7.808533e-06
36556,the TU,22,24,136,142,"Consistently, we found an increased expression of IL-35+Foxp-3+ cells, which associated with ARG1 mRNA expression and decreased TNFA in the TU region of the lung of patients with NSCLC as compared to their CTR region.",30956278_5,-1,-1,-1,-1,36556,-1,4.366313e-06,0.9999907,4.887582e-06
36558,to their,34,36,197,205,"Consistently, we found an increased expression of IL-35+Foxp-3+ cells, which associated with ARG1 mRNA expression and decreased TNFA in the TU region of the lung of patients with NSCLC as compared to their CTR region.",30956278_5,-1,-1,-1,-1,36558,-1,4.7661233e-06,0.99999,5.211038e-06
36564,the TU,10,12,64,70,"Finally, IL-35 positively correlated with TTF-1+PD-L1+ cells in the TU region of NSCLC patients.",30956278_7,-1,-1,-1,-1,36564,-1,5.839091e-06,0.9999869,7.219321e-06
36566,the TU,8,10,50,56,CONCLUSIONS: Induced IL-35+Foxp3+ cell numbers in the TU region of the lung of patients with NSCLC associated with ARG1 mRNA expression and with TTF-1+PD-L1+ cells.,30956278_8,-1,-1,-1,-1,36566,-1,4.7776334e-06,0.9999893,5.9732547e-06
36570,the tumour-free,1,3,3,18,"In the tumour-free CTR area, IL-35 correlated with CD68+ macrophages.",30956278_9,-1,-1,-1,-1,36570,-1,9.873352e-06,0.99998164,8.501439e-06
36579,the TU,45,47,333,339,Thus inhibitors to IL-35 would probably succeed in combination with antibodies against immune checkpoints like PD-L1 and PD-1 currently used against NSCLC because they would inhibit immunosuppressive macrophages and T regulatory cells while promoting T cell-mediated anti-tumoural immune responses in the microenvironment as well as the TU region of NSCLC patients.,30956278_10,-1,-1,-1,-1,36579,-1,4.919878e-06,0.9999907,4.411143e-06
36585,Tissue,0,1,0,6,"Tissue expression of Forkhead box P3 (FOXP3), one of the transcription factors of Treg cells, and transforming growth factor-beta (TGF-) were examined by immunohistochemistry.",30981619_3,-1,1,2,-1,36585,-1,8.2594115e-06,0.9999825,9.259423e-06
36588,the transcription factors,12,15,53,78,"Tissue expression of Forkhead box P3 (FOXP3), one of the transcription factors of Treg cells, and transforming growth factor-beta (TGF-) were examined by immunohistochemistry.",30981619_3,-1,-1,-1,-1,36588,-1,5.574906e-06,0.9999882,6.1967594e-06
36605,related to,10,12,75,85,"CONCLUSIONS: This study confirms current speculation that endometriosis is related to alteration in Treg cells, causing survival and implantation of ectopic endometrial lesions in women with endometrioma and dermoid cysts.",30981619_8,-1,-1,-1,-1,36605,-1,7.502198e-06,0.9999862,6.332963e-06
36608,the general,11,13,50,61,The findings may clarify why only 10% of women in the general population develop endometriosis despite cyclic menstruation with retrograde flow occurring in >90% of women.,30981619_9,-1,-1,-1,-1,36608,-1,9.328864e-06,0.99998295,7.772496e-06
36618,therapy,10,11,51,58,"However, in both mice and humans, chronic imatinib therapy decreases intratumoral DCs and effector CD8+ T cells.",31000683_3,0,1,-1,-1,36618,-1,5.289807e-06,0.99999046,4.2524175e-06
36622,to the,17,19,103,109,"The mechanism in our mouse model depends on Kit inhibition, which reduces intratumoral GM-CSF, leading to the accumulation of Batf3-lineage DC progenitors.",31000683_4,-1,-1,-1,-1,36622,-1,4.461975e-06,0.99999106,4.504568e-06
36628,immunity,11,12,82,90,Stimulants that expand and mature DCs during imatinib treatment improve antitumor immunity.,31000683_6,0,-1,2,-1,36628,-1,0.9999188,1.9249863e-05,6.201511e-05
36630,tumor cell,6,8,40,50,Our findings identify the importance of tumor cell oncogene activity in modulating the Batf3-dependent DC lineage and reveal therapeutic limitations for combined checkpoint blockade and tyrosine kinase inhibition.,31000683_7,-1,-1,-1,-1,36630,-1,0.00011668599,0.0012229065,0.99866045
36637,The tumor,0,2,0,9,The tumor immune microenvironment and secreted cytokines play a substantial role in development of resistance to chemotherapy.,31018021_1,-1,-1,-1,-1,36637,-1,5.107446e-06,0.9999901,4.8153106e-06
36638,cytokines play,6,8,47,61,The tumor immune microenvironment and secreted cytokines play a substantial role in development of resistance to chemotherapy.,31018021_1,-1,-1,-1,-1,36638,-1,0.97429955,0.024430327,0.0012701578
36639,to chemotherapy,15,17,110,125,The tumor immune microenvironment and secreted cytokines play a substantial role in development of resistance to chemotherapy.,31018021_1,-1,-1,-1,-1,36639,-1,0.6036358,0.38976964,0.006594562
36644,T-cell,26,27,155,161,"Our previous study has demonstrated that CD4+ T cells in prostate tumor microenvironment contribute to PCa progression; meanwhile, we found increased CD4+ T-cell infiltration in tumor area after Doc treatment; however, their effects on PCa chemosensitivity remain unclear.",31018021_2,-1,1,2,-1,36644,-1,1.1413373e-05,6.566042e-06,0.999982
36653,T-cell,4,5,14,20,"METHODS: CD4+ T-cell infiltration in Doc-treated paraffin-embedded specimens from transurethral resection of prostate, radical prostatectomy, or bone metastasis was detected by immunohistochemistry.",31018021_4,-1,1,2,-1,36653,-1,1.3284257e-05,7.2236544e-06,0.9999795
36657,T-cell,13,14,68,74,"The castration-resistant PCa cell lines-C4-2 and CWR22RV1, and CD4+ T-cell lines-HH and Molt-3 were used in the coculture system.",31018021_5,-1,1,2,-1,36657,-1,1.057558e-05,7.088951e-06,0.99998236
36659,the lymphocytes,3,5,21,36,"After coculture with the lymphocytes, PCa cell chemosensitivity was detected by cell counting kit-8, terminal deoxynucleotidyl transferase dUTP nick-end labeling assays, and Western blot analysis.",31018021_6,-1,-1,-1,-1,36659,-1,0.00045172698,0.012446304,0.987102
36660,cell chemosensitivity,7,9,42,63,"After coculture with the lymphocytes, PCa cell chemosensitivity was detected by cell counting kit-8, terminal deoxynucleotidyl transferase dUTP nick-end labeling assays, and Western blot analysis.",31018021_6,-1,-1,-1,-1,36660,-1,0.4793279,0.008620686,0.51205146
36664,analysis,27,28,187,195,"After coculture with the lymphocytes, PCa cell chemosensitivity was detected by cell counting kit-8, terminal deoxynucleotidyl transferase dUTP nick-end labeling assays, and Western blot analysis.",31018021_6,0,1,-1,-1,36664,-1,5.876445e-06,0.9999876,6.4767273e-06
36665,cell cytokines,1,3,8,22,Various cell cytokines were determined by cytokine arrays and reverse-transcription polymerase chain reaction.,31018021_7,-1,-1,-1,-1,36665,-1,0.41991666,0.0011693151,0.578914
36673,to the,17,19,91,97,"S3I-201, a signal transducer and activator of transcription 3 (STAT3) inhibitor, was added to the coculture system to detect STAT3 role in chemosensitivity.",31018021_9,-1,-1,-1,-1,36673,-1,6.0494476e-06,0.9999889,5.0262242e-06
36682,tissues,19,20,103,110,RESULTS: We found more infiltrated CD4+ T cells in human PCa lesions than in the adjacent noncancerous tissues after Doc treatment.,31018021_11,-1,1,2,-1,36682,-1,3.252179e-05,0.99865603,0.0013113723
36696,the chemoresistance,21,23,120,139,We found that CD4+ T cells could activate P-STAT3 signaling via secreting CCL5 and adding a STAT3 inhibitor can reverse the chemoresistance.,31018021_15,-1,-1,-1,-1,36696,-1,0.00879586,0.990974,0.00023007281
36716,that these,10,12,71,81,We hypothesized that a mechanism for IL-6-associated poor prognosis is that these patients would have altered T-cell populations and impaired T-cell signaling.,31027698_2,-1,-1,-1,-1,36716,-1,5.7762286e-06,0.9999889,5.2975734e-06
36717,T-cell,16,17,110,116,We hypothesized that a mechanism for IL-6-associated poor prognosis is that these patients would have altered T-cell populations and impaired T-cell signaling.,31027698_2,-1,1,2,-1,36717,-1,1.3860194e-05,1.0548896e-05,0.9999757
36718,T-cell,20,21,142,148,We hypothesized that a mechanism for IL-6-associated poor prognosis is that these patients would have altered T-cell populations and impaired T-cell signaling.,31027698_2,-1,1,2,-1,36718,-1,2.2290624e-05,1.0800732e-05,0.99996686
36721,T-cell,0,1,0,6,"T-cell populations from Non-small cell lung cancer patients were characterized using surface markers by flow cytometry, and signaling in the T-cell populations were measured by PhosFlow cytometry.",31027698_4,-1,1,2,-1,36721,-1,1.3492735e-05,7.72993e-06,0.9999788
36723,the T-cell,20,22,137,147,"T-cell populations from Non-small cell lung cancer patients were characterized using surface markers by flow cytometry, and signaling in the T-cell populations were measured by PhosFlow cytometry.",31027698_4,-1,-1,-1,-1,36723,-1,0.0017499104,0.14337927,0.8548708
36727,relative to those,16,19,106,123,RESULTS: We determine that patients with high circulating IL-6 levels had distinct T cell characteristics relative to those with low levels.,31027698_5,-1,-1,-1,-1,36727,-1,7.1939944e-06,0.999985,7.798201e-06
36731,protein-1,16,17,103,112,"Patients with high levels of IL-6 had significantly more Treg cells and elevated Programmed cell death protein-1 (PD-1) expression on CD4+, CD8+, Treg, and Th17 cells.",31027698_6,0,1,-1,-1,36731,-1,0.0003640529,0.9851629,0.014473066
36733,Th17 cells,31,33,156,166,"Patients with high levels of IL-6 had significantly more Treg cells and elevated Programmed cell death protein-1 (PD-1) expression on CD4+, CD8+, Treg, and Th17 cells.",31027698_6,-1,-1,-1,-1,36733,-1,4.9023893e-05,0.00025643432,0.9996946
36740,T-Cells,28,29,179,186,"These patients also showed impaired signal transducer and activator of transcription-1 (STAT1) signaling upon stimulation with IL-6 and phorbol 12-myristate 13-acetate (PMA), and T-Cells from a healthy donor that were treated for four days with IL-6 displayed a similar muting of STAT signaling, which verified the effect seen in patient samples.",31027698_7,-1,1,2,-1,36740,-1,2.0181178e-05,9.958883e-06,0.99996984
36754,function,10,11,59,67,Our data suggest that alteration in T cell populations and function may be a mechanism underlying the poor prognosis seen in NSCLC patients with high IL-6 levels.,31027698_9,0,1,2,-1,36754,-1,0.001654584,0.07632645,0.9220189
36759,the tumor,11,13,58,67,INTRODUCTION: Regulatory T cells (Tregs) are important in the tumor microenvironment.,31036318_0,-1,-1,-1,-1,36759,-1,4.4165104e-06,0.9999908,4.768678e-06
36761,immunity,9,10,72,80,Many subpopulations of Tregs have participated in suppressing antitumor immunity.,31036318_1,0,-1,2,-1,36761,-1,0.9998902,2.9195195e-05,8.058138e-05
36765,Tregs that,12,14,58,68,"Recently, FOXA1+ Tregs were reported as a novel subset of Tregs that control autoimmune diseases.",31036318_2,-1,-1,-1,-1,36765,-1,3.523058e-06,0.99999213,4.36619e-06
36768,blood,1,2,11,16,Peripheral blood samples were collected from 15 lung cancer patients.,31036318_5,0,1,-1,-1,36768,-1,0.015951404,0.5828569,0.40119174
36770,the analysis,14,16,97,109,Another 45 advanced stage lung cancer patients with malignant pleural effusion were enrolled for the analysis of FOXA1+ Tregs in pleural effusions.,31036318_6,-1,-1,-1,-1,36770,-1,5.547339e-06,0.99998915,5.2530413e-06
36774,tissues,2,3,12,19,Lung cancer tissues were collected from 3 patients.,31036318_7,-1,1,2,-1,36774,-1,0.00090527727,0.016098391,0.9829964
36787,that FOXA1,5,7,31,41,RESULTS: Our data demonstrated that FOXA1+ Tregs were increased in lung cancer.,31036318_10,-1,-1,-1,-1,36787,-1,1.1133061e-05,0.99995863,3.019842e-05
36792,that FOXA1,5,7,25,35,"Invitro assays revealed that FOXA1+ Tregs inhibited the proliferation of T cells, the production of IFN- and IL-2 by T cells.",31036318_12,-1,-1,-1,-1,36792,-1,9.5530795e-06,0.9999677,2.274644e-05
36806,function,13,14,80,88,"DISCUSSION: Collectively, our study is the first to investigate the suppressive function of FOXA1+ Tregs against T cells in lung cancer, and the results showed that FOXA1+ Tregs are markers of poor treatment responses in lung cancer patients.",31036318_14,0,1,2,-1,36806,-1,1.1012374e-05,0.9999814,7.599056e-06
36811,that FOXA1,29,31,160,170,"DISCUSSION: Collectively, our study is the first to investigate the suppressive function of FOXA1+ Tregs against T cells in lung cancer, and the results showed that FOXA1+ Tregs are markers of poor treatment responses in lung cancer patients.",31036318_14,-1,-1,-1,-1,36811,-1,1.1547088e-05,0.9999604,2.808541e-05
36818,immunity,14,15,88,96,The inhibition of FOXA1+ Tregs represents a promising new strategy to enhance antitumor immunity.,31036318_15,0,-1,2,-1,36818,-1,0.99983466,3.3077496e-05,0.00013218625
36819,the tumor,4,6,28,37,Macrophages are presents in the tumor microenvironment and acquire different phenotypic and functional characteristics in response to microenvironmental signals.,31099286_0,-1,-1,-1,-1,36819,-1,4.304845e-06,0.9999912,4.5372153e-06
36820,functional,12,13,92,102,Macrophages are presents in the tumor microenvironment and acquire different phenotypic and functional characteristics in response to microenvironmental signals.,31099286_0,0,1,2,-1,36820,-1,0.014178422,0.9801676,0.0056539467
36823,to the,2,4,12,18,"In response to the microenvironment, macrophages activate transcription factors as STAT1 and NF-B-p65 for M1 macrophages or STAT3 and STAT6 for M2 macrophages; activation impacts on the profile of cytokine, chemokines and growth factors secreted by macrophages.",31099286_2,-1,-1,-1,-1,36823,-1,6.3618295e-06,0.9999887,4.945515e-06
36831,factors,36,37,230,237,"In response to the microenvironment, macrophages activate transcription factors as STAT1 and NF-B-p65 for M1 macrophages or STAT3 and STAT6 for M2 macrophages; activation impacts on the profile of cytokine, chemokines and growth factors secreted by macrophages.",31099286_2,0,1,-1,-1,36831,-1,0.9999523,7.75622e-06,3.9924897e-05
36836,transcriptional factors STAT1,22,25,132,161,"We evaluated the effect of the supernatant of cervical-derived carcinoma cell lines HeLa, SiHa, and C-33A on the phosphorylation of transcriptional factors STAT1, NF-B-p65, and STAT6, and their impact in the profile of secretion of cytokines and growth factors by macrophages derived from the U937 cell line.",31099286_3,-1,-1,-1,-1,36836,-1,4.1697317e-06,0.9999888,7.01128e-06
36841,factors,43,44,254,261,"We evaluated the effect of the supernatant of cervical-derived carcinoma cell lines HeLa, SiHa, and C-33A on the phosphorylation of transcriptional factors STAT1, NF-B-p65, and STAT6, and their impact in the profile of secretion of cytokines and growth factors by macrophages derived from the U937 cell line.",31099286_3,0,1,-1,-1,36841,-1,0.99995565,6.842905e-06,3.7503698e-05
36862,factors that,32,34,192,204,"Our results suggest that HeLa, SiHa, and C-33A cell lines down-regulate the activation of transcription factors characteristic of M1 macrophages (STAT1, NF-B-p65) and induce the secretion of factors that favor tumor growth.",31099286_5,-1,-1,-1,-1,36862,-1,1.7028135e-05,0.9999778,5.162401e-06
36864,functional,6,7,36,46,BACKGROUND: Helios is important for functional and phenotype stability of regulatory T cells (Tregs).,31118027_0,0,1,2,-1,36864,-1,6.5248634e-05,0.9999045,3.0254783e-05
36873,tumor necrosis factor receptor,18,22,111,141,This study aimed to investigate the role of Helios+ Tregs in myasthenia gravis (MG) and glucocorticoid-induced tumor necrosis factor receptor (GITR) and its ligand (GITRL) in the modulation of Helios.,31118027_2,-1,-1,-1,-1,36873,-1,0.80035245,0.1579704,0.041677173
36877,blood,13,14,87,92,METHOD: Multicolor flow cytometry was performed to analyze Helios+ Tregs in peripheral blood from MG patients and healthy donors (HDs).,31118027_3,0,1,-1,-1,36877,-1,0.003779421,0.5173723,0.47884828
36884,other,9,10,53,58,"Membrane GITRL on Tregs and expression of Helios and other markers (FOXP3, CD25, CD39, CTLA-4, PD-L1 and IL-10) involved in immunosuppressive activity were determined by flow cytometry.",31118027_6,-1,-1,-1,-1,36884,-1,2.1998645e-05,0.99996424,1.3727292e-05
36893,analysis,1,2,8,16,"Further analysis indicates soluble GITR was negatively correlated with quantitative MG score and promoted Helios expression and enhanced function of Tregs independently of membrane GITRL.CONCLUSION: This work demonstrates abnormal changes in Helios+ Tregs and soluble GITR in MG, as well as direct regulation of Helios by GITR in the context of Tregs.",31118027_9,0,1,-1,-1,36893,-1,6.4007513e-06,0.9999883,5.283171e-06
36894,function,18,19,137,145,"Further analysis indicates soluble GITR was negatively correlated with quantitative MG score and promoted Helios expression and enhanced function of Tregs independently of membrane GITRL.CONCLUSION: This work demonstrates abnormal changes in Helios+ Tregs and soluble GITR in MG, as well as direct regulation of Helios by GITR in the context of Tregs.",31118027_9,0,1,2,-1,36894,-1,0.00017750465,0.9997243,9.815066e-05
36908,cell types,6,8,36,46,"Itch is expressed in most mammalian cell types, and, based on published data, it regulates many cellular pathways ranging from T cell differentiation to liver tumorigenesis.",31126634_1,-1,-1,-1,-1,36908,-1,3.3985623e-05,4.162199e-05,0.9999244
36917,cell function,24,26,137,150,"However, while autoimmunity is the primary clinical feature that occurs in both mice and humans lacking Itch, and Itch control of immune cell function has been well-studied, it remains unclear how Itch prevents the emergence of autoimmune disease.",31126634_4,-1,-1,-1,-1,36917,-1,3.1536954e-05,1.8088766e-05,0.9999503
36928,to therapeutically target,24,27,138,163,"Additionally, we discuss how molecular regulators of Itch impact its ability to control these processes, as this may provide clues on how to therapeutically target Itch to treat patients with autoimmune disease.",31126634_6,-1,-1,-1,-1,36928,-1,7.1126224e-06,0.9999887,4.244096e-06
36929,to treat,28,30,169,177,"Additionally, we discuss how molecular regulators of Itch impact its ability to control these processes, as this may provide clues on how to therapeutically target Itch to treat patients with autoimmune disease.",31126634_6,-1,-1,-1,-1,36929,-1,6.1932105e-06,0.9999894,4.358041e-06
36935,that the,3,5,15,23,We showed here that the spatial distribution of interleukin-4 (IL4) in invariant natural killer T (iNKT) cells regulated crosstalk between iNKT cells and dendritic cells (DCs) and controlled iNKT cell-mediated T-helper type 1 (Th1) responses.,31160756_1,-1,-1,-1,-1,36935,-1,3.620631e-06,0.99999213,4.2093e-06
36942,cell-mediated T-helper type,35,38,196,223,We showed here that the spatial distribution of interleukin-4 (IL4) in invariant natural killer T (iNKT) cells regulated crosstalk between iNKT cells and dendritic cells (DCs) and controlled iNKT cell-mediated T-helper type 1 (Th1) responses.,31160756_1,-1,-1,-1,-1,36942,-1,0.0017356136,0.08755211,0.91071224
36961,the immune response to,29,33,182,204,"Conversely, the nonpolarized secretion of IL4 induced by Th2 lipid antigens with a short or unsaturated chain was incapable of enhancing this iNKT cell-DC crosstalk and thus shifted the immune response to a Th2-type response.",31160756_3,-1,-1,-1,-1,36961,-1,0.00011777003,0.9998512,3.0991403e-05
36964,to Th2,7,9,46,52,The nonpolarized secretion of IL4 in response to Th2 lipid antigens was caused by the degradation of Cdc42 in iNKT cells.,31160756_4,-1,-1,-1,-1,36964,-1,3.0292314e-05,0.9999589,1.0885045e-05
36974,T cells through,14,17,70,85,BACKGROUND: B cells can increase the expression of granzyme B in CD8+ T cells through 4-1BBL/4-1BB interaction and promote anti-tumor immunity.,31182685_0,-1,-1,-1,-1,36974,-1,0.0014936335,0.037224133,0.9612822
36975,immunity,26,27,134,142,BACKGROUND: B cells can increase the expression of granzyme B in CD8+ T cells through 4-1BBL/4-1BB interaction and promote anti-tumor immunity.,31182685_0,0,-1,2,-1,36975,-1,0.99935156,0.00042410084,0.00022429359
36997,the TDLNs,48,50,257,266,"However, in patients with invasive ductal carcinoma, the percentage of 4-1BBL expressing B cells in stimulated condition had a decreasing trend in grade III, compared to grade II+I. In addition, significantly higher frequency of 4-1BBL+ B cells was seen in the TDLNs of ER+ or PR+ compared with ER or PR patients (p=0.021 and p=0.015, respectively).",31182685_7,-1,-1,-1,-1,36997,-1,7.67361e-06,0.9999846,7.6635615e-06
37006,receptor status,29,31,184,199,"CONCLUSIONS: The frequency of 4-1BBL+ B cells significantly increased following a short time activation, and showed relative and significant associations with tumor grade and estrogen receptor status, respectively.",31182685_9,-1,-1,-1,-1,37006,-1,0.00011107202,0.99970406,0.00018484281
37018,transformed TC-1 tumour,6,9,38,61,METHOD: Human papillomavirus 16 E6/E7 transformed TC-1 tumour bearing mice were intravenously administered with low (1  108 CFU/kg) or high dosage (3  108 CFU/kg) of Derivative Clostridial spore (DCG).RESULTS: Intravenous administration of the derivative of Clostridial ghonii (DCG) spores leads to both tumour and systemic inflammatory responses characterized by increased IFN/IL-9 secreting T cells in the spleen and the tumour.,31183361_2,-1,-1,-1,-1,37018,-1,5.586972e-06,0.99998534,9.0653775e-06
37024,the tumour,68,70,422,432,METHOD: Human papillomavirus 16 E6/E7 transformed TC-1 tumour bearing mice were intravenously administered with low (1  108 CFU/kg) or high dosage (3  108 CFU/kg) of Derivative Clostridial spore (DCG).RESULTS: Intravenous administration of the derivative of Clostridial ghonii (DCG) spores leads to both tumour and systemic inflammatory responses characterized by increased IFN/IL-9 secreting T cells in the spleen and the tumour.,31183361_2,-1,-1,-1,-1,37024,-1,4.095109e-06,0.9999901,5.8564983e-06
37029,the tumour,17,19,80,90,Low numbers of antigen specific T cells (<20/106 spleen cells) in the spleen of the tumour bearing mice are also detected after intravenous DCG delivery.,31183361_3,-1,-1,-1,-1,37029,-1,5.259303e-06,0.9999893,5.4306565e-06
37032,the tumour,16,18,100,110,"Interestingly, our results showed that a mixed IL-9/IFN secreting T cell response was induced when the tumour bearing mice received a low dose of DCG spore (1  108 CFU/kg), while a strong IFN response was elicited with a high dosage of DCG spore (3  108 CFU/kg).CONCLUSION: The dosage of DCG spore will determine the types of the DCG induced immune responses.",31183361_4,-1,-1,-1,-1,37032,-1,5.278096e-06,0.9999895,5.2301984e-06
37035,the types,61,63,317,326,"Interestingly, our results showed that a mixed IL-9/IFN secreting T cell response was induced when the tumour bearing mice received a low dose of DCG spore (1  108 CFU/kg), while a strong IFN response was elicited with a high dosage of DCG spore (3  108 CFU/kg).CONCLUSION: The dosage of DCG spore will determine the types of the DCG induced immune responses.",31183361_4,-1,-1,-1,-1,37035,-1,5.9094964e-06,0.9999877,6.3702014e-06
37043,function,14,15,81,89,"In this study, we investigated the distribution, prognostic value, and potential function of pDCs in HCC patients undergoing curative resection.",31201473_1,0,1,2,-1,37043,-1,0.00040715947,0.99941826,0.00017454365
37050,tissue,5,6,34,40,The findings were validated using tissue microarrays from another two independent cohorts totaling 841 HCC patients undergoing curative resection.,31201473_3,-1,1,2,-1,37050,-1,9.575986e-06,0.99998224,8.182326e-06
37056,tissues,14,15,91,98,"However, patient outcomes were not associated with pDCs in peritumoral stromal or nontumor tissues.",31201473_5,-1,1,2,-1,37056,-1,0.0012028901,0.2529182,0.74587893
37059,IL-17-producing cells,20,22,135,156,"Furthermore, an increase in intratumoral pDCs was associated with increased intratumoral infiltration of Foxp3+ regulatory T cells and IL-17-producing cells and correlated with tumor vascular density.",31201473_6,-1,-1,-1,-1,37059,-1,0.96685654,0.000103891114,0.033039633
37061,that the,5,7,46,54,Univariate and multivariate analyses revealed that the presence of intratumoral pDCs alone or in combination with regulatory T and/or IL-17-producing cells was an independent predictor of time to recurrence and overall survival.,31201473_7,-1,-1,-1,-1,37061,-1,4.4779454e-06,0.9999914,4.084042e-06
37063,IL-17-producing cells,19,21,134,155,Univariate and multivariate analyses revealed that the presence of intratumoral pDCs alone or in combination with regulatory T and/or IL-17-producing cells was an independent predictor of time to recurrence and overall survival.,31201473_7,-1,-1,-1,-1,37063,-1,0.9685279,0.00010019765,0.03137188
37064,time to,26,28,188,195,Univariate and multivariate analyses revealed that the presence of intratumoral pDCs alone or in combination with regulatory T and/or IL-17-producing cells was an independent predictor of time to recurrence and overall survival.,31201473_7,-1,-1,-1,-1,37064,-1,6.0866914e-06,0.9999869,7.030791e-06
37066,through the,24,26,148,159,"In conclusion, our study demonstrated that intratumoral infiltration by pDCs is a novel indicator for poor prognosis in patients with HCC, possibly through the induction of an immune tolerogenic and inflammatory tumor microenvironment comprising regulatory T and IL-17-producing cells.",31201473_8,-1,-1,-1,-1,37066,-1,4.8057723e-06,0.99999094,4.3028244e-06
37070,IL-17-producing cells,39,41,263,284,"In conclusion, our study demonstrated that intratumoral infiltration by pDCs is a novel indicator for poor prognosis in patients with HCC, possibly through the induction of an immune tolerogenic and inflammatory tumor microenvironment comprising regulatory T and IL-17-producing cells.",31201473_8,-1,-1,-1,-1,37070,-1,0.9685592,0.0001016693,0.031339064
37072,these cells,6,8,36,47,An assessment of the combination of these cells represents a superior predictor of patient outcome.,31201473_9,-1,-1,-1,-1,37072,-1,9.256582e-05,0.00014076558,0.99976665
37077,to chemotherapy,17,19,97,112,BACKGROUND: Type I interferons (IFN-I) have recently emerged as key regulators of tumor response to chemotherapy and immunotherapy.,31228946_0,-1,-1,-1,-1,37077,-1,0.81033754,0.18588413,0.003778265
37078,IFN-I function,2,4,9,23,"However, IFN-I function in cytotoxic T lymphocytes (CTLs) in the tumor microenvironment is largely unknown.",31228946_1,-1,-1,-1,-1,37078,-1,0.99971706,8.6819484e-05,0.00019607568
37081,the tumor,12,14,61,70,"However, IFN-I function in cytotoxic T lymphocytes (CTLs) in the tumor microenvironment is largely unknown.",31228946_1,-1,-1,-1,-1,37081,-1,5.7137977e-06,0.99999,4.3328146e-06
37082,Tumor tissues,2,4,9,22,METHODS: Tumor tissues and CTLs of human colorectal cancer patients were analyzed for interferon (alpha and beta) receptor 1 (IFNAR1) expression.,31228946_2,-1,-1,-1,-1,37082,-1,1.4168269e-05,0.9999298,5.608584e-05
37085,receptor,20,21,114,122,METHODS: Tumor tissues and CTLs of human colorectal cancer patients were analyzed for interferon (alpha and beta) receptor 1 (IFNAR1) expression.,31228946_2,0,1,2,-1,37085,-1,0.00023595378,0.0007890252,0.99897504
37091,IFNAR1 deficiency,23,25,104,121,"IFNAR1 knock out (IFNAR-KO), mixed wild type (WT) and IFNAR1-KO bone marrow chimera mice, and mice with IFNAR1 deficiency only in T cells (IFNAR1-TKO) were used to determine IFN-I function in T cells in tumor suppression.",31228946_3,-1,-1,-1,-1,37091,-1,0.9998591,4.6537512e-05,9.440798e-05
37095,IFN-I function,36,38,174,188,"IFNAR1 knock out (IFNAR-KO), mixed wild type (WT) and IFNAR1-KO bone marrow chimera mice, and mice with IFNAR1 deficiency only in T cells (IFNAR1-TKO) were used to determine IFN-I function in T cells in tumor suppression.",31228946_3,-1,-1,-1,-1,37095,-1,0.99979764,6.4007174e-05,0.00013831498
37098,IFN-I target genes,0,3,0,18,IFN-I target genes in tumor-infiltrating and antigen-specific CTLs were identified and functionally analyzed.,31228946_4,-1,-1,-1,-1,37098,-1,0.99626285,0.003117001,0.00062013796
37100,antigen-specific CTLs,6,8,45,66,IFN-I target genes in tumor-infiltrating and antigen-specific CTLs were identified and functionally analyzed.,31228946_4,-1,-1,-1,-1,37100,-1,0.6985039,0.0004378084,0.3010583
37101,functionally,11,12,87,99,IFN-I target genes in tumor-infiltrating and antigen-specific CTLs were identified and functionally analyzed.,31228946_4,0,1,2,-1,37101,-1,0.0001435639,0.9998215,3.5032353e-05
37103,tissue than,12,14,86,97,RESULTS: IFNAR1 expression level is significantly lower in human colorectal carcinoma tissue than in normal colon tissue.,31228946_5,-1,-1,-1,-1,37103,-1,9.286844e-05,0.99765563,0.0022515322
37104,tissue,17,18,114,120,RESULTS: IFNAR1 expression level is significantly lower in human colorectal carcinoma tissue than in normal colon tissue.,31228946_5,-1,1,2,-1,37104,-1,0.00030419527,0.41904274,0.580653
37105,IFNAR1 protein,0,2,0,14,IFNAR1 protein is also significantly lower on CTLs from colorectal cancer patients than those from healthy donors.,31228946_6,-1,-1,-1,-1,37105,-1,0.9996613,0.00010854138,0.00023014528
37107,than those,12,14,83,93,IFNAR1 protein is also significantly lower on CTLs from colorectal cancer patients than those from healthy donors.,31228946_6,-1,-1,-1,-1,37107,-1,7.687812e-06,0.9999856,6.718026e-06
37110,IFNAR1-sufficient tumors,10,12,98,122,"Although IFNAR1-KO mice exhibited increased susceptibility to methylcholanthrene-induced sarcoma, IFNAR1-sufficient tumors also grow significantly faster in IFNAR1-KO mice and in mice with IFNAR1 deficiency only in T cells (IFNAR1-TKO), suggesting that IFN-I functions in T cells to enhance host cancer immunosurveillance.",31228946_7,-1,-1,-1,-1,37110,-1,0.9985493,0.00097207987,0.00047867463
37112,IFNAR1 deficiency,23,25,189,206,"Although IFNAR1-KO mice exhibited increased susceptibility to methylcholanthrene-induced sarcoma, IFNAR1-sufficient tumors also grow significantly faster in IFNAR1-KO mice and in mice with IFNAR1 deficiency only in T cells (IFNAR1-TKO), suggesting that IFN-I functions in T cells to enhance host cancer immunosurveillance.",31228946_7,-1,-1,-1,-1,37112,-1,0.999913,2.4598652e-05,6.242233e-05
37115,that IFN-I functions,34,37,248,268,"Although IFNAR1-KO mice exhibited increased susceptibility to methylcholanthrene-induced sarcoma, IFNAR1-sufficient tumors also grow significantly faster in IFNAR1-KO mice and in mice with IFNAR1 deficiency only in T cells (IFNAR1-TKO), suggesting that IFN-I functions in T cells to enhance host cancer immunosurveillance.",31228946_7,-1,-1,-1,-1,37115,-1,0.023284098,0.9760317,0.00068421935
37116,T cells to,38,41,272,282,"Although IFNAR1-KO mice exhibited increased susceptibility to methylcholanthrene-induced sarcoma, IFNAR1-sufficient tumors also grow significantly faster in IFNAR1-KO mice and in mice with IFNAR1 deficiency only in T cells (IFNAR1-TKO), suggesting that IFN-I functions in T cells to enhance host cancer immunosurveillance.",31228946_7,-1,-1,-1,-1,37116,-1,0.0027969065,0.06092965,0.9362735
37117,tumor-infiltrating CTL,2,4,12,34,"Strikingly, tumor-infiltrating CTL levels are similar between tumor-bearing WT and IFNAR1-KO mice.",31228946_8,-1,-1,-1,-1,37117,-1,0.0043567778,0.7684199,0.22722326
37121,that IFNAR1-deficient,13,15,97,118,Competitive reconstitution of mixed WT and IFNAR1-KO bone marrow chimera mice further determined that IFNAR1-deficient nave CTLs exhibit no deficiency in response to vaccination to generate antigen-specific CTLs as compared to WT CTLs.,31228946_9,-1,-1,-1,-1,37121,-1,0.59898335,0.3983117,0.0027049566
37123,deficiency,19,20,141,151,Competitive reconstitution of mixed WT and IFNAR1-KO bone marrow chimera mice further determined that IFNAR1-deficient nave CTLs exhibit no deficiency in response to vaccination to generate antigen-specific CTLs as compared to WT CTLs.,31228946_9,0,1,-1,-1,37123,-1,0.0011953893,0.9984767,0.00032797287
37125,to generate antigen-specific CTLs,24,28,179,212,Competitive reconstitution of mixed WT and IFNAR1-KO bone marrow chimera mice further determined that IFNAR1-deficient nave CTLs exhibit no deficiency in response to vaccination to generate antigen-specific CTLs as compared to WT CTLs.,31228946_9,-1,-1,-1,-1,37125,-1,0.057444576,0.4722022,0.4703532
37130,tumor-infiltrating CTLs,10,12,79,102,"Gene expression profiling determined that Gzmb expression is down-regulated in tumor-infiltrating CTLs of IFNAR1-KO mice as compared to WT mice, and in antigen-specific IFNAR1-KO CTLs as compared to WT CTLs in vivo.",31228946_10,-1,-1,-1,-1,37130,-1,0.0032827132,0.7868101,0.20990717
37133,antigen-specific IFNAR1-KO CTLs,23,26,152,183,"Gene expression profiling determined that Gzmb expression is down-regulated in tumor-infiltrating CTLs of IFNAR1-KO mice as compared to WT mice, and in antigen-specific IFNAR1-KO CTLs as compared to WT CTLs in vivo.",31228946_10,-1,-1,-1,-1,37133,-1,0.9483381,0.00023196368,0.0514299
37136,that IFN-I,4,6,31,41,"Mechanistically, we determined that IFN-I activates STAT3 that binds to the Gzmb promoter to activate Gzmb transcription in CTLs.",31228946_11,-1,-1,-1,-1,37136,-1,0.95528895,0.042365864,0.0023452817
37137,STAT3 that,7,9,52,62,"Mechanistically, we determined that IFN-I activates STAT3 that binds to the Gzmb promoter to activate Gzmb transcription in CTLs.",31228946_11,-1,-1,-1,-1,37137,-1,4.761389e-06,0.99998987,5.3664894e-06
37138,to the,10,12,69,75,"Mechanistically, we determined that IFN-I activates STAT3 that binds to the Gzmb promoter to activate Gzmb transcription in CTLs.",31228946_11,-1,-1,-1,-1,37138,-1,4.752475e-06,0.99999094,4.329762e-06
37147,function to,14,16,95,106,CONCLUSION: IFN-I induces STAT3 activation to activate Gzmb expression to enhance CTL effector function to suppress tumor development.,31228946_12,-1,-1,-1,-1,37147,-1,0.0005418796,0.9904,0.009058066
37150,CTLs to,9,11,64,71,Human colorectal carcinoma may use down-regulation of IFNAR1 on CTLs to suppress CTL effector function to evade host cancer immunosurveillance.,31228946_13,-1,-1,-1,-1,37150,-1,0.007824666,0.026359761,0.9658156
37152,function to,14,16,94,105,Human colorectal carcinoma may use down-regulation of IFNAR1 on CTLs to suppress CTL effector function to evade host cancer immunosurveillance.,31228946_13,-1,-1,-1,-1,37152,-1,0.00034812852,0.99437153,0.0052803443
37153,IFN- therapy,0,2,0,13,IFN- therapy has been approved by the Food and Drug Administration (FDA) for the treatment of chronic granulomatous disease and severe malignant osteopetrosis.,31233057_0,-1,-1,-1,-1,37153,-1,0.99941266,0.00029719318,0.00029004941
37155,the treatment,15,17,78,91,IFN- therapy has been approved by the Food and Drug Administration (FDA) for the treatment of chronic granulomatous disease and severe malignant osteopetrosis.,31233057_0,-1,-1,-1,-1,37155,-1,7.317287e-06,0.99998724,5.3822364e-06
37157,IFN--based therapeutic,3,5,22,45,"Despite the promising IFN--based therapeutic applications, its limited success in clinical trials is related with limitations inherent to its molecular properties and with the difficulties to deliver it locally or with adequate periodicity to achieve a therapeutic effect.",31233057_1,-1,-1,-1,-1,37157,-1,0.9990338,0.0005893793,0.0003768685
37178,These IFN--NPs,0,2,0,15,"These IFN--NPs induced an immunostimulatory profile on dendritic cells (DCs) with increased cell surface costimulatory molecules and secretion of pro-inflammatory cytokines, including IL-6, IL-12p40 and TNF-.",31233057_6,-1,-1,-1,-1,37178,-1,0.004181488,0.99550724,0.00031129085
37183,TNF-,29,30,204,209,"These IFN--NPs induced an immunostimulatory profile on dendritic cells (DCs) with increased cell surface costimulatory molecules and secretion of pro-inflammatory cytokines, including IL-6, IL-12p40 and TNF-.",31233057_6,0,1,-1,-1,37183,-1,0.0077520716,0.99204004,0.00020791322
37185,the IL-10-stimulated,3,5,25,45,"IFN--NPs also modulated the IL-10-stimulated macrophage profile, increasing their ability to secrete the pro-inflammatory cytokines IL-6, IL-12p40 and TNF-.",31233057_7,-1,-1,-1,-1,37185,-1,0.7261549,0.27143434,0.002410759
37189,cytokines IL-6,15,17,123,137,"IFN--NPs also modulated the IL-10-stimulated macrophage profile, increasing their ability to secrete the pro-inflammatory cytokines IL-6, IL-12p40 and TNF-.",31233057_7,-1,-1,-1,-1,37189,-1,0.9999615,5.9762574e-06,3.2601e-05
37190,TNF-,20,21,152,157,"IFN--NPs also modulated the IL-10-stimulated macrophage profile, increasing their ability to secrete the pro-inflammatory cytokines IL-6, IL-12p40 and TNF-.",31233057_7,0,1,-1,-1,37190,-1,0.0060117114,0.99376464,0.00022368107
37213,to their,1,3,4,12,"Due to their ease of synthesis, good biocompatibility and designable bioactivity, peptide derivatives-based supramolecular nanomaterials have attracted increasing interest in improving the immunogenicity of cancer vaccines.",31244959_1,-1,-1,-1,-1,37213,-1,5.3793906e-06,0.9999895,5.1313373e-06
37214,peptide,13,14,82,89,"Due to their ease of synthesis, good biocompatibility and designable bioactivity, peptide derivatives-based supramolecular nanomaterials have attracted increasing interest in improving the immunogenicity of cancer vaccines.",31244959_1,0,-1,2,-1,37214,-1,0.00037285624,0.99944323,0.00018387429
37219,peptide,24,25,178,185,"Methods: Herein, we synthesized an NF-B-activating supramolecular nanoadjuvant (3DSNA) that is prepared by pH-triggering self-assembly of a positively charged D-configurational peptide derivative.",31244959_2,0,-1,2,-1,37219,-1,1.8880795e-05,0.99996555,1.5613534e-05
37225,factors,13,14,92,99,"Then, 3DSNA promotes ingestion and cross-presentation of OVA, upregulation of costimulatory factors (CD80 and CD86) and secretion of proinflammatory cytokines (IL-6 and IL-12) by dendritic cells (DCs), accompanied by activation of the innate immune response (NF-B signaling), resulting in long-term antigen-specific memory and effector CD8+ T cells response.",31244959_5,0,1,-1,-1,37225,-1,0.007986861,0.9917497,0.00026341013
37231,the innate immune response,40,44,231,257,"Then, 3DSNA promotes ingestion and cross-presentation of OVA, upregulation of costimulatory factors (CD80 and CD86) and secretion of proinflammatory cytokines (IL-6 and IL-12) by dendritic cells (DCs), accompanied by activation of the innate immune response (NF-B signaling), resulting in long-term antigen-specific memory and effector CD8+ T cells response.",31244959_5,-1,-1,-1,-1,37231,-1,0.9002761,0.09818536,0.0015385781
37236,the tumor,38,40,268,277,"When compared with conventional aluminum hydroxide adjuvant and the corresponding L-configurational supramolecular nanoadjuvant (3LSNA), 3DSNA-adjuvanted OVA (3DSNA+OVA) significantly prevents oncogenesis in nave mice with a complete response rate of 60 %, restrains the tumor growth and prolongs the survival of melanoma-bearing mice.",31244959_6,-1,-1,-1,-1,37236,-1,5.402123e-06,0.9999893,5.2865425e-06
37244,the tumor,7,9,49,58,Macrophages play an important role in regulating the tumor microenvironment (TME).,31249575_0,-1,-1,-1,-1,37244,-1,4.2706956e-06,0.99999094,4.8140205e-06
37247,the zinc finger protein,24,28,126,149,"Here we show that classical (M1) macrophage polarization reduced expression of LSD1, nuclear REST corepressor 1 (CoREST), and the zinc finger protein SNAIL.",31249575_1,-1,-1,-1,-1,37247,-1,4.703954e-06,0.99999034,4.9923274e-06
37252,targeted the,28,30,167,179,"The LSD1 inhibitor phenelzine targeted both the flavin adenine dinucleotide (FAD) and CoREST binding domains of LSD1, unlike the LSD1 inhibitor GSK2879552, which only targeted the FAD domain.",31249575_2,-1,-1,-1,-1,37252,-1,4.356373e-06,0.9999919,3.7827176e-06
37260,complex to,23,25,161,171,"Overall, the LSD1 inhibitors phenelzine and GSK2879552 are useful tools for dissecting the contribution of LSD1 demethylase activity and the nuclear LSD1-CoREST complex to switching macrophage polarization programs.",31249575_4,-1,-1,-1,-1,37260,-1,4.868095e-06,0.9999907,4.3817263e-06
37267,T cell to,5,8,35,44,"Fas induces apoptosis in activated T cell to maintain immune homeostasis, but the effects of non-apoptotic Fas signaling on T cells remain unclear.",31266950_0,-1,-1,-1,-1,37267,-1,0.00223278,0.07302945,0.92473775
37271,TH9 cell,6,8,31,39,Here we show that Fas promotes TH9 cell differentiation by activating NF-B via Ca2+-dependent PKC- activation.,31266950_1,-1,-1,-1,-1,37271,-1,1.9173067e-05,3.6833582e-05,0.999944
37275,TH9 transcription,18,20,121,138,"In addition, PKC- also phosphorylates p38 to inactivate NFAT1 and reduce NFAT1-NF-B synergy to promote the Fas-induced TH9 transcription program.",31266950_2,-1,-1,-1,-1,37275,-1,8.68986e-06,0.99997425,1.7043007e-05
37276,TH9 cell,8,10,66,74,"Fas ligation exacerbates inflammatory bowel disease by increasing TH9 cell differentiation, and promotes antitumor activity in p38 inhibitor-treated TH9 cells.",31266950_3,-1,-1,-1,-1,37276,-1,2.5840447e-05,9.770868e-05,0.9998764
37277,TH9 cells,19,21,149,158,"Fas ligation exacerbates inflammatory bowel disease by increasing TH9 cell differentiation, and promotes antitumor activity in p38 inhibitor-treated TH9 cells.",31266950_3,-1,-1,-1,-1,37277,-1,2.134845e-05,4.9727936e-05,0.99992895
37279,adverse effects,11,13,86,101,"Furthermore, low-dose p38 inhibitor suppresses tumor growth without inducing systemic adverse effects.",31266950_4,0,1,-1,-1,37279,-1,0.020180793,0.9787123,0.0011068659
37282,TH9 cell,7,9,40,48,"In patients with tumor, relatively high TH9 cell numbers are associated with good prognosis.",31266950_5,-1,-1,-1,-1,37282,-1,0.00034045064,0.0076424708,0.99201703
37286,therapy,17,18,89,96,Our study thus implicates Fas in CD4+ T cells as a target for inflammatory bowel disease therapy.,31266950_6,0,1,-1,-1,37286,-1,4.2470924e-06,0.9999906,5.1737093e-06
37287,TH9 cell,15,17,100,108,"Furthermore, simultaneous Fas ligation and low-dose p38 inhibition may be an effective approach for TH9 cell induction and cancer therapy.",31266950_7,-1,-1,-1,-1,37287,-1,0.000122186,0.002018648,0.9978592
37288,therapy,20,21,130,137,"Furthermore, simultaneous Fas ligation and low-dose p38 inhibition may be an effective approach for TH9 cell induction and cancer therapy.",31266950_7,0,1,-1,-1,37288,-1,4.6093155e-06,0.99999,5.364449e-06
37295,that TET2,3,5,13,22,"Here we show that TET2 mediates interferon  (IFN)-JAK-STAT signaling pathway to control chemokine and PD-L1 expression, lymphocyte infiltration and cancer immunity.",31310587_2,-1,-1,-1,-1,37295,-1,1.3338265e-05,0.99997985,6.8294707e-06
37300,immunity,22,23,157,165,"Here we show that TET2 mediates interferon  (IFN)-JAK-STAT signaling pathway to control chemokine and PD-L1 expression, lymphocyte infiltration and cancer immunity.",31310587_2,0,-1,2,-1,37300,-1,0.99916625,0.00010431681,0.0007294734
37302,STAT1 to,2,4,16,24,IFN stimulated STAT1 to bind TET2 and recruit TET2 to hydroxymethylate chemokine and PD-L1 genes.,31310587_3,-1,-1,-1,-1,37302,-1,4.616447e-06,0.9999882,7.1603213e-06
37304,TET2 to,8,10,47,54,IFN stimulated STAT1 to bind TET2 and recruit TET2 to hydroxymethylate chemokine and PD-L1 genes.,31310587_3,-1,-1,-1,-1,37304,-1,6.6197313e-06,0.99998593,7.449006e-06
37308,TH1-type chemokines,7,9,51,70,Reduced TET activity was associated with decreased TH1-type chemokines and tumor-infiltrating lymphocytes (TILs) and the progression of human colon cancer.,31310587_4,-1,-1,-1,-1,37308,-1,0.03403612,0.9632836,0.002680261
37309,tumor-infiltrating lymphocytes,10,12,75,105,Reduced TET activity was associated with decreased TH1-type chemokines and tumor-infiltrating lymphocytes (TILs) and the progression of human colon cancer.,31310587_4,-1,-1,-1,-1,37309,-1,0.0049645496,0.7676072,0.22742826
37313,tumor cells,8,10,46,57,"Deletion of Tet2 in murine melanoma and colon tumor cells reduced chemokine expression and TILs, enabling tumors to evade anti-tumor immunity and to resist anti-PD-L1 therapy.",31310587_5,-1,-1,-1,-1,37313,-1,0.00018203481,0.000681413,0.9991366
37316,tumors to,17,19,106,115,"Deletion of Tet2 in murine melanoma and colon tumor cells reduced chemokine expression and TILs, enabling tumors to evade anti-tumor immunity and to resist anti-PD-L1 therapy.",31310587_5,-1,-1,-1,-1,37316,-1,3.4738644e-06,0.99999225,4.3238583e-06
37317,immunity,21,22,133,141,"Deletion of Tet2 in murine melanoma and colon tumor cells reduced chemokine expression and TILs, enabling tumors to evade anti-tumor immunity and to resist anti-PD-L1 therapy.",31310587_5,0,-1,2,-1,37317,-1,0.9998512,3.7567934e-05,0.0001111615
37319,therapy,26,27,167,174,"Deletion of Tet2 in murine melanoma and colon tumor cells reduced chemokine expression and TILs, enabling tumors to evade anti-tumor immunity and to resist anti-PD-L1 therapy.",31310587_5,0,1,-1,-1,37319,-1,3.569403e-06,0.9999919,4.5019783e-06
37324,immunity,24,25,161,169,"Conversely, stimulating TET activity by systematic injection of its co-factor, ascorbate/vitamin C, increased chemokine and TILs, leading to enhanced anti-tumor immunity and anti-PD-L1 efficacy and extended lifespan of tumor-bearing mice.",31310587_6,0,-1,2,-1,37324,-1,0.99978155,7.4689604e-05,0.00014377684
37325,lifespan,30,31,207,215,"Conversely, stimulating TET activity by systematic injection of its co-factor, ascorbate/vitamin C, increased chemokine and TILs, leading to enhanced anti-tumor immunity and anti-PD-L1 efficacy and extended lifespan of tumor-bearing mice.",31310587_6,0,-1,2,-1,37325,-1,1.80515e-05,0.9999747,7.160751e-06
37332,therapy,13,14,109,116,These results suggest an IFN-JAK-STAT-TET signaling pathway that mediates tumor response to anti-PD-L1/PD-1 therapy and is frequently disrupted in solid tumors.,31310587_7,0,1,-1,-1,37332,-1,5.245739e-06,0.99998844,6.303994e-06
37337,therapy,18,19,122,129,"Our findings also suggest TET activity as a biomarker for predicting the efficacy and patient response to anti-PD-1/PD-L1 therapy, and stimulating TET activity as an adjuvant immunotherapy of solid tumors.",31310587_8,0,1,-1,-1,37337,-1,5.264253e-06,0.9999888,5.8983046e-06
37342,through the,24,26,165,176,"Caloric restriction mimetics (CRMs), compounds that mimic the biochemical effects of nutrient deprivation, administered via systemic route promote antitumor effects through the induction of autophagy and the modulation of the immune microenvironment; however, collateral effects due to metabolic changes and the possible weight loss might potentially limit their administration at long term.",31321243_0,-1,-1,-1,-1,37342,-1,7.661219e-06,0.99998784,4.4739427e-06
37353,that target,9,11,56,67,"Hydroxycitrate, spermidine, and alpha-lipoic acid, CRMs that target different metabolic enzymes, administered by aerosol, strongly reduced implantation of intravenously injected B16 melanoma cells without overt signs of toxicity, such as weight loss and changes in lung structure.",31321243_2,-1,-1,-1,-1,37353,-1,6.466635e-06,0.99998736,6.2250733e-06
37356,toxicity,32,33,220,228,"Hydroxycitrate, spermidine, and alpha-lipoic acid, CRMs that target different metabolic enzymes, administered by aerosol, strongly reduced implantation of intravenously injected B16 melanoma cells without overt signs of toxicity, such as weight loss and changes in lung structure.",31321243_2,0,1,-1,-1,37356,-1,1.1857938e-05,0.9999801,8.080553e-06
37357,analysis,1,2,17,25,Cytofluorimetric analysis of lung immune infiltrates revealed a significant increase of alveolar macrophages and CD103+ dendritic cells in mice treated with CRMs that paralleled an increased recruitment and activation of both CD3 T lymphocytes and NK cells.,31321243_3,0,1,-1,-1,37357,-1,9.919498e-06,0.9999831,7.0059327e-06
37365,genes related to,8,11,55,71,"These effects were associated with the upregulation of genes related to M1 phenotype, as IL-12 and STAT-1, and to the decrease of M2 genes, as IL-10 and STAT-6, in adherent fraction of lung immune infiltrate, as revealed by real-time PCR analysis.",31321243_4,-1,-1,-1,-1,37365,-1,3.7417303e-06,0.9999912,5.0896942e-06
37368,to the,20,22,111,117,"These effects were associated with the upregulation of genes related to M1 phenotype, as IL-12 and STAT-1, and to the decrease of M2 genes, as IL-10 and STAT-6, in adherent fraction of lung immune infiltrate, as revealed by real-time PCR analysis.",31321243_4,-1,-1,-1,-1,37368,-1,3.905131e-06,0.99999166,4.4199687e-06
37372,analysis,45,46,238,246,"These effects were associated with the upregulation of genes related to M1 phenotype, as IL-12 and STAT-1, and to the decrease of M2 genes, as IL-10 and STAT-6, in adherent fraction of lung immune infiltrate, as revealed by real-time PCR analysis.",31321243_4,0,1,-1,-1,37372,-1,5.5595706e-06,0.99998784,6.6514035e-06
37378,the tumor,28,30,186,195,"Thus, in this proof-of-principle study, we highlight the antitumor effect of CRM aerosol delivery as a new and noninvasive therapeutic approach to locally modulate immunosurveillance at the tumor site in the lung.",31321243_5,-1,-1,-1,-1,37378,-1,3.9931647e-06,0.9999912,4.8202046e-06
37405,functions,28,29,176,185,"The increase was not only associated with reduced disease-free survival but also strongly correlated with an increase in FOXP3 mRNA, a master regulator of Treg development and functions.",31325403_5,0,1,2,-1,37405,-1,9.212176e-06,0.99997485,1.598186e-05
37417,transcription factor nuclear factor kappa B,23,29,140,183,Release of interleukin 1 (IL-1) from cancer-associated fibroblasts (CAF) induces CCL22 mRNA expression in oral cancer cells by activating transcription factor nuclear factor kappa B (NF-B).,31325403_8,-1,-1,-1,-1,37417,-1,9.450368e-06,0.9999821,8.38215e-06
37420,receptor,14,15,68,76,"Our data support a model in which CAF-derived IL-1, CCL22, and its receptor CCR4 foster a protumor environment by promoting cell transformation and Treg infiltration.",31325403_9,0,1,2,-1,37420,-1,0.02842549,0.59900427,0.37257022
37422,cell transformation,22,24,125,144,"Our data support a model in which CAF-derived IL-1, CCL22, and its receptor CCR4 foster a protumor environment by promoting cell transformation and Treg infiltration.",31325403_9,-1,-1,-1,-1,37422,-1,3.9316034e-05,0.00014392183,0.9998167
37424,the IL-1-CCL22-CCR4,2,4,16,36,Intervention of the IL-1-CCL22-CCR4 signaling axis may offer a novel therapeutic strategy for oral cancer treatment.,31325403_10,-1,-1,-1,-1,37424,-1,0.04721949,0.9287089,0.024071572
37431,to tumor,16,18,87,95,"Regulatory T (Treg) cells are crucial for immune homeostasis, but they also contribute to tumor immune evasion by promoting a suppressive tumor microenvironment (TME).",31350177_0,-1,-1,-1,-1,37431,-1,5.5544597e-06,0.9999893,5.137937e-06
37435,deficiency,5,6,44,54,"Mice with Treg cell-restricted Neuropilin-1 deficiency show tumor resistance while maintaining peripheral immune homeostasis, thereby providing a controlled system to interrogate the impact of intratumoral Treg cells on the TME.",31350177_1,0,1,-1,-1,37435,-1,0.00021255497,0.99973613,5.130959e-05
37441,the TME,29,31,220,227,"Mice with Treg cell-restricted Neuropilin-1 deficiency show tumor resistance while maintaining peripheral immune homeostasis, thereby providing a controlled system to interrogate the impact of intratumoral Treg cells on the TME.",31350177_1,-1,-1,-1,-1,37441,-1,5.5441437e-06,0.99999,4.4362787e-06
37444,that Treg cells,9,12,47,62,"Using this and other genetic models, we showed that Treg cells shaped the transcriptional landscape across multiple tumor-infiltrating immune cell types.",31350177_2,-1,-1,-1,-1,37444,-1,0.0018750826,0.14116965,0.85695523
37445,the transcriptional,13,15,70,89,"Using this and other genetic models, we showed that Treg cells shaped the transcriptional landscape across multiple tumor-infiltrating immune cell types.",31350177_2,-1,-1,-1,-1,37445,-1,5.4637353e-06,0.99998987,4.689708e-06
37447,cell types,20,22,142,152,"Using this and other genetic models, we showed that Treg cells shaped the transcriptional landscape across multiple tumor-infiltrating immune cell types.",31350177_2,-1,-1,-1,-1,37447,-1,3.722926e-05,2.17215e-05,0.9999411
37453,protein,25,26,148,155,"Treg cells suppressed CD8+ Tcell secretion of interferon- (IFN), which would otherwise block the activation of sterol regulatory element-binding protein 1 (SREBP1)-mediated fatty acid synthesis in immunosuppressive (M2-like) tumor-associated macrophages (TAMs).",31350177_3,0,1,-1,-1,37453,-1,6.026129e-06,0.9999863,7.725721e-06
37460,that targeting Treg cells,11,15,83,108,"SREBP1 inhibition augmented the efficacy of immune checkpoint blockade, suggesting that targeting Treg cells or their modulation of lipid metabolism in M2-like TAMs could improve cancer immunotherapy.",31350177_5,-1,-1,-1,-1,37460,-1,0.0026282407,0.49917692,0.4981949
37462,metabolism,20,21,138,148,"SREBP1 inhibition augmented the efficacy of immune checkpoint blockade, suggesting that targeting Treg cells or their modulation of lipid metabolism in M2-like TAMs could improve cancer immunotherapy.",31350177_5,0,1,2,-1,37462,-1,0.0069816965,0.9920494,0.00096894236
37466,to tumor,25,27,143,151,"BACKGROUND: Interleukin(IL)-30/IL-27p28 production by Prostate Cancer (PC) Stem-Like Cells (SLCs) has proven, in murine models, to be critical to tumor onset and progression.",31366386_0,-1,-1,-1,-1,37466,-1,6.7048e-06,0.9999871,6.2158706e-06
37475,CD4+T,21,22,133,138,"RESULTS: Implantation of PC-SLCs in IL-30KO mice, gave rise to slow growing tumors characterized by apoptotic events associated with CD4+T lymphocyte infiltrates and lack of CD4+Foxp3+ T regulatory cells (Tregs).",31366386_5,-1,-1,-1,-1,37475,-1,0.00019093229,6.7225694e-05,0.99974185
37494,tumor cells,44,46,329,340,"In patients with high-grade and locally advanced PC, those with IL-30-/-tumors, showed distinct intra-tumoral cytotoxic granule-associated RNA binding protein (TIA-1)+CD4+Tlymphocyte infiltrate, rare Foxp3+Tregs and a lower biochemical recurrence rate compared to patients with IL-30+/+tumors in which IL-30 is expressed in both tumor cells and infiltrating leukocytes.",31366386_9,-1,-1,-1,-1,37494,-1,7.393281e-05,0.00017494996,0.99975115
37497,CD4+T,16,17,118,123,"CONCLUSION: The lack of host leukocyte-derived IL-30 inhibits Tregs expansion, promotes intra-tumoral infiltration of CD4+T lymphocytes and cancer cell apoptosis.",31366386_10,-1,-1,-1,-1,37497,-1,0.00017989609,3.5998164e-05,0.9997842
37500,cytotoxic T lymphocyte activation,14,18,79,112,"Concomitant lack of MDC influx, obtained by IL-30 silencing in PC-SLCs, boosts cytotoxic T lymphocyte activation and cancer cell apoptosis resulting in a synergistic tumor suppression with the prospective benefit of better survival for patients with advanced disease.",31366386_11,-1,-1,-1,-1,37500,-1,3.0466155e-05,7.559277e-06,0.999962
37506,protein,3,4,27,34,The WD40 repeat-containing protein EED is a core component of PRC2 and enhances PRC2 activity through interaction with H3K27me3.,31395608_1,0,1,-1,-1,37506,-1,8.4067005e-06,0.99998283,8.763146e-06
37516,T-cell,32,33,185,191,BR-001 was also efficacious in syngeneic CT26 colon tumor-bearing mice; oral dosing of 30 mg/kg of BR-001 led to 59.3% tumor growth suppression and increased frequency of effector CD8+ T-cell infiltrates in tumors.,31395608_6,-1,1,2,-1,37516,-1,1.6118756e-05,6.502221e-06,0.99997735
37518,analysis,1,2,16,24,"Pharmacodynamic analysis revealed that CXCL10 was highly upregulated, suggesting that CXCL10 triggers the trafficking of CD8+ T cells toward tumor sites.",31395608_7,0,1,-1,-1,37518,-1,8.0210775e-06,0.9999864,5.516835e-06
37519,that CXCL10,3,5,34,45,"Pharmacodynamic analysis revealed that CXCL10 was highly upregulated, suggesting that CXCL10 triggers the trafficking of CD8+ T cells toward tumor sites.",31395608_7,-1,-1,-1,-1,37519,-1,0.8892314,0.10874957,0.0020190817
37520,that CXCL10 triggers the trafficking,10,15,81,117,"Pharmacodynamic analysis revealed that CXCL10 was highly upregulated, suggesting that CXCL10 triggers the trafficking of CD8+ T cells toward tumor sites.",31395608_7,-1,-1,-1,-1,37520,-1,0.0005046268,0.99938416,0.000111206245
37521,T cells toward tumor,18,22,126,146,"Pharmacodynamic analysis revealed that CXCL10 was highly upregulated, suggesting that CXCL10 triggers the trafficking of CD8+ T cells toward tumor sites.",31395608_7,-1,-1,-1,-1,37521,-1,0.0035707215,0.30651405,0.68991524
37523,time that,6,8,38,47,Our results demonstrate for the first time that inhibition of EED modulates the tumor immune microenvironment to induce regression of colon tumors and therefore has the potential to be used in combination with immune-oncology therapy.,31395608_8,-1,-1,-1,-1,37523,-1,3.738195e-06,0.9999919,4.332864e-06
37524,the tumor,12,14,76,85,Our results demonstrate for the first time that inhibition of EED modulates the tumor immune microenvironment to induce regression of colon tumors and therefore has the potential to be used in combination with immune-oncology therapy.,31395608_8,-1,-1,-1,-1,37524,-1,4.572321e-06,0.99999106,4.415627e-06
37530,therapy,34,35,226,233,Our results demonstrate for the first time that inhibition of EED modulates the tumor immune microenvironment to induce regression of colon tumors and therefore has the potential to be used in combination with immune-oncology therapy.,31395608_8,0,1,-1,-1,37530,-1,4.5029865e-06,0.9999908,4.677612e-06
37536,the tumor,21,23,124,133,"SIGNIFICANCE: BR-001, a potent inhibitor of the EED subunit of the PRC2 complex, suppresses tumor progression by modulating the tumor microenvironment.",31395608_9,-1,-1,-1,-1,37536,-1,4.4400936e-06,0.99999106,4.5529487e-06
37537,The helper T cell,0,4,0,17,"The helper T cell 9 (Thelper-9, Th9), as a functional subgroup of CD4+T cells, was first discovered in 2008.",31414895_0,-1,-1,-1,-1,37537,-1,0.0016464654,0.10010034,0.8982532
37540,functional,13,14,43,53,"The helper T cell 9 (Thelper-9, Th9), as a functional subgroup of CD4+T cells, was first discovered in 2008.",31414895_0,0,1,2,-1,37540,-1,0.00055585837,0.99928445,0.00015968914
37541,CD4+T cells,16,18,66,77,"The helper T cell 9 (Thelper-9, Th9), as a functional subgroup of CD4+T cells, was first discovered in 2008.",31414895_0,-1,-1,-1,-1,37541,-1,1.554048e-05,4.3722966e-06,0.9999801
37542,Th9 cells,0,2,0,9,Th9 cells expressed transcription factor PU.1 and cytokine interleukin-9 (IL-9) characteristically.,31414895_1,-1,-1,-1,-1,37542,-1,1.2560954e-05,2.1447584e-05,0.999966
37544,cytokine interleukin-9,7,9,50,72,Th9 cells expressed transcription factor PU.1 and cytokine interleukin-9 (IL-9) characteristically.,31414895_1,-1,-1,-1,-1,37544,-1,0.99996924,4.658129e-06,2.6061334e-05
37546,that the,4,6,29,37,"Recent researches have shown that the differentiation of Th9 cells was coregulated by cytokine transforming growth factor , IL-4, and various transcription factors.",31414895_2,-1,-1,-1,-1,37546,-1,3.969808e-06,0.9999919,4.1504236e-06
37547,Th9 cells,8,10,57,66,"Recent researches have shown that the differentiation of Th9 cells was coregulated by cytokine transforming growth factor , IL-4, and various transcription factors.",31414895_2,-1,-1,-1,-1,37547,-1,1.1303866e-05,1.7427046e-05,0.9999713
37548,cytokine transforming growth factor,13,17,86,121,"Recent researches have shown that the differentiation of Th9 cells was coregulated by cytokine transforming growth factor , IL-4, and various transcription factors.",31414895_2,-1,-1,-1,-1,37548,-1,0.9998217,2.7770397e-05,0.00015058852
37550,Th9 cells,0,2,0,9,"Th9 cells, as a new player, played an important role in various immune-related diseases, including tumors, inflammatory diseases, parasite infection, and other diseases.",31414895_3,-1,-1,-1,-1,37550,-1,1.815454e-05,3.6410627e-05,0.9999455
37555,the related,6,8,30,41,"In this article, we summarize the related research progress and discuss the possible prospect.",31414895_4,-1,-1,-1,-1,37555,-1,5.1778015e-06,0.99998975,5.0992585e-06
37558,the natural,3,5,16,27,The ligands for the natural killer group 2 (NKG2D) protein render tumor cells susceptible to NKG2D-dependent immune cell attack.,31427736_0,-1,-1,-1,-1,37558,-1,1.9525234e-05,0.99997187,8.561972e-06
37559,protein,11,12,51,58,The ligands for the natural killer group 2 (NKG2D) protein render tumor cells susceptible to NKG2D-dependent immune cell attack.,31427736_0,0,1,-1,-1,37559,-1,5.516766e-05,0.99992967,1.5200492e-05
37560,tumor cells,13,15,66,77,The ligands for the natural killer group 2 (NKG2D) protein render tumor cells susceptible to NKG2D-dependent immune cell attack.,31427736_0,-1,-1,-1,-1,37560,-1,0.0001286386,0.0011485108,0.99872285
37566,tumor cells,12,14,71,82,"We previously discovered that engagement of activated CD8+ T cells and tumor cells induces NKG2D ligands on tumor cells, but the underlying mechanism remains to be defined.",31427736_2,-1,-1,-1,-1,37566,-1,7.665276e-05,0.00028390085,0.9996395
37567,tumor cells,18,20,108,119,"We previously discovered that engagement of activated CD8+ T cells and tumor cells induces NKG2D ligands on tumor cells, but the underlying mechanism remains to be defined.",31427736_2,-1,-1,-1,-1,37567,-1,0.00016278238,0.0012281479,0.9986091
37577,receptors,12,13,72,81,"Our results supported the notion that, upon engagement with the cognate receptors, CD137 ligand and CD40 initiates activation of nuclear factor-kappa B (NF-B) signaling in tumor cells even in the absence of CD8+ T cells.",31427736_4,0,1,2,-1,37577,-1,0.00045601767,0.00013945637,0.99940443
37578,factor-kappa,22,23,137,149,"Our results supported the notion that, upon engagement with the cognate receptors, CD137 ligand and CD40 initiates activation of nuclear factor-kappa B (NF-B) signaling in tumor cells even in the absence of CD8+ T cells.",31427736_4,0,1,-1,-1,37578,-1,1.3791841e-05,0.99997866,7.5369508e-06
37579,tumor cells,29,31,173,184,"Our results supported the notion that, upon engagement with the cognate receptors, CD137 ligand and CD40 initiates activation of nuclear factor-kappa B (NF-B) signaling in tumor cells even in the absence of CD8+ T cells.",31427736_4,-1,-1,-1,-1,37579,-1,4.1611867e-05,0.00013234519,0.99982613
37585,factor,24,25,193,199,"Like tumor and CD8+ T cell contact-dependent NKG2D ligand induction, this CD137L/CD40-mediated signaling activation was associated with elevated levels of acetyltransferase P300/CBP-associated factor (PCAF), whereas inhibition of phosphorylated NF-B abrogated PCAF induction.",31427736_5,0,1,-1,-1,37585,-1,1.0856986e-05,0.9999832,5.9396248e-06
37589,TNF,18,19,127,131,"Although stimulation of CD137L/CD40-mediated signaling is vital, inflammatory cytokines, including interferon gamma (IFN) and TNF, also facilitate NKG2D ligand-induced immune surveillance via both facilitating T-cell chemotaxis and CD137L/CD40 induced NF-B/PCAF activation.",31427736_6,0,1,-1,-1,37589,-1,3.686881e-05,0.99994814,1.5013023e-05
37590,T-cell chemotaxis,29,31,212,229,"Although stimulation of CD137L/CD40-mediated signaling is vital, inflammatory cytokines, including interferon gamma (IFN) and TNF, also facilitate NKG2D ligand-induced immune surveillance via both facilitating T-cell chemotaxis and CD137L/CD40 induced NF-B/PCAF activation.",31427736_6,-1,-1,-1,-1,37590,-1,0.38806438,0.0017137671,0.61022186
37591,tumor cells,20,22,130,141,"Collectively, our results unveil a novel mechanism of NKG2D ligand upregulation involving reverse signaling of CD40 and CD137L on tumor cells which, along with inflammatory cytokines IFN and TNF, stimulate downstream NF-B and PCAF activation.",31427736_7,-1,-1,-1,-1,37591,-1,0.00018100826,0.0022800989,0.9975389
37592,cytokines IFN,27,29,173,187,"Collectively, our results unveil a novel mechanism of NKG2D ligand upregulation involving reverse signaling of CD40 and CD137L on tumor cells which, along with inflammatory cytokines IFN and TNF, stimulate downstream NF-B and PCAF activation.",31427736_7,-1,-1,-1,-1,37592,-1,0.99996054,5.630458e-06,3.390776e-05
37593,TNF,30,31,192,196,"Collectively, our results unveil a novel mechanism of NKG2D ligand upregulation involving reverse signaling of CD40 and CD137L on tumor cells which, along with inflammatory cytokines IFN and TNF, stimulate downstream NF-B and PCAF activation.",31427736_7,0,1,-1,-1,37593,-1,0.00028704255,0.9996767,3.626512e-05
37595,T-cell therapy,11,13,87,101,Understanding this mechanism may help in development of induced NKG2D ligand-dependent T-cell therapy against cancers.,31427736_8,-1,-1,-1,-1,37595,-1,0.0008700206,0.017895874,0.98123413
37604,the regulation,7,9,37,51,We investigated the role of IL-17 in the regulation of expression of programmed cell death 1 ligand 1 in ovarian cancer by evaluating changes in the number of IL-17-producing cluster of differentiation 4 helper T cells (Th17) and T cells (T17) in PBMC of 52 gynecological cancer patients (including 30 ovarian cancer patients) and 18 healthy controls.,31432577_2,-1,-1,-1,-1,37604,-1,3.7558505e-06,0.99999166,4.5471284e-06
37620,factors,13,14,77,84,We found that programmed cell death 1 ligand 1 expression and its associated factors (IL-6 and phospho-signal transducer and activator of transcription 3) were induced by IL-17 in an ovarian cancer cell line.,31432577_6,0,1,-1,-1,37620,-1,6.226626e-06,0.9999888,5.0033345e-06
37636,immunity,33,34,222,230,"Kynurenine pathway (KP) activation by the enzymatic activity of indoleamine 2,3-dioxygenase1 (IDO1) and kynurenine (KYN) production represents an attractive target for reducing tumour progression and improving anti-tumour immunity in multiple cancers.",31434983_0,0,-1,2,-1,37636,-1,0.99982244,4.0579263e-05,0.00013710061
37639,T-cell status,8,10,57,70,"The association of the kynurenine metabolic pathway with T-cell status in the tumour microenvironment were characterized, using gene expression data of 368 cutaneous skin melanoma (SKCM) patients from the TCGA cohort.",31434983_2,-1,-1,-1,-1,37639,-1,4.168909e-05,7.575523e-05,0.99988246
37640,the tumour,11,13,74,84,"The association of the kynurenine metabolic pathway with T-cell status in the tumour microenvironment were characterized, using gene expression data of 368 cutaneous skin melanoma (SKCM) patients from the TCGA cohort.",31434983_2,-1,-1,-1,-1,37640,-1,5.302122e-06,0.9999889,5.752864e-06
37642,the TCGA,31,33,201,209,"The association of the kynurenine metabolic pathway with T-cell status in the tumour microenvironment were characterized, using gene expression data of 368 cutaneous skin melanoma (SKCM) patients from the TCGA cohort.",31434983_2,-1,-1,-1,-1,37642,-1,1.10581095e-05,0.99997735,1.1558114e-05
37646,T-cells,28,29,159,166,"Based on the identified correlations, we characterized the production of KYN, 3-HK, and KYNA in vitro using melanoma-derived cell lines and primary CD4+ CD25- T-cells.",31434983_3,-1,1,2,-1,37646,-1,1.39574895e-05,9.258857e-06,0.99997675
37648,T-cells,5,6,23,30,"Activation of the CD4+ T-cells produced IFN, which yielded increased levels of KYN and KYNA.",31434983_4,-1,1,2,-1,37648,-1,1.8557663e-05,1.1074357e-05,0.9999703
37650,T-cells,13,14,84,91,"Concurrently, kynurenine 3-monooxygenase (KMO) expression and proliferation of CD4+ T-cells were reduced, whereas exhaustion markers such as PD-L1, AHR, FOXP3, and CTLA4 were increased.",31434983_5,-1,1,2,-1,37650,-1,1.4715428e-05,8.67256e-06,0.99997663
37654,analysis,3,4,17,25,"Additionally, an analysis of the correlation network reconstructed using TCGA-SKCM emphasized KMO and KYNU with high variability among BRAF wild-type compared with V600E, which underscored their role in distinct CD4+ T-cell behavior in tumour immunity.",31434983_6,0,1,-1,-1,37654,-1,7.642677e-06,0.999987,5.3117888e-06
37658,T-cell,33,34,217,223,"Additionally, an analysis of the correlation network reconstructed using TCGA-SKCM emphasized KMO and KYNU with high variability among BRAF wild-type compared with V600E, which underscored their role in distinct CD4+ T-cell behavior in tumour immunity.",31434983_6,-1,1,2,-1,37658,-1,1.0632099e-05,6.0310554e-06,0.9999833
37659,tumour immunity,36,38,236,251,"Additionally, an analysis of the correlation network reconstructed using TCGA-SKCM emphasized KMO and KYNU with high variability among BRAF wild-type compared with V600E, which underscored their role in distinct CD4+ T-cell behavior in tumour immunity.",31434983_6,-1,-1,-1,-1,37659,-1,0.03529511,0.9636201,0.0010848064
37666,T-cell,36,37,221,227,"Our results suggest that, in addition to IDO1, there is an alternative immune regulatory mechanism associated with the lower KMO expression and the higher KYNA production, which contributes to dysfunctional effector CD4+ T-cell response.",31434983_7,-1,1,2,-1,37666,-1,2.2553868e-05,8.004985e-06,0.9999695
37670,tumor cells,10,12,65,76,"Blocking the PD-L1/PD-1 pathway to prevent the immune evasion of tumor cells is a powerful approach for treating multiple cancers, including hepatocellular carcinoma (HCC).",31437792_0,-1,-1,-1,-1,37670,-1,0.00034860018,0.006759902,0.99289155
37677,these two,25,27,156,165,"Previous studies have shown that baicalein and baicalin are directly cytotoxic to some tumors, here we demonstrate that in addition to direct cytotoxicity, these two flavonoids stimulate the T cell mediated immune response against tumors through reduction of PD-L1 expression in cancer cells.",31437792_1,-1,-1,-1,-1,37677,-1,1.3137237e-05,0.9999809,5.991908e-06
37678,the T cell,29,32,187,197,"Previous studies have shown that baicalein and baicalin are directly cytotoxic to some tumors, here we demonstrate that in addition to direct cytotoxicity, these two flavonoids stimulate the T cell mediated immune response against tumors through reduction of PD-L1 expression in cancer cells.",31437792_1,-1,-1,-1,-1,37678,-1,0.0019806277,0.19466616,0.80335313
37680,tumors through,36,38,231,245,"Previous studies have shown that baicalein and baicalin are directly cytotoxic to some tumors, here we demonstrate that in addition to direct cytotoxicity, these two flavonoids stimulate the T cell mediated immune response against tumors through reduction of PD-L1 expression in cancer cells.",31437792_1,-1,-1,-1,-1,37680,-1,4.2515735e-06,0.99999225,3.5009398e-06
37687,these two,12,14,82,91,PD-L1 upregulation induced by interferon- (IFN-) was significantly inhibited by these two flavonoids in vitro.,31437792_3,-1,-1,-1,-1,37687,-1,2.4125393e-05,0.999967,8.923663e-06
37689,T cells to,8,11,57,67,"Both baicalein and baicalin enhanced the cytotoxicity of T cells to eliminate tumor cells, which was abrogated after HCC cells were transfected with a PD-L1 overexpression plasmid or after T cells were pretreated with an anti-PD-1 blocking antibody.",31437792_4,-1,-1,-1,-1,37689,-1,0.0014961349,0.051739916,0.94676393
37690,tumor cells,12,14,78,89,"Both baicalein and baicalin enhanced the cytotoxicity of T cells to eliminate tumor cells, which was abrogated after HCC cells were transfected with a PD-L1 overexpression plasmid or after T cells were pretreated with an anti-PD-1 blocking antibody.",31437792_4,-1,-1,-1,-1,37690,-1,6.8301815e-05,0.00038135244,0.9995504
37695,that the IFN--induced,4,7,39,61,"Further mechanistic research indicated that the IFN--induced expression and promoter activity of PD-L1 were suppressed by these two flavonoids, and these effects were mediated by STAT3 activity inhibition.",31437792_5,-1,-1,-1,-1,37695,-1,0.32231742,0.6757019,0.001980701
37696,these two,16,18,123,132,"Further mechanistic research indicated that the IFN--induced expression and promoter activity of PD-L1 were suppressed by these two flavonoids, and these effects were mediated by STAT3 activity inhibition.",31437792_5,-1,-1,-1,-1,37696,-1,3.7969134e-05,0.9999491,1.2899806e-05
37704,tumor cells,22,24,166,177,"Therefore, baicalein and baicalin decreased STAT3 activity, further downregulated IFN--induced PD-L1 expression and subsequently restored T cell sensitivity to kill tumor cells.",31437792_6,-1,-1,-1,-1,37704,-1,0.0009898192,0.037787665,0.9612225
37708,that these,25,27,176,186,Our findings provide novel insight into the anticancer effects of baicalein and baicalin through which tumor growth is inhibited by PD-L1 expression downregulation and suggest that these flavonoids have great potential for clinical treatment.,31437792_7,-1,-1,-1,-1,37708,-1,5.2070855e-06,0.9999913,3.4744935e-06
37711,cells generate,5,7,20,34,Natural killer (NK) cells generate proinflammatory cytokines that are required to contain infections and tumor growth.,31515257_0,-1,-1,-1,-1,37711,-1,0.0056639872,0.29989943,0.6944366
37712,cytokines that,8,10,51,65,Natural killer (NK) cells generate proinflammatory cytokines that are required to contain infections and tumor growth.,31515257_0,-1,-1,-1,-1,37712,-1,0.97839284,0.020591931,0.0010153368
37717,cell functions,8,10,61,75,"However, the posttranscriptional mechanisms that regulate NK cell functions are not fully understood.",31515257_1,-1,-1,-1,-1,37717,-1,2.5713987e-05,2.7357102e-05,0.99994683
37725,factors,9,10,62,69,"However, loss of Mirc11 reduced generation of proinflammatory factors in vitro and interferon--dependent clearance of Listeria monocytogenes or B16F10 melanoma in vivo by NK cells.",31515257_4,0,1,-1,-1,37725,-1,0.9998369,9.176366e-05,7.1252805e-05
37728,These functional,0,2,0,16,"These functional changes resulted from Mirc11 silencing ubiquitin modifiers A20, Cbl-b, and Itch, allowing TRAF6-dependent activation of NF-B and AP-1.",31515257_5,-1,-1,-1,-1,37728,-1,4.384769e-05,0.9999242,3.193177e-05
37733,proteins,13,14,68,76,"Lack of Mirc11 caused increased translation of A20, Cbl-b, and Itch proteins, resulting in deubiquitylation of scaffolding K63 and addition of degradative K48 moieties on TRAF6.",31515257_6,0,1,-1,-1,37733,-1,3.0876323e-05,0.9999218,4.7334554e-05
37735,function,6,7,37,45,"Collectively, our results describe a function of Mirc11 that regulates generation of proinflammatory cytokines from effector lymphocytes.",31515257_7,0,1,2,-1,37735,-1,1.0793945e-05,0.99998105,8.179649e-06
37740,the treatment,7,9,61,74,Immune-checkpoint blockade antibodies have been approved for the treatment of cancer.,31515801_0,-1,-1,-1,-1,37740,-1,5.756662e-06,0.9999889,5.300818e-06
37744,receptor,2,3,25,33,"Agonistic anti-Toll-like receptor 4 (TLR4) monoclonal antibodies (mAbs) activate only cell-surface TLR4; in contrast, lipopolysaccharide (LPS) activates both TLR4 and intracellular inflammatory caspases.",31515801_2,0,1,2,-1,37744,-1,8.584532e-05,2.1740192e-05,0.9998925
37746,cell-surface TLR4,14,16,86,103,"Agonistic anti-Toll-like receptor 4 (TLR4) monoclonal antibodies (mAbs) activate only cell-surface TLR4; in contrast, lipopolysaccharide (LPS) activates both TLR4 and intracellular inflammatory caspases.",31515801_2,-1,-1,-1,-1,37746,-1,0.0018654935,0.030388726,0.9677459
37751,T-cell-mediated,14,15,76,91,"In this study, we investigated the adjuvant activity of an anti-TLR4 mAb in T-cell-mediated antitumour immunity.",31515801_3,-1,1,2,-1,37751,-1,1.3184758e-05,8.448406e-06,0.9999783
37752,immunity,16,17,103,111,"In this study, we investigated the adjuvant activity of an anti-TLR4 mAb in T-cell-mediated antitumour immunity.",31515801_3,0,-1,2,-1,37752,-1,0.9998115,3.96649e-05,0.00014881752
37755,antigen-specific T-cells,7,9,44,68,The anti-TLR4 mAb induced the activation of antigen-specific T-cells in adoptive transfer studies.,31515801_4,-1,-1,-1,-1,37755,-1,0.5924702,0.0006503962,0.40687934
37761,plus the,13,15,82,90,The antitumour effect of anti-PD-1 mAb was enhanced in mice administered with OVA plus the anti-TLR4 mAb.,31515801_6,-1,-1,-1,-1,37761,-1,7.452249e-06,0.9999864,6.1117175e-06
37764,T-cells,4,5,37,44,The OVA-specific IFN--producing CD8 T-cells were induced by administration of OVA and the anti-TLR4 mAb.,31515801_7,-1,1,2,-1,37764,-1,1.6566672e-05,1.2968034e-05,0.99997044
37768,T-cells,16,17,82,89,"The suppression of tumour growth was diminished by depletion of CD8, but not CD4, T-cells.",31515801_8,-1,1,2,-1,37768,-1,1.3681761e-05,7.5656717e-06,0.9999788
37770,to the,3,5,26,32,"The inflammatory response to the anti-TLR4 mAb was of significantly lesser magnitude than that to LPS, as assessed by NF-B activation and production of TNF-, IL-6 and IL-1.",31515801_9,-1,-1,-1,-1,37770,-1,4.4566304e-06,0.99999034,5.231999e-06
37771,than that to LPS,12,16,85,101,"The inflammatory response to the anti-TLR4 mAb was of significantly lesser magnitude than that to LPS, as assessed by NF-B activation and production of TNF-, IL-6 and IL-1.",31515801_9,-1,-1,-1,-1,37771,-1,1.2693285e-05,0.9999747,1.2586389e-05
37772,TNF-,25,26,153,158,"The inflammatory response to the anti-TLR4 mAb was of significantly lesser magnitude than that to LPS, as assessed by NF-B activation and production of TNF-, IL-6 and IL-1.",31515801_9,0,1,-1,-1,37772,-1,0.00030718857,0.9996207,7.2077186e-05
37778,to those,14,16,94,102,Administration of LPS (at a dose that elicited levels of proinflammatory cytokines comparable to those by the anti-TLR4 mAb) plus OVA induced no or less-marked activation of OVA-specific T-cells and failed to suppress tumour growth in mice.,31515801_10,-1,-1,-1,-1,37778,-1,8.810369e-06,0.9999851,6.141415e-06
37781,T-cells,30,31,187,194,Administration of LPS (at a dose that elicited levels of proinflammatory cytokines comparable to those by the anti-TLR4 mAb) plus OVA induced no or less-marked activation of OVA-specific T-cells and failed to suppress tumour growth in mice.,31515801_10,-1,1,2,-1,37781,-1,1.6673e-05,9.5493215e-06,0.9999738
37785,T-cell-dependent,10,11,62,78,"In conclusion, the agonistic anti-TLR4 mAb induces potent CD8 T-cell-dependent antitumour immunity and an inflammatory response of lesser magnitude than does LPS.",31515801_11,-1,1,2,-1,37785,-1,1.6608927e-05,1.10007195e-05,0.99997246
37786,immunity,12,13,90,98,"In conclusion, the agonistic anti-TLR4 mAb induces potent CD8 T-cell-dependent antitumour immunity and an inflammatory response of lesser magnitude than does LPS.",31515801_11,0,-1,2,-1,37786,-1,0.9998368,4.6474735e-05,0.00011669883
37791,factor-,2,3,20,28,"Transforming growth factor- (TGF-) is produced by tumors, and increased amounts of this cytokine in the tumor microenvironment and serum are associated with poor patient survival.",31530731_0,0,1,-1,-1,37791,-1,0.99992764,6.173711e-06,6.62058e-05
37794,this cytokine,15,17,85,98,"Transforming growth factor- (TGF-) is produced by tumors, and increased amounts of this cytokine in the tumor microenvironment and serum are associated with poor patient survival.",31530731_0,-1,-1,-1,-1,37794,-1,0.8951106,0.10039812,0.0044911914
37795,the tumor,18,20,102,111,"Transforming growth factor- (TGF-) is produced by tumors, and increased amounts of this cytokine in the tumor microenvironment and serum are associated with poor patient survival.",31530731_0,-1,-1,-1,-1,37795,-1,4.4968856e-06,0.99999106,4.4150624e-06
37798,to tumor,8,10,69,77,TGF--mediated suppression of antitumor T cell responses contributes to tumor growth and survival.,31530731_1,-1,-1,-1,-1,37798,-1,6.445555e-06,0.99998665,6.8626186e-06
37802,cell type-specific,11,13,69,87,"However, TGF- also has tumor-suppressive activity; thus, dissecting cell type-specific molecular effects may inform therapeutic strategies targeting this cytokine.",31530731_2,-1,-1,-1,-1,37802,-1,0.0012075726,0.0056032566,0.9931892
37804,targeting this cytokine,19,22,140,163,"However, TGF- also has tumor-suppressive activity; thus, dissecting cell type-specific molecular effects may inform therapeutic strategies targeting this cytokine.",31530731_2,-1,-1,-1,-1,37804,-1,0.15217434,0.8447634,0.0030622184
37805,tumor-associated lymphocytes,6,8,33,61,"Here, using human peripheral and tumor-associated lymphocytes, we investigated how tumor-derived TGF- suppresses a key antitumor function of CD4+ T cells, interferon- (IFN-) production.",31530731_3,-1,-1,-1,-1,37805,-1,0.001541573,0.86949575,0.12896262
37806,tumor-derived TGF-,12,14,83,102,"Here, using human peripheral and tumor-associated lymphocytes, we investigated how tumor-derived TGF- suppresses a key antitumor function of CD4+ T cells, interferon- (IFN-) production.",31530731_3,-1,-1,-1,-1,37806,-1,1.3801959e-05,0.9999776,8.624714e-06
37807,function,18,19,130,138,"Here, using human peripheral and tumor-associated lymphocytes, we investigated how tumor-derived TGF- suppresses a key antitumor function of CD4+ T cells, interferon- (IFN-) production.",31530731_3,0,1,2,-1,37807,-1,2.5095034e-05,0.999951,2.395574e-05
37813,the TGF-,10,12,76,85,"Suppression required the expression and phosphorylation of Smad proteins in the TGF- signaling pathway, but not their nuclear translocation, and depended on oxygen availability, suggesting a metabolic basis for these effects.",31530731_4,-1,-1,-1,-1,37813,-1,1.6993818e-05,0.99997354,9.480962e-06
37825,tumor-associated lymphocytes,11,13,80,108,Phosphorylated Smad proteins were also detected in the mitochondria of isolated tumor-associated lymphocytes.,31530731_6,-1,-1,-1,-1,37825,-1,0.0019833702,0.85927004,0.13874665
37834,immunity,9,10,59,67,"These results, which have implications for human antitumor immunity, suggest that TGF- targets T cell metabolism directly, thus diminishing T cell function through metabolic paralysis.",31530731_9,0,-1,2,-1,37834,-1,0.9997507,0.000103958606,0.0001453411
37835,that TGF- targets T cell metabolism,12,18,77,113,"These results, which have implications for human antitumor immunity, suggest that TGF- targets T cell metabolism directly, thus diminishing T cell function through metabolic paralysis.",31530731_9,-1,-1,-1,-1,37835,-1,0.0017450992,0.9724077,0.025847277
37837,T cell function through,22,26,141,164,"These results, which have implications for human antitumor immunity, suggest that TGF- targets T cell metabolism directly, thus diminishing T cell function through metabolic paralysis.",31530731_9,-1,-1,-1,-1,37837,-1,0.002115526,0.040331982,0.9575525
37842,the tumor,28,30,166,175,We examined whether this ligand is a prognostic marker for high-grade serous ovarian cancer (HGSOC) and whether it is associated with accumulation of immune cells in the tumor.,31537619_1,-1,-1,-1,-1,37842,-1,4.2752395e-06,0.99999094,4.775109e-06
37851,tumor tissues,15,17,60,73,"Although the intensity of CD3, CD8, CD4, CD20, and CD163 in tumor tissues remained constant regardless of membrane CD95L expression, tumors in patients with HGSOC with s-CD95L levels 516 pg/mL showed increased infiltration by CD3+ T cells (P = 0.001), comprising both cytotoxic CD8+ (P = 0.01) and CD4+ (P = 0.0062) cells including FoxP3+ regulatory T cells (P = 0.0044).",31537619_4,-1,-1,-1,-1,37851,-1,5.3311023e-06,0.99998474,9.9085755e-06
37863,factors,57,58,238,245,"Multivariate analyses revealed that low s-CD95L concentrations [<516 pg/mL, HR, 3.54; 95% confidence interval (CI), 1.13-11.11), and <1,200 activated CD8+ (Granzyme B+) cells (HR, 2.63; 95% CI, 1.16-5.95) were independent poor prognostic factors for recurrence, whereas >6,000 CD3+ cells (HR, 0.34; 95% CI, 0.15-0.79) was a good prognostic factor.",31537619_6,0,1,-1,-1,37863,-1,0.0010537883,0.9987949,0.00015128961
37865,factor,84,85,340,346,"Multivariate analyses revealed that low s-CD95L concentrations [<516 pg/mL, HR, 3.54; 95% confidence interval (CI), 1.13-11.11), and <1,200 activated CD8+ (Granzyme B+) cells (HR, 2.63; 95% CI, 1.16-5.95) were independent poor prognostic factors for recurrence, whereas >6,000 CD3+ cells (HR, 0.34; 95% CI, 0.15-0.79) was a good prognostic factor.",31537619_6,0,1,-1,-1,37865,-1,0.001079572,0.99883574,8.4715604e-05
37867,tumor-infiltrating lymphocytes,17,19,78,108,"Thus, low levels of s-CD95L (<516 pg/mL) are correlated with lower numbers of tumor-infiltrating lymphocytes (CD3+ and CD8+, and also CD4 and FoxP3 T cells) in advanced HGSOC and are a poor prognostic marker.",31537619_7,-1,-1,-1,-1,37867,-1,0.002516716,0.84519875,0.15228456
37868,FoxP3 T cells,30,33,142,155,"Thus, low levels of s-CD95L (<516 pg/mL) are correlated with lower numbers of tumor-infiltrating lymphocytes (CD3+ and CD8+, and also CD4 and FoxP3 T cells) in advanced HGSOC and are a poor prognostic marker.",31537619_7,-1,-1,-1,-1,37868,-1,0.0023744185,0.772295,0.2253306
37873,trials that,33,35,217,228,IMPLICATIONS: Serum s-CD95L is correlated with a number of tumor-infiltrating immune cells in HGSOC and could be used as a noninvasive marker of tumor immune infiltration to select patients referred for immunotherapy trials that evaluate checkpoint inhibitor treatment.,31537619_8,-1,-1,-1,-1,37873,-1,5.015259e-06,0.9999908,4.1081807e-06
37877,tumor-infiltrating lymphocytes,20,22,130,160,BACKGROUND AND AIMS: Hepatocellular carcinoma (HCC) is often accompanied by resistance to immunotherapies despite the presence of tumor-infiltrating lymphocytes.,31539182_0,-1,-1,-1,-1,37877,-1,0.0026767815,0.8957704,0.10155282
37892,T cells trigger,3,6,29,44,"Intriguingly, HDAC6-depleted T cells trigger programmed cell death protein 1 (PD-1)-PD-1 ligand 1 expression to achieve a strong synergistic effect to sensitize advanced HCC to an immune checkpoint blocker, while blockade of IL-17A partially suppresses it.",31539182_3,-1,-1,-1,-1,37892,-1,0.0016254531,0.03519901,0.9631755
37894,protein,9,10,67,74,"Intriguingly, HDAC6-depleted T cells trigger programmed cell death protein 1 (PD-1)-PD-1 ligand 1 expression to achieve a strong synergistic effect to sensitize advanced HCC to an immune checkpoint blocker, while blockade of IL-17A partially suppresses it.",31539182_3,0,1,-1,-1,37894,-1,0.0001681384,0.9996189,0.00021294289
37905,receptor,23,24,160,168,"HDAC6 binds and deacetylates cytosolic FoxO1 at K242, which is required for its nuclear translocation and stabilization to repress retinoic acid-related orphan receptor gamma (RoRt), the transcription factor of TH 17 cell.",31539182_5,0,1,2,-1,37905,-1,0.006820134,0.95695955,0.03622034
37906,the transcription factor,29,32,184,208,"HDAC6 binds and deacetylates cytosolic FoxO1 at K242, which is required for its nuclear translocation and stabilization to repress retinoic acid-related orphan receptor gamma (RoRt), the transcription factor of TH 17 cell.",31539182_5,-1,-1,-1,-1,37906,-1,5.256833e-06,0.99998975,4.973141e-06
37909,This regulation,0,2,0,15,This regulation of HDAC6 for murine and human TH 17 cell is highly conserved.,31539182_6,-1,-1,-1,-1,37909,-1,5.5846394e-06,0.9999893,5.179291e-06
37913,that targeting the,5,8,39,57,"CONCLUSIONS: These results demonstrate that targeting the cytosolic HDAC6-FoxO1 axis reprograms the pathogenicity and antitumor response of TH 17 cells in HCC, with a pathogenicity-driven responsiveness to facilitate immunotherapies.",31539182_7,-1,-1,-1,-1,37913,-1,3.9913575e-06,0.9999925,3.4612822e-06
37922,that chemotherapeutics,8,10,38,60,"A key discovery in the past decade is that chemotherapeutics can alter tumor cell immunogenicity via inducing release of damage-associated molecular patterns (DAMPs), including ecto-calreticulin (ecto-CALR), high mobility group box 1 (HMGB1) and ATP, causing tumor cells to die in a manner known as bona fide immunogenic apoptosis or immunogenic cell death (ICD).",31600692_2,-1,-1,-1,-1,37922,-1,0.19614552,0.8020883,0.0017661566
37923,tumor cell,12,14,71,81,"A key discovery in the past decade is that chemotherapeutics can alter tumor cell immunogenicity via inducing release of damage-associated molecular patterns (DAMPs), including ecto-calreticulin (ecto-CALR), high mobility group box 1 (HMGB1) and ATP, causing tumor cells to die in a manner known as bona fide immunogenic apoptosis or immunogenic cell death (ICD).",31600692_2,-1,-1,-1,-1,37923,-1,0.0001393486,0.0016933156,0.9981673
37925,tumor cells to,44,47,259,273,"A key discovery in the past decade is that chemotherapeutics can alter tumor cell immunogenicity via inducing release of damage-associated molecular patterns (DAMPs), including ecto-calreticulin (ecto-CALR), high mobility group box 1 (HMGB1) and ATP, causing tumor cells to die in a manner known as bona fide immunogenic apoptosis or immunogenic cell death (ICD).",31600692_2,-1,-1,-1,-1,37925,-1,0.0005953486,0.9225778,0.07682684
37950,these cells,7,9,41,52,We aimed to investigate the frequency of these cells and their ability to produce cytokines in tumor-draining lymph nodes from patients with breast cancer (BC).MATERIALS AND METHODS: Mononuclear cells from lymph nodes of 20 patients with BC were activated and stained for appropriate markers.,31630080_1,-1,-1,-1,-1,37950,-1,1.941992e-05,1.2503325e-05,0.99996805
37956,The cells,0,2,0,9,The cells were assayed with four-color flow cytometry.,31630080_2,-1,-1,-1,-1,37956,-1,4.251212e-05,3.7367954e-05,0.9999201
37990,functions through,23,25,145,162,"Since oral delivery of plasmid DNA is intervened by various physical obstacles, here we constructed a nanogel (Alg-Tat-gp100) with multi-faceted functions through blending-by-blending method.",31655203_1,-1,-1,-1,-1,37990,-1,6.1507875e-05,0.9998721,6.634364e-05
37991,to the cooperation,1,4,4,22,"Due to the cooperation of alginate and Tat peptide, Alg-Tat-gp100 demonstrated the significant improvement of stability in the stomach, mucus penetration ability in intestine, and transport across mucus layer and MDCK cells.",31655203_2,-1,-1,-1,-1,37991,-1,6.170309e-06,0.9999888,4.991263e-06
37992,Tat peptide,7,9,39,50,"Due to the cooperation of alginate and Tat peptide, Alg-Tat-gp100 demonstrated the significant improvement of stability in the stomach, mucus penetration ability in intestine, and transport across mucus layer and MDCK cells.",31655203_2,-1,-1,-1,-1,37992,-1,5.1387884e-05,0.9999027,4.5839734e-05
38008,that this,20,22,114,123,"Benefiting from those cases, the B16F10 tumor inhibition rate achieved 42.5% by this oral DNA vaccine, suggesting that this multi-faceted nanogel prepared by simple blending-by-blending method may provide a new strategy for oral DNA vaccine delivery.",31655203_5,-1,-1,-1,-1,38008,-1,4.056152e-06,0.99999213,3.801767e-06
38013,to the tumor,10,13,53,65,Blocking the migration of regulatory T cells (Tregs) to the tumor microenvironment is a promising strategy for tumor immunotherapy.,31669202_0,-1,-1,-1,-1,38013,-1,7.4050095e-06,0.99998546,7.098146e-06
38026,to Treg,28,30,175,182,"Here, we studied the distribution and characteristics of Tregs in the LHME, investigated the effects of Treg ablation on leukemia progression, explored the mechanisms leading to Treg accumulation, and studied whether blocking Treg migration to the LHME delayed leukemia progression in MLL-AF9-induced mouse acute myeloid leukemia (AML) models using wildtype (WT) and Foxp3DTR/GFP mice.",31669202_3,-1,-1,-1,-1,38026,-1,6.2472072e-06,0.9999881,5.7201496e-06
38028,to the,38,40,241,247,"Here, we studied the distribution and characteristics of Tregs in the LHME, investigated the effects of Treg ablation on leukemia progression, explored the mechanisms leading to Treg accumulation, and studied whether blocking Treg migration to the LHME delayed leukemia progression in MLL-AF9-induced mouse acute myeloid leukemia (AML) models using wildtype (WT) and Foxp3DTR/GFP mice.",31669202_3,-1,-1,-1,-1,38028,-1,8.519943e-06,0.9999795,1.2019629e-05
38054,that tumor-infiltrating FOXP3,2,5,12,41,"Data showed that tumor-infiltrating FOXP3+ Treg cells expressed granzyme B immediately following resection, indicating that granzyme B-expressing Treg cells were present directly ex vivo.",31669380_3,-1,-1,-1,-1,38054,-1,1.0414316e-05,0.9999819,7.712973e-06
38058,the tumor-associated,1,3,3,23,"In the tumor-associated lymph nodes (LNs) and circulating lymphocytes, however, granzyme B-expressing Treg cells were only scarcely found.",31669380_4,-1,-1,-1,-1,38058,-1,8.627211e-06,0.9999809,1.0454239e-05
38066,TCR,16,17,90,93,"Granzyme B upregulation in Treg cells could not be activated by standard T cell receptor (TCR) activation through anti-CD3/CD28 and IL-2 but required stimulation with bacterial products, such as with heat-killed Staphylococcus aureus.",31669380_6,-1,1,2,-1,38066,-1,2.4497496e-05,0.9998673,0.00010817649
38070,Treg subset,15,17,85,96,"Interestingly, granzyme B expression was highly concentrated in TIM-3+ Treg cells, a Treg subset previously shown to be enriched in the tumor microenvironment and presented increased suppressive capacity.",31669380_7,-1,-1,-1,-1,38070,-1,0.00012228062,0.00357438,0.9963033
38072,the tumor,23,25,132,141,"Interestingly, granzyme B expression was highly concentrated in TIM-3+ Treg cells, a Treg subset previously shown to be enriched in the tumor microenvironment and presented increased suppressive capacity.",31669380_7,-1,-1,-1,-1,38072,-1,4.492525e-06,0.99999094,4.5538777e-06
38073,These TIM-3,0,2,0,11,"These TIM-3+ Treg cells presented higher cytolytic capacity toward autologous T conventional cells than the TIM-3- Treg cells, in a manner that was dependent on granzyme B but not TIM-3.",31669380_8,-1,-1,-1,-1,38073,-1,7.802861e-06,0.99998426,7.8934745e-06
38077,cells than the TIM-3- Treg cells,13,19,93,125,"These TIM-3+ Treg cells presented higher cytolytic capacity toward autologous T conventional cells than the TIM-3- Treg cells, in a manner that was dependent on granzyme B but not TIM-3.",31669380_8,-1,-1,-1,-1,38077,-1,0.00010913369,0.00023296931,0.99965787
38082,the tumors,12,14,73,83,"Overall, we found that granzyme B-expressing Treg cells were enriched in the tumors from CRC patients and had the potential to eliminate autologous T conventional cells.",31669380_9,-1,-1,-1,-1,38082,-1,3.7538598e-06,0.9999918,4.502433e-06
38093,classification,7,8,45,59,"Recently, a new global transcriptomic immune classification of solid tumours has identified six immune subtypes (ISs) (C1-C6).",31678770_1,0,1,2,-1,38093,-1,3.671492e-05,0.99992335,3.9963925e-05
38103,analysis,11,12,78,86,"Immune cell populations, differential gene expression and gene set enrichment analysiswere performed to characterise ISs in the global CRC population by using CMSs.",31678770_3,0,1,-1,-1,38103,-1,1.1295833e-05,0.9999795,9.17312e-06
38119,classification,31,32,179,193,"Prognostic relevance of ISs in CRC substantially differed from that reported for the global TCGA, and ISs had a greater ability to stratify the prognosis of CRC patients than CMS classification.",31678770_7,0,1,2,-1,38119,-1,3.3084754e-05,0.99990535,6.150394e-05
38123,related to the,7,10,43,57,"C2 had a heightened activation of pathways related to the immune system, apoptosis and DNA repair, mTOR signalling and oxidative phosphorylation, whereas C1 was more dependent of metabolic pathways.",31678770_9,-1,-1,-1,-1,38123,-1,1.086196e-05,0.99997866,1.0505797e-05
38126,tools to,26,28,166,174,"CONCLUSIONS: The correlation of IS and CMS allows a more precise categorisation of patients with relevant clinical and biological implications, which may be valuable tools to improve tailored therapeutic interventions in CRC patients.",31678770_10,-1,-1,-1,-1,38126,-1,8.099178e-06,0.9999858,6.1345354e-06
38127,tailored therapeutic,29,31,183,203,"CONCLUSIONS: The correlation of IS and CMS allows a more precise categorisation of patients with relevant clinical and biological implications, which may be valuable tools to improve tailored therapeutic interventions in CRC patients.",31678770_10,-1,-1,-1,-1,38127,-1,6.81924e-06,0.99998844,4.7998656e-06
38128,therapy,9,10,49,56,"Glucocorticoids (GCs) are a central component of therapy for patients with T cell acute lymphoblastic leukemia (T-ALL), and although resistance to GCs is a strong negative prognostic indicator in T-ALL, the mechanisms of GC resistance remain poorly understood.",31687977_0,0,1,-1,-1,38128,-1,6.7240703e-06,0.99998844,4.8208394e-06
38143,cytokine that,43,45,251,264,"Using diagnostic samples from patients enrolled in the frontline Children's Oncology Group (COG) T-ALL clinical trial AALL1231, we demonstrated that one-third of primary T-ALLs were resistant to GCs when cells were cultured in the presence of IL-7, a cytokine that is critical for normal T cell function and that plays a well-established role in leukemogenesis.",31687977_1,-1,-1,-1,-1,38143,-1,0.99558985,0.003940909,0.00046931175
38144,T cell function,49,52,288,303,"Using diagnostic samples from patients enrolled in the frontline Children's Oncology Group (COG) T-ALL clinical trial AALL1231, we demonstrated that one-third of primary T-ALLs were resistant to GCs when cells were cultured in the presence of IL-7, a cytokine that is critical for normal T cell function and that plays a well-established role in leukemogenesis.",31687977_1,-1,-1,-1,-1,38144,-1,2.7207398e-05,1.7332924e-05,0.99995553
38145,that plays,53,55,308,318,"Using diagnostic samples from patients enrolled in the frontline Children's Oncology Group (COG) T-ALL clinical trial AALL1231, we demonstrated that one-third of primary T-ALLs were resistant to GCs when cells were cultured in the presence of IL-7, a cytokine that is critical for normal T cell function and that plays a well-established role in leukemogenesis.",31687977_1,-1,-1,-1,-1,38145,-1,1.0135843e-05,0.9999838,6.133738e-06
38147,these T-ALLs,4,6,24,36,"We demonstrated that in these T-ALLs and in distinct populations of normal developing thymocytes, GCs paradoxically induced their own resistance by promoting upregulation of IL-7 receptor (IL-7R) expression.",31687977_2,-1,-1,-1,-1,38147,-1,6.5891254e-06,0.99998474,8.641886e-06
38148,thymocytes,13,14,86,96,"We demonstrated that in these T-ALLs and in distinct populations of normal developing thymocytes, GCs paradoxically induced their own resistance by promoting upregulation of IL-7 receptor (IL-7R) expression.",31687977_2,-1,1,2,-1,38148,-1,0.0019144161,0.55991715,0.4381684
38150,IL-7 receptor,25,27,174,187,"We demonstrated that in these T-ALLs and in distinct populations of normal developing thymocytes, GCs paradoxically induced their own resistance by promoting upregulation of IL-7 receptor (IL-7R) expression.",31687977_2,-1,-1,-1,-1,38150,-1,0.9989506,6.4340195e-05,0.0009850642
38156,STAT5 transcriptional,15,17,95,116,"In the presence of IL-7, this augmented downstream signal transduction, resulting in increased STAT5 transcriptional output and upregulation of the prosurvival protein BCL-2.",31687977_3,-1,-1,-1,-1,38156,-1,5.376012e-06,0.99998677,7.861522e-06
38158,protein,23,24,160,167,"In the presence of IL-7, this augmented downstream signal transduction, resulting in increased STAT5 transcriptional output and upregulation of the prosurvival protein BCL-2.",31687977_3,0,1,-1,-1,38158,-1,5.3493422e-06,0.99999,4.70362e-06
38159,Taken together,0,2,0,14,"Taken together, we showed that IL-7 mediates an intrinsic and physiologic mechanism of GC resistance in normal thymocyte development that is retained during leukemogenesis in a subset of T-ALLs and is reversible with targeted inhibition of the IL-7R/JAK/STAT5/BCL-2 axis.",31687977_4,-1,-1,-1,-1,38159,-1,7.3882093e-06,0.9999857,6.9037173e-06
38160,that IL-7,5,7,26,35,"Taken together, we showed that IL-7 mediates an intrinsic and physiologic mechanism of GC resistance in normal thymocyte development that is retained during leukemogenesis in a subset of T-ALLs and is reversible with targeted inhibition of the IL-7R/JAK/STAT5/BCL-2 axis.",31687977_4,-1,-1,-1,-1,38160,-1,0.85993594,0.13749316,0.002570869
38161,thymocyte development that,18,21,111,137,"Taken together, we showed that IL-7 mediates an intrinsic and physiologic mechanism of GC resistance in normal thymocyte development that is retained during leukemogenesis in a subset of T-ALLs and is reversible with targeted inhibition of the IL-7R/JAK/STAT5/BCL-2 axis.",31687977_4,-1,-1,-1,-1,38161,-1,4.9004047e-05,0.99987996,7.1017406e-05
38173,Tcell Stat3,1,5,9,21,"Ablating Tcell Stat3 or treatment with an FAO inhibitor in obese mice spontaneously developing breast tumor reduces FAO, increases glycolysis and CD8+ T effector cell functions, leading to inhibition of breast tumor development.",31761565_2,-1,-1,-1,-1,38173,-1,0.0028935499,0.11367404,0.8834323
38177,cell functions,28,30,163,177,"Ablating Tcell Stat3 or treatment with an FAO inhibitor in obese mice spontaneously developing breast tumor reduces FAO, increases glycolysis and CD8+ T effector cell functions, leading to inhibition of breast tumor development.",31761565_2,-1,-1,-1,-1,38177,-1,1.5902648e-05,1.328655e-05,0.9999709
38181,STAT3 to,11,13,50,58,"Moreover, PD-1 ligation in CD8+ Tcells activates STAT3 to increase FAO, inhibiting CD8+ T effector cell glycolysis and functions.",31761565_3,-1,-1,-1,-1,38181,-1,5.0945227e-06,0.9999895,5.3919844e-06
38184,functions,24,25,120,129,"Moreover, PD-1 ligation in CD8+ Tcells activates STAT3 to increase FAO, inhibiting CD8+ T effector cell glycolysis and functions.",31761565_3,0,1,2,-1,38184,-1,0.0004983926,0.00261534,0.9968862
38185,tissues,9,10,55,62,"Finally, leptin enriched in mammary adipocytes and fat tissues downregulates CD8+ Tcell effector functions through activating STAT3-FAO and inhibiting glycolysis.",31761565_4,-1,1,2,-1,38185,-1,0.00070758595,0.07761411,0.9216783
38187,functions through,17,19,98,115,"Finally, leptin enriched in mammary adipocytes and fat tissues downregulates CD8+ Tcell effector functions through activating STAT3-FAO and inhibiting glycolysis.",31761565_4,-1,-1,-1,-1,38187,-1,0.0032343674,0.8636277,0.13313794
38189,through STAT3,16,18,92,105,We identify a critical role of increased oxidation of fatty acids driven by leptin and PD-1 through STAT3 in inhibiting CD8+ T effector cell glycolysis and in promoting obesity-associated breast tumorigenesis.,31761565_5,-1,-1,-1,-1,38189,-1,7.1427667e-06,0.99998724,5.565721e-06
38193,CCL22 played,2,4,12,24,BACKGROUND: CCL22 played critical roles in Tregs recruitment.,31769216_0,-1,-1,-1,-1,38193,-1,0.9982668,0.00060090673,0.001132233
38202,tissues,14,15,86,93,Immunofluorescence assay was used to perform the costaining of Foxp3 and CD4 on liver tissues.,31769216_3,-1,1,2,-1,38202,-1,0.00057820877,0.48329544,0.5161263
38214,the functions,7,9,53,66,Xenograft tumor models were developed to investigate the functions of p65 and miR-23a in vivo.,31769216_7,-1,-1,-1,-1,38214,-1,6.2856493e-06,0.9999877,6.027948e-06
38221,targeted CCL22,2,4,17,31,"MiR-23a directly targeted CCL22 3'UTR, leading to CCL22 reduction and attenuated Tregs recruitment.",31769216_11,-1,-1,-1,-1,38221,-1,0.8417347,0.15610571,0.0021595692
38222,to CCL22,7,9,47,55,"MiR-23a directly targeted CCL22 3'UTR, leading to CCL22 reduction and attenuated Tregs recruitment.",31769216_11,-1,-1,-1,-1,38222,-1,0.78247476,0.21450672,0.003018533
38224,functioned,3,4,15,25,"Meanwhile, p65 functioned as a transcription repressor of miR-23a by directly binding to its promoter.",31769216_12,0,1,2,-1,38224,-1,3.8246046e-05,0.99994683,1.4974881e-05
38235,to CCL22,10,12,69,77,"CONCLUSION: Blockage of p65 disinhibited miR-23a expression, leading to CCL22 reduction and repress Tregs recruitment.",31769216_16,-1,-1,-1,-1,38235,-1,0.77476215,0.22211869,0.0031191842
38242,the tumor-infiltrating lymphocytes,10,13,48,82,"Low Foxp3+ regulatory T-cell (Treg) presence in the tumor-infiltrating lymphocytes (TILs) is considered favorable in breast cancer, and numerous CD25-targeting agents have been applied in the attempt to remove Foxp3+ Treg cells, which typically present CD4+ CD25+/hi surface phenotype.",31811667_0,-1,-1,-1,-1,38242,-1,0.0015482766,0.9153753,0.08307641
38252,T cells that,10,13,61,73,"Hence, CD25 depletion may cause the elimination of activated T cells that are responding to tumor-specific antigens.",31811667_2,-1,-1,-1,-1,38252,-1,0.0012487608,0.024190191,0.97456104
38253,to tumor-specific antigens,15,18,89,115,"Hence, CD25 depletion may cause the elimination of activated T cells that are responding to tumor-specific antigens.",31811667_2,-1,-1,-1,-1,38253,-1,0.4148373,0.58097494,0.0041877516
38256,function,7,8,35,43,"In this study, the composition and function of CD4+ CD25+ cells inside the microenvironment of triple-negative breast carcinoma (TNBC) were investigated.",31811667_3,0,1,2,-1,38256,-1,8.5664906e-05,0.9997713,0.00014309143
38261,the Foxp3,4,6,18,27,"Directly ex vivo, the Foxp3+ Treg cells represented a minor subset in total CD4+ CD25+ TILs.",31811667_4,-1,-1,-1,-1,38261,-1,6.1941632e-06,0.9999887,5.1615316e-06
38270,Foxp3- TILs,23,25,131,142,Significant differences were observed in the expression of Treg-associated molecules between CD4+ CD25+ Foxp3+ TILs and CD4+ CD25+ Foxp3- TILs.,31811667_5,-1,-1,-1,-1,38270,-1,7.452924e-06,0.9999864,6.130667e-06
38274,Foxp3- TILs,15,17,52,63,"While both the CD4+ CD25+ Foxp3+ and the CD4+ CD25+ Foxp3- TILs could express CTLA-4 and LAG-3, the expression levels were significantly higher in CD4+ CD25+ Foxp3+ TILs than in CD4+ CD25+ Foxp3- TILs.",31811667_6,-1,-1,-1,-1,38274,-1,8.209642e-06,0.99998486,6.983865e-06
38278,TILs than,36,38,165,174,"While both the CD4+ CD25+ Foxp3+ and the CD4+ CD25+ Foxp3- TILs could express CTLA-4 and LAG-3, the expression levels were significantly higher in CD4+ CD25+ Foxp3+ TILs than in CD4+ CD25+ Foxp3- TILs.",31811667_6,-1,-1,-1,-1,38278,-1,4.7652056e-06,0.99999106,4.159153e-06
38279,Foxp3- TILs,43,45,189,200,"While both the CD4+ CD25+ Foxp3+ and the CD4+ CD25+ Foxp3- TILs could express CTLA-4 and LAG-3, the expression levels were significantly higher in CD4+ CD25+ Foxp3+ TILs than in CD4+ CD25+ Foxp3- TILs.",31811667_6,-1,-1,-1,-1,38279,-1,9.01038e-06,0.99998367,7.2715566e-06
38280,TCR,1,2,5,8,"Upon TCR stimulation, the expression of TGF-beta was significantly higher in CD4+ CD25+ Foxp3+ TILs, while the expression of IL-10 was significantly higher in CD4+ CD25+ Foxp3- TILs.",31811667_7,-1,1,2,-1,38280,-1,3.0045154e-05,0.99992764,4.2273303e-05
38282,TGF-beta,7,8,40,48,"Upon TCR stimulation, the expression of TGF-beta was significantly higher in CD4+ CD25+ Foxp3+ TILs, while the expression of IL-10 was significantly higher in CD4+ CD25+ Foxp3- TILs.",31811667_7,0,1,-1,-1,38282,-1,3.391484e-05,0.9999547,1.1360904e-05
38287,Foxp3- TILs,33,35,170,181,"Upon TCR stimulation, the expression of TGF-beta was significantly higher in CD4+ CD25+ Foxp3+ TILs, while the expression of IL-10 was significantly higher in CD4+ CD25+ Foxp3- TILs.",31811667_7,-1,-1,-1,-1,38287,-1,6.761862e-06,0.99998736,5.8482105e-06
38289,the blood,5,7,36,45,These differences were conserved in the blood counterparts of these cells.,31811667_8,-1,-1,-1,-1,38289,-1,7.5901764e-05,0.99987984,4.4233268e-05
38290,these cells,9,11,62,73,These differences were conserved in the blood counterparts of these cells.,31811667_8,-1,-1,-1,-1,38290,-1,2.0311953e-05,1.2950251e-05,0.99996674
38300,Foxp3- cells,39,41,175,187,"Interestingly, the level of CD25+ Foxp3+ cells in circulating CD4+ T cells was positively correlated with the level of CD25+ Foxp3+ cells in CD4+ TILs, but the level of CD25+ Foxp3- cells in circulating CD4+ T cells was not associated with the level of CD25+ Foxp3- cells in CD4+ TILs.",31811667_9,-1,-1,-1,-1,38300,-1,0.002738694,0.6649771,0.33228424
38303,Foxp3- cells,56,58,259,271,"Interestingly, the level of CD25+ Foxp3+ cells in circulating CD4+ T cells was positively correlated with the level of CD25+ Foxp3+ cells in CD4+ TILs, but the level of CD25+ Foxp3- cells in circulating CD4+ T cells was not associated with the level of CD25+ Foxp3- cells in CD4+ TILs.",31811667_9,-1,-1,-1,-1,38303,-1,0.0026935455,0.6663358,0.33097062
38309,IL-17-expressing T cells,25,28,120,144,"Th17-polarizing medium could readily remodel CD4+ CD25+ Foxp3- , but not CD4+ CD25+ Foxp3+ , T cells into RORgammat and IL-17-expressing T cells, demonstrating stronger plasticity of the former subset.",31811667_10,-1,-1,-1,-1,38309,-1,0.93759334,0.00028080185,0.062125873
38315,that the,5,7,34,42,"Together, these data demonstrated that the CD4+ CD25+ TILs were composed of distinctive Foxp3- and Foxp3+ cells, with the former representing the major subset.",31811667_11,-1,-1,-1,-1,38315,-1,3.675869e-06,0.99999285,3.4857037e-06
38323,The antigen,0,2,0,11,The antigen specificity and effector molecule expression of the CD4+ CD25+ Foxp3- thus require further analyses.,31811667_12,-1,-1,-1,-1,38323,-1,0.26173636,0.73313165,0.0051320274
38325,Foxp3- thus,13,15,75,86,The antigen specificity and effector molecule expression of the CD4+ CD25+ Foxp3- thus require further analyses.,31811667_12,-1,-1,-1,-1,38325,-1,8.316629e-06,0.9999845,7.2135986e-06
38331,the immune response,13,16,75,94,OBJECTIVE: The study aimed to review the most potent compounds that affect the immune response and diseases associated with it.,31814545_1,-1,-1,-1,-1,38331,-1,0.48862195,0.5092624,0.002115597
38334,transcriptional factors,11,13,68,91,"RESULTS: In vitro, flavonoids and their derivatives inhibit various transcriptional factors, which modulate differentiation, proliferation, activation of immune cells and enhance regulatory T cell generation.",31814545_3,-1,-1,-1,-1,38334,-1,5.6380486e-06,0.99998975,4.617229e-06
38336,regulatory T cell generation,26,30,179,207,"RESULTS: In vitro, flavonoids and their derivatives inhibit various transcriptional factors, which modulate differentiation, proliferation, activation of immune cells and enhance regulatory T cell generation.",31814545_3,-1,-1,-1,-1,38336,-1,7.860934e-05,0.0004485033,0.9994729
38341,TNF-,27,28,171,176,"Some flavonoids exert anti-inflammatory effects through: Blockade of NF-B, and NLRP3 inflammasome, inhibition of pro-inflammatory cytokine production, IL-1, IL-2, IL-6, TNF-, IL-17A, down regulation of chemokines, and reduction of reactive oxygen and nitrogen species.",31814545_4,0,1,-1,-1,38341,-1,0.14381959,0.8548071,0.0013733637
38348,receptors,30,31,211,220,"Nevertheless, several reports have shown that some flavonoids enhance immune response by enhancing: oxygen and nitrogen radicals, antibody production, cytotoxic activity against tumours by increasing activating receptors and down regulating inhibitory receptors.",31814545_5,0,1,2,-1,38348,-1,1.7868133e-05,4.0663243e-05,0.99994147
38349,receptors,35,36,252,261,"Nevertheless, several reports have shown that some flavonoids enhance immune response by enhancing: oxygen and nitrogen radicals, antibody production, cytotoxic activity against tumours by increasing activating receptors and down regulating inhibitory receptors.",31814545_5,0,1,2,-1,38349,-1,1.7010356e-05,4.1707604e-05,0.99994123
38361,to the,17,19,108,114,Respiratory diseases compromise the health of millions of people all over the world and are strongly linked to the immune dysfunction.,31827925_0,-1,-1,-1,-1,38361,-1,6.0897196e-06,0.9999893,4.596332e-06
38365,tissue,16,17,84,90,"CD4+FOXP3+ T regulatory cells, also known as Tregs, have a central role maintaining tissue homeostasis during immune responses.",31827925_1,-1,1,2,-1,38365,-1,2.4331672e-05,0.9999255,5.014786e-05
38369,transcription factor forkhead,2,5,14,43,"Tregs express transcription factor forkhead box P3 (FOXP3), which allows regulation of the immune response through anti-inflammatory cytokines such as IL-10 or transforming growth factor beta (TGF-) and direct cell-to-cell interaction.",31827925_3,-1,-1,-1,-1,38369,-1,5.784134e-06,0.99998903,5.2096166e-06
38372,the immune response through,15,19,87,114,"Tregs express transcription factor forkhead box P3 (FOXP3), which allows regulation of the immune response through anti-inflammatory cytokines such as IL-10 or transforming growth factor beta (TGF-) and direct cell-to-cell interaction.",31827925_3,-1,-1,-1,-1,38372,-1,0.00021821006,0.999742,3.9775252e-05
38390,cells that,1,3,7,17,Cancer cells that succeed in forming metastasis need to be reprogrammed to evade immune surveillance and survive in a new microenvironment.,31848193_0,-1,-1,-1,-1,38390,-1,0.0052701794,0.19957125,0.79515857
38396,tumor cells,14,16,105,116,This is facilitated by metastatic niches that are either postformed through reciprocal signaling between tumor cells and local stromal cells or preformed as premetastatic niches before tumor cell arrival.,31848193_1,-1,-1,-1,-1,38396,-1,5.561736e-05,0.00011030663,0.99983406
38398,tumor cell,26,28,185,195,This is facilitated by metastatic niches that are either postformed through reciprocal signaling between tumor cells and local stromal cells or preformed as premetastatic niches before tumor cell arrival.,31848193_1,-1,-1,-1,-1,38398,-1,5.4076456e-05,7.1189614e-05,0.9998747
38404,tumor cells,12,14,67,78,"Here, we showed that blockade of intrinsic STAT3 signaling in lung tumor cells suppressed lung metastasis in immune-competent syngeneic mice, but not in immune-deficient nude mice.",31848193_3,-1,-1,-1,-1,38404,-1,0.0005132781,0.008106861,0.99137986
38406,tumor cells made them,7,11,47,68,"Consistently, repression of STAT3 signaling in tumor cells made them susceptible to T-cell-mediated cytotoxicity.",31848193_4,-1,-1,-1,-1,38406,-1,0.000102433434,0.99823725,0.0016602773
38407,to T-cell-mediated,12,14,81,99,"Consistently, repression of STAT3 signaling in tumor cells made them susceptible to T-cell-mediated cytotoxicity.",31848193_4,-1,-1,-1,-1,38407,-1,0.0011987227,0.072284035,0.9265173
38411,the tumor,27,29,158,167,"Noticeably, lung metastasis was greatly increased in Gprc5a-knockout (ko; 5a -/-) mice compared with wild-type mice, which correlated with upregulated IL6 in the tumor microenvironment.",31848193_6,-1,-1,-1,-1,38411,-1,5.2796995e-06,0.99999,4.7222957e-06
38416,the STAT3,5,7,47,56,"Mechanistically, dysregulated IL6 reprogrammed the STAT3 pathway in metastatic tumor cells, and induced recruitment of myeloid-derived suppressor cells and polarized macrophages to evade host immunity.",31848193_8,-1,-1,-1,-1,38416,-1,8.978768e-06,0.99998426,6.7536366e-06
38417,tumor cells,10,12,79,90,"Mechanistically, dysregulated IL6 reprogrammed the STAT3 pathway in metastatic tumor cells, and induced recruitment of myeloid-derived suppressor cells and polarized macrophages to evade host immunity.",31848193_8,-1,-1,-1,-1,38417,-1,0.00037636913,0.0074199843,0.9922037
38420,immunity,26,27,192,200,"Mechanistically, dysregulated IL6 reprogrammed the STAT3 pathway in metastatic tumor cells, and induced recruitment of myeloid-derived suppressor cells and polarized macrophages to evade host immunity.",31848193_8,0,-1,2,-1,38420,-1,0.99991584,2.244422e-05,6.171439e-05
38426,IL6 plays,2,4,14,23,"Significance: IL6 plays important roles not only in cell autonomous propensity for metastasis, but also in establishing the metastatic niche.",31848193_11,-1,-1,-1,-1,38426,-1,0.9960045,0.002764296,0.0012311528
38430,cytokine interleukin-6,7,9,61,83,"BACKGROUND/AIM: We previously demonstrated that inflammatory cytokine interleukin-6 (IL-6) was produced during cancer progression, worked together with transforming growth factor-beta 1 (TGF-1), and induced the epithelial-mesenchymal transition (EMT) with chemo-resistance against gemcitabine (GR) at the invasion front of biliary tract cancers (BTCs).",31853779_0,-1,-1,-1,-1,38430,-1,0.99996066,4.4583644e-06,3.4963734e-05
38441,cytokine-induced T cell,5,8,29,52,"However, the significance of cytokine-induced T cell accumulation at the tumor microenvironment in biliary tract cancer (BTC) is not well understood.",31853779_1,-1,-1,-1,-1,38441,-1,0.81203014,0.0006049849,0.18736485
38442,the tumor,10,12,69,78,"However, the significance of cytokine-induced T cell accumulation at the tumor microenvironment in biliary tract cancer (BTC) is not well understood.",31853779_1,-1,-1,-1,-1,38442,-1,4.174899e-06,0.9999913,4.543719e-06
38444,these cytokines,1,3,8,23,"Because these cytokines (IL-6 and TGF-1) are able to differentiate nave T cells into Foxp3-expressing T cells (Tregs) and/or IL-17-producing T helper 17 (Th17) cells, we investigated the relationship between heterogeneous, cancer-producing cytokines and T cell differentiation.",31853779_2,-1,-1,-1,-1,38444,-1,0.61257184,0.3827459,0.004682265
38448,nave T cells,12,15,68,81,"Because these cytokines (IL-6 and TGF-1) are able to differentiate nave T cells into Foxp3-expressing T cells (Tregs) and/or IL-17-producing T helper 17 (Th17) cells, we investigated the relationship between heterogeneous, cancer-producing cytokines and T cell differentiation.",31853779_2,-1,-1,-1,-1,38448,-1,0.0020929764,0.12735233,0.8705546
38449,Foxp3-expressing T cells,16,19,87,111,"Because these cytokines (IL-6 and TGF-1) are able to differentiate nave T cells into Foxp3-expressing T cells (Tregs) and/or IL-17-producing T helper 17 (Th17) cells, we investigated the relationship between heterogeneous, cancer-producing cytokines and T cell differentiation.",31853779_2,-1,-1,-1,-1,38449,-1,0.0012428847,0.91552293,0.08323422
38451,IL-17-producing T,23,25,127,144,"Because these cytokines (IL-6 and TGF-1) are able to differentiate nave T cells into Foxp3-expressing T cells (Tregs) and/or IL-17-producing T helper 17 (Th17) cells, we investigated the relationship between heterogeneous, cancer-producing cytokines and T cell differentiation.",31853779_2,-1,-1,-1,-1,38451,-1,0.9989278,0.0006653693,0.00040680583
38454,the relationship,34,36,185,201,"Because these cytokines (IL-6 and TGF-1) are able to differentiate nave T cells into Foxp3-expressing T cells (Tregs) and/or IL-17-producing T helper 17 (Th17) cells, we investigated the relationship between heterogeneous, cancer-producing cytokines and T cell differentiation.",31853779_2,-1,-1,-1,-1,38454,-1,7.910185e-06,0.9999875,4.561442e-06
38462,Th17 cells,31,33,170,180,"METHODS: In total, 127 curative resected specimens from patients with BTCs at Osaka University Hospital between 2000 and 2012 were evaluated for IL-6, TGF-1, Tregs, and Th17 cells by immunohistochemistry.",31853779_3,-1,-1,-1,-1,38462,-1,5.4481337e-05,0.00026082323,0.9996847
38464,cells to,4,6,22,30,The ability of BTC-GR cells to undergo T cell differentiation was investigated in vitro.,31853779_4,-1,-1,-1,-1,38464,-1,0.0033449214,0.30605534,0.69059974
38467,the tumor,5,7,30,39,RESULTS: Tregs accumulated at the tumor center and Th17 cells accumulated at the invasion front during cancer progression and/or metastasis; each signaled poor prognosis.,31853779_5,-1,-1,-1,-1,38467,-1,4.093673e-06,0.99999034,5.611211e-06
38468,Th17 cells,9,11,51,61,RESULTS: Tregs accumulated at the tumor center and Th17 cells accumulated at the invasion front during cancer progression and/or metastasis; each signaled poor prognosis.,31853779_5,-1,-1,-1,-1,38468,-1,0.00019269293,0.0047625764,0.9950448
38471,related to TGF-1,3,6,22,39,"Treg accumulation was related to TGF-1 expression by cancer cells, and Th17 cell accumulation was related to IL-6 expression by cancer cells, in resected specimens; this was confirmed in vitro.",31853779_6,-1,-1,-1,-1,38471,-1,1.0876253e-05,0.999972,1.7085327e-05
38473,Th17 cell,12,14,72,81,"Treg accumulation was related to TGF-1 expression by cancer cells, and Th17 cell accumulation was related to IL-6 expression by cancer cells, in resected specimens; this was confirmed in vitro.",31853779_6,-1,-1,-1,-1,38473,-1,9.107688e-05,0.0016091326,0.9982999
38474,related to IL-6,16,19,99,114,"Treg accumulation was related to TGF-1 expression by cancer cells, and Th17 cell accumulation was related to IL-6 expression by cancer cells, in resected specimens; this was confirmed in vitro.",31853779_6,-1,-1,-1,-1,38474,-1,0.7432586,0.2531844,0.003556997
38483,to Th17 cells,26,29,147,160,"Compared with parent cells, GR cells produced IL-6 but not TGF-1 in a time-dependent manner, had EMT features, and induced T cell differentiation to Th17 cells but not Tregs.",31853779_7,-1,-1,-1,-1,38483,-1,0.0018905301,0.31155473,0.6865548
38490,Th17 cells,17,19,100,110,"CONCLUSION: Cytokines produced by cancer cells (IL-6 and TGF-1) induced heterogeneity of Tregs and Th17 cells in the tumor microenvironment, supporting progression of BTC.",31853779_8,-1,-1,-1,-1,38490,-1,0.00020910375,0.0057571684,0.99403363
38491,the tumor,20,22,114,123,"CONCLUSION: Cytokines produced by cancer cells (IL-6 and TGF-1) induced heterogeneity of Tregs and Th17 cells in the tumor microenvironment, supporting progression of BTC.",31853779_8,-1,-1,-1,-1,38491,-1,4.3247533e-06,0.9999913,4.326808e-06
38505,tissues,12,13,86,93,METHODS: Whole-exome and transcriptome sequencing were performed on cancer and normal tissues from seven colorectal cancer patients diagnosed with mismatch repair-proficient tumors to detect putative neoantigens.,31888734_3,-1,1,2,-1,38505,-1,0.00021295111,0.9518716,0.047915537
38507,tumors to,22,24,174,183,METHODS: Whole-exome and transcriptome sequencing were performed on cancer and normal tissues from seven colorectal cancer patients diagnosed with mismatch repair-proficient tumors to detect putative neoantigens.,31888734_3,-1,-1,-1,-1,38507,-1,3.6839392e-06,0.9999925,3.8248722e-06
38509,T cells that,12,15,92,104,Corresponding neo-epitopes were synthesized and tested for recognition by in vitro expanded T cells that were isolated from tumor tissues (tumor-infiltrating lymphocytes) and from peripheral mononuclear blood cells stimulated with tumor material.,31888734_4,-1,-1,-1,-1,38509,-1,0.0014400738,0.033945788,0.96461415
38510,tumor tissues,18,20,124,137,Corresponding neo-epitopes were synthesized and tested for recognition by in vitro expanded T cells that were isolated from tumor tissues (tumor-infiltrating lymphocytes) and from peripheral mononuclear blood cells stimulated with tumor material.,31888734_4,-1,-1,-1,-1,38510,-1,8.21782e-06,0.99997723,1.4551377e-05
38511,tumor-infiltrating lymphocytes,21,23,139,169,Corresponding neo-epitopes were synthesized and tested for recognition by in vitro expanded T cells that were isolated from tumor tissues (tumor-infiltrating lymphocytes) and from peripheral mononuclear blood cells stimulated with tumor material.,31888734_4,-1,-1,-1,-1,38511,-1,0.0022552132,0.88218576,0.115559004
38512,blood cells,28,30,203,214,Corresponding neo-epitopes were synthesized and tested for recognition by in vitro expanded T cells that were isolated from tumor tissues (tumor-infiltrating lymphocytes) and from peripheral mononuclear blood cells stimulated with tumor material.,31888734_4,-1,-1,-1,-1,38512,-1,1.682881e-05,6.121011e-06,0.9999771
38516,the tumor-infiltrating lymphocytes,12,15,87,121,"RESULTS: Neoantigen-specific T cell reactivity was detected to several neo-epitopes in the tumor-infiltrating lymphocytes of three patients while their respective cancers expressed 15, 21, and 30 non-synonymous variants.",31888734_5,-1,-1,-1,-1,38516,-1,0.0015655059,0.88786566,0.11056887
38520,tumor-infiltrating lymphocytes,3,5,16,46,Cell sorting of tumor-infiltrating lymphocytes based on the co-expression of CD39 and CD103 pinpointed the presence of neoantigen-specific T cells in the CD39+CD103+ T cell subset.,31888734_6,-1,-1,-1,-1,38520,-1,0.0019843206,0.9242653,0.07375041
38526,the tumors,2,4,12,22,"Strikingly, the tumors containing neoantigen-reactive TIL were classified as consensus molecular subtype 4 (CMS4), which is associated with TGF- pathway activation and worse clinical outcome.",31888734_7,-1,-1,-1,-1,38526,-1,4.0908126e-06,0.9999913,4.5655593e-06
38537,target the TGF-,19,22,151,167,These findings warrant the development of specific immunotherapeutic strategies that selectively boost the activity of neoantigen-specific T cells and target the TGF- pathway to reinforce T cell reactivity in this patient group.,31888734_9,-1,-1,-1,-1,38537,-1,1.3182087e-05,0.9999796,7.2285625e-06
38541,the tumor,1,3,14,23,Reprogramming the tumor microenvironment to increase immune-mediated responses is currently of intense interest.,31888983_0,-1,-1,-1,-1,38541,-1,5.3472218e-06,0.9999902,4.382719e-06
38552,tumors to,21,23,132,141,"Here, we report that unadjuvanted seasonal influenza vaccination via intratumoral, but not intramuscular, injection converts ""cold"" tumors to hot, generates systemic CD8+ T cell-mediated antitumor immunity, and sensitizes resistant tumors to checkpoint blockade.",31888983_5,-1,-1,-1,-1,38552,-1,4.358026e-06,0.99998975,5.8543296e-06
38555,immunity,32,33,197,205,"Here, we report that unadjuvanted seasonal influenza vaccination via intratumoral, but not intramuscular, injection converts ""cold"" tumors to hot, generates systemic CD8+ T cell-mediated antitumor immunity, and sensitizes resistant tumors to checkpoint blockade.",31888983_5,0,-1,2,-1,38555,-1,0.9996798,3.2081996e-05,0.0002881562
38556,tumors to,37,39,232,241,"Here, we report that unadjuvanted seasonal influenza vaccination via intratumoral, but not intramuscular, injection converts ""cold"" tumors to hot, generates systemic CD8+ T cell-mediated antitumor immunity, and sensitizes resistant tumors to checkpoint blockade.",31888983_5,-1,-1,-1,-1,38556,-1,3.7626198e-06,0.9999919,4.3146424e-06
38570,the The,5,7,33,40,RNA-seq data were collected from the The Cancer Genome Atlas database.,31898342_2,-1,-1,-1,-1,38570,-1,4.463973e-06,0.99999046,5.048932e-06
38571,The relationships,0,2,0,17,The relationships between transcription factors and immune infiltrates were assessed.,31898342_3,-1,-1,-1,-1,38571,-1,1.5291282e-05,0.99997854,6.136749e-06
38578,analysis,25,26,176,184,"Runt-related transcription factor 3 (RUNX3)-associated immune pathways were investigated by the Kyoto Encyclopedia of Genes and Genomes, Gene Ontology, and Gene set enrichment analysis.",31898342_4,0,1,-1,-1,38578,-1,8.819423e-06,0.99998224,8.898414e-06
38582,These chemokines,0,2,0,16,These chemokines were further confirmed in RUNX3-downregulated cell lines.,31898342_6,-1,-1,-1,-1,38582,-1,0.7988759,0.1975217,0.0036024319
38589,tissues,26,27,140,147,"Immunochemistry was conducted to determine the expression of RUNX3, CCL3, CCL20, and the numbers of CD8+ T lymphocytes in human lung cancer tissues.",31898342_7,-1,1,2,-1,38589,-1,5.800771e-05,0.9962302,0.0037117978
38590,Chemokine receptors,0,2,0,19,Chemokine receptors in CD8+ T cells were explored by flow cytometry and immunofluorescence.,31898342_8,-1,-1,-1,-1,38590,-1,0.9950237,2.6644813e-05,0.004949598
38603,receptors CCR5,10,12,76,90,"Further investigation exhibited RUNX3 could upregulate CCL3 and CCL20 whose receptors CCR5 and CCR6 were upregulated in CD8+ effector T cells, while downregulation of RUNX3 decreased the expression of CCL3 and CCL20 and the infiltration of CD8+ T cells in RUNX3-downregulated lung cancer cell lines.",31898342_13,-1,-1,-1,-1,38603,-1,0.000256009,0.0003130466,0.99943084
38613,The chemotaxis,0,2,0,14,The chemotaxis assay proved RUNX3 could promote CD8+ T cell recruitment by upregulating CCL3 and CCL20.,31898342_15,-1,-1,-1,-1,38613,-1,0.7356548,0.262227,0.0021182026
38620,cell therapy,29,31,216,228,This study unearths RUNX3 related molecular mechanisms of tumor immune microenvironment and may reverse the immune-desert condition in lung adenocarcinoma and be combined with immune checkpoint blockade and adoptive cell therapy.,31898342_16,-1,-1,-1,-1,38620,-1,0.0011818003,0.04716101,0.95165724
38625,TNBC cells,8,10,51,61,"Here, we report BRCA1-IRIS-overexpressing (IRISOE) TNBC cells secrete high levels of GM-CSF in a hypoxia-inducible factor-1 (HIF1)- and a NF-B-dependent manner to recruit macrophages to IRISOE cells and polarize them to protumor M2 TAMs.",31911557_1,-1,-1,-1,-1,38625,-1,0.0012436731,0.11989633,0.87886
38627,factor-1,18,19,115,124,"Here, we report BRCA1-IRIS-overexpressing (IRISOE) TNBC cells secrete high levels of GM-CSF in a hypoxia-inducible factor-1 (HIF1)- and a NF-B-dependent manner to recruit macrophages to IRISOE cells and polarize them to protumor M2 TAMs.",31911557_1,0,1,-1,-1,38627,-1,4.8121754e-05,0.9999256,2.6206793e-05
38631,them to,32,34,215,222,"Here, we report BRCA1-IRIS-overexpressing (IRISOE) TNBC cells secrete high levels of GM-CSF in a hypoxia-inducible factor-1 (HIF1)- and a NF-B-dependent manner to recruit macrophages to IRISOE cells and polarize them to protumor M2 TAMs.",31911557_1,-1,-1,-1,-1,38631,-1,1.0748378e-05,0.99998105,8.222901e-06
38633,GM-CSF triggered TGF1,0,3,0,22,"GM-CSF triggered TGF1 expression by M2 TAMs by activating STAT5, NF-B, and/or ERK signaling.",31911557_2,-1,-1,-1,-1,38633,-1,0.95775694,0.03043602,0.011807026
38636,TGF1 receptors,5,7,34,49,"Despite expressing high levels of TGF1 receptors on their surface, IRISOE TNBC cells channeled TGF1/TRI/II signaling toward AKT, not SMAD, which activated stemness/EMT phenotypes.",31911557_3,-1,-1,-1,-1,38636,-1,0.000119776785,0.99926966,0.0006106068
38638,TNBC cells,12,14,75,85,"Despite expressing high levels of TGF1 receptors on their surface, IRISOE TNBC cells channeled TGF1/TRI/II signaling toward AKT, not SMAD, which activated stemness/EMT phenotypes.",31911557_3,-1,-1,-1,-1,38638,-1,0.0008990251,0.096330166,0.90277076
38641,TNBC cells,12,14,76,86,"In orthotopic and syngeneic mouse models, silencing or inactivating IRIS in TNBC cells lowered the levels of circulating GM-CSF, suppressed TAM recruitment, and decreased the levels of circulating TGF1.",31911557_4,-1,-1,-1,-1,38641,-1,0.0010216116,0.09870962,0.90026873
38647,TNBC cells,4,6,36,46,Coinjecting macrophages with IRISOE TNBC cells induced earlier metastasis in athymic mice accompanied by high levels of circulating GM-CSF and TGF1.,31911557_5,-1,-1,-1,-1,38647,-1,0.0028187297,0.18259956,0.8145818
38650,TNBC cells,1,3,7,17,"IRISOE TNBC cells expressed low levels of calreticulin (the ""eat me"" signal for macrophages) and high levels of CD47 (the ""do not eat me"" signal for macrophages) and PD-L1 (a T-cell inactivator) on their surface.",31911557_6,-1,-1,-1,-1,38650,-1,0.001488153,0.16774227,0.8307696
38653,T-cell,39,40,175,181,"IRISOE TNBC cells expressed low levels of calreticulin (the ""eat me"" signal for macrophages) and high levels of CD47 (the ""do not eat me"" signal for macrophages) and PD-L1 (a T-cell inactivator) on their surface.",31911557_6,-1,1,2,-1,38653,-1,1.3042856e-05,7.4254604e-06,0.9999796
38655,TNBC tumors,3,5,20,31,"Accordingly, IRISOE TNBC tumors had significantly few CD8+/PD-1+ cytotoxic T cells and more CD25+/FOXP3+ regulatory T cells.",31911557_7,-1,-1,-1,-1,38655,-1,5.556219e-06,0.9999875,6.9498324e-06
38659,that the,3,5,16,24,These data show that the bidirectional interaction between IRISOE cells and macrophages triggers an immunosuppressive microenvironment within TNBC tumors that is favorable for the generation of immune-evading/stem-like/IRISOE TNBC metastatic precursors.,31911557_8,-1,-1,-1,-1,38659,-1,4.167528e-06,0.99999225,3.5969979e-06
38662,TNBC tumors that,17,20,142,158,These data show that the bidirectional interaction between IRISOE cells and macrophages triggers an immunosuppressive microenvironment within TNBC tumors that is favorable for the generation of immune-evading/stem-like/IRISOE TNBC metastatic precursors.,31911557_8,-1,-1,-1,-1,38662,-1,4.7371973e-06,0.99998975,5.529326e-06
38663,the generation,23,25,176,190,These data show that the bidirectional interaction between IRISOE cells and macrophages triggers an immunosuppressive microenvironment within TNBC tumors that is favorable for the generation of immune-evading/stem-like/IRISOE TNBC metastatic precursors.,31911557_8,-1,-1,-1,-1,38663,-1,4.38909e-06,0.9999914,4.215793e-06
38670,immunity,5,6,51,59,Understanding the mechanisms underlying anti-tumor immunity is pivotal for improving immune-based cancer therapies.,31911617_0,0,-1,2,-1,38670,-1,0.999706,0.0001347285,0.00015927001
38677,Ccl17,14,15,113,118,"Growth-inhibited tumors exhibit increased numbers of intra-tumoral activated T cells and decreased expression of Ccl17, Ccl22, and Foxp3.",31911617_2,0,-1,2,-1,38677,-1,0.99961543,3.145129e-05,0.00035304693
38686,therapy,3,4,20,27,"Growth of anti-PD-1 therapy resistant melanoma is effectively inhibited in Siah2-/- mice subjected to PD-1 blockade, indicating synergy between PD-1 blockade and Siah2 loss.",31911617_4,0,1,-1,-1,38686,-1,7.660295e-06,0.99998367,8.714807e-06
38695,therapy,25,26,175,182,"Overall, Siah2 regulation of Treg recruitment and cell cycle progression effectively controls melanoma development and Siah2 loss in the host sensitizes melanoma to anti-PD-1 therapy.",31911617_6,0,1,-1,-1,38695,-1,5.012747e-06,0.99999046,4.552634e-06
38696,Chemokines play,0,2,0,15,"Chemokines play essential roles in the progression of various human cancers; however, the expression and role of CXC chemokines in pancreatic adenocarcinoma (PAAD) have not yet been identified.",31913856_0,-1,-1,-1,-1,38696,-1,0.98391324,0.014612749,0.001473956
38709,tissues,17,18,99,106,"Three CXC chemokines, including CXCL5, CXCL9, and CXCL10, were significantly overexpressed in PAAD tissues, which were correlated with the poor survival of the patients.",31913856_2,-1,1,2,-1,38709,-1,0.00021905507,0.03434649,0.9654345
38713,the tumour,10,12,62,72,"CXCL9/10 was associated with change of immune cell pattern in the tumour microenvironment, and supplementation of CXCL9 in the orthotopic murine PAAD model promoted tumour progression.",31913856_3,-1,-1,-1,-1,38713,-1,4.8131374e-06,0.99998975,5.4282727e-06
38718,the tumour,12,14,65,75,"In particular, CXCL9 reduced the CD8+ cytotoxic T lymphocytes in the tumour microenvironment of PAAD, which could be attributed to the reduced CD8+ T cell proliferation, activation, and secretion of anti-tumour cytokines.",31913856_4,-1,-1,-1,-1,38718,-1,4.7952285e-06,0.99998987,5.3177855e-06
38719,to the,22,24,128,134,"In particular, CXCL9 reduced the CD8+ cytotoxic T lymphocytes in the tumour microenvironment of PAAD, which could be attributed to the reduced CD8+ T cell proliferation, activation, and secretion of anti-tumour cytokines.",31913856_4,-1,-1,-1,-1,38719,-1,5.2615187e-06,0.99999,4.6977566e-06
38723,to the,7,9,41,47,"In vitro treatment of CXCL9 directly led to the suppression of the proliferation, activation, and secretion of anti-tumour cytokines of isolated CD8+ T cells.",31913856_5,-1,-1,-1,-1,38723,-1,4.6144664e-06,0.9999912,4.1945614e-06
38733,the CD8+ T lymphocytes,15,20,97,119,Our study indicates CXCL9 as a potential target of immunotherapy in PAAD treatment by regulating the CD8+ T lymphocytes in the tumour microenvironment.,31913856_7,-1,-1,-1,-1,38733,-1,0.0024584704,0.073138915,0.9244026
38734,the tumour,21,23,123,133,Our study indicates CXCL9 as a potential target of immunotherapy in PAAD treatment by regulating the CD8+ T lymphocytes in the tumour microenvironment.,31913856_7,-1,-1,-1,-1,38734,-1,4.593017e-06,0.9999906,4.8670963e-06
38751,Transcriptional analysis,0,2,0,24,Transcriptional analysis revealed a polyfunctional helper and cytotoxic phenotype characterized by the expression of the transcription factors T-bet and Blimp-1.,31924474_3,-1,-1,-1,-1,38751,-1,5.185732e-06,0.99999046,4.3076348e-06
38753,the transcription factors T-bet,14,18,117,148,Transcriptional analysis revealed a polyfunctional helper and cytotoxic phenotype characterized by the expression of the transcription factors T-bet and Blimp-1.,31924474_3,-1,-1,-1,-1,38753,-1,5.750883e-06,0.9999877,6.5006884e-06
38769,through their,33,35,185,198,"Our findings underscore the role of Treg cells, IL-2, and Blimp-1 in controlling the differentiation of cytotoxic CD4+ Tcells and offer a pathway to enhancement of anti-tumor activity through their manipulation.",31924474_5,-1,-1,-1,-1,38769,-1,5.7331304e-06,0.99998987,4.4061276e-06
38770,tool that,10,12,71,80,"Diffusion-weighted magnetic resonance imaging (DW-MRI) is a diagnostic tool that is increasingly used for the detection and characterization of focal masses in the abdomen, among these, pancreatic ductal adenocarcinoma (PDAC).",31948053_0,-1,-1,-1,-1,38770,-1,8.651637e-06,0.9999852,6.100437e-06
38775,the tissue,5,7,41,51,"DW-MRI reflects the microarchitecture of the tissue, and changes in diffusion, which are reflected by changes in the apparent diffusion coefficient (ADC), are mainly attributed to variations in cellular density, glandular formation, and fibrosis.",31948053_1,-1,-1,-1,-1,38775,-1,1.9676001e-05,0.999861,0.00011932102
38780,the T cell,2,5,15,25,"When analyzing the T cell infiltrates, we found an association of a tumor-promoting subpopulation, characterized by the expression of interleukin (IL) 21 and IL26, with high ADC values.",31948053_2,-1,-1,-1,-1,38780,-1,0.0019992082,0.24308644,0.7549144
38786,tissue-expressed receptors,5,7,46,72,"Pancreatic cancers-but not healthy pancreatic tissue-expressed receptors for IL21 and IL26, a finding that could be confirmed in pancreatic cell lines.",31948053_4,-1,-1,-1,-1,38786,-1,0.00037998756,0.97384495,0.025775012
38789,The functionality,0,2,0,17,"The functionality of these receptors was demonstrated in pancreatic tumor cell lines, which showed phosphorylation of ERK1/2 and STAT3 pathways in response to the respective recombinant interleukins.",31948053_5,-1,-1,-1,-1,38789,-1,6.5419363e-06,0.99998796,5.4463494e-06
38790,these receptors,3,5,21,36,"The functionality of these receptors was demonstrated in pancreatic tumor cell lines, which showed phosphorylation of ERK1/2 and STAT3 pathways in response to the respective recombinant interleukins.",31948053_5,-1,-1,-1,-1,38790,-1,0.0023254235,0.26476583,0.7329087
38791,tumor cell,9,11,68,78,"The functionality of these receptors was demonstrated in pancreatic tumor cell lines, which showed phosphorylation of ERK1/2 and STAT3 pathways in response to the respective recombinant interleukins.",31948053_5,-1,-1,-1,-1,38791,-1,0.00019914535,0.0037229937,0.99607784
38793,to the,23,25,156,162,"The functionality of these receptors was demonstrated in pancreatic tumor cell lines, which showed phosphorylation of ERK1/2 and STAT3 pathways in response to the respective recombinant interleukins.",31948053_5,-1,-1,-1,-1,38793,-1,5.7883544e-06,0.99998987,4.2911e-06
38795,tumor cells,11,13,64,75,"Moreover, in vitro data showed an increased colony formation of tumor cells.",31948053_6,-1,-1,-1,-1,38795,-1,0.000511176,0.014444601,0.98504424
38798,to the,29,31,149,155,"In summary, our data showed an association of IL21+ and IL26+ immune cell infiltration, increased ADC, and aggressive tumor disease, most likely due to the activation of the key cancer signaling pathways ERK1/2 and STAT3 and formation of tumor colonies.",31948053_7,-1,-1,-1,-1,38798,-1,4.6530763e-06,0.9999912,4.215354e-06
38804,the cytokines they,14,17,75,93,CD8+ T cells can be polarized into several different subsets as defined by the cytokines they produce and the transcription factors that govern their differentiation.,31964625_0,-1,-1,-1,-1,38804,-1,0.00015323152,0.99979335,5.3386775e-05
38805,the transcription factors that,19,23,106,136,CD8+ T cells can be polarized into several different subsets as defined by the cytokines they produce and the transcription factors that govern their differentiation.,31964625_0,-1,-1,-1,-1,38805,-1,4.852084e-06,0.99999046,4.6349237e-06
38811,the aryl hydrocarbon receptor transcription factor,22,28,122,172,"Here, we identified the polarizing conditions to induce an IL22-producing CD8+ Tc22 subset, which is dependent on IL6 and the aryl hydrocarbon receptor transcription factor.",31964625_1,-1,-1,-1,-1,38811,-1,1.363727e-05,0.9999765,9.87915e-06
38812,that this subset,3,6,32,48,Further characterization showed that this subset was highly cytolytic and expressed a distinct cytokine profile and transcriptome relative to other subsets.,31964625_2,-1,-1,-1,-1,38812,-1,0.0020849085,0.83127713,0.16663794
38814,transcriptome relative to,16,19,116,141,Further characterization showed that this subset was highly cytolytic and expressed a distinct cytokine profile and transcriptome relative to other subsets.,31964625_2,-1,-1,-1,-1,38814,-1,5.6507906e-06,0.9999889,5.39194e-06
38820,the traditional IFN-producing Tc1 subset,20,25,94,135,"In addition, polarized Tc22 were able to control tumor growth as well as, if not better than, the traditional IFN-producing Tc1 subset.",31964625_3,-1,-1,-1,-1,38820,-1,0.028748045,0.7541172,0.21713479
38823,the tumors,6,8,36,46,"Tc22s were also found to infiltrate the tumors of human patients with ovarian cancer, comprising up to approximately 30% of expanded CD8+ tumor-infiltrating lymphocytes (TIL).",31964625_4,-1,-1,-1,-1,38823,-1,3.960157e-06,0.99999166,4.4438657e-06
38825,tumor-infiltrating lymphocytes,25,27,138,168,"Tc22s were also found to infiltrate the tumors of human patients with ovarian cancer, comprising up to approximately 30% of expanded CD8+ tumor-infiltrating lymphocytes (TIL).",31964625_4,-1,-1,-1,-1,38825,-1,0.0028164978,0.8026154,0.19456807
38830,Tc22 cells,5,7,34,44,"Given the antitumor properties of Tc22 cells, it may be prudent to polarize T cells to the Tc22 lineage when using chimeric antigen receptor (CAR)-T or T-cell receptor (TCR) transduction-based immunotherapies.",31964625_6,-1,-1,-1,-1,38830,-1,0.0004219243,0.007953709,0.9916244
38832,T cells to the Tc22,14,19,76,95,"Given the antitumor properties of Tc22 cells, it may be prudent to polarize T cells to the Tc22 lineage when using chimeric antigen receptor (CAR)-T or T-cell receptor (TCR) transduction-based immunotherapies.",31964625_6,-1,-1,-1,-1,38832,-1,0.102972746,0.0459905,0.8510367
38836,cellular therapy,1,3,9,25,"Adoptive cellular therapy and its derivative, chimeric AgR T cell therapy, have achieved significant progress against cancer.",31969386_0,-1,-1,-1,-1,38836,-1,0.0012490898,0.037263207,0.9614877
38837,T cell therapy,9,12,59,73,"Adoptive cellular therapy and its derivative, chimeric AgR T cell therapy, have achieved significant progress against cancer.",31969386_0,-1,-1,-1,-1,38837,-1,0.0006739997,0.022092089,0.9772339
38839,tumor-infiltrating lymphocytes,16,18,105,135,"Major barriers persist, however, including insufficient induction of cytotoxic T cells and exhaustion of tumor-infiltrating lymphocytes.",31969386_1,-1,-1,-1,-1,38839,-1,0.0026282072,0.8959439,0.10142788
38843,tumor cells,26,28,153,164,"In this study, we discovered a new role for 2-deoxy-d-glucose (2DG) in enhancing the antitumor activity of human T cells against NKG2D ligand-expressing tumor cells.",31969386_2,-1,-1,-1,-1,38843,-1,8.844639e-05,0.000672567,0.99923897
38844,T cells treated,1,4,6,21,"Human T cells treated with 2DG upregulated the NK-specific transcription factors TOX2 and EOMES, thereby acquiring NK cell properties, including high levels of perforin/granzyme and increased sensitivity to IL-2.",31969386_3,-1,-1,-1,-1,38844,-1,0.0016598273,0.053355064,0.9449852
38846,transcription factors TOX2,9,12,59,85,"Human T cells treated with 2DG upregulated the NK-specific transcription factors TOX2 and EOMES, thereby acquiring NK cell properties, including high levels of perforin/granzyme and increased sensitivity to IL-2.",31969386_3,-1,-1,-1,-1,38846,-1,2.4531972e-05,0.9999633,1.2232616e-05
38866,IFN-stimulated genes,10,12,46,66,"Type I interferons (IFN), which activate many IFN-stimulated genes (ISG), are known to regulate tumorigenesis.",31974171_0,-1,-1,-1,-1,38866,-1,0.9986987,0.0008900226,0.00041120272
38869,that the,4,6,16,24,"Here, we report that the ISG UBA7 is a tumor suppressor in breast cancer.",31974171_2,-1,-1,-1,-1,38869,-1,4.078788e-06,0.99999166,4.2124107e-06
38874,protein,12,13,85,92,"UBA7 encodes an enzyme that catalyzes the covalent conjugation of the ubiquitin-like protein product of another ISG (ISG15) to cellular proteins in a process known as ""ISGylation."" ISGylation of other ISGs, including STAT1 and STAT2, synergistically facilitates production of chemokine-receptor ligands to attract cytotoxic T cells.",31974171_3,0,1,-1,-1,38874,-1,9.65955e-06,0.9999838,6.494466e-06
38875,to cellular proteins,20,23,124,144,"UBA7 encodes an enzyme that catalyzes the covalent conjugation of the ubiquitin-like protein product of another ISG (ISG15) to cellular proteins in a process known as ""ISGylation."" ISGylation of other ISGs, including STAT1 and STAT2, synergistically facilitates production of chemokine-receptor ligands to attract cytotoxic T cells.",31974171_3,-1,-1,-1,-1,38875,-1,0.00014340764,0.99937636,0.00048021553
38881,These gene-activation,0,2,0,21,These gene-activation events are further linked to clustering and nuclear relocalization of STAT1/2 within IFN-induced promyelocytic leukemia (PML) bodies.,31974171_4,-1,-1,-1,-1,38881,-1,5.7753983e-05,0.9999076,3.4632056e-05
38888,IFN-inducible gene,5,7,36,54,These findings reveal a cooperative IFN-inducible gene network in orchestrating a tumor-suppressive microenvironment.,31974171_6,-1,-1,-1,-1,38888,-1,0.99914944,0.00053718995,0.00031341185
38894,functional,21,22,140,150,"These findings provide mechanistic insights into immune evasion in breast cancer associated with UBA7 loss, emphasizing the importance of a functional ISG-ISGylation network in tumor suppression.",31974171_8,0,1,2,-1,38894,-1,1.3333226e-05,0.99997973,6.922723e-06
38907,biosynthesis,8,9,46,58,"Here we report that iNKT cells increase lipid biosynthesis after activation, and that is promoted by PPAR and PLZF synergically through enhancing transcription of Srebf1.",31974378_1,0,1,-1,-1,38907,-1,0.0014352014,0.9982444,0.0003204087
38936,biosynthesis,18,19,127,139,Our studies provide a strategy to augment the anti-tumor efficacy of iNKT cell-based immunotherapies via promoting their lipid biosynthesis.,31974378_6,0,1,-1,-1,38936,-1,9.396598e-05,0.9998574,4.8569553e-05
38942,analysis,5,6,31,39,"METHODS: By digital microscopy analysis of a muscle-invasive BC (MIBC) cohort, we explored the density and clinical significance of CD66b+ tumor-associated-neutrophils (TAN) and CD3+ T cells.",31991796_2,0,1,-1,-1,38942,-1,8.45981e-06,0.99998415,7.347416e-06
38947,analysis,1,2,15,23,Bioinformatics analysis of UBC datasets and gene expression analysis of UBC cell lines were additionally performed.,31991796_3,0,1,-1,-1,38947,-1,1.0869313e-05,0.9999831,6.029657e-06
38949,analysis,8,9,60,68,Bioinformatics analysis of UBC datasets and gene expression analysis of UBC cell lines were additionally performed.,31991796_3,0,1,-1,-1,38949,-1,1.3072101e-05,0.9999782,8.766716e-06
38953,to the,14,16,87,93,RESULTS: Basal type BC contained a significantly higher density of CD66b+ TAN compared to the luminal type.,31991796_4,-1,-1,-1,-1,38953,-1,4.713158e-06,0.9999901,5.161229e-06
38964,T celsl,9,11,39,46,"In term of survival, a high density of T celsl and TAN was significantly associated to a better outcome, with TAN density showing a more limited statistical power and following a non-linear predicting model.",31991796_8,-1,-1,-1,-1,38964,-1,0.0027602406,0.17981374,0.817426
38973,immunity,12,13,76,84,This finding establishes a groundwork for a better understanding of the UBC immunity and its relevance.,31991796_10,0,-1,2,-1,38973,-1,0.998901,0.00036361965,0.00073525275
38975,antigen receptor-modified T cell,5,9,26,58,"In recent years, chimeric antigen receptor-modified T cell (CAR T cell) therapy has proven to be a promising approach against cancer.",31999649_0,-1,-1,-1,-1,38975,-1,0.0001000244,8.677621e-06,0.9998913
38977,therapy,14,15,72,79,"In recent years, chimeric antigen receptor-modified T cell (CAR T cell) therapy has proven to be a promising approach against cancer.",31999649_0,0,1,-1,-1,38977,-1,4.701799e-06,0.99998987,5.39604e-06
38986,TGF- receptor,9,11,55,69,"Here, we demonstrated that knocking out the endogenous TGF- receptor II (TGFBR2) in CAR T cells with CRISPR/Cas9 technology could reduce the induced Treg conversion and prevent the exhaustion of CAR T ce lls.",31999649_2,-1,-1,-1,-1,38986,-1,6.695899e-05,0.99977785,0.0001551747
38999,the TGFBR2-edited,3,5,13,30,"In addition, the TGFBR2-edited CAR T cells could eliminate contralaterally reinoculated xenografts in mice effectively, with an increased proportion of memory subsets within circulating CAR T cells of central memory and effector memory subsets.",31999649_4,-1,-1,-1,-1,38999,-1,3.83045e-05,0.9999405,2.1145524e-05
39005,function,12,13,60,68,"In conclusion, we greatly improved the in vitro and in vivo function of CAR T cells in TGF--rich tumor environments by knocking out endogenous TGFBR2 and propose a potentially new method to improve the efficacy of CAR T cell therapy for treating solid tumors.",31999649_5,0,1,2,-1,39005,-1,3.3592973e-05,0.99992526,4.1195064e-05
39007,TGF--rich tumor,18,20,87,103,"In conclusion, we greatly improved the in vitro and in vivo function of CAR T cells in TGF--rich tumor environments by knocking out endogenous TGFBR2 and propose a potentially new method to improve the efficacy of CAR T cell therapy for treating solid tumors.",31999649_5,-1,-1,-1,-1,39007,-1,1.0864884e-05,0.99997795,1.1201287e-05
39011,T cell therapy,38,41,219,233,"In conclusion, we greatly improved the in vitro and in vivo function of CAR T cells in TGF--rich tumor environments by knocking out endogenous TGFBR2 and propose a potentially new method to improve the efficacy of CAR T cell therapy for treating solid tumors.",31999649_5,-1,-1,-1,-1,39011,-1,0.0008529541,0.055093933,0.9440532
39014,The metabolism-controlled,0,2,0,25,"The metabolism-controlled differentiation of  T cells has been well documented; however, the role of a metabolism program in  T cell differentiation and function has not been clarified.",32001780_0,-1,-1,-1,-1,39014,-1,3.526395e-05,0.99994946,1.523237e-05
39017,metabolism,18,19,105,115,"The metabolism-controlled differentiation of  T cells has been well documented; however, the role of a metabolism program in  T cell differentiation and function has not been clarified.",32001780_0,0,1,2,-1,39017,-1,0.0019771524,0.9975573,0.00046558765
39019,function,26,27,157,165,"The metabolism-controlled differentiation of  T cells has been well documented; however, the role of a metabolism program in  T cell differentiation and function has not been clarified.",32001780_0,0,1,2,-1,39019,-1,0.00022509505,0.9948102,0.0049646297
39035,their cytokine,2,4,16,30,"Consistent with their cytokine production profiles, the Raptor KO  T cells lost their anti-tumor function both in vitro and in vivo, whereas both Raptor and Rictor KO mice were resistant to imiquimod (IMQ)-induced psoriasis-like skin pathogenesis.",32001780_6,-1,-1,-1,-1,39035,-1,0.41004807,0.58567625,0.004275667
39039,function,16,17,99,107,"Consistent with their cytokine production profiles, the Raptor KO  T cells lost their anti-tumor function both in vitro and in vivo, whereas both Raptor and Rictor KO mice were resistant to imiquimod (IMQ)-induced psoriasis-like skin pathogenesis.",32001780_6,0,1,2,-1,39039,-1,3.4503933e-05,0.99991775,4.7760182e-05
39041,functions,7,8,45,54,"In summary, we identified previously unknown functions of mTORC1 and mTORC2 in  T cell differentiation and clarified their divergent roles in mediating the activity of  T cells in tumors and autoimmunity.",32001780_7,0,1,2,-1,39041,-1,8.411609e-06,0.99998474,6.8066815e-06
39047,Cytokines that,0,2,0,14,"Cytokines that stimulate T cell proliferation, such as interleukin (IL)-15, have been explored as a means of boosting the antitumor activity of chimeric antigen receptor (CAR) T cells.",32015548_0,-1,-1,-1,-1,39047,-1,0.9884969,0.010656952,0.0008461454
39056,toxicity,15,16,96,104,"However, constitutive cytokine signaling in T cells and activation of bystander cells may cause toxicity.",32015548_1,0,1,-1,-1,39056,-1,1.798723e-05,0.9999747,7.286291e-06
39057,two-subunit cytokine,3,5,11,31,IL-23 is a two-subunit cytokine known to promote proliferation of memory T cells and T helper type 17 cells.,32015548_2,-1,-1,-1,-1,39057,-1,0.37686893,0.61730576,0.005825296
39065,TCR,10,11,45,48,"We found that, upon T cell antigen receptor (TCR) stimulation, T cells upregulated the IL-23 receptor and the IL-23 p19 subunit, but not the p40 subunit.",32015548_3,-1,1,2,-1,39065,-1,2.857262e-05,0.9998461,0.00012531913
39068,receptor,19,20,93,101,"We found that, upon T cell antigen receptor (TCR) stimulation, T cells upregulated the IL-23 receptor and the IL-23 p19 subunit, but not the p40 subunit.",32015548_3,0,1,2,-1,39068,-1,0.024734456,0.019179981,0.9560856
39071,the p40 subunit,28,31,138,153,"We found that, upon T cell antigen receptor (TCR) stimulation, T cells upregulated the IL-23 receptor and the IL-23 p19 subunit, but not the p40 subunit.",32015548_3,-1,-1,-1,-1,39071,-1,1.03159055e-05,0.9999707,1.8987357e-05
39072,the p40 subunit,4,7,28,43,We engineered expression of the p40 subunit in T cells (p40-Td cells) and obtained selective proliferative activity in activated T cells via autocrine IL-23 signaling.,32015548_4,-1,-1,-1,-1,39072,-1,1.262083e-05,0.9999684,1.8953013e-05
39074,p40-Td cells,11,13,56,68,We engineered expression of the p40 subunit in T cells (p40-Td cells) and obtained selective proliferative activity in activated T cells via autocrine IL-23 signaling.,32015548_4,-1,-1,-1,-1,39074,-1,0.00014935083,0.00046157566,0.99938905
39087,side effects,26,28,149,161,"In two xenograft and two syngeneic solid tumor mouse models, p40-Td CAR T cells showed superior efficacy in comparison to CAR T cells and attenuated side effects in comparison to CAR T cells expressing IL-18 or IL-15.",32015548_6,0,1,-1,-1,39087,-1,3.4747165e-05,0.9999443,2.0961208e-05
39096,T-cell,6,7,46,52,Cancer-associated mechanisms that elicit CD8+ T-cell exclusion and resistance to immunotherapy are not well-known.,32024640_1,-1,1,2,-1,39096,-1,1.7935088e-05,9.27586e-06,0.9999728
39098,mechanism of action,14,17,63,82,"Here, using a Kras- and p53-driven model of PDA, we describe a mechanism of action for the protumorigenic cytokine IL35 through STAT3 activation in CD8+ T cells.",32024640_2,0,1,-1,-1,39098,-1,5.8921298e-05,0.9999012,3.9937247e-05
39101,through STAT3,22,24,120,133,"Here, using a Kras- and p53-driven model of PDA, we describe a mechanism of action for the protumorigenic cytokine IL35 through STAT3 activation in CD8+ T cells.",32024640_2,-1,-1,-1,-1,39101,-1,6.798476e-06,0.99998784,5.3957765e-06
39105,the transcription factor STAT3,18,22,89,119,"Distinct from its action on CD4+ T cells, IL35 signaling in gp130+CD8+ T cells activated the transcription factor STAT3, which antagonized intratumoral infiltration and effector function of CD8+ T cells via suppression of CXCR3, CCR5, and IFN expression.",32024640_3,-1,-1,-1,-1,39105,-1,5.623591e-06,0.9999894,5.0404255e-06
39106,function,29,30,178,186,"Distinct from its action on CD4+ T cells, IL35 signaling in gp130+CD8+ T cells activated the transcription factor STAT3, which antagonized intratumoral infiltration and effector function of CD8+ T cells via suppression of CXCR3, CCR5, and IFN expression.",32024640_3,0,1,2,-1,39106,-1,0.00017613466,0.99869114,0.0011327586
39113,transfer to tumor-bearing,16,19,103,128,Inhibition of STAT3 signaling in tumor-educated CD8+ T cells improved PDA growth control upon adoptive transfer to tumor-bearing mice.,32024640_4,-1,-1,-1,-1,39113,-1,5.6298504e-06,0.9999881,6.2972254e-06
39127,that the,16,18,95,103,"Finally, we identified a circulating IL35+ B-cell subset in patients with PDA and demonstrated that the presence of IL35+ cells predicted increased occurrence of phosphorylated (p)Stat3+CXCR3-CD8+ T cells in tumors and inversely correlated with a cytotoxic T-cell signature in patients.",32024640_7,-1,-1,-1,-1,39127,-1,4.6341142e-06,0.9999913,4.124588e-06
39131,T-cell,40,41,257,263,"Finally, we identified a circulating IL35+ B-cell subset in patients with PDA and demonstrated that the presence of IL35+ cells predicted increased occurrence of phosphorylated (p)Stat3+CXCR3-CD8+ T cells in tumors and inversely correlated with a cytotoxic T-cell signature in patients.",32024640_7,-1,1,2,-1,39131,-1,1.2358573e-05,7.432734e-06,0.9999802
39136,T-cell,17,18,111,117,"Together, these data identified B cell-mediated IL35/gp130/STAT3 signaling as an important direct link to CD8+ T-cell exclusion and immunotherapy resistance in PDA.",32024640_8,-1,1,2,-1,39136,-1,1.761125e-05,1.073413e-05,0.9999716
39146,analysis,1,2,9,17,"Survival analysis showed differential prognosis, while principal component analysis revealed distinctly different immune phenotypes between the two risk groups.",32028264_3,0,1,-1,-1,39146,-1,1.22219735e-05,0.9999788,8.997783e-06
39147,analysis,9,10,75,83,"Survival analysis showed differential prognosis, while principal component analysis revealed distinctly different immune phenotypes between the two risk groups.",32028264_3,0,1,-1,-1,39147,-1,2.6340484e-05,0.9999547,1.8925139e-05
39148,the two,16,18,140,147,"Survival analysis showed differential prognosis, while principal component analysis revealed distinctly different immune phenotypes between the two risk groups.",32028264_3,-1,-1,-1,-1,39148,-1,8.553042e-06,0.9999858,5.579818e-06
39149,tended to,2,4,19,28,"High-risk patients tended to have advanced stage, higher grade disease, and poorer prognoses.",32028264_4,-1,-1,-1,-1,39149,-1,5.3683702e-06,0.99998546,9.131488e-06
39150,Functional,0,1,0,10,Functional enrichment analysis showed that the signature genes were mainly involved in the cytokine-cytokine receptor interaction pathway.,32028264_5,0,1,2,-1,39150,-1,2.8209597e-05,0.99995697,1.4848042e-05
39151,analysis,2,3,22,30,Functional enrichment analysis showed that the signature genes were mainly involved in the cytokine-cytokine receptor interaction pathway.,32028264_5,0,1,-1,-1,39151,-1,1.4199942e-05,0.9999759,9.9322915e-06
39152,that the,4,6,38,46,Functional enrichment analysis showed that the signature genes were mainly involved in the cytokine-cytokine receptor interaction pathway.,32028264_5,-1,-1,-1,-1,39152,-1,4.607005e-06,0.9999912,4.1940775e-06
39154,the cytokine-cytokine receptor,12,15,87,117,Functional enrichment analysis showed that the signature genes were mainly involved in the cytokine-cytokine receptor interaction pathway.,32028264_5,-1,-1,-1,-1,39154,-1,0.8518895,0.14103445,0.007076057
39155,that tumors,4,6,19,30,"Moreover, we found that tumors from high-risk patients had higher relative abundance of T follicular helper cells, regulatory T cells, and M0 macrophages, and higher expression of PD-1, CTLA-4, LAG3, and CD47 than low-risk patients.",32028264_6,-1,-1,-1,-1,39155,-1,3.998591e-06,0.9999913,4.7105577e-06
39166,tool to,22,24,115,122,"This suggests our gene signature may not only serve as an indicator of tumor immune status, but may be a promising tool to select high-risk patients who may benefit from immune checkpoint inhibitor therapy.",32028264_7,-1,-1,-1,-1,39166,-1,5.4031084e-06,0.99999046,4.0999207e-06
39167,therapy,34,35,198,205,"This suggests our gene signature may not only serve as an indicator of tumor immune status, but may be a promising tool to select high-risk patients who may benefit from immune checkpoint inhibitor therapy.",32028264_7,0,1,-1,-1,39167,-1,6.5014374e-06,0.99998844,5.039459e-06
39168,analysis,3,4,28,36,"Multivariate Cox regression analysis showed that the signature remained an independent prognostic factor after adjusting for clinicopathological variables, while prognostic accuracy was further improved after integrating clinical parameters into the analysis.",32028264_8,0,1,-1,-1,39168,-1,1.50249425e-05,0.9999732,1.1737315e-05
39169,that the,5,7,44,52,"Multivariate Cox regression analysis showed that the signature remained an independent prognostic factor after adjusting for clinicopathological variables, while prognostic accuracy was further improved after integrating clinical parameters into the analysis.",32028264_8,-1,-1,-1,-1,39169,-1,5.3211356e-06,0.99999034,4.3646833e-06
39170,factor,12,13,98,104,"Multivariate Cox regression analysis showed that the signature remained an independent prognostic factor after adjusting for clinicopathological variables, while prognostic accuracy was further improved after integrating clinical parameters into the analysis.",32028264_8,0,1,-1,-1,39170,-1,0.14392857,0.85393566,0.002135795
39171,the analysis,30,32,246,258,"Multivariate Cox regression analysis showed that the signature remained an independent prognostic factor after adjusting for clinicopathological variables, while prognostic accuracy was further improved after integrating clinical parameters into the analysis.",32028264_8,-1,-1,-1,-1,39171,-1,7.830165e-06,0.99998605,6.173883e-06
39180,T-cells to,18,20,95,105,T Follicular helper (TFH) and T follicular regulatory (TFR) cells are specialized providers of T-cells to help B-cells and shaping germinal centers (GC) response.,32061875_1,-1,-1,-1,-1,39180,-1,0.0013661548,0.03097637,0.96765745
39183,their functional,2,4,9,25,"However, their functional role in human colorectal cancer (CRC) is relatively unknown.",32061875_3,-1,-1,-1,-1,39183,-1,1.4902944e-05,0.99997795,7.2011926e-06
39185,that the,5,7,33,41,"Furthermore, recent studies show that the interaction of both TFH cells and TFR cells are essential to promote several diseases.",32061875_4,-1,-1,-1,-1,39185,-1,4.658687e-06,0.99999166,3.7135592e-06
39186,TFH cells,10,12,62,71,"Furthermore, recent studies show that the interaction of both TFH cells and TFR cells are essential to promote several diseases.",32061875_4,-1,-1,-1,-1,39186,-1,7.389611e-05,0.0013703578,0.9985557
39187,TFR cells,13,15,76,85,"Furthermore, recent studies show that the interaction of both TFH cells and TFR cells are essential to promote several diseases.",32061875_4,-1,-1,-1,-1,39187,-1,0.00012356421,0.0037101845,0.9961662
39195,TFH cells,21,23,126,135,"Under the control of specific cytokines and B-cell lymphoma 6 transcription factor (Bcl-6), the major transcription factor of TFH cells, TFH, can expand to the other distinct CD4+T helper cells (TH1, TH2, and TH17) which exert a different role in the development of CRC.",32061875_5,-1,-1,-1,-1,39195,-1,0.00022960501,0.011280026,0.98849046
39197,to the,28,30,153,159,"Under the control of specific cytokines and B-cell lymphoma 6 transcription factor (Bcl-6), the major transcription factor of TFH cells, TFH, can expand to the other distinct CD4+T helper cells (TH1, TH2, and TH17) which exert a different role in the development of CRC.",32061875_5,-1,-1,-1,-1,39197,-1,5.8966098e-06,0.9999875,6.6004827e-06
39206,the two-opposite subset,9,12,53,76,This review aims to discuss these suggested roles of the two-opposite subset of follicular T cells in colorectal cancer immune pathogenesis.,32061875_6,-1,-1,-1,-1,39206,-1,0.002231302,0.91524214,0.08252656
39208,TNF,0,1,0,3,TNF is a key proinflammatory and immunoregulatory cytokine whose deregulation is associated with the development of autoimmune diseases and other pathologies.,32083339_0,0,1,-1,-1,39208,-1,0.0018315578,0.9980556,0.00011292335
39212,functions,5,6,37,46,Recent studies suggest that distinct functions of TNF may be associated with differential engagement of its two receptors: TNFR1 or TNFR2.,32083339_1,0,1,2,-1,39212,-1,0.00027729906,0.9996228,9.9801575e-05
39213,TNF,7,8,50,53,Recent studies suggest that distinct functions of TNF may be associated with differential engagement of its two receptors: TNFR1 or TNFR2.,32083339_1,0,1,-1,-1,39213,-1,0.06453604,0.9344265,0.0010375398
39214,two receptors,16,18,108,121,Recent studies suggest that distinct functions of TNF may be associated with differential engagement of its two receptors: TNFR1 or TNFR2.,32083339_1,-1,-1,-1,-1,39214,-1,0.0041878982,0.9263133,0.06949886
39215,TNFR1,19,20,123,128,Recent studies suggest that distinct functions of TNF may be associated with differential engagement of its two receptors: TNFR1 or TNFR2.,32083339_1,0,1,-1,-1,39215,-1,2.5513791e-05,0.9999491,2.540332e-05
39216,TNFR2,21,22,132,137,Recent studies suggest that distinct functions of TNF may be associated with differential engagement of its two receptors: TNFR1 or TNFR2.,32083339_1,0,1,-1,-1,39216,-1,0.00012770582,0.99984837,2.395801e-05
39218,the relative,6,8,27,39,"In this review, we discuss the relative contributions of these receptors to pathogenesis of several diseases, with the focus on autoimmunity and neuroinflammation.",32083339_2,-1,-1,-1,-1,39218,-1,6.6487387e-06,0.9999887,4.681596e-06
39219,these receptors to,10,13,57,75,"In this review, we discuss the relative contributions of these receptors to pathogenesis of several diseases, with the focus on autoimmunity and neuroinflammation.",32083339_2,-1,-1,-1,-1,39219,-1,1.7264163e-05,0.99995255,3.0238034e-05
39222,TNFRs,8,9,38,43,"In particular, we discuss the role of TNFRs in the development of regulatory T cells during neuroinflammation and recent findings concerning targeting TNFR2 with agonistic and antagonistic reagents in various murine models of autoimmune and neuroinflammatory disorders and cancer.",32083339_3,0,1,-1,-1,39222,-1,7.853932e-06,0.99998605,6.138791e-06
39225,targeting TNFR2,22,24,141,156,"In particular, we discuss the role of TNFRs in the development of regulatory T cells during neuroinflammation and recent findings concerning targeting TNFR2 with agonistic and antagonistic reagents in various murine models of autoimmune and neuroinflammatory disorders and cancer.",32083339_3,-1,-1,-1,-1,39225,-1,1.593277e-05,0.99997795,6.15448e-06
39227,transgenic T cell receptor,5,9,27,53,Mice that express a single transgenic T cell receptor have a low incidence of T cell lymphoma development.,32143838_0,-1,-1,-1,-1,39227,-1,0.0019209831,0.12129164,0.87678736
39229,this tumor,3,5,24,34,We investigated whether this tumor development is restricted by surveillance mechanisms that are exerted by IL-15-dependent cells.,32143838_1,-1,-1,-1,-1,39229,-1,5.591548e-06,0.9999896,4.799501e-06
39231,IL-15-dependent cells,15,17,108,129,We investigated whether this tumor development is restricted by surveillance mechanisms that are exerted by IL-15-dependent cells.,32143838_1,-1,-1,-1,-1,39231,-1,0.95962906,0.00014847553,0.04022242
39233,TCR transgenes,11,13,60,74,Lymphoma incidence was increased to between 30 and 60% when TCR transgenes were expressed in IL-15-deficient mice.,32143838_2,-1,-1,-1,-1,39233,-1,8.062403e-06,0.9999821,9.876191e-06
39244,receptor,17,18,91,99,"The distinct phenotype of the lymphomas involved expression of PD1, CD30, CD24, the stress receptor ligand Mult1 and MHC class I down-regulation.",32143838_5,0,1,2,-1,39244,-1,0.9694091,0.0001843243,0.030406535
39249,Together these,0,2,0,14,Together these data support an involvement of NK cells in tumor surveillance of nascent T cell lymphomas.,32143838_7,-1,-1,-1,-1,39249,-1,7.5200246e-06,0.9999877,4.7645945e-06
39254,the tumor,2,4,15,24,Elucidation of the tumor immune microenvironment is essential for understanding tumorigenesis and for the development of immunotherapeutic strategies.,32156780_1,-1,-1,-1,-1,39254,-1,4.8945303e-06,0.99999046,4.6931377e-06
39257,the tumor,9,11,62,71,"However, it remains unclear how -catenin signaling regulates the tumor immune microenvironment in the stomach.",32156780_2,-1,-1,-1,-1,39257,-1,4.641792e-06,0.9999912,4.2059896e-06
39260,transcriptional target gene,8,11,36,63,"Here, we identify CCL28 as a direct transcriptional target gene of -catenin/T-cell factor (TCF).",32156780_3,-1,-1,-1,-1,39260,-1,5.83311e-06,0.9999883,5.8573596e-06
39261,factor,13,14,84,90,"Here, we identify CCL28 as a direct transcriptional target gene of -catenin/T-cell factor (TCF).",32156780_3,0,1,-1,-1,39261,-1,0.3334957,0.43395883,0.23254547
39263,Protein,0,1,0,7,Protein levels of -catenin and CCL28 positively correlated in human gastric adenocarcinoma.,32156780_4,0,1,-1,-1,39263,-1,1.844063e-05,0.99997246,9.067621e-06
39277,toxin-induced Treg cell,1,4,11,34,"Diphtheria toxin-induced Treg cell ablation restrained gastric cancer progression in H. felis/MNU-treated DEREG (Foxp3-DTR) mice, clarifying the tumor-promoting role of Treg cells.",32156780_8,-1,-1,-1,-1,39277,-1,0.03382897,0.19362424,0.77254677
39279,the tumor-promoting,19,21,141,160,"Diphtheria toxin-induced Treg cell ablation restrained gastric cancer progression in H. felis/MNU-treated DEREG (Foxp3-DTR) mice, clarifying the tumor-promoting role of Treg cells.",32156780_8,-1,-1,-1,-1,39279,-1,9.025306e-06,0.9999852,5.7705356e-06
39283,-catenin-CCL28-Treg cell,3,5,10,35,"Thus, the -catenin-CCL28-Treg cell axis may serve as an important mechanism for immunosuppression of the stomach tumor microenvironment.",32156780_9,-1,-1,-1,-1,39283,-1,0.021109678,0.37036335,0.608527
39287,the therapeutic,14,16,100,115,Our findings reveal an immunoregulatory role of -catenin signaling in stomach tumors and highlight the therapeutic potential of CCL28 blockade for the treatment of gastric cancer.,32156780_10,-1,-1,-1,-1,39287,-1,5.360642e-06,0.99999046,4.138647e-06
39289,the treatment,21,23,148,161,Our findings reveal an immunoregulatory role of -catenin signaling in stomach tumors and highlight the therapeutic potential of CCL28 blockade for the treatment of gastric cancer.,32156780_10,-1,-1,-1,-1,39289,-1,5.3267595e-06,0.99999,4.7256517e-06
39292,the therapeutic,13,15,110,125,SIGNIFICANCE: These findings demonstrate an immunosuppressive role of tumor-intrinsic -catenin signaling and the therapeutic potential of CCL28 blockade in gastric cancer.,32156780_11,-1,-1,-1,-1,39292,-1,4.798712e-06,0.9999912,4.0735226e-06
39300,the therapies,8,10,33,46,"However, in HGSOC, the impact of the therapies aiming at these targets remains unsatisfying.",32184777_2,-1,-1,-1,-1,39300,-1,7.3149613e-06,0.99998796,4.745812e-06
39301,these targets,12,14,57,70,"However, in HGSOC, the impact of the therapies aiming at these targets remains unsatisfying.",32184777_2,-1,-1,-1,-1,39301,-1,7.818023e-06,0.99998677,5.3551744e-06
39304,the TMEs,13,15,69,77,Tumor-associated macrophages (TAMs) in HGSOC make up a large part of the TMEs and transform between diverse phenotypes under different treatments.,32184777_3,-1,-1,-1,-1,39304,-1,7.67549e-06,0.99998164,1.0626617e-05
39327,MAF transcripts,4,6,28,43,"This modification occurs on MAF transcripts in TAMs and modified by BRD4, which is the target of AZD5153.",32184777_7,-1,-1,-1,-1,39327,-1,0.00018236386,0.99970335,0.00011428876
39330,the target,15,17,83,93,"This modification occurs on MAF transcripts in TAMs and modified by BRD4, which is the target of AZD5153.",32184777_7,-1,-1,-1,-1,39330,-1,6.0912603e-06,0.99998856,5.3248423e-06
39334,therapy,14,15,104,111,"Importantly, the 3-D microfluid model demonstrates that AZD5153 sensitizes ovarian cancer to anti-PD-L1 therapy.",32184777_8,0,1,-1,-1,39334,-1,4.954379e-06,0.99999034,4.6633963e-06
39336,tumor cells,6,8,45,56,"Our results clarify that besides eliminating tumor cells directly, AZD5153 works as a regulator of the TAM phenotype, providing a novel strategy combining AZD5153 and PD-1/PD-L1 antibody that could benefit HGSOC patients.",32184777_9,-1,-1,-1,-1,39336,-1,0.00079384045,0.050927915,0.94827825
39337,the TAM,16,18,99,106,"Our results clarify that besides eliminating tumor cells directly, AZD5153 works as a regulator of the TAM phenotype, providing a novel strategy combining AZD5153 and PD-1/PD-L1 antibody that could benefit HGSOC patients.",32184777_9,-1,-1,-1,-1,39337,-1,5.6780495e-06,0.9999889,5.3860504e-06
39348,blood lymphocytes,32,34,191,208,"A limited number of studies, largely performed on tumor infiltrating lymphocytes (TILs), has provided evidence in support of this hypothesis, but whether similar changes occur in circulating blood lymphocytes has received little attention.",32210968_1,-1,-1,-1,-1,39348,-1,3.610575e-05,2.6906082e-05,0.99993694
39350,analysis,7,8,38,46,"In the present study, a comprehensive analysis of peripheral blood leukocytes from 42 patients taken over the course of treatment with anti-PD-1 was undertaken.",32210968_2,0,1,-1,-1,39350,-1,6.661516e-06,0.99998593,7.3553374e-06
39351,blood,10,11,61,66,"In the present study, a comprehensive analysis of peripheral blood leukocytes from 42 patients taken over the course of treatment with anti-PD-1 was undertaken.",32210968_2,0,1,-1,-1,39351,-1,0.0034357074,0.47920534,0.5173589
39359,Analysis,0,1,0,8,"Analysis included surface markers of exhaustion, production of cytokines following in vitro stimulation, and assessment of transcription factor levels associated with T cell exhaustion.",32210968_4,0,1,-1,-1,39359,-1,7.732137e-06,0.99998677,5.5107735e-06
39365,throughout therapy,15,17,115,133,There were differences in innate cell populations between responders and non-responders at baseline and maintained throughout therapy.,32210968_5,-1,-1,-1,-1,39365,-1,6.995037e-06,0.9999869,6.0997545e-06
39371,blood,5,6,35,40,"However, differences in peripheral blood expression of exhaustion markers were not evident between the treatment groups.",32210968_7,0,1,-1,-1,39371,-1,0.008179759,0.5294611,0.4623591
39372,the treatment,14,16,99,112,"However, differences in peripheral blood expression of exhaustion markers were not evident between the treatment groups.",32210968_7,-1,-1,-1,-1,39372,-1,7.535066e-06,0.99998784,4.6523955e-06
39385,blood,3,4,17,22,"Thus, peripheral blood expression of T cell exhaustion markers does not distinguish between responders and non-responders to anti-PD-1 therapy.",32210968_10,0,1,-1,-1,39385,-1,0.0018175677,0.9927233,0.0054590954
39388,therapy,19,20,135,142,"Thus, peripheral blood expression of T cell exhaustion markers does not distinguish between responders and non-responders to anti-PD-1 therapy.",32210968_10,0,1,-1,-1,39388,-1,5.6653935e-06,0.99998915,5.240307e-06
39393,blood,25,26,162,167,"CD4 T cell expression of IFN also differed in pre-treatment samples, indicating that predictors of response unrelated to exhaustion may be present in peripheral blood.",32210968_11,0,1,-1,-1,39393,-1,0.0002224565,0.9979983,0.0017792099
39400,to the,12,14,74,80,"Though benign in the majority of cases, complications can be excruciating to the affected individual, and recurrences after tumor removal may happen with more aggressive clinical features.",32279926_1,-1,-1,-1,-1,39400,-1,9.420121e-06,0.9999807,9.9086965e-06
39407,cell type,12,14,76,85,T regulatory (Treg) cells are generally considered a tumor-promoting immune cell type in malignant cancers with currently unclear roles in pituitary adenoma patients.,32279926_2,-1,-1,-1,-1,39407,-1,6.0669634e-05,0.00015152813,0.99978787
39410,functional,7,8,45,55,"Therefore, we investigated the frequency and functional characteristics of Treg cells in nonfunctioning pituitary adenoma patients before and after tumor removal.",32279926_3,0,1,2,-1,39410,-1,0.0009115858,0.9987237,0.00036465796
39414,functional,16,17,130,140,"Compared to healthy controls, untreated patients with nonfunctioning pituitary adenomas presented an overrepresentation of highly functional circulating FOXP3+ Treg cells.",32279926_4,0,1,2,-1,39414,-1,0.0010420326,0.99886763,9.041011e-05
39417,the FOXP3,2,4,14,23,"Specifically, the FOXP3+ Treg cells in patients were slightly upregulated in frequency and displayed markedly elevated capacity to co-produce TGF- and IL-10.",32279926_5,-1,-1,-1,-1,39417,-1,5.5859277e-06,0.99998915,5.304885e-06
39429,cells than TIM-3- Treg cells,22,27,145,173,"In both healthy controls and pituitary adenoma patients, TIM-3+ Treg cells presented significantly higher levels of TGF- and IL-10 co-producing cells than TIM-3- Treg cells but compared to healthy controls, patients with nonfunctioning pituitary adenomas showed significantly higher levels of TIM-3+ FOXP3+ Treg cells.",32279926_7,-1,-1,-1,-1,39429,-1,9.90858e-05,0.00015557301,0.9997454
39434,the tumor,5,7,35,44,"Interestingly, surgical removal of the tumor significantly reduced the extent of Treg upregulation in patients.",32279926_8,-1,-1,-1,-1,39434,-1,4.8513853e-06,0.9999902,4.9189885e-06
39437,functional FOXP3,7,9,51,67,"Also, resected pituitary adenomas contained highly functional FOXP3+ Treg cells, with high levels of TIM-3 expression and high frequency of TGF- and IL-10 co-producers in the TIM-3+ fraction.",32279926_9,-1,-1,-1,-1,39437,-1,2.2364151e-05,0.9999584,1.9296542e-05
39442,the TIM-3,28,30,172,181,"Also, resected pituitary adenomas contained highly functional FOXP3+ Treg cells, with high levels of TIM-3 expression and high frequency of TGF- and IL-10 co-producers in the TIM-3+ fraction.",32279926_9,-1,-1,-1,-1,39442,-1,7.733154e-06,0.99998486,7.386801e-06
39445,functional Treg cells,18,21,141,162,"Overall, these results demonstrate that patients with nonfunctioning pituitary adenomas are characterized by an overrepresentation of highly functional Treg cells.",32279926_10,-1,-1,-1,-1,39445,-1,0.0024028164,0.018451443,0.97914565
39450,protein,7,8,46,53,We recently reported that cancer Forkhead box protein 3 (Cancer-FOXP3 or C-FOXP3) promoted immune evasion of PDAC by recruiting Treg cells into PDAC via upregulation of CCL5.,32300119_2,0,1,-1,-1,39450,-1,1.3991163e-05,0.9999745,1.14688355e-05
39456,tumor cells,13,15,81,92,"Moreover, C-FOXP3 was colocalized and correlated with the expression of PD-L1 in tumor cells at the mRNA and protein levels, and this finding was confirmed by the The Cancer Genome Atlas (TCGA) database.",32300119_4,-1,-1,-1,-1,39456,-1,0.00016335276,0.002029325,0.9978073
39458,protein,19,20,109,116,"Moreover, C-FOXP3 was colocalized and correlated with the expression of PD-L1 in tumor cells at the mRNA and protein levels, and this finding was confirmed by the The Cancer Genome Atlas (TCGA) database.",32300119_4,0,1,-1,-1,39458,-1,1.1050415e-05,0.99997854,1.0425929e-05
39460,the The,28,30,159,166,"Moreover, C-FOXP3 was colocalized and correlated with the expression of PD-L1 in tumor cells at the mRNA and protein levels, and this finding was confirmed by the The Cancer Genome Atlas (TCGA) database.",32300119_4,-1,-1,-1,-1,39460,-1,4.3135915e-06,0.9999914,4.28927e-06
39463,to the,10,12,74,80,Chromatin immunoprecipitation (ChIP) revealed that C-FOXP3 directly bound to the promoter region of PD-L1 in pancreatic cancer cells.,32300119_5,-1,-1,-1,-1,39463,-1,4.5150714e-06,0.9999912,4.3125374e-06
39473,that the,5,7,28,36,"Based on our recent finding that the CCL-5 antibody achieved a better response to PDAC models with high C-FOXP3 levels, we further demonstrated that the PD-L1 antibody strengthened the antitumor effect of CCL-5 blockade in xenograft and orthotopic mouse models with high C-FOXP3 levels.",32300119_9,-1,-1,-1,-1,39473,-1,4.4405433e-06,0.9999913,4.2605598e-06
39475,that the,24,26,144,152,"Based on our recent finding that the CCL-5 antibody achieved a better response to PDAC models with high C-FOXP3 levels, we further demonstrated that the PD-L1 antibody strengthened the antitumor effect of CCL-5 blockade in xenograft and orthotopic mouse models with high C-FOXP3 levels.",32300119_9,-1,-1,-1,-1,39475,-1,4.3013597e-06,0.9999918,3.867336e-06
39479,therapy,10,11,62,69,Combined blockade of PD-L1 and CCL-5 may provide an effective therapy for patients with PDAC that have high C-FOXP3 levels.,32300119_11,0,1,-1,-1,39479,-1,5.4939383e-06,0.9999902,4.2257066e-06
39481,The tumor,0,2,0,9,The tumor microenvironment (TME) is an essential contributor to the development and progression of malignancy.,32300202_0,-1,-1,-1,-1,39481,-1,4.41609e-06,0.99999106,4.567239e-06
39483,to the,10,12,61,67,The tumor microenvironment (TME) is an essential contributor to the development and progression of malignancy.,32300202_0,-1,-1,-1,-1,39483,-1,5.797095e-06,0.9999881,6.1751903e-06
39484,the TME,1,3,7,14,"Within the TME, tumor associated macrophages (TAMs) mediate angiogenesis, metastasis, and immunosuppression, which inhibits infiltration of tumor-specific cytotoxic CD8+ T cells.",32300202_1,-1,-1,-1,-1,39484,-1,4.9553096e-06,0.9999894,5.6200306e-06
39489,that the,6,8,34,42,"In previous work, we demonstrated that the synthetic triterpenoid CDDO-methyl ester (CDDO-Me) converts breast TAMs from a tumor-promoting to a tumor-inhibiting activation state in vitro.",32300202_2,-1,-1,-1,-1,39489,-1,4.9883197e-06,0.9999912,3.8903318e-06
39492,tumor-promoting to,20,22,122,140,"In previous work, we demonstrated that the synthetic triterpenoid CDDO-methyl ester (CDDO-Me) converts breast TAMs from a tumor-promoting to a tumor-inhibiting activation state in vitro.",32300202_2,-1,-1,-1,-1,39492,-1,8.4440235e-06,0.9999819,9.666452e-06
39499,T cell tumor,14,17,81,93,"We show now that CDDO-Me remodels the breast TME, redirecting TAM activation and T cell tumor infiltration in vivo.",32300202_3,-1,-1,-1,-1,39499,-1,0.00042759712,0.010972248,0.9886002
39502,TNF,12,13,94,97,"We demonstrate that CDDO-Me significantly attenuates IL-10 and VEGF expression but stimulates TNF production, and reduces surface expression of CD206 and CD115, markers of immunosuppressive TAMs.",32300202_4,0,1,-1,-1,39502,-1,0.028110864,0.9713787,0.0005103992
39505,the TAM transcriptional,3,6,28,51,"CDDO-Me treatment redirects the TAM transcriptional profile, inducing signaling pathways associated with immune stimulation, and inhibits TAM tumor infiltration, consistent with decreased expression of CCL2.",32300202_5,-1,-1,-1,-1,39505,-1,4.67325e-06,0.99999046,4.9079827e-06
39506,TAM tumor,18,20,138,147,"CDDO-Me treatment redirects the TAM transcriptional profile, inducing signaling pathways associated with immune stimulation, and inhibits TAM tumor infiltration, consistent with decreased expression of CCL2.",32300202_5,-1,-1,-1,-1,39506,-1,4.1986227e-06,0.99999094,4.8788374e-06
39518,time that,6,8,40,49,These results demonstrate for the first time that CDDO-Me relieves immunosuppression in the breast TME and unleashes host adaptive anti-tumor immunity.,32300202_8,-1,-1,-1,-1,39518,-1,4.2049887e-06,0.99999154,4.2367965e-06
39522,immunity,20,21,142,150,These results demonstrate for the first time that CDDO-Me relieves immunosuppression in the breast TME and unleashes host adaptive anti-tumor immunity.,32300202_8,0,-1,2,-1,39522,-1,0.99990857,2.512189e-05,6.6317654e-05
39532,CCL11,22,23,115,120,"The aim of the present study was to investigate the role and molecular mechanism of CC motif chemokine ligand11 (CCL11) in the regulation of Treg cells from patients with breast cancer (BC) and healthy individuals invitro, and from tumorbearing mice invivo.",32323817_1,0,-1,2,-1,39532,-1,0.9998117,1.798653e-05,0.00017027133
39533,the regulation,25,27,125,139,"The aim of the present study was to investigate the role and molecular mechanism of CC motif chemokine ligand11 (CCL11) in the regulation of Treg cells from patients with breast cancer (BC) and healthy individuals invitro, and from tumorbearing mice invivo.",32323817_1,-1,-1,-1,-1,39533,-1,3.5115413e-06,0.9999918,4.772118e-06
39536,CCL11 protein,22,24,143,156,"CD4+ Tcells isolated from patients with BC or healthy individuals were incubated with antiCCL11 neutralizing antibodies or recombinant human CCL11 protein, in the presence or absence of a STAT5 inhibitor.",32323817_2,-1,-1,-1,-1,39536,-1,0.99154234,0.0024277929,0.006029784
39540,CCL11,2,3,10,15,"The serum CCL11 level and proportion of Treg cells characterized as CD4+CD25+forkhead box P3+ (Foxp3) among the CD4+ Tcells in patients with BC and healthy individuals were analyzed by ELISA and flow cytometry, respectively.",32323817_3,0,-1,2,-1,39540,-1,0.9992736,3.7411337e-05,0.0006890313
39542,CD4+CD25+forkhead,11,12,68,85,"The serum CCL11 level and proportion of Treg cells characterized as CD4+CD25+forkhead box P3+ (Foxp3) among the CD4+ Tcells in patients with BC and healthy individuals were analyzed by ELISA and flow cytometry, respectively.",32323817_3,-1,-1,-1,-1,39542,-1,0.0043053334,0.017628128,0.97806644
39546,CCL11,0,1,0,5,"CCL11, CC motif chemokine receptor3 (CCR3), Foxp3, phosphorylatedSTAT5 and STAT5 expression levels were determined by western blotting.",32323817_4,0,-1,2,-1,39546,-1,0.9983784,7.138538e-05,0.0015502189
39547,chemokine receptor,4,6,17,35,"CCL11, CC motif chemokine receptor3 (CCR3), Foxp3, phosphorylatedSTAT5 and STAT5 expression levels were determined by western blotting.",32323817_4,-1,-1,-1,-1,39547,-1,0.98485744,4.758745e-05,0.015095033
39551,CCL11,2,3,10,15,The serum CCL11 level and the proportion of CD4+CD25+Foxp3+ Treg cells were significantly increased in patients with BC compared with healthy individuals.,32323817_5,0,-1,2,-1,39551,-1,0.99879456,4.6465535e-05,0.0011590396
39554,CCL11,0,1,0,5,"CCL11 blockade reduced the proportion of CD4+CD25+Foxp3+ Treg cells, the expression of CCR3 and Foxp3, and the level of STAT5 activation in tumorassociated CD4+ Tcells, in a dosedependent manner.",32323817_6,0,-1,2,-1,39554,-1,0.9992648,4.885676e-05,0.0006863436
39562,CCL11,0,1,0,5,CCL11 blockade also reduced the proportion of CD4+CD25+Foxp3+ Treg cells and the serum levels of interleukin (IL)2 and transforming growth factor (TGF)1 in tumorbearing mice.,32323817_7,0,-1,2,-1,39562,-1,0.99939704,4.4636923e-05,0.0005582669
39567,transforming growth factor,19,22,120,146,CCL11 blockade also reduced the proportion of CD4+CD25+Foxp3+ Treg cells and the serum levels of interleukin (IL)2 and transforming growth factor (TGF)1 in tumorbearing mice.,32323817_7,-1,-1,-1,-1,39567,-1,0.9830321,0.013959808,0.0030081165
39569,CCL11 protein,3,5,22,35,"The recombinant human CCL11 protein increased the proportion of CD4+CD25+Foxp3+ Treg cells, the expression of CCR3 and Foxp3, and the release of IL2 and TGF1 in nontumorassociated CD4+ Tcells via the STAT5 signaling pathway.",32323817_8,-1,-1,-1,-1,39569,-1,0.98559964,0.0056171105,0.008783267
39574,the release,22,24,130,141,"The recombinant human CCL11 protein increased the proportion of CD4+CD25+Foxp3+ Treg cells, the expression of CCR3 and Foxp3, and the release of IL2 and TGF1 in nontumorassociated CD4+ Tcells via the STAT5 signaling pathway.",32323817_8,-1,-1,-1,-1,39574,-1,5.605094e-06,0.9999888,5.555241e-06
39576,the STAT5,36,38,202,211,"The recombinant human CCL11 protein increased the proportion of CD4+CD25+Foxp3+ Treg cells, the expression of CCR3 and Foxp3, and the release of IL2 and TGF1 in nontumorassociated CD4+ Tcells via the STAT5 signaling pathway.",32323817_8,-1,-1,-1,-1,39576,-1,7.914593e-06,0.99998486,7.202369e-06
39579,therapeutics that,10,12,56,73,The results of the present study may aid in identifying therapeutics that could further modulate the immune system during BC.,32323817_9,-1,-1,-1,-1,39579,-1,4.598965e-06,0.99999166,3.7659759e-06
39582,T-cell,12,13,86,92,"Although melanoma is considered one of the most immunogenic malignancies, spontaneous T-cell responses to melanoma antigens are ineffective due to tumor cell-intrinsic or microenvironment-driven immune evasion mechanisms.",32330348_0,-1,1,2,-1,39582,-1,2.0152795e-05,9.932781e-06,0.99996996
39585,to tumor cell-intrinsic,20,23,144,167,"Although melanoma is considered one of the most immunogenic malignancies, spontaneous T-cell responses to melanoma antigens are ineffective due to tumor cell-intrinsic or microenvironment-driven immune evasion mechanisms.",32330348_0,-1,-1,-1,-1,39585,-1,0.0029056864,0.84366626,0.1534281
39586,cells fosters tumor,9,12,55,74,"For example, oncogenic BRAF V600E mutation in melanoma cells fosters tumor immune escape by modulating cell immunogenicity and microenvironment composition.",32330348_1,-1,-1,-1,-1,39586,-1,0.003892522,0.8339769,0.16213052
39605,these cells,24,26,162,173,"In coculture experiments, A375 melanoma cells pretreated with vemurafenib induced apoptosis of interacting Jurkat T cells, whereas genetic inhibition of Gal-1 in these cells restored the viability of cocultured T lymphocytes, indicating that Gal-1 contributes to tumor immune escape.",32330348_6,-1,-1,-1,-1,39605,-1,1.9154826e-05,1.3150777e-05,0.9999677
39609,to tumor,38,40,260,268,"In coculture experiments, A375 melanoma cells pretreated with vemurafenib induced apoptosis of interacting Jurkat T cells, whereas genetic inhibition of Gal-1 in these cells restored the viability of cocultured T lymphocytes, indicating that Gal-1 contributes to tumor immune escape.",32330348_6,-1,-1,-1,-1,39609,-1,6.3837633e-06,0.9999877,5.84256e-06
39612,Taken together,0,2,0,14,"Taken together, these results suggest a two-faceted nature of BRAF inhibition-associated immunomodulatory effects: an early immunostimulatory activity, mediated at least in part by decreased PD-L1 expression, and a delayed immunosuppressive effect associated with Gal-1 induction.",32330348_8,-1,-1,-1,-1,39612,-1,9.202461e-06,0.99998295,7.825803e-06
39614,two-faceted nature,7,9,40,58,"Taken together, these results suggest a two-faceted nature of BRAF inhibition-associated immunomodulatory effects: an early immunostimulatory activity, mediated at least in part by decreased PD-L1 expression, and a delayed immunosuppressive effect associated with Gal-1 induction.",32330348_8,-1,-1,-1,-1,39614,-1,3.3180237e-05,0.9999461,2.0756355e-05
39616,therapeutic target,17,19,107,125,"Importantly, our observations suggest that Gal-1 might be utilized as a potential biomarker and a putative therapeutic target in melanoma patients.",32330348_9,-1,-1,-1,-1,39616,-1,5.999663e-06,0.9999888,5.1504835e-06
39618,therapy,12,13,90,97,The development of immune checkpoint inhibitors represents a major breakthrough in cancer therapy.,32332858_0,0,1,-1,-1,39618,-1,4.752349e-06,0.9999902,4.965286e-06
39628,the tumors to,29,32,193,206,"Here we show that a specific small-molecule tankyrase inhibitor, G007-LK, decreases WNT/-catenin and YAP signaling in the syngeneic murine B16-F10 and Clone M-3 melanoma models and sensitizes the tumors to anti-PD-1 immune checkpoint therapy.",32332858_4,-1,-1,-1,-1,39628,-1,4.2442443e-06,0.99999106,4.651976e-06
39629,therapy,35,36,235,242,"Here we show that a specific small-molecule tankyrase inhibitor, G007-LK, decreases WNT/-catenin and YAP signaling in the syngeneic murine B16-F10 and Clone M-3 melanoma models and sensitizes the tumors to anti-PD-1 immune checkpoint therapy.",32332858_4,0,1,-1,-1,39629,-1,6.0626985e-06,0.9999882,5.691159e-06
39630,that the,4,6,32,40,"Mechanistically, we demonstrate that the synergistic effect of tankyrase and checkpoint inhibitor treatment is dependent on loss of -catenin in the tumor cells, anti-PD-1-stimulated infiltration of T cells into the tumor and induction of an IFN- and CD8+ T cell-mediated anti-tumor immune response.",32332858_5,-1,-1,-1,-1,39630,-1,4.4229596e-06,0.9999919,3.704162e-06
39633,the tumor cells,21,24,145,160,"Mechanistically, we demonstrate that the synergistic effect of tankyrase and checkpoint inhibitor treatment is dependent on loss of -catenin in the tumor cells, anti-PD-1-stimulated infiltration of T cells into the tumor and induction of an IFN- and CD8+ T cell-mediated anti-tumor immune response.",32332858_5,-1,-1,-1,-1,39633,-1,0.0016942938,0.6533334,0.34497225
39635,the tumor,31,33,212,221,"Mechanistically, we demonstrate that the synergistic effect of tankyrase and checkpoint inhibitor treatment is dependent on loss of -catenin in the tumor cells, anti-PD-1-stimulated infiltration of T cells into the tumor and induction of an IFN- and CD8+ T cell-mediated anti-tumor immune response.",32332858_5,-1,-1,-1,-1,39635,-1,4.1567523e-06,0.9999906,5.207052e-06
39645,functions,8,9,56,65,"T cells have been reported to exert immunosuppressive functions in multiple solid malignant diseases, but their immunosuppressive functional subpopulation in breast cancer (BC) is still undetermined.",32345959_0,0,1,2,-1,39645,-1,8.317829e-05,0.99984205,7.4779084e-05
39647,functional,18,19,132,142,"T cells have been reported to exert immunosuppressive functions in multiple solid malignant diseases, but their immunosuppressive functional subpopulation in breast cancer (BC) is still undetermined.",32345959_0,0,1,2,-1,39647,-1,0.00071364414,0.99695444,0.0023319405
39648,tissue,9,10,43,49,"Here, we collected 40 paired BC and normal tissue samples from Chinese patients for analysis.",32345959_1,-1,1,2,-1,39648,-1,0.00010568878,0.9876281,0.012266165
39649,analysis,15,16,84,92,"Here, we collected 40 paired BC and normal tissue samples from Chinese patients for analysis.",32345959_1,0,1,-1,-1,39649,-1,7.3333886e-06,0.9999862,6.5228924e-06
39659,that their,38,40,182,192,"First, we showed that T1 cells comprise the majority of CD3+ T cells in BC; next, we found that CD73+T1 cells were the predominant regulatory T-cell (Treg) population in BC, and that their prevalence in peripheral blood was also related to tumour burden.",32345959_2,-1,-1,-1,-1,39659,-1,4.6312857e-06,0.9999912,4.211766e-06
39660,blood,43,44,218,223,"First, we showed that T1 cells comprise the majority of CD3+ T cells in BC; next, we found that CD73+T1 cells were the predominant regulatory T-cell (Treg) population in BC, and that their prevalence in peripheral blood was also related to tumour burden.",32345959_2,0,1,-1,-1,39660,-1,0.0002984572,0.99887353,0.00082804903
39661,related to tumour,46,49,233,250,"First, we showed that T1 cells comprise the majority of CD3+ T cells in BC; next, we found that CD73+T1 cells were the predominant regulatory T-cell (Treg) population in BC, and that their prevalence in peripheral blood was also related to tumour burden.",32345959_2,-1,-1,-1,-1,39661,-1,1.00003235e-05,0.9999825,7.5660314e-06
39667,analysis,2,3,15,23,"The microarray analysis and functional experiments indicated that breast tumour cell-derived exosomes (TDEs) could transmit lncRNA SNHG16, which upregulates CD73 expression, to V1 T cells.",32345959_5,0,1,-1,-1,39667,-1,7.509013e-06,0.99998426,8.174342e-06
39668,functional,4,5,28,38,"The microarray analysis and functional experiments indicated that breast tumour cell-derived exosomes (TDEs) could transmit lncRNA SNHG16, which upregulates CD73 expression, to V1 T cells.",32345959_5,0,1,2,-1,39668,-1,0.00030448803,0.99947494,0.00022056713
39670,tumour cell-derived,9,11,73,92,"The microarray analysis and functional experiments indicated that breast tumour cell-derived exosomes (TDEs) could transmit lncRNA SNHG16, which upregulates CD73 expression, to V1 T cells.",32345959_5,-1,-1,-1,-1,39670,-1,0.00016433913,0.00055278314,0.9992829
39676,to the,17,19,83,89,"Regarding the mechanism, SNHG16 served as a ceRNA by sponging miR-16-5p, which led to the derepression of its target gene SMAD5 and resulted in potentiation of the TGF-1/SMAD5 pathway to upregulate CD73 expression in V1 T cells.",32345959_6,-1,-1,-1,-1,39676,-1,3.8377793e-06,0.999992,4.174249e-06
39677,target gene SMAD5,22,25,110,127,"Regarding the mechanism, SNHG16 served as a ceRNA by sponging miR-16-5p, which led to the derepression of its target gene SMAD5 and resulted in potentiation of the TGF-1/SMAD5 pathway to upregulate CD73 expression in V1 T cells.",32345959_6,-1,-1,-1,-1,39677,-1,1.0986905e-05,0.99997663,1.239395e-05
39681,that the,3,5,19,27,"Our results showed that the BC-derived exosomal SNHG16/miR-16-5p/SMAD5-regulatory axis potentiates TGF-1/SMAD5 pathway activation, thus inducing CD73 expression in V1 T cells.",32345959_7,-1,-1,-1,-1,39681,-1,3.9599395e-06,0.99999213,3.9051256e-06
39686,therapy targeting this,13,16,73,95,"Our results first identify the significance of CD73+V1 Tregs in BC, and therapy targeting this subpopulation or blocking TDEs might have potential for BC treatment in the future.",32345959_8,-1,-1,-1,-1,39686,-1,3.5755852e-06,0.9999925,3.9593447e-06
39702,to the,6,8,40,46,"In addition, gut microbiota contributes to the development and progression of CAC.",32357539_4,-1,-1,-1,-1,39702,-1,5.808077e-06,0.99998856,5.675546e-06
39711,receptor,3,4,30,38,"Although the estrogen-related receptor alpha (ERR) has been implicated in breast cancer cell dissemination to the bone from the primary tumor, its role after tumor cell anchorage in the bone microenvironment remains elusive.",32366476_1,0,1,2,-1,39711,-1,0.0011495829,0.19868967,0.8001607
39713,to the,16,18,108,114,"Although the estrogen-related receptor alpha (ERR) has been implicated in breast cancer cell dissemination to the bone from the primary tumor, its role after tumor cell anchorage in the bone microenvironment remains elusive.",32366476_1,-1,-1,-1,-1,39713,-1,1.4873859e-05,0.99996805,1.7101906e-05
39716,tumor cell,27,29,159,169,"Although the estrogen-related receptor alpha (ERR) has been implicated in breast cancer cell dissemination to the bone from the primary tumor, its role after tumor cell anchorage in the bone microenvironment remains elusive.",32366476_1,-1,-1,-1,-1,39716,-1,4.971875e-05,9.835192e-05,0.99985194
39723,chemokines CCL17,11,13,78,94,Overexpression of ERR in breast cancer bone metastases induced expression of chemokines CCL17 and CCL20 and repressed production of TGF3.,32366476_3,-1,-1,-1,-1,39723,-1,0.9998901,1.6531772e-05,9.329977e-05
39739,the immune response,10,13,62,81,"SIGNIFICANCE: This study places ERR at the interplay between the immune response and bone metastases of breast cancer, highlighting a potential target for intervention in advanced disease.",32366476_7,-1,-1,-1,-1,39739,-1,0.62996244,0.36765268,0.0023847858
39750,protein,39,40,232,239,"AIM: To compare cytokine patterns of active IBD patients with early and advanced CRC.METHODS: Choosing a panel of cytokines crucial for Th17/Treg differentiation and behavior, in colon specimens, as mRNA biomarkers, and their serum protein levels.",32390702_2,0,1,-1,-1,39750,-1,0.000897879,0.99900776,9.4354225e-05
39760,The protein,0,2,0,11,The protein levels of the cytokines were significantly higher in CRC patients compared to IBD patients.,32390702_5,-1,-1,-1,-1,39760,-1,1.2421779e-05,0.99998033,7.2133066e-06
39761,the cytokines,4,6,22,35,The protein levels of the cytokines were significantly higher in CRC patients compared to IBD patients.,32390702_5,-1,-1,-1,-1,39761,-1,0.6918363,0.30384257,0.004321089
39763,that IL-6,5,7,32,41,"CONCLUSION: Our findings showed that IL-6 upregulation is essential for both IBD and CRC development until the upregulation of other Th17/Treg related genes (TGFb1, IL-10, IL-23, and transcription factor FoxP3) is a crucial primarily for CRC development.",32390702_6,-1,-1,-1,-1,39763,-1,0.909574,0.08810934,0.002316703
39765,related genes,22,24,143,156,"CONCLUSION: Our findings showed that IL-6 upregulation is essential for both IBD and CRC development until the upregulation of other Th17/Treg related genes (TGFb1, IL-10, IL-23, and transcription factor FoxP3) is a crucial primarily for CRC development.",32390702_6,-1,-1,-1,-1,39765,-1,6.092766e-06,0.9999858,8.057044e-06
39768,transcription factor FoxP3,32,35,183,209,"CONCLUSION: Our findings showed that IL-6 upregulation is essential for both IBD and CRC development until the upregulation of other Th17/Treg related genes (TGFb1, IL-10, IL-23, and transcription factor FoxP3) is a crucial primarily for CRC development.",32390702_6,-1,-1,-1,-1,39768,-1,5.8041896e-06,0.99998856,5.593009e-06
39777,deficiency,30,31,141,151,Background: The role of T cell Ig and ITIM domain (TIGIT) and programmed cell death-1 (PD-1) in colorectal cancer (CRC) with mismatch repair deficiency is unknown.,32397769_0,0,1,-1,-1,39777,-1,0.0039020537,0.99574417,0.0003537509
39780,deficiency,13,14,66,76,"Methods: This was a study of 60 CRC patients with mismatch repair deficiency and 30 healthy controls between June 2015 and October 2015.Results: The expression of Foxp3, PD-1, and TIGIT was higher in cancer tissues compared with adjacent mucosa (all P <.05).",32397769_1,0,1,-1,-1,39780,-1,0.08118312,0.91271245,0.0061043855
39785,tissues,38,39,207,214,"Methods: This was a study of 60 CRC patients with mismatch repair deficiency and 30 healthy controls between June 2015 and October 2015.Results: The expression of Foxp3, PD-1, and TIGIT was higher in cancer tissues compared with adjacent mucosa (all P <.05).",32397769_1,-1,1,2,-1,39785,-1,0.00044375117,0.029980857,0.96957546
39793,than those,18,20,89,99,"The overall survival (OS) of the patients with CRC and high expression of PD-1 was worse than those with low expression (HR=4.01, 95%CI:1.26-12.69, P =.019).Conclusion: TIGIT and PD-1 are upregulated in CRC with mismatch repair deficiency and associated with TNM stage and DFS.",32397769_4,-1,-1,-1,-1,39793,-1,7.5596035e-06,0.9999851,7.334374e-06
39796,deficiency,49,50,231,241,"The overall survival (OS) of the patients with CRC and high expression of PD-1 was worse than those with low expression (HR=4.01, 95%CI:1.26-12.69, P =.019).Conclusion: TIGIT and PD-1 are upregulated in CRC with mismatch repair deficiency and associated with TNM stage and DFS.",32397769_4,0,1,-1,-1,39796,-1,0.6960427,0.29451242,0.009444817
39798,Tissue-resident,0,1,0,15,Tissue-resident memory (Trm) cells are specialized components of both CD4+ and CD8+ T cell subsets that persist in peripheral nonlymphoid tissues following infections and provide fast response in case of a secondary invasion by the same pathogen.,32441311_0,-1,1,2,-1,39798,-1,4.9602688e-05,0.99988663,6.371243e-05
39801,CD8+ T cell subsets that,14,20,79,103,Tissue-resident memory (Trm) cells are specialized components of both CD4+ and CD8+ T cell subsets that persist in peripheral nonlymphoid tissues following infections and provide fast response in case of a secondary invasion by the same pathogen.,32441311_0,-1,-1,-1,-1,39801,-1,0.0016363951,0.0042515798,0.9941121
39802,tissues,24,25,138,145,Tissue-resident memory (Trm) cells are specialized components of both CD4+ and CD8+ T cell subsets that persist in peripheral nonlymphoid tissues following infections and provide fast response in case of a secondary invasion by the same pathogen.,32441311_0,-1,1,2,-1,39802,-1,6.44347e-05,0.99789494,0.0020406796
39804,Trm cells,0,2,0,9,"Trm cells express the surface markers CD69, CD103, and the immune checkpoint molecule PD-1.",32441311_1,-1,-1,-1,-1,39804,-1,1.5561065e-05,2.3373519e-05,0.999961
39807,Trm cells,0,2,0,9,"Trm cells develop not only in the context of infections but also in tumors, where they can provide a line of defense as suggested by the positive correlation between the frequency of tumor-infiltrating Trm cells and patients' survival.",32441311_2,-1,-1,-1,-1,39807,-1,2.7428607e-05,5.9991857e-05,0.9999126
39813,tumor-infiltrating Trm cells,33,36,183,211,"Trm cells develop not only in the context of infections but also in tumors, where they can provide a line of defense as suggested by the positive correlation between the frequency of tumor-infiltrating Trm cells and patients' survival.",32441311_2,-1,-1,-1,-1,39813,-1,0.0020853619,0.88710964,0.11080498
39814,Trm cells,0,2,0,9,"Trm cells persistence in peripheral tissues depends on their adaptation to the local microenvironment and the presence of survival factors, mainly IL-7, IL-15, and Notch ligands.",32441311_3,-1,-1,-1,-1,39814,-1,2.6073298e-05,6.180451e-05,0.99991214
39815,tissues,5,6,36,43,"Trm cells persistence in peripheral tissues depends on their adaptation to the local microenvironment and the presence of survival factors, mainly IL-7, IL-15, and Notch ligands.",32441311_3,-1,1,2,-1,39815,-1,0.0011610454,0.5622637,0.43657523
39817,to the,10,12,72,78,"Trm cells persistence in peripheral tissues depends on their adaptation to the local microenvironment and the presence of survival factors, mainly IL-7, IL-15, and Notch ligands.",32441311_3,-1,-1,-1,-1,39817,-1,6.791211e-06,0.99998486,8.352727e-06
39819,factors,19,20,131,138,"Trm cells persistence in peripheral tissues depends on their adaptation to the local microenvironment and the presence of survival factors, mainly IL-7, IL-15, and Notch ligands.",32441311_3,0,1,-1,-1,39819,-1,0.9999248,2.9526811e-05,4.5633165e-05
39822,the cell,2,4,9,17,"However, the cell sources of these factors are largely unknown, especially in the context of tumors.",32441311_4,-1,-1,-1,-1,39822,-1,6.043691e-05,6.494443e-05,0.9998746
39823,these factors,6,8,29,42,"However, the cell sources of these factors are largely unknown, especially in the context of tumors.",32441311_4,-1,-1,-1,-1,39823,-1,0.0001419298,0.9998436,1.4418555e-05
39831,cells that,7,9,43,53,"Moreover, we show that mesenchymal stromal cells that accumulate in HNSCC are a source of survival factors and allow proper expression of Trm-typical markers in a VCAM1-dependent manner.",32441311_6,-1,-1,-1,-1,39831,-1,0.0040077856,0.20755146,0.7884407
39832,factors,17,18,99,106,"Moreover, we show that mesenchymal stromal cells that accumulate in HNSCC are a source of survival factors and allow proper expression of Trm-typical markers in a VCAM1-dependent manner.",32441311_6,0,1,-1,-1,39832,-1,0.7209649,0.27833837,0.00069669605
39839,factor,6,7,26,32,"A viral gene, HTLV-1 bZIP factor (HBZ), induces pathogenic Foxp3-expressing T cells and triggers systemic inflammation and T cell lymphoma in transgenic mice, indicating its significance in HTLV-1-associated diseases.",32471947_1,0,1,-1,-1,39839,-1,4.705027e-05,0.99993277,2.0195565e-05
39840,Foxp3-expressing T cells,13,16,59,83,"A viral gene, HTLV-1 bZIP factor (HBZ), induces pathogenic Foxp3-expressing T cells and triggers systemic inflammation and T cell lymphoma in transgenic mice, indicating its significance in HTLV-1-associated diseases.",32471947_1,-1,-1,-1,-1,39840,-1,0.001318982,0.90065396,0.098027125
39851,that IL-6 functions,9,12,69,88,"IL-6 innately inhibits regulatory T cell differentiation, suggesting that IL-6 functions as a suppressor against HBZ-associated complications.",32471947_4,-1,-1,-1,-1,39851,-1,0.0025527617,0.9972517,0.00019549012
39853,cytokine IL-10,6,8,53,67,HBZ up-regulates expression of the immunosuppressive cytokine IL-10.,32471947_5,-1,-1,-1,-1,39853,-1,0.9999645,5.4667917e-06,2.9987888e-05
39877,transcription factor forkhead box protein P3,19,25,100,144,Regulatory T cells (Tregs) is one of the immunosuppressive subsets of CD4+ T cells characterized by transcription factor forkhead box protein P3 (FOXP3) expression which are involved in tumor development and progression.,32480291_0,-1,-1,-1,-1,39877,-1,6.974322e-06,0.9999869,6.08751e-06
39880,the factors that,2,5,18,34,Identification of the factors that influence Treg cell function is extremely important.,32480291_1,-1,-1,-1,-1,39880,-1,1.0544698e-05,0.9999839,5.5476958e-06
39881,Treg cell function,6,9,45,63,Identification of the factors that influence Treg cell function is extremely important.,32480291_1,-1,-1,-1,-1,39881,-1,2.0729718e-05,2.2112574e-05,0.9999571
39896,TNF-,22,23,102,107,"Plasma levels of IL-10, transcription factor  (TGF-), IL-6, IL-17, IL-23 and tumor necrosis factor (TNF-) were measured by Enzyme-linked immunosorbent assay (ELISA).",32480291_4,0,1,-1,-1,39896,-1,0.010311184,0.9893679,0.00032092986
39902,TNF-,27,28,93,98,"There was a significant elevation in IL-10 (p < 0.05), IL-6 (p < 0.01), IL-23 (p < 0.05) and TNF- (p < 0.01) in ALL patients compared with controls.",32480291_7,0,1,-1,-1,39902,-1,0.0008570595,0.99906904,7.3964846e-05
39907,related cytokines,13,15,75,92,"In conclusion, the slight change in Treg cells frequency and alteration in related cytokines could possibly involve in the pathogenesis of ALL.",32480291_11,-1,-1,-1,-1,39907,-1,0.7696306,0.22490844,0.005460939
39909,to these,12,14,80,88,"Dysregulated miRNAs, as a regulatory mechanism of epigenetics, might contribute to these observed results.",32480291_12,-1,-1,-1,-1,39909,-1,9.171004e-06,0.99998546,5.3995163e-06
39912,antigen-presenting cells that,7,10,35,64,"Dendritic cells (DCs) are powerful antigen-presenting cells that are often used to evaluate adjuvants, particularly for adjuvant selection for various vaccines.",32486094_0,-1,-1,-1,-1,39912,-1,0.990252,0.0052017877,0.004546225
39921,functional,19,20,117,127,"We first confirmed the phenotypic (surface molecules, cytokines, antigen uptake, and antigen-presenting ability) and functional alterations (T cell proliferation/activation) of DCs in vitro.",32486094_2,0,1,2,-1,39921,-1,0.0040885145,0.99197245,0.003939077
39924,immunity,11,12,76,84,We also confirmed the adjuvant effect by evaluating anti-tumor activity and immunity using an ALP-treated DC-immunized mouse model.,32486094_3,0,-1,2,-1,39924,-1,0.99981874,6.190349e-05,0.00011937572
39925,functionally,1,2,4,16,"ALP functionally induced DC maturation by up-regulating the secretion of Th1-polarizing pro-inflammatory cytokines, the expression of surface molecules, and antigen-presenting ability.",32486094_4,0,1,2,-1,39925,-1,0.0006512983,0.9992906,5.8147303e-05
39935,naive T cells to Th1,8,13,60,80,ALP-activated DCs showed an ample capacity to differentiate naive T cells to Th1 and activated CD8+ T cells effectively.,32486094_6,-1,-1,-1,-1,39935,-1,4.322959e-05,0.9997875,0.00016923308
39939,peptides,10,11,64,72,"The systemic administration of DCs that pulse ALP and ovalbumin peptides strongly increased cytotoxic T lymphocyte (CTL) activity (by 9.5% compared to that in the control vaccine groups), the generation of CD107a-producing multifunctional T cells, and Th1-mediated humoral immunity, and caused a significant reduction (increased protection by 29% over that in control vaccine groups) in tumor growth.",32486094_7,0,-1,2,-1,39939,-1,0.92633367,0.053076092,0.0205902
39942,to that,25,27,148,155,"The systemic administration of DCs that pulse ALP and ovalbumin peptides strongly increased cytotoxic T lymphocyte (CTL) activity (by 9.5% compared to that in the control vaccine groups), the generation of CD107a-producing multifunctional T cells, and Th1-mediated humoral immunity, and caused a significant reduction (increased protection by 29% over that in control vaccine groups) in tumor growth.",32486094_7,-1,-1,-1,-1,39942,-1,5.706417e-06,0.9999887,5.66565e-06
39944,the generation,34,36,188,202,"The systemic administration of DCs that pulse ALP and ovalbumin peptides strongly increased cytotoxic T lymphocyte (CTL) activity (by 9.5% compared to that in the control vaccine groups), the generation of CD107a-producing multifunctional T cells, and Th1-mediated humoral immunity, and caused a significant reduction (increased protection by 29% over that in control vaccine groups) in tumor growth.",32486094_7,-1,-1,-1,-1,39944,-1,6.18529e-06,0.9999876,6.255515e-06
39947,immunity,45,46,273,281,"The systemic administration of DCs that pulse ALP and ovalbumin peptides strongly increased cytotoxic T lymphocyte (CTL) activity (by 9.5% compared to that in the control vaccine groups), the generation of CD107a-producing multifunctional T cells, and Th1-mediated humoral immunity, and caused a significant reduction (increased protection by 29% over that in control vaccine groups) in tumor growth.",32486094_7,0,-1,2,-1,39947,-1,0.9998266,3.4448713e-05,0.00013901167
39950,triggers the Th1,3,6,11,27,"ALP, which triggers the Th1 and CTL response, provides a basis for a new adjuvant for various vaccines.",32486094_8,-1,-1,-1,-1,39950,-1,9.337617e-06,0.9999727,1.795179e-05
39952,CD8+ T cell trafficking to the tumor,2,10,12,48,BACKGROUND: CD8+ T cell trafficking to the tumor site is essential for effective colorectal cancer (CRC) immunotherapy.,32503584_0,-1,-1,-1,-1,39952,-1,0.0037583052,0.047637943,0.94860375
39955,tumor tissues,12,14,73,86,"However, the mechanism underlying CD8+ T cell infiltration in colorectal tumor tissues is not fully understood.",32503584_1,-1,-1,-1,-1,39955,-1,0.000155899,0.99578506,0.0040589883
39958,tissues,14,15,70,77,"In the present study, we investigated CD8+ T cell infiltration in CRC tissues and the role of chemokine-chemokine receptor signaling in regulation of T cell recruitment.",32503584_2,-1,1,2,-1,39958,-1,0.0006127929,0.8058972,0.19349006
39960,chemokine-chemokine receptor,19,21,94,122,"In the present study, we investigated CD8+ T cell infiltration in CRC tissues and the role of chemokine-chemokine receptor signaling in regulation of T cell recruitment.",32503584_2,-1,-1,-1,-1,39960,-1,0.999874,9.507044e-06,0.00011639917
39965,tissues,12,13,71,78,METHODS: We screened chemokines and cytokines in healthy donor and CRC tissues from early- and advanced-stage patients using multiplex assays and PCR screening.,32503584_3,-1,1,2,-1,39965,-1,0.00030142962,0.005469135,0.99422944
39967,tumor tissues,4,6,23,36,"RESULTS: Compared with tumor tissues of early-stage CRC patients, CD8+ T cell density was lower in advanced-stage tumor tissues.",32503584_5,-1,-1,-1,-1,39967,-1,7.852447e-06,0.9999628,2.9291998e-05
39969,tumor tissues,20,22,114,127,"RESULTS: Compared with tumor tissues of early-stage CRC patients, CD8+ T cell density was lower in advanced-stage tumor tissues.",32503584_5,-1,-1,-1,-1,39969,-1,7.712958e-06,0.9999627,2.95777e-05
39970,that CXCL10,3,5,21,32,PCR screening showed that CXCL10 levels were significantly increased in advanced-stage tumor tissues.,32503584_6,-1,-1,-1,-1,39970,-1,0.93480426,0.063179955,0.0020157993
39971,tumor tissues,11,13,87,100,PCR screening showed that CXCL10 levels were significantly increased in advanced-stage tumor tissues.,32503584_6,-1,-1,-1,-1,39971,-1,1.9751593e-05,0.9997453,0.00023493869
39972,the receptor,2,4,7,19,CXCR3 (the receptor of CXCL10) expression on CD8+ T cells was lower in the peripheral blood of advanced-stage patients.,32503584_7,-1,-1,-1,-1,39972,-1,0.0002833514,0.99936754,0.00034915164
39976,blood,18,19,86,91,CXCR3 (the receptor of CXCL10) expression on CD8+ T cells was lower in the peripheral blood of advanced-stage patients.,32503584_7,0,1,-1,-1,39976,-1,9.446901e-05,0.9997787,0.0001268733
39978,T cells to CXCL10,6,10,30,47,The migratory ability of CD8+ T cells to CXCL10 depended on CXCR3 expression.,32503584_8,-1,-1,-1,-1,39978,-1,0.83415633,0.001941456,0.16390227
39979,that IL-17A,3,5,24,35,"Multiplex arrays showed that IL-17A was increased in advanced-stage patient sera, which markedly downregulated CXCR3 expression via activating STAT3 signaling and reduced CD8+ T cell migration.",32503584_9,-1,-1,-1,-1,39979,-1,0.9207493,0.07647705,0.0027736514
39984,Th17 cell,12,14,64,73,Similar results were found after CD8+ T cells were treated with Th17 cell supernatant.,32503584_10,-1,-1,-1,-1,39984,-1,0.00051896303,0.021836728,0.97764426
39985,the STAT3,3,5,22,31,"Adding anti-IL-17A or the STAT3 inhibitor, Stattic, rescued these effects in vitro and in vivo.",32503584_11,-1,-1,-1,-1,39985,-1,6.2668096e-06,0.99998903,4.7188473e-06
39988,analysis,3,4,19,27,"Moreover, survival analysis showed that patients with low CD8 and CXCR3 expression and high IL-17A levels had significantly worse prognosis.",32503584_12,0,1,-1,-1,39988,-1,1.1313413e-05,0.99998105,7.632958e-06
39993,Th17 cells,14,16,94,104,CONCLUSIONS: CD8+ T cell infiltration in advanced-stage tumor was systematically inhibited by Th17 cells via IL-17A/STAT3/CXCR3 axis.,32503584_13,-1,-1,-1,-1,39993,-1,0.00021693436,0.002844321,0.9969388
39994,that the T cell,3,7,22,37,Our findings indicate that the T cell infiltration in the tumor microenvironment may be improved by inhibiting STAT3 signaling.,32503584_14,-1,-1,-1,-1,39994,-1,0.0032688612,0.6256209,0.37111017
39995,the tumor,9,11,54,63,Our findings indicate that the T cell infiltration in the tumor microenvironment may be improved by inhibiting STAT3 signaling.,32503584_14,-1,-1,-1,-1,39995,-1,4.4724147e-06,0.9999914,4.112714e-06
40000,functionally,10,11,53,65,Regulatory T (Treg) cell populations are composed of functionally quiescent resting Treg (rTreg) cells which differentiate into activated Treg (aTreg) cells upon antigen stimulation.,32515782_0,0,1,2,-1,40000,-1,2.7645865e-05,0.9999573,1.5065913e-05
40009,The transcription factor,0,3,0,24,"The transcription factor BACH2 is critical for early Treg lineage specification, but its function following lineage commitment is unresolved.",32515782_2,-1,-1,-1,-1,40009,-1,7.3836786e-06,0.99998844,4.173864e-06
40011,function,14,15,89,97,"The transcription factor BACH2 is critical for early Treg lineage specification, but its function following lineage commitment is unresolved.",32515782_2,0,1,2,-1,40011,-1,5.3451553e-05,0.99993217,1.4424853e-05
40021,their TCR-driven,16,18,98,114,"In rTreg cells, BACH2 binds to enhancers of genes involved in aTreg differentiation and represses their TCR-driven induction by competing with AP-1 factors for DNA binding.",32515782_5,-1,-1,-1,-1,40021,-1,8.873417e-06,0.99998236,8.80685e-06
40022,AP-1 factors,22,24,143,155,"In rTreg cells, BACH2 binds to enhancers of genes involved in aTreg differentiation and represses their TCR-driven induction by competing with AP-1 factors for DNA binding.",32515782_5,-1,-1,-1,-1,40022,-1,7.0455026e-06,0.99998665,6.346213e-06
40024,This function,0,2,0,13,This function promotes rTreg cell quiescence and long-term maintenance and is required for immune homeostasis and durable immunosuppression in cancer.,32515782_6,-1,-1,-1,-1,40024,-1,8.554354e-06,0.9999839,7.581398e-06
40030,function,22,23,125,133,"Thus, BACH2 supports a ""division of labor"" between quiescent rTreg cells and their activated progeny in Treg maintenance and function, respectively.",32515782_7,0,1,2,-1,40030,-1,3.1190575e-05,0.9999392,2.9657704e-05
40036,Tfh subset,27,29,150,160,"Based on CD25 expression, T follicular helper cells (Tfh) could be divided into T follicular regulatory (Tfr)-like subset (CD25+CD4+CXCR5+) and CD25- Tfh subset (CD25-CD4+CXCR5+).",32534760_0,-1,-1,-1,-1,40036,-1,0.0012142415,0.6013595,0.39742625
40038,Tfr-like cells in blood,14,18,74,97,Patients with diffuse large B cell lymphoma (DLBCL) display high level of Tfr-like cells in blood and tumor.,32534760_1,-1,-1,-1,-1,40038,-1,8.373969e-05,0.99931157,0.00060470455
40040,This Tfr-like subset,0,3,0,20,This Tfr-like subset could suppress CD8 T cell response while promote tumor cell proliferation.,32534760_2,-1,-1,-1,-1,40040,-1,0.0009943433,0.9270506,0.07195508
40042,tumor cell,11,13,70,80,This Tfr-like subset could suppress CD8 T cell response while promote tumor cell proliferation.,32534760_2,-1,-1,-1,-1,40042,-1,5.6318473e-05,0.0001822689,0.9997614
40044,the transcription factors,6,9,31,56,"In this study, we investigated the transcription factors and regulatory elements associated with Tfr-like cells in DLBCL patients.",32534760_3,-1,-1,-1,-1,40044,-1,3.947039e-06,0.9999914,4.621184e-06
40045,Tfr-like cells,14,16,97,111,"In this study, we investigated the transcription factors and regulatory elements associated with Tfr-like cells in DLBCL patients.",32534760_3,-1,-1,-1,-1,40045,-1,0.0009420619,0.14151555,0.85754246
40046,tumor-infiltrating Tfr-like cells,3,6,21,54,Both circulating and tumor-infiltrating Tfr-like cells presented slightly higher Blimp-1 expression and significantly higher Foxp3 expression than the CD25- Tfh subset.,32534760_4,-1,-1,-1,-1,40046,-1,0.0016704679,0.89197725,0.10635232
40049,than the,16,18,142,150,Both circulating and tumor-infiltrating Tfr-like cells presented slightly higher Blimp-1 expression and significantly higher Foxp3 expression than the CD25- Tfh subset.,32534760_4,-1,-1,-1,-1,40049,-1,4.4470253e-06,0.9999918,3.8148223e-06
40050,Tfh subset,19,21,157,167,Both circulating and tumor-infiltrating Tfr-like cells presented slightly higher Blimp-1 expression and significantly higher Foxp3 expression than the CD25- Tfh subset.,32534760_4,-1,-1,-1,-1,40050,-1,0.0013832719,0.57745653,0.4211602
40052,receptor,3,4,12,20,"As the IL-2 receptor, CD25 could be moderately upregulated in stimulated CD25- Tfh cells.",32534760_5,0,1,2,-1,40052,-1,0.09101144,0.013745201,0.8952434
40053,Tfh cells,13,15,79,88,"As the IL-2 receptor, CD25 could be moderately upregulated in stimulated CD25- Tfh cells.",32534760_5,-1,-1,-1,-1,40053,-1,0.00018625161,0.0058178995,0.9939958
40054,Tfh cells,4,6,26,35,"However, stimulated CD25- Tfh cells could not upregulate Foxp3, indicating that the distinction between Foxp3-low CD25-CXCR5+CD4+ T cells and Foxp3-high CD25+CXCR5+CD4+ T cells was not due to differences in stimulation status.",32534760_6,-1,-1,-1,-1,40054,-1,0.0006212743,0.049420718,0.949958
40056,that the,12,14,75,83,"However, stimulated CD25- Tfh cells could not upregulate Foxp3, indicating that the distinction between Foxp3-low CD25-CXCR5+CD4+ T cells and Foxp3-high CD25+CXCR5+CD4+ T cells was not due to differences in stimulation status.",32534760_6,-1,-1,-1,-1,40056,-1,4.77769e-06,0.9999914,3.858449e-06
40065,Tfh cells,9,11,61,70,"Regarding cytokine production, while both Tfr-like and CD25- Tfh cells upregulated IL-21 and IL-10 during stimulation, the CD25- Tfh cells presented significantly higher IL-21 and lower IL-10 expression than the Tfr-like cells, and the TGF- expression was only increased in Tfr-like cells.",32534760_7,-1,-1,-1,-1,40065,-1,0.00018250714,0.008605383,0.99121207
40068,Tfh cells,20,22,129,138,"Regarding cytokine production, while both Tfr-like and CD25- Tfh cells upregulated IL-21 and IL-10 during stimulation, the CD25- Tfh cells presented significantly higher IL-21 and lower IL-10 expression than the Tfr-like cells, and the TGF- expression was only increased in Tfr-like cells.",32534760_7,-1,-1,-1,-1,40068,-1,0.0002319099,0.012266472,0.9875016
40070,than the Tfr-like cells,30,34,203,226,"Regarding cytokine production, while both Tfr-like and CD25- Tfh cells upregulated IL-21 and IL-10 during stimulation, the CD25- Tfh cells presented significantly higher IL-21 and lower IL-10 expression than the Tfr-like cells, and the TGF- expression was only increased in Tfr-like cells.",32534760_7,-1,-1,-1,-1,40070,-1,0.0017908363,0.8413995,0.1568097
40071,the TGF-,36,38,232,241,"Regarding cytokine production, while both Tfr-like and CD25- Tfh cells upregulated IL-21 and IL-10 during stimulation, the CD25- Tfh cells presented significantly higher IL-21 and lower IL-10 expression than the Tfr-like cells, and the TGF- expression was only increased in Tfr-like cells.",32534760_7,-1,-1,-1,-1,40071,-1,7.79615e-06,0.999987,5.2521887e-06
40072,Tfr-like cells,43,45,275,289,"Regarding cytokine production, while both Tfr-like and CD25- Tfh cells upregulated IL-21 and IL-10 during stimulation, the CD25- Tfh cells presented significantly higher IL-21 and lower IL-10 expression than the Tfr-like cells, and the TGF- expression was only increased in Tfr-like cells.",32534760_7,-1,-1,-1,-1,40072,-1,0.0011938448,0.42424536,0.57456076
40073,Tfh cells,6,8,41,50,"Interestingly, IL-21 secreted from CD25- Tfh cells negatively regulated the expression of Foxp3 and IL-10 of autologous Tfr-like cells.",32534760_8,-1,-1,-1,-1,40073,-1,0.00031040242,0.019837633,0.979852
40077,Tfr-like cells,18,20,120,134,"Interestingly, IL-21 secreted from CD25- Tfh cells negatively regulated the expression of Foxp3 and IL-10 of autologous Tfr-like cells.",32534760_8,-1,-1,-1,-1,40077,-1,0.0013991249,0.29929364,0.6993073
40080,that the Tfr-like,5,8,37,54,"Together, these results demonstrated that the Tfr-like and CD25- Tfh subsets of circulating Tfh cells presented different functions and should be investigated separately.",32534760_9,-1,-1,-1,-1,40080,-1,7.1993472e-06,0.99998295,9.827756e-06
40081,Tfh subsets,10,12,65,76,"Together, these results demonstrated that the Tfr-like and CD25- Tfh subsets of circulating Tfh cells presented different functions and should be investigated separately.",32534760_9,-1,-1,-1,-1,40081,-1,0.0014723735,0.18207997,0.8164477
40082,Tfh cells,14,16,92,101,"Together, these results demonstrated that the Tfr-like and CD25- Tfh subsets of circulating Tfh cells presented different functions and should be investigated separately.",32534760_9,-1,-1,-1,-1,40082,-1,0.0005338302,0.02056634,0.9788998
40083,functions,18,19,122,131,"Together, these results demonstrated that the Tfr-like and CD25- Tfh subsets of circulating Tfh cells presented different functions and should be investigated separately.",32534760_9,0,1,2,-1,40083,-1,0.0052938485,0.9577264,0.03697971
40088,peptides that,18,20,139,152,PDS0101 is a liposomal-based HPV therapeutic vaccine consisting of the immune activating cationic lipid R-DOTAP and HLA-unrestricted HPV16 peptides that has shown in vivo CD8+ Tcell induction and safety in a phase I study.,32554612_1,-1,-1,-1,-1,40088,-1,3.824226e-05,0.9999279,3.389789e-05
40092,two immune modulators,11,14,58,79,"In this report, we have employed the PDS0101 vaccine with two immune modulators previously characterized in preclinical studies and which are currently in phase II clinical trials.",32554612_2,-1,-1,-1,-1,40092,-1,0.8568274,0.13701628,0.0061564203
40094,Bintrafusp alfa,0,2,0,15,"Bintrafusp alfa (M7824) is a first-in-class bifunctional fusion protein composed of the extracellular domains of the transforming growth factor- receptor type II (TGFRII) fused to a human IgG1 monoclonal antibody blocking programmed cell death protein-1 ligand (PDL1), designed both as a checkpoint inhibitor and to bring the TGFRII 'trap' to the tumor microenvironment (TME).",32554612_3,-1,-1,-1,-1,40094,-1,0.12091667,0.875929,0.0031543786
40095,protein,10,11,64,71,"Bintrafusp alfa (M7824) is a first-in-class bifunctional fusion protein composed of the extracellular domains of the transforming growth factor- receptor type II (TGFRII) fused to a human IgG1 monoclonal antibody blocking programmed cell death protein-1 ligand (PDL1), designed both as a checkpoint inhibitor and to bring the TGFRII 'trap' to the tumor microenvironment (TME).",32554612_3,0,1,-1,-1,40095,-1,6.442341e-06,0.99998856,4.953142e-06
40097,the transforming,17,19,113,129,"Bintrafusp alfa (M7824) is a first-in-class bifunctional fusion protein composed of the extracellular domains of the transforming growth factor- receptor type II (TGFRII) fused to a human IgG1 monoclonal antibody blocking programmed cell death protein-1 ligand (PDL1), designed both as a checkpoint inhibitor and to bring the TGFRII 'trap' to the tumor microenvironment (TME).",32554612_3,-1,-1,-1,-1,40097,-1,9.809987e-06,0.9999796,1.0624366e-05
40098,factor- receptor type,20,23,137,159,"Bintrafusp alfa (M7824) is a first-in-class bifunctional fusion protein composed of the extracellular domains of the transforming growth factor- receptor type II (TGFRII) fused to a human IgG1 monoclonal antibody blocking programmed cell death protein-1 ligand (PDL1), designed both as a checkpoint inhibitor and to bring the TGFRII 'trap' to the tumor microenvironment (TME).",32554612_3,-1,-1,-1,-1,40098,-1,0.993273,0.0034379358,0.0032889892
40102,protein-1,38,39,246,255,"Bintrafusp alfa (M7824) is a first-in-class bifunctional fusion protein composed of the extracellular domains of the transforming growth factor- receptor type II (TGFRII) fused to a human IgG1 monoclonal antibody blocking programmed cell death protein-1 ligand (PDL1), designed both as a checkpoint inhibitor and to bring the TGFRII 'trap' to the tumor microenvironment (TME).",32554612_3,0,1,-1,-1,40102,-1,0.33992967,0.09733464,0.5627357
40104,the TGFRII,53,55,324,335,"Bintrafusp alfa (M7824) is a first-in-class bifunctional fusion protein composed of the extracellular domains of the transforming growth factor- receptor type II (TGFRII) fused to a human IgG1 monoclonal antibody blocking programmed cell death protein-1 ligand (PDL1), designed both as a checkpoint inhibitor and to bring the TGFRII 'trap' to the tumor microenvironment (TME).",32554612_3,-1,-1,-1,-1,40104,-1,0.00017165819,0.9995371,0.00029129424
40105,trap,56,57,337,341,"Bintrafusp alfa (M7824) is a first-in-class bifunctional fusion protein composed of the extracellular domains of the transforming growth factor- receptor type II (TGFRII) fused to a human IgG1 monoclonal antibody blocking programmed cell death protein-1 ligand (PDL1), designed both as a checkpoint inhibitor and to bring the TGFRII 'trap' to the tumor microenvironment (TME).",32554612_3,-1,1,2,-1,40105,-1,6.187475e-06,0.99998784,5.9421227e-06
40106,to the tumor,58,61,343,355,"Bintrafusp alfa (M7824) is a first-in-class bifunctional fusion protein composed of the extracellular domains of the transforming growth factor- receptor type II (TGFRII) fused to a human IgG1 monoclonal antibody blocking programmed cell death protein-1 ligand (PDL1), designed both as a checkpoint inhibitor and to bring the TGFRII 'trap' to the tumor microenvironment (TME).",32554612_3,-1,-1,-1,-1,40106,-1,5.1147567e-06,0.9999889,5.9127233e-06
40108,tumor targeting,6,8,35,50,NHS-interleukin-12 (NHS-IL12) is a tumor targeting immunocytokine designed to bring IL-12 to the TME and thus enhance the inflammatory Th1 response.,32554612_4,-1,-1,-1,-1,40108,-1,4.3351506e-06,0.99999106,4.546224e-06
40110,IL-12 to the TME,12,16,84,100,NHS-interleukin-12 (NHS-IL12) is a tumor targeting immunocytokine designed to bring IL-12 to the TME and thus enhance the inflammatory Th1 response.,32554612_4,-1,-1,-1,-1,40110,-1,0.98722935,0.011237907,0.0015327684
40115,therapy,27,28,153,160,"METHODS: We employed TC-1 carcinoma (expressing HPV16 E6 and E7 and devoid of PDL1 expression) in a syngeneic mouse model in monotherapy and combination therapy studies to analyze antitumor effects and changes in immune cell types in the spleen and the TME.RESULTS: As a monotherapy, the PDS0101 vaccine generated HPV-specific T cells and antitumor activity in mice bearing HPV-expressing mEER oropharyngeal and TC-1 lung carcinomas.",32554612_5,0,1,-1,-1,40115,-1,4.188232e-06,0.9999908,4.97886e-06
40117,cell types,37,39,220,230,"METHODS: We employed TC-1 carcinoma (expressing HPV16 E6 and E7 and devoid of PDL1 expression) in a syngeneic mouse model in monotherapy and combination therapy studies to analyze antitumor effects and changes in immune cell types in the spleen and the TME.RESULTS: As a monotherapy, the PDS0101 vaccine generated HPV-specific T cells and antitumor activity in mice bearing HPV-expressing mEER oropharyngeal and TC-1 lung carcinomas.",32554612_5,-1,-1,-1,-1,40117,-1,2.7432212e-05,1.4457124e-05,0.99995816
40124,the TC-1,6,8,30,38,"When used as a monotherapy in the TC-1 model, NHS-IL12 elicited antitumor effects as well as an increase in CD8+ T cells in the TME.",32554612_6,-1,-1,-1,-1,40124,-1,7.806023e-06,0.9999709,2.1328284e-05
40126,the TME,25,27,124,131,"When used as a monotherapy in the TC-1 model, NHS-IL12 elicited antitumor effects as well as an increase in CD8+ T cells in the TME.",32554612_6,-1,-1,-1,-1,40126,-1,5.1260636e-06,0.9999894,5.494243e-06
40127,bintrafusp alfa,6,8,28,43,"When used as a monotherapy, bintrafusp alfa did not elicit antitumor effects or any increase in T cells in the TME.",32554612_7,-1,-1,-1,-1,40127,-1,0.03058835,0.9682367,0.001174983
40129,the TME,20,22,107,114,"When used as a monotherapy, bintrafusp alfa did not elicit antitumor effects or any increase in T cells in the TME.",32554612_7,-1,-1,-1,-1,40129,-1,5.4803213e-06,0.99998915,5.3633653e-06
40133,T-cell,23,24,136,142,"When all three agents were used in combination, maximum antitumor effects were observed, which correlated with increases in T cells and T-cell clonality in the TME.CONCLUSION: These studies provide the rationale for the potential clinical use of combinations of agents that can (1) induce tumor-associated T-cell responses, (2) potentiate immune responses in the TME and (3) reduce immunosuppressive entities in the TME.",32554612_8,-1,1,2,-1,40133,-1,1.2107096e-05,6.5928994e-06,0.9999813
40139,tumor-associated T-cell,49,51,289,312,"When all three agents were used in combination, maximum antitumor effects were observed, which correlated with increases in T cells and T-cell clonality in the TME.CONCLUSION: These studies provide the rationale for the potential clinical use of combinations of agents that can (1) induce tumor-associated T-cell responses, (2) potentiate immune responses in the TME and (3) reduce immunosuppressive entities in the TME.",32554612_8,-1,-1,-1,-1,40139,-1,0.003909472,0.7768554,0.21923512
40141,the TME,60,62,359,366,"When all three agents were used in combination, maximum antitumor effects were observed, which correlated with increases in T cells and T-cell clonality in the TME.CONCLUSION: These studies provide the rationale for the potential clinical use of combinations of agents that can (1) induce tumor-associated T-cell responses, (2) potentiate immune responses in the TME and (3) reduce immunosuppressive entities in the TME.",32554612_8,-1,-1,-1,-1,40141,-1,4.748763e-06,0.9999906,4.711129e-06
40142,the TME,70,72,412,419,"When all three agents were used in combination, maximum antitumor effects were observed, which correlated with increases in T cells and T-cell clonality in the TME.CONCLUSION: These studies provide the rationale for the potential clinical use of combinations of agents that can (1) induce tumor-associated T-cell responses, (2) potentiate immune responses in the TME and (3) reduce immunosuppressive entities in the TME.",32554612_8,-1,-1,-1,-1,40142,-1,4.8377838e-06,0.99999034,4.768644e-06
40164,functional,9,10,47,57,RESULTS: We found that both the phenotypic and functional maturation of dendritic cells was suppressed by the conditioned medium.,32573300_5,0,1,2,-1,40164,-1,0.09447952,0.8979797,0.007540801
40169,TNF-,5,6,28,33,"The expression of IL-12p70, TNF-, CD80, CD83, and CD86 was significantly reduced by conditioned medium from the 786-O and HeLa cell lines, and CD4+ T cells had a weaker TH1 phenotype with significantly decreased expression of IFN- and T-bet following co-culturing.",32573300_6,0,1,-1,-1,40169,-1,6.239298e-05,0.999907,3.063284e-05
40184,the tumor,17,19,117,126,"CONCLUSION: This model can be used to screen pharmacological compounds seeking to alleviate the immunosuppression of the tumor microenvironment and can furthermore be used to investigate the immunoregulatory capacities of primary cancer cells, which could be a helpful prognostic tool following tumor resection.",32573300_8,-1,-1,-1,-1,40184,-1,5.1872535e-06,0.9999901,4.670454e-06
40192,T-cell,12,13,81,87,BACKGROUND: Systemic chemotherapy is often the last resort of advanced cutaneous T-cell lymphoma (CTCL).,32573814_0,-1,1,2,-1,40192,-1,1.6139224e-05,5.8026567e-06,0.99997807
40194,adverse effects,3,5,21,36,Tumor recurrence and adverse effects of systemic chemotherapy are the main limitations.,32573814_1,0,1,-1,-1,40194,-1,0.0051031727,0.99436283,0.0005339627
40199,tumor cells,10,12,62,73,"OBJECTIVE: We aim to investigate the metabolic alterations in tumor cells after CHOP (cyclophosphamide, hydroxydaunorubicin, oncovin and prednisone) chemotherapy.",32573814_2,-1,-1,-1,-1,40199,-1,0.00019840844,0.0028318414,0.9969699
40206,tumor cell,13,15,79,89,HIF-1 is significantly elevated in lesions of advanced MF patients as well as tumor cell line Hut78 and tumor xenograft mice model.,32573814_4,-1,-1,-1,-1,40206,-1,0.0004993927,0.0153958425,0.9841047
40208,therapy,1,2,5,12,CHOP therapy also increased glycolytic activities in a HIF-1-dependent manner.,32573814_5,0,1,-1,-1,40208,-1,7.1478667e-06,0.9999877,5.160036e-06
40228,T-cell,11,12,72,78,"Tumor progression in the host leads to severe impairment of intrathymic T-cell differentiation/maturation, leading to the paralysis of cellular anti-tumor immunity.",32582141_0,-1,1,2,-1,40228,-1,1.126299e-05,5.755218e-06,0.9999831
40229,to the,15,17,115,121,"Tumor progression in the host leads to severe impairment of intrathymic T-cell differentiation/maturation, leading to the paralysis of cellular anti-tumor immunity.",32582141_0,-1,-1,-1,-1,40229,-1,4.361634e-06,0.9999914,4.2321603e-06
40231,immunity,21,22,155,163,"Tumor progression in the host leads to severe impairment of intrathymic T-cell differentiation/maturation, leading to the paralysis of cellular anti-tumor immunity.",32582141_0,0,-1,2,-1,40231,-1,0.9996013,9.98615e-05,0.00029885615
40233,thymocytes,13,14,81,91,Such suppression manifests the erosion of CD4+CD8+ double-positive (DP) immature thymocytes and a gradual increase in CD4-CD8- double negative (DN) early T-cell progenitors.,32582141_1,-1,1,2,-1,40233,-1,0.0030536915,0.5545427,0.44240355
40234,T-cell,26,27,154,160,Such suppression manifests the erosion of CD4+CD8+ double-positive (DP) immature thymocytes and a gradual increase in CD4-CD8- double negative (DN) early T-cell progenitors.,32582141_1,-1,1,2,-1,40234,-1,1.8401237e-05,8.526609e-06,0.99997306
40236,the T-cell,6,8,30,40,The impact of such changes on the T-cell progenitor pool in the context of cancer remains poorly investigated.,32582141_2,-1,-1,-1,-1,40236,-1,0.0029775996,0.2581607,0.7388616
40238,that tumor,4,6,14,24,"Here, we show that tumor progression blocks the transition of Lin-Thy1.2+CD25+CD44+c-KitlowDN2b to Lin-Thy1.2+CD25+CD44-c-Kit-DN3 in T-cell maturation, instead leading to DN2-T-cell differentiation into dendritic cells (DC).",32582141_3,-1,-1,-1,-1,40238,-1,3.764027e-06,0.999992,4.2708266e-06
40239,the transition,8,10,44,58,"Here, we show that tumor progression blocks the transition of Lin-Thy1.2+CD25+CD44+c-KitlowDN2b to Lin-Thy1.2+CD25+CD44-c-Kit-DN3 in T-cell maturation, instead leading to DN2-T-cell differentiation into dendritic cells (DC).",32582141_3,-1,-1,-1,-1,40239,-1,4.303122e-06,0.9999913,4.438422e-06
40241,T-cell,15,16,133,139,"Here, we show that tumor progression blocks the transition of Lin-Thy1.2+CD25+CD44+c-KitlowDN2b to Lin-Thy1.2+CD25+CD44-c-Kit-DN3 in T-cell maturation, instead leading to DN2-T-cell differentiation into dendritic cells (DC).",32582141_3,-1,1,2,-1,40241,-1,1.1570337e-05,5.1798725e-06,0.9999833
40244,that thymic IL-10,2,5,12,29,"We observed that thymic IL-10 expression is upregulated, particularly at cortico-medullary junctions (CMJ), under conditions of progressive disease, resulting in the termination of IL-10Rhigh DN2-T-cell maturation due to dysregulated expression of Notch1 and its target, CCR7 (thus restricting these cells to the CMJ).",32582141_4,-1,-1,-1,-1,40244,-1,0.4146032,0.5828621,0.002534689
40246,the termination,25,27,162,177,"We observed that thymic IL-10 expression is upregulated, particularly at cortico-medullary junctions (CMJ), under conditions of progressive disease, resulting in the termination of IL-10Rhigh DN2-T-cell maturation due to dysregulated expression of Notch1 and its target, CCR7 (thus restricting these cells to the CMJ).",32582141_4,-1,-1,-1,-1,40246,-1,6.183766e-06,0.99998915,4.608428e-06
40251,these cells to the,45,49,294,312,"We observed that thymic IL-10 expression is upregulated, particularly at cortico-medullary junctions (CMJ), under conditions of progressive disease, resulting in the termination of IL-10Rhigh DN2-T-cell maturation due to dysregulated expression of Notch1 and its target, CCR7 (thus restricting these cells to the CMJ).",32582141_4,-1,-1,-1,-1,40251,-1,0.0029684782,0.30584374,0.69118786
40254,that IL-10,16,18,116,126,"Intrathymic differentiation of T-cell precursors in IL-10-/- mice and in vitro fetal thymic organ cultures revealed that IL-10 promotes the interaction between thymic stromal cells and Notch1low DN2-T cells, thus facilitating these DN2-T cells to differentiate toward CD45+CD11c+MHC-II+ thymic DCs as a consequence of activating the Ikaros/IRF8 signaling axis.",32582141_5,-1,-1,-1,-1,40254,-1,0.9205172,0.07779684,0.0016860014
40261,cells to,34,36,238,246,"Intrathymic differentiation of T-cell precursors in IL-10-/- mice and in vitro fetal thymic organ cultures revealed that IL-10 promotes the interaction between thymic stromal cells and Notch1low DN2-T cells, thus facilitating these DN2-T cells to differentiate toward CD45+CD11c+MHC-II+ thymic DCs as a consequence of activating the Ikaros/IRF8 signaling axis.",32582141_5,-1,-1,-1,-1,40261,-1,0.003001711,0.22818784,0.76881045
40266,function,5,6,25,33,"We conclude that a novel function of thymically-expressed IL-10 in the tumor-bearing host diverts T-cell differentiation toward a DC pathway, thus limiting the protective adaptive immune repertoire.",32582141_6,0,1,2,-1,40266,-1,6.613539e-05,0.999908,2.5827414e-05
40267,thymically-expressed IL-10,7,9,37,63,"We conclude that a novel function of thymically-expressed IL-10 in the tumor-bearing host diverts T-cell differentiation toward a DC pathway, thus limiting the protective adaptive immune repertoire.",32582141_6,-1,-1,-1,-1,40267,-1,0.27442023,0.72355103,0.002028736
40268,the tumor-bearing,10,12,67,84,"We conclude that a novel function of thymically-expressed IL-10 in the tumor-bearing host diverts T-cell differentiation toward a DC pathway, thus limiting the protective adaptive immune repertoire.",32582141_6,-1,-1,-1,-1,40268,-1,6.178749e-06,0.9999881,5.7521243e-06
40269,T-cell differentiation toward,14,17,98,127,"We conclude that a novel function of thymically-expressed IL-10 in the tumor-bearing host diverts T-cell differentiation toward a DC pathway, thus limiting the protective adaptive immune repertoire.",32582141_6,-1,-1,-1,-1,40269,-1,0.0013829663,0.008023334,0.99059373
40270,thus limiting the,21,24,142,159,"We conclude that a novel function of thymically-expressed IL-10 in the tumor-bearing host diverts T-cell differentiation toward a DC pathway, thus limiting the protective adaptive immune repertoire.",32582141_6,-1,-1,-1,-1,40270,-1,3.9259783e-05,0.9999461,1.4565613e-05
40275,therapy,16,17,95,102,"Small molecule targeting of the essential HH effector Smoothened (SMO) has proven an effective therapy of BCC, though the frequent development of drug resistance poses major challenges to anti-HH treatments.",32615027_1,0,1,-1,-1,40275,-1,4.4528e-06,0.9999906,4.9226837e-06
40276,though the,20,22,111,121,"Small molecule targeting of the essential HH effector Smoothened (SMO) has proven an effective therapy of BCC, though the frequent development of drug resistance poses major challenges to anti-HH treatments.",32615027_1,-1,-1,-1,-1,40276,-1,6.950822e-06,0.9999858,7.2708785e-06
40288,to the,13,15,76,82,"Anti-PD-1 monotherapy, however, did not reduce tumor growth, presumably due to the lack of immunogenic mutations in common BCC mouse models, as shown by whole-exome sequencing.",32615027_5,-1,-1,-1,-1,40288,-1,7.696777e-06,0.9999875,4.7714734e-06
40300,tumors typically relapse,9,12,60,84,"Although initial treatment of ovarian cancer is successful, tumors typically relapse and become resistant to treatment.",32641415_0,-1,-1,-1,-1,40300,-1,1.1688466e-05,0.99997973,8.523179e-06
40301,to treatment,15,17,106,118,"Although initial treatment of ovarian cancer is successful, tumors typically relapse and become resistant to treatment.",32641415_0,-1,-1,-1,-1,40301,-1,7.0392853e-06,0.9999869,6.033027e-06
40311,T-cell function,15,17,87,102,"In chemosensitive conditions, secretion of sEV-pGSN was low, allowing for optimal CD8+ T-cell function.",32641415_4,-1,-1,-1,-1,40311,-1,1.7438311e-05,9.761159e-06,0.9999728
40313,T-cell,4,5,27,33,"This resulted in increased T-cell secretion of IFN, which reduced intracellular glutathione (GSH) production and sensitized chemosensitive cells to cis-diaminedichloroplatinum (CDDP)-induced apoptosis.",32641415_5,-1,1,2,-1,40313,-1,2.4215404e-05,1.4718568e-05,0.99996114
40315,chemosensitive cells to,19,22,125,148,"This resulted in increased T-cell secretion of IFN, which reduced intracellular glutathione (GSH) production and sensitized chemosensitive cells to cis-diaminedichloroplatinum (CDDP)-induced apoptosis.",32641415_5,-1,-1,-1,-1,40315,-1,0.96038383,0.025948148,0.013667939
40325,biosynthesis,12,13,100,112,"These findings support our hypothesis that sEV-pGSN attenuates immunosurveillance and regulates GSH biosynthesis, a phenomenon that contributes to chemoresistance in ovarian cancer.",32641415_8,0,1,-1,-1,40325,-1,0.00025122263,0.99952066,0.00022808644
40327,to chemoresistance,18,20,144,162,"These findings support our hypothesis that sEV-pGSN attenuates immunosurveillance and regulates GSH biosynthesis, a phenomenon that contributes to chemoresistance in ovarian cancer.",32641415_8,-1,-1,-1,-1,40327,-1,0.08510211,0.91408974,0.0008081393
40337,subunit ARID1A,15,17,90,104,"Approximately half of ovarian clear cell carcinomas (OCCC) carry mutations in the SWI/SNF subunit ARID1A, while small cell carcinoma of the ovary hypercalcemic type (SCCOHT) presents with inactivating mutations of the SWI/SNF ATPase SMARCA4 alongside epigenetic silencing of the ATPase SMARCA2.",32649682_1,-1,-1,-1,-1,40337,-1,0.00024907812,0.9989913,0.0007595711
40342,ATPase SMARCA4,37,39,226,240,"Approximately half of ovarian clear cell carcinomas (OCCC) carry mutations in the SWI/SNF subunit ARID1A, while small cell carcinoma of the ovary hypercalcemic type (SCCOHT) presents with inactivating mutations of the SWI/SNF ATPase SMARCA4 alongside epigenetic silencing of the ATPase SMARCA2.",32649682_1,-1,-1,-1,-1,40342,-1,0.0013723333,0.9981096,0.0005180399
40343,the ATPase SMARCA2,43,46,275,293,"Approximately half of ovarian clear cell carcinomas (OCCC) carry mutations in the SWI/SNF subunit ARID1A, while small cell carcinoma of the ovary hypercalcemic type (SCCOHT) presents with inactivating mutations of the SWI/SNF ATPase SMARCA4 alongside epigenetic silencing of the ATPase SMARCA2.",32649682_1,-1,-1,-1,-1,40343,-1,0.0008457332,0.9990565,9.775742e-05
40344,these ATPases,2,4,8,21,Loss of these ATPases disrupts SWI/SNF chromatin remodeling activity and may also interfere with the function of other histone-modifying enzymes that associate with or are dependent on SWI/SNF activity.,32649682_2,-1,-1,-1,-1,40344,-1,1.7127828e-05,0.9999645,1.8380733e-05
40345,the function,14,16,97,109,Loss of these ATPases disrupts SWI/SNF chromatin remodeling activity and may also interfere with the function of other histone-modifying enzymes that associate with or are dependent on SWI/SNF activity.,32649682_2,-1,-1,-1,-1,40345,-1,8.479108e-06,0.9999845,6.9916064e-06
40346,enzymes that,19,21,137,149,Loss of these ATPases disrupts SWI/SNF chromatin remodeling activity and may also interfere with the function of other histone-modifying enzymes that associate with or are dependent on SWI/SNF activity.,32649682_2,-1,-1,-1,-1,40346,-1,0.00011561457,0.99979395,9.049775e-05
40349,proteins,22,23,148,156,"One such enzyme is lysine-specific histone demethylase 1 (LSD1/KDM1A), which regulates the chromatin landscape and gene expression by demethylating proteins such as histone H3.",32649682_3,0,1,-1,-1,40349,-1,1.0023894e-05,0.9999839,6.0352936e-06
40350,analysis,1,2,13,21,Cross-cancer analysis of the TCGA database shows that LSD1 is highly expressed in SWI/SNF-mutated tumors.,32649682_4,0,1,-1,-1,40350,-1,6.3393304e-06,0.9999877,5.967552e-06
40351,the TCGA,3,5,25,33,Cross-cancer analysis of the TCGA database shows that LSD1 is highly expressed in SWI/SNF-mutated tumors.,32649682_4,-1,-1,-1,-1,40351,-1,1.5502474e-05,0.99997294,1.1612267e-05
40355,to the,8,10,50,56,"SCCOHT and OCCC cell lines have shown sensitivity to the reversible LSD1 inhibitor SP-2577 (Seclidemstat), suggesting that SWI/SNF-deficient ovarian cancers are dependent on LSD1 activity.",32649682_5,-1,-1,-1,-1,40355,-1,5.4230286e-06,0.9999894,5.1732295e-06
40359,immunity through,14,16,101,117,"Moreover, it has been shown that inhibition of LSD1 stimulates interferon (IFN)-dependent anti-tumor immunity through induction of endogenous retroviral elements and may thereby overcome resistance to checkpoint blockade.",32649682_6,-1,-1,-1,-1,40359,-1,0.5330523,0.46462548,0.0023221653
40365,immunity,13,14,76,84,"In this study, we investigated the ability of SP-2577 to promote anti-tumor immunity and T-cell infiltration in SCCOHT and OCCC cell lines.",32649682_7,0,-1,2,-1,40365,-1,0.99968016,0.0001209418,0.00019884044
40366,T-cell,15,16,89,95,"In this study, we investigated the ability of SP-2577 to promote anti-tumor immunity and T-cell infiltration in SCCOHT and OCCC cell lines.",32649682_7,-1,1,2,-1,40366,-1,1.3002099e-05,7.1890954e-06,0.99997985
40370,immunity,7,8,58,66,We found that SP-2577 stimulated IFN-dependent anti-tumor immunity in SCCOHT and promoted the expression of PD-L1 in both SCCOHT and OCCC.,32649682_8,0,-1,2,-1,40370,-1,0.9999193,2.0484114e-05,6.0226488e-05
40374,that the,5,7,33,41,"Together, these findings suggest that the combination therapy of SP-2577 with checkpoint inhibitors may induce or augment immunogenic responses of SWI/SNF-mutated ovarian cancers and warrants further investigation.",32649682_9,-1,-1,-1,-1,40374,-1,4.5033266e-06,0.9999919,3.543264e-06
40375,therapy,8,9,54,61,"Together, these findings suggest that the combination therapy of SP-2577 with checkpoint inhibitors may induce or augment immunogenic responses of SWI/SNF-mutated ovarian cancers and warrants further investigation.",32649682_9,0,1,-1,-1,40375,-1,4.9492114e-06,0.9999901,4.962227e-06
40378,tissue,7,8,41,47,The contribution of immune cells in soft tissue sarcomas (STS) is not completely known and understanding their role is very essential for employing immunotherapy strategies.,32661685_0,-1,1,2,-1,40378,-1,1.41801975e-05,0.99994445,4.1321724e-05
40389,to Treg,17,19,104,111,This increased proliferation was found to be in B cells resulting in generation of Breg further leading to Treg population.,32661685_2,-1,-1,-1,-1,40389,-1,6.3794073e-06,0.99998796,5.6896106e-06
40399,These tumor,0,2,0,11,"These tumor evoked Bregs (tBreg), when co-cultured with B depleted T cells, suppressed their proliferation in response to anti-CD3/CD28 stimulation.",32661685_5,-1,-1,-1,-1,40399,-1,4.196744e-06,0.99999154,4.3189925e-06
40409,TGF Receptor type,24,27,148,166,"tBreg-induced suppression of T cell responses wasnot abrogated by the inhibition or neutralization of IL-10 but by the small molecule inhibitor of TGF Receptor type I, SB431542.",32661685_6,-1,-1,-1,-1,40409,-1,8.436261e-06,0.99997866,1.2874353e-05
40410,to tumor cells,7,10,40,54,"While SB531542 per se was not cytotoxic to tumor cells, administration of SB431542 in tumor-bearing mice (TBM) significantly reduced the tumor burden.",32661685_7,-1,-1,-1,-1,40410,-1,0.0023281486,0.18071586,0.8169559
40413,the tumor,22,24,133,142,"While SB531542 per se was not cytotoxic to tumor cells, administration of SB431542 in tumor-bearing mice (TBM) significantly reduced the tumor burden.",32661685_7,-1,-1,-1,-1,40413,-1,4.1213443e-06,0.9999914,4.4296353e-06
40414,the treatment,3,5,13,26,"In addition, the treatment significantly reduced Treg cells and rescued proliferation of T cells in response to mitogen and allo-antigen.",32661685_8,-1,-1,-1,-1,40414,-1,4.6030086e-06,0.9999913,4.1494873e-06
40418,that tumor,5,7,35,45,"Collectively, our results identify that tumor evoked Breg cells mediate T cell immune suppression through TGF-mediated pathway and that targeting the Breg-Treg axis can be potentially used as an immunotherapy agent.",32661685_9,-1,-1,-1,-1,40418,-1,4.363465e-06,0.9999914,4.2561865e-06
40421,through TGF-mediated,15,17,98,119,"Collectively, our results identify that tumor evoked Breg cells mediate T cell immune suppression through TGF-mediated pathway and that targeting the Breg-Treg axis can be potentially used as an immunotherapy agent.",32661685_9,-1,-1,-1,-1,40421,-1,7.04156e-05,0.999864,6.555647e-05
40422,that targeting the,19,22,132,150,"Collectively, our results identify that tumor evoked Breg cells mediate T cell immune suppression through TGF-mediated pathway and that targeting the Breg-Treg axis can be potentially used as an immunotherapy agent.",32661685_9,-1,-1,-1,-1,40422,-1,3.938545e-06,0.9999924,3.7441514e-06
40429,functional,35,36,223,233,"The lamina propria of the gastrointestinal tract and other mucosal surfaces of humans and mice host a network of mononuclear phagocytes that differ in their ontogeny, surface marker and transcription factor expression, and functional specialization.",32848032_0,0,1,2,-1,40429,-1,0.0006123332,0.999171,0.0002166621
40439,that the,22,24,131,139,"In this study, we show in various Th1- and/or Th17-polarized settings of acute and chronic bacterial infection and of tumor growth that the conditional ablation of Irf4 in CD11c+ DCs results in more efficient immune control of Helicobacter pylori, Mycobacterium bovis bacillus Calmette-Gurin, and Citrobacter rodentium and of tumor growth in a syngeneic tumor model.",32848032_2,-1,-1,-1,-1,40439,-1,3.827724e-06,0.999992,4.1635385e-06
40447,to IFN--,14,16,91,100,We attribute the phenotype of IRF4DC mice to unrestricted Th1 responses and in particular to IFN-- and TNF--expressing CD4+ T cells.,32848032_3,-1,-1,-1,-1,40447,-1,0.9517668,0.04645296,0.0017801423
40448,TNF--expressing,17,18,105,121,We attribute the phenotype of IRF4DC mice to unrestricted Th1 responses and in particular to IFN-- and TNF--expressing CD4+ T cells.,32848032_3,0,1,-1,-1,40448,-1,3.6398847e-05,0.9999461,1.7467639e-05
40464,T cell therapy,17,20,106,120,In vivo expansion of adoptively transferred CD8+ T cells is a critical determinant of successful adoptive T cell therapy.,32848036_0,-1,-1,-1,-1,40464,-1,0.00050536415,0.00670912,0.9927856
40467,the tumor,15,17,108,117,Emerging evidence indicates Batf3-dependent conventional type 1 dendritic cells (cDC1s) rarely found within the tumor myeloid compartment are crucial for effector T cell recruitment to the tumor microenvironment.,32848036_1,-1,-1,-1,-1,40467,-1,4.815794e-06,0.9999912,4.0630707e-06
40469,to the tumor,26,29,182,194,Emerging evidence indicates Batf3-dependent conventional type 1 dendritic cells (cDC1s) rarely found within the tumor myeloid compartment are crucial for effector T cell recruitment to the tumor microenvironment.,32848036_1,-1,-1,-1,-1,40469,-1,6.7164488e-06,0.99998724,6.026698e-06
40480,transferred tumor-specific,10,12,79,105,We found that TLR/CD40-mediated expansion and antitumor efficacy of adoptively transferred tumor-specific CD8+ T cells were abrogated in Batf3-/- mice.,32848036_4,-1,-1,-1,-1,40480,-1,1.548377e-05,0.999977,7.5283615e-06
40487,agonists,20,21,120,128,"Moreover, induction and activation of cDC1s by administration of FMS-like tyrosine kinase 3 ligand (Flt3L) and TLR/CD40 agonists augmented expansion of adoptively transferred CD8+ T cells, delayed tumor growth, and improved survival.",32848036_6,0,1,-1,-1,40487,-1,0.98253995,0.0010658044,0.016394313
40493,T cell therapy,26,29,157,171,These findings reveal a key role for CD40 and CD70 signaling in cDC1s and have major implications for the design of new vaccination strategies with adoptive T cell therapy.,32848036_7,-1,-1,-1,-1,40493,-1,0.000120606164,0.0009101457,0.9989692
40495,the treatment,14,16,76,89,BACKGROUND: It has been shown that dihydroartemisinin (DHA) is effective in the treatment of malaria.,32859456_0,-1,-1,-1,-1,40495,-1,8.849034e-06,0.99998486,6.243018e-06
40497,tumor cell,8,10,59,69,"Recently studies have demonstrated that DHA also regulates tumor cell growth, angiogenesis, T cell differentiation and generation.",32859456_1,-1,-1,-1,-1,40497,-1,5.0238985e-05,0.00017610913,0.99977356
40523,the tumor,15,17,86,95,"DHA diminished expression of IL-10 and IL-6, and increased the expression of IFN- in the tumor and spleen.",32859456_10,-1,-1,-1,-1,40523,-1,4.1470553e-06,0.9999906,5.2192327e-06
40525,the STAT3,13,15,106,115,"Moreover, DHA administration significantly promoted the mitochondrial apoptosis of melanoma by regulating the STAT3 pathway.",32859456_11,-1,-1,-1,-1,40525,-1,7.8296e-06,0.99998546,6.7366245e-06
40529,immunity,3,4,24,32,"DHA improves anti-tumor immunity in mice through controlling CD8+CTL function by counteracting IL-10-dependent Treg cells suppression, which promises to be an alternative drug for melanoma.",32859456_13,0,-1,2,-1,40529,-1,0.99957925,0.00020815284,0.00021263552
40531,function,9,10,69,77,"DHA improves anti-tumor immunity in mice through controlling CD8+CTL function by counteracting IL-10-dependent Treg cells suppression, which promises to be an alternative drug for melanoma.",32859456_13,0,1,2,-1,40531,-1,4.479567e-05,8.104898e-05,0.9998741
40532,IL-10-dependent Treg cells,12,15,95,121,"DHA improves anti-tumor immunity in mice through controlling CD8+CTL function by counteracting IL-10-dependent Treg cells suppression, which promises to be an alternative drug for melanoma.",32859456_13,-1,-1,-1,-1,40532,-1,0.89441013,0.00032341678,0.10526652
40546,functions,27,28,177,186,Recent studies revealed that immunosuppressive TME is directly correlated with heightened activations of T regulatory cells (Tregs) and Myeloid derived suppressor cells (MDSCs) functions.,32890791_2,0,1,2,-1,40546,-1,0.00038490657,0.016064754,0.9835503
40553,the therapeutic,2,4,9,24,"However, the therapeutic efficacy of GA in impressive regression of tumor was found to be directly correlated with induction of apoptosis and modulation of cytokines from Th2 to Th1 type.",32890791_5,-1,-1,-1,-1,40553,-1,4.1883836e-06,0.99999166,4.1034777e-06
40557,Th2 to Th1 type,27,31,171,186,"However, the therapeutic efficacy of GA in impressive regression of tumor was found to be directly correlated with induction of apoptosis and modulation of cytokines from Th2 to Th1 type.",32890791_5,-1,-1,-1,-1,40557,-1,6.541043e-06,0.999985,8.428281e-06
40562,function,22,23,135,143,"To unravel the mechanism of anti-melanoma effect of GA, it has been delineated that GA inhibits pSTAT3 to evade anti-tumor suppressive function of Tregs and MDSCs.",32890791_6,0,1,2,-1,40562,-1,1.1071221e-05,0.99997985,9.059425e-06
40566,tumor-infiltrating Tregs,8,10,43,67,"Downregulation of FOXP3, GITR and CTLA4 in tumor-infiltrating Tregs and inhibition of Cox2, PGE2 and Arginase 1 in intra-tumoral MDSC were evidenced as some of the key events during therapeutic intervention of GA in melanoma management.",32890791_7,-1,-1,-1,-1,40566,-1,8.958407e-06,0.9999819,9.144031e-06
40575,therapy,21,22,110,117,"Thus, our findings may open up a novel insight of GA as a promising agent in cancer immunotherapy or adjuvant therapy in future.",32890791_9,0,1,-1,-1,40575,-1,7.810433e-06,0.9999844,7.788445e-06
40577,tumor cells,2,4,21,32,Genetically modified tumor cells harboring immunomodulators may be used as therapeutic vaccines to stimulate antitumor immunity.,32939048_0,-1,-1,-1,-1,40577,-1,0.0005706463,0.016979996,0.9824494
40581,immunity,15,16,119,127,Genetically modified tumor cells harboring immunomodulators may be used as therapeutic vaccines to stimulate antitumor immunity.,32939048_0,0,-1,2,-1,40581,-1,0.9999409,1.3176573e-05,4.5890647e-05
40582,The therapeutic,0,2,0,15,The therapeutic benefit of these tumor vaccines is extensively investigated and mechanisms by which they boost antitumor response may be further explored.,32939048_1,-1,-1,-1,-1,40582,-1,6.5333916e-06,0.9999894,4.113263e-06
40583,these tumor,4,6,27,38,The therapeutic benefit of these tumor vaccines is extensively investigated and mechanisms by which they boost antitumor response may be further explored.,32939048_1,-1,-1,-1,-1,40583,-1,8.775341e-06,0.99998486,6.326761e-06
40585,Tumor cells,0,2,0,11,Tumor cells are large secretors of extracellular vesicles (EVs).,32939048_2,-1,-1,-1,-1,40585,-1,9.198869e-05,0.00058851816,0.99931955
40588,proteins to target cells,8,12,41,65,"These EVs are able to vehiculate RNA and proteins to target cells, and engineered EVs also vehiculate recombinant proteins.",32939048_3,-1,-1,-1,-1,40588,-1,0.0014626315,0.94629234,0.052245006
40589,proteins,19,20,114,122,"These EVs are able to vehiculate RNA and proteins to target cells, and engineered EVs also vehiculate recombinant proteins.",32939048_3,0,1,-1,-1,40589,-1,8.549417e-06,0.9999864,5.0378635e-06
40591,the TNFSF,15,17,104,113,"In this study, we explore immunomodulatory properties of EVs derived from antitumor vaccines expressing the TNFSF ligands 4-1BBL and OX40L, modulating immune response mediated by immune cells and eliminating tumors.",32939048_4,-1,-1,-1,-1,40591,-1,0.0024259742,0.9973652,0.00020880971
40596,that the,3,5,20,28,"Our results suggest that the EVs secreted by genetically modified tumor cells harboring TNFSF ligands can induce T cell proliferation, inhibit the transcription factor FoxP3, associated with the maintenance of Treg phenotype, and enhance antitumor activity mediated by immune cells.",32939048_5,-1,-1,-1,-1,40596,-1,3.889984e-06,0.9999924,3.688013e-06
40598,tumor cells,10,12,66,77,"Our results suggest that the EVs secreted by genetically modified tumor cells harboring TNFSF ligands can induce T cell proliferation, inhibit the transcription factor FoxP3, associated with the maintenance of Treg phenotype, and enhance antitumor activity mediated by immune cells.",32939048_5,-1,-1,-1,-1,40598,-1,0.00017622484,0.0030179627,0.9968058
40599,TNFSF,13,14,88,93,"Our results suggest that the EVs secreted by genetically modified tumor cells harboring TNFSF ligands can induce T cell proliferation, inhibit the transcription factor FoxP3, associated with the maintenance of Treg phenotype, and enhance antitumor activity mediated by immune cells.",32939048_5,0,1,-1,-1,40599,-1,0.003930686,0.9958568,0.00021243098
40601,the transcription factor FoxP3,22,26,143,173,"Our results suggest that the EVs secreted by genetically modified tumor cells harboring TNFSF ligands can induce T cell proliferation, inhibit the transcription factor FoxP3, associated with the maintenance of Treg phenotype, and enhance antitumor activity mediated by immune cells.",32939048_5,-1,-1,-1,-1,40601,-1,4.830574e-06,0.99999046,4.6542755e-06
40607,therapy,16,17,125,132,The immunomodulatory extracellular vesicles have potential to be further engineered for developing new approaches for cancer therapy.,32939048_6,0,1,-1,-1,40607,-1,4.9068403e-06,0.99999034,4.72446e-06
40614,that the,6,8,24,32,"In this study, we found that the upregulation of Foxp3+ regulatory T cells (Tregs) in the mesothelioma tumor microenvironment after nonablative oligofractionated irradiation significantly limited the success of irradiation.",32948683_2,-1,-1,-1,-1,40614,-1,4.07921e-06,0.99999213,3.7357759e-06
40624,that transient Foxp3,21,24,125,145,"Using DEREG mice, which allow conditional and efficient depletion of Foxp3+ Tregs by diphtheria toxin injection, we observed that transient Foxp3+ Treg depletion immediately after nonablative oligofractionated irradiation provided synergistic local control and biased the T cell repertoire toward central and effector memory T cells, resulting in long-term cure.",32948683_3,-1,-1,-1,-1,40624,-1,7.140503e-06,0.99998784,5.041302e-06
40626,the T cell,38,41,268,278,"Using DEREG mice, which allow conditional and efficient depletion of Foxp3+ Tregs by diphtheria toxin injection, we observed that transient Foxp3+ Treg depletion immediately after nonablative oligofractionated irradiation provided synergistic local control and biased the T cell repertoire toward central and effector memory T cells, resulting in long-term cure.",32948683_3,-1,-1,-1,-1,40626,-1,0.0026039788,0.1897861,0.8076099
40630,therapy,4,5,30,37,"Furthermore, this combination therapy showed significant abscopal effect on the nonirradiated tumors in a concomitant model of mesothelioma through systemic activation of cytotoxic T cells and enhanced production of IFN- and granzyme B. Although local control was preserved with one fraction of nonablative irradiation, three fractions were required to generate the abscopal effect.",32948683_4,0,1,-1,-1,40630,-1,4.422694e-06,0.99999094,4.602884e-06
40637,to generate the,50,53,351,366,"Furthermore, this combination therapy showed significant abscopal effect on the nonirradiated tumors in a concomitant model of mesothelioma through systemic activation of cytotoxic T cells and enhanced production of IFN- and granzyme B. Although local control was preserved with one fraction of nonablative irradiation, three fractions were required to generate the abscopal effect.",32948683_4,-1,-1,-1,-1,40637,-1,7.738409e-06,0.99998796,4.259095e-06
40645,to the,4,6,28,34,Our findings are applicable to the strategy of immuno-radiotherapy for generating optimal antitumor immune responses in the clinical setting.,32948683_6,-1,-1,-1,-1,40645,-1,4.735657e-06,0.99999166,3.6365684e-06
40649,Targeting Tregs,0,2,0,15,Targeting Tregs immediately after a short course of irradiation could have a major impact on the local response to irradiation and its abscopal effect.,32948683_7,-1,-1,-1,-1,40649,-1,7.5057633e-06,0.9999863,6.1617316e-06
40670,the Stat1,11,13,96,105,"Mechanistically, Mettl3 or Mettl14 loss promoted IFN--Stat1-Irf1 signaling through stabilizing the Stat1 and Irf1 mRNA via Ythdf2.",32964498_5,-1,-1,-1,-1,40670,-1,4.3343066e-06,0.99998534,1.0281896e-05
40674,the function,9,11,52,64,"Altogether, our findings uncover a new awareness of the function of RNA methylation in adaptive immunity and provide METTL3 and METTL14 as potential therapeutic targets in anticancer immunotherapy.",32964498_7,-1,-1,-1,-1,40674,-1,8.443398e-06,0.999985,6.615144e-06
40676,therapeutic targets,24,26,149,168,"Altogether, our findings uncover a new awareness of the function of RNA methylation in adaptive immunity and provide METTL3 and METTL14 as potential therapeutic targets in anticancer immunotherapy.",32964498_7,-1,-1,-1,-1,40676,-1,5.10508e-06,0.9999912,3.7738512e-06
40680,deficiency,19,20,137,147,"The depletion of eosinophils represents an efficient strategy to alleviate allergic asthma, but the consequences of prolonged eosinophil deficiency for human health remain poorly understood.",32970801_0,0,1,-1,-1,40680,-1,0.79164636,0.19463666,0.013716939
40681,that the,3,5,13,21,"We show here that the ablation of eosinophils severely compromises antitumor immunity in syngeneic and genetic models of colorectal cancer (CRC), which can be attributed to defective Th1 and CD8+ T cell responses.",32970801_1,-1,-1,-1,-1,40681,-1,4.9265527e-06,0.9999913,3.7935822e-06
40682,immunity,11,12,77,85,"We show here that the ablation of eosinophils severely compromises antitumor immunity in syngeneic and genetic models of colorectal cancer (CRC), which can be attributed to defective Th1 and CD8+ T cell responses.",32970801_1,0,-1,2,-1,40682,-1,0.9998336,4.508322e-05,0.00012136744
40696,tumor immunity,15,17,92,106,GM-CSF activates IRF5 in vitro and in vivo and can be administered recombinantly to improve tumor immunity.,32970801_3,-1,-1,-1,-1,40696,-1,0.048467238,0.9504766,0.0010561869
40706,the GM-CSF-IRF5,16,18,102,117,The combined results demonstrate a critical role of eosinophils in tumor control in CRC and introduce the GM-CSF-IRF5 axis as a critical driver of the antitumor activities of this versatile cell type.,32970801_6,-1,-1,-1,-1,40706,-1,0.005047977,0.9945585,0.00039342453
40709,cell type,30,32,190,199,The combined results demonstrate a critical role of eosinophils in tumor control in CRC and introduce the GM-CSF-IRF5 axis as a critical driver of the antitumor activities of this versatile cell type.,32970801_6,-1,-1,-1,-1,40709,-1,2.4176898e-05,2.6653852e-05,0.9999491
40711,that STAT3,3,5,23,33,We previously reported that STAT3 activation in cancer cells and immune cells was involved in immune-resistant mechanisms.,33006786_1,-1,-1,-1,-1,40711,-1,9.68744e-06,0.999984,6.2898534e-06
40719,tumor antigen-specific T cells through,14,19,96,134,The curcumin po administration resulted in the significant augmentation of in vivo induction of tumor antigen-specific T cells through restoration of dendritic cells (DCs) by inhibiting directly STAT3 in DCs and indirectly via reduced IL-6 production from STAT3 activated cancer cells in 2 syngeneic MC38 and CT26 murine tumor models.,33006786_3,-1,-1,-1,-1,40719,-1,0.0003317793,0.99952435,0.00014383941
40729,functions,3,4,21,30,Curcumin restored DC functions in xenogeneic nude mouse model implanted with high IL-6-producing human clear cell ovarian cancer cells.,33006786_5,0,1,2,-1,40729,-1,0.00016015377,0.9992925,0.0005472969
40738,tumor antigen-specific T cells,9,13,64,94,These results indicated that curcumin augments the induction of tumor antigen-specific T cells by restoring the T cell stimulatory activity of DCs targeting activated STAT3 in both cancer cells and immune cells.,33006786_7,-1,-1,-1,-1,40738,-1,0.04331367,0.3872479,0.5694384
40739,the T cell,15,18,108,118,These results indicated that curcumin augments the induction of tumor antigen-specific T cells by restoring the T cell stimulatory activity of DCs targeting activated STAT3 in both cancer cells and immune cells.,33006786_7,-1,-1,-1,-1,40739,-1,0.0031797474,0.2823779,0.7144423
40746,regulatory T cells that,10,14,50,73,"NK1.1- CD4+ NKG2D+ T cells are a subpopulation of regulatory T cells that downregulate the functions of CD4+ T, CD8+ T, natural killer (NK) cells, and macrophages through TGF-1 production.",33011290_0,-1,-1,-1,-1,40746,-1,0.000791125,0.035562683,0.9636461
40747,the functions,15,17,87,100,"NK1.1- CD4+ NKG2D+ T cells are a subpopulation of regulatory T cells that downregulate the functions of CD4+ T, CD8+ T, natural killer (NK) cells, and macrophages through TGF-1 production.",33011290_0,-1,-1,-1,-1,40747,-1,6.796759e-06,0.9999813,1.1930753e-05
40752,through TGF-1,35,37,163,177,"NK1.1- CD4+ NKG2D+ T cells are a subpopulation of regulatory T cells that downregulate the functions of CD4+ T, CD8+ T, natural killer (NK) cells, and macrophages through TGF-1 production.",33011290_0,-1,-1,-1,-1,40752,-1,1.0219081e-05,0.99997604,1.3692362e-05
40756,T cell function,24,27,138,153,"Early growth response genes 2 (Egr2) and 3 (Egr3) maintain immune homeostasis by modulating T lymphocyte development, inhibiting effector T cell function, and promoting the induction of regulatory T cells.",33011290_1,-1,-1,-1,-1,40756,-1,1.3372698e-05,1.10817255e-05,0.99997556
40760,TGF-1 transcription,6,8,40,60,Whether Egr2 and Egr3 directly regulate TGF-1 transcription in NK1.1- CD4+ NKG2D+ T cells remains elusive.,33011290_2,-1,-1,-1,-1,40760,-1,6.066673e-06,0.9999875,6.4787905e-06
40764,T cells than,14,17,73,85,The expression levels of Egr2 and Egr3 were higher in NK1.1- CD4+ NKG2D+ T cells than in NK1.1- CD4+ NKG2D- T cells.,33011290_3,-1,-1,-1,-1,40764,-1,0.0014817731,0.050930608,0.94758755
40773,to the,22,24,125,131,"The ectopic expression of Egr2 or Egr3 resulted in the enhancement of TGF-1 expression, while knockdown of Egr2 or Egr3 led to the decreased expression of TGF-1 in NK1.1- CD4+ NKG2D+ T cells.",33011290_5,-1,-1,-1,-1,40773,-1,3.7122522e-06,0.9999925,3.7620482e-06
40777,the TGF-1,6,8,34,44,Egr2 and Egr3 directly bound with the TGF-1 promoter as demonstrated by the electrophoretic mobility shift assay and dual-luciferase gene reporter assay.,33011290_6,-1,-1,-1,-1,40777,-1,8.430084e-06,0.9999757,1.5929847e-05
40780,the Egr2,2,4,13,21,"Furthermore, the Egr2 and Egr3 expression of NK1.1- CD4+ NKG2D+ T cells could be induced by the AP-1 and NF-B transcriptional factors, but had no involvement with the activation of NF-AT and STAT3.",33011290_7,-1,-1,-1,-1,40780,-1,2.1131103e-05,0.99996495,1.3954596e-05
40782,the AP-1,18,20,92,100,"Furthermore, the Egr2 and Egr3 expression of NK1.1- CD4+ NKG2D+ T cells could be induced by the AP-1 and NF-B transcriptional factors, but had no involvement with the activation of NF-AT and STAT3.",33011290_7,-1,-1,-1,-1,40782,-1,5.5937458e-06,0.9999839,1.0540967e-05
40783,transcriptional factors,22,24,111,134,"Furthermore, the Egr2 and Egr3 expression of NK1.1- CD4+ NKG2D+ T cells could be induced by the AP-1 and NF-B transcriptional factors, but had no involvement with the activation of NF-AT and STAT3.",33011290_7,-1,-1,-1,-1,40783,-1,4.67733e-06,0.9999906,4.74349e-06
40785,NF-AT,33,34,182,187,"Furthermore, the Egr2 and Egr3 expression of NK1.1- CD4+ NKG2D+ T cells could be induced by the AP-1 and NF-B transcriptional factors, but had no involvement with the activation of NF-AT and STAT3.",33011290_7,-1,1,2,-1,40785,-1,9.3312665e-06,0.99997914,1.1504887e-05
40789,TGF-1 transcription,13,15,73,93,"In conclusion, Egr2 and Egr3 induced by AP-1 and NF-B directly initiate TGF-1 transcription in NK1.1- CD4+ NKG2D+ T cells.",33011290_8,-1,-1,-1,-1,40789,-1,5.4810675e-06,0.9999889,5.592131e-06
40795,function,15,16,109,117,This study indicates that manipulating Egr2 and Egr3 expression would potentiate or alleviate the regulatory function of NK1.1- CD4+ NKG2D+ T cells and this strategy could be used in the therapy for patients with autoimmune diseases or tumor.,33011290_9,0,1,2,-1,40795,-1,8.373655e-06,0.99998283,8.797435e-06
40798,the therapy,30,32,183,194,This study indicates that manipulating Egr2 and Egr3 expression would potentiate or alleviate the regulatory function of NK1.1- CD4+ NKG2D+ T cells and this strategy could be used in the therapy for patients with autoimmune diseases or tumor.,33011290_9,-1,-1,-1,-1,40798,-1,4.751054e-06,0.9999913,4.0000787e-06
40800,Immunity to,0,2,0,11,Immunity to viruses requires an array of critical cellular proteins that include IFN regulatory factor 3 (IRF3).,33020188_0,-1,-1,-1,-1,40800,-1,0.142155,0.85662,0.0012250058
40801,cellular proteins that,8,11,50,72,Immunity to viruses requires an array of critical cellular proteins that include IFN regulatory factor 3 (IRF3).,33020188_0,-1,-1,-1,-1,40801,-1,0.0065888045,0.51756907,0.47584212
40802,IFN regulatory factor,12,15,81,102,Immunity to viruses requires an array of critical cellular proteins that include IFN regulatory factor 3 (IRF3).,33020188_0,-1,-1,-1,-1,40802,-1,0.9835375,0.014796602,0.0016660168
40805,proteins that,8,10,58,71,"Consequently, most viruses that infect vertebrates encode proteins that interfere with IRF3 activation.",33020188_1,-1,-1,-1,-1,40805,-1,5.269245e-06,0.9999906,4.168964e-06
40808,the cellular,3,5,22,34,This review describes the cellular pathways linked to IRF3 activation and where those pathways are targeted by human viral pathogens.,33020188_2,-1,-1,-1,-1,40808,-1,0.0033318803,0.6100293,0.38663888
40809,to IRF3,7,9,51,58,This review describes the cellular pathways linked to IRF3 activation and where those pathways are targeted by human viral pathogens.,33020188_2,-1,-1,-1,-1,40809,-1,1.138405e-05,0.99997866,9.952552e-06
40816,immunity,17,18,106,114,"Besides viral infections, IRF3 is also involved in resistance to some bacterial infections, in anticancer immunity, and in anticancer therapies involving DNA damage agents.",33020188_4,0,-1,2,-1,40816,-1,0.99949026,0.00014975705,0.00035997518
40818,that IRF3,4,6,23,32,A recent finding shows that IRF3 is needed for T cell effector functions that are involved in anticancer immunity and also in T cell autoimmune diseases.,33020188_5,-1,-1,-1,-1,40818,-1,7.3320257e-06,0.99998724,5.443593e-06
40820,functions that,12,14,63,77,A recent finding shows that IRF3 is needed for T cell effector functions that are involved in anticancer immunity and also in T cell autoimmune diseases.,33020188_5,-1,-1,-1,-1,40820,-1,0.0016192303,0.9394747,0.05890611
40821,immunity,18,19,105,113,A recent finding shows that IRF3 is needed for T cell effector functions that are involved in anticancer immunity and also in T cell autoimmune diseases.,33020188_5,0,-1,2,-1,40821,-1,0.999741,9.495881e-05,0.00016401168
40826,to IFN--induced,25,27,166,182,"In contrast, unregulated IRF3 activity is clearly not beneficial, considering it is implicated in certain interferonopathies, in which heightened IRF3 activity leads to IFN--induced disease.",33020188_6,-1,-1,-1,-1,40826,-1,0.5370997,0.46072018,0.002180054
40834,immunity,9,10,69,77,"To identify critical molecules for activation of effective antitumor immunity, we have profiled autologous dendritic cell (DC) vaccines used to treat 35 patients with melanoma.",33051240_1,0,-1,2,-1,40834,-1,0.9999007,1.9661815e-05,7.963544e-05
40836,to treat,22,24,141,149,"To identify critical molecules for activation of effective antitumor immunity, we have profiled autologous dendritic cell (DC) vaccines used to treat 35 patients with melanoma.",33051240_1,-1,-1,-1,-1,40836,-1,6.2624913e-06,0.9999883,5.363437e-06
40839,T-cell,10,11,70,76,Melanoma patient DCs had reduced expression of cell surface inducible T-cell costimulator ligand (ICOSL) and had defective intrinsic NF-B signaling.,33051240_3,-1,1,2,-1,40839,-1,5.5230525e-05,1.692789e-05,0.9999279
40846,to the,3,5,17,23,"These data point to the critical role of canonical NF-B signaling, the regulation of matrix metalloproteinases, and DC-derived ICOSL in the specific priming of cognate T-cell responses in the cancer setting.",33051240_6,-1,-1,-1,-1,40846,-1,5.4264992e-06,0.9999902,4.3388154e-06
40847,the regulation,12,14,68,82,"These data point to the critical role of canonical NF-B signaling, the regulation of matrix metalloproteinases, and DC-derived ICOSL in the specific priming of cognate T-cell responses in the cancer setting.",33051240_6,-1,-1,-1,-1,40847,-1,6.366013e-06,0.9999881,5.5558407e-06
40849,T-cell,27,28,169,175,"These data point to the critical role of canonical NF-B signaling, the regulation of matrix metalloproteinases, and DC-derived ICOSL in the specific priming of cognate T-cell responses in the cancer setting.",33051240_6,-1,1,2,-1,40849,-1,2.3777597e-05,1.0680812e-05,0.99996555
40864,Th cells,4,6,25,33,"However, these polarized Th cells can also adapt their function and phenotype depending on the changing cytokine environment, demonstrating functional plasticity.",33064842_1,-1,-1,-1,-1,40864,-1,7.3437e-06,7.027732e-06,0.9999856
40865,their function,9,11,49,63,"However, these polarized Th cells can also adapt their function and phenotype depending on the changing cytokine environment, demonstrating functional plasticity.",33064842_1,-1,-1,-1,-1,40865,-1,4.5423192e-05,0.99986565,8.893709e-05
40868,functional plasticity,21,23,140,161,"However, these polarized Th cells can also adapt their function and phenotype depending on the changing cytokine environment, demonstrating functional plasticity.",33064842_1,-1,-1,-1,-1,40868,-1,0.000121243145,0.99983597,4.2717144e-05
40869,Th17 cells,2,4,6,16,"Here, Th17 cells, which play a critical role in host protection from extracellular pathogens and in autoimmune disorders, are of particular interest.",33064842_2,-1,-1,-1,-1,40869,-1,0.0004588336,0.023651361,0.9758898
40873,Th17 cells,10,12,58,68,"While being able to shift phenotype within their lineage, Th17 cells can also acquire characteristics of Th1, Th2, T follicular helper (Tfh) or regulatory T cells.",33064842_3,-1,-1,-1,-1,40873,-1,0.00020072436,0.0069844383,0.9928148
40879,Th17 cell,0,2,0,9,"Th17 cell identity is determined by a spectrum of extracellular signals, including cytokines, which are critical orchestrators of cellular immune responses.",33064842_4,-1,-1,-1,-1,40879,-1,0.00020210701,0.0055959094,0.99420196
40881,cellular immune responses,20,23,130,155,"Th17 cell identity is determined by a spectrum of extracellular signals, including cytokines, which are critical orchestrators of cellular immune responses.",33064842_4,-1,-1,-1,-1,40881,-1,0.85119766,0.00064154255,0.14816085
40887,Th17 plasticity,7,9,46,61,"How these signals are integrated to determine Th17 plasticity is not well defined, yet this is a crucial point of investigation as it represents a potential target to treat autoimmune and inflammatory diseases.",33064842_6,-1,-1,-1,-1,40887,-1,1.52283055e-05,0.9999696,1.5155112e-05
40889,target to treat,27,30,157,172,"How these signals are integrated to determine Th17 plasticity is not well defined, yet this is a crucial point of investigation as it represents a potential target to treat autoimmune and inflammatory diseases.",33064842_6,-1,-1,-1,-1,40889,-1,5.2204127e-06,0.9999907,4.0561e-06
40894,the regulation,16,18,98,112,"The goal of this review was to discuss how cytokines regulate intracellular networks, focusing on the regulation of lineage-specific transcription factors, chromatin remodelling and metabolism, to control human Th17 cell plasticity.",33064842_7,-1,-1,-1,-1,40894,-1,4.9740847e-06,0.9999907,4.2948946e-06
40896,metabolism,26,27,182,192,"The goal of this review was to discuss how cytokines regulate intracellular networks, focusing on the regulation of lineage-specific transcription factors, chromatin remodelling and metabolism, to control human Th17 cell plasticity.",33064842_7,0,1,2,-1,40896,-1,2.8036695e-05,0.99994385,2.8145649e-05
40898,Th17 cell plasticity,31,34,211,231,"The goal of this review was to discuss how cytokines regulate intracellular networks, focusing on the regulation of lineage-specific transcription factors, chromatin remodelling and metabolism, to control human Th17 cell plasticity.",33064842_7,-1,-1,-1,-1,40898,-1,0.00017957538,0.016618252,0.98320216
40900,Th17 plasticity,5,7,29,44,"We discuss the importance of Th17 plasticity in autoimmunity and cancer and present current strategies and challenges in targeting pathogenic Th17 cells with cytokine-based approaches, considering human genetic variants associated with altered Th17 differentiation.",33064842_8,-1,-1,-1,-1,40900,-1,1.1528198e-05,0.9999691,1.934281e-05
40902,Th17 cells,20,22,142,152,"We discuss the importance of Th17 plasticity in autoimmunity and cancer and present current strategies and challenges in targeting pathogenic Th17 cells with cytokine-based approaches, considering human genetic variants associated with altered Th17 differentiation.",33064842_8,-1,-1,-1,-1,40902,-1,0.00014841766,0.0016361692,0.99821544
40906,Th17 plasticity,6,8,35,50,"Finally, we discuss how modulating Th17 plasticity rather than targeting the Th17 lineage as a whole might preserve its essential immune function while purging its adverse effects.",33064842_9,-1,-1,-1,-1,40906,-1,1.4016523e-05,0.9999583,2.7693364e-05
40907,than targeting the Th17,9,13,58,81,"Finally, we discuss how modulating Th17 plasticity rather than targeting the Th17 lineage as a whole might preserve its essential immune function while purging its adverse effects.",33064842_9,-1,-1,-1,-1,40907,-1,2.2995238e-05,0.99995995,1.7046632e-05
40908,function,22,23,137,145,"Finally, we discuss how modulating Th17 plasticity rather than targeting the Th17 lineage as a whole might preserve its essential immune function while purging its adverse effects.",33064842_9,0,1,2,-1,40908,-1,0.0029543117,0.9949222,0.00212353
40909,adverse effects,26,28,164,179,"Finally, we discuss how modulating Th17 plasticity rather than targeting the Th17 lineage as a whole might preserve its essential immune function while purging its adverse effects.",33064842_9,0,1,-1,-1,40909,-1,0.0009230504,0.9989254,0.00015150965
40914,transplantation,28,29,158,173,"Regulatory B cells (Bregs) and CD4+ regulatory T cells (Tregs) are subgroups of immunoregulatory cells involved in modulating autoimmunity, inflammation, and transplantation reactions.",33083479_1,-1,1,2,-1,40914,-1,7.607723e-06,0.99998546,6.969006e-06
40916,function,7,8,35,43,"Herein, by studying the number and function of Breg and Treg cell subsets in patients with AML, we explored their potential role in the pathogenesis of AML.",33083479_2,0,1,2,-1,40916,-1,2.0419187e-05,0.9999585,2.1014628e-05
40917,Treg cell subsets,11,14,56,73,"Herein, by studying the number and function of Breg and Treg cell subsets in patients with AML, we explored their potential role in the pathogenesis of AML.",33083479_2,-1,-1,-1,-1,40917,-1,1.2126568e-05,1.4048175e-05,0.9999738
40929,The relationship,0,2,0,16,The relationship of Bregs and Tregs with the clinicopathological parameters was analyzed.,33083479_7,-1,-1,-1,-1,40929,-1,7.557339e-06,0.999985,7.478288e-06
40937,plasma IL-10,19,21,127,139,"Furthermore, compared with healthy controls and AML patients in complete remission, newly diagnosed AML patients had increased plasma IL-10 but reduced TGF-.",33083479_10,-1,-1,-1,-1,40937,-1,0.9885626,0.010184207,0.0012531885
40946,that they,11,13,71,80,"Bregs and Tregs have abnormal distribution in AML patients, suggesting that they might play an important role in regulating immune responses in AML.",33083479_13,-1,-1,-1,-1,40946,-1,5.196075e-06,0.99998987,4.9311284e-06
40949,function,17,18,91,99,"Oxya chinensis sinuosa (Ocs) is consumed as representative edible insects in Asia, but its function in various immune systems remains unclear.",33105813_0,0,1,2,-1,40949,-1,1.8212262e-05,0.99996996,1.1864911e-05
40955,protein,20,21,125,132,"This study aimed to demonstrate the immunomodulatory effect, particularly on the innate and adaptive immune response, of Ocs protein (Ocs-P) and to investigate its function as a potent anticancer immunostimulant when administered during the progression stage of colon carcinoma in tumor-bearing mice.",33105813_1,0,1,-1,-1,40955,-1,0.00026876395,0.99964225,8.892197e-05
40957,function,28,29,164,172,"This study aimed to demonstrate the immunomodulatory effect, particularly on the innate and adaptive immune response, of Ocs protein (Ocs-P) and to investigate its function as a potent anticancer immunostimulant when administered during the progression stage of colon carcinoma in tumor-bearing mice.",33105813_1,0,1,2,-1,40957,-1,7.368534e-06,0.9999856,7.0343635e-06
40962,Th1-polarizing cytokines,20,22,146,170,Our in vitro results demonstrated that Ocs-P treatment induces phenotypic alteration (increased expression of surface molecules and production of Th1-polarizing cytokines and decreased antigen uptake ability) of dendritic cells (DCs) through the activation of MAPK and NF-B-dependent signaling pathways.,33105813_2,-1,-1,-1,-1,40962,-1,0.06395178,0.9316693,0.004378909
40965,through the,34,36,234,245,Our in vitro results demonstrated that Ocs-P treatment induces phenotypic alteration (increased expression of surface molecules and production of Th1-polarizing cytokines and decreased antigen uptake ability) of dendritic cells (DCs) through the activation of MAPK and NF-B-dependent signaling pathways.,33105813_2,-1,-1,-1,-1,40965,-1,4.325605e-06,0.99999166,3.997205e-06
40966,naive T cells,7,10,64,77,"Additionally, Ocs-P-stimulated DCs initiated differentiation of naive T cells into IFN--producing Th1-type T cells effectively and activated cytotoxic CD8+ T cell response.",33105813_3,-1,-1,-1,-1,40966,-1,0.0019016889,0.12712312,0.87097514
40967,IFN--producing Th1-type T cells,11,15,83,115,"Additionally, Ocs-P-stimulated DCs initiated differentiation of naive T cells into IFN--producing Th1-type T cells effectively and activated cytotoxic CD8+ T cell response.",33105813_3,-1,-1,-1,-1,40967,-1,0.90775675,0.0007400748,0.09150318
40971,the generation,5,7,43,57,"Furthermore, Ocs-P administration enhanced the generation of multifunctional CD4+ and CD8+ T cells expressing Th1-type cytokines (TNF-, IFN-, and IL-2) and the degranulation marker (CD107a).",33105813_5,-1,-1,-1,-1,40971,-1,7.123272e-06,0.9999875,5.3933777e-06
40973,Th1-type cytokines,17,19,110,128,"Furthermore, Ocs-P administration enhanced the generation of multifunctional CD4+ and CD8+ T cells expressing Th1-type cytokines (TNF-, IFN-, and IL-2) and the degranulation marker (CD107a).",33105813_5,-1,-1,-1,-1,40973,-1,0.03757056,0.9600253,0.0024041831
40974,TNF-,20,21,130,135,"Furthermore, Ocs-P administration enhanced the generation of multifunctional CD4+ and CD8+ T cells expressing Th1-type cytokines (TNF-, IFN-, and IL-2) and the degranulation marker (CD107a).",33105813_5,0,1,-1,-1,40974,-1,0.005036917,0.9947431,0.00021992483
40979,immunity,16,17,123,131,"Collectively, these results suggest that Ocs-P demonstrates an immunostimulatory effect and may induce powerful anticancer immunity.",33105813_6,0,-1,2,-1,40979,-1,0.9999008,1.866998e-05,8.048539e-05
40982,function,14,15,89,97,Eomesodermin (Eomes) is a T-box transcription factor that drives the differentiation and function of cytotoxic lymphocytes.,33113266_0,0,1,2,-1,40982,-1,0.0017063554,0.9902114,0.008082156
40985,function,4,5,24,32,"However, the underlying function and mechanism of Eomes in tumor cells remains elusive.",33113266_1,0,1,2,-1,40985,-1,0.000177796,0.9997106,0.0001115029
40986,tumor cells,10,12,59,70,"However, the underlying function and mechanism of Eomes in tumor cells remains elusive.",33113266_1,-1,-1,-1,-1,40986,-1,0.000239333,0.0044973614,0.99526334
40992,that the,18,20,110,118,"Using 2 human ESCC cell lines, we found that Eomes knockdown reduced esophageal cancer cell proliferation and that the esophageal cancer cell cycle was blocked in the G2/M phase.",33113266_3,-1,-1,-1,-1,40992,-1,4.458409e-06,0.9999907,4.7997305e-06
40998,chemoregulate regulatory T cells,7,11,39,71,"Furthermore, we found that CCL20 could chemoregulate regulatory T cells (Tregs) through their specific receptor CCR6, then promoting the proliferation of esophageal cancer cells.",33113266_5,-1,-1,-1,-1,40998,-1,0.04605873,0.00027048346,0.95367086
41000,through their,14,16,80,93,"Furthermore, we found that CCL20 could chemoregulate regulatory T cells (Tregs) through their specific receptor CCR6, then promoting the proliferation of esophageal cancer cells.",33113266_5,-1,-1,-1,-1,41000,-1,6.221548e-06,0.9999865,7.1956806e-06
41001,receptor CCR6,17,19,103,116,"Furthermore, we found that CCL20 could chemoregulate regulatory T cells (Tregs) through their specific receptor CCR6, then promoting the proliferation of esophageal cancer cells.",33113266_5,-1,-1,-1,-1,41001,-1,0.00035618403,0.000532605,0.9991111
41006,tissues,6,7,31,38,"Importantly, in 133 human ESCC tissues, high Eomes levels were associated with poor clinical prognosis.",33113266_7,-1,1,2,-1,41006,-1,0.00016308755,0.86371326,0.13612363
41007,that the,5,7,32,40,"Overall, our findings suggested that the Eomes-CCL20-CCR6 pathway plays a vital role in human ESCC progress.",33113266_8,-1,-1,-1,-1,41007,-1,4.4009944e-06,0.99999154,4.0255404e-06
41010,targeting this,2,4,11,25,"Therefore, targeting this pathway may represent a promising strategy for controlling human ESCC.",33113266_9,-1,-1,-1,-1,41010,-1,4.002418e-06,0.99999225,3.7871625e-06
41013,receptor,25,26,154,162,"Myasthenia gravis (MG) is a prototypic organ-specific autoimmune disorder that, in most cases, is mainly mediated by antibodies against the acetylcholine receptor.",33136553_0,0,1,2,-1,41013,-1,0.0026192402,0.056014508,0.94136626
41024,receptor,12,13,75,83,"In the present study, we investigated serum melatonin levels and melatonin receptor expression in MG patients and healthy controls (HCs).",33136553_4,0,1,2,-1,41024,-1,4.8418362e-05,0.9998105,0.00014109701
41026,Th cells,12,14,76,84,We also evaluated the impact of melatonin administration on peripheral CD4+ Th cells and related cytokine production.,33136553_5,-1,-1,-1,-1,41026,-1,9.674534e-06,1.0026229e-05,0.99998033
41027,related cytokine,15,17,89,105,We also evaluated the impact of melatonin administration on peripheral CD4+ Th cells and related cytokine production.,33136553_5,-1,-1,-1,-1,41027,-1,0.67869127,0.3171264,0.0041822623
41032,Th17 cell,7,9,60,69,Administration of melatonin significantly decreased Th1 and Th17 cell responses and proinflammatory cytokine production.,33136553_7,-1,-1,-1,-1,41032,-1,5.3707467e-05,0.00013766956,0.9998086
41039,function,25,26,169,177,Further investigation in vitro revealed that melatonin administration increased FoxP3 and IL-10 expression in CD4+ T cells from MG patients and enhanced the suppressive function of Tregs.,33136553_8,0,1,2,-1,41039,-1,1.5236532e-05,0.9999708,1.3942639e-05
41043,Th cell,15,17,115,122,These findings indicate that melatonin exerts immunoregulatory activity in MG by balancing effector and regulatory Th cell populations as well as by suppressing proinflammatory cytokine production.,33136553_9,-1,-1,-1,-1,41043,-1,7.3260567e-06,7.383086e-06,0.99998534
41057,the blood,15,17,63,72,"METHODS: The levels of Treg cells and IL-2, IL-10, and TGF in the blood of patients with liver cancer were detected by flow cytometry and ELISA, respectively.",33204731_1,-1,-1,-1,-1,41057,-1,2.3298451e-05,0.999941,3.5741687e-05
41065,transplanted tumor tissues,7,10,42,68,The proportion of CD4+CD25+Foxp3+ Treg in transplanted tumor tissues was detected by flow cytometry.,33204731_4,-1,-1,-1,-1,41065,-1,1.6213355e-05,0.999943,4.081549e-05
41069,transplanted tumor tissues,8,11,43,69,"The expression levels of Foxp3 and TGF in transplanted tumor tissues were detected by quantitative fluorescence PCR.RESULTS: Compared with healthy people, Treg cells and IL-2, IL-10, and TGF contents in peripheral blood of liver cancer patients were increased.",33204731_5,-1,-1,-1,-1,41069,-1,1.7747258e-05,0.99991035,7.193517e-05
41073,blood,35,36,216,221,"The expression levels of Foxp3 and TGF in transplanted tumor tissues were detected by quantitative fluorescence PCR.RESULTS: Compared with healthy people, Treg cells and IL-2, IL-10, and TGF contents in peripheral blood of liver cancer patients were increased.",33204731_5,0,1,-1,-1,41073,-1,0.0007456528,0.99140126,0.007853021
41075,the transplanted tumor,3,6,15,37,The results of the transplanted tumor model in mice showed that the tumor volume of the transplanted mice in the solanine group and the TGF inhibitor mice was reduced compared with the control group.,33204731_6,-1,-1,-1,-1,41075,-1,3.5369196e-06,0.9999918,4.6875343e-06
41076,that the tumor,10,13,59,73,The results of the transplanted tumor model in mice showed that the tumor volume of the transplanted mice in the solanine group and the TGF inhibitor mice was reduced compared with the control group.,33204731_6,-1,-1,-1,-1,41076,-1,4.036966e-06,0.9999906,5.33508e-06
41077,the transplanted,15,17,84,100,The results of the transplanted tumor model in mice showed that the tumor volume of the transplanted mice in the solanine group and the TGF inhibitor mice was reduced compared with the control group.,33204731_6,-1,-1,-1,-1,41077,-1,4.3900704e-06,0.9999896,6.0186658e-06
41079,the TGF,23,25,132,140,The results of the transplanted tumor model in mice showed that the tumor volume of the transplanted mice in the solanine group and the TGF inhibitor mice was reduced compared with the control group.,33204731_6,-1,-1,-1,-1,41079,-1,3.342865e-05,0.99994934,1.720507e-05
41086,the transplanted tumor tissues,7,11,42,72,The proportion of CD4+CD25+Foxp3+ Treg in the transplanted tumor tissues of mice in the solanine treatment group was significantly lower than that in the control group.,33204731_8,-1,-1,-1,-1,41086,-1,8.38258e-06,0.99997246,1.9174564e-05
41089,than that,21,23,137,146,The proportion of CD4+CD25+Foxp3+ Treg in the transplanted tumor tissues of mice in the solanine treatment group was significantly lower than that in the control group.,33204731_8,-1,-1,-1,-1,41089,-1,4.7919066e-06,0.9999901,5.0743593e-06
41094,the transplanted tumor tissues,7,11,37,67,The expressions of Foxp3 and TGF in the transplanted tumor tissues of mice in the solanine group were significantly lower than those in the control group.,33204731_9,-1,-1,-1,-1,41094,-1,8.567202e-06,0.9999683,2.308836e-05
41096,than those,20,22,123,133,The expressions of Foxp3 and TGF in the transplanted tumor tissues of mice in the solanine group were significantly lower than those in the control group.,33204731_9,-1,-1,-1,-1,41096,-1,5.0123845e-06,0.99998975,5.2956784e-06
41105,tumor tissues,25,27,154,167,CONCLUSION: Solanine may enhance the antitumor immune response by downregulating the proportion of CD4+CD25+ Treg and the expression of Foxp3 and TGF in tumor tissues.,33204731_10,-1,-1,-1,-1,41105,-1,9.2346445e-06,0.99995506,3.5744437e-05
41111,TRM to,5,7,29,35,"However, the contribution of TRM to anti-tumor immunity and to the response to immune checkpoint blockade has not been clearly established.",33205076_1,-1,-1,-1,-1,41111,-1,4.469423e-06,0.99998796,7.5777134e-06
41112,immunity,8,9,47,55,"However, the contribution of TRM to anti-tumor immunity and to the response to immune checkpoint blockade has not been clearly established.",33205076_1,0,-1,2,-1,41112,-1,0.9993061,0.00030335557,0.00039062224
41113,to the,10,12,60,66,"However, the contribution of TRM to anti-tumor immunity and to the response to immune checkpoint blockade has not been clearly established.",33205076_1,-1,-1,-1,-1,41113,-1,5.337093e-06,0.9999893,5.3456565e-06
41124,tumor TRM,2,4,11,20,"CD103+CD8+ tumor TRM, but not CD103-CD8+ tumor-infiltrating counterparts, express Aiolos, phosphorylated STAT-3, and IL-17; demonstrate enhanced proliferation and cytotoxicity toward autologous cancer cells; and frequently display oligoclonal expansion of TCR- clonotypes.",33205076_5,-1,-1,-1,-1,41124,-1,5.3431118e-06,0.9999881,6.556452e-06
41130,TCR-,37,38,256,261,"CD103+CD8+ tumor TRM, but not CD103-CD8+ tumor-infiltrating counterparts, express Aiolos, phosphorylated STAT-3, and IL-17; demonstrate enhanced proliferation and cytotoxicity toward autologous cancer cells; and frequently display oligoclonal expansion of TCR- clonotypes.",33205076_5,-1,1,2,-1,41130,-1,3.953467e-05,0.9999273,3.3164837e-05
41152,TNFRSF19,16,17,88,96,"A 7 immune-related genes prognostic model for OSCC was obtained, including CGB8, CTLA4, TNFRSF19, CCL26, NRG1, TPM2 and PLAU, which was further proved to be an independent prognostic indicator after adjusting for other clinical factors.",33220636_4,0,1,-1,-1,41152,-1,0.0071386416,0.9923489,0.0005124339
41156,factors,41,42,228,235,"A 7 immune-related genes prognostic model for OSCC was obtained, including CGB8, CTLA4, TNFRSF19, CCL26, NRG1, TPM2 and PLAU, which was further proved to be an independent prognostic indicator after adjusting for other clinical factors.",33220636_4,0,1,-1,-1,41156,-1,0.8823045,0.11495201,0.0027434495
41159,to the,9,11,82,88,The immune-related genes prognostic index was significantly negatively correlated to the infiltration abundances of B cells (P<0.05) and CD8+ T cells (P<0.05).,33220636_5,-1,-1,-1,-1,41159,-1,4.7369854e-06,0.9999907,4.5187658e-06
41172,tissue,14,15,80,86,"SKIL expression levels in NSCLC cell line, clinical sample, and adjacent normal tissue were measured by quantitative PCR, western blot, or immunohistochemistry.",33268765_2,-1,1,2,-1,41172,-1,6.715955e-05,0.9983047,0.0016280588
41181,protein,12,13,77,84,"Quantitative PCR and western blot were applied to evaluate relevant mRNA and protein levels, respectively.",33268765_6,0,1,-1,-1,41181,-1,8.695122e-06,0.99998343,7.833356e-06
41185,tissue,6,7,36,42,SKIL expression was higher in NSCLC tissue compared to adjacent normal tissue.,33268765_8,-1,1,2,-1,41185,-1,0.0004894265,0.5852777,0.4142329
41187,tissue,11,12,71,77,SKIL expression was higher in NSCLC tissue compared to adjacent normal tissue.,33268765_8,-1,1,2,-1,41187,-1,0.00012637356,0.98408014,0.015793547
41191,cells through,10,12,76,89,SKIL-knockdown inhibited autophagy and activated the STING pathway in NSCLC cells through down-regulation of TAZ.,33268765_10,-1,-1,-1,-1,41191,-1,0.004183442,0.36302197,0.63279456
41199,cells through,11,13,70,83,"In conclusion, SKIL promoted tumorigenesis and immune escape of NSCLC cells through upregulation of TAZ/autophagy axis and inhibition on downstream STING pathway.",33268765_13,-1,-1,-1,-1,41199,-1,0.0042216643,0.3425854,0.65319294
41201,T cell therapy,13,16,79,93,"While effective in specific settings, adoptive chimeric antigen receptor (CAR) T cell therapy for cancer requires further improvement and optimization.",33268774_0,-1,-1,-1,-1,41201,-1,0.0012217427,0.026120309,0.972658
41202,that CD40L-overexpressing,4,6,26,51,"Our previous results show that CD40L-overexpressing CAR T cells mobilize endogenous immune effectors, resulting in improved antitumor immunity.",33268774_1,-1,-1,-1,-1,41202,-1,0.0021675748,0.96576613,0.03206633
41204,immunity,18,19,134,142,"Our previous results show that CD40L-overexpressing CAR T cells mobilize endogenous immune effectors, resulting in improved antitumor immunity.",33268774_1,0,-1,2,-1,41204,-1,0.99989223,4.0222534e-05,6.763744e-05
41205,the cell,2,4,9,17,"However, the cell populations required for this protective effect remain to be identified.",33268774_2,-1,-1,-1,-1,41205,-1,0.0014979551,0.07859326,0.9199088
41209,cell type,14,16,83,92,"Here we show, by analyzing Batf3-/- mice lacking the CD103+ conventional dendritic cell type 1 (cDC1) subpopulation important for antigen cross-presentation, that CD40L-overexpressing CAR T cells elicit an impaired antitumor response in the absence of cDC1s.",33268774_3,-1,-1,-1,-1,41209,-1,0.00018953852,0.0017827763,0.9980276
41211,that CD40L-overexpressing,26,28,158,183,"Here we show, by analyzing Batf3-/- mice lacking the CD103+ conventional dendritic cell type 1 (cDC1) subpopulation important for antigen cross-presentation, that CD40L-overexpressing CAR T cells elicit an impaired antitumor response in the absence of cDC1s.",33268774_3,-1,-1,-1,-1,41211,-1,0.0054319515,0.8732161,0.12135197
41214,that CD40L-overexpressing,3,5,16,41,We further find that CD40L-overexpressing CAR T cells stimulate tumor-resident CD11b-CD103- double-negative (DN) cDCs to proliferate and differentiate into cDC1s in wild-type mice.,33268774_4,-1,-1,-1,-1,41214,-1,0.003728512,0.95360386,0.042667594
41227,T cells to,27,30,185,195,"Our findings thus demonstrate the stimulatory effect of CD40L-overexpressing CAR T cells on innate and adaptive immune cells, and provide a rationale for using CD40L-overexpressing CAR T cells to improve immunotherapy responses.",33268774_6,-1,-1,-1,-1,41227,-1,0.0020627815,0.09407073,0.9038665
41228,tumors that,8,10,63,74,"Cancer immunotherapy shows limited efficacy against many solid tumors that originate from epithelial tissues, including triple-negative breast cancer (TNBC).",33385331_0,-1,-1,-1,-1,41228,-1,3.7377233e-06,0.99999166,4.633382e-06
41229,tissues,13,14,101,108,"Cancer immunotherapy shows limited efficacy against many solid tumors that originate from epithelial tissues, including triple-negative breast cancer (TNBC).",33385331_0,-1,1,2,-1,41229,-1,3.0979052e-05,9.01587e-05,0.9998789
41232,the SOX4 transcription factor,2,6,12,41,We identify the SOX4 transcription factor as an important resistance mechanism to Tcell-mediated cytotoxicity for TNBC cells.,33385331_1,-1,-1,-1,-1,41232,-1,5.4522816e-06,0.9999894,5.2055166e-06
41233,to Tcell-mediated,11,15,79,97,We identify the SOX4 transcription factor as an important resistance mechanism to Tcell-mediated cytotoxicity for TNBC cells.,33385331_1,-1,-1,-1,-1,41233,-1,0.0014059541,0.051844336,0.94674975
41234,TNBC cells,17,19,115,125,We identify the SOX4 transcription factor as an important resistance mechanism to Tcell-mediated cytotoxicity for TNBC cells.,33385331_1,-1,-1,-1,-1,41234,-1,0.0016363836,0.22312498,0.7752386
41237,tumor cells,8,10,61,72,Mechanistic studies demonstrate that inactivation of SOX4 in tumor cells increases the expression of genes in a number of innate and adaptive immune pathways important for protective tumor immunity.,33385331_2,-1,-1,-1,-1,41237,-1,0.00010802084,0.00082519546,0.99906677
41240,tumor immunity,27,29,183,197,Mechanistic studies demonstrate that inactivation of SOX4 in tumor cells increases the expression of genes in a number of innate and adaptive immune pathways important for protective tumor immunity.,33385331_2,-1,-1,-1,-1,41240,-1,0.080115184,0.91801345,0.0018713342
41243,receptor,9,10,53,61,"Expression of SOX4 is regulated by the integrin v6 receptor on the surface of tumor cells, which activates TGF from a latent precursor.",33385331_3,0,1,2,-1,41243,-1,0.0015840866,0.0013856209,0.99703026
41245,tumor cells,14,16,80,91,"Expression of SOX4 is regulated by the integrin v6 receptor on the surface of tumor cells, which activates TGF from a latent precursor.",33385331_3,-1,-1,-1,-1,41245,-1,0.0001094792,0.0013049578,0.9985856
41249,TNBC cells to,13,16,94,107,An integrin v6/8-blocking monoclonal antibody (mAb) inhibits SOX4 expression and sensitizes TNBC cells to cytotoxic Tcells.,33385331_4,-1,-1,-1,-1,41249,-1,3.2751694e-05,0.99988496,8.226962e-05
41272,analysis,2,3,20,28,Stratified survival analysis showed IRG signature was an effective predictor of survival in patients with different clinical characteristics.,33401247_5,0,1,-1,-1,41272,-1,1.0476061e-05,0.99998045,9.051053e-06
41273,The protein,0,2,0,11,The protein expression level of six genes was validated by immunohistochemistry analysis.,33401247_6,-1,-1,-1,-1,41273,-1,1.2683153e-05,0.99998105,6.281904e-06
41275,analysis,11,12,80,88,The protein expression level of six genes was validated by immunohistochemistry analysis.,33401247_6,0,1,-1,-1,41275,-1,1.3744219e-05,0.9999777,8.538799e-06
41276,analysis,1,2,11,19,"Difference analysis indicated the mutation rate, immune cell of resting NK cells and regulatory T cells infiltration and four immune checkpoints of PD-1, PD-L1, LAG3 and VSIR expression levels in the high-risk group were significantly higher than those in the low-risk group.",33401247_7,0,1,-1,-1,41276,-1,4.918103e-06,0.99998844,6.6170905e-06
41282,than those,39,41,242,252,"Difference analysis indicated the mutation rate, immune cell of resting NK cells and regulatory T cells infiltration and four immune checkpoints of PD-1, PD-L1, LAG3 and VSIR expression levels in the high-risk group were significantly higher than those in the low-risk group.",33401247_7,-1,-1,-1,-1,41282,-1,5.601311e-06,0.9999889,5.5415794e-06
41284,the gene,3,5,25,33,"A nomogram incorporating the gene signatures and clinical factors was demonstrated had a good accuracy (1-, 3-, and 5-year AUC= 0.799, 0.791, 0.738).",33401247_8,-1,-1,-1,-1,41284,-1,6.870369e-06,0.9999852,7.859478e-06
41285,factors,8,9,58,65,"A nomogram incorporating the gene signatures and clinical factors was demonstrated had a good accuracy (1-, 3-, and 5-year AUC= 0.799, 0.791, 0.738).",33401247_8,0,1,-1,-1,41285,-1,0.9268067,0.07196157,0.0012318104
41287,that the,4,6,26,34,It is clearly established that the immune system can affect cancer response to therapy.,33419764_0,-1,-1,-1,-1,41287,-1,5.385346e-06,0.99998975,4.8840825e-06
41288,to therapy,12,14,76,86,It is clearly established that the immune system can affect cancer response to therapy.,33419764_0,-1,-1,-1,-1,41288,-1,1.0730319e-05,0.99998176,7.5055364e-06
41290,the tumor,5,7,26,35,"However, the influence of the tumor microenvironment (TME) on immune cells is not completely understood.",33419764_1,-1,-1,-1,-1,41290,-1,4.8709057e-06,0.99999094,4.1607395e-06
41296,that the TME,4,7,16,28,"Here, we showed that the TME, via a TGF-dependent mechanism, increased alternative splicing events and induced the expression of an alternative isoform of the IRF1 transcription factor (IRF17) in Th1 cells.",33419764_3,-1,-1,-1,-1,41296,-1,5.1872426e-06,0.99998987,4.933527e-06
41299,the IRF1 transcription factor,26,30,156,185,"Here, we showed that the TME, via a TGF-dependent mechanism, increased alternative splicing events and induced the expression of an alternative isoform of the IRF1 transcription factor (IRF17) in Th1 cells.",33419764_3,-1,-1,-1,-1,41299,-1,5.3178314e-06,0.99998903,5.6661706e-06
41301,that the,2,4,9,17,"We found that the SFPQ splicing factor (splicing factor, proline- and glutamine-rich) was responsible for the IRF17 production.",33419764_4,-1,-1,-1,-1,41301,-1,4.339285e-06,0.99999166,3.9567217e-06
41302,factor,6,7,32,38,"We found that the SFPQ splicing factor (splicing factor, proline- and glutamine-rich) was responsible for the IRF17 production.",33419764_4,0,1,-1,-1,41302,-1,6.1469796e-06,0.9999887,5.230294e-06
41303,factor,9,10,49,55,"We found that the SFPQ splicing factor (splicing factor, proline- and glutamine-rich) was responsible for the IRF17 production.",33419764_4,0,1,-1,-1,41303,-1,7.76201e-06,0.9999851,7.0898295e-06
41306,that the IRF1,10,13,41,54,"We also showed, in both mice and humans, that the IRF1 alternative isoform altered the full-length IRF1 transcriptional activity on the Il12rb1 promoter, resulting in decreased IFN secretion in Th1 cells.",33419764_5,-1,-1,-1,-1,41306,-1,4.5424003e-06,0.999987,8.395046e-06
41308,IRF1 transcriptional,18,20,99,119,"We also showed, in both mice and humans, that the IRF1 alternative isoform altered the full-length IRF1 transcriptional activity on the Il12rb1 promoter, resulting in decreased IFN secretion in Th1 cells.",33419764_5,-1,-1,-1,-1,41308,-1,4.2921233e-06,0.99998987,5.85567e-06
41309,the Il12rb1,22,24,132,143,"We also showed, in both mice and humans, that the IRF1 alternative isoform altered the full-length IRF1 transcriptional activity on the Il12rb1 promoter, resulting in decreased IFN secretion in Th1 cells.",33419764_5,-1,-1,-1,-1,41309,-1,0.00080145826,0.99853075,0.00066774304
41314,the TME,8,10,42,49,"Thus, the IRF17 isoform was increased in the TME, and inhibiting IRF17 expression could potentiate Th1 antitumor responses.",33419764_6,-1,-1,-1,-1,41314,-1,6.7584206e-06,0.9999856,7.647339e-06
41322,life-threatening immune response,22,25,108,140,"Engineered immune cells, such as chimeric antigen receptor (CAR) T cells, are facing the danger of an overt life-threatening immune response due to the ON-target OFF-tumor cytotoxicity and Cytokine Release Syndrome.",33514819_1,-1,-1,-1,-1,41322,-1,0.17250659,0.82560056,0.001892798
41323,to the,26,28,145,151,"Engineered immune cells, such as chimeric antigen receptor (CAR) T cells, are facing the danger of an overt life-threatening immune response due to the ON-target OFF-tumor cytotoxicity and Cytokine Release Syndrome.",33514819_1,-1,-1,-1,-1,41323,-1,4.6729765e-06,0.9999912,4.200346e-06
41324,Cytokine Release,32,34,189,205,"Engineered immune cells, such as chimeric antigen receptor (CAR) T cells, are facing the danger of an overt life-threatening immune response due to the ON-target OFF-tumor cytotoxicity and Cytokine Release Syndrome.",33514819_1,-1,-1,-1,-1,41324,-1,0.9969121,0.0026058762,0.00048205245
41329,the tumor,22,24,164,173,We therefore developed synthetic promoters for regulation of gene expression under the control of inflammation and Hypoxia-induced signals that are associated with the tumor microenvironment (TME).,33514819_2,-1,-1,-1,-1,41329,-1,4.832116e-06,0.99999106,4.1667836e-06
41331,termed this,1,3,3,14,We termed this methodology as chimeric-antigen-receptor-tumor-induced-vector (CARTIV).,33514819_3,-1,-1,-1,-1,41331,-1,1.34612255e-05,0.9999782,8.311717e-06
41333,TNF,19,20,107,111,"For proof of concept, we studied synthetic promoters based on promoter-responsive elements (PREs) of IFN, TNF and hypoxia; triple PRE-based CARTIV promoter manifested a synergistic activity in cell-lines and potent activation in human primary T-cells.",33514819_4,0,1,-1,-1,41333,-1,0.00046349454,0.99947506,6.1440485e-05
41336,T-cells,39,40,245,252,"For proof of concept, we studied synthetic promoters based on promoter-responsive elements (PREs) of IFN, TNF and hypoxia; triple PRE-based CARTIV promoter manifested a synergistic activity in cell-lines and potent activation in human primary T-cells.",33514819_4,-1,1,2,-1,41336,-1,1.4700603e-05,1.0552207e-05,0.9999747
41338,T-cells,7,8,42,49,"CARTIV platform can improve safety of CAR T-cells or other engineered immune-cells, providing TME-focused activity and opening a therapeutic window for many tumor-associated antigens that are also expressed by non-tumor healthy tissues.",33514819_5,-1,1,2,-1,41338,-1,1.8540402e-05,2.1405769e-05,0.99995995
41341,tumor-associated antigens that,23,26,157,187,"CARTIV platform can improve safety of CAR T-cells or other engineered immune-cells, providing TME-focused activity and opening a therapeutic window for many tumor-associated antigens that are also expressed by non-tumor healthy tissues.",33514819_5,-1,-1,-1,-1,41341,-1,0.00010192607,0.9998764,2.1646869e-05
41342,tissues,32,33,228,235,"CARTIV platform can improve safety of CAR T-cells or other engineered immune-cells, providing TME-focused activity and opening a therapeutic window for many tumor-associated antigens that are also expressed by non-tumor healthy tissues.",33514819_5,-1,1,2,-1,41342,-1,0.00032565225,0.97645855,0.023215793
41343,The transcription factor,0,3,0,24,"The transcription factor eomesodermin (EOMES) promotes interleukin (IL)-10 expression in CD4+ T cells, which has been linked to immunosuppressive and cytotoxic activities.",33526861_0,-1,-1,-1,-1,41343,-1,5.5932187e-06,0.99998987,4.522068e-06
41348,protein-1,7,8,45,54,"We detected cytotoxic, programmed cell death protein-1 (PD-1) and EOMES co-expressing CD4+ T cells in lymph nodes (LNs) of patients with chronic lymphocytic leukemia (CLL) or diffuse large B-cell lymphoma.",33526861_1,0,1,-1,-1,41348,-1,0.0011307189,0.9856317,0.013237585
41357,genes typical,32,34,192,205,"Transcriptome and flow cytometry analyses revealed that EOMES does not only drive IL-10 expression, but rather controls a unique transcriptional signature in CD4+ T cells, that is enriched in genes typical for T regulatory type 1 (TR1) cells.",33526861_2,-1,-1,-1,-1,41357,-1,4.448134e-06,0.9999912,4.3219698e-06
41362,The TR1 cell,0,3,0,12,"The TR1 cell identity of these CD4+ T cells was supported by their expression of interferon gamma and IL-10, as well as inhibitory receptors including PD-1.",33526861_3,-1,-1,-1,-1,41362,-1,0.0015238315,0.32362294,0.67485327
41368,receptors,25,26,131,140,"The TR1 cell identity of these CD4+ T cells was supported by their expression of interferon gamma and IL-10, as well as inhibitory receptors including PD-1.",33526861_3,0,1,2,-1,41368,-1,2.9311599e-05,8.0959166e-05,0.99988973
41369,TR1 cells,0,2,0,9,TR1 cells with cytotoxic capacity accumulate also in E-TCL1 mice that develop CLL-like disease.,33526861_4,-1,-1,-1,-1,41369,-1,2.1766737e-05,3.269485e-05,0.9999455
41376,that TR1 cell-mediated,3,6,16,38,"We further show that TR1 cell-mediated control of TCL1 leukemia requires IL-10 receptor (IL-10R) signaling, as Il10rb-deficient CD4+ T cells showed impaired antileukemia activity.",33526861_6,-1,-1,-1,-1,41376,-1,0.0015195243,0.43846938,0.5600111
41378,IL-10 receptor,11,13,73,87,"We further show that TR1 cell-mediated control of TCL1 leukemia requires IL-10 receptor (IL-10R) signaling, as Il10rb-deficient CD4+ T cells showed impaired antileukemia activity.",33526861_6,-1,-1,-1,-1,41378,-1,0.9995741,4.3233267e-05,0.0003826774
41385,TR1 cells,16,18,112,121,"Altogether, our data demonstrate that EOMES is indispensable for the development of IL-10-expressing, cytotoxic TR1 cells, which accumulate in LNs of CLL patients and control TCL1 leukemia in mice in an IL-10R-dependent manner.",33526861_7,-1,-1,-1,-1,41385,-1,3.190552e-05,0.000108946195,0.9998591
41389,to the,7,9,36,42,"Glioma stem cells (GSCs) contribute to the malignant growth of glioma, but little is known about the interaction between GSCs and tumor microenvironment.",33576874_0,-1,-1,-1,-1,41389,-1,5.4964016e-06,0.99998844,6.113188e-06
41396,through TGF-,19,21,105,118,"Here, we found that intense infiltration of regulatory T cells (Tregs) facilitated the qualities of GSCs through TGF- secretion that helped coordinately tumor growth.",33576874_1,-1,-1,-1,-1,41396,-1,1.8393806e-05,0.99997354,8.017901e-06
41399,that TGF-,3,5,37,47,"Mechanistic investigations indicated that TGF- acted on cancer cells to induce the core cancer stem cell-related genes CD133, SOX2, NESTIN, MUSASHI1 and ALDH1A expression and spheres formation via NF-B-IL6-STAT3 signaling pathway, resulting in the increased cancer stemness and tumorigenic potential.",33576874_2,-1,-1,-1,-1,41399,-1,1.6570517e-05,0.9999746,8.849466e-06
41400,cells to,8,10,64,72,"Mechanistic investigations indicated that TGF- acted on cancer cells to induce the core cancer stem cell-related genes CD133, SOX2, NESTIN, MUSASHI1 and ALDH1A expression and spheres formation via NF-B-IL6-STAT3 signaling pathway, resulting in the increased cancer stemness and tumorigenic potential.",33576874_2,-1,-1,-1,-1,41400,-1,0.0032087986,0.37006247,0.62672865
41402,cell-related genes,15,17,101,119,"Mechanistic investigations indicated that TGF- acted on cancer cells to induce the core cancer stem cell-related genes CD133, SOX2, NESTIN, MUSASHI1 and ALDH1A expression and spheres formation via NF-B-IL6-STAT3 signaling pathway, resulting in the increased cancer stemness and tumorigenic potential.",33576874_2,-1,-1,-1,-1,41402,-1,0.0014566763,0.04836245,0.9501808
41409,IL6 receptor,17,19,101,113,"Furthermore, Tregs promoted glioma tumor growth, and this effect could be abrogated with blockade of IL6 receptor by tocilizumab which also demonstrated certain level of therapeutic efficacy in xenograft model.",33576874_3,-1,-1,-1,-1,41409,-1,0.99507576,6.7199835e-05,0.004857015
41416,to target this,3,6,18,32,"Moreover, efforts to target this network may be an effective strategy for treating glioma.",33576874_6,-1,-1,-1,-1,41416,-1,4.0320815e-06,0.999992,3.952714e-06
41418,tumor-infiltrating lymphocytes,2,4,16,46,Inactivation of tumor-infiltrating lymphocytes (TIL) is one of the mechanisms mitigating antitumor immunity during tumor onset and progression.,33589517_0,-1,-1,-1,-1,41418,-1,0.005077214,0.76611394,0.22880885
41421,immunity,14,15,99,107,Inactivation of tumor-infiltrating lymphocytes (TIL) is one of the mechanisms mitigating antitumor immunity during tumor onset and progression.,33589517_0,0,-1,2,-1,41421,-1,0.9999114,2.1267626e-05,6.7406596e-05
41423,to the,9,11,70,76,Epigenetic abnormalities are regarded as a major culprit contributing to the dysfunction of TILs within tumor microenvironments.,33589517_1,-1,-1,-1,-1,41423,-1,6.4767037e-06,0.9999887,4.8667157e-06
41428,that Tet2,13,15,62,71,"In this study, we used a murine model of melanoma to discover that Tet2 inactivation significantly enhances the antitumor activity of TILs with an efficacy comparable to immune checkpoint inhibition imposed by anti-PD-L1 treatment.",33589517_2,-1,-1,-1,-1,41428,-1,2.3794082e-05,0.9999672,9.003712e-06
41433,analysis,2,3,27,35,Single-cell RNA-sequencing analysis suggested that Tet2-deficient TILs exhibit effector-like features.,33589517_3,0,1,-1,-1,41433,-1,7.5973626e-06,0.9999865,5.883269e-06
41434,that Tet2-deficient TILs,4,7,46,70,Single-cell RNA-sequencing analysis suggested that Tet2-deficient TILs exhibit effector-like features.,33589517_3,-1,-1,-1,-1,41434,-1,1.1898235e-05,0.99998033,7.720732e-06
41436,analysis,3,4,35,43,Transcriptomic and ATAC-sequencing analysis showed that Tet2 ablation reshapes chromatin accessibility and favors binding of transcription factors geared toward CD8+ T-cell activation.,33589517_4,0,1,-1,-1,41436,-1,7.2708513e-06,0.9999869,5.784855e-06
41437,that Tet2,5,7,51,60,Transcriptomic and ATAC-sequencing analysis showed that Tet2 ablation reshapes chromatin accessibility and favors binding of transcription factors geared toward CD8+ T-cell activation.,33589517_4,-1,-1,-1,-1,41437,-1,1.5460222e-05,0.99997795,6.603493e-06
41444,T-cell function,13,15,83,98,"Furthermore, the ETS family of transcription factors contributed to augmented CD8+ T-cell function following Tet2 depletion.",33589517_5,-1,-1,-1,-1,41444,-1,1.3998912e-05,8.063084e-06,0.99997795
41446,that Tet2,5,7,31,40,"Overall, our study establishes that Tet2 constitutes one of the epigenetic barriers that account for dysfunction of TILs and that Tet2 inactivation could promote antitumor immunity to suppress tumor growth.",33589517_6,-1,-1,-1,-1,41446,-1,2.316262e-05,0.9999695,7.33235e-06
41450,that Tet2,20,22,125,134,"Overall, our study establishes that Tet2 constitutes one of the epigenetic barriers that account for dysfunction of TILs and that Tet2 inactivation could promote antitumor immunity to suppress tumor growth.",33589517_6,-1,-1,-1,-1,41450,-1,2.7429025e-05,0.9999641,8.4728e-06
41451,immunity to,26,28,172,183,"Overall, our study establishes that Tet2 constitutes one of the epigenetic barriers that account for dysfunction of TILs and that Tet2 inactivation could promote antitumor immunity to suppress tumor growth.",33589517_6,-1,-1,-1,-1,41451,-1,0.6075742,0.39026767,0.0021580635
41458,function,16,17,97,105,SIGNIFICANCE: This study suggests that ablation of TET2+ from TILs could promote their antitumor function by reshaping chromatin accessibility for key transcription factors and enhancing the transcription of genes essential for antitumor activity.,33589517_7,0,1,2,-1,41458,-1,9.8730656e-05,0.99981207,8.9214605e-05
41460,the transcription,27,29,187,204,SIGNIFICANCE: This study suggests that ablation of TET2+ from TILs could promote their antitumor function by reshaping chromatin accessibility for key transcription factors and enhancing the transcription of genes essential for antitumor activity.,33589517_7,-1,-1,-1,-1,41460,-1,5.316852e-06,0.99998987,4.7697154e-06
41464,immunity through,14,16,113,129,"CTLA-4 blockade in combination with an agonist OX40-specific monoclonal antibody synergizes to augment antitumor immunity through enhanced T-cell effector function, leading to increased survival in preclinical cancer models.",33593794_0,-1,-1,-1,-1,41464,-1,0.7600958,0.23745629,0.0024479525
41465,T-cell,17,18,139,145,"CTLA-4 blockade in combination with an agonist OX40-specific monoclonal antibody synergizes to augment antitumor immunity through enhanced T-cell effector function, leading to increased survival in preclinical cancer models.",33593794_0,-1,1,2,-1,41465,-1,1.3182427e-05,8.887817e-06,0.9999778
41466,function,19,20,155,163,"CTLA-4 blockade in combination with an agonist OX40-specific monoclonal antibody synergizes to augment antitumor immunity through enhanced T-cell effector function, leading to increased survival in preclinical cancer models.",33593794_0,0,1,2,-1,41466,-1,0.00012470646,0.00035399167,0.99952126
41469,therapy,7,8,64,71,We have shown previously that anti-OX40/anti-CTLA-4 combination therapy synergistically enhances the expression of Eomesodermin (Eomes) in CD8+ T cells.,33593794_1,0,1,-1,-1,41469,-1,5.607177e-06,0.9999894,4.946641e-06
41474,function,11,12,76,84,Eomes is a critical transcription factor for the differentiation and memory function of CD8+ T cells.,33593794_2,0,1,2,-1,41474,-1,0.00075305894,0.9965029,0.0027440258
41483,therapy,14,15,95,102,"Indeed, CD8+ T cell-specific deletion of Eomes abrogated the efficacy of anti-OX40/anti-CTLA-4 therapy.",33593794_4,0,1,-1,-1,41483,-1,5.8437636e-06,0.9999896,4.518347e-06
41486,receptors,14,15,106,115,"We also found that anti-OX40/anti-CTLA-4-induced EomeshiCD8+ T cells expressed lower levels of checkpoint receptors (PD1, Tim-3, and Lag-3) and higher levels of effector cytokines (IFN and TNF) than their Eomeslo counterparts.",33593794_5,0,1,2,-1,41486,-1,5.5290846e-05,0.00069680915,0.99924785
41490,TNF,32,33,190,194,"We also found that anti-OX40/anti-CTLA-4-induced EomeshiCD8+ T cells expressed lower levels of checkpoint receptors (PD1, Tim-3, and Lag-3) and higher levels of effector cytokines (IFN and TNF) than their Eomeslo counterparts.",33593794_5,0,1,-1,-1,41490,-1,0.0023314217,0.9975752,9.339776e-05
41491,than their,34,36,196,206,"We also found that anti-OX40/anti-CTLA-4-induced EomeshiCD8+ T cells expressed lower levels of checkpoint receptors (PD1, Tim-3, and Lag-3) and higher levels of effector cytokines (IFN and TNF) than their Eomeslo counterparts.",33593794_5,-1,-1,-1,-1,41491,-1,6.5158774e-06,0.99998784,5.653976e-06
41492,T cells through interleukin-2-inducible T-cell,6,11,44,90,Eomes expression is negatively regulated in T cells through interleukin-2-inducible T-cell kinase (ITK) signaling.,33593794_6,-1,-1,-1,-1,41492,-1,0.00032913015,7.71227e-05,0.9995938
41496,therapy,21,22,161,168,"We investigated the impact of modulating ITK signaling with ibrutinib, an FDA-approved tyrosine kinase inhibitor, and found that anti-OX40/anti-CTLA-4/ibrutinib therapy further enhanced CD8+ T cell-specific Eomes expression, leading to enhanced tumor regression and improved survival, both of which were associated with increased T-cell effector function across multiple tumor models.",33593794_7,0,1,-1,-1,41496,-1,5.6222375e-06,0.99999,4.38618e-06
41500,T-cell,47,48,330,336,"We investigated the impact of modulating ITK signaling with ibrutinib, an FDA-approved tyrosine kinase inhibitor, and found that anti-OX40/anti-CTLA-4/ibrutinib therapy further enhanced CD8+ T cell-specific Eomes expression, leading to enhanced tumor regression and improved survival, both of which were associated with increased T-cell effector function across multiple tumor models.",33593794_7,-1,1,2,-1,41500,-1,1.2605778e-05,7.71047e-06,0.9999796
41501,function,49,50,346,354,"We investigated the impact of modulating ITK signaling with ibrutinib, an FDA-approved tyrosine kinase inhibitor, and found that anti-OX40/anti-CTLA-4/ibrutinib therapy further enhanced CD8+ T cell-specific Eomes expression, leading to enhanced tumor regression and improved survival, both of which were associated with increased T-cell effector function across multiple tumor models.",33593794_7,0,1,2,-1,41501,-1,0.00020913062,0.00016763862,0.9996232
41503,Taken together,0,2,0,14,"Taken together, these data demonstrate the potential of anti-OX40/anti-CTLA-4/ibrutinib as a triple therapy to improve the efficacy of immunotherapy.",33593794_8,-1,-1,-1,-1,41503,-1,9.86347e-06,0.99998176,8.372895e-06
41506,triple therapy to,12,15,93,110,"Taken together, these data demonstrate the potential of anti-OX40/anti-CTLA-4/ibrutinib as a triple therapy to improve the efficacy of immunotherapy.",33593794_8,-1,-1,-1,-1,41506,-1,6.3634952e-06,0.99998736,6.2661475e-06
41508,Th17 cells,3,5,16,26,An imbalance in Th17 cells and Tregs may be an important cause of the pathogenesis of thymoma with myasthenia gravis (MG).,33636431_0,-1,-1,-1,-1,41508,-1,0.0009190993,0.05563615,0.9434448
41515,analysis,2,3,15,23,"Flow cytometry analysis of Th17 and Tregs in peripheral blood revealed that the percentages of Th17 in thymoma were lower than those in thymoma with MG, while the percentages of Tregs were higher than those in simple thymoma.",33636431_2,0,1,-1,-1,41515,-1,1.242134e-05,0.9999794,8.259087e-06
41518,blood,9,10,56,61,"Flow cytometry analysis of Th17 and Tregs in peripheral blood revealed that the percentages of Th17 in thymoma were lower than those in thymoma with MG, while the percentages of Tregs were higher than those in simple thymoma.",33636431_2,0,1,-1,-1,41518,-1,0.0042294515,0.04518593,0.95058453
41519,that the,11,13,71,79,"Flow cytometry analysis of Th17 and Tregs in peripheral blood revealed that the percentages of Th17 in thymoma were lower than those in thymoma with MG, while the percentages of Tregs were higher than those in simple thymoma.",33636431_2,-1,-1,-1,-1,41519,-1,4.625737e-06,0.99999106,4.331844e-06
41522,than those,20,22,122,132,"Flow cytometry analysis of Th17 and Tregs in peripheral blood revealed that the percentages of Th17 in thymoma were lower than those in thymoma with MG, while the percentages of Tregs were higher than those in simple thymoma.",33636431_2,-1,-1,-1,-1,41522,-1,7.104283e-06,0.99998665,6.2670756e-06
41526,than those,34,36,196,206,"Flow cytometry analysis of Th17 and Tregs in peripheral blood revealed that the percentages of Th17 in thymoma were lower than those in thymoma with MG, while the percentages of Tregs were higher than those in simple thymoma.",33636431_2,-1,-1,-1,-1,41526,-1,6.2928216e-06,0.99998844,5.3011186e-06
41529,that IL-6,5,7,35,44,Serum cytokine ELISA assays showed that IL-6 levels in simple thymoma were lower than those in MG patients.,33636431_3,-1,-1,-1,-1,41529,-1,0.92734593,0.07020291,0.002451181
41531,than those,13,15,81,91,Serum cytokine ELISA assays showed that IL-6 levels in simple thymoma were lower than those in MG patients.,33636431_3,-1,-1,-1,-1,41531,-1,1.05022755e-05,0.999982,7.467533e-06
41534,thymoma tissue,13,15,87,101,"Further, Th17 and Tregs levels were detected by immunohistochemical double staining of thymoma tissue; the number of positive Th17 cells in thymoma with MG was higher than that in simple thymoma, while positive Tregs showed the opposite results.",33636431_4,-1,-1,-1,-1,41534,-1,1.3771156e-05,0.99995303,3.3246e-05
41536,Th17 cells,20,22,126,136,"Further, Th17 and Tregs levels were detected by immunohistochemical double staining of thymoma tissue; the number of positive Th17 cells in thymoma with MG was higher than that in simple thymoma, while positive Tregs showed the opposite results.",33636431_4,-1,-1,-1,-1,41536,-1,6.084858e-05,0.00022157501,0.99971753
41538,than that,28,30,167,176,"Further, Th17 and Tregs levels were detected by immunohistochemical double staining of thymoma tissue; the number of positive Th17 cells in thymoma with MG was higher than that in simple thymoma, while positive Tregs showed the opposite results.",33636431_4,-1,-1,-1,-1,41538,-1,6.72015e-06,0.99998796,5.3015006e-06
41542,protein,1,2,6,13,RORt protein and mRNA expression in thymoma with MG were both higher than those in simple thymoma.,33636431_5,0,1,-1,-1,41542,-1,1.5346643e-05,0.99996936,1.5307847e-05
41544,than those,12,14,70,80,RORt protein and mRNA expression in thymoma with MG were both higher than those in simple thymoma.,33636431_5,-1,-1,-1,-1,41544,-1,9.972355e-06,0.99998355,6.473638e-06
41546,FOXP3 protein,0,2,0,13,FOXP3 protein and mRNA expression in the thymoma with MG group were lower than those in simple thymoma.,33636431_6,-1,-1,-1,-1,41546,-1,6.5391e-06,0.99998736,6.0385614e-06
41547,the thymoma,6,8,37,48,FOXP3 protein and mRNA expression in the thymoma with MG group were lower than those in simple thymoma.,33636431_6,-1,-1,-1,-1,41547,-1,6.199676e-06,0.9999876,6.2483664e-06
41548,than those,13,15,74,84,FOXP3 protein and mRNA expression in the thymoma with MG group were lower than those in simple thymoma.,33636431_6,-1,-1,-1,-1,41548,-1,7.838402e-06,0.9999865,5.6708654e-06
41551,thymoma cells,5,7,28,41,The results of coculture of thymoma cells and CD4 + T cells showed that thymoma cells could promote the differentiation of Th17 cells and inhibit the Tregs.,33636431_7,-1,-1,-1,-1,41551,-1,0.002218612,0.38169324,0.61608815
41553,that thymoma cells,13,16,67,85,The results of coculture of thymoma cells and CD4 + T cells showed that thymoma cells could promote the differentiation of Th17 cells and inhibit the Tregs.,33636431_7,-1,-1,-1,-1,41553,-1,0.0031188177,0.6547146,0.34216657
41555,Th17 cells,21,23,123,133,The results of coculture of thymoma cells and CD4 + T cells showed that thymoma cells could promote the differentiation of Th17 cells and inhibit the Tregs.,33636431_7,-1,-1,-1,-1,41555,-1,0.00025167788,0.00930039,0.9904479
41556,the Tregs,25,27,146,155,The results of coculture of thymoma cells and CD4 + T cells showed that thymoma cells could promote the differentiation of Th17 cells and inhibit the Tregs.,33636431_7,-1,-1,-1,-1,41556,-1,4.391011e-06,0.99999106,4.5253178e-06
41557,Th17 cells,2,4,9,19,"Overall, Th17 cells and related transcription factors and cytokines in thymoma with MG patients were higher than those in thymoma patients, whereas, Tregs showed the opposite results, the mechanism may be that thymoma can secrete IL6 and IL21.",33636431_8,-1,-1,-1,-1,41557,-1,0.00010152055,0.0013495883,0.9985488
41558,related transcription factors,5,8,24,53,"Overall, Th17 cells and related transcription factors and cytokines in thymoma with MG patients were higher than those in thymoma patients, whereas, Tregs showed the opposite results, the mechanism may be that thymoma can secrete IL6 and IL21.",33636431_8,-1,-1,-1,-1,41558,-1,5.0444723e-06,0.9999889,6.0254206e-06
41561,than those,17,19,108,118,"Overall, Th17 cells and related transcription factors and cytokines in thymoma with MG patients were higher than those in thymoma patients, whereas, Tregs showed the opposite results, the mechanism may be that thymoma can secrete IL6 and IL21.",33636431_8,-1,-1,-1,-1,41561,-1,8.426737e-06,0.99998486,6.7280102e-06
41566,that thymoma,35,37,205,217,"Overall, Th17 cells and related transcription factors and cytokines in thymoma with MG patients were higher than those in thymoma patients, whereas, Tregs showed the opposite results, the mechanism may be that thymoma can secrete IL6 and IL21.",33636431_8,-1,-1,-1,-1,41566,-1,9.731006e-06,0.9999821,8.1169e-06
41578,immunity,28,29,156,164,Outcomes for triple negative breast cancer (TNBC) are poor and may be improved by increasing CD8+ tumor infiltrating lymphocytes (TIL) to augment antitumor immunity.,33647370_0,0,-1,2,-1,41578,-1,0.9999037,2.4718496e-05,7.167091e-05
41585,immunity,36,37,228,236,"Because metabolic alterations affect immune homeostasis and prior studies show caloric restriction (CR) combined with RT improves preclinical TNBC outcomes, we hypothesized that CR augments RT, in part, by altering intratumoral immunity.",33647370_2,0,-1,2,-1,41585,-1,0.99962485,0.00018052715,0.00019454131
41598,the tumor,12,14,56,65,"In addition, PD-1 expression on CD3+CD8+ Tcells within the tumor microenvironment was significantly increased in CR + RT versus AL + RT treated mice as per immunofluorescence.",33647370_6,-1,-1,-1,-1,41598,-1,4.0083924e-06,0.9999913,4.743647e-06
41614,gland that,12,14,55,65,"Warthin tumour (WT) is a benign tumour of the salivary gland that proliferates in both glandular epithelial and lymphoid tissue components, and rarely exhibits cystic changes.",33647861_0,-1,-1,-1,-1,41614,-1,0.010904216,0.5624348,0.42666095
41623,plasma cells,24,26,135,147,"T follicular helper cells (Tfh) are involved in the formation and maintenance of germinal centres, the differentiation of B cells into plasma cells, and the maintenance of helper T cell type 2 (Th2)-dominant humoral immune responses.",33647861_1,-1,-1,-1,-1,41623,-1,1.8059489e-05,1.2194597e-05,0.99996984
41625,helper T cell type,31,35,172,190,"T follicular helper cells (Tfh) are involved in the formation and maintenance of germinal centres, the differentiation of B cells into plasma cells, and the maintenance of helper T cell type 2 (Th2)-dominant humoral immune responses.",33647861_1,-1,-1,-1,-1,41625,-1,3.382681e-05,7.3493815e-05,0.9998926
41628,helper T cell type,4,8,35,53,T-bet induces differentiation into helper T cell type 1 (Th1) by suppressing differentiation into Tfh and enhances cellular immune responses.,33647861_2,-1,-1,-1,-1,41628,-1,9.0299596e-05,0.0005881431,0.9993216
41631,cellular immune responses,19,22,115,140,T-bet induces differentiation into helper T cell type 1 (Th1) by suppressing differentiation into Tfh and enhances cellular immune responses.,33647861_2,-1,-1,-1,-1,41631,-1,0.8762886,0.00061100547,0.12310047
41635,the immune responses,11,14,64,84,The objective of this study was to enhance our understanding of the immune responses and relationship between Tfh and Th1 cells in patients with WTs.,33647861_3,-1,-1,-1,-1,41635,-1,0.52766865,0.47042766,0.0019036874
41640,the Tfh,5,7,36,43,"We also performed immunostaining of the Tfh markers CXCR5 and CD40 L, and the Th1 marker T-bet for statistical analysis.",33647861_5,-1,-1,-1,-1,41640,-1,6.1128007e-06,0.9999881,5.8644337e-06
41641,the Th1,14,16,74,81,"We also performed immunostaining of the Tfh markers CXCR5 and CD40 L, and the Th1 marker T-bet for statistical analysis.",33647861_5,-1,-1,-1,-1,41641,-1,4.1933836e-06,0.99998593,9.871605e-06
41643,statistical analysis,19,21,99,119,"We also performed immunostaining of the Tfh markers CXCR5 and CD40 L, and the Th1 marker T-bet for statistical analysis.",33647861_5,-1,-1,-1,-1,41643,-1,9.445411e-06,0.9999838,6.738213e-06
41646,Tfh-positive lymphocytes,18,20,106,130,"The cyst-type exhibited significant atrophy of the germinal centre area (P = 0.0019), significantly fewer Tfh-positive lymphocytes in germinal centres (P < 0.0001), and significantly more T-bet-positive lymphocytes in the epithelium (P = 0.0017).",33647861_6,-1,-1,-1,-1,41646,-1,0.001768988,0.83299875,0.16523232
41647,T-bet-positive lymphocytes,32,34,188,214,"The cyst-type exhibited significant atrophy of the germinal centre area (P = 0.0019), significantly fewer Tfh-positive lymphocytes in germinal centres (P < 0.0001), and significantly more T-bet-positive lymphocytes in the epithelium (P = 0.0017).",33647861_6,-1,-1,-1,-1,41647,-1,0.0012493577,0.92013264,0.07861808
41649,that Tfh,2,4,12,20,We observed that Tfh were involved in the formation and maintenance of lymphoid follicles in WTs.,33647861_7,-1,-1,-1,-1,41649,-1,1.2420184e-05,0.9999807,6.922849e-06
41654,Th1-dominant cellular immune responses,12,16,77,115,"In the cyst-type, Th2-dominant humoral immune responses were suppressed, and Th1-dominant cellular immune responses may have caused damage to tumour tissue.",33647861_8,-1,-1,-1,-1,41654,-1,0.15075544,0.8405706,0.00867393
41655,to tumour tissue,20,23,139,155,"In the cyst-type, Th2-dominant humoral immune responses were suppressed, and Th1-dominant cellular immune responses may have caused damage to tumour tissue.",33647861_8,-1,-1,-1,-1,41655,-1,0.00014181457,0.99852127,0.0013369911
41661,blood,15,16,77,82,We isolated HLA-DR-CD33+ MDSCs and CD3+ T cells from BC patients' peripheral blood and healthy donors through MACS and immunophenotyped by flow cytometry.,33679700_3,0,1,-1,-1,41661,-1,0.0029898756,0.19161375,0.8053963
41667,These cells,0,2,0,11,These cells strongly suppress both autologous and analogous CD3+ T cell proliferation and enter the tumor microenvironment.,33679700_7,-1,-1,-1,-1,41667,-1,1.6828897e-05,9.361807e-06,0.9999738
41669,the tumor,15,17,96,105,These cells strongly suppress both autologous and analogous CD3+ T cell proliferation and enter the tumor microenvironment.,33679700_7,-1,-1,-1,-1,41669,-1,4.551856e-06,0.9999913,4.153732e-06
41696,that IRF-1,4,6,22,32,"Here, we investigated that IRF-1 regulates C-X-C motif chemokine 10 (CXCL10) and chemokine receptor 3 (CXCR3) to activate anti-tumor immunity in HCC.",33689775_1,-1,-1,-1,-1,41696,-1,6.063798e-06,0.9999808,1.3175139e-05
41699,chemokine receptor,15,17,81,99,"Here, we investigated that IRF-1 regulates C-X-C motif chemokine 10 (CXCL10) and chemokine receptor 3 (CXCR3) to activate anti-tumor immunity in HCC.",33689775_1,-1,-1,-1,-1,41699,-1,0.98540986,0.00010529112,0.014484933
41701,immunity,24,25,133,141,"Here, we investigated that IRF-1 regulates C-X-C motif chemokine 10 (CXCL10) and chemokine receptor 3 (CXCR3) to activate anti-tumor immunity in HCC.",33689775_1,0,-1,2,-1,41701,-1,0.99983263,5.2358086e-05,0.00011505313
41702,that IRF-1,2,4,9,19,We found that IRF-1 mRNA expression was positively correlated with CXCL10 and CXCR3 through qRT-PCR assay in HCC tumors and in analysis of the TCGA database.,33689775_2,-1,-1,-1,-1,41702,-1,8.948943e-06,0.9999701,2.1026559e-05
41706,analysis,21,22,127,135,We found that IRF-1 mRNA expression was positively correlated with CXCL10 and CXCR3 through qRT-PCR assay in HCC tumors and in analysis of the TCGA database.,33689775_2,0,1,-1,-1,41706,-1,4.5691268e-06,0.99999046,5.0245208e-06
41707,the TCGA,23,25,139,147,We found that IRF-1 mRNA expression was positively correlated with CXCL10 and CXCR3 through qRT-PCR assay in HCC tumors and in analysis of the TCGA database.,33689775_2,-1,-1,-1,-1,41707,-1,1.4974128e-05,0.9999728,1.2231706e-05
41709,the CXCL10,6,8,43,53,"IRF-1 response elements were identified in the CXCL10 promoter region, and ChIP-qPCR confirmed IRF-1 binding to promote CXCL10 transcription.",33689775_3,-1,-1,-1,-1,41709,-1,0.7900366,0.20735712,0.0026062168
41712,CXCL10 transcription,18,20,120,140,"IRF-1 response elements were identified in the CXCL10 promoter region, and ChIP-qPCR confirmed IRF-1 binding to promote CXCL10 transcription.",33689775_3,-1,-1,-1,-1,41712,-1,0.9948147,0.0036919657,0.0014933132
41722,that IRF-1,7,9,36,46,"In vitro and in vivo studies showed that IRF-1 increased CD8+ T cells, NK and NKT cells migration, and activated IFN- secretion in NK and NKT cells to induce tumor apoptosis through the CXCL10/CXCR3 paracrine axis.",33689775_6,-1,-1,-1,-1,41722,-1,6.926494e-06,0.99998164,1.1474442e-05
41726,NKT cells to,28,31,139,151,"In vitro and in vivo studies showed that IRF-1 increased CD8+ T cells, NK and NKT cells migration, and activated IFN- secretion in NK and NKT cells to induce tumor apoptosis through the CXCL10/CXCR3 paracrine axis.",33689775_6,-1,-1,-1,-1,41726,-1,0.0019248282,0.40001684,0.59805834
41728,through the,34,36,175,186,"In vitro and in vivo studies showed that IRF-1 increased CD8+ T cells, NK and NKT cells migration, and activated IFN- secretion in NK and NKT cells to induce tumor apoptosis through the CXCL10/CXCR3 paracrine axis.",33689775_6,-1,-1,-1,-1,41728,-1,5.8056603e-06,0.9999901,4.118141e-06
41733,to the,6,8,51,57,"Therefore, the IRF-1/CXCL10/CXCR3 axis contributes to the anti-tumor microenvironment in HCC.",33689775_8,-1,-1,-1,-1,41733,-1,5.052044e-06,0.9999896,5.355384e-06
41735,factors,4,5,23,30,The mechanisms and key factors involved in tumor environments for lung metastasis of CRC are still unclear.,33707428_0,0,1,-1,-1,41735,-1,1.7630135e-05,0.99997616,6.170778e-06
41745,tumor cells,31,33,151,162,"Erbin deletion in B cells suppressed lung metastasis of CRC in vivo. And, deletion of Erbin in B cells enhanced the killing effects of CD8+ T cells on tumor cells.",33707428_3,-1,-1,-1,-1,41745,-1,0.00010207883,0.00065215013,0.99924576
41762,cells that,5,7,30,40,"For tumor engraftment, HGC-27 cells that received LINC00152 shRNA, LINC00152 overexpression vectors, enhancer of zeste homolog 2 (EZH2) shRNA or combination transfection were injected into mice.",33709190_2,-1,-1,-1,-1,41762,-1,0.0027268894,0.18722805,0.81004506
41771,T-cell,9,10,47,53,Flow cytometry was adopted to measure the CD8+ T-cell infiltration in tumor issue.,33709190_4,-1,1,2,-1,41771,-1,1.34707725e-05,7.009731e-06,0.9999795
41777,to the,7,9,49,55,"ChIP assay verified that LINC00152 recruits EZH2 to the promoters of CXCL9 and CXCL10, thus the silencing of LINC00152 promoted the production of CXCL9 and CXCL10.",33709190_6,-1,-1,-1,-1,41777,-1,4.8263173e-06,0.9999901,5.025032e-06
41779,thus the,15,17,87,95,"ChIP assay verified that LINC00152 recruits EZH2 to the promoters of CXCL9 and CXCL10, thus the silencing of LINC00152 promoted the production of CXCL9 and CXCL10.",33709190_6,-1,-1,-1,-1,41779,-1,4.1044955e-06,0.9999918,4.1001376e-06
41782,tumor cells,4,6,34,45,"Knockdown of LINC00152 suppressed tumor cells growth in vivo and in vitro, increased tumor-infiltrating CD8+ T cells numbers and promoted the expression of CXCL9, CXCL10 and C-X-C Motif Chemokine Receptor 3 (CXCR3) in xenograft tumors.",33709190_7,-1,-1,-1,-1,41782,-1,0.00013923322,0.0027710386,0.9970898
41787,Chemokine Receptor,31,33,186,204,"Knockdown of LINC00152 suppressed tumor cells growth in vivo and in vitro, increased tumor-infiltrating CD8+ T cells numbers and promoted the expression of CXCL9, CXCL10 and C-X-C Motif Chemokine Receptor 3 (CXCR3) in xenograft tumors.",33709190_7,-1,-1,-1,-1,41787,-1,0.97945374,8.690298e-05,0.020459427
41790,the tumor,7,9,37,46,While CD8+ T cell depletion reversed the tumor suppression effect of LINC00152 silence.,33709190_8,-1,-1,-1,-1,41790,-1,4.8108204e-06,0.9999907,4.5092947e-06
41795,the tumor,7,9,57,66,Our study indicated that LINC00152 inhibition suppressed the tumor progress may through promoting CD8+ T-cell infiltration.,33709190_10,-1,-1,-1,-1,41795,-1,3.810545e-06,0.9999914,4.7309077e-06
41797,T-cell,15,16,103,109,Our study indicated that LINC00152 inhibition suppressed the tumor progress may through promoting CD8+ T-cell infiltration.,33709190_10,-1,1,2,-1,41797,-1,1.4109145e-05,7.4053614e-06,0.99997854
41799,factors,14,15,101,108,Immune escape mechanisms employed by neuroblastoma (NB) cells include secretion of immunosuppressive factors disrupting effective antitumor immunity.,33737337_0,0,1,-1,-1,41799,-1,0.3235346,0.6759528,0.0005126221
41800,immunity,18,19,140,148,Immune escape mechanisms employed by neuroblastoma (NB) cells include secretion of immunosuppressive factors disrupting effective antitumor immunity.,33737337_0,0,-1,2,-1,41800,-1,0.9999299,1.7438626e-05,5.2716172e-05
41802,cellular therapy to treat,3,7,11,36,The use of cellular therapy to treat solid tumors needs to be implemented.,33737337_1,-1,-1,-1,-1,41802,-1,0.011269828,0.60678786,0.38194233
41812,analysis,31,32,182,190,Killing activity of anti-GD2 Chimeric Antigen Receptor (CAR) T or natural killer (NK) cells against target NB cells was assessed through coculture experiments and quantified by FACS analysis.,33737337_2,0,1,-1,-1,41812,-1,5.3074687e-06,0.99998784,6.808819e-06
41820,protein,12,13,66,73,Real Time PCR and Western Blot were performed to analyze gene and protein levels modifications.,33737337_4,0,1,-1,-1,41820,-1,1.660348e-05,0.99996495,1.8407565e-05
41823,tissue,1,2,3,9,NB tissue sample were analyzed by IHC and Real Time PCR to perform correlation study.,33737337_6,-1,1,2,-1,41823,-1,5.414123e-05,0.99921536,0.0007304627
41834,T-cell,20,21,97,103,"In NB, IDO1 is able to inhibit the anti-tumor effect displayed by of both anti-GD2 CAR (GD2.CAR) T-cell and NK cells, mainly by impairing their IFN production.",33737337_8,-1,1,2,-1,41834,-1,1.2595088e-05,1.0270757e-05,0.9999771
41836,their IFN,28,30,138,148,"In NB, IDO1 is able to inhibit the anti-tumor effect displayed by of both anti-GD2 CAR (GD2.CAR) T-cell and NK cells, mainly by impairing their IFN production.",33737337_8,-1,-1,-1,-1,41836,-1,0.943591,0.05375125,0.00265782
41846,T-cell,17,18,94,100,The evidence of IDO1 involvement in NB immune escape and its ability to impair NK and GD2.CAR T-cell activity contribute to clarify one of the possible mechanisms responsible for the limited efficacy of these immunotherapeutic approaches.,33737337_12,-1,1,2,-1,41846,-1,1.4237171e-05,9.437283e-06,0.9999764
41851,therapy,2,3,11,18,"A combined therapy of NK or GD2.CAR T-cells with IDO1 inhibitors, a class of compounds already in phase I/II clinical studies, could represent a new and still unexplored strategy capable to improve long-term efficacy of these immunotherapeutic approaches.",33737337_13,0,1,-1,-1,41851,-1,4.6624964e-06,0.99999094,4.351536e-06
41852,T-cells,7,8,36,43,"A combined therapy of NK or GD2.CAR T-cells with IDO1 inhibitors, a class of compounds already in phase I/II clinical studies, could represent a new and still unexplored strategy capable to improve long-term efficacy of these immunotherapeutic approaches.",33737337_13,-1,1,2,-1,41852,-1,1.7575028e-05,1.6398017e-05,0.999966
41858,tumor cell,5,7,35,45,"Virotherapy is proposed to achieve tumor cell killing, while indirectly activating innate immunity.",33767151_1,-1,-1,-1,-1,41858,-1,0.0005067847,0.017361382,0.98213184
41861,therapy,7,8,44,51,"Here, we report that recombinant poliovirus therapy primarily mediates antitumor immunotherapy via direct infection of non-malignant tumor microenvironment (TME) cells, independent of malignant cell lysis.",33767151_2,0,1,-1,-1,41861,-1,7.1034037e-06,0.9999877,5.1969764e-06
41866,Relative to,0,2,0,11,"Relative to other innate immune agonists, virotherapy provokes selective, TBK1-IRF3 driven innate inflammation that is associated with sustained type-I/III interferon (IFN) release.",33767151_3,-1,-1,-1,-1,41866,-1,8.145502e-06,0.9999852,6.6140155e-06
41867,agonists,5,6,32,40,"Relative to other innate immune agonists, virotherapy provokes selective, TBK1-IRF3 driven innate inflammation that is associated with sustained type-I/III interferon (IFN) release.",33767151_3,0,1,-1,-1,41867,-1,0.9988336,0.0001890564,0.0009772722
41878,type-I IFN,1,3,12,22,"Recombinant type-I IFN increases tumor-localized T cell function, but does not mediate durable antitumor immunotherapy without concomitant pattern recognition receptor (PRR) signaling.",33767151_5,-1,-1,-1,-1,41878,-1,0.42162764,0.5730408,0.0053315205
41879,tumor-localized T cell function,4,8,33,64,"Recombinant type-I IFN increases tumor-localized T cell function, but does not mediate durable antitumor immunotherapy without concomitant pattern recognition receptor (PRR) signaling.",33767151_5,-1,-1,-1,-1,41879,-1,0.0033140313,0.58869463,0.4079913
41880,receptor,20,21,159,167,"Recombinant type-I IFN increases tumor-localized T cell function, but does not mediate durable antitumor immunotherapy without concomitant pattern recognition receptor (PRR) signaling.",33767151_5,0,1,2,-1,41880,-1,0.00069283956,0.00017084609,0.9991364
41882,the TME,6,8,48,55,"Thus, virus-induced MDA5-TBK1-IRF3 signaling in the TME provides PRR-contextualized IFN responses that elicit functional antitumor T cell immunity.",33767151_6,-1,-1,-1,-1,41882,-1,7.5169232e-06,0.99998426,8.175012e-06
41885,functional,14,15,110,120,"Thus, virus-induced MDA5-TBK1-IRF3 signaling in the TME provides PRR-contextualized IFN responses that elicit functional antitumor T cell immunity.",33767151_6,0,1,2,-1,41885,-1,0.00029832064,0.9996141,8.7569286e-05
41886,T cell immunity,16,19,131,146,"Thus, virus-induced MDA5-TBK1-IRF3 signaling in the TME provides PRR-contextualized IFN responses that elicit functional antitumor T cell immunity.",33767151_6,-1,-1,-1,-1,41886,-1,0.00027743986,2.1166934e-05,0.9997013
41889,function,6,7,57,65,TBK1-IRF3 innate signal transduction stimulates eventual function and differentiation of tumor-infiltrating T cells.,33767151_7,0,1,2,-1,41889,-1,3.6657166e-05,0.9999198,4.3570337e-05
41890,tumor-infiltrating T cells,10,13,89,115,TBK1-IRF3 innate signal transduction stimulates eventual function and differentiation of tumor-infiltrating T cells.,33767151_7,-1,-1,-1,-1,41890,-1,0.0024877999,0.8228768,0.17463537
41892,factor that,7,9,35,46,"Immune activation in BLBC is a key factor that influences both cancer progression and therapeutic response, although its molecular mechanisms are not well clarified.",33767579_1,-1,-1,-1,-1,41892,-1,1.4362387e-05,0.99997926,6.3266775e-06
41895,immunity-related,8,9,39,55,"In this study, we examined five cancer immunity-related pathways (IFN, IFN, STAT3, TGF and TNF) in four large independent breast cancer cohorts (n = 6,381) and their associations with the prognosis of breast cancer subtypes.",33767579_2,0,-1,2,-1,41895,-1,0.97402656,0.02478349,0.0011899786
41900,TNF,19,20,94,98,"In this study, we examined five cancer immunity-related pathways (IFN, IFN, STAT3, TGF and TNF) in four large independent breast cancer cohorts (n = 6,381) and their associations with the prognosis of breast cancer subtypes.",33767579_2,0,1,-1,-1,41900,-1,4.1262876e-05,0.99993825,2.0457699e-05
41904,analysis,23,24,169,177,Activities of the 5 pathways were calculated based on corresponding pathway signatures and associations between pathways and clinical outcomes were examined by survival analysis.,33767579_3,0,1,-1,-1,41904,-1,2.7134423e-05,0.9999534,1.9441557e-05
41909,TNF,14,15,70,74,"Among the five PAM50-based subtypes, BLBC had the highest IFN, IFN, TNF pathway activities, and the lowest TGF activity.",33767579_4,0,1,-1,-1,41909,-1,4.9712504e-05,0.9999275,2.270853e-05
41912,The IFN,0,2,0,8,"The IFN, IFN, TNF pathway activities were negatively correlated with BLBC recurrence.",33767579_5,-1,-1,-1,-1,41912,-1,0.8455541,0.15163352,0.0028123688
41914,TNF,5,6,16,20,"The IFN, IFN, TNF pathway activities were negatively correlated with BLBC recurrence.",33767579_5,0,1,-1,-1,41914,-1,0.00012825687,0.99983585,3.5915906e-05
41919,cell subset analysis,1,4,7,27,"Immune cell subset analysis in BLBC showed that M0, M1 and M2 macrophage levels were associated with either TNF or TGF pathways, whereas the level of activated memory CD4 T cells were associated with both pathways.",33767579_8,-1,-1,-1,-1,41919,-1,0.000112073554,0.00014130831,0.9997466
41921,TNF,19,20,108,112,"Immune cell subset analysis in BLBC showed that M0, M1 and M2 macrophage levels were associated with either TNF or TGF pathways, whereas the level of activated memory CD4 T cells were associated with both pathways.",33767579_8,0,1,-1,-1,41921,-1,4.7373174e-05,0.9999354,1.7210541e-05
41925,this T cell subset,2,6,10,28,"Moreover, this T cell subset was most abundant in BLBCs with low TGF and high TNF pathway activities.",33767579_9,-1,-1,-1,-1,41925,-1,0.00080591417,0.03948576,0.95970833
41927,TNF,16,17,79,83,"Moreover, this T cell subset was most abundant in BLBCs with low TGF and high TNF pathway activities.",33767579_9,0,1,-1,-1,41927,-1,4.059653e-05,0.99994266,1.6693704e-05
41929,that cooperation,3,5,24,40,These results suggested that cooperation of TNF and TGF signaling may be involved in the regulation of memory T cells and anti-cancer immunity in BLBCs.,33767579_10,-1,-1,-1,-1,41929,-1,5.3988124e-06,0.99999046,4.1755443e-06
41930,TNF,6,7,44,48,These results suggested that cooperation of TNF and TGF signaling may be involved in the regulation of memory T cells and anti-cancer immunity in BLBCs.,33767579_10,0,1,-1,-1,41930,-1,1.57612e-05,0.99997437,9.8294895e-06
41932,the regulation,14,16,87,101,These results suggested that cooperation of TNF and TGF signaling may be involved in the regulation of memory T cells and anti-cancer immunity in BLBCs.,33767579_10,-1,-1,-1,-1,41932,-1,4.4307653e-06,0.9999908,4.7986828e-06
41934,immunity,22,23,136,144,These results suggested that cooperation of TNF and TGF signaling may be involved in the regulation of memory T cells and anti-cancer immunity in BLBCs.,33767579_10,0,-1,2,-1,41934,-1,0.9998209,6.2103136e-05,0.00011706157
41937,growth factor receptor,22,25,157,179,"BACKGROUND: Poly-(ADP-Ribose)-Polymerase inhibitors (PARPi) were reported as radiosensitizers in non-small cell lung cancer (NSCLC) with wide-type epidermal growth factor receptor (EGFR), but the effects of radiation combined with PARPi were not investigated in EGFR-mutated NSCLC.",33774805_0,-1,-1,-1,-1,41937,-1,0.99359447,5.0895607e-05,0.006354642
41959,immunity,6,7,51,59,"Radiation plus niraparib could activate anti-tumor immunity, which appeared as increased CD8+ T lymphocytes and activated STING/TBK1/IRF3 pathway.",33774805_8,0,-1,2,-1,41959,-1,0.99953914,0.00011380527,0.0003470933
41965,tumorigenesis through,13,15,73,94,Programmed death ligand 1 (PD-L1) plays a significant role in colorectal tumorigenesis through induction of regulatory T cells (Tregs) and suppression of antitumor immunity.,33821473_0,-1,-1,-1,-1,41965,-1,4.3274827e-06,0.9999908,4.7975204e-06
41968,immunity,27,28,164,172,Programmed death ligand 1 (PD-L1) plays a significant role in colorectal tumorigenesis through induction of regulatory T cells (Tregs) and suppression of antitumor immunity.,33821473_0,0,-1,2,-1,41968,-1,0.9998958,3.340835e-05,7.07501e-05
41971,therapeutic target,18,20,120,138,"Furthermore, microRNAs (miRNAs) as the posttranscriptional regulators of gene expression show considerable promise as a therapeutic target for colorectal cancer (CRC) treatment.",33821473_1,-1,-1,-1,-1,41971,-1,4.634508e-06,0.99999046,4.889156e-06
41974,cell tumorigenesis,15,17,68,86,"Considering this, in vitro effects of miRNA-124 (miR-124-3p) on CRC cell tumorigenesis and Tregs differentiation via targeting PD-L1were investigated in the current study.",33821473_2,-1,-1,-1,-1,41974,-1,0.00091315,0.087767676,0.91131926
41978,Functional analysis,0,2,0,19,"Functional analysis showed that miR-124 is significantly downregulated in CRC tissues as compared with marginal normal samples (p<.0001), and its downregulation was negatively correlated with PD-L1 expression.",33821473_3,-1,-1,-1,-1,41978,-1,1.309854e-05,0.9999788,8.138298e-06
41980,tissues,10,11,78,85,"Functional analysis showed that miR-124 is significantly downregulated in CRC tissues as compared with marginal normal samples (p<.0001), and its downregulation was negatively correlated with PD-L1 expression.",33821473_3,-1,1,2,-1,41980,-1,0.00037993008,0.23093547,0.76868457
41984,that transfection,3,5,29,46,"Further investigation showed that transfection of HT29 and SW480 cells with miR-124 mimics significantly reduced PD-L1 mRNA, protein, and cell surface expression, and inhibited Tregs in coculture models via modulating interleukin[IL]-10, IL-2, tumor necrosis factor , transforming growth factor beta, and interferon gamma expression levels.",33821473_5,-1,-1,-1,-1,41984,-1,3.8572043e-06,0.9999912,4.946018e-06
41986,protein,18,19,125,132,"Further investigation showed that transfection of HT29 and SW480 cells with miR-124 mimics significantly reduced PD-L1 mRNA, protein, and cell surface expression, and inhibited Tregs in coculture models via modulating interleukin[IL]-10, IL-2, tumor necrosis factor , transforming growth factor beta, and interferon gamma expression levels.",33821473_5,0,1,-1,-1,41986,-1,8.029709e-06,0.99998045,1.1507173e-05
42000,that STAT3,3,5,20,30,We also illustrated that STAT3 signaling was repressed by miR-124 in CRC cells.,33821473_9,-1,-1,-1,-1,42000,-1,8.527997e-06,0.99998605,5.36972e-06
42002,Taken together,0,2,0,14,"Taken together, our findings imply that considering the involvement of miR-124 in the regulation of PD-L1 through colorectal tumorigenesis and its remarkable antitumor effects, this miRNA could be regarded as the promising target for the development of therapeutic approaches for colorectal cancer.",33821473_10,-1,-1,-1,-1,42002,-1,7.5103408e-06,0.9999856,6.9313123e-06
42005,the regulation,13,15,82,96,"Taken together, our findings imply that considering the involvement of miR-124 in the regulation of PD-L1 through colorectal tumorigenesis and its remarkable antitumor effects, this miRNA could be regarded as the promising target for the development of therapeutic approaches for colorectal cancer.",33821473_10,-1,-1,-1,-1,42005,-1,3.8525277e-06,0.99999106,5.099742e-06
42013,factors,6,7,41,48,UVR and immunosuppression are major risk factors for cutaneous squamous cell carcinoma (cSCC).,33848530_0,0,1,-1,-1,42013,-1,0.0026242307,0.99705744,0.0003183028
42025,nucleotides,6,7,47,58,We previously showed that extracellular purine nucleotides influence DNA damage repair.,33848530_2,-1,-1,-1,-1,42025,-1,0.99921143,0.0002797711,0.00050868664
42031,blood,19,20,111,116,"We found increased ENTPD1 expression on T cells within cSCCs when compared with the expression on T cells from blood or nonlesional skin, and accordingly, concentrations of derivative extracellular adenosine diphosphate (ADP), adenosine monophosphate (AMP), and ADO are increased in tumors compared with those in normal skin.",33848530_4,0,1,-1,-1,42031,-1,0.0014296621,0.9936877,0.0048827054
42036,those that,14,16,95,105,"Importantly, ENTPD1 expression is significantly higher in human cSCCs that metastasize than in those that are nonmetastatic.",33848530_5,-1,-1,-1,-1,42036,-1,4.936381e-06,0.99998546,9.587393e-06
42041,protein,17,18,110,117,"Finally, increased extracellular ADO is shown to downregulate the expression of NAP1L2, a nucleosome assembly protein we show to be important for DNA damage repair secondary to UVR.",33848530_7,0,1,-1,-1,42041,-1,1.6110156e-05,0.99997115,1.2787963e-05
42046,T cells to,12,15,75,85,"Together, these data suggest a role for ENTPD1 expression on skin-resident T cells to regulate DNA damage repair through purinergic signaling to promote skin carcinogenesis and metastasis.",33848530_8,-1,-1,-1,-1,42046,-1,0.0016985787,0.07432179,0.92397964
42049,Foxp3+Treg cells,0,2,0,16,"Foxp3+Treg cells display phenotypic and functional heterogeneity, which express high levels of T cell immunoglobulin and mucin-domain containing-3 (Tim-3) in the tumor microenvironment (TME) of colorectal and lung cancer.",33864956_0,-1,-1,-1,-1,42049,-1,0.0018793232,0.71988595,0.2782347
42050,functional,5,6,40,50,"Foxp3+Treg cells display phenotypic and functional heterogeneity, which express high levels of T cell immunoglobulin and mucin-domain containing-3 (Tim-3) in the tumor microenvironment (TME) of colorectal and lung cancer.",33864956_0,0,1,2,-1,42050,-1,0.0007235531,0.9989496,0.00032688884
42053,the tumor,23,25,158,167,"Foxp3+Treg cells display phenotypic and functional heterogeneity, which express high levels of T cell immunoglobulin and mucin-domain containing-3 (Tim-3) in the tumor microenvironment (TME) of colorectal and lung cancer.",33864956_0,-1,-1,-1,-1,42053,-1,3.6849008e-06,0.999992,4.3495993e-06
42060,TFT cells,8,10,46,55,"However, the expression patterns and roles of TFT cells in TME of diffuse large B cell lymphoma (DLBCL) remain to be established.",33864956_2,-1,-1,-1,-1,42060,-1,2.4668723e-05,8.646338e-05,0.9998889
42065,TFT cell,10,12,83,91,Double immunofluorescence and flow cytometry analyses were employed to investigate TFT cell enrichment in paraffin-embedded fresh tumor tissues from patients with DLBCL.,33864956_3,-1,-1,-1,-1,42065,-1,0.0007091318,0.04463056,0.95466036
42066,tumor tissues,16,18,130,143,Double immunofluorescence and flow cytometry analyses were employed to investigate TFT cell enrichment in paraffin-embedded fresh tumor tissues from patients with DLBCL.,33864956_3,-1,-1,-1,-1,42066,-1,1.4539155e-05,0.999959,2.6495036e-05
42069,TFT cell,19,21,126,134,Spearman's or Pearson's correlation and Kaplan-Meier survival analyses were further applied to decide the prognostic value of TFT cell levels in DLBCL.,33864956_4,-1,-1,-1,-1,42069,-1,0.0003805211,0.012819955,0.98679954
42070,The IL-10-secreting function,0,3,0,28,The IL-10-secreting function of TFT cells in vitro was examined via flow cytometry and ELISA.,33864956_5,-1,-1,-1,-1,42070,-1,0.008211749,0.9904221,0.0013661757
42071,TFT cells,4,6,32,41,The IL-10-secreting function of TFT cells in vitro was examined via flow cytometry and ELISA.,33864956_5,-1,-1,-1,-1,42071,-1,4.2301283e-05,0.00023066165,0.9997271
42073,time that TFT cells,6,10,33,52,Our results showed for the first time that TFT cells are highly enriched in TME of DLBCL patients and associated with predictions of poor prognoses.,33864956_6,-1,-1,-1,-1,42073,-1,0.0022079886,0.5968246,0.40096745
42075,TFT cell-induced,0,2,0,16,TFT cell-induced secretion of IL-10 in the TME was suppressed by an anti-Tim-3 antibody in vitro.,33864956_7,-1,-1,-1,-1,42075,-1,0.00011948421,0.0008037585,0.9990767
42077,the TME,6,8,39,46,TFT cell-induced secretion of IL-10 in the TME was suppressed by an anti-Tim-3 antibody in vitro.,33864956_7,-1,-1,-1,-1,42077,-1,7.644487e-06,0.99998355,8.768109e-06
42078,TFT cells,6,8,33,42,"In conclusion, high abundance of TFT cells in the TME is predictive of poor outcomes of DLBCL.",33864956_8,-1,-1,-1,-1,42078,-1,0.00032953057,0.01154422,0.98812616
42079,the TME,9,11,46,53,"In conclusion, high abundance of TFT cells in the TME is predictive of poor outcomes of DLBCL.",33864956_8,-1,-1,-1,-1,42079,-1,6.915858e-06,0.9999851,7.946664e-06
42080,TFT cells,0,2,0,9,TFT cells promote DLBCL development partly by secreting IL-10 in the TME.,33864956_9,-1,-1,-1,-1,42080,-1,7.061356e-05,0.00038590166,0.99954337
42082,the TME,10,12,65,72,TFT cells promote DLBCL development partly by secreting IL-10 in the TME.,33864956_9,-1,-1,-1,-1,42082,-1,8.185479e-06,0.999985,6.8287372e-06
42098,functions,33,34,198,207,"In this study, we generated a humanized neutralizing antihuman DNAM-1 monoclonal antibody (mAb), named TNAX101A, which contains an engineered Fc portion of human IgG1 to reduce Fc-mediated effector functions.",33900821_2,0,1,2,-1,42098,-1,0.0030950087,0.9460292,0.050875794
42102,functions,17,18,105,114,"We show that TNAX101A efficiently interfered the binding of DNAM-1 to its ligand CD155 and showed unique functions; it decreased production of the inflammatory cytokines such as interferon-gamma, tumor necrosis factor alpha, interleukin (IL)-6, IL-17A, and IL-17F by anti-CD3 antibody-stimulated or alloantigen-stimulated T cells and increased FOXP3 expression in anti-CD3-stimulated regulatory T (Treg) cells.",33900821_3,0,1,2,-1,42102,-1,1.3293607e-05,0.9999678,1.8861727e-05
42116,functions,2,3,11,20,These dual functions of TNAX101A may be advantageous for the treatment of T cell-mediated inflammatory diseases through both downregulation of effector T cell function and upregulation of Treg cell function.,33900821_4,0,1,2,-1,42116,-1,7.2623654e-05,0.9998666,6.079547e-05
42117,the treatment,9,11,57,70,These dual functions of TNAX101A may be advantageous for the treatment of T cell-mediated inflammatory diseases through both downregulation of effector T cell function and upregulation of Treg cell function.,33900821_4,-1,-1,-1,-1,42117,-1,5.1867523e-06,0.9999907,4.167498e-06
42120,T cell function,21,24,152,167,These dual functions of TNAX101A may be advantageous for the treatment of T cell-mediated inflammatory diseases through both downregulation of effector T cell function and upregulation of Treg cell function.,33900821_4,-1,-1,-1,-1,42120,-1,9.807573e-06,8.657217e-06,0.9999815
42121,Treg cell function,27,30,188,206,These dual functions of TNAX101A may be advantageous for the treatment of T cell-mediated inflammatory diseases through both downregulation of effector T cell function and upregulation of Treg cell function.,33900821_4,-1,-1,-1,-1,42121,-1,1.0626534e-05,9.815461e-06,0.9999796
42123,the tumor,6,8,35,44,Inflammation is the main driver of the tumor initiation and progression in colitis-associated colorectal cancer (CAC).,33919941_0,-1,-1,-1,-1,42123,-1,4.257723e-06,0.99999094,4.790946e-06
42124,that the signal transducer and activator of transcription 6,4,13,31,90,"Recent findings have indicated that the signal transducer and activator of transcription 6 (STAT6) plays a fundamental role in the early stages of CAC, and STAT6 knockout (STAT6-/-) mice are highly resistant to CAC development.",33919941_1,-1,-1,-1,-1,42124,-1,7.1840295e-06,0.99998164,1.115968e-05
42132,cells play,5,7,20,30,"Regulatory T (Treg) cells play a major role in coordinating immunomodulation in cancer; however, the role of STAT6 in the induction and function of Treg cells is poorly understood.",33919941_2,-1,-1,-1,-1,42132,-1,0.0027001032,0.26711833,0.7301816
42136,function,26,27,136,144,"Regulatory T (Treg) cells play a major role in coordinating immunomodulation in cancer; however, the role of STAT6 in the induction and function of Treg cells is poorly understood.",33919941_2,0,1,2,-1,42136,-1,2.5757608e-05,0.99995375,2.043785e-05
42140,STAT6 to,5,7,31,39,"To clarify the contribution of STAT6 to CAC, STAT6-/- and wild type (WT) mice were subjected to an AOM/DSS regimen, and the frequency of peripheral and local Treg cells was determined during the progression of CAC.",33919941_3,-1,-1,-1,-1,42140,-1,4.2097413e-06,0.9999901,5.7023017e-06
42150,TGF-beta,41,42,246,254,"When STAT6 was lacking, a remarkable reduction in tumor growth was observed, which was associated with decreased inflammation and an increased number of CD4+CD25+Foxp3+ cells in the colon, circulation, and spleen, including an over-expression of TGF-beta, IL-10, and Foxp3, compared to WT mice, during the early stages of CAC development.",33919941_4,0,1,-1,-1,42150,-1,7.626539e-05,0.999908,1.5727945e-05
42161,STAT6 deficiency,3,5,11,27,"Thus, with STAT6 deficiency, an increased number of Treg cells induce resistance against tumorigenesis, arresting tumor-promoting inflammation.",33919941_7,-1,-1,-1,-1,42161,-1,1.1299487e-05,0.9999795,9.192649e-06
42167,function,11,12,56,64,We reported a direct role of STAT6 in the induction and function of Treg cells during CAC development and suggest that STAT6 is a potential target for the modulation of immune response in colitis and CAC.,33919941_8,0,1,2,-1,42167,-1,3.3843677e-05,0.9999275,3.857101e-05
42169,that STAT6,20,22,114,124,We reported a direct role of STAT6 in the induction and function of Treg cells during CAC development and suggest that STAT6 is a potential target for the modulation of immune response in colitis and CAC.,33919941_8,-1,-1,-1,-1,42169,-1,5.3164435e-06,0.9999893,5.3846243e-06
42175,IL-17-expressing cells,8,10,52,74,"The presence and clinical significance of IL-17 and IL-17-expressing cells have been studied for several cancers, although their correlation with tumor development remains controversial.",33971545_0,-1,-1,-1,-1,42175,-1,0.9417017,0.00017281604,0.05812552
42178,blood,1,2,11,16,Peripheral blood was collected from healthy donors and glioma patients to isolate peripheral blood mononuclear cells (PBMCs).,33971545_1,0,1,-1,-1,42178,-1,0.015731255,0.8878569,0.09641183
42180,blood,13,14,93,98,Peripheral blood was collected from healthy donors and glioma patients to isolate peripheral blood mononuclear cells (PBMCs).,33971545_1,0,1,-1,-1,42180,-1,0.0048088212,0.90946096,0.08573025
42183,IL-17-expressing cells,3,5,18,40,The percentage of IL-17-expressing cells and the production of inflammatory cytokines in PBMCs and tissues were measured.,33971545_2,-1,-1,-1,-1,42183,-1,0.958818,0.0001440955,0.041037783
42186,tissues,14,15,99,106,The percentage of IL-17-expressing cells and the production of inflammatory cytokines in PBMCs and tissues were measured.,33971545_2,-1,1,2,-1,42186,-1,0.0003313741,0.9724081,0.027260464
42196,the IL-17,28,30,156,165,"Human IL17 cDNA was then inserted into the pEGFPN1 plasmid and transfected into the glioma U87MG cell line, and tumstatin was used to block the effect of the IL-17 overexpression.",33971545_3,-1,-1,-1,-1,42196,-1,0.73565084,0.2617969,0.002552339
42197,cell transcription factors,1,4,5,31,"Stem cell transcription factors were evaluated in each group using qRT-PCR and western blotting, and proliferation and migration were detected using colony formation and wound-healing assays.",33971545_4,-1,-1,-1,-1,42197,-1,0.0061906036,0.72450143,0.2693079
42198,The cells,0,2,0,9,The cells were then subcutaneously inoculated into nude mice to evaluate the growth of glioma.,33971545_5,-1,-1,-1,-1,42198,-1,0.00012295286,0.00034677493,0.9995303
42203,IL-17-expressing T cells,15,18,98,122,"Compared with healthy donors, the PBMCs from glioma patients showed a significant accumulation of IL-17-expressing T cells.",33971545_6,-1,-1,-1,-1,42203,-1,0.9251388,0.00022816054,0.074633025
42204,Th17 cell,0,2,0,9,"Th17 cell differentiation-related cytokines (IL-23, TGF- and IL-6) were increased in the tumor microenvironment.",33971545_7,-1,-1,-1,-1,42204,-1,0.00019969631,0.0053416872,0.99445856
42208,the tumor,14,16,86,95,"Th17 cell differentiation-related cytokines (IL-23, TGF- and IL-6) were increased in the tumor microenvironment.",33971545_7,-1,-1,-1,-1,42208,-1,4.252827e-06,0.9999913,4.5052398e-06
42211,protein,6,7,42,49,IL17 transfection increased the mRNA and protein expression of stem cell transcription factors in U87MG cells in vitro.,33971545_8,0,1,-1,-1,42211,-1,9.523493e-06,0.9999844,6.1498026e-06
42212,cell transcription factors,10,13,69,95,IL17 transfection increased the mRNA and protein expression of stem cell transcription factors in U87MG cells in vitro.,33971545_8,-1,-1,-1,-1,42212,-1,0.0026542933,0.81951356,0.17783214
42228,factors,12,13,105,112,Tumstatin effectively suppressed IL-17-derived U87MG cell growth by downregulating stem cell maintenance factors and inducing proliferation and migration.,33971545_12,0,1,-1,-1,42228,-1,0.9990853,0.0007407883,0.00017383309
42230,that IL-17,3,5,25,35,"These findings indicated that IL-17 represents a potential prognostic marker for glioma, while tumstatin has potential in the treatment for glioma.",33971545_13,-1,-1,-1,-1,42230,-1,0.8310736,0.16634493,0.002581506
42232,the treatment,18,20,122,135,"These findings indicated that IL-17 represents a potential prognostic marker for glioma, while tumstatin has potential in the treatment for glioma.",33971545_13,-1,-1,-1,-1,42232,-1,6.3561215e-06,0.99998856,5.1197667e-06
42236,immunity,14,15,81,89,BACKGROUND: Conventional type 1 dendritic cells (cDC1s) are central to antitumor immunity and their presence in the tumor microenvironment associates with improved outcomes in patients with cancer.,33980589_0,0,-1,2,-1,42236,-1,0.99984634,3.5342262e-05,0.00011819611
42238,the tumor,19,21,112,121,BACKGROUND: Conventional type 1 dendritic cells (cDC1s) are central to antitumor immunity and their presence in the tumor microenvironment associates with improved outcomes in patients with cancer.,33980589_0,-1,-1,-1,-1,42238,-1,4.3713103e-06,0.99999106,4.520103e-06
42239,cell-sensing receptor,7,9,26,47,DNGR-1 (CLEC9A) is a dead cell-sensing receptor highly restricted to cDC1s.,33980589_1,-1,-1,-1,-1,42239,-1,9.1397094e-05,3.360638e-05,0.99987495
42241,cell-associated antigens,9,11,60,84,"DNGR-1 has been involved in both cross-presentation of dead cell-associated antigens and processes of disease tolerance, but its role in antitumor immunity has not been clarified yet.",33980589_2,-1,-1,-1,-1,42241,-1,0.11729975,0.000974217,0.881726
42243,immunity,22,23,147,155,"DNGR-1 has been involved in both cross-presentation of dead cell-associated antigens and processes of disease tolerance, but its role in antitumor immunity has not been clarified yet.",33980589_2,0,-1,2,-1,42243,-1,0.9998996,2.8857039e-05,7.156189e-05
42244,tumor cell,5,7,22,32,METHODS: B16 and MC38 tumor cell lines were inoculated subcutaneously into wild-type (WT) and DNGR-1-deficient mice.,33980589_3,-1,-1,-1,-1,42244,-1,0.0005326664,0.025856756,0.97361064
42246,gene therapy through the,7,11,48,72,"To overexpress Flt3L systemically, we performed gene therapy through the hydrodynamic injection of an Flt3L-encoding plasmid.",33980589_4,-1,-1,-1,-1,42246,-1,5.6764056e-06,0.9999902,4.0439777e-06
42249,the immune response,2,5,16,35,"To characterize the immune response, we performed flow cytometry and RNA-Seq of tumor-infiltrating cDC1s.",33980589_5,-1,-1,-1,-1,42249,-1,0.52586657,0.47232333,0.0018101521
42252,tumor antigens,9,11,51,65,"RESULTS: Here, we found that cross-presentation of tumor antigens in the steady state was DNGR-1-independent.",33980589_6,-1,-1,-1,-1,42252,-1,0.5576233,0.43746752,0.0049091587
42257,gene therapy,14,16,102,114,"Of note, this protection was recapitulated by anti-DNGR-1-blocking antibodies in mice following Flt3L gene therapy.",33980589_8,-1,-1,-1,-1,42257,-1,5.7838547e-06,0.99998844,5.7547054e-06
42259,immunity,3,4,24,32,This improved antitumor immunity was associated with Batf3-dependent enhanced accumulation of CD8+ T cells and cDC1s within tumors.,33980589_9,0,-1,2,-1,42259,-1,0.9998293,5.7097946e-05,0.0001135929
42262,the deficiency,2,4,17,31,"Mechanistically, the deficiency in DNGR-1 boosted an Flt3L-induced specific inflammatory gene signature in cDC1s, including Ccl5 expression.",33980589_10,-1,-1,-1,-1,42262,-1,1.9926185e-05,0.9999714,8.737318e-06
42269,CCR5 gene,6,8,29,38,"Moreover, FLT3LG and CCL5 or CCR5 gene expression signatures correlate with an enhanced cDC1 signature and a favorable overall survival in patients with cancer.",33980589_12,-1,-1,-1,-1,42269,-1,0.0037668268,0.019553969,0.9766792
42275,immunity,7,8,44,52,"Thus, DNGR-1 blockade may improve antitumor immunity in tumor therapy settings associated to high Flt3L expression.",33980589_15,0,-1,2,-1,42275,-1,0.99988604,3.2334217e-05,8.158979e-05
42276,tumor therapy,9,11,56,69,"Thus, DNGR-1 blockade may improve antitumor immunity in tumor therapy settings associated to high Flt3L expression.",33980589_15,-1,-1,-1,-1,42276,-1,5.113414e-06,0.99999046,4.4312874e-06
42284,tumors that,8,10,50,61,"Thus, additional treatment options are needed for tumors that lose expression of MHC class I. The cellular inhibitor of apoptosis proteins 1 and 2 (cIAP1/2) regulate classical and alternative nuclear factor B (NF-B) signaling.",34011631_1,-1,-1,-1,-1,42284,-1,3.7648829e-06,0.9999924,3.8597664e-06
42285,The cellular,16,18,94,106,"Thus, additional treatment options are needed for tumors that lose expression of MHC class I. The cellular inhibitor of apoptosis proteins 1 and 2 (cIAP1/2) regulate classical and alternative nuclear factor B (NF-B) signaling.",34011631_1,-1,-1,-1,-1,42285,-1,0.0048016603,0.5598911,0.43530726
42286,proteins,21,22,130,138,"Thus, additional treatment options are needed for tumors that lose expression of MHC class I. The cellular inhibitor of apoptosis proteins 1 and 2 (cIAP1/2) regulate classical and alternative nuclear factor B (NF-B) signaling.",34011631_1,0,1,-1,-1,42286,-1,1.8146657e-05,0.999966,1.5821184e-05
42288,immunity,14,15,120,128,"Induction of noncanonical NF-B signaling with cIAP1/2 antagonists mimics costimulatory signaling, augmenting antitumor immunity.",34011631_2,0,-1,2,-1,42288,-1,0.9998884,3.29346e-05,7.862319e-05
42290,T cell-dependent immune responses,9,13,63,96,"We show that induction of noncanonical NF-B signaling induces T cell-dependent immune responses, even in 2-microglobulin (2M)-deficient tumors, demonstrating that direct CD8 T cell recognition of tumor cell-expressed MHC class I is not required.",34011631_3,-1,-1,-1,-1,42290,-1,0.09287741,0.00095013686,0.9061724
42294,tumor cell-expressed,28,30,199,219,"We show that induction of noncanonical NF-B signaling induces T cell-dependent immune responses, even in 2-microglobulin (2M)-deficient tumors, demonstrating that direct CD8 T cell recognition of tumor cell-expressed MHC class I is not required.",34011631_3,-1,-1,-1,-1,42294,-1,0.0007979236,0.0184004,0.98080176
42298,antigen-specific T cell,9,12,45,68,"In wild-type mice, but not mice incapable of antigen-specific T cell responses, cIAP1/2 antagonism reduces tumor burden by increasing phagocytosis of live tumor cells.",34011631_5,-1,-1,-1,-1,42298,-1,0.86327153,0.00033281857,0.1363957
42300,tumor cells,24,26,155,166,"In wild-type mice, but not mice incapable of antigen-specific T cell responses, cIAP1/2 antagonism reduces tumor burden by increasing phagocytosis of live tumor cells.",34011631_5,-1,-1,-1,-1,42300,-1,0.00016682749,0.0007511925,0.99908197
42304,tumors that,15,17,99,110,"Thus, activation of noncanonical NF-B stimulates a T cell-macrophage axis that curtails growth of tumors that are resistant to checkpoint blockade because of loss of MHC class I or IFN- sensing.",34011631_7,-1,-1,-1,-1,42304,-1,4.104879e-06,0.99999166,4.2942966e-06
42309,the MYCN,4,6,29,37,"BACKGROUND: Amplification of the MYCN oncogene is a molecular hallmark of aggressive neuroblastoma (NB), a childhood cancer of the sympathetic nervous system.",34016720_0,-1,-1,-1,-1,42309,-1,5.249497e-06,0.99998844,6.3261327e-06
42312,that MYCN,3,5,18,27,There is evidence that MYCN promotes a non-inflamed and T-cell infiltration-poor ('cold') tumor microenvironment (TME) by suppressing interferon signaling.,34016720_1,-1,-1,-1,-1,42312,-1,6.9373286e-06,0.99998534,7.7827735e-06
42313,T-cell,9,10,56,62,There is evidence that MYCN promotes a non-inflamed and T-cell infiltration-poor ('cold') tumor microenvironment (TME) by suppressing interferon signaling.,34016720_1,-1,1,2,-1,42313,-1,1.5877427e-05,1.0526404e-05,0.99997365
42319,therapy,26,27,136,143,"This may explain, at least in part, why patients with NB seem to have little benefit from single-agent immune checkpoint blockade (ICB) therapy.",34016720_2,0,1,-1,-1,42319,-1,5.7906127e-06,0.9999889,5.3395866e-06
42320,Targeting MYCN,0,2,0,14,Targeting MYCN or its effectors could be a strategy to convert a cold TME into a 'hot' (inflamed) TME and improve the efficacy of ICB therapy.,34016720_3,-1,-1,-1,-1,42320,-1,7.893255e-06,0.9999831,9.028369e-06
42325,therapy,29,30,134,141,Targeting MYCN or its effectors could be a strategy to convert a cold TME into a 'hot' (inflamed) TME and improve the efficacy of ICB therapy.,34016720_3,0,1,-1,-1,42325,-1,3.831228e-06,0.99999154,4.59522e-06
42328,T-cell,13,14,81,87,METHODS: NB transcriptome analyses were used to identify epigenetic drivers of a T-cell infiltration-poor TME.,34016720_4,-1,1,2,-1,42328,-1,1.9602963e-05,1.0356106e-05,0.9999701
42330,cells to,6,8,41,49,"Biological and molecular responses of NB cells to epigenetic drugs and interferon (IFN)- exposure were assessed by proliferation assays, immunoblotting, ELISA, qRT-PCR, RNA-seq and ChIP-qPCR as well as co-culture assays with T cells.",34016720_5,-1,-1,-1,-1,42330,-1,0.0038692346,0.40070328,0.5954275
42333,the MYCN-driven,23,25,145,160,"RESULTS: We identified H3K9 euchromatic histone-lysine methyltransferases EHMT2 and EHMT1, also known as G9a and GLP, as epigenetic effectors of the MYCN-driven malignant phenotype and repressors of IFN- transcriptional responses in NB cells.",34016720_6,-1,-1,-1,-1,42333,-1,8.429624e-06,0.99998236,9.2426235e-06
42334,IFN- transcriptional,30,32,199,220,"RESULTS: We identified H3K9 euchromatic histone-lysine methyltransferases EHMT2 and EHMT1, also known as G9a and GLP, as epigenetic effectors of the MYCN-driven malignant phenotype and repressors of IFN- transcriptional responses in NB cells.",34016720_6,-1,-1,-1,-1,42334,-1,0.9993118,0.0004545073,0.00023376226
42337,the Th1-type chemokines,6,9,53,76,"EHMT inhibitors enhanced IFN--induced expression of the Th1-type chemokines CXCL9 and CXCL10, key factors of T-cell recruitment into the TME.",34016720_7,-1,-1,-1,-1,42337,-1,0.025570406,0.97290087,0.0015287795
42339,factors,14,15,99,106,"EHMT inhibitors enhanced IFN--induced expression of the Th1-type chemokines CXCL9 and CXCL10, key factors of T-cell recruitment into the TME.",34016720_7,0,1,-1,-1,42339,-1,7.4615523e-06,0.9999875,5.0336807e-06
42340,T-cell,16,17,110,116,"EHMT inhibitors enhanced IFN--induced expression of the Th1-type chemokines CXCL9 and CXCL10, key factors of T-cell recruitment into the TME.",34016720_7,-1,1,2,-1,42340,-1,2.853786e-05,9.444007e-06,0.9999621
42341,the TME,19,21,134,141,"EHMT inhibitors enhanced IFN--induced expression of the Th1-type chemokines CXCL9 and CXCL10, key factors of T-cell recruitment into the TME.",34016720_7,-1,-1,-1,-1,42341,-1,5.0475546e-06,0.99998844,6.5605573e-06
42345,to IFN-,30,32,189,197,"In MYCN-amplified NB cells, co-inhibition of EZH2 (enhancer of zeste homologue 2), a H3K27 histone methyltransferase cooperating with EHMTs, was needed for strong transcriptional responses to IFN-, in line with histone mark changes at CXCL9 and CXCL10 chemokine gene loci.",34016720_8,-1,-1,-1,-1,42345,-1,0.98770463,0.011274047,0.0010213144
42346,CXCL10 chemokine gene,42,45,246,267,"In MYCN-amplified NB cells, co-inhibition of EZH2 (enhancer of zeste homologue 2), a H3K27 histone methyltransferase cooperating with EHMTs, was needed for strong transcriptional responses to IFN-, in line with histone mark changes at CXCL9 and CXCL10 chemokine gene loci.",34016720_8,-1,-1,-1,-1,42346,-1,0.99949896,0.0001365038,0.0003644925
42352,T-cell-infiltrated TME,35,37,225,247,"CONCLUSION: Our results delineate a strategy for targeted epigenetic immunomodulation of high-risk NBs, whereby EHMT inhibitors alone or in combination with EZH2 inhibitors (in particular, MYCN-amplified NBs) could promote a T-cell-infiltrated TME via enhanced Th1-type chemokine expression.",34016720_10,-1,-1,-1,-1,42352,-1,0.0017570892,0.021400074,0.9768429
42353,Th1-type chemokine,39,41,261,279,"CONCLUSION: Our results delineate a strategy for targeted epigenetic immunomodulation of high-risk NBs, whereby EHMT inhibitors alone or in combination with EZH2 inhibitors (in particular, MYCN-amplified NBs) could promote a T-cell-infiltrated TME via enhanced Th1-type chemokine expression.",34016720_10,-1,-1,-1,-1,42353,-1,0.024560247,0.97348547,0.0019543227
42355,the tumor,8,10,41,50,"The immune system is a fine modulator of the tumor biology supporting or inhibiting its progression, growth, invasion and conveys the pharmacological treatment effect.",34070750_0,-1,-1,-1,-1,42355,-1,4.9888467e-06,0.9999901,4.9094274e-06
42363,the cellular,30,32,179,191,"Tumors, on their side, have developed escaping mechanisms from the immune system action ranging from the direct secretion of biochemical signals to an indirect reaction, in which the cellular actors of the tumor microenvironment (TME) collaborate to mechanically condition the extracellular matrix (ECM) making it inhospitable to immune cells.",34070750_1,-1,-1,-1,-1,42363,-1,0.0013075261,0.10780161,0.8908909
42364,the tumor,34,36,202,211,"Tumors, on their side, have developed escaping mechanisms from the immune system action ranging from the direct secretion of biochemical signals to an indirect reaction, in which the cellular actors of the tumor microenvironment (TME) collaborate to mechanically condition the extracellular matrix (ECM) making it inhospitable to immune cells.",34070750_1,-1,-1,-1,-1,42364,-1,4.4546955e-06,0.99998987,5.68871e-06
42375,innate immunity cells,26,29,162,183,"TME is composed of several cell lines besides cancer cells, including tumor-associated macrophages, cancer-associated fibroblasts, CD4+ and CD8+ lymphocytes, and innate immunity cells.",34070750_2,-1,-1,-1,-1,42375,-1,0.091433,0.00041597796,0.9081511
42387,therapy,35,36,169,176,"The presence or absence, in particular, of cytotoxic CD8+ cells in the vicinity of the main tumor mass, is able to predict, respectively, the success or failure of drug therapy.",34070750_4,0,1,-1,-1,42387,-1,8.359984e-06,0.9999856,6.012646e-06
42393,to the,33,35,184,190,"Among various mechanisms of immunescaping, in this study, we characterized the modulation of the phenotypic profile of CD4+ and CD8+ cells in resting and activated states, in response to the mechanical pressure exerted by a three-dimensional in vitro system, able to recapitulate the rheological and stiffness properties of the tumor ECM.",34070750_5,-1,-1,-1,-1,42393,-1,5.829072e-06,0.99999,4.2230386e-06
42397,the tumor,54,56,324,333,"Among various mechanisms of immunescaping, in this study, we characterized the modulation of the phenotypic profile of CD4+ and CD8+ cells in resting and activated states, in response to the mechanical pressure exerted by a three-dimensional in vitro system, able to recapitulate the rheological and stiffness properties of the tumor ECM.",34070750_5,-1,-1,-1,-1,42397,-1,4.77969e-06,0.99999034,4.887179e-06
42402,immunity,14,15,90,98,Interleukin 9 (IL-9)-producing helper T (Th9) cells are essential for inducing anti-tumor immunity and inflammation in allergic and autoimmune diseases.,34075041_0,0,-1,2,-1,42402,-1,0.9996644,0.00012997435,0.00020560938
42403,transcription factors that,1,4,9,35,"Although transcription factors that are essential for Th9 cell differentiation have been identified, other signaling pathways that are required for their generation and functions are yet to be explored.",34075041_1,-1,-1,-1,-1,42403,-1,5.430941e-06,0.9999901,4.4950716e-06
42404,Th9 cell,7,9,54,62,"Although transcription factors that are essential for Th9 cell differentiation have been identified, other signaling pathways that are required for their generation and functions are yet to be explored.",34075041_1,-1,-1,-1,-1,42404,-1,1.723255e-05,3.0833144e-05,0.99995184
42406,their generation,21,23,148,164,"Although transcription factors that are essential for Th9 cell differentiation have been identified, other signaling pathways that are required for their generation and functions are yet to be explored.",34075041_1,-1,-1,-1,-1,42406,-1,7.6263436e-06,0.9999858,6.6167895e-06
42407,functions,24,25,169,178,"Although transcription factors that are essential for Th9 cell differentiation have been identified, other signaling pathways that are required for their generation and functions are yet to be explored.",34075041_1,0,1,2,-1,42407,-1,8.082526e-06,0.9999839,8.001673e-06
42410,Growth Factor Receptor,6,9,33,55,"Here, we identify that Epidermal Growth Factor Receptor (EGFR) is essential for IL-9 induction in helper T (Th) cells.",34075041_2,-1,-1,-1,-1,42410,-1,0.9821827,0.00013582197,0.017681472
42416,Th9 cells,17,19,84,93,"Moreover, amphiregulin (Areg), an EGFR ligand, is critical for the amplification of Th9 cells induced by TGF-1 and IL-4.",34075041_3,-1,-1,-1,-1,42416,-1,3.563872e-05,0.00024275643,0.9997216
42420,transactivates IL-9,14,16,83,102,"Furthermore, our data show that Areg-EGFR signaling induces HIF1, which binds and transactivates IL-9 and NOS2 promoters in Th9 cells.",34075041_4,-1,-1,-1,-1,42420,-1,0.1722848,0.8256793,0.0020358718
42421,Th9 cells,20,22,125,134,"Furthermore, our data show that Areg-EGFR signaling induces HIF1, which binds and transactivates IL-9 and NOS2 promoters in Th9 cells.",34075041_4,-1,-1,-1,-1,42421,-1,1.7444881e-05,3.8390546e-05,0.9999442
42423,Th9 cell,6,8,32,40,Loss of EGFR or HIF1 abrogates Th9 cell differentiation and suppresses their anti-tumor functions.,34075041_5,-1,-1,-1,-1,42423,-1,0.00013146928,0.0025659981,0.99730253
42425,functions,13,14,89,98,Loss of EGFR or HIF1 abrogates Th9 cell differentiation and suppresses their anti-tumor functions.,34075041_5,0,1,2,-1,42425,-1,1.09779985e-05,0.9999764,1.2673856e-05
42428,Th9 cells,14,16,83,92,"Moreover, in line with its reliance on HIF1 expression, metabolomics profiling of Th9 cells revealed that Succinate, a TCA cycle metabolite, promotes Th9 cell differentiation and Th9 cell-mediated tumor regression.",34075041_6,-1,-1,-1,-1,42428,-1,1.2641073e-05,1.3562863e-05,0.9999738
42431,Th9 cell,26,28,151,159,"Moreover, in line with its reliance on HIF1 expression, metabolomics profiling of Th9 cells revealed that Succinate, a TCA cycle metabolite, promotes Th9 cell differentiation and Th9 cell-mediated tumor regression.",34075041_6,-1,-1,-1,-1,42431,-1,1.1111804e-05,9.26664e-06,0.9999796
42432,Th9 cell-mediated tumor,30,33,180,203,"Moreover, in line with its reliance on HIF1 expression, metabolomics profiling of Th9 cells revealed that Succinate, a TCA cycle metabolite, promotes Th9 cell differentiation and Th9 cell-mediated tumor regression.",34075041_6,-1,-1,-1,-1,42432,-1,0.001039379,0.19644827,0.8025123
42446,The tumor,2,4,9,18,Methods: The tumor growth of the syngeneic mouse allograft in wild type or Rab37 knockout mice was analyzed.,34093869_3,-1,-1,-1,-1,42446,-1,4.6744017e-06,0.9999908,4.5323786e-06
42454,the protein,7,9,68,79,"Multiplex fluorescence immunohistochemistry was performed to detect the protein level of Rab37, IL-6 and PD-1 and localization of the tumor-infiltrating immune cells in allografts from mice or tumor specimens from lung cancer patients.",34093869_6,-1,-1,-1,-1,42454,-1,6.150277e-06,0.99998903,4.763306e-06
42456,the tumor-infiltrating,19,21,130,152,"Multiplex fluorescence immunohistochemistry was performed to detect the protein level of Rab37, IL-6 and PD-1 and localization of the tumor-infiltrating immune cells in allografts from mice or tumor specimens from lung cancer patients.",34093869_6,-1,-1,-1,-1,42456,-1,1.5284928e-05,0.9999701,1.4638655e-05
42462,to trigger,17,19,108,118,Results: We revealed that Rab37 regulates the secretion of IL-6 in a GTPase-dependent manner in macrophages to trigger M2 polarization.,34093869_7,-1,-1,-1,-1,42462,-1,6.015711e-06,0.99998975,4.2150427e-06
42469,T cells that,18,21,124,136,"Clinically, tumors with high stromal Rab37 and IL-6 expression coincide with tumor infiltrating M2-macrophages and PD1+CD8+ T cells that predicts poor prognosis in lung cancer patients.",34093869_9,-1,-1,-1,-1,42469,-1,0.0018759395,0.05485259,0.9432714
42470,in plasma IL-6,9,12,51,65,"In addition, lung cancer patients with an increase in plasma IL-6 level are found to be associated with immunotherapeutic resistance.",34093869_10,-1,-1,-1,-1,42470,-1,0.7045199,0.28928614,0.0061938805
42478,transcription regulation to foster,8,12,71,105,Conclusions: Rab37/IL-6 trafficking pathway links with IL-6/STAT3/PD-1 transcription regulation to foster an immunosuppressive TME and combined IL-6/CTLA-4 blockade therapy exerts potent anti-tumor efficacy.,34093869_12,-1,-1,-1,-1,42478,-1,7.831702e-06,0.9999858,6.3398256e-06
42480,therapy,19,20,165,172,Conclusions: Rab37/IL-6 trafficking pathway links with IL-6/STAT3/PD-1 transcription regulation to foster an immunosuppressive TME and combined IL-6/CTLA-4 blockade therapy exerts potent anti-tumor efficacy.,34093869_12,0,1,-1,-1,42480,-1,4.5994184e-06,0.99999106,4.3626683e-06
42486,immunity,15,16,89,97,"T regulatory (Treg) cells are crucial to maintain immune tolerance and repress antitumor immunity, but the mechanisms governing their cellular redox homeostasis remain elusive.",34133924_0,0,-1,2,-1,42486,-1,0.99938285,0.00039066083,0.00022649035
42488,their cellular,21,23,128,142,"T regulatory (Treg) cells are crucial to maintain immune tolerance and repress antitumor immunity, but the mechanisms governing their cellular redox homeostasis remain elusive.",34133924_0,-1,-1,-1,-1,42488,-1,0.0031544983,0.49116647,0.505679
42491,immunity,23,24,154,162,We report that glutathione peroxidase 4 (Gpx4) prevents Treg cells from lipid peroxidation and ferroptosis in regulating immune homeostasis and antitumor immunity.,34133924_1,0,-1,2,-1,42491,-1,0.99974567,0.000116912866,0.00013735992
42507,immunity,13,14,107,115,"Furthermore, Treg-specific ablation of Gpx4 represses tumor growth and concomitantly potentiates antitumor immunity.",34133924_6,0,-1,2,-1,42507,-1,0.99990654,2.0687436e-05,7.267823e-05
42514,The tumor,0,2,0,9,"The tumor microenvironment (TME) of PCa is involved in the emergence of immunosuppressive factors such as myeloid-derived suppressor cells (MDSC), which regulate the immune system by several mechanisms, including interleukin (IL)-10 production.",34184811_1,-1,-1,-1,-1,42514,-1,3.765562e-06,0.99999154,4.7021026e-06
42517,factors,15,16,90,97,"The tumor microenvironment (TME) of PCa is involved in the emergence of immunosuppressive factors such as myeloid-derived suppressor cells (MDSC), which regulate the immune system by several mechanisms, including interleukin (IL)-10 production.",34184811_1,0,1,-1,-1,42517,-1,1.9420895e-05,0.99997354,7.016002e-06
42528,that the,3,5,24,32,This study demonstrated that the frequency of CD33+ pSTAT3+ MDSC and IL-17+ lymphocyte as well as IL-10 messenger RNA (mRNA) expression were significantly higher in the PCa patients than in the benign prostatic hyperplasia (BPH) group.,34184811_3,-1,-1,-1,-1,42528,-1,3.7566447e-06,0.9999924,3.820176e-06
42541,that the,2,4,13,21,We suggested that the higher frequency of CD33+ pSTAT3+ MDSC and IL-17+ lymphocyte and the more frequent expression of IL-10 mRNA in PCa patients may play roles in tumor progression from BPH to PCa.,34184811_5,-1,-1,-1,-1,42541,-1,4.6541863e-06,0.9999913,4.0728237e-06
42551,to the,4,6,39,45,"SOX11 oncogenic expression contributes to the aggressiveness of these tumors by different mechanisms, including tumor and stromal cell interactions.",34189576_1,-1,-1,-1,-1,42551,-1,5.0803565e-06,0.99998975,5.2264304e-06
42552,these tumors,8,10,64,76,"SOX11 oncogenic expression contributes to the aggressiveness of these tumors by different mechanisms, including tumor and stromal cell interactions.",34189576_1,-1,-1,-1,-1,42552,-1,3.7782709e-06,0.9999906,5.661216e-06
42558,relationship to SOX11,15,18,90,111,"However, the precise composition of the immune cell microenvironment of MCL, its possible relationship to SOX11 expression, and how it may contribute to tumor behavior is not well known.",34189576_2,-1,-1,-1,-1,42558,-1,6.491696e-05,0.9998894,4.5640558e-05
42559,to tumor,25,27,150,158,"However, the precise composition of the immune cell microenvironment of MCL, its possible relationship to SOX11 expression, and how it may contribute to tumor behavior is not well known.",34189576_2,-1,-1,-1,-1,42559,-1,6.269716e-06,0.99998736,6.4226233e-06
42560,transcriptome analysis,6,8,34,56,"Here, we performed an integrative transcriptome analysis of 730 immune-related genes combined with the immune cell phenotype analysis by immunohistochemistry in SOX11+ and SOX11- primary nodal MCL cases and non-neoplastic reactive lymph nodes.",34189576_3,-1,-1,-1,-1,42560,-1,8.177825e-06,0.99998415,7.73531e-06
42564,analysis,18,19,125,133,"Here, we performed an integrative transcriptome analysis of 730 immune-related genes combined with the immune cell phenotype analysis by immunohistochemistry in SOX11+ and SOX11- primary nodal MCL cases and non-neoplastic reactive lymph nodes.",34189576_3,0,1,-1,-1,42564,-1,2.2778886e-05,0.9999521,2.5187685e-05
42569,T-cell,7,8,35,41,SOX11+ MCL had a significant lower T-cell intratumoral infiltration compared with negative cases.,34189576_4,-1,1,2,-1,42569,-1,1.3207367e-05,1.1751493e-05,0.99997497
42570,T-cell,6,7,41,47,A reduced expression of MHCI/II-like and T-cell costimulation and signaling activation related transcripts was significantly associated with poor clinical outcome.,34189576_5,-1,1,2,-1,42570,-1,2.6824395e-05,1.08826225e-05,0.99996233
42571,related transcripts,11,13,87,106,A reduced expression of MHCI/II-like and T-cell costimulation and signaling activation related transcripts was significantly associated with poor clinical outcome.,34189576_5,-1,-1,-1,-1,42571,-1,1.6626716e-05,0.9999702,1.3140968e-05
42573,target gene,9,11,47,58,"Moreover, we identified CD70 as a SOX11 direct target gene, whose overexpression was induced in SOX11+, but not SOX11- tumor cells by CD40L in vitro.",34189576_6,-1,-1,-1,-1,42573,-1,4.4808125e-06,0.9999906,4.8991496e-06
42575,SOX11- tumor cells,22,25,112,130,"Moreover, we identified CD70 as a SOX11 direct target gene, whose overexpression was induced in SOX11+, but not SOX11- tumor cells by CD40L in vitro.",34189576_6,-1,-1,-1,-1,42575,-1,0.0014346109,0.9027797,0.09578573
42578,the tumor,17,19,95,104,"CD70 was overexpressed in primary SOX11+ MCL and it was associated with an immune unbalance of the tumor microenvironment characterized by increased number of effector regulatory t (Treg) cell infiltration, higher proliferation, and aggressive clinical course.",34189576_7,-1,-1,-1,-1,42578,-1,4.700348e-06,0.99999034,4.9376154e-06
42583,that SOX11,5,7,29,39,"Overall, our results suggest that SOX11 expression in MCL is associated with an immunosuppressive microenvironment characterized by CD70 overexpression in tumor cells, increased Treg cell infiltration and downmodulation of antigen processing, and presentation and T-cell activation that could promote MCL progression and represent a potential target for tailored therapies.",34189576_9,-1,-1,-1,-1,42583,-1,1.943632e-05,0.9999691,1.1414923e-05
42584,tumor cells,21,23,155,166,"Overall, our results suggest that SOX11 expression in MCL is associated with an immunosuppressive microenvironment characterized by CD70 overexpression in tumor cells, increased Treg cell infiltration and downmodulation of antigen processing, and presentation and T-cell activation that could promote MCL progression and represent a potential target for tailored therapies.",34189576_9,-1,-1,-1,-1,42584,-1,9.436461e-05,0.0006241094,0.9992816
42587,T-cell activation that,37,40,264,286,"Overall, our results suggest that SOX11 expression in MCL is associated with an immunosuppressive microenvironment characterized by CD70 overexpression in tumor cells, increased Treg cell infiltration and downmodulation of antigen processing, and presentation and T-cell activation that could promote MCL progression and represent a potential target for tailored therapies.",34189576_9,-1,-1,-1,-1,42587,-1,0.0012242438,0.016344186,0.9824316
42589,tailored therapies,50,52,354,372,"Overall, our results suggest that SOX11 expression in MCL is associated with an immunosuppressive microenvironment characterized by CD70 overexpression in tumor cells, increased Treg cell infiltration and downmodulation of antigen processing, and presentation and T-cell activation that could promote MCL progression and represent a potential target for tailored therapies.",34189576_9,-1,-1,-1,-1,42589,-1,5.694463e-06,0.99998975,4.5259553e-06
42601,immunity,27,28,175,183,"OBJECTIVES: We aimed to pulsate lymphocytes of breast cancer patients and normal individuals, using Diospyros peregrina fruit preparation (DFP) to study the cancer-protective immunity, and the signal transduction processes involved with it.",34190692_2,0,-1,2,-1,42601,-1,0.99830997,0.00012742449,0.0015626131
42605,the release,8,10,40,51,"We also investigated the role of DFP in the release of lymphocytic nitric oxide (NO), which is a key tumoricidal agent, known to regulate T-cell proliferation, cytokine production, cell signaling, and apoptosis.",34190692_3,-1,-1,-1,-1,42605,-1,6.178975e-06,0.99998844,5.3380204e-06
42613,the blood,11,13,86,95,"METHODS: Using Ficoll-Hypaque gradient centrifugation, lymphocytes were isolated from the blood of 12 patients and 12 normal individuals.",34190692_4,-1,-1,-1,-1,42613,-1,2.1364505e-05,0.999954,2.4600859e-05
42632,T-Box Transcription Factor 21,26,30,125,154,"DFP also noticeably enhances the expression of T helper (TH) cell 1 specific interferon-gamma (IFNG), interleukin 12 (IL12), T-Box Transcription Factor 21 (TBX21) and signal transducer and activator of transcription 1 (STAT1) genes.",34190692_8,-1,-1,-1,-1,42632,-1,5.981387e-06,0.999984,1.0041586e-05
42633,TBX21,31,32,156,161,"DFP also noticeably enhances the expression of T helper (TH) cell 1 specific interferon-gamma (IFNG), interleukin 12 (IL12), T-Box Transcription Factor 21 (TBX21) and signal transducer and activator of transcription 1 (STAT1) genes.",34190692_8,-1,1,2,-1,42633,-1,4.8178466e-05,0.99991906,3.2788437e-05
42639,immunity,6,7,55,63,"DFP treatment significantly increases tumor protective immunity by decreasing the expression levels of TH2 network-specific GATA3 and interleukin 4 (IL4) genes but increasing the expression levels of TH1 network-specific IFNG, IL12, TBX21, and STAT1 genes.",34190692_9,0,-1,2,-1,42639,-1,0.9998412,3.8399518e-05,0.00012036601
42649,TBX21,35,36,233,238,"DFP treatment significantly increases tumor protective immunity by decreasing the expression levels of TH2 network-specific GATA3 and interleukin 4 (IL4) genes but increasing the expression levels of TH1 network-specific IFNG, IL12, TBX21, and STAT1 genes.",34190692_9,-1,1,2,-1,42649,-1,9.033138e-05,0.99985445,5.5181088e-05
42650,STAT1 genes,38,40,244,255,"DFP treatment significantly increases tumor protective immunity by decreasing the expression levels of TH2 network-specific GATA3 and interleukin 4 (IL4) genes but increasing the expression levels of TH1 network-specific IFNG, IL12, TBX21, and STAT1 genes.",34190692_9,-1,-1,-1,-1,42650,-1,3.7145546e-06,0.9999888,7.476228e-06
42656,immunity,20,21,125,133,CONCLUSION: DFP increases the expression levels of TH1 specific network genes which in turn help in evoking tumor protective immunity.,34190692_10,0,-1,2,-1,42656,-1,0.9998801,2.6741427e-05,9.322502e-05
42658,transforming growth factor,7,10,34,60,"v8 integrin, a key activator of transforming growth factor  (TGF-), inhibits anti-tumor immunity.",34233193_0,-1,-1,-1,-1,42658,-1,0.9749448,0.019868648,0.0051865363
42660,immunity,17,18,92,100,"v8 integrin, a key activator of transforming growth factor  (TGF-), inhibits anti-tumor immunity.",34233193_0,0,-1,2,-1,42660,-1,0.999752,0.00010834242,0.00013967075
42673,tumor cell,22,24,128,138,"ADWA-11 increases expression of a suite of genes in tumor-infiltrating CD8+ Tcells normally inhibited by TGF- and involved in tumor cell killing, including granzyme B and interferon-.",34233193_3,-1,-1,-1,-1,42673,-1,4.714602e-05,0.0001470592,0.99980575
42688,that the,13,15,66,74,"In this study, in accordance with our previous findings, we found that the expression of NFAT2 and pri-miR-17~92 are lower in peripheral blood CD3+ T cells from chronic myelogenous leukemia (CML) patients by gene expression analysis.",34237654_2,-1,-1,-1,-1,42688,-1,4.0232167e-06,0.99999213,3.8613007e-06
42689,blood,28,29,139,144,"In this study, in accordance with our previous findings, we found that the expression of NFAT2 and pri-miR-17~92 are lower in peripheral blood CD3+ T cells from chronic myelogenous leukemia (CML) patients by gene expression analysis.",34237654_2,0,1,-1,-1,42689,-1,0.000116847135,0.9997068,0.0001763128
42692,analysis,44,45,226,234,"In this study, in accordance with our previous findings, we found that the expression of NFAT2 and pri-miR-17~92 are lower in peripheral blood CD3+ T cells from chronic myelogenous leukemia (CML) patients by gene expression analysis.",34237654_2,0,1,-1,-1,42692,-1,1.3608023e-05,0.9999734,1.2926622e-05
42693,that the,3,5,23,31,"We further demonstrate that the NFAT2-induced activation, differentiation, and expression of cytokines in human umbilical cord blood CD8+ nave T cells are miR-20a-5p dependent.",34237654_3,-1,-1,-1,-1,42693,-1,4.2216016e-06,0.999992,3.801596e-06
42695,blood,18,19,127,132,"We further demonstrate that the NFAT2-induced activation, differentiation, and expression of cytokines in human umbilical cord blood CD8+ nave T cells are miR-20a-5p dependent.",34237654_3,0,1,-1,-1,42695,-1,0.00041811814,0.9993498,0.00023208601
42697,the relationship,4,6,31,47,We also preliminarily explored the relationship between NFAT2 and miR-20a-5p in naive T cells.,34237654_4,-1,-1,-1,-1,42697,-1,1.0706423e-05,0.99998486,4.4503463e-06
42698,naive T cells,11,14,80,93,We also preliminarily explored the relationship between NFAT2 and miR-20a-5p in naive T cells.,34237654_4,-1,-1,-1,-1,42698,-1,0.0031657952,0.19458833,0.8022458
42701,functional,11,12,72,82,These results suggest that NFAT2 and miR-20a are crucial for regulating functional CD8+ T cells.,34237654_5,0,1,2,-1,42701,-1,3.9337945e-05,0.9999399,2.0758047e-05
42704,related to CD8+ T cell,6,12,38,60,"Additionally, their alteration may be related to CD8+ T cell dysfunction in CML patients; thus, NFAT2 and miR-20a-5p may be considered potential targets for revising T cell function in leukemia immunotherapy.",34237654_6,-1,-1,-1,-1,42704,-1,0.0032209328,0.12141495,0.8753642
42707,T cell function,29,32,166,181,"Additionally, their alteration may be related to CD8+ T cell dysfunction in CML patients; thus, NFAT2 and miR-20a-5p may be considered potential targets for revising T cell function in leukemia immunotherapy.",34237654_6,-1,-1,-1,-1,42707,-1,1.964724e-05,1.0551007e-05,0.9999697
42711,deficiency,18,19,134,144,"In this study, we investigate mechanisms leading to inflammation and immunoreactivity in ovarian tumors with homologous recombination deficiency (HRD).",34289354_0,0,1,-1,-1,42711,-1,0.0014151855,0.9981604,0.0004243765
42713,to transcriptional,6,8,28,46,BRCA1 loss is found to lead to transcriptional reprogramming in tumor cells and cell-intrinsic inflammation involving type I interferon (IFN) and stimulator of IFN genes (STING).,34289354_1,-1,-1,-1,-1,42713,-1,4.3358923e-06,0.9999906,5.071246e-06
42714,tumor cells,10,12,64,75,BRCA1 loss is found to lead to transcriptional reprogramming in tumor cells and cell-intrinsic inflammation involving type I interferon (IFN) and stimulator of IFN genes (STING).,34289354_1,-1,-1,-1,-1,42714,-1,0.0002788406,0.014556581,0.98516464
42719,IFN genes,25,27,160,169,BRCA1 loss is found to lead to transcriptional reprogramming in tumor cells and cell-intrinsic inflammation involving type I interferon (IFN) and stimulator of IFN genes (STING).,34289354_1,-1,-1,-1,-1,42719,-1,0.9986926,0.00089332496,0.00041405627
42721,thus Tcell,6,10,36,47,BRCA1-mutated (BRCA1mut) tumors are thus Tcell inflamed at baseline.,34289354_2,-1,-1,-1,-1,42721,-1,0.0016335222,0.065332614,0.9330339
42742,analysis to,7,9,44,55,"Herein, we carried out flow cytometry-based analysis to readdress issues on NK and T lymphocyte subsets in women with advanced EOC, additionally evaluating phenotypic modulation of their intracellular pathways involved in interleukin (IL)-2 and IL-15 signaling.",34359872_3,-1,-1,-1,-1,42742,-1,5.272996e-06,0.9999889,5.836475e-06
42748,IL-10 than,22,24,144,154,"Results depicted ascites as an inflammatory and immunosuppressive environment, presenting significantly (p < 0.0001) higher amounts of IL-6 and IL-10 than in the patients' blood, as well as significantly (p < 0.05) increased expression of checkpoint inhibitory receptors (programmed death protein-1, PD-1) and ectonucleotidase (CD39) on T lymphocytes.",34359872_4,-1,-1,-1,-1,42748,-1,0.99896884,0.00066953455,0.0003616135
42750,blood,28,29,172,177,"Results depicted ascites as an inflammatory and immunosuppressive environment, presenting significantly (p < 0.0001) higher amounts of IL-6 and IL-10 than in the patients' blood, as well as significantly (p < 0.05) increased expression of checkpoint inhibitory receptors (programmed death protein-1, PD-1) and ectonucleotidase (CD39) on T lymphocytes.",34359872_4,0,1,-1,-1,42750,-1,0.0004766019,0.99747026,0.0020531341
42751,receptors,44,45,261,270,"Results depicted ascites as an inflammatory and immunosuppressive environment, presenting significantly (p < 0.0001) higher amounts of IL-6 and IL-10 than in the patients' blood, as well as significantly (p < 0.05) increased expression of checkpoint inhibitory receptors (programmed death protein-1, PD-1) and ectonucleotidase (CD39) on T lymphocytes.",34359872_4,0,1,2,-1,42751,-1,3.54412e-05,3.2027554e-05,0.9999325
42752,protein-1,48,49,289,298,"Results depicted ascites as an inflammatory and immunosuppressive environment, presenting significantly (p < 0.0001) higher amounts of IL-6 and IL-10 than in the patients' blood, as well as significantly (p < 0.05) increased expression of checkpoint inhibitory receptors (programmed death protein-1, PD-1) and ectonucleotidase (CD39) on T lymphocytes.",34359872_4,0,1,-1,-1,42752,-1,0.012929554,0.91784,0.06923039
42755,blood,20,21,119,124,"However, NK lymphocytes from EOC-associated ascites showed higher (p < 0.05) pS6 phosphorylation compared with NK from blood.",34359872_5,0,1,-1,-1,42755,-1,0.00018147942,0.9995454,0.00027306785
42759,the STAT5 protein,20,23,121,138,"Additionally, in vitro treatment of lymphocytes with IL-2 or IL-15 elicited significantly (p < 0.001) phosphorylation of the STAT5 protein in NK, CD3 and CD8 lymphocytes, both from blood and ascites.",34359872_6,-1,-1,-1,-1,42759,-1,6.280734e-06,0.9999883,5.3589124e-06
42761,blood,33,34,181,186,"Additionally, in vitro treatment of lymphocytes with IL-2 or IL-15 elicited significantly (p < 0.001) phosphorylation of the STAT5 protein in NK, CD3 and CD8 lymphocytes, both from blood and ascites.",34359872_6,0,1,-1,-1,42761,-1,0.00011366984,0.99978834,9.800158e-05
42762,lymphocytes than blood,15,18,91,113,"EOC-associated ascites had a significantly (p < 0.0001) higher proportion of NK CD56bright lymphocytes than blood, which, in addition, were more responsive (p < 0.05) to stimulation by IL-2 than CD56dim NK.",34359872_7,-1,-1,-1,-1,42762,-1,0.0018418484,0.045270186,0.9528881
42766,the tumor,9,11,75,84,"EOC-associated ascites allow studies on lymphocyte phenotype modulation in the tumor environment, where inflammatory profile contrasts with the presence of immunosuppressive elements and development of cellular self-regulating mechanisms.",34359872_8,-1,-1,-1,-1,42766,-1,5.2016767e-06,0.9999906,4.2529573e-06
42786,the STAT3,30,32,165,174,"Our results indicate that germline variation in DPF3, a component of the BAF complex, part of the SWI/SNF complexes, can lead to reduced apoptosis and activation of the STAT3 pathway, both critical in RCC carcinogenesis.",34390653_4,-1,-1,-1,-1,42786,-1,6.768754e-06,0.9999875,5.7049524e-06
42791,tumor cytokine,25,27,156,170,"In addition, we show that altered DPF3 expression in the 14q24 RCC locus could influence the effectiveness of immunotherapy treatment for RCC by regulating tumor cytokine secretion and immune cell activation.",34390653_5,-1,-1,-1,-1,42791,-1,0.432184,0.56456,0.0032559752
42793,that the,4,6,32,40,Accumulating evidence has shown that the cystathionine -synthase/hydrogen sulfide (CBS/H2S) axis is involved in the regulation of inflammation.,34413167_1,-1,-1,-1,-1,42793,-1,4.4523886e-06,0.9999918,3.8169983e-06
42794,the regulation,16,18,113,127,Accumulating evidence has shown that the cystathionine -synthase/hydrogen sulfide (CBS/H2S) axis is involved in the regulation of inflammation.,34413167_1,-1,-1,-1,-1,42794,-1,4.8243587e-06,0.99999046,4.691133e-06
42797,tumor cells,9,11,42,53,"Here, we investigated the roles of CBS in tumor cells and tumor microenvironment of HCC.METHODS: 236 HCC samples were collected to detect the expression of CBS, cleaved Caspase-3 and paired related homeobox 2 (PRRX2) and the number of immune cells.",34413167_3,-1,-1,-1,-1,42797,-1,0.00019235967,0.0046034977,0.9952042
42801,related homeobox,33,35,190,206,"Here, we investigated the roles of CBS in tumor cells and tumor microenvironment of HCC.METHODS: 236 HCC samples were collected to detect the expression of CBS, cleaved Caspase-3 and paired related homeobox 2 (PRRX2) and the number of immune cells.",34413167_3,-1,-1,-1,-1,42801,-1,1.3576618e-05,0.9999765,9.936598e-06
42810,functions,24,25,154,163,"Cbs heterozygous knockout mice, C57BL/6 mice, nude mice and non-obese diabetic severe combined immunodeficiency mice were used to investigate the in vivo functions of CBS.RESULTS: Downregulation of CBS was observed in HCC, and low expression of CBS predicted poor prognosis in HCC patients.",34413167_5,0,1,2,-1,42810,-1,1.2942675e-05,0.9999757,1.1382714e-05
42815,tumor-infiltrating Tregs,10,12,61,85,"Activation of the Cbs/H2S axis also reduced the abundance of tumor-infiltrating Tregs, while Cbs deficiency promoted Tregs-mediated immune evasion and boosted tumor growth in Cbs heterozygous knockout mice.",34413167_7,-1,-1,-1,-1,42815,-1,1.407376e-05,0.99997556,1.0360855e-05
42816,deficiency,15,16,97,107,"Activation of the Cbs/H2S axis also reduced the abundance of tumor-infiltrating Tregs, while Cbs deficiency promoted Tregs-mediated immune evasion and boosted tumor growth in Cbs heterozygous knockout mice.",34413167_7,0,1,-1,-1,42816,-1,0.00015929627,0.99980503,3.563354e-05
42820,tumor cells,9,11,69,80,"Mechanistically, CBS facilitated the expression cleaved Caspase-3 in tumor cells, and on the other hand, suppressed Foxp3 expression in Tregs via inactivating IL-6/STAT3 pathway.",34413167_8,-1,-1,-1,-1,42820,-1,0.0002200984,0.004633419,0.9951466
42828,function,22,23,126,134,"Additionally, miR-24-3p was proven to be an upstream suppressor of CBS in HCC.CONCLUSIONS: Our results indicate the antitumor function of CBS in HCC by inactivation of the PRRX2/IL-6/STAT3 pathway, which may serve as a potential target for HCC clinical immunotherapy.",34413167_10,0,1,2,-1,42828,-1,1.1968837e-05,0.9999782,9.839647e-06
42848,TCR,7,8,57,60,Single-cell TCR/RNA sequencing revealed the existence of TCR clonotypes shared between the liver and CCA tumor of a PBC host.,34495298_7,-1,1,2,-1,42848,-1,3.7036654e-05,0.9998344,0.00012853414
42860,that CXCL10,31,33,207,218,We performed immune profiling to compare immune-related gene expression between ductal carcinoma in situ (DCIS) and invasive carcinoma of the breast using nCounter PanCancer immune Profiling Panel and found that CXCL10 was the most significant gene that had the highest difference in expression between them.,34504204_1,-1,-1,-1,-1,42860,-1,0.94646454,0.051751405,0.0017840174
42862,gene that,37,39,244,253,We performed immune profiling to compare immune-related gene expression between ductal carcinoma in situ (DCIS) and invasive carcinoma of the breast using nCounter PanCancer immune Profiling Panel and found that CXCL10 was the most significant gene that had the highest difference in expression between them.,34504204_1,-1,-1,-1,-1,42862,-1,5.996577e-06,0.9999883,5.682423e-06
42875,that CXCL10,2,4,13,24,"We confirmed that CXCL10 mRNA expression was significantly higher in invasive carcinoma than in DCIS, especially in hormone receptor (HR)-negative tumors using a validation set.",34504204_4,-1,-1,-1,-1,42875,-1,0.89928097,0.098683506,0.0020355822
42883,CXCL10-positive tumors generally,22,25,139,171,"CXCL10 mRNA expression showed a positive correlation with tumor infiltrating lymphocyte (TIL) density in both DCIS and invasive carcinoma; CXCL10-positive tumors generally showed higher infiltration of CD8+and FOXP3+TILs as well as PD-L1+immune cells compared to CXCL10-negative tumors, albeit with different patterns according to HR status.",34504204_5,-1,-1,-1,-1,42883,-1,0.9813741,0.01611844,0.0025074282
42886,to CXCL10-negative tumors,43,46,262,287,"CXCL10 mRNA expression showed a positive correlation with tumor infiltrating lymphocyte (TIL) density in both DCIS and invasive carcinoma; CXCL10-positive tumors generally showed higher infiltration of CD8+and FOXP3+TILs as well as PD-L1+immune cells compared to CXCL10-negative tumors, albeit with different patterns according to HR status.",34504204_5,-1,-1,-1,-1,42886,-1,0.0005827324,0.9992993,0.00011796887
42889,that CXCL10,6,8,32,43,"In conclusion, our study showed that CXCL10 promotes tumor cell proliferation, invasion, and immune cell infiltration, implying its contribution in the progression of DCIS to invasive carcinoma of the breast.",34504204_6,-1,-1,-1,-1,42889,-1,0.9165132,0.08140794,0.0020787963
42890,tumor cell,9,11,53,63,"In conclusion, our study showed that CXCL10 promotes tumor cell proliferation, invasion, and immune cell infiltration, implying its contribution in the progression of DCIS to invasive carcinoma of the breast.",34504204_6,-1,-1,-1,-1,42890,-1,0.0003698567,0.010774004,0.98885614
42899,their function,19,21,98,112,"Regulatory T (Treg) cells, possess a strategic role in the maintenance of immune homeostasis, and their function has been closely linked to development of diverse pathologies including autoimmunity and cancer.",34539668_0,-1,-1,-1,-1,42899,-1,8.625277e-06,0.9999778,1.35461005e-05
42903,Treg cell plasticity,1,4,9,29,"Although Treg cell plasticity comes in various flavors, the major categories enclose the loss of Foxp3 expression, which is the master regulator of Treg cell lineage, giving rise to ""ex-Treg"" cells and the ""fragile"" Treg cells in which FOXP3 expression is retained but accompanied by the engagement of an inflammatory program and attenuation of the suppressive activity.",34539668_2,-1,-1,-1,-1,42903,-1,1.7371369e-05,2.2218788e-05,0.9999604
42916,Treg cell plasticity,0,3,0,20,"Treg cell plasticity possess a tremendous therapeutic potential either by inducing Treg cell de-stabilization to promote anti-tumor immunity, or re-enforcing Treg cell stability to attenuate chronic inflammation.",34539668_3,-1,-1,-1,-1,42916,-1,3.0597108e-05,0.00014797384,0.99982136
42917,tremendous therapeutic,5,7,31,53,"Treg cell plasticity possess a tremendous therapeutic potential either by inducing Treg cell de-stabilization to promote anti-tumor immunity, or re-enforcing Treg cell stability to attenuate chronic inflammation.",34539668_3,-1,-1,-1,-1,42917,-1,6.30359e-06,0.99998736,6.3236284e-06
42920,immunity,17,18,132,140,"Treg cell plasticity possess a tremendous therapeutic potential either by inducing Treg cell de-stabilization to promote anti-tumor immunity, or re-enforcing Treg cell stability to attenuate chronic inflammation.",34539668_3,0,-1,2,-1,42920,-1,0.99983037,6.3275795e-05,0.00010637618
42924,the Treg cell plasticity,7,11,36,60,"Herein, we review the literature on the Treg cell plasticity with lessons learned in autoimmunity and cancer and discuss challenges and open questions with potential therapeutic implications.",34539668_4,-1,-1,-1,-1,42924,-1,0.0011476534,0.84665906,0.15219335
42926,receptor-positive,3,4,22,39,"BACKGROUND: Oestrogen receptor-positive (ER+) breast cancer is commonly treated using endocrine therapies such as aromatase inhibitors which block synthesis of oestradiol, but the influence of this therapy on the immune composition of breast tumours has not been fully explored.",34602068_0,0,1,2,-1,42926,-1,0.042081285,0.11400158,0.84391713
42930,this therapy,29,31,193,205,"BACKGROUND: Oestrogen receptor-positive (ER+) breast cancer is commonly treated using endocrine therapies such as aromatase inhibitors which block synthesis of oestradiol, but the influence of this therapy on the immune composition of breast tumours has not been fully explored.",34602068_0,-1,-1,-1,-1,42930,-1,6.80393e-06,0.99998856,4.673642e-06
42933,that tumour,3,5,26,37,Previous findings suggest that tumour infiltrating lymphocytes and immune-related gene expression may be altered by treatment with aromatase inhibitors.,34602068_1,-1,-1,-1,-1,42933,-1,5.727529e-06,0.9999888,5.5101386e-06
42939,through tumour cells,18,21,100,120,"However, whether these changes are a direct result of impacts on the host immune system or mediated through tumour cells is not known.",34602068_2,-1,-1,-1,-1,42939,-1,0.0026234235,0.3080295,0.6893471
42951,blood,15,16,92,97,"A migration assay and flow cytometry were used to measure the migration of human peripheral blood mononuclear cells (PBMCs) to MCF-7 cells grown without the main biologically active oestrogen, oestradiol.",34602068_5,0,1,-1,-1,42951,-1,0.0020535581,0.95749336,0.04045311
42953,to MCF-7 cells,21,24,124,138,"A migration assay and flow cytometry were used to measure the migration of human peripheral blood mononuclear cells (PBMCs) to MCF-7 cells grown without the main biologically active oestrogen, oestradiol.",34602068_5,-1,-1,-1,-1,42953,-1,0.10185248,0.24196307,0.65618443
42961,TNF,13,14,97,100,"RESULTS: This study demonstrates that oestrogen deprivation increases breast cancer secretion of TNF, CCL5, IL-6, IL-8, and CCL22 and alters total human peripheral blood mononuclear cell migration in an in vitro assay.",34602068_7,0,1,-1,-1,42961,-1,0.003868953,0.99565697,0.00047414252
42966,blood,28,29,164,169,"RESULTS: This study demonstrates that oestrogen deprivation increases breast cancer secretion of TNF, CCL5, IL-6, IL-8, and CCL22 and alters total human peripheral blood mononuclear cell migration in an in vitro assay.",34602068_7,0,1,-1,-1,42966,-1,0.005148742,0.9328504,0.062000837
42977,therapy,3,4,25,32,Treatment with endocrine therapy using the aromatase inhibitor letrozole increases CD4+ T cell infiltration into ER+ breast cancer tumours in immune competent mice.,34602068_10,0,1,-1,-1,42977,-1,1.0120568e-05,0.9999833,6.5666327e-06
42996,the tumor,7,9,37,46,Little is known about its effects on the tumor immune microenvironment.,34680134_1,-1,-1,-1,-1,42996,-1,5.042442e-06,0.9999907,4.2521224e-06
43006,analysis,6,7,53,61,Tumor immune composition determined by deconvolution analysis revealed significant increases in M0 macrophages and B lymphocytes in both I2 groups.,34680134_4,0,1,-1,-1,43006,-1,8.407336e-06,0.999984,7.590485e-06
43014,factor-beta,26,27,133,144,"Real-time RT-PCR showed that I2 tumors overexpress T-BET (p = 0.019) and interferon-gamma (IFN; p = 0.020) and silence tumor growth factor-beta (TGF; p = 0.049), whereas in Cht+I2 tumors, GATA3 is silenced (p = 0.014).",34680134_5,0,1,-1,-1,43014,-1,0.9999571,4.4424796e-06,3.855898e-05
43018,analysis,2,3,24,32,Preliminary methylation analysis shows that I2 activates IFN gene promoter (by increasing its unmethylated form) and silences TGF in Cht+I2.,34680134_6,0,1,-1,-1,43018,-1,7.562534e-06,0.99998546,6.9331163e-06
43020,IFN gene,7,9,57,66,Preliminary methylation analysis shows that I2 activates IFN gene promoter (by increasing its unmethylated form) and silences TGF in Cht+I2.,34680134_6,-1,-1,-1,-1,43020,-1,0.99845123,0.00090638234,0.00064239715
43024,the immune response,13,16,76,95,"In conclusion, our data showed that I2 supplements induce the activation of the immune response and that when combined with Cht, the Th1 pathways are stimulated.",34680134_7,-1,-1,-1,-1,43024,-1,0.7201589,0.27713263,0.0027084583
43026,the Th1,23,25,129,136,"In conclusion, our data showed that I2 supplements induce the activation of the immune response and that when combined with Cht, the Th1 pathways are stimulated.",34680134_7,-1,-1,-1,-1,43026,-1,4.491028e-06,0.99998665,8.893517e-06
43037,traps,13,14,92,97,"C3 is found to promote neutrophil recruitment and the formation of neutrophil extracellular traps (NETs), which facilitate cancer cell metastasis to the lungs.",34707103_3,-1,1,2,-1,43037,-1,0.1969042,0.80178773,0.0013080838
43039,to the,23,25,146,152,"C3 is found to promote neutrophil recruitment and the formation of neutrophil extracellular traps (NETs), which facilitate cancer cell metastasis to the lungs.",34707103_3,-1,-1,-1,-1,43039,-1,6.5117897e-06,0.999984,9.427863e-06
43040,Th2 cytokines,9,11,51,64,C3 expression in LMSCs is induced and sustained by Th2 cytokines in a STAT6-dependent manner.,34707103_4,-1,-1,-1,-1,43040,-1,0.2937588,0.70051426,0.005726902
43042,Th1-skewing Stat6-deficient,6,8,45,72,LMSCs-driven lung metastasis is abolished in Th1-skewing Stat6-deficient mice.,34707103_5,-1,-1,-1,-1,43042,-1,2.1110207e-05,0.99996257,1.6283699e-05
43043,to the,10,12,76,82,Blockade of IL-4 by antibody also attenuates LMSCs-driven cancer metastasis to the lungs.,34707103_6,-1,-1,-1,-1,43043,-1,8.171332e-06,0.99998045,1.1367808e-05
43044,Th2-skewing T-bet-deficient,7,9,48,75,"Consistently, metastasis is greatly enhanced in Th2-skewing T-bet-deficient mice or in nude mice adoptively transferred with T-bet-deficient T cells.",34707103_7,-1,-1,-1,-1,43044,-1,1.3992033e-05,0.9999757,1.0283238e-05
43046,T-bet-deficient T cells,17,20,125,148,"Consistently, metastasis is greatly enhanced in Th2-skewing T-bet-deficient mice or in nude mice adoptively transferred with T-bet-deficient T cells.",34707103_7,-1,-1,-1,-1,43046,-1,0.0011934635,0.9170892,0.08171733
43047,that targeting the Th2-STAT6-C3-NETs,3,7,20,56,Our results suggest that targeting the Th2-STAT6-C3-NETs cascade may reduce breast cancer metastasis to the lungs.,34707103_9,-1,-1,-1,-1,43047,-1,9.8026125e-05,0.9998117,9.02773e-05
43048,to the,13,15,101,107,Our results suggest that targeting the Th2-STAT6-C3-NETs cascade may reduce breast cancer metastasis to the lungs.,34707103_9,-1,-1,-1,-1,43048,-1,7.241082e-06,0.9999831,9.726794e-06
43051,that cell-permeable,3,5,13,32,"Here we show that cell-permeable -ketoglutarate (KG) alters the DNA methylation profile of naive CD4 Tcells activated under Treg polarizing conditions, markedly attenuating FoxP3+ Treg differentiation and increasing inflammatory cytokines.",34731632_1,-1,-1,-1,-1,43051,-1,0.00037777654,0.99854124,0.0010810264
43060,these Tcells,3,7,21,34,"Adoptive transfer of these Tcells into tumor-bearing mice results in enhanced tumor infiltration, decreased FoxP3 expression, and delayed tumor growth.",34731632_2,-1,-1,-1,-1,43060,-1,0.001249094,0.065194555,0.9335564
43066,state that,7,9,43,53,"Mechanistically, KG leads to an energetic state that is reprogrammed toward a mitochondrial metabolism, with increased oxidative phosphorylation and expression of mitochondrial complex enzymes.",34731632_3,-1,-1,-1,-1,43066,-1,4.7837334e-06,0.99998915,6.0456086e-06
43068,metabolism,14,15,93,103,"Mechanistically, KG leads to an energetic state that is reprogrammed toward a mitochondrial metabolism, with increased oxidative phosphorylation and expression of mitochondrial complex enzymes.",34731632_3,0,1,2,-1,43068,-1,0.00029228211,0.9958597,0.0038480116
43069,complex enzymes,24,26,178,193,"Mechanistically, KG leads to an energetic state that is reprogrammed toward a mitochondrial metabolism, with increased oxidative phosphorylation and expression of mitochondrial complex enzymes.",34731632_3,-1,-1,-1,-1,43069,-1,8.7862914e-05,0.99958175,0.00033036803
43070,the generation,10,12,63,77,"Furthermore, carbons from ectopic KG are directly utilized in the generation of fatty acids, associated with lipidome remodeling and increased triacylglyceride stores.",34731632_4,-1,-1,-1,-1,43070,-1,1.1338295e-05,0.99998164,6.9872403e-06
43077,metabolism,10,11,57,67,"Thus, we identify a crosstalk between KG, mitochondrial metabolism and triacylglyceride synthesis that controls Treg fate.",34731632_6,0,1,2,-1,43077,-1,0.0002494605,0.9973878,0.0023626827
43090,therapeutic target,20,22,130,148,"As inhibition of EZH2 activity could upregulate the expression of tumor suppressor genes, EZH2 has recently become an interesting therapeutic target for cancer therapy.",34737746_2,-1,-1,-1,-1,43090,-1,4.653698e-06,0.9999912,4.191231e-06
43091,therapy,24,25,160,167,"As inhibition of EZH2 activity could upregulate the expression of tumor suppressor genes, EZH2 has recently become an interesting therapeutic target for cancer therapy.",34737746_2,0,1,-1,-1,43091,-1,4.186326e-06,0.9999914,4.437246e-06
43093,to the regulation,10,13,67,84,"Moreover, accumulating evidence has shown that EZH2 may contribute to the regulation of immune cells, especially T cells.",34737746_3,-1,-1,-1,-1,43093,-1,6.905585e-06,0.99998534,7.710375e-06
43097,function,9,10,56,64,"EZH2 regulates T cell development, differentiation, and function, suggesting that EZH2 also regulates immune homeostasis in addition to tumor suppressor genes.",34737746_4,0,1,2,-1,43097,-1,0.00026048635,0.9986125,0.0011269604
43099,to tumor,20,22,133,141,"EZH2 regulates T cell development, differentiation, and function, suggesting that EZH2 also regulates immune homeostasis in addition to tumor suppressor genes.",34737746_4,-1,-1,-1,-1,43099,-1,5.082637e-06,0.9999902,4.733623e-06
43104,metabolism,15,16,80,90,"Moreover, EZH2 can regulate T cell fate by targeting non-T cell factors such as metabolism, cytokines, and myeloid-derived suppressor cells.",34737746_5,0,1,2,-1,43104,-1,0.000542977,0.9989791,0.00047795987
43111,function,10,11,87,95,This review discusses up-to-date research on EZH2-mediated regulation of immunological function and the progress of immunological therapeutic strategies based on this regulation.,34737746_7,0,1,2,-1,43111,-1,0.0152336825,0.9689117,0.015854653
43114,this regulation,20,22,162,177,This review discusses up-to-date research on EZH2-mediated regulation of immunological function and the progress of immunological therapeutic strategies based on this regulation.,34737746_7,-1,-1,-1,-1,43114,-1,4.6033206e-06,0.9999894,6.014567e-06
43116,side effects,6,8,34,46,"While lower gastrointestinal (GI) side effects are more common, upper gastrointestinal adverse events are rarely reported.",34755133_1,0,1,-1,-1,43116,-1,0.014838487,0.9827472,0.0024143504
43118,the immunology,2,4,13,27,"To elucidate the immunology underlying this condition, we leverage multiplexed ion beam imaging by time-of-flight (MIBI-TOF) to identify the presence and proportion of infiltrating immune cells from a single section of biopsy specimen.",34755133_3,-1,-1,-1,-1,43118,-1,0.0058100964,0.9936288,0.0005611056
43124,tissue,10,11,75,81,"Using MIBI-TOF, we analyze formalin-fixed, paraffin-embedded human gastric tissue with 28 labels simultaneously.",34755133_4,-1,1,2,-1,43124,-1,0.00023248591,0.9626552,0.037112325
43130,tissue,11,12,82,88,"Here, we provide a comprehensive multiplexed histopathological mapping of gastric tissue, which identifies IFN--producing epithelial cells as possible contributors to the nivolumab-associated gastritis.",34755133_6,-1,1,2,-1,43130,-1,5.5228298e-05,0.99855727,0.0013875115
43133,to the,21,23,165,171,"Here, we provide a comprehensive multiplexed histopathological mapping of gastric tissue, which identifies IFN--producing epithelial cells as possible contributors to the nivolumab-associated gastritis.",34755133_6,-1,-1,-1,-1,43133,-1,6.855588e-06,0.9999877,5.4631137e-06
43134,to target the,7,10,57,70,New approaches beyond PD-1/PD-L1 inhibition are required to target the immunologically diverse tumor microenvironment (TME) in high-grade serous ovarian cancer (HGSOC).,34799346_0,-1,-1,-1,-1,43134,-1,4.3346936e-06,0.99999166,4.010592e-06
43140,the CCL2-CCR2-M2,15,17,77,93,"In this study, we explored the immunosuppressive effect of B7-H3 (CD276) via the CCL2-CCR2-M2 macrophage axis and its potential as a therapeutic target.",34799346_1,-1,-1,-1,-1,43140,-1,0.026327558,0.9726716,0.0010008574
43141,therapeutic target,24,26,133,151,"In this study, we explored the immunosuppressive effect of B7-H3 (CD276) via the CCL2-CCR2-M2 macrophage axis and its potential as a therapeutic target.",34799346_1,-1,-1,-1,-1,43141,-1,4.802738e-06,0.9999907,4.4866197e-06
43142,Transcriptome analysis,0,2,0,22,"Transcriptome analysis revealed that B7-H3 is highly expressed in PD-L1-low, nonimmunoreactive HGSOC tumors, and its expression negatively correlated with an IFN signature, which reflects the tumor immune reactivity.",34799346_2,-1,-1,-1,-1,43142,-1,5.1035527e-06,0.99999034,4.529421e-06
43143,that B7-H3,3,5,32,42,"Transcriptome analysis revealed that B7-H3 is highly expressed in PD-L1-low, nonimmunoreactive HGSOC tumors, and its expression negatively correlated with an IFN signature, which reflects the tumor immune reactivity.",34799346_2,-1,-1,-1,-1,43143,-1,0.0043900376,0.45848843,0.53712153
43146,the tumor,27,29,189,198,"Transcriptome analysis revealed that B7-H3 is highly expressed in PD-L1-low, nonimmunoreactive HGSOC tumors, and its expression negatively correlated with an IFN signature, which reflects the tumor immune reactivity.",34799346_2,-1,-1,-1,-1,43146,-1,4.9675523e-06,0.9999907,4.285231e-06
43148,tumor cells,14,16,58,69,"In syngeneic mouse models, B7-H3 (Cd276) knockout (KO) in tumor cells, but not in stromal cells, suppressed tumor progression, with a reduced number of M2 macrophages and an increased number of IFN+CD8+ T cells.",34799346_3,-1,-1,-1,-1,43148,-1,8.836605e-05,0.00060210057,0.99930954
43154,the B7-H3,5,7,37,46,CCL2 expression was downregulated in the B7-H3 KO tumor cell lines.,34799346_4,-1,-1,-1,-1,43154,-1,0.0044004493,0.67482984,0.3207697
43155,tumor cell,8,10,50,60,CCL2 expression was downregulated in the B7-H3 KO tumor cell lines.,34799346_4,-1,-1,-1,-1,43155,-1,0.00020120073,0.006923849,0.992875
43156,the CCL2-CCR2,2,4,14,27,"Inhibition of the CCL2-CCR2 axis partly negated the effects of B7-H3 suppression on M2 macrophage migration and differentiation, and tumor progression.",34799346_5,-1,-1,-1,-1,43156,-1,0.06792869,0.9299868,0.0020845577
43162,B7-H3-high tumors,20,22,131,148,"In patients with HGSOC, B7-H3 expression positively correlated with CCL2 expression and M2 macrophage abundance, and patients with B7-H3-high tumors had fewer tumoral IFN+CD8+ T cells and poorer prognosis than patients with B7-H3-low tumors.",34799346_6,-1,-1,-1,-1,43162,-1,0.0012748215,0.016539635,0.98218554
43163,tumoral IFN+CD8,24,26,159,175,"In patients with HGSOC, B7-H3 expression positively correlated with CCL2 expression and M2 macrophage abundance, and patients with B7-H3-high tumors had fewer tumoral IFN+CD8+ T cells and poorer prognosis than patients with B7-H3-low tumors.",34799346_6,-1,-1,-1,-1,43163,-1,0.16646229,0.8227511,0.010786635
43166,B7-H3-low tumors,35,37,225,241,"In patients with HGSOC, B7-H3 expression positively correlated with CCL2 expression and M2 macrophage abundance, and patients with B7-H3-high tumors had fewer tumoral IFN+CD8+ T cells and poorer prognosis than patients with B7-H3-low tumors.",34799346_6,-1,-1,-1,-1,43166,-1,0.0016478844,0.023604658,0.9747474
43169,tumor cells,5,7,26,37,"Thus, B7-H3 expression in tumor cells contributes to CCL2-CCR2-M2 macrophage axis-mediated immunosuppression and tumor progression.",34799346_7,-1,-1,-1,-1,43169,-1,0.00027310255,0.00867732,0.9910495
43170,to CCL2-CCR2-M2,8,10,50,65,"Thus, B7-H3 expression in tumor cells contributes to CCL2-CCR2-M2 macrophage axis-mediated immunosuppression and tumor progression.",34799346_7,-1,-1,-1,-1,43170,-1,0.106887124,0.8901794,0.0029335353
43179,T-cell therapy,17,19,110,124,"The unprecedented successes of immunotherapies (IOs) including immune checkpoint blockers (ICBs) and adoptive T-cell therapy (ACT) in patients with late-stage cancer provide proof-of-principle evidence that harnessing the immune system, in particular T cells, can be an effective approach to eradicate cancer.",34830176_0,-1,-1,-1,-1,43179,-1,0.00017640692,0.0027127424,0.99711084
43191,immunity,27,28,154,162,"With the ""newly"" discovered immunogenic responses from RT, numerous endeavors have been undertaken to combine RT with IOs, in order to bolster anti-tumor immunity.",34830176_2,0,-1,2,-1,43191,-1,0.999752,8.221939e-05,0.00016574042
43195,the IFN-JAK-STAT,19,21,142,158,"We therefore conducted a systematic literature search on the molecular underpinnings of RT-induced immunomodulation and IOs, which identified the IFN-JAK-STAT pathway as a major regulator.",34830176_4,-1,-1,-1,-1,43195,-1,0.003709566,0.9960477,0.0002427306
43196,analysis,2,3,12,20,Our further analysis of relevant studies revealed that the signaling strength and duration of this pathway in response to RT and IOs may determine eventual immunological outcomes.,34830176_5,0,1,-1,-1,43196,-1,8.285915e-06,0.9999857,5.991914e-06
43198,that the,7,9,50,58,Our further analysis of relevant studies revealed that the signaling strength and duration of this pathway in response to RT and IOs may determine eventual immunological outcomes.,34830176_5,-1,-1,-1,-1,43198,-1,4.1705443e-06,0.9999919,3.9370593e-06
43207,therapy,27,28,178,185,"We propose that strategic targeting of this axis can boost the immunostimulatory effects of RT and radiosensitizing effects of IOs, thereby promoting the efficacy of combination therapy of RT and IOs.",34830176_6,0,1,-1,-1,43207,-1,5.4868406e-06,0.99998975,4.820915e-06
43213,IFN- treatment,7,9,61,76,AX-0085 effectively blocks JAK2/STAT1 signaling initiated by IFN- treatment and prevents nuclear localization of STAT1.,35011581_1,-1,-1,-1,-1,43213,-1,0.9998404,5.4215514e-05,0.00010540838
43216,the IFN--mediated,7,9,50,68,"Importantly, we demonstrate that AX-0085 reverses the IFN--mediated repression of T cell activation in vitro and enhances the anti-tumor activity of anti-PD-1 antibody in vivo when used in combination.",35011581_2,-1,-1,-1,-1,43216,-1,0.29948172,0.69761825,0.002900082
43221,targeting the IFN--pathway,11,14,78,105,"Finally, transcriptomic analyses indicated that AX-0085 is highly specific in targeting the IFN--pathway, thereby raising the possibility of applying this reagent in combination therapy with checkpoint inhibitor antibodies.",35011581_3,-1,-1,-1,-1,43221,-1,0.060594905,0.9373893,0.0020157727
43225,therapy,25,26,179,186,"Finally, transcriptomic analyses indicated that AX-0085 is highly specific in targeting the IFN--pathway, thereby raising the possibility of applying this reagent in combination therapy with checkpoint inhibitor antibodies.",35011581_3,0,1,-1,-1,43225,-1,4.9213004e-06,0.99998987,5.218721e-06
43231,tissues,13,14,85,92,The GATA4 transcription factor acts as a master regulator of development of multiple tissues.,35017504_0,-1,1,2,-1,43231,-1,0.00042660127,0.031343583,0.9682299
43239,factors,11,12,68,75,"This secretory pathway is composed of chemokines, cytokines, growth factors, and proteases.",35017504_2,0,1,-1,-1,43239,-1,0.99994195,8.986294e-06,4.909077e-05
43250,Analysis,0,1,0,8,"Analysis of transcriptome data in human tumors reveals reduced lymphocyte infiltration in GATA4-deficient tumors, consistent with our murine data.",35017504_6,0,1,-1,-1,43250,-1,6.6777757e-06,0.9999881,5.247963e-06
43258,receptor,2,3,11,19,"The apelin receptor (APLNR) regulates many biological processes including metabolism, angiogenesis, circulating blood volume and cardiovascular function.",35084016_0,0,1,2,-1,43258,-1,0.0018704382,0.981818,0.016311571
43259,metabolism,11,12,74,84,"The apelin receptor (APLNR) regulates many biological processes including metabolism, angiogenesis, circulating blood volume and cardiovascular function.",35084016_0,0,1,2,-1,43259,-1,4.3745335e-05,0.9999188,3.746428e-05
43260,blood,16,17,112,117,"The apelin receptor (APLNR) regulates many biological processes including metabolism, angiogenesis, circulating blood volume and cardiovascular function.",35084016_0,0,1,-1,-1,43260,-1,0.014326943,0.84694064,0.13873239
43261,function,20,21,144,152,"The apelin receptor (APLNR) regulates many biological processes including metabolism, angiogenesis, circulating blood volume and cardiovascular function.",35084016_0,0,1,2,-1,43261,-1,0.001566458,0.9929041,0.0055293827
43265,the IFN-,12,14,89,98,APLNR is reported to regulate tumor recognition during immune surveillance by modulating the IFN- response.,35084016_2,-1,-1,-1,-1,43265,-1,0.9807717,0.017891183,0.001337074
43270,cells through,13,15,80,93,"Here, we show that activation of APLNR up-regulates IFN- signaling in melanoma cells through APLNR mediated -arrestin 1 but not -arrestin 2 recruitment.",35084016_4,-1,-1,-1,-1,43270,-1,0.003650556,0.40136912,0.59498036
43272,STAT1 to,9,11,60,68,Our data suggests that -arrestin 1 directly interacts with STAT1 to inhibit STAT1 phosphorylation to attenuate IFN- signaling.,35084016_5,-1,-1,-1,-1,43272,-1,3.7713955e-06,0.9999907,5.5503797e-06
43277,receptor,3,4,17,25,"The APLNR mutant receptor, I109A, which is deficient in -arrestins recruitment, is unable to enhance intratumoral IFN- signaling.",35084016_6,0,1,2,-1,43277,-1,0.0003608705,0.02406266,0.9755764
43280,receptor,9,10,50,58,"While APLNR N112G, a constitutively active mutant receptor, increases intratumoral sensitivity to IFN- signaling by enhancing STAT1 phosphorylation upon IFN- exposure.",35084016_7,0,1,2,-1,43280,-1,0.00027792336,0.029900331,0.96982175
43281,to IFN-,14,16,95,103,"While APLNR N112G, a constitutively active mutant receptor, increases intratumoral sensitivity to IFN- signaling by enhancing STAT1 phosphorylation upon IFN- exposure.",35084016_7,-1,-1,-1,-1,43281,-1,0.9845664,0.013826299,0.0016073063
43286,Taken together,0,2,0,14,"Taken together, our findings reveal that APLNR modulates IFN- signaling in melanoma cells and suggest that APLNR may be a potential target to enhance the efficacy of immunotherapy.",35084016_9,-1,-1,-1,-1,43286,-1,1.0195743e-05,0.9999814,8.4417e-06
43291,target to,22,24,133,142,"Taken together, our findings reveal that APLNR modulates IFN- signaling in melanoma cells and suggest that APLNR may be a potential target to enhance the efficacy of immunotherapy.",35084016_9,-1,-1,-1,-1,43291,-1,3.9537076e-06,0.9999925,3.5656556e-06
43293,tumor types,8,10,57,68,"Despite recent advances in cancer immunotherapy, certain tumor types, such as Glioblastomas, are highly resistant due to their tumor microenvironment disabling the anti-tumor immune response.",35177622_0,-1,-1,-1,-1,43293,-1,5.4525744e-06,0.9999831,1.1503549e-05
43294,to their tumor,19,22,118,132,"Despite recent advances in cancer immunotherapy, certain tumor types, such as Glioblastomas, are highly resistant due to their tumor microenvironment disabling the anti-tumor immune response.",35177622_0,-1,-1,-1,-1,43294,-1,6.1242044e-06,0.9999875,6.4499686e-06
43306,T-cell,46,47,302,308,"Here we show, by applying an in-silico multidimensional model integrating spatially resolved and single-cell gene expression data of 45,615 immune cells from 12 tumor samples, that a subset of Interleukin-10-releasing HMOX1+myeloid cells, spatially localizing to mesenchymal-like tumor regions, drive T-cell exhaustion and thus contribute to the immunosuppressive tumor microenvironment.",35177622_1,-1,1,2,-1,43306,-1,1.4459521e-05,6.569649e-06,0.999979
43308,to the,51,53,340,346,"Here we show, by applying an in-silico multidimensional model integrating spatially resolved and single-cell gene expression data of 45,615 immune cells from 12 tumor samples, that a subset of Interleukin-10-releasing HMOX1+myeloid cells, spatially localizing to mesenchymal-like tumor regions, drive T-cell exhaustion and thus contribute to the immunosuppressive tumor microenvironment.",35177622_1,-1,-1,-1,-1,43308,-1,5.0024173e-06,0.99999046,4.5370475e-06
43311,T-cells to,16,18,125,135,These findings are validated using a human ex-vivo neocortical glioblastoma model inoculated with patient derived peripheral T-cells to simulate the immune compartment.,35177622_2,-1,-1,-1,-1,43311,-1,0.0017830554,0.059522204,0.9386947
43317,T-cells,9,10,80,87,This model recapitulates the dysfunctional transformation of tumor infiltrating T-cells.,35177622_3,-1,1,2,-1,43317,-1,2.0239568e-05,1.5243761e-05,0.9999645
43319,T-cell functionality,6,8,43,63,"Inhibition of the JAK/STAT pathway rescues T-cell functionality both in our model and in-vivo, providing further evidence of IL-10 release being an important driving force of tumor immune escape.",35177622_4,-1,-1,-1,-1,43319,-1,2.4027431e-05,1.4149049e-05,0.99996173
43320,IL-10 release,19,21,125,138,"Inhibition of the JAK/STAT pathway rescues T-cell functionality both in our model and in-vivo, providing further evidence of IL-10 release being an important driving force of tumor immune escape.",35177622_4,-1,-1,-1,-1,43320,-1,0.9993318,0.00039572874,0.0002723931
43326,tool to,17,19,111,118,Our results thus show that integrative modelling of single cell and spatial transcriptomics data is a valuable tool to interrogate the tumor immune microenvironment and might contribute to the development of successful immunotherapies.,35177622_5,-1,-1,-1,-1,43326,-1,8.462936e-06,0.9999857,5.838616e-06
43327,the tumor,20,22,131,140,Our results thus show that integrative modelling of single cell and spatial transcriptomics data is a valuable tool to interrogate the tumor immune microenvironment and might contribute to the development of successful immunotherapies.,35177622_5,-1,-1,-1,-1,43327,-1,4.8224842e-06,0.99999094,4.2460897e-06
43328,to the,27,29,186,192,Our results thus show that integrative modelling of single cell and spatial transcriptomics data is a valuable tool to interrogate the tumor immune microenvironment and might contribute to the development of successful immunotherapies.,35177622_5,-1,-1,-1,-1,43328,-1,5.617009e-06,0.9999894,4.9491327e-06
43334,immunity,19,20,122,130,T regulatory (Treg) cells are essential for self-tolerance whereas they are detrimental for dampening the host anti-tumor immunity.,35895684_0,0,-1,2,-1,43334,-1,0.9998485,6.046064e-05,9.111367e-05
43339,functions,12,13,83,92,How Treg cells adapt to environmental signals to orchestrate their homeostasis and functions remains poorly understood.,35895684_1,0,1,2,-1,43339,-1,0.00018162483,0.99914,0.0006783449
43340,that transcription factor EB,4,8,20,48,"Here, we identified that transcription factor EB (TFEB) is induced by host nutrition deprivation or interleukin (IL)-2 in CD4+ T cells.",35895684_2,-1,-1,-1,-1,43340,-1,5.968588e-06,0.99998975,4.2444244e-06
43349,Treg function,14,16,79,92,The loss of TFEB in Treg cells leads to reduced Treg accumulation and impaired Treg function in mouse models of cancer and autoimmune disease.,35895684_3,-1,-1,-1,-1,43349,-1,1.1743316e-05,0.99996746,2.0836129e-05
43353,function,11,12,90,98,TFEB intrinsically regulates genes involved in Treg cell differentiation and mitochondria function while it suppresses expression of proinflammatory cytokines independently of its established roles in autophagy.,35895684_4,0,1,2,-1,43353,-1,0.00085321226,0.9747806,0.02436621
43356,metabolism,11,12,85,95,This coordinated action is required for mitochondria integrity and appropriate lipid metabolism in Treg cells.,35895684_5,0,1,2,-1,43356,-1,0.024669463,0.97269315,0.002637384
43360,Treg generation,10,12,71,86,"These findings identify TFEB as a critical regulator for orchestrating Treg generation and function, which may contribute to the adaptive responses of T cells to local environmental cues.",35895684_6,-1,-1,-1,-1,43360,-1,5.1025713e-06,0.9999888,6.092993e-06
43361,function,13,14,91,99,"These findings identify TFEB as a critical regulator for orchestrating Treg generation and function, which may contribute to the adaptive responses of T cells to local environmental cues.",35895684_6,0,1,2,-1,43361,-1,3.0523195e-05,0.9999337,3.5695917e-05
43362,to the,18,20,122,128,"These findings identify TFEB as a critical regulator for orchestrating Treg generation and function, which may contribute to the adaptive responses of T cells to local environmental cues.",35895684_6,-1,-1,-1,-1,43362,-1,6.7282035e-06,0.9999888,4.5135503e-06
43363,T cells to,23,26,151,161,"These findings identify TFEB as a critical regulator for orchestrating Treg generation and function, which may contribute to the adaptive responses of T cells to local environmental cues.",35895684_6,-1,-1,-1,-1,43363,-1,0.0023396015,0.03159351,0.9660669
43366,adaptive immune responses,9,12,50,75,B cells are emerging as key players of anti-tumor adaptive immune responses.,35909944_0,-1,-1,-1,-1,43366,-1,0.9999218,3.244024e-05,4.57953e-05
43373,TNF-+,14,15,90,96,"We found enhanced circulating regulatory (TGF-+ and PD-L1+) and reduced pro-inflammatory TNF-+ B cell populations in patients compared with healthy volunteers (HVs), including lower IFN-+:IL-4+and higher TGF-+:TNF-+ B cell ratios in patients.",35909944_2,0,1,-1,-1,43373,-1,0.00039558933,0.9994981,0.00010630625
43386,to blood,5,7,33,41,"While reduced in tumors compared to blood, TNF--expressing B cells engaged in crosstalk with Tregs via TNF- signaling and the ICOS/ICOSL axis.",35909944_4,-1,-1,-1,-1,43386,-1,1.0494533e-05,0.9999778,1.1672458e-05
43387,TNF--expressing,8,9,43,59,"While reduced in tumors compared to blood, TNF--expressing B cells engaged in crosstalk with Tregs via TNF- signaling and the ICOS/ICOSL axis.",35909944_4,0,1,-1,-1,43387,-1,9.627219e-05,0.9998474,5.6262925e-05
43390,TNF-,17,18,104,109,"While reduced in tumors compared to blood, TNF--expressing B cells engaged in crosstalk with Tregs via TNF- signaling and the ICOS/ICOSL axis.",35909944_4,0,1,-1,-1,43390,-1,2.0310208e-05,0.99996865,1.1011392e-05
43397,TNF-,19,20,131,136,"Patient-derived B cells promoted FOXP3+ Treg differentiation in a TGF--dependent manner, while sustaining expression of IFN- and TNF- by autologous T-helper cells and promoting T-helper cell proliferation ex vivo, an effect further enhanced with anti-PD-1 checkpoint blockade.",35909944_5,0,1,-1,-1,43397,-1,9.560878e-05,0.99987924,2.5096586e-05
43413,T-cells,16,17,113,120,The mechanisms through which Vascular Endothelial Growth Factor A(VEGF-A) modulates tumor EC response to exclude T-cells are not well understood.,36403190_1,-1,1,2,-1,43413,-1,3.474004e-05,2.9733892e-05,0.9999356
43419,T-cells,26,27,180,187,"EC-specific Rap1B deletion inhibits angiogenesis, but also leads to an altered tumor microenvironment with increased recruitment of leukocytes and increased activity of tumor CD8+ T-cells.",36403190_3,-1,1,2,-1,43419,-1,1.3611902e-05,8.337184e-06,0.99997807
43420,T-cells,4,5,18,25,Depletion of CD8+ T-cells restored tumor growth in Rap1BiEC mice.,36403190_4,-1,1,2,-1,43420,-1,1.753915e-05,9.641838e-06,0.9999728
43423,functional,5,6,42,52,"Mechanistically, global transcriptome and functional analyses indicated upregulation of signaling by a tumor cytokine, TNF-, and increased NF-B transcription in Rap1B-deficient ECs.",36403190_5,0,1,2,-1,43423,-1,0.00011974389,0.99980146,7.876653e-05
43424,tumor cytokine,13,15,103,117,"Mechanistically, global transcriptome and functional analyses indicated upregulation of signaling by a tumor cytokine, TNF-, and increased NF-B transcription in Rap1B-deficient ECs.",36403190_5,-1,-1,-1,-1,43424,-1,0.62316346,0.3711717,0.0056648245
43425,TNF-,16,17,119,124,"Mechanistically, global transcriptome and functional analyses indicated upregulation of signaling by a tumor cytokine, TNF-, and increased NF-B transcription in Rap1B-deficient ECs.",36403190_5,0,1,-1,-1,43425,-1,0.0010187017,0.99886346,0.0001178566
43430,TNF-,15,16,108,113,Rap1B-deficiency led to elevated proinflammatory chemokine and Cell Adhesion Molecules (CAMs) expression in TNF- stimulated ECs.,36403190_6,0,1,-1,-1,43430,-1,0.0004127294,0.9995376,4.9654936e-05
43437,the regulation,3,5,17,31,"We have examined the regulation of the AP-1 DNA transcription complex during T cell activation in response to interleukin 1 (IL-1) and phorbol ester (TPA) treatment of the IL-1 responsive murine thymoma T cell line, EL4 6.1 C 10.",7675040_0,-1,-1,-1,-1,43437,-1,3.890894e-06,0.99999166,4.4640974e-06
43438,the AP-1,6,8,35,43,"We have examined the regulation of the AP-1 DNA transcription complex during T cell activation in response to interleukin 1 (IL-1) and phorbol ester (TPA) treatment of the IL-1 responsive murine thymoma T cell line, EL4 6.1 C 10.",7675040_0,-1,-1,-1,-1,43438,-1,4.0651003e-06,0.9999881,7.913117e-06
43439,transcription complex,9,11,48,69,"We have examined the regulation of the AP-1 DNA transcription complex during T cell activation in response to interleukin 1 (IL-1) and phorbol ester (TPA) treatment of the IL-1 responsive murine thymoma T cell line, EL4 6.1 C 10.",7675040_0,-1,-1,-1,-1,43439,-1,3.9862452e-06,0.9999907,5.289687e-06
43441,to interleukin 1,17,20,107,123,"We have examined the regulation of the AP-1 DNA transcription complex during T cell activation in response to interleukin 1 (IL-1) and phorbol ester (TPA) treatment of the IL-1 responsive murine thymoma T cell line, EL4 6.1 C 10.",7675040_0,-1,-1,-1,-1,43441,-1,0.8812161,0.113223135,0.005560758
43445,the IL-1,31,33,168,176,"We have examined the regulation of the AP-1 DNA transcription complex during T cell activation in response to interleukin 1 (IL-1) and phorbol ester (TPA) treatment of the IL-1 responsive murine thymoma T cell line, EL4 6.1 C 10.",7675040_0,-1,-1,-1,-1,43445,-1,0.89898753,0.09626692,0.004745606
43446,thymoma T cell,35,38,195,209,"We have examined the regulation of the AP-1 DNA transcription complex during T cell activation in response to interleukin 1 (IL-1) and phorbol ester (TPA) treatment of the IL-1 responsive murine thymoma T cell line, EL4 6.1 C 10.",7675040_0,-1,-1,-1,-1,43446,-1,0.002354912,0.56126267,0.43638244
43450,AP-1-mediated gene,9,11,63,81,IL-1 synergistically enhances the stimulatory effect of TPA on AP-1-mediated gene expression in this cell line.,7675040_1,-1,-1,-1,-1,43450,-1,1.4066539e-05,0.9999745,1.1453938e-05
43451,this cell,13,15,96,105,IL-1 synergistically enhances the stimulatory effect of TPA on AP-1-mediated gene expression in this cell line.,7675040_1,-1,-1,-1,-1,43451,-1,0.0005361043,0.033924628,0.9655393
43455,AP-1-mediated gene,9,11,53,71,"To elucidate the mechanism(s) by which IL-1 enhances AP-1-mediated gene expression, we examined the effect of IL-1 on the synthesis and turnover of Jun B, the member of the jun gene family that is present in AP-1 complexes in EL4 cells.",7675040_2,-1,-1,-1,-1,43455,-1,9.114421e-06,0.99998116,9.671674e-06
43462,the jun gene,31,34,169,181,"To elucidate the mechanism(s) by which IL-1 enhances AP-1-mediated gene expression, we examined the effect of IL-1 on the synthesis and turnover of Jun B, the member of the jun gene family that is present in AP-1 complexes in EL4 cells.",7675040_2,-1,-1,-1,-1,43462,-1,5.3501044e-06,0.9999894,5.2939345e-06
43466,that IL-1,2,4,9,18,We found that IL-1 + TPA-treated cells contain significantly higher Jun B protein levels than cells treated with TPA alone.,7675040_3,-1,-1,-1,-1,43466,-1,0.6202321,0.37391528,0.005852565
43467,TPA-treated cells,5,7,21,38,We found that IL-1 + TPA-treated cells contain significantly higher Jun B protein levels than cells treated with TPA alone.,7675040_3,-1,-1,-1,-1,43467,-1,0.0022208246,0.9137354,0.08404378
43469,protein,12,13,74,81,We found that IL-1 + TPA-treated cells contain significantly higher Jun B protein levels than cells treated with TPA alone.,7675040_3,0,1,-1,-1,43469,-1,5.245024e-06,0.9999876,7.172927e-06
43470,than cells treated,14,17,89,107,We found that IL-1 + TPA-treated cells contain significantly higher Jun B protein levels than cells treated with TPA alone.,7675040_3,-1,-1,-1,-1,43470,-1,2.6448162e-05,0.9999249,4.862901e-05
43475,the cellular,10,12,59,71,"IL-1 promotes the prolonged accumulation of Jun B, whereas the cellular content of Jun B decreases dramatically after 6 hr in cells treated with only TPA.",7675040_4,-1,-1,-1,-1,43475,-1,0.004155906,0.63761884,0.3582253
43477,cells treated,22,24,126,139,"IL-1 promotes the prolonged accumulation of Jun B, whereas the cellular content of Jun B decreases dramatically after 6 hr in cells treated with only TPA.",7675040_4,-1,-1,-1,-1,43477,-1,0.004257325,0.33056974,0.66517293
43481,protein,5,6,26,33,"IL-1 enhancement of Jun B protein levels is not the result of a change in the turnover rate of the Jun B protein, but rather results from the maintenance of sufficient jun B mRNA to support continued accumulation of newly synthesized protein.",7675040_5,0,1,-1,-1,43481,-1,1.3478023e-05,0.99997306,1.3429037e-05
43483,the turnover,15,17,74,86,"IL-1 enhancement of Jun B protein levels is not the result of a change in the turnover rate of the Jun B protein, but rather results from the maintenance of sufficient jun B mRNA to support continued accumulation of newly synthesized protein.",7675040_5,-1,-1,-1,-1,43483,-1,1.0270951e-05,0.9999845,5.2355776e-06
43484,the Jun,19,21,95,102,"IL-1 enhancement of Jun B protein levels is not the result of a change in the turnover rate of the Jun B protein, but rather results from the maintenance of sufficient jun B mRNA to support continued accumulation of newly synthesized protein.",7675040_5,-1,-1,-1,-1,43484,-1,8.580039e-06,0.99998355,7.893342e-06
43485,protein,22,23,105,112,"IL-1 enhancement of Jun B protein levels is not the result of a change in the turnover rate of the Jun B protein, but rather results from the maintenance of sufficient jun B mRNA to support continued accumulation of newly synthesized protein.",7675040_5,0,1,-1,-1,43485,-1,1.9870351e-05,0.9999577,2.2500924e-05
43489,protein,42,43,234,241,"IL-1 enhancement of Jun B protein levels is not the result of a change in the turnover rate of the Jun B protein, but rather results from the maintenance of sufficient jun B mRNA to support continued accumulation of newly synthesized protein.",7675040_5,0,1,-1,-1,43489,-1,4.7137517e-05,0.99993813,1.4733762e-05
43490,to Jun,2,4,12,18,"In addition to Jun B, we found that the T cell AP-1 complex contains the Fra-1 protein, a member of the fos gene family.",7675040_6,-1,-1,-1,-1,43490,-1,7.0814817e-06,0.9999858,7.0646524e-06
43491,that the T cell AP-1 complex,8,14,31,59,"In addition to Jun B, we found that the T cell AP-1 complex contains the Fra-1 protein, a member of the fos gene family.",7675040_6,-1,-1,-1,-1,43491,-1,1.8270335e-05,0.99995303,2.8658915e-05
43492,the Fra-1 protein,15,18,69,86,"In addition to Jun B, we found that the T cell AP-1 complex contains the Fra-1 protein, a member of the fos gene family.",7675040_6,-1,-1,-1,-1,43492,-1,6.1590727e-06,0.99998665,7.17895e-06
43493,the fos gene,22,25,100,112,"In addition to Jun B, we found that the T cell AP-1 complex contains the Fra-1 protein, a member of the fos gene family.",7675040_6,-1,-1,-1,-1,43493,-1,5.3704193e-06,0.99998844,6.166142e-06
43496,TPA-induced Fra-1 protein,12,15,77,102,"Although IL-1 dramatically increases Jun B accumulation, it does not enhance TPA-induced Fra-1 protein levels in EL4 cells.",7675040_7,-1,-1,-1,-1,43496,-1,9.452915e-06,0.9999826,7.923404e-06
43500,AP-1-mediated gene,5,7,25,43,"Thus, the stimulation of AP-1-mediated gene expression by IL-1 in EL4 cells is due to the promotion of Jun B protein accumulation that, in turn, facilitates Jun B heterodimerization with TPA-induced Fra-1 protein, thereby forming an active AP-1 complex.",7675040_8,-1,-1,-1,-1,43500,-1,1.0603474e-05,0.99997866,1.0765628e-05
43503,to the,15,17,83,89,"Thus, the stimulation of AP-1-mediated gene expression by IL-1 in EL4 cells is due to the promotion of Jun B protein accumulation that, in turn, facilitates Jun B heterodimerization with TPA-induced Fra-1 protein, thereby forming an active AP-1 complex.",7675040_8,-1,-1,-1,-1,43503,-1,3.9605397e-06,0.999992,4.032512e-06
43505,protein,21,22,109,116,"Thus, the stimulation of AP-1-mediated gene expression by IL-1 in EL4 cells is due to the promotion of Jun B protein accumulation that, in turn, facilitates Jun B heterodimerization with TPA-induced Fra-1 protein, thereby forming an active AP-1 complex.",7675040_8,0,1,-1,-1,43505,-1,4.896391e-06,0.99998903,6.019644e-06
43509,TPA-induced Fra-1 protein,33,36,187,212,"Thus, the stimulation of AP-1-mediated gene expression by IL-1 in EL4 cells is due to the promotion of Jun B protein accumulation that, in turn, facilitates Jun B heterodimerization with TPA-induced Fra-1 protein, thereby forming an active AP-1 complex.",7675040_8,-1,-1,-1,-1,43509,-1,6.034249e-06,0.9999882,5.7762077e-06
43514,TH2 lymphocytes,8,10,38,53,Interleukin 10 (IL-10) is produced by TH2 lymphocytes and regulates both lymphoid and myeloid cells.,8037735_0,-1,-1,-1,-1,43514,-1,3.62514e-05,0.00011415765,0.99984956
43517,that IL-10,6,8,36,46,"In the present study we demonstrate that IL-10 is expressed and produced spontaneously in the peripheral blood mononuclear cells (PBMCs) of all HIV-1 infected individuals tested, 3 of 19 cases of HIV-negative lymphoma and none of five healthy controls.",8037735_1,-1,-1,-1,-1,43517,-1,0.92382765,0.074238695,0.0019336169
43519,blood,16,17,105,110,"In the present study we demonstrate that IL-10 is expressed and produced spontaneously in the peripheral blood mononuclear cells (PBMCs) of all HIV-1 infected individuals tested, 3 of 19 cases of HIV-negative lymphoma and none of five healthy controls.",8037735_1,0,1,-1,-1,43519,-1,0.0024802068,0.989073,0.00844684
43535,Receptor-dependent tumor necrosis factor,0,4,0,40,Receptor-dependent tumor necrosis factor (TNF)-mediated activities against mouse thymoma cells and normal thymocytes syngeneic for C57 mice were examined to determine the specific involvement of TNF receptors R1 and R2.,8258153_0,-1,-1,-1,-1,43535,-1,0.9429756,0.0022460218,0.054778457
43536,thymoma cells,8,10,81,94,Receptor-dependent tumor necrosis factor (TNF)-mediated activities against mouse thymoma cells and normal thymocytes syngeneic for C57 mice were examined to determine the specific involvement of TNF receptors R1 and R2.,8258153_0,-1,-1,-1,-1,43536,-1,0.0027773376,0.364847,0.63237566
43537,thymocytes,12,13,106,116,Receptor-dependent tumor necrosis factor (TNF)-mediated activities against mouse thymoma cells and normal thymocytes syngeneic for C57 mice were examined to determine the specific involvement of TNF receptors R1 and R2.,8258153_0,-1,1,2,-1,43537,-1,0.0032004945,0.43708867,0.55971086
43540,TNF receptors,25,27,195,208,Receptor-dependent tumor necrosis factor (TNF)-mediated activities against mouse thymoma cells and normal thymocytes syngeneic for C57 mice were examined to determine the specific involvement of TNF receptors R1 and R2.,8258153_0,-1,-1,-1,-1,43540,-1,0.0017580873,0.9751717,0.023070294
43541,receptors,1,2,5,14,Both receptors are expressed by EL4 thymoma cells and normal C57 thymocytes.,8258153_1,0,1,2,-1,43541,-1,0.00027130044,9.072134e-05,0.99963796
43542,thymoma cells,6,8,36,49,Both receptors are expressed by EL4 thymoma cells and normal C57 thymocytes.,8258153_1,-1,-1,-1,-1,43542,-1,0.0018039123,0.22693937,0.77125674
43543,thymocytes,11,12,65,75,Both receptors are expressed by EL4 thymoma cells and normal C57 thymocytes.,8258153_1,-1,1,2,-1,43543,-1,0.0007597883,0.041411623,0.9578286
43544,TNF-mediated,0,1,0,12,"TNF-mediated activities included (a) cytotoxicity, (b) induction of hyposensitivity to TNF-mediated lysis, (c) costimulatory stimulation of thymocyte proliferation, and (d) activation of NF-kB-like transcription factor.",8258153_2,0,1,-1,-1,43544,-1,0.0006471419,0.9992212,0.0001316151
43545,to TNF-mediated,14,16,84,99,"TNF-mediated activities included (a) cytotoxicity, (b) induction of hyposensitivity to TNF-mediated lysis, (c) costimulatory stimulation of thymocyte proliferation, and (d) activation of NF-kB-like transcription factor.",8258153_2,-1,-1,-1,-1,43545,-1,0.0015104954,0.99821055,0.00027897608
43546,thymocyte,24,25,140,149,"TNF-mediated activities included (a) cytotoxicity, (b) induction of hyposensitivity to TNF-mediated lysis, (c) costimulatory stimulation of thymocyte proliferation, and (d) activation of NF-kB-like transcription factor.",8258153_2,-1,1,2,-1,43546,-1,0.0067273257,0.59939504,0.3938776
43547,NF-kB-like transcription factor,33,36,187,218,"TNF-mediated activities included (a) cytotoxicity, (b) induction of hyposensitivity to TNF-mediated lysis, (c) costimulatory stimulation of thymocyte proliferation, and (d) activation of NF-kB-like transcription factor.",8258153_2,-1,-1,-1,-1,43547,-1,7.0347746e-06,0.99998677,6.2490103e-06
43549,TNF receptors to,6,9,43,59,The ability of polyclonal antisera against TNF receptors to mimic the above TNF-mediated activities was determined.,8258153_3,-1,-1,-1,-1,43549,-1,5.031183e-05,0.9999169,3.2772085e-05
43551,TNF-mediated,12,13,76,88,The ability of polyclonal antisera against TNF receptors to mimic the above TNF-mediated activities was determined.,8258153_3,0,1,-1,-1,43551,-1,0.00093419146,0.9988319,0.00023383234
43555,to TNF,17,19,122,128,"The results clearly showed that anti-TNF-R1 antibodies were cytotoxic against EL4 cells, induced hyposensitivity of S-EL4 to TNF lysis and activated the NF-kB-like transcription factor in EL 4 cells and syngeneic normal thymocytes.",8258153_4,-1,-1,-1,-1,43555,-1,0.0003462155,0.99960953,4.4308563e-05
43556,the NF-kB-like transcription factor,22,26,149,184,"The results clearly showed that anti-TNF-R1 antibodies were cytotoxic against EL4 cells, induced hyposensitivity of S-EL4 to TNF lysis and activated the NF-kB-like transcription factor in EL 4 cells and syngeneic normal thymocytes.",8258153_4,-1,-1,-1,-1,43556,-1,7.405242e-06,0.99998724,5.3815897e-06
43558,thymocytes,33,34,220,230,"The results clearly showed that anti-TNF-R1 antibodies were cytotoxic against EL4 cells, induced hyposensitivity of S-EL4 to TNF lysis and activated the NF-kB-like transcription factor in EL 4 cells and syngeneic normal thymocytes.",8258153_4,-1,1,2,-1,43558,-1,0.0025626847,0.3716463,0.625791
43559,TNF-R2,2,3,17,23,Antisera against TNF-R2 only mimicked TNF-mediated costimulation of thymocyte proliferation with IL2.,8258153_5,0,1,-1,-1,43559,-1,0.0016541232,0.998223,0.0001228135
43560,TNF-mediated,5,6,38,50,Antisera against TNF-R2 only mimicked TNF-mediated costimulation of thymocyte proliferation with IL2.,8258153_5,0,1,-1,-1,43560,-1,0.00184143,0.9978834,0.0002752035
43561,thymocyte,8,9,68,77,Antisera against TNF-R2 only mimicked TNF-mediated costimulation of thymocyte proliferation with IL2.,8258153_5,-1,1,2,-1,43561,-1,0.008309432,0.8130755,0.17861508
43562,TNF,6,7,40,43,No direct correlation was noted between TNF activation of NF-kB and TNF-mediated lysis.,8258153_6,0,1,-1,-1,43562,-1,0.004232761,0.99563473,0.00013248157
43564,TNF-mediated,11,12,68,80,No direct correlation was noted between TNF activation of NF-kB and TNF-mediated lysis.,8258153_6,0,1,-1,-1,43564,-1,0.0016843313,0.99804425,0.00027145777
43567,the T cell,8,11,49,59,"The activation of T cells requires engagement of the T cell receptor/CD3 complex and co-stimulatory molecules, and results in the triggering of several signaling pathways which lead rapidly to the nuclear translocation of several transcription factors, such as nuclear factor (NF)-kappa B and NF-AT.",8605941_0,-1,-1,-1,-1,43567,-1,0.002347922,0.17533386,0.8223182
43569,the triggering,20,22,126,140,"The activation of T cells requires engagement of the T cell receptor/CD3 complex and co-stimulatory molecules, and results in the triggering of several signaling pathways which lead rapidly to the nuclear translocation of several transcription factors, such as nuclear factor (NF)-kappa B and NF-AT.",8605941_0,-1,-1,-1,-1,43569,-1,5.415711e-06,0.9999895,5.078883e-06
43570,to the,29,31,190,196,"The activation of T cells requires engagement of the T cell receptor/CD3 complex and co-stimulatory molecules, and results in the triggering of several signaling pathways which lead rapidly to the nuclear translocation of several transcription factors, such as nuclear factor (NF)-kappa B and NF-AT.",8605941_0,-1,-1,-1,-1,43570,-1,4.1305016e-06,0.99999154,4.2923107e-06
43574,NF-AT,45,46,293,298,"The activation of T cells requires engagement of the T cell receptor/CD3 complex and co-stimulatory molecules, and results in the triggering of several signaling pathways which lead rapidly to the nuclear translocation of several transcription factors, such as nuclear factor (NF)-kappa B and NF-AT.",8605941_0,-1,1,2,-1,43574,-1,7.633263e-06,0.99998474,7.646305e-06
43584,factor,6,7,34,40,"We report here that a DNA-binding factor containing STAT1 also becomes activated in human peripheral blood T lymphocytes or Jurkat cells, although not until 1-2 h after stimulation.",8605941_2,0,1,-1,-1,43584,-1,7.0637147e-06,0.99998856,4.3622704e-06
43586,blood T lymphocytes,15,18,101,120,"We report here that a DNA-binding factor containing STAT1 also becomes activated in human peripheral blood T lymphocytes or Jurkat cells, although not until 1-2 h after stimulation.",8605941_2,-1,-1,-1,-1,43586,-1,0.00040542174,0.0009392755,0.9986552
43590,the STAT1 factor,2,5,14,30,"Appearance of the STAT1 factor is significantly reduced in the presence of cyclosporin A, and blocked by cycloheximide, indicating that its activation is dependent upon a protein(s) synthesized in response to initial signaling events.",8605941_4,-1,-1,-1,-1,43590,-1,9.469734e-06,0.99998355,6.986834e-06
43593,protein(s,28,29,171,180,"Appearance of the STAT1 factor is significantly reduced in the presence of cyclosporin A, and blocked by cycloheximide, indicating that its activation is dependent upon a protein(s) synthesized in response to initial signaling events.",8605941_4,0,1,-1,-1,43593,-1,3.2520657e-05,0.9999505,1.689173e-05
43596,cytokines tested,8,10,56,72,"Neutralizing antiserum against IFN-gamma, but not other cytokines tested, blocked activation of the factor almost completely, and IFN-gamma was found in the culture supernatants of stimulated cells at levels at which recombinant IFN-gamma could activate the factor in naive cells.",8605941_5,-1,-1,-1,-1,43596,-1,0.9941391,0.0052459543,0.0006148977
43597,the factor,14,16,96,106,"Neutralizing antiserum against IFN-gamma, but not other cytokines tested, blocked activation of the factor almost completely, and IFN-gamma was found in the culture supernatants of stimulated cells at levels at which recombinant IFN-gamma could activate the factor in naive cells.",8605941_5,-1,-1,-1,-1,43597,-1,0.00011811486,0.99986625,1.5630338e-05
43602,the factor,38,40,254,264,"Neutralizing antiserum against IFN-gamma, but not other cytokines tested, blocked activation of the factor almost completely, and IFN-gamma was found in the culture supernatants of stimulated cells at levels at which recombinant IFN-gamma could activate the factor in naive cells.",8605941_5,-1,-1,-1,-1,43602,-1,0.00020044686,0.9997824,1.7207365e-05
43603,naive cells,41,43,268,279,"Neutralizing antiserum against IFN-gamma, but not other cytokines tested, blocked activation of the factor almost completely, and IFN-gamma was found in the culture supernatants of stimulated cells at levels at which recombinant IFN-gamma could activate the factor in naive cells.",8605941_5,-1,-1,-1,-1,43603,-1,3.45875e-05,1.7658711e-05,0.9999478
43605,STAT1 transcription factor,3,6,13,39,"Therefore, a STAT1 transcription factor is activated by IFN-gamma synthesized and released upon stimulation of T lymphocyte populations.",8605941_6,-1,-1,-1,-1,43605,-1,4.493007e-06,0.99999034,5.1634356e-06
43610,to IFN-gamma,7,9,44,56,"While Jurkat cells both secrete and respond to IFN-gamma in an autocrine loop, it seems likely that the responding cells may differ from those synthesizing this cytokine in the mononuclear cell cultures in the light of the recent report that Th1 cells lack the IFN-gamma receptor chain necessary for activation of STAT1 (Pernis, A., Gupta, S., Gollob, K.J., Garfein, E., Coffman, R.L., Schindler, C., and Rothman, P., Science 1995. 269:245).",8605941_7,-1,-1,-1,-1,43610,-1,0.9755823,0.022870569,0.0015470616
43611,that the,17,19,95,103,"While Jurkat cells both secrete and respond to IFN-gamma in an autocrine loop, it seems likely that the responding cells may differ from those synthesizing this cytokine in the mononuclear cell cultures in the light of the recent report that Th1 cells lack the IFN-gamma receptor chain necessary for activation of STAT1 (Pernis, A., Gupta, S., Gollob, K.J., Garfein, E., Coffman, R.L., Schindler, C., and Rothman, P., Science 1995. 269:245).",8605941_7,-1,-1,-1,-1,43611,-1,4.2773013e-06,0.9999906,5.1732454e-06
43614,this cytokine,26,28,156,169,"While Jurkat cells both secrete and respond to IFN-gamma in an autocrine loop, it seems likely that the responding cells may differ from those synthesizing this cytokine in the mononuclear cell cultures in the light of the recent report that Th1 cells lack the IFN-gamma receptor chain necessary for activation of STAT1 (Pernis, A., Gupta, S., Gollob, K.J., Garfein, E., Coffman, R.L., Schindler, C., and Rothman, P., Science 1995. 269:245).",8605941_7,-1,-1,-1,-1,43614,-1,0.7447061,0.24984798,0.005445908
43619,that Th1 cells,40,43,237,251,"While Jurkat cells both secrete and respond to IFN-gamma in an autocrine loop, it seems likely that the responding cells may differ from those synthesizing this cytokine in the mononuclear cell cultures in the light of the recent report that Th1 cells lack the IFN-gamma receptor chain necessary for activation of STAT1 (Pernis, A., Gupta, S., Gollob, K.J., Garfein, E., Coffman, R.L., Schindler, C., and Rothman, P., Science 1995. 269:245).",8605941_7,-1,-1,-1,-1,43619,-1,0.0012938005,0.08122488,0.91748136
43620,the IFN-gamma receptor,44,47,257,279,"While Jurkat cells both secrete and respond to IFN-gamma in an autocrine loop, it seems likely that the responding cells may differ from those synthesizing this cytokine in the mononuclear cell cultures in the light of the recent report that Th1 cells lack the IFN-gamma receptor chain necessary for activation of STAT1 (Pernis, A., Gupta, S., Gollob, K.J., Garfein, E., Coffman, R.L., Schindler, C., and Rothman, P., Science 1995. 269:245).",8605941_7,-1,-1,-1,-1,43620,-1,0.48825037,0.4620508,0.04969879
43623,the receptor,4,6,26,38,The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.,8662928_0,-1,-1,-1,-1,43623,-1,8.070208e-05,0.9995302,0.00038910867
43629,receptor subunits,25,27,154,171,The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.,8662928_0,-1,-1,-1,-1,43629,-1,0.0014528186,0.864662,0.1338852
43630,IL-6-type cytokines,28,30,176,195,The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.,8662928_0,-1,-1,-1,-1,43630,-1,0.9999527,6.8174036e-06,4.058749e-05
43633,transcription through IL-6-responsive,40,43,255,292,The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.,8662928_0,-1,-1,-1,-1,43633,-1,0.016487135,0.9832191,0.00029378812
43635,the IL-10R,3,5,21,31,"To determine whether the IL-10R has signaling functions similar to IL-6R in cells normally expressing these receptors, leukocytes of the B-, T-, and NK-cell lineages were treated with either cytokine.",8662928_1,-1,-1,-1,-1,43635,-1,0.23693609,0.7592456,0.0038183122
43636,functions,7,8,46,55,"To determine whether the IL-10R has signaling functions similar to IL-6R in cells normally expressing these receptors, leukocytes of the B-, T-, and NK-cell lineages were treated with either cytokine.",8662928_1,0,1,2,-1,43636,-1,0.0025728613,0.99478936,0.0026377875
43637,to IL-6R,9,11,64,72,"To determine whether the IL-10R has signaling functions similar to IL-6R in cells normally expressing these receptors, leukocytes of the B-, T-, and NK-cell lineages were treated with either cytokine.",8662928_1,-1,-1,-1,-1,43637,-1,0.41815767,0.57687503,0.0049673137
43639,these receptors,15,17,102,117,"To determine whether the IL-10R has signaling functions similar to IL-6R in cells normally expressing these receptors, leukocytes of the B-, T-, and NK-cell lineages were treated with either cytokine.",8662928_1,-1,-1,-1,-1,43639,-1,0.00070735125,0.9607696,0.03852309
43645,factors that,3,5,25,37,Both cytokines activated factors that bound to the sis-inducible element and included STAT1 and STAT3.,8662928_2,-1,-1,-1,-1,43645,-1,7.2537346e-06,0.9999883,4.4421017e-06
43646,to the,6,8,44,50,Both cytokines activated factors that bound to the sis-inducible element and included STAT1 and STAT3.,8662928_2,-1,-1,-1,-1,43646,-1,4.617375e-06,0.9999908,4.5687107e-06
43649,The cell,0,2,0,8,"The cell response to IL-10 characteristically differed from that to IL-2/IL-15, IL-4, and interferon gamma.",8662928_3,-1,-1,-1,-1,43649,-1,2.4772566e-05,1.1276736e-05,0.9999639
43650,to IL-10,3,5,18,26,"The cell response to IL-10 characteristically differed from that to IL-2/IL-15, IL-4, and interferon gamma.",8662928_3,-1,-1,-1,-1,43650,-1,0.96023476,0.037906032,0.001859243
43651,that to,8,10,60,67,"The cell response to IL-10 characteristically differed from that to IL-2/IL-15, IL-4, and interferon gamma.",8662928_3,-1,-1,-1,-1,43651,-1,1.3089298e-05,0.99997103,1.5844653e-05
43654,the IL-10R,4,6,30,40,The signaling capabilities of the IL-10R for activating specific STAT proteins and inducing gene transcription were defined by reconstitution of receptor functions in transfected tissue culture cells.,8662928_4,-1,-1,-1,-1,43654,-1,0.6589008,0.33421338,0.0068859486
43657,receptor functions,20,22,145,163,The signaling capabilities of the IL-10R for activating specific STAT proteins and inducing gene transcription were defined by reconstitution of receptor functions in transfected tissue culture cells.,8662928_4,-1,-1,-1,-1,43657,-1,0.017301712,0.22712833,0.75556993
43658,transfected tissue,23,25,167,185,The signaling capabilities of the IL-10R for activating specific STAT proteins and inducing gene transcription were defined by reconstitution of receptor functions in transfected tissue culture cells.,8662928_4,-1,-1,-1,-1,43658,-1,9.462443e-06,0.99997616,1.4322882e-05
43664,the IL-10R,16,18,100,110,"COS-1 cells, co-expressing the human IL-10R and individual STAT proteins, confirmed a preference of the IL-10R for STAT3 and STAT1.",8662928_5,-1,-1,-1,-1,43664,-1,0.8059794,0.18998018,0.0040404885
43667,receptors,3,4,26,35,"Unlike many hematopoietin receptors, the IL-10R did not detectably activate STAT5.",8662928_6,0,1,2,-1,43667,-1,0.0034816763,0.00011695061,0.9964013
43668,the IL-10R,5,7,37,47,"Unlike many hematopoietin receptors, the IL-10R did not detectably activate STAT5.",8662928_6,-1,-1,-1,-1,43668,-1,0.6286399,0.36553338,0.0058267154
43670,The IL-10R,0,2,0,10,"The IL-10R, together with reporter gene constructs containing different IL-6-responsive gene elements, reconstituted in hepatoma cells an induction of transcription by IL-10 that was comparable to that by IL-6.",8662928_7,-1,-1,-1,-1,43670,-1,0.15267165,0.8431477,0.00418062
43673,IL-6-responsive gene,10,12,72,92,"The IL-10R, together with reporter gene constructs containing different IL-6-responsive gene elements, reconstituted in hepatoma cells an induction of transcription by IL-10 that was comparable to that by IL-6.",8662928_7,-1,-1,-1,-1,43673,-1,0.99802184,0.0014268957,0.0005512711
43676,IL-10 that,23,25,168,178,"The IL-10R, together with reporter gene constructs containing different IL-6-responsive gene elements, reconstituted in hepatoma cells an induction of transcription by IL-10 that was comparable to that by IL-6.",8662928_7,-1,-1,-1,-1,43676,-1,0.9986929,0.00088938314,0.00041772757
43677,to that,27,29,194,201,"The IL-10R, together with reporter gene constructs containing different IL-6-responsive gene elements, reconstituted in hepatoma cells an induction of transcription by IL-10 that was comparable to that by IL-6.",8662928_7,-1,-1,-1,-1,43677,-1,5.8894407e-06,0.9999889,5.24227e-06
43679,This regulation,0,2,0,15,This regulation could not be appreciably modified by enhanced expression of STAT proteins.,8662928_8,-1,-1,-1,-1,43679,-1,9.012696e-06,0.99998593,5.0398503e-06
43685,IL-6-responsive genes,12,14,71,92,The similar actions of IL-10R and IL-6R on the induction of endogenous IL-6-responsive genes were demonstrated in hepatoma cells stably expressing the IL-10R.,8662928_9,-1,-1,-1,-1,43685,-1,0.99817467,0.0013833886,0.0004418989
43687,the IL-10R,21,23,147,157,The similar actions of IL-10R and IL-6R on the induction of endogenous IL-6-responsive genes were demonstrated in hepatoma cells stably expressing the IL-10R.,8662928_9,-1,-1,-1,-1,43687,-1,0.4526695,0.5415468,0.0057836236
43688,These receptor functions,0,3,0,24,"These receptor functions required the presence of the box 3 motifs, as shown by the analysis of the mouse IL-10R constructs containing progressively truncated cytoplasmic domains.",8662928_10,-1,-1,-1,-1,43688,-1,0.00029471758,0.9992323,0.00047303786
43691,the analysis,15,17,80,92,"These receptor functions required the presence of the box 3 motifs, as shown by the analysis of the mouse IL-10R constructs containing progressively truncated cytoplasmic domains.",8662928_10,-1,-1,-1,-1,43691,-1,6.095555e-06,0.9999895,4.385141e-06
43696,that the IL-10R,3,6,21,36,"The data demonstrate that the IL-10R, unlike other members of the interferon receptor family, is highly effective in recruiting the signaling pathways of IL-6-type cytokine receptors.",8662928_11,-1,-1,-1,-1,43696,-1,0.1548474,0.8410633,0.004089339
43697,the interferon receptor,11,14,62,85,"The data demonstrate that the IL-10R, unlike other members of the interferon receptor family, is highly effective in recruiting the signaling pathways of IL-6-type cytokine receptors.",8662928_11,-1,-1,-1,-1,43697,-1,0.007999449,0.97949684,0.0125037
43699,IL-6-type cytokine receptors,25,28,154,182,"The data demonstrate that the IL-10R, unlike other members of the interferon receptor family, is highly effective in recruiting the signaling pathways of IL-6-type cytokine receptors.",8662928_11,-1,-1,-1,-1,43699,-1,0.9970624,9.3953226e-05,0.002843681
43700,Analysis,0,1,0,8,Analysis of melanoma cell lines with abnormalities in HLA Class I antigen expression has identified two serological phenotypes caused by distinct molecular defects.,8795138_0,0,1,-1,-1,43700,-1,7.5640864e-06,0.9999876,4.7917433e-06
43720,antigen trimolecular complex,23,26,155,183,"This phenotype reflects abnormalities in TAP heterodimer expression, which cause defects in stable assembly and intracellular transport of the HLA Class I antigen trimolecular complex.",8795138_4,-1,-1,-1,-1,43720,-1,0.83940154,0.15431023,0.006288236
43724,antigen-restricted cytotoxic T cells,16,20,86,122,Loss of HLA Class I antigens renders melanoma cells resistant to lysis by HLA Class I antigen-restricted cytotoxic T cells which specifically recognize melanoma associated antigens.,8795138_5,-1,-1,-1,-1,43724,-1,0.2957652,0.00039063458,0.70384413
43739,interleukin-8 (IL-8) receptor,6,11,44,73,"HHV-8 possesses genes including homologs of interleukin-8 (IL-8) receptor, Bcl-2, and cyclin D, which can potentially transform the host cell.",9446657_1,-1,-1,-1,-1,43739,-1,0.9989083,0.0001315469,0.0009601909
43740,transform the,21,23,118,131,"HHV-8 possesses genes including homologs of interleukin-8 (IL-8) receptor, Bcl-2, and cyclin D, which can potentially transform the host cell.",9446657_1,-1,-1,-1,-1,43740,-1,4.7074955e-06,0.9999895,5.8146998e-06
43743,these genes,5,7,27,38,"However, the expression of these genes in KS tissues is very low or undetectable and HHV-8 does not seem to transform human cells in vitro.",9446657_2,-1,-1,-1,-1,43743,-1,4.9601213e-06,0.99998903,5.972274e-06
43744,tissues,9,10,45,52,"However, the expression of these genes in KS tissues is very low or undetectable and HHV-8 does not seem to transform human cells in vitro.",9446657_2,-1,1,2,-1,43744,-1,0.00020962606,0.09529233,0.90449804
43745,to transform,20,22,105,117,"However, the expression of these genes in KS tissues is very low or undetectable and HHV-8 does not seem to transform human cells in vitro.",9446657_2,-1,-1,-1,-1,43745,-1,7.006193e-06,0.9999839,9.121465e-06
43755,the nature,6,8,28,38,"However, little is known on the nature of the inflammatory cell infiltration present in KS, on the type of cytokines produced and on their role in KS, and whether this correlates with the presence of HHV-8.",9446657_6,-1,-1,-1,-1,43755,-1,5.02732e-06,0.9999895,5.4751517e-06
43758,the type,18,20,95,103,"However, little is known on the nature of the inflammatory cell infiltration present in KS, on the type of cytokines produced and on their role in KS, and whether this correlates with the presence of HHV-8.",9446657_6,-1,-1,-1,-1,43758,-1,7.80474e-06,0.9999857,6.5368445e-06
43770,cells to,8,10,40,48,"gamma IFN, in fact, induces endothelial cells to acquire the same features of KS cells, including the spindle morphology and the pattern of cell marker expression.",9446657_8,-1,-1,-1,-1,43770,-1,0.002439569,0.2856503,0.7119101
43780,factor,15,16,101,107,"These KS-like lesions are accompanied by production of basic fibroblast growth factor, an angiogenic factor highly expressed in primary lesions that mediates angiogenesis and spindle cell growth.",9446657_10,0,1,-1,-1,43780,-1,0.9999355,1.6150349e-05,4.8436053e-05
43786,factor,20,21,136,142,The formation of KS-like lesions is upregulated by the human immunodeficiency virus Tat protein demonstrating its role as a progression factor in AIDS-KS.,9446657_11,0,1,-1,-1,43786,-1,2.0817763e-05,0.99996865,1.0490654e-05
43789,tissues,17,18,105,112,"Finally, gamma IFN and HLA-DR expression correlate with the presence of HHV-8 in lesional and uninvolved tissues from the same patients.",9446657_12,-1,1,2,-1,43789,-1,4.4982447e-05,0.99775094,0.0022041034
43801,the tumour plasma cells,11,15,61,84,The monoclonal immunoglobulin (Ig) (M-component) secreted by the tumour plasma cells in multiple myeloma (MM) has specific antigenic determinants (idiotypes; id) that can serve as tumour-specific antigens.,9531329_0,-1,-1,-1,-1,43801,-1,0.00268716,0.7130775,0.2842353
43804,tumour-specific antigens,35,37,180,204,The monoclonal immunoglobulin (Ig) (M-component) secreted by the tumour plasma cells in multiple myeloma (MM) has specific antigenic determinants (idiotypes; id) that can serve as tumour-specific antigens.,9531329_0,-1,-1,-1,-1,43804,-1,0.20974594,0.7854718,0.0047822944
43807,protein,15,16,68,75,"The intact Ig molecule is a weak antigen, and small fragments of id protein might be more immunogenic for the induction of id-specific immunity.",9531329_1,0,1,-1,-1,43807,-1,0.0077838693,0.97168005,0.020536104
43809,immunity,25,26,135,143,"The intact Ig molecule is a weak antigen, and small fragments of id protein might be more immunogenic for the induction of id-specific immunity.",9531329_1,0,-1,2,-1,43809,-1,0.9998258,3.867345e-05,0.00013565466
43812,antigen-presenting cells,12,14,68,92,Dendritic cells (DC) have attracted attention as the most efficient antigen-presenting cells and promising adjuvants for immunotherapy in tumours.,9531329_2,-1,-1,-1,-1,43812,-1,0.7388902,0.00024080448,0.2608691
43816,T-cell,6,7,27,33,"In this study the in vitro T-cell response against F(ab')2 and Fab fragments, heavy and light chains of the M-component was examined in five patients with MM clinical stage I. All fragments were able to stimulate T cells but F(ab')2 or Fab fragments and heavy chains induced a stronger response than light chains.",9531329_3,-1,1,2,-1,43816,-1,1.2464298e-05,7.966514e-06,0.9999795
43821,immune response than,6,9,48,68,DC induced a significantly stronger id-specific immune response than monocytes.,9531329_4,-1,-1,-1,-1,43821,-1,0.98947513,0.009896445,0.0006284476
43822,antigen-presenting cells,5,7,21,45,"Moreover, with DC as antigen-presenting cells, a predominant interferon (IFN)-gamma (type-1 T-cell) response was seen in all patients.",9531329_5,-1,-1,-1,-1,43822,-1,0.5820157,0.00031259045,0.41767174
43824,type-1 T-cell,13,15,85,98,"Moreover, with DC as antigen-presenting cells, a predominant interferon (IFN)-gamma (type-1 T-cell) response was seen in all patients.",9531329_5,-1,-1,-1,-1,43824,-1,0.002952319,0.4741873,0.5228604
43828,type-2 T-cell,8,10,50,63,Both IFN-gamma and interleukin (IL)-4 (type-1 and type-2 T-cell) responses were noted when monocytes were used.,9531329_6,-1,-1,-1,-1,43828,-1,0.0032975294,0.58587813,0.41082436
43832,T-cell,25,26,155,161,Our study suggests that DC pulsed with idiotypic fragments such as F(ab')2 fragment and heavy chain can be used for the induction of type-1 anti-idiotypic T-cell response for immunotherapy in MM.,9531329_7,-1,1,2,-1,43832,-1,1.8492607e-05,7.767364e-06,0.9999738
43847,factor,25,26,187,193,The efficacy of the activated LN cells is augmented when the sensitizing tumor is a genetically modified variant (designated D5G6) that secretes granulocyte/macrophage-colony-stimulating factor.,9690455_1,0,1,-1,-1,43847,-1,0.9999126,1.0297811e-05,7.716349e-05
43856,function,7,8,50,58,"To determine whether the acquisition of antitumor function during ex vivo activation is associated with modifications in signal transduction capacity, the protein tyrosine kinases p56lck and p59fyn and proteins of the NF-kappaB family were analyzed in tumor-draining LN T cells.",9690455_3,0,1,2,-1,43856,-1,0.00042231102,0.99921465,0.00036303865
43858,the protein tyrosine,21,24,151,171,"To determine whether the acquisition of antitumor function during ex vivo activation is associated with modifications in signal transduction capacity, the protein tyrosine kinases p56lck and p59fyn and proteins of the NF-kappaB family were analyzed in tumor-draining LN T cells.",9690455_3,-1,-1,-1,-1,43858,-1,6.769116e-06,0.9999877,5.5442683e-06
43859,proteins,29,30,202,210,"To determine whether the acquisition of antitumor function during ex vivo activation is associated with modifications in signal transduction capacity, the protein tyrosine kinases p56lck and p59fyn and proteins of the NF-kappaB family were analyzed in tumor-draining LN T cells.",9690455_3,0,1,-1,-1,43859,-1,5.661011e-06,0.9999896,4.757212e-06
43860,the NF-kappaB,31,33,214,227,"To determine whether the acquisition of antitumor function during ex vivo activation is associated with modifications in signal transduction capacity, the protein tyrosine kinases p56lck and p59fyn and proteins of the NF-kappaB family were analyzed in tumor-draining LN T cells.",9690455_3,-1,-1,-1,-1,43860,-1,1.2523139e-05,0.99997795,9.5319e-06
43864,tumor-draining than,9,11,46,65,The levels of p56lck and p59fyn were lower in tumor-draining than in normal LN T cells and production of tyrosine-phosphorylated substrates was markedly depressed following anti-CD3 stimulation.,9690455_4,-1,-1,-1,-1,43864,-1,1.1341373e-05,0.99997926,9.435968e-06
43872,than they,25,27,141,150,"Interestingly, the levels of p56lck, p59fyn, and tyrosine kinase activity were higher in activated T cells derived from LN that drained D5G6 than they were in those from D5 tumors.",9690455_6,-1,-1,-1,-1,43872,-1,9.32684e-06,0.9999825,8.25386e-06
43880,tumor cells,7,9,42,53,Stimulation of activated LN cells with D5 tumor cells induced the nuclear translocation of NF-kappaB. These findings indicate that the recovery of proteins mediating signal transduction through the T cell receptor/CD3 complex in LN T cells activated ex vivo was associated with the acquisition of antitumor function.,9690455_8,-1,-1,-1,-1,43880,-1,5.140642e-05,9.254214e-05,0.9998561
43884,that the,18,20,126,134,Stimulation of activated LN cells with D5 tumor cells induced the nuclear translocation of NF-kappaB. These findings indicate that the recovery of proteins mediating signal transduction through the T cell receptor/CD3 complex in LN T cells activated ex vivo was associated with the acquisition of antitumor function.,9690455_8,-1,-1,-1,-1,43884,-1,4.0815444e-06,0.999992,3.8609246e-06
43885,proteins,22,23,147,155,Stimulation of activated LN cells with D5 tumor cells induced the nuclear translocation of NF-kappaB. These findings indicate that the recovery of proteins mediating signal transduction through the T cell receptor/CD3 complex in LN T cells activated ex vivo was associated with the acquisition of antitumor function.,9690455_8,0,1,-1,-1,43885,-1,7.2213084e-06,0.9999875,5.3012045e-06
43886,transduction through the T cell,25,30,173,204,Stimulation of activated LN cells with D5 tumor cells induced the nuclear translocation of NF-kappaB. These findings indicate that the recovery of proteins mediating signal transduction through the T cell receptor/CD3 complex in LN T cells activated ex vivo was associated with the acquisition of antitumor function.,9690455_8,-1,-1,-1,-1,43886,-1,0.0035275521,0.718583,0.27788946
43890,function,46,47,307,315,Stimulation of activated LN cells with D5 tumor cells induced the nuclear translocation of NF-kappaB. These findings indicate that the recovery of proteins mediating signal transduction through the T cell receptor/CD3 complex in LN T cells activated ex vivo was associated with the acquisition of antitumor function.,9690455_8,0,1,2,-1,43890,-1,0.00075824314,0.99783176,0.0014099629
43891,blood T lymphocytes,6,9,46,65,We examined signaling molecules of peripheral blood T lymphocytes obtained from women with breast cancer.,9724088_0,-1,-1,-1,-1,43891,-1,0.00029961954,0.00044691144,0.99925345
43893,to translocate,12,14,65,79,"In 6 of 14 patients, T lymphocytes displayed an impaired ability to translocate NFB p65 (Rel-A) following activation by anti-CD3 and IL-2.",9724088_1,-1,-1,-1,-1,43893,-1,5.825862e-06,0.99998856,5.577275e-06
43897,the Rel-A protein,9,12,63,80,This observation was made despite normal cytoplasmic levels of the Rel-A protein.,9724088_2,-1,-1,-1,-1,43897,-1,1.1713479e-05,0.9999802,8.016333e-06
43901,T-cell,29,30,164,170,"We also detected abnormally low levels of the signaling molecules T-cell receptor (TCR)-zeta, ZAP-70 and p56lck in 4 of 14 breast cancer patients, i.e., defects in T-cell signaling molecules.",9724088_3,-1,1,2,-1,43901,-1,1.5147989e-05,7.686884e-06,0.99997723
43907,T cells that,21,24,108,120,"Abnormalities of I or more signaling molecules were found in 9 of 14 patients; however, only 3 patients had T cells that exhibited all 5 defects.",9724088_6,-1,-1,-1,-1,43907,-1,0.0010532471,0.026459921,0.9724868
43910,the analysis,3,5,13,25,"For example, the analysis of only 1 signaling molecule may allow patients with significant defects in T-cell signaling to go unnoticed.",9724088_8,-1,-1,-1,-1,43910,-1,7.112087e-06,0.9999887,4.15693e-06
43911,T-cell,17,18,102,108,"For example, the analysis of only 1 signaling molecule may allow patients with significant defects in T-cell signaling to go unnoticed.",9724088_8,-1,1,2,-1,43911,-1,1.716671e-05,8.150894e-06,0.9999747
43913,Rel-A translocation,4,6,26,45,"Finally, despite impaired Rel-A translocation, T cells were capable of transcribing IL-2.",9724088_9,-1,-1,-1,-1,43913,-1,6.518925e-06,0.9999863,7.1732875e-06
43916,the translocation,2,4,15,32,"Impairments in the translocation of Rel-B and c-Rel further suggest that the NFKB family members Rel-A, Rel-B and c-Rel are not required for the transcription of IL-2 in the peripheral T lymphocytes of patients with breast cancer.",9724088_10,-1,-1,-1,-1,43916,-1,4.3069613e-06,0.9999914,4.250739e-06
43919,that the NFKB,10,13,68,81,"Impairments in the translocation of Rel-B and c-Rel further suggest that the NFKB family members Rel-A, Rel-B and c-Rel are not required for the transcription of IL-2 in the peripheral T lymphocytes of patients with breast cancer.",9724088_10,-1,-1,-1,-1,43919,-1,1.2341823e-05,0.9999801,7.560517e-06
43923,the transcription,24,26,141,158,"Impairments in the translocation of Rel-B and c-Rel further suggest that the NFKB family members Rel-A, Rel-B and c-Rel are not required for the transcription of IL-2 in the peripheral T lymphocytes of patients with breast cancer.",9724088_10,-1,-1,-1,-1,43923,-1,5.321125e-06,0.9999902,4.4198446e-06
31020,immune responses,26,28,167,183,"Thus, our study revealed a novel IL-33-ST2-MyD88-STAT1 axis that restores mDC activation and maturation in established cancer and, thereby, the magnitude of antitumor immune responses, suggesting a potential use of rIL-33 as a new immunotherapy option to treat established cancer.",28011934_7,0,-1,-1,0,31020,-1,0.9999708,7.5328394e-06,2.1725251e-05
38757,IFN-,6,7,46,51,"While T-bet ablation restricted interferon- (IFN-) production, loss of Blimp-1 prevented GzmB expression in response to IL-2, suggesting two independent programs required for polyfunctionality of tumor-reactive CD4+ Tcells.",31924474_4,0,-1,-1,0,38757,-1,0.9999777,2.6763569e-06,1.961497e-05
42105,interferon-gamma,28,29,178,194,"We show that TNAX101A efficiently interfered the binding of DNAM-1 to its ligand CD155 and showed unique functions; it decreased production of the inflammatory cytokines such as interferon-gamma, tumor necrosis factor alpha, interleukin (IL)-6, IL-17A, and IL-17F by anti-CD3 antibody-stimulated or alloantigen-stimulated T cells and increased FOXP3 expression in anti-CD3-stimulated regulatory T (Treg) cells.",33900821_3,0,-1,-1,0,42105,-1,0.99997485,3.3132885e-06,2.1809474e-05
7737,cytokine,9,10,54,62,"Using a novel approach, we examined the intracellular cytokine production capacity of tumor-infiltrating T cells in the single-cell suspensions of enzymatically digested tumors to differentiate T(reg) cells from effector T cells.",18820132_1,0,-1,-1,0,7737,-1,0.99996674,5.6702825e-06,2.7559652e-05
13604,antigen,14,15,105,112,The present study was designed to test whether a replication-defective adenovirus vaccine expressing HBx antigen could be effectively used in the immunotherapy of hepatocellular carcinoma.,21042781_1,0,-1,-1,0,13604,-1,0.9999347,6.7328465e-06,5.8598078e-05
27805,IL-10+cells,1,2,9,20,"Numerous IL-10+cells were observed in the adenomatous stroma, but not in adenomatous epithelium, as compared with the controls.",26724144_4,0,-1,-1,0,27805,-1,0.97442853,0.00011401722,0.025457319
1292,chemotactic factor,5,7,22,40,IL-16 is a ligand and chemotactic factor for CD4+ T cells.,12528894_0,0,-1,-1,0,1292,-1,0.99996316,6.563558e-06,3.0332223e-05
36855,G-CSF,43,44,237,242,"The results show that in macrophages, these supernatants induce a decrease in the phosphorylation of NF-B-p65 and STAT1 in U937-macrophages accompanied by an increase in the secretion of IL-10, IL-6, MCP-1, and IL-8, as well as GM-CSF, G-CSF, PDGF-AA, PDGF-BB, and VEGF.",31099286_4,0,-1,-1,0,36855,-1,0.9999324,8.935371e-06,5.860091e-05
33140,IFN-,4,5,35,40,Anti-TIM-4 downregulated T-bet and IFN- expression by TIM-4+ B cells and indirectly increased IL-10 expression by TIM-1+ B cells.,28848066_11,0,-1,-1,0,33140,-1,0.9999777,3.0273666e-06,1.932579e-05
41609,cytokine,14,15,110,118,Breast cancer patients undergoing CR concurrently with RT also had significant reduction in immunosuppressive cytokine levels compared with those receiving RT alone.,33647370_9,0,-1,-1,0,41609,-1,0.9999589,6.0453617e-06,3.501379e-05
12217,monokine,19,20,113,121,Our previous study has shown abundant infiltration of CXCR3(+) T cells and their frequent clustering with CXCL9 (monokine induced by interferon-gamma)-expressing stromal cells in the lymphoid stroma of Ly-rich GCs.,20422211_1,0,-1,-1,0,12217,-1,0.005470678,0.99422824,0.00030106783
3652,cytokines,4,5,26,35,Expression profiles of 80 cytokines were determined in the supernatant of mesothelioma cell lines and the original patient's pleural effusion.,16540497_2,0,-1,-1,0,3652,-1,0.99995387,5.825143e-06,4.0248266e-05
20416,immunotherapeutic agent,11,13,71,94,Our findings highlight the potential application of miR-124 as a novel immunotherapeutic agent for neoplasms and serve as a model for identifying miRNAs that can be exploited as immunotherapeutics.,23636127_7,0,-1,-1,0,20416,-1,0.9616597,0.036494795,0.0018455099
9531,IL-1,9,10,63,67,"Proinflammatory cytokines, for macrophage activation, IL-6 and IL-1 beta were also increased.",19375802_5,0,-1,-1,0,9531,-1,0.99994326,5.3449417e-06,5.1386978e-05
17475,chemokine,28,29,191,200,"In this study, we investigated the feasibility of enhancing tumor production of T(eff)-attracting chemokines as a cancer therapeutic strategy using a tissue explant culture system to analyze chemokine induction in intact tumor tissues.",22593190_2,0,-1,-1,0,17475,-1,0.9999535,5.7462235e-06,4.0804596e-05
30091,interferon,15,16,98,108,"Coculture of Tr1 cells with proinflammatory CD4+ T cells resulted in TGF--dependent reduction of interferon gamma (IFN-) and IL-10-dependent reduction of tumor necrosis factor alpha (TNF-), while coculture of Tr1 cells with CD8+ T cells resulted in lower tumor-specific cytotoxicity.",27644153_8,0,-1,-1,0,30091,-1,0.99995565,6.1635355e-06,3.8110207e-05
3357,IFN-gamma,36,37,222,231,"Interestingly, the modified plasmid vaccine predominantly enhanced the type 2 immune responses manifested by an increased IgG1 to IgG2a antibody ratio and a greater induction of GATA-3 and IL-4 mRNA than that of T-bet and IFN-gamma mRNA in spleen cells from vaccinated mice.",16341143_4,0,-1,-1,0,3357,-1,0.9999789,2.620303e-06,1.8461233e-05
32988,IL10,15,16,110,114,"Elevated concentrations of G-CSF in PDAC promoted differentiation of Ly6G+ cells from progenitors, stimulated IL10 secretion from myeloid cells, and decreased T-cell proliferation via upregulation of Arg, iNOS, VEGF, IL6, and IL1b from CD11b+ cells.",28775207_3,0,-1,-1,0,32988,-1,0.99997413,4.4077306e-06,2.1465765e-05
24464,IL-6,39,40,236,240,"Embelin substantially reduced the tumorigenicity of pancreatic cancer cells in vivo, which was associated with reduced inflammatory cells and immune suppressive cells, IL-17A(+) Th17, GM-CSF(+) Th, MDSCs and Treg, through inhibition of IL-6 secretion.",25128650_3,0,-1,-1,0,24464,-1,0.9999778,2.8071422e-06,1.9361933e-05
9061,immune responses,20,22,112,128,"Dendritic cells (DC) are key components of the immune system, which actively participate in innate and adaptive immune responses.",19275918_0,0,-1,-1,0,9061,-1,0.99996865,8.657981e-06,2.268282e-05
42629,IFNG,17,18,95,99,"DFP also noticeably enhances the expression of T helper (TH) cell 1 specific interferon-gamma (IFNG), interleukin 12 (IL12), T-Box Transcription Factor 21 (TBX21) and signal transducer and activator of transcription 1 (STAT1) genes.",34190692_8,0,-1,-1,0,42629,-1,0.9999298,8.099975e-06,6.205922e-05
33362,IL-10,14,15,85,90,"BACKGROUND/AIM: Recently CD4+CD49b+ LAG3+regulatory T (Tr1) cells are reported to be IL-10 driven, have strong regulatory activities.",28982868_0,0,-1,-1,0,33362,-1,0.99997866,3.252e-06,1.8129933e-05
9663,transforming growth factor-beta,3,6,21,52,"They produced active transforming growth factor-beta but none of cytokines IFN-gamma, interleukin-2 (IL-2), IL-4, IL-5, and IL-10.",19435913_6,0,-1,-1,0,9663,-1,0.9945792,0.0039934753,0.0014274289
10120,cytokine,7,8,43,51,"Although the Th17 subset and its signature cytokine, interleukin (IL)-17A (IL-17), are implicated in certain autoimmune diseases, their role in cancer remains to be further explored.",19564351_0,0,-1,-1,0,10120,-1,0.9999591,5.1733587e-06,3.5703226e-05
25505,chemerin,19,20,143,151,"We demonstrated that pDCs are recruited during the cervical metaplasia-dysplasia-cancer sequence, through the action of their chemoattractant, chemerin.",25492101_2,0,-1,-1,0,25505,-1,0.9999044,1.4339813e-05,8.1340346e-05
31483,immune responses,15,17,84,100,"This review discusses the recent findings on Tim-3, the role it plays in regulating immune responses in different cell types and the rationale for targeting Tim-3 for effective cancer immunotherapy.",28258697_6,0,-1,-1,0,31483,-1,0.999959,1.3368218e-05,2.770654e-05
12723,IFN-gamma,43,44,224,233,"It has not been established, however, whether IL-4 can induce comprehensive type 2 cytokine expression by CD8 T cells in vivo, nor whether the effects of IL-4 on type 2 cytokine production by CD8 T cells can be inhibited by IFN-gamma.",20562261_2,0,-1,-1,0,12723,-1,0.9999789,2.8515226e-06,1.819359e-05
32349,interferon-,5,6,38,50,Cytosolic DNA stimulates secretion of interferon- by cancer cells following activation of the DNA sensor cGAS and its downstream effector STING.,28598415_3,0,-1,-1,0,32349,-1,0.99996746,5.3590047e-06,2.7204973e-05
24729,IL-10(+,16,17,100,107,"Relevance to women is implicated, as we find postlactational human breast tissue has transient high IL-10(+) and Foxp3(+) immune cell infiltrate.",25187059_8,0,-1,-1,0,24729,-1,0.9999285,1.0015445e-05,6.154578e-05
41778,CXCL10,13,14,79,85,"ChIP assay verified that LINC00152 recruits EZH2 to the promoters of CXCL9 and CXCL10, thus the silencing of LINC00152 promoted the production of CXCL9 and CXCL10.",33709190_6,0,-1,-1,0,41778,-1,0.99991953,1.1168314e-05,6.925678e-05
35939,cytokines,26,27,157,166,"We showed that Notch inhibition could enhances GVL while reducing GVHD via modulating host DCs and donor T cell activity, and the production of inflammatory cytokines.",30445020_8,0,-1,-1,0,35939,-1,0.9999616,5.5553337e-06,3.2744305e-05
25841,immune response,8,10,44,59,The poor efficacy of the in vivo anti-tumor immune response has been partially attributed to ineffective T-cell responses mounted against the tumor.,25745993_0,0,-1,-1,0,25841,-1,0.9999559,1.4213883e-05,2.9971048e-05
15387,immune response,7,9,51,66,Chronic activation of the gastric mucosal adaptive immune response is a characteristic trait of gastric cancer.,21710691_0,0,-1,-1,0,15387,-1,0.99996555,8.384793e-06,2.6055648e-05
16522,limiting,28,29,213,221,The dysfunction of immune system such as decreased antigen presentation along with increased frequencies of suppressive cells and cytokines might facilitate progression of the disease and infectious complications limiting survival of MM patients.,22223085_6,0,-1,-1,0,16522,-1,0.9988152,0.0005483198,0.00063650386
17548,IL-6,29,30,183,187,"Both IL-6 and STAT3 have recently emerged as main regulators of the differentiation and function of Th17 cells, via a positive feedback loop enhancing expression and/or activation of IL-6 itself, IL-17 and STAT3.",22652781_4,0,-1,-1,0,17548,-1,0.99997365,3.5293822e-06,2.275328e-05
34357,immune response,34,36,227,242,"The decrease of this IFN gene expression signature was associated with more aggressive disease in human colon cancer patients, suggesting that lack of IL33 signaling impaired the generation of a potent IFN-mediated antitumor immune response.",29463593_10,0,-1,-1,0,34357,-1,0.99997425,5.7696525e-06,2.0082123e-05
30525,IL-6,10,11,75,79,CD8-depleting but not CD4-depleting Abs abrogated the efficacy of combined IL-6 and PD-L1 blockade in mice bearing Panc02 tumours (p=0.0016).,27797936_7,0,-1,-1,0,30525,-1,0.99996865,3.7268383e-06,2.7648683e-05
35483,IFNG,30,31,212,216,"Tumour-infiltrating CD4+ lymphocytes were significantly hypomethylated in all four investigated lineage loci compared to CD4+ lymphocytes in lymph nodes and blood (lymph nodes vs tumour-infiltrating lymphocytes: IFNG -4229bp p<0.0001, IL13 -11bp p<0.05, IL17A -122bp p<0.01 and FOXP3 -77bp p>0.05).",30075815_9,0,-1,-1,0,35483,-1,0.99993086,7.264726e-06,6.1910796e-05
15118,Interleukin-2,0,1,0,13,Interleukin-2 induces Foxp3 expression in activated human CD8 T cells in vitro and expands circulating CD8 Foxp3+ T cells in melanoma patients.,21638127_1,0,-1,-1,0,15118,-1,0.9999795,3.6891722e-06,1.6833312e-05
42529,IL-17,13,14,69,74,This study demonstrated that the frequency of CD33+ pSTAT3+ MDSC and IL-17+ lymphocyte as well as IL-10 messenger RNA (mRNA) expression were significantly higher in the PCa patients than in the benign prostatic hyperplasia (BPH) group.,34184811_3,0,-1,-1,0,42529,-1,0.99997365,4.4881012e-06,2.1758926e-05
18599,Innate immunity,0,2,0,15,Innate immunity and adaptive immunity thus are important in defense against pancreatic cancer.,22996369_13,0,-1,-1,0,18599,-1,0.999943,1.2234223e-05,4.4748285e-05
9783,antigen,15,16,99,106,"Adaptive Foxp3(+)CD4(+) regulatory T (iTreg) cells develop outside the thymus under subimmunogenic antigen presentation, during chronic inflammation, and during normal homeostasis of the gut.",19464985_0,0,-1,-1,0,9783,-1,0.99993336,9.136361e-06,5.743481e-05
11178,CCL22,20,21,111,116,"Moreover, an in vitro migration assay using T-regs derived from ESCC was performed in the presence of CCL17 or CCL22.",20002703_5,0,-1,-1,0,11178,-1,0.9998673,1.4322101e-05,0.0001183862
19841,cytokines,3,4,16,25,"Levels of serum cytokines (IL-6, IL-17, IL-10, and TGF-1) were analyzed by ELISA.",23335103_2,0,-1,-1,0,19841,-1,0.9999633,4.962094e-06,3.1756783e-05
41604,IL-10R,40,41,246,253,"Serum from breast cancer patients undergoing RT alone or CR and RT was collected pre- and postintervention, and a cytokine array demonstrated that patients treated with CR + RT had notable decreases in immunosuppressive cytokines such as IL-2R, IL-10R, and TGF-2 and 3 compared with patients receiving RT alone.",33647370_7,0,-1,-1,0,41604,-1,0.99968493,6.368331e-05,0.00025145977
14147,CXCL2,41,42,263,268,"Several inflammatory factors are subsequently upregulated, notably CD30 and its ligand CD153, also leukocyte trafficking factors including CXCL10, CXCL13, L-selectin and TGF1, and inflammatory cytokines including IL-1, IL-3 and the murine IL-8 analogues CXCL1, CXCL2 and CXCL5-6, amongst others.",21291541_8,0,-1,-1,0,14147,-1,0.9998975,2.1635107e-05,8.077756e-05
28749,cytokine signaling,19,21,139,157,"Collectively, our results show how JAK/STAT pathway mutations contribute to disease progression in CTCL cells by potentiating inflammatory cytokine signaling, widening the potential therapeutic target range for this intractable entity.",27144517_9,0,-1,-1,0,28749,-1,0.9998554,4.5589986e-05,9.909908e-05
17518,Interleukin-6,0,1,0,13,"Interleukin-6 (IL-6) is a pleiotropic cytokine involved in the regulation of the cross talk between haematopoietic/immune cells and stromal cells, including the onset and resolution of inflammation, responses to infection, tissue remodelling and cancer.",22652781_0,0,-1,-1,0,17518,-1,0.99996996,3.0328335e-06,2.7057686e-05
23221,antigen,26,27,172,179,"Variability within isogenic T cell populations yields heterogeneous 'local' signaling responses to shared antigenic stimuli, but responding clones may communicate 'global' antigen load through paracrine messengers, such as cytokines.",24719192_0,0,-1,-1,0,23221,-1,0.99991655,8.910976e-06,7.452834e-05
28414,immune responses,15,17,120,136,Our study provides one possible mechanism describing Foxp3 promoter demethylation changes by which NSCLC down-regulates immune responses and contributes to tumor progression.,27000869_11,0,-1,-1,0,28414,-1,0.9999659,9.772223e-06,2.4299192e-05
15427,IL-17A,2,3,13,19,"Furthermore, IL-17A and RORC gene expression was strongly increased in human gastric biopsies from patients with gastritis, but not gastric cancer.",21710691_8,0,-1,-1,0,15427,-1,0.99996233,3.579203e-06,3.4134187e-05
25075,IFN-,42,43,241,246,"Our results showed that the expression levels of Runx3, T-bet, and IFN- in patients with gastric carcinoma were obviously lower than those in control groups, and there was a positive correlation between the expression of Runx3 and T-bet or IFN- in patients (p<0.01).",25270738_2,0,-1,-1,0,25075,-1,0.9999739,2.8780614e-06,2.3218103e-05
43131,IFN--producing,15,16,107,122,"Here, we provide a comprehensive multiplexed histopathological mapping of gastric tissue, which identifies IFN--producing epithelial cells as possible contributors to the nivolumab-associated gastritis.",34755133_6,0,-1,-1,0,43131,-1,0.9999554,6.0529096e-06,3.845316e-05
29701,IL-17,5,6,26,31,"Serum levels of IL-10 and IL-17 were determined with ELISA, and expression of Foxp3 and RORt was assessed with quantitative real-time PCR.RESULTS: Treg and Th17 cell proportions in peripheral blood in the CLL patients were significantly higher than control.",27584054_2,0,-1,-1,0,29701,-1,0.9999746,3.6692875e-06,2.168048e-05
12074,chemotherapeutic,7,8,45,61,"Recent studies support the idea that certain chemotherapeutic agents do not act only by cytotoxicity, but also have immunomodulatory activity.",20386470_0,0,-1,-1,0,12074,-1,0.9999254,8.250454e-06,6.635203e-05
24236,IL-17-,16,17,113,119,"Results showed that the percentage of T-bet-positive cells was significantly decreased, while the percentages of IL-17-, FOXP3-, CD49b-, and LAG-3-positive cells were significantly increased in tumor tissues compared to that in peritumoral tissues.",25034363_5,0,-1,-1,0,24236,-1,0.99995327,6.743208e-06,3.9937844e-05
18825,IL-18,24,25,159,164,"Lack of p50 in murine DC promoted increased lifespan, enhanced level of maturation associated with increased expression of the proinflammatory cytokines IL-1, IL-18 and IFN-, enhanced capacity of activating and expanding CD4(+) and CD8(+) T cells in vivo and decreased ability to induce differentiation of FoxP3(+) regulatory T cells.",23049782_3,0,-1,-1,0,18825,-1,0.9999763,3.5024068e-06,2.0270385e-05
15601,IL-17(+)FOXP3(-,50,51,279,294,"A unique subset of FOXP3(+) IL-17-producing CD4(+) T cells was consistently identified in tumor-infiltrating lymphocytes from advanced stages of cancer, but not in the circulation, at a frequency of 0.5% to 5.5 % of total CD4(+) T and positively correlated with the frequency of IL-17(+)FOXP3(-) T cells.",21837700_3,0,-1,-1,0,15601,-1,0.99741673,0.0020508654,0.00053243845
25089,IFN-,47,48,276,281,"In order to further confirm this result, the Runx3 gene was constructed into pIRES2-eGFP and the recombined plasmid was transfected into SGC-7901 cells with liposome in vitro, the results obtained from the reverse transcription PCR indicated that the mRNA of Runx3, T-bet, or IFN- was significantly upregulated individually in Runx3 gene-transfected SGC-7901 cells.",25270738_3,0,-1,-1,0,25089,-1,0.99997437,2.654371e-06,2.2966222e-05
36066,IFN-4,36,37,204,210,"Moreover, N1 and R848 synergistically increased nuclear translocation of interferon (IFN) regulatory transcription factors (e.g., IRF3 and IRF7) and promoted the expression of type 1 IFNs such as IFN-2, IFN-4, and IFN-1.",30619338_4,0,-1,-1,0,36066,-1,0.999905,1.6883663e-05,7.808633e-05
15017,IL-10,8,9,56,61,"This study evaluated relationships between plasma IL-6, IL-10, circulating MDSC subsets, and IFN--induced signal transduction in 40 patients with GI malignancies.",21604071_2,0,-1,-1,0,15017,-1,0.9999784,2.8760878e-06,1.8736679e-05
42107,interleukin,35,36,225,236,"We show that TNAX101A efficiently interfered the binding of DNAM-1 to its ligand CD155 and showed unique functions; it decreased production of the inflammatory cytokines such as interferon-gamma, tumor necrosis factor alpha, interleukin (IL)-6, IL-17A, and IL-17F by anti-CD3 antibody-stimulated or alloantigen-stimulated T cells and increased FOXP3 expression in anti-CD3-stimulated regulatory T (Treg) cells.",33900821_3,0,-1,-1,0,42107,-1,0.9999578,6.594354e-06,3.5611603e-05
8300,interferon-gamma,3,4,18,34,"The expression of interferon-gamma, IL-4, and transforming growth factor-beta was similar in both lesions.",19121066_4,0,-1,-1,0,8300,-1,0.99997246,3.5706134e-06,2.3921439e-05
39049,interleukin,9,10,55,66,"Cytokines that stimulate T cell proliferation, such as interleukin (IL)-15, have been explored as a means of boosting the antitumor activity of chimeric antigen receptor (CAR) T cells.",32015548_0,0,-1,-1,0,39049,-1,0.9999511,6.476652e-06,4.2478747e-05
21278,CCL22,5,6,30,35,"Our study indicates that both CCL22 and TGF-1 are candidate chemoattractants for intratumoral Foxp3 (+)Tregs infiltration; however, unlike the later, CCL22 is an independent prognostic predictor of BC patients, and it therefore may have the potential to serve as a target for immunotherapeutic strategy of BC.",24124553_9,0,-1,-1,0,21278,-1,0.9998971,9.259586e-06,9.3611845e-05
18096,IFN-gamma,8,9,42,51,One of the mechanisms is considered to be IFN-gamma inhibiting the induction of Tregs.,22812187_11,0,-1,-1,0,18096,-1,0.9999764,3.0122576e-06,2.0666183e-05
29579,IL-17,37,38,188,193,"The objective of the present study was to explore the impact of IL-17 on the in vivo differentiation of Th9 cells in relation to Th2 cells in a murine model of MPE, and to explore whether IL-17 inhibits MPE formation via IL-9dependent mechanism.",27535421_2,0,-1,-1,0,29579,-1,0.9999714,4.3530654e-06,2.4140989e-05
18151,IFN,7,8,37,40,"In mice deficient in the interferon (IFN) receptor or in natural killer (NK) and CD8(+) T cell responses, metastasis was accelerated, indicating that Irf7-driven suppression of metastasis was reliant on IFN signaling to host immune cells.",22820642_3,0,-1,-1,0,18151,-1,0.99996173,4.8978545e-06,3.339469e-05
21947,IL-10,17,18,116,121,"This effect of tmTNF- was mediated by TNFR2, as TNFR2 deficiency significantly impaired tmTNF--induced release of IL-10 and NO and inhibition of T cell proliferation by MDSC supernatant.",24379122_3,0,-1,-1,0,21947,-1,0.99997926,2.8348347e-06,1.791763e-05
7144,chemotherapy,5,6,35,47,Studies assessing the influence of chemotherapy on Treg cells have also been included in this review.,18512029_5,0,-1,-1,0,7144,-1,0.99993,1.0040575e-05,5.996339e-05
17902,IL-6,3,4,24,28,Administration of hyper IL-6 abrogated protection from tumor progression in NFATc2-knockout mice and restored tumor incidence to control levels.,22738913_5,0,-1,-1,0,17902,-1,0.99997044,3.691729e-06,2.581824e-05
29972,antigen,7,8,63,70,We demonstrated that MCL-secreted IL-10 inhibits CD1d-mediated antigen presentation and pre-treatment with TSA abrogates secretion of IL-10 by MCL.,27614429_10,0,-1,-1,0,29972,-1,0.9999354,8.694231e-06,5.587495e-05
30767,IL-17A,16,17,117,123,SHP2 deficiency in T cells aggravated colitis with increased level of pro-inflammatory cytokines including IFN- and IL-17A.,27935860_3,0,-1,-1,0,30767,-1,0.9999714,3.853382e-06,2.4809895e-05
25325,cytokine,17,18,113,121,OBJECTIVE: To investigate B7-H4 expression and its correlation with the number of infiltrating T lymphocytes and cytokine production by those lymphocytes in human cervical cancer and to determine the effect of recombinant B7-H4 on the active peripheral blood T cells of the patients in vitro.,25446402_0,0,-1,-1,0,25325,-1,0.9999658,5.643174e-06,2.8589777e-05
17027,IL-17,13,14,75,80,"Because many tumours lack expression of the IL-17 receptor, the effects of IL-17 on tumour growth are generated by cells that surround the tumour cells.",22471280_5,0,-1,-1,0,17027,-1,0.99995553,6.7720757e-06,3.769186e-05
40609,immune responses,19,21,146,162,Increasing evidence indicates that local hypofractionated radiotherapy (LRT) can elicit both immunogenic and immunosuppressive local and systemic immune responses.,32948683_0,0,-1,-1,0,40609,-1,0.9999641,1.0195567e-05,2.565738e-05
35367,MIP2,10,11,34,38,"Among them, CCL5, IL6 and IL8, or MIP2 in mouse, were consistently reduced by Notch1 depletion in several human and mouse melanoma cell lines.",30036609_5,0,-1,-1,0,35367,-1,0.9968401,0.0011890511,0.0019708776
43381,CXCL13,22,23,146,152,"TGF--expressing B cells in the melanoma tumor microenvironment assembled in clusters and interacted with T cells via lymphoid recruitment (SELL, CXCL13, CCL4, CD74) signals and with Tregs via CD47:SIRP-, and FOXP3-promoting Galectin-9:CD44.",35909944_3,0,-1,-1,0,43381,-1,0.99988115,2.029e-05,9.8615055e-05
39795,mismatch,47,48,215,223,"The overall survival (OS) of the patients with CRC and high expression of PD-1 was worse than those with low expression (HR=4.01, 95%CI:1.26-12.69, P =.019).Conclusion: TIGIT and PD-1 are upregulated in CRC with mismatch repair deficiency and associated with TNM stage and DFS.",32397769_4,0,-1,-1,0,39795,-1,0.99988174,1.873526e-05,9.9537094e-05
29781,IL-6,9,10,62,66,"Consequently, methods in which immunotherapy is combined with IL-6, SDF-1a or STAT3 inhibition may offer an improved option to eliminate suppressive CD11b+ myeloid cells in HCC patients.",27593937_12,0,-1,-1,0,29781,-1,0.9999665,4.1233648e-06,2.9352594e-05
14498,IL-10,22,23,131,136,"We now show that TEMs also express higher levels of IL-10 than TIE2(-) macrophages in tumors and that ANGPT2-stimulated release of IL-10 by TEMs suppresses T cell proliferation, increases the ratio of CD4(+) T cells to CD8(+) T cells, and promotes the expansion of CD4(+)CD25(high)FOXP3(+) Tregs.",21368233_4,0,-1,-1,0,14498,-1,0.9999796,3.1780462e-06,1.7177212e-05
13482,Chemokine CXCL11,0,2,0,16,Chemokine CXCL11 was examined in CRC tissue by Western blotting.,20952660_4,0,-1,-1,0,13482,-1,0.9999455,7.5137077e-06,4.6936948e-05
14146,CXCL1,39,40,256,261,"Several inflammatory factors are subsequently upregulated, notably CD30 and its ligand CD153, also leukocyte trafficking factors including CXCL10, CXCL13, L-selectin and TGF1, and inflammatory cytokines including IL-1, IL-3 and the murine IL-8 analogues CXCL1, CXCL2 and CXCL5-6, amongst others.",21291541_8,0,-1,-1,0,14146,-1,0.9998692,2.4119883e-05,0.00010662164
2157,immune response,20,22,134,149,These results suggest that CD4(+)CD25(bright) T cells found in the normal and inflamed intestinal mucosa selectively inhibit the host immune response and therefore may contribute to the intestinal immune homeostasis.,15322172_7,0,-1,-1,0,2157,-1,0.999964,1.3948569e-05,2.2015072e-05
12218,interferon-gamma)-expressing,22,23,133,161,Our previous study has shown abundant infiltration of CXCR3(+) T cells and their frequent clustering with CXCL9 (monokine induced by interferon-gamma)-expressing stromal cells in the lymphoid stroma of Ly-rich GCs.,20422211_1,0,-1,-1,0,12218,-1,0.9994912,0.00018939299,0.00031927243
1983,IL-18,7,8,35,40,"In contrast, E6 inhibited IL-2 and IL-18 mRNA expression that would further contribute to a cytokine microenvironment unfavorable to HPV-specific, T-cell responses that should control persistent HPV infection.",15138179_8,0,-1,-1,0,1983,-1,0.9999776,3.353249e-06,1.9064202e-05
5406,IFN,3,4,14,17,The defect in IFN signaling in the melanoma patient group as a whole was partially overcome at the level of expression of IFN-stimulated genes by prolonged stimulation with the high concentration of IFN-alpha that is achievable only in IFN therapy used in melanoma.,17488182_7,0,-1,-1,0,5406,-1,0.9999522,6.3994944e-06,4.1370145e-05
7666,MCP-1,31,32,217,222,"Although WP1066 did not induce immunologic memory or enhance humoral responses to EGFRvIII, this compound reduced the production of immunosuppressive cytokines and chemokines (transforming growth factor-beta, RANTES, MCP-1, vascular endothelial growth factor), markedly inhibited natural and inducible Treg proliferation, and significantly increased cytotoxic immune responses of T cells.",18794085_7,0,-1,-1,0,7666,-1,0.9998758,3.0452753e-05,9.3855495e-05
3934,IL-10,13,14,96,101,Analysis of tumor-infiltrating T lymphocyte populations showed that the expression of Foxp3 and IL-10 was associated with CD4(+)CD25(+) T cells.,16751376_6,0,-1,-1,0,3934,-1,0.99997914,3.0914673e-06,1.7767938e-05
7667,growth factor,35,37,245,258,"Although WP1066 did not induce immunologic memory or enhance humoral responses to EGFRvIII, this compound reduced the production of immunosuppressive cytokines and chemokines (transforming growth factor-beta, RANTES, MCP-1, vascular endothelial growth factor), markedly inhibited natural and inducible Treg proliferation, and significantly increased cytotoxic immune responses of T cells.",18794085_7,0,-1,-1,0,7667,-1,0.9999081,8.188979e-06,8.366631e-05
42865,CXCL10,2,3,10,16,"Effect of CXCL10 on breast cancer cell proliferation and invasion was examined in vitro, and expression of CXCL10 and its relationship with immune cell infiltration was assessed in breast cancer samples.",34504204_2,0,-1,-1,0,42865,-1,0.9999205,1.1326752e-05,6.820159e-05
34053,cytokines,8,9,67,76,"The mRNA expression and supernatant secretion of immunosuppressive cytokines, TGF-1, VEGF, IL-10 and IFN- were measured by RT-PCR and ELISA, respectively.",29301578_6,0,-1,-1,0,34053,-1,0.9999635,5.480353e-06,3.1032716e-05
26259,IL-17A,6,7,40,46,HPV16 E6 stimulation resulted in higher IL-17A secretion in the controls than in the CIN women (p=0.035).,25990808_6,0,-1,-1,0,26259,-1,0.9999604,4.568127e-06,3.5041005e-05
6373,cytokine,25,26,162,170,"HPV16-specific T-cell immune responses were analyzed by evaluating the magnitude, breadth, type, and polarization by proliferation assays, IFN gamma-ELISPOT, and cytokine production and phenotyped by the T-cell markers CD4, CD8, CD25, and Foxp3.RESULTS: Vaccine-induced T-cell responses against HPV16 E6 and E7 were detected in six of six and five of six patients, respectively.",18172269_2,0,-1,-1,0,6373,-1,0.99996674,5.8434184e-06,2.7458804e-05
30380,IL-10,5,6,29,34,"The correlation among Foxp3, IL-10 and Stat3, and the clinical relevance of these three indexes were analyzed.",27752897_2,0,-1,-1,0,30380,-1,0.9999778,3.2680305e-06,1.8982206e-05
20145,macrophage colony-stimulating factor,25,28,145,181,"Culture of peripheral blood mononuclear cells [peripheral blood mononuclear cell (PBMC), n = 3 donors] with PSC supernatants or IL-6/granulocyte macrophage colony-stimulating factor (GM-CSF; positive control) for 7 days promoted PBMC differentiation into an MDSC (CD11b+CD33+) phenotype and a subpopulation of polymorphonuclear CD11b+CD33+CD15+ cells.",23514705_5,0,-1,-1,0,20145,-1,0.99994683,5.9524564e-06,4.725279e-05
19604,HGF,8,9,52,55,"Mechanistically, the antagonism of MET receptor for HGF with SU11274, a MET inhibitor, prevented HGF-induced AKT phosphorylation in MM cells and translated into reduced IDO protein levels and functional activity.",23232072_9,0,-1,-1,0,19604,-1,0.99983215,1.756477e-05,0.00015027246
39100,cytokine,20,21,106,114,"Here, using a Kras- and p53-driven model of PDA, we describe a mechanism of action for the protumorigenic cytokine IL35 through STAT3 activation in CD8+ T cells.",32024640_2,0,-1,-1,0,39100,-1,0.9999566,5.5087107e-06,3.785437e-05
36830,chemokines,33,34,208,218,"In response to the microenvironment, macrophages activate transcription factors as STAT1 and NF-B-p65 for M1 macrophages or STAT3 and STAT6 for M2 macrophages; activation impacts on the profile of cytokine, chemokines and growth factors secreted by macrophages.",31099286_2,0,-1,-1,0,36830,-1,0.99995625,5.915756e-06,3.779862e-05
2836,IL-12,6,7,52,57,IL-27 induced synergistic IFN-gamma production with IL-12 and proliferation of naive CD8+ T cells.,16034109_4,0,-1,-1,0,2836,-1,0.9999753,3.8567905e-06,2.0904481e-05
29168,immune response,12,14,77,92,"In addition to their unfavorable role as mediators of evasion from antitumor immune response, Tregs might also have a beneficial role by reducing inflammation thereby limiting early tumor growth and spreading.",27272839_10,0,-1,-1,0,29168,-1,0.99996924,7.151028e-06,2.3587469e-05
34269,IL-17,13,14,74,79,"The expression level of TGF-1 and IL-6 was positively related to that of IL-17 and FoxP3, similar to FoxP3 and IL-17 in gastric cancer tissues.",29391307_7,0,-1,-1,0,34269,-1,0.9999763,3.4074021e-06,2.026998e-05
32168,IFN-mRNA,15,16,94,103,"We observed significant upregulation of Th1 and Th17 effector pathways (>10-fold increase for IFN-mRNA, >5-fold for IL-17A, p < 0.01 vs. controls).",28548891_4,0,-1,-1,0,32168,-1,0.9993956,0.00010180335,0.0005025564
36931,cytokines,4,5,35,44,"The spatiotemporal distribution of cytokines orchestrates immune responses in vivo, yet the underlying mechanisms remain to be explored.",31160756_0,0,-1,-1,0,36931,-1,0.9999652,6.24977e-06,2.8549817e-05
2611,immune responses,15,17,115,131,"Although the proinflammatory cytokine interferon-gamma (IFN-gamma) has been generally thought to enhance antitumor immune responses and be involved in antitumor mechanisms of many other immunotherapy molecules, it has also been reported that IFN-gamma could promote tumor immune evasion.",15776283_0,0,-1,-1,0,2611,-1,0.9999565,1.1466517e-05,3.2066037e-05
3728,IL-13,23,24,161,166,"Distinct from other murine tumor models, the negative regulation induced by CD1d-restricted NKT cells was not dependent on IL-4Ralpha-STAT6 signaling, including IL-13, or on TGF-beta.",16585215_7,0,-1,-1,0,3728,-1,0.9999763,3.7405828e-06,1.99926e-05
6348,cytokines,3,4,20,29,Increased levels of cytokines in serum correlated with enhanced survival in the subcutaneous model.,18157010_11,0,-1,-1,0,6348,-1,0.99996114,5.387642e-06,3.347792e-05
25708,cytokine,21,22,157,165,"Lymphodepleting regimens are used before adoptive immunotherapy to augment the antitumor efficacy of transferred T cells by removing endogenous homeostatic ""cytokine sinks."" These conditioning modalities, however, are often associated with severe toxicities.",25548153_0,0,-1,-1,0,25708,-1,0.99996233,6.0666475e-06,3.1644107e-05
26814,cytokine,5,6,30,38,"Nevertheless, IL-12 remains a cytokine of outstanding importance with lots of unresolved questions.",26182974_6,0,-1,-1,0,26814,-1,0.999954,5.695069e-06,4.0278836e-05
3544,IL-10,3,4,20,25,The predominance of IL-10 production indicated that regulatory T cells directly participate in modulating the anti-tumor immune response.,16391798_7,0,-1,-1,0,3544,-1,0.9999788,3.1598443e-06,1.8047269e-05
36237,IFN-,5,6,34,39,Suppression of IL-10 could rescue IFN- production but was unable to completely rescue perforin and granzyme B expression.,30711567_8,0,-1,-1,0,36237,-1,0.9999788,2.9986732e-06,1.8193761e-05
10482,leukemia inhibitory factor (LIF,34,39,255,286,"Neutralization assays revealed that neutralizing antibody against transforming growth factor beta (TGF-beta), interleukin-10, and interleukin-4 did not abrogate elevated FOXP3 expression induced by carcinoma cell culture supernatant, whereas neutralizing leukemia inhibitory factor (LIF) partially abrogated FOXP3 expression, but LIF alone could not increase FOXP3 expression in activated nave T cells.",19673890_6,0,-1,-1,0,10482,-1,0.025083575,0.9742192,0.0006971915
30822,IL-17A,9,10,48,54,"Thus, our study established a pro-tumor role of IL-17A in promoting tumor immune escape and supports the development of a novel cytokine immunotherapy against breast cancer.",27935862_8,0,-1,-1,0,30822,-1,0.9999558,4.9341356e-06,3.930017e-05
7446,IL-15,5,6,23,28,"However, only IL-2 and IL-15, but not IL-21, induced expression of FOXP3.",18684941_3,0,-1,-1,0,7446,-1,0.9999708,4.2748516e-06,2.4912992e-05
653,IFN-gamma,15,16,105,114,"Under Th1 conditions, cellular proliferation of CD2-GATA3-transgenic CD4(+) cells was severely hampered, IFN-gamma production was decreased and Th2 cytokine production was increased.",11441076_7,0,-1,-1,0,653,-1,0.99997866,2.725853e-06,1.8616245e-05
20287,IL-12,16,17,104,109,"In addition, compared to exosomes from CT26 cells, CT26-CIITA-derived exosomes induced higher TNF- and IL-12 mRNA levels.",23621273_6,0,-1,-1,0,20287,-1,0.9999784,3.4252537e-06,1.8129653e-05
35366,IL8,7,8,26,29,"Among them, CCL5, IL6 and IL8, or MIP2 in mouse, were consistently reduced by Notch1 depletion in several human and mouse melanoma cell lines.",30036609_5,0,-1,-1,0,35366,-1,0.9999448,6.730828e-06,4.8528425e-05
14329,chemotactic,5,6,39,50,"This pro-inflammatory milieu induced a chemotactic response in isolated natural killer (NK) cells, dendritic cells (DC) and anti-melanoma cytotoxic T cells (CTL).",21338484_4,0,-1,-1,0,14329,-1,0.99996245,4.750355e-06,3.2730066e-05
27326,pGITRL,14,15,94,100,"Because GITR signaling could not neutralize the suppressive activity of activated Treg cells, pGITRL seems to lose its adjuvant effect when sufficient activated Treg cells have accumulated in the lymph nodes and tumor tissue.",26423152_8,0,-1,-1,0,27326,-1,0.9998159,2.4547708e-05,0.00015962511
38707,chemokines,2,3,10,20,"Three CXC chemokines, including CXCL5, CXCL9, and CXCL10, were significantly overexpressed in PAAD tissues, which were correlated with the poor survival of the patients.",31913856_2,0,-1,-1,0,38707,-1,0.99995136,6.1954147e-06,4.2469565e-05
10744,osteopontin,35,36,197,208,Here we identify a bona fide age-dependent PD-1(+) memory phenotype (MP) CD4(+) T cell subpopulation that hardly proliferates in response to T cell receptor (TCR) stimulation and produces abundant osteopontin at the cost of typical T cell lymphokines.,19805226_1,0,-1,-1,0,10744,-1,0.9997719,9.378865e-05,0.00013433272
2846,IFN-gamma,16,17,100,109,"In STAT1-deficient naive CD8+ T cells, IL-27-induced proliferation was not reduced, but synergistic IFN-gamma production with IL-12 was diminished with decreased expression of T-bet, IL-12Rbeta2, granzyme B, and perforin.",16034109_6,0,-1,-1,0,2846,-1,0.9999783,2.9353487e-06,1.877166e-05
9334,transforming growth factor-beta(1,13,16,66,99,"Adoptive transfer of CD8(+) T cells of NFATc2((-/-)) mice induced transforming growth factor-beta(1) in the airways of recipient mice, thus supporting CD4(+)CD25(+)Foxp-3(+)glucocorticoid-induced tumor necrosis factor receptor (GITR)(+) regulatory T (T(reg)) cell survival.",19318584_4,0,-1,-1,0,9334,-1,0.34019876,0.64026225,0.019539049
42520,interleukin,35,36,213,224,"The tumor microenvironment (TME) of PCa is involved in the emergence of immunosuppressive factors such as myeloid-derived suppressor cells (MDSC), which regulate the immune system by several mechanisms, including interleukin (IL)-10 production.",34184811_1,0,-1,-1,0,42520,-1,0.99995863,5.9641693e-06,3.5424855e-05
6097,cytokines,13,14,82,91,"Upon IgE-mediated stimulation, mast cells produce and secrete a broad spectrum of cytokines and other inflammatory mediators.",17982078_1,0,-1,-1,0,6097,-1,0.9999585,5.8892e-06,3.5589932e-05
33704,IFN-positive,12,13,84,97,Splenocytes isolated from CpG+IRF-1-Exo-injected Hepa 1-6 tumour mice had increased IFN-positive and granzyme B-positive CD8+ cells after co-culturing with Hepa 1-6 cells as compared with MC38 cells.,29112686_12,0,-1,-1,0,33704,-1,0.99978083,4.8169466e-05,0.0001709876
43777,IFN,8,9,50,53,"In addition, endothelial cells activated by gamma IFN induce angiogenic lesions in nude mice closely resembling early KS.",9446657_9,0,-1,-1,0,43777,-1,0.9999404,6.977989e-06,5.252848e-05
32985,G-CSF,21,22,121,126,"Using an animal model of aggressive PDAC (Kras/p48TGFRIIKO), we discovered an effect of TGF signaling in regulation of G-CSF secretion in pancreatic epithelium.",28775207_2,0,-1,-1,0,32985,-1,0.9999074,1.133821e-05,8.1300255e-05
14686,cytokine,12,13,83,91,"Several studies have shown physiological functions of interleukin (IL)-32, a novel cytokine.",21423208_0,0,-1,-1,0,14686,-1,0.99978524,9.494466e-06,0.00020519794
19907,IFN-,5,6,24,29,Hepa1-6 cells inhibited IFN- and CD83 expression in CD8(+) or dendritic cells by secreting TGF-1.,23361571_7,0,-1,-1,0,19907,-1,0.9999783,2.994459e-06,1.869181e-05
24049,cytokine,12,13,78,86,"Instead, SEs triggered a cascade of events involving cell-cell and asymmetric cytokine interactions between malignant and benign T cells, which stimulated the malignant T cells to express high levels of IL-10.",24957145_4,0,-1,-1,0,24049,-1,0.9999634,5.3753724e-06,3.12906e-05
36720,IL-6,7,8,40,44,MATERIALS AND METHODS: Plasma levels of IL-6 were measured using a Cytometric Bead Array.,31027698_3,0,-1,-1,0,36720,-1,0.99997103,3.4545367e-06,2.5516445e-05
20011,IFN-,50,51,274,279,"In testing this hypothesis, we showed that combined regimens to deplete Tregs, MDSC, and PD-1(+) T cells in patients with advanced HCC restored production of granzyme B by CD8(+) T cells, reaching levels observed in normal controls and also modestly increased the number of IFN- producing CD4(+) T cells.",23423978_5,0,-1,-1,0,20011,-1,0.99998045,2.6601192e-06,1.6936385e-05
8707,IL-10,51,52,302,307,"Using multiparameter flow cytometry, splenic T cells were assessed for FoxP3 expression to identify regulatory T cells (Tregs) and production of IFN-gamma and IL-10 after stimulation with PMA/ionomycin; within the CNS, CD4+ TILs were quantified, and TAMs were quantified and assessed for TNF-alpha and IL-10 production after stimulation with LPS.",19226468_4,0,-1,-1,0,8707,-1,0.9999813,2.5820405e-06,1.6107064e-05
16718,mediators,11,12,65,74,"CD4(+)CD25(hi)Foxp3(+) regulatory T cells (T(regs)) are critical mediators of self-tolerance, which is crucial for the prevention of autoimmune disease, but T(regs) can also inhibit antitumor immunity.",22375050_0,0,-1,-1,0,16718,-1,0.999645,4.064177e-05,0.00031431668
35099,chemotherapy,11,12,91,103,"Consequently, the multifunctional nanoplatform provides a potential strategy of synergetic chemotherapy and immunotherapy.",29882235_6,0,-1,-1,0,35099,-1,0.99989843,1.10829005e-05,9.0460184e-05
42870,CXCL10,0,1,0,6,"CXCL10 induced cell proliferation, migration and epithelial-mesenchymal transition in MCF-7 and MDA-MB-231 breast cancer cell lines.",34504204_3,0,-1,-1,0,42870,-1,0.99992085,1.167863e-05,6.743166e-05
25263,cytokine,30,31,166,174,"However, in response to injections with LPS (a bacterial mimic) or polyinosinic-polycytidylic acid (a viral mimic), M-TRAF3(-/-) mice exhibited an altered profile of cytokine production.",25422508_5,0,-1,-1,0,25263,-1,0.99996483,6.185008e-06,2.8934539e-05
18479,interferon-,30,31,216,228,"Here we identify an alternative, Batf3-independent pathway in mice for CD8(+) dendritic cell development operating during infection with intracellular pathogens and mediated by the cytokines interleukin (IL)-12 and interferon-.",22992524_1,0,-1,-1,0,18479,-1,0.99997103,4.2480665e-06,2.4632265e-05
31002,IFN-,15,16,69,74,"Notably, in addition to a direct action on CD8+ T cell expansion and IFN- production, rIL-33 therapy activated myeloid dendritic cells (mDCs) in tumor-bearing mice, restored antitumor T cell activity, and increased Ag cross-presentation within the tumor microenvironment.",28011934_3,0,-1,-1,0,31002,-1,0.9999751,3.0352305e-06,2.1991753e-05
18995,interferon-,35,36,216,228,"This work provides evidence that native preparations of the Euplotes raikovi pheromone Er-1 (a helical protein of 40 amino acids) specifically increases viability, DNA synthesis, proliferation, and the production of interferon-, tumor necrosis factor-, interleukin (IL)-1, IL-2, and IL-13 in human Jurkat T-cells.",23103669_1,0,-1,-1,0,18995,-1,0.9999758,3.080741e-06,2.10407e-05
25244,IFN,12,13,70,73,"In vitro studies showed that TRAF3 is required for TLR-induced type I IFN production, but the in vivo function of TRAF3 in myeloid cells remains unknown.",25422508_2,0,-1,-1,0,25244,-1,0.9999461,6.3725006e-06,4.753724e-05
35462,IL-17A,32,33,162,168,"Activated CD4+ T cells differentiate into four main separate lineages: Th1, Th2, Th17 and Treg, and they are recognized by their effector molecules IFN-, IL-13, IL-17A, and the transcription factor Foxp3, respectively.",30075815_5,0,-1,-1,0,35462,-1,0.99996996,4.155165e-06,2.588455e-05
7205,antigen-loading,34,35,221,236,"To verify this hypothesis and develop the most effective dendritic cell vaccine against Ewing's sarcoma, we evaluated the antitumor efficacy of dendritic cell-Ewing's sarcoma hybrids and dendritic cells pulsed with other antigen-loading methods, including cell lysates and the characteristic EWS-FLI1 gene of Ewing's sarcoma, using an A673 cell line as a model.",18563501_1,0,-1,-1,0,7205,-1,0.99989855,1.9487732e-05,8.203351e-05
25197,IFNs,16,17,102,106,"Although cell death in these situations is considered sterile, various reports have implicated type I IFNs as drivers of the ensuing adaptive immune response to cell-associated Ags.",25385820_1,0,-1,-1,0,25197,-1,0.999764,2.6457526e-05,0.00020950726
27671,IL-12R,9,10,64,70,"In conclusion, genetically determined low signaling activity of IL-12R predisposes to the development of LAC.",26547104_7,0,-1,-1,0,27671,-1,0.9999101,1.2520665e-05,7.738313e-05
43823,interferon,10,11,61,71,"Moreover, with DC as antigen-presenting cells, a predominant interferon (IFN)-gamma (type-1 T-cell) response was seen in all patients.",9531329_5,0,-1,-1,0,43823,-1,0.9999622,6.9943644e-06,3.0733736e-05
5263,interferons,28,29,135,146,"c-MYC acts at at least two different levels, the level of interferon induction as well as at the level of action of type I and type II interferons on their respective target promoters.",17419945_6,0,-1,-1,0,5263,-1,0.99991846,2.7849446e-05,5.358449e-05
12649,immune responses,12,14,84,100,We observed a strong correlation between a defined set of vaccine-prompted specific immune responses and the clinical efficacy of therapeutic vaccination.,20547850_7,0,-1,-1,0,12649,-1,0.9999602,1.1593838e-05,2.8300039e-05
31248,SCF,13,14,86,89,"The results showed c-Rel expression increased among cells cultured in the presence of SCF and FLT3 but was reduced when IL-2, IL-7, and IL-15 were used all together.",28090796_5,0,-1,-1,0,31248,-1,0.99987614,1.32675905e-05,0.000110557405
28656,IL-17A,33,34,198,204,"RESULTS: AO-1 could down-regulate expression of TLR4/MD-2 complex, resulting in downregulation of MyD88/NF-B signaling and activation of NF-B, Akt and IDO1 and secretion of IL-6, TGF-1, VEGF and IL-17A by EOC SKOV3 cells, and further reduce increased levels of regulatory T cells (Treg cells) and improve decreased proliferative response and antitumor cytotoxicity of T lymphocytes exposed to EOC SKOV3 cell supernatant.",27118139_4,0,-1,-1,0,28656,-1,0.9999757,3.0407662e-06,2.1205436e-05
24545,IFN-,26,27,172,177,"We furthermore observed that the JAK-STAT signaling pathway was highly activated in endothelial cells in response to stimulated iNKT cells, indicating the possible role of IFN- in the anti-angiogenic process.",25142285_7,0,-1,-1,0,24545,-1,0.99997354,3.1349268e-06,2.3415756e-05
13291,GM-CSF,19,20,93,99,CD8(+) Foxp3(+) T cells are induced in TIL in regressing tumors of FVB/N mice treated with a GM-CSF secreting HER-2/neu targeted whole cell vaccine.,20857491_3,0,-1,-1,0,13291,-1,0.9999443,7.978422e-06,4.7661353e-05
17091,immune responses,25,27,150,166,"In MM patients, Tregs seem to contribute to myeloma-related immune dysfunction and targeting them could, therefore, help to restore and enhance vital immune responses.",22489248_4,0,-1,-1,0,17091,-1,0.9999672,9.490211e-06,2.322275e-05
41210,antigen,23,24,130,137,"Here we show, by analyzing Batf3-/- mice lacking the CD103+ conventional dendritic cell type 1 (cDC1) subpopulation important for antigen cross-presentation, that CD40L-overexpressing CAR T cells elicit an impaired antitumor response in the absence of cDC1s.",33268774_3,0,-1,-1,0,41210,-1,0.99995327,7.172216e-06,3.9516242e-05
13878,cytokine,3,4,19,27,The percentage and cytokine production of these FOXP3+ T-cell subsets were assessed by flow cytometry.,21198537_5,0,-1,-1,0,13878,-1,0.9999671,5.8629685e-06,2.7101589e-05
35003,IL10,34,35,197,201,"However, in contrast with SeV and poly I:C, rintatolimod did not activate the MAVS/helicase pathway, thus avoiding NFB- and TNF-dependent induction of COX2, COX2/PGE2-dependent induction of IDO, IL10, CCL22, and CXCL12, and eliminating Treg attraction.",29853604_3,0,-1,-1,0,35003,-1,0.9999722,4.081596e-06,2.3724255e-05
23596,interleukin 10,10,12,61,75,"Tumor-derived vascular endothelial growth factor A (VEGF-A), interleukin 10 (IL-10) and prostaglandin E2 (PGE2) cooperatively induced FasL expression in endothelial cells, which acquired the ability to kill effector CD8(+) T cells but not Treg cells because of higher levels of c-FLIP expression in Treg cells.",24793239_3,0,-1,-1,0,23596,-1,0.9999753,3.5105827e-06,2.1194734e-05
43678,IL-6,30,31,205,209,"The IL-10R, together with reporter gene constructs containing different IL-6-responsive gene elements, reconstituted in hepatoma cells an induction of transcription by IL-10 that was comparable to that by IL-6.",8662928_7,0,-1,-1,0,43678,-1,0.99997497,3.393437e-06,2.1700596e-05
24460,GM-CSF(+,28,29,184,192,"Embelin substantially reduced the tumorigenicity of pancreatic cancer cells in vivo, which was associated with reduced inflammatory cells and immune suppressive cells, IL-17A(+) Th17, GM-CSF(+) Th, MDSCs and Treg, through inhibition of IL-6 secretion.",25128650_3,0,-1,-1,0,24460,-1,0.9999374,1.0890003e-05,5.173057e-05
14802,CXCL12,0,1,0,6,"CXCL12 positivity correlated with improved survival (P = 0.005), whereas high Treg correlated with shorter survival for all breast cancers (P = 0.001), luminal cancers (P < 0.001) and basal-like cancers (P = 0.040) that were confirmed in a multivariate analysis (OR 1.61, 95% CI 1.02 to 2.53, P = 0.042).",21521526_5,0,-1,-1,0,14802,-1,0.9999316,9.995248e-06,5.842235e-05
39919,antigen,11,12,65,72,"We first confirmed the phenotypic (surface molecules, cytokines, antigen uptake, and antigen-presenting ability) and functional alterations (T cell proliferation/activation) of DCs in vitro.",32486094_2,0,-1,-1,0,39919,-1,0.9999329,6.777563e-06,6.0367154e-05
41044,cytokine,24,25,177,185,These findings indicate that melatonin exerts immunoregulatory activity in MG by balancing effector and regulatory Th cell populations as well as by suppressing proinflammatory cytokine production.,33136553_9,0,-1,-1,0,41044,-1,0.9999559,6.1168143e-06,3.7971633e-05
4467,interleukin,4,5,24,35,PURPOSE: Treatment with interleukin (IL)-2 (Proleukin) yields a 10% to 20% response rate in patients with metastatic melanoma or metastatic renal cell carcinoma.,17020993_0,0,-1,-1,0,4467,-1,0.9999498,6.066144e-06,4.415384e-05
14169,cytokines,5,6,34,43,"Recent studies indicate that some cytokines, such as interleukin (IL)-17, and regulatory T cells are involved in the development of cancer.",21314287_1,0,-1,-1,0,14169,-1,0.9999591,5.3317895e-06,3.5481367e-05
42151,IL-10,43,44,256,261,"When STAT6 was lacking, a remarkable reduction in tumor growth was observed, which was associated with decreased inflammation and an increased number of CD4+CD25+Foxp3+ cells in the colon, circulation, and spleen, including an over-expression of TGF-beta, IL-10, and Foxp3, compared to WT mice, during the early stages of CAC development.",33919941_4,0,-1,-1,0,42151,-1,0.9999809,2.7061271e-06,1.6345051e-05
5458,interferon,10,11,39,49,"In contrast, abundant CD8+ T cells, an interferon signal, and IL-12/23 suggest partial host antitumor response.",17508019_5,0,-1,-1,0,5458,-1,0.99994445,1.4663598e-05,4.085402e-05
40556,cytokines,25,26,156,165,"However, the therapeutic efficacy of GA in impressive regression of tumor was found to be directly correlated with induction of apoptosis and modulation of cytokines from Th2 to Th1 type.",32890791_5,0,-1,-1,0,40556,-1,0.99996257,5.5238047e-06,3.1994998e-05
33683,IFN-Exo,19,20,127,134,METHODS: Exosomes released by tumour cells infected with IRF-1-expressing adenovirus (IRF-1-Exo) or treated with interferon- (IFN-Exo) were isolated via ultracentrifugation.,29112686_2,0,-1,-1,0,33683,-1,0.9998603,2.6876403e-05,0.00011284825
34996,IFN,49,50,220,224,"Here, we use human tumor explant cultures and cell culture models to show that the (ds) RNA Sendai Virus (SeV), poly-I:C, and rintatolimod (poly-I:C12U) all activate the TLR3 pathway involving TRAF3 and IRF3, and induce IFN, ISG-60, and CXCL10 to promote CTL chemotaxis to ex vivo-treated tumors.",29853604_2,0,-1,-1,0,34996,-1,0.99996996,3.822955e-06,2.626856e-05
3403,IL-13,15,16,120,125,These results show that effective immune surveillance against established metastatic disease is negatively regulated by IL-13 and requires the induction of tumoricidal M1 macrophages and lymphocytes combined with a reduction in tumor-induced myeloid suppressor cells.,16357187_5,0,-1,-1,0,3403,-1,0.99997044,4.3737223e-06,2.5099018e-05
27026,interleukin,7,8,39,50,Here we demonstrate a crucial role for interleukin (IL)-9 in antitumor immunity generated by the GITR agonistic antibody DTA-1.,26280119_1,0,-1,-1,0,27026,-1,0.99995077,6.3377784e-06,4.2939067e-05
32058,interleukin,12,13,90,101,We found that the gastric cancer patients presented significantly elevated frequencies of interleukin 10-expressing cells in both CD4+ and CD8+ T cells compared to healthy controls.,28488547_4,0,-1,-1,0,32058,-1,0.9999602,7.096539e-06,3.2669708e-05
15025,IL-10,14,15,76,81,Plasma IL-6 was correlated with CD33(+)HLADR(-)CD15(+) MDSC (P = 0.008) and IL-10 with CD33(+)HLADR(-)CD15(-) MDSC (P = 0.002).,21604071_5,0,-1,-1,0,15025,-1,0.9999796,2.8763245e-06,1.7531478e-05
19137,CCL2,8,9,44,48,"In murine established tumor model, however, CCL2 blockade utilizing the specific siRNA or neutralizing mAb significantly inhibits Snail(+) tumor growth and metastasis following systemic induction of anti-tumor immune responses in host.",23143679_8,0,-1,-1,0,19137,-1,0.9996246,5.1742456e-05,0.00032362825
9649,antigen,13,14,69,76,About 5% of the CD4(+) T-cell clones that recognized the MAGE-A3.DP4 antigen had a CD25(+) phenotype in the resting state.,19435913_3,0,-1,-1,0,9649,-1,0.9999386,6.6917314e-06,5.468035e-05
11348,growth factor,28,30,147,160,"CD8+, CD4+ and Foxp3+ tumor-infiltrating lymphocytes, tryptase and chymase mast cells (MCs), CD34, number of microvessels and vascular endothelial growth factor were determined by immunohistochemistry.",20053697_2,0,-1,-1,0,11348,-1,0.99987936,1.0645603e-05,0.000109987355
23791,IL-6-dependent,23,24,116,130,"Herein we show that MSCs support the viability of FL-infiltrating TFH and TFR, as well as Tregs, in part through an IL-6-dependent mechanism.",24836297_4,0,-1,-1,0,23791,-1,0.9998994,2.3871218e-05,7.679724e-05
15376,IL-10,21,22,120,125,These Tr1-type regulatory T cell clones suppressed tumor rejection in vivo as well as Th cell activation in vitro in an IL-10 dependent manner.,21710495_5,0,-1,-1,0,15376,-1,0.99998057,3.0990818e-06,1.6272923e-05
22184,interleukin,9,10,60,71,"The DCs were recovered from abnormal cytokine secretions of interleukin (IL)-10, IL-6, and IL-23 without any effect on production of IL-12p70.",24407159_5,0,-1,-1,0,22184,-1,0.9999479,7.133833e-06,4.4984565e-05
16839,IFN-,31,32,151,156,"The results demonstrated that effectors induced by peptides of Pokemon containing residues 32-40, 61-69, 87-95, and 319-327 could specifically secrete IFN- and lyse tumor cell lines of Pokemon-positive and HLA-A2-matched.",22405859_3,0,-1,-1,0,16839,-1,0.99997115,3.892005e-06,2.4885076e-05
28451,IFN,15,16,96,100,"Furthermore, we determined in a syngeneic sarcoma mouse model that radiation up-regulates IRF3, IFN, and the T cell chemokines CCL2 and CCL5 in the tumor microenvironment, which are associated with activation and increased infiltration of Th1/Tc1 T cells in the tumor microenvironment.",27014915_6,0,-1,-1,0,28451,-1,0.99995553,5.889452e-06,3.860083e-05
14419,IL-17(+)Foxp3(+)CD4(+,4,5,22,43,A small population of IL-17(+)Foxp3(+)CD4(+) T cells has been observed in peripheral blood in healthy human beings.,21357259_2,0,-1,-1,0,14419,-1,0.9986909,0.00026216265,0.0010469019
11029,interleukin,26,27,160,171,"In this report, Treg cells were analyzed in patients with metastatic renal cell carcinoma (RCC) following IFN-alpha monotherapy or treatment with IFN-alpha and interleukin (IL)-2.",19929575_1,0,-1,-1,0,11029,-1,0.9999572,6.2097247e-06,3.6550566e-05
27040,IL-9-producing,8,9,60,74,"Furthermore, GITR signaling enhanced the differentiation of IL-9-producing CD4(+) T-helper (TH9) cells in a TNFR-associated factor 6 (TRAF6)- and NF-B-dependent manner and inhibited the generation of induced regulatory T cells in vitro.",26280119_5,0,-1,-1,0,27040,-1,0.9999291,1.17201425e-05,5.929029e-05
34822,immune responses,26,28,173,189,The purpose of this study is to investigate whether extract of frankincense and myrrh (FM) downregulates inflammatory microenvironment of HCC and thereby restores antitumor immune responses.,29784005_3,0,-1,-1,0,34822,-1,0.99996746,8.904939e-06,2.3622952e-05
31827,IL-6,19,20,110,114,"Here, we report that IL-35 can induce N2 neutrophil polarization (protumor phenotype) by increasing G-CSF and IL-6 production, and promote neutrophil infiltration into tumor microenvironment.",28432279_3,0,-1,-1,0,31827,-1,0.9999765,3.0325325e-06,2.04698e-05
13261,IL-15,1,2,6,11,Serum IL-15 levels increased after the preparative regimen (P = <0.001).,20849361_10,0,-1,-1,0,13261,-1,0.9999653,4.50334e-06,3.016794e-05
2280,cytokine,16,17,115,123,"Moreover, KLRG1 ligation on Vgamma9/Vdelta2 T cells by antibodies did not inhibit HMB-PP-induced proliferation and cytokine production nor cytolysis of Daudi cells.",15498816_6,0,-1,-1,0,2280,-1,0.99996436,5.8911896e-06,2.9834533e-05
29141,chemokine,22,23,141,150,"BACKGROUND: Regulatory T-cells (Tregs) are a T-cell subpopulation with suppressive capacities, which are specifically attracted by C-C motif chemokine 22 (CCL22).",27272839_0,0,-1,-1,0,29141,-1,0.9999324,8.451549e-06,5.9154263e-05
17051,IL-10,20,21,127,132,We show further that IL-22 activation of HPAFII cells diminished T cell production of interferon (IFN)- through the action of IL-10.,22471280_9,0,-1,-1,0,17051,-1,0.9999777,3.239016e-06,1.9047306e-05
29549,immune responses,16,18,95,111,"Foxp3+ regulatory T cells (Tregs) maintain immune tolerance, prevent autoimmunity and modulate immune responses during infection and cancer.",27497235_0,0,-1,-1,0,29549,-1,0.99996996,9.4649195e-06,2.0639185e-05
978,MIP-2,31,32,151,156,"Nevertheless, intermediate-maturity DCs expressed substantial levels of Flt-3L, IGF-1, IL-1alpha and -1beta, IL-6, CCL-2, -3, -4, -9/10, -17, and -22, MIP-2, osteopontin, CCR-1, -2, -5, and -7, and CXCR-4.",11902830_3,0,-1,-1,0,978,-1,0.999203,0.0002036627,0.0005933341
6626,cytokine,12,13,62,70,AIM: IL-21 is the most recently identified member of the IL-2 cytokine family.,18324400_0,0,-1,-1,0,6626,-1,0.99996364,5.9052927e-06,3.0428082e-05
34229,interleukin,24,25,113,124,"BACKGROUND/AIMS: The function of regulatory T cells (Treg) and helper T cells 17 (Th17) related indexes, such as interleukin (IL)-6, IL-17, transforming growth factor (TGF)-1, and forkhead box protein 3(FoxP3) in gastric adenocarcinoma tissues remains undefined.",29391307_0,0,-1,-1,0,34229,-1,0.99995995,5.4483007e-06,3.461389e-05
33405,IL10,12,13,68,72,Treatment of TIDC and bone marrow-derived dendritic cells (DC) with IL10 led to increased PD-1 expression.,28993412_5,0,-1,-1,0,33405,-1,0.99997115,4.2777815e-06,2.460562e-05
958,cytokines,24,25,148,157,"We systematically investigated the impact of the relative maturation levels of dendritic cells (DCs) on their cell surface phenotype, expression of cytokines and chemokines/chemokine receptors (by DNA array and RNase protection analyses), biological activities, and abilities to induce tumor immunity.",11902830_0,0,-1,-1,0,958,-1,0.99996364,4.8213597e-06,3.1546675e-05
9981,immune responses,13,15,73,89,Regulatory T cells (Tregs) are T cells that suppress potentially harmful immune responses.,19538496_2,0,-1,-1,0,9981,-1,0.9999645,1.4178249e-05,2.1378364e-05
28830,IL-6,17,18,98,102,"Furthermore, increased levels of Th17-related cytokines including IL-17, IL-21, IL-23, IL-1, and IL-6 were presented in between blood and marrow in B-ALL patients.",27176825_7,0,-1,-1,0,28830,-1,0.9999734,3.7040406e-06,2.2937835e-05
22969,cytokine,20,21,130,138,"MTS, flow cytometry and ELISA assay were used to evaluate T-cell immune responses, cancer cell proliferation and pro-inflammatory cytokine secretion, respectively.",24676671_2,0,-1,-1,0,22969,-1,0.99996054,6.3573925e-06,3.3156703e-05
6344,cytokine,9,10,45,53,"In the orthotopic model, BCG induced a local cytokine storm during treatment initiation whereas CpG affected a more refined cytokine pattern over time.",18157010_10,0,-1,-1,0,6344,-1,0.99996173,6.188812e-06,3.2067368e-05
36484,IL-10,23,24,164,169,"Regulatory T-cells taken from children diagnosed with leukemia showed a higher suppressive capability, which was confirmed by detecting elevated levels of secreted IL-10 and TGF-beta.",30944830_5,0,-1,-1,0,36484,-1,0.9999783,3.0768406e-06,1.8597711e-05
33985,immune responses,5,7,34,50,HCV-high livers had two molecular immune responses: increased APC numbers and adaptive immunity and the induction of immune tolerance.,29248968_8,0,-1,-1,0,33985,-1,0.9999578,1.3696814e-05,2.851434e-05
28287,IL-17(+,7,8,39,46,"This suggests that a high frequency of IL-17(+) non-T cells was related to a poor immune response, which was further supported by the observation that a high number of T cells was correlated with improved disease-free survival in the HPV-positive OPSCC (p = 0.008).",26899388_7,0,-1,-1,0,28287,-1,0.99992275,1.4065355e-05,6.3143525e-05
14376,IL-17(+,9,10,45,52,The results showed that a number of Foxp3(+) IL-17(+) T cells were found in CRC tissue (22.8  2.6 cells/mm(2) tissue) that was significantly more than in non-cancer colonic mucosa (5.6  1.04 cells/mm(2) tissue).,21352252_6,0,-1,-1,0,14376,-1,0.99994254,1.09867815e-05,4.652258e-05
37600,interleukin-17,1,2,9,23,"Elevated interleukin-17 (IL-17), which is known in autoimmune diseases, has recently been recognized in cancer patients.",31432577_1,0,-1,-1,0,37600,-1,0.9999714,4.011242e-06,2.449708e-05
40330,chemoresistance,15,16,110,125,SIGNIFICANCE: These findings provide new insight into pGSN-mediated immune cell dysfunction in ovarian cancer chemoresistance and demonstrate how this dysfunction can be exploited to enhance immunotherapy.,32641415_9,0,-1,-1,0,40330,-1,0.9999052,1.85558e-05,7.6179844e-05
30251,interferon,5,6,28,38,This subtype was defined by interferon signaling.,27707838_2,0,-1,-1,0,30251,-1,0.99994683,1.509865e-05,3.8070608e-05
10720,cytokine,29,30,159,167,Twenty-four patients with CTCL and 14 patients with GVHD were included to assess the relative numbers of regulatory T cells (Treg) and any change in the serum cytokine profile during 6 months of ECP therapy.,19773201_2,0,-1,-1,0,10720,-1,0.99996483,6.574006e-06,2.860516e-05
13011,IFN-alpha,6,7,43,52,BACKGROUND: High-dose interferon-alpha 2b (IFN-alpha 2b) is the only approved systemic therapy in the United States for the adjuvant treatment of melanoma.,20712892_0,0,-1,-1,0,13011,-1,0.9999716,3.6471545e-06,2.4638599e-05
36852,MCP-1,33,34,201,206,"The results show that in macrophages, these supernatants induce a decrease in the phosphorylation of NF-B-p65 and STAT1 in U937-macrophages accompanied by an increase in the secretion of IL-10, IL-6, MCP-1, and IL-8, as well as GM-CSF, G-CSF, PDGF-AA, PDGF-BB, and VEGF.",31099286_4,0,-1,-1,0,36852,-1,0.99987495,3.059049e-05,9.436573e-05
21180,IL-7,5,6,16,20,"Foxn1, KGF, and IL-7, three factors known to be involved in thymic development, were also downregulated in the thymuses of tumor bearers.",24051497_6,0,-1,-1,0,21180,-1,0.99997556,3.1683194e-06,2.1183847e-05
41626,immune responses,38,40,216,232,"T follicular helper cells (Tfh) are involved in the formation and maintenance of germinal centres, the differentiation of B cells into plasma cells, and the maintenance of helper T cell type 2 (Th2)-dominant humoral immune responses.",33647861_1,0,-1,-1,0,41626,-1,0.9999671,1.1515274e-05,2.1377156e-05
11298,cytokine,7,8,30,38,"IL-21 is a member of the IL-2 cytokine family, produced by CD4+ T cells.",20039320_0,0,-1,-1,0,11298,-1,0.99996424,5.4743236e-06,3.0326935e-05
27652,il12rb2,10,11,48,55,"In a previous study, lack of IL-12 signaling in il12rb2 knock-out mice was found to predispose to lung adenocarcinoma (LAC).",26547104_0,0,-1,-1,0,27652,-1,0.999858,4.187315e-05,0.00010006325
2021,tumor necrosis factor alpha,12,16,76,103,"In vitro generation of DC was achieved using a cytokine cocktail containing tumor necrosis factor alpha, granulocyte macrophage-colony stimulating factor, c-kit ligand, and soluble CD40 ligand; yet, addition of the HDAC inhibitor (Hdi) trichostatin A enhanced DC differentiation with retention of the fusion transcripts.",15197237_3,0,-1,-1,0,2021,-1,0.99877304,0.00054747897,0.00067954516
5019,mediators,7,8,50,59,"BACKGROUND AND OBJECTIVES: Chemokines are soluble mediators involved in angiogenesis, cellular growth control and immunomodulation.",17339182_0,0,-1,-1,0,5019,-1,0.99994767,6.8637646e-06,4.5443554e-05
31084,IL-15,19,20,144,149,"In bortezomib-treated 4T1HA tumor-bearing mice, CD4+T-cells showed increased IL-2 production, CD11c+ dendritic cells showed increased IL-12 and IL-15 production, and HA-specific activated CD8+T-cells showed enhanced expression of IFN, granzyme-B and transcription factor eomesodermin.",28052005_6,0,-1,-1,0,31084,-1,0.99997866,3.4889167e-06,1.7925191e-05
32319,chemotherapy,14,15,95,107,Elevated A2AR expression was also detected in recurrent HNSCC and HNSCC tissues with induction chemotherapy.,28592285_6,0,-1,-1,0,32319,-1,0.99990773,1.1462089e-05,8.084728e-05
30956,IL-12,14,15,78,83,"Th1 (neopterin, tryptophan, kynurenine, kynurenine-to-tryptophan ratio (KTR), IL-12, IFN-, soluble TNF-R75 and IL-2R) and Th2 (IL-4, IL-10) biomarkers as well as CD4 expression in T helper (Th), effector and regulatory T cells were determined.",28005163_3,0,-1,-1,0,30956,-1,0.99998176,2.859532e-06,1.541257e-05
11026,IFN-alpha,19,20,106,115,"In this report, Treg cells were analyzed in patients with metastatic renal cell carcinoma (RCC) following IFN-alpha monotherapy or treatment with IFN-alpha and interleukin (IL)-2.",19929575_1,0,-1,-1,0,11026,-1,0.99997437,3.2616206e-06,2.2468876e-05
43779,growth factor,10,12,72,85,"These KS-like lesions are accompanied by production of basic fibroblast growth factor, an angiogenic factor highly expressed in primary lesions that mediates angiogenesis and spindle cell growth.",9446657_10,0,-1,-1,0,43779,-1,0.9998466,1.270132e-05,0.00014069698
23547,cytokines,22,23,122,131,"However, these same signals are not sufficient to induce autocrine IL-2 production by naive CD8(+) T cells, which require cytokines provided by other cell types to drive their differentiation.",24778448_1,0,-1,-1,0,23547,-1,0.9999696,5.613374e-06,2.4756695e-05
2625,IFN-gamma,9,10,54,63,"On the other hand, sustained high-level expression of IFN-gamma mediates significant antitumor effect on H22 hepatoma.",15776283_3,0,-1,-1,0,2625,-1,0.999977,2.603251e-06,2.0417656e-05
15675,IL-6,17,18,138,142,"In bronchioalveolar lavage fluid and plasma of doxycycline-treated bitransgenic mice, concentrations of MDSC-stimulating cytokines IL-1, IL-6, IL-10, IL-13, INF-, TNF-, and GM-CSF were significantly increased, which stimulated alveolar monocytes/macrophages to CD11b(+)Gr-1(+) cell conversion in vitro.",21864492_3,0,-1,-1,0,15675,-1,0.99997246,3.9751712e-06,2.3602286e-05
38626,GM-CSF,14,15,85,91,"Here, we report BRCA1-IRIS-overexpressing (IRISOE) TNBC cells secrete high levels of GM-CSF in a hypoxia-inducible factor-1 (HIF1)- and a NF-B-dependent manner to recruit macrophages to IRISOE cells and polarize them to protumor M2 TAMs.",31911557_1,0,-1,-1,0,38626,-1,0.99995935,4.7541744e-06,3.5883706e-05
33612,IL6-positive,10,11,58,70,The Treg and TAM counts surrounding the cancer lesion and IL6-positive cancer cell counts were evaluated against clinicopathological variables.,29048388_3,0,-1,-1,0,33612,-1,0.99984014,2.118985e-05,0.00013856617
16368,IL-10,9,10,57,62,SocL extract and wogonin also inhibited the secretion of IL-10 in T(reg) culture; whereas the level of IL-2 was either unchanged or marginally enhanced.,22057676_6,0,-1,-1,0,16368,-1,0.9999796,2.895858e-06,1.7524522e-05
11008,IFN-gamma-knockout,13,14,81,99,Adoptive transfer of wild-type CD8(+) T cells induced T-suppressor cell death in IFN-gamma-knockout mice confirming that autocrine IFN-gamma was sufficient for CD8(+) T cell FasL expression.,19923444_6,0,-1,-1,0,11008,-1,0.9999306,1.9888788e-05,4.9504495e-05
43606,IFN-gamma,9,10,56,65,"Therefore, a STAT1 transcription factor is activated by IFN-gamma synthesized and released upon stimulation of T lymphocyte populations.",8605941_6,0,-1,-1,0,43606,-1,0.99997675,2.9083126e-06,2.0376356e-05
42825,IL-6,5,6,29,33,"As a transcription factor of IL-6, PRRX2 was reduced by CBS.",34413167_9,0,-1,-1,0,42825,-1,0.9999734,3.8001556e-06,2.275258e-05
37391,CCL22,5,6,29,34,We used RT-qPCR to determine CCL22 mRNA expression in clinical specimens and cultured cells.,31325403_2,0,-1,-1,0,37391,-1,0.9998883,1.2316646e-05,9.9448465e-05
13267,chemotherapy,10,11,81,93,CONCLUSIONS: Adoptive transfer of haplo-identical NK cells after lymphodepleting chemotherapy is associated with transient donor chimerism and may be limited by reconstituting recipient Treg cells.,20849361_13,0,-1,-1,0,13267,-1,0.99988914,1.1728629e-05,9.9200566e-05
38437,chemo-resistance,38,39,257,273,"BACKGROUND/AIM: We previously demonstrated that inflammatory cytokine interleukin-6 (IL-6) was produced during cancer progression, worked together with transforming growth factor-beta 1 (TGF-1), and induced the epithelial-mesenchymal transition (EMT) with chemo-resistance against gemcitabine (GR) at the invasion front of biliary tract cancers (BTCs).",31853779_0,0,-1,-1,0,38437,-1,0.9998683,2.494479e-05,0.00010676276
40076,IL-10,15,16,100,105,"Interestingly, IL-21 secreted from CD25- Tfh cells negatively regulated the expression of Foxp3 and IL-10 of autologous Tfr-like cells.",32534760_8,0,-1,-1,0,40076,-1,0.999979,3.2930752e-06,1.7641018e-05
16142,IFN--stimulated,12,13,91,107,The extent of T-cell migration toward culture supernatants obtained from interferon-gamma (IFN--stimulated gastric carcinoma cell lines was additionally affected by expression of PML in vitro.,22022583_4,0,-1,-1,0,16142,-1,0.99997103,4.7569783e-06,2.4248251e-05
2558,antigens,41,42,230,238,"Expression of the transcription factor STAT4 was evident in group A, but not in groups B-D. Serum IFNgamma, IL12 and IL4 levels were increased in groups A and E. Adoptive transfer of NKT lymphocytes exposed ex vivo by HCC-derived antigens loaded on dendritic cells and NKT cells from immunized donors led to suppression of HCC in mice.",15688366_12,0,-1,-1,0,2558,-1,0.9999523,6.1059523e-06,4.164622e-05
17483,CXCL10,16,17,85,91,"In contrast, a combination of IFN and poly-I:C uniformly enhanced the production of CXCL10 and CCL5 in all tumor lesions.",22593190_4,0,-1,-1,0,17483,-1,0.9999186,1.185531e-05,6.959226e-05
34197,IL-6,9,10,58,62,The PI3K/AKT pathway may participate in the regulation of IL-6 expression and secretion.,29337110_8,0,-1,-1,0,34197,-1,0.99996567,4.1142875e-06,3.014957e-05
7926,IFN-alpha,7,8,43,52,"Here we hypothesized that a combination of IFN-alpha and IL-21, a novel cytokine of the IL-2 family with anti-cancer effects, will increase the anti-cancer efficacy at sub-optimal cytokine doses.",18947877_4,0,-1,-1,0,7926,-1,0.9999771,2.806886e-06,2.004122e-05
11978,immune response,1,3,10,25,"Antitumor immune response and chemotherapy-induced immunomodulation in colon cancer patients represented the rationale to design new strategies, like GOLFIG chemoimmunotherapy (gemcitabine, oxaliplatin, 5-fluorouracil/folinic acid, granulocyte macrophage colony-stimulating factor, and aldesleukine), that resulted a safe and very active regimen.",20386463_0,0,-1,-1,0,11978,-1,0.9999348,1.7748453e-05,4.742608e-05
33994,immune responses,10,12,68,84,Tumor-specific CD8 T cells often fail to elicit effective antitumor immune responses due to an inability to expand into a substantial effector population and persist long-term in vivo.,29271784_0,0,-1,-1,0,33994,-1,0.9999702,8.989857e-06,2.0881622e-05
43601,IFN-gamma,35,36,229,238,"Neutralizing antiserum against IFN-gamma, but not other cytokines tested, blocked activation of the factor almost completely, and IFN-gamma was found in the culture supernatants of stimulated cells at levels at which recombinant IFN-gamma could activate the factor in naive cells.",8605941_5,0,-1,-1,0,43601,-1,0.9999794,2.7686224e-06,1.7863238e-05
30092,IFN-,18,19,116,121,"Coculture of Tr1 cells with proinflammatory CD4+ T cells resulted in TGF--dependent reduction of interferon gamma (IFN-) and IL-10-dependent reduction of tumor necrosis factor alpha (TNF-), while coculture of Tr1 cells with CD8+ T cells resulted in lower tumor-specific cytotoxicity.",27644153_8,0,-1,-1,0,30092,-1,0.9999763,2.9728167e-06,2.0779718e-05
39857,IL-10,7,8,38,43,"As a mechanism of growth promotion by IL-10, HBZ interacts with STAT1 and STAT3 and modulates the IL-10/JAK/STAT signaling pathway.",32471947_7,0,-1,-1,0,39857,-1,0.99997795,3.356136e-06,1.8693137e-05
19439,IFN-,13,14,114,119,"Upon PC61 administration, -galactosylceramide (-GalCer)-mediated activation of iNKT cells resulted in decreased IFN- but not IL-4 production.",23182710_5,0,-1,-1,0,19439,-1,0.999977,2.9939413e-06,2.0051386e-05
1345,cytokine,17,18,103,111,"Here we demonstrate that CD4(+) T cells that recognize a secreted tumor-specific antigen and exhibit a cytokine secretion profile characteristic of Th2 cells, are capable of clearing established lung and visceral metastases of a CTL-resistant melanoma.",12566422_2,0,-1,-1,0,1345,-1,0.99996924,5.5565097e-06,2.516989e-05
14630,interferon,2,3,13,23,"Furthermore, interferon (IFN)--secreting CD4(+) and CD8(+) T cells were induced which suppressed B16.OVA tumor growth in C57BL/6 mice.",21383765_4,0,-1,-1,0,14630,-1,0.99996316,7.2715525e-06,2.9541548e-05
40728,antigens,15,16,98,106,Curcumin also showed direct DC enhancing activity and enhanced T cell induction for the immunized antigens in non-tumor-bearing mice and human hosts.,33006786_4,0,-1,-1,0,40728,-1,0.99994564,9.174971e-06,4.5170003e-05
21336,IL-7,18,19,125,129,Patients with recurrent or prolonged CMV replications had significantly lower pSTAT5 upon stimulation of T cells with either IL-7 or IL-2 at time points 1 through 3 than those without CMV replication (P < .05).,24140122_4,0,-1,-1,0,21336,-1,0.9999758,3.4009597e-06,2.0762078e-05
13247,interleukin,17,18,95,106,"An NK cell product, from a haplo-identical related donor, was incubated overnight in 1000 U/mL interleukin (IL)-2 prior to infusion.",20849361_3,0,-1,-1,0,13247,-1,0.9999559,5.755144e-06,3.8439575e-05
20857,cytokines,22,23,140,149,"CONCLUSIONS: Th17 and Treg cells seem to interact at the site of injury, suggesting the involvement of proinflammatory and immunoregulatory cytokines in the pathogenesis of periapical lesions.",23880265_9,0,-1,-1,0,20857,-1,0.9999653,5.5933533e-06,2.9051898e-05
11675,antigenic,8,9,46,55,Despite the fact that malignant cells do have antigenic properties their immunogenic effects are minor suggesting tumor induced mechanisms to circumvent cancer immunosurveillance.,20205946_1,0,-1,-1,0,11675,-1,0.99987257,1.9196232e-05,0.000108217726
4036,antigen,33,34,189,196,"Anti-CTLA4 did not deplete Tregs or permanently impair their function but acted in a cell-intrinsic manner on both Tregs and Teffs, allowing them to expand, most likely in response to self antigen.",16778987_3,0,-1,-1,0,4036,-1,0.9999528,6.861706e-06,4.0313986e-05
18114,IL-10,6,7,23,28,"IL-6, TGF-, IL-17 and IL-10 were detected by enzyme-linked immunosorbent assay (ELISA).",22820395_3,0,-1,-1,0,18114,-1,0.9999764,3.0464632e-06,2.05079e-05
17693,IL-12,2,3,16,21,Interleukin-12 (IL-12) is a disulfide-linked heterodimeric cytokine with potent immunostimulatory activity and anti-angiogenic properties.,22710287_2,0,-1,-1,0,17693,-1,0.9999771,2.746167e-06,2.0129235e-05
27448,IFN-,53,54,311,316,"On recombinant IFN- treatment of splenocytes in vitro, Suppressor of Cytokine Signaling (SOCS) 1 and SOCS3 protein expression was higher in Gal-3(-/-) mice compared to that in Gal-3(+/+) and Gal-3(+/-) mice; suggesting possible attenuation of Signal Transducer and Activator of Transcription (STAT) 1 mediated IFN- signaling in Gal-3(-/-) mice.",26442663_9,0,-1,-1,0,27448,-1,0.9999782,2.5500265e-06,1.9342322e-05
25604,chemokines,26,27,147,157,"These data suggest that CLL cells attract CLL-specific Th cells and initiate a positive feedback loop with upregulation of T-bet, CD38, and type 1 chemokines allowing further recruitment of Th cells and increased type 1 cytokine secretion.",25505279_7,0,-1,-1,0,25604,-1,0.99995637,5.8513883e-06,3.7839312e-05
40519,IL-10,4,5,29,34,"DHA diminished expression of IL-10 and IL-6, and increased the expression of IFN- in the tumor and spleen.",32859456_10,0,-1,-1,0,40519,-1,0.99997985,2.7626418e-06,1.7394086e-05
10234,antigens,8,9,43,51,Invariant NKT (iNKT) cells recognize lipid antigens presented by CD1d and respond rapidly by killing tumor cells and release cytokines that activate and regulate adaptive immune responses.,19585513_0,0,-1,-1,0,10234,-1,0.99993145,1.18042435e-05,5.6736284e-05
24884,immune responses,22,24,125,141,"In summary, our data suggest that GEP might be a powerful tool for the prediction of immunosuppression and the monitoring of immune responses within immunotherapy trials.",25242680_5,0,-1,-1,0,24884,-1,0.9999647,1.1327535e-05,2.3932296e-05
27034,IL-9,4,5,29,33,"In particular, DTA-1-induced IL-9 promoted tumor-specific cytotoxic T lymphocyte (CTL) responses by enhancing the function of dendritic cells in vivo.",26280119_4,0,-1,-1,0,27034,-1,0.99996984,4.461838e-06,2.5780411e-05
37701,IFN--induced,11,12,82,95,"Therefore, baicalein and baicalin decreased STAT3 activity, further downregulated IFN--induced PD-L1 expression and subsequently restored T cell sensitivity to kill tumor cells.",31437792_6,0,-1,-1,0,37701,-1,0.99997497,4.2041092e-06,2.0910915e-05
35046,cytokines,27,28,180,189,"We found that IL-21 promoted the generation of TSCM cells, described as CD45RACD45ROCD62LCCR7CD122CD95 cells, with a higher efficiency than that observed with other common -chain cytokines.",29864078_3,0,-1,-1,0,35046,-1,0.99996126,5.635942e-06,3.3101183e-05
1796,IFN-gamma,29,30,163,172,"Interestingly, mice lacking the major IFN-gamma-inducing cytokines IL-12 and IL-18 or T cells, B cells, and the majority of NK cells that are potential sources of IFN-gamma nevertheless inhibited tumor development.",14978132_4,0,-1,-1,0,1796,-1,0.9999794,2.7306162e-06,1.7879498e-05
33697,IFN-Exo,4,5,26,33,Injection of IRF-1-Exo or IFN-Exo combined with CpG had improved antitumour effects in mice.,29112686_9,0,-1,-1,0,33697,-1,0.9998611,2.526507e-05,0.000113569324
2278,interleukin-2,36,37,238,251,"Unlike alphabeta T cells, where possession of KLRG1 identified effector memory cells with impaired proliferative capacity, KLRG1+ Vgamma9/Vdelta2 T cells were able to proliferate vigorously upon stimulation with HMB-PP in the presence of interleukin-2.",15498816_5,0,-1,-1,0,2278,-1,0.9999809,3.0368694e-06,1.6076243e-05
10267,immune responses,17,19,101,117,"In mice, injection of messenger RNA (mRNA) coding for tumor-associated antigens can induce antitumor immune responses and therefore offers a broadly applicable immunotherapy approach.",19609242_0,0,-1,-1,0,10267,-1,0.9999702,6.2005265e-06,2.3611168e-05
39272,CCL28,33,34,229,234,"In a clinically relevant mouse gastric cancer model established by Helicobacter (H.) felis infection and N-methyl-N-nitrosourea (MNU) treatment, inhibition of -catenin/TCF activity by a pharmacologic inhibitor iCRT14 suppressed CCL28 expression and Treg cell infiltration in the stomach.",32156780_6,0,-1,-1,0,39272,-1,0.9997198,2.1182228e-05,0.0002589591
10534,IFN-gamma,14,15,97,106,In addition the results indicated a significant increase in the proliferation of splenocytes and IFN-gamma production.,19706340_7,0,-1,-1,0,10534,-1,0.99997497,3.0468077e-06,2.1966785e-05
42724,chemokine,9,10,65,74,Genetic deletion or methylation of DNA-sensing/IFN genes or CCL5 chemokine is identified as a potential mechanism to attenuate Tcell inflammation.,34289354_3,0,-1,-1,0,42724,-1,0.9999347,6.693498e-06,5.8590867e-05
36932,immune responses,6,8,58,74,"The spatiotemporal distribution of cytokines orchestrates immune responses in vivo, yet the underlying mechanisms remain to be explored.",31160756_0,0,-1,-1,0,36932,-1,0.99996436,1.1703254e-05,2.3966593e-05
43797,IFN,41,42,250,253,"As HHV-8 infects both mononuclear cells infiltrating KS lesions and KS spindle cells, these results suggest that HHV-8 may elicit or participate in a local immune response characterized by infiltration of CD8+ T cells and intense production of gamma IFN which, in turn, plays a key role in KS development.",9446657_13,0,-1,-1,0,43797,-1,0.999933,7.753608e-06,5.9224174e-05
17223,antigens,26,27,187,195,"These data support the use of mRNA-electroporated LCs, or moDCs supplemented with exogenous rhuIL-15, as vaccines for cancer immunotherapy to break tolerance against self-differentiation antigens shared by tumors.",22510877_7,0,-1,-1,0,17223,-1,0.9999559,6.638156e-06,3.741361e-05
12383,IL-17,57,58,367,372,"Significantly higher IL-17 levels were also observed in cases of patients with sinus tract (P = .03).CONCLUSIONS: We observed that chronic periapical lesions might experience a reagudization process that is correlated with an increased leukocyte infiltration, with the predominance of neutrophils attracted by a chemokine milieu, as well as the increased presence of IL-17.",20478453_9,0,-1,-1,0,12383,-1,0.99996984,3.6326621e-06,2.6640351e-05
33129,IL-10,19,20,118,123,"Moreover, TIM-4+ B cells promoted proinflammatory Th differentiation in vivo, increasing IFN- while decreasing IL-4, IL-10, and Foxp3 expression by CD4+ T cells-effects that are opposite from those of TIM-1+ B cells.",28848066_9,0,-1,-1,0,33129,-1,0.9999807,2.7414642e-06,1.6539263e-05
12435,IL-10,14,15,78,83,"In this study, we investigated the effect of simvastatin on the production of IL-10, TGF-beta and IDO production and the proliferation of T(regs) using several cancer cell lines, and Lewis lung cancer (3LL) cells-inoculated mouse tumour model.",20491794_4,0,-1,-1,0,12435,-1,0.9999782,2.8762738e-06,1.89562e-05
43296,immune response,26,28,175,190,"Despite recent advances in cancer immunotherapy, certain tumor types, such as Glioblastomas, are highly resistant due to their tumor microenvironment disabling the anti-tumor immune response.",35177622_0,0,-1,-1,0,43296,-1,0.9999672,9.551208e-06,2.3286844e-05
27691,CXCL10,27,28,190,196,"We found that PRC2 components and demethylase JMJD3-mediated histone H3 lysine 27 trimethylation (H3K27me3) repress the expression and subsequent production of Th1-type chemokines CXCL9 and CXCL10, mediators of effector T-cell trafficking.",26567139_4,0,-1,-1,0,27691,-1,0.9999485,8.4371895e-06,4.3005602e-05
11210,CCL22,5,6,25,30,"In conclusion, CCL17 and CCL22 within the tumor are related to the increased population of Foxp3(+) T-regs in ESCC.",20002703_10,0,-1,-1,0,11210,-1,0.9998461,1.5445834e-05,0.00013839517
5340,IFN-gamma,38,39,241,250,"Indoleamine 2, 3-dioxygenase (IDO), a key enzyme that catalyses the initial and rate-limiting step in the degradation of the tryptophan, is simultaneously expressed in murine dendritic cells and macrophages stimulated with interferon-gamma (IFN-gamma).",17466914_0,0,-1,-1,0,5340,-1,0.99997854,2.618843e-06,1.8781082e-05
42522,IL-17,5,6,19,24,"On the other hand, IL-17+ helper T cells (Th17) induce MDSCs and chronic inflammation in TME by producing IL-17.",34184811_2,0,-1,-1,0,42522,-1,0.9999701,4.8290476e-06,2.504786e-05
14037,IFN-,24,25,156,161,Urethane led to lung nodules development after 120 days and the time point evaluation showed that splenocytes stimulated ex vivo expressed higher levels of IFN- 20 days after the chemical injection.,21238620_5,0,-1,-1,0,14037,-1,0.99997485,2.9273206e-06,2.2115393e-05
24809,adaptive immunity,7,9,51,68,"Thus, anti-CD20 therapy promotes strong anti-tumor adaptive immunity, opposes Treg expansion and inhibits tumor cells from maintaining an immunosuppressive environment.",25231744_7,0,-1,-1,0,24809,-1,0.9998691,3.993071e-05,9.099753e-05
12673,Interleukin,0,1,0,11,"Interleukin (IL)-17-producing CD4(+) cells as Th17 cells and CD4(+)CD25(+)FoxP3(+) cells as Treg were evaluated by flow cytometry and expressed as a percentage of the total CD4(+) cells, in addition to performing a Th1/Th2 balance assay.",20550524_2,0,-1,-1,0,12673,-1,0.99995923,6.3530324e-06,3.445443e-05
11163,CCL22,21,22,139,144,"Furthermore, in order to elucidate the mechanisms behind T-regs accumulation within tumors, we evaluated the relationship between CCL17 or CCL22 expression and the frequency of Foxp3(+) T-regs.",20002703_2,0,-1,-1,0,11163,-1,0.99985814,1.4387599e-05,0.00012736687
30059,transforming growth factor beta,19,23,94,125,"CD4+Foxp3- type 1 regulatory T (Tr1) cells are potent producers of interleukin 10 (IL-10) and transforming growth factor beta (TGF-), through which they suppress pathogenic inflammation and autoimmune responses.",27644153_0,0,-1,-1,0,30059,-1,0.99307525,0.0051235314,0.0018012141
39390,IFN,5,6,25,29,"CD4 T cell expression of IFN also differed in pre-treatment samples, indicating that predictors of response unrelated to exhaustion may be present in peripheral blood.",32210968_11,0,-1,-1,0,39390,-1,0.99996877,3.9111615e-06,2.7311406e-05
39776,mismatch,28,29,125,133,Background: The role of T cell Ig and ITIM domain (TIGIT) and programmed cell death-1 (PD-1) in colorectal cancer (CRC) with mismatch repair deficiency is unknown.,32397769_0,0,-1,-1,0,39776,-1,0.99987423,2.4961144e-05,0.000100872676
19813,cytokine,16,17,117,125,"Analyses of survivin peptide-pulsed spleen and lymph node cells from vaccinated mice using ELISPOT and intracellular cytokine staining confirmed antigen-specific, interferon--producing CD8(+) T-cell responses.",23335100_5,0,-1,-1,0,19813,-1,0.99996066,5.438099e-06,3.3864977e-05
25095,IFN-,11,12,75,80,It suggested that the Runx3 and Th1-associated factors including T-bet and IFN- synchronization declines in gastric carcinoma may contribute to the development of cancer.,25270738_4,0,-1,-1,0,25095,-1,0.9999751,3.058476e-06,2.182954e-05
37964,IFN,3,4,18,22,"The expression of IFN and IL-2 in the CD4+CD25-FoxP3+ subset was significantly higher than in Treg cells, but lower than in the effector subset.",31630080_4,0,-1,-1,0,37964,-1,0.9999715,3.5957742e-06,2.4900397e-05
34883,IL-10,16,17,94,99,"Thus, we investigated the prevalence of Tregs and the relationship between them and TGF- and IL-10 concentrations and measured expression of FOXP3, CTLA-4, CD28, and GITR genes, as well as protein expression of selected genes in benign effusions and MPEs.",29785404_2,0,-1,-1,0,34883,-1,0.9999759,3.1377042e-06,2.1015196e-05
17346,immune responses,16,18,91,107,"CD4(+)FoxP3(+) regulatory T cells (Tregs) have been shown to suppress T cell-mediated host immune responses against self- and nonself-antigens; however, the impact of CD4(+) Tregs on human antitumor immune responses and their influence on cancer treatment are unknown.",22555974_0,0,-1,-1,0,17346,-1,0.999969,1.0227432e-05,2.0735224e-05
33292,CXCL10,18,19,103,109,"Further experiments showed that the gene and/or protein expression of caspase-1, iNOS, IL-1, IL-6 and CXCL10 and the levels of nitric oxide were modulated following CTX in an IRF-1-direct- or -indirect-dependent manner, and highlighted the importance of caspase-1 in driving the sterile inflammatory response to CTX.",28975621_7,0,-1,-1,0,33292,-1,0.99993324,1.1474226e-05,5.5324923e-05
39918,cytokines,9,10,54,63,"We first confirmed the phenotypic (surface molecules, cytokines, antigen uptake, and antigen-presenting ability) and functional alterations (T cell proliferation/activation) of DCs in vitro.",32486094_2,0,-1,-1,0,39918,-1,0.99995446,5.2816927e-06,4.0233397e-05
15409,IL-11,28,29,196,201,"At the molecular level, these tumours demonstrate hyper-activation of the latent transcription factor signal transducer and activator of transcription (STAT)3 via the IL-6 cytokine family member, IL-11.",21710691_4,0,-1,-1,0,15409,-1,0.9999776,3.0407805e-06,1.9269584e-05
2853,IL-12,19,20,129,134,"In T-bet-deficient naive CD8+ T cells, IL-27-induced proliferation was hardly reduced, but synergistic IFN-gamma production with IL-12 was diminished with decreased expression of IL-12Rbeta2, granzyme B, and perforin.",16034109_7,0,-1,-1,0,2853,-1,0.9999771,3.4251284e-06,1.9460791e-05
33783,mediators,27,28,189,198,"In this regard, NFAT5 upregulated the Th1-stimulatory cytokine IL-12 in classically activated macrophages, whereas in alternatively polarized ones it enhanced the expression of the pro-Th1 mediators Fizz-1 and arginase 1, indicating that it could promote proinflammatory readiness by regulating independent genes in differently polarized macrophages.",29150563_4,0,-1,-1,0,33783,-1,0.99992275,1.0067042e-05,6.727596e-05
3767,IL-10,6,7,48,53,The suppression mechanism requires TGF-beta and IL-10 and is associated with induction of the Smad signaling pathway and activation of the STAT3 transcription factor.,16612596_5,0,-1,-1,0,3767,-1,0.9999776,3.1412121e-06,1.9264053e-05
21878,chemotherapy,1,2,6,18,"After chemotherapy using the MCP841 protocol, the frequency of CD4(+) CD25(+) cells was gradually enhanced with the reduction of FoxP3, interleukin-10 positivity corresponded with disease presentation, indicating reduced immunosuppression.",24354800_9,0,-1,-1,0,21878,-1,0.99990976,1.0735381e-05,7.947842e-05
37366,IL-12,15,16,89,94,"These effects were associated with the upregulation of genes related to M1 phenotype, as IL-12 and STAT-1, and to the decrease of M2 genes, as IL-10 and STAT-6, in adherent fraction of lung immune infiltrate, as revealed by real-time PCR analysis.",31321243_4,0,-1,-1,0,37366,-1,0.9999757,3.6074262e-06,2.0773146e-05
35905,IFN-,12,13,71,76,"The excretion of intra-tumor IL-10, TGF- was notably lower but higher IFN- excretion in this combination immunotherapy.",30359281_12,0,-1,-1,0,35905,-1,0.9999695,3.5320209e-06,2.689208e-05
16231,chemosensitivity,4,5,37,53,"miR-135b introduction also decreased chemosensitivity in Jurkat cells, suggesting its contribution to oncogenic activities of NPM-ALK.",22042699_5,0,-1,-1,0,16231,-1,0.99981004,4.7707246e-05,0.00014226652
5422,IFN-gamma,28,29,188,197,"Finally, T cells from low-IFN-response patients exhibited functional abnormalities, including decreased expression of activation markers CD69, CD25, and CD71; TH1 cytokines interleukin-2, IFN-gamma, and tumor necrosis factor alpha, and reduced survival following stimulation with anti-CD3/CD28 antibodies compared to controls.",17488182_9,0,-1,-1,0,5422,-1,0.99997723,2.8171817e-06,1.9848521e-05
37321,chemokine,16,17,110,119,"Conversely, stimulating TET activity by systematic injection of its co-factor, ascorbate/vitamin C, increased chemokine and TILs, leading to enhanced anti-tumor immunity and anti-PD-L1 efficacy and extended lifespan of tumor-bearing mice.",31310587_6,0,-1,-1,0,37321,-1,0.9999505,5.283284e-06,4.4181503e-05
20158,IL-6,18,19,130,134,"Finally, the FLLL32 STAT3 inhibitor abrogated PSC supernatant-mediated MDSC differentiation, PSC viability, and reduced autocrine IL-6 production indicating these processes are STAT3 dependent.",23514705_10,0,-1,-1,0,20158,-1,0.9999752,3.240596e-06,2.1633796e-05
30388,IL-10,14,15,96,101,"The results showed that the levels of Foxp3 expressed in infiltrating CD4+CD25+Foxp3+Tregs, and IL-10 and Stat3 in CRC tissues were all significantly higher than those in polypus tissues and normal colon tissues (P< 0.01).",27752897_3,0,-1,-1,0,30388,-1,0.99997914,3.0846468e-06,1.775718e-05
38915,IFN-,10,11,60,65,"Among those lipids, cholesterol is required for the optimal IFN- production from iNKT cells.",31974378_2,0,-1,-1,0,38915,-1,0.9999763,3.1230231e-06,2.0582276e-05
21727,chemotaxis,15,16,80,90,BACKGROUND: Secondary lymphoid tissue chemokine (SLC) is a key CC chemokine for chemotaxis of immune cells and has been an attractive candidate for anti-tumor treatments.,24304581_0,0,-1,-1,0,21727,-1,0.99995947,8.286489e-06,3.2181353e-05
5212,IL-7,6,7,30,34,"Interestingly, IL-15, but not IL-7 or IL-21, also led to de novo induction of FOXP3 in antigen-specific CD8 T cells, suggesting that signaling by IL-2/IL-15Rbeta chain is pivotal for induction of FOXP3 in human CD8 T cells.",17414320_4,0,-1,-1,0,5212,-1,0.9999713,4.5304837e-06,2.4146882e-05
2908,IFN-gamma,17,18,103,112,"Extracellular regulated kinase (ERK)1/2, an upstream signal of AP-1, was also responsive to LPS and/or IFN-gamma.",16094077_10,0,-1,-1,0,2908,-1,0.9999771,2.6436767e-06,2.020906e-05
27167,IFN-,39,40,199,204,"The proportion and FoxP3 expression of the induced CD4(+)CD25(+) T cells are the highest at the level of 40ng/ml IFN-, and the suppressive function of the CD4(+)CD25(+) T cells induced by 40ng/ml IFN- is the strongest in MG patients.",26347149_12,0,-1,-1,0,27167,-1,0.9999765,2.9679707e-06,2.0509193e-05
31585,Il1rl1,19,20,108,114,"Transcriptome analysis and flow cytometry of IL-17A+Foxp3+ cells indicate that Folr4, GARP, Itgb8, Pglyrp1, Il1rl1, Itgae, TIGIT and ICOS are Th17-to-Treg cell transdifferentiation-associated markers.",28290453_5,0,-1,-1,0,31585,-1,0.96204156,0.0010612159,0.03689722
21042,immune response,5,7,32,47,"Although evidence for an active immune response, including infiltration with CD8(+) T cells, can be found in a subset of patients, those tumors are nonetheless not immunologically rejected.",23986400_1,0,-1,-1,0,21042,-1,0.99995935,1.6650642e-05,2.401672e-05
20215,immune response,37,39,222,237,"In contrast, interleukin-27 (IL-27) induces STAT1 and STAT3 activation, thus resulting in the enhancement of naive CD4 T-cell proliferation, the promotion of early Th1 differentiation, and the induction of the anti-tumour immune response.",23572151_2,0,-1,-1,0,20215,-1,0.9999713,9.269091e-06,1.9428337e-05
37387,CCL22,6,7,31,36,C-C motif chemokine ligand 22 (CCL22) has been implicated in the recruitment of Tregs.,31325403_1,0,-1,-1,0,37387,-1,0.99992085,9.652965e-06,6.946172e-05
14488,chemokine,23,24,148,157,"Previously, we demonstrated that ANGPT2 augments the expression of various proangiogenic genes, the potent immunosuppressive cytokine, IL-10, and a chemokine for regulatory T cells (Tregs), CCL17 by TEMs in vitro.",21368233_3,0,-1,-1,0,14488,-1,0.99994826,5.4861002e-06,4.62988e-05
8204,interferon-gamma,21,22,139,155,"Indoleamine 2,3-dioxygenase (IDO) catalyzes the initial and rate-limiting step in the degradation of tryptophan and is strongly induced in interferon-gamma (IFNgamma)-stimulated dendritic cells (DCs).",19075017_0,0,-1,-1,0,8204,-1,0.99997234,3.7422021e-06,2.3978033e-05
32041,cytokines,39,40,245,254,It was demonstrated that ILC2s and MDSCs were clearly upregulated and accompanied by a predominant Th2 phenotype in patients with lung cancer; this may lead to new immunotherapy approaches for lung cancer based on the associated metabolites and cytokines.,28487978_8,0,-1,-1,0,32041,-1,0.99996567,5.0566605e-06,2.9272005e-05
9529,cytokines,1,2,16,25,"Proinflammatory cytokines, for macrophage activation, IL-6 and IL-1 beta were also increased.",19375802_5,0,-1,-1,0,9529,-1,0.9999615,5.0818658e-06,3.3319826e-05
3437,interleukin-12,7,8,33,47,"As a sign of transgene function, interleukin-12 (IL-12) expression was significantly increased.",16361570_6,0,-1,-1,0,3437,-1,0.9999777,2.9426958e-06,1.9302728e-05
26038,IL-6-stimulated,2,3,13,28,"Furthermore, IL-6-stimulated production of IL-4/IL-21 through c-Maf induction is responsible for impaired Th1 differentiation.",25850032_4,0,-1,-1,0,26038,-1,0.99996614,5.460413e-06,2.8403547e-05
31133,IL-17A,31,32,209,215,"Most CD8+RORt+ T cells coexpressed T-bet, a lineage transcription factor for TH1 and TC1 development, suggesting that CD8+RORt+ T cells undergo plasticity toward a TC17/1-like phenotype with coproduction of IL-17A and INF-.",28053236_4,0,-1,-1,0,31133,-1,0.9999728,3.471644e-06,2.3668155e-05
18998,interleukin,41,42,255,266,"This work provides evidence that native preparations of the Euplotes raikovi pheromone Er-1 (a helical protein of 40 amino acids) specifically increases viability, DNA synthesis, proliferation, and the production of interferon-, tumor necrosis factor-, interleukin (IL)-1, IL-2, and IL-13 in human Jurkat T-cells.",23103669_1,0,-1,-1,0,18998,-1,0.99995613,6.2353056e-06,3.764605e-05
37048,IL-17,29,30,153,158,"We performed immunohistochemical analyses of whole tumor sections from 224 patients to assess the expression of BDCA2, CD3, CD4, CD8, Foxp3, granzyme B, IL-17, and CD34.",31201473_2,0,-1,-1,0,37048,-1,0.99997413,3.949851e-06,2.1965532e-05
363,immune responses,20,22,122,138,"The CD40 and CD40 ligand (CD40L) interaction has been implicated in the generation of effective cell-mediated and humoral immune responses, where cytokines have been shown to play a significant role in the expression of these molecules.",11129327_1,0,-1,-1,0,363,-1,0.9999639,1.2064482e-05,2.4099401e-05
1955,IL-18,16,17,75,80,"T(H)1-like (interleukin-2 [IL-2], gamma interferon [IFN-gamma], IL-12, and IL-18), and T(H)2-like (IL-4 and IL-10) cytokine mRNAs were identified by reverse transcription-PCR, and IFN-gamma and IL-10 cytokine-producing cells were identified by enzyme-linked immunospot assay.",15138179_3,0,-1,-1,0,1955,-1,0.9999788,3.1642774e-06,1.797218e-05
15011,cytokines,15,16,116,125,We hypothesized that elevated percentages of myeloid-derived suppressor cells (MDSC) and increased pro-inflammatory cytokines in peripheral blood would be associated with impaired response to IFN- in patients with gastrointestinal (GI) malignancies.,21604071_1,0,-1,-1,0,15011,-1,0.9999597,5.2269165e-06,3.5103792e-05
6480,cytokine,21,22,112,120,Here we report the effects of systemic IL-21 therapy on the immune system in two phase 1 trials with this novel cytokine.,18286285_1,0,-1,-1,0,6480,-1,0.9999604,4.7240615e-06,3.4805897e-05
6186,antigen,51,52,272,279,"In lymph nodes, Nrp1 identified a small regulatory CD4+ CD25(high) T-cell subpopulation (Nrp1+ Treg) that expressed higher levels of Forkhead box P3 (Foxp3) message and protein than Nrp1- Treg, and various molecular markers of activated Treg, i.e. CD45RO, human leucocyte antigen (HLA)-DR and glucocorticoid-induced tumour necrosis factor receptor (GITR).",18028372_1,0,-1,-1,0,6186,-1,0.9997763,8.27166e-06,0.00021554016
40221,IL-17,7,8,54,59,CONCLUSION: CHOP chemotherapy promotes glycolysis and IL-17 pathways in a HIF-1-dependent fashion.,32573814_8,0,-1,-1,0,40221,-1,0.99997246,4.4169055e-06,2.3080156e-05
21038,growth factor,35,37,227,240,"In conclusion, our study demonstrated that triptolide might inhibit tumor growth by inhibiting regulatory T cells and some cytokines such as IL-10 and transforming growth factor-, as well as production of vascular endothelial growth factor.",23975869_10,0,-1,-1,0,21038,-1,0.99986625,1.0386423e-05,0.00012334788
28396,IL-10,37,38,197,202,"To verify the effect of tumor cells on the phenotype and function of CD4(+) Tregs, we established a coculture system using NSCLC cell line and healthy CD4(+) T cells and showed that SPC-A1 induced IL-10 and TGF-1 secretion by affecting the function of CD4(+) Tregs.",27000869_6,0,-1,-1,0,28396,-1,0.99998164,2.9315536e-06,1.5363934e-05
27526,IFN-,36,37,230,235,"In a xenograft mouse model, MFE significantly enhanced anti-cancer activity combined with 5-fluorouracil and markedly promoted splenocyte proliferation, natural killer (NK) cell activity, cytotoxic T lymphocyte (CTL) activity and IFN- production.",26473845_7,0,-1,-1,0,27526,-1,0.99997914,2.6521266e-06,1.8284583e-05
11484,interferon,19,20,130,140,"This robust effector differentiation, which was antigen-driven and mechanistically dependent on an intact host response to type I interferon, gave rise to activated polyfunctional T helper cells with high interleukin-7 receptor, rapid clonal expansion, and potent antitumor activity against established B-cell lymphomas.",20118405_7,0,-1,-1,0,11484,-1,0.9999591,8.783026e-06,3.208123e-05
32961,antigen-specific,18,19,102,118,Results: CD8+BTLA- TILs could not control tumor growth in vivo as well as their BTLA+ counterpart and antigen-specific CD8+BTLA- T cells had impaired recall response to a vaccine.,28754817_6,0,-1,-1,0,32961,-1,0.9999651,7.9015035e-06,2.7107815e-05
6436,CCL22,21,22,121,126,"Moreover, an in vitro migration assay using Tregs derived from gastric cancers was performed in the presence of CCL17 or CCL22.",18224687_5,0,-1,-1,0,6436,-1,0.99984026,1.5933176e-05,0.00014371058
10378,antigen,1,2,17,24,"Carcinoembryonic antigen (CEA) is over-expressed on various human cancer cells and has been the target of immunotherapies using dendritic cells (DCs) pulsed with CEA-specific RNA or peptides, or transduced by CEA-expressing adenovirus or vaccinia virus.",19659778_0,0,-1,-1,0,10378,-1,0.9999219,5.78009e-06,7.2346804e-05
40516,IL-10+CD4+CD25,23,24,125,139,"In tumor microenvironment and spleen, DHA induced expansion of CD8+CTL, while, CD4+CD25+Foxp3+ regulatory T (Treg) cells and IL-10+CD4+CD25+ T cells were normalized by DHA treatment.",32859456_9,0,-1,-1,0,40516,-1,0.9991665,0.0001259252,0.0007076514
18413,IFN-,14,15,87,92,"Colonic IL-17 transcription increased 40- to 70-fold in all stages of colitis, whereas IFN- mRNA was gradually up-regulated 12- to 55-fold with colitis progression, and further to 62-fold in mice with dysplasia/cancer.",22962436_6,0,-1,-1,0,18413,-1,0.99997747,2.7203334e-06,1.9817187e-05
19265,IFN-,32,33,204,209,"Other tumor immunogenic settings revealed anti-tumor pathways including induction of cytotoxic activity, expression of MHC antigens, the ability Th17 cells to reside within the tumor, and to convert into IFN- producers.",23159638_3,0,-1,-1,0,19265,-1,0.9999795,2.6484622e-06,1.7897106e-05
39265,CCL28,1,2,20,25,-Catenin-activated CCL28 recruited regulatory T (Treg) cells in a transwell migration assay.,32156780_5,0,-1,-1,0,39265,-1,0.99965334,3.4469555e-05,0.00031217857
12111,IL-1beta,11,12,61,69,"LPS stimulation of DCs induced IL-10, IL-12p70, TNFalpha and IL-1beta secretion, and taxol pretreatment modified this response by down-regulating IL-1beta secretion whereas colchicine induced a proinflammatory cytokine profile with reduced IL-10 and increased IL-12p70 and TNFalpha secretion.",20386470_6,0,-1,-1,0,12111,-1,0.99997497,2.8759353e-06,2.2136917e-05
12385,immune modulators,10,12,60,77,"Myeloid-derived suppressor cells (MDSC) have emerged as key immune modulators in various tumor models and human malignancies, but their characteristics in humans remain to be unequivocally defined.",20484028_0,0,-1,-1,0,12385,-1,0.99941707,0.0003704597,0.00021251063
4412,IFN-gamma,3,4,15,24,The amounts of IFN-gamma secreted by the co-culture of irradiated OVHM cells with spleen cells from mice injected with CD40L/OVHM were much higher than those from OVHM/parental cell inoculated and naive mice.,16965650_11,0,-1,-1,0,4412,-1,0.9999764,2.7855692e-06,2.0821835e-05
28971,IL-15,14,15,85,90,"Combination with PD-1 blocking Ab showed synergistic activity with RLI, but not with IL-15.",27217584_7,0,-1,-1,0,28971,-1,0.9999722,3.835929e-06,2.3986517e-05
3987,interleukin-2,14,15,88,101,"DC-mediated expansion of FOXP3(high) Treg's is enhanced by endogenous but not exogenous interleukin-2 (IL-2), and DC-T-cell contact, including the CD80/CD86 membrane costimulatory molecules.",16763205_4,0,-1,-1,0,3987,-1,0.9999807,3.0506892e-06,1.6228076e-05
36703,chemotherapy,16,17,93,105,"CONCLUSIONS: Together, our results indicate that infiltrating CD4+ T cells could promote PCa chemotherapy resistance via modulation of the CCL5/STAT3 signaling pathway.",31018021_17,0,-1,-1,0,36703,-1,0.99989736,1.0989995e-05,9.165743e-05
28633,cytokines,24,25,197,206,"BACKGROUND: TLR4/MD-2 complex-mediated MyD88-dependent activation of NF-B and Akt promotes tumor-associated immunosuppression in epithelial ovarian cancer (EOC) via induction of immunesuppressive cytokines and indoleamine 2,3-dioxygenase (IDO).",27118139_0,0,-1,-1,0,28633,-1,0.99996805,6.0680363e-06,2.5854302e-05
43806,antigen,7,8,33,40,"The intact Ig molecule is a weak antigen, and small fragments of id protein might be more immunogenic for the induction of id-specific immunity.",9531329_1,0,-1,-1,0,43806,-1,0.99994004,6.5340278e-06,5.3390737e-05
42718,IFN,20,21,137,140,BRCA1 loss is found to lead to transcriptional reprogramming in tumor cells and cell-intrinsic inflammation involving type I interferon (IFN) and stimulator of IFN genes (STING).,34289354_1,0,-1,-1,0,42718,-1,0.99995923,5.2803684e-06,3.5521258e-05
43715,IFN-gamma,15,16,91,100,The other phenotype manifests very low HLA Class I antigen expression which is enhanced by IFN-gamma or by incubation at 25 degrees C for 24 hrs.,8795138_3,0,-1,-1,0,43715,-1,0.9999746,3.0366941e-06,2.2467104e-05
10140,IL-17,20,21,127,132,Adoptive transfer studies and analysis of the tumor microenvironment suggest that CD4(+) T cells are the predominant source of IL-17.,19564351_3,0,-1,-1,0,10140,-1,0.9999739,4.413135e-06,2.1713717e-05
18440,chemotherapy,39,40,217,229,"In the present study, we investigated whether tumor infiltrating FOXP3+ regulatory T cells, CD8+ cytotoxic T cells, and IL17F+ helper T cells were associated with a pathological complete response (pCR) to neoadjuvant chemotherapy (NAC).",22986814_1,0,-1,-1,0,18440,-1,0.99990416,9.528889e-06,8.6275744e-05
40611,that,3,4,21,25,We thus hypothesized that blockade of LRT-induced immunosuppressive responses could augment the antitumor effects and induce an abscopal response.,32948683_1,-1,1,-1,1,40611,-1,4.778046e-06,0.99999166,3.5574192e-06
7293,the,42,43,212,215,"A fraction of cervicitis, CIN I, CIN II and CIN III had natural (n) regulatory T cells (Tregs); their lesional distribution was predominantly intraepithelial in cervicitis, while in CIN they were also present in the stroma.",18593438_5,-1,1,-1,1,7293,-1,4.1845046e-06,0.99999106,4.7579083e-06
11924,that,5,6,22,26,"In addition, we found that CagA protein was tyrosine-phosphorylated in DC.",20363211_2,-1,1,-1,1,11924,-1,4.7595972e-06,0.9999912,4.096055e-06
24850,GATA-3,18,19,115,121,The impaired IL-4 production by SAP-deficient 24 T cells was associated with reduced IFN regulatory factor 4 and GATA-3 induction following TCR stimulation.,25236978_5,-1,1,-1,1,24850,-1,1.1667607e-05,0.9999771,1.1224772e-05
9496,Tregs,14,15,75,80,"We now show that IDO functions as a molecular switch in TDLNs, maintaining Tregs in their normal suppressive phenotype when IDO was active, but allowing inflammation-induced conversion of Tregs to a polyfunctional T-helper phenotype similar to proinflammatory T-helper-17 (TH17) cells when IDO was blocked.",19366986_1,-1,1,-1,1,9496,-1,4.506707e-06,0.9999907,4.75203e-06
41694,tumor,29,30,189,194,"Interferon regulatory factor 1 (IRF-1) is a tumor suppressor gene in cancer biology with anti-proliferative and pro-apoptotic effect on cancer cells, however mechanisms of IRF-1 regulating tumor microenvironment (TME) in hepatocellular carcinoma (HCC) remain only partially characterized.",33689775_0,-1,1,-1,1,41694,-1,4.334622e-06,0.9999913,4.4255726e-06
5847,Treg,29,30,165,169,"Transwell inserts partly prevented suppression (60 +/- 5% versus 95 +/- 5%).CONCLUSIONS: Suppression in the tumor microenvironment is mediated by a unique subset of Treg, which produce IL-10 and TGF-beta1 and do not require cell-to-cell contact between Treg and responder cells for inhibition.",17671115_10,-1,1,-1,1,5847,-1,5.1901775e-06,0.9999871,7.678021e-06
38155,transduction,10,11,58,70,"In the presence of IL-7, this augmented downstream signal transduction, resulting in increased STAT5 transcriptional output and upregulation of the prosurvival protein BCL-2.",31687977_3,-1,1,-1,1,38155,-1,8.794361e-06,0.99998426,6.934027e-06
11405,the,1,2,6,9,"Given the infusion related toxicities and pro-survival effect of IL-2 in CLL, these studies provide a rationale to explore IL-21 as an alternate gamma chain cytokine in CLL therapy.",20081380_7,-1,1,-1,1,11405,-1,5.6597173e-06,0.99999,4.321862e-06
41414,to,12,13,67,69,"Additionally, expression levels of CD133, IL6 and TGF- were found to serve as prognosis markers of glioma patients.",33576874_4,-1,1,-1,1,41414,-1,5.1082575e-06,0.9999906,4.2833512e-06
36998,the,6,7,50,53,"No significant associations were observed between the frequency of 4-1BBL+ B cells and the number of involved LNs, Her2 expression or disease stage.",31182685_8,-1,1,-1,1,36998,-1,4.966761e-06,0.99999154,3.534562e-06
34754,tumor,5,6,21,26,"At the late stage of tumor development, when CD4+ Treg cells dominate the tumor-microenvironment, CD4+ Tregs mediate the clonal deletion of these tumor-suppressive FOXP3- IFN+ CD8+ CD25+ CD127- T cells and ensure tumor immune evasion.",29768737_7,-1,1,-1,1,34754,-1,4.0864497e-06,0.9999914,4.496865e-06
7295,FOXP3(+,3,4,18,25,The proportion of FOXP3(+) CD25(+); FOXP3(+) CD25(-) and TGFbeta(+) CD25(+) in invasive tumors was 17; 19 and 22 respectively.,18593438_6,-1,1,-1,1,7295,-1,2.3637238e-05,0.999956,2.0383843e-05
33688,Tumours,0,1,0,7,Tumours were harvested for immunofluorescence staining.,29112686_5,-1,1,-1,1,33688,-1,6.7219944e-06,0.99998677,6.494709e-06
12926,the,4,5,34,37,"Moreover, CD40-Ad-MART-1 enhanced the expansion of functional MART-1-specific CD8(+) T cells from SLN with concomitant decreases in CD4:CD8 T-cell ratios and CD4(+)CD25(hi)FoxP3(+) regulatory T-cell rates.",20664356_5,-1,1,-1,1,12926,-1,3.6272709e-06,0.9999924,4.0561918e-06
33330,platform,13,14,95,103,These studies illuminate the interaction between tonic CAR signaling and the chosen expression platform and identify inhibitory properties of the 4-1BB costimulatory domain that have direct implications for rational CAR design.,28978471_5,-1,1,-1,1,33330,-1,5.3487706e-06,0.9999889,5.7827433e-06
30227,Tr1,5,6,25,28,"To examine the effect of Tr1 upregulation, we cocultured the enriched in vitro-induced Tr1 cells (iTr1) with autologous primary DLBCL cells and CD3+ T cells and found that iTr1 cells both enhanced the survival of CD20+ DLBCL tumor cells and suppressed the antitumor response of CD3+ T cells through the production of IL-10.",27704876_7,-1,1,-1,1,30227,-1,3.6225263e-06,0.99998903,7.3180954e-06
32397,This,0,1,0,4,This predominance of CCR6+ Treg cells was also found in the draining lymph nodes and tumor-infiltrating lymphocytes of OSCC patients with early or late clinical staging.,28600287_6,-1,1,-1,1,32397,-1,4.3779646e-06,0.999992,3.5738108e-06
39766,TGFb1,25,26,158,163,"CONCLUSION: Our findings showed that IL-6 upregulation is essential for both IBD and CRC development until the upregulation of other Th17/Treg related genes (TGFb1, IL-10, IL-23, and transcription factor FoxP3) is a crucial primarily for CRC development.",32390702_6,-1,1,-1,1,39766,-1,9.108991e-06,0.99996984,2.1087037e-05
40362,this,1,2,3,7,"In this study, we investigated the ability of SP-2577 to promote anti-tumor immunity and T-cell infiltration in SCCOHT and OCCC cell lines.",32649682_7,-1,1,-1,1,40362,-1,4.117237e-06,0.9999918,4.0827113e-06
24924,tumorigenesis,25,26,181,194,"Recent studies have revealed that treatment with nicotine ameliorates colitis in humans and experimental murine models, whereas the effect of nicotine on colitis-associated colonic tumorigenesis remains unclear.",25258409_2,-1,1,-1,1,24924,-1,4.6273617e-06,0.99999034,5.0818862e-06
23377,the,1,2,3,6,"On the other hand, after depletion of CD4+ T cells or blocked perforin with CMA in a tumor-bearing model, CPT could not effectively suppress tumor growth, but this phenomenon could be reversed by injecting naive CD4+ T cells.",24761844_4,-1,1,-1,1,23377,-1,9.669949e-06,0.9999831,7.30757e-06
14830,the,4,5,18,21,AIM: To elucidate the molecular and cellular features responsible for the increase of regulatory T cells (Tregs) in gastric cancer.,21528082_0,-1,1,-1,1,14830,-1,4.091323e-06,0.99999213,3.7355978e-06
30951,treatment,17,18,97,106,The aim was to evaluate the relationship of Th1 and Th2 components in 23 patients undergoing BCG treatment.,28005163_1,-1,1,-1,1,30951,-1,4.9488467e-06,0.9999888,6.2733616e-06
38283,Foxp3,16,17,88,93,"Upon TCR stimulation, the expression of TGF-beta was significantly higher in CD4+ CD25+ Foxp3+ TILs, while the expression of IL-10 was significantly higher in CD4+ CD25+ Foxp3- TILs.",31811667_7,-1,1,-1,1,38283,-1,9.51781e-06,0.9999826,7.894576e-06
19664,T(reg,19,20,100,105,Forkhead box P3 (FOXP3) is a transcription factor necessary for the function of regulatory T cells (T(reg) cells).,23252899_0,-1,1,-1,1,19664,-1,5.5051632e-06,0.9999839,1.0543994e-05
14899,the,28,29,160,163,The forkhead transcription factor Foxp3 is the only definitive marker of CD4(+)CD25(+) regulatory T cells (Tregs) and has been identified as a key regulator in the development and function of Tregs.,21547596_0,-1,1,-1,1,14899,-1,3.674953e-06,0.9999925,3.8190624e-06
12560,Their,0,1,0,5,"Their effect on the immune response is due to a phenomenon known as cross-priming of antigen, in which exogenous antigens are presented via MHC class I by antigen presenting cells.",20544406_1,-1,1,-1,1,12560,-1,5.803709e-06,0.9999896,4.525955e-06
21559,The,0,1,0,3,"The splenocyte proliferation, shifting of cytokine profile, and the presence of naturally-occurring CD4+CD25+Foxp3+ Treg cells were assessed to describe the anti-tumor immune response.",24270218_4,-1,1,-1,1,21559,-1,4.3522273e-06,0.9999914,4.2802103e-06
8643,Treg,13,14,78,82,"From cancerous and non-cancerous patients, we derived stable clones of CD4(+) Treg, defined as clones that expressed high CD25 at rest, were anergic in vitro, and suppressed the proliferation of co-cultured CD4(+) cells.",19224638_0,-1,1,-1,1,8643,-1,6.174617e-06,0.99998677,7.0254287e-06
28163,to,44,45,312,314,"CONCLUSION: The striking accumulation of immune cells, expression of leukocyte adhesion molecules, as well as pro-inflammatory and pro-fibrotic cytokines near markedly narrowed vessels supports the theory that the abnormal proliferation of fibroblasts and production of extracellular matrix proteins in DD seems to be related to immune-mediated microvascular damage.",26852784_7,-1,1,-1,1,28163,-1,4.750814e-06,0.99999034,4.8943666e-06
28347,plus,9,10,61,65,The tumor-bearing mice were vaccinated with LC cell extracts plus adjuvant TNBS or adoptive transplantation with specific CD8(+) CD196(+) T cells.,26910585_3,-1,1,-1,1,28347,-1,0.00014884296,0.9997782,7.294638e-05
20489,TSCC,0,1,0,4,"TSCC, however, had a higher percentage of IL-22 producing CD8(+) T cells compared to SCC.",23667456_6,-1,1,-1,1,20489,-1,0.0002772909,0.9994467,0.00027599605
2904,AP-1,5,6,37,41,Specific inhibition of NF-kappaB and AP-1 pathways decreased the production of MDC and IP-10.,16094077_9,-1,1,-1,1,2904,-1,9.993313e-06,0.9999707,1.9306719e-05
2803,that,3,4,22,26,"These results suggest that vaccines consisting of tumor cells engineered to produce the type 2 cytokine, IL-4, critically depend on type 1 immunity for their observed therapeutic efficacy.",15905564_6,-1,1,-1,1,2803,-1,5.1438938e-06,0.9999912,3.7024538e-06
32735,tolerogenic,6,7,35,46,We conclude that the generation of tolerogenic DCs is one of many immunosuppressive mechanisms that can be induced by GC.,28675711_7,-1,1,-1,1,32735,-1,2.8990911e-05,0.9999591,1.1946418e-05
13832,than,6,7,28,32,"In treated patients, a more than 2-fold decrease in Tregs was observed in one out of 11 patients receiving cyclophosphamide and in four out of 13 receiving daclizumab, but there was no such Treg decrease in any of the six patients who received denileukin diftitox.",21177412_6,-1,1,-1,1,13832,-1,9.0407075e-06,0.99998295,7.9709125e-06
14717,natural,18,19,79,86,"In tumor, spleen and blood, the number of cytotoxic CD8(+) T cells and CD57(+) natural killer cells and the levels of IL-10 increased, but that of tumor necrosis factor- (TNF-), IL-1 and IL-6 decreased.",21423208_5,-1,1,-1,1,14717,-1,8.434413e-05,0.99987257,4.3051088e-05
12417,therapeutic,15,16,96,107,These results emphasize the diversity of MDSC in human cancer and provide potential targets for therapeutic interventions.,20484028_10,-1,1,-1,1,12417,-1,5.3645854e-06,0.9999907,3.9511974e-06
38534,that,9,10,80,84,These findings warrant the development of specific immunotherapeutic strategies that selectively boost the activity of neoantigen-specific T cells and target the TGF- pathway to reinforce T cell reactivity in this patient group.,31888734_9,-1,1,-1,1,38534,-1,5.340091e-06,0.99999094,3.7332964e-06
41093,TGF,5,6,29,33,The expressions of Foxp3 and TGF in the transplanted tumor tissues of mice in the solanine group were significantly lower than those in the control group.,33204731_9,-1,1,-1,1,41093,-1,9.4110634e-05,0.9998698,3.6098027e-05
34213,that,24,25,150,154,"In sum, our study demonstrated that the relationship between the MUC16c level and Foxp3 expression in the local tumor environment was consistent with that of the serum CA125 level and circulating Treg proportion in the systemic environment.",29337110_10,-1,1,-1,1,34213,-1,5.425138e-06,0.9999901,4.456281e-06
4430,These,0,1,0,5,"These CD8+ T cells selectively express CD103, which is upregulated locally by transforming growth factor (TGF)-beta, and adhere to E-cadherin expressed by mucosal epithelia.",16978200_1,-1,1,-1,1,4430,-1,4.40557e-06,0.9999902,5.3585854e-06
42324,the,25,26,114,117,Targeting MYCN or its effectors could be a strategy to convert a cold TME into a 'hot' (inflamed) TME and improve the efficacy of ICB therapy.,34016720_3,-1,1,-1,1,42324,-1,4.0040095e-06,0.99999213,3.828155e-06
32369,tumor,25,26,166,171,"Human oral squamous cell carcinoma (OSCC) constitutes an inflammatory microenvironment enriched with chemokines such as CCL20, which promote cancer cell invasion and tumor progression.",28600287_0,-1,1,-1,1,32369,-1,4.3539676e-06,0.9999908,4.8373845e-06
9801,that,2,3,13,17,"We speculate that iTreg cell development is driven by the need to maintain a noninflammatory environment in the gut, to suppress immune responses to environmental and food allergens, and to decrease chronic inflammation, whereas nTreg cells prevent autoimmunity and raise the activation threshold for all immune responses.",19464985_4,-1,1,-1,1,9801,-1,5.2399755e-06,0.9999907,4.029067e-06
21603,the,7,8,58,61,The treatment with the antibody synergistically augmented the antitumor effect of IFN- gene therapy not only in the vector-injected tumors but also in the vector-uninjected tumors.,24289533_5,-1,1,-1,1,21603,-1,4.7276885e-06,0.9999918,3.4794227e-06
29632,the,4,5,18,21,"Overall, however, the median frequency of HPV 16-specific cells with a favorable secretion profile (Th1 balanced and cytotoxic) was low even in vaccinated volunteers (IFN-: 0.0018% and 0.0023%, perforin: 0.01% and 0.0087% for E6-specific and E7-specific cells, respectively).",27548034_8,-1,1,-1,1,29632,-1,4.337123e-06,0.999992,3.6490344e-06
18069,tumor,27,28,145,150,"In an in vivo study, Treg populations in Balb/c mice colon26 transplant model after ACT were analyzed in peripheral blood, local lymph node, and tumor.",22812187_1,-1,1,-1,1,18069,-1,4.1119574e-06,0.99999034,5.55897e-06
30252,this,1,2,3,7,"In this study, we address the mechanism of this immune response and its possible clinical significance.",27707838_3,-1,1,-1,1,30252,-1,4.5470138e-06,0.9999913,4.113632e-06
11910,to,34,35,227,229,"In general, neutralization of any lymphocyte subset or effector mechanism was insufficient to alter tumor suppression initiated by Treg depletion, and in some settings, the neutralization of multiple effector mechanisms failed to prevent tumor rejection.",20332236_6,-1,1,-1,1,11910,-1,7.4853033e-06,0.99998796,4.548018e-06
34303,to,12,13,65,67,Helios in combination with CD4 and FoxP3 may be an effective way to detect functional Tregs in pre-B ALL by promoting the secretion of transforming growth factor (TGF)-1.,29455107_4,-1,1,-1,1,34303,-1,4.6256932e-06,0.999992,3.351926e-06
5706,than,9,10,66,70,"Infiltrating cancers had higher FOXP3 transcription (7.43+/-3.44) than did ductal carcinoma in situ (4.27+/-1.97, p<0.05) and normal tissues (3.51+/-1.22, p<0.001).",17653902_4,-1,1,-1,1,5706,-1,6.515235e-06,0.9999875,6.0280213e-06
3611,that,4,5,30,34,Recent studies have indicated that in breast cancers the pro-tumor role of TAMs is dominant.,16530087_1,-1,1,-1,1,3611,-1,4.373874e-06,0.9999919,3.704971e-06
17094,TGF-,3,4,17,22,"The interplay of TGF- and IL-6, expressed at high levels in the bone marrow of myeloma patients, may affect generation of Th17 cells both directly or via other pro-inflammatory cytokines and thereby modulate antitumor immune responses.",22489248_6,-1,1,-1,1,17094,-1,9.7720185e-06,0.9999832,7.0707747e-06
4081,Tregs,2,3,13,18,Depletion of Tregs resulted in a persistent antitumor response that was maintained over a month after the last treatment.,16785502_6,-1,1,-1,1,4081,-1,9.211557e-06,0.9999839,6.862122e-06
23827,to,3,4,18,20,This study sought to advance development of LPC-targeted therapies by exploring nongenetic ways to slow the decay and to increase the immunogenicity of primary CD34(+) AML cells.,24855276_4,-1,1,-1,1,23827,-1,3.7054433e-06,0.9999925,3.773928e-06
19643,TB,15,16,110,112,"Pleural effusions from both tuberculous and malignant groups represented significantly higher levels (more in TB) for the following cell populations than peripheral blood: total lymphocytes, CD3+lymphocyte, CD4+CD25+lymphocyte and Treg (CD4+ CD25+FoxP3+).",23252864_5,-1,1,-1,1,19643,-1,1.0066553e-05,0.9999734,1.6562266e-05
33486,tumor,2,3,10,15,"Moreover, tumor growth is accelerated, not only in tristetraprolin-deficient mice after cytotoxic T lymphocyte depletion, but also in WSX-1/tristetraprolin double knockout mice, with substantial reduction in the number of tumor cytotoxic T lymphocytes.",29021521_6,-1,1,-1,1,33486,-1,4.2585752e-06,0.9999918,4.012919e-06
6875,treatments,3,4,15,25,"The effects of treatments on tumor growth, survival and antitumor immune responses were evaluated.",18392040_3,-1,1,-1,1,6875,-1,4.923106e-06,0.9999906,4.4457393e-06
37525,to,16,17,110,112,Our results demonstrate for the first time that inhibition of EED modulates the tumor immune microenvironment to induce regression of colon tumors and therefore has the potential to be used in combination with immune-oncology therapy.,31395608_8,-1,1,-1,1,37525,-1,3.982079e-06,0.99999213,3.9040606e-06
11950,the,31,32,218,221,These data suggest that CagA protein negatively regulates the functions of DC via CagA phosphorylation and that cagA-positive H. pylori strains suppress host immune responses resulting in their chronic colonization of the stomach.,20363211_6,-1,1,-1,1,11950,-1,3.979773e-06,0.9999907,5.315883e-06
43027,The,0,1,0,3,"The molecular mechanisms involved in these responses are being analyzed, but preliminary data suggest that methylation/demethylation mechanisms could also participate.",34680134_8,-1,1,-1,1,43027,-1,4.6889727e-06,0.9999914,3.896756e-06
31584,that,10,11,74,78,"Transcriptome analysis and flow cytometry of IL-17A+Foxp3+ cells indicate that Folr4, GARP, Itgb8, Pglyrp1, Il1rl1, Itgae, TIGIT and ICOS are Th17-to-Treg cell transdifferentiation-associated markers.",28290453_5,-1,1,-1,1,31584,-1,4.556189e-06,0.99999106,4.3268233e-06
26378,that,3,4,23,27,"We further demonstrate that ablating STAT3 in T cells allows expression of CXCR3, the receptor of CXCL10, on CD8(+) T cells, resulting in efficient accumulation of CD8(+) T cells at tumor sites.",26025380_4,-1,1,-1,1,26378,-1,4.2715765e-06,0.999992,3.7038978e-06
31878,tumour,22,23,149,155,"Here using genetically modified mouse models we show that ablation of E-cadherin, a process associated with epithelial to mesenchymal transition and tumour progression, promotes the accumulation of intestinal Treg cells by the specific accumulation of the KLRG1+ GATA3+ Treg subset.",28437001_2,-1,1,-1,1,31878,-1,4.904462e-06,0.99999,5.133405e-06
39462,that,6,7,46,50,Chromatin immunoprecipitation (ChIP) revealed that C-FOXP3 directly bound to the promoter region of PD-L1 in pancreatic cancer cells.,32300119_5,-1,1,-1,1,39462,-1,4.4430167e-06,0.99999213,3.4270718e-06
18930,These,0,1,0,5,These findings provide molecular insight into defective MHC-I expression in NB cells and provide the rational for T cell-based immunotherapy in NB variants refractory to conventional therapy.,23071666_8,-1,1,-1,1,18930,-1,4.513374e-06,0.9999918,3.7269922e-06
16156,transcription,22,23,152,165,"PML knockdown increased IFN--mediated Signal Transducer and Activator of Transcription-1 (STAT-1) binding to the IP-10 promoter, resulting in elevated transcription of the IP-10 gene.",22022583_7,-1,1,-1,1,16156,-1,4.351069e-06,0.99999046,5.1576094e-06
14471,TIE2,5,6,28,32,"Expression of its receptor, TIE2, defines a highly proangiogenic subpopulation of myeloid cells in circulation and tumors called TIE2-expressing monocytes/macrophages (TEMs).",21368233_1,-1,1,-1,1,14471,-1,0.00012738776,0.99984086,3.1709078e-05
10043,Foxp3(+,20,21,137,144,"As growing evidences suggest that gammadelta T cells also have immunoregulatory function, we have attempted to identify and characterize Foxp3(+) cells in mouse and human gammadelta T cells.",19539651_3,-1,1,-1,1,10043,-1,7.2170275e-05,0.999887,4.0803316e-05
3248,treated,16,17,93,100,"Thirteen patients (12 with metastatic melanoma, 1 with metastatic renal cell carcinoma) were treated at one of the two Food and Drug Administration-approved doses of Denileukin Diftitox (seven patients at 9 microg/kg, six patients at 18 microg/kg).",16224276_3,-1,1,-1,1,3248,-1,4.857117e-06,0.9999894,5.782123e-06
17710,These,0,1,0,5,"These results suggest that HBx-mIL-12 can not only induce cell cycle arrest and apoptosis in HCC cells, but also effectively shift the tumor microenvironment from pro-oncogenic to antitumor through recruitment of immune cells and inhibiting stromal cell growth, such as vascular endothelial cells.",22710287_6,-1,1,-1,1,17710,-1,4.0009013e-06,0.9999919,4.1581493e-06
39353,the,17,18,106,109,"In the present study, a comprehensive analysis of peripheral blood leukocytes from 42 patients taken over the course of treatment with anti-PD-1 was undertaken.",32210968_2,-1,1,-1,1,39353,-1,7.2207263e-06,0.999987,5.7767625e-06
30369,this,26,27,179,183,"Taken together, our findings indicate that HDIL-2 combined with the conditions of malignancy create an immune environment supportive of Th17 differentiation and that expansion of this compartment may occur through the transdifferentiation of IL-17-secreting FoxP3CD4 T cells.",27741090_8,-1,1,-1,1,30369,-1,4.2967017e-06,0.9999907,4.9468554e-06
16913,to,6,7,38,40,"In preclinical models, it contributes to antitumor immunity.",22426209_1,-1,1,-1,1,16913,-1,1.1723012e-05,0.99998033,7.92582e-06
8718,This,0,1,0,4,This early increase in Tregs was paralleled by an increase in IL-10 production from Tregs.,19226468_7,-1,1,-1,1,8718,-1,4.546477e-06,0.99999154,3.914314e-06
20528,play,11,12,59,63,"BACKGROUND: In cancer immunotherapy, dendritic cells (DCs) play a fundamental role in the dialog between innate and adaptive immune response, but several immunosuppressive mechanisms remain to be overcome.",23725550_0,-1,1,-1,1,20528,-1,7.953395e-06,0.99998295,9.143116e-06
20353,types,7,8,49,54,"NF-B is constitutively activated in many cancer types and is a potential key mediator of tumor-associated inflammation, tumor growth, and metastasis.",23635779_0,-1,1,-1,1,20353,-1,1.03810535e-05,0.9999604,2.921256e-05
9642,tetramers,12,13,65,74,The CD4(+) blood T lymphocytes that stained ex vivo with HLA-DP4 tetramers folded with the MAGE-A3 peptide were selected by flow cytometry and amplified under clonal conditions.,19435913_2,-1,1,-1,1,9642,-1,2.408811e-05,0.9999577,1.8282552e-05
31204,tumor,14,15,80,85,"In addition, MENK treated DCs may serve as a new immunotherapy approach against tumor.",28088065_9,-1,1,-1,1,31204,-1,5.422149e-06,0.9999902,4.2983143e-06
25602,T-bet,19,20,123,128,"These data suggest that CLL cells attract CLL-specific Th cells and initiate a positive feedback loop with upregulation of T-bet, CD38, and type 1 chemokines allowing further recruitment of Th cells and increased type 1 cytokine secretion.",25505279_7,-1,1,-1,1,25602,-1,5.1229827e-06,0.999987,7.888123e-06
32870,Treg,7,8,41,45,Relapse of AML was not prognosticated by Treg counts at onset of treatment or after the first cycle of immunotherapy.,28721449_5,-1,1,-1,1,32870,-1,7.1552575e-05,0.9998115,0.00011704674
16158,gene,26,27,179,183,"PML knockdown increased IFN--mediated Signal Transducer and Activator of Transcription-1 (STAT-1) binding to the IP-10 promoter, resulting in elevated transcription of the IP-10 gene.",22022583_7,-1,1,-1,1,16158,-1,4.9980863e-06,0.9999883,6.70344e-06
32215,to,15,16,95,97,Inflammation plays a critical role in the initiation of colorectal cancer but is also required to mediate antitumor immunity in established tumors.,28558303_0,-1,1,-1,1,32215,-1,9.21716e-06,0.9999864,4.3643545e-06
10511,tumor,9,10,54,59,"Therefore, we used BALB/c mouse model of fibrosarcoma tumor and analyzed the tumor size, splenocyte proliferation, spleen and tumor-infiltrated lymphocytes.",19706340_2,-1,1,-1,1,10511,-1,4.1186954e-06,0.9999912,4.687286e-06
5594,treatment,30,31,173,182,We defined the nature of the cellular immune response in 5 women with human papillomavirus (HPV) 16+cervical carcinoma at a single time point when surgery was performed for treatment.,17589293_0,-1,1,-1,1,5594,-1,5.0910976e-06,0.9999902,4.6705086e-06
13467,talk,2,3,11,15,This cross talk could sustain FL pathogenesis and represent a new potential therapeutic target.,20944673_9,-1,1,-1,1,13467,-1,0.00010448335,0.9998636,3.1887997e-05
24074,The,2,3,9,12,"METHODS: The PDA cell lines were analyzed for the expression of MHC class I, II, and antigen-processing molecules by flow cytometry or polymerase chain reaction.",24987872_2,-1,1,-1,1,24074,-1,5.7874827e-06,0.99998796,6.220727e-06
34228,related,19,20,88,95,"BACKGROUND/AIMS: The function of regulatory T cells (Treg) and helper T cells 17 (Th17) related indexes, such as interleukin (IL)-6, IL-17, transforming growth factor (TGF)-1, and forkhead box protein 3(FoxP3) in gastric adenocarcinoma tissues remains undefined.",29391307_0,-1,1,-1,1,34228,-1,2.2121772e-05,0.999961,1.6887621e-05
13797,Tregs,6,7,29,34,"PURPOSE: Regulatory T cells (Tregs) are thought to inhibit antitumor immune responses, and their depletion could therefore have a synergistic effect with therapeutic cancer vaccines.",21177412_0,-1,1,-1,1,13797,-1,4.1081516e-06,0.9999914,4.5184156e-06
36584,Treg,15,16,91,95,RESEARCH QUESTION: Is there any relationship between numbers of FOXP3+ regulatory T-cells (Treg) and occurrence of peritoneal lesions in women with ovarian endometrioma and dermoid cysts?DESIGN: Retrospective and prospective case-controlled cohort study.,30981619_0,-1,1,-1,1,36584,-1,7.59284e-06,0.9999833,9.109253e-06
30760,to,12,13,72,74,Src homology 2 domain-containing tyrosine phosphatase 2 (SHP2) is known to inhibit acute inflammation but its role in chronic inflammation-associated cancer remains unclear.,27935860_1,-1,1,-1,1,30760,-1,5.840134e-06,0.9999901,4.0842233e-06
1920,The,2,3,13,16,"CONCLUSIONS: The prime-boost regimen is immunogenic in AGIN patients (humoral and cellular immunity), but there is no simple relationship between induction of systemic HPV-16-specific immunity and clinical outcome.",15131030_10,-1,1,-1,1,1920,-1,4.7423086e-06,0.9999914,3.8737576e-06
13268,transient,14,15,113,122,CONCLUSIONS: Adoptive transfer of haplo-identical NK cells after lymphodepleting chemotherapy is associated with transient donor chimerism and may be limited by reconstituting recipient Treg cells.,20849361_13,-1,1,-1,1,13268,-1,2.287433e-05,0.9999696,7.4809263e-06
32400,the,11,12,56,59,This predominance of CCR6+ Treg cells was also found in the draining lymph nodes and tumor-infiltrating lymphocytes of OSCC patients with early or late clinical staging.,28600287_6,-1,1,-1,1,32400,-1,4.631259e-06,0.99999106,4.35868e-06
28489,this,3,4,19,23,"In accordance with this reduction in FoxO1, pro-apoptotic Foxo1 target genes Puma, Fas ligand and Bim were also seen to be down-regulated in MT-2Rst cells.",27042963_4,-1,1,-1,1,28489,-1,4.096809e-06,0.99999225,3.618833e-06
41040,Tregs,27,28,181,186,Further investigation in vitro revealed that melatonin administration increased FoxP3 and IL-10 expression in CD4+ T cells from MG patients and enhanced the suppressive function of Tregs.,33136553_8,-1,1,-1,1,41040,-1,4.3952055e-06,0.9999913,4.270188e-06
39181,TFH,7,8,48,51,Recent researches reported a high percentage of TFH and TFR in different infectious diseases and certain malignancies.,32061875_2,-1,1,-1,1,39181,-1,8.762133e-06,0.9999827,8.5822085e-06
26102,type,10,11,59,63,Pancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic malignancies.,25952647_0,-1,1,-1,1,26102,-1,6.86008e-06,0.99998283,1.0293419e-05
32035,transcription factors,12,14,86,107,"In addition, increased autophagy related 1 was closely associated with Th2associated transcription factors.",28487978_7,-1,1,-1,1,32035,-1,5.039108e-06,0.9999902,4.7197977e-06
25974,Treg,7,8,41,45,We hypothesized that regulatory T cells (Treg) may exert a functional and clinical impact on antitumor immunity in cetuximab-treated individuals.,25832655_1,-1,1,-1,1,25974,-1,5.2036744e-06,0.9999883,6.446414e-06
28329,Transfer,0,1,0,8,Transfer of constitutively active IKK-transduced T cells also boosted endogenous T cell responses that controlled pre-established tumors.,26903482_7,-1,1,-1,1,28329,-1,5.306104e-06,0.99999094,3.776014e-06
32275,timescales,3,4,22,32,"Given these divergent timescales, we addressed how cytokine-responsive cells translate brief cytokine exposure into phenotypic changes that persist over long timescales.",28575659_2,-1,1,-1,1,32275,-1,2.0069534e-05,0.9999708,9.085333e-06
27131,The,0,1,0,3,The percentages of the induced CD4(+)CD25(+) T cells were detected by flow cytometry.,26347149_6,-1,1,-1,1,27131,-1,4.7719873e-06,0.9999912,3.990093e-06
4075,Tregs,5,6,23,28,"To examine the role of Tregs in blocking immune-mediated rejection of tumor, we depleted CD4+CD25+ T cells with an IL-2 immunotoxin.",16785502_4,-1,1,-1,1,4075,-1,4.9077207e-06,0.99999046,4.6385053e-06
21319,signal transducer and activator of transcription 5,5,12,36,86,"We evaluated the phosphorylation of signal transducer and activator of transcription 5 (STAT5) in CD4(+) T cells, CD8(+) T cells, and TCR T cells in response to stimulation with IL-7 or IL-2 after HSCT by analyzing blood samples taken monthly 1 to 6 months after HSCT.",24140122_1,-1,1,-1,1,21319,-1,9.613413e-06,0.99998164,8.791328e-06
22145,the,3,4,13,16,"In addition, the role of TNF- in the defect in Tconv cells from MG patients was further confirmed by functional studies.",24405842_10,-1,1,-1,1,22145,-1,4.579446e-06,0.9999918,3.6603926e-06
28549,FOXP3,11,12,49,54,CD4(+) T cells that express the forkhead box P3 (FOXP3) transcription factor function as regulatory T (Treg) cells and hinder effective immune responses against cancer cells.,27111280_0,-1,1,-1,1,28549,-1,5.237301e-06,0.9999895,5.202361e-06
8160,The,0,1,0,3,"The number of cells in all populations with the luminal CSC phenotype [epithelial specific antigen(+) (ESA) CD44(hi) CD24(lo), CD44(hi) CD133(+), and CD133(+) CD24(lo)] increased in drug-resistant MCF7 and SK-OV-3 cells.",19048252_2,-1,1,-1,1,8160,-1,3.803181e-06,0.9999912,5.067348e-06
19695,that,15,16,102,106,These findings indicate a clinically relevant T(reg) cell-intrinsic defect in immune regulation in MG that may reveal a novel therapeutic target.,23252899_5,-1,1,-1,1,19695,-1,4.2137062e-06,0.9999912,4.5683373e-06
17380,Tregs,9,10,66,71,"These observations provide strong evidence that endogenous CD4(+) Tregs have a negative impact on cancer therapy, and suggest that strategies reducing Treg levels may provide clinical benefit to cancer patients.",22555974_5,-1,1,-1,1,17380,-1,4.9491086e-06,0.9999902,4.821671e-06
16717,T(regs,6,7,43,49,"CD4(+)CD25(hi)Foxp3(+) regulatory T cells (T(regs)) are critical mediators of self-tolerance, which is crucial for the prevention of autoimmune disease, but T(regs) can also inhibit antitumor immunity.",22375050_0,-1,1,-1,1,16717,-1,4.8828156e-06,0.99998784,7.2301104e-06
12683,TILs,1,2,3,7,"In TILs from patients with early disease (n = 27), the frequency of Th17 cells was significantly higher than that in the normal gastric mucosa (23.7  8.9 vs 4.5  3.1%).",20550524_4,-1,1,-1,1,12683,-1,4.0978352e-06,0.99999094,4.931388e-06
33943,Tregs,15,16,90,95,"More specifically, CD206- M1 macrophages and NKG2D+ NK cells increased in number, whereas Tregs, suppressive CD103+ DCs, and M2 macrophages decreased, suggesting that ""iIL18 TRUCKs"" can be used to sensitize large solid tumor lesions for successful immune destruction.",29241547_6,-1,1,-1,1,33943,-1,4.083882e-06,0.9999913,4.6035534e-06
36751,the,26,27,160,163,"CONCLUSIONS: This work directly links circulating IL-6 with other poor prognostic indicators, STAT1 and PD-1, and highlights the effects of circulating IL-6 on the immune system.",31027698_8,-1,1,-1,1,36751,-1,7.709018e-06,0.99998784,4.449256e-06
577,traits,24,25,160,166,"Kaposi's sarcoma (KS) is an angioproliferative disease occurring in several different clinical-epidemiological forms that, however, share the same histological traits and are all associated with infection by the human herpesvirus 8 (HHV8).",11423257_0,-1,1,-1,1,577,-1,1.7751394e-05,0.9999527,2.9555104e-05
26685,tumors,15,16,98,104,Recent studies show that CD8(+) Treg cells might impede effective immune responses to established tumors.,26166762_1,-1,1,-1,1,26685,-1,3.921702e-06,0.99999166,4.3886143e-06
2067,type,9,10,38,42,"In some cases, the presence of T(reg) type 1/Th3-like lymphocytes could also be demonstrated.",15240741_5,-1,1,-1,1,2067,-1,5.0059607e-06,0.9999881,6.935588e-06
20942,tumors,16,17,112,118,Signals from the T-cell recognition of antigen program effector functions are necessary to clear infections and tumors.,23963642_0,-1,1,-1,1,20942,-1,4.6501887e-06,0.99999034,4.949189e-06
24567,the,71,72,446,449,"Although several studies assessing the potential prognostic value of InfBMs in cancer have been published in the past decades, they have had no impact on the management of patients with urothelial bladder carcinoma (UBC).OBJECTIVE: To review and summarise the scientific literature on the prognostic value of tumour, serum, urine, and germline DNA InfBMs on UBC.EVIDENCE ACQUISITION: A systematic review of the literature was performed searching the Medline and Embase databases for original articles published between January 1975 and November 2013.",25151017_2,-1,1,-1,1,24567,-1,6.6521657e-06,0.999987,6.30633e-06
15438,complex,6,7,43,50,Their development and maturation involve a complex variety of interactions with nonlymphoid cell products and receptors.,21740230_1,-1,1,-1,1,15438,-1,2.2383476e-05,0.999962,1.5583772e-05
30350,that,2,3,10,14,We report that HDIL-2 increased both frequencies and absolute numbers of Th17 cells on day 4 of treatment.,27741090_5,-1,1,-1,1,30350,-1,5.492418e-06,0.99999106,3.4836237e-06
30939,the,9,10,62,65,The second approach in autoimmunity is to selectively enhance the production of TGF- by Tregs at sites of chronic inflammation.,28001437_7,-1,1,-1,1,30939,-1,4.4934436e-06,0.99999225,3.303099e-06
30568,STAT3,23,24,155,160,Reversal of laricitrin on lung cancer-induced DCs' paralysis was via inhibiting the phosphorylation of signal transducer and activator of transcription 3 (STAT3).,27833081_6,-1,1,-1,1,30568,-1,5.537194e-06,0.9999888,5.633996e-06
5942,the,3,4,18,21,The inhibition of the VZV replication with a drug interfering with its DNA replication had no effect on the IL-8 release.,17909856_2,-1,1,-1,1,5942,-1,4.8529055e-06,0.99998987,5.2282458e-06
2879,LPS,19,20,117,120,"In this study we examined the signal mechanisms for inducting these 2 chemokines in RT4 cells by lipopolysaccharide (LPS), IFN-gamma and TNF-alpha.",16094077_1,-1,1,-1,1,2879,-1,0.00030608315,0.9995596,0.00013431071
21234,Tregs,12,13,77,82,It has been reported that dense intratumoral infiltration of Foxp3 (+)Tregs (Tregs) was an independent factor for poor prognosis of breast cancer (BC) patients.,24124553_0,-1,1,-1,1,21234,-1,5.28644e-06,0.999987,7.710174e-06
43480,Jun,3,4,20,23,"IL-1 enhancement of Jun B protein levels is not the result of a change in the turnover rate of the Jun B protein, but rather results from the maintenance of sufficient jun B mRNA to support continued accumulation of newly synthesized protein.",7675040_5,-1,1,-1,1,43480,-1,1.1536765e-05,0.99997675,1.1699661e-05
7235,Treg,7,8,43,47,Down-regulation of CD4+CD25+ regulatory T (Treg) cell function might be beneficial to enhance the immunogenicity of viral and tumor vaccines or to induce breakdown of immunotolerance.,18566377_0,-1,1,-1,1,7235,-1,5.4299944e-06,0.9999875,7.144253e-06
35023,to,24,25,180,182,Significance: This study characterizes two different poly-I:C-induced signaling pathways in their induction of immunostimulatory and suppressive factors and suggests improved ways to reprogram the TME to enhance the antitumor efficacy of immunotherapies.,29853604_6,-1,1,-1,1,35023,-1,4.4962626e-06,0.9999918,3.7417506e-06
6158,their,14,15,104,109,Rapamycin inhibited mTORC1 signaling and suppressed CTCL cell proliferation but showed little effect on their apoptotic rate when used as a single agent.,18025151_5,-1,1,-1,1,6158,-1,6.376946e-06,0.99998736,6.279482e-06
35987,this,3,4,11,15,The aim of this study was to identify the role of the two major Treg-attracting chemokines CCL1 and CCL22 in human breast cancer.,30572845_2,-1,1,-1,1,35987,-1,4.2671877e-06,0.9999913,4.4870803e-06
41137,genes,2,3,23,28,Various immune-related genes have been suggested as significant roles in the development and progression of malignant cancers.,33220636_1,-1,1,-1,1,41137,-1,5.6518315e-06,0.9999871,7.238136e-06
10159,this,9,10,55,59,More needs to be learned about mechanisms that control this process.,19567680_1,-1,1,-1,1,10159,-1,6.7892647e-06,0.9999881,5.1561124e-06
19420,Tregs,6,7,42,47,CD4(+)CD25(+)Foxp3(+) T regulatory cells (Tregs) and CD1d-restricted invariant natural killer T (iNKT) cells are two cell types that are known to regulate immune reactions.,23182710_0,-1,1,-1,1,19420,-1,3.8710577e-06,0.99999046,5.6890394e-06
12344,to,18,19,123,125,INTRODUCTION: Cysts and granulomas are chronic periapical lesions mediated by a set of inflammatory mediators that develop to contain a periapical infection.,20478453_0,-1,1,-1,1,12344,-1,8.0109385e-06,0.9999832,8.8441175e-06
32821,tumor,8,9,45,50,"In a cHL xenograft model, SEL24-B489 delayed tumor growth by 95.8% (P = .0002).",28698206_7,-1,1,-1,1,32821,-1,4.8434886e-06,0.9999901,5.0517137e-06
32307,the,6,7,27,30,"Here, we sought to explore the expression and immunotherapeutic value of A2AR blockade in HNSCC.METHODS: The expression of A2AR was evaluated by immunostaining in 43 normal mucosae, 48 dysplasia and 165 primary HNSCC tissues.",28592285_3,-1,1,-1,1,32307,-1,3.6150234e-06,0.99999285,3.5957207e-06
42988,the,24,25,163,166,CONCLUSIONS: These results suggest that anti-oestrogen treatment of ER+ breast cancer cells can alter cytokine production and immune cells in the area surrounding the cancer cells.,34602068_11,-1,1,-1,1,42988,-1,4.321499e-06,0.99999,5.7200186e-06
43529,transfected,10,11,39,50,"Furthermore, a T cell line (H9) stably transfected with a HIV tat expression-vector secreted higher levels of IL-10.",8037735_4,-1,1,-1,1,43529,-1,4.1194785e-06,0.9999896,6.216461e-06
42991,the,6,7,41,44,These findings may have implications for the combination and timing of anti-oestrogen therapies with other therapies.,34602068_12,-1,1,-1,1,42991,-1,4.9029136e-06,0.9999918,3.292907e-06
24664,the,8,9,56,59,"This process also changed CTLA-4 molecule expression on the surfaces of CD4(+)CD25(+)Treg cells and reduced their inhibitory function against CD4(+)CD25(-)T cell proliferation, and the suppression function of CD4(+)CD25(+)Treg cells was further weakened with the introduction of the CTLA-4 inhibitor.",25168696_8,-1,1,-1,1,24664,-1,5.326868e-06,0.9999894,5.3044814e-06
12631,treatment,5,6,36,45,"To investigate immune correlates of treatment failure, patients were grouped according to median lesion size at study entry, and HPV16-specific immunity was analyzed at different time points by complementary immunological assays.",20547850_2,-1,1,-1,1,12631,-1,6.7760957e-06,0.99998724,5.9534123e-06
43790,the,19,20,118,121,"Finally, gamma IFN and HLA-DR expression correlate with the presence of HHV-8 in lesional and uninvolved tissues from the same patients.",9446657_12,-1,1,-1,1,43790,-1,4.9846417e-06,0.99998975,5.2441246e-06
27474,related,8,9,58,65,This study therefore investigated the functional role and related mechanism of Treg cells in BCL.,26464657_3,-1,1,-1,1,27474,-1,9.296714e-06,0.9999821,8.613937e-06
12202,Thus,0,1,0,4,"Thus, potent pleiotropic immune functions of SA-4-1BBL combined with its ability to serve as a vehicle to increase the delivery of antigens to DCs in vivo endow this molecule with the potential to serve as an effective immunomodulatory component of therapeutic vaccines against cancer and chronic infections.",20406989_7,-1,1,-1,1,12202,-1,4.0344744e-06,0.9999912,4.7294175e-06
27784,tumors,20,21,114,120,OBJECTIVES: T regulatory cells (Tregs) play a critical important role for the occurrence and development of human tumors.,26724144_0,-1,1,-1,1,27784,-1,4.48592e-06,0.99999106,4.4589974e-06
3482,genes,5,6,34,39,"STAT5 regulates the expression of genes, which determine important cellular phenotypes.",16375697_2,-1,1,-1,1,3482,-1,5.4568873e-06,0.9999869,7.703514e-06
41056,TGF,13,14,55,59,"METHODS: The levels of Treg cells and IL-2, IL-10, and TGF in the blood of patients with liver cancer were detected by flow cytometry and ELISA, respectively.",33204731_1,-1,1,-1,1,41056,-1,2.6553398e-05,0.99995637,1.702131e-05
11062,type,20,21,144,148,"T cells were functionally characterized by antigen-dependent secretion of interferon (IFN)-gamma, interleukin (Il)-4, and IL-10, which indicate type 1, type 2, or regulatory T-cell responses, respectively.",19931255_3,-1,1,-1,1,11062,-1,6.7437977e-06,0.9999845,8.7666385e-06
18058,the,28,29,169,172,"Together, our findings support the concept that natural CXCR3(+) T-bet(+) Treg selectively accumulate in ovarian tumors to control type I T-cell responses, resulting in the collateral limitation of efficient antitumor immunity.",22798340_8,-1,1,-1,1,18058,-1,5.6940617e-06,0.9999907,3.5540793e-06
1396,triggering,22,23,151,161,Our goal was to convert murine RM-9 prostate carcinoma cells in vivo into antigen-presenting cells capable of presenting endogenous tumor antigens and triggering a potent T-helper cell-mediated immune response essential for the generation of a specific antitumor response.,12804139_0,-1,1,-1,1,1396,-1,8.412491e-06,0.99998283,8.805157e-06
32706,the,3,4,23,26,"Our study investigates the effects of tolerogenic GC-treated DCs on NK and T cell anti-tumor responses in OT-1/Rag-/- mice, expressing a transgenic TCR in CD8+ T cells.",28675711_1,-1,1,-1,1,32706,-1,3.5652213e-06,0.9999927,3.6725678e-06
1566,The,0,1,0,3,The identification of cancer antigens has been of critical importance and cancer vaccine is at present a very fast moving field.,14609757_1,-1,1,-1,1,1566,-1,4.620393e-06,0.99999106,4.294012e-06
27452,to,27,28,154,156,"The ability of B16F10 melanoma cells to form metastatic colonies in the lungs of Gal-3(+/+) and Gal-3(-/-) mice remained comparable, whereas it was found to be reduced in Gal-3(+/-) mice.",26442663_10,-1,1,-1,1,27452,-1,3.978278e-06,0.9999918,4.1984217e-06
16495,to,5,6,26,28,"METHODS: This study aimed to characterise the frequency of T regulatory cells (Tregs), dendritic cells (DCs) as well as sub-populations of T cells bearing regulatory properties like CD4(+)GITR(+), CD4(+)CD62L(+), CD3(+)TCR(+) along with the concentrations of IL-10, TGF, IL-6 in 66 patients with MM.",22223085_1,-1,1,-1,1,16495,-1,3.5920036e-06,0.9999924,4.0421046e-06
29591,thus,15,16,107,111,"IL-17 deficiency enhanced MPE formation by promoting angiogenesis and proliferation of pleural tumors, and thus accelerated the death of mice bearing MPE.",27535421_5,-1,1,-1,1,29591,-1,5.8134774e-06,0.99998903,5.155935e-06
678,to,15,16,95,97,"In this study, we investigated functional consequences and molecular events in T cells exposed to low levels of oxidative stress.",11509600_2,-1,1,-1,1,678,-1,6.8770305e-06,0.9999883,4.77736e-06
1170,to,15,16,98,100,"CnA beta(-/-) mice also were permissive to allogeneic tumor-cell transplantation in vivo, similar to cyclosporin-treated wild-type mice.",12091710_6,-1,1,-1,1,1170,-1,4.52846e-06,0.9999918,3.7355824e-06
30472,the,15,16,95,98,An imperative demand is present for a better understanding of the functions and regulations of the immune system and how they affect HCC pathogenesis.,27797409_1,-1,1,-1,1,30472,-1,6.7059214e-06,0.9999883,4.9203827e-06
3823,the,2,3,12,15,We examined the effects of IL-2 signaling in human Tregs.,16645171_1,-1,1,-1,1,3823,-1,4.180891e-06,0.99999213,3.7337672e-06
33112,TIM-1,0,1,0,5,TIM-1+ B cells enhanced the growth of B16-F10 melanoma.,28848066_5,-1,1,-1,1,33112,-1,1.0911948e-05,0.99996305,2.6034122e-05
15647,these,22,23,133,138,"Interaction between Foxp3, p-NFATc3 and p-Smad2/3, needed for successful Treg function, is also inhibited by NLGP.CONCLUSION: All of these coordinated events might result in inhibition of Treg associated-tumor growth and therefore increased survivability of mice having NLGP treatment before or/and after tumor inoculation.",21843083_9,-1,1,-1,1,15647,-1,7.1229206e-06,0.9999877,5.133511e-06
31097,the,15,16,112,115,"These data support the therapeutic potential of bortezomib in conjunction with other immunotherapies to augment the strength of convergent signals from CD8+T-cell signaling molecules including TCR, cytokine receptors and downstream PI3K/Akt/STAT5 pathways to sustain CD8+T-cell effector function in the tumor microenvironment.",28052005_9,-1,1,-1,1,31097,-1,3.981155e-06,0.9999927,3.3282515e-06
41011,that,11,12,74,78,"Myasthenia gravis (MG) is a prototypic organ-specific autoimmune disorder that, in most cases, is mainly mediated by antibodies against the acetylcholine receptor.",33136553_0,-1,1,-1,1,41011,-1,6.919007e-06,0.99998724,5.878158e-06
23536,that,13,14,81,85,Our data provide new insight into the regulation of T-bet expression and suggest that ICOS can be targeted to improve Th1 antitumor responses.,24778280_10,-1,1,-1,1,23536,-1,4.36331e-06,0.99999213,3.5568785e-06
15476,tetramers,48,49,318,327,"EXPERIMENTAL DESIGN: CD8(+) T cells isolated from tumor, adjacent normal skin, and peripheral blood of 17 HLA-A2(+) patients with advanced-stage melanoma were analyzed for their antigen specificity and effector function against melanocyte differentiation antigens MART-1, gp100, and tyrosinase by using HLA-A2/peptide tetramers and functional assays.",21750202_1,-1,1,-1,1,15476,-1,1.6804941e-05,0.99996734,1.582297e-05
3649,the,9,10,50,53,"The objective of the present study was to address the role of the immune system, tumour micro-environment and potential immunosuppression in mesothelioma.",16540497_1,-1,1,-1,1,3649,-1,4.4137905e-06,0.9999919,3.665514e-06
42852,the,14,15,115,118,"Altogether, these results evidence a mechanistic overlapping between autoimmunity and cancer immunosurveillance in the biliary tract.",34495298_8,-1,1,-1,1,42852,-1,5.054319e-06,0.9999907,4.244453e-06
40597,genetically,8,9,45,56,"Our results suggest that the EVs secreted by genetically modified tumor cells harboring TNFSF ligands can induce T cell proliferation, inhibit the transcription factor FoxP3, associated with the maintenance of Treg phenotype, and enhance antitumor activity mediated by immune cells.",32939048_5,-1,1,-1,1,40597,-1,4.1886983e-06,0.9999914,4.3408027e-06
23011,The,0,1,0,3,The objectives of this study were to evaluate the in vivo antitumor potential of the peptide fraction from Musca domestica larvae (MDPF) and to elucidate its immunological mechanisms.,24690776_3,-1,1,-1,1,23011,-1,4.1980525e-06,0.9999914,4.4035214e-06
20726,Therefore,0,1,0,9,"Therefore, the increased percentage of the Foxp3+ Tregs and the upregulation of Foxp3 expression on CCR6+ Tregs in LSCC patients may have accounted for the downregulation of antitumor immunity in these patients, which could be valuable for assessment of prognosis in LSCC treatment.",23835793_7,-1,1,-1,1,20726,-1,5.090176e-06,0.99999034,4.613433e-06
13639,Foxp3(+,17,18,108,115,We investigated the migration of PBMCs to these tumor cells using Transwell plates and showed enrichment of Foxp3(+) CD4 regulatory T cells (Tregs) in migrated T cells to both IL-6- and IL-8-producing tumors.,21048114_1,-1,1,-1,1,13639,-1,2.3711953e-05,0.9999571,1.9178988e-05
35740,the,47,48,274,277,"Interestingly, in the absence of autologous lymphomas, the granzyme B and perforin expression levels in CD8+ T cells from patients with MYD88 WT lymphomas and from patients with MYD88 L265P mutant lymphomas were comparable; however, in the presence of autologous lymphomas, the CD8+ T cells from patients with MYD88 L265P mutant lymphomas presented significantly lower granzyme B and perforin expression than CD8+ T cells from patients with MYD88 WT lymphomas.",30253331_4,-1,1,-1,1,35740,-1,4.4457556e-06,0.99999034,5.209072e-06
28760,the,1,2,7,10,"Within the lesions, all of the early papillomavirus genes are expressed and promote the excessive replication of fibroblasts which characterise these tumours.",27160146_1,-1,1,-1,1,28760,-1,3.6183972e-06,0.99999106,5.3551726e-06
7716,that,5,6,20,24,"In summary, we find that SCCs evade the immune response at least in part by down-regulating vascular E-selectin and recruiting T reg cells.",18794336_8,-1,1,-1,1,7716,-1,4.3018185e-06,0.99999166,4.046669e-06
9818,the,22,23,133,136,"Although T central memory cells have been described as the most effective T-cell subtype against tumor growth, little is known about the requirements needed for their optimal ex vivo generation.",19501956_0,-1,1,-1,1,9818,-1,7.474997e-06,0.9999882,4.3247155e-06
17544,STAT3,3,4,14,19,"Both IL-6 and STAT3 have recently emerged as main regulators of the differentiation and function of Th17 cells, via a positive feedback loop enhancing expression and/or activation of IL-6 itself, IL-17 and STAT3.",22652781_4,-1,1,-1,1,17544,-1,5.979211e-06,0.99998736,6.6505886e-06
28105,the,3,4,28,31,HPV-related cancers express the viral oncoproteins E6 and E7.,26851223_1,-1,1,-1,1,28105,-1,4.4586927e-06,0.9999913,4.1896287e-06
18181,this,2,3,11,15,"To address this question, circulating CD14(+)HLA-DR(low/neg) cells were studied retrospectively in 51 allo-HSCT patients.",22828446_3,-1,1,-1,1,18181,-1,7.887999e-06,0.9999875,4.589666e-06
188,the,25,26,137,140,"By contrast, no specific mCTLp activity was detected in 11 HPV-negative patients or in 7 patients who had cleared an HPV 16 infection at the end of follow-up.",10962445_4,-1,1,-1,1,188,-1,4.910395e-06,0.99998975,5.3270633e-06
42026,this,1,2,3,7,"In this study, we investigate whether DNA damage repair is modulated through purinergic signaling in cSCC.",33848530_3,-1,1,-1,1,42026,-1,4.456024e-06,0.99999154,3.967089e-06
19635,the,19,20,112,115,Sixty patients with pleural effusion (26 tuberculous and 34 malignant) and 20 healthy controls were included in the study.,23252864_3,-1,1,-1,1,19635,-1,4.86135e-06,0.99998987,5.3156964e-06
35911,TGF-,7,8,38,43,"CONCLUSIONS: The combination of CD25, TGF- and PD-1 blockade plays a potentially effective role in inhibiting tumor formation and progression.",30359281_14,-1,1,-1,1,35911,-1,1.4301614e-05,0.999977,8.709281e-06
14152,their,15,16,97,102,"The crucial role of mature T- and/or B-lymphocytes in the advancing pathology is demonstrated by their elimination, which precludes mast cell infiltration and limits the pathology to an early, benign stage.",21291541_9,-1,1,-1,1,14152,-1,7.4664063e-06,0.9999856,7.008617e-06
8677,the,3,4,15,18,"In conclusion, the hallmark of our panel of activated human Treg clones is to produce bioactive TGF-beta which has autocrine actions on Tregs and can have paracrine actions on other T cells.",19224638_8,-1,1,-1,1,8677,-1,4.1679555e-06,0.9999918,4.0487766e-06
26868,This,0,1,0,4,This maneuver also abolished the improved chemotherapeutic response of Stat3(-/-) cancers.,26208907_7,-1,1,-1,1,26868,-1,5.836918e-06,0.99999046,3.6877034e-06
7308,tolerance,21,22,136,145,"Although mature dendritic cells (DCs) are potent initiators of adaptive immune response, immature steady-state DCs contribute to immune tolerance.",18599457_0,-1,1,-1,1,7308,-1,7.697934e-06,0.999987,5.242855e-06
17618,The,0,1,0,3,The mechanisms for the induction and regulation of immunosuppression in humans are ill defined.,22678911_1,-1,1,-1,1,17618,-1,5.7242373e-06,0.99999,4.2953175e-06
13605,the,20,21,142,145,The present study was designed to test whether a replication-defective adenovirus vaccine expressing HBx antigen could be effectively used in the immunotherapy of hepatocellular carcinoma.,21042781_1,-1,1,-1,1,13605,-1,4.3731593e-06,0.9999924,3.2814853e-06
344,tumors,7,8,48,54,This hypothesis was tested by implanting P1.HTR tumors into mice deficient in Stat6.,11086033_4,-1,1,-1,1,344,-1,4.016518e-06,0.9999918,4.2510037e-06
7537,than,16,17,105,109,"The likely explanation for this was the NS3/4A-mediated cleavage of mouse IPS-1, albeit less efficiently than human IPS-1.",18689426_9,-1,1,-1,1,7537,-1,8.955795e-06,0.999985,6.033033e-06
11800,the,12,13,70,73,"Importantly, stimulation of the TIL and TDLNC with cognate antigen in the presence of commonly used Toll-like receptor ligands significantly enhanced the effector T-cell function.",20233872_6,-1,1,-1,1,11800,-1,5.828447e-06,0.9999896,4.5537327e-06
8832,these,38,39,250,255,"Remarkably, analysis of EOC-associated conventional CD4CD25 T cell and Treg populations isolated ex vivo from tumor samples by cell sorting and cultured with tumor-associated CD3- cells in the presence of IL-2 revealed that EOC Treg stimulated under these conditions were rapidly converted into TH17 cells, down-regulated FOXP3 expression, and lost their suppressive capacity.",19238008_5,-1,1,-1,1,8832,-1,4.9732325e-06,0.99999094,4.0630075e-06
35451,the,3,4,17,20,"Thus, increasing the knowledge of tumour-associated immunological processes is important.",30075815_4,-1,1,-1,1,35451,-1,7.123756e-06,0.9999877,5.1832358e-06
23114,Tr-cells,14,15,87,95,"In addition, we demonstrate that IL-6 down-regulates Foxp3-expression of CD4+25+Foxp3+ Tr-cells in vitro.",24690994_6,-1,1,-1,1,23114,-1,0.0016046566,0.36023277,0.6381626
2884,transcriptase-polymerase,10,11,69,93,The expression of toll-like receptor (TLR)-4 was analyzed by reverse transcriptase-polymerase chain reaction and flow cytometry.,16094077_4,-1,1,-1,1,2884,-1,1.6273272e-05,0.9999696,1.4164362e-05
10751,Cebpa,2,3,16,21,Transduction of Cebpa in regular CD4(+) T cells inhibited the TCR-mediated proliferation with c-Myc and cyclin D1 repression and caused a striking activation of Spp1 encoding osteopontin along with concomitant repression of T cell lymphokine genes.,19805226_4,-1,1,-1,1,10751,-1,8.624553e-05,0.99953115,0.00038267515
38268,Foxp3,15,16,104,109,Significant differences were observed in the expression of Treg-associated molecules between CD4+ CD25+ Foxp3+ TILs and CD4+ CD25+ Foxp3- TILs.,31811667_5,-1,1,-1,1,38268,-1,9.535401e-06,0.9999827,7.731213e-06
18980,to,17,18,119,121,"Overall, these findings demonstrate that transient depletion of Foxp3(+) Tregs constitutes a highly effective strategy to improve the therapeutic efficacy of anticancer vaccination with NKT cell adjuvants.",23090488_5,-1,1,-1,1,18980,-1,3.8504245e-06,0.9999924,3.766e-06
30663,transwell,5,6,42,51,Chemotactic migration was evaluated using transwell assays.,27887569_6,-1,1,-1,1,30663,-1,1.59645e-05,0.9999753,8.67485e-06
2663,their,19,20,133,138,"These cells were anergic toward T-cell receptor stimulation and, when cocultured with activated CD4+CD25- cells, potently suppressed their proliferation and cytokine secretion.",15781662_9,-1,1,-1,1,2663,-1,5.398789e-06,0.99998915,5.419016e-06
29750,their,16,17,126,131,Tumor-associated fibroblasts (TAFs) attracted monocytes by the stromal cell-derived factor (SDF)-1a/CXCR4 pathway and induced their differentiation into MDSCs through interleukin (IL)-6-mediated STAT3 activation.,27593937_5,-1,1,-1,1,29750,-1,6.9977273e-06,0.99998415,8.805102e-06
29276,the,4,5,36,39,Distinct metabolic programs support the differentiation of CD4(+) Tcells into separate functional subsets.,27317260_0,-1,1,-1,1,29276,-1,6.1933456e-06,0.9999902,3.6154279e-06
16325,TILs,16,17,108,112,RESULTS: We observed an increased prevalence of Tcregs and Tc17 cells among tumor-infiltrating lymphocytes (TILs) and different distribution among peripheral blood mononuclear cells (PBMCs) in NPC patients.,22051182_7,-1,1,-1,1,16325,-1,6.387715e-06,0.9999857,7.9163665e-06
3303,the,4,5,17,20,"Here, we studied the impact of IL-2 administration on the frequency and function of human CD4+ CD25(hi) T cells in immune intact patients with melanoma or renal cancer.",16304057_3,-1,1,-1,1,3303,-1,3.937652e-06,0.9999926,3.4920445e-06
40137,the,35,36,216,219,"When all three agents were used in combination, maximum antitumor effects were observed, which correlated with increases in T cells and T-cell clonality in the TME.CONCLUSION: These studies provide the rationale for the potential clinical use of combinations of agents that can (1) induce tumor-associated T-cell responses, (2) potentiate immune responses in the TME and (3) reduce immunosuppressive entities in the TME.",32554612_8,-1,1,-1,1,40137,-1,4.3081113e-06,0.9999924,3.2687356e-06
1902,time,17,18,102,106,Ten of the patients showed at least a 3-fold increase in TA-CIN-specific proliferation at one or more time points after vaccination.,15131030_3,-1,1,-1,1,1902,-1,9.935949e-06,0.99997973,1.0378977e-05
20030,The,0,1,0,3,The absence of DNAM-1 on the donor graft attenuated GVHD in major histocompatibility complex (MHC)-mismatched and MHC-matched BMT following conditioning with lethal and sublethal irradiation.,23430112_3,-1,1,-1,1,20030,-1,4.3858613e-06,0.99999166,3.977094e-06
10835,the,27,28,180,183,Significantly higher numbers of Treg were found in skin tumors and metastatic lymph nodes at early stages of melanoma progression compared with more advanced stages accompanied by the elevated CCR4 expression on Treg and higher production of its ligand CCL2 in tumor lesions.,19841169_3,-1,1,-1,1,10835,-1,3.7373838e-06,0.9999924,3.8396297e-06
43341,TFEB,9,10,50,54,"Here, we identified that transcription factor EB (TFEB) is induced by host nutrition deprivation or interleukin (IL)-2 in CD4+ T cells.",35895684_2,-1,1,-1,1,43341,-1,8.5907095e-06,0.99998665,4.7816325e-06
26650,the,3,4,20,23,"The peptide induced the upregulation of both IL-6 and Ccl2 in peritoneal macrophages obtained from wild-type mice, but not TLR4-deficient mice.",26165843_6,-1,1,-1,1,26650,-1,4.5165057e-06,0.999992,3.5104138e-06
34575,Tr1,6,7,25,28,The type 1 regulatory T (Tr1) cells have recently emerged as a critical participant in maintaining self-tolerance.,29625086_2,-1,1,-1,1,34575,-1,6.4270453e-06,0.9999757,1.790368e-05
36487,the,6,7,51,54,The possibility of pharmacological intervention in the self-control of the immunological system is now under extensive investigation in many human cancers.,30944830_6,-1,1,-1,1,36487,-1,5.1398924e-06,0.9999912,3.6233803e-06
13365,to,2,3,12,14,"In response to autologous tumor plus IL-2/IL-15, the CD8(+) FOXP3(+) T cells proliferated promptly and showed competence for differentiation (downregulation of CD27 and upregulation of T-bet).",20861189_8,-1,1,-1,1,13365,-1,7.1591307e-06,0.9999887,4.158849e-06
26566,the,16,17,103,106,"MUTYH DNA glycosylase removes mismatched adenine opposite 7, 8-dihydro-8-oxoguanine (8-oxoG), which is the major mutagenic lesion induced by oxidative stress.",26109431_0,-1,1,-1,1,26566,-1,7.554118e-06,0.9999869,5.5783767e-06
2823,the,7,8,39,42,"In this study, we further investigated the in vitro effect of IL-27 on CD8+ T cells of mouse spleen cells.",16034109_2,-1,1,-1,1,2823,-1,4.2200722e-06,0.99999213,3.6029712e-06
31840,the,13,14,70,73,"IL-1 stimulated  T cells to produce IL-17, which in turn increased the production of G-CSF.",28432279_6,-1,1,-1,1,31840,-1,6.597361e-06,0.9999893,4.0757454e-06
23277,The,0,1,0,3,The altered ratio between Foxp3(+) Tregs and Th17 cells plays an important role in the pathogenesis of immune-related diseases.,24744433_2,-1,1,-1,1,23277,-1,3.4276652e-06,0.9999926,4.0186824e-06
22742,to,14,15,87,89,We hypothesized that the proposed treatment schedule is feasible and safe and may lead to enhanced tumor response.,24598448_2,-1,1,-1,1,22742,-1,6.1983874e-06,0.9999895,4.2762445e-06
38522,the,14,15,103,106,Cell sorting of tumor-infiltrating lymphocytes based on the co-expression of CD39 and CD103 pinpointed the presence of neoantigen-specific T cells in the CD39+CD103+ T cell subset.,31888734_6,-1,1,-1,1,38522,-1,6.9734515e-06,0.9999881,4.9133287e-06
3393,that,22,23,128,132,"In contrast, CD1(-/-) mice, which are deficient for IL-13 because they lack IL-13-producting NKT cells, generate M1 macrophages that are cytotoxic for 4T1 via the production of nitric oxide.",16357187_3,-1,1,-1,1,3393,-1,7.2393104e-06,0.99998343,9.371e-06
7250,to,25,26,134,136,"In this study, we show that P17, a short synthetic peptide that inhibits TGF-beta1 and TGF-beta2 developed in our laboratory, is able to inhibit Treg activity in vitro and in vivo.",18566377_2,-1,1,-1,1,7250,-1,4.0010145e-06,0.9999925,3.4974398e-06
21637,the,12,13,75,78,Generation of functional dendritic cells (DCs) with boosted immunity after the withdrawal of initial activation/maturation conditions remains a significant challenge.,24296809_0,-1,1,-1,1,21637,-1,5.5657174e-06,0.99999034,4.0412406e-06
32664,The,0,1,0,3,"The immunomodulatory compound imiquimod (IQM) stimulates innate immune cells, including macrophages, to induce antitumor effects.",28668835_1,-1,1,-1,1,32664,-1,5.353293e-06,0.9999901,4.491609e-06
32606,that,14,15,97,101,"Furthermore, excellent antitumor immune responses can also be achieved using combinations of Abs that block CTLA4, PD1, OX40, and CD30 ligands, without CD4 T cell-driven autoimmunity.",28646041_3,-1,1,-1,1,32606,-1,6.6464986e-06,0.9999864,6.902603e-06
9060,the,9,10,43,46,"Dendritic cells (DC) are key components of the immune system, which actively participate in innate and adaptive immune responses.",19275918_0,-1,1,-1,1,9060,-1,5.1108254e-06,0.9999896,5.22091e-06
24710,tumors,5,6,23,29,"In this model, mammary tumors in the involution group are sixfold larger than nulliparous group tumors, have decreased CD4(+) and CD8(+) T cell infiltrates and contain a greater number of macrophages with the ability to inhibit T cell activation.",25187059_6,-1,1,-1,1,24710,-1,3.472905e-06,0.9999918,4.693233e-06
28715,to,36,37,261,263,"Furthermore, administration of GIFT4 protein promoted the expansion of human T cells in NOD-scid IL2R(null) immune deficient mice adoptively pre-transferred with peripheral blood mononuclear cells from subjects with CLL.CONCLUSION: GIFT4 has potent capability to converts primary CLL cells into APC-like immune helper cells that initiate a T cell driven anti-CLL immune response.",27118475_9,-1,1,-1,1,28715,-1,3.653626e-06,0.99999154,4.782887e-06
843,that,42,43,257,261,"IFN-gamma-inducible CIITA expression in MG cells, as well as primary human astrocytes, was directed by two CIITA promoters, pIV, the promoter for IFN-gamma-inducible CIITA expression in nonprofessional antigen-presenting cells (APC), and pIII, the promoter that directs constitutive CIITA expression in B cells.",11746775_4,-1,1,-1,1,843,-1,4.5989764e-06,0.9999913,4.0716745e-06
28135,the,15,16,107,110,"E6E7.p16 with Ad.PD1 could improve antitumor immunity against HPV-related tumors and that p16 may enhance the immunogenicity of DC, through cyclin-dependent pathways, Th1 cytokine secretion, and by adding a nonviral Ag highly overexpressed in HPV-induced cancers.",26851223_15,-1,1,-1,1,28135,-1,5.1122424e-06,0.99999034,4.51128e-06
1385,The,0,1,0,3,"The majority of the ramp mRNA was the transcript normally spliced between exons 14 and 15, but a minor population of mRNA with an extended exon 14 was also present in Meth A cells.",12707369_5,-1,1,-1,1,1385,-1,4.7726558e-06,0.9999883,6.9075822e-06
5408,the,17,18,95,98,The defect in IFN signaling in the melanoma patient group as a whole was partially overcome at the level of expression of IFN-stimulated genes by prolonged stimulation with the high concentration of IFN-alpha that is achievable only in IFN therapy used in melanoma.,17488182_7,-1,1,-1,1,5408,-1,4.6708346e-06,0.9999914,3.9122424e-06
34361,to,5,6,27,29,"A majority of cancers fail to respond to immunotherapy with antibodies targeting immune checkpoints, such as cytotoxic T-lymphocyte antigen-4 (CTLA-4) or programmed death-1 (PD-1)/PD-1 ligand (PD-L1).",29467463_0,-1,1,-1,1,34361,-1,5.9256645e-06,0.9999876,6.5039744e-06
3811,that,5,6,24,28,"Together, the data show that inhibition of Stat1 expression in the host enhances tumor-local IL-12 gene therapy for regressing tumors.",16618773_6,-1,1,-1,1,3811,-1,4.0558984e-06,0.9999925,3.452177e-06
6659,therapeutically,16,17,109,124,Immunohistochemical analysis indicated a reduction of CD31+ and VEGFR2+ microvessels in late metastases from therapeutically vaccinated mice.,18324400_8,-1,1,-1,1,6659,-1,5.799111e-06,0.9999906,3.6433196e-06
15153,tumor,23,24,130,135,These findings suggest expansion of CD8 Foxp3+ T cell population in response to rhIL-2 treatment may serve as an early marker for tumor responsiveness to immunotherapy in an immune competent model.,21638127_6,-1,1,-1,1,15153,-1,4.6986274e-06,0.9999913,4.004285e-06
15244,the,13,14,88,91,Regulatory T cells can affect antiviral immune response thus influencing the outcome of the disease.,21684822_1,-1,1,-1,1,15244,-1,5.1453153e-06,0.99999,4.880629e-06
3467,to,2,3,14,16,STAT5 belongs to a small family of transcription factors with dual functions.,16375697_0,-1,1,-1,1,3467,-1,4.915125e-06,0.9999902,4.8551065e-06
13873,Tregs,22,23,136,141,"METHODS: FOXP3+ T cells were classified into three subsets, namely CD45RO+FOXP3(low) nonregulatory T cells, CD45RO+FOXP3(high) effector Tregs, and CD45RO-FOXP3(low) nave Tregs, according to their expression levels of FOXP3 and CD45RO.",21198537_4,-1,1,-1,1,13873,-1,5.2790574e-06,0.9999895,5.186904e-06
4056,tumors,8,9,54,60,Studies in cancer patients have suggested that breast tumors recruit regulatory T cells (Tregs) into the tumor microenvironment.,16785502_0,-1,1,-1,1,4056,-1,3.6664546e-06,0.9999919,4.4412445e-06
15234,the,5,6,35,38,"CONCLUSION: Our study demonstrated the increased frequencies of CD4(+) CD25(+) FOXP3(+) Treg cells in NIP tumors, which might be influenced by CCL22.",21674673_6,-1,1,-1,1,15234,-1,4.218058e-06,0.9999925,3.3483905e-06
13779,treatment,33,34,204,213,"IL-10 and TGF- mRNA levels, regulatory T-cell (Treg) counts, and frequencies of IL-10/TGF- producing mononuclear cell subsets were determined in pB from 46 patients with mRCC before receiving sorafenib treatment.",21150720_3,-1,1,-1,1,13779,-1,7.152608e-06,0.999987,5.8720498e-06
2735,the,36,37,231,234,"STAT6-deficient, but not wild type BALB/c, mice generate nitric oxide producing macrophages because they lack the STAT6 transcription factor which is necessary for signaling through the type 2 IL-4Ralpha complex, and which induces the production of arginase instead of nitric oxide.",15877228_4,-1,1,-1,1,2735,-1,4.923077e-06,0.9999913,3.7979228e-06
2050,that,2,3,9,13,We found that CD4(+)CD25(high) T cells are overrepresented in metastatic lymph nodes (LNs) with a 2-fold increased frequency compared with both tumor-free LNs and autologous PBMCs.,15240741_2,-1,1,-1,1,2050,-1,4.380295e-06,0.99999213,3.4874167e-06
15459,This,0,1,0,4,This review examines the processes and pathways involved in the highly orchestrated development of T cell fate specification under physiological as well as pathological conditions.,21740230_5,-1,1,-1,1,15459,-1,5.2851005e-06,0.9999901,4.582693e-06
32698,Treg,13,14,111,115,"Furthermore, intratumoral administration of anti-CCL22 antibody inhibited B16F10 melanoma growth by decreasing Treg recruitment at the tumor site.",28668835_8,-1,1,-1,1,32698,-1,8.870934e-06,0.999982,9.163297e-06
13751,to,28,29,154,156,"In addition, in an aggressive mouse leukemia model (12B1), Th-1 lymphocytes act synergistically with a chaperone-rich cell lysate (CRCL) vaccine, leading to improved survival and long-lasting protection against leukemia.",21123824_3,-1,1,-1,1,13751,-1,4.5352854e-06,0.9999912,4.3246705e-06
12157,to,36,37,220,222,FoxP3 expression was significantly higher in HIV-infected cases than in controls with AIN3/cancer (P < 0.04).CONCLUSION: Depletion of CD1a(+) and CD3(+) cells and overexpression of FoxP3 in the anal mucosa appear likely to contribute to the risk of HPV-related anal cancer in HIV-infected patients.,20394639_7,-1,1,-1,1,12157,-1,4.705164e-06,0.99999106,4.1935573e-06
22776,T-regulatory,19,20,109,121,The vaccine was given alone or in sequence with an anti-CD25 antibody (PC61) and cyclophosphamide to deplete T-regulatory (Treg) cells.,24607504_3,-1,1,-1,1,22776,-1,9.8076656e-05,0.99884284,0.0010590572
31207,that,14,15,87,91,"The c-Rel transcription factor is a unique member of the nuclear factor (NF)-B family that has a role in curtailing the proliferation, differentiation, cytokine production, and overall activity of B- and T-cells.",28090796_0,-1,1,-1,1,31207,-1,4.5402626e-06,0.9999913,4.152813e-06
43855,the,3,4,21,24,"To determine whether the acquisition of antitumor function during ex vivo activation is associated with modifications in signal transduction capacity, the protein tyrosine kinases p56lck and p59fyn and proteins of the NF-kappaB family were analyzed in tumor-draining LN T cells.",9690455_3,-1,1,-1,1,43855,-1,4.017462e-06,0.99999213,3.878954e-06
32522,Tumors,0,1,0,6,Tumors also contain natural killer cells with reduced expression of lytic granzyme.,28620836_10,-1,1,-1,1,32522,-1,4.618717e-06,0.99999154,3.8586113e-06
3627,transfection,19,20,150,162,The results demonstrate that induced macrophages displayed a reduction of cytotoxicity and antigen-presenting function in comparison with control but transfection with Stat3 decoy ODNs enhanced cytotoxicity and antigen-presenting function of the macrophages.,16530087_4,-1,1,-1,1,3627,-1,3.9326756e-06,0.99999166,4.41608e-06
35518,to,17,18,104,106,"Thus, the aim of this study was to investigate the immunomodulatory activity of Notch signaling pathway to peripheral and lung-resident CD8+ T cells in patients with lung adenocarcinoma.",30086535_2,-1,1,-1,1,35518,-1,6.578206e-06,0.9999856,7.847101e-06
20029,this,6,7,29,33,We have analyzed the role of this pathway in GVHD and GVL.,23430112_2,-1,1,-1,1,20029,-1,4.4114345e-06,0.99999106,4.489061e-06
30317,tumors,11,12,90,96,Host CXCR2 inhibition by genetic ablation prevented neutrophil accumulation in pancreatic tumors and led to a T cell-dependent suppression of tumor growth.,27737879_6,-1,1,-1,1,30317,-1,4.295714e-06,0.9999907,4.9707937e-06
29263,TILeff,33,34,210,216,"In line with the greater proliferation activity and longer telomere lengths of NTeff populations, cells of nave origin exhibited significantly less amounts of T cell exhaustion markers than those of MTeff and TILeff, and moreover, acquired distinct expression patterns of memory-promoting transcription factors, T-bet and Eomes, induced in a rapid and sustainable manner.",27306834_2,-1,1,-1,1,29263,-1,4.9175585e-05,0.9999163,3.4476125e-05
38989,technology,21,22,114,124,"Here, we demonstrated that knocking out the endogenous TGF- receptor II (TGFBR2) in CAR T cells with CRISPR/Cas9 technology could reduce the induced Treg conversion and prevent the exhaustion of CAR T ce lls.",31999649_2,-1,1,-1,1,38989,-1,3.7464583e-06,0.99999225,4.0052855e-06
38944,tumor-associated-neutrophils,24,25,139,167,"METHODS: By digital microscopy analysis of a muscle-invasive BC (MIBC) cohort, we explored the density and clinical significance of CD66b+ tumor-associated-neutrophils (TAN) and CD3+ T cells.",31991796_2,-1,1,-1,1,38944,-1,0.0020602213,0.99719715,0.00074257003
18483,T,21,22,137,138,"This alternative pathway results from molecular compensation for Batf3 provided by the related AP1 factors Batf, which also functions in T and B cells, and Batf2 induced by cytokines in response to infection.",22992524_2,-1,1,-1,1,18483,-1,5.0499893e-06,0.9999844,1.05993895e-05
21794,the,24,25,159,162,"CONCLUSIONS: Our data demonstrated that intratumoral co-administration of SLC and anti-CD25 mAbs was an effective treatment for HCC, which was correlated with the altered tumor microenvironment and systemically optimized percentages of Tregs, CD8+ T cells and CD4+ T cells in peripheral immune organs.",24304581_14,-1,1,-1,1,21794,-1,3.909275e-06,0.9999918,4.315033e-06
6183,protein than,33,35,169,181,"In lymph nodes, Nrp1 identified a small regulatory CD4+ CD25(high) T-cell subpopulation (Nrp1+ Treg) that expressed higher levels of Forkhead box P3 (Foxp3) message and protein than Nrp1- Treg, and various molecular markers of activated Treg, i.e. CD45RO, human leucocyte antigen (HLA)-DR and glucocorticoid-induced tumour necrosis factor receptor (GITR).",18028372_1,-1,1,-1,1,6183,-1,5.1083016e-06,0.99998975,5.20073e-06
16122,These,0,1,0,5,"These observations indicate that IL-21 amplifies an inflammatory milieu that promotes CAC, and suggest that IL-21 blockade may be useful in reducing the risk of UC-associated colon cancer.",21987656_7,-1,1,-1,1,16122,-1,4.906167e-06,0.9999914,3.7363434e-06
20484,to,10,11,51,53,TSCC showed a higher proportion of Foxp3(+) T regs to CD8(+) T cells compared to SCC and a lower percentage of IFN- producing CD4(+) T cells.,23667456_5,-1,1,-1,1,20484,-1,5.1208767e-06,0.99998784,6.994804e-06
21909,they,22,23,124,128,"In addition, in one acute-type patient, HBZ-specific CD4 T cell responses were absent in complete remission before HCT, but they became detectable after allogeneic HCT.",24363428_3,-1,1,-1,1,21909,-1,6.691356e-06,0.9999864,6.871943e-06
37692,transfected,22,23,132,143,"Both baicalein and baicalin enhanced the cytotoxicity of T cells to eliminate tumor cells, which was abrogated after HCC cells were transfected with a PD-L1 overexpression plasmid or after T cells were pretreated with an anti-PD-1 blocking antibody.",31437792_4,-1,1,-1,1,37692,-1,5.1211564e-06,0.9999862,8.662294e-06
10067,Foxp3(+,32,33,224,231,"In contrast, although a small fraction of human peripheral blood and tumor infiltrating gammadelta T cells expressed Foxp3, similar culture condition with anti-TCRgammadelta plus TGF-beta failed to generate functional human Foxp3(+) gammadelta T cells.",19539651_8,-1,1,-1,1,10067,-1,5.2501415e-05,0.9999114,3.601528e-05
11542,Tehranolide,29,30,195,206,"In the present research we emphasized on the direct correlation between the tumor sizes, immune response; including cytokin network, T regulatory cells and Tehranolide intraperitoneally injected Tehranolide.",20138670_2,-1,1,-1,1,11542,-1,1.001823e-05,0.9999795,1.0428593e-05
27894,the,15,16,98,101,"Furthermore, we show that their combined effect on melanoma OS is substantially enhanced reaching the level of clinical applicability (HR, 1.92; 95% CI, 1.43-2.60; P = 2.38e-5).CONCLUSIONS: Our unique approach of interrogating lymphocyte-specific eQTLs reveals novel and biologically relevant immunomodulatory eQTL predictors of cutaneous melanoma prognosis that are independent of current histopathologic markers.",26733611_6,-1,1,-1,1,27894,-1,4.2359256e-06,0.9999919,3.8506505e-06
17452,that,5,6,33,37,"Collectively, these results show that in humans, a large proportion of CD4(+) memory T cells express intermediate levels of CD25, and this CD25(INT) FOXP3(-) subset is a functionally distinct memory population that is uniquely affected by IL-2.",22585674_5,-1,1,-1,1,17452,-1,3.7411749e-06,0.9999925,3.7663629e-06
37258,the,13,14,87,90,"Overall, the LSD1 inhibitors phenelzine and GSK2879552 are useful tools for dissecting the contribution of LSD1 demethylase activity and the nuclear LSD1-CoREST complex to switching macrophage polarization programs.",31249575_4,-1,1,-1,1,37258,-1,4.837357e-06,0.9999918,3.434075e-06
10808,that,6,7,37,41,"Taken together, these data indicated that anti-TGF-beta enhances efficacy of a prophylactic vaccine in normal individuals despite their not having the elevated TGF-beta levels found in patients with cancer and that the effect is not dependent on TGF-beta solely from CD4(+)CD25(+) T regulatory cells or the NKT cell-IL-13-IL-4R-STAT-6 immunoregulatory pathway.",19830696_7,-1,1,-1,1,10808,-1,3.854165e-06,0.9999925,3.640916e-06
23762,tumor,20,21,119,124,The biology of follicular lymphoma (FL) is largely dictated by the immune-effector and stromal cells that comprise its tumor microenvironment.,24836297_0,-1,1,-1,1,23762,-1,4.9489445e-06,0.99999046,4.622149e-06
26571,tract,21,22,135,140,Mutyh-/- mice were more sensitive than wild-type (WT) animals to AOM/DSS toxicity and accumulated DNA 8-oxoG in their gastrointestinal tract.,26109431_3,-1,1,-1,1,26571,-1,1.5335218e-05,0.9999218,6.288302e-05
5176,Thus,0,1,0,4,"Thus, after primary EBV infection, T cells may escape activation by NPC-LMP1.",17372611_4,-1,1,-1,1,5176,-1,7.3482806e-06,0.99998736,5.3077706e-06
18698,Tregs,18,19,128,133,"The changes in intracellular cAMP concentrations correlated with the upregulation of effector T cells and the downregulation of Tregs, indicating the close association of cAMP analogs and low-dose CY in the immune therapy of B-cell lymphoma.",23000689_7,-1,1,-1,1,18698,-1,4.5279103e-06,0.9999907,4.818208e-06
22290,the,7,8,44,47,IL-6 signaling is of central importance for the maintenance of chronic intestinal inflammation in inflammatory bowel diseases (IBD) such as Crohn's disease and ulcerative colitis.,24447345_0,-1,1,-1,1,22290,-1,5.213385e-06,0.99999106,3.708542e-06
23206,Then,0,1,0,4,"Then, A20 attenuation with siRNA in AML-DC enhanced the expression of several co-stimulatory molecules and proinflammatory cytokines.",24713261_4,-1,1,-1,1,23206,-1,5.5076234e-06,0.99999,4.4469534e-06
18142,genes,26,27,157,162,"By comparing the transcriptomes of primary and metastatic tumor cells in a mouse model of spontaneous bone metastasis, we found that a substantial number of genes suppressed in bone metastases are targets of the interferon regulatory factor Irf7.",22820642_1,-1,1,-1,1,18142,-1,7.9800675e-06,0.9999846,7.408323e-06
30714,The,0,1,0,3,"The molecular pathways impacted by cigarette smoking involve NFB, MAP kinases and histone modification.",27902485_6,-1,1,-1,1,30714,-1,4.708753e-06,0.99999154,3.7221391e-06
27719,the,5,6,25,28,"In addition, we explored the accumulation mechanisms of Tregs in EBVaGC by using EBV (+) gastric carcinoma cell lines SNU719 and GT39 as ex vivo models.",26673957_4,-1,1,-1,1,27719,-1,3.7411044e-06,0.9999927,3.5821595e-06
4608,to,19,20,120,122,Naturally arising CD4(+)CD25(+) regulatory T cells (Tregs) have the potential to suppress aberrant immune responses and to regulate peripheral T-cell homeostasis.,17084366_0,-1,1,-1,1,4608,-1,3.4542065e-06,0.9999918,4.7951007e-06
22206,treated,3,4,9,16,"Thus, we treated mouse 4T1 mammary carcinoma with 1D11, a neutralizing anti-TGF (1,2,3) antibody.",24416401_1,-1,1,-1,1,22206,-1,5.3805525e-06,0.9999881,6.496923e-06
14182,The,0,1,0,3,The surgically removed Eca tissue was collected.,21314287_4,-1,1,-1,1,14182,-1,4.812656e-06,0.9999907,4.4522058e-06
21472,to,5,6,36,38,"We describe the challenges inherent to unambiguously defining roles for Th9 cells using the available experimental animal models, and suggest new experimental models to address these concerns.",24215739_5,-1,1,-1,1,21472,-1,7.79879e-06,0.9999869,5.363337e-06
29976,the,6,7,40,43,"Taken together, our studies demonstrate the efficacy of HDACi in restoring anti-tumor responses to MCL through both cell-intrinsic and cell-extrinsic mechanisms and strongly implicate a role for HDACi in enhancing immune responses to cancer.",27614429_11,-1,1,-1,1,29976,-1,3.7006603e-06,0.99999297,3.3397976e-06
12409,The,0,1,0,3,The described MM-MDSC use arginase in conjunction with other yet undefined mechanisms to suppress CD4(+) and CD8(+) T cells.,20484028_8,-1,1,-1,1,12409,-1,4.866427e-06,0.9999913,3.8258163e-06
42703,their,2,3,14,19,"Additionally, their alteration may be related to CD8+ T cell dysfunction in CML patients; thus, NFAT2 and miR-20a-5p may be considered potential targets for revising T cell function in leukemia immunotherapy.",34237654_6,-1,1,-1,1,42703,-1,4.6143177e-06,0.99999046,4.939891e-06
1433,plasmid,4,5,25,32,Increasing the number of plasmid injections after tumor irradiation induced tumor regression in 70% of the mice.,12804139_7,-1,1,-1,1,1433,-1,1.4356446e-05,0.99997747,8.124546e-06
41045,To,2,3,11,13,OBJECTIVE: To observe the inhibitory effect of solanine on regulatory T cells (Treg) in transplanted hepatoma mice and to study the mechanism of solanine inhibiting tumor growth.,33204731_0,-1,1,-1,1,41045,-1,4.1074713e-06,0.9999918,4.0599202e-06
28323,activator,18,19,106,115,NF-B was activated in T cells by inducing the expression of a constitutively active form of the upstream activator IB kinase  (IKK).,26903482_5,-1,1,-1,1,28323,-1,7.143691e-06,0.999987,5.8075584e-06
6036,T(regs,21,22,135,141,These results imply that T(regs) may suppress the immune control of cervical neoplasia and furthermore that suppression of immunity by T(regs) will be another hurdle to overcome in therapeutic immunization strategies against cervical neoplasia.,17937675_9,-1,1,-1,1,6036,-1,6.5012287e-06,0.999985,8.507664e-06
28238,that,3,4,18,22,This work implies that a combination of Treg-specific markers could be used to more accurately determine expanded Treg subsets and to understand their contribution in cancer settings.,26885615_6,-1,1,-1,1,28238,-1,4.401157e-06,0.99999225,3.3446495e-06
29021,T,3,4,25,26,Invariant natural killer T (iNKT) cells are a subset of innate-like T cells that act as important mediators of immune responses.,27226296_0,-1,1,-1,1,29021,-1,4.9248692e-06,0.9999881,6.985886e-06
16169,tumor,37,38,231,236,"Based on these results, we propose that loss of PML protein expression in gastric cancer cells contributes to increased IP-10 transcription via enhancement of STAT-1 activity, which, in turn, promotes lymphocyte trafficking within tumor regions.",22022583_9,-1,1,-1,1,16169,-1,4.1942017e-06,0.9999912,4.618389e-06
16124,that,9,10,72,76,"These observations indicate that IL-21 amplifies an inflammatory milieu that promotes CAC, and suggest that IL-21 blockade may be useful in reducing the risk of UC-associated colon cancer.",21987656_7,-1,1,-1,1,16124,-1,1.0730213e-05,0.99998426,5.036128e-06
9682,that,10,11,71,75,"However, the efficacy of therapeutic vaccines may require formulations that not only generate effective immune responses but also overcome immune evasion mechanisms employed by progressing tumor.",19435920_1,-1,1,-1,1,9682,-1,6.288172e-06,0.9999894,4.3676773e-06
41251,This,0,1,0,4,This integrin mAb induces a substantial survival benefit in highly metastatic murine TNBC models poorly responsive to PD-1 blockade.,33385331_5,-1,1,-1,1,41251,-1,6.0614834e-06,0.99998903,4.955256e-06
34126,to,2,3,9,11,We aimed to investigate whether IL-17-producing CD4+ T cells (Th17) and CD4+ Foxp3+ T cells (Treg) are involved in the early stages of CCA genesis and can be targeted for suppression by melatonin.,29331794_2,-1,1,-1,1,34126,-1,3.760413e-06,0.9999926,3.6247993e-06
13681,tremelimumab,11,12,63,75,"Importantly, Treg frequency was not reduced in the presence of tremelimumab, and expanded Tregs in cancer patients treated with tremelimumab expressed FoxP3 with no IL-2 release, confirming them as bona fide Tregs.",21056008_5,-1,1,-1,1,13681,-1,1.1107107e-05,0.9999745,1.4448483e-05
12177,tested,2,3,10,16,We herein tested whether these effects can translate into effective cancer immunotherapy when SA-4-1BBL was also used as a vehicle to deliver TAAs in vivo to dendritic cells (DCs) constitutively expressing the 4-1BB receptor.,20406989_3,-1,1,-1,1,12177,-1,6.5582717e-06,0.99998903,4.3783607e-06
21040,that,11,12,100,104,Tumor escape from immune-mediated destruction has been associated with immunosuppressive mechanisms that inhibit T cell activation.,23986400_0,-1,1,-1,1,21040,-1,6.2414315e-06,0.99998915,4.599493e-06
12902,transduction,11,12,73,85,"We previously showed that CD40 targeting of Ad vectors enhanced specific transduction of DC in human skin, while simultaneously ensuring their stable maturation and superior allogeneic T-cell stimulatory capacity.",20664356_1,-1,1,-1,1,12902,-1,6.502891e-06,0.9999889,4.6199116e-06
33614,the,3,4,14,17,We focused on the ability of the Treg and TAM counts around the cancer lesion to predict outcomes after adjuvant intravesical Bacille Calmette-Gurin (BCG) treatment.,29048388_4,-1,1,-1,1,33614,-1,3.8139078e-06,0.9999924,3.7933405e-06
41241,SOX4,2,3,14,18,"Expression of SOX4 is regulated by the integrin v6 receptor on the surface of tumor cells, which activates TGF from a latent precursor.",33385331_3,-1,1,-1,1,41241,-1,1.051341e-05,0.99996877,2.069638e-05
600,the,29,30,187,190,"HHV8 dissemination is favoured by virus escape mechanisms and immune dysregulation, and leads to immune responses that are not effective against the virus but, paradoxically, exacerbates the reactive process.",11423257_4,-1,1,-1,1,600,-1,5.394791e-06,0.99999106,3.581235e-06
26640,the,6,7,31,34,"In this study, we investigated the TLR4/MD-2 dependency by S100A8 on tumor progression.",26165843_3,-1,1,-1,1,26640,-1,3.6373697e-06,0.9999926,3.7757968e-06
42386,the,29,30,138,141,"The presence or absence, in particular, of cytotoxic CD8+ cells in the vicinity of the main tumor mass, is able to predict, respectively, the success or failure of drug therapy.",34070750_4,-1,1,-1,1,42386,-1,4.463263e-06,0.99999154,4.0485675e-06
35623,the,15,16,97,100,"Compared with patients with NF-B-94 ins/del ATTG ins/ins and ins/del, patients with del/del had the highest myeloma cell ratio.",30211233_6,-1,1,-1,1,35623,-1,5.335845e-06,0.9999889,5.718284e-06
28055,TGF-,14,15,92,97,These local Treg express a suppressive cytokine profile characterized by high IL-10 and low TGF- and IFN- production.,26782287_7,-1,1,-1,1,28055,-1,1.2783198e-05,0.99997795,9.230708e-06
19393,genesis,21,22,158,165,We examined their biological characteristics as well as immunological function and further detected the possible molecular mechanism involved in the leukemia genesis.,23180012_3,-1,1,-1,1,19393,-1,9.589318e-06,0.99997544,1.4956969e-05
28019,the,7,8,41,44,"In stomach cancer, the mechanisms behind the accumulation of Tregs in tumor tissue has not been fully elucidated, and neither has Treg gene expression in situ.",26782287_2,-1,1,-1,1,28019,-1,4.795265e-06,0.99999166,3.575139e-06
42074,TME,14,15,76,79,Our results showed for the first time that TFT cells are highly enriched in TME of DLBCL patients and associated with predictions of poor prognoses.,33864956_6,-1,1,-1,1,42074,-1,8.9611785e-06,0.99998224,8.770189e-06
22100,the,8,9,51,54,Defects in a suppressive assay can indicate either the defective function of Treg cells or the resistance of Tconv cells to suppression by Treg cells.,24405842_1,-1,1,-1,1,22100,-1,3.982118e-06,0.9999924,3.7006366e-06
42035,than,12,13,87,91,"Importantly, ENTPD1 expression is significantly higher in human cSCCs that metastasize than in those that are nonmetastatic.",33848530_5,-1,1,-1,1,42035,-1,4.242211e-06,0.9999907,5.1086577e-06
17415,to,6,7,46,48,These results suggest a possible contribution to disease control by TK inhibitor therapies.,22585600_8,-1,1,-1,1,17415,-1,5.8414184e-06,0.99998784,6.371138e-06
38646,TGF1,31,32,197,202,"In orthotopic and syngeneic mouse models, silencing or inactivating IRIS in TNBC cells lowered the levels of circulating GM-CSF, suppressed TAM recruitment, and decreased the levels of circulating TGF1.",31911557_4,-1,1,-1,1,38646,-1,1.9507957e-05,0.9999554,2.512297e-05
33583,tumors,10,11,81,87,These results suggest that a fucoidan-supplemented diet can inhibit DMBA-induced tumors in rats.,29043842_9,-1,1,-1,1,33583,-1,4.031669e-06,0.9999908,5.1961742e-06
37003,time,15,16,88,92,"CONCLUSIONS: The frequency of 4-1BBL+ B cells significantly increased following a short time activation, and showed relative and significant associations with tumor grade and estrogen receptor status, respectively.",31182685_9,-1,1,-1,1,37003,-1,1.015773e-05,0.99997973,1.0118438e-05
12680,to,33,34,199,201,"Interleukin (IL)-17-producing CD4(+) cells as Th17 cells and CD4(+)CD25(+)FoxP3(+) cells as Treg were evaluated by flow cytometry and expressed as a percentage of the total CD4(+) cells, in addition to performing a Th1/Th2 balance assay.",20550524_2,-1,1,-1,1,12680,-1,5.365472e-06,0.99998903,5.59163e-06
37346,the,46,47,308,311,"Caloric restriction mimetics (CRMs), compounds that mimic the biochemical effects of nutrient deprivation, administered via systemic route promote antitumor effects through the induction of autophagy and the modulation of the immune microenvironment; however, collateral effects due to metabolic changes and the possible weight loss might potentially limit their administration at long term.",31321243_0,-1,1,-1,1,37346,-1,8.849846e-06,0.9999862,4.999992e-06
4964,These,0,1,0,5,These data suggest that MSCs suppress NK cell cytotoxicity.,17244679_5,-1,1,-1,1,4964,-1,4.7140775e-06,0.99999154,3.7745867e-06
1670,the,36,37,243,246,"Here, the T-bet pathway in the autochthonous transgenic adenocarcinoma mouse prostate model is demonstrated to have only a modest effect on the characteristics of primary prostate cancers but rather exerts a significant suppressor function in the development of metastatic disease.",14744755_2,-1,1,-1,1,1670,-1,3.641271e-06,0.9999926,3.7215468e-06
15257,T-regs,1,2,12,18,"Circulating T-regs did not correlate with intrahepatic distribution of Foxp3.CONCLUSIONS: In chronic hepatitis C, selective expansion of peripheral T-regs in patients with normal aminotransferases and advanced disease suggests that, though a continual low level inflammation does not prevent liver disease progression, once cirrhosis has developed it may represent an attempt to prevent immuno-mediated decompensation.",21684822_9,-1,1,-1,1,15257,-1,6.378653e-06,0.99998605,7.5623357e-06
14774,the,11,12,52,55,"And the third link is the ability of IDO to prevent the inflammation-induced conversion (""reprogramming"") of Tregs into pro-inflammatory T-helper-like cells in vivo.",21517755_6,-1,1,-1,1,14774,-1,4.249547e-06,0.9999924,3.3819365e-06
39517,the,4,5,30,33,These results demonstrate for the first time that CDDO-Me relieves immunosuppression in the breast TME and unleashes host adaptive anti-tumor immunity.,32300202_8,-1,1,-1,1,39517,-1,5.4177976e-06,0.9999894,5.154683e-06
31554,tumour,23,24,134,140,CONCLUSION: Our data indicate that oxygen availability can function as a local modulator of CD4+ T cell responses and thus influences tumour immune surveillance in inflammation-associated colon cancer.,28278498_8,-1,1,-1,1,31554,-1,8.876747e-06,0.9999857,5.3981944e-06
3162,the,35,36,205,208,In this study we analyze tumor-draining lymph nodes (LNs) and demonstrate that both antitumor effector T cells and Treg capable of abrogating the antitumor reactivity of the effector T cells are primed in the same LNs during tumor progression.,16210609_3,-1,1,-1,1,3162,-1,4.3623722e-06,0.99999094,4.7390968e-06
42855,plays,3,4,30,35,Tumor immune microenvironment plays a crucial role in tumor progression.,34504204_0,-1,1,-1,1,42855,-1,1.0524154e-05,0.99997735,1.2177999e-05
37217,nanoadjuvant,9,10,67,79,"Methods: Herein, we synthesized an NF-B-activating supramolecular nanoadjuvant (3DSNA) that is prepared by pH-triggering self-assembly of a positively charged D-configurational peptide derivative.",31244959_2,-1,1,-1,1,37217,-1,4.182955e-05,0.999913,4.524501e-05
24305,genetic,6,7,36,43,BACKGROUND: TEL-AML the most common genetic alteration in childhood precursor B acute lymphoblastic leukemia (BCP-ALL) is associated with a favorable prognosis.,25062112_0,-1,1,-1,1,24305,-1,1.4005346e-05,0.99995685,2.9156568e-05
11005,transfer,1,2,9,17,Adoptive transfer of wild-type CD8(+) T cells induced T-suppressor cell death in IFN-gamma-knockout mice confirming that autocrine IFN-gamma was sufficient for CD8(+) T cell FasL expression.,19923444_6,-1,1,-1,1,11005,-1,5.6858134e-06,0.99998975,4.52466e-06
13976,tumor,19,20,127,132,"We have addressed this question by inoculating NFAT1-/- mice with B16F10 melanoma cells intravenously, an established model of tumor homing and growth.",21225259_3,-1,1,-1,1,13976,-1,4.045509e-06,0.999992,3.9816837e-06
31957,TAM,30,31,183,186,"Mice deficient in the Th1 transcription factor T-bet did not gain any survival advantage from RABV infection, exhibiting only limited tumor necrosis and no change in TME cytokines or TAM phenotype and highlighting the importance of type 1 mechanisms in this process.",28461570_7,-1,1,-1,1,31957,-1,5.403262e-06,0.99998844,6.2025138e-06
3016,the,17,18,109,112,Transforming growth factor-beta (TGF-beta) plays an essential role in regulating the homeostasis of cells in the lymphoid lineage.,16123803_0,-1,1,-1,1,3016,-1,4.536028e-06,0.999987,8.418321e-06
14453,the,15,16,82,85,"Our data indicate that IL-17(+)Foxp3(+) cells may be ""inflammatory"" Treg cells in the pathological microenvironments.",21357259_9,-1,1,-1,1,14453,-1,3.9531415e-06,0.99999154,4.4680455e-06
26227,tumour,27,28,175,181,We conclude that Slc5a8 is an obligatory link between dietary fibre and mucosal immune system via the bacterial metabolite butyrate and that this transporter is a conditional tumour suppressor in colon linked to dietary fibre content.,25984582_9,-1,1,-1,1,26227,-1,7.3916194e-06,0.9999856,6.9969833e-06
32645,the,7,8,42,45,"Stat6 also promoted expansion of MDSCs in the spleen and lamina propria of ApcMin/+ mice, implying regulation of antitumor T-cell response.",28654863_9,-1,1,-1,1,32645,-1,3.5074484e-06,0.9999919,4.6582745e-06
35130,that,10,11,56,60,This study reveals a strategy to target Tregs in cancer that mitigates autoimmunity by reprogramming their function in tumors to enhance anti-cancer immunity.,29898397_4,-1,1,-1,1,35130,-1,4.509274e-06,0.9999918,3.6652725e-06
25528,this,2,3,8,12,"Indeed, this molecule inhibited pDC maturation, decreased IFN secretion following TLR9 stimulation and forced these cells to become tolerogenic.",25492101_8,-1,1,-1,1,25528,-1,8.938804e-06,0.99998474,6.2621943e-06
27327,to,16,17,107,109,"Because GITR signaling could not neutralize the suppressive activity of activated Treg cells, pGITRL seems to lose its adjuvant effect when sufficient activated Treg cells have accumulated in the lymph nodes and tumor tissue.",26423152_8,-1,1,-1,1,27327,-1,8.378204e-06,0.9999863,5.3458853e-06
39143,this,1,2,3,7,"In this study, we identified an immune-related, five-gene signature that improves survival prediction in ccRCC.",32028264_1,-1,1,-1,1,39143,-1,4.3327586e-06,0.9999914,4.2331453e-06
28281,their,19,20,111,116,"Although a high number of intra-tumoral T cells showed a trend toward improved survival of all OPSCC patients, their prognostic effect in patients with a low number of intra-tumoral IL-17(+) non-T cells was significant with regard to disease-specific (p = 0.033) and disease-free survival (p = 0.012).",26899388_6,-1,1,-1,1,28281,-1,6.0317566e-06,0.99998987,4.081948e-06
5187,FOXP3,29,30,155,160,"Although FOXP3 is primarily expressed by regulatory CD4 T cells (Treg) in vivo, polyclonal activation of human CD8 T cells can result in the expression of FOXP3 in a fraction of CD8 T cells.",17414320_0,-1,1,-1,1,5187,-1,4.844482e-06,0.9999912,3.987479e-06
2158,therefore,23,24,154,163,These results suggest that CD4(+)CD25(bright) T cells found in the normal and inflamed intestinal mucosa selectively inhibit the host immune response and therefore may contribute to the intestinal immune homeostasis.,15322172_7,-1,1,-1,1,2158,-1,4.1385256e-06,0.9999907,5.211772e-06
38017,The,0,1,0,3,The mechanism and effective methods of disrupting Treg accumulation in the LHME have not been well established.,31669202_2,-1,1,-1,1,38017,-1,4.3154005e-06,0.9999912,4.4563285e-06
15127,twice,48,49,231,236,"Employing IL-2 responsive (B16-F1, B16-BL6, JB/MS, MCA-205) and nonresponsive (JB/RH, B16-F10) subcutaneous tumor mouse models, we evaluated CD8 Foxp3+ T cell distribution and changes in response to rhIL-2 (50,000 U, i.p. or s.q., twice daily for 5 days).",21638127_2,-1,1,-1,1,15127,-1,0.00023159519,0.99973685,3.157e-05
33918,Th2-dominant,47,48,300,312,"Peripheral blood mononuclear cells from one patient with Szary syndrome expressed IL-25R and showed increase of IL-13 production by IL-25.CONCLUSIONS: Th2 cytokines highly expressed in CTCL lesional skin induce IL-25 production by epidermal keratinocytes, which may, in turn, lead to formation of a Th2-dominant microenvironment through the direct induction of IL-13 by tumour cells.",29238954_11,-1,1,-1,1,33918,-1,1.0117552e-05,0.99997616,1.3762875e-05
41252,TNBC,12,13,85,89,This integrin mAb induces a substantial survival benefit in highly metastatic murine TNBC models poorly responsive to PD-1 blockade.,33385331_5,-1,1,-1,1,41252,-1,2.7987697e-05,0.999938,3.3989654e-05
1430,than,27,28,186,190,These data were reproduced in additional experiments and confirmed that tumor irradiation prior to gene therapy resulted in complete tumor regression and specific tumor immunity in more than 50% of the mice.,12804139_6,-1,1,-1,1,1430,-1,7.319442e-06,0.9999862,6.479239e-06
27960,the,6,7,64,67,Immunosuppression in tumor microenvironments critically affects the success of cancer immunotherapy.,26759006_0,-1,1,-1,1,27960,-1,5.7882294e-06,0.9999901,4.161371e-06
27716,Tregs,22,23,126,131,"Because regulatory T cells (Tregs) are regarded as a critical hurdle in anti-tumour immunity, we assessed the distribution of Tregs in 45 cases of EBVaGC and 45 cases of EBV-negative gastric carcinoma (EBVnGC) with matched clinicopathological parameters by immunohistochemistry.",26673957_2,-1,1,-1,1,27716,-1,5.95923e-06,0.9999883,5.7676657e-06
36080,the,23,24,102,105,"Overall, our findings show that (1) N1 synergizes with R848 in activating human and mouse DCs and (2) the synergistic effect based on various intracellular signaling events culminated in the activation of multiple transcriptional factors.",30619338_7,-1,1,-1,1,36080,-1,4.818913e-06,0.9999912,3.966664e-06
17154,the,10,11,67,70,"Although TCR engagement is necessary for inducing OX40 expression, the downstream signals that regulate OX40 itself remain unclear.",22496812_3,-1,1,-1,1,17154,-1,6.9986536e-06,0.9999887,4.307586e-06
41325,therefore,1,2,3,12,We therefore developed synthetic promoters for regulation of gene expression under the control of inflammation and Hypoxia-induced signals that are associated with the tumor microenvironment (TME).,33514819_2,-1,1,-1,1,41325,-1,4.7291105e-06,0.99999106,4.1683693e-06
28341,to,3,4,17,19,This study aimed to inhibit lung cancer (LC) growth in a mouse model by using an LC-specific vaccination.,26910585_1,-1,1,-1,1,28341,-1,3.811603e-06,0.9999925,3.7325865e-06
40198,the,6,7,33,36,"OBJECTIVE: We aim to investigate the metabolic alterations in tumor cells after CHOP (cyclophosphamide, hydroxydaunorubicin, oncovin and prednisone) chemotherapy.",32573814_2,-1,1,-1,1,40198,-1,4.236168e-06,0.9999919,3.9253587e-06
22952,tumor,19,20,137,142,Increasing evidence suggests that communication between tumor and immune cells can alter the tumor microenvironment in ways that promote tumor development.,24676671_0,-1,1,-1,1,22952,-1,4.408017e-06,0.9999913,4.2960282e-06
31470,their,34,35,192,197,"Tim-3 is a co-inhibitory receptor that is expressed on IFN-g-producing T cells, FoxP3+ Treg cells and innate immune cells (macrophages and dendritic cells) where it has been shown to suppress their responses upon interaction with their ligand(s).",28258697_4,-1,1,-1,1,31470,-1,5.366201e-06,0.9999894,5.2412033e-06
31349,transcription factors,29,31,165,186,These CTLs carry not only the activation of mechanistic target of rapamycin (mTOR) and AMP-activated protein kinase (AMPK) but also an increment of their downstream transcription factors such as PPAR-gamma coactivator 1 (PGC-1) and T-bet.,28096382_3,-1,1,-1,1,31349,-1,4.59775e-06,0.9999906,4.832556e-06
19825,T,8,9,43,44,"It has been reported that the imbalance of T helper IL-17-producing cells (Th17 cells)/regulatory T cells (Tregs) was closely associated with advanced tumor growth and poor prognosis in lung cancer, but little is known about whether this imbalance is existed in the peripheral blood of patients with non-small cell lung cancer (NSCLC).",23335103_0,-1,1,-1,1,19825,-1,7.675345e-06,0.99997604,1.631966e-05
22865,thyroid,28,29,136,143,"Furthermore, upon stimulation, the DN T cells associated with cancer remained unchanged, while the few (<5%) DN T cells associated with thyroid autoimmunity increased in numbers (>20%).",24623740_7,-1,1,-1,1,22865,-1,9.57504e-06,0.9999827,7.743794e-06
34770,their,3,4,20,25,"Hence, manipulating their profile can open up a new avenue in cancer immunotherapy.",29768737_9,-1,1,-1,1,34770,-1,6.5481654e-06,0.9999889,4.538858e-06
38168,that,4,5,14,18,"Here, we show that increased fatty acid oxidation (FAO) driven by activated STAT3 in CD8+ T effector cells is critical for obesity-associated breast tumor progression.",31761565_1,-1,1,-1,1,38168,-1,4.8865127e-06,0.9999913,3.8646535e-06
35600,Treg,9,10,53,57,High NLR correlates with increased IL-6 and IL-8 and Treg expression.,30199269_3,-1,1,-1,1,35600,-1,5.2502437e-06,0.99998856,6.174511e-06
18676,the,19,20,107,110,"In this study, we used A20 B-cell lymphoma mice as aggressive tumor models to investigate the mechanism of the depletion of Tregs by low-dose cyclophosphamide (CY, 20 mg/kg).",23000689_3,-1,1,-1,1,18676,-1,4.256757e-06,0.999992,3.7150835e-06
1431,the,31,32,198,201,These data were reproduced in additional experiments and confirmed that tumor irradiation prior to gene therapy resulted in complete tumor regression and specific tumor immunity in more than 50% of the mice.,12804139_6,-1,1,-1,1,1431,-1,6.3183184e-06,0.9999865,7.1453774e-06
35888,TGF-,2,3,20,25,Association between TGF- expression and infiltrating Tregs was also verified.,30359281_8,-1,1,-1,1,35888,-1,2.469654e-05,0.9999629,1.2388793e-05
5636,The,0,1,0,3,"The CD45RA+/CCR7+ phenotype of HPV antigen-reactive T cells may serve as an indicator of dysfunctional T cells, despite effective interferon-gamma production in response to HPV antigens.",17589293_6,-1,1,-1,1,5636,-1,4.115598e-06,0.99999225,3.6397141e-06
15337,to,5,6,35,37,"We previously showed that exposure to UV radiation after immunization suppresses Th1 and Th2 immune responses, leading to impaired Ab and allo-immune responses, but the impact of UV radiation after immunization on anti-tumor immune responses mediated by tumor-specific CD8(+) T cell responses remains less clear.",21710495_0,-1,1,-1,1,15337,-1,6.2176455e-06,0.99998844,5.32507e-06
23444,Tregs,6,7,32,37,BACKGROUND: T regulatory cells (Tregs) contribute to the progression of head and neck squamous cell carcinoma (HNSCC) by suppressing antitumor immunity.,24761979_0,-1,1,-1,1,23444,-1,3.875339e-06,0.99999154,4.640072e-06
24885,trials,26,27,163,169,"In summary, our data suggest that GEP might be a powerful tool for the prediction of immunosuppression and the monitoring of immune responses within immunotherapy trials.",25242680_5,-1,1,-1,1,24885,-1,6.3145603e-06,0.99998856,5.082202e-06
1205,These,0,1,0,5,These results suggest a rationale for combining rexinoids with IL-2R-targeted therapies in lymphoid malignancies as well as possibly in autoimmune diseases.,12149223_5,-1,1,-1,1,1205,-1,4.330823e-06,0.9999918,3.8587964e-06
17296,than,11,12,68,72,There is no effective treatment and overall 2-year survival is less than 5%.,22532287_2,-1,1,-1,1,17296,-1,2.079674e-05,0.9999634,1.5771928e-05
38931,tumor-bearing,17,18,163,176,Combination of pioglitazone and alpha-galactosylceramide treatments significantly enhances iNKT cell-mediated anti-tumor immune responses and prolongs survival of tumor-bearing mice.,31974378_5,-1,1,-1,1,38931,-1,5.0683393e-06,0.9999894,5.581089e-06
34863,the,16,17,85,88,"Finally, we identified that depletion of CD8+ T cells rather than NK cells abrogated the antitumor activity of FM.CONCLUSIONS: Our results show for the first time that CD8+ T cells mediate the antitumor activity of FM at a non-toxic dose.",29784005_15,-1,1,-1,1,34863,-1,8.493584e-06,0.9999869,4.6246373e-06
1750,STAT,27,28,180,184,"Moreover, the antitumor activity was abolished in T-bet-deficient mice, whereas it was observed unexpectedly in mice deficient of signal transducer and activator of transcription (STAT) 4.",14871851_7,-1,1,-1,1,1750,-1,5.1908773e-06,0.99999034,4.514336e-06
24602,their,15,16,92,97,"Myeloid-derived suppressor cells (MDSC) are elevated in most individuals with cancer, where their accumulation and suppressive activity are driven by inflammation.",25164013_2,-1,1,-1,1,24602,-1,5.8524697e-06,0.9999887,5.494239e-06
31043,trigger,19,20,125,132,"Using an in vitro approach, we could demonstrate that peripheral blood mononuclear cells including the clonal population can trigger a phenotype switch of epithelial renal cells from a quiescent state to a pro-inflammatory state characterized by NF-B nuclear translocation and overexpression of inflammatory cytokine or chemokine.",28018996_5,-1,1,-1,1,31043,-1,6.010489e-06,0.99998915,4.780222e-06
9672,FOXP3,18,19,102,107,"Most of the CD25(-) clonal populations contained cells that expressed FOXP3 in the resting state, but FOXP3 demethylation was not observed.",19435913_8,-1,1,-1,1,9672,-1,4.621484e-06,0.99999154,3.891012e-06
15147,tumors,50,51,311,317,"Following treatment with rhIL-2, a dramatic increase in CD8 Foxp3+ T cell prevalence was observed in the circulation and tumor-draining lymph nodes (TD.LNs) of animals bearing IL-2 nonresponsive tumors, while no significant changes were observed in the circulation and TD.LNs of animals bearing IL-2 responsive tumors.",21638127_5,-1,1,-1,1,15147,-1,3.955467e-06,0.9999912,4.871715e-06
824,regulation,2,3,13,23,"We evaluated regulation of the MHC class II transactivator (CIITA), the key intermediate that controls class II expression, in MG cells and tested whether MG cells could process native Ag.",11746775_2,-1,1,-1,1,824,-1,4.925422e-06,0.9999907,4.3337927e-06
35688,to,17,18,97,99,"PBMCs were stimulated with PMA and ionomycin in the presence of Berefeldin A as Golgi stop agent to detect intracellular cytokine production (IFN-, IL-17, and IL-4) from CD3+CD4+T cells population indicating T helper (Th) cells subsets by flowcytometry.",30246693_4,-1,1,-1,1,35688,-1,4.3690575e-06,0.9999914,4.176154e-06
36562,TTF-1+PD-L1,6,7,42,53,"Finally, IL-35 positively correlated with TTF-1+PD-L1+ cells in the TU region of NSCLC patients.",30956278_7,-1,1,-1,1,36562,-1,0.00029287627,0.9968683,0.002838779
28509,to,12,13,68,70,"Given that tumors are often resistant to apoptosis, it is important to identify alternative molecular mechanisms that elicit immunogenic cell death.",27050509_1,-1,1,-1,1,28509,-1,6.5990935e-06,0.9999896,3.737894e-06
40853,targeted,6,7,42,50,This study supports the implementation of targeted strategies to augment these pathways for improved immunotherapeutic outcomes in patients with cancer.,33051240_7,-1,1,-1,1,40853,-1,7.3621995e-06,0.9999877,4.870323e-06
16885,FOXP3-,36,37,189,195,We determined two types of CD4+ CD127- T cells with comparable regulatory ability; one is CD25(high+) cells expressing FOXP3 (CD25(high+) FOXP3+ Tregs) and the other is CD25- cells without FOXP3- expression (CD25- FOXP3- cells).,22419479_7,-1,1,-1,1,16885,-1,5.698433e-06,0.9999895,4.735101e-06
10443,therapeutic,8,9,63,74,Data has shown that FasL-mediated cytotoxicity has significant therapeutic effect on EBV-associated nasopharyngeal carcinoma (NPC).,19664329_4,-1,1,-1,1,10443,-1,4.914471e-06,0.9999907,4.343657e-06
40394,these,3,4,17,22,The phenotype of these B cells was CD19+CD81+CD27+CD25+PD-L1hi and they secreted both IL-10 and TGF-.,32661685_4,-1,1,-1,1,40394,-1,6.308627e-06,0.999984,9.706842e-06
8285,to,3,4,17,19,"This study aimed to investigate whether different forms of apical periodontitis, namely cysts and granulomas, show different balances of Th1, Th2 regulators, Treg markers, and factors involved in osteoclast chemotaxis and activation.",19121066_2,-1,1,-1,1,8285,-1,3.8874005e-06,0.9999918,4.328845e-06
14054,there,23,24,136,141,In periphery there was an increase at the effector immune response (as depicted by IFN--producing cells) and in tumor development site there was an increase at the suppressor cell (CD11b+Gr-1+) phenotype.,21238620_10,-1,1,-1,1,14054,-1,4.1915164e-06,0.9999907,5.0929452e-06
24896,tumor,4,5,24,29,"Galectins, expressed in tumor, stromal, and endothelial cells, contribute to thwart the development of immune responses by favoring the expansion of T regulatory cells and contributing to their immunosuppressive activity, driving the differentiation of tolerogenic dendritic cells, limiting T cell viability, and maintaining T cell anergy.",25253145_2,-1,1,-1,1,24896,-1,5.7681937e-06,0.9999893,4.9766973e-06
15777,that,4,5,16,20,"Here, we report that in vivo genetic targeting of the active transcription factor XBP1s to DC (XBP1s/DC) potentiated vaccine-induced prophylactic and therapeutic antitumor immunity in multiple tumor models.",21934655_2,-1,1,-1,1,15777,-1,4.0650793e-06,0.9999924,3.6113727e-06
38226,to,13,14,86,88,"Meanwhile, p65 functioned as a transcription repressor of miR-23a by directly binding to its promoter.",31769216_12,-1,1,-1,1,38226,-1,4.74168e-06,0.99999046,4.797555e-06
21407,there,2,3,9,14,"Instead, there were significant increases in regulatory T cells (3.7 vs. 6.8 %) and a population of myeloid-derived suppressor cells (CD14(-)HLA-DR(-)CD15(hi), 12.38 vs. 21.92 %).",24146146_6,-1,1,-1,1,21407,-1,3.6850024e-06,0.999992,4.3178743e-06
19064,T,6,7,43,44,PURPOSE: To evaluate CD4(+)CD25(+)FOXP3(+) T regulatory cells (T(REG)) and associated immune-regulatory pathways in peripheral blood lymphocytes (PBL) of metastatic renal cell carcinoma (mRCC) patients and healthy volunteers.,23118856_0,-1,1,-1,1,19064,-1,6.3339203e-06,0.9999846,9.073242e-06
17545,the,11,12,64,67,"Both IL-6 and STAT3 have recently emerged as main regulators of the differentiation and function of Th17 cells, via a positive feedback loop enhancing expression and/or activation of IL-6 itself, IL-17 and STAT3.",22652781_4,-1,1,-1,1,17545,-1,3.721942e-06,0.999992,4.265092e-06
35844,the,28,29,195,198,Functional investigation demonstrated that IL-33 increased the proportion of Foxp3+GATA3+ Tregs and improved the suppressive functions of Tregs by inducing IL-10 and TGF-1 as well as decreasing the proliferation of responder T cells.,30357458_8,-1,1,-1,1,35844,-1,4.4933304e-06,0.9999918,3.6853776e-06
35605,the,2,3,15,18,"To investigate the role of the NLRP3 inflammasome in MM, we determined the genetic polymorphisms and expression of NLRP3 inflammasome-related genes (IL-1, IL-18, CARD8, and NF-B) in MM patients, and explored their clinical relevance.",30211233_1,-1,1,-1,1,35605,-1,3.7810685e-06,0.9999926,3.5969788e-06
8476,Treg,7,8,59,63,This divergent IL-2-dependent resistance or sensitivity of Treg and RC to apoptosis is amplified in patients with cancer.,19155494_9,-1,1,-1,1,8476,-1,7.4385075e-06,0.99997663,1.5887017e-05
7991,the,9,10,52,55,"Given similar findings in the regional lymph nodes, the lymphoid stroma of lymphocyte-rich GCs may represent a tertiary lymphoid tissue with predominantly Th1-shifted immune responses.",18980207_11,-1,1,-1,1,7991,-1,3.8365083e-06,0.99999166,4.5472193e-06
1532,therefore,6,7,28,37,"Deletion of the Stat6 gene, therefore, provides significantly enhanced immunosurveillance.",14593499_3,-1,1,-1,1,1532,-1,8.177738e-06,0.99998486,6.9336147e-06
5982,to,8,9,61,63,"The level of SVV-specific cytotoxic T-cell response appeared to be significantly higher for the T-cell line that was primed with the tatSVV-pulsed DCs, as compared to the T-cell line produced with naked (n)-SVV-pulsed DCs in vitro.",17931768_3,-1,1,-1,1,5982,-1,4.18394e-06,0.99999154,4.3054133e-06
24111,Treg,22,23,124,128,We investigated the immunological changes induced by PDT and the effect of PDT on level and function of regulatory T cells (Treg) in patients with invasive esophageal squamous cell carcinoma (ESCC).,25005268_2,-1,1,-1,1,24111,-1,6.682179e-06,0.9999825,1.0858479e-05
35174,to,22,23,153,155,This molecular circuit underlies the co-expression of co-inhibitory receptors in T cells and identifies regulators of T cell function with the potential to control autoimmunity and tumour immunity.,29899446_6,-1,1,-1,1,35174,-1,4.5060146e-06,0.99999166,3.845013e-06
17836,TLR4,0,1,0,4,TLR4 expression was examined in tumor tissues and cell lines.,22736917_1,-1,1,-1,1,17836,-1,9.512777e-06,0.99997044,2.0107536e-05
21264,the,14,15,97,100,"Similar to intratumoral Treg infiltrates, CCL22 tumor secretion correlated with the prognosis of the molecular subtypes of breast carcinoma (P<0.0001).",24124553_6,-1,1,-1,1,21264,-1,4.8556467e-06,0.99999,5.135305e-06
1301,the,15,16,73,76,"The effects of IL-16 on the target cells are dependent on the cell type, the presence of co-activators etc.",12528894_2,-1,1,-1,1,1301,-1,4.455816e-06,0.9999906,4.933536e-06
4845,Tumor-induced,0,1,0,13,Tumor-induced oxidative stress increased cytosolic IkappaBalpha retention and inhibited NF-kappaB nuclear translocation in thymic T cells.,17210719_4,-1,1,-1,1,4845,-1,1.0751725e-05,0.9999825,6.713439e-06
12952,three,20,21,154,159,Three adenoviral (Ad)-based immunogene therapy regimens were administered to animals with large malignant mesothelioma and lung cancer tumors followed by three weekly administrations of a drug regimen commonly used to treat these tumors (Cisplatin/Gemcitabine).,20683443_3,-1,1,-1,1,12952,-1,1.2960652e-05,0.99997807,8.986902e-06
41313,the,2,3,6,9,"Thus, the IRF17 isoform was increased in the TME, and inhibiting IRF17 expression could potentiate Th1 antitumor responses.",33419764_6,-1,1,-1,1,41313,-1,3.7478662e-06,0.99999225,3.968386e-06
2977,the,31,32,176,179,"This argues that T-cell responses against early and late HPV16 antigens essentially differ in the manner in which they are induced and regulated, as well as in their impact on the subsequent stages of HPV16-induced cervical disease.",16108057_5,-1,1,-1,1,2977,-1,3.668505e-06,0.99999213,4.1407507e-06
12340,to,24,25,164,166,Our findings support the hypothesis that nontumor-bearing skin adjacent to SCC in OTRs is not necessarily normal and that the local microenvironment may contribute to a field effect contributing to higher recurrence rates and more aggressive behavior observed in these patients.,20463594_13,-1,1,-1,1,12340,-1,5.063412e-06,0.99999046,4.4762164e-06
17568,Thus,0,1,0,4,"Thus, the molecular subtype of CSCs TGF-beta-dependently contributes to the degree of immune infiltration.",22676416_6,-1,1,-1,1,17568,-1,5.4159796e-06,0.9999896,4.898393e-06
13213,their,17,18,112,117,"caAkt expression in activated human T cells increased proliferation and cytokine production, a likely result of their sustained expression of nuclear factor-B (NF-B) and provided resistance to apoptosis by upregulating antiapoptotic molecules.",20842106_3,-1,1,-1,1,13213,-1,5.734537e-06,0.99998903,5.228665e-06
13989,these,2,3,9,14,"However, these processes are independent of an IL-4-induced regulatory tumor microenvironment, since lack of this cytokine does not alter the phenotype in NFAT1-/- animals.",21225259_7,-1,1,-1,1,13989,-1,4.296986e-06,0.99999106,4.693472e-06
13053,the,6,7,40,43,"No significant effects were observed on the levels of TGF-beta, IL-10, and autoantibodies in patients with melanoma treated with IFN-alpha 2b.",20712892_8,-1,1,-1,1,13053,-1,4.0282034e-06,0.999992,3.944298e-06
16594,this,13,14,64,68,Low dose (5 mg/kg) entinostat reduced Foxp3 levels in Tregs and this was associated with enhanced tumor growth inhibition in combination with either IL-2 or a SurVaxM vaccine.,22303460_8,-1,1,-1,1,16594,-1,4.974524e-06,0.9999912,3.8021442e-06
14954,that,4,5,22,26,Recent work has shown that induced FoxP3+ Tregs (iTregs) do not express Helios; an Ikaros family transcription factor.,21570917_2,-1,1,-1,1,14954,-1,4.2448673e-06,0.999992,3.7445927e-06
25134,this,3,4,13,17,"The focus of this study is to define the interaction between tumour and immune system, i.e. how immune tolerance starts and gradually leads to the induction of adaptive Treg cells in the tumour microenvironment.",25284464_2,-1,1,-1,1,25134,-1,4.4959593e-06,0.99999106,4.4984213e-06
30179,TME,28,29,181,184,"In addition to TGF1's previously known effects on T-cell function, our findings suggest that TGF1 mediates T-cell suppression via PD-1 upregulation in the tumor microenvironment (TME).",27683557_3,-1,1,-1,1,30179,-1,9.8857145e-06,0.99998283,7.295842e-06
41760,through,5,6,42,49,LINC00152 expression levels were detected through RT-PCR.,33709190_1,-1,1,-1,1,41760,-1,8.733397e-06,0.99998605,5.1779107e-06
17589,the,53,54,232,235,"At 6 months following the first vaccination, flow cytometric analysis demonstrated a significant increase in the frequency of CD4+ICOS(hi) T cells from 52% pre-vaccination to 234% (p<0.001), with a concomitant decrease in the frequency of CD4+FoxP3+ T cells (regulatory T cells [Treg]) from 196 to 105% (p<0.05).",22678162_5,-1,1,-1,1,17589,-1,3.825375e-06,0.9999924,3.777604e-06
33466,Foxp1,13,14,67,72,"Thus, we identified the roles of Foxo1 as a positive regulator and Foxp1 as a negative regulator of TH9 cell differentiation and antitumor activity, which may provide potential targets for cancer immunotherapy.",29018172_6,-1,1,-1,1,33466,-1,3.6715635e-06,0.9999881,8.303979e-06
28545,TGF-,17,18,99,104,GARP has also been proved to promote the activation and secretion of transforming growth factor  (TGF-).,27095576_5,-1,1,-1,1,28545,-1,1.2516167e-05,0.999979,8.503436e-06
27168,the,41,42,208,211,"The proportion and FoxP3 expression of the induced CD4(+)CD25(+) T cells are the highest at the level of 40ng/ml IFN-, and the suppressive function of the CD4(+)CD25(+) T cells induced by 40ng/ml IFN- is the strongest in MG patients.",26347149_12,-1,1,-1,1,27168,-1,7.4615705e-06,0.9999862,6.3915386e-06
15873,STAT3,9,10,52,57,"FO reduced mucosal injury, tumor incidence, colonic STAT3 activation, and inflammatory cytokine gene expression, independent of PPAR genotype.",21940900_6,-1,1,-1,1,15873,-1,9.6457625e-06,0.9999794,1.0920641e-05
43421,tumor,6,7,35,40,Depletion of CD8+ T-cells restored tumor growth in Rap1BiEC mice.,36403190_4,-1,1,-1,1,43421,-1,4.6611144e-06,0.99999106,4.2935367e-06
33500,to,13,14,63,65,"Here the authors show that TTP, encoded by Zfp36, degrades p28 to inhibit IL-27 production by macrophages and is thereby a negative regulator of the antitumour response.",29021521_9,-1,1,-1,1,33500,-1,5.1637626e-06,0.9999888,6.0009734e-06
38047,releasing,16,17,116,125,"In addition to expressing inhibitory cytokines and suppressive molecules, Treg cells could downplay inflammation by releasing cytotoxic molecules and eliminating proinflammatory immune cells.",31669380_0,-1,1,-1,1,38047,-1,3.2635457e-05,0.9999449,2.2398513e-05
31926,to,4,5,33,35,"These neurotropic viruses spread to CNS tissues trans-axonally, where they induce a strong type 1 immune response that involves Th1, CD8, and B cell entry across the blood-brain barrier and virus clearance in the absence of overt sequelae.",28461570_3,-1,1,-1,1,31926,-1,4.7940557e-06,0.9999894,5.805745e-06
40146,the,12,13,82,85,"However, a major challenge in cancer immunotherapies remains the heterogeneity of the immunoregulatory capacities of cancers, and not all patients of a given cancer responds to current therapeutic strategies.",32573300_1,-1,1,-1,1,40146,-1,4.946109e-06,0.9999906,4.4885624e-06
16164,to,18,19,107,109,"Based on these results, we propose that loss of PML protein expression in gastric cancer cells contributes to increased IP-10 transcription via enhancement of STAT-1 activity, which, in turn, promotes lymphocyte trafficking within tumor regions.",22022583_9,-1,1,-1,1,16164,-1,4.7404246e-06,0.9999908,4.446554e-06
13347,FOXP3(+,2,3,7,14,"CD8(+) FOXP3(+) T cells did not express markers of regulatory [CTLA-4, CCL4, interleukin-10 (IL-10), transforming growth factor-1], exhausted (PD-1), or senescent (CD57) CD8(+) T lymphocytes.",20861189_5,-1,1,-1,1,13347,-1,3.370334e-05,0.9999361,3.0140398e-05
39886,the,15,16,88,91,"Our current study aimed to evaluate the frequency of Treg cells, cytokine secretion and the expression of microRNAs (miRNAs) in pediatric acute lymphoblastic leukemia (ALL) patients.",32480291_2,-1,1,-1,1,39886,-1,3.6053032e-06,0.9999926,3.7612986e-06
5237,the,2,3,9,12,"To study the contribution of EBV genes and of the c-MYC protein to this phenotype, we have generated a conditional B cell system in which the viral proliferation program and expression of c-myc can be regulated independently of each other.",17419945_2,-1,1,-1,1,5237,-1,4.3064338e-06,0.99999213,3.539783e-06
15294,Treg,3,4,19,23,High proportion of Treg is correlated to advance TNM stage and reduced survival.,21695703_7,-1,1,-1,1,15294,-1,8.32741e-06,0.999982,9.62761e-06
17642,that,2,3,11,15,"We propose that CD69 expression on CD39(+) Treg cells enables them to interact with CD73-expressing CD8(+) T cells to generate adenosine, thereby suppressing cytotoxicity.",22678911_7,-1,1,-1,1,17642,-1,4.507227e-06,0.9999918,3.721061e-06
845,transcription,6,7,33,46,Both pIII and pIV directed CIITA transcription in vivo in MGs and ex vivo in IFN-gamma-activated primary MG cultures.,11746775_5,-1,1,-1,1,845,-1,4.483904e-06,0.99998975,5.826208e-06
7536,the,6,7,36,39,"The likely explanation for this was the NS3/4A-mediated cleavage of mouse IPS-1, albeit less efficiently than human IPS-1.",18689426_9,-1,1,-1,1,7536,-1,6.205002e-06,0.99999,3.8032638e-06
2295,transfer,1,2,9,17,Adoptive transfer of E7-specific T-cell receptor transgenic CD8+ T cells combined with immunization resulted in induction of antigen-specific interferon gamma-secreting CD8+ T cells and rejection of HPV16 E7-expressing grafts.,15523090_4,-1,1,-1,1,2295,-1,5.044441e-06,0.99999046,4.502058e-06
5783,the,16,17,92,95,"In contrast, Gal1 treatment of activated T cells favored the secretion of Th2 cytokines and the expansion of CD4+CD25high FOXP3+ Treg cells.",17670934_4,-1,1,-1,1,5783,-1,4.466393e-06,0.99999166,3.9250017e-06
26388,STAT3-deficient,8,9,51,66,Blocking IFN or CXCR3 impairs the accumulation of STAT3-deficient CD8(+) T cells in tumor and their antitumor effects.,26025380_5,-1,1,-1,1,26388,-1,7.17885e-05,0.99988544,4.274375e-05
24199,transferred,13,14,73,84,"In contrast, relief from the A20 brake in NF-B activation in adoptively transferred antitumor CD8 T cells led to improved control of melanoma growth.",25024217_7,-1,1,-1,1,24199,-1,6.8125705e-06,0.9999875,5.756742e-06
2624,the,1,2,3,6,"On the other hand, sustained high-level expression of IFN-gamma mediates significant antitumor effect on H22 hepatoma.",15776283_3,-1,1,-1,1,2624,-1,9.5369405e-06,0.999984,6.432716e-06
30030,the,13,14,65,68,"In this study, we investigated the role of TSLP and periostin in the development of cutaneous T-cell lymphoma (CTCL), where Th2 cytokines and chemokines are also dominant.",27634769_3,-1,1,-1,1,30030,-1,4.1991366e-06,0.99999225,3.5253775e-06
37456,Thus,0,1,0,4,"Thus, Treg cells indirectly but selectively sustained M2-like TAM metabolic fitness, mitochondrial integrity, and survival.",31350177_4,-1,1,-1,1,37456,-1,7.20045e-06,0.99998736,5.472279e-06
27165,the,29,30,153,156,"The proportion and FoxP3 expression of the induced CD4(+)CD25(+) T cells are the highest at the level of 40ng/ml IFN-, and the suppressive function of the CD4(+)CD25(+) T cells induced by 40ng/ml IFN- is the strongest in MG patients.",26347149_12,-1,1,-1,1,27165,-1,4.852783e-06,0.99999046,4.693111e-06
27502,Their,0,1,0,5,"Their medicinal attributes include cardiovascular, hepatoprotective, neuroprotective and immunomodulatory actions.",26473845_1,-1,1,-1,1,27502,-1,6.336253e-06,0.9999887,5.017741e-06
28449,that,10,11,62,66,"Furthermore, we determined in a syngeneic sarcoma mouse model that radiation up-regulates IRF3, IFN, and the T cell chemokines CCL2 and CCL5 in the tumor microenvironment, which are associated with activation and increased infiltration of Th1/Tc1 T cells in the tumor microenvironment.",27014915_6,-1,1,-1,1,28449,-1,3.7719906e-06,0.999992,4.2531374e-06
13091,To,0,1,0,2,"To address this we used a mouse melanoma cell line expressing Fas ligand (B16FasL), which induces an inflammatory response following subcutaneous injection of mice.",20722759_4,-1,1,-1,1,13091,-1,4.4945186e-06,0.99999106,4.4898493e-06
18503,tumor,20,21,159,164,Immune-mediated gene therapy using adenovirus expressing Flt3 ligand and thymidine kinase followed by ganciclovir administration (Flt3/TK) effectively elicits tumor regression in preclinical glioma models.,22996231_0,-1,1,-1,1,18503,-1,5.177827e-06,0.9999908,3.9839124e-06
42668,tumor,32,33,155,160,"v8 is expressed at the highest levels in CD4+CD25+ Tcells in tumors, and specific deletion of 8 from Tcells is as effective as ADWA-11 in suppressing tumor growth.",34233193_2,-1,1,-1,1,42668,-1,4.146634e-06,0.999992,3.8034418e-06
5235,their,16,17,100,105,"A characteristic feature of BL cells, compared to Epstein-Barr Virus (EBV)-immortalized B cells, is their lack of immunogenicity.",17419945_1,-1,1,-1,1,5235,-1,6.1072496e-06,0.9999875,6.4196597e-06
1007,though,4,5,20,26,"In particular, even though a broad distribution of Th2 cytokine receptors by AML blasts was shown, we demonstrated the almost exclusive expression of interleukin 4 (IL-4) receptor (R), in the absence of its cognate cytokine, by CD30L+ AML.",11918534_2,-1,1,-1,1,1007,-1,6.1050964e-06,0.9999877,6.2162117e-06
17785,gene,5,6,42,46,"We performed highly sensitive single-cell gene expression profiling, allowing the direct ex vivo characterization of individual virus-specific and tumor-specific T cells from healthy donors and melanoma patients.",22735807_3,-1,1,-1,1,17785,-1,6.876102e-06,0.99998677,6.358724e-06
5629,the,10,11,69,72,"We found that HPV16 E6-reactive T cells reside preferentially within the CD45RA+ CCR7+ T-cell subpopulation of tumor-infiltrating lymphocyte, peripheral blood lymphocyte, and T-LN in cervical cancer patients, suggesting that successful immune surveillance of HPV16+ tumor cells in cervical cancer patients is impaired.",17589293_5,-1,1,-1,1,5629,-1,3.6015542e-06,0.9999926,3.83903e-06
34449,the,3,4,21,24,"To further delineate the immunoregulatory role of PIP, we compared the expression of IFN-R and TLR4, pro-inflammatory cytokine production, and intracellular signaling events by IFN- and lipopolysaccharide (LPS)-stimulated macrophages from wild-type (WT) and PIP-/- mice.",29536339_3,-1,1,-1,1,34449,-1,4.316047e-06,0.99999225,3.4113846e-06
7338,generation,19,20,121,131,"Collectively, this study highlights the cellular and molecular parameters that might be exploited to control the de novo generation of aTregs and peripheral tolerance.",18599457_9,-1,1,-1,1,7338,-1,7.4486243e-06,0.99998534,7.2425973e-06
26542,Treg,10,11,68,72,Blockade of selected molecular mechanisms that are known to promote Treg expansion identified IDO-positive dendritic cells as the primary mediator of post-IL-12 pTreg expansion.,26085681_6,-1,1,-1,1,26542,-1,5.5151972e-06,0.9999889,5.559614e-06
10227,the,9,10,53,56,CONCLUSION: IRF-1-E7 was shown to be responsible for the positive regulation of many interleukins and to be involved in the differentiation of T-helper cells.,19574175_6,-1,1,-1,1,10227,-1,4.0386526e-06,0.9999925,3.5246994e-06
17771,tumor,16,17,110,115,"CONCLUSIONS: Our data have shown that increased intratumoral CD8(+)Foxp3(+) T lymphocytes are associated with tumor stage and potentially influence CD4(+) T-cell functions, which may provide insights for developing novel immunotherapy protocols against gastric cancer.",22729557_11,-1,1,-1,1,17771,-1,4.0423643e-06,0.99999166,4.3370505e-06
40542,T,13,14,105,106,Recent studies revealed that immunosuppressive TME is directly correlated with heightened activations of T regulatory cells (Tregs) and Myeloid derived suppressor cells (MDSCs) functions.,32890791_2,-1,1,-1,1,40542,-1,5.575929e-06,0.99998474,9.6260765e-06
35342,to,19,20,128,130,These results establish for the first time that inhibition of MALT1 proteolytic activity could be a viable therapeutic strategy to augment anti-tumor immunity.,30025160_7,-1,1,-1,1,35342,-1,4.284493e-06,0.999992,3.6676931e-06
4768,tumor,13,14,99,104,"We demonstrated that immunization with the fusion protein vaccine caused significant inhibition of tumor growth with the delay time to tumor detection (tests vs. controls, 16 d vs. 9 d, p<0.01) and much smaller tumor size (p<0.01) in vivo.",17202676_4,-1,1,-1,1,4768,-1,4.110322e-06,0.9999913,4.6487567e-06
5885,the,3,4,21,24,Our findings support the concept that administration of IL-2 numerically and functionally affects the Treg cell compartment.,17671219_9,-1,1,-1,1,5885,-1,5.0674553e-06,0.9999914,3.463841e-06
0,The,0,1,0,3,"The outcome of antigen recognition by naive CD8+ cytotoxic T lymphocytes (CTLs) in the periphery is orchestrated by CD4+ T-helper cells, and can either lead to priming or tolerization.",10395322_0,-1,1,-1,1,0,-1,4.6572286e-06,0.99999154,3.8110104e-06
760,the,18,19,109,112,"These observations place constraints on the use of this, and potentially other, HPV-derived CTL epitopes for the immunotherapy of cervical cancer.",11673561_9,-1,1,-1,1,760,-1,5.927379e-06,0.9999907,3.3753865e-06
35504,tumour,69,70,415,421,"Neoadjuvant chemotherapy seemed to result in a relocation of Th1-committed CD4+ T cells from blood, presumably to the tumour, indicated by shifts in the methylation patterns, whereas no such shifts were seen for lineages corresponding to IL13, IL17A and FOXP3.CONCLUSION: Increased lineage commitment in CD4+ T cells, as determined by demethylation in predictive CpG sites, is associated with lower post-cystectomy tumour stage, complete response to neoadjuvant chemotherapy and overall better outcome, suggesting epigenetic profiling of CD4+ T cell lineages as a useful readout for clinical staging.",30075815_13,-1,1,-1,1,35504,-1,6.8093123e-06,0.99998593,7.1977347e-06
32897,treated,10,11,42,49,"In this study, a group of LC patients was treated with curcumin.",28731226_4,-1,1,-1,1,32897,-1,7.0889864e-06,0.99998736,5.529492e-06
32464,The,0,1,0,3,"The models are complementary: hamsters are semi-permissive for human oncolytic adenovirus, whereas detailed immunological analyses are possible in mice.",28614908_3,-1,1,-1,1,32464,-1,5.045415e-06,0.9999908,4.147499e-06
9604,tumor,20,21,152,157,Eighty-three percent of TS/A-CIITA-vaccinated mice were completely protected from tumor growth and the remaining 17% displayed significant reduction of tumor growth.,19395374_1,-1,1,-1,1,9604,-1,4.085911e-06,0.9999912,4.6820096e-06
29992,their,22,23,111,116,"As little is known about their function in TDLNs of cancer patients, in this study, their frequency as well as their ability to produce interleukin (IL)-2, IL-10, or interferon (IFN)- were investigated in TDLNs of colorectal cancer (CRC) patients.",27619682_2,-1,1,-1,1,29992,-1,4.8277884e-06,0.9999896,5.5916653e-06
899,through,6,7,36,43,"The mechanism of IL-8 induction was through a mitogen-activated protein kinase and NF-kappaB pathway, as inhibitors of both systems abrogated IL-8 protein induction.",11801678_10,-1,1,-1,1,899,-1,8.19818e-06,0.9999857,6.1651963e-06
3468,transcription factors,7,9,35,56,STAT5 belongs to a small family of transcription factors with dual functions.,16375697_0,-1,1,-1,1,3468,-1,7.797557e-06,0.9999863,5.9105196e-06
13494,TGF-,15,16,88,93,"Abundant Foxp3+IL-17+ T cells were detected in CRC tissue that expresses high levels of TGF-, CXCR3, CCR6, and RORt.",20952660_7,-1,1,-1,1,13494,-1,1.2781771e-05,0.9999789,8.263857e-06
1594,generated,19,20,110,119,Here we report the identification of the LAGE1 protein as a ligand for tumor-specific CD4(+) Treg cell clones generated from the tumor-infiltrating lymphocytes (TILs) of cancer patients.,14738769_2,-1,1,-1,1,1594,-1,7.0657793e-06,0.999987,5.8851065e-06
901,NF-kappaB,12,13,83,92,"The mechanism of IL-8 induction was through a mitogen-activated protein kinase and NF-kappaB pathway, as inhibitors of both systems abrogated IL-8 protein induction.",11801678_10,-1,1,-1,1,901,-1,1.3940069e-05,0.9999771,8.990965e-06
8733,These,2,3,12,17,CONCLUSION: These data provide insight into the kinetics of the immunosuppressive state associated with tumor growth in a murine model of human gliomas.,19226468_10,-1,1,-1,1,8733,-1,4.8123998e-06,0.99999094,4.2785678e-06
2045,the,19,20,105,108,Dominant tolerance is mediated by regulatory T cells (T(reg)) that control harmful autoimmune T cells in the periphery.,15240741_0,-1,1,-1,1,2045,-1,4.9458768e-06,0.99998844,6.6677617e-06
24882,the,14,15,67,70,"In summary, our data suggest that GEP might be a powerful tool for the prediction of immunosuppression and the monitoring of immune responses within immunotherapy trials.",25242680_5,-1,1,-1,1,24882,-1,4.480391e-06,0.9999919,3.6444123e-06
31857,tumor,7,8,44,49,Our findings suggest that IL-35 can promote tumor progression by functioning as an up-stream cytokine to promote cancer-associated inflammation and control neutrophil polarization.,28432279_9,-1,1,-1,1,31857,-1,5.264828e-06,0.9999902,4.502254e-06
31567,Foxp3,20,21,131,136,"In addition to natural (n)Treg and induced (i)Treg cells that develop from naive precursors, suppressive IL-17A+Foxp3+ and ex-Th17 Foxp3+ cells are converted from IL-17A+Foxp3neg cells in tumour-bearing mice.",28290453_2,-1,1,-1,1,31567,-1,1.7886383e-05,0.9999714,1.0725052e-05
36253,this,2,3,9,13,"Overall, this study suggests that B cell-mediated IL-10 production can exert complex effects toward autologous T cells.",30711567_13,-1,1,-1,1,36253,-1,5.003246e-06,0.9999902,4.716644e-06
2100,the,4,5,18,21,"The other half of the patients showed impaired HPV16-specific proliferative responses, which generally lacked both IFN-gamma and interleukin 5.",15289354_5,-1,1,-1,1,2100,-1,4.384702e-06,0.9999906,5.0299154e-06
20965,complex,6,7,40,47,"Furthermore, disruption of the POSH/JIP complex in CD8(+) T cells resulted in impaired proliferation, decreased cytokine expression, and the inability to control tumors.",23963642_6,-1,1,-1,1,20965,-1,4.1319636e-06,0.9999907,5.1071524e-06
31051,that,6,7,43,47,"CONCLUSION: These preliminary data suggest that circulating T-cell clones may directly activate epithelial renal cells or promote a T-/B-cell population with autoimmune reactive properties against kidney cells, which, in the absence of overt renal lymphoma infiltration, lead to the subsequent inflammatory renal fibrotic phenotype.",28018996_6,-1,1,-1,1,31051,-1,4.1518356e-06,0.9999925,3.3644947e-06
16711,the,16,17,121,124,Gal-1-induced IL-10(+) T cells efficiently suppressed T cell proliferation and T cell-mediated inflammation and promoted the establishment of cancer immune-privileged sites.,22345665_3,-1,1,-1,1,16711,-1,3.5993214e-06,0.9999924,4.057697e-06
24439,transfection,61,62,385,397,"One common denominator of these stimuli is the activation of NF-B. Here, we show that human monocyte-derived, cytokine cocktail-matured DCs transfected with constitutively active mutants of IB kinases (caIKKs) by mRNA electroporation, further upregulated maturation markers, and secreted enhanced amounts of cytokines, including IL-12p70, which was produced for more than 48 h after transfection.",25100611_2,-1,1,-1,1,24439,-1,5.478547e-06,0.9999895,5.026002e-06
6899,This,0,1,0,4,This study has provided the proof-of-principle for combining CpG and JSI-124 to enhance antitumor immune responses.,18392040_7,-1,1,-1,1,6899,-1,4.378497e-06,0.99999154,4.0815503e-06
6347,time,23,24,146,150,"In the orthotopic model, BCG induced a local cytokine storm during treatment initiation whereas CpG affected a more refined cytokine pattern over time.",18157010_10,-1,1,-1,1,6347,-1,6.404625e-06,0.9999888,4.764091e-06
24467,the,11,12,70,73,"In summary, embelin represents a novel therapeutic drug candidate for the clinical treatment of pancreatic cancer.",25128650_5,-1,1,-1,1,24467,-1,4.1232197e-06,0.9999924,3.4489844e-06
19011,the,9,10,66,69,"Jurkat T-cell treatments with Er-1 induced the down-regulation of the IL-2R subunit by a reversible and time-dependent endocytosis, and increased the levels of phosphorylation of the extracellular signal-regulated kinases (ERK).",23103669_3,-1,1,-1,1,19011,-1,3.7068007e-06,0.99999154,4.743001e-06
29327,the,24,25,158,161,"Since the binding of antigen-specific dextramers mimics antigen presentation to the TCR, the present study sought to determine whether this TCR engagement on the AST was sufficient to elicit a functional T cell response.",27327144_3,-1,1,-1,1,29327,-1,4.1184385e-06,0.9999908,5.043303e-06
41143,TFs,22,23,149,152,"In this study, we acquired and integrated differentially expressed genes of OSCC patients, including immune-related genes and transcription factors (TFs), from The Cancer Genome Atlas (TCGA) database.",33220636_2,-1,1,-1,1,41143,-1,7.767388e-06,0.99998534,6.861203e-06
2614,this,1,2,3,7,"In this report, by using an ideal mouse model that expresses IFN-gamma locally in muscle, we demonstrate that sustained low-level expression of IFN-gamma promotes the development of several types of tumor including H22 hepatoma, MA782/5S mammary adenocarcinoma and B16 melanoma.",15776283_1,-1,1,-1,1,2614,-1,3.8195412e-06,0.99999213,4.1036515e-06
29357,therefore,16,17,81,90,"Importantly, no effect of the dextramers was observed in the CD8+ non-CASTs, and therefore dextramer negative cell populations.",27327144_10,-1,1,-1,1,29357,-1,5.481263e-06,0.99998736,7.2054236e-06
7230,The,0,1,0,3,The data suggest A673 cells respond to dendritic cell-based immunotherapy.,18563501_6,-1,1,-1,1,7230,-1,4.1981407e-06,0.9999914,4.4244634e-06
26806,therapeutic,24,25,139,150,"Following its identification and the finding of its association to TH1 commitment, great hopes were placed in IL-12 to become a target for therapeutic applications in multiple settings of autoimmunity and cancer.",26182974_4,-1,1,-1,1,26806,-1,4.9242544e-06,0.99999106,3.968215e-06
5341,the,1,2,3,6,"In the present study, we investigated whether p-Coumaric acid (CA), which is suggested to exhibit antioxidant properties, could suppress the functional expression of IDO in murine bone marrow-derived dendritic cells (BMDCs) stimulated with IFN-gamma.",17466914_1,-1,1,-1,1,5341,-1,4.864803e-06,0.99999034,4.82561e-06
40794,the,13,14,94,97,This study indicates that manipulating Egr2 and Egr3 expression would potentiate or alleviate the regulatory function of NK1.1- CD4+ NKG2D+ T cells and this strategy could be used in the therapy for patients with autoimmune diseases or tumor.,33011290_9,-1,1,-1,1,40794,-1,4.009686e-06,0.9999926,3.3877122e-06
10821,to,15,16,96,98,CD4(+)CD25(+)Foxp3(+) regulatory T cells (Treg) known to mediate self-tolerance were also shown to contribute to tumor progression.,19841169_0,-1,1,-1,1,10821,-1,4.840956e-06,0.9999907,4.431504e-06
34673,These,2,3,13,18,"CONCLUSIONS: These results suggest that the attenuated expression of MHC-I molecules by CICs represents a potential strategy of CICs to escape immune recognition, and that the development of successful immunotherapy strategies targeting CICs may decrease their resistance to T cell-mediated immune detection by enhancing CIC MHC-I expression.",29699516_11,-1,1,-1,1,34673,-1,4.4258004e-06,0.9999913,4.2382753e-06
5719,Regulation,0,1,0,10,Regulation of T cell homeostasis is critical for maintaining normal immune function.,17659375_0,-1,1,-1,1,5719,-1,1.3947996e-05,0.99997723,8.8607385e-06
31518,tumors,21,22,141,147,We confirmed this trend of IDO1 methylation by bisulfite pyrosequencing breast cancer cell lines and an independent cohort of primary breast tumors.,28264810_8,-1,1,-1,1,31518,-1,4.2918696e-06,0.99999,5.679967e-06
22435,this,20,21,117,121,"Given the recent disclosure of a major contribution of the thymus to murine  T cell functional differentiation, in this study we have analyzed a series of human pediatric thymuses.",24489097_2,-1,1,-1,1,22435,-1,4.8016764e-06,0.9999908,4.4327853e-06
43848,to,2,3,12,14,"In contrast to anti-CD3/IL-2-activated LN cells, adoptive transfer of freshly isolated tumor-draining LN T cells has no therapeutic activity.",9690455_2,-1,1,-1,1,43848,-1,4.543398e-06,0.9999912,4.281214e-06
9618,type,38,39,278,282,"Important qualitative differences were observed between the two cell-based vaccines, as TS/A-CIITA-vaccinated mice developed a CTL response containing a large proportion of anti-gp70 AH1 epitope-specific cells, completely absent in TS/A-vaccinated mice, and a mixed T(h)1/T(h)2 type of response as opposed to a T(h)2 type of response in TS/A-vaccinated mice.",19395374_4,-1,1,-1,1,9618,-1,7.754549e-06,0.99998295,9.27079e-06
14560,tolerance,49,50,328,337,CMFs from patients with inflammatory bowel diseases had reduced capacity to induce active Treg cells and increased capacity to transiently generate CD4+CD25+/- CD127+ T cells that express low levels of FoxP3.CONCLUSIONS: CMFs suppress the immune response in normal colon tissue and might therefore help maintain colonic mucosal tolerance.,21376048_7,-1,1,-1,1,14560,-1,5.8031783e-06,0.99998784,6.342257e-06
38835,transduction-based,32,33,174,192,"Given the antitumor properties of Tc22 cells, it may be prudent to polarize T cells to the Tc22 lineage when using chimeric antigen receptor (CAR)-T or T-cell receptor (TCR) transduction-based immunotherapies.",31964625_6,-1,1,-1,1,38835,-1,1.2232892e-05,0.9999782,9.540688e-06
21652,than,14,15,105,109,"Functionally, OK-432 plus IFN--conditioned DCs induce remarkable Th1 and Tc1 responses more effectively than OK-432 alone, even more than the use of -type-1 cytokine cocktail.",24296809_4,-1,1,-1,1,21652,-1,6.636246e-06,0.99998856,4.787217e-06
35865,the,29,30,138,141,"In this study, we aim to analyze the expression of CD8 and FoxP3 on T lymphocytes and TGF- expressionin tumor tissues, andthen analyze the possible clinical significance of these finding in order to find a novel effective immunotherapy target in PDAC using a murine model.",30359281_2,-1,1,-1,1,35865,-1,3.75062e-06,0.9999924,3.857967e-06
34295,Tregs,18,19,101,106,"Our results demonstrated that patients with pre-B ALL had a higher percentage of Helios+ FoxP3+ CD4+ Tregs. And there was a positive correlation between the expression of Helios and the suppressive function of Tregs, the risk gradation of ALL.",29455107_3,-1,1,-1,1,34295,-1,4.908623e-06,0.9999893,5.779184e-06
18031,Treg,7,8,28,32,"Here, we show that CXCR3(+) Treg are highly enriched in human ovarian carcinomas, particularly in solid tumor masses, where they represent the majority of Treg.",22798340_4,-1,1,-1,1,18031,-1,5.846552e-06,0.99998796,6.23485e-06
41352,that,6,7,51,55,"Transcriptome and flow cytometry analyses revealed that EOMES does not only drive IL-10 expression, but rather controls a unique transcriptional signature in CD4+ T cells, that is enriched in genes typical for T regulatory type 1 (TR1) cells.",33526861_2,-1,1,-1,1,41352,-1,4.516795e-06,0.9999913,4.1548246e-06
4143,Treg,16,17,90,94,"In the current study, we tested the hypothesis that tumor cells promote the prevalence of Treg.",16799337_1,-1,1,-1,1,4143,-1,5.968398e-06,0.9999883,5.7153034e-06
27372,this,22,23,161,165,"Collectively, these data indicate superior activation of Tregs in the tumor microenvironment, promoting their suppressive ability and selective proliferation at this site.",26433463_6,-1,1,-1,1,27372,-1,4.8582215e-06,0.9999889,6.2317054e-06
21834,Th1,8,9,48,51,"In summary, umbelliprenin has shown a partially Th1 bias with a reduction of regulatory immune response.",24325354_10,-1,1,-1,1,21834,-1,6.590658e-06,0.9999598,3.3552766e-05
29437,the,19,20,116,119,METHODS: In vivo tumor models were prepared via subcutaneous injection with a suspension of B16 melanoma cells into the left upper flank of C57BL/6J mice.,27389040_2,-1,1,-1,1,29437,-1,4.187832e-06,0.9999906,5.182124e-06
8094,the,16,17,89,92,"Aged NZB mice that have developed a B-1 cell malignancy identified as IgM(+)CD5(+), have the most pronounced increase in Tregs.",19022624_4,-1,1,-1,1,8094,-1,5.2329096e-06,0.9999889,5.882015e-06
30307,the,2,3,10,13,"CXCL5 was the most prominently expressed CXCR2 ligand in human PDA, and its expression was higher in PDA than in any other common tumor represented in The Cancer Genome Atlas.",27737879_3,-1,1,-1,1,30307,-1,9.032532e-06,0.99998343,7.550498e-06
2601,The,0,1,0,3,The radiation contributes to the gene therapy by causing tumor debulking and increasing the permeability of tumors to infiltration of inflammatory cells.,15761259_7,-1,1,-1,1,2601,-1,5.183241e-06,0.9999906,4.2044876e-06
3998,Treg,30,31,170,174,"The efficacy of induction of Treg's by DCs depends on the nature of the DC maturation stimulus, with inflammatory cytokine-treated DCs (Cyt-DCs) being the most effective Treg inducers.",16763205_6,-1,1,-1,1,3998,-1,7.688123e-06,0.99998295,9.4149245e-06
34890,The,0,1,0,3,The percentage of Tregs was determined by means of multicolor flow cytometry system.,29785404_3,-1,1,-1,1,34890,-1,4.645456e-06,0.99999154,3.837584e-06
30365,that,6,7,38,42,"Taken together, our findings indicate that HDIL-2 combined with the conditions of malignancy create an immune environment supportive of Th17 differentiation and that expansion of this compartment may occur through the transdifferentiation of IL-17-secreting FoxP3CD4 T cells.",27741090_8,-1,1,-1,1,30365,-1,5.3241843e-06,0.9999908,3.884669e-06
14243,the,8,9,53,56,We hypothesize that SLN tumor burden correlates with the degree of SLN immune dysfunction.,21327637_3,-1,1,-1,1,14243,-1,4.7873214e-06,0.9999913,3.871002e-06
16504,TGF,48,49,268,272,"METHODS: This study aimed to characterise the frequency of T regulatory cells (Tregs), dendritic cells (DCs) as well as sub-populations of T cells bearing regulatory properties like CD4(+)GITR(+), CD4(+)CD62L(+), CD3(+)TCR(+) along with the concentrations of IL-10, TGF, IL-6 in 66 patients with MM.",22223085_1,-1,1,-1,1,16504,-1,1.8346893e-05,0.9999708,1.0829726e-05
5068,to,14,15,112,114,The chemotaxis of normal immunocompetent cells for patients without constitutive chemokine release was observed to be decreased.,17339182_9,-1,1,-1,1,5068,-1,6.8899353e-06,0.9999882,4.93018e-06
41773,this,1,2,3,7,"In this study, we found increased LINC00152 expression levels are positively associated with the poor prognosis of GC patients and negatively associated with the CD8 levels.",33709190_5,-1,1,-1,1,41773,-1,3.970255e-06,0.999992,4.033551e-06
36825,STAT1,11,12,83,88,"In response to the microenvironment, macrophages activate transcription factors as STAT1 and NF-B-p65 for M1 macrophages or STAT3 and STAT6 for M2 macrophages; activation impacts on the profile of cytokine, chemokines and growth factors secreted by macrophages.",31099286_2,-1,1,-1,1,36825,-1,3.942649e-06,0.9999888,7.2484404e-06
1144,gene,23,24,171,175,The calcium-dependent phosphatase calcineurin and its downstream transcriptional effector nuclear factor of activated T cells (NFAT) are important regulators of inducible gene expression in multiple cell types.,12091710_0,-1,1,-1,1,1144,-1,5.0864865e-06,0.9999901,4.8131437e-06
4553,transferred,22,23,142,153,Autologous PBMC from nine gp100-vaccinated patients with metastatic melanoma were stimulated ex vivo with the gp100:209-217(210M) peptide and transferred in combination with high-dose IL-2 and cancer vaccine.,17056585_3,-1,1,-1,1,4553,-1,5.8463816e-06,0.9999893,4.9286714e-06
2160,Regulation of gene expression,2,6,12,41,BACKGROUND: Regulation of gene expression by signal transducer and activator of transcription 1 (STAT1) within host tissues mediates the antitumor effects of interferon alfa (IFN alpha).,15339971_0,-1,1,-1,1,2160,-1,6.2378704e-06,0.9999858,8.0005675e-06
39528,the,3,4,11,14,"The aim of the present study was to investigate the role and molecular mechanism of CC motif chemokine ligand11 (CCL11) in the regulation of Treg cells from patients with breast cancer (BC) and healthy individuals invitro, and from tumorbearing mice invivo.",32323817_1,-1,1,-1,1,39528,-1,4.6294454e-06,0.99999034,5.0709405e-06
18229,trials,13,14,75,81,"However, no standard of therapy has been established, as large prospective trials have not been conducted.",22830400_6,-1,1,-1,1,18229,-1,6.450704e-06,0.99998784,5.767949e-06
5973,tatPTD,17,18,104,110,"Here, SVV-specific immune responses were evaluated with dendritic cells (DCs) loaded with a recombinant tatPTD fused SVV (tatSVV) protein both in vitro and in vivo system.",17931768_1,-1,1,-1,1,5973,-1,1.249978e-05,0.9999763,1.1206312e-05
28177,to,11,12,65,67,"Similar to other oncogenes, KRAS acts in a cell-intrinsic manner to affect tumor growth or survival.",26880715_1,-1,1,-1,1,28177,-1,4.5161046e-06,0.99999106,4.3779896e-06
39200,TH2,42,43,202,205,"Under the control of specific cytokines and B-cell lymphoma 6 transcription factor (Bcl-6), the major transcription factor of TFH cells, TFH, can expand to the other distinct CD4+T helper cells (TH1, TH2, and TH17) which exert a different role in the development of CRC.",32061875_5,-1,1,-1,1,39200,-1,2.0116813e-05,0.9999664,1.3536982e-05
33619,treatment,26,27,156,165,We focused on the ability of the Treg and TAM counts around the cancer lesion to predict outcomes after adjuvant intravesical Bacille Calmette-Gurin (BCG) treatment.,29048388_4,-1,1,-1,1,33619,-1,7.366063e-06,0.99998677,5.827074e-06
43516,the,1,2,3,6,"In the present study we demonstrate that IL-10 is expressed and produced spontaneously in the peripheral blood mononuclear cells (PBMCs) of all HIV-1 infected individuals tested, 3 of 19 cases of HIV-negative lymphoma and none of five healthy controls.",8037735_1,-1,1,-1,1,43516,-1,4.2018655e-06,0.9999914,4.344137e-06
41169,to,6,7,26,28,The aim of this study was to investigate roles of SKIL in tumorigenesis and immune escape of non-small-cell lung cancer (NSCLC).,33268765_1,-1,1,-1,1,41169,-1,3.7472516e-06,0.99999225,3.9534502e-06
30918,the,46,47,230,233,"Areas covered: This article will focus on 1) the role of Treg-derived TGF- in the suppressive activity of Treg, 2) the cellular and molecular regulation of expression of GARP on mouse and human Tregs, 3) the role of integrins in the activation of latent-TGF-/GARP complex, 4) an overview of our present understanding of the function of the latent-TGF-/GARP complex.",28001437_3,-1,1,-1,1,30918,-1,3.970294e-06,0.9999924,3.7077016e-06
23985,Tregs,32,33,226,231,BACKGROUND: Recent reports have revealed the therapeutic potential of cell-mediated immunity in neoplasms such as cutaneous squamous cell carcinoma (SCC).OBJECTIVES: To define the antigenic coexpression of regulatory T cells (Tregs) and plasmacytoid dendritic cells (pDCs) and assess the CD8(+) /Foxp3(+) CD25(+) cell ratio at peritumoral and intratumoral levels in order to investigate a correlation with the aggressiveness of SCC tumours.,24910265_0,-1,1,-1,1,23985,-1,4.7356857e-06,0.99999,5.3269173e-06
25597,gene,16,17,114,118,"Finally, chromatin immunoprecipitation experiments revealed that T-bet can bind to regulatory regions of the CD38 gene.",25505279_6,-1,1,-1,1,25597,-1,5.541419e-06,0.9999857,8.7051385e-06
19057,Tregs,15,16,103,108,"Suppression of both polyclonal and AChR-activated Tresp cells from MG patients could be restored using Tregs isolated from healthy controls, indicating that the defect in immune regulation in MG is primarily localized to isolated Treg cells, and revealing a potential novel therapeutic target.",23110942_3,-1,1,-1,1,19057,-1,4.955539e-06,0.99998987,5.157941e-06
4546,tumor,13,14,78,83,"In this study, we evaluated the capability of vaccine-induced PBMC to mediate tumor regression after transfer to patients receiving the same chemotherapy-induced lymphodepletion used for TIL transfer therapy.",17056585_2,-1,1,-1,1,4546,-1,4.846671e-06,0.99998987,5.231273e-06
7349,that,20,21,97,101,"We show here that TRAIL is cytotoxic only against FL B cells and not against normal B cells, and that DR4 is the main receptor involved in the initiation of the apoptotic cascade.",18606651_2,-1,1,-1,1,7349,-1,4.555273e-06,0.9999902,5.2287464e-06
41766,to,8,9,52,54,"Chromatin immunoprecipitation (ChIP) assay was used to explore the interaction between LINC00152, Cys-X-cys ligand 9 (CXCL9) and Cys-X-cys ligand 10 (CXCL10).",33709190_3,-1,1,-1,1,41766,-1,4.4116664e-06,0.999992,3.5502287e-06
35360,tumor-associated,2,3,17,33,"Mechanistically, tumor-associated Notch1 regulates the expression of several chemokines involved in MDSCs and Tregs recruitment.",30036609_4,-1,1,-1,1,35360,-1,5.436706e-06,0.9999896,4.9048904e-06
15052,tumor,20,21,109,114,The aim of the study was to observe the variation of CD4(+)CD25(+) regulatory T cells in periphery blood and tumor microenvironment of non-small cell lung cancer (NSCLC) patients and the effects of CpG ODN.,21611754_0,-1,1,-1,1,15052,-1,4.0356367e-06,0.9999912,4.7910294e-06
1176,NFATc1,22,23,144,150,"A mechanism for the compromised immune response is suggested by the observation that CnA beta(-/-) T cells are defective in stimulation-induced NFATc1, NFATc2, and NFATc3 activation.",12091710_7,-1,1,-1,1,1176,-1,2.6127891e-05,0.9999373,3.6596855e-05
28471,to,2,3,9,11,"In order to establish an in vitro T-cell model to clarify the effects of long-term exposure of asbestos on tumor immunity, in this study, human T-cell line MT-2 cells were cultured with asbestos for longer than 8 months and the resultant cells (MT-2Rst) were assessed for the expression of forkhead transcription factor FoxO1.",27042963_2,-1,1,-1,1,28471,-1,3.7176296e-06,0.9999924,3.936029e-06
15862,the,10,11,55,58,"Therefore, we assessed the role of PPAR in modulating the effects of dietary n-3 PUFAs by targeted deletion of intestinal epithelial cell PPAR (PPAR(IEpC)).",21940900_2,-1,1,-1,1,15862,-1,3.8832313e-06,0.9999926,3.5548587e-06
32874,Treg,5,6,26,30,"However, the magnitude of Treg induction was diminished in subsequent treatment cycles.",28721449_6,-1,1,-1,1,32874,-1,1.4044701e-05,0.99997723,8.673096e-06
23000,the,11,12,78,81,"In addition, the TLR-9/AP-1/IL-6 pathway provides new therapeutic targets for the prevention and treatment of OSCC.",24676671_10,-1,1,-1,1,23000,-1,4.2231964e-06,0.99999213,3.6013805e-06
38389,the,15,16,99,102,This review highlights the recent progress in the understanding of Tregs in different disorders of the respiratory system.,31827925_5,-1,1,-1,1,38389,-1,5.2552277e-06,0.9999895,5.2926375e-06
7477,This,2,3,8,12,METHOD: This study included 136 breast cancer patients operated in our department from 2003 to 2006.,18685848_1,-1,1,-1,1,7477,-1,4.863493e-06,0.99998903,6.075854e-06
22525,transfected,24,25,127,138,"Coculture of CTCL cells with normal T lymphocytes consisting of both CD4(+) and CD8(+) populations or the CD4(+) subset alone, transfected with CD152 mRNA, inhibits proliferation of normal T cells in a CD152- and CD80-dependent manner.",24523507_4,-1,1,-1,1,22525,-1,4.8039747e-06,0.9999887,6.5577e-06
1434,tumor,7,8,50,55,Increasing the number of plasmid injections after tumor irradiation induced tumor regression in 70% of the mice.,12804139_7,-1,1,-1,1,1434,-1,5.880715e-06,0.99998915,4.964888e-06
3045,the,12,13,81,84,"The TGF-beta receptor-activated Smad3 plays a critical role in mediating many of the inhibitory effects of TGF-beta signaling in T cells, and has now been established as an important suppressor of leukemogenesis.",16123803_5,-1,1,-1,1,3045,-1,1.0114645e-05,0.99998164,8.267979e-06
17949,Therapeutic,0,1,0,11,"Therapeutic immunization with Stat3Y705F-breast cancer cells inhibited tumor growth, promoted tumor cell differentiation, and decreased metastasis.",22753933_7,-1,1,-1,1,17949,-1,5.4353477e-06,0.9999906,3.9813062e-06
15298,TGF-1,7,8,51,57,Primary gastric cancer cells produced abundance of TGF-1 which was responsible for conversion of Treg.,21695703_8,-1,1,-1,1,15298,-1,8.668832e-06,0.9999757,1.562032e-05
7759,tumors,16,17,116,122,"Accordingly, we enumerated FOXP3(+)CD4 T(reg) cells in intratumoral and peritumoral sections of metastatic melanoma tumors and found a significant increase in proportion of FOXP3(+)CD4 T(reg) cells in the intratumoral compared with peritumoral areas.",18820132_3,-1,1,-1,1,7759,-1,3.817332e-06,0.9999914,4.787957e-06
11901,the,20,21,116,119,"However, whereas all three mAbs quantitatively depleted FoxP3(+) T cells to a similar extent, subtle differences in the downstream mechanisms of tumor control existed for all three approaches.",20332236_5,-1,1,-1,1,11901,-1,5.0930166e-06,0.9999913,3.5585108e-06
11504,that,33,34,233,237,"Interestingly, although p38-chemical inhibitor (p38-inhibitor) is capable of breaking CD25(-) iTreg-induced immunotolerance, the p38-inhibitor had hardly any immunotolerance breaking effect when CD25(+) Treg were present, suggesting that depletion of CD25(+) Treg is necessary for p38-inhibitor to be effective.",20127675_2,-1,1,-1,1,11504,-1,6.5848603e-06,0.9999895,3.890881e-06
1404,This,0,1,0,4,"This phenotype was created by intratumoral injection of plasmid cDNAs coding for interferon gamma, MHC class II transactivator, and an antisense reverse gene construct (RGC) for a segment of the gene for Ii protein (-92,97).",12804139_2,-1,1,-1,1,1404,-1,3.6869076e-06,0.999992,4.3071072e-06
9082,the,16,17,108,111,"Conspicuously among the latter is the immunoglobulin-like transcript 3 (ILT3), which independently prevents the activation of both DC and T cells.",19275918_4,-1,1,-1,1,9082,-1,8.110448e-06,0.99998784,4.0721884e-06
17849,the,23,24,154,157,"Following activation of TLR4 in H22 murine hepatoma cells pre-incubated with lipopolysaccharide (LPS) and co-cultured with macrophage cell line RAW246.7, the synthesis of cytokines tumor necrosis factor-, CCL22, and interleukin (IL)-10 by the two cell lines was detected and analyzed.",22736917_3,-1,1,-1,1,17849,-1,4.4107146e-06,0.99999094,4.6980163e-06
34548,than,24,25,152,156,"Immunohistochemistry revealed that latency-associated peptide (LAP) of TGF1 was localized in mainly immune cells in all cases, which was more abundant than in control GCs.",29594353_4,-1,1,-1,1,34548,-1,5.411484e-06,0.9999888,5.8528058e-06
26424,tumors,23,24,148,154,"CCR5 blockade also suppresses interleukin (IL)-6 induction, which in turn deactivates signal transducer and activator of transcription 3 (Stat3) in tumors.",26047948_3,-1,1,-1,1,26424,-1,4.161124e-06,0.99999166,4.207268e-06
27194,tumorigenesis,32,33,214,227,"In the present manuscript, we explore known and potential various types of cancer prevention strategies and focus on nonvaccine-based cancer preventive strategies targeting the immune system at the early stages of tumorigenesis.",26364615_3,-1,1,-1,1,27194,-1,3.6170397e-06,0.99999154,4.7991393e-06
13984,TGF-,9,10,72,77,A massive mononuclear perivascular infiltrate and reduced expression of TGF- in the absence of NFAT1 suggested a role for tumor-infiltrating immune cells and the cytokine milieu.,21225259_6,-1,1,-1,1,13984,-1,8.940957e-06,0.9999833,7.763683e-06
12255,Tregs,22,23,116,121,"On the other hand, conventional GCs were characterized by a paucity of CXCR3(+) T cells and a relative abundance of Tregs.",20422211_7,-1,1,-1,1,12255,-1,4.376413e-06,0.9999914,4.2162196e-06
9843,the,4,5,19,22,"PURPOSE: To assess the extent of signal transducer and activator of transcription (STAT) activation in response to interleukin 2 (IL-2) in melanoma patients' T cells, along with clinical stage of tumor progression.",19509154_0,-1,1,-1,1,9843,-1,3.8482995e-06,0.9999925,3.7209643e-06
15669,the,5,6,22,25,"In the present study, the population of CD11b(+)Gr-1(+) myeloid-derived suppressor cells (MDSCs) was significantly increased in lung and blood of doxycycline-treated bitransgenic mice, but CD4(+) and CD8(+) T cells were decreased.",21864492_2,-1,1,-1,1,15669,-1,3.553875e-06,0.9999924,4.039808e-06
14965,FoxP3,6,7,40,45,Our work shows that expanded peripheral FoxP3+ Tregs in untreated RCC patients co-express Helios.,21570917_4,-1,1,-1,1,14965,-1,7.3129527e-06,0.999987,5.647278e-06
14849,The,0,1,0,3,The production of TGF-1 was detected in supernatant of MGC and GES-1.,21528082_5,-1,1,-1,1,14849,-1,4.009709e-06,0.9999925,3.4980635e-06
3514,The,0,1,0,3,The challenge for drug developers will be the exploitation of defined protein-protein or protein-DNA interactions as targets of inhibition.,16375697_10,-1,1,-1,1,3514,-1,4.7694634e-06,0.99999154,3.7435416e-06
6189,Treg,3,4,26,30,"Similarly to conventional Treg, Nrp1+ Treg proliferated poorly in vitro, and exerted contact-dependent in vitro suppression of T-cell proliferation and cytokine secretion.",18028372_2,-1,1,-1,1,6189,-1,7.162386e-06,0.9999865,6.2823697e-06
28788,the,3,4,13,16,"In contrast, the levels of mRNA transcripts for effector T cell cytokines IL2, IL4 and interferon-gamma (IFN) were not elevated in sarcoids compared to healthy skin or spleen.",27160146_6,-1,1,-1,1,28788,-1,3.7639352e-06,0.9999924,3.811886e-06
28755,targets,17,18,122,129,MAC-1/2A cells also provide a candidate human Th17 laboratory model for identifying potentally actionable CTCL markers or targets and testing their druggability in vitro.,27144517_10,-1,1,-1,1,28755,-1,5.803491e-06,0.9999883,5.8676237e-06
20923,The,0,1,0,3,"The increased suppressive capacity can be explained by a distinct cell surface expression profile, which includes high levels of CD39, CD73, TGF- and GARP.",23948613_4,-1,1,-1,1,20923,-1,4.539463e-06,0.99999154,3.955491e-06
43717,TAP,5,6,41,44,"This phenotype reflects abnormalities in TAP heterodimer expression, which cause defects in stable assembly and intracellular transport of the HLA Class I antigen trimolecular complex.",8795138_4,-1,1,-1,1,43717,-1,4.40212e-06,0.99999166,3.971064e-06
30113,this,1,2,3,7,"In this article, we will review immune checkpoint and inflammation as potential targets, as well as clinical trials and the prospects for immunotherapy in PAC.",27672267_4,-1,1,-1,1,30113,-1,5.5273854e-06,0.9999888,5.6490658e-06
34335,tumor,9,10,60,65,We demonstrated that genetic ablation of St2 enhanced colon tumor development.,29463593_5,-1,1,-1,1,34335,-1,6.31497e-06,0.99998856,5.1499715e-06
34523,Tumor-induced,0,1,0,13,Tumor-induced reductions in cDC1 development impair anti-tumor CD8+ T-cell responses and correlate with poor patient outcomes.,29593283_7,-1,1,-1,1,34523,-1,1.0792278e-05,0.9999831,6.154899e-06
7695,FOXP3(+,11,12,66,73,Approximately 50% of the T cells infiltrating untreated SCCs were FOXP3(+) regulatory T (T reg) cells.,18794336_4,-1,1,-1,1,7695,-1,6.9663656e-05,0.9998816,4.869368e-05
39874,the,9,10,37,40,Regulatory T cells (Tregs) is one of the immunosuppressive subsets of CD4+ T cells characterized by transcription factor forkhead box protein P3 (FOXP3) expression which are involved in tumor development and progression.,32480291_0,-1,1,-1,1,39874,-1,4.7450644e-06,0.9999906,4.677865e-06
34682,target,6,7,34,40,"Tyrosine kinase inhibitors (TKIs) target angiogenesis by affecting, for example, the VEGF receptors in tumors and have improved outcomes for patients with metastatic renal cell carcinoma (mRCC).",29700053_0,-1,1,-1,1,34682,-1,6.9522985e-06,0.99998844,4.561751e-06
12479,FoxP3(+,8,9,38,45,"However, the cause of the increase in FoxP3(+) cell frequency in HTLV-1 infection was unknown.",20525891_3,-1,1,-1,1,12479,-1,7.055393e-05,0.9998878,4.1577026e-05
9401,the,15,16,111,114,This failure of the immune system has been associated both with glioma-derived immunosuppressive molecules and the immune-privileged state of the CNS.,19337997_1,-1,1,-1,1,9401,-1,3.9595184e-06,0.9999924,3.7182822e-06
42156,tumor,21,22,124,129,"Conversely, WT mice showed an inverse frequency of Treg cells compared with STAT6-/- mice, which was followed by intestinal tumor formation.",33919941_5,-1,1,-1,1,42156,-1,4.5435404e-06,0.99999,5.456795e-06
30978,to,78,79,272,274,"BCG responders showed significantly higher levels of urinary (p=0.003) and serum neopterin (p=0.012), kynurenine (p=0.015), KTR (p=0.005), IFN- (p=0.005) and IL-12 (p=0.003) during therapy, whereas levels of IL-10 decreased significantly (p<0.001) compared to non-responders.",28005163_6,-1,1,-1,1,30978,-1,4.9699574e-06,0.99999034,4.634216e-06
40298,the,15,16,95,98,This study also underlines the need for predictive immunogenic mouse models of BCC to evaluate the efficacy of immunotherapeutic strategies invivo.,32615027_8,-1,1,-1,1,40298,-1,4.4375156e-06,0.99999213,3.4694372e-06
37959,that,14,15,85,89,RESULTS: A very small fraction of CD4+CD25-FoxP3+ cells produced cytokines at levels that were significantly lower than in the regulatory (CD4+CD25+FoxP3+) and effector cell (CD4+CD25+FoxP3-) subpopulations.,31630080_3,-1,1,-1,1,37959,-1,5.769038e-06,0.9999888,5.3816234e-06
11117,the,23,24,134,137,"We found that, in addition to a significant suppression of growth on the DR-treated side of the tumor, combination therapy suppressed the growth of DR-untreated remote tumors in both tumor-specific and T cell-dependent manners.",19940990_3,-1,1,-1,1,11117,-1,3.6814813e-06,0.9999926,3.736936e-06
11730,The,0,1,0,3,The mice treated with Allo-BMT + Allo-TT or 3rd-party TT showed the longest survival.,20229083_3,-1,1,-1,1,11730,-1,4.252518e-06,0.9999912,4.57124e-06
30366,the,10,11,64,67,"Taken together, our findings indicate that HDIL-2 combined with the conditions of malignancy create an immune environment supportive of Th17 differentiation and that expansion of this compartment may occur through the transdifferentiation of IL-17-secreting FoxP3CD4 T cells.",27741090_8,-1,1,-1,1,30366,-1,4.807152e-06,0.9999908,4.4010667e-06
17086,to,6,7,27,29,"In MM patients, Tregs seem to contribute to myeloma-related immune dysfunction and targeting them could, therefore, help to restore and enhance vital immune responses.",22489248_4,-1,1,-1,1,17086,-1,3.9322476e-06,0.99999154,4.590061e-06
18778,to,14,15,94,96,"The receptor tyrosine kinase inhibitor, sunitinib, is astonishingly effective in its capacity to reduce MDSCs in peripheral tissues such as blood (human) and spleen (mouse), restoring responsiveness of bystander T lymphocytes to TcR stimulation.",23017141_0,-1,1,-1,1,18778,-1,5.575149e-06,0.99998975,4.7326503e-06
41514,thymoma,13,14,68,75,"In this study, 30 patients with simple thymoma and 30 patients with thymoma with MG were analyzed.",33636431_1,-1,1,-1,1,41514,-1,5.024276e-06,0.9999865,8.47181e-06
32955,tumor-bearing,40,41,283,296,"Functional assays were used including single-cell analysis, reverse-phase protein array (RPPA), antigen-specific vaccination models with adoptively transferred TCR-transgenic T cells as well as patient-derived xenograft (PDX) model using immunodeficient NOD-scid IL2Rgammanull (NSG) tumor-bearing mice treated with autologous TILs.",28754817_5,-1,1,-1,1,32955,-1,9.364803e-06,0.99998283,7.793873e-06
17679,to,21,22,123,125,"Thus, IFN- is not only an important CD8 T cell effector cytokine, it is an autocrine/paracrine factor whose contributions to differentiation vary depending on whether the response is supported by IL-12 or type I IFN.",22706089_3,-1,1,-1,1,17679,-1,8.208876e-06,0.9999831,8.738103e-06
33213,to,15,16,106,108,Emerging evidence suggests a role for micro-environmental factors such as CD25+ cells modulating response to PD-1 inhibition.,28940183_1,-1,1,-1,1,33213,-1,6.132968e-06,0.99998975,4.102832e-06
29253,namely,21,22,136,142,"We therefore investigated the phenotypic and functional differences among in vitro activated CD8(+) T cells of three different sources, namely nave (NTeff), memory (MTeff) and tumor-infiltrating lymphocytes (TILeff) from human and mice, to better understand mechanisms behind potent effector functions and potential for overcoming current limitations.",27306834_1,-1,1,-1,1,29253,-1,5.338875e-06,0.9999902,4.4475437e-06
32845,trial,4,5,14,19,"In a phase IV trial (Re:Mission Trial, NCT01347996, http://www.clinicaltrials.gov ) 84 patients (age 18-79) with acute myeloid leukemia (AML) in first complete remission (CR) received ten consecutive 3-week cycles of immunotherapy with histamine dihydrochloride (HDC) and low-dose interleukin-2 (IL-2) to prevent relapse of leukemia in the post-consolidation phase.",28721449_1,-1,1,-1,1,32845,-1,4.6770024e-06,0.9999893,6.0224243e-06
24781,Tregs,7,8,43,48,"Splenic CD4(+)FoxP3(+) regulatory T cells (Tregs) expanded substantially in untreated mice that exhibited then a reduced survival, whereas Tregs depletion led to long-term survival of the animals, suggesting the establishment of a Treg-dependent immunosuppressive environment after tumor injection.",25231744_3,-1,1,-1,1,24781,-1,4.49711e-06,0.99999034,5.1853754e-06
19702,tumor,23,24,143,148,The transcription factor interferon regulatory factor-8 (IRF-8) is crucial for myeloid cell development and immune response and also acts as a tumor suppressor gene.,23308054_0,-1,1,-1,1,19702,-1,4.5884794e-06,0.9999902,5.182389e-06
23091,the,18,19,111,114,"However, the efficacy of DC-mediated cancer vaccines is still limited as they are unable to sufficiently break the immune tolerance.",24690994_1,-1,1,-1,1,23091,-1,1.1091654e-05,0.9999833,5.583658e-06
41517,Tregs,6,7,36,41,"Flow cytometry analysis of Th17 and Tregs in peripheral blood revealed that the percentages of Th17 in thymoma were lower than those in thymoma with MG, while the percentages of Tregs were higher than those in simple thymoma.",33636431_2,-1,1,-1,1,41517,-1,5.0668737e-06,0.99998915,5.7704815e-06
37937,their,18,19,133,138,Immature dendritic cells (Im-DCs) cocultured with JQ1-pretreated Cal27 cells exhibited significant upregulation of mature markers on their surface and an increase in the secretion of cytokines.,31600692_5,-1,1,-1,1,37937,-1,7.88555e-06,0.99998116,1.0961376e-05
28734,treatment,15,16,101,110,"Importantly, indolent stage cells remained poised for Th17 cytokine expression, readily inducible by treatment with IL-2 - a cytokine which mitigates Th17 differentiation in mice.",27144517_4,-1,1,-1,1,28734,-1,7.4474624e-06,0.99998856,3.9487404e-06
5262,type,26,27,127,131,"c-MYC acts at at least two different levels, the level of interferon induction as well as at the level of action of type I and type II interferons on their respective target promoters.",17419945_6,-1,1,-1,1,5262,-1,7.697562e-06,0.99998546,6.9000757e-06
36007,to,10,11,76,78,CCL1 was significantly over-expressed in invasive breast cancer as compared to normal breast tissue.,30572845_6,-1,1,-1,1,36007,-1,5.1134707e-06,0.9999901,4.7340786e-06
10882,the,30,31,150,153,"Ten patients had blood lymphocyte proliferative T cell responses directed against E6/2 (14-34) and/or E6/4 (45-68) peptides, which were identified in the present study as immunodominant among HPV-16 E6 and E7 large peptides.",19843089_1,-1,1,-1,1,10882,-1,4.903266e-06,0.9999902,4.8563847e-06
14469,tumors,18,19,114,120,Angiopoietin 2 (ANGPT2) is a proangiogenic cytokine whose expression is often upregulated by endothelial cells in tumors.,21368233_0,-1,1,-1,1,14469,-1,4.9495975e-06,0.9999908,4.281572e-06
10357,the,35,36,177,180,"When E6(Co) and E7(Co) were fused (E67(Co)), CD8(+) T cell responses specific for E6 or E7 antigen decreased, but the preventive antitumor effect rather improved, demonstrating the importance of broad immunity.",19651174_2,-1,1,-1,1,10357,-1,4.813912e-06,0.9999913,3.8459066e-06
13649,to,17,18,112,114,Marked induction of CXCR1 expression on Foxp3(+) CD4 Tregs by IL-6 followed by IL-8-mediated migration appeared to be responsible for enriched migration.,21048114_2,-1,1,-1,1,13649,-1,4.825711e-06,0.99999034,4.8261304e-06
37902,forkhead box protein O1,13,17,94,117,"Mechanistically, HDAC6 limits TH 17 pathogenicity and the antitumor effect through regulating forkhead box protein O1 (FoxO1).",31539182_4,-1,1,-1,1,37902,-1,1.2760741e-05,0.999961,2.6232028e-05
9351,thus,11,12,60,64,"Agonistic signaling through GITR, in the absence of NFATc2, thus emerges as a novel possible strategy for the treatment of human bronchial adenocarcinoma in the absence of NFATc2 by enhancing IL-2Ralpha(+) effector and IL-7Ralpha(+) memory-expressing T cells.",19318584_6,-1,1,-1,1,9351,-1,3.6796594e-06,0.99999154,4.786921e-06
26742,the,12,13,74,77,Here we show altered numbers of forkhead box P3 (Foxp3)-positive Tregs in the intestine of dogs with IBD and intestinal lymphoma.,26173451_1,-1,1,-1,1,26742,-1,3.0712688e-06,0.999992,4.918102e-06
34161,through,14,15,86,93,"In contrast, increased CD4+ cell infiltration and TNF- expression were also observed through melatonin treatment.",29331794_9,-1,1,-1,1,34161,-1,1.2904181e-05,0.9999821,4.9437194e-06
6082,the,22,23,133,136,"Finally, the dual APL-induced CD4(+)CD25(+)Foxp3(+) cells were up-regulated in CD8(-/-) mice to a similar extent to that observed in the WT mice.",17956982_8,-1,1,-1,1,6082,-1,3.916e-06,0.999992,4.112219e-06
4635,therapeutic,15,16,83,94,"In this review, we discuss the current knowledge of Treg biology and the potential therapeutic strategies and barriers of Treg immunotherapy in human hematopoietic cell transplantation.",17084366_5,-1,1,-1,1,4635,-1,5.3776603e-06,0.9999902,4.3877626e-06
12394,the,18,19,110,113,"Contrary to the common notion that MDSC are a heterogeneous population of exclusively immature cells, we find the coexpression of markers associated with mature phenotype.",20484028_3,-1,1,-1,1,12394,-1,5.3079807e-06,0.9999908,3.8539088e-06
40692,the,17,18,111,114,The specific loss of GM-CSF signaling or IRF5 expression in the eosinophil compartment phenocopies the loss of the entire lineage.,32970801_2,-1,1,-1,1,40692,-1,5.192342e-06,0.9999902,4.5954507e-06
34060,the,7,8,50,53,Notch1 expression in B16 melanoma cells inhibited the infiltration of CD8+ cytotoxic T lymphocytes and NK cells and reduced IFN- release in tumor tissue.,29301578_8,-1,1,-1,1,34060,-1,3.8474914e-06,0.9999924,3.8218127e-06
23811,To,0,1,0,2,"To eliminate relapse-causing leukemic stem/progenitor cells (LPCs), patient-specific immune therapies may be required.",24855276_1,-1,1,-1,1,23811,-1,5.761292e-06,0.99998987,4.3590494e-06
14823,Treg,42,43,232,236,"Up-regulation of CXCR4 in Treg correlated with the basal-like phenotype (P = 0.029) and tumour hypoxia, as indicated by CA9 expression (P = 0.049).CONCLUSIONS: Our data show that in the setting of hypoxia and CXCR4 up-regulation in Treg, CXCL12 expression may have the negative consequence of enhancing Treg recruitment and suppressing the anti-tumour immune response.",21521526_8,-1,1,-1,1,14823,-1,4.114787e-06,0.9999906,5.2446694e-06
35814,tumor,11,12,62,67,"However, the interaction between IL-33 and Tregs in the HNSCC tumor microenvironment remains uncertain.",30357458_2,-1,1,-1,1,35814,-1,4.2663614e-06,0.9999912,4.533902e-06
32037,Th2,15,16,99,102,It was demonstrated that ILC2s and MDSCs were clearly upregulated and accompanied by a predominant Th2 phenotype in patients with lung cancer; this may lead to new immunotherapy approaches for lung cancer based on the associated metabolites and cytokines.,28487978_8,-1,1,-1,1,32037,-1,4.042526e-05,0.9999397,1.9919396e-05
29252,three,17,18,111,116,"We therefore investigated the phenotypic and functional differences among in vitro activated CD8(+) T cells of three different sources, namely nave (NTeff), memory (MTeff) and tumor-infiltrating lymphocytes (TILeff) from human and mice, to better understand mechanisms behind potent effector functions and potential for overcoming current limitations.",27306834_1,-1,1,-1,1,29252,-1,1.1926895e-05,0.9999783,9.749909e-06
19108,the,15,16,104,107,Adoption of methodology for quantifying T(REG) with the least variability and subjectivity will enhance the ability to compare and interpret findings across studies.,23118856_13,-1,1,-1,1,19108,-1,4.9183977e-06,0.9999912,3.931106e-06
8403,the,15,16,104,107,"Although our data generally correspond to data obtained with gene expression and protein-based methods, the results are less fluctuating and more specific to Treg.",19147574_9,-1,1,-1,1,8403,-1,4.2539673e-06,0.99999154,4.2371767e-06
37285,target,12,13,51,57,Our study thus implicates Fas in CD4+ T cells as a target for inflammatory bowel disease therapy.,31266950_6,-1,1,-1,1,37285,-1,5.3230688e-06,0.9999893,5.383751e-06
16934,TIM-3,22,23,128,133,"Long-term exposure of freshly isolated human CD4+ T cells to IL-12 in vitro caused T cell dysfunction and induced expression of TIM-3, a T cell immunoglobulin and mucin domain protein with a known role in T cell exhaustion, via an IFN--independent mechanism.",22426209_6,-1,1,-1,1,16934,-1,7.626605e-06,0.999982,1.0411795e-05
42843,type,11,12,55,59,"The protective effect of PBC was relying on type 1 and type 2 T cell responses and, to a lesser extent, on B cells.",34495298_6,-1,1,-1,1,42843,-1,6.700754e-06,0.9999862,7.1482987e-06
34855,treated,12,13,75,82,"While the number of IFN--producing cells within TME was increased in mice treated with FM, the infiltration of CD8+ T cells and NK cells was not increased.",29784005_14,-1,1,-1,1,34855,-1,5.2796418e-06,0.9999895,5.226374e-06
4824,These,0,1,0,5,These results support a rationale for manipulating Treg to enhance cancer immunotherapy.,17205133_7,-1,1,-1,1,4824,-1,4.696679e-06,0.9999914,3.8916273e-06
51,tumor,32,33,187,192,"Although both E6 and E7 proteins contain numerous predicted cytotoxic T lymphocyte (CTL) epitopes that are capable of binding to human leukocyte antigens, the majority of earlier in vivo tumor rejection studies have focused on E7.",10419051_2,-1,1,-1,1,51,-1,4.571135e-06,0.99999106,4.3282184e-06
3093,turnover,30,31,229,237,"Because NO-treated tumor cells displayed a preferential loss of survivin protein expression via a proteasome-dependent pathway, enhanced tumor sensitivity to dendritic cell-mediated killing may be associated with the accelerated turnover of this critical antiapoptotic gene product.",16166326_7,-1,1,-1,1,3093,-1,9.03772e-06,0.9999863,4.7096087e-06
40672,STAT1,12,13,71,76,"Finally, we found a negative correlation between METTL3 or METTL14 and STAT1 in 59 patients with pMMR-MSI-L CRC tumors.",32964498_6,-1,1,-1,1,40672,-1,6.148962e-06,0.99996877,2.5040568e-05
11495,the,14,15,83,86,"In a basic study of immunotolerance, injection of an endogenous superantigen, i.e. the minor lymphocyte stimulatory (Mls)-1(a), into specific TCR Vbeta8.1-Tg mice enabled generation of anergic CD25(-) iTreg, the immunosuppressive function of which was maintained by IL-10 production via p38-MAPK activation.",20127675_1,-1,1,-1,1,11495,-1,5.3861772e-06,0.9999887,5.960357e-06
40564,FOXP3,2,3,18,23,"Downregulation of FOXP3, GITR and CTLA4 in tumor-infiltrating Tregs and inhibition of Cox2, PGE2 and Arginase 1 in intra-tumoral MDSC were evidenced as some of the key events during therapeutic intervention of GA in melanoma management.",32890791_7,-1,1,-1,1,40564,-1,5.027921e-06,0.99998975,5.228953e-06
40051,the,1,2,3,6,"As the IL-2 receptor, CD25 could be moderately upregulated in stimulated CD25- Tfh cells.",32534760_5,-1,1,-1,1,40051,-1,7.375824e-06,0.99998736,5.303611e-06
30917,the,41,42,205,208,"Areas covered: This article will focus on 1) the role of Treg-derived TGF- in the suppressive activity of Treg, 2) the cellular and molecular regulation of expression of GARP on mouse and human Tregs, 3) the role of integrins in the activation of latent-TGF-/GARP complex, 4) an overview of our present understanding of the function of the latent-TGF-/GARP complex.",28001437_3,-1,1,-1,1,30917,-1,4.010602e-06,0.99999213,3.8192575e-06
12466,type,7,8,53,57,We recently reported that human T-lymphotropic virus type 1 (HTLV-1) infection is accompanied by a high frequency of CD4(+)FoxP3(+) cells in the circulation.,20525891_0,-1,1,-1,1,12466,-1,8.896259e-06,0.9999783,1.27920075e-05
39031,transcription factor,27,29,170,190,"We further studied the underlying molecular mechanisms and found that depletion of mTORC1 resulted in the increased expression of SOCS1, which in turn suppressed the key transcription factor Eomes, consequentially reducing IFN- production.",32001780_3,-1,1,-1,1,39031,-1,4.7828653e-06,0.9999908,4.429371e-06
6839,to,3,4,25,27,"IL-9-deficient mice fail to develop experimental oral antigen-induced intestinal anaphylaxis, and intestinal IL-9 overexpression induces an intestinal anaphylaxis phenotype (intestinal mastocytosis, intestinal permeability, and intravascular leakage).",18378796_3,-1,1,-1,1,6839,-1,5.090355e-06,0.9999902,4.7072067e-06
27096,Treg,16,17,87,91,"In this study, we identified the mRNA expression pattern of Th2 and regulatory T-cell (Treg) cytokines in IgG4-RD and in IgG4-associated MZL and IgG4-negative MZL using real-time polymerase chain reaction analysis.",26311608_2,-1,1,-1,1,27096,-1,9.529101e-06,0.99997413,1.6390457e-05
26969,the,14,15,79,82,"Subsequently, there was a significant decrease in the size of tumor tissue and the numbers of heteromorphic tumor cells.",26270121_6,-1,1,-1,1,26969,-1,4.094474e-06,0.9999914,4.52997e-06
29020,natural,1,2,10,17,Invariant natural killer T (iNKT) cells are a subset of innate-like T cells that act as important mediators of immune responses.,27226296_0,-1,1,-1,1,29020,-1,1.7978578e-05,0.99997234,9.664295e-06
10497,FOXP3,39,40,241,246,"In summary, our findings show that ovarian carcinoma cells are able to induce expression of FOXP3 and exhibit suppressive ability in activated nave T cells by producing soluble substances, and multiple cytokines involve in the induction of FOXP3 expression.",19673890_8,-1,1,-1,1,10497,-1,4.2596644e-06,0.9999919,3.7973743e-06
28092,the,6,7,28,31,The effect of DC vaccine on the accumulation of Foxp3+CD4+ regulatory T cells within the tumor microenvironment and on the production of TGF- suggests that tumor regression by DC vaccination may be associated with an altered immunosuppressive tumor microenvironment.,26786094_8,-1,1,-1,1,28092,-1,3.5192331e-06,0.9999931,3.3421013e-06
29802,the,13,14,78,81,"In this study, we found that IRF4 expression was remarkably suppressed during the development of MDSCs in the tumor microenvironment.",27601624_4,-1,1,-1,1,29802,-1,4.043655e-06,0.9999924,3.5277862e-06
24090,the,7,8,58,61,In vitro assays and immunohistochemical analyses revealed the recruitment of T effector cells and CD8 T cells into the tumor area.,24987872_7,-1,1,-1,1,24090,-1,4.5463926e-06,0.999992,3.3976726e-06
41627,T-bet,0,1,0,5,T-bet induces differentiation into helper T cell type 1 (Th1) by suppressing differentiation into Tfh and enhances cellular immune responses.,33647861_2,-1,1,-1,1,41627,-1,5.5393216e-06,0.9999877,6.7809533e-06
7891,Foxp3(+,11,12,72,79,"Consistent with previous reports, we observed a significant increase of Foxp3(+) cells in the tumor tissue.",18941744_5,-1,1,-1,1,7891,-1,9.852257e-05,0.99985945,4.1962954e-05
40748,T,20,21,109,110,"NK1.1- CD4+ NKG2D+ T cells are a subpopulation of regulatory T cells that downregulate the functions of CD4+ T, CD8+ T, natural killer (NK) cells, and macrophages through TGF-1 production.",33011290_0,-1,1,-1,1,40748,-1,1.0197282e-05,0.9999082,8.160498e-05
15568,to,7,8,42,44,"Thus, spontaneous CD4(+) T-cell responses to ESO in cancer patients are prevalently of T(H)1 type and not Treg.",21829534_6,-1,1,-1,1,15568,-1,1.4506373e-05,0.99997246,1.2999821e-05
20979,Triptolide,0,1,0,10,"Triptolide, a major active component isolated from the Chinese medicinal herb Tripterygium wilfordii, has been proven to possess multiple antitumor activities.",23975869_1,-1,1,-1,1,20979,-1,2.727003e-05,0.9999461,2.6660662e-05
39030,the,25,26,162,165,"We further studied the underlying molecular mechanisms and found that depletion of mTORC1 resulted in the increased expression of SOCS1, which in turn suppressed the key transcription factor Eomes, consequentially reducing IFN- production.",32001780_3,-1,1,-1,1,39030,-1,4.006512e-06,0.99999225,3.7433083e-06
24822,their,47,48,250,255,"CD1d-restricted NKT cells represent a unique lineage of immunoregulatory T cells that are divided into two groups, type I and type II, based on their TCR usage. Because there are no specific tools to identify type II NKT cells, little is known about their developmental requirements and functional regulation.",25236978_0,-1,1,-1,1,24822,-1,5.364009e-06,0.99999,4.620397e-06
9551,to,10,11,50,52,It is thought that FOXP3 is not a specific marker to determine regulatory T cells (Treg) in humans.,19383912_1,-1,1,-1,1,9551,-1,4.365659e-06,0.9999906,5.0300496e-06
18048,that,18,19,97,101,"Finally, we show that the proportion of CXCR3(+) Treg at tumor sites is directly correlated with that of CXCR3(+) T effectors, consistent with expression of CXCR3 ligands.",22798340_7,-1,1,-1,1,18048,-1,5.418777e-06,0.99998903,5.5217442e-06
2047,the,6,7,30,33,"In this study, we investigate the implication of T(reg) in modulating infiltrating T lymphocytes in human metastatic melanoma.",15240741_1,-1,1,-1,1,2047,-1,3.7425461e-06,0.9999927,3.481368e-06
8742,tumor,12,13,74,79,"Functional impairment of TAMs occurs relatively late in the course of GBM tumor growth, potentially providing a window of opportunity for therapeutic strategies directed towards preventing their functional impairment.",19226468_11,-1,1,-1,1,8742,-1,4.3975924e-06,0.9999907,4.950499e-06
24630,tumor,7,8,51,56,The increased number of CD4(+)CD25(+)Treg cells in tumor local and peripheral splenic tissues is related to the low immune function as well as to tumor recurrence and metastasis.,25168696_0,-1,1,-1,1,24630,-1,3.972372e-06,0.99999094,5.0521658e-06
23158,These,0,1,0,5,"These findings indicate that EBV-induced IDO expression in MDMs is substantially mediated by IL-6- and TNF--dependent mechanisms via the p38/MAPK and NF-B pathways, suggesting that a possible role of EBV-mediated IDO expression in tumor stroma of NPC may be to create a microenvironment of suppressed T cell immune responses.",24696473_6,-1,1,-1,1,23158,-1,4.122582e-06,0.99999213,3.773761e-06
6677,to,2,3,11,13,"Therefore, to determine whether resveratrol performs these actions via Treg cells, we investigated changes in Treg cell population and immunomodulatory cytokines in EG7 tumor-bearing C57BL/6 mice.",18328445_2,-1,1,-1,1,6677,-1,4.4900203e-06,0.99999106,4.4399285e-06
33127,Th,8,9,50,52,"Moreover, TIM-4+ B cells promoted proinflammatory Th differentiation in vivo, increasing IFN- while decreasing IL-4, IL-10, and Foxp3 expression by CD4+ T cells-effects that are opposite from those of TIM-1+ B cells.",28848066_9,-1,1,-1,1,33127,-1,4.7388844e-06,0.9999882,7.085755e-06
36085,Th1,16,17,121,124,These findings have important implications for future clinical trials since N1 and R848 synergistically promoted optimal Th1 lineage immune responses resulting in tumor rejection in mice.,30619338_8,-1,1,-1,1,36085,-1,9.758222e-06,0.9998578,0.00013247895
27816,Tregs,21,22,153,158,Double IHCs with CD4/CD25 and IL-10/FoxP3 antibodies confirmed above observations and revealed that IL-10 was at least partially released from increased Tregs.,26724144_6,-1,1,-1,1,27816,-1,5.014393e-06,0.99998975,5.2805244e-06
26698,the,2,3,12,15,We examined the expression of Treg markers in CD8(+) T cells from the peripheral blood and fresh tumor tissues of OC patients using flow cytometry.,26166762_5,-1,1,-1,1,26698,-1,4.034095e-06,0.9999926,3.3790068e-06
6893,the,2,3,15,18,"Concomitantly, the combination therapy led to a significantly decreased level of immunosuppression, as evidenced by lower intra-tumoral level of VEGF and TGF-beta, and decreased number of CD4+CD25+Foxp3+ regulatory T cells in the regional LNs.",18392040_6,-1,1,-1,1,6893,-1,4.516676e-06,0.9999918,3.7408015e-06
8440,The,0,1,0,3,"The results suggested that low-dose basiliximab can safely be administered repeatedly, and can target CD4+CD25high Treg cells whilst relatively preserving CD4+CD25low activated T cells.",19148493_9,-1,1,-1,1,8440,-1,4.3881314e-06,0.9999913,4.359513e-06
35390,the,5,6,35,38,"Compared with littermate controls, the miR-15a/16-/- mice exhibited retarded tumour growth and increased sensibility to DSS-induced colitis.",30047999_3,-1,1,-1,1,35390,-1,3.941028e-06,0.99999225,3.778205e-06
16596,Foxp3,2,3,26,31,Entinostat down-regulated Foxp3 expression transcriptionally and blocked Tregs suppressive function without affecting T effector cells (Teffs).,22303460_9,-1,1,-1,1,16596,-1,4.1497783e-06,0.9999918,4.0960845e-06
34297,the,27,28,153,156,"Our results demonstrated that patients with pre-B ALL had a higher percentage of Helios+ FoxP3+ CD4+ Tregs. And there was a positive correlation between the expression of Helios and the suppressive function of Tregs, the risk gradation of ALL.",29455107_3,-1,1,-1,1,34297,-1,3.8883218e-06,0.99999225,3.897867e-06
20739,target,14,15,85,91,Our previous study has shown that mesothelin (MSLN) is a potential immunotherapeutic target for pancreatic cancer.,23874581_0,-1,1,-1,1,20739,-1,8.2581055e-06,0.9999864,5.287284e-06
7363,NF-kappaB,20,21,136,145,"The induction of these antiapoptotic molecules as well as the inhibition of TRAIL-induced apoptosis by CD40 is partially abolished when NF-kappaB activity is inhibited by a selective inhibitor, BAY 117085.",18606651_5,-1,1,-1,1,7363,-1,1.036955e-05,0.9999809,8.7161625e-06
27940,the,37,38,116,119,"In our study, allogeneic polyclonal CD4(+)CD25(+)Tregs and CD4(+)CD25(+)CD127(lo)Tregs expanded in vitro in the presence of rapamycin and low dose IL-2 suppressed proliferation of 11 out of 12 established lymphoma B-cell lines.",26758248_1,-1,1,-1,1,27940,-1,5.270599e-06,0.9999901,4.58735e-06
546,STAT5,26,27,145,150,"Activating T cells with IL-15, which does not use the high affinity IL-2R, completely restored the ability of T cells to phosphorylate STAT3 and STAT5 when cultured with tumor cells.",11418694_4,-1,1,-1,1,546,-1,9.785643e-06,0.99998116,9.080317e-06
18658,to,5,6,40,42,Lymphoma cells mobilize many mechanisms to evade the immune system.,23000689_0,-1,1,-1,1,18658,-1,6.266792e-06,0.99998903,4.7124336e-06
3354,GATA-3,27,28,178,184,"Interestingly, the modified plasmid vaccine predominantly enhanced the type 2 immune responses manifested by an increased IgG1 to IgG2a antibody ratio and a greater induction of GATA-3 and IL-4 mRNA than that of T-bet and IFN-gamma mRNA in spleen cells from vaccinated mice.",16341143_4,-1,1,-1,1,3354,-1,3.6284368e-05,0.99990785,5.587043e-05
15662,Stat3,8,9,52,57,Signal transducer and activator of transcription 3 (Stat3) is a potent transcription factor with diverse biological functions.,21864492_0,-1,1,-1,1,15662,-1,6.5222844e-06,0.99998736,6.1087867e-06
37915,TH,18,19,140,142,"CONCLUSIONS: These results demonstrate that targeting the cytosolic HDAC6-FoxO1 axis reprograms the pathogenicity and antitumor response of TH 17 cells in HCC, with a pathogenicity-driven responsiveness to facilitate immunotherapies.",31539182_7,-1,1,-1,1,37915,-1,1.133419e-05,0.99994946,3.9185627e-05
2896,LPS,1,2,9,12,"Although LPS and IFN-gamma alone marginally activated nuclear factor (NF)-kappaB but not AP-1, LPS plus IFN-gamma augmented NF-kappaB and AP-1.",16094077_8,-1,1,-1,1,2896,-1,1.2200392e-05,0.9999758,1.1991568e-05
42783,the,18,19,94,97,"Our results indicate that germline variation in DPF3, a component of the BAF complex, part of the SWI/SNF complexes, can lead to reduced apoptosis and activation of the STAT3 pathway, both critical in RCC carcinogenesis.",34390653_4,-1,1,-1,1,42783,-1,4.6120003e-06,0.99998975,5.5938262e-06
35347,that,3,4,13,17,Here we show that Notch1 also contributes to an immune-suppressive tumor microenvironment (TME).,30036609_1,-1,1,-1,1,35347,-1,4.948226e-06,0.9999912,3.8631865e-06
8299,The,0,1,0,3,"The expression of interferon-gamma, IL-4, and transforming growth factor-beta was similar in both lesions.",19121066_4,-1,1,-1,1,8299,-1,3.9870565e-06,0.999992,4.0079444e-06
10336,the,40,41,224,227,"However, neither in the expression of T-bet and GATA-3, nor in the plasma level of IFN-gamma and IL-4, showed a significant difference between group A and B.CONCLUSION: In the peripheral blood of esophageal cancer patients, the expression of T-bet decreased, while GATA-3 increased, Th1/Th2 balance is broken, and the Th2 is dominant.",19615257_5,-1,1,-1,1,10336,-1,3.5532307e-06,0.99999225,4.229743e-06
8022,gene,15,16,90,94,"A dominant T-cell clone was identified in 14 cases, whereas polymerase chain reaction IgH gene rearrangement studies showed that all cases were polyclonal.",18987541_12,-1,1,-1,1,8022,-1,1.7617147e-05,0.999964,1.832837e-05
22267,The,0,1,0,3,The increase in NK cell and myeloid-derived suppressor cell numbers was associated with increased bone marrow and splenic hematopoiesis.,24446520_4,-1,1,-1,1,22267,-1,4.1750573e-06,0.999992,3.86851e-06
37675,that,18,19,115,119,"Previous studies have shown that baicalein and baicalin are directly cytotoxic to some tumors, here we demonstrate that in addition to direct cytotoxicity, these two flavonoids stimulate the T cell mediated immune response against tumors through reduction of PD-L1 expression in cancer cells.",31437792_1,-1,1,-1,1,37675,-1,3.9197157e-06,0.9999925,3.600908e-06
6217,tumour,32,33,209,215,"We show here that Treg and Nrp1+ Treg levels dropped in the tumour-draining lymph nodes of patients with cervical cancer following preoperative chemoradiotherapy in a direct relationship with the reduction of tumour mass, suggesting that suppressor cell elimination facilitated the generation of T cells mediating the destruction of the neoplastic cells left behind after cytotoxic therapy.",18028372_8,-1,1,-1,1,6217,-1,4.732093e-06,0.9999902,5.066705e-06
29789,Two,0,1,0,3,Two major populations of PMN-MDSCs (Ly6GhighLy6ClowGr1highCD11b+) and MO-MDSCs (Ly6G-Ly6ChighGr-1intCD11b+) have an immune suppressive function.,27601624_1,-1,1,-1,1,29789,-1,5.6938043e-06,0.99998844,5.83409e-06
4131,to,27,28,184,186,These results demonstrated IL-2-enhancing effects of the anti-IL-2 mAb in vivo and suggest that combining a neutralizing anti-IL-2 Ab with IL-2 gene delivery might be used effectively to enhance IL-2 functions in clinical applications.,16785526_6,-1,1,-1,1,4131,-1,4.0519017e-06,0.9999927,3.2439486e-06
4632,the,6,7,27,30,"In this review, we discuss the current knowledge of Treg biology and the potential therapeutic strategies and barriers of Treg immunotherapy in human hematopoietic cell transplantation.",17084366_5,-1,1,-1,1,4632,-1,4.6947066e-06,0.99999094,4.400253e-06
38740,the,4,5,18,21,"Here, we examined the molecular and cellular mechanisms underpinning the differentiation of cytotoxic CD4+ Tcells following immunotherapy.",31924474_1,-1,1,-1,1,38740,-1,6.5046825e-06,0.9999896,3.908771e-06
8144,This,0,1,0,4,This demonstrates that NF-kappaB activation is sufficient to induce many aspects of DC maturation and that expression of a constitutive NF-kappaB activator can improve the efficacy of a vaccine vector.,19036811_8,-1,1,-1,1,8144,-1,4.722082e-06,0.99999154,3.7233463e-06
42443,the,13,14,81,84,"We have previously reported dysregulation of Rab37 in lung cancer cells, whereas the roles of Rab37 in tumor-infiltrating immune cells and cancer immunotherapy are unclear.",34093869_2,-1,1,-1,1,42443,-1,5.898393e-06,0.99999046,3.6832225e-06
42342,MYCN-amplified,1,2,3,17,"In MYCN-amplified NB cells, co-inhibition of EZH2 (enhancer of zeste homologue 2), a H3K27 histone methyltransferase cooperating with EHMTs, was needed for strong transcriptional responses to IFN-, in line with histone mark changes at CXCL9 and CXCL10 chemokine gene loci.",34016720_8,-1,1,-1,1,42342,-1,1.282862e-05,0.99997246,1.4719971e-05
16190,T(reg,5,6,35,40,"Isolation and enrichment of canine T(reg) is possible, but high purities are difficult to achieve without significant cell loss.",22041284_5,-1,1,-1,1,16190,-1,6.9275684e-06,0.99998415,8.934827e-06
15315,the,17,18,96,99,"Accordingly, there are reasons to believe that the immune system is a key player in eradicating the JAK2 mutated clone in these patients.",21708889_1,-1,1,-1,1,15315,-1,3.7107652e-06,0.9999925,3.7969892e-06
8865,TKTCs,5,6,32,37,"With this cultivation strategy, TKTCs from peripheral blood mononuclear cells are generated within a short period of time using a pulse with a stimulating cell line followed by continuous growth in serum-free medium supplemented with a mixture of interleukin-2 and cyclosporin A. Expression and functional profiling did not allow a classification of TKTCs to any thus far defined subtype of T cells.",19240181_3,-1,1,-1,1,8865,-1,5.1704146e-06,0.9999896,5.1760535e-06
36036,to,15,16,101,103,"CCL1 significantly correlated with the infiltration of immunosuppressive FoxP3+ Treg, that are known to negatively affect survival.",30572845_11,-1,1,-1,1,36036,-1,6.9256994e-06,0.9999889,4.194644e-06
7200,the,6,7,38,41,"To verify this hypothesis and develop the most effective dendritic cell vaccine against Ewing's sarcoma, we evaluated the antitumor efficacy of dendritic cell-Ewing's sarcoma hybrids and dendritic cells pulsed with other antigen-loading methods, including cell lysates and the characteristic EWS-FLI1 gene of Ewing's sarcoma, using an A673 cell line as a model.",18563501_1,-1,1,-1,1,7200,-1,4.4974495e-06,0.9999907,4.8443876e-06
15658,Tregs,21,22,123,128,"Thus, the possibility of NLGP being an excellent tool as a T-cell anergy breaker by abrogating the suppressor functions of Tregs in cancer needs to be explored further in the clinic.",21843083_10,-1,1,-1,1,15658,-1,4.794415e-06,0.99999094,4.255486e-06
43634,To,0,1,0,2,"To determine whether the IL-10R has signaling functions similar to IL-6R in cells normally expressing these receptors, leukocytes of the B-, T-, and NK-cell lineages were treated with either cytokine.",8662928_1,-1,1,-1,1,43634,-1,5.103154e-06,0.99999034,4.6057353e-06
17978,the,5,6,31,34,"Following an induction period, the B16 melanoma cell model, a transplantable model for spontaneous malignant melanoma, inhibited the response of a T helper cell model to IL12.",22777646_5,-1,1,-1,1,17978,-1,4.4949584e-06,0.9999906,4.9108585e-06
32181,that,8,9,53,57,"Using EGFP-HDAC11 transgenic reporter mice, we found that HDAC11 expression was lower in effector relative to naive and central memory T-cell populations, and activation of resting T cells resulted in its decreased expression.",28550044_2,-1,1,-1,1,32181,-1,4.4625826e-06,0.9999918,3.7081734e-06
28001,that,19,20,126,130,"Our findings indicate that IL-6 causes a dysfunction in human DCs that activates cancer antigen-specific Th cells, suggesting that blocking the IL-6/STAT3 signaling pathway might be a promising strategy to improve cancer immunotherapy.",26759006_9,-1,1,-1,1,28001,-1,4.2667803e-06,0.999992,3.6889367e-06
14261,t-test,5,6,32,38,Statistical test used Student's t-test and stepwise multivariate regression analysis.,21327637_8,-1,1,-1,1,14261,-1,3.949953e-05,0.99992883,3.1606407e-05
43189,to,16,17,99,101,"With the ""newly"" discovered immunogenic responses from RT, numerous endeavors have been undertaken to combine RT with IOs, in order to bolster anti-tumor immunity.",34830176_2,-1,1,-1,1,43189,-1,5.514489e-06,0.99999034,4.156803e-06
5336,the,19,20,102,105,"Indoleamine 2, 3-dioxygenase (IDO), a key enzyme that catalyses the initial and rate-limiting step in the degradation of the tryptophan, is simultaneously expressed in murine dendritic cells and macrophages stimulated with interferon-gamma (IFN-gamma).",17466914_0,-1,1,-1,1,5336,-1,5.396506e-06,0.99999046,4.1378894e-06
11632,that,17,18,141,145,"Our findings offer evidence that antiestrogen induces immunosuppression in the tumor microenvironment, through a TGFbeta-dependent mechanism that may contribute to the development of antiestrogen resistance in breast cancer.",20145137_7,-1,1,-1,1,11632,-1,5.1696898e-06,0.9999906,4.220557e-06
1829,gene,13,14,91,95,FasL expression was up-regulated in LS180 colon cancer cells transfected with the survivin gene.,15004200_6,-1,1,-1,1,1829,-1,6.4301e-06,0.99998546,8.111155e-06
2129,this,1,2,3,7,"In this study, we demonstrate that the CD4(+)CD25(bright) T cells reside in the human intestinal lamina propria (LP) and functionally retain regulatory activities.",15322172_1,-1,1,-1,1,2129,-1,3.6964595e-06,0.99999213,4.20386e-06
32496,these,15,16,86,91,Expression of SOX2 by pediatric glial tumors and the capacity of the immune system in these patients to recognize SOX2 has not been previously studied.,28620836_3,-1,1,-1,1,32496,-1,3.893009e-06,0.99999154,4.627235e-06
19164,that,25,26,122,126,"Using a novel form of the 4-1BBL costimulatory molecule, SA-4-1BBL, as the adjuvant of choice, we previously demonstrated that a single vaccination with survivin (SVN) as a bona fide self TAA was effective in eradicating weakly immunogenic 3LL tumors in >70% of C57BL/6 mice.",23144888_2,-1,1,-1,1,19164,-1,4.6683017e-06,0.99999166,3.6323538e-06
34446,their,17,18,101,106,"Studies with PIP-deficient (PIP-/-) mice demonstrated significantly lower numbers of CD4+ T cells in their secondary lymphoid organs, impaired Th1 response, and impaired nitric oxide (NO) production.",29536339_2,-1,1,-1,1,34446,-1,4.8606935e-06,0.99998844,6.753646e-06
31478,This,0,1,0,4,"This review discusses the recent findings on Tim-3, the role it plays in regulating immune responses in different cell types and the rationale for targeting Tim-3 for effective cancer immunotherapy.",28258697_6,-1,1,-1,1,31478,-1,5.4722796e-06,0.9999894,5.080999e-06
42481,T,0,1,0,1,"T regulatory (Treg) cells are crucial to maintain immune tolerance and repress antitumor immunity, but the mechanisms governing their cellular redox homeostasis remain elusive.",34133924_0,-1,1,-1,1,42481,-1,4.286229e-06,0.9999908,4.871142e-06
3396,they,15,16,100,104,"Although tumoricidal macrophages are a necessary component of immune surveillance in CD1(-/-) mice, they alone are not sufficient for tumor resistance because IL-4Ralpha(-/-) mice have M1 macrophages and retain high levels of myeloid suppressor cells after surgery; in addition, they are susceptible to 4T1 metastatic disease.",16357187_4,-1,1,-1,1,3396,-1,1.1093648e-05,0.99998176,7.1411405e-06
40563,Tregs,24,25,147,152,"To unravel the mechanism of anti-melanoma effect of GA, it has been delineated that GA inhibits pSTAT3 to evade anti-tumor suppressive function of Tregs and MDSCs.",32890791_6,-1,1,-1,1,40563,-1,5.24158e-06,0.9999888,5.9989648e-06
25039,the,2,3,13,16,"Furthermore, the enrichment of LAP Treg population in peripheral blood mononuclear cells (PBMCs) of CRC patients correlated with cancer metastases.",25268580_7,-1,1,-1,1,25039,-1,3.8453354e-06,0.9999925,3.6886324e-06
36531,Together,0,1,0,8,"Together, this highlights a pathway that restrains cDC2 and whose reversal enhances CD4+ Tconv abundance and controls tumor growth.",30955881_5,-1,1,-1,1,36531,-1,5.6186514e-06,0.99998903,5.3776744e-06
37067,tolerogenic,30,31,183,194,"In conclusion, our study demonstrated that intratumoral infiltration by pDCs is a novel indicator for poor prognosis in patients with HCC, possibly through the induction of an immune tolerogenic and inflammatory tumor microenvironment comprising regulatory T and IL-17-producing cells.",31201473_8,-1,1,-1,1,37067,-1,4.7169124e-05,0.99993324,1.952921e-05
39707,the,15,16,118,121,This review summarizes the signaling pathways involved in the pathogenesis following colon inflammation to understand the underlying molecular mechanisms in CAC tumorigenesis.,32357539_5,-1,1,-1,1,39707,-1,5.6464364e-06,0.9999906,3.7760199e-06
3856,to,9,10,62,64,Our findings support the clinical evaluation of low-dose IL-2 to selectively modulate CD4+CD25+ Tregs and increase expression of FOXP3 in vivo.,16645171_8,-1,1,-1,1,3856,-1,5.2740197e-06,0.9999902,4.4887324e-06
43263,to,3,4,18,20,APLNR is reported to regulate tumor recognition during immune surveillance by modulating the IFN- response.,35084016_2,-1,1,-1,1,43263,-1,4.6972336e-06,0.9999912,4.076072e-06
9138,This,0,1,0,4,This study supports earlier data that T(reg) cells are present at higher frequencies in breast cancer patients compared with healthy individuals.,19277040_6,-1,1,-1,1,9138,-1,4.314373e-06,0.9999914,4.273077e-06
21870,the,19,20,103,106,The frequency and immunosuppressive potential of CD4(+) CD25(+) FoxP3(+) Treg cells became high with the progression of malignancy in B-ALL.,24354800_6,-1,1,-1,1,21870,-1,3.8826047e-06,0.9999914,4.7014382e-06
1407,transactivator,18,19,112,126,"This phenotype was created by intratumoral injection of plasmid cDNAs coding for interferon gamma, MHC class II transactivator, and an antisense reverse gene construct (RGC) for a segment of the gene for Ii protein (-92,97).",12804139_2,-1,1,-1,1,1407,-1,7.876803e-06,0.9999832,8.979906e-06
1703,to,3,4,23,25,Imiquimod use appeared to increase the magnitude of the response and broaden the specificity of response in some patients.,14751153_10,-1,1,-1,1,1703,-1,6.700086e-06,0.99998856,4.7298927e-06
27782,play,8,9,39,43,OBJECTIVES: T regulatory cells (Tregs) play a critical important role for the occurrence and development of human tumors.,26724144_0,-1,1,-1,1,27782,-1,1.095683e-05,0.9999783,1.0688122e-05
12421,statins,9,10,43,50,"However, little is known about the role of statins in tumour immune tolerance.",20491794_2,-1,1,-1,1,12421,-1,0.03904441,0.9605344,0.0004212625
36272,the,7,8,28,31,"However, the role of TNF-, the prototype of the TNF superfamily cytokines, in Th9 cell differentiation and their antitumor efficacy is not defined.",30717817_2,-1,1,-1,1,36272,-1,4.1158796e-06,0.99999106,4.765756e-06
11105,the,11,12,77,80,"This study was designed to investigate the potential synergistic activity of the combined use of cyclophosphamide (CP) and doxorubicin (DR), both of which are known to resolve these two issues.",19940990_1,-1,1,-1,1,11105,-1,6.4835303e-06,0.9999902,3.3481372e-06
13882,three,4,5,19,24,"Moreover, we found three unexpected perturbations in FOXP3+ T-cell subsets: (i) patients with melanoma showed higher frequencies of FOXP3(low) nonregulatory T cells, which decreased and normalized after tumour removal; (ii) FOXP3(low) nave Tregs containing higher frequencies of interferon-+ cells increased with tumour progression; and (iii) CD45RO+FOXP3(high) effector Tregs were pronouncedly infiltrated around tumour tissues.",21198537_7,-1,1,-1,1,13882,-1,5.5472456e-06,0.9999895,4.959102e-06
36063,type,29,30,176,180,"Moreover, N1 and R848 synergistically increased nuclear translocation of interferon (IFN) regulatory transcription factors (e.g., IRF3 and IRF7) and promoted the expression of type 1 IFNs such as IFN-2, IFN-4, and IFN-1.",30619338_4,-1,1,-1,1,36063,-1,7.347633e-06,0.9999832,9.458133e-06
26964,the,6,7,54,57,RESULTS: Ad-mIL-28B treatment significantly decreased the number of CD4CD25FoxP3Treg cells.,26270121_5,-1,1,-1,1,26964,-1,4.525366e-06,0.9999912,4.2765373e-06
642,Th2,22,23,111,114,"Moreover, CD4(+) T cells manifested rapid secretion of the Th2 cytokines IL-4, IL-5, and IL-10, reminiscent of Th2 memory cells.",11441076_5,-1,1,-1,1,642,-1,0.00012066085,0.99979395,8.544255e-05
16683,This,0,1,0,4,This downregulation induced a TGF--associated mechanism in glioma cells altering the tumor microenvironment and causing reduced resistance of the tumor to the immune system.,22323550_6,-1,1,-1,1,16683,-1,3.789125e-06,0.9999925,3.7245682e-06
18693,Tregs-mediated,10,11,61,75,Our study demonstrates the ability of low-dose CY to reverse Tregs-mediated immune evasion in a mouse model.,23000689_6,-1,1,-1,1,18693,-1,3.45078e-05,0.99991727,4.823861e-05
34443,that,19,20,118,122,"The function of PIP in breast tumorigenesis remains unknown; however, evidence from our laboratory and others suggest that it regulates host immunity.",29536339_1,-1,1,-1,1,34443,-1,5.182745e-06,0.99999034,4.5030015e-06
17686,that,5,6,39,43,Our previous studies have demonstrated that hepatitis B virus X protein (HBx) was able to inhibit the growth of HCC cells via inducing apoptosis and inhibiting tumor angiogenesis.,22710287_1,-1,1,-1,1,17686,-1,3.866402e-06,0.9999925,3.6982876e-06
2344,initiation factor,21,23,171,188,"Moreover, we demonstrate that chemotherapeutic agents that suppress protein synthesis and reverse the CD40-mediated dissociation of the translational repressor eukaryotic initiation factor 4E-binding protein from the initiation factor eukaryotic initiation factor 4E, such as 5-fluorouracil, etoposide, and quercetin, dramatically increase the susceptibility of cervical carcinoma cells to CD40L-induced apoptosis.",15611226_6,-1,1,-1,1,2344,-1,5.8519418e-06,0.9999881,6.0754364e-06
37822,TGF-,20,21,116,121,"Smad proteins were detected in the mitochondria of CD4+ T cells, where they were phosphorylated upon treatment with TGF-.",31530731_5,-1,1,-1,1,37822,-1,1.1173407e-05,0.9999826,6.200757e-06
43078,triacylglyceride,12,13,72,88,"Thus, we identify a crosstalk between KG, mitochondrial metabolism and triacylglyceride synthesis that controls Treg fate.",34731632_6,-1,1,-1,1,43078,-1,0.0022211024,0.9970822,0.00069675926
33997,transfer,3,4,18,26,"Using an adoptive transfer model of cancer immunotherapy, we demonstrate that constitutive eomesodermin (Eomes) expression in tumor-specific CD8 T cells improves tumor rejection and survival.",29271784_1,-1,1,-1,1,33997,-1,6.166765e-06,0.9999865,7.31055e-06
18314,LPS-stimulated,36,37,234,248,"We tested how mcd-exosomes influence CD4+ T cell proliferation induced by bone marrow derived dendritic cells; we quantified NF-B activation in mature macrophages stimulated with mcd-exosomes, and we compared the cytokine profile of LPS-stimulated, IL-4 induced, and mcd-exosome treated macrophages.",22898052_1,-1,1,-1,1,18314,-1,0.00077113864,0.99911946,0.000109430184
27740,therefore,13,14,95,104,Histone/protein deacetylases (HDACs) are frequently upregulated in human malignancies and have therefore become therapeutic targets in cancer therapy.,26704363_0,-1,1,-1,1,27740,-1,4.7559674e-06,0.9999893,5.946196e-06
3865,that,2,3,10,14,We showed that migratory CD4(+) cells induced by HL cells were hyporesponsive to T-cell receptor stimulation and suppressed the activation/proliferation of the effector CD4(+) T cells in an autologous setting.,16740709_1,-1,1,-1,1,3865,-1,4.5067386e-06,0.99999213,3.33825e-06
31771,that,5,6,33,37,"Together, these data demonstrate that CXCR5+CD8+ T cells represent a significant CD8+ T cell subset in colorectal tumors and have the potential to contribute to antitumor immunity, but their specific roles require further studies in vivo.",28412245_10,-1,1,-1,1,31771,-1,3.868062e-06,0.9999926,3.507511e-06
18277,The,0,1,0,3,The mechanisms by which tumors promote the expansion and/or function of these suppressive cells and the cross-talk between MDSC and Treg remain incompletely defined.,22891289_1,-1,1,-1,1,18277,-1,6.0925477e-06,0.9999901,3.8522376e-06
29707,than,39,40,245,249,"Serum levels of IL-10 and IL-17 were determined with ELISA, and expression of Foxp3 and RORt was assessed with quantitative real-time PCR.RESULTS: Treg and Th17 cell proportions in peripheral blood in the CLL patients were significantly higher than control.",27584054_2,-1,1,-1,1,29707,-1,5.742305e-06,0.99998856,5.741013e-06
4032,Tregs,18,19,115,120,"Anti-CTLA4 did not deplete Tregs or permanently impair their function but acted in a cell-intrinsic manner on both Tregs and Teffs, allowing them to expand, most likely in response to self antigen.",16778987_3,-1,1,-1,1,4032,-1,4.1125404e-06,0.99999106,4.8309457e-06
6662,that,6,7,39,43,"CONCLUSIONS: Our present data indicate that IL-21-secreting NB cells are effective as therapeutic vaccine in mice bearing metastatic NB, through a specific CTL response involving survivin as antigen, and suggest a potential interest for IL-21 in NB immuno-gene therapy.",18324400_10,-1,1,-1,1,6662,-1,3.863261e-06,0.9999924,3.8239746e-06
28340,This,0,1,0,4,This study aimed to inhibit lung cancer (LC) growth in a mouse model by using an LC-specific vaccination.,26910585_1,-1,1,-1,1,28340,-1,4.5365146e-06,0.9999913,4.151403e-06
10843,their,16,17,105,110,"Numbers of tumor infiltrating Treg inversely correlated with Treg amounts in the bone marrow, suggesting their possible recruitment to melanoma lesions from this organ.",19841169_4,-1,1,-1,1,10843,-1,1.7020524e-05,0.9999732,9.811356e-06
30045,STAT5,16,17,88,93,TSLP induced production of IL4 and IL13 by Hut78 and MJ cells through the activation of STAT5.,27634769_8,-1,1,-1,1,30045,-1,6.48532e-06,0.99998486,8.683838e-06
40460,this,9,10,70,74,The combined data provide evidence for immunoregulatory properties of this versatile DC population in Th1-polarized infection settings.,32848032_6,-1,1,-1,1,40460,-1,4.3503355e-06,0.99999166,3.9761803e-06
25519,to,11,12,93,95,"Accordingly, pDCs cocultured with cervical/vulvar neoplastic keratinocytes have the capacity to induce a Treg cell differentiation from nave CD4(+) T cells, which is in agreement with the development of a tolerogenic response.",25492101_6,-1,1,-1,1,25519,-1,4.5419874e-06,0.99999154,3.9804668e-06
439,These,40,41,249,254,"Furthermore, using promoter deletion constructs and gel shift analysis, we defined a functional NF-kappaB-binding motif in the human IL-15Ralpha promoter, suggesting that Tax activation of IL-15Ralpha is due, in part, to the induction of NF-kappaB. These data indicate that IL-15Ralpha is transcriptionally regulated by the HTLV-I Tax protein through the action of NF-kappaB. These findings suggest a role for IL-15Ralpha in aberrant T cell proliferation observed in HTLV-I-associated diseases.",11160322_4,-1,1,-1,1,439,-1,4.507933e-06,0.99999106,4.401286e-06
36607,The,0,1,0,3,The findings may clarify why only 10% of women in the general population develop endometriosis despite cyclic menstruation with retrograde flow occurring in >90% of women.,30981619_9,-1,1,-1,1,36607,-1,5.0232156e-06,0.99999106,3.9323954e-06
24017,than,18,19,75,79,"Intratumorally, CD4(+) and CD8(+) cells infiltrated G2-G3 (P=0048) more than G1 (P=0004), whereas almost all cells were CD123 negative.",24910265_5,-1,1,-1,1,24017,-1,1.6308672e-05,0.9999701,1.3665146e-05
23892,the,7,8,43,46,"Therefore, these data provide evidence for the use of the EWS/FLI-l peptide epitope in T cell-based immunotherapeutic concepts against Ewing's sarcoma cell in vitro and in vivo.",24861249_4,-1,1,-1,1,23892,-1,3.908854e-06,0.9999927,3.326808e-06
29839,The,0,1,0,3,"The immunogenic tumor dormancy has been demonstrated in animal models of cancer, which can explain clinical observations such as an increased incidence of cancer following organ transplantation.",27603507_0,-1,1,-1,1,29839,-1,4.0643e-06,0.99999225,3.7276125e-06
13550,These,0,1,0,5,"These data suggest that vaccination with MVA-survivin in combination with gemcitabine represents an attractive strategy to overcome tumor-induced peripheral immune tolerance, and this effect has potential for clinical benefit in pancreatic cancer.",20960189_12,-1,1,-1,1,13550,-1,4.3437276e-06,0.99999166,4.0129607e-06
2590,to,18,19,95,97,"Upregulation of MHC class I with pIFN-gamma or class II with pCIITA, separately, does not lead to a complete response even if supplemented with pIL-2 or pIi-RGC.",15761259_4,-1,1,-1,1,2590,-1,5.8740593e-06,0.9999896,4.4662515e-06
33125,TIM-4,2,3,10,15,"Moreover, TIM-4+ B cells promoted proinflammatory Th differentiation in vivo, increasing IFN- while decreasing IL-4, IL-10, and Foxp3 expression by CD4+ T cells-effects that are opposite from those of TIM-1+ B cells.",28848066_9,-1,1,-1,1,33125,-1,1.14949435e-05,0.99996805,2.0474234e-05
37576,the,10,11,60,63,"Our results supported the notion that, upon engagement with the cognate receptors, CD137 ligand and CD40 initiates activation of nuclear factor-kappa B (NF-B) signaling in tumor cells even in the absence of CD8+ T cells.",31427736_4,-1,1,-1,1,37576,-1,4.4856733e-06,0.9999914,4.152164e-06
12477,the,2,3,9,12,"However, the cause of the increase in FoxP3(+) cell frequency in HTLV-1 infection was unknown.",20525891_3,-1,1,-1,1,12477,-1,5.391733e-06,0.9999906,3.9760166e-06
39285,tumor,17,18,114,119,"Thus, the -catenin-CCL28-Treg cell axis may serve as an important mechanism for immunosuppression of the stomach tumor microenvironment.",32156780_9,-1,1,-1,1,39285,-1,4.3238438e-06,0.9999907,5.0322574e-06
28014,this,20,21,137,141,"Tregs promote tumor growth by modulating the antitumor immune response, mainly through inhibition of T-cell-mediated tumor cell killing: this has been suggested to be dependent on IL-10 and/or TGF-.",26782287_1,-1,1,-1,1,28014,-1,4.6847535e-06,0.99999154,3.7516827e-06
12638,this,2,3,20,24,"Characteristically, this response was accompanied by a distinct peak in cytokine levels after the first vaccination.",20547850_4,-1,1,-1,1,12638,-1,4.925006e-06,0.99999106,4.055057e-06
14103,the,28,29,176,179,"BACKGROUND: The importance of the malignant cell environment to its growth and survival is becoming increasingly apparent, with dynamic cross talk between the neoplastic cell, the leukocyte infiltrate and the stroma.",21291541_0,-1,1,-1,1,14103,-1,4.034078e-06,0.99999106,4.9342675e-06
19767,genes,3,4,29,34,"The differentially expressed genes in mCRPC Tregs are involved in cell cycle processes, cellular growth and proliferation, immune responses, hematological system development and function and the interleukin-2 (IL-2) and transforming growth factor- (TGF-) pathways.",23319273_4,-1,1,-1,1,19767,-1,4.0819195e-06,0.99999046,5.437877e-06
43594,to,33,34,206,208,"Appearance of the STAT1 factor is significantly reduced in the presence of cyclosporin A, and blocked by cycloheximide, indicating that its activation is dependent upon a protein(s) synthesized in response to initial signaling events.",8605941_4,-1,1,-1,1,43594,-1,6.754799e-06,0.99998844,4.8283996e-06
17382,that,20,21,126,130,"These observations provide strong evidence that endogenous CD4(+) Tregs have a negative impact on cancer therapy, and suggest that strategies reducing Treg levels may provide clinical benefit to cancer patients.",22555974_5,-1,1,-1,1,17382,-1,4.316114e-06,0.9999924,3.2558244e-06
27743,the,11,12,77,80,"However, inhibiting certain HDAC isoforms can have protolerogenic effects on the immune system, which could make it easier for tumor cells to evade the host immune system.",26704363_1,-1,1,-1,1,27743,-1,5.9255076e-06,0.9999896,4.4227386e-06
22369,the,8,9,53,56,"We also identified promoter and enhancer elements of the human ITGAE gene, encoding CD103, involved in its induction by these transcriptional regulators.",24477908_4,-1,1,-1,1,22369,-1,4.0701457e-06,0.99999154,4.3833097e-06
13672,the,1,2,3,6,"In the presence of tremelimumab, frequencies of IL-2-secreting CD4(+) T cells and IFN--secreting CD4(+) and CD8(+) T cells were increased in response to polyclonal activation and tumor antigens.",21056008_4,-1,1,-1,1,13672,-1,4.1467997e-06,0.9999919,3.920181e-06
24435,transfected,22,23,141,152,"One common denominator of these stimuli is the activation of NF-B. Here, we show that human monocyte-derived, cytokine cocktail-matured DCs transfected with constitutively active mutants of IB kinases (caIKKs) by mRNA electroporation, further upregulated maturation markers, and secreted enhanced amounts of cytokines, including IL-12p70, which was produced for more than 48 h after transfection.",25100611_2,-1,1,-1,1,24435,-1,4.459546e-06,0.99999,5.5269757e-06
5260,the,18,19,93,96,"c-MYC acts at at least two different levels, the level of interferon induction as well as at the level of action of type I and type II interferons on their respective target promoters.",17419945_6,-1,1,-1,1,5260,-1,3.8941403e-06,0.99999225,3.8167527e-06
7180,tumor,5,6,42,47,"SCF-activated mast cells also exacerbated tumor immunosuppression by releasing adenosine and increasing T regulatory cells, which augmented the suppression of T cells and natural killer cells in tumors.",18524989_6,-1,1,-1,1,7180,-1,5.748495e-06,0.9999902,4.0280925e-06
7106,These,0,1,0,5,"These data suggest that immunity to EGFR expressing tumors, including glioma, can be enhanced through the concerted function of antitumor monoclonal antibodies, activating FcgammaR, and DCs.",18481381_5,-1,1,-1,1,7106,-1,4.10697e-06,0.9999918,4.1751596e-06
42187,then,4,5,21,25,"Human IL17 cDNA was then inserted into the pEGFPN1 plasmid and transfected into the glioma U87MG cell line, and tumstatin was used to block the effect of the IL-17 overexpression.",33971545_3,-1,1,-1,1,42187,-1,4.274206e-06,0.99999046,5.2441087e-06
26871,the,2,3,9,12,"Finally, the neutralization of the common type-1 interferon receptor or that of the chemokine receptor CXCR3 (which binds CXCL9 and CXCL10) abolished the difference in the chemotherapeutic response between Stat3(-/-) and control tumors.",26208907_8,-1,1,-1,1,26871,-1,4.0820896e-06,0.99999213,3.7818024e-06
25207,released,19,20,105,113,"In this article, we show that dendritic cells (DCs) can uptake and sense nuclear DNA-associated entities released by dying cells to induce type I IFN.",25385820_3,-1,1,-1,1,25207,-1,8.816647e-06,0.9999832,7.97642e-06
9869,to,46,47,274,276,"By phospho-specific flow cytometry, defective STAT1 and STAT5 activation in response to IL-2 was found mainly in T lymphocytes from peripheral blood and/or tumor site of American Joint Committee on Cancer stage III and IV patients, compared with stage I and II patients and to donors, and in melanoma antigen-specific T cells isolated from metastatic lymph nodes.",19509154_6,-1,1,-1,1,9869,-1,9.146068e-06,0.99998057,1.0265975e-05
24453,STAT3,13,14,107,112,"Embelin significantly attenuated cells invasion, proliferation and induced apoptosis through inhibition of STAT3 and activation of p53 signaling pathways.",25128650_2,-1,1,-1,1,24453,-1,9.796751e-06,0.99998,1.0282057e-05
31332,the,8,9,66,69,"Although immunotherapy by PD-1 blockade has dramatically improved the survival rate of cancer patients, further improvement in efficacy is required to reduce the fraction of less sensitive patients.",28096382_0,-1,1,-1,1,31332,-1,5.598922e-06,0.99999046,3.951739e-06
22283,These,0,1,0,5,"These studies reveal a novel role for TNF- in the antitumor immune response, specifically in stimulating hematopoiesis and increasing the numbers and activity of NK cells.",24446520_8,-1,1,-1,1,22283,-1,4.1366957e-06,0.9999919,3.9170413e-06
27253,thus,9,10,70,74,"These results demonstrate the adjuvant properties of pVAX14 providing thus new approaches to improve clinical outcome in two different models of myeloid malignancies, which may have potential for a broader applicability in other cancers.",26378812_7,-1,1,-1,1,27253,-1,6.449392e-06,0.99998856,5.0200333e-06
20270,tumor,5,6,28,33,Immune effects in vitro and tumor protective results in vivo were tested and monitored.,23621273_2,-1,1,-1,1,20270,-1,4.524742e-06,0.9999907,4.821692e-06
14544,transforming,45,46,227,239,"RESULTS: Coculture of normal CMF with resting or nave CD4+ T cells led to development of cells with a Treg phenotype; it also induced proliferation of a CD25+ CD127- FoxP3+ T cells, which expressed CTLA-4, interleukin-10, and transforming growth factor- and had suppressive activities.",21376048_4,-1,1,-1,1,14544,-1,1.3749297e-05,0.9999752,1.10395395e-05
43495,Jun,4,5,37,40,"Although IL-1 dramatically increases Jun B accumulation, it does not enhance TPA-induced Fra-1 protein levels in EL4 cells.",7675040_7,-1,1,-1,1,43495,-1,9.589329e-06,0.9999814,9.028045e-06
41714,IRF-1,6,7,38,43,"IRF-2 is a competitive antagonist for IRF-1 mediated transcriptional effects, and overexpression of IRF-2 decreased basal and IFN- induced CXCL10 expression.",33689775_4,-1,1,-1,1,41714,-1,7.1487784e-06,0.99997795,1.4893836e-05
10249,these,17,18,99,104,"Analysis of 39 omental samples revealed that T cells are the predominant lymphoid cell type and of these, 10% expressed the invariant Valpha24Jalpha18 TCR chain, found on iNKT cells, higher than in any other human organ tested to date.",19585513_3,-1,1,-1,1,10249,-1,5.2607716e-06,0.99998724,7.455063e-06
31329,through,25,26,165,172,"Taken together, our investigation reveals that assigning antigen specificity to nonspecific polyclonal CD8+25+ Tregs for enhanced immune suppression can be achieved through exosomal pMHC arming.",28096300_9,-1,1,-1,1,31329,-1,8.469947e-06,0.9999877,3.832997e-06
32553,to,5,6,38,40,The correlation of Blimp-1 expression to clinical characteristics of AML patients was analyzed.,28629373_4,-1,1,-1,1,32553,-1,4.952571e-06,0.99998975,5.2844234e-06
35474,time,14,15,79,83,"RESULTS: Blood, tumour and regional lymph nodes were obtained from patients at time of transurethral resection of the bladder and at radical cystectomy.",30075815_8,-1,1,-1,1,35474,-1,4.9310215e-06,0.99998915,5.9188005e-06
1137,the,16,17,136,139,Tumor-specific CTLs expressing HATGF-betaRII-Deltacyt should have a selective functional and survival advantage over unmodified CTLs in the presence of TGF-beta-secreting tumors and may be of value in treatment of these diseases.,11964281_9,-1,1,-1,1,1137,-1,4.865263e-06,0.9999914,3.7010213e-06
26900,that,3,4,36,40,"Mechanistic investigations revealed that CCL5 activates CCR3, a highly expressed chemokine receptor on CD4 T cells, and also boosts Gfi1 expression to promote the differentiation of Th2 cells, which enhance the prometastatic activity of tumor-associated myeloid cells.",26249173_3,-1,1,-1,1,26900,-1,5.249329e-06,0.9999908,3.9075344e-06
32466,the,22,23,139,142,"In both models, local production of IL-2 successfully replaced the need for systemic recombinant IL-2 (rIL-2) administration and increased the efficacy of the cell therapy.",28614908_4,-1,1,-1,1,32466,-1,4.5271054e-06,0.9999912,4.2515326e-06
40332,to,24,25,180,182,SIGNIFICANCE: These findings provide new insight into pGSN-mediated immune cell dysfunction in ovarian cancer chemoresistance and demonstrate how this dysfunction can be exploited to enhance immunotherapy.,32641415_9,-1,1,-1,1,40332,-1,5.3416143e-06,0.99999094,3.6826025e-06
12227,play,16,17,92,96,Foxp3(+) regulatory T cells (Tregs) suppress immune responses in the peripheral tissues and play a role in the immunosuppression of cancer tissues.,20422211_2,-1,1,-1,1,12227,-1,4.8304155e-06,0.99998915,5.999934e-06
27765,that,2,3,9,13,"We found that CD8(+) T cells missing HDAC5 had a reduced ability to produce the cytokine, IFN-, in vitro and in vivo, which may offset the benefit of weakened Treg function and formation.",26704363_8,-1,1,-1,1,27765,-1,4.506649e-06,0.9999913,4.175815e-06
20864,tumor,13,14,92,97,Increased recruitment of immune cells into tumors and suppression of the immune suppressive tumor environment are critical components toward effective cancer immunotherapies.,23922012_1,-1,1,-1,1,20864,-1,4.1521307e-06,0.9999912,4.7061476e-06
6185,Treg,44,45,237,241,"In lymph nodes, Nrp1 identified a small regulatory CD4+ CD25(high) T-cell subpopulation (Nrp1+ Treg) that expressed higher levels of Forkhead box P3 (Foxp3) message and protein than Nrp1- Treg, and various molecular markers of activated Treg, i.e. CD45RO, human leucocyte antigen (HLA)-DR and glucocorticoid-induced tumour necrosis factor receptor (GITR).",18028372_1,-1,1,-1,1,6185,-1,5.234347e-06,0.999987,7.808748e-06
23163,that,25,26,178,182,"These findings indicate that EBV-induced IDO expression in MDMs is substantially mediated by IL-6- and TNF--dependent mechanisms via the p38/MAPK and NF-B pathways, suggesting that a possible role of EBV-mediated IDO expression in tumor stroma of NPC may be to create a microenvironment of suppressed T cell immune responses.",24696473_6,-1,1,-1,1,23163,-1,4.902979e-06,0.9999908,4.2613665e-06
40291,the,11,12,69,72,The study provides a comprehensive survey of and novel insights into the immune status of murine BCC and serves as a basis for the design of efficacious rational combination treatments.,32615027_7,-1,1,-1,1,40291,-1,3.8962485e-06,0.9999927,3.400453e-06
8197,to,7,8,54,56,Targeting both antagonistic proteins should be useful to prevent metastases in patients whose tumors are resistant to conventional treatments.,19048252_12,-1,1,-1,1,8197,-1,5.241511e-06,0.99999094,3.8730354e-06
18158,to,39,40,217,219,"In mice deficient in the interferon (IFN) receptor or in natural killer (NK) and CD8(+) T cell responses, metastasis was accelerated, indicating that Irf7-driven suppression of metastasis was reliant on IFN signaling to host immune cells.",22820642_3,-1,1,-1,1,18158,-1,2.6138834e-05,0.99996114,1.2672635e-05
21808,transplanted,6,7,29,41,"Mice into which LLC had been transplanted were treated with umbelliprenin on alternate days, at 2.5mg/200l intraperitoneally.",24325354_3,-1,1,-1,1,21808,-1,6.309333e-06,0.99998724,6.447944e-06
40242,to,20,21,168,170,"Here, we show that tumor progression blocks the transition of Lin-Thy1.2+CD25+CD44+c-KitlowDN2b to Lin-Thy1.2+CD25+CD44-c-Kit-DN3 in T-cell maturation, instead leading to DN2-T-cell differentiation into dendritic cells (DC).",32582141_3,-1,1,-1,1,40242,-1,3.6510473e-06,0.99999225,4.134442e-06
23797,the,22,23,131,134,"We further demonstrate that MSCs mediate TFH to TFR conversion by inducing the expression of FoxP3 in TFH cells, demonstrating for the first time that human TFR can be derived from TFH cells.",24836297_5,-1,1,-1,1,23797,-1,6.547628e-06,0.99998784,5.641706e-06
30943,to,4,5,32,34,"Th1-type immunity is considered to be required for efficient response to BCG in bladder cancer, although Th2 predisposition of BCG responders has recently been reported.",28005163_0,-1,1,-1,1,30943,-1,7.521532e-06,0.99998784,4.6631712e-06
18665,the,18,19,95,98,There is substantial evidence that CD4(+)CD25(+) regulatory T cells (Tregs) play a key role in the control of immune evasion.,23000689_1,-1,1,-1,1,18665,-1,4.2472093e-06,0.99999225,3.5079447e-06
10176,natural,21,22,134,141,"However, CCR4-mediated chemotaxis was not sufficient to produce metastasis, as tumor cells in the lung were efficiently eliminated by natural killer (NK) cells.",19567680_6,-1,1,-1,1,10176,-1,1.4628518e-05,0.99997926,6.1117908e-06
18193,to,14,15,101,103,"Serum levels of granulocyte colony-stimulating factor and interleukin-6, which both have been linked to MDSC induction, correlated positively with the frequency of CD14(+)HLA-DR(low/neg) cells.",22828446_7,-1,1,-1,1,18193,-1,1.135517e-05,0.999982,6.6579837e-06
25088,T-bet,44,45,266,271,"In order to further confirm this result, the Runx3 gene was constructed into pIRES2-eGFP and the recombined plasmid was transfected into SGC-7901 cells with liposome in vitro, the results obtained from the reverse transcription PCR indicated that the mRNA of Runx3, T-bet, or IFN- was significantly upregulated individually in Runx3 gene-transfected SGC-7901 cells.",25270738_3,-1,1,-1,1,25088,-1,4.925084e-06,0.99998784,7.2251482e-06
26336,transcription factors,17,19,84,105,"The frequencies of Th22, Th17, and Th1 cells, along with the expression of specific transcription factors RORC and AHR, were significantly decreased in ND patients compared with healthy controls, while all these abnormality recovered in CP patients.",26000313_6,-1,1,-1,1,26336,-1,5.602111e-06,0.9999887,5.6634944e-06
14002,tumor-associated,10,11,69,85,"These results suggest an important role for NFAT1 in radio-resistant tumor-associated parenchyma, which is independent of the anti-tumor immune response and Th1 versus Th2 cytokine milieu established by the cancer cells, but able to promote site-specific tumor growth.",21225259_9,-1,1,-1,1,14002,-1,1.4196251e-05,0.9999726,1.3265618e-05
35037,to,4,5,15,17,"Here, we aimed to induce human CD8 TSCM cells by stimulating naive precursors with interleukin-21 (IL-21).",29864078_2,-1,1,-1,1,35037,-1,4.722641e-06,0.99999154,3.7800296e-06
26234,their,11,12,59,64,"To cast further light on the question why most women clear their HPV infection while others develop high-grade cervical intraepithelial neoplasia (CIN), we analyzed HPV16 E2-, E6- and E7 -specific CMI in women who developed CIN during a 10-year follow-up of the Finnish Family HPV cohort.",25990808_1,-1,1,-1,1,26234,-1,9.173479e-06,0.99998057,1.0308258e-05
29682,Thus,0,1,0,4,"Thus, repressing KLRG1 on human memory T cells might be a novel therapeutics against cancer.",27557510_7,-1,1,-1,1,29682,-1,5.0235362e-06,0.99999,4.9657347e-06
43073,triacylglyceride,10,11,73,89,"Notably, inhibition of either mitochondrial complex II or DGAT2-mediated triacylglyceride synthesis restores Treg differentiation and decreases the KG-induced inflammatory phenotype.",34731632_5,-1,1,-1,1,43073,-1,0.0021981667,0.9971686,0.0006332099
35837,Foxp3+GATA3,9,10,77,88,Functional investigation demonstrated that IL-33 increased the proportion of Foxp3+GATA3+ Tregs and improved the suppressive functions of Tregs by inducing IL-10 and TGF-1 as well as decreasing the proliferation of responder T cells.,30357458_8,-1,1,-1,1,35837,-1,1.270093e-05,0.9999732,1.4152099e-05
40606,to,6,7,59,61,The immunomodulatory extracellular vesicles have potential to be further engineered for developing new approaches for cancer therapy.,32939048_6,-1,1,-1,1,40606,-1,5.3465506e-06,0.9999906,4.01649e-06
27881,the,19,20,135,138,"As melanoma progression is controlled by host immunity, here we present a novel approach interrogating immunoregulatory pathways using the genome-wide maps of expression quantitative trait loci (eQTL) to reveal biologically relevant germline variants modulating cutaneous melanoma outcomes.",26733611_1,-1,1,-1,1,27881,-1,4.770614e-06,0.9999914,3.7997381e-06
9357,This,0,1,0,4,This study demonstrates that CD8+ T cells in the tumor microenvironment display reduced functionality and hyporesponsiveness.,19319531_0,-1,1,-1,1,9357,-1,4.0321847e-06,0.9999919,4.0225523e-06
25012,the,4,5,24,27,"In order to investigate the role of LAP in human CD4Foxp3 Tregs, we designed a cross-sectional study that involved 42 colorectal cancer (CRC) patients.",25268580_1,-1,1,-1,1,25012,-1,3.7145123e-06,0.9999927,3.506595e-06
12040,The,0,1,0,3,"The frequency of Treg cells decreased when patients had been off IL-2 treatment for only 8 days, but remained higher than pretreatment levels.",20386464_3,-1,1,-1,1,12040,-1,4.1044104e-06,0.999992,3.849667e-06
22642,TSC1-deficient,2,3,10,24,"Moreover, TSC1-deficient iNKT cells display enhanced antitumor immunity in a melanoma lung metastasis model.",24532578_7,-1,1,-1,1,22642,-1,0.00010212455,0.9998362,6.164342e-05
8446,The,0,1,0,3,The host conditioning with low-dose basiliximab may augment the efficacy of AIT for cancer using activated autologous lymphocytes.,19148493_10,-1,1,-1,1,8446,-1,5.0498047e-06,0.9999907,4.2958454e-06
17742,the,10,11,67,70,The percentages of CD8(+)Foxp3(+) T lymphocytes were evaluated for the association with tumor stage.,22729557_5,-1,1,-1,1,17742,-1,4.3913933e-06,0.99999154,4.0838163e-06
23741,T-bet,9,10,72,77,"However, inflammation associated with acute microbial infection induced T-bet and Eomes expression and promoted effector differentiation of self-reactive T cells under conditions that normally favor tolerance.",24823810_4,-1,1,-1,1,23741,-1,5.7705984e-06,0.99998844,5.81654e-06
14576,the,3,4,18,21,These results beg the question: can the ineffective polarization of T lymphocytes in the context of CLL be effectively modulated using methylation inhibitors in a sustainable therapeutic fashion? To answer this question our laboratory has studied the effects of 5-aza-2'-deoxycytidine (5A2) in helper and cytotoxic T lymphocytes from healthy donors and CLL patients in well characterized molecular and epigenetic signaling pathways involved in effective polarization.,21377729_4,-1,1,-1,1,14576,-1,5.6842e-06,0.9999901,4.255158e-06
40617,Tregs,16,17,76,81,"In this study, we found that the upregulation of Foxp3+ regulatory T cells (Tregs) in the mesothelioma tumor microenvironment after nonablative oligofractionated irradiation significantly limited the success of irradiation.",32948683_2,-1,1,-1,1,40617,-1,6.6256084e-06,0.9999864,6.981052e-06
43035,to,3,4,12,14,"C3 is found to promote neutrophil recruitment and the formation of neutrophil extracellular traps (NETs), which facilitate cancer cell metastasis to the lungs.",34707103_3,-1,1,-1,1,43035,-1,5.559269e-06,0.99998987,4.6232e-06
9804,to,11,12,63,65,"We speculate that iTreg cell development is driven by the need to maintain a noninflammatory environment in the gut, to suppress immune responses to environmental and food allergens, and to decrease chronic inflammation, whereas nTreg cells prevent autoimmunity and raise the activation threshold for all immune responses.",19464985_4,-1,1,-1,1,9804,-1,4.298157e-06,0.9999918,3.889128e-06
39202,the,53,54,249,252,"Under the control of specific cytokines and B-cell lymphoma 6 transcription factor (Bcl-6), the major transcription factor of TFH cells, TFH, can expand to the other distinct CD4+T helper cells (TH1, TH2, and TH17) which exert a different role in the development of CRC.",32061875_5,-1,1,-1,1,39202,-1,3.985486e-06,0.9999919,4.156167e-06
3816,This,0,1,0,4,This conclusion provides a new concept for designing an effective treatment strategy.,16618773_7,-1,1,-1,1,3816,-1,5.0216713e-06,0.9999906,4.4512885e-06
31172,this,3,4,11,15,The aim of this work was to investigate the antitumor mechanisms of MENK via regulating DC.,28088065_2,-1,1,-1,1,31172,-1,4.5185466e-06,0.9999908,4.6258947e-06
35694,Th,38,39,219,221,"PBMCs were stimulated with PMA and ionomycin in the presence of Berefeldin A as Golgi stop agent to detect intracellular cytokine production (IFN-, IL-17, and IL-4) from CD3+CD4+T cells population indicating T helper (Th) cells subsets by flowcytometry.",30246693_4,-1,1,-1,1,35694,-1,1.5480256e-05,0.99996734,1.7180768e-05
20225,the,3,4,17,20,We also examined the presence of CD3+ Foxp3+ Tregs cells in lesional skin from 10 patients with KA and 18 patients with SCC.,23572151_4,-1,1,-1,1,20225,-1,3.7504715e-06,0.99999285,3.396266e-06
36318,This,0,1,0,4,"This study investigated the therapeutic potential of combining niraparib, a highly selective PARP1/2 inhibitor, with anti-PD-1 immune checkpoint inhibitors in preclinical tumor models.",30755715_2,-1,1,-1,1,36318,-1,3.707877e-06,0.999992,4.2724073e-06
35251,the,16,17,115,118,"Our results showed that BJ extract induced caspase-dependent apoptosis of T-ALL Jurkat cells through inhibition of the CK2-mediated signaling pathway, while exerting no significant cytotoxicity in normal peripheral blood mononuclear cells.",29966986_2,-1,1,-1,1,35251,-1,4.2110214e-06,0.9999918,4.039012e-06
11452,tumor-specific,4,5,30,44,The functional development of tumor-specific CD4(+) T cells has a critical impact on the outcome of antitumor immune responses.,20118405_0,-1,1,-1,1,11452,-1,3.0467168e-05,0.99995995,9.593816e-06
38882,to,6,7,48,50,These gene-activation events are further linked to clustering and nuclear relocalization of STAT1/2 within IFN-induced promyelocytic leukemia (PML) bodies.,31974171_4,-1,1,-1,1,38882,-1,4.5626616e-06,0.99999154,3.892348e-06
33586,the,7,8,61,64,This study provides experimental evidence toward elucidating the immune enhancement induced by fucoidan through the programmed cell death 1/PDL1 signaling pathway.,29043842_10,-1,1,-1,1,33586,-1,4.631093e-06,0.9999914,3.9180336e-06
20418,The,0,1,0,3,The immune system has evolved regulatory mechanisms to control immune responses to self-antigens.,23657628_0,-1,1,-1,1,20418,-1,4.8433994e-06,0.9999908,4.3733903e-06
6535,Tr1,13,14,87,90,"ICOShigh and ICOS- Treg were also expanded under conditions previously shown to induce Tr1 from RC.RESULTS: Treg in tumor-infiltrating lymphocytes expressed ICOS (mean fluorescence intensity=70+/-10), while Treg in PBMC had low ICOS expression (mean fluorescence intensity=3.5+/-2.5, p<or=0.001).",18292519_6,-1,1,-1,1,6535,-1,6.1441915e-06,0.99997556,1.834483e-05
4690,to,11,12,83,85,"RESULTS: Administration of beta-glucosylceramide led to alleviation of colitis and to suppression of HCC, manifested by improved survival and decreased tumour volume.",17172586_3,-1,1,-1,1,4690,-1,4.3644686e-06,0.9999907,4.899281e-06
33493,tristetraprolin,16,17,111,126,"This study describes a regulatory pathway for IL-27 expression and cytotoxic T lymphocyte function mediated by tristetraprolin, contributing to regulation of antitumour immunity.",29021521_7,-1,1,-1,1,33493,-1,3.1156465e-05,0.9999522,1.6678285e-05
4506,treatment,65,66,245,254,"P-STAT5 was detected within a subset of normal donor CD4(+) T cells (52.2 +/- 15.0%), CD8(+) T cells (57.6 +/- 25.8%), and CD56(+) natural killer (NK) cells (54.2 +/- 27.2%), but not CD14(+) monocytes or CD21(+) B cells, following in vitro IL-2 treatment.",17020993_8,-1,1,-1,1,4506,-1,3.302844e-05,0.99995446,1.2555382e-05
38642,the,15,16,95,98,"In orthotopic and syngeneic mouse models, silencing or inactivating IRIS in TNBC cells lowered the levels of circulating GM-CSF, suppressed TAM recruitment, and decreased the levels of circulating TGF1.",31911557_4,-1,1,-1,1,38642,-1,5.106558e-06,0.9999907,4.2037823e-06
6012,These,0,1,0,5,"These CD4(+)/CD25(high) T cells represent T(regs) as demonstrated by their low proliferation rate, low interferon (IFN)-gamma/interleukin (IL)-10 ratio, high expression of CD45RO, GITR, CTLA-4, forkhead box P3 (FoxP3) and low CD45RA expression.",17937675_4,-1,1,-1,1,6012,-1,3.986103e-06,0.9999912,4.858353e-06
2070,T(reg,2,3,6,11,"Thus, T(reg) are a major component of the immunosuppressive microenvironment of metastatic melanoma LNs.",15240741_6,-1,1,-1,1,2070,-1,5.4558905e-06,0.9999863,8.24442e-06
26865,transactivation-deficient,16,17,105,130,This enhanced type-1 interferon response could be suppressed by reintroducing wild-type Stat3 (but not a transactivation-deficient mutant Stat3(Y705F)) into the tumor cells.,26208907_6,-1,1,-1,1,26865,-1,1.1123008e-05,0.99998033,8.537909e-06
18673,tumor,12,13,62,67,"In this study, we used A20 B-cell lymphoma mice as aggressive tumor models to investigate the mechanism of the depletion of Tregs by low-dose cyclophosphamide (CY, 20 mg/kg).",23000689_3,-1,1,-1,1,18673,-1,4.280605e-06,0.99999106,4.717763e-06
3365,target,36,37,237,243,"In addition, protection against tumor challenge in vaccinated mice showed that there was no significant change in mice survival after in vivo CD8+CTL depletion, indicating that antitumor immunity augmented by plasmid encoding GM-CSF and target PDTRP gene vaccine was dominated by Th2 immune response.",16341143_5,-1,1,-1,1,3365,-1,5.8583632e-06,0.99999,4.195521e-06
36938,T,16,17,96,97,We showed here that the spatial distribution of interleukin-4 (IL4) in invariant natural killer T (iNKT) cells regulated crosstalk between iNKT cells and dendritic cells (DCs) and controlled iNKT cell-mediated T-helper type 1 (Th1) responses.,31160756_1,-1,1,-1,1,36938,-1,5.757832e-06,0.9999765,1.7691922e-05
39740,target,23,24,145,151,"SIGNIFICANCE: This study places ERR at the interplay between the immune response and bone metastases of breast cancer, highlighting a potential target for intervention in advanced disease.",32366476_7,-1,1,-1,1,39740,-1,5.0541216e-06,0.9999907,4.2950255e-06
7228,tumor,8,9,53,58,"However, the hybrids most inhibited the subcutaneous tumor growth in SCID mice compared with dendritic cells pulsed with other loading methods.",18563501_5,-1,1,-1,1,7228,-1,5.0970107e-06,0.99999034,4.561438e-06
4304,the,17,18,109,112,"The results show that the i.t. injection of the AdCDIRESE1A chemotherapy sensitization vector, which encodes the cytosine deaminase chemotherapy sensitization transcription unit, to the i.t. injection of Ad-sig-ecdCD40L vector-infected dendritic cells increased the level of suppression of the growth of the CCL-51 breast cancer cells.",16928818_6,-1,1,-1,1,4304,-1,3.9448673e-06,0.9999914,4.6925425e-06
34742,Tregs,7,8,27,32,"In contrast to FOXP3+ CD8+ Tregs, this subset does not inhibit effector T-cell proliferation or their functions as they are HLA-E- .",29768737_5,-1,1,-1,1,34742,-1,4.0142886e-06,0.99999166,4.306005e-06
10719,the,27,28,149,152,Twenty-four patients with CTCL and 14 patients with GVHD were included to assess the relative numbers of regulatory T cells (Treg) and any change in the serum cytokine profile during 6 months of ECP therapy.,19773201_2,-1,1,-1,1,10719,-1,4.778405e-06,0.9999906,4.645757e-06
14664,genes,10,11,85,90,Both FACS and quantitative real-time-PCR analysis revealed that ex-Tregs upregulated genes characteristic of a Th1 effector-memory phenotype including IFN- and downregulated a panel of Treg-specific genes.,21389255_3,-1,1,-1,1,14664,-1,6.352664e-06,0.9999851,8.5538095e-06
10414,Tat-CEA,6,7,17,24,"In vivo, the DC (Tat-CEA) vaccine delayed tumour growth significantly and prolonged survival of tumour-bearing mice.",19659778_7,-1,1,-1,1,10414,-1,8.5416956e-05,0.99963355,0.00028102496
11753,the,42,43,237,240,"Furthermore, there was a positive correlation between survival days and the number of T cells or T cell function, while there was a negative correlation between survival days and lung metastasis, the number of Gr-1(+)/CD11b(+) cells, or the percentage of FoxP3(+) cells.",20229083_6,-1,1,-1,1,11753,-1,4.8319575e-06,0.99998987,5.2899404e-06
266,the,18,19,89,92,"Here, we include an update on our studies regarding CD154 expression in CLL, a review of the data regarding the consequences of CD40 engagement in CLL B cells, and a discussion of these findings in the context of the complex and potentially opposite outcomes that have been reported for CD40-mediated signals in CLL.",11042507_3,-1,1,-1,1,266,-1,4.8063184e-06,0.9999901,5.105036e-06
8479,the,4,5,20,23,"OBJECTIVE: To study the mechanism of enhancement of the CTL activity in mice co-expressing of CD80, CD86 and CD137L genes.",19173904_0,-1,1,-1,1,8479,-1,4.219896e-06,0.99999225,3.5432888e-06
35435,the,7,8,45,48,Data on the CTL population further supported the results as above.,30068989_10,-1,1,-1,1,35435,-1,5.4181032e-06,0.9999906,3.9581782e-06
1051,tumors,22,23,144,150,"The aggregation state of the death-inducing ligand is a crucial factor, particularly when these molecules are used as recombinant drugs against tumors.",11924906_1,-1,1,-1,1,1051,-1,5.389573e-06,0.99999046,4.087568e-06
27694,the,2,3,10,13,"Moreover, the expression levels of PRC2 components, including EZH2, SUZ12, and EED, were inversely associated with those of CD4, CD8, and Th1-type chemokines in human colon cancer tissue, and this expression pattern was significantly associated with patient survival.",26567139_5,-1,1,-1,1,27694,-1,3.5534717e-06,0.9999924,4.0504706e-06
42785,to,24,25,126,128,"Our results indicate that germline variation in DPF3, a component of the BAF complex, part of the SWI/SNF complexes, can lead to reduced apoptosis and activation of the STAT3 pathway, both critical in RCC carcinogenesis.",34390653_4,-1,1,-1,1,42785,-1,4.7247995e-06,0.9999908,4.4983553e-06
11440,MITF-M,27,28,169,175,"Finally, we observed large amounts of biologically active IL-1alpha or IL-1beta secreted by two melanoma cell lines that did not express MITF-M, suggesting an autocrine MITF-M downregulation.",20099279_4,-1,1,-1,1,11440,-1,7.887026e-05,0.9998815,3.9632137e-05
34328,the,11,12,77,80,"Although IL33 can prevent colon cancer associated with inflammatory colitis, the contribution of IL33 signaling to sporadic colon cancer remains unknown.",29463593_3,-1,1,-1,1,34328,-1,8.037323e-06,0.99998784,4.0961268e-06
26250,their,6,7,28,33,"RESULTS: Women with CIN and their controls had similar T-cell mediated immunity against HPV16 E2, E6 and E7 peptide pools.",25990808_4,-1,1,-1,1,26250,-1,7.561079e-06,0.9999839,8.545654e-06
32250,the,26,27,167,170,The tumor-infiltrating IL-10+ CD19loCD27hi plasmablasts were found to be gut-homing due to their higher expression of 47 while peripheral blood B cells did not show the same characteristic.,28558303_5,-1,1,-1,1,32250,-1,6.589988e-06,0.99998784,5.571141e-06
26001,Treg,8,9,78,82,"Importantly, cetuximab-activated NK cells selectively eliminated intratumoral Treg but preserved effector T cells.",25832655_6,-1,1,-1,1,26001,-1,5.823697e-06,0.9999869,7.2647454e-06
2913,the,9,10,55,58,"However, TNF-alpha plus IFN- gamma was associated with the activation of NF-kappaB but not of AP-1/ERK1/2 for the induction of MDC and IP-10.CONCLUSIONS: IFN-gamma enhances LPS for the induction of MDC and IP-10 through up-regulation of TLR-4, and the signal pathways of NF-kappaB and AP-1/ERK1/2.",16094077_12,-1,1,-1,1,2913,-1,4.984321e-06,0.9999913,3.7568448e-06
7826,tumor,24,25,138,143,AIM: To elucidate the distribution of CD4(+)CD25(+) regulatory T cells (Tregs) in different lymphoid tissues and its local enhancement on tumor growth before and after depletion of CD4(+)CD25(+) Tregs.,18855977_0,-1,1,-1,1,7826,-1,4.028167e-06,0.99999154,4.415751e-06
20816,to,7,8,38,40,"In this perspective, this study aimed to evaluate the immunoexpression of interleukin (IL)-17, transforming growth factor (TGF)-1, and the forkhead box P3 (FoxP3) in periapical lesions, correlating them with the type of lesion, the intensity of the inflammatory infiltrate, and the thickness of the cystic epithelial lining.",23880265_1,-1,1,-1,1,20816,-1,3.7667392e-06,0.99999225,3.9342685e-06
38012,Tregs,8,9,46,51,Blocking the migration of regulatory T cells (Tregs) to the tumor microenvironment is a promising strategy for tumor immunotherapy.,31669202_0,-1,1,-1,1,38012,-1,5.375158e-06,0.99998915,5.465759e-06
1931,that,24,25,144,148,Other factors that may play a role in the eradication of long-term established AGIN lesions need to be determined to identify the patient group that would benefit from immunotherapy with the vaccines used in this study.,15131030_11,-1,1,-1,1,1931,-1,6.5170398e-06,0.99998784,5.7009624e-06
15822,the,6,7,52,55,"METHODOLOGY/PRINCIPAL FINDING: We here investigated the frequency, phenotype and trafficking property of Tregs and their prognostic value in patients with hepatocellular carcinoma (HCC).",21935436_2,-1,1,-1,1,15822,-1,4.035941e-06,0.99999225,3.6951524e-06
40437,Th17-polarized,10,11,46,60,"In this study, we show in various Th1- and/or Th17-polarized settings of acute and chronic bacterial infection and of tumor growth that the conditional ablation of Irf4 in CD11c+ DCs results in more efficient immune control of Helicobacter pylori, Mycobacterium bovis bacillus Calmette-Gurin, and Citrobacter rodentium and of tumor growth in a syngeneic tumor model.",32848032_2,-1,1,-1,1,40437,-1,2.866097e-05,0.9999275,4.38266e-05
32638,this,18,19,111,115,"To determine whether polyp progression in ApcMin/+ mice is dependent on Stat6 signaling, we disrupted Stat6 in this model.",28654863_6,-1,1,-1,1,32638,-1,4.2988167e-06,0.99999166,4.0818154e-06
4511,absent,4,5,25,31,"NK cells were noticeably absent in the posttreatment sample, a finding that was consistent for all patients examined.",17020993_10,-1,1,-1,1,4511,-1,0.003800006,0.99522614,0.0009737793
694,NF-kappaB,27,28,146,155,"The reduction of Th1 cytokines, induced by H2O2, was predominantly observed in memory/effector (CD45RO(+)) T cells and correlated with a block in NF-kappaB activation.",11509600_6,-1,1,-1,1,694,-1,9.017162e-06,0.99998343,7.6111114e-06
8421,the,15,16,92,95,Peripheral blood mononuclear cells (PBMCs) from cancer patients were cultivated in vitro in the presence of a high-affinity chimeric anti-CD25 Ab (basiliximab).,19148493_2,-1,1,-1,1,8421,-1,4.8461457e-06,0.9999902,4.9549594e-06
22103,the,15,16,91,94,Defects in a suppressive assay can indicate either the defective function of Treg cells or the resistance of Tconv cells to suppression by Treg cells.,24405842_1,-1,1,-1,1,22103,-1,3.881801e-06,0.9999924,3.7495183e-06
39461,TCGA,34,35,188,192,"Moreover, C-FOXP3 was colocalized and correlated with the expression of PD-L1 in tumor cells at the mRNA and protein levels, and this finding was confirmed by the The Cancer Genome Atlas (TCGA) database.",32300119_4,-1,1,-1,1,39461,-1,1.684938e-05,0.9999676,1.56059e-05
5054,the,3,4,26,29,Chemokines also increased the proliferation of clonogenic AML cells from the first subset of patients.,17339182_6,-1,1,-1,1,5054,-1,5.8551113e-06,0.99998975,4.3822197e-06
19405,MSCs,20,21,160,164,"CML patient-derived MSCs have dampening immunomodulatory functions, suggesting that the dysregulation of hematopoiesis and immune response might originate from MSCs rather than HSCs.",23180012_6,-1,1,-1,1,19405,-1,7.1820236e-06,0.9999789,1.39290105e-05
19313,the,11,12,48,51,Both CD4(+) and CD8(+) T cells were involved in the anti-neuroblastoma responses induced by YB-1 immunization combined with Treg depletion.,23169344_8,-1,1,-1,1,19313,-1,4.084693e-06,0.9999925,3.4049692e-06
40573,tumor,34,35,224,229,"Moreover, GA effectively restricted advanced stage solid tumor while used in combination with Mycobacterium indicus pranii, a known immunomodulator, which alone is reported to be ineffective to restrict advanced stage solid tumor.",32890791_8,-1,1,-1,1,40573,-1,3.880008e-06,0.99999,6.157267e-06
16188,T(reg,1,2,7,12,"Canine T(reg) could be phenotypically characterized by CD4, CD25, and FOXP3 expression.",22041284_4,-1,1,-1,1,16188,-1,5.8082123e-06,0.9999862,7.977706e-06
33436,their,21,22,127,132,We found that pretreatment of nave CD4+ T cells with IL-7 further enhanced their differentiation into TH9 cells and augmented their antitumor activity.,29018172_1,-1,1,-1,1,33436,-1,5.6732692e-06,0.99998975,4.5789257e-06
43578,those,16,17,85,90,"A result of this activation process is the induction of a number of genes, including those encoding cytokines such as interleukin-2, tumor necrosis factor-alpha, and interferon (IFN)-gamma which have important immunoregulatory effects.",8605941_1,-1,1,-1,1,43578,-1,5.4265406e-06,0.99998736,7.2295766e-06
21294,target,14,15,83,89,"The fact that many tumors are oncogene-addicted to c-MYC, renders c-MYC a powerful target for anti-tumor therapy.",24130880_1,-1,1,-1,1,21294,-1,5.507789e-06,0.9999895,4.98214e-06
3906,this,5,6,29,33,"However, tumor regression in this model is transient and long-term cure is not achieved due to recurrence.",16751376_1,-1,1,-1,1,3906,-1,4.5529064e-06,0.9999913,4.1663593e-06
37010,tumour,13,14,85,91,BACKGROUND: Anaerobic Clostridial spores (CG) cause significant oncolysis in hypoxic tumour microenvironment and result in tumour regression in both animal models and clinical trials.,31183361_0,-1,1,-1,1,37010,-1,6.582128e-06,0.9999865,6.9183484e-06
30906,Tregs,9,10,63,68,"As Treg-derived TGF- may mediate the suppressive functions of Tregs, GARP may represent a target to inhibit Treg suppression in cancer or augment suppression in autoimmunity.",28001437_2,-1,1,-1,1,30906,-1,4.3464556e-06,0.9999901,5.5295914e-06
35327,to,11,12,79,81,"Significantly, we further establish that Treg homeostasis is critically linked to Malt1 function via a Treg intrinsic and extrinsic mechanism.",30025160_4,-1,1,-1,1,35327,-1,6.2114877e-06,0.9999894,4.4128456e-06
42351,MYCN-amplified,29,30,189,203,"CONCLUSION: Our results delineate a strategy for targeted epigenetic immunomodulation of high-risk NBs, whereby EHMT inhibitors alone or in combination with EZH2 inhibitors (in particular, MYCN-amplified NBs) could promote a T-cell-infiltrated TME via enhanced Th1-type chemokine expression.",34016720_10,-1,1,-1,1,42351,-1,1.4506762e-05,0.9999716,1.3849607e-05
25532,tolerogenic,20,21,133,144,"Indeed, this molecule inhibited pDC maturation, decreased IFN secretion following TLR9 stimulation and forced these cells to become tolerogenic.",25492101_8,-1,1,-1,1,25532,-1,4.7040965e-05,0.9999305,2.2463606e-05
29352,tested,33,34,230,236,"Sample preparation, temperature, and duration of dextramer exposure were important parameters affecting the dextramer-induced NFAT activation with 2h exposure in whole blood at room temperature being the optimal of the conditions tested.",27327144_8,-1,1,-1,1,29352,-1,7.106634e-06,0.99998736,5.535844e-06
42245,To,0,1,0,2,"To overexpress Flt3L systemically, we performed gene therapy through the hydrodynamic injection of an Flt3L-encoding plasmid.",33980589_4,-1,1,-1,1,42245,-1,4.030609e-06,0.999992,3.9475985e-06
25878,the,29,30,193,196,"Therefore, our study demonstrates that the modulation of AICD of tumor-infiltrating CD4(+) T cells using HDACIs can enhance anti-tumor immune responses, uncovering a novel mechanism underlying the anti-tumor effect of HDACIs.",25745993_7,-1,1,-1,1,25878,-1,4.3242585e-06,0.9999924,3.349393e-06
4773,The,0,1,0,3,"The inhibitory rate was ca. 69.6%, and 25% of the fusion protein vaccinated-mice remained tumor free by the end of the experiment (42 d).",17202676_5,-1,1,-1,1,4773,-1,3.7437287e-06,0.999992,4.2146744e-06
10750,Transduction,0,1,0,12,Transduction of Cebpa in regular CD4(+) T cells inhibited the TCR-mediated proliferation with c-Myc and cyclin D1 repression and caused a striking activation of Spp1 encoding osteopontin along with concomitant repression of T cell lymphokine genes.,19805226_4,-1,1,-1,1,10750,-1,3.9884485e-06,0.999992,4.0009095e-06
40587,to,4,5,19,21,"These EVs are able to vehiculate RNA and proteins to target cells, and engineered EVs also vehiculate recombinant proteins.",32939048_3,-1,1,-1,1,40587,-1,3.865037e-06,0.99999225,3.9263823e-06
38774,the,2,3,16,19,"DW-MRI reflects the microarchitecture of the tissue, and changes in diffusion, which are reflected by changes in the apparent diffusion coefficient (ADC), are mainly attributed to variations in cellular density, glandular formation, and fibrosis.",31948053_1,-1,1,-1,1,38774,-1,4.7285316e-06,0.9999907,4.5851043e-06
17458,that,37,38,210,214,"Collectively, these results show that in humans, a large proportion of CD4(+) memory T cells express intermediate levels of CD25, and this CD25(INT) FOXP3(-) subset is a functionally distinct memory population that is uniquely affected by IL-2.",22585674_5,-1,1,-1,1,17458,-1,4.4637754e-06,0.99999106,4.5058227e-06
38209,to,7,8,49,51,Chromatin immunoprecipitation (ChIP) was applied to detect the direct binding of p65 to miR-23a promoter.,31769216_6,-1,1,-1,1,38209,-1,4.341618e-06,0.99999225,3.4491813e-06
31067,the,21,22,144,147,"We observed that treatment with a reversible proteasome inhibitor bortezomib (1 mg/kg body weight) in tumor-bearing mice significantly enhanced the expression of lymphocyte-stimulatory cytokines IL-2, IL-12, and IL-15.",28052005_2,-1,1,-1,1,31067,-1,3.7388143e-06,0.9999925,3.7218233e-06
26661,tumor,7,8,43,48,"To further evaluate the TLR4 dependency on tumor microenvironment, Lewis lung carcinoma-bearing mice were treated with Eritoran, an antagonist of TLR4/MD-2 complex.",26165843_8,-1,1,-1,1,26661,-1,4.526969e-06,0.9999906,4.855997e-06
29889,the,18,19,93,96,The objective of this study was to observe the distribution of regulatory T cells (Tregs) in the development of tongue squamous cell carcinoma (SCC) and to determine the role of Tregs in the progression of tongue SCC.,27614428_0,-1,1,-1,1,29889,-1,3.6674464e-06,0.9999925,3.8875955e-06
17860,tumor,25,26,141,146,"RESULTS: FOXP3+ Tregs were enriched in tumor sites, and circulating FOXP3+ Tregs were increased in HCC patients in correlation with multiple tumor foci and up-regulated TLR4 expression in HCC tissues.",22736917_4,-1,1,-1,1,17860,-1,4.2144525e-06,0.9999908,4.99383e-06
24953,the,19,20,142,145,"These results demonstrate that nicotine suppresses acute colitis and colitis-associated tumorigenesis, and this effect may be associated with the activation of 7-nAChR. Furthermore, it is presumed that nicotine downregulates the expression of inflammatory mediators such as IL-6/Stat3 and TNF-, thereby reducing the colonic tumorigenesis associated with chronic colitis.",25258409_9,-1,1,-1,1,24953,-1,4.357052e-06,0.99999213,3.5624457e-06
4578,the,18,19,139,142,"We have analyzed the DNA elements and interacting transcription factors that control the constitutive and IFNgamma-inducible expression of the class II transactivator (CIITA), a co-activator essential for transcription of all MHC class II genes.",17067677_2,-1,1,-1,1,4578,-1,4.5230618e-06,0.9999912,4.3045493e-06
24387,The,2,3,9,12,"RESULTS: The APH complex significantly promoted antigen uptake, maturation and cross-presentation of dendritic cells and enhanced the secretion of TNF-, MCP-1 and IFN- by human peripheral blood mononuclear cells compared with individual components.",25070035_5,-1,1,-1,1,24387,-1,3.975568e-06,0.99999213,3.9359566e-06
37510,that,3,4,32,36,X-ray co-crystallography showed that BR-001 directly binds EED in the H3K27me3-binding pocket.,31395608_3,-1,1,-1,1,37510,-1,4.043353e-06,0.99999213,3.820361e-06
31028,genes,7,8,55,60,NF-B staining and mRNA quantification of inflammatory genes in HK-2 epithelial renal cells exposed to supernatants of peripheral blood mononuclear cells with clonal T-cell population.,28018996_3,-1,1,-1,1,31028,-1,0.009245076,0.9905896,0.00016528802
16681,their,16,17,106,111,"Third, FTS induced an increase in antitumor cytotoxic T-cell reactivity in glioma cells by downregulating their own expression of Foxp3.",22323550_5,-1,1,-1,1,16681,-1,7.951641e-06,0.9999857,6.342056e-06
30112,therapies,18,19,114,123,"However, PAC is an immune-resistant tumor, and it is still unclear whether immune checkpoint or anti-inflammation therapies would be an ideal strategy.",27672267_3,-1,1,-1,1,30112,-1,6.563259e-06,0.9999882,5.270871e-06
12629,generally,5,6,40,49,Patients with relatively larger lesions generally did not display a CR.,20547850_1,-1,1,-1,1,12629,-1,8.746132e-06,0.9999821,9.133687e-06
23519,that,4,5,14,18,"Here, we show that CD4(+)ICOS(hi) T cells from anti-CTLA-4-treated patients had an increase in signaling via the phospoinositide-3-kinase (PI3K) pathway and an increase in expression of T-bet.",24778280_5,-1,1,-1,1,23519,-1,3.6412862e-06,0.99999213,4.180955e-06
5363,the,11,12,72,75,"To determine whether these inhibitory effects of CA are associated with the alteration of the signal transducer and activator of transcription 1 (STAT1) and IFN-gamma-inducible, dsRNA-activated serine/threonine protein kinase (PKR), BMDCs were pretreated with various concentrations of CA.",17466914_5,-1,1,-1,1,5363,-1,3.6516167e-06,0.9999927,3.5788373e-06
43778,These,0,1,0,5,"These KS-like lesions are accompanied by production of basic fibroblast growth factor, an angiogenic factor highly expressed in primary lesions that mediates angiogenesis and spindle cell growth.",9446657_10,-1,1,-1,1,43778,-1,6.938432e-06,0.99998605,7.0560427e-06
20507,the,2,3,15,18,"Unfortunately, the link between hypoxia and Treg-mediated immune tolerance in gastric cancer remains poorly understood.",23723999_2,-1,1,-1,1,20507,-1,8.998099e-06,0.9999871,3.9177366e-06
42171,the,27,28,151,154,We reported a direct role of STAT6 in the induction and function of Treg cells during CAC development and suggest that STAT6 is a potential target for the modulation of immune response in colitis and CAC.,33919941_8,-1,1,-1,1,42171,-1,4.0088144e-06,0.9999926,3.3853546e-06
5426,These,0,1,0,5,These findings may be used to design therapies to counteract immune dysfunction in melanoma and to improve cancer immunotherapy.,17488182_11,-1,1,-1,1,5426,-1,4.615526e-06,0.9999918,3.6419203e-06
1077,their,27,28,152,157,"When expressed on cytotoxic T lymphocytes, natural killer cells, monocytes, and dendritic cells, they induce the apoptosis of many tumor cells, whereas their expression on tumor cells induces the apoptosis of killer cells.",11924906_5,-1,1,-1,1,1077,-1,4.7659905e-06,0.9999907,4.5234356e-06
31945,the,52,53,305,308,"Despite the failure of virus spread to the tumor, infection resulted in significantly enhanced tumor necrosis, extensive CD4 T cell accumulation, and high levels of the proinflammatory factors IFN-, TNF-, and inducible NO synthase in the TME merely 4 d postinfection, before significant virus spread or the appearance of RABV-specific immune mechanisms in CNS tissues.",28461570_5,-1,1,-1,1,31945,-1,4.078936e-06,0.99999166,4.2466027e-06
24832,that,14,15,75,79,"Here, using a type II NKT-cell TCR transgenic mouse model, we demonstrated that CD1d-expressing hematopoietic cells, but not thymic epithelial cells, meditate efficient selection of type II NKT cells.",25236978_2,-1,1,-1,1,24832,-1,4.279478e-06,0.999992,3.7484658e-06
43036,the,8,9,50,53,"C3 is found to promote neutrophil recruitment and the formation of neutrophil extracellular traps (NETs), which facilitate cancer cell metastasis to the lungs.",34707103_3,-1,1,-1,1,43036,-1,4.2426273e-06,0.99999154,4.22263e-06
20258,target,6,7,42,48,These findings identify miRNA-155 and its target SOCS-1 as key regulators of effector CD8(+) Tcells that can be modulated to potentiate immunotherapies for infectious diseases and cancer.,23601686_6,-1,1,-1,1,20258,-1,5.4797124e-06,0.9999896,4.9502005e-06
14850,TGF-1,3,4,18,24,The production of TGF-1 was detected in supernatant of MGC and GES-1.,21528082_5,-1,1,-1,1,14850,-1,9.789457e-06,0.99997413,1.609184e-05
14499,TEMs,24,25,140,144,"We now show that TEMs also express higher levels of IL-10 than TIE2(-) macrophages in tumors and that ANGPT2-stimulated release of IL-10 by TEMs suppresses T cell proliferation, increases the ratio of CD4(+) T cells to CD8(+) T cells, and promotes the expansion of CD4(+)CD25(high)FOXP3(+) Tregs.",21368233_4,-1,1,-1,1,14499,-1,5.0563795e-06,0.9999901,4.86373e-06
21118,that,6,7,25,29,"In this article, we show that resveratrol (RSV), a plant-derived polyphenol, at low and noncytotoxic doses for immune cells, can efficiently inhibit lung metastasis in mice.",24043896_1,-1,1,-1,1,21118,-1,4.0109076e-06,0.999992,3.958784e-06
22231,tumor,4,5,34,39,"This treatment markedly inhibited tumor growth, and was accompanied by massive infiltration of IFN-producing T cells.",24416401_7,-1,1,-1,1,22231,-1,4.4459016e-06,0.99999094,4.5809447e-06
14753,Tregs,2,3,9,14,Foxp3(+) Tregs are now recognized as a major contributor to tumor-induced immune suppression and functional tolerance.,21517755_2,-1,1,-1,1,14753,-1,5.386143e-06,0.99999,4.601458e-06
22604,The,0,1,0,3,The children of the mothers with incident CIN3 had significantly higher IFN- (p=0.032) and TNF- (p=0.008) levels than other children.,24524328_10,-1,1,-1,1,22604,-1,4.950821e-06,0.99998903,5.9772656e-06
25655,that,2,3,12,16,We conclude that NPC-derived miR-21 induces IL-10(+) B cells; the latter is capable of suppressing CD8(+) T-cell activities.,25544502_11,-1,1,-1,1,25655,-1,4.1599355e-06,0.99999213,3.6798301e-06
6030,T(regs,9,10,74,80,This study demonstrates increased frequencies and suppressive activity of T(regs) in cervical cancer.,17937675_8,-1,1,-1,1,6030,-1,7.617247e-06,0.99998057,1.1857447e-05
7668,natural,41,42,280,287,"Although WP1066 did not induce immunologic memory or enhance humoral responses to EGFRvIII, this compound reduced the production of immunosuppressive cytokines and chemokines (transforming growth factor-beta, RANTES, MCP-1, vascular endothelial growth factor), markedly inhibited natural and inducible Treg proliferation, and significantly increased cytotoxic immune responses of T cells.",18794085_7,-1,1,-1,1,7668,-1,9.708424e-06,0.99998486,5.376401e-06
36711,the,6,7,46,49,"While the inflammatory cytokine can stimulate the immune system and promote tumor growth, it remains unclear how circulating IL-6 can potentiate a poor prognosis.",31027698_1,-1,1,-1,1,36711,-1,7.465359e-06,0.9999883,4.228766e-06
24563,the,44,45,285,288,"Although several studies assessing the potential prognostic value of InfBMs in cancer have been published in the past decades, they have had no impact on the management of patients with urothelial bladder carcinoma (UBC).OBJECTIVE: To review and summarise the scientific literature on the prognostic value of tumour, serum, urine, and germline DNA InfBMs on UBC.EVIDENCE ACQUISITION: A systematic review of the literature was performed searching the Medline and Embase databases for original articles published between January 1975 and November 2013.",25151017_2,-1,1,-1,1,24563,-1,4.921815e-06,0.9999914,3.7186971e-06
9800,to,14,15,85,87,The full extent of differences and similarities between iTreg and nTreg cells is yet to be defined.,19464985_3,-1,1,-1,1,9800,-1,1.1407374e-05,0.99997973,8.898139e-06
13367,the,8,9,49,52,"In response to autologous tumor plus IL-2/IL-15, the CD8(+) FOXP3(+) T cells proliferated promptly and showed competence for differentiation (downregulation of CD27 and upregulation of T-bet).",20861189_8,-1,1,-1,1,13367,-1,4.676151e-06,0.99999034,5.008537e-06
21072,targeting,29,30,203,212,"Our results argue that these major immunosuppressive pathways are intrinsically driven by the immune system rather than being orchestrated by cancer cells, and imply that cancer immunotherapy approaches targeting negative regulatory immune checkpoints might be preferentially beneficial for patients with a preexisting T cell-inflamed tumor microenvironment.",23986400_5,-1,1,-1,1,21072,-1,5.241333e-06,0.9999913,3.4096577e-06
16243,to,39,40,261,263,"Interestingly, miR-135b suppressed T-helper (Th) 2 master regulators STAT6 and GATA3, and miR-135b blockade attenuated IL-17 production and paracrine inflammatory response by ALCL cells, indicating that miR-135b-mediated Th2 suppression may lead to the skewing to ALCL immunophenotype overlapping with Th17 cells.",22042699_6,-1,1,-1,1,16243,-1,5.499754e-06,0.9999888,5.6992285e-06
15129,tumor-bearing,5,6,36,49,"In tumor-free mice and subcutaneous tumor-bearing mouse models, CD8 Foxp3+ T cells were a rare but naturally occurring cell subset.",21638127_3,-1,1,-1,1,15129,-1,5.4806196e-06,0.9999882,6.290204e-06
16261,this,3,4,12,16,The goal of this study was to examine whether DKK1 can be used as a tumor vaccine to elicit DKK1-specific immunity that can control myeloma growth or even eradicate established myeloma in vivo.,22049519_2,-1,1,-1,1,16261,-1,4.2506467e-06,0.99999166,4.079037e-06
17143,that,29,30,145,149,"The provision of T cell co-stimulation via members of the TNFR super-family, including OX40 (CD134) and 4-1BB (CD137), provides critical signals that promote T cell survival and differentiation.",22496812_0,-1,1,-1,1,17143,-1,6.9772486e-06,0.9999888,4.1863473e-06
27662,those,9,10,56,61,Genotypes of 49 individuals with LAC were compared with those of 93 healthy subjects.,26547104_3,-1,1,-1,1,27662,-1,5.672475e-06,0.9999889,5.361901e-06
9977,Th17,30,31,169,173,"In many cases, this process is related to an inappropriate T cell response to environmental allergens, and other T cell-dependent pathways may also be involved (such as Th17).",19538496_1,-1,1,-1,1,9977,-1,1.2685847e-05,0.999977,1.032735e-05
13480,Foxp3+IL-17,6,7,38,49,The frequency and cytokine profile of Foxp3+IL-17+ T cells in CRC were examined by flow cytometry.,20952660_3,-1,1,-1,1,13480,-1,0.039709717,0.95948833,0.0008019768
25074,T-bet,40,41,232,237,"Our results showed that the expression levels of Runx3, T-bet, and IFN- in patients with gastric carcinoma were obviously lower than those in control groups, and there was a positive correlation between the expression of Runx3 and T-bet or IFN- in patients (p<0.01).",25270738_2,-1,1,-1,1,25074,-1,4.3436744e-06,0.99998987,5.7501657e-06
9098,tolerance,15,16,136,145,"Understanding and manipulating the functional immunogenic/tolerogenic dichotomy of DC has important clinical applications for achieving tolerance in organ transplantation, stemming autoimmune diseases or, conversely, generating efficient immunogenic vaccines for immunotherapy in cancer and chronic viral diseases.",19275918_7,-1,1,-1,1,9098,-1,1.319512e-05,0.99997985,6.9423268e-06
8009,this,5,6,32,36,"Sixteen CSTCLs were included in this study, and also 20 reactive inflammatory conditions, 10 primary cutaneous marginal zone, 10 follicular center lymphomas, and 5 primary CD30 cutaneous lymphomas.",18987541_4,-1,1,-1,1,8009,-1,4.472386e-06,0.9999907,4.8386437e-06
26528,The,0,1,0,3,"The expanding pTreg displayed hypermethylation of the CpG islands in Treg-specific demethylated region, CTLA-4 exon 2, and glucocorticoid-induced TNFR exon 5, were phenotypically unstable, and exhibited diminished suppressive function consistent with an uncommitted in vitro-induced Treg-like phenotype.",26085681_4,-1,1,-1,1,26528,-1,3.7425164e-06,0.9999924,3.929956e-06
13961,the,6,7,47,50,Further examinations are needed to investigate the after/before percentage ratio of CD4+Foxp3+T-cells can be useful predicting parameters for the selection of responders of PSK.,21224532_6,-1,1,-1,1,13961,-1,3.7656166e-06,0.9999926,3.5906962e-06
26940,Th22,11,12,74,78,We also found that there was a significantly positive correlation between Th22 and Th17 cells in MM patients.,26255628_7,-1,1,-1,1,26940,-1,0.0042297193,0.99538475,0.0003854859
40721,STAT3,29,30,195,200,The curcumin po administration resulted in the significant augmentation of in vivo induction of tumor antigen-specific T cells through restoration of dendritic cells (DCs) by inhibiting directly STAT3 in DCs and indirectly via reduced IL-6 production from STAT3 activated cancer cells in 2 syngeneic MC38 and CT26 murine tumor models.,33006786_3,-1,1,-1,1,40721,-1,6.410327e-06,0.99998796,5.5983473e-06
43734,these,2,3,13,18,Inclusion of these approaches in the protocols of T cell based immunotherapy may improve its efficacy.,8795138_8,-1,1,-1,1,43734,-1,5.6360427e-06,0.9999896,4.7299654e-06
23604,genetic,3,4,9,16,"In mice, genetic or pharmacologic suppression of FasL produced a substantial increase in the influx of tumor-rejecting CD8(+) over FoxP3(+) T cells.",24793239_4,-1,1,-1,1,23604,-1,7.318233e-06,0.99998593,6.799436e-06
41420,the,10,11,63,66,Inactivation of tumor-infiltrating lymphocytes (TIL) is one of the mechanisms mitigating antitumor immunity during tumor onset and progression.,33589517_0,-1,1,-1,1,41420,-1,8.3167415e-06,0.9999865,5.173846e-06
40935,Tregs,11,12,72,77,"Meanwhile, patients in complete remission exhibited levels of Bregs and Tregs comparable to healthy controls.",33083479_9,-1,1,-1,1,40935,-1,4.1323246e-06,0.99999034,5.5271257e-06
43092,that,6,7,42,46,"Moreover, accumulating evidence has shown that EZH2 may contribute to the regulation of immune cells, especially T cells.",34737746_3,-1,1,-1,1,43092,-1,4.2426686e-06,0.9999918,3.9655088e-06
32714,The,0,1,0,3,"The effects of DCs on anti-tumor immune responses were analyzed using the EG7 tumor model, where the tumor cells express the peptide epitope recognized by OT-1 T cells.",28675711_3,-1,1,-1,1,32714,-1,3.7322131e-06,0.9999926,3.7165457e-06
25310,This,0,1,0,4,"This literature study gives an overview of the current accessible information on the topic of the characterization, the generation, regulation and functions of the Inducible Treg populations and their subsets in the human immune system.",25427312_5,-1,1,-1,1,25310,-1,4.689309e-06,0.9999907,4.604209e-06
7857,the,7,8,38,41,"In the draining regional lymph nodes, the number of CD4(+)CD25(+) Tregs also decreased significantly.",18855977_10,-1,1,-1,1,7857,-1,3.8757053e-06,0.9999925,3.594677e-06
40815,to,10,11,62,64,"Besides viral infections, IRF3 is also involved in resistance to some bacterial infections, in anticancer immunity, and in anticancer therapies involving DNA damage agents.",33020188_4,-1,1,-1,1,40815,-1,1.1889625e-05,0.9999745,1.356916e-05
2461,the,15,16,110,113,"Immunity in STAT6-deficient mice requires the activation of NO-producing M1 macrophages that are tumoricidal, the reduction in MSC levels to baseline after surgical removal of primary tumor, and the activation of tumor-specific T cells.",15634881_6,-1,1,-1,1,2461,-1,4.180756e-06,0.9999914,4.3511645e-06
10944,that,13,14,65,69,"Total CD4(+) T cell counts are not constant, however, suggesting that homeostatic mechanisms, or susceptibility to cytotoxic or malignant insults, fundamentally differ for regulatory and non-regulatory CD4(+) T cells.",19855964_7,-1,1,-1,1,10944,-1,4.3412524e-06,0.9999919,3.7489442e-06
18032,tumor,19,20,104,109,"Here, we show that CXCR3(+) Treg are highly enriched in human ovarian carcinomas, particularly in solid tumor masses, where they represent the majority of Treg.",22798340_4,-1,1,-1,1,18032,-1,4.6881537e-06,0.99999034,5.015448e-06
14947,T,6,7,40,41,Conversion of conventional T cells into T regulatory cells (Tregs) has been proposed as a potential mechanism for Treg expansion in cancer.,21570917_0,-1,1,-1,1,14947,-1,1.096524e-05,0.9999703,1.8687508e-05
36649,to,4,5,13,15,"Here, we aim to explore the role and mechanisms of CD4+ T cells in PCa chemotherapy sensitivity.",31018021_3,-1,1,-1,1,36649,-1,3.5914422e-06,0.9999925,3.875439e-06
25985,treatment,3,4,19,28,"Notably, cetuximab treatment increased the frequency of CD4(+)FOXP3(+) intratumoral Treg expressing CTLA-4, CD39, and TGF.",25832655_3,-1,1,-1,1,25985,-1,4.9411597e-06,0.9999907,4.306198e-06
42685,the,2,3,9,12,"However, the mechanism underlying T cell dysfunction and its reversal remains unclear.",34237654_1,-1,1,-1,1,42685,-1,6.9568946e-06,0.99998844,4.6287296e-06
12138,the,9,10,47,50,Patients were followed every 3 to 6 months for the development of anal intraepithelial neoplasia (AIN3) and cancer for up to 60 months.,20394639_2,-1,1,-1,1,12138,-1,4.5556058e-06,0.9999908,4.5699653e-06
24398,tumor,6,7,44,49,Vaccination of NAPH resulted in significant tumor regression or delayed tumor progression in prophylactic and therapeutic models.,25070035_6,-1,1,-1,1,24398,-1,4.5528736e-06,0.9999907,4.7454178e-06
7830,These,0,1,0,5,"These mice were divided into BaP-only, BaP + IgG, BaP + PC61, and control groups.",18855977_3,-1,1,-1,1,7830,-1,4.5459074e-06,0.9999902,5.220067e-06
23854,transforming,10,11,69,81,"Our results suggest RepSox may reduce Tim-3 expression by inhibiting transforming growth factor- signaling and slow decay of CD34(+) AML cells by increasing CXCL12 and MYC, two factors that inhibit AML cell differentiation.",24855276_9,-1,1,-1,1,23854,-1,1.7766157e-05,0.9999676,1.4663895e-05
2179,the,51,52,275,278,METHODS: Peripheral blood mononuclear cells (PBMCs) isolated from healthy donors (n = 17) or melanoma patients (n = 19) were treated in vitro with interferon alfa-2b (IFN alpha-2b) or phosphate-buffered saline (PBS) and subjected to multiparametric flow cytometry to measure the levels of phosphorylated STAT1 (P-STAT1) within immune cell subsets.,15339971_2,-1,1,-1,1,2179,-1,4.261449e-06,0.999992,3.7453713e-06
37757,The,0,1,0,3,"The growth of ovalbumin (OVA)-expressing tumours was significantly suppressed by administration of OVA and the anti-TLR4 mAb in combination, but not individually.",31515801_5,-1,1,-1,1,37757,-1,3.7902632e-06,0.9999924,3.8532644e-06
23059,absent,18,19,125,131,"Based on our prior genome-wide interrogation of human prostate cancer tissues to identify genes over-expressed in cancer and absent in the periphery, we targeted SIM2 as a prototype autologous tumor antigen for these studies.",24690990_1,-1,1,-1,1,23059,-1,1.1456681e-05,0.9999794,9.162592e-06
27160,the,13,14,77,80,"The proportion and FoxP3 expression of the induced CD4(+)CD25(+) T cells are the highest at the level of 40ng/ml IFN-, and the suppressive function of the CD4(+)CD25(+) T cells induced by 40ng/ml IFN- is the strongest in MG patients.",26347149_12,-1,1,-1,1,27160,-1,6.7109618e-06,0.9999864,6.842385e-06
3155,tumor-draining,5,6,25,39,In this study we analyze tumor-draining lymph nodes (LNs) and demonstrate that both antitumor effector T cells and Treg capable of abrogating the antitumor reactivity of the effector T cells are primed in the same LNs during tumor progression.,16210609_3,-1,1,-1,1,3155,-1,2.1415019e-05,0.9999647,1.3852788e-05
26736,play,7,8,36,40,"Although regulatory T cells (Tregs) play an integral role in immunologic tolerance and the maintenance of intestinal homeostasis, their involvement in canine gastrointestinal diseases, including idiopathic inflammatory bowel disease (IBD) and intestinal lymphoma, remains unclear.",26173451_0,-1,1,-1,1,26736,-1,6.7056912e-06,0.9999865,6.7890733e-06
40277,to,30,31,185,187,"Small molecule targeting of the essential HH effector Smoothened (SMO) has proven an effective therapy of BCC, though the frequent development of drug resistance poses major challenges to anti-HH treatments.",32615027_1,-1,1,-1,1,40277,-1,5.9329673e-06,0.9999889,5.1591906e-06
37673,to,11,12,79,81,"Previous studies have shown that baicalein and baicalin are directly cytotoxic to some tumors, here we demonstrate that in addition to direct cytotoxicity, these two flavonoids stimulate the T cell mediated immune response against tumors through reduction of PD-L1 expression in cancer cells.",31437792_1,-1,1,-1,1,37673,-1,1.5366233e-05,0.9999691,1.5470217e-05
32922,the,28,29,186,189,The data of the in vitro experiments showed that curcumin converted the LC patient-isolated Tregs to Th1 cells via repressing the gene transcription of forkhead protein-3 and increasing the expression of interferon-.,28731226_9,-1,1,-1,1,32922,-1,4.264054e-06,0.99999094,4.7972508e-06
33033,tumor,9,10,66,71,"Genetic deletion of macrophagic GS in tumor-bearing mice promotes tumor vessel pruning, vascular normalization, accumulation of cytotoxic Tcells, and metastasis inhibition.",28813676_4,-1,1,-1,1,33033,-1,4.5573865e-06,0.9999906,4.8353586e-06
13194,the,8,9,46,49,"Finally, we demonstrated that the increase in the frequency of MDSC was mediated by MyD88-NF-kB pathway.",20822377_10,-1,1,-1,1,13194,-1,4.708743e-06,0.9999913,4.034706e-06
22256,tumor,27,28,126,131,"Bcl11b(-/-) CD4(+) T cells, with elevated TNF- levels, but not the Bcl11b(-/-) CD8(+) T cells, were required for the reduced tumor burden, as were NK1.1(+) cells, found in increased numbers in Bcl11b(F/F)/CD4-Cre mice.",24446520_1,-1,1,-1,1,22256,-1,4.1033927e-06,0.999992,3.8387716e-06
25454,the,32,33,241,244,The antigenic variability of tumor cells leading to dynamic changes in cancer epitope landscape along with escape from immune surveillance by down-regulating tumor antigen expression/presentation and immune tolerance are major obstacles for the design of effective vaccines.,25483665_0,-1,1,-1,1,25454,-1,4.4499275e-06,0.9999919,3.631641e-06
6788,to,9,10,55,57,It is anticipated that such research efforts will lead to novel DNA-based vaccines that will be effective for the treatment of cancer.,18363997_6,-1,1,-1,1,6788,-1,4.0745163e-06,0.9999919,4.039567e-06
13853,tumour-bearing,18,19,80,94,"BACKGROUND: 'FOXP3+ regulatory T cells' (Tregs) are reported to be increased in tumour-bearing hosts including patients with melanoma, leading to tumour immune suppression.",21198537_0,-1,1,-1,1,13853,-1,1.0372933e-05,0.9999809,8.74332e-06
16450,that,4,5,23,27,We have recently shown that intratumor (i.t.) injection of syngenic dendritic cells (DC) engineered to express the transcription factor Tbet (TBX21) promotes protective type-1 T cell-mediated immunity via a mechanism that is largely interleukin (IL)-12p70-independent.,22215017_0,-1,1,-1,1,16450,-1,4.211661e-06,0.999992,3.782628e-06
43774,the,23,24,125,128,"gamma IFN, in fact, induces endothelial cells to acquire the same features of KS cells, including the spindle morphology and the pattern of cell marker expression.",9446657_8,-1,1,-1,1,43774,-1,4.7508593e-06,0.99999046,4.840692e-06
24881,tool,12,13,58,62,"In summary, our data suggest that GEP might be a powerful tool for the prediction of immunosuppression and the monitoring of immune responses within immunotherapy trials.",25242680_5,-1,1,-1,1,24881,-1,9.951865e-06,0.9999838,6.2585823e-06
33363,Thus,0,1,0,4,"Thus, this study aimed to investigate whether Treg and Tr1 cells participate in immunological status against cancer.",28982868_1,-1,1,-1,1,33363,-1,5.1862917e-06,0.9999896,5.2358787e-06
202,interferon regulatory factor 4,7,11,37,67,"We wanted to study the expression of interferon regulatory factor 4 (IRF4) in various hematologic disorders, especially chronic myeloid leukemia (CML), and its association with response to interferon alfa (IFN-alpha) treatment in CML.MATERIALS AND METHODS: Blood samples from various hematopoietic cell lines, different leukemia patients (70 CML, 29 acute myeloid leukemia [AML], 10 chronic myelomonocytic leukemia [CMMoL], 10 acute lymphoblastic leukemia, and 10 chronic lymphoid leukemia patients), and 33 healthy volunteers were monitored for IRF4 expression by reverse transcriptase polymerase chain reaction.",11013272_1,-1,1,-1,1,202,-1,0.054238085,0.94366115,0.0021007126
10475,that,3,4,31,35,"Neutralization assays revealed that neutralizing antibody against transforming growth factor beta (TGF-beta), interleukin-10, and interleukin-4 did not abrogate elevated FOXP3 expression induced by carcinoma cell culture supernatant, whereas neutralizing leukemia inhibitory factor (LIF) partially abrogated FOXP3 expression, but LIF alone could not increase FOXP3 expression in activated nave T cells.",19673890_6,-1,1,-1,1,10475,-1,5.528003e-06,0.9999908,3.6507952e-06
30316,genetic,4,5,25,32,Host CXCR2 inhibition by genetic ablation prevented neutrophil accumulation in pancreatic tumors and led to a T cell-dependent suppression of tumor growth.,27737879_6,-1,1,-1,1,30316,-1,5.604549e-06,0.9999889,5.484403e-06
36284,transfer,5,6,31,39,"More importantly, the adoptive transfer of TNF--treated Th9 cells induced more potent antitumor effects than regular Th9 cells in mouse tumor model.",30717817_5,-1,1,-1,1,36284,-1,5.1382854e-06,0.99999034,4.5699417e-06
6444,TILs,7,8,38,42,"Importantly, the increase in Tregs in TILs occurred to the same extent in early and advanced disease.",18224687_7,-1,1,-1,1,6444,-1,8.174347e-06,0.9999831,8.771501e-06
15426,tumours,22,23,126,133,"Importantly, genetic ablation of IL-17A in gp130(F/F) :IL-17a(-/-) mice did not suppress the initiation and growth of gastric tumours.",21710691_7,-1,1,-1,1,15426,-1,5.240158e-06,0.99998736,7.447688e-06
38684,to,28,29,185,187,"Marked reduction in Treg proliferation and tumor infiltration coincide with G1 arrest in tumor infiltrated Siah2-/- Tregs in vivo or following T cell stimulation in culture, attributed to elevated expression of the cyclin-dependent kinase inhibitor p27, a Siah2 substrate.",31911617_3,-1,1,-1,1,38684,-1,3.865896e-06,0.99999225,3.940648e-06
3309,treatment,17,18,92,101,"We found that the frequency of CD4+ CD25(hi) T cells was significantly increased after IL-2 treatment, and these cells expressed phenotypic markers associated with regulatory T cells.",16304057_4,-1,1,-1,1,3309,-1,5.4065862e-05,0.9999306,1.5338117e-05
5100,that,6,7,50,54,"Intracellular staining for Foxp3 protein revealed that combined treatment with rFL plus rGM-CSF results in a significant increase in CD4+Foxp3+ T cells in the spleen of both control and tumor-bearing mice, and that nearly half of CD4+ TIL expressed this marker.",17339434_3,-1,1,-1,1,5100,-1,4.510383e-06,0.9999918,3.6690742e-06
40506,the,12,13,80,83,METHODS: B16F10 cells and melanoma-bearing BALB/c mice were used to investigate the effects of DHA on melanoma.,32859456_4,-1,1,-1,1,40506,-1,3.964537e-06,0.9999926,3.4724842e-06
20218,to,6,7,30,32,"The purpose of this study was to investigate the involvement of immunosuppressive cells, such as Tregs and CD163+ macrophages, as well as immunomodulatory cells (i.e. IL-27-producing cells) in keratoacanthoma (KA) and invasive squamous cell carcinoma (SCC).",23572151_3,-1,1,-1,1,20218,-1,3.7975321e-06,0.9999924,3.814599e-06
24230,LAG-3 protein,8,10,43,56,The Tr1 cells were identified by CD49b and LAG-3 protein expression.,25034363_3,-1,1,-1,1,24230,-1,1.2507251e-05,0.9999778,9.668644e-06
36735,transducer,6,7,43,53,"These patients also showed impaired signal transducer and activator of transcription-1 (STAT1) signaling upon stimulation with IL-6 and phorbol 12-myristate 13-acetate (PMA), and T-Cells from a healthy donor that were treated for four days with IL-6 displayed a similar muting of STAT signaling, which verified the effect seen in patient samples.",31027698_7,-1,1,-1,1,36735,-1,5.86075e-06,0.99998915,5.0324893e-06
18281,these,11,12,72,77,The mechanisms by which tumors promote the expansion and/or function of these suppressive cells and the cross-talk between MDSC and Treg remain incompletely defined.,22891289_1,-1,1,-1,1,18281,-1,6.0831917e-06,0.99998677,7.189289e-06
4901,Tregs,28,29,166,171,"Therefore, we investigated whether expression of FoxP3, a transcription factor that is highly expressed in Tregs in humans and rodents could also be used to identify Tregs in dogs.",17224188_4,-1,1,-1,1,4901,-1,4.1523454e-06,0.9999913,4.5703428e-06
25513,to,20,21,150,152,We also demonstrated that cervical/vulvar neoplastic keratinocytes inhibit the proper function of pDCs by decreasing their IFN secretion in response to CpG oligonucleotides.,25492101_4,-1,1,-1,1,25513,-1,6.4222118e-06,0.99999,3.6212034e-06
17245,to,3,4,13,15,FCM was used to detect T subgroup ratio of spleen cells of tumor-bearing mice.,22522606_6,-1,1,-1,1,17245,-1,4.2877477e-06,0.99999225,3.4866125e-06
5851,Treg,43,44,253,257,"Transwell inserts partly prevented suppression (60 +/- 5% versus 95 +/- 5%).CONCLUSIONS: Suppression in the tumor microenvironment is mediated by a unique subset of Treg, which produce IL-10 and TGF-beta1 and do not require cell-to-cell contact between Treg and responder cells for inhibition.",17671115_10,-1,1,-1,1,5851,-1,6.7395317e-06,0.99998486,8.430128e-06
23363,there,21,22,119,124,"Numerous researchers have found that it could work as a potent antitumor agent to inhibit tumor growth in vitro, buith there has been much less emphasis on its in vivo role against breast tumors.",24761844_1,-1,1,-1,1,23363,-1,7.301117e-06,0.9999857,7.0533956e-06
35915,the,7,8,41,44,Graft-versus host disease (GVHD) remains the most significant complication of allogeneic hematopoietic stem cell transplantation (allo-HSCT).,30445020_0,-1,1,-1,1,35915,-1,6.432557e-06,0.999987,6.519552e-06
42138,To,0,1,0,2,"To clarify the contribution of STAT6 to CAC, STAT6-/- and wild type (WT) mice were subjected to an AOM/DSS regimen, and the frequency of peripheral and local Treg cells was determined during the progression of CAC.",33919941_3,-1,1,-1,1,42138,-1,4.187957e-06,0.9999919,3.9647416e-06
8502,the,15,16,73,76,"RESULTS: Apoptosis was found in a great number of T lymphocytes in CG on the 14th day, much more than that in group C and E. The number of apoptotic T cells in group C had a significant difference compared with that in the group E from 14th to 84th day (P = 0.003).",19173904_5,-1,1,-1,1,8502,-1,7.847791e-06,0.9999819,1.02492695e-05
22910,than,26,27,186,190,"In hepatocellular carcinoma patients, here, we identified tumor-infiltrating human CD4CD69 Tregs which represent ~67.2 % of tumor-infiltrating CD4 T cells that is significantly higher than conventional CD4CD25Foxp3 Tregs.",24668348_3,-1,1,-1,1,22910,-1,5.1148377e-06,0.99999046,4.435397e-06
8203,tryptophan,15,16,101,111,"Indoleamine 2,3-dioxygenase (IDO) catalyzes the initial and rate-limiting step in the degradation of tryptophan and is strongly induced in interferon-gamma (IFNgamma)-stimulated dendritic cells (DCs).",19075017_0,-1,1,-1,1,8203,-1,1.32031255e-05,0.99997985,6.997544e-06
4717,protein together,22,24,117,133,"One of the first identified family members, SSX-1, is expressed in a large fraction of synovial sarcomas as a fusion protein together with the product of the SYT gene.",17186289_1,-1,1,-1,1,4717,-1,6.6628804e-06,0.99998665,6.743433e-06
42199,then,3,4,15,19,The cells were then subcutaneously inoculated into nude mice to evaluate the growth of glioma.,33971545_5,-1,1,-1,1,42199,-1,4.241336e-06,0.9999912,4.5395786e-06
3924,that,4,5,39,43,"Serial long-term analysis demonstrated that although chronic stimulation enhanced the IFN-gamma response, this was countered by a parallel increase in Foxp3, TGFbeta, and IL-10 expression.",16751376_5,-1,1,-1,1,3924,-1,6.577674e-06,0.9999887,4.7777858e-06
12628,relatively,2,3,14,24,Patients with relatively larger lesions generally did not display a CR.,20547850_1,-1,1,-1,1,12628,-1,2.6738378e-05,0.99996054,1.2765883e-05
12336,the,3,4,21,24,Our findings support the hypothesis that nontumor-bearing skin adjacent to SCC in OTRs is not necessarily normal and that the local microenvironment may contribute to a field effect contributing to higher recurrence rates and more aggressive behavior observed in these patients.,20463594_13,-1,1,-1,1,12336,-1,4.7031085e-06,0.9999918,3.5395317e-06
34642,tumorspheres,5,6,37,49,"METHODS: We established CIC-enriched tumorspheres from murine TC-1 lung cancer cells, expressing human papillomavirus 16 (HPV-16) E6/E7 antigens, and evaluated their susceptibility to antitumor immune responses both in vitro and in vivo.",29699516_4,-1,1,-1,1,34642,-1,2.8896204e-05,0.9999523,1.8728437e-05
32493,tumors,6,7,38,44,Expression of SOX2 by pediatric glial tumors and the capacity of the immune system in these patients to recognize SOX2 has not been previously studied.,28620836_3,-1,1,-1,1,32493,-1,3.4523669e-06,0.99999034,6.2366375e-06
6990,this,5,6,44,48,However the molecular mechanisms underlying this process have been only recently started to be clarified.,18473765_3,-1,1,-1,1,6990,-1,6.930473e-06,0.99998844,4.6561886e-06
19610,These,2,3,13,18,CONCLUSIONS: These data suggest that IDO1 expression may contribute to immune suppression in patients with MM and possibly other HGF-producing cancers.,23232072_10,-1,1,-1,1,19610,-1,5.2214195e-06,0.99998987,4.873846e-06
36515,Tconv,40,41,240,245,"We comprehensively characterized myeloid cells in tumor draining lymph nodes (tdLN) of mice and identified two subsets of conventional type-2 dendritic cells (cDC2) that traffic from tumor to tdLN and present tumor-derived antigens to CD4+ Tconv, but then fail to support antitumor CD4+ Tconv differentiation.",30955881_1,-1,1,-1,1,36515,-1,3.2781285e-05,0.99994683,2.034557e-05
25646,naive,47,48,262,267,"The results showed that NPC cell line C666-1 and surgically removed NPC tissue expressed miR-21, which was upregulated by the presence of the Toll-like receptor 3 ligand, Poly I: C. Exposure to miR-21 increased the expression of NFI-A and interleukin (IL)-10 in naive B cells.",25544502_8,-1,1,-1,1,25646,-1,1.8904495e-05,0.99997437,6.753164e-06
16939,TIM-3,0,1,0,5,TIM-3 was required for the negative effect of IL-12 on T cell function.,22426209_7,-1,1,-1,1,16939,-1,1.2480991e-05,0.99997985,7.713428e-06
7344,the,7,8,37,40,"However, its mechanism of action and the possible modulation of its effect by the microenvironment in follicular lymphomas (FL) remain unknown.",18606651_1,-1,1,-1,1,7344,-1,5.747141e-06,0.9999902,4.072501e-06
40779,gene,19,20,134,138,Egr2 and Egr3 directly bound with the TGF-1 promoter as demonstrated by the electrophoretic mobility shift assay and dual-luciferase gene reporter assay.,33011290_6,-1,1,-1,1,40779,-1,5.524637e-06,0.9999882,6.27264e-06
12833,the,18,19,108,111,"We found that Th17 but not Treg cells were differently represented in the two lymphomas and correlated with the amount of mast cells (MCs) and granulocytes, which preferentially occurred in the cellular milieu of AITL cases.",20595635_2,-1,1,-1,1,12833,-1,4.660423e-06,0.9999914,3.8763073e-06
43882,translocation,12,13,74,87,Stimulation of activated LN cells with D5 tumor cells induced the nuclear translocation of NF-kappaB. These findings indicate that the recovery of proteins mediating signal transduction through the T cell receptor/CD3 complex in LN T cells activated ex vivo was associated with the acquisition of antitumor function.,9690455_8,-1,1,-1,1,43882,-1,4.163702e-06,0.9999913,4.479017e-06
39753,TGFb1,14,15,84,89,"RESULTS: We found a significant difference between higher gene expression of FoxP3, TGFb1, IL-10, and IL-23, and approximately equal level of IL-6 in CRC patients in comparison with IBD patients.",32390702_3,-1,1,-1,1,39753,-1,8.9670675e-06,0.999964,2.6978625e-05
16286,targeting,8,9,47,56,"Thus, our studies provide strong rationale for targeting DKK1 for immunotherapy of myeloma patients.",22049519_6,-1,1,-1,1,16286,-1,5.9458857e-06,0.9999896,4.4579024e-06
16094,the,8,9,49,52,"Chronic inflammation is a major driving force in the development of cancer in many tissues, but the array of factors involved in this neoplastic transformation are not well understood.",21987656_0,-1,1,-1,1,16094,-1,4.9644673e-06,0.9999912,3.8183684e-06
20958,the,2,3,14,17,"Disruption of the POSH/JIP-1 complex led to profound defects in the activation of JNK1, as well as deficient activation or induction of the transcription factors c-Jun, T-bet, and Eomesodermin.",23963642_5,-1,1,-1,1,20958,-1,3.3772117e-06,0.9999925,4.0801533e-06
22523,the,18,19,102,105,"Coculture of CTCL cells with normal T lymphocytes consisting of both CD4(+) and CD8(+) populations or the CD4(+) subset alone, transfected with CD152 mRNA, inhibits proliferation of normal T cells in a CD152- and CD80-dependent manner.",24523507_4,-1,1,-1,1,22523,-1,4.0350974e-06,0.99999106,4.8601873e-06
4911,there,5,6,21,26,"In dogs with cancer, there was a significant increase in numbers of Treg in blood (7.5%) and tumor-draining lymph nodes (17.1%) compared to age-matched healthy control dogs.",17224188_7,-1,1,-1,1,4911,-1,4.49499e-06,0.99999106,4.3954515e-06
12307,The,0,1,0,3,"The immune system plays a major role in the fight against SCC, however, little is known about the local inflammatory response in SCC at all.",20463594_1,-1,1,-1,1,12307,-1,3.9568504e-06,0.9999918,4.30001e-06
25946,through,14,15,71,78,"So far, there is a single connecting report that TGF- also may signal through CEAR.",25832000_3,-1,1,-1,1,25946,-1,2.8996184e-05,0.99995494,1.6032236e-05
25345,the,2,3,13,16,Cytokines in the supernatant were detected by ELISA.RESULTS: B7-H4 was expressed in 46% (31/67) of the cases of cervical cancer.,25446402_4,-1,1,-1,1,25345,-1,5.565001e-06,0.9999895,4.9388923e-06
30302,tumors,15,16,105,111,"Evidence from various murine models has shown that the chemokine receptor CXCR2 attracts neutrophil into tumors and, therefore, represents a tractable therapeutic target.",27737879_1,-1,1,-1,1,30302,-1,3.9183956e-06,0.9999913,4.800992e-06
1989,that,24,25,164,168,"In contrast, E6 inhibited IL-2 and IL-18 mRNA expression that would further contribute to a cytokine microenvironment unfavorable to HPV-specific, T-cell responses that should control persistent HPV infection.",15138179_8,-1,1,-1,1,1989,-1,8.289748e-06,0.9999856,6.171078e-06
27494,TGF-1,15,16,73,79,"mRNA levels of Foxp3, TGF-1 and IL-10, in addition to protein levels of TGF-1 and IL-10 were potentiated in lymphoma patients but decreased in CR patients (P<0.05 in all cases).",26464657_10,-1,1,-1,1,27494,-1,7.3405604e-06,0.9999757,1.6966016e-05
373,Tumor-transplanted,0,1,0,18,"Tumor-transplanted animals showed enhanced expression of CD40L on natural killer (NK) and T cells, when compared to cells from normal animals.",11129327_4,-1,1,-1,1,373,-1,5.1163893e-06,0.99999046,4.436184e-06
9207,the,4,5,23,26,"Therefore, we analyzed the pathologic, phenotypic, and cytogenetic features of a series of 30 patients (range: 33 to 88 y) that showed histopathologic features of PTCL-F in at least 1 biopsy (n=30), either at initial presentation (n=26) or at relapse (n=4).",19295409_2,-1,1,-1,1,9207,-1,4.157519e-06,0.9999919,3.983206e-06
32130,to,4,5,35,37,Tumors develop numerous strategies to fine-tune inflammation and avoid detection and eradication by the immune system.,28533483_0,-1,1,-1,1,32130,-1,5.325558e-06,0.99999046,4.246837e-06
10967,Treg,11,12,60,64,"In conclusion, VEGFR2 may be a novel target for controlling Treg with highly suppressive function.",19902430_4,-1,1,-1,1,10967,-1,5.905912e-06,0.99998844,5.6654007e-06
34488,The,0,1,0,3,"The MM-niche-derived IL-18 drove generation of myeloid-derived suppressor cells (MDSCs), leading to accelerated disease progression.",29551594_3,-1,1,-1,1,34488,-1,4.036341e-06,0.99999225,3.7170055e-06
21687,FoxP3,5,6,26,31,"The expressions of IL-17, FoxP3, CD4, and CD8 in liver tissue were measured by immunochemistry for the evaluation of liver-infiltrating lymphocytes.",24303990_3,-1,1,-1,1,21687,-1,5.5202e-06,0.9999887,5.8613396e-06
22556,Tc17,6,7,32,36,"Besides, the increased level of Tc17 in UCC patients was associated with the status of pelvic lymph node metastases and increased microvessel density.",24523865_4,-1,1,-1,1,22556,-1,0.00027220589,0.99958163,0.00014618665
14265,Ten,0,1,0,3,Ten of seventy-four patients (13.5%) had tumor-positive SLNs.,21327637_10,-1,1,-1,1,14265,-1,1.0623409e-05,0.99998105,8.36972e-06
19274,Y Box protein 1,7,11,33,48,"In a previous study, we screened Y Box protein 1 (YB-1) as a potential neuroblastoma-associated antigen from sera of AGN2a-immunized mice by serological analysis of recombinant cDNA expression libraries technique.",23169344_2,-1,1,-1,1,19274,-1,8.3809655e-06,0.99996483,2.6783307e-05
11725,tumors,6,7,39,45,"Although the BALB/c mice with advanced tumors (Meth-A sarcoma; H-2(d), >4 cm(2)) treated with either Syn- or Allo-BMT alone showed a slight improvement in survival compared with non-treated controls, the mice treated with BMT + TT showed a longer survival.",20229083_2,-1,1,-1,1,11725,-1,3.3238339e-06,0.99999106,5.579262e-06
30660,the,18,19,110,113,This study investigated the immune modulation of Treg cells by ZA.METHODS: Flow cytometry was used to analyze the phenotypic and immunosuppressive characteristics of Treg cells treated with ZA.,27887569_5,-1,1,-1,1,30660,-1,4.007769e-06,0.99999213,3.897365e-06
19477,the,12,13,73,76,"Priming (conditioning) of PC cells with AT-101 can significantly enhance the anti-tumor activity of EGFRBi armed ATC through increased IFN- induced activation of pS(727)-Stat1 and inhibition of pY(705)-Stat3 phosphorylation, and resulting in increased ratio of pro-apoptotic to anti-apoptotic proteins.",23185240_6,-1,1,-1,1,19477,-1,4.188007e-06,0.99999225,3.580867e-06
14649,the,33,34,198,201,"Although polyclonal regulatory T cells (Tregs) that once expressed Foxp3 (ex-Tregs) derived from Foxp3(+) Tregs have been described in homeostatic and autoimmune settings, little is known regarding the influence of the tumor environment on ex-Treg development.",21389255_0,-1,1,-1,1,14649,-1,4.9564746e-06,0.99999166,3.4336065e-06
4203,the,4,5,22,25,"T cells purified from the growing tumor expressed mRNA for IL-10, TGF-beta, and Foxp3.",16818744_2,-1,1,-1,1,4203,-1,3.6872175e-06,0.9999912,5.1926045e-06
35464,these,12,13,89,94,We have previously demonstrated signature CpG sites predictive for lineage commitment of these four major CD4+ T cell lineages.,30075815_6,-1,1,-1,1,35464,-1,5.4188713e-06,0.99998915,5.4030907e-06
43052,the,10,11,62,65,"Here we show that cell-permeable -ketoglutarate (KG) alters the DNA methylation profile of naive CD4 Tcells activated under Treg polarizing conditions, markedly attenuating FoxP3+ Treg differentiation and increasing inflammatory cytokines.",34731632_1,-1,1,-1,1,43052,-1,4.148534e-06,0.9999924,3.464287e-06
13888,FOXP3(low,40,41,224,233,"Moreover, we found three unexpected perturbations in FOXP3+ T-cell subsets: (i) patients with melanoma showed higher frequencies of FOXP3(low) nonregulatory T cells, which decreased and normalized after tumour removal; (ii) FOXP3(low) nave Tregs containing higher frequencies of interferon-+ cells increased with tumour progression; and (iii) CD45RO+FOXP3(high) effector Tregs were pronouncedly infiltrated around tumour tissues.",21198537_7,-1,1,-1,1,13888,-1,3.132507e-05,0.99995327,1.5423013e-05
13677,to,26,27,151,153,"In the presence of tremelimumab, frequencies of IL-2-secreting CD4(+) T cells and IFN--secreting CD4(+) and CD8(+) T cells were increased in response to polyclonal activation and tumor antigens.",21056008_4,-1,1,-1,1,13677,-1,6.03833e-06,0.99999,3.992059e-06
14301,the,12,13,60,63,"In our data, IFN is the sole cytokine that correlates with the SLN tumor burden and seems to play a central role in tumor-induced immunological changes in the SLN immune microenvironment.",21327637_19,-1,1,-1,1,14301,-1,4.0061577e-06,0.99999166,4.2794927e-06
40579,therapeutic,10,11,75,86,Genetically modified tumor cells harboring immunomodulators may be used as therapeutic vaccines to stimulate antitumor immunity.,32939048_0,-1,1,-1,1,40579,-1,7.895342e-06,0.999987,5.139405e-06
39466,gene,9,10,73,77,"Furthermore, overexpression of C-FOXP3 activated the luciferase reporter gene under the control of the PD-L1 promoter.",32300119_6,-1,1,-1,1,39466,-1,5.685289e-06,0.99998915,5.206687e-06
22270,the,2,3,9,12,"Finally, the reduced tumor burden, increased numbers of NK cells in the lung, and increased hematopoiesis in Bcl11b(F/F)/CD4-Cre mice were all dependent on TNF-.",24446520_5,-1,1,-1,1,22270,-1,3.7356963e-06,0.9999918,4.4683447e-06
31077,tumor,33,34,241,246,Neutralization of IL-12 and IL-15 cytokines with a regimen of blocking antibodies pre- and post-adoptive transfer of low-avidity HA518-526-specific CD8+T-cells following intravenous injection of 4T1HA cells increased the number of pulmonary tumor nodules.,28052005_4,-1,1,-1,1,31077,-1,4.346525e-06,0.9999908,4.775186e-06
17385,trials,3,4,15,21,"All 5 clinical trials are registered at www.clinicaltrials.gov as NCT00001832, NCT00096382, NCT00335127, NCT00509496, and NCT00513604.",22555974_6,-1,1,-1,1,17385,-1,8.390605e-06,0.9999833,8.258882e-06
11417,treated,26,27,180,187,We report that melanoma cell lines expressing the interleukin-1 receptor exhibit 4- to 10-fold lower levels of mRNA of microphthalmia-associated transcription factor (MITF-M) when treated with interleukin-1beta.,20099279_0,-1,1,-1,1,11417,-1,8.70712e-06,0.99998534,5.9915747e-06
23361,to,13,14,79,81,"Numerous researchers have found that it could work as a potent antitumor agent to inhibit tumor growth in vitro, buith there has been much less emphasis on its in vivo role against breast tumors.",24761844_1,-1,1,-1,1,23361,-1,4.374839e-06,0.9999902,5.3892327e-06
21462,this,17,18,114,118,The discovery of additional CD4 Th cell subsets has extended our understanding of Th cell differentiation beyond this dichotomy.,24215739_2,-1,1,-1,1,21462,-1,7.819808e-06,0.9999871,5.0551735e-06
28601,FOXP3(lo,39,40,235,243,"Depletion of FOXP3(hi) Treg cells from tumor tissues, which would augment antitumor immunity, could thus be used as an effective treatment strategy for CRCs and other cancers, whereas strategies that locally increase the population of FOXP3(lo) non-Treg cells could be used to suppress or prevent tumor formation.",27111280_8,-1,1,-1,1,28601,-1,3.4234137e-05,0.9999535,1.2246305e-05
10460,the,1,2,3,6,"In the present study, we collected high-purity human CD4(+)CD25(-)CD45RA(+) nave T cells by microbead cell separation.",19673890_3,-1,1,-1,1,10460,-1,4.867474e-06,0.99999,5.1271327e-06
7366,TRAIL-induced,11,12,65,78,"Thus, the antiapoptotic signaling of CD40, which interferes with TRAIL-induced apoptosis in FL B cells, involves NF-kappaB-mediated induction of c-FLIP and Bcl-x(L) which can respectively interfere with caspase 8 activation or mitochondrial-mediated apoptosis.",18606651_6,-1,1,-1,1,7366,-1,1.4238199e-05,0.99996185,2.3912198e-05
41305,the,18,19,106,109,"We found that the SFPQ splicing factor (splicing factor, proline- and glutamine-rich) was responsible for the IRF17 production.",33419764_4,-1,1,-1,1,41305,-1,4.1624353e-06,0.99999213,3.7407958e-06
41935,that,4,5,26,30,Our data also demonstrate that TNF/TGF pathway combination may represent a better biomarker for BLBC prognosis and clinical management.,33767579_11,-1,1,-1,1,41935,-1,4.23403e-06,0.9999925,3.3321e-06
17089,therefore,17,18,105,114,"In MM patients, Tregs seem to contribute to myeloma-related immune dysfunction and targeting them could, therefore, help to restore and enhance vital immune responses.",22489248_4,-1,1,-1,1,17089,-1,5.645452e-06,0.99998784,6.459328e-06
8730,TIL,3,4,15,18,An increase in TIL frequency was also observed at these final time points.,19226468_9,-1,1,-1,1,8730,-1,1.2703908e-05,0.9999807,6.628844e-06
15020,transduction,17,18,114,126,"This study evaluated relationships between plasma IL-6, IL-10, circulating MDSC subsets, and IFN--induced signal transduction in 40 patients with GI malignancies.",21604071_2,-1,1,-1,1,15020,-1,1.0373922e-05,0.99998283,6.812734e-06
36926,these,14,15,88,93,"Additionally, we discuss how molecular regulators of Itch impact its ability to control these processes, as this may provide clues on how to therapeutically target Itch to treat patients with autoimmune disease.",31126634_6,-1,1,-1,1,36926,-1,5.1729808e-06,0.9999908,3.9957e-06
32876,that,3,4,29,33,Exploratory analyses implied that a reduced expansion of Tregs in later treatment cycles and a short Treg telomere length were significantly associated with a favorable clinical outcome.,28721449_7,-1,1,-1,1,32876,-1,4.2398574e-06,0.9999918,4.0220607e-06
37929,therapeutic,10,11,53,64,"Intriguingly, JQ1 was found in this study to exhibit therapeutic potential in tongue squamous cell carcinoma (TSCC) by inducing ICD.",31600692_3,-1,1,-1,1,37929,-1,4.6138293e-06,0.9999913,4.076562e-06
33402,Treatment,0,1,0,9,Treatment of TIDC and bone marrow-derived dendritic cells (DC) with IL10 led to increased PD-1 expression.,28993412_5,-1,1,-1,1,33402,-1,4.859304e-06,0.99999046,4.699623e-06
37844,FoxP3,15,16,50,55,"IHC staining of CD3, CD4, CD8, CD20, CD163, CD31, FoxP3, CCR6, IL-17, Granzyme B, PD-L1, and membrane CD95L was used to assess tumor-infiltrating immune cells.",31537619_3,-1,1,-1,1,37844,-1,6.8455247e-06,0.99998367,9.45151e-06
23058,genes,13,14,90,95,"Based on our prior genome-wide interrogation of human prostate cancer tissues to identify genes over-expressed in cancer and absent in the periphery, we targeted SIM2 as a prototype autologous tumor antigen for these studies.",24690990_1,-1,1,-1,1,23058,-1,7.2685575e-06,0.9999832,9.494073e-06
37473,to,11,12,60,62,"RESULTS: Implantation of PC-SLCs in IL-30KO mice, gave rise to slow growing tumors characterized by apoptotic events associated with CD4+T lymphocyte infiltrates and lack of CD4+Foxp3+ T regulatory cells (Tregs).",31366386_5,-1,1,-1,1,37473,-1,3.9270726e-06,0.99999166,4.4756925e-06
33302,Treg,28,29,164,168,"Our data identify IRF-1 as important for the antitumor efficacy of CTX and for the regulation of many immunomodulatory activities of CTX, such as Th1 polarization, Treg depletion and inflammation.",28975621_8,-1,1,-1,1,33302,-1,7.3740075e-06,0.99998426,8.302427e-06
38422,STAT3,7,8,49,54,"Consistently, IHC staining showed that activated STAT3 correlated with repressed infiltration of CD8+ T cells in non-small cell lung cancer.",31848193_9,-1,1,-1,1,38422,-1,9.0775875e-06,0.9999846,6.279261e-06
40226,the,3,4,21,24,"Tumor progression in the host leads to severe impairment of intrathymic T-cell differentiation/maturation, leading to the paralysis of cellular anti-tumor immunity.",32582141_0,-1,1,-1,1,40226,-1,4.047448e-06,0.99999154,4.3955793e-06
10661,complex-loaded,5,6,23,37,"When peptide/poly(I:C) complex-loaded DCs were used for autologous T cell stimulation, epitope-specific interferon-gamma secretion was quantitatively superior in comparison to peptide-loaded DCs matured by a cytokine cocktail, as detected by enzyme-linked immunospot assays.",19758325_6,-1,1,-1,1,10661,-1,1.0638802e-05,0.9999784,1.0961408e-05
7372,NF-kappaB,12,13,73,82,These findings suggest that a cotreatment with TRAIL and an inhibitor of NF-kappaB signaling or a blocking anti-CD40 Ab could be of great interest in FL therapy.,18606651_7,-1,1,-1,1,7372,-1,1.5495285e-05,0.99997175,1.2728595e-05
14506,tumors,4,5,30,36,"Furthermore, syngeneic murine tumors expressing high levels of ANGPT2 contained not only high numbers of TEMs but also increased numbers of Tregs, whereas genetic depletion of tumor TEMs resulted in a marked reduction in the frequency of Tregs in tumors.",21368233_5,-1,1,-1,1,14506,-1,3.8578846e-06,0.999992,4.1313424e-06
29062,T-bet,10,11,59,64,These results indicate that Bhlhe40 works as a cofactor of T-bet for enhancing IFN- production in iNKT cells.,27226296_8,-1,1,-1,1,29062,-1,6.41222e-06,0.9999857,7.8405865e-06
40554,tumor,11,12,68,73,"However, the therapeutic efficacy of GA in impressive regression of tumor was found to be directly correlated with induction of apoptosis and modulation of cytokines from Th2 to Th1 type.",32890791_5,-1,1,-1,1,40554,-1,3.7783739e-06,0.9999912,5.041718e-06
30049,that,17,18,96,100,"Moreover, TSLP induced proliferation of CTCL cells both in vitro and in vivo These data suggest that periostin-mediated TSLP production by keratinocytes directly stimulates CTCL tumor cell growth in addition to inducing a Th2-dominant tumor environment in CTCL.",27634769_9,-1,1,-1,1,30049,-1,5.063962e-06,0.9999913,3.6799531e-06
41740,the,30,31,162,165,"Single-cell RNA sequencing discovered a subtype of B cells positive for Erbin, one member of the leucine-rich repeat and PDZ domain (LAP) family, was involved in the lung metastases.",33707428_2,-1,1,-1,1,41740,-1,3.7991447e-06,0.99999166,4.5493407e-06
39931,triggered,1,2,4,13,"ALP triggered DC maturation, which is dependent on the activation of the MAPK and NF-B signaling pathways.",32486094_5,-1,1,-1,1,39931,-1,0.00010661984,0.99987054,2.2842722e-05
35802,that,9,10,61,65,Regulatory T cells (Tregs) mediate immunosuppressive signals that can contribute to the progression of head and neck squamous cell carcinoma (HNSCC).,30357458_0,-1,1,-1,1,35802,-1,9.183327e-06,0.99998534,5.4935654e-06
41180,relevant,9,10,59,67,"Quantitative PCR and western blot were applied to evaluate relevant mRNA and protein levels, respectively.",33268765_6,-1,1,-1,1,41180,-1,5.430703e-06,0.9999901,4.4599547e-06
38722,treatment,2,3,9,18,"In vitro treatment of CXCL9 directly led to the suppression of the proliferation, activation, and secretion of anti-tumour cytokines of isolated CD8+ T cells.",31913856_5,-1,1,-1,1,38722,-1,5.5983483e-06,0.99999,4.3813975e-06
20897,the,9,10,73,76,"This study demonstrates that local low-dose tumor irradiation influences the intratumoral immune population induced by SFVeE6,7 immunization by a strong increase in the ratio of antitumoral to immune suppressive cells, thus changing the intratumoral immune balance in favor of antitumor activity.",23922012_10,-1,1,-1,1,20897,-1,4.1561843e-06,0.99999225,3.623153e-06
19369,this,31,32,205,209,These data present a significant role for CD200 in suppressing anti-tumor immune response through stimulation of regulatory mechanisms in AML patients and suggest that CD200 may have a prognostic value in this malignancy and its blockade may be used as a target for AML immunotherapy.,23179394_10,-1,1,-1,1,19369,-1,4.780291e-06,0.99998844,6.7470473e-06
23629,their,10,11,54,59,"To determine the role of Tregs in CRC development and their effects on NK cells, we created novel transgenic Rag-Apc mice that lack T cells and develop spontaneous intestinal tumors, and we adoptively transferred Tregs or transiently depleted NK cells during initial stages of tumorigenesis.",24797894_1,-1,1,-1,1,23629,-1,4.4220283e-06,0.9999912,4.4501535e-06
17682,type,34,35,206,210,"Thus, IFN- is not only an important CD8 T cell effector cytokine, it is an autocrine/paracrine factor whose contributions to differentiation vary depending on whether the response is supported by IL-12 or type I IFN.",22706089_3,-1,1,-1,1,17682,-1,1.7531907e-05,0.9999727,9.723048e-06
18190,signal transducer and activator of transcription,11,17,70,118,"Compared to healthy donor cells they were pSTAT1(low) (phosphorylated signal transducer and activator of transcription) and indoleamine 2,3-dioxygenase (IDO)(high).",22828446_6,-1,1,-1,1,18190,-1,8.787942e-06,0.99998355,7.683825e-06
23648,tumors,23,24,113,119,"Importantly, Treg transfer increased small intestinal polyp formation up to 65% (P<0.0005) and increased colon tumors multiplicities by 84% (P<0.0001) with a significant decrease in NK cells as compared to control mice.",24797894_3,-1,1,-1,1,23648,-1,4.596389e-06,0.9999902,5.127623e-06
22233,this,2,3,13,17,"Furthermore, this combination markedly decreased the number of splenic CD11b(+)Gr1(+) cells, and increased their expression levels of MHC II and CD80.",24416401_8,-1,1,-1,1,22233,-1,5.2394e-06,0.9999906,4.204828e-06
27365,that,5,6,24,28,"Moreover, we have found that CD69(+) Tregs are more suppressive than their CD69- counterparts.",26433463_5,-1,1,-1,1,27365,-1,4.1583517e-06,0.999992,3.8205394e-06
35336,to,10,11,74,76,"Remarkably, the loss of Malt1-mediated self-cleavage alone was sufficient to cause a significant Treg deficit resulting in increased anti-tumor immune reactivity without associated autoimmunity complications.",30025160_6,-1,1,-1,1,35336,-1,4.768549e-06,0.9999914,3.7791317e-06
9765,Tregs,28,29,154,159,"In addition, Tregs inhibited the proliferation of TCR-stimulated (primed) CD4(+) T cells and nave CD8(+) T cells after TCR-mediated activation, however, Tregs with OX40 costimulation lost their suppressive function.",19455675_6,-1,1,-1,1,9765,-1,5.1288353e-06,0.99999106,3.842203e-06
13849,FOXP3,3,4,13,18,"BACKGROUND: 'FOXP3+ regulatory T cells' (Tregs) are reported to be increased in tumour-bearing hosts including patients with melanoma, leading to tumour immune suppression.",21198537_0,-1,1,-1,1,13849,-1,6.2387057e-06,0.9999882,5.5536166e-06
775,the,4,5,26,29,These effects occurred in the absence of AML cell-T cell contact.,11698483_3,-1,1,-1,1,775,-1,5.1457923e-06,0.9999912,3.6651795e-06
42365,TME,38,39,230,233,"Tumors, on their side, have developed escaping mechanisms from the immune system action ranging from the direct secretion of biochemical signals to an indirect reaction, in which the cellular actors of the tumor microenvironment (TME) collaborate to mechanically condition the extracellular matrix (ECM) making it inhospitable to immune cells.",34070750_1,-1,1,-1,1,42365,-1,1.1922229e-05,0.99997497,1.3055787e-05
20941,to,12,13,88,90,Signals from the T-cell recognition of antigen program effector functions are necessary to clear infections and tumors.,23963642_0,-1,1,-1,1,20941,-1,7.4388995e-06,0.99998736,5.2367054e-06
29339,the,7,8,44,47,Our results demonstrate that an increase in the nuclear localization of NFAT1 was detectable in the CASTs following the CMV-dextramer binding and could be observed as early as 10min post-exposure.,27327144_6,-1,1,-1,1,29339,-1,3.6888512e-06,0.9999926,3.6828367e-06
29076,the,42,43,226,229,"Recent studies have demonstrated pivotal roles of mTOR-mediated metabolism in the maturation, differentiation, and effector function of diverse immune cells, including DCs, NK cells, CD4+ T cell subsets, and CD8+ T cells, but the role of mTOR signaling in  T cells is barely known.",27256566_1,-1,1,-1,1,29076,-1,4.9484624e-06,0.9999913,3.7807606e-06
36353,TGF-,17,18,81,86,"Here we show, by contrast, that Th9 cell development can occur in the absence of TGF- signaling.",30914642_2,-1,1,-1,1,36353,-1,1.4567225e-05,0.9999776,7.795482e-06
25469,natural,36,37,230,237,"The constructed VELs had complexities of 10,500 and 8,000 individual members, generated as combinatorial M13 phage display and synthetic peptide libraries, respectively, with structural composition GWXPXDXPI, where X is any of 20 natural amino acids.",25483665_4,-1,1,-1,1,25469,-1,7.022185e-05,0.9999145,1.5288932e-05
23214,the,8,9,53,56,"Additionally, receptor-interacting protein (RIP) and the NF-Bp65 pathway were elevated in AML-DCs when A20 was reduced.",24713261_6,-1,1,-1,1,23214,-1,4.006489e-06,0.99999213,3.857933e-06
6557,the,9,10,51,54,ICOShigh Treg induce Tr1 or Th2 cells depending on the activation state of RC.,18292519_10,-1,1,-1,1,6557,-1,5.810599e-06,0.99998975,4.4711614e-06
34719,to,15,16,79,81,"Previous studies have reported the presence of FOXP3+ CD8+ Treg cells, similar to CD4+ Tregs, in cancer patients which produce high levels of the immunosuppressive cytokines, IL10 and TGF.",29768737_1,-1,1,-1,1,34719,-1,4.3157197e-06,0.9999907,4.9684336e-06
35282,the,3,4,22,25,Tumor development and the intratumoral inflammatory milieu were characterized in these mice.,29991500_4,-1,1,-1,1,35282,-1,3.7425878e-06,0.9999924,3.8637254e-06
9957,the,18,19,112,115,"Our data suggest that in NSCLC patients, there is an increase of CD4(+)CD25(high)FOXP3(+) regulatory T-cells in the peripheral blood and tumor microenvironment.",19538059_6,-1,1,-1,1,9957,-1,4.3733817e-06,0.99998987,5.7096954e-06
26348,the,24,25,108,111,"A significantly negative relationship was found between Th cells (Th22, Th17, or Th1) and BCR-ABL (%) IS or the number of PB white blood cells.",26000313_8,-1,1,-1,1,26348,-1,5.3252247e-06,0.99998784,6.8640666e-06
12996,these,23,24,151,156,"Compared to the L. casei-PgsA-treated mice, significantly higher levels of serum IgG and mucosal IgA were observed in L. casei-PgsA-E6-immunized mice; these differences were significantly enhanced after boost.",20706715_3,-1,1,-1,1,12996,-1,5.9419544e-06,0.9999901,3.92216e-06
42214,The,0,1,0,3,The proliferation and migration of U87MG cells were also increased.,33971545_9,-1,1,-1,1,42214,-1,5.216766e-06,0.99999094,3.870757e-06
11420,NF-kappaB,3,4,15,24,This effect is NF-kappaB and JNK-dependent.,20099279_1,-1,1,-1,1,11420,-1,2.4894587e-05,0.9999566,1.8552331e-05
39241,The,0,1,0,3,"The distinct phenotype of the lymphomas involved expression of PD1, CD30, CD24, the stress receptor ligand Mult1 and MHC class I down-regulation.",32143838_5,-1,1,-1,1,39241,-1,3.385592e-06,0.99999213,4.476924e-06
22610,to,7,8,36,38,CONCLUSIONS: Our study is the first to show that also children could have HPV-specific immunity.,24524328_11,-1,1,-1,1,22610,-1,4.736973e-06,0.99999094,4.30838e-06
20738,that,5,6,29,33,Our previous study has shown that mesothelin (MSLN) is a potential immunotherapeutic target for pancreatic cancer.,23874581_0,-1,1,-1,1,20738,-1,4.615195e-06,0.99999166,3.7117784e-06
22236,their,16,17,107,112,"Furthermore, this combination markedly decreased the number of splenic CD11b(+)Gr1(+) cells, and increased their expression levels of MHC II and CD80.",24416401_8,-1,1,-1,1,22236,-1,5.184126e-06,0.99998975,5.080609e-06
41019,Tregs,21,22,99,104,"Evidence implicates CD4+ T helper (Th) cells in the development of MG, whereas regulatory T cells (Tregs) are associated with disease resolution.",33136553_1,-1,1,-1,1,41019,-1,4.2328725e-06,0.9999908,4.909268e-06
14475,TEMs,23,24,168,172,"Expression of its receptor, TIE2, defines a highly proangiogenic subpopulation of myeloid cells in circulation and tumors called TIE2-expressing monocytes/macrophages (TEMs).",21368233_1,-1,1,-1,1,14475,-1,7.482475e-06,0.9999858,6.6867265e-06
30819,treatment,3,4,18,27,"More importantly, treatment with combined anti-IL-17A and anti-PDL1 antibodies enhanced antitumor effects in favor of tumor eradication.",27935862_7,-1,1,-1,1,30819,-1,6.2409163e-06,0.9999895,4.239666e-06
2348,the,45,46,340,343,"Moreover, we demonstrate that chemotherapeutic agents that suppress protein synthesis and reverse the CD40-mediated dissociation of the translational repressor eukaryotic initiation factor 4E-binding protein from the initiation factor eukaryotic initiation factor 4E, such as 5-fluorouracil, etoposide, and quercetin, dramatically increase the susceptibility of cervical carcinoma cells to CD40L-induced apoptosis.",15611226_6,-1,1,-1,1,2348,-1,4.8631578e-06,0.99999166,3.5154142e-06
23642,transient,14,15,99,108,"In 6-weeks old Rag-Apc mice containing microscopic intestinal tumors adoptive transfer of Tregs or transient NK cell depletion dramatically associated with an increase in intestinal tumor multiplicity and tumor size, with significantly decreased survival rates.",24797894_2,-1,1,-1,1,23642,-1,4.907153e-06,0.99999106,4.0086093e-06
7332,tumor-induced,9,10,59,72,In vivo blocking PD-L1 signaling abolished conversion in a tumor-induced aTreg conversion model.,18599457_8,-1,1,-1,1,7332,-1,6.415954e-06,0.99998796,5.6065865e-06
16818,Pokemon,0,1,0,7,Pokemon is a member of the POK family of transcriptional repressors and aberrant overexpressed in various human cancers.,22405859_0,-1,1,-1,1,16818,-1,1.9774052e-05,0.99996054,1.9717598e-05
18375,that,2,3,9,13,"We found that, compared with the healthy controls, patients had a significantly (p < 0.0001) higher proportion of both Th17 (CD4(+)IL17A(+)) and Treg (CD4(+)CD25(+)FOXP3(+)) cells, which further showed a reciprocal balance in relation to clinico-pathological parameters in patients.",22956260_3,-1,1,-1,1,18375,-1,3.6806448e-06,0.9999924,3.950093e-06
28087,TGF-,17,18,117,122,The DC vaccine reduced accumulation of Foxp3+CD4+ regulatory T cells within the tumor microenvironment and prevented TGF- production from the tumor tissue.,26786094_6,-1,1,-1,1,28087,-1,1.7289938e-05,0.9999758,6.9226307e-06
40435,this,1,2,3,7,"In this study, we show in various Th1- and/or Th17-polarized settings of acute and chronic bacterial infection and of tumor growth that the conditional ablation of Irf4 in CD11c+ DCs results in more efficient immune control of Helicobacter pylori, Mycobacterium bovis bacillus Calmette-Gurin, and Citrobacter rodentium and of tumor growth in a syngeneic tumor model.",32848032_2,-1,1,-1,1,40435,-1,3.548875e-06,0.99999213,4.308599e-06
24062,the,17,18,112,115,"The present findings thereby establish a novel link between SEs and immune dysregulation in CTCL, strengthening the rationale for antibiotic treatment of colonized patients with severe or progressive disease.",24957145_6,-1,1,-1,1,24062,-1,6.2484287e-06,0.99998903,4.771194e-06
42476,TME,25,26,157,160,"Importantly, combined blockade of IL-6 and CTLA-4 improves survival of tumor-bearing mice by reducing infiltration of PD1+CD8+ T cells and M2 macrophages in TME.",34093869_11,-1,1,-1,1,42476,-1,6.474334e-06,0.99998796,5.5975356e-06
30932,to,3,4,16,18,One approach is to specifically block the production of active TGF-1 from Tregs as an adjunct to tumor immunotherapy.,28001437_6,-1,1,-1,1,30932,-1,5.5311216e-06,0.9999902,4.23933e-06
39043,their,19,20,119,124,"In summary, we identified previously unknown functions of mTORC1 and mTORC2 in  T cell differentiation and clarified their divergent roles in mediating the activity of  T cells in tumors and autoimmunity.",32001780_7,-1,1,-1,1,39043,-1,5.7687207e-06,0.99999,4.2576175e-06
10444,nasopharyngeal,12,13,100,114,Data has shown that FasL-mediated cytotoxicity has significant therapeutic effect on EBV-associated nasopharyngeal carcinoma (NPC).,19664329_4,-1,1,-1,1,10444,-1,1.634401e-05,0.99996126,2.2425726e-05
5171,to,13,14,78,80,"Unexpectedly, antigen presentation to CD4(+) T helper cells was reduced owing to potentiation of regulatory T-cell function by NPC-LMP1 transfectants, which produce increased levels of interleukin-10, rendering CD4(+) T cells hyporesponsive.",17372611_3,-1,1,-1,1,5171,-1,4.9782525e-06,0.9999908,4.1986223e-06
21950,tmTNF--mediated,24,25,173,189,"Furthermore, tmTNF- caused p38 phosphorylation and NF-B activation, whereas inhibition of NF-B or p38 with an inhibitor pyrrolidine dithiocarbamate or SB203580 abrogated tmTNF--mediated increased suppression of lymphocyte proliferation by MDSCs.",24379122_4,-1,1,-1,1,21950,-1,3.6395708e-05,0.99994004,2.3557533e-05
36944,The,0,1,0,3,"The persistent polarization of IL4 induced by strong lipid antigens, that is, -galactosylceramide (GC), caused IL4 accumulation at the immunological synapse (IS), which promoted the activation of the IL4R-STAT6 (signal transducer and activator of transcription 6) pathway and production of IL12 in DCs, which enhanced interferon- (IFN) production in iNKT cells.",31160756_2,-1,1,-1,1,36944,-1,3.5573796e-06,0.9999919,4.549949e-06
25397,subunit,4,5,16,23,"CD25, the alpha subunit of the IL2 receptor, is a canonical marker of regulatory T cells (Treg) and hence has been implicated in immune suppression in cancer.",25480168_0,-1,1,-1,1,25397,-1,7.428323e-06,0.9999826,9.953959e-06
43820,than,51,52,295,299,"In this study the in vitro T-cell response against F(ab')2 and Fab fragments, heavy and light chains of the M-component was examined in five patients with MM clinical stage I. All fragments were able to stimulate T cells but F(ab')2 or Fab fragments and heavy chains induced a stronger response than light chains.",9531329_3,-1,1,-1,1,43820,-1,7.1016107e-06,0.999987,5.8587148e-06
30083,TAMs,20,21,149,153,"Interestingly, naive CD4+CD45RA+ T cells could differentiate into IL-10- and TGF--expressing cells, if incubated with tumor-associated macrophages (TAMs) or with macrophages conditioned with primary glioma cells, suggesting that tumor cells and TAMs had a role in inducing Tr1 cells in GBM patients.",27644153_7,-1,1,-1,1,30083,-1,7.4725385e-06,0.9999845,8.033479e-06
33118,this,4,5,18,22,"tumor growth, and this was IFN- dependent.",28848066_7,-1,1,-1,1,33118,-1,7.1594004e-06,0.9999883,4.482666e-06
5305,to,6,7,32,34,"Thus, breast cancer targets DCs to facilitate its development.",17438063_7,-1,1,-1,1,5305,-1,5.2335076e-06,0.9999887,6.0356106e-06
5894,play,10,11,44,48,"Dendritic cells (DCs), as specialized APCs, play a key role in the induction of anti-tumor immunity.",17895399_0,-1,1,-1,1,5894,-1,5.3030376e-06,0.99998796,6.7387296e-06
30255,to,8,9,44,46,"METHODS: We used immunohistochemistry (IHC) to characterize immune infiltration in 184 breast cancer samples, of which 65 were within the DDRD subtype.",27707838_4,-1,1,-1,1,30255,-1,3.9668944e-06,0.999992,3.971122e-06
21607,the,23,24,152,155,The treatment with the antibody synergistically augmented the antitumor effect of IFN- gene therapy not only in the vector-injected tumors but also in the vector-uninjected tumors.,24289533_5,-1,1,-1,1,21607,-1,3.9434194e-06,0.9999924,3.6445076e-06
10640,their,2,3,9,14,"Based on their role for the induction of T-cell responses, dendritic cells (DCs) are popular candidates in cancer vaccine development.",19758325_0,-1,1,-1,1,10640,-1,5.1741426e-06,0.99999046,4.395411e-06
24838,that,4,5,23,27,"Furthermore, we showed that SAP regulates type II NKT-cell development by controlling early growth response 2 protein and promyelocytic leukemia zinc finger expression.",25236978_3,-1,1,-1,1,24838,-1,4.0695318e-06,0.99999225,3.69269e-06
38194,Tregs,7,8,43,48,BACKGROUND: CCL22 played critical roles in Tregs recruitment.,31769216_0,-1,1,-1,1,38194,-1,5.389647e-06,0.9999889,5.7040897e-06
33516,to,17,18,118,120,"Moreover, H-LAMs expressed increased level of cytokines in charge of recruiting inflammatory cells, which contributed to pro-inflammatory hepatic microenvironment.",29030004_6,-1,1,-1,1,33516,-1,6.65788e-06,0.99998736,6.03505e-06
39439,TIM-3,17,18,101,106,"Also, resected pituitary adenomas contained highly functional FOXP3+ Treg cells, with high levels of TIM-3 expression and high frequency of TGF- and IL-10 co-producers in the TIM-3+ fraction.",32279926_9,-1,1,-1,1,39439,-1,5.7772454e-06,0.99998665,7.5232665e-06
31432,FOXP3,0,1,0,5,"FOXP3 expression was most potently induced by tumours secreting higher levels of total and active TGF1 and this induction could be potently counteracted with IL-21, restoring T cell proliferation.",28239749_5,-1,1,-1,1,31432,-1,4.530733e-06,0.999992,3.4186203e-06
21523,the,2,3,10,13,"Moreover, the number of CD8 in TILs was positively correlated with a distant metastasis-free period.",24243586_5,-1,1,-1,1,21523,-1,4.0099676e-06,0.99999213,3.8896933e-06
9063,traditionally,2,3,9,22,They are traditionally viewed as the immunologic centerpiece that is able to prime CD4(+) helper and CD8(+) cytotoxic T-cell effector populations.,19275918_1,-1,1,-1,1,9063,-1,4.8679685e-06,0.99999046,4.647357e-06
19646,than,22,23,149,153,"Pleural effusions from both tuberculous and malignant groups represented significantly higher levels (more in TB) for the following cell populations than peripheral blood: total lymphocytes, CD3+lymphocyte, CD4+CD25+lymphocyte and Treg (CD4+ CD25+FoxP3+).",23252864_5,-1,1,-1,1,19646,-1,6.5820745e-06,0.99998224,1.1151122e-05
12375,the,27,28,133,136,A significant difference in the expression of IL-17 (P = .001) and TGF-beta (P = .003) was observed between cysts and granulomas and the control group.,20478453_8,-1,1,-1,1,12375,-1,4.919267e-06,0.9999906,4.4601866e-06
43506,that,23,24,130,134,"Thus, the stimulation of AP-1-mediated gene expression by IL-1 in EL4 cells is due to the promotion of Jun B protein accumulation that, in turn, facilitates Jun B heterodimerization with TPA-induced Fra-1 protein, thereby forming an active AP-1 complex.",7675040_8,-1,1,-1,1,43506,-1,4.7058866e-06,0.99999106,4.2115844e-06
2939,Treg,26,27,177,181,Our studies in a mouse pancreas cancer model suggest that the tumor actively promotes the accrual of Treg through several mechanisms involving activation of naturally occurring Treg as well as conversion of non-Treg into Treg.,16106066_3,-1,1,-1,1,2939,-1,9.369501e-06,0.9999808,9.842966e-06
37437,thereby,15,16,126,133,"Mice with Treg cell-restricted Neuropilin-1 deficiency show tumor resistance while maintaining peripheral immune homeostasis, thereby providing a controlled system to interrogate the impact of intratumoral Treg cells on the TME.",31350177_1,-1,1,-1,1,37437,-1,5.7762004e-06,0.99998975,4.473192e-06
30382,the,10,11,50,53,"The correlation among Foxp3, IL-10 and Stat3, and the clinical relevance of these three indexes were analyzed.",27752897_2,-1,1,-1,1,30382,-1,4.6096543e-06,0.99999106,4.323573e-06
42417,TGF-1,21,22,105,111,"Moreover, amphiregulin (Areg), an EGFR ligand, is critical for the amplification of Th9 cells induced by TGF-1 and IL-4.",34075041_3,-1,1,-1,1,42417,-1,8.649946e-06,0.9999747,1.6581633e-05
22665,the,2,3,10,13,"Moreover, the hepatocyte growth factor/c-MET interaction activates STAT3(TYR705) phosphorylation in nurse-like cells.",24561793_4,-1,1,-1,1,22665,-1,4.7398066e-06,0.99999106,4.2113916e-06
11671,the,24,25,161,164,BACKGROUND: The local and systemic activation and regulation of the immune system by malignant cells during carcinogenesis is highly complex with involvement of the innate and acquired immune system.,20205946_0,-1,1,-1,1,11671,-1,5.5224205e-06,0.99999034,4.1859585e-06
13802,therapeutic,26,27,154,165,"PURPOSE: Regulatory T cells (Tregs) are thought to inhibit antitumor immune responses, and their depletion could therefore have a synergistic effect with therapeutic cancer vaccines.",21177412_0,-1,1,-1,1,13802,-1,5.177145e-06,0.9999907,4.180658e-06
29646,the,2,3,9,12,"However, the effect of bladder cancer cell (BCC) on phenotype and function of DCs remains unclear.",27556503_1,-1,1,-1,1,29646,-1,4.9099986e-06,0.99999106,3.985042e-06
33428,their,14,15,65,70,"Tumor-specific CD4+ T helper 9 (TH9) cells, so-called because of their production of the cytokine interleukin-9 (IL-9), are a powerful effector T cell subset for cancer immunotherapy.",29018172_0,-1,1,-1,1,33428,-1,5.5885967e-06,0.9999881,6.3584166e-06
11653,tumor,11,12,44,49,"In a second model (TC1), it induced initial tumor mass reduction, but 90% of the animals showed delayed tumor progression.",20145549_4,-1,1,-1,1,11653,-1,4.1905178e-06,0.9999908,4.9389128e-06
6180,that,20,21,101,105,"In lymph nodes, Nrp1 identified a small regulatory CD4+ CD25(high) T-cell subpopulation (Nrp1+ Treg) that expressed higher levels of Forkhead box P3 (Foxp3) message and protein than Nrp1- Treg, and various molecular markers of activated Treg, i.e. CD45RO, human leucocyte antigen (HLA)-DR and glucocorticoid-induced tumour necrosis factor receptor (GITR).",18028372_1,-1,1,-1,1,6180,-1,3.920678e-06,0.9999908,5.249254e-06
7634,Thus,0,1,0,4,"Thus, this is the first description of FOXP3 splice forms in human disease.",18769452_10,-1,1,-1,1,7634,-1,5.2751348e-06,0.99999,4.757372e-06
9275,Treg,14,15,90,94,"Collectively, these observations further support the role of TGF-beta in the induction of Treg in pancreas adenocarcinoma.",19307989_10,-1,1,-1,1,9275,-1,7.0820906e-06,0.99998593,7.0156475e-06
32776,the,10,11,60,63,"Therefore, without the use of mutations, PEGylation reduces the affinity for IL2R to a greater extent than for IL2R, the receptor complex predominant on CD8 T cells.",28678791_8,-1,1,-1,1,32776,-1,4.970965e-06,0.9999908,4.1842122e-06
32114,tumor,10,11,98,103,Immunization with NY-ESO-1 antigen plus alum-CpG-HH2 combinatorial adjuvant effectively inhibited tumor growth and reduced tumor burden in prophylactic and therapeutic tumor models and even in passive serum or cellular therapy.,28515346_4,-1,1,-1,1,32114,-1,3.9025877e-06,0.99999154,4.528886e-06
13110,treatment,5,6,42,51,"BACKGROUND: Anti-CD20 monoclonal antibody treatment has not only increased survival and cure rates in many non-Hodgkin lymphomas, but also has prompted an explosion in the development of novel antibodies and biologically active substances with specific cellular targets in the field of malignancies treatment.",20815894_0,-1,1,-1,1,13110,-1,5.9657823e-06,0.9999887,5.3224817e-06
11564,Tehranolide,23,24,121,132,"Our results showed a significant (p<0.05) decrease in the tumor volume and the level of IL-4 in the animals treated with Tehranolide, compared to untreated group.",20138670_5,-1,1,-1,1,11564,-1,1.3719617e-05,0.9999714,1.4881457e-05
21718,that,38,39,210,214,"High intratumoral FoxP3(+) Tregs with high peritumoral IL-17(+) T cells showed a significantly lower survival rate compared with other groups (OS, P < 0.001 and DFS, P < 0.001).CONCLUSION: Our findings suggest that intrahepatic IL-17(+) T cells and FoxP3(+) Tregs may cooperate to promote the progression of HCC.",24303990_8,-1,1,-1,1,21718,-1,4.3764144e-06,0.99999166,3.966681e-06
14268,the,8,9,62,65,MART1 gene expression showed a significant difference between the SLN (+) and SLN (-) groups (P=0.04).,21327637_11,-1,1,-1,1,14268,-1,4.2362167e-06,0.9999919,3.9029615e-06
8037,the,32,33,208,211,Lenalidomide (Revlimid; CC-5013) and pomalidomide (CC-4047) are IMiDs proprietary drugs having immunomodulatory properties that have both shown activity in cancer clinical trials; lenalidomide is approved in the United States for a subset of MDS patients and for treatment of patients with multiple myeloma when used in combination with dexamethasone.,19009291_0,-1,1,-1,1,8037,-1,4.779969e-06,0.99998975,5.5221067e-06
10615,transcription,11,12,84,97,The secreted mp28 prevented the IL-27-mediated signal transduction and activator of transcription 1 phosphorylation and subsequently inhibited the IL-27-mediated intercellular adhesion molecule-1 induction and interferon-gamma production in CD4(+) T cells.,19740343_4,-1,1,-1,1,10615,-1,7.6268e-06,0.9999808,1.1507177e-05
24983,the,15,16,77,80,"Dendritic cells (DC) that interact with T cells represent a crucial site for the development of tolerance to tumor antigens, but there remains incomplete knowledge about how DC-tolerizing signals evolve during tumorigenesis.",25261236_1,-1,1,-1,1,24983,-1,4.4988437e-06,0.99999166,3.8167395e-06
42499,generation,6,7,44,54,"Moreover, Gpx4-deficient Treg cells elevate generation of mitochondrial superoxide and production of interleukin-1 (IL-1) that facilitates T helper 17 (TH17) responses.",34133924_5,-1,1,-1,1,42499,-1,9.5407295e-06,0.9999815,8.90576e-06
992,the,11,12,58,61,A corollary to the latter is that survival of melanoma in the host is due to the development of anti-apoptotic mechanisms in melanoma cells.,11905805_2,-1,1,-1,1,992,-1,5.4231023e-06,0.9999896,4.976196e-06
16103,the,22,23,132,135,"We have investigated the role of interleukin (IL)-21 in colitis-associated colon cancer (CAC), as this cytokine is overexpressed in the gut mucosa of patients with ulcerative colitis (UC), a chronic inflammatory disease associated with colon cancer.",21987656_1,-1,1,-1,1,16103,-1,3.8510448e-06,0.9999913,4.8471907e-06
14583,the,38,39,247,250,These results beg the question: can the ineffective polarization of T lymphocytes in the context of CLL be effectively modulated using methylation inhibitors in a sustainable therapeutic fashion? To answer this question our laboratory has studied the effects of 5-aza-2'-deoxycytidine (5A2) in helper and cytotoxic T lymphocytes from healthy donors and CLL patients in well characterized molecular and epigenetic signaling pathways involved in effective polarization.,21377729_4,-1,1,-1,1,14583,-1,4.4769918e-06,0.999992,3.47083e-06
24168,These,0,1,0,5,These findings indicate that blocking STAT3 in HCC cells can initiate innate immunity in vivo.,25015826_7,-1,1,-1,1,24168,-1,4.387636e-06,0.9999919,3.7392147e-06
33479,tristetraprolin-deficient,4,5,25,50,IL-27 is overproduced by tristetraprolin-deficient macrophages and increased systemically in tristetraprolin-deficient mice.,29021521_3,-1,1,-1,1,33479,-1,0.00013034005,0.9998248,4.487628e-05
8084,this,1,2,3,7,"In this study, we examined the functional role of CD4(+)CD25(+) Foxp3(+) Tregs in these different manifestations.",19022624_2,-1,1,-1,1,8084,-1,4.250808e-06,0.99999154,4.210165e-06
12975,trials,16,17,90,96,This approach is currently being tested in a clinical trial and could be applied to other trials of viral immunogene therapy.,20683443_6,-1,1,-1,1,12975,-1,6.2258887e-06,0.9999887,5.137238e-06
27540,to,3,4,17,19,This study aimed to identify the recovery profile of T-cell subsets following x-ray irradiation and to highlight the role of cinnamon on efficient T-cell restoration postexposure in the antitumor response.,26475064_2,-1,1,-1,1,27540,-1,3.91781e-06,0.9999925,3.6511838e-06
41092,Foxp3,3,4,19,24,The expressions of Foxp3 and TGF in the transplanted tumor tissues of mice in the solanine group were significantly lower than those in the control group.,33204731_9,-1,1,-1,1,41092,-1,5.835852e-06,0.9999871,7.0454053e-06
29175,the,2,3,9,12,"However, the impact of Gfi1-deficiency on the iNKT cell differentiation remains unclear.",27284976_1,-1,1,-1,1,29175,-1,5.6221174e-06,0.9999906,3.825959e-06
4015,trials,26,27,178,184,"CTL-associated antigen 4 (CTLA4) blockade releases inhibitory controls on T cell activation and proliferation, inducing antitumor immunity in both preclinical and early clinical trials.",16778987_0,-1,1,-1,1,4015,-1,5.0870776e-06,0.99999,4.903517e-06
30879,trans-activated,5,6,31,46,"Furthermore, CCL5 was directly trans-activated by cancer-FOXP3 and promoted the recruitment of Treg cells from peripheral blood to the tumor site in vitro and in vivo.",27991933_6,-1,1,-1,1,30879,-1,4.409439e-05,0.9999386,1.7349963e-05
26264,to,9,10,56,58,"Smoking and use of alcohol affected the T-cell response to common antigens but not to HPV peptides (p=0.032 and 0.045, respectively).CONCLUSION: While both the CIN women and controls exhibited an HPV16-specific CMI, IL-17A might be of importance in HPV induced pathology.",25990808_7,-1,1,-1,1,26264,-1,2.2593693e-05,0.99996173,1.5725507e-05
11808,This,0,1,0,4,This vast existing local T-cell population is awaiting proper stimulation and can be exploited for the immunotherapy of cancer.,20233872_8,-1,1,-1,1,11808,-1,5.972079e-06,0.9999888,5.2505757e-06
42282,Thus,0,1,0,4,"Thus, additional treatment options are needed for tumors that lose expression of MHC class I. The cellular inhibitor of apoptosis proteins 1 and 2 (cIAP1/2) regulate classical and alternative nuclear factor B (NF-B) signaling.",34011631_1,-1,1,-1,1,42282,-1,6.8836994e-06,0.9999877,5.4249335e-06
19797,absent,21,22,142,148,Survivin protein is an attractive candidate for cancer immunotherapy since it is abundantly expressed in most common human cancers and mostly absent in normal adult tissues.,23335100_0,-1,1,-1,1,19797,-1,2.0300307e-05,0.99996936,1.0377888e-05
9654,the,10,11,53,56,These CD25(+) clones had a high capacity to suppress the proliferation of another T-cell clone after peptide stimulation in vitro.,19435913_4,-1,1,-1,1,9654,-1,4.5861843e-06,0.99999154,3.870464e-06
21182,to,10,11,42,44,"Foxn1, KGF, and IL-7, three factors known to be involved in thymic development, were also downregulated in the thymuses of tumor bearers.",24051497_6,-1,1,-1,1,21182,-1,7.350958e-06,0.99998736,5.339013e-06
32775,the,3,4,19,22,"Therefore, without the use of mutations, PEGylation reduces the affinity for IL2R to a greater extent than for IL2R, the receptor complex predominant on CD8 T cells.",28678791_8,-1,1,-1,1,32775,-1,4.9555642e-06,0.99999106,3.986338e-06
28552,Treg,20,21,103,107,CD4(+) T cells that express the forkhead box P3 (FOXP3) transcription factor function as regulatory T (Treg) cells and hinder effective immune responses against cancer cells.,27111280_0,-1,1,-1,1,28552,-1,5.025229e-06,0.9999882,6.754102e-06
2579,transactivator,15,16,88,102,"The transfected genes are cDNA plasmids for interferon-gamma (pIFN-gamma), MHC class II transactivator (pCIITA), an Ii reverse gene construct (pIi-RGC), and a subtherapeutic dose of adjuvant IL-2 (pIL-2).",15761259_1,-1,1,-1,1,2579,-1,6.171966e-06,0.9999864,7.3937404e-06
13034,Treg,1,2,6,10,"Serum Treg levels were measured as whole lymphocytes in CD4+ cells using flow cytometry while TGF-beta, IL-10, and autoantibody levels were measured using enzyme-linked immunosorbent assays.",20712892_3,-1,1,-1,1,13034,-1,6.754009e-06,0.9999869,6.3991183e-06
2607,the,1,2,9,12,"Although the proinflammatory cytokine interferon-gamma (IFN-gamma) has been generally thought to enhance antitumor immune responses and be involved in antitumor mechanisms of many other immunotherapy molecules, it has also been reported that IFN-gamma could promote tumor immune evasion.",15776283_0,-1,1,-1,1,2607,-1,5.623135e-06,0.99999034,4.0355485e-06
13583,the,15,16,98,101,"When the same culture supernatant was added to ASCs isolated from normal subjects augmentation of the mRNA expressions of IL-4, IL-10, IL-8, MMP2, VEGF and SDF-1 in normal ASCs was also observed.",20970781_6,-1,1,-1,1,13583,-1,4.6475934e-06,0.99999094,4.373036e-06
17111,the,24,25,133,136,"Human MutS homologue 2 (hMSH2), a crucial element of the highly conserved DNA mismatch repair system, maintains genetic stability in the nucleus of normal cells.",22493490_0,-1,1,-1,1,17111,-1,3.4585855e-06,0.9999914,5.0703457e-06
30629,the,36,37,242,245,"Since these sublines showed a remarkable reduction of FoxO1 transcription factor, which regulates various cell cycle regulators in asbestos-exposed sublines, the cell cycle progression in these sublines was examined and compared with that of the original MT-2 cells.",27878235_3,-1,1,-1,1,30629,-1,3.590557e-06,0.999992,4.3900227e-06
16922,plays,39,40,223,228,"Moreover, in a clinical trial testing a combination of IL-12 and rituximab in patients with follicular B cell non-Hodgkin lymphoma (FL), those treated with IL-12 showed a lower response rate, suggesting that IL-12 actually plays a detrimental role.",22426209_3,-1,1,-1,1,16922,-1,1.2857646e-05,0.99998,7.197651e-06
29641,to,11,12,72,74,"In conclusion, our data suggest that vaccinated volunteers are superior to nonvaccinated donors for HPV-specific cellular cancer immunotherapy.",27548034_10,-1,1,-1,1,29641,-1,5.7402385e-06,0.99999,4.31519e-06
29029,to,8,9,43,45,"In particular, iNKT cells have the ability to immediately produce large amounts of IFN- upon activation and thus initiate immune responses in various pathological conditions.",27226296_1,-1,1,-1,1,29029,-1,3.4980353e-06,0.999992,4.4317844e-06
36780,Tumor-bearing,0,1,0,13,Tumor-bearing mice model was utilized to explore the effects of Foxa1+ Treg on tumor growth and the prognoses.,31036318_9,-1,1,-1,1,36780,-1,5.438716e-06,0.9999883,6.1934047e-06
7638,transducers,5,6,30,41,PURPOSE: Activation of signal transducers and activators of transcription 3 (STAT3) has been identified as a central mediator of melanoma growth and metastasis.,18794085_0,-1,1,-1,1,7638,-1,1.2507099e-05,0.999979,8.510957e-06
17828,transcription factor,27,29,196,216,AIM: To investigated the interaction between toll-like receptor 4 (TLR4)-activated hepatoma cells and macrophages in the induction of tumor-immune suppression mediated by CD4+CD25(high) family of transcription factor P3 (FOXP3) regulatory T cells (Tregs).METHODS: The proportion of FOXP3+ Tregs was identified in peripheral blood and tumor tissues of 60 hepatocellular carcinoma (HCC) patients.,22736917_0,-1,1,-1,1,17828,-1,4.920958e-06,0.9999908,4.3168397e-06
38667,The,2,3,14,17,SIGNIFICANCE: The BRCA1-IRIS oncogene promotes breast cancer aggressiveness by recruiting macrophages and promoting their M2 polarization.,31911557_10,-1,1,-1,1,38667,-1,3.652151e-06,0.99999213,4.241813e-06
6533,Treg,3,4,19,23,"ICOShigh and ICOS- Treg were also expanded under conditions previously shown to induce Tr1 from RC.RESULTS: Treg in tumor-infiltrating lymphocytes expressed ICOS (mean fluorescence intensity=70+/-10), while Treg in PBMC had low ICOS expression (mean fluorescence intensity=3.5+/-2.5, p<or=0.001).",18292519_6,-1,1,-1,1,6533,-1,5.982879e-06,0.99998736,6.650379e-06
35297,tumors,4,5,36,42,"RORt-deficient Tregs isolated from tumors overexpressed CTLA-4 and induced DCs to have elevated expression of the transcription factor FoxO3, thus reducing IL6 expression.",29991500_9,-1,1,-1,1,35297,-1,3.5579676e-06,0.99999225,4.164596e-06
10759,their,4,5,20,25,"In both conditions, their predominance is associated with the diminution of specific CD4(+) T cell response.",19805226_6,-1,1,-1,1,10759,-1,6.586104e-06,0.9999887,4.716344e-06
39903,TGF-,6,7,38,43,"Meanwhile, a significant reduction in TGF- (p < 0.001) was recorded.",32480291_8,-1,1,-1,1,39903,-1,2.1460075e-05,0.9999646,1.3987661e-05
29559,the,22,23,173,176,We review how dysfunctional Tregs contribute to disease pathogenesis in inflammatory conditions and how inappropriate regulatory responses may hamper protective immunity in the context of infection and cancer.,27497235_2,-1,1,-1,1,29559,-1,6.011977e-06,0.9999896,4.3206483e-06
30458,Foxp3,5,6,26,31,The expression of ICOS in Foxp3+ cells was closely related to plasmacytoid dendritic cells (pDCs) and their expression of ICOS-L and TLR9 as well as Helicobacter pylori infection.,27756099_6,-1,1,-1,1,30458,-1,1.0917591e-05,0.9999784,1.0624586e-05
12707,Treg,42,43,259,263,"In conclusion, the accumulation of Th17 cells as well as Treg in the tumor microenvironment of gastric cancer occurred in early disease and then the infiltration of Th17 cells gradually decreased according to the disease progression, in contrast to increased Treg.",20550524_8,-1,1,-1,1,12707,-1,4.1954218e-06,0.9999912,4.6100067e-06
35269,the,16,17,104,107,"FoxP3+ regulatory T cells (Treg) coexpressing the Th17-related transcription factor RORt accumulate in the lamina propria of IBD patients, where they are thought to represent an intermediate stage of development toward a Th17 proinflammatory phenotype.",29991500_1,-1,1,-1,1,35269,-1,3.4595573e-06,0.99999285,3.7311004e-06
6938,the,12,13,86,89,"Hence reovirus recognition by DC may trigger innate effector mechanisms to complement the virus's direct cytotoxicity, potentially enhancing the efficacy of reovirus as a therapeutic agent.",18424722_8,-1,1,-1,1,6938,-1,2.1002854e-05,0.99996936,9.688767e-06
35759,subunit,21,22,121,128,"Interleukin 35 (IL-35) is a potent immunosuppressive cytokine, consisting of an Epstein-Barr virus-induced gene 3 (EBI3) subunit and a p35 subunit.",30321288_0,-1,1,-1,1,35759,-1,6.269103e-06,0.99998105,1.2659057e-05
34386,TGF-mediated,6,7,45,58,"Our data demonstrate that Y-traps counteract TGF-mediated differentiation of Tregs and immune tolerance, thereby providing a potentially more effective immunotherapeutic strategy against cancers that are resistant to current immune checkpoint inhibitors.",29467463_5,-1,1,-1,1,34386,-1,6.391603e-05,0.9998965,3.951883e-05
323,that,3,4,31,35,Experimental evidence suggests that a type 1 T cell response may result in optimal tumor rejection in vivo.,11086033_0,-1,1,-1,1,323,-1,4.6127407e-06,0.9999919,3.5517248e-06
42439,the,32,33,196,199,"Background: Increased IL-6 level, M2 macrophages and PD-1+CD8+ T cells in tumor microenvironments (TME) have been identified to correlate with resistance to checkpoint blockade immunotherapy, yet the mechanism remains poorly understood.",34093869_0,-1,1,-1,1,42439,-1,6.1889255e-06,0.9999896,4.230345e-06
8831,Treg,35,36,228,232,"Remarkably, analysis of EOC-associated conventional CD4CD25 T cell and Treg populations isolated ex vivo from tumor samples by cell sorting and cultured with tumor-associated CD3- cells in the presence of IL-2 revealed that EOC Treg stimulated under these conditions were rapidly converted into TH17 cells, down-regulated FOXP3 expression, and lost their suppressive capacity.",19238008_5,-1,1,-1,1,8831,-1,6.939774e-06,0.99998784,5.2421497e-06
7535,this,4,5,27,31,"The likely explanation for this was the NS3/4A-mediated cleavage of mouse IPS-1, albeit less efficiently than human IPS-1.",18689426_9,-1,1,-1,1,7535,-1,9.042824e-06,0.9999863,4.6992177e-06
23853,Tim-3,6,7,38,43,"Our results suggest RepSox may reduce Tim-3 expression by inhibiting transforming growth factor- signaling and slow decay of CD34(+) AML cells by increasing CXCL12 and MYC, two factors that inhibit AML cell differentiation.",24855276_9,-1,1,-1,1,23853,-1,7.1039412e-06,0.9999862,6.7021087e-06
32529,targeting,10,11,69,78,Harnessing tumor immunity in glioma will likely require the combined targeting of multiple inhibitory checkpoints.,28620836_12,-1,1,-1,1,32529,-1,6.7867845e-06,0.9999889,4.309337e-06
38302,the,51,52,240,243,"Interestingly, the level of CD25+ Foxp3+ cells in circulating CD4+ T cells was positively correlated with the level of CD25+ Foxp3+ cells in CD4+ TILs, but the level of CD25+ Foxp3- cells in circulating CD4+ T cells was not associated with the level of CD25+ Foxp3- cells in CD4+ TILs.",31811667_9,-1,1,-1,1,38302,-1,3.9425586e-06,0.9999925,3.5940702e-06
20959,complex,4,5,29,36,"Disruption of the POSH/JIP-1 complex led to profound defects in the activation of JNK1, as well as deficient activation or induction of the transcription factors c-Jun, T-bet, and Eomesodermin.",23963642_5,-1,1,-1,1,20959,-1,4.6271775e-06,0.9999887,6.642864e-06
39491,TAMs,17,18,110,114,"In previous work, we demonstrated that the synthetic triterpenoid CDDO-methyl ester (CDDO-Me) converts breast TAMs from a tumor-promoting to a tumor-inhibiting activation state in vitro.",32300202_2,-1,1,-1,1,39491,-1,6.2541035e-06,0.9999832,1.055137e-05
5711,FOXP3,9,10,70,75,"In infiltrating carcinoma, a significant positive correlation between FOXP3 expression and TGF-beta1 expression was noted (p<0.001).",17653902_6,-1,1,-1,1,5711,-1,5.6242948e-06,0.9999887,5.7390976e-06
6529,Treg,3,4,29,33,Transwell inserts separating Treg from RC were used to evaluate suppression mechanisms used by Treg.,18292519_4,-1,1,-1,1,6529,-1,5.5542405e-06,0.999987,7.431948e-06
17308,T,29,30,197,198,"We show that some, but not all, SCLC tumour cell lines secrete molecules that induce IL-10 secretion by and de novo differentiation of functional CD4(+)CD25(+)FOXP3(+)CD127(lo)Helios(-) regulatory T (Treg) cells in healthy blood lymphocytes.",22532287_5,-1,1,-1,1,17308,-1,4.174612e-06,0.9999902,5.5849164e-06
3837,treatment,8,9,46,55,We also examined the effects of low-dose IL-2 treatment in 12 patients with metastatic cancer and 9 patients with chronic myelogenous leukemia after allogeneic hematopoietic stem cell transplantation.,16645171_4,-1,1,-1,1,3837,-1,1.0307517e-05,0.9999831,6.6076905e-06
10124,to,27,28,159,161,"Although the Th17 subset and its signature cytokine, interleukin (IL)-17A (IL-17), are implicated in certain autoimmune diseases, their role in cancer remains to be further explored.",19564351_0,-1,1,-1,1,10124,-1,6.8921163e-06,0.9999881,5.0015897e-06
30321,the,1,2,3,6,"In the absence of neutrophils, activated and functional T cells infiltrated pancreatic tumors otherwise devoid of effector T cells.",27737879_7,-1,1,-1,1,30321,-1,6.130697e-06,0.9999894,4.4739836e-06
34611,the,9,10,67,70,"Increasing evidence indicates that Wnt/-catenin signaling, one of the best-characterized cancer drivers, promotes cancer progression by regulating the tumor-immune cycle in most of the nodes, including dendritic cells, T cells, and tumor cells.",29678298_1,-1,1,-1,1,34611,-1,5.8791584e-06,0.99998856,5.5167097e-06
4066,that,7,8,35,39,"As in human breast cancer, cancers that develop in these mice attract Tregs into the tumor microenvironment to levels of approximately 10-25% of the total CD4+ T cells.",16785502_3,-1,1,-1,1,4066,-1,4.0930945e-06,0.99999106,4.8491734e-06
42834,the,16,17,92,95,"Although PSC is an inflammatory condition predisposing to CCA, CCA is almost never found in the autoimmune context of PBC.",34495298_2,-1,1,-1,1,42834,-1,6.359311e-06,0.9999895,4.0808027e-06
43002,the,10,11,63,66,"RNA-seq, I2 and Cht+I2 samples showed significant increases in the expression of Th1 and Th17 pathways.",34680134_3,-1,1,-1,1,43002,-1,3.7517766e-06,0.9999918,4.4272215e-06
29050,to,12,13,87,89,Bhlhe40 alone shows no significant effects on Ifng promoter activities but contributes to enhance T-box transcription factor Tbx21 (T-bet)-mediated Ifng promoter activation.,27226296_6,-1,1,-1,1,29050,-1,3.7069606e-06,0.9999918,4.5073257e-06
32361,Trex1,2,3,6,11,"Thus, Trex1 is an upstream regulator of radiation-driven anti-tumour immunity.",28598415_6,-1,1,-1,1,32361,-1,5.6358613e-06,0.99997556,1.8843893e-05
1888,Twenty-nine,28,29,210,221,PURPOSE: The purpose is to study the immunogenicity of heterologous prime-boost human papillomavirus (HPV) oncogene vaccination in patients with anogenital intraepithelial neoplasia (AGIN).EXPERIMENTAL DESIGN: Twenty-nine women with high-grade AGIN received three i.m.,15131030_0,-1,1,-1,1,1888,-1,7.038972e-05,0.99989307,3.648237e-05
6915,the,9,10,64,67,"Reovirus induced DC maturation and stimulated the production of the proinflammatory cytokines IFN-alpha, TNF-alpha, IL-12p70, and IL-6.",18424722_3,-1,1,-1,1,6915,-1,8.396157e-06,0.99998665,4.9651117e-06
12664,the,1,2,3,6,"In the present study, we investigated the distribution of Th17 cells in relation to regulatory T cells (Treg) in the tumor-infiltrating lymphocytes (TILs), regional lymph node lymphocytes, and peripheral blood lymphocytes of gastric cancer patients.",20550524_1,-1,1,-1,1,12664,-1,4.4358126e-06,0.9999907,4.8873767e-06
43418,tumor,23,24,169,174,"EC-specific Rap1B deletion inhibits angiogenesis, but also leads to an altered tumor microenvironment with increased recruitment of leukocytes and increased activity of tumor CD8+ T-cells.",36403190_3,-1,1,-1,1,43418,-1,4.5141496e-06,0.99999106,4.388306e-06
38182,T,19,20,89,90,"Moreover, PD-1 ligation in CD8+ Tcells activates STAT3 to increase FAO, inhibiting CD8+ T effector cell glycolysis and functions.",31761565_3,-1,1,-1,1,38182,-1,1.607159e-05,0.9998592,0.00012470272
3361,that,27,28,172,176,"In addition, protection against tumor challenge in vaccinated mice showed that there was no significant change in mice survival after in vivo CD8+CTL depletion, indicating that antitumor immunity augmented by plasmid encoding GM-CSF and target PDTRP gene vaccine was dominated by Th2 immune response.",16341143_5,-1,1,-1,1,3361,-1,4.4395515e-06,0.999992,3.5720186e-06
36742,treated,35,36,218,225,"These patients also showed impaired signal transducer and activator of transcription-1 (STAT1) signaling upon stimulation with IL-6 and phorbol 12-myristate 13-acetate (PMA), and T-Cells from a healthy donor that were treated for four days with IL-6 displayed a similar muting of STAT signaling, which verified the effect seen in patient samples.",31027698_7,-1,1,-1,1,36742,-1,1.0022756e-05,0.999982,7.965767e-06
34598,the,18,19,114,117,"In addition, the frequency and function of Tr1 cells were positively correlated with the disease-free survival of the gastric cancer patients.",29625086_6,-1,1,-1,1,34598,-1,4.4083517e-06,0.99999106,4.477483e-06
33274,tumor-bearing,4,5,25,38,"Moreover, experiments in tumor-bearing C57BL/6 mice showed that Irf1 gene expression in the spleen was transiently increased following CTX administration and correlated with the induction of Th1 cell expansion and of Il12p40 gene expression, which is the main Th1-driving cytokine.",28975621_4,-1,1,-1,1,33274,-1,5.8141927e-06,0.9999882,6.035803e-06
12172,generated,20,21,136,145,"We recently proposed the tumor necrosis factor family costimulatory ligands as potential adjuvants for therapeutic vaccines and, hence, generated a soluble form of 4-1BBL chimeric with streptavidin (SA-4-1BBL) that has pleiotropic effects on cells of innate, adaptive, and regulatory immunity.",20406989_2,-1,1,-1,1,12172,-1,6.6673883e-06,0.9999887,4.6057935e-06
8067,T,2,3,14,15,Inhibition of T regulatory cell function was not due to changes in TGF-beta or IL-10 production but was associated with decreased T regulatory cell FOXP3 expression.,19009291_8,-1,1,-1,1,8067,-1,4.7358844e-06,0.99998903,6.2628123e-06
38861,the,16,17,97,100,"Our results, therefore, suggest that modifying N-glycosylation of T cells with 2DG could improve the efficacy of T cell-based immunotherapies against cancer.",31969386_6,-1,1,-1,1,38861,-1,4.707219e-06,0.9999918,3.5399164e-06
18604,trial,21,22,149,154,Progression-free interval and survival were longer than observed in a phase III trial where gemcitabine preceded pemetrexed suggesting that a larger trial of pemetrexed preceding gemcitabine is warranted.,22996369_14,-1,1,-1,1,18604,-1,8.831753e-06,0.9999851,6.1010005e-06
22482,the,4,5,24,27,"Our study describes for the first time, to our knowledge, the role of Notch as an additional signal contributing to Ag-specific effector functions of  T cells.",24489102_7,-1,1,-1,1,22482,-1,6.5414324e-06,0.9999863,7.2191515e-06
24740,gene,1,2,6,10,CIITA gene was found highly methylated in pancreatic carcinoma cell line PANC-1 and responsible for the low expression of major histocompatability complex II (MHC-II) that may lead to immune evasion.,25198660_1,-1,1,-1,1,24740,-1,8.266402e-06,0.9999796,1.2072268e-05
3402,that,3,4,19,23,These results show that effective immune surveillance against established metastatic disease is negatively regulated by IL-13 and requires the induction of tumoricidal M1 macrophages and lymphocytes combined with a reduction in tumor-induced myeloid suppressor cells.,16357187_5,-1,1,-1,1,3402,-1,3.9836145e-06,0.9999924,3.663122e-06
16790,the,6,7,35,38,"We found that ST2 deletion enhance the development of T cell-mediated autoimmune disorders, EAE and diabetes mellitus type I. Disease development was accompanied by dominantly Th1/Th17 immune response but also higher IL-33 production, which suggest that IL-33 in receptor independent manner could promote the development of inflammatory autoreactive T cells.",22392053_5,-1,1,-1,1,16790,-1,4.4291387e-06,0.9999918,3.740031e-06
2430,the,10,11,44,47,"After a median follow-up of 50 months, 6 of the 10 patients remain in continuous first complete remission.",15623607_8,-1,1,-1,1,2430,-1,1.0716855e-05,0.9999794,9.87833e-06
8396,the,9,10,55,58,"In addition, Treg numbers are predictively elevated in the peripheral blood of patients with various solid tumors.",19147574_8,-1,1,-1,1,8396,-1,3.9419465e-06,0.9999918,4.3071595e-06
12585,this,1,2,3,7,"In this study, we investigated the macrophage populations and phenotypes, and their correlation to angiogenesis, immunosuppression, and clinical prognosis in intrahepatic cholangiocarcinoma (ICC).",20545696_1,-1,1,-1,1,12585,-1,4.258505e-06,0.9999914,4.294882e-06
12570,tumors,7,8,44,50,"In this study, animals with Her2-expressing tumors were vaccinated by co-administration of GP96+ Her2/neu DNA vaccines.",20544406_3,-1,1,-1,1,12570,-1,3.874705e-06,0.9999918,4.329683e-06
8359,that,22,23,143,147,"Increased Treg frequencies measured by mRNA expression or protein synthesis of the Treg marker FOXP3 were found in various cancers, indicating that dysregulation of Treg levels contributes to tumor establishment.",19147574_1,-1,1,-1,1,8359,-1,3.9504275e-06,0.99999225,3.8110204e-06
11700,to,20,21,115,117,T cells of regulatory phenotype (CD4+CD25+Foxp3+) which might play a role in protumoral immune response were found to infiltrate peritumoral tissue increasingly during carcinogenesis.,20205946_8,-1,1,-1,1,11700,-1,4.2515035e-06,0.99999106,4.7438903e-06
3693,T,13,14,76,77,"In this study, we evaluated the role of the immunoregulatory natural killer T (NKT) cells in the biology of immunosurveillance of osteosarcoma.",16585215_1,-1,1,-1,1,3693,-1,4.4135936e-06,0.99998736,8.233868e-06
32620,to,23,24,180,182,Increased IL-4 expression in human colorectal cancer tissue and growth of colon cancer cell lines implied that IL-4-induced Stat6-mediated tumorigenic signaling likely contributes to intestinal tumor progression in ApcMin/+ mice.,28654863_1,-1,1,-1,1,32620,-1,4.9204386e-06,0.9999902,4.8880593e-06
1551,to,8,9,50,52,"Although the first three mechanisms do not appear to be relevant, regression of myeloid suppressor cells in Stat6-deficient and CD1-deficient mice may be responsible for enhanced immunosurveillance.",14593499_7,-1,1,-1,1,1551,-1,7.915614e-06,0.99998605,6.0865996e-06
6592,to,10,11,42,44,"In this context, the aim of our study was to determine whether functional Treg cells were detectable and amplified among in vitro-expanded TIL from 10 metastatic melanoma lymph nodes (LNs).",18312383_1,-1,1,-1,1,6592,-1,4.090015e-06,0.9999919,4.038958e-06
191,This,0,1,0,4,This study demonstrates that HPV 16 oncogene-specific mCTLp are present in women with HPV 16-positive CIN prior to any intervention.,10962445_6,-1,1,-1,1,191,-1,4.1666276e-06,0.99999166,4.207813e-06
27595,the,17,18,132,135,Improvement resulting from cinnamon pretreatment on the efficient T-cell recovery profile from SLTBI promoted antitumor immunity in the lung melanoma model.,26475064_10,-1,1,-1,1,27595,-1,3.933358e-06,0.99999166,4.4555018e-06
24606,The,0,1,0,3,"The secreted alarmin HMGB1 is a proinflammatory partner, inducer, and chaperone for many proinflammatory molecules that MDSCs develop.",25164013_4,-1,1,-1,1,24606,-1,5.1487755e-06,0.99999094,3.9641295e-06
34458,TLR4,9,10,54,58,"We showed that although the expressions of IFN-R and TLR4 were comparable, productions of pro-inflammatory cytokines were decreased in PIP-/- macrophages.",29536339_4,-1,1,-1,1,34458,-1,9.200369e-06,0.9999702,2.0658214e-05
17997,that,5,6,31,35,"Collectively, the data suggest that (1) biochemical cues associated with epithelial-to-mesenchymal transition can shape anti-tumor immunity through paracrine action and (2) remnants of the immunoselective pressure associated with evolution in cancer include both sculpting of tumor antigens and expression of proteins that proactively shape anti-tumor immunity.",22777646_9,-1,1,-1,1,17997,-1,4.2787433e-06,0.9999919,3.7914688e-06
32760,than,11,12,68,72,Free-IL2 protein is undetectable in vivo as it is eliminated faster than formed.,28678791_5,-1,1,-1,1,32760,-1,7.94497e-06,0.99998665,5.419116e-06
28780,the,13,14,85,88,"Compared to healthy skin, sarcoids showed increased mRNA transcription for FOXP3 and the regulatory cytokine TGF.",27160146_4,-1,1,-1,1,28780,-1,4.359079e-06,0.99999106,4.623298e-06
15338,Th1,11,12,81,84,"We previously showed that exposure to UV radiation after immunization suppresses Th1 and Th2 immune responses, leading to impaired Ab and allo-immune responses, but the impact of UV radiation after immunization on anti-tumor immune responses mediated by tumor-specific CD8(+) T cell responses remains less clear.",21710495_0,-1,1,-1,1,15338,-1,5.344756e-06,0.99998486,9.7808925e-06
2724,the,43,44,244,247,Rejection of metastastic disease and survival of STAT6-deficient mice after removal of primary tumor involve three mechanisms: (1) The generation of M1 type macrophages that produce nitric oxide and are tumoricidal; (2) A decrease to normal in the elevated levels of myeloid suppressor cells that accumulate during primary tumor growth; and (3) CD8+ tumor-specific T lymphocytes.,15877228_3,-1,1,-1,1,2724,-1,3.8228004e-06,0.9999924,3.8303583e-06
19338,the,1,2,3,6,"In the current study, simultaneous CD200 expression and Foxp3(+) regulatory T cell levels were investigated in Iranian patients with AML by flow cytometry.",23179394_2,-1,1,-1,1,19338,-1,4.0851096e-06,0.9999907,5.253275e-06
33617,the,12,13,60,63,We focused on the ability of the Treg and TAM counts around the cancer lesion to predict outcomes after adjuvant intravesical Bacille Calmette-Gurin (BCG) treatment.,29048388_4,-1,1,-1,1,33617,-1,6.8882982e-06,0.9999794,1.3688216e-05
17000,therapies,9,10,57,66,Additional insights into IL-15 biology may lead to novel therapies aimed at bolstering targeted immune responses against cancer and infectious disease.,22447977_7,-1,1,-1,1,17000,-1,4.9118335e-06,0.9999908,4.230758e-06
28257,The,0,1,0,3,The role of the immune response in this phenomenon is yet unclear.,26899388_1,-1,1,-1,1,28257,-1,9.106318e-06,0.9999862,4.7155677e-06
20972,the,8,9,50,53,"Collectively, these data identify a mechanism for the specific regulation of TCR-dependent JNK1 activation and function that is key for CD8(+) T-cell responses.",23963642_7,-1,1,-1,1,20972,-1,4.146524e-06,0.99999225,3.6322033e-06
9540,treatment,1,2,14,23,"Methylglyoxal treatment also increased M-CSF, an upregulator of macrophage production.",19375802_8,-1,1,-1,1,9540,-1,1.937778e-05,0.99997294,7.712699e-06
15164,There,0,1,0,5,"There is considerable knowledge about the contributions of IFN-producing Th1 cells that supports the role of cytotoxic cluster of differentiation (CD8) T cells and natural killer (NK) cells, but much less is known about how IL-4-producing Th2 cells contribute to tumor immunity.",21646476_1,-1,1,-1,1,15164,-1,5.304725e-06,0.9999895,5.1747597e-06
15955,the,1,2,3,6,"In the lymph nodes of the tumor microenvironment and spleen, the proportion of Treg cells was significantly higher in the tumor-bearing mice.",21963624_4,-1,1,-1,1,15955,-1,4.034311e-06,0.9999907,5.281753e-06
21424,the,9,10,52,55,The thymus is a central lymphoid organ critical for the development and maintenance of an effective peripheral T-cell repertoire.,24198066_0,-1,1,-1,1,21424,-1,4.6633195e-06,0.99999094,4.3485156e-06
13235,the,19,20,133,136,"In conclusion, caAkt-transduced T cells showed resistance to several evasion strategies employed by tumors and may therefore enhance the antitumor activity of adoptively transferred T lymphocytes.",20842106_6,-1,1,-1,1,13235,-1,4.4511257e-06,0.99999225,3.29321e-06
7507,The,0,1,0,3,"The non-structural (NS) 3/4A complex participates in this process by cleavage of interferon beta (IFN beta) promoter stimulator-1 (IPS-1; also termed Cardif/MAVS/VISA), which inhibits responses to double stranded (ds) RNA.",18689426_1,-1,1,-1,1,7507,-1,3.420522e-06,0.99999213,4.387976e-06
999,the,1,2,3,6,"In the present study, we found that leukaemic blasts presenting surface CD30L displayed a characteristic cytokine-receptor pattern that makes them ideal targets for those cytokines usually produced by Th2-type cell subsets.",11918534_1,-1,1,-1,1,999,-1,4.517802e-06,0.9999912,4.349438e-06
20425,tumour,16,17,83,89,"Regulatory T (Treg) cells play a pivotal role in maintaining immune tolerance, but tumour growth is associated with local immunosuppression, which can subvert effector immune responses.",23657628_1,-1,1,-1,1,20425,-1,5.5303185e-06,0.99998903,5.3856606e-06
10079,generated,40,41,244,253,"In conclusion, our results suggest that mouse splenic Foxp3(+) gammadelta T cells with suppressive function can be induced by TCR and TGF-beta costimulation, whereas functional human Foxp3(+) gammadelta T cells in peripheral blood could not be generated under the same condition.",19539651_9,-1,1,-1,1,10079,-1,0.0002648023,0.9996991,3.6151563e-05
16553,This,0,1,0,4,This finding could be confirmed in nave murine T(reg) cells after IL-2 administration.,22276195_7,-1,1,-1,1,16553,-1,5.2653195e-06,0.99999106,3.732574e-06
13111,the,26,27,168,171,"BACKGROUND: Anti-CD20 monoclonal antibody treatment has not only increased survival and cure rates in many non-Hodgkin lymphomas, but also has prompted an explosion in the development of novel antibodies and biologically active substances with specific cellular targets in the field of malignancies treatment.",20815894_0,-1,1,-1,1,13111,-1,3.6269712e-06,0.9999927,3.667346e-06
41354,transcriptional,20,21,129,144,"Transcriptome and flow cytometry analyses revealed that EOMES does not only drive IL-10 expression, but rather controls a unique transcriptional signature in CD4+ T cells, that is enriched in genes typical for T regulatory type 1 (TR1) cells.",33526861_2,-1,1,-1,1,41354,-1,5.1183874e-06,0.99999,4.8981888e-06
7432,the,19,20,136,139,"Whereas seven cell lines representing a spectrum of primary cutaneous T cell lymphoproliferative disorders expressed CD25 and TGF-beta, the expression of FOXP3 and, to a lesser degree, IL-10 was restricted to two CTCL cell lines that are dependent on exogenous IL-2.",18684941_1,-1,1,-1,1,7432,-1,4.3725136e-06,0.99999154,4.0662967e-06
26848,the,10,11,72,75,"Anthracyclines are known to induce several stress pathways that enhance the immunogenicity of dying and dead cancer cells, thereby stimulating a dendritic cell-dependent and T lymphocyte-mediated anticancer immune response.",26208907_4,-1,1,-1,1,26848,-1,6.184183e-06,0.99998975,4.105575e-06
4295,the,13,14,70,73,The second goal is to test the effect of adding local chemotherapy in the form of i.t.,16928818_3,-1,1,-1,1,4295,-1,9.358403e-06,0.9999839,6.748484e-06
29583,type,20,21,100,104,It was found that Th9 and Th2 cells were decreased in MPE from IL-17 -/- mice as compared with wild type mice.,27535421_3,-1,1,-1,1,29583,-1,5.442109e-06,0.99998915,5.4463194e-06
26337,AHR,21,22,115,118,"The frequencies of Th22, Th17, and Th1 cells, along with the expression of specific transcription factors RORC and AHR, were significantly decreased in ND patients compared with healthy controls, while all these abnormality recovered in CP patients.",26000313_6,-1,1,-1,1,26337,-1,0.00020532325,0.9990742,0.00072042155
21441,the,2,3,14,17,"Collectively, the understanding of the mechanisms and pathways associated with the tumor-induced thymic involution is essential for the development of innovative and safe therapies to fight against the immune suppression caused by the tumor development.",24198066_4,-1,1,-1,1,21441,-1,3.9954994e-06,0.99999213,3.908695e-06
21617,Therefore,0,1,0,9,"Therefore, the combination therapy strongly inclined the immune balance of the tumor microenvironment in an antitumor direction, leading to a marked systemic antitumor effect.",24289533_7,-1,1,-1,1,21617,-1,4.6653104e-06,0.9999906,4.7530357e-06
11071,to,14,15,109,111,Isolated regulatory T cells were tested for their capacity to recognize pancreatitis-associated antigens and to suppress conventional T cells in an antigen-dependent manner.,19931255_5,-1,1,-1,1,11071,-1,3.6677845e-06,0.99999213,4.2360075e-06
4169,Foxp3,18,19,103,108,"Reconstitution of Pan02-bearing Rag-/- mice with naive syngeneic CD25- CD4+ T cells induced CD25+ CD4+ Foxp3+ T cells in TDLNs, but not in the spleen.",16799337_6,-1,1,-1,1,4169,-1,1.0992593e-05,0.99998033,8.719432e-06
33563,the,2,3,10,13,"Moreover, the percentage of CD3+ Foxp3+ regulatory T cells in the blood and the levels of IL-10 and transforming growth factor  in the serum were lower in the rats treated with fucoidan.",29043842_6,-1,1,-1,1,33563,-1,3.6117162e-06,0.99999213,4.231655e-06
27161,the,16,17,92,95,"The proportion and FoxP3 expression of the induced CD4(+)CD25(+) T cells are the highest at the level of 40ng/ml IFN-, and the suppressive function of the CD4(+)CD25(+) T cells induced by 40ng/ml IFN- is the strongest in MG patients.",26347149_12,-1,1,-1,1,27161,-1,4.8486118e-06,0.9999906,4.5986008e-06
43082,subunit,11,12,52,59,"Enhancer of zeste homolog 2 (EZH2) is the catalytic subunit of polycomb repressive complex 2 (PRC2), which regulates downstream gene expression by trimethylation of lysine 27 in histone H3 (H3K27me3).",34737746_0,-1,1,-1,1,43082,-1,6.8379636e-06,0.99998486,8.27692e-06
20333,twice,52,53,219,224,"Elevated Th1 cytokines were also detected in women with ER(-) and TNBCs, with women in the highest tertile of interferon 2 (OR = 2.39, 95 % CI 1.31-4.35) or tumor necrosis factor- (OR = 2.27, 95 % CI 1.21-4.26) being twice as likely to have TNBC versus LumA cancer.",23624818_6,-1,1,-1,1,20333,-1,0.00060963474,0.9993425,4.7835474e-05
22847,thyroid,7,8,63,70,We characterized the lymphocytic infiltration that accompanies thyroid cancer and compared it with that present in thyroid autoimmunity.,24623740_4,-1,1,-1,1,22847,-1,9.668997e-06,0.9999782,1.215645e-05
38382,Th17,24,25,107,111,"Maintenance of immune tolerance is achieved via modulation of effector CD4+ T helper 1, 2 or 17 (Th1, Th2, Th17) cells by Tregs.",31827925_4,-1,1,-1,1,38382,-1,1.8712073e-05,0.9999651,1.6206603e-05
4589,the,20,21,150,153,"Furthermore, we show that constitutive and IFNgamma-inducible expression of the CIITA-PIII isoform is governed by separate regulatory elements within the PIII upstream regulatory region (PURR).",17067677_4,-1,1,-1,1,4589,-1,3.7229938e-06,0.99999225,4.075198e-06
38493,to,14,15,109,111,BACKGROUND: The efficacy of checkpoint blockade immunotherapies in colorectal cancer is currently restricted to a minority of patients diagnosed with mismatch repair-deficient tumors having high mutation burden.,31888734_0,-1,1,-1,1,38493,-1,6.069311e-06,0.9999883,5.6604417e-06
34008,that,31,32,181,185,"The increase in tumor rejection was associated with an increased number and persistence of CD8 T cells in lymphoid tissues during acute tumor rejection, tumor regrowth, and in mice that remained tumor-free.",29271784_2,-1,1,-1,1,34008,-1,3.884136e-06,0.99999094,5.212201e-06
36444,the,29,30,200,203,"Here, we examined the association of programmed cell death ligand 1 (PD-L1) expression with epithelial-mesenchymal transition (EMT)-associated markers in pancreatic ductal adenocarcinoma (PDA) within the context of the tumor microenvironment.",30927618_1,-1,1,-1,1,36444,-1,4.1584103e-06,0.99999166,4.2398933e-06
37412,Release,0,1,0,7,Release of interleukin 1 (IL-1) from cancer-associated fibroblasts (CAF) induces CCL22 mRNA expression in oral cancer cells by activating transcription factor nuclear factor kappa B (NF-B).,31325403_8,-1,1,-1,1,37412,-1,1.3240642e-05,0.9999783,8.440725e-06
40888,this,15,16,87,91,"How these signals are integrated to determine Th17 plasticity is not well defined, yet this is a crucial point of investigation as it represents a potential target to treat autoimmune and inflammatory diseases.",33064842_6,-1,1,-1,1,40888,-1,5.0470967e-06,0.9999902,4.7687795e-06
33019,that,2,3,10,14,"We report that pharmacologic inhibition of GS skews M2-polarized macrophages toward the M1-like phenotype, characterized by reduced intracellular glutamine and increased succinate with enhanced glucose flux through glycolysis, which could be partly related to HIF1 activation.",28813676_2,-1,1,-1,1,33019,-1,5.2253617e-06,0.9999912,3.6436138e-06
3454,Foxp3,2,3,9,14,"However, Foxp3 mRNA levels were down-regulated in the lymph nodes of AdCD40L-treated mice.",16361570_11,-1,1,-1,1,3454,-1,4.436631e-06,0.9999912,4.3341547e-06
31245,c-Rel,3,4,19,24,"The results showed c-Rel expression increased among cells cultured in the presence of SCF and FLT3 but was reduced when IL-2, IL-7, and IL-15 were used all together.",28090796_5,-1,1,-1,1,31245,-1,3.607592e-05,0.9999095,5.4392134e-05
31609,to,20,21,125,127,"Moreover, grafted D2F2 tumor cells grew faster and intratumoral Foxp3+ cell accumulation was observed in these mice compared to sham-treated controls.",28332605_4,-1,1,-1,1,31609,-1,4.522369e-06,0.99999154,3.98322e-06
11677,tumor,16,17,114,119,Despite the fact that malignant cells do have antigenic properties their immunogenic effects are minor suggesting tumor induced mechanisms to circumvent cancer immunosurveillance.,20205946_1,-1,1,-1,1,11677,-1,5.858218e-06,0.99999,4.1371222e-06
12668,Treg,19,20,104,108,"In the present study, we investigated the distribution of Th17 cells in relation to regulatory T cells (Treg) in the tumor-infiltrating lymphocytes (TILs), regional lymph node lymphocytes, and peripheral blood lymphocytes of gastric cancer patients.",20550524_1,-1,1,-1,1,12668,-1,5.950629e-06,0.99998605,8.00705e-06
35797,This,0,1,0,4,This study highlights that IL-35 produced by BCCs are a potential therapeutic target for breast cancer.,30321288_9,-1,1,-1,1,35797,-1,4.408781e-06,0.9999912,4.3862688e-06
12998,the,12,13,80,83,"Consistent with this, systemic and local CMI were significantly increased after the boost, as shown by increased counts of IFN-gamma-secreting cells in splenocytes, mesenteric lymph nodes (MLN), and vaginal samples.",20706715_4,-1,1,-1,1,12998,-1,6.1876153e-06,0.9999896,4.1566923e-06
5647,Foxp3,10,11,54,59,"However, recent studies suggest that forkhead box P3 (Foxp3) is expressed in CD4(+)CD25(-) T cells in aged mice.",17615291_1,-1,1,-1,1,5647,-1,5.8264363e-06,0.9999889,5.306301e-06
6123,the,6,7,29,32,"In line with these findings, the contribution of JunB-deficient mast cells to angiogenesis, as analyzed in an in vitro tube formation assay on matrigel, is severely impaired due to limiting amounts of synthesized and secreted vascular endothelial growth factor.",17982078_7,-1,1,-1,1,6123,-1,4.7717613e-06,0.99999166,3.576312e-06
6229,T,24,25,169,170,Among the several mechanisms that play role in maintaining peripheral self-tolerance is the existence of a unique CD4+CD25+ population of naturally occurring regulatory T (Treg) cells that actively prevent both the activation and the effector function of autoreactive T cells that have escaped different mechanisms of tolerance.,18092144_0,-1,1,-1,1,6229,-1,3.5316612e-06,0.9999896,6.8229688e-06
16570,to,9,10,57,59,Histone deacetylase (HDAC) inhibitors have been reported to have antitumor activity in different malignancies and immunomodulatory effects.,22303460_1,-1,1,-1,1,16570,-1,5.3911667e-06,0.99999046,4.132908e-06
15957,the,11,12,61,64,"In the lymph nodes of the tumor microenvironment and spleen, the proportion of Treg cells was significantly higher in the tumor-bearing mice.",21963624_4,-1,1,-1,1,15957,-1,3.7330672e-06,0.9999925,3.729779e-06
7908,the,12,13,85,88,"In conclusion, the tumor microenvironment of hepatocellular carcinoma is featured by the presence of multiple immunosuppressive factors.",18941744_8,-1,1,-1,1,7908,-1,4.4738317e-06,0.99999166,3.917635e-06
37496,Tregs,9,10,62,67,"CONCLUSION: The lack of host leukocyte-derived IL-30 inhibits Tregs expansion, promotes intra-tumoral infiltration of CD4+T lymphocytes and cancer cell apoptosis.",31366386_10,-1,1,-1,1,37496,-1,5.35899e-06,0.9999876,6.9877015e-06
8306,that,12,13,83,87,CONCLUSION: Our results showed a predominance of osteoclast activity in granulomas that was correlated with the Th1 response.,19121066_7,-1,1,-1,1,8306,-1,6.282674e-06,0.99998915,4.6159716e-06
41624,the,28,29,153,156,"T follicular helper cells (Tfh) are involved in the formation and maintenance of germinal centres, the differentiation of B cells into plasma cells, and the maintenance of helper T cell type 2 (Th2)-dominant humoral immune responses.",33647861_1,-1,1,-1,1,41624,-1,3.80708e-06,0.99999154,4.601096e-06
6034,that,16,17,103,107,These results imply that T(regs) may suppress the immune control of cervical neoplasia and furthermore that suppression of immunity by T(regs) will be another hurdle to overcome in therapeutic immunization strategies against cervical neoplasia.,17937675_9,-1,1,-1,1,6034,-1,3.9956826e-06,0.99999213,3.8602993e-06
14024,the,11,12,67,70,"In another set of experiments the same protocol was performed with the harvest of spleen, lung and blood at 20 and 30 days after Urethane injection.",21238620_2,-1,1,-1,1,14024,-1,4.2562933e-06,0.99999166,4.078901e-06
18801,to,20,21,146,148,The clinical sunitinib experience underscores that strategies for MDSC and Treg depletions must be mindful of disparities among body compartments to avoid sanctuary effects.,23017141_5,-1,1,-1,1,18801,-1,5.6948475e-06,0.99999046,3.862716e-06
4958,the,8,9,54,57,Fluorescence-activated cell sorter (FACS) analysis of the composition of lung leukocytes further indicates that the removal of tumors also leads to the reduction of MSCs accumulated in the lung.,17244679_4,-1,1,-1,1,4958,-1,4.751959e-06,0.99999106,4.229867e-06
35893,This,0,1,0,4,This combination therapy significantly depleted periphery and intra-tumor FoxP3+ Tregs while increasing intra-tumor CD8+ TILs levels compared to controls or anti-TGF- monotherapy (p<0.05).,30359281_10,-1,1,-1,1,35893,-1,3.911978e-06,0.9999926,3.4849352e-06
38460,TGF-1,26,27,151,157,"METHODS: In total, 127 curative resected specimens from patients with BTCs at Osaka University Hospital between 2000 and 2012 were evaluated for IL-6, TGF-1, Tregs, and Th17 cells by immunohistochemistry.",31853779_3,-1,1,-1,1,38460,-1,1.1827433e-05,0.99996376,2.4400713e-05
15921,tumor,14,15,71,76,Vaccine with a mixture of TAT-CEA fusion protein and poly(I:C) delayed tumor growth in MC-38-cea-2 tumor-bearing mice.,21945963_8,-1,1,-1,1,15921,-1,5.452129e-06,0.99999,4.570537e-06
25801,then,21,22,118,122,"Taken together, this is the first evidence to reveal that both TGF- and EGF can induce HLA-I downregulation which is then proven to be associated with EMT in prostate cancer cells.",25618241_8,-1,1,-1,1,25801,-1,4.9508576e-06,0.9999907,4.38242e-06
11562,the,19,20,96,99,"Our results showed a significant (p<0.05) decrease in the tumor volume and the level of IL-4 in the animals treated with Tehranolide, compared to untreated group.",20138670_5,-1,1,-1,1,11562,-1,4.415434e-06,0.99999034,5.2358173e-06
28497,the,1,2,3,6,"On the other hand, over-expression of FoxO1 did not affect asbestos-induced apoptosis in MT-2Rst cells.",27042963_6,-1,1,-1,1,28497,-1,1.0387339e-05,0.9999821,7.502161e-06
17006,type,19,20,126,130,Interleukin (IL)-22 is a cytokine involved in inflammatory and wound healing processes that is secreted primarily by T helper type 17 (Th17) cells.,22471280_0,-1,1,-1,1,17006,-1,7.609127e-06,0.9999783,1.4065277e-05
16161,that,7,8,35,39,"Based on these results, we propose that loss of PML protein expression in gastric cancer cells contributes to increased IP-10 transcription via enhancement of STAT-1 activity, which, in turn, promotes lymphocyte trafficking within tumor regions.",22022583_9,-1,1,-1,1,16161,-1,4.399863e-06,0.9999919,3.7180641e-06
29019,the,20,21,102,105,"Our model provides a versatile tool to examine the roles of these hits, in collaboration with HBZ, in the development of acute ATL.",27223899_7,-1,1,-1,1,29019,-1,4.46201e-06,0.99999213,3.3939486e-06
20100,tumor-bearing,29,30,180,193,The percentages and cytotoxicity of CD8(+) T cells and NK cells and their infiltration into the tumor tissues were significantly increased by the transgenic expression of IL-33 in tumor-bearing mice.,23499895_2,-1,1,-1,1,20100,-1,4.895343e-06,0.9999896,5.480585e-06
34690,the,12,13,64,67,"A better understanding of the activity of immune cells in mRCC, the immunomodulatory effects of TKIs, and the characteristics defining patients most likely to benefit from various therapies will help optimize immunotherapeutic approaches.",29700053_2,-1,1,-1,1,34690,-1,5.127487e-06,0.99999046,4.379294e-06
38432,together,19,20,138,146,"BACKGROUND/AIM: We previously demonstrated that inflammatory cytokine interleukin-6 (IL-6) was produced during cancer progression, worked together with transforming growth factor-beta 1 (TGF-1), and induced the epithelial-mesenchymal transition (EMT) with chemo-resistance against gemcitabine (GR) at the invasion front of biliary tract cancers (BTCs).",31853779_0,-1,1,-1,1,38432,-1,1.0013068e-05,0.99998295,6.9918483e-06
10807,these,3,4,16,21,"Taken together, these data indicated that anti-TGF-beta enhances efficacy of a prophylactic vaccine in normal individuals despite their not having the elevated TGF-beta levels found in patients with cancer and that the effect is not dependent on TGF-beta solely from CD4(+)CD25(+) T regulatory cells or the NKT cell-IL-13-IL-4R-STAT-6 immunoregulatory pathway.",19830696_7,-1,1,-1,1,10807,-1,4.007275e-06,0.9999919,4.1155026e-06
16249,These,0,1,0,5,These results collectively illuminated unique contribution of oncogenic kinase-linked microRNA to tumorigenesis through modulation of tumor immune-phenotype and microenvironment.,22042699_8,-1,1,-1,1,16249,-1,4.4730036e-06,0.99999154,4.0075024e-06
40062,status,34,35,219,225,"However, stimulated CD25- Tfh cells could not upregulate Foxp3, indicating that the distinction between Foxp3-low CD25-CXCR5+CD4+ T cells and Foxp3-high CD25+CXCR5+CD4+ T cells was not due to differences in stimulation status.",32534760_6,-1,1,-1,1,40062,-1,6.233913e-06,0.9999883,5.4129005e-06
37241,to,15,16,108,110,Conclusion: These findings demonstrate that 3DSNA is a promising neo-adjuvant that enables various vaccines to be therapeutic for many important diseases including cancer.,31244959_7,-1,1,-1,1,37241,-1,5.4472453e-06,0.9999875,7.0650012e-06
37364,the,5,6,35,38,"These effects were associated with the upregulation of genes related to M1 phenotype, as IL-12 and STAT-1, and to the decrease of M2 genes, as IL-10 and STAT-6, in adherent fraction of lung immune infiltrate, as revealed by real-time PCR analysis.",31321243_4,-1,1,-1,1,37364,-1,3.6776212e-06,0.9999926,3.7358277e-06
42468,tumor,12,13,77,82,"Clinically, tumors with high stromal Rab37 and IL-6 expression coincide with tumor infiltrating M2-macrophages and PD1+CD8+ T cells that predicts poor prognosis in lung cancer patients.",34093869_9,-1,1,-1,1,42468,-1,4.61697e-06,0.9999908,4.577948e-06
2214,the,39,40,235,238,P-STAT1 levels in the PBMCs of a patient treated sequentially with 5 MU/m2 and 10 MU/m2 IFN alpha-2b (administered by subcutaneous injection) also increased in response to treatments with IFN alpha-2b but did not increase further with the increased dosage of IFN alpha-2b.,15339971_9,-1,1,-1,1,2214,-1,4.8669426e-06,0.9999914,3.7356735e-06
26176,These,0,1,0,5,"These data support an important intrinsic role for XBP1 in DC for effective cross-priming and orchestration of Batf3(+) DC-pDC interactions, thereby enabling effective vaccine induction of protective antitumor immunity.",25972487_7,-1,1,-1,1,26176,-1,4.625283e-06,0.9999912,4.2238207e-06
29270,TGF-,15,16,93,98,"NTeff cells appeared to have lower expression of Foxp1 and were refractory to apoptosis upon TGF- conditioning, implying better survival potential and resistance to tumor-induced immune suppression.",27306834_3,-1,1,-1,1,29270,-1,3.248085e-05,0.9999523,1.522434e-05
38566,to,3,4,16,18,This study aims to investigate the ability of transcription factors in regulating tumor immune microenvironment in lung adenocarcinoma.,31898342_1,-1,1,-1,1,38566,-1,3.513939e-06,0.9999925,4.001892e-06
16468,tumors,8,9,45,51,"Mice bearing established subcutaneous (s.c.) tumors injected with DC concomitantly expressing ectopic Tbet and IL12 (i.e., DC.Tbet/IL12) displayed superior (i) rates of tumor rejection and extended overall survival, (ii) cross-priming of Tc1 reactive against antigens expressed within the tumor microenvironment, and (iii) infiltration of CD8(+) T cells into treated tumors in association with elevated locoregional production of CXCR3 ligand chemokines.",22215017_2,-1,1,-1,1,16468,-1,3.7553962e-06,0.99999094,5.322956e-06
20045,to,8,9,65,67,These findings provide support for therapeutic DNAM-1 inhibition to promote tolerance in relevant inflammatory-based diseases characterized by T-cell activation.,23430112_7,-1,1,-1,1,20045,-1,4.3022806e-06,0.99999225,3.4623179e-06
7630,FOXP3,14,15,92,97,"Furthermore, we provide evidence that FOXP3 splice forms are functionally different from wt FOXP3 and not involved in the execution of the suppressive function.",18769452_9,-1,1,-1,1,7630,-1,4.4725502e-06,0.99999034,5.142001e-06
33991,Tumor-specific,0,1,0,14,Tumor-specific CD8 T cells often fail to elicit effective antitumor immune responses due to an inability to expand into a substantial effector population and persist long-term in vivo.,29271784_0,-1,1,-1,1,33991,-1,0.00010938214,0.99987483,1.5777132e-05
9786,tolerance,7,8,44,53,"iTreg cells are essential in mucosal immune tolerance and in the control of severe chronic allergic inflammation, and most likely are one of the main barriers to the eradication of tumors.",19464985_1,-1,1,-1,1,9786,-1,7.4411882e-06,0.99998593,6.6016687e-06
19389,their,2,3,12,17,We examined their biological characteristics as well as immunological function and further detected the possible molecular mechanism involved in the leukemia genesis.,23180012_3,-1,1,-1,1,19389,-1,5.977647e-06,0.99998796,6.119257e-06
260,tumor,31,32,160,165,"We have established that in some cases of CLL the malignant cells express both CD40 and CD154, and on the basis of those observations, proposed a model for CLL tumor growth due to CD40-CD154 interactions within and among the malignant cells, and for the occurrence of autoimmune syndromes in some cases of CLL.",11042507_2,-1,1,-1,1,260,-1,3.933343e-06,0.99998975,6.3164534e-06
23891,these,2,3,11,16,"Therefore, these data provide evidence for the use of the EWS/FLI-l peptide epitope in T cell-based immunotherapeutic concepts against Ewing's sarcoma cell in vitro and in vivo.",24861249_4,-1,1,-1,1,23891,-1,4.4185717e-06,0.9999912,4.4040075e-06
14148,The,0,1,0,3,"The crucial role of mature T- and/or B-lymphocytes in the advancing pathology is demonstrated by their elimination, which precludes mast cell infiltration and limits the pathology to an early, benign stage.",21291541_9,-1,1,-1,1,14148,-1,4.480868e-06,0.99999154,3.9670663e-06
17352,the,1,2,3,6,"In the present study, we explored the factors that influence CD4(+) Treg reconstitution in patients receiving adoptive immunotherapy following conditioning regimens designed to enhance T-cell function and evaluated potential associations between CD4(+) Treg levels and clinical responses to therapy.",22555974_1,-1,1,-1,1,17352,-1,4.8196152e-06,0.99999094,4.241221e-06
11256,tumors,13,14,87,93,"We have made a detailed inventory of the immune infiltrate of gastrointestinal stromal tumors (GISTs), which originate from mesenchymal cells in the intestinal tract.",20013807_0,-1,1,-1,1,11256,-1,3.6259175e-06,0.9999882,8.116634e-06
8467,to,19,20,123,125,"However, Treg cocultured with CD4(+) RC suppressed proliferation independently of Fas/FasL. In cocultures, Treg were found to be resistant to apoptosis in the presence of 1000 IU/ml IL-2, but at lower IL-2 concentrations (150 IU/ml) they became susceptible to RC-induced death.",19155494_7,-1,1,-1,1,8467,-1,4.165962e-06,0.9999912,4.657947e-06
1898,time,36,37,239,243,"Immunity to HPV-16 was assessed by lymphoproliferation, IFN-gamma enzyme-linked immunospot (ELISPOT), and ELISA.RESULTS: The patient group significantly responded to TA-CIN and not to the control antigen HPV-6 L2/E7 at all postvaccination time points when compared with baseline responses (P < or = 0.05).",15131030_2,-1,1,-1,1,1898,-1,1.4933853e-05,0.9999709,1.4136015e-05
2109,status,25,26,160,166,"This indicates that the HPV16-specific CD4+ T-cell response in cervical cancer patients is either absent or severely impaired, despite a relatively good immune status of the patients, as indicated by intact responses against recall antigens.",15289354_6,-1,1,-1,1,2109,-1,9.292528e-06,0.999979,1.1698583e-05
20591,the,27,28,191,194,"Finally, the combination of obesity and gastric inflammation synergistically increased serum proinflammatory cytokines, including IL-6.CONCLUSIONS: Here, we have established a model to study the molecular mechanism by which obesity predisposes individuals to gastric cancer.",23729675_7,-1,1,-1,1,20591,-1,4.2079996e-06,0.99999213,3.6076162e-06
42271,tumor,19,20,121,126,"Notably, cyclophosphamide elevated serum Flt3L levels and, in combination with the absence of DNGR-1, synergized against tumor growth.",33980589_13,-1,1,-1,1,42271,-1,4.65932e-06,0.9999913,4.0669634e-06
22300,the,7,8,41,44,"Furthermore, IL-6 has been implicated in the pathogenesis of colorectal cancer (CRC).",24447345_2,-1,1,-1,1,22300,-1,5.1657485e-06,0.99999094,3.918379e-06
11686,technique,20,21,144,153,METHODS: CT26.WT murine colon carcinoma cells were injected intraportally in Balb/c mice after median laparotomy using a standardized injection technique.,20205946_3,-1,1,-1,1,11686,-1,7.5924386e-06,0.99998665,5.7833863e-06
33542,to,6,7,49,51,"Sixty Sprague-Dawley rats were randomly assigned to four equal groups: the control group (control group), the cancer model group (model group), and the F1 and F2 groups, which were fed fucoidan at concentrations of 200 and 400mg/kgbody weight, respectively.",29043842_2,-1,1,-1,1,33542,-1,4.412999e-06,0.99998987,5.732485e-06
31401,TGF-,11,12,69,74,"LAP+CD4+ T cells expressed significantly larger amounts of IL-10 and TGF- but lower levels of IL-2, IL-4, IL-17 and interferon-, compared with LAP-CD4+ T cells.",28210081_9,-1,1,-1,1,31401,-1,1.1721146e-05,0.9999794,8.93049e-06
22725,TGF--mediated,3,4,23,37,These findings confirm TGF--mediated effector Tm cell exhaustion as an important mechanism of immune suppression in B-cell NHL.,24569779_9,-1,1,-1,1,22725,-1,3.2108564e-05,0.9999399,2.7964512e-05
24226,the,7,8,39,42,"Th1 and Tregs cells were determined by the positiveexpression of T-bet and FOXP3 proteins, respectively.",25034363_2,-1,1,-1,1,24226,-1,3.773799e-06,0.9999927,3.548275e-06
6145,to,31,32,214,216,"Whereas the spontaneously growing CTCL-derived cell lines displayed persistent activation of the TORC1 as well as the PI3K/Akt and MEK/ERK pathways, the IL-2-dependent cell lines activated the pathways in response to IL-2 and IL-15 but not IL-21.",18025151_1,-1,1,-1,1,6145,-1,1.830055e-05,0.9999746,7.105797e-06
11317,the,10,11,50,53,"Depletion of CD8+ T cells abrogated the effect of the combined IT, indicating a predominant role of these cells in driving the immune response.",20039320_6,-1,1,-1,1,11317,-1,5.536601e-06,0.99999046,3.955012e-06
10792,tumors,14,15,80,86,"Depletion of CD25(+) T regulatory cells led to the almost complete rejection of tumors without the vaccine, whereas anti-TGF-beta did not change the number of CD25(+) T regulatory cells in unvaccinated and vaccinated mice.",19830696_5,-1,1,-1,1,10792,-1,5.652889e-06,0.9999901,4.194881e-06
32340,to,10,11,73,75,Radiotherapy is under investigation for its ability to enhance responses to immunotherapy.,28598415_0,-1,1,-1,1,32340,-1,2.3532186e-05,0.99996686,9.612804e-06
33366,Treg,8,9,46,50,"Thus, this study aimed to investigate whether Treg and Tr1 cells participate in immunological status against cancer.",28982868_1,-1,1,-1,1,33366,-1,4.3174255e-06,0.99998915,6.5315267e-06
4384,to,7,8,57,59,"Immunofluorescent technique and flow cytometry were used to evaluate the expression of CD40, CD40L, MHC-I, MHC-II, CD80, CD86.",16965650_3,-1,1,-1,1,4384,-1,4.665658e-06,0.99999166,3.7219975e-06
33884,Th9,30,31,193,196,"Our results show that IRF8 complexes boost the Th9 program and repress Il4 expression to modulate Th9 cell differentiation, thereby implicating IRF8 as a potential therapeutic target to affect Th9 responses in cancer therapy.",29233972_6,-1,1,-1,1,33884,-1,3.8064038e-05,0.9998859,7.5976095e-05
32246,to,8,9,67,69,The tumor-infiltrating IL-10+ CD19loCD27hi plasmablasts were found to be gut-homing due to their higher expression of 47 while peripheral blood B cells did not show the same characteristic.,28558303_5,-1,1,-1,1,32246,-1,5.152252e-06,0.99998975,5.158127e-06
24144,that,6,7,24,28,"In this study, we found that blocking the STAT3 pathway in HCC cells dramatically inhibited murine HCC growth in vivo and prolonged survival of tumor-bearing mice.",25015826_2,-1,1,-1,1,24144,-1,4.2819324e-06,0.99999213,3.5673618e-06
31947,the,1,2,9,12,"Although the majority of infiltrating CD4 cells appeared functionally inactive, the proinflammatory changes in the TME later resulted in the loss of accumulating M2 and increased M1 TAMs.",28461570_6,-1,1,-1,1,31947,-1,6.4762808e-06,0.9999844,9.145649e-06
20590,to,25,26,182,184,"Finally, the combination of obesity and gastric inflammation synergistically increased serum proinflammatory cytokines, including IL-6.CONCLUSIONS: Here, we have established a model to study the molecular mechanism by which obesity predisposes individuals to gastric cancer.",23729675_7,-1,1,-1,1,20590,-1,4.299553e-06,0.9999913,4.3626737e-06
21059,T(regs,18,19,110,116,"Mechanistic studies in mice revealed that up-regulated expression of IDO and PD-L1, as well as recruitment of T(regs), in the tumor microenvironment depended on the presence of CD8(+) T cells.",23986400_3,-1,1,-1,1,21059,-1,5.3177973e-06,0.9999865,8.181987e-06
35283,these,10,11,81,86,Tumor development and the intratumoral inflammatory milieu were characterized in these mice.,29991500_4,-1,1,-1,1,35283,-1,4.37463e-06,0.99999106,4.61271e-06
18412,to,5,6,42,44,"Colonic IL-17 transcription increased 40- to 70-fold in all stages of colitis, whereas IFN- mRNA was gradually up-regulated 12- to 55-fold with colitis progression, and further to 62-fold in mice with dysplasia/cancer.",22962436_6,-1,1,-1,1,18412,-1,1.3208585e-05,0.99996793,1.8884119e-05
13660,the,2,3,9,12,"However, the exact mechanism of immune mediation by anti-CTLA4 remains to be elucidated.",21056008_1,-1,1,-1,1,13660,-1,5.481376e-06,0.99998987,4.618119e-06
38425,Therefore,0,1,0,9,"Therefore, IL6/STAT3 signaling is crucial for orchestrating premetastatic niche formation and immunosuppression in lung.",31848193_10,-1,1,-1,1,38425,-1,6.851154e-06,0.9999875,5.6904114e-06
31429,FOXP3,26,27,122,127,"Here, we show that in the context of a number of cancers, nave CD45RA+ CD4 T cells are induced to express high levels of FOXP3, and that FOXP3 expression correlates with inhibition of T cell proliferation.",28239749_4,-1,1,-1,1,31429,-1,4.4856133e-06,0.9999914,4.072257e-06
42652,TH1,8,9,51,54,CONCLUSION: DFP increases the expression levels of TH1 specific network genes which in turn help in evoking tumor protective immunity.,34190692_10,-1,1,-1,1,42652,-1,3.985708e-06,0.9999838,1.2205913e-05
25766,that,7,8,45,49,"Taken together, our studies provide evidence that 14-3-3 may regulate tumor inflammation and immune response through Stat3 signaling in OSCC.",25556369_8,-1,1,-1,1,25766,-1,3.9224597e-06,0.99999225,3.7872094e-06
26914,Th2,12,13,83,86,"Thus, our findings showed that CCL5/CCR3 signaling promotes metastasis by inducing Th2 polarization of CD4 T cells, with implications for prognosis and immunotherapy of luminal breast cancer.",26249173_5,-1,1,-1,1,26914,-1,4.3859534e-05,0.99994254,1.3589083e-05
28097,TGF-,23,24,137,142,The effect of DC vaccine on the accumulation of Foxp3+CD4+ regulatory T cells within the tumor microenvironment and on the production of TGF- suggests that tumor regression by DC vaccination may be associated with an altered immunosuppressive tumor microenvironment.,26786094_8,-1,1,-1,1,28097,-1,1.3947283e-05,0.9999795,6.577162e-06
29919,tongue,8,9,51,57,COX-2 inhibitor did not prevent the progression of tongue SCC and did not reduce the total amount of Tregs.,27614428_7,-1,1,-1,1,29919,-1,8.759676e-06,0.99998355,7.7420955e-06
31244,The,0,1,0,3,"The results showed c-Rel expression increased among cells cultured in the presence of SCF and FLT3 but was reduced when IL-2, IL-7, and IL-15 were used all together.",28090796_5,-1,1,-1,1,31244,-1,3.8854873e-06,0.99999166,4.501805e-06
38052,the,6,7,31,34,"In this study, we investigated the cytotoxic aspect of Treg cells in CRC patients.",31669380_2,-1,1,-1,1,38052,-1,3.8543126e-06,0.9999926,3.515079e-06
33731,the,24,25,131,134,"In addition, STAT3-blocked whole HCC cell lysates stimulated the activation of T cells and natural killer (NK) cells, and enhanced the infiltration of cytotoxic CD8+ T cells in the tumor tissues.",29115974_3,-1,1,-1,1,33731,-1,4.011296e-06,0.9999925,3.5314151e-06
20647,to,12,13,68,70,"While the mechanism is not well understood, BM-MSCs have been shown to contribute to the immunosuppressive response found in a number of diseases.",23777268_1,-1,1,-1,1,20647,-1,4.5520624e-06,0.99999094,4.4727794e-06
33024,HIF1,8,9,43,48,"As a result of these metabolic changes and HIF1 accumulation, GS-inhibited macrophages display an increased capacity to induce Tcell recruitment, reduced Tcell suppressive potential, and an impaired ability to foster endothelial cell branching or cancer cell motility.",28813676_3,-1,1,-1,1,33024,-1,1.6672646e-05,0.9999707,1.2706956e-05
9446,triggering,11,12,80,90,Our results offer a possibility to elicit specific anti-tumor responses without triggering unwanted tissue autoimmune diseases.,19338001_3,-1,1,-1,1,9446,-1,3.038191e-05,0.9999548,1.47570145e-05
22586,the,11,12,57,60,"METHODS: We used overlapping 30-35 mer peptides covering the entire HPV16 E2, E6 and E7 protein sequences.",24524328_4,-1,1,-1,1,22586,-1,1.1652586e-05,0.999982,6.3042653e-06
20439,tumour,19,20,105,111,This study addresses the hypothesis that blocking RA receptor alpha (RAR) may enhance the efficacy of a tumour vaccine by inhibiting the induction of Treg cells.,23657628_4,-1,1,-1,1,20439,-1,1.4709622e-05,0.99997675,8.592328e-06
32412,these,2,3,14,19,"Incidentally, these 2 hurdles usually coexist inside tumors, therefore making therapy significantly more complicated, as both oncogenic mechanisms must be addressed for successful therapeutic intervention.",28612394_1,-1,1,-1,1,32412,-1,6.2191207e-06,0.99998915,4.5891748e-06
14519,Treg,7,8,33,37,BACKGROUND & AIMS: Regulatory T (Treg) cells (CD4+ CD25high FoxP3+) regulate mucosal tolerance; their adoptive transfer prevents or reduces symptoms of colitis in mouse models of inflammatory bowel disease.,21376048_0,-1,1,-1,1,14519,-1,3.979724e-06,0.99999,5.992608e-06
15659,to,25,26,145,147,"Thus, the possibility of NLGP being an excellent tool as a T-cell anergy breaker by abrogating the suppressor functions of Tregs in cancer needs to be explored further in the clinic.",21843083_10,-1,1,-1,1,15659,-1,5.1394827e-06,0.9999906,4.2267275e-06
42931,the,32,33,209,212,"BACKGROUND: Oestrogen receptor-positive (ER+) breast cancer is commonly treated using endocrine therapies such as aromatase inhibitors which block synthesis of oestradiol, but the influence of this therapy on the immune composition of breast tumours has not been fully explored.",34602068_0,-1,1,-1,1,42931,-1,4.704661e-06,0.9999919,3.3914791e-06
25678,the,5,6,18,21,"At the same time, the irradiation markedly increased IL-6 production of the k1106 cells.",25544504_6,-1,1,-1,1,25678,-1,6.1844357e-06,0.9999887,5.130393e-06
33079,the,14,15,120,123,This study therefore identifies a novel immunosuppressive pathway involving CD45RA-CCR7- Treg subset development within the GC microenvironment.,28817117_7,-1,1,-1,1,33079,-1,3.7375512e-06,0.99999225,4.0585905e-06
5760,nature,2,3,11,17,The skewed nature of the T cell infiltrate and the lack of an effective host antitumor immune response suggest that RS cells use potent mechanisms to evade immune attack.,17670934_1,-1,1,-1,1,5760,-1,6.1732617e-06,0.9999846,9.178697e-06
28993,type,10,11,44,48,"Here, we present a new mouse model of acute type ATL that can be generated rapidly by transplanting invitro-induced T cells that have been retrovirally transduced with HBZ and two cooperative genes, BCLxL and AKT, into mice.",27223899_3,-1,1,-1,1,28993,-1,4.632263e-06,0.9999865,8.895161e-06
27996,T,17,18,98,99,There was a relationship between HLA-DR expression levels in tumor tissues and the size of CD4(+) T and CD8(+) T cell compartments.,26759006_8,-1,1,-1,1,27996,-1,2.0566411e-05,0.99986994,0.00010941958
7550,the,3,4,14,17,The status of the immune system of patients with B-cell chronic lymphocytic leukemia (B-CLL) is not yet sufficiently characterized.,18695923_0,-1,1,-1,1,7550,-1,4.9209098e-06,0.9999906,4.4872268e-06
28576,FOXP3(lo,7,8,43,51,"Indeed, CRCs with abundant infiltration of FOXP3(lo) T cells showed significantly better prognosis than those with predominantly FOXP3(hi) Treg cell infiltration.",27111280_5,-1,1,-1,1,28576,-1,1.6322047e-05,0.9999745,9.2390255e-06
20343,to,11,12,68,70,"The strongest associations were in premenopausal women, who were up to 80 % less likely to have TNBC than LumA cancers (IL-12p40/IL-5, OR = 0.19, 95 % CI 0.07-0.56).",23624818_8,-1,1,-1,1,20343,-1,6.719496e-06,0.999985,8.320926e-06
12752,the,7,8,62,65,The results demonstrate that endogenous IFN-gamma counteracts the induction of type 2 cytokines and the downregulation of both CD8 coreceptor levels and the anti-tumor response in CD8 T cells exposed to IL-4 during activation in vivo.,20562261_7,-1,1,-1,1,12752,-1,4.936741e-06,0.99999154,3.527359e-06
22061,FOXP3,11,12,72,77,The SP immunohistochemical method was used to detect the expressions of FOXP3 in cervical lesions.,24401583_4,-1,1,-1,1,22061,-1,6.200156e-06,0.9999887,5.1620727e-06
36874,the,32,33,175,178,This study aimed to investigate the role of Helios+ Tregs in myasthenia gravis (MG) and glucocorticoid-induced tumor necrosis factor receptor (GITR) and its ligand (GITRL) in the modulation of Helios.,31118027_2,-1,1,-1,1,36874,-1,4.0454966e-06,0.9999919,4.024847e-06
26332,Th22,3,4,19,23,"The frequencies of Th22, Th17, and Th1 cells, along with the expression of specific transcription factors RORC and AHR, were significantly decreased in ND patients compared with healthy controls, while all these abnormality recovered in CP patients.",26000313_6,-1,1,-1,1,26332,-1,0.0020245784,0.9976241,0.0003513608
34237,the,10,11,64,67,We investigated and analyzed the relevance of the proteins with the clinicopathological characteristics and the interactions among them in gastric cancer.,29391307_1,-1,1,-1,1,34237,-1,4.3585596e-06,0.9999901,5.4986913e-06
31345,the,5,6,26,29,These CTLs carry not only the activation of mechanistic target of rapamycin (mTOR) and AMP-activated protein kinase (AMPK) but also an increment of their downstream transcription factors such as PPAR-gamma coactivator 1 (PGC-1) and T-bet.,28096382_3,-1,1,-1,1,31345,-1,3.820113e-06,0.999992,4.160371e-06
11084,to,7,8,50,52,T cells from pancreatic cancer patients responded to pancreatic cancer-associated but not pancreatitis-associated antigens with IFN-gamma secretion.,19931255_8,-1,1,-1,1,11084,-1,6.151025e-06,0.99998856,5.3324043e-06
7913,sclerosis,27,28,164,173,"For decades cytokines such as type I interferons and IL-2 have been used in immunotherapy against cancer, viral hepatitis, and autoimmune diseases such as multiple sclerosis.",18947877_0,-1,1,-1,1,7913,-1,0.00025240908,0.99965346,9.4183284e-05
38849,to,29,30,204,206,"Human T cells treated with 2DG upregulated the NK-specific transcription factors TOX2 and EOMES, thereby acquiring NK cell properties, including high levels of perforin/granzyme and increased sensitivity to IL-2.",31969386_3,-1,1,-1,1,38849,-1,9.866153e-06,0.99998283,7.2772177e-06
42103,the,23,24,143,146,"We show that TNAX101A efficiently interfered the binding of DNAM-1 to its ligand CD155 and showed unique functions; it decreased production of the inflammatory cytokines such as interferon-gamma, tumor necrosis factor alpha, interleukin (IL)-6, IL-17A, and IL-17F by anti-CD3 antibody-stimulated or alloantigen-stimulated T cells and increased FOXP3 expression in anti-CD3-stimulated regulatory T (Treg) cells.",33900821_3,-1,1,-1,1,42103,-1,6.858382e-06,0.9999881,5.02564e-06
35809,to,28,29,142,144,"Interleukin-33 (IL-33) is defined as an 'alarmin', an endogenous factor that is expressed during tissue and cell damage, which has been shown to promote Treg proliferation in non-lymphoid organs.",30357458_1,-1,1,-1,1,35809,-1,4.738675e-06,0.9999918,3.5122882e-06
3427,tumor-bearing,13,14,80,93,EXPERIMENTAL DESIGN: The gene for murine CD40L was transferred into bladders of tumor-bearing mice using an adenoviral vector construct.,16361570_2,-1,1,-1,1,3427,-1,5.301541e-06,0.9999889,5.843091e-06
42620,to,20,21,125,127,Both non-stimulated and stimulated cells were then subjected to MTT and NO release assay; following which qPCR was performed to estimate mRNA levels and percentage enrichment of certain genes.,34190692_6,-1,1,-1,1,42620,-1,4.566772e-06,0.9999918,3.6599981e-06
33021,through,27,28,207,214,"We report that pharmacologic inhibition of GS skews M2-polarized macrophages toward the M1-like phenotype, characterized by reduced intracellular glutamine and increased succinate with enhanced glucose flux through glycolysis, which could be partly related to HIF1 activation.",28813676_2,-1,1,-1,1,33021,-1,2.739685e-05,0.99995947,1.30833805e-05
12640,the,14,15,94,97,"Characteristically, this response was accompanied by a distinct peak in cytokine levels after the first vaccination.",20547850_4,-1,1,-1,1,12640,-1,6.112612e-06,0.9999896,4.3059636e-06
3061,this,1,2,3,7,"In this study, we investigated the mechanism by which murine dendritic cells mediate the apoptotic death of murine lymphoma cell lines, and whether dendritic cell effector function could be enhanced by preconditioning tumor cells with the protein phosphatase inhibitor nitric oxide (NO) by altering the balance of proapoptotic/antiapoptotic proteins in the treated cells.",16166326_2,-1,1,-1,1,3061,-1,3.9743e-06,0.9999918,4.294367e-06
35013,the,7,8,54,57,Our data identify the helicase/NFB/TNF/COX2 axis as the key suppressive pathway of dsRNA signaling in human TME and suggest that selective targeting of TLR3 or elimination of NFB/TNF/COX2-driven suppression may allow for selective enhancement of type-1 immunity.,29853604_5,-1,1,-1,1,35013,-1,4.5111283e-06,0.9999919,3.570305e-06
43188,the,1,2,5,8,"With the ""newly"" discovered immunogenic responses from RT, numerous endeavors have been undertaken to combine RT with IOs, in order to bolster anti-tumor immunity.",34830176_2,-1,1,-1,1,43188,-1,4.2943007e-06,0.99999154,4.2241e-06
38577,Gene,22,23,156,160,"Runt-related transcription factor 3 (RUNX3)-associated immune pathways were investigated by the Kyoto Encyclopedia of Genes and Genomes, Gene Ontology, and Gene set enrichment analysis.",31898342_4,-1,1,-1,1,38577,-1,1.5994092e-05,0.99996173,2.2304459e-05
43550,the,10,11,66,69,The ability of polyclonal antisera against TNF receptors to mimic the above TNF-mediated activities was determined.,8258153_3,-1,1,-1,1,43550,-1,7.727361e-06,0.99998784,4.4488233e-06
14216,the,5,6,42,45,Treatment with hypoxia markedly increased the expression of IL-6 in peripheral CD68+ cells.,21314287_10,-1,1,-1,1,14216,-1,5.742515e-06,0.9999907,3.614885e-06
24256,Th17,4,5,27,31,The percentage of positive Th17 and Tr1 cells is a marker for poor prognosis in patients with CRC.,25034363_9,-1,1,-1,1,24256,-1,1.3811016e-05,0.999967,1.9155961e-05
14702,STAT3,32,33,208,213,The inhibitory effect of IL-32 on tumor growth was associated with the inhibition of constitutive activated nuclear transcription factor-B (NF-B) and of signal transducer and activator of transcription 3 (STAT3).,21423208_3,-1,1,-1,1,14702,-1,6.510897e-06,0.9999871,6.3246766e-06
4082,that,9,10,63,67,Depletion of Tregs resulted in a persistent antitumor response that was maintained over a month after the last treatment.,16785502_6,-1,1,-1,1,4082,-1,6.8879403e-06,0.99998844,4.6668e-06
14110,the,28,29,192,195,"Epstein-Barr virus (EBV) associated cancers, including nasopharyngeal carcinoma and Hodgkin's Disease, show a considerable leukocyte infiltration which surrounds the neoplastic cells, raising the questions as to what role these cells play in either restricting or supporting the tumour and what draws the cells into the tumour.",21291541_2,-1,1,-1,1,14110,-1,5.79805e-06,0.9999888,5.3937597e-06
27120,Tregs,13,14,72,77,METHODS: Flow cytometry was used to analyze the number of CD4(+)CD25(+) Tregs in MG patients and healthy controls (HCs).,26347149_3,-1,1,-1,1,27120,-1,5.847551e-06,0.9999871,7.0083743e-06
665,to,4,5,34,36,"The increased functional capacity to secrete Th2 cytokines, along with the increased expression of surface markers for Ag-experienced Th2-committed cells, would argue for a role of GATA-3 in Th2 memory formation.",11441076_10,-1,1,-1,1,665,-1,5.1039524e-06,0.99998856,6.39381e-06
39552,the,5,6,26,29,The serum CCL11 level and the proportion of CD4+CD25+Foxp3+ Treg cells were significantly increased in patients with BC compared with healthy individuals.,32323817_5,-1,1,-1,1,39552,-1,3.7984184e-06,0.99999213,4.0796454e-06
9403,the,19,20,142,145,This failure of the immune system has been associated both with glioma-derived immunosuppressive molecules and the immune-privileged state of the CNS.,19337997_1,-1,1,-1,1,9403,-1,4.177815e-06,0.9999914,4.3997643e-06
28543,the,7,8,37,40,GARP has also been proved to promote the activation and secretion of transforming growth factor  (TGF-).,27095576_5,-1,1,-1,1,28543,-1,3.998627e-06,0.9999926,3.3901554e-06
42992,timing,9,10,61,67,These findings may have implications for the combination and timing of anti-oestrogen therapies with other therapies.,34602068_12,-1,1,-1,1,42992,-1,1.4547729e-05,0.9999783,7.153719e-06
42535,there,2,3,10,15,"Moreover, there was no significant relationship between the frequency of CD33+ pSTAT3+ MDSC, and IL-17+ lymphocyte with Gleason scores in the PCa group.",34184811_4,-1,1,-1,1,42535,-1,4.811135e-06,0.99999034,4.794271e-06
19406,than,22,23,172,176,"CML patient-derived MSCs have dampening immunomodulatory functions, suggesting that the dysregulation of hematopoiesis and immune response might originate from MSCs rather than HSCs.",23180012_6,-1,1,-1,1,19406,-1,5.8034716e-06,0.99998784,6.3554685e-06
16039,to,6,7,35,37,"Additionally, T-bet has been shown to regulate histone acetylation of the ifng promoter and enhancer to loosen condensed DNA, creating greater accessibility for other transcription factor binding, which further amplifies IFN production.",21983879_3,-1,1,-1,1,16039,-1,4.7304015e-06,0.9999913,4.0270943e-06
7877,tumor,31,32,158,163,"In contrast to the increasing number of CD4(+) T cells, CD8(+), CD3(-)CD56(+), CD3(+)CD56(+), and gammadeltaT cells were all found to be under-represented in tumor infiltrating lymphocytes.",18941744_2,-1,1,-1,1,7877,-1,4.2594606e-06,0.99999166,4.0583327e-06
284,Stat5b,9,10,66,72,"Janus tyrosine kinase (Jak)3 and transcription factors Stat5a and Stat5b are essential for the proliferation of normal T cells and are constitutively hyperactivated in both HTLV-1-transformed human T cell lines and lymphocytes isolated from HTLV-1-infected patients; therefore, a critical role for the Jak3-Stat5 pathway in the progression of this disease has been postulated.",11046040_1,-1,1,-1,1,284,-1,1.4030672e-05,0.9999753,1.0692842e-05
43903,the,5,6,24,27,"T lymphocytes from 6 of the 14 patients also exhibited an increased expression of the dual specificity phosphatase, map kinase phosphatase-1 (MKP-1).",9724088_4,-1,1,-1,1,43903,-1,1.31185525e-05,0.99997485,1.203025e-05
28405,Foxp3,0,1,0,5,"Foxp3 is highly expressed in CD4(+) T cells, and this may be caused by gene promoter demethylation.",27000869_9,-1,1,-1,1,28405,-1,4.9267064e-06,0.99999106,4.0054983e-06
41947,to,3,4,33,35,Immunofluorescence was conducted to detect the double-strand DNA breaks.,33774805_4,-1,1,-1,1,41947,-1,5.198056e-06,0.9999914,3.4145453e-06
10422,that,11,12,74,78,This strategy may provide a basic platform for DC-based anti-CEA vaccines that could be utilized in combination with advanced immune-enhancing therapeutics.,19659778_9,-1,1,-1,1,10422,-1,5.0548447e-06,0.9999907,4.18402e-06
6064,the,8,9,39,42,"Moreover, the dual APL did not inhibit the secretion of IFN-gamma by LN cells from CD8(-/-) mice immunized with Torpedo acetylcholine receptor.",17956982_5,-1,1,-1,1,6064,-1,4.489103e-06,0.9999918,3.7326051e-06
42413,Th,21,22,108,110,"Here, we identify that Epidermal Growth Factor Receptor (EGFR) is essential for IL-9 induction in helper T (Th) cells.",34075041_2,-1,1,-1,1,42413,-1,5.8776964e-06,0.999984,1.0081715e-05
12103,therefore,1,2,3,12,We therefore determined whether the cytokine secretion profile in response to lipopolysaccharide (LPS) was modified.,20386470_5,-1,1,-1,1,12103,-1,6.6289645e-06,0.99998736,5.993049e-06
39236,genetically,8,9,41,52,Mice in which NK cells had been depleted genetically or with neutralizing antibodies allowed lymphoma growth while the absence of CD8 T cells was without consequence.,32143838_3,-1,1,-1,1,39236,-1,4.8598768e-06,0.9999901,5.001652e-06
3624,The,0,1,0,3,The results demonstrate that induced macrophages displayed a reduction of cytotoxicity and antigen-presenting function in comparison with control but transfection with Stat3 decoy ODNs enhanced cytotoxicity and antigen-presenting function of the macrophages.,16530087_4,-1,1,-1,1,3624,-1,3.6011486e-06,0.9999925,3.871789e-06
13292,targeted,22,23,120,128,CD8(+) Foxp3(+) T cells are induced in TIL in regressing tumors of FVB/N mice treated with a GM-CSF secreting HER-2/neu targeted whole cell vaccine.,20857491_3,-1,1,-1,1,13292,-1,5.6814993e-06,0.99998987,4.47969e-06
17576,trial,13,14,62,67,"In this article, we present our results on a phase I clinical trial of a Mam-A cDNA vaccination in breast cancer patients with stage-IV metastatic disease, including the impact of vaccination on the expression of the inducible co-stimulator molecule (ICOS) on CD4 T cells.",22678162_2,-1,1,-1,1,17576,-1,5.4587126e-06,0.9999895,5.0763165e-06
27314,the,2,3,13,16,"Nonetheless, the growth of MC38 adenocarcinoma cells in vivo was only suppressed for initial 15 d by pGITRL, whereas it was suppressed indefinitely by anti-GITR mAb.",26423152_6,-1,1,-1,1,27314,-1,5.019372e-06,0.9999913,3.653998e-06
13184,the,5,6,26,29,"Meanwhile, an increase in the frequency of MDSC in tumor development was detected in spleen, PB, LN and tumor, and the IL-10 levels were higher in HCC mice derived MDSC than in control.",20822377_8,-1,1,-1,1,13184,-1,4.020649e-06,0.9999918,4.2577267e-06
22243,that,6,7,30,34,"Taken together, our data show that anti-TGF antibody and cyclophosphamide represents an effective chemoimmunotherapeutic combination.",24416401_10,-1,1,-1,1,22243,-1,4.2749334e-06,0.9999918,3.898378e-06
20221,Tregs,16,17,97,102,"The purpose of this study was to investigate the involvement of immunosuppressive cells, such as Tregs and CD163+ macrophages, as well as immunomodulatory cells (i.e. IL-27-producing cells) in keratoacanthoma (KA) and invasive squamous cell carcinoma (SCC).",23572151_3,-1,1,-1,1,20221,-1,4.5203938e-06,0.99998856,6.9032963e-06
11608,tumor,45,46,271,276,"To evaluate the potential role of tumor-derived, antiestrogen-induced TGFbeta as an immune suppressor, we established in vitro mixed lymphocyte tumor reactions (MLTR) using MCF-7 cells and peripheral blood mononuclear cells (PBMC), as well as tumor tissue and autologous tumor infiltrating lymphocytes (TIL) obtained from primary breast cancer biopsies.",20145137_2,-1,1,-1,1,11608,-1,4.761228e-06,0.99999046,4.796695e-06
42405,that,17,18,126,130,"Although transcription factors that are essential for Th9 cell differentiation have been identified, other signaling pathways that are required for their generation and functions are yet to be explored.",34075041_1,-1,1,-1,1,42405,-1,8.666075e-06,0.9999857,5.5867554e-06
37196,the,18,19,106,109,"In addition, the ability of DCs and macrophages to induce colorectal cancer cell invasion was hampered in the presence of IFN--NPs.",31233057_9,-1,1,-1,1,37196,-1,7.933831e-06,0.9999882,3.8766793e-06
17603,The,0,1,0,3,The ratio of CD4+ICOS(hi) T cells to CD4+FoxP3+ T cells increased from 0.370.12 before vaccination to 2.30.72 (p=0.021) following vaccination.,22678162_7,-1,1,-1,1,17603,-1,4.2975466e-06,0.9999919,3.7982002e-06
10081,made,2,3,17,21,"Despite progress made over the past 25 years, existing immunotherapies have limited clinical effectiveness in patients with cancer.",19561540_0,-1,1,-1,1,10081,-1,1.5900447e-05,0.9999765,7.5299376e-06
18362,T,10,11,67,68,BACKGROUND: Several studies have documented modulation of Th17 and T regulatory (Treg) cells in various human malignancies which may vary with the type and extent of the disease.,22956260_0,-1,1,-1,1,18362,-1,4.0270497e-06,0.99998975,6.1726455e-06
9657,them,2,3,8,12,Most of them had high FOXP3 expression in the resting state and an unmethylated FOXP3 intron 1.,19435913_5,-1,1,-1,1,9657,-1,5.756862e-06,0.99998736,6.90747e-06
41788,tumors,39,40,228,234,"Knockdown of LINC00152 suppressed tumor cells growth in vivo and in vitro, increased tumor-infiltrating CD8+ T cells numbers and promoted the expression of CXCL9, CXCL10 and C-X-C Motif Chemokine Receptor 3 (CXCR3) in xenograft tumors.",33709190_7,-1,1,-1,1,41788,-1,4.0547725e-06,0.9999914,4.5620777e-06
5779,treatment,4,5,18,27,"In contrast, Gal1 treatment of activated T cells favored the secretion of Th2 cytokines and the expansion of CD4+CD25high FOXP3+ Treg cells.",17670934_4,-1,1,-1,1,5779,-1,4.627716e-06,0.9999906,4.8154234e-06
14490,Tregs,29,30,182,187,"Previously, we demonstrated that ANGPT2 augments the expression of various proangiogenic genes, the potent immunosuppressive cytokine, IL-10, and a chemokine for regulatory T cells (Tregs), CCL17 by TEMs in vitro.",21368233_3,-1,1,-1,1,14490,-1,4.0108075e-06,0.99998987,6.127532e-06
42266,their,10,11,62,67,"Indeed, the increased infiltration of cDC1s within tumors and their protective effect rely on CCL5/CCR5 chemoattraction.",33980589_11,-1,1,-1,1,42266,-1,5.796235e-06,0.9999895,4.7499216e-06
32444,these,2,3,10,15,"Together, these data suggest that CD70 expression is involved in promoting tumor aggressiveness and immunosuppression via tumor-associated macrophage recruitment/activation.",28612394_10,-1,1,-1,1,32444,-1,5.0343724e-06,0.99999034,4.5628994e-06
23340,transiently,9,10,52,63,We show that in vivo RANKL blockade selectively and transiently depletes Aire and TSA expression in the thymus to create a window of defective negative selection.,24752296_6,-1,1,-1,1,23340,-1,4.473921e-06,0.99999154,3.9560423e-06
42546,play,28,29,150,154,We suggested that the higher frequency of CD33+ pSTAT3+ MDSC and IL-17+ lymphocyte and the more frequent expression of IL-10 mRNA in PCa patients may play roles in tumor progression from BPH to PCa.,34184811_5,-1,1,-1,1,42546,-1,8.651773e-06,0.99998474,6.592765e-06
38141,the,37,38,227,230,"Using diagnostic samples from patients enrolled in the frontline Children's Oncology Group (COG) T-ALL clinical trial AALL1231, we demonstrated that one-third of primary T-ALLs were resistant to GCs when cells were cultured in the presence of IL-7, a cytokine that is critical for normal T cell function and that plays a well-established role in leukemogenesis.",31687977_1,-1,1,-1,1,38141,-1,7.4034015e-06,0.9999876,5.016817e-06
10064,Foxp3,18,19,117,122,"In contrast, although a small fraction of human peripheral blood and tumor infiltrating gammadelta T cells expressed Foxp3, similar culture condition with anti-TCRgammadelta plus TGF-beta failed to generate functional human Foxp3(+) gammadelta T cells.",19539651_8,-1,1,-1,1,10064,-1,4.978526e-06,0.99999046,4.534651e-06
37176,tested,29,30,171,177,"In this study, Ch/IFN-/-PGA nanoparticles (IFN--NPs) prepared by a co-acervation method, presenting a size of approximately 180 nm and a low polydispersity index, were tested for their immunomodulatory activity.",31233057_5,-1,1,-1,1,37176,-1,1.348078e-05,0.99997914,7.3955134e-06
21429,the,19,20,129,132,"Most important, it provides a specialized environment for the selection of rearranged clones that will function appropriately in the adaptive immune response.",24198066_1,-1,1,-1,1,21429,-1,7.773784e-06,0.9999875,4.742145e-06
37198,the,1,2,9,12,"Although the major observations were mediated by Ch/-PGA NPs, the incorporation of IFN- into NPs potentiated the expression of CD40 and CD86, and the impairment of colorectal cancer cell invasion.",31233057_10,-1,1,-1,1,37198,-1,5.122474e-06,0.9999907,4.1643434e-06
15453,through,7,8,40,47,"The steps in this process are regulated through a complex transcriptional network, specific receptor-ligand pair interactions, and sensitization to trophic factors, which mediate the homing, proliferation, survival, and differentiation of developing T cells.",21740230_4,-1,1,-1,1,15453,-1,4.310978e-06,0.99999106,4.644936e-06
41554,the,18,19,100,103,The results of coculture of thymoma cells and CD4 + T cells showed that thymoma cells could promote the differentiation of Th17 cells and inhibit the Tregs.,33636431_7,-1,1,-1,1,41554,-1,4.286077e-06,0.99999166,4.022482e-06
38937,two,11,12,62,65,"BACKGROUND: Urothelial bladder cancers (UBCs) are distinct in two main molecular subtypes, namely basal and luminal type.",31991796_0,-1,1,-1,1,38937,-1,1.1238695e-05,0.99997985,8.870688e-06
5379,nature,2,3,12,18,The precise nature and molecular basis of immune dysfunction in the cancer state are not well defined.,17488182_1,-1,1,-1,1,5379,-1,9.991342e-06,0.99997663,1.3354514e-05
10834,tumors,9,10,56,62,Significantly higher numbers of Treg were found in skin tumors and metastatic lymph nodes at early stages of melanoma progression compared with more advanced stages accompanied by the elevated CCR4 expression on Treg and higher production of its ligand CCL2 in tumor lesions.,19841169_3,-1,1,-1,1,10834,-1,3.7990792e-06,0.9999896,6.5642325e-06
1913,TA-CIN-specific,12,13,69,84,"Of the 6 clinical responders, 2 patients showed both a proliferative TA-CIN-specific response and an E6-specific IFN-gamma response, whereas 3 other patients displayed E6-specific reactivity only.",15131030_7,-1,1,-1,1,1913,-1,9.302397e-05,0.9998336,7.333665e-05
25977,The,0,1,0,3,"The frequency, immunosuppressive phenotype, and activation status of Treg and natural killer (NK) cells were analyzed in the circulation and tumor microenvironment of cetuximab-treated patients with HNSCC enrolled in a novel neoadjuvant, single-agent cetuximab clinical trial.",25832655_2,-1,1,-1,1,25977,-1,3.848615e-06,0.99999154,4.6226037e-06
15586,transcriptase-polymerase,8,9,57,81,"The cytokine milieu was analyzed by quantitative reverse transcriptase-polymerase chain reaction (RT-PCR).RESULTS: Oral squamous cell carcinoma expresses high levels of IL-1, IL-6, and transforming growth factor (TGF)-.",21837700_2,-1,1,-1,1,15586,-1,1.1467442e-05,0.99997604,1.2434964e-05
6150,the,6,7,39,42,mTORC1 activation was also detected in the CTCL tissues in the lymphoma stage-dependent manner with the highest percentage of positive cells present in the cases with a large cell transformation.,18025151_4,-1,1,-1,1,6150,-1,4.542081e-06,0.99999106,4.4216486e-06
20028,the,3,4,17,20,We have analyzed the role of this pathway in GVHD and GVL.,23430112_2,-1,1,-1,1,20028,-1,4.0260493e-06,0.99999213,3.8159883e-06
8862,their,32,33,158,163,"Here we describe the propagation of large amounts of a unique population of CD4(+) cytotoxic T cells, which we termed tumor killer T cells (TKTC), because of their potent and broad antitumor cell activity.",19240181_2,-1,1,-1,1,8862,-1,5.6017607e-06,0.99998903,5.3917042e-06
19831,this,40,41,233,237,"It has been reported that the imbalance of T helper IL-17-producing cells (Th17 cells)/regulatory T cells (Tregs) was closely associated with advanced tumor growth and poor prognosis in lung cancer, but little is known about whether this imbalance is existed in the peripheral blood of patients with non-small cell lung cancer (NSCLC).",23335103_0,-1,1,-1,1,19831,-1,5.460661e-06,0.9999907,3.7845966e-06
18271,TGF-1,29,30,178,184,The transcriptional regulation of TGF-1 by GLI2 is a new extension to Sonic Hedgehog (SHH) and TGF-1 cross-regulation and may provide insight into the detrimental elevation of TGF-1 leading to pathogenesis in cancer and HIV infection.,22859956_6,-1,1,-1,1,18271,-1,7.554037e-06,0.9999771,1.5314681e-05
41082,the,4,5,23,26,The combined group had the smallest tumor volume.,33204731_7,-1,1,-1,1,41082,-1,6.5186846e-06,0.9999865,7.0056567e-06
19253,The,0,1,0,3,"The pro-tumor efficacy of Th17 response included promotion of neutrophilia and induction of angiogenic (e.g. VEGF, MMP2 and MMP9) and anti-apoptotic factors (e.g. Bcl-XL), as well as expansion and activation of myeloid-derived suppressor cells, which facilitate generation of tumor-specific regulatory T cells.",23159638_2,-1,1,-1,1,19253,-1,3.8046444e-06,0.9999925,3.7389852e-06
43180,that,30,31,202,206,"The unprecedented successes of immunotherapies (IOs) including immune checkpoint blockers (ICBs) and adoptive T-cell therapy (ACT) in patients with late-stage cancer provide proof-of-principle evidence that harnessing the immune system, in particular T cells, can be an effective approach to eradicate cancer.",34830176_0,-1,1,-1,1,43180,-1,4.5978845e-06,0.9999913,4.1357707e-06
29733,the,14,15,91,94,"CONCLUSION: Altered Treg/Th17 and IL-10/IL-17 ratios in CLL would be aggravated along with the disease progression, which might be used as indicators for the disease prognosis.",27584054_10,-1,1,-1,1,29733,-1,4.302758e-06,0.9999907,5.0130584e-06
9962,the,10,11,70,73,"These T-cells might prevent effective antitumor immune responses, and the increase in frequency of CD4(+)CD25(high)FOXP3(+) Tregs might play a role in the modulation of the immune response against NSCLC and could be important in the design of immunotherapeutic approaches.",19538059_7,-1,1,-1,1,9962,-1,4.0959567e-06,0.99999213,3.7350064e-06
22598,the,16,17,86,89,Nine of 10 children had responses against both E2 peptide pools compared to only 4 of the 10 mothers.,24524328_7,-1,1,-1,1,22598,-1,1.4041566e-05,0.9999714,1.4612105e-05
42509,therapeutic,22,23,143,154,Our studies establish a crucial role for Gpx4 in protecting activated Treg cells from lipid peroxidation and ferroptosis and offer a potential therapeutic strategy to improve cancer treatment.,34133924_7,-1,1,-1,1,42509,-1,4.965971e-06,0.9999908,4.236737e-06
38731,target,7,8,41,47,Our study indicates CXCL9 as a potential target of immunotherapy in PAAD treatment by regulating the CD8+ T lymphocytes in the tumour microenvironment.,31913856_7,-1,1,-1,1,38731,-1,7.2372245e-06,0.9999871,5.68091e-06
8911,to,21,22,131,133,"These Ti-Treg could be selectively recruited through CCR4 as illustrated by (a) selective blood Treg CCR4 expression and migration to CCR4 ligands, (b) CCR4 down-regulation on Ti-Treg, and (c) correlation between Ti-Treg in lymphoid infiltrates and intratumoral CCL22 expression.",19244125_2,-1,1,-1,1,8911,-1,6.951478e-06,0.99998677,6.2416425e-06
2510,Tim-3(+,8,9,64,71,These results provide evidence that adoptive immunotherapy with Tim-3(+) T-bet(+) tumor-specific Th1 cells can be used to induce host cytotoxic responses that inhibit the development and growth of neoplastic cells.,15661898_7,-1,1,-1,1,2510,-1,0.00014348673,0.9997539,0.00010260384
6876,tumor,5,6,29,34,"The effects of treatments on tumor growth, survival and antitumor immune responses were evaluated.",18392040_3,-1,1,-1,1,6876,-1,4.2647466e-06,0.9999912,4.592362e-06
920,to,32,33,186,188,"In advanced stages of CTCL, a shift in cytokine profile from T(H)1 to T(H)2 is observed, which coincides with eosinophilia, high levels of immunoglobulin E, and increased susceptibility to bacterial infections.",11807001_1,-1,1,-1,1,920,-1,1.432442e-05,0.9999758,9.844467e-06
37385,their,39,40,223,228,"Oral cancer, a subtype of head and neck cancer, is characterized by increased infiltrating regulatory T cells (Treg); however, the pathological significance of the increase in Tregs in disease prognosis and progression and their underlying mechanism remain unestablished.",31325403_0,-1,1,-1,1,37385,-1,5.8078963e-06,0.99998987,4.3493865e-06
7479,Total,0,1,0,5,"Total RNA was extracted from frozen normal breast and breast cancer tissues, and the expression of FOXP3, IL-10, TGFbeta1 and CCL22 mRNA was evaluated using quantitative real-time RT-PCR.RESULT: FOXP3, IL-10, TGFbeta1 and CCL22 mRNA expressions were significantly higher in cancer tissue than in normal tissue, not only at pT1, 2, and 3 stages but also at the DCIS stage.",18685848_2,-1,1,-1,1,7479,-1,3.7665475e-06,0.99998903,7.2448347e-06
38746,Treg,10,11,59,63,"CD4+ transfer into lymphodepleted animals or regulatory T (Treg) cell depletion promoted GzmB expression by tumor-infiltrating CD4+, and this was prevented by interleukin-2 (IL-2) neutralization.",31924474_2,-1,1,-1,1,38746,-1,5.08063e-06,0.9999863,8.612494e-06
1784,these,3,4,15,20,The ability of these mice to suppress tumor growth was restored after they were reconstituted with bone marrow cells from Wt mice.,14978132_3,-1,1,-1,1,1784,-1,5.783557e-06,0.99998844,5.820175e-06
4285,this,4,5,18,22,The first goal of this article is to test if the injection of autologous dendritic cells infected ex vivo with the Ad-sig-TAA/ecdCD40L can increase the immune response induced against TAA.,16928818_2,-1,1,-1,1,4285,-1,5.691513e-06,0.9999883,6.0060834e-06
19768,Tregs,6,7,44,49,"The differentially expressed genes in mCRPC Tregs are involved in cell cycle processes, cellular growth and proliferation, immune responses, hematological system development and function and the interleukin-2 (IL-2) and transforming growth factor- (TGF-) pathways.",23319273_4,-1,1,-1,1,19768,-1,3.6021274e-06,0.99999154,4.895628e-06
36119,types,22,23,120,125,"However, it is also able to induce tumor cell apoptosis and enhance NK and cytotoxic T cell sensitivity in other cancer types.",30638183_7,-1,1,-1,1,36119,-1,1.0392481e-05,0.99996006,2.9514986e-05
27685,the,9,10,52,55,"In this study, we examined the relationship between the repressive PRC2 machinery and effector T-cell trafficking.",26567139_3,-1,1,-1,1,27685,-1,3.7469028e-06,0.9999926,3.6806389e-06
35280,Treg-specific,32,33,216,229,"RORt+FoxP3+ cells were investigated in human samples of CAC, and their phenotypic stability and function were investigated in an azoxymethane/dextran sulfate sodium model of CAC using Treg fate-mapping reporter and Treg-specific RORt conditional knockout mice.",29991500_3,-1,1,-1,1,35280,-1,1.5576625e-05,0.9999753,9.056568e-06
21883,FoxP3,23,24,130,135,"After chemotherapy using the MCP841 protocol, the frequency of CD4(+) CD25(+) cells was gradually enhanced with the reduction of FoxP3, interleukin-10 positivity corresponded with disease presentation, indicating reduced immunosuppression.",24354800_9,-1,1,-1,1,21883,-1,4.9408204e-06,0.9999907,4.3402288e-06
8629,tumors,18,19,125,131,"These data correlate with increased CTL expansion in the peripheral blood of responders, increased infiltration of responder tumors by CD8+ cells and interleukin-17+ cells, and decreased infiltration of responder tumors by CD11b+Gr-1+ cells and FoxP3+ cells.",19223534_8,-1,1,-1,1,8629,-1,3.6221873e-06,0.9999918,4.6300875e-06
21959,TGF-,47,48,290,295,"Consistently, our in vivo study showed that ectopic expression of uncleavable tmTNF- mutant by 4T1 cells significantly promoted tumor progression and angiogenesis, accompanied with more accumulation of MDSCs and regulatory T cells in the tumor site, increased production of NO, IL-10, and TGF-, as well as poor lymphocyte infiltration.",24379122_5,-1,1,-1,1,21959,-1,1.0748667e-05,0.9999831,6.192085e-06
25525,the,12,13,82,85,We identified HMGB1 as a soluble factor produced by neoplastic keratinocytes from the genital tract involved in pDCs functional alteration.,25492101_7,-1,1,-1,1,25525,-1,4.293789e-06,0.99998975,5.9708545e-06
33208,to,13,14,85,87,Only mismatch repair (MMR)-deficient colorectal cancer (CRC) appears to respond well to programmed death (PD)-1 inhibition at the present time.,28940183_0,-1,1,-1,1,33208,-1,5.5960763e-06,0.9999895,4.8872075e-06
28999,two,32,33,177,180,"Here, we present a new mouse model of acute type ATL that can be generated rapidly by transplanting invitro-induced T cells that have been retrovirally transduced with HBZ and two cooperative genes, BCLxL and AKT, into mice.",27223899_3,-1,1,-1,1,28999,-1,7.735483e-06,0.99998736,4.9032424e-06
8101,treatment,2,3,8,17,"In vivo treatment of both NZB and C57Bl/6 mice with poly (I:C), a potent inducer of IFN-alpha, also led to a decrease in the levels of Tregs and malignant B-1 cells (NZB only) while amplifying autoimmune manifestations.",19022624_6,-1,1,-1,1,8101,-1,4.528579e-06,0.9999914,4.069066e-06
194,the,21,22,146,149,"Since HPV-specific mCTLp were detected predominantly in women with high-grade lesions or invasive cervical carcinoma and not in women who cleared the virus, the role of naturally occurring mCTLp in the protection against HPV-associated cervical neoplasia remains to be established.",10962445_7,-1,1,-1,1,194,-1,8.082659e-06,0.9999851,6.8616782e-06
33115,TIM-4,3,4,13,18,"In contrast, TIM-4+ B cells decreased B16-F10 metastasis and s.c.",28848066_6,-1,1,-1,1,33115,-1,1.3050402e-05,0.99996865,1.828331e-05
19489,tumoral,2,3,12,19,We explored tumoral expression of CXCL10 and determined the relationship between CXCL10 and lymphocytic infiltrate in a cohort of breast cancers.,23213058_2,-1,1,-1,1,19489,-1,6.4191945e-06,0.9999875,6.0867415e-06
6631,therapeutic,18,19,109,120,MATERIALS AND METHODS: Neuro2a/IL-21 cells were tested as subcutaneous (sc) vaccine both in prophylactic and therapeutic settings.,18324400_2,-1,1,-1,1,6631,-1,6.8212516e-06,0.9999887,4.4999288e-06
6430,Tregs,27,28,177,182,"Furthermore, to elucidate the mechanisms behind Treg accumulation within tumors, they evaluated the relationship between CCL17 or CCL22 expression and the frequency of Foxp3(+) Tregs in gastric cancer.",18224687_3,-1,1,-1,1,6430,-1,5.1601596e-06,0.9999889,5.9209838e-06
19630,their,17,18,89,94,"In addition, to evaluate Interferon-gamma (IFN- ) and interleukin-16 (IL-16) levels and their correlation to Treg cells in malignant and tuberculous pleural effusions.",23252864_2,-1,1,-1,1,19630,-1,5.988121e-06,0.9999887,5.340746e-06
42250,tumor-infiltrating,13,14,80,98,"To characterize the immune response, we performed flow cytometry and RNA-Seq of tumor-infiltrating cDC1s.",33980589_5,-1,1,-1,1,42250,-1,2.3978222e-05,0.9999621,1.3944713e-05
12212,therapeutic,43,44,249,260,"Thus, potent pleiotropic immune functions of SA-4-1BBL combined with its ability to serve as a vehicle to increase the delivery of antigens to DCs in vivo endow this molecule with the potential to serve as an effective immunomodulatory component of therapeutic vaccines against cancer and chronic infections.",20406989_7,-1,1,-1,1,12212,-1,5.3374956e-06,0.9999902,4.4420212e-06
32485,to,18,19,104,106,"However, glial tumors including those seen in children carry fewer mutations and there is an unmet need to identify new antigenic targets of anti-tumor immunity.",28620836_1,-1,1,-1,1,32485,-1,6.8189515e-06,0.99998903,4.172103e-06
25347,the,19,20,99,102,Cytokines in the supernatant were detected by ELISA.RESULTS: B7-H4 was expressed in 46% (31/67) of the cases of cervical cancer.,25446402_4,-1,1,-1,1,25347,-1,5.3679364e-06,0.99998856,6.0897155e-06
603,to,20,21,106,108,"Although early KS is a reactive process of polyclonal nature that can regress, in time it can progress in to a true sarcoma.",11423257_5,-1,1,-1,1,603,-1,4.844701e-06,0.9999887,6.488821e-06
43181,the,32,33,218,221,"The unprecedented successes of immunotherapies (IOs) including immune checkpoint blockers (ICBs) and adoptive T-cell therapy (ACT) in patients with late-stage cancer provide proof-of-principle evidence that harnessing the immune system, in particular T cells, can be an effective approach to eradicate cancer.",34830176_0,-1,1,-1,1,43181,-1,6.163276e-06,0.9999889,4.909033e-06
30934,TGF-1,10,11,63,69,One approach is to specifically block the production of active TGF-1 from Tregs as an adjunct to tumor immunotherapy.,28001437_6,-1,1,-1,1,30934,-1,2.2304956e-05,0.9999268,5.0864484e-05
29198,the,3,4,27,30,These findings demonstrate the important role of Gfi1 in regulating the development and function of NKT1- and NKT2-type iNKT cell subsets.,27284976_7,-1,1,-1,1,29198,-1,3.9587594e-06,0.9999924,3.6156289e-06
27010,This,0,1,0,4,This control was mainly mediated by EBV-specific CD8(+) cells with an oligoclonal epitope signature covering both latent and lytic viral proteins.,26276009_7,-1,1,-1,1,27010,-1,4.5250385e-06,0.9999913,4.1581065e-06
42725,to,16,17,114,116,Genetic deletion or methylation of DNA-sensing/IFN genes or CCL5 chemokine is identified as a potential mechanism to attenuate Tcell inflammation.,34289354_3,-1,1,-1,1,42725,-1,5.1377597e-06,0.99999106,3.830912e-06
31959,type,37,38,232,236,"Mice deficient in the Th1 transcription factor T-bet did not gain any survival advantage from RABV infection, exhibiting only limited tumor necrosis and no change in TME cytokines or TAM phenotype and highlighting the importance of type 1 mechanisms in this process.",28461570_7,-1,1,-1,1,31959,-1,4.7503745e-06,0.9999895,5.7590487e-06
89,to,13,14,97,99,"The inhibitory agent has several features characteristic of a ganglioside, including sensitivity to neuraminidase but not protease treatment; hydrophobicity; and molecular weight less than 3 kDa.",10491412_3,-1,1,-1,1,89,-1,1.2558664e-05,0.9999764,1.1084229e-05
5292,To,0,1,0,2,"To determine the link between breast cancer, DCs, and CD4(+) T cells, we implanted human breast cancer cell lines in nonobese diabetic/LtSz-scid/scid beta2 microglobulin-deficient mice engrafted with human CD34(+) hematopoietic progenitor cells and autologous T cells.",17438063_4,-1,1,-1,1,5292,-1,4.3953314e-06,0.9999914,4.1685735e-06
14871,the,20,21,115,118,"Moreover, using the purified CD4(+)CD25(-) T cells, we confirmed that the increased Tregs were mainly induced from the conversation of CD4(+)CD25(-) naive T cells, and induced Tregs were functional and able to suppress the proliferation of effector T cells.",21528082_11,-1,1,-1,1,14871,-1,3.955049e-06,0.99999225,3.831238e-06
25937,TGF-,23,24,143,148,"Immune infiltration by regulatory T- and B-lymphocytes (Tregs, Bregs) has recently gained increased attention for being an important source of TGF-.",25832000_1,-1,1,-1,1,25937,-1,7.656593e-06,0.99998665,5.6367626e-06
8052,tumour-cell,13,14,104,115,"Having shown that pomalidomide confers T cell-dependent adjuvant-like protection in a preclinical whole tumour-cell vaccine-model, we now show that lenalidomide and pomalidomide strongly inhibit T-regulatory cell proliferation and suppressor-function.",19009291_4,-1,1,-1,1,8052,-1,0.002504697,0.9054261,0.092069164
39387,to,17,18,122,124,"Thus, peripheral blood expression of T cell exhaustion markers does not distinguish between responders and non-responders to anti-PD-1 therapy.",32210968_10,-1,1,-1,1,39387,-1,5.657281e-06,0.99998856,5.748124e-06
35489,to,4,5,32,34,"Patients with complete response to neoadjuvant chemotherapy displayed significant hypomethylation in CD4+ T cells for all four investigated loci, most prominently in IFNG p<0.0001.",30075815_12,-1,1,-1,1,35489,-1,7.574371e-06,0.99998546,7.0073193e-06
1341,to,17,18,108,110,"Many tumors, however, have been immunoselected to evade recognition by CTLs and thus alternative approaches to cancer immunotherapy are urgently needed.",12566422_1,-1,1,-1,1,1341,-1,9.329034e-06,0.999984,6.6295997e-06
9967,the,36,37,229,232,"These T-cells might prevent effective antitumor immune responses, and the increase in frequency of CD4(+)CD25(high)FOXP3(+) Tregs might play a role in the modulation of the immune response against NSCLC and could be important in the design of immunotherapeutic approaches.",19538059_7,-1,1,-1,1,9967,-1,4.7380586e-06,0.9999913,3.9411666e-06
35416,the,6,7,26,29,Dendritic cells (DCs) are the most potent professional antigen presenting cells and inducers of T cell-mediated immunity.,30068989_0,-1,1,-1,1,35416,-1,6.1660735e-06,0.9999869,6.8946592e-06
42130,T,1,2,11,12,"Regulatory T (Treg) cells play a major role in coordinating immunomodulation in cancer; however, the role of STAT6 in the induction and function of Treg cells is poorly understood.",33919941_2,-1,1,-1,1,42130,-1,3.6610004e-06,0.99999094,5.3422355e-06
32671,the,25,26,155,158,"In order to elucidate the effects of IQM on the tumor microenvironment, we investigated the immunomodulatory effect of IQM during melanoma growth by using the B16F10 melanoma model.",28668835_2,-1,1,-1,1,32671,-1,4.4649823e-06,0.9999914,4.058525e-06
12750,that,3,4,24,28,The results demonstrate that endogenous IFN-gamma counteracts the induction of type 2 cytokines and the downregulation of both CD8 coreceptor levels and the anti-tumor response in CD8 T cells exposed to IL-4 during activation in vivo.,20562261_7,-1,1,-1,1,12750,-1,4.319671e-06,0.99999225,3.3916158e-06
22364,tumor-associated,18,19,90,106,"Using a human CTL system model based on a CD8(+)/CD103(-) T cell clone specific of a lung tumor-associated Ag, we demonstrated that the transcription factors Smad2/3 and NFAT-1 are two critical regulators of this process.",24477908_3,-1,1,-1,1,22364,-1,8.585647e-06,0.99998283,8.5529755e-06
33297,to,48,49,310,312,"Further experiments showed that the gene and/or protein expression of caspase-1, iNOS, IL-1, IL-6 and CXCL10 and the levels of nitric oxide were modulated following CTX in an IRF-1-direct- or -indirect-dependent manner, and highlighted the importance of caspase-1 in driving the sterile inflammatory response to CTX.",28975621_7,-1,1,-1,1,33297,-1,1.6409813e-05,0.99997187,1.17005075e-05
42722,Genetic,0,1,0,7,Genetic deletion or methylation of DNA-sensing/IFN genes or CCL5 chemokine is identified as a potential mechanism to attenuate Tcell inflammation.,34289354_3,-1,1,-1,1,42722,-1,5.2299706e-06,0.99998987,4.943399e-06
12295,genetic,5,6,33,40,The prognostic value of germline genetic variants of some immune genes suggests that the host genetic background may also influence the biology of FL.,20425464_4,-1,1,-1,1,12295,-1,8.6905675e-06,0.99998033,1.09395505e-05
12621,to,21,22,158,160,"Down-regulation of Stat3 by siRNA significantly suppressed the production of IL-10 and VEGF-A. These results provide suggestive evidence that TAMs contribute to cancer progression via Stat3 activation, and CD163 is useful for evaluating M2 TAMs and predicting the clinical prognosis of ICC patients.",20545696_11,-1,1,-1,1,12621,-1,5.3205963e-06,0.9999881,6.611897e-06
39029,turn,23,24,146,150,"We further studied the underlying molecular mechanisms and found that depletion of mTORC1 resulted in the increased expression of SOCS1, which in turn suppressed the key transcription factor Eomes, consequentially reducing IFN- production.",32001780_3,-1,1,-1,1,39029,-1,5.960007e-06,0.99998903,4.961039e-06
39852,the,4,5,31,34,HBZ up-regulates expression of the immunosuppressive cytokine IL-10.,32471947_5,-1,1,-1,1,39852,-1,9.51145e-06,0.9999856,4.8785223e-06
3302,the,2,3,9,12,"However, the impact of administered IL-2 in an immune intact host has not been studied in rodents or humans.",16304057_2,-1,1,-1,1,3302,-1,4.197427e-06,0.99999225,3.5430253e-06
36508,tdLN,11,12,78,82,"We comprehensively characterized myeloid cells in tumor draining lymph nodes (tdLN) of mice and identified two subsets of conventional type-2 dendritic cells (cDC2) that traffic from tumor to tdLN and present tumor-derived antigens to CD4+ Tconv, but then fail to support antitumor CD4+ Tconv differentiation.",30955881_1,-1,1,-1,1,36508,-1,1.26946825e-05,0.9999647,2.2581782e-05
2099,The,0,1,0,3,"The other half of the patients showed impaired HPV16-specific proliferative responses, which generally lacked both IFN-gamma and interleukin 5.",15289354_5,-1,1,-1,1,2099,-1,4.158304e-06,0.99999094,4.8713055e-06
13144,AP-1,2,3,12,16,"Activity of AP-1 was analyzed by EMSA.RESULTS: Following efficient transduction of peripheral blood-derived T cells with anti-CD20scFvFc/CD28/CD3zeta gene, an obvious cell lysis of Raji cells was observed in co-culture.",20815894_8,-1,1,-1,1,13144,-1,1.1880281e-05,0.9999598,2.8277447e-05
18814,tolerance,14,15,87,96,Dendritic cells play a central role in keeping the balance between immunity and immune tolerance.,23049782_0,-1,1,-1,1,18814,-1,6.226056e-06,0.99998784,5.9831555e-06
41708,IRF-1,0,1,0,5,"IRF-1 response elements were identified in the CXCL10 promoter region, and ChIP-qPCR confirmed IRF-1 binding to promote CXCL10 transcription.",33689775_3,-1,1,-1,1,41708,-1,5.4250245e-06,0.99998546,9.104748e-06
18141,that,21,22,128,132,"By comparing the transcriptomes of primary and metastatic tumor cells in a mouse model of spontaneous bone metastasis, we found that a substantial number of genes suppressed in bone metastases are targets of the interferon regulatory factor Irf7.",22820642_1,-1,1,-1,1,18141,-1,5.1590773e-06,0.9999908,4.056139e-06
36488,the,9,10,71,74,The possibility of pharmacological intervention in the self-control of the immunological system is now under extensive investigation in many human cancers.,30944830_6,-1,1,-1,1,36488,-1,6.178026e-06,0.9999894,4.456601e-06
21605,the,17,18,113,116,The treatment with the antibody synergistically augmented the antitumor effect of IFN- gene therapy not only in the vector-injected tumors but also in the vector-uninjected tumors.,24289533_5,-1,1,-1,1,21605,-1,4.037273e-06,0.99999225,3.6768731e-06
10685,treatment,18,19,104,113,"Using MUC1 peptide and IL-2 for ex vivo CD4(+)/Th1 effector cell generation, we show that three monthly treatment cycles of peripheral blood T cell restimulation and intraperitoneal re-infusion selectively modulated endogenous T cell-mediated immune responses that correlated with diminished serum CA125 tumor marker levels and enhanced patient survival.",19762283_2,-1,1,-1,1,10685,-1,7.5027347e-06,0.999987,5.529949e-06
14193,Foxp3,29,30,142,147,The results showed that 2-10% Eca tissue-derived CD4(+) T cells expressed Foxp3; only 0.2-0.8% non-ca tissue-derived CD4(+) T cells expressed Foxp3.,21314287_6,-1,1,-1,1,14193,-1,5.2295322e-06,0.99998987,4.8615816e-06
13931,Treg,23,24,132,136,"However, although TLR4 expression on Treg cells was higher than that on Teff cells, the expression level remained unaltered in both Treg and Teff cells after PTX treatment.",21223350_4,-1,1,-1,1,13931,-1,4.899711e-06,0.99998593,9.162258e-06
37001,The,2,3,13,16,"CONCLUSIONS: The frequency of 4-1BBL+ B cells significantly increased following a short time activation, and showed relative and significant associations with tumor grade and estrogen receptor status, respectively.",31182685_9,-1,1,-1,1,37001,-1,3.880683e-06,0.9999924,3.725637e-06
21913,through,9,10,60,67,We surmise that HTLV-1 transmission from mothers to infants through breast milk in early life induces tolerance to HBZ and results in insufficient HBZ-specific T cell responses in HTLV-1 asymptomatic carriers or ATL patients.,24363428_4,-1,1,-1,1,21913,-1,1.3243808e-05,0.999977,9.769406e-06
10637,therapeutic,17,18,108,119,We propose that p28 can be a regulatory subunit for IL-27-mediated cellular immune responses and a possible therapeutic agent to suppress unfavourable immune responses.,19740343_10,-1,1,-1,1,10637,-1,8.799812e-06,0.99998593,5.294497e-06
28786,tumours,16,17,109,116,"Transcription of IL17, which has been shown to have a regulatory function in human papillomavirus-associated tumours, was also elevated in equine sarcoids compared to spleen.",27160146_5,-1,1,-1,1,28786,-1,9.886279e-06,0.99997604,1.4048021e-05
41686,STAT3,0,1,0,5,STAT3 inhibition and TLR7/8 pathway stimulation in MDSCs repolarize and suppress MDSCs from breast cancer patients.,33679700_13,-1,1,-1,1,41686,-1,6.7152255e-06,0.9999863,6.9647726e-06
23549,their,30,31,170,175,"However, these same signals are not sufficient to induce autocrine IL-2 production by naive CD8(+) T cells, which require cytokines provided by other cell types to drive their differentiation.",24778448_1,-1,1,-1,1,23549,-1,6.8959566e-06,0.9999871,5.942986e-06
23358,the,14,15,73,76,"Cryptotanshinone (CPT), is a quinoid diterpene isolated from the root of the Asian medicinal plant, Salvia miotiorrhiza bunge.",24761844_0,-1,1,-1,1,23358,-1,3.9722067e-06,0.9999913,4.7542176e-06
24799,treatment,9,10,63,72,"Interleukin-12 serum level was also increased by the anti-CD20 treatment, and activated myeloid dendritic cells producing interleukin-12 could be detected in lymph nodes of treated animals, while interferon- blockade strongly reduced survival.",25231744_5,-1,1,-1,1,24799,-1,5.3043595e-06,0.9999893,5.44253e-06
14574,types,24,25,165,170,Recent in vitro evidence indicates that this plasticity may be phenotypically altered by using methylation inhibitors which are approved for clinical use in certain types of cancer.,21377729_3,-1,1,-1,1,14574,-1,5.9838585e-06,0.9999852,8.857219e-06
20496,to,8,9,49,51,Diminished cytotoxic T cell function in TSCC due to decreased CD8/T-reg ratio may permit tumor progression.,23667456_9,-1,1,-1,1,20496,-1,4.6188306e-06,0.9999913,4.0795376e-06
15904,the,17,18,100,103,Poly(I:C) is a synthetic double-stranded RNA that is negatively charged and favors interaction with the cationic TAT peptide.,21945963_4,-1,1,-1,1,15904,-1,5.9586437e-06,0.99998915,4.853851e-06
12687,the,24,25,117,120,"In TILs from patients with early disease (n = 27), the frequency of Th17 cells was significantly higher than that in the normal gastric mucosa (23.7  8.9 vs 4.5  3.1%).",20550524_4,-1,1,-1,1,12687,-1,3.1778861e-06,0.99999213,4.6872506e-06
35520,twenty,5,6,45,51,"Forty-eight lung adenocarcinoma patients and twenty healthy individuals were enrolled in the current study, and CD8+ T cells were purified from both peripheral bloods and bronchoalveolar lavage fluids.",30086535_3,-1,1,-1,1,35520,-1,1.0446427e-05,0.99998105,8.5128895e-06
2810,their,26,27,152,157,"These results suggest that vaccines consisting of tumor cells engineered to produce the type 2 cytokine, IL-4, critically depend on type 1 immunity for their observed therapeutic efficacy.",15905564_6,-1,1,-1,1,2810,-1,6.6283837e-06,0.99998856,4.7847434e-06
13243,TBI,36,37,194,197,"METHODS: Patients underwent a lymphodepleting preparative regimen: fludarabine 25 mg/m(2)  5 doses, cyclophosphamide 60 mg/kg  2 doses, and, in seven patients, 200 cGy total body irradiation (TBI) to increase host immune suppression.",20849361_2,-1,1,-1,1,13243,-1,0.000121085155,0.9998072,7.181013e-05
4371,regulation,18,19,134,144,BACKGROUND & OBJECTIVE: Accumulative evidences have indicated the importance of CD40-CD40L receptor-ligand pair in the initiation and regulation of human immune response.,16965650_0,-1,1,-1,1,4371,-1,5.6221893e-06,0.99998724,7.1573313e-06
41568,These,0,1,0,5,These findings indicated that imbalances in Th17/Tregs may account for the pathogeny of thymoma with MG.,33636431_9,-1,1,-1,1,41568,-1,4.452788e-06,0.9999918,3.821227e-06
2620,types,30,31,190,195,"In this report, by using an ideal mouse model that expresses IFN-gamma locally in muscle, we demonstrate that sustained low-level expression of IFN-gamma promotes the development of several types of tumor including H22 hepatoma, MA782/5S mammary adenocarcinoma and B16 melanoma.",15776283_1,-1,1,-1,1,2620,-1,5.7306106e-06,0.9999831,1.1195001e-05
31428,to,21,22,96,98,"Here, we show that in the context of a number of cancers, nave CD45RA+ CD4 T cells are induced to express high levels of FOXP3, and that FOXP3 expression correlates with inhibition of T cell proliferation.",28239749_4,-1,1,-1,1,31428,-1,3.7589546e-06,0.9999919,4.2898328e-06
28200,tumorigenesis,16,17,97,110,"Finally, we report that inhibition of KRAS reduces the infiltration of Tregs in KRAS-driven lung tumorigenesis even before tumor formation.",26880715_6,-1,1,-1,1,28200,-1,3.7271304e-06,0.9999907,5.5179157e-06
11532,to,3,4,28,30,"Tehranolide is hypothesized to possess effects akin to Artemisinin, which is active against cancer cells.",20138670_1,-1,1,-1,1,11532,-1,5.0820563e-06,0.99999046,4.408101e-06
36238,to,10,11,66,68,Suppression of IL-10 could rescue IFN- production but was unable to completely rescue perforin and granzyme B expression.,30711567_8,-1,1,-1,1,36238,-1,8.514081e-06,0.9999875,4.019957e-06
315,Tax,25,26,156,159,"In contrast, AG-490 had no effect on DNA binding by p50/p65 components of NF-kappaB, a transcription factor activated by the HTLV-1-encoded phosphoprotein, Tax.",11046040_6,-1,1,-1,1,315,-1,5.7062693e-06,0.9999894,4.8595634e-06
42915,the,61,62,345,348,"Although Treg cell plasticity comes in various flavors, the major categories enclose the loss of Foxp3 expression, which is the master regulator of Treg cell lineage, giving rise to ""ex-Treg"" cells and the ""fragile"" Treg cells in which FOXP3 expression is retained but accompanied by the engagement of an inflammatory program and attenuation of the suppressive activity.",34539668_2,-1,1,-1,1,42915,-1,3.961384e-06,0.9999925,3.5017285e-06
25124,the,23,24,169,172,"Tumour progression is associated with immune-suppressive conditions that facilitate the escape of tumour cells from the regimen of immune cells, subsequently paralysing the host defence mechanisms.",25284464_0,-1,1,-1,1,25124,-1,4.6312703e-06,0.99999154,3.8768326e-06
32999,tumor,11,12,89,94,"Anti-G-CSF treatment in combination with the DNA synthesis inhibitor gemcitabine reduced tumor size, increased the number of infiltrating T cells, and decreased the number of Ly6G+ cells more effectively than gemcitabine alone.",28775207_5,-1,1,-1,1,32999,-1,4.4758904e-06,0.9999901,5.417455e-06
15167,the,13,14,97,100,"There is considerable knowledge about the contributions of IFN-producing Th1 cells that supports the role of cytotoxic cluster of differentiation (CD8) T cells and natural killer (NK) cells, but much less is known about how IL-4-producing Th2 cells contribute to tumor immunity.",21646476_1,-1,1,-1,1,15167,-1,4.255093e-06,0.9999919,3.8015594e-06
18009,this,18,19,113,117,"Antitumor type I T-cell responses involving IFN- production are critical to control cancer, but the efficacy of this response is limited by a variety of immunosuppressive mechanisms that promote tumoral immune escape.",22798340_0,-1,1,-1,1,18009,-1,6.3435905e-06,0.99998915,4.491048e-06
24721,tumor,12,13,103,108,"Targeting involution with a neutralizing antibody against the immunosuppressive cytokine IL-10 reduces tumor growth in involution group mice but not in nulliparous mice, implicating the involution microenvironment as the primary target of IL-10 treatment.",25187059_7,-1,1,-1,1,24721,-1,4.5926554e-06,0.99999106,4.396026e-06
25017,Tregs,10,11,70,75,"The phenotypes, cytokine-release patterns, and suppressive ability of Tregs isolated from peripheral blood and tumor tissues were analyzed.",25268580_2,-1,1,-1,1,25017,-1,5.4138723e-06,0.9999895,5.0982408e-06
14880,the,9,10,59,62,"Finally, we demonstrated that gastric cancer cells induced the increased CD4(+)Foxp3(+) Tregs via producing TGF-1.",21528082_12,-1,1,-1,1,14880,-1,3.6190504e-06,0.99999225,4.081296e-06
34146,the,6,7,37,40,"Expression of Foxp3 was localized in the bile duct epithelial cells, and especially in the bile duct hyperplasia.",29331794_6,-1,1,-1,1,34146,-1,4.004163e-06,0.99999154,4.501723e-06
785,the,6,7,35,38,"Furthermore, IL-2 did not overcome the block, despite normal IL-2R expression.",11698483_5,-1,1,-1,1,785,-1,7.4275604e-06,0.9999877,4.8175366e-06
8973,Stat3,13,14,71,76,"Here, we show that signal transducer and activator of transcription 3 (Stat3) plays a key role in down-modulating immunostimulatory effects of CpG. In the absence of interleukin-6 (IL-6) and IL-10 induction, CpG directly activates Stat3 within minutes through TLR9.",19258507_1,-1,1,-1,1,8973,-1,5.04421e-06,0.9999894,5.6188837e-06
27277,tumor-bearing,7,8,50,63,Adoptive transfer of Nr2f6-deficient T cells into tumor-bearing immunocompetent mice is sufficient to delay tumor outgrowth.,26387951_5,-1,1,-1,1,27277,-1,7.125228e-06,0.99998736,5.451933e-06
21068,the,12,13,90,93,"Our results argue that these major immunosuppressive pathways are intrinsically driven by the immune system rather than being orchestrated by cancer cells, and imply that cancer immunotherapy approaches targeting negative regulatory immune checkpoints might be preferentially beneficial for patients with a preexisting T cell-inflamed tumor microenvironment.",23986400_5,-1,1,-1,1,21068,-1,5.798032e-06,0.9999895,4.6813325e-06
17462,types,18,19,106,111,"Tumor infiltration with effector CD8(+) T cells (T(eff)) predicts longer recurrence-free survival in many types of human cancer, illustrating the broad significance of T(eff) for effective immunosurveillance.",22593190_0,-1,1,-1,1,17462,-1,6.477423e-06,0.99998343,1.0108955e-05
16544,T(reg,9,10,64,69,Higher frequencies of T-cell receptor excision circles in nave T(reg) cells indicate IL-2 dependent thymic generation of nave T(reg) cells as a mechanism leading to increased frequencies of T(reg) cells post IL-2 treatment in cancer patients.,22276195_6,-1,1,-1,1,16544,-1,5.6907415e-06,0.9999845,9.865652e-06
27242,the,2,3,10,13,"Moreover, the survival advantage correlated with decreased PML-RARA transcript levels and increase in anti-RARA antibody production.",26378812_4,-1,1,-1,1,27242,-1,4.1846583e-06,0.99999166,4.1372277e-06
6895,to,6,7,43,45,"Concomitantly, the combination therapy led to a significantly decreased level of immunosuppression, as evidenced by lower intra-tumoral level of VEGF and TGF-beta, and decreased number of CD4+CD25+Foxp3+ regulatory T cells in the regional LNs.",18392040_6,-1,1,-1,1,6895,-1,3.830799e-06,0.99999213,4.0554714e-06
23948,tumor,12,13,75,80,Here we show in a syngeneic tumor transplantation model that STAT2 reduces tumor growth.,24895110_2,-1,1,-1,1,23948,-1,5.0445674e-06,0.9999907,4.2587417e-06
32871,treatment,12,13,65,74,Relapse of AML was not prognosticated by Treg counts at onset of treatment or after the first cycle of immunotherapy.,28721449_5,-1,1,-1,1,32871,-1,9.090869e-06,0.9999839,7.003019e-06
14240,tumor-induced,27,28,149,162,The goal of this study is to examine the relationship between melanoma SLN tumor burden and the degree of SLN immune dysfunction as a model to study tumor-induced immune dysfunction.,21327637_2,-1,1,-1,1,14240,-1,7.838616e-06,0.9999851,7.013461e-06
10676,treatment,10,11,71,80,Adoptive T cell immunotherapy using autologous lymphocytes is a viable treatment for patients with cancer and requires participation of Ag-specific CD4 and CD8 T cells.,19762283_0,-1,1,-1,1,10676,-1,5.22454e-06,0.9999894,5.366692e-06
23605,the,14,15,89,92,"In mice, genetic or pharmacologic suppression of FasL produced a substantial increase in the influx of tumor-rejecting CD8(+) over FoxP3(+) T cells.",24793239_4,-1,1,-1,1,23605,-1,4.512458e-06,0.999992,3.4924685e-06
6587,the,33,34,182,185,"The exact role of CD4+CD25(high) regulatory T cells (Treg) in adoptive immunotherapy of melanoma is still to be determined, and an association between an expansion of Treg cells and the expansion of therapeutic tumor-infiltrating lymphocytes (TIL) remains unelucidated.",18312383_0,-1,1,-1,1,6587,-1,3.85325e-06,0.9999925,3.6231847e-06
37665,to,31,32,190,192,"Our results suggest that, in addition to IDO1, there is an alternative immune regulatory mechanism associated with the lower KMO expression and the higher KYNA production, which contributes to dysfunctional effector CD4+ T-cell response.",31434983_7,-1,1,-1,1,37665,-1,4.3590426e-06,0.9999912,4.4947637e-06
36949,the,35,36,198,201,"The persistent polarization of IL4 induced by strong lipid antigens, that is, -galactosylceramide (GC), caused IL4 accumulation at the immunological synapse (IS), which promoted the activation of the IL4R-STAT6 (signal transducer and activator of transcription 6) pathway and production of IL12 in DCs, which enhanced interferon- (IFN) production in iNKT cells.",31160756_2,-1,1,-1,1,36949,-1,4.093625e-06,0.99999106,4.814916e-06
34938,the,2,3,9,12,"However, the data regarding phenotypic and functional heterogeneity of Treg subpopulations in breast cancer are limited.",29797233_2,-1,1,-1,1,34938,-1,1.1504938e-05,0.99998164,6.9081284e-06
3787,treatment,32,33,224,233,"Stat1 deficiency in the host significantly enhances IL-12-mediated tumor regression, resulting in tumor eradication from 60% of SCCVII tumor-bearing mice and significant inhibition of tumor growth when compared with control treatment (P < 0.01).",16618773_2,-1,1,-1,1,3787,-1,4.3527416e-06,0.9999914,4.222702e-06
21123,that,6,7,33,37,"The mechanism of this process is that RSV inactivates Stat3, preventing the generation and function of tBregs, including expression of TGF-.",24043896_2,-1,1,-1,1,21123,-1,4.8031634e-06,0.99999046,4.7884137e-06
40813,IRF3,7,8,47,51,"Moreover, key regulatory pathways that control IRF3 are discussed.",33020188_3,-1,1,-1,1,40813,-1,1.2653075e-05,0.99997663,1.0663812e-05
32977,the,37,38,218,221,"Conclusions: Our data portrays BTLA as a molecule with the singular ability to provide both costimulatory and coinhibitory signals to activated CD8+ T cells, resulting in extended survival, improved tumor control, and the development of a functional recall response.",28754817_9,-1,1,-1,1,32977,-1,4.0649734e-06,0.999992,3.9690663e-06
39344,tumor,9,10,50,55,"A limited number of studies, largely performed on tumor infiltrating lymphocytes (TILs), has provided evidence in support of this hypothesis, but whether similar changes occur in circulating blood lymphocytes has received little attention.",32210968_1,-1,1,-1,1,39344,-1,3.962455e-06,0.999992,4.0455975e-06
22672,the,3,4,57,60,"Immunohistochemical/immunostaining analyses demonstrated the presence of c-MET(+) and indoleamine 2,3-dioxygenase(+) cells in lymph node biopsies, co-expressed with CD68 and vimentin.",24561793_6,-1,1,-1,1,22672,-1,5.143625e-06,0.9999913,3.5599296e-06
29214,the,8,9,50,53,Recombinant IL18 alone had no antitumor effect in the syngeneic mice with orthotopically transplanted tumors and promoted tumors in immunocompromised mice; it also facilitated immune responses in vitro and in vivo by augmenting the activity of cytotoxic T cells and NK cells in peripheral blood and lymph nodes.,27297583_4,-1,1,-1,1,29214,-1,4.0115733e-06,0.999992,3.958829e-06
16569,the,13,14,79,82,BACKGROUND: Immunosuppressive factors such as regulatory T cells (Tregs) limit the efficacy of immunotherapies.,22303460_0,-1,1,-1,1,16569,-1,1.0734504e-05,0.9999845,4.735113e-06
41829,tryptophan,15,16,95,105,"We demonstrate that Indoleamine-pyrrole 2,3-dioxygenase1 (IDO1), due to its ability to convert tryptophan into kynurenines, is involved in NB resistance to activity of immune cells.",33737337_7,-1,1,-1,1,41829,-1,1.60987e-05,0.9999769,7.0213005e-06
20660,This,0,1,0,4,This observation was correlated with an increased percentage of CD4IL-10 cells and CD4CD25FoxP3 cells in splenic mononuclear cells compared with H. pylori-infected mice not receiving BM-MSCs.,23777268_5,-1,1,-1,1,20660,-1,4.440694e-06,0.9999918,3.7798757e-06
13954,that,13,14,88,92,"However, no correlation was found between the ratio of CD4+IL-10+T-cell percentages and that of CD4+Foxp3+T-cell percentages after/before PSK treatment.",21224532_4,-1,1,-1,1,13954,-1,5.5051705e-06,0.99998903,5.4416982e-06
650,Th1,1,2,6,9,"Under Th1 conditions, cellular proliferation of CD2-GATA3-transgenic CD4(+) cells was severely hampered, IFN-gamma production was decreased and Th2 cytokine production was increased.",11441076_7,-1,1,-1,1,650,-1,6.119934e-06,0.9999813,1.2605259e-05
15210,FOXP3(+,52,53,281,288,"BACKGROUND: The purpose of this study was to investigate the presence of CD4(+) CD25(+) FOXP3(+) regulatory T (Treg) cells both in peripheral blood and local tumors in patients with nasal inverted papilloma (NIP).METHODS: By using flow cytometry, the frequencies of CD4(+) CD25(+) FOXP3(+) Treg cells in both peripheral blood and tissues from 18 patients with NIP and 8 control subjects were determined.",21674673_0,-1,1,-1,1,15210,-1,3.8821596e-05,0.9999355,2.5625515e-05
1383,The,0,1,0,3,The ramp gene consisted of 15 exons.,12707369_4,-1,1,-1,1,1383,-1,4.1970807e-06,0.9999918,4.0767777e-06
30950,Th2,10,11,52,55,The aim was to evaluate the relationship of Th1 and Th2 components in 23 patients undergoing BCG treatment.,28005163_1,-1,1,-1,1,30950,-1,4.5581666e-05,0.9999342,2.017407e-05
38890,transcription factors,17,19,118,139,"SIGNIFICANCE: We report a highly cooperative ISG network, in which UBA7-mediated ISGylation facilitates clustering of transcription factors and activates an antitumor gene-expression program.",31974171_7,-1,1,-1,1,38890,-1,5.9783074e-06,0.9999888,5.2711757e-06
31595,relevant,21,22,135,143,"Here, we aimed to assess whether acrolein at concentrations relevant for smokers may also exert immunomodulatory effects that could be relevant in allergy or cancer.",28332605_1,-1,1,-1,1,31595,-1,4.9194692e-05,0.9999348,1.6009439e-05
2152,These,0,1,0,5,These results suggest that CD4(+)CD25(bright) T cells found in the normal and inflamed intestinal mucosa selectively inhibit the host immune response and therefore may contribute to the intestinal immune homeostasis.,15322172_7,-1,1,-1,1,2152,-1,3.6105084e-06,0.9999924,4.056486e-06
375,natural,8,9,66,73,"Tumor-transplanted animals showed enhanced expression of CD40L on natural killer (NK) and T cells, when compared to cells from normal animals.",11129327_4,-1,1,-1,1,375,-1,1.6253296e-05,0.99997437,9.353442e-06
2374,the,15,16,82,85,"Antioxidants, such as 2-mercaptoethanol (2-ME), or fetal calf serum could prevent the death of these cells but caused them to enter distinct states of differentiation.",15614042_3,-1,1,-1,1,2374,-1,7.4203085e-06,0.99998844,4.0859773e-06
19077,status,9,10,56,62,T(REG) were also quantified by analyzing the epigenetic status of the FOXP3 locus using methylation specific PCR.,23118856_5,-1,1,-1,1,19077,-1,5.5895553e-06,0.99998987,4.586833e-06
22897,The,0,1,0,3,The complicated tumor-related Treg subsets and their functional mechanisms are not fully addressed yet.,24668348_1,-1,1,-1,1,22897,-1,5.3641065e-06,0.9999901,4.518013e-06
16123,that,3,4,28,32,"These observations indicate that IL-21 amplifies an inflammatory milieu that promotes CAC, and suggest that IL-21 blockade may be useful in reducing the risk of UC-associated colon cancer.",21987656_7,-1,1,-1,1,16123,-1,6.428864e-06,0.9999896,3.9467945e-06
25155,towards,7,8,37,44,"Finally, for a more radical approach towards a safe MEK inhibitor, we validate the potential of multi-kinase inhibitor curcumin, especially the nano-curcumin made out of pure curcumin with greater bioavailability; in repealing tumour-shed TGF--induced Treg cell augmentation.",25284464_6,-1,1,-1,1,25155,-1,4.9183695e-06,0.9999902,4.831508e-06
15485,the,14,15,88,91,RESULTS: Higher percentages of melanocyte antigen-specific CD8(+) T cells were found in the melanoma tissues as compared with adjacent normal skin and peripheral blood.,21750202_3,-1,1,-1,1,15485,-1,4.9287078e-06,0.99998903,5.9981026e-06
37858,tumor-infiltrating,5,6,20,38,"Also, the number of tumor-infiltrating CD20+ B cells (P = 0.0094) increased in these patients.",31537619_5,-1,1,-1,1,37858,-1,2.1686648e-05,0.9999671,1.1155623e-05
19385,gene,28,29,170,174,"This is particularly true in chronic myeloid leukemia (CML).METHODS: In this study, we isolated fetal liver kinase-1-positive (Flk1(+)) cells carrying the BCR/ABL fusion gene from the bone marrow of Philadelphia chromosome-positive (Ph(+)) patients with stem cells property.",23180012_2,-1,1,-1,1,19385,-1,6.677388e-06,0.9999863,7.003858e-06
24867,gene,38,39,278,282,"To further elucidate why an allogeneic gene-modified [interleukin-7 (IL-7)/CD80-cotransfected] renal cell cancer (RCC) vaccine failed to induce clinically relevant TH-1-polarized immune responses, peripheral blood mononuclear cells from enrolled study patients were analyzed by gene expression profiling (GEP) both prior and after vaccination.",25242680_1,-1,1,-1,1,24867,-1,4.9179694e-06,0.99998987,5.2117184e-06
5870,the,10,11,67,70,"The potency of Treg cell proliferation is negatively determined by the initial prevalence of Treg cells, suggesting that Treg cells are a factor for self-controlling Treg cell proliferation.",17671219_6,-1,1,-1,1,5870,-1,4.5565325e-06,0.999992,3.3807517e-06
5770,the,17,18,101,104,"In a screen for T cell-inhibitory molecules in cHL, we found that RS cells selectively overexpressed the immunoregulatory glycan-binding protein, galectin-1 (Gal1), through an AP1-dependent enhancer.",17670934_2,-1,1,-1,1,5770,-1,4.242222e-06,0.9999914,4.371795e-06
21018,tumor-bearing,26,27,166,179,The results showed that triptolide significantly decreased the proportion of regulatory T cells and lowered the Foxp3 level in the spleen and axillary lymph nodes of tumor-bearing mice.,23975869_7,-1,1,-1,1,21018,-1,4.960494e-06,0.99998987,5.2239343e-06
2448,STAT6-deficient,12,13,65,80,"After removal of primary tumor, MSC levels revert to baseline in STAT6-deficient mice, but remain elevated in BALB/c mice.",15634881_2,-1,1,-1,1,2448,-1,2.2817565e-05,0.999954,2.320376e-05
2429,the,30,31,160,163,"Antitumor immune responses were mediated by both CD4+ and CD8+ T cells, were human lymphocyte antigen class I and II associated, and persisted 18 months beyond the completion of vaccination.",15623607_6,-1,1,-1,1,2429,-1,7.2541447e-06,0.9999877,5.0172625e-06
9429,the,14,15,72,75,"Thus, not the tumor itself, but its location dictates the efficiency of the anti-tumor immune response.",19337997_8,-1,1,-1,1,9429,-1,3.9231663e-06,0.99999213,3.9760835e-06
4724,types,16,17,107,112,"In addition, the full-length SSX-1 antigen is frequently expressed in tumors of several other histological types such as sarcoma, melanoma, hepatocellular carcinoma, ovarian cancer and myeloma.",17186289_2,-1,1,-1,1,4724,-1,8.333655e-05,0.9987225,0.0011941191
897,The,0,1,0,3,"The mechanism of IL-8 induction was through a mitogen-activated protein kinase and NF-kappaB pathway, as inhibitors of both systems abrogated IL-8 protein induction.",11801678_10,-1,1,-1,1,897,-1,4.9673117e-06,0.99999094,4.0341965e-06
18021,Treg,7,8,43,47,Recent studies have revealed that FOXP3(+) Treg include distinct subsets specifically controlling over the corresponding effector subset.,22798340_2,-1,1,-1,1,18021,-1,6.9393104e-06,0.99998784,5.2720657e-06
39328,TAMs,7,8,47,51,"This modification occurs on MAF transcripts in TAMs and modified by BRD4, which is the target of AZD5153.",32184777_7,-1,1,-1,1,39328,-1,5.5458186e-06,0.999985,9.516644e-06
1389,The,0,1,0,3,"The epitope was derived from the newly created open reading frame, which resulted from extension of exon 14 after splicing of the adjacent intronic sequence.",12707369_6,-1,1,-1,1,1389,-1,4.919487e-06,0.9999913,3.7388097e-06
4319,the,13,14,93,96,CCL-51 breast cancer nodules suppressed the growth of uninjected metastatic tumor nodules in the lung.,16928818_9,-1,1,-1,1,4319,-1,5.3517756e-06,0.999987,7.683756e-06
28422,the,20,21,127,130,"Radiation modulates both tumor cells and immune cells in the tumor microenvironment to exert its anti-tumor activity; however, the molecular connection between tumor cells and immune cells that mediates radiation-exerted tumor suppression activity in the tumor microenvironment is largely unknown.",27014915_0,-1,1,-1,1,28422,-1,6.141972e-06,0.99998915,4.7400104e-06
19351,Foxp3,2,3,14,19,"Expression of Foxp3, IL-10, and TGF- mRNAs in MLRs were detected by real-time PCR.",23179394_5,-1,1,-1,1,19351,-1,5.0525205e-06,0.9999887,6.2322865e-06
28728,the,12,13,87,90,"Though isogenic, indolent and aggressive-stage cell lines had diverged phenotypically, the latter expressing multiple Th17 related cytokines, the former a narrower profile.",27144517_3,-1,1,-1,1,28728,-1,4.571598e-06,0.9999894,6.066615e-06
21778,Tregs,9,10,66,71,"Unexpectedly, we observed a significantly decreased percentage of Tregs, and increased CD8+ T cells and CD4+ T cells in the lymph nodes, spleen and liver after the combination therapy.",24304581_11,-1,1,-1,1,21778,-1,4.42594e-06,0.99999034,5.2157584e-06
24914,tumor,34,35,210,215,"The emerging data promise a future scenario in which the selective blockade of individual members of the galectin family, either alone or in combination with other therapeutic regimens, will contribute to halt tumor progression by counteracting tumor-immune escape.",25253145_3,-1,1,-1,1,24914,-1,4.258454e-06,0.9999918,3.9474544e-06
28653,complex,8,9,58,65,"RESULTS: AO-1 could down-regulate expression of TLR4/MD-2 complex, resulting in downregulation of MyD88/NF-B signaling and activation of NF-B, Akt and IDO1 and secretion of IL-6, TGF-1, VEGF and IL-17A by EOC SKOV3 cells, and further reduce increased levels of regulatory T cells (Treg cells) and improve decreased proliferative response and antitumor cytotoxicity of T lymphocytes exposed to EOC SKOV3 cell supernatant.",27118139_4,-1,1,-1,1,28653,-1,4.146203e-06,0.9999901,5.774693e-06
15155,these,2,3,14,19,"Additionally, these data may provide insight to predict response in patients with melanoma undergoing rhIL-2 treatment.",21638127_7,-1,1,-1,1,15155,-1,5.7694297e-06,0.99999,4.2872193e-06
10331,GATA-3,9,10,48,54,"However, neither in the expression of T-bet and GATA-3, nor in the plasma level of IFN-gamma and IL-4, showed a significant difference between group A and B.CONCLUSION: In the peripheral blood of esophageal cancer patients, the expression of T-bet decreased, while GATA-3 increased, Th1/Th2 balance is broken, and the Th2 is dominant.",19615257_5,-1,1,-1,1,10331,-1,1.1749459e-05,0.99996984,1.8468003e-05
26316,the,1,2,3,6,"In the present study, we mainly investigated the role of Th22, Th17, and Th1 cell and their related cytokines (IL-22, IL-17, and IFN-r) in the pathophysiology of CML.",26000313_1,-1,1,-1,1,26316,-1,4.4548538e-06,0.9999902,5.304992e-06
42274,Thus,0,1,0,4,"Thus, DNGR-1 blockade may improve antitumor immunity in tumor therapy settings associated to high Flt3L expression.",33980589_15,-1,1,-1,1,42274,-1,6.055661e-06,0.9999893,4.6215355e-06
9775,to,7,8,36,38,"Our data indicate that, in addition to controlling effector T-cell function, OX40 costimulation directly controls Treg-mediated suppression in tumor immunity.",19455675_9,-1,1,-1,1,9775,-1,6.48519e-06,0.9999877,5.7345073e-06
10889,the,19,20,131,134,"Twelve months later, proliferative T cell responses remained detectable in only six women and the immunodominant antigens remained the E6/2 (14-34) and E6/4 (45-68) peptides.",19843089_3,-1,1,-1,1,10889,-1,6.5734325e-06,0.99998736,6.091288e-06
37430,they,13,14,66,70,"Regulatory T (Treg) cells are crucial for immune homeostasis, but they also contribute to tumor immune evasion by promoting a suppressive tumor microenvironment (TME).",31350177_0,-1,1,-1,1,37430,-1,6.6814573e-06,0.9999862,7.093935e-06
41621,the,18,19,99,102,"T follicular helper cells (Tfh) are involved in the formation and maintenance of germinal centres, the differentiation of B cells into plasma cells, and the maintenance of helper T cell type 2 (Th2)-dominant humoral immune responses.",33647861_1,-1,1,-1,1,41621,-1,3.534916e-06,0.99999154,4.9743926e-06
29837,the,29,30,173,176,"Our present findings indicate that IRF4 reduction induced by tumor formation can increase the number of MDSCs, and increases in the IRF4 expression in MDSCs may infringe on the immune-suppressive function of MDSCs.",27601624_11,-1,1,-1,1,29837,-1,4.7039252e-06,0.9999919,3.3634626e-06
9046,plasma,3,4,38,44,Fludarabine lymphodepletion increased plasma levels of the homeostatic cytokines IL-7 and IL-15.,19270751_13,-1,1,-1,1,9046,-1,2.3263967e-05,0.9999627,1.4010451e-05
33105,TIM-1,17,18,90,95,We now show that TIM-4 is expressed by a subset of B cells distinct from those expressing TIM-1.,28848066_3,-1,1,-1,1,33105,-1,6.253798e-06,0.9999801,1.3695369e-05
14287,tumor,3,4,16,21,CONCLUSION: SLN tumor burden correlates with immunosuppressive IDO and Foxp3 expressions within the SLNs of melanoma patients.,21327637_16,-1,1,-1,1,14287,-1,4.4334442e-06,0.9999887,6.948548e-06
22293,thereby,12,13,87,94,"IL-6 regulates T cell differentiation, activation and resistance against apoptosis and thereby controls the balance between pro-inflammatory T cell subsets such as Th1 or Th17 cells and immunosuppressive regulatory T cells.",24447345_1,-1,1,-1,1,22293,-1,4.4792946e-06,0.9999913,4.249073e-06
720,that,11,12,70,74,We generated HLA-A*0201-restricted CTL clones against HPV16 E6(29-38) that recognized HPV16 E6 Ags transfected into B lymphoblastoid cells.,11673561_3,-1,1,-1,1,720,-1,4.894495e-06,0.99998987,5.275617e-06
14780,Treg,15,16,109,113,"Taken together, these findings suggest that IDO may represent an important regulatory checkpoint influencing Treg activity: both by stabilizing and augmenting the suppressive phenotype, and by preventing Treg reprogramming into non-suppressive helper-like cells.",21517755_7,-1,1,-1,1,14780,-1,4.791097e-06,0.99999094,4.2230868e-06
25006,this,11,12,70,74,"Furthermore, by defining a critical role for adiponectin signaling in this process, our work suggests new and broadly applicable strategies for immunometabolic therapy in patients with cancer.",25261236_7,-1,1,-1,1,25006,-1,5.767792e-06,0.9999902,3.972354e-06
21398,to,28,29,176,178,"HPV-specific T cell responses against HPV16 E6 and E7 peptides were detected by enzyme-linked immunoSPOT in 10/13 and 8/13 evaluable patients, respectively, but did not appear to correlate with HPV status.",24146146_3,-1,1,-1,1,21398,-1,4.7974004e-06,0.9999906,4.633448e-06
18966,Foxp3(+,3,4,26,33,Short-term elimination of Foxp3(+) Tregs (<7 days) was sufficient to boost vaccine-induced immunity.,23090488_3,-1,1,-1,1,18966,-1,4.815271e-05,0.99991834,3.3462125e-05
10258,targets,7,8,43,50,Enriched omental iNKT cells killed CD1d(+) targets and released IFN-gamma and IL-4 upon activation.,19585513_5,-1,1,-1,1,10258,-1,7.2158205e-06,0.9999815,1.12460475e-05
6477,two,14,15,77,80,Here we report the effects of systemic IL-21 therapy on the immune system in two phase 1 trials with this novel cytokine.,18286285_1,-1,1,-1,1,6477,-1,7.813285e-06,0.9999871,5.104655e-06
31736,Blimp1,19,20,116,122,"Compared to CXCR5-CD8+ T cells, the CXCR5+CD8+ T cells demonstrated significantly higher Bcl-6 expression and lower Blimp1 expression, suggesting that CXCR5+CD8+ T cells might represent a memory CD8+ T cell subset.",28412245_3,-1,1,-1,1,31736,-1,6.943929e-06,0.99998164,1.1449956e-05
2046,this,1,2,3,7,"In this study, we investigate the implication of T(reg) in modulating infiltrating T lymphocytes in human metastatic melanoma.",15240741_1,-1,1,-1,1,2046,-1,4.2278407e-06,0.99999166,4.1454546e-06
10785,tumor,28,29,229,234,"However, tumor growth was inhibited significantly more in vaccinated mice treated with anti-TGF-beta antibodies compared to vaccinated mice without anti-TGF-beta, suggesting that anti-TGF-beta synergistically enhanced irradiated tumor vaccine efficacy.",19830696_3,-1,1,-1,1,10785,-1,6.5634626e-06,0.9999887,4.722312e-06
14187,that,3,4,19,23,The results showed that 2-10% Eca tissue-derived CD4(+) T cells expressed Foxp3; only 0.2-0.8% non-ca tissue-derived CD4(+) T cells expressed Foxp3.,21314287_6,-1,1,-1,1,14187,-1,3.788812e-06,0.9999919,4.3182113e-06
13435,tight,8,9,42,47,"Follicular lymphoma (FL) B cells contract tight connections with their microenvironment, which governs the pathogenesis and progression of the disease.",20944673_0,-1,1,-1,1,13435,-1,1.2451974e-05,0.9999697,1.7872506e-05
18244,the,4,5,19,22,We report here for the first time that the transcription factor GLI2 regulates the expression of TGF-1 in human CD4(+) T cells.,22859956_2,-1,1,-1,1,18244,-1,6.9114944e-06,0.9999862,6.936825e-06
30842,the,5,6,53,56,"Tumor-infiltrating lymphocytes coexpressed PD-1 with the inhibitory receptors TIM-3, CTLA-4, LAG-3, and TIGIT, but also displayed a recently activated, nonexhausted phenotype.",27979840_3,-1,1,-1,1,30842,-1,4.3451637e-06,0.9999912,4.459823e-06
19900,TGF-1,9,10,51,57,"The supernatant from Hepa1-6 cells and recombinant TGF-1 significantly induced the expression of Foxp3 gene in vitro, while that from sh TGF-1 Hepa1-6 cells restored it.",23361571_6,-1,1,-1,1,19900,-1,7.402803e-06,0.9999764,1.6232972e-05
3222,tumor,28,29,187,192,"Our results showed that antisense GATA-3 treatment could inhibit the expression of TNF-alpha and Th2 cytokines in tumor cells, and antisense-induced blockade of GATA-3 could also depress tumor growth in tumor-bearing mice.",16212886_4,-1,1,-1,1,3222,-1,4.075461e-06,0.999992,3.9090187e-06
15630,the,9,10,63,66,"NLGP is not apoptotic to Tregs but significantly downregulates the expression of Foxp3, CTLA4 and GITR.",21843083_6,-1,1,-1,1,15630,-1,4.3875834e-06,0.9999914,4.2129436e-06
38685,the,32,33,211,214,"Marked reduction in Treg proliferation and tumor infiltration coincide with G1 arrest in tumor infiltrated Siah2-/- Tregs in vivo or following T cell stimulation in culture, attributed to elevated expression of the cyclin-dependent kinase inhibitor p27, a Siah2 substrate.",31911617_3,-1,1,-1,1,38685,-1,4.254255e-06,0.9999914,4.3213154e-06
11546,Tehranolide,6,7,34,45,"First we evaluated the effects of Tehranolide on cell growth inhibition (in vitro) by MTT assay and second investigated the immune responses, these include measuring tumor growth in the female Balb/c mice transplanted with spontaneous mouse mammary tumor and treated with Tehranolide, splenocyte proliferation detected by using the BrdU kit, measurement of cytokine profile by ELISA and analysis of T-lymphocytes subpopulation in spleen by Flow cytometry.",20138670_4,-1,1,-1,1,11546,-1,8.966225e-06,0.99998164,9.437161e-06
4813,Treg,2,3,13,17,"Depletion of Treg from peripheral blood mononuclear cells (PBMC) of CRC patients unmasked CD4(+) T cell responses, as observed by IFNgamma release, to the tumor associated antigen 5T4, whereas no effect was observed in a healthy age-matched control group.",17205133_5,-1,1,-1,1,4813,-1,5.4354255e-06,0.9999896,4.982573e-06
11176,the,15,16,86,89,"Moreover, an in vitro migration assay using T-regs derived from ESCC was performed in the presence of CCL17 or CCL22.",20002703_5,-1,1,-1,1,11176,-1,5.4328684e-06,0.9999902,4.2909383e-06
11650,to,14,15,71,73,"In a tumor model for cervical cancer (C3), therapeutic vaccination led to complete eradication in 100% of the mice.",20145549_3,-1,1,-1,1,11650,-1,5.183981e-06,0.99999046,4.3652876e-06
19928,these,14,15,69,74,"Here, we report that the Notch pathway has an important role in both these processes in human CD8(+) T cells.",23380742_2,-1,1,-1,1,19928,-1,9.278764e-06,0.9999826,8.179505e-06
15854,The,0,1,0,3,"The ligand-activated transcription factor peroxisome proliferator-activated receptor (PPAR)- is highly expressed in colonic epithelial cells; however, the role of PPAR ligands, such as fatty acids, in mucosal inflammation and malignant transformation has not been clarified.",21940900_0,-1,1,-1,1,15854,-1,4.1144117e-06,0.999992,3.848393e-06
35313,the,13,14,88,91,Mucosa-associated lymphoid tissue 1 (Malt1) regulates immune cell function by mediating the activation of nuclear factor B (NF-B) signaling through both its adaptor and proteolytic function.,30025160_0,-1,1,-1,1,35313,-1,5.1749594e-06,0.99999,4.78023e-06
8725,there,14,15,63,68,"At the final time points examined (tumor morbidity or 40 dpi), there was an increase in the frequency of TAMs with decreased capacity to secrete TNF-alpha.",19226468_8,-1,1,-1,1,8725,-1,4.993691e-06,0.99998975,5.233044e-06
18202,to,7,8,56,58,The mechanisms responsible for such accumulation remain to be elucidated.,22828446_10,-1,1,-1,1,18202,-1,8.5492775e-06,0.99998534,6.1162596e-06
41881,Thus,0,1,0,4,"Thus, virus-induced MDA5-TBK1-IRF3 signaling in the TME provides PRR-contextualized IFN responses that elicit functional antitumor T cell immunity.",33767151_6,-1,1,-1,1,41881,-1,5.5013634e-06,0.9999895,4.9438495e-06
6398,the,4,5,17,20,"Notably, part of the vaccine-induced T cells display a CD4(+)CD25(+)Foxp3(+) phenotype that is frequently associated with regulatory T-cell function, suggesting that strategies to disarm this subset of T cells should be considered as components of immunotherapeutic modalities against HPV-induced cancers.",18172269_7,-1,1,-1,1,6398,-1,4.411922e-06,0.9999919,3.6899812e-06
26247,tested,69,70,354,360,"METHODS: Overlapping 30-35 mer peptides covering the entire HPV16 E2-, E6- and E7 protein sequences were used for defining the lymphocyte proliferation capacity, cytokine production (IL-2, IL-5, IL-10, IL-17A, IFN- and TNF-) and numbers of HPV16 -specific CD4+ CD25+ Foxp3+ regulatory T-cells in 10 women who developed CIN, and in 22 control women who tested constantly HPV-negative during the follow-up.",25990808_2,-1,1,-1,1,26247,-1,6.5022523e-06,0.999987,6.4709693e-06
1319,the,3,4,22,25,"The treatment blocked the expression of FasL, but up-regulated the c-myc and Bid expression in the cells.",12528894_6,-1,1,-1,1,1319,-1,4.043718e-06,0.9999918,4.240711e-06
36879,the,10,11,64,67,Enzyme-linked immunosorbent assay (ELISA) was used to determine the levels of soluble GITRL/GITR in plasma.,31118027_4,-1,1,-1,1,36879,-1,4.507228e-06,0.9999919,3.6138965e-06
26077,that,21,22,117,121,"RESULTS: The percentage of Th22 cells in the CD4(+) T subset was significantly higher in tumor tissues compared with that in paratumor tissues (1.47%  0.083% vs 1.23%  0.077%, P < 0.05) as determined by flow cytometry.",25892871_4,-1,1,-1,1,26077,-1,4.9680143e-06,0.9999902,4.7563076e-06
22906,tumor-infiltrating,9,10,58,76,"In hepatocellular carcinoma patients, here, we identified tumor-infiltrating human CD4CD69 Tregs which represent ~67.2 % of tumor-infiltrating CD4 T cells that is significantly higher than conventional CD4CD25Foxp3 Tregs.",24668348_3,-1,1,-1,1,22906,-1,9.470347e-06,0.9999825,8.098965e-06
16387,They,0,1,0,4,They depend on adjuvants to create an immunogenic microenvironment for antigen presentation.,22130163_1,-1,1,-1,1,16387,-1,6.8026347e-06,0.999987,6.191684e-06
42265,tumors,8,9,51,57,"Indeed, the increased infiltration of cDC1s within tumors and their protective effect rely on CCL5/CCR5 chemoattraction.",33980589_11,-1,1,-1,1,42265,-1,3.7638943e-06,0.999992,4.250032e-06
22532,The,2,3,12,15,"BACKGROUND: The existence of Tc17 cells was recently shown in several types of infectious and autoimmune diseases, but their distribution and functions in uterine cervical cancer (UCC) have not been fully elucidated.",24523865_0,-1,1,-1,1,22532,-1,3.9696647e-06,0.99999213,3.9180213e-06
15209,the,45,46,247,250,"BACKGROUND: The purpose of this study was to investigate the presence of CD4(+) CD25(+) FOXP3(+) regulatory T (Treg) cells both in peripheral blood and local tumors in patients with nasal inverted papilloma (NIP).METHODS: By using flow cytometry, the frequencies of CD4(+) CD25(+) FOXP3(+) Treg cells in both peripheral blood and tissues from 18 patients with NIP and 8 control subjects were determined.",21674673_0,-1,1,-1,1,15209,-1,3.6822107e-06,0.99999225,4.112161e-06
32766,the,21,22,99,102,"The PEG chains on NKTR-214 are located at the region of IL2 that contacts the alpha () subunit of the heterotrimeric IL2 receptor complex, IL2R, reducing its ability to bind and activate the heterotrimer.",28678791_6,-1,1,-1,1,32766,-1,4.0757764e-06,0.9999912,4.7852805e-06
22127,To,0,1,0,2,"To investigate the factors that could explain these differences, we analyzed the transcriptomes of purified thymic Treg and Tconv cells from MG patients in comparison to CTRL cells.",24405842_6,-1,1,-1,1,22127,-1,7.3211095e-06,0.9999888,3.8854682e-06
32601,that,6,7,23,27,"In this study, we show that excellent antitumor CD8 T cell responses can be achieved in Foxp3KO mice deficient in OX40 and CD30 signals, particularly in the presence of concurrent PD1 blockade.",28646041_2,-1,1,-1,1,32601,-1,5.24216e-06,0.9999908,3.9020974e-06
15230,tumors,4,5,23,29,CCL22 increased in NIP tumors.,21674673_4,-1,1,-1,1,15230,-1,3.9174247e-06,0.9999895,6.5228332e-06
27665,to,11,12,78,80,Two allele variants were found to be associated with increased susceptibility to LAC.,26547104_4,-1,1,-1,1,27665,-1,6.404168e-06,0.99998796,5.684979e-06
7660,to,11,12,79,81,"Although WP1066 did not induce immunologic memory or enhance humoral responses to EGFRvIII, this compound reduced the production of immunosuppressive cytokines and chemokines (transforming growth factor-beta, RANTES, MCP-1, vascular endothelial growth factor), markedly inhibited natural and inducible Treg proliferation, and significantly increased cytotoxic immune responses of T cells.",18794085_7,-1,1,-1,1,7660,-1,1.1724795e-05,0.9999769,1.1397173e-05
13680,the,8,9,47,50,"Importantly, Treg frequency was not reduced in the presence of tremelimumab, and expanded Tregs in cancer patients treated with tremelimumab expressed FoxP3 with no IL-2 release, confirming them as bona fide Tregs.",21056008_5,-1,1,-1,1,13680,-1,3.7895447e-06,0.9999926,3.6218344e-06
9420,that,3,4,14,18,"Our data show that gliomas in the CNS, but not in the skin, give rise to TGF-beta production and accumulation of both Treg and functionally impaired DC.",19337997_7,-1,1,-1,1,9420,-1,4.1130393e-06,0.99999213,3.7647744e-06
39331,the,2,3,13,16,"Importantly, the 3-D microfluid model demonstrates that AZD5153 sensitizes ovarian cancer to anti-PD-L1 therapy.",32184777_8,-1,1,-1,1,39331,-1,3.8023363e-06,0.99999213,4.0189716e-06
11830,the,14,15,94,97,Curcumin has previously been shown to have antitumor activity and some research has addressed the immunoprotective potential of this plant-derived polyphenol in tumor-bearing hosts.,20305684_4,-1,1,-1,1,11830,-1,5.5995174e-06,0.99999094,3.5141982e-06
22415,Tregs,2,3,18,23,More intratumoral Tregs and less IL-17A+T cells were associated with suppressed MMPs activities and decreased metastases score.,24487033_9,-1,1,-1,1,22415,-1,4.113119e-06,0.9999906,5.3128415e-06
34794,the,4,5,19,22,"The key factors in the canonical Wnt signaling pathway in the experimental group (PE+mDC+naive CD4+T cells) were challenged, and the levels of beta-catenin, C-myc, cyclin D1 and PPAR1 were significantly enhanced at the 5th day.",29783020_5,-1,1,-1,1,34794,-1,3.7627444e-06,0.9999925,3.7241382e-06
19063,To,2,3,9,11,PURPOSE: To evaluate CD4(+)CD25(+)FOXP3(+) T regulatory cells (T(REG)) and associated immune-regulatory pathways in peripheral blood lymphocytes (PBL) of metastatic renal cell carcinoma (mRCC) patients and healthy volunteers.,23118856_0,-1,1,-1,1,19063,-1,4.1329863e-06,0.9999912,4.655833e-06
13845,tested,51,52,295,301,"As a positive control, a more than 2-fold increase in blood Tregs was detected in four out of nine patients who were treated with interleukin-2.CONCLUSIONS: We used a MS-qPCR method that detects Tregs but not other activated T lymphocytes; however, none of the Treg-depleting strategies that we tested led, in the majority of patients, to a conservative 50% reduction in blood Tregs.",21177412_7,-1,1,-1,1,13845,-1,7.265085e-06,0.99998784,4.872656e-06
5613,the,5,6,42,45,"HPV16 E6 tetramer-sorted lymphocytes from the different anatomic sites recognized an HLA-A*0201-restricted E6 peptide irrespective of the type of antigen-presenting cells used for stimulation as determined by interferon-gamma production: autologous tumor cells, HLA-A*0201 surrogate antigen-presenting cells pulsed with the nominal peptide, and an HLA-A*0201-matched human dendritic cell line transgenic for HPV16 E6.",17589293_3,-1,1,-1,1,5613,-1,4.6213936e-06,0.99998915,6.2749555e-06
42322,TME,13,14,70,73,Targeting MYCN or its effectors could be a strategy to convert a cold TME into a 'hot' (inflamed) TME and improve the efficacy of ICB therapy.,34016720_3,-1,1,-1,1,42322,-1,2.371226e-05,0.999951,2.5269073e-05
17809,the,20,21,145,148,"Remarkably, these findings reveal a previously unknown level of gene expression diversity among vaccine-specific and virus-specific T cells with the simultaneous coexpression of multiple memory/homing-related and effector-related genes by the same cell.",22735807_7,-1,1,-1,1,17809,-1,4.5685847e-06,0.9999919,3.5200683e-06
13891,tumour,52,53,315,321,"Moreover, we found three unexpected perturbations in FOXP3+ T-cell subsets: (i) patients with melanoma showed higher frequencies of FOXP3(low) nonregulatory T cells, which decreased and normalized after tumour removal; (ii) FOXP3(low) nave Tregs containing higher frequencies of interferon-+ cells increased with tumour progression; and (iii) CD45RO+FOXP3(high) effector Tregs were pronouncedly infiltrated around tumour tissues.",21198537_7,-1,1,-1,1,13891,-1,5.192014e-06,0.99999,4.8504444e-06
12236,Tregs,19,20,116,121,The present study was therefore undertaken to evaluate the significance of the balance between CXCR3(+) T cells and Tregs in 44 Ly-rich and 37 conventional GCs by morphometrical analyses of immunohistochemistry.,20422211_3,-1,1,-1,1,12236,-1,3.5887736e-06,0.999992,4.3635837e-06
30154,the,11,12,72,75,Programmed death-1 (PD-1) is a coinhibitory receptor that downregulates the activity of tumor-infiltrating lymphocytes (TIL) in cancer and of virus-specific T cells in chronic infection.,27683557_0,-1,1,-1,1,30154,-1,4.3245345e-06,0.9999913,4.3366276e-06
30106,that,5,6,38,42,"Recent research studies have revealed that immunosuppression and inflammation are associated with oncogenesis, as well as tumor development, invasion, and metastasis in PAC.",27672267_1,-1,1,-1,1,30106,-1,4.3289747e-06,0.9999913,4.3835767e-06
42978,the,5,6,39,42,Treatment with endocrine therapy using the aromatase inhibitor letrozole increases CD4+ T cell infiltration into ER+ breast cancer tumours in immune competent mice.,34602068_10,-1,1,-1,1,42978,-1,4.5587335e-06,0.9999914,3.998859e-06
20356,the,2,3,16,19,We investigated the role of cancer cell NF-B activity in T cell-mediated antitumor responses.,23635779_1,-1,1,-1,1,20356,-1,4.3328646e-06,0.999992,3.601253e-06
27051,thus,19,20,148,152,Our findings demonstrate that GITR co-stimulation mediates antitumor immunity by promoting TH9 cell differentiation and enhancing CTL responses and thus provide a mechanism of action for GITR agonist-mediated cancer immunotherapies.,26280119_6,-1,1,-1,1,27051,-1,5.405083e-06,0.9999896,4.9417104e-06
13646,Tregs,9,10,53,58,Marked induction of CXCR1 expression on Foxp3(+) CD4 Tregs by IL-6 followed by IL-8-mediated migration appeared to be responsible for enriched migration.,21048114_2,-1,1,-1,1,13646,-1,5.677181e-06,0.99998474,9.542443e-06
17411,that,3,4,21,25,Our data demonstrate that chronic phase CML is associated with functional deficiencies of iNKT cells that are restored upon remission.,22585600_7,-1,1,-1,1,17411,-1,4.0102036e-06,0.9999919,4.112199e-06
28409,These,0,1,0,5,These induced Tregs are highly immunosuppressive and dramatically inhibit the proliferative activity of nave CD4(+) T cells.,27000869_10,-1,1,-1,1,28409,-1,4.5668494e-06,0.99999154,3.8748403e-06
5596,the,2,3,11,14,"To monitor the differences in T-cell recognition, 2 approaches of tetramer-guided technology were employed: (i) the in situ localization of major histocompatibility complex class I peptide complexes in the tumor lesions and (ii) the ex vivo sorting of HLA-A*0201-restricted and HPV16 E6-reactive T cells.",17589293_1,-1,1,-1,1,5596,-1,3.789212e-06,0.9999926,3.5703142e-06
31183,subunit,14,15,101,108,These observations were further supported by an enhancement of nuclear translocation of the p65NF-B subunit involved in this process.,28088065_5,-1,1,-1,1,31183,-1,8.386638e-06,0.9999815,1.0079258e-05
14359,Foxp3(+,0,1,0,7,Foxp3(+) IL-17(+) T cells in cancer tissue were examined by flow cytometry.,21352252_3,-1,1,-1,1,14359,-1,4.907405e-05,0.9999199,3.0975625e-05
25445,Thus,0,1,0,4,"Thus, CD25 identifies a subset of CD4FoxP3 TIL that, despite being exhausted at diagnosis, have a strong, positive association with patient survival and warrant consideration as effector T cells for immunotherapy.",25480168_10,-1,1,-1,1,25445,-1,5.518048e-06,0.9999889,5.6217004e-06
42736,therapies,36,37,242,251,"VEGF-A blockade phenocopies genetic STING loss and synergizes with ICB and/or poly(ADP-ribose) polymerase (PARP) inhibitors to control the outgrowth of Trp53-/-Brca1-/- but not Brca1+/+ ovarian tumors invivo, offering rational combinatorial therapies for HRD cancers.",34289354_6,-1,1,-1,1,42736,-1,5.754247e-06,0.99998987,4.3714967e-06
5954,to,9,10,50,52,"In melanoma cells, the JNK/SAPK pathway was shown to be important for the IL-8 secretion during the VZV replication, whereas in the T cell line, not only the JNK/SAPK but also the p38/MAPK pathways were required for IL-8 secretion.",17909856_4,-1,1,-1,1,5954,-1,6.524026e-06,0.9999883,5.145189e-06
25115,STAT3,19,20,137,142,"In conclusion, these data suggest that malignant T-cells orchestrate accumulation and activation of eosinophils supporting the notion of STAT3 being a putative target for therapy.",25275020_6,-1,1,-1,1,25115,-1,6.315732e-06,0.99998915,4.4924705e-06
5346,Treatment,0,1,0,9,Treatment with CA reduced intracellular expression of IDO mRNA and protein levels in IFN-gamma-activated murine BMDCs in vitro and in CD11c(+)CD8alpha(+) DCs of tumor-draining lymph node (TDLN) of tumor-bearing mice in vivo.,17466914_2,-1,1,-1,1,5346,-1,5.200879e-06,0.99998975,5.0915905e-06
3113,naturally,28,29,189,198,Our experiments indicate that the accumulation of CD4+CD25+ regulatory T cells (T reg cells) expressing FoxP3 and exhibiting immunosuppressive function originates from the proliferation of naturally occurring CD25+ T cells and requires signaling through transforming growth factor (TGF)-beta receptor II.,16186184_1,-1,1,-1,1,3113,-1,5.148314e-06,0.99999094,3.94549e-06
6311,relatively,9,10,51,61,Regulatory T cells (CD4+CD25+Foxp3+-positive) were relatively deficient in the spleen cells from tumor-bearing mice injected intracerebrally with the enriched vaccine.,18157008_5,-1,1,-1,1,6311,-1,1.5792868e-05,0.99997425,9.949643e-06
37193,the,3,4,13,16,"In addition, the ability of DCs and macrophages to induce colorectal cancer cell invasion was hampered in the presence of IFN--NPs.",31233057_9,-1,1,-1,1,37193,-1,8.814807e-06,0.9999871,4.036729e-06
11838,type,14,15,90,94,"We observed severe loss of both effector and memory T-cell populations, downregulation of type 1 and upregulation of type 2 immune responses and decreased proliferation of effector T cells in the presence of tumors.",20305684_6,-1,1,-1,1,11838,-1,5.8397495e-06,0.9999871,7.035931e-06
40334,complex,6,7,46,53,"Mutations of the SWI/SNF chromatin remodeling complex occur in 20% of all human cancers, including ovarian cancer.",32649682_0,-1,1,-1,1,40334,-1,8.693008e-06,0.99998343,7.886418e-06
43409,through,2,3,15,22,The mechanisms through which Vascular Endothelial Growth Factor A(VEGF-A) modulates tumor EC response to exclude T-cells are not well understood.,36403190_1,-1,1,-1,1,43409,-1,3.0001569e-05,0.99995804,1.1975709e-05
4102,that,17,18,104,108,Here we show that a widely used neutralizing anti-murine IL-2 mAb (S4B6) exhibits unexpected activities that enhance the treatment effects of IL-2 in vivo.,16785526_1,-1,1,-1,1,4102,-1,4.548862e-06,0.9999913,4.1068192e-06
41731,Therefore,0,1,0,9,"Therefore, the IRF-1/CXCL10/CXCR3 axis contributes to the anti-tumor microenvironment in HCC.",33689775_8,-1,1,-1,1,41731,-1,5.340091e-06,0.99998903,5.6401364e-06
35021,their,13,14,92,97,Significance: This study characterizes two different poly-I:C-induced signaling pathways in their induction of immunostimulatory and suppressive factors and suggests improved ways to reprogram the TME to enhance the antitumor efficacy of immunotherapies.,29853604_6,-1,1,-1,1,35021,-1,4.586513e-06,0.9999908,4.545217e-06
663,The,0,1,0,3,"The increased functional capacity to secrete Th2 cytokines, along with the increased expression of surface markers for Ag-experienced Th2-committed cells, would argue for a role of GATA-3 in Th2 memory formation.",11441076_10,-1,1,-1,1,663,-1,4.1932017e-06,0.99999213,3.676273e-06
14680,the,13,14,85,88,"Collectively, our study not only demonstrates the plasticity of Ag-specific Tregs in the context of the tumor environment, but also defines key molecular and cellular events that modulate ex-Treg differentiation.",21389255_7,-1,1,-1,1,14680,-1,4.4115422e-06,0.99999154,4.0891555e-06
6546,Treg,1,2,9,13,"ICOShigh Treg exposed to Tr1 cytokines expressed IL-10 and suppressed RC (92+/-12%) in contrast to ICOSlow Treg, which mediated low suppression (21+/-15%; p<or=0.0028).CONCLUSION: ICOShigh Treg can induce diverse immune responses in RC, depending on activation signals and cytokines present.",18292519_9,-1,1,-1,1,6546,-1,6.1145756e-06,0.9999865,7.3491647e-06
26205,the,8,9,46,49,"We found that DCs exposed to butyrate express the immunosuppressive enzymes indoleamine 2,3-dioxygenase 1 (IDO1) and aldehyde dehydrogenase 1A2 (Aldh1A2), promote conversion of naive T-cells into immunosuppressive forkhead box P3(+) (FoxP3(+)) Tregs (regulatory T-cells) and suppress conversion of naive T-cells into pro-inflammatory interferon (IFN)--producing cells.",25984582_4,-1,1,-1,1,26205,-1,3.8179865e-06,0.99999213,4.041726e-06
36977,the,4,5,26,29,OBJECTIVE: To investigate the expression of 4-1BBL on B cells in the breast tumor draining lymph nodes (TDLNs) and its association with disease parameters.,31182685_1,-1,1,-1,1,36977,-1,3.5608386e-06,0.99999297,3.4861096e-06
36883,Tregs,3,4,18,23,"Membrane GITRL on Tregs and expression of Helios and other markers (FOXP3, CD25, CD39, CTLA-4, PD-L1 and IL-10) involved in immunosuppressive activity were determined by flow cytometry.",31118027_6,-1,1,-1,1,36883,-1,3.751388e-06,0.9999912,5.0539597e-06
32420,the,12,13,66,69,"In this study, we investigated how CD70 expression by GBM affects the characteristics of tumor cells and the tumor microenvironment.",28612394_3,-1,1,-1,1,32420,-1,4.158291e-06,0.99999166,4.152466e-06
13822,tumor,9,10,65,70,"The patients participated in three clinical trials that combined tumor vaccines with potential Treg-depleting agents: low-dose cyclophosphamide, anti-CD25 monoclonal antibody daclizumab, and the IL-2/diphtheria toxin fusion protein denileukin diftitox.",21177412_4,-1,1,-1,1,13822,-1,5.2977402e-06,0.99999,4.719477e-06
19375,to,26,27,144,146,BACKGROUND: Cancer stem cells (CSCs) are proposed to persist in tumors as a distinct population and cause relapse and metastasis by giving rise to new tumors.,23180012_0,-1,1,-1,1,19375,-1,6.8918107e-06,0.9999865,6.544922e-06
18887,the,29,30,195,198,"After CD3 and CD28 antibody stimulation, a significantly higher phosphorylated TCR chain level was demonstrated, and an increased IL-2 production in TCR-upregulated T cells was associated with the increased expression of the phosphorylated NF-B. In conclusion, TCR gene transfection could restore TCR chain deficiency and enhance IL-2 production in T cells from patients with CML.",23057733_5,-1,1,-1,1,18887,-1,4.006985e-06,0.999992,3.993221e-06
21299,c-MYC protein,22,24,142,155,"Using a xenogenic vaccination strategy by immunizing C57BL/6 mice with human c-MYC protein or non-homologous peptides, we show that the human c-MYC protein, despite its high homology between mouse and man, contains several immunogenic epitopes presented in the context of murine H2(b) haplotype.",24130880_2,-1,1,-1,1,21299,-1,9.49088e-05,0.9998217,8.344402e-05
15460,the,3,4,21,24,This review examines the processes and pathways involved in the highly orchestrated development of T cell fate specification under physiological as well as pathological conditions.,21740230_5,-1,1,-1,1,15460,-1,4.1633284e-06,0.999992,3.8014834e-06
1999,this,1,2,3,7,"In this study, three leukemic cell lines were investigated: Kasumi-1 and SKNO-1 (two acute myeloid leukemia (AML) cell lines carrying the (8;21)-chromosomal translocation, resulting in the expression of the leukemia-specific fusion protein AML1-eight-twenty-one) and REH, an acute lymphoblastic leukemia cell line with the (12;21)-chromosomal translocation and expression of translocation ETS-like leukemia-AML1.",15197237_1,-1,1,-1,1,1999,-1,3.8661015e-06,0.99999106,5.070305e-06
19013,time-dependent,16,17,105,119,"Jurkat T-cell treatments with Er-1 induced the down-regulation of the IL-2R subunit by a reversible and time-dependent endocytosis, and increased the levels of phosphorylation of the extracellular signal-regulated kinases (ERK).",23103669_3,-1,1,-1,1,19013,-1,1.360819e-05,0.99997234,1.3992e-05
41719,IRF-1,1,2,9,14,"Although IRF-1 upregulated CXCR3 expression in HCC cells, it inhibited proliferation and exerted pro-apoptotic effects, which overcome proliferation partly mediated by activating the CXCL10/CXCR3 autocrine axis.",33689775_5,-1,1,-1,1,41719,-1,7.4332906e-06,0.9999788,1.3811904e-05
1256,translational,13,14,78,91,"The expression of IL-11 in the tumor is detectable at the transcriptional and translational levels, as evidenced by RT-PCR and Western blots.",12527946_2,-1,1,-1,1,1256,-1,5.713802e-06,0.9999888,5.5117202e-06
37776,that,7,8,33,37,Administration of LPS (at a dose that elicited levels of proinflammatory cytokines comparable to those by the anti-TLR4 mAb) plus OVA induced no or less-marked activation of OVA-specific T-cells and failed to suppress tumour growth in mice.,31515801_10,-1,1,-1,1,37776,-1,6.2105732e-06,0.99998903,4.7897765e-06
37128,Gene,0,1,0,4,"Gene expression profiling determined that Gzmb expression is down-regulated in tumor-infiltrating CTLs of IFNAR1-KO mice as compared to WT mice, and in antigen-specific IFNAR1-KO CTLs as compared to WT CTLs in vivo.",31228946_10,-1,1,-1,1,37128,-1,5.616422e-06,0.9999889,5.462037e-06
16114,the,10,11,65,68,Administration of a neutralizing IL-21 antibody to WT mice after the last DSS cycle decreased the colonic T cell infiltrate and the production of IL-6 and IL-17A and reduced the number of tumors.,21987656_6,-1,1,-1,1,16114,-1,5.7346306e-06,0.9999882,6.028233e-06
31181,translocation,10,11,71,84,These observations were further supported by an enhancement of nuclear translocation of the p65NF-B subunit involved in this process.,28088065_5,-1,1,-1,1,31181,-1,4.363814e-06,0.9999913,4.333853e-06
36597,FOXP3,2,3,11,16,"Numbers of FOXP3+ Treg cells were significantly higher in peritoneal lesions of women coexistent with ovarian endometrioma (F=21.52, P<0.001) and dermoid cysts (F=22.01, P<0.001) compared with women without peritoneal lesions.",30981619_6,-1,1,-1,1,36597,-1,7.1086642e-06,0.999987,5.837031e-06
6144,the,27,28,189,192,"Whereas the spontaneously growing CTCL-derived cell lines displayed persistent activation of the TORC1 as well as the PI3K/Akt and MEK/ERK pathways, the IL-2-dependent cell lines activated the pathways in response to IL-2 and IL-15 but not IL-21.",18025151_1,-1,1,-1,1,6144,-1,4.66971e-06,0.99999094,4.4422736e-06
25154,FoxP3,31,32,223,228,"As a result high-affinity binding of interleukin-2 on those cells was prohibited, causing lack of Janus kinase 1 (JAK1)/JAK3-mediated signal transducer and activator of transcription 3 (STAT3)/STAT5 activation required for FoxP3 expression.",25284464_5,-1,1,-1,1,25154,-1,4.7782164e-06,0.9999912,4.061215e-06
27102,This,0,1,0,4,This finding further supports our prior observations that a significant subset of ocular MZLs arises in the setting of IgG4-RD.,26311608_4,-1,1,-1,1,27102,-1,4.618303e-06,0.99999154,3.826299e-06
19314,YB-1,16,17,92,96,Both CD4(+) and CD8(+) T cells were involved in the anti-neuroblastoma responses induced by YB-1 immunization combined with Treg depletion.,23169344_8,-1,1,-1,1,19314,-1,1.302824e-05,0.99995697,2.9974311e-05
24603,Thus,0,1,0,4,"Thus, MDSCs may define an element of the pathogenic inflammatory processes that drives immune escape.",25164013_3,-1,1,-1,1,24603,-1,5.559083e-06,0.99998975,4.734095e-06
20888,that,3,4,28,32,"We furthermore demonstrated that following irradiation CCR2 and CCL2, CXCR6 and CCL16, chemokines and ligands involved in tumor homing of immune cells, were significantly up regulated.",23922012_9,-1,1,-1,1,20888,-1,4.2178744e-06,0.9999919,3.9055267e-06
19006,the,26,27,126,129,"Also, Er-1 significantly decreases the mRNA levels of the  and  subunits of IL-2 receptor (IL-2R), while the mRNA levels of the  subunit appeared to be not affected.",23103669_2,-1,1,-1,1,19006,-1,4.353103e-06,0.99999046,5.1345824e-06
27528,the,3,4,23,26,These results indicate the indirect anti-cancer activity of MFE through improved immune response mediated by TLR4 signaling.,26473845_9,-1,1,-1,1,27528,-1,5.068626e-06,0.99999154,3.3834174e-06
43756,the,9,10,42,45,"However, little is known on the nature of the inflammatory cell infiltration present in KS, on the type of cytokines produced and on their role in KS, and whether this correlates with the presence of HHV-8.",9446657_6,-1,1,-1,1,43756,-1,4.415503e-06,0.9999906,5.0335525e-06
12179,translate,7,8,43,52,We herein tested whether these effects can translate into effective cancer immunotherapy when SA-4-1BBL was also used as a vehicle to deliver TAAs in vivo to dendritic cells (DCs) constitutively expressing the 4-1BB receptor.,20406989_3,-1,1,-1,1,12179,-1,1.0361595e-05,0.9999839,5.713175e-06
21331,the,11,12,83,86,We identified a correlation between clinical outcome regarding CMV replication and the ability to respond to IL-7 and IL-2 defined by STAT5 phosphorylation (pSTAT5).,24140122_3,-1,1,-1,1,21331,-1,4.4157605e-06,0.9999918,3.8217117e-06
9326,tumor,4,5,22,27,"The extent of central tumor necrosis was decreased in the tumors in NFATc2((-/-)) mice, and this finding was associated with reduced tumor necrosis factor-alpha and interleukin-2 (IL-2) production by CD8(+) T cells.",19318584_3,-1,1,-1,1,9326,-1,5.0260214e-06,0.99998856,6.4674937e-06
28640,complex-mediated,9,10,56,72,This study examined the modulation by AO-1 of TLR4/MD-2 complex-mediated MyD88/NF-B signaling.,27118139_2,-1,1,-1,1,28640,-1,2.6052732e-05,0.99993956,3.4416447e-05
475,the,21,22,155,158,"Although similar tyrosine phosphorylation and calcium influx were induced after either pre-TCR or alphabetaTCR cross-linking, the two pathways diverged at the level of Fas ligand induction.",11290785_7,-1,1,-1,1,475,-1,4.3918767e-06,0.9999918,3.8407993e-06
3765,The,0,1,0,3,The suppression mechanism requires TGF-beta and IL-10 and is associated with induction of the Smad signaling pathway and activation of the STAT3 transcription factor.,16612596_5,-1,1,-1,1,3765,-1,4.016513e-06,0.99999225,3.6750116e-06
37799,TGF-,2,3,9,14,"However, TGF- also has tumor-suppressive activity; thus, dissecting cell type-specific molecular effects may inform therapeutic strategies targeting this cytokine.",31530731_2,-1,1,-1,1,37799,-1,1.1342165e-05,0.9999814,7.2492444e-06
38870,tumor,10,11,39,44,"Here, we report that the ISG UBA7 is a tumor suppressor in breast cancer.",31974171_2,-1,1,-1,1,38870,-1,5.1559596e-06,0.99998903,5.765217e-06
18414,to,20,21,129,131,"Colonic IL-17 transcription increased 40- to 70-fold in all stages of colitis, whereas IFN- mRNA was gradually up-regulated 12- to 55-fold with colitis progression, and further to 62-fold in mice with dysplasia/cancer.",22962436_6,-1,1,-1,1,18414,-1,1.2697077e-05,0.9999702,1.7082999e-05
37843,tested,11,12,70,76,Serum s-CD95L levels in 51 patients with advanced ovarian cancer were tested by ELISA.,31537619_2,-1,1,-1,1,37843,-1,8.561056e-06,0.999985,6.4553133e-06
17909,the,12,13,68,71,"Taken together, our findings highlight a pivotal role for NFATc2 in the establishment of inflammation-associated colorectal tumors mediated by control of IL-6 expression.",22738913_6,-1,1,-1,1,17909,-1,4.1220173e-06,0.9999925,3.3989609e-06
43671,together,3,4,12,20,"The IL-10R, together with reporter gene constructs containing different IL-6-responsive gene elements, reconstituted in hepatoma cells an induction of transcription by IL-10 that was comparable to that by IL-6.",8662928_7,-1,1,-1,1,43671,-1,5.6657987e-06,0.99998724,7.050454e-06
7112,Treg,4,5,20,24,"Regulatory T cells (Treg) enriched in FoxP3+, glucocorticoid-induced TNF receptor+, and cytotoxic T-lymphocyte-associated antigen-4+ exert a potential to suppress effector T cells in the periphery.",18512029_0,-1,1,-1,1,7112,-1,5.008249e-06,0.99998724,7.731212e-06
10899,thus,23,24,93,97,"In order to build a therapeutic anti-HPV-16 vaccine, E6/2 (14-34) and E6/4 (45-68) fragments thus appear to be good candidates to increase HPV-specific effector T lymphocyte responses and clear classic VIN (BP) disease lesions.",19843089_5,-1,1,-1,1,10899,-1,4.3262103e-06,0.99999046,5.234305e-06
20612,the,8,9,41,44,The aim of this study was to investigate the level of IL-17-producing cells in the breast cancer tumour microenvironment and its prognostic role.,23738752_1,-1,1,-1,1,20612,-1,3.67617e-06,0.9999927,3.547781e-06
8483,The,2,3,9,12,"METHODS: The mice were randomly divided into five groups, named A, B, C, D and E. The group A and B were control groups (CG).",19173904_1,-1,1,-1,1,8483,-1,5.7990374e-06,0.99998736,6.7776796e-06
7143,the,2,3,18,21,Studies assessing the influence of chemotherapy on Treg cells have also been included in this review.,18512029_5,-1,1,-1,1,7143,-1,6.0192674e-06,0.99999046,3.482841e-06
1371,truncated,2,3,12,21,Analysis of truncated S35 constructs and overlapping peptides revealed that the peptide epitope was LGAEAIFRL.,12707369_1,-1,1,-1,1,1371,-1,1.0566286e-05,0.9999777,1.1783912e-05
41363,these,5,6,25,30,"The TR1 cell identity of these CD4+ T cells was supported by their expression of interferon gamma and IL-10, as well as inhibitory receptors including PD-1.",33526861_3,-1,1,-1,1,41363,-1,4.745435e-06,0.9999887,6.544986e-06
832,native,32,33,178,184,"We evaluated regulation of the MHC class II transactivator (CIITA), the key intermediate that controls class II expression, in MG cells and tested whether MG cells could process native Ag.",11746775_2,-1,1,-1,1,832,-1,8.785394e-06,0.99998546,5.782966e-06
43233,that,14,15,104,108,"GATA4 also acts in a distinct capacity to control a stress-inducible pro-inflammatory secretory program that is associated with senescence, a potent tumor suppression mechanism, but also operates in non-senescent contexts such as tumorigenesis.",35017504_1,-1,1,-1,1,43233,-1,5.2192e-06,0.9999901,4.618772e-06
19029,that,5,6,30,34,"Overall, these findings imply that Er-1 coupling to IL-2R and ERK immuno-enhances T-cell activity, and that this effect likely translates to an inhibition of glioma cell growth.",23103669_5,-1,1,-1,1,19029,-1,3.7717875e-06,0.9999926,3.6420208e-06
26465,the,5,6,36,39,This novel strategy will facilitate the clinical application of Treg-based therapies.,26063163_9,-1,1,-1,1,26465,-1,4.290865e-06,0.99999225,3.513315e-06
40736,that,3,4,24,28,These results indicated that curcumin augments the induction of tumor antigen-specific T cells by restoring the T cell stimulatory activity of DCs targeting activated STAT3 in both cancer cells and immune cells.,33006786_7,-1,1,-1,1,40736,-1,4.2393212e-06,0.99999213,3.569002e-06
7239,tumor,21,22,126,131,Down-regulation of CD4+CD25+ regulatory T (Treg) cell function might be beneficial to enhance the immunogenicity of viral and tumor vaccines or to induce breakdown of immunotolerance.,18566377_0,-1,1,-1,1,7239,-1,7.796447e-06,0.9999869,5.2706027e-06
22345,the,18,19,114,117,"Taken together, our data suggest that EPA and DHA may suppress Th2-skewed allergic immune responses by inhibiting the expression of basophilic IL-4 and IL-13.",24460246_10,-1,1,-1,1,22345,-1,3.7511866e-06,0.9999927,3.5472463e-06
20361,that,17,18,119,123,"In tumors rendered immunogenic by model antigen expression or following administration of antitumor vaccines, we found that high NF-B activity leads to tumor rejection and/or growth suppression in mice.",23635779_2,-1,1,-1,1,20361,-1,4.333973e-06,0.99999213,3.562541e-06
14133,STAT3,5,6,33,38,"Along with NF-kappaB activation, STAT3, a central factor in inflammation regulation, is activated in the transgenic tissue.",21291541_7,-1,1,-1,1,14133,-1,5.5795263e-06,0.9999888,5.621775e-06
32550,Blimp-1,0,1,0,7,Blimp-1 expression was examined by flow cytometry.,28629373_3,-1,1,-1,1,32550,-1,2.543268e-05,0.9999312,4.330707e-05
418,this,1,2,3,7,"In this study, we demonstrated that IL-15Ralpha, the IL-15-specific binding receptor, mRNA and protein levels were also elevated in HTLV-I-infected cells.",11160322_1,-1,1,-1,1,418,-1,3.9254187e-06,0.999992,4.1207895e-06
19342,Th1,9,10,56,59,We also assessed the effect of CD200-CD200R blockade on Th1 and T-reg cytokine production and T cell proliferation in autologous AML- and monocyte-DC mixed lymphocyte reactions (MLRs).,23179394_3,-1,1,-1,1,19342,-1,3.802202e-06,0.99998534,1.0802519e-05
12399,Stat3,13,14,81,86,"Further, increased levels of signal transducer and activator of transcription 3 (Stat3), an important regulator in MDSC development and function, were noted in MM-MDSC.",20484028_5,-1,1,-1,1,12399,-1,6.0765983e-06,0.9999876,6.3743937e-06
1053,to,4,5,29,31,Whether tumors are sensitive to such ligands is determined by both the net abundance of death receptors versus decoy receptors and the balance between intracellular apoptotic and antiapoptotic mechanisms.,11924906_2,-1,1,-1,1,1053,-1,8.202553e-06,0.9999858,6.032808e-06
31261,T-,19,20,101,103,"These results indicated that with cells isolated from cord blood, c-Rel has an important role in B-, T-, and NK cell differentiation and, further, that agents (select cytokines/growth factors) that could impact on its expression might not only affect immune cell profiles in a host but could potentially also limit apoptotic activities in (non-)immune cells in that host.",28090796_7,-1,1,-1,1,31261,-1,8.976001e-06,0.9999716,1.9446585e-05
12254,relative,19,20,94,102,"On the other hand, conventional GCs were characterized by a paucity of CXCR3(+) T cells and a relative abundance of Tregs.",20422211_7,-1,1,-1,1,12254,-1,6.8639156e-06,0.9999877,5.4378e-06
34352,The,0,1,0,3,"The decrease of this IFN gene expression signature was associated with more aggressive disease in human colon cancer patients, suggesting that lack of IL33 signaling impaired the generation of a potent IFN-mediated antitumor immune response.",29463593_10,-1,1,-1,1,34352,-1,3.6986119e-06,0.9999925,3.7784257e-06
9653,to,8,9,41,43,These CD25(+) clones had a high capacity to suppress the proliferation of another T-cell clone after peptide stimulation in vitro.,19435913_4,-1,1,-1,1,9653,-1,4.035177e-06,0.99999166,4.2937277e-06
18782,total,11,12,64,69,"Ironically, sunitinib's profound effects are observed even in a total absence of detectable anti-tumor therapeutic response.",23017141_2,-1,1,-1,1,18782,-1,6.2632416e-06,0.9999889,4.789219e-06
43015,TGF,28,29,146,150,"Real-time RT-PCR showed that I2 tumors overexpress T-BET (p = 0.019) and interferon-gamma (IFN; p = 0.020) and silence tumor growth factor-beta (TGF; p = 0.049), whereas in Cht+I2 tumors, GATA3 is silenced (p = 0.014).",34680134_5,-1,1,-1,1,43015,-1,8.7625995e-05,0.9998913,2.1027769e-05
30008,The,0,1,0,3,The percentage of CD127dim/- cells and also the MFI of FoxP3 expression was significantly lower in CD4+CD25-FoxP3+ in comparison with CD4+CD25+FoxP3+ population.,27619682_6,-1,1,-1,1,30008,-1,4.2529546e-06,0.9999919,3.9090182e-06
29578,to,34,35,169,171,"The objective of the present study was to explore the impact of IL-17 on the in vivo differentiation of Th9 cells in relation to Th2 cells in a murine model of MPE, and to explore whether IL-17 inhibits MPE formation via IL-9dependent mechanism.",27535421_2,-1,1,-1,1,29578,-1,3.66102e-06,0.9999925,3.8520484e-06
13065,Tregs,20,21,124,129,"Treg levels shifted in patients with melanoma treated with IFN-alpha 2b, although no firm conclusions regarding the role of Tregs as a marker of treatment response or outcome can be made at present.",20712892_10,-1,1,-1,1,13065,-1,4.905114e-06,0.9999894,5.7588945e-06
3951,treatment,29,30,178,187,"Monitoring of CD8(+) T cells that specifically recognized a dominant MHC class I her-2/neu peptide showed a dramatic increase in tetramer-specific CD8(+) T cells after the first treatment; however, continuous therapy resulted in the loss of this population.",16751376_9,-1,1,-1,1,3951,-1,4.983377e-06,0.9999907,4.3357522e-06
9166,therefore,11,12,71,80,"Th17 cells, their developmental pathways and their effector functions, therefore, provide novel therapeutic targets.",19283720_2,-1,1,-1,1,9166,-1,5.780559e-06,0.9999869,7.3465676e-06
30753,the,9,10,73,76,CONCLUSION: Combination therapy with sunitinib and celecoxib intensified the curative effects to renal cell carcinoma by suppressing immune regulatory cells.,27926489_11,-1,1,-1,1,30753,-1,8.425068e-06,0.999987,4.509381e-06
40831,targeting,3,4,28,37,Therapeutic cancer vaccines targeting melanoma-associated antigens are commonly immunogenic but are rarely effective in promoting objective clinical responses.,33051240_0,-1,1,-1,1,40831,-1,9.117203e-06,0.9999858,5.125752e-06
8597,tumors,23,24,173,179,Single vaccination with tumor cells expressing gp96-Ig stimulates robust expansion of tumor-specific CTLs in tumor-nave mice and this expansion is inhibited by established tumors.,19223534_1,-1,1,-1,1,8597,-1,4.2391493e-06,0.99999154,4.191456e-06
5877,than,15,16,95,99,"After IL-2 cessation, the number of Treg cells more efficiently dropped in clinical responders than nonresponders.",17671219_7,-1,1,-1,1,5877,-1,6.6125763e-06,0.99998784,5.5701103e-06
36320,tumor,23,24,171,176,"This study investigated the therapeutic potential of combining niraparib, a highly selective PARP1/2 inhibitor, with anti-PD-1 immune checkpoint inhibitors in preclinical tumor models.",30755715_2,-1,1,-1,1,36320,-1,3.807999e-06,0.99999166,4.512259e-06
30197,through,22,23,146,153,Our findings represent a novel immunosuppressive function of TGF and demonstrate that TGF1 allows tumors to evade host immune responses in part through enhanced SMAD3-mediated PD-1 expression on TILs.,27683557_6,-1,1,-1,1,30197,-1,4.9552473e-06,0.99999106,4.014585e-06
30023,Th2-mediated,11,12,72,84,Thymic stromal lymphopoietin (TSLP) activates dendritic cells to induce Th2-mediated inflammation.,27634769_0,-1,1,-1,1,30023,-1,0.00019264438,0.99932206,0.00048528617
22163,Signal transducer and activator of transcription 3,0,7,0,50,Signal transducer and activator of transcription 3 (STAT3) is highly activated in multiple myeloma.,24407159_0,-1,1,-1,1,22163,-1,1.661293e-05,0.9999732,1.0236882e-05
7008,to,24,25,138,140,"IL-6 and IL-23, cytokines which play key roles in the induction and maintenance of gut inflammation during IBDs, have been recently shown to influence the development and growth of colitis associated colorectal cancer.",18473765_5,-1,1,-1,1,7008,-1,4.507243e-06,0.9999914,4.0658156e-06
8433,that,4,5,27,31,"In vitro analysis revealed that a low concentration of 0.01 microg/ml basiliximab reduced almost all of CD4+CD25high cells, but less of the CD4+ CD25low cells, and augmented IFN-gamma production of activated PBMCs.",19148493_6,-1,1,-1,1,8433,-1,5.0289555e-06,0.99999046,4.4745857e-06
1970,to,9,10,60,62,"In addition, there is a general cytokine hyporesponsiveness to E6 that is more prominent for T(H)1-like cytokine expression by patients with severe disease.",15138179_5,-1,1,-1,1,1970,-1,5.249212e-06,0.99998856,6.1966316e-06
4418,naive,30,31,197,202,The amounts of IFN-gamma secreted by the co-culture of irradiated OVHM cells with spleen cells from mice injected with CD40L/OVHM were much higher than those from OVHM/parental cell inoculated and naive mice.,16965650_11,-1,1,-1,1,4418,-1,7.6002257e-06,0.9999875,4.973386e-06
33280,gene,33,34,225,229,"Moreover, experiments in tumor-bearing C57BL/6 mice showed that Irf1 gene expression in the spleen was transiently increased following CTX administration and correlated with the induction of Th1 cell expansion and of Il12p40 gene expression, which is the main Th1-driving cytokine.",28975621_4,-1,1,-1,1,33280,-1,6.68709e-06,0.9999857,7.6172855e-06
29120,their,32,33,155,160,"A link between 4-1BB and TLR1-TLR2 signaling in CD8(+) T cells was highlighted by the suboptimal responses of 4-1BB(-/-) T cells to TLR1-TLR2 agonist, but their normal response to CD28 or OX40 costimulation.",27267778_4,-1,1,-1,1,29120,-1,6.959588e-06,0.9999864,6.618093e-06
37823,Smad proteins,1,3,15,28,Phosphorylated Smad proteins were also detected in the mitochondria of isolated tumor-associated lymphocytes.,31530731_6,-1,1,-1,1,37823,-1,1.546002e-05,0.99997354,1.0949799e-05
33541,the,6,7,36,39,"This study was designed to evaluate the protective and immunomodulatory effects of dietary fucoidan on 7,12-dimethyl benz[a]anthracene (DMBA)-induced experimental mammary carcinogenesis in rats.",29043842_1,-1,1,-1,1,33541,-1,4.1741664e-06,0.99999225,3.598257e-06
27356,to,16,17,102,104,"Moreover, we show that the TH1 phenotype of tumor-infiltrating Tregs is dispensable for their ability to influence tumor progression.",26433463_3,-1,1,-1,1,27356,-1,5.041997e-06,0.9999912,3.7279497e-06
11493,Treg,5,6,53,57,Cancer-induced immunotolerance mediated by inducible Treg (iTreg) is a major obstacle to cancer immunotherapy.,20127675_0,-1,1,-1,1,11493,-1,5.9818985e-06,0.99998856,5.50959e-06
6488,STAT3,18,19,120,125,"The following biomarkers were studied in peripheral blood mononuclear cells (PBMC) during treatment: phosphorylation of STAT3, alterations in the composition of leukocyte subsets, ex vivo cytotoxicity, expression of effector molecules in enriched CD8(+) T cells and CD56(+) NK cells by quantitative RT-PCR, and gene array profiling of CD8(+) T cells.",18286285_3,-1,1,-1,1,6488,-1,5.5321716e-06,0.99998736,7.061585e-06
32441,genes,9,10,54,59,"Additionally, the co-expression of the CD70 and CD163 genes was found to correlate with decreased survival for patients with primary GBM.",28612394_9,-1,1,-1,1,32441,-1,5.879417e-06,0.9999877,6.370043e-06
39262,TCF,15,16,92,95,"Here, we identify CCL28 as a direct transcriptional target gene of -catenin/T-cell factor (TCF).",32156780_3,-1,1,-1,1,39262,-1,0.011661597,0.9878945,0.00044391552
8944,to,8,9,41,43,"However, Tregs also pose a major problem to anti-tumor immunity.",19254475_1,-1,1,-1,1,8944,-1,6.2722524e-06,0.9999875,6.2144386e-06
2686,T,3,4,25,26,"Specifically, long-lived T memory cells were maintained dormant in nonlymphoid tissues by IL-18 in the absence of tumor antigen.",15833877_3,-1,1,-1,1,2686,-1,1.5585096e-05,0.9999248,5.962862e-05
16654,to,4,5,49,51,CD4(+)CD25(-)CD127(low/-)Foxp3(-) T-cells failed to suppress PBMC proliferation and may be exhausted.,22322668_13,-1,1,-1,1,16654,-1,5.0945405e-06,0.9999902,4.636739e-06
26324,the,31,32,139,142,"In the present study, we mainly investigated the role of Th22, Th17, and Th1 cell and their related cytokines (IL-22, IL-17, and IFN-r) in the pathophysiology of CML.",26000313_1,-1,1,-1,1,26324,-1,4.0001955e-06,0.9999918,4.2031693e-06
10030,the,16,17,94,97,Regulatory T cells (Tregs) expressing TCRalphabeta play a critical role in the maintenance of the immune system homeostasis.,19539651_0,-1,1,-1,1,10030,-1,4.446663e-06,0.99999046,5.1096945e-06
7199,this,2,3,10,14,"To verify this hypothesis and develop the most effective dendritic cell vaccine against Ewing's sarcoma, we evaluated the antitumor efficacy of dendritic cell-Ewing's sarcoma hybrids and dendritic cells pulsed with other antigen-loading methods, including cell lysates and the characteristic EWS-FLI1 gene of Ewing's sarcoma, using an A673 cell line as a model.",18563501_1,-1,1,-1,1,7199,-1,4.700713e-06,0.9999906,4.7272097e-06
21168,tumor,9,10,47,52,MATERIALS AND METHODS: An MB 49 murine bladder tumor model was used to identify mechanisms that might underlie this process.,24051497_3,-1,1,-1,1,21168,-1,4.8500233e-06,0.99999,5.143559e-06
25821,to,22,23,149,151,"Further studies revealed that DC--catenin(-/-) mice were deficient in generating CD8(+) T-cell immunity despite normal clonal expansion, likely due to impaired IL-10 production by -catenin(-/-) DCs.",25730849_3,-1,1,-1,1,25821,-1,6.0473367e-06,0.99998987,4.047669e-06
13814,to,13,14,76,78,"Thus, we used a FOXP3 methylation-specific quantitative PCR assay (MS-qPCR) to measure Treg frequencies in the peripheral blood mononuclear cells (PBMCs) of melanoma patients.",21177412_3,-1,1,-1,1,13814,-1,4.0476166e-06,0.99999225,3.663733e-06
17090,to,20,21,121,123,"In MM patients, Tregs seem to contribute to myeloma-related immune dysfunction and targeting them could, therefore, help to restore and enhance vital immune responses.",22489248_4,-1,1,-1,1,17090,-1,4.201513e-06,0.9999914,4.3361606e-06
9603,the,12,13,99,102,Eighty-three percent of TS/A-CIITA-vaccinated mice were completely protected from tumor growth and the remaining 17% displayed significant reduction of tumor growth.,19395374_1,-1,1,-1,1,9603,-1,4.607266e-06,0.9999906,4.844267e-06
7264,tumors,1,2,9,15,"EG.7-OVA tumors, administration of P17 improved their proliferation, reduced the number of CD4+Foxp3+ T cells, and inhibited tumor growth.",18566377_6,-1,1,-1,1,7264,-1,3.3499139e-06,0.9999914,5.175253e-06
5098,related,49,50,268,275,"In this study, we show that this cytokine regimen also results in the profound enhancement of CD4+ tumor-infiltrating lymphocytes (TIL) expressing FoxP3, IL-10, and TGF-beta mRNA, with 50 or 90% of CD4+ TIL coexpressing the CD25 and glucocorticoid-induced TNFR family related molecules, respectively.",17339434_2,-1,1,-1,1,5098,-1,6.126873e-05,0.99990475,3.39534e-05
18756,the,23,24,140,143,"We show that OX40 engagement, in the context of chemotherapy-induced lymphopenia, induces a novel CD4(+) T cell population characterized by the expression of the master regulator eomesodermin that leads to both terminal differentiation and central memory phenotype, with concomitant secretion of Th1 and Th2 cytokines.",23008334_4,-1,1,-1,1,18756,-1,3.86161e-06,0.999992,4.1014523e-06
36919,this,1,2,3,7,"In this review, we explore recent discoveries that advance our understanding of how Itch regulates immune cell biology, and the extent to which these clarify how Itch prevents autoimmune disease.",31126634_5,-1,1,-1,1,36919,-1,5.3381636e-06,0.9999895,5.171864e-06
15422,STAT3,39,40,242,247,"Consistent with a role for IL-6 and STAT3 in regulating IL-17A, increased Th17 generation and gastric expression of Th17-related factors in gp130(F/F) mice were reduced to wild-type levels in gp130(F/F) :Stat3(-/+) mice displaying normalized STAT3 activity, and also in gp130(F/F) :IL-6(-/-) mice.",21710691_6,-1,1,-1,1,15422,-1,5.4037987e-06,0.9999887,5.919391e-06
14997,the,28,29,223,226,The very recently discovered neutralizing autoantibodies (autoAbs) against Th17-related cells and cytokines in two autoimmunity-related syndromes associated with AIRE-mutant thymi or AIRE-deficient thymomas help to explain the chronic mucocutaneous candidiasis (CMC) seen in both syndromes.,21574164_2,-1,1,-1,1,14997,-1,6.8359477e-06,0.9999894,3.8269363e-06
40830,Therapeutic,0,1,0,11,Therapeutic cancer vaccines targeting melanoma-associated antigens are commonly immunogenic but are rarely effective in promoting objective clinical responses.,33051240_0,-1,1,-1,1,40830,-1,7.913088e-06,0.99998724,4.8468846e-06
33220,Treg,12,13,58,62,"To gain insight into this, we compared regulatory T cell (Treg ) populations between ApcMin/+ and wild-type mice prior to and after the phase of increased intestinal Cox-2-dependent prostaglandin E2 (PGE2 ) production.",28940183_3,-1,1,-1,1,33220,-1,5.7998636e-06,0.99998486,9.2910495e-06
9502,TH17,41,42,273,277,"We now show that IDO functions as a molecular switch in TDLNs, maintaining Tregs in their normal suppressive phenotype when IDO was active, but allowing inflammation-induced conversion of Tregs to a polyfunctional T-helper phenotype similar to proinflammatory T-helper-17 (TH17) cells when IDO was blocked.",19366986_1,-1,1,-1,1,9502,-1,5.6341116e-05,0.9999201,2.3467666e-05
27597,Th1,10,11,76,79,CONCLUSIONS: T-cell reconstitution from SLTBI was characterized by impaired Th1 and elevated Th17 and Treg cells.,26475064_11,-1,1,-1,1,27597,-1,8.346505e-06,0.99996066,3.1020438e-05
6719,the,22,23,127,130,"In this study, we report the identification and characterization of subsets of CD4(+) T cells that recognize an epitope within the AFP sequence (AFP(46-55)) and develop into TGF-beta-producing CD4(+) T cells.",18354237_2,-1,1,-1,1,6719,-1,3.866782e-06,0.99999166,4.4197964e-06
39520,the,12,13,88,91,These results demonstrate for the first time that CDDO-Me relieves immunosuppression in the breast TME and unleashes host adaptive anti-tumor immunity.,32300202_8,-1,1,-1,1,39520,-1,3.6620995e-06,0.99999166,4.7018343e-06
17553,translational,22,23,151,164,"Dysregulated IL-6 production and signalling are associated with chronic inflammatory diseases, auto-immunity and cancer, and are the object of intense translational research as promising therapeutic targets.",22652781_5,-1,1,-1,1,17553,-1,5.192653e-06,0.99999094,3.8620915e-06
6807,to,16,17,121,123,"Nonetheless, most subjects eventually succumbed to progressive disease, implying that additional immune defects remained to be addressed.",18364009_2,-1,1,-1,1,6807,-1,6.2618874e-06,0.9999882,5.495494e-06
9677,the,7,8,56,59,Vaccines represent an attractive treatment modality for the management of cancer primarily because of their specificity and generation of immunologic memory important for controlling recurrences.,19435920_0,-1,1,-1,1,9677,-1,4.3954765e-06,0.9999919,3.7113439e-06
35169,the,4,5,33,36,This molecular circuit underlies the co-expression of co-inhibitory receptors in T cells and identifies regulators of T cell function with the potential to control autoimmunity and tumour immunity.,29899446_6,-1,1,-1,1,35169,-1,4.1243684e-06,0.9999924,3.4932361e-06
6806,that,11,12,81,85,"Nonetheless, most subjects eventually succumbed to progressive disease, implying that additional immune defects remained to be addressed.",18364009_2,-1,1,-1,1,6806,-1,5.744206e-06,0.9999906,3.6591316e-06
30666,the,15,16,81,84,Quantitative real-time PCR (qRT-PCR) was used to investigate the effect of ZA on the expression of suppressive molecules by Treg cells.,27887569_7,-1,1,-1,1,30666,-1,3.789097e-06,0.9999927,3.4622271e-06
9994,Foxp3,12,13,72,77,Recent work has extended these findings into the airway in asthma where Foxp3 expression was reduced and CD25(hi) Treg-suppressive function was deficient.,19538496_4,-1,1,-1,1,9994,-1,4.372598e-06,0.9999919,3.7121404e-06
14975,Tregs,27,28,162,167,"Our work shows that the increased FoxP3+ Treg subpopulation in RCC patients co-express Helios, indicating that they could be derived from natural but not induced Tregs.",21570917_6,-1,1,-1,1,14975,-1,4.889932e-06,0.99998987,5.2120063e-06
20882,the,4,5,13,16,"As a result, the ratio of antigen-specific CD8+ T cells and MDSCs in tumors increased up to 85-fold compared to the control.",23922012_8,-1,1,-1,1,20882,-1,3.7967359e-06,0.9999925,3.7188927e-06
36867,the,2,3,9,12,"However, the role of Helios in autoimmune diseases and its regulation remains unclear.",31118027_1,-1,1,-1,1,36867,-1,5.330383e-06,0.99999094,3.697668e-06
26985,the,14,15,85,88,"The efficacy of EBV-specific T-cell transfer for PTLD has been previously shown, yet the optimal choice of EBV-derived antigens inducing polyclonal CD4(+) and CD8(+) T cells that cover a wide range of human leukocyte antigen types and efficiently control PTLD remains unclear.",26276009_1,-1,1,-1,1,26985,-1,4.373765e-06,0.99999166,4.0083287e-06
39917,the,3,4,19,22,"We first confirmed the phenotypic (surface molecules, cytokines, antigen uptake, and antigen-presenting ability) and functional alterations (T cell proliferation/activation) of DCs in vitro.",32486094_2,-1,1,-1,1,39917,-1,4.2808238e-06,0.99999166,4.0655295e-06
25699,Tregs,11,12,71,76,"Collectively, irradiated k1106 cells induce the expression of IL-17 in Tregs, which interferes with the expression of p53 protein in k1106 cells and thereby represses irradiation-triggered apoptosis in k1106 cells.",25544504_10,-1,1,-1,1,25699,-1,3.9286097e-06,0.99999106,5.013204e-06
16297,the,1,2,3,6,"In the present study, we aimed to investigate the distribution, characterization, and generation of CD8+ Tcregs and Tc17 cells in NPC patients.",22051182_3,-1,1,-1,1,16297,-1,4.291488e-06,0.9999907,4.9687364e-06
14719,the,22,23,104,107,"In tumor, spleen and blood, the number of cytotoxic CD8(+) T cells and CD57(+) natural killer cells and the levels of IL-10 increased, but that of tumor necrosis factor- (TNF-), IL-1 and IL-6 decreased.",21423208_5,-1,1,-1,1,14719,-1,4.623721e-06,0.99999,5.3494596e-06
23241,generates,13,14,98,107,Our study reveals how time-integration of these regulatory loops within individual cell signaling generates scaled collective responses and can be leveraged for immune monitoring.,24719192_5,-1,1,-1,1,23241,-1,1.1073538e-05,0.9999832,5.7361112e-06
14410,Foxp3(+)CD4(+,0,1,0,13,Foxp3(+)CD4(+) regulatory T (Treg) cells inhibit immune responses and temper inflammation.,21357259_0,-1,1,-1,1,14410,-1,0.00063216937,0.9987656,0.0006022996
9321,NFATc2,6,7,31,37,"Here, we describe reduction of NFATc2 mRNA expression in the lungs of patients with bronchial adenocarcinoma.",19318584_1,-1,1,-1,1,9321,-1,0.0012888168,0.99857724,0.0001338887
486,ICSBP,10,11,69,74,"Mice deficient in the interferon consensus sequence binding protein (ICSBP) develop a disease resembling chronic myeloid leukemia (CML), which in humans is caused by the BCR/ABL oncoprotein.",11369642_0,-1,1,-1,1,486,-1,0.007853198,0.97841793,0.013728856
12941,the,11,12,78,81,"Unfortunately, the need for multiple administrations of antigens often limits the use of one of the most effective vaccine approaches, immunogene therapy using viral vectors, because neutralizing antibodies are rapidly produced.",20683443_1,-1,1,-1,1,12941,-1,8.90394e-06,0.9999869,4.231641e-06
37041,this,1,2,3,7,"In this study, we investigated the distribution, prognostic value, and potential function of pDCs in HCC patients undergoing curative resection.",31201473_1,-1,1,-1,1,37041,-1,4.355965e-06,0.99999166,4.041169e-06
25591,T-bet,25,26,171,176,"The expression of the transcription factor T-bet in peripheral blood CLL cells significantly correlated with CD38 expression, and transient transfection of CLL cells with T-bet resulted in T-bet(hi)CD38(hi) cells.",25505279_5,-1,1,-1,1,25591,-1,5.836595e-06,0.99998665,7.455791e-06
10856,tumors,8,9,54,60,"Furthermore, the treatment of mice with macroscopical tumors also failed to inhibit tumor progression, which correlated with the inability to deplete intratumoral Treg.",19841169_7,-1,1,-1,1,10856,-1,4.16964e-06,0.9999896,6.1959295e-06
1032,The,0,1,0,3,The notion that IL-4 was able to enhance in vitro proliferation of CD30L+/IL-4R+ purified leukaemic blasts suggests that the selective interaction of IL-4-producing CD30+ T cells with CD30L+ leukaemic progenitors may have a role in the progression of this particular AML subset.,11918534_6,-1,1,-1,1,1032,-1,3.9489823e-06,0.9999925,3.5974208e-06
3432,T,21,22,127,128,"Survival of mice as well as transgene expression and immunologic effect, such as resistance to tumor challenge and presence of T regulatory cells, were monitored.",16361570_4,-1,1,-1,1,3432,-1,7.969834e-06,0.99997926,1.2830529e-05
34209,the,10,11,61,64,"In sum, our study demonstrated that the relationship between the MUC16c level and Foxp3 expression in the local tumor environment was consistent with that of the serum CA125 level and circulating Treg proportion in the systemic environment.",29337110_10,-1,1,-1,1,34209,-1,5.3787003e-06,0.99998903,5.5908995e-06
108,generated,1,2,3,12,We generated recombinant vaccines based on E1-deleted adenovirus human strain 5 or on vaccinia virus strain Copenhagen expressing either the E6 or E7 oncoproteins of HPV-16.,10772987_2,-1,1,-1,1,108,-1,1.031281e-05,0.99998534,4.4011017e-06
4242,the,17,18,98,101,"However, CD8+ T regulatory cells expressing IL-10 and TGF-beta are also recruited or activated by the immunosuppressive environment of the lung, where they may suppress the induction of antitumor immunity.",16818744_9,-1,1,-1,1,4242,-1,5.5179194e-06,0.99999034,4.1130866e-06
13696,The,0,1,0,3,The authors provide an update on a previously reported patient with in-transit metastatic melanoma of the scalp treated with topical diphencyprone (DPCP).,21061759_0,-1,1,-1,1,13696,-1,4.5671404e-06,0.99999046,4.9246087e-06
25725,Stat5,32,33,216,221,"miR-155 restrained the expression of the inositol 5-phosphatase Ship1, an inhibitor of the serine-threonine protein kinase Akt, and multiple negative regulators of signal transducer and activator of transcription 5 (Stat5), including suppressor of cytokine signaling 1 (Socs1) and the protein tyrosine phosphatase Ptpn2.",25548153_3,-1,1,-1,1,25725,-1,8.103316e-06,0.9999826,9.252926e-06
16066,through,4,5,25,32,We inhibited the pathway through -Secretase inhibitor and Notch1 RNA interference and analysed the effect on the expression and function of chemokine receptors.,21984373_3,-1,1,-1,1,16066,-1,5.2821506e-06,0.9999896,5.12431e-06
334,to,5,6,34,36,"We hypothesized that this failure to reject may be due to poor generation of a type 1 phenotype, through a dominant influence of the type 2-promoting cytokines IL-4 and/or IL-13.",11086033_3,-1,1,-1,1,334,-1,8.589816e-06,0.9999838,7.670414e-06
23543,these,2,3,9,14,"However, these same signals are not sufficient to induce autocrine IL-2 production by naive CD8(+) T cells, which require cytokines provided by other cell types to drive their differentiation.",24778448_1,-1,1,-1,1,23543,-1,1.0610823e-05,0.99998486,4.5174597e-06
19974,These,0,1,0,5,These results suggested that RG-II expedites the DC-based immune response through the TLR4 signaling pathway.,23392255_6,-1,1,-1,1,19974,-1,4.14039e-06,0.9999919,3.9228808e-06
974,tumor,16,17,118,123,"Furthermore, mice vaccinated with tumor peptide-pulsed mature DCs better survived challenge with a weakly immunogenic tumor (8 of 8 survivors) than did mice vaccinated with less mature (3 of 8 survived) or immature (0 of 8 survivors) DCs.",11902830_2,-1,1,-1,1,974,-1,4.8047787e-06,0.9999901,5.0474328e-06
28759,zebras,28,29,153,159,"Bovine papillomavirus (BPV) infections of equine species have a central role in the aetiology of equine sarcoids; a common benign skin tumour of horses, zebras and donkeys.",27160146_0,-1,1,-1,1,28759,-1,1.1464059e-05,0.99996996,1.8630253e-05
13942,TLR4,15,16,89,93,These data indicate that the selective impairment of Treg cells by PTX is independent of TLR4.,21223350_7,-1,1,-1,1,13942,-1,7.252527e-06,0.99998116,1.1613703e-05
14306,treatment,10,11,59,68,"BACKGROUND: As well as inducing direct oncolysis, reovirus treatment of melanoma is associated with activation of innate and adaptive anti-tumour immune responses.",21338484_0,-1,1,-1,1,14306,-1,8.250325e-06,0.99998605,5.66207e-06
39335,that,3,4,20,24,"Our results clarify that besides eliminating tumor cells directly, AZD5153 works as a regulator of the TAM phenotype, providing a novel strategy combining AZD5153 and PD-1/PD-L1 antibody that could benefit HGSOC patients.",32184777_9,-1,1,-1,1,39335,-1,4.157325e-06,0.999992,3.802644e-06
12203,pleiotropic,3,4,13,24,"Thus, potent pleiotropic immune functions of SA-4-1BBL combined with its ability to serve as a vehicle to increase the delivery of antigens to DCs in vivo endow this molecule with the potential to serve as an effective immunomodulatory component of therapeutic vaccines against cancer and chronic infections.",20406989_7,-1,1,-1,1,12203,-1,1.2814642e-05,0.9999752,1.199712e-05
41135,the,17,18,101,104,Oral squamous cell carcinoma (OSCC) is an aggressive tumor whose prognosis has little improvement in the last three decades.,33220636_0,-1,1,-1,1,41135,-1,9.031731e-06,0.9999833,7.664135e-06
31988,the,10,11,64,67,"Moreover, OA reduced the secretion of TGF-1 and down-regulated the activation of NF-B signaling in H460 cells.",28472762_7,-1,1,-1,1,31988,-1,3.724635e-06,0.9999924,3.96115e-06
25431,they,7,8,38,42,"Moreover, after in vitro stimulation, they failed to produce common T-helper cytokines (IFN, TNF, IL2, IL4, IL10, or IL17A), suggesting that they were functionally exhausted.",25480168_8,-1,1,-1,1,25431,-1,6.0518596e-06,0.99998605,7.949051e-06
1905,to,16,17,116,118,Comparison of stimulation with HPV-16 E6- or E7-GST fusion proteins showed that proliferative responses were biased to HPV-16 E6.,15131030_4,-1,1,-1,1,1905,-1,1.5422935e-05,0.9999769,7.671231e-06
9191,tumor,17,18,107,112,"Furthermore, depletion of CD8(+) but not CD4(+) T-cells completely abrogated the pUS-high mediated primary tumor growth suppression, demonstrating a CD8(+) T-cell mediated effect.",19291796_6,-1,1,-1,1,9191,-1,4.8829625e-06,0.9999902,4.863633e-06
21564,to,20,21,141,143,"The splenocyte proliferation, shifting of cytokine profile, and the presence of naturally-occurring CD4+CD25+Foxp3+ Treg cells were assessed to describe the anti-tumor immune response.",24270218_4,-1,1,-1,1,21564,-1,4.583019e-06,0.99999154,3.8928342e-06
41102,the,18,19,118,121,CONCLUSION: Solanine may enhance the antitumor immune response by downregulating the proportion of CD4+CD25+ Treg and the expression of Foxp3 and TGF in tumor tissues.,33204731_10,-1,1,-1,1,41102,-1,3.763719e-06,0.99999213,4.0852756e-06
21596,tumor,36,37,236,241,"First we showed that an intraperitoneal administration of an agonistic anti-glucocorticoid induced TNF receptor (GITR) monoclonal antibody (mAb), which is reported to suppress the function of Tregs, significantly inhibited subcutaneous tumor growth in a murine pancreatic cancer model.",24289533_3,-1,1,-1,1,21596,-1,4.9834644e-06,0.9999901,4.8612396e-06
42669,genes,7,8,43,48,"ADWA-11 increases expression of a suite of genes in tumor-infiltrating CD8+ Tcells normally inhibited by TGF- and involved in tumor cell killing, including granzyme B and interferon-.",34233193_3,-1,1,-1,1,42669,-1,5.1132693e-06,0.99998987,5.005497e-06
7621,the,37,38,218,221,"In contrast to wt FOXP3, the low molecular splice forms of FOXP3 have no inhibitory effect on nuclear factor-kappaB (NF-kappaB) activity in reporter assays which is in keeping with a constitutive NF-kappaB activity in the malignant T cells.",18769452_7,-1,1,-1,1,7621,-1,3.6851302e-06,0.9999924,3.929574e-06
37878,that,2,3,10,14,"We report that histone deacetylase 6 (HDAC6) represses interleukin-17 (IL-17)-producing helper T (TH 17) cell pathogenicity and the antitumor immune response, dependent on its deacetylase activity.",31539182_1,-1,1,-1,1,37878,-1,4.1638045e-06,0.9999919,3.9459983e-06
33183,The,0,1,0,3,The NK cell functional activity was govern by high level of IFN- measurement during tumor progression.,28891726_6,-1,1,-1,1,33183,-1,8.641789e-06,0.999985,6.384038e-06
29784,to,20,21,124,126,"Consequently, methods in which immunotherapy is combined with IL-6, SDF-1a or STAT3 inhibition may offer an improved option to eliminate suppressive CD11b+ myeloid cells in HCC patients.",27593937_12,-1,1,-1,1,29784,-1,4.2281613e-06,0.999992,3.811703e-06
13910,Treg,17,18,93,97,"Here, we demonstrated that PTX not only decreased the percentage of CD4+Foxp3+ regulatory T (Treg) cells both in vitro and in vivo but also impaired cell viability and cytokine production of Treg cells rather than CD4+Foxp3- effector T (Teff) cells.",21223350_2,-1,1,-1,1,13910,-1,6.342941e-06,0.9999869,6.734482e-06
18805,tumoricidal,15,16,111,122,"Ironically, m-MDSCs manifesting resistance to sunitinib also have the greatest potential to differentiate into tumoricidal accessory cells, by virtue of their capacity to respond to T cell-secreted IFN- or to TLR agonists with nitric oxide and peroxynitrate production.",23017141_6,-1,1,-1,1,18805,-1,2.9165549e-05,0.9999596,1.119034e-05
23012,this,3,4,18,22,The objectives of this study were to evaluate the in vivo antitumor potential of the peptide fraction from Musca domestica larvae (MDPF) and to elucidate its immunological mechanisms.,24690776_3,-1,1,-1,1,23012,-1,4.2938577e-06,0.9999914,4.3395903e-06
14482,that,4,5,28,32,"Previously, we demonstrated that ANGPT2 augments the expression of various proangiogenic genes, the potent immunosuppressive cytokine, IL-10, and a chemokine for regulatory T cells (Tregs), CCL17 by TEMs in vitro.",21368233_3,-1,1,-1,1,14482,-1,4.3614527e-06,0.9999918,3.873589e-06
36741,that,33,34,208,212,"These patients also showed impaired signal transducer and activator of transcription-1 (STAT1) signaling upon stimulation with IL-6 and phorbol 12-myristate 13-acetate (PMA), and T-Cells from a healthy donor that were treated for four days with IL-6 displayed a similar muting of STAT signaling, which verified the effect seen in patient samples.",31027698_7,-1,1,-1,1,36741,-1,6.667808e-06,0.99998677,6.5689983e-06
9695,TC-1,43,44,232,236,"In this study, we tested the function of a novel soluble form of 4-1BB ligand (4-1BBL) costimulatory molecule in modulating innate, adaptive, and regulatory immunity and assessed its therapeutic efficacy in the HPV-16 E7-expressing TC-1 cervical cancer and survivin-expressing 3LL lung carcinoma mouse models.",19435920_3,-1,1,-1,1,9695,-1,5.6021297e-05,0.99909735,0.0008466312
31730,tumor-associated,34,35,211,227,"In this study, we demonstrated that CXCR5+CD8+ T cells were very rare in peripheral blood mononuclear cells from healthy and colorectal cancer individuals, but were significantly enriched in resected tumors and tumor-associated lymph nodes.",28412245_2,-1,1,-1,1,31730,-1,3.3428398e-05,0.99994266,2.3869794e-05
37162,to,26,27,190,192,"Despite the promising IFN--based therapeutic applications, its limited success in clinical trials is related with limitations inherent to its molecular properties and with the difficulties to deliver it locally or with adequate periodicity to achieve a therapeutic effect.",31233057_1,-1,1,-1,1,37162,-1,4.9785867e-06,0.99999034,4.6912173e-06
38926,tumor-infiltrating,19,20,129,147,"Importantly, PPAR agonist pioglitazone, a thiazolidinedione drug for type 2 diabetes, successfully restores IFN- production in tumor-infiltrating iNKT cells from both human patients and mouse models.",31974378_4,-1,1,-1,1,38926,-1,1.1439205e-05,0.99998057,7.963804e-06
36330,tumors,37,38,193,199,Our results indicate that niraparib treatment increases the activity of the type I (alpha) and type II (gamma) interferon pathways and enhances the infiltration of CD8+ cells and CD4+ cells in tumors.,30755715_3,-1,1,-1,1,36330,-1,3.640013e-06,0.9999924,4.0342866e-06
16113,to,6,7,48,50,Administration of a neutralizing IL-21 antibody to WT mice after the last DSS cycle decreased the colonic T cell infiltrate and the production of IL-6 and IL-17A and reduced the number of tumors.,21987656_6,-1,1,-1,1,16113,-1,5.939408e-06,0.99998856,5.498846e-06
21887,FoxP3(+,14,15,62,69,"Taken together, our study indicated that the CD4(+) CD25(+) FoxP3(+) Treg cells played an important role in immunosuppression, resulting in a positive disease-correlation in these patients.",24354800_10,-1,1,-1,1,21887,-1,0.000108710155,0.9998216,6.9679e-05
11447,genes,8,9,73,78,These results indicate that the repression of melanocyte-differentiation genes by IL-1 produced by stromal cells or by tumor cells themselves may represent an additional mechanism of melanoma immune escape.,20099279_6,-1,1,-1,1,11447,-1,5.9370773e-06,0.9999871,6.8940294e-06
27221,that,3,4,34,38,Neutralization experiments showed that Bregs convert CD4+CD25- effector T cells to CD4+FoxP3+Tregs via TGF-1.,26378021_7,-1,1,-1,1,27221,-1,3.9892634e-06,0.99999225,3.74111e-06
27132,the,3,4,19,22,The percentages of the induced CD4(+)CD25(+) T cells were detected by flow cytometry.,26347149_6,-1,1,-1,1,27132,-1,4.7929666e-06,0.99999094,4.241524e-06
2276,to,25,26,164,166,"Unlike alphabeta T cells, where possession of KLRG1 identified effector memory cells with impaired proliferative capacity, KLRG1+ Vgamma9/Vdelta2 T cells were able to proliferate vigorously upon stimulation with HMB-PP in the presence of interleukin-2.",15498816_5,-1,1,-1,1,2276,-1,9.135607e-06,0.99998534,5.5850223e-06
28298,tumors,16,17,113,119,"However, T cells obtained from HPV-positive OPSCC produced significantly more IL-17 than those from HPV-negative tumors (p = 0.006).",26899388_9,-1,1,-1,1,28298,-1,3.7303096e-06,0.9999908,5.4674992e-06
35387,the,17,18,130,133,"To evaluate whether miR-15a/16 is involved in macrophage polarization under tumour or inflammation microenvironments, we observed the growth of transplanted hepatic cancer (H22) cells or severity of dextran sulphate sodium (DSS)-induced colitis in 8-week-old miR-15a/16 knockout (KO) mice.",30047999_2,-1,1,-1,1,35387,-1,4.522022e-06,0.999992,3.4171535e-06
24830,type,4,5,14,18,"Here, using a type II NKT-cell TCR transgenic mouse model, we demonstrated that CD1d-expressing hematopoietic cells, but not thymic epithelial cells, meditate efficient selection of type II NKT cells.",25236978_2,-1,1,-1,1,24830,-1,4.3115806e-06,0.9999906,5.1342404e-06
3966,The,0,1,0,3,The mechanisms controlling the induction and maintenance of Treg's in humans need to be defined.,16763205_1,-1,1,-1,1,3966,-1,4.84682e-06,0.99999106,4.060529e-06
31897,Tumours,0,1,0,7,Tumours often present reduced E-cadherin expression and increased -catenin signalling and interleukin-33 production.,28437001_5,-1,1,-1,1,31897,-1,5.4497964e-06,0.99998844,6.07245e-06
11407,these,13,14,78,83,"Given the infusion related toxicities and pro-survival effect of IL-2 in CLL, these studies provide a rationale to explore IL-21 as an alternate gamma chain cytokine in CLL therapy.",20081380_7,-1,1,-1,1,11407,-1,4.9263385e-06,0.9999907,4.3288774e-06
37266,triple-negative,25,26,177,192,These findings suggest that inhibitors must have dual FAD and CoREST targeting abilities to successfully initiate or prime macrophages toward an anti-tumor M1-like phenotype in triple-negative breast cancer.,31249575_5,-1,1,-1,1,37266,-1,1.9209412e-05,0.99995613,2.4715479e-05
32111,the,21,22,133,136,"The CpG-HH2 complex significantly enhanced the production of IFN-, TNF- and IL-1, promoted the uptake of antigen and strengthened the activation of p38, Erk1/2 and NF-B in vitro, compared to CpG or HH2 alone.",28515346_3,-1,1,-1,1,32111,-1,3.6143956e-06,0.9999927,3.6712304e-06
36989,state,2,3,10,15,"In steady state, the percentage of 4-1BBL+ B cells was not associated with cancer characteristics.",31182685_6,-1,1,-1,1,36989,-1,4.755562e-06,0.99998987,5.3510253e-06
1141,The,0,1,0,3,The calcium-dependent phosphatase calcineurin and its downstream transcriptional effector nuclear factor of activated T cells (NFAT) are important regulators of inducible gene expression in multiple cell types.,12091710_0,-1,1,-1,1,1141,-1,4.0797227e-06,0.9999919,4.0703953e-06
17996,the,2,3,14,17,"Collectively, the data suggest that (1) biochemical cues associated with epithelial-to-mesenchymal transition can shape anti-tumor immunity through paracrine action and (2) remnants of the immunoselective pressure associated with evolution in cancer include both sculpting of tumor antigens and expression of proteins that proactively shape anti-tumor immunity.",22777646_9,-1,1,-1,1,17996,-1,4.0566547e-06,0.999992,3.882914e-06
7969,they,12,13,71,75,"CXCL9(+) stromal cells were judged to include dendritic cells, because they partly co-expressed fascin, DC-sign, CD83, DC-lamp or HLA-DR.",18980207_4,-1,1,-1,1,7969,-1,1.0653593e-05,0.99997926,1.0128087e-05
11092,to,29,30,204,206,"Pancreatitis-specific IL-10 responses were mediated by IL-10(+)IFN-gamma(-)FoxP3(+) regulatory T cells, which were expanded in the blood, bone marrow, and pancreatitis lesions and possessed the potential to suppress the proliferation of autologous conventional T cells in an antigen-specific manner.",19931255_9,-1,1,-1,1,11092,-1,4.2755414e-06,0.9999919,3.873959e-06
29391,T,23,24,149,150,The forkhead lineage-transcription factor (FoxP3) was considered for many years to be a highly specific intracellular regulatory marker of CD4+CD25+ T regulatory cells.,27339600_3,-1,1,-1,1,29391,-1,1.02199165e-05,0.99996626,2.356622e-05
20132,that,3,4,27,31,"Luminex analysis indicated that PSC but not human fetal primary pancreatic fibroblast cells (HPF; negative controls) produced MDSC-promoting cytokines [interleukin (IL-6), VEGF, macrophage colony-stimulating factor (M-CSF) ] and chemokines (SDF-1, MCP-1).",23514705_4,-1,1,-1,1,20132,-1,5.439574e-06,0.9999896,4.940108e-06
3648,to,7,8,39,41,"The objective of the present study was to address the role of the immune system, tumour micro-environment and potential immunosuppression in mesothelioma.",16540497_1,-1,1,-1,1,3648,-1,4.3828427e-06,0.9999918,3.809627e-06
1705,the,8,9,52,55,Imiquimod use appeared to increase the magnitude of the response and broaden the specificity of response in some patients.,14751153_10,-1,1,-1,1,1705,-1,6.663764e-06,0.9999876,5.7691855e-06
16319,that,11,12,80,84,The suppressive function of Tcregs was investigated using a proliferation assay that involved co-culture of sorted CD8+CD25+ T cells with nave CD4+ T cells in vitro.,22051182_6,-1,1,-1,1,16319,-1,4.9824635e-06,0.99999046,4.521459e-06
32180,transgenic,2,3,18,28,"Using EGFP-HDAC11 transgenic reporter mice, we found that HDAC11 expression was lower in effector relative to naive and central memory T-cell populations, and activation of resting T cells resulted in its decreased expression.",28550044_2,-1,1,-1,1,32180,-1,5.2282944e-06,0.99998975,4.9908344e-06
31108,tolerogenic,26,27,161,172,CD8+ T cells that express retinoic acid-related orphan receptor (ROR)t (TC17 cells) have been shown to promote procarcinogenic inflammation and contribute to a tolerogenic microenvironment in tumors.,28053236_0,-1,1,-1,1,31108,-1,1.4332508e-05,0.99997854,7.1101636e-06
905,the,17,18,101,104,"Therefore, 15-d-PGJ(2) can act as a potent proinflammatory mediator in activated T cells by inducing the production of IL-8.",11801678_11,-1,1,-1,1,905,-1,5.0627677e-06,0.99999106,3.8759404e-06
17238,the,6,7,31,34,MTT assay was used to evaluate the proliferation of T lymphocytes and splenic NK cell and CTL activity.,22522606_4,-1,1,-1,1,17238,-1,4.571178e-06,0.9999919,3.5450823e-06
10934,Tregs,3,4,15,20,"Thus, although Tregs comprise an increased percentage of circulating CD4(+) T cells in patients with metastatic breast cancer and patients in remission after completing the adjuvant chemotherapy, the systemic Treg pool, as measured by absolute counts, appears relatively constant regardless of disease stage or treatment status.",19855964_6,-1,1,-1,1,10934,-1,3.9316224e-06,0.9999918,4.3147857e-06
27592,the,6,7,52,55,Improvement resulting from cinnamon pretreatment on the efficient T-cell recovery profile from SLTBI promoted antitumor immunity in the lung melanoma model.,26475064_10,-1,1,-1,1,27592,-1,3.570923e-06,0.9999924,4.000442e-06
12794,then,8,9,65,69,The immune mechanisms underlying this combination treatment were then analyzed.,20563597_4,-1,1,-1,1,12794,-1,6.834479e-06,0.9999881,5.0454973e-06
40969,tumor,11,12,80,85,"In colon carcinoma-bearing mouse models, oral administration of Ocs-P inhibited tumor growth and restored the expression of decreased surface molecules in lineage-CD11c+MHC-II+ splenic DCs.",33105813_4,-1,1,-1,1,40969,-1,5.075921e-06,0.99998975,5.176864e-06
29778,STAT3,8,9,46,51,These data also suggest an important role for STAT3 activation in TAF-mediated MDSC generation and MDSC-mediated immune suppression.,27593937_11,-1,1,-1,1,29778,-1,6.6595962e-06,0.9999876,5.727522e-06
30445,the,1,2,5,8,"With the agonistic ICOS-L protein (rICOS-L Ig), ICOS+ Foxp3+ cells were efficiently induced from naive CD4+ T cells under a stimulation with TGF- and CD3/CD28 mAbs.",27756099_4,-1,1,-1,1,30445,-1,4.348611e-06,0.9999919,3.813404e-06
1513,transducer,10,11,57,67,"Since Stat6-deficient or ""knockout"" mice lack the signal transducer and activator of transcription-6 protein and are unable to transmit signals initiated by the type 2 cytokines, IL-4 and IL-13, they have been studied to confirm the T(h)1 vs T(h)2 paradigm.",14593499_1,-1,1,-1,1,1513,-1,6.7887418e-06,0.99998736,5.798788e-06
32129,Tumors,0,1,0,6,Tumors develop numerous strategies to fine-tune inflammation and avoid detection and eradication by the immune system.,28533483_0,-1,1,-1,1,32129,-1,4.134928e-06,0.99999166,4.2613374e-06
18016,Treg,13,14,81,85,"One critical mechanism involves the accumulation of FOXP3(+) T regulatory cells (Treg), a class of suppressive T cells that prevent excessive tissue destruction caused by unchecked immune responses.",22798340_1,-1,1,-1,1,18016,-1,7.722701e-06,0.99998546,6.872644e-06
7998,the,5,6,32,35,Cases are also characterized by the presence of a rich infiltrate of reactive B cells.,18987541_1,-1,1,-1,1,7998,-1,3.931943e-06,0.9999924,3.7398763e-06
35628,TT,17,18,81,83,Patients with IL-18 (rs16944) TT had the highest hemoglobin concentration (GG<GT<TT).,30211233_7,-1,1,-1,1,35628,-1,4.1194e-05,0.9998317,0.00012709512
20278,to,28,29,158,160,"When loaded on dendritic cells (DCs), exosomes from CT26-CIITA cells significantly increased expression of MHC class II molecules, CD86 and CD80, as compared to exosomes from CT26 cells.",23621273_4,-1,1,-1,1,20278,-1,4.714915e-06,0.9999908,4.4498206e-06
39700,to,41,42,239,241,"Immune signaling pathways, such as nuclear factor (NF)-B, prostaglandin E2 (PGE2)/cyclooxygenase-2 (COX-2), interleukin (IL)-6/signal transducer and activator of transcription 3 (STAT3), and IL-23/T helper 17 cell (Th17), have been shown to promote CAC tumorigenesis.",32357539_3,-1,1,-1,1,39700,-1,4.686515e-06,0.99999154,3.8320395e-06
20994,triptolide-high,28,29,172,187,"Fifty male C57BL/6 mice were randomly grouped as follows: normal control group, model group with B16-F10 cells implanted, and three treatment groups with cyclophosphamide, triptolide-high dose, triptolide-low dose.",23975869_3,-1,1,-1,1,20994,-1,7.059311e-05,0.99988604,4.330433e-05
804,STAT5,21,22,146,151,"In contrast, calcium mobilization and activation of other signal transduction pathways, namely extracellular signal-regulated kinase1/2, p38, and STAT5 were unaffected, but activation of c-Jun N-terminal kinase 1/2 was delayed.",11698483_9,-1,1,-1,1,804,-1,1.08862105e-05,0.9999753,1.376318e-05
4450,status,19,20,133,139,Logistic regression was then carried out in order to identify predictors of elevated lymphocytic infiltration independent of DNA MMR status.,16978200_5,-1,1,-1,1,4450,-1,5.7398674e-06,0.9999883,5.998916e-06
42872,transition,8,9,72,82,"CXCL10 induced cell proliferation, migration and epithelial-mesenchymal transition in MCF-7 and MDA-MB-231 breast cancer cell lines.",34504204_3,-1,1,-1,1,42872,-1,1.0680577e-05,0.999974,1.5254303e-05
21020,transforming,4,5,24,36,"Production of IL-10 and transforming growth factor- in peripheral blood, and the mRNA level of IL-10 and transforming growth factor- in the spleen were also decreased.",23975869_8,-1,1,-1,1,21020,-1,9.8475475e-06,0.99997866,1.1500843e-05
8556,treatment,19,20,153,162,"FOXP3-positive cells were positively correlated with CD3-positive, CD4-positive, and CD8-positive tumor-infiltrating immune cells at baseline and during treatment (P < 0.05 in all comparisons).",19188179_6,-1,1,-1,1,8556,-1,5.0788963e-06,0.9999902,4.654319e-06
17016,there,2,3,15,20,"Interestingly, there is an increase in Th17 frequency within the peripheral blood and tumour microenvironment of advanced cancer patients.",22471280_3,-1,1,-1,1,17016,-1,4.6639843e-06,0.99999046,4.850673e-06
27169,This,2,3,13,17,CONCLUSIONS: This subject will further reveal the role of IFN- in the pathogenesis of MG from a new perspective.,26347149_13,-1,1,-1,1,27169,-1,5.182842e-06,0.99998987,4.9687615e-06
29973,TSA,12,13,107,110,We demonstrated that MCL-secreted IL-10 inhibits CD1d-mediated antigen presentation and pre-treatment with TSA abrogates secretion of IL-10 by MCL.,27614429_10,-1,1,-1,1,29973,-1,2.6545595e-05,0.9998617,0.000111771995
30757,the,5,6,41,44,Nonresolving inflammation is involved in the initiation and progression process of tumorigenesis.,27935860_0,-1,1,-1,1,30757,-1,3.936862e-06,0.99999225,3.85754e-06
18292,FoxP3,13,14,85,90,"Furthermore, gr-MDSCs impede the proliferation of nTregs without, however, affecting FoxP3 expression.",22891289_4,-1,1,-1,1,18292,-1,4.676427e-06,0.9999912,4.1078765e-06
22842,that,2,3,9,13,The fact that cancer can survive in this adverse microenvironment is indicative of immune regulation.,24623740_3,-1,1,-1,1,22842,-1,8.9134855e-06,0.9999845,6.5852414e-06
42777,gene,15,16,105,109,"Overexpression of DPF3 in renal cell lines increases growth rates and alters chromatin accessibility and gene expression, leading to inhibition of apoptosis and activation of oncogenic pathways.",34390653_2,-1,1,-1,1,42777,-1,6.834908e-06,0.99998415,8.961419e-06
11944,that,3,4,19,23,These data suggest that CagA protein negatively regulates the functions of DC via CagA phosphorylation and that cagA-positive H. pylori strains suppress host immune responses resulting in their chronic colonization of the stomach.,20363211_6,-1,1,-1,1,11944,-1,3.7971781e-06,0.9999926,3.5658056e-06
1848,to,20,21,128,130,"Thus, survivin enables cancer cells not only to suppress immune cell attack by inhibiting Fas-mediated apoptotic signaling, but to attack immune cells by induction of FasL.",15004200_10,-1,1,-1,1,1848,-1,4.824851e-06,0.9999895,5.63277e-06
1405,plasmid,8,9,56,63,"This phenotype was created by intratumoral injection of plasmid cDNAs coding for interferon gamma, MHC class II transactivator, and an antisense reverse gene construct (RGC) for a segment of the gene for Ii protein (-92,97).",12804139_2,-1,1,-1,1,1405,-1,5.552818e-06,0.99998844,5.9529707e-06
43839,the,27,28,148,151,The adoptive transfer of tumor-draining lymph node (LN) T cells activated ex vivo with anti-CD3 and interleukin 2 (IL-2) mediates the regression of the poorly immunogenic murine melanoma D5.,9690455_0,-1,1,-1,1,43839,-1,4.3533196e-06,0.9999906,5.01989e-06
40328,These,2,3,14,19,SIGNIFICANCE: These findings provide new insight into pGSN-mediated immune cell dysfunction in ovarian cancer chemoresistance and demonstrate how this dysfunction can be exploited to enhance immunotherapy.,32641415_9,-1,1,-1,1,40328,-1,5.0412664e-06,0.9999902,4.760628e-06
35570,the,7,8,46,49,"The addition of a STAT3 inhibitor ameliorated the increase in Tregs, enhanced suppressive function, and decreased T-cell IL10 production in vitro.",30131384_9,-1,1,-1,1,35570,-1,3.7416023e-06,0.99999225,4.0246296e-06
9940,their,6,7,40,45,Functional studies were done to analyze their inhibitory role.,19538059_2,-1,1,-1,1,9940,-1,8.077046e-06,0.99998665,5.3303097e-06
6944,the,15,16,89,92,Natural CD25(+)CD4(+) regulatory T cells (Treg) are essential for self-tolerance and for the control of T cell-mediated immune pathologies.,18424726_0,-1,1,-1,1,6944,-1,4.1595363e-06,0.99999166,4.1524263e-06
16682,Foxp3,20,21,130,135,"Third, FTS induced an increase in antitumor cytotoxic T-cell reactivity in glioma cells by downregulating their own expression of Foxp3.",22323550_5,-1,1,-1,1,16682,-1,4.810993e-06,0.9999913,3.946334e-06
38497,the,7,8,43,46,"However, this observation does not exclude the existence of neoantigen-specific T cells in colorectal cancers with low mutation burden and the exploitation of their anti-cancer potential for immunotherapy.",31888734_1,-1,1,-1,1,38497,-1,4.827172e-06,0.99999166,3.5418814e-06
13555,this,23,24,179,183,"These data suggest that vaccination with MVA-survivin in combination with gemcitabine represents an attractive strategy to overcome tumor-induced peripheral immune tolerance, and this effect has potential for clinical benefit in pancreatic cancer.",20960189_12,-1,1,-1,1,13555,-1,4.4885164e-06,0.99999166,3.910509e-06
24551,treatments,10,11,81,91,This gives a rationale for combining immunotherapy with conventional anti-tumour treatments in view of increasing their therapeutic potential.,25142285_9,-1,1,-1,1,24551,-1,6.4964433e-06,0.9999887,4.842502e-06
30136,treatment,1,2,6,15,IL-35 treatment activated the phosphorylation of both STAT1 and STAT3 in human CD4+ T cells.,27682874_6,-1,1,-1,1,30136,-1,2.5570289e-05,0.99996567,8.797469e-06
31268,that,63,64,361,365,"These results indicated that with cells isolated from cord blood, c-Rel has an important role in B-, T-, and NK cell differentiation and, further, that agents (select cytokines/growth factors) that could impact on its expression might not only affect immune cell profiles in a host but could potentially also limit apoptotic activities in (non-)immune cells in that host.",28090796_7,-1,1,-1,1,31268,-1,5.1463917e-06,0.9999894,5.4622014e-06
13547,the,9,10,72,75,Increased survivin-specific CD8(+) T cells that specifically recognized the Pan02 tumor line were seen in mice treated with MVA-survivin and gemcitabine.,20960189_11,-1,1,-1,1,13547,-1,4.455597e-06,0.99999106,4.4537614e-06
36265,TL1A,5,6,26,30,"TNF family members OX40L, TL1A and GITRL have been shown to promote the induction of Th9 cells and antitumor immunity.",30717817_1,-1,1,-1,1,36265,-1,1.4025855e-05,0.9999467,3.924779e-05
39888,Treg,11,12,48,52,"The frequency of CD3+, CD4+ and CD4+CD25+FOXP3+ Treg was assessed by flow cytometry in 43 ALL patients versus 42 controls.",32480291_3,-1,1,-1,1,39888,-1,5.6694666e-06,0.9999888,5.5207215e-06
21977,Treg,19,20,72,76,"OBJECTIVES: T helper 17 (Th17), T cytotoxic 17 (Tc17) and regulatory T (Treg) cells are important factors in the pathogenesis of inflammatory and autoimmune diseases.",24388919_0,-1,1,-1,1,21977,-1,6.985785e-06,0.99998224,1.0741279e-05
40508,Treatment,0,1,0,9,Treatment of DHA attenuated melanoma severity and histopathological changes in BALB/c mice.,32859456_6,-1,1,-1,1,40508,-1,6.0812436e-06,0.9999888,5.0841036e-06
18860,the,6,7,27,30,"In this review, we discuss the heterogeneity of IL-17-producing T cell types focusing on their development, regulation, and function.",23052209_4,-1,1,-1,1,18860,-1,4.503988e-06,0.9999918,3.7412935e-06
14022,tumor,23,24,152,157,To investigate this scenario we administered the chemical carcinogen Urethane in BALB/c mice and followed these animals during 120 days to observe lung tumor development.,21238620_1,-1,1,-1,1,14022,-1,4.697176e-06,0.99999034,4.903599e-06
15064,These,0,1,0,5,These indicators were compared before and after CpG ODN treatment.,21611754_2,-1,1,-1,1,15064,-1,9.384953e-06,0.9999846,5.9517733e-06
16104,the,4,5,23,26,"IL-21 was increased in the gut of patients with UC-associated colon cancer, and in mice with CAC induced by azoxymethane (AOM) and dextran sulfate sodium (DSS).",21987656_2,-1,1,-1,1,16104,-1,3.542657e-06,0.9999913,5.10164e-06
43530,tat,14,15,62,65,"Furthermore, a T cell line (H9) stably transfected with a HIV tat expression-vector secreted higher levels of IL-10.",8037735_4,-1,1,-1,1,43530,-1,4.9621603e-06,0.99998796,7.1084137e-06
31175,The,0,1,0,3,"The monitoring methods, such as ELISA, MTS assay, CFSE, Real-time PCR and Western blot were included in our research.",28088065_3,-1,1,-1,1,31175,-1,3.9495444e-06,0.9999918,4.2176853e-06
14564,that,13,14,83,87,T cell immune dysfunction has an important role in the profound immune suppression that characterizes chronic lymphocytic leukemia (CLL).,21377729_0,-1,1,-1,1,14564,-1,5.475261e-06,0.99998844,6.0570364e-06
19002,the,9,10,54,57,"Also, Er-1 significantly decreases the mRNA levels of the  and  subunits of IL-2 receptor (IL-2R), while the mRNA levels of the  subunit appeared to be not affected.",23103669_2,-1,1,-1,1,19002,-1,4.6238574e-06,0.99999,5.3485105e-06
31417,tumour-antigen,10,11,56,70,It has also been shown to limit Treg frequencies during tumour-antigen stimulations.,28239749_1,-1,1,-1,1,31417,-1,0.6849009,0.31024358,0.004855484
38664,TNBC,27,28,226,230,These data show that the bidirectional interaction between IRISOE cells and macrophages triggers an immunosuppressive microenvironment within TNBC tumors that is favorable for the generation of immune-evading/stem-like/IRISOE TNBC metastatic precursors.,31911557_8,-1,1,-1,1,38664,-1,1.1177642e-05,0.99997425,1.4523065e-05
2080,the,35,36,213,216,Cervical cancer is the possible outcome of genital infection with high-risk human papillomavirus (HPV) and is preceded by a phase of persistent HPV infection during which the host immune system fails to eliminate the virus.,15289354_0,-1,1,-1,1,2080,-1,9.031497e-06,0.9999851,5.884921e-06
4406,tumor,3,4,18,23,"Although, delayed tumor growth was observed when CD40L-expressing OVHM cells and OVHM cells were injected simultaneously and contralaterally, the tumor growth of OVHM and CD40L/OVHM in BALB/c nude mice was not different.",16965650_10,-1,1,-1,1,4406,-1,4.5957463e-06,0.99999154,3.9240435e-06
20265,this,3,4,12,16,"METHODS: In this study, we established an MHC class II molecule-expressing murine colon cancer cell line (CT26-CIITA) by transduction of the CIITA gene.",23621273_1,-1,1,-1,1,20265,-1,4.405122e-06,0.9999906,4.992467e-06
7047,the,7,8,48,51,Autologous DCs were generated from monocytes of the peripheral blood from 10 patients with SzS. Total RNA was extracted from Szary cells and amplified by T7 in vitro transcription.,18480841_3,-1,1,-1,1,7047,-1,5.1751135e-06,0.9999883,6.468535e-06
36640,that,5,6,36,40,"Our previous study has demonstrated that CD4+ T cells in prostate tumor microenvironment contribute to PCa progression; meanwhile, we found increased CD4+ T-cell infiltration in tumor area after Doc treatment; however, their effects on PCa chemosensitivity remain unclear.",31018021_2,-1,1,-1,1,36640,-1,4.103342e-06,0.999992,3.8581275e-06
37016,the,13,14,79,82,The immune mediated response plays a critical role in the antitumour effect by the anaerobic spore treatment.,31183361_1,-1,1,-1,1,37016,-1,5.0509566e-06,0.99999094,4.0386158e-06
2147,themselves,6,7,33,43,"LP CD4(+)CD25(bright) T cells by themselves produced fewer amounts of IL-2, IFN-gamma, and IL-10.",15322172_5,-1,1,-1,1,2147,-1,1.7832035e-05,0.9999591,2.304068e-05
43499,the,2,3,6,9,"Thus, the stimulation of AP-1-mediated gene expression by IL-1 in EL4 cells is due to the promotion of Jun B protein accumulation that, in turn, facilitates Jun B heterodimerization with TPA-induced Fra-1 protein, thereby forming an active AP-1 complex.",7675040_8,-1,1,-1,1,43499,-1,3.845215e-06,0.9999926,3.5481019e-06
24768,to,7,8,56,58,The long-lasting clinical response by lymphoma patients to anti-CD20 therapy has been attributed to the induction of an anti-tumor adaptive immunity.,25231744_0,-1,1,-1,1,24768,-1,7.5420885e-06,0.9999858,6.670785e-06
18603,that,18,19,135,139,Progression-free interval and survival were longer than observed in a phase III trial where gemcitabine preceded pemetrexed suggesting that a larger trial of pemetrexed preceding gemcitabine is warranted.,22996369_14,-1,1,-1,1,18603,-1,5.6770054e-06,0.9999901,4.198227e-06
25791,that,3,4,23,27,We further illustrated that overexpression of Snail is crucial for HLA-I downregulation and its association with EMT.,25618241_6,-1,1,-1,1,25791,-1,4.4056314e-06,0.9999918,3.7635202e-06
32517,tumors,1,2,6,12,"Glial tumors are enriched for CD8/CD4 T-cells with tissue resident memory (TRM; CD45RO+, CD69+, CCR7-) phenotype, which co-express multiple inhibitory checkpoints including PD-1, PD-L1 and TIGIT.",28620836_9,-1,1,-1,1,32517,-1,3.5558396e-06,0.9999919,4.534398e-06
42170,target,25,26,140,146,We reported a direct role of STAT6 in the induction and function of Treg cells during CAC development and suggest that STAT6 is a potential target for the modulation of immune response in colitis and CAC.,33919941_8,-1,1,-1,1,42170,-1,5.018609e-06,0.99999106,3.943459e-06
1889,three,34,35,258,263,PURPOSE: The purpose is to study the immunogenicity of heterologous prime-boost human papillomavirus (HPV) oncogene vaccination in patients with anogenital intraepithelial neoplasia (AGIN).EXPERIMENTAL DESIGN: Twenty-nine women with high-grade AGIN received three i.m.,15131030_0,-1,1,-1,1,1889,-1,6.6825116e-05,0.99990785,2.5308187e-05
32142,tumors,38,39,256,262,"We here demonstrate that Interleukin-1 receptor 8 (IL-1R8 - previously known as SIGIRR/TIR8), a negative regulator of Toll-Like and Interleukin-1 Receptor family signaling, is up-regulated during breast epithelial cell transformation and in primary breast tumors.",28533483_2,-1,1,-1,1,32142,-1,3.6288827e-06,0.9999913,5.033758e-06
43730,the,2,3,20,23,Characterization of the molecular defects underlying loss of HLA Class I antigens may suggest approaches to restore their expression.,8795138_7,-1,1,-1,1,43730,-1,5.0170024e-06,0.9999912,3.74589e-06
24889,the,19,20,127,130,"During the past decade, a better understanding of the cellular and molecular mechanisms underlying tumor immunity has provided the appropriate framework for the development of therapeutic strategies for cancer immunotherapy.",25253145_0,-1,1,-1,1,24889,-1,1.0767437e-05,0.9999827,6.504228e-06
39742,plays,24,25,155,160,"BACKGROUND: The connection between inflammatory bowel disease (IBD) and colorectal cancer (CRC) is well-established, as persistent intestinal inflammation plays a substantial role in both disorders.",32390702_0,-1,1,-1,1,39742,-1,8.448758e-06,0.9999846,6.922843e-06
17891,tumors,22,23,149,155,"Here, we used an experimental model of colitis-associated colorectal carcinoma to investigate the contribution of NFATc2 to the promotion of colonic tumors.",22738913_2,-1,1,-1,1,17891,-1,4.342624e-06,0.9999902,5.3940244e-06
4345,Treg,13,14,75,79,"However, little is known about the phenotype and function of human mucosal Treg.",16934529_1,-1,1,-1,1,4345,-1,9.042299e-06,0.9999778,1.3075438e-05
39717,the,31,32,183,186,"Although the estrogen-related receptor alpha (ERR) has been implicated in breast cancer cell dissemination to the bone from the primary tumor, its role after tumor cell anchorage in the bone microenvironment remains elusive.",32366476_1,-1,1,-1,1,39717,-1,5.367879e-06,0.9999902,4.384709e-06
9179,the,5,6,31,34,Mice receiving the pUS-high in the prophylactic setting presented a 48-52% reduction in s.c.,19291796_3,-1,1,-1,1,9179,-1,4.0285795e-06,0.9999919,4.1032827e-06
29204,treatments,8,9,44,54,PURPOSE: We sought to find new immune-based treatments for pancreatic cancer.,27297583_0,-1,1,-1,1,29204,-1,6.156713e-06,0.99998784,5.965663e-06
1012,the,36,37,188,191,"In particular, even though a broad distribution of Th2 cytokine receptors by AML blasts was shown, we demonstrated the almost exclusive expression of interleukin 4 (IL-4) receptor (R), in the absence of its cognate cytokine, by CD30L+ AML.",11918534_2,-1,1,-1,1,1012,-1,5.4683915e-06,0.99999,4.538621e-06
21664,tumor,15,16,103,108,Peripheral blood mononuclear cells activated by DCs matured with OK-432 plus IFN- also showed greater tumor growth inhibition in vivo in null mice.,24296809_6,-1,1,-1,1,21664,-1,5.2523874e-06,0.99999046,4.2779457e-06
982,nature,9,10,57,63,"Taken together, our data clearly underscore the critical nature of employing DCs of full maturity for DC-based antitumor vaccination strategies.",11902830_4,-1,1,-1,1,982,-1,6.832736e-06,0.9999857,7.4933996e-06
34909,to,13,14,75,77,Relative mRNA expression of all the genes was higher in CD4+CD25+ compared to CD4+CD25- cells.,29785404_7,-1,1,-1,1,34909,-1,5.6868334e-06,0.9999888,5.4652874e-06
41540,Tregs,36,37,211,216,"Further, Th17 and Tregs levels were detected by immunohistochemical double staining of thymoma tissue; the number of positive Th17 cells in thymoma with MG was higher than that in simple thymoma, while positive Tregs showed the opposite results.",33636431_4,-1,1,-1,1,41540,-1,4.093915e-06,0.9999913,4.63839e-06
18802,to,5,6,43,45,"Ironically, m-MDSCs manifesting resistance to sunitinib also have the greatest potential to differentiate into tumoricidal accessory cells, by virtue of their capacity to respond to T cell-secreted IFN- or to TLR agonists with nitric oxide and peroxynitrate production.",23017141_6,-1,1,-1,1,18802,-1,6.0343887e-06,0.99998844,5.529461e-06
39704,the,3,4,23,26,This review summarizes the signaling pathways involved in the pathogenesis following colon inflammation to understand the underlying molecular mechanisms in CAC tumorigenesis.,32357539_5,-1,1,-1,1,39704,-1,5.2902815e-06,0.9999906,4.1342373e-06
2078,the,28,29,171,174,Cervical cancer is the possible outcome of genital infection with high-risk human papillomavirus (HPV) and is preceded by a phase of persistent HPV infection during which the host immune system fails to eliminate the virus.,15289354_0,-1,1,-1,1,2078,-1,6.165763e-06,0.9999889,4.9295677e-06
40130,three,2,3,9,14,"When all three agents were used in combination, maximum antitumor effects were observed, which correlated with increases in T cells and T-cell clonality in the TME.CONCLUSION: These studies provide the rationale for the potential clinical use of combinations of agents that can (1) induce tumor-associated T-cell responses, (2) potentiate immune responses in the TME and (3) reduce immunosuppressive entities in the TME.",32554612_8,-1,1,-1,1,40130,-1,6.066515e-05,0.99991226,2.712464e-05
34125,the,7,8,43,46,"Thus, suppression of inflammatory cells at the initial stages of CCA development would be of benefit.",29331794_1,-1,1,-1,1,34125,-1,5.4702714e-06,0.99998856,5.9961953e-06
40705,tumor,10,11,67,72,The combined results demonstrate a critical role of eosinophils in tumor control in CRC and introduce the GM-CSF-IRF5 axis as a critical driver of the antitumor activities of this versatile cell type.,32970801_6,-1,1,-1,1,40705,-1,4.262287e-06,0.9999913,4.485844e-06
11736,the,12,13,73,76,"Interestingly, although there was no difference in main tumor size among the BMT groups, lung metastasis was significantly inhibited by Allo-BMT + Allo-TT or 3rd-party TT.",20229083_4,-1,1,-1,1,11736,-1,6.304907e-06,0.9999893,4.3918735e-06
32520,TRM,12,13,75,78,"Glial tumors are enriched for CD8/CD4 T-cells with tissue resident memory (TRM; CD45RO+, CD69+, CCR7-) phenotype, which co-express multiple inhibitory checkpoints including PD-1, PD-L1 and TIGIT.",28620836_9,-1,1,-1,1,32520,-1,5.370518e-06,0.99998677,7.863472e-06
25169,that,9,10,49,53,"Using the C1498 AML mouse model, we demonstrated that leukemia development was associated with thymus atrophy, which was defined by abnormal organ weight and reduced cellularity.",25382729_2,-1,1,-1,1,25169,-1,5.839543e-06,0.99999,4.2133515e-06
6203,Foxp3,24,25,137,142,"In contrast, in peripheral blood Nrp1 identified a minor CD4+ T-cell subset that did not display the phenotypic features of Treg lacking Foxp3 expression and marginally expressing CD25.",18028372_5,-1,1,-1,1,6203,-1,4.5581983e-06,0.9999913,4.100112e-06
40348,gene,18,19,115,119,"One such enzyme is lysine-specific histone demethylase 1 (LSD1/KDM1A), which regulates the chromatin landscape and gene expression by demethylating proteins such as histone H3.",32649682_3,-1,1,-1,1,40348,-1,7.913434e-06,0.9999833,8.817035e-06
36859,transcription factors,16,18,90,111,"Our results suggest that HeLa, SiHa, and C-33A cell lines down-regulate the activation of transcription factors characteristic of M1 macrophages (STAT1, NF-B-p65) and induce the secretion of factors that favor tumor growth.",31099286_5,-1,1,-1,1,36859,-1,4.505994e-06,0.99999094,4.5291386e-06
21260,to,1,2,8,10,"Similar to intratumoral Treg infiltrates, CCL22 tumor secretion correlated with the prognosis of the molecular subtypes of breast carcinoma (P<0.0001).",24124553_6,-1,1,-1,1,21260,-1,3.9623033e-06,0.9999919,4.1535754e-06
178,therefore,13,14,81,90,The E6 and E7 oncoproteins are constitutively expressed in these lesions and are therefore putative targets for the immune response against HPV.,10962445_1,-1,1,-1,1,178,-1,4.3622867e-06,0.99999034,5.3262534e-06
35110,their,21,22,130,135,"Here, we reveal a mechanism to selectively target and reprogram the function of tumor-infiltrating Tregs (TI-Tregs) by exploiting their dependency on the histone H3K27 methyltransferase enhancer of zeste homolog 2 (EZH2) in tumors.",29898397_1,-1,1,-1,1,35110,-1,4.6934456e-06,0.9999913,4.0388677e-06
33000,the,15,16,111,114,"Anti-G-CSF treatment in combination with the DNA synthesis inhibitor gemcitabine reduced tumor size, increased the number of infiltrating T cells, and decreased the number of Ly6G+ cells more effectively than gemcitabine alone.",28775207_5,-1,1,-1,1,33000,-1,3.926639e-06,0.99999094,5.1739034e-06
36002,statistically,28,29,190,203,"Chemokine expression and tumor infiltration by regulatory T cells, determined by expression of the transcription factor FoxP3, were quantified and their correlation to clinical features was statistically analyzed.",30572845_4,-1,1,-1,1,36002,-1,7.352034e-06,0.9999869,5.7516454e-06
6446,the,2,3,13,16,"Furthermore, the frequency of CCL17(+) or CCL22(+) cells among CD14(+) cells within tumors was significantly higher than that of normal gastric mucosa, and there was a significant correlation between the frequency of CCL17(+) or CCL22(+) cells and Foxp3(+) Tregs in TILs.",18224687_8,-1,1,-1,1,6446,-1,3.6514182e-06,0.9999927,3.6115666e-06
22562,This,2,3,13,17,CONCLUSIONS: This study indicates that Tc17 cell infiltration in cervical cancers is associated with cancer progression accompanied by increased infiltrations of Th17 cells and regulatory T cells as well as promoted tumor vasculogenesis.,24523865_6,-1,1,-1,1,22562,-1,4.786335e-06,0.9999894,5.831915e-06
11973,The,0,1,0,3,The enhanced cytotoxic effects of T lymphocytes might partly depend on EXO/IL-12 reversing the suppressed expression of p-Stat5 by Jak2/Stat5 pathway.,20372811_7,-1,1,-1,1,11973,-1,5.271408e-06,0.99999094,3.7298976e-06
6955,that,37,38,220,224,"Our experiments indicate that TIRC7, T cell immune response cDNA 7, a novel membrane molecule involved in the regulation of T lymphocyte activation, identifies two Treg subsets (CD25(low)TIRC7(+) and CD25(high)TIRC7(-)) that are characterized by the expression of Foxp3 and a suppressive activity in vitro and in vivo.",18424726_2,-1,1,-1,1,6955,-1,4.9487876e-06,0.9999902,4.8517827e-06
24988,that,6,7,23,27,"In this study, we show that DCs isolated from patients with metastatic or locally advanced breast cancer express high levels of the adiponectin receptors AdipoR1 and AdipoR2, which are sufficient to blunt antitumor immunity.",25261236_2,-1,1,-1,1,24988,-1,4.5936154e-06,0.9999913,4.166117e-06
10164,the,2,3,10,13,"Moreover, the primary tumor growing in mammary pads activates remotely the expression of TARC/CCL17 and MDC/CCL22 in the lungs.",19567680_4,-1,1,-1,1,10164,-1,4.086784e-06,0.9999913,4.644139e-06
43223,the,17,18,123,126,"Finally, transcriptomic analyses indicated that AX-0085 is highly specific in targeting the IFN--pathway, thereby raising the possibility of applying this reagent in combination therapy with checkpoint inhibitor antibodies.",35011581_3,-1,1,-1,1,43223,-1,4.5936376e-06,0.9999913,4.131509e-06
42032,tumors,48,49,283,289,"We found increased ENTPD1 expression on T cells within cSCCs when compared with the expression on T cells from blood or nonlesional skin, and accordingly, concentrations of derivative extracellular adenosine diphosphate (ADP), adenosine monophosphate (AMP), and ADO are increased in tumors compared with those in normal skin.",33848530_4,-1,1,-1,1,42032,-1,4.216646e-06,0.99999046,5.2644327e-06
763,the,10,11,72,75,Tumors produce a variety of immunosuppressive factors which can prevent the proliferation and maturation of a number of normal hemopoietic cell types.,11698483_0,-1,1,-1,1,763,-1,5.1577376e-06,0.9999906,4.234486e-06
42326,transcriptome,3,4,12,25,METHODS: NB transcriptome analyses were used to identify epigenetic drivers of a T-cell infiltration-poor TME.,34016720_4,-1,1,-1,1,42326,-1,1.0187146e-05,0.999977,1.2778871e-05
19201,the,8,9,33,36,"In this study, we aimed to prove the presence of functionally suppressive Treg cells expressing CD8 phenotype (CD8 Treg cells) in MM.",23152910_2,-1,1,-1,1,19201,-1,3.6464487e-06,0.9999927,3.5880196e-06
19782,to,35,36,202,204,"Studies revealed that the levels of expression of genes responsible for T-cell proliferation (C-FOS, C-JUN and DUSP1) and cellular migration (RGS1) were greater in Tregs from mCRPC patients as compared to values observed in healthy donors.",23319273_5,-1,1,-1,1,19782,-1,4.615899e-06,0.9999906,4.7474455e-06
40379,their,18,19,105,110,The contribution of immune cells in soft tissue sarcomas (STS) is not completely known and understanding their role is very essential for employing immunotherapy strategies.,32661685_0,-1,1,-1,1,40379,-1,6.3223392e-06,0.9999875,6.1587307e-06
18506,to,4,5,23,25,"Specifically, we aimed to optimize the therapeutic efficacy of Flt3L/TK treatment in the RG2 model by overexpressing the following genes within the brain tumor microenvironment: 1) a TK mutant with enhanced cytotoxicity (SR39 mutant TK), 2) Flt3L-IgG fusion protein that has a longer half-life, 3) CD40L to stimulate DC maturation, 4) T helper cell type 1 polarizing dendritic cell cytokines interleukin-12 or C-X-C motif ligand 10 chemokine (CXCL)-10, 5) C-C motif ligand 2 chemokine (CCL2) or C-C motif ligand 3 chemokine (CCL3) to enhance dendritic cell recruitment into the tumor microenvironment, 6) T helper cell type 1 cytokines interferon- or interleukin-2 to enhance effector T-cell functions, and 7) IB or p65RHD (nuclear factor kappa-B [NF-B] inhibitors) to suppress the function of Foxp3+ Tregs and enhanced effector T-cell functions.",22996231_2,-1,1,-1,1,18506,-1,3.3556098e-06,0.99999285,3.7561845e-06
4945,tumor-bearing,15,16,99,112,"After adoptive transfer to naive recipients, CD11b(+)Gr-1(+) MSCs freshly isolated from spleens of tumor-bearing mice but not naive mice were able to inhibit NK cell cytotoxicity.",17244679_2,-1,1,-1,1,4945,-1,6.054492e-06,0.99998796,6.0387383e-06
34312,the,13,14,86,89,We also found Helios+ Tregs decreased apoptosis rate of nalm-6 cells by up-regulating the expression of anti-apoptosis protein Bcl-2.,29455107_6,-1,1,-1,1,34312,-1,3.7304005e-06,0.99999225,4.0218515e-06
778,TSN,5,6,30,33,"We have demonstrated that AML TSN contained none of the immunosuppressors described to date, namely gangliosides, nitric oxide, TGF-beta, IL-10, vascular endothelial growth factor, or PGs.",11698483_4,-1,1,-1,1,778,-1,1.85234e-05,0.99992085,6.0621136e-05
12328,Th2,7,8,36,39,Skin adjacent to SCC in OTRs showed Th2 expression pattern as compared with immunocompetent patients.,20463594_9,-1,1,-1,1,12328,-1,1.2969183e-05,0.9999809,6.110659e-06
1782,tumor,36,37,226,231,"Suppression also required an endogenous IFN-gamma pathway consisting minimally of IFN-gamma, IFN-gamma receptor, Stat1, and IFN regulatory factor 1 since mice with targeted disruption of any of the four genes failed to arrest tumor growth.",14978132_2,-1,1,-1,1,1782,-1,4.0453115e-06,0.9999919,4.0518985e-06
6124,JunB-deficient,9,10,49,63,"In line with these findings, the contribution of JunB-deficient mast cells to angiogenesis, as analyzed in an in vitro tube formation assay on matrigel, is severely impaired due to limiting amounts of synthesized and secreted vascular endothelial growth factor.",17982078_7,-1,1,-1,1,6124,-1,8.4831765e-05,0.99987435,4.07935e-05
21858,FoxP3,19,20,110,115,"These diagnosed patients demonstrated a lower number of CD4(+) CD25(+) cells co-expressing a higher level of FoxP3, interleukin-10, transforming growth factor- and CD152/CTLA-4 than the normal population.",24354800_4,-1,1,-1,1,21858,-1,5.571027e-06,0.9999893,5.148198e-06
36440,tumor,13,14,85,90,BACKGROUND: Tumor immune reactions not only provide host defense but also accelerate tumor immune escape and phenotype switching.,30927618_0,-1,1,-1,1,36440,-1,5.0901285e-06,0.9999906,4.368016e-06
2946,type,14,15,99,103,Cervical cancer is the possible outcome of a genital infection with high-risk human papillomavirus type 16 (HPV16) and is preceded by a phase of persistent HPV infection during which the host immune system fails to eliminate the virus.,16108057_0,-1,1,-1,1,2946,-1,0.0003592737,0.9995017,0.00013896107
41066,The,0,1,0,3,"The expression levels of Foxp3 and TGF in transplanted tumor tissues were detected by quantitative fluorescence PCR.RESULTS: Compared with healthy people, Treg cells and IL-2, IL-10, and TGF contents in peripheral blood of liver cancer patients were increased.",33204731_5,-1,1,-1,1,41066,-1,3.9049046e-06,0.9999918,4.2946044e-06
25229,the,12,13,77,80,"These findings suggest that the STING pathway could be manipulated to enable the rational design of immunotherapies that enhance or diminish antitumor and autoimmune responses, respectively.",25385820_7,-1,1,-1,1,25229,-1,4.68083e-06,0.9999919,3.3840931e-06
16463,Tbet,22,23,138,142,"Since IL-12 is a classical promoter of type-1 immunity, the current study was undertaken to determine whether gene therapy using combined Tbet and IL-12 complementary DNA (cDNA) would yield improved antitumor efficacy based on the complementary/synergistic action of these biologic modifiers.",22215017_1,-1,1,-1,1,16463,-1,1.14794375e-05,0.99996865,1.986117e-05
39196,TFH,24,25,137,140,"Under the control of specific cytokines and B-cell lymphoma 6 transcription factor (Bcl-6), the major transcription factor of TFH cells, TFH, can expand to the other distinct CD4+T helper cells (TH1, TH2, and TH17) which exert a different role in the development of CRC.",32061875_5,-1,1,-1,1,39196,-1,4.472144e-06,0.9999901,5.4093753e-06
4271,the,12,13,80,83,This review discusses the factors in the tumor microenvironment that can affect the efficacy of cancer vaccines.,16916758_4,-1,1,-1,1,4271,-1,6.246336e-06,0.99998975,4.000462e-06
42749,the,25,26,158,161,"Results depicted ascites as an inflammatory and immunosuppressive environment, presenting significantly (p < 0.0001) higher amounts of IL-6 and IL-10 than in the patients' blood, as well as significantly (p < 0.05) increased expression of checkpoint inhibitory receptors (programmed death protein-1, PD-1) and ectonucleotidase (CD39) on T lymphocytes.",34359872_4,-1,1,-1,1,42749,-1,4.124762e-06,0.9999906,5.2975215e-06
21829,treated,9,10,55,62,Serum level of IFN- was elevated in the umbelliprenin treated cancerous mice compared to the control group while IL-10 and IL-4 secretions were reduced.,24325354_8,-1,1,-1,1,21829,-1,8.318135e-06,0.99998426,7.3744295e-06
3650,the,12,13,62,65,"The objective of the present study was to address the role of the immune system, tumour micro-environment and potential immunosuppression in mesothelioma.",16540497_1,-1,1,-1,1,3650,-1,4.831773e-06,0.9999907,4.5068527e-06
267,the,21,22,108,111,"Here, we include an update on our studies regarding CD154 expression in CLL, a review of the data regarding the consequences of CD40 engagement in CLL B cells, and a discussion of these findings in the context of the complex and potentially opposite outcomes that have been reported for CD40-mediated signals in CLL.",11042507_3,-1,1,-1,1,267,-1,4.0902073e-06,0.99999225,3.6063852e-06
25860,This,0,1,0,4,This inhibitory effect is specific for AICD through suppressing NFAT1-regulated FasL expression on activated CD4(+) T cells.,25745993_4,-1,1,-1,1,25860,-1,3.870876e-06,0.999992,4.1163507e-06
41194,the,4,5,27,30,Silencing of TAZ cancelled the effects of SKIL overexpression on malignant phenotypes and autophagy of NSCLC cells.,33268765_11,-1,1,-1,1,41194,-1,8.549645e-06,0.99998736,4.0275395e-06
38296,Foxp3,25,26,125,130,"Interestingly, the level of CD25+ Foxp3+ cells in circulating CD4+ T cells was positively correlated with the level of CD25+ Foxp3+ cells in CD4+ TILs, but the level of CD25+ Foxp3- cells in circulating CD4+ T cells was not associated with the level of CD25+ Foxp3- cells in CD4+ TILs.",31811667_9,-1,1,-1,1,38296,-1,5.269437e-05,0.9999044,4.287177e-05
27460,STAT1,51,52,326,331,"Our data indicates that complete absence of endogenous host galectin-3 facilitates lung metastasis of B16F10 cells in mice, which may be contributed by dysregulated immune responses resulting from decreased NK cytotoxicity, disturbed serum Th1, Th2, Th17 cytokine milieu, reduced serum IFN- levels and attenuation of splenic STAT1 mediated IFN- signalling in Gal-3(-/-) mice.",26442663_11,-1,1,-1,1,27460,-1,5.669101e-06,0.99998343,1.0926375e-05
40283,the,21,22,120,123,"Using a genetic mouse model of BCC, we identified profound differences in the infiltration of BCC lesions with cells of the adaptive and innate immune system.",32615027_3,-1,1,-1,1,40283,-1,1.011036e-05,0.99998033,9.599914e-06
4280,to,11,12,94,96,injection of the Ad-sig-tumor-associated antigen (TAA)/ecdCD40L vector vaccine has been shown to induce a CD8 immune response against TAA for up to 1 year.,16928818_1,-1,1,-1,1,4280,-1,4.6479367e-06,0.9999914,3.9938814e-06
23567,to,9,10,61,63,"Naive murine CD8 T cells haplo-insufficient for Ikzf1 failed to upregulate Ikaros, produced autocrine IL-2, and differentiated in an IL-2-dependent manner into IFN--producing CTLs in response to TCR/CD28 stimulation alone.",24778448_5,-1,1,-1,1,23567,-1,6.5400327e-06,0.9999888,4.661415e-06
14846,The,0,1,0,3,"The normal gastric mucosa cell line, GES-1, was used as the control.",21528082_4,-1,1,-1,1,14846,-1,4.3905598e-06,0.99999046,5.19879e-06
27183,tumor,17,18,94,99,"On one hand, the surveillance role of the immune system plays an important role in endogenous tumor prevention, but on the other hand, in some special circumstances such as in chronic inflammation, the immune system can actually contribute to the formation and progression of tumors.",26364615_1,-1,1,-1,1,27183,-1,4.744728e-06,0.9999902,5.0525477e-06
10917,FoxP3(+,11,12,55,62,"Here, we evaluated peripheral blood CD4(+) T cells and FoxP3(+) CD4(+) T cells from 45 patients with early or late stage breast cancer and compared percentages, absolute counts, and Treg function to those from healthy volunteers (HV) of comparable age.",19855964_2,-1,1,-1,1,10917,-1,5.79504e-05,0.999902,4.0021543e-05
22059,to,6,7,43,45,The SP immunohistochemical method was used to detect the expressions of FOXP3 in cervical lesions.,24401583_4,-1,1,-1,1,22059,-1,4.5219103e-06,0.999992,3.493075e-06
22423,through,15,16,115,122,Our findings suggested the possibility that intratumoral Tregs protected against metastasis of CRC after resection through overcoming IL-17 producing T cells.,24487033_11,-1,1,-1,1,22423,-1,7.721427e-06,0.99998736,4.8856828e-06
26773,the,7,8,39,42,"These results suggest that a change in the number of Foxp3-positive Tregs contributes to the pathogenesis of canine IBD and intestinal lymphoma by disrupting mucosal tolerance and suppressing antitumor immunity, respectively.",26173451_10,-1,1,-1,1,26773,-1,3.5149378e-06,0.9999925,3.947261e-06
15030,generated,32,33,184,193,"The percentage of CD15(+) and CD15(-) but not CD14(+) MDSC subsets were inversely correlated with IFN--induced STAT1 phosphorylation in CD4(+) T cells, while co-culture with in vitro generated MDSC led to reduced IFN- responsiveness in both PBMC and the CD4(+) subset of T cells from normal donors.",21604071_6,-1,1,-1,1,15030,-1,3.5063935e-05,0.99995375,1.1168504e-05
35783,the,2,3,11,14,"Meanwhile, the expression of inhibitory receptor CD73 was also elevated on the surface of Tconv cells following the BCCs' supernatant treatment.",30321288_6,-1,1,-1,1,35783,-1,3.9601596e-06,0.99999225,3.8287726e-06
18065,transplant,26,27,135,145,We examined the effects of adoptive T-cell transfer (ACT) on the population of regulatory T cells (Tregs) in a mouse colorectal cancer transplant model.,22812187_0,-1,1,-1,1,18065,-1,4.626519e-06,0.99999034,5.04883e-06
6141,the,16,17,114,117,"Whereas the spontaneously growing CTCL-derived cell lines displayed persistent activation of the TORC1 as well as the PI3K/Akt and MEK/ERK pathways, the IL-2-dependent cell lines activated the pathways in response to IL-2 and IL-15 but not IL-21.",18025151_1,-1,1,-1,1,6141,-1,4.249102e-06,0.99999154,4.2074757e-06
41520,Th17,15,16,95,99,"Flow cytometry analysis of Th17 and Tregs in peripheral blood revealed that the percentages of Th17 in thymoma were lower than those in thymoma with MG, while the percentages of Tregs were higher than those in simple thymoma.",33636431_2,-1,1,-1,1,41520,-1,4.5160694e-05,0.9999026,5.2164272e-05
9493,that,3,4,12,16,"We now show that IDO functions as a molecular switch in TDLNs, maintaining Tregs in their normal suppressive phenotype when IDO was active, but allowing inflammation-induced conversion of Tregs to a polyfunctional T-helper phenotype similar to proinflammatory T-helper-17 (TH17) cells when IDO was blocked.",19366986_1,-1,1,-1,1,9493,-1,4.619758e-06,0.9999918,3.5995668e-06
20344,to,16,17,88,90,"The strongest associations were in premenopausal women, who were up to 80 % less likely to have TNBC than LumA cancers (IL-12p40/IL-5, OR = 0.19, 95 % CI 0.07-0.56).",23624818_8,-1,1,-1,1,20344,-1,6.453213e-06,0.9999876,5.8945293e-06
15369,the,20,21,106,109,"In addition, we generated a panel of T cell clones from UV-irradiated and non-irradiated mice, and all of the clones derived from UV-irradiated mice had a Tr1-type regulatory T cell phenotype with expression of IL-10 and c-Maf, but not Foxp3.",21710495_4,-1,1,-1,1,15369,-1,4.0249383e-06,0.9999918,4.2550355e-06
8679,to,14,15,75,77,"In conclusion, the hallmark of our panel of activated human Treg clones is to produce bioactive TGF-beta which has autocrine actions on Tregs and can have paracrine actions on other T cells.",19224638_8,-1,1,-1,1,8679,-1,4.137879e-06,0.9999918,4.1073386e-06
16180,T(reg,17,18,110,115,"In this study, the phenotypic characteristics, function and feasibility of enrichment and expansion of canine T(reg) were examined.",22041284_1,-1,1,-1,1,16180,-1,7.7654095e-06,0.99998057,1.1674995e-05
19066,T(REG,10,11,63,68,PURPOSE: To evaluate CD4(+)CD25(+)FOXP3(+) T regulatory cells (T(REG)) and associated immune-regulatory pathways in peripheral blood lymphocytes (PBL) of metastatic renal cell carcinoma (mRCC) patients and healthy volunteers.,23118856_0,-1,1,-1,1,19066,-1,5.5177097e-06,0.99998665,7.777293e-06
14812,There,0,1,0,5,"There was a tendency for luminal cancers to show CXCL12 expression (102/138, 74%) compared to basal-like cancers (16/27, 59%), which verged on statistical significance (P = 0.050).",21521526_7,-1,1,-1,1,14812,-1,4.1253243e-06,0.9999914,4.425776e-06
2404,this,24,25,166,170,The observation that CLL cells can acquire features of dendritic cells that promote type 1 immunity may find clinical application in immunotherapeutic strategies for this disease.,15614042_8,-1,1,-1,1,2404,-1,4.134241e-06,0.9999914,4.4411836e-06
34667,treatment,1,2,10,19,"Following treatment with IFN-, both CIC enriched and non-enriched TC-1 cells expressed similar levels of MHC-I, and the increased MHC-I expression on CICs resulted in greater CTL-mediated tumor lysis and improved tumor-free survival in mice.",29699516_10,-1,1,-1,1,34667,-1,5.673401e-06,0.9999901,4.2592424e-06
3788,This,0,1,0,4,This effect is independent of both Stat1-activating cytokine IFN-gamma and Stat1-downstream effector molecule FasL because neither neutralization of IFN-gamma nor knocking out of FasL enhances or inhibits IL-12-mediated tumor regression.,16618773_3,-1,1,-1,1,3788,-1,4.3083787e-06,0.99999154,4.116301e-06
32176,these,10,11,76,81,Histone acetylation and the families of enzymes responsible for controlling these epigenetic marks have been implicated in regulating T-cell maturation and phenotype.,28550044_0,-1,1,-1,1,32176,-1,4.7412627e-06,0.99999106,4.189344e-06
16283,Foxp3,34,35,216,221,"Mechanistic studies revealed that DKK1 vaccine elicited a strong DKK1- and tumor-specific CD4+ and CD8+ immune responses, and treatment with B7H1 or OX40 Abs significantly reduced the numbers of IL-10-expressing and Foxp3+ regulatory T cells in vaccinated mice.",22049519_5,-1,1,-1,1,16283,-1,8.569425e-06,0.99998546,5.9780878e-06
21489,Nanog,6,7,47,52,"Stable short hairpin RNA-mediated depletion of Nanog, combined with melanocyte differentiation Ag tyrosinase-related protein-2 peptide-based vaccination, resulted in complete inhibition of B16-F10 tumor growth.",24227785_4,-1,1,-1,1,21489,-1,6.325682e-06,0.99998593,7.719951e-06
4982,Treg,18,19,108,112,"Recent studies demonstrated that FOXP3, which is a master control gene of naturally occurring regulatory T (Treg) cells, is expressed in the tumor cells from a subset of patients with ATLL.",17278106_1,-1,1,-1,1,4982,-1,5.902083e-06,0.9999846,9.431692e-06
17034,the,14,15,74,77,"Like IL-17, high levels of IL-22 have been detected in tumour tissues and the peripheral blood of cancer patients; however, the direct effect of IL-22 on tumour cells has remained largely unknown.",22471280_6,-1,1,-1,1,17034,-1,4.026834e-06,0.99999046,5.535714e-06
8088,these,16,17,82,87,"In this study, we examined the functional role of CD4(+)CD25(+) Foxp3(+) Tregs in these different manifestations.",19022624_2,-1,1,-1,1,8088,-1,4.40867e-06,0.9999908,4.8140014e-06
28199,Tregs,12,13,71,76,"Finally, we report that inhibition of KRAS reduces the infiltration of Tregs in KRAS-driven lung tumorigenesis even before tumor formation.",26880715_6,-1,1,-1,1,28199,-1,5.2454234e-06,0.99998844,6.2940335e-06
38546,tumors,6,7,30,36,"However, only the minority of tumors are hot, and a limited proportion of patients benefit from immunotherapies.",31888983_2,-1,1,-1,1,38546,-1,3.9714887e-06,0.9999889,7.092027e-06
13957,that,3,4,22,26,These results suggest that PSK could release Th2-dominated and Treg-dominated immunological condition in patients with colorectal cancer.,21224532_5,-1,1,-1,1,13957,-1,3.7012205e-06,0.9999927,3.613589e-06
7928,the,15,16,84,87,"Here we hypothesized that a combination of IFN-alpha and IL-21, a novel cytokine of the IL-2 family with anti-cancer effects, will increase the anti-cancer efficacy at sub-optimal cytokine doses.",18947877_4,-1,1,-1,1,7928,-1,7.3309207e-06,0.99998724,5.431625e-06
8289,Treg,26,27,158,162,"This study aimed to investigate whether different forms of apical periodontitis, namely cysts and granulomas, show different balances of Th1, Th2 regulators, Treg markers, and factors involved in osteoclast chemotaxis and activation.",19121066_2,-1,1,-1,1,8289,-1,5.8192986e-06,0.99998665,7.475185e-06
14005,Th1,22,23,157,160,"These results suggest an important role for NFAT1 in radio-resistant tumor-associated parenchyma, which is independent of the anti-tumor immune response and Th1 versus Th2 cytokine milieu established by the cancer cells, but able to promote site-specific tumor growth.",21225259_9,-1,1,-1,1,14005,-1,5.1295356e-06,0.99998164,1.327261e-05
26597,the,9,10,44,47,"In this study, we analyzed the mechanism of the pathological function of IL-22 in intestinal aGVHD.",26153763_2,-1,1,-1,1,26597,-1,3.8532944e-06,0.99999166,4.46609e-06
8649,Th,20,21,118,120,"A conserved region of FOXP3 intron 1 was demethylated in all Treg clones, whereas it was methylated in non-regulatory Th and CTL clones.",19224638_1,-1,1,-1,1,8649,-1,3.3387657e-06,0.9999901,6.5733257e-06
8366,the,5,6,36,39,"One core obstacle for understanding the role of Treg, thus far, is the inability of FOXP3 mRNA or protein detection methods to differentiate between Treg and activated T cells.",19147574_3,-1,1,-1,1,8366,-1,4.866415e-06,0.9999918,3.3857812e-06
37253,treatment,1,2,11,20,Phenelzine treatment reduced nuclear demethylase activity and increased transcription and expression of M1-like signatures both in vitro and in a murine triple-negative breast cancer model.,31249575_3,-1,1,-1,1,37253,-1,7.200179e-06,0.99998784,4.907418e-06
8687,tumor-associated,19,20,124,140,"It is not known when immunosuppression occurs during tumor development but it likely involves cross-talk among tumor cells, tumor-associated macrophages and microglia (TAMs), and peripheral as well as tumor-infiltrating lymphocytes (TILs).RESULTS: We have performed a kinetic study of this immunomodulation, assessing the dynamics of immune infiltration and function, within the central nervous system (CNS) and peripherally.",19226468_1,-1,1,-1,1,8687,-1,2.1205084e-05,0.9999666,1.2154722e-05
28500,that,3,4,24,28,These results suggested that FoxO1 played an important role in regulating asbestos-induced apoptosis and confirmed the presence of multiple pathways regulating resistance to asbestos in MT-2Rst cells.,27042963_7,-1,1,-1,1,28500,-1,3.69296e-06,0.99999285,3.4734555e-06
41192,TAZ,14,15,109,112,SKIL-knockdown inhibited autophagy and activated the STING pathway in NSCLC cells through down-regulation of TAZ.,33268765_10,-1,1,-1,1,41192,-1,9.231878e-06,0.99998355,7.1796667e-06
34373,To,0,1,0,2,"To address this therapeutic challenge, we invent bifunctional antibody-ligand traps (Y-traps) comprising an antibody targeting CTLA-4 or PD-L1 fused to a TGF receptor II ectodomain sequence that simultaneously disables autocrine/paracrine TGF in the target cell microenvironment (a-CTLA4-TGFRIIecd and a-PDL1-TGFRIIecd).",29467463_2,-1,1,-1,1,34373,-1,4.077404e-06,0.9999918,4.093187e-06
36461,the,41,42,267,270,"PDA tumor cells promoted PD-L1 expression and EMT under the presence of IFN-, which was inhibited by the signal transducer and activator of transcription (STAT)1 small interfering RNA.CONCLUSIONS: Strong correlations were observed between PD-L1 expression, EMT, and the immunosuppressive tumor microenvironment.",30927618_6,-1,1,-1,1,36461,-1,5.269939e-06,0.9999906,4.1358735e-06
26374,tumor-associated,17,18,93,109,"Here, we show that STAT3 signaling in CD8(+) T cells inhibits chemokine CXCL10 production by tumor-associated myeloid cells by reducing IFN expression by T cells.",26025380_3,-1,1,-1,1,26374,-1,9.673766e-06,0.99998486,5.4823154e-06
5351,tumor-bearing,31,32,197,210,Treatment with CA reduced intracellular expression of IDO mRNA and protein levels in IFN-gamma-activated murine BMDCs in vitro and in CD11c(+)CD8alpha(+) DCs of tumor-draining lymph node (TDLN) of tumor-bearing mice in vivo.,17466914_2,-1,1,-1,1,5351,-1,6.667596e-06,0.9999865,6.8560107e-06
6434,the,16,17,96,99,"Moreover, an in vitro migration assay using Tregs derived from gastric cancers was performed in the presence of CCL17 or CCL22.",18224687_5,-1,1,-1,1,6434,-1,5.0931303e-06,0.9999908,4.1054623e-06
7186,natural,24,25,171,178,"SCF-activated mast cells also exacerbated tumor immunosuppression by releasing adenosine and increasing T regulatory cells, which augmented the suppression of T cells and natural killer cells in tumors.",18524989_6,-1,1,-1,1,7186,-1,1.7683265e-05,0.9999716,1.0671327e-05
39824,the,14,15,78,81,"However, the cell sources of these factors are largely unknown, especially in the context of tumors.",32441311_4,-1,1,-1,1,39824,-1,5.941729e-06,0.9999902,3.82304e-06
26262,the,13,14,81,84,HPV16 E6 stimulation resulted in higher IL-17A secretion in the controls than in the CIN women (p=0.035).,25990808_6,-1,1,-1,1,26262,-1,4.622441e-06,0.9999907,4.641803e-06
41426,this,1,2,3,7,"In this study, we used a murine model of melanoma to discover that Tet2 inactivation significantly enhances the antitumor activity of TILs with an efficacy comparable to immune checkpoint inhibition imposed by anti-PD-L1 treatment.",33589517_2,-1,1,-1,1,41426,-1,4.2111865e-06,0.9999919,3.9310717e-06
33344,the,6,7,41,44,"Ultimately, mouse Apc deficiency reduces the presence of NFAT in the nucleus of intestinal regulatory Tcells (Tregs) and impairs Treg differentiation and the acquisition of a suppressive phenotype, which is characterized by the production of the anti-inflammatory cytokine IL-10.",28978472_4,-1,1,-1,1,33344,-1,3.5323144e-06,0.9999925,3.938767e-06
17156,this,1,2,3,7,"In this study, we demonstrate that OX40 expression is regulated through a TCR and common gamma chain cytokine-dependent signaling cascade that requires JAK3-mediated activation of the downstream transcription factors STAT3 and STAT5.",22496812_4,-1,1,-1,1,17156,-1,3.9821725e-06,0.9999918,4.2670313e-06
6569,genes,33,34,201,206,"Approximately 5% of infected people will develop an aggressive form of ATL, characterized by high circulating cell count, skin and organ infiltration and expression of cytokine, chemokine and survival genes.",18300056_1,-1,1,-1,1,6569,-1,4.8517795e-06,0.9999896,5.5048326e-06
42206,TGF-,7,8,52,57,"Th17 cell differentiation-related cytokines (IL-23, TGF- and IL-6) were increased in the tumor microenvironment.",33971545_7,-1,1,-1,1,42206,-1,1.5611842e-05,0.9999716,1.2755413e-05
8230,that,6,7,27,31,"Our results, thus, suggest that down-regulation of IDO in DCs is an important immunomodulatory property of curcumin that may be exploited therapeutically in the control of cancers.",19075017_7,-1,1,-1,1,8230,-1,3.845823e-06,0.9999925,3.6787608e-06
29470,TGF,34,35,162,166,"Expression of TGF and IL-10 in the tumor microenvironment in the CT and RT groups was higher compared with the control group (P<0.01), while the expression of TGF and IL-10 in the INF group was not significantly different (P>0.05).CONCLUSIONS: The results show that INF-2b inhibits cancer cell immune evasion by decreasing the levels of CD4(+)CD25(+)Foxp3(+) Tregs and suppressing the expression of TGF and IL-10 in the tumor microenvironment.",27389040_7,-1,1,-1,1,29470,-1,1.8369545e-05,0.99996686,1.4791713e-05
37836,thus,20,21,124,128,"These results, which have implications for human antitumor immunity, suggest that TGF- targets T cell metabolism directly, thus diminishing T cell function through metabolic paralysis.",31530731_9,-1,1,-1,1,37836,-1,6.219582e-06,0.9999889,4.826721e-06
19318,Treg,8,9,61,65,These results indicated that YB-1 immunization combined with Treg depletion could induce specific T-cell responses against neuroblastoma and could be a potential strategy for the prevention and treatment of neuroblastoma in the early stage.,23169344_9,-1,1,-1,1,19318,-1,6.257489e-06,0.9999865,7.258468e-06
25680,the,12,13,72,75,"At the same time, the irradiation markedly increased IL-6 production of the k1106 cells.",25544504_6,-1,1,-1,1,25680,-1,5.518343e-06,0.99998903,5.5050655e-06
10340,T-bet,0,1,0,5,T-bet and GATA-3 play a part role in the regulation of Th1/Th2 balance.,19615257_6,-1,1,-1,1,10340,-1,5.211231e-06,0.99998784,6.9156063e-06
23461,to,68,69,427,429,"METHODS: Using multicolor flow cytometry, the frequency of three Treg subsets, separated on the basis of CD45RA and Foxp3, from the peripheral circulation of newly-presenting HNSCC patients (19 oral cavity squamous cell carcinoma, 20 hypopharyngeal squamous cell carcinoma, 18 nasopharyngeal squamous cell carcinoma, 19 oropharyngeal squamous cell carcinoma, and 36 laryngeal squamous cell carcinoma) were assessed with regard to 31 healthy donors and clinicopathological features.",24761979_2,-1,1,-1,1,23461,-1,4.822759e-06,0.99998975,5.4498246e-06
42859,the,21,22,138,141,We performed immune profiling to compare immune-related gene expression between ductal carcinoma in situ (DCIS) and invasive carcinoma of the breast using nCounter PanCancer immune Profiling Panel and found that CXCL10 was the most significant gene that had the highest difference in expression between them.,34504204_1,-1,1,-1,1,42859,-1,1.1147386e-05,0.99995995,2.8869623e-05
25492,that,7,8,35,39,"In the present study, we postulate that molecules secreted by (pre)neoplastic epithelial cells of the genital tract (cervix/vulva) might attract pDCs but also modify their proper functionality, allowing these cells to initiate a tolerogenic response interfering with antitumor immunity.",25492101_1,-1,1,-1,1,25492,-1,5.91986e-06,0.99998987,4.2402744e-06
20540,Twenty-one,2,3,9,19,METHODS: Twenty-one patients were entered onto our vaccination protocol using autologous DCs pulsed with autologous tumor lysate and keyhole limpet hemocyanin.,23725550_3,-1,1,-1,1,20540,-1,2.6316598e-05,0.99994206,3.1629766e-05
41564,the,27,28,162,165,"Overall, Th17 cells and related transcription factors and cytokines in thymoma with MG patients were higher than those in thymoma patients, whereas, Tregs showed the opposite results, the mechanism may be that thymoma can secrete IL6 and IL21.",33636431_8,-1,1,-1,1,41564,-1,4.5654992e-06,0.9999914,3.9758797e-06
16276,that,3,4,29,33,"Mechanistic studies revealed that DKK1 vaccine elicited a strong DKK1- and tumor-specific CD4+ and CD8+ immune responses, and treatment with B7H1 or OX40 Abs significantly reduced the numbers of IL-10-expressing and Foxp3+ regulatory T cells in vaccinated mice.",22049519_5,-1,1,-1,1,16276,-1,4.807197e-06,0.99999166,3.5312773e-06
36001,to,24,25,165,167,"Chemokine expression and tumor infiltration by regulatory T cells, determined by expression of the transcription factor FoxP3, were quantified and their correlation to clinical features was statistically analyzed.",30572845_4,-1,1,-1,1,36001,-1,5.656066e-06,0.9999893,5.0854005e-06
9715,the,43,44,234,237,"4-1BBL was more effective than TLR agonists LPS, MPL, and CpG and an agonistic 4-1BB antibody as a component of E7 peptide-based therapeutic vaccine for the generation of immune responses and eradication of TC-1 established tumors in the absence of detectable toxicity.",19435920_6,-1,1,-1,1,9715,-1,4.673029e-06,0.9999908,4.559283e-06
20616,total,5,6,23,28,"METHODS AND RESULTS: A total of 207 breast carcinoma specimens were assessed by IL-17 immunohistochemistry, and the findings were correlated with clinicopathological parameters.",23738752_2,-1,1,-1,1,20616,-1,6.7059e-06,0.9999862,7.063085e-06
14059,Targeted,0,1,0,8,"Targeted cancer-specific gene therapy is a promising strategy for treating metastatic lung cancer, which is a leading cause of lung cancer-related deaths.",21282355_0,-1,1,-1,1,14059,-1,4.544806e-06,0.9999901,5.352568e-06
17958,that,10,11,54,58,"In this work, we provide preclinical proof of concept that ablating Stat3 signaling in breast cancer cells results in an effective immunotherapy against breast cancer growth and metastasis.",22753933_9,-1,1,-1,1,17958,-1,4.059216e-06,0.9999919,4.050283e-06
8539,FOXP3-positive,9,10,56,70,The impact of IL-2-based therapy on the accumulation of FOXP3-positive immune cells in the tumor microenvironment in metastatic renal cell carcinoma is unknown.,19188179_1,-1,1,-1,1,8539,-1,2.6912167e-05,0.9999428,3.0358115e-05
14480,their,14,15,99,104,"Genetic depletion of TEMs markedly reduces tumor angiogenesis in various tumor models, emphasizing their essential role in driving tumor progression.",21368233_2,-1,1,-1,1,14480,-1,6.1445235e-06,0.9999887,5.152134e-06
10432,the,26,27,175,178,"Whereas, LMP1 up-regulates anti-apoptotic proteins to support viral replication, it also potentiates apoptosis, suggesting that a viral protein contributes to the survival of the virus, and it also elicit host defense leading to the destruction of the infected cells.",19664329_1,-1,1,-1,1,10432,-1,7.060195e-06,0.999987,5.9796816e-06
8834,FOXP3,48,49,322,327,"Remarkably, analysis of EOC-associated conventional CD4CD25 T cell and Treg populations isolated ex vivo from tumor samples by cell sorting and cultured with tumor-associated CD3- cells in the presence of IL-2 revealed that EOC Treg stimulated under these conditions were rapidly converted into TH17 cells, down-regulated FOXP3 expression, and lost their suppressive capacity.",19238008_5,-1,1,-1,1,8834,-1,4.482134e-06,0.99999166,3.8674684e-06
30452,the,8,9,50,53,"Furthermore, when A*0201 PBMCs were cultured with the CMV or Melan-A antigenic peptide and rICOS-L Ig, the induction of CMV or Melan-A tetramer-binding CD8+ T cells, respectively, was inhibited.",27756099_5,-1,1,-1,1,30452,-1,5.1912994e-06,0.9999896,5.2109317e-06
1862,the,9,10,52,55,Activated CD3(+) T cells are likely responsible for the production of IL-22 in the liver after injection of ConA. The IL-22 receptor is normally expressed at high levels by hepatocytes and further induced after ConA injection.,15122762_3,-1,1,-1,1,1862,-1,4.6968416e-06,0.99999166,3.6909378e-06
9413,tumor-infiltrating,10,11,67,85,"In contrast to DC infiltrating subcutaneously grown GL261 gliomas, tumor-infiltrating DC from intracranial gliomas do not activate antigen-dependent T-cell proliferation in vitro.",19337997_5,-1,1,-1,1,9413,-1,1.721255e-05,0.99997103,1.179033e-05
11400,the,11,12,73,76,"Interestingly, in contrast to their differential effects on expansion of the CD4(+)CD25(+)Foxp3(+)T cells, IL-2 and IL-21 exhibited a redundant role in Treg mediated suppression of NK cell mediated antibody dependent cytotoxicity function.",20081380_6,-1,1,-1,1,11400,-1,3.72551e-06,0.99999166,4.5919264e-06
2065,the,4,5,15,18,"In some cases, the presence of T(reg) type 1/Th3-like lymphocytes could also be demonstrated.",15240741_5,-1,1,-1,1,2065,-1,4.8979027e-06,0.99999166,3.4709449e-06
21557,Tanacetum,4,5,29,38,"Salvigenin was purified from Tanacetum canescens, and its effect on the tumor volume was investigated.",24270218_3,-1,1,-1,1,21557,-1,1.6071072e-05,0.99996996,1.3969074e-05
1038,this,39,40,251,255,The notion that IL-4 was able to enhance in vitro proliferation of CD30L+/IL-4R+ purified leukaemic blasts suggests that the selective interaction of IL-4-producing CD30+ T cells with CD30L+ leukaemic progenitors may have a role in the progression of this particular AML subset.,11918534_6,-1,1,-1,1,1038,-1,3.7972363e-06,0.9999908,5.351643e-06
22766,that,13,14,107,111,BACKGROUND & AIMS: Premalignant lesions and early stage tumors contain immunosuppressive microenvironments that create barriers for cancer vaccines.,24607504_0,-1,1,-1,1,22766,-1,6.350183e-06,0.9999883,5.327147e-06
6866,STAT3,22,23,100,105,"In this study, we tested the hypothesis that the combination of CpG (a DC activator) and JSI-124 (a STAT3 inhibitor) may generate synergistic antitumor effects compared to CpG or JSI-124 alone.",18392040_1,-1,1,-1,1,6866,-1,7.984538e-06,0.9999838,8.244785e-06
8237,to,9,10,94,96,Alterations in genes encoding transforming growth factor-beta-signaling components contribute to colon cancer in humans.,19119184_0,-1,1,-1,1,8237,-1,6.739514e-06,0.9999862,7.032852e-06
33596,TAM,14,15,89,92,The clinical significance of regulatory T cells (Treg) and tumor-associated macrophages (TAM) in the tumor microenvironment of human bladder cancer remains unclear.,29048388_0,-1,1,-1,1,33596,-1,7.819057e-06,0.99998546,6.7838555e-06
27391,they,5,6,19,23,"On the other hand, they acquired surface expression of CD25 and CTLA-4 typically found in regulatory T (Treg) cells.",26437631_4,-1,1,-1,1,27391,-1,5.314574e-06,0.99998856,6.162216e-06
25535,therapeutic,27,28,209,220,Our findings indicate that the use of inhibitory molecules notably directed against HMGB1 in cervical/vulvar (pre)neoplastic lesions might prevent alterations of pDCs functionality and represent an attractive therapeutic strategy to overcome immune tolerance in cancers.,25492101_10,-1,1,-1,1,25535,-1,4.6619175e-06,0.99999166,3.7078864e-06
40541,TME,5,6,47,50,Recent studies revealed that immunosuppressive TME is directly correlated with heightened activations of T regulatory cells (Tregs) and Myeloid derived suppressor cells (MDSCs) functions.,32890791_2,-1,1,-1,1,40541,-1,8.578021e-06,0.999985,6.3963726e-06
22689,through,12,13,80,87,Hepatocyte growth factor may thus have a dual pathophysiological role: directly through enhancement of survival of the leukemic clone and indirectly by favoring T-cell immunosuppression.,24561793_9,-1,1,-1,1,22689,-1,1.1159473e-05,0.9999831,5.806439e-06
6555,Tr1,3,4,21,24,ICOShigh Treg induce Tr1 or Th2 cells depending on the activation state of RC.,18292519_10,-1,1,-1,1,6555,-1,6.2801773e-06,0.99997795,1.5822716e-05
28413,Foxp3,7,8,53,58,Our study provides one possible mechanism describing Foxp3 promoter demethylation changes by which NSCLC down-regulates immune responses and contributes to tumor progression.,27000869_11,-1,1,-1,1,28413,-1,4.3738487e-06,0.9999918,3.8952007e-06
20148,The,0,1,0,3,The resulting CD11b+CD33+ cells functionally suppressed autologous T-lymphocyte proliferation.,23514705_6,-1,1,-1,1,20148,-1,4.990392e-06,0.9999907,4.320513e-06
15863,targeted,17,18,91,99,"Therefore, we assessed the role of PPAR in modulating the effects of dietary n-3 PUFAs by targeted deletion of intestinal epithelial cell PPAR (PPAR(IEpC)).",21940900_2,-1,1,-1,1,15863,-1,4.52874e-06,0.99999166,3.7747957e-06
25778,Thus,0,1,0,4,"Thus, we wondered whether TGF- or EGF was involved in the regulation of HLA-I during the development of prostate cancer cells.",25618241_3,-1,1,-1,1,25778,-1,6.4432274e-06,0.9999888,4.7508106e-06
43833,The,0,1,0,3,The adoptive transfer of tumor-draining lymph node (LN) T cells activated ex vivo with anti-CD3 and interleukin 2 (IL-2) mediates the regression of the poorly immunogenic murine melanoma D5.,9690455_0,-1,1,-1,1,43833,-1,4.0313307e-06,0.9999918,4.154288e-06
20772,tumor,22,23,148,153,"This study reveals that mMSLN-VLP immunization is capable of controlling PC progression by effectively mounting an immune response against mMSLN, a tumor self-antigen, and altering the immunosuppressive tumor microenvironment via activation of pDCs-like cells and reduction in the frequency of CD4(+)foxp3(+)ICOS(-) Treg cells.",23874581_6,-1,1,-1,1,20772,-1,4.948468e-06,0.9999895,5.522869e-06
16229,targeted,5,6,27,35,"In turn, elevated miR-135b targeted FOXO1 in ALCL cells.",22042699_4,-1,1,-1,1,16229,-1,5.619597e-06,0.99999034,4.0374616e-06
23667,that,3,4,20,24,Our results suggest that adoptive transfer of Tregs aggressively promote intestinal tumorigenesis by decreasing NK cell number and activity by modulating IL-22 BP.,24797894_7,-1,1,-1,1,23667,-1,3.9600022e-06,0.9999926,3.4781385e-06
37452,the,19,20,96,99,"Treg cells suppressed CD8+ Tcell secretion of interferon- (IFN), which would otherwise block the activation of sterol regulatory element-binding protein 1 (SREBP1)-mediated fatty acid synthesis in immunosuppressive (M2-like) tumor-associated macrophages (TAMs).",31350177_3,-1,1,-1,1,37452,-1,4.4638077e-06,0.99999154,3.976312e-06
9826,toward,20,21,113,119,"Hence, our goal is to establish a protocol that will lead to consistent ex vivo generation of lymphocytes skewed toward a central memory phenotype.",19501956_1,-1,1,-1,1,9826,-1,9.082748e-06,0.9999819,9.085209e-06
21482,that,2,3,12,16,We observed that hypoxia-induced Nanog correlated with the acquisition of stem cell-like properties in B16-F10 cells.,24227785_2,-1,1,-1,1,21482,-1,4.7189874e-06,0.999992,3.2998428e-06
11216,The,0,1,0,3,The immunoregulatory events leading to OSCC persistence remain to be elucidated.,20012605_1,-1,1,-1,1,11216,-1,5.8025926e-06,0.99999,4.244005e-06
22216,the,2,3,11,14,"To enhance the anti-tumor effects, 1D11 was administered with cyclophosphamide which was reported to eliminate intratumoral Tregs.",24416401_4,-1,1,-1,1,22216,-1,4.301927e-06,0.99999213,3.595629e-06
39521,TME,14,15,99,102,These results demonstrate for the first time that CDDO-Me relieves immunosuppression in the breast TME and unleashes host adaptive anti-tumor immunity.,32300202_8,-1,1,-1,1,39521,-1,1.1209573e-05,0.99997354,1.5313546e-05
42317,This,0,1,0,4,"This may explain, at least in part, why patients with NB seem to have little benefit from single-agent immune checkpoint blockade (ICB) therapy.",34016720_2,-1,1,-1,1,42317,-1,7.6675215e-06,0.99998724,5.096455e-06
30499,STAT3,27,28,179,184,"We found that incubation of primary HCC cells with autologous Th9 significantly elevated the CCL20 production from tumour cells, which could be partially inhibited by suppressing STAT3.",27797409_10,-1,1,-1,1,30499,-1,6.1584897e-06,0.9999893,4.5318097e-06
39099,the,18,19,87,90,"Here, using a Kras- and p53-driven model of PDA, we describe a mechanism of action for the protumorigenic cytokine IL35 through STAT3 activation in CD8+ T cells.",32024640_2,-1,1,-1,1,39099,-1,4.7579283e-06,0.9999914,3.7768546e-06
23588,tumors,25,26,136,142,"We detected selective expression of the death mediator Fas ligand (FasL, also called CD95L) in the vasculature of human and mouse solid tumors but not in normal vasculature.",24793239_1,-1,1,-1,1,23588,-1,3.8130481e-06,0.99999106,5.092743e-06
9377,the,10,11,62,65,"This study demonstrates for the first time the association of the Spred-1 gene, an inhibitor of the Ras/MAPK pathway, with CD8+ TILs and TGF-beta activity.",19319531_3,-1,1,-1,1,9377,-1,3.5301205e-06,0.999992,4.462175e-06
3779,tumors,7,8,49,55,"Using syngeneic Stat1-/- C3H mice bearing SCCVII tumors in this study, we discovered opposite results.",16618773_1,-1,1,-1,1,3779,-1,4.21396e-06,0.9999893,6.5042213e-06
1601,the,23,24,172,175,Phenotypic and functional analyses demonstrated that they were antigen-specific CD4(+) Treg cells expressing CD25 and GITR molecules and possessing suppressive activity on the proliferative response of naive CD4(+) T cells to anti-CD3 antibody stimulation.,14738769_3,-1,1,-1,1,1601,-1,3.7945813e-06,0.9999924,3.7792652e-06
36817,to,11,12,67,69,The inhibition of FOXA1+ Tregs represents a promising new strategy to enhance antitumor immunity.,31036318_15,-1,1,-1,1,36817,-1,4.35122e-06,0.9999918,3.8402936e-06
11352,Tryptase,0,1,0,8,"Tryptase MCs, CD8+ and Foxp3+ lymphocytes had significantly increased in the interleukin 2 (IL-2) treated group.",20053697_6,-1,1,-1,1,11352,-1,5.8480724e-05,0.9999155,2.5982263e-05
3566,treatments,11,12,63,73,"SS has an unfavourable prognosis, and is refractory to current treatments.",16457762_2,-1,1,-1,1,3566,-1,6.931747e-06,0.9999882,4.8719376e-06
18400,technology,2,3,11,21,"Using xMAP technology and RT-PCR, we investigated cytokine/chemokine profiles during histologically defined phases of disease: (i) no/mild, (ii) moderate, (iii) severe colitis without dysplasia/cancer and (iv) severe colitis with dysplasia/cancer, compared with age-matched wild-type (WT) littermates.",22962436_1,-1,1,-1,1,18400,-1,4.68376e-06,0.9999893,6.077571e-06
18233,that,10,11,54,58,The lack of a curative therapy for LGL leukemia means that new treatment options are needed.,22830400_8,-1,1,-1,1,18233,-1,7.300816e-06,0.9999882,4.5467746e-06
6991,to,12,13,89,91,However the molecular mechanisms underlying this process have been only recently started to be clarified.,18473765_3,-1,1,-1,1,6991,-1,7.278425e-06,0.9999875,5.206574e-06
21693,Tregs,9,10,51,56,"RESULTS: The density of liver infiltrated FoxP3(+) Tregs was increased in a stepwise manner from CHB to AH then HCC, while there was a decreasing trend for the density of IL-17(+) T cells and CD8(+) T cells.",24303990_4,-1,1,-1,1,21693,-1,4.2656247e-06,0.9999902,5.542918e-06
11543,this,1,2,3,7,"In this study, Tehranolide was purified from Artemisia difussa.",20138670_3,-1,1,-1,1,11543,-1,5.153241e-06,0.99999,4.9020723e-06
12286,the,21,22,137,140,Gene expression studies have shown that the nature of the tumor microenvironment predicts survival in patients with FL and may influence the response to immunotherapy and risk of transformation.,20425464_2,-1,1,-1,1,12286,-1,5.753025e-06,0.9999902,4.0238197e-06
34617,the,13,14,99,102,"Specifically, abnormal Wnt/-catenin signaling directly alters a number of regulators critical for the antitumor activities of T cells, especially effector T cells, T helper cells, and regulatory T cells.",29678298_2,-1,1,-1,1,34617,-1,4.035332e-06,0.999992,3.9693464e-06
24932,the,6,7,36,39,Nicotine and a selective agonist of the 7-nicotinic acetylcholine receptor (7-nAChR) reduced the severity of DSS-induced acute colonic inflammation.,25258409_5,-1,1,-1,1,24932,-1,4.6945047e-06,0.9999908,4.4802114e-06
3995,the,14,15,68,71,"The efficacy of induction of Treg's by DCs depends on the nature of the DC maturation stimulus, with inflammatory cytokine-treated DCs (Cyt-DCs) being the most effective Treg inducers.",16763205_6,-1,1,-1,1,3995,-1,6.9940493e-06,0.99998677,6.1807564e-06
5988,that,1,2,5,9,"Mice that received a xenogeneic tatSVV-pulsed DC vaccine developed a higher immune response than mice vaccinated with the nSVV-pulsed DCs and exhibited prolonged mean survival rate, though mice injected with the DCs alone or the nSVV-pulsed DC also showed anti-tumor effects in the subcutaneous GL26 glioma model.",17931768_4,-1,1,-1,1,5988,-1,4.1172852e-06,0.9999912,4.697713e-06
22088,status,3,4,17,23,"In the different status of HPV16 type DNA, the expression of Foxp3(+) was closely correlated with Federation International of Gynecology and Obstetrics (FIGO) stage, histological grade and lymphnode metastasis (P < 0.05) except for age (P > 0.05).CONCLUSION: Treg cytokines, HPV16 integration rate and severity of cervical lesions are positively correlated while Th17 cytokines show opposite effects.",24401583_7,-1,1,-1,1,22088,-1,3.7871196e-06,0.9999914,4.8036763e-06
2112,that,4,5,25,29,"It is highly conceivable that proper CD4+ T-cell help is important for launching an effective immune attack against HPV because infection of cervical epithelia by this virus is, at least initially, not accompanied by gross disturbance of this tissue and/or strong proinflammatory stimuli.",15289354_7,-1,1,-1,1,2112,-1,4.787116e-06,0.9999913,3.9194047e-06
37377,to,23,24,144,146,"Thus, in this proof-of-principle study, we highlight the antitumor effect of CRM aerosol delivery as a new and noninvasive therapeutic approach to locally modulate immunosurveillance at the tumor site in the lung.",31321243_5,-1,1,-1,1,37377,-1,3.7382295e-06,0.9999925,3.7298107e-06
16731,T(regs,6,7,27,33,"Here, we showed that human T(regs) rapidly suppressed the release of calcium ions (Ca(2+)) from intracellular stores in response to T cell receptor (TCR) activation in T(cons).",22375050_2,-1,1,-1,1,16731,-1,5.4610955e-06,0.9999863,8.284933e-06
6212,Treg,8,9,33,37,"We show here that Treg and Nrp1+ Treg levels dropped in the tumour-draining lymph nodes of patients with cervical cancer following preoperative chemoradiotherapy in a direct relationship with the reduction of tumour mass, suggesting that suppressor cell elimination facilitated the generation of T cells mediating the destruction of the neoplastic cells left behind after cytotoxic therapy.",18028372_8,-1,1,-1,1,6212,-1,5.2965147e-06,0.9999883,6.380882e-06
13132,gene,21,22,178,182,One non-Hodgkin lymphoma cell line Raji cells co-cultured with peripheral blood-derived T cells were stably transfected with anti-CD20scFvFc/CD28/CD3zeta gene or anti-CD20scFvFc gene.,20815894_3,-1,1,-1,1,13132,-1,7.5824887e-06,0.9999857,6.693023e-06
13083,the,1,2,9,12,"Although the suppressive effect of Treg cells on T cells is well documented, less is known about the types of innate immune cells influenced by Treg cells and whether the Treg cells suppress acute innate immune responses in vivo.",20722759_3,-1,1,-1,1,13083,-1,4.7339236e-06,0.9999918,3.483573e-06
41383,the,10,11,65,68,"Altogether, our data demonstrate that EOMES is indispensable for the development of IL-10-expressing, cytotoxic TR1 cells, which accumulate in LNs of CLL patients and control TCL1 leukemia in mice in an IL-10R-dependent manner.",33526861_7,-1,1,-1,1,41383,-1,4.3238374e-06,0.99999213,3.597135e-06
7300,the,7,8,42,45,"CONCLUSION: Cervical tumors are marked by the presence of an immunoregulatory environment, and harbor equal proportions of 'inactive' n Tregs; activated n Tregs; and Tregs operating via TGFbeta.",18593438_7,-1,1,-1,1,7300,-1,3.568785e-06,0.9999924,4.0815653e-06
33786,transfer,3,4,18,26,"Finally, adoptive transfer assays in vivo revealed a reduced antitumor capacity in NFAT5-deficient macrophages against syngeneic Lewis lung carcinoma and ID8 ovarian carcinoma cells, a defect that in the ID8 model was associated with a reduced accumulation of effector CD8 T cells at the tumor site.",29150563_5,-1,1,-1,1,33786,-1,5.5972423e-06,0.99998796,6.4843007e-06
28131,that,3,4,19,23,These data suggest that careful sequencing of Ad.,26851223_14,-1,1,-1,1,28131,-1,2.206707e-05,0.99997044,7.553778e-06
23354,thymic,11,12,81,87,These results indicate that modulating central tolerance through RANKL can alter thymic output and potentially provide therapeutic benefit by enhancing anti-tumor immunity.,24752296_8,-1,1,-1,1,23354,-1,1.3786228e-05,0.99997973,6.4522756e-06
28632,tumor-associated,11,12,92,108,"BACKGROUND: TLR4/MD-2 complex-mediated MyD88-dependent activation of NF-B and Akt promotes tumor-associated immunosuppression in epithelial ovarian cancer (EOC) via induction of immunesuppressive cytokines and indoleamine 2,3-dioxygenase (IDO).",27118139_0,-1,1,-1,1,28632,-1,9.309555e-06,0.99998426,6.433687e-06
7767,the,16,17,93,96,"Moreover, their frequencies were 3- to 5-fold higher in tumors than in peripheral blood from the same patients or healthy donors, respectively.",18820132_4,-1,1,-1,1,7767,-1,5.322048e-06,0.99998915,5.4769353e-06
8562,FOXP3-positive,3,4,25,39,"CONCLUSION: Intratumoral FOXP3-positive regulatory immune cells significantly increased during IL-2-based immunotherapy, and high numbers of on-treatment FOXP3-positive cells were correlated with poor prognosis in patients with metastatic renal cell carcinoma.",19188179_9,-1,1,-1,1,8562,-1,8.60577e-06,0.99998057,1.0822966e-05
39341,to,9,10,48,50,"The development of changes in T cells, referred to as T cell exhaustion, has been suggested as a cause of primary or acquired resistance to immunotherapy by immune checkpoint blockade (ICB).",32210968_0,-1,1,-1,1,39341,-1,1.1687944e-05,0.999979,9.343447e-06
11601,tumor-derived,6,7,34,47,"To evaluate the potential role of tumor-derived, antiestrogen-induced TGFbeta as an immune suppressor, we established in vitro mixed lymphocyte tumor reactions (MLTR) using MCF-7 cells and peripheral blood mononuclear cells (PBMC), as well as tumor tissue and autologous tumor infiltrating lymphocytes (TIL) obtained from primary breast cancer biopsies.",20145137_2,-1,1,-1,1,11601,-1,1.25493025e-05,0.9999783,9.176521e-06
7967,to,6,7,35,37,"CXCL9(+) stromal cells were judged to include dendritic cells, because they partly co-expressed fascin, DC-sign, CD83, DC-lamp or HLA-DR.",18980207_4,-1,1,-1,1,7967,-1,9.738819e-06,0.99998176,8.4508465e-06
39966,transcription factor,3,5,17,37,We also utilized transcription factor activation profiling arrays and established a xenograft mouse model.,32503584_4,-1,1,-1,1,39966,-1,9.046506e-06,0.9999852,5.785022e-06
13606,To,0,1,0,2,"To validate the possibility, we developed a novel HBx-positive hepatocellular carcinoma in mice by inoculated the pcDNA-HBx transfected Hepa1-6 cells subcutaneously into the right flank of mice.",21042781_2,-1,1,-1,1,13606,-1,3.3867948e-06,0.9999926,3.9505044e-06
2604,the,13,14,88,91,The radiation contributes to the gene therapy by causing tumor debulking and increasing the permeability of tumors to infiltration of inflammatory cells.,15761259_7,-1,1,-1,1,2604,-1,4.9013825e-06,0.99999034,4.7411636e-06
10224,IRF-1,11,12,87,92,The combined IRF-1-E7 demonstrated more functions and biologic processes compared with IRF-1 alone.,19574175_5,-1,1,-1,1,10224,-1,7.5178323e-06,0.9999708,2.1706466e-05
23644,tumor,25,26,182,187,"In 6-weeks old Rag-Apc mice containing microscopic intestinal tumors adoptive transfer of Tregs or transient NK cell depletion dramatically associated with an increase in intestinal tumor multiplicity and tumor size, with significantly decreased survival rates.",24797894_2,-1,1,-1,1,23644,-1,4.395061e-06,0.99999094,4.627793e-06
4655,to,22,23,136,138,"Although it was unable to recognize the SiHa cervical cancer cell line positive for HPV-16 and HLA-A*2402, the cells became susceptible to lysis when transduced with E6-E7 genes, which was unexpectedly offset by pretreatment with interferon (IFN)-gamma alone.",17096336_3,-1,1,-1,1,4655,-1,6.3061143e-06,0.99998903,4.656778e-06
42297,tumoricidal,13,14,87,98,"Instead, T cell-produced lymphotoxin reprograms both mouse and human macrophages to be tumoricidal.",34011631_4,-1,1,-1,1,42297,-1,7.745622e-05,0.99990535,1.7230863e-05
31599,to,19,20,131,133,"In a BALB/c allergy model repeated nasal exposure to acrolein abrogated allergen-specific antibody and cytokine formation, and led to a relative accumulation of regulatory T cells in the lungs.",28332605_2,-1,1,-1,1,31599,-1,4.186374e-06,0.9999914,4.355636e-06
15451,The,0,1,0,3,"The steps in this process are regulated through a complex transcriptional network, specific receptor-ligand pair interactions, and sensitization to trophic factors, which mediate the homing, proliferation, survival, and differentiation of developing T cells.",21740230_4,-1,1,-1,1,15451,-1,3.82292e-06,0.9999912,4.9393952e-06
34579,Tr1,9,10,63,66,"While H. pylori-uninfected (uninfected) subjects presented low Tr1 frequency in the peripheral blood, H. pylori-infected asymptomatic (infected) individuals and H. pylori-infected gastric cancer (cancer) individuals both presented elevated Tr1 frequency.",29625086_4,-1,1,-1,1,34579,-1,4.1288527e-06,0.9999862,9.730107e-06
6747,the,11,12,72,75,"Our data demonstrate that tumor Ags may contain epitopes which activate the expansion of inducible regulatory T cells, leading to evasion of tumor control.",18354237_7,-1,1,-1,1,6747,-1,4.2943448e-06,0.9999924,3.3862448e-06
5446,IRF1,59,60,306,310,"Our results demonstrated the following: (1) CD4+ CD25+ Foxp3+ surround epithelial tumor aggregates; (2) Immature dendritic cells (DCs) were abundant in the tumor microenvironment; (3) BCC showed increased expression of IL-4, IL-10, and CCL22 and increased expression of interferon-associated genes (IFI27, IRF1, IRF7, and G1P2) and IL-12/23, gene indicating a Th2 dominant microenvironment.",17508019_2,-1,1,-1,1,5446,-1,1.473869e-05,0.9999387,4.6550584e-05
40147,to,27,28,174,176,"However, a major challenge in cancer immunotherapies remains the heterogeneity of the immunoregulatory capacities of cancers, and not all patients of a given cancer responds to current therapeutic strategies.",32573300_1,-1,1,-1,1,40147,-1,5.0760877e-06,0.9999902,4.7214953e-06
16490,the,14,15,85,88,These data support the translation use of combined Tbet and IL-12p70 gene therapy in the cancer setting.,22215017_6,-1,1,-1,1,16490,-1,4.2723073e-06,0.99999154,4.2175916e-06
36824,transcription factors,8,10,58,79,"In response to the microenvironment, macrophages activate transcription factors as STAT1 and NF-B-p65 for M1 macrophages or STAT3 and STAT6 for M2 macrophages; activation impacts on the profile of cytokine, chemokines and growth factors secreted by macrophages.",31099286_2,-1,1,-1,1,36824,-1,5.026739e-06,0.9999902,4.715924e-06
32038,this,23,24,143,147,It was demonstrated that ILC2s and MDSCs were clearly upregulated and accompanied by a predominant Th2 phenotype in patients with lung cancer; this may lead to new immunotherapy approaches for lung cancer based on the associated metabolites and cytokines.,28487978_8,-1,1,-1,1,32038,-1,4.5083184e-06,0.99999166,3.8377743e-06
4522,The,58,59,329,332,"Surprisingly, activated STAT5 persisted within CD4(+) and CD8(+) T lymphocytes, as well as CD56(+) NK cells, for up to 3 weeks post-IL-2 treatment in three patients who exhibited a clinical response to therapy and in a fourth who exhibited a significant inflammatory response after 11 doses of therapy (first cycle).CONCLUSIONS: The flow cytometric assay described herein is a highly efficient and reliable method by which to assess the cellular response to IL-2 within PBMC and specific immune effector subsets, both in vitro and in the clinical setting.",17020993_11,-1,1,-1,1,4522,-1,4.3295786e-06,0.99999154,4.1068165e-06
16068,the,16,17,110,113,We inhibited the pathway through -Secretase inhibitor and Notch1 RNA interference and analysed the effect on the expression and function of chemokine receptors.,21984373_3,-1,1,-1,1,16068,-1,3.5696567e-06,0.9999925,3.9868264e-06
35458,they,21,22,100,104,"Activated CD4+ T cells differentiate into four main separate lineages: Th1, Th2, Th17 and Treg, and they are recognized by their effector molecules IFN-, IL-13, IL-17A, and the transcription factor Foxp3, respectively.",30075815_5,-1,1,-1,1,35458,-1,4.754027e-06,0.9999894,5.8905284e-06
20429,tumours,10,11,55,62,"Indeed, the induction and recruitment of Treg cells by tumours is a major barrier in the development of effective immunotherapeutics and vaccines against cancer.",23657628_2,-1,1,-1,1,20429,-1,7.2337775e-06,0.9999865,6.2620743e-06
20462,tumour-infiltrating,22,23,153,172,This protective effect was associated with significant reduction in tumour-infiltrating FoxP3(+) and IL-10(+) Treg cells and a corresponding increase in tumour-infiltrating CD4(+) and CD8(+) T cells that secreted IFN-.,23657628_8,-1,1,-1,1,20462,-1,1.5889666e-05,0.9999716,1.2538942e-05
18398,Tregs,6,7,36,41,Such counter regulation of Th17 and Tregs may be a significant prognostic factor in oral cancer patients.,22956260_9,-1,1,-1,1,18398,-1,5.8945952e-06,0.99998915,5.0117505e-06
19341,the,3,4,17,20,We also assessed the effect of CD200-CD200R blockade on Th1 and T-reg cytokine production and T cell proliferation in autologous AML- and monocyte-DC mixed lymphocyte reactions (MLRs).,23179394_3,-1,1,-1,1,19341,-1,4.298195e-06,0.999992,3.7054663e-06
9364,TILs,12,13,71,75,"TGF-beta contributed markedly to the tumor-infiltrating CD8+ T cells' (TILs) reduced functionality, which could be reversed using a small molecule TGF-beta inhibitor.",19319531_1,-1,1,-1,1,9364,-1,8.82985e-06,0.9999833,7.879568e-06
14821,that,32,33,174,178,"Up-regulation of CXCR4 in Treg correlated with the basal-like phenotype (P = 0.029) and tumour hypoxia, as indicated by CA9 expression (P = 0.049).CONCLUSIONS: Our data show that in the setting of hypoxia and CXCR4 up-regulation in Treg, CXCL12 expression may have the negative consequence of enhancing Treg recruitment and suppressing the anti-tumour immune response.",21521526_8,-1,1,-1,1,14821,-1,4.1266494e-06,0.99999213,3.7445288e-06
25712,tumor-specific,8,9,45,59,We found that microRNA-155 (miR-155) enabled tumor-specific CD8(+) T cells to mediate profound antitumor responses in lymphoreplete hosts that were not potentiated by immune-ablation.,25548153_1,-1,1,-1,1,25712,-1,1.7599841e-05,0.99997485,7.529473e-06
35159,gene,23,24,122,126,The module of co-inhibitory receptors is co-expressed in both CD4+ and CD8+ T cells and is part of a larger co-inhibitory gene program that is shared by non-responsive T cells in several physiological contexts and is driven by the immunoregulatory cytokine IL-27.,29899446_4,-1,1,-1,1,35159,-1,4.6965183e-06,0.9999895,5.77518e-06
527,STAT5,11,12,83,88,There have been conflicting reports regarding inhibition of IL-2-induced STAT3 and STAT5 phosphorylation by TGFbeta and subsequent suppression of immune responses.,11418694_1,-1,1,-1,1,527,-1,7.683342e-06,0.99998367,8.666438e-06
12968,trafficking,69,70,398,409,"Possible mechanisms included: (i) decreases in immunosuppressive cells such as myeloid-derived suppressor cells (MDSC), T-regulatory cells (T-regs), and B-cells, (ii) stimulation of memory cells by intratumoral antigen release leading to efficient cross-priming, (iii) alteration of the tumor microenvironment with production of ""danger signals"" and immunostimulatory cytokines, and (iv) augmented trafficking of T-cells into the tumors.",20683443_5,-1,1,-1,1,12968,-1,9.68925e-06,0.9999801,1.025065e-05
24376,time,5,6,20,24,"Here, for the first time, we developed a novel combination adjuvant alum-polysaccharide-HH2 (APH) with potent immunomodulating activities, consisting of alum, polysaccharide of Escherichia coli and the synthetic cationic innate defense regulator peptide HH2.METHODS: The adjuvant effects of APH were examined using NY-ESO-1 protein-based vaccines in prophylactic and therapeutic models.",25070035_2,-1,1,-1,1,24376,-1,4.706423e-06,0.9999896,5.635328e-06
10092,the,16,17,113,116,"To address these twin-tier deficiencies, we developed a translational model of melanoma immunotherapy focused on the exploitation of high-avidity CD4+ T cells that become generated in germline antigen-deficient mice.",19561540_2,-1,1,-1,1,10092,-1,4.320973e-06,0.99999225,3.4132947e-06
9689,therapeutic,24,25,172,183,"Costimulatory molecules play critical roles in modulating innate, adaptive, and regulatory immunity and have potential to serve as effective immunomodulatory components of therapeutic vaccines.",19435920_2,-1,1,-1,1,9689,-1,6.2666777e-06,0.99998903,4.744469e-06
17499,relied,2,3,14,20,"These effects relied on the increased propensity of tumor-associated cells (mostly fibroblasts and infiltrating inflammatory cells) to hyperactivate NF-B and produce T(eff)-attracting chemokines in response to treatment, resulting in an enhanced ability of the treated tumors to attract T(eff) cells and reduced ability to attract T(reg) cells.",22593190_8,-1,1,-1,1,17499,-1,7.1843288e-06,0.999987,5.766486e-06
6542,Treg,22,23,121,125,ICOShigh Treg up-regulated Treg markers (p<or=0.0016) and mediated stronger suppression (p<or=0.001) relative to ICOSlow Treg.,18292519_7,-1,1,-1,1,6542,-1,5.6859817e-06,0.9999869,7.3716787e-06
28502,the,15,16,115,118,These results suggested that FoxO1 played an important role in regulating asbestos-induced apoptosis and confirmed the presence of multiple pathways regulating resistance to asbestos in MT-2Rst cells.,27042963_7,-1,1,-1,1,28502,-1,3.782327e-06,0.9999926,3.575265e-06
40256,thymic,22,23,160,166,"Intrathymic differentiation of T-cell precursors in IL-10-/- mice and in vitro fetal thymic organ cultures revealed that IL-10 promotes the interaction between thymic stromal cells and Notch1low DN2-T cells, thus facilitating these DN2-T cells to differentiate toward CD45+CD11c+MHC-II+ thymic DCs as a consequence of activating the Ikaros/IRF8 signaling axis.",32582141_5,-1,1,-1,1,40256,-1,1.2165533e-05,0.9999821,5.6852764e-06
17620,regulation,6,7,37,47,The mechanisms for the induction and regulation of immunosuppression in humans are ill defined.,22678911_1,-1,1,-1,1,17620,-1,8.066085e-06,0.9999838,8.098999e-06
26519,transient,14,15,105,114,Quantitative analysis of Treg kinetics in IL-12-treated tumors and tumor-draining lymph nodes revealed a transient loss followed by a rapid 4-fold expansion of tumor Treg between days 3 and 10.,26085681_2,-1,1,-1,1,26519,-1,6.723225e-06,0.9999877,5.4963507e-06
15055,The,0,1,0,3,"The proportion of CD4(+)CD25(+) regulatory T cells, Foxp3 gene expression, levels of tumor growth factor- (TGF-) and immunoreactive fibronectin- (IFN-) in the periphery blood of 30 NSCLC patients and 30 healthy volunteers were compared.",21611754_1,-1,1,-1,1,15055,-1,3.6258386e-06,0.99999225,4.1403364e-06
40652,treating,8,9,52,60,An impressive clinical success has been observed in treating a variety of cancers using immunotherapy with programmed cell death-1 (PD-1) checkpoint blockade.,32964498_0,-1,1,-1,1,40652,-1,4.9713253e-06,0.99998987,5.119066e-06
3715,treating,38,39,239,247,"We also asked the role of interleukin (IL)-4 receptor alpha (IL-4Ralpha)-signal transducer and activator of transcription 6 (STAT6) signaling, including IL-13, and transforming growth factor beta (TGF-beta) by using gene-disrupted mice or treating mice with cytokine antagonists.",16585215_4,-1,1,-1,1,3715,-1,5.613109e-06,0.99998915,5.283145e-06
26864,Stat3,11,12,88,93,This enhanced type-1 interferon response could be suppressed by reintroducing wild-type Stat3 (but not a transactivation-deficient mutant Stat3(Y705F)) into the tumor cells.,26208907_6,-1,1,-1,1,26864,-1,6.325797e-06,0.9999869,6.767975e-06
41583,TNBC,20,21,142,146,"Because metabolic alterations affect immune homeostasis and prior studies show caloric restriction (CR) combined with RT improves preclinical TNBC outcomes, we hypothesized that CR augments RT, in part, by altering intratumoral immunity.",33647370_2,-1,1,-1,1,41583,-1,1.6061142e-05,0.99995947,2.4494684e-05
10627,the,5,6,37,40,Forced production of mp28 suppressed the allogeneic cytotoxic T-lymphocyte induction and subsequently retarded the graft rejection.,19740343_8,-1,1,-1,1,10627,-1,6.376213e-06,0.99998975,3.8355133e-06
35767,that,6,7,31,35,"In this study, we demonstrated that breast cancer cells (BCCs) also expressed and secreted IL-35 and higher level of IL-35 in BCCs was closely associated with poor prognosis of patients and was an independent unfavorable prognostic factor for breast cancer.",30321288_3,-1,1,-1,1,35767,-1,3.992671e-06,0.99999154,4.4223802e-06
2193,the,25,26,129,132,"Compared with melanoma patients, healthy donors had higher basal levels of P-STAT1 (specific fluorescence [Fsp]; i.e., Fsp(PBS), the level of P-STAT1 in PBS-treated cells) in total PBMCs, natural killer (NK) cells, and T cells (mean Fsp(PBS) in total PBMCs: 5.5 in healthy donors versus 1.6 in patients, difference = 3.9, 95% confidence interval [CI] = 1.4 to 6.5, P =.004; mean Fsp(PBS) in NK cells: 4.6 in healthy donors versus 0.9 in patients, difference = 3.7, 95% CI = 1.7 to 5.7, P =.001; mean Fsp(PBS) in T cells: 6.8 in healthy donors versus 0.9 in patients, difference = 5.9, 95% CI = 2.5 to 9.3, P =.002).",15339971_7,-1,1,-1,1,2193,-1,3.984283e-06,0.99999034,5.6385247e-06
6984,that,27,28,162,166,Statistics indicate that the risk to develop colorectal cancer is higher in patients affected by ulcerative colitis and to a lesser extent by Crohn's disease and that such a risk is directly proportional to the number of years of active disease.,18473765_1,-1,1,-1,1,6984,-1,5.174762e-06,0.99999,4.8829843e-06
19234,the,5,6,33,36,CONCLUSIONS: These findings show the presence of increased number of functionally suppressive CD8 Treg cells in MM patients.,23152910_12,-1,1,-1,1,19234,-1,4.2764605e-06,0.99999225,3.4928528e-06
27058,to,20,21,111,113,"Follicular helper CD4(+) T (TFH) cells play a fundamental role in humoral immunity deriving from their ability to provide help for germinal center (GC) formation, B cell differentiation into plasma cells and memory cells, and antibody production in secondary lymphoid tissues.",26300592_0,-1,1,-1,1,27058,-1,5.3691597e-06,0.9999894,5.185974e-06
31792,to,8,9,43,45,Dendritic cells (DCs) have great potential to sensitize CD4+ T and CD8+ T cells to precisely target and eradicate GBM.,28412740_3,-1,1,-1,1,31792,-1,3.4431746e-06,0.9999925,4.0594277e-06
28951,to,19,20,112,114,"In this work, we studied the antitumor activity of the IL-15 superagonist receptor-linker-IL-15 (RLI), designed to bypass the need of endogenous IL-15R.",27217584_3,-1,1,-1,1,28951,-1,5.591278e-06,0.9999908,3.6440747e-06
9106,the,18,19,119,122,"In addition to the direct targeting effects on HER2-positive cells, trastuzumab may have a therapeutic role modulating the activity of the cellular immune system in patients with breast cancer.",19277040_0,-1,1,-1,1,9106,-1,4.4863464e-06,0.99999166,3.8872254e-06
28460,tumor,8,9,63,68,"Consequently, combined BV6 and radiation completely suppressed tumor growth in vivo.",27014915_8,-1,1,-1,1,28460,-1,4.9147716e-06,0.9999908,4.257333e-06
1520,they,33,34,195,199,"Since Stat6-deficient or ""knockout"" mice lack the signal transducer and activator of transcription-6 protein and are unable to transmit signals initiated by the type 2 cytokines, IL-4 and IL-13, they have been studied to confirm the T(h)1 vs T(h)2 paradigm.",14593499_1,-1,1,-1,1,1520,-1,6.581009e-06,0.9999882,5.224135e-06
36645,tumor,29,30,178,183,"Our previous study has demonstrated that CD4+ T cells in prostate tumor microenvironment contribute to PCa progression; meanwhile, we found increased CD4+ T-cell infiltration in tumor area after Doc treatment; however, their effects on PCa chemosensitivity remain unclear.",31018021_2,-1,1,-1,1,36645,-1,4.217043e-06,0.9999913,4.5261086e-06
36612,that,12,13,57,61,"Using a mouse model of GIST and human specimens, we show that intratumoral murine CD103+CD11b- dendritic cells (DCs) and human CD141+ DCs are associated with CD8+ T cell infiltration and differentiation.",31000683_1,-1,1,-1,1,36612,-1,3.8580106e-06,0.99999225,3.850013e-06
5157,the,24,25,152,155,"Normal B cell-associated LMP1 (B-LMP1) upregulates B cell APC function through activation of the necrosis factor (NF)-kappaB subunit, RelB. We examined the ability of B-LMP1 and a nasopharyngeal carcinoma-associated LMP1 (NPC-LMP1) to modulate B cell APC function and T-cell responses.",17372611_1,-1,1,-1,1,5157,-1,3.857099e-06,0.9999924,3.7502766e-06
4099,Tregs,23,24,149,154,"These results suggest that Tregs play a major role in preventing an effective endogenous immune response against breast cancer and that depletion of Tregs, without any additional immunotherapy, may mediate a significant antitumor response.",16785502_9,-1,1,-1,1,4099,-1,5.857397e-06,0.99998903,5.07751e-06
37886,TH,8,9,59,61,"APPROACH AND RESULTS: Adoptive transfer of HDAC6-deficient TH 17 cells impedes HCC growth, dependent on elevated IL-17A, by enhancing the production of antitumor cytokine and cluster of differentiation 8-positive (CD8+) T cell-mediated antitumor responses.",31539182_2,-1,1,-1,1,37886,-1,9.856324e-06,0.99996173,2.8460798e-05
37129,that,4,5,37,41,"Gene expression profiling determined that Gzmb expression is down-regulated in tumor-infiltrating CTLs of IFNAR1-KO mice as compared to WT mice, and in antigen-specific IFNAR1-KO CTLs as compared to WT CTLs in vivo.",31228946_10,-1,1,-1,1,37129,-1,3.9921097e-06,0.99999213,3.876887e-06
17611,that,2,3,12,16,"We conclude that Mam-A cDNA vaccination is associated with specific expansion and activation of CD4+ICOS(hi) T cells, with a concomitant decrease in Treg frequency.",22678162_9,-1,1,-1,1,17611,-1,4.21387e-06,0.9999919,3.8869002e-06
39485,tumor,4,5,16,21,"Within the TME, tumor associated macrophages (TAMs) mediate angiogenesis, metastasis, and immunosuppression, which inhibits infiltration of tumor-specific cytotoxic CD8+ T cells.",32300202_1,-1,1,-1,1,39485,-1,4.369701e-06,0.99999094,4.7292992e-06
948,to,8,9,55,57,"In conclusion, constitutively activated Stat3 is found to mediate a spontaneous IL-5 production and regulate IL-13 production in CTCL cell lines, pointing toward a new role of Stat3 in malignant transformation.",11807001_8,-1,1,-1,1,948,-1,3.9468373e-06,0.9999919,4.1078833e-06
34696,the,6,7,31,34,"In this study, we investigated the influence of the TKI pazopanib on dendritic cell (DC) performance and immune priming.",29700053_3,-1,1,-1,1,34696,-1,4.063602e-06,0.99999213,3.7479942e-06
16390,cellular,7,8,47,55,"However, remarkably little is understood about cellular and molecular changes induced by these adjuvants in the vaccine microenvironment.",22130163_2,-1,-1,2,2,16390,-1,3.4626948e-05,6.9048665e-06,0.9999585
27943,cells,24,25,89,94,The effect of expanded CD4(+)CD25(+)Tregs on survival of freshly isolated lymphoma B cells maintained in culture with soluble multimeric CD40L and IL-4 was variable across lymphoma entities.,26758248_2,-1,-1,2,2,27943,-1,2.0143601e-05,8.3145e-06,0.9999715
19034,cell,27,28,165,169,"Overall, these findings imply that Er-1 coupling to IL-2R and ERK immuno-enhances T-cell activity, and that this effect likely translates to an inhibition of glioma cell growth.",23103669_5,-1,-1,2,2,19034,-1,1.1666416e-05,6.6500115e-06,0.99998164
15100,cells,36,37,205,210,"Ectopic expression of HPV16E6 in HeLa cells, which are infected with HPV18, suppressed MHC I expression, and that knockdown by antisense or siRNA of the HPV16E6 strongly enhanced MHC I expression in Caski cells, which are infected with HPV18, but not HPV16.",21621523_2,-1,-1,2,2,15100,-1,1.2111442e-05,9.213494e-06,0.99997866
34731,T-cell subset,9,11,46,59,"However, this early-induced CD8+ CD25+ CD127- T-cell subset is certainly distinct from the IFN+ CD8+ T-effector cells.",29768737_3,-1,-1,2,2,34731,-1,1.1517341e-05,7.897647e-06,0.99998057
35171,T cells,10,12,81,88,This molecular circuit underlies the co-expression of co-inhibitory receptors in T cells and identifies regulators of T cell function with the potential to control autoimmunity and tumour immunity.,29899446_6,-1,-1,2,2,35171,-1,8.749733e-06,5.752055e-06,0.9999856
13215,T cells,2,4,17,24,caAkt expressing T cells (caAkt-T-cells) were also relatively resistant to suppression by and conversion into regulatory T cells (Tregs).,20842106_4,-1,-1,2,2,13215,-1,8.108712e-06,5.4983357e-06,0.9999864
43588,cell,11,12,56,60,Activation is delayed a further 1-2 hr when mononuclear cell cultures are stimulated by an antigen which requires processing.,8605941_3,-1,-1,2,2,43588,-1,1.7342309e-05,6.6936345e-06,0.99997604
10902,T lymphocyte,33,35,161,173,"In order to build a therapeutic anti-HPV-16 vaccine, E6/2 (14-34) and E6/4 (45-68) fragments thus appear to be good candidates to increase HPV-specific effector T lymphocyte responses and clear classic VIN (BP) disease lesions.",19843089_5,-1,-1,2,2,10902,-1,1.2298622e-05,7.4239856e-06,0.99998033
33107,cells,4,5,18,23,"Although TIM-1+ B cells are enriched for IL-10, TIM-4+ B cells are enriched for IFN-.",28848066_4,-1,-1,2,2,33107,-1,1.6751052e-05,1.1872998e-05,0.9999713
18477,cell,14,15,89,93,"Here we identify an alternative, Batf3-independent pathway in mice for CD8(+) dendritic cell development operating during infection with intracellular pathogens and mediated by the cytokines interleukin (IL)-12 and interferon-.",22992524_1,-1,-1,2,2,18477,-1,1.6921322e-05,7.4289937e-06,0.9999757
27281,T cells,12,14,81,88,"Altogether, this defines NR2F6 as an intracellular immune checkpoint in effector T cells, governing the amplitude of anti-cancer immunity.",26387951_6,-1,-1,2,2,27281,-1,9.179303e-06,7.9922465e-06,0.99998283
24492,cells,12,13,74,79,We found that apoptosis occurred in T cells after cocultured with IDO+2LL cells and the proportion of CD4+CD25+ cells and FoxP3+ cells increased while CD8+ cells decreased.,25138378_8,-1,-1,2,2,24492,-1,1.1401735e-05,8.331026e-06,0.9999802
11974,T lymphocytes,5,7,34,47,The enhanced cytotoxic effects of T lymphocytes might partly depend on EXO/IL-12 reversing the suppressed expression of p-Stat5 by Jak2/Stat5 pathway.,20372811_7,-1,-1,2,2,11974,-1,1.5938269e-05,7.2021057e-06,0.9999769
35235,cells,39,40,222,227,"CONCLUSIONS: In studies of mice and cell lines, we found that NFB activity in PSCs promotes tumor growth by increasing expression of CXCL12, which prevents cytotoxic Tcells from infiltrating the tumor and killing cancer cells.",29909021_15,-1,-1,2,2,35235,-1,1.1701692e-05,6.766738e-06,0.9999815
13274,lymphocytes,5,6,38,49,The composition of tumor infiltrating lymphocytes (TIL) is heterogeneous.,20857491_0,-1,-1,2,2,13274,-1,1.7592845e-05,6.314493e-06,0.99997604
8093,cell,8,9,40,44,"Aged NZB mice that have developed a B-1 cell malignancy identified as IgM(+)CD5(+), have the most pronounced increase in Tregs.",19022624_4,-1,-1,2,2,8093,-1,1.3679297e-05,8.371402e-06,0.99997795
28149,cells,39,40,172,177,"RESULTS: Locally, microvascular alterations and massive infiltration by mononuclear cells (CD3+, CD4>CD8, CD45RO>CD45RA, S100 protein, CD56, CD68, scarce CD19 and mast cells) forming perivascular clusters were found in DD tissue.",26852784_4,-1,-1,2,2,28149,-1,1.6512186e-05,5.7012853e-06,0.9999777
20800,T cells,13,15,82,89,"Unexpectedly, however, both MDSC populations stimulate IFN- production by CD8(+) T cells on a per cell basis, illustrating that some T-cell activation characteristics are actually stimulated by MDSCs.",23878002_4,-1,-1,2,2,20800,-1,1.1089909e-05,6.6984653e-06,0.99998224
9359,T cells,6,8,34,41,This study demonstrates that CD8+ T cells in the tumor microenvironment display reduced functionality and hyporesponsiveness.,19319531_0,-1,-1,2,2,9359,-1,1.0233069e-05,5.6729555e-06,0.999984
9830,cells,17,18,128,133,Antigen-specific T-cell lines were generated by ex vivo stimulation with Class-I and Class-II melanoma peptide pulsed dendritic cells in the presence of either IL-2 or IL-15 plus IL-21.,19501956_2,-1,-1,2,2,9830,-1,1.4453013e-05,7.464499e-06,0.99997807
6273,cells,42,43,263,268,"The presence of such non-Th1 CD4(+) T cells in peripheral blood was independent of treatment status, while the frequencies of responding cells varied between patients and reached the same order of magnitude as those measured for tetanus toxoid-specific Th memory cells.",18156498_4,-1,-1,2,2,6273,-1,1.2108348e-05,7.176627e-06,0.9999807
21194,T-cell differentiation,8,10,56,78,CONCLUSIONS: The decreases in thymopoiesis and impaired T-cell differentiation may be attributable to changes in the thymic microenvironment.,24051497_8,-1,-1,2,2,21194,-1,2.1070551e-05,8.2712e-06,0.9999707
37464,Cells,11,12,85,90,"BACKGROUND: Interleukin(IL)-30/IL-27p28 production by Prostate Cancer (PC) Stem-Like Cells (SLCs) has proven, in murine models, to be critical to tumor onset and progression.",31366386_0,-1,-1,2,2,37464,-1,1.4822508e-05,8.0439095e-06,0.99997723
19038,cells,15,16,89,94,"Previous studies have reported alterations in numbers or function of regulatory T (Treg) cells in myasthenia gravis (MG) patients, but published results have been inconsistent, likely due to the isolation of heterogenous ""Treg"" populations.",23110942_0,-1,-1,2,2,19038,-1,1.2078793e-05,7.7068125e-06,0.9999802
256,cells,11,12,60,65,"We have established that in some cases of CLL the malignant cells express both CD40 and CD154, and on the basis of those observations, proposed a model for CLL tumor growth due to CD40-CD154 interactions within and among the malignant cells, and for the occurrence of autoimmune syndromes in some cases of CLL.",11042507_2,-1,-1,2,2,256,-1,1.5298003e-05,6.445372e-06,0.9999783
25862,T cells,16,18,116,123,This inhibitory effect is specific for AICD through suppressing NFAT1-regulated FasL expression on activated CD4(+) T cells.,25745993_4,-1,-1,2,2,25862,-1,8.75917e-06,5.5005457e-06,0.9999858
34529,lymphocytes,13,14,90,101,"Although cancer tissue generally shows limited immune responses, some cancers abound with lymphocytes, which generally show favorable prognosis.",29594353_0,-1,-1,2,2,34529,-1,1.2358999e-05,6.3163816e-06,0.9999813
40458,cell,28,29,186,190,"In contrast, in Th2-polarized settings such as house dust mite-induced allergic airway inflammation, the lack of IRF4 expression in the DC compartment alleviates inflammation and goblet cell metaplasia.",32848032_5,-1,-1,2,2,40458,-1,1.5961838e-05,6.83846e-06,0.99997723
22824,CD80(low,39,40,231,239,"Data generated from this study support that NLGP is effective in preventing the SLTCL induced generation (CD68(+)CD206(+)IL-10(high) to CD68(+)CD206(-)IL-10(low) TAMs) and functions (NO(low) to NO(high), MHC-I(low) to MHC-I(high), CD80(low) to CD80(high)) of pro-tumorous M2 macrophages, which in turn associated with sustained anti-tumor effector functions by promoting cytotoxic T cell activities and suppressing regulatory T cells.",24607970_2,-1,-1,2,2,22824,-1,0.0021011413,0.00029307342,0.9976058
12930,regulatory T-cell,25,27,181,198,"Moreover, CD40-Ad-MART-1 enhanced the expansion of functional MART-1-specific CD8(+) T cells from SLN with concomitant decreases in CD4:CD8 T-cell ratios and CD4(+)CD25(hi)FoxP3(+) regulatory T-cell rates.",20664356_5,-1,-1,2,2,12930,-1,3.5053443e-05,5.0156363e-05,0.99991477
6242,cells,11,12,79,84,Therapies that could possibly increase the suppressive ability of T regulatory cells were proven to improve that course of autoimmune diseases.,18092144_2,-1,-1,2,2,6242,-1,1.4871843e-05,6.7210794e-06,0.9999784
107,cells,30,31,198,203,"Vaccine-induced immune responses to the HPV early antigens E6 and E7, which contribute to cell transformation and are thus expressed in these cervical cancers, could potentially eradicate malignant cells.",10772987_1,-1,-1,2,2,107,-1,1.0181492e-05,6.1711426e-06,0.99998367
27668,T cell,7,9,51,57,"Furthermore, IL-12 driven STAT4 phosphorylation in T cell blasts from healthy individuals was found to correlate with both single allele variants and haplotypes.",26547104_6,-1,-1,2,2,27668,-1,1.1319698e-05,6.2706895e-06,0.99998236
39662,cells,4,5,23,28,"In addition, CD73+T1 cells exert an immunosuppressive effect via adenosine generation.",32345959_3,-1,-1,2,2,39662,-1,1.2897856e-05,9.907792e-06,0.99997723
8486,cells,13,14,100,105,"H22-BAL B/c HCC mouse model was established by subcutaneous injection with hepatocellular carcinoma cells of cell line H22-Wt (group A), H22-neo (group B), H22-CD80/CD86(+) (group C), H22-CD137L(+) (group D) and H22-CD80/CD86/CD137L(+) (group E), respectively.",19173904_2,-1,-1,2,2,8486,-1,1.512359e-05,5.957855e-06,0.9999789
34543,lymphocyte-rich,13,14,71,86,The present study analyzes the in situ TGF1 expression in 23 cases of lymphocyte-rich gastric carcinomas (Ly-rich GCs) using immunohistochemistry and in situ hybridization.,29594353_3,-1,-1,2,2,34543,-1,4.6254656e-05,1.7973618e-05,0.99993575
639,T cells,4,6,17,24,"Moreover, CD4(+) T cells manifested rapid secretion of the Th2 cytokines IL-4, IL-5, and IL-10, reminiscent of Th2 memory cells.",11441076_5,-1,-1,2,2,639,-1,8.739282e-06,5.918885e-06,0.99998534
39509,T cells,14,16,81,88,"In CDDO-Me-treated mice, both the absolute number and proportion of splenic CD4+ T cells were reduced, while the proportion of CD8+ T cells was significantly increased in both tumors and spleen.",32300202_6,-1,-1,2,2,39509,-1,1.0486371e-05,5.6800995e-06,0.9999838
10903,regulatory T cells,8,11,20,38,"FoxP3( + ) CD4( + ) regulatory T cells (Tregs) are important mediators of peripheral immune tolerance, acting via multiple mechanisms to suppress cellular immunity including antitumor responses.",19855964_0,-1,-1,2,2,10903,-1,7.769699e-06,5.0369354e-06,0.99998724
9762,T cells,14,16,81,88,"In addition, Tregs inhibited the proliferation of TCR-stimulated (primed) CD4(+) T cells and nave CD8(+) T cells after TCR-mediated activation, however, Tregs with OX40 costimulation lost their suppressive function.",19455675_6,-1,-1,2,2,9762,-1,9.8000455e-06,5.9134227e-06,0.99998426
19325,Treg cells,7,9,36,46,The presence of regulatory T cells (Treg cells) in human uterine cancer is crucial for maintaining immunological homeostasis.,23178746_1,-1,-1,2,2,19325,-1,1.4720906e-05,1.5187081e-05,0.9999702
22248,T cells,21,23,120,127,"Using several tumor models, we demonstrate that mice deficient in Bcl11b in T cells, although having reduced numbers of T cells in the peripheral lymphoid organs, developed significantly less tumors compared with wild-type mice.",24446520_0,-1,-1,2,2,22248,-1,1.0248467e-05,5.1587012e-06,0.9999846
34505,cells,12,13,96,101,"One mechanism is tumor-induced myelopoiesis, whereby the expansion of immunosuppressive myeloid cells can impair tumor immunity.",29593283_1,-1,-1,2,2,34505,-1,1.5446334e-05,6.947153e-06,0.9999776
11744,T cells,38,40,211,218,"Numbers of CD4(+) and CD8(+) T cells, Con A response, and IFN-gamma production increased significantly, whereas number of Gr-1(+)/CD11b(+) myeloid suppressor cells and the percentage of FoxP3(+) cells in CD4(+) T cells significantly decreased in these mice.",20229083_5,-1,-1,2,2,11744,-1,8.600836e-06,5.5373416e-06,0.99998593
39235,cells,4,5,17,22,Mice in which NK cells had been depleted genetically or with neutralizing antibodies allowed lymphoma growth while the absence of CD8 T cells was without consequence.,32143838_3,-1,-1,2,2,39235,-1,1.3818947e-05,8.659543e-06,0.99997747
8065,cells,12,13,67,72,"Also, Balb/C mice exhibit 25% reduction of lymph-node T regulatory cells after pomalidomide treatment.",19009291_7,-1,-1,2,2,8065,-1,1.17098225e-05,7.3750803e-06,0.9999809
8493,T lymphocytes,31,33,164,177,"On the 14th, 35th, 56th and 84th day after the first inoculation of tumor cells, TUNEL staining and DNA ladder examination were used to detect apoptosis of splenic T lymphocytes in all groups at each post-inoculation time point.",19173904_3,-1,-1,2,2,8493,-1,1.173889e-05,7.751758e-06,0.99998057
27615,T cells,0,2,0,7,T cells are ineffective in eliminating the leukemic clone and may actually promote tumor growth and survival.,26478573_2,-1,-1,2,2,27615,-1,1.0900864e-05,4.709056e-06,0.9999844
4352,Treg cells,1,3,8,18,Gastric Treg cells were able to suppress H. pylori-induced T cell proliferation and IFN-gamma production.,16934529_4,-1,-1,2,2,4352,-1,1.3900396e-05,1.1338152e-05,0.9999747
38833,antigen receptor,23,25,124,140,"Given the antitumor properties of Tc22 cells, it may be prudent to polarize T cells to the Tc22 lineage when using chimeric antigen receptor (CAR)-T or T-cell receptor (TCR) transduction-based immunotherapies.",31964625_6,-1,-1,2,2,38833,-1,0.00018814104,1.2965821e-05,0.99979883
29664,cell,1,2,7,11,Killer cell lectin-like receptor subfamily G member 1 (KLRG1) has been found on human memory T lymphocytes.,27557510_0,-1,-1,2,2,29664,-1,1.7737166e-05,7.453996e-06,0.9999747
37022,T cells,62,64,396,403,METHOD: Human papillomavirus 16 E6/E7 transformed TC-1 tumour bearing mice were intravenously administered with low (1  108 CFU/kg) or high dosage (3  108 CFU/kg) of Derivative Clostridial spore (DCG).RESULTS: Intravenous administration of the derivative of Clostridial ghonii (DCG) spores leads to both tumour and systemic inflammatory responses characterized by increased IFN/IL-9 secreting T cells in the spleen and the tumour.,31183361_2,-1,-1,2,2,37022,-1,2.1312238e-05,6.012878e-06,0.9999727
31123,T cells,17,19,111,118,The CD8+RORt+ T cells represented a highly activated subset and produced IL-17A in equal amount as CD4+RORt+ T cells (TH17 cells).,28053236_3,-1,-1,2,2,31123,-1,7.784367e-06,5.1950497e-06,0.999987
30230,cells,23,24,134,139,"To examine the effect of Tr1 upregulation, we cocultured the enriched in vitro-induced Tr1 cells (iTr1) with autologous primary DLBCL cells and CD3+ T cells and found that iTr1 cells both enhanced the survival of CD20+ DLBCL tumor cells and suppressed the antitumor response of CD3+ T cells through the production of IL-10.",27704876_7,-1,-1,2,2,30230,-1,1.1673841e-05,7.3884626e-06,0.9999809
9785,cells,1,2,6,11,"iTreg cells are essential in mucosal immune tolerance and in the control of severe chronic allergic inflammation, and most likely are one of the main barriers to the eradication of tumors.",19464985_1,-1,-1,2,2,9785,-1,1.347612e-05,6.782206e-06,0.99997973
30562,cells,13,14,99,104,"Laricitrin treatment stimulated DC differentiation and maturation in the condition media of cancer cells, a finding supported by monocyte marker CD14's disappearance and DC marker CD1a's upregulation.",27833081_4,-1,-1,2,2,30562,-1,1.525829e-05,6.9276307e-06,0.9999778
15035,T cells,48,50,273,280,"The percentage of CD15(+) and CD15(-) but not CD14(+) MDSC subsets were inversely correlated with IFN--induced STAT1 phosphorylation in CD4(+) T cells, while co-culture with in vitro generated MDSC led to reduced IFN- responsiveness in both PBMC and the CD4(+) subset of T cells from normal donors.",21604071_6,-1,-1,2,2,15035,-1,1.03201755e-05,5.5856435e-06,0.999984
5775,cell,8,9,47,51,"In cocultures of activated T cells and Hodgkin cell lines, RNAi-mediated blockade of RS cell Gal1 increased T cell viability and restored the Th1/Th2 balance.",17670934_3,-1,-1,2,2,5775,-1,1.1936296e-05,7.703023e-06,0.99998033
37931,cell,15,16,94,98,"Intriguingly, JQ1 was found in this study to exhibit therapeutic potential in tongue squamous cell carcinoma (TSCC) by inducing ICD.",31600692_3,-1,-1,2,2,37931,-1,2.0194344e-05,8.183817e-06,0.9999716
3935,T cells,19,21,136,143,Analysis of tumor-infiltrating T lymphocyte populations showed that the expression of Foxp3 and IL-10 was associated with CD4(+)CD25(+) T cells.,16751376_6,-1,-1,2,2,3935,-1,9.018463e-06,5.113146e-06,0.9999858
20707,regulatory T cells,11,14,73,91,Flow cytometry was used to investigate the percentage of CD4+CD25+Foxp3+ regulatory T cells (Tregs) in peripheral blood mononuclear cells (PBMCs).,23835793_3,-1,-1,2,2,20707,-1,1.009894e-05,5.8540168e-06,0.999984
31634,cells,8,9,39,44,"Here we found that the absence of iNKT cells markedly decreased the total number of intestinal polyps in APCMin/+ mice, a model for colorectal cancer.",28401935_2,-1,-1,2,2,31634,-1,1.1507941e-05,7.060021e-06,0.9999814
43126,cells,16,17,126,131,"Our analyses reveal a gastritis characterized by severe mucosal injury, interferon gamma (IFN-)-producing gastric epithelial cells, and mixed inflammation that includes CD8 and CD4 Tcell infiltrates with reduced expression of granzyme B and FOXP3, respectively.",34755133_5,-1,-1,2,2,43126,-1,1.2081338e-05,7.899911e-06,0.9999801
5666,T cells,18,20,128,135,We found that the presence of lymphoma B cells during activation augmented activation-induced Foxp3 expression in CD4(+)CD25(-) T cells.,17615291_4,-1,-1,2,2,5666,-1,9.6207905e-06,5.455471e-06,0.99998486
37429,cells,5,6,20,25,"Regulatory T (Treg) cells are crucial for immune homeostasis, but they also contribute to tumor immune evasion by promoting a suppressive tumor microenvironment (TME).",31350177_0,-1,-1,2,2,37429,-1,1.3408717e-05,7.6935785e-06,0.9999789
1604,cell-cell,3,4,31,40,Ligand-specific activation and cell-cell contact were required for TIL102 Treg cells to exert suppressive activity on CD4(+) effector cells.,14738769_4,-1,-1,2,2,1604,-1,3.6635527e-05,9.366587e-06,0.999954
3081,cells,38,39,275,280,"Fas ligand (FasL)-Fas engagement proved important in this activity because elevated expression of membrane-bound FasL was detected on SM-DCs, and dendritic cells derived from FasL-deficient mice were less capable of killing NO-sensitized tumor cells than wild-type dendritic cells.",16166326_5,-1,-1,2,2,3081,-1,1.7179593e-05,6.696266e-06,0.99997616
34111,T cell,16,18,83,89,"Here, we show that LMP1 expression in B cells induces potent cytotoxic CD4 and CD8 T cell responses, by enhancing antigen presentation and costimulation by CD70, OX40 ligand, and 4-1BB ligand.",29311309_8,-1,-1,2,2,34111,-1,1.1336215e-05,5.428335e-06,0.9999832
36249,cells,16,17,80,85,"In addition, the phosphorylation level of STAT3 and Erk was examined in CD27+ B cells.",30711567_11,-1,-1,2,2,36249,-1,1.4768606e-05,1.28517495e-05,0.99997234
6494,T cells,58,60,342,349,"The following biomarkers were studied in peripheral blood mononuclear cells (PBMC) during treatment: phosphorylation of STAT3, alterations in the composition of leukocyte subsets, ex vivo cytotoxicity, expression of effector molecules in enriched CD8(+) T cells and CD56(+) NK cells by quantitative RT-PCR, and gene array profiling of CD8(+) T cells.",18286285_3,-1,-1,2,2,6494,-1,1.1372747e-05,5.6704935e-06,0.99998295
18650,CTLA-4,11,12,72,78,"The suppressive function of Tregs was mediated by cell-to-cell contact, CTLA-4 expression and IL-10 secretion.",23000301_7,-1,-1,2,2,18650,-1,2.5023088e-05,8.399648e-06,0.9999666
33663,CTLA,24,25,156,160,"The multipeptide-specific CTL included antigen-specific memory CD8+ T cells expressing both T-cell activation (CD38, CD69) and immune checkpoints antigens (CTLA, PD-1, LAG-3, TIM-3).",29089645_4,-1,-1,2,2,33663,-1,1.4306069e-05,4.3425644e-06,0.9999814
876,T lymphocytes,14,16,78,91,"IL-8, a cytokine with both chemotactic and angiogenic effects, is produced by T lymphocytes following activation.",11801678_4,-1,-1,2,2,876,-1,1.1617828e-05,8.813261e-06,0.9999796
16172,T lymphocytes,10,12,39,52,"Regulatory T cells (T(reg)) are CD4(+) T lymphocytes with constitutive expression of CD25 and FOXP3, as well as the ability to modulate cellular immune responses.",22041284_0,-1,-1,2,2,16172,-1,8.408188e-06,5.3834165e-06,0.9999862
33653,CD40L,19,20,125,130,"Furthermore, a cocktail containing the four HLA-A24 peptides evoked MM-specific CTL with distinct phenotypic profiles (CD28, CD40L, 41BB, CD38, CD69) and anti-tumor activities, evidenced by perforin upregulation, CD107a degranulation (cytotoxicity) and Th1-type cytokines (IFN-/IL-2/TNF-) production in response to HLA-A24+ MM cells.",29089645_3,-1,-1,2,2,33653,-1,3.7842445e-05,7.882677e-06,0.99995434
21212,CTLA-4,26,27,163,169,Flow cytometry revealed that the majority of intratumoral CD4Foxp3 T cells (Tregs) were Helios and expressed higher levels of cytotoxic T-lymphocyte antigen 4 (CTLA-4) and CD39 than Tregs from colon and blood.,24064667_1,-1,-1,2,2,21212,-1,0.0003376738,3.61093e-05,0.99962616
4417,cell,27,28,177,181,The amounts of IFN-gamma secreted by the co-culture of irradiated OVHM cells with spleen cells from mice injected with CD40L/OVHM were much higher than those from OVHM/parental cell inoculated and naive mice.,16965650_11,-1,-1,2,2,4417,-1,1.7685263e-05,6.5852973e-06,0.9999758
33311,Tcells,31,34,168,175,"Incorporating 4-1BB costimulation in CARs may enable Tcells to resist this functional exhaustion; however, the potential ramifications of tonic 4-1BB signaling in CAR Tcells remain unclear.",28978471_1,-1,-1,2,2,33311,-1,8.999986e-06,6.825926e-06,0.99998426
4312,cells,48,49,329,334,"The results show that the i.t. injection of the AdCDIRESE1A chemotherapy sensitization vector, which encodes the cytosine deaminase chemotherapy sensitization transcription unit, to the i.t. injection of Ad-sig-ecdCD40L vector-infected dendritic cells increased the level of suppression of the growth of the CCL-51 breast cancer cells.",16928818_6,-1,-1,2,2,4312,-1,1.5581385e-05,6.6607754e-06,0.9999777
39828,T cells,20,22,90,97,"Here, we show that head-neck squamous cell carcinoma (HNSCC) is enriched in CD4+ and CD8+ T cells with a Trm phenotype.",32441311_5,-1,-1,2,2,39828,-1,8.9712385e-06,4.705685e-06,0.9999864
15560,cells,15,16,82,87,"We detected tetramer(+) cells ex vivo, at an average frequency of 1:25,000 memory cells, that is, significantly lower than in patients immunized with an ESO vaccine.",21829534_4,-1,-1,2,2,15560,-1,1.2688123e-05,8.319217e-06,0.999979
16716,regulatory T cells,2,5,23,41,"CD4(+)CD25(hi)Foxp3(+) regulatory T cells (T(regs)) are critical mediators of self-tolerance, which is crucial for the prevention of autoimmune disease, but T(regs) can also inhibit antitumor immunity.",22375050_0,-1,-1,2,2,16716,-1,7.777627e-06,5.5790083e-06,0.99998665
28707,cytotoxic T cells,11,14,88,105,"GIFT4-CLL cells directly propelled the expansion of autologous IFN--producing CD314(+) cytotoxic T cells in vitro, and that these could lyse autologous CLL cells.",27118475_8,-1,-1,2,2,28707,-1,1.1057861e-05,5.292072e-06,0.99998367
12046,Treg cells,6,8,40,50,A functional assay showed that isolated Treg cells were capable of inhibiting proliferation of responder cells.,20386464_4,-1,-1,2,2,12046,-1,1.1760687e-05,1.02042e-05,0.99997795
3015,cells,15,16,100,105,Transforming growth factor-beta (TGF-beta) plays an essential role in regulating the homeostasis of cells in the lymphoid lineage.,16123803_0,-1,-1,2,2,3015,-1,1.4926091e-05,7.6180586e-06,0.99997747
1606,cells,19,20,134,139,Ligand-specific activation and cell-cell contact were required for TIL102 Treg cells to exert suppressive activity on CD4(+) effector cells.,14738769_4,-1,-1,2,2,1606,-1,1.1191929e-05,8.325738e-06,0.99998045
22440,cells,16,17,118,123,We found that ex vivo-isolated  thymocytes produced negligible IFN- and lacked cytolytic activity against leukemia cells.,24489097_3,-1,-1,2,2,22440,-1,1.1745046e-05,7.920214e-06,0.99998033
39655,cells,24,25,108,113,"First, we showed that T1 cells comprise the majority of CD3+ T cells in BC; next, we found that CD73+T1 cells were the predominant regulatory T-cell (Treg) population in BC, and that their prevalence in peripheral blood was also related to tumour burden.",32345959_2,-1,-1,2,2,39655,-1,1.188965e-05,7.686183e-06,0.99998045
43388,cells,10,11,62,67,"While reduced in tumors compared to blood, TNF--expressing B cells engaged in crosstalk with Tregs via TNF- signaling and the ICOS/ICOSL axis.",35909944_4,-1,-1,2,2,43388,-1,1.5365093e-05,9.6818485e-06,0.99997497
11383,regulatory T cell,29,32,163,180,"Since members of this family of cytokines are known to exhibit their effects on diverse immune cells, we have examined the effects of IL-21 on CLL patient derived regulatory T cell (Treg) induction, expansion and the inhibitory effect on natural killer cells in vitro.",20081380_3,-1,-1,2,2,11383,-1,8.813348e-06,5.5133596e-06,0.9999857
30846,subset,4,5,21,27,"We also identified a subset of CD8+PD-1+FOXP3+ T lymphocytes at the earliest phase of functional differentiation after priming, termed ""early effector cells"" (EEC), which also exhibited an activated nonexhausted phenotype, but was less differentiated and associated with coexpression of multiple inhibitory receptors.",27979840_4,-1,-1,2,2,30846,-1,1.872047e-05,1.0028614e-05,0.9999713
39364,cell,5,6,33,37,There were differences in innate cell populations between responders and non-responders at baseline and maintained throughout therapy.,32210968_5,-1,-1,2,2,39364,-1,1.7893197e-05,7.41225e-06,0.9999747
18063,regulatory T cells,15,18,79,97,We examined the effects of adoptive T-cell transfer (ACT) on the population of regulatory T cells (Tregs) in a mouse colorectal cancer transplant model.,22812187_0,-1,-1,2,2,18063,-1,1.0047784e-05,5.141968e-06,0.99998486
36986,cells,16,17,72,77,"RESULTS: 4-1BBL expression was detected on 2.8  1.7% of unstimulated B cells, while 27.4  11.9% of B cells expressed this co-stimulatory molecule following stimulation.",31182685_5,-1,-1,2,2,36986,-1,1.4346144e-05,1.0804919e-05,0.99997485
20377,cell,21,22,129,133,"In patient tumor samples, overall lung tumor NF-B activity was strongly associated with T cell infiltration but not with cancer cell proliferation.",23635779_5,-1,-1,2,2,20377,-1,1.2505571e-05,5.670817e-06,0.99998176
31742,cells,12,13,68,73,CXCR5+CD8+ T cells also enhanced the IgG expression by autologous B cells.,28412245_4,-1,-1,2,2,31742,-1,1.2936604e-05,1.0370535e-05,0.99997663
24694,cells,16,17,102,107,"Herein, we characterize the postpartum murine mammary gland and find an orchestrated influx of immune cells similar to that which occurs during wound healing.",25187059_3,-1,-1,2,2,24694,-1,2.3488376e-05,5.813326e-06,0.9999707
20285,cells,8,9,44,49,"In addition, compared to exosomes from CT26 cells, CT26-CIITA-derived exosomes induced higher TNF- and IL-12 mRNA levels.",23621273_6,-1,-1,2,2,20285,-1,1.2214242e-05,9.535886e-06,0.9999783
5658,cells,11,12,67,72,In vitro activation with OKT3/anti-CD28 antibody (Ab) or dendritic cells (DCs) induced Foxp3 expression in a subset of these CD4(+)CD25(-)Foxp3(-) T cells.,17615291_3,-1,-1,2,2,5658,-1,1.261803e-05,6.245151e-06,0.99998116
31451,CTLA-4,19,20,146,152,"Fighting cancer with immunotherapy has revolutionized treatment for some patients and therapies targeting the immune checkpoint molecules such as CTLA-4 and PD-1 have achieved durable responses in melanoma, renal cancer, Hodgkin's diseases and lung cancer.",28258697_1,-1,-1,2,2,31451,-1,3.938802e-05,1.0407991e-05,0.9999503
68,CTL,17,18,118,121,We demonstrate here that local expression of transgenic mIL-12 at the E6 DNA vaccination site potentiated E6-specific CTL responses and increased vaccine-induced antitumor therapeutic efficacy.,10419051_5,-1,-1,2,2,68,-1,4.6787864e-05,6.503174e-06,0.9999466
22748,T cells,10,12,45,52,"The percentage of Tregs, MDSC, and pSTAT5 in T cells were evaluated in peripheral blood by flow cytometry.",24598448_6,-1,-1,2,2,22748,-1,1.0696749e-05,6.2048653e-06,0.9999831
36984,cells,4,5,33,38,Both unstimulated and stimulated cells were stained with antiCD19 and anti4-1BBL antibodies and subjected to flow cytometry.,31182685_4,-1,-1,2,2,36984,-1,1.3169473e-05,7.074164e-06,0.99997985
7367,cells,16,17,97,102,"Thus, the antiapoptotic signaling of CD40, which interferes with TRAIL-induced apoptosis in FL B cells, involves NF-kappaB-mediated induction of c-FLIP and Bcl-x(L) which can respectively interfere with caspase 8 activation or mitochondrial-mediated apoptosis.",18606651_6,-1,-1,2,2,7367,-1,1.3888404e-05,1.22686e-05,0.9999738
33790,T cells,42,44,273,280,"Finally, adoptive transfer assays in vivo revealed a reduced antitumor capacity in NFAT5-deficient macrophages against syngeneic Lewis lung carcinoma and ID8 ovarian carcinoma cells, a defect that in the ID8 model was associated with a reduced accumulation of effector CD8 T cells at the tumor site.",29150563_5,-1,-1,2,2,33790,-1,1.1464522e-05,5.918124e-06,0.9999826
10402,T cell proliferation,1,4,13,33,CEA-specific T cell proliferation and cytotoxic T cell responses were enhanced significantly in mice immunized with Tat-CEA-pulsed DCs [DC (Tat-CEA)] compared with those immunized with CEA-pulsed DCs [DC (CEA)].,19659778_5,-1,-1,2,2,10402,-1,1.5798974e-05,5.821037e-06,0.9999783
2480,T cells,15,17,121,128,"Strategies to stimulate CTL-mediated antitumor immunity have included in vitro stimulation and/or genetic engineering of T cells, followed by adoptive transfer into tumor-bearing hosts.",15661898_1,-1,-1,2,2,2480,-1,1.1070925e-05,5.281877e-06,0.99998367
33153,cells,5,6,20,25,"Natural killer (NK) cells are large granular lymphocytes of the innate immune system and play a pivotal role against virus-infected cells, microbial pathogens, and tumor cells.",28891726_0,-1,-1,2,2,33153,-1,1.120832e-05,7.736482e-06,0.99998105
3262,T cells,15,17,79,86,JNK1 has divergent roles in regulating the effector functions of CD4+ and CD8+ T cells.,16237070_0,-1,-1,2,2,3262,-1,8.315004e-06,5.1806355e-06,0.9999865
28279,T cells,6,8,40,47,"Although a high number of intra-tumoral T cells showed a trend toward improved survival of all OPSCC patients, their prognostic effect in patients with a low number of intra-tumoral IL-17(+) non-T cells was significant with regard to disease-specific (p = 0.033) and disease-free survival (p = 0.012).",26899388_6,-1,-1,2,2,28279,-1,1.11028085e-05,5.7240563e-06,0.9999832
20396,T-cell proliferation,24,26,151,171,"Upon upregulating miR-124 in glioma cancer stem cells (gCSC), the STAT3 pathway was inhibited, and miR-124 reversed gCSC-mediated immunosuppression of T-cell proliferation and induction of forkhead box P3 (Foxp3)(+) regulatory T cells (Treg).",23636127_3,-1,-1,2,2,20396,-1,1.3308121e-05,6.150963e-06,0.99998045
21323,T cells,28,30,140,147,"We evaluated the phosphorylation of signal transducer and activator of transcription 5 (STAT5) in CD4(+) T cells, CD8(+) T cells, and TCR T cells in response to stimulation with IL-7 or IL-2 after HSCT by analyzing blood samples taken monthly 1 to 6 months after HSCT.",24140122_1,-1,-1,2,2,21323,-1,8.641605e-06,5.6685626e-06,0.9999857
7261,T cells,3,5,10,17,When CD4+ T cells purified from OT-II transgenic mice were transferred into C57BL/6 mice bearing s.c.,18566377_5,-1,-1,2,2,7261,-1,9.877305e-06,4.8080105e-06,0.99998534
39621,subset,10,11,75,81,Evidence for WNT/-catenin signaling-mediated immune evasion is found in a subset of cancers including melanoma.,32332858_2,-1,-1,2,2,39621,-1,2.1704547e-05,9.191984e-06,0.9999691
33314,Tcells,15,18,78,85,"Here, we found that tonic CAR-derived 4-1BB signaling can produce toxicity in Tcells via continuous TRAF2-dependent activation of the nuclear factor B (NF-B) pathway and augmented FAS-dependent cell death.",28978471_2,-1,-1,2,2,33314,-1,1.0231222e-05,6.938853e-06,0.99998283
5671,T cells,20,22,143,150,We also found that CD70(+) lymphoma B cells significantly contributed to the activation-induced Foxp3 expression in intratumoral CD4(+)CD25(-) T cells.,17615291_5,-1,-1,2,2,5671,-1,9.107053e-06,5.002585e-06,0.99998593
3101,T cells,25,27,183,190,"Importantly, NO-treated tumor cells were also engulfed more readily than control tumor cells and this resulted in enhanced cross-presentation of tumor-associated antigens to specific T cells in vitro.",16166326_8,-1,-1,2,2,3101,-1,9.876395e-06,6.495172e-06,0.99998367
32607,CTLA4,16,17,108,113,"Furthermore, excellent antitumor immune responses can also be achieved using combinations of Abs that block CTLA4, PD1, OX40, and CD30 ligands, without CD4 T cell-driven autoimmunity.",28646041_3,-1,-1,2,2,32607,-1,2.977563e-05,1.2778658e-05,0.99995744
23210,T cells,11,13,72,79,"Furthermore, after A20 attenuation in AML-DCs, the autologous cytolytic T cells (CTLs) induced by AML-DCs had higher killing capability and specificity for primary AML cells.",24713261_5,-1,-1,2,2,23210,-1,9.68656e-06,5.585722e-06,0.99998474
8153,cells,2,3,13,18,"To eliminate cells with phenotypic markers of CSC-like we characterized: (1) expression of CD44, CD24, CD133 and MIC-A/B (NKG2 receptors) in breast (MCF7) and ovarian (SK-OV-3) cells resistant to gemcitabine (GEM), paclitaxel (PTX) and 5-fluorouracil (5-FU) and (2) their elimination by Numb- and Notch-peptide activated CTL.",19048252_1,-1,-1,2,2,8153,-1,1.1560557e-05,6.646766e-06,0.99998176
19476,cells,6,7,29,34,"Priming (conditioning) of PC cells with AT-101 can significantly enhance the anti-tumor activity of EGFRBi armed ATC through increased IFN- induced activation of pS(727)-Stat1 and inhibition of pY(705)-Stat3 phosphorylation, and resulting in increased ratio of pro-apoptotic to anti-apoptotic proteins.",23185240_6,-1,-1,2,2,19476,-1,1.678492e-05,1.00743e-05,0.99997306
19779,T-cell proliferation,11,13,72,92,"Studies revealed that the levels of expression of genes responsible for T-cell proliferation (C-FOS, C-JUN and DUSP1) and cellular migration (RGS1) were greater in Tregs from mCRPC patients as compared to values observed in healthy donors.",23319273_5,-1,-1,2,2,19779,-1,1.07034375e-05,5.7754096e-06,0.99998355
31940,T cell,20,22,125,131,"Despite the failure of virus spread to the tumor, infection resulted in significantly enhanced tumor necrosis, extensive CD4 T cell accumulation, and high levels of the proinflammatory factors IFN-, TNF-, and inducible NO synthase in the TME merely 4 d postinfection, before significant virus spread or the appearance of RABV-specific immune mechanisms in CNS tissues.",28461570_5,-1,-1,2,2,31940,-1,9.32521e-06,6.5251065e-06,0.99998415
18972,T-cell activation,19,21,125,142,"Enhanced antitumor activity with combination therapy was associated with an increase in systemic NK cell and effector CD8(+) T-cell activation and IFN- production, as well as infiltration of effector CD8(+) T cells into the tumor.",23090488_4,-1,-1,2,2,18972,-1,1.6907821e-05,8.244585e-06,0.99997485
2544,NKT cells,3,5,21,30,"Adoptive transfer of NKT cells pulsed with HCC-derived antigens (group A) and NKT cells from immunized donors (group E) resulted in complete disappearance of tumors within 4 weeks and attenuated weight loss (6.5% and 7% in groups A and E, respectively).",15688366_9,-1,-1,2,2,2544,-1,2.5473113e-05,4.4601056e-05,0.9999299
27007,cells,22,23,123,128,"T cells of all specificities expanded similarly in vitro, recognized cognate antigen, and, to a lower extent, EBV-infected cells, exerted moderate cytotoxicity and showed reduced alloreactivity.",26276009_5,-1,-1,2,2,27007,-1,1.0806209e-05,7.4752684e-06,0.99998164
11496,lymphocyte,16,17,93,103,"In a basic study of immunotolerance, injection of an endogenous superantigen, i.e. the minor lymphocyte stimulatory (Mls)-1(a), into specific TCR Vbeta8.1-Tg mice enabled generation of anergic CD25(-) iTreg, the immunosuppressive function of which was maintained by IL-10 production via p38-MAPK activation.",20127675_1,-1,-1,2,2,11496,-1,2.5270634e-05,7.774077e-06,0.999967
23598,cells,27,28,165,170,"Tumor-derived vascular endothelial growth factor A (VEGF-A), interleukin 10 (IL-10) and prostaglandin E2 (PGE2) cooperatively induced FasL expression in endothelial cells, which acquired the ability to kill effector CD8(+) T cells but not Treg cells because of higher levels of c-FLIP expression in Treg cells.",24793239_3,-1,-1,2,2,23598,-1,1.0180596e-05,8.298589e-06,0.9999815
4479,cells,12,13,77,82,We examined the phosphorylation of STAT5 (P-STAT5) in IL-2-stimulated immune cells of normal subjects and in patients receiving IL-2 therapy using a novel flow cytometric assay to characterize the pattern and level of activation within immune subsets.,17020993_2,-1,-1,2,2,4479,-1,2.0121815e-05,6.212136e-06,0.99997365
33576,cell,11,12,81,85,"Furthermore, fucoidan treatment decreased the expression of Foxp3 and programmed cell death 1 ligand 1 (PDL1) in tumor tissues.",29043842_7,-1,-1,2,2,33576,-1,3.063252e-05,7.948286e-06,0.9999614
9363,T cells,8,10,61,68,"TGF-beta contributed markedly to the tumor-infiltrating CD8+ T cells' (TILs) reduced functionality, which could be reversed using a small molecule TGF-beta inhibitor.",19319531_1,-1,-1,2,2,9363,-1,1.0400752e-05,5.4615216e-06,0.99998415
25566,lymphocytic,1,2,8,19,Chronic lymphocytic leukemia (CLL) is a B cell malignancy associated with increased levels of inflammatory cytokines.,25505279_0,-1,-1,2,2,25566,-1,8.8854904e-05,9.775936e-06,0.9999014
19340,regulatory T cell,11,14,65,82,"In the current study, simultaneous CD200 expression and Foxp3(+) regulatory T cell levels were investigated in Iranian patients with AML by flow cytometry.",23179394_2,-1,-1,2,2,19340,-1,7.704378e-06,5.7323296e-06,0.9999865
10976,T cells,16,18,103,110,"Intratumoral delivery of IL-12, in contrast, can restore cytotoxic function to tumor-associated CD8(+) T cells and induce the apoptotic death of T-suppressor cells.",19923444_1,-1,-1,2,2,10976,-1,9.01494e-06,5.8372148e-06,0.9999851
40383,T cell,15,17,113,119,"Here, we show that murine fibrosarcoma-conditioned medium promoted total spleen cell proliferation but inhibited T cell responses to mitogenic and allo-antigen-mediated stimulation.",32661685_1,-1,-1,2,2,40383,-1,1.0993632e-05,5.8990813e-06,0.9999832
15770,cells,3,4,18,23,"In vivo dendritic cells (DC) targeting is an attractive approach with potential advantages in vaccine efficacy, cost, and availability.",21934655_0,-1,-1,2,2,15770,-1,1.993029e-05,5.9786357e-06,0.99997413
36393,Treg cells,14,16,86,96,"The aim of this study was to investigate the frequency of circulating CD4+CD25-Foxp3+ Treg cells and their role in NSCLC. Methods: The frequencies of Treg, T helper (Th)1, Th2, and Th17 cells in peripheral blood were separately measured in 36 NSCLC patients and 20 healthy controls (HCs) using flow cytometry.",30925076_2,-1,-1,2,2,36393,-1,1.2545254e-05,8.458782e-06,0.999979
18974,T cells,33,35,208,215,"Enhanced antitumor activity with combination therapy was associated with an increase in systemic NK cell and effector CD8(+) T-cell activation and IFN- production, as well as infiltration of effector CD8(+) T cells into the tumor.",23090488_4,-1,-1,2,2,18974,-1,1.12950875e-05,5.57273e-06,0.9999831
4904,subset,9,10,59,65,We found that a cross-reactive FoxP3 antibody identified a subset of CD4(+) T cells in blood and lymph nodes of dogs.,17224188_5,-1,-1,2,2,4904,-1,1.8309987e-05,1.0192549e-05,0.9999714
21087,cells,5,6,21,26,"The number of FoxP3+ cells was increased in a stepwise manner from CC to GA and GBC (GA versus CC, P = 0.036; early GBC versus GA, P = 0.032; advanced versus early GBC, P = 0.025).",24007242_3,-1,-1,2,2,21087,-1,1.42653935e-05,8.649462e-06,0.999977
6112,cells,15,16,92,97,"Mast cells lacking JunB display a normal in vivo maturation, and JunB-deficient bone marrow cells in vitro differentiated to mast cells show no alterations in proliferation or apoptosis.",17982078_4,-1,-1,2,2,6112,-1,1.6959748e-05,6.9560197e-06,0.99997616
24214,cells,1,2,7,12,"Cancer cells may escape from host immune responses through active suppression of the immune response, but the detailed mechanisms in colorectal cancer remain to be elucidated.",25034363_0,-1,-1,2,2,24214,-1,1.5149993e-05,6.9601397e-06,0.99997795
10695,cells,1,2,5,10,Such cells co-expressed different levels of Foxp3 and CTLA-4 that resulted in progressively lower systemic Foxp3/CTLA-4 memory T cell ratios that further correlated with disease-free survival.,19762283_6,-1,-1,2,2,10695,-1,1.3622319e-05,6.33426e-06,0.9999801
42452,T cells,7,9,40,47,STAT3 binding sites at PD-1 promoter in T cells were identified by chromatin immunoprecipitation assay.,34093869_5,-1,-1,2,2,42452,-1,9.9824165e-06,5.9567155e-06,0.999984
40258,cells,28,29,201,206,"Intrathymic differentiation of T-cell precursors in IL-10-/- mice and in vitro fetal thymic organ cultures revealed that IL-10 promotes the interaction between thymic stromal cells and Notch1low DN2-T cells, thus facilitating these DN2-T cells to differentiate toward CD45+CD11c+MHC-II+ thymic DCs as a consequence of activating the Ikaros/IRF8 signaling axis.",32582141_5,-1,-1,2,2,40258,-1,1.46560715e-05,8.819287e-06,0.9999765
5565,T cells,18,20,107,114,The induction of T(reg) cells in these PBMCs was determined by measuring the proportion of CD25(+)FOXP3(+) T cells in all CD4(+) T cells by flow cytometry.,17574040_4,-1,-1,2,2,5565,-1,9.331477e-06,5.262027e-06,0.99998546
13241,cells,12,13,71,76,We evaluated the tumor response and in vivo expansion of allogeneic NK cells in recurrent ovarian and breast cancer.,20849361_1,-1,-1,2,2,13241,-1,1.3789854e-05,8.582541e-06,0.9999776
27762,cell,28,29,194,198,"To test if this attenuated Treg formation and suppressive function translated into improved anticancer immunity, we inoculated HDAC5(-/-) mice and littermate controls with a lung adenocarcinoma cell line.",26704363_6,-1,-1,2,2,27762,-1,1.718443e-05,6.5829395e-06,0.9999763
19828,T cells,15,17,98,105,"It has been reported that the imbalance of T helper IL-17-producing cells (Th17 cells)/regulatory T cells (Tregs) was closely associated with advanced tumor growth and poor prognosis in lung cancer, but little is known about whether this imbalance is existed in the peripheral blood of patients with non-small cell lung cancer (NSCLC).",23335103_0,-1,-1,2,2,19828,-1,8.029529e-06,5.258046e-06,0.99998677
24195,T cells,8,10,56,63,Overexpression of A20 by retroviral transduction of CD8 T cells dampened their intratumor accumulation and antitumor activity.,25024217_6,-1,-1,2,2,24195,-1,9.917839e-06,5.504459e-06,0.9999846
37009,cells,13,14,72,77,More investigations are required to evaluate the potential of 4-1BBL+ B cells for use in immunotherapy.,31182685_10,-1,-1,2,2,37009,-1,1.5322516e-05,1.021054e-05,0.99997437
20903,regulatory T cells,12,15,100,118,Ovarian cancer is a prevalent gynecological malignancy with potent immune-suppression capabilities; regulatory T cells (Tregs) are significant contributors to this immune-suppression.,23948613_0,-1,-1,2,2,20903,-1,7.402166e-06,5.026189e-06,0.9999876
30287,cell,8,9,45,49,"Importantly, this pathway was activated in a cell cycle-specific manner.",27707838_11,-1,-1,2,2,30287,-1,4.5756355e-05,8.598479e-06,0.99994564
23237,cell,32,33,222,226,"Through experimental quantitation and computational modeling, we demonstrate that this scaling is enforced by an inhibitory cross-talk between antigen and IL-2 signaling, and a nonlinear acceleration of IL-2 secretion per cell.",24719192_4,-1,-1,2,2,23237,-1,3.8460632e-05,1.0034167e-05,0.9999515
28896,T cells,13,15,92,99,"The tumor microenvironment impacts tumor progression and individual cells, including CD4(+) T cells, which have been detected in bladder cancer tissues.",27196763_0,-1,-1,2,2,28896,-1,9.002699e-06,5.7267325e-06,0.9999852
20445,T cells,14,16,97,104,We found that RA significantly enhanced TGF--induced expression of Foxp3 on nave and committed T cells in vitro and that this was blocked by an antagonist of RAR (RARi).,23657628_5,-1,-1,2,2,20445,-1,1.0416338e-05,6.1436067e-06,0.99998343
14930,cells,9,10,70,75,We observed an attenuated antiproliferative effect even when melanoma cells and T cells in the coculture were separated using Transwell inserts.,21547596_7,-1,-1,2,2,14930,-1,1.2042904e-05,6.1343476e-06,0.9999819
21134,cells,22,23,161,166,We propose that low doses of RSV may also benefit humans by controlling cancer escape-promoting tBregs/Tregs without nonspecific inactivation of effector immune cells.,24043896_4,-1,-1,2,2,21134,-1,1.8961488e-05,7.149609e-06,0.9999739
28725,cell,9,10,66,70,"Accordingly, we developed a lymphoma progression model comprising cell lines established at indolent (MAC-1) and aggressive (MAC-2A) CTCL stages.",27144517_1,-1,-1,2,2,28725,-1,1.4487387e-05,6.644427e-06,0.9999788
6953,T lymphocyte activation,22,25,124,147,"Our experiments indicate that TIRC7, T cell immune response cDNA 7, a novel membrane molecule involved in the regulation of T lymphocyte activation, identifies two Treg subsets (CD25(low)TIRC7(+) and CD25(high)TIRC7(-)) that are characterized by the expression of Foxp3 and a suppressive activity in vitro and in vivo.",18424726_2,-1,-1,2,2,6953,-1,1.4669987e-05,7.757895e-06,0.9999776
29533,OX40L,9,10,61,66,"Notably, dectin-1 stimulation of DCs upregulates TNFSF15 and OX40L, which are essential for dectin-1-activated DC-induced Th9 cell priming.",27492902_4,-1,-1,2,2,29533,-1,0.0003465947,4.0610623e-05,0.99961275
21209,T cells,9,11,69,76,Flow cytometry revealed that the majority of intratumoral CD4Foxp3 T cells (Tregs) were Helios and expressed higher levels of cytotoxic T-lymphocyte antigen 4 (CTLA-4) and CD39 than Tregs from colon and blood.,24064667_1,-1,-1,2,2,21209,-1,8.472952e-06,6.6279295e-06,0.99998486
29266,cells,1,2,6,11,"NTeff cells appeared to have lower expression of Foxp1 and were refractory to apoptosis upon TGF- conditioning, implying better survival potential and resistance to tumor-induced immune suppression.",27306834_3,-1,-1,2,2,29266,-1,1.2494041e-05,7.835014e-06,0.9999796
40058,T cells,19,21,130,137,"However, stimulated CD25- Tfh cells could not upregulate Foxp3, indicating that the distinction between Foxp3-low CD25-CXCR5+CD4+ T cells and Foxp3-high CD25+CXCR5+CD4+ T cells was not due to differences in stimulation status.",32534760_6,-1,-1,2,2,40058,-1,9.788189e-06,5.4000334e-06,0.99998486
28692,CD54,17,18,117,121,"RESULTS: GIFT4-CLL up-regulated the expression of co-stimulatory molecules CD40, CD80 and CD86 and adhesion molecule CD54.",27118475_5,-1,-1,2,2,28692,-1,3.374518e-05,9.417095e-06,0.99995685
39224,regulatory T cells,13,16,66,84,"In particular, we discuss the role of TNFRs in the development of regulatory T cells during neuroinflammation and recent findings concerning targeting TNFR2 with agonistic and antagonistic reagents in various murine models of autoimmune and neuroinflammatory disorders and cancer.",32083339_3,-1,-1,2,2,39224,-1,9.417803e-06,6.2442955e-06,0.9999844
35638,cell,25,26,154,158,PURPOSE: Clinical responses with programmed death (PD-1) receptor-directed antibodies occur in about 20% of patients with advanced head and neck squamous cell cancer (HNSCCa).,30242022_0,-1,-1,2,2,35638,-1,1.4349384e-05,7.1788572e-06,0.99997854
17316,cells,19,20,97,102,"FOXP3(+) T cells were found in SCLC tumour biopsies, and patients with higher ratios of FOXP3(+) cells in tumour infiltrates have a worse survival rate.",22532287_6,-1,-1,2,2,17316,-1,1.2638564e-05,7.1600666e-06,0.9999802
16259,cells,14,15,103,108,Our previous studies have shown that DKK1 (peptide)-specific CTLs can effectively lyse primary myeloma cells in vitro.,22049519_1,-1,-1,2,2,16259,-1,1.3951228e-05,7.83268e-06,0.9999782
26320,Th1 cell,16,18,73,81,"In the present study, we mainly investigated the role of Th22, Th17, and Th1 cell and their related cytokines (IL-22, IL-17, and IFN-r) in the pathophysiology of CML.",26000313_1,-1,-1,2,2,26320,-1,1.119098e-05,1.1140687e-05,0.9999777
34445,T cells,14,16,90,97,"Studies with PIP-deficient (PIP-/-) mice demonstrated significantly lower numbers of CD4+ T cells in their secondary lymphoid organs, impaired Th1 response, and impaired nitric oxide (NO) production.",29536339_2,-1,-1,2,2,34445,-1,9.009789e-06,5.1574575e-06,0.9999858
3417,CD40L,0,1,0,5,CD40L stimulation of dendritic cells induces interleukin-12 expression that drives Th1 type of immune responses with activation of cytotoxic T cells.,16361570_1,-1,-1,2,2,3417,-1,7.457137e-05,9.501178e-06,0.99991584
29618,cellular,20,21,144,152,We here addressed the question whether specific T cells from HPV-vaccinated healthy volunteers could be especially suitable for an HPV-specific cellular immunotherapy.,27548034_4,-1,-1,2,2,29618,-1,1.5765243e-05,6.1283895e-06,0.9999782
972,T cell,65,67,332,338,"Mature DCs expressed significantly heightened levels of their antigen-presenting machinery (e.g., CD54, CD80, CD86) and numerous cytokines and chemokines/chemokine receptors (i.e., Flt-3L, G-CSF, IL-1alpha and -1beta, IL-6, IL-12, CCL-2, -3, -4, -5, -17, and -22, MIP-2, and CCR7) and were significantly better at inducing effector T cell responses in vitro.",11902830_1,-1,-1,2,2,972,-1,1.4536912e-05,8.088998e-06,0.99997735
9057,regulatory T cells,39,42,301,319,"Surprisingly, fludarabine also increased the relative percentage of CD4+ T cells expressing the regulatory protein Foxp3.CONCLUSIONS/SIGNIFICANCE: Lymphodepletion with fludarabine enhances transferred T cell persistence but suggest that additional improvements to optimize T cell survival and address regulatory T cells are critical in providing anti-tumor efficacy.",19270751_14,-1,-1,2,2,9057,-1,9.501376e-06,6.1893766e-06,0.99998426
21900,T cell,15,17,86,92,"We document human T lymphotropic virus type 1 (HTLV-1) bZIP factor (HBZ)-specific CD4 T cell responses in an adult T cell leukemia/lymphoma (ATL) patient after allogeneic hematopoietic stem cell transplantation (HCT) and identified a novel HLA-DRB1*15:01-restricted HBZ-derived naturally presented minimum epitope sequence, RRRAEKKAADVA (HBZ114-125).",24363428_0,-1,-1,2,2,21900,-1,8.59922e-06,4.550968e-06,0.9999869
16772,precursor,5,6,26,35,"IL-33 exists as a nuclear precursor and may act as an alarmin, when it is released after cell damage or as negative regulator of NFB gene transcription, when acts in an intracrine manner.",22392053_1,-1,-1,2,2,16772,-1,5.8208938e-05,3.637842e-05,0.99990547
8526,CD80,39,40,234,238,"CONCLUSION: H22-CD80/CD86/CD137L(+) induces higher NF-kappaB activity of the host T cells by synergistic action of CD28 and CD137, which may be one of the mechanisms of enhancement of the host CTL activity induced by co-expression of CD80, CD86 and CD137L genes.",19173904_9,-1,-1,2,2,8526,-1,3.63632e-05,7.466194e-06,0.99995613
8156,cells,37,38,177,182,"To eliminate cells with phenotypic markers of CSC-like we characterized: (1) expression of CD44, CD24, CD133 and MIC-A/B (NKG2 receptors) in breast (MCF7) and ovarian (SK-OV-3) cells resistant to gemcitabine (GEM), paclitaxel (PTX) and 5-fluorouracil (5-FU) and (2) their elimination by Numb- and Notch-peptide activated CTL.",19048252_1,-1,-1,2,2,8156,-1,1.1647234e-05,6.9854723e-06,0.9999813
1180,T cell development,12,15,77,95,These results establish a critical role for CnA beta signaling in regulating T cell development and activation in vivo.,12091710_8,-1,-1,2,2,1180,-1,3.8932525e-05,2.750457e-05,0.9999335
5653,T cells,25,27,137,144,"In the present study in B-cell non-Hodgkin lymphoma (NHL), we found that a subset of intratumoral but not peripheral blood CD4(+)CD25(-) T cells, comprising about 15% of intratumoral CD4(+) T cells, express Foxp3 and are capable of suppressing the proliferation of autologous infiltrating CD8(+) T cells.",17615291_2,-1,-1,2,2,5653,-1,8.888547e-06,4.5553516e-06,0.9999865
15834,CCR6,19,20,126,130,"These tumor-infiltrating Tregs could be selectively recruited though CCR6-CCL20 axis as illustrated by (a) high expression of CCR6 on circulating Tregs and their selective migration to CCR6 ligand CCL20, and (b) correlation of distribution and expression between tumor-infiltrating Tregs and intratumoral CCL20.",21935436_4,-1,-1,2,2,15834,-1,0.00023962946,6.220178e-05,0.99969816
39160,CTLA-4,33,34,186,192,"Moreover, we found that tumors from high-risk patients had higher relative abundance of T follicular helper cells, regulatory T cells, and M0 macrophages, and higher expression of PD-1, CTLA-4, LAG3, and CD47 than low-risk patients.",32028264_6,-1,-1,2,2,39160,-1,5.5370205e-05,1.2419925e-05,0.99993217
22170,cells,20,21,144,149,We investigated whether pretreating myeloma cells with a phosphor (p)-STAT3 inhibitor (JSI-124) and/or bortezomib before loading into dendritic cells (DCs) can affect DC function.,24407159_2,-1,-1,2,2,22170,-1,1.6426793e-05,6.4924166e-06,0.9999771
32902,cells,10,11,41,46,The peripheral Tregs and T helper (Th) 1 cells were analyzed by flow cytometry.,28731226_5,-1,-1,2,2,32902,-1,1.4488484e-05,7.137684e-06,0.9999783
10538,B7-DC,18,19,101,106,"The negative signal provided by interactions of programmed death-1 (PD-1) and its ligands, B7-H1 and B7-DC, has been suggested to play an important role in tumor evasion from host immunity.",19724910_0,-1,-1,2,2,10538,-1,4.9433555e-05,1.5697467e-05,0.9999348
21657,CTL,16,17,89,92,"As a result, DCs matured with OK-432 plus IFN- can prime stronger cytotoxic lymphocyte (CTL) and natural killer (NK) cell response against tumor cells in vitro.",24296809_5,-1,-1,2,2,21657,-1,2.0278898e-05,4.2144447e-06,0.99997556
20357,cell,6,7,35,39,We investigated the role of cancer cell NF-B activity in T cell-mediated antitumor responses.,23635779_1,-1,-1,2,2,20357,-1,1.16164665e-05,7.721692e-06,0.9999807
27009,cell,9,10,87,91,"However, EBVmix-specific cells most efficiently controlled EBV-infected lymphoblastoid cell lines (LCLs).",26276009_6,-1,-1,2,2,27009,-1,1.2968738e-05,8.054385e-06,0.9999789
25067,cells,39,40,249,254,The aim of this study was to investigate the role of Runx3 on the levels of transcription factors in patients with gastric carcinoma and analyze the relationship between the expression of Runx3 and Th1-type cytokines in peripheral blood mononuclear cells (PBMCs).,25270738_1,-1,-1,2,2,25067,-1,2.0163823e-05,8.200003e-06,0.9999716
36089,IL-32,2,3,16,21,Interleukin-32 (IL-32) was originally identified in natural killer (NK) cells activated by IL-2 in 1992.,30638183_0,-1,-1,2,2,36089,-1,0.047284435,0.0002751492,0.95244044
33346,Tcells,16,19,102,109,"Ultimately, mouse Apc deficiency reduces the presence of NFAT in the nucleus of intestinal regulatory Tcells (Tregs) and impairs Treg differentiation and the acquisition of a suppressive phenotype, which is characterized by the production of the anti-inflammatory cytokine IL-10.",28978472_4,-1,-1,2,2,33346,-1,8.285939e-06,5.952557e-06,0.9999857
36546,cells,32,33,181,186,"In this study, we analysed the localisation and regulation of IL-35 in the lung of patients with non-small cell lung cancer (NSCLC) to further elucidate the immune-escape of cancer cells in perioperative course of disease.",30956278_1,-1,-1,2,2,36546,-1,1.4213196e-05,5.8029e-06,0.99998
7592,cellular,13,14,93,101,"During disease progression, immunodeficiency develops; however, the underlying molecular and cellular mechanisms are not fully understood.",18769452_1,-1,-1,2,2,7592,-1,2.4274543e-05,7.1097397e-06,0.9999685
7416,Treg cells,14,16,73,83,"The current data, showing that the ability of mature DC to interact with Treg cells is predetermined at the stage of DC maturation, pave the way to preferentially target the regulatory versus proinflammatory T cells in autoimmunity and transplantation, as opposed to intracellular infections and cancer.",18632653_6,-1,-1,2,2,7416,-1,1.0256797e-05,7.979604e-06,0.99998176
8321,cells,11,12,67,72,Increased levels of naturally occurring regulatory T cells (T(Reg) cells) have been found in a variety of solid tumours and haematological malignancies.,19133978_0,-1,-1,2,2,8321,-1,1.33811545e-05,9.2731425e-06,0.99997735
14565,lymphocytic,16,17,110,121,T cell immune dysfunction has an important role in the profound immune suppression that characterizes chronic lymphocytic leukemia (CLL).,21377729_0,-1,-1,2,2,14565,-1,4.8227816e-05,8.378036e-06,0.9999434
34336,cell,11,12,78,82,"Conversely, administration of recombinant IL33 reduced growth of colon cancer cell allografts.",29463593_6,-1,-1,2,2,34336,-1,1.6050735e-05,5.81011e-06,0.99997807
37002,cells,9,10,40,45,"CONCLUSIONS: The frequency of 4-1BBL+ B cells significantly increased following a short time activation, and showed relative and significant associations with tumor grade and estrogen receptor status, respectively.",31182685_9,-1,-1,2,2,37002,-1,1.565737e-05,1.0391446e-05,0.999974
36506,cells,4,5,41,46,"We comprehensively characterized myeloid cells in tumor draining lymph nodes (tdLN) of mice and identified two subsets of conventional type-2 dendritic cells (cDC2) that traffic from tumor to tdLN and present tumor-derived antigens to CD4+ Tconv, but then fail to support antitumor CD4+ Tconv differentiation.",30955881_1,-1,-1,2,2,36506,-1,1.6748414e-05,6.4865108e-06,0.9999769
30461,cells,14,15,85,90,The expression of ICOS in Foxp3+ cells was closely related to plasmacytoid dendritic cells (pDCs) and their expression of ICOS-L and TLR9 as well as Helicobacter pylori infection.,27756099_6,-1,-1,2,2,30461,-1,1.7126811e-05,7.1693266e-06,0.9999757
9119,cells,6,7,45,50,"Sequential frequencies of circulating T(reg) cells, Th17 cells, NK and NKT cells were measured in peripheral blood of breast cancer patients and normal controls throughout therapy.",19277040_2,-1,-1,2,2,9119,-1,1.3740655e-05,8.492437e-06,0.9999778
29999,Cells,0,1,0,5,"Cells were stimulated in vitro and stained with CD25, CD4, FoxP3, IFN-, IL-10, and IL-2 or isotype matched antibodies and subjected to flow cytometry.",27619682_4,-1,-1,2,2,29999,-1,1.1641973e-05,8.669247e-06,0.9999796
3182,cells,15,16,105,110,"Thus, only CD62L expression could distinguish regulatory CD4(+)CD25(+) cells from effector CD4(+)CD25(+) cells in draining LNs as a surface marker.",16210609_7,-1,-1,2,2,3182,-1,1.554848e-05,7.54667e-06,0.999977
3114,T cells,32,34,215,222,Our experiments indicate that the accumulation of CD4+CD25+ regulatory T cells (T reg cells) expressing FoxP3 and exhibiting immunosuppressive function originates from the proliferation of naturally occurring CD25+ T cells and requires signaling through transforming growth factor (TGF)-beta receptor II.,16186184_1,-1,-1,2,2,3114,-1,8.562938e-06,4.9825144e-06,0.9999864
11125,T lymphocytes,8,10,80,93,Combination therapy increased the frequency of interferon (IFN)-gamma-producing T lymphocytes specific to a CT-26-associated class I-binding tumor peptide in the tumor-draining lymph nodes.,19940990_5,-1,-1,2,2,11125,-1,8.67378e-06,6.6632615e-06,0.9999846
20861,cells,4,5,32,37,Increased recruitment of immune cells into tumors and suppression of the immune suppressive tumor environment are critical components toward effective cancer immunotherapies.,23922012_1,-1,-1,2,2,20861,-1,2.1222817e-05,5.902323e-06,0.9999728
30847,T lymphocytes,8,10,47,60,"We also identified a subset of CD8+PD-1+FOXP3+ T lymphocytes at the earliest phase of functional differentiation after priming, termed ""early effector cells"" (EEC), which also exhibited an activated nonexhausted phenotype, but was less differentiated and associated with coexpression of multiple inhibitory receptors.",27979840_4,-1,-1,2,2,30847,-1,9.599161e-06,5.6332046e-06,0.99998474
21115,regulatory T cells,28,31,197,215,We reported previously that tumor-evoked regulatory B cells (tBregs) play an essential role in breast cancer lung metastasis by inducing TGF--dependent conversion of metastasis-promoting Foxp3(+) regulatory T cells (Tregs).,24043896_0,-1,-1,2,2,21115,-1,9.28039e-06,6.441809e-06,0.99998426
9875,T cells,22,24,111,118,"At tumor site, impaired STAT activation in T cells did not correlate with frequency of CD4(+) CD25(+) Foxp3(+) T cells.",19509154_7,-1,-1,2,2,9875,-1,8.971292e-06,5.2324594e-06,0.9999858
24812,NKT cells,1,3,16,25,"CD1d-restricted NKT cells represent a unique lineage of immunoregulatory T cells that are divided into two groups, type I and type II, based on their TCR usage. Because there are no specific tools to identify type II NKT cells, little is known about their developmental requirements and functional regulation.",25236978_0,-1,-1,2,2,24812,-1,2.7515482e-05,4.655842e-05,0.99992585
14697,IL-32,4,5,25,31,The inhibitory effect of IL-32 on tumor growth was associated with the inhibition of constitutive activated nuclear transcription factor-B (NF-B) and of signal transducer and activator of transcription 3 (STAT3).,21423208_3,-1,-1,2,2,14697,-1,0.00038046303,6.952583e-05,0.99955004
35209,cytotoxic T cells,17,20,111,128,"Tumors that formed when KPC cells were injected along with p50-/- PSCs had increased infiltration by activated cytotoxic T cells along with decreased levels of CXCL12, compared with tumors grown from KPC cells injected along with control PSCs.",29909021_9,-1,-1,2,2,35209,-1,2.4266705e-05,6.7705255e-06,0.9999689
19133,cells,3,4,28,33,"The CCL2/LCN2-induced DCreg cells subsequently induce immunosuppressive CD4(+)FOXP3(+) Treg cells, and finally impair tumor-specific CTL induction.",23143679_7,-1,-1,2,2,19133,-1,1.0826985e-05,8.3653995e-06,0.9999808
16182,cells,4,5,36,41,"Canine peripheral blood mononuclear cells were isolated and enriched by labelling of CD25, and expansion of T(reg) was achieved by adding interleukin (IL)-2 for 1 week.",22041284_2,-1,-1,2,2,16182,-1,1.6536173e-05,6.5512904e-06,0.9999769
37396,cell,15,16,110,114,"Loss-of-function and gain-of-function studies were carried out to analyze the effects of CCL22 modulations on cell proliferation, migration, invasion, and tumorigenesis and the mechanism involved in the deregulation of CCL22.",31325403_3,-1,-1,2,2,37396,-1,1.7646968e-05,6.5709683e-06,0.9999758
41189,T cell,11,13,77,83,Silencing of SKIL inhibited malignant phenotypes of NSCLC cells and promoted T cell infiltration.,33268765_9,-1,-1,2,2,41189,-1,1.1812678e-05,6.19567e-06,0.999982
42979,CD4+ T cell,10,14,83,94,Treatment with endocrine therapy using the aromatase inhibitor letrozole increases CD4+ T cell infiltration into ER+ breast cancer tumours in immune competent mice.,34602068_10,-1,-1,2,2,42979,-1,2.0213049e-05,4.5375023e-06,0.9999752
28577,T cells,9,11,53,60,"Indeed, CRCs with abundant infiltration of FOXP3(lo) T cells showed significantly better prognosis than those with predominantly FOXP3(hi) Treg cell infiltration.",27111280_5,-1,-1,2,2,28577,-1,1.0852752e-05,6.956606e-06,0.99998224
42757,lymphocytes,6,7,36,47,"Additionally, in vitro treatment of lymphocytes with IL-2 or IL-15 elicited significantly (p < 0.001) phosphorylation of the STAT5 protein in NK, CD3 and CD8 lymphocytes, both from blood and ascites.",34359872_6,-1,-1,2,2,42757,-1,2.933262e-05,7.720877e-06,0.9999629
36447,cell,27,28,149,153,"MATERIALS AND METHODS: PDA samples from 36 patients were analyzed for PD-L1, vimentin, E-cadherin, and Snail expressions and for PDA cell and immune cell infiltration.",30927618_2,-1,-1,2,2,36447,-1,1.6522647e-05,5.58854e-06,0.9999778
5441,cells,25,26,123,128,"Our results demonstrated the following: (1) CD4+ CD25+ Foxp3+ surround epithelial tumor aggregates; (2) Immature dendritic cells (DCs) were abundant in the tumor microenvironment; (3) BCC showed increased expression of IL-4, IL-10, and CCL22 and increased expression of interferon-associated genes (IFI27, IRF1, IRF7, and G1P2) and IL-12/23, gene indicating a Th2 dominant microenvironment.",17508019_2,-1,-1,2,2,5441,-1,1.45247795e-05,6.6167295e-06,0.9999788
15469,T cells,5,7,28,35,"EXPERIMENTAL DESIGN: CD8(+) T cells isolated from tumor, adjacent normal skin, and peripheral blood of 17 HLA-A2(+) patients with advanced-stage melanoma were analyzed for their antigen specificity and effector function against melanocyte differentiation antigens MART-1, gp100, and tyrosinase by using HLA-A2/peptide tetramers and functional assays.",21750202_1,-1,-1,2,2,15469,-1,8.754772e-06,5.173943e-06,0.9999862
33511,cells,14,15,100,105,Increase in proportion and absolute counts of H-LAMs was detected with infiltration of inflammatory cells.,29030004_4,-1,-1,2,2,33511,-1,2.6314361e-05,5.0505746e-06,0.99996865
38059,lymphocytes,10,11,58,69,"In the tumor-associated lymph nodes (LNs) and circulating lymphocytes, however, granzyme B-expressing Treg cells were only scarcely found.",31669380_4,-1,-1,2,2,38059,-1,1.1798299e-05,7.2467524e-06,0.9999809
17181,cells,6,7,59,64,Human CD34(+) progenitor-derived Langerhans-type dendritic cells (LCs) are more potent stimulators of T-cell immunity against tumor and viral antigens in vitro than are monocyte-derived DCs (moDCs).,22510877_0,-1,-1,2,2,17181,-1,1.796817e-05,6.0388434e-06,0.9999759
32151,cells,26,27,170,175,"In a murine breast cancer model (MMTV-neu), IL-1R8-deficiency reduced tumor growth and metastasis and was associated with increased mobilization and activation of immune cells, such as NK cells and CD8+ T cells.",28533483_4,-1,-1,2,2,32151,-1,1.6642354e-05,6.7575793e-06,0.9999765
17875,cell,4,5,24,28,"CONCLUSION: In hepatoma cell lines, TLR4 may indirectly facilitate the recruitment of Tregs to the tumor site and promote intrahepatic metastasis through its interaction with macrophages.",22736917_7,-1,-1,2,2,17875,-1,2.6210526e-05,8.866537e-06,0.99996495
16884,cells,34,35,175,180,We determined two types of CD4+ CD127- T cells with comparable regulatory ability; one is CD25(high+) cells expressing FOXP3 (CD25(high+) FOXP3+ Tregs) and the other is CD25- cells without FOXP3- expression (CD25- FOXP3- cells).,22419479_7,-1,-1,2,2,16884,-1,1.4750272e-05,1.0451443e-05,0.9999747
18629,cytotoxic T lymphocytes,16,19,100,123,The evidence for their ability to act as natural adjuvant in the stimulation of specific anti-tumor cytotoxic T lymphocytes and in the induction of protective and therapeutic anti-tumor immunity is now overwhelming.,23000301_4,-1,-1,2,2,18629,-1,1.3598162e-05,5.4241723e-06,0.9999809
24279,cells,22,23,151,156,"Different cellular localization of OPN is associated with its distinct activities, being mainly secreted in tumor cells while intracellular in myeloid cells.",25035397_2,-1,-1,2,2,24279,-1,1.4279657e-05,6.01139e-06,0.99997973
15721,T cells,22,24,135,142,"Furthermore, we found that Smad4 deficiency attenuated TGF--mediated in vitro polarization of FoxP3+CD4+ T cells, but not IL-17A+CD4+ T cells, suggesting that the epithelial lesions may have arisen as a consequence of unchecked Th17 cell activity.",21881210_3,-1,-1,2,2,15721,-1,1.2196041e-05,6.3253888e-06,0.9999815
26563,T cells,28,30,197,204,"In this review, we overview the updated understanding on the exhausted T cells in cancer and their potential regulatory mechanisms and discuss current therapeutic interventions targeting exhausted T cells in clinical trials.",26086965_3,-1,-1,2,2,26563,-1,1.0090582e-05,5.9688327e-06,0.9999839
9920,cell,7,8,36,40,"Furthermore, the reversal of T(reg) cell activity by LPS or CpG-A resulted in an enhancement of IL-17-producing cells.",19509224_6,-1,-1,2,2,9920,-1,1.07542755e-05,8.897431e-06,0.99998033
3423,cytotoxic T cells,18,21,131,148,CD40L stimulation of dendritic cells induces interleukin-12 expression that drives Th1 type of immune responses with activation of cytotoxic T cells.,16361570_1,-1,-1,2,2,3423,-1,2.9528434e-05,6.941366e-06,0.9999635
9051,T cells,11,13,73,80,"Surprisingly, fludarabine also increased the relative percentage of CD4+ T cells expressing the regulatory protein Foxp3.CONCLUSIONS/SIGNIFICANCE: Lymphodepletion with fludarabine enhances transferred T cell persistence but suggest that additional improvements to optimize T cell survival and address regulatory T cells are critical in providing anti-tumor efficacy.",19270751_14,-1,-1,2,2,9051,-1,1.0000559e-05,5.021174e-06,0.999985
5809,T cells,24,26,203,210,Single-cell sorted CD4(+)CD25(high) T cells were tested for regulatory function by coculture with carboxyfluorescein diacetate succinimidyl ester-labeled and activated autologous CD4(+)CD25(-) responder T cells.,17671115_3,-1,-1,2,2,5809,-1,8.123464e-06,5.607331e-06,0.9999863
42490,Treg cells,10,12,56,66,We report that glutathione peroxidase 4 (Gpx4) prevents Treg cells from lipid peroxidation and ferroptosis in regulating immune homeostasis and antitumor immunity.,34133924_1,-1,-1,2,2,42490,-1,1.1822966e-05,1.0128171e-05,0.99997807
17324,Treg cells,33,35,195,205,"The inhibitory effect of SCLC tumour cells was not affected by blocking IL-10 receptor or TGF- signalling but was partially reversed by blocking IL-15, which is reported to be involved in human Treg cells induction.",22532287_7,-1,-1,2,2,17324,-1,1.3729125e-05,1.0554229e-05,0.9999757
18705,cytotoxic T lymphocyte,12,15,64,86,PURPOSE: To explore cancer stem cell susceptibility to a host's cytotoxic T lymphocyte (CTL)-mediated immune response.,23001491_0,-1,-1,2,2,18705,-1,1.2556101e-05,5.319225e-06,0.9999821
12201,cell,30,31,201,205,Therapeutic efficacy of the vaccines was associated with increased CD4(+) T and CD8(+) T-cell effector and memory responses and higher intratumoral CD8(+) T effector/CD4(+)CD25(+)Foxp3(+) T regulatory cell ratio.,20406989_6,-1,-1,2,2,12201,-1,1.2320004e-05,6.0875827e-06,0.99998164
18579,T cells,5,7,13,20,"FoxP3*, CD8* T cells correlated positively with progression-free interval and survival.",22996369_9,-1,-1,2,2,18579,-1,8.844357e-06,4.788924e-06,0.9999864
17011,cells,10,11,60,65,"IL-22 receptor (IL-22R) expression is limited to epithelial cells of the digestive organs, respiratory tract and skin.",22471280_1,-1,-1,2,2,17011,-1,1.3004383e-05,8.019649e-06,0.999979
3278,cells,24,25,162,167,JNK1-/- CD8+ T cells have an intrinsic defect in early IFN-gamma gene transcription and production after activation by either anti-CD3/anti-CD28 Abs or dendritic cells loaded with specific Ag in vitro.,16237070_4,-1,-1,2,2,3278,-1,1.3436564e-05,6.237771e-06,0.99998033
33340,Tcells,15,18,99,106,"We found that APC ensures Tcell receptor-triggered activation through Nuclear Factor of Activated Tcells (NFAT), since APC is necessary for NFAT's nuclear localization in a microtubule-dependent fashion and for NFAT-driven transcription leading to cytokine gene expression.",28978472_2,-1,-1,2,2,33340,-1,1.0302261e-05,5.439825e-06,0.99998426
38854,T cells,5,7,34,41,"Moreover, 2DG treatment prevented T cells from binding to galectin-3, a potent tumor Ag associated with T cell anergy.",31969386_5,-1,-1,2,2,38854,-1,1.0029498e-05,6.00961e-06,0.999984
26211,regulatory T-cells,42,44,251,269,"We found that DCs exposed to butyrate express the immunosuppressive enzymes indoleamine 2,3-dioxygenase 1 (IDO1) and aldehyde dehydrogenase 1A2 (Aldh1A2), promote conversion of naive T-cells into immunosuppressive forkhead box P3(+) (FoxP3(+)) Tregs (regulatory T-cells) and suppress conversion of naive T-cells into pro-inflammatory interferon (IFN)--producing cells.",25984582_4,-1,-1,2,2,26211,-1,1.2076627e-05,7.825131e-06,0.9999801
2250,cell,2,3,11,15,The killer cell lectin-like receptor G1 (KLRG1) is expressed in natural killer (NK) cells and effector memory alphabeta T cells.,15498816_0,-1,-1,2,2,2250,-1,1.5093002e-05,7.824824e-06,0.999977
36909,cellular,19,20,96,104,"Itch is expressed in most mammalian cell types, and, based on published data, it regulates many cellular pathways ranging from T cell differentiation to liver tumorigenesis.",31126634_1,-1,-1,2,2,36909,-1,2.0388063e-05,7.3085434e-06,0.99997234
40382,cell,11,12,80,84,"Here, we show that murine fibrosarcoma-conditioned medium promoted total spleen cell proliferation but inhibited T cell responses to mitogenic and allo-antigen-mediated stimulation.",32661685_1,-1,-1,2,2,40382,-1,1.1885575e-05,7.1811137e-06,0.9999809
7609,T cells,14,16,99,106,The malignant T cells produce interleukin-10 and TGF-beta and suppress the growth of non-malignant T cells.,18769452_5,-1,-1,2,2,7609,-1,1.0213288e-05,5.603785e-06,0.99998415
30597,cells,12,13,75,80,"Based on our hypothesis in which continuous exposure to asbestos of immune cells cause reduction of antitumor immunity, the decrease of natural killer cell killing activity with reduction of NKp46 activating receptor expression, inhibition of cytotoxic Tcell clonal expansion, reduced CXCR3 chemokine receptor expression and production of interferon- production in CD4+ Tcells were reported using cell line models, freshly isolated peripheral blood immune cells from health donors as well as asbestos exposed patients such as pleural plaque and mesothelioma.",27878235_1,-1,-1,2,2,30597,-1,1.4507176e-05,6.342541e-06,0.99997914
27968,cells,26,27,166,171,"Here, we focused on the role of interleukin (IL)-6/signal transducer and activator of transcription (STAT3) signaling cascade in immune regulation by human dendritic cells (DCs).",26759006_1,-1,-1,2,2,27968,-1,1.611099e-05,6.792383e-06,0.9999771
42874,cell,15,16,121,125,"CXCL10 induced cell proliferation, migration and epithelial-mesenchymal transition in MCF-7 and MDA-MB-231 breast cancer cell lines.",34504204_3,-1,-1,2,2,42874,-1,1.4326099e-05,6.188674e-06,0.9999795
7686,T cells,21,23,127,134,"We found that blood vessels in SCCs did not express E-selectin, and tumors contained few cutaneous lymphocyte antigen (CLA)(+) T cells, the cell type thought to provide cutaneous immunosurveillance.",18794336_1,-1,-1,2,2,7686,-1,8.23969e-06,5.2489663e-06,0.9999865
4211,T cells,20,22,125,132,"Intracellular cytokine staining revealed a high frequency of IL-10-secreting macrophages, dendritic cells, and CD4+ and CD8+ T cells infiltrating the tumor.",16818744_3,-1,-1,2,2,4211,-1,1.1203817e-05,5.325221e-06,0.99998343
13520,cells,11,12,84,89,CRC tissue-derived Foxp3+IL-17+ cells have the capacity to induce cancer-initiating cells.,20952660_11,-1,-1,2,2,13520,-1,1.3248379e-05,7.0257274e-06,0.99997973
13424,cells,12,13,78,83,"TGF- was determined as the major suppressive cytokine secreted by the immune cells of tumor-bearing animals, in addition, proliferation capacity of the T cells was diminished.",20883319_7,-1,-1,2,2,13424,-1,1.8967185e-05,6.1673286e-06,0.99997485
7874,T cells,9,11,47,54,"In contrast to the increasing number of CD4(+) T cells, CD8(+), CD3(-)CD56(+), CD3(+)CD56(+), and gammadeltaT cells were all found to be under-represented in tumor infiltrating lymphocytes.",18941744_2,-1,-1,2,2,7874,-1,9.234597e-06,5.59459e-06,0.9999852
17263,T cell,8,10,68,74,"Spleen cells of tumor-bearing mice had high CD4(+)CD25(+)regulatory T cell (CD4(+)CD25(+)T(reg)) ratio and high mRNA and proteins expression of Foxp3 and TIM-3, but in the BLTA and 5-FU group, CD4(+)CD25(+)T(reg) ratio degraded, with down regulation mRNA and proteins expression of Foxp3 and TIM-3.",22522606_10,-1,-1,2,2,17263,-1,8.75573e-06,5.408569e-06,0.99998593
22893,regulatory T cells,8,11,39,57,"Tumors can recruit, induce, and expand regulatory T cells (Tregs) to suppress antitumor immune responses for survival and progression.",24668348_0,-1,-1,2,2,22893,-1,8.20278e-06,4.8474744e-06,0.9999869
36328,cells,31,32,169,174,Our results indicate that niraparib treatment increases the activity of the type I (alpha) and type II (gamma) interferon pathways and enhances the infiltration of CD8+ cells and CD4+ cells in tumors.,30755715_3,-1,-1,2,2,36328,-1,1.7674112e-05,1.1535751e-05,0.9999708
36154,CD8+ T cell,17,21,119,130,"Altogether, this work provides evidence indicating that ex-vivo activation of the IRE1/XBP1 pathway in BMDCs enhances CD8+ T cell specific responses against tumor antigens.",30687308_4,-1,-1,2,2,36154,-1,1.39813965e-05,4.972026e-06,0.99998105
37355,cells,27,28,191,196,"Hydroxycitrate, spermidine, and alpha-lipoic acid, CRMs that target different metabolic enzymes, administered by aerosol, strongly reduced implantation of intravenously injected B16 melanoma cells without overt signs of toxicity, such as weight loss and changes in lung structure.",31321243_2,-1,-1,2,2,37355,-1,1.534012e-05,7.427638e-06,0.99997723
871,T cells,9,11,52,59,Data concerning the effects of 15-d-PGJ(2) on human T cells and immune regulation are sparse.,11801678_3,-1,-1,2,2,871,-1,1.1432009e-05,7.703298e-06,0.9999808
27709,CTL,14,15,72,75,"EBVaGCs are known to be accompanied by massive CD8(+) cytotoxic T cell (CTL) infiltration; however, adoptive cellular immunotherapy based on EBV-specific CD8(+) CTLs has been explored with limited success.",26673957_1,-1,-1,2,2,27709,-1,2.3955618e-05,5.322422e-06,0.9999707
42442,cells,10,11,66,71,"We have previously reported dysregulation of Rab37 in lung cancer cells, whereas the roles of Rab37 in tumor-infiltrating immune cells and cancer immunotherapy are unclear.",34093869_2,-1,-1,2,2,42442,-1,1.5336533e-05,7.558318e-06,0.9999771
20644,cells,4,5,37,42,Bone marrow-derived mesenchymal stem cells (BM-MSCs) play an important role in Helicobacter pylori-induced gastric carcinogenesis.,23777268_0,-1,-1,2,2,20644,-1,1.916901e-05,7.1872073e-06,0.99997365
14946,T cells,3,5,27,34,Conversion of conventional T cells into T regulatory cells (Tregs) has been proposed as a potential mechanism for Treg expansion in cancer.,21570917_0,-1,-1,2,2,14946,-1,8.360417e-06,4.9397645e-06,0.99998677
3890,T cells,27,29,148,155,"In addition, we showed that a chimeric anti-CCR4 monoclonal antibody (mAb) could deplete CCR4(+) T cells and inhibit the migration of CD4(+)CD25(+) T cells in vitro.",16740709_4,-1,-1,2,2,3890,-1,1.0458029e-05,5.663256e-06,0.9999838
36446,cell,24,25,133,137,"MATERIALS AND METHODS: PDA samples from 36 patients were analyzed for PD-L1, vimentin, E-cadherin, and Snail expressions and for PDA cell and immune cell infiltration.",30927618_2,-1,-1,2,2,36446,-1,1.2345765e-05,7.584586e-06,0.99998
24200,T cells,16,18,99,106,"In contrast, relief from the A20 brake in NF-B activation in adoptively transferred antitumor CD8 T cells led to improved control of melanoma growth.",25024217_7,-1,-1,2,2,24200,-1,1.0051611e-05,4.8277348e-06,0.9999852
15958,Treg cells,14,16,79,89,"In the lymph nodes of the tumor microenvironment and spleen, the proportion of Treg cells was significantly higher in the tumor-bearing mice.",21963624_4,-1,-1,2,2,15958,-1,1.0995275e-05,8.905951e-06,0.9999801
22872,T cells,35,37,217,224,"CD25 expression on DN T cells remained unchanged after stimulation, which indicates that the increase in the absolute number of DN T cells in thyroid autoimmunity was at the expense of inactivation of single-positive T cells.",24623740_8,-1,-1,2,2,22872,-1,9.794211e-06,5.493861e-06,0.99998474
41347,cell,5,6,34,38,"We detected cytotoxic, programmed cell death protein-1 (PD-1) and EOMES co-expressing CD4+ T cells in lymph nodes (LNs) of patients with chronic lymphocytic leukemia (CLL) or diffuse large B-cell lymphoma.",33526861_1,-1,-1,2,2,41347,-1,2.3047587e-05,7.0847877e-06,0.99996996
19986,cell,3,4,45,49,"Using multi-parameter fluorescence-activated cell sorting analysis, we quantified the cumulative frequency of regulatory T cells (Treg), exhausted CD4(+) helper T cells, and myeloid-derived suppressor cells (MDSC) to gain concurrent views on the overall level of immune dysfunction in these inoperable patients.",23423978_2,-1,-1,2,2,19986,-1,2.1008074e-05,8.090055e-06,0.9999709
16252,cells,9,10,48,53,"Dickkopf-1 (DKK1), broadly expressed in myeloma cells but highly restricted in normal tissues, together with its functional roles as an osteoblast formation inhibitor, may be an ideal target for immunotherapy in myeloma.",22049519_0,-1,-1,2,2,16252,-1,1.2403817e-05,6.6660077e-06,0.9999809
10026,Regulatory T cells,0,3,0,18,Regulatory T cells (Tregs) expressing TCRalphabeta play a critical role in the maintenance of the immune system homeostasis.,19539651_0,-1,-1,2,2,10026,-1,9.299347e-06,4.932322e-06,0.9999858
19212,Treg cells,1,3,4,14,CD8 Treg cells from 5 MM patients and 5 healthy donors were functionally evaluated using proliferation assays.,23152910_5,-1,-1,2,2,19212,-1,1.6490125e-05,1.2303063e-05,0.9999713
36472,cells,16,17,111,116,Tregs are decisive not only in the protection against destruction of own tissues by autoimmune immunocompetent cells but also in the immunological answer to developing cancers.,30944830_1,-1,-1,2,2,36472,-1,1.552269e-05,6.285739e-06,0.9999782
2338,CTLs,26,27,185,189,"However, CD154 treatment of carcinoma cells expressing proteasome-dependent but TAP-independent Ags from the EBV-encoded BRLF1 and BMLF1 failed to increase tumor cell lysis by specific CTLs.",15611226_5,-1,-1,2,2,2338,-1,1.6007278e-05,4.0239547e-06,0.99998
16292,T cells,15,17,87,94,"However, CD8+Foxp3+ regulatory T cells (Tcregs) and interleukin (IL)-17-producing CD8+ T cells (Tc17 cells) also derive from the CD8+ T cell lineage.",22051182_1,-1,-1,2,2,16292,-1,8.440103e-06,5.7691086e-06,0.9999858
14102,cell,26,27,170,174,"BACKGROUND: The importance of the malignant cell environment to its growth and survival is becoming increasingly apparent, with dynamic cross talk between the neoplastic cell, the leukocyte infiltrate and the stroma.",21291541_0,-1,-1,2,2,14102,-1,1.5277321e-05,6.014251e-06,0.9999788
22685,cells,26,27,192,197,"We suggest that nurse-like cells display features of immunosuppressive type 2 macrophages: higher hepatocyte growth factor levels, produced by leukemic or other microenvironmental surrounding cells, may cooperate to induce M2 polarization.",24561793_8,-1,-1,2,2,22685,-1,1.4299528e-05,7.802269e-06,0.99997795
34973,T cells,5,7,27,34,"Presence of cytotoxic CD8+ T cells (CTL) in tumor microenvironments (TME) is critical for the effectiveness of immune therapies and patients' outcome, whereas regulatory T(reg) cells promote cancer progression.",29853604_0,-1,-1,2,2,34973,-1,9.5226e-06,5.5351134e-06,0.999985
2687,cells,5,6,34,39,"Specifically, long-lived T memory cells were maintained dormant in nonlymphoid tissues by IL-18 in the absence of tumor antigen.",15833877_3,-1,-1,2,2,2687,-1,1.35780765e-05,8.3610375e-06,0.99997807
11242,T cells,25,27,154,161,"Interestingly, approximately 25% of CD4(+)CD25(-) T cells of PBMC from patients also expressed FoxP3 and, although these cells weakly suppress allogeneic T cells proliferative response, they inhibited IFN-gamma and induced IL-10 and TGF-beta secretion in these co-cultures.",20012605_7,-1,-1,2,2,11242,-1,1.4480941e-05,6.4292744e-06,0.99997914
33692,cells,7,8,59,64,The IFN-positive and granzyme B-positive CD8+ splenocyte cells were quantified by flow cytometry.,29112686_7,-1,-1,2,2,33692,-1,1.3785165e-05,9.129129e-06,0.999977
33705,cells,18,19,127,132,Splenocytes isolated from CpG+IRF-1-Exo-injected Hepa 1-6 tumour mice had increased IFN-positive and granzyme B-positive CD8+ cells after co-culturing with Hepa 1-6 cells as compared with MC38 cells.,29112686_12,-1,-1,2,2,33705,-1,1.3733011e-05,8.038633e-06,0.9999783
26482,cells,2,3,11,16,"Id2-kd N2a cells grew aggressively in immune-compromised hosts, thereby establishing the immunogenicity of these cells.",26079374_4,-1,-1,2,2,26482,-1,1.5338208e-05,7.0321476e-06,0.9999776
10617,intercellular adhesion molecule-1,19,22,162,195,The secreted mp28 prevented the IL-27-mediated signal transduction and activator of transcription 1 phosphorylation and subsequently inhibited the IL-27-mediated intercellular adhesion molecule-1 induction and interferon-gamma production in CD4(+) T cells.,19740343_4,-1,-1,2,2,10617,-1,0.00053130894,7.314027e-05,0.9993955
1105,CTLs,18,19,125,129,We have determined whether this immune evasion strategy can be manipulated to shield tumor-specific cytotoxic T lymphocytes (CTLs) from the inhibitory effects of tumor-derived TGF-beta.,11964281_2,-1,-1,2,2,1105,-1,1.9514471e-05,4.9014925e-06,0.99997556
40594,cells,30,31,186,191,"In this study, we explore immunomodulatory properties of EVs derived from antitumor vaccines expressing the TNFSF ligands 4-1BBL and OX40L, modulating immune response mediated by immune cells and eliminating tumors.",32939048_4,-1,-1,2,2,40594,-1,2.2105909e-05,5.716629e-06,0.9999722
31607,cell,12,13,71,75,"Moreover, grafted D2F2 tumor cells grew faster and intratumoral Foxp3+ cell accumulation was observed in these mice compared to sham-treated controls.",28332605_4,-1,-1,2,2,31607,-1,1.4692291e-05,6.6448947e-06,0.99997866
37983,cells,14,15,84,89,CONCLUSION: We suggest that CD4+CD25-FoxP3+ cells in patients with BC are exhausted cells with an intermediate phenotype between effector and regulatory cells.,31630080_7,-1,-1,2,2,37983,-1,1.2808316e-05,7.079781e-06,0.9999802
7204,cells,30,31,197,202,"To verify this hypothesis and develop the most effective dendritic cell vaccine against Ewing's sarcoma, we evaluated the antitumor efficacy of dendritic cell-Ewing's sarcoma hybrids and dendritic cells pulsed with other antigen-loading methods, including cell lysates and the characteristic EWS-FLI1 gene of Ewing's sarcoma, using an A673 cell line as a model.",18563501_1,-1,-1,2,2,7204,-1,1.544421e-05,5.191404e-06,0.99997926
6045,T cell,39,41,206,212,"A dual altered peptide ligand (APL), composed of the tandemly arranged two single amino acid analogs of two myasthenogenic peptides, p195-212 and p259-271, down-regulated in vitro and in vivo MG-associated T cell responses.",17956982_1,-1,-1,2,2,6045,-1,1.2399099e-05,5.6145896e-06,0.999982
15378,CTL,5,6,38,41,"Given that suppression of Ag-specific CTL responses can be induced in Ag-sensitized mice by UV irradiation, our results may imply that exposure to UV radiation during premalignant stage induces tumor-Ag specific Tr1 cells that mediate tumor-Ag specific immune suppression resulting in the promotion of tumor progression.",21710495_6,-1,-1,2,2,15378,-1,2.4836463e-05,5.41671e-06,0.99996984
257,CD154,16,17,88,93,"We have established that in some cases of CLL the malignant cells express both CD40 and CD154, and on the basis of those observations, proposed a model for CLL tumor growth due to CD40-CD154 interactions within and among the malignant cells, and for the occurrence of autoimmune syndromes in some cases of CLL.",11042507_2,-1,-1,2,2,257,-1,7.90891e-05,1.1176749e-05,0.99990964
24167,cell,30,31,198,202,"Furthermore, regulatory T cells and immunosuppressive IL-10 and TGF- cytokines were reduced in mice bearing STAT3-blocked HCC cells, suggesting that these factors may be involved in HCC-induced NK cell suppression.",25015826_6,-1,-1,2,2,24167,-1,1.0532114e-05,9.535465e-06,0.99998
5915,cells,4,5,16,21,"In contrast, BM cells without Mll-Een expression (EGFP(-)) showed normal DC differentiation and functions.",17895399_6,-1,-1,2,2,5915,-1,1.3487008e-05,8.912998e-06,0.9999776
23917,cells,27,28,183,188,"Intravaginal imiquimod deposition induced upregulation of CXCL9 and CXCL10 mRNA expression in the genital tract, which are produced in response to IFN receptor signaling and attract cells expressing their ligand, CXCR3.",24893628_4,-1,-1,2,2,23917,-1,1.3429443e-05,7.019183e-06,0.9999795
34593,CD8+ T cell,60,64,390,401,"Although the Tr1 cells from infected asymptomatic subjects were functionally more potent than those from uninfected healthy subjects, the Tr1 cells in cancer individuals demonstrated several functional impairments, such as reduced interleukin 10 (IL-10) expression, lower secretion of cytolytic factors including granzyme B and perforin, and lower capacity to suppress CD4+CD25- T cell and CD8+ T cell proliferation.",29625086_5,-1,-1,2,2,34593,-1,1.9336594e-05,5.7856296e-06,0.99997485
4358,cells,15,16,98,103,"Furthermore, gastric Treg expressed increased levels of l-selectin and CCR4, compared to non-Treg cells, suggesting that these receptors contribute to Treg recruitment.",16934529_5,-1,-1,2,2,4358,-1,9.945676e-06,8.40896e-06,0.99998164
40489,T cells,28,30,180,187,"Moreover, induction and activation of cDC1s by administration of FMS-like tyrosine kinase 3 ligand (Flt3L) and TLR/CD40 agonists augmented expansion of adoptively transferred CD8+ T cells, delayed tumor growth, and improved survival.",32848036_6,-1,-1,2,2,40489,-1,1.0386164e-05,5.228915e-06,0.9999844
40796,T cells,21,23,140,147,This study indicates that manipulating Egr2 and Egr3 expression would potentiate or alleviate the regulatory function of NK1.1- CD4+ NKG2D+ T cells and this strategy could be used in the therapy for patients with autoimmune diseases or tumor.,33011290_9,-1,-1,2,2,40796,-1,8.2977585e-06,4.4336743e-06,0.99998724
34059,cells,5,6,34,39,Notch1 expression in B16 melanoma cells inhibited the infiltration of CD8+ cytotoxic T lymphocytes and NK cells and reduced IFN- release in tumor tissue.,29301578_8,-1,-1,2,2,34059,-1,1.3049772e-05,7.5616663e-06,0.9999795
30881,Treg cells,13,15,95,105,"Furthermore, CCL5 was directly trans-activated by cancer-FOXP3 and promoted the recruitment of Treg cells from peripheral blood to the tumor site in vitro and in vivo.",27991933_6,-1,-1,2,2,30881,-1,1.2076874e-05,8.420313e-06,0.9999795
38293,cells,9,10,41,46,"Interestingly, the level of CD25+ Foxp3+ cells in circulating CD4+ T cells was positively correlated with the level of CD25+ Foxp3+ cells in CD4+ TILs, but the level of CD25+ Foxp3- cells in circulating CD4+ T cells was not associated with the level of CD25+ Foxp3- cells in CD4+ TILs.",31811667_9,-1,-1,2,2,38293,-1,1.3956086e-05,9.79722e-06,0.9999763
27201,cells,13,14,86,91,We detected an increase in Bregs producing IL-10 both in peripheral blood mononuclear cells (PBMCs) and in gastric tumors.,26378021_2,-1,-1,2,2,27201,-1,1.6647327e-05,7.507861e-06,0.9999758
35730,T cell-mediated,16,18,102,117,It remains unclear whether B cell lymphomas with MYD88 L265P mutation respond differently toward CD8+ T cell-mediated cytotoxicity.,30253331_2,-1,-1,2,2,35730,-1,1.36040735e-05,6.6897287e-06,0.99997973
24420,cells,10,11,79,84,"Understanding the signaling that governs the immunogenicity of human dendritic cells (DCs) is a prerequisite for improving DC-based therapeutic vaccination strategies, in which the ability of DCs to induce robust and lasting Ag-specific CTL responses is of critical importance.",25100611_0,-1,-1,2,2,24420,-1,1.8989722e-05,6.9726498e-06,0.99997413
14213,T cells,8,10,31,38,Less than 1% Foxp3(+) IL-17(+) T cells in isolated CD4(+) T cells in both Eca patients and healthy controls.,21314287_9,-1,-1,2,2,14213,-1,1.1801562e-05,6.306394e-06,0.9999819
263,cells,42,43,235,240,"We have established that in some cases of CLL the malignant cells express both CD40 and CD154, and on the basis of those observations, proposed a model for CLL tumor growth due to CD40-CD154 interactions within and among the malignant cells, and for the occurrence of autoimmune syndromes in some cases of CLL.",11042507_2,-1,-1,2,2,263,-1,1.4869698e-05,6.0179195e-06,0.99997914
7201,cell,10,11,67,71,"To verify this hypothesis and develop the most effective dendritic cell vaccine against Ewing's sarcoma, we evaluated the antitumor efficacy of dendritic cell-Ewing's sarcoma hybrids and dendritic cells pulsed with other antigen-loading methods, including cell lysates and the characteristic EWS-FLI1 gene of Ewing's sarcoma, using an A673 cell line as a model.",18563501_1,-1,-1,2,2,7201,-1,1.6050408e-05,5.403394e-06,0.99997854
42508,Treg cells,11,13,70,80,Our studies establish a crucial role for Gpx4 in protecting activated Treg cells from lipid peroxidation and ferroptosis and offer a potential therapeutic strategy to improve cancer treatment.,34133924_7,-1,-1,2,2,42508,-1,1.0254016e-05,8.3411e-06,0.9999814
6692,cell,11,12,86,90,"Single intraperitoneal administration of 4 mg/kg resveratrol suppressed the CD4+CD25+ cell population among CD4+ cells and downregulated secretion of TGF-beta, an immunosuppressive cytokine, measured from the spleens of tumor-bearing mice.",18328445_5,-1,-1,2,2,6692,-1,1.2881832e-05,9.518987e-06,0.9999776
36635,subset,12,13,64,70,"BACKGROUND: Chemotherapy with Docetaxel (Doc) is efficient in a subset of prostate cancer (PCa) cases; however, most patients ultimately develop resistance to Docetaxel.",31018021_0,-1,-1,2,2,36635,-1,2.1332671e-05,1.28200345e-05,0.9999658
5543,T lymphocytes,15,17,105,118,These data provide novel insights into control mechanisms governing the functional activity of human CD8 T lymphocytes via T-box transcription factors in cancer.,17566017_9,-1,-1,2,2,5543,-1,9.2265755e-06,6.8123527e-06,0.999984
5199,T cells,33,35,204,211,"Here, we demonstrate that interleukin-2 (IL-2) induces FOXP3 expression in OKT3-stimulated or antigen-stimulated CD8 T cells, indicating that FOXP3 expression is neither limited to a unique subset of CD8 T cells nor dependent on the mode of T-cell receptor stimulation.",17414320_2,-1,-1,2,2,5199,-1,9.199948e-06,6.2154404e-06,0.9999846
38785,T cells,11,13,51,58,"Moreover, the presence of IL21+ and IL26+ positive T cells was associated with poor prognosis.",31948053_3,-1,-1,2,2,38785,-1,1.1919757e-05,7.760114e-06,0.99998033
10088,CD4+ T cell,27,31,164,175,"Immune tolerance consistently blunts the generated immune response, and the largely solitary focus on CD8+ T cell immunity has proven ineffective in the absence of CD4+ T cell help.",19561540_1,-1,-1,2,2,10088,-1,2.399035e-05,5.2914334e-06,0.9999708
11490,cell,7,8,57,61,We hypothesize that prevention of tumor-induced effector cell dysfunction is a major mechanism contributing to the efficacy of combined chemoimmunotherapy.,20118405_8,-1,-1,2,2,11490,-1,1.2049688e-05,9.450723e-06,0.99997854
5790,cells,30,31,210,215,These data directly implicate RS cell Gal1 in the development and maintenance of an immunosuppressive Th2/Treg-skewed microenvironment in cHL and provide the molecular basis for selective Gal1 expression in RS cells.,17670934_5,-1,-1,2,2,5790,-1,1.1925493e-05,8.271395e-06,0.99997985
14677,T cells,19,21,127,134,"In addition, the preferential development of ex-Tregs in mLN was significantly impaired by cotransfer of HY-specific naive CD4 T cells.",21389255_6,-1,-1,2,2,14677,-1,9.437115e-06,5.160713e-06,0.99998546
36583,regulatory T-cells,12,14,71,89,RESEARCH QUESTION: Is there any relationship between numbers of FOXP3+ regulatory T-cells (Treg) and occurrence of peritoneal lesions in women with ovarian endometrioma and dermoid cysts?DESIGN: Retrospective and prospective case-controlled cohort study.,30981619_0,-1,-1,2,2,36583,-1,1.0627361e-05,7.4300115e-06,0.999982
35994,CCL1,16,17,105,109,METHODS: One hundred ninety-nine tissue samples of patients with invasive breast cancer were stained for CCL1 and CCL22 by immunohistochemistry.,30572845_3,-1,-1,2,2,35994,-1,0.009413688,0.00042303043,0.9901633
34698,cell,14,15,79,83,"In this study, we investigated the influence of the TKI pazopanib on dendritic cell (DC) performance and immune priming.",29700053_3,-1,-1,2,2,34698,-1,1.79819e-05,6.022091e-06,0.9999759
2562,CD8+ T lymphocyte,8,12,66,83,"NKT-mediated anti-tumor activity was associated increased NKT and CD8+ T lymphocyte numbers, increased expression of STAT4, a marker for IL-12 activity and elevated serum levels of the proinflammatory cytokines IFNgamma and IL12, and of IL4.",15688366_13,-1,-1,2,2,2562,-1,1.1063828e-05,5.609876e-06,0.9999833
6744,T cell,19,21,132,138,"In contrast, tumor necrosis-inducing treatments that are shown to improve survival rate can shift the Th1/TGF-beta-producing CD4(+) T cell balance in favor of Th1 responses.",18354237_6,-1,-1,2,2,6744,-1,1.0208058e-05,5.747588e-06,0.999984
5294,T cells,13,15,61,68,"To determine the link between breast cancer, DCs, and CD4(+) T cells, we implanted human breast cancer cell lines in nonobese diabetic/LtSz-scid/scid beta2 microglobulin-deficient mice engrafted with human CD34(+) hematopoietic progenitor cells and autologous T cells.",17438063_4,-1,-1,2,2,5294,-1,9.611998e-06,5.2337186e-06,0.9999851
43007,lymphocytes,15,16,117,128,Tumor immune composition determined by deconvolution analysis revealed significant increases in M0 macrophages and B lymphocytes in both I2 groups.,34680134_4,-1,-1,2,2,43007,-1,1.4179034e-05,8.992258e-06,0.9999769
8039,subset,37,38,232,238,Lenalidomide (Revlimid; CC-5013) and pomalidomide (CC-4047) are IMiDs proprietary drugs having immunomodulatory properties that have both shown activity in cancer clinical trials; lenalidomide is approved in the United States for a subset of MDS patients and for treatment of patients with multiple myeloma when used in combination with dexamethasone.,19009291_0,-1,-1,2,2,8039,-1,2.5852265e-05,9.488964e-06,0.9999646
43502,cells,12,13,70,75,"Thus, the stimulation of AP-1-mediated gene expression by IL-1 in EL4 cells is due to the promotion of Jun B protein accumulation that, in turn, facilitates Jun B heterodimerization with TPA-induced Fra-1 protein, thereby forming an active AP-1 complex.",7675040_8,-1,-1,2,2,43502,-1,1.2300286e-05,1.051363e-05,0.99997723
41311,Th1 cells,32,34,195,204,"We also showed, in both mice and humans, that the IRF1 alternative isoform altered the full-length IRF1 transcriptional activity on the Il12rb1 promoter, resulting in decreased IFN secretion in Th1 cells.",33419764_5,-1,-1,2,2,41311,-1,1.7101998e-05,1.5096735e-05,0.9999678
21720,T cells,42,44,237,244,"High intratumoral FoxP3(+) Tregs with high peritumoral IL-17(+) T cells showed a significantly lower survival rate compared with other groups (OS, P < 0.001 and DFS, P < 0.001).CONCLUSION: Our findings suggest that intrahepatic IL-17(+) T cells and FoxP3(+) Tregs may cooperate to promote the progression of HCC.",24303990_8,-1,-1,2,2,21720,-1,1.3536968e-05,6.8539107e-06,0.9999796
33485,cytotoxic T lymphocyte,20,23,144,166,"Importantly, deletion of IL-27 receptor WSX-1 in tristetraprolin-deficient mice (WSX-1/tristetraprolin double knockout) leads to a reduction in cytotoxic T lymphocyte numbers.",29021521_5,-1,-1,2,2,33485,-1,2.5749485e-05,6.9106454e-06,0.99996734
856,T-cell activation,24,26,127,144,"CIITA may be a key target to modulate MHC class II expression, which could augment immunogenicity, Ag presentation, and CD4(+) T-cell activation in MG therapy.",11746775_7,-1,-1,2,2,856,-1,1.327156e-05,5.968774e-06,0.9999808
36809,T cells,19,21,113,120,"DISCUSSION: Collectively, our study is the first to investigate the suppressive function of FOXA1+ Tregs against T cells in lung cancer, and the results showed that FOXA1+ Tregs are markers of poor treatment responses in lung cancer patients.",31036318_14,-1,-1,2,2,36809,-1,9.8756445e-06,6.126608e-06,0.999984
33732,T cells,30,32,166,173,"In addition, STAT3-blocked whole HCC cell lysates stimulated the activation of T cells and natural killer (NK) cells, and enhanced the infiltration of cytotoxic CD8+ T cells in the tumor tissues.",29115974_3,-1,-1,2,2,33732,-1,9.276127e-06,5.404049e-06,0.99998534
11279,subsets,1,2,6,13,Other subsets of macrophages (CD14(+)CD163(-)) were occasionally detected.,20013807_5,-1,-1,2,2,11279,-1,8.237658e-05,1.1356011e-05,0.9999063
4815,cells,7,8,52,57,"Depletion of Treg from peripheral blood mononuclear cells (PBMC) of CRC patients unmasked CD4(+) T cell responses, as observed by IFNgamma release, to the tumor associated antigen 5T4, whereas no effect was observed in a healthy age-matched control group.",17205133_5,-1,-1,2,2,4815,-1,1.7464621e-05,7.812294e-06,0.9999746
24644,cell,11,12,78,82,"Using the diethylnitrosamine (DEN)-induced rat liver tumor model and in vitro cell experiments, the percentage of CD4(+)CD25(+)Treg/CD4(+) cells in the blood and the expressions of Foxp3(+), IL-10, TGF-, and cytotoxic T lymphocyte-associated antigen-4(CTLA-4) in spleen and liver tumors significantly decreased after LDR of the spleen in rats with liver cancer.",25168696_4,-1,-1,2,2,24644,-1,1.48182635e-05,7.35553e-06,0.9999778
3673,cells,19,20,96,101,"There was a massive influx of CD4+ and CD8+ T-lymphocytes and macrophages, but not of dendritic cells, in human mesothelioma biopsies.",16540497_6,-1,-1,2,2,3673,-1,1.6721851e-05,5.847656e-06,0.99997747
2827,T cells,7,9,28,35,"In a manner similar to CD4+ T cells, IL-27 activated STAT1, -2, -3, -4, and -5, and augmented the expression of T-bet, IL-12Rbeta2, and granzyme B, and slightly that of perforin in naive CD8+ T cells stimulated with anti-CD3.",16034109_3,-1,-1,2,2,2827,-1,8.798021e-06,5.611066e-06,0.9999856
25590,cells,23,24,160,165,"The expression of the transcription factor T-bet in peripheral blood CLL cells significantly correlated with CD38 expression, and transient transfection of CLL cells with T-bet resulted in T-bet(hi)CD38(hi) cells.",25505279_5,-1,-1,2,2,25590,-1,1.2006117e-05,7.855218e-06,0.9999801
3415,CD40L,26,27,159,164,PURPOSE: The aim of this study was to develop an immunostimulating gene therapy for the treatment of orthotopic bladder carcinoma by transferring the gene for CD40L into the tumor site.,16361570_0,-1,-1,2,2,3415,-1,6.121452e-05,7.414473e-06,0.99993134
29426,T cells,31,33,181,188,"BACKGROUND: Regulatory T cells (Tregs), particularly the CD4(+)CD25(+)Foxp3(+) Tregs, down regulate immunity and promote tumor cell growth by directly suppressing CD8(+) and CD4(+) T cells.",27389040_0,-1,-1,2,2,29426,-1,8.570959e-06,5.2017876e-06,0.9999862
19929,T cells,20,22,101,108,"Here, we report that the Notch pathway has an important role in both these processes in human CD8(+) T cells.",23380742_2,-1,-1,2,2,19929,-1,9.124861e-06,6.497059e-06,0.99998426
16551,cells,32,33,199,204,Higher frequencies of T-cell receptor excision circles in nave T(reg) cells indicate IL-2 dependent thymic generation of nave T(reg) cells as a mechanism leading to increased frequencies of T(reg) cells post IL-2 treatment in cancer patients.,22276195_6,-1,-1,2,2,16551,-1,1.3396353e-05,7.960523e-06,0.99997866
2649,cell,7,8,61,65,Regulatory T cells were identified by fluorescence-activated cell sorting using a panel of antibodies and by real-time PCR analysis for Foxp3 expression.,15781662_5,-1,-1,2,2,2649,-1,1.9104036e-05,8.446085e-06,0.99997246
26844,cytotoxic T lymphocytes,19,22,133,156,"As compared with Stat3-sufficient control tumors, Stat3(-/-) cancer cells exhibited an increased infiltration by dendritic cells and cytotoxic T lymphocytes after chemotherapy.",26208907_3,-1,-1,2,2,26844,-1,2.5741332e-05,6.8816494e-06,0.99996734
416,T cell,10,12,60,66,IL-15 mRNA levels are increased in diseases caused by human T cell lymphotropic virus type I (HTLV-I).,11160322_0,-1,-1,2,2,416,-1,1.2593672e-05,8.21258e-06,0.99997914
25746,cell,3,4,17,21,"In oral squamous cell carcinoma (OSCC) cell lines and cancer tissues, we found that 14-3-3 is overexpressed.",25556369_3,-1,-1,2,2,25746,-1,1.6756714e-05,7.768873e-06,0.99997544
13492,T cells,3,5,22,29,"Abundant Foxp3+IL-17+ T cells were detected in CRC tissue that expresses high levels of TGF-, CXCR3, CCR6, and RORt.",20952660_7,-1,-1,2,2,13492,-1,1.5001036e-05,7.741123e-06,0.99997723
17008,cells,24,25,141,146,Interleukin (IL)-22 is a cytokine involved in inflammatory and wound healing processes that is secreted primarily by T helper type 17 (Th17) cells.,22471280_0,-1,-1,2,2,17008,-1,1.2880505e-05,9.54192e-06,0.9999776
8857,cells,16,17,114,119,These strategies are hampered by the lack of efficient and economical large-scale production methods for effector cells.,19240181_1,-1,-1,2,2,8857,-1,1.2732975e-05,9.041215e-06,0.9999782
33740,T cell,22,24,135,141,"Furthermore, secondary immune responses could be primed as soon as these immunized mice were challenged with HCC cells, accompanied by T cell and NK cell activation and infiltration.",29115974_5,-1,-1,2,2,33740,-1,9.690479e-06,6.4742585e-06,0.9999839
7429,cell,2,3,14,18,"Whereas seven cell lines representing a spectrum of primary cutaneous T cell lymphoproliferative disorders expressed CD25 and TGF-beta, the expression of FOXP3 and, to a lesser degree, IL-10 was restricted to two CTCL cell lines that are dependent on exogenous IL-2.",18684941_1,-1,-1,2,2,7429,-1,1.2630015e-05,6.685538e-06,0.9999807
18709,cell,12,13,78,82,METHODS: We compared the susceptibility of putative CSC generated from cancer cell lines to immunologic recognition and killing by alloantigen-specific CD8(+) CTL.,23001491_1,-1,-1,2,2,18709,-1,1.6229087e-05,6.500559e-06,0.99997723
29282,Tcells,15,18,108,115,"In this study, we investigated metabolic mechanisms underlying the differentiation of IL-9-producing CD4(+) Tcells (Th9) in allergic airway inflammation and cancerous tumors.",27317260_1,-1,-1,2,2,29282,-1,1.1023199e-05,6.4076467e-06,0.9999826
10537,B7-H1,16,17,91,96,"The negative signal provided by interactions of programmed death-1 (PD-1) and its ligands, B7-H1 and B7-DC, has been suggested to play an important role in tumor evasion from host immunity.",19724910_0,-1,-1,2,2,10537,-1,2.1855505e-05,1.3163779e-05,0.9999651
5576,cells,7,8,34,39,The expression of FOXP3 in T(reg) cells from PBMCs exposed to MCM increased over time by MFI and Western blot but was not significantly different than those exposed to control media.,17574040_7,-1,-1,2,2,5576,-1,1.3171352e-05,9.322891e-06,0.9999776
38069,Treg cells,11,13,71,81,"Interestingly, granzyme B expression was highly concentrated in TIM-3+ Treg cells, a Treg subset previously shown to be enriched in the tumor microenvironment and presented increased suppressive capacity.",31669380_7,-1,-1,2,2,38069,-1,1.0719803e-05,1.1433327e-05,0.9999778
24043,T cells,36,38,228,235,"Here, we show that SA isolates from involved skin express staphylococcal enterotoxins (SEs) that induce crosstalk between malignant and benign T cells leading to Stat3-mediated interleukin-10 (IL-10) production by the malignant T cells.",24957145_2,-1,-1,2,2,24043,-1,1.1539966e-05,6.1034566e-06,0.99998236
35332,Tcells,16,19,113,120,"TCR-mediated Malt1 proteolytic activity and self-cleavage was found to drive Il2 expression in conventional CD4+ Tcells, thereby regulating Il2 availability for Treg homeostasis.",30025160_5,-1,-1,2,2,35332,-1,8.992539e-06,5.805958e-06,0.9999852
19922,cells,1,2,10,15,Dendritic cells (DCs) provide important signals to promote naive CD8(+) T cell priming and activation of effector T cells.,23380742_1,-1,-1,2,2,19922,-1,2.1026503e-05,6.8532063e-06,0.9999722
42686,T cell,5,7,34,40,"However, the mechanism underlying T cell dysfunction and its reversal remains unclear.",34237654_1,-1,-1,2,2,42686,-1,1.0442097e-05,7.2531366e-06,0.99998224
11056,T cells,0,2,0,7,"T cells were functionally characterized by antigen-dependent secretion of interferon (IFN)-gamma, interleukin (Il)-4, and IL-10, which indicate type 1, type 2, or regulatory T-cell responses, respectively.",19931255_3,-1,-1,2,2,11056,-1,1.3594828e-05,6.504836e-06,0.99997985
25927,cell,28,29,201,205,"This contrasts with the correlations described in squamous cell carcinoma, suggesting that the local immune response in cervical adenocarcinoma contributes differently to tumor growth than in squamous cell carcinoma.",25795131_11,-1,-1,2,2,25927,-1,1.6126152e-05,7.5120765e-06,0.9999764
36730,cell,14,15,92,96,"Patients with high levels of IL-6 had significantly more Treg cells and elevated Programmed cell death protein-1 (PD-1) expression on CD4+, CD8+, Treg, and Th17 cells.",31027698_6,-1,-1,2,2,36730,-1,1.8056284e-05,7.4160885e-06,0.9999746
1347,CTL-resistant,36,37,229,242,"Here we demonstrate that CD4(+) T cells that recognize a secreted tumor-specific antigen and exhibit a cytokine secretion profile characteristic of Th2 cells, are capable of clearing established lung and visceral metastases of a CTL-resistant melanoma.",12566422_2,-1,-1,2,2,1347,-1,9.995488e-05,3.2676304e-05,0.9998673
17938,cells,24,25,200,205,Prophylactic administration of breast cancer cells transfected with Stat3Y705F (Stat3Y705F-breast cancer cells) inhibited primary tumor growth compared with administration of empty vector-transfected cells in both models.,22753933_4,-1,-1,2,2,17938,-1,1.1182203e-05,7.014033e-06,0.99998176
42844,T cell,13,15,62,68,"The protective effect of PBC was relying on type 1 and type 2 T cell responses and, to a lesser extent, on B cells.",34495298_6,-1,-1,2,2,42844,-1,1.2705888e-05,6.200499e-06,0.99998105
3614,cell-conditioned,9,10,61,77,We induced rat peritoneal macrophages with rat breast cancer cell-conditioned medium and analyzed signal transducer and activators of transcription 3 (Stat3) activities of the cells.,16530087_2,-1,-1,2,2,3614,-1,0.00022671802,2.0053994e-05,0.9997533
182,T-cell precursor,7,9,54,70,The relation between HPV 16-specific memory cytotoxic T-cell precursor (mCTLp) activity to both oncoproteins and the natural course of cervical dysplasia was analyzed in 38 patients participating in a nonintervention cohort study of women with CIN and 11 HPV 16-positive cervical carcinoma patients.,10962445_2,-1,-1,2,2,182,-1,9.302033e-06,6.028418e-06,0.9999846
29761,cells,2,3,15,20,"CD11b+ myeloid cells, which resembled T-MDSCs both phenotypically and functionally, were primarily in the peritumoral stroma and a positive association with TAFs in vivo.",27593937_7,-1,-1,2,2,29761,-1,1.7477332e-05,6.9839057e-06,0.99997544
10474,cell,29,30,185,189,"However, more cells expressed FOXP3 when the supernatant of human epithelial ovarian carcinoma cell culture was added, yet not the supernatant of normal human ovarian surface epithelia cell culture.",19673890_5,-1,-1,2,2,10474,-1,1.4649284e-05,6.701931e-06,0.99997866
7708,cells,4,5,19,24,"Treatment of T reg cells in vitro with imiquimod inhibited their suppressive activity and reduced FOXP3, CD39, CD73, IL-10, and TGF-beta by indirect mechanisms.",18794336_6,-1,-1,2,2,7708,-1,1.0318414e-05,7.501481e-06,0.9999821
11335,CD8+ T cell,31,35,211,222,"In conclusion, anti-CD4 mAb potentiated IL-21-based IT by removing Treg cells and/or their precursors and other potentially immune-suppressive CD4+ cell subsets, thus allowing the development of an IL-21-driven CD8+ T cell response, which mediates NB rejection.",20039320_10,-1,-1,2,2,11335,-1,3.2262815e-05,5.475039e-06,0.9999622
39275,Treg cell,6,8,44,53,"Moreover, an anti-CCL28 antibody attenuated Treg cell infiltration and tumor progression in H. felis/MNU mouse models.",32156780_7,-1,-1,2,2,39275,-1,1.4552856e-05,1.34867005e-05,0.999972
31193,cells,9,10,40,45,"In vivo study the activated CD4+, CD8+T cells and decreased ability to induce differentiation of Foxp3+ regulatory T cells were detected post treatment of MENK.",28088065_7,-1,-1,2,2,31193,-1,1.4046272e-05,9.385603e-06,0.9999765
6583,regulatory T cells,6,9,33,51,"The exact role of CD4+CD25(high) regulatory T cells (Treg) in adoptive immunotherapy of melanoma is still to be determined, and an association between an expansion of Treg cells and the expansion of therapeutic tumor-infiltrating lymphocytes (TIL) remains unelucidated.",18312383_0,-1,-1,2,2,6583,-1,8.016453e-06,5.406881e-06,0.99998665
7129,cell-to-cell,7,8,65,77,"Tumor-specific Treg cells require ligand-specific activation and cell-to-cell contact to exert their suppressive activity on tumor-specific effector cells (CD8+ cytotoxic T lymphocytes and CD4+ Th cells), which includes decreased cytotoxity, proliferation, and Th1 cytokine secrection.",18512029_2,-1,-1,2,2,7129,-1,3.6177236e-05,1.9472482e-05,0.99994445
4020,T cells,25,27,145,152,We examined the mechanisms of action of anti-CTLA4 and a GM-CSF-transduced tumor cell vaccine (Gvax) and their impact on the balance of effector T cells (Teffs) and Tregs in an in vivo model of B16/BL6 melanoma.,16778987_1,-1,-1,2,2,4020,-1,8.450249e-06,6.0379743e-06,0.99998546
4732,lymphocytes,19,20,104,115,"Here, we have assessed the presence of CD4(+) T cells directed against the SSX-1 antigen in circulating lymphocytes of cancer-free individuals.",17186289_4,-1,-1,2,2,4732,-1,1.3526687e-05,7.4829522e-06,0.999979
10943,T cell,3,5,13,19,"Total CD4(+) T cell counts are not constant, however, suggesting that homeostatic mechanisms, or susceptibility to cytotoxic or malignant insults, fundamentally differ for regulatory and non-regulatory CD4(+) T cells.",19855964_7,-1,-1,2,2,10943,-1,1.2112244e-05,5.8762553e-06,0.999982
40565,CTLA4,6,7,34,39,"Downregulation of FOXP3, GITR and CTLA4 in tumor-infiltrating Tregs and inhibition of Cox2, PGE2 and Arginase 1 in intra-tumoral MDSC were evidenced as some of the key events during therapeutic intervention of GA in melanoma management.",32890791_7,-1,-1,2,2,40565,-1,9.268773e-05,2.7880193e-05,0.99987936
11328,T cells,19,21,140,147,"Moreover, mice receiving vaccine therapy alone or vaccine+anti-CD4 mAb showed increased IFN-gamma serum levels and IFN-gamma-producing CD8+ T cells were found in spleen cells.",20039320_9,-1,-1,2,2,11328,-1,1.0096822e-05,5.76365e-06,0.99998415
2821,CTL,31,32,182,185,"We have recently demonstrated that IL-27 has a potent antitumor activity, which is mainly mediated through CD8+ T cells, and also has an adjuvant activity to induce epitope-specific CTL in vivo.",16034109_1,-1,-1,2,2,2821,-1,1.8318298e-05,4.609928e-06,0.999977
3157,T cells,17,19,103,110,In this study we analyze tumor-draining lymph nodes (LNs) and demonstrate that both antitumor effector T cells and Treg capable of abrogating the antitumor reactivity of the effector T cells are primed in the same LNs during tumor progression.,16210609_3,-1,-1,2,2,3157,-1,8.743264e-06,5.312878e-06,0.99998593
43909,T cells,10,12,74,81,Our data have implications for the detection of potentially dysfunctional T cells in patients with cancer.,9724088_7,-1,-1,2,2,43909,-1,8.763052e-06,5.7454095e-06,0.99998546
40910,cells,2,3,13,18,"Regulatory B cells (Bregs) and CD4+ regulatory T cells (Tregs) are subgroups of immunoregulatory cells involved in modulating autoimmunity, inflammation, and transplantation reactions.",33083479_1,-1,-1,2,2,40910,-1,1.3553173e-05,8.23724e-06,0.9999782
29272,T cell,3,5,10,16,"Of CD8(+) T cell pools activated to tumor-specific CTLs, nave cell generated effectors possessed the most potent cytotoxic activity, validating implications for use in rational design of adoptive immunotherapy.",27306834_4,-1,-1,2,2,29272,-1,1.0930107e-05,5.322156e-06,0.99998367
26375,cells,19,20,118,123,"Here, we show that STAT3 signaling in CD8(+) T cells inhibits chemokine CXCL10 production by tumor-associated myeloid cells by reducing IFN expression by T cells.",26025380_3,-1,-1,2,2,26375,-1,1.1869852e-05,9.019865e-06,0.999979
2269,T cells,26,28,164,171,"Here, we demonstrate that KLRG1 is expressed in a significant proportion of Vgamma9/Vdelta2 T cells in cord blood and in the majority of peripheral Vgamma9/Vdelta2 T cells from adult donors.",15498816_3,-1,-1,2,2,2269,-1,9.636523e-06,5.216427e-06,0.9999851
37916,cells,20,21,146,151,"CONCLUSIONS: These results demonstrate that targeting the cytosolic HDAC6-FoxO1 axis reprograms the pathogenicity and antitumor response of TH 17 cells in HCC, with a pathogenicity-driven responsiveness to facilitate immunotherapies.",31539182_7,-1,-1,2,2,37916,-1,1.3609109e-05,7.513901e-06,0.9999789
6640,cells,15,16,101,106,"More importantly, in mice bearing Neuro2a/pc micrometastases, a single sc injection of Neuro2a/IL-21 cells significantly increased the mean tumor-free survival of treated animals (43 vs. 22 days) and cured 14% of them.",18324400_5,-1,-1,2,2,6640,-1,3.0955896e-05,6.347846e-06,0.9999627
8714,regulatory T cells,5,8,25,43,"The percentage of FoxP3+ regulatory T cells (Tregs) increased by day 26, with elevated frequencies throughout the duration of the study.",19226468_6,-1,-1,2,2,8714,-1,8.895711e-06,5.7681873e-06,0.99998534
13850,regulatory T cells,5,8,20,38,"BACKGROUND: 'FOXP3+ regulatory T cells' (Tregs) are reported to be increased in tumour-bearing hosts including patients with melanoma, leading to tumour immune suppression.",21198537_0,-1,-1,2,2,13850,-1,8.931299e-06,5.1073666e-06,0.99998593
7815,CD8+ T lymphocytes,35,39,257,275,"Phenotypic analyses demonstrate that, during their commitment from circulating nonregulatory CD8+CD28- T lymphocytes to Treg (an interleukin-10-dependent process), these cells downmodulate the IL7-receptor, thus differentiating them from long-lived, memory CD8+ T lymphocytes.",18832002_4,-1,-1,2,2,7815,-1,1.7317598e-05,5.9232893e-06,0.99997675
22565,regulatory T cells,25,28,177,195,CONCLUSIONS: This study indicates that Tc17 cell infiltration in cervical cancers is associated with cancer progression accompanied by increased infiltrations of Th17 cells and regulatory T cells as well as promoted tumor vasculogenesis.,24523865_6,-1,-1,2,2,22565,-1,9.298957e-06,4.9115097e-06,0.9999858
31032,cells,20,21,148,153,NF-B staining and mRNA quantification of inflammatory genes in HK-2 epithelial renal cells exposed to supernatants of peripheral blood mononuclear cells with clonal T-cell population.,28018996_3,-1,-1,2,2,31032,-1,1.1913186e-05,7.881634e-06,0.9999802
31120,T cells,2,4,15,22,The CD8+RORt+ T cells represented a highly activated subset and produced IL-17A in equal amount as CD4+RORt+ T cells (TH17 cells).,28053236_3,-1,-1,2,2,31120,-1,7.63299e-06,5.1395973e-06,0.99998724
42702,T cells,14,16,88,95,These results suggest that NFAT2 and miR-20a are crucial for regulating functional CD8+ T cells.,34237654_5,-1,-1,2,2,42702,-1,8.894047e-06,5.8248647e-06,0.9999852
3978,T cells,5,7,33,40,"Coculture of DCs with autologous T cells leads to an increase in both the number of Treg's, as well as the expression of FOXP3 protein per cell both in healthy donors and myeloma patients.",16763205_3,-1,-1,2,2,3978,-1,9.898502e-06,5.053297e-06,0.9999851
18982,NKT cell,26,28,186,194,"Overall, these findings demonstrate that transient depletion of Foxp3(+) Tregs constitutes a highly effective strategy to improve the therapeutic efficacy of anticancer vaccination with NKT cell adjuvants.",23090488_5,-1,-1,2,2,18982,-1,4.0002204e-05,4.239048e-05,0.9999175
2009,cell,47,48,304,308,"In this study, three leukemic cell lines were investigated: Kasumi-1 and SKNO-1 (two acute myeloid leukemia (AML) cell lines carrying the (8;21)-chromosomal translocation, resulting in the expression of the leukemia-specific fusion protein AML1-eight-twenty-one) and REH, an acute lymphoblastic leukemia cell line with the (12;21)-chromosomal translocation and expression of translocation ETS-like leukemia-AML1.",15197237_1,-1,-1,2,2,2009,-1,1.4458406e-05,6.3834527e-06,0.99997914
31387,T cells,11,13,74,81,"We also observed positive correlations between the proportion of LAP+CD4+ T cells and TNM stage (P < 0.001), distant metastasis (P < 0.001) and serum level of carcinoembryonic antigen (P < 0.05).",28210081_6,-1,-1,2,2,31387,-1,9.451754e-06,5.977262e-06,0.9999846
23186,T cells,27,29,185,192,"Instead, EBV-induced IDO expression in MDMs is substantially mediated by IL-6- and TNF--dependent mechanisms via the p38/MAPK and NF-B pathways, which suppressed the proliferation of T cells and impaired the cytotoxic activity of CD8(+) T cells.",24696473_11,-1,-1,2,2,23186,-1,1.0151868e-05,5.6575045e-06,0.99998426
6860,cells,36,37,244,249,"One of the major limitations for cancer immunotherapy is related to the frequent existence of an intra-tumoral immunosuppressive environment, to which STAT3 (Signal transducer and activator of transcription-3) activation in tumor and dendritic cells (DCs) are believed to contribute.",18392040_0,-1,-1,2,2,6860,-1,1.920386e-05,6.539052e-06,0.99997425
10701,T cells,9,11,63,70,"Lastly, these patients showed elevated levels of MUC1-specific T cells expressing the CCR5 and CCR1 chemokine receptors and the chemokine CCL4 associated with Th1 cell differentiation/memory.",19762283_7,-1,-1,2,2,10701,-1,7.087876e-06,5.858581e-06,0.9999871
26195,cells,3,4,21,26,"Among various immune cells in colon, dendritic cells (DCs) are unique not only in their accessibility to luminal contents but also in their ability to induce tolerogenic phenotype in T-cells.",25984582_3,-1,-1,2,2,26195,-1,1.944256e-05,6.0419575e-06,0.9999745
3841,cells,17,18,93,98,"Overall, IL-2 treatment resulted in a 1.9 median fold increase in the frequency of CD4+CD25+ cells in peripheral blood as well as a 9.7 median fold increase in FOXP3 expression in CD3+ T cells.",16645171_5,-1,-1,2,2,3841,-1,1.4671003e-05,9.078688e-06,0.9999763
41993,cell,6,7,46,50,"Besides, miR-124 overexpression decreased CRC cell proliferation and arrested cell cycle at the G1 phase through downregulation of c-Myc and induced apoptosis in CRC cells via upregulation of both intrinsic and extrinsic pathways.",33821473_6,-1,-1,2,2,41993,-1,1.042551e-05,7.4432896e-06,0.99998224
42391,cells,24,25,133,138,"Among various mechanisms of immunescaping, in this study, we characterized the modulation of the phenotypic profile of CD4+ and CD8+ cells in resting and activated states, in response to the mechanical pressure exerted by a three-dimensional in vitro system, able to recapitulate the rheological and stiffness properties of the tumor ECM.",34070750_5,-1,-1,2,2,42391,-1,1.3960397e-05,8.992852e-06,0.9999771
40335,cell,5,6,36,40,"Approximately half of ovarian clear cell carcinomas (OCCC) carry mutations in the SWI/SNF subunit ARID1A, while small cell carcinoma of the ovary hypercalcemic type (SCCOHT) presents with inactivating mutations of the SWI/SNF ATPase SMARCA4 alongside epigenetic silencing of the ATPase SMARCA2.",32649682_1,-1,-1,2,2,40335,-1,1.6406451e-05,8.678378e-06,0.99997485
20220,cells,12,13,82,87,"The purpose of this study was to investigate the involvement of immunosuppressive cells, such as Tregs and CD163+ macrophages, as well as immunomodulatory cells (i.e. IL-27-producing cells) in keratoacanthoma (KA) and invasive squamous cell carcinoma (SCC).",23572151_3,-1,-1,2,2,20220,-1,1.9417625e-05,5.772425e-06,0.99997485
5272,cells,58,59,251,256,"We previously reported (Bell, D., P. Chomarat, D. Broyles, G. Netto, G.M. Harb, S. Lebecque, J. Valladeau, J. Davoust, K.A. Palucka, and J. Banchereau. 1999. J. Exp. Med. 190: 1417-1426) that breast cancer tumors are infiltrated with mature dendritic cells (DCs), which cluster with CD4(+) T cells.",17438063_0,-1,-1,2,2,5272,-1,1.5220843e-05,6.6037333e-06,0.9999782
7044,cells,10,11,55,60,"In this study, we determined whether mRNAs from Szary cells could be used for loading DCs and stimulating antitumor immunity.",18480841_2,-1,-1,2,2,7044,-1,1.43584075e-05,8.951068e-06,0.99997675
17950,cells,5,6,55,60,"Therapeutic immunization with Stat3Y705F-breast cancer cells inhibited tumor growth, promoted tumor cell differentiation, and decreased metastasis.",22753933_7,-1,-1,2,2,17950,-1,1.4258705e-05,7.472734e-06,0.9999782
9471,lymphocytes,36,37,234,245,"Furthermore, the irf-1/CN2 mice showed decreased activation of caspases-3/7 and caspase-9 and increased levels of interleukin (IL)-2, IL-10, and Bcl-2, as well as increased Bcl-2 expression, which promoted oncogenic transformation of lymphocytes.",19362089_8,-1,-1,2,2,9471,-1,1.3849904e-05,6.494849e-06,0.99997973
18989,cell-cell,24,25,160,169,Water-soluble protein signals (pheromones) of the ciliate Euplotes have been supposed to be functional precursors of growth factors and cytokines that regulate cell-cell interaction in multi-cellular eukaryotes.,23103669_0,-1,-1,2,2,18989,-1,6.209976e-05,1.6881551e-05,0.99992096
39142,cell,23,24,130,134,"Immune status affects the initiation and progression of clear cell renal cell carcinoma (ccRCC), the most common subtype of renal cell carcinoma.",32028264_0,-1,-1,2,2,39142,-1,1.4416999e-05,7.694684e-06,0.9999778
34320,cell,12,13,75,79,Interleukin 33 (IL33) is an inflammatory cytokine released during necrotic cell death.,29463593_0,-1,-1,2,2,34320,-1,1.7111865e-05,6.6710763e-06,0.99997616
43729,T cell,18,20,104,110,"Therefore, abnormalities in HLA Class I antigen expression may have a negative impact on the outcome of T cell based immunotherapy.",8795138_6,-1,-1,2,2,43729,-1,9.225653e-06,5.6184585e-06,0.9999852
11437,cell,16,17,105,109,"Finally, we observed large amounts of biologically active IL-1alpha or IL-1beta secreted by two melanoma cell lines that did not express MITF-M, suggesting an autocrine MITF-M downregulation.",20099279_4,-1,-1,2,2,11437,-1,1.5678945e-05,7.58595e-06,0.99997663
28844,cell,23,24,186,190,"Additionally, IL-17A promoted resistance to daunorubicin via activation of Akt signaling and the PI3K/Akt inhibitor LY294002 or perifosine almost completely rescued daunorubicin-induced cell death in B-ALL cells.",27176825_9,-1,-1,2,2,28844,-1,1.6923042e-05,6.8332643e-06,0.9999763
29947,cells,30,31,201,206,"We hypothesize that tumors use epigenetic mechanisms to dysregulate CD1d-mediated antigen presentation, thereby impairing the ability of natural killer T (NKT) cells to recognize and destroy malignant cells.",27614429_2,-1,-1,2,2,29947,-1,1.1492549e-05,7.5334265e-06,0.99998105
7133,cells,17,18,149,154,"Tumor-specific Treg cells require ligand-specific activation and cell-to-cell contact to exert their suppressive activity on tumor-specific effector cells (CD8+ cytotoxic T lymphocytes and CD4+ Th cells), which includes decreased cytotoxity, proliferation, and Th1 cytokine secrection.",18512029_2,-1,-1,2,2,7133,-1,1.15562625e-05,8.191477e-06,0.9999802
35212,cells,33,34,204,209,"Tumors that formed when KPC cells were injected along with p50-/- PSCs had increased infiltration by activated cytotoxic T cells along with decreased levels of CXCL12, compared with tumors grown from KPC cells injected along with control PSCs.",29909021_9,-1,-1,2,2,35212,-1,1.3798138e-05,6.888035e-06,0.99997926
39059,T cells,11,13,73,80,IL-23 is a two-subunit cytokine known to promote proliferation of memory T cells and T helper type 17 cells.,32015548_2,-1,-1,2,2,39059,-1,8.43302e-06,6.946652e-06,0.9999846
40002,cells,17,18,97,102,Regulatory T (Treg) cell populations are composed of functionally quiescent resting Treg (rTreg) cells which differentiate into activated Treg (aTreg) cells upon antigen stimulation.,32515782_0,-1,-1,2,2,40002,-1,1.1792111e-05,8.325448e-06,0.99997985
2318,cell,6,7,52,56,The stimulation of CD40-positive cervical carcinoma cell lines with soluble CD40L (CD154) resulted in activation of the NF-kappaB and MAPK signaling pathways and up-regulation of cell surface markers and intracellular molecules associated with Ag processing and presentation.,15611226_2,-1,-1,2,2,2318,-1,1.7552093e-05,6.293338e-06,0.99997616
3122,subset,2,3,8,14,This DC subset selectively promotes the proliferation of T reg cells in a TGF-beta-dependent manner in mice and rats.,16186184_3,-1,-1,2,2,3122,-1,1.5531334e-05,8.444394e-06,0.99997604
3136,subset,14,15,75,81,"In conclusion, tumor expansion can stimulate T reg cells via a specific DC subset.",16186184_5,-1,-1,2,2,3136,-1,1.7171942e-05,9.663833e-06,0.9999732
10501,regulatory T cells,13,16,86,104,New strategies that stimulate cell-mediated immunity (CMI) against tumors and inhibit regulatory T cells are needed to improve the outcome of cancer immunotherapy.,19706340_0,-1,-1,2,2,10501,-1,7.581707e-06,4.9266796e-06,0.9999875
30878,Treg cell-depleted,16,18,123,141,Overexpression of cancer-FOXP3 promoted the tumor growth in immunocompetent syngeneic mice but not in immunocompromised or Treg cell-depleted mice.,27991933_5,-1,-1,2,2,30878,-1,3.832092e-05,3.2322732e-05,0.9999294
26206,enzymes,10,11,68,75,"We found that DCs exposed to butyrate express the immunosuppressive enzymes indoleamine 2,3-dioxygenase 1 (IDO1) and aldehyde dehydrogenase 1A2 (Aldh1A2), promote conversion of naive T-cells into immunosuppressive forkhead box P3(+) (FoxP3(+)) Tregs (regulatory T-cells) and suppress conversion of naive T-cells into pro-inflammatory interferon (IFN)--producing cells.",25984582_4,-1,-1,2,2,26206,-1,0.0003721524,0.9993772,0.00025070674
28556,Treg cell,1,3,9,18,Abundant Treg cell infiltration into tumors is associated with poor clinical outcomes in various types of cancers.,27111280_1,-1,-1,2,2,28556,-1,2.3237953e-05,3.1326166e-05,0.9999454
33387,cell,3,4,23,27,Ligation of programmed cell death-1 (PD-1) in the tumor microenvironment is known to inhibit effective adaptive antitumor immunity.,28993412_0,-1,-1,2,2,33387,-1,4.014633e-05,6.967836e-06,0.9999529
3589,subsets,19,20,116,123,"Gene expression studies suggest that in the future we may develop new diagnostic and prognostic tools, and identify subsets of patients who would benefit from more appropriate treatment protocols.",16457762_9,-1,-1,2,2,3589,-1,4.2456086e-05,1.9283512e-05,0.99993825
38901,cells,9,10,49,54,"Dysfunction of invariant natural killer T (iNKT) cells in tumor microenvironment hinders their anti-tumor efficacy, and the underlying mechanisms remain unclear.",31974378_0,-1,-1,2,2,38901,-1,1.3934719e-05,8.382489e-06,0.9999777
41037,T cells,16,18,115,122,Further investigation in vitro revealed that melatonin administration increased FoxP3 and IL-10 expression in CD4+ T cells from MG patients and enhanced the suppressive function of Tregs.,33136553_8,-1,-1,2,2,41037,-1,1.0793713e-05,5.7616176e-06,0.99998343
37946,T cell,3,5,14,20,BACKGROUND: A T cell subtype with the CD4+CD25-FoxP3+ phenotype was recently described.,31630080_0,-1,-1,2,2,37946,-1,7.5555968e-06,4.4684007e-06,0.9999881
43775,cell,26,27,140,144,"gamma IFN, in fact, induces endothelial cells to acquire the same features of KS cells, including the spindle morphology and the pattern of cell marker expression.",9446657_8,-1,-1,2,2,43775,-1,1.4646947e-05,7.836777e-06,0.99997747
18196,T cells,5,7,32,39,"In vitro dysfunction of patient T cells, such as reduced proliferative capacity or CD3-chain expression, was rescued by blocking the IDO activity of CD14(+)HLA-DR(low/neg) cells.",22828446_8,-1,-1,2,2,18196,-1,8.466762e-06,5.9869662e-06,0.9999856
43497,cells,18,19,117,122,"Although IL-1 dramatically increases Jun B accumulation, it does not enhance TPA-induced Fra-1 protein levels in EL4 cells.",7675040_7,-1,-1,2,2,43497,-1,1.161498e-05,9.734044e-06,0.99997866
6890,T cells,39,41,252,259,"Correlating with these findings, the combination therapy resulted in significantly higher intra-tumoral levels of several proinflammatory, TH1-related cytokines (including IL-12, IFN-gamma, TNF-alpha and IL-2), increases in intra-tumoral CD8+ and CD4+ T cells expressing activation/memory markers and NK cells and increases in activated DCs in the tumors and regional lymph nodes (LNs).",18392040_5,-1,-1,2,2,6890,-1,8.95997e-06,5.3438025e-06,0.9999857
745,cells,13,14,60,65,CTL recognition of the HPV16 E6(29-38) epitope in 721.174 B cells was dependent on TAP expression but independent of immunoproteasome expression.,11673561_7,-1,-1,2,2,745,-1,1.4036903e-05,9.0623535e-06,0.9999769
19590,T cells,30,32,184,191,RESULTS: KYN was increased in 75% of patients with symptomatic MM and correlated with the expansion of CD4(+)CD25(+)FoxP3(+) Treg cells and the contraction of NY-ESO-1-specific CD8(+) T cells.,23232072_5,-1,-1,2,2,19590,-1,8.883363e-06,5.19826e-06,0.9999858
9573,T cells,16,18,92,99,"Compared with primary FOXP3(-) T cells in the same microenvironment, these primary FOXP3(+) T cells expressed minimal levels of effector cytokines, negligible amount of cytotoxic molecule granzyme B, and levels of suppressive molecules interleukin-10 and PD-1.",19383912_4,-1,-1,2,2,9573,-1,9.761483e-06,5.2307137e-06,0.999985
31800,cells,25,26,147,152,"Here, we show that PEPvIII could be loaded by DCs and presented to T lymphocytes, especially PEPvIII-specific CTLs, to precisely kill U87-EGFRvIII cells.",28412740_4,-1,-1,2,2,31800,-1,1.170504e-05,7.770262e-06,0.99998057
14065,cell,22,23,159,163,"Previously, we developed a cancer-targeted gene therapy expression system with high tumor specificity and strong activity that selectively induced lung cancer cell killing without affecting normal cells in immunocompromised mice.",21282355_1,-1,-1,2,2,14065,-1,1.4818579e-05,6.0911916e-06,0.99997914
21574,cells,35,36,218,223,Our results demonstrated that a significant decrease in the level of IL-4 and increase in the IFN- in the animals treated with salvigenin and significant decreased in the level of splenic CD4+CD25+Foxp3+ T regulatory cells.,24270218_5,-1,-1,2,2,21574,-1,1.0389051e-05,6.810792e-06,0.99998283
23681,regulatory T cells,9,12,61,79,This study aimed to characterize the glioma-derived IL-17(+) regulatory T cells (Treg).,24813240_3,-1,-1,2,2,23681,-1,9.861207e-06,6.984359e-06,0.9999831
3255,lymphocytes,6,7,38,49,"Furthermore, the increased numbers of lymphocytes in patients resulting from treatment with IL-2 were not susceptible to Denileukin Diftitox.",16224276_7,-1,-1,2,2,3255,-1,1.8367917e-05,6.156244e-06,0.99997544
26412,CCR5,12,13,58,62,"In our current study, we found that chemokine receptor 5 (CCR5) neutralization resulted in reduced melanoma tumor size, decreased percentage of CD11b+ Gr-1(+) myeloid-derived suppressor cells (MDSCs), and increased proportion of cluster of differentiation (CD)3+ T cells in tumor tissues.",26047948_1,-1,-1,2,2,26412,-1,0.0011808036,0.0001278601,0.9986914
21659,cell,24,25,118,122,"As a result, DCs matured with OK-432 plus IFN- can prime stronger cytotoxic lymphocyte (CTL) and natural killer (NK) cell response against tumor cells in vitro.",24296809_5,-1,-1,2,2,21659,-1,1.25872775e-05,6.779017e-06,0.99998057
34767,Treg cells,32,34,201,211,"Our findings suggest that at an early stage of the tumor, this tumor-induced IFN-producing FOXP3- CD8+ CD25+ CD127- T-cell subset can potentiate immune surveillance by targeting HLA-E-restricted CD4+ Treg cells while leaving the effector T-cell population unaffected.",29768737_8,-1,-1,2,2,34767,-1,1.3186622e-05,8.295825e-06,0.9999784
33181,cell,4,5,25,29,"We observed increased NK cell population at an early stage of Dalton's lymphoma (DL) growth, while at late stage, NK cell numbers were decreased.",28891726_5,-1,-1,2,2,33181,-1,1.1414279e-05,7.298802e-06,0.9999813
41723,T cells,12,14,62,69,"In vitro and in vivo studies showed that IRF-1 increased CD8+ T cells, NK and NKT cells migration, and activated IFN- secretion in NK and NKT cells to induce tumor apoptosis through the CXCL10/CXCR3 paracrine axis.",33689775_6,-1,-1,2,2,41723,-1,7.796097e-06,6.347703e-06,0.99998593
39000,T cells,6,8,35,42,"In addition, the TGFBR2-edited CAR T cells could eliminate contralaterally reinoculated xenografts in mice effectively, with an increased proportion of memory subsets within circulating CAR T cells of central memory and effector memory subsets.",31999649_4,-1,-1,2,2,39000,-1,7.5842718e-06,5.301354e-06,0.9999871
27462,cell,1,2,2,6,B cell lymphoma (BCL) has a higher degree of malignancy and complicated pathogenic mechanism.,26464657_0,-1,-1,2,2,27462,-1,1.4463791e-05,8.795343e-06,0.99997675
20119,subset,8,9,38,44,Pancreatic stellate cells (PSC) are a subset of pancreatic cancer-associated fibroblasts.,23514705_0,-1,-1,2,2,20119,-1,2.3826711e-05,9.83664e-06,0.99996626
21713,T cells,10,12,65,72,"High intratumoral FoxP3(+) Tregs with high intratumoral IL-17(+) T cells showed a significantly lower overall survival (OS) and disease-free survival (DFS) compared with other groups (OS, P = 0.033; DFS, P = 0.004).",24303990_7,-1,-1,2,2,21713,-1,1.6043277e-05,7.160233e-06,0.99997675
6524,T cells,17,19,96,103,METHODS: Expression of ICOS and T regulatory (Treg) cell markers was determined on CD4+CD25high T cells in PBMC and tumor-infiltrating lymphocytes from melanoma patients (n=10) and PBMC of normal controls (n=10) by multicolor flow cytometry.,18292519_2,-1,-1,2,2,6524,-1,9.740139e-06,4.6856194e-06,0.9999856
13668,cells,12,13,85,90,"Our results show that tremelimumab enhanced the proliferative response of T effector cells (Teff) upon TCR stimulation, and abrogated Treg suppressive ability.",21056008_3,-1,-1,2,2,13668,-1,1.392126e-05,8.678061e-06,0.99997735
19598,cells,10,11,64,69,"Both Treg expansion and inhibition of Th1 differentiation by MM cells were reverted, at least in part, by D,L-1-methyl-tryptophan, a chemical inhibitor of IDO.",23232072_7,-1,-1,2,2,19598,-1,1.6513268e-05,9.685863e-06,0.9999738
34004,T cells,15,17,95,102,"The increase in tumor rejection was associated with an increased number and persistence of CD8 T cells in lymphoid tissues during acute tumor rejection, tumor regrowth, and in mice that remained tumor-free.",29271784_2,-1,-1,2,2,34004,-1,1.1315629e-05,5.3514805e-06,0.9999833
37485,cells,17,18,128,133,"IL-30-silenced tumors developed in IL-30KO mice, IL-30-/-tumors, lacked vascular supply and displayed frequent apoptotic cancer cells entrapped by perforin+TRAIL+CD3+Tlymphocytes, most of which had a CD4+T phenotype, whereas IL-10+TGF+Foxp3+Tregs were lacking.",31366386_7,-1,-1,2,2,37485,-1,1.542475e-05,6.459752e-06,0.9999782
33749,cell,5,6,37,41,"Importantly, STAT3-blocked whole HCC cell lysates prevented HCC-mediated exhaustion of T cells and NK cells, showing low expression of checkpoint molecules such as PD-1 and TIGIT on T cells and NK cells in the immunized mice.",29115974_7,-1,-1,2,2,33749,-1,1.7944229e-05,8.94949e-06,0.99997306
25870,T cells,19,21,123,130,"Importantly, we found that the co-administration of HDACIs and anti-CTLA4 could further enhance the infiltration of CD4(+) T cells and achieve a synergistic therapeutic effect on tumor.",25745993_6,-1,-1,2,2,25870,-1,9.861003e-06,5.7916463e-06,0.99998426
23911,T cells,12,14,75,82,"Recruitment was not dependent upon the specificity of the activated CD8(+) T cells, but was significantly reduced in mice lacking the IFN receptor.",24893628_3,-1,-1,2,2,23911,-1,9.776273e-06,6.6975936e-06,0.99998355
37434,Treg cell-restricted,2,4,10,30,"Mice with Treg cell-restricted Neuropilin-1 deficiency show tumor resistance while maintaining peripheral immune homeostasis, thereby providing a controlled system to interrogate the impact of intratumoral Treg cells on the TME.",31350177_1,-1,-1,2,2,37434,-1,1.79778e-05,1.6713007e-05,0.9999653
1509,T cells,32,34,169,176,"Many tumor immunologists favor the hypothesis that optimal anti-tumor activity is mediated by type 1 CD4(+) and CD8(+) T cells, and that the production of type 2 CD4(+) T cells may be counterproductive for effective anti-tumor immunity.",14593499_0,-1,-1,2,2,1509,-1,9.790696e-06,4.899409e-06,0.99998534
33518,T cells,5,7,38,45,"Allogeneic immune cells, particularly T cells in donor grafts, recognize and eliminate leukemic cells via graft-versus-leukemia (GVL) reactivity, and transfer of these cells is often used for high-risk hematological malignancies, including acute myeloid leukemia.",29038366_0,-1,-1,2,2,33518,-1,1.3300476e-05,5.6919534e-06,0.9999809
10997,T cells,26,28,178,185,Adoptive transfer of wild-type CD8(+) T cells to FasL-knockout mice restored posttherapy T-suppressor cell elimination from tumors establishing that expression of FasL on CD8(+) T cells was sufficient to promote T-suppressor cell death.,19923444_4,-1,-1,2,2,10997,-1,9.514794e-06,5.3937915e-06,0.9999851
23485,T cells,12,14,107,114,Functionally study revealed that CD45RA-CD25+++ Tregs significantly inhibit the proliferation of CD4+CD25- T cells (P <0.001) and secrete lower levels of cytokines (P <0.01) compared with CD45RA-CD25++CD4+ T cells.,24761979_7,-1,-1,2,2,23485,-1,9.133774e-06,5.8580326e-06,0.999985
24621,T cells,29,31,178,185,"We found that HMGB1 promotes the development of MDSCs from bone marrow progenitor cells, contributing to their ability to suppress antigen-driven activation of CD4(+) and CD8(+) T cells.",25164013_7,-1,-1,2,2,24621,-1,1.0955527e-05,5.651519e-06,0.99998343
22737,suppressor cells,26,28,167,183,"Biomarkers relevant to the antitumor effects of IL-2 that may be altered by sorafenib including the percentages of natural T-regulatory cells (Tregs), myeloid-derived suppressor cells (MDSC), and STAT5 phosphorylation (pSTAT5) in T cells were evaluated.",24598448_1,-1,-1,2,2,22737,-1,1.0728328e-05,6.183286e-06,0.9999831
4,CTLs,13,14,74,78,"The outcome of antigen recognition by naive CD8+ cytotoxic T lymphocytes (CTLs) in the periphery is orchestrated by CD4+ T-helper cells, and can either lead to priming or tolerization.",10395322_0,-1,-1,2,2,4,-1,1.669988e-05,4.5447205e-06,0.9999788
6168,cells,15,16,118,123,"These findings document the selective gammac-signaling cytokine-mediated activation of the mTORC1 pathway in the CTCL cells and suggest that the pathway represents a therapeutic target in CTCL and, possibly, other T-cell lymphomas.",18025151_8,-1,-1,2,2,6168,-1,2.0856787e-05,6.924408e-06,0.9999722
23671,cell,15,16,115,119,Our results suggest that adoptive transfer of Tregs aggressively promote intestinal tumorigenesis by decreasing NK cell number and activity by modulating IL-22 BP.,24797894_7,-1,-1,2,2,23671,-1,1.0937166e-05,8.370147e-06,0.9999807
41579,cell,7,8,39,43,Radiation (RT) can promote immunogenic cell death with increased antitumor T cell activity but also stimulates suppressive regulatory T cells (Tregs).,33647370_1,-1,-1,2,2,41579,-1,1.2487033e-05,7.14269e-06,0.99998033
29136,T cells,13,15,85,92,These studies reveal that the costimulatory effects of TLR1-TLR2 signaling in CD8(+) T cells are in part mediated by 4-1BB and are important for mounting an effective antitumor immune response.,27267778_8,-1,-1,2,2,29136,-1,9.443292e-06,6.20923e-06,0.9999844
858,cells,1,2,5,10,"Mast cells, platelets, and some macrophages are abundant sources of PGD(2) and its active metabolite 15-deoxy-Delta(12,14)-PGJ(2) (15-d-PGJ(2)).",11801678_0,-1,-1,2,2,858,-1,1.7002843e-05,6.6680936e-06,0.9999763
10788,T cells,16,18,101,108,"CD8(+) T-cell depletion completely abrogated the vaccine efficacy, and so protection required CD8(+) T cells.",19830696_4,-1,-1,2,2,10788,-1,9.95268e-06,5.529213e-06,0.9999846
214,cells,28,29,159,164,"Then, with a focus on CML, the IRF4 level was determined in sorted cell subpopulations from CML patients and healthy volunteers and in in vitro-stimulated CML cells.",11013272_2,-1,-1,2,2,214,-1,1.1523268e-05,7.394251e-06,0.99998105
26915,T cells,16,18,108,115,"Thus, our findings showed that CCL5/CCR3 signaling promotes metastasis by inducing Th2 polarization of CD4 T cells, with implications for prognosis and immunotherapy of luminal breast cancer.",26249173_5,-1,-1,2,2,26915,-1,1.0421357e-05,8.0739555e-06,0.9999815
725,cell,13,14,80,84,These CTL were unable to recognize HLA-A*0201(+) HPV16 E6(+) cervical carcinoma cell lines even when the level of endogenous HPV16 E6 in these cells was increased by transfection.,11673561_4,-1,-1,2,2,725,-1,1.3638494e-05,6.9508906e-06,0.9999795
21586,regulatory T cells,7,10,44,62,Here we examined whether the suppression of regulatory T cells (Tregs) within tumors can enhance an antitumor immunity induced by an intratumoral IFN- gene transfer.,24289533_2,-1,-1,2,2,21586,-1,7.805968e-06,5.437297e-06,0.99998677
25911,cells,6,7,32,37,"An increased number of IL-17(+) cells were significantly correlated with the absence of vaso-invasion (p=0.001), smaller tumor size (p=0.030) and less infiltration depth (p=0.021).",25795131_9,-1,-1,2,2,25911,-1,1.524797e-05,8.379848e-06,0.9999764
31136,T cells,9,11,54,61,"In comparison with CD8+RORt- T cells, the CD8+RORt+ T cells had a higher level of TCR signaling and were terminally differentiated and exhausted.",28053236_5,-1,-1,2,2,31136,-1,8.175802e-06,5.2549967e-06,0.9999865
43764,T cells,21,23,124,131,"Here we show that both acquired immunodeficiency syndrome (AIDS)-KS and classical KS (C-KS) lesions are infiltrated by CD8+ T cells and CD14+/CD68+ monocytes-macrophages producing high levels of gamma-interferon (gamma IFN) which, in turn, promotes the formation of KS spindle cells with angiogenic phenotype.",9446657_7,-1,-1,2,2,43764,-1,9.940052e-06,5.6443027e-06,0.9999845
17390,T cells,2,4,22,29,"Although conventional T cells are acknowledged as important players in the control of CML, a possible modification of invariant NKT (iNKT) cells, known for their antitumoral activity, has not been established as yet.",22585600_1,-1,-1,2,2,17390,-1,8.504761e-06,5.454562e-06,0.99998605
22200,CTLs,38,39,258,262,"The data suggest that pretreatment of myeloma cells with JSI-124 and bortezomib can recover DC function through the up-regulation of HSP90 and the down-regulation of p-STAT3 and inhibitory cytokines, and that these DCs can potently generate myeloma-specific CTLs.",24407159_7,-1,-1,2,2,22200,-1,1.5731459e-05,4.496157e-06,0.99997973
37984,cells,23,24,153,158,CONCLUSION: We suggest that CD4+CD25-FoxP3+ cells in patients with BC are exhausted cells with an intermediate phenotype between effector and regulatory cells.,31630080_7,-1,-1,2,2,37984,-1,1.1774568e-05,7.5033304e-06,0.9999807
42846,cells,25,26,109,114,"The protective effect of PBC was relying on type 1 and type 2 T cell responses and, to a lesser extent, on B cells.",34495298_6,-1,-1,2,2,42846,-1,1.6676446e-05,1.0866627e-05,0.99997246
15484,T cells,9,11,66,73,RESULTS: Higher percentages of melanocyte antigen-specific CD8(+) T cells were found in the melanoma tissues as compared with adjacent normal skin and peripheral blood.,21750202_3,-1,-1,2,2,15484,-1,9.941304e-06,6.5759723e-06,0.99998355
42155,Treg cells,9,11,51,61,"Conversely, WT mice showed an inverse frequency of Treg cells compared with STAT6-/- mice, which was followed by intestinal tumor formation.",33919941_5,-1,-1,2,2,42155,-1,1.036731e-05,9.299172e-06,0.99998033
40472,T cells,12,14,63,70,"However, the role of cDC1s in expansion of tumor-specific CD8+ T cells remains unclear.",32848036_2,-1,-1,2,2,40472,-1,1.0671337e-05,6.164945e-06,0.9999831
36698,T cells,11,13,58,65,In vivo mouse model with xenografted 22RV1 cells and CD4+ T cells also confirmed the in vitro results.,31018021_16,-1,-1,2,2,36698,-1,8.490332e-06,5.80404e-06,0.9999857
2331,CTLs,25,26,168,172,"Thus, CD40 stimulation in cervical carcinoma cell lines expressing a TAP-dependent human papillomavirus 16 E6 Ag epitope resulted in their enhanced killing by specific CTLs.",15611226_4,-1,-1,2,2,2331,-1,1.5091478e-05,4.921998e-06,0.99998
7742,cells,28,29,201,206,"Using a novel approach, we examined the intracellular cytokine production capacity of tumor-infiltrating T cells in the single-cell suspensions of enzymatically digested tumors to differentiate T(reg) cells from effector T cells.",18820132_1,-1,-1,2,2,7742,-1,1.1010317e-05,8.449352e-06,0.99998057
31820,cells,14,15,83,88,"IL-35 is an immunosuppressive cytokine and exerts regulatory effects on T cells, B cells, macrophages and dendritic cells.",28432279_0,-1,-1,2,2,31820,-1,1.2150777e-05,9.987821e-06,0.9999778
250,lymphocytic,21,22,152,163,Advances in immunology during the past three decades have facilitated our understanding of the biology of specific lymphoid neoplasms including chronic lymphocytic leukemia (CLL).,11042507_0,-1,-1,2,2,250,-1,4.4722696e-05,8.403177e-06,0.99994695
23838,cells,7,8,43,48,"Along with exposure to bone marrow stromal cells and low (1%-5%) oxygen, culture with RepSox (a reprogramming tool and inhibitor of transforming growth factor- receptor 1) consistently slowed decline of CD34(+) AML and myelodysplastic syndrome (MDS) cells.",24855276_6,-1,-1,2,2,23838,-1,1.8943636e-05,7.80311e-06,0.9999733
37972,Treg cells,5,7,32,42,"Conversely, IL-22 expression in Treg cells was significantly higher than in the CD4+CD25-FoxP3+ subpopulation.",31630080_5,-1,-1,2,2,37972,-1,1.0239945e-05,9.220491e-06,0.99998057
20900,cells,29,30,212,217,"This study demonstrates that local low-dose tumor irradiation influences the intratumoral immune population induced by SFVeE6,7 immunization by a strong increase in the ratio of antitumoral to immune suppressive cells, thus changing the intratumoral immune balance in favor of antitumor activity.",23922012_10,-1,-1,2,2,20900,-1,1.26494715e-05,6.535491e-06,0.9999808
10282,T cells,5,7,44,51,A reproducible increase of vaccine-directed T cells was observed in 2 of 4 immunologically evaluable patients.,19609242_7,-1,-1,2,2,10282,-1,1.0456979e-05,5.9483223e-06,0.99998355
36983,Cells,0,1,0,5,"Cells received 4 hours of PMA/Ionomycin stimulation, in vitro.",31182685_3,-1,-1,2,2,36983,-1,1.6904933e-05,9.239636e-06,0.9999738
33396,cells,20,21,133,138,PD-1 was recently shown to be expressed on and thereby impair the functions of tumor-infiltrating murine and human myeloid dendritic cells (TIDC) in ovarian cancer.,28993412_3,-1,-1,2,2,33396,-1,2.2105296e-05,6.672125e-06,0.9999713
11923,cells,14,15,85,90,"In this report, we demonstrate how CagA protein regulates the functions of dendritic cells (DC) against H. pylori infection.",20363211_1,-1,-1,2,2,11923,-1,1.696064e-05,6.894658e-06,0.99997616
251,cell,14,15,81,85,"Investigations in our laboratory have focused on CD40, a critical regulator of B cell survival and differentiation, and its ligand, CD154 (CD40L).",11042507_1,-1,-1,2,2,251,-1,1.7817149e-05,8.67079e-06,0.99997354
9781,cells,8,9,45,50,"Adaptive Foxp3(+)CD4(+) regulatory T (iTreg) cells develop outside the thymus under subimmunogenic antigen presentation, during chronic inflammation, and during normal homeostasis of the gut.",19464985_0,-1,-1,2,2,9781,-1,1.1196897e-05,7.0785636e-06,0.99998176
23378,T cells,10,12,43,50,"On the other hand, after depletion of CD4+ T cells or blocked perforin with CMA in a tumor-bearing model, CPT could not effectively suppress tumor growth, but this phenomenon could be reversed by injecting naive CD4+ T cells.",24761844_4,-1,-1,2,2,23378,-1,1.1147202e-05,6.2756676e-06,0.9999825
24701,regulatory T cells,21,24,124,142,"Further, the normal involuting gland may be in an immunosuppressed state as discerned by the transient presence of Foxp3(+) regulatory T cells and IL-10(+) macrophages with T cell suppressive function.",25187059_4,-1,-1,2,2,24701,-1,9.535646e-06,6.8290933e-06,0.99998367
9486,subset,12,13,80,86,"The immunoregulatory enzyme indoleamine 2,3-dioxygenase (IDO) is expressed by a subset of murine plasmacytoid DCs (pDCs) in tumor-draining lymph nodes (TDLNs), where it can potently activate Foxp3+ regulatory T cells (Tregs).",19366986_0,-1,-1,2,2,9486,-1,1.922614e-05,9.575031e-06,0.9999713
21062,T cells,32,34,184,191,"Mechanistic studies in mice revealed that up-regulated expression of IDO and PD-L1, as well as recruitment of T(regs), in the tumor microenvironment depended on the presence of CD8(+) T cells.",23986400_3,-1,-1,2,2,21062,-1,1.04280925e-05,5.714368e-06,0.9999839
40354,cell,3,4,16,20,"SCCOHT and OCCC cell lines have shown sensitivity to the reversible LSD1 inhibitor SP-2577 (Seclidemstat), suggesting that SWI/SNF-deficient ovarian cancers are dependent on LSD1 activity.",32649682_5,-1,-1,2,2,40354,-1,1.6595292e-05,8.216801e-06,0.9999752
11620,T-cell activation,20,22,108,125,"Furthermore, we documented induction of regulatory T cells in CD4(+) T cells, based on Foxp3 expression and T-cell activation in cocultures.",20145137_4,-1,-1,2,2,11620,-1,1.4907964e-05,6.8906024e-06,0.9999782
22513,CD80,29,30,179,183,"In IL-2-dependent CTCL cells, CD80 expression is induced by the cytokine in a Jak1/3- and STAT5a/b-dependent manner, whereas in the CTCL cells with constitutive STAT5 activation, CD80 expression is also STAT5a/b dependent but is independent of Jak activity.",24523507_2,-1,-1,2,2,22513,-1,2.320881e-05,8.300974e-06,0.9999684
30233,cells,33,34,177,182,"To examine the effect of Tr1 upregulation, we cocultured the enriched in vitro-induced Tr1 cells (iTr1) with autologous primary DLBCL cells and CD3+ T cells and found that iTr1 cells both enhanced the survival of CD20+ DLBCL tumor cells and suppressed the antitumor response of CD3+ T cells through the production of IL-10.",27704876_7,-1,-1,2,2,30233,-1,1.2847935e-05,7.3679294e-06,0.99997973
39015,T cells,5,7,48,55,"The metabolism-controlled differentiation of  T cells has been well documented; however, the role of a metabolism program in  T cell differentiation and function has not been clarified.",32001780_0,-1,-1,2,2,39015,-1,1.0027e-05,6.1763776e-06,0.9999838
11100,T cell-mediated,3,5,25,40,Mitigation of regulatory T cell-mediated immunosuppression and elicitation of immunogenic tumor cell death are crucial events for optimal anti-tumor immune activity in vivo.,19940990_0,-1,-1,2,2,11100,-1,1.2076591e-05,8.041775e-06,0.99998
39418,Treg cells,5,7,25,35,"Specifically, the FOXP3+ Treg cells in patients were slightly upregulated in frequency and displayed markedly elevated capacity to co-produce TGF- and IL-10.",32279926_5,-1,-1,2,2,39418,-1,1.1447744e-05,1.0321946e-05,0.9999782
39922,T cell,22,24,141,147,"We first confirmed the phenotypic (surface molecules, cytokines, antigen uptake, and antigen-presenting ability) and functional alterations (T cell proliferation/activation) of DCs in vitro.",32486094_2,-1,-1,2,2,39922,-1,1.01378555e-05,5.912372e-06,0.9999839
25474,cell,5,6,50,54,"Vaccinated mice developed epitope-specific spleen cell and CD8+ IFN-+ T-cell responses that recognize more than 50% of the panel of 87 mutated epitope variants, as demonstrated in T-cell proliferation assays and FACS analysis.",25483665_6,-1,-1,2,2,25474,-1,1.8099654e-05,7.71983e-06,0.99997413
32720,T cells,27,29,160,167,"The effects of DCs on anti-tumor immune responses were analyzed using the EG7 tumor model, where the tumor cells express the peptide epitope recognized by OT-1 T cells.",28675711_3,-1,-1,2,2,32720,-1,7.947755e-06,5.0372228e-06,0.999987
17764,T lymphocytes,5,7,37,50,"Finally, intratumoral CD8(+)Foxp3(+) T lymphocytes were significantly increased with tumor progression in terms of tumor-node-metastasis (TNM) stage.",22729557_10,-1,-1,2,2,17764,-1,1.08412405e-05,6.6584316e-06,0.9999825
36258,T cells,16,18,111,118,"Overall, this study suggests that B cell-mediated IL-10 production can exert complex effects toward autologous T cells.",30711567_13,-1,-1,2,2,36258,-1,1.298601e-05,8.425068e-06,0.99997854
11576,T lymphocytes,6,8,49,62,The measurement of splenic CD4(+)CD25(+)Foxp3(+) T lymphocytes indicated that Tehranolide significantly (p<0.05) decreased the number of these lymphocytes.,20138670_8,-1,-1,2,2,11576,-1,1.095599e-05,7.27998e-06,0.99998176
4936,cell,9,10,51,55,An inverse correlation between natural killer (NK) cell activation and myeloid suppressor cell (MSC) expansion in tumor-bearing patients and mice prompted us to investigate the role of MSCs in controlling NK antitumor cytotocixity.,17244679_1,-1,-1,2,2,4936,-1,1.3268118e-05,7.836399e-06,0.9999789
8581,T cells,14,16,90,97,Notch1 plays a critical role in the differentiation from SOCS3-transfected BMCs to CD8(+) T cells.,19190337_4,-1,-1,2,2,8581,-1,8.288892e-06,5.3079266e-06,0.9999863
42969,T cells,11,13,73,80,Oestrogen deprivation of breast cancer cells increases migration of CD4+ T cells and decreases migration of CD11c+ and CD14+ PBMC towards cancer cells.,34602068_8,-1,-1,2,2,42969,-1,1.0915705e-05,6.0175585e-06,0.9999831
15205,cells,24,25,117,122,"BACKGROUND: The purpose of this study was to investigate the presence of CD4(+) CD25(+) FOXP3(+) regulatory T (Treg) cells both in peripheral blood and local tumors in patients with nasal inverted papilloma (NIP).METHODS: By using flow cytometry, the frequencies of CD4(+) CD25(+) FOXP3(+) Treg cells in both peripheral blood and tissues from 18 patients with NIP and 8 control subjects were determined.",21674673_0,-1,-1,2,2,15205,-1,1.156782e-05,6.9837342e-06,0.9999814
13458,cells,13,14,75,80,The majority of phospho-STAT6(pos) B cells were located at the vicinity of cells expressing the programmed death 1 (PD-1) T(FH) marker.,20944673_6,-1,-1,2,2,13458,-1,1.2435917e-05,6.5012714e-06,0.99998105
12532,T cells,19,21,106,113,We also found that these effects were exerted by the activated (CD44(high)) portion of Vgamma4 gammadelta T cells.,20525896_4,-1,-1,2,2,12532,-1,9.656464e-06,5.77318e-06,0.9999846
31374,cell,15,16,85,89,LAP-CD4+ and LAP+CD4+ T cells were isolated using a magnetic cell-sorting system and cell purity was analyzed by flow cytometry.,28210081_2,-1,-1,2,2,31374,-1,1.6636995e-05,6.394479e-06,0.9999769
38539,T cell,25,27,189,195,These findings warrant the development of specific immunotherapeutic strategies that selectively boost the activity of neoantigen-specific T cells and target the TGF- pathway to reinforce T cell reactivity in this patient group.,31888734_9,-1,-1,2,2,38539,-1,8.958942e-06,4.7823146e-06,0.9999863
19914,cells,17,18,108,113,The animal experiments indicated that the knockdown TGF-1 gene impaired the tumorigenic ability of Hepa1-6 cells.,23361571_8,-1,-1,2,2,19914,-1,1.4083251e-05,7.685426e-06,0.9999783
27145,T cells,9,11,51,58,RESULTS: It shows the percentages of CD4(+)CD25(+) T cells among CD4(+) T cells have no significant difference in MG patients compared with those in HCs.,26347149_9,-1,-1,2,2,27145,-1,9.481272e-06,5.157568e-06,0.99998534
26902,T cells,15,17,108,115,"Mechanistic investigations revealed that CCL5 activates CCR3, a highly expressed chemokine receptor on CD4 T cells, and also boosts Gfi1 expression to promote the differentiation of Th2 cells, which enhance the prometastatic activity of tumor-associated myeloid cells.",26249173_3,-1,-1,2,2,26902,-1,1.0407728e-05,8.349264e-06,0.9999813
35937,T cell,17,19,105,111,"We showed that Notch inhibition could enhances GVL while reducing GVHD via modulating host DCs and donor T cell activity, and the production of inflammatory cytokines.",30445020_8,-1,-1,2,2,35937,-1,1.2695377e-05,8.013604e-06,0.9999794
23996,cell,27,28,144,148,"METHODS: We evaluated the content and distribution of Foxp3(+) CD25(+) Treg and CD123(+) pDC infiltration and assessed CD8(+) /Foxp3(+) CD25(+) cell ratio at peritumoral and intratumoral levels in 40 SCCs (20 well-differentiated, G1; and 20 moderately to poorly differentiated, G2-G3) to investigate a correlation with their aggressiveness.",24910265_1,-1,-1,2,2,23996,-1,1.5299343e-05,7.358951e-06,0.99997735
31313,CTL,25,26,169,172,"Moreover, CD8+25+ Tregs inhibit CTLs through inducing CTL death via perforin-mediated apoptosis and through reducing effector CTL cytotoxic activity via down-regulating CTL perforin-production and degranulation.",28096300_6,-1,-1,2,2,31313,-1,1.9487588e-05,5.4400966e-06,0.9999751
1296,lymphocyte,5,6,32,42,IL-16 inhibits the CD3 mediated lymphocyte activation and proliferation.,12528894_1,-1,-1,2,2,1296,-1,1.3214139e-05,7.637516e-06,0.99997914
9140,cells,8,9,45,50,This study supports earlier data that T(reg) cells are present at higher frequencies in breast cancer patients compared with healthy individuals.,19277040_6,-1,-1,2,2,9140,-1,1.2470589e-05,8.76677e-06,0.99997866
18931,cells,11,12,79,84,These findings provide molecular insight into defective MHC-I expression in NB cells and provide the rational for T cell-based immunotherapy in NB variants refractory to conventional therapy.,23071666_8,-1,-1,2,2,18931,-1,1.0815335e-05,9.2352975e-06,0.99998
19022,cells,25,26,154,159,"The cell-type specificity of these effects was supported by the finding that Er-1, although unable to directly influence the growth of human glioma U-373 cells, induced Jurkat cells to synthesize and release factors that, in turn, inhibited the U-373 cell proliferation.",23103669_4,-1,-1,2,2,19022,-1,1.1411231e-05,6.4124424e-06,0.9999821
759,CTL,15,16,92,95,"These observations place constraints on the use of this, and potentially other, HPV-derived CTL epitopes for the immunotherapy of cervical cancer.",11673561_9,-1,-1,2,2,759,-1,2.5859197e-05,4.6771106e-06,0.9999695
39954,CD8+ T cell,5,9,34,45,"However, the mechanism underlying CD8+ T cell infiltration in colorectal tumor tissues is not fully understood.",32503584_1,-1,-1,2,2,39954,-1,2.6387755e-05,5.4322413e-06,0.9999682
22168,cells,20,21,135,140,"Activated STAT3 promotes survival and proliferation of cancer cells, suppresses Th1 immune response, and induces dysfunction of immune cells.",24407159_1,-1,-1,2,2,22168,-1,1.6241042e-05,6.3932994e-06,0.99997735
1095,cell,13,14,82,86,"Transforming growth factor beta (TGF-beta), a pleiotropic cytokine that regulates cell growth and differentiation, is secreted by many human tumors and markedly inhibits tumor-specific cellular immunity.",11964281_0,-1,-1,2,2,1095,-1,1.2693776e-05,6.3973657e-06,0.9999809
28688,cells,20,21,123,128,"The phenotype and secretome of GIFT4-treated CLL cells (GIFT4-CLL cells), and the immune stimulatory function of GIFT4-CLL cells on autologous T cells were analyzed by flow cytometry and luminex assay.",27118475_4,-1,-1,2,2,28688,-1,1.3223217e-05,8.291025e-06,0.9999784
29395,cells,9,10,57,62,The possibility of FoxP3 being expressed in B regulatory cells was suggested in many studies.,27339600_4,-1,-1,2,2,29395,-1,1.2674639e-05,1.0282635e-05,0.9999771
6106,cell,8,9,36,40,"To study the impact of JunB on mast cell biology, we analyzed JunB-deficient mast cells.",17982078_3,-1,-1,2,2,6106,-1,1.2746496e-05,7.270295e-06,0.99998
13329,cells,31,32,200,205,"Such early effectors, if present, should be characterized by a specific phenotype, distinct from that expressed at later stages of the antigen-induced differentiation program, by short-lived effector cells, memory precursors, and terminal effectors.",20861189_1,-1,-1,2,2,13329,-1,1.0191267e-05,7.814303e-06,0.999982
25322,B7-H4,4,5,26,31,OBJECTIVE: To investigate B7-H4 expression and its correlation with the number of infiltrating T lymphocytes and cytokine production by those lymphocytes in human cervical cancer and to determine the effect of recombinant B7-H4 on the active peripheral blood T cells of the patients in vitro.,25446402_0,-1,-1,2,2,25322,-1,3.1864773e-05,1.1874337e-05,0.99995625
14547,cells,4,5,25,30,"In contrast to dendritic cells, normal CMFs required exogenous interleukin-2 to induce proliferation of naturally occurring Treg cells.",21376048_5,-1,-1,2,2,14547,-1,1.3401689e-05,8.426142e-06,0.9999782
4164,T cells,27,29,158,165,"In addition, their functional activity resembled that of Treg, as evidenced by a poor proliferative capacity; suppression of proliferation of CD25- CD4 or CD8T cells and inhibition of interferon-gamma release by CD25- CD4+ T cells.",16799337_5,-1,-1,2,2,4164,-1,1.0337578e-05,6.8879995e-06,0.9999827
36242,cells,23,24,91,96,"The proliferation of CD4+ and CD8+ T cells, on the other hand, was not affected by CD27+ B cells.",30711567_9,-1,-1,2,2,36242,-1,1.3830571e-05,9.882813e-06,0.9999763
16902,cell,23,24,119,123,"CD25- FOXP3- T cells with CD127- IL-10+ phenoype are inducible in vitro from naive CD4(+) T cells, in which programmed cell death 1 ligand 1, immunoglobulin-like transcript 4 and human leukocyte antigen G are involved.. In conclusion, CD25- FOXP3- Tregs with suppressive capacity are increased in patients with HCC, suggesting their distinct roles from CD25+ FOXP3+ Tregs.",22419479_10,-1,-1,2,2,16902,-1,2.3228164e-05,8.369558e-06,0.9999684
1147,cellular,12,13,81,89,"In T cells, calcineurin-NFAT signaling represents a critical event for mediating cellular activation and the immune response.",12091710_1,-1,-1,2,2,1147,-1,1.31817815e-05,6.4335877e-06,0.99998033
41108,cells,10,11,51,56,Accumulation of CD103+CD8+ resident memory T (TRM) cells in human lung tumors has been associated with a favorable prognosis.,33205076_0,-1,-1,2,2,41108,-1,1.4151388e-05,7.5466724e-06,0.9999783
33835,T cells,17,19,103,110,"Although CD26neg T cells possess a regulatory phenotype, CD26int T cells are mainly naive and CD26high T cells appear terminally differentiated and exhausted.",29213079_2,-1,-1,2,2,33835,-1,8.9825435e-06,5.044121e-06,0.99998605
43375,cell,37,38,224,228,"We found enhanced circulating regulatory (TGF-+ and PD-L1+) and reduced pro-inflammatory TNF-+ B cell populations in patients compared with healthy volunteers (HVs), including lower IFN-+:IL-4+and higher TGF-+:TNF-+ B cell ratios in patients.",35909944_2,-1,-1,2,2,43375,-1,1.1567824e-05,9.6744725e-06,0.9999788
43335,Treg cells,1,3,4,14,How Treg cells adapt to environmental signals to orchestrate their homeostasis and functions remains poorly understood.,35895684_1,-1,-1,2,2,43335,-1,1.3088039e-05,1.1792763e-05,0.9999751
389,cells,9,10,49,54,"Naive NK cells, when co-cultured with fixed AK-5 cells, were induced to express CD40L.",11129327_7,-1,-1,2,2,389,-1,1.4559668e-05,8.042123e-06,0.99997747
16239,cells,27,28,180,185,"Interestingly, miR-135b suppressed T-helper (Th) 2 master regulators STAT6 and GATA3, and miR-135b blockade attenuated IL-17 production and paracrine inflammatory response by ALCL cells, indicating that miR-135b-mediated Th2 suppression may lead to the skewing to ALCL immunophenotype overlapping with Th17 cells.",22042699_6,-1,-1,2,2,16239,-1,3.7548354e-05,5.9306594e-06,0.9999565
40463,T cells,8,10,49,56,In vivo expansion of adoptively transferred CD8+ T cells is a critical determinant of successful adoptive T cell therapy.,32848036_0,-1,-1,2,2,40463,-1,9.962288e-06,5.506532e-06,0.9999845
35224,cells,4,5,26,31,"When cultured with cancer cells, control PSCs expressed 10-fold higher levels of CXCL12 than p50-/- PSCs.",29909021_13,-1,-1,2,2,35224,-1,1.570608e-05,9.351584e-06,0.99997497
23889,cells,27,28,156,161,"In addition, mice treated with dendritic cells pulsed with the EWS/FLI-1 epitope were able to reject a lethal tumor inoculation of the Ewing's sarcoma A673 cells.",24861249_3,-1,-1,2,2,23889,-1,1.38904325e-05,6.489505e-06,0.9999796
15053,cell,24,25,145,149,The aim of the study was to observe the variation of CD4(+)CD25(+) regulatory T cells in periphery blood and tumor microenvironment of non-small cell lung cancer (NSCLC) patients and the effects of CpG ODN.,21611754_0,-1,-1,2,2,15053,-1,2.1122174e-05,9.464175e-06,0.9999695
17591,regulatory T cells,61,64,269,287,"At 6 months following the first vaccination, flow cytometric analysis demonstrated a significant increase in the frequency of CD4+ICOS(hi) T cells from 52% pre-vaccination to 234% (p<0.001), with a concomitant decrease in the frequency of CD4+FoxP3+ T cells (regulatory T cells [Treg]) from 196 to 105% (p<0.05).",22678162_5,-1,-1,2,2,17591,-1,1.169823e-05,5.133233e-06,0.9999832
28878,cells,14,15,78,83,"Moreover, C-C chemokine receptor 4 (CCR4) was specifically expressed by aTreg cells in the peripheral blood of HNSCC patients.",27177223_3,-1,-1,2,2,28878,-1,9.773821e-06,7.671443e-06,0.9999826
13239,cells,19,20,121,126,BACKGROUND: Natural killer (NK) cells derived from patients with cancer exhibit diminished cytotoxicity compared with NK cells from healthy individuals.,20849361_0,-1,-1,2,2,13239,-1,1.2577693e-05,8.515445e-06,0.9999789
2256,lymphocyte,6,7,47,57,Gammadelta T cells represent an unconventional lymphocyte population that shares characteristics of NK cells and T cells and links innate and adaptive immunity.,15498816_1,-1,-1,2,2,2256,-1,1.1681767e-05,9.496294e-06,0.9999788
15790,T cell,9,11,55,61,The novel targeted vaccine induced durable Th1 and CD8 T cell responses to poorly immunogenic self/tumor antigen (Ag) and attenuated tumor-associated Treg suppressive function.,21934655_4,-1,-1,2,2,15790,-1,1.2645822e-05,5.190404e-06,0.9999821
31697,CTLs,1,2,7,11,"Memory CTLs responded more quickly and with greater strength than their naive counterparts upon stimulation, which is associated with higher upregulation of important transcription factors such as T-bet and phosphorylated STAT4.",28405920_6,-1,-1,2,2,31697,-1,3.9220515e-05,5.3502285e-06,0.9999554
17915,cell,11,12,92,96,"Aberrant Stat3 activation and signaling contribute to malignant transformation by promoting cell cycle progression, inhibiting apoptosis, and mediating tumor immune evasion.",22753933_0,-1,-1,2,2,17915,-1,3.209052e-05,1.0248278e-05,0.9999577
28304,cells,28,29,174,179,"The improved prognosis of HPV-positive OPSCC is thus correlated with higher numbers of tumor-infiltrating T cells, more active Th17 cells and lower numbers of IL-17(+) non-T cells.",26899388_10,-1,-1,2,2,28304,-1,1.2047221e-05,8.145645e-06,0.99997985
22202,regulatory T cells,9,12,66,84,TGF is reportedly responsible for accumulation of CD4(+)Foxp3(+) regulatory T cells (Tregs) in tumor.,24416401_0,-1,-1,2,2,22202,-1,7.895463e-06,5.96223e-06,0.9999862
18015,cells,11,12,74,79,"One critical mechanism involves the accumulation of FOXP3(+) T regulatory cells (Treg), a class of suppressive T cells that prevent excessive tissue destruction caused by unchecked immune responses.",22798340_1,-1,-1,2,2,18015,-1,1.14490385e-05,7.839111e-06,0.9999807
33142,cells,10,11,64,69,Anti-TIM-4 downregulated T-bet and IFN- expression by TIM-4+ B cells and indirectly increased IL-10 expression by TIM-1+ B cells.,28848066_11,-1,-1,2,2,33142,-1,1.3882195e-05,1.0323989e-05,0.9999758
23304,T cells,7,9,42,49,"Furthermore, the role of IL-17(+)Foxp3(+) T cells in tumorigenesis and clinical implications in cancer therapy are discussed in this review.",24744433_6,-1,-1,2,2,23304,-1,1.25663155e-05,6.6810776e-06,0.9999808
33065,T cells,14,16,123,130,"These tumor-associated CD45RA-CCR7- Treg subset exerted superior immunosuppressive properties to effectively suppress CD8+ T cells' anti-tumor function including CD8+ T-cell IFN- and granzyme B (GrB) production as well as CD8+ T-cell proliferation in vitro, and also contributed to the growth and progression of human gastric tumors in vivo, via IL-10 secretion and cell-cell contact mechanisms.",28817117_5,-1,-1,2,2,33065,-1,9.407073e-06,4.6991445e-06,0.99998593
2254,T cells,22,24,120,127,The killer cell lectin-like receptor G1 (KLRG1) is expressed in natural killer (NK) cells and effector memory alphabeta T cells.,15498816_0,-1,-1,2,2,2254,-1,8.702912e-06,5.008631e-06,0.9999863
25981,cells,17,18,98,103,"The frequency, immunosuppressive phenotype, and activation status of Treg and natural killer (NK) cells were analyzed in the circulation and tumor microenvironment of cetuximab-treated patients with HNSCC enrolled in a novel neoadjuvant, single-agent cetuximab clinical trial.",25832655_2,-1,-1,2,2,25981,-1,1.2877573e-05,8.244178e-06,0.9999789
14342,cells,26,27,207,212,"CONCLUSIONS: These data demonstrate that the PKR- and NF-B-dependent induction of pro-inflammatory molecules that accompanies reovirus-mediated killing can recruit and activate innate and adaptive effector cells, thus potentially altering the tumour microenvironment to support bystander immune-mediated therapy as well as direct viral oncolysis.",21338484_7,-1,-1,2,2,14342,-1,1.5253443e-05,8.025201e-06,0.99997675
33093,subsets,1,2,5,12,"Such subsets likely explain why B cell depletion can either ameliorate or exacerbate inflammatory diseases; however, these cells remain poorly understood because of the absence of specific markers.",28848066_1,-1,-1,2,2,33093,-1,2.0510288e-05,7.739893e-06,0.99997175
17192,lymphocytes,18,19,113,124,"LCs synthesize the highest amounts of IL-15R- mRNA and protein, which binds IL-15 for presentation to responder lymphocytes, thereby signaling the phosphorylation of signal transducer and activator of transcription 5 (pSTAT5).",22510877_2,-1,-1,2,2,17192,-1,1.772629e-05,1.0442127e-05,0.99997175
6736,T cells,16,18,63,70,"In this study, we show that the frequency of AFP(46-55) CD4(+) T cells is significantly higher (p = 001) in patients with hepatocellular carcinoma than in healthy donors, suggesting that these cells are expanded in response to tumor Ag.",18354237_5,-1,-1,2,2,6736,-1,9.050133e-06,5.350676e-06,0.9999856
17590,T cells,58,60,260,267,"At 6 months following the first vaccination, flow cytometric analysis demonstrated a significant increase in the frequency of CD4+ICOS(hi) T cells from 52% pre-vaccination to 234% (p<0.001), with a concomitant decrease in the frequency of CD4+FoxP3+ T cells (regulatory T cells [Treg]) from 196 to 105% (p<0.05).",22678162_5,-1,-1,2,2,17590,-1,8.680278e-06,4.5696597e-06,0.99998677
38377,cell-to-cell,34,35,211,223,"Tregs express transcription factor forkhead box P3 (FOXP3), which allows regulation of the immune response through anti-inflammatory cytokines such as IL-10 or transforming growth factor beta (TGF-) and direct cell-to-cell interaction.",31827925_3,-1,-1,2,2,38377,-1,5.1741376e-05,3.371496e-05,0.9999145
14831,cellular,7,8,36,44,AIM: To elucidate the molecular and cellular features responsible for the increase of regulatory T cells (Tregs) in gastric cancer.,21528082_0,-1,-1,2,2,14831,-1,1.5307747e-05,6.645537e-06,0.99997807
2534,NKT cells,10,12,46,55,Group E mice were transplanted with 1 x 10(6) NKT cells from HBV-immunized donors.,15688366_6,-1,-1,2,2,2534,-1,3.5149504e-05,7.421958e-05,0.99989057
13256,cell,8,9,39,43,Donor DNA was detected 7 days after NK cell infusion in 9/13 (69%) patients without TBI and 6/7 (85%) with TBI.,20849361_8,-1,-1,2,2,13256,-1,1.9171752e-05,8.13592e-06,0.9999727
43368,cells,7,8,70,75,"We investigated regulatory and pro-inflammatory cytokine-expressing B cells in patients with melanoma by flow cytometric intracellular cytokine, CyTOF, transcriptomic, immunofluorescence, single-cell RNA-seq, and B:T cell co-culture analyses.",35909944_1,-1,-1,2,2,43368,-1,1.1444549e-05,9.026942e-06,0.9999795
24513,T cell,20,22,126,132,"These results suggest that GA-Me contributing to IDO helps to create a tolerogenic milieu in lung tumors by directly inducing T cell apoptosis, restraining CD8+ T cell activation, and enhancing Treg-mediated immunosuppression.",25138378_12,-1,-1,2,2,24513,-1,1.2778223e-05,6.5486734e-06,0.9999807
28612,cell,17,18,88,92,"Regulatory T cells (T-regs) contribute to tumour immune escape, but their role in basal cell carcinoma (BCC) is not understood.",27117439_1,-1,-1,2,2,28612,-1,1.4357106e-05,7.0560914e-06,0.99997866
32175,enzymes,6,7,40,47,Histone acetylation and the families of enzymes responsible for controlling these epigenetic marks have been implicated in regulating T-cell maturation and phenotype.,28550044_0,-1,-1,2,2,32175,-1,0.0010784368,0.9985127,0.00040890998
34701,T-cell proliferation,28,30,189,209,"Pazopanib improved DC differentiation and performance by promoting upregulation of the maturation markers HLA-DR, CD40, and CCR7; decreasing IL10 production and endocytosis; and increasing T-cell proliferation.",29700053_4,-1,-1,2,2,34701,-1,1.2251325e-05,5.8359324e-06,0.9999819
2201,cells,89,90,394,399,"Compared with melanoma patients, healthy donors had higher basal levels of P-STAT1 (specific fluorescence [Fsp]; i.e., Fsp(PBS), the level of P-STAT1 in PBS-treated cells) in total PBMCs, natural killer (NK) cells, and T cells (mean Fsp(PBS) in total PBMCs: 5.5 in healthy donors versus 1.6 in patients, difference = 3.9, 95% confidence interval [CI] = 1.4 to 6.5, P =.004; mean Fsp(PBS) in NK cells: 4.6 in healthy donors versus 0.9 in patients, difference = 3.7, 95% CI = 1.7 to 5.7, P =.001; mean Fsp(PBS) in T cells: 6.8 in healthy donors versus 0.9 in patients, difference = 5.9, 95% CI = 2.5 to 9.3, P =.002).",15339971_7,-1,-1,2,2,2201,-1,1.1495319e-05,8.774517e-06,0.99997973
39872,Regulatory T cells,0,3,0,18,Regulatory T cells (Tregs) is one of the immunosuppressive subsets of CD4+ T cells characterized by transcription factor forkhead box protein P3 (FOXP3) expression which are involved in tumor development and progression.,32480291_0,-1,-1,2,2,39872,-1,8.8588695e-06,4.708604e-06,0.9999865
15436,cell-mediated immunity,7,9,33,55,T cells are the key mediators in cell-mediated immunity.,21740230_0,-1,-1,2,2,15436,-1,0.0004096521,3.215197e-05,0.99955815
38397,cells,19,20,135,140,This is facilitated by metastatic niches that are either postformed through reciprocal signaling between tumor cells and local stromal cells or preformed as premetastatic niches before tumor cell arrival.,31848193_1,-1,-1,2,2,38397,-1,1.9976256e-05,6.0613397e-06,0.9999739
2068,lymphocytes,11,12,54,65,"In some cases, the presence of T(reg) type 1/Th3-like lymphocytes could also be demonstrated.",15240741_5,-1,-1,2,2,2068,-1,1.1599488e-05,7.526596e-06,0.9999809
37581,T cells,38,40,213,220,"Our results supported the notion that, upon engagement with the cognate receptors, CD137 ligand and CD40 initiates activation of nuclear factor-kappa B (NF-B) signaling in tumor cells even in the absence of CD8+ T cells.",31427736_4,-1,-1,2,2,37581,-1,8.904215e-06,5.7140987e-06,0.99998534
4408,cells,10,11,71,76,"Although, delayed tumor growth was observed when CD40L-expressing OVHM cells and OVHM cells were injected simultaneously and contralaterally, the tumor growth of OVHM and CD40L/OVHM in BALB/c nude mice was not different.",16965650_10,-1,-1,2,2,4408,-1,1.7467462e-05,7.3371825e-06,0.9999751
26553,T cells,2,4,20,27,"Restoring exhausted T cells represents an inspiring strategy for cancer treatment, which has yielded promising results and become a significant breakthrough in the cancer immunotherapy.",26086965_2,-1,-1,2,2,26553,-1,1.3442179e-05,6.2557197e-06,0.99998033
34032,cells,6,7,32,37,METHODS: Melanoma cell line B16 cells were transfected by lentivirus containing mouse Notch1 gene or Notch1 shRNA to generate B16 cell line that highly or lowly expressed Notch1.,29301578_2,-1,-1,2,2,34032,-1,1.4542079e-05,8.499454e-06,0.999977
24289,cell,6,7,43,47,"Of the expanded monocytic and granulocytic cell populations of MDSCs, the monocytic subset was the predominant source of OPN.",25035397_5,-1,-1,2,2,24289,-1,1.4470788e-05,7.702218e-06,0.9999778
34576,cells,8,9,30,35,The type 1 regulatory T (Tr1) cells have recently emerged as a critical participant in maintaining self-tolerance.,29625086_2,-1,-1,2,2,34576,-1,1.2945903e-05,7.983122e-06,0.999979
38363,cells,4,5,24,29,"CD4+FOXP3+ T regulatory cells, also known as Tregs, have a central role maintaining tissue homeostasis during immune responses.",31827925_1,-1,-1,2,2,38363,-1,1.1486792e-05,7.0446135e-06,0.9999815
13349,CTLA-4,13,14,63,69,"CD8(+) FOXP3(+) T cells did not express markers of regulatory [CTLA-4, CCL4, interleukin-10 (IL-10), transforming growth factor-1], exhausted (PD-1), or senescent (CD57) CD8(+) T lymphocytes.",20861189_5,-1,-1,2,2,13349,-1,4.604111e-05,1.3744595e-05,0.9999403
12062,Treg cells,10,12,62,72,"Further, the results indicate that the IL-2-induced effect on Treg cells is reversible and declines shortly after termination of IL-2 treatment.",20386464_7,-1,-1,2,2,12062,-1,1.509569e-05,1.5706946e-05,0.9999691
27290,cells,22,23,128,133,"The glucocorticoid-induced TNFR family-related protein (GITR, TNFRSF18, CD357) is expressed on effector and regulatory T (Treg) cells.",26423152_0,-1,-1,2,2,27290,-1,1.0605239e-05,9.179794e-06,0.9999802
4956,cell,1,2,23,27,Fluorescence-activated cell sorter (FACS) analysis of the composition of lung leukocytes further indicates that the removal of tumors also leads to the reduction of MSCs accumulated in the lung.,17244679_4,-1,-1,2,2,4956,-1,3.084035e-05,7.655013e-06,0.9999615
17738,T-cell proliferation,16,18,96,116,The suppressive function of CD8(+)Foxp3(+) T lymphocytes was analyzed by their effect on CD4(+) T-cell proliferation and IFN- production.,22729557_4,-1,-1,2,2,17738,-1,1.3755592e-05,7.397536e-06,0.9999789
23423,cells,22,23,116,121,The expression of an apoptosis marker (annexin V) and the death receptor Fas in CD8+T cells and FasL in CD3+Foxp3+T cells were evaluated.,24761872_4,-1,-1,2,2,23423,-1,1.2918683e-05,9.208779e-06,0.99997795
20247,Tcells,6,9,30,37,"Similarly, Mir155(-/-) CD8(+) Tcells were ineffective at controlling tumor growth, whereas miRNA-155 overexpression enhanced the antitumor response.",23601686_3,-1,-1,2,2,20247,-1,9.80022e-06,5.366555e-06,0.99998486
16997,cells,17,18,96,101,Our data clearly show that IL-15 signaling in NK cells is different from that of myeloid immune cells.,22447977_6,-1,-1,2,2,16997,-1,1.567841e-05,7.431688e-06,0.9999769
29960,cell,20,21,90,94,"The observed changes are due, at least in part, to an increase in both CD1D mRNA and CD1d cell surface expression.",27614429_6,-1,-1,2,2,29960,-1,1.3743671e-05,7.3853057e-06,0.9999789
3561,T cells,24,26,157,164,"Primary cutaneous T cell lymphomas (CTCL) represent the most frequently occurring group of extra-nodal T cell lymphomas, originating from skin-homing memory T cells.",16457762_0,-1,-1,2,2,3561,-1,8.673418e-06,4.6854993e-06,0.99998665
33800,cell,16,17,132,136,Metabolic shifts in mitochondrial dynamics may be involved in Toll-like receptor agonist-mediated inflammatory responses and immune cell polarization.,29180626_1,-1,-1,2,2,33800,-1,1.899665e-05,6.3819507e-06,0.9999746
33651,CTL,11,12,80,83,"Furthermore, a cocktail containing the four HLA-A24 peptides evoked MM-specific CTL with distinct phenotypic profiles (CD28, CD40L, 41BB, CD38, CD69) and anti-tumor activities, evidenced by perforin upregulation, CD107a degranulation (cytotoxicity) and Th1-type cytokines (IFN-/IL-2/TNF-) production in response to HLA-A24+ MM cells.",29089645_3,-1,-1,2,2,33651,-1,1.395814e-05,4.7390236e-06,0.9999813
12597,cells,7,8,24,29,The number of CD163 (+) cells was more closely associated with them.,20545696_6,-1,-1,2,2,12597,-1,1.495763e-05,8.311356e-06,0.99997675
17426,cells,36,37,183,188,Surface expression of the IL-2 receptor -chain (CD25) has been used to discriminate between CD4(+) CD25(HI) FOXP3(+) regulatory T (Treg) cells and CD4(+) CD25(NEG) FOXP3(-) non-Treg cells.,22585674_0,-1,-1,2,2,17426,-1,1.1012876e-05,7.816823e-06,0.99998116
32469,T cells,13,15,87,94,"Furthermore, vectored delivery of IL-2 significantly enhanced the infiltration of CD8+ T cells, M1-like macrophages, and B-cells while systemic rIL-2 increased CD25+FoxP3+ T cells at the tumor.",28614908_5,-1,-1,2,2,32469,-1,1.0050916e-05,6.227325e-06,0.9999838
23026,CTLs,29,30,154,158,"The effects of MDPF on the growth of mouse S180 sarcoma, splenocyte proliferation, the activity of natural killer (NK) cells and cytotoxic T lymphocytes (CTLs), production and mRNA expression of cytokines from splenocytes, and serum antigen-specific antibody levels in tumor-bearing mice were measured.",24690776_5,-1,-1,2,2,23026,-1,1.784809e-05,4.2619367e-06,0.9999778
12959,cells,10,11,65,70,"Possible mechanisms included: (i) decreases in immunosuppressive cells such as myeloid-derived suppressor cells (MDSC), T-regulatory cells (T-regs), and B-cells, (ii) stimulation of memory cells by intratumoral antigen release leading to efficient cross-priming, (iii) alteration of the tumor microenvironment with production of ""danger signals"" and immunostimulatory cytokines, and (iv) augmented trafficking of T-cells into the tumors.",20683443_5,-1,-1,2,2,12959,-1,1.2820474e-05,8.017585e-06,0.99997914
14716,T cells,13,15,59,66,"In tumor, spleen and blood, the number of cytotoxic CD8(+) T cells and CD57(+) natural killer cells and the levels of IL-10 increased, but that of tumor necrosis factor- (TNF-), IL-1 and IL-6 decreased.",21423208_5,-1,-1,2,2,14716,-1,9.582165e-06,5.9859663e-06,0.9999845
14907,cells,14,15,91,96,"In this study, we validated Foxp3 expression in both tumor-infiltrating Tregs and melanoma cells by performing immunohistochemical analysis of human melanoma tissue sections.",21547596_2,-1,-1,2,2,14907,-1,1.35741975e-05,5.9069857e-06,0.99998045
25425,T cells,7,9,37,44,"In tumors with CD8 TIL, CD25FoxP3 T cells showed a strong positive association with patient survival (HR, 0.56; P = 0.02), which exceeded the negative effect of Tregs (HR, 1.55; P = 0.09).",25480168_6,-1,-1,2,2,25425,-1,8.637955e-06,5.703354e-06,0.9999857
9083,T cells,22,24,138,145,"Conspicuously among the latter is the immunoglobulin-like transcript 3 (ILT3), which independently prevents the activation of both DC and T cells.",19275918_4,-1,-1,2,2,9083,-1,9.525122e-06,5.83871e-06,0.9999846
26175,T cells,16,18,98,105,"Similarly, human XBP1 improved the capacity of human blood- and skin-derived DC to activate human T cells.",25972487_6,-1,-1,2,2,26175,-1,1.0369241e-05,6.1082333e-06,0.99998355
24846,cells,25,26,186,191,SAP-deficient 24 transgenic T cells (24 T cells) exhibited an immature phenotype with reduced Th2 cytokine-producing capacity and diminished cytotoxicity to CD1d-expressing lymphoma cells.,25236978_4,-1,-1,2,2,24846,-1,1.0651727e-05,7.837967e-06,0.9999815
40755,T lymphocyte,18,20,92,104,"Early growth response genes 2 (Egr2) and 3 (Egr3) maintain immune homeostasis by modulating T lymphocyte development, inhibiting effector T cell function, and promoting the induction of regulatory T cells.",33011290_1,-1,-1,2,2,40755,-1,8.273824e-06,6.350286e-06,0.99998546
29984,T cells,9,11,55,62,CD4+CD25-FoxP3+ cells are a newly recognized subset of T cells which was first reported in autoimmune diseases.,27619682_0,-1,-1,2,2,29984,-1,8.508296e-06,4.7894005e-06,0.99998677
13674,T cells,11,13,70,77,"In the presence of tremelimumab, frequencies of IL-2-secreting CD4(+) T cells and IFN--secreting CD4(+) and CD8(+) T cells were increased in response to polyclonal activation and tumor antigens.",21056008_4,-1,-1,2,2,13674,-1,1.0646955e-05,6.768908e-06,0.9999826
13964,T cell,7,9,43,49,Members of the nuclear factor of activated T cell (NFAT) family of transcription factors were originally described in T lymphocytes but later shown to be expressed in several immune and non-immune cell types.,21225259_0,-1,-1,2,2,13964,-1,8.879565e-06,5.692039e-06,0.99998546
36122,IL-32,11,12,53,58,"In this review, we will address the function of each IL-32 isoform in different cancer types studied to date, and suggest further strategies to comprehensively elucidate the roles of IL-32 in a contextdependent manner. [BMB Reports 2019; 52(3): 165-174].",30638183_8,-1,-1,2,2,36122,-1,0.00010532388,3.5019864e-05,0.9998596
36972,cells,3,4,14,19,BACKGROUND: B cells can increase the expression of granzyme B in CD8+ T cells through 4-1BBL/4-1BB interaction and promote anti-tumor immunity.,31182685_0,-1,-1,2,2,36972,-1,1.3703783e-05,9.869788e-06,0.9999764
34886,CD28,26,27,157,161,"Thus, we investigated the prevalence of Tregs and the relationship between them and TGF- and IL-10 concentrations and measured expression of FOXP3, CTLA-4, CD28, and GITR genes, as well as protein expression of selected genes in benign effusions and MPEs.",29785404_2,-1,-1,2,2,34886,-1,5.129813e-05,8.850459e-06,0.9999399
29630,cells,6,7,46,51,The frequency of peripheral blood mononuclear cells secreting IFN- and perforin was significantly (P<0.05) increased in HPV-vaccinated versus nonvaccinated volunteers.,27548034_7,-1,-1,2,2,29630,-1,1.699735e-05,7.565069e-06,0.99997544
36886,CTLA-4,18,19,87,93,"Membrane GITRL on Tregs and expression of Helios and other markers (FOXP3, CD25, CD39, CTLA-4, PD-L1 and IL-10) involved in immunosuppressive activity were determined by flow cytometry.",31118027_6,-1,-1,2,2,36886,-1,7.988701e-05,1.9196686e-05,0.99990094
41381,T cells,22,24,133,140,"We further show that TR1 cell-mediated control of TCL1 leukemia requires IL-10 receptor (IL-10R) signaling, as Il10rb-deficient CD4+ T cells showed impaired antileukemia activity.",33526861_6,-1,-1,2,2,41381,-1,9.491726e-06,5.6571253e-06,0.99998486
41685,T cell-suppressive,23,25,145,163,"Finally, while chemotherapy is able to significantly reduce circulating MDSCs' level in patients with breast cancer, these MDSCs remained highly T cell-suppressive.",33679700_11,-1,-1,2,2,41685,-1,0.0003174249,0.0008425945,0.99884003
11089,regulatory T cells,8,11,84,102,"Pancreatitis-specific IL-10 responses were mediated by IL-10(+)IFN-gamma(-)FoxP3(+) regulatory T cells, which were expanded in the blood, bone marrow, and pancreatitis lesions and possessed the potential to suppress the proliferation of autologous conventional T cells in an antigen-specific manner.",19931255_9,-1,-1,2,2,11089,-1,8.504842e-06,6.399711e-06,0.9999851
20473,T cell,2,4,14,20,We determined T cell polarization in TSCC and SCC by intracellular cytokine staining of T cell crawl outs from human skin explants.,23667456_2,-1,-1,2,2,20473,-1,8.210142e-06,5.1626976e-06,0.99998665
41680,T cells,14,16,88,95,"This also alters the expression of critical cytokines and transcription factors in CD3+ T cells and, importantly, reduces breast cancer cells' proliferation.",33679700_10,-1,-1,2,2,41680,-1,8.2084325e-06,5.6110152e-06,0.9999862
37955,cells,29,30,195,200,We aimed to investigate the frequency of these cells and their ability to produce cytokines in tumor-draining lymph nodes from patients with breast cancer (BC).MATERIALS AND METHODS: Mononuclear cells from lymph nodes of 20 patients with BC were activated and stained for appropriate markers.,31630080_1,-1,-1,2,2,37955,-1,1.6110744e-05,5.9479316e-06,0.99997795
13323,T cells,2,4,7,14,CD8(+) T cells at the earliest stage of effector generation have not been identified at tumor site of melanoma patients.,20861189_0,-1,-1,2,2,13323,-1,1.0054837e-05,5.267948e-06,0.99998474
2838,T cells,13,15,90,97,IL-27 induced synergistic IFN-gamma production with IL-12 and proliferation of naive CD8+ T cells.,16034109_4,-1,-1,2,2,2838,-1,1.1596173e-05,7.181801e-06,0.9999813
40972,T cells,14,16,91,98,"Furthermore, Ocs-P administration enhanced the generation of multifunctional CD4+ and CD8+ T cells expressing Th1-type cytokines (TNF-, IFN-, and IL-2) and the degranulation marker (CD107a).",33105813_5,-1,-1,2,2,40972,-1,8.8224815e-06,5.438458e-06,0.9999857
26632,cell,16,17,91,95,"S100A8/A9 is a major component of the acute phase of inflammation, and appears to regulate cell proliferation, redox regulation and chemotaxis.",26165843_0,-1,-1,2,2,26632,-1,1.2334154e-05,6.3952516e-06,0.9999813
12797,B7,24,25,112,114,"RESULTS: Syngeneic BALB/c mice injected with H22/B7-1/B7-2/4-1BBL cells that expressed elevated levels of B7-1, B7-2 and 4-1BBL showed a tumor development frequency of 50% compared with 100% in mice injected with the H22 parental line, H22/neo, H22/B7-1/B7-2 and H22/4-1BBL.",20563597_5,-1,-1,2,2,12797,-1,3.2504908e-05,1.0925527e-05,0.9999565
799,T cells,13,15,82,89,We show that nuclear translocation of NFATc and NF-kappaB are markedly reduced in T cells activated in the presence of primary AML cells.,11698483_8,-1,-1,2,2,799,-1,7.83622e-06,4.5769207e-06,0.9999876
35967,cellular,9,10,52,60,"Inhibition of Notch signaling by GSI did not affect cellular proliferation, but reduced IL-22 production in CD4+ T cells from BALF, along with down-regulation of AhR, but not RORt.",30473538_10,-1,-1,2,2,35967,-1,1.4147971e-05,6.7609353e-06,0.999979
15224,Treg cell,13,15,68,77,RESULTS: Patients with NIP showed increased CD4(+) CD25(+) FOXP3(+) Treg cell frequencies in tumor tissues and CD4(+) T cell fraction rather than in peripheral blood.,21674673_3,-1,-1,2,2,15224,-1,1.8473998e-05,1.7043212e-05,0.9999645
4210,cells,12,13,100,105,"Intracellular cytokine staining revealed a high frequency of IL-10-secreting macrophages, dendritic cells, and CD4+ and CD8+ T cells infiltrating the tumor.",16818744_3,-1,-1,2,2,4210,-1,1.3188857e-05,6.625636e-06,0.9999801
11988,T cells,25,27,171,178,"Antitumor activity and immunity feedback to GOLFIG were strictly correlated with the best outcome observed in patients with autoimmunity signs, increase of central memory T cells, and decrease of regulatory T cells (Treg) in the peripheral blood.",20386463_1,-1,-1,2,2,11988,-1,8.971547e-06,6.330406e-06,0.99998474
37058,regulatory T cells,16,19,112,130,"Furthermore, an increase in intratumoral pDCs was associated with increased intratumoral infiltration of Foxp3+ regulatory T cells and IL-17-producing cells and correlated with tumor vascular density.",31201473_6,-1,-1,2,2,37058,-1,9.359834e-06,6.42984e-06,0.99998415
35738,T cells,19,21,109,116,"Interestingly, in the absence of autologous lymphomas, the granzyme B and perforin expression levels in CD8+ T cells from patients with MYD88 WT lymphomas and from patients with MYD88 L265P mutant lymphomas were comparable; however, in the presence of autologous lymphomas, the CD8+ T cells from patients with MYD88 L265P mutant lymphomas presented significantly lower granzyme B and perforin expression than CD8+ T cells from patients with MYD88 WT lymphomas.",30253331_4,-1,-1,2,2,35738,-1,1.0181055e-05,5.3706285e-06,0.9999845
25140,Treg cells,29,31,169,179,"The focus of this study is to define the interaction between tumour and immune system, i.e. how immune tolerance starts and gradually leads to the induction of adaptive Treg cells in the tumour microenvironment.",25284464_2,-1,-1,2,2,25140,-1,1.1167556e-05,8.3310515e-06,0.99998045
2220,cells,17,18,104,109,CONCLUSION: This flow cytometry method can be used to monitor STAT1 activation within subsets of immune cells from patients undergoing IFN alpha immunotherapy.,15339971_10,-1,-1,2,2,2220,-1,1.6630154e-05,6.564705e-06,0.99997675
33085,cells,1,2,2,7,"B cells give rise to polarized subsets, including B effector 1 (Be1) cells and regulatory B cells, which can promote or inhibit immune responses through expression of IFN- and IL-10, respectively.",28848066_0,-1,-1,2,2,33085,-1,1.1759765e-05,9.552819e-06,0.99997866
12522,T cells,14,16,99,106,Vgamma1 and Vgamma4 gammadelta T cells are the principal subsets of peripheral lymphoid gammadelta T cells and they might play distinct roles in tumor immunity.,20525896_2,-1,-1,2,2,12522,-1,1.10520305e-05,5.4027614e-06,0.99998355
43033,cells,7,8,43,48,Here we find that lung mesenchymal stromal cells (LMSCs) at pre-metastatic stage possess potent metastasis-promoting activity.,34707103_1,-1,-1,2,2,43033,-1,2.3338986e-05,6.4205838e-06,0.9999702
13166,cell,13,14,95,99,Accumulation of myeloid-derived suppressor cell (MDSC) associated with inhibition of dendritic cell (DC) function is one of the major immunological abnormalities in cancer.,20822377_1,-1,-1,2,2,13166,-1,1.7205148e-05,6.877293e-06,0.9999759
15082,regulatory T cells,11,14,65,83,"In conclusion, a rise in the proportion of CD4(+)CD25(+)Foxp3(+) regulatory T cells was demonstrated in the periphery blood and tumor microenvironments of NSCLC patients.",21611754_6,-1,-1,2,2,15082,-1,8.915178e-06,6.452443e-06,0.9999846
5388,T cells,6,8,37,44,"Of 25 significantly altered genes in T cells and B cells from melanoma patients, 17 are interferon (IFN)-stimulated genes.",17488182_3,-1,-1,2,2,5388,-1,8.409171e-06,5.7515517e-06,0.9999858
14734,cell,25,26,148,152,"In addition, when IL-32 was knocked down by small interfering RNA (siRNA) or neutralized with an anti-IL-32 antibody, IL-32-induced colon cancer cell growth inhibition, the IL-32-induced decrease of TNF-, IL-1 and IL-6 production, and the increase of IL-10 production were abolished.",21423208_7,-1,-1,2,2,14734,-1,1.3432289e-05,7.836502e-06,0.99997866
38657,regulatory T cells,17,20,105,123,"Accordingly, IRISOE TNBC tumors had significantly few CD8+/PD-1+ cytotoxic T cells and more CD25+/FOXP3+ regulatory T cells.",31911557_7,-1,-1,2,2,38657,-1,8.8859215e-06,6.139223e-06,0.99998486
10542,B7-H1,4,5,30,35,Pancreas cancer patients with B7-H1 expression have a poor prognosis.,19724910_1,-1,-1,2,2,10542,-1,1.7937029e-05,1.2649232e-05,0.9999695
6247,cells,9,10,42,47,Activation and expansion of T helper (Th) cells followed by regulation of activation are essential to the generation of immune responses while limiting concomitant autoreactivity.,18156498_0,-1,-1,2,2,6247,-1,1.3891884e-05,9.664289e-06,0.9999764
32045,CD8+ T cell,1,5,10,21,Increased CD8+ T cell frequency and function is associated with better prognosis in cancer patients.,28488547_1,-1,-1,2,2,32045,-1,4.0931856e-05,6.2879717e-06,0.9999528
40367,cell,21,22,128,132,"In this study, we investigated the ability of SP-2577 to promote anti-tumor immunity and T-cell infiltration in SCCOHT and OCCC cell lines.",32649682_7,-1,-1,2,2,40367,-1,1.2277599e-05,6.428405e-06,0.9999813
